# RGD-PIPELINE: ftp-file-extracts
# MODULE: annotations-version-1.2.0 (Jul 27, 2026)
# GENERATED-ON: 2026/08/15
# PURPOSE: annotations about active Rat objects extracted from RGD database
# ONTOLOGY: ChEBI: ChEBI Ontology
# CONTACT: rgd.data@mcw.edu
# FORMAT: tab delimited text
# NOTES: multiple values in a single column are separated by '|'
#
# MIGRATION NOTE (July 2026): these files were previously located in the
#   'annotated_rgd_objects_by_ontology/with_terms' directory and named using the organism
#   genus (f.e. 'rattus_terms_go'). They are now located in the 'annotations/with_terms' directory,
#   named with the RGD species short name (f.e. 'rat_terms_go.txt.gz'), and gzip-compressed.
#
#COLUMN INFORMATION:
#
#1   RGD_ID	          unique RGD_ID of the annotated object
#2   OBJECT_SYMBOL      official symbol of the annotated object
#3   OBJECT_NAME        official name of the annotated object
#4   OBJECT_TYPE        annotated object data type: one of ['gene','qtl','strain']
#5   TERM_ACC_ID        ontology term accession id
#6   TERM_NAME          ontology term name
#7   QUALIFIER          optional qualifier
#8   EVIDENCE           evidence
#9   WITH               with info
#10  ASPECT             aspect
#11  REFERENCES         db references (Reference RGDID|PUBMED ID)
#12  CREATED_DATE       created date
#13  ASSIGNED_BY        assigned by
#14  MESH_OMIM_ID       MESH:xxx or OMIM:xxx id corresponding to RDO:xxx id found in TERM_ACC_ID column (RGD/CTD Disease Ontology annotations only)
#15  CURATION_NOTES     curation notes provided by RGD curators
#16  ORIGINAL_REFERENCE original reference
RGD_ID	OBJECT_SYMBOL	OBJECT_NAME	OBJECT_TYPE	TERM_ACC_ID	TERM_NAME	QUALIFIER	EVIDENCE	WITH	ASPECT	REFERENCES	CREATED_DATE	ASSIGNED_BY	MESH_OMIM_ID	CURATION_NOTES	ORIGINAL_REFERENCE
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:145535	pevonedistat	affects expression	ISO	RGD:1350378	E	RGD:6480464	20191203	CTD	MESH:C539933	pevonedistat affects the expression of MIR155HG mRNA	PMID:24634471
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1350378	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MIR155HG; Lipopolysaccharides results in increased expression of MIR155HG mRNA	PMID:35438468|PMID:35811015
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1350378	E	RGD:6480464	20221101	CTD	MESH:D008070	METTL14 protein affects the reaction [Lipopolysaccharides results in increased expression of MIR155HG]; MIR155HG promotes the reaction [Lipopolysaccharides results in increased expression of CD274 mRNA]; MIR155HG promotes the reaction [Lipopolysaccharides results in increased expression of CD274 protein]; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MIR155HG mRNA]	PMID:35438468|PMID:35811015
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1350378	E	RGD:6480464	20151215	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of BIC mRNA	PMID:20660070
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1350378	E	RGD:6480464	20151215	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of BIC mRNA	PMID:20660070
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:11040463	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIR155HG mRNA	PMID:37992649
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1350378	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of MIR155HG mRNA	PMID:33359661
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:11040463	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIR155HG mRNA	PMID:37992649
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1350378	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of MIR155HG mRNA	PMID:41430723
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1350378	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MIR155HG mRNA	PMID:23557933
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1350378	E	RGD:6480464	20151215	CTD	MESH:D009532	Nickel results in increased expression of MIR155HG mRNA	PMID:25583101
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1350378	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MIR155HG mRNA	PMID:33212167
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:11040463	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIR155HG mRNA	PMID:37992649
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:29678	sodium arsenite	increases stability	ISO	RGD:1350378	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased stability of MIR155HG mRNA	PMID:25493608
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:11040463	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA	PMID:34876320
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:11040463	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA	PMID:34876320
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1350378	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MIR155HG promoter	PMID:27901495
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1350378	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MIR155HG mRNA	PMID:38382870
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:11040463	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIR155HG mRNA	PMID:37992649
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1350378	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MIR155HG mRNA]	PMID:35811015
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:11040463	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA	PMID:34876320
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1350378	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of MIR155HG mRNA	PMID:22714537
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:11040463	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MIR155HG mRNA	PMID:38701926
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1350378	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MIR155HG mRNA	PMID:31758290
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:11040463	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MIR155HG mRNA	PMID:38648751
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1350378	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of MIR155HG mRNA	PMID:26705709
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:11040463	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of MIR155HG mRNA	PMID:39847705
10045371	Mir155hg	Mir155 host gene	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:11040463	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA	PMID:34876320
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1623164	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KANTR mRNA	PMID:25510870
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1623164	E	RGD:6480464	20151215	CTD	MESH:D014284	Triiodothyronine results in increased expression of KANTR mRNA	PMID:25172293
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1623164	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KANTR mRNA	PMID:25510870
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1623164	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KANTR mRNA	PMID:25510870
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1623164	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KANTR mRNA	PMID:25629700
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623164	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KANTR mRNA	PMID:22206623
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623164	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KANTR mRNA	PMID:40504410
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623164	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KANTR mRNA	PMID:40504410
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:7779000	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of KANTR mRNA	PMID:34973136
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1623164	E	RGD:6480464	20151215	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KANTR mRNA	PMID:25510870
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1623164	E	RGD:6480464	20151215	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KANTR mRNA	PMID:25510870
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623164	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of KANTR mRNA	PMID:40203079
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:7779000	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KANTR mRNA	PMID:37042841
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:7779000	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KANTR mRNA	PMID:38568856
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1623164	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of KANTR mRNA	PMID:28903501
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1623164	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of KANTR mRNA	PMID:28962523
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:7779000	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of KANTR mRNA	PMID:40419075
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623164	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KANTR mRNA	PMID:40504410
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623164	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KANTR mRNA	PMID:22206623
10045415	Kantr	KANTR integral membrane protein	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1623164	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of KANTR mRNA	PMID:30953684
10059728	Cahm	colon adenocarcinoma hypermethylated	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:6480342	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CAHM mRNA	PMID:25812627
10059728	Cahm	colon adenocarcinoma hypermethylated	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:6480342	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of CAHM mRNA	PMID:31614463
10059728	Cahm	colon adenocarcinoma hypermethylated	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:4889399	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of CAHM mRNA	PMID:39984025
10059728	Cahm	colon adenocarcinoma hypermethylated	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:6480342	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CAHM mRNA	PMID:30851411
10059728	Cahm	colon adenocarcinoma hypermethylated	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:6480342	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CAHM mRNA	PMID:25812627
10059728	Cahm	colon adenocarcinoma hypermethylated	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:6480342	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CAHM mRNA	PMID:25812627
10059728	Cahm	colon adenocarcinoma hypermethylated	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:6480342	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CAHM mRNA	PMID:31533062
10059728	Cahm	colon adenocarcinoma hypermethylated	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:6480342	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CAHM mRNA	PMID:26272509
10059728	Cahm	colon adenocarcinoma hypermethylated	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:6480342	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CAHM mRNA	PMID:30851411
10059728	Cahm	colon adenocarcinoma hypermethylated	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:6480342	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CAHM mRNA	PMID:29301935
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1318052	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of BAIAP3 mRNA	PMID:38218311
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1611478	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of BAIAP3 mRNA	PMID:33045310
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1318052	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of BAIAP3 mRNA	PMID:25812627
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1318052	E	RGD:6480464	20151208	CTD	MESH:C018475	butyraldehyde results in increased expression of BAIAP3 mRNA	PMID:26079696
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1611478	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of BAIAP3 mRNA	PMID:30319688
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of BAIAP3 mRNA	PMID:32145629
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1318052	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of BAIAP3 mRNA	PMID:38568856
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of BAIAP3 mRNA	PMID:33387578
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1318052	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BAIAP3 mRNA	PMID:37042841
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1318052	E	RGD:6480464	20151208	CTD	MESH:C005556	propionaldehyde results in increased expression of BAIAP3 mRNA	PMID:26079696
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1611478	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BAIAP3 mRNA	PMID:37992649
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1318052	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of BAIAP3 mRNA	PMID:33647349
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1611478	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BAIAP3 mRNA	PMID:37992649
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1611478	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of BAIAP3 mRNA	PMID:34319233
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1318052	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of BAIAP3 mRNA	PMID:28818685
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1318052	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of BAIAP3 mRNA	PMID:39836092
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1318052	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of BAIAP3 intron	PMID:30157460
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1611478	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BAIAP3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of BAIAP3 mRNA	PMID:34911549
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of BAIAP3 mRNA	PMID:30779732
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of BAIAP3 mRNA	PMID:38314887
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1611478	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of BAIAP3 mRNA	PMID:28960355
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1318052	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of BAIAP3 mRNA	PMID:28903495
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1318052	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of BAIAP3 mRNA	PMID:27392435
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1611478	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of BAIAP3 mRNA	PMID:32186404
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1611478	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BAIAP3 mRNA	PMID:26377647
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1318052	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of BAIAP3 mRNA	PMID:33212167
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1318052	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of BAIAP3 mRNA	PMID:32763439
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1611478	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BAIAP3 mRNA	PMID:37992649
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1318052	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of BAIAP3 mRNA	PMID:34032870
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1318052	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BAIAP3 exon; Benzo(a)pyrene results in increased methylation of BAIAP3 promoter	PMID:27901495
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1318052	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of BAIAP3 mRNA	PMID:25895662
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1611478	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of BAIAP3 mRNA	PMID:29341224
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1611478	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BAIAP3 gene	PMID:35295148
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of BAIAP3 mRNA	PMID:34492290
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20151208	CTD	MESH:C006780	bisphenol A results in decreased expression of BAIAP3 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1318052	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of BAIAP3 gene	PMID:31601247
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BAIAP3 mRNA	PMID:36041667
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1318052	E	RGD:6480464	20151208	CTD	MESH:D002330	Carmustine results in decreased expression of BAIAP3 mRNA	PMID:15980968
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BAIAP3 mRNA	PMID:36041667
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1611478	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of BAIAP3 mRNA	PMID:38685157
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BAIAP3 mRNA	PMID:36041667
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1318052	E	RGD:6480464	20151208	CTD	MESH:D003976	Diazinon results in increased methylation of BAIAP3 gene	PMID:22964155
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1318052	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BAIAP3 mRNA	PMID:37042841
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1318052	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of BAIAP3 mRNA	PMID:39836092
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1611478	E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride affects the expression of BAIAP3 mRNA	PMID:29408670
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1318052	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of BAIAP3 mRNA	PMID:25812627
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1318052	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of BAIAP3 mRNA	PMID:25812627
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1611478	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of BAIAP3 mRNA	PMID:40194260
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1318052	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of BAIAP3 mRNA	PMID:25812627
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1318052	E	RGD:6480464	20151208	CTD	MESH:D014635	Valproic Acid affects the expression of BAIAP3 mRNA	PMID:25979313
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1318052	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of BAIAP3 gene	PMID:29154799
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1611478	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of BAIAP3 mRNA	PMID:28973697
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1611478	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BAIAP3 mRNA	PMID:37992649
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1318052	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of BAIAP3 mRNA	PMID:38832940
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1318052	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of BAIAP3 mRNA	PMID:28542535
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1318052	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of BAIAP3 mRNA	PMID:39836092
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1318052	E	RGD:6480464	20151208	CTD	MESH:D008694	Methamphetamine results in increased expression of BAIAP3 mRNA	PMID:25290377
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1318052	E	RGD:6480464	20151208	CTD	MESH:C046012	pentanal results in increased expression of BAIAP3 mRNA	PMID:26079696
10059729	Baiap3	BAI1-associated protein 3	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1611478	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of BAIAP3 mRNA	PMID:32835833
10398753	Crnde	colorectal neoplasia differentially expressed	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20250325	CTD	MESH:D004237	Diuron results in decreased expression of CRNDE mRNA	PMID:21551480
10398753	Crnde	colorectal neoplasia differentially expressed	gene	CHEBI:6015	isoflurane	increases expression	EXP		E	RGD:6480464	20250325	CTD	MESH:D007530	Isoflurane results in increased expression of CRNDE mRNA	PMID:36263453
10398753	Crnde	colorectal neoplasia differentially expressed	gene	CHEBI:6015	isoflurane	multiple interactions	EXP		E	RGD:6480464	20250325	CTD	MESH:D007530	CRNDE affects the reaction [Isoflurane results in decreased expression of MIR212 mRNA]; CRNDE affects the reaction [Isoflurane results in increased expression of IL1B protein]; CRNDE affects the reaction [Isoflurane results in increased expression of IL6 protein]; CRNDE affects the reaction [Isoflurane results in increased expression of TNF protein]	PMID:36263453
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:2304161	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MIRLET7BHG mRNA	PMID:38218311
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:2304161	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of MIRLET7BHG mRNA	PMID:25812627
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:9999811	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of LNCPPARA mRNA	PMID:36706583
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:9999811	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LNCPPARA mRNA	PMID:36331819
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:9999811	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of LNCPPARA mRNA	PMID:39984025
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:2304161	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MIRLET7BHG mRNA	PMID:27392435
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:2304161	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MIRLET7BHG mRNA	PMID:32763439
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:2304161	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MIRLET7BHG mRNA	PMID:38568856
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:2304161	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MIRLET7BHG promoter	PMID:27901495
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:2304161	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MIRLET7BHG gene	PMID:31601247
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2304161	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MIRLET7BHG gene	PMID:31601247
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:9999811	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of LNCPPARA mRNA	PMID:40203079
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:2304161	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of MIRLET7BHG gene	PMID:31601247
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:2304161	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MIRLET7BHG mRNA	PMID:25812627
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:2304161	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MIRLET7BHG mRNA	PMID:24449571
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:2304161	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MIRLET7BHG mRNA	PMID:25812627
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:9999811	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LNCPPARA mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of LNCPPARA mRNA	PMID:36331819
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:2304161	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MIRLET7BHG gene	PMID:29154799
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:46661	asbestos	affects response to substance	ISO	RGD:2304161	E	RGD:6480464	20161115	CTD	MESH:D001194	MIRLET7BHG gene SNP affects the susceptibility to Asbestos	PMID:26199339
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:9999811	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of LNCPPARA mRNA	PMID:36706583
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:2304161	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MIRLET7BHG mRNA	PMID:38568856
10398754	Mirlet7bhg	Mirlet7b host gene	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:9999811	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of LNCPPARA mRNA	PMID:35537566
10401149	Mtln	mitoregulin	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:2292400	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MTLN mRNA	PMID:37995155
10401149	Mtln	mitoregulin	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:2292400	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of MTLN mRNA	PMID:40945087
10401149	Mtln	mitoregulin	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:2292400	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MTLN mRNA	PMID:39241906
10401149	Mtln	mitoregulin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:2303856	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MTLN mRNA	PMID:37042841
10401149	Mtln	mitoregulin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:2292400	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MTLN mRNA	PMID:37992649
10401149	Mtln	mitoregulin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:2292400	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MTLN mRNA	PMID:37992649
10401149	Mtln	mitoregulin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:2292400	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTLN mRNA	PMID:22206623
10401149	Mtln	mitoregulin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:2292400	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MTLN mRNA	PMID:40504410
10401149	Mtln	mitoregulin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:2303856	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MTLN mRNA	PMID:29803840
10401149	Mtln	mitoregulin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:2292400	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MTLN mRNA	PMID:37992649
10401149	Mtln	mitoregulin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:2303856	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MTLN mRNA	PMID:38568856
10401149	Mtln	mitoregulin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:2303856	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of MTLN mRNA	PMID:34032870
10401149	Mtln	mitoregulin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:2292400	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MTLN mRNA	PMID:40504410
10401149	Mtln	mitoregulin	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:2303856	E	RGD:6480464	20241105	CTD	MESH:D001564	[AHR gene mutant form affects the susceptibility to Benzo(a)pyrene] which results in decreased expression of MTLN mRNA	PMID:38036013
10401149	Mtln	mitoregulin	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:2303856	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MTLN gene	PMID:31601247
10401149	Mtln	mitoregulin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2292400	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of MTLN mRNA	PMID:30245210|PMID:35598803
10401149	Mtln	mitoregulin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2292400	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MTLN mRNA	PMID:32156529|PMID:38074096
10401149	Mtln	mitoregulin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2303856	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MTLN gene	PMID:31601247
10401149	Mtln	mitoregulin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:2292400	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MTLN mRNA	PMID:40203079
10401149	Mtln	mitoregulin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:2292400	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MTLN mRNA	PMID:39298647|PMID:40203079
10401149	Mtln	mitoregulin	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:2292400	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MTLN mRNA	PMID:38685157
10401149	Mtln	mitoregulin	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:2292400	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MTLN mRNA	PMID:34813904
10401149	Mtln	mitoregulin	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:2303856	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of MTLN mRNA	PMID:29024780
10401149	Mtln	mitoregulin	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:2303856	E	RGD:6480464	20151215	CTD	MESH:D014635	Valproic Acid results in decreased expression of MTLN mRNA	PMID:23179753
10401149	Mtln	mitoregulin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:2292400	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MTLN mRNA	PMID:37992649
10401149	Mtln	mitoregulin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:2292400	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MTLN mRNA	PMID:40504410
10401149	Mtln	mitoregulin	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:2292400	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MTLN mRNA	PMID:35436446
10401149	Mtln	mitoregulin	gene	CHEBI:5063	fipronil	multiple interactions	ISO	RGD:2303856	E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in increased expression of MTLN mRNA	PMID:28991164
10401149	Mtln	mitoregulin	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:2303856	E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in increased expression of MTLN mRNA	PMID:28991164
10401149	Mtln	mitoregulin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:2292400	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTLN mRNA	PMID:22206623
10401149	Mtln	mitoregulin	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:2303856	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MTLN mRNA	PMID:38568856
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:16130	DDT	increases expression	ISO	RGD:5490463	E	RGD:6480464	20151215	CTD	MESH:D003634	DDT results in increased expression of CARMN mRNA	PMID:25014179
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:5490463	E	RGD:6480464	20151215	CTD	MESH:C005556	propionaldehyde results in decreased expression of CARMN mRNA	PMID:26079696
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:5490463	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CARMN gene	PMID:27153756
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:5490463	E	RGD:6480464	20151215	CTD	MESH:D009532	Nickel results in decreased expression of CARMN mRNA	PMID:24768652|PMID:25583101
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:5490463	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of CARMN mRNA	PMID:29301061
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:29678	sodium arsenite	increases stability	ISO	RGD:5490463	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased stability of CARMN mRNA	PMID:25493608
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:5490463	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CARMN promoter	PMID:27901495
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:7181169	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CARMN promoter	PMID:27901495
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:7181169	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of CARMN mRNA	PMID:30245210
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:5490463	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CARMN gene	PMID:31601247
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:7181169	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CARMN mRNA	PMID:38685157
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:5490463	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CARMN mRNA	PMID:24449571
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:7181169	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of CARMN mRNA	PMID:29038090
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:5490463	E	RGD:6480464	20160607	CTD	MESH:D014635	Valproic Acid results in increased expression of CARMN mRNA	PMID:26705709
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:5490463	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CARMN gene	PMID:29154799
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:5490463	E	RGD:6480464	20160210	CTD	MESH:C012589	trichostatin A results in increased expression of CARMN mRNA	PMID:26705709
10401674	Carmn	cardiac mesoderm enhancer-associated non-coding RNA	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:5490463	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of CARMN mRNA	PMID:30458266
11052049	Igkv8-30l1	immunoglobulin kappa chain variable 8-30 like 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1346817	E	RGD:6480464	20180417	CTD	MESH:D005557	Formaldehyde results in decreased expression of IGKV4-1 mRNA	PMID:23649840
11052049	Igkv8-30l1	immunoglobulin kappa chain variable 8-30 like 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1346817	E	RGD:6480464	20180417	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of IGKV4-1 mRNA	PMID:23649840
11052049	Igkv8-30l1	immunoglobulin kappa chain variable 8-30 like 1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1346817	E	RGD:6480464	20180417	CTD	MESH:D014750	Vincristine results in decreased expression of IGKV4-1 mRNA	PMID:23649840
11052049	Igkv8-30l1	immunoglobulin kappa chain variable 8-30 like 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:11266467	E	RGD:6480464	20220913	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IGKV8-27 mRNA	PMID:29341224
11052049	Igkv8-30l1	immunoglobulin kappa chain variable 8-30 like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1346817	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of IGKV4-1 protein	PMID:31675489
11052049	Igkv8-30l1	immunoglobulin kappa chain variable 8-30 like 1	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1346817	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of IGKV4-1 mRNA	PMID:31675489
11052049	Igkv8-30l1	immunoglobulin kappa chain variable 8-30 like 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:11266467	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of IGKV8-27 mRNA	PMID:35964746
11052049	Igkv8-30l1	immunoglobulin kappa chain variable 8-30 like 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1346817	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IGKV4-1 protein	PMID:31675489
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:17356	2-acetamidofluorene	multiple interactions	EXP		E	RGD:6480464	20260811	CTD	MESH:D015073	[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of SPG7 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of SPG7 mRNA	PMID:14656948|PMID:16158176
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D005839	Gentamicins results in increased expression of SPG7 mRNA	PMID:33387578
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of SPG7 protein	PMID:34915118
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20260811	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of SPG7 gene	PMID:28505145
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPG7 mRNA	PMID:33387578|PMID:34747641
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D012402	Rotenone results in increased expression of SPG7 protein	PMID:35544339
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in decreased expression of SPG7 mRNA	PMID:30816183
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20260811	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of SPG7 gene	PMID:28505145
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20260811	CTD	MESH:D004052	[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of SPG7 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of SPG7 mRNA	PMID:14656948|PMID:16158176
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20260811	CTD	MESH:C039281	furan results in increased methylation of SPG7 gene	PMID:22079235
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D014303	Trinitrotoluene affects the expression of SPG7 mRNA	PMID:21346803
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D000082	Acetaminophen results in increased expression of SPG7 mRNA	PMID:33387578
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C082360	fipronil results in increased expression of SPG7 mRNA	PMID:31881178
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20260811	CTD	MESH:D008731	Methoxychlor affects the methylation of SPG7 gene	PMID:35440735
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SPG7 mRNA	PMID:21346803
11081189	Nup50-ps1	nucleoporin 50, pseudogene 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SPG7 mRNA	PMID:21346803
11081208	Da2-19	uncharacterized LOC302729	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DA2-19 mRNA	PMID:33387578
11081208	Da2-19	uncharacterized LOC302729	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DA2-19 mRNA	PMID:33387578
11081208	Da2-19	uncharacterized LOC302729	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of DA2-19 mRNA	PMID:28959563
11081208	Da2-19	uncharacterized LOC302729	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DA2-19 mRNA	PMID:35163327
11081208	Da2-19	uncharacterized LOC302729	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DA2-19 mRNA	PMID:35163327
11081208	Da2-19	uncharacterized LOC302729	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DA2-19 mRNA	PMID:21346803
11081208	Da2-19	uncharacterized LOC302729	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DA2-19 mRNA	PMID:21346803
11359066	Cnot6l2	CCR4-NOT transcription complex, subunit 6 like 2	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of CNOT6L2 mRNA	PMID:38314887
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:7247411	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of INAFM2 mRNA	PMID:30510588
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:7247411	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of INAFM2 mRNA	PMID:37042841
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:7247411	E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of INAFM2 mRNA	PMID:29993192
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1609984	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INAFM2 mRNA	PMID:37236586
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1609984	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INAFM2 mRNA	PMID:40504410
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:7247411	E	RGD:6480464	20160906	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of INAFM2 mRNA	PMID:26272509
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:7247411	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA	PMID:27188386
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:7247411	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of INAFM2 mRNA	PMID:30851411
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:7247411	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of INAFM2 mRNA	PMID:29803840
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1609984	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INAFM2 mRNA	PMID:40504410
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1609984	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of INAFM2 mRNA	PMID:27195522
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:7247411	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of INAFM2 mRNA	PMID:27685785
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1609984	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of INAFM2 gene	PMID:31683443
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1609984	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of INAFM2 mRNA	PMID:40203079
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1609984	E	RGD:6480464	20160906	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of INAFM2 mRNA	PMID:26377693
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1609984	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of INAFM2 mRNA	PMID:34813904
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1609984	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of INAFM2 mRNA	PMID:34813904
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:7247411	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of INAFM2 mRNA	PMID:37042841
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1609984	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INAFM2 mRNA	PMID:37236586
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:7247411	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of INAFM2 mRNA	PMID:24449571
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:7247411	E	RGD:6480464	20160906	CTD	MESH:D014635	Valproic Acid affects the expression of INAFM2 mRNA	PMID:25979313
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:7247411	E	RGD:6480464	20160906	CTD	MESH:D014635	Valproic Acid results in increased expression of INAFM2 mRNA	PMID:26272509|PMID:29154799
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:7247411	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA	PMID:27188386
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:7247411	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of INAFM2 mRNA	PMID:38832940
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:7247411	E	RGD:6480464	20160906	CTD	MESH:C012589	trichostatin A results in increased expression of INAFM2 mRNA	PMID:26272509
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1609984	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INAFM2 mRNA	PMID:40504410
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1609984	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of INAFM2 mRNA	PMID:40234311
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1609984	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of INAFM2 mRNA	PMID:35964746
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1609984	E	RGD:6480464	20160906	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of INAFM2 mRNA	PMID:26377693
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1609984	E	RGD:6480464	20160906	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of INAFM2 mRNA	PMID:25566086
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:7247411	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of INAFM2 mRNA	PMID:30851411
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:7247411	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA	PMID:27188386
11361547	Inafm2	InaF motif containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:7247411	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA	PMID:27188386
11362385	Mindy4b	MINDY family member 4B	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:2306135	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of MINDY4B promoter	PMID:30157460
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:11284073	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA	PMID:37567420
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:11284073	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA	PMID:37567420
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:11284073	E	RGD:6480464	20210803	CTD	MESH:D019833	Genistein results in increased expression of IGKV1-133 mRNA	PMID:32186404
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:11284073	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA	PMID:37567420
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:11284073	E	RGD:6480464	20231031	CTD	MESH:D015084	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA	PMID:37567420
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:11284073	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA	PMID:34876320
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:11284073	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA	PMID:34876320
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:11284073	E	RGD:6480464	20210803	CTD	MESH:C009495	titanium dioxide results in increased expression of IGKV1-133 mRNA	PMID:23557971
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:11284073	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA	PMID:37567420
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:11284073	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA	PMID:34876320
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:11284073	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of IGKV1-133 protein	PMID:35926579
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:11284073	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA	PMID:37567420
11362919	Igkvl-ps13	immunoglobulin kappa variable like, pseudogene 13	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:11284073	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA	PMID:34876320
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:C084079	triptonide results in increased expression of ZFP568 mRNA	PMID:33045310
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1617313	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ZFP568 mRNA	PMID:37995155
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ZFP568 mRNA	PMID:26251327
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of ZFP568 promoter	PMID:26251327
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1617313	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFP568 mRNA	PMID:36331819
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1617313	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP568 mRNA	PMID:36331819
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of ZFP568 gene	PMID:15755804
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZFP568 mRNA	PMID:19770486
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ZFP568 mRNA	PMID:34911549
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZFP568 mRNA	PMID:31919559
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D005492	Folic Acid results in decreased expression of ZFP568 mRNA	PMID:25629700
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1617313	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of ZFP568 mRNA	PMID:40618947
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D014414	Tungsten results in decreased expression of ZFP568 mRNA	PMID:30912803
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP568 mRNA	PMID:21570461
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP568 mRNA	PMID:19770486
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZFP568 mRNA	PMID:19770486
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230110	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP568 mRNA	PMID:25181051
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1617313	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ZFP568 mRNA	PMID:39298647
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617313	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP568 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFP568 mRNA	PMID:36331819
11363847	Zfp568	zinc finger protein 568	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1617313	E	RGD:6480464	20230110	CTD	MESH:D014635	Valproic Acid affects the expression of ZFP568 mRNA	PMID:17963808
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C118739	entinostat results in decreased expression of PCDHB7 mRNA	PMID:26272509
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA	PMID:27188386
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314072	E	RGD:6480464	20230126	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB7 mRNA	PMID:20938992
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20230126	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDHB7 mRNA	PMID:33387578
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314072	E	RGD:6480464	20230126	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB7 mRNA	PMID:20938992
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20230126	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of PCDHB7 mRNA	PMID:26496021
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHB7 gene	PMID:27153756
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314072	E	RGD:6480464	20230126	CTD	MESH:D005492	Folic Acid results in decreased expression of PCDHB7 mRNA	PMID:25629700
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314072	E	RGD:6480464	20230126	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB7 mRNA	PMID:20938992
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314072	E	RGD:6480464	20230126	CTD	MESH:C024565	ethylene dichloride results in increased expression of PCDHB7 mRNA	PMID:28960355
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDHB7 mRNA	PMID:20106945
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDHB7 mRNA	PMID:27188386
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDHB7 exon; Benzo(a)pyrene affects the methylation of PCDHB7 promoter	PMID:27901495
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C015001	arsenite results in increased methylation of PCDHB7 promoter	PMID:23974009
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1314071	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of PCDHB7 mRNA	PMID:37690743
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PCDHB7 gene	PMID:31601247
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230126	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDHB7 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C006780	bisphenol A results in increased methylation of PCDHB7 gene	PMID:31601247
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230126	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of PCDHB7 mRNA	PMID:26496021
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PCDHB7 gene	PMID:31601247
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PCDHB7 mRNA	PMID:35163327
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314072	E	RGD:6480464	20230126	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PCDHB7 mRNA	PMID:26377693
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PCDHB7 mRNA	PMID:35163327
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C473478	Sunitinib results in decreased expression of PCDHB7 mRNA	PMID:31533062
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:D014635	Valproic Acid affects the expression of PCDHB7 mRNA	PMID:25979313
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDHB7 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PCDHB7 gene	PMID:29154799
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA	PMID:27188386
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCDHB7 mRNA	PMID:20106945
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C012589	trichostatin A results in decreased expression of PCDHB7 mRNA	PMID:26272509
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA	PMID:27188386
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1314072	E	RGD:6480464	20230126	CTD	MESH:C016766	sulforaphane results in decreased expression of PCDHB7 mRNA	PMID:30529165
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20230126	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of PCDHB7 mRNA	PMID:27840820
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1314071	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of PCDHB7 mRNA	PMID:29522793
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDHB7 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA	PMID:27188386
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:82527	Ptaquiloside	decreases expression	ISO	RGD:1314072	E	RGD:6480464	20230126	CTD	MESH:C043680	ptaquiloside results in decreased expression of PCDHB7 mRNA	PMID:23274088
11368541	Pcdhb15	protocadherin beta 15	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314071	E	RGD:6480464	20230126	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDHB7 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA	PMID:27188386
11370628	Gapdh-ps24	Glyceraldehyde-3-phosphate dehydrogenase, pseudogene 24	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of GAPDH-PS24 mRNA	PMID:38314887
11371108	Speer4cl6	spermatogenesis associated glutamate (E)-rich protein 4C like 6	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in increased expression of SPEER4CL6 mRNA	PMID:38314887
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1611476	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CCDC194 mRNA	PMID:33045310
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:13208416	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CCDC194 mRNA	PMID:35811015
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:13208416	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CCDC194 mRNA	PMID:35811015
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:13208416	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of CCDC194 mRNA	PMID:33647349
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1611476	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CCDC194 mRNA	PMID:35716406
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1611476	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of CCDC194 mRNA	PMID:39984025
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:13208416	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CCDC194 mRNA	PMID:33212167
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:13208416	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CCDC194 mRNA	PMID:38568856
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1611476	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of CCDC194 mRNA	PMID:37682722
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:13208416	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of CCDC194 mRNA	PMID:37690743
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of CCDC194 mRNA	PMID:41034487
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:13208416	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCDC194 mRNA	PMID:37042841
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1611476	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of CCDC194 mRNA	PMID:39529242
11373735	Ccdc194	coiled-coil domain containing 194	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:13208416	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CCDC194 mRNA	PMID:35811015
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1321102	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PCDHB6 mRNA	PMID:26272509
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1321102	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB6 mRNA	PMID:27188386
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1321102	E	RGD:6480464	20161018	CTD	MESH:C018475	butyraldehyde results in increased expression of PCDHB6 mRNA	PMID:26079696
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:16494	lipoic acid	multiple interactions	ISO	RGD:1321103	E	RGD:6480464	20161018	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of PCDHB6 mRNA]	PMID:23608068
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDHB11 mRNA	PMID:33387578
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1321102	E	RGD:6480464	20161018	CTD	MESH:C005556	propionaldehyde results in increased expression of PCDHB6 mRNA	PMID:26079696
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1321103	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PCDHB13 mRNA	PMID:34319233
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1321102	E	RGD:6480464	20161018	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PCDHB6 protein	PMID:20106945
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1321103	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PCDHB6 mRNA	PMID:25629700
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1321102	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PCDHB6 mRNA	PMID:38460933
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1321102	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of PCDHB6 mRNA	PMID:41028656
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1321102	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PCDHB6 mRNA	PMID:27392435
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1321102	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PCDHB6 mRNA	PMID:27392435
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1321102	E	RGD:6480464	20161018	CTD	MESH:D019833	Genistein results in increased expression of PCDHB6 mRNA	PMID:20884965
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDHB11 mRNA	PMID:33387578
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D020106	Acrylamide results in decreased expression of PCDHB11 mRNA	PMID:28959563
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1321102	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of PCDHB6 mRNA	PMID:41028656
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1321102	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDHB6 exon; Benzo(a)pyrene affects the methylation of PCDHB6 promoter	PMID:27901495
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1321102	E	RGD:6480464	20161018	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of PCDHB6 gene	PMID:25435355
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1321103	E	RGD:6480464	20161018	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to PCDHB6 promoter]	PMID:19654925
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1321102	E	RGD:6480464	20161018	CTD	MESH:C015001	arsenite results in increased methylation of PCDHB6 promoter	PMID:23974009
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1321102	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of PCDHB6 mRNA	PMID:41028656
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	ISO	RGD:1321103	E	RGD:6480464	20161018	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of PCDHB6 mRNA]	PMID:23608068
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1321102	E	RGD:6480464	20161018	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PCDHB6 mRNA	PMID:25895662
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161018	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDHB11 mRNA; bisphenol A results in decreased expression of PCDHB6 mRNA	PMID:25181051|PMID:41034487
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PCDHB6 mRNA	PMID:34947998
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20161018	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PCDHB6 mRNA	PMID:21266533
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1321102	E	RGD:6480464	20161018	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PCDHB6 mRNA	PMID:26472689
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1321102	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PCDHB6 mRNA	PMID:31533062
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1321102	E	RGD:6480464	20161018	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDHB6 mRNA	PMID:24383497
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1321102	E	RGD:6480464	20161018	CTD	MESH:D016572	Cyclosporine results in increased expression of PCDHB6 mRNA	PMID:20106945
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1321102	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PCDHB6 mRNA	PMID:27188386
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1321102	E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in decreased expression of PCDHB6 mRNA	PMID:27188386
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCDHB11 mRNA	PMID:30723492|PMID:33387578
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1321102	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PCDHB6 mRNA	PMID:38460933
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1321103	E	RGD:6480464	20161018	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of PCDHB6 mRNA	PMID:23608068
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1321103	E	RGD:6480464	20161018	CTD	MESH:D011192	Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of PCDHB6 mRNA]	PMID:23608068
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1321102	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PCDHB6 mRNA	PMID:37199045
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1321102	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB6 mRNA	PMID:27188386
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1321102	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDHB6 gene]	PMID:28238834
11376545	Pcdhb13	protocadherin beta 13	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1321102	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB6 mRNA	PMID:27188386
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1316561	E	RGD:6480464	20160906	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RTL1 mRNA	PMID:20188158
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1316561	E	RGD:6480464	20160906	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of RTL1 mRNA; Diethylhexyl Phthalate affects the expression of RTL1 mRNA alternative form	PMID:21636974
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:2208	purine-6-thiol	decreases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:D015122	Mercaptopurine results in decreased expression of RTL1 mRNA	PMID:23358152
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1316561	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of RTL1 mRNA	PMID:40618947
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602404	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RTL1 promoter	PMID:27901495
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1316561	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RTL1 mRNA	PMID:27195522
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	ISO	RGD:1602404	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of RTL1 mRNA	PMID:25075043
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1602404	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of RTL1 mRNA	PMID:37690743
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1316561	E	RGD:6480464	20160906	CTD	MESH:C006780	bisphenol A affects the expression of RTL1 mRNA; bisphenol A affects the expression of RTL1 mRNA alternative form	PMID:21636974
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:C006780	bisphenol A results in decreased expression of RTL1 mRNA	PMID:25181051|PMID:41034487
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1316561	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RTL1 promoter	PMID:27312807
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1316561	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RTL1 mRNA	PMID:37019170
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of RTL1 mRNA	PMID:32680482
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602404	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RTL1 gene	PMID:29154799
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:50035	alpha-phellandrene	decreases expression	ISO	RGD:1602404	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of RTL1 mRNA	PMID:25075043
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:50667	mercaptopurine	decreases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:D015122	Mercaptopurine results in decreased expression of RTL1 mRNA	PMID:23358152
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1316561	E	RGD:6480464	20160906	CTD	MESH:D010634	Phenobarbital results in increased expression of RTL1 mRNA; Phenobarbital results in increased expression of RTL1 mRNA alternative form	PMID:23091169|PMID:28541575
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1602404	E	RGD:6480464	20190219	CTD	MESH:D010634	Phenobarbital results in increased expression of RTL1 mRNA alternative form	PMID:28541575
11378340	Rtl1	retrotransposon-like 1	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of RTL1 mRNA	PMID:23358152
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1605603	E	RGD:6480464	20230725	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CEACAM21 mRNA	PMID:35811015
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605603	E	RGD:6480464	20230725	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEACAM21 mRNA	PMID:35811015
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230725	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of CEACAM15 mRNA	PMID:26496021
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605603	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CEACAM21 mRNA	PMID:37042841
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1623866	E	RGD:6480464	20230725	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEACAM15 mRNA	PMID:27106289
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:2682	amphotericin B	increases expression	ISO	RGD:1605603	E	RGD:6480464	20230725	CTD	MESH:D000666	Amphotericin B analog results in increased expression of CEACAM21 mRNA	PMID:28534445
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605603	E	RGD:6480464	20230725	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CEACAM21 5' UTR	PMID:27901495
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:29866	arsenite(3-)	affects expression	ISO	RGD:1605603	E	RGD:6480464	20230725	CTD	MESH:C015001	arsenite affects the expression of CEACAM21 mRNA	PMID:22959463
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1605603	E	RGD:6480464	20230725	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CEACAM21 mRNA	PMID:19710929
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230725	CTD	MESH:C006780	bisphenol A results in decreased expression of CEACAM15 mRNA	PMID:25181051
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230725	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of CEACAM15 mRNA	PMID:26496021
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605603	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEACAM21 mRNA	PMID:37042841
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1605603	E	RGD:6480464	20230725	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CEACAM21 mRNA	PMID:36326898
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1605603	E	RGD:6480464	20230725	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CEACAM21 mRNA	PMID:24449571
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1605603	E	RGD:6480464	20230725	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEACAM21 mRNA	PMID:35811015
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605603	E	RGD:6480464	20230725	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CEACAM21 gene]	PMID:28238834
11382285	Ceacam15	CEA cell adhesion molecule 15	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1605603	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CEACAM21 mRNA	PMID:29301935
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1618244	E	RGD:6480464	20170210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of VPS37C mRNA	PMID:20188158
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605989	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of VPS37C mRNA	PMID:33167477
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1605989	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of VPS37C protein	PMID:39571964
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1618244	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VPS37C mRNA	PMID:39241906
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1618244	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of VPS37C mRNA	PMID:39298647
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1605989	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of VPS37C 5' UTR	PMID:33872906
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1605989	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of VPS37C 5' UTR	PMID:33872906
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605989	E	RGD:6480464	20170210	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VPS37C mRNA	PMID:19549813
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of VPS37C protein	PMID:33236894
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605989	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of VPS37C 3' UTR	PMID:30157460
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605989	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of VPS37C mRNA	PMID:35430440
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of VPS37C mRNA	PMID:31150632
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1618244	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of VPS37C mRNA	PMID:31919559
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605989	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of VPS37C mRNA	PMID:23557933
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VPS37C mRNA	PMID:22298810
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618244	E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VPS37C mRNA	PMID:21570461
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1618244	E	RGD:6480464	20170210	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VPS37C mRNA	PMID:25975270
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605989	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VPS37C mRNA	PMID:29803840
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605989	E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of VPS37C protein	PMID:39571964
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605989	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of VPS37C 5' UTR	PMID:27901495
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1618244	E	RGD:6480464	20170210	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of VPS37C mRNA]	PMID:22228805
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1618244	E	RGD:6480464	20170210	CTD	MESH:D012822	Silicon Dioxide results in increased expression of VPS37C mRNA	PMID:23221170
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1618244	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VPS37C gene	PMID:35295148
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of VPS37C mRNA	PMID:34492290
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1618244	E	RGD:6480464	20170210	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of VPS37C mRNA	PMID:18648102
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1605989	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of VPS37C gene	PMID:31601247
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A results in increased expression of VPS37C mRNA	PMID:25181051
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1605989	E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A results in increased expression of VPS37C mRNA	PMID:25047013
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1618244	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of VPS37C exon	PMID:33297965
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605989	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VPS37C mRNA	PMID:37042841
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20170210	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of VPS37C promoter	PMID:22457795
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20170210	CTD	MESH:C039281	furan results in increased methylation of VPS37C gene	PMID:22079235
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605989	E	RGD:6480464	20170210	CTD	MESH:D014635	Valproic Acid affects the expression of VPS37C mRNA	PMID:25979313
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1618244	E	RGD:6480464	20170210	CTD	MESH:D014635	Valproic Acid affects the expression of VPS37C mRNA	PMID:17292431
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605989	E	RGD:6480464	20170210	CTD	MESH:D016572	Cyclosporine results in increased expression of VPS37C mRNA	PMID:20106945|PMID:25562108
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1618244	E	RGD:6480464	20170210	CTD	MESH:D000082	Acetaminophen affects the expression of VPS37C mRNA	PMID:17562736
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1618244	E	RGD:6480464	20170210	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of VPS37C mRNA	PMID:25554681
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of VPS37C gene	PMID:35440735
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1618244	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VPS37C mRNA	PMID:22206623
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of VPS37C mRNA	PMID:33484710
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605989	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to VPS37C gene]	PMID:28238834
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1618244	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of VPS37C mRNA	PMID:30953684
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1618244	E	RGD:6480464	20170210	CTD	MESH:C045950	propiconazole results in increased expression of VPS37C mRNA	PMID:21278054
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605989	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of VPS37C mRNA	PMID:38568856
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1605989	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of VPS37C mRNA	PMID:29301935
11384366	Vps37c	VPS37C subunit of ESCRT-I	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C025643	vinclozolin results in decreased expression of VPS37C mRNA	PMID:23034163
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:C118739	entinostat results in increased expression of SMIM43 mRNA	PMID:26272509
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM43 mRNA	PMID:27188386
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:D004958	Estradiol affects the expression of SMIM43 mRNA	PMID:22574217
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:5136450	E	RGD:6480464	20210202	CTD	MESH:D019833	Genistein results in decreased expression of SMIM43 mRNA	PMID:32186404
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SMIM43 mRNA	PMID:28001369
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMEM155 promoter	PMID:27901495
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM155 exon	PMID:27901495
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of SMIM43 mRNA	PMID:20382639
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604239	E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in decreased expression of SMIM43 mRNA	PMID:33476716
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:5136450	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMIM43 mRNA	PMID:37019170
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:D014635	Valproic Acid affects the expression of SMIM43 mRNA	PMID:25979313
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SMIM43 gene	PMID:29154799
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:D014635	Valproic Acid results in increased expression of SMIM43 mRNA	PMID:28001369
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:C012589	trichostatin A results in increased expression of SMIM43 mRNA	PMID:24935251
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:4953	exemestane	increases expression	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:C056516	exemestane results in increased expression of SMIM43 mRNA	PMID:17254854
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM43 mRNA	PMID:27188386
11384727	Smim43	small integral membrane protein 43	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604239	E	RGD:6480464	20210202	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM43 mRNA	PMID:27188386
11394442	Vom1r113	vomeronasal 1 receptor 113	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A results in decreased expression of VMN1R83 mRNA	PMID:25181051
11394442	Vom1r113	vomeronasal 1 receptor 113	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550904	E	RGD:6480464	20230801	CTD	MESH:D014635	Valproic Acid affects the expression of VMN1R83 mRNA	PMID:17963808
11394460	Znf660	zinc finger protein 660	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346042	E	RGD:6480464	20160906	CTD	MESH:D014212	Tretinoin results in decreased expression of ZNF660 mRNA	PMID:21934132|PMID:33167477
11394460	Znf660	zinc finger protein 660	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1346042	E	RGD:6480464	20160906	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ZNF660 mRNA	PMID:24236059
11394460	Znf660	zinc finger protein 660	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1618544	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP660 mRNA	PMID:39241906
11394460	Znf660	zinc finger protein 660	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1346042	E	RGD:6480464	20160906	CTD	MESH:D001151	Arsenic affects the methylation of ZNF660 gene	PMID:25304211
11394460	Znf660	zinc finger protein 660	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1346042	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ZNF660 mRNA	PMID:28903495
11394460	Znf660	zinc finger protein 660	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZNF660 mRNA	PMID:32109520
11394460	Znf660	zinc finger protein 660	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346042	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF660 mRNA	PMID:29803840
11394460	Znf660	zinc finger protein 660	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346042	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF660 mRNA	PMID:22714537
11394460	Znf660	zinc finger protein 660	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346042	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZNF660 5' UTR; Benzo(a)pyrene results in increased methylation of ZNF660 promoter	PMID:27901495
11394460	Znf660	zinc finger protein 660	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1346042	E	RGD:6480464	20160906	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ZNF660 mRNA	PMID:25895662
11394460	Znf660	zinc finger protein 660	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1346042	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF660 mRNA	PMID:28628672
11394460	Znf660	zinc finger protein 660	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1346042	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF660 mRNA	PMID:28628672
11394460	Znf660	zinc finger protein 660	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346042	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF660 mRNA	PMID:37042841
11394460	Znf660	zinc finger protein 660	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346042	E	RGD:6480464	20160906	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF660 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
11394460	Znf660	zinc finger protein 660	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1346042	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF660 gene	PMID:29154799
11394460	Znf660	zinc finger protein 660	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1346042	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of ZNF660 promoter	PMID:27989131
11394460	Znf660	zinc finger protein 660	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1346042	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF660 mRNA	PMID:28628672
11394460	Znf660	zinc finger protein 660	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1346042	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of ZNF660 mRNA	PMID:27188386
11394460	Znf660	zinc finger protein 660	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1346042	E	RGD:6480464	20160906	CTD	MESH:C012589	trichostatin A results in decreased expression of ZNF660 mRNA	PMID:24935251|PMID:26272509
11394460	Znf660	zinc finger protein 660	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1346042	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF660 mRNA	PMID:27188386
11394460	Znf660	zinc finger protein 660	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1346042	E	RGD:6480464	20160906	CTD	MESH:D001151	Arsenic affects the methylation of ZNF660 gene	PMID:25304211
11394460	Znf660	zinc finger protein 660	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1346042	E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of ZNF660 mRNA	PMID:26615145
11394460	Znf660	zinc finger protein 660	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1346042	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF660 mRNA	PMID:28628672
11394460	Znf660	zinc finger protein 660	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1346042	E	RGD:6480464	20160906	CTD	MESH:C001277	geldanamycin results in increased expression of ZNF660 mRNA	PMID:26705709
11394460	Znf660	zinc finger protein 660	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1346042	E	RGD:6480464	20160906	CTD	MESH:C029938	nickel sulfate results in decreased expression of ZNF660 mRNA	PMID:22714537
11394460	Znf660	zinc finger protein 660	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346042	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF660 mRNA	PMID:27188386
11394460	Znf660	zinc finger protein 660	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346042	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF660 gene]	PMID:28238834
11394460	Znf660	zinc finger protein 660	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of ZNF660 mRNA	PMID:32109520
11394460	Znf660	zinc finger protein 660	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346042	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF660 mRNA	PMID:27188386
11394460	Znf660	zinc finger protein 660	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1346042	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZNF660 mRNA	PMID:29301935
11405111	Vom1r75	vomeronasal 1 receptor 75	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20200211	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of VOM1R75 gene	PMID:27618143
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:3403707	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of C5ORF58 mRNA	PMID:35811015
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:3403707	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of C5ORF58 mRNA	PMID:37042841
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:3403707	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of C5ORF58 mRNA	PMID:41430723
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:3403707	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of C5ORF58 mRNA	PMID:21867686
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:3403707	E	RGD:6480464	20160906	CTD	MESH:D007854	Lead results in increased expression of C5ORF58 mRNA	PMID:19921347
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:3403707	E	RGD:6480464	20160906	CTD	MESH:D009532	Nickel results in increased expression of C5ORF58 mRNA	PMID:24768652|PMID:25583101
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:3403707	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of C5ORF58 mRNA	PMID:29955902
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:3403707	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of C5ORF58 mRNA	PMID:26705709
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:3403707	E	RGD:6480464	20160906	CTD	MESH:D014635	Valproic Acid affects the expression of C5ORF58 mRNA	PMID:25979313
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:3403707	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of C5ORF58 mRNA	PMID:28001369
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:3403707	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of C5ORF58 gene	PMID:29154799
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:3403707	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of C5ORF58 mRNA	PMID:35811015
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:3403707	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of C5ORF58 mRNA	PMID:22077320
11411272	C10h5orf58	similar to human chromosome 5 open reading frame 58	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:3403707	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of C5ORF58 mRNA	PMID:26705709
11414885	Hoxa1	homeobox A1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA	PMID:27188386
11414885	Hoxa1	homeobox A1	gene	CHEBI:132098	methoxyacetic acid	increases expression	ISO	RGD:732851	E	RGD:6480464	20230905	CTD	MESH:C013598	methoxyacetic acid results in increased expression of HOXA1 mRNA	PMID:32496642
11414885	Hoxa1	homeobox A1	gene	CHEBI:132098	methoxyacetic acid	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20230905	CTD	MESH:C013598	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [methoxyacetic acid results in increased expression of HOXA1 mRNA]	PMID:32496642
11414885	Hoxa1	homeobox A1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:732851	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of HOXA1 mRNA	PMID:33045310
11414885	Hoxa1	homeobox A1	gene	CHEBI:132604	monohexyl phthalate	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20250805	CTD	MESH:C049841	mono-n-hexyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D014212	Tretinoin affects the expression of HOXA1	PMID:15722554
11414885	Hoxa1	homeobox A1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D014212	Tretinoin results in increased expression of HOXA1 mRNA	PMID:16989981|PMID:20488242
11414885	Hoxa1	homeobox A1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D014212	Tretinoin results in increased expression of HOXA1; Tretinoin results in increased expression of HOXA1 mRNA	PMID:16038797|PMID:16604517|PMID:16788091|PMID:19897914|PMID:27532513|PMID:32496642|PMID:36189433|PMID:8838863
11414885	Hoxa1	homeobox A1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D014212	Tretinoin results in increased expression of HOXA1 mRNA	PMID:17185360|PMID:17218384|PMID:21934132|PMID:33167477|PMID:40359302
11414885	Hoxa1	homeobox A1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D014212	[DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of HOXA1 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA1 mRNA; Anisomycin promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA]; Dibutyl Phthalate promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA]	PMID:16038797|PMID:24005908|PMID:27532513|PMID:36189433
11414885	Hoxa1	homeobox A1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D014212	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; 4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [Tretinoin results in increased expression of HOXA1 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [Tretinoin results in increased expression of HOXA1 mRNA]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline affects the reaction [Tretinoin results in increased expression of HOXA1 mRNA]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline promotes the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; [bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA; [Tretinoin co-treated with bisphenol A] results in increased expression of HOXA1 mRNA; Fulvestrant promotes the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; Fulvestrant promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA]; LE 135 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; LE 135 promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA]; LY2955303 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; LY2955303 inhibits the reaction [Tretinoin results in increased expression of HOXA1 mRNA]; Tretinoin promotes the reaction [CXCL8 protein results in increased expression of HOXA1 mRNA polymorphism]	PMID:17218384|PMID:40359302
11414885	Hoxa1	homeobox A1	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of HOXA1 mRNA	PMID:24205000
11414885	Hoxa1	homeobox A1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:732851	E	RGD:6480464	20200804	CTD	MESH:D000431	Ethanol results in decreased expression of HOXA1 mRNA; Ethanol results in decreased expression of HOXA1 protein	PMID:19091803
11414885	Hoxa1	homeobox A1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20200804	CTD	MESH:D000431	Folic Acid inhibits the reaction [Ethanol results in decreased expression of HOXA1 mRNA]	PMID:19091803
11414885	Hoxa1	homeobox A1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of HOXA1 mRNA	PMID:20044591
11414885	Hoxa1	homeobox A1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:737614	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HOXA1 mRNA	PMID:35811015
11414885	Hoxa1	homeobox A1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HOXA1 mRNA	PMID:35811015
11414885	Hoxa1	homeobox A1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:737614	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of HOXA1 mRNA	PMID:30510588
11414885	Hoxa1	homeobox A1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA; Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA]	PMID:20823114
11414885	Hoxa1	homeobox A1	gene	CHEBI:167162	L-ascorbic acid 2-phosphate	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20220208	CTD	MESH:C011669	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA1 mRNA	PMID:34480604
11414885	Hoxa1	homeobox A1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D005557	Formaldehyde results in increased expression of HOXA1 mRNA	PMID:23649840
11414885	Hoxa1	homeobox A1	gene	CHEBI:16980	geranial	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C007076	citral inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197
11414885	Hoxa1	homeobox A1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA1 mRNA; mono-(2-ethylhexyl)phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:27532513|PMID:36189433
11414885	Hoxa1	homeobox A1	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:732851	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of HOXA1 mRNA	PMID:17178593
11414885	Hoxa1	homeobox A1	gene	CHEBI:17336	all-trans-retinol	increases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D014801	Vitamin A results in increased expression of HOXA1; Vitamin A results in increased expression of HOXA1 mRNA	PMID:23696197|PMID:26820057|PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:17336	all-trans-retinol	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D014801	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Vitamin A results in increased expression of HOXA1]; 3,4-methylenedioxy-beta-nitrostyrene inhibits the reaction [Vitamin A results in increased expression of HOXA1]; 4-nonylphenol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; BAY 11-7085 inhibits the reaction [Vitamin A results in increased expression of HOXA1]; bisphenol A inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; butyl phthalyl butyl glycolate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; butylbenzyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Camptothecin inhibits the reaction [Vitamin A results in increased expression of HOXA1]; citral inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; di-n-pentyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; diallyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Dibutyl Phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; dicyclohexyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Diethylstilbestrol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; diisobutyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Disulfiram inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Genistein inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; mono-n-hexyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; monobutyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; N,N'-bis(dichloroacetyl)-1,8-octamethylenediamine inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; nitrofen inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197|PMID:26820057|PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D013739	Testosterone results in decreased expression of HOXA1 mRNA	PMID:19693291
11414885	Hoxa1	homeobox A1	gene	CHEBI:17650	cortisol	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20220208	CTD	MESH:D006854	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA1 mRNA	PMID:34480604
11414885	Hoxa1	homeobox A1	gene	CHEBI:17898	all-trans-retinal	increases expression	ISO	RGD:732851	E	RGD:6480464	20250805	CTD	MESH:D012172	Retinaldehyde results in increased expression of HOXA1 mRNA	PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:732851	E	RGD:6480464	20251202	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of HOXA1 mRNA	PMID:40692086
11414885	Hoxa1	homeobox A1	gene	CHEBI:191079	Butyl phthalyl butylglycolate	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20250805	CTD	MESH:C048569	butyl phthalyl butyl glycolate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D001374	Azacitidine results in increased expression of HOXA1 mRNA	PMID:20823114
11414885	Hoxa1	homeobox A1	gene	CHEBI:2038	5-azacytidine	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D001374	Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA]	PMID:20823114
11414885	Hoxa1	homeobox A1	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D005944	Glucosamine results in decreased expression of HOXA1 mRNA	PMID:17178593
11414885	Hoxa1	homeobox A1	gene	CHEBI:23316	citral	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C007076	citral inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197
11414885	Hoxa1	homeobox A1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HOXA1 gene	PMID:27153756
11414885	Hoxa1	homeobox A1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D009151	Mustard Gas results in increased expression of HOXA1 mRNA	PMID:15674843
11414885	Hoxa1	homeobox A1	gene	CHEBI:2567	alendronic acid	affects expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D019386	Alendronate affects the expression of HOXA1 mRNA	PMID:16079270
11414885	Hoxa1	homeobox A1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of HOXA1 mRNA	PMID:41430723
11414885	Hoxa1	homeobox A1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [Ethanol results in decreased expression of HOXA1 mRNA]	PMID:19091803
11414885	Hoxa1	homeobox A1	gene	CHEBI:27656	camptothecin	decreases response to substance	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D002166	HOXA1 mRNA results in decreased susceptibility to Camptothecin	PMID:25269479
11414885	Hoxa1	homeobox A1	gene	CHEBI:27656	camptothecin	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D002166	Camptothecin inhibits the reaction [Vitamin A results in increased expression of HOXA1]	PMID:26820057
11414885	Hoxa1	homeobox A1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:C059514	resveratrol results in decreased expression of HOXA1 mRNA	PMID:20878097
11414885	Hoxa1	homeobox A1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXA1 mRNA	PMID:23557933
11414885	Hoxa1	homeobox A1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:732851	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of HOXA1 mRNA	PMID:32186404
11414885	Hoxa1	homeobox A1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D019833	Genistein inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197
11414885	Hoxa1	homeobox A1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HOXA1 mRNA	PMID:24058054
11414885	Hoxa1	homeobox A1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:737614	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HOXA1 mRNA	PMID:33212167
11414885	Hoxa1	homeobox A1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:737614	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of HOXA1 mRNA	PMID:39709020
11414885	Hoxa1	homeobox A1	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D005944	Glucosamine results in decreased expression of HOXA1 mRNA	PMID:17178593
11414885	Hoxa1	homeobox A1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of HOXA1 mRNA	PMID:20971185
11414885	Hoxa1	homeobox A1	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:D003840	[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of HOXA1 mRNA	PMID:16556975
11414885	Hoxa1	homeobox A1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:737614	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HOXA1 5' UTR; Benzo(a)pyrene results in decreased methylation of HOXA1 exon; Benzo(a)pyrene results in decreased methylation of HOXA1 promoter	PMID:27901495
11414885	Hoxa1	homeobox A1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:737614	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HOXA1 3' UTR	PMID:27901495
11414885	Hoxa1	homeobox A1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of HOXA1 mRNA	PMID:20971185
11414885	Hoxa1	homeobox A1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of HOXA1 mRNA	PMID:19073995|PMID:33720480
11414885	Hoxa1	homeobox A1	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D000643	Ammonium Chloride affects the expression of HOXA1 mRNA	PMID:16483693
11414885	Hoxa1	homeobox A1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20260113	CTD	MESH:C070081	Fulvestrant promotes the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; Fulvestrant promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA]	PMID:40359302
11414885	Hoxa1	homeobox A1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:732851	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HOXA1 mRNA	PMID:29264374
11414885	Hoxa1	homeobox A1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:732851	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HOXA1 promoter	PMID:35295148
11414885	Hoxa1	homeobox A1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HOXA1 mRNA	PMID:19710929
11414885	Hoxa1	homeobox A1	gene	CHEBI:33198	D-gluconic acid	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:C030691	[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of HOXA1 mRNA	PMID:16556975
11414885	Hoxa1	homeobox A1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A results in decreased expression of HOXA1 mRNA	PMID:25181051
11414885	Hoxa1	homeobox A1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A results in decreased expression of HOXA1 mRNA	PMID:26063408|PMID:31288075
11414885	Hoxa1	homeobox A1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:732851	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of HOXA1 mRNA	PMID:30951980
11414885	Hoxa1	homeobox A1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A results in increased expression of HOXA1 mRNA	PMID:27685785
11414885	Hoxa1	homeobox A1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197
11414885	Hoxa1	homeobox A1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20260113	CTD	MESH:C006780	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline promotes the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; [bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA; [Tretinoin co-treated with bisphenol A] results in increased expression of HOXA1 mRNA; Fulvestrant promotes the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; LE 135 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]; LY2955303 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA1 mRNA]	PMID:40359302
11414885	Hoxa1	homeobox A1	gene	CHEBI:338412	(-)-anisomycin	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D000841	Anisomycin promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA]	PMID:16038797
11414885	Hoxa1	homeobox A1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D002220	Carbamazepine affects the expression of HOXA1 mRNA	PMID:25979313
11414885	Hoxa1	homeobox A1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:732851	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of HOXA1 mRNA	PMID:30951980
11414885	Hoxa1	homeobox A1	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C041594	4-nonylphenol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197
11414885	Hoxa1	homeobox A1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:732851	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of HOXA1 mRNA	PMID:30951980
11414885	Hoxa1	homeobox A1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:732851	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of HOXA1 mRNA	PMID:37019170
11414885	Hoxa1	homeobox A1	gene	CHEBI:34680	dipentyl phthalate	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C034171	di-n-pentyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197|PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D003993	Dibutyl Phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Dibutyl Phthalate promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA]	PMID:23696197|PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:34693	Dicyclohexyl phthalate	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20250805	CTD	MESH:C036042	dicyclohexyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HOXA1 mRNA	PMID:18164116
11414885	Hoxa1	homeobox A1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of HOXA1 mRNA	PMID:32680482
11414885	Hoxa1	homeobox A1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HOXA1 mRNA	PMID:12160620
11414885	Hoxa1	homeobox A1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D002737	Chloroprene results in decreased expression of HOXA1 mRNA	PMID:23125180
11414885	Hoxa1	homeobox A1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D014635	Valproic Acid affects the expression of HOXA1 mRNA	PMID:17292431|PMID:26072468
11414885	Hoxa1	homeobox A1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D014635	Valproic Acid affects the expression of HOXA1 mRNA	PMID:25979313|PMID:26072468
11414885	Hoxa1	homeobox A1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D014635	Valproic Acid analog results in increased expression of HOXA1 mRNA; Valproic Acid results in increased expression of HOXA1 mRNA	PMID:16989981
11414885	Hoxa1	homeobox A1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D014635	Valproic Acid results in increased expression of HOXA1 mRNA	PMID:21427059|PMID:27693483
11414885	Hoxa1	homeobox A1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D014635	Valproic Acid results in increased expression of HOXA1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
11414885	Hoxa1	homeobox A1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D014635	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [Valproic Acid results in increased expression of HOXA1 mRNA]; [Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] affects the expression of HOXA1 mRNA	PMID:27693483
11414885	Hoxa1	homeobox A1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA	PMID:27188386
11414885	Hoxa1	homeobox A1	gene	CHEBI:4027	cyclophosphamide	affects response to substance	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D003520	HOXA1 protein affects the susceptibility to Cyclophosphamide	PMID:16217747
11414885	Hoxa1	homeobox A1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of HOXA1 protein	PMID:22198180
11414885	Hoxa1	homeobox A1	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D004054	Diethylstilbestrol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197
11414885	Hoxa1	homeobox A1	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D003703	Demecolcine results in increased expression of HOXA1 mRNA	PMID:23649840
11414885	Hoxa1	homeobox A1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:737614	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of HOXA1 mRNA	PMID:26690555
11414885	Hoxa1	homeobox A1	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:737614	E	RGD:6480464	20180703	CTD	MESH:D005472	Fluorouracil results in decreased expression of HOXA1 mRNA	PMID:24737281
11414885	Hoxa1	homeobox A1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D004221	Disulfiram inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197
11414885	Hoxa1	homeobox A1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HOXA1 mRNA	PMID:35811015
11414885	Hoxa1	homeobox A1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D004726	Endosulfan results in increased expression of HOXA1 protein	PMID:22198180
11414885	Hoxa1	homeobox A1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D005944	Glucosamine results in decreased expression of HOXA1 mRNA	PMID:17178593
11414885	Hoxa1	homeobox A1	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of HOXA1 mRNA	PMID:16122865
11414885	Hoxa1	homeobox A1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of HOXA1 mRNA	PMID:16079270
11414885	Hoxa1	homeobox A1	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA; Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA]	PMID:20823114
11414885	Hoxa1	homeobox A1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HOXA1 mRNA; Nanotubes, Carbon results in decreased expression of HOXA1 mRNA	PMID:25554681
11414885	Hoxa1	homeobox A1	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:C029938	nickel sulfate results in increased expression of HOXA1 mRNA	PMID:22714537
11414885	Hoxa1	homeobox A1	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:737614	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of HOXA1 mRNA	PMID:31629900
11414885	Hoxa1	homeobox A1	gene	CHEBI:62878	XAV939	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20220208	CTD	MESH:C544261	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA1 mRNA	PMID:34480604
11414885	Hoxa1	homeobox A1	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Vitamin A results in increased expression of HOXA1]	PMID:26820057
11414885	Hoxa1	homeobox A1	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA; Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA]	PMID:20823114
11414885	Hoxa1	homeobox A1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:732851	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HOXA1 mRNA	PMID:22206623
11414885	Hoxa1	homeobox A1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of HOXA1 mRNA	PMID:34480604
11414885	Hoxa1	homeobox A1	gene	CHEBI:75261	arotinoid acid	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20220208	CTD	MESH:C038864	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA1 mRNA	PMID:34480604
11414885	Hoxa1	homeobox A1	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:732851	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in increased expression of HOXA1	PMID:26820057
11414885	Hoxa1	homeobox A1	gene	CHEBI:7590	nitrofen	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C007350	nitrofen inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197
11414885	Hoxa1	homeobox A1	gene	CHEBI:76359	butylated hydroxyanisole	decreases expression	ISO	RGD:732851	E	RGD:6480464	20180116	CTD	MESH:D002083	Butylated Hydroxyanisole results in decreased expression of HOXA1 mRNA	PMID:28927898
11414885	Hoxa1	homeobox A1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HOXA1 mRNA	PMID:18164116
11414885	Hoxa1	homeobox A1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA	PMID:27188386
11414885	Hoxa1	homeobox A1	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20250805	CTD	MESH:C025605	diisobutyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HOXA1 mRNA	PMID:27291303
11414885	Hoxa1	homeobox A1	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C409722	hexaconazole affects the expression of HOXA1 mRNA	PMID:21195148
11414885	Hoxa1	homeobox A1	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C061365	flusilazole affects the expression of HOXA1 mRNA	PMID:21195148
11414885	Hoxa1	homeobox A1	gene	CHEBI:81922	flusilazole	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C061365	flusilazole results in increased expression of HOXA1 mRNA	PMID:28263823
11414885	Hoxa1	homeobox A1	gene	CHEBI:81922	flusilazole	increases expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C061365	flusilazole results in increased expression of HOXA1 mRNA	PMID:21192963
11414885	Hoxa1	homeobox A1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of HOXA1 mRNA	PMID:23640034
11414885	Hoxa1	homeobox A1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA	PMID:27188386
11414885	Hoxa1	homeobox A1	gene	CHEBI:86290	6-bromoindirubin-3'-oxime	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C483321	[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] affects the expression of HOXA1 mRNA	PMID:27693483
11414885	Hoxa1	homeobox A1	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of HOXA1 mRNA	PMID:16079270
11414885	Hoxa1	homeobox A1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:27532513
11414885	Hoxa1	homeobox A1	gene	CHEBI:90441	WIN 18446	multiple interactions	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C002491	N,N'-bis(dichloroacetyl)-1,8-octamethylenediamine inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]	PMID:23696197
11414885	Hoxa1	homeobox A1	gene	CHEBI:91091	CHIR 99021	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20220208	CTD	MESH:C473711	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA1 mRNA; [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA1 mRNA	PMID:34480604
11414885	Hoxa1	homeobox A1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:737614	E	RGD:6480464	20170210	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of HOXA1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA	PMID:27188386|PMID:34480604
11414885	Hoxa1	homeobox A1	gene	CHEBI:92658	kenpaullone	increases expression	ISO	RGD:732851	E	RGD:6480464	20211109	CTD	MESH:C119620	kenpaullone results in increased expression of HOXA1	PMID:26820057
11414885	Hoxa1	homeobox A1	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:732851	E	RGD:6480464	20170210	CTD	MESH:C032910	triadimefon affects the expression of HOXA1 mRNA	PMID:21195148
11421297	Oog3-ps1	oogenesin 3, pseudogene 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of OOG3-PS1 mRNA	PMID:41034487
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1617055	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of HS3ST4 mRNA	PMID:37995155
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1617055	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of HS3ST4 mRNA	PMID:29980752
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1352921	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of HS3ST4 gene	PMID:33872906
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1352921	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of HS3ST4 gene	PMID:33872906
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1352921	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HS3ST4 gene	PMID:27153756
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1617055	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HS3ST4 mRNA	PMID:25629700
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1352921	E	RGD:6480464	20160913	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of HS3ST4 mRNA	PMID:26272509
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1352921	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST4 mRNA	PMID:27188386
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1352921	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of HS3ST4 mRNA	PMID:23557933
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1352921	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of HS3ST4 mRNA	PMID:30031762
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352921	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HS3ST4 5' UTR; Benzo(a)pyrene results in increased methylation of HS3ST4 exon; Benzo(a)pyrene results in increased methylation of HS3ST4 promoter	PMID:27901495
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1617055	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in increased expression of HS3ST4 mRNA	PMID:33053406
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1617055	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of HS3ST4 mRNA	PMID:32156529
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1352921	E	RGD:6480464	20160913	CTD	MESH:D014635	Valproic Acid affects the expression of HS3ST4 mRNA	PMID:25979313
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1352921	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HS3ST4 mRNA	PMID:27188386
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:6809	methamphetamine	affects response to substance	ISO	RGD:1352921	E	RGD:6480464	20160913	CTD	MESH:D008694	HS3ST4 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of HS3ST4 gene	PMID:35440735
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1352921	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HS3ST4 mRNA	PMID:27188386
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352921	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HS3ST4 gene]	PMID:28238834
11422907	Hs3st4	heparan sulfate-glucosamine 3-sulfotransferase 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1352921	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HS3ST4 mRNA	PMID:27188386
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ZFTRAF1 mRNA	PMID:20188158
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D014212	Tretinoin results in increased expression of ZFTRAF1 mRNA	PMID:23724009
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D000431	Ethanol affects the splicing of ZFTRAF1 mRNA	PMID:30319688
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1557821	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFTRAF1 mRNA	PMID:39241906
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ZFTRAF1 protein	PMID:31163220
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1557821	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CYHR1 mRNA	PMID:33754040
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of ZFTRAF1 mRNA	PMID:33914522
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20230221	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ZFTRAF1 protein	PMID:34915118
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D002104	Cadmium results in increased expression of ZFTRAF1 mRNA	PMID:24376830
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZFTRAF1 mRNA	PMID:19549813
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ZFTRAF1 mRNA	PMID:23649840
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C016517	indole-3-carbinol affects the expression of ZFTRAF1 mRNA	PMID:21396975
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZFTRAF1 mRNA	PMID:19770486
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZFTRAF1 mRNA	PMID:23649840
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344193	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CYHR1 mRNA	PMID:35430440
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZFTRAF1 mRNA	PMID:22206623
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D001151	Arsenic affects the methylation of ZFTRAF1 gene	PMID:25304211
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:27585	selenomethionine	affects expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D012645	Selenomethionine affects the expression of ZFTRAF1 mRNA	PMID:17222674
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C030686	acetamide results in decreased expression of ZFTRAF1 mRNA	PMID:31881176
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ZFTRAF1 mRNA	PMID:23557933
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D009532	Nickel results in decreased expression of ZFTRAF1 mRNA	PMID:23195993|PMID:25583101
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFTRAF1 mRNA	PMID:21570461
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFTRAF1 mRNA	PMID:21215274
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZFTRAF1 mRNA	PMID:33212167
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D024483	Vitamin K 3 affects the expression of ZFTRAF1 mRNA	PMID:20044591
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZFTRAF1 mRNA	PMID:22228805
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZFTRAF1 3' UTR	PMID:27901495
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:C070081	Fulvestrant results in increased methylation of ZFTRAF1 gene	PMID:31601247
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557821	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CYHR1 gene	PMID:35295148
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1557821	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CYHR1 gene	PMID:35295148
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFTRAF1 mRNA	PMID:34492290
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:C006253	pirinixic acid results in increased expression of ZFTRAF1 mRNA	PMID:17426115
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D011190	Potassium Cyanide results in increased expression of ZFTRAF1 mRNA	PMID:33914522
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A affects the expression of ZFTRAF1 mRNA	PMID:30816183|PMID:34947998
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFTRAF1 mRNA	PMID:32528016
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFTRAF1 protein	PMID:33376534
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in increased expression of ZFTRAF1 mRNA	PMID:25181051
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFTRAF1 mRNA	PMID:36041667
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFTRAF1 mRNA	PMID:28628672
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFTRAF1 mRNA	PMID:36041667
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFTRAF1 mRNA	PMID:36041667
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZFTRAF1 mRNA	PMID:21266533
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFTRAF1 mRNA	PMID:28628672
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D010269	Paraquat results in decreased expression of ZFTRAF1 mRNA	PMID:32680482
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344193	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CYHR1 mRNA	PMID:37042841
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ZFTRAF1 mRNA	PMID:30589522
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1344193	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CYHR1 mRNA	PMID:38568856
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D002994	Clofibrate results in decreased expression of ZFTRAF1 mRNA	PMID:17585979|PMID:23811191
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ZFTRAF1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ZFTRAF1 mRNA]	PMID:17585979
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D014635	Valproic Acid affects the expression of ZFTRAF1 mRNA	PMID:17963808
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZFTRAF1 gene	PMID:29154799
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFTRAF1 mRNA	PMID:28628672
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D000082	Acetaminophen affects the expression of ZFTRAF1 mRNA	PMID:17562736
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFTRAF1 mRNA	PMID:22230336
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ZFTRAF1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ZFTRAF1 mRNA]	PMID:17585979
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D001151	Arsenic affects the methylation of ZFTRAF1 gene	PMID:25304211
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:C109476	epoxiconazole results in decreased expression of ZFTRAF1 mRNA	PMID:35436446
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFTRAF1 mRNA	PMID:28628672
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of ZFTRAF1 mRNA	PMID:25554681
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ZFTRAF1 mRNA	PMID:25554681
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ZFTRAF1 mRNA	PMID:25620056
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1557821	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ZFTRAF1 mRNA	PMID:35964746
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ZFTRAF1 mRNA	PMID:22206623
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFTRAF1 mRNA	PMID:22206623
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZFTRAF1 mRNA	PMID:22206623
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1557821	E	RGD:6480464	20230404	CTD	MESH:C045950	propiconazole results in decreased expression of ZFTRAF1 mRNA	PMID:21278054
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D012999	Soman results in decreased expression of ZFTRAF1 mRNA	PMID:19281266
11425062	Zftraf1	zinc finger TRAF-type and ring finger containing 1	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1344193	E	RGD:6480464	20230221	CTD	MESH:C004648	testosterone enanthate affects the expression of ZFTRAF1 mRNA	PMID:17440010
11426996	Mymx	myomixer, myoblast fusion factor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620251	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYMX mRNA	PMID:33045310
11426996	Mymx	myomixer, myoblast fusion factor	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1620251	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of MYMX mRNA	PMID:39984025
11426996	Mymx	myomixer, myoblast fusion factor	gene	CHEBI:28618	1,4-dichlorobenzene	increases expression	ISO	RGD:1620251	E	RGD:6480464	20171114	CTD	MESH:C018511	4-dichlorobenzene results in increased expression of MYMX mRNA	PMID:26975756
11426996	Mymx	myomixer, myoblast fusion factor	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1620251	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MYMX mRNA	PMID:32715474
11428339	Hsfx3	heat shock transcription factor family, X-linked member 3	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:12801022	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of HSFX3 mRNA	PMID:35984750
11428339	Hsfx3	heat shock transcription factor family, X-linked member 3	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:12801022	E	RGD:6480464	20230620	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of HSFX3 mRNA	PMID:31734321
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:15343	acetaldehyde	affects expression	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:D000079	Acetaldehyde affects the expression of EVX1 mRNA	PMID:22634333
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EVX1 gene	PMID:20938992
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1344299	E	RGD:6480464	20170210	CTD	MESH:D014212	Tretinoin results in decreased expression of EVX1 mRNA	PMID:15498508
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:D014212	Tretinoin results in decreased expression of EVX1 mRNA	PMID:16604517
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EVX1 gene	PMID:20938992
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1558128	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of EVX1 mRNA	PMID:33848595
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1344299	E	RGD:6480464	20170210	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EVX1 gene	PMID:27153756
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1344299	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EVX1 mRNA	PMID:21867686
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EVX1 gene	PMID:20938992
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1344299	E	RGD:6480464	20170210	CTD	MESH:D001151	Arsenic affects the methylation of EVX1 gene	PMID:25304211
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344299	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of EVX1 mRNA	PMID:23557933
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EVX1 mRNA	PMID:21570461
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EVX1 mRNA	PMID:24058054
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:29287	gold atom	increases expression	ISO	RGD:1344299	E	RGD:6480464	20170210	CTD	MESH:D006046	Gold results in increased expression of EVX1 mRNA	PMID:25523186
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1558128	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of EVX1 mRNA	PMID:37682722
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344299	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EVX1 exon; Benzo(a)pyrene affects the methylation of EVX1 promoter	PMID:27901495
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:30050	gold(0)	increases expression	ISO	RGD:1344299	E	RGD:6480464	20170210	CTD	MESH:D006046	Gold results in increased expression of EVX1 mRNA	PMID:25523186
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1344299	E	RGD:6480464	20170210	CTD	MESH:C061133	tamibarotene results in decreased expression of EVX1 mRNA	PMID:15498508
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1558128	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EVX1 gene; titanium dioxide results in decreased methylation of EVX1 promoter	PMID:35295148
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1558128	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of EVX1 gene	PMID:35295148
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A results in decreased expression of EVX1 mRNA	PMID:25181051
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A results in decreased expression of EVX1 mRNA	PMID:26063408|PMID:34585602
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of EVX1 mRNA	PMID:41034487
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1558128	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of EVX1 mRNA	PMID:32156529
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1344299	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of EVX1 gene	PMID:31601247
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1558128	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of EVX1 exon	PMID:33297965
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1558128	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EVX1 mRNA	PMID:37019170
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1344299	E	RGD:6480464	20170210	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of EVX1 mRNA	PMID:24449571
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1558128	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EVX1 mRNA	PMID:40194260
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1344299	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of EVX1 promoter	PMID:29626692
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1344299	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of EVX1 promoter	PMID:29626692
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1344299	E	RGD:6480464	20170210	CTD	MESH:D001151	Arsenic affects the methylation of EVX1 gene	PMID:25304211
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:D011192	Potassium Dichromate results in increased expression of EVX1 mRNA	PMID:23608068
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of EVX1 mRNA	PMID:33484710
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:C061365	flusilazole affects the expression of EVX1 mRNA	PMID:22634333
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EVX1 mRNA	PMID:24780913
11434685	Evx1	even-skipped homeobox 1	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1558128	E	RGD:6480464	20170210	CTD	MESH:C028577	monobutyl phthalate affects the expression of EVX1 mRNA	PMID:19162170
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:D001280	Atrazine results in increased expression of ZNF470 mRNA	PMID:22378314
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603830	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF470 mRNA	PMID:37042841
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZNF470 gene	PMID:27153756
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZNF470 mRNA	PMID:28001369
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF470 promoter	PMID:27901495
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:C543008	bisphenol S results in increased methylation of ZNF470 gene	PMID:31601247
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603830	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF470 mRNA	PMID:37042841
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603830	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNF470 mRNA	PMID:38568856
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:C473478	Sunitinib results in increased expression of ZNF470 mRNA	PMID:31533062
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:C480342	clothianidin results in increased expression of ZNF470 mRNA	PMID:31626844
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF470 mRNA	PMID:25979313
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF470 mRNA	PMID:26272509
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF470 mRNA	PMID:27188386
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1603830	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ZNF470 mRNA	PMID:38832940
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:C005223	methyleugenol results in decreased expression of ZNF470 mRNA	PMID:32234424
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:C029938	nickel sulfate results in decreased expression of ZNF470 mRNA	PMID:22714537
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:C047246	Temozolomide results in increased expression of ZNF470 mRNA	PMID:31758290
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1603830	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF470 protein	PMID:31285264
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF470 mRNA	PMID:27188386
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603830	E	RGD:6480464	20230404	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF470 mRNA	PMID:27188386
11436011	Zfp470	zinc finger protein 470	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1603830	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZNF470 mRNA	PMID:29301935
11436036	Prss48	serine protease 48	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRSS48 mRNA	PMID:33387578
11436036	Prss48	serine protease 48	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1621203	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of PRSS48 gene	PMID:34319233
11436036	Prss48	serine protease 48	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1621203	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PRSS48 mRNA	PMID:25629700
11436036	Prss48	serine protease 48	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1605534	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of PRSS48 mRNA	PMID:29955902
11436036	Prss48	serine protease 48	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1605534	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PRSS48 mRNA	PMID:30851411
11436036	Prss48	serine protease 48	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621203	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of PRSS48 mRNA	PMID:37682722
11436036	Prss48	serine protease 48	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1621203	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PRSS48 exon	PMID:33297965
11436036	Prss48	serine protease 48	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1605534	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PRSS48 mRNA	PMID:30851411
11436036	Prss48	serine protease 48	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605534	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PRSS48 mRNA	PMID:38568856
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:C084079	triptonide results in increased expression of FLYWCH2 mRNA	PMID:33045310
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FLYWCH2 mRNA	PMID:20188158
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D000431	Ethanol affects the expression of FLYWCH2 mRNA	PMID:30319688
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1602659	E	RGD:6480464	20220215	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of FLYWCH2 protein	PMID:20109541
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602659	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FLYWCH2 mRNA	PMID:37042841
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1602659	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FLYWCH2 protein	PMID:37730182
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1602659	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FLYWCH2 mRNA	PMID:39836092
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1602659	E	RGD:6480464	20220215	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FLYWCH2 protein	PMID:23301498
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FLYWCH2 mRNA	PMID:22206623
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602659	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FLYWCH2 mRNA	PMID:39836092
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1602659	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of FLYWCH2 protein	PMID:35688186
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FLYWCH2 mRNA	PMID:21570461
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FLYWCH2 mRNA	PMID:34747641
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FLYWCH2 promoter]	PMID:19654925
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1602659	E	RGD:6480464	20220215	CTD	MESH:C000228	aristolochic acid I results in increased expression of FLYWCH2 mRNA	PMID:33212167
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602659	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FLYWCH2 mRNA; sodium arsenite results in decreased expression of FLYWCH2 protein	PMID:38228842|PMID:38568856
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602659	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FLYWCH2 mRNA	PMID:39836092
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FLYWCH2 mRNA	PMID:22228805
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FLYWCH2 mRNA	PMID:22228805
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602659	E	RGD:6480464	20220215	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FLYWCH2 5' UTR	PMID:27901495
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of FLYWCH2 mRNA	PMID:18648102
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:C006253	pirinixic acid results in decreased expression of FLYWCH2 mRNA	PMID:23811191
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1602659	E	RGD:6480464	20220215	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FLYWCH2 mRNA	PMID:19710929
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20220203	CTD	MESH:C006780	bisphenol A affects the expression of FLYWCH2 mRNA	PMID:30816183|PMID:34947998
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332127	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of FLYWCH2 mRNA	PMID:38685157
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332127	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FLYWCH2 mRNA	PMID:37019170
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1332127	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of FLYWCH2 mRNA	PMID:36117858
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1602659	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FLYWCH2 mRNA	PMID:39836092
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20220203	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of FLYWCH2 mRNA	PMID:30723492
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602659	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FLYWCH2 mRNA	PMID:38568856
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D013629	Tamoxifen affects the expression of FLYWCH2 mRNA	PMID:17555576
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602659	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FLYWCH2 mRNA	PMID:39836092
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FLYWCH2 mRNA	PMID:17555576
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20220203	CTD	MESH:C017690	fenvalerate results in increased expression of FLYWCH2 mRNA	PMID:30307764
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FLYWCH2 mRNA	PMID:25554681
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1332127	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of FLYWCH2 mRNA	PMID:36117858
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1602659	E	RGD:6480464	20220215	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FLYWCH2 protein	PMID:23718831
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1602659	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FLYWCH2 mRNA	PMID:39836092
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332127	E	RGD:6480464	20220215	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FLYWCH2 mRNA	PMID:22206623
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of FLYWCH2 mRNA	PMID:32109520
11436072	Flywch2	FLYWCH family member 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602659	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FLYWCH2 mRNA	PMID:38568856
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1602147	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of SPACDR mRNA	PMID:34925699
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:150340542	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SPACDR mRNA	PMID:39241906
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1602147	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of SPACDR mRNA	PMID:31614463
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1602147	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SPACDR mRNA	PMID:33647349
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D005839	Gentamicins results in decreased expression of SPACDR mRNA	PMID:33387578
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602147	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SPACDR mRNA	PMID:41430723
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1602147	E	RGD:6480464	20161018	CTD	MESH:D001151	Arsenic affects the methylation of SPACDR gene	PMID:25304211
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPACDR mRNA	PMID:33387578
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1602147	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SPACDR mRNA	PMID:33212167
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1602147	E	RGD:6480464	20161018	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SPACDR mRNA	PMID:24690739
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1602147	E	RGD:6480464	20161018	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SPACDR mRNA	PMID:24690739
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SPACDR mRNA	PMID:21241498
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:150340542	E	RGD:6480464	20230808	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SPACDR mRNA	PMID:37019170
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:150340542	E	RGD:6480464	20230808	CTD	MESH:C005828	methidathion results in increased expression of SPACDR mRNA	PMID:34813904
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SPACDR mRNA	PMID:33453195
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1602147	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SPACDR mRNA	PMID:24449571
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602147	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SPACDR gene	PMID:29154799
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D000082	Acetaminophen results in increased expression of SPACDR mRNA	PMID:33387578
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1602147	E	RGD:6480464	20161018	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of SPACDR mRNA	PMID:24690739
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1602147	E	RGD:6480464	20161018	CTD	MESH:D001151	Arsenic affects the methylation of SPACDR gene	PMID:25304211
11442159	Spacdr	sperm acrosome developmental regulator	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1602147	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of SPACDR mRNA	PMID:31629900
11444414	Hmgb1l1	high mobility group box 1 like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of HMGB1L1 mRNA	PMID:41034487
11445134	Smim34	small integral membrane protein 34	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:13208721	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SMIM34 mRNA	PMID:30851411
11445134	Smim34	small integral membrane protein 34	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:13208721	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of SMIM34 mRNA	PMID:37047231
11445134	Smim34	small integral membrane protein 34	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:13208721	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SMIM34 mRNA	PMID:30851411
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:D014212	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ZNF28 protein	PMID:15894607
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1622203	E	RGD:6480464	20230808	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFP712 mRNA	PMID:36331819
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:D001280	Atrazine results in decreased expression of ZNF28 mRNA	PMID:22378314
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1622203	E	RGD:6480464	20230808	CTD	MESH:D000431	Ethanol results in increased expression of ZFP712 mRNA	PMID:30319688
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1352869	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF28 mRNA	PMID:37042841
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF28 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ZNF28 mRNA	PMID:39836092
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ZNF28 mRNA	PMID:35430440
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1622203	E	RGD:6480464	20230808	CTD	MESH:D005492	Folic Acid results in decreased expression of ZFP712 mRNA	PMID:25629700
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF28 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF28 mRNA	PMID:39836092
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF28 mRNA	PMID:29803840
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352869	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF28 mRNA	PMID:38568856
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF28 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF28 mRNA	PMID:39836092
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF28 intron	PMID:30157460
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZNF28 promoter	PMID:27901495
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1622203	E	RGD:6480464	20230808	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZFP712 promoter	PMID:27901495
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZNF28 protein	PMID:15894607
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ZNF28 protein	PMID:15894607
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622203	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP712 gene	PMID:35295148
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1622203	E	RGD:6480464	20230808	CTD	MESH:C543008	bisphenol S results in decreased expression of ZFP712 mRNA	PMID:30951980
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:C543008	bisphenol S results in increased methylation of ZNF28 gene	PMID:31601247
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1622203	E	RGD:6480464	20230808	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP712 mRNA	PMID:37019170
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352869	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF28 mRNA	PMID:37042841
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF28 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ZNF28 mRNA	PMID:39836092
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1352869	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF28 mRNA	PMID:38382870
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1352869	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ZNF28 mRNA	PMID:40419075
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1622203	E	RGD:6480464	20230808	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFP712 mRNA	PMID:36331819
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZNF28 gene	PMID:29154799
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF28 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF28 mRNA	PMID:39836092
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:C016766	sulforaphane results in increased expression of ZNF28 mRNA	PMID:31838189
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZNF28 protein	PMID:15894607
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ZNF28 protein	PMID:15894607
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1622203	E	RGD:6480464	20230808	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ZFP712 mRNA	PMID:25554681
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF28 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ZNF28 mRNA	PMID:39836092
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622203	E	RGD:6480464	20230808	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP712 mRNA	PMID:22206623
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1352869	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF28 protein	PMID:31285264
11447466	Zfp712	zinc finger protein 712	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352869	E	RGD:6480464	20230808	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF28 gene]	PMID:28238834
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1346508	E	RGD:6480464	20170210	CTD	MESH:D014212	Tretinoin results in increased expression of DMRTC1 mRNA	PMID:23724009
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1346508	E	RGD:6480464	20170210	CTD	MESH:D001280	Atrazine results in increased expression of DMRTC1 mRNA	PMID:22378314
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346508	E	RGD:6480464	20170210	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DMRTC1 gene	PMID:27153756
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1619135	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of DMRTC1A mRNA	PMID:28960355
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346508	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of DMRTC1 mRNA	PMID:23557933
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1346508	E	RGD:6480464	20170210	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DMRTC1 mRNA	PMID:25895662
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of DMRTC1A mRNA	PMID:30047161
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of DMRTC1A mRNA	PMID:41034487
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DMRTC1A mRNA	PMID:30816183|PMID:32528016|PMID:34947998
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1619135	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of DMRTC1A mRNA	PMID:32156529
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1346508	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DMRTC1 gene	PMID:29154799
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of DMRTC1A mRNA	PMID:30047161
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C005219	methyl cellosolve results in increased expression of DMRTC1A mRNA	PMID:21061450
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of DMRTC1A mRNA	PMID:30047161
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D007649	Ketamine results in increased expression of DMRTC1A mRNA	PMID:20080153
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of DMRTC1A mRNA	PMID:30047161
11451771	Dmrtc1a	DMRT-like family C1a	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DMRTC1A mRNA	PMID:30047161
11452860	Igsf22	immunoglobulin superfamily member 22	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1601807	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of IGSF22 mRNA	PMID:35811015
11452860	Igsf22	immunoglobulin superfamily member 22	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1601807	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IGSF22 mRNA	PMID:35811015
11452860	Igsf22	immunoglobulin superfamily member 22	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1601807	E	RGD:6480464	20160906	CTD	MESH:C005556	propionaldehyde results in decreased expression of IGSF22 mRNA	PMID:26079696
11452860	Igsf22	immunoglobulin superfamily member 22	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1601807	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IGSF22 mRNA	PMID:31163220
11452860	Igsf22	immunoglobulin superfamily member 22	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1601807	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of IGSF22 mRNA	PMID:28903495
11452860	Igsf22	immunoglobulin superfamily member 22	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1601807	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IGSF22 promoter	PMID:27901495
11452860	Igsf22	immunoglobulin superfamily member 22	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1601807	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of IGSF22 5' UTR	PMID:27901495
11452860	Igsf22	immunoglobulin superfamily member 22	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1601807	E	RGD:6480464	20160906	CTD	MESH:D000082	Acetaminophen results in decreased expression of IGSF22 mRNA	PMID:22230336
11452860	Igsf22	immunoglobulin superfamily member 22	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1601807	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IGSF22 mRNA	PMID:35811015
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550222	E	RGD:6480464	20230808	CTD	MESH:C084079	triptonide results in decreased expression of ALG13 mRNA	PMID:33045310
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of ALG13 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] affects the expression of ALG13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of ALG13 mRNA	PMID:32699268|PMID:32845096
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550222	E	RGD:6480464	20230808	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALG13 mRNA	PMID:30529165
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D001280	Atrazine results in increased expression of ALG13 mRNA	PMID:22378314
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ALG13 mRNA	PMID:20044591
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D011794	Quercetin results in increased expression of ALG13 mRNA	PMID:21632981
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550222	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ALG13 mRNA	PMID:39241906
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550222	E	RGD:6480464	20230808	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ALG13 mRNA	PMID:25510870
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550222	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ALG13 mRNA	PMID:33754040
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20230808	CTD	MESH:D003471	Cuprizone results in decreased expression of ALG13 mRNA	PMID:26577399
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20230808	CTD	MESH:D003471	Cuprizone results in increased expression of ALG13 mRNA	PMID:27523638
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D002117	Calcitriol results in decreased expression of ALG13 mRNA	PMID:16002434
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550222	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ALG13 mRNA	PMID:25510870
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550222	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ALG13 mRNA	PMID:25510870
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of ALG13 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] affects the expression of ALG13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of ALG13 mRNA; [Volatile Organic Compounds co-treated with Ozone] affects the expression of ALG13 mRNA	PMID:32699268|PMID:32845096
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG13 mRNA	PMID:39836092
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550222	E	RGD:6480464	20230808	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ALG13 mRNA	PMID:28189721|PMID:28960355
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ALG13 mRNA	PMID:22574217
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20230808	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ALG13 mRNA	PMID:21215274|PMID:32109520
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20230808	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALG13 mRNA]	PMID:21215274
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ALG13 mRNA	PMID:33212167
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ALG13 mRNA	PMID:20971185
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D004317	Doxorubicin results in decreased expression of ALG13 mRNA	PMID:29803840
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C017947	sodium arsenite results in decreased expression of ALG13 mRNA	PMID:28595984|PMID:34032870
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550222	E	RGD:6480464	20230808	CTD	MESH:C017947	sodium arsenite results in decreased expression of ALG13 mRNA	PMID:36209798
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG13 mRNA	PMID:39836092
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ALG13 intron	PMID:30157460
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ALG13 promoter	PMID:27901495
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:29866	arsenite(3-)	affects expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C015001	arsenite affects the expression of ALG13 mRNA	PMID:22959463
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ALG13 mRNA	PMID:20971185
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ALG13 mRNA	PMID:15761015
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550222	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ALG13 gene; titanium dioxide results in increased methylation of ALG13 promoter	PMID:35295148
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ALG13 mRNA	PMID:38479592
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230808	CTD	MESH:C006780	bisphenol A results in decreased expression of ALG13 mRNA	PMID:25181051
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C006780	bisphenol A results in decreased expression of ALG13 protein	PMID:33376534
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C006780	bisphenol A results in decreased methylation of ALG13 gene	PMID:31601247
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230808	CTD	MESH:C006780	bisphenol A results in increased expression of ALG13 mRNA	PMID:34947998
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550222	E	RGD:6480464	20230808	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ALG13 mRNA	PMID:25510870
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550222	E	RGD:6480464	20230808	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ALG13 mRNA	PMID:25510870
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ALG13 intron	PMID:30157460
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20230808	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ALG13 mRNA	PMID:21266533
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ALG13 mRNA	PMID:19376846
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ALG13 mRNA	PMID:24449571
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of ALG13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of ALG13 mRNA	PMID:32699268
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550222	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ALG13 mRNA	PMID:39529242
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D014635	Valproic Acid affects the expression of ALG13 mRNA	PMID:23179753|PMID:25192806|PMID:26272509
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D014635	Valproic Acid results in decreased expression of ALG13 mRNA	PMID:24935251|PMID:25716160|PMID:28001369
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D014635	Valproic Acid results in increased expression of ALG13 mRNA	PMID:24383497|PMID:24935251|PMID:28001369
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALG13 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALG13 mRNA	PMID:27188386
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20230808	CTD	MESH:C005219	methyl cellosolve results in increased expression of ALG13 mRNA	PMID:21061450
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG13 mRNA	PMID:39836092
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ALG13 mRNA	PMID:15761015
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550222	E	RGD:6480464	20230808	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ALG13 mRNA	PMID:25554681
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20230808	CTD	MESH:D005485	Flutamide results in increased expression of ALG13 mRNA	PMID:24136188
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550222	E	RGD:6480464	20230808	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ALG13 mRNA	PMID:19042947
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D015474	Isotretinoin results in decreased expression of ALG13 mRNA	PMID:20436886
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20230808	CTD	MESH:C066340	Tolcapone results in decreased expression of ALG13 mRNA	PMID:24136188
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ALG13 intron	PMID:30157460
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550222	E	RGD:6480464	20230808	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ALG13 mRNA	PMID:22206623
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C025589	ochratoxin A results in decreased expression of ALG13 mRNA	PMID:19287073
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALG13 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALG13 mRNA	PMID:27188386
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1550222	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of ALG13 mRNA	PMID:40826991
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALG13 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALG13 mRNA	PMID:27188386
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1351399	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ALG13 mRNA	PMID:38568856
11453602	Alg13	ALG13, UDP-N-acetylglucosaminyltransferase subunit	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1351399	E	RGD:6480464	20230808	CTD	MESH:D013849	Thimerosal results in increased expression of ALG13 mRNA	PMID:27188386
11455030	Rnf228	ring finger protein 228	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:150340634	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RNF228 mRNA	PMID:38832940
11466397	Cyp2c6-ps2	cytochrome P450, family 2, subfamily C, polypeptide 6, pseudogene 2	gene	CHEBI:35036	fentin chloride	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in increased expression of CYP2C6-PS2 mRNA	PMID:37156404
11468112	Hoxa2	homeobox A2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1353431	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of HOXA2 mRNA	PMID:38218311
11468112	Hoxa2	homeobox A2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1353431	E	RGD:6480464	20170210	CTD	MESH:D014212	Tretinoin results in increased expression of HOXA2 mRNA	PMID:17185360|PMID:21934132|PMID:40359302
11468112	Hoxa2	homeobox A2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20260113	CTD	MESH:D014212	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]; 4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [Tretinoin results in increased expression of HOXA2 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [Tretinoin results in increased expression of HOXA2 mRNA]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline affects the reaction [Tretinoin results in increased expression of HOXA2 mRNA]; [bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA; [Tretinoin co-treated with bisphenol A] results in increased expression of HOXA2 mRNA; Fulvestrant promotes the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]; Fulvestrant promotes the reaction [Tretinoin results in increased expression of HOXA2 mRNA]; LE 135 promotes the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]; LE 135 promotes the reaction [Tretinoin results in increased expression of HOXA2 mRNA]; LY2955303 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]; LY2955303 inhibits the reaction [Tretinoin results in increased expression of HOXA2 mRNA]	PMID:40359302
11468112	Hoxa2	homeobox A2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA2 mRNA	PMID:36189433
11468112	Hoxa2	homeobox A2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1353431	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of HOXA2 mRNA	PMID:30510588
11468112	Hoxa2	homeobox A2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of HOXA2 mRNA	PMID:33387578
11468112	Hoxa2	homeobox A2	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D005947	Glucose results in increased expression of HOXA2 mRNA	PMID:21818840
11468112	Hoxa2	homeobox A2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA	PMID:37567420
11468112	Hoxa2	homeobox A2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1353431	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of HOXA2 mRNA	PMID:36695872
11468112	Hoxa2	homeobox A2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA2 mRNA	PMID:36189433
11468112	Hoxa2	homeobox A2	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D005947	Glucose results in increased expression of HOXA2 mRNA	PMID:21818840
11468112	Hoxa2	homeobox A2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA	PMID:37567420
11468112	Hoxa2	homeobox A2	gene	CHEBI:17650	cortisol	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20220208	CTD	MESH:D006854	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA2 mRNA	PMID:34480604
11468112	Hoxa2	homeobox A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1353431	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HOXA2 mRNA	PMID:31163220
11468112	Hoxa2	homeobox A2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HOXA2 mRNA	PMID:33387578
11468112	Hoxa2	homeobox A2	gene	CHEBI:188938	Allylamine	affects expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D000499	Allylamine affects the expression of HOXA2 mRNA	PMID:15910882
11468112	Hoxa2	homeobox A2	gene	CHEBI:24527	herbicide	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20231031	CTD	MESH:D006540	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA	PMID:37567420
11468112	Hoxa2	homeobox A2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1353431	E	RGD:6480464	20170210	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HOXA2 gene	PMID:27153756
11468112	Hoxa2	homeobox A2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D009151	Mustard Gas results in decreased expression of HOXA2 mRNA	PMID:15674843
11468112	Hoxa2	homeobox A2	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of HOXA2 mRNA	PMID:31129395
11468112	Hoxa2	homeobox A2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of HOXA2 mRNA	PMID:27392435
11468112	Hoxa2	homeobox A2	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1353431	E	RGD:6480464	20170210	CTD	MESH:D010278	Parathion results in increased methylation of HOXA2 promoter	PMID:22847954
11468112	Hoxa2	homeobox A2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:731539	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of HOXA2 mRNA	PMID:32186404
11468112	Hoxa2	homeobox A2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1353431	E	RGD:6480464	20170210	CTD	MESH:D009532	Nickel results in decreased expression of HOXA2 mRNA	PMID:24768652|PMID:25583101
11468112	Hoxa2	homeobox A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HOXA2 mRNA	PMID:21570461
11468112	Hoxa2	homeobox A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HOXA2 mRNA	PMID:19897914
11468112	Hoxa2	homeobox A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HOXA2 mRNA	PMID:19933214|PMID:24058054
11468112	Hoxa2	homeobox A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HOXA2 mRNA	PMID:17942748
11468112	Hoxa2	homeobox A2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of HOXA2 mRNA	PMID:28959563
11468112	Hoxa2	homeobox A2	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1353431	E	RGD:6480464	20170210	CTD	MESH:D003561	Cytarabine results in increased expression of HOXA2 mRNA	PMID:21198554
11468112	Hoxa2	homeobox A2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA	PMID:37567420
11468112	Hoxa2	homeobox A2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20220208	CTD	MESH:D001205	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mRNA	PMID:34480604
11468112	Hoxa2	homeobox A2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D001205	Ascorbic Acid inhibits the reaction [Valproic Acid results in decreased expression of HOXA2 mRNA]	PMID:19655241
11468112	Hoxa2	homeobox A2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353431	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HOXA2 mRNA	PMID:38568856
11468112	Hoxa2	homeobox A2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:731539	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of HOXA2 mRNA	PMID:37682722
11468112	Hoxa2	homeobox A2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353431	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HOXA2 exon	PMID:27901495
11468112	Hoxa2	homeobox A2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1353431	E	RGD:6480464	20170210	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of HOXA2 mRNA	PMID:25895662
11468112	Hoxa2	homeobox A2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1353431	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of HOXA2 mRNA	PMID:26705709
11468112	Hoxa2	homeobox A2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D000643	Ammonium Chloride affects the expression of HOXA2 mRNA	PMID:16483693
11468112	Hoxa2	homeobox A2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20260113	CTD	MESH:C070081	Fulvestrant promotes the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]; Fulvestrant promotes the reaction [Tretinoin results in increased expression of HOXA2 mRNA]	PMID:40359302
11468112	Hoxa2	homeobox A2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:C009495	titanium dioxide results in decreased expression of HOXA2 mRNA	PMID:29264374
11468112	Hoxa2	homeobox A2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:731539	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of HOXA2 promoter	PMID:27334623
11468112	Hoxa2	homeobox A2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A results in decreased expression of HOXA2 mRNA	PMID:25181051
11468112	Hoxa2	homeobox A2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1353431	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of HOXA2 gene	PMID:31601247
11468112	Hoxa2	homeobox A2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A results in increased expression of HOXA2 mRNA	PMID:22687993|PMID:30951980
11468112	Hoxa2	homeobox A2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of HOXA2 mRNA	PMID:31129395
11468112	Hoxa2	homeobox A2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20260113	CTD	MESH:C006780	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]; [bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA; [Tretinoin co-treated with bisphenol A] results in increased expression of HOXA2 mRNA; Fulvestrant promotes the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]; LE 135 promotes the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]; LY2955303 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in increased expression of HOXA2 mRNA]	PMID:40359302
11468112	Hoxa2	homeobox A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1353431	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of HOXA2 gene	PMID:31601247
11468112	Hoxa2	homeobox A2	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:731539	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of HOXA2 gene	PMID:38995845
11468112	Hoxa2	homeobox A2	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of HOXA2 gene	PMID:27387713
11468112	Hoxa2	homeobox A2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of HOXA2 mRNA	PMID:27387713
11468112	Hoxa2	homeobox A2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of HOXA2 mRNA	PMID:22698814
11468112	Hoxa2	homeobox A2	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1353431	E	RGD:6480464	20170210	CTD	MESH:D004397	Fonofos results in increased methylation of HOXA2 promoter	PMID:22847954
11468112	Hoxa2	homeobox A2	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1353431	E	RGD:6480464	20170210	CTD	MESH:C012568	terbufos results in increased methylation of HOXA2 promoter	PMID:22847954
11468112	Hoxa2	homeobox A2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1353431	E	RGD:6480464	20190910	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of HOXA2 mRNA	PMID:30738844
11468112	Hoxa2	homeobox A2	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D002737	Chloroprene results in decreased expression of HOXA2 mRNA	PMID:23125180
11468112	Hoxa2	homeobox A2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D014635	Valproic Acid results in decreased expression of HOXA2 mRNA; Valproic Acid results in decreased expression of HOXA2 protein	PMID:19655241
11468112	Hoxa2	homeobox A2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D014635	Valproic Acid results in increased expression of HOXA2 mRNA	PMID:24896083
11468112	Hoxa2	homeobox A2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D014635	Ascorbic Acid inhibits the reaction [Valproic Acid results in decreased expression of HOXA2 mRNA]	PMID:19655241
11468112	Hoxa2	homeobox A2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D005947	Glucose results in increased expression of HOXA2 mRNA	PMID:21818840
11468112	Hoxa2	homeobox A2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA	PMID:37567420
11468112	Hoxa2	homeobox A2	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of HOXA2 mRNA	PMID:16122865
11468112	Hoxa2	homeobox A2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of HOXA2 mRNA	PMID:17942748
11468112	Hoxa2	homeobox A2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HOXA2 mRNA	PMID:17942748
11468112	Hoxa2	homeobox A2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1353431	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of HOXA2 mRNA	PMID:26705709
11468112	Hoxa2	homeobox A2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1353431	E	RGD:6480464	20170210	CTD	MESH:C029938	nickel sulfate results in increased expression of HOXA2 mRNA	PMID:22714537
11468112	Hoxa2	homeobox A2	gene	CHEBI:62878	XAV939	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20220208	CTD	MESH:C544261	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mRNA	PMID:34480604
11468112	Hoxa2	homeobox A2	gene	CHEBI:72544	flavonoids	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of HOXA2 mRNA	PMID:18035473
11468112	Hoxa2	homeobox A2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of HOXA2 mRNA	PMID:34480604
11468112	Hoxa2	homeobox A2	gene	CHEBI:75261	arotinoid acid	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20220208	CTD	MESH:C038864	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA2 mRNA	PMID:34480604
11468112	Hoxa2	homeobox A2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:731539	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA	PMID:37567420
11468112	Hoxa2	homeobox A2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HOXA2 gene]	PMID:28238834
11468112	Hoxa2	homeobox A2	gene	CHEBI:8107	phenytoin	decreases expression	ISO	RGD:731539	E	RGD:6480464	20170210	CTD	MESH:D010672	Phenytoin results in decreased expression of HOXA2 mRNA; Phenytoin results in decreased expression of HOXA2 protein	PMID:10789828
11468112	Hoxa2	homeobox A2	gene	CHEBI:91091	CHIR 99021	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20220208	CTD	MESH:C473711	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA2 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mRNA	PMID:34480604
11468112	Hoxa2	homeobox A2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353431	E	RGD:6480464	20220208	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of HOXA2 mRNA	PMID:34480604
11468112	Hoxa2	homeobox A2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1353431	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of HOXA2 mRNA	PMID:38568856
11468112	Hoxa2	homeobox A2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1353431	E	RGD:6480464	20170210	CTD	MESH:C057693	troglitazone results in decreased expression of HOXA2 mRNA	PMID:19140230
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:C084079	triptonide results in increased expression of SPRR2A2 mRNA	PMID:33045310
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SPRR2A2 mRNA	PMID:33484791
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:D004051	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of SPRR2A2 mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of SPRR2A2 mRNA]	PMID:33484791
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:D010126	Ozone results in increased expression of SPRR2A2 mRNA	PMID:31626304|PMID:33026818
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SPRR2A2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SPRR2A2 mRNA	PMID:34911549
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1354484	E	RGD:6480464	20230321	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPRR2E mRNA	PMID:32525701
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:C024565	ethylene dichloride results in increased expression of SPRR2A2 mRNA	PMID:28960355
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1354484	E	RGD:6480464	20230321	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPRR2E mRNA	PMID:23152189
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1354484	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SPRR2E mRNA	PMID:38568856
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPRR2A2 mRNA	PMID:23735875
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1354484	E	RGD:6480464	20230321	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPRR2E 3' UTR; Benzo(a)pyrene results in increased methylation of SPRR2E promoter	PMID:27901495
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:C009495	titanium dioxide results in decreased expression of SPRR2A2 mRNA	PMID:29264374
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:C006253	pirinixic acid results in decreased expression of SPRR2A2 mRNA	PMID:12727805
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1354484	E	RGD:6480464	20230321	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SPRR2E mRNA	PMID:26472689
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1354484	E	RGD:6480464	20230321	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SPRR2E gene	PMID:29154799
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1354484	E	RGD:6480464	20230321	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPRR2E mRNA	PMID:32525701
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SPRR2A2 mRNA; Nanotubes, Carbon results in increased expression of SPRR2A2 mRNA	PMID:25554681
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:2313363	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of SPRR2A2 mRNA	PMID:36907384
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1354484	E	RGD:6480464	20230321	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of SPRR2E mRNA	PMID:32151702
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:7823	oxazepam	decreases expression	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:D010076	Oxazepam results in decreased expression of SPRR2A2 mRNA	PMID:12727805
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1354484	E	RGD:6480464	20230321	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPRR2E gene]	PMID:28238834
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1354484	E	RGD:6480464	20230321	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPRR2E mRNA	PMID:32525701
11469006	Sprr2a2	small proline-rich protein 2A2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:2313363	E	RGD:6480464	20221213	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of SPRR2A2 mRNA; [Streptozocin co-treated with Dietary Fats] results in increased expression of SPRR2A2 mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of SPRR2A2 mRNA]	PMID:33484791
11469551	Fam180b	family with sequence similarity 180 member B	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:2298817	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FAM180B mRNA	PMID:33212167
11469551	Fam180b	family with sequence similarity 180 member B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:2298817	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM180B promoter	PMID:27901495
11469551	Fam180b	family with sequence similarity 180 member B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:2298817	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FAM180B mRNA	PMID:38382870
11469551	Fam180b	family with sequence similarity 180 member B	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:2298817	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FAM180B gene	PMID:29154799
11470817	Krtap9-1-ps1	keratin associated protein 9-1, pseudogene 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1343161	E	RGD:6480464	20170530	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of KRTAP9-9 mRNA	PMID:24763279
11470817	Krtap9-1-ps1	keratin associated protein 9-1, pseudogene 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1343161	E	RGD:6480464	20170530	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KRTAP9-9 gene	PMID:27153756
11470817	Krtap9-1-ps1	keratin associated protein 9-1, pseudogene 1	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1343161	E	RGD:6480464	20170530	CTD	MESH:D015032	Zinc deficiency results in decreased expression of KRTAP9-9 mRNA	PMID:18356318
11470817	Krtap9-1-ps1	keratin associated protein 9-1, pseudogene 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1343161	E	RGD:6480464	20170530	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KRTAP9-9 mRNA	PMID:22316170
11470817	Krtap9-1-ps1	keratin associated protein 9-1, pseudogene 1	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1343161	E	RGD:6480464	20170530	CTD	MESH:D015032	Zinc deficiency results in decreased expression of KRTAP9-9 mRNA	PMID:18356318
11470817	Krtap9-1-ps1	keratin associated protein 9-1, pseudogene 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1343161	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of KRTAP9-9 mRNA	PMID:40706910
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1350112	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HHLA2 mRNA	PMID:35811015
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1350112	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HHLA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of HHLA2 mRNA	PMID:35811015
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1350112	E	RGD:6480464	20160906	CTD	MESH:D004958	Estradiol results in increased expression of HHLA2 mRNA	PMID:23019147
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1350112	E	RGD:6480464	20160906	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of HHLA2 mRNA	PMID:23649840
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1350112	E	RGD:6480464	20160906	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of HHLA2 mRNA	PMID:23649840
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350112	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HHLA2 promoter	PMID:27901495
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350112	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HHLA2 5' UTR	PMID:27901495
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1350112	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of HHLA2 mRNA	PMID:31715268
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1350112	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HHLA2 gene	PMID:29154799
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1350112	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HHLA2 mRNA	PMID:38832940
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1350112	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of HHLA2 mRNA	PMID:26690555
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1350112	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of HHLA2 mRNA	PMID:24714768
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1350112	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HHLA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of HHLA2 mRNA	PMID:35811015
11472061	Hhla2	HHLA2 member of B7 family	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350112	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HHLA2 gene]	PMID:28238834
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1347447	E	RGD:6480464	20161018	CTD	MESH:D014212	Tretinoin results in decreased expression of MTCL3 mRNA	PMID:21934132
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1316772	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MTCL3 mRNA	PMID:30319688
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1347447	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MTCL3 mRNA	PMID:30165855
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1347447	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MTCL3 gene	PMID:27153756
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1316772	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of MTCL3 mRNA	PMID:28960355
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1347447	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MTCL3 mRNA	PMID:27392435
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1316772	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of MTCL3 mRNA	PMID:40618947
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1347447	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MTCL3 mRNA	PMID:27392435
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1347447	E	RGD:6480464	20161018	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MTCL3 mRNA	PMID:23179753
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347447	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MTCL3 promoter	PMID:27901495
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347447	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MTCL3 3' UTR; Benzo(a)pyrene results in increased methylation of MTCL3 5' UTR	PMID:27901495
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1347447	E	RGD:6480464	20161018	CTD	MESH:C015001	arsenite results in increased methylation of MTCL3 promoter	PMID:23974009
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1347447	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MTCL3 mRNA	PMID:26705709
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1316772	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of MTCL3 mRNA	PMID:29264374
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1316772	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of MTCL3 mRNA	PMID:28329830
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1316772	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MTCL3 mRNA	PMID:32156529
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1347447	E	RGD:6480464	20161018	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to MTCL3 promoter]	PMID:20348232
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1316772	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of MTCL3 mRNA	PMID:30951980
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1316772	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of MTCL3 mRNA	PMID:30951980
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347447	E	RGD:6480464	20241105	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MTCL3 mRNA	PMID:38382870
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347447	E	RGD:6480464	20161018	CTD	MESH:D014635	Valproic Acid affects the expression of MTCL3 mRNA	PMID:25979313
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1347447	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MTCL3 gene	PMID:29154799
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1347447	E	RGD:6480464	20161018	CTD	MESH:D014635	Valproic Acid results in increased expression of MTCL3 mRNA	PMID:23179753|PMID:24383497
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347447	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTCL3 mRNA	PMID:27188386
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1347447	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MTCL3 mRNA	PMID:38832940
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1347447	E	RGD:6480464	20161213	CTD	MESH:C111237	Vorinostat results in decreased expression of MTCL3 mRNA	PMID:27188386
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MTCL3 mRNA	PMID:33387578
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1347447	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MTCL3 mRNA	PMID:26705709
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20161018	CTD	MESH:D007649	Ketamine results in decreased expression of MTCL3 mRNA	PMID:20080153
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347447	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTCL3 mRNA	PMID:27188386
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of MTCL3 protein	PMID:28903499
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:82284	2-Amino-9H-pyrido[2,3-b]indole	increases expression	ISO	RGD:1347447	E	RGD:6480464	20260113	CTD	MESH:C017822	2-amino-9H-pyrido(2,3-b)indole results in increased expression of SOGA3 mRNA	PMID:40713012
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20161018	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MTCL3 mRNA	PMID:23640034
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347447	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTCL3 mRNA	PMID:27188386
11479453	Mtcl3	MTCL family member 3	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1347447	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MTCL3 mRNA	PMID:27188386
11485321	Gng5-ps3	G protein subunit gamma 5, pseudogene 3	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:D024502	[Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [sodium arsenite results in decreased expression of GNG5-PS3 mRNA]	PMID:37704839
11485321	Gng5-ps3	G protein subunit gamma 5, pseudogene 3	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:D001205	[Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [sodium arsenite results in decreased expression of GNG5-PS3 mRNA]	PMID:37704839
11485321	Gng5-ps3	G protein subunit gamma 5, pseudogene 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of GNG5-PS3 mRNA	PMID:37704839
11485321	Gng5-ps3	G protein subunit gamma 5, pseudogene 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	[Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [sodium arsenite results in decreased expression of GNG5-PS3 mRNA]	PMID:37704839
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1343753	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PCDHB16 mRNA	PMID:25812627
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1343753	E	RGD:6480464	20240604	CTD	MESH:D000431	Ethanol results in decreased expression of PCDHB16 mRNA	PMID:25566775
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1343753	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PCDHB16 mRNA	PMID:35811015
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1343753	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDHB16 mRNA	PMID:35811015
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDHB13 mRNA; Trichloroethylene results in decreased expression of PCDHB16L mRNA	PMID:33387578
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:C005556	propionaldehyde results in increased expression of PCDHB16 mRNA	PMID:26079696
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1343753	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of PCDHB16 mRNA	PMID:33647349
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHB16 gene	PMID:27153756
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDHB13 mRNA	PMID:33387578
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1343753	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PCDHB16 mRNA	PMID:32763439
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDHB16 mRNA	PMID:29803840
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343753	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDHB16 5' UTR; Benzo(a)pyrene affects the methylation of PCDHB16 exon; Benzo(a)pyrene affects the methylation of PCDHB17 promoter	PMID:27901495
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:C015001	arsenite results in increased methylation of PCDHB16 promoter	PMID:23974009
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20170321	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDHB16 mRNA	PMID:25181051
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1343753	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PCDHB16 gene	PMID:31601247
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1343753	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PCDHB16 mRNA	PMID:25812627
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1343753	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PCDHB16 mRNA	PMID:31533062
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:D014635	Valproic Acid results in increased expression of PCDHB16 mRNA	PMID:23179753|PMID:27188386
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCDHB16 mRNA	PMID:20106945
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:C111237	Vorinostat results in decreased expression of PCDHB16 mRNA	PMID:27188386
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:C012589	trichostatin A results in decreased expression of PCDHB16 mRNA	PMID:24935251|PMID:26272509
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB16 mRNA	PMID:27188386
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1343753	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDHB16 mRNA	PMID:35811015
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB16 mRNA	PMID:27188386
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1343753	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDHB16 gene]	PMID:28238834
11492646	Pcdhb16	protocadherin beta 16	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1343753	E	RGD:6480464	20190219	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB16 mRNA	PMID:27188386
11493370	Sprr5	small proline rich protein 5	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:13208275	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPRR5 mRNA	PMID:38174414
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1343074	E	RGD:6480464	20160906	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of GPR32 mRNA	PMID:24763279
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1343074	E	RGD:6480464	20160906	CTD	MESH:C018475	butyraldehyde results in increased expression of GPR32 mRNA	PMID:26079696
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	ISO	RGD:1343074	E	RGD:6480464	20160906	CTD	MESH:D001104	Arbutin results in increased expression of GPR32 mRNA	PMID:17103032
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1343074	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPR32 mRNA	PMID:35301059
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1343074	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GPR32 exon	PMID:27901495
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1343074	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of GPR32 gene	PMID:31601247
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1343074	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GPR32 mRNA	PMID:28628672
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1343074	E	RGD:6480464	20160906	CTD	MESH:D002330	Carmustine results in decreased expression of GPR32 mRNA	PMID:15980968
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1343074	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of GPR32 exon	PMID:30157460
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1343074	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GPR32 mRNA	PMID:28628672
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1343074	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPR32 mRNA	PMID:35301059
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1343074	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GPR32 gene	PMID:29154799
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1343074	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GPR32 mRNA	PMID:28628672
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1343074	E	RGD:6480464	20160906	CTD	MESH:C011890	kojic acid results in increased expression of GPR32 mRNA	PMID:16595896
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1343074	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of GPR32 mRNA	PMID:26690555
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1343074	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GPR32 mRNA	PMID:28628672
11496573	Gpr32	G protein-coupled receptor 32	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1343074	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of GPR32 exon	PMID:30157460
11496771	Smim40	small integral membrane protein 40	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1616348	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SMIM40 mRNA	PMID:33045310
11496771	Smim40	small integral membrane protein 40	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1616348	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SMIM40 mRNA	PMID:37995155
11496771	Smim40	small integral membrane protein 40	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1616348	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SMIM40 mRNA	PMID:36331819
11496771	Smim40	small integral membrane protein 40	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1616348	E	RGD:6480464	20210202	CTD	MESH:C009495	titanium dioxide results in decreased expression of SMIM40 mRNA	PMID:29264374
11496771	Smim40	small integral membrane protein 40	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1616348	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SMIM40 mRNA	PMID:37019170
11496771	Smim40	small integral membrane protein 40	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616348	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SMIM40 mRNA	PMID:36331819
11496771	Smim40	small integral membrane protein 40	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1616348	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of SMIM40 mRNA	PMID:40633821
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1318007	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of EPS8L3 mRNA	PMID:38218311
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1318008	E	RGD:6480464	20170210	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS8L3 mRNA	PMID:20938992
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of EPS8L3 mRNA	PMID:33387578
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1318008	E	RGD:6480464	20170210	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS8L3 mRNA	PMID:20938992
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1318008	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EPS8L3 mRNA	PMID:34319233
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EPS8L3 promoter	PMID:23359474
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1318007	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of EPS8L3 intron	PMID:30157460
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:184401	3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine	affects response to substance	ISO	RGD:1318007	E	RGD:6480464	20220104	CTD	MESH:C045421	EPS8L3 protein affects the susceptibility to 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine	PMID:19223546
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1318008	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of EPS8L3 mRNA	PMID:39984025
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1318007	E	RGD:6480464	20170210	CTD	MESH:D016604	Aflatoxin B1 affects the expression of EPS8L3 protein	PMID:20106945
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1318007	E	RGD:6480464	20170210	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EPS8L3 gene	PMID:27153756
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1318008	E	RGD:6480464	20170210	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS8L3 mRNA	PMID:20938992
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1318007	E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of EPS8L3 mRNA	PMID:38460933
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1318007	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of EPS8L3 protein	PMID:35688186
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1318007	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of EPS8L3 mRNA	PMID:27392435
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1318007	E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPS8L3 mRNA	PMID:20106945|PMID:21632981
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1318008	E	RGD:6480464	20170210	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EPS8L3 mRNA	PMID:17942748
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D003300	Copper deficiency results in increased expression of EPS8L3 mRNA	PMID:26033743
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1318007	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of EPS8L3 mRNA	PMID:29301061
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1318008	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of EPS8L3 mRNA	PMID:37682722
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1318007	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EPS8L3 5' UTR; Benzo(a)pyrene affects the methylation of EPS8L3 intron	PMID:27901495|PMID:30157460
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1318007	E	RGD:6480464	20170210	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EPS8L3 mRNA	PMID:21632981|PMID:32234424
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D003300	Copper deficiency results in increased expression of EPS8L3 mRNA	PMID:26033743
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1318007	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of EPS8L3 gene	PMID:31601247
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of EPS8L3 mRNA	PMID:32479839
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A results in decreased expression of EPS8L3 mRNA	PMID:25181051
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1318008	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of EPS8L3 promoter	PMID:27312807
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EPS8L3 promoter	PMID:23359474
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1318008	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of EPS8L3 mRNA	PMID:26682919
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1318008	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of EPS8L3 mRNA	PMID:40203079
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1318007	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of EPS8L3 intron	PMID:30157460
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EPS8L3 promoter	PMID:23359474
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of EPS8L3 mRNA	PMID:27387713
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1318008	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EPS8L3 mRNA	PMID:40194260
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1318007	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of EPS8L3 mRNA	PMID:29154799
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1318007	E	RGD:6480464	20170210	CTD	MESH:D016572	Cyclosporine results in decreased expression of EPS8L3 mRNA	PMID:20106945|PMID:27989131
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1318007	E	RGD:6480464	20170210	CTD	MESH:D016572	Cyclosporine results in increased expression of EPS8L3 mRNA	PMID:25562108
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1318007	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EPS8L3 mRNA	PMID:38832940
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1318007	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of EPS8L3 mRNA	PMID:29067470
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:48981	quinolin-8-ol	increases expression	ISO	RGD:1318007	E	RGD:6480464	20170210	CTD	MESH:D015125	Oxyquinoline results in increased expression of EPS8L3 mRNA	PMID:21632981
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EPS8L3 mRNA	PMID:17557909
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1318008	E	RGD:6480464	20170210	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EPS8L3 mRNA	PMID:17942748
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1318008	E	RGD:6480464	20170210	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EPS8L3 mRNA	PMID:17942748
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1318007	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of EPS8L3 mRNA	PMID:32234424
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1318007	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of EPS8L3 intron	PMID:30157460
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1318008	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EPS8L3 mRNA	PMID:22206623
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1318007	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in increased expression of EPS8L3 mRNA	PMID:28284560
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:76290	PhIP	affects response to substance	ISO	RGD:1318007	E	RGD:6480464	20170210	CTD	MESH:C049584	EPS8L3 protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	PMID:19223546
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:76604	MeIQx	affects response to substance	ISO	RGD:1318007	E	RGD:6480464	20170210	CTD	MESH:C036990	EPS8L3 protein affects the susceptibility to 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline	PMID:19223546
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1318008	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of EPS8L3 mRNA	PMID:26655953
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1318007	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of EPS8L3 mRNA	PMID:32234424
11498829	Eps8l3	EPS8 signaling adaptor L3	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:C025643	vinclozolin results in decreased methylation of EPS8L3 gene	PMID:30207508|PMID:31079544
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:10162	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of ANP32A protein	PMID:36252740
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:10162	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ANP32A mRNA	PMID:33045310
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:10162	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ANP32A mRNA	PMID:37995155
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ANP32A mRNA]	PMID:31150632
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D014212	Tretinoin results in decreased expression of ANP32A mRNA	PMID:21934132
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ANP32A gene	PMID:35440735
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D001280	Atrazine results in increased expression of ANP32A mRNA; Atrazine results in increased expression of ANP32A protein	PMID:25275270
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ANP32A mRNA	PMID:18951874
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D011794	Quercetin results in decreased expression of ANP32A protein	PMID:19207037
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:10162	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ANP32A mRNA	PMID:39241906
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:16469	17beta-estradiol	affects localization	ISO	RGD:1606331	E	RGD:6480464	20230502	CTD	MESH:D004958	Estradiol affects the localization of ANP32A protein	PMID:36534342
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D004958	Estradiol results in decreased expression of ANP32A mRNA	PMID:19484750
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D004958	Estradiol results in increased expression of ANP32A mRNA	PMID:20068009
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:10162	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ANP32A mRNA	PMID:39298647
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ANP32A protein	PMID:21673325
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:10162	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ANP32A mRNA	PMID:33711761
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1606331	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ANP32A mRNA	PMID:38568856
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D005557	Formaldehyde results in decreased expression of ANP32A mRNA	PMID:23649840
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:10162	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of ANP32A mRNA	PMID:33848595
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:17362	quinoline	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:C037219	quinoline analog results in decreased expression of ANP32A protein	PMID:18645022
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ANP32A promoter	PMID:23359474
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D005839	Gentamicins results in increased expression of ANP32A mRNA	PMID:22061828
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ANP32A mRNA	PMID:28818685
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANP32A mRNA	PMID:36331819
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20221101	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ANP32A mRNA	PMID:35690225
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ANP32A mRNA	PMID:19549813
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ANP32A mRNA	PMID:23649840
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of ANP32A protein	PMID:33236894
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ANP32A mRNA	PMID:19770486
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANP32A gene	PMID:27153756
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ANP32A mRNA	PMID:23649840
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of ANP32A protein	PMID:33146391
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ANP32A mRNA	PMID:35430440
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ANP32A mRNA	PMID:31150632
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ANP32A mRNA	PMID:27339419|PMID:31919559
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ANP32A mRNA]	PMID:31150632
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:10162	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ANP32A mRNA	PMID:25629700
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ANP32A mRNA	PMID:21867686
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ANP32A mRNA	PMID:22206623
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ANP32A mRNA	PMID:39836092
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ANP32A protein	PMID:38460933
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27690	acetazolamide	increases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D000086	Acetazolamide results in increased expression of ANP32A mRNA	PMID:19274763
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:10162	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of ANP32A protein	PMID:37208198
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:10162	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of ANP32A mRNA	PMID:28189721|PMID:28960355
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ANP32A mRNA	PMID:23557933
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20231003	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A exon; [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A intron	PMID:33445541
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D002945	Cisplatin results in decreased expression of ANP32A mRNA	PMID:21151649
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ANP32A mRNA	PMID:27594783
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D002945	Cisplatin promotes the reaction [Piroxicam results in decreased expression of ANP32A mRNA]	PMID:21858171
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D019833	Genistein results in decreased expression of ANP32A mRNA	PMID:18847459
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANP32A mRNA	PMID:34747641
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANP32A mRNA	PMID:21570461
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANP32A mRNA	PMID:19933214
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ANP32A mRNA	PMID:25975270
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of ANP32A mRNA	PMID:28374803
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ANP32A mRNA	PMID:33212167
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ANP32A mRNA	PMID:20971185
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1606331	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of ANP32A protein	PMID:29385562
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ANP32A mRNA	PMID:29803840
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1606331	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of ANP32A mRNA	PMID:29319823
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANP32A mRNA; sodium arsenite results in decreased expression of ANP32A protein	PMID:38228842|PMID:38568856
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:10162	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ANP32A protein	PMID:29044176
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ANP32A mRNA	PMID:39836092
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ANP32A mRNA	PMID:21964900
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ANP32A mRNA	PMID:20064835
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANP32A mRNA	PMID:21839799
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANP32A mRNA	PMID:22228805
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANP32A protein	PMID:17292933
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:29866	arsenite(3-)	affects localization	ISO	RGD:1606331	E	RGD:6480464	20230502	CTD	MESH:C015001	arsenite affects the localization of ANP32A protein	PMID:36534342
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ANP32A mRNA	PMID:20971185
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ANP32A mRNA	PMID:25895662
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANP32A mRNA	PMID:20382639
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D000643	Ammonium Chloride affects the expression of ANP32A mRNA	PMID:16483693
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20231003	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A exon; [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A intron	PMID:33445541
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ANP32A mRNA	PMID:25729387
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:C009495	titanium dioxide affects the expression of ANP32A mRNA	PMID:23557971
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:10162	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ANP32A mRNA	PMID:35295148
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:10162	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ANP32A gene; titanium dioxide results in decreased methylation of ANP32A promoter	PMID:35295148
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:10162	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ANP32A gene	PMID:35295148
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:C006253	pirinixic acid results in decreased expression of ANP32A mRNA	PMID:18445702
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C006253	pirinixic acid results in increased expression of ANP32A mRNA	PMID:12832660|PMID:19162173
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:C006253	pirinixic acid results in increased expression of ANP32A mRNA	PMID:23811191
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of ANP32A mRNA	PMID:19191707
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C006780	bisphenol A affects the expression of ANP32A mRNA	PMID:25181051|PMID:30903817
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1606331	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ANP32A mRNA	PMID:30903817
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ANP32A mRNA	PMID:30816183|PMID:34947998
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:10162	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ANP32A mRNA	PMID:33221593
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606331	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ANP32A mRNA; bisphenol A results in increased expression of ANP32A protein	PMID:33376534|PMID:33670352
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ANP32A promoter	PMID:23359474
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:10162	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ANP32A mRNA	PMID:39298647
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:10162	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ANP32A exon	PMID:33297965
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34565	benzo[b]fluoranthene	affects expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:C006703	benzo(b)fluoranthene affects the expression of ANP32A mRNA	PMID:26377693
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ANP32A mRNA	PMID:26377693
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1606331	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ANP32A protein	PMID:34186270
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:10162	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of ANP32A intron	PMID:28392331
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:10162	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ANP32A mRNA	PMID:28392331
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D003976	Diazinon results in increased methylation of ANP32A gene	PMID:22964155
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ANP32A mRNA	PMID:21266533
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ANP32A promoter	PMID:23359474
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:10162	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ANP32A mRNA	PMID:34813904
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANP32A mRNA	PMID:18164116
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606331	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANP32A mRNA	PMID:37042841
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20221101	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ANP32A mRNA	PMID:35690225
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ANP32A mRNA	PMID:19376846
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D002994	Clofibrate results in decreased expression of ANP32A mRNA	PMID:17585979
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:38757	isoflavones	affects expression	ISO	RGD:1606331	E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones affects the expression of ANP32A mRNA	PMID:16365062
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ANP32A mRNA	PMID:31533062
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D003375	Coumestrol results in increased expression of ANP32A mRNA	PMID:19167446
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANP32A mRNA	PMID:36331819
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D014635	Valproic Acid results in decreased expression of ANP32A mRNA	PMID:21427059
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ANP32A mRNA	PMID:28001369
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1606331	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ANP32A gene	PMID:29154799
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D016572	Cyclosporine results in decreased expression of ANP32A mRNA	PMID:20106945|PMID:25562108
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:45863	paclitaxel	affects response to substance	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D017239	ANP32A protein affects the susceptibility to Paclitaxel	PMID:16217747
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D000082	Acetaminophen affects the expression of ANP32A mRNA	PMID:17562736
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D000082	Acetaminophen results in decreased expression of ANP32A mRNA	PMID:18544908
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D000082	Acetaminophen results in decreased expression of ANP32A mRNA	PMID:21420995|PMID:29067470
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:10162	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ANP32A mRNA	PMID:29279043
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:46680	serpentine asbestos	increases methylation	ISO	RGD:1606331	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of ANP32A gene	PMID:29523930
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ANP32A protein	PMID:38460933
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:47105	1-bromopropane	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C118559	1-bromopropane results in increased expression of ANP32A protein	PMID:21925529
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ANP32A mRNA	PMID:39836092
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:10162	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ANP32A mRNA	PMID:35436446
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ANP32A mRNA; Nanotubes, Carbon results in decreased expression of ANP32A mRNA	PMID:25554681|PMID:25620056
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20171010	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ANP32A mRNA	PMID:28673683
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D018120	Finasteride results in increased expression of ANP32A mRNA	PMID:24136188
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ANP32A mRNA	PMID:35964746
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:5118	fluoxetine	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D005473	Fluoxetine results in decreased expression of ANP32A mRNA	PMID:17033635
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:5130	flurbiprofen	increases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D005480	Flurbiprofen results in increased expression of ANP32A mRNA	PMID:16949054
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:C030935	benz(a)anthracene results in increased expression of ANP32A mRNA	PMID:26377693
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ANP32A protein	PMID:32959892
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20221101	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ANP32A mRNA	PMID:35690225
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D019772	ANP32A protein affects the susceptibility to Topotecan	PMID:16217747
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D019772	Topotecan results in decreased expression of ANP32A mRNA	PMID:25729387
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ANP32A mRNA	PMID:25729387
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ANP32A mRNA	PMID:15336504
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:D007545	Isoproterenol results in decreased expression of ANP32A mRNA	PMID:20003209|PMID:21335049
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of ANP32A mRNA	PMID:35283115
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D008701	Methapyrilene results in increased expression of ANP32A mRNA	PMID:22484513
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:72544	flavonoids	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in decreased expression of ANP32A mRNA	PMID:18035473
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1606331	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ANP32A protein	PMID:34186270
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:10162	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ANP32A mRNA	PMID:22206623
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:749217	halofuginone	decreases expression	EXP		E	RGD:6480464	20260721	CTD	MESH:C010176	halofuginone results in decreased expression of ANP32A mRNA	PMID:17180598
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C051752	nefazodone results in decreased expression of ANP32A mRNA	PMID:24136188
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:76987	metacetamol	decreases expression	ISO	RGD:10162	E	RGD:6480464	20170210	CTD	MESH:C026137	3-hydroxyacetanilide results in decreased expression of ANP32A mRNA	PMID:18544908
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20170210	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANP32A mRNA	PMID:18164116
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D010894	Piroxicam results in decreased expression of ANP32A mRNA	PMID:21858171
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1606331	E	RGD:6480464	20170210	CTD	MESH:D010894	Cisplatin promotes the reaction [Piroxicam results in decreased expression of ANP32A mRNA]	PMID:21858171
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of ANP32A protein	PMID:38348393
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:10162	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ANP32A mRNA	PMID:21795629
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20170210	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ANP32A mRNA	PMID:24780913
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1606331	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ANP32A mRNA	PMID:38568856
11508551	Anp32a	acidic nuclear phosphoprotein 32 family member A	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20170210	CTD	MESH:C025643	vinclozolin affects the expression of ANP32A mRNA	PMID:19015723
1302933	Mcpt1l3	mast cell protease 1-like 3	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of MCPT1L3 mRNA	PMID:21396975
1302933	Mcpt1l3	mast cell protease 1-like 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of MCPT1L3 mRNA	PMID:23869203
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1549984	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ST8SIA5 mRNA	PMID:37995155
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1549984	E	RGD:6480464	20220111	CTD	MESH:D014212	Tretinoin affects the expression of ST8SIA5 mRNA	PMID:34627992
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20220111	CTD	MESH:D014212	3,3'-dichlorobiphenyl affects the reaction [Tretinoin affects the expression of ST8SIA5 mRNA]; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ST8SIA5 mRNA	PMID:34627992|PMID:36189433
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1349184	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ST8SIA5 mRNA	PMID:26079696
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1349184	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ST8SIA5 mRNA	PMID:35811015
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1349184	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ST8SIA5 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ST8SIA5 mRNA	PMID:35811015
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST8SIA5 mRNA	PMID:25510870
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ST8SIA5 mRNA	PMID:33387578
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1349184	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ST8SIA5 mRNA	PMID:26079696
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1549984	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ST8SIA5 mRNA	PMID:22401849
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ST8SIA5 mRNA	PMID:36189433
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1549984	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ST8SIA5 mRNA	PMID:20403060
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST8SIA5 mRNA	PMID:25510870
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST8SIA5 mRNA	PMID:25510870
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1349184	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ST8SIA5 gene	PMID:25304211
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1349184	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ST8SIA5 mRNA	PMID:23557933
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1349184	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of ST8SIA5 gene	PMID:31636367
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20150512	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ST8SIA5 mRNA	PMID:17942748
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1349184	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ST8SIA5 mRNA	PMID:32763439
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1349184	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ST8SIA5 mRNA	PMID:29803840
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349184	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ST8SIA5 promoter	PMID:27901495
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1349184	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ST8SIA5 mRNA	PMID:21871943
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1549984	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ST8SIA5 mRNA	PMID:15894712
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349184	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ST8SIA5 3' UTR	PMID:27901495
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20120412	CTD	MESH:D001564	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of ST8SIA5 mRNA	PMID:15894712
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1549984	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of ST8SIA5 mRNA	PMID:15894712
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1349184	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of ST8SIA5 promoter	PMID:23974009
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20120412	CTD	MESH:C015001	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of ST8SIA5 mRNA	PMID:15894712
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	ISO	RGD:1349184	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of ST8SIA5 mRNA	PMID:25075043
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1549984	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ST8SIA5 gene; titanium dioxide results in decreased methylation of ST8SIA5 promoter	PMID:35295148
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ST8SIA5 mRNA	PMID:25181051|PMID:34947998
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ST8SIA5 mRNA	PMID:36041667
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST8SIA5 mRNA	PMID:25510870
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST8SIA5 mRNA	PMID:25510870
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1549984	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ST8SIA5 gene	PMID:31683443
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ST8SIA5 mRNA	PMID:36041667
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ST8SIA5 mRNA	PMID:36041667
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ST8SIA5 mRNA	PMID:21266533
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of ST8SIA5 mRNA	PMID:36117858
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ST8SIA5 mRNA	PMID:33453195
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1349184	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ST8SIA5 mRNA	PMID:31533062
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349184	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ST8SIA5 mRNA	PMID:25979313
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349184	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of ST8SIA5 mRNA	PMID:28001369
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1549984	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ST8SIA5 mRNA	PMID:21427059
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1349184	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ST8SIA5 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ST8SIA5 mRNA	PMID:35811015
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1349184	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ST8SIA5 gene	PMID:25304211
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1549984	E	RGD:6480464	20150512	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ST8SIA5 mRNA	PMID:17942748
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20150512	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ST8SIA5 mRNA	PMID:17942748
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:50035	alpha-phellandrene	decreases expression	ISO	RGD:1349184	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of ST8SIA5 mRNA	PMID:25075043
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1549984	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of ST8SIA5 mRNA	PMID:36117858
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1549984	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ST8SIA5 mRNA	PMID:23608068
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1549984	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ST8SIA5 mRNA	PMID:22206623
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:8093	phenylephrine	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D010656	Phenylephrine results in increased expression of ST8SIA5 mRNA	PMID:18158353
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ST8SIA5 mRNA	PMID:32109520
1302934	St8sia5	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ST8SIA5 mRNA	PMID:24780913
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NUDT19 gene	PMID:20938992
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1602031	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of NUDT19 mRNA	PMID:21934132
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of NUDT19 protein	PMID:40631627
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1602031	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of NUDT19 mRNA	PMID:20044591
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551965	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NUDT19 mRNA	PMID:39241906
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551965	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NUDT19 mRNA	PMID:39298647
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1602031	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of NUDT19 mRNA	PMID:23019147
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1602031	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NUDT19 mRNA	PMID:38568856
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NUDT19 gene	PMID:20938992
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602031	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NUDT19 mRNA	PMID:37042841
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of NUDT19 protein	PMID:40631627
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of NUDT19 protein	PMID:40631627
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1602031	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NUDT19 mRNA	PMID:28818685
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NUDT19 mRNA	PMID:36331819
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUDT19 mRNA	PMID:37236586
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602031	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NUDT19 mRNA	PMID:19549813
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUDT19 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NUDT19 gene	PMID:20938992|PMID:22206623
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NUDT19 mRNA	PMID:40504410
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1551965	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NUDT19 mRNA	PMID:30912803
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1551965	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of NUDT19 mRNA	PMID:32186404
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551965	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUDT19 mRNA	PMID:21570461
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUDT19 mRNA	PMID:18796159
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of NUDT19 mRNA	PMID:28374803
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1602031	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUDT19 mRNA	PMID:20971185
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1551965	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of NUDT19 protein	PMID:28918527
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602031	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NUDT19 mRNA	PMID:29803840
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602031	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NUDT19 mRNA	PMID:38568856
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NUDT19 mRNA	PMID:40504410
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1602031	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of NUDT19 gene	PMID:25435355
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1602031	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUDT19 mRNA	PMID:20971185
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551965	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NUDT19 gene	PMID:35295148
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NUDT19 mRNA	PMID:19710929
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NUDT19 mRNA	PMID:30816183|PMID:32528016
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551965	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NUDT19 mRNA	PMID:33221593
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602031	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of NUDT19 protein	PMID:34186270
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NUDT19 gene	PMID:28505145
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1602031	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of NUDT19 mRNA	PMID:25979313
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551965	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NUDT19 mRNA	PMID:39298647
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1602031	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of NUDT19 protein	PMID:34186270
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1602031	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NUDT19 mRNA	PMID:28628672
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1602031	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of NUDT19 protein	PMID:34186270
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of NUDT19 mRNA	PMID:21241498
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551965	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of NUDT19 mRNA	PMID:34813904
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1602031	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NUDT19 mRNA	PMID:28628672
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1551965	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of NUDT19 mRNA	PMID:34813904
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602031	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NUDT19 mRNA	PMID:37042841
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602031	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NUDT19 mRNA	PMID:38174414|PMID:38568856
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUDT19 mRNA	PMID:37236586
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1551965	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of NUDT19 mRNA	PMID:18353800
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1602031	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of NUDT19 mRNA	PMID:28302478
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602031	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NUDT19 mRNA	PMID:31533062
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NUDT19 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NUDT19 mRNA	PMID:36331819
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551965	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NUDT19 mRNA	PMID:17292431
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602031	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NUDT19 mRNA	PMID:25979313
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602031	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NUDT19 mRNA	PMID:23179753
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602031	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of NUDT19 mRNA	PMID:20106945
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1602031	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NUDT19 mRNA	PMID:28628672
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551965	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NUDT19 mRNA	PMID:28973697
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of NUDT19 protein	PMID:40631627
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1602031	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of NUDT19 mRNA	PMID:28542535
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NUDT19 mRNA	PMID:40504410
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1602031	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NUDT19 mRNA	PMID:28628672
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NUDT19 mRNA	PMID:24136188
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1551965	E	RGD:6480464	20120412	CTD	MESH:D010081	Oxazolone results in increased expression of NUDT19 mRNA	PMID:11379042
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1602031	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NUDT19 protein	PMID:32959892
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of NUDT19 mRNA	PMID:24136188
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551965	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NUDT19 mRNA	PMID:22206623
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551965	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUDT19 mRNA	PMID:22206623
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602031	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NUDT19 gene]	PMID:28238834
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1551965	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of NUDT19 mRNA	PMID:38648751
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1551965	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of NUDT19 mRNA	PMID:21278054
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1551965	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of NUDT19 mRNA	PMID:40826991
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NUDT19 mRNA	PMID:21346803
1302935	Nudt19	nudix hydrolase 19	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602031	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NUDT19 mRNA	PMID:38568856
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1346889	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of C1RL mRNA	PMID:38218311
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1549998	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of C1RL mRNA	PMID:26251327
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1346889	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of C1RL mRNA	PMID:33167477
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of C1RL mRNA	PMID:26079696
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1549998	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of C1RL mRNA	PMID:39241906
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1549998	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of C1RL mRNA	PMID:39298647
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346889	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of C1RL mRNA	PMID:30165855
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1549998	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of C1RL mRNA	PMID:33711761
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of C1RL mRNA	PMID:33387578
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1549998	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of C1RL mRNA	PMID:34319233
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of C1RL mRNA	PMID:33387578
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of C1RL mRNA	PMID:28818685
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1549998	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of C1RL mRNA	PMID:36331819
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1346889	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of C1RL mRNA	PMID:39836092
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of C1RL mRNA	PMID:19549813
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1346889	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of C1RL mRNA	PMID:23649840
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of C1RL mRNA	PMID:22100608|PMID:27153756
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1346889	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of C1RL mRNA	PMID:23649840
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1549998	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of C1RL mRNA	PMID:34911549
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of C1RL mRNA	PMID:31129395
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of C1RL mRNA	PMID:31150632
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1549998	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of C1RL mRNA	PMID:25629700
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346889	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of C1RL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C1RL mRNA	PMID:39836092
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1346889	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of C1RL mRNA	PMID:38460933
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of C1RL mRNA	PMID:31881176
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1346889	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of C1RL mRNA	PMID:27392435
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1549998	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of C1RL mRNA	PMID:21570461
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of C1RL mRNA	PMID:33387578
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1346889	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of C1RL mRNA	PMID:20106945|PMID:21632981
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of C1RL mRNA	PMID:28001369
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of C1RL mRNA	PMID:32763439
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of C1RL mRNA	PMID:38568856
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1549998	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of C1RL mRNA	PMID:37682722
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346889	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of C1RL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C1RL mRNA	PMID:39836092
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1346889	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of C1RL mRNA	PMID:20064835
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346889	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C1RL promoter	PMID:27901495
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1549998	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C1RL 3' UTR; Benzo(a)pyrene results in increased methylation of C1RL exon	PMID:27901495
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of C1RL mRNA	PMID:25895662
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of C1RL mRNA	PMID:23411599|PMID:34492290
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1549998	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of C1RL mRNA	PMID:28329830
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of C1RL mRNA	PMID:30816183|PMID:32145629
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1549998	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of C1RL protein	PMID:35999755
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of C1RL mRNA	PMID:25181051
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of C1RL gene	PMID:28505145
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of C1RL mRNA	PMID:31129395
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1346889	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of C1RL mRNA	PMID:25979313
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:34107	1-nitropyrene	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of C1RL mRNA	PMID:19041380
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1346889	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of C1RL gene	PMID:31601247
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1549998	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of C1RL mRNA	PMID:39298647
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1549998	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with LIF protein] results in increased expression of C1RL mRNA	PMID:30951980
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1549998	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of C1RL mRNA	PMID:34813904
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346889	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of C1RL mRNA	PMID:37042841
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1346889	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of C1RL mRNA	PMID:39836092
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of C1RL mRNA	PMID:33453195
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of C1RL mRNA	PMID:25539665
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of C1RL mRNA	PMID:19376846
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of C1RL mRNA	PMID:24449571
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1549998	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of C1RL mRNA	PMID:40194260
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1549998	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of C1RL mRNA	PMID:36331819
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346889	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of C1RL mRNA	PMID:25979313
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1549998	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of C1RL mRNA	PMID:17292431
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of C1RL mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1346889	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of C1RL gene	PMID:29154799
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346889	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of C1RL mRNA	PMID:24935251
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of C1RL mRNA	PMID:20106945|PMID:25562108
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1346889	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of C1RL promoter	PMID:27989131
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of C1RL mRNA	PMID:38832940
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1346889	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of C1RL mRNA	PMID:24935251
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1549998	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of C1RL mRNA	PMID:17562736
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of C1RL mRNA	PMID:33387578
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of C1RL mRNA	PMID:29067470
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1346889	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of C1RL mRNA	PMID:38460933
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346889	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of C1RL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C1RL mRNA	PMID:39836092
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1549998	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of C1RL mRNA	PMID:35436446
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1346889	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of C1RL mRNA	PMID:19194470
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1549998	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of C1RL mRNA	PMID:25620056
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1346889	E	RGD:6480464	20191008	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of C1RL mRNA	PMID:29348435
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1346889	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of C1RL mRNA	PMID:39836092
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1549998	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of C1RL mRNA	PMID:22206623
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of C1RL mRNA	PMID:38568856
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of C1RL mRNA	PMID:29301935
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1346889	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of C1RL mRNA	PMID:27188386
1302936	C1rl	complement C1r subcomponent like	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1549998	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of C1RL mRNA	PMID:35537566
1302937	Krt13	keratin 13	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of KRT13 mRNA	PMID:25152437
1302937	Krt13	keratin 13	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of KRT13 protein	PMID:36641056
1302937	Krt13	keratin 13	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20140211	CTD	MESH:D014212	Tretinoin results in decreased expression of KRT13 mRNA	PMID:17185354
1302937	Krt13	keratin 13	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1349257	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of KRT13 mRNA	PMID:23830798
1302937	Krt13	keratin 13	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1332221	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of KRT13 mRNA	PMID:39298647
1302937	Krt13	keratin 13	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332221	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of KRT13 mRNA	PMID:15289156|PMID:19484750
1302937	Krt13	keratin 13	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1349257	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of KRT13 mRNA	PMID:31614463
1302937	Krt13	keratin 13	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol inhibits the reaction [afimoxifene results in increased expression of KRT13 mRNA]; Estradiol promotes the reaction [ESR2 protein affects the expression of KRT13 mRNA]	PMID:16849584|PMID:20404318
1302937	Krt13	keratin 13	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KRT13 mRNA	PMID:23829299
1302937	Krt13	keratin 13	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KRT13 mRNA	PMID:33387578
1302937	Krt13	keratin 13	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of KRT13 mRNA	PMID:31256213
1302937	Krt13	keratin 13	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20120412	CTD	MESH:D014284	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KRT13 mRNA	PMID:14761676
1302937	Krt13	keratin 13	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20120501	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KRT13 mRNA	PMID:20599845
1302937	Krt13	keratin 13	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1349257	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KRT13 mRNA	PMID:19549813
1302937	Krt13	keratin 13	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1332221	E	RGD:6480464	20240604	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT13 protein	PMID:38307155
1302937	Krt13	keratin 13	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1332221	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in increased expression of KRT13 mRNA	PMID:31626304|PMID:33026818
1302937	Krt13	keratin 13	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT13 protein	PMID:38598786
1302937	Krt13	keratin 13	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20120412	CTD	MESH:D003513	[afimoxifene co-treated with Cycloheximide] results in increased expression of KRT13 mRNA	PMID:16849584
1302937	Krt13	keratin 13	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of KRT13 gene	PMID:31011160
1302937	Krt13	keratin 13	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1332221	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of KRT13 mRNA	PMID:28960355
1302937	Krt13	keratin 13	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of KRT13 mRNA	PMID:15289156
1302937	Krt13	keratin 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT13 mRNA	PMID:22298810
1302937	Krt13	keratin 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KRT13 mRNA	PMID:17035482
1302937	Krt13	keratin 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20120412	CTD	MESH:D013749	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KRT13 mRNA	PMID:14761676
1302937	Krt13	keratin 13	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1349257	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of KRT13 protein	PMID:39603559
1302937	Krt13	keratin 13	gene	CHEBI:28358	rac-lactic acid	multiple interactions	ISO	RGD:1332221	E	RGD:6480464	20250603	CTD	MESH:D019344	[Sodium Lactate results in increased abundance of Lactic Acid] which results in increased expression of KRT13 mRNA	PMID:39922521
1302937	Krt13	keratin 13	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of KRT13 mRNA	PMID:28959563
1302937	Krt13	keratin 13	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1332221	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT13 mRNA	PMID:15467011
1302937	Krt13	keratin 13	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1332221	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of KRT13 protein	PMID:27548804
1302937	Krt13	keratin 13	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRT13 mRNA	PMID:12634122|PMID:39719251
1302937	Krt13	keratin 13	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1349257	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased methylation of KRT13 gene	PMID:24570342
1302937	Krt13	keratin 13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349257	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT13 mRNA; sodium arsenite results in increased expression of KRT13 protein	PMID:19524636|PMID:24570342|PMID:34032870
1302937	Krt13	keratin 13	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KRT13 mRNA	PMID:40419235
1302937	Krt13	keratin 13	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1349257	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KRT13 promoter	PMID:27901495
1302937	Krt13	keratin 13	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349257	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT13 exon	PMID:27901495
1302937	Krt13	keratin 13	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of KRT13 mRNA	PMID:18929588
1302937	Krt13	keratin 13	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in increased expression of KRT13 mRNA]	PMID:18929588
1302937	Krt13	keratin 13	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1332221	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT13 mRNA	PMID:15467011
1302937	Krt13	keratin 13	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1349257	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of KRT13 protein	PMID:25419056
1302937	Krt13	keratin 13	gene	CHEBI:31206	ammonium chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of KRT13 protein	PMID:16483693
1302937	Krt13	keratin 13	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1332221	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of KRT13 mRNA	PMID:36087614
1302937	Krt13	keratin 13	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20120412	CTD	MESH:C070081	Fulvestrant inhibits the reaction [afimoxifene results in increased expression of KRT13 mRNA]	PMID:16849584
1302937	Krt13	keratin 13	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of KRT13 mRNA	PMID:20059764
1302937	Krt13	keratin 13	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of KRT13 mRNA]	PMID:20059764
1302937	Krt13	keratin 13	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1332221	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of KRT13 mRNA	PMID:28472532
1302937	Krt13	keratin 13	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of KRT13 mRNA	PMID:19167457
1302937	Krt13	keratin 13	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT13 mRNA	PMID:25181051
1302937	Krt13	keratin 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20181016	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT13 mRNA; bisphenol A results in decreased expression of KRT13 protein	PMID:29718440|PMID:33376534
1302937	Krt13	keratin 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332221	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of KRT13 mRNA	PMID:32156529
1302937	Krt13	keratin 13	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20241001	CTD	MESH:C006780	bisphenol A results in decreased expression of and results in increased methylation of KRT13 mRNA	PMID:38354435
1302937	Krt13	keratin 13	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of KRT13 mRNA	PMID:24096037
1302937	Krt13	keratin 13	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1332221	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of KRT13 mRNA	PMID:24096037
1302937	Krt13	keratin 13	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of KRT13 mRNA	PMID:23829299
1302937	Krt13	keratin 13	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of KRT13 mRNA	PMID:21266533
1302937	Krt13	keratin 13	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT13 protein	PMID:38598786
1302937	Krt13	keratin 13	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of KRT13 mRNA	PMID:17942915
1302937	Krt13	keratin 13	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1349257	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of KRT13 mRNA	PMID:21527772
1302937	Krt13	keratin 13	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of KRT13 protein	PMID:20935162
1302937	Krt13	keratin 13	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of KRT13 mRNA]	PMID:17942915
1302937	Krt13	keratin 13	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349257	E	RGD:6480464	20190507	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KRT13 protein	PMID:30572105
1302937	Krt13	keratin 13	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of KRT13 mRNA	PMID:24386269
1302937	Krt13	keratin 13	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1332221	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of KRT13 mRNA	PMID:40633821
1302937	Krt13	keratin 13	gene	CHEBI:41774	tamoxifen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of KRT13 mRNA	PMID:19400957
1302937	Krt13	keratin 13	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of KRT13 mRNA	PMID:19400957
1302937	Krt13	keratin 13	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1332221	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of KRT13 mRNA	PMID:15171707|PMID:15289156|PMID:15591538
1302937	Krt13	keratin 13	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1349257	E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in increased expression of KRT13 mRNA	PMID:16849584
1302937	Krt13	keratin 13	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20200211	CTD	MESH:C016601	[afimoxifene co-treated with Cycloheximide] results in increased expression of KRT13 mRNA; Estradiol inhibits the reaction [afimoxifene results in increased expression of KRT13 mRNA]; Fulvestrant inhibits the reaction [afimoxifene results in increased expression of KRT13 mRNA]	PMID:16849584
1302937	Krt13	keratin 13	gene	CHEBI:45863	paclitaxel	decreases response to substance	ISO	RGD:1349257	E	RGD:6480464	20161213	CTD	MESH:D017239	KRT13 mRNA results in decreased susceptibility to Paclitaxel	PMID:16322897
1302937	Krt13	keratin 13	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332221	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KRT13 mRNA	PMID:17562736
1302937	Krt13	keratin 13	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRT13 mRNA	PMID:33387578
1302937	Krt13	keratin 13	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1332221	E	RGD:6480464	20200804	CTD	MESH:D002101	Cacodylic Acid results in increased expression of KRT13 mRNA	PMID:32052077
1302937	Krt13	keratin 13	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of KRT13 mRNA	PMID:19400957|PMID:24096037
1302937	Krt13	keratin 13	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1332221	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of KRT13 mRNA	PMID:19400957|PMID:24096037
1302937	Krt13	keratin 13	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1349257	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of KRT13 protein	PMID:25419056
1302937	Krt13	keratin 13	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332221	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of KRT13 mRNA; Nanotubes, Carbon results in increased expression of KRT13 mRNA	PMID:25554681
1302937	Krt13	keratin 13	gene	CHEBI:507499	tricetin	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20240903	CTD	MESH:C469689	tricetin results in decreased expression of KRT13 mRNA	PMID:38654487
1302937	Krt13	keratin 13	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1332221	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of KRT13 mRNA	PMID:26377693
1302937	Krt13	keratin 13	gene	CHEBI:52774	pentane-2,3-dione	increases expression	ISO	RGD:1349257	E	RGD:6480464	20190507	CTD	MESH:C013186	2,3-pentanedione results in increased expression of KRT13 mRNA	PMID:30710127
1302937	Krt13	keratin 13	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1332221	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of KRT13 mRNA	PMID:23608068
1302937	Krt13	keratin 13	gene	CHEBI:69120	withaferin A	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20210608	CTD	MESH:C009684	withaferin A results in decreased expression of KRT13 mRNA	PMID:33665778
1302937	Krt13	keratin 13	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332221	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KRT13 mRNA	PMID:22206623
1302937	Krt13	keratin 13	gene	CHEBI:75228	sodium lactate	multiple interactions	ISO	RGD:1332221	E	RGD:6480464	20250603	CTD	MESH:D019354	[Sodium Lactate results in increased abundance of Lactic Acid] which results in increased expression of KRT13 mRNA	PMID:39922521
1302937	Krt13	keratin 13	gene	CHEBI:75261	arotinoid acid	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20161025	CTD	MESH:C038864	4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of KRT13 mRNA	PMID:8853895
1302937	Krt13	keratin 13	gene	CHEBI:76326	N-nitrosomorpholine	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in decreased expression of KRT13 protein	PMID:19716841
1302937	Krt13	keratin 13	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1349257	E	RGD:6480464	20200714	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of KRT13 mRNA	PMID:32151702
1302937	Krt13	keratin 13	gene	CHEBI:78320	2-hydroxypropanoic acid	multiple interactions	ISO	RGD:1332221	E	RGD:6480464	20250603	CTD	MESH:D019344	[Sodium Lactate results in increased abundance of Lactic Acid] which results in increased expression of KRT13 mRNA	PMID:39922521
1302937	Krt13	keratin 13	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT13 gene]	PMID:28238834
1302937	Krt13	keratin 13	gene	CHEBI:8069	phenobarbital	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of KRT13 protein	PMID:20935162
1302937	Krt13	keratin 13	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of KRT13 mRNA	PMID:32109520
1302937	Krt13	keratin 13	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of KRT13 mRNA	PMID:24780913
1302937	Krt13	keratin 13	gene	CHEBI:91108	SB 431542	increases expression	ISO	RGD:1349257	E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of KRT13 protein	PMID:25670856
1302937	Krt13	keratin 13	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1349257	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of KRT13 mRNA	PMID:17428261
1302937	Krt13	keratin 13	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT13 protein	PMID:38598786
1302937	Krt13	keratin 13	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1349257	E	RGD:6480464	20210810	CTD	MESH:C057693	Troglitazone results in decreased expression of KRT13 mRNA; Troglitazone results in decreased expression of KRT13 protein	PMID:32822399
1302937	Krt13	keratin 13	gene	CHEBI:9753	troglitazone	multiple interactions	ISO	RGD:1349257	E	RGD:6480464	20210810	CTD	MESH:C057693	[Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT13 mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT13 protein	PMID:32822399
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of MCPT1L2 mRNA; Mercaptopurine results in increased expression of MCPT8L2 mRNA	PMID:23358152
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20240326	CTD	MESH:C016517	indole-3-carbinol affects the expression of MCPT1L2 mRNA	PMID:21396975
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCPT8L2 mRNA	PMID:34747641
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of MCPT8L2 mRNA	PMID:16483693
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of MCPT8L2 mRNA	PMID:32680482
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of MCPT8L2 mRNA	PMID:30723492
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of MCPT1L2 mRNA; Mercaptopurine results in increased expression of MCPT8L2 mRNA	PMID:23358152
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in decreased expression of MCPT8L2 mRNA	PMID:22504374
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of MCPT8L2 mRNA	PMID:27840820
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MCPT8L2 mRNA	PMID:22504374
1302938	Mcpt8l2	mast cell protease 8-like 2	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of MCPT1L2 mRNA; Mercaptopurine results in increased expression of MCPT8L2 mRNA	PMID:23358152
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1349957	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of EEF1G mRNA	PMID:38218311
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:1224	2-nitrofluorene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C019499	2-nitrofluorene results in increased expression of EEF1G mRNA	PMID:15890375
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of EEF1G mRNA	PMID:25812627
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:144804	nickel subsulfide	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in increased expression of EEF1G mRNA	PMID:21086188
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EEF1G mRNA	PMID:20938992
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of EEF1G mRNA	PMID:17218384
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D000431	Ethanol results in decreased expression of EEF1G protein	PMID:24646710
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol results in increased expression of EEF1G protein	PMID:19609968
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of EEF1G mRNA	PMID:30319688
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of EEF1G protein	PMID:23178681
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D006861	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of EEF1G protein]	PMID:23178681
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16336	hyaluronic acid	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D006820	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of EEF1G protein]	PMID:23178681
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550009	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EEF1G mRNA	PMID:39241906
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1349957	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of EEF1G mRNA	PMID:11179685
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20120412	CTD	MESH:D004958	3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of EEF1G mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of EEF1G mRNA]	PMID:11179685
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EEF1G mRNA	PMID:20938992
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20140408	CTD	MESH:D008550	Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA]	PMID:23963992
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:17362	quinoline	increases expression	ISO	RGD:1349957	E	RGD:6480464	20120412	CTD	MESH:C037219	quinoline analog results in increased expression of EEF1G protein	PMID:18645022
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550009	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EEF1G mRNA	PMID:33754040
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of EEF1G protein; [Cuprizone co-treated with Haloperidol] results in decreased expression of EEF1G protein	PMID:34122009
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1349957	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of EEF1G protein	PMID:37730182
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D000517	alpha-Chlorohydrin analog results in decreased expression of EEF1G protein; alpha-Chlorohydrin results in decreased expression of EEF1G protein	PMID:26072098
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of EEF1G protein	PMID:34915118
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EEF1G protein	PMID:23301498
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EEF1G mRNA	PMID:15890375
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of EEF1G protein	PMID:26760959
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of EEF1G mRNA	PMID:19483382
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EEF1G protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EEF1G protein	PMID:38598786
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1349957	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of EEF1G mRNA	PMID:15672453
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EEF1G mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EEF1G mRNA	PMID:20938992|PMID:22206623
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1349957	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EEF1G gene	PMID:25304211
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EEF1G mRNA	PMID:40504410
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EEF1G protein	PMID:38460933
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:1349957	E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in increased expression of EEF1G protein	PMID:31195006
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20140812	CTD	MESH:D002945	Cisplatin results in increased expression of and results in increased secretion of EEF1G protein	PMID:24980261
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of EEF1G mRNA	PMID:15009677
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550009	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EEF1G mRNA	PMID:21570461
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EEF1G mRNA	PMID:32109520
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550009	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EEF1G mRNA	PMID:19770486
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EEF1G mRNA	PMID:33387578
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550009	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EEF1G mRNA	PMID:17942748
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of EEF1G mRNA]	PMID:11179685
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of EEF1G mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EEF1G mRNA	PMID:16214954|PMID:17942748
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of EEF1G protein	PMID:35544339
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1349957	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of EEF1G protein	PMID:33212167
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EEF1G mRNA	PMID:30851411
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1349957	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of EEF1G mRNA	PMID:29803840
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of EEF1G protein	PMID:30528433
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of EEF1G mRNA	PMID:19072884
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EEF1G mRNA	PMID:40504410
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349957	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EEF1G promoter	PMID:27901495
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to EEF1G mRNA]; arsenite promotes the reaction [G3BP1 protein binds to EEF1G protein]	PMID:32406909
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1550009	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of EEF1G protein	PMID:40770094
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1550009	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of EEF1G protein	PMID:40770094
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1550009	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of EEF1G mRNA	PMID:34850242
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of EEF1G mRNA	PMID:19483382
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of EEF1G protein	PMID:34122009
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EEF1G protein	PMID:15894607
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of EEF1G mRNA	PMID:24136188
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:31823	mercury dichloride	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20140812	CTD	MESH:D008627	Mercuric Chloride results in increased expression of and results in increased secretion of EEF1G protein	PMID:24980261
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20190910	CTD	MESH:C009495	titanium dioxide results in decreased expression of EEF1G protein	PMID:30910687
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of EEF1G mRNA	PMID:19483382
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of EEF1G mRNA	PMID:19483382
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of EEF1G mRNA	PMID:15890375
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550009	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of EEF1G mRNA	PMID:23811191
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of EEF1G mRNA	PMID:15890375
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of EEF1G mRNA	PMID:15890375
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of EEF1G mRNA	PMID:19167457
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of EEF1G mRNA; bisphenol A results in decreased expression of EEF1G protein	PMID:29275510|PMID:33024228|PMID:34186270
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550009	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of EEF1G protein	PMID:35999755
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1349957	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EEF1G gene	PMID:31601247
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EEF1G mRNA	PMID:25181051|PMID:30816183|PMID:38750585
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of EEF1G gene	PMID:28505145
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of EEF1G mRNA	PMID:24096037
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1550009	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of EEF1G mRNA	PMID:24096037
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:3423	carmustine	increases expression	ISO	RGD:1349957	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of EEF1G mRNA	PMID:15980968
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of EEF1G mRNA	PMID:17316808
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1349957	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of EEF1G protein	PMID:34186270
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550009	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EEF1G mRNA	PMID:39298647
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550009	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EEF1G mRNA	PMID:37019170
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1550009	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of EEF1G protein	PMID:35999755
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EEF1G protein	PMID:38598786
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20140408	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA]; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA]	PMID:23963992
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20140812	CTD	MESH:D019256	Cadmium Chloride results in increased expression of and results in increased secretion of EEF1G protein	PMID:24980261
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of EEF1G mRNA	PMID:25812627
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1349957	E	RGD:6480464	20220208	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of EEF1G mRNA	PMID:33772556
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1349957	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of EEF1G mRNA	PMID:17553155
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of EEF1G mRNA	PMID:15890375
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1349957	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EEF1G mRNA	PMID:24449571
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of EEF1G mRNA	PMID:19483382
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone promotes the reaction [NDRG1 protein binds to EEF1G protein]	PMID:17220478
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of EEF1G mRNA	PMID:25812627
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1349957	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of EEF1G mRNA	PMID:26352163
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20171010	CTD	MESH:C100187	chloropicrin results in decreased expression of EEF1G mRNA	PMID:28476498
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of EEF1G mRNA	PMID:25812627
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1349957	E	RGD:6480464	20220208	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of EEF1G mRNA	PMID:33772556
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20140812	CTD	MESH:D016572	Cyclosporine results in increased expression of and results in increased secretion of EEF1G protein	PMID:24980261
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550009	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of EEF1G mRNA	PMID:17555576
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of EEF1G mRNA	PMID:15890375
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of EEF1G mRNA	PMID:21346803
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EEF1G protein	PMID:38460933
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1349957	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EEF1G gene	PMID:25304211
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EEF1G mRNA	PMID:40504410
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of EEF1G mRNA	PMID:19483382
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EEF1G mRNA	PMID:24096037
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550009	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EEF1G mRNA	PMID:17555576|PMID:17942748|PMID:24096037
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EEF1G mRNA	PMID:17942748
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EEF1G protein	PMID:15894607
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:5011	fenpyroximate	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of EEF1G mRNA	PMID:33512557
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:50182	3,3'-diindolylmethane	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20180116	CTD	MESH:C016392	3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of EEF1G mRNA]	PMID:11179685
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550009	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EEF1G mRNA; Nanotubes, Carbon results in increased expression of EEF1G mRNA	PMID:25554681
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EEF1G mRNA	PMID:35964746
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005485	Flutamide results in decreased expression of EEF1G mRNA	PMID:21525395
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EEF1G mRNA	PMID:24136188
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20140408	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA]; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA]	PMID:23963992
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:5613	haloperidol	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in decreased expression of EEF1G protein	PMID:34122009
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EEF1G protein	PMID:32959892
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:64153	tanespimycin	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20200804	CTD	MESH:C112765	tanespimycin analog results in decreased expression of EEF1G protein	PMID:31370342
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:64153	tanespimycin	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20200804	CTD	MESH:C112765	[tanespimycin co-treated with VER 155008] results in decreased expression of EEF1G protein	PMID:31370342
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of EEF1G protein	PMID:30467583
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008701	Methapyrilene results in increased expression of EEF1G mRNA	PMID:15890375
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of EEF1G mRNA	PMID:31758290
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1349957	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EEF1G protein	PMID:34186270
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550009	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EEF1G mRNA	PMID:22206623
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1349957	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of EEF1G protein	PMID:31285264
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of EEF1G mRNA	PMID:19483382
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of EEF1G mRNA	PMID:19483382
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1349957	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EEF1G mRNA	PMID:30851411
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of EEF1G mRNA	PMID:32109520
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1550009	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of EEF1G mRNA	PMID:30294300
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of EEF1G mRNA	PMID:19483382
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1550009	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of EEF1G mRNA	PMID:40826991
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:9381	T-2 toxin	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of EEF1G protein	PMID:26141394
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1349957	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EEF1G protein	PMID:38598786
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EEF1G mRNA	PMID:21346803
1302939	Eef1g	eukaryotic translation elongation factor 1 gamma	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EEF1G mRNA	PMID:23034163
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NT5DC3 mRNA	PMID:20188158
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:10002693	E	RGD:6480464	20211102	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TTC41P mRNA	PMID:24763279
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1626389	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NT5DC3 mRNA	PMID:39298647
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:D007631	Chlordecone results in increased expression of NT5DC3 mRNA	PMID:33711761
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1626389	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NT5DC3 mRNA	PMID:37236586
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:10002693	E	RGD:6480464	20211102	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TTC41P gene	PMID:27153756
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NT5DC3 mRNA	PMID:31919559
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1626389	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NT5DC3 mRNA	PMID:40504410
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:D014414	Tungsten results in decreased expression of NT5DC3 mRNA	PMID:30912803
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:D019833	Genistein results in decreased expression of NT5DC3 mRNA	PMID:32186404
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NT5DC3 mRNA	PMID:21570461
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:10002693	E	RGD:6480464	20211102	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTC41P mRNA	PMID:34032870
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1626389	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NT5DC3 mRNA	PMID:40504410
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:3016	Benoxacor	increases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:C085163	benoxacor results in increased expression of NT5DC3 mRNA	PMID:34850242
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:C009495	titanium dioxide results in decreased expression of NT5DC3 mRNA	PMID:29264374
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1626389	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NT5DC3 gene	PMID:35295148
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of NT5DC3 mRNA	PMID:28329830
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20211102	CTD	MESH:C006780	bisphenol A results in decreased expression of TTC41 mRNA; bisphenol A results in decreased expression of TTC41P mRNA	PMID:25181051|PMID:34947998
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1626389	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of NT5DC3 mRNA	PMID:32156529
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in increased expression of TTC41 mRNA	PMID:32528016
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1626389	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of NT5DC3 mRNA	PMID:39298647
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1626389	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of NT5DC3 mRNA	PMID:40203079
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1626389	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of NT5DC3 mRNA	PMID:38685157
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:10002693	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TTC41P mRNA	PMID:38568856
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1626389	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NT5DC3 mRNA	PMID:37236586
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:D000082	Acetaminophen affects the expression of NT5DC3 mRNA	PMID:17562736
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1626389	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NT5DC3 mRNA	PMID:40504410
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:C109476	epoxiconazole results in decreased expression of NT5DC3 mRNA	PMID:35436446
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:D002193	Cantharidin results in decreased expression of NT5DC3 mRNA	PMID:36907384
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NT5DC3 mRNA	PMID:22206623
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1626389	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of NT5DC3 mRNA	PMID:39847705
1302940	Ttc41	tetratricopeptide repeat domain 41	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1626389	E	RGD:6480464	20240903	CTD	MESH:C057693	Troglitazone results in decreased expression of NT5DC3 mRNA	PMID:28973697
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1602708	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of P2RY13 mRNA	PMID:33167477
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:15422	ATP	multiple interactions	ISO	RGD:1602708	E	RGD:6480464	20121009	CTD	MESH:D000255	MRS 2211 inhibits the reaction [P2RY13 protein promotes the reaction [Adenosine Triphosphate results in decreased susceptibility to Hydrogen Peroxide]]; P2RY13 protein promotes the reaction [Adenosine Triphosphate results in decreased susceptibility to Hydrogen Peroxide]	PMID:22129738
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1551996	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of P2RY13 mRNA	PMID:30319688
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1602708	E	RGD:6480464	20121009	CTD	MESH:D006861	MRS 2211 inhibits the reaction [P2RY13 protein promotes the reaction [Adenosine Triphosphate results in decreased susceptibility to Hydrogen Peroxide]]; P2RY13 protein promotes the reaction [Adenosine Triphosphate results in decreased susceptibility to Hydrogen Peroxide]	PMID:22129738
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551996	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of P2RY13 mRNA	PMID:39241906
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20161228	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P2RY13 mRNA]; P2RY13 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]	PMID:24849676|PMID:39241906
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of P2RY13 mRNA	PMID:32145629
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551996	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of P2RY13 mRNA	PMID:39298647
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of P2RY13 mRNA	PMID:32741896
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of P2RY13 mRNA	PMID:33387578
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of P2RY13 gene	PMID:27618143
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602708	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of P2RY13 mRNA	PMID:37042841
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P2RY13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P2RY13 mRNA	PMID:37992649
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1551996	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of P2RY13 mRNA	PMID:33848595
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of P2RY13 mRNA	PMID:32741896
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of P2RY13 mRNA]	PMID:33848595
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P2RY13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P2RY13 mRNA	PMID:37992649
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of P2RY13 mRNA	PMID:36331819
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:18721	3-chloropropane-1,2-diol	affects expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin affects the expression of P2RY13 mRNA	PMID:28522335
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1602708	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of P2RY13 mRNA	PMID:35301059
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of P2RY13 mRNA	PMID:33354967
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of P2RY13 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of P2RY13 mRNA	PMID:27106289|PMID:34911549
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602708	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of P2RY13 mRNA	PMID:35430440
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of P2RY13 mRNA	PMID:40504410
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P2RY13 mRNA]	PMID:37992649
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of P2RY13 mRNA	PMID:31881176
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1602708	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of P2RY13 mRNA	PMID:23195993
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1602708	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of P2RY13 mRNA	PMID:24768652|PMID:25583101
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of P2RY13 mRNA	PMID:27913140
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551996	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of P2RY13 mRNA	PMID:27913140
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1602708	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of P2RY13 mRNA	PMID:27913140
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of P2RY13 mRNA	PMID:32109520
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551996	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of P2RY13 mRNA	PMID:20819909|PMID:26290441|PMID:39401686
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to P2RY13 gene]	PMID:20819909
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of P2RY13 mRNA	PMID:28374803
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P2RY13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P2RY13 mRNA	PMID:37992649
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P2RY13 mRNA]	PMID:37992649
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551996	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of P2RY13 mRNA	PMID:37682722
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of P2RY13 mRNA	PMID:40504410
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1551996	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of P2RY13 mRNA	PMID:27131904
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in increased expression of P2RY13 mRNA	PMID:32721576
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1602708	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of P2RY13 protein	PMID:25258189
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1551996	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of P2RY13 mRNA	PMID:18648102
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551996	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of P2RY13 mRNA	PMID:38701888
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551996	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of P2RY13 mRNA	PMID:39298647
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1551996	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of P2RY13 mRNA	PMID:26377693
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P2RY13 mRNA]	PMID:39241906
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602708	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of P2RY13 mRNA	PMID:37042841
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1602708	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of P2RY13 mRNA	PMID:35301059
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1602708	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of P2RY13 mRNA	PMID:24449571
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of P2RY13 mRNA	PMID:36331819
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1551996	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of P2RY13 mRNA	PMID:28973697
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P2RY13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P2RY13 mRNA	PMID:37992649
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of P2RY13 mRNA	PMID:40504410
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of P2RY13 mRNA	PMID:37567419
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1602708	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of P2RY13 protein	PMID:25258189
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551996	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of P2RY13 mRNA; Nanotubes, Carbon results in increased expression of P2RY13 mRNA	PMID:25554681
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1551996	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of P2RY13 mRNA	PMID:40234311
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of P2RY13 mRNA	PMID:23537331
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1551996	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of P2RY13 mRNA	PMID:38701926
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1551996	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of P2RY13 mRNA	PMID:19812364
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551996	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of P2RY13 mRNA	PMID:22206623
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of P2RY13 mRNA	PMID:32741896
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1551996	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P2RY13 mRNA]	PMID:39241906
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1551996	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of P2RY13 mRNA	PMID:27131904
1302941	P2ry13	purinergic receptor P2Y13	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of P2RY13 mRNA	PMID:19281266
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of BCAP31 mRNA	PMID:30071829
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1349319	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of BCAP31 mRNA	PMID:33167477
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1552028	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of BCAP31 mRNA	PMID:40945087
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of BCAP31 mRNA	PMID:30319688
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552028	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BCAP31 mRNA	PMID:39241906
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552028	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of BCAP31 mRNA	PMID:39298647
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552028	E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in increased expression of BCAP31 mRNA	PMID:22467019
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349319	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BCAP31 mRNA	PMID:37042841
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552028	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of BCAP31 mRNA	PMID:33754040
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1349319	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of BCAP31 protein	PMID:37730182
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BCAP31 mRNA	PMID:36331819
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCAP31 mRNA	PMID:37236586
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:231515	lanthanum trichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C028521	lanthanum chloride results in decreased expression of BCAP31 protein	PMID:35090998
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1552028	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of BCAP31 gene	PMID:27776689
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of BCAP31 protein	PMID:33236894
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:2654	aminoglutethimide	decreases expression	ISO	RGD:1349319	E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of BCAP31 protein	PMID:26102013
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of BCAP31 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of BCAP31 protein	PMID:38598786
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCAP31 mRNA	PMID:22206623
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BCAP31 mRNA	PMID:40504410
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1349319	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of BCAP31 mRNA	PMID:19371625
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1349319	E	RGD:6480464	20120918	CTD	MESH:D007854	Lead affects the expression of BCAP31 mRNA	PMID:22313790
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1349319	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of BCAP31 mRNA	PMID:27392435
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of BCAP31 mRNA	PMID:20187946
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552028	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BCAP31 mRNA	PMID:21570461
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BCAP31 mRNA	PMID:32109520
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of BCAP31 mRNA	PMID:28959563
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1349319	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of BCAP31 mRNA	PMID:32763439
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1349319	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of BCAP31 mRNA	PMID:29803840
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349319	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of BCAP31 protein	PMID:38228842
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349319	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BCAP31 mRNA	PMID:38568856
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BCAP31 mRNA	PMID:40504410
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349319	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BCAP31 promoter	PMID:27901495
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552028	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BCAP31 mRNA	PMID:22228805
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552028	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BCAP31 gene	PMID:35295148
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1349319	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of BCAP31 mRNA	PMID:30903817
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of BCAP31 mRNA	PMID:34947998|PMID:41034487
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349319	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of BCAP31 protein	PMID:31675489
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BCAP31 mRNA	PMID:25181051|PMID:41034487
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1349319	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of BCAP31 mRNA; bisphenol A results in increased expression of BCAP31 protein	PMID:33670352|PMID:34186270
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1349319	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of BCAP31 protein	PMID:31675489
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1349319	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of BCAP31 mRNA	PMID:19244175
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1552028	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of BCAP31 mRNA	PMID:39298647
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1349319	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of BCAP31 intron	PMID:30157460
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCAP31 mRNA	PMID:28628672
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1349319	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of BCAP31 gene	PMID:22964155
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of BCAP31 protein	PMID:38598786
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCAP31 mRNA	PMID:28628672
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552028	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of BCAP31 mRNA	PMID:34813904
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349319	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BCAP31 mRNA	PMID:37042841
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCAP31 mRNA	PMID:37236586
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1349319	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of BCAP31 mRNA	PMID:31533062
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BCAP31 mRNA	PMID:36331819
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552028	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of BCAP31 mRNA	PMID:17963808
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349319	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of BCAP31 mRNA	PMID:23179753|PMID:27188386
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1349319	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of BCAP31 gene	PMID:29154799
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of BCAP31 mRNA	PMID:41580965
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCAP31 mRNA	PMID:28628672
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552028	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of BCAP31 mRNA	PMID:28973697
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552028	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of BCAP31 mRNA	PMID:29279043
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BCAP31 mRNA	PMID:40504410
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1349319	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of BCAP31 mRNA	PMID:31675489
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of BCAP31 mRNA	PMID:31464424
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:48707	(-)-citrinin	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20250603	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in decreased expression of BCAP31 protein	PMID:39638853
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCAP31 mRNA	PMID:28628672
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of BCAP31 mRNA	PMID:24136188
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of BCAP31 mRNA	PMID:35964746
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of BCAP31 mRNA	PMID:24136188
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:6030	isoniazide	increases expression	ISO	RGD:1349319	E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of BCAP31 protein	PMID:40015660
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1349319	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of BCAP31 mRNA	PMID:20436886
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349319	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of BCAP31 protein	PMID:32959892
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1552028	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of BCAP31 protein	PMID:26558463
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1349319	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of BCAP31 intron	PMID:30157460
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1349319	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of BCAP31 protein	PMID:34186270
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552028	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of BCAP31 mRNA	PMID:22206623
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552028	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCAP31 mRNA	PMID:22206623
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of BCAP31 protein	PMID:37664457
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20250603	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in decreased expression of BCAP31 protein	PMID:39638853
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1349319	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCAP31 protein	PMID:31675489
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1349319	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of BCAP31 protein	PMID:31675489
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of BCAP31 protein	PMID:37664457
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of BCAP31 mRNA	PMID:19281266
1302944	Bcap31	B-cell receptor-associated protein 31	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1349319	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of BCAP31 protein	PMID:38598786
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NAPRT mRNA	PMID:38218311
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1558072	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NAPRT mRNA	PMID:33045310
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NAPRT mRNA]	PMID:31150632
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of NAPRT protein	PMID:40631627
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1558072	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NAPRT mRNA	PMID:39241906
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1602193	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of NAPRT mRNA	PMID:30165855
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of NAPRT protein	PMID:40631627
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of NAPRT protein	PMID:40631627
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of NAPRT mRNA	PMID:27523638
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1602193	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of NAPRT protein	PMID:37730182
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1558072	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NAPRT mRNA	PMID:36331819
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of NAPRT protein	PMID:34915118
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1558072	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NAPRT mRNA	PMID:37236586
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1602193	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of NAPRT protein	PMID:20106945
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of NAPRT mRNA	PMID:30779732
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NAPRT mRNA	PMID:30723492|PMID:31150632
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1558072	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NAPRT mRNA	PMID:27339419
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NAPRT mRNA]	PMID:31150632
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1558072	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAPRT mRNA	PMID:22206623
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558072	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NAPRT mRNA	PMID:21570461
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NAPRT mRNA	PMID:21215274
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NAPRT mRNA	PMID:33387578
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1558072	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NAPRT mRNA	PMID:18796159|PMID:19933214
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NAPRT mRNA	PMID:32763439
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NAPRT mRNA	PMID:29803840
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1558072	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of NAPRT mRNA	PMID:37682722
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NAPRT mRNA	PMID:38568856
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NAPRT mRNA	PMID:20106945
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602193	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NAPRT exon; Benzo(a)pyrene results in decreased methylation of NAPRT promoter	PMID:27901495
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of NAPRT mRNA	PMID:38568856
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NAPRT mRNA	PMID:25729387
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NAPRT1 mRNA	PMID:30047161
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1558072	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NAPRT1 enhancer; titanium dioxide results in decreased methylation of NAPRT1 gene	PMID:35295148
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1558072	E	RGD:6480464	20140909	CTD	MESH:C009495	titanium dioxide results in increased expression of NAPRT mRNA	PMID:23557971
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D013853	Thioacetamide results in decreased expression of NAPRT mRNA	PMID:23411599|PMID:34492290
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1558072	E	RGD:6480464	20161115	CTD	MESH:C006780	bisphenol A results in decreased expression of NAPRT mRNA	PMID:26063408
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C006780	bisphenol A results in increased expression of NAPRT mRNA	PMID:25181051|PMID:30816183
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1558072	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NAPRT mRNA	PMID:33221593
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602193	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of NAPRT protein	PMID:34186270
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1558072	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of NAPRT mRNA	PMID:39298647
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1558072	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of NAPRT gene	PMID:31683443
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1602193	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of NAPRT polyA tail	PMID:30157460
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAPRT mRNA	PMID:21266533
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1558072	E	RGD:6480464	20140909	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAPRT mRNA	PMID:21266533
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1602193	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to NAPRT protein	PMID:32991956
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1558072	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of NAPRT mRNA	PMID:34813904
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602193	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NAPRT mRNA	PMID:37042841
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NAPRT mRNA	PMID:33453195
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1558072	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NAPRT mRNA	PMID:37236586
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NAPRT1 mRNA	PMID:30047161
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NAPRT mRNA	PMID:24386269
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:38102	triazines	multiple interactions	ISO	RGD:1558072	E	RGD:6480464	20180313	CTD	MESH:D014227	Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of NAPRT mRNA]	PMID:27469509
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1558072	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NAPRT mRNA	PMID:40194260
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1558072	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of NAPRT mRNA	PMID:34254344
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NAPRT mRNA	PMID:31533062
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1558072	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NAPRT mRNA	PMID:36331819
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602193	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NAPRT mRNA	PMID:25979313
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of NAPRT mRNA	PMID:23179753|PMID:29154799
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602193	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NAPRT gene	PMID:29154799
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NAPRT mRNA; Amitrole results in increased expression of NAPRT1 mRNA	PMID:30047161|PMID:38685447
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1558072	E	RGD:6480464	20140909	CTD	MESH:D016572	Cyclosporine results in decreased expression of NAPRT mRNA	PMID:19770486
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of NAPRT mRNA	PMID:20106945|PMID:27989131
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of NAPRT protein	PMID:40631627
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014303	Trinitrotoluene affects the expression of NAPRT mRNA	PMID:21346803
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1558072	E	RGD:6480464	20140909	CTD	MESH:D000082	Acetaminophen affects the expression of NAPRT mRNA	PMID:17562736
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NAPRT mRNA	PMID:33387578
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of NAPRT mRNA	PMID:29391264
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1558072	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of NAPRT mRNA	PMID:22334560|PMID:35436446
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NAPRT1 mRNA	PMID:30047161
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NAPRT protein	PMID:32959892
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20161115	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NAPRT mRNA	PMID:25729387
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1558072	E	RGD:6480464	20140909	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of NAPRT mRNA	PMID:23650126
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1602193	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of NAPRT polyA tail	PMID:30157460
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1558072	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NAPRT mRNA	PMID:22206623
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1558072	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAPRT mRNA	PMID:22206623
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C025589	ochratoxin A results in decreased expression of NAPRT mRNA	PMID:23358140
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1558072	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of NAPRT mRNA	PMID:22334560
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1558072	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of NAPRT mRNA	PMID:39847705
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1558072	E	RGD:6480464	20140909	CTD	MESH:C045950	propiconazole results in decreased expression of NAPRT mRNA	PMID:22334560
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:8493	Propiverine	affects binding	EXP		E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine binds to NAPRT protein	PMID:29273565
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NAPRT1 mRNA	PMID:30047161
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D012999	Soman results in increased expression of NAPRT mRNA	PMID:19281266
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NAPRT mRNA	PMID:21346803
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NAPRT mRNA	PMID:38568856
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1602193	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of NAPRT mRNA	PMID:27188386
1302945	Naprt	nicotinate phosphoribosyltransferase	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1558072	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of NAPRT mRNA	PMID:35537566
1302946	Capn11	calpain 11	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1552037	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CAPN11 mRNA	PMID:37995155
1302946	Capn11	calpain 11	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1342957	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of CAPN11 mRNA	PMID:34925699
1302946	Capn11	calpain 11	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1552037	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of CAPN11 mRNA	PMID:36189433
1302946	Capn11	calpain 11	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CAPN11 mRNA	PMID:33387578
1302946	Capn11	calpain 11	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552037	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of CAPN11 mRNA	PMID:23892564
1302946	Capn11	calpain 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1552037	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of CAPN11 exon; Diethylhexyl Phthalate results in decreased methylation of CAPN11 intron	PMID:32864567
1302946	Capn11	calpain 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552037	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CAPN11 mRNA	PMID:34319233
1302946	Capn11	calpain 11	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1342957	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of CAPN11 mRNA	PMID:26760959
1302946	Capn11	calpain 11	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1342957	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of CAPN11 mRNA	PMID:19774075
1302946	Capn11	calpain 11	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1342957	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of CAPN11 mRNA	PMID:22171008
1302946	Capn11	calpain 11	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1342957	E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CAPN11 mRNA	PMID:16979875
1302946	Capn11	calpain 11	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1342957	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CAPN11 gene	PMID:25304211
1302946	Capn11	calpain 11	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1342957	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of CAPN11 mRNA	PMID:36861143
1302946	Capn11	calpain 11	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1342957	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of CAPN11 mRNA	PMID:23300844
1302946	Capn11	calpain 11	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1552037	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of CAPN11 mRNA	PMID:32186404
1302946	Capn11	calpain 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552037	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CAPN11 mRNA	PMID:26377647|PMID:28922406
1302946	Capn11	calpain 11	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1552037	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CAPN11 protein	PMID:28918527
1302946	Capn11	calpain 11	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552037	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CAPN11 mRNA	PMID:27195522
1302946	Capn11	calpain 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1342957	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CAPN11 3' UTR; Benzo(a)pyrene results in increased methylation of CAPN11 promoter	PMID:27901495
1302946	Capn11	calpain 11	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1342957	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of CAPN11 mRNA	PMID:22171008
1302946	Capn11	calpain 11	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1342957	E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CAPN11 mRNA	PMID:16979875
1302946	Capn11	calpain 11	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1342957	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of CAPN11 gene	PMID:31601247
1302946	Capn11	calpain 11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552037	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CAPN11 gene	PMID:35295148
1302946	Capn11	calpain 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPN11 mRNA	PMID:25181051
1302946	Capn11	calpain 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552037	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPN11 mRNA	PMID:38074096
1302946	Capn11	calpain 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552037	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of CAPN11 mRNA	PMID:32365465
1302946	Capn11	calpain 11	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CAPN11 gene	PMID:28505145
1302946	Capn11	calpain 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552037	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CAPN11 gene	PMID:31683443
1302946	Capn11	calpain 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1342957	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of CAPN11 gene	PMID:31601247
1302946	Capn11	calpain 11	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1552037	E	RGD:6480464	20121113	CTD	MESH:D010269	[Paraquat co-treated with Maneb] affects the expression of CAPN11 mRNA	PMID:22563483
1302946	Capn11	calpain 11	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1342957	E	RGD:6480464	20120412	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CAPN11 mRNA	PMID:16979875
1302946	Capn11	calpain 11	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552037	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CAPN11 mRNA	PMID:40194260
1302946	Capn11	calpain 11	gene	CHEBI:38626	pyridaben	decreases expression	ISO	RGD:1552037	E	RGD:6480464	20121113	CTD	MESH:C428725	pyridaben results in decreased expression of CAPN11 mRNA	PMID:22563483
1302946	Capn11	calpain 11	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1342957	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in increased expression of CAPN11 mRNA	PMID:28542535
1302946	Capn11	calpain 11	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1342957	E	RGD:6480464	20150825	CTD	MESH:D000082	CAPN11 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1302946	Capn11	calpain 11	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1342957	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CAPN11 gene	PMID:25304211
1302946	Capn11	calpain 11	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1342957	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of CAPN11 mRNA	PMID:36861143
1302946	Capn11	calpain 11	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1342957	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of CAPN11 mRNA	PMID:23300844
1302946	Capn11	calpain 11	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1552037	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of CAPN11 mRNA	PMID:26377693
1302946	Capn11	calpain 11	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1552037	E	RGD:6480464	20121113	CTD	MESH:D008344	[Paraquat co-treated with Maneb] affects the expression of CAPN11 mRNA	PMID:22563483
1302947	Prss59	protease, serine 59	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552038	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of PRSS59 mRNA	PMID:35295148
1302947	Prss59	protease, serine 59	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552038	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PRSS59 intron	PMID:28392331
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TACC3 mRNA	PMID:38218311
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550045	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of TACC3 mRNA	PMID:33045310
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TACC3 mRNA	PMID:39752319
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TACC3 mRNA	PMID:20188158
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TACC3 gene	PMID:20938992
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of TACC3 mRNA	PMID:15928584
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TACC3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TACC3 mRNA	PMID:32699268
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of TACC3 mRNA	PMID:26516004
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1353438	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TACC3 mRNA	PMID:20044591
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550045	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TACC3 mRNA	PMID:39241906
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of TACC3 mRNA	PMID:32145629
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1353438	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of TACC3 mRNA	PMID:16474171|PMID:19167446|PMID:20106945
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550045	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of TACC3 mRNA	PMID:19484750
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TACC3 mRNA	PMID:32741896
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of TACC3 mRNA	PMID:22217510
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TACC3 mRNA	PMID:25510870
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TACC3 mRNA	PMID:33387578
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1550045	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of TACC3 mRNA	PMID:25549359
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TACC3 gene	PMID:20938992
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353438	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TACC3 mRNA	PMID:37042841
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TACC3 mRNA	PMID:37992649
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TACC3 mRNA	PMID:39752319
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:17315	D-glucosamine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of TACC3 mRNA	PMID:17109745
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of TACC3 mRNA	PMID:21592394
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TACC3 mRNA	PMID:32741896
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of TACC3 mRNA	PMID:21592394
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TACC3 mRNA	PMID:37992649
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1353438	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TACC3 protein	PMID:37730182
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of TACC3 mRNA	PMID:21592394
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of TACC3 mRNA	PMID:21592394
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of TACC3 mRNA	PMID:17109745
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TACC3 mRNA	PMID:39012411
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TACC3 mRNA	PMID:25510870
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TACC3 mRNA	PMID:25510870
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:233362	Abemaciclib	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20250408	CTD	MESH:C000590451	abemaciclib results in decreased expression of TACC3 mRNA	PMID:28620137
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TACC3 mRNA	PMID:19549813
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TACC3 protein	PMID:23301498
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1353438	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TACC3 protein	PMID:20106945
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TACC3 mRNA	PMID:23630614|PMID:25378103
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of TACC3 mRNA	PMID:25102026
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of TACC3 mRNA	PMID:24336422
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1550045	E	RGD:6480464	20150609	CTD	MESH:D010126	Ozone results in increased expression of TACC3 mRNA	PMID:25658374
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TACC3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TACC3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TACC3 mRNA	PMID:32699268
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TACC3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TACC3 mRNA; TTPA protein affects the reaction [Ozone results in increased expression of TACC3 mRNA]	PMID:19555225|PMID:27106289|PMID:34911549
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TACC3 mRNA	PMID:17484886
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550045	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TACC3 mRNA	PMID:27339419|PMID:29987408|PMID:31919559
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of TACC3 mRNA	PMID:24657277
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TACC3 gene	PMID:20938992
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1353438	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TACC3 gene	PMID:25304211
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TACC3 mRNA	PMID:40504410
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1353438	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of TACC3 mRNA	PMID:33512557
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1353438	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of TACC3 protein	PMID:35688186
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TACC3 mRNA	PMID:31881176
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of TACC3 mRNA	PMID:19167446
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1353438	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TACC3 mRNA	PMID:28903495
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of TACC3 mRNA	PMID:21151649
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1353438	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of TACC3 mRNA	PMID:16474171
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TACC3 mRNA	PMID:33387578
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TACC3 mRNA	PMID:34747641
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TACC3 mRNA	PMID:17942748
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of TACC3 mRNA	PMID:29955902
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1353438	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of TACC3 mRNA	PMID:33512557
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1353438	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TACC3 mRNA	PMID:26272509
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC3 mRNA	PMID:27188386
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1353438	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TACC3 protein	PMID:33212167
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of TACC3 mRNA	PMID:17109745
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TACC3 mRNA	PMID:20971185
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TACC3 mRNA	PMID:37992649
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1353438	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of TACC3 protein	PMID:35688186
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TACC3 mRNA	PMID:38568856
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353438	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of TACC3 mRNA	PMID:28595984|PMID:29301061|PMID:34032870
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TACC3 mRNA	PMID:40504410
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of TACC3 mRNA	PMID:22378314|PMID:29453283
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TACC3 mRNA	PMID:17942131|PMID:19770486
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TACC3 mRNA	PMID:20504355|PMID:27195522|PMID:32417428
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TACC3 mRNA	PMID:20971185
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of TACC3 mRNA	PMID:26551752
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TACC3 mRNA	PMID:34973136
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550045	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TACC3 mRNA	PMID:29341224
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TACC3 mRNA	PMID:19150397|PMID:20382639|PMID:26238291
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of TACC3 mRNA	PMID:34408198
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TACC3 mRNA	PMID:25729387
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550045	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TACC3 gene	PMID:35295148
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550045	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TACC3 mRNA	PMID:23557971
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TACC3 mRNA	PMID:34492290
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of TACC3 mRNA	PMID:19136022
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550045	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TACC3 mRNA	PMID:17950772|PMID:21318169|PMID:23811191
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of TACC3 mRNA]; PPARA protein promotes the reaction [pirinixic acid results in increased expression of TACC3 mRNA]	PMID:17950772|PMID:21318169
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TACC3 mRNA	PMID:19191707
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1550045	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of TACC3 mRNA	PMID:19191707
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of TACC3 mRNA	PMID:38479592
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:33216	bisphenol A	affects binding	ISO	RGD:1353438	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A binds to TACC3 protein	PMID:20403423
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1353438	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TACC3 mRNA	PMID:30903817
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TACC3 mRNA	PMID:25181051|PMID:30816183
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TACC3 mRNA; bisphenol A results in decreased expression of TACC3 protein	PMID:29275510|PMID:37567409
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1353438	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TACC3 gene	PMID:31601247
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of TACC3 mRNA	PMID:32145629
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1353438	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of TACC3 mRNA	PMID:16474171
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1353438	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TACC3 mRNA	PMID:25979313
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1550045	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TACC3 mRNA	PMID:26682919
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TACC3 mRNA	PMID:25510870
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TACC3 mRNA	PMID:25510870
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TACC3 mRNA	PMID:23196670
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TACC3 mRNA	PMID:40203079
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550045	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TACC3 mRNA	PMID:26377693
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TACC3 mRNA	PMID:37019170
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of TACC3 mRNA	PMID:22546817
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TACC3 mRNA	PMID:17361019
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353438	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TACC3 mRNA	PMID:37042841
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1550045	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of TACC3 mRNA	PMID:26377693
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TACC3 mRNA	PMID:30723492
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TACC3 mRNA	PMID:39012411
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1550045	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TACC3 mRNA	PMID:22698814
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20230704	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TACC3 protein	PMID:36739938
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TACC3 mRNA	PMID:24449571
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1550045	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of TACC3 mRNA	PMID:28962523
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TACC3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TACC3 mRNA	PMID:32699268
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1353438	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of TACC3 mRNA	PMID:33512557
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TACC3 mRNA	PMID:31533062
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1353438	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of TACC3 mRNA	PMID:19167446
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of TACC3 mRNA	PMID:19167446
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TACC3 mRNA	PMID:39529242
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TACC3 mRNA	PMID:40419075
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TACC3 mRNA	PMID:36331819
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1353438	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TACC3 gene	PMID:29154799
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of TACC3 mRNA	PMID:41580965
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TACC3 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of TACC3 mRNA	PMID:17942131
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1353438	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of TACC3 mRNA	PMID:33512557
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TACC3 mRNA	PMID:17555576
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TACC3 mRNA	PMID:36653537
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TACC3 mRNA	PMID:37992649
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1353438	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of TACC3 mRNA	PMID:33512557
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of TACC3 mRNA	PMID:24657277
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1353438	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TACC3 mRNA	PMID:38832940
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of TACC3 protein	PMID:15907983
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TACC3 mRNA	PMID:33387578
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of TACC3 mRNA	PMID:17942131
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1353438	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TACC3 mRNA	PMID:22230336
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TACC3 mRNA	PMID:24714768
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1353438	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TACC3 gene	PMID:25304211
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TACC3 mRNA	PMID:40504410
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TACC3 mRNA	PMID:29391264
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of TACC3 mRNA	PMID:17109745
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TACC3 mRNA	PMID:17351261
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TACC3 mRNA	PMID:17555576
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TACC3 mRNA	PMID:17942748
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TACC3 mRNA	PMID:17942748
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1353438	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of TACC3 mRNA	PMID:33512557
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550045	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TACC3 mRNA; Nanotubes, Carbon results in increased expression of TACC3 mRNA	PMID:25554681
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550045	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TACC3 mRNA	PMID:19042947
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550045	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TACC3 mRNA	PMID:38701926
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TACC3 protein	PMID:32959892
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TACC3 mRNA	PMID:25729387
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TACC3 mRNA	PMID:23650126
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TACC3 mRNA	PMID:28988120
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TACC3 mRNA	PMID:37269647
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of TACC3 mRNA	PMID:35283115
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of TACC3 mRNA	PMID:37939859
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TACC3 mRNA	PMID:39752319
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550045	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TACC3 mRNA	PMID:22206623
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TACC3 protein	PMID:37664457
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1550045	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of TACC3 mRNA	PMID:27858113
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1353438	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TACC3 mRNA	PMID:37199045
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of TACC3 mRNA	PMID:28284560
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TACC3 mRNA	PMID:32741896
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of TACC3 mRNA	PMID:34995734
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC3 mRNA	PMID:27188386
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550045	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TACC3 mRNA	PMID:19136022|PMID:23091169
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TACC3 mRNA	PMID:19482888
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of TACC3 mRNA]	PMID:19482888
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550045	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TACC3 mRNA	PMID:31388691
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1550045	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of TACC3 mRNA	PMID:17942131|PMID:18958704
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA	PMID:19167446
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550045	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TACC3 mRNA	PMID:38648751
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20191112	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TACC3 mRNA	PMID:31173147
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of TACC3 mRNA	PMID:32234424
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of TACC3 mRNA	PMID:23640034
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550045	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TACC3 mRNA	PMID:39847705
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TACC3 mRNA	PMID:24780913
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20200331	CTD	MESH:C500026	palbociclib results in decreased expression of TACC3 mRNA	PMID:28620137
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:87368	diethyl malate	increases expression	ISO	RGD:1353438	E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of TACC3 mRNA	PMID:38498338
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1550045	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TACC3 mRNA	PMID:39752319
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:90724	AM-251	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20170303	CTD	MESH:C103505	AM 251 results in decreased expression of TACC3 mRNA	PMID:16500647
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353438	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TACC3 protein; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC3 mRNA	PMID:27188386|PMID:37664457
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of TACC3 mRNA	PMID:26551752
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1353438	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of TACC3 mRNA	PMID:33512557
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1353438	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TACC3 mRNA	PMID:38568856
1302948	Tacc3	transforming, acidic coiled-coil containing protein 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TACC3 mRNA	PMID:23555832
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1604561	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TANC1 mRNA	PMID:27188386
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1332359	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TANC1 mRNA	PMID:33045310
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TANC1 mRNA	PMID:30071829
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1604561	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TANC1 mRNA; Tretinoin results in increased expression of TANC1 protein	PMID:21934132|PMID:23724009|PMID:30093655
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of TANC1 mRNA	PMID:30951980
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1332359	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of TANC1 promoter	PMID:24205000
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1332359	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TANC1 mRNA	PMID:24205000
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1332359	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TANC1 mRNA	PMID:30319688
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TANC1 mRNA	PMID:35811015
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TANC1 mRNA	PMID:25510870
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TANC1 gene	PMID:27618143
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1604561	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TANC1 mRNA	PMID:20655997
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1604561	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TANC1 mRNA	PMID:23649840
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1604561	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of TANC1 mRNA	PMID:22017230
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1604561	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of TANC1 mRNA	PMID:21592394
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of TANC1 mRNA	PMID:21592394
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TANC1 mRNA	PMID:27523638
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1604561	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TANC1 protein	PMID:37730182
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1604561	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of TANC1 mRNA	PMID:21592394
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of TANC1 mRNA	PMID:21592394
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TANC1 mRNA	PMID:33387578
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1604561	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TANC1 mRNA	PMID:28818685
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TANC1 mRNA	PMID:40850461
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TANC1 mRNA	PMID:25510870
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TANC1 mRNA	PMID:25510870
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1604561	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TANC1 mRNA	PMID:23649840
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1604561	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TANC1 gene	PMID:27153756
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604561	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TANC1 mRNA	PMID:23649840
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TANC1 mRNA	PMID:40504410
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1604561	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TANC1 mRNA	PMID:26272509
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA	PMID:27188386
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1604561	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of TANC1 protein	PMID:35688186
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of TANC1 gene	PMID:35440735
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1604561	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of TANC1 mRNA	PMID:19561079
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1604561	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TANC1 mRNA	PMID:24768652|PMID:25583101
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1604561	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TANC1 mRNA	PMID:20106945|PMID:21632981
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TANC1 mRNA	PMID:34747641
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of TANC1 mRNA	PMID:24690739
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:28748	doxorubicin	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of TANC1 gene	PMID:28962528
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1604561	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of TANC1 protein	PMID:35688186
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TANC1 mRNA	PMID:40504410
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604561	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TANC1 5' UTR	PMID:27901495
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332359	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TANC1 mRNA	PMID:19770486
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604561	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TANC1 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604561	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TANC1 promoter	PMID:27901495
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TANC1 mRNA	PMID:21839799
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1332359	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TANC1 intron	PMID:27901495
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of TANC1 mRNA	PMID:24690739
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TANC1 mRNA	PMID:34779285
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604561	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TANC1 mRNA	PMID:19150397
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1604561	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TANC1 protein	PMID:30093655
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of TANC1 gene	PMID:31601247
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of TANC1 mRNA	PMID:32479839
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TANC1 mRNA	PMID:19710929
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TANC1 mRNA	PMID:32145629|PMID:34947998
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TANC1 mRNA	PMID:25181051
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604561	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of TANC1 mRNA	PMID:29275510
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TANC1 gene	PMID:28505145
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1604561	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TANC1 mRNA	PMID:25979313
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TANC1 mRNA	PMID:25510870
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TANC1 mRNA	PMID:25510870
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1332359	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TANC1 gene	PMID:31683443
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1332359	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of TANC1 mRNA	PMID:26377693
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of TANC1 mRNA	PMID:30951980
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of TANC1 gene	PMID:31601247
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332359	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TANC1 mRNA	PMID:37019170
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1332359	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TANC1 mRNA	PMID:21266533
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1332359	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of TANC1 gene	PMID:38995845
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1604561	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of TANC1 mRNA	PMID:29024780
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TANC1 mRNA	PMID:40850461
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1604561	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TANC1 mRNA	PMID:24449571
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1332359	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TANC1 mRNA	PMID:40194260
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604561	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TANC1 mRNA	PMID:25979313
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604561	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TANC1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA	PMID:27188386
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1604561	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TANC1 mRNA	PMID:38832940
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1604561	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TANC1 mRNA	PMID:24935251
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332359	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TANC1 mRNA	PMID:17562736
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604561	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TANC1 mRNA	PMID:22230336
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of TANC1 mRNA	PMID:24690739
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TANC1 mRNA	PMID:35811015
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332359	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TANC1 mRNA	PMID:40504410
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TANC1 mRNA	PMID:22079256
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1604561	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of TANC1 mRNA	PMID:26272509
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA	PMID:27188386
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1604561	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TANC1 protein	PMID:30093655
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332359	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TANC1 mRNA	PMID:25554681
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of TANC1 mRNA	PMID:23962444
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1332359	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of TANC1 mRNA	PMID:19042947
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TANC1 gene	PMID:35440735
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1604561	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TANC1 mRNA	PMID:31758290
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1332359	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of TANC1 mRNA	PMID:22206623
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1604561	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TANC1 mRNA	PMID:22079256
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TANC1 mRNA	PMID:22079256
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA	PMID:27188386
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1332359	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TANC1 mRNA	PMID:19270015
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of TANC1 protein	PMID:28903499
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1604561	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of TANC1 mRNA	PMID:26272509
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA	PMID:27188386
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604561	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA	PMID:27188386
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TANC1 mRNA	PMID:21346803
1302949	Tanc1	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1332359	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of TANC1 mRNA	PMID:28973697
1302950	Rnf166	ring finger protein 166	gene	CHEBI:132098	methoxyacetic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in increased expression of RNF166 mRNA	PMID:20864626
1302950	Rnf166	ring finger protein 166	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1351592	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RNF166 mRNA	PMID:26079696
1302950	Rnf166	ring finger protein 166	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1351592	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF166 mRNA	PMID:35811015
1302950	Rnf166	ring finger protein 166	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1615102	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF166 mRNA	PMID:39241906
1302950	Rnf166	ring finger protein 166	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1351592	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNF166 mRNA	PMID:35811015
1302950	Rnf166	ring finger protein 166	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RNF166 mRNA	PMID:33387578
1302950	Rnf166	ring finger protein 166	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1351592	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RNF166 mRNA	PMID:35430440
1302950	Rnf166	ring finger protein 166	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1615102	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RNF166 mRNA	PMID:25629700
1302950	Rnf166	ring finger protein 166	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1615102	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RNF166 mRNA]	PMID:22206623
1302950	Rnf166	ring finger protein 166	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in increased expression of RNF166 mRNA	PMID:20864626
1302950	Rnf166	ring finger protein 166	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1351592	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RNF166 mRNA	PMID:24768652|PMID:25583101
1302950	Rnf166	ring finger protein 166	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615102	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF166 mRNA	PMID:21570461
1302950	Rnf166	ring finger protein 166	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1351592	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF166 mRNA	PMID:20106945|PMID:21632981
1302950	Rnf166	ring finger protein 166	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RNF166 mRNA	PMID:33387578
1302950	Rnf166	ring finger protein 166	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1615102	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RNF166 mRNA	PMID:17942748
1302950	Rnf166	ring finger protein 166	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RNF166 mRNA	PMID:20864626
1302950	Rnf166	ring finger protein 166	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1351592	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNF166 mRNA	PMID:33212167
1302950	Rnf166	ring finger protein 166	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1351592	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF166 mRNA	PMID:29803840
1302950	Rnf166	ring finger protein 166	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351592	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF166 mRNA	PMID:22714537|PMID:39719251
1302950	Rnf166	ring finger protein 166	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1615102	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RNF166 mRNA	PMID:19710929
1302950	Rnf166	ring finger protein 166	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RNF166 mRNA	PMID:25181051
1302950	Rnf166	ring finger protein 166	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1615102	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RNF166 promoter	PMID:27312807
1302950	Rnf166	ring finger protein 166	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RNF166 mRNA	PMID:34947998
1302950	Rnf166	ring finger protein 166	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1615102	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RNF166 mRNA	PMID:38685157
1302950	Rnf166	ring finger protein 166	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1615102	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RNF166 mRNA	PMID:28392331
1302950	Rnf166	ring finger protein 166	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1615102	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RNF166 mRNA	PMID:34813904
1302950	Rnf166	ring finger protein 166	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351592	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNF166 mRNA	PMID:37042841
1302950	Rnf166	ring finger protein 166	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1351592	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RNF166 mRNA	PMID:31533062
1302950	Rnf166	ring finger protein 166	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1351592	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RNF166 gene	PMID:29154799
1302950	Rnf166	ring finger protein 166	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1351592	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RNF166 mRNA	PMID:28542535
1302950	Rnf166	ring finger protein 166	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1351592	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNF166 mRNA	PMID:35811015
1302950	Rnf166	ring finger protein 166	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1615102	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RNF166 mRNA	PMID:17942748
1302950	Rnf166	ring finger protein 166	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1615102	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RNF166 mRNA	PMID:17942748
1302950	Rnf166	ring finger protein 166	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615102	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RNF166 mRNA; Nanotubes, Carbon results in decreased expression of RNF166 mRNA	PMID:25554681
1302950	Rnf166	ring finger protein 166	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1351592	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of RNF166 mRNA	PMID:22714537
1302950	Rnf166	ring finger protein 166	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1615102	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RNF166 mRNA	PMID:22206623
1302950	Rnf166	ring finger protein 166	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1615102	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RNF166 mRNA]	PMID:22206623
1302950	Rnf166	ring finger protein 166	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1615102	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RNF166 mRNA	PMID:40826991
1302950	Rnf166	ring finger protein 166	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in increased expression of RNF166 mRNA	PMID:20864626
1302950	Rnf166	ring finger protein 166	gene	CHEBI:9513	thalidomide	multiple interactions	ISO	RGD:1351592	E	RGD:6480464	20180828	CTD	MESH:D013792	Thalidomide results in increased degradation of and results in decreased expression of RNF166 protein	PMID:30067223
1302950	Rnf166	ring finger protein 166	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of RNF166 mRNA	PMID:23034163
1302951	mt-Tv	mitochondrially encoded tRNA valine	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRNV mRNA	PMID:31150632
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552047	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of COPS4 mRNA	PMID:33045310
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of COPS4 mRNA	PMID:33167477
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COPS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COPS4 mRNA	PMID:32699268
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552047	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of COPS4 mRNA	PMID:30319688
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of COPS4 protein	PMID:23178681
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D006861	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of COPS4 protein]	PMID:23178681
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of COPS4 mRNA	PMID:21632981
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:16336	hyaluronic acid	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D006820	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of COPS4 protein]	PMID:23178681
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1345570	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COPS4 mRNA	PMID:37042841
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1345570	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of COPS4 mRNA	PMID:21179406
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of COPS4 mRNA	PMID:38685446
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of COPS4 mRNA	PMID:33387578
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of COPS4 mRNA	PMID:23369406
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552047	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COPS4 mRNA	PMID:37236586
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COPS4 mRNA	PMID:19549813
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COPS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COPS4 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of COPS4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of COPS4 mRNA	PMID:32699268|PMID:35430440
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of COPS4 mRNA	PMID:19483382
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of COPS4 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of COPS4 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of COPS4 protein	PMID:38598786
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552047	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COPS4 mRNA	PMID:22206623
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552047	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COPS4 mRNA	PMID:21570461
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COPS4 mRNA	PMID:33387578
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552047	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COPS4 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to COPS4 promoter]	PMID:17942748|PMID:19654925
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COPS4 mRNA	PMID:29803840
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of COPS4 protein	PMID:29459688
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of COPS4 mRNA	PMID:39719251
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1345570	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of COPS4 mRNA	PMID:17879257
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1345570	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COPS4 promoter	PMID:27901495
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to COPS4 protein]; arsenite promotes the reaction [G3BP1 protein binds to COPS4 mRNA]	PMID:32406909
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of COPS4 mRNA	PMID:19483382
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:3048	benzatropine	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in decreased expression of COPS4 protein	PMID:34122009
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552047	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of COPS4 gene	PMID:35295148
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of COPS4 mRNA	PMID:19483382
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of COPS4 mRNA	PMID:19483382
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of COPS4 mRNA	PMID:26982218
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of COPS4 protein	PMID:34186270
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552047	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of COPS4 mRNA	PMID:33221593
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COPS4 mRNA	PMID:25181051
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1345570	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of COPS4 protein	PMID:37567409
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of COPS4 mRNA	PMID:17316808
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552047	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of COPS4 mRNA	PMID:39298647
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1552047	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of COPS4 mRNA	PMID:26377693
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1345570	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of COPS4 protein	PMID:34186270
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552047	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of COPS4 mRNA	PMID:38685157
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1345570	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of COPS4 protein	PMID:34186270
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552047	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of COPS4 mRNA	PMID:17361019
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of COPS4 mRNA	PMID:21266533
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of COPS4 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of COPS4 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of COPS4 protein	PMID:38598786
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1345570	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COPS4 mRNA	PMID:37042841
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552047	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COPS4 mRNA	PMID:37236586
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1345570	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of COPS4 mRNA	PMID:24449571
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COPS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COPS4 mRNA	PMID:32699268
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of COPS4 mRNA	PMID:19483382
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of COPS4 mRNA	PMID:28302478
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552047	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of COPS4 mRNA	PMID:17292431
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of COPS4 mRNA	PMID:17183730
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552047	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of COPS4 mRNA	PMID:17562736
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COPS4 mRNA	PMID:33387578
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of COPS4 mRNA	PMID:19483382
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552047	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of COPS4 mRNA	PMID:17942748
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552047	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COPS4 mRNA	PMID:17942748
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of COPS4 mRNA	PMID:24136188
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of COPS4 mRNA	PMID:24136188
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:5613	haloperidol	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in decreased expression of COPS4 protein	PMID:34122009
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of COPS4 mRNA	PMID:17183730
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COPS4 protein	PMID:32959892
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of COPS4 mRNA	PMID:24136188
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1345570	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of COPS4 protein	PMID:34186270
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552047	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of COPS4 mRNA	PMID:22206623
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552047	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COPS4 mRNA	PMID:22206623
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of COPS4 protein	PMID:37664457
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of COPS4 mRNA	PMID:24136188
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1345570	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of COPS4 protein	PMID:39638853
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of COPS4 mRNA	PMID:19483382
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of COPS4 mRNA	PMID:19483382
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of COPS4 protein	PMID:38348393
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of COPS4 mRNA	PMID:19483382
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:90633	perfluorododecanoic acid	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in increased expression of COPS4 protein	PMID:26168851
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of COPS4 protein	PMID:37664457
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1345570	E	RGD:6480464	20120613	CTD	MESH:D019284	Thapsigargin results in decreased expression of COPS4 protein	PMID:21692457
1302952	Cops4	COP9 signalosome subunit 4	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1345570	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of COPS4 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of COPS4 protein	PMID:38598786
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1615544	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of SPATA21 mRNA	PMID:36189433
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1615544	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPATA21 mRNA	PMID:36189433
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1602628	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of SPATA21 gene	PMID:30521419
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1615544	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPATA21 mRNA	PMID:36189433
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1602628	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SPATA21 mRNA	PMID:28818685
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SPATA21 mRNA	PMID:28522335
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602628	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SPATA21 intron	PMID:30157460
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1615544	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SPATA21 mRNA	PMID:28960355
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of SPATA21 gene	PMID:28505145
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPATA21 mRNA	PMID:33387578
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1602628	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SPATA21 mRNA	PMID:33212167
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1615544	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SPATA21 protein	PMID:28918527
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602628	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPATA21 mRNA	PMID:34032870
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602628	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPATA21 intron; Benzo(a)pyrene affects the methylation of SPATA21 promoter	PMID:27901495|PMID:30157460
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SPATA21 mRNA	PMID:25181051
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of SPATA21 gene	PMID:28505145
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1615544	E	RGD:6480464	20200519	CTD	MESH:C543008	bisphenol S results in increased expression of SPATA21 mRNA	PMID:31881267
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1602628	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SPATA21 intron	PMID:30157460
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:37187	lead nitrate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate results in decreased expression of SPATA21 mRNA	PMID:21628963
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SPATA21 mRNA	PMID:33387578
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1602628	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SPATA21 intron	PMID:30157460
1302954	Spata21	spermatogenesis associated 21	gene	CHEBI:8069	phenobarbital	decreases methylation	ISO	RGD:1615544	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased methylation of SPATA21 gene	PMID:19233941
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of DDAH2 mRNA	PMID:25152437
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of DDAH2 mRNA	PMID:26272509|PMID:27188386
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA	PMID:27188386
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DDAH2 mRNA	PMID:33045310
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:133246	tetramethylpyrazine	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20210608	CTD	MESH:C017953	DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased abundance of Nitric Oxide]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Malondialdehyde]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of N,N-dimethylarginine]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Reactive Oxygen Species]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased expression of CASP3 protein modified form]]; tetramethylpyrazine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased expression of DDAH2 protein]	PMID:32135237
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of DDAH2 mRNA	PMID:17218384
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	DDAH2 protein promotes the reaction [Tretinoin inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein]]; Tretinoin inhibits the reaction [cobaltous chloride results in decreased expression of DDAH2 mRNA]; Tretinoin inhibits the reaction [cobaltous chloride results in decreased expression of DDAH2 protein]	PMID:19156866
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of DDAH2 protein	PMID:27313889
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D010100	Oxygen deficiency results in increased expression of DDAH2 mRNA	PMID:27313889
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DDAH2 mRNA	PMID:39241906
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:16467	L-arginine	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20210608	CTD	MESH:D001120	Arginine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; Arginine inhibits the reaction [Iron-Dextran Complex results in decreased expression of DDAH2 protein]	PMID:32135237
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1346413	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of DDAH2 mRNA	PMID:22574217
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in decreased expression of DDAH2 mRNA	PMID:23373633
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in decreased expression of DDAH2 protein	PMID:26903627
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of DDAH2 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of DDAH2 mRNA	PMID:17404688|PMID:30165855
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:16480	nitric oxide	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20210608	CTD	MESH:D009569	DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased abundance of Nitric Oxide]]	PMID:32135237
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:16796	melatonin	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D008550	Melatonin inhibits the reaction [Methotrexate results in decreased expression of DDAH2 protein]	PMID:36890697
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20140211	CTD	MESH:D005557	Formaldehyde results in decreased expression of DDAH2 mRNA; Formaldehyde results in decreased expression of DDAH2 protein	PMID:24140967
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of DDAH2 mRNA	PMID:17404688
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550062	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DDAH2 mRNA	PMID:37992649
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:17303	morphine	increases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine results in increased expression of DDAH2 protein	PMID:23056601
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:17303	morphine	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine deficiency affects the reaction [Morphine deficiency affects the reaction [Morphine results in increased expression of DDAH2 protein]]; Morphine deficiency affects the reaction [Morphine results in increased expression of DDAH2 protein]	PMID:23056601
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of DDAH2 mRNA	PMID:22967744
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550062	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DDAH2 mRNA	PMID:37992649
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DDAH2 mRNA	PMID:34319233
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:17929	N(omega),N(omega)-dimethyl-L-arginine	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20210608	CTD	MESH:C018524	[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine; Arginine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of N,N-dimethylarginine]]; tetramethylpyrazine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]	PMID:32135237
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DDAH2 mRNA	PMID:19549813
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of DDAH2 mRNA	PMID:21396975
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of DDAH2 mRNA	PMID:41580963
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DDAH2 mRNA	PMID:35430440
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550062	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DDAH2 mRNA	PMID:34911549
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20210608	CTD	MESH:D017382	DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Reactive Oxygen Species]]	PMID:32135237
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of DDAH2 mRNA	PMID:30779732
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1346413	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DDAH2 mRNA	PMID:19244175
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:27638	cobalt atom	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20120918	CTD	MESH:D003035	[tungsten carbide co-treated with Cobalt] results in decreased expression of DDAH2 mRNA	PMID:18078969
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin inhibits the reaction [Nebivolol results in increased expression of DDAH2 mRNA]	PMID:17977009
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DDAH2 mRNA	PMID:31881176
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of DDAH2 mRNA	PMID:19167446
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of DDAH2 mRNA	PMID:27392435
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of DDAH2 mRNA	PMID:27392435
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of DDAH2 mRNA	PMID:18930951
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1346413	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of DDAH2 mRNA	PMID:26865667
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDAH2 mRNA	PMID:22298810|PMID:34747641
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550062	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDAH2 mRNA	PMID:21570461
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DDAH2 mRNA	PMID:19933214
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1346413	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DDAH2 mRNA	PMID:33212167
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:28304	heparin	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006493	Heparin results in decreased expression of DDAH2 protein	PMID:17488504
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DDAH2 mRNA	PMID:30851411
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DDAH2 mRNA	PMID:29803840
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of DDAH2 mRNA	PMID:39631538
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550062	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DDAH2 mRNA	PMID:37992649
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346413	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DDAH2 mRNA; sodium arsenite results in increased expression of DDAH2 protein	PMID:22714537|PMID:38228842|PMID:38568856
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346413	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DDAH2 promoter	PMID:27901495
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DDAH2 mRNA	PMID:32234424
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DDAH2 mRNA	PMID:21569818
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550062	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DDAH2 mRNA	PMID:22228805|PMID:32417428
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DDAH2 gene	PMID:31601247
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550062	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DDAH2 gene	PMID:35295148
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of DDAH2 mRNA	PMID:34492290
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1346413	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of DDAH2 gene	PMID:31601247
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DDAH2 mRNA	PMID:25181051
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1346413	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of DDAH2 protein	PMID:37567409
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550062	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of DDAH2 mRNA	PMID:32156529
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DDAH2 gene	PMID:31601247
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DDAH2 mRNA	PMID:25172293
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1346413	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of DDAH2 mRNA	PMID:19244175
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550062	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DDAH2 gene	PMID:31683443
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1346413	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of DDAH2 protein	PMID:34186270
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550062	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DDAH2 mRNA	PMID:39298647
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1346413	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of DDAH2 protein	PMID:34186270
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550062	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DDAH2 mRNA	PMID:37019170
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DDAH2 mRNA	PMID:21266533
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of DDAH2 mRNA	PMID:32680482
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of DDAH2 mRNA	PMID:20388547
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346413	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DDAH2 mRNA	PMID:37042841
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20150609	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DDAH2 protein	PMID:24419708
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1346413	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DDAH2 protein	PMID:24527689
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of DDAH2 mRNA	PMID:27387713
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DDAH2 mRNA; cobaltous chloride results in decreased expression of DDAH2 protein	PMID:19156866
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DDAH2 mRNA	PMID:19376846
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C018021	DDAH2 protein promotes the reaction [Tretinoin inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein]]; Tretinoin inhibits the reaction [cobaltous chloride results in decreased expression of DDAH2 mRNA]; Tretinoin inhibits the reaction [cobaltous chloride results in decreased expression of DDAH2 protein]	PMID:19156866
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1346413	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DDAH2 mRNA	PMID:24449571
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1346413	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DDAH2 mRNA	PMID:19244175
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DDAH2 mRNA	PMID:31533062
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of DDAH2 mRNA	PMID:19167446
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DDAH2 mRNA	PMID:19167446
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346413	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DDAH2 mRNA	PMID:25979313
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of DDAH2 mRNA	PMID:23179753|PMID:26272509|PMID:27188386
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA	PMID:27188386
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of DDAH2 mRNA	PMID:27989131
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550062	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DDAH2 mRNA	PMID:17555576
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550062	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DDAH2 mRNA	PMID:28973697
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550062	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DDAH2 mRNA	PMID:37992649
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D008727	Methotrexate results in decreased expression of DDAH2 protein	PMID:36890697
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D008727	Melatonin inhibits the reaction [Methotrexate results in decreased expression of DDAH2 protein]	PMID:36890697
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1346413	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DDAH2 mRNA	PMID:38832940
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of DDAH2 mRNA	PMID:27188386
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of DDAH2 mRNA	PMID:24935251|PMID:26272509
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA	PMID:27188386
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550062	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DDAH2 mRNA	PMID:17562736
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DDAH2 mRNA	PMID:33387578
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1346413	E	RGD:6480464	20120412	CTD	MESH:D005472	DDAH2 protein affects the susceptibility to Fluorouracil	PMID:16217747
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of DDAH2 mRNA	PMID:31838189
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DDAH2 mRNA	PMID:29391264
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DDAH2 mRNA	PMID:26865667
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1346413	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DDAH2 mRNA	PMID:26865667
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DDAH2 mRNA	PMID:17557909
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DDAH2 mRNA	PMID:17555576
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550062	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of DDAH2 mRNA	PMID:25554681
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1346413	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of DDAH2 mRNA	PMID:22714537
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550062	E	RGD:6480464	20120412	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DDAH2 mRNA	PMID:16141432
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:566274	malonaldehyde	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20210608	CTD	MESH:D008315	DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Malondialdehyde]]	PMID:32135237
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DDAH2 protein	PMID:32959892
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:64022	nebivolol	increases activity	ISO	RGD:1346413	E	RGD:6480464	20170303	CTD	MESH:D000068577	Nebivolol results in increased activity of DDAH2 protein	PMID:17977009
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:64022	nebivolol	increases expression	ISO	RGD:1346413	E	RGD:6480464	20170303	CTD	MESH:D000068577	Nebivolol results in increased expression of DDAH2 mRNA; Nebivolol results in increased expression of DDAH2 protein	PMID:17977009
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:64022	nebivolol	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20170303	CTD	MESH:D000068577	Dactinomycin inhibits the reaction [Nebivolol results in increased expression of DDAH2 mRNA]	PMID:17977009
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:6456	lidocaine	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D008012	Lidocaine results in decreased expression of DDAH2 protein	PMID:27018092
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D008012	Lidocaine results in increased expression of DDAH2 mRNA	PMID:27018092
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1346413	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DDAH2 protein	PMID:34186270
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550062	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DDAH2 mRNA	PMID:22206623
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DDAH2 protein	PMID:37664457
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1346413	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of DDAH2 mRNA	PMID:36318118
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of DDAH2 promoter	PMID:27415467
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:78291	iron dextran	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20210608	CTD	MESH:D007505	Iron-Dextran Complex results in decreased expression of DDAH2 protein	PMID:32135237
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:78291	iron dextran	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20210608	CTD	MESH:D007505	[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine; Arginine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; Arginine inhibits the reaction [Iron-Dextran Complex results in decreased expression of DDAH2 protein]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased abundance of Nitric Oxide]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Malondialdehyde]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of N,N-dimethylarginine]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Reactive Oxygen Species]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased expression of CASP3 protein modified form]]; tetramethylpyrazine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased expression of DDAH2 protein]	PMID:32135237
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DDAH2 mRNA	PMID:30851411
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA	PMID:27188386
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA	PMID:19167446
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:82283	Tungsten carbide	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20170303	CTD	MESH:C002802	[tungsten carbide co-treated with Cobalt] results in decreased expression of DDAH2 mRNA	PMID:18078969
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1346413	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DDAH2 protein	PMID:38348393
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550062	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of DDAH2 mRNA	PMID:39847705
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DDAH2 mRNA	PMID:24780913
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:88212	lead(II) chloride	increases expression	ISO	RGD:1346413	E	RGD:6480464	20151103	CTD	MESH:C029891	lead chloride results in increased expression of DDAH2 protein	PMID:24419708
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346413	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DDAH2 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA	PMID:27188386|PMID:37664457
1302955	Ddah2	DDAH family member 2, ADMA-independent	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DDAH2 mRNA	PMID:19281266
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1349585	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of SPINK2 mRNA	PMID:35967413
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1349585	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SPINK2 mRNA	PMID:26272509|PMID:27188386
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1349585	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA	PMID:27188386
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1349585	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of SPINK2 mRNA	PMID:34925699
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349585	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of SPINK2 mRNA	PMID:15498508
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1349585	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SPINK2 mRNA	PMID:26079696
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SPINK2 gene	PMID:27618143
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1349585	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SPINK2 mRNA	PMID:26079696
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552067	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SPINK2 mRNA	PMID:34319233
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SPINK2 mRNA	PMID:30779732
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1349585	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SPINK2 mRNA	PMID:26272509
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1349585	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPINK2 mRNA	PMID:27188386
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552067	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of SPINK2 mRNA	PMID:40618947
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1552067	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of SPINK2 mRNA	PMID:32186404
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of SPINK2 gene	PMID:28505145
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1349585	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SPINK2 mRNA	PMID:28001369
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1349585	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of SPINK2 mRNA	PMID:24834073
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SPINK2 mRNA	PMID:28959563
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1552067	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SPINK2 protein	PMID:28918527
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349585	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPINK2 promoter	PMID:27901495
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1349585	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SPINK2 mRNA	PMID:27829220
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1552067	E	RGD:6480464	20150303	CTD	MESH:C008261	lead acetate results in increased expression of SPINK2 mRNA	PMID:20542052
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1349585	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of SPINK2 mRNA	PMID:15498508
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552067	E	RGD:6480464	20150303	CTD	MESH:C009495	titanium dioxide results in decreased expression of SPINK2 mRNA	PMID:23557971
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552067	E	RGD:6480464	20150303	CTD	MESH:C006253	pirinixic acid results in decreased expression of SPINK2 mRNA	PMID:20813756
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SPINK2 mRNA	PMID:25181051|PMID:30816183
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SPINK2 gene	PMID:28505145
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of SPINK2 gene	PMID:28505145
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1349585	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SPINK2 mRNA	PMID:25979313
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1349585	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SPINK2 mRNA	PMID:38382870
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552067	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SPINK2 mRNA	PMID:39529242
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349585	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPINK2 mRNA	PMID:25979313
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349585	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SPINK2 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:28001369
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1349585	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA	PMID:27188386
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1349585	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SPINK2 mRNA	PMID:24935251|PMID:26272509
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1552067	E	RGD:6480464	20240702	CTD	MESH:D004008	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of SPINK2 mRNA	PMID:37844793
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552067	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SPINK2 mRNA	PMID:35436446
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552067	E	RGD:6480464	20240702	CTD	MESH:D004997	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of SPINK2 mRNA	PMID:37844793
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1349585	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SPINK2 mRNA	PMID:27829220
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	ISO	RGD:1349585	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of SPINK2 mRNA	PMID:38825487
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552067	E	RGD:6480464	20150303	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SPINK2 mRNA	PMID:19042947
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1552067	E	RGD:6480464	20240702	CTD	MESH:D007052	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of SPINK2 mRNA	PMID:37844793
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1349585	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of SPINK2 mRNA	PMID:26272509
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of SPINK2 mRNA	PMID:35283115
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1349585	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPINK2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA	PMID:27188386
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1552067	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SPINK2 mRNA	PMID:38648751
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	ISO	RGD:1349585	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of SPINK2 mRNA	PMID:24834073
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1349585	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of SPINK2 mRNA	PMID:26079696
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1349585	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SPINK2 mRNA	PMID:26272509
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1349585	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA	PMID:27188386
1302956	Spink2	serine peptidase inhibitor, Kazal type 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349585	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPINK2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA	PMID:27188386
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1552068	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of KCNE4 mRNA	PMID:20880076
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552068	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNE4 mRNA	PMID:30529165
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of KCNE4 gene	PMID:35440735
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1346142	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of KCNE4 mRNA	PMID:30510588
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1346142	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of KCNE4 mRNA	PMID:19619570
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346142	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of KCNE4 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of KCNE4 mRNA	PMID:19619570|PMID:20660070
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KCNE4 mRNA	PMID:33387578
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1346142	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of KCNE4 mRNA	PMID:21795739
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1346142	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of KCNE4 mRNA	PMID:20660070
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552068	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KCNE4 mRNA	PMID:37992649
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552068	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KCNE4 mRNA	PMID:37992649
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1346142	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KCNE4 mRNA	PMID:28818685
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552068	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KCNE4 mRNA	PMID:37325564
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552068	E	RGD:6480464	20120412	CTD	MESH:D010126	pyrazolanthrone promotes the reaction [Ozone results in increased expression of KCNE4 mRNA]	PMID:17460151
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552068	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KCNE4 mRNA	PMID:25629700
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1552068	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of KCNE4 mRNA	PMID:19654921
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1346142	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of KCNE4 mRNA	PMID:28903495
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:27899	cisplatin	decreases phosphorylation	ISO	RGD:1552068	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased phosphorylation of KCNE4 protein	PMID:22006019
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1346142	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of KCNE4 mRNA	PMID:25583101
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1346142	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KCNE4 mRNA	PMID:19619570
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552068	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KCNE4 mRNA	PMID:29673856
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1346142	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of KCNE4 mRNA	PMID:19619570
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1346142	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of KCNE4 mRNA	PMID:33212167
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1346142	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of KCNE4 mRNA	PMID:29803840
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552068	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KCNE4 mRNA	PMID:37992649
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346142	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KCNE4 exon; Benzo(a)pyrene affects the methylation of KCNE4 promoter	PMID:27901495
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552068	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KCNE4 mRNA	PMID:22228805|PMID:27195522
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552068	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to KCNE4 promoter]	PMID:19654925
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552068	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of KCNE4 mRNA	PMID:23557971
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KCNE4 mRNA	PMID:25181051|PMID:27178563
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552068	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of KCNE4 mRNA	PMID:25594700
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of KCNE4 mRNA	PMID:30816183
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1346142	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of KCNE4 mRNA	PMID:29275510
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552068	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of KCNE4 mRNA	PMID:30951980|PMID:32156529
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552068	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of KCNE4 mRNA	PMID:30951980
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552068	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of KCNE4 mRNA	PMID:30951980
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552068	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KCNE4 mRNA	PMID:37325564
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of KCNE4 mRNA	PMID:24386269
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1346142	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of KCNE4 gene	PMID:29154799
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552068	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KCNE4 mRNA	PMID:28973697
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552068	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KCNE4 mRNA	PMID:37992649
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1552068	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of KCNE4 mRNA	PMID:18502557
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552068	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KCNE4 mRNA	PMID:17562736
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1346142	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of KCNE4 mRNA	PMID:26690555
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1346142	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of KCNE4 mRNA	PMID:33725128
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1552068	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of KCNE4 mRNA	PMID:19654921
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of KCNE4 mRNA	PMID:29391264
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552068	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of KCNE4 mRNA; Nanotubes, Carbon results in increased expression of KCNE4 mRNA	PMID:25554681
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552068	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of KCNE4 mRNA	PMID:19042947
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1552068	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of KCNE4 mRNA	PMID:36851058
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1346142	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCNE4 mRNA	PMID:22079614
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of KCNE4 mRNA	PMID:33484710
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346142	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KCNE4 gene]	PMID:28238834
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1552068	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of KCNE4 mRNA	PMID:26655953
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1552068	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of KCNE4 mRNA	PMID:38648751
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1346142	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of KCNE4 mRNA	PMID:26705709
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KCNE4 mRNA	PMID:24780913
1302957	Kcne4	potassium voltage-gated channel subfamily E regulatory subunit 4	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1552068	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone promotes the reaction [Ozone results in increased expression of KCNE4 mRNA]	PMID:17460151
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1342499	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ZBTB12 mRNA	PMID:38218311
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1552092	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ZBTB12 mRNA	PMID:33045310
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZBTB12 mRNA]	PMID:31150632
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1342499	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ZBTB12 mRNA	PMID:33167477
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552092	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ZBTB12 mRNA	PMID:30319688
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552092	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ZBTB12 mRNA	PMID:34319233
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZBTB12 mRNA	PMID:33387578
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1342499	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZBTB12 mRNA	PMID:28818685
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552092	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZBTB12 mRNA	PMID:37236586
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1342499	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZBTB12 gene	PMID:27153756
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZBTB12 mRNA	PMID:30779732
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZBTB12 mRNA	PMID:31150632
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZBTB12 mRNA]	PMID:31150632
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1342499	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZBTB12 mRNA	PMID:39836092
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of ZBTB12 gene	PMID:31011160
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552092	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ZBTB12 mRNA	PMID:28960355
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1342499	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ZBTB12 mRNA	PMID:23557933
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1552092	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ZBTB12 mRNA	PMID:32186404
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZBTB12 mRNA	PMID:33387578
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1342499	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZBTB12 mRNA	PMID:33212167
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ZBTB12 mRNA	PMID:28959563
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1342499	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ZBTB12 mRNA	PMID:32763439
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1342499	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZBTB12 mRNA	PMID:39836092
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1342499	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZBTB12 promoter	PMID:27901495
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1342499	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZBTB12 5' UTR	PMID:27901495
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1552092	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ZBTB12 mRNA	PMID:27131904
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1552092	E	RGD:6480464	20120522	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ZBTB12 mRNA	PMID:19073995
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552092	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZBTB12 promoter	PMID:35295148
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZBTB12 mRNA	PMID:25181051
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1342499	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of ZBTB12 mRNA	PMID:27685785
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552092	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZBTB12 gene	PMID:31683443
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZBTB12 mRNA	PMID:35163327
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552092	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZBTB12 mRNA	PMID:37236586
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZBTB12 mRNA	PMID:35163327
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ZBTB12 mRNA	PMID:24386269
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1552092	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of ZBTB12 mRNA	PMID:18353800
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1342499	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZBTB12 gene	PMID:29154799
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552092	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of ZBTB12 mRNA	PMID:17562736
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZBTB12 mRNA	PMID:32479839|PMID:33387578
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1342499	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZBTB12 mRNA	PMID:39836092
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1342499	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ZBTB12 mRNA	PMID:22079614
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552092	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ZBTB12 mRNA	PMID:22206623
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1342499	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZBTB12 protein	PMID:31285264
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ZBTB12 mRNA	PMID:32109520
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZBTB12 mRNA	PMID:24780913
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552092	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ZBTB12 mRNA	PMID:40826991
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1552092	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ZBTB12 mRNA	PMID:27131904
1302958	Zbtb12	zinc finger and BTB domain containing 12	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1342499	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZBTB12 mRNA	PMID:29301935
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CRIP2 mRNA]	PMID:31150632
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1351980	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of CRIP2 protein	PMID:28073184
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1351980	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CRIP2 mRNA	PMID:22378314
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1331956	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CRIP2 mRNA	PMID:30319688
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1351980	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CRIP2 mRNA	PMID:21179406
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1331956	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CRIP2 mRNA	PMID:39241906
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of CRIP2 mRNA	PMID:30510588
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of CRIP2 mRNA	PMID:32145629
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1331956	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CRIP2 mRNA	PMID:39298647
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of CRIP2 protein	PMID:20109541
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CRIP2 mRNA	PMID:19448997|PMID:33387578
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1351980	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CRIP2 mRNA	PMID:26079696
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1331956	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of CRIP2 mRNA	PMID:33848595
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1331956	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CRIP2 mRNA	PMID:33754040
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CRIP2 mRNA	PMID:26577399
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CRIP2 mRNA	PMID:19549813
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1351980	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CRIP2 protein	PMID:20106945
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1331956	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CRIP2 mRNA	PMID:19770486
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CRIP2 mRNA	PMID:31150632
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CRIP2 mRNA]	PMID:31150632
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1331956	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of CRIP2 mRNA	PMID:25270620
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CRIP2 mRNA	PMID:40512198
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of CRIP2 protein; [Dactinomycin co-treated with nutlin 3] results in increased expression of CRIP2 mRNA	PMID:38460933
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1351980	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CRIP2 protein	PMID:35688186
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1331956	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of CRIP2 mRNA	PMID:28189721|PMID:28960355
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of CRIP2 mRNA	PMID:19167446
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1331956	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of CRIP2 mRNA	PMID:24280081|PMID:25270620
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1351980	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of CRIP2 mRNA	PMID:24280081|PMID:27392435
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CRIP2 mRNA	PMID:27392435
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of CRIP2 mRNA	PMID:20187946
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D019833	[Genistein co-treated with Methoxychlor] results in decreased expression of CRIP2 mRNA	PMID:21782745
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CRIP2 mRNA	PMID:34747641
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1331956	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CRIP2 mRNA	PMID:21570461
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CRIP2 mRNA	PMID:18796159|PMID:20959002|PMID:21215274|PMID:32109520
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1331956	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CRIP2 mRNA	PMID:26290441|PMID:28922406
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CRIP2 mRNA	PMID:33387578
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1331956	E	RGD:6480464	20140715	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CRIP2 mRNA	PMID:24713691
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1351980	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CRIP2 mRNA	PMID:20106945
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1351980	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of CRIP2 protein	PMID:39603559
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CRIP2 mRNA	PMID:28959563
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1351980	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of CRIP2 mRNA; Doxorubicin affects the expression of CRIP2 protein	PMID:29385562|PMID:29803840
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:28787	nitroglycerin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005996	Nitroglycerin results in decreased expression of CRIP2 mRNA	PMID:12102619
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29073	L-ascorbic acid	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D001205	Ascorbic Acid results in increased expression of CRIP2 mRNA	PMID:15372504
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1351980	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of CRIP2 mRNA	PMID:34032870
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1351980	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of CRIP2 gene	PMID:28589171
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1331956	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CRIP2 protein	PMID:29044176
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351980	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CRIP2 mRNA	PMID:39719251
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CRIP2 mRNA	PMID:40512198
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351980	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CRIP2 promoter	PMID:27901495
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1331956	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CRIP2 mRNA	PMID:22228805
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1351980	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CRIP2 mRNA	PMID:32234424
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1331956	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of CRIP2 protein	PMID:37955338
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CRIP2 protein]	PMID:32406909
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1331956	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CRIP2 mRNA	PMID:27131904
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CRIP2 mRNA	PMID:25895662
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1351980	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CRIP2 mRNA	PMID:20382639
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CRIP2 mRNA	PMID:16483693
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:3139	bleomycin A2	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001761	Bleomycin affects the expression of CRIP2 protein	PMID:25933445
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1351980	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of CRIP2 mRNA	PMID:37690743
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CRIP2 gene	PMID:31601247
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:31767	lead diacetate	affects expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C008261	lead acetate affects the expression of CRIP2 protein	PMID:36539177
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1331956	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CRIP2 gene	PMID:35295148
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of CRIP2 mRNA	PMID:23411599|PMID:34492290
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CRIP2 mRNA	PMID:19162173
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1331956	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CRIP2 mRNA	PMID:18301758
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CRIP2 mRNA	PMID:30903817
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1351980	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CRIP2 mRNA	PMID:30903817
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CRIP2 mRNA	PMID:25181051
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1331956	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CRIP2 mRNA	PMID:33221593
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CRIP2 protein	PMID:37664457
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1351980	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CRIP2 gene	PMID:31601247
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of CRIP2 mRNA	PMID:32145629
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1331956	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CRIP2 mRNA	PMID:32156529
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1351980	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of CRIP2 protein	PMID:37567409
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1331956	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CRIP2 promoter	PMID:27312807
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CRIP2 gene	PMID:31601247
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CRIP2 protein	PMID:31675489
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CRIP2 mRNA	PMID:20959002
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1331956	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CRIP2 exon	PMID:33297965
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1331956	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CRIP2 mRNA	PMID:39298647
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1331956	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CRIP2 mRNA	PMID:37019170
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of CRIP2 mRNA	PMID:17602206
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1351980	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CRIP2 gene	PMID:22964155
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1351980	E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of CRIP2 protein	PMID:34064677
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1331956	E	RGD:6480464	20130514	CTD	MESH:D010269	[Paraquat co-treated with Maneb] results in decreased expression of CRIP2 mRNA	PMID:18386188
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CRIP2 mRNA	PMID:30589522
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CRIP2 promoter	PMID:22457795
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1351980	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CRIP2 mRNA	PMID:38568856
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CRIP2 mRNA; perfluorooctanoic acid results in decreased expression of CRIP2 protein	PMID:19162173|PMID:34958885
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of CRIP2 mRNA	PMID:25539665|PMID:26194646
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of CRIP2 mRNA	PMID:19162173
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1331956	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CRIP2 mRNA	PMID:28903501
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CRIP2 mRNA	PMID:19320972
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1331956	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CRIP2 mRNA	PMID:40194260
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of CRIP2 mRNA	PMID:19167446
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CRIP2 mRNA	PMID:19162173
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1331956	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CRIP2 mRNA	PMID:17963808
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351980	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CRIP2 mRNA	PMID:25979313
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1331956	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in increased expression of CRIP2 mRNA	PMID:20546886
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351980	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of CRIP2 mRNA	PMID:23179753
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1351980	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CRIP2 gene	PMID:29154799
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in increased expression of CRIP2 mRNA	PMID:38685447
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CRIP2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1331956	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of CRIP2 mRNA	PMID:19770486
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1331956	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of CRIP2 mRNA	PMID:25123088
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in decreased expression of CRIP2 mRNA	PMID:16671099
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1331956	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CRIP2 mRNA	PMID:28973697
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1351980	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CRIP2 mRNA	PMID:38832940
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1331956	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CRIP2 mRNA	PMID:17562736
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CRIP2 mRNA	PMID:33387578
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1351980	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CRIP2 mRNA	PMID:22230336
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of CRIP2 protein; [Dactinomycin co-treated with nutlin 3] results in increased expression of CRIP2 mRNA	PMID:38460933
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351980	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CRIP2 mRNA	PMID:40512198
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CRIP2 mRNA	PMID:31675489
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of CRIP2 mRNA	PMID:31838189
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CRIP2 mRNA	PMID:29391264
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1331956	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CRIP2 mRNA	PMID:35436446
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of CRIP2 mRNA	PMID:17108234
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1331956	E	RGD:6480464	20150127	CTD	MESH:D005047	Etoposide results in increased expression of CRIP2 mRNA	PMID:25270620
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1331956	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of CRIP2 mRNA	PMID:25270620
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1331956	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CRIP2 mRNA; Nanotubes, Carbon results in decreased expression of CRIP2 mRNA	PMID:25554681
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1331956	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CRIP2 mRNA	PMID:25620056
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of CRIP2 mRNA	PMID:23962444
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CRIP2 mRNA	PMID:24136188
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1331956	E	RGD:6480464	20130514	CTD	MESH:D008344	[Paraquat co-treated with Maneb] results in decreased expression of CRIP2 mRNA	PMID:18386188
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of CRIP2 mRNA	PMID:20977926
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CRIP2 protein	PMID:32959892
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:63630	tolcapone	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in increased expression of CRIP2 mRNA	PMID:24136188
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CRIP2 mRNA	PMID:18178546
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1331956	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of CRIP2 mRNA	PMID:36907384
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:6842	methoxychlor	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D008731	[Genistein co-treated with Methoxychlor] results in decreased expression of CRIP2 mRNA	PMID:21782745
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1351980	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CRIP2 mRNA	PMID:31758290
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1331956	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CRIP2 mRNA	PMID:22206623
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of CRIP2 mRNA	PMID:24136188
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1331956	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CRIP2 mRNA	PMID:25566086
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CRIP2 mRNA	PMID:22714537
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of CRIP2 mRNA	PMID:32858204
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1351980	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CRIP2 mRNA	PMID:19159669
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CRIP2 mRNA	PMID:19162173
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1331956	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CRIP2 mRNA	PMID:19270015
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1331956	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CRIP2 mRNA	PMID:24713691
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CRIP2 protein	PMID:31675489
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of CRIP2 protein	PMID:28903499
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1351980	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CRIP2 protein	PMID:31675489
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1331956	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of CRIP2 mRNA	PMID:39847705
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:8493	Propiverine	affects binding	EXP		E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine binds to CRIP2 protein	PMID:29273565
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CRIP2 mRNA	PMID:24780913
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1331956	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CRIP2 mRNA	PMID:27131904
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CRIP2 mRNA	PMID:19281266
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CRIP2 mRNA	PMID:21346803
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1331956	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of CRIP2 mRNA	PMID:32835833
1302959	Crip2	cysteine-rich protein 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CRIP2 mRNA	PMID:23034163
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:15948	lycopene	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C015329	lycopene results in decreased expression of SCGB1D4 mRNA	PMID:15084515
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1606365	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SCGB1D4 gene	PMID:27153756
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of SCGB1D4 mRNA	PMID:31129395
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606365	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SCGB1D4 mRNA	PMID:23557933
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D020106	Acrylamide results in decreased expression of SCGB2B2 mRNA	PMID:28959563
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606365	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SCGB1D4 promoter	PMID:27901495
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D000643	Ammonium Chloride affects the expression of SCGB1D4 mRNA	PMID:16483693
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C006780	bisphenol A results in decreased expression of SCGB1D4 mRNA; bisphenol A results in decreased expression of SCGB2B2 mRNA	PMID:18180321|PMID:25181051
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SCGB1D4 mRNA	PMID:31129395
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of SCGB1D4 mRNA	PMID:31129395
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D024502	Vitamin E results in decreased expression of SCGB1D4 mRNA	PMID:15084515
1302961	Scgb1d4	secretoglobin family 1D member 4	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SCGB1D4 mRNA	PMID:23914054
1302962	Mug2	murinoglobulin 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MUG2 mRNA]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PZP mRNA]	PMID:31150632
1302962	Mug2	murinoglobulin 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of MUG2 mRNA	PMID:36189433
1302962	Mug2	murinoglobulin 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1616849	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MUG2 mRNA	PMID:36189433
1302962	Mug2	murinoglobulin 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1616849	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MUG2 mRNA	PMID:36331819
1302962	Mug2	murinoglobulin 2	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:736140	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of PZP mRNA	PMID:39506029
1302962	Mug2	murinoglobulin 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D001280	Atrazine results in increased expression of PZP mRNA	PMID:36841081
1302962	Mug2	murinoglobulin 2	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D000431	Ethanol results in increased expression of PZP protein	PMID:19609968
1302962	Mug2	murinoglobulin 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased expression of MUG2 mRNA	PMID:21565894
1302962	Mug2	murinoglobulin 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MUG2 mRNA	PMID:32145629
1302962	Mug2	murinoglobulin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MUG2 mRNA	PMID:39298647
1302962	Mug2	murinoglobulin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D004958	Estradiol results in decreased expression of PZP mRNA	PMID:16705744
1302962	Mug2	murinoglobulin 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20160621	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MUG2 mRNA	PMID:19448997
1302962	Mug2	murinoglobulin 2	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of MUG2 gene	PMID:27618143
1302962	Mug2	murinoglobulin 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D014241	Trichloroethylene results in increased expression of PZP mRNA	PMID:33387578
1302962	Mug2	murinoglobulin 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MUG2 mRNA	PMID:36189433
1302962	Mug2	murinoglobulin 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1616849	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MUG2 mRNA	PMID:36189433
1302962	Mug2	murinoglobulin 2	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:C541528	licochalcone B results in decreased expression of PZP mRNA	PMID:33647349
1302962	Mug2	murinoglobulin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PZP mRNA	PMID:31163220
1302962	Mug2	murinoglobulin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1616849	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MUG2 mRNA	PMID:34319233
1302962	Mug2	murinoglobulin 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D005839	Gentamicins results in decreased expression of PZP mRNA	PMID:22061828
1302962	Mug2	murinoglobulin 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D005839	Gentamicins results in increased expression of PZP mRNA	PMID:33387578
1302962	Mug2	murinoglobulin 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1616849	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MUG2 mRNA	PMID:36331819
1302962	Mug2	murinoglobulin 2	gene	CHEBI:22977	cadmium atom	affects binding	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D002104	PZP protein binds to Cadmium	PMID:23896426
1302962	Mug2	murinoglobulin 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PZP mRNA	PMID:19549813
1302962	Mug2	murinoglobulin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PZP mRNA	PMID:27153756
1302962	Mug2	murinoglobulin 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PZP gene	PMID:27153756
1302962	Mug2	murinoglobulin 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:736140	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PZP mRNA	PMID:35430440
1302962	Mug2	murinoglobulin 2	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D000638	Amiodarone affects the expression of PZP mRNA	PMID:19483382
1302962	Mug2	murinoglobulin 2	gene	CHEBI:27363	zinc atom	affects binding	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D015032	PZP protein binds to Zinc	PMID:23896426
1302962	Mug2	murinoglobulin 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MUG2 mRNA; Carbon Tetrachloride results in decreased expression of PZP mRNA	PMID:31150632
1302962	Mug2	murinoglobulin 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MUG2 mRNA]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PZP mRNA]	PMID:31150632
1302962	Mug2	murinoglobulin 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MUG2 mRNA; acetamide results in decreased expression of PZP mRNA	PMID:31881176
1302962	Mug2	murinoglobulin 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1616849	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of MUG2 mRNA]	PMID:31298478
1302962	Mug2	murinoglobulin 2	gene	CHEBI:27889	lead(0)	affects binding	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D007854	PZP protein binds to Lead	PMID:23896426
1302962	Mug2	murinoglobulin 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of MUG2 mRNA	PMID:32186404
1302962	Mug2	murinoglobulin 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D019833	Genistein results in increased expression of PZP mRNA	PMID:16705744
1302962	Mug2	murinoglobulin 2	gene	CHEBI:28112	nickel atom	affects binding	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D009532	PZP protein binds to Nickel	PMID:23896426
1302962	Mug2	murinoglobulin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PZP mRNA	PMID:18178546
1302962	Mug2	murinoglobulin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PZP mRNA; Tetrachlorodibenzodioxin results in increased expression of PZP protein	PMID:15822908|PMID:33387578
1302962	Mug2	murinoglobulin 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of PZP mRNA; Dimethyl Sulfoxide results in increased expression of PZP protein	PMID:14757319
1302962	Mug2	murinoglobulin 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D020106	Acrylamide results in decreased expression of PZP mRNA	PMID:28959563
1302962	Mug2	murinoglobulin 2	gene	CHEBI:28741	sodium fluoride	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PZP protein	PMID:29653260
1302962	Mug2	murinoglobulin 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of MUG2 protein	PMID:28918527
1302962	Mug2	murinoglobulin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:C017947	sodium arsenite results in decreased expression of PZP mRNA	PMID:29301061
1302962	Mug2	murinoglobulin 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C017947	sodium arsenite results in increased expression of PZP protein	PMID:29459688
1302962	Mug2	murinoglobulin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PZP mRNA	PMID:22316170
1302962	Mug2	murinoglobulin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PZP exon; Benzo(a)pyrene results in increased methylation of PZP promoter	PMID:27901495
1302962	Mug2	murinoglobulin 2	gene	CHEBI:30185	zinc(0)	affects binding	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D015032	PZP protein binds to Zinc	PMID:23896426
1302962	Mug2	murinoglobulin 2	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D001553	Benzbromarone affects the expression of PZP mRNA	PMID:19483382
1302962	Mug2	murinoglobulin 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PZP mRNA	PMID:20458559
1302962	Mug2	murinoglobulin 2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D000643	Ammonium Chloride affects the expression of PZP mRNA	PMID:16483693
1302962	Mug2	murinoglobulin 2	gene	CHEBI:3139	bleomycin A2	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D001761	Bleomycin results in increased expression of PZP protein	PMID:25933445
1302962	Mug2	murinoglobulin 2	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C032036	bromobenzene results in decreased expression of PZP mRNA	PMID:12628495
1302962	Mug2	murinoglobulin 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1616849	E	RGD:6480464	20200211	CTD	MESH:C009495	titanium dioxide results in increased expression of MUG2 mRNA	PMID:31298478
1302962	Mug2	murinoglobulin 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1616849	E	RGD:6480464	20200211	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of MUG2 mRNA]	PMID:31298478
1302962	Mug2	murinoglobulin 2	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D013853	Thioacetamide affects the expression of PZP mRNA	PMID:19483382
1302962	Mug2	murinoglobulin 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20160621	CTD	MESH:D013853	Thioacetamide results in decreased expression of MUG2 mRNA; Thioacetamide results in decreased expression of PZP mRNA	PMID:23411599|PMID:34492290
1302962	Mug2	murinoglobulin 2	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of MUG2 mRNA	PMID:28943392
1302962	Mug2	murinoglobulin 2	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C006253	pirinixic acid affects the expression of PZP mRNA	PMID:19483382
1302962	Mug2	murinoglobulin 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20160621	CTD	MESH:C006253	pirinixic acid results in decreased expression of MUG2 mRNA	PMID:15302862|PMID:16221962|PMID:20813756|PMID:23811191
1302962	Mug2	murinoglobulin 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1616849	E	RGD:6480464	20160621	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in decreased expression of MUG2 mRNA	PMID:20813756
1302962	Mug2	murinoglobulin 2	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of PZP protein	PMID:28596144
1302962	Mug2	murinoglobulin 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MUG2 mRNA; bisphenol A affects the expression of PZP mRNA	PMID:30903817|PMID:32145629
1302962	Mug2	murinoglobulin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C006780	bisphenol A results in decreased expression of PZP mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1302962	Mug2	murinoglobulin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MUG2 mRNA	PMID:32156529
1302962	Mug2	murinoglobulin 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in decreased methylation of PZP gene	PMID:31601247
1302962	Mug2	murinoglobulin 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C006780	bisphenol A results in increased expression of PZP mRNA	PMID:36779543
1302962	Mug2	murinoglobulin 2	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D002330	Carmustine results in decreased expression of PZP mRNA	PMID:15980968
1302962	Mug2	murinoglobulin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MUG2 mRNA	PMID:39298647
1302962	Mug2	murinoglobulin 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1616849	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MUG2 mRNA	PMID:38685157
1302962	Mug2	murinoglobulin 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PZP mRNA	PMID:21266533
1302962	Mug2	murinoglobulin 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1616849	E	RGD:6480464	20160621	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MUG2 mRNA	PMID:17942915
1302962	Mug2	murinoglobulin 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PZP mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of MUG2 mRNA	PMID:20360939|PMID:28943392
1302962	Mug2	murinoglobulin 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1616849	E	RGD:6480464	20160621	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of MUG2 mRNA]	PMID:17942915
1302962	Mug2	murinoglobulin 2	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D019256	Cadmium Chloride affects the expression of PZP mRNA	PMID:22110744
1302962	Mug2	murinoglobulin 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PZP mRNA	PMID:19162173
1302962	Mug2	murinoglobulin 2	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160621	CTD	MESH:C039281	furan results in decreased expression of MUG2 mRNA; furan results in decreased expression of PZP mRNA	PMID:25539665|PMID:26194646
1302962	Mug2	murinoglobulin 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of MUG2 mRNA	PMID:28903501
1302962	Mug2	murinoglobulin 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PZP mRNA	PMID:24386269
1302962	Mug2	murinoglobulin 2	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D002994	Clofibrate affects the expression of PZP mRNA	PMID:19483382
1302962	Mug2	murinoglobulin 2	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1616849	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of MUG2 mRNA	PMID:34254344
1302962	Mug2	murinoglobulin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616849	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MUG2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MUG2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MUG2 mRNA	PMID:36331819
1302962	Mug2	murinoglobulin 2	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C016104	sodium bichromate affects the expression of PZP mRNA	PMID:22110744
1302962	Mug2	murinoglobulin 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D014635	Valproic Acid results in decreased expression of PZP mRNA	PMID:29154799
1302962	Mug2	murinoglobulin 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D014635	Valproic Acid results in increased expression of PZP mRNA	PMID:35594946
1302962	Mug2	murinoglobulin 2	gene	CHEBI:40036	amitrole	affects expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole affects the expression of PZP mRNA	PMID:41580965
1302962	Mug2	murinoglobulin 2	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D000082	Acetaminophen affects the expression of PZP protein	PMID:16099942
1302962	Mug2	murinoglobulin 2	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D005001	Ethionine affects the expression of PZP mRNA	PMID:19483382
1302962	Mug2	murinoglobulin 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PZP mRNA	PMID:20458559
1302962	Mug2	murinoglobulin 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of PZP mRNA	PMID:41580965
1302962	Mug2	murinoglobulin 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of PZP mRNA	PMID:19162173
1302962	Mug2	murinoglobulin 2	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1616849	E	RGD:6480464	20160621	CTD	MESH:D011192	Potassium Dichromate affects the expression of MUG2 mRNA	PMID:23608068
1302962	Mug2	murinoglobulin 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D007559	Ivermectin results in decreased expression of PZP protein	PMID:32959892
1302962	Mug2	murinoglobulin 2	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PZP mRNA	PMID:22079614
1302962	Mug2	murinoglobulin 2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D008012	Lidocaine results in increased expression of PZP mRNA	PMID:35283115
1302962	Mug2	murinoglobulin 2	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of MUG2 protein	PMID:35926579
1302962	Mug2	murinoglobulin 2	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20160621	CTD	MESH:D008687	Metformin results in decreased expression of MUG2 mRNA	PMID:23457588
1302962	Mug2	murinoglobulin 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MUG2 gene	PMID:35440735
1302962	Mug2	murinoglobulin 2	gene	CHEBI:72544	flavonoids	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D005419	Flavonoids results in increased expression of PZP mRNA	PMID:18035473
1302962	Mug2	murinoglobulin 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C051752	nefazodone results in decreased expression of PZP mRNA	PMID:24136188
1302962	Mug2	murinoglobulin 2	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D012524	Sarin results in increased expression of PZP protein	PMID:26778279
1302962	Mug2	murinoglobulin 2	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C007350	nitrofen results in increased expression of PZP mRNA	PMID:33484710
1302962	Mug2	murinoglobulin 2	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D009853	Omeprazole affects the expression of PZP mRNA	PMID:19483382
1302962	Mug2	murinoglobulin 2	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D009853	Omeprazole affects the expression of PZP mRNA	PMID:19483382
1302962	Mug2	murinoglobulin 2	gene	CHEBI:8062	phenethyl caffeate	multiple interactions	EXP		E	RGD:6480464	20250812	CTD	MESH:C055494	[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PZP mRNA	PMID:20360939
1302962	Mug2	murinoglobulin 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:736140	E	RGD:6480464	20230404	CTD	MESH:D010634	Phenobarbital affects the expression of PZP mRNA	PMID:19159669
1302962	Mug2	murinoglobulin 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1616849	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MUG2 mRNA	PMID:38648751
1302962	Mug2	murinoglobulin 2	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C013418	bromfenacoum results in decreased expression of PZP protein	PMID:28903499
1302962	Mug2	murinoglobulin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20250812	CTD	MESH:D011441	Propylthiouracil affects the expression of PZP mRNA	PMID:19483382
1302962	Mug2	murinoglobulin 2	gene	CHEBI:90633	perfluorododecanoic acid	decreases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C522391	perfluorododecanoic acid results in decreased expression of PZP protein	PMID:26168851
1302962	Mug2	murinoglobulin 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20160621	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MUG2 mRNA; 2,4-dinitrotoluene affects the expression of PZP mRNA	PMID:21346803
1302962	Mug2	murinoglobulin 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20160621	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MUG2 mRNA; 2,6-dinitrotoluene affects the expression of PZP mRNA	PMID:21346803
1302962	Mug2	murinoglobulin 2	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1616849	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of MUG2 mRNA	PMID:32835833
1302962	Mug2	murinoglobulin 2	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of MUG2 gene	PMID:31682807
1302962	Mug2	murinoglobulin 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20250812	CTD	MESH:C025643	vinclozolin results in increased expression of PZP mRNA	PMID:23034163
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1552119	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DHX16 mRNA	PMID:37995155
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1344132	E	RGD:6480464	20160712	CTD	MESH:D001280	Atrazine results in decreased expression of DHX16 mRNA	PMID:22378314
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552119	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of DHX16 mRNA	PMID:30319688
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552119	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DHX16 mRNA	PMID:39298647
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1344132	E	RGD:6480464	20160712	CTD	MESH:C044887	beta-methylcholine affects the expression of DHX16 mRNA	PMID:21179406
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of DHX16 mRNA	PMID:27523638
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of DHX16 mRNA	PMID:26577399
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1344132	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DHX16 protein	PMID:37730182
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552119	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DHX16 mRNA	PMID:36331819
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1344132	E	RGD:6480464	20160712	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DHX16 mRNA	PMID:19549813
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344132	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DHX16 mRNA	PMID:35430440
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of DHX16 mRNA	PMID:19483382
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1344132	E	RGD:6480464	20210504	CTD	MESH:D001151	Arsenic affects the methylation of DHX16 gene	PMID:32603190
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552119	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHX16 mRNA	PMID:40504410
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1344132	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DHX16 protein	PMID:35688186
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1552119	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DHX16 protein	PMID:25505154
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552119	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DHX16 mRNA	PMID:21570461
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DHX16 mRNA	PMID:21215274
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHX16 mRNA	PMID:33387578
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1344132	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of DHX16 mRNA	PMID:32763439
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552119	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHX16 mRNA	PMID:40504410
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344132	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DHX16 promoter	PMID:27901495
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of DHX16 mRNA	PMID:19483382
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552119	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DHX16 gene	PMID:35295148
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of DHX16 mRNA	PMID:19483382
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of DHX16 mRNA	PMID:19483382
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:33128	C60 fullerene	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 affects the expression of DHX16 mRNA	PMID:19167457
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DHX16 mRNA	PMID:25181051
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1344132	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DHX16 protein	PMID:33376534
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1344132	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DHX16 gene	PMID:31601247
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DHX16 mRNA	PMID:34947998
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1344132	E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of DHX16 protein]	PMID:33376534
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1344132	E	RGD:6480464	20160712	CTD	MESH:D002330	Carmustine results in decreased expression of DHX16 mRNA	PMID:15980968
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552119	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DHX16 mRNA	PMID:38685157
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of DHX16 mRNA	PMID:22546817
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344132	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DHX16 mRNA	PMID:37042841
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of DHX16 promoter	PMID:22457795
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of DHX16 mRNA	PMID:19483382
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552119	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DHX16 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of DHX16 mRNA	PMID:36331819
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344132	E	RGD:6480464	20160712	CTD	MESH:D014635	Valproic Acid results in increased expression of DHX16 mRNA	PMID:23179753|PMID:29154799
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1344132	E	RGD:6480464	20210504	CTD	MESH:D001151	Arsenic affects the methylation of DHX16 gene	PMID:32603190
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552119	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHX16 mRNA	PMID:40504410
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of DHX16 mRNA	PMID:19483382
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1344132	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of DHX16 mRNA	PMID:38568856
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552119	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DHX16 mRNA	PMID:35964746
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DHX16 mRNA	PMID:24136188
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1344132	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DHX16 protein	PMID:32959892
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of DHX16 mRNA	PMID:24136188
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1552119	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DHX16 mRNA	PMID:26307267
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1344132	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DHX16 mRNA	PMID:31758290
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552119	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DHX16 mRNA	PMID:22206623
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of DHX16 mRNA	PMID:19483382
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of DHX16 mRNA	PMID:19483382
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344132	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DHX16 gene]	PMID:28238834
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of DHX16 mRNA	PMID:19162173
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552119	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DHX16 mRNA	PMID:30294300
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of DHX16 mRNA	PMID:19483382
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DHX16 mRNA	PMID:24780913
1302963	Dhx16	DEAH-box helicase 16	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552119	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of DHX16 mRNA	PMID:28973697
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621447	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TSGA10IP mRNA	PMID:33045310
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1346501	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of TSGA10IP mRNA	PMID:30510588
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TSGA10IP mRNA	PMID:33387578
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1346501	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TSGA10IP mRNA	PMID:31163220
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1621447	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TSGA10IP mRNA	PMID:33754040
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1621447	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TSGA10IP mRNA	PMID:28960355
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1346501	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TSGA10IP mRNA	PMID:33212167
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621447	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of TSGA10IP mRNA	PMID:37682722
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346501	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TSGA10IP promoter	PMID:27901495
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1346501	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of TSGA10IP mRNA	PMID:37690743
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TSGA10IP mRNA	PMID:25181051
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1346501	E	RGD:6480464	20191210	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of TSGA10IP mRNA	PMID:31326446
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1621447	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TSGA10IP mRNA	PMID:37019170
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TSGA10IP mRNA	PMID:33453195
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1346501	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TSGA10IP mRNA	PMID:38568856
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1346501	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TSGA10IP gene	PMID:29154799
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621447	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TSGA10IP mRNA	PMID:17562736
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1346501	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TSGA10IP mRNA	PMID:31758290
1302964	Tsga10ip	testis specific 10 interacting protein	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of TSGA10IP gene	PMID:31079544
1302965	Pon3	paraoxonase 3	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of PON3 mRNA	PMID:21551480|PMID:25152437
1302965	Pon3	paraoxonase 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552156	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PON3 mRNA	PMID:37995155
1302965	Pon3	paraoxonase 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 mRNA]	PMID:31150632
1302965	Pon3	paraoxonase 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1344009	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PON3 mRNA	PMID:26516004
1302965	Pon3	paraoxonase 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552156	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PON3 mRNA	PMID:36331819
1302965	Pon3	paraoxonase 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of PON3 mRNA	PMID:40945087
1302965	Pon3	paraoxonase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PON3 mRNA	PMID:39241906
1302965	Pon3	paraoxonase 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PON3 mRNA	PMID:39298647
1302965	Pon3	paraoxonase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of PON3 mRNA	PMID:32145629
1302965	Pon3	paraoxonase 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PON3 mRNA	PMID:33387578
1302965	Pon3	paraoxonase 3	gene	CHEBI:16856	glutathione	multiple interactions	ISO	RGD:1344009	E	RGD:6480464	20120918	CTD	MESH:D005978	PON3 protein inhibits the reaction [Carbon Tetrachloride results in decreased abundance of Glutathione]	PMID:20079818
1302965	Pon3	paraoxonase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1552156	E	RGD:6480464	20120515	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of PON3 mRNA alternative form	PMID:21636974
1302965	Pon3	paraoxonase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PON3 mRNA	PMID:34319233
1302965	Pon3	paraoxonase 3	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1344009	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of PON3 protein	PMID:34122009
1302965	Pon3	paraoxonase 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552156	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PON3 mRNA	PMID:36331819
1302965	Pon3	paraoxonase 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PON3 mRNA; alpha-Chlorohydrin results in increased expression of PON3 protein	PMID:28522335|PMID:34915118
1302965	Pon3	paraoxonase 3	gene	CHEBI:23403	coumarins	increases hydrolysis	ISO	RGD:1344009	E	RGD:6480464	20170110	CTD	MESH:D003374	PON3 protein results in increased hydrolysis of Coumarins analog	PMID:16099434|PMID:16139510
1302965	Pon3	paraoxonase 3	gene	CHEBI:24858	iodide salt	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D007454	Iodides deficiency results in decreased expression of PON3 protein	PMID:26795019
1302965	Pon3	paraoxonase 3	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1344009	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PON3 protein	PMID:20106945
1302965	Pon3	paraoxonase 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1344009	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PON3 gene	PMID:27153756
1302965	Pon3	paraoxonase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344009	E	RGD:6480464	20240109	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the methylation of PON3 gene	PMID:35835166
1302965	Pon3	paraoxonase 3	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1552156	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PON3 mRNA	PMID:17484886
1302965	Pon3	paraoxonase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PON3 mRNA; Carbon Tetrachloride results in decreased expression of PON3 protein	PMID:25478064|PMID:31150632
1302965	Pon3	paraoxonase 3	gene	CHEBI:27385	tetrachloromethane	decreases response to substance	ISO	RGD:1344009	E	RGD:6480464	20120918	CTD	MESH:D002251	PON3 protein results in decreased susceptibility to Carbon Tetrachloride	PMID:20079818
1302965	Pon3	paraoxonase 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D002251	Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 protein]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 mRNA]	PMID:25478064|PMID:31150632
1302965	Pon3	paraoxonase 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1344009	E	RGD:6480464	20120918	CTD	MESH:D002251	PON3 protein inhibits the reaction [Carbon Tetrachloride results in decreased abundance of Glutathione]; PON3 protein inhibits the reaction [Carbon Tetrachloride results in increased abundance of Malondialdehyde]; PON3 protein inhibits the reaction [Carbon Tetrachloride results in increased secretion of IL1B protein]; PON3 protein inhibits the reaction [Carbon Tetrachloride results in increased secretion of TNF protein]	PMID:20079818
1302965	Pon3	paraoxonase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552156	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PON3 mRNA	PMID:22206623
1302965	Pon3	paraoxonase 3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PON3 mRNA	PMID:31881176
1302965	Pon3	paraoxonase 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PON3 mRNA	PMID:24768652|PMID:25583101
1302965	Pon3	paraoxonase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PON3 mRNA	PMID:22298810
1302965	Pon3	paraoxonase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552156	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PON3 mRNA	PMID:21570461
1302965	Pon3	paraoxonase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PON3 mRNA	PMID:33956508
1302965	Pon3	paraoxonase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PON3 mRNA; Tetrachlorodibenzodioxin results in increased expression of PON3 protein	PMID:16497791|PMID:26006071
1302965	Pon3	paraoxonase 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344009	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PON3 mRNA	PMID:33212167
1302965	Pon3	paraoxonase 3	gene	CHEBI:28527	rutin	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D012431	Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 protein]	PMID:25478064
1302965	Pon3	paraoxonase 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1552156	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PON3 protein	PMID:28918527
1302965	Pon3	paraoxonase 3	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1344009	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PON3 mRNA	PMID:20044591
1302965	Pon3	paraoxonase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PON3 mRNA	PMID:37682722|PMID:39515575
1302965	Pon3	paraoxonase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344009	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PON3 exon; Benzo(a)pyrene affects the methylation of PON3 promoter	PMID:27901495
1302965	Pon3	paraoxonase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PON3 mRNA	PMID:32234424
1302965	Pon3	paraoxonase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552156	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PON3 mRNA	PMID:22228805
1302965	Pon3	paraoxonase 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1344009	E	RGD:6480464	20250114	CTD	MESH:D001564	[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of PON3 protein	PMID:36982514
1302965	Pon3	paraoxonase 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1344009	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of PON3 promoter	PMID:23974009
1302965	Pon3	paraoxonase 3	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1344009	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of PON3 protein	PMID:34122009
1302965	Pon3	paraoxonase 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PON3 mRNA	PMID:23806026|PMID:25895662
1302965	Pon3	paraoxonase 3	gene	CHEBI:30745	phenylacetic acid	increases hydrolysis	ISO	RGD:1344009	E	RGD:6480464	20120717	CTD	MESH:C025136	PON3 protein results in increased hydrolysis of phenylacetic acid	PMID:16099434|PMID:16139510
1302965	Pon3	paraoxonase 3	gene	CHEBI:3093	bifenthrin	increases expression	ISO	RGD:1552156	E	RGD:6480464	20160822	CTD	MESH:C099952	bifenthrin results in increased expression of PON3 mRNA	PMID:26071804
1302965	Pon3	paraoxonase 3	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1344009	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of PON3 mRNA	PMID:37690743
1302965	Pon3	paraoxonase 3	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PON3 mRNA	PMID:24136188
1302965	Pon3	paraoxonase 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PON3 mRNA	PMID:30047161
1302965	Pon3	paraoxonase 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PON3 mRNA	PMID:34492290
1302965	Pon3	paraoxonase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1344009	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PON3 mRNA	PMID:19710929
1302965	Pon3	paraoxonase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PON3 mRNA	PMID:25181051
1302965	Pon3	paraoxonase 3	gene	CHEBI:33234	vitamin E	increases activity	ISO	RGD:1552156	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased activity of PON3 protein	PMID:12615656
1302965	Pon3	paraoxonase 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1552156	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of PON3 mRNA	PMID:26682919
1302965	Pon3	paraoxonase 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20140513	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PON3 mRNA	PMID:22653878
1302965	Pon3	paraoxonase 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PON3 mRNA	PMID:25530946|PMID:26006071
1302965	Pon3	paraoxonase 3	gene	CHEBI:34342	3-methylcholanthrene	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D008748	Methylcholanthrene results in increased expression of PON3 mRNA	PMID:26006071
1302965	Pon3	paraoxonase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PON3 mRNA	PMID:39298647
1302965	Pon3	paraoxonase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552156	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of PON3 mRNA	PMID:40203079
1302965	Pon3	paraoxonase 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of PON3 mRNA	PMID:21241498
1302965	Pon3	paraoxonase 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552156	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PON3 intron	PMID:28392331
1302965	Pon3	paraoxonase 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20180828	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PON3 mRNA	PMID:29404631
1302965	Pon3	paraoxonase 3	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1552156	E	RGD:6480464	20180828	CTD	MESH:D004390	[APOE protein results in increased susceptibility to Chlorpyrifos] which results in decreased expression of PON3 mRNA	PMID:29404631
1302965	Pon3	paraoxonase 3	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of PON3 mRNA	PMID:35093514
1302965	Pon3	paraoxonase 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PON3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of PON3 mRNA	PMID:18544905
1302965	Pon3	paraoxonase 3	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PON3 mRNA	PMID:32680482
1302965	Pon3	paraoxonase 3	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of PON3 mRNA	PMID:22110744
1302965	Pon3	paraoxonase 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PON3 mRNA	PMID:38382870
1302965	Pon3	paraoxonase 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PON3 mRNA	PMID:24982889
1302965	Pon3	paraoxonase 3	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of PON3 promoter	PMID:22457795
1302965	Pon3	paraoxonase 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PON3 mRNA	PMID:24386269
1302965	Pon3	paraoxonase 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PON3 mRNA	PMID:19376846
1302965	Pon3	paraoxonase 3	gene	CHEBI:3750	clofibrate	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002994	Clofibrate results in decreased expression of PON3 mRNA	PMID:12851107
1302965	Pon3	paraoxonase 3	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1344009	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of PON3 protein	PMID:34122009
1302965	Pon3	paraoxonase 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PON3 mRNA	PMID:28302478
1302965	Pon3	paraoxonase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552156	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PON3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PON3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PON3 mRNA	PMID:36331819
1302965	Pon3	paraoxonase 3	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of PON3 mRNA	PMID:22110744
1302965	Pon3	paraoxonase 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1344009	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PON3 gene	PMID:29154799
1302965	Pon3	paraoxonase 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PON3 mRNA	PMID:30047161
1302965	Pon3	paraoxonase 3	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of PON3 mRNA	PMID:41580965
1302965	Pon3	paraoxonase 3	gene	CHEBI:40303	lovastatin	increases hydrolysis	ISO	RGD:1344009	E	RGD:6480464	20120412	CTD	MESH:D008148	PON3 protein results in increased hydrolysis of Lovastatin	PMID:15772423
1302965	Pon3	paraoxonase 3	gene	CHEBI:40303	lovastatin	increases metabolic processing	ISO	RGD:1552156	E	RGD:6480464	20120412	CTD	MESH:D008148	PON3 protein results in increased metabolism of Lovastatin	PMID:12615656
1302965	Pon3	paraoxonase 3	gene	CHEBI:40303	lovastatin	multiple interactions	ISO	RGD:1552156	E	RGD:6480464	20120412	CTD	MESH:D008148	7-ketocholesterol inhibits the reaction [PON3 protein results in increased metabolism of Lovastatin]; Phosphatidylcholines inhibits the reaction [PON3 protein results in increased metabolism of Lovastatin]	PMID:12615656
1302965	Pon3	paraoxonase 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PON3 mRNA	PMID:20106945|PMID:25562108
1302965	Pon3	paraoxonase 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1344009	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of PON3 mRNA	PMID:27989131
1302965	Pon3	paraoxonase 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PON3 mRNA	PMID:28973697
1302965	Pon3	paraoxonase 3	gene	CHEBI:43572	kojic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PON3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of PON3 mRNA	PMID:18544905
1302965	Pon3	paraoxonase 3	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of PON3 mRNA	PMID:24136188
1302965	Pon3	paraoxonase 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PON3 mRNA	PMID:38832940
1302965	Pon3	paraoxonase 3	gene	CHEBI:4489	Diallyl sulfide	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20141111	CTD	MESH:C038491	allyl sulfide results in decreased expression of PON3 mRNA	PMID:22653878
1302965	Pon3	paraoxonase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552156	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PON3 mRNA	PMID:17562736
1302965	Pon3	paraoxonase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of PON3 mRNA	PMID:29067470
1302965	Pon3	paraoxonase 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1344009	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PON3 mRNA	PMID:22230336
1302965	Pon3	paraoxonase 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PON3 mRNA	PMID:29391264
1302965	Pon3	paraoxonase 3	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552156	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of PON3 mRNA	PMID:22334560
1302965	Pon3	paraoxonase 3	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of PON3 mRNA	PMID:32234424
1302965	Pon3	paraoxonase 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of PON3 mRNA	PMID:25554681
1302965	Pon3	paraoxonase 3	gene	CHEBI:5062	finasteride	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in decreased expression of PON3 mRNA	PMID:24136188
1302965	Pon3	paraoxonase 3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PON3 mRNA	PMID:30047161
1302965	Pon3	paraoxonase 3	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PON3 mRNA	PMID:24136188
1302965	Pon3	paraoxonase 3	gene	CHEBI:566274	malonaldehyde	multiple interactions	ISO	RGD:1344009	E	RGD:6480464	20120918	CTD	MESH:D008315	PON3 protein inhibits the reaction [Carbon Tetrachloride results in increased abundance of Malondialdehyde]	PMID:20079818
1302965	Pon3	paraoxonase 3	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1344009	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of PON3 mRNA	PMID:20436886
1302965	Pon3	paraoxonase 3	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1344009	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PON3 mRNA	PMID:22079614
1302965	Pon3	paraoxonase 3	gene	CHEBI:64294	7-ketocholesterol	multiple interactions	ISO	RGD:1552156	E	RGD:6480464	20120412	CTD	MESH:C003001	7-ketocholesterol inhibits the reaction [PON3 protein results in increased metabolism of Lovastatin]	PMID:12615656
1302965	Pon3	paraoxonase 3	gene	CHEBI:64482	phosphatidylcholine	multiple interactions	ISO	RGD:1552156	E	RGD:6480464	20170228	CTD	MESH:D010713	Phosphatidylcholines inhibits the reaction [PON3 protein results in increased metabolism of Lovastatin]	PMID:12615656
1302965	Pon3	paraoxonase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PON3 mRNA	PMID:22206623
1302965	Pon3	paraoxonase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552156	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PON3 mRNA	PMID:22206623
1302965	Pon3	paraoxonase 3	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PON3 mRNA	PMID:24136188
1302965	Pon3	paraoxonase 3	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of PON3 mRNA	PMID:33484710
1302965	Pon3	paraoxonase 3	gene	CHEBI:79089	ceric oxide	multiple interactions	ISO	RGD:1344009	E	RGD:6480464	20250114	CTD	MESH:C030583	[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of PON3 protein	PMID:36982514
1302965	Pon3	paraoxonase 3	gene	CHEBI:80630	irinotecan	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan affects the expression of PON3 mRNA	PMID:20097248
1302965	Pon3	paraoxonase 3	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1552156	E	RGD:6480464	20140513	CTD	MESH:D010634	Phenobarbital results in decreased expression of PON3 mRNA	PMID:22653878
1302965	Pon3	paraoxonase 3	gene	CHEBI:8082	phenyl acetate	affects hydrolysis	ISO	RGD:1344009	E	RGD:6480464	20170303	CTD	MESH:C570634	PON3 gene SNP affects the hydrolysis of phenyl acetate	PMID:20839225
1302965	Pon3	paraoxonase 3	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1552156	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of PON3 mRNA	PMID:22334560
1302965	Pon3	paraoxonase 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552156	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PON3 mRNA	PMID:39847705
1302965	Pon3	paraoxonase 3	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1552156	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of PON3 mRNA	PMID:21278054|PMID:22334560
1302965	Pon3	paraoxonase 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PON3 mRNA	PMID:24780913|PMID:30047161
1302965	Pon3	paraoxonase 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PON3 mRNA	PMID:21346803
1302965	Pon3	paraoxonase 3	gene	CHEBI:9241	spironolactone	increases hydrolysis	ISO	RGD:1344009	E	RGD:6480464	20120412	CTD	MESH:D013148	PON3 protein results in increased hydrolysis of Spironolactone	PMID:15772423
1302965	Pon3	paraoxonase 3	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of PON3 mRNA	PMID:24136188
1302965	Pon3	paraoxonase 3	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PON3 mRNA	PMID:19015723
1302966	Nrm	nurim	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NRM mRNA	PMID:38218311
1302966	Nrm	nurim	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1614232	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NRM mRNA	PMID:26251327
1302966	Nrm	nurim	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1614232	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of NRM promoter	PMID:26251327
1302966	Nrm	nurim	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of NRM; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NRM gene	PMID:20938992
1302966	Nrm	nurim	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of NRM mRNA	PMID:30951980
1302966	Nrm	nurim	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614232	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NRM mRNA	PMID:39241906
1302966	Nrm	nurim	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1352240	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NRM mRNA	PMID:38568856
1302966	Nrm	nurim	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of NRM; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NRM gene	PMID:20938992
1302966	Nrm	nurim	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NRM mRNA	PMID:37992649
1302966	Nrm	nurim	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of NRM mRNA	PMID:21592394
1302966	Nrm	nurim	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of NRM mRNA	PMID:21592394
1302966	Nrm	nurim	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NRM mRNA	PMID:37992649
1302966	Nrm	nurim	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of NRM mRNA	PMID:26577399
1302966	Nrm	nurim	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1352240	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of NRM protein	PMID:37730182
1302966	Nrm	nurim	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of NRM mRNA	PMID:21592394
1302966	Nrm	nurim	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of NRM mRNA	PMID:21592394
1302966	Nrm	nurim	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NRM mRNA	PMID:33387578
1302966	Nrm	nurim	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NRM mRNA	PMID:35301059
1302966	Nrm	nurim	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NRM mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NRM mRNA	PMID:34911549
1302966	Nrm	nurim	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614232	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NRM mRNA	PMID:25629700
1302966	Nrm	nurim	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of NRM; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NRM gene	PMID:20938992
1302966	Nrm	nurim	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NRM mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRM mRNA	PMID:39836092|PMID:40512198
1302966	Nrm	nurim	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NRM mRNA	PMID:31881176
1302966	Nrm	nurim	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of NRM mRNA	PMID:19167446
1302966	Nrm	nurim	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1352240	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NRM mRNA	PMID:22574217
1302966	Nrm	nurim	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614232	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NRM mRNA	PMID:21570461
1302966	Nrm	nurim	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1614232	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NRM mRNA	PMID:19933214
1302966	Nrm	nurim	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NRM mRNA	PMID:17942748
1302966	Nrm	nurim	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1614232	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of NRM mRNA	PMID:27862939
1302966	Nrm	nurim	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NRM mRNA	PMID:37992649
1302966	Nrm	nurim	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1352240	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of NRM mRNA	PMID:34032870
1302966	Nrm	nurim	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NRM mRNA	PMID:38568856
1302966	Nrm	nurim	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NRM mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRM mRNA	PMID:39836092|PMID:40512198
1302966	Nrm	nurim	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NRM mRNA	PMID:22378314
1302966	Nrm	nurim	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1614232	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NRM exon; Benzo(a)pyrene results in decreased methylation of NRM intron	PMID:27901495
1302966	Nrm	nurim	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1352240	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NRM mRNA	PMID:32234424
1302966	Nrm	nurim	gene	CHEBI:30512	silver atom	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D012834	[Silver analog co-treated with Povidone] results in decreased expression of NRM mRNA	PMID:25194297
1302966	Nrm	nurim	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NRM mRNA	PMID:30047161
1302966	Nrm	nurim	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614232	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NRM gene	PMID:35295148
1302966	Nrm	nurim	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NRM mRNA	PMID:19710929
1302966	Nrm	nurim	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of NRM mRNA	PMID:38479592
1302966	Nrm	nurim	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NRM mRNA	PMID:25181051
1302966	Nrm	nurim	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1352240	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NRM mRNA	PMID:30903817
1302966	Nrm	nurim	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1352240	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of NRM gene	PMID:31601247
1302966	Nrm	nurim	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NRM mRNA	PMID:36041667
1302966	Nrm	nurim	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1614232	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of NRM mRNA	PMID:25172293
1302966	Nrm	nurim	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1352240	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of NRM mRNA	PMID:25979313
1302966	Nrm	nurim	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1614232	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of NRM mRNA	PMID:26682919
1302966	Nrm	nurim	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NRM mRNA	PMID:23196670
1302966	Nrm	nurim	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614232	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of NRM mRNA	PMID:40203079
1302966	Nrm	nurim	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NRM mRNA	PMID:36041667
1302966	Nrm	nurim	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of NRM mRNA	PMID:30951980
1302966	Nrm	nurim	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1614232	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of NRM mRNA	PMID:38685157
1302966	Nrm	nurim	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NRM mRNA	PMID:36041667
1302966	Nrm	nurim	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1614232	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NRM mRNA	PMID:37019170
1302966	Nrm	nurim	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NRM mRNA	PMID:21266533
1302966	Nrm	nurim	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1614232	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NRM mRNA	PMID:21266533
1302966	Nrm	nurim	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352240	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NRM mRNA	PMID:37042841
1302966	Nrm	nurim	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of NRM mRNA	PMID:26678675
1302966	Nrm	nurim	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of NRM mRNA	PMID:18500788
1302966	Nrm	nurim	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NRM mRNA	PMID:35301059
1302966	Nrm	nurim	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of NRM mRNA	PMID:36326898
1302966	Nrm	nurim	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614232	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NRM mRNA	PMID:40194260
1302966	Nrm	nurim	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1352240	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NRM mRNA	PMID:19167446
1302966	Nrm	nurim	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NRM mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of NRM mRNA	PMID:19167446
1302966	Nrm	nurim	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1614232	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of NRM mRNA	PMID:39529242
1302966	Nrm	nurim	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NRM mRNA	PMID:30047161
1302966	Nrm	nurim	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NRM mRNA	PMID:25562108
1302966	Nrm	nurim	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1614232	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of NRM mRNA	PMID:17555576
1302966	Nrm	nurim	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1614232	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NRM mRNA	PMID:28973697
1302966	Nrm	nurim	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NRM mRNA	PMID:37992649
1302966	Nrm	nurim	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NRM mRNA	PMID:33387578
1302966	Nrm	nurim	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NRM mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRM mRNA	PMID:39836092|PMID:40512198
1302966	Nrm	nurim	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NRM mRNA	PMID:29391264
1302966	Nrm	nurim	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1614232	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NRM mRNA	PMID:17555576
1302966	Nrm	nurim	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1614232	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NRM mRNA	PMID:17942748
1302966	Nrm	nurim	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NRM mRNA	PMID:17942748
1302966	Nrm	nurim	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614232	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NRM mRNA; Nanotubes, Carbon results in increased expression of NRM mRNA	PMID:25554681
1302966	Nrm	nurim	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NRM mRNA	PMID:30047161
1302966	Nrm	nurim	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NRM mRNA	PMID:35964746
1302966	Nrm	nurim	gene	CHEBI:53248	poly(vinylpyrrolidone)	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D011205	[Silver analog co-treated with Povidone] results in decreased expression of NRM mRNA	PMID:25194297
1302966	Nrm	nurim	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1614232	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of NRM mRNA	PMID:38701926
1302966	Nrm	nurim	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of NRM mRNA	PMID:28988120
1302966	Nrm	nurim	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of NRM mRNA	PMID:19564919
1302966	Nrm	nurim	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of NRM mRNA	PMID:19564919
1302966	Nrm	nurim	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of NRM mRNA	PMID:19564919
1302966	Nrm	nurim	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1614232	E	RGD:6480464	20160315	CTD	MESH:C072553	[MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of NRM mRNA	PMID:25566086
1302966	Nrm	nurim	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1614232	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of NRM mRNA	PMID:23091169
1302966	Nrm	nurim	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NRM mRNA	PMID:32109520
1302966	Nrm	nurim	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1352240	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NRM mRNA	PMID:19167446
1302966	Nrm	nurim	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1614232	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of NRM mRNA	PMID:39847705
1302966	Nrm	nurim	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NRM mRNA	PMID:24780913
1302966	Nrm	nurim	gene	CHEBI:9141	silver(0)	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D012834	[Silver analog co-treated with Povidone] results in decreased expression of NRM mRNA	PMID:25194297
1302966	Nrm	nurim	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NRM mRNA	PMID:38568856
1302966	Nrm	nurim	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of NRM mRNA	PMID:29301935
1302966	Nrm	nurim	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1352240	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of NRM mRNA	PMID:27188386
1302966	Nrm	nurim	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of NRM mRNA	PMID:30047161
1302967	Tmprss11c	transmembrane protease, serine 11C	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1621147	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TMPRSS11C intron	PMID:28392331
1302967	Tmprss11c	transmembrane protease, serine 11C	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20150818	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of TMPRSS11C promoter	PMID:22457795
1302967	Tmprss11c	transmembrane protease, serine 11C	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20150818	CTD	MESH:C039281	furan results in increased methylation of TMPRSS11C gene	PMID:22079235
1302968	Krt77	keratin 77	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1352886	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of KRT77 mRNA	PMID:26079696
1302968	Krt77	keratin 77	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1352886	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of KRT77 mRNA	PMID:30510588
1302968	Krt77	keratin 77	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of KRT77 mRNA	PMID:23829299
1302968	Krt77	keratin 77	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin analog results in decreased expression of KRT77 protein; alpha-Chlorohydrin results in decreased expression of KRT77 protein	PMID:26597043
1302968	Krt77	keratin 77	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1352886	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KRT77 mRNA	PMID:22100608
1302968	Krt77	keratin 77	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1352886	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT77 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT77 protein	PMID:38598786
1302968	Krt77	keratin 77	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352886	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT77 mRNA	PMID:32525701
1302968	Krt77	keratin 77	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1352886	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of KRT77 mRNA	PMID:24768652|PMID:25583101
1302968	Krt77	keratin 77	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618726	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT77 mRNA	PMID:24680724
1302968	Krt77	keratin 77	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1352886	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KRT77 mRNA	PMID:23152189
1302968	Krt77	keratin 77	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of KRT77 mRNA	PMID:26033743
1302968	Krt77	keratin 77	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352886	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT77 mRNA	PMID:34032870|PMID:39719251
1302968	Krt77	keratin 77	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1618726	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KRT77 mRNA	PMID:27195522
1302968	Krt77	keratin 77	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352886	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT77 exon; Benzo(a)pyrene results in increased methylation of KRT77 promoter	PMID:27901495
1302968	Krt77	keratin 77	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of KRT77 mRNA	PMID:26033743
1302968	Krt77	keratin 77	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT77 mRNA	PMID:25181051
1302968	Krt77	keratin 77	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1352886	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT77 protein	PMID:38598786
1302968	Krt77	keratin 77	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased expression of KRT77 mRNA	PMID:27387713
1302968	Krt77	keratin 77	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352886	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT77 mRNA	PMID:32525701
1302968	Krt77	keratin 77	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1352886	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of KRT77 protein	PMID:31195006
1302968	Krt77	keratin 77	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1352886	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of KRT77 mRNA	PMID:26079696
1302968	Krt77	keratin 77	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1352886	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT77 mRNA	PMID:32525701
1302968	Krt77	keratin 77	gene	CHEBI:91108	SB 431542	increases expression	ISO	RGD:1352886	E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of KRT77 protein	PMID:25670856
1302968	Krt77	keratin 77	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1352886	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT77 protein	PMID:38598786
1302969	Phf23	PHD finger protein 23	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PHF23 mRNA	PMID:38218311
1302969	Phf23	PHD finger protein 23	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PHF23 mRNA	PMID:22378314
1302969	Phf23	PHD finger protein 23	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1601853	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHF23 mRNA	PMID:37042841
1302969	Phf23	PHD finger protein 23	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PHF23 mRNA	PMID:20655997|PMID:23649840
1302969	Phf23	PHD finger protein 23	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1601853	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PHF23 mRNA	PMID:21179406
1302969	Phf23	PHD finger protein 23	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1601853	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PHF23 protein	PMID:37730182
1302969	Phf23	PHD finger protein 23	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PHF23 mRNA	PMID:33387578
1302969	Phf23	PHD finger protein 23	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PHF23 mRNA	PMID:28818685
1302969	Phf23	PHD finger protein 23	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1622205	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PHF23 mRNA	PMID:37236586
1302969	Phf23	PHD finger protein 23	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PHF23 mRNA	PMID:23649840
1302969	Phf23	PHD finger protein 23	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1601853	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PHF23 gene	PMID:27153756
1302969	Phf23	PHD finger protein 23	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PHF23 mRNA	PMID:23649840
1302969	Phf23	PHD finger protein 23	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1622205	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PHF23 mRNA	PMID:27339419|PMID:31919559
1302969	Phf23	PHD finger protein 23	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1622205	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHF23 mRNA	PMID:22206623
1302969	Phf23	PHD finger protein 23	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1601853	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PHF23 gene	PMID:25304211
1302969	Phf23	PHD finger protein 23	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1601853	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PHF23 protein	PMID:35688186
1302969	Phf23	PHD finger protein 23	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1601853	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PHF23 mRNA	PMID:28903495
1302969	Phf23	PHD finger protein 23	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1601853	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of PHF23 gene	PMID:31636367
1302969	Phf23	PHD finger protein 23	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of PHF23 mRNA	PMID:23195993
1302969	Phf23	PHD finger protein 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622205	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHF23 mRNA	PMID:21570461
1302969	Phf23	PHD finger protein 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PHF23 mRNA	PMID:33387578
1302969	Phf23	PHD finger protein 23	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1601853	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PHF23 protein	PMID:35688186
1302969	Phf23	PHD finger protein 23	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601853	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PHF23 mRNA	PMID:38568856
1302969	Phf23	PHD finger protein 23	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1601853	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of PHF23 mRNA	PMID:20382639
1302969	Phf23	PHD finger protein 23	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PHF23 mRNA	PMID:35984750
1302969	Phf23	PHD finger protein 23	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622205	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHF23 gene	PMID:35295148
1302969	Phf23	PHD finger protein 23	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1622205	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PHF23 gene; titanium dioxide results in increased methylation of PHF23 promoter	PMID:35295148
1302969	Phf23	PHD finger protein 23	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PHF23 mRNA	PMID:34492290
1302969	Phf23	PHD finger protein 23	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF23 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1302969	Phf23	PHD finger protein 23	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1622205	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PHF23 mRNA	PMID:39298647
1302969	Phf23	PHD finger protein 23	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1622205	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PHF23 mRNA	PMID:37019170
1302969	Phf23	PHD finger protein 23	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1601853	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHF23 mRNA	PMID:37042841
1302969	Phf23	PHD finger protein 23	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PHF23 mRNA	PMID:38568856
1302969	Phf23	PHD finger protein 23	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1622205	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PHF23 mRNA	PMID:37236586
1302969	Phf23	PHD finger protein 23	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1622205	E	RGD:6480464	20130618	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of PHF23 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PHF23 mRNA]	PMID:17585979
1302969	Phf23	PHD finger protein 23	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1622205	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PHF23 mRNA	PMID:40194260
1302969	Phf23	PHD finger protein 23	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1601853	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHF23 mRNA	PMID:25979313
1302969	Phf23	PHD finger protein 23	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF23 mRNA	PMID:19101580|PMID:24935251|PMID:29154799
1302969	Phf23	PHD finger protein 23	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1622205	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF23 mRNA	PMID:20546886|PMID:21427059
1302969	Phf23	PHD finger protein 23	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PHF23 mRNA	PMID:25562108|PMID:27989131
1302969	Phf23	PHD finger protein 23	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1622205	E	RGD:6480464	20130618	CTD	MESH:D013629	Tamoxifen affects the expression of PHF23 mRNA	PMID:17555576
1302969	Phf23	PHD finger protein 23	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of PHF23 mRNA	PMID:24449571
1302969	Phf23	PHD finger protein 23	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1601853	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PHF23 mRNA	PMID:28542535
1302969	Phf23	PHD finger protein 23	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of PHF23 mRNA	PMID:24935251
1302969	Phf23	PHD finger protein 23	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622205	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of PHF23 mRNA	PMID:17562736
1302969	Phf23	PHD finger protein 23	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHF23 mRNA	PMID:33387578
1302969	Phf23	PHD finger protein 23	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHF23 mRNA	PMID:21420995
1302969	Phf23	PHD finger protein 23	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1622205	E	RGD:6480464	20130618	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of PHF23 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PHF23 mRNA]	PMID:17585979
1302969	Phf23	PHD finger protein 23	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1601853	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PHF23 gene	PMID:25304211
1302969	Phf23	PHD finger protein 23	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1622205	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PHF23 mRNA	PMID:35436446
1302969	Phf23	PHD finger protein 23	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1622205	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PHF23 mRNA	PMID:17555576
1302969	Phf23	PHD finger protein 23	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1622205	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PHF23 mRNA	PMID:25554681
1302969	Phf23	PHD finger protein 23	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1622205	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PHF23 mRNA	PMID:35964746
1302969	Phf23	PHD finger protein 23	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PHF23 mRNA	PMID:24793618
1302969	Phf23	PHD finger protein 23	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PHF23 protein	PMID:32959892
1302969	Phf23	PHD finger protein 23	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of PHF23 mRNA	PMID:28988120
1302969	Phf23	PHD finger protein 23	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1622205	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of PHF23 mRNA	PMID:22206623
1302969	Phf23	PHD finger protein 23	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1622205	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHF23 mRNA	PMID:22206623
1302969	Phf23	PHD finger protein 23	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1601853	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PHF23 protein	PMID:31285264
1302969	Phf23	PHD finger protein 23	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PHF23 mRNA	PMID:19281266
1302969	Phf23	PHD finger protein 23	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PHF23 mRNA	PMID:38568856
1302969	Phf23	PHD finger protein 23	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1601853	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PHF23 mRNA	PMID:29301935
1302970	Prss46	protease, serine, 46	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PRSS46 mRNA	PMID:36841081
1302970	Prss46	protease, serine, 46	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRSS46 mRNA	PMID:33387578
1302970	Prss46	protease, serine, 46	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of PRSS46 gene	PMID:31011160
1302970	Prss46	protease, serine, 46	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PRSS46 mRNA	PMID:26033743
1302970	Prss46	protease, serine, 46	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1552176	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PRSS46 protein	PMID:28918527
1302970	Prss46	protease, serine, 46	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PRSS46 mRNA	PMID:26033743
1302970	Prss46	protease, serine, 46	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1552176	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PRSS46 mRNA	PMID:27131904
1302970	Prss46	protease, serine, 46	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1552176	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of PRSS46 mRNA	PMID:27131904
1302970	Prss46	protease, serine, 46	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552176	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PRSS46 mRNA	PMID:29203145
1302970	Prss46	protease, serine, 46	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRSS46 mRNA	PMID:25181051
1302970	Prss46	protease, serine, 46	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552176	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PRSS46 mRNA	PMID:32715474
1302970	Prss46	protease, serine, 46	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1552176	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of PRSS46 mRNA	PMID:22733784
1302970	Prss46	protease, serine, 46	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PRSS46 mRNA	PMID:29391264
1302970	Prss46	protease, serine, 46	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552176	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PRSS46 mRNA	PMID:25554681
1302970	Prss46	protease, serine, 46	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1552176	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PRSS46 mRNA	PMID:27131904
1302970	Prss46	protease, serine, 46	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1552176	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of PRSS46 mRNA	PMID:27131904
1302971	Adm2	adrenomedullin 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1348112	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ADM2 mRNA	PMID:38218311
1302971	Adm2	adrenomedullin 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ADM2 mRNA]	PMID:31150632
1302971	Adm2	adrenomedullin 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADM2 mRNA	PMID:36189433
1302971	Adm2	adrenomedullin 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1348112	E	RGD:6480464	20120717	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ADM2 mRNA	PMID:16474185
1302971	Adm2	adrenomedullin 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1348112	E	RGD:6480464	20120717	CTD	MESH:D010100	VULM 1457 inhibits the reaction [Oxygen deficiency results in increased expression of ADM2 mRNA]	PMID:16474185
1302971	Adm2	adrenomedullin 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1348112	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ADM2 mRNA	PMID:26079696
1302971	Adm2	adrenomedullin 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1348112	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ADM2 mRNA	PMID:22378314
1302971	Adm2	adrenomedullin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of ADM2 mRNA	PMID:16002435|PMID:32145629
1302971	Adm2	adrenomedullin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1348112	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ADM2 mRNA	PMID:31614463
1302971	Adm2	adrenomedullin 2	gene	CHEBI:16480	nitric oxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide deficiency results in increased expression of ADM2 mRNA	PMID:16326922
1302971	Adm2	adrenomedullin 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADM2 mRNA	PMID:25510870
1302971	Adm2	adrenomedullin 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1348112	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ADM2 mRNA	PMID:38568856
1302971	Adm2	adrenomedullin 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ADM2 gene	PMID:27618143
1302971	Adm2	adrenomedullin 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348112	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADM2 mRNA	PMID:37042841
1302971	Adm2	adrenomedullin 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1348112	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ADM2 mRNA	PMID:36695872
1302971	Adm2	adrenomedullin 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADM2 mRNA	PMID:36189433
1302971	Adm2	adrenomedullin 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1622982	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of ADM2 mRNA	PMID:28973375
1302971	Adm2	adrenomedullin 2	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	[Cholecalciferol co-treated with Nicotine] results in decreased expression of ADM2 protein	PMID:19910445
1302971	Adm2	adrenomedullin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of ADM2 mRNA	PMID:32533902
1302971	Adm2	adrenomedullin 2	gene	CHEBI:17967	urethane	affects expression	ISO	RGD:1348112	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane affects the expression of ADM2 mRNA	PMID:28818685
1302971	Adm2	adrenomedullin 2	gene	CHEBI:181932	3-Nitrobenzanthrone	decreases expression	ISO	RGD:1348112	E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in decreased expression of ADM2 mRNA	PMID:34036453
1302971	Adm2	adrenomedullin 2	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	[Cholecalciferol co-treated with Nicotine] results in decreased expression of ADM2 protein	PMID:19910445
1302971	Adm2	adrenomedullin 2	gene	CHEBI:188855	Octicizer	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20220104	CTD	MESH:C018535	[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA	PMID:33367866
1302971	Adm2	adrenomedullin 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADM2 mRNA	PMID:25510870
1302971	Adm2	adrenomedullin 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADM2 mRNA	PMID:25510870
1302971	Adm2	adrenomedullin 2	gene	CHEBI:2663	amiodarone	multiple interactions	ISO	RGD:1348112	E	RGD:6480464	20230801	CTD	MESH:D000638	ADM2 protein inhibits the reaction [Amiodarone results in decreased activity of CAT protein]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of and results in decreased phosphorylation of CTNNB1 protein]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of BCL2 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of BCL2 protein]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of CAT mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of GPX1 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of IL10 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of IL10 protein]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of SOD1 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of SOD2 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX protein]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of CASP3 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of CASP3 protein]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL1B mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL1B protein]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL6 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL6 protein]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of TNF mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of TNF protein]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of BCL2 mRNA]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of BCL2 protein]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of IL10 mRNA]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX mRNA]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX protein]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of CASP3 mRNA]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of CASP3 protein]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL1B protein]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL6 protein]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of TNF protein]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased activity of CAT protein]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of and results in decreased phosphorylation of CTNNB1 protein]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of BCL2 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of CAT mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of GPX1 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of IL10 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of SOD1 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of SOD2 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX protein]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of CASP3 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL1B mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL6 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of TNF mRNA]]	PMID:34434487
1302971	Adm2	adrenomedullin 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ADM2 mRNA	PMID:31150632
1302971	Adm2	adrenomedullin 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ADM2 mRNA]	PMID:31150632
1302971	Adm2	adrenomedullin 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ADM2 mRNA	PMID:31881176
1302971	Adm2	adrenomedullin 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1348112	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ADM2 mRNA	PMID:23557933
1302971	Adm2	adrenomedullin 2	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1348112	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ADM2 mRNA	PMID:23300844
1302971	Adm2	adrenomedullin 2	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D019833	[Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of ADM2 mRNA	PMID:32533902
1302971	Adm2	adrenomedullin 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1348112	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ADM2 mRNA	PMID:32763439
1302971	Adm2	adrenomedullin 2	gene	CHEBI:28940	calciol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002762	[Cholecalciferol co-treated with Nicotine] results in decreased expression of ADM2 protein	PMID:19910445
1302971	Adm2	adrenomedullin 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1348112	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ADM2 mRNA	PMID:34032870
1302971	Adm2	adrenomedullin 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1348112	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ADM2 mRNA	PMID:38568856|PMID:39719251
1302971	Adm2	adrenomedullin 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1348112	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of ADM2 mRNA	PMID:22378314
1302971	Adm2	adrenomedullin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348112	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADM2 promoter	PMID:27901495
1302971	Adm2	adrenomedullin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1622982	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADM2 mRNA	PMID:21715664
1302971	Adm2	adrenomedullin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1348112	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADM2 5' UTR	PMID:27901495
1302971	Adm2	adrenomedullin 2	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ADM2 mRNA	PMID:32479839
1302971	Adm2	adrenomedullin 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1622982	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ADM2 mRNA	PMID:35295148
1302971	Adm2	adrenomedullin 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ADM2 mRNA	PMID:25181051
1302971	Adm2	adrenomedullin 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1348112	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ADM2 mRNA	PMID:30903817
1302971	Adm2	adrenomedullin 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ADM2 mRNA	PMID:32145629
1302971	Adm2	adrenomedullin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1348112	E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A analog results in increased expression of ADM2 mRNA	PMID:32387340
1302971	Adm2	adrenomedullin 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ADM2 gene	PMID:28505145
1302971	Adm2	adrenomedullin 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADM2 mRNA	PMID:25510870
1302971	Adm2	adrenomedullin 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADM2 mRNA	PMID:25510870
1302971	Adm2	adrenomedullin 2	gene	CHEBI:34421	4-Hydroxybenzophenone	increases expression	ISO	RGD:1622982	E	RGD:6480464	20221101	CTD	MESH:C024292	4-hydroxybenzophenone results in increased expression of ADM2 mRNA	PMID:35476924
1302971	Adm2	adrenomedullin 2	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ADM2 mRNA	PMID:32680482
1302971	Adm2	adrenomedullin 2	gene	CHEBI:35019	tributyl phosphate	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20210406	CTD	MESH:C009524	[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA	PMID:33367866
1302971	Adm2	adrenomedullin 2	gene	CHEBI:35033	triphenyl phosphate	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20210406	CTD	MESH:C005445	[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA	PMID:33367866
1302971	Adm2	adrenomedullin 2	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20210406	CTD	MESH:C031324	[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA	PMID:33367866
1302971	Adm2	adrenomedullin 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	multiple interactions	ISO	RGD:1622982	E	RGD:6480464	20210406	CTD	MESH:C013320	[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA	PMID:33367866
1302971	Adm2	adrenomedullin 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348112	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ADM2 mRNA	PMID:38382870
1302971	Adm2	adrenomedullin 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1348112	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ADM2 mRNA	PMID:38174414|PMID:38568856
1302971	Adm2	adrenomedullin 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1348112	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ADM2 mRNA	PMID:36326898
1302971	Adm2	adrenomedullin 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1622982	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADM2 mRNA	PMID:40194260
1302971	Adm2	adrenomedullin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1348112	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ADM2 mRNA	PMID:40419075
1302971	Adm2	adrenomedullin 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1348112	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADM2 gene	PMID:29154799
1302971	Adm2	adrenomedullin 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ADM2 mRNA	PMID:16002435
1302971	Adm2	adrenomedullin 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1348112	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ADM2 mRNA	PMID:38832940
1302971	Adm2	adrenomedullin 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in increased expression of ADM2 mRNA	PMID:30723492|PMID:32479839
1302971	Adm2	adrenomedullin 2	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1348112	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ADM2 mRNA	PMID:24714768
1302971	Adm2	adrenomedullin 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1348112	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of ADM2 mRNA	PMID:33725128
1302971	Adm2	adrenomedullin 2	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1348112	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of ADM2 mRNA	PMID:25757056
1302971	Adm2	adrenomedullin 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ADM2 mRNA	PMID:29391264
1302971	Adm2	adrenomedullin 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1348112	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ADM2 mRNA	PMID:23300844
1302971	Adm2	adrenomedullin 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of ADM2 mRNA	PMID:21808981
1302971	Adm2	adrenomedullin 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1348112	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ADM2 mRNA	PMID:28988120
1302971	Adm2	adrenomedullin 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1348112	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ADM2 mRNA	PMID:24810058
1302971	Adm2	adrenomedullin 2	gene	CHEBI:64648	enniatin	increases expression	ISO	RGD:1348112	E	RGD:6480464	20230502	CTD	MESH:C100264	enniatins results in increased expression of ADM2 mRNA	PMID:36016515
1302971	Adm2	adrenomedullin 2	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1348112	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ADM2 mRNA	PMID:36318118
1302971	Adm2	adrenomedullin 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in decreased expression of ADM2 mRNA	PMID:32741896
1302971	Adm2	adrenomedullin 2	gene	CHEBI:82036	prothioconazole	increases expression	ISO	RGD:1348112	E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of ADM2 mRNA	PMID:35048155
1302971	Adm2	adrenomedullin 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1348112	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ADM2 mRNA	PMID:26079696
1302971	Adm2	adrenomedullin 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1348112	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ADM2 mRNA	PMID:38568856
1302971	Adm2	adrenomedullin 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1348112	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ADM2 mRNA	PMID:29301935
1302971	Adm2	adrenomedullin 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1348112	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of ADM2 mRNA	PMID:22378314
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1605700	E	RGD:6480464	20200804	CTD	MESH:D015025	Zearalenone results in increased expression of EHMT2 mRNA	PMID:32119988
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of EHMT2 mRNA	PMID:38218311
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of EHMT2 mRNA	PMID:33045310
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1605700	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of EHMT2 mRNA	PMID:11906190
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of EHMT2 mRNA	PMID:33167477
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D014212	EHMT2 protein promotes the reaction [Tretinoin promotes the reaction [CBX1 protein binds to POU5F1 promoter]]; EHMT2 protein promotes the reaction [Tretinoin promotes the reaction [CBX1 protein binds to ZFP42 promoter]]; EHMT2 protein promotes the reaction [Tretinoin results in increased methylation of POU5F1 promoter]	PMID:16415856
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1550173	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of EHMT2 mRNA	PMID:40945087
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550173	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of EHMT2 mRNA	PMID:30319688
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20201215	CTD	MESH:D000431	Ethanol promotes the reaction [EHMT2 protein binds to RAC1 promoter]; Rimonabant inhibits the reaction [Ethanol promotes the reaction [EHMT2 protein binds to RAC1 promoter]]; Roscovitine inhibits the reaction [Ethanol promotes the reaction [EHMT2 protein binds to RAC1 promoter]]	PMID:30143782
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EHMT2 mRNA	PMID:35811015
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EHMT2 mRNA	PMID:35811015
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550173	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EHMT2 mRNA	PMID:39298647
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605700	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of EHMT2 mRNA	PMID:32030086
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:16480	nitric oxide	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20140211	CTD	MESH:D009569	Nitric Oxide results in decreased expression of EHMT2 protein	PMID:23546878
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:16643	L-methionine	increases expression	ISO	RGD:1550173	E	RGD:6480464	20221206	CTD	MESH:D008715	Methionine deficiency results in increased expression of EHMT2 mRNA	PMID:35314295
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605700	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EHMT2 mRNA	PMID:37042841
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20241105	CTD	MESH:D008550	Melatonin inhibits the reaction [[Particulate Matter co-treated with Dietary Fats] results in decreased expression of EHMT2 protein]	PMID:37994397
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:17303	morphine	affects expression	ISO	RGD:1550173	E	RGD:6480464	20220111	CTD	MESH:D009020	Morphine affects the expression of EHMT2 mRNA	PMID:33891991
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of EHMT2 mRNA	PMID:21669218
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:17401	myo-inositol hexakisphosphate	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20141223	CTD	MESH:D010833	Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 protein]	PMID:25168426
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20180116	CTD	MESH:C031927	hydroquinone results in decreased expression of EHMT2 protein	PMID:27979589
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20150825	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of EHMT2 mRNA; Diethylhexyl Phthalate results in decreased expression of EHMT2 protein	PMID:25975992
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1605700	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of EHMT2 protein	PMID:37730182
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EHMT2 mRNA	PMID:28818685
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1550173	E	RGD:6480464	20141223	CTD	MESH:D014520	Urethane results in increased expression of EHMT2 mRNA; Urethane results in increased expression of EHMT2 protein	PMID:25168426
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:17967	urethane	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20141223	CTD	MESH:D014520	Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 protein]	PMID:25168426
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of EHMT2 mRNA	PMID:39836092
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of EHMT2 mRNA	PMID:24067728
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EHMT2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EHMT2 mRNA	PMID:28111341|PMID:37236586|PMID:37325564
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:233643	UNC0642	decreases activity	ISO	RGD:1605700	E	RGD:6480464	20250408	CTD	MESH:C000621860	UNC0642 results in decreased activity of EHMT2 protein	PMID:24102134
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of EHMT2 mRNA	PMID:19549813
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of EHMT2 mRNA	PMID:19376150
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605700	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EHMT2 gene	PMID:27153756
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550173	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EHMT2 mRNA	PMID:19770486
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605700	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EHMT2 polyA tail	PMID:30157460
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of EHMT2 mRNA	PMID:17460151
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1605700	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EHMT2 gene	PMID:25304211
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EHMT2 mRNA	PMID:40504410
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20210309	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 protein	PMID:33378118
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of EHMT2 mRNA	PMID:26272509
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA	PMID:27188386
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1605700	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of EHMT2 protein	PMID:35688186
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of EHMT2 mRNA	PMID:26302742
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1605700	E	RGD:6480464	20260407	CTD	MESH:C010974	Glyphosate results in increased expression of EHMT2 mRNA	PMID:40578477
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of EHMT2 gene	PMID:31011160
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1605700	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of EHMT2 gene	PMID:31636367
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of EHMT2 mRNA	PMID:27392435
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of EHMT2 mRNA; Cocaine results in decreased expression of EHMT2 protein	PMID:20056891
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27958	cocaine	decreases response to substance	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D003042	EHMT2 results in decreased susceptibility to Cocaine	PMID:20056891
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine inhibits the reaction [Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]]; Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]; EHMT2 inhibits the reaction [Cocaine results in increased expression of ATM mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of ELMO1 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of TGFBR1 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of TNFRSF25 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of USP9X mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of WNK3 mRNA]; EHMT2 protein inhibits the reaction [Cocaine results in increased expression of FOSB mRNA]	PMID:20056891
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in decreased expression of and results in decreased activity of EHMT2 protein	PMID:16648469
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550173	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EHMT2 mRNA	PMID:21570461
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EHMT2 mRNA	PMID:33387578
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EHMT2 mRNA	PMID:17942748
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EHMT2 protein	PMID:33212167
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EHMT2 mRNA	PMID:29803840
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin promotes the reaction [EHMT2 protein binds to BIRC5 promoter]	PMID:17124180
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:28812	(aminomethyl)phosphonic acid	increases expression	ISO	RGD:1605700	E	RGD:6480464	20260407	CTD	MESH:C036423	1-aminomethylphosphonic acid results in increased expression of EHMT2 mRNA	PMID:40578477
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of EHMT2 mRNA; sodium arsenite results in decreased expression of G9A mRNA	PMID:30557709|PMID:38578163
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of EHMT2 mRNA	PMID:28414027
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of EHMT2 mRNA; sodium arsenite results in decreased expression of EHMT2 protein	PMID:38228842|PMID:38568856
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605700	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of EHMT2 mRNA; sodium arsenite results in increased expression of EHMT2 protein	PMID:27217333|PMID:39719251
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EHMT2 mRNA; sodium arsenite promotes the reaction [EHMT2 protein binds to CDKN2A promoter]	PMID:22733434|PMID:40504410
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 protein; BRD4770 inhibits the reaction [sodium arsenite promotes the reaction [EHMT2 protein binds to PDK4 promoter]]; sodium arsenite inhibits the reaction [BRD4770 results in decreased expression of EHMT2 protein]; sodium arsenite promotes the reaction [EHMT2 protein binds to PDK4 promoter]	PMID:27217333|PMID:33378118
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605700	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EHMT2 exon	PMID:30157460
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605700	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EHMT2 promoter	PMID:27901495
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1605700	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of EHMT2 mRNA; arsenite results in increased expression of EHMT2 protein	PMID:18321869
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EHMT2 mRNA	PMID:22521957
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of EHMT2 mRNA	PMID:30047161
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550173	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EHMT2 gene	PMID:35295148
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of EHMT2 mRNA	PMID:18648102
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of EHMT2 mRNA	PMID:19167457
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EHMT2 mRNA	PMID:25181051
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of EHMT2 mRNA	PMID:30816183
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of EHMT2 protein	PMID:37567409
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1605700	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EHMT2 gene	PMID:31601247
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1605700	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of EHMT2 mRNA	PMID:28765096|PMID:29275510
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EHMT2 mRNA	PMID:36041667
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1605700	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of EHMT2 mRNA	PMID:25979313
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EHMT2 mRNA	PMID:36041667
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EHMT2 mRNA	PMID:36041667
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects expression	ISO	RGD:1550173	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the expression of EHMT2 mRNA	PMID:36464114
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of EHMT2 mRNA	PMID:21241498
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550173	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EHMT2 mRNA	PMID:37019170
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1550173	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of EHMT2 mRNA	PMID:35093514
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1550173	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of EHMT2 mRNA	PMID:34813904
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Ethanol promotes the reaction [EHMT2 protein binds to RAC1 promoter]]	PMID:30143782
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605700	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EHMT2 mRNA	PMID:37042841
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of EHMT2 mRNA	PMID:39836092
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EHMT2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EHMT2 mRNA	PMID:28111341|PMID:37236586|PMID:37325564
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of EHMT2 mRNA	PMID:23811191
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1605700	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of EHMT2 mRNA	PMID:28302478
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of EHMT2 mRNA	PMID:17963808
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of EHMT2 mRNA	PMID:19101580|PMID:23179753|PMID:26272509|PMID:28001369
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605700	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of EHMT2 gene	PMID:29154799
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of EHMT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA	PMID:17183730|PMID:27188386
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of EHMT2 mRNA	PMID:30047161
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of EHMT2 mRNA	PMID:25562108
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:4356	desferrioxamine B	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine results in decreased expression of EHMT2 mRNA	PMID:23483119
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EHMT2 mRNA	PMID:17562736
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EHMT2 mRNA	PMID:33387578
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of EHMT2 mRNA	PMID:29067470
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EHMT2 mRNA	PMID:35811015
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1605700	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EHMT2 gene	PMID:25304211
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EHMT2 mRNA	PMID:40504410
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20210309	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 protein	PMID:33378118
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EHMT2 mRNA	PMID:35436446
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1550173	E	RGD:6480464	20200804	CTD	MESH:D002101	Cacodylic Acid results in increased expression of EHMT2 mRNA	PMID:32052077
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EHMT2 mRNA	PMID:17942748
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EHMT2 mRNA	PMID:17942748
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EHMT2 mRNA	PMID:22521957
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects response to substance	ISO	RGD:1605700	E	RGD:6480464	20191114	CTD	MESH:C014347	EHMT2 protein affects the susceptibility to Decitabine	PMID:19531572
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of EHMT2 mRNA	PMID:25554681
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of EHMT2 mRNA	PMID:30047161
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550173	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EHMT2 mRNA	PMID:35964746
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of EHMT2 mRNA	PMID:20977926
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1605700	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of EHMT2 mRNA	PMID:22714537
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1605700	E	RGD:6480464	20180828	CTD	MESH:D011192	Potassium Dichromate results in increased expression of EHMT2 protein	PMID:29391238
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20180828	CTD	MESH:D011192	EHMT2 protein promotes the reaction [Potassium Dichromate results in increased expression of H2AX protein modified form]	PMID:29391238
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of EHMT2 mRNA	PMID:17183730
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1550173	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of EHMT2 mRNA	PMID:20829426
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EHMT2 protein	PMID:32959892
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:61390	afatinib	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20171114	CTD	MESH:C522924	afatinib inhibits the reaction [EGF protein results in increased expression of EHMT2 protein]	PMID:28787001
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of EHMT2 mRNA	PMID:39836092
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1550173	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of EHMT2 mRNA	PMID:26307267
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1550173	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of EHMT2 mRNA	PMID:20829426
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550173	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EHMT2 mRNA	PMID:22206623
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EHMT2 protein	PMID:37664457
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:756894	tak-243	affects sumoylation	ISO	RGD:1605700	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of EHMT2 protein	PMID:31285264
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA	PMID:27188386
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EHMT2 gene]	PMID:28238834
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EHMT2 mRNA	PMID:30047161
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1605700	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of EHMT2 mRNA; cylindrospermopsin results in increased expression of EHMT2 protein	PMID:24921660
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EHMT2 protein; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA	PMID:27188386|PMID:37664457
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of EHMT2 mRNA	PMID:11906190
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:94552	sepantronium	decreases expression	ISO	RGD:1605700	E	RGD:6480464	20221101	CTD	MESH:C523798	sepantronium results in decreased expression of EHMT2 protein	PMID:28787001
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:94552	sepantronium	multiple interactions	ISO	RGD:1605700	E	RGD:6480464	20221101	CTD	MESH:C523798	EGF protein inhibits the reaction [sepantronium results in decreased expression of EHMT2 protein]	PMID:28787001
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1605700	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of EHMT2 mRNA	PMID:29301935
1302972	Ehmt2	euchromatic histone lysine methyltransferase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EHMT2 mRNA	PMID:21346803
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552181	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of RXFP1 mRNA	PMID:37995155
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RXFP1 mRNA	PMID:30071829
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1351067	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RXFP1 mRNA	PMID:26516004
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1351067	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of RXFP1 mRNA	PMID:24763279
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1351067	E	RGD:6480464	20170516	CTD	MESH:D001280	Atrazine results in decreased expression of RXFP1 protein	PMID:27431321
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1351067	E	RGD:6480464	20170516	CTD	MESH:D001280	Atrazine inhibits the reaction [RLN1 protein binds to RXFP1 protein]	PMID:27431321
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552181	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RXFP1 mRNA	PMID:39241906
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1351067	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RXFP1 mRNA	PMID:35811015
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RXFP1 mRNA	PMID:32741896
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1351067	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of RXFP1 mRNA	PMID:20660070
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1351067	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of RXFP1 mRNA	PMID:20660070
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RXFP1 mRNA	PMID:32741896
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RXFP1 mRNA	PMID:33387578
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1552181	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RXFP1 mRNA	PMID:29950665
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:27496	simazine	decreases expression	ISO	RGD:1351067	E	RGD:6480464	20170516	CTD	MESH:D012839	Simazine results in decreased expression of RXFP1 mRNA; Simazine results in decreased expression of RXFP1 protein	PMID:27431321
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:27496	simazine	decreases expression	ISO	RGD:1552181	E	RGD:6480464	20121113	CTD	MESH:D012839	Simazine results in decreased expression of RXFP1 mRNA; Simazine results in decreased expression of RXFP1 protein	PMID:22984576|PMID:27431321
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:27496	simazine	multiple interactions	ISO	RGD:1351067	E	RGD:6480464	20170516	CTD	MESH:D012839	Simazine inhibits the reaction [RLN1 protein binds to RXFP1 protein]	PMID:27431321
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552181	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RXFP1 mRNA	PMID:28960355
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of RXFP1 mRNA	PMID:28374803
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RXFP1 mRNA	PMID:30556269
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1351067	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of RXFP1 mRNA	PMID:34032870
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552181	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of RXFP1 mRNA	PMID:37682722
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1351067	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RXFP1 mRNA	PMID:22316170
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351067	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RXFP1 3' UTR	PMID:27901495
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RXFP1 mRNA	PMID:30556269
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:30263	terbutylazine	decreases expression	ISO	RGD:1351067	E	RGD:6480464	20170516	CTD	MESH:C037565	terbutylazine results in decreased expression of RXFP1 protein	PMID:27431321
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:30263	terbutylazine	multiple interactions	ISO	RGD:1351067	E	RGD:6480464	20170516	CTD	MESH:C037565	terbutylazine inhibits the reaction [RLN1 protein binds to RXFP1 protein]	PMID:27431321
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552181	E	RGD:6480464	20131008	CTD	MESH:C009495	titanium dioxide results in increased expression of RXFP1 mRNA	PMID:23131501
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1552181	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RXFP1 mRNA	PMID:29950665
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RXFP1 mRNA	PMID:25181051
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RXFP1 mRNA	PMID:34947998
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RXFP1 gene	PMID:28505145
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1552181	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RXFP1 mRNA	PMID:29950665
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:38067	propazine	decreases expression	ISO	RGD:1351067	E	RGD:6480464	20170516	CTD	MESH:C100043	propazine results in decreased expression of RXFP1 protein	PMID:27431321
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:38067	propazine	multiple interactions	ISO	RGD:1351067	E	RGD:6480464	20170516	CTD	MESH:C100043	propazine inhibits the reaction [RLN1 protein binds to RXFP1 protein]	PMID:27431321
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552181	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RXFP1 mRNA	PMID:40194260
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1351067	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RXFP1 mRNA	PMID:38832940
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1351067	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of RXFP1 mRNA	PMID:24714768
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1351067	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of RXFP1 mRNA	PMID:35811015
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1351067	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RXFP1 mRNA	PMID:35811015
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1351067	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in decreased expression of RXFP1 mRNA	PMID:26833863
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D015735	Mifepristone results in decreased expression of RXFP1 mRNA; Mifepristone results in decreased expression of RXFP1 protein	PMID:20686183
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of RXFP1 mRNA	PMID:20080153
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of RXFP1 mRNA	PMID:33484710
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RXFP1 mRNA	PMID:32741896
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RXFP1 mRNA	PMID:25825206
1302973	Rxfp1	relaxin family peptide receptor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RXFP1 mRNA	PMID:24780913
1302974	Tcf19	transcription factor 19	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1550178	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TCF19 mRNA	PMID:37995155
1302974	Tcf19	transcription factor 19	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCF19 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCF19 mRNA	PMID:32699268
1302974	Tcf19	transcription factor 19	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of TCF19 mRNA	PMID:26516004
1302974	Tcf19	transcription factor 19	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1345711	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TCF19 mRNA	PMID:21632981
1302974	Tcf19	transcription factor 19	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550178	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TCF19 mRNA	PMID:39241906
1302974	Tcf19	transcription factor 19	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of TCF19 mRNA	PMID:32145629
1302974	Tcf19	transcription factor 19	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1345711	E	RGD:6480464	20130212	CTD	MESH:D004958	Estradiol results in increased expression of TCF19 mRNA	PMID:18310284|PMID:19167446
1302974	Tcf19	transcription factor 19	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1550178	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of TCF19 mRNA	PMID:18978301
1302974	Tcf19	transcription factor 19	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1345711	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TCF19 mRNA	PMID:38568856
1302974	Tcf19	transcription factor 19	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1345711	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TCF19 mRNA	PMID:37042841
1302974	Tcf19	transcription factor 19	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1345711	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TCF19 mRNA	PMID:23649840
1302974	Tcf19	transcription factor 19	gene	CHEBI:17234	glucose	affects activity	ISO	RGD:1345711	E	RGD:6480464	20180828	CTD	MESH:D005947	Glucose affects the activity of TCF19 protein	PMID:29042441
1302974	Tcf19	transcription factor 19	gene	CHEBI:17234	glucose	affects response to substance	ISO	RGD:1345711	E	RGD:6480464	20180828	CTD	MESH:D005947	TCF19 protein affects the susceptibility to Glucose	PMID:29042441
1302974	Tcf19	transcription factor 19	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20180828	CTD	MESH:D005947	Glucose promotes the reaction [TCF19 protein binds to CHD2 protein]	PMID:29042441
1302974	Tcf19	transcription factor 19	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TCF19 mRNA	PMID:37992649
1302974	Tcf19	transcription factor 19	gene	CHEBI:17270	glycerol 2-phosphate	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20151215	CTD	MESH:C031463	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of TCF19 mRNA	PMID:26424790
1302974	Tcf19	transcription factor 19	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of TCF19 mRNA	PMID:21592394
1302974	Tcf19	transcription factor 19	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of TCF19 mRNA	PMID:21592394
1302974	Tcf19	transcription factor 19	gene	CHEBI:17634	D-glucose	affects activity	ISO	RGD:1345711	E	RGD:6480464	20180828	CTD	MESH:D005947	Glucose affects the activity of TCF19 protein	PMID:29042441
1302974	Tcf19	transcription factor 19	gene	CHEBI:17634	D-glucose	affects response to substance	ISO	RGD:1345711	E	RGD:6480464	20180828	CTD	MESH:D005947	TCF19 protein affects the susceptibility to Glucose	PMID:29042441
1302974	Tcf19	transcription factor 19	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20180828	CTD	MESH:D005947	Glucose promotes the reaction [TCF19 protein binds to CHD2 protein]	PMID:29042441
1302974	Tcf19	transcription factor 19	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TCF19 mRNA	PMID:37992649
1302974	Tcf19	transcription factor 19	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1345711	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of TCF19 protein	PMID:37730182
1302974	Tcf19	transcription factor 19	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of TCF19 mRNA	PMID:21592394
1302974	Tcf19	transcription factor 19	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of TCF19 mRNA	PMID:21592394
1302974	Tcf19	transcription factor 19	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TCF19 mRNA	PMID:39836092
1302974	Tcf19	transcription factor 19	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of TCF19 mRNA	PMID:21120746
1302974	Tcf19	transcription factor 19	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TCF19 mRNA	PMID:19549813
1302974	Tcf19	transcription factor 19	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1345711	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TCF19 mRNA	PMID:23649840
1302974	Tcf19	transcription factor 19	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TCF19 protein	PMID:20106945
1302974	Tcf19	transcription factor 19	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TCF19 mRNA	PMID:25378103
1302974	Tcf19	transcription factor 19	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1345711	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TCF19 mRNA	PMID:22100608
1302974	Tcf19	transcription factor 19	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1345711	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TCF19 mRNA	PMID:23649840
1302974	Tcf19	transcription factor 19	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCF19 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCF19 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TCF19 mRNA	PMID:32699268
1302974	Tcf19	transcription factor 19	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TCF19 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TCF19 mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of TCF19 mRNA; TTPA protein affects the reaction [Ozone results in increased expression of TCF19 mRNA]	PMID:19555225|PMID:25658374|PMID:27106289|PMID:34911549
1302974	Tcf19	transcription factor 19	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550178	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TCF19 mRNA	PMID:17484886
1302974	Tcf19	transcription factor 19	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550178	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TCF19 mRNA	PMID:27339419|PMID:31919559
1302974	Tcf19	transcription factor 19	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TCF19 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TCF19 mRNA	PMID:39836092
1302974	Tcf19	transcription factor 19	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TCF19 mRNA	PMID:31881176
1302974	Tcf19	transcription factor 19	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of TCF19 mRNA	PMID:19167446
1302974	Tcf19	transcription factor 19	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1345711	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of TCF19 mRNA	PMID:27594783
1302974	Tcf19	transcription factor 19	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of TCF19 mRNA	PMID:17898221
1302974	Tcf19	transcription factor 19	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1550178	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of TCF19 mRNA	PMID:18930951
1302974	Tcf19	transcription factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550178	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TCF19 mRNA	PMID:21570461
1302974	Tcf19	transcription factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TCF19 mRNA	PMID:34747641
1302974	Tcf19	transcription factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TCF19 mRNA	PMID:17942748
1302974	Tcf19	transcription factor 19	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TCF19 mRNA	PMID:28374803
1302974	Tcf19	transcription factor 19	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TCF19 mRNA	PMID:28001369
1302974	Tcf19	transcription factor 19	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TCF19 mRNA	PMID:33212167
1302974	Tcf19	transcription factor 19	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TCF19 mRNA	PMID:30851411
1302974	Tcf19	transcription factor 19	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of TCF19 mRNA	PMID:23649840
1302974	Tcf19	transcription factor 19	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TCF19 mRNA	PMID:32763439
1302974	Tcf19	transcription factor 19	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TCF19 mRNA	PMID:20971185
1302974	Tcf19	transcription factor 19	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550178	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TCF19 mRNA	PMID:27862939
1302974	Tcf19	transcription factor 19	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TCF19 mRNA	PMID:37992649
1302974	Tcf19	transcription factor 19	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20151215	CTD	MESH:D001205	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of TCF19 mRNA	PMID:26424790
1302974	Tcf19	transcription factor 19	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of TCF19 mRNA	PMID:22623647
1302974	Tcf19	transcription factor 19	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TCF19 mRNA	PMID:38568856
1302974	Tcf19	transcription factor 19	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1345711	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of TCF19 mRNA	PMID:29301061|PMID:34032870
1302974	Tcf19	transcription factor 19	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TCF19 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TCF19 mRNA	PMID:39836092
1302974	Tcf19	transcription factor 19	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1345711	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TCF19 5' UTR	PMID:27901495
1302974	Tcf19	transcription factor 19	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1345711	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TCF19 mRNA	PMID:32234424
1302974	Tcf19	transcription factor 19	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550178	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TCF19 mRNA	PMID:22228805
1302974	Tcf19	transcription factor 19	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TCF19 mRNA	PMID:27858113
1302974	Tcf19	transcription factor 19	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TCF19 mRNA	PMID:20971185
1302974	Tcf19	transcription factor 19	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TCF19 mRNA	PMID:23806026
1302974	Tcf19	transcription factor 19	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TCF19 mRNA	PMID:20382639
1302974	Tcf19	transcription factor 19	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TCF19 mRNA	PMID:26705709
1302974	Tcf19	transcription factor 19	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of TCF19 mRNA	PMID:24915197
1302974	Tcf19	transcription factor 19	gene	CHEBI:31638	fulvestrant	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of TCF19 mRNA	PMID:19016759
1302974	Tcf19	transcription factor 19	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:C070081	[fulvestrant co-treated with Sirolimus] results in decreased expression of TCF19 mRNA	PMID:19016759
1302974	Tcf19	transcription factor 19	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of TCF19 mRNA	PMID:25729387
1302974	Tcf19	transcription factor 19	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TCF19 mRNA	PMID:25729387
1302974	Tcf19	transcription factor 19	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550178	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TCF19 mRNA	PMID:23557971
1302974	Tcf19	transcription factor 19	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550178	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TCF19 gene	PMID:35295148
1302974	Tcf19	transcription factor 19	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550178	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TCF19 mRNA	PMID:23811191
1302974	Tcf19	transcription factor 19	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550178	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TCF19 mRNA	PMID:28472532
1302974	Tcf19	transcription factor 19	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of TCF19 mRNA	PMID:38479592
1302974	Tcf19	transcription factor 19	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TCF19 mRNA	PMID:25181051|PMID:32145629
1302974	Tcf19	transcription factor 19	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1345711	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TCF19 mRNA	PMID:30903817
1302974	Tcf19	transcription factor 19	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1550178	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TCF19 promoter	PMID:27334623
1302974	Tcf19	transcription factor 19	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TCF19 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1302974	Tcf19	transcription factor 19	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TCF19 mRNA	PMID:29275510
1302974	Tcf19	transcription factor 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550178	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TCF19 mRNA	PMID:30951980
1302974	Tcf19	transcription factor 19	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1550178	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TCF19 mRNA	PMID:26682919
1302974	Tcf19	transcription factor 19	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1550178	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of TCF19 mRNA	PMID:20713471
1302974	Tcf19	transcription factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1550178	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of TCF19 promoter	PMID:33297965
1302974	Tcf19	transcription factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550178	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TCF19 mRNA	PMID:30951980
1302974	Tcf19	transcription factor 19	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550178	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TCF19 mRNA	PMID:26377693
1302974	Tcf19	transcription factor 19	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TCF19 mRNA	PMID:27858113
1302974	Tcf19	transcription factor 19	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550178	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TCF19 mRNA	PMID:30951980|PMID:38685157
1302974	Tcf19	transcription factor 19	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of TCF19 mRNA	PMID:21241498
1302974	Tcf19	transcription factor 19	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550178	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TCF19 mRNA	PMID:17361019|PMID:21266533
1302974	Tcf19	transcription factor 19	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of TCF19 mRNA	PMID:22546817
1302974	Tcf19	transcription factor 19	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550178	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of TCF19 mRNA	PMID:17854601
1302974	Tcf19	transcription factor 19	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TCF19 mRNA	PMID:18164116
1302974	Tcf19	transcription factor 19	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of TCF19 mRNA]	PMID:17854601
1302974	Tcf19	transcription factor 19	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of TCF19 mRNA	PMID:22110744|PMID:22546817
1302974	Tcf19	transcription factor 19	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of TCF19 mRNA	PMID:32680482
1302974	Tcf19	transcription factor 19	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1345711	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TCF19 mRNA	PMID:37042841
1302974	Tcf19	transcription factor 19	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of TCF19 mRNA	PMID:30589522
1302974	Tcf19	transcription factor 19	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TCF19 mRNA	PMID:39836092
1302974	Tcf19	transcription factor 19	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of TCF19 mRNA	PMID:18500788
1302974	Tcf19	transcription factor 19	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TCF19 mRNA	PMID:30723492
1302974	Tcf19	transcription factor 19	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TCF19 mRNA	PMID:25993096
1302974	Tcf19	transcription factor 19	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TCF19 mRNA	PMID:38174414|PMID:38568856
1302974	Tcf19	transcription factor 19	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TCF19 mRNA	PMID:25539665
1302974	Tcf19	transcription factor 19	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1550178	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TCF19 mRNA	PMID:22698814
1302974	Tcf19	transcription factor 19	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TCF19 mRNA	PMID:24386269
1302974	Tcf19	transcription factor 19	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TCF19 mRNA	PMID:19320972
1302974	Tcf19	transcription factor 19	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:C018021	cobaltous chloride results in increased expression of TCF19 mRNA	PMID:20105288
1302974	Tcf19	transcription factor 19	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCF19 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCF19 mRNA	PMID:32699268
1302974	Tcf19	transcription factor 19	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550178	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TCF19 mRNA	PMID:40194260
1302974	Tcf19	transcription factor 19	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TCF19 mRNA	PMID:31533062
1302974	Tcf19	transcription factor 19	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1345711	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of TCF19 mRNA	PMID:19167446
1302974	Tcf19	transcription factor 19	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TCF19 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of TCF19 mRNA	PMID:19167446
1302974	Tcf19	transcription factor 19	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550178	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TCF19 mRNA	PMID:39529242
1302974	Tcf19	transcription factor 19	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1550178	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of TCF19 mRNA	PMID:29038090
1302974	Tcf19	transcription factor 19	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1345711	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TCF19 mRNA	PMID:25979313
1302974	Tcf19	transcription factor 19	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1345711	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TCF19 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1302974	Tcf19	transcription factor 19	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1550178	E	RGD:6480464	20120918	CTD	MESH:D014635	Valproic Acid results in increased expression of TCF19 mRNA	PMID:19136453|PMID:20546886|PMID:21427059
1302974	Tcf19	transcription factor 19	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TCF19 mRNA	PMID:27188386
1302974	Tcf19	transcription factor 19	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TCF19 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1302974	Tcf19	transcription factor 19	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20151215	CTD	MESH:D003907	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of TCF19 mRNA	PMID:26424790
1302974	Tcf19	transcription factor 19	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550178	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TCF19 mRNA	PMID:28973697
1302974	Tcf19	transcription factor 19	gene	CHEBI:42758	aldehydo-D-glucose	affects activity	ISO	RGD:1345711	E	RGD:6480464	20180828	CTD	MESH:D005947	Glucose affects the activity of TCF19 protein	PMID:29042441
1302974	Tcf19	transcription factor 19	gene	CHEBI:42758	aldehydo-D-glucose	affects response to substance	ISO	RGD:1345711	E	RGD:6480464	20180828	CTD	MESH:D005947	TCF19 protein affects the susceptibility to Glucose	PMID:29042441
1302974	Tcf19	transcription factor 19	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20180828	CTD	MESH:D005947	Glucose promotes the reaction [TCF19 protein binds to CHD2 protein]	PMID:29042441
1302974	Tcf19	transcription factor 19	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TCF19 mRNA	PMID:37992649
1302974	Tcf19	transcription factor 19	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of TCF19 mRNA	PMID:23649840
1302974	Tcf19	transcription factor 19	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1345711	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TCF19 mRNA	PMID:38832940
1302974	Tcf19	transcription factor 19	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1345711	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TCF19 mRNA	PMID:22230336
1302974	Tcf19	transcription factor 19	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:D005472	TCF19 protein affects the susceptibility to Fluorouracil	PMID:15331170
1302974	Tcf19	transcription factor 19	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of TCF19 mRNA	PMID:15331170
1302974	Tcf19	transcription factor 19	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TCF19 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TCF19 mRNA	PMID:39836092
1302974	Tcf19	transcription factor 19	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of TCF19 mRNA	PMID:31838189
1302974	Tcf19	transcription factor 19	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TCF19 mRNA	PMID:17942748
1302974	Tcf19	transcription factor 19	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TCF19 mRNA	PMID:26705709
1302974	Tcf19	transcription factor 19	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550178	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TCF19 mRNA; Nanotubes, Carbon results in increased expression of TCF19 mRNA	PMID:25554681
1302974	Tcf19	transcription factor 19	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TCF19 mRNA	PMID:27858113
1302974	Tcf19	transcription factor 19	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1550178	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TCF19 mRNA	PMID:27858113
1302974	Tcf19	transcription factor 19	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of TCF19 mRNA	PMID:17659339
1302974	Tcf19	transcription factor 19	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550178	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TCF19 mRNA	PMID:19042947
1302974	Tcf19	transcription factor 19	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550178	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TCF19 mRNA	PMID:38701926
1302974	Tcf19	transcription factor 19	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TCF19 mRNA	PMID:39836092
1302974	Tcf19	transcription factor 19	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of TCF19 mRNA	PMID:25729387
1302974	Tcf19	transcription factor 19	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TCF19 mRNA	PMID:25729387
1302974	Tcf19	transcription factor 19	gene	CHEBI:6382	Lasiocarpine	increases expression	ISO	RGD:1345711	E	RGD:6480464	20200714	CTD	MESH:C005136	lasiocarpine results in increased expression of TCF19 mRNA	PMID:32234424
1302974	Tcf19	transcription factor 19	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TCF19 mRNA	PMID:28988120
1302974	Tcf19	transcription factor 19	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TCF19 mRNA	PMID:16026605
1302974	Tcf19	transcription factor 19	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of TCF19 mRNA	PMID:35283115
1302974	Tcf19	transcription factor 19	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of TCF19 mRNA	PMID:29522793
1302974	Tcf19	transcription factor 19	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1550178	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of TCF19 mRNA	PMID:27858113
1302974	Tcf19	transcription factor 19	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of TCF19 mRNA	PMID:33484710
1302974	Tcf19	transcription factor 19	gene	CHEBI:76290	PhIP	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of TCF19 mRNA	PMID:15059925
1302974	Tcf19	transcription factor 19	gene	CHEBI:76989	phytoestrogen	increases expression	ISO	RGD:1345711	E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of TCF19 mRNA	PMID:18310284
1302974	Tcf19	transcription factor 19	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TCF19 mRNA	PMID:18164116
1302974	Tcf19	transcription factor 19	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TCF19 mRNA	PMID:30851411
1302974	Tcf19	transcription factor 19	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TCF19 mRNA	PMID:27188386
1302974	Tcf19	transcription factor 19	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TCF19 gene]	PMID:28238834
1302974	Tcf19	transcription factor 19	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550178	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of TCF19 mRNA	PMID:23091169
1302974	Tcf19	transcription factor 19	gene	CHEBI:81555	Enterolactone	increases expression	ISO	RGD:1345711	E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TCF19 mRNA	PMID:19167446
1302974	Tcf19	transcription factor 19	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TCF19 mRNA	PMID:19167446
1302974	Tcf19	transcription factor 19	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TCF19 mRNA	PMID:24780913
1302974	Tcf19	transcription factor 19	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of TCF19 mRNA	PMID:32419051
1302974	Tcf19	transcription factor 19	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TCF19 mRNA	PMID:27188386
1302974	Tcf19	transcription factor 19	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1345711	E	RGD:6480464	20120412	CTD	MESH:D020123	[fulvestrant co-treated with Sirolimus] results in decreased expression of TCF19 mRNA	PMID:19016759
1302974	Tcf19	transcription factor 19	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TCF19 mRNA	PMID:19281266
1302974	Tcf19	transcription factor 19	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TCF19 mRNA	PMID:38568856
1302974	Tcf19	transcription factor 19	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TCF19 mRNA	PMID:29301935
1302974	Tcf19	transcription factor 19	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1345711	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of TCF19 mRNA	PMID:22378314
1302974	Tcf19	transcription factor 19	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550178	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TCF19 mRNA	PMID:35537566
1302975	Mcpt8l3	mast cell protease 8-like 3	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of MCPT8L3 mRNA	PMID:23358152
1302975	Mcpt8l3	mast cell protease 8-like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCPT8L3 mRNA	PMID:34747641
1302975	Mcpt8l3	mast cell protease 8-like 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of MCPT8L3 mRNA	PMID:30723492
1302975	Mcpt8l3	mast cell protease 8-like 3	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of MCPT8L3 mRNA	PMID:23358152
1302975	Mcpt8l3	mast cell protease 8-like 3	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of MCPT8L3 mRNA	PMID:23358152
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1345925	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of RPL18A protein	PMID:39638853
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1345925	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RPL18A mRNA	PMID:38218311
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552187	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RPL18A mRNA	PMID:33045310
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL18A mRNA	PMID:39752319
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552187	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RPL18A mRNA	PMID:39241906
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552187	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RPL18A mRNA	PMID:39298647
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RPL18A mRNA	PMID:33387578
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1345925	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RPL18A mRNA	PMID:39613055
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL18A mRNA	PMID:39752319
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1345925	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RPL18A mRNA	PMID:39613055
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552187	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RPL18A mRNA	PMID:33754040
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1345925	E	RGD:6480464	20211207	CTD	MESH:D003471	Cuprizone results in decreased expression of RPL18A protein	PMID:34122009
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Haloperidol] results in increased expression of RPL18A protein	PMID:34122009
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1345925	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RPL18A protein	PMID:37730182
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL18A mRNA	PMID:36331819
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPL18A mRNA	PMID:39836092
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1345925	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of RPL18A mRNA	PMID:24376830
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL18A mRNA	PMID:37236586
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL18A protein	PMID:23301498
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of RPL18A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RPL18A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of RPL18A protein	PMID:38598786
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552187	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RPL18A mRNA	PMID:25629700
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL18A mRNA	PMID:22206623
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPL18A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL18A mRNA	PMID:39836092
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RPL18A mRNA	PMID:40504410
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552187	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of RPL18A mRNA	PMID:28960355
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPL18A mRNA	PMID:34747641
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPL18A mRNA	PMID:33387578
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552187	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPL18A mRNA	PMID:18796159|PMID:31511937
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPL18A mRNA	PMID:17942748
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of RPL18A protein	PMID:35544339
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of RPL18A mRNA	PMID:28374803
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1345925	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RPL18A protein	PMID:33212167
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1552187	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RPL18A protein	PMID:28918527
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1345925	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of RPL18A protein	PMID:29385562
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1345925	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of RPL18A protein	PMID:35688186
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:28824	stigmasterol	decreases expression	ISO	RGD:1552187	E	RGD:6480464	20181113	CTD	MESH:D013265	Stigmasterol results in decreased expression of RPL18A mRNA	PMID:30245210
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1345925	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of RPL18A protein	PMID:30528433
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPL18A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL18A mRNA	PMID:39836092
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RPL18A mRNA	PMID:40504410
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RPL18A mRNA]	PMID:32406909
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1345925	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of RPL18A mRNA	PMID:15725085
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RPL18A mRNA	PMID:16483693
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of RPL18A mRNA	PMID:24136188
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:33146	vanadyl sulfate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of RPL18A mRNA]	PMID:16684804
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL18A mRNA	PMID:32145629
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1345925	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL18A mRNA; bisphenol A results in decreased expression of RPL18A protein	PMID:29275510|PMID:37567409
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552187	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL18A mRNA	PMID:33221593
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RPL18A mRNA	PMID:25181051|PMID:41034487
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RPL18A mRNA	PMID:36041667
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1345925	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of RPL18A protein	PMID:31945527
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552187	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RPL18A mRNA	PMID:39298647
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RPL18A mRNA	PMID:36041667
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552187	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RPL18A mRNA	PMID:38685157
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1345925	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RPL18A protein	PMID:34186270
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RPL18A mRNA	PMID:36041667
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1345925	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RPL18A protein	PMID:34186270
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1552187	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RPL18A mRNA	PMID:28392331
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552187	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RPL18A mRNA	PMID:37019170
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RPL18A protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of RPL18A protein	PMID:38598786
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1345925	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RPL18A mRNA	PMID:37042841
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPL18A mRNA	PMID:39836092
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of RPL18A mRNA	PMID:20551477
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RPL18A promoter	PMID:22457795
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1345925	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RPL18A mRNA	PMID:38568856
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL18A mRNA	PMID:37236586
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of RPL18A mRNA	PMID:19162173
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1345925	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of RPL18A mRNA	PMID:26352163
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL18A mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RPL18A mRNA	PMID:36331819
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of RPL18A mRNA	PMID:22561333
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1345925	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RPL18A gene	PMID:29154799
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL18A mRNA	PMID:17183730
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1345925	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RPL18A mRNA	PMID:39613055
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of RPL18A mRNA	PMID:24136188
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552187	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RPL18A mRNA	PMID:17562736
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPL18A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL18A mRNA	PMID:39836092
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RPL18A mRNA	PMID:40504410
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RPL18A mRNA	PMID:29391264
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPL18A mRNA	PMID:22079256
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1345925	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RPL18A mRNA	PMID:18175754
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552187	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RPL18A mRNA	PMID:17942748
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPL18A mRNA	PMID:17942748
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1345925	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of RPL18A mRNA	PMID:15725085
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of RPL18A mRNA	PMID:34044035
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:50859	bexarotene	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in increased expression of RPL18A mRNA	PMID:16648578
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of RPL18A mRNA	PMID:19162173
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RPL18A mRNA	PMID:24136188
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:5613	haloperidol	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in increased expression of RPL18A protein	PMID:34122009
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL18A mRNA	PMID:17183730
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1345925	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPL18A protein	PMID:32959892
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPL18A mRNA	PMID:39836092
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:63630	tolcapone	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to RPL18A protein	PMID:19783845
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL18A mRNA	PMID:39752319
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1345925	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RPL18A protein	PMID:34186270
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL18A mRNA	PMID:22206623
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL18A protein	PMID:37664457
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RPL18A mRNA	PMID:24136188
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1345925	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RPL18A mRNA	PMID:22079256
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPL18A mRNA	PMID:22079256
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1345925	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RPL18A protein	PMID:31285264
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552187	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPL18A mRNA	PMID:30294300
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RPL18A mRNA	PMID:21394737
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of RPL18A protein	PMID:28903499
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1552187	E	RGD:6480464	20180703	CTD	MESH:C089595	cylindrospermopsin results in increased expression of RPL18A mRNA	PMID:20936652
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1552187	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of RPL18A protein	PMID:20553848
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1552187	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL18A mRNA	PMID:39752319
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL18A protein	PMID:37664457
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013311	Streptozocin results in increased expression of RPL18A mRNA	PMID:16684804
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013311	vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of RPL18A mRNA]	PMID:16684804
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1345925	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RPL18A mRNA	PMID:38568856
1302976	Rpl18a	ribosomal protein L18A	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1345925	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RPL18A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RPL18A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of RPL18A protein	PMID:38598786
1302977	Slpi-ps2	secretory leukocyte peptidase inhibitor, pseudogene 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SLPI-PS2 mRNA	PMID:28522335
1302977	Slpi-ps2	secretory leukocyte peptidase inhibitor, pseudogene 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SLPI-PS2 mRNA	PMID:31378766
1302977	Slpi-ps2	secretory leukocyte peptidase inhibitor, pseudogene 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLPI-PS2 mRNA	PMID:25181051
1302977	Slpi-ps2	secretory leukocyte peptidase inhibitor, pseudogene 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SLPI-PS2 mRNA	PMID:41034487
1302977	Slpi-ps2	secretory leukocyte peptidase inhibitor, pseudogene 2	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SLPI-PS2 gene	PMID:22079235
1302977	Slpi-ps2	secretory leukocyte peptidase inhibitor, pseudogene 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of SLPI-PS2 mRNA	PMID:23869203
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1343556	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of GGNBP2 mRNA	PMID:22378314
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1614194	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of GGNBP2 mRNA	PMID:30319688
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1614194	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of GGNBP2 protein	PMID:31494107
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1343556	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GGNBP2 mRNA	PMID:37042841
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1343556	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of GGNBP2 mRNA	PMID:27664576
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1343556	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of GGNBP2 protein	PMID:37730182
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1343556	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of GGNBP2 intron	PMID:30157460
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1343556	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GGNBP2 gene	PMID:27153756
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1614194	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GGNBP2 mRNA	PMID:19770486
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1614194	E	RGD:6480464	20150127	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GGNBP2 mRNA	PMID:25270620
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614194	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GGNBP2 mRNA	PMID:22206623
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1343556	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of GGNBP2 protein	PMID:35688186
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of GGNBP2 mRNA	PMID:25905778
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1343556	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GGNBP2 mRNA	PMID:23557933
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1343556	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of GGNBP2 mRNA	PMID:27392435
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614194	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GGNBP2 mRNA	PMID:21570461
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GGNBP2 mRNA	PMID:21215274
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1614194	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GGNBP2 mRNA	PMID:11728448|PMID:19770486
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1614194	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GGNBP2 mRNA	PMID:17942748
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1343556	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GGNBP2 mRNA	PMID:30851411
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1343556	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of GGNBP2 protein	PMID:35688186
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1343556	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GGNBP2 mRNA	PMID:38568856
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614194	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GGNBP2 mRNA	PMID:22228805
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1343556	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of GGNBP2 mRNA	PMID:26238291
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1614194	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of GGNBP2 gene	PMID:35295148
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GGNBP2 mRNA	PMID:34947998
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GGNBP2 mRNA	PMID:25181051
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614194	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GGNBP2 mRNA	PMID:39298647
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1614194	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GGNBP2 mRNA	PMID:21266533
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343556	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GGNBP2 mRNA	PMID:37042841
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1343556	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GGNBP2 mRNA	PMID:38568856
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1343556	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of GGNBP2 mRNA	PMID:19320972|PMID:19376846
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1343556	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GGNBP2 mRNA	PMID:28302478
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343556	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GGNBP2 mRNA	PMID:25979313
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1343556	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of GGNBP2 mRNA	PMID:23179753
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1343556	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GGNBP2 gene	PMID:29154799
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1614194	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of GGNBP2 mRNA	PMID:28973697
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1614194	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of GGNBP2 mRNA	PMID:18502557
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1614194	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of GGNBP2 mRNA	PMID:17942748
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1614194	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GGNBP2 mRNA	PMID:17942748
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1614194	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of GGNBP2 mRNA	PMID:40234311
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614194	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GGNBP2 mRNA	PMID:22206623
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614194	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GGNBP2 mRNA	PMID:22206623
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1343556	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of GGNBP2 protein	PMID:31285264
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1343556	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GGNBP2 mRNA	PMID:30851411
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1614194	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GGNBP2 mRNA	PMID:23091169
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1614194	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of GGNBP2 mRNA	PMID:21278054
1302978	Ggnbp2	gametogenetin binding protein 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1343556	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GGNBP2 mRNA	PMID:38568856
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HABP2 mRNA]	PMID:31150632
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1350340	E	RGD:6480464	20230905	CTD	MESH:C000628730	graphene oxide results in increased expression of HABP2 protein	PMID:33219560|PMID:33219584
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550193	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HABP2 mRNA	PMID:36331819
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of HABP2 mRNA	PMID:26079696
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of HABP2 mRNA	PMID:20106945
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of HABP2 mRNA	PMID:39298647
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of HABP2 mRNA	PMID:32145629
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1350340	E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of HABP2 mRNA	PMID:17404688
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1350340	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of HABP2 mRNA	PMID:21540246
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1350340	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of HABP2 mRNA	PMID:17404688
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of HABP2 mRNA	PMID:26079696
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1350340	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of HABP2 gene	PMID:33872906
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of HABP2 mRNA	PMID:21669218
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1350340	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of HABP2 gene	PMID:33872906
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550193	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of and results in decreased expression of HABP2 mRNA	PMID:34120004
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1350340	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of HABP2 mRNA	PMID:28818685
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550193	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HABP2 mRNA	PMID:36331819
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1350340	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of HABP2 protein	PMID:20106945
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of HABP2 mRNA	PMID:19770486
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1350340	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HABP2 gene	PMID:27153756
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550193	E	RGD:6480464	20140610	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of HABP2 mRNA	PMID:11510480
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HABP2 mRNA	PMID:31150632
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases activity	ISO	RGD:1550193	E	RGD:6480464	20140610	CTD	MESH:D002251	Carbon Tetrachloride results in increased activity of HABP2 protein	PMID:11510480
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HABP2 mRNA]	PMID:31150632
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of HABP2 mRNA	PMID:34813904
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HABP2 mRNA	PMID:22298810
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550193	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HABP2 mRNA	PMID:21570461
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of HABP2 mRNA	PMID:29301061|PMID:32844245
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of HABP2 mRNA	PMID:37682722
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1350340	E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in increased methylation of HABP2 exon	PMID:32844245
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350340	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HABP2 promoter	PMID:27901495
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HABP2 mRNA	PMID:21839799
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HABP2 mRNA	PMID:32234424
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350340	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HABP2 3' UTR	PMID:27901495
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of HABP2 mRNA	PMID:25895662
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HABP2 mRNA	PMID:34492290
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of HABP2 mRNA	PMID:28943392
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of HABP2 mRNA	PMID:18648102
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1350340	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HABP2 mRNA	PMID:19710929
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HABP2 mRNA	PMID:25181051
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550193	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of HABP2 mRNA	PMID:34585602
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HABP2 gene	PMID:28505145
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:34107	1-nitropyrene	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of HABP2 mRNA	PMID:19041380
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HABP2 mRNA	PMID:39298647
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550193	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of HABP2 mRNA	PMID:30951980
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of HABP2 mRNA	PMID:34813904
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of HABP2 mRNA	PMID:34813904
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of HABP2 mRNA	PMID:28943392
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of HABP2 mRNA	PMID:17585979
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of HABP2 mRNA	PMID:32588087
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550193	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HABP2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HABP2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of HABP2 mRNA	PMID:36331819
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350340	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HABP2 mRNA	PMID:25979313
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of HABP2 mRNA	PMID:29154799
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1350340	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HABP2 gene	PMID:29154799
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of HABP2 mRNA	PMID:20106945|PMID:27989131
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HABP2 mRNA	PMID:38832940
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of HABP2 mRNA	PMID:21420995|PMID:29067470
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HABP2 mRNA	PMID:25620056
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:60312	2-amino-2-deoxy-D-galactopyranose	increases activity	ISO	RGD:1550193	E	RGD:6480464	20140610	CTD	MESH:D005688	Galactosamine results in increased activity of HABP2 protein	PMID:11510480
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:7438	N-methylformamide	increases expression	ISO	RGD:1550193	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in increased expression of HABP2 mRNA; methylformamide results in increased expression of HABP2 mRNA	PMID:17040096
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of HABP2 mRNA	PMID:33484710
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of HABP2 promoter	PMID:27415467
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350340	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HABP2 gene]	PMID:28238834
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550193	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of HABP2 mRNA	PMID:19270015
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550193	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of HABP2 mRNA	PMID:38648751
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:C010902	[Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in increased expression of HABP2 mRNA	PMID:32207525
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1350340	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of HABP2 mRNA	PMID:26079696
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of HABP2 mRNA	PMID:21346803
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of HABP2 mRNA	PMID:21346803
1302979	Habp2	hyaluronan binding protein 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550193	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of HABP2 mRNA	PMID:28973697
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1347436	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of XIRP2 mRNA	PMID:26516004
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of XIRP2 mRNA	PMID:33729688
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1552200	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of XIRP2 mRNA	PMID:40945087
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of XIRP2 mRNA	PMID:23649840
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552200	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of XIRP2 mRNA	PMID:28085963
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of XIRP2 mRNA	PMID:33387578
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XIRP2 mRNA	PMID:39012411
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of XIRP2 mRNA	PMID:23649840
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of XIRP2 mRNA	PMID:23649840
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of XIRP2 mRNA	PMID:23649840
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of XIRP2 mRNA	PMID:28959563
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of XIRP2 mRNA	PMID:29803840|PMID:30031762
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1347436	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of XIRP2 protein	PMID:35688186
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1347436	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of XIRP2 3' UTR; Benzo(a)pyrene results in decreased methylation of XIRP2 exon	PMID:27901495
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1552200	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of XIRP2 exon	PMID:27901495
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1347436	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XIRP2 mRNA	PMID:22316170
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:3048	benzatropine	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in decreased expression of XIRP2 protein	PMID:34122009
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1347436	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of XIRP2 gene	PMID:31601247
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552200	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of XIRP2 mRNA	PMID:23557971
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of XIRP2 mRNA	PMID:25181051
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of XIRP2 protein	PMID:31675489
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1347436	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of XIRP2 gene	PMID:31601247
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347436	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of XIRP2 gene	PMID:31601247
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of XIRP2 protein	PMID:31675489
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1347436	E	RGD:6480464	20210504	CTD	MESH:C543008	bisphenol S results in increased expression of XIRP2 mRNA	PMID:33476716
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of XIRP2 mRNA	PMID:35163327
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of XIRP2 mRNA	PMID:35163327
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XIRP2 mRNA	PMID:39012411
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of XIRP2 mRNA	PMID:35163327
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of XIRP2 mRNA	PMID:31533062
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1347436	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of XIRP2 gene	PMID:29154799
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1347436	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of XIRP2 mRNA	PMID:24383497
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of XIRP2 mRNA	PMID:31675489
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of XIRP2 mRNA	PMID:29391264
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1552200	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of XIRP2 mRNA	PMID:23608068
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:5613	haloperidol	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in decreased expression of XIRP2 protein	PMID:34122009
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347436	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to XIRP2 gene]	PMID:28238834
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of XIRP2 mRNA	PMID:32109520
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of XIRP2 protein	PMID:31675489
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1552200	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of XIRP2 mRNA	PMID:27935865
1302980	Xirp2	xin actin-binding repeat containing 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1347436	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of XIRP2 protein	PMID:31675489
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ZFP57 mRNA]	PMID:31150632
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZFP57 mRNA	PMID:32741896
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1344217	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ZFP57 mRNA	PMID:30165855
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP57 mRNA	PMID:25510870
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1332036	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of ZFP57 protein	PMID:29980752
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1344217	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ZFP57 mRNA	PMID:26079696
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFP57 mRNA	PMID:37992649
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZFP57 mRNA	PMID:32741896
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFP57 mRNA	PMID:37992649
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ZFP57 mRNA	PMID:33387578
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1332036	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of ZFP57 mRNA	PMID:27462272
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP57 mRNA	PMID:25510870
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP57 mRNA	PMID:25510870
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZFP57 mRNA	PMID:31150632
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ZFP57 mRNA]	PMID:31150632
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1344217	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZFP57 mRNA	PMID:21867686
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:27470	folic acid	increases methylation	ISO	RGD:1344217	E	RGD:6480464	20201103	CTD	MESH:D005492	Folic Acid results in increased methylation of ZFP57 promoter	PMID:30777123
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP57 mRNA	PMID:40504410
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ZFP57 mRNA	PMID:31881176
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332036	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP57 mRNA	PMID:21570461
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP57 mRNA	PMID:33387578
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1344217	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ZFP57 mRNA	PMID:30851411
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:28498	acadesine	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20230404	CTD	MESH:C011651	acadesine inhibits the reaction [Palmitates results in increased expression of ZFP57 mRNA]; acadesine inhibits the reaction [Palmitates results in increased expression of ZFP57 protein]	PMID:36375515
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFP57 mRNA	PMID:37992649
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1332036	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZFP57 mRNA	PMID:37682722
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344217	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ZFP57 mRNA	PMID:39719251
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP57 mRNA	PMID:40504410
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344217	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZFP57 promoter	PMID:27901495
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1344217	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ZFP57 mRNA	PMID:25895662
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1344217	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ZFP57 gene	PMID:31601247
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1332036	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZFP57 mRNA	PMID:29264374
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332036	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP57 promoter	PMID:35295148
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ZFP57 mRNA	PMID:23411599|PMID:34492290
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZFP57 mRNA	PMID:25181051
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332036	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP57 mRNA	PMID:38074096
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1344217	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ZFP57 gene	PMID:31601247
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP57 mRNA	PMID:25510870
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP57 mRNA	PMID:25510870
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1344217	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ZFP57 gene	PMID:31601247
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332036	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ZFP57 mRNA	PMID:38685157
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1332036	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP57 mRNA	PMID:37019170
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZFP57 mRNA	PMID:30589522
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZFP57 mRNA	PMID:35163327
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZFP57 mRNA	PMID:35163327
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ZFP57 mRNA	PMID:25539665
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1332036	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ZFP57 mRNA	PMID:40194260
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1332036	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ZFP57 mRNA	PMID:40194260
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344217	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ZFP57 mRNA	PMID:29154799
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFP57 mRNA	PMID:37992649
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZFP57 mRNA	PMID:33387578
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP57 mRNA	PMID:40504410
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of ZFP57 mRNA	PMID:20080153
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1332036	E	RGD:6480464	20230404	CTD	MESH:D008687	Metformin inhibits the reaction [Dietary Fats results in increased expression of ZFP57 protein]	PMID:36375515
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZFP57 mRNA	PMID:32741896
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1344217	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ZFP57 mRNA	PMID:30851411
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1344217	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of ZFP57 mRNA	PMID:31734321
1302981	Zfp57	zinc finger protein 57	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ZFP57 mRNA	PMID:19281266
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:113455	sodium benzoate	increases expression	ISO	RGD:1344350	E	RGD:6480464	20250506	CTD	MESH:D020160	Sodium Benzoate results in increased expression of PLA2G15 protein	PMID:30154464
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552207	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PLA2G15 mRNA	PMID:20188158|PMID:26251327
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1344350	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PLA2G15 mRNA	PMID:35811015
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552207	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PLA2G15 mRNA	PMID:39241906
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1344350	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLA2G15 mRNA	PMID:35811015
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552207	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PLA2G15 mRNA	PMID:39298647
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344350	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PLA2G15 mRNA	PMID:37042841
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1552207	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PLA2G15 mRNA	PMID:21669218
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1344350	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PLA2G15 protein	PMID:31163220
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1344350	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PLA2G15 mRNA	PMID:28818685
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PLA2G15 mRNA	PMID:28522335
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLA2G15 mRNA	PMID:39012411
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1344350	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PLA2G15 mRNA	PMID:23649840
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1344350	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PLA2G15 mRNA	PMID:23649840
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1344350	E	RGD:6480464	20180515	CTD	MESH:D000638	Amiodarone affects the expression of PLA2G15 mRNA	PMID:29248575
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1344350	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PLA2G15 mRNA	PMID:28903495
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1344350	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of PLA2G15 mRNA	PMID:27594783
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552207	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of PLA2G15 mRNA	PMID:15464296
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLA2G15 mRNA	PMID:22298810
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552207	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLA2G15 mRNA	PMID:21570461
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLA2G15 mRNA	PMID:21215274
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLA2G15 mRNA	PMID:34747641
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of PLA2G15 mRNA	PMID:28374803
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1344350	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of PLA2G15 protein	PMID:39603559
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:28428	beta-hexachlorocyclohexane	decreases expression	ISO	RGD:1552207	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in decreased expression of PLA2G15 mRNA	PMID:25270620
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1344350	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PLA2G15 mRNA	PMID:29803840
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552207	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLA2G15 mRNA	PMID:22228805
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1552207	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PLA2G15 mRNA	PMID:19073995
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PLA2G15 mRNA	PMID:32721576
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1344350	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PLA2G15 mRNA	PMID:25351596
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PLA2G15 mRNA	PMID:30047161
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552207	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLA2G15 promoter	PMID:35295148
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PLA2G15 mRNA	PMID:23411599
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1344350	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLA2G15 mRNA	PMID:19710929
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of PLA2G15 mRNA	PMID:19167457
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of PLA2G15 mRNA	PMID:32145629
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1552207	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of PLA2G15 promoter	PMID:27312807
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLA2G15 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:3374	capsaicin	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in decreased expression of PLA2G15 mRNA	PMID:20349343
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552207	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PLA2G15 mRNA	PMID:39298647
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552207	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PLA2G15 intron	PMID:28392331
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552207	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLA2G15 mRNA	PMID:37019170
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552207	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PLA2G15 mRNA	PMID:34813904
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PLA2G15 mRNA	PMID:32680482
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:35036	fentin chloride	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in increased expression of PLA2G15 mRNA	PMID:37156404
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLA2G15 mRNA	PMID:39012411
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1552207	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PLA2G15 mRNA	PMID:40194260
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1344350	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PLA2G15 mRNA	PMID:40419075
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344350	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PLA2G15 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1344350	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PLA2G15 gene	PMID:29154799
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552207	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PLA2G15 mRNA	PMID:17555576
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1344350	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PLA2G15 mRNA	PMID:38832940
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PLA2G15 mRNA	PMID:33387578
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1344350	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PLA2G15 mRNA	PMID:22230336|PMID:29067470
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1344350	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLA2G15 mRNA	PMID:35811015
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLA2G15 mRNA	PMID:29391264
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552207	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PLA2G15 mRNA	PMID:17555576
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552207	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PLA2G15 mRNA	PMID:25554681
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PLA2G15 mRNA	PMID:24136188
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PLA2G15 mRNA	PMID:30047161
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PLA2G15 mRNA	PMID:24136188
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1552207	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of PLA2G15 mRNA	PMID:22078008
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:70778	GW 7647	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C453899	GW 7647 results in decreased expression of PLA2G15 mRNA	PMID:31628012
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552207	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PLA2G15 mRNA	PMID:22206623
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552207	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PLA2G15 mRNA	PMID:39847705
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLA2G15 mRNA	PMID:30047161
1302982	Pla2g15	phospholipase A2, group XV	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PLA2G15 mRNA	PMID:21346803
1302983	Osmr	oncostatin M receptor	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OSMR mRNA	PMID:20938992
1302983	Osmr	oncostatin M receptor	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1352311	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of OSMR mRNA	PMID:21934132
1302983	Osmr	oncostatin M receptor	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of OSMR mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of OSMR mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of OSMR mRNA	PMID:30951980
1302983	Osmr	oncostatin M receptor	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OSMR mRNA	PMID:30529165
1302983	Osmr	oncostatin M receptor	gene	CHEBI:15551	prostaglandin E2	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20150310	CTD	MESH:D015232	Dinoprostone inhibits the reaction [PTGS1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]]	PMID:25432964
1302983	Osmr	oncostatin M receptor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552210	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of OSMR mRNA	PMID:15919760|PMID:22687549
1302983	Osmr	oncostatin M receptor	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20161228	CTD	MESH:D008070	genipin inhibits the reaction [Lipopolysaccharides results in increased expression of OSMR mRNA]	PMID:22687549
1302983	Osmr	oncostatin M receptor	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1352311	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of OSMR mRNA	PMID:19619570
1302983	Osmr	oncostatin M receptor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with EGF protein] results in increased expression of OSMR mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of OSMR mRNA	PMID:19619570|PMID:24758408
1302983	Osmr	oncostatin M receptor	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of OSMR mRNA	PMID:38568856
1302983	Osmr	oncostatin M receptor	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OSMR mRNA	PMID:20938992
1302983	Osmr	oncostatin M receptor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1352311	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of OSMR mRNA	PMID:37042841
1302983	Osmr	oncostatin M receptor	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of OSMR mRNA	PMID:24304932
1302983	Osmr	oncostatin M receptor	gene	CHEBI:16907	4-nitroquinoline N-oxide	increases expression	ISO	RGD:1552210	E	RGD:6480464	20121009	CTD	MESH:D015112	4-Nitroquinoline-1-oxide results in increased expression of OSMR mRNA	PMID:22561872
1302983	Osmr	oncostatin M receptor	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of OSMR mRNA	PMID:38160208
1302983	Osmr	oncostatin M receptor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OSMR mRNA	PMID:37992649
1302983	Osmr	oncostatin M receptor	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of OSMR mRNA	PMID:38685446
1302983	Osmr	oncostatin M receptor	gene	CHEBI:17356	2-acetamidofluorene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of OSMR mRNA	PMID:15743783
1302983	Osmr	oncostatin M receptor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OSMR mRNA	PMID:37992649
1302983	Osmr	oncostatin M receptor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1352311	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of OSMR mRNA	PMID:31163220
1302983	Osmr	oncostatin M receptor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of OSMR mRNA	PMID:33387578
1302983	Osmr	oncostatin M receptor	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of OSMR mRNA	PMID:28818685
1302983	Osmr	oncostatin M receptor	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1352311	E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of OSMR mRNA	PMID:22562489
1302983	Osmr	oncostatin M receptor	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OSMR mRNA	PMID:29950665
1302983	Osmr	oncostatin M receptor	gene	CHEBI:2340	docebenone	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20150310	CTD	MESH:C036837	2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone inhibits the reaction [PTGS1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]]	PMID:25432964
1302983	Osmr	oncostatin M receptor	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1352311	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of OSMR protein	PMID:20106945
1302983	Osmr	oncostatin M receptor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of OSMR mRNA	PMID:25378103
1302983	Osmr	oncostatin M receptor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1352311	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of OSMR mRNA	PMID:21632981|PMID:21641981|PMID:27153756
1302983	Osmr	oncostatin M receptor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552210	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of OSMR mRNA	PMID:19770486
1302983	Osmr	oncostatin M receptor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of OSMR mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of OSMR mRNA	PMID:34911549
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552210	E	RGD:6480464	20150310	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of OSMR mRNA	PMID:25432964|PMID:31919559
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D002251	2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone inhibits the reaction [PTGS1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]]; [Carbon Tetrachloride co-treated with Tamoxifen] affects the expression of OSMR mRNA; Dinoprostone inhibits the reaction [PTGS1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]]; OSMR protein affects the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein]; OSMR protein affects the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]; OSMR protein affects the reaction [Carbon Tetrachloride results in increased expression of TIMP2 mRNA]; PTGS1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]; SC 560 inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]	PMID:14999682|PMID:25432964|PMID:29974145
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552210	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of OSMR mRNA	PMID:25629700
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of OSMR mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OSMR mRNA	PMID:20938992|PMID:22206623
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of OSMR mRNA	PMID:19654921
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1352311	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of OSMR mRNA	PMID:26272509
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OSMR mRNA	PMID:27188386
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1352311	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of OSMR protein	PMID:35688186
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of OSMR mRNA	PMID:31295307
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552210	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of OSMR mRNA	PMID:28960355
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of OSMR mRNA	PMID:31881176
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of OSMR mRNA	PMID:23557933
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1352311	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of OSMR mRNA	PMID:28903495
1302983	Osmr	oncostatin M receptor	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552210	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of OSMR mRNA	PMID:40618947
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of OSMR mRNA	PMID:18930951
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1352311	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of OSMR mRNA	PMID:24768652|PMID:25583101
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1552210	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in increased expression of OSMR mRNA	PMID:12540486
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552210	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of OSMR mRNA	PMID:21570461
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OSMR mRNA	PMID:34747641
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OSMR mRNA	PMID:19619570
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552210	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OSMR mRNA	PMID:19770486
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OSMR mRNA	PMID:15251184
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of OSMR mRNA	PMID:19619570
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of OSMR mRNA	PMID:15251184
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1352311	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of OSMR mRNA	PMID:28001369
1302983	Osmr	oncostatin M receptor	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of OSMR mRNA; aristolochic acid I results in decreased expression of OSMR protein	PMID:33212167
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of OSMR mRNA	PMID:30851411
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OSMR mRNA	PMID:26033743
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20150512	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of OSMR mRNA; [Disulfiram binds to Copper] which results in increased expression of OSMR mRNA	PMID:24690739|PMID:30911355
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of OSMR mRNA	PMID:29803840
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of OSMR mRNA	PMID:19277126|PMID:39631538
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20120918	CTD	MESH:D004317	[[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of OSMR mRNA	PMID:21040762
1302983	Osmr	oncostatin M receptor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OSMR mRNA	PMID:37992649
1302983	Osmr	oncostatin M receptor	gene	CHEBI:29365	phosgene	affects expression	ISO	RGD:1552210	E	RGD:6480464	20120515	CTD	MESH:D010705	Phosgene affects the expression of OSMR mRNA	PMID:16300373
1302983	Osmr	oncostatin M receptor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of OSMR mRNA	PMID:38568856
1302983	Osmr	oncostatin M receptor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552210	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of OSMR mRNA	PMID:19770486
1302983	Osmr	oncostatin M receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1352311	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of OSMR mRNA	PMID:21632981|PMID:21871943|PMID:26238291|PMID:32234424
1302983	Osmr	oncostatin M receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552210	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of OSMR mRNA	PMID:20713471|PMID:22228805
1302983	Osmr	oncostatin M receptor	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OSMR mRNA	PMID:26033743
1302983	Osmr	oncostatin M receptor	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20150512	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of OSMR mRNA; [Disulfiram binds to Copper] which results in increased expression of OSMR mRNA	PMID:24690739|PMID:30911355
1302983	Osmr	oncostatin M receptor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1352311	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of OSMR mRNA	PMID:25895662
1302983	Osmr	oncostatin M receptor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552210	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of OSMR mRNA	PMID:23221170
1302983	Osmr	oncostatin M receptor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of OSMR mRNA	PMID:19150397|PMID:20018196
1302983	Osmr	oncostatin M receptor	gene	CHEBI:31521	doxifluridine	decreases response to substance	ISO	RGD:1352311	E	RGD:6480464	20130806	CTD	MESH:C025034	OSMR protein results in decreased susceptibility to doxifluridine	PMID:16734730
1302983	Osmr	oncostatin M receptor	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1352311	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of OSMR mRNA	PMID:37690743
1302983	Osmr	oncostatin M receptor	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1552210	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of OSMR mRNA	PMID:21829687
1302983	Osmr	oncostatin M receptor	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1552210	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of OSMR mRNA	PMID:17656681
1302983	Osmr	oncostatin M receptor	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552210	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of OSMR mRNA	PMID:27760801
1302983	Osmr	oncostatin M receptor	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OSMR mRNA	PMID:29950665
1302983	Osmr	oncostatin M receptor	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of OSMR mRNA	PMID:23411599|PMID:34492290
1302983	Osmr	oncostatin M receptor	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of OSMR mRNA	PMID:30723492
1302983	Osmr	oncostatin M receptor	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552210	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of OSMR mRNA	PMID:23811191
1302983	Osmr	oncostatin M receptor	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of OSMR mRNA	PMID:19710929
1302983	Osmr	oncostatin M receptor	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552210	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of OSMR mRNA	PMID:28472532
1302983	Osmr	oncostatin M receptor	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of OSMR mRNA	PMID:28329830
1302983	Osmr	oncostatin M receptor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of OSMR mRNA	PMID:25181051
1302983	Osmr	oncostatin M receptor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of OSMR mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1302983	Osmr	oncostatin M receptor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1352311	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of OSMR mRNA	PMID:29275510
1302983	Osmr	oncostatin M receptor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552210	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of OSMR mRNA	PMID:25594700
1302983	Osmr	oncostatin M receptor	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of OSMR mRNA	PMID:30951980
1302983	Osmr	oncostatin M receptor	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1552210	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of OSMR mRNA	PMID:25172293
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of OSMR mRNA	PMID:23829299
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of OSMR mRNA	PMID:23196670
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552210	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of OSMR mRNA	PMID:30951980
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of OSMR mRNA	PMID:30951980
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1552210	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of OSMR mRNA	PMID:26377693
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552210	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of OSMR mRNA	PMID:38685157
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552210	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of OSMR mRNA	PMID:30951980
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of OSMR mRNA	PMID:30951980
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1552210	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of OSMR intron	PMID:28392331
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OSMR mRNA	PMID:29950665
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552210	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of OSMR mRNA	PMID:17361019|PMID:21266533
1302983	Osmr	oncostatin M receptor	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of OSMR mRNA	PMID:32680482
1302983	Osmr	oncostatin M receptor	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of OSMR mRNA	PMID:35163327
1302983	Osmr	oncostatin M receptor	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of OSMR mRNA	PMID:18500788
1302983	Osmr	oncostatin M receptor	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of OSMR mRNA	PMID:30723492
1302983	Osmr	oncostatin M receptor	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of OSMR mRNA	PMID:35163327
1302983	Osmr	oncostatin M receptor	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552210	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of OSMR mRNA	PMID:28903501
1302983	Osmr	oncostatin M receptor	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of OSMR mRNA	PMID:24449571
1302983	Osmr	oncostatin M receptor	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1352311	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of OSMR mRNA	PMID:28302478
1302983	Osmr	oncostatin M receptor	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1552210	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of OSMR mRNA	PMID:39529242
1302983	Osmr	oncostatin M receptor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1352311	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of OSMR mRNA	PMID:40419075
1302983	Osmr	oncostatin M receptor	gene	CHEBI:39426	perfluorobutyric acid	increases expression	ISO	RGD:1552210	E	RGD:6480464	20220308	CTD	MESH:C033094	perfluorobutyric acid results in increased expression of OSMR mRNA	PMID:34474067
1302983	Osmr	oncostatin M receptor	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of OSMR mRNA]	PMID:18200517
1302983	Osmr	oncostatin M receptor	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1352311	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of OSMR mRNA	PMID:27188386
1302983	Osmr	oncostatin M receptor	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1352311	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of OSMR mRNA	PMID:20106945|PMID:25562108
1302983	Osmr	oncostatin M receptor	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1352311	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of OSMR mRNA	PMID:14699072
1302983	Osmr	oncostatin M receptor	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20181016	CTD	MESH:D013629	[Carbon Tetrachloride co-treated with Tamoxifen] affects the expression of OSMR mRNA	PMID:29974145
1302983	Osmr	oncostatin M receptor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OSMR mRNA	PMID:37992649
1302983	Osmr	oncostatin M receptor	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1352311	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of OSMR mRNA	PMID:38832940
1302983	Osmr	oncostatin M receptor	gene	CHEBI:45863	paclitaxel	increases response to substance	ISO	RGD:1352311	E	RGD:6480464	20161213	CTD	MESH:D017239	OSMR protein results in increased susceptibility to Paclitaxel	PMID:16734730
1302983	Osmr	oncostatin M receptor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of OSMR mRNA	PMID:17562736
1302983	Osmr	oncostatin M receptor	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of OSMR mRNA	PMID:21420995
1302983	Osmr	oncostatin M receptor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1352311	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of OSMR mRNA	PMID:29067470
1302983	Osmr	oncostatin M receptor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of OSMR mRNA	PMID:19420014
1302983	Osmr	oncostatin M receptor	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of OSMR mRNA	PMID:24690739
1302983	Osmr	oncostatin M receptor	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1552210	E	RGD:6480464	20161213	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of OSMR mRNA	PMID:23917077
1302983	Osmr	oncostatin M receptor	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1552210	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of OSMR mRNA	PMID:19654921
1302983	Osmr	oncostatin M receptor	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of OSMR mRNA	PMID:29391264
1302983	Osmr	oncostatin M receptor	gene	CHEBI:49668	gefitinib	affects response to substance	ISO	RGD:1352311	E	RGD:6480464	20120412	CTD	MESH:C419708	OSMR protein affects the susceptibility to gefitinib	PMID:15496427
1302983	Osmr	oncostatin M receptor	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1552210	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of OSMR mRNA	PMID:15251184
1302983	Osmr	oncostatin M receptor	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20191114	CTD	MESH:C014347	[Tetrachlorodibenzodioxin co-treated with Decitabine] results in increased expression of OSMR mRNA	PMID:15251184
1302983	Osmr	oncostatin M receptor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552210	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of OSMR mRNA; Nanotubes, Carbon results in increased expression of OSMR mRNA	PMID:25554681|PMID:25620056
1302983	Osmr	oncostatin M receptor	gene	CHEBI:50845	doxycycline	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D004318	Doxycycline inhibits the reaction [Isoproterenol results in increased expression of OSMR mRNA]	PMID:18089841
1302983	Osmr	oncostatin M receptor	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of OSMR mRNA	PMID:24793618
1302983	Osmr	oncostatin M receptor	gene	CHEBI:5298	Genipin	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20141111	CTD	MESH:C007834	genipin inhibits the reaction [Lipopolysaccharides results in increased expression of OSMR mRNA]	PMID:22687549
1302983	Osmr	oncostatin M receptor	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1552210	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of OSMR mRNA	PMID:16166746
1302983	Osmr	oncostatin M receptor	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of OSMR mRNA	PMID:17982090|PMID:18200517
1302983	Osmr	oncostatin M receptor	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of OSMR mRNA]	PMID:18200517
1302983	Osmr	oncostatin M receptor	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1552210	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of OSMR mRNA	PMID:23608068
1302983	Osmr	oncostatin M receptor	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1352311	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of OSMR mRNA	PMID:28988120
1302983	Osmr	oncostatin M receptor	gene	CHEBI:64227	ciglitazone	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein] which results in increased expression of OSMR mRNA	PMID:16197558
1302983	Osmr	oncostatin M receptor	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1552210	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of OSMR mRNA	PMID:18089841|PMID:20003209
1302983	Osmr	oncostatin M receptor	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20120515	CTD	MESH:D007545	Doxycycline inhibits the reaction [Isoproterenol results in increased expression of OSMR mRNA]	PMID:18089841
1302983	Osmr	oncostatin M receptor	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of OSMR mRNA	PMID:28935588
1302983	Osmr	oncostatin M receptor	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1352311	E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of OSMR mRNA	PMID:28935588
1302983	Osmr	oncostatin M receptor	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1552210	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of OSMR mRNA	PMID:31052254
1302983	Osmr	oncostatin M receptor	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552210	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of OSMR mRNA	PMID:22206623
1302983	Osmr	oncostatin M receptor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552210	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of OSMR mRNA	PMID:22206623
1302983	Osmr	oncostatin M receptor	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1352311	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of OSMR mRNA	PMID:29522793
1302983	Osmr	oncostatin M receptor	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1352311	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of OSMR mRNA	PMID:37199045
1302983	Osmr	oncostatin M receptor	gene	CHEBI:75701	sarin	increases expression	ISO	RGD:1352311	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of OSMR mRNA	PMID:19522546
1302983	Osmr	oncostatin M receptor	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of OSMR mRNA	PMID:30851411
1302983	Osmr	oncostatin M receptor	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OSMR mRNA	PMID:27188386
1302983	Osmr	oncostatin M receptor	gene	CHEBI:80630	irinotecan	decreases response to substance	ISO	RGD:1352311	E	RGD:6480464	20181113	CTD	MESH:D000077146	OSMR protein results in decreased susceptibility to Irinotecan	PMID:16734730
1302983	Osmr	oncostatin M receptor	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1352311	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in increased expression of OSMR mRNA; Irinotecan results in increased expression of OSMR mRNA	PMID:15956246
1302983	Osmr	oncostatin M receptor	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1552210	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of OSMR mRNA	PMID:18958704
1302983	Osmr	oncostatin M receptor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552210	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of OSMR mRNA	PMID:30294300
1302983	Osmr	oncostatin M receptor	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1352311	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OSMR mRNA	PMID:27188386
1302983	Osmr	oncostatin M receptor	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1352311	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of OSMR mRNA	PMID:38568856
1302984	Lmo7	LIM domain 7	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LMO7 mRNA	PMID:38218311
1302984	Lmo7	LIM domain 7	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1351855	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LMO7 mRNA	PMID:38218311
1302984	Lmo7	LIM domain 7	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1351855	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of LMO7 mRNA	PMID:26272509
1302984	Lmo7	LIM domain 7	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA	PMID:27188386
1302984	Lmo7	LIM domain 7	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LMO7 mRNA]	PMID:31150632
1302984	Lmo7	LIM domain 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMO7 gene	PMID:20938992
1302984	Lmo7	LIM domain 7	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1351855	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of LMO7 mRNA	PMID:15456535
1302984	Lmo7	LIM domain 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of LMO7 mRNA	PMID:23724009
1302984	Lmo7	LIM domain 7	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of LMO7 mRNA	PMID:30951980
1302984	Lmo7	LIM domain 7	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LMO7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LMO7 mRNA	PMID:32699268
1302984	Lmo7	LIM domain 7	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1351855	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of LMO7 protein	PMID:28073184
1302984	Lmo7	LIM domain 7	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552223	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of LMO7 mRNA	PMID:30319688
1302984	Lmo7	LIM domain 7	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20120515	CTD	MESH:D000431	Ethanol results in decreased expression of LMO7 mRNA	PMID:21955143
1302984	Lmo7	LIM domain 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1351855	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LMO7 mRNA	PMID:20044591
1302984	Lmo7	LIM domain 7	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of LMO7 mRNA	PMID:21632981
1302984	Lmo7	LIM domain 7	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of LMO7 mRNA	PMID:30510588
1302984	Lmo7	LIM domain 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of LMO7 mRNA	PMID:24758408
1302984	Lmo7	LIM domain 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LMO7 mRNA	PMID:39298647
1302984	Lmo7	LIM domain 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20160412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of LMO7 mRNA; EGF protein inhibits the reaction [Estradiol results in decreased expression of LMO7 mRNA]	PMID:24758408|PMID:30165855
1302984	Lmo7	LIM domain 7	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1552223	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of LMO7 mRNA	PMID:33711761
1302984	Lmo7	LIM domain 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMO7 gene	PMID:20938992
1302984	Lmo7	LIM domain 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1351855	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LMO7 mRNA	PMID:37042841
1302984	Lmo7	LIM domain 7	gene	CHEBI:17303	morphine	increases expression	ISO	RGD:1552223	E	RGD:6480464	20120515	CTD	MESH:D009020	Morphine results in increased expression of LMO7 mRNA	PMID:21955143
1302984	Lmo7	LIM domain 7	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of LMO7 mRNA	PMID:22967744
1302984	Lmo7	LIM domain 7	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of LMO7 mRNA	PMID:21955143
1302984	Lmo7	LIM domain 7	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1351855	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LMO7 protein	PMID:37730182
1302984	Lmo7	LIM domain 7	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1351855	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LMO7 promoter	PMID:30157460
1302984	Lmo7	LIM domain 7	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of LMO7 mRNA	PMID:21955143
1302984	Lmo7	LIM domain 7	gene	CHEBI:190294	calcium silicate	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in decreased expression of LMO7 mRNA	PMID:29279043
1302984	Lmo7	LIM domain 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1351855	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LMO7 mRNA	PMID:19549813
1302984	Lmo7	LIM domain 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1351855	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LMO7 gene	PMID:27153756
1302984	Lmo7	LIM domain 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552223	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LMO7 mRNA	PMID:19770486
1302984	Lmo7	LIM domain 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LMO7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LMO7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LMO7 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of LMO7 mRNA	PMID:32699268|PMID:41430723
1302984	Lmo7	LIM domain 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LMO7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LMO7 mRNA	PMID:34911549
1302984	Lmo7	LIM domain 7	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of LMO7 protein	PMID:38598786
1302984	Lmo7	LIM domain 7	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of LMO7 mRNA	PMID:30779732
1302984	Lmo7	LIM domain 7	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LMO7 mRNA	PMID:16979875
1302984	Lmo7	LIM domain 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LMO7 mRNA	PMID:31150632
1302984	Lmo7	LIM domain 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LMO7 mRNA	PMID:31919559
1302984	Lmo7	LIM domain 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LMO7 mRNA]	PMID:31150632
1302984	Lmo7	LIM domain 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LMO7 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMO7 gene	PMID:20938992|PMID:22206623
1302984	Lmo7	LIM domain 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LMO7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO7 mRNA	PMID:32525701|PMID:39836092
1302984	Lmo7	LIM domain 7	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA]	PMID:11007951
1302984	Lmo7	LIM domain 7	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of LMO7 protein	PMID:38460933
1302984	Lmo7	LIM domain 7	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1351855	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of LMO7 mRNA	PMID:26272509
1302984	Lmo7	LIM domain 7	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA	PMID:27188386
1302984	Lmo7	LIM domain 7	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1351855	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of LMO7 protein	PMID:35688186
1302984	Lmo7	LIM domain 7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LMO7 mRNA	PMID:28960355
1302984	Lmo7	LIM domain 7	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1351855	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of LMO7 mRNA	PMID:27392435
1302984	Lmo7	LIM domain 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of LMO7 mRNA	PMID:27392435
1302984	Lmo7	LIM domain 7	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of LMO7 mRNA	PMID:17898221
1302984	Lmo7	LIM domain 7	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of LMO7 mRNA	PMID:18930951
1302984	Lmo7	LIM domain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1351855	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LMO7 mRNA	PMID:22298810
1302984	Lmo7	LIM domain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552223	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LMO7 mRNA	PMID:18343893|PMID:26377647
1302984	Lmo7	LIM domain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA	PMID:23238561
1302984	Lmo7	LIM domain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1351855	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA	PMID:11007951|PMID:11489354|PMID:20106945|PMID:21632981
1302984	Lmo7	LIM domain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552223	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA	PMID:18796159|PMID:19770486|PMID:19933214|PMID:21889950|PMID:23238561|PMID:28922406
1302984	Lmo7	LIM domain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20120412	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA]	PMID:11007951
1302984	Lmo7	LIM domain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of LMO7 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LMO7 gene]	PMID:16214954|PMID:21762485
1302984	Lmo7	LIM domain 7	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1351855	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LMO7 mRNA	PMID:28001369
1302984	Lmo7	LIM domain 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LMO7 mRNA	PMID:33212167
1302984	Lmo7	LIM domain 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LMO7 mRNA	PMID:30851411
1302984	Lmo7	LIM domain 7	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1351855	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of LMO7 mRNA	PMID:26272509
1302984	Lmo7	LIM domain 7	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA	PMID:27188386
1302984	Lmo7	LIM domain 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LMO7 mRNA	PMID:29803840
1302984	Lmo7	LIM domain 7	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1351855	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of LMO7 protein	PMID:35688186
1302984	Lmo7	LIM domain 7	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1351855	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of LMO7 gene	PMID:28589171
1302984	Lmo7	LIM domain 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of LMO7 mRNA	PMID:28595984|PMID:34032870
1302984	Lmo7	LIM domain 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552223	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of LMO7 mRNA	PMID:39515575
1302984	Lmo7	LIM domain 7	gene	CHEBI:29678	sodium arsenite	increases stability	ISO	RGD:1351855	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased stability of LMO7 mRNA	PMID:25493608
1302984	Lmo7	LIM domain 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO7 mRNA	PMID:39836092
1302984	Lmo7	LIM domain 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351855	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LMO7 5' UTR	PMID:27901495
1302984	Lmo7	LIM domain 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1351855	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LMO7 exon	PMID:27901495
1302984	Lmo7	LIM domain 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552223	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LMO7 mRNA	PMID:19770486
1302984	Lmo7	LIM domain 7	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LMO7 mRNA]	PMID:32406909
1302984	Lmo7	LIM domain 7	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LMO7 mRNA	PMID:16979875
1302984	Lmo7	LIM domain 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LMO7 mRNA	PMID:19150397|PMID:20018196
1302984	Lmo7	LIM domain 7	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LMO7 gene; [bisphenol S co-treated with Fulvestrant] results in increased methylation of LMO7 gene	PMID:31601247
1302984	Lmo7	LIM domain 7	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of LMO7 mRNA	PMID:25729387
1302984	Lmo7	LIM domain 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of LMO7 mRNA	PMID:25729387
1302984	Lmo7	LIM domain 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552223	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LMO7 promoter	PMID:35295148
1302984	Lmo7	LIM domain 7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552223	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of LMO7 mRNA	PMID:27760801|PMID:29264374
1302984	Lmo7	LIM domain 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552223	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LMO7 promoter	PMID:35295148
1302984	Lmo7	LIM domain 7	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LMO7 mRNA	PMID:23411599
1302984	Lmo7	LIM domain 7	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1552223	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of LMO7 mRNA	PMID:18648102
1302984	Lmo7	LIM domain 7	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552223	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LMO7 mRNA	PMID:28472532
1302984	Lmo7	LIM domain 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of LMO7 mRNA	PMID:32145629
1302984	Lmo7	LIM domain 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LMO7 mRNA	PMID:25181051
1302984	Lmo7	LIM domain 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552223	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of LMO7 mRNA	PMID:30951980|PMID:32156529
1302984	Lmo7	LIM domain 7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LMO7 gene	PMID:28505145
1302984	Lmo7	LIM domain 7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1351855	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of LMO7 gene	PMID:31601247
1302984	Lmo7	LIM domain 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LMO7 gene	PMID:31601247
1302984	Lmo7	LIM domain 7	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LMO7 mRNA	PMID:23196670
1302984	Lmo7	LIM domain 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1351855	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of LMO7 protein	PMID:31945527
1302984	Lmo7	LIM domain 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552223	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of LMO7 gene	PMID:31683443
1302984	Lmo7	LIM domain 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of LMO7 mRNA	PMID:33297965|PMID:39298647
1302984	Lmo7	LIM domain 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552223	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LMO7 mRNA	PMID:30951980
1302984	Lmo7	LIM domain 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of LMO7 gene	PMID:31601247
1302984	Lmo7	LIM domain 7	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1552223	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of LMO7 mRNA	PMID:26377693
1302984	Lmo7	LIM domain 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552223	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LMO7 mRNA	PMID:30951980
1302984	Lmo7	LIM domain 7	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of LMO7 mRNA	PMID:30951980
1302984	Lmo7	LIM domain 7	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1552223	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of LMO7 mRNA	PMID:28392331
1302984	Lmo7	LIM domain 7	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552223	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LMO7 intron	PMID:28392331
1302984	Lmo7	LIM domain 7	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of LMO7 protein	PMID:38598786
1302984	Lmo7	LIM domain 7	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1552223	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of LMO7 mRNA	PMID:17854601
1302984	Lmo7	LIM domain 7	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LMO7 mRNA	PMID:18164116
1302984	Lmo7	LIM domain 7	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of LMO7 mRNA]	PMID:17854601
1302984	Lmo7	LIM domain 7	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of LMO7 gene	PMID:33148267
1302984	Lmo7	LIM domain 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351855	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LMO7 mRNA	PMID:37042841
1302984	Lmo7	LIM domain 7	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LMO7 mRNA	PMID:33453195
1302984	Lmo7	LIM domain 7	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LMO7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LMO7 mRNA	PMID:32699268
1302984	Lmo7	LIM domain 7	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20120412	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LMO7 mRNA	PMID:16979875
1302984	Lmo7	LIM domain 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552223	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LMO7 mRNA	PMID:40194260
1302984	Lmo7	LIM domain 7	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1552223	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of LMO7 mRNA	PMID:34254344
1302984	Lmo7	LIM domain 7	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LMO7 mRNA	PMID:31533062
1302984	Lmo7	LIM domain 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LMO7 mRNA	PMID:40419075
1302984	Lmo7	LIM domain 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351855	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LMO7 mRNA	PMID:25979313
1302984	Lmo7	LIM domain 7	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1351855	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LMO7 gene	PMID:29154799
1302984	Lmo7	LIM domain 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351855	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of LMO7 mRNA	PMID:24383497|PMID:26272509|PMID:28001369
1302984	Lmo7	LIM domain 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552223	E	RGD:6480464	20120717	CTD	MESH:D014635	Valproic Acid results in increased expression of LMO7 mRNA	PMID:19136453|PMID:21427059
1302984	Lmo7	LIM domain 7	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA	PMID:27188386
1302984	Lmo7	LIM domain 7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LMO7 mRNA	PMID:20106945|PMID:25562108
1302984	Lmo7	LIM domain 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552223	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of LMO7 mRNA	PMID:28973697
1302984	Lmo7	LIM domain 7	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1351855	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LMO7 mRNA	PMID:38832940
1302984	Lmo7	LIM domain 7	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1351855	E	RGD:6480464	20160210	CTD	MESH:C012589	trichostatin A results in increased expression of LMO7 mRNA	PMID:24935251|PMID:26705709
1302984	Lmo7	LIM domain 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of LMO7 mRNA	PMID:29279043
1302984	Lmo7	LIM domain 7	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of LMO7 mRNA	PMID:29279043
1302984	Lmo7	LIM domain 7	gene	CHEBI:46680	serpentine asbestos	increases methylation	ISO	RGD:1351855	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of LMO7 exon	PMID:29523930
1302984	Lmo7	LIM domain 7	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of LMO7 protein	PMID:38460933
1302984	Lmo7	LIM domain 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LMO7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO7 mRNA	PMID:32525701|PMID:39836092
1302984	Lmo7	LIM domain 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of LMO7 mRNA	PMID:35436446
1302984	Lmo7	LIM domain 7	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1351855	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of LMO7 mRNA	PMID:26272509
1302984	Lmo7	LIM domain 7	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA	PMID:27188386
1302984	Lmo7	LIM domain 7	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1552223	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of LMO7 mRNA	PMID:25554681
1302984	Lmo7	LIM domain 7	gene	CHEBI:5130	flurbiprofen	increases expression	ISO	RGD:1552223	E	RGD:6480464	20120412	CTD	MESH:D005480	Flurbiprofen results in increased expression of LMO7 mRNA	PMID:16949054
1302984	Lmo7	LIM domain 7	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1351855	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of LMO7 mRNA	PMID:26705709
1302984	Lmo7	LIM domain 7	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LMO7 protein	PMID:32959892
1302984	Lmo7	LIM domain 7	gene	CHEBI:63598	levofloxacin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of LMO7 mRNA	PMID:24136188
1302984	Lmo7	LIM domain 7	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of LMO7 mRNA	PMID:25729387
1302984	Lmo7	LIM domain 7	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of LMO7 mRNA	PMID:25729387
1302984	Lmo7	LIM domain 7	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of LMO7 mRNA	PMID:24136188
1302984	Lmo7	LIM domain 7	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1552223	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of LMO7 mRNA	PMID:26307267
1302984	Lmo7	LIM domain 7	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LMO7 gene	PMID:35440735
1302984	Lmo7	LIM domain 7	gene	CHEBI:68508	diethyl maleate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased expression of LMO7 mRNA	PMID:21161181
1302984	Lmo7	LIM domain 7	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of LMO7 gene	PMID:33148267
1302984	Lmo7	LIM domain 7	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1351855	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LMO7 protein	PMID:34186270
1302984	Lmo7	LIM domain 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LMO7 mRNA	PMID:22206623
1302984	Lmo7	LIM domain 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LMO7 mRNA	PMID:22206623
1302984	Lmo7	LIM domain 7	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1552223	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LMO7 mRNA	PMID:25566086
1302984	Lmo7	LIM domain 7	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LMO7 mRNA]	PMID:25566086
1302984	Lmo7	LIM domain 7	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LMO7 mRNA	PMID:18164116
1302984	Lmo7	LIM domain 7	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in decreased expression of LMO7 protein	PMID:39638853
1302984	Lmo7	LIM domain 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LMO7 mRNA	PMID:30851411
1302984	Lmo7	LIM domain 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA	PMID:27188386
1302984	Lmo7	LIM domain 7	gene	CHEBI:80630	irinotecan	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan affects the expression of LMO7 mRNA	PMID:20097248
1302984	Lmo7	LIM domain 7	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1552223	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of LMO7 mRNA	PMID:19482888
1302984	Lmo7	LIM domain 7	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1552223	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LMO7 mRNA]	PMID:19482888
1302984	Lmo7	LIM domain 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1552223	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of LMO7 mRNA	PMID:18343893
1302984	Lmo7	LIM domain 7	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1552223	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of LMO7 mRNA	PMID:31388691
1302984	Lmo7	LIM domain 7	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1552223	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LMO7 mRNA	PMID:38648751
1302984	Lmo7	LIM domain 7	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LMO7 mRNA	PMID:32525701
1302984	Lmo7	LIM domain 7	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA	PMID:27188386
1302984	Lmo7	LIM domain 7	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA	PMID:27188386
1302984	Lmo7	LIM domain 7	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of LMO7 mRNA	PMID:19281266
1302984	Lmo7	LIM domain 7	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of LMO7 mRNA	PMID:19281266
1302984	Lmo7	LIM domain 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LMO7 mRNA	PMID:21346803
1302984	Lmo7	LIM domain 7	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1351855	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of LMO7 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of LMO7 protein	PMID:38598786
1302984	Lmo7	LIM domain 7	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LMO7 mRNA	PMID:21346803
1302984	Lmo7	LIM domain 7	gene	CHEBI:9944	venlafaxine hydrochloride	decreases expression	ISO	RGD:1351855	E	RGD:6480464	20170303	CTD	MESH:D000069470	Venlafaxine Hydrochloride results in decreased expression of LMO7 mRNA	PMID:16341940
1302984	Lmo7	LIM domain 7	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of LMO7 mRNA	PMID:19015723
1302984	Lmo7	LIM domain 7	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of LMO7 gene	PMID:31079544
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of RGL2 mRNA	PMID:21551480
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552224	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RGL2 gene	PMID:20938992
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1347432	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RGL2 mRNA	PMID:33167477
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552224	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RGL2 mRNA	PMID:39241906
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1347432	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of RGL2 mRNA	PMID:31614463
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552224	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RGL2 mRNA	PMID:39298647
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552224	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RGL2 gene	PMID:20938992
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552224	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RGL2 mRNA	PMID:34319233
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1347432	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RGL2 protein	PMID:37730182
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347432	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RGL2 mRNA	PMID:35301059
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1552224	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of RGL2 mRNA	PMID:15664270
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1552224	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of RGL2 mRNA	PMID:19376150
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1347432	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RGL2 mRNA	PMID:23649840
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1347432	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RGL2 mRNA	PMID:35430440
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552224	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RGL2 mRNA	PMID:34911549
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552224	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RGL2 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RGL2 mRNA]	PMID:20938992|PMID:22206623
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1347432	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RGL2 gene	PMID:25304211
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347432	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RGL2 mRNA	PMID:39836092
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552224	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RGL2 mRNA	PMID:40504410
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1347432	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RGL2 protein	PMID:35688186
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552224	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RGL2 mRNA	PMID:21570461
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RGL2 mRNA	PMID:34747641
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1347432	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RGL2 protein	PMID:39603559
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1347432	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RGL2 mRNA	PMID:29803840
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1552224	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of RGL2 gene	PMID:39894169
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347432	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RGL2 mRNA	PMID:22714537|PMID:38568856
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347432	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RGL2 mRNA	PMID:39836092
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552224	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RGL2 mRNA	PMID:40504410
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:3020	benzalkonium chloride	affects response to substance	ISO	RGD:1347432	E	RGD:6480464	20180220	CTD	MESH:D001548	RGL2 SNP affects the susceptibility to Benzalkonium Compounds	PMID:27258892
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RGL2 mRNA	PMID:16483693
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1347432	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RGL2 gene	PMID:31601247
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552224	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RGL2 gene	PMID:35295148
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552224	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RGL2 gene	PMID:35295148
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of RGL2 mRNA	PMID:19167457
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RGL2 mRNA	PMID:30816183|PMID:33296240
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RGL2 mRNA	PMID:25181051
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552224	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RGL2 mRNA	PMID:33221593
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RGL2 mRNA	PMID:36041667
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347432	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RGL2 gene	PMID:31601247
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RGL2 mRNA	PMID:36041667
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552224	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RGL2 mRNA	PMID:38685157
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RGL2 mRNA	PMID:36041667
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552224	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RGL2 mRNA	PMID:37019170
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1347432	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of RGL2 gene	PMID:22964155
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347432	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RGL2 mRNA	PMID:37042841
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RGL2 mRNA	PMID:33453195
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347432	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RGL2 mRNA	PMID:38174414
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347432	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RGL2 mRNA	PMID:35301059
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1347432	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RGL2 mRNA	PMID:19320972
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347432	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RGL2 mRNA	PMID:25979313
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of RGL2 mRNA	PMID:29427782
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1347432	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RGL2 gene	PMID:29154799
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552224	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RGL2 mRNA	PMID:17562736
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RGL2 mRNA	PMID:33387578
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1347432	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of RGL2 mRNA	PMID:17331233
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1347432	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RGL2 gene	PMID:25304211
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347432	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RGL2 mRNA	PMID:39836092
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552224	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RGL2 mRNA	PMID:40504410
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RGL2 mRNA	PMID:24136188
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1347432	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of RGL2 mRNA	PMID:22714537
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1552224	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of RGL2 mRNA	PMID:26307267
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552224	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RGL2 mRNA	PMID:22206623
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552224	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RGL2 mRNA]	PMID:22206623
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RGL2 mRNA	PMID:19281266
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RGL2 mRNA	PMID:21346803
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RGL2 mRNA	PMID:21346803
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1552224	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of RGL2 mRNA	PMID:32835833
1302985	Rgl2	ral guanine nucleotide dissociation stimulator like 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RGL2 mRNA	PMID:19015723
1302986	Lcn6	lipocalin 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349815	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of LCN6 mRNA	PMID:33167477
1302986	Lcn6	lipocalin 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1611507	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of LCN6 mRNA	PMID:27106289
1302986	Lcn6	lipocalin 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1611507	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LCN6 mRNA	PMID:25629700
1302986	Lcn6	lipocalin 6	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1611507	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of LCN6 mRNA	PMID:28960355
1302986	Lcn6	lipocalin 6	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of LCN6 mRNA	PMID:26033743
1302986	Lcn6	lipocalin 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349815	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LCN6 promoter	PMID:27901495
1302986	Lcn6	lipocalin 6	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of LCN6 mRNA	PMID:26033743
1302986	Lcn6	lipocalin 6	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1611507	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LCN6 mRNA	PMID:27131904
1302986	Lcn6	lipocalin 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LCN6 mRNA	PMID:25181051
1302986	Lcn6	lipocalin 6	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1349815	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LCN6 gene	PMID:29154799
1302986	Lcn6	lipocalin 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349815	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of LCN6 mRNA	PMID:26690555
1302986	Lcn6	lipocalin 6	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1611507	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LCN6 mRNA	PMID:27131904
1302987	Ano7	anoctamin 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1557827	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ANO7 gene	PMID:20938992
1302987	Ano7	anoctamin 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1557827	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ANO7 mRNA	PMID:39241906
1302987	Ano7	anoctamin 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1557827	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ANO7 gene	PMID:20938992
1302987	Ano7	anoctamin 7	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1351029	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANO7 mRNA	PMID:36139627
1302987	Ano7	anoctamin 7	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1557827	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANO7 mRNA	PMID:29950665
1302987	Ano7	anoctamin 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1351029	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ANO7 intron	PMID:30157460
1302987	Ano7	anoctamin 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1351029	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANO7 polyA tail	PMID:30157460
1302987	Ano7	anoctamin 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ANO7 mRNA	PMID:31150632
1302987	Ano7	anoctamin 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557827	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ANO7 gene	PMID:20938992
1302987	Ano7	anoctamin 7	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1351029	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ANO7 gene	PMID:25304211
1302987	Ano7	anoctamin 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1351029	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ANO7 mRNA	PMID:23557933
1302987	Ano7	anoctamin 7	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1351029	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ANO7 mRNA	PMID:27594783
1302987	Ano7	anoctamin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557827	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANO7 mRNA	PMID:21570461
1302987	Ano7	anoctamin 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1351029	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ANO7 mRNA	PMID:33212167
1302987	Ano7	anoctamin 7	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ANO7 mRNA	PMID:26033743
1302987	Ano7	anoctamin 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1351029	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANO7 mRNA	PMID:38568856
1302987	Ano7	anoctamin 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1557827	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ANO7 mRNA	PMID:37682722
1302987	Ano7	anoctamin 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351029	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ANO7 polyA tail	PMID:30157460
1302987	Ano7	anoctamin 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1351029	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ANO7 promoter	PMID:27901495
1302987	Ano7	anoctamin 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1557827	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ANO7 intron	PMID:27901495
1302987	Ano7	anoctamin 7	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ANO7 mRNA	PMID:26033743
1302987	Ano7	anoctamin 7	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of ANO7 mRNA	PMID:24395379
1302987	Ano7	anoctamin 7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1557827	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ANO7 mRNA	PMID:35295148
1302987	Ano7	anoctamin 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557827	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ANO7 gene	PMID:35295148
1302987	Ano7	anoctamin 7	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1557827	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANO7 mRNA	PMID:29950665
1302987	Ano7	anoctamin 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1351029	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ANO7 mRNA	PMID:19710929
1302987	Ano7	anoctamin 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ANO7 mRNA	PMID:25181051
1302987	Ano7	anoctamin 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1351029	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ANO7 gene	PMID:31601247
1302987	Ano7	anoctamin 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1557827	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ANO7 exon	PMID:33297965
1302987	Ano7	anoctamin 7	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1351029	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ANO7 polyA tail	PMID:30157460
1302987	Ano7	anoctamin 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1557827	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ANO7 mRNA	PMID:37019170
1302987	Ano7	anoctamin 7	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1557827	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANO7 mRNA	PMID:29950665
1302987	Ano7	anoctamin 7	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ANO7 mRNA	PMID:30723492
1302987	Ano7	anoctamin 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1557827	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ANO7 mRNA	PMID:40194260
1302987	Ano7	anoctamin 7	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1351029	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ANO7 mRNA	PMID:28302478
1302987	Ano7	anoctamin 7	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1351029	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ANO7 gene	PMID:29154799
1302987	Ano7	anoctamin 7	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1351029	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ANO7 gene	PMID:25304211
1302987	Ano7	anoctamin 7	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1351029	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ANO7 polyA tail	PMID:30157460
1302987	Ano7	anoctamin 7	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1351029	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANO7 mRNA	PMID:36139627
1302987	Ano7	anoctamin 7	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1557827	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of ANO7 mRNA	PMID:35537566
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SMARCA2 mRNA	PMID:38218311
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1348339	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SMARCA2 mRNA	PMID:38218311
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1348339	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SMARCA2 mRNA	PMID:26272509|PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1617553	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SMARCA2 mRNA	PMID:33045310
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SMARCA2 mRNA]	PMID:31150632
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SMARCA2 mRNA]	PMID:19467301
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SMARCA2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of SMARCA2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SMARCA2 gene	PMID:20938992
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1348339	E	RGD:6480464	20141014	CTD	MESH:D014212	Tretinoin results in increased expression of SMARCA2 mRNA	PMID:17218384|PMID:21934132|PMID:22906706
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1617553	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of SMARCA2 mRNA	PMID:16604517
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of SMARCA2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of SMARCA2 mRNA	PMID:32699268
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1617553	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SMARCA2 mRNA	PMID:24205000
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20190611	CTD	MESH:D010100	SMARCA2 protein promotes the reaction [Oxygen deficiency results in increased expression of COL7A1 mRNA]; SMARCA2 protein promotes the reaction [Oxygen deficiency results in increased expression of LAMC2 mRNA]	PMID:30381462
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SMARCA2 mRNA	PMID:30529165
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1617553	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of SMARCA2 mRNA	PMID:15282401
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of SMARCA2 mRNA	PMID:30319688
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone promotes the reaction [AR protein binds to SMARCA2 protein]; Dihydrotestosterone promotes the reaction [SMARCA2 protein binds to KLK3 promoter]	PMID:18487222
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SMARCA2 mRNA	PMID:39298647
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SMARCA2 gene	PMID:27618143
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SMARCA2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of SMARCA2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SMARCA2 gene	PMID:20938992
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348339	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SMARCA2 mRNA	PMID:37042841
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of SMARCA2 mRNA	PMID:27683099
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1348339	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SMARCA2 mRNA	PMID:31163220
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SMARCA2 promoter	PMID:23359474
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1348339	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SMARCA2 protein	PMID:37730182
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1348339	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SMARCA2 mRNA	PMID:28818685
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SMARCA2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SMARCA2 mRNA	PMID:28111341|PMID:37236586|PMID:37325564
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1348339	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SMARCA2 mRNA	PMID:19549813
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1348339	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SMARCA2 intron	PMID:30157460
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of SMARCA2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of SMARCA2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of SMARCA2 mRNA	PMID:32699268
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SMARCA2 mRNA	PMID:27106289
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SMARCA2 mRNA	PMID:31150632
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SMARCA2 mRNA	PMID:31919559
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SMARCA2 mRNA]	PMID:31150632
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SMARCA2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of SMARCA2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SMARCA2 gene	PMID:20938992
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1348339	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SMARCA2 mRNA	PMID:26272509
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1348339	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SMARCA2 protein	PMID:35688186
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1348339	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SMARCA2 mRNA	PMID:28903495
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of SMARCA2 mRNA	PMID:17898221
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of SMARCA2 mRNA	PMID:25583101
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMARCA2 mRNA	PMID:22298810
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMARCA2 mRNA	PMID:21215274|PMID:33387578|PMID:34747641
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMARCA2 mRNA	PMID:15328365|PMID:19770486
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCA2 mRNA	PMID:17942748
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SMARCA2 mRNA	PMID:28374803
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of SMARCA2 mRNA	PMID:29955902
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20180703	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SMARCA2 mRNA	PMID:29261810
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1348339	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SMARCA2 mRNA	PMID:28001369
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMARCA2 mRNA	PMID:33212167
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SMARCA2 mRNA	PMID:30851411
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1348339	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of SMARCA2 mRNA	PMID:26272509
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SMARCA2 mRNA	PMID:28959563
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20180703	CTD	MESH:D020106	Acrylamide results in decreased expression of SMARCA2 mRNA	PMID:29261810
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of SMARCA2 mRNA	PMID:30556269
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20120717	CTD	MESH:D003300	[Thiosemicarbazones binds to Copper] which results in increased expression of SMARCA2 protein	PMID:20931265
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMARCA2 mRNA	PMID:29803840
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1348339	E	RGD:6480464	20260203	CTD	MESH:D004317	Doxorubicin results in increased expression of SMARCA2 mRNA	PMID:40854400
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1617553	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SMARCA2 mRNA	PMID:39631538
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20260203	CTD	MESH:D004317	FOXO3 protein affects the reaction [Doxorubicin results in increased expression of SMARCA2 mRNA]	PMID:40854400
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1348339	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of SMARCA2 mRNA	PMID:29319823
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1348339	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SMARCA2 mRNA; sodium arsenite results in increased expression of SMARCA2 protein	PMID:38072110|PMID:38568856
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348339	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SMARCA2 promoter	PMID:27901495
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMARCA2 mRNA	PMID:20106945|PMID:21632981
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617553	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SMARCA2 mRNA	PMID:20504355
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of SMARCA2 mRNA	PMID:30556269
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20120717	CTD	MESH:D003300	[Thiosemicarbazones binds to Copper] which results in increased expression of SMARCA2 protein	PMID:20931265
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SMARCA2 mRNA	PMID:25895662
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SMARCA2 mRNA	PMID:39716349
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1348339	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SMARCA2 mRNA	PMID:20458559
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of SMARCA2 gene	PMID:31601247
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of SMARCA2 mRNA	PMID:24136188
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1348339	E	RGD:6480464	20251007	CTD	MESH:C008261	lead acetate results in increased expression of SMARCA2 protein	PMID:38072110
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SMARCA2 mRNA	PMID:30047161
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of SMARCA2 mRNA	PMID:27760801
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617553	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SMARCA2 gene; titanium dioxide results in decreased methylation of SMARCA2 promoter	PMID:35295148
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1617553	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SMARCA2 mRNA	PMID:23557971|PMID:29264374
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1617553	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SMARCA2 gene	PMID:35295148
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SMARCA2 mRNA	PMID:34492290
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of SMARCA2 mRNA	PMID:18445702|PMID:23811191
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SMARCA2 mRNA	PMID:25181051
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SMARCA2 protein	PMID:31675489
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SMARCA2 mRNA	PMID:33221593
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SMARCA2 mRNA	PMID:41034487
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1617553	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SMARCA2 mRNA	PMID:37611474
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SMARCA2 gene	PMID:28505145
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SMARCA2 promoter	PMID:23359474
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMARCA2 mRNA	PMID:28628672
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1617553	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SMARCA2 gene	PMID:31683443
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20240206	CTD	MESH:C543008	bisphenol S results in decreased expression of SMARCA2 mRNA	PMID:37611474|PMID:39298647|PMID:40203079
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SMARCA2 mRNA	PMID:28628672
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1348339	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SMARCA2 intron	PMID:30157460
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20180116	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of SMARCA2 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCA2 mRNA	PMID:28628672|PMID:31601247
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SMARCA2 promoter	PMID:23359474
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMARCA2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCA2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SMARCA2 mRNA	PMID:28628672
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of SMARCA2 mRNA]	PMID:19030233
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348339	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SMARCA2 mRNA	PMID:37042841
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SMARCA2 mRNA	PMID:30589522
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1617553	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of SMARCA2 mRNA	PMID:26377693
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SMARCA2 mRNA	PMID:18560533
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SMARCA2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SMARCA2 mRNA	PMID:28111341|PMID:37236586|PMID:37325564
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20190611	CTD	MESH:C018021	cobaltous chloride promotes the reaction [[SMARCA4 protein binds to SMARCA2 protein] which binds to COL7A1 gene]	PMID:30381462
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1348339	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SMARCA2 mRNA	PMID:24449571
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of SMARCA2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of SMARCA2 mRNA	PMID:32699268
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1617553	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SMARCA2 mRNA	PMID:40194260
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1348339	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SMARCA2 mRNA	PMID:31533062
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of SMARCA2 mRNA	PMID:25993096
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1348339	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SMARCA2 mRNA	PMID:25979313
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SMARCA2 mRNA	PMID:29427782
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20180703	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCA2 mRNA	PMID:29261810
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1348339	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SMARCA2 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1617553	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SMARCA2 mRNA	PMID:21427059
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SMARCA2 mRNA	PMID:30047161|PMID:38685447|PMID:41580965
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMARCA2 mRNA	PMID:21865292
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMARCA2 mRNA	PMID:25562108
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMARCA2 mRNA	PMID:19770486
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMARCA2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCA2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SMARCA2 mRNA	PMID:28628672
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1348339	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1348339	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SMARCA2 mRNA	PMID:24935251|PMID:26272509
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1617553	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SMARCA2 mRNA	PMID:17562736
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMARCA2 mRNA	PMID:21420995
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SMARCA2 mRNA	PMID:33387578
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1348339	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SMARCA2 mRNA	PMID:22230336
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of SMARCA2 mRNA	PMID:31675489
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SMARCA2 mRNA	PMID:29391264
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMARCA2 mRNA	PMID:22079256
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1617553	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SMARCA2 mRNA	PMID:17942748
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1617553	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCA2 mRNA	PMID:17942748
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1348339	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SMARCA2 mRNA	PMID:26272509
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMARCA2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCA2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SMARCA2 mRNA	PMID:28628672
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SMARCA2 mRNA	PMID:39716349
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1348339	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SMARCA2 mRNA	PMID:20458559
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1617553	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SMARCA2 mRNA; Nanotubes, Carbon results in decreased expression of SMARCA2 mRNA	PMID:25554681|PMID:25620056
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SMARCA2 mRNA	PMID:30047161|PMID:41580965
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of SMARCA2 mRNA	PMID:24136188
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1348339	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SMARCA2 mRNA	PMID:26705709
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of SMARCA2 mRNA	PMID:22714537
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SMARCA2 protein	PMID:32959892
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1348339	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of SMARCA2 mRNA	PMID:26272509
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:63924	riddelliine	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of SMARCA2 mRNA	PMID:33884520
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SMARCA2 mRNA	PMID:15336504
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1348339	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SMARCA2 intron	PMID:30157460
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1617553	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SMARCA2 mRNA	PMID:37611474
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:73390	promegestone	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20130723	CTD	MESH:D011397	SMARCA2 protein affects the reaction [Promegestone results in increased expression of FOS mRNA]; SMARCA2 protein affects the reaction [Promegestone results in increased expression of MYC mRNA]	PMID:19609353
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SMARCA2 mRNA	PMID:22079256
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMARCA2 mRNA	PMID:22079256
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of SMARCA2 mRNA	PMID:21346803
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SMARCA2 mRNA	PMID:30851411
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SMARCA2 gene]	PMID:28238834
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1617553	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SMARCA2 mRNA	PMID:23091169
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SMARCA2 protein	PMID:31675489
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1348339	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SMARCA2 protein	PMID:31675489
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SMARCA2 mRNA	PMID:23640034
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SMARCA2 mRNA	PMID:30047161
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1348339	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SMARCA2 mRNA	PMID:26272509
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1348339	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA	PMID:27188386
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SMARCA2 mRNA	PMID:21346803
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SMARCA2 mRNA	PMID:19015723
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of SMARCA2 mRNA	PMID:18042343
1302988	Smarca2	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of SMARCA2 gene	PMID:31682807
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552253	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LAG3 mRNA	PMID:33045310
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LAG3 mRNA]	PMID:31150632
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1344873	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of LAG3 mRNA	PMID:40865780
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552253	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of LAG3 mRNA	PMID:30319688
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552253	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LAG3 mRNA	PMID:39241906
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552253	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LAG3 mRNA	PMID:39298647
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAG3 mRNA	PMID:32741896
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344873	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LAG3 mRNA	PMID:37042841
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1344873	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in increased expression of LAG3 mRNA	PMID:28937961
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1552253	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LAG3 mRNA	PMID:39922521
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1552253	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of LAG3 mRNA	PMID:28973375
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1552253	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of LAG3 mRNA	PMID:20844152
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAG3 mRNA	PMID:32741896
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1344873	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of LAG3 mRNA	PMID:33647349
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1552253	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LAG3 mRNA	PMID:39922521
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1344873	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LAG3 mRNA	PMID:31163220
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LAG3 mRNA	PMID:33387578
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552253	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LAG3 mRNA	PMID:36331819
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1552253	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of LAG3 mRNA	PMID:15664270
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1344873	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LAG3 mRNA	PMID:19549813
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:234430	gardiquimod	increases expression	ISO	RGD:1344873	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of LAG3 mRNA	PMID:28003376
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1344873	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LAG3 mRNA]	PMID:28003376
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:2674	amodiaquine	multiple interactions	ISO	RGD:1552253	E	RGD:6480464	20181113	CTD	MESH:D000655	[PDCD1 protein co-treated with LAG3 protein] affects the reaction [Amodiaquine results in increased expression of GPT protein]	PMID:29938495
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LAG3 mRNA	PMID:31150632
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LAG3 mRNA]	PMID:31150632
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552253	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LAG3 mRNA	PMID:25629700
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1344873	E	RGD:6480464	20180515	CTD	MESH:D001151	Arsenic affects the expression of LAG3 mRNA	PMID:28793237
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344873	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LAG3 mRNA	PMID:23557933
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1344873	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of LAG3 mRNA	PMID:23300844
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1344873	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of LAG3 mRNA	PMID:27392435
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552253	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of LAG3 mRNA	PMID:40618947
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1344873	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of LAG3 mRNA	PMID:24768652
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LAG3 mRNA	PMID:34747641
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552253	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LAG3 mRNA	PMID:21570461
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344873	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LAG3 mRNA	PMID:33212167
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1344873	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LAG3 mRNA	PMID:32763439
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344873	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LAG3 mRNA	PMID:29301061
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552253	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of LAG3 mRNA	PMID:37682722
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552253	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of LAG3 mRNA	PMID:39515575
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1344873	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LAG3 promoter	PMID:27901495
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552253	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of LAG3 mRNA]	PMID:22228805
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:29866	arsenite(3-)	affects expression	ISO	RGD:1344873	E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of LAG3 mRNA	PMID:22959463
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:30563	silicon dioxide	affects expression	ISO	RGD:1552253	E	RGD:6480464	20260505	CTD	MESH:D012822	Silicon Dioxide affects the expression of LAG3 mRNA; Silicon Dioxide affects the expression of LAG3 protein	PMID:40975466
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552253	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LAG3 mRNA	PMID:29341224
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1344873	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of LAG3 mRNA	PMID:37690743
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of LAG3 mRNA	PMID:34492290
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of LAG3 mRNA	PMID:23411599
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1344873	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LAG3 mRNA	PMID:19710929
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LAG3 mRNA	PMID:25181051
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of LAG3 mRNA	PMID:41034487
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1552253	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of LAG3 promoter	PMID:27312807
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552253	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LAG3 mRNA	PMID:32156529
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552253	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of LAG3 gene	PMID:31683443
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1552253	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of LAG3 exon	PMID:33297965
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552253	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LAG3 mRNA	PMID:38685157
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1552253	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of LAG3 promoter	PMID:28392331
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1552253	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of LAG3 mRNA	PMID:28392331
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552253	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LAG3 mRNA	PMID:37019170
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344873	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LAG3 mRNA	PMID:37042841
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1344873	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of LAG3 mRNA	PMID:29024780
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1552253	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of LAG3 mRNA	PMID:26377693
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1344873	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LAG3 mRNA	PMID:24449571
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552253	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of LAG3 mRNA	PMID:17585979
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1344873	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LAG3 mRNA]	PMID:28003376
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552253	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LAG3 mRNA	PMID:40194260
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552253	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LAG3 mRNA	PMID:36331819
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552253	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of LAG3 mRNA	PMID:28973697
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1552253	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LAG3 mRNA	PMID:39922521
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1344873	E	RGD:6480464	20180515	CTD	MESH:D001151	Arsenic affects the expression of LAG3 mRNA	PMID:28793237
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LAG3 mRNA	PMID:29391264
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552253	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of LAG3 mRNA	PMID:35436446
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1344873	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of LAG3 mRNA	PMID:23300844
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552253	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of LAG3 mRNA	PMID:19042947
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552253	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LAG3 mRNA	PMID:38701926
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552253	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LAG3 mRNA	PMID:22206623
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAG3 mRNA	PMID:32741896
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of LAG3 mRNA	PMID:23665939
1302990	Lag3	lymphocyte activating 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552253	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of LAG3 mRNA	PMID:39847705
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TRAPPC4 mRNA	PMID:38218311
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of TRAPPC4 mRNA	PMID:32145629
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TRAPPC4 mRNA	PMID:38685446
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of TRAPPC4 mRNA	PMID:33359661
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1550274	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of TRAPPC4 mRNA	PMID:23892564
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TRAPPC4 mRNA	PMID:36331819
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1348300	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of TRAPPC4 mRNA	PMID:39836092
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1348300	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAPPC4 mRNA	PMID:35301059
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TRAPPC4 mRNA	PMID:19549813
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of TRAPPC4 protein	PMID:33236894
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550274	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRAPPC4 mRNA	PMID:31919559
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TRAPPC4 mRNA	PMID:22206623
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TRAPPC4 mRNA	PMID:40504410
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1348300	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TRAPPC4 mRNA	PMID:23557933
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRAPPC4 mRNA	PMID:17942748
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRAPPC4 mRNA	PMID:29803840
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TRAPPC4 mRNA	PMID:40504410
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550274	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRAPPC4 mRNA	PMID:22228805
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1348300	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TRAPPC4 mRNA	PMID:25258189
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550274	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRAPPC4 promoter alternative form	PMID:35295148
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550274	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TRAPPC4 mRNA	PMID:23811191
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TRAPPC4 mRNA	PMID:29275510
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TRAPPC4 mRNA	PMID:25181051|PMID:32145629
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550274	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TRAPPC4 mRNA	PMID:33221593
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550274	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TRAPPC4 mRNA	PMID:38685157
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550274	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TRAPPC4 mRNA	PMID:37019170
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348300	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRAPPC4 mRNA	PMID:37042841
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1348300	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of TRAPPC4 mRNA	PMID:39836092
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TRAPPC4 mRNA	PMID:33453195
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1348300	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAPPC4 mRNA	PMID:35301059
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TRAPPC4 mRNA	PMID:19376846
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TRAPPC4 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TRAPPC4 mRNA]	PMID:17585979
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TRAPPC4 mRNA	PMID:28302478
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1348300	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of TRAPPC4 mRNA	PMID:31626844
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TRAPPC4 mRNA	PMID:36331819
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1348300	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TRAPPC4 mRNA	PMID:25979313
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1348300	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TRAPPC4 mRNA	PMID:17183730
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550274	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TRAPPC4 mRNA	PMID:28973697
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1348300	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TRAPPC4 protein	PMID:20543569
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1348300	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TRAPPC4 mRNA	PMID:28542535
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550274	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TRAPPC4 mRNA	PMID:17562736
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TRAPPC4 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TRAPPC4 mRNA]	PMID:17585979
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TRAPPC4 mRNA	PMID:40504410
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of TRAPPC4 mRNA	PMID:36621641
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550274	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TRAPPC4 mRNA	PMID:17942748
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRAPPC4 mRNA	PMID:17942748
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1348300	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TRAPPC4 mRNA	PMID:25258189
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TRAPPC4 mRNA	PMID:35964746
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1348300	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TRAPPC4 mRNA	PMID:17183730
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TRAPPC4 protein	PMID:32959892
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1348300	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of TRAPPC4 mRNA	PMID:39836092
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TRAPPC4 mRNA	PMID:28988120
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1348300	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TRAPPC4 mRNA	PMID:31758290
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550274	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TRAPPC4 mRNA	PMID:22206623
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1348300	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TRAPPC4 mRNA	PMID:37199045
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348300	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRAPPC4 gene]	PMID:28238834
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of TRAPPC4 mRNA	PMID:21858171
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRAPPC4 mRNA	PMID:21346803
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1348300	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TRAPPC4 mRNA	PMID:38568856
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TRAPPC4 mRNA	PMID:21346803
1302991	Trappc4	trafficking protein particle complex subunit 4	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TRAPPC4 mRNA	PMID:23555832
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1617323	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of CCHCR1 mRNA	PMID:33045310
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1617323	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CCHCR1 mRNA	PMID:37995155
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1344859	E	RGD:6480464	20130806	CTD	MESH:D000431	Ethanol results in decreased expression of CCHCR1 protein	PMID:20621659
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1344859	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in increased expression of CCHCR1 mRNA	PMID:21632981
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1617323	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CCHCR1 mRNA	PMID:39241906
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of CCHCR1 mRNA	PMID:32145629
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1344859	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of CCHCR1 mRNA	PMID:31614463
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344859	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CCHCR1 mRNA	PMID:37042841
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CCHCR1 mRNA	PMID:37992649
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CCHCR1 mRNA	PMID:37992649
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1617323	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCHCR1 mRNA	PMID:34319233
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CCHCR1 mRNA	PMID:26577399
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCHCR1 mRNA	PMID:36331819
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CCHCR1 protein	PMID:34915118
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1344859	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CCHCR1 mRNA	PMID:23649840
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1344859	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CCHCR1 mRNA	PMID:23649840
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of CCHCR1 mRNA	PMID:28623178
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCHCR1 mRNA	PMID:22206623
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1344859	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CCHCR1 gene	PMID:25304211
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCHCR1 mRNA	PMID:40504410
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1344859	E	RGD:6480464	20130806	CTD	MESH:D012643	Selenium results in increased expression of CCHCR1 mRNA	PMID:19244175
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1344859	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CCHCR1 mRNA	PMID:26272509
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1344859	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCHCR1 mRNA	PMID:27188386
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CCHCR1 mRNA	PMID:31881176
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1344859	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CCHCR1 mRNA	PMID:27594783
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1617323	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCHCR1 mRNA	PMID:21570461
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCHCR1 mRNA	PMID:33387578
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1344859	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CCHCR1 mRNA	PMID:28001369
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344859	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CCHCR1 mRNA	PMID:33212167
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1344859	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CCHCR1 mRNA	PMID:23649840
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CCHCR1 mRNA	PMID:37992649
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1344859	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of CCHCR1 mRNA	PMID:34032870
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1617323	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of CCHCR1 gene	PMID:39894169
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCHCR1 mRNA	PMID:40504410
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617323	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCHCR1 mRNA	PMID:22228805
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617323	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCHCR1 gene	PMID:35295148
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CCHCR1 mRNA	PMID:23411599
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of CCHCR1 mRNA	PMID:19167457
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of CCHCR1 mRNA	PMID:32145629
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CCHCR1 mRNA	PMID:25181051|PMID:27571134|PMID:30816183|PMID:32528016
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1344859	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CCHCR1 gene	PMID:31601247
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1344859	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CCHCR1 mRNA	PMID:33670352
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CCHCR1 gene	PMID:28505145
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1344859	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of CCHCR1 mRNA	PMID:19244175
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1617323	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CCHCR1 mRNA	PMID:38685157
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1617323	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CCHCR1 mRNA	PMID:30951980
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1617323	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CCHCR1 mRNA	PMID:28392331
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1617323	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of CCHCR1 mRNA	PMID:35093514
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1344859	E	RGD:6480464	20130806	CTD	MESH:D012643	Selenium results in increased expression of CCHCR1 mRNA	PMID:19244175
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1344859	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CCHCR1 mRNA	PMID:31533062
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCHCR1 mRNA	PMID:36331819
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344859	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CCHCR1 mRNA	PMID:25979313
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1344859	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CCHCR1 mRNA	PMID:26272509|PMID:28001369
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344859	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCHCR1 mRNA	PMID:27188386
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CCHCR1 mRNA	PMID:37992649
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1344859	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of CCHCR1 mRNA	PMID:23649840
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1617323	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of CCHCR1 mRNA	PMID:17562736
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CCHCR1 mRNA	PMID:33387578
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1344859	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in increased expression of CCHCR1 mRNA	PMID:22230336
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1344859	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CCHCR1 gene	PMID:25304211
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCHCR1 mRNA	PMID:40504410
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1344859	E	RGD:6480464	20130806	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCHCR1 mRNA	PMID:22079256
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:6809	methamphetamine	affects response to substance	ISO	RGD:1344859	E	RGD:6480464	20130806	CTD	MESH:D008694	CCHCR1 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1617323	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCHCR1 mRNA	PMID:22206623
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1344859	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CCHCR1 mRNA	PMID:22079256
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1344859	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCHCR1 mRNA	PMID:22079256
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1344859	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CCHCR1 mRNA	PMID:37199045
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344859	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCHCR1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCHCR1 mRNA	PMID:27188386
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344859	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCHCR1 gene]	PMID:28238834
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of CCHCR1 mRNA	PMID:25825206
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344859	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCHCR1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCHCR1 mRNA	PMID:27188386
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CCHCR1 mRNA	PMID:21346803
1302992	Cchcr1	coiled-coil alpha-helical rod protein 1	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1344859	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of CCHCR1 mRNA	PMID:17440010
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1349135	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LY96 mRNA	PMID:38218311
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of LY96 mRNA	PMID:35967413
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20170725	CTD	MESH:D010100	LY96 results in increased susceptibility to [Oxygen deficiency co-treated with Blood Glucose deficiency]	PMID:28063877
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1349135	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of LY96 mRNA	PMID:26079696
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D000431	Ethanol results in increased expression of LY96 mRNA	PMID:28852734
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D000431	platycodin D inhibits the reaction [Ethanol results in increased expression of LY96 mRNA]	PMID:28852734
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1349135	E	RGD:6480464	20220607	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of LY96 mRNA	PMID:34581912
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1349135	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of LY96 mRNA	PMID:21632981
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16335	adenosine	increases expression	ISO	RGD:1349135	E	RGD:6480464	20120522	CTD	MESH:D000241	Adenosine results in increased expression of LY96 mRNA	PMID:21538184
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16412	lipopolysaccharide	affects binding	ISO	RGD:1349135	E	RGD:6480464	20170725	CTD	MESH:D008070	Lipopolysaccharides binds to [TLR4 protein binds to LY96 protein]; Lipopolysaccharides binds to LY96 protein	PMID:26037075|PMID:28063877
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1623303	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LY96 mRNA	PMID:39241906
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16412	lipopolysaccharide	decreases response to substance	ISO	RGD:1349135	E	RGD:6480464	20161228	CTD	MESH:D008070	LY96 exon mutant form results in decreased susceptibility to Lipopolysaccharides; LY96 protein mutant form results in decreased susceptibility to Lipopolysaccharides	PMID:16367934
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:632518337|PMID:25342286	20260203	RGD	MESH:D008070	Lipopolysaccharides increases expression of Ly96 mRNA and protein in rat lung macrophages	
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:632522753|PMID:21849156	20260219	RGD	MESH:D008070	lipopolysaccharide increases expression of Ly96 mRNA and protein in rat alveolar macrophage cell line	
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1349135	E	RGD:6480464	20230207	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LY96 mRNA	PMID:26037075
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16412	lipopolysaccharide	increases response to substance	ISO	RGD:1623303	E	RGD:6480464	20161228	CTD	MESH:D008070	LY96 protein results in increased susceptibility to Lipopolysaccharides	PMID:16367934
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20161228	CTD	MESH:D008070	1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [Lipopolysaccharides binds to LY96 protein]; [LY96 protein results in increased expression of CD14 mRNA] which results in increased susceptibility to Lipopolysaccharides; [LY96 protein results in increased expression of TLR4 mRNA] which results in increased susceptibility to Lipopolysaccharides; LY96 protein promotes the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein]; procyanidin B1 inhibits the reaction [Lipopolysaccharides results in increased expression of LY96 mRNA]	PMID:20700758|PMID:26037075|PMID:28063877
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in decreased expression of LY96 mRNA	PMID:34681664
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349135	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LY96 mRNA	PMID:37042841
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1349135	E	RGD:6480464	20210209	CTD	MESH:D001554	Benzene results in increased expression of LY96 mRNA	PMID:33064461
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20211012	CTD	MESH:D002635	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA	PMID:33819548
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16796	melatonin	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D008550	Melatonin inhibits the reaction [tetrachlorobenzoquinone results in increased expression of LY96 protein]; Melatonin inhibits the reaction [tetrachlorobenzoquinone results in increased localization of LY96 protein]; Melatonin inhibits the reaction [TLR4 protein promotes the reaction [MYD88 protein binds to LY96 protein binds to CD14 protein]]	PMID:27413111|PMID:28238930
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1349135	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of LY96 mRNA	PMID:23649840|PMID:27664576
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1349135	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LY96 mRNA	PMID:26079696
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1623303	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of LY96 mRNA	PMID:33448797
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA]	PMID:33448797
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1349135	E	RGD:6480464	20120522	CTD	MESH:D013739	Testosterone results in increased expression of LY96 mRNA	PMID:21592394
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20120522	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of LY96 mRNA	PMID:21592394
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17573	glycyrrhetinate	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20191114	CTD	MESH:C119129	Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of [TLR4 protein binds to LY96 protein]]	PMID:28213090
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1349135	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of LY96 mRNA	PMID:31256213
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17627	ferroheme b	affects binding	ISO	RGD:1623303	E	RGD:6480464	20230502	CTD	MESH:D006418	Heme binds to LY96 protein	PMID:36115635
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17627	ferroheme b	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20230502	CTD	MESH:D006418	ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Heme promotes the reaction [TLR4 protein binds to LY96 protein]]; Heme promotes the reaction [TLR4 protein binds to LY96 protein]; LY96 protein promotes the reaction [Heme results in decreased localization of NFKBIA protein]; LY96 protein promotes the reaction [Heme results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [Heme results in increased expression of IL6 protein]; LY96 protein promotes the reaction [Heme results in increased expression of TNF mRNA]; LY96 protein promotes the reaction [Heme results in increased expression of TNF protein]; LY96 protein promotes the reaction [Heme results in increased localization of RELA protein]; LY96 protein promotes the reaction [Heme results in increased phosphorylation of MAPK1 protein]; LY96 protein promotes the reaction [Heme results in increased phosphorylation of MAPK3 protein]; LY96 protein promotes the reaction [Heme results in increased phosphorylation of MAPK8 protein]	PMID:36115635
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1623303	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of LY96 mRNA	PMID:33448797
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA]	PMID:33448797
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20211012	CTD	MESH:D006000	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA	PMID:33819548
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20250708	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LY96 mRNA	PMID:35818422
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20250708	CTD	MESH:D004051	Asian ginseng inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of LY96 mRNA]	PMID:35818422
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1349135	E	RGD:6480464	20120522	CTD	MESH:D002117	Calcitriol results in increased expression of LY96 mRNA	PMID:21592394
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20120522	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of LY96 mRNA	PMID:21592394
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of LY96 mRNA	PMID:22061828
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1349135	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LY96 intron	PMID:30157460
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1349135	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of LY96 mRNA	PMID:21120746
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1349135	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LY96 mRNA	PMID:19549813
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1349135	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of LY96 mRNA	PMID:23649840
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of LY96 mRNA	PMID:21396975
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1349135	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 affects the expression of LY96 protein	PMID:20106945
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1349135	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LY96 mRNA	PMID:21632981|PMID:21641981
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1349135	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of LY96 mRNA	PMID:23649840
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1349135	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of LY96 mRNA	PMID:25102026
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:26355	heme b	affects binding	ISO	RGD:1623303	E	RGD:6480464	20230502	CTD	MESH:D006418	Heme binds to LY96 protein	PMID:36115635
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:26355	heme b	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20230502	CTD	MESH:D006418	ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Heme promotes the reaction [TLR4 protein binds to LY96 protein]]; Heme promotes the reaction [TLR4 protein binds to LY96 protein]; LY96 protein promotes the reaction [Heme results in decreased localization of NFKBIA protein]; LY96 protein promotes the reaction [Heme results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [Heme results in increased expression of IL6 protein]; LY96 protein promotes the reaction [Heme results in increased expression of TNF mRNA]; LY96 protein promotes the reaction [Heme results in increased expression of TNF protein]; LY96 protein promotes the reaction [Heme results in increased localization of RELA protein]; LY96 protein promotes the reaction [Heme results in increased phosphorylation of MAPK1 protein]; LY96 protein promotes the reaction [Heme results in increased phosphorylation of MAPK3 protein]; LY96 protein promotes the reaction [Heme results in increased phosphorylation of MAPK8 protein]	PMID:36115635
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LY96 mRNA	PMID:30779732
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27363	zinc atom	affects expression	ISO	RGD:1349135	E	RGD:6480464	20120522	CTD	MESH:D015032	Zinc affects the expression of LY96 mRNA	PMID:16979875
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1623303	E	RGD:6480464	20181016	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LY96 mRNA	PMID:29987408
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1623303	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LY96 mRNA	PMID:27339419|PMID:31919559
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20181016	CTD	MESH:D002251	[PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of LY96 mRNA	PMID:29987408
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LY96 mRNA	PMID:28752528
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1349135	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid deficiency results in increased expression of LY96 mRNA	PMID:28752528
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20211012	CTD	MESH:D006002	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA	PMID:33819548
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA	PMID:32525701
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA	PMID:40504410
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY96 mRNA	PMID:27188386
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of LY96 mRNA	PMID:31881176
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1623303	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of LY96 mRNA	PMID:30912803
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623303	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LY96 mRNA	PMID:21570461
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1349135	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of LY96 mRNA	PMID:23649840
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of LY96 mRNA	PMID:20971185
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LY96 mRNA	PMID:29803840
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1623303	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of LY96 mRNA	PMID:39631538
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D004317	[Doxorubicin co-treated with Fungal Polysaccharides] results in decreased expression of LY96 mRNA	PMID:27181935
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20211012	CTD	MESH:D003840	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA	PMID:33819548
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1349135	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of LY96 mRNA	PMID:22623647
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1623303	E	RGD:6480464	20190910	CTD	MESH:C017947	sodium arsenite results in decreased expression of LY96 mRNA	PMID:31233874
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1623303	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of LY96 gene	PMID:32068019
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349135	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of LY96 mRNA	PMID:23876855|PMID:29301061|PMID:38568856
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA	PMID:40504410
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349135	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LY96 intron	PMID:30157460
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1349135	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LY96 mRNA	PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1623303	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LY96 mRNA	PMID:22228805
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349135	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LY96 exon	PMID:27901495
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to LY96 mRNA]	PMID:32406909
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of LY96 mRNA	PMID:20971185
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:30185	zinc(0)	affects expression	ISO	RGD:1349135	E	RGD:6480464	20120522	CTD	MESH:D015032	Zinc affects the expression of LY96 mRNA	PMID:16979875
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1349135	E	RGD:6480464	20121009	CTD	MESH:D012834	Silver results in increased expression of LY96 mRNA	PMID:22342292
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1349135	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of LY96 mRNA; Silicon Dioxide results in increased expression of LY96 mRNA	PMID:25351596|PMID:25895662|PMID:34766707
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1349135	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of LY96 mRNA	PMID:26705709|PMID:27829220
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide co-treated with Bortezomib] results in increased expression of LY96 mRNA	PMID:25913414
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:30763	4-hydroxybenzoic acid	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20241203	CTD	MESH:C038193	4-hydroxybenzoic acid affects the reaction [3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid affects the reaction [lipopolysaccharide, E coli O55-B5 affects the expression of LY96 mRNA]]; 4-hydroxybenzoic acid affects the reaction [lipopolysaccharide, E coli O55-B5 affects the expression of LY96 mRNA]; 4-hydroxybenzoic acid inhibits the reaction [SPI1 protein binds to LY96 promoter]	PMID:39389441
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:30853	glycyrrhetinic acid	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20170725	CTD	MESH:C119129	Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of [TLR4 protein binds to LY96 protein]]	PMID:28213090
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20211012	CTD	MESH:D000069446	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of LY96 mRNA	PMID:33819548
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of LY96 gene	PMID:31601247
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1623303	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of LY96 mRNA	PMID:20542052
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of LY96 mRNA	PMID:16507785
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1623303	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of LY96 mRNA	PMID:23557971
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of LY96 mRNA	PMID:25380136|PMID:30723492
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1623303	E	RGD:6480464	20120522	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of LY96 mRNA	PMID:18648102
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1623303	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of LY96 mRNA	PMID:19191707
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of LY96 mRNA	PMID:38479592
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of LY96 mRNA	PMID:28329830
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:33216	bisphenol A	affects binding	ISO	RGD:1349135	E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A binds to [TLR4 protein binds to LY96 protein]	PMID:33706241
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LY96 mRNA	PMID:25181051
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1349135	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of LY96 mRNA	PMID:25047013|PMID:27685785
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of LY96 gene	PMID:31601247
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA	PMID:28628672
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1349135	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LY96 intron	PMID:30157460
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623303	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LY96 mRNA	PMID:37019170
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA	PMID:28628672
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1349135	E	RGD:6480464	20120522	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of LY96 mRNA	PMID:21527772
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20151110	CTD	MESH:C022838	nickel chloride results in increased activity of [TLR4 protein binds to LY96 protein]	PMID:25803856
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1349135	E	RGD:6480464	20220111	CTD	MESH:D010269	Paraquat results in increased expression of LY96 mRNA	PMID:34097952|PMID:34681664
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349135	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LY96 mRNA	PMID:37042841
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1349135	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of LY96 mRNA	PMID:29024780
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of LY96 mRNA	PMID:25380136
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349135	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LY96 mRNA	PMID:38174414
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1623303	E	RGD:6480464	20151215	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LY96 mRNA	PMID:26352046
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of LY96 promoter	PMID:22457795
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of LY96 mRNA	PMID:30047161
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of LY96 mRNA	PMID:24386269
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20151110	CTD	MESH:C018021	cobaltous chloride results in increased activity of [TLR4 protein binds to LY96 protein]	PMID:25803856
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of LY96 mRNA	PMID:25380136
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LY96 mRNA	PMID:24449571
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20211012	CTD	MESH:D005999	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of LY96 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA	PMID:33819548
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of LY96 mRNA	PMID:36331819
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of LY96 mRNA	PMID:17685462
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LY96 mRNA	PMID:29154799
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of LY96 mRNA	PMID:30047161
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1349135	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LY96 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131|PMID:34681664
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20211012	CTD	MESH:D016572	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of LY96 mRNA	PMID:33819548
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA	PMID:28628672
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1623303	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of LY96 mRNA	PMID:33448797
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA]	PMID:33448797
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1349135	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of LY96 mRNA	PMID:23649840
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of LY96 mRNA	PMID:17400583
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623303	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of LY96 mRNA	PMID:17562736
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of LY96 mRNA	PMID:21420995|PMID:26690555
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1623303	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of LY96 mRNA	PMID:29246445
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20211012	CTD	MESH:D000082	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA	PMID:33819548
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of LY96 mRNA]	PMID:29246445
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA	PMID:32525701
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA	PMID:40504410
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1623303	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of LY96 mRNA	PMID:35436446
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1349135	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of LY96 mRNA	PMID:32234424
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA	PMID:28628672
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1349135	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of LY96 mRNA	PMID:26705709|PMID:27829220
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide co-treated with Bortezomib] results in increased expression of LY96 mRNA	PMID:25913414
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1623303	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of LY96 mRNA	PMID:25554681
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of LY96 mRNA	PMID:30047161
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA]	PMID:33448797
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:52717	bortezomib	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20170303	CTD	MESH:D000069286	[arsenic trioxide co-treated with Bortezomib] results in increased expression of LY96 mRNA	PMID:25913414
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1623303	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LY96 mRNA	PMID:38701926
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LY96 mRNA	PMID:26378955
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:64090	tert-butyl hydroperoxide	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20170725	CTD	MESH:D020122	1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]	PMID:28063877|PMID:29111459
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1349135	E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in increased expression of LY96 mRNA	PMID:25290377
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1349135	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LY96 intron	PMID:30157460
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of LY96 mRNA	PMID:27932991
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:70436	platycodin D	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C108953	platycodin D inhibits the reaction [Ethanol results in increased expression of LY96 mRNA]	PMID:28852734
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of LY96 mRNA	PMID:31758290
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1623303	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LY96 mRNA	PMID:22206623
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:7438	N-methylformamide	affects expression	ISO	RGD:1623303	E	RGD:6480464	20120522	CTD	MESH:C002950	methylformamide affects the expression of LY96 mRNA; methylformamide analog affects the expression of LY96 mRNA	PMID:17040096
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:7494	nefazodone	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20211012	CTD	MESH:C051752	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of LY96 mRNA	PMID:33819548
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1349135	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of LY96 mRNA	PMID:29522793
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:753435	ginseng, asian	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20260714	CTD	MESH:C000713447	Asian ginseng inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of LY96 mRNA]	PMID:35818422
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1349135	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of LY96 mRNA	PMID:37199045
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:75633	procyanidin B1	affects binding	ISO	RGD:1349135	E	RGD:6480464	20230207	CTD	MESH:C479579	procyanidin B1 binds to [TLR4 protein binds to LY96 protein]	PMID:26037075
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:75633	procyanidin B1	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20230207	CTD	MESH:C479579	procyanidin B1 inhibits the reaction [Lipopolysaccharides results in increased expression of LY96 mRNA]	PMID:26037075
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY96 mRNA	PMID:27188386
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1623303	E	RGD:6480464	20120717	CTD	MESH:D010634	Phenobarbital results in increased expression of LY96 mRNA	PMID:19270015|PMID:19482888
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1623303	E	RGD:6480464	20120522	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LY96 mRNA]	PMID:19482888
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:80852	Morroniside	affects binding	ISO	RGD:1623303	E	RGD:6480464	20221004	CTD	MESH:C488401	morroniside binds to [TLR4 protein binds to LY96 protein]	PMID:34029560
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1349135	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of LY96 mRNA	PMID:26705709
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:8378	prednisolone	decreases expression	ISO	RGD:1349135	E	RGD:6480464	20151013	CTD	MESH:D011239	Prednisolone results in decreased expression of LY96 mRNA	PMID:17379860
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA	PMID:32525701
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of LY96 mRNA	PMID:30047161
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1623303	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of LY96 mRNA	PMID:40826991
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY96 mRNA	PMID:27188386
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1349135	E	RGD:6480464	20121009	CTD	MESH:D012834	Silver results in increased expression of LY96 mRNA	PMID:22342292
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:9405	tartrazine	multiple interactions	ISO	RGD:1349135	E	RGD:6480464	20211012	CTD	MESH:D013645	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA	PMID:33819548
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1623303	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of LY96 mRNA	PMID:26006729|PMID:26217789
1302993	Ly96	lymphocyte antigen 96	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1349135	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in increased expression of LY96 mRNA	PMID:25572481
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1354307	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of PA2G4 protein	PMID:39638853
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:10033	warfarin	increases expression	ISO	RGD:1332087	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in increased expression of PA2G4 mRNA	PMID:20493250
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PA2G4 mRNA]	PMID:31150632
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of PA2G4 mRNA]	PMID:19467301
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PA2G4 gene	PMID:20938992
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of PA2G4 mRNA	PMID:16054129
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PA2G4 mRNA	PMID:30529165
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1354307	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PA2G4 mRNA	PMID:21179406
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of PA2G4 protein	PMID:15221776
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1354307	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PA2G4 mRNA	PMID:21632981
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1332087	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PA2G4 mRNA	PMID:17023530
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332087	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PA2G4 mRNA	PMID:39241906
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of PA2G4 mRNA	PMID:16705744
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332087	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PA2G4 mRNA	PMID:39298647
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1354307	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PA2G4 mRNA	PMID:38568856
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PA2G4 gene	PMID:20938992
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1354307	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PA2G4 mRNA	PMID:37042841
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	increases expression	ISO	RGD:1354307	E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in increased expression of PA2G4 protein	PMID:32044396
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of PA2G4 mRNA	PMID:27683099
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:17594	hydroquinone	affects expression	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:C031927	hydroquinone affects the expression of PA2G4 protein	PMID:17181942
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of PA2G4 protein	PMID:34122009
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1354307	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PA2G4 protein	PMID:37730182
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PA2G4 protein	PMID:22061828
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20120717	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PA2G4 mRNA	PMID:19840844
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PA2G4 protein	PMID:23301498
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1354307	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PA2G4 mRNA	PMID:27153756
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PA2G4 mRNA	PMID:34911549
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PA2G4 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of PA2G4 protein	PMID:38598786
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PA2G4 mRNA	PMID:31150632
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332087	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PA2G4 mRNA	PMID:27339419|PMID:31919559
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PA2G4 mRNA]	PMID:31150632
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332087	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PA2G4 mRNA	PMID:25629700
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PA2G4 mRNA	PMID:21867686
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PA2G4 gene	PMID:20938992
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PA2G4 mRNA	PMID:40504410
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of PA2G4 mRNA	PMID:19244175
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D003513	PA2G4 protein promotes the reaction [Cycloheximide results in decreased expression of ERBB2 protein]	PMID:20379846
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of PA2G4 protein	PMID:38460933
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1354307	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PA2G4 protein	PMID:35688186
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1332087	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PA2G4 mRNA	PMID:28960355
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1332087	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of PA2G4 mRNA	PMID:21151649
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1354307	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PA2G4 mRNA	PMID:27392435
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of PA2G4 mRNA	PMID:17898221
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of PA2G4 mRNA	PMID:16705744
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332087	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PA2G4 mRNA	PMID:21570461
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1332087	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PA2G4 mRNA	PMID:24058054
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332087	E	RGD:6480464	20120717	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PA2G4 mRNA	PMID:17942748|PMID:19770486
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PA2G4 mRNA	PMID:17942748
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1354307	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PA2G4 protein	PMID:33212167
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1354307	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PA2G4 mRNA	PMID:30851411
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PA2G4 mRNA	PMID:15467011
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:156430329|PMID:28430627	20230227	RGD	MESH:D004317	doxorubicin decreases expression of Pa2g4 mRNA and protein in cardiomyocytes	
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:28971	ampicillin	increases expression	ISO	RGD:1354307	E	RGD:6480464	20121009	CTD	MESH:D000667	Ampicillin results in increased expression of PA2G4 mRNA	PMID:21632981
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PA2G4 mRNA	PMID:38568856
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1354307	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of PA2G4 mRNA	PMID:28595984|PMID:34032870
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PA2G4 mRNA	PMID:40504410
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of and results in increased activity of PA2G4 protein	PMID:30528433
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332087	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PA2G4 mRNA	PMID:19770486|PMID:20504355
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PA2G4 mRNA	PMID:27858113
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to PA2G4 mRNA]	PMID:32406909
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PA2G4 mRNA	PMID:15467011
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of PA2G4 protein	PMID:34122009
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1354307	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PA2G4 mRNA	PMID:25895662
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:3090	bicalutamide	increases response to substance	ISO	RGD:1354307	E	RGD:6480464	20161213	CTD	MESH:C053541	PA2G4 protein results in increased susceptibility to bicalutamide	PMID:15994225
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:3090	bicalutamide	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide promotes the reaction [PA2G4 protein binds to KLK3 promoter]	PMID:15994225
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PA2G4 gene	PMID:31601247
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of PA2G4 mRNA	PMID:24136188
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1332087	E	RGD:6480464	20121113	CTD	MESH:C008261	lead acetate results in decreased expression of PA2G4 mRNA	PMID:21335049
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PA2G4 mRNA	PMID:25729387
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332087	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PA2G4 gene; titanium dioxide results in decreased methylation of PA2G4 promoter	PMID:35295148
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PA2G4 mRNA	PMID:23411599|PMID:34492290
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1332087	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of PA2G4 mRNA	PMID:19191707
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1332087	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PA2G4 mRNA	PMID:28472532
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1332087	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of PA2G4 promoter	PMID:27334623
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332087	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PA2G4 mRNA	PMID:33221593
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PA2G4 mRNA; bisphenol A results in decreased expression of PA2G4 protein	PMID:33670352|PMID:34186270|PMID:37567409
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1354307	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PA2G4 gene	PMID:31601247
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PA2G4 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PA2G4 gene	PMID:31601247
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of PA2G4 mRNA	PMID:19244175
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:33418	graphite	increases expression	ISO	RGD:1354307	E	RGD:6480464	20120918	CTD	MESH:D006108	Graphite results in increased expression of PA2G4 protein	PMID:22157353
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332087	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PA2G4 mRNA	PMID:39298647
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1354307	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PA2G4 protein	PMID:34186270
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PA2G4 mRNA	PMID:27858113
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1354307	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PA2G4 protein	PMID:34186270
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1354307	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PA2G4 protein	PMID:34186270
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1332087	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PA2G4 mRNA	PMID:37019170
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PA2G4 mRNA	PMID:17602206
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PA2G4 mRNA	PMID:21266533
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332087	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PA2G4 mRNA	PMID:17361019|PMID:21266533
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1332087	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of PA2G4 mRNA	PMID:34813904
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PA2G4 protein	PMID:38598786
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1332087	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of PA2G4 mRNA	PMID:34813904
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PA2G4 mRNA	PMID:17602206
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of PA2G4 mRNA	PMID:32680482
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:35004	Tetrachlorobisphenol A	affects expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C041181	tetrachlorodian affects the expression of PA2G4 mRNA	PMID:37992829
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:35004	Tetrachlorobisphenol A	increases expression	ISO	RGD:1332087	E	RGD:6480464	20241001	CTD	MESH:C041181	tetrachlorodian results in increased expression of PA2G4 mRNA	PMID:37992829
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:35004	Tetrachlorobisphenol A	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20241001	CTD	MESH:C041181	Wortmannin inhibits the reaction [tetrachlorodian results in increased expression of PA2G4 mRNA]	PMID:37992829
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:35176	zinc sulfate	affects expression	ISO	RGD:1354307	E	RGD:6480464	20150127	CTD	MESH:D019287	Zinc Sulfate affects the expression of PA2G4 protein	PMID:25162517
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20120717	CTD	MESH:D019256	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PA2G4 mRNA	PMID:19840844
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PA2G4 mRNA	PMID:19376846
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of PA2G4 mRNA	PMID:19244175
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D015741	PA2G4 protein inhibits the reaction [Cyproterone Acetate promotes the reaction [Metribolone results in increased expression of AR mRNA]]; PA2G4 protein inhibits the reaction [Metribolone results in increased expression of AR mRNA]	PMID:15994225
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PA2G4 mRNA	PMID:31533062
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of PA2G4 mRNA	PMID:26352163
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PA2G4 mRNA	PMID:25993096
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332087	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PA2G4 mRNA	PMID:17292431
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of PA2G4 mRNA	PMID:41580965
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:40303	lovastatin	increases expression	ISO	RGD:1332087	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in increased expression of PA2G4 mRNA	PMID:20493250
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1332087	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in decreased expression of PA2G4 mRNA	PMID:25270620
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1354307	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PA2G4 mRNA	PMID:25562108
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1332087	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PA2G4 mRNA	PMID:17555576
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:41774	tamoxifen	increases response to substance	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D013629	PA2G4 protein results in increased susceptibility to Tamoxifen	PMID:20379846
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D013629	ERBB2 protein inhibits the reaction [PA2G4 protein results in increased susceptibility to Tamoxifen]	PMID:20379846
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of PA2G4 mRNA	PMID:36621641
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PA2G4 mRNA	PMID:24136188
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of PA2G4 protein	PMID:38460933
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PA2G4 mRNA	PMID:40504410
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1354307	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of PA2G4 protein	PMID:31195006
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1332087	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PA2G4 mRNA	PMID:17555576|PMID:17942748
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PA2G4 mRNA	PMID:17942748
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of PA2G4 mRNA	PMID:15585362
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332087	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PA2G4 mRNA; Nanotubes, Carbon results in increased expression of PA2G4 mRNA	PMID:25554681
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1354307	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PA2G4 protein	PMID:22157353
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PA2G4 mRNA	PMID:24136188
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:50743	cyproterone acetate	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D017373	PA2G4 protein inhibits the reaction [Cyproterone Acetate promotes the reaction [Metribolone results in increased expression of AR mRNA]]; PA2G4 protein inhibits the reaction [Cyproterone Acetate results in increased expression of AR mRNA]	PMID:15994225
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PA2G4 mRNA	PMID:35964746
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PA2G4 mRNA	PMID:19299419|PMID:24136188
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PA2G4 mRNA	PMID:27858113
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PA2G4 mRNA	PMID:27858113
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1332087	E	RGD:6480464	20241001	CTD	MESH:C009687	Wortmannin inhibits the reaction [tetrachlorodian results in increased expression of PA2G4 mRNA]	PMID:37992829
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1332087	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PA2G4 mRNA	PMID:19042947
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PA2G4 protein	PMID:32959892
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of PA2G4 mRNA	PMID:19606018
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PA2G4 mRNA	PMID:25729387
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:64153	tanespimycin	increases expression	ISO	RGD:1354307	E	RGD:6480464	20200804	CTD	MESH:C112765	tanespimycin analog results in increased expression of PA2G4 protein; tanespimycin results in increased expression of PA2G4 protein	PMID:31370342
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:64153	tanespimycin	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20200804	CTD	MESH:C112765	[tanespimycin co-treated with VER 155008] results in increased expression of PA2G4 protein	PMID:31370342
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1332087	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of PA2G4 mRNA	PMID:27462272
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1354307	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PA2G4 mRNA; bisphenol AF results in increased expression of PA2G4 protein	PMID:34186270|PMID:36190352
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PA2G4 mRNA	PMID:24136188
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1332087	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of PA2G4 mRNA	PMID:27858113
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1354307	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of PA2G4 protein	PMID:31285264
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1354307	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PA2G4 protein	PMID:39638853
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of PA2G4 mRNA	PMID:21346803
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1354307	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PA2G4 mRNA	PMID:30851411
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PA2G4 gene]	PMID:28238834
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1332087	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PA2G4 mRNA	PMID:23091169
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of PA2G4 protein	PMID:19954255
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1332087	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PA2G4 mRNA	PMID:30294300
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:8249	piroxicam	increases expression	ISO	RGD:1354307	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of PA2G4 mRNA	PMID:21858171
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PA2G4 mRNA	PMID:24780913
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PA2G4 mRNA	PMID:21346803
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:9381	T-2 toxin	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of PA2G4 protein	PMID:26141394
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1354307	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PA2G4 mRNA	PMID:38568856
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1354307	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of PA2G4 protein	PMID:38598786
1302994	Pa2g4	proliferation-associated 2G4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PA2G4 mRNA	PMID:21346803
1302995	Smgc	submandibular gland protein C	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003300	Copper deficiency results in increased expression of SMGC mRNA	PMID:26033743
1302995	Smgc	submandibular gland protein C	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of SMGC mRNA	PMID:26033743
1302995	Smgc	submandibular gland protein C	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003300	Copper deficiency results in increased expression of SMGC mRNA	PMID:26033743
1302995	Smgc	submandibular gland protein C	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of SMGC mRNA	PMID:26033743
1302995	Smgc	submandibular gland protein C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of SMGC mRNA	PMID:25181051
1302995	Smgc	submandibular gland protein C	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C017690	fenvalerate results in increased expression of SMGC mRNA	PMID:30307764
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of C20H6ORF136 mRNA	PMID:32145629
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of C20H6ORF136 mRNA	PMID:33387578
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348259	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of C6ORF136 mRNA	PMID:37042841
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1348259	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of C6ORF136 mRNA	PMID:33359661
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1348259	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of C6ORF136 gene	PMID:25304211
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1348259	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C6ORF136 mRNA	PMID:39836092
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of C20H6ORF136 mRNA	PMID:21215274
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of C20H6ORF136 mRNA	PMID:33387578
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1348259	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of C6ORF136 mRNA	PMID:33212167
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1348259	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of C6ORF136 mRNA	PMID:34032870
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1348259	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C6ORF136 mRNA	PMID:39836092
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348259	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of C6ORF136 promoter	PMID:27901495
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1348259	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of C6ORF136 mRNA	PMID:19150397|PMID:20382639
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of C20H6ORF136 mRNA	PMID:34492290
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of C6ORF136 mRNA	PMID:25181051
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1348259	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C6ORF136 mRNA	PMID:28628672
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1348259	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C6ORF136 mRNA	PMID:28628672
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348259	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of C6ORF136 mRNA	PMID:37042841
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of C20H6ORF136 mRNA	PMID:30589522
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of C20H6ORF136 promoter	PMID:22457795
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1348259	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of C6ORF136 mRNA	PMID:24449571
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1348259	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of C6ORF136 mRNA	PMID:25979313
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1348259	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of C6ORF136 mRNA	PMID:23179753|PMID:29154799
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1348259	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of C6ORF136 mRNA	PMID:20106945
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1348259	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of C6ORF136 mRNA	PMID:25562108
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1348259	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C6ORF136 mRNA	PMID:28628672
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1348259	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of C6ORF136 mRNA	PMID:22230336
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of C20H6ORF136 mRNA	PMID:33387578
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1348259	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of C6ORF136 gene	PMID:25304211
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1348259	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C6ORF136 mRNA	PMID:39836092
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1348259	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C6ORF136 mRNA	PMID:28628672
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1348259	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of C6ORF136 mRNA	PMID:31758290
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:748572	acyline	increases expression	ISO	RGD:1348259	E	RGD:6480464	20260714	CTD	MESH:C109238	acyline results in increased expression of C6ORF136 mRNA	PMID:17510436
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1348259	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of C6ORF136 mRNA	PMID:29301935
1302996	C20h6orf136	similar to human chromosome 6 open reading frame 136	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1348259	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of C6ORF136 mRNA	PMID:27188386
1302997	Stfa3l1	stefin A3-like 1	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of STFA3L1 mRNA	PMID:30779732
1302997	Stfa3l1	stefin A3-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STFA3L1 mRNA	PMID:25181051
1302997	Stfa3l1	stefin A3-like 1	gene	CHEBI:6456	lidocaine	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in decreased expression of STFA3L1 mRNA	PMID:35283115
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1349132	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of MRPS18B mRNA	PMID:31863870
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552294	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MRPS18B mRNA	PMID:33045310
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552294	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPS18B mRNA	PMID:30529165
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1349132	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPS18B mRNA	PMID:22378314
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552294	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MRPS18B mRNA	PMID:30319688
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552294	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPS18B mRNA	PMID:39241906
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1349132	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS18B mRNA	PMID:31059760
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1552294	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MRPS18B mRNA]	PMID:39241906
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1552294	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of MRPS18B mRNA	PMID:15598610
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552294	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MRPS18B mRNA	PMID:39298647
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of MRPS18B mRNA	PMID:26496021
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MRPS18B mRNA	PMID:33387578
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349132	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPS18B mRNA	PMID:37042841
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	EXP		E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of MRPS18B gene	PMID:33923623
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MRPS18B promoter	PMID:23359474
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1349132	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MRPS18B protein	PMID:37730182
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MRPS18B mRNA	PMID:33387578
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552294	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS18B mRNA	PMID:36331819
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1349132	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRPS18B mRNA	PMID:19549813
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1349132	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of MRPS18B mRNA	PMID:12884408
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552294	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MRPS18B mRNA	PMID:34911549
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of MRPS18B mRNA	PMID:18355885
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:2666	amitriptyline	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000639	Amitriptyline affects the expression of MRPS18B mRNA	PMID:18355885
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MRPS18B mRNA	PMID:31150632
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPS18B mRNA	PMID:33854195
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1552294	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MRPS18B mRNA	PMID:22610192
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1552294	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in decreased expression of MRPS18B mRNA	PMID:12540486
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552294	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPS18B mRNA	PMID:21570461
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPS18B mRNA	PMID:32109520
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPS18B mRNA	PMID:33387578
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of MRPS18B mRNA	PMID:28374803
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1349132	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MRPS18B mRNA	PMID:33212167
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1552294	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of MRPS18B mRNA	PMID:30807115
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1349132	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MRPS18B mRNA	PMID:29803840
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349132	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPS18B mRNA	PMID:38568856
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349132	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MRPS18B mRNA	PMID:22714537
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1349132	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of MRPS18B mRNA	PMID:22378314|PMID:29453283
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349132	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MRPS18B 3' UTR	PMID:27901495
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1552294	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of MRPS18B protein	PMID:37955338
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of MRPS18B mRNA	PMID:24136188
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552294	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MRPS18B promoter alternative form	PMID:35295148
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552294	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MRPS18B mRNA	PMID:23557971
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1552294	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MRPS18B mRNA	PMID:18648102
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPS18B mRNA	PMID:22484513
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552294	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MRPS18B mRNA	PMID:28472532
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1349132	E	RGD:6480464	20170516	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of MRPS18B mRNA	PMID:27793765
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552294	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPS18B mRNA	PMID:32156529|PMID:33221593
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPS18B mRNA	PMID:25181051
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MRPS18B promoter; [bisphenol A co-treated with Estradiol] results in decreased expression of MRPS18B mRNA	PMID:23359474|PMID:26496021
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552294	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPS18B mRNA	PMID:39298647
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1349132	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of MRPS18B protein	PMID:34186270
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1349132	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS18B mRNA	PMID:28628672
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1349132	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MRPS18B protein	PMID:34186270
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552294	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MRPS18B mRNA	PMID:37019170
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPS18B mRNA	PMID:33854195
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MRPS18B mRNA	PMID:17602206
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MRPS18B promoter	PMID:23359474
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1349132	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS18B mRNA	PMID:28628672
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1552294	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of MRPS18B mRNA	PMID:34813904
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MRPS18B mRNA	PMID:17602206
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MRPS18B mRNA	PMID:32680482
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1552294	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MRPS18B mRNA]	PMID:39241906
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349132	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MRPS18B mRNA	PMID:37042841
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of MRPS18B promoter	PMID:22457795
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552294	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MRPS18B mRNA	PMID:28903501
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552294	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS18B mRNA	PMID:36331819
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of MRPS18B mRNA	PMID:25993096
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552294	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MRPS18B mRNA	PMID:17292431
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPS18B mRNA	PMID:33854195
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552294	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MRPS18B mRNA	PMID:17555576
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1349132	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS18B mRNA	PMID:28628672
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MRPS18B mRNA	PMID:24136188
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1349132	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MRPS18B mRNA	PMID:38832940
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1349132	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of MRPS18B protein	PMID:15907983
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPS18B mRNA	PMID:33854195
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1349132	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MRPS18B mRNA	PMID:28542535
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349132	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPS18B mRNA	PMID:21420995|PMID:25704631|PMID:31059760
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPS18B mRNA	PMID:33387578
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1349132	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS18B mRNA	PMID:31059760
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:47499	imipramine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007099	Imipramine affects the expression of MRPS18B mRNA	PMID:18355885
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:47519	ketoconazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007654	Ketoconazole affects the expression of MRPS18B mRNA	PMID:18355885
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:47780	clomipramine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002997	Clomipramine affects the expression of MRPS18B mRNA	PMID:18355885
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of MRPS18B mRNA	PMID:29391264
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552294	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MRPS18B mRNA	PMID:35436446
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:4811	epoxiconazole	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C109476	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MRPS18B mRNA	PMID:29038839
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552294	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MRPS18B mRNA	PMID:17555576
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1349132	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS18B mRNA	PMID:28628672
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552294	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MRPS18B mRNA; Nanotubes, Carbon results in increased expression of MRPS18B mRNA	PMID:25554681|PMID:25620056
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPS18B mRNA	PMID:24136188
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPS18B mRNA	PMID:24136188
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1349132	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MRPS18B mRNA	PMID:22714537
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPS18B mRNA	PMID:33854195
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349132	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MRPS18B protein	PMID:32959892
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of MRPS18B mRNA	PMID:24136188
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of MRPS18B mRNA	PMID:28935588
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1552294	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MRPS18B mRNA	PMID:31052254
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1349132	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MRPS18B mRNA	PMID:31758290
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1349132	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MRPS18B protein	PMID:34186270
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1552294	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of MRPS18B mRNA	PMID:22206623
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1349132	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MRPS18B protein	PMID:37664457
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MRPS18B mRNA	PMID:24136188
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1349132	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MRPS18B mRNA	PMID:22714537
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of MRPS18B mRNA	PMID:21346803
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1552294	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MRPS18B mRNA	PMID:31388691
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552294	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of MRPS18B mRNA	PMID:30294300
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:81758	cyproconazole	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C093628	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MRPS18B mRNA	PMID:29038839
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:8434	prochloraz	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C045362	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MRPS18B mRNA	PMID:29038839
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1552294	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MRPS18B mRNA]	PMID:39241906
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349132	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MRPS18B protein	PMID:37664457
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRPS18B mRNA	PMID:21346803
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1349132	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MRPS18B mRNA	PMID:38568856
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1349132	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of MRPS18B mRNA	PMID:22378314
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1552294	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in decreased expression of MRPS18B mRNA	PMID:19363144
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:9763	trovafloxacin	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of MRPS18B mRNA	PMID:24136188
1302998	Mrps18b	mitochondrial ribosomal protein S18B	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1552294	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of MRPS18B mRNA	PMID:35537566
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1617542	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of LY6G6C mRNA	PMID:37995155
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1617542	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of LY6G6C mRNA	PMID:20188158
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of LY6G6C mRNA	PMID:33387578
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1344908	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of LY6G6C mRNA	PMID:33647349
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LY6G6C mRNA	PMID:33387578
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of LY6G6C mRNA	PMID:20409345
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1344908	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of LY6G6C mRNA	PMID:24376830
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LY6G6C mRNA	PMID:39012411
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1617542	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of LY6G6C mRNA	PMID:33026818
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1617542	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LY6G6C mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LY6G6C mRNA	PMID:34911549
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LY6G6C mRNA	PMID:30779732
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1617542	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LY6G6C mRNA	PMID:25629700
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1617542	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of LY6G6C mRNA	PMID:22206623
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1344908	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LY6G6C mRNA	PMID:32525701
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344908	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LY6G6C mRNA	PMID:23557933
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1344908	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of LY6G6C mRNA	PMID:27392435
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1344908	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of LY6G6C mRNA	PMID:27392435
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LY6G6C mRNA	PMID:32109520
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1617542	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LY6G6C mRNA	PMID:17035482
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1617542	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LY6G6C mRNA	PMID:17942748
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344908	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LY6G6C mRNA	PMID:33212167
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1344908	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LY6G6C mRNA	PMID:32763439
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of LY6G6C mRNA	PMID:26033743
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344908	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of LY6G6C mRNA	PMID:21457566
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1617542	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LY6G6C mRNA	PMID:34876320
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1617542	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LY6G6C mRNA	PMID:34876320
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of LY6G6C mRNA	PMID:26033743
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1617542	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LY6G6C mRNA	PMID:27131904
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1617542	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of LY6G6C mRNA	PMID:21829687
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of LY6G6C mRNA	PMID:25729387
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1617542	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LY6G6C mRNA	PMID:28472532
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LY6G6C mRNA	PMID:25181051
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1344908	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LY6G6C gene	PMID:31601247
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:33418	graphite	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of LY6G6C mRNA	PMID:29933104
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1617542	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of LY6G6C gene	PMID:31683443
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of LY6G6C mRNA	PMID:30723492
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of LY6G6C promoter	PMID:22457795
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LY6G6C mRNA	PMID:39012411
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1617542	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LY6G6C mRNA	PMID:40194260
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1617542	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of LY6G6C mRNA	PMID:28973697
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1344908	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of LY6G6C mRNA	PMID:22230336
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1344908	E	RGD:6480464	20120412	CTD	MESH:D005472	LY6G6C protein affects the susceptibility to Fluorouracil	PMID:16217747
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1344908	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of LY6G6C mRNA	PMID:25351596
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1344908	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LY6G6C mRNA	PMID:32525701
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LY6G6C mRNA	PMID:29391264
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1617542	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LY6G6C mRNA	PMID:34876320
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1344908	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of LY6G6C mRNA	PMID:18175754
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1617542	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LY6G6C mRNA	PMID:17942748
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1617542	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LY6G6C mRNA	PMID:17942748
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1617542	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of LY6G6C mRNA; Nanotubes, Carbon analog affects the expression of LY6G6C mRNA	PMID:25554681
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1344908	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LY6G6C mRNA	PMID:31629900
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of LY6G6C mRNA	PMID:25729387
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1617542	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of LY6G6C mRNA	PMID:22206623
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in increased expression of LY6G6C mRNA	PMID:30449730
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344908	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LY6G6C gene]	PMID:28238834
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of LY6G6C mRNA	PMID:32109520
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1344908	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LY6G6C mRNA	PMID:32525701
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1617542	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LY6G6C mRNA	PMID:34876320
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of LY6G6C mRNA	PMID:24780913
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1617542	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LY6G6C mRNA	PMID:27131904
1302999	Ly6g6c	lymphocyte antigen 6 family member G6C	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of LY6G6C mRNA	PMID:23869203
1303000	Cdh15	cadherin 15	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552311	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CDH15 mRNA	PMID:36331819
1303000	Cdh15	cadherin 15	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1353127	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CDH15 mRNA	PMID:26079696
1303000	Cdh15	cadherin 15	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1353127	E	RGD:6480464	20210706	CTD	MESH:D019308	Palmitic Acid results in increased expression of CDH15 mRNA	PMID:32347412
1303000	Cdh15	cadherin 15	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1353127	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of CDH15 mRNA	PMID:30510588
1303000	Cdh15	cadherin 15	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CDH15 mRNA	PMID:32741896
1303000	Cdh15	cadherin 15	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CDH15 mRNA	PMID:33387578
1303000	Cdh15	cadherin 15	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1353127	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CDH15 mRNA	PMID:26079696
1303000	Cdh15	cadherin 15	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CDH15 mRNA	PMID:32741896
1303000	Cdh15	cadherin 15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1552311	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of CDH15 gene	PMID:38833407
1303000	Cdh15	cadherin 15	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1353127	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CDH15 mRNA	PMID:36139627
1303000	Cdh15	cadherin 15	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1353127	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CDH15 mRNA	PMID:28818685
1303000	Cdh15	cadherin 15	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552311	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDH15 mRNA	PMID:36331819
1303000	Cdh15	cadherin 15	gene	CHEBI:211249	Ampullosporin	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C109004	[ampullosporin co-treated with Ketamine] results in increased expression of CDH15 mRNA	PMID:16635253
1303000	Cdh15	cadherin 15	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1353127	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CDH15 mRNA	PMID:19549813
1303000	Cdh15	cadherin 15	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1353127	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CDH15 mRNA	PMID:21641981
1303000	Cdh15	cadherin 15	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1552311	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CDH15 mRNA	PMID:15674843
1303000	Cdh15	cadherin 15	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1353127	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of CDH15 mRNA	PMID:19774075
1303000	Cdh15	cadherin 15	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552311	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CDH15 mRNA	PMID:25629700
1303000	Cdh15	cadherin 15	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1353127	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CDH15 mRNA	PMID:23557933
1303000	Cdh15	cadherin 15	gene	CHEBI:27889	lead(0)	decreases methylation	ISO	RGD:1552311	E	RGD:6480464	20250311	CTD	MESH:D007854	Lead results in decreased methylation of CDH15 gene	PMID:38833407
1303000	Cdh15	cadherin 15	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of CDH15 mRNA	PMID:19013527
1303000	Cdh15	cadherin 15	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552311	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of CDH15 mRNA	PMID:37682722
1303000	Cdh15	cadherin 15	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1353127	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of CDH15 mRNA	PMID:22378314
1303000	Cdh15	cadherin 15	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353127	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDH15 promoter	PMID:27901495
1303000	Cdh15	cadherin 15	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1353127	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CDH15 gene	PMID:25435355
1303000	Cdh15	cadherin 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552311	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDH15 enhancer	PMID:35295148
1303000	Cdh15	cadherin 15	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552311	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CDH15 enhancer	PMID:35295148
1303000	Cdh15	cadherin 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDH15 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303000	Cdh15	cadherin 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353127	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CDH15 mRNA	PMID:33670352
1303000	Cdh15	cadherin 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552311	E	RGD:6480464	20220809	CTD	MESH:C006780	bisphenol A results in decreased expression of CDH15 mRNA	PMID:34850234
1303000	Cdh15	cadherin 15	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CDH15 gene	PMID:28505145
1303000	Cdh15	cadherin 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552311	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CDH15 gene	PMID:31683443
1303000	Cdh15	cadherin 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552311	E	RGD:6480464	20220809	CTD	MESH:C543008	bisphenol S results in decreased expression of CDH15 mRNA	PMID:34850234
1303000	Cdh15	cadherin 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552311	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CDH15 mRNA	PMID:30951980
1303000	Cdh15	cadherin 15	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1353127	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CDH15 mRNA	PMID:29024780
1303000	Cdh15	cadherin 15	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CDH15 mRNA	PMID:35163327
1303000	Cdh15	cadherin 15	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1353127	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CDH15 mRNA	PMID:38568856
1303000	Cdh15	cadherin 15	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CDH15 mRNA	PMID:35163327
1303000	Cdh15	cadherin 15	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552311	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CDH15 mRNA	PMID:28903501
1303000	Cdh15	cadherin 15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552311	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDH15 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CDH15 mRNA	PMID:36331819
1303000	Cdh15	cadherin 15	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1353127	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CDH15 gene	PMID:29154799
1303000	Cdh15	cadherin 15	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1353127	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CDH15 mRNA	PMID:38832940
1303000	Cdh15	cadherin 15	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1353127	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CDH15 mRNA	PMID:28542535
1303000	Cdh15	cadherin 15	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552311	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CDH15 mRNA	PMID:19042947
1303000	Cdh15	cadherin 15	gene	CHEBI:6121	ketamine	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D007649	[ampullosporin co-treated with Ketamine] results in increased expression of CDH15 mRNA	PMID:16635253
1303000	Cdh15	cadherin 15	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1353127	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CDH15 mRNA	PMID:36139627
1303000	Cdh15	cadherin 15	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CDH15 mRNA	PMID:32741896
1303000	Cdh15	cadherin 15	gene	CHEBI:77012	methylseleninic acid	increases expression	ISO	RGD:1353127	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of CDH15 mRNA	PMID:12517777
1303000	Cdh15	cadherin 15	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CDH15 mRNA	PMID:32109520
1303000	Cdh15	cadherin 15	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1552311	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of CDH15 mRNA	PMID:18958704
1303000	Cdh15	cadherin 15	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1353127	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of CDH15 mRNA	PMID:26079696
1303000	Cdh15	cadherin 15	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CDH15 mRNA	PMID:24780913
1303000	Cdh15	cadherin 15	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CDH15 mRNA	PMID:19281266
1303000	Cdh15	cadherin 15	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1353127	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of CDH15 mRNA	PMID:22378314
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623846	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of POFUT1 mRNA	PMID:33045310
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1623846	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POFUT1 mRNA	PMID:39241906
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1623846	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of POFUT1 mRNA	PMID:33711761
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of POFUT1 mRNA	PMID:33387578
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348314	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of POFUT1 mRNA	PMID:37042841
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1348314	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of POFUT1 mRNA	PMID:18037150
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1348314	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of POFUT1 mRNA	PMID:21179406
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1348314	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of POFUT1 mRNA	PMID:16002434
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623846	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of POFUT1 mRNA	PMID:36331819
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1348314	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POFUT1 mRNA	PMID:19549813
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1348314	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of POFUT1 protein	PMID:23301498
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1348314	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of POFUT1 gene	PMID:27153756
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of POFUT1 mRNA	PMID:30779732
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POFUT1 mRNA	PMID:31150632
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1623846	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of POFUT1 mRNA	PMID:25629700
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of POFUT1 mRNA	PMID:31881176
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1348314	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of POFUT1 protein	PMID:20884965
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1348314	E	RGD:6480464	20121113	CTD	MESH:D019833	ESR1 promotes the reaction [Genistein results in decreased expression of POFUT1 protein]	PMID:20884965
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623846	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POFUT1 mRNA	PMID:21570461
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1348314	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of POFUT1 mRNA	PMID:38568856
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1348314	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of POFUT1 mRNA	PMID:34032870
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1623846	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of POFUT1 mRNA	PMID:22228805
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1348314	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of POFUT1 mRNA	PMID:25351596
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1623846	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of POFUT1 mRNA	PMID:18648102
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1348314	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of POFUT1 mRNA	PMID:19710929
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of POFUT1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of POFUT1 mRNA	PMID:32145629
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1348314	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of POFUT1 protein	PMID:33376534|PMID:34186270|PMID:37567409
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of POFUT1 gene	PMID:28505145
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1623846	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of POFUT1 promoter	PMID:27312807
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1348314	E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in increased expression of POFUT1 protein]	PMID:33376534
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348314	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of POFUT1 mRNA	PMID:37042841
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348314	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of POFUT1 mRNA	PMID:38174414
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1348314	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of POFUT1 mRNA	PMID:26352163
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623846	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of POFUT1 mRNA	PMID:36331819
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1348314	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of POFUT1 gene	PMID:29154799
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1623846	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of POFUT1 mRNA	PMID:28973697
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of POFUT1 mRNA	PMID:21346803
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of POFUT1 mRNA	PMID:33387578
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1348314	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of POFUT1 mRNA	PMID:29523930
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1623846	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of POFUT1 mRNA	PMID:25554681
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1623846	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of POFUT1 mRNA	PMID:25554681
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1348314	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of POFUT1 protein	PMID:32959892
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:68534	enzalutamide	affects expression	ISO	RGD:1348314	E	RGD:6480464	20210608	CTD	MESH:C540278	enzalutamide affects the expression of POFUT1 mRNA	PMID:30940724
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1348314	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of POFUT1 protein	PMID:37664457
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of POFUT1 mRNA	PMID:24780913
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1348314	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of POFUT1 protein	PMID:37664457
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1348314	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of POFUT1 mRNA	PMID:38568856
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of POFUT1 mRNA	PMID:21346803
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of POFUT1 mRNA	PMID:23555832
1303001	Pofut1	protein O-fucosyltransferase 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of POFUT1 gene	PMID:31079544
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1350505	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of COPS3 protein]	PMID:38195004
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1350505	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of COPS3 mRNA	PMID:33167477
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1350505	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of COPS3 mRNA	PMID:22378314
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550334	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of COPS3 mRNA	PMID:30319688
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1350505	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COPS3 mRNA	PMID:29432896
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550334	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of COPS3 mRNA	PMID:39241906
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1350505	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of COPS3 protein	PMID:20109541
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550334	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of COPS3 mRNA	PMID:20463053
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550334	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of COPS3 mRNA	PMID:33754040
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1350505	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Clozapine] results in decreased expression of COPS3 protein; [Cuprizone co-treated with Haloperidol] results in decreased expression of COPS3 protein	PMID:34122009
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1350505	E	RGD:6480464	20221101	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of COPS3 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COPS3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of COPS3 protein	PMID:35301059|PMID:38195004
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1350505	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of COPS3 mRNA	PMID:23649840
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1350505	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of COPS3 mRNA	PMID:15672453
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550334	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of COPS3 mRNA]	PMID:22206623
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1350505	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of COPS3 protein	PMID:35688186
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1350505	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of COPS3 mRNA	PMID:12002526
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1350505	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of COPS3 mRNA	PMID:27594783
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1550334	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of COPS3 mRNA	PMID:30912803
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1350505	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COPS3 mRNA	PMID:22574217
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550334	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COPS3 mRNA	PMID:21570461
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550334	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COPS3 mRNA	PMID:17942748
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550334	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of COPS3 protein	PMID:28918527
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1350505	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of COPS3 protein	PMID:29385562
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1350505	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of COPS3 promoter	PMID:27901495
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of COPS3 mRNA	PMID:30047161
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550334	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of COPS3 mRNA	PMID:23811191
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:3312	calcium dichloride	increases expression	ISO	RGD:1350505	E	RGD:6480464	20150609	CTD	MESH:D002122	Calcium Chloride results in increased expression of COPS3 protein	PMID:25824407
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1350505	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of COPS3 mRNA	PMID:29275510
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1350505	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of COPS3 gene	PMID:31601247
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COPS3 mRNA	PMID:25181051
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1350505	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of COPS3 protein	PMID:34186270
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550334	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of COPS3 mRNA	PMID:39298647
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1350505	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of COPS3 protein	PMID:34186270
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550334	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of COPS3 mRNA	PMID:34813904
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1550334	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of COPS3 mRNA	PMID:34813904
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350505	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COPS3 mRNA	PMID:37042841
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1350505	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of COPS3 mRNA	PMID:38568856
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1350505	E	RGD:6480464	20221101	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of COPS3 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COPS3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of COPS3 protein	PMID:35301059|PMID:38195004
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of COPS3 mRNA	PMID:30047161
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:3766	clozapine	multiple interactions	ISO	RGD:1350505	E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in decreased expression of COPS3 protein	PMID:34122009
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1350505	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of COPS3 mRNA	PMID:28302478
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350505	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COPS3 mRNA	PMID:25979313
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550334	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of COPS3 mRNA	PMID:17292431
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of COPS3 mRNA	PMID:30047161
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1350505	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of COPS3 mRNA	PMID:25562108
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550334	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of COPS3 mRNA	PMID:35436446
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1350505	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of COPS3 mRNA	PMID:18175754
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550334	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COPS3 mRNA	PMID:17942748
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550334	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of COPS3 mRNA; Nanotubes, Carbon results in increased expression of COPS3 mRNA	PMID:25554681
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of COPS3 mRNA	PMID:30047161
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:5613	haloperidol	multiple interactions	ISO	RGD:1350505	E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in decreased expression of COPS3 protein	PMID:34122009
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1350505	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COPS3 protein	PMID:32959892
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550334	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of COPS3 mRNA	PMID:23650126
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1550334	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of COPS3 mRNA	PMID:22078008
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1550334	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of COPS3 mRNA	PMID:22078008
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:64317	isoprenaline	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of COPS3 mRNA	PMID:30303030
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550334	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of COPS3 mRNA	PMID:22206623
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550334	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of COPS3 mRNA]	PMID:22206623
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1350505	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of COPS3 protein	PMID:37664457
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1350505	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of COPS3 protein	PMID:31285264
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1350505	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of COPS3 protein	PMID:39638853
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1350505	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of COPS3 mRNA	PMID:21858171
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of COPS3 mRNA	PMID:30047161
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1550334	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of COPS3 protein	PMID:35357534
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1350505	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of COPS3 protein	PMID:37664457
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of COPS3 mRNA	PMID:21346803
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of COPS3 mRNA	PMID:21346803
1303002	Cops3	COP9 signalosome subunit 3	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of COPS3 mRNA	PMID:23869203
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1343023	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of GATD3 mRNA	PMID:11906190
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GATD3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GATD3 mRNA	PMID:32699268
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of GATD3 mRNA	PMID:22378314
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1616812	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GATD3A mRNA	PMID:39298647
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of GATD3A protein	PMID:32145629
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1343023	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GATD3A mRNA	PMID:37042841
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GATD3 mRNA	PMID:28818685
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GATD3 mRNA	PMID:35301059
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1616812	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GATD3A mRNA	PMID:37236586
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GATD3 mRNA	PMID:19549813
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1343023	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GATD3 intron	PMID:30157460
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of GATD3 mRNA	PMID:23649840
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GATD3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GATD3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of GATD3 mRNA	PMID:32699268
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:2654	aminoglutethimide	increases expression	ISO	RGD:1343023	E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in increased expression of GATD3 protein	PMID:26102013
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GATD3A mRNA	PMID:31150632
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1616812	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GATD3A mRNA	PMID:31919559
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616812	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of GATD3A mRNA	PMID:22206623
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GATD3 mRNA	PMID:39836092
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1616812	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GATD3A mRNA	PMID:40504410
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA	PMID:33854195
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of GATD3A mRNA	PMID:31881176
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GATD3 mRNA	PMID:23557933
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GATD3A mRNA	PMID:21215274
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GATD3A mRNA	PMID:33387578
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GATD3 mRNA	PMID:28001369
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of GATD3 mRNA	PMID:32763439
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1343023	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of GATD3 mRNA	PMID:29803840
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GATD3A mRNA	PMID:38568856
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GATD3 mRNA	PMID:39836092
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1616812	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GATD3A mRNA	PMID:40504410
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of GATD3 mRNA	PMID:22378314
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1343023	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GATD3 3' UTR	PMID:27901495
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1343023	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GATD3 promoter	PMID:27901495
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:31348	capecitabine	increases expression	ISO	RGD:1343023	E	RGD:6480464	20230502	CTD	MESH:C110904	Capecitabine results in increased expression of GATD3A mRNA	PMID:36183961
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1616812	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GATD3A gene	PMID:35295148
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D013853	Thioacetamide results in decreased expression of GATD3A mRNA	PMID:23411599|PMID:34492290
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of GATD3A protein	PMID:32145629
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GATD3A mRNA	PMID:34947998
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased methylation of GATD3A gene	PMID:28505145
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1343023	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of GATD3 mRNA	PMID:19244175
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1343023	E	RGD:6480464	20120501	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GATD3 mRNA	PMID:19692669
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA	PMID:33854195
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GATD3A mRNA	PMID:21266533
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343023	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GATD3A mRNA	PMID:37042841
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20180515	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of GATD3A promoter	PMID:22457795
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GATD3 mRNA	PMID:35301059
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1616812	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GATD3A mRNA	PMID:37236586
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1343023	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GATD3 protein	PMID:26879310
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GATD3 mRNA	PMID:19376846
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GATD3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GATD3 mRNA	PMID:32699268
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GATD3 mRNA	PMID:31533062
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of GATD3 mRNA	PMID:17183730
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of GATD3 mRNA	PMID:20106945|PMID:25562108
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA	PMID:33854195
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1616812	E	RGD:6480464	20210504	CTD	MESH:D003907	Dexamethasone results in decreased expression of GATD3A protein	PMID:33567340
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA	PMID:33854195
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of GATD3 mRNA	PMID:29067470
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GATD3A mRNA	PMID:33387578
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GATD3 mRNA	PMID:39836092
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1616812	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GATD3A mRNA	PMID:40504410
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1616812	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GATD3A mRNA	PMID:35964746
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1343023	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of GATD3 mRNA	PMID:17183730
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA	PMID:33854195
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of GATD3 mRNA	PMID:20436886
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:63959	celastrol	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in decreased expression of GATD3 mRNA	PMID:17010675
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of GATD3 mRNA	PMID:15336504
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:65954	gedunin	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in decreased expression of GATD3 mRNA	PMID:17010675
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1616812	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of GATD3A mRNA	PMID:22206623
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of GATD3 mRNA	PMID:18548127
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1616812	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of GATD3A mRNA	PMID:31388691
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:8493	Propiverine	affects binding	EXP		E	RGD:6480464	20180515	CTD	MESH:C015586	propiverine binds to GATD3A protein	PMID:29273565
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1616812	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of GATD3A mRNA	PMID:40826991
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of GATD3 mRNA	PMID:11906190
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1343023	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GATD3 mRNA	PMID:29301935
1303003	Gatd3a	glutamine amidotransferase class 1 domain containing 3A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C025643	vinclozolin results in increased expression of GATD3A mRNA	PMID:22570695
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of TACC2 mRNA	PMID:21551480
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1552326	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TACC2 mRNA	PMID:33045310
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1552326	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TACC2 mRNA	PMID:37995155
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TACC2 mRNA]	PMID:31150632
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552326	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TACC2 mRNA	PMID:26251327
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TACC2 mRNA	PMID:33167477
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of TACC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of TACC2 mRNA	PMID:32699268
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TACC2 mRNA	PMID:26079696
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1349981	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of TACC2 protein	PMID:35688186
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TACC2 mRNA	PMID:35811015
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of TACC2 mRNA	PMID:30510588
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1552326	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of TACC2 mRNA	PMID:25549359
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TACC2 mRNA	PMID:23649840
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1349981	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of TACC2 mRNA	PMID:18037150
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1349981	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TACC2 mRNA	PMID:21179406
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1552326	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of TACC2 mRNA	PMID:28973375
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1349981	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of TACC2 protein	PMID:37730182
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TACC2 mRNA	PMID:23649840
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1349981	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of TACC2 intron	PMID:30157460
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TACC2 mRNA	PMID:25378103
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1349981	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TACC2 exon; Aflatoxin B1 results in increased methylation of TACC2 gene	PMID:28458013|PMID:30157460
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TACC2 mRNA	PMID:23649840
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:2564	aldrin	decreases expression	ISO	RGD:1552326	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in decreased expression of TACC2 mRNA	PMID:18579281
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of TACC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of TACC2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of TACC2 mRNA	PMID:32699268
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1552326	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in decreased expression of TACC2 mRNA	PMID:31939706
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TACC2 mRNA	PMID:18593933
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TACC2 mRNA	PMID:31150632
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552326	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TACC2 mRNA	PMID:31919559
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TACC2 mRNA]	PMID:31150632
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1349981	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TACC2 gene	PMID:25304211
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1349981	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of TACC2 protein	PMID:35688186
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of TACC2 gene	PMID:31011160
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of TACC2 mRNA	PMID:23557933
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1349981	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of TACC2 mRNA	PMID:28903495
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TACC2 mRNA	PMID:27392435
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:27903	(2,4,5-trichlorophenoxy)acetic acid	decreases expression	ISO	RGD:1552326	E	RGD:6480464	20130514	CTD	MESH:D015085	2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of TACC2 mRNA	PMID:18579281
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1552326	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of TACC2 mRNA	PMID:18930951
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TACC2 mRNA	PMID:22298810
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TACC2 mRNA	PMID:33387578
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TACC2 mRNA	PMID:21215274|PMID:26232522|PMID:34747641
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552326	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TACC2 mRNA	PMID:25975270
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28509	chloroethene	decreases expression	ISO	RGD:1552326	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in decreased expression of TACC2 mRNA	PMID:18579281
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TACC2 mRNA	PMID:28959563
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TACC2 mRNA	PMID:29803840
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552326	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of TACC2 mRNA	PMID:39631538
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1349981	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of TACC2 protein	PMID:35688186
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1349981	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of TACC2 mRNA	PMID:20044591
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of TACC2 mRNA	PMID:22363485
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TACC2 mRNA	PMID:29432896
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552326	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of TACC2 mRNA	PMID:33933676
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349981	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TACC2 5' UTR; Benzo(a)pyrene affects the methylation of TACC2 intron; Benzo(a)pyrene affects the methylation of TACC2 promoter	PMID:27901495|PMID:30157460
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1552326	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TACC2 intron	PMID:27901495
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TACC2 mRNA	PMID:18593933
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TACC2 mRNA	PMID:19150397|PMID:20382639
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1349981	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of TACC2 gene	PMID:31601247
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of TACC2 mRNA	PMID:38568856
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TACC2 mRNA	PMID:23411599
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552326	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TACC2 mRNA	PMID:18301758|PMID:18445702|PMID:20813756|PMID:23811191
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552326	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TACC2 mRNA; [pirinixic acid co-treated with PPARA] results in increased expression of TACC2 mRNA	PMID:19710929|PMID:20813756
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1349981	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of TACC2 gene	PMID:31601247
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1552326	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of TACC2 promoter	PMID:27312807
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TACC2 mRNA	PMID:34947998
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TACC2 gene	PMID:28505145
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of TACC2 protein	PMID:31675489
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1349981	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TACC2 mRNA	PMID:25979313
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of TACC2 mRNA	PMID:36804509
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1552326	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of TACC2 mRNA	PMID:39298647
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552326	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TACC2 gene	PMID:31683443
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552326	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of TACC2 promoter	PMID:33297965
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1349981	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TACC2 intron	PMID:30157460
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1552326	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of TACC2 intron	PMID:28392331
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1552326	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of TACC2 mRNA	PMID:34813904
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349981	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TACC2 mRNA	PMID:38382870
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552326	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TACC2 mRNA	PMID:28903501
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of TACC2 mRNA	PMID:24386269
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1552326	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of TACC2 mRNA	PMID:18353800
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of TACC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of TACC2 mRNA	PMID:32699268
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1349981	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TACC2 mRNA	PMID:28302478
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TACC2 mRNA	PMID:31533062
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349981	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TACC2 mRNA	PMID:25979313
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1349981	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TACC2 gene	PMID:29154799
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TACC2 mRNA	PMID:17183730
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1349981	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TACC2 mRNA	PMID:20106945|PMID:25562108
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552326	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TACC2 mRNA	PMID:20937368
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of TACC2 mRNA	PMID:19059307
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1349981	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of TACC2 mRNA	PMID:16144939
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1349981	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of TACC2 mRNA	PMID:24449571
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552326	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TACC2 mRNA	PMID:17562736
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TACC2 mRNA	PMID:33387578
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TACC2 mRNA	PMID:21420995
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1349981	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TACC2 mRNA	PMID:29067470
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TACC2 mRNA	PMID:35811015
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TACC2 mRNA	PMID:29523930
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1349981	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TACC2 gene	PMID:25304211
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of TACC2 mRNA	PMID:31675489
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of TACC2 mRNA	PMID:38568856
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552326	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TACC2 mRNA; Nanotubes, Carbon results in decreased expression of TACC2 mRNA	PMID:25554681
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552326	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TACC2 mRNA; Nanotubes, Carbon results in increased expression of TACC2 mRNA	PMID:25620056
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TACC2 mRNA	PMID:24136188
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1552326	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of TACC2 mRNA	PMID:26377693
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1552326	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of TACC2 mRNA	PMID:23608068
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TACC2 mRNA	PMID:17183730
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1349981	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TACC2 mRNA	PMID:22079614
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1552326	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of TACC2 mRNA	PMID:20003209
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1552326	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of TACC2 mRNA	PMID:26307267|PMID:36914120
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1349981	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TACC2 intron	PMID:30157460
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TACC2 gene	PMID:35440735
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1552326	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of TACC2 mRNA	PMID:22206623
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of TACC2 mRNA	PMID:23358140
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TACC2 gene]	PMID:28238834
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TACC2 protein	PMID:31675489
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1349981	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of TACC2 protein	PMID:31675489
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552326	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of TACC2 mRNA	PMID:40826991
1303004	Tacc2	transforming, acidic coiled-coil containing protein 2	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1349981	E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of TACC2 mRNA	PMID:19059307
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1350452	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ST6GALNAC4 mRNA	PMID:38218311
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1616828	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ST6GALNAC4 mRNA	PMID:37995155
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1350452	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ST6GALNAC4 protein]	PMID:38195004
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ST6GALNAC4 mRNA	PMID:20938992
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ST6GALNAC4 mRNA	PMID:30510588
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1616828	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ST6GALNAC4 mRNA	PMID:39298647
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ST6GALNAC4 mRNA	PMID:33387578
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ST6GALNAC4 mRNA	PMID:20938992
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ST6GALNAC4 mRNA	PMID:23649840|PMID:27905399
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST6GALNAC4 mRNA	PMID:37992649
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST6GALNAC4 mRNA	PMID:37992649
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ST6GALNAC4 mRNA	PMID:33387578
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ST6GALNAC4 mRNA	PMID:28522335
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1350452	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ST6GALNAC4 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ST6GALNAC4 protein	PMID:38195004
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ST6GALNAC4 mRNA	PMID:33354967
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ST6GALNAC4 mRNA	PMID:23649840
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ST6GALNAC4 mRNA	PMID:20938992
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ST6GALNAC4 mRNA	PMID:40504410
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20130806	CTD	MESH:D000966	Antimony Potassium Tartrate results in decreased expression of ST6GALNAC4 mRNA	PMID:17547211
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of ST6GALNAC4 mRNA	PMID:17898221
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ST6GALNAC4 mRNA	PMID:34747641
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1616828	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ST6GALNAC4 mRNA	PMID:21570461|PMID:24680724
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ST6GALNAC4 mRNA	PMID:19770486
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ST6GALNAC4 mRNA	PMID:17942748
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1350452	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ST6GALNAC4 mRNA	PMID:29955902
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ST6GALNAC4 mRNA	PMID:32763439
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST6GALNAC4 mRNA	PMID:37992649
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ST6GALNAC4 mRNA	PMID:20371982|PMID:38568856
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1350452	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ST6GALNAC4 mRNA	PMID:39719251
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ST6GALNAC4 mRNA	PMID:40504410
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1350452	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of ST6GALNAC4 mRNA	PMID:22378314
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350452	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ST6GALNAC4 5' UTR; Benzo(a)pyrene affects the methylation of ST6GALNAC4 intron	PMID:27901495|PMID:30157460
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ST6GALNAC4 mRNA	PMID:22228805
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:30304	antimony(0)	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20130806	CTD	MESH:D000965	Antimony results in decreased expression of ST6GALNAC4 mRNA	PMID:17547211
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1616828	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ST6GALNAC4 mRNA	PMID:27131904
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ST6GALNAC4 mRNA	PMID:17547211
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1350452	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ST6GALNAC4 gene	PMID:31601247
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1616828	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ST6GALNAC4 promoter	PMID:35295148
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ST6GALNAC4 mRNA	PMID:34492290
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1350452	E	RGD:6480464	20130806	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ST6GALNAC4 mRNA	PMID:19710929
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1350452	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ST6GALNAC4 mRNA	PMID:30903817
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ST6GALNAC4 mRNA	PMID:30816183
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ST6GALNAC4 mRNA	PMID:25181051
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1616828	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of ST6GALNAC4 mRNA	PMID:35479511
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1616828	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of ST6GALNAC4 mRNA	PMID:26682919
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1616828	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ST6GALNAC4 mRNA	PMID:39298647
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1616828	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ST6GALNAC4 exon	PMID:33297965
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1350452	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ST6GALNAC4 mRNA	PMID:28628672
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1350452	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ST6GALNAC4 mRNA	PMID:28628672
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20130806	CTD	MESH:C022838	nickel chloride results in decreased expression of ST6GALNAC4 mRNA	PMID:17547211
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:35036	fentin chloride	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in decreased expression of ST6GALNAC4 mRNA	PMID:37156404
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1616828	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of ST6GALNAC4 mRNA	PMID:26377693
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of ST6GALNAC4 mRNA	PMID:30723492
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1350452	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ST6GALNAC4 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ST6GALNAC4 protein	PMID:38195004
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ST6GALNAC4 mRNA	PMID:19376846
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ST6GALNAC4 mRNA	PMID:24449571
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1350452	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ST6GALNAC4 mRNA	PMID:40419075
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D002737	Chloroprene results in decreased expression of ST6GALNAC4 mRNA	PMID:23125180
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1350452	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ST6GALNAC4 mRNA	PMID:29154799
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D014635	Valproic Acid results in increased expression of ST6GALNAC4 mRNA	PMID:21427059
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in decreased expression of ST6GALNAC4 mRNA	PMID:19770486
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1350452	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ST6GALNAC4 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1350452	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ST6GALNAC4 mRNA	PMID:28628672
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST6GALNAC4 mRNA	PMID:37992649
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ST6GALNAC4 mRNA	PMID:40504410
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ST6GALNAC4 mRNA	PMID:17942748
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1350452	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ST6GALNAC4 mRNA	PMID:28628672
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ST6GALNAC4 mRNA	PMID:17547211
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1616828	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of ST6GALNAC4 mRNA	PMID:25554681
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1616828	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ST6GALNAC4 mRNA	PMID:25554681|PMID:25620056
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1616828	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ST6GALNAC4 mRNA	PMID:38701926
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20130806	CTD	MESH:D015474	Isotretinoin results in decreased expression of ST6GALNAC4 mRNA	PMID:20436886
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1616828	E	RGD:6480464	20130806	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of ST6GALNAC4 mRNA	PMID:15003993
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1616828	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of ST6GALNAC4 mRNA	PMID:36907384
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20130806	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of ST6GALNAC4 mRNA	PMID:17547211
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1616828	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ST6GALNAC4 mRNA	PMID:20111022
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1616828	E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol results in decreased expression of ST6GALNAC4 mRNA	PMID:21542829
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1616828	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of ST6GALNAC4 mRNA	PMID:27858113
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1350452	E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of ST6GALNAC4 mRNA	PMID:19737606
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1616828	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ST6GALNAC4 mRNA	PMID:27131904
1303005	St6galnac4	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1350452	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ST6GALNAC4 mRNA	PMID:38568856
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332268	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PFDN6 mRNA	PMID:33045310
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332268	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PFDN6 mRNA	PMID:39241906
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1332268	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PFDN6 mRNA	PMID:39298647
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1351314	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PFDN6 mRNA	PMID:38568856
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1351314	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PFDN6 mRNA	PMID:37042841
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332268	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PFDN6 mRNA	PMID:33754040
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PFDN6 mRNA	PMID:26577399
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1351314	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PFDN6 mRNA	PMID:28818685
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1332268	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of PFDN6 mRNA	PMID:27462272
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1351314	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PFDN6 mRNA	PMID:19549813
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1351314	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PFDN6 mRNA	PMID:21641981
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PFDN6 mRNA	PMID:33387578
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332268	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PFDN6 mRNA	PMID:22206623
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332268	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PFDN6 mRNA	PMID:40504410
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PFDN6 mRNA	PMID:21215274|PMID:32109520|PMID:33387578
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332268	E	RGD:6480464	20140812	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PFDN6 mRNA	PMID:17942748
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351314	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of PFDN6 mRNA	PMID:28595984|PMID:34032870
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332268	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PFDN6 mRNA	PMID:40504410
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351314	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PFDN6 promoter	PMID:27901495
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1351314	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to PFDN6 mRNA]	PMID:32406909
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:3020	benzalkonium chloride	affects response to substance	ISO	RGD:1351314	E	RGD:6480464	20180220	CTD	MESH:D001548	PFDN6 SNP affects the susceptibility to Benzalkonium Compounds	PMID:27258892
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D000643	Ammonium Chloride affects the expression of PFDN6 mRNA	PMID:16483693
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332268	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PFDN6 promoter alternative form	PMID:35295148
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1332268	E	RGD:6480464	20140812	CTD	MESH:C006253	pirinixic acid results in decreased expression of PFDN6 mRNA	PMID:21318169
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1332268	E	RGD:6480464	20140812	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of PFDN6 mRNA]	PMID:21318169
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased expression of PFDN6 mRNA	PMID:29097150
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332268	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of PFDN6 mRNA	PMID:35598803
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1351314	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PFDN6 mRNA	PMID:29275510
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1351314	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PFDN6 gene	PMID:31601247
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PFDN6 mRNA	PMID:25181051
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PFDN6 mRNA	PMID:36041667
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332268	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PFDN6 mRNA	PMID:40203079
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PFDN6 mRNA	PMID:36041667
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332268	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PFDN6 mRNA	PMID:38685157
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PFDN6 mRNA	PMID:36041667
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1332268	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of PFDN6 protein	PMID:35362542
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1332268	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PFDN6 protein]	PMID:35362542
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332268	E	RGD:6480464	20140812	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PFDN6 mRNA	PMID:17361019|PMID:21266533
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1351314	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PFDN6 mRNA	PMID:19376846
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1351314	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PFDN6 mRNA	PMID:24449571
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351314	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PFDN6 mRNA	PMID:25979313
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1351314	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PFDN6 gene	PMID:29154799
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1351314	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of PFDN6 mRNA	PMID:36621641
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PFDN6 mRNA	PMID:33387578
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332268	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PFDN6 mRNA	PMID:40504410
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1332268	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PFDN6 mRNA	PMID:35436446
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1332268	E	RGD:6480464	20140812	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PFDN6 mRNA	PMID:17942748
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1332268	E	RGD:6480464	20140812	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PFDN6 mRNA	PMID:17942748
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1332268	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of PFDN6 protein]	PMID:35362542
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332268	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PFDN6 mRNA	PMID:25554681
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PFDN6 mRNA	PMID:24136188
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PFDN6 mRNA	PMID:24136188
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1351314	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PFDN6 protein	PMID:32959892
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1351314	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PFDN6 mRNA	PMID:15336504
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332268	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PFDN6 mRNA	PMID:22206623
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332268	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PFDN6 mRNA	PMID:22206623
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PFDN6 mRNA	PMID:24136188
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351314	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PFDN6 gene]	PMID:28238834
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of PFDN6 mRNA	PMID:32109520
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1332268	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PFDN6 mRNA	PMID:30294300
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of PFDN6 protein	PMID:28903499
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1332268	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PFDN6 mRNA	PMID:40826991
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of PFDN6 mRNA	PMID:24136188
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1351314	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PFDN6 mRNA	PMID:38568856
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1332268	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of PFDN6 mRNA	PMID:26217789
1303006	Pfdn6	prefoldin subunit 6	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PFDN6 mRNA	PMID:19015723
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1353068	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of RPL35 protein	PMID:39638853
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of RPL35 mRNA	PMID:32845096
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPL35 mRNA	PMID:36331819
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332563	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RPL35 mRNA	PMID:39241906
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:16716	benzene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of RPL35 mRNA	PMID:15878777
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1353068	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RPL35 mRNA	PMID:39613055
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1353068	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RPL35 mRNA	PMID:39613055
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332563	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RPL35 mRNA	PMID:19850644|PMID:33754040
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of RPL35 mRNA]	PMID:19850644
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL35 mRNA	PMID:36331819
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:207229	dihydroartemisinin	affects binding	ISO	RGD:1353068	E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to RPL35 protein	PMID:26340163
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20230502	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL35 mRNA	PMID:36114956
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL35 protein	PMID:23301498
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1332563	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of RPL35 mRNA	PMID:19376150
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of RPL35 mRNA	PMID:41580963
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of RPL35 mRNA	PMID:32845096
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of RPL35 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RPL35 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RPL35 protein	PMID:38598786
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RPL35 mRNA	PMID:18593933
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:27385	tetrachloromethane	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RPL35 mRNA	PMID:15963342
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RPL35 mRNA	PMID:40504410
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL35 mRNA	PMID:39836092
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1353068	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of RPL35 mRNA	PMID:33512557
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1332563	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of RPL35 mRNA	PMID:30912803
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20120412	CTD	MESH:D009532	MT1 affects the reaction [Nickel affects the expression of RPL35 mRNA]; MT2 affects the reaction [Nickel affects the expression of RPL35 mRNA]	PMID:16166738
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPL35 mRNA	PMID:34747641
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332563	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPL35 mRNA	PMID:21570461
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1332563	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RPL35 mRNA	PMID:19465110
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPL35 mRNA	PMID:33387578
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RPL35 promoter]	PMID:19654925
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1353068	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RPL35 protein	PMID:39603559
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1353068	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of RPL35 mRNA	PMID:33512557
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353068	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of RPL35 mRNA; sodium arsenite results in decreased expression of RPL35 protein	PMID:30528433|PMID:38228842|PMID:38568856|PMID:39719251
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RPL35 mRNA	PMID:40504410
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL35 mRNA	PMID:39836092
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RPL35 mRNA]	PMID:32406909
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RPL35 mRNA	PMID:18593933
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RPL35 mRNA	PMID:16483693
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C032036	bromobenzene results in decreased expression of RPL35 mRNA	PMID:15056800
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C032036	bromobenzene results in increased expression of RPL35 mRNA	PMID:12628495
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1353068	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of RPL35 mRNA	PMID:38568856
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1332563	E	RGD:6480464	20150310	CTD	MESH:C009495	titanium dioxide analog results in decreased expression of RPL35 mRNA	PMID:25111187
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332563	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RPL35 gene	PMID:35295148
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332563	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RPL35 gene	PMID:35295148
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332563	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RPL35 mRNA	PMID:18445702
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1332563	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RPL35 mRNA	PMID:28472532
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of RPL35 mRNA	PMID:19167457
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332563	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL35 mRNA	PMID:33221593|PMID:35598803
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353068	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL35 mRNA; bisphenol A results in decreased expression of RPL35 protein	PMID:34186270|PMID:37567409|PMID:38568856
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RPL35 mRNA	PMID:25181051
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332563	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of RPL35 mRNA	PMID:38074096
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1353068	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of RPL35 protein	PMID:37664457
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1332563	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of RPL35 mRNA	PMID:39298647
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1353068	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of RPL35 protein	PMID:34186270
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332563	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RPL35 mRNA	PMID:38685157
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1353068	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RPL35 protein	PMID:34186270
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1353068	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RPL35 protein	PMID:34186270
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1332563	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of RPL35 mRNA	PMID:34813904
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RPL35 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of RPL35 protein	PMID:38598786
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1332563	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RPL35 mRNA	PMID:17942915
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RPL35 mRNA]	PMID:17942915
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1353068	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RPL35 mRNA	PMID:38568856
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20230502	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL35 mRNA	PMID:36114956
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1353068	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of RPL35 mRNA	PMID:33512557
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1353068	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RPL35 mRNA	PMID:31533062
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1353068	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of RPL35 mRNA	PMID:26352163
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL35 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPL35 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RPL35 mRNA	PMID:36331819
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1332563	E	RGD:6480464	20190219	CTD	MESH:C017160	cypermethrin results in increased expression of RPL35 mRNA	PMID:29020013
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1353068	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RPL35 mRNA	PMID:39613055
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332563	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RPL35 mRNA	PMID:17562736
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332563	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RPL35 mRNA	PMID:40504410
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL35 mRNA	PMID:39836092
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1332563	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RPL35 mRNA	PMID:35436446
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of RPL35 mRNA	PMID:19162173
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RPL35 mRNA	PMID:24136188
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353068	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPL35 protein	PMID:32959892
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:6773	Mesaconitine	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in increased expression of RPL35 protein	PMID:37182599
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1353068	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RPL35 protein	PMID:34186270
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL35 protein	PMID:37664457
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of RPL35 mRNA	PMID:15215175
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1353068	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of RPL35 protein	PMID:39638853
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1332563	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPL35 mRNA	PMID:30294300
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of RPL35 mRNA	PMID:36843608
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1332563	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RPL35 mRNA	PMID:40826991
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL35 protein	PMID:37664457
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1353068	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of RPL35 mRNA	PMID:33512557
1303007	Rpl35	ribosomal protein L35	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1353068	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RPL35 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RPL35 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RPL35 protein	PMID:38598786
1303008	Msh5	mutS homolog 5	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MSH5 mRNA	PMID:38218311
1303008	Msh5	mutS homolog 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552336	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MSH5 mRNA	PMID:33045310
1303008	Msh5	mutS homolog 5	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1552336	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of MSH5 mRNA	PMID:15282401
1303008	Msh5	mutS homolog 5	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1343663	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of MSH5 mRNA	PMID:21632981
1303008	Msh5	mutS homolog 5	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MSH5 mRNA	PMID:33387578
1303008	Msh5	mutS homolog 5	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MSH5 mRNA	PMID:21592394
1303008	Msh5	mutS homolog 5	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1343663	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MSH5 mRNA	PMID:21592394
1303008	Msh5	mutS homolog 5	gene	CHEBI:17579	beta-carotene	increases expression	ISO	RGD:1343663	E	RGD:6480464	20120412	CTD	MESH:D019207	beta Carotene results in increased expression of MSH5 mRNA	PMID:17034753
1303008	Msh5	mutS homolog 5	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MSH5 mRNA	PMID:27523638
1303008	Msh5	mutS homolog 5	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MSH5 mRNA	PMID:21592394
1303008	Msh5	mutS homolog 5	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1343663	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MSH5 mRNA	PMID:21592394
1303008	Msh5	mutS homolog 5	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MSH5 mRNA	PMID:28818685
1303008	Msh5	mutS homolog 5	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MSH5 mRNA	PMID:39012411
1303008	Msh5	mutS homolog 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1343663	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MSH5 mRNA	PMID:19549813
1303008	Msh5	mutS homolog 5	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MSH5 mRNA	PMID:30779732
1303008	Msh5	mutS homolog 5	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1343663	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MSH5 gene	PMID:25304211
1303008	Msh5	mutS homolog 5	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MSH5 mRNA	PMID:19244175
1303008	Msh5	mutS homolog 5	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in increased expression of MSH5 mRNA	PMID:38314887
1303008	Msh5	mutS homolog 5	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1552336	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of MSH5 mRNA	PMID:32186404
1303008	Msh5	mutS homolog 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MSH5 mRNA	PMID:33387578
1303008	Msh5	mutS homolog 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1343663	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MSH5 mRNA	PMID:29704546
1303008	Msh5	mutS homolog 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1343663	E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of MSH5 mRNA	PMID:29704546
1303008	Msh5	mutS homolog 5	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1343663	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of MSH5 mRNA	PMID:29955902
1303008	Msh5	mutS homolog 5	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MSH5 mRNA	PMID:32763439
1303008	Msh5	mutS homolog 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MSH5 mRNA	PMID:12377979|PMID:20371982|PMID:38568856
1303008	Msh5	mutS homolog 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552336	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MSH5 mRNA	PMID:37682722
1303008	Msh5	mutS homolog 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343663	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MSH5 promoter	PMID:27901495
1303008	Msh5	mutS homolog 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MSH5 mRNA	PMID:25690898
1303008	Msh5	mutS homolog 5	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1552336	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of MSH5 mRNA	PMID:22609695|PMID:22613225
1303008	Msh5	mutS homolog 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552336	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MSH5 gene	PMID:35295148
1303008	Msh5	mutS homolog 5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1343663	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MSH5 mRNA	PMID:19710929
1303008	Msh5	mutS homolog 5	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1552336	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of MSH5 mRNA	PMID:19191707
1303008	Msh5	mutS homolog 5	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of MSH5 mRNA	PMID:19167457
1303008	Msh5	mutS homolog 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MSH5 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303008	Msh5	mutS homolog 5	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of MSH5 mRNA	PMID:19244175
1303008	Msh5	mutS homolog 5	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1552336	E	RGD:6480464	20221101	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of MSH5 mRNA	PMID:35487396
1303008	Msh5	mutS homolog 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552336	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MSH5 mRNA	PMID:38685157
1303008	Msh5	mutS homolog 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343663	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MSH5 mRNA	PMID:37042841
1303008	Msh5	mutS homolog 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MSH5 mRNA	PMID:39012411
1303008	Msh5	mutS homolog 5	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MSH5 mRNA	PMID:19244175
1303008	Msh5	mutS homolog 5	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1552336	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MSH5 mRNA	PMID:40194260
1303008	Msh5	mutS homolog 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552336	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MSH5 mRNA	PMID:40194260
1303008	Msh5	mutS homolog 5	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MSH5 mRNA	PMID:31533062
1303008	Msh5	mutS homolog 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343663	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MSH5 mRNA	PMID:25979313
1303008	Msh5	mutS homolog 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552336	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MSH5 mRNA	PMID:17963808
1303008	Msh5	mutS homolog 5	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of MSH5 mRNA	PMID:41580965
1303008	Msh5	mutS homolog 5	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MSH5 mRNA	PMID:38832940
1303008	Msh5	mutS homolog 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552336	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MSH5 mRNA	PMID:17562736
1303008	Msh5	mutS homolog 5	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MSH5 mRNA	PMID:33387578
1303008	Msh5	mutS homolog 5	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1343663	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MSH5 gene	PMID:25304211
1303008	Msh5	mutS homolog 5	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	increases expression	ISO	RGD:1343663	E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in increased expression of MSH5 mRNA	PMID:17034753
1303008	Msh5	mutS homolog 5	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of MSH5 mRNA	PMID:28801915
1303008	Msh5	mutS homolog 5	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1552336	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MSH5 mRNA	PMID:21641980
1303008	Msh5	mutS homolog 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of MSH5 mRNA	PMID:28801915
1303008	Msh5	mutS homolog 5	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1552336	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of MSH5 mRNA	PMID:36907384
1303008	Msh5	mutS homolog 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552336	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MSH5 mRNA	PMID:22206623
1303008	Msh5	mutS homolog 5	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in decreased expression of MSH5 mRNA	PMID:23358140
1303008	Msh5	mutS homolog 5	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of MSH5 mRNA	PMID:21346803
1303008	Msh5	mutS homolog 5	gene	CHEBI:79089	ceric oxide	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C030583	ceric oxide results in increased expression of MSH5 mRNA	PMID:29463257
1303008	Msh5	mutS homolog 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1343663	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MSH5 gene]	PMID:28238834
1303008	Msh5	mutS homolog 5	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1552336	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MSH5 mRNA	PMID:31388691
1303008	Msh5	mutS homolog 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MSH5 mRNA	PMID:27291303
1303008	Msh5	mutS homolog 5	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MSH5 mRNA	PMID:38568856
1303008	Msh5	mutS homolog 5	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1343663	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MSH5 mRNA	PMID:29301935
1303008	Msh5	mutS homolog 5	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552336	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of MSH5 mRNA	PMID:35537566
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1618147	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SLC4A5 mRNA	PMID:37995155
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1618147	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC4A5 mRNA	PMID:30529165
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1618147	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A5 mRNA	PMID:25510870
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:731047	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SLC4A5 mRNA	PMID:26079696
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1618147	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of SLC4A5 mRNA	PMID:31525975
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1618147	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SLC4A5 mRNA	PMID:36706583
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1618147	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of SLC4A5 mRNA	PMID:31525975
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1618147	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A5 mRNA	PMID:25510870
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1618147	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A5 mRNA	PMID:25510870
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:731047	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC4A5 gene	PMID:27153756
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:731047	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SLC4A5 promoter	PMID:30157460
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1618147	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SLC4A5 mRNA	PMID:34911549
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC4A5 mRNA	PMID:30723492
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1618147	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of SLC4A5 mRNA	PMID:25629700
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:731047	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC4A5 gene	PMID:25304211
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1618147	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SLC4A5 mRNA	PMID:28960355
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC4A5 mRNA	PMID:31881176
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:28088	genistein	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in decreased methylation of SLC4A5 gene	PMID:28505145
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1618147	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC4A5 mRNA	PMID:33956508
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1618147	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of SLC4A5 mRNA	PMID:35032568
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:731047	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SLC4A5 mRNA	PMID:32763439
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:731047	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC4A5 mRNA	PMID:29432896
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:731047	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC4A5 mRNA	PMID:38568856
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1618147	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC4A5 mRNA	PMID:27195522
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:731047	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLC4A5 mRNA	PMID:20382639
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of SLC4A5 mRNA	PMID:24395379
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:731047	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC4A5 gene	PMID:31601247
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:31767	lead diacetate	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C008261	lead acetate affects the expression of SLC4A5 mRNA	PMID:21864555
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of SLC4A5 mRNA	PMID:32479839
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1618147	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SLC4A5 mRNA	PMID:28472532
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC4A5 mRNA	PMID:25181051
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:731047	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SLC4A5 gene	PMID:31601247
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:731047	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC4A5 gene	PMID:31601247
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1618147	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A5 mRNA	PMID:25510870
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1618147	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A5 mRNA	PMID:25510870
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1618147	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of SLC4A5 mRNA	PMID:40203079
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1618147	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SLC4A5 exon	PMID:33297965
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1618147	E	RGD:6480464	20230704	CTD	MESH:C008745	bisphenol F results in decreased expression of SLC4A5 mRNA	PMID:36706583
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1618147	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SLC4A5 intron	PMID:28392331
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SLC4A5 mRNA	PMID:32680482
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:731047	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of SLC4A5 mRNA	PMID:19691856
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1618147	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC4A5 mRNA	PMID:40194260
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:731047	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SLC4A5 mRNA	PMID:40419075
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1618147	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of SLC4A5 mRNA	PMID:31525975
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:731047	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC4A5 gene	PMID:25304211
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:731047	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of SLC4A5 mRNA	PMID:32234424
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:731047	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of SLC4A5 mRNA	PMID:38825487
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1618147	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SLC4A5 mRNA; Nanotubes, Carbon results in decreased expression of SLC4A5 mRNA	PMID:25554681
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:6651	malathion	decreases expression	ISO	RGD:731047	E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of SLC4A5 mRNA	PMID:37047231
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:731047	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC4A5 gene]	PMID:28238834
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1618147	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC4A5 mRNA	PMID:27935865
1303009	Slc4a5	solute carrier family 4 member 5	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1618147	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SLC4A5 mRNA	PMID:36706583
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1604621	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SARAF mRNA	PMID:38218311
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of SARAF mRNA	PMID:21551480
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1604621	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of SARAF mRNA	PMID:35967413
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	ISO	RGD:1604621	E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SARAF mRNA	PMID:19074003
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552339	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SARAF mRNA	PMID:36331819
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552339	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SARAF mRNA	PMID:30319688
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552339	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SARAF mRNA	PMID:39241906
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1604621	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of SARAF mRNA	PMID:20823114
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SARAF mRNA	PMID:33387578
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604621	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SARAF mRNA	PMID:37042841
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:16716	benzene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene affects the expression of SARAF mRNA	PMID:15878777
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1604621	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of SARAF mRNA	PMID:15929907
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552339	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SARAF mRNA	PMID:33754040
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SARAF mRNA	PMID:33387578
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1604621	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SARAF mRNA	PMID:28818685
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1552339	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SARAF mRNA	PMID:27462272
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604621	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SARAF mRNA	PMID:19549813
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SARAF mRNA	PMID:30779732
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1552339	E	RGD:6480464	20140909	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SARAF mRNA	PMID:17484886
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SARAF mRNA	PMID:30723492
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552339	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SARAF mRNA	PMID:31919559
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552339	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SARAF mRNA	PMID:22206623
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552339	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SARAF mRNA	PMID:40504410
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604621	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SARAF mRNA	PMID:39836092
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SARAF mRNA	PMID:31881176
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1604621	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SARAF mRNA	PMID:28903495
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552339	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SARAF mRNA	PMID:21570461
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SARAF mRNA	PMID:33387578|PMID:34747641
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1604621	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SARAF mRNA	PMID:32763439
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1604621	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of SARAF mRNA	PMID:21198554
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1552339	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SARAF protein	PMID:28918527
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552339	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SARAF mRNA	PMID:39631538
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1604621	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SARAF mRNA	PMID:29803840
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:28794	coumarin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of SARAF mRNA	PMID:18480146
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604621	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of SARAF mRNA	PMID:28595984|PMID:34032870
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604621	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SARAF mRNA	PMID:38568856
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552339	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SARAF mRNA	PMID:40504410
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604621	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SARAF mRNA	PMID:39836092
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552339	E	RGD:6480464	20140909	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SARAF mRNA	PMID:15034205|PMID:22228805
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552339	E	RGD:6480464	20140909	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of SARAF mRNA]	PMID:15034205
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of SARAF mRNA	PMID:16483693
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SARAF mRNA	PMID:24136188
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1604621	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of SARAF mRNA	PMID:31745603
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552339	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM66 gene	PMID:35295148
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SARAF mRNA	PMID:30816183
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C006780	bisphenol A results in increased expression of SARAF mRNA	PMID:25181051
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552339	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SARAF mRNA	PMID:33221593
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604621	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SARAF mRNA	PMID:25047013
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SARAF mRNA	PMID:36041667
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552339	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of SARAF mRNA	PMID:40203079
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SARAF mRNA	PMID:36041667
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SARAF mRNA	PMID:36041667
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SARAF mRNA	PMID:21266533
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552339	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SARAF mRNA	PMID:34813904
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604621	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SARAF mRNA	PMID:37042841
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SARAF promoter	PMID:22457795
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SARAF mRNA	PMID:33453195
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1604621	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SARAF mRNA	PMID:19376846
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1604621	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SARAF mRNA	PMID:24449571
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552339	E	RGD:6480464	20140909	CTD	MESH:D002994	Clofibrate results in decreased expression of SARAF mRNA	PMID:17585979
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1604621	E	RGD:6480464	20161115	CTD	MESH:C100187	chloropicrin affects the expression of SARAF mRNA	PMID:26352163
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552339	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SARAF mRNA	PMID:36331819
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552339	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of SARAF mRNA	PMID:20546886
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604621	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SARAF mRNA	PMID:17183730
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1604621	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SARAF mRNA	PMID:20106945
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:41423	celecoxib	affects expression	ISO	RGD:1552339	E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib affects the expression of SARAF mRNA	PMID:20562220
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of SARAF mRNA	PMID:24136188
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552339	E	RGD:6480464	20140909	CTD	MESH:D000082	Acetaminophen affects the expression of SARAF mRNA	PMID:17562736
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SARAF mRNA	PMID:33387578
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604621	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SARAF mRNA	PMID:22230336
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552339	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SARAF mRNA	PMID:40504410
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604621	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SARAF mRNA	PMID:39836092
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SARAF mRNA	PMID:29391264
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SARAF mRNA	PMID:17557909
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1604621	E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of SARAF mRNA	PMID:20823114
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1604621	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SARAF mRNA	PMID:17183730
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1552339	E	RGD:6480464	20140909	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SARAF mRNA	PMID:23650126
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1552339	E	RGD:6480464	20140909	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SARAF mRNA	PMID:15003993
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:6443	levonorgestrel	multiple interactions	ISO	RGD:1604621	E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SARAF mRNA	PMID:19074003
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1604621	E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of SARAF mRNA	PMID:20823114
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:67895	corosolic acid	increases expression	ISO	RGD:1604621	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of SARAF mRNA	PMID:37939859
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:72544	flavonoids	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in decreased expression of SARAF mRNA	PMID:18035473
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552339	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SARAF mRNA	PMID:22206623
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1604621	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SARAF protein	PMID:31285264
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1552339	E	RGD:6480464	20140909	CTD	MESH:C045950	propiconazole results in increased expression of SARAF mRNA	PMID:21278054
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SARAF mRNA	PMID:21346803
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1604621	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SARAF mRNA	PMID:29301935
1303011	Saraf	store-operated calcium entry-associated regulatory factor	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of SARAF protein	PMID:35544339
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1343729	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GPSM3 mRNA	PMID:27188386
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614233	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GPSM3 mRNA	PMID:33045310
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPSM3 mRNA	PMID:20938992
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1343729	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of GPSM3 mRNA	PMID:33167477
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GPSM3 mRNA	PMID:33729688
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of GPSM3 mRNA	PMID:36841081
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GPSM3 mRNA	PMID:33387578
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPSM3 mRNA	PMID:20938992
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GPSM3 mRNA	PMID:37992649
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1343729	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of GPSM3 mRNA	PMID:33359661
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GPSM3 mRNA	PMID:37992649
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of GPSM3 mRNA	PMID:26577399|PMID:27523638
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1343729	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of GPSM3 protein	PMID:37730182
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of GPSM3 mRNA	PMID:41580963
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GPSM3 mRNA	PMID:34911549
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of GPSM3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPSM3 mRNA	PMID:20938992|PMID:22206623
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GPSM3 mRNA	PMID:40504410
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GPSM3 mRNA	PMID:31881176
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1343729	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of GPSM3 mRNA	PMID:23557933
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1614233	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of GPSM3 mRNA	PMID:18930951
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1343729	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of GPSM3 mRNA	PMID:24768652|PMID:25583101
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPSM3 mRNA	PMID:34747641
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614233	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPSM3 mRNA	PMID:21570461
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GPSM3 mRNA	PMID:33387578
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1614233	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of GPSM3 mRNA	PMID:39631538
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GPSM3 mRNA	PMID:37992649
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1343729	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GPSM3 mRNA	PMID:38568856
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GPSM3 mRNA	PMID:40504410
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343729	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GPSM3 promoter	PMID:27901495
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1343729	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GPSM3 5' UTR	PMID:27901495
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1343729	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of GPSM3 mRNA	PMID:20458559
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of GPSM3 mRNA	PMID:34492290
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1614233	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of GPSM3 mRNA	PMID:18648102
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1614233	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of GPSM3 mRNA	PMID:17426115
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPSM3 mRNA	PMID:19710929
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of GPSM3 mRNA	PMID:19167457
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GPSM3 mRNA	PMID:25181051
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1614233	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of GPSM3 mRNA	PMID:32156529
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1614233	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of GPSM3 gene	PMID:31683443
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614233	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of GPSM3 mRNA	PMID:40203079
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of GPSM3 mRNA	PMID:21241498
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1614233	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of GPSM3 mRNA	PMID:28392331
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1343729	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of GPSM3 gene	PMID:22964155
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343729	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GPSM3 mRNA	PMID:37042841
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of GPSM3 promoter	PMID:22457795
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1343729	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of GPSM3 mRNA	PMID:24449571
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1343729	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of GPSM3 mRNA	PMID:28001369
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GPSM3 mRNA	PMID:37992649
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614233	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GPSM3 mRNA	PMID:17562736
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GPSM3 mRNA	PMID:40504410
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1343729	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of GPSM3 mRNA	PMID:31838189
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1343729	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of GPSM3 mRNA	PMID:20458559
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GPSM3 mRNA	PMID:35964746
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1343729	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of GPSM3 mRNA	PMID:20977926
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1614233	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of GPSM3 mRNA	PMID:38701926
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1343729	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of GPSM3 mRNA	PMID:15336504
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1614233	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GPSM3 mRNA	PMID:22206623
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614233	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of GPSM3 mRNA	PMID:22206623
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of GPSM3 mRNA	PMID:32109520
1303014	Gpsm3	G-protein signaling modulator 3	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1614233	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of GPSM3 protein	PMID:35357534
1303015	Commd10	COMM domain containing 10	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of COMMD10 mRNA	PMID:21934132
1303015	Commd10	COMM domain containing 10	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of COMMD10 mRNA	PMID:21632981
1303015	Commd10	COMM domain containing 10	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of COMMD10 gene	PMID:27618143
1303015	Commd10	COMM domain containing 10	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1346630	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in increased expression of COMMD10 mRNA	PMID:27905399
1303015	Commd10	COMM domain containing 10	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of COMMD10 mRNA	PMID:33387578
1303015	Commd10	COMM domain containing 10	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332145	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COMMD10 mRNA	PMID:36331819
1303015	Commd10	COMM domain containing 10	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COMMD10 mRNA	PMID:19549813
1303015	Commd10	COMM domain containing 10	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of COMMD10 mRNA	PMID:23649840
1303015	Commd10	COMM domain containing 10	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1346630	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of COMMD10 protein	PMID:20106945
1303015	Commd10	COMM domain containing 10	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1332145	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of COMMD10 mRNA	PMID:19770486
1303015	Commd10	COMM domain containing 10	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of COMMD10 mRNA	PMID:23649840
1303015	Commd10	COMM domain containing 10	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of COMMD10 mRNA	PMID:25102026
1303015	Commd10	COMM domain containing 10	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332145	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of COMMD10 mRNA	PMID:31919559
1303015	Commd10	COMM domain containing 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332145	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COMMD10 mRNA	PMID:22206623
1303015	Commd10	COMM domain containing 10	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346630	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of COMMD10 mRNA	PMID:23557933
1303015	Commd10	COMM domain containing 10	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of COMMD10 mRNA	PMID:27392435|PMID:27594783
1303015	Commd10	COMM domain containing 10	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1346630	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of COMMD10 mRNA	PMID:27392435
1303015	Commd10	COMM domain containing 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332145	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COMMD10 mRNA	PMID:21570461|PMID:24680724
1303015	Commd10	COMM domain containing 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COMMD10 mRNA	PMID:17101203
1303015	Commd10	COMM domain containing 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332145	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COMMD10 mRNA	PMID:17942748
1303015	Commd10	COMM domain containing 10	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of COMMD10 mRNA	PMID:33212167
1303015	Commd10	COMM domain containing 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of COMMD10 mRNA	PMID:39719251
1303015	Commd10	COMM domain containing 10	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346630	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COMMD10 mRNA	PMID:38568856
1303015	Commd10	COMM domain containing 10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332145	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COMMD10 mRNA	PMID:19770486|PMID:21715664
1303015	Commd10	COMM domain containing 10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COMMD10 mRNA	PMID:20064835|PMID:21632981|PMID:26238291
1303015	Commd10	COMM domain containing 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1346630	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of COMMD10 promoter	PMID:27901495
1303015	Commd10	COMM domain containing 10	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1346630	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to COMMD10 mRNA]	PMID:32406909
1303015	Commd10	COMM domain containing 10	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of COMMD10 mRNA	PMID:26238291
1303015	Commd10	COMM domain containing 10	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of COMMD10 mRNA	PMID:25729387
1303015	Commd10	COMM domain containing 10	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of COMMD10 mRNA	PMID:30047161
1303015	Commd10	COMM domain containing 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332145	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of COMMD10 gene	PMID:35295148
1303015	Commd10	COMM domain containing 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of COMMD10 mRNA	PMID:30816183|PMID:32528016
1303015	Commd10	COMM domain containing 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COMMD10 mRNA	PMID:25181051
1303015	Commd10	COMM domain containing 10	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346630	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COMMD10 mRNA	PMID:28628672
1303015	Commd10	COMM domain containing 10	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332145	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COMMD10 mRNA	PMID:37019170
1303015	Commd10	COMM domain containing 10	gene	CHEBI:34687	dibutyl phthalate	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D003993	Dibutyl Phthalate affects the expression of COMMD10 mRNA	PMID:30934153
1303015	Commd10	COMM domain containing 10	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1346630	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COMMD10 mRNA	PMID:28628672
1303015	Commd10	COMM domain containing 10	gene	CHEBI:35176	zinc sulfate	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of COMMD10 mRNA	PMID:16330358
1303015	Commd10	COMM domain containing 10	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of COMMD10 mRNA	PMID:38568856
1303015	Commd10	COMM domain containing 10	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of COMMD10 gene	PMID:22079235
1303015	Commd10	COMM domain containing 10	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of COMMD10 mRNA	PMID:30047161
1303015	Commd10	COMM domain containing 10	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of COMMD10 mRNA	PMID:28302478
1303015	Commd10	COMM domain containing 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332145	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COMMD10 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of COMMD10 mRNA	PMID:36331819
1303015	Commd10	COMM domain containing 10	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332145	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid affects the expression of COMMD10 mRNA	PMID:17292431|PMID:17963808
1303015	Commd10	COMM domain containing 10	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of COMMD10 mRNA	PMID:23179753|PMID:27188386
1303015	Commd10	COMM domain containing 10	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of COMMD10 mRNA	PMID:30047161
1303015	Commd10	COMM domain containing 10	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346630	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of COMMD10 mRNA	PMID:25562108
1303015	Commd10	COMM domain containing 10	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1346630	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COMMD10 mRNA	PMID:28628672
1303015	Commd10	COMM domain containing 10	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1332145	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of COMMD10 mRNA	PMID:28973697
1303015	Commd10	COMM domain containing 10	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COMMD10 mRNA	PMID:33387578
1303015	Commd10	COMM domain containing 10	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1332145	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of COMMD10 mRNA	PMID:17942748
1303015	Commd10	COMM domain containing 10	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1332145	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COMMD10 mRNA	PMID:17942748
1303015	Commd10	COMM domain containing 10	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of COMMD10 mRNA	PMID:32234424
1303015	Commd10	COMM domain containing 10	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in decreased expression of COMMD10 mRNA	PMID:17211630
1303015	Commd10	COMM domain containing 10	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1346630	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COMMD10 mRNA	PMID:28628672
1303015	Commd10	COMM domain containing 10	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1346630	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of COMMD10 mRNA]	PMID:21095227
1303015	Commd10	COMM domain containing 10	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332145	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of COMMD10 mRNA	PMID:25620056
1303015	Commd10	COMM domain containing 10	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of COMMD10 mRNA	PMID:24136188
1303015	Commd10	COMM domain containing 10	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of COMMD10 mRNA	PMID:30047161
1303015	Commd10	COMM domain containing 10	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332145	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of COMMD10 mRNA	PMID:35964746
1303015	Commd10	COMM domain containing 10	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of COMMD10 mRNA	PMID:24136188
1303015	Commd10	COMM domain containing 10	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of COMMD10 mRNA	PMID:25729387
1303015	Commd10	COMM domain containing 10	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of COMMD10 gene	PMID:35440735
1303015	Commd10	COMM domain containing 10	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332145	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of COMMD10 mRNA	PMID:22206623
1303015	Commd10	COMM domain containing 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332145	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COMMD10 mRNA	PMID:22206623
1303015	Commd10	COMM domain containing 10	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of COMMD10 mRNA	PMID:19287073
1303015	Commd10	COMM domain containing 10	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1346630	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of COMMD10 mRNA	PMID:30928695
1303015	Commd10	COMM domain containing 10	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of COMMD10 mRNA	PMID:30047161
1303015	Commd10	COMM domain containing 10	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of COMMD10 mRNA	PMID:30047161
1303015	Commd10	COMM domain containing 10	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of COMMD10 mRNA	PMID:21346803
1303017	RT1-CE6	RT1 class I, locus CE6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-CE6 mRNA	PMID:32741896
1303017	RT1-CE6	RT1 class I, locus CE6	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-CE6 mRNA	PMID:32741896
1303017	RT1-CE6	RT1 class I, locus CE6	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RT1-CE6 mRNA	PMID:31881176
1303017	RT1-CE6	RT1 class I, locus CE6	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RT1-CE6 mRNA	PMID:32721576
1303017	RT1-CE6	RT1 class I, locus CE6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RT1-CE6 mRNA	PMID:25181051
1303017	RT1-CE6	RT1 class I, locus CE6	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-CE6 mRNA	PMID:32741896
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MCM7 mRNA	PMID:38218311
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20170228	CTD	MESH:C014026	hexamethylene bisacetamide results in decreased expression of MCM7 mRNA	PMID:26941288
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:132098	methoxyacetic acid	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20260602	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of MCM7 mRNA	PMID:41903202
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1557018	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MCM7 mRNA	PMID:33045310
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MCM7 mRNA]	PMID:31150632
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:133296	microcystin RR	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20161004	CTD	MESH:C063855	microcystin RR results in decreased expression of MCM7 protein	PMID:19111056
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:133296	microcystin RR	increases expression	ISO	RGD:1347363	E	RGD:6480464	20161004	CTD	MESH:C063855	microcystin RR results in increased expression of MCM7 protein	PMID:19111056
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MCM7 gene	PMID:20938992
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MCM7 mRNA	PMID:16249480|PMID:33167477
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1557018	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MCM7 mRNA	PMID:30319688
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of MCM7 mRNA	PMID:23727915
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557018	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MCM7 mRNA	PMID:39241906
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MCM7 mRNA	PMID:32145629
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1347363	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of MCM7 mRNA	PMID:16474171|PMID:19167446|PMID:24758408
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20160412	CTD	MESH:D004958	[Estradiol co-treated with EGF protein] results in increased expression of MCM7 mRNA; Tamoxifen inhibits the reaction [[Estradiol co-treated with EGF protein] results in increased expression of MCM7 mRNA]; Tamoxifen inhibits the reaction [Estradiol results in increased expression of MCM7 mRNA]	PMID:24758408
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol inhibits the reaction [Progesterone affects the localization of MCM7 protein]	PMID:16966611
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1347363	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MCM7 mRNA	PMID:38568856
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MCM7 gene	PMID:20938992
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:16827	corticosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003345	Corticosterone results in decreased expression of MCM7 mRNA	PMID:15755911
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17026	progesterone	affects localization	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the localization of MCM7 protein	PMID:16966611
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D011374	Estradiol inhibits the reaction [Progesterone affects the localization of MCM7 protein]	PMID:16966611
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1347363	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MCM7 mRNA	PMID:21179406
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of MCM7 mRNA	PMID:26079696
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of MCM7 mRNA	PMID:38160208
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20250311	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MCM7 mRNA	PMID:33162236
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MCM7 mRNA	PMID:21592394
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM7 mRNA	PMID:21592394
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1557018	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MCM7 mRNA	PMID:23892564
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17750	glycine betaine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in decreased expression of MCM7 mRNA	PMID:26391144
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MCM7 mRNA	PMID:26577399
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MCM7 mRNA	PMID:21592394
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM7 mRNA	PMID:21592394
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MCM7 mRNA	PMID:33387578
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MCM7 mRNA	PMID:28818685
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MCM7 mRNA	PMID:39836092
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MCM7 mRNA	PMID:37236586
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1347363	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM7 mRNA	PMID:22100608
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1557018	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM7 mRNA	PMID:19770486
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1347363	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MCM7 gene	PMID:27153756
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MCM7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MCM7 mRNA	PMID:34911549
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MCM7 mRNA	PMID:17484886
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MCM7 mRNA	PMID:31150632
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1557018	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MCM7 mRNA; Carbon Tetrachloride results in increased expression of MCM7 protein	PMID:19887370|PMID:27339419|PMID:31919559
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MCM7 mRNA]	PMID:31150632
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MCM7 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MCM7 gene	PMID:20938992|PMID:22206623
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27496	simazine	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20160705	CTD	MESH:D012839	Simazine results in decreased expression of MCM7 mRNA	PMID:25461544
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MCM7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MCM7 mRNA	PMID:39836092
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MCM7 mRNA	PMID:40504410
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of MCM7 mRNA	PMID:19244175
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1347363	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of MCM7 mRNA	PMID:33512557
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MCM7 mRNA	PMID:26272509
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA	PMID:27188386
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MCM7 mRNA	PMID:31295307
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MCM7 mRNA	PMID:31881176
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of MCM7 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of MCM7 mRNA	PMID:19167446|PMID:23557933
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1347363	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MCM7 mRNA	PMID:28903495
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1347363	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of MCM7 mRNA	PMID:27594783
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of MCM7 mRNA	PMID:18930951
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of MCM7 mRNA	PMID:16474171
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28112	nickel atom	affects expression	ISO	RGD:1347363	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel affects the expression of MCM7 mRNA	PMID:14575637
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20120717	CTD	MESH:D009532	trichostatin A inhibits the reaction [Nickel affects the expression of MCM7 mRNA]	PMID:14575637
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1347363	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM7 mRNA	PMID:22574217
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557018	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM7 mRNA	PMID:21570461
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MCM7 mRNA	PMID:21802500
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MCM7 mRNA	PMID:16611356
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM7 mRNA	PMID:34747641
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM7 mRNA	PMID:15667827
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MCM7 mRNA	PMID:17942748
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MCM7 protein	PMID:39603559
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MCM7 mRNA	PMID:28001369
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of MCM7 mRNA	PMID:26272509
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA	PMID:27188386
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of MCM7 mRNA	PMID:22465980|PMID:30556269
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MCM7 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MCM7 mRNA	PMID:20971185|PMID:30911355
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MCM7 mRNA	PMID:29803840
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1557018	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of MCM7 mRNA	PMID:25896364|PMID:39631538
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1347363	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of MCM7 protein	PMID:35688186
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCM7 mRNA	PMID:35314868
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCM7 mRNA	PMID:12760830|PMID:24516582|PMID:38568856
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCM7 mRNA	PMID:16014739
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347363	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of MCM7 mRNA	PMID:34032870
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MCM7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MCM7 mRNA	PMID:39836092
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MCM7 mRNA	PMID:40504410
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM7 mRNA	PMID:16120219|PMID:20064835|PMID:21802500
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1557018	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MCM7 exon	PMID:27901495
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCM7 mRNA; Benzo(a)pyrene results in increased expression of MCM7 protein	PMID:20097212|PMID:32234424
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1557018	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCM7 mRNA	PMID:19770486|PMID:22342234
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of MCM7 mRNA	PMID:22465980|PMID:30556269
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MCM7 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MCM7 mRNA	PMID:20971185|PMID:30911355
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MCM7 mRNA	PMID:25351596
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MCM7 mRNA	PMID:20382639
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MCM7 mRNA; Arsenic Trioxide results in decreased expression of MCM7 protein	PMID:26705709|PMID:34413873
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1347363	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MCM7 protein	PMID:19364129
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MCM7 protein]	PMID:26598702
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:30660	thyroxine	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:D013974	Thyroxine results in increased expression of MCM7 protein	PMID:25298361
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MCM7 mRNA	PMID:25729387
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM7 mRNA	PMID:25729387
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of MCM7 mRNA	PMID:24136188
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1557018	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MCM7 mRNA	PMID:23557971
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MCM7 mRNA	PMID:34492290
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557018	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MCM7 mRNA	PMID:17426115|PMID:17950772|PMID:18301758|PMID:20813756|PMID:23811191
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of MCM7 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of MCM7 mRNA]	PMID:17950772|PMID:20813756
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MCM7 mRNA	PMID:38479592
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MCM7 mRNA	PMID:25181051|PMID:32145629
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1347363	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MCM7 mRNA	PMID:30903817
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM7 mRNA	PMID:26982218
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM7 mRNA; bisphenol A results in decreased expression of MCM7 protein	PMID:29275510|PMID:37567409
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1347363	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MCM7 gene	PMID:31601247
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MCM7 mRNA	PMID:30816183|PMID:32528016
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of MCM7 mRNA	PMID:16474171
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MCM7 mRNA	PMID:36041667
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1347363	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of MCM7 mRNA	PMID:24752500
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MCM7 mRNA	PMID:40203079
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MCM7 mRNA	PMID:36041667
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1557018	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MCM7 mRNA	PMID:26377693
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MCM7 mRNA	PMID:36041667
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MCM7 mRNA	PMID:21241498
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of MCM7 mRNA	PMID:31558096
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MCM7 mRNA	PMID:37019170
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MCM7 mRNA	PMID:21266533
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MCM7 mRNA	PMID:17361019|PMID:21266533
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1557018	E	RGD:6480464	20180703	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of MCM7 mRNA	PMID:21404309
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of MCM7 mRNA	PMID:19996281
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MCM7 mRNA; Diethylnitrosamine results in increased expression of MCM7 protein	PMID:17854601|PMID:19887370
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D004052	AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of MCM7 mRNA]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MCM7 mRNA]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MCM7 protein]	PMID:17854601|PMID:19887370|PMID:19996281
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20220111	CTD	MESH:D010269	Paraquat results in decreased expression of MCM7 mRNA	PMID:34097952
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of MCM7 mRNA	PMID:26678675
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MCM7 mRNA	PMID:39836092
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of MCM7 mRNA	PMID:18500788
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MCM7 mRNA; Cadmium Chloride results in decreased expression of MCM7 protein	PMID:24527689|PMID:38174414|PMID:38568856
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MCM7 mRNA	PMID:37236586
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MCM7 mRNA	PMID:19376846
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of MCM7 mRNA	PMID:19244175
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of MCM7 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MCM7 mRNA]	PMID:17585979
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1347363	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of MCM7 mRNA	PMID:33512557
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MCM7 mRNA	PMID:31533062
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1347363	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MCM7 mRNA	PMID:19167446
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM7 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MCM7 mRNA	PMID:19167446
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MCM7 mRNA	PMID:39529242
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:3930	cryptolepine	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of MCM7 mRNA	PMID:16120219
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of MCM7 mRNA	PMID:22110744
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of MCM7 mRNA	PMID:31558096
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of MCM7 mRNA	PMID:25993096
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of MCM7 mRNA	PMID:17198877
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347363	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MCM7 mRNA	PMID:25979313
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MCM7 mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of MCM7 mRNA	PMID:41580965
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MCM7 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of MCM7 mRNA	PMID:15604281
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20160412	CTD	MESH:D013629	Tamoxifen inhibits the reaction [[Estradiol co-treated with EGF protein] results in increased expression of MCM7 mRNA]; Tamoxifen inhibits the reaction [Estradiol results in increased expression of MCM7 mRNA]	PMID:24758408
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MCM7 mRNA	PMID:37077353
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MCM7 mRNA	PMID:24136188
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1347363	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MCM7 mRNA	PMID:28542535
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20120717	CTD	MESH:C012589	trichostatin A inhibits the reaction [Nickel affects the expression of MCM7 mRNA]	PMID:14575637
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MCM7 mRNA	PMID:17562736
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1347363	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MCM7 protein	PMID:22230336
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of MCM7 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MCM7 mRNA]	PMID:17585979
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D005472	MCM7 protein affects the susceptibility to Fluorouracil	PMID:15548681
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM7 mRNA]	PMID:15016801
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MCM7 mRNA	PMID:29432896
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MCM7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MCM7 mRNA	PMID:39836092
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MCM7 mRNA	PMID:40504410
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1347363	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of MCM7 mRNA	PMID:24752500
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of MCM7 mRNA	PMID:37077353
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:48607	lithium chloride	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in decreased expression of MCM7 mRNA	PMID:17440966
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:48707	(-)-citrinin	increases expression	ISO	RGD:1347363	E	RGD:6480464	20250603	CTD	MESH:D002953	Citrinin results in increased expression of MCM7 protein	PMID:39638853
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MCM7 mRNA	PMID:17942748
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MCM7 mRNA	PMID:17942748
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20130416	CTD	MESH:D005047	Etoposide results in decreased expression of MCM7 mRNA	PMID:16120219
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:49603	lapatinib	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20170228	CTD	MESH:C490728	lapatinib results in decreased expression of MCM7 protein	PMID:25221644
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:49603	lapatinib	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20170228	CTD	MESH:C490728	ERBB2 protein affects the reaction [lapatinib results in decreased expression of MCM7 protein]	PMID:25221644
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of MCM7 mRNA	PMID:26272509
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA	PMID:27188386
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MCM7 mRNA; Arsenic Trioxide results in decreased expression of MCM7 protein	PMID:26705709|PMID:34413873
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1347363	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MCM7 protein	PMID:19364129
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MCM7 protein]	PMID:26598702
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1347363	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of MCM7 mRNA	PMID:33512557
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects methylation	ISO	RGD:1347363	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the methylation of MCM7 gene	PMID:17630775
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557018	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MCM7 mRNA; Nanotubes, Carbon results in increased expression of MCM7 mRNA	PMID:25554681
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MCM7 mRNA	PMID:24136188
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of MCM7 mRNA	PMID:17659339
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1557018	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MCM7 mRNA	PMID:19042947
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1557018	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in increased expression of MCM7 mRNA	PMID:21404309
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of MCM7 mRNA	PMID:11678601
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1557018	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of MCM7 mRNA	PMID:21404309
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MCM7 protein	PMID:32959892
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of MCM7 mRNA	PMID:19606018
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MCM7 mRNA	PMID:39836092
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MCM7 mRNA	PMID:25729387
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM7 mRNA	PMID:25729387
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MCM7 mRNA	PMID:15336504
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MCM7 mRNA	PMID:37269647
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of MCM7 protein	PMID:35926579
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1557018	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of MCM7 mRNA	PMID:27462272
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of MCM7 mRNA	PMID:36519830
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MCM7 mRNA	PMID:22206623
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of MCM7 protein	PMID:29031202
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1347363	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MCM7 protein	PMID:31285264
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1347363	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MCM7 mRNA; 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MCM7 protein	PMID:16120219
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of MCM7 mRNA	PMID:12517777
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1347363	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of MCM7 protein	PMID:39638853
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of MCM7 mRNA	PMID:21346803
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of MCM7 mRNA	PMID:34995734
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA	PMID:27188386
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1347363	E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in increased expression of MCM7 mRNA	PMID:31437187
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1347363	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MCM7 mRNA	PMID:19159669
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1557018	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of MCM7 mRNA	PMID:23091169
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM7 mRNA	PMID:19167446
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1557018	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MCM7 mRNA	PMID:38648751
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of MCM7 mRNA	PMID:31558096
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of MCM7 protein	PMID:38348393
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1557018	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MCM7 mRNA	PMID:39847705
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MCM7 protein	PMID:25298361
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MCM7 mRNA	PMID:24780913
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of MCM7 mRNA; palbociclib results in decreased expression of MCM7 protein	PMID:20473330|PMID:22869556
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:85993	palbociclib	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20170303	CTD	MESH:C500026	RB1 protein affects the reaction [palbociclib results in decreased expression of MCM7 protein]	PMID:20473330
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347363	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA	PMID:27188386
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1557018	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus inhibits the reaction [IL2 protein results in increased expression of MCM7 mRNA]	PMID:11355896
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MCM7 mRNA	PMID:21346803
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:9381	T-2 toxin	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of MCM7 protein	PMID:26141394
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1347363	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MCM7 mRNA	PMID:33512557
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MCM7 mRNA	PMID:38568856
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1347363	E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in increased expression of MCM7 mRNA	PMID:19442820
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1347363	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of MCM7 mRNA	PMID:19140230
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of MCM7 mRNA	PMID:28973697
1303018	Mcm7	minichromosome maintenance complex component 7	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1557018	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of MCM7 mRNA	PMID:35537566
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1347180	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of RPL17 protein	PMID:39638853
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of RPL17 mRNA	PMID:35967413
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:1224	2-nitrofluorene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C019499	2-nitrofluorene results in increased expression of RPL17 mRNA	PMID:15890375
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPL17 protein]	PMID:38195004
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:15368	acrolein	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of RPL17 mRNA	PMID:38090360
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RPL17 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of RPL17 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RPL17 mRNA	PMID:32699268|PMID:32845096
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of RPL17 mRNA	PMID:24763279
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1552369	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of RPL17 mRNA	PMID:30319688
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552369	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RPL17 mRNA	PMID:39241906
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1552369	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RPL17 mRNA]	PMID:39241906
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1347180	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RPL17 mRNA	PMID:37042841
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of RPL17 mRNA	PMID:20655997
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1347180	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RPL17 protein	PMID:37730182
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RPL17 mRNA	PMID:22061828
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552369	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL17 mRNA	PMID:36331819
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPL17 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPL17 protein	PMID:38195004
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20121023	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RPL17 mRNA	PMID:19549813
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL17 protein	PMID:23301498
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C016517	indole-3-carbinol affects the expression of RPL17 mRNA	PMID:21396975
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RPL17 mRNA	PMID:15890375
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RPL17 mRNA	PMID:23649840
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of RPL17 mRNA	PMID:41580963
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RPL17 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of RPL17 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RPL17 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RPL17 mRNA	PMID:32699268|PMID:32845096
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of RPL17 mRNA	PMID:19483382
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RPL17 mRNA	PMID:30723492|PMID:31150632
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552369	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RPL17 mRNA	PMID:25629700
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552369	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL17 mRNA	PMID:22206623
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1347180	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of RPL17 mRNA	PMID:33512557
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1347180	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RPL17 protein	PMID:35688186
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:1347180	E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in increased expression of RPL17 protein	PMID:31195006
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552369	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of RPL17 mRNA	PMID:28960355
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1552369	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of RPL17 mRNA	PMID:30912803
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPL17 mRNA	PMID:34747641
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPL17 mRNA	PMID:33387578
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552369	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RPL17 mRNA	PMID:16214954
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1347180	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of RPL17 mRNA	PMID:33512557
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1347180	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RPL17 mRNA	PMID:34089799
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of RPL17 mRNA	PMID:23649840
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1552369	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RPL17 protein	PMID:28918527
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1347180	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of RPL17 protein	PMID:29385562
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RPL17 mRNA	PMID:29803840
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of RPL17 mRNA	PMID:35314868
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RPL17 mRNA	PMID:38568856|PMID:39719251
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552369	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of RPL17 mRNA	PMID:39515575
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of and results in increased activity of RPL17 protein	PMID:30528433
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552369	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RPL17 mRNA	PMID:19770486
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RPL17 mRNA]; arsenite promotes the reaction [G3BP1 protein binds to RPL17 protein]	PMID:32406909
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of RPL17 mRNA	PMID:19483382
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of RPL17 mRNA	PMID:12852829
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1347180	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of RPL17 mRNA	PMID:20458559
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RPL17 mRNA	PMID:16483693
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RPL17 gene	PMID:31601247
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:31767	lead diacetate	affects expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C008261	lead acetate affects the expression of RPL17 protein	PMID:36539177
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of RPL17 mRNA	PMID:19483382
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of RPL17 mRNA	PMID:19483382
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RPL17 mRNA	PMID:15890375
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of RPL17 mRNA	PMID:15890375
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of RPL17 mRNA	PMID:15890375
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552369	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RPL17 mRNA	PMID:28472532
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1347180	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RPL17 mRNA	PMID:30903817
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL17 mRNA; bisphenol A results in decreased expression of RPL17 protein	PMID:29275510|PMID:34186270|PMID:37567409
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552369	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL17 mRNA	PMID:33221593
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RPL17 mRNA	PMID:25181051|PMID:30816183|PMID:41034487
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552369	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of RPL17 mRNA	PMID:25594700|PMID:32156529|PMID:38074096
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RPL17 gene	PMID:28505145
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RPL17 gene	PMID:31601247
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1552369	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of RPL17 mRNA	PMID:39298647
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1347180	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RPL17 gene	PMID:31601247
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1347180	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of RPL17 protein	PMID:34186270
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552369	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RPL17 mRNA	PMID:38685157
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1347180	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RPL17 protein	PMID:34186270
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RPL17 mRNA	PMID:28628672
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1347180	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RPL17 protein	PMID:34186270
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RPL17 mRNA	PMID:28628672
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1552369	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RPL17 mRNA	PMID:17942915
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1552369	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RPL17 mRNA]	PMID:17942915
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of RPL17 mRNA	PMID:32680482
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1552369	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RPL17 mRNA]	PMID:39241906
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPL17 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RPL17 protein	PMID:38195004
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1347180	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of RPL17 protein	PMID:26879310
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of RPL17 mRNA	PMID:15890375
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	ISO	RGD:1552369	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of RPL17 mRNA	PMID:25908611
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RPL17 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RPL17 mRNA	PMID:32699268
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of RPL17 mRNA	PMID:19483382
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1347180	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of RPL17 mRNA	PMID:33512557
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of RPL17 mRNA	PMID:26352163
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552369	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL17 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RPL17 mRNA	PMID:36331819
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552369	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RPL17 mRNA	PMID:17963808
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL17 mRNA	PMID:17183730
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1347180	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of RPL17 mRNA	PMID:33512557
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RPL17 mRNA	PMID:28628672
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RPL17 mRNA	PMID:15890375
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1347180	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of RPL17 mRNA	PMID:33512557
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of RPL17 mRNA	PMID:23649840
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of RPL17 mRNA	PMID:24136188
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1347180	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of RPL17 protein	PMID:31195006
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1347180	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RPL17 mRNA	PMID:18175754
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of RPL17 mRNA	PMID:19483382
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RPL17 mRNA	PMID:28628672
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of RPL17 mRNA	PMID:12852829
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1347180	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of RPL17 mRNA	PMID:20458559
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1347180	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of RPL17 mRNA	PMID:33512557
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552369	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RPL17 mRNA; Nanotubes, Carbon results in increased expression of RPL17 mRNA	PMID:25554681
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20161228	CTD	MESH:D037742	[Nanotubes, Carbon co-treated with calfactant] results in increased expression of RPL17 protein	PMID:23026733
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RPL17 mRNA	PMID:24136188
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL17 mRNA	PMID:17183730
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPL17 protein	PMID:32959892
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1552369	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of RPL17 protein	PMID:36851058
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008701	Methapyrilene results in increased expression of RPL17 mRNA	PMID:15890375
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1552369	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of RPL17 mRNA	PMID:27462272
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of RPL17 mRNA	PMID:39938710
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1347180	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RPL17 protein	PMID:34186270
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552369	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL17 mRNA	PMID:22206623
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL17 protein	PMID:37664457
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RPL17 mRNA	PMID:24136188
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:749466	calfactant	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20260721	CTD	MESH:C117342	[Nanotubes, Carbon co-treated with calfactant] results in increased expression of RPL17 protein	PMID:23026733
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1347180	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RPL17 protein	PMID:31285264
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of RPL17 mRNA	PMID:19483382
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of RPL17 mRNA	PMID:19483382
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552369	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPL17 mRNA	PMID:30294300
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1347180	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of RPL17 mRNA	PMID:33512557
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RPL17 protein	PMID:38348393
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of RPL17 mRNA	PMID:19483382
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1552369	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RPL17 mRNA]	PMID:39241906
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347180	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL17 protein	PMID:37664457
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RPL17 mRNA	PMID:21346803
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1347180	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RPL17 mRNA	PMID:38568856
1303019	Rpl17	ribosomal protein L17	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RPL17 mRNA	PMID:21346803
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1353772	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of RNASE6 mRNA	PMID:35967413
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1353772	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of RNASE6 mRNA	PMID:11906190
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RNASE6 mRNA	PMID:36331819
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1331923	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNASE6 mRNA	PMID:39241906
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RNASE6 mRNA	PMID:33387578
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353772	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RNASE6 mRNA	PMID:37042841
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNASE6 mRNA	PMID:37992649
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNASE6 mRNA	PMID:37992649
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RNASE6 mRNA	PMID:33387578
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1353772	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of RNASE6 mRNA	PMID:21120746
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNASE6 mRNA	PMID:37236586
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1353772	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNASE6 mRNA	PMID:35301059
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1353772	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RNASE6 gene	PMID:27153756
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RNASE6 mRNA	PMID:30779732
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RNASE6 mRNA	PMID:19784758
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1353772	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of RNASE6 mRNA	PMID:27594783
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1353772	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RNASE6 mRNA	PMID:25583101
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1331923	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNASE6 mRNA	PMID:26377647
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNASE6 mRNA	PMID:33387578
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1353772	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of RNASE6 mRNA	PMID:23649840
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1331923	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNASE6 mRNA	PMID:39631538
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNASE6 mRNA	PMID:37992649
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RNASE6 mRNA	PMID:34876320
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RNASE6 mRNA	PMID:34876320
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1331923	E	RGD:6480464	20151006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNASE6 mRNA	PMID:21569818
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:29866	arsenite(3-)	affects expression	ISO	RGD:1353772	E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of RNASE6 mRNA	PMID:22959463
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1331923	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of RNASE6 mRNA	PMID:27760801|PMID:29264374
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1331923	E	RGD:6480464	20151006	CTD	MESH:C009495	titanium dioxide results in increased expression of RNASE6 mRNA	PMID:23557971|PMID:35295148
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide results in increased expression of RNASE6 mRNA	PMID:19784758
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1353772	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RNASE6 mRNA	PMID:19710929
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RNASE6 mRNA	PMID:25181051
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNASE6 gene	PMID:28505145
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1331923	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RNASE6 mRNA	PMID:32715474
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353772	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNASE6 mRNA	PMID:37042841
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNASE6 mRNA	PMID:37236586
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1353772	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNASE6 mRNA	PMID:35301059
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1353772	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RNASE6 mRNA	PMID:24449571
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1331923	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RNASE6 mRNA	PMID:40194260
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RNASE6 mRNA	PMID:36331819
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1331923	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of RNASE6 mRNA	PMID:29038090
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:39481	chloroprene	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of RNASE6 mRNA	PMID:23125180
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1331923	E	RGD:6480464	20151006	CTD	MESH:D002737	Chloroprene results in decreased expression of RNASE6 mRNA	PMID:23125180
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1353772	E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of RNASE6 mRNA	PMID:17685462
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1353772	E	RGD:6480464	20210608	CTD	MESH:D016572	Cyclosporine results in decreased expression of RNASE6 mRNA	PMID:33631201
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNASE6 mRNA	PMID:37992649
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of RNASE6 mRNA	PMID:19784758|PMID:33387578
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of RNASE6 mRNA	PMID:19784758
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:47381	diclofenac	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D004008	Diclofenac results in increased expression of RNASE6 mRNA	PMID:30723492
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:48109	nitrobenzenes	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D009578	Nitrobenzenes analog results in increased expression of RNASE6 mRNA	PMID:19784758
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:48318	fragrance	increases expression	ISO	RGD:1353772	E	RGD:6480464	20170228	CTD	MESH:D010476	Perfume results in increased expression of RNASE6 mRNA	PMID:24768652
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RNASE6 mRNA	PMID:34876320
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1353772	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RNASE6 mRNA	PMID:18175754
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1331923	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RNASE6 mRNA; Nanotubes, Carbon results in decreased expression of RNASE6 mRNA	PMID:25554681
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RNASE6 mRNA	PMID:35964746
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1353772	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of RNASE6 mRNA	PMID:16780908
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1331923	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RNASE6 mRNA	PMID:38701926
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1331923	E	RGD:6480464	20151006	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of RNASE6 mRNA	PMID:19812364
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1331923	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of RNASE6 mRNA	PMID:36851058
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008294	Malathion results in increased expression of RNASE6 mRNA	PMID:19784758
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1331923	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RNASE6 mRNA	PMID:22206623
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1353772	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RNASE6 gene]	PMID:28238834
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1331923	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of RNASE6 mRNA	PMID:38648751
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RNASE6 mRNA	PMID:27935865
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1331923	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RNASE6 mRNA	PMID:39847705
1303020	Rnase6	ribonuclease A family member 6	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1331923	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RNASE6 mRNA	PMID:34876320
1303021	Prss45	serine protease 45	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1606871	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PRSS45P mRNA	PMID:22378314
1303021	Prss45	serine protease 45	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1620491	E	RGD:6480464	20240806	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PRSS45 mRNA; Diethylhexyl Phthalate results in decreased expression of PRSS45 protein	PMID:36356568
1303021	Prss45	serine protease 45	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1620491	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PRSS45 mRNA	PMID:34319233
1303021	Prss45	serine protease 45	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1606871	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PRSS45P gene	PMID:27153756
1303021	Prss45	serine protease 45	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of PRSS45 gene	PMID:31011160
1303021	Prss45	serine protease 45	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606871	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PRSS45P mRNA	PMID:23557933
1303021	Prss45	serine protease 45	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1620491	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PRSS45 mRNA	PMID:27862939
1303021	Prss45	serine protease 45	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1620491	E	RGD:6480464	20240604	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PRSS45 mRNA	PMID:38641015
1303021	Prss45	serine protease 45	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRSS45 mRNA	PMID:25181051
1303021	Prss45	serine protease 45	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606871	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PRSS45 mRNA	PMID:38382870
1303021	Prss45	serine protease 45	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606871	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PRSS45P gene]	PMID:28238834
1303021	Prss45	serine protease 45	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of PRSS45 mRNA	PMID:29162477
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20211109	CTD	MESH:C007262	deoxynivalenol results in decreased expression of TOMM40 protein	PMID:33890134
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1331920	E	RGD:6480464	20141223	CTD	MESH:D015025	Zearalenone results in increased expression of TOMM40 protein	PMID:25058043
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1331920	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TOMM40 mRNA	PMID:33045310
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TOMM40 mRNA]	PMID:31150632
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1331920	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TOMM40 mRNA	PMID:20188158
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TOMM40 gene	PMID:20938992
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of TOMM40 mRNA	PMID:26516004
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TOMM40 mRNA	PMID:30529165
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TOMM40 mRNA	PMID:22378314
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1331920	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TOMM40 mRNA	PMID:39241906
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TOMM40 mRNA]	PMID:39241906
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of TOMM40 mRNA	PMID:32145629
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1343121	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TOMM40 mRNA	PMID:31614463
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1343121	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TOMM40 mRNA	PMID:38568856
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TOMM40 gene	PMID:20938992
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1343121	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TOMM40 mRNA	PMID:21179406
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TOMM40 mRNA	PMID:28818685
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TOMM40 mRNA	PMID:36331819
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM40 mRNA	PMID:39836092
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20210706	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TOMM40 protein	PMID:33040242
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of TOMM40 mRNA	PMID:41580963
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TOMM40 mRNA	PMID:34911549
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of TOMM40 protein	PMID:38598786
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TOMM40 mRNA	PMID:31150632
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TOMM40 mRNA]	PMID:31150632
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TOMM40 gene	PMID:20938992
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1343121	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of TOMM40 mRNA	PMID:18414638
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOMM40 mRNA	PMID:40504410
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM40 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOMM40 mRNA	PMID:39836092
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TOMM40 mRNA	PMID:27392435
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1331920	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of TOMM40 mRNA	PMID:40618947
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TOMM40 mRNA	PMID:27392435
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of TOMM40 protein	PMID:20884965
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20121113	CTD	MESH:D019833	ESR1 promotes the reaction [Genistein results in decreased expression of TOMM40 protein]	PMID:20884965
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TOMM40 mRNA	PMID:32109520
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TOMM40 mRNA	PMID:33387578
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D012402	Rotenone results in decreased expression of TOMM40 protein	PMID:24036476
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1343121	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of TOMM40 protein	PMID:39603559
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1343121	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TOMM40 mRNA	PMID:39709020
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1343121	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of TOMM40 mRNA	PMID:30851411
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1331920	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of TOMM40 mRNA	PMID:30807115
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TOMM40 mRNA	PMID:29803840
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TOMM40 mRNA	PMID:38568856
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1343121	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TOMM40 mRNA	PMID:34032870
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOMM40 mRNA	PMID:40504410
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM40 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOMM40 mRNA	PMID:39836092
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1343121	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TOMM40 mRNA	PMID:25895662
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TOMM40 mRNA	PMID:24136188
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TOMM40 mRNA	PMID:30047161
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1331920	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TOMM40 gene; titanium dioxide results in decreased methylation of TOMM40 promoter	PMID:35295148
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TOMM40 mRNA	PMID:34492290
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1331920	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TOMM40 mRNA	PMID:18301758
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TOMM40 mRNA	PMID:25181051|PMID:32145629
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1331920	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TOMM40 mRNA	PMID:33221593
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1343121	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of TOMM40 protein	PMID:31945527
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1331920	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TOMM40 mRNA	PMID:39298647
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1343121	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TOMM40 protein	PMID:34186270
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1331920	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TOMM40 mRNA	PMID:37019170
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1343121	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TOMM40 gene	PMID:22964155
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TOMM40 mRNA	PMID:21266533
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1331920	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TOMM40 mRNA	PMID:17361019|PMID:21266533
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1343121	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to TOMM40 protein	PMID:32991956
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1331920	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of TOMM40 mRNA	PMID:34813904
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of TOMM40 protein	PMID:38598786
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TOMM40 mRNA]	PMID:39241906
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM40 mRNA	PMID:39836092
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20210706	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TOMM40 protein	PMID:33040242
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1343121	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of TOMM40 protein	PMID:26879310
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1331920	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TOMM40 mRNA	PMID:28903501
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of TOMM40 mRNA	PMID:26352163
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TOMM40 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TOMM40 mRNA	PMID:36331819
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of TOMM40 mRNA	PMID:25993096
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1331920	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TOMM40 mRNA	PMID:17292431
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1343121	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TOMM40 mRNA	PMID:23179753
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1343121	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TOMM40 gene	PMID:29154799
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:42588	4-hydroxyphenyl retinamide	affects expression	ISO	RGD:1343121	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide affects the expression of TOMM40 mRNA	PMID:16570282
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1343121	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of TOMM40 mRNA	PMID:17400583
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TOMM40 mRNA	PMID:24136188
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of TOMM40 mRNA]	PMID:21233418
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1343121	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TOMM40 mRNA	PMID:38832940
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of TOMM40 mRNA	PMID:21346803
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1331920	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TOMM40 mRNA	PMID:17562736
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of TOMM40 mRNA	PMID:32479839
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1343121	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of TOMM40 mRNA	PMID:18414638
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOMM40 mRNA	PMID:40504410
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM40 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOMM40 mRNA	PMID:39836092
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1331920	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TOMM40 mRNA	PMID:35436446
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1331920	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TOMM40 mRNA; Nanotubes, Carbon results in increased expression of TOMM40 mRNA	PMID:25554681|PMID:25620056
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of TOMM40 mRNA	PMID:41580965
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TOMM40 mRNA	PMID:30047161
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TOMM40 mRNA	PMID:24136188
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1331920	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TOMM40 mRNA	PMID:19042947
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1331920	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of TOMM40 mRNA	PMID:23608068
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TOMM40 protein	PMID:32959892
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM40 mRNA	PMID:39836092
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:63630	tolcapone	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to TOMM40 protein	PMID:19783845
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TOMM40 protein	PMID:24806433
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1343121	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TOMM40 protein	PMID:34186270
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1331920	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TOMM40 mRNA	PMID:22206623
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TOMM40 protein	PMID:37664457
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20260602	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [USP30 protein affects the expression of TOMM40 protein]	PMID:40227042
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1343121	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TOMM40 mRNA	PMID:37199045
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of TOMM40 mRNA	PMID:28960945
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of TOMM40 mRNA	PMID:21346803
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1343121	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of TOMM40 mRNA	PMID:30851411
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of TOMM40 mRNA	PMID:32109520
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1331920	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of TOMM40 mRNA	PMID:21278054
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TOMM40 mRNA	PMID:30047161
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1331920	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TOMM40 mRNA]	PMID:39241906
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1331920	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of TOMM40 mRNA	PMID:40826991
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1343121	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TOMM40 protein	PMID:37664457
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TOMM40 mRNA	PMID:21346803
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1331920	E	RGD:6480464	20120501	CTD	MESH:D013311	Streptozocin affects the expression of TOMM40 mRNA	PMID:18583417
1303022	Tomm40	translocase of outer mitochondrial membrane 40	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1343121	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TOMM40 mRNA	PMID:38568856
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1352613	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NUDT2 mRNA	PMID:38218311
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1352613	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of NUDT2 mRNA	PMID:20044591
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1352613	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of NUDT2 mRNA	PMID:20533549|PMID:23019147
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:17422	P(1),P(4)-bis(5'-adenosyl) tetraphosphate	increases hydrolysis	ISO	RGD:1352613	E	RGD:6480464	20161213	CTD	MESH:C020733	NUDT2 protein results in increased hydrolysis of diadenosine tetraphosphate	PMID:20533549
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NUDT2 mRNA	PMID:33387578
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550397	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NUDT2 mRNA	PMID:36331819
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1352613	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NUDT2 mRNA	PMID:19549813
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of NUDT2 protein	PMID:33236894
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1352613	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of NUDT2 mRNA	PMID:35430440
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550397	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NUDT2 mRNA	PMID:31919559
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550397	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUDT2 mRNA	PMID:22206623
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352613	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NUDT2 mRNA	PMID:40512198
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550397	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUDT2 mRNA	PMID:21570461
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1352613	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NUDT2 protein	PMID:33212167
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352613	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of NUDT2 protein	PMID:38228842
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352613	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NUDT2 mRNA	PMID:40512198
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of NUDT2 mRNA	PMID:25729387
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUDT2 mRNA	PMID:25729387
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of NUDT2 mRNA	PMID:30047161
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NUDT2 mRNA	PMID:34492290
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1352613	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of NUDT2 mRNA	PMID:22576693
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NUDT2 mRNA	PMID:25181051
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1352613	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of NUDT2 gene	PMID:22576693
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NUDT2 mRNA	PMID:36041667
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NUDT2 mRNA	PMID:36041667
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NUDT2 mRNA	PMID:36041667
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550397	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NUDT2 mRNA	PMID:17361019|PMID:21266533
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352613	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NUDT2 mRNA	PMID:37042841
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1352613	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NUDT2 protein	PMID:24527689
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:37825	p-toluidine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of NUDT2 mRNA	PMID:27638505
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1352613	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NUDT2 mRNA	PMID:28302478
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1352613	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NUDT2 mRNA	PMID:40419075
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550397	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NUDT2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NUDT2 mRNA	PMID:36331819
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550397	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NUDT2 mRNA	PMID:17963808
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1352613	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of NUDT2 gene	PMID:29154799
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of NUDT2 mRNA	PMID:30047161
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1352613	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of NUDT2 mRNA	PMID:25562108
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1352613	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NUDT2 mRNA	PMID:38832940
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550397	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NUDT2 mRNA	PMID:17562736
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1352613	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NUDT2 mRNA	PMID:29432896
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352613	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NUDT2 mRNA	PMID:40512198
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550397	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of NUDT2 mRNA	PMID:35436446
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550397	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of NUDT2 mRNA	PMID:25620056
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550397	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of NUDT2 mRNA	PMID:25554681
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of NUDT2 mRNA	PMID:23962444
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of NUDT2 mRNA	PMID:30047161
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NUDT2 mRNA	PMID:25729387
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUDT2 mRNA	PMID:25729387
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1550397	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of NUDT2 protein	PMID:36851058
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1550397	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of NUDT2 mRNA	PMID:22078008
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550397	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUDT2 mRNA	PMID:22206623
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352613	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NUDT2 gene]	PMID:28238834
1303023	Nudt2	nudix hydrolase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NUDT2 mRNA	PMID:30047161
1303024	Krt83	keratin 83	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1318342	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT83 protein]	PMID:38195004
1303024	Krt83	keratin 83	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1318342	E	RGD:6480464	20221025	CTD	MESH:C018475	butyraldehyde results in increased expression of KRT83 mRNA	PMID:26079696
1303024	Krt83	keratin 83	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20251118	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KRT83 mRNA	PMID:33387578
1303024	Krt83	keratin 83	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20251118	CTD	MESH:D014241	Trichloroethylene results in increased expression of KRT83 mRNA	PMID:33387578
1303024	Krt83	keratin 83	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1318342	E	RGD:6480464	20221025	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KRT83 mRNA	PMID:31163220
1303024	Krt83	keratin 83	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1318342	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT83 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT83 protein	PMID:38195004
1303024	Krt83	keratin 83	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1318342	E	RGD:6480464	20221025	CTD	MESH:D001151	Arsenic results in increased methylation of KRT83 promoter	PMID:21291286
1303024	Krt83	keratin 83	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1318342	E	RGD:6480464	20221025	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KRT83 mRNA	PMID:23557933
1303024	Krt83	keratin 83	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1318342	E	RGD:6480464	20221025	CTD	MESH:D002945	Cisplatin results in decreased expression of KRT83 mRNA	PMID:27392435
1303024	Krt83	keratin 83	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1318342	E	RGD:6480464	20221025	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of KRT83 mRNA	PMID:27392435
1303024	Krt83	keratin 83	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615965	E	RGD:6480464	20251118	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT83 mRNA	PMID:21570461
1303024	Krt83	keratin 83	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1318342	E	RGD:6480464	20221025	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT83 promoter	PMID:27901495
1303024	Krt83	keratin 83	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615965	E	RGD:6480464	20251118	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KRT83 gene	PMID:35295148
1303024	Krt83	keratin 83	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1318342	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of KRT83 mRNA	PMID:38479592
1303024	Krt83	keratin 83	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251118	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT83 mRNA	PMID:25181051
1303024	Krt83	keratin 83	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20251118	CTD	MESH:C006780	bisphenol A results in increased methylation of KRT83 gene	PMID:28505145
1303024	Krt83	keratin 83	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1615965	E	RGD:6480464	20251118	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KRT83 mRNA	PMID:32715474
1303024	Krt83	keratin 83	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20251118	CTD	MESH:D015029	Zeranol results in decreased expression of KRT83 mRNA	PMID:35163327
1303024	Krt83	keratin 83	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20251118	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of KRT83 mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT83 mRNA	PMID:35163327
1303024	Krt83	keratin 83	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1318342	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KRT83 mRNA	PMID:38382870
1303024	Krt83	keratin 83	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1318342	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT83 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT83 protein	PMID:38195004
1303024	Krt83	keratin 83	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20251118	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of KRT83 mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT83 mRNA	PMID:35163327
1303024	Krt83	keratin 83	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20251118	CTD	MESH:C039281	furan results in increased methylation of KRT83 gene	PMID:22079235
1303024	Krt83	keratin 83	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1318342	E	RGD:6480464	20221025	CTD	MESH:D001151	Arsenic results in increased methylation of KRT83 promoter	PMID:21291286
1303024	Krt83	keratin 83	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615965	E	RGD:6480464	20251118	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KRT83 mRNA	PMID:25620056
1303024	Krt83	keratin 83	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1615965	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of KRT83 mRNA	PMID:38701926
1303024	Krt83	keratin 83	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20251118	CTD	MESH:C025340	manganese chloride results in increased expression of KRT83 mRNA	PMID:28801915
1303024	Krt83	keratin 83	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20251118	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of KRT83 mRNA	PMID:28801915
1303024	Krt83	keratin 83	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20251118	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of KRT83 promoter	PMID:27415467
1303024	Krt83	keratin 83	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1318342	E	RGD:6480464	20221025	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT83 gene]	PMID:28238834
1303024	Krt83	keratin 83	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1615965	E	RGD:6480464	20251118	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of KRT83 mRNA	PMID:38648751
1303024	Krt83	keratin 83	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20251118	CTD	MESH:C028577	monobutyl phthalate results in increased expression of KRT83 mRNA	PMID:29162477
1303024	Krt83	keratin 83	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20251118	CTD	MESH:C025643	vinclozolin results in decreased expression of KRT83 mRNA	PMID:23869203
1303024	Krt83	keratin 83	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20251118	CTD	MESH:C025643	vinclozolin results in increased expression of KRT83 mRNA	PMID:22615374
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1350670	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of PRRC2A protein	PMID:39638853
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1350670	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PRRC2A mRNA	PMID:38218311
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:15600	(+)-catechin	increases expression	ISO	RGD:1350670	E	RGD:6480464	20120412	CTD	MESH:D002392	Catechin results in increased expression of PRRC2A mRNA	PMID:15465739
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1350670	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PRRC2A mRNA	PMID:26079696
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1350670	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PRRC2A mRNA	PMID:22378314
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552374	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PRRC2A mRNA	PMID:30319688
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1552374	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of PRRC2A mRNA	PMID:29018328
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552374	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PRRC2A mRNA	PMID:30319688
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552374	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PRRC2A mRNA	PMID:39298647
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1350670	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of PRRC2A mRNA	PMID:18070364
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1350670	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PRRC2A protein	PMID:37730182
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1350670	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PRRC2A mRNA	PMID:28818685
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PRRC2A protein	PMID:23301498
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1350670	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PRRC2A exon	PMID:30157460
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PRRC2A mRNA	PMID:35430440
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PRRC2A protein	PMID:38598786
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552374	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PRRC2A mRNA]	PMID:22206623
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1350670	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRRC2A gene	PMID:25304211
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PRRC2A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRRC2A mRNA	PMID:40512198
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552374	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRRC2A mRNA	PMID:40504410
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1350670	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PRRC2A protein	PMID:35688186
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1350670	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of PRRC2A mRNA	PMID:12002526
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PRRC2A mRNA	PMID:23557933
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1350670	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of PRRC2A mRNA	PMID:27594783
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552374	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PRRC2A mRNA	PMID:30912803
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PRRC2A mRNA	PMID:33387578
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRRC2A mRNA	PMID:18796159
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of PRRC2A protein	PMID:35544339
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1350670	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PRRC2A protein	PMID:35688186
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1552374	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in increased expression of PRRC2A mRNA	PMID:19695318
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1350670	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PRRC2A mRNA	PMID:39719251
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PRRC2A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRRC2A mRNA	PMID:40512198
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552374	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRRC2A mRNA	PMID:40504410
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350670	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRRC2A exon	PMID:30157460
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1552374	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in increased expression of PRRC2A mRNA	PMID:19695318
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1350670	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of PRRC2A gene	PMID:31601247
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PRRC2A gene	PMID:31601247
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552374	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PRRC2A gene; titanium dioxide results in decreased methylation of PRRC2A promoter	PMID:35295148
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552374	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of PRRC2A mRNA	PMID:29264374
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1552374	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of PRRC2A mRNA	PMID:19136022
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C069837	fullerene C60 results in increased expression of PRRC2A mRNA	PMID:19167457
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PRRC2A mRNA	PMID:30816183|PMID:32145629
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1350670	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of PRRC2A protein	PMID:37567409
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552374	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of PRRC2A mRNA	PMID:38074096
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PRRC2A mRNA	PMID:25181051|PMID:41034487
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1350670	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PRRC2A gene	PMID:31601247
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRRC2A mRNA	PMID:36041667
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PRRC2A gene	PMID:31601247
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1552374	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of PRRC2A mRNA	PMID:39298647
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552374	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PRRC2A gene	PMID:31683443
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1350670	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of PRRC2A gene	PMID:31601247
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRRC2A mRNA	PMID:36041667
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1350670	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PRRC2A exon	PMID:30157460
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRRC2A mRNA	PMID:36041667
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552374	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PRRC2A exon	PMID:28392331
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of PRRC2A protein	PMID:38598786
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1552374	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of PRRC2A mRNA	PMID:34813904
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350670	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PRRC2A mRNA	PMID:37042841
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1350670	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRRC2A mRNA	PMID:38382870
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:3766	clozapine	decreases expression	ISO	RGD:1552374	E	RGD:6480464	20120412	CTD	MESH:D003024	Clozapine results in decreased expression of PRRC2A mRNA	PMID:18797397
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1350670	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PRRC2A mRNA	PMID:28302478
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1350670	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of PRRC2A mRNA	PMID:19167446
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRRC2A mRNA	PMID:19167446
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552374	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PRRC2A mRNA	PMID:36331819
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1552374	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of PRRC2A mRNA	PMID:29038090
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552374	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PRRC2A mRNA	PMID:17292431
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PRRC2A mRNA	PMID:29427782
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552374	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PRRC2A mRNA	PMID:17562736
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1350670	E	RGD:6480464	20121218	CTD	MESH:D000082	Acetaminophen results in increased expression of PRRC2A mRNA	PMID:22230336
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1350670	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRRC2A gene	PMID:25304211
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PRRC2A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRRC2A mRNA	PMID:40512198
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552374	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRRC2A mRNA	PMID:40504410
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552374	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PRRC2A mRNA	PMID:25554681
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:5613	haloperidol	decreases expression	ISO	RGD:1552374	E	RGD:6480464	20120412	CTD	MESH:D006220	Haloperidol results in decreased expression of PRRC2A mRNA	PMID:18797397
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1350670	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PRRC2A protein	PMID:32959892
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1350670	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PRRC2A exon	PMID:30157460
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:72544	flavonoids	increases expression	ISO	RGD:1350670	E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of PRRC2A mRNA	PMID:15465739
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552374	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PRRC2A mRNA	PMID:22206623
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552374	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PRRC2A mRNA]	PMID:22206623
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1350670	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of PRRC2A mRNA	PMID:19946333
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of PRRC2A mRNA]	PMID:19946333
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of PRRC2A mRNA	PMID:33484710
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of PRRC2A promoter	PMID:27415467
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:7735	olanzapine	decreases expression	ISO	RGD:1552374	E	RGD:6480464	20120412	CTD	MESH:C076029	olanzapine results in decreased expression of PRRC2A mRNA	PMID:18797397
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PRRC2A gene]	PMID:28238834
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552374	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of PRRC2A mRNA	PMID:19136022
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1552374	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PRRC2A mRNA	PMID:31388691
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRRC2A mRNA	PMID:19167446
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552374	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PRRC2A mRNA	PMID:40826991
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:8984	sodium dodecyl sulfate	affects response to substance	ISO	RGD:1350670	E	RGD:6480464	20180220	CTD	MESH:D012967	PRRC2A SNP affects the susceptibility to Sodium Dodecyl Sulfate	PMID:27258892
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PRRC2A mRNA	PMID:21346803
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1350670	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PRRC2A mRNA	PMID:38568856
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1350670	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of PRRC2A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PRRC2A protein	PMID:38598786
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PRRC2A mRNA	PMID:21346803
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552374	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PRRC2A mRNA	PMID:28973697
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PRRC2A mRNA	PMID:23034163
1303025	Prrc2a	proline-rich coiled-coil 2A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of PRRC2A mRNA	PMID:20566332
1303026	Wfdc15a	WAP four-disulfide core domain 15A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of WFDC15A mRNA	PMID:25181051
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1616450	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of C5AR2 mRNA	PMID:33045310
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1354173	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of C5AR2 mRNA	PMID:34925699
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1354173	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of C5AR2 mRNA	PMID:33167477
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of C5AR2 gene	PMID:35440735
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1354173	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in increased expression of C5AR2 mRNA	PMID:21632981
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1616450	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of C5AR2 mRNA	PMID:25890327
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1616450	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in decreased expression of C5AR2 mRNA; Estradiol results in decreased expression of C5AR2 protein	PMID:18615583
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1354173	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of C5AR2 mRNA	PMID:31614463
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1616450	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in increased expression of C5AR2 mRNA	PMID:19484750
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C5AR2 mRNA	PMID:32741896
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of C5AR2 mRNA	PMID:23829299
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of C5AR2 mRNA	PMID:33387578
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1354173	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of C5AR2 mRNA	PMID:37042841
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1616450	E	RGD:6480464	20130806	CTD	MESH:D011374	Progesterone results in decreased expression of C5AR2 mRNA; Progesterone results in decreased expression of C5AR2 protein	PMID:18615583
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1616450	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of C5AR2 mRNA	PMID:37992649
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1616450	E	RGD:6480464	20130806	CTD	MESH:D013739	Testosterone results in decreased expression of C5AR2 mRNA; Testosterone results in decreased expression of C5AR2 protein	PMID:18615583
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C5AR2 mRNA	PMID:32741896
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1354173	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of C5AR2 mRNA	PMID:33647349
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1616450	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of C5AR2 mRNA	PMID:37992649
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of C5AR2 mRNA	PMID:33387578
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:18357	(R)-noradrenaline	increases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D009638	Norepinephrine results in increased expression of C5AR2 mRNA; Norepinephrine results in increased expression of C5AR2 protein	PMID:15715664
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of C5AR2 mRNA	PMID:21515302
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1616450	E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium results in decreased expression of C5AR2 mRNA	PMID:34953275
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1354173	E	RGD:6480464	20191008	CTD	MESH:D002104	Cadmium results in increased expression of C5AR2 mRNA	PMID:31082426
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of C5AR2 mRNA	PMID:31150632
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1616450	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of C5AR2 mRNA	PMID:28960355
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of C5AR2 mRNA	PMID:33387578
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1354173	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of C5AR2 mRNA	PMID:20106945|PMID:21632981
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1354173	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of C5AR2 mRNA	PMID:33212167
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1354173	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of C5AR2 mRNA	PMID:30851411
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of C5AR2 mRNA	PMID:28959563
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1616450	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of C5AR2 mRNA	PMID:37992649
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1616450	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of C5AR2 mRNA	PMID:37682722
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1354173	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of C5AR2 promoter	PMID:27901495
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1616450	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of C5AR2 mRNA	PMID:32417428
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1354173	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C5AR2 5' UTR	PMID:27901495
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1616450	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C5AR2 mRNA	PMID:27858113
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1616450	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of C5AR2 mRNA	PMID:27131904
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1616450	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of C5AR2 mRNA	PMID:29203145
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1354173	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of C5AR2 mRNA	PMID:35984750
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of C5AR2 mRNA	PMID:21515302
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1616450	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of C5AR2 mRNA	PMID:23557971
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D013853	Thioacetamide results in decreased expression of C5AR2 mRNA	PMID:23411599
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C006780	bisphenol A results in decreased expression of C5AR2 mRNA	PMID:25181051|PMID:34947998
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1354173	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of C5AR2 protein	PMID:33376534
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1354173	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of C5AR2 gene	PMID:31601247
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1616450	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of C5AR2 exon	PMID:33297965
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1616450	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C5AR2 mRNA	PMID:27858113
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1354173	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of C5AR2 mRNA	PMID:37042841
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1354173	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of C5AR2 mRNA	PMID:38568856
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C039281	furan results in decreased expression of C5AR2 mRNA	PMID:25539665
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1616450	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of C5AR2 mRNA	PMID:40194260
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1354173	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of C5AR2 gene	PMID:29154799
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1616450	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of C5AR2 mRNA	PMID:37992649
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:43602	obeticholic acid	decreases expression	ISO	RGD:1354173	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of C5AR2 mRNA	PMID:27939613
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1616450	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of C5AR2 mRNA	PMID:17562736
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of C5AR2 mRNA	PMID:33387578
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of C5AR2 mRNA	PMID:29391264
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1616450	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of C5AR2 mRNA; Nanotubes, Carbon results in increased expression of C5AR2 mRNA	PMID:25620056
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1616450	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C5AR2 mRNA	PMID:27858113
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1616450	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C5AR2 mRNA	PMID:27858113
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1616450	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of C5AR2 mRNA	PMID:38701926
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of C5AR2 gene	PMID:35440735
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1616450	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of C5AR2 mRNA	PMID:27935865
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C5AR2 mRNA	PMID:32741896
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1354173	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of C5AR2 mRNA	PMID:30851411
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1616450	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of C5AR2 mRNA	PMID:27131904
1303027	C5ar2	complement C5a receptor 2	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C057693	troglitazone results in decreased expression of C5AR2 mRNA	PMID:21515302
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552383	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CHST7 mRNA	PMID:37995155
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1344494	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of CHST7 mRNA	PMID:21934132|PMID:23724009
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1344494	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CHST7 mRNA	PMID:33167477
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552383	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHST7 mRNA	PMID:30529165
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1344494	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CHST7 mRNA	PMID:35811015
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1344494	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CHST7 mRNA	PMID:35811015
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1344494	E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in decreased expression of CHST7 mRNA	PMID:17982697
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1344494	E	RGD:6480464	20120412	CTD	MESH:D004958	[Parathion co-treated with Estradiol] results in increased expression of CHST7 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of CHST7 mRNA	PMID:17404688|PMID:17982697
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1344494	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CHST7 mRNA	PMID:38568856
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1344494	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of CHST7 mRNA	PMID:19162166
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1344494	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CHST7 mRNA	PMID:23649840
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1344494	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of CHST7 mRNA	PMID:17404688|PMID:20864642
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1344494	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in increased expression of CHST7 mRNA	PMID:17404688
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552383	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHST7 mRNA	PMID:37992649
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552383	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHST7 mRNA	PMID:37992649
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1344494	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CHST7 mRNA	PMID:16002434
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CHST7 mRNA	PMID:33387578
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1344494	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CHST7 mRNA	PMID:28818685
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1552383	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of CHST7 mRNA	PMID:33914522
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1344494	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CHST7 mRNA	PMID:23649840
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CHST7 mRNA	PMID:31150632
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1344494	E	RGD:6480464	20130514	CTD	MESH:D010278	Parathion results in increased expression of CHST7 mRNA	PMID:17982697
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:27928	parathion	multiple interactions	ISO	RGD:1344494	E	RGD:6480464	20130514	CTD	MESH:D010278	[Parathion co-treated with Estradiol] results in increased expression of CHST7 mRNA	PMID:17982697
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHST7 mRNA	PMID:33387578
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344494	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CHST7 mRNA	PMID:33212167
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1552383	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of CHST7 mRNA	PMID:30807115
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552383	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHST7 mRNA	PMID:37992649
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1344494	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of CHST7 mRNA	PMID:20044591
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1344494	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CHST7 mRNA	PMID:29432896
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552383	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CHST7 mRNA	PMID:37682722
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344494	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHST7 exon; Benzo(a)pyrene affects the methylation of CHST7 promoter	PMID:27901495
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552383	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CHST7 mRNA	PMID:21569818|PMID:27195522
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552383	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CHST7 mRNA	PMID:22228805
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552383	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CHST7 mRNA	PMID:29264374
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552383	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CHST7 gene	PMID:35295148
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552383	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CHST7 gene	PMID:35295148
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1552383	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of CHST7 mRNA	PMID:33914522
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CHST7 mRNA	PMID:25181051|PMID:30816183|PMID:34947998|PMID:41034487
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552383	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CHST7 mRNA	PMID:32156529
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1552383	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of CHST7 mRNA	PMID:26377693
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552383	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CHST7 mRNA	PMID:30951980
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344494	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHST7 mRNA	PMID:37042841
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of CHST7 mRNA	PMID:18500788
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CHST7 mRNA	PMID:27387713
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1344494	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CHST7 mRNA	PMID:28302478
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1344494	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CHST7 mRNA	PMID:29154799
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1344494	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CHST7 gene	PMID:29154799
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552383	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHST7 mRNA	PMID:37992649
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1552383	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CHST7 mRNA	PMID:18502557
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1344494	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CHST7 mRNA	PMID:38832940
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552383	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CHST7 mRNA	PMID:17562736
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CHST7 mRNA	PMID:33387578
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1344494	E	RGD:6480464	20120412	CTD	MESH:D005472	CHST7 protein affects the susceptibility to Fluorouracil	PMID:16217747
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1344494	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CHST7 mRNA	PMID:35811015
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552383	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CHST7 mRNA; Nanotubes, Carbon results in decreased expression of CHST7 mRNA	PMID:25620056
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1344494	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CHST7 mRNA	PMID:31758290
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552383	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CHST7 mRNA	PMID:22206623
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344494	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CHST7 gene]	PMID:28238834
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1344494	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of CHST7 mRNA	PMID:19095052
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552383	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of CHST7 mRNA	PMID:39847705
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CHST7 mRNA	PMID:21346803
1303028	Chst7	carbohydrate sulfotransferase 7	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552383	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CHST7 mRNA	PMID:35537566
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1605886	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of PHACTR3 mRNA	PMID:31016361
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1605886	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PHACTR3 mRNA	PMID:22378314
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1623923	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PHACTR3 mRNA	PMID:30319688
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1623923	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PHACTR3 mRNA	PMID:30319688
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PHACTR3 mRNA	PMID:29432896
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1605886	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PHACTR3 mRNA	PMID:35811015
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PHACTR3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PHACTR3 mRNA	PMID:35811015
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1605886	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of PHACTR3 mRNA	PMID:30510588
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of PHACTR3 mRNA	PMID:20660070
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605886	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PHACTR3 mRNA	PMID:20655997
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of PHACTR3 mRNA	PMID:20660070
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1623923	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PHACTR3 mRNA	PMID:34319233
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1623923	E	RGD:6480464	20210608	CTD	MESH:D004051	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of PHACTR3 mRNA	PMID:33484791
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of PHACTR3 mRNA	PMID:23358152
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PHACTR3 mRNA	PMID:35301059
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605886	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PHACTR3 gene	PMID:27153756
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605886	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PHACTR3 intron	PMID:30157460
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1623923	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PHACTR3 mRNA	PMID:25629700
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of PHACTR3 gene	PMID:31011160
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1623923	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of PHACTR3 mRNA	PMID:40618947
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1623923	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PHACTR3 mRNA	PMID:32186404
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1605886	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PHACTR3 mRNA	PMID:33212167
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PHACTR3 mRNA	PMID:28959563
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PHACTR3 mRNA	PMID:20971185
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1623923	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHACTR3 mRNA	PMID:39631538
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PHACTR3 mRNA	PMID:29432896
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1605886	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PHACTR3 gene	PMID:28589171
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1623923	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PHACTR3 mRNA	PMID:37682722
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605886	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PHACTR3 promoter	PMID:27901495
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605886	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PHACTR3 5' UTR	PMID:27901495
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605886	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PHACTR3 3' UTR	PMID:27901495
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PHACTR3 mRNA	PMID:20971185
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1605886	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of PHACTR3 mRNA	PMID:37690743
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623923	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHACTR3 gene	PMID:35295148
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1623923	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PHACTR3 gene	PMID:35295148
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PHACTR3 mRNA	PMID:25181051|PMID:41034487
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1623923	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PHACTR3 mRNA	PMID:32156529
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PHACTR3 mRNA	PMID:34947998
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1623923	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PHACTR3 mRNA	PMID:26063408
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1623923	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PHACTR3 intron	PMID:28392331
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:34682	diazinon	decreases methylation	ISO	RGD:1605886	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of PHACTR3 gene	PMID:22964155
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605886	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PHACTR3 mRNA	PMID:38174414
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1605886	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PHACTR3 mRNA	PMID:38382870
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PHACTR3 mRNA	PMID:35301059
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1623923	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PHACTR3 mRNA	PMID:40194260
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605886	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHACTR3 mRNA	PMID:25979313
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605886	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHACTR3 mRNA	PMID:23179753
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605886	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PHACTR3 mRNA	PMID:26272509
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1623923	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of PHACTR3 mRNA	PMID:21427059
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605886	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PHACTR3 gene	PMID:29154799
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHACTR3 mRNA	PMID:27188386
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1605886	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PHACTR3 mRNA	PMID:38832940
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1605886	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PHACTR3 mRNA	PMID:24935251
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PHACTR3 mRNA	PMID:29432896
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PHACTR3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PHACTR3 mRNA	PMID:35811015
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of PHACTR3 mRNA	PMID:23358152
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PHACTR3 mRNA	PMID:20080153
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1605886	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of PHACTR3 mRNA	PMID:28988120
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1605886	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PHACTR3 mRNA	PMID:22079614
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHACTR3 mRNA	PMID:27188386
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PHACTR3 gene]	PMID:28238834
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1623923	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PHACTR3 mRNA	PMID:38648751
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605886	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHACTR3 mRNA	PMID:27188386
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1623923	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of PHACTR3 mRNA	PMID:33484791
1303029	Phactr3	phosphatase and actin regulator 3	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of PHACTR3 mRNA	PMID:23358152
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552386	E	RGD:6480464	20240903	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TLR6 mRNA	PMID:38458531
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TLR6 mRNA	PMID:20938992
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1344850	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TLR6 mRNA	PMID:33167477
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TLR6 mRNA	PMID:30529165
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of TLR6 mRNA	PMID:30517762
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[Testosterone co-treated with Estradiol] results in increased expression of TLR6 mRNA	PMID:32741896
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TLR6 mRNA	PMID:20938992
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344850	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TLR6 mRNA	PMID:37042841
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20210209	CTD	MESH:D001554	Benzene results in decreased expression of TLR6 mRNA	PMID:33064461
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TLR6 mRNA	PMID:37992649
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] results in increased expression of TLR6 mRNA	PMID:32741896
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TLR6 mRNA	PMID:37992649
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TLR6 mRNA	PMID:27523638
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1344850	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TLR6 mRNA	PMID:36139627
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TLR6 mRNA	PMID:33387578
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1344850	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TLR6 mRNA	PMID:28818685
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of TLR6 mRNA	PMID:28522335
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of TLR6 mRNA	PMID:21515302
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1344850	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TLR6 mRNA	PMID:32234424
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TLR6 mRNA	PMID:30779732
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1344850	E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TLR6 mRNA	PMID:16979875
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of TLR6 mRNA	PMID:30517762
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TLR6 mRNA	PMID:20938992
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1344850	E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic results in increased expression of TLR6 mRNA	PMID:27838757
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TLR6 mRNA	PMID:31881176
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552386	E	RGD:6480464	20160210	CTD	MESH:D002945	Cisplatin results in increased expression of TLR6 mRNA	PMID:26546572|PMID:40618947
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20160210	CTD	MESH:D002945	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Cisplatin results in increased expression of TLR6 mRNA]	PMID:26546572
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of TLR6 mRNA	PMID:23195993
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TLR6 mRNA	PMID:22298810
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D004317	Doxorubicin results in increased expression of TLR6 mRNA	PMID:27181935
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D004317	Fungal Polysaccharides inhibits the reaction [Doxorubicin results in increased expression of TLR6 mRNA]	PMID:27181935
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TLR6 mRNA	PMID:37992649
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344850	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TLR6 mRNA; sodium arsenite results in increased expression of TLR6 protein	PMID:21925251|PMID:38568856
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1344850	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TLR6 mRNA	PMID:32234424
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552386	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TLR6 mRNA	PMID:22228805
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of TLR6 mRNA]	PMID:22228805
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1344850	E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TLR6 mRNA	PMID:16979875
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1344850	E	RGD:6480464	20121009	CTD	MESH:D012834	Silver results in increased expression of TLR6 mRNA	PMID:22342292
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1552386	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TLR6 mRNA	PMID:39716349
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:30772	butyric acid	increases expression	ISO	RGD:1344850	E	RGD:6480464	20120412	CTD	MESH:D020148	Butyric Acid results in increased expression of TLR6 mRNA	PMID:15196572
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1344850	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of TLR6 mRNA	PMID:37690743
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of TLR6 mRNA	PMID:22641619
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of TLR6 mRNA	PMID:21515302
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1344850	E	RGD:6480464	20121009	CTD	MESH:C009495	titanium dioxide results in increased expression of TLR6 mRNA	PMID:22342292
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of TLR6 mRNA	PMID:23146750
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of TLR6 mRNA	PMID:23146750
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TLR6 mRNA	PMID:23146750
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344850	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TLR6 mRNA	PMID:37042841
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TLR6 mRNA	PMID:23146750
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TLR6 mRNA	PMID:24449571
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:36560	zinc oxide	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20230704	CTD	MESH:D015034	Zinc Oxide analog promotes the reaction [OVAL protein results in increased expression of TLR6 mRNA]; Zinc Oxide analog promotes the reaction [OVAL protein results in increased expression of TLR6 protein]	PMID:25127755
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1344850	E	RGD:6480464	20120412	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TLR6 mRNA	PMID:16979875
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552386	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TLR6 mRNA	PMID:40194260
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1552386	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of TLR6 mRNA	PMID:29038090
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1552386	E	RGD:6480464	20200714	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of TLR6 mRNA	PMID:32151603
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20200714	CTD	MESH:D003520	Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of TLR6 mRNA]; Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of TLR6 mRNA]	PMID:32151603
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1344850	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TLR6 mRNA	PMID:20106945
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TLR6 mRNA	PMID:37992649
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1344850	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TLR6 mRNA	PMID:38832940
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1344850	E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in increased expression of TLR6 mRNA	PMID:29309887
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TLR6 mRNA	PMID:33387578
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1344850	E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic results in increased expression of TLR6 mRNA	PMID:27838757
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1344850	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of TLR6 mRNA	PMID:26833863|PMID:31838189
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TLR6 mRNA	PMID:29391264
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552386	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TLR6 mRNA	PMID:17942748
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1344850	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of TLR6 mRNA	PMID:32234424
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1552386	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TLR6 mRNA	PMID:39716349
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552386	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TLR6 mRNA; Nanotubes, Carbon results in increased expression of TLR6 mRNA	PMID:25554681
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:50834	cadmium selenide	multiple interactions	ISO	RGD:1344850	E	RGD:6480464	20121009	CTD	MESH:C058667	[cadmium selenide co-treated with zinc sulfide] results in increased expression of TLR6 mRNA	PMID:22342292
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of TLR6 mRNA	PMID:24793618
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552386	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TLR6 mRNA	PMID:38701926
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of TLR6 mRNA	PMID:28801915
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TLR6 mRNA	PMID:28801915
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:6432	levamisole	multiple interactions	ISO	RGD:1552386	E	RGD:6480464	20200714	CTD	MESH:D007978	Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of TLR6 mRNA]	PMID:32151603
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:6682	mangiferin	decreases expression	ISO	RGD:1552386	E	RGD:6480464	20120412	CTD	MESH:C013592	mangiferin results in decreased expression of TLR6 mRNA	PMID:15135318
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1344850	E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in increased expression of TLR6 mRNA	PMID:29309887
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1552386	E	RGD:6480464	20210706	CTD	MESH:D008694	Methamphetamine results in increased expression of TLR6 mRNA	PMID:32768653
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552386	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TLR6 mRNA	PMID:22206623
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1344850	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TLR6 mRNA	PMID:36139627
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:79089	ceric oxide	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20150310	CTD	MESH:C030583	ceric oxide analog results in decreased expression of TLR6 mRNA	PMID:24821434
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:7939	parthenolide	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20170303	CTD	MESH:C002669	parthenolide results in decreased expression of TLR6 mRNA	PMID:16921510
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TLR6 mRNA	PMID:23146750
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:82288	o-anisidine	decreases expression	ISO	RGD:1344850	E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine results in decreased expression of TLR6 mRNA	PMID:28089782
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1552386	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of TLR6 mRNA	PMID:39847705
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TLR6 mRNA	PMID:36843608
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1344850	E	RGD:6480464	20121009	CTD	MESH:D012834	Silver results in increased expression of TLR6 mRNA	PMID:22342292
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TLR6 mRNA	PMID:21346803
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TLR6 mRNA	PMID:21346803
1303030	Tlr6	toll-like receptor 6	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TLR6 mRNA	PMID:18629315
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of CRAT mRNA	PMID:18313992
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:132098	methoxyacetic acid	decreases activity	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased activity of CRAT protein	PMID:4035690
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550428	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of CRAT mRNA	PMID:33045310
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CRAT mRNA	PMID:40754286
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1550428	E	RGD:6480464	20171010	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CRAT mRNA	PMID:28558994
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CRAT mRNA]	PMID:31150632
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of CRAT protein	PMID:36641056
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:15351	acetyl-CoA	decreases activity	EXP		E	RGD:6480464	20120613	CTD	MESH:D000105	Acetyl Coenzyme A deficiency results in decreased activity of CRAT protein	PMID:8075222
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CRAT gene	PMID:20938992
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1350289	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CRAT mRNA	PMID:22378314
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CRAT mRNA	PMID:39241906
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of CRAT mRNA	PMID:35192832
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550428	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CRAT mRNA	PMID:39298647
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:16509	1,4-benzoquinone	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20210309	CTD	MESH:C004532	quinone results in decreased expression of CRAT mRNA	PMID:32478940
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:16602	trichloroethene	affects expression	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene affects the expression of CRAT mRNA	PMID:21135412
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1550428	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of CRAT mRNA	PMID:25549359
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CRAT gene	PMID:20938992
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350289	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CRAT mRNA	PMID:37042841
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1550428	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of CRAT mRNA	PMID:28973375
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:173365	Ethoxyacetic acid	decreases activity	EXP		E	RGD:6480464	20210706	CTD	MESH:C034096	ethoxyacetic acid results in decreased activity of CRAT protein	PMID:4035690
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:173542	Butoxyacetic acid	decreases activity	EXP		E	RGD:6480464	20210706	CTD	MESH:C017095	n-butoxyacetic acid results in decreased activity of CRAT protein	PMID:4035690
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20240806	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CRAT mRNA; Diethylhexyl Phthalate results in decreased expression of CRAT protein	PMID:36356568
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CRAT mRNA	PMID:19850644
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of CRAT mRNA]	PMID:19850644
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014284	Triiodothyronine results in increased expression of CRAT mRNA	PMID:15953391
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of CRAT mRNA	PMID:21515302
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:22977	cadmium atom	increases oxidation	ISO	RGD:1550428	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased oxidation of CRAT protein	PMID:24496640
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CRAT mRNA	PMID:37236586
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:232547	etomoxir	increases activity	EXP		E	RGD:6480464	20241203	CTD	MESH:C054207	etomoxir results in increased activity of CRAT protein	PMID:3421940
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:232547	etomoxir	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:C054207	etomoxir inhibits the reaction [Bezafibrate results in increased activity of CRAT protein]	PMID:3421940
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CRAT mRNA	PMID:19549813
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRAT mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRAT mRNA	PMID:22129741
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D016604	[sulforaphane co-treated with Aflatoxin B1] affects the expression of CRAT mRNA	PMID:25450479
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D010126	Ozone results in decreased expression of CRAT mRNA	PMID:33217375|PMID:33524448
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of CRAT mRNA	PMID:12763052
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of CRAT mRNA	PMID:35737395
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210504	CTD	MESH:D010126	[Coconut Oil co-treated with Ozone] results in decreased expression of CRAT mRNA; [Fish Oils co-treated with Ozone] results in increased expression of CRAT mRNA; Ozone inhibits the reaction [Olive Oil results in decreased expression of CRAT mRNA]	PMID:33217375
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CRAT mRNA	PMID:31150632
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CRAT mRNA]	PMID:31150632
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CRAT gene	PMID:20938992
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1350289	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CRAT mRNA	PMID:39836092
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CRAT mRNA	PMID:40504410
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1350289	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CRAT mRNA	PMID:19244175
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550428	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CRAT mRNA	PMID:28960355
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:27902	tetracycline	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in decreased expression of CRAT mRNA	PMID:16917069
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of CRAT mRNA	PMID:24768652
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550428	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CRAT mRNA	PMID:21570461|PMID:26377647
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CRAT mRNA	PMID:21215274
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CRAT mRNA	PMID:21998131
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CRAT mRNA	PMID:19770486|PMID:26290441|PMID:28922406
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CRAT mRNA	PMID:33387578
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CRAT mRNA	PMID:17942748
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of CRAT mRNA	PMID:28374803
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1350289	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CRAT mRNA; aristolochic acid I results in increased expression of CRAT protein	PMID:33212167
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in decreased expression of CRAT mRNA	PMID:26033743
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550428	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CRAT protein	PMID:28918527
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of CRAT mRNA	PMID:26873546
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28854	2,4-D	increases activity	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in increased activity of CRAT protein	PMID:1755024
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRAT mRNA	PMID:22129741
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of CRAT mRNA	PMID:38359550
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1350289	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CRAT mRNA	PMID:39836092
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20251007	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CRAT mRNA; Ketoglutaric Acids inhibits the reaction [sodium arsenite results in decreased expression of CRAT mRNA]	PMID:38359550|PMID:40504410
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1350289	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of CRAT mRNA	PMID:22378314
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CRAT mRNA	PMID:32234424
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CRAT mRNA	PMID:22228805|PMID:32417428
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in decreased expression of CRAT mRNA	PMID:26033743
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1350289	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CRAT mRNA	PMID:34108876
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:31412	Clinofibrate	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:C006231	clinofibrate results in increased activity of CRAT protein	PMID:3625448
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of CRAT mRNA	PMID:24136188
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CRAT mRNA	PMID:32479839
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:31823	mercury dichloride	decreases activity	EXP		E	RGD:6480464	20120613	CTD	MESH:D008627	Mercuric Chloride results in decreased activity of CRAT protein	PMID:8075222
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of CRAT mRNA	PMID:21515302
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CRAT mRNA	PMID:23557971|PMID:35295148
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550428	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CRAT gene	PMID:35295148
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550428	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CRAT gene	PMID:35295148
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CRAT mRNA	PMID:34492290
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of CRAT mRNA	PMID:22484513|PMID:27665778|PMID:32741897
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550428	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CRAT mRNA	PMID:11798191|PMID:15375163|PMID:17426115|PMID:17950772|PMID:18301758|PMID:18445702|PMID:20059764|PMID:20813756|PMID:23811191
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CRAT mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of CRAT mRNA]	PMID:17950772|PMID:19710929|PMID:20059764
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of CRAT mRNA	PMID:19167457
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of CRAT mRNA	PMID:32145629
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CRAT mRNA	PMID:25181051|PMID:35192832
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of CRAT mRNA	PMID:15980968
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1350289	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CRAT protein	PMID:34186270
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550428	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CRAT mRNA	PMID:39298647|PMID:40203079
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:C008745	bisphenol F results in increased expression of CRAT protein	PMID:40188933
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1350289	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CRAT protein	PMID:34186270
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1350289	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CRAT protein	PMID:34186270
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1350289	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CRAT gene	PMID:22964155
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CRAT mRNA	PMID:12771043
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CRAT mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in increased activity of CRAT protein; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CRAT mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRAT mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRAT mRNA	PMID:18164116|PMID:18253720|PMID:22129741
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1550428	E	RGD:6480464	20190507	CTD	MESH:D026023	Permethrin results in increased expression of CRAT mRNA	PMID:30629241
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350289	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CRAT mRNA	PMID:37042841
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CRAT mRNA	PMID:30589522
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CRAT mRNA	PMID:37236586
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CRAT mRNA	PMID:28511854
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1350289	E	RGD:6480464	20150609	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CRAT mRNA; perfluorooctanoic acid results in increased expression of CRAT protein	PMID:23978341|PMID:25868421|PMID:26879310
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1550428	E	RGD:6480464	20140311	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CRAT mRNA	PMID:17681415|PMID:23626681|PMID:28558994|PMID:30508572|PMID:30711707
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20140311	CTD	MESH:C023036	Dietary Fats, Unsaturated inhibits the reaction [perfluorooctanoic acid results in increased expression of CRAT mRNA]	PMID:23626681
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CRAT mRNA	PMID:19376846
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1550428	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of CRAT mRNA	PMID:28962523
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1550428	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CRAT mRNA	PMID:18353800
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1350289	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CRAT mRNA	PMID:19244175
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:3750	clofibrate	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate results in increased activity of CRAT protein	PMID:3625448
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:3750	clofibrate	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002994	Clofibrate results in increased expression of CRAT mRNA; Clofibrate results in increased expression of CRAT protein	PMID:12851107|PMID:1914008|PMID:27665778|PMID:32741897|PMID:6845354
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1550428	E	RGD:6480464	20150127	CTD	MESH:D002994	Clofibrate results in increased expression of CRAT mRNA	PMID:23811191|PMID:25270620|PMID:30629241
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:3750	clofibrate	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D002994	Nicardipine results in decreased activity of [Clofibrate results in increased expression of CRAT protein]	PMID:1914008
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of CRAT mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CRAT mRNA]	PMID:17585979
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550428	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CRAT mRNA	PMID:28558994
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1550428	E	RGD:6480464	20171010	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CRAT mRNA	PMID:28558994
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350289	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CRAT mRNA	PMID:25979313
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CRAT mRNA	PMID:17292431
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1350289	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CRAT gene	PMID:29154799
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of CRAT mRNA	PMID:41580965
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CRAT mRNA	PMID:20106945
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of CRAT mRNA	PMID:19770486
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550428	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CRAT mRNA	PMID:28973697
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CRAT mRNA	PMID:24136188
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CRAT mRNA	PMID:38832940
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CRAT mRNA	PMID:17562736
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of CRAT mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CRAT mRNA]	PMID:17585979
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid results in decreased expression of CRAT mRNA	PMID:28871336
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1350289	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CRAT mRNA	PMID:39836092
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CRAT mRNA	PMID:40504410
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:47612	bezafibrate	increases activity	EXP		E	RGD:6480464	20120717	CTD	MESH:D001629	Bezafibrate results in increased activity of CRAT protein	PMID:3421940|PMID:8075222|PMID:9920142
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:47612	bezafibrate	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D001629	etomoxir inhibits the reaction [Bezafibrate results in increased activity of CRAT protein]	PMID:3421940
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:47807	sulforaphane	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:C016766	[sulforaphane co-treated with Aflatoxin B1] affects the expression of CRAT mRNA	PMID:25450479
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550428	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CRAT mRNA	PMID:35436446
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CRAT mRNA	PMID:17942748
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of CRAT mRNA	PMID:38568856
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of CRAT mRNA	PMID:36868495
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1350289	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CRAT mRNA	PMID:34108876
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:5001	fenofibrate	increases activity	EXP		E	RGD:6480464	20121113	CTD	MESH:D011345	Fenofibrate results in increased activity of CRAT protein	PMID:17264098
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D011345	Fenofibrate results in increased expression of CRAT mRNA	PMID:27665778|PMID:32741897
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D011345	Fenofibrate results in increased expression of CRAT mRNA	PMID:11798191
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:5001	fenofibrate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011345	[Fenofibrate co-treated with Diethylnitrosamine] results in increased activity of CRAT protein; [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CRAT mRNA	PMID:18253720
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:50223	(+)-dexrazoxane	increases expression	ISO	RGD:1550428	E	RGD:6480464	20170303	CTD	MESH:D064730	Dexrazoxane results in increased expression of CRAT mRNA	PMID:26873546
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550428	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CRAT mRNA	PMID:25620056
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CRAT mRNA	PMID:24136188
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CRAT mRNA	PMID:30047161
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:50867	ciprofibrate	increases expression	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:C019304	ciprofibrate results in increased expression of CRAT mRNA	PMID:12771043
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CRAT mRNA	PMID:24136188
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1550428	E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in decreased expression of CRAT mRNA	PMID:19442681
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:5296	gemfibrozil	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D015248	Gemfibrozil results in increased expression of CRAT mRNA	PMID:27665778
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1350289	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CRAT protein	PMID:23718831
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CRAT mRNA	PMID:20436886
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CRAT protein	PMID:32959892
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of CRAT mRNA	PMID:18313992
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:63618	pravastatin	affects expression	ISO	RGD:1550428	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of CRAT mRNA	PMID:27225895
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:63618	pravastatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of CRAT mRNA	PMID:27225895
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CRAT mRNA	PMID:24136188
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:6382	Lasiocarpine	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of CRAT mRNA	PMID:40054833
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1550428	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of CRAT mRNA	PMID:19812364
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CRAT mRNA	PMID:24136188
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CRAT mRNA	PMID:15336504
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CRAT mRNA	PMID:19001666
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:70778	GW 7647	increases expression	ISO	RGD:1550428	E	RGD:6480464	20250805	CTD	MESH:C453899	GW 7647 results in increased expression of CRAT mRNA	PMID:40216583
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:70778	GW 7647	multiple interactions	ISO	RGD:1550428	E	RGD:6480464	20250805	CTD	MESH:C453899	PPARA gene mutant form inhibits the reaction [GW 7647 results in increased expression of CRAT mRNA]	PMID:40216583
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1350289	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CRAT protein	PMID:34186270
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:748688	ertiprotafib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C498182	ertiprotafib results in increased expression of CRAT	PMID:17178630
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CRAT mRNA	PMID:24136188
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:75170	zaragozic acid A	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CRAT mRNA	PMID:27225895
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1550428	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CRAT mRNA	PMID:27225895
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:752944	olive oil	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D000069463	Olive Oil results in decreased expression of CRAT mRNA	PMID:33217375
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:752944	olive oil	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D000069463	Ozone inhibits the reaction [Olive Oil results in decreased expression of CRAT mRNA]	PMID:33217375
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:7550	nicardipine	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D009529	Nicardipine results in decreased activity of [Clofibrate results in increased expression of CRAT protein]	PMID:1914008
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:75704	2-(4-chloro-2-methylphenoxy)propanoic acid	increases activity	ISO	RGD:1550428	E	RGD:6480464	20131008	CTD	MESH:C008340	mecoprop results in increased activity of CRAT protein	PMID:1755024
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:75711	mecoprop	increases activity	ISO	RGD:1550428	E	RGD:6480464	20131008	CTD	MESH:C008340	mecoprop results in increased activity of CRAT protein	PMID:1755024
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of CRAT protein	PMID:39638853
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CRAT mRNA	PMID:18164116
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of CRAT mRNA	PMID:23665939
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:8064	phenformin	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in increased expression of CRAT mRNA	PMID:31324951
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550428	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CRAT mRNA	PMID:23091169
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:82251	Tridiphane	increases expression	ISO	RGD:1550428	E	RGD:6480464	20141111	CTD	MESH:C051460	tridiphane results in increased expression of CRAT protein	PMID:3590187
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CRAT mRNA	PMID:23640034
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CRAT mRNA	PMID:36843608
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CRAT mRNA	PMID:30047161
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1350289	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CRAT mRNA	PMID:38568856
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1350289	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of CRAT mRNA	PMID:22378314
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CRAT mRNA	PMID:21346803
1303031	Crat	carnitine O-acetyltransferase	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of CRAT mRNA	PMID:21515302
1303032	Krt39	keratin 39	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1604916	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KRT39 mRNA	PMID:38218311
1303032	Krt39	keratin 39	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1604916	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of KRT39 mRNA	PMID:26079696
1303032	Krt39	keratin 39	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604916	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KRT39 gene	PMID:27153756
1303032	Krt39	keratin 39	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623767	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT39 mRNA	PMID:21570461
1303032	Krt39	keratin 39	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604916	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KRT39 3' UTR	PMID:27901495
1303032	Krt39	keratin 39	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604916	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT39 promoter	PMID:27901495
1303032	Krt39	keratin 39	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT39 mRNA	PMID:25181051
1303032	Krt39	keratin 39	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of KRT39 mRNA	PMID:25539665
1303032	Krt39	keratin 39	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604916	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KRT39 gene	PMID:29154799
1303033	RT1-T24-2	RT1 class I, locus T24, gene 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RT1-T24-2 mRNA	PMID:31881176
1303033	RT1-T24-2	RT1 class I, locus T24, gene 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RT1-T24-2 mRNA	PMID:25181051
1303033	RT1-T24-2	RT1 class I, locus T24, gene 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of RT1-T24-2 mRNA	PMID:23914054
1303033	RT1-T24-2	RT1 class I, locus T24, gene 2	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:C010902	[Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in increased expression of RT1-T24-2 mRNA	PMID:32207525
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1557274	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of GPN3 mRNA	PMID:26251327
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606002	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GPN3 mRNA	PMID:33167477
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1606002	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of GPN3 mRNA	PMID:20044591
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1606002	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of GPN3 mRNA	PMID:38568856
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606002	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GPN3 mRNA	PMID:37042841
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606002	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of GPN3 mRNA	PMID:35430440
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1557274	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GPN3 mRNA	PMID:25629700
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606002	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GPN3 mRNA	PMID:39836092
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1557274	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of GPN3 mRNA	PMID:28960355
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606002	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GPN3 mRNA	PMID:23557933
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1606002	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of GPN3 mRNA	PMID:23195993
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557274	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPN3 mRNA	PMID:21570461
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GPN3 mRNA	PMID:33387578
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557274	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GPN3 promoter]	PMID:19654925
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1606002	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GPN3 mRNA	PMID:30851411
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606002	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GPN3 mRNA	PMID:39836092
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1557274	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GPN3 mRNA	PMID:21715664
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1606002	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of GPN3 mRNA	PMID:20458559
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1606002	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GPN3 mRNA	PMID:19710929
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557274	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GPN3 mRNA	PMID:33221593
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606002	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GPN3 protein	PMID:33376534
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GPN3 mRNA	PMID:25181051
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GPN3 mRNA	PMID:36041667
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1606002	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of GPN3 mRNA	PMID:19244175
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GPN3 mRNA	PMID:36041667
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GPN3 mRNA	PMID:36041667
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GPN3 mRNA	PMID:33453195
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1606002	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GPN3 mRNA	PMID:28302478
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606002	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of GPN3 mRNA	PMID:29154799
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606002	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of GPN3 mRNA	PMID:20106945
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606002	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GPN3 mRNA	PMID:25562108
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606002	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GPN3 mRNA	PMID:39836092
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1606002	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of GPN3 mRNA	PMID:20458559
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1557274	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GPN3 mRNA	PMID:22206623
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1606002	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GPN3 mRNA	PMID:30851411
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606002	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GPN3 gene]	PMID:28238834
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of GPN3 mRNA	PMID:23640034
1303034	Gpn3	GPN-loop GTPase 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of GPN3 mRNA	PMID:21346803
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:10101	zalcitabine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016047	[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of KIF5A mRNA	PMID:18606552
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1347916	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KIF5A mRNA	PMID:38218311
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550437	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of KIF5A mRNA	PMID:20188158
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF5A mRNA	PMID:20938992
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:15422	ATP	increases hydrolysis	ISO	RGD:1347916	E	RGD:6480464	20140610	CTD	MESH:D000255	KIF5A protein results in increased hydrolysis of Adenosine Triphosphate	PMID:24239783
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:15422	ATP	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20140610	CTD	MESH:D000255	Adenosine Triphosphate inhibits the reaction [zinc chloride results in decreased activity of KIF5A protein]; Cadmium Chloride inhibits the reaction [KIF5A protein results in increased hydrolysis of Adenosine Triphosphate]; Egtazic Acid inhibits the reaction [Cadmium Chloride inhibits the reaction [KIF5A protein results in increased hydrolysis of Adenosine Triphosphate]]	PMID:24239783|PMID:28122263
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1347916	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of KIF5A mRNA	PMID:22378314
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550437	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of KIF5A mRNA	PMID:30319688
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of KIF5A mRNA	PMID:30319688
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550437	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KIF5A mRNA	PMID:39241906
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KIF5A mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of KIF5A mRNA	PMID:35811015
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF5A mRNA	PMID:25510870
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KIF5A mRNA	PMID:33387578
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF5A mRNA	PMID:20938992
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1347916	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of KIF5A mRNA	PMID:33647349
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:17561	L-cysteine	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20160210	CTD	MESH:D003545	Cysteine inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]	PMID:24853401
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1347916	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KIF5A mRNA	PMID:31163220
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550437	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KIF5A mRNA	PMID:34319233
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240305	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5A mRNA	PMID:37690569
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of KIF5A mRNA	PMID:22061828|PMID:33387578
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1550437	E	RGD:6480464	20150714	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of KIF5A mRNA	PMID:15329391
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1347916	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KIF5A mRNA	PMID:28818685
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of KIF5A mRNA	PMID:39836092
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:18320	1,4-dithiothreitol	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20160210	CTD	MESH:D004229	Dithiothreitol inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]	PMID:24853401
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1550437	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of KIF5A mRNA	PMID:27462272
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF5A mRNA	PMID:25510870
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF5A mRNA	PMID:25510870
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1550437	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of KIF5A mRNA	PMID:25629700
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KIF5A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF5A mRNA	PMID:20938992|PMID:22206623
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KIF5A mRNA	PMID:39836092
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1347916	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of KIF5A mRNA	PMID:26272509
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF5A mRNA	PMID:27188386
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of KIF5A mRNA	PMID:31881176
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20201006	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of KIF5A mRNA; [lead acetate results in increased abundance of Lead] which results in increased methylation of KIF5A intron	PMID:32458983|PMID:33445541
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KIF5A mRNA	PMID:33387578
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIF5A mRNA	PMID:32109520
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1347916	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIF5A mRNA	PMID:27913140
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in increased expression of KIF5A mRNA	PMID:23263842
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1347916	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KIF5A mRNA	PMID:28001369
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347916	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KIF5A mRNA	PMID:29803840
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347916	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KIF5A mRNA	PMID:38568856
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KIF5A mRNA; sodium arsenite promotes the reaction [KIF5A protein binds to CAPRIN1 protein]	PMID:33939924|PMID:39836092
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347916	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KIF5A promoter	PMID:27901495
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1347916	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KIF5A mRNA	PMID:21871943
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347916	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KIF5A exon	PMID:27901495
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:30740	ethylene glycol bis(2-aminoethyl)tetraacetic acid	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20140610	CTD	MESH:D004533	Egtazic Acid inhibits the reaction [Cadmium Chloride inhibits the reaction [KIF5A protein results in increased hydrolysis of Adenosine Triphosphate]]; Egtazic Acid inhibits the reaction [Cadmium Chloride results in decreased activity of KIF5A protein]; Egtazic Acid inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]	PMID:24239783|PMID:24853401
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1550437	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of KIF5A mRNA	PMID:22609695
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20201006	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of KIF5A mRNA; [lead acetate results in increased abundance of Lead] which results in increased methylation of KIF5A intron	PMID:32458983|PMID:33445541
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550437	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KIF5A gene	PMID:35295148
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF5A mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550437	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF5A mRNA	PMID:32156529
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1347916	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KIF5A gene	PMID:31601247
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of KIF5A mRNA	PMID:41034487
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of KIF5A mRNA	PMID:36041667
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF5A mRNA	PMID:25510870
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1347916	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of KIF5A mRNA	PMID:36804509
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF5A mRNA	PMID:25510870
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1347916	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of KIF5A mRNA	PMID:15980968
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550437	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of KIF5A gene	PMID:31683443
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of KIF5A mRNA	PMID:36041667
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550437	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of KIF5A mRNA	PMID:38685157
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of KIF5A mRNA	PMID:36041667
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20240305	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5A mRNA	PMID:37690569
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550437	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KIF5A mRNA	PMID:37019170
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20240305	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5A mRNA	PMID:37690569
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34698	diethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20240305	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5A mRNA	PMID:37690569
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550437	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of KIF5A mRNA	PMID:17854601
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of KIF5A mRNA]	PMID:17854601
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of KIF5A mRNA	PMID:39836092
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:35456	cadmium dichloride	decreases activity	ISO	RGD:1347916	E	RGD:6480464	20140610	CTD	MESH:D019256	Cadmium Chloride results in decreased activity of KIF5A protein	PMID:24239783
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20140610	CTD	MESH:D019256	Cadmium Chloride inhibits the reaction [KIF5A protein results in increased hydrolysis of Adenosine Triphosphate]; Egtazic Acid inhibits the reaction [Cadmium Chloride inhibits the reaction [KIF5A protein results in increased hydrolysis of Adenosine Triphosphate]]; Egtazic Acid inhibits the reaction [Cadmium Chloride results in decreased activity of KIF5A protein]	PMID:24239783
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	EXP		E	RGD:6480464	20240305	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5A mRNA	PMID:37690569
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550437	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KIF5A mRNA	PMID:40194260
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1347916	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of KIF5A mRNA	PMID:28302478
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of KIF5A mRNA	PMID:29427782
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:42106	L-1,4-dithiothreitol	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20160210	CTD	MESH:D004229	Dithiothreitol inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]	PMID:24853401
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1347916	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KIF5A mRNA	PMID:38832940
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KIF5A mRNA	PMID:33387578
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1347916	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of KIF5A mRNA	PMID:35811015
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KIF5A mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of KIF5A mRNA	PMID:35811015
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KIF5A mRNA	PMID:39836092
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KIF5A mRNA	PMID:29391264
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:48607	lithium chloride	decreases expression	ISO	RGD:1347916	E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in decreased expression of KIF5A mRNA	PMID:23527032
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:49553	copper(II) chloride	decreases activity	ISO	RGD:1347916	E	RGD:6480464	20160210	CTD	MESH:C029892	cupric chloride results in decreased activity of KIF5A protein	PMID:24853401
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:49553	copper(II) chloride	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20160210	CTD	MESH:C029892	Cysteine inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]; Dithiothreitol inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]; Egtazic Acid inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]	PMID:24853401
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:49976	zinc dichloride	decreases activity	ISO	RGD:1347916	E	RGD:6480464	20170613	CTD	MESH:C016837	zinc chloride results in decreased activity of KIF5A protein	PMID:28122263
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:49976	zinc dichloride	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20170613	CTD	MESH:C016837	Adenosine Triphosphate inhibits the reaction [zinc chloride results in decreased activity of KIF5A protein]; Magnesium Chloride affects the reaction [zinc chloride results in decreased activity of KIF5A protein]	PMID:28122263
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of KIF5A mRNA	PMID:30307764
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1550437	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of KIF5A mRNA	PMID:19042947
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of KIF5A mRNA	PMID:39836092
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1550437	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of KIF5A mRNA	PMID:36851058
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:6636	magnesium dichloride	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20170613	CTD	MESH:D015636	Magnesium Chloride affects the reaction [zinc chloride results in decreased activity of KIF5A protein]	PMID:28122263
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of KIF5A gene	PMID:35440735
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:6842	methoxychlor	increases methylation	EXP		E	RGD:6480464	20130611	CTD	MESH:D008731	Methoxychlor results in increased methylation of KIF5A gene	PMID:23303685
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550437	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KIF5A mRNA	PMID:22206623
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550437	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KIF5A mRNA	PMID:22206623
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:755540	docetaxel	decreases response to substance	ISO	RGD:1347916	E	RGD:6480464	20260714	CTD	MESH:D000077143	KIF5A protein results in decreased susceptibility to Docetaxel	PMID:21479552
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF5A mRNA	PMID:27188386
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20240305	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5A mRNA	PMID:37690569
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KIF5A gene]	PMID:28238834
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1550437	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of KIF5A mRNA	PMID:26655953
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1347916	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of KIF5A mRNA	PMID:30458266
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:83258	fenamidone	decreases expression	ISO	RGD:1550437	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in decreased expression of KIF5A mRNA	PMID:27029645
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550437	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of KIF5A mRNA	PMID:21795629
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347916	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF5A mRNA	PMID:27188386
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:9944	venlafaxine hydrochloride	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000069470	Venlafaxine Hydrochloride results in decreased expression of KIF5A mRNA	PMID:25423262
1303035	Kif5a	kinesin family member 5A	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of KIF5A mRNA	PMID:19015723
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1620772	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RPAP3 mRNA	PMID:36331819
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1620772	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RPAP3 mRNA	PMID:27339419|PMID:39241906
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1620772	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RPAP3 mRNA	PMID:39298647
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RPAP3 gene	PMID:27618143
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1603005	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RPAP3 mRNA	PMID:21179406
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1620772	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RPAP3 mRNA	PMID:33754040
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1603005	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RPAP3 protein	PMID:37730182
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1603005	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RPAP3 mRNA	PMID:39836092
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1603005	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPAP3 protein	PMID:23301498
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1603005	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RPAP3 mRNA	PMID:23649840
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1620772	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RPAP3 mRNA	PMID:31919559
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620772	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RPAP3 mRNA	PMID:22206623
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of RPAP3 mRNA	PMID:33512557
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1603005	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of RPAP3 protein	PMID:38460933
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1603005	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RPAP3 protein	PMID:35688186
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1620772	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RPAP3 mRNA	PMID:30912803
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of RPAP3 mRNA	PMID:23195993
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620772	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPAP3 mRNA	PMID:21570461
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of RPAP3 mRNA	PMID:33512557
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RPAP3 mRNA	PMID:30556269
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1620772	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of RPAP3 mRNA	PMID:27862939
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1620772	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of RPAP3 mRNA	PMID:39631538
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of RPAP3 protein	PMID:30528433
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620772	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RPAP3 mRNA	PMID:22228805
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RPAP3 mRNA	PMID:30556269
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1620772	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of RPAP3 mRNA	PMID:27131904
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1620772	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RPAP3 mRNA	PMID:23221170
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RPAP3 mRNA	PMID:20018196
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1620772	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RPAP3 mRNA	PMID:28472532
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RPAP3 mRNA	PMID:34947998
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of RPAP3 protein	PMID:37567409
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1603005	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RPAP3 gene	PMID:31601247
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RPAP3 mRNA	PMID:25181051
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RPAP3 gene	PMID:28505145
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1603005	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RPAP3 gene	PMID:31601247
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1620772	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RPAP3 mRNA	PMID:37019170
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1620772	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RPAP3 mRNA	PMID:34813904
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1620772	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of RPAP3 mRNA	PMID:34813904
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of RPAP3 mRNA	PMID:30589522
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1603005	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RPAP3 mRNA	PMID:39836092
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RPAP3 mRNA	PMID:33453195
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RPAP3 mRNA	PMID:28302478
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620772	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RPAP3 mRNA	PMID:36331819
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of RPAP3 mRNA	PMID:23125180
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RPAP3 mRNA	PMID:23179753|PMID:27188386
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1603005	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RPAP3 gene	PMID:29154799
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603005	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of RPAP3 mRNA	PMID:20106945
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of RPAP3 mRNA	PMID:33512557
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1620772	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of RPAP3 mRNA	PMID:25123088
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1603005	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RPAP3 mRNA	PMID:38832940
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1603005	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RPAP3 mRNA	PMID:28542535
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of RPAP3 mRNA	PMID:24935251|PMID:26272509
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1603005	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPAP3 mRNA	PMID:27188386
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1620772	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RPAP3 mRNA	PMID:17562736
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1603005	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of RPAP3 protein	PMID:38460933
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1620772	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of RPAP3 mRNA	PMID:26934552
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:50292	cadmium sulfate	decreases expression	ISO	RGD:1620772	E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in decreased expression of RPAP3 mRNA	PMID:19274763
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1620772	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RPAP3 mRNA; Nanotubes, Carbon results in increased expression of RPAP3 mRNA	PMID:25620056
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1603005	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of RPAP3 mRNA	PMID:20977926
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPAP3 protein	PMID:32959892
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1603005	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RPAP3 mRNA	PMID:39836092
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1603005	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RPAP3 mRNA	PMID:31758290
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1620772	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RPAP3 mRNA	PMID:22206623
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603005	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPAP3 mRNA	PMID:27188386
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of RPAP3 mRNA	PMID:30928695
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of RPAP3 mRNA	PMID:33512557
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1603005	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RPAP3 protein	PMID:38348393
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603005	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPAP3 mRNA	PMID:27188386
1303036	Rpap3	RNA polymerase II associated protein 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1620772	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of RPAP3 mRNA	PMID:27131904
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550447	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of TMEM106B mRNA]	PMID:19467301
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TMEM106B mRNA	PMID:33167477
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1603394	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM106B mRNA	PMID:21934132
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TMEM106B mRNA	PMID:26079696
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of TMEM106B protein	PMID:40631627
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1603394	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of TMEM106B mRNA	PMID:18951874
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of TMEM106B protein	PMID:18951874
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550447	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TMEM106B mRNA	PMID:39241906
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of TMEM106B mRNA	PMID:32145629
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1550447	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of TMEM106B mRNA	PMID:39298647
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1603394	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TMEM106B mRNA	PMID:21179406
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of TMEM106B protein	PMID:40631627
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1550447	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of TMEM106B mRNA	PMID:28973375
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1603394	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of TMEM106B mRNA	PMID:21592394
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of TMEM106B mRNA	PMID:21592394
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of TMEM106B protein	PMID:40631627
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1603394	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TMEM106B protein	PMID:37730182
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1603394	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of TMEM106B mRNA	PMID:21592394
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of TMEM106B mRNA	PMID:21592394
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TMEM106B mRNA	PMID:39836092
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1550447	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TMEM106B mRNA	PMID:18579281
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1550447	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TMEM106B mRNA	PMID:19770486
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1603394	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TMEM106B gene	PMID:27153756
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of TMEM106B mRNA	PMID:22171008
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550447	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TMEM106B mRNA	PMID:17484886
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550447	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM106B mRNA	PMID:40504410
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TMEM106B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM106B mRNA	PMID:39836092
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of TMEM106B protein	PMID:38460933
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1603394	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TMEM106B protein	PMID:35688186
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TMEM106B mRNA	PMID:31881176
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM106B mRNA	PMID:22298810
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1603394	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM106B mRNA	PMID:22298810
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM106B mRNA	PMID:21215274
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM106B mRNA	PMID:32109520
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of TMEM106B protein	PMID:18951874
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of TMEM106B mRNA	PMID:28374803
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1603394	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of TMEM106B protein	PMID:39603559
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TMEM106B mRNA	PMID:33212167
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TMEM106B mRNA	PMID:20971185
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550447	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TMEM106B mRNA	PMID:27862939
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM106B mRNA	PMID:29803840
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550447	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM106B mRNA	PMID:40504410
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TMEM106B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM106B mRNA	PMID:39836092
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603394	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMEM106B promoter	PMID:27901495
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TMEM106B mRNA	PMID:20971185
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of TMEM106B mRNA	PMID:22171008
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TMEM106B mRNA	PMID:25895662
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TMEM106B mRNA	PMID:20018196
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of TMEM106B mRNA	PMID:24136188
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of TMEM106B mRNA	PMID:27188386
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TMEM106B mRNA	PMID:30047161
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of TMEM106B mRNA	PMID:24136188
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1603394	E	RGD:6480464	20150714	CTD	MESH:C009495	titanium dioxide affects the expression of TMEM106B mRNA	PMID:24023007
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550447	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM106B gene	PMID:35295148
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550447	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TMEM106B mRNA	PMID:18301758
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of TMEM106B mRNA	PMID:32145629
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM106B mRNA	PMID:34947998
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM106B mRNA	PMID:25181051|PMID:33296240
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMEM106B gene	PMID:28505145
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550447	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TMEM106B mRNA	PMID:39298647
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1550447	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of TMEM106B mRNA	PMID:26377693
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550447	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TMEM106B mRNA	PMID:38685157
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1550447	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TMEM106B mRNA	PMID:28392331
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603394	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMEM106B mRNA	PMID:37042841
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TMEM106B mRNA	PMID:39836092
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1603394	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of TMEM106B mRNA	PMID:19691856
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TMEM106B mRNA	PMID:28302478
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of TMEM106B mRNA	PMID:19167446
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603394	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM106B mRNA	PMID:25979313
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM106B mRNA	PMID:23179753|PMID:24935251|PMID:25192806|PMID:26272509
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1603394	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TMEM106B gene	PMID:29154799
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM106B mRNA	PMID:27188386
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of TMEM106B mRNA	PMID:41580965
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550447	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of TMEM106B mRNA	PMID:19770486
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of TMEM106B protein	PMID:40631627
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TMEM106B mRNA	PMID:24136188
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TMEM106B mRNA	PMID:38832940
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of TMEM106B mRNA	PMID:27188386
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of TMEM106B mRNA	PMID:24935251
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of TMEM106B mRNA	PMID:21346803
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550447	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMEM106B mRNA	PMID:17562736
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550447	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TMEM106B mRNA	PMID:29279043
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of TMEM106B protein	PMID:38460933
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550447	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM106B mRNA	PMID:40504410
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TMEM106B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM106B mRNA	PMID:39836092
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of TMEM106B mRNA	PMID:36621641
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550447	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TMEM106B mRNA; Nanotubes, Carbon results in decreased expression of TMEM106B mRNA	PMID:25554681
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of TMEM106B mRNA	PMID:34044035
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TMEM106B mRNA	PMID:30047161
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TMEM106B mRNA	PMID:39836092
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1550447	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of TMEM106B protein	PMID:36851058
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of TMEM106B mRNA	PMID:30467583
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TMEM106B gene	PMID:35440735
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1550447	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of TMEM106B mRNA	PMID:27462272
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550447	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMEM106B mRNA	PMID:22206623
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TMEM106B mRNA	PMID:24136188
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM106B mRNA	PMID:27188386
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of TMEM106B mRNA	PMID:30928695
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550447	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TMEM106B mRNA	PMID:19270015
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TMEM106B mRNA	PMID:27291303
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:81781	tebuconazole	increases expression	ISO	RGD:1603394	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in increased expression of TMEM106B mRNA	PMID:30458266
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TMEM106B mRNA	PMID:23640034
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550447	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of TMEM106B mRNA	PMID:21795629
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TMEM106B mRNA	PMID:30047161
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603394	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM106B mRNA	PMID:27188386
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1603394	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TMEM106B mRNA	PMID:38568856
1303037	Tmem106b	transmembrane protein 106B	gene	CHEBI:9763	trovafloxacin	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in increased expression of TMEM106B mRNA	PMID:24136188
1303038	G4	G4 protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1354435	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of C6ORF47 mRNA	PMID:23724009
1303038	G4	G4 protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1354435	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of C6ORF47 mRNA	PMID:37042841
1303038	G4	G4 protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1354435	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of C6ORF47 promoter	PMID:33872906
1303038	G4	G4 protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1354435	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of C6ORF47 promoter	PMID:33872906
1303038	G4	G4 protein	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1354435	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of C6ORF47 protein	PMID:37730182
1303038	G4	G4 protein	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of G4 mRNA	PMID:33387578
1303038	G4	G4 protein	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1354435	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of C6ORF47 mRNA	PMID:28818685
1303038	G4	G4 protein	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1354435	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of C6ORF47 promoter	PMID:30157460
1303038	G4	G4 protein	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1354435	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of C6ORF47 mRNA	PMID:19549813
1303038	G4	G4 protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1354435	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of C6ORF47 promoter	PMID:30157460
1303038	G4	G4 protein	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1623029	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of D17H6S53E mRNA	PMID:25629700
1303038	G4	G4 protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of G4 mRNA	PMID:33387578
1303038	G4	G4 protein	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1354435	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of C6ORF47 mRNA	PMID:30851411
1303038	G4	G4 protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1354435	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of C6ORF47 exon	PMID:27901495
1303038	G4	G4 protein	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1354435	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of C6ORF47 gene	PMID:31601247
1303038	G4	G4 protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1623029	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of D17H6S53E mRNA	PMID:29264374
1303038	G4	G4 protein	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of G4 mRNA	PMID:34492290
1303038	G4	G4 protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of G4 mRNA	PMID:30816183|PMID:32528016
1303038	G4	G4 protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1354435	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of C6ORF47 protein	PMID:31675489
1303038	G4	G4 protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of C6ORF47 mRNA	PMID:25181051
1303038	G4	G4 protein	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1354435	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of C6ORF47 protein	PMID:31675489
1303038	G4	G4 protein	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1354435	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C6ORF47 mRNA	PMID:28628672
1303038	G4	G4 protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1354435	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C6ORF47 mRNA	PMID:28628672
1303038	G4	G4 protein	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of G4 promoter	PMID:22457795
1303038	G4	G4 protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1354435	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of C6ORF47 mRNA	PMID:25979313
1303038	G4	G4 protein	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1354435	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C6ORF47 mRNA	PMID:28628672
1303038	G4	G4 protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of G4 mRNA	PMID:33387578
1303038	G4	G4 protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1354435	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of C6ORF47 mRNA	PMID:22230336
1303038	G4	G4 protein	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1354435	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of C6ORF47 mRNA	PMID:31675489
1303038	G4	G4 protein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1354435	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of C6ORF47 mRNA	PMID:22079256
1303038	G4	G4 protein	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1354435	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C6ORF47 mRNA	PMID:28628672
1303038	G4	G4 protein	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1354435	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of C6ORF47 mRNA	PMID:22714537
1303038	G4	G4 protein	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1354435	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of C6ORF47 mRNA	PMID:22079256
1303038	G4	G4 protein	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1354435	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of C6ORF47 mRNA	PMID:22079256
1303038	G4	G4 protein	gene	CHEBI:7553	niclosamide	affects expression	ISO	RGD:1354435	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide affects the expression of C6ORF47 mRNA	PMID:36318118
1303038	G4	G4 protein	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1354435	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of C6ORF47 mRNA	PMID:30851411
1303038	G4	G4 protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1354435	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of C6ORF47 protein	PMID:31675489
1303038	G4	G4 protein	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1354435	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of C6ORF47 protein	PMID:31675489
1303038	G4	G4 protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of G4 mRNA	PMID:21346803
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1550450	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of ECE2 protein	PMID:36252740
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550450	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ECE2 mRNA	PMID:33045310
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ECE2 mRNA]	PMID:31150632
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550450	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ECE2 mRNA	PMID:20188158
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550450	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ECE2 gene	PMID:20938992
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349338	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ECE2 mRNA	PMID:23724009
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550450	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ECE2 mRNA	PMID:30529165
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1349338	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ECE2 mRNA	PMID:22378314
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1349338	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ECE2 mRNA	PMID:31614463
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1349338	E	RGD:6480464	20130611	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of ECE2 mRNA	PMID:21453500
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ECE2 mRNA	PMID:33387578
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550450	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ECE2 gene	PMID:20938992
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1349338	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ECE2 mRNA	PMID:23649840
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1349338	E	RGD:6480464	20130611	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of ECE2 mRNA	PMID:21453500
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1349338	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ECE2 mRNA	PMID:31163220
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA	PMID:31199487
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ECE2 mRNA	PMID:27523638
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ECE2 mRNA	PMID:22061828
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1349338	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ECE2 mRNA	PMID:19549813
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1349338	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ECE2 mRNA	PMID:23649840
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1349338	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ECE2 gene	PMID:27153756
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1349338	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ECE2 mRNA	PMID:23649840
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550450	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ECE2 mRNA	PMID:34911549
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ECE2 mRNA	PMID:31150632
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ECE2 mRNA]	PMID:31150632
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550450	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ECE2 gene	PMID:20938992
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:27585	selenomethionine	affects expression	ISO	RGD:1349338	E	RGD:6480464	20120412	CTD	MESH:D012645	Selenomethionine affects the expression of ECE2 mRNA	PMID:17222674
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1349338	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of ECE2 protein	PMID:35688186
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ECE2 mRNA	PMID:31881176
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1349338	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of ECE2 mRNA	PMID:41028656
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1349338	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of ECE2 mRNA	PMID:19561079|PMID:27594783
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1349338	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ECE2 mRNA	PMID:25583101
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1349338	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ECE2 mRNA	PMID:41028656
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349338	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ECE2 mRNA	PMID:38568856
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349338	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ECE2 promoter	PMID:27901495
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349338	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ECE2 3' UTR	PMID:27901495
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1349338	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ECE2 mRNA	PMID:41028656
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550450	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ECE2 promoter alternative form	PMID:35295148
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550450	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of ECE2 mRNA	PMID:27760801
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550450	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ECE2 gene	PMID:35295148
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ECE2 mRNA	PMID:25181051
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ECE2 mRNA	PMID:34947998
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ECE2 gene	PMID:28505145
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550450	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ECE2 gene	PMID:31683443
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA	PMID:31199487
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA	PMID:31199487
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:34698	diethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA	PMID:31199487
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA	PMID:31199487
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ECE2 gene	PMID:22079235
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1349338	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of ECE2 mRNA	PMID:31626844
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1349338	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ECE2 mRNA	PMID:40419075
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349338	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ECE2 mRNA	PMID:23179753|PMID:26272509
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1349338	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ECE2 gene	PMID:29154799
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1349338	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECE2 mRNA	PMID:27188386
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550450	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ECE2 mRNA	PMID:17555576
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1349338	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of ECE2 mRNA	PMID:24449571
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1349338	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of ECE2 mRNA]	PMID:21233418
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550450	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ECE2 mRNA	PMID:17562736
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550450	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ECE2 mRNA	PMID:17555576
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550450	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ECE2 mRNA; Nanotubes, Carbon results in increased expression of ECE2 mRNA	PMID:25554681
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1550450	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ECE2 mRNA	PMID:23608068
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1349338	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECE2 mRNA	PMID:27188386
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA	PMID:31199487
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349338	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ECE2 gene]	PMID:28238834
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550450	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ECE2 mRNA	PMID:31388691
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ECE2 mRNA	PMID:24780913
1303039	Ece2	endothelin-converting enzyme 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349338	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECE2 mRNA	PMID:27188386
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of AHI1 mRNA	PMID:38218311
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of AHI1 mRNA	PMID:35967413
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of AHI1 mRNA	PMID:26272509
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AHI1 mRNA	PMID:27188386
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of AHI1 mRNA	PMID:33167477
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552406	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AHI1 mRNA	PMID:30529165
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of AHI1 gene	PMID:35440735
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of AHI1 mRNA	PMID:22378314
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552406	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of AHI1 mRNA	PMID:30319688
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552406	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of AHI1 mRNA	PMID:39298647
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of AHI1 mRNA	PMID:38568856
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of AHI1 mRNA	PMID:33387578
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348620	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AHI1 mRNA	PMID:37042841
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1552406	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of AHI1 mRNA	PMID:17178593
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of AHI1 mRNA	PMID:31163220
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of AHI1 mRNA	PMID:33387578
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1348620	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of AHI1 intron	PMID:30157460
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AHI1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of AHI1 mRNA	PMID:39836092
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1552406	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of AHI1 mRNA	PMID:17178593
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of AHI1 mRNA	PMID:21396975
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1348620	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AHI1 gene	PMID:27153756
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1348620	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of AHI1 mRNA	PMID:23649840
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AHI1 mRNA	PMID:33387578
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1348620	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AHI1 gene	PMID:25304211
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AHI1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AHI1 mRNA	PMID:39836092
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of AHI1 mRNA	PMID:31881176
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of AHI1 mRNA	PMID:27392435
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552406	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AHI1 mRNA	PMID:21570461
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AHI1 mRNA	PMID:33387578
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552406	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of AHI1 mRNA	PMID:25975270
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1552406	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of AHI1 mRNA	PMID:17178593
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1348620	E	RGD:6480464	20151013	CTD	MESH:D003561	Cytarabine results in increased expression of AHI1 protein alternative form	PMID:19379585
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of AHI1 mRNA	PMID:20971185
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AHI1 mRNA	PMID:29803840
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1348620	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of AHI1 protein	PMID:35688186
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552406	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of AHI1 mRNA	PMID:36209798
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AHI1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AHI1 mRNA	PMID:39836092
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1348620	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of AHI1 mRNA	PMID:22378314
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348620	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AHI1 intron	PMID:30157460
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552406	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AHI1 mRNA	PMID:22228805
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of AHI1 mRNA	PMID:20971185
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552406	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AHI1 gene	PMID:35295148
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of AHI1 mRNA	PMID:23411599|PMID:34492290
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AHI1 mRNA	PMID:30816183
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AHI1 mRNA	PMID:25181051
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AHI1 gene	PMID:28505145
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AHI1 mRNA	PMID:36041667
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of AHI1 mRNA	PMID:27914987
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of AHI1 mRNA	PMID:23196670
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552406	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of AHI1 mRNA	PMID:40203079
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AHI1 mRNA	PMID:36041667
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1348620	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of AHI1 intron	PMID:30157460
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AHI1 mRNA	PMID:36041667
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552406	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of AHI1 intron	PMID:28392331
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552406	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of AHI1 mRNA	PMID:37019170
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348620	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AHI1 mRNA	PMID:37042841
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AHI1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of AHI1 mRNA	PMID:39836092
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of AHI1 promoter	PMID:22457795
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of AHI1 mRNA	PMID:27153767
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1348620	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of AHI1 mRNA	PMID:40419075
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of AHI1 mRNA	PMID:29427782
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1348620	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of AHI1 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1348620	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of AHI1 gene	PMID:29154799
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1348620	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of AHI1 mRNA	PMID:24935251
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552406	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of AHI1 mRNA	PMID:21427059
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AHI1 mRNA	PMID:27188386
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of AHI1 mRNA	PMID:41580965
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1348620	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AHI1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1348620	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of AHI1 protein alternative form	PMID:19379585
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1348620	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of AHI1 mRNA	PMID:24935251
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of AHI1 mRNA	PMID:33387578
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1348620	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AHI1 gene	PMID:25304211
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AHI1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AHI1 mRNA	PMID:39836092
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1552406	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of AHI1 mRNA	PMID:17178593
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1348620	E	RGD:6480464	20151013	CTD	MESH:D005047	Etoposide results in increased expression of AHI1 protein alternative form	PMID:19379585
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of AHI1 mRNA	PMID:34044035
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AHI1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of AHI1 mRNA	PMID:39836092
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1348620	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of AHI1 intron	PMID:30157460
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:71019	omacetaxine mepesuccinate	increases expression	ISO	RGD:1348620	E	RGD:6480464	20191114	CTD	MESH:C001652	Homoharringtonine results in increased expression of AHI1 protein alternative form	PMID:19379585
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552406	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AHI1 mRNA	PMID:22206623
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AHI1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AHI1 mRNA	PMID:27188386
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AHI1 gene]	PMID:28238834
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1348620	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AHI1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AHI1 mRNA	PMID:27188386
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552406	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of AHI1 mRNA	PMID:35537566
1303040	Ahi1	Abelson helper integration site 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of AHI1 mRNA	PMID:23034163
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of PCLAF mRNA	PMID:19371625
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1332466	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PCLAF mRNA	PMID:33045310
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PCLAF mRNA	PMID:39752319
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PCLAF mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PCLAF mRNA	PMID:33729688
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332466	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PCLAF mRNA	PMID:39241906
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20190702	CTD	MESH:D014260	Triclosan results in decreased expression of PCLAF mRNA	PMID:30510588
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of PCLAF mRNA	PMID:32145629
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1332466	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PCLAF mRNA	PMID:39298647
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of PCLAF mRNA	PMID:23019147
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1353661	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of PCLAF mRNA	PMID:16474171|PMID:16514628|PMID:19167446
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:16482	naphthalene	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C031721	naphthalene analog results in increased expression of PCLAF mRNA	PMID:24976557
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1353661	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PCLAF mRNA	PMID:38568856
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCLAF mRNA	PMID:33387578
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353661	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PCLAF mRNA	PMID:37042841
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of PCLAF mRNA	PMID:21795739
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of PCLAF mRNA	PMID:18070364
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of PCLAF mRNA	PMID:26079696
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCLAF mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCLAF mRNA	PMID:37992649
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PCLAF mRNA	PMID:39752319
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PCLAF mRNA	PMID:21592394
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of PCLAF mRNA	PMID:21592394
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCLAF mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCLAF mRNA	PMID:37992649
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PCLAF mRNA	PMID:26577399
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1353661	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PCLAF protein	PMID:37730182
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of PCLAF mRNA	PMID:21592394
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of PCLAF mRNA	PMID:21592394
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PCLAF mRNA	PMID:19549813
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PCLAF protein	PMID:20106945
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PCLAF mRNA	PMID:23630614
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1353661	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PCLAF mRNA	PMID:22100608
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PCLAF mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PCLAF mRNA	PMID:34911549
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332466	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PCLAF mRNA	PMID:31919559
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PCLAF mRNA	PMID:22206623
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of PCLAF mRNA	PMID:24657277
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1353661	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PCLAF protein	PMID:35688186
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCLAF mRNA]	PMID:37992649
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PCLAF mRNA	PMID:31881176
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1353661	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in increased expression of PCLAF mRNA	PMID:19167446
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of PCLAF mRNA	PMID:19167446
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D002945	Cisplatin results in decreased expression of PCLAF mRNA	PMID:22023808
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1353661	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PCLAF mRNA	PMID:27392435
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PCLAF mRNA	PMID:27392435
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28077	rifampicin	increases expression	ISO	RGD:1353661	E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in increased expression of PCLAF mRNA	PMID:24552687
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of PCLAF mRNA	PMID:19371625
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of PCLAF mRNA	PMID:16474171
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1353661	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PCLAF mRNA	PMID:25583101
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCLAF mRNA	PMID:32109520|PMID:33387578|PMID:34747641
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCLAF mRNA	PMID:19684285|PMID:21802500
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of PCLAF mRNA	PMID:28374803
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PCLAF mRNA	PMID:28001369
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PCLAF mRNA	PMID:32763439
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PCLAF mRNA	PMID:30556269
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PCLAF mRNA	PMID:20971185
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCLAF mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCLAF mRNA	PMID:37992649
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCLAF mRNA]	PMID:37992649
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PCLAF mRNA	PMID:20044591
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20181016	CTD	MESH:D001379	Azathioprine results in decreased expression of PCLAF mRNA	PMID:22623647
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PCLAF mRNA; sodium arsenite results in decreased expression of PCLAF protein	PMID:38228842|PMID:38568856
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353661	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of PCLAF mRNA	PMID:29301061|PMID:34032870
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PCLAF mRNA	PMID:22378314
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PCLAF mRNA	PMID:21839799
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PCLAF mRNA	PMID:20064835|PMID:21802500
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332466	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PCLAF mRNA	PMID:32417428
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1353661	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PCLAF mRNA	PMID:32234424
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to PCLAF mRNA]	PMID:32406909
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PCLAF mRNA	PMID:30556269
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PCLAF mRNA	PMID:20971185
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PCLAF mRNA	PMID:25895662
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1332466	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PCLAF mRNA	PMID:29341224
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PCLAF mRNA	PMID:20382639
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of PCLAF mRNA	PMID:24395379
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:31638	fulvestrant	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of PCLAF mRNA	PMID:16514628
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C030110	oxaliplatin results in decreased expression of PCLAF mRNA	PMID:25729387
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PCLAF mRNA	PMID:25729387
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of PCLAF mRNA	PMID:30012374
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PCLAF mRNA	PMID:34492290
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of PCLAF mRNA	PMID:22484513
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of PCLAF mRNA	PMID:32145629
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1353661	E	RGD:6480464	20211109	CTD	MESH:C006780	bisphenol A affects the expression of PCLAF mRNA	PMID:30903817
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PCLAF mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PCLAF mRNA	PMID:29275510|PMID:33670352
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C006780	bisphenol A results in increased expression of PCLAF mRNA	PMID:18180321
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of PCLAF mRNA	PMID:16474171
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20181016	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PCLAF mRNA	PMID:28628672
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PCLAF mRNA	PMID:19244175
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:3374	capsaicin	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D002211	Capsaicin results in increased expression of PCLAF mRNA	PMID:20349343
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1353661	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PCLAF mRNA	PMID:25979313
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1332466	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of PCLAF mRNA	PMID:26682919
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20200915	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl affects the reaction [NR1I2 protein affects the expression of PCLAF mRNA]	PMID:32352317
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332466	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PCLAF mRNA	PMID:40203079
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1332466	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PCLAF mRNA	PMID:30951980
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PCLAF mRNA	PMID:21266533
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20181016	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PCLAF mRNA	PMID:28628672
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PCLAF mRNA	PMID:19638242
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PCLAF mRNA	PMID:18164116
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C022838	nickel chloride affects the expression of PCLAF mRNA	PMID:22110744
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of PCLAF mRNA	PMID:36117858
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of PCLAF mRNA	PMID:30589522
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of PCLAF mRNA	PMID:26678675
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D002509	Cephaloridine results in increased expression of PCLAF mRNA	PMID:18500788
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PCLAF mRNA	PMID:30723492
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C039281	furan results in increased expression of PCLAF mRNA	PMID:25539665
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1332466	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PCLAF mRNA	PMID:40194260
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PCLAF mRNA	PMID:31533062
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1353661	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of PCLAF mRNA	PMID:19167446
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCLAF mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of PCLAF mRNA	PMID:19167446
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1332466	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PCLAF mRNA	PMID:39529242
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1353661	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of PCLAF mRNA	PMID:26352163
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PCLAF mRNA	PMID:40419075
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C016104	sodium bichromate affects the expression of PCLAF mRNA	PMID:22110744
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353661	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCLAF mRNA	PMID:25979313
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCLAF mRNA	PMID:29154799
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353661	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PCLAF mRNA	PMID:23179753|PMID:26272509
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCLAF mRNA	PMID:27188386
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of PCLAF mRNA	PMID:41580965
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1353661	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of PCLAF mRNA	PMID:25562108
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCLAF mRNA	PMID:20106945|PMID:21632981
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of PCLAF mRNA	PMID:15604281
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20181016	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PCLAF mRNA	PMID:28628672
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332466	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PCLAF mRNA	PMID:28973697
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCLAF mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCLAF mRNA	PMID:37992649
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of PCLAF mRNA	PMID:24657277
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of PCLAF mRNA	PMID:24657277
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of PCLAF mRNA	PMID:16514628
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PCLAF mRNA	PMID:33387578
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1353661	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of PCLAF mRNA	PMID:25704631
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of PCLAF mRNA	PMID:17039268
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D005472	[Fluorouracil co-treated with irinotecan] results in decreased expression of PCLAF mRNA	PMID:16391804
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of PCLAF mRNA	PMID:24714768
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20181016	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PCLAF mRNA	PMID:29523930
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of PCLAF mRNA	PMID:31838189
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1353661	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of PCLAF mRNA	PMID:40706910
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:4846	erythromycin estolate	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D004918	Erythromycin Estolate results in decreased expression of PCLAF mRNA	PMID:24412560
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:4846	erythromycin estolate	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D004918	Erythromycin Estolate results in increased expression of PCLAF mRNA	PMID:24412560
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20181016	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PCLAF mRNA	PMID:28628672
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of PCLAF mRNA	PMID:21148553
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of PCLAF mRNA	PMID:36117858
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1332466	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PCLAF mRNA	PMID:38701926
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PCLAF protein	PMID:32959892
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D007649	Ketamine results in decreased expression of PCLAF mRNA	PMID:20080153
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PCLAF mRNA	PMID:25729387
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C045463	leflunomide results in decreased expression of PCLAF mRNA	PMID:24136188
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PCLAF mRNA	PMID:16026605
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20171114	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PCLAF mRNA	PMID:24810058
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of PCLAF mRNA	PMID:35283115
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D008694	Methamphetamine results in decreased expression of PCLAF mRNA	PMID:19564919
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in decreased expression of PCLAF mRNA	PMID:25290377
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of PCLAF mRNA	PMID:19564919
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1332466	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of PCLAF mRNA	PMID:27462272
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:70778	GW 7647	increases expression	ISO	RGD:1332466	E	RGD:6480464	20250805	CTD	MESH:C453899	GW 7647 results in increased expression of PCLAF mRNA	PMID:40216583
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:70778	GW 7647	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20250805	CTD	MESH:C453899	PPARA gene mutant form inhibits the reaction [GW 7647 results in increased expression of PCLAF mRNA]	PMID:40216583
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PCLAF mRNA	PMID:39752319
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of PCLAF mRNA	PMID:19564919
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:73458	NS-398	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20130604	CTD	MESH:C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PCLAF mRNA	PMID:11494140
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PCLAF mRNA	PMID:22206623
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:749016	gossypol acetic acid	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of PCLAF protein	PMID:29938581
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of PCLAF mRNA	PMID:27225895
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1332466	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of PCLAF mRNA	PMID:27225895
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of PCLAF mRNA	PMID:29877212
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of PCLAF mRNA	PMID:32858204
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PCLAF mRNA	PMID:18164116
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of PCLAF mRNA	PMID:34995734
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCLAF mRNA	PMID:27188386
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:80630	irinotecan	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20181113	CTD	MESH:D000077146	[Fluorouracil co-treated with Irinotecan] results in decreased expression of PCLAF mRNA	PMID:16391804
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of PCLAF mRNA	PMID:31324951
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:81555	Enterolactone	increases expression	ISO	RGD:1353661	E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PCLAF mRNA	PMID:19167446
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCLAF mRNA	PMID:19167446
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1332466	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PCLAF mRNA	PMID:38648751
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of PCLAF mRNA	PMID:26705709
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of PCLAF mRNA	PMID:21858171
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D011441	Propylthiouracil results in increased expression of PCLAF mRNA	PMID:24780913
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of PCLAF mRNA	PMID:22869556
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1332466	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of PCLAF mRNA	PMID:40826991
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of PCLAF mRNA	PMID:16514628
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1332466	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PCLAF mRNA	PMID:39752319
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of PCLAF mRNA	PMID:32419051
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353661	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCLAF mRNA	PMID:27188386
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:9111	Senkirkine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of PCLAF mRNA	PMID:32419051
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1353661	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of PCLAF mRNA	PMID:22378314
1303041	Pclaf	PCNA clamp associated factor	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1332466	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PCLAF mRNA	PMID:35537566
1303042	Wfdc15b	WAP four-disulfide core domain 15B	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D000661	Amphetamine results in increased expression of WFDC15B mRNA	PMID:30779732
1303042	Wfdc15b	WAP four-disulfide core domain 15B	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C030686	acetamide results in decreased expression of WFDC15B mRNA	PMID:31881176
1303042	Wfdc15b	WAP four-disulfide core domain 15B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of WFDC15B mRNA	PMID:25181051
1303042	Wfdc15b	WAP four-disulfide core domain 15B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of WFDC15B mRNA	PMID:41034487
1303042	Wfdc15b	WAP four-disulfide core domain 15B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in increased methylation of WFDC15B gene	PMID:28505145
1303043	Clic1	CLIC family member 1	gene	CHEBI:10033	warfarin	decreases expression	ISO	RGD:1623030	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in decreased expression of CLIC1 mRNA	PMID:20493250
1303043	Clic1	CLIC family member 1	gene	CHEBI:10093	yohimbine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D015016	Yohimbine results in decreased expression of CLIC1 mRNA	PMID:21983523
1303043	Clic1	CLIC family member 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1353337	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CLIC1 mRNA	PMID:38218311
1303043	Clic1	CLIC family member 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1353337	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of CLIC1 mRNA	PMID:35967413
1303043	Clic1	CLIC family member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1353337	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CLIC1 mRNA	PMID:33167477
1303043	Clic1	CLIC family member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1623030	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CLIC1 mRNA	PMID:39241906
1303043	Clic1	CLIC family member 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLIC1 mRNA	PMID:37992649
1303043	Clic1	CLIC family member 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of CLIC1 promoter	PMID:33872906
1303043	Clic1	CLIC family member 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLIC1 mRNA	PMID:37992649
1303043	Clic1	CLIC family member 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1623030	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of CLIC1 mRNA	PMID:23892564
1303043	Clic1	CLIC family member 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1353337	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of CLIC1 mRNA	PMID:16949557
1303043	Clic1	CLIC family member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of CLIC1 promoter	PMID:33872906
1303043	Clic1	CLIC family member 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CLIC1 mRNA	PMID:26577399
1303043	Clic1	CLIC family member 1	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of CLIC1 protein; [Cuprizone co-treated with Clozapine] results in decreased expression of CLIC1 protein	PMID:34122009
1303043	Clic1	CLIC family member 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1353337	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CLIC1 protein	PMID:37730182
1303043	Clic1	CLIC family member 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1353337	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CLIC1 promoter	PMID:30157460
1303043	Clic1	CLIC family member 1	gene	CHEBI:18243	dopamine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004298	Dopamine results in increased expression of CLIC1 mRNA	PMID:21983523
1303043	Clic1	CLIC family member 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CLIC1 mRNA	PMID:36331819
1303043	Clic1	CLIC family member 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of CLIC1 mRNA	PMID:28522335
1303043	Clic1	CLIC family member 1	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1353337	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of CLIC1 mRNA	PMID:16949557
1303043	Clic1	CLIC family member 1	gene	CHEBI:207229	dihydroartemisinin	affects binding	ISO	RGD:1353337	E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to CLIC1 protein modified form	PMID:26340163
1303043	Clic1	CLIC family member 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20210706	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CLIC1 protein	PMID:33040242
1303043	Clic1	CLIC family member 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CLIC1 protein	PMID:23301498
1303043	Clic1	CLIC family member 1	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of CLIC1 protein	PMID:33236894
1303043	Clic1	CLIC family member 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1353337	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CLIC1 protein	PMID:20106945
1303043	Clic1	CLIC family member 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1353337	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CLIC1 promoter	PMID:30157460
1303043	Clic1	CLIC family member 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1353337	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CLIC1 mRNA	PMID:22100608
1303043	Clic1	CLIC family member 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CLIC1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CLIC1 protein	PMID:38598786
1303043	Clic1	CLIC family member 1	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CLIC1 mRNA	PMID:30779732
1303043	Clic1	CLIC family member 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1623030	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CLIC1 mRNA	PMID:31919559
1303043	Clic1	CLIC family member 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1623030	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CLIC1 mRNA	PMID:25629700
1303043	Clic1	CLIC family member 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLIC1 mRNA	PMID:22206623
1303043	Clic1	CLIC family member 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1353337	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CLIC1 gene	PMID:25304211
1303043	Clic1	CLIC family member 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CLIC1 protein	PMID:38460933
1303043	Clic1	CLIC family member 1	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:1353337	E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in increased expression of CLIC1 protein	PMID:31195006
1303043	Clic1	CLIC family member 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CLIC1 mRNA	PMID:31881176
1303043	Clic1	CLIC family member 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1623030	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of CLIC1 protein	PMID:25505154
1303043	Clic1	CLIC family member 1	gene	CHEBI:27928	parathion	decreases methylation	ISO	RGD:1353337	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of CLIC1 promoter	PMID:22847954
1303043	Clic1	CLIC family member 1	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1353337	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of CLIC1 mRNA	PMID:18000554
1303043	Clic1	CLIC family member 1	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1623030	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of CLIC1 mRNA	PMID:18930951
1303043	Clic1	CLIC family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLIC1 mRNA	PMID:22298810|PMID:34747641
1303043	Clic1	CLIC family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623030	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLIC1 mRNA	PMID:21570461
1303043	Clic1	CLIC family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLIC1 mRNA	PMID:17942748
1303043	Clic1	CLIC family member 1	gene	CHEBI:28694	copper atom	affects binding	ISO	RGD:1353337	E	RGD:6480464	20120814	CTD	MESH:D003300	CLIC1 protein binds to Copper	PMID:15359738
1303043	Clic1	CLIC family member 1	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of CLIC1 mRNA	PMID:30556269
1303043	Clic1	CLIC family member 1	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1353337	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of CLIC1 mRNA	PMID:29803840
1303043	Clic1	CLIC family member 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLIC1 mRNA	PMID:37992649
1303043	Clic1	CLIC family member 1	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1353337	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CLIC1 protein	PMID:35688186
1303043	Clic1	CLIC family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1353337	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLIC1 mRNA	PMID:32234424
1303043	Clic1	CLIC family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1623030	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLIC1 mRNA	PMID:22228805
1303043	Clic1	CLIC family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353337	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CLIC1 promoter	PMID:27901495
1303043	Clic1	CLIC family member 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CLIC1 mRNA]	PMID:22228805
1303043	Clic1	CLIC family member 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CLIC1 mRNA]	PMID:32406909
1303043	Clic1	CLIC family member 1	gene	CHEBI:30052	copper(0)	affects binding	ISO	RGD:1353337	E	RGD:6480464	20120814	CTD	MESH:D003300	CLIC1 protein binds to Copper	PMID:15359738
1303043	Clic1	CLIC family member 1	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of CLIC1 mRNA	PMID:30556269
1303043	Clic1	CLIC family member 1	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1353337	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of CLIC1 mRNA	PMID:35984750
1303043	Clic1	CLIC family member 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CLIC1 gene	PMID:31601247
1303043	Clic1	CLIC family member 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of CLIC1 mRNA	PMID:24136188
1303043	Clic1	CLIC family member 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CLIC1 mRNA	PMID:30047161
1303043	Clic1	CLIC family member 1	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of CLIC1 mRNA	PMID:24136188
1303043	Clic1	CLIC family member 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1623030	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of CLIC1 mRNA	PMID:27760801
1303043	Clic1	CLIC family member 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CLIC1 mRNA	PMID:34492290
1303043	Clic1	CLIC family member 1	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CLIC1 mRNA	PMID:28943392
1303043	Clic1	CLIC family member 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CLIC1 mRNA	PMID:25380136
1303043	Clic1	CLIC family member 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1353337	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CLIC1 mRNA	PMID:30903817
1303043	Clic1	CLIC family member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353337	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CLIC1 mRNA; bisphenol A results in decreased expression of CLIC1 protein	PMID:29275510|PMID:34186270
1303043	Clic1	CLIC family member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1623030	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CLIC1 protein	PMID:35999755
1303043	Clic1	CLIC family member 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CLIC1 mRNA	PMID:25181051|PMID:32145629
1303043	Clic1	CLIC family member 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CLIC1 gene	PMID:31601247
1303043	Clic1	CLIC family member 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20230207	CTD	MESH:C006780	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of CLIC1 protein	PMID:35999755
1303043	Clic1	CLIC family member 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1353337	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of CLIC1 mRNA	PMID:19244175
1303043	Clic1	CLIC family member 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1623030	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CLIC1 mRNA	PMID:26682919
1303043	Clic1	CLIC family member 1	gene	CHEBI:3423	carmustine	decreases response to substance	ISO	RGD:1353337	E	RGD:6480464	20120412	CTD	MESH:D002330	CLIC1 protein results in decreased susceptibility to Carmustine	PMID:18590702
1303043	Clic1	CLIC family member 1	gene	CHEBI:3423	carmustine	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20120412	CTD	MESH:D002330	[4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of CLIC1 protein] which results in increased susceptibility to Carmustine	PMID:18590702
1303043	Clic1	CLIC family member 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1623030	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of CLIC1 mRNA	PMID:26377693
1303043	Clic1	CLIC family member 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1353337	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CLIC1 protein	PMID:34186270
1303043	Clic1	CLIC family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1623030	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CLIC1 mRNA	PMID:28392331
1303043	Clic1	CLIC family member 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623030	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CLIC1 mRNA	PMID:37019170
1303043	Clic1	CLIC family member 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1623030	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of CLIC1 protein	PMID:35999755
1303043	Clic1	CLIC family member 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20230207	CTD	MESH:D016264	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of CLIC1 protein	PMID:35999755
1303043	Clic1	CLIC family member 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CLIC1 mRNA	PMID:21266533
1303043	Clic1	CLIC family member 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1623030	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CLIC1 mRNA	PMID:21266533
1303043	Clic1	CLIC family member 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1353337	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to CLIC1 protein	PMID:32991956
1303043	Clic1	CLIC family member 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of CLIC1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CLIC1 protein	PMID:38598786
1303043	Clic1	CLIC family member 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CLIC1 mRNA	PMID:28943392
1303043	Clic1	CLIC family member 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353337	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CLIC1 mRNA	PMID:37042841
1303043	Clic1	CLIC family member 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CLIC1 mRNA	PMID:25380136
1303043	Clic1	CLIC family member 1	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of CLIC1 mRNA	PMID:22110744
1303043	Clic1	CLIC family member 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CLIC1 promoter	PMID:22457795
1303043	Clic1	CLIC family member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20210706	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CLIC1 protein	PMID:33040242
1303043	Clic1	CLIC family member 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CLIC1 mRNA	PMID:27387713
1303043	Clic1	CLIC family member 1	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of CLIC1 mRNA	PMID:25380136
1303043	Clic1	CLIC family member 1	gene	CHEBI:3766	clozapine	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in decreased expression of CLIC1 protein	PMID:34122009
1303043	Clic1	CLIC family member 1	gene	CHEBI:38689	fonofos	decreases methylation	ISO	RGD:1353337	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of CLIC1 promoter	PMID:22847954
1303043	Clic1	CLIC family member 1	gene	CHEBI:38960	terbufos	decreases methylation	ISO	RGD:1353337	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of CLIC1 promoter	PMID:22847954
1303043	Clic1	CLIC family member 1	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1353337	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of CLIC1 mRNA	PMID:26352163
1303043	Clic1	CLIC family member 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CLIC1 mRNA	PMID:36331819
1303043	Clic1	CLIC family member 1	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of CLIC1 mRNA	PMID:22110744
1303043	Clic1	CLIC family member 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353337	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CLIC1 mRNA	PMID:25979313
1303043	Clic1	CLIC family member 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1623030	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CLIC1 mRNA	PMID:17292431
1303043	Clic1	CLIC family member 1	gene	CHEBI:40303	lovastatin	decreases expression	ISO	RGD:1623030	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in decreased expression of CLIC1 mRNA	PMID:20493250
1303043	Clic1	CLIC family member 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1353337	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CLIC1 mRNA	PMID:20106945|PMID:25562108
1303043	Clic1	CLIC family member 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1623030	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CLIC1 mRNA	PMID:17555576
1303043	Clic1	CLIC family member 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1623030	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CLIC1 mRNA	PMID:28973697
1303043	Clic1	CLIC family member 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLIC1 mRNA	PMID:37992649
1303043	Clic1	CLIC family member 1	gene	CHEBI:4286	4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20120412	CTD	MESH:D017878	[4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of CLIC1 protein] which results in increased susceptibility to Carmustine	PMID:18590702
1303043	Clic1	CLIC family member 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1353337	E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in decreased expression of CLIC1 protein	PMID:19294695
1303043	Clic1	CLIC family member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623030	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CLIC1 mRNA	PMID:17562736
1303043	Clic1	CLIC family member 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLIC1 mRNA	PMID:33387578
1303043	Clic1	CLIC family member 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1353337	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLIC1 mRNA	PMID:21420995
1303043	Clic1	CLIC family member 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1353337	E	RGD:6480464	20120412	CTD	MESH:D005472	CLIC1 protein affects the susceptibility to Fluorouracil	PMID:16217747
1303043	Clic1	CLIC family member 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CLIC1 protein	PMID:38460933
1303043	Clic1	CLIC family member 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1353337	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CLIC1 gene	PMID:25304211
1303043	Clic1	CLIC family member 1	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1623030	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide analog results in decreased expression of CLIC1 protein	PMID:23882024
1303043	Clic1	CLIC family member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1623030	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CLIC1 mRNA	PMID:17555576
1303043	Clic1	CLIC family member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1623030	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CLIC1 mRNA	PMID:17942748
1303043	Clic1	CLIC family member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLIC1 mRNA	PMID:17942748
1303043	Clic1	CLIC family member 1	gene	CHEBI:5002	fenoldopam	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D018818	Fenoldopam results in increased expression of CLIC1 mRNA	PMID:21983523
1303043	Clic1	CLIC family member 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1353337	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of CLIC1 protein	PMID:19294695
1303043	Clic1	CLIC family member 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CLIC1 mRNA	PMID:30047161
1303043	Clic1	CLIC family member 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CLIC1 mRNA	PMID:35964746
1303043	Clic1	CLIC family member 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CLIC1 mRNA	PMID:24793618
1303043	Clic1	CLIC family member 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1623030	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CLIC1 mRNA	PMID:38701926
1303043	Clic1	CLIC family member 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353337	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CLIC1 protein	PMID:32959892
1303043	Clic1	CLIC family member 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1353337	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CLIC1 mRNA	PMID:28988120
1303043	Clic1	CLIC family member 1	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of CLIC1 protein	PMID:34122009
1303043	Clic1	CLIC family member 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1353337	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CLIC1 protein	PMID:34186270
1303043	Clic1	CLIC family member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623030	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLIC1 mRNA	PMID:22206623
1303043	Clic1	CLIC family member 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CLIC1 protein	PMID:37664457
1303043	Clic1	CLIC family member 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1353337	E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CLIC1 mRNA; beta-Naphthoflavone results in increased expression of CLIC1 protein	PMID:19737606|PMID:39638853
1303043	Clic1	CLIC family member 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CLIC1 gene]	PMID:28238834
1303043	Clic1	CLIC family member 1	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1353337	E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of CLIC1 mRNA	PMID:19682730
1303043	Clic1	CLIC family member 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1623030	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of CLIC1 mRNA	PMID:27029645
1303043	Clic1	CLIC family member 1	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of CLIC1 mRNA	PMID:30047161
1303043	Clic1	CLIC family member 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CLIC1 mRNA	PMID:24780913|PMID:30047161
1303043	Clic1	CLIC family member 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1623030	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of CLIC1 mRNA	PMID:40826991
1303043	Clic1	CLIC family member 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CLIC1 protein	PMID:37664457
1303043	Clic1	CLIC family member 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CLIC1 mRNA	PMID:21346803
1303043	Clic1	CLIC family member 1	gene	CHEBI:9381	T-2 toxin	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of CLIC1 protein	PMID:26141394
1303043	Clic1	CLIC family member 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1353337	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of CLIC1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CLIC1 protein	PMID:38598786
1303044	Krt15	keratin 15	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1342638	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KRT15 mRNA	PMID:38218311
1303044	Krt15	keratin 15	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of KRT15 mRNA	PMID:21551480
1303044	Krt15	keratin 15	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1342638	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin metabolite results in increased expression of KRT15 mRNA; Tretinoin results in increased expression of KRT15 mRNA	PMID:15982314|PMID:23830798
1303044	Krt15	keratin 15	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1552418	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of KRT15 mRNA	PMID:36189433
1303044	Krt15	keratin 15	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1552418	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of KRT15 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of KRT15 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of KRT15 mRNA	PMID:30951980|PMID:36189433
1303044	Krt15	keratin 15	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of KRT15 mRNA	PMID:25596134
1303044	Krt15	keratin 15	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of KRT15 mRNA	PMID:26079696
1303044	Krt15	keratin 15	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of KRT15 mRNA	PMID:39506029
1303044	Krt15	keratin 15	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1342638	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of KRT15 mRNA	PMID:20044591
1303044	Krt15	keratin 15	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1342638	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of KRT15 mRNA	PMID:21632981
1303044	Krt15	keratin 15	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KRT15 mRNA	PMID:35811015
1303044	Krt15	keratin 15	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KRT15 mRNA	PMID:35811015
1303044	Krt15	keratin 15	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1342638	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol affects the expression of KRT15 mRNA	PMID:14699072|PMID:25321415
1303044	Krt15	keratin 15	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552418	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of KRT15 mRNA; Estradiol results in increased expression of KRT15 protein	PMID:19484750|PMID:26903627
1303044	Krt15	keratin 15	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of KRT15 mRNA; Estradiol promotes the reaction [ESR2 protein affects the expression of KRT15 mRNA]	PMID:20404318|PMID:30165855
1303044	Krt15	keratin 15	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of KRT15 mRNA	PMID:38568856
1303044	Krt15	keratin 15	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KRT15 mRNA	PMID:33387578
1303044	Krt15	keratin 15	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1552418	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of KRT15 mRNA	PMID:22238285
1303044	Krt15	keratin 15	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552418	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of KRT15 mRNA	PMID:36189433
1303044	Krt15	keratin 15	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1552418	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of KRT15 mRNA	PMID:17317680
1303044	Krt15	keratin 15	gene	CHEBI:17356	2-acetamidofluorene	multiple interactions	ISO	RGD:1552418	E	RGD:6480464	20120412	CTD	MESH:D015073	TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT15 mRNA]	PMID:17317680
1303044	Krt15	keratin 15	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1342638	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of KRT15 mRNA	PMID:23825647
1303044	Krt15	keratin 15	gene	CHEBI:177387	brequinar	increases expression	ISO	RGD:1342638	E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in increased expression of KRT15 mRNA	PMID:39900124
1303044	Krt15	keratin 15	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of KRT15 mRNA	PMID:36139627
1303044	Krt15	keratin 15	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of KRT15 mRNA	PMID:26485663
1303044	Krt15	keratin 15	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1342638	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of KRT15 mRNA	PMID:26485663
1303044	Krt15	keratin 15	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KRT15 mRNA	PMID:33387578
1303044	Krt15	keratin 15	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1342638	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of KRT15 mRNA	PMID:23825647
1303044	Krt15	keratin 15	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1342638	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KRT15 mRNA	PMID:19549813
1303044	Krt15	keratin 15	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20170303	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of KRT15 mRNA	PMID:23487506|PMID:23876855
1303044	Krt15	keratin 15	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1342638	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of KRT15 protein	PMID:20106945
1303044	Krt15	keratin 15	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1342638	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KRT15 mRNA	PMID:21632981|PMID:21641981|PMID:22100608
1303044	Krt15	keratin 15	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1552418	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of KRT15 mRNA	PMID:15674843
1303044	Krt15	keratin 15	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of KRT15 mRNA	PMID:25102026
1303044	Krt15	keratin 15	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552418	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of KRT15 mRNA	PMID:34911549
1303044	Krt15	keratin 15	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT15 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT15 protein	PMID:38598786
1303044	Krt15	keratin 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of KRT15 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT15 mRNA	PMID:32525701|PMID:40512198
1303044	Krt15	keratin 15	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1342638	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of KRT15 mRNA	PMID:38460933
1303044	Krt15	keratin 15	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of KRT15 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of KRT15 protein	PMID:38460933
1303044	Krt15	keratin 15	gene	CHEBI:27871	chloroacetaldehyde	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of KRT15 mRNA	PMID:25596134
1303044	Krt15	keratin 15	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150714	CTD	MESH:C059514	resveratrol results in increased expression of KRT15 mRNA	PMID:25888808
1303044	Krt15	keratin 15	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of KRT15 mRNA	PMID:41028656
1303044	Krt15	keratin 15	gene	CHEBI:27889	lead(0)	affects binding	ISO	RGD:1342638	E	RGD:6480464	20150512	CTD	MESH:D007854	KRT15 protein binds to Lead	PMID:23896426
1303044	Krt15	keratin 15	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552418	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of KRT15 mRNA	PMID:40618947
1303044	Krt15	keratin 15	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of KRT15 mRNA	PMID:27392435
1303044	Krt15	keratin 15	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of KRT15 mRNA	PMID:20187946
1303044	Krt15	keratin 15	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of KRT15 mRNA	PMID:17341692
1303044	Krt15	keratin 15	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1552418	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of KRT15 mRNA	PMID:32186404
1303044	Krt15	keratin 15	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of KRT15 mRNA	PMID:24768652|PMID:25583101
1303044	Krt15	keratin 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KRT15 mRNA	PMID:33387578
1303044	Krt15	keratin 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KRT15 mRNA	PMID:23152189
1303044	Krt15	keratin 15	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1342638	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of KRT15 mRNA	PMID:33212167
1303044	Krt15	keratin 15	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20121009	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of KRT15 mRNA	PMID:22105179
1303044	Krt15	keratin 15	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1342638	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of KRT15 mRNA	PMID:30851411
1303044	Krt15	keratin 15	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in decreased expression of KRT15 mRNA	PMID:16246896
1303044	Krt15	keratin 15	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of KRT15 mRNA	PMID:41028656
1303044	Krt15	keratin 15	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRT15 mRNA	PMID:12016162|PMID:38568856
1303044	Krt15	keratin 15	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1342638	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT15 mRNA; sodium arsenite results in increased expression of KRT15 protein	PMID:19524636
1303044	Krt15	keratin 15	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552418	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT15 mRNA	PMID:17350061
1303044	Krt15	keratin 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20240430	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of KRT15 mRNA; sodium arsenite inhibits the reaction [H3-3A protein binds to KRT15 protein]	PMID:37734572|PMID:40512198
1303044	Krt15	keratin 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1342638	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KRT15 5' UTR	PMID:27901495
1303044	Krt15	keratin 15	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1342638	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KRT15 promoter	PMID:27901495
1303044	Krt15	keratin 15	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1342638	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KRT15 mRNA	PMID:20106945|PMID:21632981|PMID:21871943|PMID:32234424
1303044	Krt15	keratin 15	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552418	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KRT15 mRNA	PMID:21569818
1303044	Krt15	keratin 15	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20120412	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of KRT15 mRNA	PMID:20146248
1303044	Krt15	keratin 15	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552418	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KRT15 mRNA	PMID:27858113
1303044	Krt15	keratin 15	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1342638	E	RGD:6480464	20120918	CTD	MESH:C015001	arsenite results in increased expression of KRT15 mRNA	PMID:22011395
1303044	Krt15	keratin 15	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in decreased expression of KRT15 mRNA	PMID:16246896
1303044	Krt15	keratin 15	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of KRT15 mRNA	PMID:41028656
1303044	Krt15	keratin 15	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of KRT15 mRNA	PMID:34779285
1303044	Krt15	keratin 15	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1552418	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of KRT15 mRNA	PMID:29341224
1303044	Krt15	keratin 15	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1342638	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of KRT15 mRNA	PMID:25895662
1303044	Krt15	keratin 15	gene	CHEBI:31175	adefovir pivoxil	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of KRT15 mRNA	PMID:25596134
1303044	Krt15	keratin 15	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1342638	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of KRT15 mRNA	PMID:37690743
1303044	Krt15	keratin 15	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of KRT15 mRNA	PMID:38568856
1303044	Krt15	keratin 15	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552418	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of KRT15 mRNA	PMID:23557971
1303044	Krt15	keratin 15	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552418	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of KRT15 mRNA	PMID:35295148
1303044	Krt15	keratin 15	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1552418	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of KRT15 mRNA	PMID:18648102
1303044	Krt15	keratin 15	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20120412	CTD	MESH:C016583	[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of KRT15 mRNA	PMID:20146248
1303044	Krt15	keratin 15	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552418	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of KRT15 mRNA	PMID:28472532
1303044	Krt15	keratin 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT15 mRNA	PMID:25181051
1303044	Krt15	keratin 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT15 mRNA	PMID:36232920
1303044	Krt15	keratin 15	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of KRT15 mRNA	PMID:32145629|PMID:41034487
1303044	Krt15	keratin 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1342638	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of KRT15 mRNA	PMID:36232920
1303044	Krt15	keratin 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552418	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of KRT15 mRNA	PMID:30951980|PMID:32156529
1303044	Krt15	keratin 15	gene	CHEBI:33418	graphite	increases expression	ISO	RGD:1552418	E	RGD:6480464	20180515	CTD	MESH:D006108	Graphite results in increased expression of KRT15 mRNA	PMID:27440207
1303044	Krt15	keratin 15	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of KRT15 mRNA	PMID:36804509
1303044	Krt15	keratin 15	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KRT15 mRNA	PMID:23196670
1303044	Krt15	keratin 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552418	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of KRT15 mRNA	PMID:30951980
1303044	Krt15	keratin 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1552418	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of KRT15 mRNA	PMID:30951980
1303044	Krt15	keratin 15	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1552418	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KRT15 mRNA	PMID:27858113
1303044	Krt15	keratin 15	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552418	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of KRT15 mRNA	PMID:30951980
1303044	Krt15	keratin 15	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1552418	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of KRT15 mRNA	PMID:30951980
1303044	Krt15	keratin 15	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT15 protein	PMID:38598786
1303044	Krt15	keratin 15	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT15 mRNA	PMID:35163327
1303044	Krt15	keratin 15	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KRT15 mRNA	PMID:38568856
1303044	Krt15	keratin 15	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KRT15 mRNA	PMID:25596134
1303044	Krt15	keratin 15	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT15 mRNA	PMID:35163327
1303044	Krt15	keratin 15	gene	CHEBI:3696	cidofovir anhydrous	increases expression	ISO	RGD:1342638	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of KRT15 mRNA	PMID:25596134
1303044	Krt15	keratin 15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of KRT15 mRNA	PMID:40419075
1303044	Krt15	keratin 15	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1342638	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KRT15 gene	PMID:29154799
1303044	Krt15	keratin 15	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KRT15 mRNA	PMID:25562108|PMID:25596134
1303044	Krt15	keratin 15	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1342638	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KRT15 mRNA	PMID:38832940
1303044	Krt15	keratin 15	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRT15 mRNA	PMID:33387578
1303044	Krt15	keratin 15	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1342638	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of KRT15 mRNA	PMID:22230336
1303044	Krt15	keratin 15	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1342638	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of KRT15 mRNA	PMID:25596134
1303044	Krt15	keratin 15	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KRT15 mRNA	PMID:35811015
1303044	Krt15	keratin 15	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of KRT15 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of KRT15 protein	PMID:38460933
1303044	Krt15	keratin 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of KRT15 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT15 mRNA	PMID:32525701|PMID:40512198
1303044	Krt15	keratin 15	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1552418	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of KRT15 mRNA	PMID:30529165
1303044	Krt15	keratin 15	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1552418	E	RGD:6480464	20200804	CTD	MESH:D002101	Cacodylic Acid results in increased expression of KRT15 mRNA	PMID:32052077
1303044	Krt15	keratin 15	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of KRT15 mRNA	PMID:38568856
1303044	Krt15	keratin 15	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of KRT15 mRNA	PMID:30307764
1303044	Krt15	keratin 15	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	ISO	RGD:1342638	E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of KRT15 mRNA	PMID:15982314
1303044	Krt15	keratin 15	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of KRT15 mRNA	PMID:30047161
1303044	Krt15	keratin 15	gene	CHEBI:50859	bexarotene	increases expression	ISO	RGD:1342638	E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in increased expression of KRT15 mRNA	PMID:17178900
1303044	Krt15	keratin 15	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1552418	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KRT15 mRNA	PMID:27858113
1303044	Krt15	keratin 15	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1552418	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KRT15 mRNA	PMID:27858113
1303044	Krt15	keratin 15	gene	CHEBI:5864	ifosfamide	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of KRT15 mRNA	PMID:25596134
1303044	Krt15	keratin 15	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1342638	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of KRT15 mRNA	PMID:15982314
1303044	Krt15	keratin 15	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of KRT15 mRNA	PMID:31758290
1303044	Krt15	keratin 15	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552418	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KRT15 mRNA	PMID:22206623
1303044	Krt15	keratin 15	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of KRT15 mRNA	PMID:36139627
1303044	Krt15	keratin 15	gene	CHEBI:77012	methylseleninic acid	increases expression	ISO	RGD:1342638	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of KRT15 mRNA	PMID:18548127
1303044	Krt15	keratin 15	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1342638	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of KRT15 mRNA	PMID:22124623
1303044	Krt15	keratin 15	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1342638	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of KRT15 mRNA	PMID:30851411
1303044	Krt15	keratin 15	gene	CHEBI:80656	all-trans-4-oxoretinoic acid	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150120	CTD	MESH:C002202	4-oxoretinoic acid results in increased expression of KRT15 mRNA	PMID:15982314
1303044	Krt15	keratin 15	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of KRT15 mRNA	PMID:30047161
1303044	Krt15	keratin 15	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KRT15 mRNA	PMID:23914054
1303044	Krt15	keratin 15	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1342638	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of KRT15 mRNA	PMID:26079696
1303044	Krt15	keratin 15	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT15 mRNA	PMID:32525701
1303044	Krt15	keratin 15	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KRT15 mRNA	PMID:30047161
1303044	Krt15	keratin 15	gene	CHEBI:91275	N-butyl-N-(4-hydroxybutyl)nitrosamine	increases expression	ISO	RGD:1552418	E	RGD:6480464	20160315	CTD	MESH:D002085	Butylhydroxybutylnitrosamine results in increased expression of KRT15 protein	PMID:24998975
1303044	Krt15	keratin 15	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1342638	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of KRT15 mRNA	PMID:17428261
1303044	Krt15	keratin 15	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1342638	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of KRT15 mRNA	PMID:38568856
1303044	Krt15	keratin 15	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1342638	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT15 protein	PMID:38598786
1303044	Krt15	keratin 15	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of KRT15 mRNA	PMID:23869203
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1347555	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MTIF2 mRNA	PMID:38218311
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1347555	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MTIF2 mRNA	PMID:38218311
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1347555	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MTIF2 mRNA	PMID:33167477
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1347555	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MTIF2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of MTIF2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MTIF2 mRNA	PMID:32699268|PMID:32845096
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1347555	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MTIF2 mRNA	PMID:20044591
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1347555	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MTIF2 mRNA	PMID:21632981
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552423	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MTIF2 mRNA	PMID:39298647
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1347555	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MTIF2 mRNA	PMID:21179406
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1347555	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of MTIF2 mRNA	PMID:16949557
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:17698	chloramphenicol	decreases response to substance	ISO	RGD:1347555	E	RGD:6480464	20200609	CTD	MESH:D002701	MTIF2 protein results in decreased susceptibility to Chloramphenicol	PMID:31915244
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552423	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MTIF2 mRNA	PMID:34319233
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1347555	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTIF2 mRNA	PMID:39836092
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of MTIF2 protein	PMID:34915118
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1347555	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of MTIF2 mRNA	PMID:16949557
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1347555	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MTIF2 mRNA	PMID:19549813
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of MTIF2 protein	PMID:33236894
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of MTIF2 protein	PMID:33146391
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1347555	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MTIF2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of MTIF2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MTIF2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MTIF2 mRNA	PMID:32699268|PMID:32845096
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1552423	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MTIF2 mRNA	PMID:31919559
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552423	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MTIF2 mRNA	PMID:25629700
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552423	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MTIF2 mRNA	PMID:22206623
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1347555	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MTIF2 gene	PMID:25304211
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347555	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTIF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MTIF2 mRNA	PMID:39836092|PMID:40512198
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552423	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MTIF2 mRNA	PMID:21354282
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1347555	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MTIF2 mRNA	PMID:32763439
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347555	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTIF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MTIF2 mRNA	PMID:39836092|PMID:40512198
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1552423	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of MTIF2 protein	PMID:37955338
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1347555	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MTIF2 mRNA]	PMID:32406909
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:31739	josamycin	decreases response to substance	ISO	RGD:1347555	E	RGD:6480464	20200609	CTD	MESH:D015570	MTIF2 protein results in decreased susceptibility to Josamycin	PMID:31915244
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MTIF2 mRNA	PMID:30047161
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552423	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MTIF2 gene; titanium dioxide results in decreased methylation of MTIF2 promoter	PMID:35295148
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MTIF2 mRNA	PMID:34492290
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552423	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of MTIF2 mRNA	PMID:18445702
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1347555	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MTIF2 mRNA	PMID:30903817
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MTIF2 mRNA	PMID:30816183
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1347555	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of MTIF2 mRNA	PMID:20678512
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MTIF2 mRNA	PMID:25181051
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1347555	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of MTIF2 protein	PMID:31945527
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1347555	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MTIF2 protein	PMID:34186270
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552423	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MTIF2 mRNA	PMID:39298647
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552423	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MTIF2 mRNA	PMID:37019170
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347555	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MTIF2 mRNA	PMID:37042841
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1347555	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTIF2 mRNA	PMID:39836092
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MTIF2 mRNA	PMID:33453195
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347555	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MTIF2 mRNA	PMID:38568856
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1347555	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MTIF2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MTIF2 mRNA	PMID:32699268
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:3732	clarithromycin	decreases response to substance	ISO	RGD:1347555	E	RGD:6480464	20200609	CTD	MESH:D017291	MTIF2 protein results in decreased susceptibility to Clarithromycin	PMID:31915244
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1552423	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of MTIF2 mRNA	PMID:17585979
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552423	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MTIF2 mRNA	PMID:40194260
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1347555	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MTIF2 mRNA	PMID:28302478
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of MTIF2 mRNA	PMID:30047161
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1347555	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MTIF2 mRNA	PMID:28542535
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552423	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MTIF2 mRNA	PMID:17562736
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MTIF2 mRNA	PMID:33387578
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1347555	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MTIF2 mRNA	PMID:21420995
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1347555	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MTIF2 gene	PMID:25304211
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347555	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTIF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MTIF2 mRNA	PMID:39836092|PMID:40512198
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552423	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MTIF2 mRNA; Nanotubes, Carbon results in decreased expression of MTIF2 mRNA	PMID:25554681
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MTIF2 mRNA	PMID:24136188
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MTIF2 mRNA	PMID:30047161
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MTIF2 mRNA	PMID:24136188
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1347555	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTIF2 mRNA	PMID:39836092
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1552423	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MTIF2 mRNA	PMID:23650126
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552423	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MTIF2 mRNA	PMID:22206623
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552423	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MTIF2 mRNA	PMID:22206623
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552423	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MTIF2 mRNA	PMID:23091169
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of MTIF2 mRNA	PMID:30047161
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MTIF2 mRNA	PMID:30047161
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MTIF2 mRNA	PMID:21346803
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MTIF2 mRNA	PMID:21346803
1303046	Mtif2	mitochondrial translational initiation factor 2	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:C025643	vinclozolin results in increased methylation of MTIF2 gene	PMID:30207508|PMID:31079544
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1353847	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of FSCN3 mRNA	PMID:34925699
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of FSCN3 mRNA	PMID:33387578
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353847	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FSCN3 mRNA	PMID:37042841
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FSCN3 mRNA	PMID:33387578
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of FSCN3 mRNA	PMID:30779732
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of FSCN3 mRNA	PMID:31881176
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550470	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FSCN3 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FSCN3 promoter]	PMID:17942748|PMID:19654925
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1353847	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FSCN3 mRNA	PMID:33212167
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of FSCN3 mRNA	PMID:28959563
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1353847	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of FSCN3 mRNA	PMID:32763439
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550470	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of FSCN3 protein	PMID:28918527
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353847	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of FSCN3 mRNA	PMID:21457566
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353847	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FSCN3 3' UTR	PMID:27901495
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1353847	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FSCN3 mRNA	PMID:22316170
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550470	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FSCN3 mRNA	PMID:27858113
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of FSCN3 mRNA	PMID:30047161
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of FSCN3 mRNA	PMID:23411599|PMID:34492290
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FSCN3 mRNA	PMID:25181051|PMID:41034487
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1550470	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FSCN3 mRNA	PMID:27858113
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353847	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FSCN3 mRNA	PMID:37042841
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FSCN3 mRNA	PMID:36928142
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of FSCN3 mRNA	PMID:30047161
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550470	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FSCN3 mRNA	PMID:40194260
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550470	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of FSCN3 mRNA	PMID:17555576
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550470	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FSCN3 mRNA	PMID:17562736
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1353847	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of FSCN3 mRNA	PMID:40706910
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of FSCN3 mRNA	PMID:29391264
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550470	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FSCN3 mRNA	PMID:17555576
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550470	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FSCN3 mRNA	PMID:17942748
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550470	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FSCN3 mRNA	PMID:17942748
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550470	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FSCN3 mRNA; Nanotubes, Carbon results in decreased expression of FSCN3 mRNA	PMID:25554681
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1550470	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FSCN3 mRNA	PMID:27858113
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1550470	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FSCN3 mRNA	PMID:27858113
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of FSCN3 mRNA	PMID:35283115
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550470	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FSCN3 mRNA	PMID:22206623
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1353847	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FSCN3 gene]	PMID:28238834
1303047	Fscn3	fascin actin-bundling protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FSCN3 mRNA	PMID:30047161
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:131762	dodecyldimethylamine N-oxide	increases expression	ISO	RGD:1354473	E	RGD:6480464	20260407	CTD	MESH:C014518	dodecyldimethylamine oxide results in increased expression of SLCO4C1 mRNA	PMID:40571133
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1354473	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SLCO4C1 mRNA	PMID:26272509
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1354473	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SLCO4C1 mRNA	PMID:21934132|PMID:33167477
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1354473	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SLCO4C1 mRNA	PMID:26079696
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SLCO4C1 mRNA	PMID:21632981
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLCO4C1 mRNA	PMID:35811015
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLCO4C1 mRNA	PMID:35811015
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1354473	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of SLCO4C1 mRNA	PMID:21185374
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1354473	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLCO4C1 mRNA	PMID:37042841
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SLCO4C1 mRNA	PMID:23649840
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:17929	N(omega),N(omega)-dimethyl-L-arginine	increases uptake	ISO	RGD:1354473	E	RGD:6480464	20201103	CTD	MESH:C018524	SLCO4C1 protein results in increased uptake of N,N-dimethylarginine	PMID:30865704
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLCO4C1 mRNA	PMID:35301059
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SLCO4C1 mRNA	PMID:23649840
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:24527	herbicide	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:D006540	[Phytochemicals co-treated with Environmental Pollutants co-treated with Food Preservatives co-treated with Plasticizers co-treated with Sunscreening Agents co-treated with Insecticides co-treated with Fungicides, Industrial co-treated with Herbicides] inhibits the reaction [perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 protein]	PMID:25588985
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1354473	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SLCO4C1 protein	PMID:20106945
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLCO4C1 mRNA	PMID:21632981|PMID:21641981|PMID:27153756
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1354473	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SLCO4C1 intron	PMID:30157460
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552434	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLCO4C1 mRNA	PMID:34911549
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1354473	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of SLCO4C1 mRNA	PMID:19774075
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SLCO4C1 mRNA	PMID:30779732
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552434	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SLCO4C1 mRNA	PMID:25629700
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1354473	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SLCO4C1 mRNA	PMID:26272509
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1354473	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SLCO4C1 protein	PMID:35688186
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:27747	L-homoarginine	increases export	ISO	RGD:1354473	E	RGD:6480464	20201103	CTD	MESH:D006709	SLCO4C1 protein results in increased export of Homoarginine	PMID:30865704
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552434	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLCO4C1 mRNA	PMID:28960355
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28077	rifampicin	increases expression	ISO	RGD:1354473	E	RGD:6480464	20180313	CTD	MESH:D012293	Rifampin results in increased expression of SLCO4C1 mRNA	PMID:27199754
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of SLCO4C1 mRNA	PMID:23195993|PMID:24768652
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLCO4C1 mRNA	PMID:20106945|PMID:21632981|PMID:21998131
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552434	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLCO4C1 mRNA	PMID:19770486
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SLCO4C1 mRNA	PMID:28001369
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1552434	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SLCO4C1 mRNA	PMID:27720909
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SLCO4C1 mRNA	PMID:33212167
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1354473	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of SLCO4C1 mRNA	PMID:26272509
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SLCO4C1 mRNA	PMID:23649840
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SLCO4C1 mRNA	PMID:28959563
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1354473	E	RGD:6480464	20150414	CTD	MESH:D004317	Doxorubicin affects the expression of SLCO4C1 mRNA	PMID:25529476
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:29021	hexane	decreases methylation	EXP		E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of SLCO4C1 promoter	PMID:23740543
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:2904	atenolol	increases expression	ISO	RGD:1354473	E	RGD:6480464	20120412	CTD	MESH:D001262	Atenolol results in increased expression of SLCO4C1 mRNA	PMID:19915711
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of SLCO4C1 mRNA	PMID:22623647
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552434	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLCO4C1 mRNA	PMID:37682722
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1354473	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of SLCO4C1 mRNA	PMID:22714537
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1354473	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLCO4C1 3' UTR; Benzo(a)pyrene affects the methylation of SLCO4C1 promoter	PMID:27901495
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLCO4C1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:26238291|PMID:32234424|PMID:38036013
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552434	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLCO4C1 mRNA	PMID:19770486|PMID:21715664
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1354473	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLCO4C1 exon	PMID:27901495
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SLCO4C1 mRNA	PMID:38458666
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1354473	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SLCO4C1 mRNA	PMID:25895662
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLCO4C1 mRNA	PMID:26238291
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of SLCO4C1 mRNA	PMID:28536007
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1552434	E	RGD:6480464	20170516	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of SLCO4C1 mRNA	PMID:27720909
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552434	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SLCO4C1 mRNA	PMID:23557971
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLCO4C1 mRNA	PMID:25181051
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1552434	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SLCO4C1 mRNA	PMID:26682919
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLCO4C1 mRNA	PMID:16997883
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SLCO4C1 mRNA	PMID:32680482
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1354473	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLCO4C1 mRNA	PMID:37042841
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1354473	E	RGD:6480464	20171114	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SLCO4C1 mRNA	PMID:28934090
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SLCO4C1 mRNA	PMID:38458666
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLCO4C1 mRNA	PMID:35301059
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 protein	PMID:25588985
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 mRNA	PMID:32588087
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552434	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLCO4C1 mRNA	PMID:40194260
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:38397	perfluorononanoic acid	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	[Phytochemicals co-treated with Environmental Pollutants co-treated with Food Preservatives co-treated with Plasticizers co-treated with Sunscreening Agents co-treated with Insecticides co-treated with Fungicides, Industrial co-treated with Herbicides] inhibits the reaction [perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 protein]	PMID:25588985
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SLCO4C1 mRNA	PMID:28302478
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1354473	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SLCO4C1 mRNA	PMID:31533062
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SLCO4C1 mRNA	PMID:27153767|PMID:40419075
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1552434	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of SLCO4C1 mRNA	PMID:23125180
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1354473	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLCO4C1 mRNA	PMID:25979313
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1354473	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SLCO4C1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:40279	allopurinol	decreases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:D000493	Allopurinol results in decreased expression of SLCO4C1 mRNA	PMID:37876353
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLCO4C1 mRNA	PMID:20106945|PMID:24907557|PMID:25562108
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1552434	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of SLCO4C1 mRNA	PMID:19770486|PMID:25270620
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in increased expression of SLCO4C1 mRNA	PMID:19059307
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLCO4C1 mRNA	PMID:16997883
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of SLCO4C1 mRNA	PMID:23649840
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:45409	ritonavir	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20241001	CTD	MESH:D019438	Ritonavir inhibits the reaction [SLCO4C1 protein affects the transport of traumatic acid]	PMID:39041788
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1354473	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SLCO4C1 mRNA	PMID:26272509
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1354473	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SLCO4C1 mRNA	PMID:24935251|PMID:26272509
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of SLCO4C1 mRNA	PMID:24714768
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLCO4C1 mRNA	PMID:35811015
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1354473	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of SLCO4C1 mRNA	PMID:26833863
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1552434	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of SLCO4C1 mRNA	PMID:25554681
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552434	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLCO4C1 mRNA	PMID:25554681
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:545687	traumatic acid	affects transport	EXP		E	RGD:6480464	20241001	CTD	MESH:C509089	SLCO4C1 protein affects the transport of traumatic acid	PMID:39041788
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:545687	traumatic acid	affects transport	ISO	RGD:1354473	E	RGD:6480464	20241001	CTD	MESH:C509089	SLCO4C1 protein affects the transport of traumatic acid	PMID:39041788
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:545687	traumatic acid	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20241001	CTD	MESH:C509089	Ritonavir inhibits the reaction [SLCO4C1 protein affects the transport of traumatic acid]	PMID:39041788
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1354473	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of SLCO4C1 mRNA	PMID:20436886
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1354473	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of SLCO4C1 mRNA	PMID:26272509
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1354473	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SLCO4C1 mRNA	PMID:24810058
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:64211	8-Br-cAMP	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20120412	CTD	MESH:D015124	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLCO4C1 mRNA	PMID:16997883
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1354473	E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in increased expression of SLCO4C1 mRNA	PMID:25290377
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1354473	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of SLCO4C1 mRNA	PMID:22714537
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1354473	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SLCO4C1 mRNA	PMID:37199045
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of SLCO4C1 mRNA	PMID:33484710
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1552434	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLCO4C1 mRNA	PMID:27935865
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1354473	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SLCO4C1 mRNA	PMID:26272509
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of SLCO4C1 mRNA	PMID:19059307
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:89700	3-iodothyronamine	affects uptake	ISO	RGD:1354473	E	RGD:6480464	20170110	CTD	MESH:C487948	SLCO4C1 mRNA affects the uptake of 3-iodothyronamine	PMID:19074582
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1354473	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA	PMID:27188386
1303048	Slco4c1	solute carrier organic anion transporter family, member 4C1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1552434	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of SLCO4C1 mRNA	PMID:26217789
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20211109	CTD	MESH:C007262	deoxynivalenol results in decreased expression of TOMM70A protein	PMID:33890134
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:10022	deoxynivalenol	increases phosphorylation	ISO	RGD:1551718	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased phosphorylation of TOMM70A protein	PMID:23352502
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1551718	E	RGD:6480464	20141223	CTD	MESH:D015025	Zearalenone results in increased expression of TOMM70A protein	PMID:25058043
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TOMM70A mRNA	PMID:33167477
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of TOMM70A mRNA	PMID:16169686
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TOMM70A mRNA	PMID:30529165
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1343038	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of TOMM70 mRNA	PMID:22378314
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1551718	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TOMM70A mRNA	PMID:30319688
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20120515	CTD	MESH:D000431	Ethanol results in decreased expression of TOMM70A mRNA	PMID:21955143
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551718	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TOMM70A mRNA	PMID:39241906
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TOMM70A mRNA]	PMID:39241906
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551718	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TOMM70A mRNA	PMID:39298647
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [TOMM70A protein binds to ESR1 protein]	PMID:27156127
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:17303	morphine	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20120515	CTD	MESH:D009020	Morphine results in decreased expression of TOMM70A mRNA	PMID:21955143
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1551718	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of TOMM70A mRNA	PMID:21955143
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1343038	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TOMM70 protein	PMID:37730182
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TOM70 mRNA	PMID:22061828
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TOMM70A mRNA	PMID:36331819
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM70 mRNA	PMID:39836092
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TOMM70 protein	PMID:34915118
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1551718	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of TOMM70A mRNA	PMID:21955143
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TOMM70 mRNA	PMID:35301059
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TOMM70A mRNA	PMID:37325564
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TOMM70 mRNA	PMID:19549813
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TOMM70 protein	PMID:23301498
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TOMM70A mRNA	PMID:19770486
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1343038	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TOMM70A gene	PMID:27153756
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of TOMM70 protein	PMID:38598786
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551718	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TOMM70A mRNA	PMID:31919559
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TOMM70A mRNA	PMID:25629700
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TOMM70A mRNA	PMID:22206623
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM70 mRNA	PMID:39836092
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1343038	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of TOMM70 protein	PMID:35688186
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TOMM70A mRNA	PMID:28960355
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TOMM70 mRNA	PMID:31881176
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1551718	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of TOMM70A protein	PMID:25505154
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TOMM70 mRNA	PMID:23557933
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551718	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TOMM70A mRNA	PMID:17942748
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TOMM70A mRNA	PMID:17942748
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of TOMM70 mRNA	PMID:33512557
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of TOMM70A mRNA	PMID:23186747
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of TOMM70 mRNA	PMID:23649840
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1343038	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of TOMM70 protein	PMID:35688186
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM70 mRNA	PMID:39836092
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343038	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TOMM70A intron	PMID:30157460
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551718	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TOMM70A mRNA	PMID:19770486|PMID:22228805
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to TOMM70A promoter]	PMID:19654925
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TOMM70 mRNA	PMID:19150397
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551718	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TOMM70A gene	PMID:35295148
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TOMM70 mRNA	PMID:34492290
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551718	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TOMM70A mRNA	PMID:17426115|PMID:18301758|PMID:23811191
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of TOMM70 mRNA	PMID:38479592
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1551718	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TOMM70A promoter	PMID:27334623
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TOMM70 mRNA	PMID:30816183|PMID:34947998
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TOMM70A mRNA	PMID:33221593
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TOMM70 mRNA; bisphenol A results in increased expression of TOMM70A mRNA	PMID:25181051|PMID:32145629
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1343038	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of TOMM70 protein	PMID:37567409
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551718	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TOMM70A mRNA	PMID:39298647
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1343038	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TOMM70 protein	PMID:34186270
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TOMM70A mRNA	PMID:37019170
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TOMM70 mRNA	PMID:21266533
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of TOMM70 protein	PMID:38598786
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of TOMM70 mRNA	PMID:32680482
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TOMM70A mRNA]	PMID:39241906
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of TOMM70A mRNA	PMID:30589522
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343038	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TOMM70 mRNA	PMID:37042841
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM70 mRNA	PMID:39836092
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TOMM70 mRNA	PMID:33453195
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TOMM70 mRNA	PMID:38568856
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TOMM70 mRNA	PMID:35301059
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TOMM70A mRNA	PMID:37325564
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1343038	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of TOMM70 mRNA	PMID:19376846
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1551718	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of TOMM70A mRNA	PMID:17585979
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TOMM70A mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TOMM70A mRNA]	PMID:17585979
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TOMM70A mRNA	PMID:28302478
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TOMM70A mRNA	PMID:36331819
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TOMM70A mRNA	PMID:29427782
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TOMM70 mRNA; Valproic Acid results in decreased expression of TOMM70A mRNA	PMID:23179753|PMID:27188386
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551718	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TOMM70A mRNA	PMID:17562736
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of TOMM70 mRNA	PMID:25704631
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TOMM70A mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TOMM70A mRNA]	PMID:17585979
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM70 mRNA	PMID:39836092
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1551718	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TOMM70A mRNA	PMID:17942748
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TOMM70A mRNA	PMID:17942748
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TOMM70A mRNA	PMID:35964746
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TOMM70A mRNA	PMID:24136188
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1551718	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TOMM70A mRNA	PMID:19042947
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of TOMM70 mRNA	PMID:20436886
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TOMM70 protein	PMID:32959892
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM70 mRNA	PMID:39836092
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1343038	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TOMM70 protein	PMID:34186270
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TOMM70A mRNA	PMID:22206623
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TOMM70A mRNA	PMID:22206623
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TOMM70 protein	PMID:37664457
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TOMM70A mRNA	PMID:24136188
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20160607	CTD	MESH:C025589	ochratoxin A results in decreased expression of TOMM70 protein	PMID:26861962
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TOMM70A gene]	PMID:28238834
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1551718	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of TOMM70A mRNA; Phenobarbital results in decreased expression of TOMM70A protein	PMID:19363144|PMID:35881160
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1343038	E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in increased expression of TOMM70 protein	PMID:35881160
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1551718	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TOMM70A mRNA]	PMID:39241906
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1343038	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TOMM70 protein	PMID:37664457
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TOMM70 mRNA	PMID:19281266
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TOMM70 mRNA	PMID:21346803
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:9422	tebufenpyrad	decreases expression	ISO	RGD:1343038	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of TOMM70 mRNA	PMID:33512557
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TOMM70 mRNA	PMID:21346803
1303049	Tomm70	translocase of outer mitochondrial membrane 70	gene	CHEBI:9763	trovafloxacin	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of TOMM70A mRNA	PMID:24136188
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1332213	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ZBTB9 mRNA	PMID:37995155
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1354226	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZBTB9 mRNA	PMID:22378314
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1354226	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of ZBTB9 mRNA	PMID:22574217
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1354226	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ZBTB9 protein	PMID:37730182
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZBTB9 mRNA	PMID:33387578
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1354226	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZBTB9 mRNA	PMID:19549813
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1354226	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZBTB9 gene	PMID:27153756
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZBTB9 mRNA	PMID:30779732
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332213	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZBTB9 mRNA	PMID:25629700
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1354226	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZBTB9 protein	PMID:35688186
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332213	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZBTB9 mRNA	PMID:21570461
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZBTB9 mRNA	PMID:33387578
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1354226	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZBTB9 mRNA	PMID:32763439
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1354226	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ZBTB9 protein	PMID:35688186
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1354226	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZBTB9 mRNA	PMID:38568856
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1354226	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ZBTB9 mRNA	PMID:35984750
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ZBTB9 mRNA	PMID:30047161
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332213	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZBTB9 gene; titanium dioxide results in decreased methylation of ZBTB9 promoter	PMID:35295148
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1354226	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ZBTB9 mRNA	PMID:19710929
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZBTB9 mRNA	PMID:25181051
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZBTB9 mRNA	PMID:34947998
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1354226	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZBTB9 mRNA	PMID:28628672
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1332213	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ZBTB9 exon	PMID:33297965
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1332213	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ZBTB9 mRNA	PMID:38685157
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1354226	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZBTB9 mRNA	PMID:28628672
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1354226	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZBTB9 mRNA; Cadmium Chloride results in decreased expression of ZBTB9 protein	PMID:38174414|PMID:38185225|PMID:38568856
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ZBTB9 promoter	PMID:22457795
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1354226	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZBTB9 mRNA	PMID:25979313
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZBTB9 mRNA	PMID:30047161
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1354226	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZBTB9 mRNA	PMID:28628672
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZBTB9 mRNA	PMID:33387578
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1354226	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZBTB9 mRNA	PMID:28628672
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZBTB9 mRNA	PMID:30047161
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1354226	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ZBTB9 mRNA	PMID:28988120
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1354226	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ZBTB9 mRNA	PMID:31758290
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332213	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ZBTB9 mRNA	PMID:22206623
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1354226	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZBTB9 protein	PMID:31285264
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZBTB9 mRNA	PMID:30047161
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1354226	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of ZBTB9 mRNA	PMID:24921660
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ZBTB9 mRNA	PMID:19281266
1303050	Zbtb9	zinc finger and BTB domain containing 9	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1354226	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZBTB9 mRNA	PMID:29301935
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552449	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GNL1 mRNA	PMID:20188158
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1352530	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GNL1 mRNA	PMID:33167477
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552449	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of GNL1 mRNA	PMID:30319688
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1352530	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of GNL1 protein	PMID:35688186
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552449	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GNL1 mRNA	PMID:39241906
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1352530	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GNL1 mRNA	PMID:37042841
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1552449	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of GNL1 mRNA	PMID:33848595
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of GNL1 mRNA	PMID:22967744
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1352530	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of GNL1 protein	PMID:37730182
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1352530	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of GNL1 mRNA	PMID:35430440
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:2663	amiodarone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in decreased expression of GNL1 mRNA	PMID:17991464
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552449	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of GNL1 mRNA]	PMID:22206623
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1352530	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GNL1 gene	PMID:25304211
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552449	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNL1 mRNA	PMID:40504410
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1352530	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of GNL1 mRNA	PMID:19244175
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1352530	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of GNL1 protein	PMID:35688186
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1352530	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GNL1 mRNA	PMID:33212167
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1352530	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GNL1 mRNA	PMID:29803840
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1352530	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of GNL1 protein	PMID:35688186
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552449	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of GNL1 mRNA	PMID:36209798
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352530	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GNL1 mRNA	PMID:38568856
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552449	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNL1 mRNA	PMID:40504410
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1352530	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GNL1 3' UTR	PMID:27901495
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1352530	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GNL1 mRNA	PMID:26238291
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1352530	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of GNL1 mRNA	PMID:26238291
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1352530	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GNL1 gene	PMID:31601247
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552449	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GNL1 mRNA	PMID:29264374
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552449	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GNL1 gene	PMID:35295148
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1352530	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of GNL1 mRNA	PMID:38479592
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1352530	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GNL1 gene	PMID:31601247
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GNL1 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552449	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of GNL1 mRNA	PMID:32156529
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1352530	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GNL1 gene	PMID:31601247
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1352530	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of GNL1 protein	PMID:31675489
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GNL1 protein	PMID:34896426
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:34575	bisphenol F	increases methylation	ISO	RGD:1352530	E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in increased methylation of GNL1 gene	PMID:31601247
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of GNL1 mRNA	PMID:21241498
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1552449	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of GNL1 mRNA	PMID:35093514
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1352530	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of GNL1 mRNA	PMID:24449571
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1352530	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of GNL1 mRNA	PMID:19244175
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552449	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of GNL1 mRNA	PMID:17585979
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1352530	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GNL1 mRNA	PMID:31533062
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of GNL1 protein	PMID:34896426
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1352530	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GNL1 mRNA	PMID:25979313
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1352530	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of GNL1 mRNA	PMID:23179753|PMID:27188386
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of GNL1 mRNA	PMID:41580965
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GNL1 protein	PMID:34896426
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GNL1 protein	PMID:34896426
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552449	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GNL1 mRNA	PMID:17562736
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GNL1 mRNA	PMID:33387578
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1352530	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GNL1 gene	PMID:25304211
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552449	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNL1 mRNA	PMID:40504410
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of GNL1 mRNA	PMID:30307764
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GNL1 protein	PMID:34896426
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552449	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GNL1 mRNA	PMID:25620056
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552449	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GNL1 mRNA	PMID:35964746
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552449	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GNL1 mRNA	PMID:22206623
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552449	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of GNL1 mRNA]	PMID:22206623
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1352530	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of GNL1 protein	PMID:37664457
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1352530	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of GNL1 protein	PMID:31675489
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1352530	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of GNL1 protein	PMID:37664457
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GNL1 mRNA	PMID:21346803
1303051	Gnl1	G protein nucleolar 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of GNL1 mRNA	PMID:21346803
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:132098	methoxyacetic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in increased expression of USP11 mRNA	PMID:20864626
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1347156	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of USP11 mRNA	PMID:33167477
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1347156	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of USP11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of USP11 mRNA	PMID:32699268
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1347156	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of USP11 mRNA	PMID:26079696
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550499	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of USP11 mRNA	PMID:30319688
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550499	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of USP11 mRNA	PMID:39241906
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1550499	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of USP11 mRNA]	PMID:39241906
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of USP11 mRNA	PMID:33387578
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1347156	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of USP11 mRNA	PMID:23649840
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550499	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of USP11 mRNA	PMID:34319233
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of USP11 mRNA	PMID:26577399
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1347156	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of USP11 protein	PMID:37730182
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of USP11 mRNA	PMID:22061828
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1347156	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of USP11 protein	PMID:23301498
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of USP11 mRNA	PMID:21396975
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1347156	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of USP11 gene	PMID:27153756
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1347156	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of USP11 mRNA	PMID:23649840
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1347156	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of USP11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of USP11 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of USP11 mRNA	PMID:32699268
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550499	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of USP11 mRNA	PMID:34911549
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550499	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of USP11 mRNA	PMID:22206623
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550499	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP11 mRNA	PMID:40504410
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in increased expression of USP11 mRNA	PMID:20864626
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550499	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of USP11 mRNA	PMID:28960355
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of USP11 mRNA	PMID:31881176
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1347156	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of USP11 mRNA	PMID:27594783
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1550499	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of USP11 mRNA	PMID:32186404
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USP11 mRNA	PMID:22298810
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of USP11 mRNA	PMID:20864626
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1347156	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of USP11 mRNA; aristolochic acid I results in increased expression of USP11 protein	PMID:33212167
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550499	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of USP11 mRNA	PMID:27862939
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1347156	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of USP11 mRNA	PMID:29803840
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:29021	hexane	increases methylation	EXP		E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in increased methylation of USP11 promoter	PMID:23740543
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347156	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of USP11 mRNA	PMID:38568856
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550499	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP11 mRNA	PMID:40504410
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347156	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of USP11 promoter	PMID:27901495
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1347156	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of USP11 3' UTR	PMID:27901495
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347156	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of USP11 exon	PMID:27901495
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1550499	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of USP11 mRNA	PMID:39826883
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550499	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of USP11 gene	PMID:35295148
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of USP11 mRNA	PMID:32145629
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1347156	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of USP11 protein	PMID:33376534|PMID:37567409
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of USP11 mRNA	PMID:30816183|PMID:32528016|PMID:41034487
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1347156	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of USP11 exon	PMID:30157460
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1550499	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of USP11 mRNA]	PMID:39241906
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:35456	cadmium dichloride	affects localization	ISO	RGD:1347156	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the localization of USP11 protein	PMID:18261755
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1347156	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of USP11 mRNA	PMID:38568856
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1347156	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of USP11 mRNA	PMID:19376846
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1347156	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of USP11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of USP11 mRNA	PMID:32699268
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550499	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of USP11 mRNA	PMID:40194260
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347156	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of USP11 mRNA	PMID:31533062
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347156	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of USP11 mRNA	PMID:25979313
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1347156	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of USP11 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1347156	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of USP11 gene	PMID:29154799
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347156	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP11 mRNA	PMID:27188386
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550499	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of USP11 mRNA	PMID:28973697
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1347156	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of USP11 mRNA	PMID:27188386
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550499	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of USP11 mRNA	PMID:17562736
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of USP11 mRNA	PMID:33387578
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1347156	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of USP11 mRNA	PMID:22230336
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of USP11 mRNA	PMID:21061450
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550499	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP11 mRNA	PMID:40504410
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of USP11 mRNA	PMID:29391264
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1550499	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of USP11 mRNA	PMID:35436446
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of USP11 mRNA	PMID:30307764
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550499	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of USP11 mRNA	PMID:25554681
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1347156	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of USP11 protein	PMID:32959892
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1347156	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of USP11 exon	PMID:30157460
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550499	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of USP11 mRNA	PMID:22206623
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347156	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP11 mRNA	PMID:27188386
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347156	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to USP11 gene]	PMID:28238834
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of USP11 mRNA	PMID:24780913
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1550499	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of USP11 mRNA]	PMID:39241906
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in increased expression of USP11 mRNA	PMID:20864626
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347156	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP11 mRNA	PMID:27188386
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1550499	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of USP11 mRNA	PMID:32835833
1303052	Usp11	ubiquitin specific peptidase 11	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of USP11 mRNA	PMID:18042343
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of FUCA2 mRNA	PMID:25152437
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FUCA2 mRNA]	PMID:31150632
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552462	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FUCA2 mRNA	PMID:20938992
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1344103	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of FUCA2 mRNA	PMID:33167477
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1344103	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of FUCA2 mRNA	PMID:24763279
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552462	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FUCA2 mRNA	PMID:30319688
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of FUCA2 mRNA	PMID:32145629
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of FUCA2 mRNA	PMID:26496021
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552462	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FUCA2 mRNA	PMID:20938992
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552462	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FUCA2 mRNA	PMID:37992649
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of FUCA2 mRNA	PMID:26496021
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552462	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FUCA2 mRNA	PMID:37992649
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552462	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FUCA2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FUCA2 mRNA	PMID:34911549
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of FUCA2 mRNA	PMID:30779732
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1552462	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of FUCA2 mRNA	PMID:17484886
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FUCA2 mRNA	PMID:31150632
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FUCA2 mRNA]	PMID:31150632
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552462	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FUCA2 mRNA	PMID:20938992
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552462	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FUCA2 mRNA	PMID:28960355
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FUCA2 mRNA	PMID:31881176
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344103	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FUCA2 mRNA	PMID:23557933
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552462	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FUCA2 mRNA	PMID:21570461
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FUCA2 mRNA	PMID:34747641
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344103	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FUCA2 protein	PMID:33212167
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552462	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of FUCA2 mRNA	PMID:39631538
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552462	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FUCA2 mRNA	PMID:37992649
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1552462	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of FUCA2 mRNA	PMID:17127020
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1344103	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FUCA2 promoter	PMID:27901495
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FUCA2 mRNA	PMID:24136188
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of FUCA2 mRNA	PMID:30047161
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FUCA2 mRNA	PMID:34492290
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552462	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of FUCA2 mRNA	PMID:23811191
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552462	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of FUCA2 mRNA	PMID:17426115
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552462	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of FUCA2 mRNA	PMID:28472532
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FUCA2 mRNA	PMID:25181051
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FUCA2 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552462	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FUCA2 mRNA	PMID:33221593
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of FUCA2 mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of FUCA2 mRNA	PMID:26496021
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552462	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of FUCA2 mRNA	PMID:40203079
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552462	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of FUCA2 intron	PMID:28392331
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552462	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FUCA2 mRNA	PMID:37019170
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1552462	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of FUCA2 mRNA	PMID:18353800
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552462	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FUCA2 mRNA	PMID:40194260
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1344103	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of FUCA2 mRNA	PMID:29501571
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of FUCA2 mRNA	PMID:30047161|PMID:41580965
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1344103	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of FUCA2 mRNA	PMID:36621641
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552462	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FUCA2 mRNA	PMID:28973697
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552462	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FUCA2 mRNA	PMID:37992649
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FUCA2 mRNA	PMID:33387578
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552462	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FUCA2 mRNA	PMID:29279043
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1344103	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FUCA2 mRNA	PMID:22079256
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:48318	fragrance	increases expression	ISO	RGD:1344103	E	RGD:6480464	20170228	CTD	MESH:D010476	Perfume results in increased expression of FUCA2 mRNA	PMID:24768652
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FUCA2 mRNA	PMID:17557909
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552462	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FUCA2 mRNA	PMID:25554681
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of FUCA2 mRNA	PMID:23962444
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of FUCA2 mRNA	PMID:30047161
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1552462	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FUCA2 mRNA	PMID:23608068
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1344103	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FUCA2 protein	PMID:32959892
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552462	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FUCA2 mRNA	PMID:22206623
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1344103	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of FUCA2 mRNA	PMID:22079256
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1344103	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FUCA2 mRNA	PMID:22079256
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1344103	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of FUCA2 mRNA	PMID:19159669
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of FUCA2 mRNA	PMID:30047161
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of FUCA2 mRNA	PMID:30047161
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FUCA2 mRNA	PMID:19281266
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FUCA2 mRNA	PMID:21346803
1303053	Fuca2	alpha-L-fucosidase 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of FUCA2 mRNA	PMID:22570695
1303054	Prss58	serine protease 58	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1606966	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PRSS58 gene	PMID:27153756
1303054	Prss58	serine protease 58	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606966	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PRSS58 mRNA	PMID:23557933
1303054	Prss58	serine protease 58	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606966	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PRSS58 5' UTR	PMID:27901495
1303054	Prss58	serine protease 58	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1623780	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of PRSS58 mRNA	PMID:35295148
1303054	Prss58	serine protease 58	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1623780	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PRSS58 mRNA	PMID:20813756
1303054	Prss58	serine protease 58	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRSS58 mRNA	PMID:25181051
1303054	Prss58	serine protease 58	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1606966	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PRSS58 gene	PMID:29154799
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550160	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of UBL7 mRNA	PMID:33045310
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602843	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of UBL7 mRNA	PMID:33167477
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1602843	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of UBL7 mRNA	PMID:21179406
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550160	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of UBL7 mRNA	PMID:39241906
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1602843	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of UBL7 mRNA	PMID:19167446
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1550160	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of UBL7 mRNA	PMID:33711761
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1602843	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of UBL7 mRNA	PMID:21179406
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550160	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UBL7 mRNA	PMID:33754040
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1602843	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of UBL7 protein	PMID:37730182
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602843	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UBL7 gene	PMID:27153756
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550160	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBL7 mRNA	PMID:40504410
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1602843	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of UBL7 gene	PMID:31636367
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1602843	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of UBL7 mRNA	PMID:27392435
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1602843	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of UBL7 mRNA	PMID:27392435
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBL7 mRNA	PMID:22298810
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550160	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBL7 mRNA	PMID:21570461|PMID:24680724
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550160	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBL7 mRNA	PMID:21354282
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBL7 mRNA	PMID:33387578
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1602843	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBL7 mRNA	PMID:30851411
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1602843	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of UBL7 protein	PMID:35688186
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602843	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBL7 mRNA	PMID:38568856
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550160	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBL7 mRNA	PMID:40504410
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550160	E	RGD:6480464	20130723	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBL7 mRNA	PMID:14625279
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550160	E	RGD:6480464	20130723	CTD	MESH:D001564	[Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of UBL7 mRNA]	PMID:14625279
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550160	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of UBL7 mRNA	PMID:29264374
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1602843	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of UBL7 mRNA	PMID:19710929
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of UBL7 mRNA	PMID:25181051
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1602843	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBL7 mRNA	PMID:28628672
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550160	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of UBL7 mRNA	PMID:37019170
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550160	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UBL7 mRNA	PMID:21266533
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1550160	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of UBL7 mRNA	PMID:34813904
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1602843	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBL7 mRNA	PMID:28628672
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1550160	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of UBL7 mRNA	PMID:34813904
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602843	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBL7 mRNA	PMID:37042841
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of UBL7 mRNA	PMID:18500788
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1602843	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of UBL7 mRNA	PMID:31533062
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602843	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of UBL7 mRNA	PMID:25562108
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1602843	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBL7 mRNA	PMID:28628672
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550160	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBL7 mRNA	PMID:40504410
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1550160	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of UBL7 mRNA	PMID:35436446
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1602843	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBL7 mRNA	PMID:28628672
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550160	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UBL7 mRNA	PMID:25554681
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of UBL7 mRNA	PMID:24136188
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBL7 mRNA	PMID:24136188
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1550160	E	RGD:6480464	20130723	CTD	MESH:D011192	[Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of UBL7 mRNA]	PMID:14625279
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1550160	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of UBL7 mRNA	PMID:23650126
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of UBL7 mRNA	PMID:24136188
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:6456	lidocaine	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D008012	Lidocaine results in decreased expression of UBL7 protein	PMID:27018092
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1550160	E	RGD:6480464	20130903	CTD	MESH:C027373	[Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of UBL7 mRNA]	PMID:14625279
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of UBL7 mRNA	PMID:21346803
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1602843	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBL7 mRNA	PMID:30851411
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602843	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to UBL7 gene]	PMID:28238834
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of UBL7 mRNA	PMID:24780913
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of UBL7 mRNA	PMID:19281266
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UBL7 mRNA	PMID:21346803
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602843	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of UBL7 mRNA	PMID:38568856
1303055	Ubl7	ubiquitin-like 7	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of UBL7 mRNA	PMID:21346803
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of TMEM178A mRNA	PMID:26272509
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA	PMID:27188386
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TMEM178 gene	PMID:20938992
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM178 mRNA	PMID:30529165
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM178 mRNA	PMID:36331819
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1602302	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of TMEM178 mRNA	PMID:21632981
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TMEM178A mRNA	PMID:35811015
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of TMEM178A mRNA	PMID:32145629
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TMEM178 gene	PMID:20938992
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM178 mRNA	PMID:37992649
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM178 mRNA	PMID:37992649
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TMEM178A mRNA	PMID:33387578
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1602302	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TMEM178A intron	PMID:30157460
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1602302	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TMEM178A protein	PMID:20106945
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TMEM178A mRNA	PMID:32234424
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602302	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TMEM178A intron	PMID:30157460
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TMEM178 mRNA	PMID:34911549
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TMEM178 gene	PMID:20938992
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TMEM178A mRNA	PMID:31881176
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1332223	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of TMEM178 mRNA	PMID:32186404
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TMEM178A mRNA	PMID:24768652|PMID:25583101
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM178 mRNA	PMID:22298810
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM178A mRNA	PMID:32109520|PMID:33387578
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM178 mRNA; Tetrachlorodibenzodioxin results in decreased expression of TMEM178A mRNA	PMID:20106945|PMID:21632981
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TMEM178A mRNA	PMID:28001369
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of TMEM178A mRNA	PMID:26272509
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA	PMID:27188386
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM178 mRNA	PMID:37992649
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMEM178A mRNA	PMID:29301061
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMEM178 mRNA; Benzo(a)pyrene results in decreased expression of TMEM178A mRNA	PMID:20106945|PMID:21632981|PMID:32234424
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602302	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM178 exon; Benzo(a)pyrene results in increased methylation of TMEM178 promoter	PMID:27901495
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TMEM178 mRNA	PMID:25895662
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TMEM178A mRNA	PMID:26705709
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TMEM178A gene	PMID:31601247
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of TMEM178 mRNA; oxaliplatin results in increased expression of TMEM178A mRNA	PMID:25729387
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] affects the expression of TMEM178 mRNA; [Topotecan co-treated with oxaliplatin] results in increased expression of TMEM178A mRNA	PMID:25729387
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1332223	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of TMEM178 mRNA	PMID:23557971
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332223	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TMEM178 gene	PMID:35295148
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TMEM178 mRNA	PMID:25181051
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332223	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM178 mRNA	PMID:32365465|PMID:34585602|PMID:39742910
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM178A mRNA	PMID:32145629
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TMEM178A gene	PMID:31601247
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1602302	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TMEM178A gene	PMID:31601247
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1332223	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TMEM178 mRNA	PMID:26377693
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TMEM178 mRNA	PMID:21266533
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TMEM178A mRNA	PMID:35163327
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TMEM178 mRNA	PMID:25380136
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TMEM178A mRNA	PMID:35163327
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TMEM178A mRNA	PMID:27387713
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of TMEM178 gene	PMID:22079235
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of TMEM178 mRNA	PMID:25380136
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TMEM178A mRNA	PMID:31533062
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM178 mRNA	PMID:36331819
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1332223	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of TMEM178 mRNA	PMID:23125180
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602302	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM178A mRNA	PMID:25979313
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM178 mRNA; Valproic Acid results in decreased expression of TMEM178A mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1602302	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TMEM178A gene	PMID:29154799
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA	PMID:27188386
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of TMEM178 mRNA; Cyclosporine results in decreased expression of TMEM178A mRNA	PMID:20106945|PMID:25562108
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332223	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM178 mRNA	PMID:37992649
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TMEM178A mRNA	PMID:38832940
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of TMEM178A mRNA	PMID:26272509|PMID:27188386
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA	PMID:27188386
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of TMEM178 mRNA; trichostatin A results in decreased expression of TMEM178A mRNA	PMID:24935251|PMID:26272509
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA	PMID:27188386
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMEM178A mRNA	PMID:33387578
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TMEM178A mRNA	PMID:35811015
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of TMEM178A mRNA	PMID:32234424
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TMEM178A mRNA	PMID:26705709
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332223	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TMEM178 mRNA	PMID:25554681
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:52774	pentane-2,3-dione	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in increased expression of TMEM178 mRNA	PMID:25710175
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of TMEM178A mRNA	PMID:28801915
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of TMEM178 mRNA; Topotecan results in increased expression of TMEM178A mRNA	PMID:25729387
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] affects the expression of TMEM178 mRNA; [Topotecan co-treated with oxaliplatin] results in increased expression of TMEM178A mRNA	PMID:25729387
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TMEM178A mRNA	PMID:24810058
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TMEM178A gene	PMID:35440735
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA	PMID:27188386
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of TMEM178A mRNA	PMID:32234424
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:83258	fenamidone	decreases expression	ISO	RGD:1332223	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in decreased expression of TMEM178 mRNA	PMID:27029645
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1602302	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of TMEM178A mRNA	PMID:26272509
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA	PMID:27188386
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602302	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM178A mRNA	PMID:27188386
1303057	Tmem178a	transmembrane protein 178A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TMEM178 mRNA	PMID:20566332
1303058	Chia	chitinase, acidic	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1615785	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHIA mRNA	PMID:30529165
1303058	Chia	chitinase, acidic	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1615785	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of CHIA mRNA	PMID:19693291
1303058	Chia	chitinase, acidic	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CHIA mRNA	PMID:27523638
1303058	Chia	chitinase, acidic	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604020	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CHIA gene; Aflatoxin B1 results in increased methylation of CHIA intron	PMID:27153756|PMID:30157460
1303058	Chia	chitinase, acidic	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1615785	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CHIA1 mRNA	PMID:34911549
1303058	Chia	chitinase, acidic	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1615785	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CHIA mRNA	PMID:28960355
1303058	Chia	chitinase, acidic	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1615785	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of CHIA mRNA	PMID:32186404
1303058	Chia	chitinase, acidic	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHIA mRNA	PMID:22298810
1303058	Chia	chitinase, acidic	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1615785	E	RGD:6480464	20150127	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHIA1 mRNA	PMID:25270620
1303058	Chia	chitinase, acidic	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604020	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHIA promoter	PMID:27901495
1303058	Chia	chitinase, acidic	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1615785	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CHIA mRNA	PMID:27858113
1303058	Chia	chitinase, acidic	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1604020	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CHIA mRNA	PMID:20458559
1303058	Chia	chitinase, acidic	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1615785	E	RGD:6480464	20120717	CTD	MESH:C009495	titanium dioxide results in decreased expression of CHIA mRNA	PMID:19464567
1303058	Chia	chitinase, acidic	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of CHIA mRNA	PMID:30012374
1303058	Chia	chitinase, acidic	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CHIA mRNA	PMID:25181051
1303058	Chia	chitinase, acidic	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1615785	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CHIA mRNA	PMID:27858113
1303058	Chia	chitinase, acidic	gene	CHEBI:34709	Diisodecyl phthalate	decreases expression	ISO	RGD:1615785	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in decreased expression of CHIA1 mRNA	PMID:25270620
1303058	Chia	chitinase, acidic	gene	CHEBI:34905	paraquat	affects expression	ISO	RGD:1615785	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat affects the expression of CHIA protein	PMID:39748354
1303058	Chia	chitinase, acidic	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1615785	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of CHIA1 mRNA	PMID:29038090
1303058	Chia	chitinase, acidic	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1604020	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CHIA gene	PMID:29154799
1303058	Chia	chitinase, acidic	gene	CHEBI:42223	emodin	multiple interactions	ISO	RGD:1615785	E	RGD:6480464	20121009	CTD	MESH:D004642	Emodin inhibits the reaction [Ovalbumin results in increased expression of CHIA mRNA]	PMID:22484343
1303058	Chia	chitinase, acidic	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1604020	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CHIA mRNA	PMID:38832940
1303058	Chia	chitinase, acidic	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1615785	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of CHIA mRNA	PMID:18544908
1303058	Chia	chitinase, acidic	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1615785	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of CHIA1 mRNA	PMID:29279043
1303058	Chia	chitinase, acidic	gene	CHEBI:46727	quartz	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D011791	Quartz results in increased expression of CHIA mRNA	PMID:19836432|PMID:32976597
1303058	Chia	chitinase, acidic	gene	CHEBI:46727	quartz	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D011791	Tobacco Smoke Pollution promotes the reaction [Quartz results in increased expression of CHIA mRNA]	PMID:32976597
1303058	Chia	chitinase, acidic	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1615785	E	RGD:6480464	20190312	CTD	MESH:C016766	[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CHIA mRNA	PMID:30529165
1303058	Chia	chitinase, acidic	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1604020	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CHIA mRNA	PMID:20458559
1303058	Chia	chitinase, acidic	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1615785	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CHIA mRNA; Nanotubes, Carbon results in increased expression of CHIA1 mRNA; Nanotubes, Carbon results in increased expression of CHIA1 protein	PMID:25554681|PMID:27106021
1303058	Chia	chitinase, acidic	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1615785	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CHIA mRNA	PMID:27858113
1303058	Chia	chitinase, acidic	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1615785	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CHIA mRNA	PMID:27858113
1303058	Chia	chitinase, acidic	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1615785	E	RGD:6480464	20120412	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CHIA mRNA	PMID:16141432
1303058	Chia	chitinase, acidic	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1615785	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CHIA mRNA	PMID:22206623
1303058	Chia	chitinase, acidic	gene	CHEBI:753160	lard	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in increased expression of CHIA mRNA	PMID:26115784
1303058	Chia	chitinase, acidic	gene	CHEBI:76987	metacetamol	decreases expression	ISO	RGD:1615785	E	RGD:6480464	20140204	CTD	MESH:C026137	3-hydroxyacetanilide results in decreased expression of CHIA mRNA	PMID:18544908
1303058	Chia	chitinase, acidic	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604020	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CHIA gene]	PMID:28238834
1303058	Chia	chitinase, acidic	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of CHIA mRNA	PMID:24780913
1303058	Chia	chitinase, acidic	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CHIA mRNA	PMID:19015723
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1351044	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SKIV2L mRNA	PMID:38218311
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1351044	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SKIV2L mRNA	PMID:38218311
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:C084079	triptonide results in increased expression of SKIC2 mRNA	PMID:33045310
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1550527	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of SKIC2 mRNA	PMID:40945087
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:D000431	Ethanol affects the splicing of SKIC2 mRNA	PMID:30319688
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1351044	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SKIV2L mRNA	PMID:37042841
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:16716	benzene	affects expression	ISO	RGD:1351044	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene affects the expression of SKIC2 mRNA	PMID:16188086
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1351044	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SKIC2 protein	PMID:37730182
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550527	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SKIV2L mRNA	PMID:36331819
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550527	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SKIV2L mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SKIC2 mRNA	PMID:37236586|PMID:37325564
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1351044	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SKIV2L mRNA	PMID:35430440
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1351044	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SKIC2 gene	PMID:25304211
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550527	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SKIC2 mRNA	PMID:40504410
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1351044	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SKIC2 protein	PMID:35688186
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SKIC2 mRNA	PMID:21570461
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SKIC2 mRNA	PMID:17942748
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1351044	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SKIC2 mRNA	PMID:39709020
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1351044	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SKIC2 mRNA	PMID:32763439
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1351044	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SKIC2 protein	PMID:35688186
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550527	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SKIC2 mRNA	PMID:40504410
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SKIC2 mRNA	PMID:22228805
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to SKIC2 promoter]	PMID:19654925
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550527	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SKIV2L promoter alternative form	PMID:35295148
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SKIC2 mRNA	PMID:34492290
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SKIC2 mRNA	PMID:25181051
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1351044	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SKIC2 mRNA; bisphenol A results in increased expression of SKIV2L protein	PMID:33670352|PMID:34186270
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1351044	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SKIV2L protein	PMID:34186270
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550527	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SKIC2 mRNA	PMID:39298647
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1351044	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SKIC2 mRNA	PMID:28628672
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1351044	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SKIV2L protein	PMID:34186270
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1351044	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SKIC2 mRNA	PMID:28628672
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351044	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SKIV2L mRNA	PMID:37042841
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SKIC2 promoter	PMID:22457795
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550527	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SKIV2L mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SKIC2 mRNA	PMID:37236586|PMID:37325564
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550527	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SKIV2L mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SKIV2L mRNA	PMID:36331819
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of SKIV2L mRNA	PMID:41580965
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1351044	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SKIC2 mRNA	PMID:25562108
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:D013629	Tamoxifen affects the expression of SKIC2 mRNA	PMID:17555576
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1351044	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SKIC2 mRNA	PMID:28628672
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SKIC2 mRNA	PMID:33387578
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1351044	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SKIC2 gene	PMID:25304211
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550527	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SKIC2 mRNA	PMID:40504410
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SKIC2 mRNA	PMID:17555576
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SKIC2 mRNA	PMID:17942748
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SKIC2 mRNA	PMID:17942748
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1351044	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SKIC2 mRNA	PMID:28628672
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1351044	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of SKIC2 mRNA	PMID:22714537
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1351044	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SKIC2 mRNA	PMID:31758290
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SKIC2 mRNA	PMID:22206623
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1351044	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SKIC2 protein	PMID:31675489
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SKIC2 mRNA	PMID:21346803
1303059	Skic2	SKI2 subunit of superkiller complex	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550527	E	RGD:6480464	20230207	CTD	MESH:C057693	Troglitazone results in decreased expression of SKIC2 mRNA	PMID:28973697
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of HYAL1 mRNA	PMID:38218311
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1352194	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of HYAL1 mRNA	PMID:27188386
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of HYAL1 mRNA	PMID:33045310
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550529	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of HYAL1 mRNA	PMID:30951980
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1550529	E	RGD:6480464	20250401	CTD	MESH:D011794	[Quercetin co-treated with Lipopolysaccharides] results in decreased expression of HYAL1 mRNA	PMID:38823456
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HYAL1 mRNA	PMID:39241906
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1550529	E	RGD:6480464	20250401	CTD	MESH:D008070	[Quercetin co-treated with Lipopolysaccharides] results in decreased expression of HYAL1 mRNA	PMID:38823456
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550529	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of HYAL1 mRNA	PMID:39298647
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of HYAL1 mRNA	PMID:33387578
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:166595	Yessotoxin	increases expression	ISO	RGD:1352194	E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in increased expression of HYAL1 mRNA	PMID:30679557
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1352194	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of HYAL1 mRNA	PMID:26079696
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1352194	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HYAL1 mRNA	PMID:36139627
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HYAL1 mRNA	PMID:33387578
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550529	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HYAL1 mRNA	PMID:36331819
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of HYAL1 mRNA	PMID:28522335
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:22977	cadmium atom	decreases methylation	ISO	RGD:1352194	E	RGD:6480464	20150825	CTD	MESH:D002104	Cadmium results in decreased methylation of HYAL1 gene	PMID:25922126
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1352194	E	RGD:6480464	20150825	CTD	MESH:D002104	Cadmium results in increased expression of HYAL1 mRNA	PMID:25922126
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HYAL1 mRNA	PMID:19549813
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1352194	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of HYAL1 protein	PMID:20106945
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of HYAL1 mRNA	PMID:27153756
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1352194	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of HYAL1 mRNA	PMID:25102026
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550529	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of HYAL1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of HYAL1 mRNA	PMID:34911549
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HYAL1 mRNA	PMID:31150632
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1352194	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of HYAL1 mRNA	PMID:21867686
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1352194	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HYAL1 gene	PMID:25304211
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:27563	arsenic atom	decreases methylation	ISO	RGD:1352194	E	RGD:6480464	20150825	CTD	MESH:D001151	Arsenic results in decreased methylation of HYAL1 gene	PMID:25922126
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1352194	E	RGD:6480464	20150825	CTD	MESH:D001151	Arsenic results in increased expression of HYAL1 mRNA	PMID:25922126
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of HYAL1 gene	PMID:31011160
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1352194	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of HYAL1 mRNA	PMID:23557933
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1352194	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin promotes the reaction [jinfukang results in increased expression of HYAL1 mRNA]; jinfukang promotes the reaction [Cisplatin results in increased expression of HYAL1 mRNA]	PMID:27392435
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550529	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HYAL1 mRNA	PMID:21570461
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HYAL1 mRNA	PMID:19770486|PMID:25270620|PMID:26290441
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1352194	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HYAL1 mRNA	PMID:12377990
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550529	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HYAL1 mRNA	PMID:17942748
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of HYAL1 mRNA	PMID:28374803
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:28428	beta-hexachlorocyclohexane	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in decreased expression of HYAL1 mRNA	PMID:25270620
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of HYAL1 mRNA	PMID:30556269
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HYAL1 mRNA	PMID:29803840
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HYAL1 mRNA	PMID:38568856
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352194	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HYAL1 mRNA	PMID:12377979
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HYAL1 mRNA	PMID:32234424
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352194	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HYAL1 5' UTR; Benzo(a)pyrene results in increased methylation of HYAL1 promoter	PMID:27901495
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of HYAL1 mRNA	PMID:30556269
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of HYAL1 mRNA	PMID:25895662
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550529	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of HYAL1 mRNA	PMID:29203145
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1352194	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HYAL1 mRNA	PMID:20458559|PMID:22521957
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of HYAL1 mRNA	PMID:35984750
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HYAL1 mRNA	PMID:30047161
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of HYAL1 mRNA	PMID:23557971
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of HYAL1 mRNA	PMID:23411599|PMID:34492290
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1550529	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of HYAL1 mRNA	PMID:18648102
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of HYAL1 mRNA	PMID:23811191
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550529	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of HYAL1 mRNA	PMID:18301758
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550529	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HYAL1 mRNA	PMID:19710929
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of HYAL1 mRNA	PMID:30903817
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1352194	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of HYAL1 mRNA	PMID:30903817
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HYAL1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1550529	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of HYAL1 promoter	PMID:27312807
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1550529	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of HYAL1 mRNA	PMID:25172293
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of HYAL1 mRNA	PMID:23196670
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HYAL1 mRNA	PMID:39298647
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1550529	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of HYAL1 exon	PMID:33297965
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20230207	CTD	MESH:C008745	bisphenol F results in decreased expression of HYAL1 mRNA	PMID:35387338
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550529	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of HYAL1 mRNA	PMID:38685157
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1550529	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of HYAL1 mRNA	PMID:30951980
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1352194	E	RGD:6480464	20191008	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of HYAL1 mRNA	PMID:31226360
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:34786	Heptachlor epoxide	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in decreased expression of HYAL1 mRNA	PMID:25270620
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of HYAL1 mRNA	PMID:25539665
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of HYAL1 mRNA	PMID:19376846
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1550529	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of HYAL1 mRNA	PMID:18353800
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:3750	clofibrate	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002994	Clofibrate results in decreased expression of HYAL1 mRNA	PMID:12851107
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HYAL1 mRNA	PMID:31533062
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550529	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HYAL1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of HYAL1 mRNA	PMID:36331819
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1352194	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HYAL1 mRNA	PMID:25979313
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550529	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of HYAL1 mRNA	PMID:17292431
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of HYAL1 mRNA	PMID:29154799
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of HYAL1 mRNA	PMID:20106945|PMID:25562108
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550529	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of HYAL1 mRNA	PMID:28973697
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of HYAL1 mRNA	PMID:29067470
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HYAL1 mRNA	PMID:33387578
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1352194	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HYAL1 gene	PMID:25304211
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:47217	arsane	decreases methylation	ISO	RGD:1352194	E	RGD:6480464	20150825	CTD	MESH:D001151	Arsenic results in decreased methylation of HYAL1 gene	PMID:25922126
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1352194	E	RGD:6480464	20150825	CTD	MESH:D001151	Arsenic results in increased expression of HYAL1 mRNA	PMID:25922126
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:4784	enalapril	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004656	Enalapril results in decreased expression of HYAL1 mRNA; Enalapril results in decreased expression of HYAL1 protein	PMID:20933085
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of HYAL1 mRNA	PMID:29391264
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550529	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HYAL1 mRNA	PMID:17942748
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1352194	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HYAL1 mRNA	PMID:20458559|PMID:22521957
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1352194	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of HYAL1 mRNA	PMID:25922126
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1352194	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of HYAL1 mRNA	PMID:25511174
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HYAL1 mRNA	PMID:25554681
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550529	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of HYAL1 mRNA	PMID:25554681
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of HYAL1 mRNA	PMID:30047161
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:50819	ferric oxide	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20150127	CTD	MESH:C000499	ferric oxide analog results in decreased expression of HYAL1 mRNA	PMID:24525745
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1550529	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in increased expression of HYAL1 mRNA	PMID:25086211
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of HYAL1 mRNA	PMID:24793618
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of HYAL1 mRNA	PMID:26377693
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:51403	1,4-phenylenediamine	increases expression	ISO	RGD:1352194	E	RGD:6480464	20191008	CTD	MESH:C029728	4-phenylenediamine results in increased expression of HYAL1 mRNA	PMID:31226360
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of HYAL1 mRNA	PMID:25270620
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1550529	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of HYAL1 mRNA	PMID:36851058
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1352194	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HYAL1 mRNA	PMID:36139627
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352194	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HYAL1 gene]	PMID:28238834
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1352194	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of HYAL1 mRNA	PMID:19159669
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550529	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of HYAL1 mRNA	PMID:23091169
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550529	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of HYAL1 mRNA	PMID:19270015
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1550529	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of HYAL1 mRNA	PMID:27029645
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550529	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of HYAL1 mRNA	PMID:39847705
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HYAL1 mRNA	PMID:25825206
1303060	Hyal1	hyaluronidase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of HYAL1 mRNA	PMID:30047161
1303061	Cenpc	centromere protein C	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:D003634	DDT results in increased methylation of CENPC gene	PMID:31682807
1303061	Cenpc	centromere protein C	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CENPC mRNA	PMID:21632981
1303061	Cenpc	centromere protein C	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553164	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CENPC1 mRNA	PMID:39241906
1303061	Cenpc	centromere protein C	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of CENPC mRNA	PMID:31614463
1303061	Cenpc	centromere protein C	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1553164	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of CENPC1 mRNA	PMID:29980752
1303061	Cenpc	centromere protein C	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CENPC mRNA	PMID:33387578
1303061	Cenpc	centromere protein C	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1354407	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CENPC mRNA	PMID:37042841
1303061	Cenpc	centromere protein C	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of CENPC mRNA	PMID:20655997
1303061	Cenpc	centromere protein C	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1354407	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CENPC protein	PMID:37730182
1303061	Cenpc	centromere protein C	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553164	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CENPC1 mRNA	PMID:37236586
1303061	Cenpc	centromere protein C	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CENPC mRNA	PMID:19549813
1303061	Cenpc	centromere protein C	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1354407	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CENPC gene	PMID:27153756
1303061	Cenpc	centromere protein C	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1354407	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CENPC1 mRNA	PMID:23649840
1303061	Cenpc	centromere protein C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1354407	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CENPC mRNA	PMID:41430723
1303061	Cenpc	centromere protein C	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1553164	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CENPC1 mRNA	PMID:31919559
1303061	Cenpc	centromere protein C	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1553164	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CENPC1 mRNA	PMID:25629700
1303061	Cenpc	centromere protein C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1354407	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CENPC mRNA	PMID:39836092
1303061	Cenpc	centromere protein C	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1354407	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CENPC protein	PMID:35688186
1303061	Cenpc	centromere protein C	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1354407	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CENPC1 mRNA	PMID:27392435
1303061	Cenpc	centromere protein C	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1553164	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CENPC1 mRNA	PMID:30912803
1303061	Cenpc	centromere protein C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CENPC1 mRNA	PMID:22298810
1303061	Cenpc	centromere protein C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CENPC mRNA	PMID:33387578
1303061	Cenpc	centromere protein C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553164	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CENPC1 promoter]	PMID:19654925
1303061	Cenpc	centromere protein C	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CENPC mRNA	PMID:33212167
1303061	Cenpc	centromere protein C	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CENPC1 mRNA	PMID:23649840
1303061	Cenpc	centromere protein C	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CENPC mRNA	PMID:29803840
1303061	Cenpc	centromere protein C	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1354407	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CENPC protein	PMID:35688186
1303061	Cenpc	centromere protein C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1354407	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CENPC mRNA	PMID:39836092
1303061	Cenpc	centromere protein C	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1354407	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CENPC mRNA	PMID:20382639
1303061	Cenpc	centromere protein C	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1354407	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CENPC mRNA	PMID:20458559
1303061	Cenpc	centromere protein C	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of CENPC1 mRNA	PMID:21515302
1303061	Cenpc	centromere protein C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553164	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CENPC1 gene; titanium dioxide results in decreased methylation of CENPC1 promoter alternative form	PMID:35295148
1303061	Cenpc	centromere protein C	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553164	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CENPC1 mRNA	PMID:18445702
1303061	Cenpc	centromere protein C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553164	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CENPC1 mRNA	PMID:33221593
1303061	Cenpc	centromere protein C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of CENPC mRNA	PMID:32145629
1303061	Cenpc	centromere protein C	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1553164	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CENPC1 intron	PMID:28392331
1303061	Cenpc	centromere protein C	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553164	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CENPC1 mRNA	PMID:37019170
1303061	Cenpc	centromere protein C	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CENPC1 mRNA	PMID:19041683
1303061	Cenpc	centromere protein C	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1553164	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of CENPC1 mRNA	PMID:36117858
1303061	Cenpc	centromere protein C	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1354407	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CENPC mRNA	PMID:37042841
1303061	Cenpc	centromere protein C	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of CENPC1 mRNA	PMID:17616710
1303061	Cenpc	centromere protein C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553164	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CENPC1 mRNA	PMID:37236586
1303061	Cenpc	centromere protein C	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CENPC1 gene	PMID:22079235
1303061	Cenpc	centromere protein C	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1354407	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of CENPC mRNA	PMID:19691856
1303061	Cenpc	centromere protein C	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CENPC mRNA	PMID:28302478
1303061	Cenpc	centromere protein C	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CENPC mRNA	PMID:31533062
1303061	Cenpc	centromere protein C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CENPC mRNA	PMID:27153767|PMID:40419075
1303061	Cenpc	centromere protein C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553164	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CENPC1 mRNA	PMID:36331819
1303061	Cenpc	centromere protein C	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1354407	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CENPC mRNA	PMID:25979313
1303061	Cenpc	centromere protein C	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CENPC mRNA; Valproic Acid results in decreased expression of CENPC1 mRNA	PMID:23179753|PMID:24383497|PMID:27188386|PMID:29154799
1303061	Cenpc	centromere protein C	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1354407	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CENPC gene	PMID:29154799
1303061	Cenpc	centromere protein C	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CENPC1 mRNA	PMID:25562108
1303061	Cenpc	centromere protein C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1553164	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CENPC mRNA	PMID:28973697
1303061	Cenpc	centromere protein C	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of CENPC1 mRNA	PMID:23649840
1303061	Cenpc	centromere protein C	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CENPC mRNA	PMID:33387578
1303061	Cenpc	centromere protein C	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1553164	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CENPC1 mRNA	PMID:29279043
1303061	Cenpc	centromere protein C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1354407	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CENPC mRNA	PMID:39836092
1303061	Cenpc	centromere protein C	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553164	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CENPC1 mRNA	PMID:35436446
1303061	Cenpc	centromere protein C	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of CENPC1 mRNA	PMID:17557909
1303061	Cenpc	centromere protein C	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1354407	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CENPC mRNA	PMID:20458559
1303061	Cenpc	centromere protein C	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1553164	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of CENPC1 mRNA	PMID:36117858
1303061	Cenpc	centromere protein C	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1354407	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of CENPC mRNA	PMID:20977926
1303061	Cenpc	centromere protein C	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of CENPC1 mRNA	PMID:20080153
1303061	Cenpc	centromere protein C	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CENPC mRNA	PMID:28988120
1303061	Cenpc	centromere protein C	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553164	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CENPC1 mRNA	PMID:22206623
1303061	Cenpc	centromere protein C	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1354407	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CENPC1 mRNA	PMID:22714537
1303061	Cenpc	centromere protein C	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1354407	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CENPC protein	PMID:31285264
1303061	Cenpc	centromere protein C	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1553164	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CENPC1 mRNA	PMID:23091169
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1353857	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KATNA1 mRNA	PMID:38218311
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550533	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KATNA1 mRNA	PMID:33045310
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1353857	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of KATNA1 mRNA	PMID:33167477
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550533	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of KATNA1 mRNA	PMID:30319688
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550533	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of KATNA1 mRNA	PMID:39298647
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1353857	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of KATNA1 protein	PMID:37730182
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1353857	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KATNA1 mRNA	PMID:28818685
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of KATNA1 protein	PMID:34915118
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1353857	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KATNA1 mRNA	PMID:19549813
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1353857	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KATNA1 mRNA	PMID:23649840
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550533	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KATNA1 mRNA	PMID:22206623
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1353857	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of KATNA1 protein	PMID:35688186
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550533	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KATNA1 mRNA	PMID:21570461
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KATNA1 mRNA	PMID:33387578
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1353857	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KATNA1 mRNA	PMID:33212167
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1353857	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of KATNA1 mRNA	PMID:39709020
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353857	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KATNA1 mRNA	PMID:38568856
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1353857	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to KATNA1 mRNA]	PMID:32406909
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550533	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KATNA1 gene	PMID:35295148
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550533	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KATNA1 promoter	PMID:35295148
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of KATNA1 mRNA	PMID:34492290
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KATNA1 mRNA	PMID:25181051
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353857	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of KATNA1 mRNA	PMID:20678512
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1353857	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KATNA1 gene	PMID:31601247
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of KATNA1 mRNA	PMID:30816183|PMID:32528016
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KATNA1 gene	PMID:28505145
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1550533	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of KATNA1 promoter	PMID:33297965
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of KATNA1 mRNA	PMID:21241498
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of KATNA1 mRNA	PMID:22546817
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of KATNA1 mRNA	PMID:22546817
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of KATNA1 mRNA	PMID:22546817
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of KATNA1 mRNA	PMID:32680482
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1353857	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of KATNA1 mRNA	PMID:28302478
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353857	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of KATNA1 mRNA	PMID:29154799
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1353857	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KATNA1 mRNA	PMID:25562108
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of KATNA1 mRNA	PMID:36653537
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1353857	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KATNA1 mRNA	PMID:38832940
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1353857	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of KATNA1 mRNA	PMID:22230336
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550533	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of KATNA1 mRNA	PMID:29279043
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of KATNA1 mRNA	PMID:24136188
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KATNA1 mRNA	PMID:24136188
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550533	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KATNA1 mRNA	PMID:22206623
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550533	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KATNA1 mRNA	PMID:22206623
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1353857	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of KATNA1 mRNA	PMID:37199045
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550533	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of KATNA1 mRNA	PMID:19363144
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550533	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of KATNA1 mRNA	PMID:31388691
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KATNA1 mRNA	PMID:21346803
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1353857	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KATNA1 mRNA	PMID:38568856
1303062	Katna1	katanin catalytic subunit A1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of KATNA1 mRNA	PMID:21346803
1303063	mt-Tc	mitochondrially encoded tRNA cysteine	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013853	Thioacetamide results in decreased expression of TRNC mRNA	PMID:34492290
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1622149	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LY6G6D mRNA	PMID:20938992
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1622149	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LY6G6D mRNA	PMID:39241906
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1354154	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of LY6G6D mRNA	PMID:30510588
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1622149	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LY6G6D mRNA	PMID:20938992
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LY6G6D mRNA	PMID:39012411
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LY6G6D mRNA	PMID:30779732
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1622149	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LY6G6D mRNA	PMID:20938992
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of LY6G6D gene	PMID:31011160
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1622149	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LY6G6D mRNA	PMID:28960355
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622149	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LY6G6D mRNA	PMID:21570461|PMID:26377647
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1622149	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of LY6G6D intron] which results in decreased expression of LY6G6D mRNA	PMID:33017471
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1354154	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LY6G6D mRNA	PMID:30851411
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1354154	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of LY6G6D mRNA	PMID:29453283
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1622149	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LY6G6D mRNA	PMID:22228805
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1354154	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LY6G6D promoter	PMID:27901495
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of LY6G6D mRNA	PMID:24915197
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1622149	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of LY6G6D mRNA	PMID:23557971
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of LY6G6D mRNA	PMID:19167457
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LY6G6D mRNA	PMID:25181051|PMID:34947998
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LY6G6D mRNA	PMID:30816183|PMID:32528016
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LY6G6D mRNA	PMID:39012411
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1354154	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LY6G6D mRNA	PMID:24449571
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1622149	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LY6G6D mRNA	PMID:40194260
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1622149	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LY6G6D mRNA	PMID:17963808
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1622149	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of LY6G6D mRNA	PMID:25123088
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1354154	E	RGD:6480464	20120412	CTD	MESH:D005472	LY6G6D protein affects the susceptibility to Fluorouracil	PMID:16217747
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1622149	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LY6G6D mRNA; Nanotubes, Carbon results in decreased expression of LY6G6D mRNA	PMID:25554681
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1622149	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of LY6G6D mRNA	PMID:23608068
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1622149	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of LY6G6D mRNA	PMID:38701926
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622149	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LY6G6D mRNA	PMID:22206623
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1354154	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of LY6G6D mRNA	PMID:37199045
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1354154	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LY6G6D mRNA	PMID:30851411
1303064	Ly6g6d	lymphocyte antigen 6 family member G6D	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1354154	E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in decreased expression of LY6G6D mRNA	PMID:29453283
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1348615	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SPATA4 mRNA	PMID:26079696
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550557	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SPATA4 mRNA	PMID:34319233
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550557	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SPATA4 mRNA	PMID:28960355
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550557	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SPATA4 mRNA	PMID:20813756
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPATA4 mRNA	PMID:25181051
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SPATA4 promoter	PMID:22457795
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1348615	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SPATA4 gene	PMID:29154799
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1550557	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SPATA4 mRNA	PMID:23608068
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1348615	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of SPATA4 mRNA	PMID:31629900
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1348615	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SPATA4 mRNA	PMID:31758290
1303065	Spata4	spermatogenesis associated 4	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1348615	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SPATA4 mRNA	PMID:26079696
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1347627	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ATAT1 mRNA	PMID:38218311
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1347627	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ATAT1 mRNA	PMID:26079696
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552512	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ATAT1 mRNA	PMID:30319688
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552512	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ATAT1 mRNA	PMID:39241906
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ATAT1 mRNA	PMID:33387578
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552512	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATAT1 mRNA	PMID:36331819
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1347627	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of ATAT1 mRNA	PMID:24376830
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347627	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATAT1 mRNA	PMID:35301059
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552512	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATAT1 mRNA	PMID:37325564
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1347627	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ATAT1 mRNA	PMID:27392435
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1347627	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ATAT1 mRNA	PMID:27392435
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of ATAT1 mRNA	PMID:31734292
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATAT1 mRNA	PMID:22298810
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATAT1 mRNA	PMID:33387578
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347627	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATAT1 mRNA	PMID:29803840
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347627	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATAT1 mRNA	PMID:34032870
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1552512	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ATAT1 gene	PMID:39894169
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347627	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of ATAT1 protein	PMID:38228842
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347627	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATAT1 promoter	PMID:27901495
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1552512	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ATAT1 mRNA	PMID:39716349
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552512	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ATAT1 mRNA	PMID:23811191
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATAT1 mRNA	PMID:25181051
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ATAT1 protein	PMID:32145629
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552512	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ATAT1 mRNA	PMID:32156529
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of ATAT1 mRNA	PMID:38750585
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1347627	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ATAT1 mRNA	PMID:25047013
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552512	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ATAT1 mRNA	PMID:39298647
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552512	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ATAT1 mRNA	PMID:37019170
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ATAT1 mRNA	PMID:21266533
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ATAT1 mRNA	PMID:35163327
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ATAT1 promoter	PMID:22457795
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347627	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATAT1 mRNA	PMID:35301059
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552512	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATAT1 mRNA	PMID:37325564
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ATAT1 mRNA	PMID:35163327
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1552512	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ATAT1 mRNA	PMID:28903501
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ATAT1 mRNA	PMID:24386269
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1347627	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ATAT1 mRNA	PMID:24449571
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552512	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ATAT1 mRNA	PMID:40194260
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1347627	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ATAT1 mRNA	PMID:28302478
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347627	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ATAT1 mRNA	PMID:31533062
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552512	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATAT1 mRNA	PMID:36331819
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1347627	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATAT1 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347627	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAT1 mRNA	PMID:27188386
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552512	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ATAT1 mRNA	PMID:28973697
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1347627	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of ATAT1 mRNA	PMID:27188386
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATAT1 mRNA	PMID:33387578
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1552512	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ATAT1 mRNA	PMID:19446018
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1552512	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ATAT1 mRNA	PMID:39716349
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552512	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATAT1 mRNA; Nanotubes, Carbon results in decreased expression of ATAT1 mRNA	PMID:25620056
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:53001	nickel sulfate	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of ATAT1 mRNA	PMID:31734292
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1347627	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ATAT1 mRNA	PMID:28988120
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1347627	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of ATAT1 mRNA	PMID:27932991
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552512	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ATAT1 mRNA	PMID:22206623
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1347627	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ATAT1 protein	PMID:37664457
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347627	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAT1 mRNA	PMID:27188386
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1347627	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ATAT1 mRNA	PMID:26079696
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATAT1 mRNA	PMID:24780913
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347627	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ATAT1 protein; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAT1 mRNA	PMID:27188386|PMID:37664457
1303066	Atat1	alpha tubulin acetyltransferase 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ATAT1 mRNA	PMID:23034163
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:736450	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of FCGR3A mRNA; Tretinoin results in increased expression of FCGR3A protein	PMID:33167477|PMID:7579340
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FCGR3A mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FCGR3A mRNA	PMID:33729688
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:736450	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of FCGR3A mRNA	PMID:16823088
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of FCGR4 mRNA	PMID:30517762
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:736450	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FCGR3A mRNA	PMID:35811015
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550776	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FCGR4 mRNA	PMID:39241906
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:736450	E	RGD:6480464	20191008	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FCGR3A mRNA	PMID:31059760
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FCGR4 mRNA]	PMID:39241906
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:736450	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of FCGR3A mRNA; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FCGR3A mRNA	PMID:31059760|PMID:35811015
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550776	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of FCGR4 mRNA	PMID:39298647
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FCGR3A mRNA	PMID:33387578
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:736450	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of FCGR3A mRNA	PMID:21540246
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FCGR4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FCGR4 mRNA	PMID:37567420|PMID:37992649
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FCGR4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FCGR4 mRNA	PMID:37567420|PMID:37992649
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1550776	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of FCGR4 mRNA	PMID:27405655
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of FCGR3A mRNA	PMID:26577399|PMID:27523638
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:736450	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of FCGR3A mRNA	PMID:26485663
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FCGR3A mRNA	PMID:22061828
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FCGR4 mRNA	PMID:36331819
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of FCGR3A mRNA	PMID:23358152
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR4 mRNA	PMID:29950665
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:24828	indoles	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in decreased expression of FCGR3A mRNA	PMID:20521778
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:24828	indoles	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in increased expression of FCGR3A mRNA	PMID:20521778
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:736450	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of FCGR3A mRNA	PMID:16823088
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FCGR4 mRNA	PMID:34911549
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:736450	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of FCGR3A mRNA	PMID:41430723
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FCGR3A mRNA	PMID:31150632
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550776	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FCGR4 mRNA	PMID:27339419|PMID:31919559
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of FCGR4 mRNA	PMID:30517762
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FCGR4 mRNA	PMID:22206623
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FCGR4 mRNA	PMID:37567420
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of FCGR3A mRNA	PMID:31881176
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of FCGR3A mRNA	PMID:22023808
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1550776	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of FCGR4 mRNA	PMID:40618947
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:736450	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of FCGR3A mRNA	PMID:23195993
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550776	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FCGR4 mRNA	PMID:21570461|PMID:26377647|PMID:28922406
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FCGR3A mRNA	PMID:34747641
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FCGR3A mRNA	PMID:33387578
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550776	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FCGR4 mRNA	PMID:26290441
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FCGR4 mRNA	PMID:25975270
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of FCGR3A mRNA	PMID:31378766
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:2825	aristolochic acid A	multiple interactions	EXP		E	RGD:6480464	20160510	CTD	MESH:C000228	[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of FCGR3A mRNA	PMID:23912714
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:736450	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of FCGR3A protein	PMID:17852453
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FCGR4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FCGR4 mRNA	PMID:37567420|PMID:37992649
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:736450	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FCGR3A mRNA	PMID:38568856
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550776	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FCGR4 mRNA	PMID:22228805
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:736450	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FCGR3A promoter	PMID:27901495
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in increased expression of FCGR3A mRNA	PMID:32721576
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:736450	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FCGR3A mRNA	PMID:20458559
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1550776	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of FCGR4 mRNA	PMID:21829687
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of FCGR3A mRNA	PMID:25729387
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of FCGR3A mRNA	PMID:25729387
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR4 mRNA	PMID:29950665
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of FCGR3A mRNA	PMID:23411599
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FCGR3A mRNA	PMID:34492290
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of FCGR3A mRNA	PMID:25380136
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550776	E	RGD:6480464	20140513	CTD	MESH:C074702	chromium hexavalent ion affects the expression of FCGR4 mRNA	PMID:24374135
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FCGR3A mRNA	PMID:25181051
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:736450	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of FCGR3A protein	PMID:32080224
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of FCGR3A mRNA	PMID:41034487
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:736450	E	RGD:6480464	20231205	CTD	MESH:C006780	endotoxin, Escherichia coli inhibits the reaction [bisphenol A results in decreased expression of FCGR3A protein]	PMID:32080224
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1550776	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of FCGR4 mRNA	PMID:25172293
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1550776	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of FCGR4 mRNA	PMID:39298647
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:736450	E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of FCGR3A mRNA	PMID:23626723
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:736450	E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of FCGR3A mRNA	PMID:23626723
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR4 mRNA	PMID:29950665
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of FCGR3A mRNA	PMID:32680482
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FCGR4 mRNA]	PMID:39241906
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:736450	E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of FCGR3A mRNA	PMID:23626723
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of FCGR3A mRNA	PMID:18500788
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FCGR3A mRNA	PMID:25993096
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:736450	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FCGR3A mRNA	PMID:38568856
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of FCGR3A mRNA	PMID:25380136
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of FCGR3A mRNA	PMID:40128328
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FCGR4 mRNA	PMID:36331819
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of FCGR3A mRNA]	PMID:18200517
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of FCGR3A mRNA	PMID:30047161
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550776	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FCGR3A mRNA	PMID:28973697
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FCGR4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FCGR4 mRNA	PMID:37567420|PMID:37992649
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550776	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FCGR4 mRNA	PMID:17562736
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:736450	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of FCGR3A mRNA	PMID:31059760
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:736450	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of FCGR3A mRNA	PMID:31059760
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:736450	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FCGR3A mRNA	PMID:35811015
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:4744	Echimidine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C000615871	echimidine results in increased expression of FCGR3A mRNA	PMID:34185104
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of FCGR3A mRNA	PMID:29391264
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of FCGR3A mRNA	PMID:36868495
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:736450	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FCGR3A mRNA	PMID:20458559
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:736450	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of FCGR3A mRNA]	PMID:21095227
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550776	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FCGR4 mRNA; Nanotubes, Carbon results in increased expression of FCGR4 mRNA	PMID:25554681
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of FCGR3A mRNA	PMID:23358152
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1550776	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of FCGR3A mRNA	PMID:18200517
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of FCGR3A mRNA]	PMID:18200517
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:5643	Heliotrine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in increased expression of FCGR3A mRNA	PMID:34185104
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550776	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of FCGR4 mRNA	PMID:38701926
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of FCGR3A mRNA	PMID:28801915
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FCGR4 mRNA	PMID:21641980
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of FCGR3A mRNA	PMID:25729387
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of FCGR3A mRNA	PMID:25729387
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of FCGR3A mRNA	PMID:28801915
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1550776	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of FCGR4 mRNA	PMID:20003209
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FCGR4 mRNA	PMID:22206623
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FCGR4 mRNA	PMID:37567420
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of FCGR3A mRNA	PMID:21346803
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:79736	ziram	decreases expression	ISO	RGD:736450	E	RGD:6480464	20141014	CTD	MESH:D015039	Ziram results in decreased expression of FCGR3A protein	PMID:18670896
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:736450	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FCGR3A gene]	PMID:28238834
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550776	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of FCGR4 mRNA	PMID:38648751
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1550776	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FCGR4 mRNA]	PMID:39241906
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C009237	senecionine results in increased expression of FCGR3A mRNA	PMID:34185104
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:9130	sevoflurane	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:C009250	Sevoflurane results in increased expression of FCGR3A protein	PMID:35174938
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:9130	sevoflurane	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C009250	Dietary Fats promotes the reaction [Sevoflurane results in increased expression of FCGR3A protein]	PMID:35174938
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FCGR3A mRNA	PMID:21346803
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of FCGR3A mRNA	PMID:23358152
1303067	Fcgr3a	Fc gamma receptor 3A	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:736450	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of FCGR3A mRNA	PMID:29301935
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ST3GAL4 mRNA	PMID:33045310
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1353529	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of ST3GAL4 mRNA	PMID:23830798
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:16325	lithocholic acid	increases phosphorylation	ISO	RGD:1353529	E	RGD:6480464	20131210	CTD	MESH:D008095	Lithocholic Acid results in increased phosphorylation of ST3GAL4 protein	PMID:21224350
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550578	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ST3GAL4 mRNA	PMID:39241906
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550578	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ST3GAL4 mRNA	PMID:39298647
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1353529	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ST3GAL4 mRNA	PMID:30165855
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ST3GAL4 mRNA	PMID:33387578
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1353529	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ST3GAL4 mRNA	PMID:22017230
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20130122	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ST3GAL4 mRNA	PMID:19245819
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D004051	[Genistein co-treated with Diethylhexyl Phthalate] results in increased expression of ST3GAL4 mRNA	PMID:36674726
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1353529	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of ST3GAL4 mRNA	PMID:26485663
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ST3GAL4 mRNA	PMID:33387578
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1353529	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ST3GAL4 intron	PMID:30157460
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ST3GAL4 mRNA	PMID:36331819
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:22718	benzoates	affects expression	ISO	RGD:1353529	E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog affects the expression of ST3GAL4 mRNA	PMID:29472718
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ST3GAL4 mRNA	PMID:37325564
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ST3GAL4 mRNA	PMID:19770486
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ST3GAL4 mRNA	PMID:33354967
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1353529	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ST3GAL4 gene; Aflatoxin B1 results in increased methylation of ST3GAL4 intron	PMID:27153756|PMID:30157460
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ST3GAL4 mRNA	PMID:30779732
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550578	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of ST3GAL4 mRNA	PMID:17484886
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1353529	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ST3GAL4 mRNA	PMID:40512198
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ST3GAL4 mRNA	PMID:40504410
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of ST3GAL4 gene	PMID:31011160
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1353529	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ST3GAL4 mRNA	PMID:28903495
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1353529	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ST3GAL4 mRNA	PMID:27392435
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1353529	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ST3GAL4 mRNA	PMID:27392435
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1550578	E	RGD:6480464	20120717	CTD	MESH:D013752	Tetracycline results in increased expression of ST3GAL4 mRNA	PMID:16917069
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D019833	[Genistein co-treated with Diethylhexyl Phthalate] results in increased expression of ST3GAL4 mRNA	PMID:36674726
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ST3GAL4 mRNA	PMID:22298810|PMID:34747641
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ST3GAL4 mRNA	PMID:18372398|PMID:19770486
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ST3GAL4 mRNA	PMID:33387578
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1353529	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ST3GAL4 mRNA	PMID:29803840
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ST3GAL4 mRNA	PMID:39631538
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353529	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ST3GAL4 mRNA	PMID:38568856
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1353529	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ST3GAL4 mRNA	PMID:40512198
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST3GAL4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ST3GAL4 mRNA	PMID:34876320|PMID:40504410
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1550578	E	RGD:6480464	20120717	CTD	MESH:D014415	Tunicamycin results in increased expression of ST3GAL4 mRNA	PMID:17127020
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST3GAL4 mRNA	PMID:34876320
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353529	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ST3GAL4 5' UTR; Benzo(a)pyrene affects the methylation of ST3GAL4 intron; Benzo(a)pyrene affects the methylation of ST3GAL4 promoter	PMID:27901495|PMID:30157460
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ST3GAL4 mRNA	PMID:19770486
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353529	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ST3GAL4 exon	PMID:27901495
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of ST3GAL4 protein	PMID:37955338
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:29866	arsenite(3-)	decreases methylation	ISO	RGD:1353529	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of ST3GAL4 promoter	PMID:23974009
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ST3GAL4 mRNA	PMID:24136188
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ST3GAL4 mRNA	PMID:29264374
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of ST3GAL4 mRNA	PMID:30012374
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ST3GAL4 mRNA	PMID:34492290
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ST3GAL4 mRNA	PMID:11798191|PMID:17426115|PMID:23811191
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of ST3GAL4 mRNA	PMID:29161229
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ST3GAL4 mRNA	PMID:25181051
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550578	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ST3GAL4 mRNA	PMID:33221593
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1353529	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST3GAL4 mRNA	PMID:28628672
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550578	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ST3GAL4 mRNA	PMID:39298647
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1353529	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ST3GAL4 intron	PMID:30157460
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1353529	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of ST3GAL4 gene	PMID:22964155
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ST3GAL4 mRNA	PMID:21266533
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1353529	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST3GAL4 mRNA	PMID:28628672
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of ST3GAL4 mRNA	PMID:19041683
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550578	E	RGD:6480464	20120717	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ST3GAL4 mRNA	PMID:17854601
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20120717	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ST3GAL4 mRNA]	PMID:17854601
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353529	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ST3GAL4 mRNA	PMID:37042841
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ST3GAL4 mRNA	PMID:37325564
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1353529	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ST3GAL4 mRNA	PMID:31533062
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ST3GAL4 mRNA	PMID:36331819
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550578	E	RGD:6480464	20120717	CTD	MESH:D014635	Valproic Acid affects the expression of ST3GAL4 mRNA	PMID:17292431
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353529	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ST3GAL4 mRNA	PMID:29154799
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ST3GAL4 mRNA	PMID:41580965
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ST3GAL4 mRNA	PMID:19770486
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1353529	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of ST3GAL4 mRNA	PMID:27989131
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1353529	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST3GAL4 mRNA	PMID:28628672
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ST3GAL4 mRNA	PMID:28973697
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550578	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ST3GAL4 mRNA	PMID:17562736
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ST3GAL4 mRNA	PMID:33387578
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1353529	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ST3GAL4 mRNA	PMID:40512198
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ST3GAL4 mRNA	PMID:40504410
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST3GAL4 mRNA	PMID:34876320
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1353529	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of ST3GAL4 mRNA	PMID:38568856
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1353529	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST3GAL4 mRNA	PMID:28628672
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20120412	CTD	MESH:D011345	Fenofibrate results in decreased expression of ST3GAL4 mRNA	PMID:11798191
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550578	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ST3GAL4 mRNA; Nanotubes, Carbon results in increased expression of ST3GAL4 mRNA	PMID:25554681|PMID:25620056
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of ST3GAL4 mRNA	PMID:23962444
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ST3GAL4 mRNA	PMID:24136188
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of ST3GAL4 mRNA	PMID:21983209
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1353529	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ST3GAL4 mRNA	PMID:22714537
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1353529	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ST3GAL4 intron	PMID:30157460
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550578	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ST3GAL4 mRNA	PMID:22206623
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of ST3GAL4 mRNA	PMID:19482888
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550578	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ST3GAL4 mRNA	PMID:19270015
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ST3GAL4 mRNA]	PMID:19482888
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:8093	phenylephrine	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D010656	Phenylephrine results in increased expression of ST3GAL4 mRNA	PMID:18158353
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1550578	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ST3GAL4 mRNA	PMID:39847705
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1550578	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST3GAL4 mRNA	PMID:34876320
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:9211	soyasaponin I	decreases expression	ISO	RGD:1353529	E	RGD:6480464	20130514	CTD	MESH:C056684	soyasaponin I results in decreased expression of ST3GAL4 mRNA	PMID:15661230
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1353529	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ST3GAL4 mRNA	PMID:38568856
1303068	St3gal4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ST3GAL4 mRNA	PMID:23034163
1303069	Nup35	nucleoporin 35	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1353367	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of NUP35 protein	PMID:39638853
1303069	Nup35	nucleoporin 35	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550583	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of NUP35 mRNA	PMID:26251327
1303069	Nup35	nucleoporin 35	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1550583	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of NUP35 promoter	PMID:26251327
1303069	Nup35	nucleoporin 35	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NUP35 mRNA	PMID:33167477
1303069	Nup35	nucleoporin 35	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NUP35 mRNA	PMID:26516004
1303069	Nup35	nucleoporin 35	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NUP35 mRNA	PMID:22378314
1303069	Nup35	nucleoporin 35	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NUP35 mRNA	PMID:21632981
1303069	Nup35	nucleoporin 35	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1353367	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of NUP35 mRNA	PMID:31614463
1303069	Nup35	nucleoporin 35	gene	CHEBI:17323	trans-pinosylvin	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20140805	CTD	MESH:C049032	pinosylvin results in decreased expression of NUP35 mRNA	PMID:23333577
1303069	Nup35	nucleoporin 35	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of NUP35 mRNA	PMID:21592394
1303069	Nup35	nucleoporin 35	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1353367	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of NUP35 mRNA	PMID:21592394
1303069	Nup35	nucleoporin 35	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1353367	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NUP35 protein	PMID:37730182
1303069	Nup35	nucleoporin 35	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of NUP35 mRNA	PMID:21592394
1303069	Nup35	nucleoporin 35	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1353367	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of NUP35 mRNA	PMID:21592394
1303069	Nup35	nucleoporin 35	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NUP35 mRNA	PMID:33387578
1303069	Nup35	nucleoporin 35	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of NUP35 mRNA	PMID:24376830
1303069	Nup35	nucleoporin 35	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1353367	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP35 protein	PMID:23301498
1303069	Nup35	nucleoporin 35	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of NUP35 mRNA	PMID:23649840
1303069	Nup35	nucleoporin 35	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of NUP35 mRNA	PMID:23649840
1303069	Nup35	nucleoporin 35	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1353367	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of NUP35 protein	PMID:35688186
1303069	Nup35	nucleoporin 35	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1353367	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of NUP35 mRNA	PMID:27392435
1303069	Nup35	nucleoporin 35	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1550583	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NUP35 mRNA	PMID:30912803
1303069	Nup35	nucleoporin 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1353367	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUP35 mRNA	PMID:22574217
1303069	Nup35	nucleoporin 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550583	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUP35 mRNA	PMID:21570461
1303069	Nup35	nucleoporin 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NUP35 mRNA	PMID:21632981
1303069	Nup35	nucleoporin 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUP35 mRNA	PMID:33387578
1303069	Nup35	nucleoporin 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1353367	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUP35 mRNA	PMID:17555868
1303069	Nup35	nucleoporin 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550583	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NUP35 mRNA	PMID:17942748
1303069	Nup35	nucleoporin 35	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1353367	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of NUP35 protein	PMID:39603559
1303069	Nup35	nucleoporin 35	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NUP35 mRNA	PMID:33212167
1303069	Nup35	nucleoporin 35	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1353367	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of NUP35 protein	PMID:35688186
1303069	Nup35	nucleoporin 35	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NUP35 mRNA	PMID:38568856
1303069	Nup35	nucleoporin 35	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP35 mRNA	PMID:19150397|PMID:20382639
1303069	Nup35	nucleoporin 35	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUP35 mRNA	PMID:25729387
1303069	Nup35	nucleoporin 35	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NUP35 mRNA	PMID:34492290
1303069	Nup35	nucleoporin 35	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NUP35 mRNA	PMID:25181051
1303069	Nup35	nucleoporin 35	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NUP35 mRNA	PMID:34947998
1303069	Nup35	nucleoporin 35	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NUP35 mRNA; bisphenol A results in decreased expression of NUP35 protein	PMID:29275510|PMID:37567409
1303069	Nup35	nucleoporin 35	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of NUP35 mRNA	PMID:32145629
1303069	Nup35	nucleoporin 35	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550583	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NUP35 mRNA	PMID:33221593
1303069	Nup35	nucleoporin 35	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NUP35 gene	PMID:28505145
1303069	Nup35	nucleoporin 35	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550583	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of NUP35 mRNA	PMID:40203079
1303069	Nup35	nucleoporin 35	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NUP35 mRNA	PMID:38568856
1303069	Nup35	nucleoporin 35	gene	CHEBI:36011	pinosylvin	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20140311	CTD	MESH:C049032	pinosylvin results in decreased expression of NUP35 mRNA	PMID:23333577
1303069	Nup35	nucleoporin 35	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1550583	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of NUP35 mRNA	PMID:18353800
1303069	Nup35	nucleoporin 35	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550583	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of NUP35 mRNA	PMID:17585979
1303069	Nup35	nucleoporin 35	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NUP35 mRNA	PMID:28302478
1303069	Nup35	nucleoporin 35	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1353367	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NUP35 mRNA	PMID:19167446
1303069	Nup35	nucleoporin 35	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550583	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of NUP35 mRNA	PMID:39529242
1303069	Nup35	nucleoporin 35	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of NUP35 mRNA	PMID:41580965
1303069	Nup35	nucleoporin 35	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NUP35 mRNA	PMID:30047161
1303069	Nup35	nucleoporin 35	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550583	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of NUP35 mRNA	PMID:17555576
1303069	Nup35	nucleoporin 35	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550583	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NUP35 mRNA	PMID:17562736
1303069	Nup35	nucleoporin 35	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of NUP35 mRNA	PMID:21420995
1303069	Nup35	nucleoporin 35	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NUP35 mRNA	PMID:33387578
1303069	Nup35	nucleoporin 35	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550583	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NUP35 mRNA	PMID:17555576
1303069	Nup35	nucleoporin 35	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550583	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NUP35 mRNA	PMID:17942748
1303069	Nup35	nucleoporin 35	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550583	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NUP35 mRNA	PMID:17942748
1303069	Nup35	nucleoporin 35	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	ISO	RGD:1550583	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of NUP35 gene	PMID:27923600
1303069	Nup35	nucleoporin 35	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550583	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NUP35 mRNA; Nanotubes, Carbon results in increased expression of NUP35 mRNA	PMID:25554681
1303069	Nup35	nucleoporin 35	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of NUP35 mRNA	PMID:24136188
1303069	Nup35	nucleoporin 35	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NUP35 mRNA	PMID:30047161
1303069	Nup35	nucleoporin 35	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NUP35 mRNA	PMID:24136188
1303069	Nup35	nucleoporin 35	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353367	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NUP35 protein	PMID:32959892
1303069	Nup35	nucleoporin 35	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of NUP35 mRNA	PMID:20080153
1303069	Nup35	nucleoporin 35	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUP35 mRNA	PMID:25729387
1303069	Nup35	nucleoporin 35	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550583	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NUP35 mRNA	PMID:22206623
1303069	Nup35	nucleoporin 35	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1353367	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NUP35 protein	PMID:37664457
1303069	Nup35	nucleoporin 35	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550583	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of NUP35 mRNA	PMID:23091169
1303069	Nup35	nucleoporin 35	gene	CHEBI:80799	Bufotalin	increases expression	ISO	RGD:1353367	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of NUP35 mRNA	PMID:39904859
1303069	Nup35	nucleoporin 35	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1550583	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NUP35 mRNA	PMID:30294300
1303069	Nup35	nucleoporin 35	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1550583	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of NUP35 mRNA	PMID:21278054
1303069	Nup35	nucleoporin 35	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NUP35 mRNA	PMID:30047161
1303069	Nup35	nucleoporin 35	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353367	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NUP35 protein	PMID:37664457
1303069	Nup35	nucleoporin 35	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NUP35 mRNA	PMID:19281266
1303069	Nup35	nucleoporin 35	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NUP35 mRNA	PMID:21346803
1303069	Nup35	nucleoporin 35	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NUP35 mRNA	PMID:21346803
1303069	Nup35	nucleoporin 35	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of NUP35 mRNA	PMID:30047161
1303069	Nup35	nucleoporin 35	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of NUP35 gene	PMID:31079544
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of AKAP7 gene	PMID:35440735
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1350760	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of AKAP7 mRNA	PMID:20044591
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of AKAP7 mRNA	PMID:39241906
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350760	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AKAP7 mRNA	PMID:37042841
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1617174	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of AKAP7 mRNA	PMID:28973375
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1617174	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of AKAP7 gene	PMID:34319233
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of AKAP7 mRNA	PMID:33387578
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1617174	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AKAP7 mRNA	PMID:36331819
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of AKAP7 mRNA	PMID:17175027
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617174	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AKAP7 mRNA	PMID:37236586
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AKAP7 mRNA	PMID:19549813
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AKAP7 mRNA	PMID:22100608
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AKAP7 mRNA	PMID:19770486
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1350760	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AKAP7 gene	PMID:27153756
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of AKAP7 mRNA	PMID:25629700
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1350760	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of AKAP7 mRNA	PMID:23300844
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of AKAP7 gene	PMID:28505145
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AKAP7 mRNA	PMID:33387578
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1350760	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of AKAP7 protein	PMID:39603559
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of AKAP7 mRNA	PMID:28001369
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of AKAP7 mRNA	PMID:33212167
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of AKAP7 mRNA	PMID:28959563
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of AKAP7 mRNA	PMID:32763439
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of AKAP7 mRNA	PMID:39719251
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AKAP7 mRNA	PMID:19770486
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1350760	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of AKAP7 exon; Benzo(a)pyrene results in decreased methylation of AKAP7 promoter	PMID:27901495
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1617174	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AKAP7 5' UTR; Benzo(a)pyrene results in increased methylation of AKAP7 exon; Benzo(a)pyrene results in increased methylation of AKAP7 intron; Benzo(a)pyrene results in increased methylation of AKAP7 promoter	PMID:27901495
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1617174	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AKAP7 mRNA	PMID:27858113
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of AKAP7 mRNA	PMID:33053406
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1350760	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of AKAP7 gene	PMID:31601247
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1617174	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of AKAP7 mRNA	PMID:22609695
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of AKAP7 mRNA	PMID:30047161
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1617174	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of AKAP7 mRNA	PMID:20813756|PMID:23811191
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of AKAP7 mRNA	PMID:25181051
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of AKAP7 mRNA	PMID:33221593
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1350760	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of AKAP7 gene	PMID:31601247
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350760	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of AKAP7 gene	PMID:31601247
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1617174	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of AKAP7 mRNA	PMID:40203079
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of AKAP7 mRNA	PMID:26377693
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1617174	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AKAP7 mRNA	PMID:27858113
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1617174	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of AKAP7 intron	PMID:28392331
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of AKAP7 mRNA	PMID:21266533
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1350760	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AKAP7 mRNA	PMID:16997883
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350760	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AKAP7 mRNA	PMID:37042841
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of AKAP7 mRNA	PMID:17175027
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617174	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AKAP7 mRNA	PMID:37236586
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AKAP7 mRNA	PMID:24386269
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1617174	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of AKAP7 mRNA	PMID:40194260
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of AKAP7 mRNA	PMID:28302478
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617174	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AKAP7 mRNA	PMID:36331819
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of AKAP7 mRNA	PMID:23179753|PMID:29154799
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of AKAP7 mRNA	PMID:30047161
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:40303	lovastatin	decreases response to substance	ISO	RGD:1350760	E	RGD:6480464	20120501	CTD	MESH:D008148	AKAP7 SNP results in decreased susceptibility to Lovastatin	PMID:21483694
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of AKAP7 mRNA	PMID:27989131
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1350760	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AKAP7 mRNA	PMID:16997883
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1350760	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of AKAP7 mRNA	PMID:24449571
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of AKAP7 mRNA	PMID:33387578
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1350760	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of AKAP7 mRNA	PMID:22230336
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of AKAP7 mRNA	PMID:24714768
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of AKAP7 mRNA	PMID:29391264
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1350760	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of AKAP7 mRNA	PMID:23300844
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of AKAP7 mRNA	PMID:30307764
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of AKAP7 mRNA; Nanotubes, Carbon results in decreased expression of AKAP7 mRNA	PMID:25554681
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1617174	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AKAP7 mRNA	PMID:25620056
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of AKAP7 mRNA	PMID:30047161
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1617174	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AKAP7 mRNA	PMID:27858113
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1617174	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AKAP7 mRNA	PMID:27858113
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1350760	E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of AKAP7 mRNA	PMID:17175027
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:64211	8-Br-cAMP	multiple interactions	ISO	RGD:1350760	E	RGD:6480464	20120412	CTD	MESH:D015124	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AKAP7 mRNA	PMID:16997883
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of AKAP7 mRNA	PMID:22206623
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of AKAP7 mRNA	PMID:27858113
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350760	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AKAP7 gene]	PMID:28238834
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of AKAP7 mRNA	PMID:30047161
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of AKAP7 mRNA	PMID:27291303
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AKAP7 mRNA	PMID:24780913|PMID:30047161
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of AKAP7 mRNA	PMID:19281266
1303071	Akap7	A-kinase anchoring protein 7	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1617174	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of AKAP7 mRNA	PMID:35537566
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1332312	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of XBP1 protein	PMID:19336499
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:10022	deoxynivalenol	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased splicing of XBP1 mRNA	PMID:19336499
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1352787	E	RGD:6480464	20180116	CTD	MESH:D015025	Zearalenone results in increased expression of XBP1 mRNA	PMID:28965971
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1352787	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of XBP1 mRNA	PMID:38218311
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:110423	clodronic acid	affects activity	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of XBP1 mRNA	PMID:21551480
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:119486	efavirenz	increases expression	ISO	RGD:1352787	E	RGD:6480464	20260303	CTD	MESH:C098320	efavirenz results in increased expression of XBP1 mRNA	PMID:40582629
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1352787	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of XBP1 mRNA	PMID:26272509
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of XBP1 mRNA	PMID:27188386
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:132889	graphene oxide	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20230801	CTD	MESH:C000628730	graphene oxide results in increased expression of and results in increased splicing of XBP1 mRNA	PMID:33973267
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:134606	toyocamycin	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20240305	CTD	MESH:D014127	Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]	PMID:37692514
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:135946	sincalide	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:D012844	[Palmitic Acid co-treated with Sincalide] results in increased expression of XBP1 mRNA alternative form; [Palmitic Acid co-treated with Sincalide] results in increased expression of XBP1 protein alternative form; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form]	PMID:26873426
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20240402	CTD	MESH:C585473	[Methotrexate co-treated with theaflavin-3,3'-digallate] results in decreased expression of and results in decreased splicing of XBP1 mRNA; theaflavin-3,3'-digallate results in decreased expression of and results in decreased splicing of XBP1 mRNA	PMID:34350509
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:137693	rhosin	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20250204	CTD	MESH:C586690	rhosin inhibits the reaction [4-nitro-3-cresol results in increased expression of XBP1 mRNA]; rhosin inhibits the reaction [4-nitro-3-cresol results in increased expression of XBP1 protein]	PMID:35910793
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:142921	3-phenylprop-2-enal	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20250114	CTD	MESH:C012843	Acetylcysteine inhibits the reaction [cinnamaldehyde inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; cinnamaldehyde inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]	PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:145373	pexidartinib	increases expression	ISO	RGD:1352787	E	RGD:6480464	20260113	CTD	MESH:C000600259	pexidartinib results in increased expression of XBP1 protein alternative form	PMID:40617559
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:145373	pexidartinib	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20260113	CTD	MESH:C000600259	4-phenylbutyric acid inhibits the reaction [pexidartinib results in increased expression of XBP1 protein alternative form]	PMID:40617559
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:146195	3-acetyldeoxynivalenol	increases expression	ISO	RGD:1332312	E	RGD:6480464	20221206	CTD	MESH:C043247	3-acetyldeoxynivalenol results in increased expression of XBP1 mRNA	PMID:35413383
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:146195	3-acetyldeoxynivalenol	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20221206	CTD	MESH:C043247	4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of XBP1 mRNA]	PMID:35413383
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:146245	SR 144528	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20200407	CTD	MESH:C110630	[Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of XBP1 mRNA alternative form]	PMID:31054322
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of XBP1 gene	PMID:20938992
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of XBP1 mRNA	PMID:33167477
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1332312	E	RGD:6480464	20121009	CTD	MESH:D014212	Tretinoin results in increased expression of XBP1 mRNA; Tretinoin results in increased expression of XBP1 protein	PMID:22498432
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of XBP1 mRNA alternative form; Tretinoin results in increased expression of XBP1 protein alternative form	PMID:17031849|PMID:19960509
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D014212	MGAT5 protein inhibits the reaction [Tretinoin results in increased expression of XBP1 protein alternative form]	PMID:17031849
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15368	acrolein	affects splicing	ISO	RGD:1352787	E	RGD:6480464	20120814	CTD	MESH:D000171	Acrolein affects the splicing of XBP1 mRNA	PMID:18951912
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XBP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XBP1 mRNA	PMID:32699268
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15379	dioxygen	affects activity	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D010100	Oxygen deficiency results in increased expression of XBP1 protein	PMID:21337367
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15428	glycine	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20161115	CTD	MESH:D005998	Glycine affects the reaction [Homocysteine results in increased splicing of XBP1 mRNA]	PMID:27064126
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of XBP1 mRNA	PMID:24763279
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of XBP1 mRNA	PMID:26079696
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1332312	E	RGD:6480464	20180828	CTD	MESH:D019308	Palmitic Acid results in increased expression of XBP1 mRNA alternative form; Palmitic Acid results in increased expression of XBP1 protein alternative form	PMID:29414781|PMID:36030031
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1352787	E	RGD:6480464	20200714	CTD	MESH:D019308	Palmitic Acid results in increased expression of XBP1 protein	PMID:32283200
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D019308	[Palmitic Acid co-treated with Sincalide] results in increased expression of XBP1 mRNA alternative form; [Palmitic Acid co-treated with Sincalide] results in increased expression of XBP1 protein alternative form; Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form]	PMID:26873426
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20180828	CTD	MESH:D019308	4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form]; 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Palmitic Acid results in increased expression of XBP1 protein alternative form]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form]; [Glucose co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form; ATP2A2 protein promotes the reaction [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form]]; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form]; Thapsigargin inhibits the reaction [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form]]	PMID:29414781|PMID:36030031|PMID:39701215
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20200714	CTD	MESH:D019308	3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased splicing of XBP1 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased splicing of XBP1 mRNA; Deferoxamine promotes the reaction [Palmitic Acid results in increased expression of XBP1 protein]; ferric ammonium citrate inhibits the reaction [Palmitic Acid results in increased expression of XBP1 protein]	PMID:32283200|PMID:32369900
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15767	dichloromethane	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D008752	Methylene Chloride results in increased expression of XBP1 mRNA	PMID:20359517
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15864	luteolin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20201103	CTD	MESH:D047311	Luteolin inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA alternative form]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of XBP1 mRNA alternative form]	PMID:32407927
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15866	2-deoxy-D-glucose	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20250114	CTD	MESH:D003847	Deoxyglucose results in increased splicing of XBP1 mRNA	PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15866	2-deoxy-D-glucose	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20250114	CTD	MESH:D003847	toxoflavin inhibits the reaction [Deoxyglucose results in increased splicing of XBP1 mRNA]	PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15930	atrazine	affects splicing	ISO	RGD:1332312	E	RGD:6480464	20231205	CTD	MESH:D001280	Atrazine affects the splicing of XBP1	PMID:25259610
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D001280	Atrazine results in increased expression of XBP1 mRNA	PMID:38056589
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1352787	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of XBP1 mRNA	PMID:22378314
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20231205	CTD	MESH:D001280	Melatonin inhibits the reaction [Atrazine affects the splicing of XBP1]	PMID:25259610
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20240402	CTD	MESH:C015329	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of XBP1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of XBP1 protein]	PMID:36583613
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16015	L-glutamic acid	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D018698	Glutamic Acid results in increased expression of XBP1 protein alternative form	PMID:35028790
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16015	L-glutamic acid	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:D018698	MKC8866 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of XBP1 protein alternative form]]; shikonin inhibits the reaction [Glutamic Acid results in increased expression of XBP1 protein alternative form]	PMID:35028790
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16101	ethylbenzene	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:C004912	ethylbenzene results in increased expression of XBP1 mRNA	PMID:20359517
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16112	chlorogenic acid	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D002726	Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]	PMID:34801538
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20220208	CTD	MESH:D019301	Oleic Acid inhibits the reaction [[Palmitates co-treated with bisphenol A] results in increased splicing of XBP1 mRNA]	PMID:32976987
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20201006	CTD	MESH:D019301	3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased splicing of XBP1 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased splicing of XBP1 mRNA	PMID:32369900
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16236	ethanol	decreases splicing	ISO	RGD:1332312	E	RGD:6480464	20180313	CTD	MESH:D000431	Ethanol results in decreased splicing of XBP1 mRNA	PMID:28119953
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1332312	E	RGD:6480464	20200310	CTD	MESH:D000431	Ethanol results in increased expression of XBP1 protein	PMID:29044621
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16240	hydrogen peroxide	affects splicing	ISO	RGD:1352787	E	RGD:6480464	20161213	CTD	MESH:D006861	Hydrogen Peroxide affects the splicing of XBP1 mRNA	PMID:23885834
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16240	hydrogen peroxide	decreases response to substance	ISO	RGD:1352787	E	RGD:6480464	20140408	CTD	MESH:D006861	XBP1 protein results in decreased susceptibility to Hydrogen Peroxide	PMID:21138464
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1352787	E	RGD:6480464	20161213	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of XBP1 protein alternative form	PMID:23885834
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20140408	CTD	MESH:D006861	Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species]]; XBP1 protein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species]	PMID:21138464
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of XBP1 mRNA	PMID:21632981
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in increased expression of XBP1 protein	PMID:30152185
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16243	quercetin	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20170207	CTD	MESH:D011794	Quercetin results in increased splicing of XBP1 mRNA	PMID:19017364|PMID:19428936|PMID:22115781
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [[Sincalide co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form]; Quercetin inhibits the reaction [Cadmium results in increased expression of XBP1 mRNA]; Quercetin inhibits the reaction [Cadmium results in increased expression of XBP1 protein]; Quercetin inhibits the reaction [Ceruletide results in increased expression of XBP1 mRNA alternative form]; Quercetin inhibits the reaction [Ceruletide results in increased expression of XBP1 protein alternative form]	PMID:26873426|PMID:35714484
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [4-nitrophenol results in increased expression of XBP1 mRNA]	PMID:23997041
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20161213	CTD	MESH:D011794	[Quercetin results in increased splicing of XBP1 mRNA] which results in increased expression of XBP1 protein alternative form; Quercetin inhibits the reaction [Calcimycin results in increased splicing of XBP1 mRNA]	PMID:19017364|PMID:19428936
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20260602	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of XBP1 protein	PMID:40772592
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332312	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of XBP1 mRNA; Lipopolysaccharides results in increased expression of XBP1 protein	PMID:14600275|PMID:18483191|PMID:19675145|PMID:39241906
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170613	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of XBP1 protein alternative form	PMID:28245985
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased splicing of XBP1 mRNA	PMID:18483191
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20161228	CTD	MESH:D008070	Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of XBP1 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of XBP1 protein]; Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased splicing of XBP1 mRNA]	PMID:14600275|PMID:18483191|PMID:19675145
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20170613	CTD	MESH:D008070	4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of XBP1 protein alternative form]; [Estrogens, Conjugated (USP) co-treated with Lipopolysaccharides] results in increased expression of XBP1 mRNA; XBP1 protein affects the reaction [YTHDC1 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of BECN1 protein]]; XBP1 protein affects the reaction [YTHDC1 protein inhibits the reaction [Lipopolysaccharides results in decreased lipidation of MAP1LC3B protein]]; XBP1 protein affects the reaction [YTHDC1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of SQSTM1 protein]]; XBP1 protein affects the reaction [YTHDC1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MTOR protein]]; XBP1 protein affects the reaction [YTHDC1 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; XBP1 protein affects the reaction [YTHDC1 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; XBP1 protein affects the reaction [YTHDC1 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; YTHDC1 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of XBP1 protein]	PMID:28245985|PMID:31217279|PMID:40772592
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1332312	E	RGD:6480464	20240305	CTD	MESH:D014260	Triclosan results in increased expression of XBP1 mRNA	PMID:36277366
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of XBP1 mRNA	PMID:32145629
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332312	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of XBP1 mRNA	PMID:39298647
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1352787	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of XBP1 mRNA	PMID:14605097|PMID:20068169|PMID:25321415|PMID:25721606|PMID:31614463|PMID:32387340
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D004958	(+)-JQ1 compound inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to XBP1 promoter]]; (+)-JQ1 compound inhibits the reaction [Estradiol promotes the reaction [NCOA3 protein binds to XBP1 promoter]]; (+)-JQ1 compound inhibits the reaction [Estradiol results in increased expression of XBP1 mRNA]; Estradiol promotes the reaction [ESR1 protein binds to XBP1 enhancer]; Estradiol promotes the reaction [ESR1 protein binds to XBP1 promoter]; Estradiol promotes the reaction [NCOA3 protein binds to XBP1 promoter]; TBX21 protein inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to XBP1 enhancer]]; TBX21 protein inhibits the reaction [Estradiol results in increased expression of XBP1 mRNA]	PMID:20068169|PMID:25721606
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of XBP1 mRNA	PMID:38568856
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of XBP1 mRNA	PMID:33387578
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of XBP1 mRNA	PMID:20359517
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of XBP1 gene	PMID:20938992
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1352787	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of XBP1 mRNA	PMID:37042841
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of XBP1 mRNA	PMID:20359517
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16738	2,4-dichlorophenol	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20170516	CTD	MESH:C004762	2,4-dichlorophenol results in increased splicing of XBP1 mRNA	PMID:25160872|PMID:27853103
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16738	2,4-dichlorophenol	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20170516	CTD	MESH:C004762	2,4-dichlorophenol results in increased splicing of XBP1 mRNA	PMID:27853103
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16796	melatonin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008550	Melatonin inhibits the reaction [Methamphetamine results in increased expression of XBP1 mRNA alternative form]; Melatonin inhibits the reaction [sodium arsenite results in increased expression of XBP1 protein]	PMID:17645694|PMID:28070110
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20231205	CTD	MESH:D008550	Melatonin inhibits the reaction [Atrazine affects the splicing of XBP1]; Melatonin inhibits the reaction [bisphenol A results in increased expression of XBP1 protein]	PMID:25259610|PMID:38538260
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1332312	E	RGD:6480464	20161213	CTD	MESH:C024836	4-nitrophenol results in increased expression of XBP1 mRNA	PMID:23997041
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16836	4-nitrophenol	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20161213	CTD	MESH:C024836	Quercetin inhibits the reaction [4-nitrophenol results in increased expression of XBP1 mRNA]	PMID:23997041
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16856	glutathione	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20180116	CTD	MESH:D005978	Glutathione inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased expression of XBP1 protein alternative form]; Glutathione inhibits the reaction [NR4A1 protein affects the expression of XBP1 protein alternative form]	PMID:24515801
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16990	bilirubin IXalpha	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170516	CTD	MESH:D001663	Bilirubin results in increased expression of XBP1 mRNA	PMID:27578021
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16990	bilirubin IXalpha	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D001663	Bilirubin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of XBP1 mRNA alternative form]	PMID:37054934
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:16990	bilirubin IXalpha	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20170516	CTD	MESH:D001663	4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of XBP1 mRNA]	PMID:27578021
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of XBP1 mRNA	PMID:18037150
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:171741	cerulenin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D002569	Cerulenin affects the reaction [ERN1 protein affects the splicing of XBP1 mRNA]	PMID:17283163
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17230	homocysteine	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:D006710	Homocysteine results in decreased expression of XBP1 protein	PMID:22964297
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17230	homocysteine	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:D006710	Homocysteine results in increased expression of XBP1 mRNA alternative form	PMID:19960509
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17230	homocysteine	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:D006710	Homocysteine results in increased splicing of XBP1 mRNA	PMID:27064126
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17230	homocysteine	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:D006710	Glycine affects the reaction [Homocysteine results in increased splicing of XBP1 mRNA]	PMID:27064126
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of XBP1 mRNA	PMID:24349266
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in decreased expression of XBP1 mRNA	PMID:17178593
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D005947	Glucose deficiency results in increased expression of XBP1 protein; Glucose results in increased expression of XBP1 mRNA	PMID:21337367|PMID:34801538
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17234	glucose	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20191008	CTD	MESH:D005947	Glucose deficiency results in increased splicing of XBP1 mRNA	PMID:31022492
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D005947	Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]; Metformin inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]	PMID:34801538
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20260407	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form]	PMID:39701215
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20191008	CTD	MESH:D005947	4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased splicing of XBP1 mRNA]; XBP1 mRNA alternative form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]	PMID:31022492
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332312	E	RGD:6480464	20240305	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form	PMID:37692514
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20240305	CTD	MESH:C016599	4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased localization of XBP1 protein alternative form; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]	PMID:37692514
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17315	D-glucosamine	decreases splicing	ISO	RGD:1352787	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased splicing of XBP1 mRNA	PMID:19383982
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17315	D-glucosamine	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 mRNA	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1332312	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 protein alternative form	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1352787	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 mRNA	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17315	D-glucosamine	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased splicing of XBP1 mRNA	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17315	D-glucosamine	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased splicing of XBP1 mRNA	PMID:33812996
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17315	D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17315	D-glucosamine	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20260203	CTD	MESH:D005944	4-methylumbelliferone 8-carbaldehyde affects the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased splicing of XBP1 mRNA]	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17315	D-glucosamine	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20260203	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]	PMID:20165829|PMID:33812996
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17447	geraniol	increases expression	ISO	RGD:1352787	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of XBP1 mRNA	PMID:27683099
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:174748	C.I. Natural Red 20	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:C016101	MKC8866 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of XBP1 protein alternative form]]; shikonin inhibits the reaction [Glutamic Acid results in increased expression of XBP1 protein alternative form]	PMID:35028790
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:174748	C.I. Natural Red 20	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20250114	CTD	MESH:C016101	Acetylcysteine inhibits the reaction [shikonin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; shikonin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]	PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17515	L-gamma-glutamyl-L-cysteine	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20260407	CTD	MESH:C017341	gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form]	PMID:39701215
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17573	glycyrrhetinate	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20181016	CTD	MESH:C119129	18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]	PMID:29444456
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D014050	Toluene results in increased expression of XBP1 mRNA	PMID:20359517
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:175901	gemcitabine	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine promotes the reaction [1-(2,3-dichlorobenzoyl)-5-methoxy-2-methyl-(2-(mopholin-4-yl)ethyl)-1H-indole results in increased expression of XBP1 mRNA]; Gemcitabine promotes the reaction [arachidonylcyclopropylamide results in increased expression of XBP1 mRNA]; Gemcitabine promotes the reaction [Rimonabant results in increased expression of XBP1 mRNA]	PMID:21525939
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17594	hydroquinone	affects response to substance	ISO	RGD:1332312	E	RGD:6480464	20220405	CTD	MESH:C031927	XBP1 protein affects the susceptibility to hydroquinone	PMID:24053669
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in decreased expression of XBP1 protein alternative form	PMID:24053669
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1352787	E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in increased expression of XBP1 protein	PMID:32334435
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17594	hydroquinone	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in increased splicing of XBP1 mRNA	PMID:24053669
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17594	hydroquinone	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20220405	CTD	MESH:C031927	[XBP1 protein affects the susceptibility to hydroquinone] which affects the expression of DDIT3 protein; hydroquinone promotes the reaction [XBP1 protein affects the expression of BCL2 mRNA]; hydroquinone promotes the reaction [XBP1 protein affects the expression of DDIT3 mRNA]; XBP1 protein affects the reaction [hydroquinone results in decreased expression of BCL2 mRNA]; XBP1 protein affects the reaction [hydroquinone results in increased expression of DDIT3 mRNA]; XBP1 protein affects the reaction [hydroquinone results in increased expression of DDIT3 protein]	PMID:24053669
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17594	hydroquinone	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20220405	CTD	MESH:C031927	Resveratrol inhibits the reaction [hydroquinone results in increased expression of XBP1 protein]; XBP1 protein alternative form inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein]; XBP1 protein alternative form inhibits the reaction [hydroquinone results in increased phosphorylation of EIF2S1 protein]	PMID:24053669|PMID:32334435
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17602	4-aminophenol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C026729	4-aminophenol results in increased expression of XBP1 mRNA; 4-aminophenol results in increased expression of XBP1 protein	PMID:17567590|PMID:17567592
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17602	4-aminophenol	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:C026729	PD 150606 inhibits the reaction [4-aminophenol results in increased expression of XBP1 protein]	PMID:17567592
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of XBP1 mRNA	PMID:24349266
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in decreased expression of XBP1 mRNA	PMID:17178593
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D005947	Glucose deficiency results in increased expression of XBP1 protein; Glucose results in increased expression of XBP1 mRNA	PMID:21337367|PMID:34801538
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17634	D-glucose	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20191008	CTD	MESH:D005947	Glucose deficiency results in increased splicing of XBP1 mRNA	PMID:31022492
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D005947	Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]; Metformin inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]	PMID:34801538
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20260407	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form]	PMID:39701215
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20191008	CTD	MESH:D005947	4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased splicing of XBP1 mRNA]; XBP1 mRNA alternative form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]	PMID:31022492
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]	PMID:18477628
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:177387	brequinar	increases expression	ISO	RGD:1352787	E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in increased expression of XBP1 mRNA	PMID:39900124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	EXP		E	RGD:6480464	20240305	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of XBP1 protein alternative form	PMID:37692514
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of XBP1 mRNA	PMID:35550907
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332312	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of XBP1 mRNA; Diethylhexyl Phthalate results in increased expression of XBP1 protein	PMID:36583613
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20240402	CTD	MESH:D004051	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of XBP1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of XBP1 protein]	PMID:36583613
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of XBP1 mRNA; Gentamicins results in increased expression of XBP1 protein	PMID:17567590|PMID:33387578
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases response to substance	ISO	RGD:1352787	E	RGD:6480464	20130514	CTD	MESH:D015632	XBP1 protein results in decreased susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	PMID:19135031
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of XBP1 mRNA	PMID:28818685
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	increases expression	ISO	RGD:1352787	E	RGD:6480464	20121113	CTD	MESH:D024502	alpha-Tocopherol analog results in increased expression of XBP1 mRNA	PMID:20686688
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:182159	Cannabidivarin	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20250401	CTD	MESH:C580853	cannabidivarin results in increased splicing of XBP1 mRNA	PMID:38748041
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of XBP1 protein alternative form; [manganese chloride results in increased abundance of Manganese] which results in increased splicing of XBP1 mRNA	PMID:32574669
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:18320	1,4-dithiothreitol	increases splicing	EXP		E	RGD:6480464	20230801	CTD	MESH:D004229	Dithiothreitol results in increased splicing of XBP1 mRNA	PMID:23123503
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:18320	1,4-dithiothreitol	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20220405	CTD	MESH:D004229	Dithiothreitol results in increased splicing of XBP1 mRNA	PMID:34244458
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:18357	(R)-noradrenaline	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D009638	Norepinephrine affects the localization of XBP1 protein	PMID:16338971
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:18422	sulfur dioxide	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20210608	CTD	MESH:D013458	[Air Pollutants results in increased abundance of Sulfur Dioxide] which results in decreased expression of XBP1 mRNA	PMID:32248990
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of XBP1 mRNA; alpha-Chlorohydrin results in increased expression of XBP1 protein alternative form	PMID:28522335|PMID:33651226
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D000517	4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of XBP1 protein alternative form]	PMID:33651226
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]	PMID:18477628
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:193591	Didecyldimethylammonium	increases expression	ISO	RGD:1352787	E	RGD:6480464	20250805	CTD	MESH:C027118	didecyldimethylammonium results in increased expression of XBP1 mRNA	PMID:39710153
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:201674	icaritin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20260303	CTD	MESH:C499403	icaritin inhibits the reaction [Thapsigargin results in increased expression of XBP1 protein]	PMID:36372277
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases splicing	ISO	RGD:1352787	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased splicing of XBP1 mRNA	PMID:19383982
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 mRNA	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1332312	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 protein alternative form	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 mRNA	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:20993	aldehydo-D-glucosamine	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased splicing of XBP1 mRNA	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:20993	aldehydo-D-glucosamine	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20211109	CTD	MESH:D005944	Glucosamine results in increased splicing of XBP1 mRNA	PMID:33812996
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20190312	CTD	MESH:D005944	4-methylumbelliferone 8-carbaldehyde affects the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased splicing of XBP1 mRNA]	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]	PMID:20165829|PMID:33812996
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:22718	benzoates	increases expression	ISO	RGD:1352787	E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in increased expression of XBP1 mRNA	PMID:29472718
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:227454	Trienomycin A	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20231219	CTD	MESH:C045958	trienomycin A inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA]	PMID:17917237
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:227530	Mycotrienin II	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20231219	CTD	MESH:C036971	mycotrienin II inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA]	PMID:17917237
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:22977	cadmium atom	increases activity	ISO	RGD:1332312	E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased activity of XBP1 protein	PMID:20600546
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium results in increased expression of XBP1 mRNA; Cadmium results in increased expression of XBP1 protein	PMID:35714484|PMID:37886005
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:22977	cadmium atom	increases splicing	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in increased splicing of XBP1 mRNA	PMID:38238535
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein; Gallic Acid inhibits the reaction [Cadmium results in increased expression of XBP1 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein]; morin inhibits the reaction [Cadmium results in increased splicing of XBP1 mRNA]; Quercetin inhibits the reaction [Cadmium results in increased expression of XBP1 mRNA]; Quercetin inhibits the reaction [Cadmium results in increased expression of XBP1 protein]	PMID:35714484|PMID:37886005|PMID:38001299|PMID:38238535
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20251007	CTD	MESH:D002104	2-aminoethyl diphenylborinate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein alternative form]; [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of XBP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein alternative form; STF 083010 inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein alternative form]	PMID:37236586|PMID:40398541
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of and results in increased splicing of XBP1 mRNA	PMID:28860664
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:232991	Perhexiline maleate	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20250107	CTD	MESH:C023470	perhexiline maleate results in increased splicing of XBP1 mRNA	PMID:33309543
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of XBP1 mRNA	PMID:19549813
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of XBP1 mRNA	PMID:27153756
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of XBP1 protein alternative form	PMID:29956773
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:25812	ozone	increases splicing	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased splicing of XBP1 mRNA	PMID:29956773
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of XBP1 mRNA	PMID:36412511
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XBP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XBP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of XBP1 mRNA	PMID:32699268
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2607	Aloe emodin	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20161228	CTD	MESH:C518327	aloe emodin results in increased splicing of XBP1 mRNA	PMID:22210228
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2639	amiloride	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20120412	CTD	MESH:D000584	Amiloride inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]	PMID:20015086
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:26523	reactive oxygen species	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:D017382	Reactive Oxygen Species results in decreased expression of XBP1 mRNA	PMID:25800948
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:D017382	Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species]]; XBP1 protein inhibits the reaction [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species]; XBP1 protein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species]	PMID:21138464
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2663	amiodarone	affects localization	ISO	RGD:1332312	E	RGD:6480464	20171114	CTD	MESH:D000638	Amiodarone affects the localization of XBP1 protein	PMID:28962527
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2663	amiodarone	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20230404	CTD	MESH:D000638	Amiodarone results in decreased expression of XBP1 mRNA	PMID:35641671
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of XBP1 mRNA	PMID:19774075|PMID:36586010
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2663	amiodarone	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20171114	CTD	MESH:D000638	Amiodarone results in increased splicing of XBP1 mRNA	PMID:28962527
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2663	amiodarone	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20230801	CTD	MESH:D000638	Amiodarone results in increased splicing of XBP1 mRNA	PMID:25295624
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2663	amiodarone	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20171114	CTD	MESH:D000638	1-(3,4-dihydroxyphenyl)-2-thiocyanate-ethanone inhibits the reaction [Amiodarone results in increased splicing of XBP1 mRNA]; DDIT3 gene mutant form inhibits the reaction [Amiodarone results in increased splicing of XBP1 mRNA]	PMID:28962527
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2663	amiodarone	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20230801	CTD	MESH:D000638	4-phenylbutyric acid inhibits the reaction [[Amiodarone results in increased splicing of XBP1 mRNA] which results in increased expression of XBP1 mRNA alternative form]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of XBP1 mRNA]; [Amiodarone results in increased splicing of XBP1 mRNA] which results in increased expression of XBP1 mRNA alternative form	PMID:25295624
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27086	tributylstannane	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20140211	CTD	MESH:C011559	tributyltin results in increased splicing of XBP1 mRNA	PMID:23743301
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of XBP1 protein	PMID:33779329
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332312	E	RGD:6480464	20150714	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of XBP1 mRNA; Carbon Tetrachloride results in increased expression of XBP1 protein	PMID:25827057
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27385	tetrachloromethane	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in increased splicing of XBP1 mRNA	PMID:30538632
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:D002251	baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of XBP1 protein]	PMID:33779329
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20150714	CTD	MESH:D002251	1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea inhibits the reaction [Carbon Tetrachloride results in increased expression of XBP1 mRNA]; 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea inhibits the reaction [Carbon Tetrachloride results in increased expression of XBP1 protein]; STF 083010 inhibits the reaction [Carbon Tetrachloride results in increased splicing of XBP1 mRNA]	PMID:25827057|PMID:30538632
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of XBP1 gene	PMID:20938992
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XBP1 mRNA	PMID:40504410
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20191105	CTD	MESH:D000968	Antimycin A results in increased expression of XBP1 protein	PMID:21337367
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1352787	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of XBP1 mRNA	PMID:33512557
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27869	chloroacetic acid	increases expression	ISO	RGD:1332312	E	RGD:6480464	20150414	CTD	MESH:C006972	chloroacetic acid results in increased expression of XBP1 mRNA alternative form; chloroacetic acid results in increased expression of XBP1 protein alternative form	PMID:25451595
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27869	chloroacetic acid	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20150414	CTD	MESH:C006972	Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of XBP1 protein alternative form]	PMID:25451595
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27871	chloroacetaldehyde	affects activity	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27871	chloroacetaldehyde	affects expression	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde affects the expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1352787	E	RGD:6480464	20220405	CTD	MESH:C059514	Resveratrol results in increased expression of XBP1 protein	PMID:32334435
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27881	resveratrol	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased splicing of XBP1 mRNA	PMID:17914584|PMID:20198347
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:C059514	Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein]	PMID:31433112
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20130122	CTD	MESH:C059514	[resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of XBP1 mRNA alternative form]	PMID:21321189
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20190702	CTD	MESH:C059514	Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; Resveratrol inhibits the reaction [hydroquinone results in increased expression of XBP1 protein]	PMID:30796460|PMID:32334435
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27889	lead(0)	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of XBP1 mRNA	PMID:36642386
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27899	cisplatin	affects activity	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of XBP1 mRNA	PMID:21151649
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of XBP1 mRNA; Cisplatin results in increased expression of XBP1 protein	PMID:17567590|PMID:37561086
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of XBP1 mRNA	PMID:19561079
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D002945	isoliquiritigenin inhibits the reaction [Cisplatin results in increased expression of XBP1 mRNA]	PMID:37561086
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of XBP1 mRNA	PMID:27392435
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D003042	Cocaine results in increased expression of XBP1 mRNA	PMID:23644055
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27997	elaidic acid	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C011459	elaidic acid results in increased expression of XBP1 protein alternative form	PMID:38740238
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:27997	elaidic acid	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C011459	Acrylamide promotes the reaction [elaidic acid results in increased expression of XBP1 protein alternative form]; elaidic acid promotes the reaction [Acrylamide results in increased expression of XBP1 protein alternative form]	PMID:38740238
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28063	o-xylene	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:C026114	2-xylene results in increased expression of XBP1 mRNA	PMID:20359517
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332312	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of XBP1 mRNA	PMID:24058054
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XBP1 mRNA	PMID:33387578
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332312	E	RGD:6480464	20120717	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XBP1 mRNA	PMID:17942748|PMID:20819909
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of XBP1 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of XBP1 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of XBP1 protein]; Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased splicing of XBP1 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to XBP1 gene]	PMID:14600275|PMID:17942748|PMID:18483191|PMID:19675145|PMID:20819909
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of XBP1 mRNA	PMID:23186747
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1332312	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of XBP1 mRNA	PMID:32189544
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1352787	E	RGD:6480464	20171114	CTD	MESH:D012402	Rotenone results in increased expression of XBP1 mRNA; Rotenone results in increased expression of XBP1 protein	PMID:26864693|PMID:36586010
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20210907	CTD	MESH:D012402	Metformin inhibits the reaction [Rotenone results in increased expression of XBP1 mRNA]	PMID:32189544
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20171114	CTD	MESH:D012402	MIR384 mRNA promotes the reaction [Rotenone results in increased expression of XBP1 protein]; Rotenone results in increased expression of and results in increased splicing of XBP1 mRNA	PMID:26864693|PMID:27345029
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1332312	E	RGD:6480464	20191210	CTD	MESH:C004925	methylmercuric chloride results in increased expression of XBP1 mRNA alternative form; methylmercuric chloride results in increased expression of XBP1 protein alternative form	PMID:31330229
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1352787	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in increased expression of XBP1 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28216	methylmercury chloride	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20210608	CTD	MESH:C004925	methylmercuric chloride results in increased splicing of XBP1 mRNA	PMID:33454823
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20191210	CTD	MESH:C004925	Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of XBP1 protein alternative form]; XBP1 protein promotes the reaction [methylmercuric chloride results in decreased expression of CASP12 protein]; XBP1 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]; XBP1 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]	PMID:31330229
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of XBP1 mRNA	PMID:33212167
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1332312	E	RGD:6480464	20260407	CTD	MESH:C000228	aristolochic acid I results in increased expression of XBP1 protein	PMID:40480416
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2825	aristolochic acid A	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20121009	CTD	MESH:C000228	aristolochic acid I results in increased splicing of XBP1 mRNA	PMID:22445861
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28299	quercetin 3-O-beta-D-glucofuranoside	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C016527	isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein]	PMID:38001299
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28393	beta-D-glucosamine	decreases splicing	ISO	RGD:1352787	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased splicing of XBP1 mRNA	PMID:19383982
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28393	beta-D-glucosamine	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 mRNA	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1332312	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 protein alternative form	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 mRNA	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28393	beta-D-glucosamine	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased splicing of XBP1 mRNA	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28393	beta-D-glucosamine	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20211109	CTD	MESH:D005944	Glucosamine results in increased splicing of XBP1 mRNA	PMID:33812996
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20190312	CTD	MESH:D005944	4-methylumbelliferone 8-carbaldehyde affects the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased splicing of XBP1 mRNA]	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]	PMID:20165829|PMID:33812996
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28527	rutin	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D012431	Rutin inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 mRNA]; Rutin inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein]	PMID:30973085
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:D020106	Acrylamide results in increased expression of XBP1 protein alternative form	PMID:38740238
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1352787	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of XBP1 mRNA	PMID:32763439
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28619	acrylamide	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D020106	Acrylamide promotes the reaction [elaidic acid results in increased expression of XBP1 protein alternative form]; elaidic acid promotes the reaction [Acrylamide results in increased expression of XBP1 protein alternative form]	PMID:38740238
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of XBP1 mRNA	PMID:20971185
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28741	sodium fluoride	affects expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D012969	Sodium Fluoride affects the expression of XBP1 mRNA	PMID:25132241
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28741	sodium fluoride	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of XBP1 protein modified form	PMID:18696052
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1332312	E	RGD:6480464	20140311	CTD	MESH:D012969	Sodium Fluoride results in increased expression of XBP1 mRNA; Sodium Fluoride results in increased expression of XBP1 protein	PMID:21626649|PMID:38823497
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28741	sodium fluoride	increases splicing	EXP		E	RGD:6480464	20191210	CTD	MESH:D012969	Sodium Fluoride results in increased splicing of XBP1 mRNA	PMID:30633982
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28741	sodium fluoride	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20140610	CTD	MESH:D012969	Sodium Fluoride results in increased splicing of XBP1 mRNA	PMID:24231001
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28741	sodium fluoride	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:D012969	Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased splicing of XBP1 mRNA]	PMID:30633982
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20140610	CTD	MESH:D012969	Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased splicing of XBP1 mRNA]	PMID:24231001
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1332312	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of XBP1 mRNA	PMID:39631538
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of XBP1 mRNA	PMID:15205334
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20250114	CTD	MESH:D004317	Acetylcysteine inhibits the reaction [Doxorubicin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Doxorubicin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]	PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28757	fructose	affects localization	ISO	RGD:1332312	E	RGD:6480464	20121009	CTD	MESH:D005632	Fructose affects the localization of XBP1 protein	PMID:22698815
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of XBP1 mRNA	PMID:20044591
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of XBP1 mRNA	PMID:29432896
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28901	busulfan	affects expression	ISO	RGD:1352787	E	RGD:6480464	20230404	CTD	MESH:D002066	Busulfan affects the expression of XBP1 mRNA	PMID:35641671
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28939	N-acetyl-L-cysteine	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine results in increased splicing of XBP1 mRNA	PMID:19722195
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of XBP1 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased splicing of XBP1 mRNA]	PMID:21145380|PMID:30633982|PMID:40368022
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20121218	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of XBP1 protein alternative form]	PMID:21911445|PMID:25451595|PMID:31330229|PMID:37692514
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20161115	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [cinnamaldehyde inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [Doxorubicin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [Ethylmercury Compounds results in increased splicing of XBP1 mRNA]; Acetylcysteine inhibits the reaction [shikonin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [toxoflavin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species]]	PMID:21138464|PMID:27511942|PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:28984	aluminium atom	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20231031	CTD	MESH:D000535	Aluminum results in decreased expression of XBP1 mRNA	PMID:37544489
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1332312	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of XBP1 protein	PMID:31145545
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29678	sodium arsenite	affects localization	ISO	RGD:1332312	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of XBP1 protein	PMID:21911445
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29678	sodium arsenite	affects splicing	ISO	RGD:1332312	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the splicing of XBP1 mRNA	PMID:21911445
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of XBP1 mRNA	PMID:19822182
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of XBP1 mRNA	PMID:28595984|PMID:34032870
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of XBP1 protein	PMID:17645694|PMID:17681577
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1332312	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of XBP1 mRNA; sodium arsenite results in increased expression of XBP1 mRNA alternative form; sodium arsenite results in increased expression of XBP1 protein alternative form	PMID:21911445|PMID:23221991
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352787	E	RGD:6480464	20230502	CTD	MESH:C017947	sodium arsenite results in increased expression of XBP1 mRNA	PMID:36586010|PMID:38568856|PMID:39719251|PMID:39900124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	Melatonin inhibits the reaction [sodium arsenite results in increased expression of XBP1 protein]	PMID:17645694
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XBP1 mRNA; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of XBP1 protein alternative form]	PMID:21911445|PMID:40504410
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20180220	CTD	MESH:C017947	sodium arsenite promotes the reaction [[XBP1 protein binds to HIF1A protein] which binds to ACE enhancer]; sodium arsenite promotes the reaction [[XBP1 protein binds to HIF1A protein] which binds to AGT enhancer]; sodium arsenite promotes the reaction [[XBP1 protein binds to HIF1A protein] which binds to AGTR1 enhancer]; sodium arsenite promotes the reaction [XBP1 protein binds to HIF1A protein]; sodium arsenite results in increased expression of and results in increased splicing of XBP1 mRNA; XBP1 affects the reaction [sodium arsenite results in increased expression of ACE mRNA]; XBP1 affects the reaction [sodium arsenite results in increased expression of AGT mRNA]; XBP1 affects the reaction [sodium arsenite results in increased expression of AGTR1 mRNA]; XBP1 affects the reaction [sodium arsenite results in increased expression of and results in increased secretion of AGT protein modified form]; XBP1 affects the reaction [sodium arsenite results in increased expression of HIF1A protein]; XBP1 affects the reaction [sodium arsenite results in increased expression of SELE protein]; XBP1 affects the reaction [sodium arsenite results in increased secretion of CCL2 protein]; XBP1 affects the reaction [sodium arsenite results in increased secretion of CXCL8 protein]; XBP1 affects the reaction [sodium arsenite results in increased secretion of ICAM1 protein]	PMID:28973481
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D014415	Tunicamycin results in increased expression of XBP1 protein	PMID:28399139
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1332312	E	RGD:6480464	20121113	CTD	MESH:D014415	Tunicamycin results in increased expression of XBP1 mRNA; Tunicamycin results in increased expression of XBP1 mRNA alternative form; Tunicamycin results in increased expression of XBP1 protein alternative form	PMID:21321189|PMID:22414386|PMID:22509299|PMID:36030031
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20130416	CTD	MESH:D014415	Tunicamycin results in increased expression of XBP1 mRNA; Tunicamycin results in increased expression of XBP1 mRNA alternative form; Tunicamycin results in increased expression of XBP1 protein; Tunicamycin results in increased expression of XBP1 protein alternative form	PMID:22378314|PMID:22959463|PMID:23741617|PMID:27358234|PMID:29453283|PMID:32407927|PMID:36586010|PMID:39900124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29699	tunicamycin	increases splicing	EXP		E	RGD:6480464	20140513	CTD	MESH:D014415	Tunicamycin results in increased splicing of XBP1 mRNA	PMID:18477628|PMID:24291486|PMID:29956773|PMID:32574669
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29699	tunicamycin	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20160510	CTD	MESH:D014415	Tunicamycin results in increased splicing of XBP1 mRNA	PMID:16330322|PMID:20015086|PMID:20554909|PMID:22001960|PMID:25160872|PMID:25324550|PMID:29380555|PMID:33454823
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29699	tunicamycin	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20140513	CTD	MESH:D014415	Tunicamycin results in increased splicing of XBP1 mRNA	PMID:19135031|PMID:23741617|PMID:24210820|PMID:31022492|PMID:34560123|PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29699	tunicamycin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014415	ibutilide inhibits the reaction [Tunicamycin results in increased expression of XBP1 protein]; Nicotine inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]	PMID:18477628|PMID:28399139
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29699	tunicamycin	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20120412	CTD	MESH:D014415	[ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of XBP1 mRNA; [Resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of XBP1 mRNA alternative form]; Amiloride inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; Particulate Matter inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; Tunicamycin inhibits the reaction [mevastatin results in increased cleavage of XBP1 protein]	PMID:16330322|PMID:20015086|PMID:20554909|PMID:21321189|PMID:29793971
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29699	tunicamycin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20140211	CTD	MESH:D014415	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [toxoflavin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [cinnamaldehyde inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [Doxorubicin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [shikonin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [toxoflavin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; cinnamaldehyde inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; Doxorubicin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of XBP1 mRNA alternative form]; shikonin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; toxoflavin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; Tunicamycin inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA]; Tunicamycin results in increased splicing of and results in increased expression of XBP1 mRNA alternative form	PMID:17917237|PMID:24210820|PMID:24312631|PMID:32407927|PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:2979	baicalein	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:C006680	baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of XBP1 protein]	PMID:33779329
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of XBP1 mRNA	PMID:21632981|PMID:32234424
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1352787	E	RGD:6480464	20230404	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XBP1 mRNA	PMID:35641671
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of XBP1 mRNA	PMID:27858113
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29866	arsenite(3-)	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20121218	CTD	MESH:C015001	arsenite results in increased splicing of XBP1 mRNA	PMID:22215663
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20121218	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to XBP1 mRNA]; Sirolimus inhibits the reaction [arsenite results in increased splicing of XBP1 mRNA]; SLC38A2 mutant form inhibits the reaction [arsenite results in increased splicing of XBP1 mRNA]	PMID:22215663|PMID:32406909
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of XBP1 mRNA	PMID:20971185
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3020	benzalkonium chloride	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20200317	CTD	MESH:D001548	Benzalkonium Compounds results in decreased expression of XBP1 mRNA alternative form	PMID:28236482
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30304	antimony(0)	increases expression	ISO	RGD:1332312	E	RGD:6480464	20240702	CTD	MESH:D000965	Antimony results in increased expression of XBP1 protein	PMID:37858840
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30304	antimony(0)	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:D000965	4-phenylbutyric acid inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form]; [antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form; Acetylcysteine inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form]; pyrazolanthrone inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form]	PMID:40368022
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30512	silver atom	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20121113	CTD	MESH:D012834	[Silicon Dioxide analog co-treated with Silver] results in increased splicing of XBP1 mRNA	PMID:22245057
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of XBP1 mRNA	PMID:25895662
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30563	silicon dioxide	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20121113	CTD	MESH:D012822	Silicon Dioxide analog results in increased splicing of XBP1 mRNA	PMID:22245057
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20121113	CTD	MESH:D012822	[Silicon Dioxide analog co-treated with Silver] results in increased splicing of XBP1 mRNA	PMID:22245057
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of XBP1 mRNA	PMID:39826883
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1352787	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of XBP1 mRNA	PMID:19150397
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of XBP1 protein	PMID:21145380
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1332312	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of XBP1 mRNA; Arsenic Trioxide results in increased expression of XBP1 protein	PMID:24157283|PMID:34091186
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1352787	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of XBP1 mRNA; Arsenic Trioxide results in increased expression of XBP1 mRNA alternative form; Arsenic Trioxide results in increased expression of XBP1 protein	PMID:22959511|PMID:23883479
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30621	diarsenic trioxide	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased splicing of XBP1 mRNA	PMID:22922937
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of XBP1 protein]	PMID:21145380
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20231003	CTD	MESH:C006632	antimony trichloride promotes the reaction [Arsenic Trioxide results in increased expression of XBP1 protein]	PMID:34091186
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20191114	CTD	MESH:C006632	Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species]]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased splicing of XBP1 mRNA]; XBP1 protein inhibits the reaction [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species]	PMID:21138464|PMID:22922937
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30742	ethylene glycol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D019855	Ethylene Glycol results in increased expression of XBP1 mRNA	PMID:34468068
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30742	ethylene glycol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:D019855	caryophyllene inhibits the reaction [Ethylene Glycol results in increased expression of XBP1 mRNA]	PMID:34468068
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30778	gallic acid	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D005707	Gallic Acid inhibits the reaction [Cadmium results in increased expression of XBP1 mRNA]	PMID:37886005
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30816	vanillic acid	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20230704	CTD	MESH:D014641	Vanillic Acid inhibits the reaction [INS protein results in increased expression of XBP1 protein]	PMID:36764371
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:30853	glycyrrhetinic acid	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20181016	CTD	MESH:C119129	18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]	PMID:29444456
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:310312	isoliquiritigenin	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:C040920	isoliquiritigenin inhibits the reaction [Cisplatin results in increased expression of XBP1 mRNA]	PMID:37561086
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of XBP1 mRNA	PMID:16483693
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:31604	ferric ammonium citrate	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20200714	CTD	MESH:C013531	ferric ammonium citrate inhibits the reaction [Palmitic Acid results in increased expression of XBP1 protein]	PMID:32283200
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1352787	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of XBP1 mRNA	PMID:38568856
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of XBP1 mRNA	PMID:36642386
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:31781	lopinavir	increases expression	ISO	RGD:1352787	E	RGD:6480464	20260303	CTD	MESH:D061466	Lopinavir results in increased expression of XBP1 mRNA	PMID:40582629
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of XBP1 mRNA	PMID:32479839
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:32063	propylparaben	increases expression	ISO	RGD:1332312	E	RGD:6480464	20240305	CTD	MESH:C006068	propylparaben results in increased expression of XBP1 mRNA; propylparaben results in increased expression of XBP1 mRNA alternative form	PMID:36277366
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:C061133	tamibarotene results in increased expression of XBP1 mRNA	PMID:17229644
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3219	bupropion	decreases splicing	ISO	RGD:1352787	E	RGD:6480464	20120613	CTD	MESH:D016642	Bupropion results in decreased splicing of XBP1 mRNA	PMID:21354251
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332312	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of XBP1 gene	PMID:35295148
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1332312	E	RGD:6480464	20130611	CTD	MESH:C009495	titanium dioxide results in increased expression of XBP1 protein alternative form	PMID:31298478|PMID:31769605
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:32234	titanium dioxide	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20200211	CTD	MESH:C009495	titanium dioxide results in increased splicing of XBP1 mRNA	PMID:31298478|PMID:31769605
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20200211	CTD	MESH:C009495	4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased splicing of XBP1 mRNA]	PMID:31298478
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of XBP1 mRNA	PMID:34492290
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of XBP1 mRNA	PMID:18648102
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of XBP1 mRNA	PMID:20813756|PMID:23811191
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:32585	4-hydroxynon-2-enal	increases splicing	EXP		E	RGD:6480464	20140513	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased splicing of XBP1 mRNA	PMID:24291486
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3305	Calcimycin	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20141111	CTD	MESH:D000001	Calcimycin results in increased splicing of XBP1 mRNA	PMID:19428936
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3305	Calcimycin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20141111	CTD	MESH:D000001	Quercetin inhibits the reaction [Calcimycin results in increased splicing of XBP1 mRNA]	PMID:19428936
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33090	picene	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20200609	CTD	MESH:C056699	picene results in decreased expression of XBP1 mRNA	PMID:32251684
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33118	boric acid	increases expression	ISO	RGD:1352787	E	RGD:6480464	20171010	CTD	MESH:C032688	boric acid results in increased expression of XBP1 mRNA	PMID:27587023
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1332312	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of XBP1 promoter	PMID:27334623
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of XBP1 mRNA	PMID:32145629
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of XBP1 mRNA	PMID:25181051
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332312	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of XBP1 mRNA; bisphenol A results in increased expression of XBP1 protein; bisphenol A results in increased expression of XBP1 protein alternative form	PMID:33221593|PMID:36670177|PMID:38538260
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1352787	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of XBP1 mRNA; bisphenol A results in increased expression of XBP1 protein; bisphenol A results in increased expression of XBP1 protein alternative form	PMID:36306618|PMID:36670177
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20220208	CTD	MESH:C006780	[Palmitates co-treated with bisphenol A] results in increased splicing of XBP1 mRNA; Melatonin inhibits the reaction [bisphenol A results in increased expression of XBP1 protein]; Oleic Acid inhibits the reaction [[Palmitates co-treated with bisphenol A] results in increased splicing of XBP1 mRNA]; sulforaphane inhibits the reaction [bisphenol A results in increased expression of XBP1 protein alternative form]	PMID:32976987|PMID:36670177|PMID:38538260
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20240206	CTD	MESH:C006780	4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of XBP1 protein alternative form]; sulforaphane inhibits the reaction [bisphenol A results in increased expression of XBP1 protein alternative form]; XBP1 protein affects the reaction [bisphenol A results in increased expression of ITGA2 mRNA]; XBP1 protein affects the reaction [bisphenol A results in increased expression of ITGA2 protein]; XBP1 protein affects the reaction [bisphenol A results in increased phosphorylation of AKT1 protein]; XBP1 protein affects the reaction [bisphenol A results in increased phosphorylation of PIK3R1 protein]	PMID:36306618|PMID:36670177
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33336	lanthanum atom	increases expression	ISO	RGD:1352787	E	RGD:6480464	20121218	CTD	MESH:D007811	Lanthanum results in increased expression of XBP1 mRNA alternative form	PMID:18773883
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33369	cerium	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20230404	CTD	MESH:D002563	Cerium results in decreased expression of XBP1 mRNA	PMID:35641671
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:33629	aluminium(0)	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20231031	CTD	MESH:D000535	Aluminum results in decreased expression of XBP1 mRNA	PMID:37544489
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:338412	(-)-anisomycin	decreases splicing	ISO	RGD:1332312	E	RGD:6480464	20150414	CTD	MESH:D000841	Anisomycin results in decreased splicing of XBP1 mRNA	PMID:25324550
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1352787	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of XBP1 mRNA	PMID:25979313
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3390	carbaryl	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170516	CTD	MESH:D012721	Carbaryl results in increased expression of XBP1 mRNA	PMID:27829164
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34283	oxybenzone	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20250311	CTD	MESH:C005290	oxybenzone results in decreased expression of XBP1 mRNA	PMID:39343157
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1332312	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of XBP1 mRNA	PMID:37080397
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1352787	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of XBP1 gene	PMID:31601247
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332312	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of XBP1 mRNA	PMID:39298647
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1332312	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of XBP1 mRNA	PMID:26377693
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of XBP1 mRNA	PMID:27858113
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of XBP1 mRNA	PMID:31558096
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34631	chlorpyrifos	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20170516	CTD	MESH:D004390	Chlorpyrifos results in increased splicing of XBP1 mRNA	PMID:27993609
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20260602	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of XBP1 mRNA	PMID:40772592
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20260602	CTD	MESH:D016264	YTHDC1 protein inhibits the reaction [Dextran Sulfate results in decreased expression of XBP1 mRNA]	PMID:40772592
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34682	diazinon	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D003976	Diazinon results in increased expression of XBP1 mRNA	PMID:42004505
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34682	diazinon	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D003976	protocatechuic acid inhibits the reaction [Diazinon results in increased expression of XBP1 mRNA]	PMID:42004505
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of XBP1 mRNA	PMID:21266533
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1332312	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of XBP1 mRNA	PMID:21266533
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34698	diethyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of XBP1 mRNA	PMID:32341500
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1332312	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of XBP1 mRNA	PMID:34813904
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34848	mevastatin	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20170110	CTD	MESH:C012258	Tunicamycin inhibits the reaction [mevastatin results in increased cleavage of XBP1 protein]	PMID:16330322
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of XBP1 mRNA	PMID:18164116
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010269	Paraquat results in increased expression of XBP1 protein	PMID:22245251
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1352787	E	RGD:6480464	20220111	CTD	MESH:D010269	Paraquat results in increased expression of XBP1 mRNA	PMID:34097952|PMID:35641671
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D010269	Minocycline inhibits the reaction [Paraquat results in increased expression of XBP1 protein]	PMID:22245251
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of XBP1 gene	PMID:33148267
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34967	rimonabant	increases expression	ISO	RGD:1352787	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant results in increased expression of XBP1 mRNA	PMID:21525939
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20210202	CTD	MESH:D000077285	[Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of XBP1 mRNA alternative form]; Gemcitabine promotes the reaction [Rimonabant results in increased expression of XBP1 mRNA]	PMID:21525939|PMID:31054322
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352787	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of XBP1 mRNA	PMID:37042841
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35036	fentin chloride	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in increased expression of XBP1 mRNA	PMID:37156404
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of XBP1 protein alternative form; [manganese chloride results in increased abundance of Manganese] which results in increased splicing of XBP1 mRNA	PMID:32574669
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1332312	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of XBP1 mRNA	PMID:26377693
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35456	cadmium dichloride	affects activity	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases acetylation	ISO	RGD:1352787	E	RGD:6480464	20190702	CTD	MESH:D019256	Cadmium Chloride results in increased acetylation of XBP1 protein alternative form	PMID:30796460
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D019256	Cadmium Chloride results in increased expression of XBP1 mRNA; Cadmium Chloride results in increased expression of XBP1 protein	PMID:30973085|PMID:31433112
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1332312	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in increased expression of XBP1 mRNA; Cadmium Chloride results in increased expression of XBP1 mRNA alternative form; Cadmium Chloride results in increased expression of XBP1 protein; Cadmium Chloride results in increased expression of XBP1 protein alternative form	PMID:21908765|PMID:33813002|PMID:38242296
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1352787	E	RGD:6480464	20121009	CTD	MESH:D019256	Cadmium Chloride results in increased expression of XBP1 mRNA; Cadmium Chloride results in increased expression of XBP1 mRNA alternative form; Cadmium Chloride results in increased expression of XBP1 protein alternative form	PMID:19426795|PMID:29444456|PMID:30796460|PMID:33813002|PMID:38568856
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased splicing of XBP1 mRNA	PMID:17588656
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D019256	4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein]; Rutin inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 mRNA]; Rutin inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein]	PMID:30973085|PMID:31433112|PMID:38001299
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20120501	CTD	MESH:D019256	2-aminoethyl diphenylborinate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein alternative form]; [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of XBP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein alternative form; Phenylbutyrates inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 mRNA alternative form]; STF 083010 inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein alternative form]	PMID:21908765|PMID:37236586|PMID:40398541
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20181016	CTD	MESH:D019256	18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; AKT activator SC79 inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; Cadmium Chloride inhibits the reaction [SIRT1 protein binds to XBP1 protein alternative form]; KIRA6 inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; MK 2206 promotes the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; SIRT1 protein inhibits the reaction [Cadmium Chloride results in increased acetylation of XBP1 protein alternative form]; SIRT1 protein inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 mRNA alternative form]; SIRT1 protein inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; STF 083010 inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; XBP1 protein affects the reaction [Cadmium Chloride results in increased expression of CASP1 mRNA]; XBP1 protein affects the reaction [Cadmium Chloride results in increased expression of GSDMD mRNA]; XBP1 protein affects the reaction [Cadmium Chloride results in increased expression of NLRP3 mRNA]; XBP1 protein affects the reaction [Cadmium Chloride results in increased expression of PYCARD mRNA]; XBP1 protein alternative form inhibits the reaction [SIRT1 protein inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP1 protein]]; XBP1 protein alternative form inhibits the reaction [SIRT1 protein inhibits the reaction [Cadmium Chloride results in increased cleavage of IL1B protein]]; XBP1 protein alternative form inhibits the reaction [SIRT1 protein inhibits the reaction [Cadmium Chloride results in increased expression of NLRP3 protein]]	PMID:29444456|PMID:30796460|PMID:33813002
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1332312	E	RGD:6480464	20201006	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of XBP1 mRNA; perfluorooctanoic acid results in increased expression of XBP1 mRNA alternative form	PMID:32578922
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20201006	CTD	MESH:C023036	2-aminoethoxydiphenyl borate inhibits the reaction [perfluorooctanoic acid results in increased expression of XBP1 mRNA alternative form]; 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [perfluorooctanoic acid results in increased expression of XBP1 mRNA alternative form]; Dantrolene inhibits the reaction [perfluorooctanoic acid results in increased expression of XBP1 mRNA alternative form]	PMID:32578922
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1332312	E	RGD:6480464	20220111	CTD	MESH:C039281	furan results in increased expression of XBP1 protein	PMID:34450210
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of XBP1 gene	PMID:22079235
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35559	furan	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20220111	CTD	MESH:C039281	rhodioloside inhibits the reaction [furan results in increased expression of XBP1 protein]	PMID:34450210
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of XBP1 mRNA	PMID:19320972
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of XBP1 protein	PMID:21337367
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of XBP1 mRNA	PMID:24449571
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:36062	3,4-dihydroxybenzoic acid	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C009091	protocatechuic acid inhibits the reaction [Diazinon results in increased expression of XBP1 mRNA]	PMID:42004505
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3647	chlorpromazine	affects activity	EXP		E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3647	chlorpromazine	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in decreased expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:36560	zinc oxide	increases expression	ISO	RGD:1332312	E	RGD:6480464	20150714	CTD	MESH:D015034	Zinc Oxide analog results in increased expression of XBP1 mRNA	PMID:25680694
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XBP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XBP1 mRNA	PMID:32699268
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3696	cidofovir anhydrous	affects activity	ISO	RGD:1352787	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3696	cidofovir anhydrous	increases expression	ISO	RGD:1352787	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:37288	gadolinium trichloride	increases splicing	EXP		E	RGD:6480464	20120501	CTD	MESH:C038958	gadolinium chloride results in increased splicing of XBP1 mRNA	PMID:21198628
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of XBP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of XBP1 mRNA]	PMID:17585979
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:38319	usnic acid	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20150714	CTD	MESH:C073339	usnic acid results in increased splicing of XBP1 mRNA	PMID:25870318
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:38683	4-nitro-m-cresol	increases expression	ISO	RGD:1332312	E	RGD:6480464	20250204	CTD	MESH:C008636	4-nitro-3-cresol results in increased expression of XBP1 mRNA; 4-nitro-3-cresol results in increased expression of XBP1 protein	PMID:35910793
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:38683	4-nitro-m-cresol	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20250204	CTD	MESH:C008636	ESR1 protein affects the reaction [4-nitro-3-cresol results in increased expression of XBP1 protein]; RHOA protein affects the reaction [4-nitro-3-cresol results in increased expression of XBP1 mRNA]; RHOA protein affects the reaction [4-nitro-3-cresol results in increased expression of XBP1 protein]; rhosin inhibits the reaction [4-nitro-3-cresol results in increased expression of XBP1 mRNA]; rhosin inhibits the reaction [4-nitro-3-cresol results in increased expression of XBP1 protein]; XBP1 protein affects the reaction [4-nitro-3-cresol results in increased expression of IL13 protein]; XBP1 protein affects the reaction [4-nitro-3-cresol results in increased expression of IL4 protein]; XBP1 protein affects the reaction [4-nitro-3-cresol results in increased expression of IL5 protein]; XBP1 protein affects the reaction [[4-nitro-3-cresol co-treated with ERF1 protein] results in increased phosphorylation of GATA2 protein]; XBP1 protein affects the reaction [[ERF1 protein co-treated with 4-nitro-3-cresol] results in increased expression of CCL2 protein]; XBP1 protein affects the reaction [[ERF1 protein co-treated with 4-nitro-3-cresol] results in increased expression of EPX protein]; XBP1 protein affects the reaction [[ERF1 protein co-treated with 4-nitro-3-cresol] results in increased expression of IL13 protein]; XBP1 protein affects the reaction [[ERF1 protein co-treated with 4-nitro-3-cresol] results in increased expression of IL4 protein]; XBP1 protein affects the reaction [[ERF1 protein co-treated with 4-nitro-3-cresol] results in increased expression of IL5 protein]	PMID:35910793
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:38940	sunitinib	affects splicing	ISO	RGD:1332312	E	RGD:6480464	20250603	CTD	MESH:C473478	Sunitinib affects the splicing of XBP1 mRNA	PMID:39613054
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1352787	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of XBP1 mRNA	PMID:31533062
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1352787	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of XBP1 mRNA	PMID:26352163
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:39391	prallethrin	increases activity	ISO	RGD:1352787	E	RGD:6480464	20120717	CTD	MESH:C055818	d,d-T80-prallethrin results in increased activity of XBP1 protein	PMID:20143881
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of XBP1 mRNA	PMID:37955688
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of XBP1 mRNA	PMID:36331819
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20180828	CTD	MESH:D003474	Curcumin results in increased expression of XBP1 mRNA	PMID:29723631
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332312	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of XBP1 mRNA	PMID:17292431
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1352787	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of XBP1 mRNA	PMID:25979313
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of XBP1 mRNA	PMID:29154799
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:D003520	Cyclophosphamide results in increased expression of XBP1 protein alternative form	PMID:38740238
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4031	cyclosporin A	affects activity	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4031	cyclosporin A	affects activity	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1332312	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of XBP1 mRNA; Cyclosporine results in increased expression of XBP1 protein modified form	PMID:23958496|PMID:25270620
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of XBP1 mRNA; Cyclosporine results in increased expression of XBP1 protein alternative form	PMID:25596134|PMID:35033536
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4031	cyclosporin A	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20220607	CTD	MESH:D016572	Cyclosporine results in increased splicing of XBP1 mRNA	PMID:35033536
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20140114	CTD	MESH:D016572	Cyclosporine results in increased expression of and affects the localization of XBP1 protein modified form	PMID:23958496
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20220607	CTD	MESH:D016572	ATF6 protein affects the reaction [Cyclosporine results in increased expression of XBP1 protein alternative form]	PMID:35033536
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:41500	4-phenylbutyric acid	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20181016	CTD	MESH:C075773	4-phenylbutyric acid results in decreased expression of XBP1 protein alternative form	PMID:29444456|PMID:30796460
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of XBP1 protein alternative form]	PMID:20165829|PMID:33651226|PMID:34214594|PMID:38001299|PMID:40368022
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20131210	CTD	MESH:C075773	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of XBP1 protein alternative form]]; 4-phenylbutyric acid affects the reaction [LEPR gene mutant form affects the splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased splicing of XBP1 mRNA]	PMID:23274897|PMID:27578021|PMID:30602124|PMID:31298478|PMID:33771661|PMID:35413383|PMID:37692514
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20120501	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [[Amiodarone results in increased splicing of XBP1 mRNA] which results in increased expression of XBP1 mRNA alternative form]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [pexidartinib results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of XBP1 protein alternative form]	PMID:20165829|PMID:25295624|PMID:27638906|PMID:28245985|PMID:29444456|PMID:30796460|PMID:36670177|PMID:40617559
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1332312	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of XBP1 mRNA	PMID:17555576
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20240430	CTD	MESH:D003907	Dexamethasone inhibits the reaction [[Ovalbumin co-treated with aluminum sulfate] results in increased expression of XBP1 protein]	PMID:27660012
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42106	L-1,4-dithiothreitol	increases splicing	EXP		E	RGD:6480464	20230801	CTD	MESH:D004229	Dithiothreitol results in increased splicing of XBP1 mRNA	PMID:23123503
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42106	L-1,4-dithiothreitol	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20220405	CTD	MESH:D004229	Dithiothreitol results in increased splicing of XBP1 mRNA	PMID:34244458
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of XBP1 mRNA	PMID:28973697
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in increased splicing of XBP1 mRNA	PMID:17353921
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of XBP1 mRNA	PMID:24349266
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in decreased expression of XBP1 mRNA	PMID:17178593
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose deficiency results in increased expression of XBP1 protein; Glucose results in increased expression of XBP1 mRNA	PMID:21337367|PMID:34801538
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20191008	CTD	MESH:D005947	Glucose deficiency results in increased splicing of XBP1 mRNA	PMID:31022492
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D005947	Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]; Metformin inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]	PMID:34801538
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20260407	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of XBP1 protein alternative form]	PMID:39701215
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20191008	CTD	MESH:D005947	4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased splicing of XBP1 mRNA]; XBP1 mRNA alternative form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]	PMID:31022492
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4317	dantrolene	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20201006	CTD	MESH:D003620	Dantrolene inhibits the reaction [perfluorooctanoic acid results in increased expression of XBP1 mRNA alternative form]; Dantrolene inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA alternative form]	PMID:32578922
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:43355	indoxyl sulfate	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20190910	CTD	MESH:D007200	Indican results in increased splicing of XBP1 mRNA	PMID:29380555
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4356	desferrioxamine B	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20200714	CTD	MESH:D003676	Deferoxamine promotes the reaction [Palmitic Acid results in increased expression of XBP1 protein]	PMID:32283200
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of XBP1 mRNA	PMID:33512557
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20200331	CTD	MESH:D008727	[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of XBP1 mRNA; [Methotrexate co-treated with theaflavin-3,3'-digallate] results in decreased expression of and results in decreased splicing of XBP1 mRNA; Methotrexate results in decreased expression of and results in decreased splicing of XBP1 mRNA	PMID:28863153|PMID:34350509
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of XBP1 mRNA]	PMID:21233418
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D019319	Okadaic Acid results in increased expression of XBP1 protein	PMID:26732598
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:45285	pyrazinecarboxamide	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170613	CTD	MESH:D011718	Pyrazinamide results in increased expression of XBP1 mRNA alternative form	PMID:28063906
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:45409	ritonavir	increases expression	ISO	RGD:1352787	E	RGD:6480464	20260303	CTD	MESH:D019438	Ritonavir results in increased expression of XBP1 mRNA	PMID:40582629
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of XBP1 mRNA	PMID:29309887
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1352787	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of XBP1 mRNA	PMID:28542535
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1352787	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of XBP1 mRNA	PMID:24935251
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332312	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of XBP1 mRNA	PMID:17562736
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of XBP1 mRNA	PMID:33387578
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of XBP1 mRNA	PMID:21420995
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of XBP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of XBP1 mRNA]	PMID:17585979
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of XBP1 mRNA	PMID:15205334
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4659	disulfiram	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20250114	CTD	MESH:D004221	Disulfiram results in increased splicing of XBP1 mRNA	PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20250114	CTD	MESH:D004221	toxoflavin inhibits the reaction [Disulfiram results in increased splicing of XBP1 mRNA]	PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46678	amosite asbestos	increases expression	ISO	RGD:1352787	E	RGD:6480464	20161213	CTD	MESH:D017639	Asbestos, Amosite results in increased expression of XBP1 protein alternative form	PMID:23885834
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46678	amosite asbestos	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20161213	CTD	MESH:D017639	Asbestos, Amosite results in increased expression of and affects the splicing of XBP1 mRNA; BCL2L1 protein inhibits the reaction [Asbestos, Amosite results in increased expression of XBP1 protein alternative form]	PMID:23885834
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46680	serpentine asbestos	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased splicing of XBP1 mRNA	PMID:25324550
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:46680	serpentine asbestos	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased splicing of XBP1 mRNA	PMID:25324550
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XBP1 mRNA	PMID:40504410
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1332312	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of XBP1 mRNA	PMID:26934552
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20240206	CTD	MESH:C016766	sulforaphane inhibits the reaction [bisphenol A results in increased expression of XBP1 protein alternative form]	PMID:36670177
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane inhibits the reaction [bisphenol A results in increased expression of XBP1 protein alternative form]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased splicing of XBP1 mRNA]	PMID:22922937|PMID:36670177
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of XBP1 mRNA	PMID:29391264|PMID:31464424
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases splicing	ISO	RGD:1352787	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased splicing of XBP1 mRNA	PMID:19383982
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 mRNA	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1332312	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 protein alternative form	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of XBP1 mRNA	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased splicing of XBP1 mRNA	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20211109	CTD	MESH:D005944	Glucosamine results in increased splicing of XBP1 mRNA	PMID:33812996
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20190312	CTD	MESH:D005944	4-methylumbelliferone 8-carbaldehyde affects the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased splicing of XBP1 mRNA]	PMID:30602124
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; NUS1 protein inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]	PMID:20165829|PMID:33812996
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:48080	brefeldin A	increases activity	ISO	RGD:1352787	E	RGD:6480464	20150714	CTD	MESH:D020126	Brefeldin A results in increased activity of XBP1 protein	PMID:18723477
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:48080	brefeldin A	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170516	CTD	MESH:D020126	Brefeldin A results in increased expression of XBP1 protein	PMID:27358234
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:48080	brefeldin A	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20150714	CTD	MESH:D020126	bortezomib inhibits the reaction [Brefeldin A results in increased activity of XBP1 protein]	PMID:18723477
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1352787	E	RGD:6480464	20130514	CTD	MESH:D002101	Cacodylic Acid results in increased expression of XBP1 mRNA; Cacodylic Acid results in increased expression of XBP1 mRNA alternative form	PMID:23221991
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of XBP1 mRNA	PMID:18175754
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1332312	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of XBP1 mRNA	PMID:17555576|PMID:17942748
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of XBP1 mRNA	PMID:17942748
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1352787	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of XBP1 mRNA	PMID:38568856
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of XBP1 mRNA	PMID:17401462
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of XBP1 protein	PMID:21145380
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1332312	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of XBP1 mRNA; Arsenic Trioxide results in increased expression of XBP1 protein	PMID:24157283|PMID:34091186
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1352787	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of XBP1 mRNA; Arsenic Trioxide results in increased expression of XBP1 mRNA alternative form; Arsenic Trioxide results in increased expression of XBP1 protein	PMID:22959511|PMID:23883479
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:49900	arsenous acid	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased splicing of XBP1 mRNA	PMID:22922937
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of XBP1 protein]	PMID:21145380
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20231003	CTD	MESH:C032793	antimony trichloride promotes the reaction [Arsenic Trioxide results in increased expression of XBP1 protein]	PMID:34091186
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20191114	CTD	MESH:C032793	Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species]]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased splicing of XBP1 mRNA]; XBP1 protein inhibits the reaction [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species]	PMID:21138464|PMID:22922937
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:5001	fenofibrate	affects activity	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:5001	fenofibrate	affects activity	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1352787	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of XBP1 mRNA	PMID:33512557
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:50385	hemin	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20221101	CTD	MESH:D006427	Hemin results in increased splicing of XBP1 mRNA	PMID:35341795
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:50594	carbon nanotube	decreases splicing	ISO	RGD:1352787	E	RGD:6480464	20190219	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased splicing of XBP1 mRNA	PMID:30138652
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332312	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of XBP1 mRNA; Nanotubes, Carbon results in increased expression of XBP1 mRNA	PMID:25554681|PMID:25620056
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1352787	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of XBP1 mRNA; Nanotubes, Carbon results in increased expression of XBP1 mRNA alternative form	PMID:25511174|PMID:30802478|PMID:31047983|PMID:32493873
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:50694	minocycline	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D008911	Minocycline inhibits the reaction [Paraquat results in increased expression of XBP1 protein]	PMID:22245251
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:50730	montelukast	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20240430	CTD	MESH:C093875	montelukast inhibits the reaction [[Ovalbumin co-treated with aluminum sulfate] results in increased expression of XBP1 mRNA]; montelukast inhibits the reaction [[Ovalbumin co-treated with aluminum sulfate] results in increased expression of XBP1 protein]	PMID:27660012
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:50859	bexarotene	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in decreased expression of XBP1 mRNA	PMID:17178900
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:50924	sorafenib	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:C471405	sorafenib results in increased splicing of XBP1 mRNA	PMID:17548474
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of XBP1 mRNA	PMID:24136188
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1332312	E	RGD:6480464	20241105	CTD	MESH:D005485	Flutamide results in increased expression of XBP1 mRNA	PMID:32662666
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of XBP1 mRNA	PMID:27858113
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of XBP1 mRNA	PMID:27858113
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:52172	nilotinib	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170228	CTD	MESH:C498826	nilotinib results in increased expression of XBP1 mRNA alternative form	PMID:23883479
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:52717	bortezomib	increases activity	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased activity of XBP1 protein	PMID:18723477
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1352787	E	RGD:6480464	20220510	CTD	MESH:D000069286	Bortezomib results in increased expression of XBP1 protein alternative form	PMID:22262760
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:52717	bortezomib	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:D000069286	[ricolinostat co-treated with Bortezomib] results in increased expression of XBP1 protein alternative form; Bortezomib inhibits the reaction [Brefeldin A results in increased activity of XBP1 protein]	PMID:18723477|PMID:22262760
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:52722	lactacystin	decreases response to substance	ISO	RGD:1352787	E	RGD:6480464	20130514	CTD	MESH:C067713	XBP1 protein results in decreased susceptibility to lactacystin	PMID:19135031
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:53509	erlotinib hydrochloride	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069347	Erlotinib Hydrochloride results in increased expression of XBP1 protein modified form	PMID:24768708
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:5801	hydroxychloroquine	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20200331	CTD	MESH:D006886	[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of XBP1 mRNA	PMID:28863153
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:5855	ibuprofen	affects activity	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:5856	Ibutilide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C067192	ibutilide inhibits the reaction [Tunicamycin results in increased expression of XBP1 protein]	PMID:28399139
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:5864	ifosfamide	affects activity	ISO	RGD:1352787	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:59219	ceruletide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D002108	Ceruletide results in increased expression of XBP1 mRNA alternative form; Ceruletide results in increased expression of XBP1 protein alternative form	PMID:26873426
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:59219	ceruletide	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D002108	Dietary Fats promotes the reaction [Ceruletide results in increased expression of XBP1 mRNA alternative form]; Dietary Fats promotes the reaction [Ceruletide results in increased expression of XBP1 protein alternative form]; Quercetin inhibits the reaction [Ceruletide results in increased expression of XBP1 mRNA alternative form]; Quercetin inhibits the reaction [Ceruletide results in increased expression of XBP1 protein alternative form]	PMID:26873426
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:60799	esketamine	increases expression	ISO	RGD:1352787	E	RGD:6480464	20240702	CTD	MESH:C000629870	Esketamine results in increased expression of XBP1 mRNA	PMID:38219984
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1332312	E	RGD:6480464	20150127	CTD	MESH:D016559	Tacrolimus results in increased expression of XBP1 mRNA	PMID:25270620
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:61057	tacrolimus hydrate	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20140114	CTD	MESH:D016559	Tacrolimus results in increased expression of and affects the localization of XBP1 protein modified form	PMID:23958496
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6121	ketamine	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20221206	CTD	MESH:D007649	Ketamine affects the expression of and affects the splicing of XBP1 mRNA	PMID:35728656
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:63041	manganese(II) chloride	increases splicing	EXP		E	RGD:6480464	20140408	CTD	MESH:C025340	manganese chloride results in increased splicing of XBP1 mRNA	PMID:23948121
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of XBP1 protein alternative form; [manganese chloride results in increased abundance of Manganese] which results in increased splicing of XBP1 mRNA; manganese chloride results in increased expression of and results in increased splicing of XBP1 mRNA; SNCA protein promotes the reaction [manganese chloride results in increased expression of and results in increased splicing of XBP1 mRNA]	PMID:23934647|PMID:32574669
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6382	Lasiocarpine	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of XBP1 mRNA	PMID:40054833
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:63952	arsenic trichloride	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20231003	CTD	MESH:C050510	[arsenic trichloride co-treated with antimony trichloride] results in increased expression of XBP1 mRNA; arsenic trichloride inhibits the reaction [antimony trichloride results in increased expression of XBP1 protein]	PMID:34091186
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1352787	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of XBP1 mRNA; leflunomide results in increased expression of XBP1 protein alternative form	PMID:28988120
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases response to substance	ISO	RGD:1352787	E	RGD:6480464	20130514	CTD	MESH:D015655	XBP1 protein results in decreased susceptibility to 1-Methyl-4-phenylpyridinium	PMID:19135031
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of XBP1 mRNA	PMID:24810058
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6413	letrozole	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C067431	Letrozole results in increased expression of XBP1 mRNA	PMID:33491863
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6413	letrozole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C067431	ADM protein inhibits the reaction [Letrozole results in increased expression of XBP1 mRNA]	PMID:33491863
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1352787	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of XBP1 mRNA	PMID:22079614
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6482	linuron	decreases response to substance	ISO	RGD:1332312	E	RGD:6480464	20210112	CTD	MESH:D008044	XBP1 gene mutant form results in decreased susceptibility to Linuron	PMID:30661753
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6482	linuron	increases activity	ISO	RGD:1332312	E	RGD:6480464	20210112	CTD	MESH:D008044	Linuron results in increased activity of XBP1 protein	PMID:30661753
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6482	linuron	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20210112	CTD	MESH:D008044	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of XBP1 protein modified form]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased splicing of XBP1 mRNA]; [IL1B protein co-treated with TNF protein co-treated with Linuron] promotes the reaction [XBP1 protein binds to NOS2 promoter]; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of XBP1 protein modified form; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased splicing of XBP1 mRNA; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of ARG1 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL1 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL20 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCR2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CSF2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of HIF1A mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IFNG mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL13 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL1B mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL23A mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL5 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL6 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of MMP12 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of NOS2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of TLR5 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of TNF mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of AHR mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of ARNT mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of CNTF mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of CSPG4 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of CXCL12 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of CYP1B1 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of ENTPD1 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IFNAR1 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IL10 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IRF3 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IRF7 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IRF9 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of LIF mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of TGFB2 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of TGFB3 mRNA]	PMID:30661753
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6482	linuron	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20210112	CTD	MESH:D008044	STF 083010 inhibits the reaction [[Linuron co-treated with IL1B protein co-treated with TNF protein] results in increased splicing of XBP1 mRNA]	PMID:30661753
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:65347	carfilzomib	increases expression	ISO	RGD:1352787	E	RGD:6480464	20250506	CTD	MESH:C524865	carfilzomib results in increased expression of XBP1 protein alternative form	PMID:39645617
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:65347	carfilzomib	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20250506	CTD	MESH:C524865	Canagliflozin inhibits the reaction [carfilzomib results in increased expression of XBP1 protein alternative form]	PMID:39645617
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:66262	trierixin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20180828	CTD	MESH:C525271	trierixin inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA]; trierixin inhibits the reaction [Thapsigargin results in increased splicing of XBP1 mRNA]	PMID:17917237
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:67271	MK-2206	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20181016	CTD	MESH:C548887	MK 2206 promotes the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]	PMID:29444456
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6801	metformin	affects activity	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin affects the activity of XBP1 protein	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6801	metformin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin affects the expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D008687	Metformin inhibits the reaction [Glucose results in increased expression of XBP1 mRNA]	PMID:34801538
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20210907	CTD	MESH:D008687	Metformin inhibits the reaction [Rotenone results in increased expression of XBP1 mRNA]	PMID:32189544
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of XBP1 mRNA; Metformin inhibits the reaction [INS protein results in increased expression of XBP1 protein]	PMID:29309887|PMID:36764371
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of XBP1 mRNA; Methamphetamine results in increased expression of XBP1 mRNA alternative form; Methamphetamine results in increased expression of XBP1 protein alternative form	PMID:19564919|PMID:28070110|PMID:34214594
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1332312	E	RGD:6480464	20180220	CTD	MESH:D008694	Methamphetamine results in increased expression of XBP1 protein	PMID:27323860
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1352787	E	RGD:6480464	20180220	CTD	MESH:D008694	Methamphetamine results in increased expression of XBP1 mRNA; Methamphetamine results in increased expression of XBP1 protein; Methamphetamine results in increased expression of XBP1 protein alternative form	PMID:27323860|PMID:38901802
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of XBP1 protein alternative form]; Melatonin inhibits the reaction [Methamphetamine results in increased expression of XBP1 mRNA alternative form]; Methamphetamine results in increased expression of and results in increased splicing of XBP1 mRNA; SCH 23390 inhibits the reaction [Methamphetamine results in increased splicing of XBP1 mRNA]	PMID:19564919|PMID:28070110|PMID:34214594
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20180220	CTD	MESH:D008694	ATF6 protein affects the reaction [Methamphetamine results in increased expression of XBP1 mRNA]; ATF6 protein affects the reaction [Methamphetamine results in increased expression of XBP1 protein]; STIM1 protein affects the reaction [Methamphetamine results in increased expression of XBP1 protein alternative form]	PMID:27323860|PMID:38901802
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:68352	quercetin 3-O-beta-D-glucopyranoside	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C016527	isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XBP1 protein]	PMID:38001299
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:69120	withaferin A	increases expression	ISO	RGD:1352787	E	RGD:6480464	20130806	CTD	MESH:C009684	withaferin A results in increased expression of XBP1 protein	PMID:21266191
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:69120	withaferin A	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20130806	CTD	MESH:C009684	withaferin A results in increased splicing of XBP1 mRNA	PMID:21266191
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1332312	E	RGD:6480464	20211012	CTD	MESH:C057862	cyanoginosin LR results in increased expression of XBP1 protein alternative form	PMID:33290805
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:6925	microcystin-LR	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20211012	CTD	MESH:C057862	4-methylumbelliferone 8-carbaldehyde inhibits the reaction [cyanoginosin LR results in increased expression of XBP1 protein alternative form]; ERN1 protein affects the reaction [cyanoginosin LR results in increased expression of XBP1 protein alternative form]	PMID:33290805
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:69355	casticin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170516	CTD	MESH:C054133	casticin results in increased expression of XBP1 mRNA	PMID:27862857
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:69477	cannabigerol	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20250401	CTD	MESH:C037036	cannabigerol results in increased splicing of XBP1 mRNA	PMID:38748041
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1332312	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol results in increased expression of XBP1 mRNA	PMID:32033040
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20210209	CTD	MESH:D002185	[Dronabinol co-treated with Cannabidiol] results in increased expression of XBP1 mRNA	PMID:26504004
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of XBP1 gene	PMID:33148267
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1352787	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of XBP1 mRNA	PMID:31758290
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:73274	canagliflozin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20250506	CTD	MESH:D000068896	Canagliflozin inhibits the reaction [carfilzomib results in increased expression of XBP1 protein alternative form]	PMID:39645617
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 inhibits the reaction [Methamphetamine results in increased splicing of XBP1 mRNA]	PMID:19564919
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:74460	5-chloro-7-iodoquinolin-8-ol	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20230404	CTD	MESH:D007464	Clioquinol affects the splicing of and results in decreased expression of XBP1 mRNA alternative form	PMID:36396104
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:74768	aluminium sulfate (anhydrous)	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20240430	CTD	MESH:C041524	[Ovalbumin co-treated with aluminum sulfate] results in increased expression of XBP1 mRNA; [Ovalbumin co-treated with aluminum sulfate] results in increased expression of XBP1 protein; Dexamethasone inhibits the reaction [[Ovalbumin co-treated with aluminum sulfate] results in increased expression of XBP1 protein]; Gu-Ben-Fang-Xiao decoction inhibits the reaction [[Ovalbumin co-treated with aluminum sulfate] results in increased expression of XBP1 mRNA]; Gu-Ben-Fang-Xiao decoction inhibits the reaction [[Ovalbumin co-treated with aluminum sulfate] results in increased expression of XBP1 protein]; montelukast inhibits the reaction [[Ovalbumin co-treated with aluminum sulfate] results in increased expression of XBP1 mRNA]; montelukast inhibits the reaction [[Ovalbumin co-treated with aluminum sulfate] results in increased expression of XBP1 protein]	PMID:27660012
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:74856	antimony trichloride	increases expression	ISO	RGD:1332312	E	RGD:6480464	20231003	CTD	MESH:C054672	antimony trichloride results in increased expression of XBP1 mRNA; antimony trichloride results in increased expression of XBP1 protein	PMID:34091186
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:74856	antimony trichloride	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:C054672	4-phenylbutyric acid inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form]; [antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form; Acetylcysteine inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form]; pyrazolanthrone inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form]	PMID:40368022
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:74856	antimony trichloride	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20231003	CTD	MESH:C054672	[arsenic trichloride co-treated with antimony trichloride] results in increased expression of XBP1 mRNA; antimony trichloride promotes the reaction [Arsenic Trioxide results in increased expression of XBP1 protein]; arsenic trichloride inhibits the reaction [antimony trichloride results in increased expression of XBP1 protein]	PMID:34091186
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:748790	exenatide	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20260714	CTD	MESH:D000077270	Exenatide inhibits the reaction [Dietary Fats results in increased splicing of XBP1 mRNA]	PMID:30253173
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:748790	exenatide	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20260714	CTD	MESH:D000077270	Exenatide inhibits the reaction [Palmitates results in increased splicing of XBP1 mRNA]	PMID:30253173
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:74926	patulin	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20150414	CTD	MESH:D010365	Patulin results in increased splicing of XBP1 mRNA	PMID:21844328|PMID:25577197
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:7494	nefazodone	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20170516	CTD	MESH:C051752	nefazodone results in increased splicing of XBP1 mRNA	PMID:27613715
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:75092	morin	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C008548	morin inhibits the reaction [Cadmium results in increased splicing of XBP1 mRNA]	PMID:38238535
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases response to substance	ISO	RGD:1352787	E	RGD:6480464	20130903	CTD	MESH:C072553	XBP1 protein results in decreased susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde	PMID:19135031
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1352787	E	RGD:6480464	20220510	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of XBP1 protein alternative form	PMID:27638906
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20150714	CTD	MESH:C072553	4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of XBP1 protein alternative form]; [XBP1 mutant form co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] inhibits the reaction [Tobacco Smoke Pollution analog results in increased phosphorylation of EIF2S1 protein]; [XBP1 mutant form co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] promotes the reaction [Tobacco Smoke Pollution analog results in increased cleavage of CASP3 protein]	PMID:25568320|PMID:27638906
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:7549	N(gamma)-nitro-L-arginine methyl ester	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20250902	CTD	MESH:D019331	[NG-Nitroarginine Methyl Ester co-treated with Dietary Fats] results in decreased splicing of XBP1 mRNA; imeglimin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with Dietary Fats] results in decreased splicing of XBP1 mRNA]	PMID:34375928
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt results in increased expression of and results in increased cleavage of XBP1 mRNA; TP53 protein affects the reaction [eprenetapopt results in increased expression of and results in increased cleavage of XBP1 mRNA]	PMID:19946333
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1352787	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of XBP1 protein	PMID:31285264
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20260714	CTD	MESH:C575881	imeglimin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with Dietary Fats] results in decreased splicing of XBP1 mRNA]	PMID:34375928
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:759101	me-344	increases expression	ISO	RGD:1352787	E	RGD:6480464	20260714	CTD	MESH:C000597890	ME-344 results in increased expression of XBP1 mRNA; ME-344 results in increased expression of XBP1 protein	PMID:31227482
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:77012	methylseleninic acid	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased splicing of XBP1 mRNA	PMID:16205645|PMID:28161410
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of XBP1 mRNA	PMID:18164116
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of XBP1 mRNA	PMID:30559759
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:77543	ebselen	increases phosphorylation	EXP		E	RGD:6480464	20161025	CTD	MESH:C042986	ebselen results in increased phosphorylation of XBP1 protein	PMID:27282967
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of XBP1 mRNA; dorsomorphin inhibits the reaction [pachymic acid results in increased expression of XBP1 protein]	PMID:27188386|PMID:35524978
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:7959	D-penicillamine	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D010396	Penicillamine results in increased splicing of XBP1 mRNA	PMID:19722195
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to XBP1 gene]	PMID:28238834
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:80043	Nodularin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20161115	CTD	MESH:C063998	nodularin results in increased expression of XBP1 mRNA alternative form	PMID:27061667
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:80491	pinostrobin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20240109	CTD	MESH:C411294	pinostrobin results in increased expression of XBP1 mRNA	PMID:37777166
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1332312	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of XBP1 mRNA	PMID:23091169
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1332312	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in increased expression of XBP1 mRNA	PMID:25270620
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:80729	toxoflavin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20250114	CTD	MESH:C009570	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [toxoflavin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [toxoflavin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; toxoflavin inhibits the reaction [Deoxyglucose results in increased splicing of XBP1 mRNA]; toxoflavin inhibits the reaction [Disulfiram results in increased splicing of XBP1 mRNA]; toxoflavin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]	PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:80774	tauroursodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C031655	ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]	PMID:20165829
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:80774	tauroursodeoxycholic acid	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20170207	CTD	MESH:C031655	ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; ursodoxicoltaurine inhibits the reaction [pachymic acid results in increased expression of XBP1 protein]	PMID:20165829|PMID:35524978
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:80885	Pachymic acid	increases expression	ISO	RGD:1352787	E	RGD:6480464	20230307	CTD	MESH:C102487	pachymic acid results in increased expression of XBP1 mRNA; pachymic acid results in increased expression of XBP1 protein	PMID:35524978
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:80885	Pachymic acid	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20230307	CTD	MESH:C102487	dorsomorphin inhibits the reaction [pachymic acid results in increased expression of XBP1 protein]; ursodoxicoltaurine inhibits the reaction [pachymic acid results in increased expression of XBP1 protein]	PMID:35524978
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81068	Shikonin	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:C016101	MKC8866 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of XBP1 protein alternative form]]; shikonin inhibits the reaction [Glutamic Acid results in increased expression of XBP1 protein alternative form]	PMID:35028790
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81068	Shikonin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20250114	CTD	MESH:C016101	Acetylcysteine inhibits the reaction [shikonin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; shikonin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]	PMID:35840659
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1332312	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of XBP1 mRNA	PMID:22434021
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1352787	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of XBP1 mRNA	PMID:21601586
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1332312	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of XBP1 mRNA	PMID:38648751
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1332312	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of XBP1 mRNA	PMID:30294300
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of XBP1 mRNA; 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of XBP1 mRNA; 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of XBP1 mRNA modified form	PMID:19095052|PMID:22543052
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:C511295	ERN1 protein affects the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of XBP1 mRNA modified form]	PMID:22543052
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81708	Sodium iodate	affects response to substance	ISO	RGD:1332312	E	RGD:6480464	20220405	CTD	MESH:C032285	XBP1 protein affects the susceptibility to sodium iodate	PMID:24053669
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81708	Sodium iodate	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20220405	CTD	MESH:C032285	sodium iodate results in increased splicing of XBP1 mRNA	PMID:24053669
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1352787	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of XBP1 mRNA	PMID:33512557
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1332312	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of XBP1 mRNA	PMID:31558096
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20200609	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of XBP1 mRNA	PMID:32251684
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:82445	Dibromoacetonitrile	decreases splicing	ISO	RGD:1332312	E	RGD:6480464	20240806	CTD	MESH:C051715	dibromoacetonitrile results in decreased splicing of XBP1 protein	PMID:38065397
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:82538	Sunset Yellow FCF	increases expression	ISO	RGD:1332312	E	RGD:6480464	20250506	CTD	MESH:C005842	6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt results in increased expression of XBP1 mRNA	PMID:33063357
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of XBP1 mRNA	PMID:33512557
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:8346	potassium iodide	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20140610	CTD	MESH:D011193	Potassium Iodide inhibits the reaction [Sodium Fluoride results in increased splicing of XBP1 mRNA]	PMID:24231001
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1332312	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate analog results in increased expression of XBP1 mRNA; sodium arsenate analog results in increased expression of XBP1 mRNA alternative form	PMID:23221991
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:8450	procymidone	increases expression	ISO	RGD:1332312	E	RGD:6480464	20230704	CTD	MESH:C035988	procymidone results in increased expression of XBP1 mRNA	PMID:35913088
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of XBP1 mRNA	PMID:36038036
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:88542	Butylparaben	increases expression	ISO	RGD:1332312	E	RGD:6480464	20240305	CTD	MESH:C038091	butylparaben results in increased expression of XBP1 mRNA; butylparaben results in increased expression of XBP1 mRNA alternative form	PMID:36277366
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:8863	Riluzole	increases expression	ISO	RGD:1352787	E	RGD:6480464	20200331	CTD	MESH:D019782	Riluzole results in increased expression of XBP1 protein	PMID:30280407
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9009	Salidroside	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20220111	CTD	MESH:C009172	rhodioloside inhibits the reaction [furan results in increased expression of XBP1 protein]	PMID:34450210
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased expression of XBP1 protein alternative form]	PMID:40368022
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:90724	AM-251	increases expression	ISO	RGD:1352787	E	RGD:6480464	20170303	CTD	MESH:C103505	AM 251 results in increased expression of XBP1 mRNA	PMID:16500647
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of XBP1 mRNA	PMID:27188386
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9123	sertraline	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20140909	CTD	MESH:D020280	Sertraline results in increased splicing of XBP1 mRNA	PMID:24865413
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9141	silver(0)	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20121113	CTD	MESH:D012834	[Silicon Dioxide analog co-treated with Silver] results in increased splicing of XBP1 mRNA	PMID:22245057
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9150	simvastatin	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in decreased expression of XBP1 protein	PMID:18807172
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20121218	CTD	MESH:D020123	Sirolimus inhibits the reaction [arsenite results in increased splicing of XBP1 mRNA]	PMID:22215663
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:92519	1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20210112	CTD	MESH:C093337	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of XBP1 protein modified form]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased splicing of XBP1 mRNA]	PMID:30661753
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in decreased expression of XBP1 mRNA alternative form; Bilirubin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of XBP1 mRNA alternative form]; moutan cortex inhibits the reaction [Streptozocin results in increased expression of and results in increased secretion of XBP1 protein alternative form]; Streptozocin results in increased expression of and results in increased secretion of XBP1 protein alternative form	PMID:27664441|PMID:37054934
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20211109	CTD	MESH:D013311	[Dietary Fats co-treated with Streptozocin] results in increased splicing of XBP1 mRNA; NUS1 protein inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased splicing of XBP1 mRNA]	PMID:33812996
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9334	sulfasalazine	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20200331	CTD	MESH:D012460	[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of XBP1 mRNA	PMID:28863153
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1352787	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of XBP1 mRNA	PMID:11906190
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1352787	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of XBP1 mRNA	PMID:31863870
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1332312	E	RGD:6480464	20190910	CTD	MESH:D013605	T-2 Toxin results in increased expression of XBP1 protein alternative form	PMID:31170431
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20190910	CTD	MESH:D013605	T-2 Toxin results in increased expression of XBP1 protein alternative form	PMID:31170431
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:94686	orlistat	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20170808	CTD	MESH:C055122	orlistat affects the reaction [ERN1 protein affects the splicing of XBP1 mRNA]	PMID:17283163
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1352787	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of XBP1 mRNA	PMID:38568856
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:95073	ricolinostat	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20240702	CTD	MESH:C572255	[ricolinostat co-treated with Bortezomib] results in increased expression of XBP1 protein alternative form	PMID:22262760
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D019284	Thapsigargin affects the localization of XBP1 protein	PMID:16338971
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	affects splicing	ISO	RGD:1352787	E	RGD:6480464	20161213	CTD	MESH:D019284	Thapsigargin affects the splicing of XBP1 mRNA	PMID:23885834
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	decreases response to substance	ISO	RGD:1352787	E	RGD:6480464	20130514	CTD	MESH:D019284	XBP1 protein results in decreased susceptibility to Thapsigargin	PMID:19135031
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	increases activity	ISO	RGD:1352787	E	RGD:6480464	20130611	CTD	MESH:D019284	Thapsigargin results in increased activity of XBP1 protein	PMID:20816668|PMID:23383089
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	increases cleavage	ISO	RGD:1352787	E	RGD:6480464	20181016	CTD	MESH:D019284	Thapsigargin results in increased cleavage of XBP1 mRNA	PMID:19946333
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1332312	E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in increased expression of XBP1 mRNA; Thapsigargin results in increased expression of XBP1 mRNA alternative form; Thapsigargin results in increased expression of XBP1 protein	PMID:20589738|PMID:22509299|PMID:23576437|PMID:32578922
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1352787	E	RGD:6480464	20140211	CTD	MESH:D019284	Thapsigargin results in increased expression of XBP1 mRNA; Thapsigargin results in increased expression of XBP1 mRNA alternative form; Thapsigargin results in increased expression of XBP1 protein; Thapsigargin results in increased expression of XBP1 protein alternative form	PMID:17917237|PMID:18773883|PMID:22378314|PMID:23576437|PMID:23741617|PMID:25289770|PMID:27358234|PMID:27587023|PMID:29453283|PMID:30796460|PMID:32407927|PMID:35033536
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	increases splicing	EXP		E	RGD:6480464	20150714	CTD	MESH:D019284	Thapsigargin results in increased splicing of XBP1 mRNA	PMID:18477628|PMID:23123503|PMID:24638036
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	increases splicing	ISO	RGD:1332312	E	RGD:6480464	20150414	CTD	MESH:D019284	Thapsigargin results in increased splicing of XBP1 mRNA	PMID:25324550
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	increases splicing	ISO	RGD:1352787	E	RGD:6480464	20160315	CTD	MESH:D019284	Thapsigargin results in increased splicing of XBP1 mRNA	PMID:17353921|PMID:17917237|PMID:19428936|PMID:25164867|PMID:25324550|PMID:25616597|PMID:29126784|PMID:35033536|PMID:38748041
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1332312	E	RGD:6480464	20121113	CTD	MESH:D019284	1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Thapsigargin results in increased expression of XBP1 protein]; Dantrolene inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA alternative form]; PTPN1 gene mutant form promotes the reaction [Thapsigargin results in increased expression of XBP1 mRNA]; Thapsigargin inhibits the reaction [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form]]; XBP1 gene mutant form inhibits the reaction [Thapsigargin results in increased expression of SIRT7 mRNA]; XBP1 gene mutant form inhibits the reaction [Thapsigargin results in increased expression of SIRT7 protein]	PMID:22509299|PMID:23576437|PMID:24210820|PMID:29414781|PMID:32578922
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1352787	E	RGD:6480464	20160315	CTD	MESH:D019284	1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Thapsigargin results in increased expression of XBP1 protein]; BCL2L1 protein inhibits the reaction [Thapsigargin results in increased expression of XBP1 protein alternative form]; icaritin inhibits the reaction [Thapsigargin results in increased expression of XBP1 protein]; Luteolin inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA alternative form]; MKC9989 inhibits the reaction [Thapsigargin results in increased splicing of XBP1 mRNA]; mycotrienin II inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA]; trienomycin A inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA]; trierixin inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA]; trierixin inhibits the reaction [Thapsigargin results in increased splicing of XBP1 mRNA]; Tunicamycin inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA]	PMID:17917237|PMID:23576437|PMID:23885834|PMID:25164867|PMID:32407927|PMID:36372277
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of XBP1 mRNA	PMID:25596134
1303073	Xbp1	X-box binding protein 1	gene	CHEBI:9763	trovafloxacin	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in increased expression of XBP1 mRNA	PMID:24136188
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1354312	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of EDEM2 mRNA	PMID:33167477
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332424	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EDEM2 mRNA	PMID:39241906
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1332424	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of EDEM2 mRNA	PMID:39298647
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1354312	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of EDEM2 mRNA	PMID:38568856
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of EDEM2 mRNA	PMID:33387578
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1332424	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of EDEM2 mRNA	PMID:33848595
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332424	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EDEM2 mRNA	PMID:33754040
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of EDEM2 mRNA	PMID:26577399
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1354312	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of EDEM2 intron	PMID:30157460
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of EDEM2 mRNA	PMID:39836092
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1354312	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EDEM2 intron	PMID:30157460
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1332424	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EDEM2 mRNA	PMID:19770486
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EDEM2 mRNA	PMID:39836092
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of EDEM2 mRNA	PMID:23557933
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EDEM2 mRNA	PMID:22298810
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332424	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EDEM2 mRNA	PMID:21570461
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EDEM2 mRNA	PMID:32109520
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EDEM2 mRNA	PMID:33387578
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1332424	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of EDEM2 mRNA	PMID:23186747
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1354312	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EDEM2 mRNA	PMID:30851411
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1354312	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of EDEM2 mRNA	PMID:38568856
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EDEM2 mRNA	PMID:39836092
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1354312	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of EDEM2 mRNA	PMID:22378314
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1354312	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EDEM2 intron	PMID:30157460
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1354312	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EDEM2 promoter	PMID:27901495
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of EDEM2 gene	PMID:31601247
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of EDEM2 mRNA	PMID:24136188
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332424	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EDEM2 gene	PMID:35295148
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of EDEM2 mRNA	PMID:34492290
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1332424	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of EDEM2 mRNA	PMID:23811191
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1354312	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of EDEM2 mRNA	PMID:30903817
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1354312	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of EDEM2 gene	PMID:31601247
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EDEM2 mRNA	PMID:25181051
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EDEM2 mRNA	PMID:36041667
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of EDEM2 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EDEM2 mRNA	PMID:28628672|PMID:31601247
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332424	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of EDEM2 mRNA	PMID:40203079
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EDEM2 mRNA	PMID:36041667
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1354312	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of EDEM2 intron	PMID:30157460
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EDEM2 mRNA	PMID:36041667
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EDEM2 mRNA	PMID:28628672
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332424	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EDEM2 mRNA	PMID:37019170
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1332424	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of EDEM2 mRNA	PMID:34813904
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EDEM2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EDEM2 mRNA	PMID:28628672
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1354312	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EDEM2 mRNA	PMID:37042841
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of EDEM2 mRNA	PMID:30589522
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of EDEM2 mRNA	PMID:39836092
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EDEM2 mRNA	PMID:24386269
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1354312	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of EDEM2 mRNA	PMID:24449571
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1332424	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of EDEM2 mRNA	PMID:17585979
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1354312	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EDEM2 mRNA	PMID:31533062
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1354312	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of EDEM2 mRNA	PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1354312	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of EDEM2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EDEM2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EDEM2 mRNA	PMID:28628672
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of EDEM2 mRNA	PMID:24136188
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EDEM2 mRNA	PMID:39836092
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in decreased expression of EDEM2 mRNA	PMID:31464424
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EDEM2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EDEM2 mRNA	PMID:28628672
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1354312	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of EDEM2 mRNA	PMID:39836092
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1354312	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of EDEM2 intron	PMID:30157460
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332424	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EDEM2 mRNA	PMID:22206623
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1354312	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EDEM2 mRNA	PMID:30851411
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1332424	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of EDEM2 mRNA	PMID:30294300
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of EDEM2 mRNA	PMID:19281266
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1354312	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EDEM2 mRNA	PMID:38568856
1303074	Edem2	ER degradation enhancing alpha-mannosidase like protein 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EDEM2 mRNA	PMID:23034163
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:10022	deoxynivalenol	affects phosphorylation	ISO	RGD:1552591	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol affects the phosphorylation of HSP90AB1 protein	PMID:23811945
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:10033	warfarin	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in decreased expression of HSP90AB1 mRNA	PMID:20493250
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of HSP90AB1 protein	PMID:36252740
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:15354	choline	affects expression	ISO	RGD:1346893	E	RGD:6480464	20151110	CTD	MESH:D002794	Choline affects the expression of HSP90AB1 mRNA	PMID:17616785
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in decreased expression of HSP90AB1 mRNA	PMID:15498508|PMID:17218384
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases acetylation	ISO	RGD:1346893	E	RGD:6480464	20171010	CTD	MESH:D014212	Tretinoin results in increased acetylation of HSP90AB1 protein	PMID:28053092
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1346893	E	RGD:6480464	20260804	CTD	MESH:D014212	Tretinoin results in increased expression of HSP90AB1 mRNA	PMID:38091671
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:15384	limonene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C008281	limonene results in increased expression of HSP90AB1 mRNA	PMID:12815608
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:15545	prostaglandin A1	increases metabolic processing	ISO	RGD:1552591	E	RGD:6480464	20120501	CTD	MESH:C100573	prostaglandin A1 analog results in increased metabolism of HSP90AB1 protein	PMID:19800325
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1346893	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HSP90AB1 mRNA	PMID:26079696
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:15843	arachidonic acid	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20161213	CTD	MESH:D016718	Arachidonic Acid results in decreased expression of HSP90AB1 mRNA	PMID:16623957
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1346893	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of HSP90AB1 mRNA	PMID:22378314
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D003634	DDT results in decreased expression of HSP90AB1 mRNA	PMID:19797855
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16151	3,4-dihydrocoumarin	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:C026308	3,4-dihydrocoumarin results in decreased expression of HSP90AB1 mRNA	PMID:22016648
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in increased expression of HSP90AB1 mRNA	PMID:16784954
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of HSP90AB1 mRNA	PMID:30319688
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D011794	Quercetin results in decreased expression of HSP90AB1 mRNA; Quercetin results in decreased expression of HSP90AB1 protein	PMID:11318950|PMID:17103110|PMID:18095365
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of HSP90AB1 protein	PMID:19207037
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in decreased expression of HSP90AB1 mRNA	PMID:17023530
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1552591	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of HSP90AB1 mRNA	PMID:17023530
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552591	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HSP90AB1 mRNA	PMID:15919760|PMID:39241906
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20161228	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of HSP90AB1 mRNA; [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSP90AB1 mRNA	PMID:22777745|PMID:35877022
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of HSP90AB1 mRNA]	PMID:39241906
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1346893	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of HSP90AB1 mRNA	PMID:22574217
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of HSP90AB1 protein	PMID:32145629
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1346893	E	RGD:6480464	20151110	CTD	MESH:D004958	Estradiol results in increased expression of HSP90AB1 mRNA	PMID:15223131|PMID:16514628
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552591	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of HSP90AB1 mRNA	PMID:39298647
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20151110	CTD	MESH:D004958	ESR1 protein affects the reaction [Estradiol results in increased expression of HSP90AB1 mRNA]	PMID:15223131
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:165219	PCB138	affects expression	ISO	RGD:1346893	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl affects the expression of HSP90AB1 mRNA	PMID:21703328
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HSP90AB1 protein	PMID:21673325
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1346893	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of HSP90AB1 mRNA	PMID:38568856
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HSP90AB1 mRNA	PMID:28973375
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:16664	albendazole	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20130514	CTD	MESH:D015766	[Ivermectin co-treated with Albendazole] results in increased expression of HSP90AB1 mRNA	PMID:16861626
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1552591	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of HSP90AB1 mRNA	PMID:17945193
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17296	aniline	increases expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:C023650	aniline results in increased expression of HSP90AB1 mRNA	PMID:22016648
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17303	morphine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009020	Morphine results in increased expression of HSP90AB1 mRNA	PMID:15497504
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17323	trans-pinosylvin	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20140805	CTD	MESH:C049032	pinosylvin results in decreased expression of HSP90AB1 mRNA	PMID:23333577
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17712	9H-xanthine	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D019820	[Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of HSP90AB1 protein; [Xanthine co-treated with XDH protein] results in decreased expression of HSP90AB1 protein	PMID:19464573
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HSP90AB1 mRNA	PMID:33754040
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HSP90AB1 mRNA	PMID:21318169|PMID:26361869
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552591	E	RGD:6480464	20250805	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HSP90AB1 mRNA	PMID:26845775
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of HSP90AB1 promoter; Curcumin promotes the reaction [Diethylhexyl Phthalate results in increased expression of HSP90AB1 mRNA]; resveratrol promotes the reaction [Diethylhexyl Phthalate results in increased expression of HSP90AB1 mRNA]	PMID:23359474|PMID:26361869
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of HSP90AB1 mRNA	PMID:26577399
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of HSP90AB1 mRNA	PMID:27523638
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1346893	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of HSP90AB1 protein	PMID:37730182
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HSP90AB1 mRNA	PMID:33387578
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:17933	calcidiol	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D002112	Calcifediol deficiency results in decreased expression of HSP90AB1 mRNA	PMID:17293106
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:18243	dopamine	increases expression	ISO	RGD:1346893	E	RGD:6480464	20150714	CTD	MESH:D004298	Dopamine results in increased expression of HSP90AB1 protein	PMID:24675778
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HSP90AB1 mRNA	PMID:36331819
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:187088	Muconic dialdehyde	increases expression	ISO	RGD:1346893	E	RGD:6480464	20250805	CTD	MESH:C034476	muconaldehyde results in increased expression of HSP90AB1 mRNA	PMID:40300100
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D000517	alpha-Chlorohydrin analog results in increased expression of HSP90AB1 protein	PMID:26072098
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of HSP90AB1 mRNA	PMID:21346803
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20120717	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of HSP90AB1 mRNA	PMID:19840844
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1346893	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in increased expression of HSP90AB1 mRNA	PMID:24284285|PMID:29993192
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:233415	Pf-06840003	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20250408	CTD	MESH:C000625742	PF-06840003 inhibits the reaction [MAPT protein mutant form results in decreased expression of HSP90AB1 mRNA]	PMID:39172838
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20120501	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HSP90AB1 mRNA	PMID:20599845
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1346893	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of HSP90AB1 mRNA	PMID:19549813|PMID:20599845
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HSP90AB1 protein	PMID:23301498
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	EXP		E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of HSP90AB1 gene	PMID:16495775
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of HSP90AB1 mRNA	PMID:33354967
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1346893	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HSP90AB1 mRNA	PMID:27153756
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of HSP90AB1 mRNA; Menthol results in decreased expression of HSP90AB1 protein	PMID:26760959
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of HSP90AB1 mRNA	PMID:23649840
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSP90AB1 protein	PMID:22248470
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HSP90AB1 protein	PMID:22248470
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1552591	E	RGD:6480464	20120515	CTD	MESH:D010126	Ozone results in increased expression of HSP90AB1 mRNA	PMID:21543283
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:25812	ozone	increases phosphorylation	EXP		E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased phosphorylation of HSP90AB1 protein	PMID:33146391
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1346893	E	RGD:6480464	20151110	CTD	MESH:D014501	Uranium affects the expression of HSP90AB1 mRNA; Uranium affects the expression of HSP90AB1 protein	PMID:15672453
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552591	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HSP90AB1 mRNA	PMID:27339419|PMID:31919559
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:27470	folic acid	affects expression	ISO	RGD:1552591	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid affects the expression of HSP90AB1 mRNA	PMID:26547318
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of HSP90AB1 mRNA	PMID:22206623
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1346893	E	RGD:6480464	20151110	CTD	MESH:D012643	Selenium results in increased expression of HSP90AB1 mRNA	PMID:19244175
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1346893	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of HSP90AB1 mRNA	PMID:33512557
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of HSP90AB1 protein	PMID:38460933
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1346893	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of HSP90AB1 protein	PMID:35688186
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:27827	paraoxon	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20120717	CTD	MESH:D010261	Paraoxon results in decreased expression of HSP90AB1 protein	PMID:20931991
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol promotes the reaction [Diethylhexyl Phthalate results in increased expression of HSP90AB1 mRNA]	PMID:26361869
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of HSP90AB1 mRNA	PMID:17898221
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D019833	Genistein results in increased expression of HSP90AB1 mRNA; Genistein results in increased expression of HSP90AB1 protein	PMID:15229138
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HSP90AB1 mRNA	PMID:22298810|PMID:34747641
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552591	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HSP90AB1 mRNA	PMID:21570461
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HSP90AB1 mRNA; Tetrachlorodibenzodioxin results in decreased expression of HSP90AB1 protein	PMID:16548065|PMID:21215274
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSP90AB1 mRNA	PMID:33387578
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSP90AB1 mRNA	PMID:17942748
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of HSP90AB1 protein	PMID:35544339
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of HSP90AB1 mRNA	PMID:33512557
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of HSP90AB1 mRNA	PMID:23186747
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:D012402	Rotenone results in increased expression of HSP90AB1 mRNA	PMID:22016648
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28201	rotenone	increases oxidation	EXP		E	RGD:6480464	20190910	CTD	MESH:D012402	Rotenone results in increased oxidation of HSP90AB1 protein	PMID:30951809
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of HSP90AB1 mRNA	PMID:28959563
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1346893	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of HSP90AB1 mRNA	PMID:32763439
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20150512	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of HSP90AB1 mRNA; [Disulfiram binds to Copper] which results in decreased expression of HSP90AB1 mRNA	PMID:24690739|PMID:30911355
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	ISO	RGD:1552591	E	RGD:6480464	20120814	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of HSP90AB1 mRNA	PMID:15707499
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1552591	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of HSP90AB1 protein	PMID:27548804
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1346893	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of HSP90AB1 protein	PMID:29385562
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:D004317	Doxorubicin results in increased expression of HSP90AB1 mRNA	PMID:22016648
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1346893	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of HSP90AB1 protein	PMID:35688186
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:28918	(R)-adrenaline	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D004837	[Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of HSP90AB1 protein	PMID:19464573
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:2896	astemizole	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D016589	Astemizole results in decreased expression of HSP90AB1 mRNA	PMID:20221588
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29019	nonanoic acid	increases expression	ISO	RGD:1552591	E	RGD:6480464	20120412	CTD	MESH:C008776	pelargonic acid results in increased expression of HSP90AB1 mRNA	PMID:11379042
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29073	L-ascorbic acid	affects expression	ISO	RGD:1552591	E	RGD:6480464	20120501	CTD	MESH:D001205	Ascorbic Acid affects the expression of HSP90AB1 protein	PMID:19224539
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSP90AB1 mRNA	PMID:19695318
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of HSP90AB1 protein	PMID:21925251
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of HSP90AB1 mRNA	PMID:18996350
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HSP90AB1 mRNA; sodium arsenite results in increased expression of HSP90AB1 protein	PMID:16456883|PMID:37368603
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346893	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HSP90AB1 mRNA	PMID:12119132|PMID:38568856
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552591	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HSP90AB1 mRNA	PMID:16014739|PMID:16322246
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	Benzo(a)pyrene promotes the reaction [sodium arsenite results in increased expression of HSP90AB1 protein]; sodium arsenite promotes the reaction [Benzo(a)pyrene results in increased expression of HSP90AB1 protein]	PMID:16456883
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20161228	CTD	MESH:C017947	ATM protein affects the reaction [sodium arsenite results in decreased expression of HSP90AB1 mRNA]; CHEK2 protein affects the reaction [sodium arsenite results in decreased expression of HSP90AB1 mRNA]; sodium arsenite promotes the reaction [TRP53 protein binds to HSP90AB1 promoter]	PMID:18996350
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29693	thiostrepton	increases expression	ISO	RGD:1346893	E	RGD:6480464	20140715	CTD	MESH:D013883	Thiostrepton results in increased expression of HSP90AB1 mRNA	PMID:22321511
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of HSP90AB1 mRNA	PMID:29453283
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1552591	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of HSP90AB1 mRNA	PMID:22342234
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HSP90AB1 protein	PMID:16456883
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552591	E	RGD:6480464	20140114	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HSP90AB1 mRNA	PMID:21569818|PMID:23747951
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346893	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HSP90AB1 promoter	PMID:27901495
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1346893	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of HSP90AB1 gene	PMID:25435355
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [sodium arsenite results in increased expression of HSP90AB1 protein]; sodium arsenite promotes the reaction [Benzo(a)pyrene results in increased expression of HSP90AB1 protein]	PMID:16456883
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of HSP90AB1 mRNA]	PMID:22228805
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSP90AB1 mRNA	PMID:19695318
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20150512	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of HSP90AB1 mRNA; [Disulfiram binds to Copper] which results in decreased expression of HSP90AB1 mRNA	PMID:24690739|PMID:30911355
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:30304	antimony(0)	increases expression	ISO	RGD:1346893	E	RGD:6480464	20241001	CTD	MESH:D000965	Antimony results in increased expression of HSP90AB1 protein	PMID:38097005
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:30304	antimony(0)	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20241001	CTD	MESH:D000965	MCOLN1 protein inhibits the reaction [Antimony results in increased expression of HSP90AB1 protein]	PMID:38097005
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:30537	triphenylstannane	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20200609	CTD	MESH:C030665	triphenyltin analog results in decreased expression of HSP90AB1 protein	PMID:31634547
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:30563	silicon dioxide	affects secretion	ISO	RGD:1346893	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the secretion of HSP90AB1 protein	PMID:25895662
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HSP90AB1 mRNA	PMID:20018196
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:30621	diarsenic trioxide	affects response to substance	ISO	RGD:1346893	E	RGD:6480464	20191114	CTD	MESH:C006632	HSP90AB1 protein affects the susceptibility to Arsenic Trioxide	PMID:19371599
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of HSP90AB1 protein	PMID:25419056
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1346893	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HSP90AB1 mRNA; Arsenic Trioxide results in increased expression of HSP90AB1 protein	PMID:19364129|PMID:20458559|PMID:22521957
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of HSP90AB1 mRNA	PMID:16483693
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:31638	fulvestrant	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of HSP90AB1 mRNA	PMID:16514628
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:32076	zinc pyrithione	increases expression	ISO	RGD:1346893	E	RGD:6480464	20170303	CTD	MESH:C010423	pyrithione zinc results in increased expression of HSP90AB1 mRNA	PMID:21424779
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:32181	tamibarotene	affects expression	ISO	RGD:1346893	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of HSP90AB1 mRNA	PMID:15498508
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552591	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HSP90AB1 promoter	PMID:35295148
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HSP90AB1 mRNA	PMID:34492290
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of HSP90AB1 mRNA	PMID:18648102
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of HSP90AB1 mRNA	PMID:19162173|PMID:21318169|PMID:22484513
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:C006253	pirinixic acid results in increased expression of HSP90AB1 mRNA	PMID:18301758|PMID:23811191
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:32585	4-hydroxynon-2-enal	affects binding	EXP		E	RGD:6480464	20120717	CTD	MESH:C027576	4-hydroxy-2-nonenal binds to HSP90AB1 protein	PMID:21749116
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552591	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of HSP90AB1 mRNA	PMID:28472532
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of HSP90AB1 mRNA	PMID:30903817
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of HSP90AB1 mRNA	PMID:33221593
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C006780	bisphenol A results in increased expression of HSP90AB1 mRNA; bisphenol A results in increased expression of HSP90AB1 protein	PMID:15229138|PMID:25181051|PMID:32145629
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1346893	E	RGD:6480464	20151110	CTD	MESH:C006780	bisphenol A results in increased expression of HSP90AB1 mRNA; bisphenol A results in increased expression of HSP90AB1 protein	PMID:15223131|PMID:34186270
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552591	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of HSP90AB1 mRNA	PMID:26063408
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of HSP90AB1 promoter	PMID:23359474
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20151110	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSP90AB1 mRNA; ESR1 protein affects the reaction [bisphenol A results in increased expression of HSP90AB1 mRNA]	PMID:15223131|PMID:28628672
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1346893	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of HSP90AB1 mRNA	PMID:19244175
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT affects the expression of HSP90AB1 mRNA	PMID:17984292
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1346893	E	RGD:6480464	20120613	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of HSP90AB1 mRNA	PMID:21703328
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34237	2,4-diaminotoluene	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:C010914	2,4-diaminotoluene results in decreased expression of HSP90AB1 mRNA	PMID:22016648
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1346893	E	RGD:6480464	20120613	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of HSP90AB1 mRNA	PMID:21703328
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of HSP90AB1 mRNA	PMID:17316808
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1346893	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of HSP90AB1 protein	PMID:34186270
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552591	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of HSP90AB1 mRNA	PMID:39298647
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSP90AB1 mRNA	PMID:28628672
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1346893	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of HSP90AB1 protein	PMID:34186270
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552591	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of HSP90AB1 mRNA	PMID:38685157
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSP90AB1 mRNA	PMID:28628672
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1346893	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of HSP90AB1 protein	PMID:34186270
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HSP90AB1 mRNA	PMID:37019170
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of HSP90AB1 mRNA	PMID:17602206
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34674	dextran sulfate	increases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:D016264	Dextran Sulfate results in increased expression of HSP90AB1 protein	PMID:32470352
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D016264	celastrol inhibits the reaction [Dextran Sulfate results in increased expression of HSP90AB1 protein]	PMID:32470352
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of HSP90AB1 promoter	PMID:23359474
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSP90AB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSP90AB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSP90AB1 mRNA	PMID:28628672
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of HSP90AB1 mRNA	PMID:19638242|PMID:20360939
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of HSP90AB1 mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSP90AB1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of HSP90AB1 mRNA	PMID:17602206|PMID:18544905
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20180703	CTD	MESH:C022838	nickel chloride inhibits the reaction [HIF1A protein binds to HSP90AB1 protein]	PMID:29355601
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of HSP90AB1 mRNA]	PMID:39241906
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of HSP90AB1 mRNA	PMID:20551477
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1346893	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride affects the expression of HSP90AB1 mRNA	PMID:23828170
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HSP90AB1 mRNA	PMID:18560533
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20120717	CTD	MESH:D019256	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of HSP90AB1 mRNA	PMID:19840844
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of HSP90AB1 mRNA	PMID:19162173|PMID:21318169
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1346893	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of HSP90AB1 mRNA	PMID:17553155
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20180703	CTD	MESH:C018021	cobaltous chloride promotes the reaction [HIF1A protein binds to HSP90AB1 protein]	PMID:29355601
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:36011	pinosylvin	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20140311	CTD	MESH:C049032	pinosylvin results in decreased expression of HSP90AB1 mRNA	PMID:23333577
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1346893	E	RGD:6480464	20151110	CTD	MESH:D012643	Selenium results in increased expression of HSP90AB1 mRNA	PMID:19244175
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:37187	lead nitrate	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate affects the reaction [HSP90AB1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [HSP90AB1 affects the expression of MT2 mRNA]	PMID:11891201
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of HSP90AB1 mRNA	PMID:17585979
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:3750	clofibrate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate results in increased expression of HSP90AB1 mRNA; Clofibrate results in increased expression of HSP90AB1 protein	PMID:16470657|PMID:21318169
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:38319	usnic acid	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20140408	CTD	MESH:C073339	[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSP90AB1 mRNA	PMID:22777745
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:38757	isoflavones	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HSP90AB1 protein; [ENNG co-treated with Isoflavones] results in increased expression of HSP90AB1 protein	PMID:22248470
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D003375	Coumestrol results in increased expression of HSP90AB1 mRNA; Coumestrol results in increased expression of HSP90AB1 protein	PMID:15229138
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1346893	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of HSP90AB1 mRNA	PMID:26352163
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1346893	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HSP90AB1 mRNA	PMID:40419075
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HSP90AB1 mRNA	PMID:36331819
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1552591	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of HSP90AB1 mRNA	PMID:23125180
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of HSP90AB1 mRNA	PMID:22561333
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of HSP90AB1 mRNA	PMID:31558096
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of HSP90AB1 mRNA	PMID:25993096
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D003474	Curcumin promotes the reaction [Diethylhexyl Phthalate results in increased expression of HSP90AB1 mRNA]	PMID:26361869
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of HSP90AB1 mRNA	PMID:21318169
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:4027	cyclophosphamide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of HSP90AB1 mRNA	PMID:11906922
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:40303	lovastatin	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in decreased expression of HSP90AB1 mRNA	PMID:20493250
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1346893	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of HSP90AB1 promoter	PMID:27989131
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346893	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of HSP90AB1 mRNA	PMID:20106945
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:D013629	Tamoxifen affects the expression of HSP90AB1 mRNA	PMID:17555576
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSP90AB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSP90AB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSP90AB1 mRNA	PMID:28628672
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of HSP90AB1 mRNA; Diethylstilbestrol results in increased expression of HSP90AB1 protein	PMID:15229138
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1346893	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of HSP90AB1 mRNA	PMID:33512557
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:43572	kojic acid	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:C011890	[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSP90AB1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of HSP90AB1 mRNA	PMID:18544905
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of HSP90AB1 mRNA	PMID:24136188
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of HSP90AB1 mRNA	PMID:16514628
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of HSP90AB1 mRNA; vorinostat results in decreased expression of HSP90AB1 protein	PMID:20543569|PMID:27188386
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552591	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HSP90AB1 mRNA	PMID:17562736
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of HSP90AB1 mRNA	PMID:33387578
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1346893	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of HSP90AB1 mRNA	PMID:21420995
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1552591	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of HSP90AB1 mRNA	PMID:11743745|PMID:12958197
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20120412	CTD	MESH:D000082	PTGS2 protein affects the reaction [Acetaminophen results in increased expression of HSP90AB1 mRNA]	PMID:11743745
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of HSP90AB1 mRNA	PMID:24690739
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:46677	amphibole asbestos	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20170303	CTD	MESH:D017636	Asbestos, Amphibole results in decreased expression of HSP90AB1 protein	PMID:20855422
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of HSP90AB1 protein	PMID:38460933
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:48517	7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D019820	[Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of HSP90AB1 protein; [Xanthine co-treated with XDH protein] results in decreased expression of HSP90AB1 protein	PMID:19464573
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1346893	E	RGD:6480464	20151110	CTD	MESH:D018038	Sodium Selenite results in increased expression of HSP90AB1 mRNA	PMID:18175754
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of HSP90AB1 mRNA	PMID:17555576
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of HSP90AB1 mRNA	PMID:17108234
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of HSP90AB1 mRNA	PMID:17942748
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSP90AB1 mRNA	PMID:17942748
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:4948	Evodiamine	increases expression	ISO	RGD:1346893	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in increased expression of HSP90AB1 mRNA	PMID:38878560
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSP90AB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSP90AB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSP90AB1 mRNA	PMID:28628672
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:49900	arsenous acid	affects response to substance	ISO	RGD:1346893	E	RGD:6480464	20191114	CTD	MESH:C032793	HSP90AB1 protein affects the susceptibility to Arsenic Trioxide	PMID:19371599
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of HSP90AB1 protein	PMID:25419056
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1346893	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HSP90AB1 mRNA; Arsenic Trioxide results in increased expression of HSP90AB1 protein	PMID:19364129|PMID:20458559|PMID:22521957
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1552591	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of HSP90AB1 mRNA	PMID:21318169
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in increased expression of HSP90AB1 mRNA]	PMID:21318169
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:50161	motexafin gadolinium	increases expression	ISO	RGD:1346893	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of HSP90AB1 mRNA	PMID:16357179
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HSP90AB1 mRNA	PMID:16357179
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1346893	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate results in increased expression of HSP90AB1 mRNA	PMID:12064557|PMID:21783983
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HSP90AB1 mRNA; Nanotubes, Carbon results in decreased expression of HSP90AB1 mRNA	PMID:25620056
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of HSP90AB1 mRNA	PMID:24136188
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of HSP90AB1 mRNA	PMID:40234311
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of HSP90AB1 mRNA	PMID:19162173
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1552591	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of HSP90AB1 mRNA	PMID:15375163
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of HSP90AB1 mRNA	PMID:35964746
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of HSP90AB1 mRNA	PMID:24136188
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1346893	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of HSP90AB1 mRNA	PMID:17895889
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:5292	geldanamycin	affects binding	EXP		E	RGD:6480464	20120613	CTD	MESH:C001277	geldanamycin binds to HSP90AB1 protein	PMID:21749116
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1346893	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of HSP90AB1 mRNA	PMID:26705709
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552591	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of HSP90AB1 mRNA	PMID:19042947
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of HSP90AB1 protein	PMID:23718831
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:53556	toluene 2,4-diisocyanate	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20120412	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in decreased expression of HSP90AB1 mRNA	PMID:11379042
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1346893	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of HSP90AB1 mRNA	PMID:31629900
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:5692	hexachlorobenzene	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D006581	Hexachlorobenzene results in decreased expression of HSP90AB1 mRNA	PMID:15159207
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1552591	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of HSP90AB1 mRNA	PMID:20829426
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:6030	isoniazide	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of HSP90AB1 protein	PMID:40015660
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HSP90AB1 protein	PMID:32959892
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:6078	ivermectin	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20130514	CTD	MESH:D007559	[Ivermectin co-treated with Albendazole] results in increased expression of HSP90AB1 mRNA	PMID:16861626
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:60888	BAPTA	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20160210	CTD	MESH:C025603	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Humic Substances results in increased expression of HSP90AB1 protein]	PMID:23836447
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:62984	zinc acetate	increases expression	ISO	RGD:1346893	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of HSP90AB1 mRNA	PMID:16357179
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:62984	zinc acetate	multiple interactions	ISO	RGD:1346893	E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HSP90AB1 mRNA	PMID:16357179
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of HSP90AB1 mRNA	PMID:24136188
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of HSP90AB1 mRNA	PMID:23650126
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:63959	celastrol	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:C050414	celastrol inhibits the reaction [Dextran Sulfate results in increased expression of HSP90AB1 protein]	PMID:32470352
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of HSP90AB1 mRNA	PMID:24136188
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1346893	E	RGD:6480464	20150714	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of HSP90AB1 protein	PMID:24675778
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:64153	tanespimycin	affects binding	ISO	RGD:1346893	E	RGD:6480464	20170228	CTD	MESH:C112765	tanespimycin binds to HSP90AB1 protein	PMID:22895790
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:68233	(Z)-3-butylidenephthalide	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20140311	CTD	MESH:C026105	butylidenephthalide results in decreased expression of HSP90AB1 protein	PMID:23770345
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1552591	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of HSP90AB1 mRNA	PMID:27462272
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1346893	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of HSP90AB1 mRNA	PMID:28025562
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1346893	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of HSP90AB1 protein	PMID:34186270
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552591	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of HSP90AB1 mRNA	PMID:22206623
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of HSP90AB1 mRNA	PMID:22206623
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of HSP90AB1 mRNA	PMID:24136188
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of HSP90AB1 mRNA	PMID:15215175
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:76326	N-nitrosomorpholine	affects expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine affects the expression of HSP90AB1 protein	PMID:19716841
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1346893	E	RGD:6480464	20200714	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of HSP90AB1 mRNA; beta-Naphthoflavone results in increased expression of HSP90AB1 protein	PMID:32151702|PMID:39638853
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C025589	ochratoxin A results in decreased expression of HSP90AB1 protein	PMID:31369848
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of HSP90AB1 mRNA	PMID:21346803
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:78677	6-anilino-5,8-quinolinedione	increases expression	EXP		E	RGD:6480464	20160510	CTD	MESH:C041715	6-anilino-5,8-quinolinedione results in increased expression of HSP90AB1 protein	PMID:10617604
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:78741	oxidopamine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D016627	Oxidopamine results in increased expression of HSP90AB1 mRNA	PMID:12486162
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of HSP90AB1 mRNA	PMID:19162173
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of HSP90AB1 mRNA	PMID:19162173
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1552591	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of HSP90AB1 mRNA	PMID:19482888
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of HSP90AB1 mRNA]	PMID:19482888
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:80805	Cinobufagin	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20220906	CTD	MESH:C002471	cinobufagin results in decreased expression of HSP90AB1 mRNA	PMID:35447139
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1552591	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of HSP90AB1 mRNA	PMID:22538082
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:81543	Tributyltin oxide	decreases phosphorylation	ISO	RGD:1552591	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased phosphorylation of HSP90AB1 protein	PMID:22174045
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552591	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of HSP90AB1 mRNA	PMID:30294300
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:82341	Methylazoxymethanol acetate	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D008746	Methylazoxymethanol Acetate results in increased expression of HSP90AB1 mRNA	PMID:28349193
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1552591	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of HSP90AB1 mRNA]	PMID:39241906
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of HSP90AB1 mRNA	PMID:16514628
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:90703	gamendazole	affects binding	EXP		E	RGD:10401123|PMID:18218611	20210728	RGD		gamendazole binds to Hsp90ab1 protein	
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of HSP90AB1 mRNA	PMID:21346803
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:9334	sulfasalazine	increases expression	ISO	RGD:1552591	E	RGD:6480464	20151110	CTD	MESH:D012460	Sulfasalazine results in increased expression of HSP90AB1 mRNA	PMID:22016648
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:9381	T-2 toxin	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of HSP90AB1 protein	PMID:26141394
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in decreased expression of HSP90AB1 mRNA	PMID:26141394
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1346893	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of HSP90AB1 mRNA	PMID:38568856
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1346893	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of HSP90AB1 mRNA	PMID:27188386
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1346893	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of HSP90AB1 mRNA	PMID:19631733
1303075	Hsp90ab1	heat shock protein 90 alpha family class B member 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C025643	vinclozolin affects the expression of HSP90AB1 mRNA	PMID:19015723
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1345635	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SH2D2A mRNA	PMID:38218311
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1550627	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of SH2D2A mRNA	PMID:36189433
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550627	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SH2D2A mRNA	PMID:36189433
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1345635	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SH2D2A mRNA	PMID:26079696
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1345635	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of SH2D2A protein	PMID:18951874
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1345635	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SH2D2A mRNA	PMID:31614463
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1345635	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SH2D2A mRNA	PMID:30165855
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SH2D2A mRNA	PMID:23829299
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1345635	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SH2D2A mRNA	PMID:38568856
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SH2D2A mRNA	PMID:33387578
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1345635	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of SH2D2A mRNA	PMID:19162166
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1345635	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of SH2D2A mRNA	PMID:28937961
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550627	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH2D2A mRNA	PMID:37992649
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550627	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SH2D2A mRNA	PMID:36189433
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550627	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH2D2A mRNA	PMID:37992649
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1345635	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SH2D2A mRNA	PMID:23825647
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1345635	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SH2D2A mRNA	PMID:23825647
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1345635	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SH2D2A mRNA	PMID:21641981
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1550627	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of SH2D2A mRNA	PMID:33026818
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550627	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SH2D2A mRNA	PMID:34911549
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1345635	E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in increased expression of SH2D2A mRNA	PMID:24657277
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1345635	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of SH2D2A mRNA	PMID:38460933
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SH2D2A mRNA	PMID:31881176
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1345635	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SH2D2A mRNA	PMID:27392435
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1345635	E	RGD:6480464	20151013	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SH2D2A mRNA; [Cisplatin co-treated with Paclitaxel] results in increased expression of SH2D2A mRNA	PMID:20705681|PMID:27392435
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1345635	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SH2D2A mRNA	PMID:24768652|PMID:25583101
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SH2D2A mRNA	PMID:34747641
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1345635	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of SH2D2A protein	PMID:18951874
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1345635	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of SH2D2A mRNA	PMID:29955902
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1345635	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SH2D2A mRNA	PMID:33212167
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550627	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH2D2A mRNA	PMID:37992649
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550627	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SH2D2A mRNA	PMID:37682722
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1345635	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SH2D2A mRNA	PMID:38568856
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550627	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of SH2D2A mRNA	PMID:39515575
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550627	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SH2D2A mRNA	PMID:29341224
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1345635	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of SH2D2A mRNA	PMID:38568856
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SH2D2A mRNA	PMID:34492290
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SH2D2A mRNA	PMID:25181051
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SH2D2A gene	PMID:28505145
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1345635	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SH2D2A mRNA	PMID:25979313
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1345635	E	RGD:6480464	20240702	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SH2D2A mRNA	PMID:38568856
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of SH2D2A mRNA	PMID:23829299
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1550627	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of SH2D2A mRNA	PMID:28392331
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1345635	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SH2D2A mRNA	PMID:21527772
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of SH2D2A mRNA	PMID:35163327
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1345635	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SH2D2A mRNA	PMID:38568856
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1345635	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SH2D2A mRNA	PMID:24449571
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1345635	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SH2D2A mRNA	PMID:28302478
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550627	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SH2D2A mRNA	PMID:17292431
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1345635	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SH2D2A mRNA	PMID:25562108
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550627	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH2D2A mRNA	PMID:37992649
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1345635	E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in increased expression of SH2D2A mRNA	PMID:24657277
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1345635	E	RGD:6480464	20161213	CTD	MESH:D017239	[Cisplatin co-treated with Paclitaxel] results in increased expression of SH2D2A mRNA	PMID:20705681
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1550627	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of SH2D2A mRNA	PMID:29279043
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1345635	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of SH2D2A mRNA	PMID:38460933
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1550627	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of SH2D2A mRNA	PMID:17555576
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1345635	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SH2D2A mRNA	PMID:38568856
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550627	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SH2D2A mRNA	PMID:38701926
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550627	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SH2D2A mRNA	PMID:22206623
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in increased expression of SH2D2A mRNA	PMID:32741896
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1345635	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of SH2D2A mRNA	PMID:34995734
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1345635	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SH2D2A gene]	PMID:28238834
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1345635	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of SH2D2A mRNA	PMID:39904859
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550627	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SH2D2A mRNA	PMID:38648751
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1345635	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of SH2D2A mRNA	PMID:30458266
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SH2D2A mRNA	PMID:23640034
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SH2D2A mRNA	PMID:23914054
1303076	Sh2d2a	SH2 domain containing 2A	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1345635	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SH2D2A mRNA	PMID:38568856
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1606769	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SPINK7 gene	PMID:27153756
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606769	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SPINK7 mRNA	PMID:41430723
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606769	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPINK7 mRNA	PMID:32525701
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1606769	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPINK7 mRNA	PMID:23152189
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1606769	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPINK7 mRNA	PMID:30851411
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606769	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPINK7 promoter	PMID:27901495
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606769	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPINK7 mRNA	PMID:38174414
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606769	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPINK7 mRNA	PMID:32525701
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1606769	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPINK7 mRNA	PMID:30851411
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606769	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPINK7 gene]	PMID:28238834
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1606769	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPINK7 mRNA	PMID:32525701
1303077	Spink7	serine peptidase inhibitor, Kazal type 7	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1606769	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of SPINK7 mRNA	PMID:31734321
1303078	Krt76	keratin 76	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1621451	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in decreased expression of KRT76 protein	PMID:26903627
1303078	Krt76	keratin 76	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KRT76 mRNA	PMID:33387578
1303078	Krt76	keratin 76	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1621451	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KRT76 mRNA	PMID:34319233
1303078	Krt76	keratin 76	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KRT76 mRNA	PMID:33387578
1303078	Krt76	keratin 76	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605387	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KRT76 mRNA	PMID:35301059
1303078	Krt76	keratin 76	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605387	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KRT76 gene	PMID:27153756
1303078	Krt76	keratin 76	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1621451	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT76 protein	PMID:39910959
1303078	Krt76	keratin 76	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1621451	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of KRT76 protein	PMID:25505154
1303078	Krt76	keratin 76	gene	CHEBI:28358	rac-lactic acid	multiple interactions	ISO	RGD:1621451	E	RGD:6480464	20250603	CTD	MESH:D019344	[Sodium Lactate results in increased abundance of Lactic Acid] which results in increased expression of KRT76 mRNA	PMID:39922521
1303078	Krt76	keratin 76	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of KRT76 mRNA	PMID:26033743
1303078	Krt76	keratin 76	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605387	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT76 mRNA	PMID:34032870
1303078	Krt76	keratin 76	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605387	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT76 promoter	PMID:27901495
1303078	Krt76	keratin 76	gene	CHEBI:3000	beauvericin	multiple interactions	ISO	RGD:1605387	E	RGD:6480464	20200915	CTD	MESH:C004456	[beauvericin co-treated with enniatins] results in decreased expression of KRT76 protein	PMID:32407736
1303078	Krt76	keratin 76	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of KRT76 mRNA	PMID:26033743
1303078	Krt76	keratin 76	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of KRT76 mRNA	PMID:34779285
1303078	Krt76	keratin 76	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of KRT76 mRNA	PMID:30047161
1303078	Krt76	keratin 76	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of KRT76 mRNA	PMID:30012374
1303078	Krt76	keratin 76	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT76 mRNA	PMID:25181051
1303078	Krt76	keratin 76	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621451	E	RGD:6480464	20250805	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT76 protein	PMID:26903627
1303078	Krt76	keratin 76	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1621451	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KRT76 promoter	PMID:27312807
1303078	Krt76	keratin 76	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1621451	E	RGD:6480464	20250805	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of KRT76 protein	PMID:26903627
1303078	Krt76	keratin 76	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KRT76 mRNA	PMID:32119087
1303078	Krt76	keratin 76	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1605387	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to KRT76 protein	PMID:32991956
1303078	Krt76	keratin 76	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of KRT76 mRNA	PMID:32680482
1303078	Krt76	keratin 76	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605387	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KRT76 mRNA	PMID:35301059
1303078	Krt76	keratin 76	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of KRT76 mRNA	PMID:25539665
1303078	Krt76	keratin 76	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of KRT76 mRNA	PMID:30047161
1303078	Krt76	keratin 76	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1621451	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of KRT76 protein	PMID:26178269
1303078	Krt76	keratin 76	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of KRT76 mRNA	PMID:30047161
1303078	Krt76	keratin 76	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRT76 mRNA	PMID:33387578
1303078	Krt76	keratin 76	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of KRT76 mRNA	PMID:30047161
1303078	Krt76	keratin 76	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of KRT76 mRNA	PMID:28801915
1303078	Krt76	keratin 76	gene	CHEBI:64648	enniatin	multiple interactions	ISO	RGD:1605387	E	RGD:6480464	20200915	CTD	MESH:C100264	[beauvericin co-treated with enniatins] results in decreased expression of KRT76 protein	PMID:32407736
1303078	Krt76	keratin 76	gene	CHEBI:67895	corosolic acid	increases expression	ISO	RGD:1605387	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of KRT76 mRNA	PMID:37939859
1303078	Krt76	keratin 76	gene	CHEBI:75228	sodium lactate	multiple interactions	ISO	RGD:1621451	E	RGD:6480464	20250603	CTD	MESH:D019354	[Sodium Lactate results in increased abundance of Lactic Acid] which results in increased expression of KRT76 mRNA	PMID:39922521
1303078	Krt76	keratin 76	gene	CHEBI:78320	2-hydroxypropanoic acid	multiple interactions	ISO	RGD:1621451	E	RGD:6480464	20250603	CTD	MESH:D019344	[Sodium Lactate results in increased abundance of Lactic Acid] which results in increased expression of KRT76 mRNA	PMID:39922521
1303078	Krt76	keratin 76	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1621451	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of KRT76 mRNA	PMID:38648751
1303078	Krt76	keratin 76	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of KRT76 mRNA	PMID:30047161
1303078	Krt76	keratin 76	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of KRT76 mRNA	PMID:30047161
1303078	Krt76	keratin 76	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1621451	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of KRT76 protein	PMID:20553848|PMID:26903627
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1552604	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of AMIGO1 mRNA	PMID:33045310
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552604	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of AMIGO1 mRNA	PMID:37995155
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552604	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of AMIGO1 mRNA	PMID:20188158
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606525	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of AMIGO1 mRNA	PMID:33167477
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1606525	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of AMIGO1 mRNA	PMID:30510588
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of AMIGO1 mRNA	PMID:32145629
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552604	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of AMIGO1 mRNA	PMID:39298647
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606525	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of AMIGO1 mRNA	PMID:31614463
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552604	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of AMIGO1 mRNA	PMID:37992649
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552604	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of AMIGO1 mRNA	PMID:37992649
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1606525	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of AMIGO1 protein	PMID:37730182
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of AMIGO1 mRNA	PMID:33387578
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of AMIGO1 mRNA	PMID:22061828
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1606525	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of AMIGO1 mRNA	PMID:28818685
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552604	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AMIGO1 mRNA	PMID:36331819
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552604	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AMIGO1 mRNA	PMID:37236586
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552604	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of AMIGO1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of AMIGO1 mRNA	PMID:34911549
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606525	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of AMIGO1 mRNA	PMID:35430440
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1606525	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of AMIGO1 mRNA	PMID:19774075
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of AMIGO1 mRNA	PMID:30779732
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1552604	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AMIGO1 mRNA	PMID:17484886
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of AMIGO1 mRNA	PMID:31881176
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606525	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of AMIGO1 mRNA	PMID:23557933
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606525	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of AMIGO1 mRNA	PMID:27392435
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606525	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AMIGO1 mRNA	PMID:27392435
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of AMIGO1 mRNA	PMID:20187946
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1606525	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of AMIGO1 mRNA	PMID:25583101
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552604	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AMIGO1 mRNA	PMID:21570461
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AMIGO1 mRNA	PMID:33387578
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1606525	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of AMIGO1 mRNA	PMID:32763439
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606525	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AMIGO1 mRNA	PMID:29803840
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552604	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of AMIGO1 mRNA	PMID:37992649
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552604	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AMIGO1 mRNA	PMID:22228805
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606525	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AMIGO1 3' UTR	PMID:27901495
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in decreased expression of AMIGO1 mRNA	PMID:33150645
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:30966	glycidol	increases methylation	EXP		E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in increased methylation of AMIGO1 promoter	PMID:33150595
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of AMIGO1 mRNA	PMID:16483693
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1606525	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of AMIGO1 mRNA	PMID:38568856
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AMIGO1 mRNA	PMID:34492290
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of AMIGO1 mRNA	PMID:19167457
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of AMIGO1 mRNA	PMID:25181051|PMID:32145629
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of AMIGO1 mRNA	PMID:30816183|PMID:41034487
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606525	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of AMIGO1 mRNA	PMID:29275510
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552604	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in increased expression of AMIGO1 mRNA	PMID:20350560
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606525	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AMIGO1 mRNA	PMID:37042841
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of AMIGO1 mRNA	PMID:30723492
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AMIGO1 mRNA	PMID:33453195
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552604	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AMIGO1 mRNA	PMID:37236586
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552604	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AMIGO1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of AMIGO1 mRNA	PMID:36331819
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606525	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of AMIGO1 mRNA	PMID:23179753|PMID:28001369
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552604	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of AMIGO1 mRNA	PMID:21427059
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1606525	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of AMIGO1 gene	PMID:29154799
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606525	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AMIGO1 mRNA	PMID:27188386
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552604	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of AMIGO1 mRNA	PMID:37992649
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1606525	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of AMIGO1 mRNA	PMID:38832940
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1606525	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of AMIGO1 mRNA	PMID:24935251
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of AMIGO1 mRNA	PMID:33387578
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1552604	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of AMIGO1 mRNA	PMID:23608068
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1552604	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of AMIGO1 mRNA	PMID:38701926
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552604	E	RGD:6480464	20211109	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of AMIGO1 mRNA	PMID:34265337
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552604	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AMIGO1 mRNA	PMID:22206623
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606525	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AMIGO1 mRNA	PMID:27188386
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:82527	Ptaquiloside	decreases expression	ISO	RGD:1552604	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in decreased expression of AMIGO1 mRNA	PMID:23274088
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606525	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AMIGO1 mRNA	PMID:27188386
1303079	Amigo1	adhesion molecule with Ig like domain 1	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of AMIGO1 protein	PMID:32495657
1303080	Senp17	Sumo1/sentrin/SMT3 specific peptidase 17	gene	CHEBI:16130	DDT	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:D003634	DDT results in decreased methylation of SENP17 gene	PMID:31682807
1303080	Senp17	Sumo1/sentrin/SMT3 specific peptidase 17	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SENP17 mRNA	PMID:23829299
1303080	Senp17	Sumo1/sentrin/SMT3 specific peptidase 17	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of SENP17 mRNA	PMID:21396975
1303080	Senp17	Sumo1/sentrin/SMT3 specific peptidase 17	gene	CHEBI:34631	chlorpyrifos	increases methylation	EXP		E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in increased methylation of SENP17 gene	PMID:32905263
1303080	Senp17	Sumo1/sentrin/SMT3 specific peptidase 17	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of SENP17 mRNA	PMID:22546817
1303080	Senp17	Sumo1/sentrin/SMT3 specific peptidase 17	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of SENP17 gene	PMID:31079544
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1351113	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TYROBP mRNA	PMID:27188386
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TYROBP mRNA	PMID:20938992
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1351113	E	RGD:6480464	20120717	CTD	MESH:D014212	Tretinoin results in increased expression of TYROBP mRNA	PMID:12875902|PMID:15498508|PMID:16054129|PMID:16322758|PMID:33167477
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of TYROBP mRNA	PMID:24205000
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of TYROBP mRNA	PMID:33729688
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:16130	DDT	increases expression	ISO	RGD:1624060	E	RGD:6480464	20260804	CTD	MESH:D003634	DDT results in increased expression of TYROBP mRNA	PMID:41187876
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:16130	DDT	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20260804	CTD	MESH:D003634	Tetrodotoxin inhibits the reaction [DDT results in increased expression of TYROBP mRNA]	PMID:41187876
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1624060	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TYROBP mRNA	PMID:27339419
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20250114	CTD	MESH:D008070	[Midazolam co-treated with Lipopolysaccharides] affects the expression of TYROBP mRNA; jujuboside A affects the reaction [[Midazolam co-treated with Lipopolysaccharides] affects the expression of TYROBP mRNA]; NFIL3 protein affects the reaction [jujuboside A affects the reaction [[Midazolam co-treated with Lipopolysaccharides] affects the expression of TYROBP mRNA]]	PMID:37330271
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TYROBP mRNA	PMID:39298647
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1624060	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of TYROBP mRNA	PMID:19484750
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TYROBP mRNA	PMID:32741896
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:166055	trimellitic acid	decreases methylation	ISO	RGD:1624060	E	RGD:6480464	20160510	CTD	MESH:C014871	trimellitic acid results in decreased methylation of TYROBP gene	PMID:26732893
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:166055	trimellitic acid	increases methylation	ISO	RGD:1624060	E	RGD:6480464	20160510	CTD	MESH:C014871	trimellitic acid results in increased methylation of TYROBP gene	PMID:26732893
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TYROBP mRNA	PMID:20938992
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TYROBP mRNA	PMID:37992649
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TYROBP mRNA	PMID:32741896
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TYROBP mRNA	PMID:37992649
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:177582	Jujuboside A	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20250114	CTD	MESH:C087808	jujuboside A affects the reaction [[Midazolam co-treated with Lipopolysaccharides] affects the expression of TYROBP mRNA]; NFIL3 protein affects the reaction [jujuboside A affects the reaction [[Midazolam co-treated with Lipopolysaccharides] affects the expression of TYROBP mRNA]]	PMID:37330271
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TYROBP mRNA	PMID:27523638
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1351113	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of TYROBP mRNA	PMID:26485663
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1351113	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of TYROBP mRNA	PMID:12875902|PMID:16322758
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TYROBP mRNA	PMID:22061828
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TYROBP mRNA	PMID:36331819
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of TYROBP mRNA	PMID:28522335
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1624060	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of TYROBP mRNA	PMID:15664270
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1351113	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TYROBP gene	PMID:27153756
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of TYROBP mRNA	PMID:32553695
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TYROBP mRNA	PMID:30779732
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1624060	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TYROBP mRNA	PMID:31919559
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1624060	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TYROBP mRNA	PMID:27339419|PMID:29987408
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TYROBP mRNA	PMID:20938992
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TYROBP mRNA	PMID:40504410
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1351113	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of TYROBP mRNA	PMID:38460933
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TYROBP mRNA	PMID:28960355
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TYROBP mRNA	PMID:31881176
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of TYROBP mRNA	PMID:25905778
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1351113	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of TYROBP mRNA	PMID:27594783
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TYROBP mRNA	PMID:30912803
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of TYROBP mRNA	PMID:18930951
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1624060	E	RGD:6480464	20140513	CTD	MESH:D019833	Genistein results in increased expression of TYROBP mRNA	PMID:22553218
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1351113	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TYROBP mRNA	PMID:24768652|PMID:25583101
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TYROBP mRNA	PMID:34747641
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1624060	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TYROBP mRNA	PMID:28922406
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TYROBP mRNA	PMID:15251184
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TYROBP mRNA	PMID:21215274|PMID:32109520
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1624060	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TYROBP mRNA	PMID:21041162
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:D013749	[decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TYROBP mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TYROBP mRNA	PMID:15251184|PMID:17942748
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of TYROBP mRNA	PMID:28374803
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TYROBP mRNA	PMID:28959563
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of TYROBP mRNA	PMID:30556269
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28741	sodium fluoride	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TYROBP protein	PMID:30273629
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of TYROBP mRNA	PMID:39631538
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TYROBP mRNA	PMID:37992649
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1351113	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of TYROBP mRNA	PMID:29319823
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TYROBP mRNA	PMID:40504410
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351113	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TYROBP promoter	PMID:27901495
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1624060	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TYROBP mRNA	PMID:22228805
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1351113	E	RGD:6480464	20121113	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of TYROBP mRNA; [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of TYROBP mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of TYROBP mRNA	PMID:17690111
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of TYROBP mRNA	PMID:30556269
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:31746	kainic acid	increases expression	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in increased expression of TYROBP mRNA	PMID:17997037
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1351113	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of TYROBP mRNA	PMID:15498508
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1624060	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TYROBP mRNA	PMID:23557971
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TYROBP mRNA	PMID:34492290
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of TYROBP mRNA	PMID:28943392
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of TYROBP mRNA	PMID:25380136
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TYROBP mRNA	PMID:17426115
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1351113	E	RGD:6480464	20121113	CTD	MESH:C007738	[Benzo(a)pyrene co-treated with fluoranthene] affects the expression of TYROBP mRNA	PMID:17690111
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of TYROBP mRNA	PMID:32145629
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TYROBP mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of TYROBP mRNA	PMID:35598803
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1624060	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TYROBP mRNA	PMID:32156529|PMID:38701888
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1624060	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TYROBP mRNA	PMID:26682919
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TYROBP mRNA	PMID:39298647
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1624060	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TYROBP mRNA	PMID:30951980
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1624060	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of TYROBP mRNA	PMID:26377693
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1624060	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TYROBP mRNA	PMID:30951980
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1624060	E	RGD:6480464	20240305	CTD	MESH:D016264	Dextran Sulfate results in increased expression of TYROBP mRNA; Dextran Sulfate results in increased expression of TYROBP protein	PMID:37263316
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20240305	CTD	MESH:D016264	huanglian-jie-du decoction inhibits the reaction [Dextran Sulfate results in increased expression of TYROBP mRNA]; huanglian-jie-du decoction inhibits the reaction [Dextran Sulfate results in increased expression of TYROBP protein]	PMID:37263316
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases methylation	ISO	RGD:1624060	E	RGD:6480464	20160510	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased methylation of TYROBP gene	PMID:26732893
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of TYROBP mRNA	PMID:28943392
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351113	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TYROBP mRNA	PMID:37042841
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:35299	dibenz[a,h]anthracene	multiple interactions	ISO	RGD:1351113	E	RGD:6480464	20121113	CTD	MESH:C026486	[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of TYROBP mRNA	PMID:17690111
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TYROBP mRNA	PMID:25380136
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of TYROBP mRNA	PMID:25380136
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1351113	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TYROBP mRNA	PMID:24449571
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:35861	dibenzo[a,l]pyrene	multiple interactions	ISO	RGD:1351113	E	RGD:6480464	20121113	CTD	MESH:C041517	[Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of TYROBP mRNA	PMID:17690111
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1624060	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of TYROBP mRNA	PMID:38531469
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1351113	E	RGD:6480464	20120814	CTD	MESH:D013755	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA]; [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA]	PMID:15477007
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1624060	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TYROBP mRNA	PMID:40194260
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TYROBP mRNA	PMID:36331819
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TYROBP mRNA]	PMID:18200517
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1351113	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of TYROBP mRNA	PMID:29154799
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1351113	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TYROBP gene	PMID:29154799
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TYROBP mRNA	PMID:30047161|PMID:41580965
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1624060	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in increased expression of TYROBP mRNA	PMID:21041162
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1351113	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of TYROBP mRNA	PMID:27989131
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1624060	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in increased expression of TYROBP mRNA	PMID:21041162
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1624060	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TYROBP mRNA	PMID:21041162
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TYROBP mRNA	PMID:37992649
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1351113	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of TYROBP mRNA	PMID:17400583
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TYROBP mRNA	PMID:17562736
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1351113	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of TYROBP mRNA	PMID:38460933
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TYROBP mRNA	PMID:40504410
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1624060	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of TYROBP mRNA	PMID:26934552
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1351113	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of TYROBP mRNA	PMID:26833863
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TYROBP mRNA	PMID:17942748
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TYROBP mRNA	PMID:17942748
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of TYROBP mRNA	PMID:15251184
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TYROBP mRNA	PMID:15251184
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1624060	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TYROBP mRNA; Nanotubes, Carbon results in increased expression of TYROBP mRNA	PMID:25554681
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TYROBP mRNA	PMID:30047161
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of TYROBP mRNA	PMID:24136188
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of TYROBP mRNA	PMID:17982090|PMID:18200517
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TYROBP mRNA]	PMID:18200517
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1624060	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TYROBP mRNA	PMID:38701926
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1624060	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of TYROBP mRNA	PMID:19812364
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:63934	bathocuproine disulfonic acid	multiple interactions	ISO	RGD:1351113	E	RGD:6480464	20120814	CTD	MESH:C028559	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA]	PMID:15477007
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:63954	ionomycin	multiple interactions	ISO	RGD:1351113	E	RGD:6480464	20120814	CTD	MESH:D015759	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA]; [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA]	PMID:15477007
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1624060	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of TYROBP mRNA	PMID:36851058
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of TYROBP mRNA	PMID:35283115
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:6931	midazolam	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20250114	CTD	MESH:D008874	[Midazolam co-treated with Lipopolysaccharides] affects the expression of TYROBP mRNA; jujuboside A affects the reaction [[Midazolam co-treated with Lipopolysaccharides] affects the expression of TYROBP mRNA]; NFIL3 protein affects the reaction [jujuboside A affects the reaction [[Midazolam co-treated with Lipopolysaccharides] affects the expression of TYROBP mRNA]]	PMID:37330271
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1624060	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TYROBP mRNA	PMID:22206623
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1624060	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of TYROBP mRNA	PMID:37914412
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TYROBP mRNA	PMID:32741896
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	ISO	RGD:1351113	E	RGD:6480464	20140708	CTD	MESH:C020972	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA]	PMID:15477007
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:80630	irinotecan	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20210608	CTD	MESH:D000077146	[PHY 906 co-treated with Irinotecan] affects the expression of TYROBP mRNA	PMID:32812032
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1624060	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TYROBP mRNA	PMID:38648751
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TYROBP mRNA	PMID:30047161
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of TYROBP mRNA	PMID:25905778
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:9506	tetrodotoxin	multiple interactions	ISO	RGD:1624060	E	RGD:6480464	20260804	CTD	MESH:D013779	Tetrodotoxin inhibits the reaction [DDT results in increased expression of TYROBP mRNA]	PMID:41187876
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1351113	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TYROBP mRNA	PMID:29301935
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1624060	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of TYROBP mRNA	PMID:28973697
1303081	Tyrobp	transmembrane immune signaling adaptor Tyrobp	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of TYROBP mRNA	PMID:19015723|PMID:23034163
1303082	Fcar	Fc alpha receptor	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1344251	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of FCAR mRNA	PMID:33167477
1303082	Fcar	Fc alpha receptor	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FCAR mRNA	PMID:33729688
1303082	Fcar	Fc alpha receptor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344251	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FCAR mRNA	PMID:37042841
1303082	Fcar	Fc alpha receptor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1344251	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FCAR mRNA	PMID:35301059
1303082	Fcar	Fc alpha receptor	gene	CHEBI:234430	gardiquimod	decreases expression	ISO	RGD:1344251	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in decreased expression of FCAR mRNA	PMID:28003376
1303082	Fcar	Fc alpha receptor	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1344251	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of FCAR mRNA]	PMID:28003376
1303082	Fcar	Fc alpha receptor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344251	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of FCAR mRNA	PMID:41430723
1303082	Fcar	Fc alpha receptor	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of FCAR mRNA	PMID:30779732
1303082	Fcar	Fc alpha receptor	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1344251	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of FCAR mRNA	PMID:21867686
1303082	Fcar	Fc alpha receptor	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1344251	E	RGD:6480464	20130402	CTD	MESH:D003609	Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of FCAR mRNA]	PMID:21911031
1303082	Fcar	Fc alpha receptor	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1344251	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of FCAR mRNA	PMID:27594783
1303082	Fcar	Fc alpha receptor	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of FCAR mRNA	PMID:26033743
1303082	Fcar	Fc alpha receptor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344251	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FCAR 3' UTR	PMID:27901495
1303082	Fcar	Fc alpha receptor	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1344251	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FCAR exon	PMID:27901495
1303082	Fcar	Fc alpha receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20130402	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FCAR mRNA	PMID:21911031
1303082	Fcar	Fc alpha receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1344251	E	RGD:6480464	20130402	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FCAR mRNA; Benzo(a)pyrene results in increased expression of FCAR protein	PMID:20064835|PMID:21911031
1303082	Fcar	Fc alpha receptor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1344251	E	RGD:6480464	20130402	CTD	MESH:D001564	AHR mutant form inhibits the reaction [Benzo(a)pyrene results in increased expression of FCAR mRNA]; Dactinomycin inhibits the reaction [Benzo(a)pyrene results in increased expression of FCAR mRNA]	PMID:21911031
1303082	Fcar	Fc alpha receptor	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of FCAR mRNA	PMID:26033743
1303082	Fcar	Fc alpha receptor	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in increased expression of FCAR mRNA	PMID:32721576
1303082	Fcar	Fc alpha receptor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FCAR mRNA	PMID:25181051
1303082	Fcar	Fc alpha receptor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of FCAR mRNA	PMID:41034487
1303082	Fcar	Fc alpha receptor	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1344251	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FCAR mRNA	PMID:23146750
1303082	Fcar	Fc alpha receptor	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1344251	E	RGD:6480464	20130402	CTD	MESH:D008748	Methylcholanthrene results in increased expression of FCAR mRNA	PMID:21911031
1303082	Fcar	Fc alpha receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1344251	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FCAR gene	PMID:31601247
1303082	Fcar	Fc alpha receptor	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344251	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FCAR mRNA	PMID:37042841
1303082	Fcar	Fc alpha receptor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1344251	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FCAR mRNA	PMID:35301059
1303082	Fcar	Fc alpha receptor	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1344251	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FCAR mRNA	PMID:24449571
1303082	Fcar	Fc alpha receptor	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1344251	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of FCAR mRNA]	PMID:28003376
1303082	Fcar	Fc alpha receptor	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1344251	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of FCAR mRNA	PMID:26833863
1303082	Fcar	Fc alpha receptor	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1344251	E	RGD:6480464	20161025	CTD	MESH:C082360	fipronil results in decreased expression of FCAR mRNA	PMID:27091632
1303082	Fcar	Fc alpha receptor	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344251	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FCAR gene]	PMID:28238834
1303083	mt-Ts1	mitochondrially encoded tRNA serine 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013853	Thioacetamide results in decreased expression of TRNS1 mRNA	PMID:34492290
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PBX2 mRNA	PMID:27188386
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1621601	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PBX2 mRNA	PMID:33045310
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PBX2 mRNA]	PMID:31150632
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin affects the expression of PBX2 mRNA	PMID:22262565
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of PBX2 mRNA	PMID:20488242
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1350680	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of PBX2 mRNA	PMID:33167477
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1621601	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of PBX2 mRNA	PMID:16604517
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1621601	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PBX2 mRNA	PMID:30319688
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1621601	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PBX2 mRNA	PMID:12057914
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350680	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PBX2 mRNA	PMID:37042841
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1621601	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PBX2 mRNA	PMID:23892564
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PBX2 mRNA	PMID:33387578
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PBX2 mRNA	PMID:23649840
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1621601	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of PBX2 mRNA	PMID:15674843
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1350680	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PBX2 mRNA	PMID:35430440
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PBX2 mRNA	PMID:31150632
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PBX2 mRNA]	PMID:31150632
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1621601	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PBX2 mRNA	PMID:25629700
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1621601	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PBX2 mRNA	PMID:22206623
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1350680	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PBX2 gene	PMID:25304211
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1350680	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PBX2 protein	PMID:35688186
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PBX2 mRNA	PMID:31881176
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1350680	E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with panobinostat] affects the expression of PBX2 mRNA	PMID:21791302
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1621601	E	RGD:6480464	20120412	CTD	MESH:D003042	[Cocaine co-treated with FOS protein mutant form] results in decreased expression of PBX2 mRNA	PMID:18355967
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621601	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PBX2 mRNA	PMID:21570461
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PBX2 mRNA	PMID:21215274|PMID:33387578
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1621601	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PBX2 mRNA	PMID:24058054
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PBX2 mRNA	PMID:23179753
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of PBX2 mRNA	PMID:26272509
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1350680	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBX2 mRNA	PMID:27188386
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1621601	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of PBX2 mRNA	PMID:30807115
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PBX2 mRNA	PMID:29803840
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1350680	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PBX2 protein	PMID:35688186
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1621601	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of PBX2 mRNA	PMID:17170073
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1350680	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PBX2 mRNA	PMID:39719251
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1621601	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of PBX2 mRNA	PMID:17127020
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1621601	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PBX2 mRNA	PMID:22228805
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350680	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PBX2 3' UTR; Benzo(a)pyrene results in increased methylation of PBX2 promoter	PMID:27901495
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1621601	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of PBX2 mRNA	PMID:27131904
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PBX2 mRNA	PMID:26238291
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PBX2 mRNA	PMID:30047161
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621601	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PBX2 gene	PMID:35295148
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PBX2 mRNA	PMID:34492290
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PBX2 mRNA	PMID:25181051
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PBX2 mRNA	PMID:36041667
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of PBX2 mRNA	PMID:15980968
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PBX2 mRNA	PMID:36041667
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PBX2 mRNA	PMID:36041667
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1350680	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of PBX2 gene	PMID:22964155
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350680	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PBX2 mRNA	PMID:37042841
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PBX2 promoter	PMID:22457795
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PBX2 mRNA	PMID:24386269
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002994	Clofibrate affects the expression of PBX2 mRNA	PMID:12851107
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350680	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PBX2 mRNA	PMID:25979313
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PBX2 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1350680	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of PBX2 mRNA	PMID:28001369
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1350680	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of PBX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBX2 mRNA	PMID:17183730|PMID:27188386
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PBX2 mRNA	PMID:30047161|PMID:38685447|PMID:41580965
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of PBX2 mRNA	PMID:22147139
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1621601	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PBX2 mRNA	PMID:18502557
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of PBX2 mRNA	PMID:24449571
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of PBX2 mRNA	PMID:21346803
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621601	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PBX2 mRNA	PMID:17562736
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of PBX2 mRNA	PMID:32479839|PMID:33387578
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PBX2 mRNA	PMID:22230336|PMID:29067470
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1350680	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PBX2 gene	PMID:25304211
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1350680	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PBX2 mRNA	PMID:22079256
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PBX2 mRNA	PMID:30047161|PMID:41580965
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1350680	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of PBX2 mRNA	PMID:17183730
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of PBX2 mRNA	PMID:27188386
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1621601	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of PBX2 mRNA	PMID:19812364
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1350680	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PBX2 mRNA	PMID:15336504
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:72544	flavonoids	increases expression	ISO	RGD:1350680	E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of PBX2 mRNA	PMID:15465739
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1621601	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PBX2 mRNA	PMID:22206623
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1350680	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PBX2 mRNA	PMID:22079256
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1350680	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PBX2 mRNA	PMID:22079256
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1350680	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of PBX2 mRNA	PMID:36318118
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1350680	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBX2 mRNA	PMID:27188386
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1621601	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PBX2 mRNA	PMID:21278054
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PBX2 mRNA	PMID:30047161
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1350680	E	RGD:6480464	20161228	CTD	MESH:C496932	[Cisplatin co-treated with panobinostat] affects the expression of PBX2 mRNA	PMID:21791302
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1350680	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBX2 mRNA	PMID:27188386
1303084	Pbx2	PBX homeobox 2	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1621601	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of PBX2 mRNA	PMID:27131904
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of GLTSCR2 mRNA	PMID:25812627
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1558540	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NOP53 mRNA	PMID:20188158
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of NOP53 mRNA	PMID:23724009
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1558540	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of NOP53 mRNA	PMID:30319688
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1353107	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of NOP53 mRNA	PMID:22574217
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of NOP53 mRNA	PMID:31614463
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1558540	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NOP53 mRNA	PMID:39298647
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1558540	E	RGD:6480464	20181016	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of NOP53 mRNA	PMID:28973375
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1558540	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NOP53 mRNA	PMID:33754040
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1558540	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of NOP53 mRNA	PMID:29279043
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1353107	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NOP53 protein	PMID:23301498
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NOP53 mRNA	PMID:27153756
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1558540	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NOP53 mRNA	PMID:40504410
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1353107	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of NOP53 protein	PMID:35688186
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1353107	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NOP53 mRNA	PMID:23557933
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1353107	E	RGD:6480464	20181016	CTD	MESH:D007854	Lead affects the expression of NOP53 mRNA	PMID:28903495
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1353107	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of NOP53 mRNA	PMID:27392435
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NOP53 mRNA	PMID:34747641
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1353107	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NOP53 mRNA	PMID:22574217
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NOP53 mRNA	PMID:21215274
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NOP53 mRNA	PMID:33387578
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1558540	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOP53 mRNA	PMID:17942748
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of GLTSCR2 mRNA	PMID:28374803
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NOP53 protein	PMID:33212167
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:2825	aristolochic acid A	multiple interactions	EXP		E	RGD:6480464	20160510	CTD	MESH:C000228	[aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of NOP53 mRNA	PMID:23912714
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1558540	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of NOP53 mRNA	PMID:30807115
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NOP53 mRNA	PMID:29803840
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353107	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NOP53 mRNA	PMID:38568856|PMID:39719251
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1558540	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NOP53 mRNA	PMID:40504410
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1353107	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of NOP53 mRNA	PMID:29453283
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1558540	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NOP53 mRNA	PMID:39716349
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of NOP53 mRNA	PMID:24136188
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of NOP53 mRNA	PMID:24136188
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1558540	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of NOP53 mRNA	PMID:23557971
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1558540	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NOP53 mRNA	PMID:18648102
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NOP53 protein	PMID:33376534
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NOP53 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:41034487
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1558540	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of NOP53 mRNA	PMID:26063408|PMID:32156529
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1558540	E	RGD:6480464	20200519	CTD	MESH:C543008	bisphenol S results in increased expression of NOP53 mRNA	PMID:31881267|PMID:39298647
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of NOP53 mRNA	PMID:21241498
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of NOP53 mRNA	PMID:17616710
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of GLTSCR2 mRNA	PMID:25812627
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1353107	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of NOP53 mRNA	PMID:19376846
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:3766	clozapine	affects expression	ISO	RGD:1558540	E	RGD:6480464	20120412	CTD	MESH:D003024	Clozapine affects the expression of NOP53 mRNA	PMID:14647396
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of GLTSCR2 mRNA	PMID:25812627
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1353107	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of NOP53 mRNA	PMID:26352163
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GLTSCR2 mRNA	PMID:25812627
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353107	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NOP53 mRNA	PMID:25979313
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of NOP53 mRNA	PMID:23179753|PMID:28001369
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1353107	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of NOP53 mRNA	PMID:20106945|PMID:27989131
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NOP53 mRNA	PMID:38832940
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1558540	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NOP53 mRNA	PMID:17562736
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NOP53 mRNA	PMID:33387578
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1558540	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NOP53 mRNA	PMID:40504410
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1353107	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NOP53 mRNA	PMID:22079256
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1558540	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOP53 mRNA	PMID:17942748
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1558540	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NOP53 mRNA	PMID:39716349
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1558540	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of NOP53 mRNA	PMID:25620056
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of NOP53 mRNA	PMID:34044035
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:5613	haloperidol	increases expression	ISO	RGD:1558540	E	RGD:6480464	20120412	CTD	MESH:D006220	Haloperidol results in increased expression of NOP53 mRNA	PMID:14647396
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NOP53 protein	PMID:32959892
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1353107	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NOP53 mRNA	PMID:31758290
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1558540	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GLTSCR2 mRNA	PMID:22206623
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1353107	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of NOP53 mRNA	PMID:22079256
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1353107	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NOP53 mRNA	PMID:22079256
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of NOP53 mRNA	PMID:32109520
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1558540	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of NOP53 mRNA	PMID:21278054
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1558540	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of NOP53 mRNA	PMID:40826991
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1353107	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NOP53 mRNA	PMID:38568856
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1353107	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of NOP53 mRNA	PMID:29301935
1303085	Nop53	NOP53 ribosome biogenesis factor	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1353107	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of NOP53 mRNA	PMID:27188386
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1351480	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ABCB7 mRNA	PMID:38218311
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1550653	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ABCB7 mRNA	PMID:37995155
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABCB7 mRNA]	PMID:31150632
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550653	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ABCB7 mRNA	PMID:26251327
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550653	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ABCB7 mRNA	PMID:39241906
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of ABCB7 mRNA	PMID:32145629
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1550653	E	RGD:6480464	20120522	CTD	MESH:D005947	Glucose results in decreased expression of ABCB7 mRNA	PMID:17178593
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1550653	E	RGD:6480464	20120522	CTD	MESH:D005947	Glucose results in decreased expression of ABCB7 mRNA	PMID:17178593
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550653	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ABCB7 mRNA	PMID:36331819
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1351480	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABCB7 mRNA	PMID:35301059
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:231505	gallium nitrate	decreases expression	ISO	RGD:1351480	E	RGD:6480464	20240702	CTD	MESH:C027235	gallium nitrate results in decreased expression of ABCB7 mRNA	PMID:18586083
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1351480	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ABCB7 protein	PMID:23301498
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1351480	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ABCB7 intron	PMID:30157460
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550653	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABCB7 mRNA	PMID:19770486
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1351480	E	RGD:6480464	20260707	CTD	MESH:D000452	Aldrin results in increased expression of ABCB7 mRNA	PMID:38723972
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ABCB7 mRNA	PMID:30779732
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ABCB7 mRNA	PMID:31150632
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABCB7 mRNA]	PMID:31150632
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ABCB7 mRNA	PMID:31881176
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1351480	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ABCB7 mRNA	PMID:23557933
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1351480	E	RGD:6480464	20120814	CTD	MESH:D002945	ABCB7 mRNA affects the susceptibility to Cisplatin	PMID:18610736
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550653	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ABCB7 mRNA	PMID:28213091
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550653	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ABCB7 gene]	PMID:28213091
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of ABCB7 protein	PMID:35544339
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1351480	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ABCB7 mRNA	PMID:33212167
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ABCB7 mRNA	PMID:28959563
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1351480	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABCB7 mRNA	PMID:29803840
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1351480	E	RGD:6480464	20120522	CTD	MESH:D024483	Vitamin K 3 affects the expression of ABCB7 mRNA	PMID:20044591
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1351480	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of ABCB7 mRNA	PMID:22378314
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351480	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ABCB7 promoter	PMID:27901495
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351480	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ABCB7 exon	PMID:27901495
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1550653	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in increased expression of ABCB7 protein	PMID:40770094
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1550653	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in increased expression of ABCB7 protein	PMID:40770094
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:31348	capecitabine	decreases response to substance	ISO	RGD:1351480	E	RGD:6480464	20170228	CTD	MESH:C110904	ABCB7 protein results in decreased susceptibility to Capecitabine	PMID:16734730
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ABCB7 mRNA	PMID:32479839
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550653	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ABCB7 gene	PMID:35295148
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550653	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ABCB7 mRNA	PMID:23811191
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCB7 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ABCB7 mRNA	PMID:32145629
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:3387	carbamazepine	increases expression	ISO	RGD:1351480	E	RGD:6480464	20120522	CTD	MESH:D002220	Carbamazepine results in increased expression of ABCB7 mRNA	PMID:17112801
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351480	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABCB7 mRNA	PMID:37042841
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1351480	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABCB7 mRNA	PMID:35301059
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1550653	E	RGD:6480464	20120522	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ABCB7 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ABCB7 mRNA]	PMID:17585979
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:37918	fluorescein 5-isothiocyanate	affects binding	ISO	RGD:1351480	E	RGD:6480464	20180116	CTD	MESH:D016650	Fluorescein-5-isothiocyanate binds to ABCB7 protein	PMID:27129696
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1351480	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ABCB7 mRNA	PMID:28302478
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550653	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ABCB7 mRNA	PMID:36331819
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351480	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABCB7 mRNA	PMID:25979313
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1351480	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ABCB7 mRNA	PMID:23179753|PMID:25192806|PMID:27188386
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ABCB7 mRNA	PMID:41580965
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1351480	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ABCB7 mRNA	PMID:25562108
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1550653	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in decreased expression of ABCB7 mRNA	PMID:17178593
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1351480	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ABCB7 mRNA	PMID:38832940
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCB7 mRNA	PMID:33387578
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1351480	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCB7 mRNA	PMID:29067470
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1550653	E	RGD:6480464	20120522	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ABCB7 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ABCB7 mRNA]	PMID:17585979
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1550653	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ABCB7 mRNA	PMID:35436446
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ABCB7 mRNA	PMID:24793618
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550653	E	RGD:6480464	20120522	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ABCB7 mRNA	PMID:19042947
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1351480	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ABCB7 protein	PMID:32959892
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ABCB7 gene	PMID:35440735
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550653	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ABCB7 mRNA	PMID:22206623
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:7602	nobiletin	multiple interactions	ISO	RGD:1351480	E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of ABCB7 protein]	PMID:38348393
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351480	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ABCB7 gene]	PMID:28238834
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550653	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ABCB7 mRNA	PMID:23091169
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1351480	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of ABCB7 protein	PMID:38348393
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1351480	E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of ABCB7 protein]	PMID:38348393
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1550653	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of ABCB7 mRNA	PMID:40826991
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120522	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ABCB7 mRNA	PMID:21346803
1303086	Abcb7	ATP binding cassette subfamily B member 7	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550653	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ABCB7 mRNA	PMID:35537566
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1624875	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of WFDC9 mRNA	PMID:33711761
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of WFDC9 gene	PMID:33854195
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350341	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of WFDC9 promoter	PMID:27901495
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350341	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WFDC9 3' UTR; Benzo(a)pyrene results in increased methylation of WFDC9 5' UTR	PMID:27901495
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1624875	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of WFDC9 mRNA	PMID:29264374
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of WFDC9 mRNA	PMID:25181051
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of WFDC9 gene	PMID:33854195
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of WFDC9 gene	PMID:33854195
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of WFDC9 gene	PMID:33854195
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of WFDC9 gene	PMID:33854195
1303087	Wfdc9	WAP four-disulfide core domain 9	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350341	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WFDC9 gene]	PMID:28238834
1303089	Gsn	gelsolin	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of GSN mRNA	PMID:25152437
1303089	Gsn	gelsolin	gene	CHEBI:131174	navitoclax	increases cleavage	ISO	RGD:1346375	E	RGD:6480464	20201103	CTD	MESH:C528561	navitoclax results in increased cleavage of GSN protein	PMID:21562047
1303089	Gsn	gelsolin	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1346375	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GSN mRNA	PMID:27188386
1303089	Gsn	gelsolin	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GSN protein]	PMID:38195004
1303089	Gsn	gelsolin	gene	CHEBI:134926	drometrizole	affects expression	ISO	RGD:1346375	E	RGD:6480464	20250805	CTD	MESH:C033674	benazol P affects the expression of GSN mRNA	PMID:36586167
1303089	Gsn	gelsolin	gene	CHEBI:136185	VX nerve agent	increases expression	ISO	RGD:1346375	E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of GSN mRNA	PMID:38555327
1303089	Gsn	gelsolin	gene	CHEBI:15365	acetylsalicylic acid	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D001241	Aspirin affects the expression of GSN protein	PMID:23533533
1303089	Gsn	gelsolin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1346375	E	RGD:6480464	20120613	CTD	MESH:D014212	Tretinoin results in increased expression of GSN mRNA	PMID:15498508|PMID:16054129|PMID:33167477|PMID:38091671
1303089	Gsn	gelsolin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of GSN mRNA	PMID:16604517
1303089	Gsn	gelsolin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of GSN mRNA	PMID:30951980
1303089	Gsn	gelsolin	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GSN mRNA	PMID:36331819
1303089	Gsn	gelsolin	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1346375	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of GSN mRNA	PMID:22378314
1303089	Gsn	gelsolin	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1550660	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of GSN mRNA	PMID:40945087
1303089	Gsn	gelsolin	gene	CHEBI:16130	DDT	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20121218	CTD	MESH:D003634	[DDT results in increased activity of ESR1 protein] which results in decreased expression of GSN mRNA	PMID:22403704
1303089	Gsn	gelsolin	gene	CHEBI:16170	mercury(0)	affects expression	ISO	RGD:1346375	E	RGD:6480464	20120814	CTD	MESH:D008628	Mercury affects the expression of GSN protein	PMID:22030286
1303089	Gsn	gelsolin	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of GSN mRNA	PMID:17547211
1303089	Gsn	gelsolin	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of GSN mRNA	PMID:20044591
1303089	Gsn	gelsolin	gene	CHEBI:16240	hydrogen peroxide	decreases secretion	ISO	RGD:1550660	E	RGD:6480464	20121218	CTD	MESH:D006861	Hydrogen Peroxide results in decreased secretion of GSN mRNA	PMID:21179422
1303089	Gsn	gelsolin	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1346375	E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of GSN mRNA	PMID:39709020
1303089	Gsn	gelsolin	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D006861	[Hyaluronic Acid analog co-treated with Hydrogen Peroxide] results in decreased expression of GSN protein	PMID:23178681
1303089	Gsn	gelsolin	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1346375	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of GSN mRNA	PMID:21632981
1303089	Gsn	gelsolin	gene	CHEBI:16336	hyaluronic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D006820	Hyaluronic Acid analog results in decreased expression of GSN protein	PMID:23178681
1303089	Gsn	gelsolin	gene	CHEBI:16336	hyaluronic acid	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D006820	[Hyaluronic Acid analog co-treated with Hydrogen Peroxide] results in decreased expression of GSN protein	PMID:23178681
1303089	Gsn	gelsolin	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550660	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GSN mRNA	PMID:27339419
1303089	Gsn	gelsolin	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of GSN mRNA	PMID:32145629
1303089	Gsn	gelsolin	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1346375	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of GSN mRNA	PMID:22574217
1303089	Gsn	gelsolin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550660	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of GSN mRNA	PMID:39298647
1303089	Gsn	gelsolin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol results in increased activity of ESR1 protein] which results in decreased expression of GSN mRNA; Estradiol inhibits the reaction [ESR1 protein binds to GSN protein]	PMID:22403704|PMID:29389661
1303089	Gsn	gelsolin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of GSN mRNA	PMID:18556351
1303089	Gsn	gelsolin	gene	CHEBI:16480	nitric oxide	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide deficiency results in increased expression of GSN mRNA	PMID:15878706
1303089	Gsn	gelsolin	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GSN protein	PMID:21673325
1303089	Gsn	gelsolin	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of GSN protein	PMID:20109541
1303089	Gsn	gelsolin	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of GSN mRNA	PMID:38568856
1303089	Gsn	gelsolin	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of GSN mRNA	PMID:20196124
1303089	Gsn	gelsolin	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20130910	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of GSN mRNA	PMID:18556351
1303089	Gsn	gelsolin	gene	CHEBI:17234	glucose	decreases secretion	ISO	RGD:1346375	E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency results in decreased secretion of GSN protein	PMID:24802182
1303089	Gsn	gelsolin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GSN mRNA	PMID:37992649
1303089	Gsn	gelsolin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550660	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of GSN protein	PMID:20463053
1303089	Gsn	gelsolin	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of GSN mRNA	PMID:21592394
1303089	Gsn	gelsolin	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of GSN mRNA	PMID:20403060
1303089	Gsn	gelsolin	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of GSN mRNA	PMID:21592394
1303089	Gsn	gelsolin	gene	CHEBI:17634	D-glucose	decreases secretion	ISO	RGD:1346375	E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency results in decreased secretion of GSN protein	PMID:24802182
1303089	Gsn	gelsolin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GSN mRNA	PMID:37992649
1303089	Gsn	gelsolin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1346375	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of GSN mRNA	PMID:31163220
1303089	Gsn	gelsolin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of GSN mRNA	PMID:25031359
1303089	Gsn	gelsolin	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of GSN mRNA	PMID:26577399|PMID:27523638
1303089	Gsn	gelsolin	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in increased expression of GSN protein	PMID:34122009
1303089	Gsn	gelsolin	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of GSN mRNA	PMID:21592394
1303089	Gsn	gelsolin	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of GSN mRNA	PMID:21592394
1303089	Gsn	gelsolin	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of GSN protein	PMID:22061828
1303089	Gsn	gelsolin	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D014520	Urethane results in decreased expression of GSN mRNA	PMID:16289808
1303089	Gsn	gelsolin	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1346375	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of GSN intron	PMID:30157460
1303089	Gsn	gelsolin	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GSN mRNA	PMID:36331819
1303089	Gsn	gelsolin	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GSN mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of GSN mRNA	PMID:39836092
1303089	Gsn	gelsolin	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of GSN mRNA	PMID:21515302
1303089	Gsn	gelsolin	gene	CHEBI:22977	cadmium atom	affects binding	ISO	RGD:1346375	E	RGD:6480464	20150512	CTD	MESH:D002104	GSN protein binds to Cadmium	PMID:23896426
1303089	Gsn	gelsolin	gene	CHEBI:22977	cadmium atom	affects localization	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium affects the localization of GSN protein	PMID:22553113
1303089	Gsn	gelsolin	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in decreased expression of GSN mRNA	PMID:17547211
1303089	Gsn	gelsolin	gene	CHEBI:22977	cadmium atom	increases oxidation	ISO	RGD:1550660	E	RGD:6480464	20150310	CTD	MESH:D002104	Cadmium results in increased oxidation of GSN protein	PMID:24077948
1303089	Gsn	gelsolin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20210706	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GSN protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GSN protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GSN protein	PMID:33040242|PMID:38195004
1303089	Gsn	gelsolin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GSN mRNA	PMID:37236586
1303089	Gsn	gelsolin	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GSN mRNA	PMID:29950665
1303089	Gsn	gelsolin	gene	CHEBI:233415	Pf-06840003	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20250408	CTD	MESH:C000625742	PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in increased expression of GSN mRNA]	PMID:39172838
1303089	Gsn	gelsolin	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of GSN mRNA	PMID:21396975
1303089	Gsn	gelsolin	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of GSN protein	PMID:20106945
1303089	Gsn	gelsolin	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GSN mRNA	PMID:33354967
1303089	Gsn	gelsolin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1346375	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GSN mRNA	PMID:21632981|PMID:22100608|PMID:27153756
1303089	Gsn	gelsolin	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of GSN mRNA	PMID:26760959
1303089	Gsn	gelsolin	gene	CHEBI:25195	mercury atom	affects expression	ISO	RGD:1346375	E	RGD:6480464	20120814	CTD	MESH:D008628	Mercury affects the expression of GSN protein	PMID:22030286
1303089	Gsn	gelsolin	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of GSN mRNA	PMID:17547211
1303089	Gsn	gelsolin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA	PMID:33656867
1303089	Gsn	gelsolin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GSN mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GSN mRNA	PMID:34911549
1303089	Gsn	gelsolin	gene	CHEBI:2654	aminoglutethimide	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of GSN protein	PMID:26102013
1303089	Gsn	gelsolin	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of GSN mRNA	PMID:17991464
1303089	Gsn	gelsolin	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of GSN protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of GSN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of GSN protein	PMID:38598786
1303089	Gsn	gelsolin	gene	CHEBI:27363	zinc atom	affects binding	ISO	RGD:1346375	E	RGD:6480464	20150512	CTD	MESH:D015032	GSN protein binds to Zinc	PMID:23896426
1303089	Gsn	gelsolin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550660	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GSN mRNA	PMID:27339419
1303089	Gsn	gelsolin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GSN mRNA	PMID:22206623
1303089	Gsn	gelsolin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GSN mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of GSN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GSN mRNA	PMID:39836092|PMID:40512198
1303089	Gsn	gelsolin	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of GSN mRNA	PMID:19244175
1303089	Gsn	gelsolin	gene	CHEBI:27569	arabinogalactan	decreases expression	EXP		E	RGD:329333030|PMID:28622474	20230426	RGD		arabinogalactan decreases expression of Gsn protein in heart	
1303089	Gsn	gelsolin	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20130212	CTD	MESH:C059514	[resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of GSN protein	PMID:19423619
1303089	Gsn	gelsolin	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1346375	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of GSN mRNA	PMID:28903495
1303089	Gsn	gelsolin	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of GSN mRNA	PMID:21151649
1303089	Gsn	gelsolin	gene	CHEBI:27924	phenylhydrazine	affects response to substance	ISO	RGD:1550660	E	RGD:6480464	20170725	CTD	MESH:C030299	GSN protein affects the susceptibility to phenylhydrazine	PMID:22271892
1303089	Gsn	gelsolin	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of GSN mRNA	PMID:12629581
1303089	Gsn	gelsolin	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D019833	[Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of GSN mRNA	PMID:25031359
1303089	Gsn	gelsolin	gene	CHEBI:28112	nickel atom	affects binding	ISO	RGD:1346375	E	RGD:6480464	20150512	CTD	MESH:D009532	GSN protein binds to Nickel	PMID:23896426
1303089	Gsn	gelsolin	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of GSN mRNA	PMID:25583101
1303089	Gsn	gelsolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GSN mRNA	PMID:22298810|PMID:34747641
1303089	Gsn	gelsolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550660	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GSN mRNA	PMID:26377647
1303089	Gsn	gelsolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GSN mRNA	PMID:21215274
1303089	Gsn	gelsolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GSN mRNA	PMID:20044593|PMID:33956508
1303089	Gsn	gelsolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1346375	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GSN mRNA	PMID:20044593|PMID:20106945|PMID:21632981
1303089	Gsn	gelsolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GSN mRNA	PMID:17035482|PMID:19770486
1303089	Gsn	gelsolin	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GSN mRNA	PMID:23179753|PMID:28001369
1303089	Gsn	gelsolin	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GSN mRNA	PMID:33212167
1303089	Gsn	gelsolin	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of GSN mRNA	PMID:28959563
1303089	Gsn	gelsolin	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1346375	E	RGD:6480464	20240903	CTD	MESH:D020106	Acrylamide results in increased expression of GSN mRNA	PMID:38554842
1303089	Gsn	gelsolin	gene	CHEBI:28694	copper atom	affects binding	ISO	RGD:1346375	E	RGD:6480464	20150512	CTD	MESH:D003300	GSN protein binds to Copper	PMID:23896426
1303089	Gsn	gelsolin	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of GSN mRNA	PMID:15878706
1303089	Gsn	gelsolin	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of GSN protein	PMID:28918527
1303089	Gsn	gelsolin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1346375	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of GSN mRNA	PMID:29803840
1303089	Gsn	gelsolin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of GSN mRNA	PMID:15033991
1303089	Gsn	gelsolin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GSN mRNA	PMID:37992649
1303089	Gsn	gelsolin	gene	CHEBI:28787	nitroglycerin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005996	Nitroglycerin results in increased expression of GSN mRNA	PMID:12187120
1303089	Gsn	gelsolin	gene	CHEBI:28869	menadione	affects response to substance	ISO	RGD:1346375	E	RGD:6480464	20120613	CTD	MESH:D024483	GSN mRNA affects the susceptibility to Vitamin K 3	PMID:14652020|PMID:15033777
1303089	Gsn	gelsolin	gene	CHEBI:29191	hydroxyl	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA	PMID:33656867
1303089	Gsn	gelsolin	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20150310	CTD	MESH:D006046	Gold analog results in decreased expression of GSN protein	PMID:24780912
1303089	Gsn	gelsolin	gene	CHEBI:29287	gold atom	increases degradation	ISO	RGD:1346375	E	RGD:6480464	20170516	CTD	MESH:D006046	Gold analog results in increased degradation of GSN protein	PMID:26551149
1303089	Gsn	gelsolin	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1550660	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the expression of GSN mRNA	PMID:17450228
1303089	Gsn	gelsolin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of GSN protein	PMID:29459688
1303089	Gsn	gelsolin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of GSN mRNA; sodium arsenite results in decreased expression of GSN protein	PMID:29044176|PMID:37682722
1303089	Gsn	gelsolin	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1550660	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of GSN gene	PMID:39894169
1303089	Gsn	gelsolin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346375	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GSN mRNA	PMID:38568856
1303089	Gsn	gelsolin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GSN mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of GSN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GSN mRNA	PMID:39836092|PMID:40512198
1303089	Gsn	gelsolin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346375	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GSN 5' UTR	PMID:27901495
1303089	Gsn	gelsolin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GSN mRNA	PMID:19770486|PMID:22228805
1303089	Gsn	gelsolin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1346375	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GSN mRNA	PMID:22316170
1303089	Gsn	gelsolin	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20150310	CTD	MESH:D006046	Gold analog results in decreased expression of GSN protein	PMID:24780912
1303089	Gsn	gelsolin	gene	CHEBI:30050	gold(0)	increases degradation	ISO	RGD:1346375	E	RGD:6480464	20170516	CTD	MESH:D006046	Gold analog results in increased degradation of GSN protein	PMID:26551149
1303089	Gsn	gelsolin	gene	CHEBI:30052	copper(0)	affects binding	ISO	RGD:1346375	E	RGD:6480464	20150512	CTD	MESH:D003300	GSN protein binds to Copper	PMID:23896426
1303089	Gsn	gelsolin	gene	CHEBI:30185	zinc(0)	affects binding	ISO	RGD:1346375	E	RGD:6480464	20150512	CTD	MESH:D015032	GSN protein binds to Zinc	PMID:23896426
1303089	Gsn	gelsolin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of GSN mRNA	PMID:25895662
1303089	Gsn	gelsolin	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GSN protein]	PMID:26598702
1303089	Gsn	gelsolin	gene	CHEBI:30772	butyric acid	increases expression	ISO	RGD:1346375	E	RGD:6480464	20220607	CTD	MESH:D020148	Butyric Acid results in increased expression of GSN mRNA	PMID:34581912
1303089	Gsn	gelsolin	gene	CHEBI:3139	bleomycin A2	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001761	Bleomycin results in decreased expression of GSN protein	PMID:25933445
1303089	Gsn	gelsolin	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of GSN gene	PMID:31601247
1303089	Gsn	gelsolin	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1346375	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of GSN mRNA	PMID:15498508
1303089	Gsn	gelsolin	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of GSN mRNA	PMID:21515302
1303089	Gsn	gelsolin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of GSN mRNA	PMID:23557971|PMID:27760801
1303089	Gsn	gelsolin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550660	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GSN gene; titanium dioxide results in decreased methylation of GSN promoter	PMID:35295148
1303089	Gsn	gelsolin	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GSN mRNA	PMID:29950665
1303089	Gsn	gelsolin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of GSN mRNA	PMID:18648102
1303089	Gsn	gelsolin	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of GSN mRNA	PMID:17426115
1303089	Gsn	gelsolin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550660	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of GSN mRNA	PMID:23811191
1303089	Gsn	gelsolin	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GSN mRNA	PMID:19710929
1303089	Gsn	gelsolin	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of GSN mRNA	PMID:19191707
1303089	Gsn	gelsolin	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GSN mRNA	PMID:25181051|PMID:32145629
1303089	Gsn	gelsolin	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1346375	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of GSN mRNA	PMID:30903817
1303089	Gsn	gelsolin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of GSN mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1303089	Gsn	gelsolin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1346375	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GSN gene	PMID:31601247
1303089	Gsn	gelsolin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550660	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of GSN mRNA	PMID:30951980|PMID:32156529|PMID:34585602
1303089	Gsn	gelsolin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20121218	CTD	MESH:C006780	[bisphenol A binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to GSN protein modified form]; [bisphenol A co-treated with Fulvestrant] results in decreased methylation of GSN gene; [bisphenol A results in increased activity of ESR1 protein] which results in decreased expression of GSN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GSN mRNA; bisphenol A inhibits the reaction [ESR1 protein binds to GSN protein]	PMID:22403704|PMID:28628672|PMID:28751236|PMID:29389661|PMID:31601247
1303089	Gsn	gelsolin	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1346375	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of GSN mRNA	PMID:19244175
1303089	Gsn	gelsolin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550660	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of GSN mRNA	PMID:30951980|PMID:40203079
1303089	Gsn	gelsolin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20180703	CTD	MESH:C543008	bisphenol S inhibits the reaction [ESR1 protein binds to GSN protein]	PMID:29389661
1303089	Gsn	gelsolin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1346375	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of GSN protein	PMID:34186270
1303089	Gsn	gelsolin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550660	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of GSN mRNA	PMID:30951980|PMID:36706583
1303089	Gsn	gelsolin	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of GSN mRNA	PMID:30951980
1303089	Gsn	gelsolin	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1346375	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of GSN protein	PMID:34186270
1303089	Gsn	gelsolin	gene	CHEBI:34656	cumene	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:C015763	cumene results in decreased expression of GSN mRNA	PMID:18648096
1303089	Gsn	gelsolin	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GSN mRNA	PMID:29950665
1303089	Gsn	gelsolin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of GSN mRNA	PMID:21266533
1303089	Gsn	gelsolin	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of GSN protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of GSN protein	PMID:38598786
1303089	Gsn	gelsolin	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GSN mRNA	PMID:28628672
1303089	Gsn	gelsolin	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346375	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GSN mRNA	PMID:37042841
1303089	Gsn	gelsolin	gene	CHEBI:351346	phenethyl isothiocyanate	increases expression	ISO	RGD:1346375	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in increased expression of GSN mRNA	PMID:26678675
1303089	Gsn	gelsolin	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GSN mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of GSN mRNA	PMID:39836092
1303089	Gsn	gelsolin	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GSN mRNA	PMID:17547211
1303089	Gsn	gelsolin	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of GSN promoter	PMID:22457795
1303089	Gsn	gelsolin	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1346375	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GSN mRNA	PMID:38382870
1303089	Gsn	gelsolin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20210706	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GSN protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GSN protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of GSN protein	PMID:33040242|PMID:38195004
1303089	Gsn	gelsolin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GSN mRNA	PMID:37236586
1303089	Gsn	gelsolin	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of GSN mRNA	PMID:27387713
1303089	Gsn	gelsolin	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GSN mRNA	PMID:19320972
1303089	Gsn	gelsolin	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of GSN mRNA	PMID:17547211
1303089	Gsn	gelsolin	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1550660	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of GSN mRNA	PMID:18353800
1303089	Gsn	gelsolin	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of GSN mRNA	PMID:19244175
1303089	Gsn	gelsolin	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20180116	CTD	MESH:D015741	[Metribolone binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to GSN protein modified form]	PMID:28751236
1303089	Gsn	gelsolin	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GSN mRNA	PMID:31533062
1303089	Gsn	gelsolin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GSN mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GSN mRNA	PMID:36331819
1303089	Gsn	gelsolin	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of GSN mRNA]	PMID:18200517
1303089	Gsn	gelsolin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346375	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of GSN mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386
1303089	Gsn	gelsolin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in increased expression of GSN mRNA	PMID:20546886
1303089	Gsn	gelsolin	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of GSN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSN mRNA	PMID:17183730|PMID:27188386
1303089	Gsn	gelsolin	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of GSN mRNA	PMID:38685447
1303089	Gsn	gelsolin	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of GSN mRNA	PMID:41580965
1303089	Gsn	gelsolin	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of GSN mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1303089	Gsn	gelsolin	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1346375	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of GSN mRNA	PMID:25047013
1303089	Gsn	gelsolin	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1550660	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of GSN mRNA	PMID:22733784
1303089	Gsn	gelsolin	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GSN mRNA	PMID:28628672
1303089	Gsn	gelsolin	gene	CHEBI:42758	aldehydo-D-glucose	decreases secretion	ISO	RGD:1346375	E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency results in decreased secretion of GSN protein	PMID:24802182
1303089	Gsn	gelsolin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GSN mRNA	PMID:37992649
1303089	Gsn	gelsolin	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1346375	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of GSN mRNA	PMID:21678067
1303089	Gsn	gelsolin	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of GSN mRNA	PMID:18769122
1303089	Gsn	gelsolin	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of GSN mRNA	PMID:15000894
1303089	Gsn	gelsolin	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1346375	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of GSN mRNA	PMID:28542535
1303089	Gsn	gelsolin	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C012589	trichostatin A results in increased expression of GSN protein	PMID:12445420
1303089	Gsn	gelsolin	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1346375	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of GSN mRNA	PMID:24935251|PMID:26272509
1303089	Gsn	gelsolin	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSN mRNA	PMID:27188386
1303089	Gsn	gelsolin	gene	CHEBI:4610	dimethylselenide	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA	PMID:33656867
1303089	Gsn	gelsolin	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GSN protein	PMID:16099942
1303089	Gsn	gelsolin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GSN mRNA	PMID:17562736
1303089	Gsn	gelsolin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of GSN mRNA	PMID:29067470
1303089	Gsn	gelsolin	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20150414	CTD	MESH:D000082	[CTH gene mutant form results in increased susceptibility to Acetaminophen] which results in increased expression of GSN protein	PMID:25499718
1303089	Gsn	gelsolin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GSN mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of GSN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GSN mRNA	PMID:39836092|PMID:40512198
1303089	Gsn	gelsolin	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of GSN mRNA	PMID:26934552
1303089	Gsn	gelsolin	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of GSN mRNA	PMID:31838189
1303089	Gsn	gelsolin	gene	CHEBI:47807	sulforaphane	increases methylation	ISO	RGD:1346375	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased methylation of GSN gene	PMID:31838189
1303089	Gsn	gelsolin	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GSN mRNA	PMID:29391264
1303089	Gsn	gelsolin	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1346375	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of GSN mRNA	PMID:38568856
1303089	Gsn	gelsolin	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GSN mRNA	PMID:28628672
1303089	Gsn	gelsolin	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GSN protein]	PMID:26598702
1303089	Gsn	gelsolin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of GSN mRNA]	PMID:21095227
1303089	Gsn	gelsolin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GSN mRNA; Nanotubes, Carbon results in decreased expression of GSN mRNA	PMID:25554681|PMID:25620056
1303089	Gsn	gelsolin	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20161228	CTD	MESH:D037742	[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of GSN protein	PMID:23026733
1303089	Gsn	gelsolin	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of GSN mRNA	PMID:23962444
1303089	Gsn	gelsolin	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GSN mRNA	PMID:35964746
1303089	Gsn	gelsolin	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of GSN mRNA	PMID:21983209
1303089	Gsn	gelsolin	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1346375	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of GSN mRNA	PMID:18651567
1303089	Gsn	gelsolin	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20120717	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of GSN mRNA	PMID:17982090|PMID:18200517
1303089	Gsn	gelsolin	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of GSN mRNA]	PMID:18200517
1303089	Gsn	gelsolin	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1346375	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of GSN protein	PMID:23718831
1303089	Gsn	gelsolin	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of GSN mRNA	PMID:17183730
1303089	Gsn	gelsolin	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GSN protein	PMID:32959892
1303089	Gsn	gelsolin	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GSN mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of GSN mRNA	PMID:39836092
1303089	Gsn	gelsolin	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GSN mRNA	PMID:26378955
1303089	Gsn	gelsolin	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of GSN mRNA	PMID:15003993
1303089	Gsn	gelsolin	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of GSN mRNA	PMID:36907384
1303089	Gsn	gelsolin	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of GSN mRNA	PMID:17547211
1303089	Gsn	gelsolin	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	ISO	RGD:1346375	E	RGD:6480464	20130910	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of GSN mRNA	PMID:18497975
1303089	Gsn	gelsolin	gene	CHEBI:67895	corosolic acid	increases expression	ISO	RGD:1346375	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of GSN mRNA	PMID:37939859
1303089	Gsn	gelsolin	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:D008687	Metformin results in increased expression of GSN mRNA	PMID:19022234
1303089	Gsn	gelsolin	gene	CHEBI:68508	diethyl maleate	decreases reduction	ISO	RGD:1550660	E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased reduction of GSN protein	PMID:19843705
1303089	Gsn	gelsolin	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of GSN mRNA	PMID:17654400
1303089	Gsn	gelsolin	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in increased expression of GSN protein	PMID:34122009
1303089	Gsn	gelsolin	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of GSN mRNA	PMID:31758290
1303089	Gsn	gelsolin	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1346375	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GSN protein	PMID:34186270
1303089	Gsn	gelsolin	gene	CHEBI:72754	bisphenol AF	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20250114	CTD	MESH:C583074	[bisphenol AF binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to GSN protein modified form]	PMID:28751236
1303089	Gsn	gelsolin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GSN mRNA	PMID:22206623
1303089	Gsn	gelsolin	gene	CHEBI:749466	calfactant	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20260721	CTD	MESH:C117342	[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of GSN protein	PMID:23026733
1303089	Gsn	gelsolin	gene	CHEBI:77012	methylseleninic acid	increases expression	ISO	RGD:1346375	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of GSN mRNA	PMID:18548127
1303089	Gsn	gelsolin	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014700	Verapamil affects the expression of GSN protein	PMID:23533533
1303089	Gsn	gelsolin	gene	CHEBI:77850	toxaphene	increases degradation	ISO	RGD:1346375	E	RGD:6480464	20140415	CTD	MESH:D014112	Toxaphene results in increased degradation of GSN protein	PMID:12139946
1303089	Gsn	gelsolin	gene	CHEBI:77850	toxaphene	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20140415	CTD	MESH:D014112	CAT protein inhibits the reaction [Toxaphene results in increased degradation of GSN protein]	PMID:12139946
1303089	Gsn	gelsolin	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSN mRNA	PMID:27188386
1303089	Gsn	gelsolin	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1550660	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of GSN mRNA	PMID:26655953
1303089	Gsn	gelsolin	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of GSN mRNA	PMID:19482888
1303089	Gsn	gelsolin	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1550660	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of GSN mRNA]	PMID:19482888
1303089	Gsn	gelsolin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550660	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of GSN mRNA	PMID:38648751
1303089	Gsn	gelsolin	gene	CHEBI:85014	2,5-hexanedione	decreases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in decreased expression of GSN protein	PMID:19033394
1303089	Gsn	gelsolin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GSN mRNA	PMID:24780913|PMID:25825206
1303089	Gsn	gelsolin	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSN mRNA	PMID:27188386
1303089	Gsn	gelsolin	gene	CHEBI:9180	Sodium salicylate	increases cleavage	ISO	RGD:1346375	E	RGD:6480464	20141111	CTD	MESH:D012980	Sodium Salicylate results in increased cleavage of GSN protein	PMID:10090950
1303089	Gsn	gelsolin	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of GSN mRNA	PMID:19281266
1303089	Gsn	gelsolin	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D013605	T-2 Toxin results in increased expression of GSN mRNA	PMID:42167635
1303089	Gsn	gelsolin	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GSN mRNA	PMID:29301935
1303089	Gsn	gelsolin	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of GSN protein	PMID:35544339
1303089	Gsn	gelsolin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1346375	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of GSN protein	PMID:38598786
1303089	Gsn	gelsolin	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C057693	troglitazone results in decreased expression of GSN mRNA	PMID:19022234
1303089	Gsn	gelsolin	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1346375	E	RGD:6480464	20120412	CTD	MESH:C057693	troglitazone results in decreased expression of GSN mRNA	PMID:19022234
1303089	Gsn	gelsolin	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550660	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of GSN mRNA	PMID:28973697
1303089	Gsn	gelsolin	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1346375	E	RGD:6480464	20140408	CTD	MESH:C057693	troglitazone results in increased expression of GSN mRNA	PMID:22684020
1303089	Gsn	gelsolin	gene	CHEBI:9948	verapamil	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014700	Verapamil affects the expression of GSN protein	PMID:23533533
1303089	Gsn	gelsolin	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of GSN mRNA	PMID:19015723
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1550661	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of RPP21 mRNA	PMID:25056781
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550661	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RPP21 mRNA	PMID:39298647
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of RPP21 mRNA	PMID:32145629
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:17151	xylitol	decreases expression	ISO	RGD:1346051	E	RGD:6480464	20200804	CTD	MESH:D014993	Xylitol results in decreased expression of RPP21 mRNA	PMID:32275922
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of RPP21 mRNA	PMID:22967744
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550661	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RPP21 mRNA	PMID:33754040
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RPP21 mRNA	PMID:33387578
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPP21 mRNA	PMID:39836092
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1346051	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of RPP21 mRNA	PMID:20823114
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1346051	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RPP21 mRNA	PMID:19549813
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:24527	herbicide	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20220906	CTD	MESH:D006540	[Herbicides results in increased abundance of metolachlor] which affects the methylation of RPP21 gene	PMID:34516295
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1550661	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of RPP21 mRNA	PMID:25056781
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550661	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPP21 mRNA	PMID:22206623
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPP21 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPP21 mRNA	PMID:39836092
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RPP21 mRNA	PMID:31881176
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550661	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPP21 mRNA	PMID:21570461
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RPP21 mRNA	PMID:21215274|PMID:32109520
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550661	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RPP21 mRNA	PMID:19770486
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPP21 mRNA	PMID:18796159|PMID:33387578|PMID:34747641
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1346051	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RPP21 mRNA	PMID:34089799
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1550661	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of RPP21 gene	PMID:32068019
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPP21 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPP21 mRNA	PMID:39836092
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346051	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RPP21 promoter	PMID:27901495
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550661	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RPP21 mRNA]	PMID:22228805
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RPP21 mRNA	PMID:30047161
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550661	E	RGD:6480464	20150310	CTD	MESH:C009495	titanium dioxide analog results in decreased expression of RPP21 mRNA	PMID:25111187
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550661	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RPP21 promoter	PMID:35295148
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RPP21 mRNA	PMID:34492290
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1550661	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of RPP21 mRNA	PMID:18648102
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RPP21 mRNA	PMID:30903817
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1346051	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RPP21 mRNA	PMID:30903817
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550661	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of RPP21 mRNA	PMID:30245210
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RPP21 mRNA	PMID:25181051|PMID:32145629
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550661	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RPP21 mRNA	PMID:39298647
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1346051	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RPP21 gene	PMID:31601247
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550661	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RPP21 mRNA	PMID:38685157
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550661	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RPP21 mRNA	PMID:37019170
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPP21 mRNA	PMID:39836092
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RPP21 promoter	PMID:22457795
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RPP21 mRNA	PMID:19162173
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:37825	p-toluidine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of RPP21 mRNA	PMID:27638505
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RPP21 mRNA	PMID:19162173
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346051	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RPP21 mRNA	PMID:25979313
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RPP21 mRNA	PMID:17183730
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RPP21 mRNA	PMID:30047161
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550661	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of RPP21 mRNA	PMID:19770486
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346051	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RPP21 mRNA	PMID:20106945|PMID:25562108
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550661	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RPP21 mRNA	PMID:17562736
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RPP21 mRNA	PMID:33387578
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPP21 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPP21 mRNA	PMID:39836092
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550661	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RPP21 mRNA	PMID:35436446
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RPP21 mRNA	PMID:17183730
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RPP21 mRNA	PMID:39836092
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of RPP21 mRNA	PMID:24136188
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1550661	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of RPP21 mRNA	PMID:23650126
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of RPP21 mRNA	PMID:30467583
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:6902	metolachlor	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20220906	CTD	MESH:C051786	[Herbicides results in increased abundance of metolachlor] which affects the methylation of RPP21 gene	PMID:34516295
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1346051	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RPP21 mRNA	PMID:31758290
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550661	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPP21 mRNA	PMID:22206623
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of RPP21 mRNA	PMID:24136188
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1346051	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RPP21 mRNA	PMID:37199045
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346051	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RPP21 gene]	PMID:28238834
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of RPP21 mRNA	PMID:30047161
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RPP21 mRNA	PMID:30047161
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1550661	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in increased expression of RPP21 protein	PMID:26903627
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1346051	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of RPP21 mRNA	PMID:34581912
1303090	Rpp21	ribonuclease P subunit p21	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of RPP21 mRNA	PMID:30047161
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1552636	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of KCNK18 mRNA	PMID:37995155
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:15854	quinine	multiple interactions	ISO	RGD:1346775	E	RGD:6480464	20120412	CTD	MESH:D011803	Quinine inhibits the reaction [KCNK18 protein results in increased transport of Potassium]	PMID:12754259
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KCNK18 mRNA	PMID:33387578
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552636	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KCNK18 mRNA	PMID:28085963
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KCNK18 mRNA	PMID:33387578
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:26216	potassium atom	increases transport	ISO	RGD:1346775	E	RGD:6480464	20120412	CTD	MESH:D011188	KCNK18 protein results in increased transport of Potassium	PMID:12754259|PMID:18568022
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:26216	potassium atom	multiple interactions	ISO	RGD:1346775	E	RGD:6480464	20120412	CTD	MESH:D011188	Barium inhibits the reaction [KCNK18 protein results in increased transport of Potassium]; Glyburide inhibits the reaction [KCNK18 protein results in increased transport of Potassium]; Lidocaine inhibits the reaction [KCNK18 protein results in increased transport of Potassium]; Propafenone inhibits the reaction [KCNK18 protein results in increased transport of Potassium]; Quinidine inhibits the reaction [KCNK18 protein results in increased transport of Potassium]; Quinine inhibits the reaction [KCNK18 protein results in increased transport of Potassium]; sanshool inhibits the reaction [KCNK18 protein results in increased transport of Potassium]; triethanolamine inhibits the reaction [KCNK18 protein results in increased transport of Potassium]	PMID:12754259|PMID:18568022
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1346775	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KCNK18 gene	PMID:25304211
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552636	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KCNK18 mRNA	PMID:21570461
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KCNK18 mRNA	PMID:33387578
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:28593	quinidine	multiple interactions	ISO	RGD:1346775	E	RGD:6480464	20120412	CTD	MESH:D011802	Quinidine inhibits the reaction [KCNK18 protein results in increased transport of Potassium]	PMID:12754259
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:28621	triethanolamine	multiple interactions	ISO	RGD:1346775	E	RGD:6480464	20120412	CTD	MESH:C009546	triethanolamine inhibits the reaction [KCNK18 protein results in increased transport of Potassium]	PMID:12754259
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346775	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of KCNK18 mRNA	PMID:25879800
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552636	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of KCNK18 mRNA	PMID:37682722
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346775	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KCNK18 exon; Benzo(a)pyrene results in increased methylation of KCNK18 promoter	PMID:27901495
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552636	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to KCNK18 promoter]	PMID:19654925
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552636	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of KCNK18 mRNA	PMID:35295148
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:32595	barium(0)	multiple interactions	ISO	RGD:1346775	E	RGD:6480464	20120412	CTD	MESH:D001464	Barium inhibits the reaction [KCNK18 protein results in increased transport of Potassium]	PMID:12754259
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KCNK18 mRNA	PMID:25181051
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552636	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KCNK18 mRNA	PMID:37019170
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1346775	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KCNK18 gene	PMID:29154799
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KCNK18 mRNA	PMID:33387578
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1346775	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KCNK18 gene	PMID:25304211
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:5441	glyburide	multiple interactions	ISO	RGD:1346775	E	RGD:6480464	20120412	CTD	MESH:D005905	Glyburide inhibits the reaction [KCNK18 protein results in increased transport of Potassium]	PMID:12754259
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:63619	propafenone	multiple interactions	ISO	RGD:1346775	E	RGD:6480464	20120412	CTD	MESH:D011405	Propafenone inhibits the reaction [KCNK18 protein results in increased transport of Potassium]	PMID:12754259
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:6456	lidocaine	multiple interactions	ISO	RGD:1346775	E	RGD:6480464	20120412	CTD	MESH:D008012	Lidocaine inhibits the reaction [KCNK18 protein results in increased transport of Potassium]	PMID:12754259
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:80920	alpha-Sanshool	affects response to substance	ISO	RGD:1346775	E	RGD:6480464	20141111	CTD	MESH:C100574	KCNK18 protein affects the susceptibility to sanshool	PMID:18568022
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:80920	alpha-Sanshool	decreases activity	ISO	RGD:1346775	E	RGD:6480464	20141111	CTD	MESH:C100574	sanshool results in decreased activity of KCNK18 protein	PMID:18568022
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:80920	alpha-Sanshool	multiple interactions	ISO	RGD:1346775	E	RGD:6480464	20141111	CTD	MESH:C100574	sanshool inhibits the reaction [KCNK18 protein results in increased transport of Potassium]	PMID:18568022
1303091	Kcnk18	potassium two pore domain channel subfamily K member 18	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of KCNK18 mRNA	PMID:23869203
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RT1-T18 mRNA	PMID:23829299
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RT1-T18 mRNA	PMID:33387578
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RT1-T18 gene	PMID:27618143
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of RT1-T18 mRNA	PMID:26577399
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RT1-T18 mRNA	PMID:27523638
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RT1-T18 mRNA	PMID:30779732
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of RT1-T18 mRNA	PMID:24395379
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RT1-T18 mRNA	PMID:16483693
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of RT1-T18 mRNA	PMID:19167457
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A affects the expression of H2-T3 mRNA	PMID:25181051
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of RT1-T18 mRNA	PMID:41034487
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of RT1-T18 mRNA	PMID:23829299
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RT1-T18 promoter	PMID:22457795
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RT1-T18 mRNA	PMID:24780913
1303092	RT1-T18	RT1 class Ib, locus T18	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of H2-T18 mRNA	PMID:21346803
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614352	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TMEM35A mRNA	PMID:33045310
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1614352	E	RGD:6480464	20260707	CTD	MESH:C000628730	graphene oxide results in decreased expression of TMEM35A mRNA	PMID:33227293
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:135741	testosterone undecanoate	decreases expression	ISO	RGD:1345227	E	RGD:6480464	20170307	CTD	MESH:C010792	testosterone undecanoate results in decreased expression of TMEM35A mRNA	PMID:19074003
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	ISO	RGD:1345227	E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMEM35A mRNA	PMID:19074003
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1614352	E	RGD:6480464	20161115	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TMEM35A mRNA	PMID:26251327
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1345227	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of TMEM35A mRNA	PMID:21934132
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1345227	E	RGD:6480464	20260707	CTD	MESH:D014260	Triclosan results in increased expression of TMEM35A mRNA	PMID:30510588
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1614352	E	RGD:6480464	20260707	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TMEM35A mRNA	PMID:34319233
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM35A mRNA	PMID:31199487
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1345227	E	RGD:6480464	20260707	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TMEM35A intron	PMID:30157460
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1614352	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of TMEM35A mRNA	PMID:27462272
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1345227	E	RGD:6480464	20161115	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TMEM35A gene	PMID:27153756
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614352	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TMEM35A mRNA	PMID:27106289|PMID:34911549
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1345227	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of TMEM35A mRNA	PMID:26272509
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1345227	E	RGD:6480464	20161115	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA	PMID:27188386
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1614352	E	RGD:6480464	20260707	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TMEM35A mRNA	PMID:28960355
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1345227	E	RGD:6480464	20260707	CTD	MESH:D007854	Lead affects the expression of TMEM35A mRNA	PMID:28903495
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1345227	E	RGD:6480464	20170725	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TMEM35A mRNA	PMID:28001369
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1345227	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of TMEM35A mRNA	PMID:26272509
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1345227	E	RGD:6480464	20161115	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA	PMID:27188386
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D003300	Copper results in increased expression of TMEM35A mRNA	PMID:30556269
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1614352	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM35A mRNA	PMID:39631538
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1345227	E	RGD:6480464	20260707	CTD	MESH:C017947	sodium arsenite affects the methylation of TMEM35A gene	PMID:28589171
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1614352	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMEM35A mRNA	PMID:37682722
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1345227	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of TMEM35A mRNA	PMID:22378314
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1345227	E	RGD:6480464	20260707	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMEM35A intron	PMID:30157460
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1345227	E	RGD:6480464	20260707	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMEM35A promoter	PMID:27901495
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1345227	E	RGD:6480464	20260707	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM35A exon	PMID:27901495
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D003300	Copper results in increased expression of TMEM35A mRNA	PMID:30556269
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1345227	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TMEM35A mRNA	PMID:20382639
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C030110	oxaliplatin results in increased expression of TMEM35A mRNA	PMID:25729387
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20170725	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of TMEM35A mRNA	PMID:25729387
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1614352	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in decreased expression of TMEM35A mRNA	PMID:27760801
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM35A mRNA	PMID:25181051
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614352	E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM35A mRNA	PMID:30245210
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM35A mRNA	PMID:33296240
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TMEM35A mRNA	PMID:36041667
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1345227	E	RGD:6480464	20161115	CTD	MESH:C543008	bisphenol S results in increased expression of TMEM35A mRNA	PMID:27685785
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TMEM35A mRNA	PMID:36041667
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1345227	E	RGD:6480464	20260707	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TMEM35A intron	PMID:30157460
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TMEM35A mRNA	PMID:36041667
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM35A mRNA	PMID:31199487
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM35A mRNA	PMID:31199487
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:34698	diethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM35A mRNA	PMID:31199487
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TMEM35A mRNA	PMID:35163327
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM35A mRNA	PMID:31199487
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TMEM35A mRNA	PMID:35163327
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C039281	furan results in increased expression of TMEM35A mRNA	PMID:25539665|PMID:27387713
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1345227	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TMEM35A mRNA	PMID:24449571
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1345227	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TMEM35A mRNA	PMID:31533062
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1345227	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM35A mRNA	PMID:25979313
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1345227	E	RGD:6480464	20170725	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM35A mRNA	PMID:28001369
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1345227	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM35A mRNA	PMID:24935251
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in increased expression of TMEM35A mRNA	PMID:38685447
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1345227	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA	PMID:27188386
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1345227	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TMEM35A mRNA	PMID:24935251|PMID:26272509
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1345227	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TMEM35A mRNA	PMID:24935251
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1345227	E	RGD:6480464	20161115	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA	PMID:27188386
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TMEM35A mRNA	PMID:29391264
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TMEM35A mRNA	PMID:17557909
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614352	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TMEM35A mRNA; Nanotubes, Carbon results in decreased expression of TMEM35A mRNA	PMID:25554681
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1345227	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TMEM35A protein	PMID:32959892
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D019772	Topotecan results in increased expression of TMEM35A mRNA	PMID:25729387
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20170725	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of TMEM35A mRNA	PMID:25729387
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:6443	levonorgestrel	multiple interactions	ISO	RGD:1345227	E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMEM35A mRNA	PMID:19074003
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1345227	E	RGD:6480464	20260707	CTD	MESH:D008701	Methapyrilene results in increased methylation of TMEM35A intron	PMID:30157460
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614352	E	RGD:6480464	20260707	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMEM35A mRNA	PMID:22206623
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:7719	ochratoxin A	decreases methylation	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased methylation of TMEM35A gene	PMID:37162024
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased expression of TMEM35A mRNA	PMID:37162024
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1345227	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA	PMID:27188386
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM35A mRNA	PMID:31199487
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1345227	E	RGD:6480464	20260707	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TMEM35A gene]	PMID:28238834
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of TMEM35A mRNA	PMID:32109520
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1614352	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TMEM35A mRNA	PMID:38648751
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D011441	Propylthiouracil results in increased expression of TMEM35A mRNA	PMID:24780913|PMID:36843608
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1345227	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM35A mRNA	PMID:27188386
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D012999	Soman results in increased expression of TMEM35A mRNA	PMID:19281266
1303093	Tmem35a	transmembrane protein 35A	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of TMEM35A gene	PMID:31682807
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550676	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ABLIM2 mRNA	PMID:33045310
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550676	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ABLIM2 mRNA	PMID:26251327
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1550676	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of ABLIM2 promoter	PMID:26251327
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550676	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ABLIM2 mRNA	PMID:30319688
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ABLIM2 mRNA	PMID:35811015
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of ABLIM2 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of ABLIM2 mRNA	PMID:20660070|PMID:30165855
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1349528	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ABLIM2 mRNA	PMID:38568856
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ABLIM2 mRNA	PMID:33387578
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of ABLIM2 mRNA	PMID:20660070
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1349528	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ABLIM2 mRNA	PMID:36314267
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1349528	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ABLIM2 mRNA	PMID:26717081
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:17578	toluene	increases methylation	ISO	RGD:1349528	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ABLIM2 gene	PMID:26717081
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1349528	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ABLIM2 3' UTR; aflatoxin B2 results in increased methylation of ABLIM2 intron	PMID:30157460
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1349528	E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of ABLIM2 mRNA	PMID:34773240
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ABLIM2 mRNA	PMID:39012411
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20251007	CTD	MESH:D002104	Selenium inhibits the reaction [Cadmium results in decreased expression of ABLIM2 mRNA]	PMID:34773240
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1349528	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ABLIM2 mRNA	PMID:22100608
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1349528	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ABLIM2 3' UTR; Aflatoxin B1 results in increased methylation of ABLIM2 exon; Aflatoxin B1 results in increased methylation of ABLIM2 intron	PMID:30157460
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of ABLIM2 protein	PMID:33146391
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550676	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ABLIM2 mRNA]	PMID:22206623
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1349528	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ABLIM2 gene	PMID:25304211
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABLIM2 mRNA	PMID:32525701
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of ABLIM2 mRNA]	PMID:34773240
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1349528	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ABLIM2 mRNA	PMID:28903495
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABLIM2 mRNA	PMID:32109520|PMID:33387578
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1349528	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ABLIM2 gene	PMID:28589171
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349528	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ABLIM2 mRNA	PMID:29301061|PMID:39719251
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349528	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ABLIM2 3' UTR; Benzo(a)pyrene affects the methylation of ABLIM2 intron	PMID:27901495|PMID:30157460
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ABLIM2 mRNA	PMID:21839799
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550676	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ABLIM2 mRNA	PMID:22228805
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550676	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABLIM2 mRNA	PMID:22228805
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349528	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ABLIM2 promoter	PMID:27901495
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550676	E	RGD:6480464	20130618	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ABLIM2 mRNA]; Benzo(a)pyrene promotes the reaction [AHR protein binds to ABLIM2 promoter]	PMID:19654925|PMID:22228805
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:30563	silicon dioxide	affects expression	ISO	RGD:1349528	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the expression of ABLIM2 mRNA	PMID:25895662
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1349528	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ABLIM2 mRNA	PMID:35984750
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1550676	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ABLIM2 mRNA	PMID:18648102
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ABLIM2 mRNA	PMID:19167457
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ABLIM2 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1349528	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ABLIM2 gene	PMID:31601247
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABLIM2 mRNA	PMID:28628672
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550676	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ABLIM2 mRNA	PMID:40203079
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1349528	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of ABLIM2 exon	PMID:30157460
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1349528	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ABLIM2 intron	PMID:30157460
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550676	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ABLIM2 mRNA	PMID:38685157
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550676	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ABLIM2 mRNA	PMID:32715474
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550676	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ABLIM2 mRNA	PMID:37019170
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABLIM2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ABLIM2 mRNA	PMID:28628672
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ABLIM2 mRNA	PMID:32680482
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1550676	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of ABLIM2 mRNA	PMID:36117858
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ABLIM2 gene	PMID:33148267
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of ABLIM2 mRNA	PMID:35163327
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ABLIM2 mRNA	PMID:35163327
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349528	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ABLIM2 mRNA	PMID:38174414|PMID:38568856
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ABLIM2 mRNA	PMID:39012411
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ABLIM2 mRNA	PMID:35163327
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1349528	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ABLIM2 mRNA	PMID:24449571
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of ABLIM2 mRNA]	PMID:34773240
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1349528	E	RGD:6480464	20120412	CTD	MESH:D003024	Clozapine results in increased expression of ABLIM2 mRNA	PMID:17346280
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550676	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABLIM2 mRNA	PMID:40194260
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1349528	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ABLIM2 mRNA	PMID:31533062
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1550676	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ABLIM2 mRNA	PMID:39529242
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1349528	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ABLIM2 gene	PMID:29154799
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ABLIM2 mRNA	PMID:30047161
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABLIM2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ABLIM2 mRNA	PMID:28628672
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1349528	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ABLIM2 mRNA	PMID:38832940
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349528	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABLIM2 mRNA	PMID:22230336
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABLIM2 mRNA	PMID:33387578
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ABLIM2 mRNA	PMID:35811015
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1349528	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ABLIM2 gene	PMID:25304211
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABLIM2 mRNA	PMID:32525701
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1349528	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ABLIM2 mRNA	PMID:31838189
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABLIM2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ABLIM2 mRNA	PMID:28628672
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ABLIM2 mRNA	PMID:30047161
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1550676	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of ABLIM2 mRNA	PMID:36117858
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1550676	E	RGD:6480464	20130618	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of ABLIM2 mRNA	PMID:19042947
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1349528	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ABLIM2 mRNA	PMID:22079614
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1349528	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of ABLIM2 exon	PMID:30157460
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1349528	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ABLIM2 intron	PMID:30157460
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ABLIM2 gene	PMID:35440735
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ABLIM2 gene	PMID:33148267
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550676	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ABLIM2 mRNA	PMID:22206623
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550676	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ABLIM2 mRNA]	PMID:22206623
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:756028	mivebresib	increases expression	ISO	RGD:1349528	E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of ABLIM2 mRNA	PMID:35486664
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1349528	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ABLIM2 mRNA	PMID:19159669
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of ABLIM2 protein	PMID:28903499
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1550676	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ABLIM2 mRNA	PMID:27935865
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1349528	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABLIM2 mRNA	PMID:32525701
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ABLIM2 mRNA	PMID:24780913|PMID:30047161
1303094	Ablim2	actin binding LIM protein family, member 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1349528	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ABLIM2 mRNA	PMID:38568856
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1343689	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in increased expression of ZBTB1 mRNA	PMID:24172598
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1332366	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ZBTB1 mRNA	PMID:26251327
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZBTB1 mRNA	PMID:26079696
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:15866	2-deoxy-D-glucose	increases expression	ISO	RGD:1343689	E	RGD:6480464	20210608	CTD	MESH:D003847	Deoxyglucose results in increased expression of ZBTB1 mRNA	PMID:33770205
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1343689	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of ZBTB1 mRNA	PMID:16823088
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1343689	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ZBTB1 mRNA	PMID:21632981
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:16767	3,4-dichloroaniline	increases expression	ISO	RGD:1343689	E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in increased expression of ZBTB1 mRNA	PMID:24172598
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZBTB1 mRNA	PMID:20655997
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1343689	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ZBTB1 mRNA	PMID:23649840
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ZBTB1 mRNA	PMID:38685446
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:17447	geraniol	increases expression	ISO	RGD:1343689	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of ZBTB1 mRNA	PMID:27683099
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1343689	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZBTB1 protein	PMID:37730182
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1343689	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZBTB1 gene	PMID:27153756
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1343689	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of ZBTB1 mRNA	PMID:16823088
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZBTB1 mRNA	PMID:30779732
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZBTB1 mRNA	PMID:18593933
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1343689	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ZBTB1 mRNA	PMID:26272509
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZBTB1 mRNA	PMID:27188386
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1343689	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZBTB1 protein	PMID:35688186
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1332366	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ZBTB1 mRNA	PMID:28960355
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332366	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZBTB1 mRNA	PMID:21570461|PMID:24680724
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1343689	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZBTB1 mRNA	PMID:22298810
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZBTB1 mRNA	PMID:32109520
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1343689	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZBTB1 mRNA	PMID:20106945|PMID:21632981
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1343689	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ZBTB1 mRNA	PMID:23179753|PMID:27188386
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZBTB1 mRNA	PMID:33212167
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ZBTB1 mRNA	PMID:20971185
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1343689	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ZBTB1 protein	PMID:35688186
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343689	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZBTB1 5' UTR	PMID:27901495
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1343689	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZBTB1 mRNA	PMID:20064835|PMID:20106945
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ZBTB1 mRNA	PMID:20971185
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZBTB1 mRNA	PMID:18593933
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1332366	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ZBTB1 mRNA	PMID:27131904
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1332366	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ZBTB1 mRNA	PMID:19073995
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZBTB1 mRNA	PMID:19150397
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1343689	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZBTB1 mRNA	PMID:18231732
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of ZBTB1 mRNA	PMID:31745603
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1332366	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZBTB1 mRNA	PMID:29264374
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332366	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZBTB1 promoter alternative form	PMID:35295148
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1332366	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZBTB1 mRNA	PMID:20813756
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:33146	vanadyl sulfate	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in decreased expression of ZBTB1 mRNA	PMID:16330358
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZBTB1 mRNA	PMID:25181051
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332366	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZBTB1 mRNA	PMID:33221593
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZBTB1 gene	PMID:28505145
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZBTB1 mRNA	PMID:28628672
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZBTB1 mRNA	PMID:28628672
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343689	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZBTB1 mRNA	PMID:37042841
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZBTB1 mRNA	PMID:33453195
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZBTB1 mRNA	PMID:38568856
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1343689	E	RGD:6480464	20210608	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZBTB1 mRNA	PMID:33770205
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1343689	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ZBTB1 mRNA	PMID:19376846
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1343689	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of ZBTB1 mRNA	PMID:19691856
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZBTB1 mRNA	PMID:28302478
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ZBTB1 mRNA	PMID:19167446
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ZBTB1 mRNA	PMID:40419075
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1343689	E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in increased expression of ZBTB1 mRNA	PMID:17685462
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343689	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZBTB1 mRNA	PMID:25979313
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZBTB1 mRNA	PMID:22083351|PMID:23179753|PMID:24935251|PMID:27188386|PMID:28001369|PMID:29154799
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1343689	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZBTB1 gene	PMID:29154799
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZBTB1 mRNA	PMID:28628672
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1343689	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ZBTB1 mRNA	PMID:23649840
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20161213	CTD	MESH:C111237	Vorinostat results in decreased expression of ZBTB1 mRNA	PMID:22083351|PMID:27188386|PMID:33770205
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1343689	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ZBTB1 mRNA	PMID:28542535
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ZBTB1 mRNA	PMID:24935251
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1332366	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ZBTB1 mRNA	PMID:35436446
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZBTB1 mRNA	PMID:28628672
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1343689	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZBTB1 mRNA	PMID:18231732
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of ZBTB1 mRNA	PMID:34044035
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of ZBTB1 mRNA	PMID:27188386
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1343689	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ZBTB1 mRNA	PMID:28988120
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ZBTB1 mRNA	PMID:28801915
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332366	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZBTB1 mRNA	PMID:22206623
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:756894	tak-243	affects sumoylation	ISO	RGD:1343689	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of ZBTB1 protein	PMID:31285264
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZBTB1 mRNA	PMID:27188386
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1332366	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ZBTB1 mRNA	PMID:39847705
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1343689	E	RGD:6480464	20210608	CTD	MESH:C496932	Panobinostat results in decreased expression of ZBTB1 mRNA	PMID:33770205
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1343689	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZBTB1 mRNA	PMID:27188386
1303095	Zbtb1	zinc finger and BTB domain containing 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1332366	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ZBTB1 mRNA	PMID:27131904
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550689	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FUT8 mRNA	PMID:33045310
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550689	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FUT8 gene	PMID:20938992
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of FUT8 mRNA	PMID:21934132|PMID:33167477
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:15996	GTP	decreases activity	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D006160	Guanosine Triphosphate results in decreased activity of FUT8 protein	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FUT8 mRNA	PMID:21632981
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1344316	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of FUT8 mRNA	PMID:22574217
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550689	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of FUT8 mRNA	PMID:39298647
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of FUT8 mRNA	PMID:32145629
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FUT8 mRNA	PMID:23829299
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1550689	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of FUT8 mRNA	PMID:33711761
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of FUT8 gene	PMID:27618143
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550689	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FUT8 gene	PMID:20938992
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:17345	guanosine 5'-monophosphate	decreases activity	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D006157	Guanosine Monophosphate results in decreased activity of FUT8 protein	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:17552	GDP	decreases activity	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D006153	Guanosine Diphosphate results in decreased activity of FUT8 protein	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:17552	GDP	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D006153	Guanosine Diphosphate inhibits the reaction [Mersalyl results in decreased activity of FUT8 protein]; Guanosine Diphosphate inhibits the reaction [p-Chloromercuribenzoic Acid results in decreased activity of FUT8 protein]; Guanosine Diphosphate inhibits the reaction [Phenylglyoxal results in decreased activity of FUT8 protein]	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550689	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FUT8 mRNA	PMID:33754040
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of FUT8 mRNA	PMID:26485663
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FUT8 mRNA	PMID:33387578
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550689	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FUT8 mRNA	PMID:36331819
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FUT8 mRNA	PMID:39836092
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:18405	pyridoxal 5'-phosphate	decreases activity	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D011732	Pyridoxal Phosphate results in decreased activity of FUT8 protein	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:18405	pyridoxal 5'-phosphate	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D011732	Fucose analog inhibits the reaction [Pyridoxal Phosphate results in decreased activity of FUT8 protein]	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of FUT8 mRNA	PMID:28522335
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FUT8 mRNA	PMID:19549813
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of FUT8 mRNA	PMID:23649840
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of FUT8 mRNA	PMID:15651846
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of FUT8 mRNA	PMID:15672453
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550689	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FUT8 mRNA	PMID:25629700
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550689	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FUT8 gene	PMID:20938992
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1344316	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FUT8 gene	PMID:25304211
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FUT8 mRNA	PMID:39836092
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of FUT8 mRNA	PMID:26272509
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUT8 mRNA	PMID:27188386
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1344316	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of FUT8 protein	PMID:35688186
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of FUT8 gene	PMID:35440735
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FUT8 mRNA	PMID:31881176
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of FUT8 mRNA	PMID:19561079
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in increased expression of FUT8 mRNA	PMID:21858171
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of FUT8 mRNA	PMID:20187946
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FUT8 mRNA	PMID:22298810
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550689	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FUT8 mRNA	PMID:21570461|PMID:24680724
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FUT8 mRNA	PMID:17555868
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of FUT8 mRNA	PMID:28374803
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FUT8 mRNA	PMID:28001369
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FUT8 mRNA	PMID:33212167
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases activity	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased activity of FUT8 protein	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of FUT8 mRNA	PMID:26272509
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUT8 mRNA; Fucose analog inhibits the reaction [p-Chloromercuribenzoic Acid results in decreased activity of FUT8 protein]; Guanosine Diphosphate inhibits the reaction [p-Chloromercuribenzoic Acid results in decreased activity of FUT8 protein]	PMID:12770769|PMID:27188386
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FUT8 mRNA	PMID:29803840
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FUT8 mRNA	PMID:20044591
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FUT8 mRNA	PMID:38568856
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550689	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of FUT8 mRNA	PMID:33933676
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344316	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of FUT8 mRNA	PMID:39719251
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FUT8 mRNA	PMID:39836092
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FUT8 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1344316	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FUT8 promoter	PMID:27901495
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1344316	E	RGD:6480464	20190910	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FUT8 mRNA	PMID:31255691
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550689	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FUT8 mRNA	PMID:22228805
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FUT8 mRNA	PMID:20382639|PMID:26238291
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1550689	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FUT8 mRNA	PMID:35676786
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1344316	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of FUT8 gene	PMID:31601247
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of FUT8 gene	PMID:31601247
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of FUT8 mRNA	PMID:24136188
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of FUT8 mRNA	PMID:25729387
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550689	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FUT8 gene; titanium dioxide results in decreased methylation of FUT8 promoter	PMID:35295148
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FUT8 mRNA	PMID:34492290
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550689	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of FUT8 mRNA	PMID:17426115|PMID:18301758
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FUT8 mRNA	PMID:30816183|PMID:34947998
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1344316	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FUT8 gene	PMID:31601247
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FUT8 mRNA	PMID:25181051
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1344316	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of FUT8 mRNA	PMID:25047013
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of FUT8 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FUT8 mRNA	PMID:28628672|PMID:31601247
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:33984	fucose	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20170303	CTD	MESH:D005643	Fucose analog inhibits the reaction [Mersalyl results in decreased activity of FUT8 protein]; Fucose analog inhibits the reaction [p-Chloromercuribenzoic Acid results in decreased activity of FUT8 protein]; Fucose analog inhibits the reaction [Phenylglyoxal results in decreased activity of FUT8 protein]; Fucose analog inhibits the reaction [Pyridoxal Phosphate results in decreased activity of FUT8 protein]	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:3423	carmustine	affects response to substance	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D002330	FUT8 mRNA affects the susceptibility to Carmustine	PMID:16365179
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1550689	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of FUT8 mRNA	PMID:20713471
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1550689	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of FUT8 mRNA	PMID:20713471
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550689	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FUT8 mRNA	PMID:39298647
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FUT8 mRNA	PMID:28628672
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FUT8 mRNA	PMID:28628672
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1550689	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of FUT8 mRNA	PMID:28392331
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FUT8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FUT8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FUT8 mRNA	PMID:28628672
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1550689	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of FUT8 mRNA	PMID:20524982
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1344316	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of FUT8 mRNA	PMID:17312168
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344316	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FUT8 mRNA	PMID:37042841
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FUT8 mRNA	PMID:39836092
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FUT8 mRNA	PMID:19320972
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20190910	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of FUT8 mRNA	PMID:31255691
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:39282	iodomethane	decreases activity	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:C014055	methyl iodide results in decreased activity of FUT8 protein	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550689	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FUT8 mRNA	PMID:36331819
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344316	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FUT8 mRNA	PMID:25979313
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1344316	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FUT8 mRNA	PMID:25562108
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1550689	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of FUT8 mRNA	PMID:25123088
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FUT8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FUT8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FUT8 mRNA	PMID:28628672
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of FUT8 mRNA]	PMID:21233418
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FUT8 mRNA	PMID:26272509
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUT8 mRNA	PMID:27188386
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FUT8 mRNA	PMID:33387578
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1344316	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of FUT8 mRNA	PMID:24714768
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1344316	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FUT8 gene	PMID:25304211
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FUT8 mRNA	PMID:39836092
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FUT8 mRNA	PMID:29391264
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FUT8 mRNA	PMID:22079256
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D005047	FUT8 protein affects the susceptibility to Etoposide	PMID:16217747
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FUT8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FUT8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FUT8 mRNA	PMID:28628672
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1550689	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FUT8 mRNA	PMID:35676786
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:59051	diethyl pyrocarbonate	decreases activity	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D004047	Diethyl Pyrocarbonate results in decreased activity of FUT8 protein	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of FUT8 mRNA	PMID:20436886
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FUT8 mRNA	PMID:39836092
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of FUT8 mRNA	PMID:25729387
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550689	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of FUT8 mRNA	PMID:23650126
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FUT8 gene	PMID:35440735
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1344316	E	RGD:6480464	20130305	CTD	MESH:C047246	FUT8 mRNA affects the susceptibility to temozolomide	PMID:16365179
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550689	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FUT8 mRNA	PMID:22206623
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:749344	mersalyl	decreases activity	ISO	RGD:1344316	E	RGD:6480464	20260714	CTD	MESH:D008634	Mersalyl results in decreased activity of FUT8 protein	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:749344	mersalyl	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20260714	CTD	MESH:D008634	Fucose analog inhibits the reaction [Mersalyl results in decreased activity of FUT8 protein]; Guanosine Diphosphate inhibits the reaction [Mersalyl results in decreased activity of FUT8 protein]	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1344316	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FUT8 mRNA	PMID:22079256
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FUT8 mRNA	PMID:22079256
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUT8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUT8 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUT8 mRNA	PMID:27188386
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550689	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of FUT8 mRNA	PMID:23091169
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550689	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of FUT8 mRNA	PMID:19270015
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of FUT8 mRNA	PMID:21858171
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:88868	Phenylglyoxal	decreases activity	ISO	RGD:1344316	E	RGD:6480464	20170303	CTD	MESH:D010658	Phenylglyoxal results in decreased activity of FUT8 protein	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:88868	Phenylglyoxal	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20170303	CTD	MESH:D010658	Fucose analog inhibits the reaction [Phenylglyoxal results in decreased activity of FUT8 protein]; Guanosine Diphosphate inhibits the reaction [Phenylglyoxal results in decreased activity of FUT8 protein]	PMID:12770769
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344316	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUT8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUT8 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FUT8 mRNA	PMID:27188386
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FUT8 mRNA	PMID:21346803
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550689	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of FUT8 mRNA	PMID:35537566
1303096	Fut8	fucosyltransferase 8	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of FUT8 gene	PMID:31079544
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of GFPT2 mRNA	PMID:21551480|PMID:25152437
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1351553	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GFPT2 mRNA	PMID:26272509
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GFPT2 mRNA	PMID:27188386
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622399	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GFPT2 mRNA	PMID:33045310
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1622399	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of GFPT2 mRNA	PMID:37995155
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of GFPT2 mRNA	PMID:21934132
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1351553	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of GFPT2 mRNA	PMID:23724009
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1622399	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GFPT2 mRNA	PMID:30529165
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1351553	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GFPT2 mRNA	PMID:26079696
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1351553	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of GFPT2 mRNA	PMID:22378314
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1622399	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of GFPT2 mRNA	PMID:30319688
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1622399	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of GFPT2 mRNA	PMID:29018328
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1351553	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GFPT2 mRNA	PMID:35811015
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of GFPT2 mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GFPT2 mRNA]	PMID:35811015
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1351553	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of GFPT2 mRNA	PMID:31614463
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of GFPT2 mRNA	PMID:38568856
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GFPT2 mRNA	PMID:33387578
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1351553	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of GFPT2 mRNA	PMID:18037150
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1622399	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GFPT2 mRNA	PMID:37992649
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1351553	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of GFPT2 mRNA	PMID:33647349
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1622399	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GFPT2 mRNA	PMID:37992649
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of GFPT2 mRNA	PMID:26485663
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GFPT2 mRNA	PMID:33387578
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:17833	gentamycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein	PMID:30545405
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1351553	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of GFPT2 mRNA	PMID:28818685
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GFPT2 mRNA	PMID:39836092
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1622399	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of GFPT2 mRNA	PMID:27462272
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1622399	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of GFPT2 mRNA	PMID:39984025
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1622399	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GFPT2 mRNA	PMID:29950665
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1351553	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of GFPT2 mRNA	PMID:19549813
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GFPT2 mRNA	PMID:25378103
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1351553	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GFPT2 mRNA	PMID:22100608
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1351553	E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of GFPT2 mRNA	PMID:23033980
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1622399	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GFPT2 mRNA	PMID:34911549
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GFPT2 mRNA	PMID:18593933
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GFPT2 mRNA	PMID:31150632
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1351553	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GFPT2 gene	PMID:25304211
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GFPT2 mRNA	PMID:39836092
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GFPT2 mRNA	PMID:27188386
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of GFPT2 mRNA	PMID:19561079
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of GFPT2 mRNA	PMID:27392435
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28001	vancomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein	PMID:30545405
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1351553	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of GFPT2 mRNA	PMID:24768652|PMID:25583101
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1351553	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GFPT2 mRNA	PMID:22298810
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GFPT2 mRNA	PMID:34747641
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GFPT2 mRNA	PMID:33387578
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1622399	E	RGD:6480464	20170110	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GFPT2 mRNA	PMID:27562557
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GFPT2 mRNA	PMID:30851411
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of GFPT2 mRNA	PMID:28959563
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1351553	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of GFPT2 mRNA	PMID:32763439
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1622399	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of GFPT2 mRNA	PMID:30807115
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GFPT2 mRNA	PMID:29803840
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1622399	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GFPT2 mRNA	PMID:37992649
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:28971	ampicillin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein	PMID:30545405
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1351553	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of GFPT2 gene	PMID:28589171
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351553	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of GFPT2 mRNA	PMID:29301061|PMID:38568856
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GFPT2 mRNA	PMID:39836092
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351553	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GFPT2 3' UTR; Benzo(a)pyrene affects the methylation of GFPT2 promoter	PMID:27901495
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1351553	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GFPT2 mRNA	PMID:20064835|PMID:32234424
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351553	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GFPT2 exon	PMID:27901495
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GFPT2 mRNA	PMID:18593933
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1351553	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of GFPT2 mRNA	PMID:23806026|PMID:25895662
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of GFPT2 gene	PMID:31601247
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of GFPT2 mRNA	PMID:31745603
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622399	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GFPT2 gene	PMID:35295148
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1622399	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GFPT2 mRNA	PMID:29950665
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of GFPT2 mRNA	PMID:34492290
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of GFPT2 mRNA	PMID:30690063
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GFPT2 mRNA	PMID:25181051
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GFPT2 mRNA	PMID:34947998
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1622399	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of GFPT2 mRNA	PMID:25594700|PMID:38074096
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1351553	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GFPT2 gene	PMID:31601247
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1622399	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of GFPT2 mRNA	PMID:30951980
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of GFPT2 gene	PMID:31601247
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1351553	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of GFPT2 mRNA	PMID:25979313
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1622399	E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of GFPT2 mRNA	PMID:19925653
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1622399	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of GFPT2 mRNA	PMID:30951980
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of GFPT2 mRNA	PMID:28628672
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1622399	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of GFPT2 mRNA	PMID:30951980
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GFPT2 mRNA	PMID:28628672
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1622399	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GFPT2 mRNA	PMID:29950665
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GFPT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of GFPT2 mRNA	PMID:28628672
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of GFPT2 mRNA	PMID:32680482
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1622399	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of GFPT2 protein	PMID:39748354
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GFPT2 mRNA	PMID:39836092
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of GFPT2 mRNA	PMID:30723492
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GFPT2 mRNA	PMID:38568856
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GFPT2 mRNA	PMID:33453195
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1351553	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GFPT2 mRNA	PMID:38174414
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1351553	E	RGD:6480464	20140610	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GFPT2 mRNA	PMID:23978341
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of GFPT2 mRNA	PMID:25539665
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of GFPT2 mRNA	PMID:24449571
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1351553	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of GFPT2 mRNA	PMID:40419075
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351553	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GFPT2 mRNA	PMID:25979313
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351553	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of GFPT2 mRNA	PMID:19101580|PMID:28001369|PMID:29154799
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1351553	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GFPT2 gene	PMID:29154799
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GFPT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of GFPT2 mRNA	PMID:28628672
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1622399	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of GFPT2 mRNA	PMID:28973697
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1622399	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GFPT2 mRNA	PMID:37992649
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1351553	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GFPT2 mRNA	PMID:38832940
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1351553	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of GFPT2 mRNA	PMID:24935251
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of GFPT2 mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GFPT2 mRNA]	PMID:35811015
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1622399	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of GFPT2 mRNA	PMID:29279043
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1351553	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of GFPT2 mRNA	PMID:24160326
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1351553	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of GFPT2 mRNA	PMID:24160326
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1351553	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GFPT2 gene	PMID:25304211
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GFPT2 mRNA	PMID:39836092
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GFPT2 mRNA	PMID:29391264
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GFPT2 mRNA	PMID:22079256
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1622399	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GFPT2 mRNA	PMID:35436446
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1351553	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of GFPT2 mRNA	PMID:32234424
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1351553	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of GFPT2 mRNA	PMID:38568856
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GFPT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of GFPT2 mRNA	PMID:28628672
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1622399	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of GFPT2 mRNA	PMID:25554681
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1351553	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of GFPT2 mRNA	PMID:25102311
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1622399	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of GFPT2 mRNA	PMID:25554681
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1351553	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of GFPT2 mRNA	PMID:22714537
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of GFPT2 mRNA	PMID:20080153
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GFPT2 mRNA	PMID:39836092
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1351553	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of GFPT2 mRNA	PMID:15336504
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1351553	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GFPT2 mRNA	PMID:24810058
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1351553	E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GFPT2 mRNA	PMID:20147733
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1622399	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of GFPT2 mRNA	PMID:20003209
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:6909	metronidazole	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein	PMID:30545405
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of GFPT2 mRNA	PMID:31758290
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622399	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GFPT2 mRNA	PMID:22206623
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:7507	neomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein	PMID:30545405
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of GFPT2 mRNA	PMID:22079256|PMID:22714537
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GFPT2 mRNA	PMID:22079256
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1351553	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of GFPT2 mRNA	PMID:37199045
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1351553	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GFPT2 mRNA	PMID:30851411
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GFPT2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GFPT2 mRNA	PMID:27188386
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GFPT2 gene]	PMID:28238834
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1622399	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of GFPT2 mRNA	PMID:38648751
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1622399	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of GFPT2 mRNA	PMID:26377693
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GFPT2 mRNA	PMID:25825206
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1351553	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GFPT2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GFPT2 mRNA	PMID:27188386
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1351553	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GFPT2 mRNA	PMID:38568856
1303097	Gfpt2	glutamine-fructose-6-phosphate transaminase 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1351553	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of GFPT2 mRNA	PMID:19140230
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552661	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CPA5 mRNA	PMID:37995155
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552661	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of CPA5 mRNA	PMID:22401849
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1345322	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of CPA5 mRNA	PMID:33359661
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1345322	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CPA5 intron	PMID:30157460
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1345322	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CPA5 mRNA	PMID:23557933
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552661	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPA5 mRNA	PMID:17942748
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1345322	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CPA5 mRNA	PMID:29301061|PMID:34032870
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1345322	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CPA5 exon	PMID:27901495
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1552661	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of CPA5 mRNA	PMID:22609695
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1552661	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of CPA5 mRNA	PMID:19136022
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552661	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CPA5 mRNA	PMID:19710929
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CPA5 mRNA	PMID:25181051|PMID:41034487
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552661	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of CPA5 mRNA	PMID:29161229
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552661	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CPA5 mRNA	PMID:17963808
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1345322	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CPA5 gene	PMID:29154799
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552661	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CPA5 mRNA	PMID:17555576
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552661	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CPA5 mRNA	PMID:17562736
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1345322	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of CPA5 mRNA	PMID:35811015
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552661	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CPA5 mRNA	PMID:17555576
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552661	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPA5 mRNA	PMID:17942748
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1345322	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of CPA5 mRNA	PMID:32234424
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552661	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of CPA5 mRNA	PMID:19136022
1303098	Cpa5	carboxypeptidase A5	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1345322	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of CPA5 mRNA	PMID:32234424
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1353496	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RASL11B mRNA	PMID:26272509
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA	PMID:27188386
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550706	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RASL11B mRNA	PMID:33045310
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RASL11B mRNA]	PMID:31150632
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASL11B mRNA	PMID:20938992
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RASL11B mRNA	PMID:23724009
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1353496	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RASL11B mRNA	PMID:26079696
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550706	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RASL11B mRNA	PMID:30319688
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550706	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RASL11B mRNA	PMID:30319688
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550706	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of RASL11B mRNA	PMID:19167417
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of RASL11B mRNA	PMID:30510588
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of RASL11B mRNA	PMID:32145629
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550706	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RASL11B mRNA	PMID:39298647
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of RASL11B mRNA	PMID:30165855
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1550706	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of RASL11B mRNA	PMID:33711761
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASL11B mRNA	PMID:20938992
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1353496	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RASL11B mRNA	PMID:21179406
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RASL11B mRNA	PMID:21592394
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of RASL11B mRNA	PMID:21592394
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RASL11B mRNA	PMID:39150890
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of RASL11B mRNA	PMID:21592394|PMID:26485663
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of RASL11B mRNA	PMID:21592394
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RASL11B mRNA	PMID:33387578
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1353496	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RASL11B mRNA	PMID:28818685
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RASL11B mRNA	PMID:35301059
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RASL11B mRNA	PMID:37236586
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RASL11B mRNA	PMID:30779732
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550706	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RASL11B mRNA	PMID:17484886
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RASL11B mRNA	PMID:31150632
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RASL11B mRNA]	PMID:31150632
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RASL11B mRNA	PMID:25629700
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASL11B mRNA	PMID:20938992
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RASL11B mRNA	PMID:32525701
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1353496	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RASL11B mRNA	PMID:26272509
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA	PMID:27188386
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550706	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of RASL11B mRNA	PMID:28960355
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RASL11B mRNA	PMID:31881176
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1353496	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of RASL11B mRNA	PMID:23300844
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of RASL11B mRNA	PMID:22023808
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1353496	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of RASL11B mRNA	PMID:26865667
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1550706	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of RASL11B mRNA	PMID:32186404
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of RASL11B mRNA	PMID:25583101
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550706	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASL11B mRNA	PMID:21570461
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASL11B mRNA	PMID:18691609|PMID:19933214
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RASL11B mRNA	PMID:21215274
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RASL11B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RASL11B mRNA	PMID:17942748|PMID:25975270
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1353496	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RASL11B mRNA	PMID:34089799
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RASL11B mRNA	PMID:30556269
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of RASL11B mRNA	PMID:24690739
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RASL11B mRNA	PMID:15467011
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1353496	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RASL11B mRNA	PMID:29803840
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:28876	melphalan	increases expression	ISO	RGD:1353496	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in increased expression of RASL11B mRNA	PMID:22363485
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RASL11B mRNA	PMID:38568856
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of RASL11B mRNA	PMID:22378314
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353496	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RASL11B promoter	PMID:27901495
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RASL11B mRNA	PMID:20064835|PMID:35870112
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353496	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RASL11B exon	PMID:27901495
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1353496	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of RASL11B promoter	PMID:23974009
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RASL11B mRNA	PMID:30556269
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of RASL11B mRNA	PMID:24690739
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RASL11B mRNA	PMID:15467011
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RASL11B mRNA	PMID:27131904
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of RASL11B mRNA	PMID:35984750
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RASL11B gene	PMID:31601247
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1353496	E	RGD:6480464	20251007	CTD	MESH:C008261	lead acetate results in increased expression of RASL11B mRNA	PMID:37939567
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RASL11B mRNA	PMID:25729387
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550706	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RASL11B gene; titanium dioxide results in decreased methylation of RASL11B promoter	PMID:35295148
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550706	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RASL11B gene; titanium dioxide results in increased methylation of RASL11B promoter	PMID:35295148
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RASL11B mRNA	PMID:23411599|PMID:34492290
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RASL11B mRNA	PMID:33221593
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RASL11B mRNA	PMID:25181051|PMID:32145629
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550706	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RASL11B mRNA	PMID:30951980
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RASL11B gene	PMID:31601247
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RASL11B mRNA	PMID:23196670
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1550706	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of RASL11B mRNA	PMID:30951980
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RASL11B mRNA	PMID:39298647|PMID:40203079
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550706	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RASL11B mRNA	PMID:30951980
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RASL11B mRNA	PMID:39150890
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550706	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RASL11B mRNA	PMID:37019170
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RASL11B mRNA	PMID:21266533
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RASL11B mRNA	PMID:21266533
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550706	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RASL11B mRNA	PMID:17361019|PMID:21266533
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RASL11B mRNA	PMID:39150890
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RASL11B mRNA	PMID:39150890
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of RASL11B mRNA	PMID:18164116
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of RASL11B mRNA	PMID:32680482
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of RASL11B mRNA	PMID:35163327
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of RASL11B mRNA	PMID:30723492
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RASL11B mRNA	PMID:35301059
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RASL11B mRNA	PMID:37236586
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RASL11B mRNA	PMID:39150890
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of RASL11B gene	PMID:27387713
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of RASL11B mRNA	PMID:27387713
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RASL11B mRNA	PMID:24386269
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RASL11B mRNA	PMID:40194260
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550706	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RASL11B mRNA	PMID:40194260
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1353496	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RASL11B mRNA	PMID:31533062
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASL11B mRNA	PMID:19167446
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RASL11B mRNA	PMID:39529242
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353496	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RASL11B mRNA	PMID:25979313
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353496	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RASL11B mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA	PMID:27188386
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550706	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RASL11B mRNA	PMID:20937368
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1550706	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of RASL11B mRNA	PMID:22733784
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1353496	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RASL11B mRNA	PMID:26272509
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA	PMID:27188386
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1353496	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RASL11B mRNA	PMID:24935251
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RASL11B mRNA	PMID:33387578
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of RASL11B mRNA	PMID:24714768
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of RASL11B mRNA	PMID:24690739
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RASL11B mRNA	PMID:32525701
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RASL11B mRNA	PMID:29391264
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RASL11B mRNA	PMID:26865667
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1353496	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RASL11B mRNA	PMID:26865667
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1353496	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of RASL11B mRNA	PMID:18936297
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RASL11B mRNA	PMID:17942748
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1353496	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of RASL11B mRNA	PMID:23300844
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of RASL11B mRNA	PMID:30307764
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of RASL11B mRNA	PMID:25554681
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550706	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RASL11B mRNA; Nanotubes, Carbon results in increased expression of RASL11B mRNA	PMID:25554681|PMID:25620056
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of RASL11B mRNA	PMID:21983209
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of RASL11B mRNA	PMID:19042947
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1353496	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of RASL11B mRNA	PMID:31629900
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of RASL11B mRNA	PMID:20080153
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RASL11B mRNA	PMID:25729387
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1550706	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in increased expression of RASL11B mRNA	PMID:36914120
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550706	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RASL11B mRNA	PMID:22206623
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of RASL11B mRNA	PMID:18164116
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA	PMID:27188386
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of RASL11B mRNA	PMID:39150890
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550706	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of RASL11B mRNA	PMID:19482888
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1550706	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RASL11B mRNA]	PMID:19482888
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASL11B mRNA	PMID:19167446
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RASL11B mRNA	PMID:32525701
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RASL11B mRNA	PMID:24780913
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353496	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL11B mRNA	PMID:27188386
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1550706	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RASL11B mRNA	PMID:27131904
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RASL11B mRNA	PMID:19281266
1303099	Rasl11b	RAS-like family 11 member B	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of RASL11B mRNA	PMID:20566332
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:10650	sumatriptan	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D018170	[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]	PMID:22150557
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1550710	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CNTFR mRNA	PMID:37315490
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1344115	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CNTFR mRNA	PMID:22378314
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550710	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CNTFR mRNA	PMID:30319688
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550710	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CNTFR mRNA	PMID:39298647
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CNTFR mRNA	PMID:20068009
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1344115	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CNTFR mRNA	PMID:30165855
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1344115	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of CNTFR mRNA	PMID:27905399
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of CNTFR mRNA	PMID:22967744
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1344115	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CNTFR mRNA	PMID:31163220
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CNTFR mRNA	PMID:33387578
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1344115	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNTFR mRNA	PMID:35301059
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1550710	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CNTFR mRNA	PMID:29950665
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1344115	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CNTFR gene	PMID:27153756
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550710	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CNTFR mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CNTFR mRNA	PMID:34911549
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1344115	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of CNTFR mRNA	PMID:36861143
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CNTFR mRNA	PMID:31881176
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1344115	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of CNTFR mRNA	PMID:23300844
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1550710	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of CNTFR mRNA	PMID:32186404
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550710	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNTFR mRNA	PMID:21570461
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CNTFR mRNA	PMID:33387578
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of CNTFR mRNA	PMID:28959563
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1344115	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CNTFR mRNA	PMID:32763439
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1344115	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of CNTFR mRNA	PMID:21198554
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344115	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of CNTFR protein	PMID:38228842
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344115	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CNTFR mRNA	PMID:29301061
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344115	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CNTFR 5' UTR	PMID:27901495
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1344115	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CNTFR promoter	PMID:27901495
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CNTFR mRNA	PMID:16483693
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1344115	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of CNTFR mRNA	PMID:37690743
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550710	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CNTFR mRNA	PMID:29264374
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550710	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CNTFR mRNA	PMID:35295148
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1550710	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CNTFR mRNA	PMID:29950665
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CNTFR mRNA	PMID:34492290
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1550710	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of CNTFR mRNA	PMID:19136022
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CNTFR mRNA	PMID:25181051
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1344115	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of CNTFR mRNA	PMID:27685785
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:3374	capsaicin	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in increased expression of CNTFR protein	PMID:22150557
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:3374	capsaicin	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D002211	[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]; Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]	PMID:22150557
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CNTFR mRNA	PMID:23196670
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550710	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CNTFR mRNA	PMID:39298647
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1550710	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CNTFR promoter	PMID:33297965
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1344115	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CNTFR intron	PMID:30157460
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550710	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CNTFR mRNA	PMID:38685157
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550710	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CNTFR mRNA	PMID:32715474
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550710	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CNTFR mRNA	PMID:37019170
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1550710	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CNTFR mRNA	PMID:29950665
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CNTFR mRNA	PMID:32680482
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of CNTFR mRNA	PMID:30723492
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CNTFR promoter	PMID:22457795
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1344115	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNTFR mRNA	PMID:35301059
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1344115	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CNTFR mRNA	PMID:31533062
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1344115	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CNTFR gene	PMID:29154799
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1344115	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CNTFR mRNA	PMID:38832940
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550710	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CNTFR mRNA	PMID:17562736
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CNTFR mRNA	PMID:33387578
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1344115	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of CNTFR mRNA	PMID:36861143
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of CNTFR mRNA	PMID:37567419
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1344115	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of CNTFR mRNA	PMID:23300844
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CNTFR mRNA	PMID:30307764
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550710	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CNTFR mRNA	PMID:25554681
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1550710	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CNTFR mRNA	PMID:23608068
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1344115	E	RGD:6480464	20160822	CTD	MESH:D015655	[RHEB protein mutant form results in increased expression of CNTFR protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium	PMID:25799580
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1550710	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CNTFR mRNA	PMID:26307267
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1344115	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CNTFR intron	PMID:30157460
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CNTFR gene	PMID:35440735
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1550710	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CNTFR mRNA	PMID:27935865
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1344115	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CNTFR protein	PMID:37664457
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:7476	naproxen	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D009288	[Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]; Naproxen inhibits the reaction [Capsaicin results in increased expression of CNTFR protein]	PMID:22150557
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344115	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CNTFR gene]	PMID:28238834
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1550710	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of CNTFR mRNA	PMID:26655953
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550710	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of CNTFR mRNA	PMID:19136022
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550710	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of CNTFR mRNA	PMID:21795629
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344115	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CNTFR protein	PMID:37664457
1303100	Cntfr	ciliary neurotrophic factor receptor	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of CNTFR protein	PMID:35544339
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622877	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LY6G5B mRNA	PMID:33045310
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LY6G5B mRNA	PMID:33387578
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349012	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LY6G5B mRNA	PMID:37042841
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1349012	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LY6G5B mRNA	PMID:28818685
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1622877	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of LY6G5B mRNA	PMID:28960355
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1349012	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of LY6G5B mRNA	PMID:27392435
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622877	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LY6G5B mRNA	PMID:21570461
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1349012	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of LY6G5B mRNA	PMID:32763439
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1349012	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of LY6G5B mRNA	PMID:29803840
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349012	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LY6G5B promoter	PMID:27901495
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1622877	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of LY6G5B mRNA	PMID:29264374
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1349012	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of LY6G5B mRNA	PMID:30690063
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LY6G5B mRNA	PMID:25181051
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349012	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LY6G5B mRNA	PMID:29275510
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LY6G5B mRNA	PMID:30816183|PMID:32528016
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1622877	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LY6G5B mRNA	PMID:38685157
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349012	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LY6G5B mRNA	PMID:37042841
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of LY6G5B promoter	PMID:22457795
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1349012	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of LY6G5B mRNA	PMID:28302478
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1349012	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LY6G5B mRNA	PMID:25562108
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349012	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of LY6G5B mRNA	PMID:26690555
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of LY6G5B mRNA	PMID:28801915
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1349012	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of LY6G5B mRNA	PMID:28988120
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1349012	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of LY6G5B mRNA	PMID:36318118
1303101	Ly6g5b	lymphocyte antigen 6 family member G5B	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of LY6G5B gene	PMID:31079544
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLPI-PS1 mRNA	PMID:32741896
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SLPI-PS1 mRNA	PMID:33387578
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLPI-PS1 mRNA	PMID:32741896
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SLPI-PS1 mRNA	PMID:30779732
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SLPI-PS1 mRNA	PMID:28959563
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SLPI-PS1 mRNA	PMID:30047161
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of SLPI-PS1 mRNA	PMID:41034487
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SLPI-PS1 mRNA	PMID:32145629
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in decreased methylation of SLPI-PS1 gene	PMID:22079235
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SLPI-PS1 mRNA	PMID:30047161
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SLPI-PS1 mRNA	PMID:28801915
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLPI-PS1 mRNA	PMID:32741896
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SLPI-PS1 mRNA	PMID:30047161
1303102	Slpi-ps1	secretory leukocyte peptidase inhibitor, pseudogene 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of SLPI-PS1 mRNA	PMID:22615374
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1347136	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of SNU13 protein	PMID:39638853
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SNU13 gene	PMID:20938992
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of SNU13 protein	PMID:39571964
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNU13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNU13 mRNA	PMID:32699268
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550293	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SNU13 mRNA	PMID:39241906
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SNU13 mRNA]	PMID:39241906
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SNU13 gene	PMID:20938992
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:166595	Yessotoxin	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of SNU13 mRNA	PMID:30679557
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SNU13 mRNA	PMID:23892564
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1347136	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SNU13 protein	PMID:37730182
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNU13 mRNA	PMID:36331819
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1347136	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of SNU13 mRNA	PMID:20823114
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SNU13 mRNA	PMID:23649840
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SNU13 mRNA	PMID:23649840
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1550293	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of SNU13 protein	PMID:39910959
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNU13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNU13 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of SNU13 mRNA	PMID:32699268
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SNU13 mRNA	PMID:33387578
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNU13 mRNA	PMID:31150632
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNU13 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SNU13 gene	PMID:20938992|PMID:22206623
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1347136	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of SNU13 mRNA	PMID:18414638
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1347136	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SNU13 mRNA	PMID:19244175
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of SNU13 mRNA	PMID:19921347
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1550293	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SNU13 mRNA	PMID:30912803
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNU13 mRNA	PMID:21570461
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNU13 mRNA	PMID:33387578
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNU13 mRNA	PMID:21354282
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNU13 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SNU13 promoter]	PMID:17942748|PMID:19654925
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1550293	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of SNU13 mRNA	PMID:32937126
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNU13 mRNA	PMID:30851411
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SNU13 mRNA	PMID:23649840
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20181113	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SNU13 mRNA	PMID:29432896
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNU13 mRNA	PMID:38568856
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of SNU13 protein	PMID:39571964
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNU13 mRNA	PMID:22228805
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347136	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SNU13 3' UTR	PMID:27901495
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SNU13 mRNA]; arsenite promotes the reaction [G3BP1 protein binds to SNU13 protein]	PMID:32406909
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SNU13 protein	PMID:25419056
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000643	Ammonium Chloride affects the expression of SNU13 mRNA	PMID:16483693
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D005897	Glafenine results in increased expression of SNU13 mRNA	PMID:24136188
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550293	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NHP2L1 gene	PMID:35295148
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SNU13 mRNA	PMID:34492290
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550293	E	RGD:6480464	20181113	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SNU13 mRNA	PMID:28472532
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of SNU13 protein	PMID:34186270
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of SNU13 mRNA	PMID:25181051
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1347136	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SNU13 mRNA	PMID:19244175
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1347136	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SNU13 protein	PMID:34186270
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550293	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SNU13 mRNA	PMID:39298647
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1347136	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to SNU13 protein	PMID:32991956
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SNU13 mRNA]	PMID:39241906
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SNU13 mRNA	PMID:19320972
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNU13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNU13 mRNA	PMID:32699268
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1347136	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SNU13 mRNA	PMID:19244175
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNU13 mRNA	PMID:36331819
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347136	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SNU13 mRNA	PMID:25979313
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1347136	E	RGD:6480464	20181113	CTD	MESH:D014635	Valproic Acid results in increased methylation of SNU13 gene	PMID:29154799
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SNU13 mRNA	PMID:17183730
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:42223	emodin	decreases expression	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D004642	Emodin results in decreased expression of SNU13 mRNA	PMID:15612046
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C012655	nimesulide results in increased expression of SNU13 mRNA	PMID:24136188
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1347136	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of SNU13 mRNA	PMID:18414638
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004726	Endosulfan results in increased expression of SNU13 mRNA	PMID:29391264
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1347136	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SNU13 mRNA	PMID:18175754
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:48981	quinolin-8-ol	decreases expression	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D015125	Oxyquinoline results in decreased expression of SNU13 mRNA	PMID:15612046
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNU13 mRNA	PMID:17942748
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:4917	eugenol	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in decreased expression of SNU13 protein	PMID:39793947
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SNU13 protein	PMID:25419056
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SNU13 mRNA	PMID:25554681
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D005485	Flutamide results in increased expression of SNU13 mRNA	PMID:24136188
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SNU13 mRNA	PMID:19042947
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SNU13 mRNA	PMID:17183730
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNU13 protein	PMID:32959892
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1550293	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of SNU13 mRNA	PMID:27462272
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNU13 mRNA	PMID:22206623
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SNU13 protein	PMID:37664457
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C051752	nefazodone results in increased expression of SNU13 mRNA	PMID:24136188
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNU13 mRNA	PMID:30851411
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SNU13 gene]	PMID:28238834
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550293	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SNU13 mRNA	PMID:31388691
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SNU13 protein	PMID:31675489
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1550293	E	RGD:6480464	20170516	CTD	MESH:C045950	propiconazole results in increased expression of SNU13 mRNA	PMID:21278054
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1550293	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SNU13 mRNA]	PMID:39241906
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347136	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SNU13 protein	PMID:37664457
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D012999	Soman results in increased expression of SNU13 mRNA	PMID:19281266
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1347136	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of SNU13 mRNA	PMID:34581912
1303103	Snu13	small nuclear ribonucleoprotein 13	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1347136	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SNU13 mRNA	PMID:38568856
1303105	Dear	dual endothelin 1, angiotensin II receptor	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DEAR mRNA	PMID:33387578
1303105	Dear	dual endothelin 1, angiotensin II receptor	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of DEAR gene	PMID:27618143
1303105	Dear	dual endothelin 1, angiotensin II receptor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DEAR mRNA	PMID:15620428
1303105	Dear	dual endothelin 1, angiotensin II receptor	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of DEAR mRNA	PMID:30047161
1303105	Dear	dual endothelin 1, angiotensin II receptor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C006780	bisphenol A results in decreased expression of DEAR mRNA	PMID:25181051
1303105	Dear	dual endothelin 1, angiotensin II receptor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DEAR mRNA	PMID:15620428
1303105	Dear	dual endothelin 1, angiotensin II receptor	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of DEAR mRNA	PMID:30047161
1303105	Dear	dual endothelin 1, angiotensin II receptor	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of DEAR mRNA	PMID:30047161
1303105	Dear	dual endothelin 1, angiotensin II receptor	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DEAR mRNA	PMID:30047161
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003471	Cuprizone affects the expression of STFA2L1 mRNA	PMID:27523638
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003300	Copper deficiency results in increased expression of STFA2L1 mRNA	PMID:26033743
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of STFA2L1 mRNA	PMID:26033743
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003300	Copper deficiency results in increased expression of STFA2L1 mRNA	PMID:26033743
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of STFA2L1 mRNA	PMID:26033743
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C004312	glycidol results in decreased expression of STFA2L1 mRNA	PMID:24915197
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of STFA2L1 mRNA	PMID:41034487
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of STFA2L1 mRNA	PMID:41580965
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of STFA2L1 mRNA	PMID:41580965
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:6456	lidocaine	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D008012	Lidocaine results in decreased expression of STFA2L1 mRNA	PMID:35283115
1303106	Stfa2l1	stefin A2-like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D011441	Propylthiouracil results in decreased expression of STFA2L1 mRNA	PMID:24780913
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	affects abundance	ISO	RGD:1604306	E	RGD:6480464	20160822	CTD	MESH:D014859	VKORC1 gene polymorphism affects the abundance of Warfarin	PMID:25986145
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	affects metabolic processing	ISO	RGD:1604306	E	RGD:6480464	20141111	CTD	MESH:D014859	VKORC1 protein affects the metabolism of Warfarin	PMID:20073138
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	affects response to substance	EXP		E	RGD:6480464	20141111	CTD	MESH:D014859	VKORC1 protein mutant form affects the susceptibility to Warfarin	PMID:23018795
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	affects response to substance	ISO	RGD:1604306	E	RGD:6480464	20160705	CTD	MESH:D014859	VKORC1 3' UTR SNP affects the susceptibility to Warfarin; VKORC1 affects the susceptibility to Warfarin; VKORC1 alternative form affects the susceptibility to Warfarin; VKORC1 gene affects the susceptibility to Warfarin; VKORC1 gene mutant form affects the susceptibility to Warfarin; VKORC1 gene polymorphism affects the susceptibility to Warfarin; VKORC1 gene SNP affects the susceptibility to Warfarin; VKORC1 intron polymorphism affects the susceptibility to Warfarin; VKORC1 intron SNP affects the susceptibility to Warfarin; VKORC1 polymorphism affects the susceptibility to Warfarin; VKORC1 promoter polymorphism affects the susceptibility to Warfarin; VKORC1 promoter SNP affects the susceptibility to Warfarin; VKORC1 protein affects the susceptibility to Warfarin; VKORC1 protein polymorphism affects the susceptibility to Warfarin; VKORC1 protein SNP affects the susceptibility to Warfarin; VKORC1 SNP affects the susceptibility to Warfarin	PMID:15358623|PMID:15578879|PMID:15630486|PMID:15930419|PMID:16270629|PMID:16432637|PMID:16611750|PMID:16847429|PMID:16879214|PMID:16890578|PMID:16960144|PMID:17048007|PMID:17049586|PMID:17111199|PMID:17329985|PMID:17387222|PMID:17391071|PMID:17456829|PMID:17496169|PMID:17510308|PMID:17764537|PMID:17995970|PMID:18240904|PMID:18370846|PMID:18523153|PMID:18532998|PMID:18535201|PMID:18542936|PMID:18574025|PMID:18698879|PMID:18776969|PMID:18805772|PMID:19018718|PMID:19135231|PMID:19207028|PMID:19300499|PMID:19567378|PMID:19752777|PMID:19998810|PMID:20072124|PMID:20339978|PMID:20354686|PMID:20375999|PMID:20386359|PMID:20553802|PMID:20579077|PMID:20615525|PMID:20637959|PMID:20716240|PMID:20833655|PMID:20842355|PMID:20854800|PMID:21110192|PMID:21176721|PMID:21228733|PMID:21270790|PMID:21320153|PMID:21321468|PMID:21326313|PMID:21428138|PMID:21562147|PMID:21590310|PMID:21635147|PMID:21639946|PMID:21681008|PMID:21786578|PMID:21911247|PMID:22040439|PMID:22161100|PMID:22198820|PMID:22248286|PMID:22266406|PMID:22528326|PMID:22533669|PMID:22571356|PMID:22855348|PMID:22907842|PMID:22990331|PMID:23061746|PMID:23167228|PMID:23183958|PMID:23208322|PMID:23276529|PMID:23279643|PMID:23571513|PMID:23602689|PMID:23710884|PMID:23800980|PMID:23990957|PMID:24399734|PMID:24474498|PMID:24601977|PMID:24750390|PMID:24966969|PMID:24978953|PMID:25042728|PMID:25312789|PMID:25652102|PMID:25699611|PMID:25747538|PMID:25946405|PMID:26167638|PMID:26219158|PMID:26223945|PMID:26257249|PMID:26418980|PMID:26445138|PMID:26568290|PMID:26583785|PMID:26644206|PMID:26757860|PMID:26940072|PMID:26996562|PMID:27055637|PMID:27258224|PMID:27262824|PMID:27488176|PMID:27622442|PMID:27632229|PMID:27743182|PMID:27938396|PMID:28079798|PMID:28083852|PMID:28135054|PMID:28262345|PMID:28401802|PMID:28550460|PMID:28686080|PMID:28689179|PMID:28867752|PMID:29182754|PMID:29234073|PMID:29776386|PMID:30647445|PMID:30883300|PMID:31064211|PMID:31173123|PMID:31395958|PMID:31720756|PMID:31854268|PMID:31869433|PMID:31973625|PMID:32219822|PMID:32669629|PMID:34382722|PMID:34729928|PMID:36476275|PMID:36789833
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	decreases activity	EXP		E	RGD:6480464	20180828	CTD	MESH:D014859	Warfarin results in decreased activity of VKORC1 protein	PMID:17941040
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in decreased activity of VKORC1 protein	PMID:14765194|PMID:14765195|PMID:18240904|PMID:18805772|PMID:19300499
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	decreases metabolic processing	ISO	RGD:1604306	E	RGD:6480464	20141111	CTD	MESH:D014859	VKORC1 gene polymorphism results in decreased metabolism of Warfarin	PMID:20073138
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	decreases response to substance	EXP		E	RGD:6480464	20141111	CTD	MESH:D014859	VKORC1 gene mutant form results in decreased susceptibility to Warfarin; VKORC1 protein polymorphism results in decreased susceptibility to Warfarin	PMID:14765194|PMID:15879509|PMID:16421894|PMID:19200363|PMID:27117082
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	decreases response to substance	ISO	RGD:1332416	E	RGD:6480464	20141111	CTD	MESH:D014859	VKORC1 gene mutant form results in decreased susceptibility to Warfarin; VKORC1 protein polymorphism results in decreased susceptibility to Warfarin	PMID:19200363|PMID:27117082
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	decreases response to substance	ISO	RGD:1604306	E	RGD:6480464	20160822	CTD	MESH:D014859	VKORC1 3' UTR results in decreased susceptibility to Warfarin; VKORC1 gene mutant form results in decreased susceptibility to Warfarin; VKORC1 gene polymorphism results in decreased susceptibility to Warfarin	PMID:14765194|PMID:16676068|PMID:17961434|PMID:18030307|PMID:18034619|PMID:18266023|PMID:19942260|PMID:25885753
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	increases response to substance	ISO	RGD:1604306	E	RGD:6480464	20141111	CTD	MESH:D014859	VKORC1 intron polymorphism results in increased susceptibility to Warfarin; VKORC1 protein results in increased susceptibility to Warfarin; VKORC1 results in increased susceptibility to Warfarin	PMID:16676068|PMID:17049586|PMID:17111199|PMID:17387222|PMID:17496169|PMID:18532998|PMID:18542936|PMID:20420818
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin inhibits the reaction [VKORC1 protein affects the reduction of vitamin K1 oxide]	PMID:23928358
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:10033	warfarin	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20141111	CTD	MESH:D014859	[CYP4F2 gene polymorphism co-treated with VKORC1 gene mutant form] affects the susceptibility to Warfarin; Warfarin binds to and results in decreased activity of VKORC1 protein; Warfarin inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; Warfarin inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide]	PMID:21084764|PMID:23928358|PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VKORC1 mRNA]	PMID:31150632
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:134975	fluindione	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C017673	fluindione results in decreased activity of VKORC1 protein	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:134975	fluindione	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C017673	fluindione inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; fluindione inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:137426	dehydroacetic acid	decreases activity	EXP		E	RGD:6480464	20180828	CTD	MESH:C027493	dehydroacetic acid results in decreased activity of VKORC1 protein	PMID:17941040
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:137426	dehydroacetic acid	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C027493	dehydroacetic acid results in decreased expression of VKORC1 protein	PMID:36403723|PMID:38103582
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:137426	dehydroacetic acid	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:C027493	FR 180204 inhibits the reaction [dehydroacetic acid results in decreased expression of VKORC1 protein]; VKORC1 protein inhibits the reaction [dehydroacetic acid results in decreased secretion of F9 protein]	PMID:36403723|PMID:38103582
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VKORC1 gene	PMID:20938992
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:15365	acetylsalicylic acid	increases response to substance	ISO	RGD:1604306	E	RGD:6480464	20180515	CTD	MESH:D001241	VKORC1 gene SNP results in increased susceptibility to Aspirin	PMID:28338108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of VKORC1 mRNA	PMID:30529165
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:15759	2,3-epoxyphylloquinone	affects reduction	EXP		E	RGD:6480464	20240604	CTD	MESH:C016186	VKORC1 protein affects the reduction of vitamin K1 oxide	PMID:23928358
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:15759	2,3-epoxyphylloquinone	increases reduction	ISO	RGD:1604306	E	RGD:6480464	20240604	CTD	MESH:C016186	VKORC1 protein results in increased reduction of vitamin K1 oxide	PMID:23928358|PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:15759	2,3-epoxyphylloquinone	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:C016186	Warfarin inhibits the reaction [VKORC1 protein affects the reduction of vitamin K1 oxide]	PMID:23928358
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:15759	2,3-epoxyphylloquinone	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20240604	CTD	MESH:C016186	[VKORC1 protein results in increased reduction of vitamin K1 oxide] which results in increased carboxylation of and results in increased activity of F9 protein; coumachlor inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide]; fluindione inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide]; Warfarin inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide]	PMID:23928358|PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1332416	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of VKORC1 mRNA	PMID:39298647
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VKORC1 gene	PMID:20938992
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604306	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of VKORC1 mRNA	PMID:37042841
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332416	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of VKORC1 mRNA	PMID:34319233
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332416	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of VKORC1 mRNA	PMID:33754040
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:180534	7-Hydroxywarfarin	affects abundance	ISO	RGD:1604306	E	RGD:6480464	20211019	CTD	MESH:C087837	VKORC1 gene polymorphism affects the abundance of 7-hydroxywarfarin	PMID:25986145
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:18067	phylloquinone	increases reduction	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:D010837	VKORC1 protein results in increased reduction of Vitamin K 1	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:18067	phylloquinone	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:D010837	4-hydroxycoumarin inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; [VKORC1 protein results in increased reduction of Vitamin K 1] which results in increased carboxylation of and results in increased activity of F9 protein; Acenocoumarol inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; bromadiolone inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; bromfenacoum inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; coumachlor inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; coumatetralyl inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; Dicumarol inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; ferulenol inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; fluindione inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; Phenindione inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; Phenprocoumon inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; Warfarin inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of VKORC1 mRNA	PMID:39836092
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:18320	1,4-dithiothreitol	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D004229	Dithiothreitol promotes the reaction [Ethylmaleimide results in decreased activity of VKORC1 protein]	PMID:2319331
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of VKORC1 mRNA	PMID:28522335
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1332416	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of VKORC1 mRNA	PMID:27462272
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VKORC1 mRNA	PMID:37236586
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:23403	coumarins	affects activity	ISO	RGD:1604306	E	RGD:6480464	20170110	CTD	MESH:D003374	Coumarins affects the activity of VKORC1 protein	PMID:18278162
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604306	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VKORC1 mRNA	PMID:19549813
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of VKORC1 mRNA	PMID:31150632
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1332416	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of VKORC1 mRNA	PMID:31919559
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VKORC1 mRNA]	PMID:31150632
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VKORC1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VKORC1 gene	PMID:20938992|PMID:22206623
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of VKORC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of VKORC1 mRNA	PMID:39836092
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VKORC1 mRNA	PMID:19244175
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA	PMID:19244175
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of VKORC1 mRNA	PMID:31881176
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of VKORC1 mRNA	PMID:19167446
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1332416	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in increased expression of VKORC1 mRNA	PMID:25270620
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28077	rifampicin	affects response to substance	ISO	RGD:1604306	E	RGD:6480464	20230606	CTD	MESH:D012293	VKORC1 alternative form affects the susceptibility to Rifampin	PMID:36789833
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VKORC1 mRNA	PMID:22298810
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VKORC1 mRNA	PMID:21724226
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VKORC1 mRNA	PMID:33387578|PMID:34747641
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VKORC1 mRNA	PMID:17942748
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of VKORC1 mRNA	PMID:28374803
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1604306	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of VKORC1 mRNA	PMID:33512557
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28371	vitamin K epoxide	affects reduction	EXP		E	RGD:6480464	20141014	CTD	MESH:C016186	VKORC1 protein affects the reduction of vitamin K1 oxide	PMID:23928358
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28371	vitamin K epoxide	increases reduction	ISO	RGD:1604306	E	RGD:6480464	20141014	CTD	MESH:C016186	VKORC1 protein results in increased reduction of vitamin K1 oxide	PMID:23928358|PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28371	vitamin K epoxide	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:C016186	Warfarin inhibits the reaction [VKORC1 protein affects the reduction of vitamin K1 oxide]	PMID:23928358
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28371	vitamin K epoxide	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20141014	CTD	MESH:C016186	[VKORC1 protein results in increased reduction of vitamin K1 oxide] which results in increased carboxylation of and results in increased activity of F9 protein; coumachlor inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide]; fluindione inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide]; Warfarin inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide]	PMID:23928358|PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28384	vitamin K	increases secretion	EXP		E	RGD:6480464	20230404	CTD	MESH:D014812	VKORC1 protein results in increased secretion of Vitamin K	PMID:36403723
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of VKORC1 mRNA	PMID:28959563
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of VKORC1 mRNA	PMID:22465980|PMID:30556269
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604306	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VKORC1 mRNA	PMID:29803840
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28794	coumarin	decreases response to substance	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:C030123	VKORC1 gene mutant form results in decreased susceptibility to coumarin	PMID:18278162
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:28794	coumarin	increases response to substance	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:C030123	VKORC1 gene mutant form results in increased susceptibility to coumarin; VKORC1 promoter SNP results in increased susceptibility to coumarin	PMID:17849045|PMID:18278162
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604306	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of VKORC1 mRNA	PMID:38568856
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of VKORC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of VKORC1 mRNA	PMID:39836092
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332416	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of VKORC1 mRNA	PMID:27195522
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of VKORC1 mRNA	PMID:20106945|PMID:32234424
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604306	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of VKORC1 promoter	PMID:27901495
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to VKORC1 promoter]	PMID:19654925
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of VKORC1 mRNA	PMID:22465980|PMID:30556269
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of VKORC1 mRNA	PMID:23411599|PMID:34492290
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1332416	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of VKORC1 mRNA	PMID:18648102
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of VKORC1 mRNA	PMID:19167457
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of VKORC1 mRNA	PMID:30903817
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332416	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of VKORC1 mRNA	PMID:33221593
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of VKORC1 mRNA	PMID:25181051|PMID:32145629
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VKORC1 mRNA	PMID:36041667
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VKORC1 mRNA	PMID:28628672
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1604306	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of VKORC1 mRNA	PMID:19244175
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA	PMID:19244175
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332416	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of VKORC1 mRNA	PMID:39298647
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1604306	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of VKORC1 protein	PMID:34186270
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VKORC1 mRNA	PMID:36041667
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VKORC1 mRNA	PMID:36041667
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VKORC1 mRNA	PMID:28628672
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1604306	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of VKORC1 protein	PMID:34186270
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of VKORC1 mRNA	PMID:17602206
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of VKORC1 mRNA	PMID:17379624|PMID:21266533
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VKORC1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VKORC1 mRNA	PMID:28628672
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of VKORC1 mRNA	PMID:17602206
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604306	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VKORC1 mRNA	PMID:37042841
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of VKORC1 mRNA	PMID:39836092
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1604306	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of VKORC1 mRNA	PMID:38568856
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VKORC1 mRNA	PMID:37236586
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VKORC1 mRNA	PMID:19244175
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA	PMID:19244175
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1332416	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of VKORC1 mRNA	PMID:17585979
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1332416	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of VKORC1 mRNA	PMID:40194260
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1604306	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of VKORC1 mRNA	PMID:33512557
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VKORC1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of VKORC1 mRNA	PMID:19167446
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1604306	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of VKORC1 mRNA	PMID:26352163
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604306	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of VKORC1 mRNA	PMID:25979313
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1332416	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of VKORC1 mRNA	PMID:21427059
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604306	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of VKORC1 mRNA	PMID:23179753|PMID:26272509|PMID:27188386
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VKORC1 mRNA	PMID:27188386
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:40070	4-hydroxycoumarin	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C068805	4-hydroxycoumarin results in decreased activity of VKORC1 protein	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:40070	4-hydroxycoumarin	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C068805	4-hydroxycoumarin inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of VKORC1 mRNA	PMID:20106945
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VKORC1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VKORC1 mRNA	PMID:28628672
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:42106	L-1,4-dithiothreitol	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D004229	Dithiothreitol promotes the reaction [Ethylmaleimide results in decreased activity of VKORC1 protein]	PMID:2319331
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:44485	N-ethylmaleimide	decreases activity	EXP		E	RGD:6480464	20241105	CTD	MESH:D005033	Ethylmaleimide results in decreased activity of VKORC1 protein	PMID:2319331
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:44485	N-ethylmaleimide	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D005033	Dithiothreitol promotes the reaction [Ethylmaleimide results in decreased activity of VKORC1 protein]	PMID:2319331
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:4513	dicoumarol	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:D001728	Dicumarol results in decreased activity of VKORC1 protein	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:4513	dicoumarol	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:D001728	Dicumarol inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332416	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of VKORC1 mRNA	PMID:17562736
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of VKORC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of VKORC1 mRNA	PMID:39836092
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of VKORC1 mRNA	PMID:18175754
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of VKORC1 mRNA	PMID:17557909
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VKORC1 mRNA	PMID:17942748
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1332416	E	RGD:6480464	20150127	CTD	MESH:D005047	Etoposide results in increased expression of VKORC1 mRNA	PMID:25270620
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VKORC1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VKORC1 mRNA	PMID:28628672
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:50438	phenprocoumon	affects response to substance	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:D010644	VKORC1 gene polymorphism affects the susceptibility to Phenprocoumon; VKORC1 intron SNP affects the susceptibility to Phenprocoumon	PMID:15536456|PMID:16201835|PMID:18698879
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:50438	phenprocoumon	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:D010644	Phenprocoumon results in decreased activity of VKORC1 protein	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:50438	phenprocoumon	decreases response to substance	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:D010644	VKORC1 protein polymorphism results in decreased susceptibility to Phenprocoumon	PMID:17036862
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:50438	phenprocoumon	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:D010644	Phenprocoumon inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332416	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of VKORC1 mRNA; Nanotubes, Carbon results in decreased expression of VKORC1 mRNA	PMID:25554681|PMID:25620056
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of VKORC1 mRNA	PMID:23962444
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:53766	acenocoumarol	affects response to substance	ISO	RGD:1604306	E	RGD:6480464	20160315	CTD	MESH:D000074	VKORC1 gene polymorphism affects the susceptibility to Acenocoumarol; VKORC1 gene SNP affects the susceptibility to Acenocoumarol; VKORC1 intron SNP affects the susceptibility to Acenocoumarol; VKORC1 polymorphism affects the susceptibility to Acenocoumarol; VKORC1 protein polymorphism affects the susceptibility to Acenocoumarol	PMID:16201835|PMID:16611310|PMID:16869821|PMID:18698879|PMID:19578179|PMID:25042728|PMID:25866574|PMID:26757860|PMID:28867752
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:53766	acenocoumarol	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:D000074	Acenocoumarol results in decreased activity of VKORC1 protein	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:53766	acenocoumarol	decreases response to substance	ISO	RGD:1604306	E	RGD:6480464	20120412	CTD	MESH:D000074	VKORC1 promoter polymorphism results in decreased susceptibility to Acenocoumarol; VKORC1 protein polymorphism results in decreased susceptibility to Acenocoumarol	PMID:17036862|PMID:19875892
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:53766	acenocoumarol	increases response to substance	ISO	RGD:1604306	E	RGD:6480464	20130514	CTD	MESH:D000074	VKORC1 protein results in increased susceptibility to Acenocoumarol	PMID:16869821
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:53766	acenocoumarol	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:D000074	Acenocoumarol inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604306	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of VKORC1 protein	PMID:32959892
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of VKORC1 mRNA	PMID:39836092
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of VKORC1 mRNA	PMID:37269647
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332416	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of VKORC1 mRNA	PMID:22206623
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VKORC1 mRNA	PMID:22206623
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of VKORC1 mRNA	PMID:24136188
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VKORC1 mRNA	PMID:27188386
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1332416	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 promotes the reaction [NR1H4 protein binds to VKORC1 gene]	PMID:20091679
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:8066	phenindione	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:D010630	Phenindione results in decreased activity of VKORC1 protein	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:8066	phenindione	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:D010630	Phenindione inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:80741	Coumachlor	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C412550	coumachlor results in decreased activity of VKORC1 protein	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:80741	Coumachlor	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C412550	coumachlor inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]; coumachlor inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:80742	Coumatetralyl	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C004699	coumatetralyl results in decreased activity of VKORC1 protein	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:80742	Coumatetralyl	decreases response to substance	EXP		E	RGD:6480464	20170516	CTD	MESH:C004699	VKORC1 protein polymorphism results in decreased susceptibility to coumatetralyl	PMID:27117082
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:80742	Coumatetralyl	decreases response to substance	ISO	RGD:1332416	E	RGD:6480464	20170516	CTD	MESH:C004699	VKORC1 protein polymorphism results in decreased susceptibility to coumatetralyl	PMID:27117082
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:80742	Coumatetralyl	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C004699	coumatetralyl inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:80743	Difenacoum	decreases response to substance	EXP		E	RGD:6480464	20170516	CTD	MESH:C012903	VKORC1 protein mutant form results in decreased susceptibility to difenacoum; VKORC1 protein polymorphism results in decreased susceptibility to difenacoum	PMID:27117082|PMID:29155484
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:80743	Difenacoum	decreases response to substance	ISO	RGD:1332416	E	RGD:6480464	20170516	CTD	MESH:C012903	VKORC1 protein polymorphism results in decreased susceptibility to difenacoum	PMID:27117082
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of VKORC1 mRNA	PMID:21724226
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1332416	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of VKORC1 mRNA	PMID:31388691
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VKORC1 mRNA	PMID:19167446
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81796	Chlorophacinone	decreases response to substance	EXP		E	RGD:6480464	20141111	CTD	MESH:C004662	VKORC1 gene mutant form results in decreased susceptibility to chlorophacinone	PMID:19752778
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81855	Bromadiolone	affects response to substance	EXP		E	RGD:6480464	20141111	CTD	MESH:C021636	VKORC1 protein affects the susceptibility to bromadiolone	PMID:17994578
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81855	Bromadiolone	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C021636	bromadiolone results in decreased activity of VKORC1 protein	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81855	Bromadiolone	decreases response to substance	EXP		E	RGD:6480464	20141111	CTD	MESH:C021636	VKORC1 gene mutant form results in decreased susceptibility to bromadiolone; VKORC1 gene polymorphism results in decreased susceptibility to bromadiolone; VKORC1 protein polymorphism results in decreased susceptibility to bromadiolone	PMID:17994578|PMID:19752778|PMID:27117082
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81855	Bromadiolone	decreases response to substance	ISO	RGD:1332416	E	RGD:6480464	20170516	CTD	MESH:C021636	VKORC1 protein polymorphism results in decreased susceptibility to bromadiolone	PMID:27117082
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81855	Bromadiolone	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C021636	bromadiolone inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81892	Brodifacoum	decreases activity	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C013418	bromfenacoum results in decreased activity of VKORC1 protein	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81892	Brodifacoum	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20191112	CTD	MESH:C013418	bromfenacoum inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:81893	Difethialone	decreases activity	EXP		E	RGD:6480464	20200804	CTD	MESH:C060340	difethialone results in decreased activity of VKORC1 protein	PMID:32047980
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1332416	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of VKORC1 mRNA	PMID:39847705
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604306	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VKORC1 mRNA	PMID:27188386
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of VKORC1 mRNA	PMID:21346803
1303107	Vkorc1	vitamin K epoxide reductase complex, subunit 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of VKORC1 mRNA	PMID:21346803
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of ANKRA2 mRNA	PMID:25596134
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552699	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ANKRA2 mRNA	PMID:33045310
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1347651	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ANKRA2 mRNA	PMID:23724009
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ANKRA2 mRNA	PMID:25596134
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552699	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ANKRA2 mRNA	PMID:30319688
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1347651	E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ANKRA2 mRNA	PMID:23410634
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1347651	E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ANKRA2 mRNA	PMID:39709020
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1347651	E	RGD:6480464	20130122	CTD	MESH:D011794	Quercetin results in increased expression of ANKRA2 mRNA	PMID:21632981
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552699	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ANKRA2 mRNA	PMID:39241906
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ANKRA2 mRNA	PMID:31614463
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1347651	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ANKRA2 mRNA	PMID:37042841
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1347651	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ANKRA2 mRNA	PMID:23649840
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1347651	E	RGD:6480464	20130122	CTD	MESH:C044887	beta-methylcholine affects the expression of ANKRA2 mRNA	PMID:21179406
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ANKRA2 mRNA	PMID:33387578
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1347651	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ANKRA2 mRNA	PMID:23649840
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1347651	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ANKRA2 protein	PMID:20106945
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1347651	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ANKRA2 gene	PMID:27153756
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1347651	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ANKRA2 mRNA	PMID:21632981|PMID:21641981|PMID:22100608|PMID:27153756
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552699	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ANKRA2 mRNA	PMID:19770486
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1347651	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ANKRA2 mRNA	PMID:23649840
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1347651	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of ANKRA2 mRNA	PMID:25102026
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1347651	E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in increased expression of ANKRA2 mRNA	PMID:24657277
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552699	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANKRA2 mRNA	PMID:22206623
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ANKRA2 mRNA	PMID:19244175
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1347651	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ANKRA2 mRNA	PMID:38460933
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1347651	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ANKRA2 mRNA	PMID:38460933
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of ANKRA2 mRNA	PMID:25596134
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1347651	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ANKRA2 mRNA	PMID:28903495
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of ANKRA2 mRNA	PMID:25596134
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1347651	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ANKRA2 mRNA	PMID:27392435
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1347651	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ANKRA2 mRNA	PMID:27392435
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANKRA2 mRNA	PMID:33387578
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552699	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANKRA2 mRNA	PMID:15034205
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552699	E	RGD:6480464	20130618	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ANKRA2 mRNA]	PMID:15034205
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ANKRA2 mRNA	PMID:30851411
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1347651	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of ANKRA2 mRNA	PMID:23649840
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1347651	E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of ANKRA2 mRNA	PMID:23410634
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347651	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ANKRA2 mRNA	PMID:38568856
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1347651	E	RGD:6480464	20130122	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANKRA2 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552699	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANKRA2 mRNA	PMID:15034205
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552699	E	RGD:6480464	20130618	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of ANKRA2 mRNA]	PMID:15034205
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ANKRA2 mRNA	PMID:25895662
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1347651	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ANKRA2 mRNA	PMID:20382639|PMID:26238291
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ANKRA2 mRNA	PMID:30047161
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKRA2 mRNA	PMID:34947998
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ANKRA2 mRNA	PMID:25181051
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ANKRA2 mRNA	PMID:38382870|PMID:38568856
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ANKRA2 mRNA	PMID:19244175
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of ANKRA2 mRNA	PMID:25596134
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ANKRA2 mRNA	PMID:28302478
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1347651	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ANKRA2 mRNA	PMID:40419075
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347651	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ANKRA2 mRNA	PMID:25979313
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ANKRA2 mRNA	PMID:23179753|PMID:25192806|PMID:26272509
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347651	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRA2 mRNA	PMID:27188386
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ANKRA2 mRNA	PMID:30047161
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1347651	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ANKRA2 mRNA	PMID:25596134
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1347651	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ANKRA2 mRNA	PMID:23649840
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1347651	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of ANKRA2 mRNA	PMID:24657277
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1347651	E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in increased expression of ANKRA2 mRNA	PMID:24657277
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ANKRA2 mRNA	PMID:38832940
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ANKRA2 mRNA	PMID:33387578
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1347651	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ANKRA2 mRNA	PMID:25596134
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1347651	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ANKRA2 mRNA	PMID:38460933
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1347651	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of ANKRA2 mRNA	PMID:24383545
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1347651	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of ANKRA2 mRNA	PMID:25596134
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552699	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ANKRA2 mRNA; Nanotubes, Carbon results in decreased expression of ANKRA2 mRNA	PMID:25554681
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ANKRA2 mRNA	PMID:30047161
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:5864	ifosfamide	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of ANKRA2 mRNA	PMID:25596134
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	ISO	RGD:1347651	E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of ANKRA2 mRNA	PMID:23410634
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1552699	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ANKRA2 mRNA	PMID:22206623
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552699	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANKRA2 mRNA	PMID:22206623
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ANKRA2 mRNA	PMID:22714537
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1347651	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ANKRA2 mRNA	PMID:30851411
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347651	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRA2 mRNA	PMID:27188386
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347651	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ANKRA2 gene]	PMID:28238834
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ANKRA2 mRNA	PMID:30047161
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ANKRA2 mRNA	PMID:24780913
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347651	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRA2 mRNA	PMID:27188386
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:9150	simvastatin	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D019821	Simvastatin results in increased expression of ANKRA2 mRNA	PMID:25055962
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ANKRA2 mRNA	PMID:21346803
1303108	Ankra2	ankyrin repeat family A member 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ANKRA2 mRNA	PMID:21346803
1303110	Ostn	osteocrin	gene	CHEBI:139047	GSK2656157	multiple interactions	ISO	RGD:1619817	E	RGD:6480464	20190312	CTD	MESH:C000597302	GSK2656157 inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]	PMID:30602124
1303110	Ostn	osteocrin	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of OSTN mRNA	PMID:33387578
1303110	Ostn	osteocrin	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1619817	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of OSTN mRNA	PMID:30602124
1303110	Ostn	osteocrin	gene	CHEBI:17315	D-glucosamine	multiple interactions	ISO	RGD:1619817	E	RGD:6480464	20260203	CTD	MESH:D005944	4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; [INS1 protein co-treated with Glucosamine] results in increased expression of OSTN mRNA; ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; EIF2AK3 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; GSK2656157 inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased uptake of 2-NBDG]]	PMID:30602124
1303110	Ostn	osteocrin	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of OSTN mRNA	PMID:21515302
1303110	Ostn	osteocrin	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1619817	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of OSTN mRNA	PMID:30602124
1303110	Ostn	osteocrin	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	ISO	RGD:1619817	E	RGD:6480464	20190312	CTD	MESH:D005944	4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; [INS1 protein co-treated with Glucosamine] results in increased expression of OSTN mRNA; ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; EIF2AK3 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; GSK2656157 inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased uptake of 2-NBDG]]	PMID:30602124
1303110	Ostn	osteocrin	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1342782	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of OSTN mRNA	PMID:24376830
1303110	Ostn	osteocrin	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1342782	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of OSTN mRNA	PMID:24834073
1303110	Ostn	osteocrin	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1619817	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of OSTN mRNA	PMID:30602124
1303110	Ostn	osteocrin	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	ISO	RGD:1619817	E	RGD:6480464	20190312	CTD	MESH:D005944	4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; [INS1 protein co-treated with Glucosamine] results in increased expression of OSTN mRNA; ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; EIF2AK3 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; GSK2656157 inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased uptake of 2-NBDG]]	PMID:30602124
1303110	Ostn	osteocrin	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1342782	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of OSTN mRNA	PMID:35984750
1303110	Ostn	osteocrin	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of OSTN mRNA	PMID:21515302
1303110	Ostn	osteocrin	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1619817	E	RGD:6480464	20160607	CTD	MESH:C006780	bisphenol A affects the expression of OSTN mRNA	PMID:27082013
1303110	Ostn	osteocrin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OSTN mRNA	PMID:25181051
1303110	Ostn	osteocrin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1619817	E	RGD:6480464	20160607	CTD	MESH:C006780	[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of OSTN mRNA]	PMID:27082013
1303110	Ostn	osteocrin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1619817	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of OSTN mRNA	PMID:40203079
1303110	Ostn	osteocrin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1619817	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of OSTN mRNA]	PMID:40203079
1303110	Ostn	osteocrin	gene	CHEBI:34421	4-Hydroxybenzophenone	increases expression	ISO	RGD:1619817	E	RGD:6480464	20221101	CTD	MESH:C024292	4-hydroxybenzophenone results in increased expression of OSTN mRNA	PMID:35476924
1303110	Ostn	osteocrin	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1619817	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of OSTN mRNA	PMID:34289071
1303110	Ostn	osteocrin	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of OSTN mRNA	PMID:32680482
1303110	Ostn	osteocrin	gene	CHEBI:38211	potassium bromate	multiple interactions	ISO	RGD:1619817	E	RGD:6480464	20160607	CTD	MESH:C019536	[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of OSTN mRNA]	PMID:27082013
1303110	Ostn	osteocrin	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1619817	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in increased expression of OSTN mRNA	PMID:40633821
1303110	Ostn	osteocrin	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1619817	E	RGD:6480464	20190312	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]	PMID:30602124
1303110	Ostn	osteocrin	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1619817	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of OSTN mRNA	PMID:30602124
1303110	Ostn	osteocrin	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	ISO	RGD:1619817	E	RGD:6480464	20190312	CTD	MESH:D005944	4-methylumbelliferone 8-carbaldehyde inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; [INS1 protein co-treated with Glucosamine] results in increased expression of OSTN mRNA; ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; EIF2AK3 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; ERN1 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]; GSK2656157 inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]]; OSTN protein affects the reaction [Glucosamine inhibits the reaction [INS1 protein results in increased uptake of 2-NBDG]]	PMID:30602124
1303110	Ostn	osteocrin	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	ISO	RGD:1342782	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of OSTN mRNA	PMID:24834073
1303110	Ostn	osteocrin	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1342782	E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in increased expression of OSTN mRNA	PMID:29453283
1303110	Ostn	osteocrin	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of OSTN mRNA	PMID:21515302
1303110	Ostn	osteocrin	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1342782	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of OSTN mRNA	PMID:16981146
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1344520	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RTCA mRNA	PMID:33167477
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1332441	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RTCA mRNA	PMID:30319688
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1344520	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RTCA mRNA	PMID:21632981
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332441	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RTCA mRNA	PMID:39241906
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344520	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RTCA mRNA	PMID:37042841
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1332441	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in decreased expression of RTCA mRNA	PMID:37084897
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1344520	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RTCA mRNA	PMID:21179406
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1344520	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RTCA mRNA	PMID:19549813
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1344520	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RTCA protein	PMID:23301498
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332441	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RTCA mRNA	PMID:31919559
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1344520	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RTCA gene	PMID:25304211
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1344520	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTCA mRNA	PMID:39836092
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1344520	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of RTCA protein	PMID:38460933
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1332441	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of RTCA protein	PMID:25505154
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344520	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RTCA mRNA	PMID:23557933
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332441	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RTCA mRNA	PMID:17942748
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332441	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RTCA mRNA	PMID:17942748
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1344520	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RTCA protein	PMID:39603559
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1344520	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of RTCA mRNA	PMID:32763439
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1344520	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of RTCA mRNA	PMID:20971185
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1344520	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RTCA mRNA	PMID:29803840
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344520	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of RTCA protein	PMID:38228842
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344520	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RTCA mRNA	PMID:38568856
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1344520	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTCA mRNA	PMID:39836092
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1332441	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RTCA exon; Benzo(a)pyrene results in decreased methylation of RTCA intron	PMID:27901495
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1344520	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of RTCA mRNA	PMID:20971185
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1344520	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RTCA mRNA	PMID:19150397
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332441	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RTCA promoter alternative form	PMID:35295148
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1344520	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RTCA mRNA	PMID:30903817
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RTCA mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RTCA mRNA	PMID:25181051
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332441	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RTCA mRNA	PMID:33221593
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332441	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RTCA mRNA	PMID:39298647
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1344520	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RTCA protein	PMID:34186270
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1344520	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RTCA mRNA	PMID:38568856
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1344520	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of RTCA mRNA	PMID:19320972|PMID:19376846
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1344520	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RTCA mRNA	PMID:28302478
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332441	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RTCA mRNA	PMID:17963808
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344520	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RTCA mRNA	PMID:25979313
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344520	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RTCA mRNA	PMID:23179753|PMID:27188386
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1344520	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of RTCA mRNA	PMID:20106945|PMID:25562108
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332441	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RTCA mRNA	PMID:28973697
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332441	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RTCA mRNA	PMID:17562736
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RTCA mRNA	PMID:33387578
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1332441	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of RTCA mRNA	PMID:29279043
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1344520	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of RTCA protein	PMID:38460933
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1344520	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RTCA gene	PMID:25304211
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1344520	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTCA mRNA	PMID:39836092
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1332441	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RTCA mRNA	PMID:17942748
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1332441	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RTCA mRNA	PMID:17942748
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332441	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RTCA mRNA; Nanotubes, Carbon results in increased expression of RTCA mRNA	PMID:25554681
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of RTCA mRNA	PMID:24136188
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332441	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RTCA mRNA	PMID:35964746
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RTCA mRNA	PMID:24136188
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1344520	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of RTCA mRNA	PMID:20436886
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1344520	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RTCA protein	PMID:32959892
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1344520	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RTCA protein	PMID:38348393
1303111	Rtca	RNA 3'-terminal phosphate cyclase	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1344520	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RTCA mRNA	PMID:38568856
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1550763	E	RGD:6480464	20140729	CTD	MESH:D014212	Tretinoin results in decreased expression of LY6G6E mRNA	PMID:16788091
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550763	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LY6G6E mRNA	PMID:36189433
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550763	E	RGD:6480464	20140729	CTD	MESH:D004958	Estradiol results in increased expression of LY6G6E mRNA	PMID:19484750
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348643	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LY6G6E mRNA	PMID:37042841
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550763	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LY6G6E mRNA	PMID:36189433
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1348643	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LY6G6E mRNA	PMID:35301059
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1348643	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LY6G6E intron	PMID:30157460
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of LY6G6E gene	PMID:31011160
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550763	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LY6G6E mRNA	PMID:28960355
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1550763	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of LY6G6E mRNA	PMID:32186404
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LY6G6E mRNA	PMID:32109520
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of LY6G6E mRNA	PMID:26033743
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348643	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LY6G6E intron; Benzo(a)pyrene affects the methylation of LY6G6E promoter	PMID:27901495|PMID:30157460
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1348643	E	RGD:6480464	20140729	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LY6G6E mRNA	PMID:22316170
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of LY6G6E mRNA	PMID:26033743
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1550763	E	RGD:6480464	20140729	CTD	MESH:C009495	titanium dioxide affects the expression of LY6G6E mRNA	PMID:23557971
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550763	E	RGD:6480464	20140729	CTD	MESH:C006253	pirinixic acid results in increased expression of LY6G6E mRNA	PMID:20813756
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LY6G6E mRNA	PMID:25181051
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550763	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in decreased expression of LY6G6E mRNA	PMID:35479511
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1348643	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LY6G6E intron	PMID:30157460
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of LY6G6E mRNA	PMID:32028152
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of LY6G6E mRNA	PMID:32680482
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348643	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LY6G6E mRNA	PMID:37042841
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of LY6G6E mRNA	PMID:35163327
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20140729	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of LY6G6E promoter	PMID:22457795
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1348643	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LY6G6E mRNA	PMID:35301059
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of LY6G6E mRNA	PMID:35163327
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1348643	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LY6G6E intron	PMID:30157460
1303112	Ly6g6e	lymphocyte antigen 6 family member G6E	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of LY6G6E mRNA	PMID:32109520
1303113	Syap1	synapse associated protein 1	gene	CHEBI:10106	zearalenone	multiple interactions	ISO	RGD:1550770	E	RGD:6480464	20141223	CTD	MESH:D015025	[Zearalenone co-treated with CGA protein] results in decreased expression of SYAP1 protein	PMID:25058043
1303113	Syap1	synapse associated protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550770	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SYAP1 mRNA	PMID:36331819
1303113	Syap1	synapse associated protein 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1353710	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SYAP1 mRNA	PMID:21179406
1303113	Syap1	synapse associated protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353710	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SYAP1 mRNA	PMID:37042841
1303113	Syap1	synapse associated protein 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1353710	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SYAP1 mRNA	PMID:33359661
1303113	Syap1	synapse associated protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1353710	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SYAP1 protein	PMID:37730182
1303113	Syap1	synapse associated protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550770	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SYAP1 mRNA	PMID:36331819
1303113	Syap1	synapse associated protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of SYAP1 protein	PMID:34915118
1303113	Syap1	synapse associated protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1353710	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SYAP1 protein	PMID:23301498
1303113	Syap1	synapse associated protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1353710	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SYAP1 mRNA	PMID:27153756
1303113	Syap1	synapse associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1353710	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SYAP1 mRNA	PMID:41430723
1303113	Syap1	synapse associated protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550770	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SYAP1 mRNA	PMID:22206623
1303113	Syap1	synapse associated protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1353710	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SYAP1 protein	PMID:35688186
1303113	Syap1	synapse associated protein 1	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SYAP1 mRNA	PMID:25905778
1303113	Syap1	synapse associated protein 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1353710	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of SYAP1 protein	PMID:20884965
1303113	Syap1	synapse associated protein 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1353710	E	RGD:6480464	20121113	CTD	MESH:D019833	ESR1 promotes the reaction [Genistein results in decreased expression of SYAP1 protein]	PMID:20884965
1303113	Syap1	synapse associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550770	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SYAP1 mRNA	PMID:21570461
1303113	Syap1	synapse associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SYAP1 mRNA	PMID:34747641
1303113	Syap1	synapse associated protein 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1353710	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SYAP1 mRNA	PMID:30851411
1303113	Syap1	synapse associated protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1353710	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SYAP1 mRNA	PMID:29803840
1303113	Syap1	synapse associated protein 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1353710	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SYAP1 protein	PMID:35688186
1303113	Syap1	synapse associated protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353710	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of SYAP1 protein	PMID:30528433|PMID:38228842
1303113	Syap1	synapse associated protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353710	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SYAP1 mRNA	PMID:38568856
1303113	Syap1	synapse associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550770	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SYAP1 mRNA	PMID:22228805
1303113	Syap1	synapse associated protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1353710	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SYAP1 mRNA]	PMID:32406909
1303113	Syap1	synapse associated protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550770	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SYAP1 gene	PMID:35295148
1303113	Syap1	synapse associated protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550770	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SYAP1 mRNA	PMID:18301758
1303113	Syap1	synapse associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SYAP1 mRNA	PMID:25181051
1303113	Syap1	synapse associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550770	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SYAP1 mRNA	PMID:39298647
1303113	Syap1	synapse associated protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1353710	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SYAP1 protein	PMID:34186270
1303113	Syap1	synapse associated protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of SYAP1 mRNA	PMID:21241498
1303113	Syap1	synapse associated protein 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SYAP1 mRNA	PMID:21266533
1303113	Syap1	synapse associated protein 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550770	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SYAP1 mRNA	PMID:17361019|PMID:21266533
1303113	Syap1	synapse associated protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353710	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SYAP1 mRNA	PMID:37042841
1303113	Syap1	synapse associated protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1353710	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SYAP1 mRNA	PMID:38568856
1303113	Syap1	synapse associated protein 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1550770	E	RGD:6480464	20240206	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SYAP1 protein	PMID:37422089
1303113	Syap1	synapse associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550770	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SYAP1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SYAP1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SYAP1 mRNA	PMID:36331819
1303113	Syap1	synapse associated protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1550770	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYAP1 mRNA	PMID:21427059
1303113	Syap1	synapse associated protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353710	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SYAP1 mRNA	PMID:28001369|PMID:29154799
1303113	Syap1	synapse associated protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1550770	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SYAP1 mRNA	PMID:21427059
1303113	Syap1	synapse associated protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550770	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SYAP1 mRNA	PMID:19770486
1303113	Syap1	synapse associated protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550770	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SYAP1 mRNA	PMID:28973697
1303113	Syap1	synapse associated protein 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1353710	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SYAP1 mRNA; Okadaic Acid results in increased expression of SYAP1 protein	PMID:38832940
1303113	Syap1	synapse associated protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SYAP1 mRNA	PMID:33387578
1303113	Syap1	synapse associated protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1353710	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SYAP1 mRNA	PMID:22230336
1303113	Syap1	synapse associated protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353710	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SYAP1 protein	PMID:32959892
1303113	Syap1	synapse associated protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550770	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SYAP1 mRNA	PMID:23650126
1303113	Syap1	synapse associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550770	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SYAP1 mRNA	PMID:22206623
1303113	Syap1	synapse associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550770	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SYAP1 mRNA	PMID:22206623
1303113	Syap1	synapse associated protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1353710	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SYAP1 mRNA	PMID:30851411
1303113	Syap1	synapse associated protein 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550770	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SYAP1 mRNA	PMID:23091169
1303113	Syap1	synapse associated protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550770	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SYAP1 mRNA	PMID:31388691
1303113	Syap1	synapse associated protein 1	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of SYAP1 protein	PMID:28903499
1303113	Syap1	synapse associated protein 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1353710	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SYAP1 mRNA	PMID:38568856
1303113	Syap1	synapse associated protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SYAP1 mRNA	PMID:21346803
1303113	Syap1	synapse associated protein 1	gene	CHEBI:9747	Triptolide	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in decreased expression of SYAP1 protein	PMID:32519852
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D000431	Ethanol results in increased expression of POLR1H mRNA	PMID:30319688
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1351679	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of POLR1H mRNA	PMID:21179406
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1351679	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of POLR1H mRNA	PMID:21632981
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1351679	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNRD1 mRNA	PMID:37042841
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1351679	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of POLR1H mRNA	PMID:21179406
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR1H mRNA	PMID:39836092
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POLR1H mRNA	PMID:35301059
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1351679	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POLR1H mRNA	PMID:19549813
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of POLR1H mRNA	PMID:19770486
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of POLR1H mRNA	PMID:31150632
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of POLR1H mRNA	PMID:31919559
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POLR1H mRNA	PMID:22206623
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR1H mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLR1H mRNA	PMID:39836092
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:C059514	Resveratrol results in decreased expression of POLR1H protein	PMID:25505154
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of POLR1H mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of POLR1H mRNA	PMID:23557933
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLR1H mRNA	PMID:32109520
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLR1H mRNA	PMID:21570461
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLR1H mRNA	PMID:21215274
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLR1H mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of POLR1H mRNA	PMID:17942748|PMID:25975270
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1351679	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POLR1H mRNA	PMID:30851411
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28445	vincristine	decreases response to substance	ISO	RGD:1351679	E	RGD:6480464	20161213	CTD	MESH:D014750	POLR1H protein results in decreased susceptibility to Vincristine	PMID:14726695
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28445	vincristine	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20161213	CTD	MESH:D014750	Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Vincristine]	PMID:14726695
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1351679	E	RGD:6480464	20151013	CTD	MESH:D004317	POLR1H protein results in decreased susceptibility to Doxorubicin	PMID:14726695|PMID:16609701
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1351679	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of POLR1H mRNA	PMID:29803840
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28748	doxorubicin	increases secretion	ISO	RGD:1351679	E	RGD:6480464	20120412	CTD	MESH:D004317	POLR1H protein results in increased secretion of Doxorubicin	PMID:14726695
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20120412	CTD	MESH:D004317	Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Doxorubicin]; Verapamil inhibits the reaction [POLR1H protein results in increased secretion of Doxorubicin]	PMID:14726695
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1332448	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ZNRD1 gene	PMID:39894169
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR1H mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLR1H mRNA	PMID:39836092
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POLR1H mRNA	PMID:22228805
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351679	E	RGD:6480464	20201215	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POLR1H promoter	PMID:27901495
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to POLR1H mRNA]	PMID:32406909
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1351679	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of POLR1H mRNA	PMID:20382639
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of POLR1H gene	PMID:31601247
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1351679	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of ZNRD1 mRNA	PMID:38568856
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of POLR1H mRNA	PMID:18648102
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1351679	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of POLR1H mRNA	PMID:30903817
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of POLR1H mRNA	PMID:25181051
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332448	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of POLR1H mRNA	PMID:39298647
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of POLR1H gene	PMID:31601247
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332448	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of POLR1H mRNA	PMID:37019170
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of POLR1H mRNA	PMID:17361019
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZNRD1 mRNA	PMID:35163327
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR1H mRNA	PMID:39836092
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of POLR1H mRNA	PMID:33453195
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1351679	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNRD1 mRNA	PMID:38568856
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POLR1H mRNA	PMID:35301059
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZNRD1 mRNA	PMID:35163327
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1351679	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of POLR1H mRNA	PMID:24449571
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1351679	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of POLR1H mRNA	PMID:28302478
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1351679	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of POLR1H mRNA	PMID:31533062
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1351679	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of POLR1H mRNA	PMID:19167446
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351679	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of POLR1H mRNA	PMID:25979313
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1351679	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of POLR1H mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1351679	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of POLR1H mRNA	PMID:27989131
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:41500	4-phenylbutyric acid	decreases expression	ISO	RGD:1351679	E	RGD:6480464	20120412	CTD	MESH:C075773	4-phenylbutyric acid results in decreased expression of POLR1H mRNA	PMID:14583596
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:41791	calyculin A	decreases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:C059041	calyculin A results in decreased expression of POLR1H mRNA	PMID:25270620
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:44185	methotrexate	decreases response to substance	ISO	RGD:1351679	E	RGD:6480464	20151013	CTD	MESH:D008727	POLR1H protein results in decreased susceptibility to Methotrexate	PMID:16609701
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D000082	Acetaminophen affects the expression of POLR1H mRNA	PMID:17562736
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D000082	Acetaminophen results in decreased expression of POLR1H mRNA	PMID:33387578
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR1H mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLR1H mRNA	PMID:39836092
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLR1H mRNA	PMID:17942748
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:4911	etoposide	decreases response to substance	ISO	RGD:1351679	E	RGD:6480464	20120412	CTD	MESH:D005047	POLR1H protein results in decreased susceptibility to Etoposide	PMID:14726695
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20120412	CTD	MESH:D005047	Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Etoposide]	PMID:14726695
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:50292	cadmium sulfate	decreases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:C037123	cadmium sulfate results in decreased expression of POLR1H mRNA	PMID:19274763
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332448	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of POLR1H mRNA	PMID:35964746
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of POLR1H mRNA	PMID:24793618
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR1H mRNA	PMID:39836092
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	Tolcapone results in decreased expression of POLR1H mRNA	PMID:24136188
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of POLR1H mRNA]	PMID:29891994
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1351679	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of POLR1H mRNA	PMID:31758290
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of POLR1H mRNA	PMID:22206623
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POLR1H mRNA	PMID:22206623
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20140805	CTD	MESH:D014700	Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Doxorubicin]; Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Etoposide]; Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [POLR1H protein results in increased secretion of Doxorubicin]	PMID:14726695
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1351679	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POLR1H mRNA	PMID:30851411
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20221206	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to POLR1H gene]	PMID:28238834
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1351679	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of POLR1H mRNA	PMID:19159669
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of POLR1H mRNA	PMID:30294300
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:C005020	folpet results in decreased expression of POLR1H mRNA	PMID:31558096
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1332448	E	RGD:6480464	20201215	CTD	MESH:C045950	propiconazole results in increased expression of POLR1H mRNA	PMID:21278054
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20121113	CTD	MESH:D020123	Sirolimus inhibits the reaction [TP73 protein results in increased expression of POLR1H mRNA]	PMID:21245298
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of POLR1H mRNA	PMID:21346803
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of POLR1H mRNA	PMID:21346803
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:9948	verapamil	multiple interactions	ISO	RGD:1351679	E	RGD:6480464	20120412	CTD	MESH:D014700	Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Doxorubicin]; Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Etoposide]; Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [POLR1H protein results in increased secretion of Doxorubicin]	PMID:14726695
1303114	Polr1h	RNA polymerase I subunit H	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of POLR1H mRNA	PMID:23869203
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1557214	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TRIM39 mRNA	PMID:33045310
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1557214	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TRIM39 mRNA	PMID:37995155
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1345253	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRIM39 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRIM39 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TRIM39 mRNA	PMID:32699268|PMID:32845096
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1345253	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIM39 mRNA	PMID:37042841
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1345253	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of TRIM39 mRNA	PMID:19162166
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1345253	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TRIM39 mRNA	PMID:21179406
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1345253	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TRIM39 polyA tail	PMID:30157460
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1557214	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRIM39 mRNA	PMID:19770486
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1345253	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TRIM39 mRNA	PMID:23649840
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1345253	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRIM39 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRIM39 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TRIM39 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of TRIM39 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRIM39 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1557214	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRIM39 mRNA	PMID:27339419|PMID:31919559
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1345253	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRIM39 gene	PMID:25304211
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1557214	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM39 mRNA	PMID:40504410
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1557214	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TRIM39 mRNA	PMID:30912803
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557214	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM39 mRNA	PMID:21570461
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM39 mRNA	PMID:34747641
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1557214	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM39 mRNA	PMID:17942748|PMID:19770486
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557214	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM39 mRNA	PMID:17942748
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1345253	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TRIM39 mRNA	PMID:33212167
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TRIM39 mRNA	PMID:30556269
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1557214	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of TRIM39 mRNA	PMID:39631538
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1557214	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of TRIM39 gene	PMID:32068019
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1345253	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TRIM39 mRNA	PMID:38568856
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1557214	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM39 mRNA	PMID:40504410
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1557214	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRIM39 mRNA	PMID:22228805
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1345253	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRIM39 promoter	PMID:27901495
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TRIM39 mRNA	PMID:30556269
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1557214	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TRIM39 mRNA	PMID:23221170
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1557214	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TRIM39 mRNA	PMID:29095437
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1557214	E	RGD:6480464	20191114	CTD	MESH:C006632	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of TRIM39 mRNA]	PMID:29095437
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1345253	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased expression of TRIM39 mRNA	PMID:34973136
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1557214	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TRIM39 mRNA	PMID:20813756
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1557214	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TRIM39 mRNA	PMID:19710929
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRIM39 mRNA	PMID:25181051
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557214	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM39 mRNA	PMID:32156529
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1345253	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to TRIM39 promoter]	PMID:20348232
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1557214	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TRIM39 mRNA	PMID:38685157
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1345253	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRIM39 mRNA	PMID:37042841
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of TRIM39 promoter	PMID:22457795
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of TRIM39 gene	PMID:22079235
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1345253	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRIM39 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TRIM39 mRNA	PMID:32699268
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1557214	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TRIM39 mRNA	PMID:36331819
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1345253	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TRIM39 mRNA	PMID:25979313
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1557214	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TRIM39 mRNA	PMID:17292431
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TRIM39 mRNA	PMID:30047161
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1345253	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TRIM39 mRNA	PMID:20106945
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557214	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TRIM39 mRNA	PMID:17562736
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1345253	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRIM39 gene	PMID:25304211
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1557214	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM39 mRNA	PMID:40504410
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TRIM39 mRNA	PMID:29391264
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1557214	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TRIM39 mRNA	PMID:17942748
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1557214	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM39 mRNA	PMID:17942748
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1557214	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TRIM39 mRNA	PMID:29095437
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1557214	E	RGD:6480464	20191114	CTD	MESH:C032793	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of TRIM39 mRNA]	PMID:29095437
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557214	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TRIM39 mRNA	PMID:25620056
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TRIM39 mRNA	PMID:30047161
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of TRIM39 mRNA	PMID:20080153
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1557214	E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of TRIM39 mRNA]	PMID:29095437
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1345253	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TRIM39 mRNA	PMID:31758290
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1557214	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TRIM39 mRNA	PMID:22206623
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TRIM39 mRNA	PMID:30047161
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRIM39 mRNA	PMID:21346803
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1557214	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TRIM39 mRNA	PMID:35537566
1303115	Trim39	tripartite motif-containing 39	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TRIM39 mRNA	PMID:23034163
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of LPPR1 mRNA	PMID:27188386
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PLPPR1 mRNA	PMID:21632981
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1331993	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PLPPR1 mRNA	PMID:39298647
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1331993	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLPPR1 mRNA	PMID:25510870
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PLPPR1 mRNA	PMID:23649840
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1331993	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PLPPR1 mRNA	PMID:37992649
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1331993	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PLPPR1 mRNA	PMID:37992649
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LPPR1 mRNA	PMID:26577399
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PLPPR1 mRNA	PMID:28522335
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1331993	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLPPR1 mRNA	PMID:25510870
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1331993	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLPPR1 mRNA	PMID:25510870
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PLPPR1 mRNA	PMID:19549813
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PLPPR1 mRNA	PMID:23649840
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of PLPPR1 mRNA	PMID:21396975
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PLPPR1 mRNA	PMID:22129741
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LPPR1 mRNA; Aflatoxin B1 results in decreased expression of PLPPR1 mRNA	PMID:23630614|PMID:25378103
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LPPR1 mRNA; Aflatoxin B1 results in decreased expression of PLPPR1 mRNA	PMID:21641981|PMID:27153756
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PLPPR1 mRNA	PMID:23649840
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PLPPR1 mRNA	PMID:31150632
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PLPPR1 mRNA	PMID:31881176
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1331993	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PLPPR1 mRNA	PMID:32186404
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLPPR1 mRNA	PMID:22298810
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1603210	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLPPR1 mRNA	PMID:22298810
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLPPR1 mRNA	PMID:32109520
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LPPR1 mRNA; Tetrachlorodibenzodioxin results in decreased expression of PLPPR1 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1603210	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLPPR1 mRNA	PMID:21802500
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of LPPR1 mRNA	PMID:28374803
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LPPR1 mRNA	PMID:28001369
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1603210	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PLPPR1 mRNA	PMID:23179753
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1331993	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PLPPR1 mRNA	PMID:37992649
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PLPPR1 mRNA	PMID:22129741
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:28971	ampicillin	increases expression	ISO	RGD:1603210	E	RGD:6480464	20121009	CTD	MESH:D000667	Ampicillin results in increased expression of PLPPR1 mRNA	PMID:21632981
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of LPPR1 mRNA	PMID:22623647
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603210	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LPPR1 5' UTR	PMID:27901495
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LPPR1 mRNA; Benzo(a)pyrene results in decreased expression of PLPPR1 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1603210	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLPPR1 mRNA	PMID:21802500
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603210	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LPPR1 promoter	PMID:27901495
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of LPPR1 mRNA	PMID:25895662
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1603210	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PLPPR1 mRNA	PMID:23806026
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of PLPPR1 mRNA	PMID:32479839
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of PLPPR1 mRNA	PMID:23411599
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1603210	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLPPR1 mRNA	PMID:19710929
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1603210	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of LPPR1 mRNA	PMID:30903817
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PLPPR1 mRNA	PMID:30816183
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1331993	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PLPPR1 mRNA	PMID:32156529
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1331993	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of PLPPR1 mRNA	PMID:30951980
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1331993	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLPPR1 mRNA	PMID:25510870
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1331993	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLPPR1 mRNA	PMID:25510870
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1331993	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PLPPR1 mRNA	PMID:39298647
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1331993	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PLPPR1 intron	PMID:28392331
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PLPPR1 mRNA	PMID:22129741
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:35176	zinc sulfate	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of PLPPR1 mRNA	PMID:16330358
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PLPPR1 mRNA	PMID:35163327
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of LPPR1 mRNA	PMID:26194646
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of LPPR1 mRNA	PMID:28302478
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603210	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLPPR1 mRNA	PMID:25979313
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603210	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of LPPR1 mRNA; Valproic Acid results in increased expression of PLPPR1 mRNA	PMID:24383497|PMID:28001369
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PLPPR1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1331993	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PLPPR1 mRNA	PMID:37992649
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:48981	quinolin-8-ol	increases expression	ISO	RGD:1603210	E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in increased expression of PLPPR1 mRNA	PMID:21632981
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PLPPR1 mRNA	PMID:29097150
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of PLPPR1 mRNA	PMID:32234424
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PLPPR1 mRNA	PMID:20080153
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:63618	pravastatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of PLPPR1 mRNA	PMID:27225895
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1331993	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of PLPPR1 mRNA	PMID:27225895
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1603210	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PLPPR1 mRNA	PMID:24810058
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1331993	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of PLPPR1 mRNA	PMID:22078008
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin results in increased expression of PLPPR1 mRNA	PMID:31324951
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of PLPPR1 mRNA	PMID:27225895
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1331993	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of PLPPR1 mRNA	PMID:27225895
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of PLPPR1 mRNA	PMID:31324951
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PLPPR1 mRNA	PMID:32109520
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLPPR1 mRNA	PMID:24780913
1303116	Plppr1	phospholipid phosphatase related 1	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PLPPR1 mRNA	PMID:19281266
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1615832	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of FAM98C mRNA	PMID:33045310
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1604231	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TSLIG3C mRNA	PMID:23649840
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1615832	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of FAM98C mRNA	PMID:33448797
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1615832	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM98C mRNA]	PMID:33448797
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1615832	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of FAM98C mRNA	PMID:33448797
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1615832	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM98C mRNA]	PMID:33448797
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FAM98C mRNA	PMID:33387578
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1615832	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FAM98C mRNA	PMID:37236586
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1604231	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TSLIG3C mRNA	PMID:19549813
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1604231	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TSLIG3C mRNA	PMID:23649840
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1604231	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TSLIG3C mRNA	PMID:21641981|PMID:22100608
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604231	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TSLIG3C mRNA	PMID:23649840
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1604231	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of TSLIG3C mRNA	PMID:38460933
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1604231	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of TSLIG3C mRNA	PMID:38460933
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1604231	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TSLIG3C mRNA	PMID:28903495
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1604231	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TSLIG3C mRNA	PMID:27392435
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1604231	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TSLIG3C mRNA	PMID:27392435
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM98C mRNA	PMID:33387578
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1615832	E	RGD:6480464	20240604	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM98C mRNA	PMID:38641015
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1604231	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of TSLIG3C mRNA	PMID:38568856
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615832	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM98C gene	PMID:35295148
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FAM98C mRNA	PMID:34492290
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of FAM98C mRNA	PMID:19167457
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM98C mRNA	PMID:30816183|PMID:32528016
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1615832	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM98C mRNA	PMID:32156529
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FAM98C mRNA	PMID:25181051
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604231	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of TSLIG3C mRNA	PMID:25047013
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1604231	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TSLIG3C mRNA	PMID:28628672
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1615832	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of FAM98C mRNA	PMID:34813904
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1604231	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TSLIG3C mRNA	PMID:28628672
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1615832	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of FAM98C mRNA	PMID:34813904
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604231	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TSLIG3C mRNA	PMID:37042841
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1615832	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FAM98C mRNA	PMID:24982889
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of FAM98C promoter	PMID:22457795
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1615832	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FAM98C mRNA	PMID:37236586
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1604231	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TSLIG3C mRNA	PMID:32588087
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1604231	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TSLIG3C mRNA	PMID:31533062
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1604231	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TSLIG3C mRNA	PMID:28628672
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1615832	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of FAM98C mRNA	PMID:33448797
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1615832	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM98C mRNA]	PMID:33448797
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604231	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of TSLIG3C mRNA	PMID:29067470
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1604231	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of TSLIG3C mRNA	PMID:38460933
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1604231	E	RGD:6480464	20120522	CTD	MESH:D018038	Sodium Selenite results in increased expression of TSLIG3C mRNA	PMID:18175754
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1604231	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TSLIG3C mRNA	PMID:28628672
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615832	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FAM98C mRNA; Nanotubes, Carbon results in decreased expression of FAM98C mRNA	PMID:25554681
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1615832	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM98C mRNA]	PMID:33448797
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1615832	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FAM98C mRNA	PMID:22206623
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604231	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TSLIG3C gene]	PMID:28238834
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1604231	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of TSLIG3C mRNA	PMID:39904859
1303117	Fam98c	family with sequence similarity 98, member C	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FAM98C mRNA	PMID:23034163
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1616464	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of LRRC36 mRNA	PMID:36189433
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1616464	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRC36 mRNA	PMID:36189433
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LRRC36 mRNA	PMID:33387578
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1616464	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of LRRC36 mRNA	PMID:22238285
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1605363	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LRRC36 mRNA	PMID:26079696
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1616464	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of LRRC36 mRNA	PMID:36189433
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1616464	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRC36 mRNA	PMID:36189433
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of LRRC36 mRNA	PMID:27523638
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LRRC36 mRNA	PMID:26577399
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1616464	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LRRC36 mRNA	PMID:34911549
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1605363	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of LRRC36 mRNA	PMID:24768652|PMID:25583101
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRRC36 mRNA	PMID:32109520
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1605363	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LRRC36 mRNA	PMID:29955902
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605363	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRRC36 promoter	PMID:27901495
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1616464	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRRC36 mRNA	PMID:22228805
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605363	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LRRC36 exon	PMID:27901495
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1616464	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LRRC36 mRNA	PMID:27131904
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1605363	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of LRRC36 mRNA	PMID:25895662
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRC36 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1616464	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of LRRC36 mRNA	PMID:26377693
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605363	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LRRC36 mRNA	PMID:38382870
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of LRRC36 mRNA	PMID:25539665
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:46666	crocidolite asbestos	affects methylation	ISO	RGD:1605363	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite affects the methylation of LRRC36 5' UTR	PMID:29523930
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1616464	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LRRC36 mRNA; Nanotubes, Carbon results in decreased expression of LRRC36 mRNA	PMID:25554681
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1616464	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of LRRC36 mRNA	PMID:26377693
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1616464	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of LRRC36 mRNA	PMID:23608068
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1616464	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of LRRC36 mRNA	PMID:38701926
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605363	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LRRC36 gene]	PMID:28238834
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LRRC36 mRNA	PMID:25825206
1303118	Lrrc36	leucine rich repeat containing 36	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1616464	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LRRC36 mRNA	PMID:27131904
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552765	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ITGB6 mRNA	PMID:33045310
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1346382	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of ITGB6 mRNA	PMID:34925699
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552765	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ITGB6 mRNA	PMID:26251327
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1552765	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of ITGB6 promoter	PMID:26251327
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB6 mRNA	PMID:20938992
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of ITGB6 mRNA	PMID:12419474
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D004958	Estradiol results in decreased expression of ITGB6 mRNA	PMID:23019147|PMID:24758408|PMID:25321415
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of ITGB6 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of ITGB6 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ITGB6 mRNA; EGF protein inhibits the reaction [Estradiol results in decreased expression of ITGB6 mRNA]	PMID:17404688|PMID:20660070|PMID:24758408|PMID:30165855
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ITGB6 mRNA	PMID:38568856
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB6 mRNA	PMID:20938992
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of ITGB6 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ITGB6 mRNA	PMID:17404688|PMID:20660070
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB6 mRNA	PMID:37992649
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D013739	Testosterone results in increased expression of ITGB6 mRNA	PMID:21592394
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1552765	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of ITGB6 mRNA	PMID:33848595
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of ITGB6 mRNA	PMID:21592394
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:175901	gemcitabine	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20230207	CTD	MESH:C056507	[ITGB6 co-treated with ITGAV] affects the susceptibility to Gemcitabine	PMID:20150628
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB6 mRNA	PMID:37992649
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ITGB6 protein	PMID:31163220
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552765	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ITGB6 mRNA	PMID:34319233
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1346382	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ITGB6 mRNA	PMID:31163220
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of ITGB6 mRNA	PMID:31606821
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ITGB6 mRNA	PMID:26577399
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D002117	Calcitriol results in increased expression of ITGB6 mRNA	PMID:21592394
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of ITGB6 mRNA	PMID:21592394
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ITGB6 mRNA	PMID:33387578
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:17992	sucrose	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D013395	Sucrose results in increased expression of ITGB6 mRNA	PMID:27470987
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ITGB6 protein	PMID:34915118
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ITGB6 mRNA	PMID:35301059
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGB6 mRNA	PMID:29950665
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ITGB6 mRNA	PMID:21396975
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ITGB6 gene	PMID:27153756
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ITGB6 mRNA	PMID:23630614|PMID:33354967
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of ITGB6 mRNA	PMID:19480007
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1552765	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in increased expression of ITGB6 mRNA	PMID:31626304|PMID:33026818
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ITGB6 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ITGB6 mRNA	PMID:34911549
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:2666	amitriptyline	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D000639	Amitriptyline results in decreased expression of ITGB6 mRNA	PMID:22341215
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of ITGB6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of ITGB6 protein	PMID:38598786
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D015032	Zinc results in decreased expression of ITGB6 mRNA	PMID:19071009
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D015032	Zinc results in increased expression of ITGB6 mRNA	PMID:16870260
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ITGB6 mRNA	PMID:16979875
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1552765	E	RGD:6480464	20150714	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ITGB6 mRNA	PMID:25827057
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB6 mRNA	PMID:20938992
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ITGB6 mRNA	PMID:40512198
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ITGB6 mRNA]; Cycloheximide inhibits the reaction [TGFB1 protein results in increased expression of ITGB6 mRNA]	PMID:11007951|PMID:21303922
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITGB6 mRNA	PMID:27188386
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of ITGB6 mRNA	PMID:31295307
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB6 mRNA]	PMID:37992649
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552765	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ITGB6 mRNA	PMID:28960355
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D002945	Cisplatin results in decreased expression of ITGB6 mRNA	PMID:27392435
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ITGB6 mRNA	PMID:27392435
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D003042	Cocaine results in increased expression of ITGB6 mRNA	PMID:18000554
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D019833	Genistein affects the expression of ITGB6 mRNA	PMID:26865667
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D019833	Genistein results in decreased expression of ITGB6 mRNA	PMID:23019147
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D009532	Nickel results in increased expression of ITGB6 mRNA	PMID:25583101
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ITGB6 mRNA	PMID:22298810
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ITGB6 mRNA	PMID:23152189
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ITGB6 mRNA	PMID:33387578
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ITGB6 mRNA	PMID:11007951
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ITGB6 mRNA]	PMID:11007951
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ITGB6 mRNA	PMID:33212167
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of ITGB6 mRNA	PMID:22276220
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ITGB6 mRNA	PMID:30911355
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552765	E	RGD:6480464	20200804	CTD	MESH:D004317	Doxorubicin results in decreased expression of ITGB6 mRNA	PMID:28608983|PMID:39631538
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB6 mRNA	PMID:37992649
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB6 mRNA]	PMID:37992649
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C017947	sodium arsenite results in decreased expression of ITGB6 mRNA	PMID:12727804|PMID:23876855|PMID:25879800|PMID:38568856|PMID:39719251
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346382	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of ITGB6 mRNA	PMID:36989763
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ITGB6 mRNA	PMID:40512198
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346382	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ITGB6 promoter	PMID:27901495
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ITGB6 mRNA	PMID:21839799
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ITGB6 mRNA	PMID:22178795
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552765	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ITGB6 mRNA	PMID:21569818|PMID:22228805
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1346382	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ITGB6 exon	PMID:27901495
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of ITGB6 mRNA	PMID:22276220
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ITGB6 mRNA	PMID:30911355
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D015032	Zinc results in decreased expression of ITGB6 mRNA	PMID:19071009
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D015032	Zinc results in increased expression of ITGB6 mRNA	PMID:16870260
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ITGB6 mRNA	PMID:16979875
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ITGB6 mRNA	PMID:25895662
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:30703	tetrathiomolybdate(2-)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C020809	[Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of ITGB6 mRNA	PMID:22276220
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C009495	titanium dioxide results in increased expression of ITGB6 mRNA	PMID:19695317
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552765	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ITGB6 mRNA	PMID:23557971
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGB6 mRNA	PMID:29950665
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1552765	E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide results in increased expression of ITGB6 mRNA	PMID:18221819
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ITGB6 mRNA	PMID:19710929
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of ITGB6 mRNA	PMID:12419474
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ITGB6 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ITGB6 mRNA	PMID:34947998
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552765	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ITGB6 mRNA	PMID:26063408|PMID:32156529
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1346382	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ITGB6 gene	PMID:31601247
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ITGB6 mRNA	PMID:36041667
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552765	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ITGB6 gene	PMID:31683443
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552765	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ITGB6 mRNA	PMID:30951980|PMID:40203079
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ITGB6 mRNA	PMID:36041667
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1552765	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ITGB6 mRNA	PMID:26377693
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552765	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ITGB6 mRNA	PMID:30951980
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ITGB6 mRNA	PMID:36041667
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ITGB6 mRNA	PMID:21241498
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552765	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ITGB6 intron	PMID:28392331
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGB6 mRNA	PMID:29950665
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552765	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ITGB6 mRNA	PMID:21266533
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of ITGB6 protein	PMID:38598786
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ITGB6 mRNA	PMID:18164116
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ITGB6 mRNA	PMID:32680482
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:34911	permethrin	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased expression of ITGB6 mRNA	PMID:37047231
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ITGB6 mRNA	PMID:35163327
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1552765	E	RGD:6480464	20160412	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA; 1-Naphthylisothiocyanate results in increased expression of ITGB6 protein	PMID:21037076|PMID:22094456|PMID:24633426|PMID:26921287|PMID:28049044
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]; [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]] which results in increased activity of TGFB1 protein; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of [ITGB6 protein co-treated with ITGA5 protein]]	PMID:21037076
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20120918	CTD	MESH:D015058	[ITGA5 protein co-treated with ITGB6 protein] promotes the reaction [1-Naphthylisothiocyanate results in increased phosphorylation of SMAD2 protein]; EGR1 protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 protein]; F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; FGG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; FGG protein affects the reaction [leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]]; IFNG protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; leukadherin-1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; RAG1 gene mutant form inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]; TGFB1 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 mRNA]	PMID:21037076|PMID:22094456|PMID:26921287|PMID:28049044
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ITGB6 mRNA	PMID:38174414
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ITGB6 mRNA	PMID:35301059
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20240109	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ITGB6 mRNA	PMID:37738295
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ITGB6 mRNA	PMID:35163327
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of ITGB6 mRNA	PMID:27387713
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ITGB6 gene	PMID:22079235
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ITGB6 mRNA	PMID:24386269
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ITGB6 mRNA	PMID:16979875
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552765	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ITGB6 mRNA	PMID:40194260
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1552765	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of ITGB6 mRNA	PMID:23125180
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D014635	Valproic Acid results in increased expression of ITGB6 mRNA	PMID:24383497
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1346382	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ITGB6 gene	PMID:29154799
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D016572	Cyclosporine results in decreased expression of ITGB6 mRNA	PMID:27989131
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C017160	cypermethrin results in increased expression of ITGB6 mRNA	PMID:22528246
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB6 mRNA	PMID:37992649
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ITGB6 mRNA	PMID:38832940
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D017239	Paclitaxel results in decreased expression of ITGB6 mRNA	PMID:19682730
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C012589	trichostatin A results in increased expression of ITGB6 mRNA	PMID:24935251
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ITGB6 mRNA	PMID:33387578
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ITGB6 mRNA	PMID:40512198
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ITGB6 mRNA	PMID:29391264
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of ITGB6 mRNA	PMID:17720352
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ITGB6 mRNA	PMID:26865667
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ITGB6 mRNA	PMID:17557909
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C042720	mercuric bromide results in increased expression of ITGB6 mRNA	PMID:26272509
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITGB6 mRNA	PMID:27188386
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:49976	zinc dichloride	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C016837	zinc chloride results in increased expression of ITGB6 mRNA	PMID:16870260
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552765	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ITGB6 mRNA; Nanotubes, Carbon results in increased expression of ITGB6 mRNA	PMID:25554681
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ITGB6 mRNA	PMID:30047161
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of ITGB6 mRNA	PMID:22504374
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:50859	bexarotene	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C095105	bexarotene results in increased expression of ITGB6 mRNA	PMID:17178900
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D000069286	Bortezomib results in increased expression of ITGB6 mRNA	PMID:20977926
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:63041	manganese(II) chloride	decreases methylation	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C025340	manganese chloride results in decreased methylation of ITGB6 gene	PMID:27913844
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of ITGB6 mRNA	PMID:28801915
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:63041	manganese(II) chloride	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased methylation of ITGB6 gene	PMID:28801915
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:63618	pravastatin	affects expression	ISO	RGD:1552765	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of ITGB6 mRNA	PMID:27225895
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ITGB6 mRNA	PMID:12419474
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ITGB6 mRNA	PMID:28801915
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1552765	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ITGB6 mRNA	PMID:22206623
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552765	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ITGB6 mRNA	PMID:22206623
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:75170	zaragozic acid A	affects expression	ISO	RGD:1552765	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 affects the expression of ITGB6 mRNA	PMID:27225895
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of ITGB6 mRNA	PMID:27225895
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1346382	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ITGB6 mRNA	PMID:37199045
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ITGB6 mRNA	PMID:18164116
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITGB6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITGB6 mRNA	PMID:27188386
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ITGB6 gene]	PMID:28238834
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of ITGB6 mRNA	PMID:30047161
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1552765	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of ITGB6 mRNA	PMID:26377693
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C009277	sodium arsenate results in decreased expression of ITGB6 mRNA	PMID:12727804
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ITGB6 mRNA	PMID:30047161
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of ITGB6 mRNA	PMID:22504374
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C093642	SB 203580 inhibits the reaction [TGFB1 protein results in increased expression of ITGB6 mRNA]	PMID:21303922
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20170808	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITGB6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITGB6 mRNA	PMID:27188386
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1552765	E	RGD:6480464	20250401	CTD	MESH:D013311	Streptozocin results in increased expression of ITGB6 mRNA	PMID:31606821
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1552765	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of ITGB6 mRNA	PMID:31606821
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:9367	swainsonine	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D017026	Swainsonine results in decreased expression of ITGB6 mRNA	PMID:40381828
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1346382	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of ITGB6 protein	PMID:38598786
1303119	Itgb6	integrin subunit beta 6	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ITGB6 mRNA	PMID:19015723
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of TACC1 mRNA	PMID:21551480
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1342908	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TACC1 mRNA	PMID:26272509|PMID:27188386
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA	PMID:27188386
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TACC1 mRNA	PMID:30071829
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of TACC1 mRNA	PMID:33729688
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552766	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TACC1 mRNA	PMID:30319688
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552766	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TACC1 mRNA	PMID:30319688
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TACC1 mRNA	PMID:20044591
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552766	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TACC1 mRNA	PMID:25890327
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of TACC1 mRNA	PMID:14699072
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of TACC1 mRNA	PMID:15072547|PMID:18984771|PMID:19619570
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D004958	[Cycloheximide co-treated with Estradiol] results in decreased expression of TACC1 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TACC1 mRNA	PMID:15072547|PMID:19619570
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1342908	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TACC1 mRNA	PMID:37042841
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1342908	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TACC1 mRNA	PMID:31163220
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1342908	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TACC1 protein	PMID:37730182
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1342908	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TACC1 intron	PMID:30157460
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552766	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TACC1 mRNA	PMID:37236586
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1342908	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TACC1 mRNA	PMID:19549813
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1342908	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TACC1 intron	PMID:30157460
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1342908	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TACC1 mRNA	PMID:23649840
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of TACC1 mRNA	PMID:41430723
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552766	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TACC1 mRNA	PMID:34911549
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552766	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TACC1 mRNA	PMID:40504410
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27641	cycloheximide	increases expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide results in increased expression of TACC1 mRNA	PMID:15072547
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D003513	[Cycloheximide co-treated with Estradiol] results in decreased expression of TACC1 mRNA	PMID:15072547
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TACC1 protein	PMID:38460933
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1342908	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TACC1 mRNA	PMID:26272509
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA	PMID:27188386
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1342908	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of TACC1 protein	PMID:35688186
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TACC1 mRNA	PMID:31881176
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1342908	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TACC1 mRNA	PMID:28903495
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of TACC1 mRNA	PMID:19921347
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1342908	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of TACC1 mRNA	PMID:23300844
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1342908	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TACC1 mRNA	PMID:27392435
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552766	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of TACC1 mRNA	PMID:40618947
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of TACC1 mRNA	PMID:20187946
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TACC1 mRNA	PMID:30912803
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of TACC1 mRNA	PMID:21048042
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TACC1 mRNA	PMID:33387578
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TACC1 mRNA	PMID:19619570
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TACC1 mRNA	PMID:34747641
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TACC1 mRNA	PMID:19619570
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552766	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TACC1 mRNA	PMID:25975270
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1342908	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TACC1 mRNA	PMID:28001369
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:28428	beta-hexachlorocyclohexane	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in decreased expression of TACC1 mRNA	PMID:25270620
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1342908	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of TACC1 protein	PMID:35688186
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of TACC1 mRNA	PMID:20044591
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1342908	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TACC1 mRNA	PMID:38568856
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552766	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TACC1 mRNA	PMID:40504410
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1342908	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TACC1 5' UTR; Benzo(a)pyrene affects the methylation of TACC1 exon; Benzo(a)pyrene affects the methylation of TACC1 intron; Benzo(a)pyrene affects the methylation of TACC1 promoter	PMID:27901495|PMID:30157460
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TACC1 mRNA	PMID:20106945
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552766	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TACC1 mRNA	PMID:22228805
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1552766	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TACC1 intron	PMID:27901495
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of TACC1 protein	PMID:37955338
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TACC1 mRNA]	PMID:32406909
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1342908	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in increased expression of TACC1 mRNA	PMID:26551752
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1342908	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TACC1 mRNA	PMID:20018196
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1342908	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TACC1 mRNA	PMID:20458559
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:31638	fulvestrant	increases expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in increased expression of TACC1 mRNA; fulvestrant results in increased expression of TACC1 protein	PMID:15072547|PMID:18984771
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552766	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TACC1 gene	PMID:35295148
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TACC1 mRNA	PMID:34492290
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of TACC1 mRNA	PMID:20813756|PMID:23811191
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TACC1 mRNA	PMID:19710929
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TACC1 mRNA	PMID:25181051
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TACC1 mRNA	PMID:36041667
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TACC1 mRNA	PMID:28628672
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TACC1 mRNA	PMID:23196670
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TACC1 mRNA	PMID:36041667
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TACC1 mRNA	PMID:36041667
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552766	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TACC1 intron	PMID:28392331
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TACC1 mRNA	PMID:34813904
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TACC1 mRNA	PMID:28628672
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TACC1 mRNA	PMID:34813904
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1342908	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TACC1 mRNA	PMID:38174414
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552766	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TACC1 mRNA	PMID:37236586
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1342908	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TACC1 protein	PMID:26879310
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of TACC1 mRNA	PMID:25539665
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TACC1 mRNA	PMID:27387713
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20150127	CTD	MESH:D002994	Clofibrate results in decreased expression of TACC1 mRNA	PMID:25270620
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of TACC1 mRNA	PMID:17010196
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of TACC1 mRNA	PMID:22561333
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1342908	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TACC1 mRNA	PMID:25979313
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TACC1 mRNA	PMID:29427782
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1342908	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TACC1 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1342908	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TACC1 gene	PMID:29154799
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA	PMID:27188386
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1342908	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TACC1 mRNA	PMID:25562108
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1342908	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of TACC1 mRNA	PMID:27989131
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TACC1 mRNA	PMID:14699072
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of TACC1 mRNA	PMID:19059307
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TACC1 mRNA	PMID:28628672
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of TACC1 mRNA; afimoxifene results in decreased expression of TACC1 protein	PMID:15072547|PMID:18984771
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of TACC1 mRNA]	PMID:21233418
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1342908	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TACC1 mRNA	PMID:22083351
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1342908	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of TACC1 mRNA	PMID:19606018|PMID:24935251|PMID:26272509
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA	PMID:27188386
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1342908	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of TACC1 mRNA	PMID:29067470
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TACC1 protein	PMID:38460933
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552766	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TACC1 mRNA	PMID:40504410
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TACC1 mRNA	PMID:29391264
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1342908	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of TACC1 mRNA	PMID:23228038
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1342908	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of TACC1 mRNA	PMID:26272509
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA	PMID:27188386
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TACC1 mRNA	PMID:28628672
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1342908	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TACC1 mRNA	PMID:20458559
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1342908	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TACC1 mRNA	PMID:23300844
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552766	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TACC1 mRNA; Nanotubes, Carbon results in increased expression of TACC1 mRNA	PMID:25554681|PMID:25620056
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552766	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TACC1 mRNA	PMID:35964746
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1342908	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TACC1 protein	PMID:32959892
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1342908	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of TACC1 mRNA	PMID:19606018
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TACC1 mRNA	PMID:23650126
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of TACC1 mRNA	PMID:27840820
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1552766	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of TACC1 mRNA	PMID:37699712
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA	PMID:27188386
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in decreased expression of TACC1 mRNA	PMID:19482888|PMID:25270620
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1552766	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of TACC1 mRNA]	PMID:19482888
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552766	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of TACC1 mRNA	PMID:21795629
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1552766	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of TACC1 mRNA	PMID:21278054
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1342908	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of TACC1 mRNA	PMID:26272509
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA	PMID:27188386
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1342908	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of TACC1 mRNA	PMID:14699072
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of TACC1 mRNA	PMID:19059307
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1342908	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA	PMID:27188386
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1342908	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in increased expression of TACC1 mRNA	PMID:26551752
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TACC1 mRNA	PMID:21346803
1303120	Tacc1	transforming, acidic coiled-coil containing protein 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1342908	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TACC1 mRNA	PMID:38568856
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TXNDC8 mRNA	PMID:22129741
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1345541	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TXNDC8 gene	PMID:27153756
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1552769	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of TXNDC8 mRNA	PMID:25629700
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1552769	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of TXNDC8 mRNA	PMID:28960355
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TXNDC8 mRNA	PMID:22129741
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552769	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TXNDC8 mRNA	PMID:20504355
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1552769	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of TXNDC8 mRNA	PMID:22609695
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of TXNDC8 mRNA	PMID:21515302
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552769	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of TXNDC8 mRNA	PMID:35295148
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TXNDC8 mRNA	PMID:25181051|PMID:41034487
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TXNDC8 mRNA	PMID:22129741
1303121	Txndc8	thioredoxin domain containing 8	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1552769	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of TXNDC8 mRNA	PMID:23608068
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1332485	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of VARS2 mRNA	PMID:20188158
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of VARS2 mRNA	PMID:20488242
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1346332	E	RGD:6480464	20191008	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VARS2 mRNA	PMID:31059760
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1346332	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of VARS2 mRNA	PMID:31059760
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1346332	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of VARS2 mRNA	PMID:19167446
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1346332	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of VARS2 protein	PMID:37730182
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of VARS2 mRNA	PMID:33387578
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332485	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VARS2 mRNA	PMID:37236586
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1346332	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VARS2 mRNA	PMID:19549813
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1332485	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of VARS2 mRNA	PMID:19376150
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1332485	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of VARS2 mRNA	PMID:19770486
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of VARS2 mRNA	PMID:30779732
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1346332	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of VARS2 gene	PMID:25304211
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1346332	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VARS2 mRNA	PMID:19244175
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332485	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VARS2 mRNA	PMID:21570461|PMID:24680724
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VARS2 mRNA	PMID:21215274
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VARS2 mRNA	PMID:32109520|PMID:33387578
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of VARS2 mRNA]	PMID:21215274
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1346332	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of VARS2 protein	PMID:39603559
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1346332	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of VARS2 mRNA	PMID:33212167
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1346332	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of VARS2 mRNA	PMID:20044591
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346332	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of VARS2 mRNA	PMID:38568856
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332485	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of VARS2 mRNA	PMID:19770486
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346332	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of VARS2 promoter	PMID:27901495
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of VARS2 mRNA	PMID:16483693
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332485	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VARS2 gene	PMID:35295148
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1332485	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of VARS2 mRNA	PMID:23557971
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of VARS2 mRNA	PMID:34492290
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1332485	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of VARS2 mRNA	PMID:18648102
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of VARS2 mRNA	PMID:30816183
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VARS2 mRNA	PMID:36041667
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1346332	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of VARS2 mRNA	PMID:19244175
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1346332	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of VARS2 protein	PMID:31945527
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332485	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of VARS2 mRNA	PMID:39298647
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VARS2 mRNA	PMID:36041667
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VARS2 mRNA	PMID:36041667
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1346332	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VARS2 mRNA	PMID:28628672
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of VARS2 mRNA	PMID:21241498
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1346332	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VARS2 mRNA	PMID:28628672
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346332	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VARS2 mRNA	PMID:37042841
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of VARS2 promoter	PMID:22457795
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332485	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VARS2 mRNA	PMID:37236586
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of VARS2 mRNA	PMID:24386269
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1346332	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VARS2 mRNA	PMID:19244175
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1346332	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of VARS2 mRNA	PMID:19167446
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1346332	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VARS2 mRNA	PMID:19167446
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346332	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of VARS2 mRNA	PMID:25979313
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346332	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of VARS2 mRNA	PMID:29154799
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346332	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of VARS2 mRNA	PMID:20106945
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1346332	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VARS2 mRNA	PMID:28628672
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346332	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of VARS2 mRNA	PMID:21420995|PMID:25704631|PMID:31059760
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1346332	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of VARS2 mRNA	PMID:31059760
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1346332	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of VARS2 gene	PMID:25304211
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of VARS2 mRNA	PMID:16174780
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1346332	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VARS2 mRNA	PMID:28628672
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332485	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of VARS2 mRNA	PMID:25620056
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1332485	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of VARS2 mRNA	PMID:19042947
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1332485	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of VARS2 mRNA	PMID:23650126
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:6437	levetiracetam	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077287	Levetiracetam results in decreased expression of VARS2 mRNA	PMID:20345932
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332485	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VARS2 mRNA	PMID:22206623
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of VARS2 mRNA	PMID:21346803
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of VARS2 mRNA	PMID:20345932
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1346332	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VARS2 mRNA	PMID:19167446
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of VARS2 mRNA	PMID:21346803
1303122	Vars2	valyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of VARS2 mRNA	PMID:21346803
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1604585	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of APOLD1 mRNA	PMID:26272509
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1604585	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOLD1 mRNA	PMID:27188386
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1616403	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of APOLD1 mRNA	PMID:33045310
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of APOLD1 mRNA	PMID:20188158
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1604585	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of APOLD1 mRNA	PMID:21934132
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:15368	acrolein	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of APOLD1 mRNA	PMID:38090360
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1604585	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of APOLD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of APOLD1 mRNA	PMID:32699268
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1616403	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of APOLD1 mRNA	PMID:20880076
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1616403	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APOLD1 mRNA	PMID:30529165
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1604585	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of APOLD1 mRNA	PMID:26079696
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:16136	hydrogen sulfide	increases expression	ISO	RGD:1616403	E	RGD:6480464	20200519	CTD	MESH:D006862	Hydrogen Sulfide results in increased expression of APOLD1 mRNA	PMID:31843631
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1604585	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of APOLD1 mRNA	PMID:21632981
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1604585	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of APOLD1 mRNA	PMID:30510588
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:164200	triclosan	increases methylation	ISO	RGD:1604585	E	RGD:6480464	20220607	CTD	MESH:D014260	Triclosan results in increased methylation of APOLD1 gene	PMID:34523531
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of APOLD1 mRNA	PMID:32145629
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1616403	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of APOLD1 mRNA	PMID:39298647
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of APOLD1 mRNA	PMID:33387578
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1604585	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of APOLD1 mRNA	PMID:23649840
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1604585	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of APOLD1 mRNA	PMID:26079696
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1616403	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of APOLD1 mRNA	PMID:39922521
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1616403	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APOLD1 mRNA	PMID:37992649
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1616403	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of APOLD1 mRNA	PMID:39922521
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1616403	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APOLD1 mRNA	PMID:37992649
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1604585	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of APOLD1 mRNA	PMID:23649840
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of APOLD1 mRNA	PMID:33354967
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in increased expression of APOLD1 mRNA	PMID:28623178
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604585	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of APOLD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of APOLD1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of APOLD1 mRNA	PMID:32699268
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1616403	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of APOLD1 mRNA	PMID:34911549
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of APOLD1 mRNA	PMID:25629700
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604585	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of APOLD1 gene	PMID:25304211
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1604585	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of APOLD1 mRNA	PMID:26272509
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1604585	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOLD1 mRNA	PMID:27188386
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1604585	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of APOLD1 mRNA	PMID:27392435
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1616403	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of APOLD1 mRNA	PMID:40618947
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1604585	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of APOLD1 mRNA	PMID:27392435
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of APOLD1 mRNA	PMID:20187946
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of APOLD1 mRNA	PMID:32109520
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of APOLD1 mRNA	PMID:34747641
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1616403	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of APOLD1 mRNA	PMID:19933214
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1616403	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of APOLD1 mRNA	PMID:32937126
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1604585	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of APOLD1 mRNA	PMID:28001369
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604585	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of APOLD1 mRNA	PMID:33212167
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1604585	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of APOLD1 mRNA	PMID:23649840
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1604585	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of APOLD1 mRNA	PMID:32763439
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1616403	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in increased expression of APOLD1 mRNA	PMID:35032568
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1616403	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APOLD1 mRNA	PMID:37992649
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:28854	2,4-D	decreases expression	ISO	RGD:1604585	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of APOLD1 mRNA	PMID:40294809
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of APOLD1 mRNA	PMID:36209798
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604585	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of APOLD1 mRNA	PMID:29301061
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1616403	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of APOLD1 mRNA	PMID:32417428
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of APOLD1 mRNA	PMID:27131904
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1604585	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of APOLD1 mRNA	PMID:25351596
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of APOLD1 mRNA	PMID:29341224
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of APOLD1 mRNA	PMID:24915197
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of APOLD1 mRNA	PMID:32479839
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of APOLD1 mRNA	PMID:30047161
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of APOLD1 mRNA	PMID:29264374
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of APOLD1 mRNA	PMID:34492290
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of APOLD1 mRNA	PMID:19167457
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of APOLD1 mRNA	PMID:25181051
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of APOLD1 mRNA	PMID:34947998|PMID:38750585
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of APOLD1 mRNA	PMID:25594700
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604585	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of APOLD1 gene	PMID:31601247
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of APOLD1 mRNA	PMID:32145629
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1616403	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of APOLD1 mRNA	PMID:30951980|PMID:32156529
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:34283	oxybenzone	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20250311	CTD	MESH:C005290	oxybenzone results in decreased expression of APOLD1 mRNA	PMID:39343157
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1616403	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of APOLD1 mRNA	PMID:30951980
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1604585	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of APOLD1 gene	PMID:31601247
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1616403	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of APOLD1 mRNA	PMID:30951980
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1616403	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of APOLD1 mRNA	PMID:37019170
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604585	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of APOLD1 mRNA	PMID:37042841
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of APOLD1 mRNA	PMID:18500788
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1604585	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of APOLD1 mRNA	PMID:38382870
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of APOLD1 promoter	PMID:22457795
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of APOLD1 mRNA	PMID:30047161
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1604585	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of APOLD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of APOLD1 mRNA	PMID:32699268
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1616403	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of APOLD1 mRNA	PMID:40194260
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of APOLD1 mRNA	PMID:23125180
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604585	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of APOLD1 mRNA	PMID:25979313
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of APOLD1 mRNA	PMID:35594946
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604585	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of APOLD1 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of APOLD1 mRNA	PMID:30047161
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1616403	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of APOLD1 mRNA	PMID:28973697
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1616403	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of APOLD1 mRNA	PMID:39922521
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1616403	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APOLD1 mRNA	PMID:37992649
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of APOLD1 mRNA	PMID:33387578
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604585	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of APOLD1 mRNA	PMID:21420995
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604585	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of APOLD1 gene	PMID:25304211
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1616403	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of APOLD1 mRNA	PMID:35436446
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of APOLD1 mRNA	PMID:25554681
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1616403	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of APOLD1 mRNA	PMID:25554681
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of APOLD1 mRNA	PMID:30047161
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:53620	methylisothiazolinone	decreases expression	ISO	RGD:1604585	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of APOLD1 mRNA	PMID:31629900
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of APOLD1 mRNA	PMID:28801915
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1604585	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of APOLD1 mRNA	PMID:28988120
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1604585	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of APOLD1 mRNA	PMID:15336504
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of APOLD1 mRNA	PMID:35283115
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of APOLD1 mRNA	PMID:19564919
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of APOLD1 mRNA	PMID:19564919
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1604585	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of APOLD1 mRNA	PMID:31758290
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of APOLD1 mRNA	PMID:19564919
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604585	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOLD1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOLD1 mRNA	PMID:27188386
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604585	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to APOLD1 gene]	PMID:28238834
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of APOLD1 mRNA	PMID:31324951
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1616403	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of APOLD1 mRNA	PMID:38648751
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of APOLD1 mRNA	PMID:21795629
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of APOLD1 mRNA	PMID:30047161
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604585	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOLD1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOLD1 mRNA	PMID:27188386
1303123	Apold1	apolipoprotein L domain containing 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1616403	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of APOLD1 mRNA	PMID:27131904
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of BTNL7 gene	PMID:35440735
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BTNL7 mRNA	PMID:39012411
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D020106	Acrylamide results in increased expression of BTN3A2 mRNA	PMID:28959563
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20131105	CTD	MESH:C008261	lead acetate results in increased expression of BTNL7 mRNA	PMID:22641619
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in decreased expression of BTN3A2 mRNA	PMID:25181051
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of BTNL7 mRNA	PMID:30723492
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20131105	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of BTNL7 promoter	PMID:22457795
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BTNL7 mRNA	PMID:39012411
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D005485	Flutamide results in increased expression of BTN3A2 mRNA	PMID:24793618
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of BTNL7 mRNA	PMID:28801915
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of BTNL7 mRNA	PMID:28801915
1303124	Btnl7	butyrophilin-like 7	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in decreased expression of BTNL7 mRNA	PMID:22615374
1303125	Mucl3	mucin like 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614839	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MUCL3 mRNA	PMID:33045310
1303125	Mucl3	mucin like 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1614839	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MUCL3 mRNA	PMID:37995155
1303125	Mucl3	mucin like 3	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1346376	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of MUCL3 mRNA	PMID:24763279
1303125	Mucl3	mucin like 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1346376	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MUCL3 mRNA	PMID:22378314
1303125	Mucl3	mucin like 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1346376	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MUCL3 mRNA	PMID:35301059
1303125	Mucl3	mucin like 3	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C016517	indole-3-carbinol affects the expression of MUCL3 mRNA	PMID:21396975
1303125	Mucl3	mucin like 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1346376	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MUCL3 gene	PMID:27153756
1303125	Mucl3	mucin like 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614839	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MUCL3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MUCL3 mRNA	PMID:34911549
1303125	Mucl3	mucin like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614839	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MUCL3 mRNA	PMID:21570461
1303125	Mucl3	mucin like 3	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1346376	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of MUCL3 mRNA	PMID:29955902
1303125	Mucl3	mucin like 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1346376	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MUCL3 mRNA	PMID:33212167
1303125	Mucl3	mucin like 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D020106	Acrylamide results in decreased expression of MUCL3 mRNA	PMID:28959563
1303125	Mucl3	mucin like 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346376	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in increased expression of MUCL3 mRNA	PMID:35954277
1303125	Mucl3	mucin like 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346376	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MUCL3 promoter	PMID:27901495
1303125	Mucl3	mucin like 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1346376	E	RGD:6480464	20131220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MUCL3 mRNA	PMID:22316170
1303125	Mucl3	mucin like 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346376	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MUCL3 3' UTR	PMID:27901495
1303125	Mucl3	mucin like 3	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1346376	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of MUCL3 gene	PMID:25435355
1303125	Mucl3	mucin like 3	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1614839	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of MUCL3 mRNA	PMID:36087614
1303125	Mucl3	mucin like 3	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1346376	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of MUCL3 gene	PMID:31601247
1303125	Mucl3	mucin like 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C006780	bisphenol A results in decreased expression of MUCL3 mRNA	PMID:25181051
1303125	Mucl3	mucin like 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614839	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of MUCL3 mRNA	PMID:30951980
1303125	Mucl3	mucin like 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1614839	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MUCL3 mRNA	PMID:37019170
1303125	Mucl3	mucin like 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of MUCL3 promoter	PMID:22457795
1303125	Mucl3	mucin like 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1346376	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MUCL3 mRNA	PMID:35301059
1303125	Mucl3	mucin like 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614839	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MUCL3 mRNA	PMID:40194260
1303125	Mucl3	mucin like 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1346376	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MUCL3 mRNA	PMID:38832940
1303125	Mucl3	mucin like 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346376	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of MUCL3 mRNA	PMID:26690555
1303125	Mucl3	mucin like 3	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1614839	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MUCL3 mRNA	PMID:35436446
1303125	Mucl3	mucin like 3	gene	CHEBI:5000	fenfluramine	increases expression	ISO	RGD:1346376	E	RGD:6480464	20231205	CTD	MESH:D005277	Fenfluramine results in increased expression of MUCL3 mRNA	PMID:22140631
1303125	Mucl3	mucin like 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614839	E	RGD:6480464	20180828	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MUCL3 mRNA; Nanotubes, Carbon results in increased expression of MUCL3 mRNA	PMID:25554681
1303125	Mucl3	mucin like 3	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1346376	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MUCL3 mRNA	PMID:27918106
1303125	Mucl3	mucin like 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346376	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MUCL3 gene]	PMID:28238834
1303125	Mucl3	mucin like 3	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1614839	E	RGD:6480464	20180828	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of MUCL3 mRNA	PMID:27935865
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of SMOC1 mRNA	PMID:21551480
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SMOC1 mRNA	PMID:26272509
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SMOC1 mRNA]	PMID:31150632
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of SMOC1 mRNA	PMID:21934132|PMID:23830798
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of SMOC1 mRNA	PMID:20488242
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1348217	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SMOC1 mRNA	PMID:23724009
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1552814	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of SMOC1 promoter	PMID:24205000
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1348217	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SMOC1 mRNA	PMID:26516004
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1552814	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SMOC1 mRNA	PMID:24205000
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1348217	E	RGD:6480464	20190611	CTD	MESH:D000431	Ethanol results in increased expression of SMOC1 mRNA	PMID:31059573
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552814	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SMOC1 mRNA	PMID:16977382|PMID:39241906
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20161228	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SMOC1 mRNA]; Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of SMOC1 mRNA]	PMID:16977382|PMID:39241906
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SMOC1 mRNA	PMID:32145629
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SMOC1 mRNA	PMID:39298647
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SMOC1 mRNA	PMID:26496021
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of SMOC1 mRNA]	PMID:16977382
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SMOC1 mRNA	PMID:38568856
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SMOC1 mRNA	PMID:33387578
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of SMOC1 mRNA	PMID:17251523
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SMOC1 mRNA	PMID:31163220
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552814	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SMOC1 mRNA	PMID:33754040|PMID:34319233
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1552814	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of SMOC1 gene	PMID:38833407
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SMOC1 mRNA	PMID:36331819
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMOC1 mRNA	PMID:39836092
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of SMOC1 mRNA	PMID:21515302
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SMOC1 mRNA	PMID:19549813
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1348217	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SMOC1 protein	PMID:20106945
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SMOC1 mRNA	PMID:21641981
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SMOC1 mRNA	PMID:19770486
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SMOC1 mRNA	PMID:31150632
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SMOC1 mRNA]	PMID:31150632
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SMOC1 mRNA	PMID:25629700
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMOC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMOC1 mRNA	PMID:39836092
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SMOC1 mRNA	PMID:40504410
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SMOC1 mRNA	PMID:26272509
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1552814	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of SMOC1 mRNA	PMID:35897073
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SMOC1 mRNA	PMID:31881176
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SMOC1 mRNA	PMID:23557933
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20151013	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SMOC1 mRNA; [Cisplatin co-treated with Paclitaxel] affects the expression of SMOC1 mRNA	PMID:20705681|PMID:27392435
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of SMOC1 mRNA	PMID:25583101
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1348217	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMOC1 mRNA	PMID:22298810
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552814	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMOC1 mRNA	PMID:21570461
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMOC1 mRNA	PMID:18796159
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMOC1 mRNA	PMID:20106945
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMOC1 mRNA	PMID:19933214
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SMOC1 mRNA	PMID:28001369
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of SMOC1 mRNA	PMID:26272509
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SMOC1 mRNA	PMID:28959563
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SMOC1 mRNA	PMID:32763439
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SMOC1 mRNA	PMID:30556269
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of SMOC1 mRNA	PMID:29301061
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMOC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMOC1 mRNA	PMID:39836092
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SMOC1 mRNA	PMID:40504410
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMOC1 mRNA	PMID:26238291|PMID:32234424|PMID:35870112
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMOC1 mRNA	PMID:19770486
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552814	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SMOC1 mRNA	PMID:22228805
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of SMOC1 mRNA	PMID:18929588
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1348217	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of SMOC1 promoter	PMID:23974009
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of SMOC1 mRNA]	PMID:18929588
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SMOC1 mRNA	PMID:30556269
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SMOC1 mRNA	PMID:25895662
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SMOC1 mRNA	PMID:20018196|PMID:26238291
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of SMOC1 mRNA	PMID:24136188
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of SMOC1 mRNA	PMID:21515302
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of SMOC1 mRNA	PMID:24136188
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SMOC1 mRNA	PMID:23557971
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552814	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SMOC1 gene; titanium dioxide results in decreased methylation of SMOC1 promoter	PMID:35295148
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of SMOC1 mRNA	PMID:23411599|PMID:34492290
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SMOC1 mRNA	PMID:25380136
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of SMOC1 mRNA	PMID:23811191
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SMOC1 mRNA	PMID:19710929
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:32687	piperonyl butoxide	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in decreased expression of SMOC1 mRNA	PMID:22484513
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	ISO	RGD:1348217	E	RGD:6480464	20120412	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of SMOC1 mRNA	PMID:19038236
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552814	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SMOC1 mRNA	PMID:28472532
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SMOC1 mRNA	PMID:25181051
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of SMOC1 mRNA	PMID:32145629|PMID:33296240
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of SMOC1 mRNA	PMID:36779543
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1348217	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SMOC1 protein	PMID:37664457
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552814	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SMOC1 mRNA	PMID:34585602|PMID:38701888
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SMOC1 gene	PMID:28505145
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SMOC1 mRNA	PMID:26496021
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMOC1 mRNA	PMID:28628672
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SMOC1 mRNA	PMID:39298647
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of SMOC1 mRNA	PMID:30951980
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552814	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SMOC1 intron	PMID:28392331
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMOC1 mRNA	PMID:37019170
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SMOC1 mRNA	PMID:21266533
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SMOC1 mRNA	PMID:21266533
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMOC1 mRNA	PMID:28628672
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of SMOC1 mRNA	PMID:19638242
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SMOC1 mRNA]	PMID:39241906
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMOC1 mRNA	PMID:39836092
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of SMOC1 mRNA	PMID:25380136
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SMOC1 mRNA	PMID:35163327
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SMOC1 mRNA	PMID:24386269
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of SMOC1 mRNA	PMID:25380136
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1348217	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SMOC1 mRNA	PMID:24449571
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552814	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SMOC1 mRNA	PMID:40194260
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SMOC1 mRNA	PMID:36331819
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of SMOC1 mRNA	PMID:22110744
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of SMOC1 mRNA	PMID:25993096
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SMOC1 mRNA	PMID:17292431
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMOC1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1348217	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of SMOC1 mRNA	PMID:23527032|PMID:29154799
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMOC1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SMOC1 mRNA	PMID:17555576
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of SMOC1 mRNA	PMID:25123088
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMOC1 mRNA	PMID:28628672
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SMOC1 mRNA	PMID:28973697
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of SMOC1 mRNA	PMID:24136188
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SMOC1 mRNA	PMID:26272509
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161213	CTD	MESH:D017239	[Cisplatin co-treated with Paclitaxel] affects the expression of SMOC1 mRNA	PMID:20705681
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SMOC1 mRNA	PMID:24935251|PMID:26272509
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMOC1 mRNA	PMID:29067470
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:46742	Nutlin-3	increases expression	ISO	RGD:1348217	E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of SMOC1 mRNA	PMID:38460933
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMOC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMOC1 mRNA	PMID:39836092
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SMOC1 mRNA	PMID:40504410
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1552814	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of SMOC1 mRNA	PMID:30529165
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SMOC1 mRNA	PMID:29391264
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SMOC1 mRNA	PMID:17555576
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SMOC1 mRNA	PMID:17942748
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of SMOC1 mRNA	PMID:32234424
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1348217	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SMOC1 mRNA	PMID:38568856
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of SMOC1 mRNA	PMID:26272509
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMOC1 mRNA	PMID:28628672
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552814	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SMOC1 mRNA; Nanotubes, Carbon results in increased expression of SMOC1 mRNA	PMID:25620056
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of SMOC1 mRNA	PMID:24136188
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of SMOC1 mRNA	PMID:26272509
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMOC1 mRNA	PMID:39836092
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMOC1 mRNA	PMID:26378955
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of SMOC1 mRNA	PMID:24136188
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1348217	E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SMOC1 mRNA	PMID:20147733
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of SMOC1 mRNA	PMID:30467583
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SMOC1 gene	PMID:35440735
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SMOC1 mRNA	PMID:31758290
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SMOC1 protein	PMID:37664457
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of SMOC1 mRNA	PMID:24136188
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1348217	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of SMOC1 mRNA	PMID:29522793
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1348217	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SMOC1 protein	PMID:31285264
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of SMOC1 mRNA	PMID:33484710
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1348217	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of SMOC1 mRNA	PMID:34995734
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SMOC1 gene]	PMID:28238834
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SMOC1 mRNA	PMID:27935865
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SMOC1 mRNA	PMID:21278054
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of SMOC1 mRNA	PMID:26272509
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1552814	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SMOC1 mRNA]	PMID:39241906
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of SMOC1 protein	PMID:26903627
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1348217	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of SMOC1 mRNA	PMID:31734321
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1552814	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of SMOC1 protein	PMID:35357534
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1348217	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SMOC1 protein; [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA	PMID:27188386|PMID:37664457
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1348217	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of SMOC1 mRNA	PMID:31863870
1303126	Smoc1	SPARC related modular calcium binding 1	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of SMOC1 mRNA	PMID:21515302
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606280	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KANSL2 mRNA	PMID:38218311
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of KANSL2 mRNA]	PMID:31150632
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1606280	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of KANSL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of KANSL2 mRNA	PMID:32699268
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1618351	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of KANSL2 mRNA	PMID:30319688
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1618351	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of KANSL2 mRNA	PMID:39298647
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of KANSL2 mRNA	PMID:20655997
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1618351	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of KANSL2 mRNA	PMID:23892564
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1606280	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of KANSL2 protein	PMID:37730182
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618351	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KANSL2 mRNA	PMID:28111341|PMID:37236586
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1606280	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KANSL2 mRNA	PMID:27153756
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1606280	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KANSL2 gene	PMID:27153756
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1606280	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KANSL2 mRNA	PMID:23649840
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606280	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of KANSL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of KANSL2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of KANSL2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of KANSL2 mRNA	PMID:32699268|PMID:35430440
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1618351	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of KANSL2 mRNA	PMID:34911549
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of KANSL2 mRNA	PMID:22171008
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KANSL2 mRNA	PMID:31150632
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of KANSL2 mRNA]	PMID:31150632
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1606280	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KANSL2 gene	PMID:25304211
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of KANSL2 mRNA	PMID:19244175
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1618351	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of KANSL2 mRNA	PMID:28960355
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606280	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of KANSL2 mRNA	PMID:27392435
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KANSL2 mRNA	PMID:21215274
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KANSL2 mRNA	PMID:32109520
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1606280	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of KANSL2 mRNA	PMID:29803840
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of KANSL2 mRNA	PMID:38568856
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1618351	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KANSL2 exon; Benzo(a)pyrene results in increased methylation of KANSL2 intron	PMID:27901495
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of KANSL2 mRNA	PMID:22171008
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1618351	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of KANSL2 mRNA	PMID:27131904
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of KANSL2 mRNA	PMID:25351596
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of KANSL2 mRNA	PMID:30047161
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KANSL2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585|PMID:41034487
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1618351	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of KANSL2 mRNA	PMID:39298647
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1606280	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KANSL2 mRNA	PMID:28628672
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1618351	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of KANSL2 intron	PMID:28392331
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1618351	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of KANSL2 mRNA	PMID:34813904
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1606280	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KANSL2 mRNA	PMID:28628672
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1618351	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of KANSL2 mRNA	PMID:34813904
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606280	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KANSL2 mRNA	PMID:37042841
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KANSL2 mRNA	PMID:38568856
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618351	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KANSL2 mRNA	PMID:28111341|PMID:37236586
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1606280	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of KANSL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of KANSL2 mRNA	PMID:32699268
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of KANSL2 mRNA	PMID:19244175
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of KANSL2 mRNA	PMID:28302478
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606280	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KANSL2 mRNA	PMID:25979313
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of KANSL2 mRNA	PMID:23179753|PMID:27188386
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of KANSL2 mRNA	PMID:30047161
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606280	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of KANSL2 mRNA	PMID:20106945
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1606280	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KANSL2 mRNA	PMID:28628672
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1606280	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of KANSL2 mRNA	PMID:21420995
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1606280	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of KANSL2 mRNA	PMID:25351596
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1606280	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KANSL2 gene	PMID:25304211
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1606280	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of KANSL2 mRNA	PMID:22079256
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1606280	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KANSL2 mRNA	PMID:28628672
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1618351	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of KANSL2 mRNA	PMID:35964746
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KANSL2 mRNA	PMID:24136188
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of KANSL2 mRNA	PMID:24136188
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1606280	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of KANSL2 mRNA	PMID:22079256
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1606280	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of KANSL2 mRNA	PMID:22079256
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1606280	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of KANSL2 protein	PMID:31285264
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of KANSL2 mRNA	PMID:32109520
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of KANSL2 mRNA	PMID:30047161
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1618351	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of KANSL2 mRNA	PMID:27131904
1303127	Kansl2	KAT8 regulatory NSL complex subunit 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of KANSL2 mRNA	PMID:23034163
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552818	E	RGD:6480464	20220329	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RNF113A2 gene	PMID:20938992
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552818	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF113A2 mRNA	PMID:39241906
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552818	E	RGD:6480464	20220329	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RNF113A2 gene	PMID:20938992
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552818	E	RGD:6480464	20220329	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RNF113A2 mRNA	PMID:31919559
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552818	E	RGD:6480464	20220329	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF113A2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RNF113A2 gene	PMID:20938992|PMID:22206623
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552818	E	RGD:6480464	20220329	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF113A2 mRNA	PMID:21570461
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552818	E	RGD:6480464	20220329	CTD	MESH:D004317	Doxorubicin results in increased expression of RNF113A2 mRNA	PMID:25896364|PMID:39631538
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552818	E	RGD:6480464	20220329	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF113A2 mRNA	PMID:22228805
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RNF113A2 mRNA	PMID:30047161
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552818	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RNF113A2 promoter	PMID:35295148
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20220329	CTD	MESH:C005445	triphenyl phosphate results in increased expression of RNF113A2 mRNA	PMID:30589522
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of RNF113A2 mRNA	PMID:30047161
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RNF113A2 mRNA	PMID:30047161
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RNF113A2 mRNA	PMID:30047161
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20220329	CTD	MESH:D005485	Flutamide results in increased expression of RNF113A2 mRNA	PMID:24136188
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20220329	CTD	MESH:D008701	Methapyrilene results in decreased expression of RNF113A2 mRNA	PMID:30467583
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552818	E	RGD:6480464	20220329	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RNF113A2 mRNA	PMID:22206623
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552818	E	RGD:6480464	20220329	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF113A2 mRNA	PMID:22206623
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20220329	CTD	MESH:C051752	nefazodone results in increased expression of RNF113A2 mRNA	PMID:24136188
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RNF113A2 mRNA	PMID:30047161
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20220329	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RNF113A2 mRNA	PMID:21346803
1303128	Rnf113a2	ring finger protein 113A2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20220329	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RNF113A2 mRNA	PMID:21346803
1303129	Selenok	selenoprotein K	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1603383	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SELENOK mRNA	PMID:38218311
1303129	Selenok	selenoprotein K	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1603383	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of SELENOK mRNA	PMID:35967413
1303129	Selenok	selenoprotein K	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SELENOK mRNA	PMID:22629407
1303129	Selenok	selenoprotein K	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SELENOK mRNA]	PMID:22629407
1303129	Selenok	selenoprotein K	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1623089	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SELK mRNA	PMID:30319688
1303129	Selenok	selenoprotein K	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1603383	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of SELK mRNA	PMID:29581250
1303129	Selenok	selenoprotein K	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1603383	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of SELENOK mRNA	PMID:23019147
1303129	Selenok	selenoprotein K	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603383	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of SELENOK mRNA	PMID:20106945
1303129	Selenok	selenoprotein K	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of SELENOK mRNA	PMID:22217510
1303129	Selenok	selenoprotein K	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603383	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SELENOK mRNA	PMID:37042841
1303129	Selenok	selenoprotein K	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1623089	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SELENOK mRNA	PMID:33754040
1303129	Selenok	selenoprotein K	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SELENOK mRNA	PMID:33387578
1303129	Selenok	selenoprotein K	gene	CHEBI:18231	arsenic acid	decreases expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:C025657	arsenic acid results in decreased expression of SELENOK mRNA	PMID:19429247
1303129	Selenok	selenoprotein K	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SELENOK mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SELENOK mRNA	PMID:39836092
1303129	Selenok	selenoprotein K	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1623089	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SELENOK mRNA	PMID:27462272
1303129	Selenok	selenoprotein K	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1603383	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SELENOK mRNA	PMID:19549813
1303129	Selenok	selenoprotein K	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1603383	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SELENOK gene	PMID:27153756
1303129	Selenok	selenoprotein K	gene	CHEBI:26523	reactive oxygen species	affects abundance	ISO	RGD:1603383	E	RGD:6480464	20170303	CTD	MESH:D017382	SELENOK protein affects the abundance of Reactive Oxygen Species	PMID:16962588
1303129	Selenok	selenoprotein K	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623089	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SELENOK mRNA	PMID:22206623
1303129	Selenok	selenoprotein K	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SELENOK mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SELENOK mRNA	PMID:39836092
1303129	Selenok	selenoprotein K	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623089	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SELENOK mRNA	PMID:40504410
1303129	Selenok	selenoprotein K	gene	CHEBI:27568	selenium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium affects the expression of SELENOK mRNA	PMID:19106321
1303129	Selenok	selenoprotein K	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603383	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of SELENOK mRNA	PMID:19561079
1303129	Selenok	selenoprotein K	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1603383	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of SELENOK mRNA	PMID:23195993
1303129	Selenok	selenoprotein K	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SELENOK mRNA	PMID:26377647
1303129	Selenok	selenoprotein K	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SELENOK mRNA	PMID:15034205|PMID:18796159
1303129	Selenok	selenoprotein K	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of SELENOK mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SELENOK mRNA]	PMID:15034205|PMID:16214954
1303129	Selenok	selenoprotein K	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SELK mRNA	PMID:28959563
1303129	Selenok	selenoprotein K	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SELENOK mRNA	PMID:20971185
1303129	Selenok	selenoprotein K	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1603383	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SELENOK mRNA	PMID:29803840
1303129	Selenok	selenoprotein K	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603383	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SELENOK mRNA	PMID:34032870
1303129	Selenok	selenoprotein K	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603383	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SELENOK mRNA	PMID:38568856
1303129	Selenok	selenoprotein K	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SELENOK mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SELENOK mRNA	PMID:39836092
1303129	Selenok	selenoprotein K	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623089	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SELENOK mRNA	PMID:40504410
1303129	Selenok	selenoprotein K	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1603383	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of SELK mRNA	PMID:29453283
1303129	Selenok	selenoprotein K	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1603383	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SELK promoter	PMID:27901495
1303129	Selenok	selenoprotein K	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SELENOK mRNA	PMID:38278498
1303129	Selenok	selenoprotein K	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SELENOK mRNA	PMID:15034205|PMID:22228805
1303129	Selenok	selenoprotein K	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of SELENOK mRNA]	PMID:15034205
1303129	Selenok	selenoprotein K	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:C015001	arsenite results in decreased expression of SELENOK mRNA	PMID:19429247
1303129	Selenok	selenoprotein K	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SELENOK mRNA]	PMID:32406909
1303129	Selenok	selenoprotein K	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SELENOK mRNA	PMID:20971185
1303129	Selenok	selenoprotein K	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1603383	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SELK mRNA	PMID:26014281
1303129	Selenok	selenoprotein K	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of SELENOK mRNA	PMID:16483693
1303129	Selenok	selenoprotein K	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of SELENOK gene	PMID:31601247
1303129	Selenok	selenoprotein K	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SELENOK mRNA	PMID:24136188
1303129	Selenok	selenoprotein K	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623089	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SELK gene	PMID:35295148
1303129	Selenok	selenoprotein K	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SELENOK mRNA	PMID:18648102
1303129	Selenok	selenoprotein K	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1603383	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SELK mRNA	PMID:30903817
1303129	Selenok	selenoprotein K	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SELENOK mRNA	PMID:25181051
1303129	Selenok	selenoprotein K	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1623089	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SELENOK mRNA	PMID:33221593
1303129	Selenok	selenoprotein K	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SELENOK mRNA	PMID:36041667
1303129	Selenok	selenoprotein K	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1623089	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SELENOK mRNA	PMID:39298647
1303129	Selenok	selenoprotein K	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SELENOK mRNA	PMID:36041667
1303129	Selenok	selenoprotein K	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of SELENOK mRNA	PMID:26377693
1303129	Selenok	selenoprotein K	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1623089	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SELENOK mRNA	PMID:38685157
1303129	Selenok	selenoprotein K	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SELENOK mRNA	PMID:36041667
1303129	Selenok	selenoprotein K	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of SELENOK gene	PMID:31601247
1303129	Selenok	selenoprotein K	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1623089	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of SELENOK mRNA	PMID:28392331
1303129	Selenok	selenoprotein K	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SELENOK mRNA	PMID:21266533
1303129	Selenok	selenoprotein K	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603383	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SELENOK mRNA	PMID:37042841
1303129	Selenok	selenoprotein K	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SELENOK mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SELENOK mRNA	PMID:39836092
1303129	Selenok	selenoprotein K	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603383	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SELENOK mRNA	PMID:38568856
1303129	Selenok	selenoprotein K	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1603383	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SELENOK mRNA	PMID:19320972
1303129	Selenok	selenoprotein K	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:D002922	Ciguatoxins affects the expression of SELENOK mRNA	PMID:18353800
1303129	Selenok	selenoprotein K	gene	CHEBI:36904	elemental selenium	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium affects the expression of SELENOK mRNA	PMID:19106321
1303129	Selenok	selenoprotein K	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1603383	E	RGD:6480464	20171114	CTD	MESH:C000944	dicrotophos results in decreased expression of SELENOK mRNA	PMID:28302478
1303129	Selenok	selenoprotein K	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1603383	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SELENOK mRNA	PMID:40419075
1303129	Selenok	selenoprotein K	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603383	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SELENOK mRNA	PMID:25979313
1303129	Selenok	selenoprotein K	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603383	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of SELK mRNA	PMID:29154799
1303129	Selenok	selenoprotein K	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603383	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of SELENOK mRNA	PMID:20106945|PMID:21632981|PMID:27989131
1303129	Selenok	selenoprotein K	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of SELENOK mRNA	PMID:24136188
1303129	Selenok	selenoprotein K	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SELENOK mRNA	PMID:33387578
1303129	Selenok	selenoprotein K	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SELENOK mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SELENOK mRNA	PMID:39836092
1303129	Selenok	selenoprotein K	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623089	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SELENOK mRNA	PMID:40504410
1303129	Selenok	selenoprotein K	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1603383	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SELENOK mRNA	PMID:18175754
1303129	Selenok	selenoprotein K	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1603383	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of SELENOK mRNA	PMID:17211630
1303129	Selenok	selenoprotein K	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1623089	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of SELENOK mRNA	PMID:40234311
1303129	Selenok	selenoprotein K	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SELENOK mRNA	PMID:24136188
1303129	Selenok	selenoprotein K	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1603383	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of SELENOK mRNA	PMID:20977926
1303129	Selenok	selenoprotein K	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1603383	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of SELENOK mRNA	PMID:16780908
1303129	Selenok	selenoprotein K	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SELENOK mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SELENOK mRNA	PMID:39836092
1303129	Selenok	selenoprotein K	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1623089	E	RGD:6480464	20161213	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SELENOK mRNA	PMID:15003993
1303129	Selenok	selenoprotein K	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1623089	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of SELENOK mRNA	PMID:27462272
1303129	Selenok	selenoprotein K	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1623089	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SELK mRNA	PMID:22206623
1303129	Selenok	selenoprotein K	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623089	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SELENOK mRNA	PMID:22206623
1303129	Selenok	selenoprotein K	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1603383	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SELENOK mRNA	PMID:37199045
1303129	Selenok	selenoprotein K	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603383	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SELK gene]	PMID:28238834
1303129	Selenok	selenoprotein K	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SELENOK mRNA	PMID:31826744
1303129	Selenok	selenoprotein K	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1603383	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SELK mRNA	PMID:26014281
1303129	Selenok	selenoprotein K	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1603383	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SELENOK mRNA	PMID:38568856
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1332499	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of GLMP mRNA	PMID:30951980
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of GLMP protein	PMID:40631627
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of GLMP mRNA	PMID:22378314
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1332499	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of GLMP mRNA	PMID:30319688
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1602078	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of GLMP mRNA	PMID:21632981
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1602078	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of GLMP mRNA	PMID:29581250
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of GLMP mRNA	PMID:31614463
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GLMP mRNA	PMID:33387578
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1602078	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of GLMP mRNA	PMID:23649840
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of GLMP protein	PMID:40631627
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of GLMP mRNA	PMID:31256213
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of GLMP protein	PMID:40631627
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332499	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of GLMP mRNA	PMID:34319233
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332499	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of GLMP mRNA	PMID:33754040
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GLMP mRNA	PMID:33387578
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GLMP mRNA	PMID:28522335
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1332499	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of GLMP mRNA	PMID:27462272
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1602078	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of GLMP mRNA	PMID:24376830
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1602078	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GLMP mRNA	PMID:35301059
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1602078	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of GLMP mRNA	PMID:23649840
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1602078	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GLMP mRNA	PMID:23649840
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332499	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GLMP mRNA	PMID:22206623
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332499	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GLMP mRNA	PMID:40504410
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1602078	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of GLMP mRNA	PMID:19167446
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1602078	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of GLMP mRNA	PMID:27392435
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1602078	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of GLMP mRNA	PMID:27392435
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GLMP mRNA	PMID:33387578|PMID:34747641
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GLMP mRNA	PMID:23179753|PMID:27188386
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GLMP mRNA	PMID:33212167
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1602078	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GLMP mRNA	PMID:30851411
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1332499	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GLMP mRNA	PMID:37668303
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602078	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GLMP mRNA	PMID:38568856
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332499	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GLMP mRNA	PMID:40504410
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1602078	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of GLMP mRNA	PMID:25895662
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GLMP mRNA	PMID:34947998
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C006780	bisphenol A results in increased expression of GLMP mRNA	PMID:25181051
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332499	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GLMP mRNA	PMID:33221593|PMID:35479511
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602078	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of GLMP mRNA	PMID:27685785|PMID:29275510
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332499	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GLMP mRNA	PMID:39298647
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332499	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of GLMP mRNA	PMID:40203079
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1332499	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of GLMP mRNA	PMID:30951980
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1332499	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of GLMP mRNA	PMID:28392331
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332499	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GLMP mRNA	PMID:37019170
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GLMP mRNA	PMID:21266533
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602078	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GLMP mRNA	PMID:37042841
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GLMP mRNA	PMID:21457566
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1602078	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GLMP mRNA	PMID:35301059
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1332499	E	RGD:6480464	20150310	CTD	MESH:D002994	Clofibrate results in increased expression of GLMP mRNA	PMID:25270620
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GLMP mRNA	PMID:31533062
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1602078	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of GLMP mRNA	PMID:19167446
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1602078	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of GLMP mRNA	PMID:40419075
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of GLMP mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602078	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of GLMP mRNA	PMID:27188386
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602078	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLMP mRNA	PMID:27188386
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of GLMP mRNA	PMID:41580965
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of GLMP mRNA	PMID:20106945
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of GLMP protein	PMID:40631627
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of GLMP mRNA	PMID:29067470
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1602078	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of GLMP mRNA	PMID:29432896
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332499	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GLMP mRNA	PMID:40504410
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1332499	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GLMP mRNA	PMID:35436446
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of GLMP mRNA	PMID:34044035
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332499	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GLMP mRNA	PMID:22206623
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1602078	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of GLMP mRNA	PMID:29522793
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1602078	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GLMP mRNA	PMID:30851411
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602078	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLMP mRNA	PMID:27188386
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GLMP mRNA	PMID:21394737
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1332499	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of GLMP mRNA	PMID:38995820
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1332499	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of GLMP mRNA	PMID:27029645
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1332499	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of GLMP mRNA	PMID:40826991
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602078	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLMP mRNA	PMID:27188386
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of GLMP mRNA	PMID:31863870
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1602078	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of GLMP mRNA	PMID:27188386
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:9747	Triptolide	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in decreased expression of GLMP protein	PMID:32519852
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1332499	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of GLMP mRNA	PMID:35537566
1303130	Glmp	glycosylated lysosomal membrane protein	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of GLMP mRNA	PMID:23034163
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1342930	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of NCAM2 mRNA	PMID:21934132|PMID:23724009
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NCAM2 mRNA	PMID:22378314
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550856	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of NCAM2 mRNA	PMID:30319688
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550856	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of NCAM2 mRNA	PMID:30319688
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550856	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NCAM2 mRNA	PMID:12057914
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of NCAM2 mRNA	PMID:21185374
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550856	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NCAM2 mRNA	PMID:39298647
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of NCAM2 gene	PMID:27618143
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of NCAM2 promoter	PMID:23359474
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of NCAM2 mRNA	PMID:26577399|PMID:27523638
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NCAM2 mRNA	PMID:33387578
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1342930	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NCAM2 mRNA	PMID:28818685
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1550856	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of NCAM2 mRNA	PMID:27462272
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1342930	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NCAM2 mRNA	PMID:35301059
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of NCAM2 mRNA	PMID:21396975
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NCAM2 mRNA	PMID:22129741
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1342930	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NCAM2 gene	PMID:27153756
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550856	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NCAM2 mRNA	PMID:25629700
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of NCAM2 mRNA	PMID:31881176
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1342930	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of NCAM2 mRNA	PMID:28903495
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550856	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NCAM2 mRNA	PMID:26377647
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NCAM2 mRNA	PMID:32109520
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NCAM2 mRNA	PMID:33387578
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of NCAM2 mRNA	PMID:28374803
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of NCAM2 mRNA	PMID:29955902
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D020106	Acrylamide results in decreased expression of NCAM2 mRNA	PMID:36328537|PMID:36801352
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NCAM2 mRNA	PMID:22129741
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of NCAM2 mRNA	PMID:29301061
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1342930	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of NCAM2 mRNA	PMID:34032870|PMID:38568856
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1342930	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of and affects the splicing of NCAM2 mRNA	PMID:25879800
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NCAM2 mRNA	PMID:22378314
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1342930	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of NCAM2 mRNA	PMID:21714911
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1342930	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NCAM2 promoter	PMID:27901495
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1342930	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NCAM2 5' UTR	PMID:27901495
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1342930	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of NCAM2 promoter	PMID:23974009
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of NCAM2 mRNA	PMID:26705709
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of NCAM2 mRNA	PMID:24395379|PMID:24915197
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1342930	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of NCAM2 mRNA	PMID:37690743
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1342930	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NCAM2 gene; [bisphenol F co-treated with Fulvestrant] results in decreased methylation of NCAM2 gene	PMID:31601247
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1550856	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in decreased expression of NCAM2 mRNA	PMID:22609695
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1342930	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of NCAM2 gene	PMID:31601247
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NCAM2 mRNA	PMID:25181051|PMID:30816183
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550856	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of NCAM2 mRNA	PMID:32156529
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of NCAM2 mRNA	PMID:29097150
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of NCAM2 promoter	PMID:23359474
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1342930	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NCAM2 gene	PMID:31601247
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550856	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of NCAM2 mRNA	PMID:39298647
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1342930	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of NCAM2 gene	PMID:31601247
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of NCAM2 promoter	PMID:23359474
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NCAM2 mRNA	PMID:22129741
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of NCAM2 promoter	PMID:22457795
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1342930	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NCAM2 mRNA	PMID:35301059
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of NCAM2 mRNA	PMID:25539665
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of NCAM2 gene	PMID:22079235
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1550856	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of NCAM2 mRNA	PMID:28962523
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550856	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of NCAM2 mRNA	PMID:40194260
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NCAM2 mRNA	PMID:31533062
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of NCAM2 mRNA	PMID:29427782
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of NCAM2 mRNA	PMID:29427782
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1342930	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of NCAM2 mRNA	PMID:26272509|PMID:28001369
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1342930	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NCAM2 mRNA	PMID:27188386
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NCAM2 mRNA	PMID:38832940
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NCAM2 mRNA	PMID:33387578
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1550856	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of NCAM2 mRNA	PMID:17585979
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in decreased expression of NCAM2 mRNA	PMID:26833863
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NCAM2 mRNA	PMID:29097150
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of NCAM2 mRNA	PMID:26705709
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NCAM2 protein	PMID:32959892
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1342930	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NCAM2 mRNA	PMID:24810058
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of NCAM2 gene	PMID:35440735
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:753160	lard	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in decreased expression of NCAM2 mRNA	PMID:26115784
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:753160	lard	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in increased expression of NCAM2 mRNA	PMID:26115784
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1342930	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NCAM2 mRNA	PMID:27188386
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1342930	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NCAM2 gene]	PMID:28238834
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NCAM2 mRNA	PMID:32109520
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NCAM2 mRNA	PMID:24780913|PMID:25825206
1303131	Ncam2	neural cell adhesion molecule 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1342930	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NCAM2 mRNA	PMID:27188386
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1603206	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PLEKHG5 mRNA	PMID:38218311
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1603206	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PLEKHG5 mRNA	PMID:38218311
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PLEKHG5 mRNA]	PMID:31150632
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:136004	linsidomine	increases oxidation	EXP		E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of PLEKHG5 protein	PMID:28086193
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550862	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PLEKHG5 mRNA	PMID:26251327
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603206	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PLEKHG5 mRNA	PMID:33167477
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PLEKHG5 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of PLEKHG5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PLEKHG5 mRNA	PMID:32699268|PMID:32845096
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1603206	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PLEKHG5 mRNA	PMID:26079696
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550862	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PLEKHG5 mRNA	PMID:30319688
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550862	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PLEKHG5 mRNA	PMID:39241906
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1550862	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PLEKHG5 mRNA]	PMID:39241906
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603206	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PLEKHG5 mRNA	PMID:23019147
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of PLEKHG5 gene	PMID:30521419
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1603206	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PLEKHG5 mRNA	PMID:26079696
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PLEKHG5 mRNA	PMID:26577399
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1603206	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PLEKHG5 protein	PMID:37730182
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PLEKHG5 mRNA	PMID:33387578
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1603206	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PLEKHG5 mRNA	PMID:28818685
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550862	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLEKHG5 mRNA	PMID:36331819
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:187088	Muconic dialdehyde	decreases expression	ISO	RGD:1603206	E	RGD:6480464	20250805	CTD	MESH:C034476	muconaldehyde results in decreased expression of PLEKHG5 mRNA	PMID:40300100
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1603206	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PLEKHG5 mRNA	PMID:19549813
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:25187	p-menthan-3-ol	increases expression	ISO	RGD:1603206	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of PLEKHG5 mRNA	PMID:26760959
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550862	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PLEKHG5 mRNA	PMID:34911549
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PLEKHG5 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of PLEKHG5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PLEKHG5 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of PLEKHG5 mRNA	PMID:32699268|PMID:32845096
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PLEKHG5 mRNA	PMID:31150632
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PLEKHG5 mRNA]	PMID:31150632
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1603206	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PLEKHG5 protein	PMID:35688186
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLEKHG5 mRNA	PMID:33854195
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550862	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PLEKHG5 mRNA	PMID:28960355
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PLEKHG5 mRNA	PMID:23557933
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PLEKHG5 mRNA	PMID:27392435
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLEKHG5 mRNA	PMID:22298810
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550862	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLEKHG5 mRNA	PMID:21570461|PMID:24680724
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLEKHG5 mRNA	PMID:21215274
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLEKHG5 mRNA	PMID:32109520|PMID:33387578|PMID:34747641
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1603206	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PLEKHG5 mRNA	PMID:33212167
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1603206	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PLEKHG5 mRNA	PMID:32763439
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of PLEKHG5 mRNA	PMID:30911355
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603206	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PLEKHG5 mRNA	PMID:29803840
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603206	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PLEKHG5 mRNA	PMID:38568856
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603206	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PLEKHG5 mRNA	PMID:39719251
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603206	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLEKHG5 5' UTR; Benzo(a)pyrene affects the methylation of PLEKHG5 intron; Benzo(a)pyrene affects the methylation of PLEKHG5 promoter	PMID:27901495|PMID:30157460
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of PLEKHG5 mRNA	PMID:30911355
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1603206	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PLEKHG5 mRNA	PMID:25895662
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PLEKHG5 mRNA	PMID:34492290
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550862	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PLEKHG5 mRNA	PMID:23811191
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PLEKHG5 mRNA	PMID:25181051|PMID:34947998
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1550862	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of PLEKHG5 promoter	PMID:27312807
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1603206	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PLEKHG5 gene	PMID:31601247
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:33418	graphite	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of PLEKHG5 mRNA	PMID:29933104
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:3423	carmustine	affects response to substance	ISO	RGD:1603206	E	RGD:6480464	20120412	CTD	MESH:D002330	PLEKHG5 mRNA affects the susceptibility to Carmustine	PMID:16365179
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550862	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PLEKHG5 mRNA	PMID:39298647
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1603206	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of PLEKHG5 gene	PMID:31601247
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550862	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PLEKHG5 mRNA	PMID:26377693
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1603206	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PLEKHG5 intron	PMID:30157460
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550862	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PLEKHG5 intron	PMID:28392331
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550862	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLEKHG5 mRNA	PMID:37019170
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLEKHG5 mRNA	PMID:33854195
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1550862	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PLEKHG5 mRNA]	PMID:39241906
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of PLEKHG5 mRNA	PMID:25539665
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1550862	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in decreased expression of PLEKHG5 mRNA	PMID:24183702
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PLEKHG5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PLEKHG5 mRNA	PMID:32699268
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550862	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of PLEKHG5 mRNA	PMID:23811191
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550862	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLEKHG5 mRNA	PMID:36331819
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603206	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLEKHG5 mRNA	PMID:25979313
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603206	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PLEKHG5 gene	PMID:29154799
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1603206	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of PLEKHG5 promoter	PMID:27989131
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLEKHG5 mRNA	PMID:33854195
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLEKHG5 mRNA	PMID:33854195
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550862	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PLEKHG5 mRNA	PMID:17562736
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLEKHG5 mRNA	PMID:33387578
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1603206	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLEKHG5 mRNA	PMID:29067470
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1603206	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of PLEKHG5 promoter	PMID:29626692
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1603206	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of PLEKHG5 promoter	PMID:29626692
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLEKHG5 mRNA	PMID:29391264
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1603206	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of PLEKHG5 mRNA	PMID:38568856
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550862	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PLEKHG5 mRNA; Nanotubes, Carbon results in decreased expression of PLEKHG5 mRNA	PMID:25554681
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20161228	CTD	MESH:D037742	[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of PLEKHG5 protein	PMID:23026733
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1550862	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of PLEKHG5 mRNA	PMID:40234311
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1550862	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of PLEKHG5 mRNA	PMID:19042947
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLEKHG5 mRNA	PMID:33854195
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1550862	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of PLEKHG5 mRNA	PMID:23650126
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1550862	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PLEKHG5 mRNA	PMID:26307267
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1603206	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PLEKHG5 intron	PMID:30157460
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PLEKHG5 gene	PMID:35440735
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1603206	E	RGD:6480464	20130305	CTD	MESH:C047246	PLEKHG5 mRNA affects the susceptibility to temozolomide	PMID:16365179
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:749466	calfactant	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20260721	CTD	MESH:C117342	[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of PLEKHG5 protein	PMID:23026733
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603206	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PLEKHG5 gene]	PMID:28238834
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1603206	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of PLEKHG5 mRNA	PMID:39904859
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1550862	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PLEKHG5 mRNA]	PMID:39241906
1303132	Plekhg5	pleckstrin homology and RhoGEF domain containing G5	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1550862	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PLEKHG5 mRNA	PMID:40826991
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of PGPEP1 protein	PMID:36252740
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552850	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PGPEP1 mRNA	PMID:33045310
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:137392	chlormequat chloride	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of PGPEP1 protein	PMID:34958886
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552850	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PGPEP1 gene	PMID:20938992
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of PGPEP1 mRNA	PMID:20488242
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1348411	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PGPEP1 mRNA	PMID:23724009|PMID:33167477
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1348411	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PGPEP1 mRNA	PMID:35811015
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PGPEP1 mRNA	PMID:39241906
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1348411	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PGPEP1 mRNA	PMID:35811015
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PGPEP1 mRNA	PMID:32145629
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1348411	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of PGPEP1 mRNA	PMID:31614463
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PGPEP1 mRNA	PMID:39298647
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1348411	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PGPEP1 mRNA	PMID:23019147
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1348411	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PGPEP1 mRNA	PMID:30165855
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552850	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PGPEP1 gene	PMID:20938992
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348411	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PGPEP1 mRNA	PMID:37042841
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PGPEP1 mRNA	PMID:20403060
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1348411	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of PGPEP1 mRNA	PMID:21592394
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1348411	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of PGPEP1 mRNA	PMID:21592394
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PGPEP1 mRNA	PMID:26577399
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1348411	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of PGPEP1 mRNA	PMID:21592394
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1348411	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of PGPEP1 mRNA	PMID:21592394
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PGPEP1 mRNA	PMID:33387578
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552850	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PGPEP1 mRNA	PMID:36331819
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PGPEP1 protein	PMID:34915118
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552850	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PGPEP1 mRNA	PMID:28111341
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1348411	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PGPEP1 mRNA	PMID:19549813
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1348411	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PGPEP1 mRNA	PMID:23649840
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1348411	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PGPEP1 intron	PMID:30157460
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1348411	E	RGD:6480464	20211109	CTD	MESH:D017382	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of PGPEP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PGPEP1 mRNA	PMID:33656867
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PGPEP1 mRNA	PMID:31150632
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PGPEP1 mRNA	PMID:31919559
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PGPEP1 mRNA	PMID:25629700
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552850	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PGPEP1 gene	PMID:20938992
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PGPEP1 mRNA	PMID:31881176
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1552850	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of PGPEP1 protein	PMID:25505154
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1348411	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PGPEP1 mRNA	PMID:27392435
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1348411	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of PGPEP1 mRNA	PMID:23019147
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552850	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PGPEP1 mRNA	PMID:21570461
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PGPEP1 mRNA	PMID:33387578
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PGPEP1 mRNA	PMID:34747641
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1348411	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PGPEP1 mRNA	PMID:33212167
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1348411	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of PGPEP1 mRNA	PMID:39709020
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PGPEP1 mRNA	PMID:28959563
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1348411	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of PGPEP1 mRNA	PMID:34032870
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348411	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PGPEP1 promoter	PMID:27901495
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1348411	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PGPEP1 mRNA	PMID:32234424
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552850	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PGPEP1 mRNA	PMID:22610609
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1348411	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PGPEP1 mRNA	PMID:25351596
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1552850	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of PGPEP1 gene	PMID:35295148
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552850	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PGPEP1 promoter	PMID:35295148
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PGPEP1 mRNA	PMID:18445702|PMID:23811191
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PGPEP1 mRNA	PMID:30903817
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PGPEP1 mRNA	PMID:32145629|PMID:34947998
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PGPEP1 mRNA	PMID:25181051
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1348411	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of PGPEP1 mRNA	PMID:25047013|PMID:27685785
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of PGPEP1 mRNA	PMID:26682919
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of PGPEP1 mRNA	PMID:30744511
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PGPEP1 mRNA	PMID:39298647
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552850	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PGPEP1 mRNA	PMID:26377693
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PGPEP1 mRNA	PMID:17361019|PMID:21266533
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of PGPEP1 mRNA	PMID:18164116
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1552850	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PGPEP1 mRNA	PMID:26377693
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348411	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PGPEP1 mRNA	PMID:38568856
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1348411	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PGPEP1 mRNA	PMID:38174414
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552850	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PGPEP1 mRNA	PMID:28111341
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1348411	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PGPEP1 mRNA	PMID:31533062
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1348411	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PGPEP1 mRNA	PMID:40419075
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552850	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PGPEP1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PGPEP1 mRNA	PMID:36331819
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1348411	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in decreased expression of PGPEP1 mRNA	PMID:23527032
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1348411	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PGPEP1 mRNA	PMID:19101580|PMID:23179753|PMID:28001369
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of PGPEP1 mRNA	PMID:19770486
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552850	E	RGD:6480464	20120515	CTD	MESH:D013629	Tamoxifen affects the expression of PGPEP1 mRNA	PMID:17555576|PMID:20937368
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552850	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PGPEP1 mRNA	PMID:28973697
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1348411	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PGPEP1 mRNA	PMID:28542535
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:4610	dimethylselenide	multiple interactions	ISO	RGD:1348411	E	RGD:6480464	20211109	CTD	MESH:C013503	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of PGPEP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PGPEP1 mRNA	PMID:33656867
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552850	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PGPEP1 mRNA	PMID:17562736
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1348411	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PGPEP1 mRNA	PMID:21420995
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1348411	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PGPEP1 mRNA	PMID:35811015
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552850	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PGPEP1 mRNA	PMID:17555576
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552850	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PGPEP1 mRNA; Nanotubes, Carbon results in decreased expression of PGPEP1 mRNA	PMID:25620056
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PGPEP1 mRNA	PMID:24136188
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PGPEP1 mRNA	PMID:24136188
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PGPEP1 mRNA	PMID:20080153
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552850	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of PGPEP1 mRNA	PMID:23650126
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1348411	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PGPEP1 mRNA	PMID:24810058
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PGPEP1 mRNA	PMID:24136188
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1348411	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of PGPEP1 mRNA	PMID:28960945
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of PGPEP1 mRNA	PMID:18164116
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:81517	3,4,5,3',4',5'-Hexachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C027309	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of PGPEP1 mRNA	PMID:30744511
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PGPEP1 mRNA	PMID:21346803
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1348411	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of PGPEP1 mRNA	PMID:27188386
1303133	Pgpep1	pyroglutamyl-peptidase I	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PGPEP1 mRNA	PMID:23034163
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:10110	zidovudine	decreases expression	ISO	RGD:1601775	E	RGD:6480464	20140909	CTD	MESH:D015215	Zidovudine results in decreased expression of ABCA7 mRNA	PMID:24292225
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1601775	E	RGD:6480464	20140909	CTD	MESH:D015215	Zidovudine results in increased expression of ABCA7 mRNA	PMID:24292225
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1601775	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ABCA7 mRNA	PMID:35967413
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1601775	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ABCA7 mRNA	PMID:23724009|PMID:33167477
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ABCA7 gene	PMID:28931070
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552857	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ABCA7 mRNA	PMID:30319688
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1601775	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ABCA7 mRNA	PMID:21632981
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552857	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ABCA7 mRNA	PMID:39298647
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552857	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ABCA7 mRNA	PMID:22401849
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1552857	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of ABCA7 mRNA	PMID:28973375
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1601775	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of ABCA7 mRNA	PMID:33359661
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1601775	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ABCA7 protein	PMID:37730182
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552857	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ABCA7 mRNA	PMID:36331819
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1601775	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA7 mRNA	PMID:39836092
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:18300	maleic acid	increases expression	ISO	RGD:1601775	E	RGD:6480464	20180220	CTD	MESH:C030272	maleic acid results in increased expression of ABCA7 mRNA	PMID:28392987
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552857	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABCA7 mRNA	PMID:37236586
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1552857	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of ABCA7 mRNA	PMID:18579281
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1601775	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ABCA7 mRNA	PMID:19549813
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1601775	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ABCA7 mRNA	PMID:23649840
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552857	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABCA7 mRNA	PMID:19770486
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1601775	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ABCA7 mRNA	PMID:35430440
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552857	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ABCA7 mRNA	PMID:22206623
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552857	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABCA7 mRNA	PMID:40504410
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1601775	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABCA7 mRNA	PMID:39836092
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1601775	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ABCA7 mRNA	PMID:19244175
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1601775	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ABCA7 mRNA	PMID:27392435
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1601775	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ABCA7 mRNA	PMID:27392435
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:27903	(2,4,5-trichlorophenoxy)acetic acid	increases expression	ISO	RGD:1552857	E	RGD:6480464	20130514	CTD	MESH:D015085	2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ABCA7 mRNA	PMID:18579281
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552857	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ABCA7 mRNA	PMID:30912803
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552857	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCA7 mRNA	PMID:21570461
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ABCA7 mRNA	PMID:33387578
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552857	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ABCA7 mRNA	PMID:24680724
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1601775	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ABCA7 mRNA	PMID:33212167
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1601775	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ABCA7 mRNA	PMID:32763439
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1601775	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABCA7 mRNA	PMID:29803840
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1601775	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABCA7 mRNA	PMID:38568856
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601775	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ABCA7 mRNA	PMID:34032870|PMID:39719251
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552857	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABCA7 mRNA	PMID:40504410
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1601775	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABCA7 mRNA	PMID:39836092
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:30145	lithium atom	affects expression	ISO	RGD:1552857	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency affects the expression of ABCA7 mRNA	PMID:40770094
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:30146	lithium hydride	affects expression	ISO	RGD:1552857	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency affects the expression of ABCA7 mRNA	PMID:40770094
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552857	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ABCA7 mRNA	PMID:23557971
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ABCA7 mRNA	PMID:34492290
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552857	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ABCA7 mRNA	PMID:17426115
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552857	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ABCA7 mRNA	PMID:28472532
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1601775	E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A affects the expression of ABCA7 mRNA	PMID:22574217
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCA7 mRNA	PMID:30816183|PMID:32528016
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ABCA7 mRNA	PMID:25181051
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552857	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ABCA7 gene	PMID:31683443
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552857	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ABCA7 mRNA	PMID:39298647
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552857	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ABCA7 mRNA	PMID:26377693
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552857	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ABCA7 mRNA	PMID:38685157
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ABCA7 mRNA	PMID:21241498
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552857	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ABCA7 intron	PMID:28392331
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1601775	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABCA7 mRNA	PMID:37042841
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ABCA7 mRNA	PMID:35163327
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1601775	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA7 mRNA	PMID:39836092
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:35456	cadmium dichloride	affects methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the methylation of ABCA7 promoter	PMID:22457795
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1601775	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ABCA7 mRNA	PMID:38568856
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552857	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABCA7 mRNA	PMID:37236586
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ABCA7 mRNA	PMID:24386269
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1601775	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ABCA7 mRNA	PMID:24449571
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1601775	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ABCA7 mRNA	PMID:19244175
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552857	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABCA7 mRNA	PMID:40194260
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552857	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ABCA7 mRNA	PMID:36331819
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552857	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in increased expression of ABCA7 mRNA	PMID:20546886
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1601775	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ABCA7 gene	PMID:29154799
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1601775	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of ABCA7 mRNA	PMID:20737486
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1601775	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ABCA7 mRNA	PMID:28542535
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552857	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ABCA7 mRNA	PMID:17562736
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552857	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABCA7 mRNA	PMID:40504410
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1601775	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABCA7 mRNA	PMID:39836092
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1601775	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ABCA7 mRNA	PMID:31838189
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552857	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ABCA7 mRNA	PMID:17555576
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552857	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ABCA7 mRNA	PMID:25620056
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1601775	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA7 mRNA	PMID:39836092
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552857	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ABCA7 mRNA	PMID:22206623
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1601775	E	RGD:6480464	20260714	CTD	MESH:D000077143	[Docetaxel results in decreased susceptibility to Docetaxel] which results in decreased expression of ABCA7 mRNA	PMID:19944135
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ABCA7 mRNA	PMID:27291303
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ABCA7 mRNA	PMID:24780913
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ABCA7 mRNA	PMID:21346803
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1601775	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ABCA7 mRNA	PMID:17440010
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1601775	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ABCA7 mRNA	PMID:38568856
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552857	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ABCA7 mRNA	PMID:35537566
1303134	Abca7	ATP binding cassette subfamily A member 7	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ABCA7 mRNA	PMID:23034163
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1345181	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NPC1L1 mRNA	PMID:38218311
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1345181	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NPC1L1 mRNA	PMID:38218311
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:124991	cefalotin	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20140909	CTD	MESH:D002512	[Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA	PMID:24657338
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1615659	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NPC1L1 mRNA	PMID:33045310
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1615659	E	RGD:6480464	20130618	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of NPC1L1 mRNA	PMID:20188158
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1345181	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NPC1L1 mRNA	PMID:26079696
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1345181	E	RGD:6480464	20250401	CTD	MESH:D019308	[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of NPC1L1 mRNA	PMID:38953992
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:15939	glycyrrhizinic acid	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20171010	CTD	MESH:D019695	Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NPC1L1 mRNA]	PMID:28549656
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:16113	cholesterol	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20130618	CTD	MESH:D002784	[Cholesterol deficiency co-treated with Dietary Fats] results in decreased expression of NPC1L1 mRNA	PMID:18356535
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:161680	aztreonam	decreases expression	ISO	RGD:1615659	E	RGD:6480464	20140909	CTD	MESH:D001398	Aztreonam results in decreased expression of NPC1L1 mRNA	PMID:24657338
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1345181	E	RGD:6480464	20250401	CTD	MESH:D019301	[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of NPC1L1 mRNA	PMID:38953992
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1615659	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of NPC1L1 mRNA	PMID:39298647
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1615659	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NPC1L1 protein	PMID:39298647
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NPC1L1 mRNA	PMID:33387578
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1615659	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NPC1L1 mRNA	PMID:39922521
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1615659	E	RGD:6480464	20130618	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of NPC1L1 mRNA	PMID:22401849
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:17573	glycyrrhetinate	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20171010	CTD	MESH:C119129	18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NPC1L1 mRNA]	PMID:28549656
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1615659	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NPC1L1 mRNA	PMID:39922521
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1615659	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NPC1L1 mRNA	PMID:34319233
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20191210	CTD	MESH:D004051	[Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of NPC1L1 mRNA	PMID:30722647
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of NPC1L1 mRNA	PMID:21515302
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1345181	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NPC1L1 gene	PMID:27153756
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1345181	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NPC1L1 mRNA	PMID:22100608
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NPC1L1 mRNA	PMID:30723492
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1345181	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of NPC1L1 protein	PMID:35688186
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:28001	vancomycin	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20140909	CTD	MESH:D014640	[Vancomycin co-treated with Imipenem] results in decreased expression of NPC1L1 mRNA	PMID:24657338
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615659	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NPC1L1 mRNA	PMID:26377647
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1615659	E	RGD:6480464	20170613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NPC1L1 mRNA	PMID:28213091|PMID:28238261
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NPC1L1 mRNA	PMID:33387578
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20191210	CTD	MESH:D013749	[Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of NPC1L1 mRNA	PMID:30722647
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1345181	E	RGD:6480464	20140311	CTD	MESH:D012402	[Stigmasterol co-treated with Rotenone] results in increased expression of NPC1L1 mRNA	PMID:23454145
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1345181	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NPC1L1 mRNA	PMID:33212167
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:28824	stigmasterol	multiple interactions	ISO	RGD:1345181	E	RGD:6480464	20140311	CTD	MESH:D013265	[Stigmasterol co-treated with KNG1 protein modified form] results in increased expression of NPC1L1 mRNA; [Stigmasterol co-treated with Rotenone] results in increased expression of NPC1L1 mRNA	PMID:23454145
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1615659	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of NPC1L1 mRNA	PMID:37668303
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1345181	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of NPC1L1 gene	PMID:25435355
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:30853	glycyrrhetinic acid	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20171010	CTD	MESH:C119129	18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NPC1L1 mRNA]	PMID:28549656
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1345181	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of NPC1L1 mRNA	PMID:37690743
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1615659	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of NPC1L1 mRNA	PMID:32156529
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1345181	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of NPC1L1 mRNA; bisphenol A results in increased expression of NPC1L1 protein	PMID:28057006
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1615659	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NPC1L1 mRNA; bisphenol A results in increased expression of NPC1L1 protein	PMID:34585602|PMID:37701206
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1345181	E	RGD:6480464	20180116	CTD	MESH:C006780	SREBF2 promotes the reaction [bisphenol A results in increased expression of NPC1L1 mRNA]	PMID:28057006
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20191210	CTD	MESH:C006780	[Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of NPC1L1 mRNA; Curcumin inhibits the reaction [bisphenol A results in increased expression of NPC1L1 protein]	PMID:30722647|PMID:37701206
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20191210	CTD	MESH:C014024	[Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of NPC1L1 mRNA	PMID:30722647
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1615659	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of NPC1L1 mRNA; bisphenol S results in decreased expression of NPC1L1 protein	PMID:39298647
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1615659	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NPC1L1 mRNA	PMID:34289071
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:34693	Dicyclohexyl phthalate	increases expression	ISO	RGD:1615659	E	RGD:6480464	20220405	CTD	MESH:C036042	dicyclohexyl phthalate results in increased expression of NPC1L1 mRNA	PMID:34851150
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:34693	Dicyclohexyl phthalate	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20220405	CTD	MESH:C036042	dicyclohexyl phthalate promotes the reaction [NR1I2 protein binds to NPC1L1 promoter]	PMID:34851150
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1615659	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NPC1L1 mRNA	PMID:24535843
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NPC1L1 mRNA	PMID:24535843
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:351346	phenethyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in increased expression of NPC1L1 mRNA	PMID:17616710
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1615659	E	RGD:6480464	20171010	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of NPC1L1 mRNA	PMID:28549656
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20171010	CTD	MESH:D015058	18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NPC1L1 mRNA]; Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NPC1L1 mRNA]	PMID:28549656
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1345181	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NPC1L1 mRNA	PMID:38568856
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1345181	E	RGD:6480464	20200714	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of NPC1L1 mRNA	PMID:32253466
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of NPC1L1 mRNA	PMID:27387713
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1615659	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NPC1L1 mRNA	PMID:40194260
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1345181	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of NPC1L1 mRNA	PMID:28302478
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1345181	E	RGD:6480464	20200714	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NPC1L1 mRNA	PMID:32253466
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20240206	CTD	MESH:D003474	Curcumin inhibits the reaction [bisphenol A results in increased expression of NPC1L1 protein]	PMID:37701206
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1345181	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of NPC1L1 mRNA	PMID:29501571
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1345181	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of NPC1L1 gene	PMID:29501571
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1345181	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of NPC1L1 mRNA	PMID:25562108
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1345181	E	RGD:6480464	20200714	CTD	MESH:D016572	Cyclosporine results in decreased expression of NPC1L1 mRNA	PMID:32253466
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1615659	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NPC1L1 mRNA	PMID:39922521
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1345181	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of NPC1L1 mRNA	PMID:24449571
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1345181	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NPC1L1 mRNA	PMID:38832940
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1345181	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of NPC1L1 mRNA	PMID:21420995
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1345181	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NPC1L1 mRNA	PMID:22230336
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1345181	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of NPC1L1 mRNA	PMID:24714768
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NPC1L1 mRNA	PMID:29391264
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:49040	ezetimibe	decreases activity	ISO	RGD:1345181	E	RGD:6480464	20180116	CTD	MESH:D000069438	Ezetimibe results in decreased activity of NPC1L1 protein	PMID:28057006
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:49040	ezetimibe	decreases expression	ISO	RGD:1345181	E	RGD:6480464	20170117	CTD	MESH:D000069438	Ezetimibe results in decreased expression of NPC1L1 mRNA	PMID:16177187
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:49040	ezetimibe	decreases response to substance	ISO	RGD:1345181	E	RGD:6480464	20170117	CTD	MESH:D000069438	NPC1L1 exon SNP results in decreased susceptibility to Ezetimibe	PMID:15679830
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:51799	imipenem hydrate	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20140909	CTD	MESH:D015378	[Vancomycin co-treated with Imipenem] results in decreased expression of NPC1L1 mRNA	PMID:24657338
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:53753	triolein	decreases expression	ISO	RGD:1615659	E	RGD:6480464	20130618	CTD	MESH:D014304	Triolein results in decreased expression of NPC1L1 mRNA	PMID:18356535
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of NPC1L1 mRNA	PMID:28801915
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:64294	7-ketocholesterol	decreases expression	ISO	RGD:1345181	E	RGD:6480464	20140311	CTD	MESH:C003001	7-ketocholesterol results in decreased expression of NPC1L1	PMID:23454145
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:7507	neomycin	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20140909	CTD	MESH:D009355	[Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA	PMID:24657338
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:75844	1,2,3-trilinoleoylglycerol	decreases expression	ISO	RGD:1615659	E	RGD:6480464	20131112	CTD	MESH:C009564	trilinolein results in decreased expression of NPC1L1 mRNA	PMID:18356535
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:75845	1,2,3-trilinolenoylglycerol	decreases expression	ISO	RGD:1615659	E	RGD:6480464	20131112	CTD	MESH:C101314	trilinolenin results in decreased expression of NPC1L1 mRNA	PMID:18356535
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:7719	ochratoxin A	decreases methylation	EXP		E	RGD:6480464	20160210	CTD	MESH:C025589	ochratoxin A results in decreased methylation of NPC1L1 gene	PMID:26431795
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1345181	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NPC1L1 gene]	PMID:28238834
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:79995	GW 3965	decreases expression	ISO	RGD:1615659	E	RGD:6480464	20170303	CTD	MESH:C473027	GW 3965 results in decreased expression of NPC1L1 mRNA	PMID:15633131
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1615659	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NPC1L1 mRNA	PMID:24535843
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:1345181	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in decreased expression of NPC1L1 mRNA	PMID:17980884
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1345181	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NPC1L1 mRNA	PMID:38568856
1303135	Npc1l1	NPC1 like intracellular cholesterol transporter 1	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of NPC1L1 mRNA	PMID:21515302
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DDX19A mRNA	PMID:38218311
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1349788	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DDX19A mRNA	PMID:38218311
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DDX19A mRNA	PMID:22378314
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1349788	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DDX19A mRNA	PMID:21179406
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349788	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DDX19A mRNA	PMID:37042841
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550254	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DDX19A mRNA	PMID:34319233
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	EXP		E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of DDX19A gene	PMID:33923623
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of DDX19A protein	PMID:22061828
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550254	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DDX19A mRNA	PMID:36331819
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1349788	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of DDX19A mRNA	PMID:39836092
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DDX19A mRNA	PMID:28522335
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1349788	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DDX19A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DDX19A protein	PMID:38598786
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550254	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DDX19A mRNA	PMID:25629700
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1349788	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DDX19A protein	PMID:35688186
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1349788	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DDX19A mRNA	PMID:23557933
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550254	E	RGD:6480464	20150303	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDX19A mRNA	PMID:21570461
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DDX19A mRNA	PMID:33387578
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of DDX19A protein	PMID:39603559
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1550254	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of DDX19A mRNA	PMID:30807115
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1349788	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of DDX19A mRNA	PMID:29803840
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DDX19A mRNA	PMID:38568856
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550254	E	RGD:6480464	20150303	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DDX19A mRNA	PMID:22228805
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550254	E	RGD:6480464	20150303	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of DDX19A mRNA]	PMID:22228805
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1349788	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DDX19A gene	PMID:31601247
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DDX19A mRNA	PMID:25729387
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX19A protein	PMID:31675489
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1349788	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DDX19A gene	PMID:31601247
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1349788	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DDX19A gene	PMID:31601247
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550254	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DDX19A mRNA	PMID:38685157
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20150303	CTD	MESH:D003976	Diazinon affects the expression of DDX19A mRNA	PMID:22546817
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DDX19A mRNA	PMID:21266533
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1349788	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DDX19A protein	PMID:38598786
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1349788	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of DDX19A mRNA	PMID:39836092
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DDX19A mRNA	PMID:23146750
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DDX19A mRNA	PMID:19320972
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550254	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DDX19A mRNA	PMID:36331819
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349788	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DDX19A mRNA	PMID:25979313
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1349788	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DDX19A gene	PMID:29154799
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349788	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DDX19A mRNA	PMID:23179753|PMID:29154799
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550254	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DDX19A mRNA; Nanotubes, Carbon results in increased expression of DDX19A mRNA	PMID:25554681
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550254	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DDX19A mRNA	PMID:35964746
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550254	E	RGD:6480464	20150303	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DDX19A mRNA	PMID:19042947
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DDX19A protein	PMID:32959892
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1349788	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of DDX19A mRNA	PMID:39836092
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DDX19A mRNA	PMID:25729387
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550254	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DDX19A mRNA	PMID:22206623
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550254	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of DDX19A mRNA	PMID:31388691
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DDX19A protein	PMID:31675489
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of DDX19A protein	PMID:31675489
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1349788	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of DDX19A mRNA	PMID:21858171
1303136	Ddx19a	DEAD-box helicase 19A	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1349788	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DDX19A protein	PMID:38598786
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620866	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of VWA7 mRNA	PMID:33045310
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1620866	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of VWA7 mRNA	PMID:37995155
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1342662	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of VWA7 mRNA	PMID:26079696
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1342662	E	RGD:6480464	20151110	CTD	MESH:D001280	Atrazine results in increased expression of VWA7 mRNA	PMID:22378314
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1620866	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VWA7 mRNA	PMID:39241906
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1342662	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of VWA7 mRNA	PMID:35811015
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of VWA7 mRNA	PMID:23829299
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1620866	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VWA7 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VWA7 mRNA]	PMID:37992649
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1620866	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VWA7 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VWA7 mRNA]	PMID:37992649
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of VWA7 mRNA	PMID:26577399
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of VWA7 mRNA	PMID:23630614
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1342662	E	RGD:6480464	20151110	CTD	MESH:D001151	Arsenic affects the methylation of VWA7 gene	PMID:25304211
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1620866	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VWA7 mRNA	PMID:40504410
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1342662	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of VWA7 mRNA	PMID:38460933
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1620866	E	RGD:6480464	20260707	CTD	MESH:C010974	Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VWA7 mRNA]	PMID:37992649
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of VWA7 mRNA	PMID:31881176
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1342662	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of VWA7 mRNA	PMID:23557933
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1342662	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of VWA7 mRNA	PMID:27392435
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1342662	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of VWA7 mRNA	PMID:27392435
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1620866	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of VWA7 mRNA	PMID:30912803
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VWA7 mRNA	PMID:32109520
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1342662	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of VWA7 mRNA	PMID:33212167
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1342662	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of VWA7 mRNA	PMID:30851411
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1342662	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VWA7 mRNA	PMID:29803840
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1620866	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VWA7 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VWA7 mRNA]	PMID:37992649
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1620866	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of VWA7 mRNA	PMID:37682722
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1620866	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VWA7 mRNA	PMID:40504410
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1342662	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of VWA7 5' UTR	PMID:27901495
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1342662	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of VWA7 mRNA	PMID:35984750
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of VWA7 mRNA	PMID:24915197
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of VWA7 mRNA	PMID:30047161
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of VWA7 mRNA	PMID:34492290
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C006780	bisphenol A affects the expression of VWA7 mRNA	PMID:25181051
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1342662	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of VWA7 gene	PMID:31601247
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1342662	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VWA7 mRNA	PMID:37042841
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of VWA7 promoter	PMID:22457795
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1342662	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of VWA7 mRNA	PMID:38568856
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of VWA7 mRNA	PMID:30047161
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620866	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of VWA7 mRNA	PMID:40194260
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1342662	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of VWA7 mRNA	PMID:31533062
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of VWA7 mRNA	PMID:30047161
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1620866	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VWA7 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VWA7 mRNA]	PMID:37992649
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1342662	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of VWA7 mRNA	PMID:38832940
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of VWA7 mRNA	PMID:33387578
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1342662	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of VWA7 mRNA	PMID:35811015
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1342662	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of VWA7 mRNA	PMID:38460933
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1342662	E	RGD:6480464	20151110	CTD	MESH:D001151	Arsenic affects the methylation of VWA7 gene	PMID:25304211
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1620866	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VWA7 mRNA	PMID:40504410
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1342662	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of VWA7 mRNA	PMID:31838189
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of VWA7 mRNA	PMID:29391264
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of VWA7 mRNA	PMID:30047161
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of VWA7 mRNA	PMID:28801915
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1620866	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of VWA7 mRNA	PMID:36907384
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1342662	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of VWA7 mRNA	PMID:30851411
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of VWA7 mRNA	PMID:30047161
1303137	Vwa7	von Willebrand factor A domain containing 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of VWA7 mRNA	PMID:24780913|PMID:25825206|PMID:30047161
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550885	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPINT1 mRNA	PMID:33045310
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:134926	drometrizole	affects expression	ISO	RGD:1606832	E	RGD:6480464	20250805	CTD	MESH:C033674	benazol P affects the expression of SPINT1 mRNA	PMID:36586167
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPINT1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPINT1 gene	PMID:20938992
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1606832	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SPINT1 mRNA	PMID:21934132
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of SPINT1 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of SPINT1 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of SPINT1 mRNA	PMID:30951980
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SPINT1 mRNA	PMID:36331819
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550885	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SPINT1 mRNA	PMID:39241906
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1606832	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of SPINT1 mRNA	PMID:30510588
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SPINT1 mRNA	PMID:32145629
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550885	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of SPINT1 mRNA	PMID:19484750
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SPINT1 mRNA	PMID:23829299
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPINT1 mRNA	PMID:25510870
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1606832	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SPINT1 mRNA	PMID:38568856
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPINT1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPINT1 gene	PMID:20938992
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPINT1 mRNA	PMID:37992649
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPINT1 mRNA	PMID:37992649
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1606832	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SPINT1 mRNA	PMID:31163220
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SPINT1 mRNA	PMID:33387578
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:181932	3-Nitrobenzanthrone	decreases expression	ISO	RGD:1606832	E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in decreased expression of SPINT1 mRNA	PMID:34036453
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPINT1 mRNA	PMID:25510870
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPINT1 mRNA	PMID:25510870
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1550885	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of SPINT1 intron	PMID:27776689
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SPINT1 mRNA	PMID:23630614|PMID:25378103|PMID:33354967
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:2564	aldrin	decreases expression	ISO	RGD:1550885	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in decreased expression of SPINT1 mRNA	PMID:18579281
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SPINT1 mRNA	PMID:34911549
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1550885	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of SPINT1 mRNA	PMID:31939706
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPINT1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPINT1 gene	PMID:20938992
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPINT1 mRNA	PMID:40504410
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SPINT1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPINT1 mRNA	PMID:40512198
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1606832	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SPINT1 mRNA	PMID:19244175
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1606832	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of SPINT1 mRNA	PMID:38460933
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1606832	E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of SPINT1 mRNA	PMID:38460933
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of SPINT1 mRNA	PMID:38460933
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SPINT1 mRNA	PMID:31881176
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606832	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SPINT1 mRNA	PMID:27594783
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550885	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPINT1 mRNA	PMID:21570461|PMID:26377647
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPINT1 mRNA	PMID:32109520
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550885	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPINT1 mRNA	PMID:17035482|PMID:19933214|PMID:20819909|PMID:26290441
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1606832	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPINT1 mRNA	PMID:23152189
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SPINT1 gene]	PMID:20819909
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606832	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SPINT1 mRNA	PMID:33212167
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1606832	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SPINT1 mRNA	PMID:30031762
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPINT1 mRNA	PMID:37992649
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SPINT1 mRNA	PMID:29432896
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550885	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPINT1 mRNA	PMID:37682722|PMID:39515575
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606832	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SPINT1 mRNA	PMID:39719251
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPINT1 mRNA	PMID:40504410
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SPINT1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPINT1 mRNA	PMID:40512198
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606832	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SPINT1 3' UTR; Benzo(a)pyrene results in decreased methylation of SPINT1 promoter	PMID:27901495
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550885	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPINT1 mRNA	PMID:19770486|PMID:32417428
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1606832	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SPINT1 mRNA	PMID:25895662
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SPINT1 protein]	PMID:26598702
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of SPINT1 mRNA	PMID:25729387
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SPINT1 mRNA	PMID:25729387
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550885	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of SPINT1 mRNA	PMID:35295148
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550885	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SPINT1 gene	PMID:35295148
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SPINT1 mRNA	PMID:23411599
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SPINT1 mRNA	PMID:19710929
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPINT1 mRNA	PMID:25181051
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SPINT1 mRNA	PMID:32145629
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550885	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SPINT1 mRNA	PMID:32156529|PMID:34585602
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SPINT1 gene	PMID:28505145
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of SPINT1 mRNA	PMID:30951980
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPINT1 mRNA	PMID:25510870
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPINT1 mRNA	PMID:25510870
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550885	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SPINT1 mRNA	PMID:30951980
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of SPINT1 mRNA	PMID:30951980
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550885	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SPINT1 mRNA	PMID:30951980
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of SPINT1 mRNA	PMID:30951980
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:34698	diethyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of SPINT1 mRNA	PMID:32341500
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SPINT1 mRNA	PMID:19638242
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606832	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SPINT1 mRNA	PMID:37042841
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1606832	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SPINT1 mRNA	PMID:29024780
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1550885	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of SPINT1 mRNA	PMID:26377693
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SPINT1 mRNA	PMID:30723492
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606832	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SPINT1 mRNA	PMID:38568856
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SPINT1 mRNA	PMID:15086199
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1606832	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SPINT1 mRNA	PMID:19244175
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550885	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SPINT1 mRNA	PMID:40194260
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606832	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SPINT1 mRNA	PMID:31533062
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1606832	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SPINT1 mRNA	PMID:40419075
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SPINT1 mRNA	PMID:36331819
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606832	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SPINT1 mRNA	PMID:23179753|PMID:26272509|PMID:29154799
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SPINT1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINT1 mRNA	PMID:17183730|PMID:27188386
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550885	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SPINT1 mRNA	PMID:28973697
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPINT1 mRNA	PMID:37992649
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1606832	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SPINT1 mRNA	PMID:24935251
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550885	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SPINT1 mRNA	PMID:17562736
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of SPINT1 mRNA	PMID:38460933
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550885	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPINT1 mRNA	PMID:40504410
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SPINT1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPINT1 mRNA	PMID:40512198
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1606832	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of SPINT1 mRNA	PMID:31838189
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SPINT1 mRNA	PMID:17557909
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SPINT1 protein]	PMID:26598702
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1550885	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SPINT1 mRNA	PMID:23608068
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SPINT1 mRNA	PMID:17183730
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SPINT1 mRNA	PMID:25729387
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SPINT1 mRNA	PMID:25729387
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1550885	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of SPINT1 mRNA	PMID:23650126
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550885	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SPINT1 mRNA	PMID:22206623
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SPINT1 protein	PMID:37664457
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINT1 mRNA	PMID:27188386
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550885	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SPINT1 mRNA	PMID:31388691
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPINT1 mRNA	PMID:24780913
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606832	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SPINT1 protein; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINT1 mRNA	PMID:27188386|PMID:37664457
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SPINT1 mRNA	PMID:19281266
1303138	Spint1	serine peptidase inhibitor, Kunitz type 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1606832	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SPINT1 mRNA	PMID:38568856
1303139	Rnf114	ring finger protein 114	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1557377	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RNF114 mRNA	PMID:30319688
1303139	Rnf114	ring finger protein 114	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1349716	E	RGD:6480464	20150512	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RNF114 mRNA	PMID:20044591
1303139	Rnf114	ring finger protein 114	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557377	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNF114 mRNA	PMID:39241906
1303139	Rnf114	ring finger protein 114	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1349716	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of RNF114 mRNA	PMID:19698761
1303139	Rnf114	ring finger protein 114	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1557377	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of RNF114 mRNA	PMID:29980752
1303139	Rnf114	ring finger protein 114	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RNF114 gene	PMID:27618143
1303139	Rnf114	ring finger protein 114	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RNF114 mRNA	PMID:22061828
1303139	Rnf114	ring finger protein 114	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1349716	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RNF114 mRNA	PMID:19549813
1303139	Rnf114	ring finger protein 114	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1349716	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RNF114 mRNA	PMID:23649840
1303139	Rnf114	ring finger protein 114	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1349716	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RNF114 mRNA	PMID:23649840
1303139	Rnf114	ring finger protein 114	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557377	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RNF114 mRNA]	PMID:22206623
1303139	Rnf114	ring finger protein 114	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1557377	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF114 mRNA	PMID:40504410
1303139	Rnf114	ring finger protein 114	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1349716	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RNF114 mRNA	PMID:19244175
1303139	Rnf114	ring finger protein 114	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1557377	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RNF114 mRNA	PMID:28960355
1303139	Rnf114	ring finger protein 114	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1349716	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RNF114 mRNA	PMID:27392435
1303139	Rnf114	ring finger protein 114	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1557377	E	RGD:6480464	20120412	CTD	MESH:D009532	MT1 affects the reaction [Nickel affects the expression of RNF114 mRNA]; MT2 affects the reaction [Nickel affects the expression of RNF114 mRNA]	PMID:16166738
1303139	Rnf114	ring finger protein 114	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557377	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF114 mRNA; Tetrachlorodibenzodioxin affects the expression of ZFP313 mRNA	PMID:21570461
1303139	Rnf114	ring finger protein 114	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1349716	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RNF114 mRNA	PMID:28001369
1303139	Rnf114	ring finger protein 114	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1349716	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNF114 mRNA	PMID:33212167
1303139	Rnf114	ring finger protein 114	gene	CHEBI:28358	rac-lactic acid	affects expression	ISO	RGD:1349716	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of RNF114 mRNA	PMID:30851411
1303139	Rnf114	ring finger protein 114	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1349716	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RNF114 mRNA	PMID:29803840
1303139	Rnf114	ring finger protein 114	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1557377	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of RNF114 mRNA	PMID:39631538
1303139	Rnf114	ring finger protein 114	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1349716	E	RGD:6480464	20150512	CTD	MESH:D024483	Vitamin K 3 affects the expression of RNF114 mRNA	PMID:20044591
1303139	Rnf114	ring finger protein 114	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349716	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF114 mRNA	PMID:38568856
1303139	Rnf114	ring finger protein 114	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1557377	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF114 mRNA	PMID:40504410
1303139	Rnf114	ring finger protein 114	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349716	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RNF114 promoter	PMID:27901495
1303139	Rnf114	ring finger protein 114	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1557377	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of RNF114 protein	PMID:37955338
1303139	Rnf114	ring finger protein 114	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1557377	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RNF114 mRNA	PMID:27131904
1303139	Rnf114	ring finger protein 114	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1349716	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RNF114 mRNA	PMID:20382639
1303139	Rnf114	ring finger protein 114	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RNF114 mRNA	PMID:25729387
1303139	Rnf114	ring finger protein 114	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557377	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF114 gene; titanium dioxide results in decreased methylation of RNF114 promoter	PMID:35295148
1303139	Rnf114	ring finger protein 114	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1557377	E	RGD:6480464	20131220	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ZFP313 mRNA	PMID:18648102
1303139	Rnf114	ring finger protein 114	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1557377	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RNF114 promoter	PMID:27312807
1303139	Rnf114	ring finger protein 114	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RNF114 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1303139	Rnf114	ring finger protein 114	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF114 gene	PMID:28505145
1303139	Rnf114	ring finger protein 114	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1557377	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF114 mRNA	PMID:39298647
1303139	Rnf114	ring finger protein 114	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1349716	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF114 mRNA	PMID:28628672
1303139	Rnf114	ring finger protein 114	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1557377	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RNF114 mRNA	PMID:37019170
1303139	Rnf114	ring finger protein 114	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1557377	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of RNF114 mRNA	PMID:34813904
1303139	Rnf114	ring finger protein 114	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1349716	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF114 mRNA	PMID:28628672
1303139	Rnf114	ring finger protein 114	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349716	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNF114 mRNA	PMID:37042841
1303139	Rnf114	ring finger protein 114	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349716	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RNF114 mRNA	PMID:38174414
1303139	Rnf114	ring finger protein 114	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1349716	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RNF114 mRNA	PMID:24449571
1303139	Rnf114	ring finger protein 114	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1349716	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RNF114 mRNA	PMID:19244175
1303139	Rnf114	ring finger protein 114	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1349716	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RNF114 mRNA	PMID:31533062
1303139	Rnf114	ring finger protein 114	gene	CHEBI:39481	chloroprene	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of RNF114 mRNA	PMID:23125180
1303139	Rnf114	ring finger protein 114	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349716	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RNF114 mRNA	PMID:23179753|PMID:29154799
1303139	Rnf114	ring finger protein 114	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1349716	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF114 mRNA	PMID:28628672
1303139	Rnf114	ring finger protein 114	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1557377	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RNF114 mRNA	PMID:28973697
1303139	Rnf114	ring finger protein 114	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1349716	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of RNF114 mRNA	PMID:24657277
1303139	Rnf114	ring finger protein 114	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1349716	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of RNF114 mRNA	PMID:19698761
1303139	Rnf114	ring finger protein 114	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1349716	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RNF114 mRNA	PMID:28542535
1303139	Rnf114	ring finger protein 114	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1349716	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF114 mRNA	PMID:21420995
1303139	Rnf114	ring finger protein 114	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1349716	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of RNF114 mRNA	PMID:20977926
1303139	Rnf114	ring finger protein 114	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1349716	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of RNF114 mRNA	PMID:29523930
1303139	Rnf114	ring finger protein 114	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1557377	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF114 mRNA	PMID:40504410
1303139	Rnf114	ring finger protein 114	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1349716	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF114 mRNA	PMID:28628672
1303139	Rnf114	ring finger protein 114	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557377	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RNF114 mRNA; Nanotubes, Carbon results in increased expression of RNF114 mRNA	PMID:25554681
1303139	Rnf114	ring finger protein 114	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RNF114 mRNA	PMID:24136188
1303139	Rnf114	ring finger protein 114	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RNF114 mRNA	PMID:25729387
1303139	Rnf114	ring finger protein 114	gene	CHEBI:68508	diethyl maleate	decreases expression	ISO	RGD:1557377	E	RGD:6480464	20150127	CTD	MESH:C014476	diethyl maleate results in decreased expression of RNF114 mRNA	PMID:25270620
1303139	Rnf114	ring finger protein 114	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1557377	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RNF114 mRNA	PMID:22206623
1303139	Rnf114	ring finger protein 114	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1557377	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RNF114 mRNA]	PMID:22206623
1303139	Rnf114	ring finger protein 114	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1349716	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RNF114 protein	PMID:37664457
1303139	Rnf114	ring finger protein 114	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RNF114 mRNA	PMID:24136188
1303139	Rnf114	ring finger protein 114	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	ISO	RGD:1349716	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of RNF114 mRNA	PMID:30851411
1303139	Rnf114	ring finger protein 114	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1349716	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of RNF114 mRNA	PMID:24921660
1303139	Rnf114	ring finger protein 114	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349716	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RNF114 protein	PMID:37664457
1303139	Rnf114	ring finger protein 114	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1557377	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RNF114 mRNA	PMID:27131904
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1606943	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RILPL2 mRNA	PMID:27188386
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1606943	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RILPL2 mRNA	PMID:33167477
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1332151	E	RGD:6480464	20220111	CTD	MESH:D000431	Ethanol results in increased expression of RILPL2 mRNA	PMID:34492310
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1606943	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RILPL2 mRNA	PMID:21632981
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1606943	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of RILPL2 mRNA	PMID:22574217
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1606943	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of RILPL2 mRNA	PMID:31614463
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606943	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of RILPL2 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of RILPL2 mRNA	PMID:20660070|PMID:22217510
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606943	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RILPL2 mRNA	PMID:37042841
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1606943	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of RILPL2 mRNA	PMID:20660070
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332151	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RILPL2 mRNA	PMID:34319233
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1606943	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of RILPL2 intron	PMID:30157460
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332151	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RILPL2 mRNA	PMID:37325564
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1606943	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RILPL2 mRNA	PMID:19549813
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1332151	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RILPL2 mRNA	PMID:19770486
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332151	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RILPL2 mRNA	PMID:25629700
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332151	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RILPL2 mRNA]	PMID:22206623
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1606943	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of RILPL2 mRNA	PMID:38460933
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606943	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RILPL2 mRNA	PMID:27392435
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606943	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RILPL2 mRNA	PMID:27392435
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332151	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RILPL2 mRNA	PMID:21570461
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RILPL2 mRNA	PMID:34747641
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RILPL2 mRNA	PMID:32109520
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606943	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RILPL2 mRNA	PMID:33212167
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1606943	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of RILPL2 mRNA	PMID:20971185
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1332151	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RILPL2 mRNA	PMID:27862939
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1606943	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RILPL2 mRNA	PMID:29803840
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606943	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RILPL2 mRNA	PMID:38568856
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RILPL2 mRNA	PMID:21839799
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1606943	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of RILPL2 mRNA	PMID:20971185
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1332151	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RILPL2 mRNA	PMID:29203145|PMID:29341224
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RILPL2 gene	PMID:35295148
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1332151	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RILPL2 mRNA	PMID:18648102
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RILPL2 mRNA	PMID:25181051
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332151	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RILPL2 mRNA	PMID:39298647
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332151	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of RILPL2 mRNA	PMID:33297965
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1332151	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RILPL2 mRNA	PMID:28392331
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332151	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RILPL2 mRNA	PMID:37019170
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RILPL2 mRNA	PMID:21266533
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332151	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RILPL2 mRNA	PMID:21266533
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606943	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RILPL2 mRNA	PMID:37042841
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1606943	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RILPL2 mRNA	PMID:29024780
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RILPL2 mRNA	PMID:21297351
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606943	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RILPL2 mRNA	PMID:38568856
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332151	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RILPL2 mRNA	PMID:37325564
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1606943	E	RGD:6480464	20210309	CTD	MESH:C023036	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of RILPL2 mRNA	PMID:33325755
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1332151	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of RILPL2 mRNA	PMID:23811191
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1332151	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RILPL2 mRNA	PMID:40194260
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332151	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RILPL2 mRNA	PMID:36331819
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332151	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RILPL2 mRNA	PMID:17292431
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606943	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RILPL2 mRNA	PMID:25979313
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1332151	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of RILPL2 mRNA	PMID:21427059
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606943	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of RILPL2 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of RILPL2 mRNA	PMID:41580965
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606943	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RILPL2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1606943	E	RGD:6480464	20150825	CTD	MESH:D000082	RILPL2 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RILPL2 mRNA	PMID:33387578
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606943	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of RILPL2 mRNA	PMID:29067470
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1606943	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of RILPL2 mRNA	PMID:38460933
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332151	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RILPL2 mRNA; Nanotubes, Carbon results in increased expression of RILPL2 mRNA	PMID:25554681
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of RILPL2 mRNA	PMID:24136188
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1332151	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RILPL2 mRNA	PMID:19042947
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1332151	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RILPL2 mRNA	PMID:38701926
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1332151	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RILPL2 mRNA	PMID:21641980
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1606943	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RILPL2 mRNA	PMID:28988120
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332151	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RILPL2 mRNA	PMID:22206623
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332151	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RILPL2 mRNA]	PMID:22206623
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:76989	phytoestrogen	multiple interactions	ISO	RGD:1606943	E	RGD:6480464	20210309	CTD	MESH:D048789	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of RILPL2 mRNA	PMID:33325755
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1332151	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of RILPL2 mRNA	PMID:38648751
1303140	Rilpl2	Rab interacting lysosomal protein-like 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1332151	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of RILPL2 mRNA	PMID:39847705
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1344472	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PHACTR2 mRNA	PMID:38218311
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of PHACTR2 mRNA	PMID:21551480
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1344472	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of PHACTR2 mRNA	PMID:33167477
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1614195	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHACTR2 mRNA	PMID:30529165
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PHACTR2 mRNA	PMID:22378314
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1614195	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PHACTR2 mRNA	PMID:30319688
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PHACTR2 mRNA	PMID:21632981
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1614195	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PHACTR2 mRNA	PMID:39241906
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344472	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHACTR2 mRNA	PMID:37042841
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PHACTR2 mRNA	PMID:26577399
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1344472	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PHACTR2 protein	PMID:37730182
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1344472	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of PHACTR2 mRNA	PMID:20823114
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PHACTR2 mRNA	PMID:41430723
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1614195	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PHACTR2 mRNA	PMID:17484886
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1614195	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PHACTR2 mRNA	PMID:27339419
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PHACTR2 mRNA	PMID:19244175
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1344472	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PHACTR2 mRNA	PMID:26272509
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHACTR2 mRNA	PMID:27188386
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1344472	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PHACTR2 protein	PMID:35688186
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1614195	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PHACTR2 mRNA	PMID:28960355
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PHACTR2 mRNA	PMID:31881176
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHACTR2 mRNA	PMID:22298810
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1344472	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHACTR2 mRNA	PMID:22298810
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614195	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHACTR2 mRNA	PMID:20702594
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1614195	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PHACTR2 mRNA	PMID:33956508
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1344472	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PHACTR2 mRNA	PMID:26272509
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHACTR2 mRNA	PMID:27188386
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PHACTR2 mRNA	PMID:33212167
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of PHACTR2 mRNA	PMID:21198554
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PHACTR2 mRNA	PMID:38568856
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344472	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PHACTR2 promoter	PMID:27901495
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PHACTR2 mRNA	PMID:20106945|PMID:21632981
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1614195	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PHACTR2 mRNA	PMID:19770486
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1344472	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PHACTR2 3' UTR	PMID:27901495
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PHACTR2 mRNA]	PMID:32406909
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PHACTR2 mRNA	PMID:19150397
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of PHACTR2 mRNA	PMID:24395379
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1614195	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in decreased expression of PHACTR2 mRNA	PMID:22609695
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614195	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHACTR2 gene	PMID:35295148
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614195	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PHACTR2 gene	PMID:35295148
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PHACTR2 mRNA	PMID:19710929
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of PHACTR2 mRNA	PMID:30690063
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PHACTR2 mRNA	PMID:25181051
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614195	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PHACTR2 mRNA	PMID:33221593
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1614195	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in decreased methylation of PHACTR2 intron	PMID:30044229
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PHACTR2 gene	PMID:28505145
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PHACTR2 mRNA	PMID:19244175
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1344472	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PHACTR2 mRNA	PMID:25979313
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1614195	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PHACTR2 mRNA	PMID:30951980
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1614195	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of PHACTR2 promoter	PMID:33297965
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1614195	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PHACTR2 mRNA	PMID:30951980
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1614195	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PHACTR2 5' UTR	PMID:28392331
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1614195	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PHACTR2 mRNA	PMID:37019170
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1614195	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PHACTR2 mRNA	PMID:21266533
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344472	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHACTR2 mRNA	PMID:37042841
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PHACTR2 mRNA	PMID:18560533
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PHACTR2 promoter	PMID:22457795
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1344472	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PHACTR2 mRNA	PMID:38382870
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PHACTR2 mRNA	PMID:19320972
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PHACTR2 mRNA	PMID:19244175
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614195	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PHACTR2 mRNA	PMID:40194260
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PHACTR2 mRNA	PMID:31533062
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PHACTR2 mRNA	PMID:19167446
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHACTR2 mRNA	PMID:19167446
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344472	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHACTR2 mRNA	PMID:25979313
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHACTR2 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:29154799
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1344472	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PHACTR2 gene	PMID:29154799
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344472	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of PHACTR2 mRNA	PMID:28001369
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHACTR2 mRNA	PMID:27188386
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PHACTR2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1614195	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PHACTR2 mRNA	PMID:28973697
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1344472	E	RGD:6480464	20120412	CTD	MESH:D008727	PHACTR2 protein affects the susceptibility to Methotrexate	PMID:16217747
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PHACTR2 mRNA	PMID:27188386
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PHACTR2 mRNA	PMID:24935251|PMID:26272509
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHACTR2 mRNA	PMID:27188386
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614195	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PHACTR2 mRNA	PMID:17562736
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHACTR2 mRNA	PMID:33387578
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHACTR2 mRNA	PMID:21420995
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1344472	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of PHACTR2 mRNA	PMID:26833863
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PHACTR2 mRNA	PMID:29391264
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PHACTR2 mRNA	PMID:22079256
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1344472	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of PHACTR2 mRNA	PMID:23228038
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614195	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PHACTR2 mRNA; Nanotubes, Carbon results in decreased expression of PHACTR2 mRNA	PMID:25554681
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1344472	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of PHACTR2 mRNA	PMID:26705709
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1344472	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of PHACTR2 mRNA	PMID:28988120
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1344472	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PHACTR2 mRNA	PMID:22079256|PMID:22714537
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PHACTR2 mRNA	PMID:22079256
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHACTR2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHACTR2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHACTR2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHACTR2 mRNA	PMID:27188386
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PHACTR2 gene]	PMID:28238834
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1614195	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of PHACTR2 mRNA	PMID:20702594
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHACTR2 mRNA	PMID:19167446
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of PHACTR2 protein	PMID:28903499
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1614195	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of PHACTR2 mRNA	PMID:21795629
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PHACTR2 mRNA	PMID:25825206
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344472	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHACTR2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHACTR2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHACTR2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHACTR2 mRNA	PMID:27188386
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1614195	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PHACTR2 mRNA	PMID:28973697
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PHACTR2 mRNA	PMID:19015723
1303141	Phactr2	phosphatase and actin regulator 2	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of PHACTR2 gene	PMID:31079544
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1350756	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of OSER1 mRNA	PMID:31863870
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1350756	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of OSER1 mRNA	PMID:38218311
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1350756	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of OSER1 mRNA	PMID:35967413
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1331969	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of OSER1 mRNA	PMID:33045310
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of OSER1 mRNA]	PMID:31150632
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1350756	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of OSER1 mRNA	PMID:26079696
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1331969	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of OSER1 mRNA	PMID:30319688
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1350756	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of OSER1 mRNA	PMID:31614463
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350756	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of OSER1 mRNA	PMID:37042841
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1350756	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of OSER1 mRNA	PMID:23649840
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1350756	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of OSER1 mRNA	PMID:33647349
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of OSER1 mRNA	PMID:33387578
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1350756	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of OSER1 mRNA	PMID:28818685
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1331969	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OSER1 mRNA	PMID:37236586
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1350756	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of OSER1 mRNA	PMID:19549813
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1350756	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of OSER1 mRNA	PMID:23649840
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1350756	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of OSER1 mRNA	PMID:23649840
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of OSER1 mRNA	PMID:18593933
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of OSER1 mRNA	PMID:31150632
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of OSER1 mRNA]	PMID:31150632
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1350756	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of OSER1 protein	PMID:35688186
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1350756	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of OSER1 mRNA	PMID:27594783
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OSER1 mRNA	PMID:33387578
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1350756	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of OSER1 mRNA	PMID:28001369
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:28358	rac-lactic acid	affects expression	ISO	RGD:1350756	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of OSER1 mRNA	PMID:30851411
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1350756	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of OSER1 mRNA	PMID:32763439
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of OSER1 mRNA	PMID:20971185
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1350756	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of OSER1 mRNA	PMID:29803840
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1350756	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of OSER1 mRNA	PMID:20044591
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of OSER1 mRNA]	PMID:18723479
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1350756	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of OSER1 mRNA	PMID:34032870
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1331969	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of OSER1 mRNA	PMID:36209798
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1350756	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of OSER1 mRNA	PMID:38568856
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1350756	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of OSER1 mRNA	PMID:20064835
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350756	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OSER1 3' UTR	PMID:27901495
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of OSER1 mRNA	PMID:20971185
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of OSER1 mRNA	PMID:18593933
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1350756	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of OSER1 mRNA	PMID:26014281
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1350756	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of OSER1 mRNA	PMID:19150397
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of OSER1 mRNA	PMID:34492290
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1331969	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of OSER1 mRNA	PMID:28329830
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1350756	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of OSER1 mRNA	PMID:30903817
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of OSER1 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1331969	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of OSER1 mRNA	PMID:33221593
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of OSER1 mRNA	PMID:28628672
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of OSER1 mRNA	PMID:28628672
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350756	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of OSER1 mRNA	PMID:37042841
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of OSER1 mRNA	PMID:19010381
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1350756	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of OSER1 mRNA	PMID:38568856
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1331969	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OSER1 mRNA	PMID:37236586
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of OSER1 mRNA	PMID:24386269
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1350756	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of OSER1 mRNA	PMID:19320972|PMID:19376846
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1350756	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of OSER1 mRNA	PMID:28302478
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSER1 mRNA	PMID:19167446
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1350756	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of OSER1 mRNA	PMID:26352163
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331969	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of OSER1 mRNA	PMID:36331819
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of OSER1 mRNA	PMID:22110744
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1350756	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of OSER1 mRNA	PMID:29154799
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1350756	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of OSER1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of OSER1 mRNA	PMID:28628672
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of OSER1 mRNA	PMID:33387578
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1350756	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of OSER1 mRNA	PMID:21420995
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1350756	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of OSER1 mRNA	PMID:18687144
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of OSER1 mRNA	PMID:29391264
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of OSER1 mRNA	PMID:22079256
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of OSER1 mRNA	PMID:28628672
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of OSER1 mRNA	PMID:24136188|PMID:24793618
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:63959	celastrol	increases expression	ISO	RGD:1350756	E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in increased expression of OSER1 mRNA	PMID:17010675
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1350756	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of OSER1 mRNA	PMID:28988120
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1350756	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of OSER1 mRNA	PMID:15336504
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:65954	gedunin	increases expression	ISO	RGD:1350756	E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in increased expression of OSER1 mRNA	PMID:17010675
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1350756	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of OSER1 mRNA	PMID:22079256
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of OSER1 mRNA	PMID:22079256
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	ISO	RGD:1350756	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of OSER1 mRNA	PMID:30851411
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:79369	elesclomol	increases expression	ISO	RGD:1350756	E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of OSER1 mRNA	PMID:18723479
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:79369	elesclomol	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20170228	CTD	MESH:C512195	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of OSER1 mRNA]	PMID:18723479
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1331969	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of OSER1 mRNA	PMID:31388691
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1350756	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSER1 mRNA	PMID:19167446
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1350756	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of OSER1 mRNA	PMID:26014281
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1350756	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of OSER1 mRNA	PMID:38568856
1303142	Oser1	oxidative stress responsive serine-rich 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1350756	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of OSER1 mRNA	PMID:29301935
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606315	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ARHGAP8 mRNA	PMID:38218311
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ARHGAP8 mRNA]	PMID:31150632
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGAP8 mRNA	PMID:20488242
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550902	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARHGAP8 mRNA	PMID:30529165
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:15940	nicotinic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009525	Niacin results in increased expression of ARHGAP8 mRNA	PMID:20303128
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGAP8 mRNA	PMID:32145629
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606315	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ARHGAP8 mRNA	PMID:30165855
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ARHGAP8 mRNA	PMID:33387578
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1606315	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARHGAP8 mRNA	PMID:36774801
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1606315	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ARHGAP8 protein	PMID:37730182
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1606315	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ARHGAP8 mRNA	PMID:36139627
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARHGAP8 mRNA	PMID:33387578
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1550902	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of ARHGAP8 mRNA	PMID:33914522
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1550902	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of ARHGAP8 mRNA	PMID:39984025
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1606315	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARHGAP8 gene	PMID:28458013
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550902	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ARHGAP8 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ARHGAP8 mRNA	PMID:34911549
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ARHGAP8 mRNA	PMID:31150632
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ARHGAP8 mRNA]	PMID:31150632
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550902	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARHGAP8 mRNA	PMID:22206623
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1606315	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ARHGAP8 gene	PMID:25304211
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606315	E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of ARHGAP8 gene	PMID:39164771
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1606315	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of ARHGAP8 mRNA	PMID:33512557
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606315	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ARHGAP8 mRNA	PMID:27392435
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1550902	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ARHGAP8 mRNA	PMID:32186404
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGAP8 mRNA	PMID:22298810
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550902	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGAP8 mRNA	PMID:20159946
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARHGAP8 mRNA	PMID:32109520|PMID:33387578
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550902	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGAP8 mRNA	PMID:17942748
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ARHGAP8 mRNA	PMID:28374803
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1606315	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ARHGAP8 mRNA	PMID:29955902
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606315	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARHGAP8 mRNA	PMID:33212167
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ARHGAP8 mRNA	PMID:28959563
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1606315	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ARHGAP8 gene	PMID:28589171
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550902	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP8 mRNA	PMID:34876320
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1550902	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP8 mRNA	PMID:34876320
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606315	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARHGAP8 5' UTR	PMID:27901495
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606315	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ARHGAP8 promoter	PMID:27901495
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1606315	E	RGD:6480464	20120412	CTD	MESH:C061133	tamibarotene results in increased expression of ARHGAP8 mRNA	PMID:17229644
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550902	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ARHGAP8 mRNA	PMID:23557971
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ARHGAP8 mRNA	PMID:34492290
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:32497	thioacetamide	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased methylation of ARHGAP8 promoter	PMID:27914986
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550902	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ARHGAP8 mRNA	PMID:23811191
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1550902	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of ARHGAP8 mRNA	PMID:33914522
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARHGAP8 mRNA	PMID:25181051
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP8 mRNA	PMID:32145629
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550902	E	RGD:6480464	20220809	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP8 mRNA	PMID:34850234
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606315	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP8 mRNA	PMID:36232920
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550902	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP8 mRNA	PMID:25594700|PMID:32156529|PMID:34585602
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ARHGAP8 gene	PMID:28505145
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1606315	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of ARHGAP8 mRNA	PMID:19244175
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550902	E	RGD:6480464	20220809	CTD	MESH:C543008	bisphenol S results in decreased expression of ARHGAP8 mRNA	PMID:34850234|PMID:40203079
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550902	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ARHGAP8 mRNA	PMID:30951980
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550902	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ARHGAP8 mRNA	PMID:30951980
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1606315	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARHGAP8 mRNA	PMID:19376846
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1606315	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of ARHGAP8 mRNA	PMID:33512557
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:39481	chloroprene	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of ARHGAP8 mRNA	PMID:23125180
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1550902	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGAP8 mRNA	PMID:21427059
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606315	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGAP8 mRNA	PMID:28001369
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1606315	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of ARHGAP8 mRNA	PMID:33512557
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1606315	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of ARHGAP8 mRNA	PMID:33512557
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1606315	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ARHGAP8 mRNA	PMID:24935251
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606315	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGAP8 mRNA	PMID:29067470
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1606315	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ARHGAP8 gene	PMID:25304211
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606315	E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of ARHGAP8 gene	PMID:39164771
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of ARHGAP8 mRNA	PMID:29391264
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1550902	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP8 mRNA	PMID:34876320
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550902	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGAP8 mRNA	PMID:17942748
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550902	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ARHGAP8 mRNA; Nanotubes, Carbon results in increased expression of ARHGAP8 mRNA	PMID:25554681
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of ARHGAP8 mRNA	PMID:24136188
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550902	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ARHGAP8 mRNA	PMID:22206623
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550902	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARHGAP8 mRNA	PMID:22206623
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1606315	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ARHGAP8 mRNA	PMID:36139627
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1606315	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of ARHGAP8 mRNA	PMID:33512557
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1550902	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP8 mRNA	PMID:34876320
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:8434	prochloraz	increases expression	ISO	RGD:1550902	E	RGD:6480464	20260707	CTD	MESH:C045362	prochloraz results in increased expression of ARHGAP8 mRNA	PMID:39210919
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARHGAP8 mRNA	PMID:24780913
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1606315	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of ARHGAP8 mRNA	PMID:33512557
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1606315	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ARHGAP8 mRNA	PMID:29301935
1303143	Arhgap8	Rho GTPase activating protein 8	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ARHGAP8 mRNA	PMID:23034163
1303144	Ak8	adenylate kinase 8	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332480	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of AK8 mRNA	PMID:33045310
1303144	Ak8	adenylate kinase 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1350831	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of AK8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of AK8 mRNA	PMID:35811015
1303144	Ak8	adenylate kinase 8	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1332480	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of AK8 mRNA	PMID:33448797
1303144	Ak8	adenylate kinase 8	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332480	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of AK8 mRNA]	PMID:33448797
1303144	Ak8	adenylate kinase 8	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1332480	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of AK8 mRNA	PMID:33448797
1303144	Ak8	adenylate kinase 8	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332480	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of AK8 mRNA]	PMID:33448797
1303144	Ak8	adenylate kinase 8	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of AK8 mRNA	PMID:26577399
1303144	Ak8	adenylate kinase 8	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1350831	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AK8 mRNA	PMID:32234424
1303144	Ak8	adenylate kinase 8	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1350831	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of AK8 mRNA	PMID:27392435
1303144	Ak8	adenylate kinase 8	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1332480	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of AK8 mRNA	PMID:30807115
1303144	Ak8	adenylate kinase 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350831	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AK8 intron	PMID:30157460
1303144	Ak8	adenylate kinase 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332480	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AK8 mRNA	PMID:22228805
1303144	Ak8	adenylate kinase 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1350831	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AK8 mRNA	PMID:32234424
1303144	Ak8	adenylate kinase 8	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1350831	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of AK8 mRNA	PMID:25895662
1303144	Ak8	adenylate kinase 8	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1350831	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of AK8 mRNA	PMID:35984750
1303144	Ak8	adenylate kinase 8	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of AK8 mRNA	PMID:24395379
1303144	Ak8	adenylate kinase 8	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1350831	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of AK8 gene	PMID:31601247
1303144	Ak8	adenylate kinase 8	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1332480	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of AK8 mRNA	PMID:23557971
1303144	Ak8	adenylate kinase 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of AK8 mRNA	PMID:25181051
1303144	Ak8	adenylate kinase 8	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1350831	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of AK8 gene	PMID:31601247
1303144	Ak8	adenylate kinase 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of AK8 mRNA	PMID:30816183|PMID:32528016
1303144	Ak8	adenylate kinase 8	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AK8 gene	PMID:28505145
1303144	Ak8	adenylate kinase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332480	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of AK8 mRNA	PMID:30951980
1303144	Ak8	adenylate kinase 8	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1332480	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of AK8 mRNA	PMID:30951980
1303144	Ak8	adenylate kinase 8	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332480	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of AK8 mRNA	PMID:37019170
1303144	Ak8	adenylate kinase 8	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of AK8 gene	PMID:33148267
1303144	Ak8	adenylate kinase 8	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of AK8 promoter	PMID:22457795
1303144	Ak8	adenylate kinase 8	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1332480	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of AK8 mRNA	PMID:40194260
1303144	Ak8	adenylate kinase 8	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1332480	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of AK8 mRNA	PMID:23125180
1303144	Ak8	adenylate kinase 8	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1350831	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of AK8 gene	PMID:29154799
1303144	Ak8	adenylate kinase 8	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1332480	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of AK8 mRNA	PMID:33448797
1303144	Ak8	adenylate kinase 8	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332480	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of AK8 mRNA]	PMID:33448797
1303144	Ak8	adenylate kinase 8	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1350831	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of AK8 mRNA	PMID:38832940
1303144	Ak8	adenylate kinase 8	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1350831	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of AK8 mRNA	PMID:28542535
1303144	Ak8	adenylate kinase 8	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1350831	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of AK8 mRNA	PMID:35811015
1303144	Ak8	adenylate kinase 8	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1350831	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of AK8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of AK8 mRNA	PMID:35811015
1303144	Ak8	adenylate kinase 8	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332480	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of AK8 mRNA; Nanotubes, Carbon results in decreased expression of AK8 mRNA	PMID:25554681
1303144	Ak8	adenylate kinase 8	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of AK8 mRNA	PMID:30047161
1303144	Ak8	adenylate kinase 8	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1332480	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in increased expression of AK8 mRNA]	PMID:33448797
1303144	Ak8	adenylate kinase 8	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of AK8 gene	PMID:33148267
1303144	Ak8	adenylate kinase 8	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of AK8 mRNA	PMID:24780913
1303144	Ak8	adenylate kinase 8	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AK8 mRNA	PMID:25825206|PMID:30047161
1303144	Ak8	adenylate kinase 8	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1350831	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of AK8 mRNA	PMID:31734321
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1349841	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ABHD12B mRNA	PMID:38218311
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1619703	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ABHD12B mRNA	PMID:37315490|PMID:37995155
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	ISO	RGD:1349841	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of ABHD12B mRNA	PMID:19524605
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1349841	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ABHD12B mRNA	PMID:30510588
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1619703	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ABHD12B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ABHD12B mRNA	PMID:34911549
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1619703	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ABHD12B mRNA	PMID:25629700
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1349841	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABHD12B mRNA	PMID:32525701
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1349841	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of ABHD12B promoter	PMID:22847954
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1349841	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ABHD12B mRNA	PMID:33212167
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1349841	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD12B mRNA	PMID:30851411
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349841	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABHD12B mRNA	PMID:38568856
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349841	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ABHD12B 5' UTR	PMID:27901495
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1349841	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ABHD12B protein]	PMID:26598702
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ABHD12B mRNA	PMID:25181051
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ABHD12B gene	PMID:28505145
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1619703	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ABHD12B mRNA	PMID:26377693
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1619703	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ABHD12B mRNA	PMID:28392331
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1349841	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of ABHD12B promoter	PMID:22847954
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1349841	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of ABHD12B promoter	PMID:22847954
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349841	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABHD12B mRNA	PMID:25979313
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349841	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ABHD12B mRNA	PMID:24383497|PMID:28001369
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1349841	E	RGD:6480464	20180703	CTD	MESH:D005472	Fluorouracil results in decreased expression of ABHD12B mRNA	PMID:24737281
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1349841	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABHD12B mRNA	PMID:32525701
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1349841	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ABHD12B protein]	PMID:26598702
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1349841	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD12B mRNA	PMID:30851411
1303145	Abhd12b	abhydrolase domain containing 12B	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1349841	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABHD12B mRNA	PMID:32525701
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1331981	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CACYBP mRNA	PMID:37995155
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CACYBP mRNA	PMID:33167477
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of CACYBP mRNA	PMID:32845096
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1331981	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CACYBP mRNA	PMID:30319688
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1331981	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CACYBP mRNA	PMID:30319688
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1346732	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CACYBP mRNA	PMID:20044591
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CACYBP mRNA	PMID:21632981
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of CACYBP mRNA	PMID:17023530
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1331981	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CACYBP mRNA	PMID:39241906
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CACYBP mRNA]	PMID:39241906
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of CACYBP mRNA	PMID:35192832
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1346732	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CACYBP mRNA	PMID:20106945
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1346732	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CACYBP mRNA	PMID:38568856
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CACYBP mRNA	PMID:33387578
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1346732	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CACYBP mRNA	PMID:37042841
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1346732	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CACYBP mRNA	PMID:22017230
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1331981	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of CACYBP mRNA	PMID:23892564
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1346732	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CACYBP protein	PMID:37730182
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CACYBP mRNA	PMID:33387578
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CACYBP mRNA	PMID:36331819
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CACYBP mRNA	PMID:39836092
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in decreased expression of CACYBP protein	PMID:16440303
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CACYBP mRNA	PMID:39012411
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1346732	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CACYBP mRNA	PMID:19549813
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CACYBP protein	PMID:23301498
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346732	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CACYBP gene	PMID:27153756
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of CACYBP mRNA	PMID:32845096
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CACYBP mRNA	PMID:18593933
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1331981	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CACYBP mRNA	PMID:27339419|PMID:31919559
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CACYBP mRNA	PMID:22206623
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CACYBP mRNA	PMID:27424125
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CACYBP mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CACYBP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CACYBP mRNA	PMID:32525701|PMID:39836092
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1346732	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CACYBP protein	PMID:35688186
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CACYBP mRNA	PMID:25905778
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of CACYBP mRNA	PMID:19167446
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CACYBP mRNA]	PMID:21858171
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CACYBP mRNA	PMID:27424125
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CACYBP mRNA	PMID:21215274|PMID:34747641
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CACYBP mRNA	PMID:20159946
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CACYBP mRNA	PMID:33387578
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CACYBP mRNA	PMID:19465110
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CACYBP mRNA	PMID:17942748
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CACYBP mRNA	PMID:27424125
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1346732	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CACYBP mRNA	PMID:32763439
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CACYBP mRNA; [NSC 689534 binds to Copper] which results in decreased expression of CACYBP mRNA	PMID:20971185|PMID:24690739
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1331981	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CACYBP protein	PMID:28918527
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1346732	E	RGD:6480464	20140610	CTD	MESH:D004317	CACYBP protein results in decreased susceptibility to Doxorubicin	PMID:24675091
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of CACYBP mRNA	PMID:29301061
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346732	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CACYBP mRNA	PMID:38568856
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CACYBP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CACYBP mRNA	PMID:39836092
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CACYBP mRNA	PMID:21839799
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1331981	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CACYBP mRNA	PMID:19770486|PMID:21569818
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1346732	E	RGD:6480464	20150512	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CACYBP mRNA; Benzo(a)pyrene results in increased expression of CACYBP protein	PMID:25628927|PMID:32234424
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346732	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CACYBP promoter	PMID:27901495
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20150512	CTD	MESH:D001564	PARG affects the reaction [Benzo(a)pyrene results in increased expression of CACYBP protein]	PMID:25628927
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CACYBP mRNA]	PMID:32406909
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CACYBP mRNA; [NSC 689534 binds to Copper] which results in decreased expression of CACYBP mRNA	PMID:20971185|PMID:24690739
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CACYBP mRNA	PMID:18593933
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1346732	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of CACYBP mRNA	PMID:26014281
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1346732	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CACYBP mRNA	PMID:25351596
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CACYBP mRNA	PMID:16507785
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CACYBP mRNA	PMID:25729387
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1331981	E	RGD:6480464	20120814	CTD	MESH:C006253	pirinixic acid results in increased expression of CACYBP mRNA	PMID:18301758|PMID:21318169
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of CACYBP mRNA]	PMID:21318169
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1331981	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CACYBP mRNA	PMID:28472532
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of CACYBP promoter	PMID:27415467
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1331981	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CACYBP mRNA	PMID:33221593
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CACYBP mRNA; bisphenol A results in decreased expression of CACYBP protein	PMID:29275510|PMID:37567409
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CACYBP mRNA	PMID:25181051
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CACYBP gene	PMID:28505145
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20200310	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CACYBP protein	PMID:30098271
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1331981	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CACYBP mRNA	PMID:39298647
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1346732	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CACYBP protein	PMID:34186270
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1346732	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CACYBP protein	PMID:34186270
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:34778	glycitein	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CACYBP mRNA	PMID:27424125
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1331981	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CACYBP mRNA	PMID:34813904
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1346732	E	RGD:6480464	20171010	CTD	MESH:D010269	Paraquat results in increased expression of CACYBP mRNA	PMID:28619522
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20130514	CTD	MESH:D010269	[Paraquat co-treated with Maneb] results in increased expression of CACYBP mRNA	PMID:18386188
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CACYBP gene	PMID:33148267
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CACYBP mRNA]	PMID:39241906
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CACYBP mRNA	PMID:39836092
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CACYBP protein	PMID:16440303
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1346732	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CACYBP mRNA	PMID:38568856
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CACYBP mRNA	PMID:39012411
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1346732	E	RGD:6480464	20161115	CTD	MESH:C018021	cobaltous chloride results in increased expression of CACYBP mRNA	PMID:19376846
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1346732	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CACYBP mRNA	PMID:24449571
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1331981	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of CACYBP mRNA	PMID:25908611
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1346732	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CACYBP mRNA	PMID:19167446
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of CACYBP mRNA	PMID:19167446
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CACYBP mRNA	PMID:36331819
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CACYBP mRNA	PMID:17292431
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346732	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CACYBP mRNA	PMID:25979313
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346732	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of CACYBP mRNA	PMID:24935251|PMID:29154799
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of CACYBP mRNA	PMID:41580965
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CACYBP mRNA	PMID:25562108
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346732	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CACYBP mRNA	PMID:20106945
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CACYBP mRNA	PMID:17555576
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of CACYBP mRNA	PMID:36621641
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CACYBP mRNA	PMID:27424125
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CACYBP mRNA	PMID:24136188
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20120717	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CACYBP protein	PMID:19397276
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1346732	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CACYBP mRNA	PMID:38832940
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1346732	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CACYBP mRNA	PMID:28542535
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1346732	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CACYBP mRNA	PMID:24935251
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CACYBP mRNA	PMID:33387578
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1346732	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CACYBP mRNA	PMID:21420995
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:4659	disulfiram	increases expression	ISO	RGD:1346732	E	RGD:6480464	20240402	CTD	MESH:D004221	Disulfiram results in increased expression of CACYBP mRNA; Disulfiram results in increased expression of CACYBP protein	PMID:34182011
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of CACYBP mRNA	PMID:24690739
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CACYBP mRNA	PMID:29432896
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1346732	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CACYBP mRNA	PMID:25351596
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CACYBP mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CACYBP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CACYBP mRNA	PMID:32525701|PMID:39836092
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CACYBP mRNA	PMID:17555576
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CACYBP mRNA	PMID:17108234
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CACYBP mRNA	PMID:17942748
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CACYBP mRNA	PMID:17942748
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1346732	E	RGD:6480464	20150310	CTD	MESH:C037123	cadmium sulfate results in increased expression of CACYBP mRNA	PMID:12064557|PMID:14676411|PMID:21783983
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1331981	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CACYBP mRNA; Nanotubes, Carbon results in increased expression of CACYBP mRNA	PMID:25554681
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1346732	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CACYBP mRNA	PMID:15585362
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CACYBP mRNA	PMID:24136188
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1331981	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CACYBP mRNA	PMID:40234311
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CACYBP mRNA	PMID:35964746
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CACYBP mRNA	PMID:24136188
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1331981	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of CACYBP mRNA	PMID:26377693
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20130514	CTD	MESH:D008344	[Paraquat co-treated with Maneb] results in increased expression of CACYBP mRNA	PMID:18386188
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1346732	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of CACYBP mRNA	PMID:31629900
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CACYBP protein	PMID:32959892
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CACYBP mRNA	PMID:39836092
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CACYBP mRNA	PMID:25729387
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CACYBP mRNA	PMID:24136188
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1331981	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CACYBP mRNA	PMID:23650126
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:63959	celastrol	increases expression	ISO	RGD:1346732	E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in increased expression of CACYBP mRNA	PMID:17010675
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CACYBP mRNA	PMID:24136188
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:65954	gedunin	increases expression	ISO	RGD:1346732	E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in increased expression of CACYBP mRNA	PMID:17010675
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CACYBP mRNA	PMID:19564919
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1346732	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of CACYBP mRNA	PMID:27918106
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CACYBP gene	PMID:33148267
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CACYBP mRNA	PMID:22206623
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:7438	N-methylformamide	increases expression	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in increased expression of CACYBP mRNA; methylformamide results in increased expression of CACYBP mRNA	PMID:17040096
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CACYBP protein	PMID:37664457
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CACYBP mRNA	PMID:24136188
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of CACYBP promoter	PMID:27415467
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1346732	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CACYBP protein	PMID:39638853
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CACYBP gene]	PMID:28238834
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:80373	glycitin	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CACYBP mRNA	PMID:27424125
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of CACYBP mRNA	PMID:20345932
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of CACYBP protein	PMID:19954255
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1331981	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of CACYBP mRNA	PMID:26377693
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1346732	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of CACYBP mRNA	PMID:21858171
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CACYBP mRNA]	PMID:21858171
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CACYBP mRNA	PMID:32525701
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1331981	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CACYBP mRNA	PMID:21278054
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1331981	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CACYBP mRNA]	PMID:39241906
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1331981	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of CACYBP mRNA	PMID:40826991
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346732	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CACYBP protein	PMID:37664457
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1346732	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of CACYBP mRNA	PMID:26014281
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CACYBP mRNA	PMID:19281266
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CACYBP mRNA	PMID:21346803
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1346732	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CACYBP mRNA	PMID:38568856
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CACYBP mRNA	PMID:21346803
1303146	Cacybp	calcyclin binding protein	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1331981	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of CACYBP mRNA	PMID:28973697
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D004237	Diuron results in decreased expression of WFDC21 mRNA	PMID:25152437
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C118739	entinostat results in increased expression of WFDC21P mRNA	PMID:27188386
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C049935	avobenzone results in decreased expression of WFDC21P mRNA	PMID:31016361
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of WFDC21P mRNA	PMID:35811015
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D004958	Estradiol affects the expression of WFDC21 mRNA	PMID:32145629
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D004958	Estradiol results in decreased expression of WFDC21 mRNA	PMID:35192832
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of WFDC21P mRNA	PMID:38568856
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D014241	Trichloroethylene results in decreased expression of WFDC21 mRNA	PMID:33387578
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250506	CTD	MESH:D002635	[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of WFDC21P mRNA	PMID:34589561
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of WFDC21P mRNA	PMID:39245080
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250506	CTD	MESH:D006000	[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of WFDC21P mRNA	PMID:34589561
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of WFDC21 mRNA	PMID:28085963
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of WFDC21P mRNA	PMID:36139627
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WFDC21 mRNA	PMID:36331819
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:195250	corn oil	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003314	Corn Oil results in increased expression of WFDC21 mRNA	PMID:22760963
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550911	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WFDC21 mRNA	PMID:37236586
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D009151	Mustard Gas results in increased expression of WFDC21P mRNA	PMID:25102026
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of WFDC21 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of WFDC21 mRNA	PMID:34911549
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250506	CTD	MESH:D006002	[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of WFDC21P mRNA	PMID:34589561
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC21P mRNA	PMID:32525701
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of WFDC21P mRNA	PMID:26272509
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA	PMID:27188386
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of WFDC21 mRNA]	PMID:31298478
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1550911	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of WFDC21 mRNA	PMID:40618947
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:D019833	Genistein results in increased expression of WFDC21 mRNA	PMID:32186404
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WFDC21 mRNA	PMID:26377647
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WFDC21 mRNA	PMID:26290441|PMID:28922406
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D012402	Rotenone results in decreased expression of WFDC21 mRNA	PMID:28374803
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D019344	Lactic Acid results in decreased expression of WFDC21P mRNA	PMID:30851411
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250506	CTD	MESH:D003840	[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of WFDC21P mRNA	PMID:34589561
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C017947	sodium arsenite results in decreased expression of WFDC21 mRNA	PMID:37682722
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C017947	sodium arsenite results in decreased expression of WFDC21P mRNA	PMID:38568856
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C017947	sodium arsenite results in increased expression of WFDC21P mRNA	PMID:34953898
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C017947	sodium arsenite promotes the reaction [STAT3 protein binds to WFDC21P mRNA]; WFDC21P mRNA promotes the reaction [sodium arsenite results in increased expression of CD274 protein]; WFDC21P mRNA promotes the reaction [sodium arsenite results in increased phosphorylation of STAT3 protein]	PMID:34953898
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WFDC21P mRNA	PMID:32234424
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:D012822	Silicon Dioxide results in increased expression of WFDC21 mRNA	PMID:29341224
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of WFDC21P gene	PMID:31601247
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D005897	Glafenine results in increased expression of WFDC21 mRNA	PMID:24136188
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C015358	methylparaben results in decreased expression of WFDC21P mRNA	PMID:38568856
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C009495	titanium dioxide results in decreased expression of WFDC21 mRNA	PMID:35295148
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C009495	titanium dioxide results in increased expression of WFDC21 mRNA	PMID:27760801|PMID:31298478
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of WFDC21 mRNA]	PMID:31298478
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013853	Thioacetamide results in increased expression of WFDC21 mRNA	PMID:34492290
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of WFDC21 mRNA	PMID:25380136
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A affects the expression of WFDC21 mRNA	PMID:30903817|PMID:32145629
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C006780	bisphenol A results in decreased expression of WFDC21P mRNA	PMID:38568856
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in increased expression of WFDC21 mRNA	PMID:25181051
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:34283	oxybenzone	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C005290	oxybenzone results in decreased expression of WFDC21 mRNA	PMID:30316929
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of WFDC21P mRNA	PMID:28628672
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C008745	bisphenol F results in decreased expression of WFDC21P mRNA	PMID:38568856
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C008745	bisphenol F results in increased expression of WFDC21 mRNA	PMID:38685157
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of WFDC21P gene	PMID:31601247
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550911	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of WFDC21 intron	PMID:28392331
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of WFDC21P mRNA	PMID:28628672
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C005828	methidathion results in increased expression of WFDC21 mRNA	PMID:34813904
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of WFDC21 mRNA	PMID:24535843
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D010269	Paraquat results in increased expression of WFDC21 mRNA	PMID:32680482
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of WFDC21 mRNA	PMID:25380136|PMID:30723492
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of WFDC21P mRNA	PMID:38568856
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019256	Cadmium Chloride results in increased expression of WFDC21 mRNA	PMID:25993096
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550911	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WFDC21 mRNA	PMID:37236586
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C012125	diisononyl phthalate results in increased expression of WFDC21 mRNA	PMID:33391822
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C039281	furan results in increased expression of WFDC21 mRNA	PMID:26194646
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C018021	cobaltous chloride results in decreased expression of WFDC21 mRNA	PMID:24386269
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of WFDC21 mRNA	PMID:25380136
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of WFDC21 mRNA	PMID:25908611
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:36015	1,1,1-trichloroethane	increases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C024566	1,1,1-trichloroethane results in increased expression of WFDC21 mRNA	PMID:25270620
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250506	CTD	MESH:D005999	[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of WFDC21P mRNA	PMID:34589561
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C100187	chloropicrin results in decreased expression of WFDC21P mRNA	PMID:26352163
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C100187	chloropicrin results in increased expression of WFDC21P mRNA	PMID:28476498
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WFDC21 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of WFDC21 mRNA	PMID:36331819
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C031763	1,3-butadiene results in increased expression of WFDC21 mRNA	PMID:29038090
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C016104	sodium bichromate results in increased expression of WFDC21 mRNA	PMID:25993096
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D014635	Valproic Acid results in increased expression of WFDC21P mRNA	PMID:26272509|PMID:28001369
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA	PMID:27188386
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of WFDC21P mRNA	PMID:28628672
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:D017313	Fenretinide results in decreased expression of WFDC21 mRNA	PMID:28973697
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C088658	Zoledronic Acid results in increased expression of WFDC21P mRNA	PMID:24714768
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of WFDC21P mRNA	PMID:35811015
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:46680	serpentine asbestos	increases methylation	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of WFDC21P gene	PMID:29523930
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC21P mRNA	PMID:32525701
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D004726	Endosulfan results in increased expression of WFDC21 mRNA	PMID:29391264
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C109476	epoxiconazole results in increased expression of WFDC21 mRNA	PMID:35436446
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of WFDC21 mRNA	PMID:37567419
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C029892	cupric chloride results in decreased expression of WFDC21P mRNA	PMID:38568856
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA	PMID:27188386
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of WFDC21P mRNA	PMID:28628672
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D005485	Flutamide results in increased expression of WFDC21 mRNA	PMID:24793618
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550911	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of WFDC21 mRNA	PMID:38701926
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C025340	manganese chloride results in increased expression of WFDC21 mRNA	PMID:28801915
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of WFDC21 mRNA	PMID:27935865
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C047246	Temozolomide results in decreased expression of WFDC21P mRNA	PMID:31758290
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of WFDC21P mRNA	PMID:36139627
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D019344	Lactic Acid results in decreased expression of WFDC21P mRNA	PMID:30851411
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA	PMID:27188386
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550911	E	RGD:6480464	20250429	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of WFDC21 mRNA	PMID:38648751
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of WFDC21P mRNA	PMID:32234424
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC21P mRNA	PMID:32525701
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA	PMID:27188386
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:9405	tartrazine	multiple interactions	ISO	RGD:8662735	E	RGD:6480464	20250506	CTD	MESH:D013645	[Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of WFDC21P mRNA	PMID:34589561
1303147	Wfdc21	WAP four-disulfide core domain 21	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:8662735	E	RGD:6480464	20250429	CTD	MESH:D013893	Thiram results in decreased expression of WFDC21P mRNA	PMID:38568856
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ST7 mRNA	PMID:38218311
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1343912	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ST7 mRNA	PMID:38218311
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1343912	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of ST7 mRNA	PMID:21934132
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ST7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ST7 mRNA	PMID:32699268
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ST7 gene	PMID:28931070
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of ST7 gene	PMID:30207508
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550912	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ST7 mRNA	PMID:30319688
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550912	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ST7 mRNA	PMID:39241906
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of ST7 mRNA	PMID:17404688
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ST7 gene	PMID:27618143
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of ST7 mRNA	PMID:17404688
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1343912	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ST7 mRNA	PMID:21179406
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ST7 mRNA	PMID:21592394|PMID:33359661
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of ST7 mRNA	PMID:21592394
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of ST7 mRNA	PMID:21592394
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of ST7 mRNA	PMID:21592394
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ST7 mRNA	PMID:19549813
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ST7 mRNA	PMID:23649840
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ST7 mRNA	PMID:21641981
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1550912	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ST7 mRNA	PMID:19770486
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1343912	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ST7 gene	PMID:27153756
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ST7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ST7 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of ST7 mRNA	PMID:32699268
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ST7 mRNA	PMID:30779732
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of ST7 mRNA	PMID:31129395
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550912	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ST7 mRNA	PMID:27339419|PMID:31919559
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1343912	E	RGD:6480464	20120412	CTD	MESH:D016685	ST7 protein affects the susceptibility to Mitomycin	PMID:16217747
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1343912	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ST7 mRNA	PMID:26272509
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST7 mRNA	PMID:27188386
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of ST7 mRNA	PMID:19561079
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550912	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ST7 mRNA	PMID:21570461
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ST7 mRNA	PMID:32109520
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550912	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ST7 mRNA	PMID:19770486
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ST7 mRNA	PMID:33212167
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ST7 mRNA	PMID:28959563
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ST7 mRNA	PMID:29803840
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ST7 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550912	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ST7 mRNA	PMID:19770486|PMID:21715664
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550912	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ST7 mRNA	PMID:22228805
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1550912	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ST7 mRNA	PMID:39716349
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ST7 mRNA	PMID:25729387
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ST7 mRNA	PMID:30047161
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1550912	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ST7 mRNA	PMID:18648102
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ST7 mRNA	PMID:25181051
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1343912	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ST7 gene	PMID:31601247
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ST7 mRNA	PMID:30816183|PMID:32528016
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ST7 gene	PMID:28505145
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of ST7 mRNA	PMID:31129395
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550912	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ST7 mRNA	PMID:39298647
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1550912	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ST7 mRNA	PMID:28392331
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550912	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ST7 intron	PMID:28392331
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550912	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ST7 mRNA	PMID:37019170
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550912	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ST7 mRNA	PMID:17942915
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1550912	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ST7 mRNA]	PMID:17942915
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ST7 gene	PMID:33148267
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343912	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ST7 mRNA	PMID:37042841
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1343912	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of ST7 mRNA	PMID:29024780
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ST7 mRNA	PMID:33453195
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ST7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ST7 mRNA	PMID:32699268
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343912	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ST7 mRNA	PMID:25979313
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ST7 mRNA	PMID:29154799
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1343912	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ST7 mRNA	PMID:24383497
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ST7 mRNA	PMID:30047161
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1343912	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ST7 mRNA	PMID:28542535
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ST7 mRNA	PMID:26690555
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1343912	E	RGD:6480464	20230404	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of ST7 mRNA	PMID:35701726
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550912	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ST7 mRNA	PMID:17942748
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1343912	E	RGD:6480464	20120412	CTD	MESH:D005047	ST7 protein affects the susceptibility to Etoposide	PMID:16217747
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1550912	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ST7 mRNA	PMID:39716349
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ST7 mRNA	PMID:24136188
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ST7 mRNA	PMID:30047161
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550912	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ST7 mRNA	PMID:19042947
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1343912	E	RGD:6480464	20120412	CTD	MESH:D019772	ST7 protein affects the susceptibility to Topotecan	PMID:16217747
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ST7 mRNA	PMID:25729387
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ST7 mRNA	PMID:15336504
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ST7 gene	PMID:33148267
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1550912	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ST7 mRNA	PMID:22206623
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:77012	methylseleninic acid	affects expression	ISO	RGD:1343912	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid affects the expression of ST7 mRNA	PMID:14617803
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of ST7 mRNA	PMID:18548127
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST7 mRNA	PMID:27188386
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ST7 gene]	PMID:28238834
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ST7 mRNA	PMID:32109520
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1343912	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of ST7 mRNA	PMID:33512557
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1550912	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ST7 mRNA	PMID:39847705
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ST7 mRNA	PMID:30047161
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1343912	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST7 mRNA	PMID:27188386
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ST7 mRNA	PMID:21346803
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1343912	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ST7 mRNA	PMID:17440010
1303148	St7	suppression of tumorigenicity 7	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of ST7 gene	PMID:31682807
1303149	Krt85	keratin 85	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552900	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT85 mRNA	PMID:25510870
1303149	Krt85	keratin 85	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1350889	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of KRT85 mRNA	PMID:23825647
1303149	Krt85	keratin 85	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1350889	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of KRT85 mRNA	PMID:23825647
1303149	Krt85	keratin 85	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552900	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT85 mRNA	PMID:25510870
1303149	Krt85	keratin 85	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552900	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT85 mRNA	PMID:25510870
1303149	Krt85	keratin 85	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552900	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of KRT85 mRNA	PMID:28960355
1303149	Krt85	keratin 85	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1350889	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KRT85 mRNA	PMID:23557933
1303149	Krt85	keratin 85	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1350889	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of KRT85 mRNA	PMID:27392435
1303149	Krt85	keratin 85	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1350889	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of KRT85 mRNA	PMID:27392435
1303149	Krt85	keratin 85	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KRT85 mRNA	PMID:32109520
1303149	Krt85	keratin 85	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of KRT85 mRNA	PMID:30556269
1303149	Krt85	keratin 85	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552900	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRT85 mRNA	PMID:37682722
1303149	Krt85	keratin 85	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350889	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT85 exon	PMID:27901495
1303149	Krt85	keratin 85	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of KRT85 mRNA	PMID:30556269
1303149	Krt85	keratin 85	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1350889	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of KRT85 protein	PMID:25419056
1303149	Krt85	keratin 85	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of KRT85 mRNA	PMID:23411599
1303149	Krt85	keratin 85	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT85 mRNA	PMID:25181051
1303149	Krt85	keratin 85	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1350889	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT85 protein	PMID:33376534
1303149	Krt85	keratin 85	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1552900	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of KRT85 promoter	PMID:27312807
1303149	Krt85	keratin 85	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KRT85 gene	PMID:28505145
1303149	Krt85	keratin 85	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1552900	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KRT85 promoter	PMID:27312807
1303149	Krt85	keratin 85	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350889	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A promotes the reaction [KRT85 protein binds to ESR1 protein]	PMID:27156127
1303149	Krt85	keratin 85	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552900	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT85 mRNA	PMID:25510870
1303149	Krt85	keratin 85	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552900	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT85 mRNA	PMID:25510870
1303149	Krt85	keratin 85	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1552900	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of KRT85 mRNA	PMID:26377693
1303149	Krt85	keratin 85	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KRT85 mRNA	PMID:35163327
1303149	Krt85	keratin 85	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT85 mRNA	PMID:35163327
1303149	Krt85	keratin 85	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT85 mRNA	PMID:35163327
1303149	Krt85	keratin 85	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1552900	E	RGD:6480464	20150210	CTD	MESH:D002737	Chloroprene results in increased expression of KRT85 mRNA	PMID:23125180
1303149	Krt85	keratin 85	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1350889	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KRT85 gene	PMID:29154799
1303149	Krt85	keratin 85	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1552900	E	RGD:6480464	20150210	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of KRT85 mRNA	PMID:15591538
1303149	Krt85	keratin 85	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1350889	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of KRT85 protein	PMID:25419056
1303149	Krt85	keratin 85	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552900	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of KRT85 mRNA; Nanotubes, Carbon results in increased expression of KRT85 mRNA	PMID:25554681
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1552904	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of RAB21 mRNA	PMID:30319688
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of RAB21 protein	PMID:18951874
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552904	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RAB21 mRNA	PMID:39298647
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1350890	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RAB21 mRNA	PMID:23649840
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552904	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RAB21 mRNA	PMID:33754040
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RAB21 mRNA	PMID:33387578
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1552904	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of RAB21 mRNA	PMID:37748715
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1350890	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of RAB21 mRNA	PMID:17175027
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAB21 mRNA	PMID:39836092
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552904	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RAB21 mRNA	PMID:37236586
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1350890	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RAB21 mRNA	PMID:19549813
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RAB21 protein	PMID:23301498
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1350890	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RAB21 mRNA	PMID:23649840
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1350890	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RAB21 mRNA	PMID:23649840
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RAB21 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RAB21 mRNA	PMID:35430440|PMID:41430723
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of RAB21 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RAB21 protein	PMID:38598786
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RAB21 mRNA	PMID:18593933
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552904	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RAB21 mRNA	PMID:25629700
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552904	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RAB21 mRNA	PMID:22206623
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAB21 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAB21 mRNA	PMID:39836092
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552904	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAB21 mRNA	PMID:40504410
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1552904	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of RAB21 protein	PMID:25505154
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RAB21 mRNA	PMID:23557933
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552904	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAB21 mRNA	PMID:21570461
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of RAB21 protein	PMID:18951874
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1350890	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of RAB21 protein	PMID:39603559
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1350890	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RAB21 mRNA	PMID:28001369
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1350890	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of RAB21 mRNA	PMID:23649840
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1350890	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of RAB21 mRNA	PMID:32763439
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1350890	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin affects the expression of RAB21 mRNA	PMID:15205334
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1350890	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RAB21 mRNA	PMID:38568856
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAB21 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAB21 mRNA	PMID:39836092
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552904	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAB21 mRNA	PMID:40504410
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1552904	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RAB21 intron	PMID:27901495
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RAB21 mRNA	PMID:18593933
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1350890	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of RAB21 mRNA	PMID:20458559
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552904	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RAB21 gene	PMID:35295148
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RAB21 mRNA	PMID:34492290
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAB21 mRNA	PMID:25181051
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1350890	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RAB21 mRNA; bisphenol A results in increased expression of RAB21 protein	PMID:25047013|PMID:34186270|PMID:37567409
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1552904	E	RGD:6480464	20230207	CTD	MESH:C006780	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of RAB21 protein	PMID:35999755
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1350890	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of RAB21 protein	PMID:34186270
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552904	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RAB21 mRNA	PMID:39298647
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1350890	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RAB21 protein	PMID:34186270
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1552904	E	RGD:6480464	20230207	CTD	MESH:D016264	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of RAB21 protein	PMID:35999755
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552904	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RAB21 mRNA	PMID:21266533
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of RAB21 protein	PMID:38598786
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1552904	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of RAB21 mRNA	PMID:34813904
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350890	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAB21 mRNA	PMID:37042841
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1350890	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of RAB21 mRNA	PMID:17175027
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAB21 mRNA	PMID:39836092
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552904	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RAB21 mRNA	PMID:37236586
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1350890	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of RAB21 mRNA	PMID:19376846
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1552904	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of RAB21 mRNA	PMID:17585979
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350890	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAB21 mRNA	PMID:25979313
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1350890	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RAB21 gene	PMID:29154799
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1350890	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of RAB21 mRNA	PMID:23179753|PMID:27188386
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1350890	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RAB21 mRNA	PMID:25562108
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1350890	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of RAB21 mRNA	PMID:23649840
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552904	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAB21 mRNA	PMID:17562736
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RAB21 mRNA	PMID:33387578
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1350890	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of RAB21 mRNA	PMID:15205334
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAB21 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAB21 mRNA	PMID:39836092
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552904	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAB21 mRNA	PMID:40504410
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1350890	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RAB21 mRNA	PMID:18175754
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1350890	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of RAB21 mRNA	PMID:20458559
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RAB21 mRNA	PMID:24136188
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1350890	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RAB21 protein	PMID:32959892
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1350890	E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of RAB21 mRNA	PMID:17175027
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAB21 mRNA	PMID:39836092
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1350890	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RAB21 mRNA	PMID:31758290
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1350890	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RAB21 protein	PMID:34186270
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552904	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RAB21 mRNA	PMID:22206623
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552904	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RAB21 mRNA	PMID:22206623
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RAB21 mRNA	PMID:24136188
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1350890	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RAB21 protein	PMID:38598786
1303150	Rab21	RAB21, member RAS oncogene family	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of RAB21 mRNA	PMID:23034163
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20201215	CTD	MESH:D019308	[osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOR1 protein; MRI-1867 inhibits the reaction [[osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOR1 protein]	PMID:31454063
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1332010	E	RGD:6480464	20211207	CTD	MESH:D000431	Ethanol results in decreased expression of ADIPOR1 mRNA	PMID:28935932
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D000431	ADIPOR1 protein promotes the reaction [Ethanol promotes the reaction [ADIPOQ protein results in increased expression of IL10 mRNA]]	PMID:20052772
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1332010	E	RGD:6480464	20120501	CTD	MESH:D000431	[Rosiglitazone co-treated with Ethanol] results in increased expression of ADIPOR1 mRNA; Cannabidiol inhibits the reaction [Ethanol results in decreased expression of ADIPOR1 mRNA]; Ethanol promotes the reaction [Resveratrol results in increased expression of ADIPOR1 mRNA]	PMID:18755807|PMID:20007851|PMID:28935932
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332010	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADIPOR1 mRNA	PMID:39241906
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1332010	E	RGD:6480464	20161228	CTD	MESH:D008070	ADIPOR1 protein promotes the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]]; ADIPOR1 protein promotes the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]]	PMID:20861358
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344545	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADIPOR1 mRNA	PMID:37042841
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1344545	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ADIPOR1 mRNA	PMID:23649840
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1344545	E	RGD:6480464	20190219	CTD	MESH:D011374	Progesterone results in increased expression of ADIPOR1 mRNA	PMID:29603059
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D005947	Glucose results in decreased expression of ADIPOR1 mRNA; Glucose results in decreased expression of ADIPOR1 protein	PMID:24413998
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D005947	FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]	PMID:24413998
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of ADIPOR1 mRNA	PMID:26496021
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17351	linoleic acid	increases expression	ISO	RGD:1332010	E	RGD:6480464	20170516	CTD	MESH:D019787	Linoleic Acid analog results in increased expression of ADIPOR1 mRNA	PMID:27939595
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D005947	Glucose results in decreased expression of ADIPOR1 mRNA; Glucose results in decreased expression of ADIPOR1 protein	PMID:24413998
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D005947	FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]	PMID:24413998
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ADIPOR1 mRNA	PMID:27103539
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332010	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ADIPOR1 mRNA	PMID:35550907
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332010	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ADIPOR1 mRNA	PMID:33754040
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ADIPOR1 mRNA	PMID:33387578
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1344545	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ADIPOR1 mRNA	PMID:28818685
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1344545	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in increased expression of ADIPOR1 mRNA	PMID:23369406
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1344545	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ADIPOR1 mRNA	PMID:23649840
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1332010	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ADIPOR1 mRNA	PMID:19770486
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1344545	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ADIPOR1 mRNA	PMID:23649840
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332010	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ADIPOR1 mRNA	PMID:25629700
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1344545	E	RGD:6480464	20220906	CTD	MESH:D001151	Arsenic results in decreased expression of ADIPOR1 mRNA	PMID:31864032
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADIPOR1 mRNA	PMID:39836092
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1332010	E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in increased expression of ADIPOR1 mRNA	PMID:18755807
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C059514	FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; resveratrol inhibits the reaction [Streptozocin results in decreased expression of ADIPOR1 protein]	PMID:24413998
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1332010	E	RGD:6480464	20121218	CTD	MESH:C059514	Ethanol promotes the reaction [resveratrol results in increased expression of ADIPOR1 mRNA]	PMID:18755807
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1344545	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ADIPOR1 mRNA	PMID:28903495
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332010	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADIPOR1 mRNA	PMID:21570461
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADIPOR1 mRNA	PMID:33387578
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332010	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADIPOR1 mRNA	PMID:17942748
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332010	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADIPOR1 mRNA	PMID:17942748
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:28948	gramine	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20230404	CTD	MESH:C007884	gramine binds to and results in increased activity of ADIPOR1 protein	PMID:23691032
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:2930	aurothioglucose	multiple interactions	ISO	RGD:1332010	E	RGD:6480464	20141111	CTD	MESH:D006051	[Dietary Fats co-treated with Aurothioglucose] results in decreased expression of ADIPOR1 protein	PMID:21382165
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344545	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ADIPOR1 mRNA	PMID:38568856
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADIPOR1 mRNA	PMID:39836092
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1344545	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADIPOR1 5' UTR; Benzo(a)pyrene results in increased methylation of ADIPOR1 promoter	PMID:27901495
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332010	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ADIPOR1 gene; titanium dioxide results in increased methylation of ADIPOR1 promoter	PMID:35295148
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1332010	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ADIPOR1 mRNA	PMID:16306350
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:32798	9-cis,11-trans-octadecadienoic acid	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C503589	[trans-10,cis-12-conjugated linoleic acid co-treated with cis-9, trans-11-conjugated linoleic acid] results in increased expression of ADIPOR1 mRNA	PMID:17408517
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of ADIPOR1 mRNA	PMID:27103539|PMID:28657538
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ADIPOR1 mRNA	PMID:25181051
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of ADIPOR1 mRNA	PMID:26496021
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1332010	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of ADIPOR1 mRNA	PMID:37080397
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1332010	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ADIPOR1 gene	PMID:31683443
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1332010	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ADIPOR1 intron	PMID:28392331
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1332010	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ADIPOR1 mRNA	PMID:21266533
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1332010	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ADIPOR1 mRNA	PMID:34813904
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1332010	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ADIPOR1 mRNA	PMID:34813904
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1344545	E	RGD:6480464	20160822	CTD	MESH:D010269	Paraquat results in increased expression of ADIPOR1 mRNA; Paraquat results in increased expression of ADIPOR1 protein	PMID:25945502
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20160822	CTD	MESH:D010269	ADIPOQ protein promotes the reaction [Paraquat results in increased expression of ADIPOR1 mRNA]; ADIPOQ protein promotes the reaction [Paraquat results in increased expression of ADIPOR1 protein]; ADIPOR1 protein inhibits the reaction [Paraquat results in increased expression of ADIPOR2 mRNA]; ADIPOR1 protein inhibits the reaction [Paraquat results in increased expression of ADIPOR2 protein]; ADIPOR1 protein promotes the reaction [ADIPOQ protein inhibits the reaction [Paraquat results in increased expression of COL3A1 mRNA]]	PMID:25945502
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344545	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADIPOR1 mRNA	PMID:37042841
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1332010	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ADIPOR1 mRNA	PMID:17681415
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ADIPOR1 gene	PMID:22079235
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1332010	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ADIPOR1 mRNA	PMID:17585979
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:38960	terbufos	affects response to substance	ISO	RGD:1344545	E	RGD:6480464	20150127	CTD	MESH:C012568	ADIPOR1 gene SNP affects the susceptibility to terbufos	PMID:22919386
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344545	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ADIPOR1 mRNA	PMID:29154799
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ADIPOR1 mRNA	PMID:17183730
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of ADIPOR1 mRNA	PMID:38685447
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D016572	Cyclosporine affects the expression of ADIPOR1 protein	PMID:28886988
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1332010	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ADIPOR1 mRNA	PMID:17555576
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D005947	Glucose results in decreased expression of ADIPOR1 mRNA; Glucose results in decreased expression of ADIPOR1 protein	PMID:24413998
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D005947	FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]	PMID:24413998
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:42977	25-hydroxycholesterol	decreases expression	ISO	RGD:1344545	E	RGD:6480464	20120412	CTD	MESH:C007997	25-hydroxycholesterol results in decreased expression of ADIPOR1 mRNA	PMID:16023994
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:42977	25-hydroxycholesterol	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20120412	CTD	MESH:C007997	[25-hydroxycholesterol co-treated with alitretinoin] results in decreased expression of ADIPOR1 mRNA	PMID:16023994
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1344545	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of ADIPOR1 mRNA	PMID:17400583
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1344545	E	RGD:6480464	20150825	CTD	MESH:D000082	ADIPOR1 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1344545	E	RGD:6480464	20220906	CTD	MESH:D001151	Arsenic results in decreased expression of ADIPOR1 mRNA	PMID:31864032
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADIPOR1 mRNA	PMID:39836092
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:47612	bezafibrate	increases expression	ISO	RGD:1332010	E	RGD:6480464	20120613	CTD	MESH:D001629	Bezafibrate results in increased expression of ADIPOR1 mRNA	PMID:16574099
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1332010	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ADIPOR1 mRNA	PMID:17555576
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1332010	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADIPOR1 mRNA	PMID:17942748
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1332010	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADIPOR1 mRNA	PMID:17942748
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:50648	9-cis-retinoic acid	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20191114	CTD	MESH:C103303	[25-hydroxycholesterol co-treated with Alitretinoin] results in decreased expression of ADIPOR1 mRNA	PMID:16023994
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of ADIPOR1 mRNA	PMID:41580965
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ADIPOR1 mRNA	PMID:17183730
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:64042	3-aminobenzamide	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C025160	3-aminobenzamide results in increased expression of ADIPOR1 mRNA	PMID:18815186
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:64042	3-aminobenzamide	increases expression	ISO	RGD:1332010	E	RGD:6480464	20200211	CTD	MESH:C025160	3-aminobenzamide results in increased expression of ADIPOR1 mRNA	PMID:18815186
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:6698	(-)-matairesinol	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20230404	CTD	MESH:C068935	matairesinol binds to and results in increased activity of ADIPOR1 protein	PMID:23691032
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin results in increased expression of ADIPOR1 mRNA	PMID:29991592
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:6842	methoxychlor	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D008731	Methoxychlor results in decreased expression of ADIPOR1 mRNA	PMID:27103539
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1332010	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol inhibits the reaction [Ethanol results in decreased expression of ADIPOR1 mRNA]	PMID:28935932
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332010	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADIPOR1 mRNA	PMID:22206623
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:79	(-)-Arctigenin	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20230404	CTD	MESH:C071942	arctigenin binds to and results in increased activity of ADIPOR1 protein	PMID:23691032
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:7931	paricalcitol	increases expression	ISO	RGD:1332010	E	RGD:6480464	20161213	CTD	MESH:C084656	paricalcitol results in increased expression of ADIPOR1 protein	PMID:25037058
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ADIPOR1 gene]	PMID:28238834
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:80793	Arctiin	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20230404	CTD	MESH:C077992	arctiin binds to and results in increased activity of ADIPOR1 protein	PMID:23691032
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:81860	Sodium oleate	multiple interactions	ISO	RGD:1344545	E	RGD:6480464	20201215	CTD	MESH:C013173	[osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOR1 protein; MRI-1867 inhibits the reaction [[osteum co-treated with Palmitic Acid] results in decreased expression of ADIPOR1 protein]	PMID:31454063
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of ADIPOR1 protein	PMID:28903499
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:82195	Clofop	decreases expression	ISO	RGD:1344545	E	RGD:6480464	20141111	CTD	MESH:C006012	fenofibric acid results in decreased expression of ADIPOR1 protein	PMID:16023994
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ADIPOR1 mRNA	PMID:19281266
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:9288	streptozocin	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013311	Streptozocin results in decreased expression of ADIPOR1 protein	PMID:17270171|PMID:24413998
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013311	Streptozocin results in increased expression of ADIPOR1 protein	PMID:29274332
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D013311	1,3-dimethoxy-5-methyl-2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)benzene inhibits the reaction [4-(3-3,4-p-menthadien-(1,8)-yl)olivetol inhibits the reaction [Streptozocin results in increased expression of ADIPOR1 protein]]; 4-(3-3,4-p-menthadien-(1,8)-yl)olivetol inhibits the reaction [Streptozocin results in increased expression of ADIPOR1 protein]; Resveratrol inhibits the reaction [Streptozocin results in decreased expression of ADIPOR1 protein]	PMID:24413998|PMID:29274332
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1344545	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ADIPOR1 mRNA	PMID:29301935
1303151	Adipor1	adiponectin receptor 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1344545	E	RGD:6480464	20120412	CTD	MESH:C057693	troglitazone results in decreased expression of ADIPOR1 protein	PMID:16023994
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550934	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ENC1 mRNA	PMID:20188158
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:149906	Tanshinone I	increases expression	ISO	RGD:1352868	E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone results in increased expression of ENC1 mRNA	PMID:15849732
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ENC1 mRNA	PMID:20938992
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of ENC1 mRNA	PMID:21934132|PMID:23830798|PMID:33167477
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of ENC1 mRNA	PMID:16604517
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1352868	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ENC1 mRNA	PMID:23724009
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ENC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ENC1 mRNA	PMID:32699268
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENC1 mRNA	PMID:30529165
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ENC1 gene	PMID:35440735
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D003634	DDT results in decreased expression of ENC1 mRNA	PMID:19797855
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16130	DDT	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased expression of ENC1 mRNA	PMID:30207508
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ENC1 mRNA	PMID:20044591
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1352868	E	RGD:6480464	20210810	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ENC1 mRNA	PMID:32949572
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in decreased expression of ENC1 mRNA	PMID:18007998
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16412	lipopolysaccharide	affects expression	ISO	RGD:1352868	E	RGD:6480464	20180313	CTD	MESH:D008070	Lipopolysaccharides affects the expression of ENC1 mRNA	PMID:28070326
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ENC1 mRNA	PMID:39241906
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of ENC1 mRNA; Plant Extracts affects the reaction [Lipopolysaccharides affects the expression of ENC1 mRNA]	PMID:26667767|PMID:28070326
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of ENC1 mRNA	PMID:14699072
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of ENC1 mRNA	PMID:20068009
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of ENC1 mRNA	PMID:25321415
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of ENC1 mRNA	PMID:32145629
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550934	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ENC1 mRNA	PMID:39298647
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of ENC1 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of ENC1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ENC1 mRNA	PMID:17404688|PMID:20660070|PMID:30165855
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16482	naphthalene	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C031721	naphthalene analog results in increased expression of ENC1 mRNA	PMID:24976557
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ENC1 mRNA	PMID:25510870
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of ENC1 mRNA	PMID:33711761
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16573	carbonyl sulfide	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C010063	carbonyl sulfide results in increased expression of ENC1 mRNA	PMID:19395590
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1352868	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ENC1 mRNA	PMID:38568856
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16602	trichloroethene	affects expression	ISO	RGD:1550934	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene affects the expression of ENC1 mRNA	PMID:21135412
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1550934	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of ENC1 mRNA	PMID:25549359
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ENC1 mRNA	PMID:20938992
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1352868	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ENC1 mRNA	PMID:37042841
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16708	adenine	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of ENC1 mRNA	PMID:24211769
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1352868	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of ENC1 mRNA	PMID:19162166
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20200804	CTD	MESH:D002635	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA	PMID:32152650
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of ENC1 mRNA	PMID:28937961
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1352868	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of ENC1 mRNA	PMID:23649840|PMID:27664576
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of ENC1 mRNA	PMID:17404688
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of ENC1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of ENC1 mRNA	PMID:17404688|PMID:20660070
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1352868	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ENC1 mRNA	PMID:21179406
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1550934	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of ENC1 mRNA	PMID:33848595
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1550934	E	RGD:6480464	20121113	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of ENC1 mRNA	PMID:21607683
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20200804	CTD	MESH:D006000	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA	PMID:32152650
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of ENC1 mRNA	PMID:17997037
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ENC1 mRNA	PMID:34319233
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550934	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ENC1 mRNA	PMID:21318169
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ENC1 mRNA	PMID:39150890
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ENC1 mRNA	PMID:33387578
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of ENC1 mRNA	PMID:17997037
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:188736	Archazolid B	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20220104	CTD	MESH:C519728	archazolid B results in decreased expression of ENC1 mRNA	PMID:25218289
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:193591	Didecyldimethylammonium	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in decreased expression of ENC1 mRNA	PMID:32763356
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ENC1 mRNA	PMID:35301059
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ENC1 mRNA	PMID:37236586
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ENC1 mRNA	PMID:25510870
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ENC1 mRNA	PMID:25510870
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1352868	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ENC1 mRNA	PMID:19549813
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1352868	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ENC1 mRNA	PMID:23649840
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ENC1 mRNA	PMID:21396975
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ENC1 mRNA	PMID:22129741
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ENC1 protein	PMID:20106945
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ENC1 mRNA	PMID:22484513|PMID:23385219|PMID:23630614|PMID:25378103
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1352868	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ENC1 mRNA	PMID:22100608|PMID:27153756
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1352868	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ENC1 promoter	PMID:30157460
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1352868	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ENC1 mRNA	PMID:23649840
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of ENC1 mRNA	PMID:15651846
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ENC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ENC1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ENC1 mRNA	PMID:32699268
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ENC1 mRNA	PMID:27106289
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of ENC1 mRNA	PMID:19483382
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ENC1 mRNA	PMID:31150632
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550934	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ENC1 mRNA	PMID:17484886
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ENC1 mRNA	PMID:25629700
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ENC1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ENC1 mRNA	PMID:20938992|PMID:22206623
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20200804	CTD	MESH:D006002	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA	PMID:32152650
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ENC1 mRNA	PMID:40512198
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ENC1 mRNA	PMID:40504410
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D003513	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in decreased expression of ENC1 mRNA	PMID:19684285
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ENC1 mRNA	PMID:38460933
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ENC1 mRNA	PMID:27188386
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ENC1 mRNA	PMID:31881176
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of ENC1 mRNA	PMID:12002526
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of ENC1 mRNA	PMID:12569576
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of ENC1 mRNA; [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ENC1 mRNA	PMID:19167446|PMID:26667767
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27882	(S)-colchicine	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of ENC1 mRNA	PMID:24211769
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1550934	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ENC1 mRNA	PMID:40618947
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of ENC1 mRNA	PMID:17898221
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of ENC1 mRNA	PMID:18930951
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of ENC1 mRNA	PMID:22228119
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550934	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ENC1 mRNA	PMID:21570461
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ENC1 mRNA	PMID:33387578|PMID:34747641
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ENC1 mRNA	PMID:19684285
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ENC1 mRNA	PMID:21215274
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in decreased expression of ENC1 mRNA	PMID:19684285
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of ENC1 mRNA	PMID:19013527
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1352868	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ENC1 mRNA	PMID:26272509|PMID:28001369
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ENC1 mRNA	PMID:30851411
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20120814	CTD	MESH:D003300	[Copper results in increased activity of TP53 protein] which results in increased expression of ENC1 mRNA	PMID:16391388
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1352868	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ENC1 mRNA	PMID:29803840|PMID:30031762
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550934	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of ENC1 mRNA	PMID:25896364|PMID:39631538
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20200804	CTD	MESH:D003840	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA	PMID:32152650
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ENC1 mRNA	PMID:20044591
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1352868	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ENC1 gene	PMID:28589171
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ENC1 mRNA	PMID:39719251
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352868	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ENC1 mRNA	PMID:29301061
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ENC1 mRNA	PMID:40512198
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ENC1 mRNA	PMID:40504410
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ENC1 mRNA	PMID:22378314|PMID:29453283
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ENC1 mRNA	PMID:21839799
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ENC1 mRNA	PMID:20064835|PMID:32234424
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550934	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ENC1 mRNA	PMID:22610609
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352868	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ENC1 3' UTR	PMID:27901495
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:29866	arsenite(3-)	affects expression	ISO	RGD:1352868	E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of ENC1 mRNA	PMID:22959463
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20120814	CTD	MESH:D003300	[Copper results in increased activity of TP53 protein] which results in increased expression of ENC1 mRNA	PMID:16391388
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of ENC1 mRNA	PMID:19483382
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ENC1 mRNA	PMID:19073995
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1352868	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ENC1 mRNA; Silicon Dioxide results in increased expression of ENC1 mRNA	PMID:25351596|PMID:25895662
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ENC1 mRNA	PMID:20018196
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ENC1 mRNA	PMID:22521957
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ENC1 mRNA	PMID:24136188
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in decreased expression of ENC1 mRNA	PMID:17997037
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of ENC1 mRNA	PMID:25729387
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of ENC1 mRNA	PMID:25729387
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550934	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ENC1 gene	PMID:35295148
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550934	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ENC1 promoter	PMID:35295148
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of ENC1 mRNA	PMID:19483382
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ENC1 mRNA	PMID:23411599|PMID:34492290
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ENC1 mRNA	PMID:28943392
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ENC1 mRNA	PMID:25380136|PMID:30723492
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ENC1 mRNA	PMID:19483382
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550934	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ENC1 mRNA	PMID:17690133|PMID:18301758|PMID:18445702|PMID:21318169|PMID:23811191
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ENC1 mRNA	PMID:19710929
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ENC1 mRNA; PPARA protein affects the reaction [pirinixic acid results in increased expression of ENC1 mRNA]	PMID:19710929|PMID:21318169
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550934	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ENC1 mRNA	PMID:28472532
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of ENC1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of ENC1 mRNA]	PMID:28329830
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ENC1 mRNA	PMID:25181051|PMID:32145629
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of ENC1 mRNA	PMID:20170705|PMID:30903817
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of ENC1 mRNA	PMID:18007998|PMID:29275510
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of ENC1 mRNA	PMID:38750585
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550934	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ENC1 mRNA	PMID:26063408
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ENC1 mRNA	PMID:36041667
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:3390	carbaryl	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20170516	CTD	MESH:D012721	Carbaryl results in decreased expression of ENC1 mRNA	PMID:27829164
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1550934	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of ENC1 mRNA	PMID:26682919
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ENC1 mRNA	PMID:25510870
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ENC1 mRNA	PMID:25510870
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:3423	carmustine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of ENC1 mRNA	PMID:16005536
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ENC1 mRNA	PMID:32119087
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550934	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ENC1 mRNA	PMID:40203079
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ENC1 mRNA	PMID:36041667
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ENC1 mRNA	PMID:36041667
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ENC1 mRNA	PMID:39150890
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550934	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ENC1 mRNA	PMID:21266533
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ENC1 mRNA	PMID:39150890
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ENC1 mRNA	PMID:39150890
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ENC1 mRNA	PMID:19638242
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550934	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ENC1 mRNA	PMID:21607683|PMID:24535843
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ENC1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ENC1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ENC1 mRNA	PMID:18164116|PMID:22129741|PMID:28943392
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of ENC1 mRNA	PMID:22110744
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ENC1 mRNA	PMID:32680482
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of ENC1 mRNA	PMID:30589522
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352868	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ENC1 mRNA	PMID:37042841
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:351346	phenethyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in increased expression of ENC1 mRNA	PMID:17616710
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of ENC1 mRNA	PMID:18500788
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ENC1 mRNA	PMID:25380136
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ENC1 mRNA	PMID:25993096
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ENC1 mRNA	PMID:35301059
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ENC1 mRNA	PMID:37236586
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ENC1 mRNA	PMID:39150890
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of ENC1 mRNA	PMID:26194646
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1550934	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of ENC1 mRNA	PMID:24183702
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35572	phorone	affects expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C018637	phorone affects the expression of ENC1 mRNA	PMID:18198479
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ENC1 mRNA	PMID:19320972
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of ENC1 mRNA	PMID:25380136
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20200804	CTD	MESH:D005999	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA	PMID:32152650
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1550934	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of ENC1 mRNA	PMID:28962523
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1550934	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of ENC1 mRNA	PMID:18353800
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ENC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ENC1 mRNA	PMID:32699268
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of ENC1 mRNA	PMID:19483382
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1550934	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of ENC1 mRNA	PMID:23811191
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ENC1 mRNA	PMID:40194260
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ENC1 mRNA	PMID:31533062
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ENC1 mRNA	PMID:19167446
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ENC1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ENC1 mRNA	PMID:19167446
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of ENC1 mRNA	PMID:25993096
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1550934	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of ENC1 mRNA	PMID:22155349
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1352868	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ENC1 mRNA	PMID:25979313
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in decreased expression of ENC1 mRNA	PMID:23527032|PMID:29154799
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1550934	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of ENC1 mRNA	PMID:20546886
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1352868	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ENC1 gene	PMID:29154799
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1352868	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ENC1 mRNA	PMID:24383497|PMID:28001369
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of ENC1 mRNA	PMID:38685447
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ENC1 mRNA	PMID:20106945|PMID:22147139|PMID:25562108|PMID:27989131
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA	PMID:32152650
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ENC1 mRNA	PMID:14699072
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR1 protein] results in decreased expression of ENC1 mRNA; [Tamoxifen co-treated with ESR2 protein] results in increased expression of ENC1 mRNA	PMID:19059307
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550934	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ENC1 mRNA	PMID:28973697
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:43602	obeticholic acid	increases expression	ISO	RGD:1352868	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in increased expression of ENC1 mRNA	PMID:27939613
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased expression of ENC1 mRNA	PMID:16005536
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ENC1 mRNA	PMID:24136188
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of ENC1 mRNA]	PMID:21233418
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1352868	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ENC1 mRNA	PMID:38832940
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of ENC1 mRNA	PMID:27188386
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1352868	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ENC1 mRNA	PMID:26272509
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1352868	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ENC1 mRNA	PMID:24935251|PMID:26272509
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20120613	CTD	MESH:C012589	[[Decitabine co-treated with trichostatin A] affects the methylation of ENC1 promoter] which affects the expression of ENC1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ENC1 mRNA	PMID:18803327|PMID:27188386
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550934	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ENC1 mRNA	PMID:17562736
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ENC1 mRNA	PMID:33387578
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ENC1 mRNA	PMID:22230336
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1352868	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ENC1 mRNA	PMID:29067470
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1352868	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ENC1 mRNA	PMID:25351596
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1550934	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ENC1 mRNA	PMID:19446018
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ENC1 mRNA	PMID:38460933
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ENC1 mRNA	PMID:40512198
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ENC1 mRNA	PMID:40504410
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1352868	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of ENC1 mRNA	PMID:31838189
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ENC1 mRNA	PMID:29391264
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550934	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ENC1 mRNA	PMID:35436446
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of ENC1 mRNA	PMID:19483382
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ENC1 mRNA	PMID:20170705
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ENC1 mRNA	PMID:18936297
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ENC1 mRNA	PMID:17351261
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1352868	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of ENC1 mRNA	PMID:38568856
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ENC1 mRNA	PMID:22521957
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1550934	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of ENC1 mRNA	PMID:21318169
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in increased expression of ENC1 mRNA]	PMID:21318169
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20191114	CTD	MESH:C014347	[[Decitabine co-treated with trichostatin A] affects the methylation of ENC1 promoter] which affects the expression of ENC1 mRNA	PMID:18803327
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550934	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ENC1 mRNA; Nanotubes, Carbon results in increased expression of ENC1 mRNA	PMID:25554681
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ENC1 mRNA	PMID:30047161
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:50692	mifepristone	increases expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of ENC1 mRNA	PMID:17584828
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:50729	mitoxantrone	affects response to substance	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:D008942	ENC1 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ENC1 mRNA	PMID:24793618
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of ENC1 mRNA	PMID:16780908
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of ENC1 mRNA	PMID:28801915
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:63598	levofloxacin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in increased expression of ENC1 mRNA	PMID:24136188
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of ENC1 mRNA	PMID:25729387
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of ENC1 mRNA	PMID:25729387
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of ENC1 mRNA	PMID:24136188
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1352868	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ENC1 mRNA	PMID:28988120
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1550934	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ENC1 mRNA	PMID:20003209
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ENC1 mRNA	PMID:30467583
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008701	Methapyrilene results in increased expression of ENC1 mRNA	PMID:22484513
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:69355	casticin	increases expression	ISO	RGD:1352868	E	RGD:6480464	20170516	CTD	MESH:C054133	casticin results in increased expression of ENC1 mRNA	PMID:27862857
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1352868	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ENC1 mRNA	PMID:31758290
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of ENC1 mRNA	PMID:27840820
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ENC1 mRNA	PMID:22206623
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in decreased expression of ENC1 mRNA	PMID:32152650
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:7494	nefazodone	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ENC1 mRNA	PMID:32152650
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ENC1 mRNA	PMID:18164116
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of ENC1 mRNA	PMID:19483382
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of ENC1 mRNA	PMID:19483382
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ENC1 mRNA	PMID:30851411
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ENC1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ENC1 mRNA	PMID:27188386
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ENC1 mRNA	PMID:39150890
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ENC1 mRNA	PMID:19167446
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550934	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ENC1 mRNA	PMID:38648751
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1352868	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of ENC1 mRNA	PMID:32234424
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550934	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ENC1 mRNA	PMID:39847705
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of ENC1 mRNA	PMID:19483382
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ENC1 mRNA	PMID:30047161
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1352868	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of ENC1 mRNA	PMID:14699072
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR1 protein] results in decreased expression of ENC1 mRNA; [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of ENC1 mRNA	PMID:19059307
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1550934	E	RGD:6480464	20170725	CTD	MESH:C093642	SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of ENC1 mRNA]	PMID:28329830
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1352868	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ENC1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ENC1 mRNA	PMID:27188386
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ENC1 mRNA	PMID:19281266
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ENC1 mRNA	PMID:21346803
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1352868	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ENC1 mRNA	PMID:38568856
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1352868	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ENC1 mRNA	PMID:29301935
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1352868	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of ENC1 mRNA	PMID:22378314
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:9555	tioguanine	increases expression	EXP		E	RGD:6480464	20130305	CTD	MESH:D013866	Thioguanine results in increased expression of ENC1 mRNA	PMID:16005536
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ENC1 mRNA	PMID:21346803
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1550934	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of ENC1 mRNA	PMID:32835833
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1550934	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of ENC1 mRNA	PMID:28973697
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ENC1 mRNA	PMID:19015723
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ENC1 mRNA	PMID:23034163
1303152	Enc1	ectodermal-neural cortex 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C025643	vinclozolin results in increased expression of ENC1 mRNA	PMID:30207508
1303153	Or12d17	olfactory receptor family 12 subfamily D member 17	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352207	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of OR12D3 mRNA	PMID:29301061
1303153	Or12d17	olfactory receptor family 12 subfamily D member 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1352207	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of OR12D3 exon	PMID:27901495
1303153	Or12d17	olfactory receptor family 12 subfamily D member 17	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1352207	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of OR12D3 gene	PMID:31601247
1303153	Or12d17	olfactory receptor family 12 subfamily D member 17	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:C006780	bisphenol A results in decreased expression of OR12D17 mRNA	PMID:25181051
1303153	Or12d17	olfactory receptor family 12 subfamily D member 17	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1352207	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of OR12D3 mRNA	PMID:26690555
1303153	Or12d17	olfactory receptor family 12 subfamily D member 17	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1352207	E	RGD:6480464	20131220	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of OR12D3 mRNA	PMID:17331233
1303153	Or12d17	olfactory receptor family 12 subfamily D member 17	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1622895	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of OR12D17 mRNA	PMID:35436446
1303153	Or12d17	olfactory receptor family 12 subfamily D member 17	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352207	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to OR12D3 gene]	PMID:28238834
1303154	Rnf141	ring finger protein 141	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of RNF141 mRNA	PMID:21551480
1303154	Rnf141	ring finger protein 141	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF141 mRNA]	PMID:31150632
1303154	Rnf141	ring finger protein 141	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550951	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RNF141 mRNA	PMID:26251327
1303154	Rnf141	ring finger protein 141	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550951	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RNF141 mRNA	PMID:20188158
1303154	Rnf141	ring finger protein 141	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of RNF141 mRNA	PMID:19937285
1303154	Rnf141	ring finger protein 141	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550951	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of RNF141 mRNA	PMID:30319688
1303154	Rnf141	ring finger protein 141	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1350770	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RNF141 mRNA	PMID:21632981
1303154	Rnf141	ring finger protein 141	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of RNF141 mRNA	PMID:32145629
1303154	Rnf141	ring finger protein 141	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550951	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RNF141 mRNA	PMID:39298647
1303154	Rnf141	ring finger protein 141	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550951	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RNF141 mRNA	PMID:25510870
1303154	Rnf141	ring finger protein 141	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350770	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RNF141 mRNA	PMID:37042841
1303154	Rnf141	ring finger protein 141	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1350770	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF141 mRNA	PMID:39836092
1303154	Rnf141	ring finger protein 141	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550951	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RNF141 mRNA	PMID:25510870
1303154	Rnf141	ring finger protein 141	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550951	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RNF141 mRNA	PMID:25510870
1303154	Rnf141	ring finger protein 141	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1350770	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RNF141 gene	PMID:27153756
1303154	Rnf141	ring finger protein 141	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550951	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RNF141 mRNA	PMID:19770486
1303154	Rnf141	ring finger protein 141	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of RNF141 mRNA	PMID:19937285
1303154	Rnf141	ring finger protein 141	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RNF141 mRNA	PMID:30779732
1303154	Rnf141	ring finger protein 141	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RNF141 mRNA	PMID:31150632
1303154	Rnf141	ring finger protein 141	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF141 mRNA]	PMID:31150632
1303154	Rnf141	ring finger protein 141	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RNF141 mRNA	PMID:21867686
1303154	Rnf141	ring finger protein 141	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550951	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RNF141 mRNA	PMID:25629700
1303154	Rnf141	ring finger protein 141	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550951	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF141 mRNA	PMID:22206623
1303154	Rnf141	ring finger protein 141	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1350770	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF141 mRNA	PMID:39836092
1303154	Rnf141	ring finger protein 141	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RNF141 mRNA	PMID:31881176
1303154	Rnf141	ring finger protein 141	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1350770	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RNF141 mRNA	PMID:23557933
1303154	Rnf141	ring finger protein 141	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550951	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF141 mRNA	PMID:16962184|PMID:21570461
1303154	Rnf141	ring finger protein 141	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF141 mRNA	PMID:21215274
1303154	Rnf141	ring finger protein 141	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of RNF141 mRNA	PMID:32763439
1303154	Rnf141	ring finger protein 141	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF141 mRNA	PMID:29803840
1303154	Rnf141	ring finger protein 141	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1350770	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RNF141 gene	PMID:28589171
1303154	Rnf141	ring finger protein 141	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1350770	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF141 mRNA	PMID:39836092
1303154	Rnf141	ring finger protein 141	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550951	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF141 mRNA	PMID:22228805
1303154	Rnf141	ring finger protein 141	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350770	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF141 promoter	PMID:27901495
1303154	Rnf141	ring finger protein 141	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1350770	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RNF141 mRNA]	PMID:32406909
1303154	Rnf141	ring finger protein 141	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1350770	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of RNF141 mRNA	PMID:25075043
1303154	Rnf141	ring finger protein 141	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RNF141 mRNA	PMID:34492290
1303154	Rnf141	ring finger protein 141	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1550951	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RNF141 mRNA	PMID:18648102
1303154	Rnf141	ring finger protein 141	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550951	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RNF141 mRNA	PMID:19710929
1303154	Rnf141	ring finger protein 141	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF141 mRNA	PMID:25181051
1303154	Rnf141	ring finger protein 141	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RNF141 mRNA	PMID:32145629|PMID:34947998
1303154	Rnf141	ring finger protein 141	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1350770	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RNF141 mRNA	PMID:25047013
1303154	Rnf141	ring finger protein 141	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF141 gene	PMID:28505145
1303154	Rnf141	ring finger protein 141	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550951	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RNF141 mRNA	PMID:25510870
1303154	Rnf141	ring finger protein 141	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550951	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RNF141 mRNA	PMID:25510870
1303154	Rnf141	ring finger protein 141	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550951	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RNF141 mRNA	PMID:39298647
1303154	Rnf141	ring finger protein 141	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550951	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RNF141 mRNA	PMID:38685157
1303154	Rnf141	ring finger protein 141	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1550951	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of RNF141 mRNA]	PMID:19030233
1303154	Rnf141	ring finger protein 141	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350770	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNF141 mRNA	PMID:37042841
1303154	Rnf141	ring finger protein 141	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1350770	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF141 mRNA	PMID:39836092
1303154	Rnf141	ring finger protein 141	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RNF141 promoter	PMID:22457795
1303154	Rnf141	ring finger protein 141	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RNF141 mRNA	PMID:19376846
1303154	Rnf141	ring finger protein 141	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RNF141 mRNA	PMID:24449571
1303154	Rnf141	ring finger protein 141	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550951	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RNF141 mRNA	PMID:40194260
1303154	Rnf141	ring finger protein 141	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RNF141 mRNA	PMID:28302478
1303154	Rnf141	ring finger protein 141	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RNF141 mRNA	PMID:40419075
1303154	Rnf141	ring finger protein 141	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350770	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RNF141 mRNA	PMID:25979313
1303154	Rnf141	ring finger protein 141	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1350770	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of RNF141 mRNA	PMID:25047013
1303154	Rnf141	ring finger protein 141	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of RNF141 mRNA	PMID:36621641
1303154	Rnf141	ring finger protein 141	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550951	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of RNF141 mRNA	PMID:28973697
1303154	Rnf141	ring finger protein 141	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550951	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF141 mRNA	PMID:17562736
1303154	Rnf141	ring finger protein 141	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1350770	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF141 mRNA	PMID:22230336
1303154	Rnf141	ring finger protein 141	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of RNF141 mRNA	PMID:20977926
1303154	Rnf141	ring finger protein 141	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1350770	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF141 mRNA	PMID:39836092
1303154	Rnf141	ring finger protein 141	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RNF141 mRNA	PMID:29391264
1303154	Rnf141	ring finger protein 141	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1350770	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of RNF141 mRNA	PMID:25075043
1303154	Rnf141	ring finger protein 141	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550951	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RNF141 mRNA; Nanotubes, Carbon results in decreased expression of RNF141 mRNA	PMID:25620056
1303154	Rnf141	ring finger protein 141	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1350770	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF141 mRNA	PMID:39836092
1303154	Rnf141	ring finger protein 141	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1350770	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RNF141 mRNA	PMID:28988120
1303154	Rnf141	ring finger protein 141	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RNF141 mRNA	PMID:28801915
1303154	Rnf141	ring finger protein 141	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550951	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RNF141 mRNA	PMID:22206623
1303154	Rnf141	ring finger protein 141	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550951	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF141 mRNA	PMID:22206623
1303154	Rnf141	ring finger protein 141	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of RNF141 mRNA	PMID:26923065
1303154	Rnf141	ring finger protein 141	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RNF141 mRNA	PMID:24780913
1303154	Rnf141	ring finger protein 141	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of RNF141 protein	PMID:19059321
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1346637	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of OXGR1 protein]	PMID:38195004
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346637	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of OXGR1 mRNA	PMID:23724009
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1346637	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of OXGR1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of OXGR1 protein	PMID:38195004
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346637	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of OXGR1 gene	PMID:27153756
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1346637	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of OXGR1 mRNA	PMID:22100608
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1346637	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of OXGR1 mRNA	PMID:25583101
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550957	E	RGD:6480464	20250708	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OXGR1 mRNA	PMID:39401686
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346637	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of OXGR1 mRNA	PMID:34032870
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1346637	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of OXGR1 mRNA	PMID:32234424
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346637	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OXGR1 5' UTR; Benzo(a)pyrene results in increased methylation of OXGR1 promoter	PMID:27901495
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1346637	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of OXGR1 mRNA	PMID:35984750
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1550957	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of OXGR1 mRNA	PMID:18648102
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of OXGR1 promoter	PMID:27415467
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OXGR1 mRNA	PMID:25181051
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of OXGR1 gene	PMID:28505145
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550957	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of OXGR1 mRNA	PMID:26682919
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of OXGR1 mRNA	PMID:18500788
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1346637	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of OXGR1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of OXGR1 protein	PMID:38195004
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550957	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of OXGR1 mRNA	PMID:40194260
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1346637	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of OXGR1 gene	PMID:29154799
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1346637	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of OXGR1 mRNA	PMID:24449571
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1346637	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of OXGR1 mRNA	PMID:38832940
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1346637	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of OXGR1 mRNA	PMID:22079614
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of OXGR1 mRNA	PMID:19564919
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of OXGR1 mRNA	PMID:19564919
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:73297	SCH 23390	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in increased expression of OXGR1 mRNA	PMID:19564919
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of OXGR1 mRNA	PMID:19564919
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of OXGR1 mRNA	PMID:27840820
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of OXGR1 promoter	PMID:27415467
1303155	Oxgr1	oxoglutarate receptor 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346637	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to OXGR1 gene]	PMID:28238834
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552932	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of NPDC1 mRNA	PMID:37995155
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NPDC1 mRNA	PMID:20938992
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1353727	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NPDC1 mRNA	PMID:22378314
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1552932	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of NPDC1 mRNA	PMID:40945087
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552932	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of NPDC1 mRNA	PMID:30319688
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of NPDC1 mRNA	PMID:32145629
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1353727	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of NPDC1 mRNA	PMID:30165855
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NPDC1 mRNA	PMID:33387578
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NPDC1 mRNA	PMID:20938992
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NPDC1 mRNA	PMID:37992649
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1552932	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in increased expression of NPDC1 mRNA	PMID:19693291
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NPDC1 mRNA	PMID:37992649
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552932	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NPDC1 mRNA	PMID:33754040
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1353727	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of NPDC1 protein	PMID:37730182
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NPDC1 mRNA	PMID:36331819
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1353727	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of NPDC1 mRNA	PMID:24376830
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1353727	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of NPDC1 mRNA	PMID:19549813
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NPDC1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NPDC1 mRNA	PMID:20938992|PMID:22206623
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:27779	griseofulvin	affects expression	ISO	RGD:1552932	E	RGD:6480464	20120412	CTD	MESH:D006118	Griseofulvin affects the expression of NPDC1 mRNA	PMID:12735108
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NPDC1 mRNA	PMID:31881176
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1353727	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of NPDC1 mRNA	PMID:23557933
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1552932	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of NPDC1 mRNA	PMID:18930951
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NPDC1 mRNA	PMID:34747641
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552932	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NPDC1 mRNA	PMID:21570461|PMID:24680724|PMID:26377647
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NPDC1 mRNA	PMID:21215274|PMID:33387578
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of NPDC1 mRNA	PMID:19013527
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1353727	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NPDC1 mRNA	PMID:32763439
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1353727	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NPDC1 mRNA	PMID:29803840
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NPDC1 mRNA	PMID:37992649
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353727	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of NPDC1 mRNA	PMID:34032870
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552932	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of NPDC1 mRNA	PMID:37682722
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353727	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of NPDC1 mRNA	PMID:39719251
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1353727	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NPDC1 promoter	PMID:27901495
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1552932	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NPDC1 3' UTR; Benzo(a)pyrene results in decreased methylation of NPDC1 exon; Benzo(a)pyrene results in decreased methylation of NPDC1 intron	PMID:27901495
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552932	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NPDC1 mRNA	PMID:22228805
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:31236	aripiprazole	decreases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C094645	Aripiprazole results in decreased expression of NPDC1 mRNA	PMID:17868501
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of NPDC1 mRNA	PMID:24136188
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of NPDC1 mRNA	PMID:25729387
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552932	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NPDC1 gene; titanium dioxide results in decreased methylation of NPDC1 promoter	PMID:35295148
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NPDC1 mRNA	PMID:23411599|PMID:34492290
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of NPDC1 mRNA	PMID:28943392
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NPDC1 mRNA	PMID:25380136
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552932	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of NPDC1 mRNA	PMID:17426115
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552932	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NPDC1 mRNA	PMID:23811191
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NPDC1 mRNA	PMID:25181051
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of NPDC1 mRNA	PMID:32145629
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NPDC1 mRNA	PMID:30816183|PMID:34947998
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NPDC1 gene	PMID:28505145
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1552932	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of NPDC1 mRNA	PMID:26682919
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552932	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NPDC1 mRNA	PMID:39298647|PMID:40203079
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1353727	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of NPDC1 gene	PMID:31601247
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552932	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NPDC1 mRNA	PMID:37019170
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of NPDC1 mRNA	PMID:21266533
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NPDC1 mRNA	PMID:19638242
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1552932	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NPDC1 mRNA	PMID:24535843
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NPDC1 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of NPDC1 mRNA	PMID:18164116|PMID:28943392
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NPDC1 mRNA	PMID:24535843
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of NPDC1 mRNA	PMID:25380136|PMID:30723492
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NPDC1 mRNA	PMID:25993096
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of NPDC1 mRNA	PMID:25539665|PMID:26194646|PMID:27387713
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:37825	p-toluidine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of NPDC1 mRNA	PMID:27638505
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NPDC1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NPDC1 mRNA	PMID:36331819
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353727	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NPDC1 mRNA	PMID:25979313
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1353727	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NPDC1 gene	PMID:29154799
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1353727	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of NPDC1 mRNA	PMID:17183730
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of NPDC1 mRNA	PMID:41580965
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1353727	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of NPDC1 mRNA	PMID:27989131
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1353727	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of NPDC1 mRNA	PMID:33512557
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552932	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NPDC1 mRNA	PMID:28973697
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NPDC1 mRNA	PMID:37992649
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1353727	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of NPDC1 mRNA	PMID:33512557
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1353727	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of NPDC1 mRNA	PMID:27188386
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552932	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NPDC1 mRNA	PMID:17562736
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NPDC1 mRNA	PMID:17557909
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1552932	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of NPDC1 mRNA	PMID:19042947
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1353727	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of NPDC1 mRNA	PMID:17183730
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of NPDC1 mRNA	PMID:25729387
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of NPDC1 mRNA	PMID:25729387
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1353727	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NPDC1 mRNA	PMID:31758290
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NPDC1 mRNA	PMID:22206623
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NPDC1 mRNA	PMID:18164116
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1552932	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of NPDC1 mRNA	PMID:19482888
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1552932	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NPDC1 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NPDC1 mRNA]	PMID:19482888|PMID:24535843
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1552932	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of NPDC1 mRNA	PMID:18958704
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1353727	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of NPDC1 mRNA	PMID:21858171
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1353727	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of NPDC1 mRNA	PMID:33512557
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NPDC1 mRNA	PMID:21346803
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NPDC1 mRNA	PMID:21346803
1303156	Npdc1	neural proliferation, differentiation and control, 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of NPDC1 mRNA	PMID:22570695|PMID:23034163
1303157	Krt24	keratin 24	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1349415	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of KRT24 mRNA	PMID:26079696
1303157	Krt24	keratin 24	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1349415	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of KRT24 mRNA	PMID:30510588
1303157	Krt24	keratin 24	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KRT24 mRNA	PMID:33387578
1303157	Krt24	keratin 24	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1349415	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of KRT24 mRNA	PMID:31256213
1303157	Krt24	keratin 24	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1349415	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KRT24 gene	PMID:27153756
1303157	Krt24	keratin 24	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1349415	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of KRT24 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT24 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT24 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT24 protein	PMID:38598786
1303157	Krt24	keratin 24	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of KRT24 mRNA	PMID:38314887
1303157	Krt24	keratin 24	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of KRT24 gene	PMID:28505145
1303157	Krt24	keratin 24	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1349415	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KRT24 mRNA	PMID:30851411
1303157	Krt24	keratin 24	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1349415	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of KRT24 mRNA	PMID:21198554
1303157	Krt24	keratin 24	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of KRT24 mRNA	PMID:24395379
1303157	Krt24	keratin 24	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of KRT24 mRNA	PMID:30047161
1303157	Krt24	keratin 24	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550968	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of KRT24 mRNA	PMID:19710929
1303157	Krt24	keratin 24	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT24 mRNA	PMID:25181051
1303157	Krt24	keratin 24	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of KRT24 gene	PMID:28505145
1303157	Krt24	keratin 24	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1349415	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT24 protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of KRT24 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of KRT24 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT24 protein	PMID:38598786
1303157	Krt24	keratin 24	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1349415	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KRT24 mRNA	PMID:25812627
1303157	Krt24	keratin 24	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1349415	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of KRT24 mRNA	PMID:25812627
1303157	Krt24	keratin 24	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550968	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of KRT24 mRNA	PMID:17963808
1303157	Krt24	keratin 24	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of KRT24 mRNA	PMID:30047161
1303157	Krt24	keratin 24	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of KRT24 mRNA	PMID:30047161
1303157	Krt24	keratin 24	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1349415	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KRT24 mRNA	PMID:30851411
1303157	Krt24	keratin 24	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KRT24 mRNA	PMID:23914054
1303157	Krt24	keratin 24	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KRT24 mRNA	PMID:30047161
1303157	Krt24	keratin 24	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of KRT24 mRNA	PMID:25825206
1303157	Krt24	keratin 24	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1349415	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT24 protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of KRT24 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT24 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT24 protein	PMID:38598786
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1351353	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of HSD17B8 mRNA	PMID:38218311
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1351353	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of HSD17B8 mRNA	PMID:27188386
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:135937	enzacamene	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C038939	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA	PMID:25607892
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:15846	NAD(+)	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20150414	CTD	MESH:D009243	[Gossypol co-treated with NAD] binds to HSD17B8 protein	PMID:25526675
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1351353	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of HSD17B8 mRNA	PMID:22378314
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of HSD17B8 mRNA	PMID:30165855
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1351353	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of HSD17B8 mRNA	PMID:38568856
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1351353	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HSD17B8 mRNA	PMID:37042841
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of HSD17B8 mRNA	PMID:28973375
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20171010	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HSD17B8 mRNA	PMID:28412506
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HSD17B8 mRNA	PMID:19560483|PMID:26472102
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550967	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HSD17B8 mRNA	PMID:33754040
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HSD17B8 mRNA	PMID:33387578
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of HSD17B8 mRNA	PMID:28818685
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:18009	NADP(+)	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of HSD17B8 protein	PMID:25526675
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HSD17B8 mRNA	PMID:19549813
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D009151	Mustard Gas results in increased expression of HSD17B8 mRNA	PMID:15674844
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of HSD17B8 mRNA	PMID:34911549
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HSD17B8 mRNA	PMID:31919559
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of HSD17B8 mRNA	PMID:22206623
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSD17B8 mRNA	PMID:32525701
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550967	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSD17B8 mRNA	PMID:40504410
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1351353	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HSD17B8 mRNA	PMID:19244175
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of HSD17B8 mRNA	PMID:26272509
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA	PMID:27188386
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1351353	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of HSD17B8 gene	PMID:31636367
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1351353	E	RGD:6480464	20120412	CTD	MESH:D002945	HSD17B8 protein affects the susceptibility to Cisplatin	PMID:16217747
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1351353	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HSD17B8 mRNA	PMID:27392435
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HSD17B8 mRNA	PMID:27392435
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1351353	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in increased expression of HSD17B8 protein	PMID:20884965
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in increased expression of HSD17B8 protein]	PMID:20884965
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HSD17B8 mRNA	PMID:21570461|PMID:24680724
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HSD17B8 mRNA	PMID:21215274
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSD17B8 mRNA	PMID:33387578
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HSD17B8 mRNA	PMID:28001369
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HSD17B8 mRNA	PMID:33212167
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of HSD17B8 mRNA	PMID:30851411
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of HSD17B8 mRNA	PMID:26272509
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA	PMID:27188386
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28584	gossypol	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20150414	CTD	MESH:D006072	[Gossypol co-treated with NAD] binds to HSD17B8 protein	PMID:25526675
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20120717	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of HSD17B8 mRNA]	PMID:18829485
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HSD17B8 mRNA	PMID:38568856
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550967	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSD17B8 mRNA	PMID:40504410
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1351353	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of HSD17B8 mRNA	PMID:29453283
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HSD17B8 mRNA	PMID:32234424
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with perfluorooctane sulfonic acid] results in increased expression of HSD17B8 mRNA	PMID:39423996
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of HSD17B8 mRNA	PMID:27829220
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HSD17B8 mRNA	PMID:34492290
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:C006253	pirinixic acid results in increased expression of HSD17B8 mRNA	PMID:17426115
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of HSD17B8 mRNA	PMID:38479592
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HSD17B8 mRNA	PMID:25181051
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA	PMID:25607892
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1351353	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of HSD17B8 mRNA	PMID:19244175
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550967	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of HSD17B8 mRNA	PMID:39298647|PMID:40203079
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of HSD17B8 mRNA	PMID:21241498
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of HSD17B8 mRNA	PMID:19560483|PMID:26472102
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550967	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of HSD17B8 exon	PMID:28392331
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:34680	dipentyl phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C034171	di-n-pentyl phthalate results in increased expression of HSD17B8 mRNA	PMID:19560483|PMID:26472102
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HSD17B8 mRNA	PMID:19560483|PMID:26472102
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:34698	diethyl phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C007379	diethyl phthalate results in increased expression of HSD17B8 mRNA	PMID:26472102
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	increases expression	ISO	RGD:1351353	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate results in increased expression of HSD17B8 mRNA	PMID:29024780
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HSD17B8 mRNA	PMID:21457566
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of HSD17B8 promoter	PMID:22457795
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:35497	androgen antagonist	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:D000726	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA	PMID:25607892
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of HSD17B8 mRNA	PMID:19376846
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1351353	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HSD17B8 mRNA	PMID:19244175
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HSD17B8 mRNA	PMID:31533062
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1351353	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of HSD17B8 mRNA	PMID:19167446
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C076994	[Benzo(a)pyrene co-treated with perfluorooctane sulfonic acid] results in increased expression of HSD17B8 mRNA	PMID:39423996
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351353	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HSD17B8 mRNA	PMID:25979313
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351353	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of HSD17B8 mRNA	PMID:19101580|PMID:23179753|PMID:27188386|PMID:29154799
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D014635	Valproic Acid results in increased expression of HSD17B8 mRNA	PMID:21427059
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of HSD17B8 mRNA	PMID:41580965
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1351353	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of HSD17B8 mRNA	PMID:27989131
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of HSD17B8 mRNA	PMID:36653537
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550967	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of HSD17B8 mRNA	PMID:28973697
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of HSD17B8 mRNA	PMID:33512557
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:44215	NAD zwitterion	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20150414	CTD	MESH:D009243	[Gossypol co-treated with NAD] binds to HSD17B8 protein	PMID:25526675
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:44409	NADP zwitterion	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of HSD17B8 protein	PMID:25526675
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HSD17B8 mRNA	PMID:38832940
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of HSD17B8 mRNA	PMID:29067470
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HSD17B8 mRNA	PMID:33387578
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D000082	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA	PMID:25607892
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HSD17B8 mRNA	PMID:29432896
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSD17B8 mRNA	PMID:32525701
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550967	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSD17B8 mRNA	PMID:40504410
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of HSD17B8 mRNA	PMID:26272509
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA	PMID:27188386
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of HSD17B8 mRNA	PMID:27829220
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HSD17B8 mRNA; Nanotubes, Carbon results in decreased expression of HSD17B8 mRNA	PMID:25554681
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:50692	mifepristone	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of HSD17B8 mRNA	PMID:17584828
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HSD17B8 protein	PMID:32959892
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of HSD17B8 mRNA	PMID:22776087
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1550967	E	RGD:6480464	20190910	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of HSD17B8 mRNA]	PMID:29891994
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of HSD17B8 mRNA	PMID:22206623
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550967	E	RGD:6480464	20230207	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of HSD17B8 mRNA	PMID:22206623
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1351353	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of HSD17B8 mRNA	PMID:28960945
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of HSD17B8 protein	PMID:39638853
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of HSD17B8 mRNA	PMID:30851411
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA	PMID:27188386
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HSD17B8 gene]	PMID:28238834
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:81794	thifluzamide	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of HSD17B8 mRNA	PMID:33512557
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSD17B8 mRNA	PMID:32525701
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:88542	Butylparaben	multiple interactions	EXP		E	RGD:6480464	20200407	CTD	MESH:C038091	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA	PMID:25607892
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1351353	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA	PMID:27188386
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of HSD17B8 mRNA	PMID:38568856
1303158	Hsd17b8	hydroxysteroid (17-beta) dehydrogenase 8	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1351353	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of HSD17B8 mRNA	PMID:29301935
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1603199	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MAIP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MAIP1 mRNA	PMID:32699268
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1620027	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MAIP1 mRNA	PMID:36331819
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1603199	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MAIP1 mRNA	PMID:22378314
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1603199	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MAIP1 mRNA	PMID:20044591
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1620027	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAIP1 mRNA	PMID:37236586
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of MAIP1 protein	PMID:33236894
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603199	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MAIP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MAIP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MAIP1 mRNA	PMID:32699268
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620027	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAIP1 mRNA	PMID:22206623
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAIP1 mRNA	PMID:33387578
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1603199	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MAIP1 protein	PMID:39603559
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1603199	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MAIP1 mRNA	PMID:30851411
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1603199	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MAIP1 mRNA	PMID:32763439
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1603199	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of MAIP1 mRNA	PMID:29803840
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1620027	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased methylation of MAIP1 gene	PMID:32068019
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MAIP1 mRNA	PMID:34947998
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1603199	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MAIP1 protein	PMID:34186270
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1603199	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to MAIP1 protein	PMID:32991956
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1620027	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAIP1 mRNA	PMID:37236586
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1603199	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MAIP1 protein	PMID:26879310
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1603199	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MAIP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MAIP1 mRNA	PMID:32699268
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1603199	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MAIP1 mRNA	PMID:31533062
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620027	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MAIP1 mRNA	PMID:36331819
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1603199	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAIP1 mRNA	PMID:22230336|PMID:25704631
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in increased expression of MAIP1 mRNA	PMID:38685447
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1620027	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAIP1 mRNA	PMID:22206623
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1603199	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MAIP1 mRNA	PMID:30851411
1303159	Maip1	matrix AAA peptidase interacting protein 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1603199	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of MAIP1 mRNA	PMID:24921660
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of ARHGAP20 mRNA	PMID:25152437
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:137392	chlormequat chloride	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of ARHGAP20 protein	PMID:34958886
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1350363	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGAP20 mRNA	PMID:23724009
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1350363	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ARHGAP20 mRNA	PMID:30510588
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ARHGAP20 mRNA	PMID:23829299
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ARHGAP20 mRNA	PMID:33387578
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARHGAP20 mRNA	PMID:33789034
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ARHGAP20 mRNA	PMID:22061828
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550452	E	RGD:6480464	20200714	CTD	MESH:D002104	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of ARHGAP20 mRNA	PMID:31904401
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1550452	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGAP20 mRNA	PMID:29950665
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1350363	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARHGAP20 gene	PMID:27153756
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550452	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARHGAP20 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ARHGAP20 mRNA	PMID:34911549
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1550452	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of ARHGAP20 mRNA	PMID:38723480
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550452	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of ARHGAP20 mRNA]	PMID:38723480
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550452	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ARHGAP20 mRNA	PMID:28960355
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1350363	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ARHGAP20 mRNA	PMID:28903495
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550452	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGAP20 mRNA	PMID:19933214
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ARHGAP20 mRNA	PMID:28959563
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550452	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ARHGAP20 mRNA	PMID:39631538
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1350363	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of ARHGAP20 mRNA	PMID:22363485
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550452	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGAP20 mRNA	PMID:37682722
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1550452	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased methylation of ARHGAP20 gene	PMID:39894169
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350363	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARHGAP20 5' UTR; Benzo(a)pyrene affects the methylation of ARHGAP20 promoter	PMID:27901495
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550452	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARHGAP20 mRNA	PMID:21715664
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1350363	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ARHGAP20 mRNA	PMID:23806026
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1350363	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of ARHGAP20 mRNA	PMID:20382639
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1350363	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ARHGAP20 gene	PMID:31601247
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550452	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARHGAP20 gene	PMID:35295148
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550452	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ARHGAP20 mRNA	PMID:23557971
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1550452	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGAP20 mRNA	PMID:29950665
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARHGAP20 mRNA	PMID:25181051
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1350363	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of ARHGAP20 gene	PMID:31601247
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP20 mRNA	PMID:41034487
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550452	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP20 mRNA	PMID:32156529
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP20 mRNA	PMID:30816183
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550452	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP20 mRNA	PMID:25594700|PMID:30951980|PMID:37105096
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350363	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARHGAP20 mRNA	PMID:28628672
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:33418	graphite	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of ARHGAP20 mRNA	PMID:29933104
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of ARHGAP20 mRNA	PMID:23829299
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ARHGAP20 mRNA	PMID:23196670
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1550452	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARHGAP20 exon	PMID:33297965
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550452	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ARHGAP20 mRNA	PMID:30951980
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1550452	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of ARHGAP20 mRNA	PMID:26377693
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550452	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ARHGAP20 mRNA	PMID:30951980
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550452	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ARHGAP20 intron	PMID:28392331
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550452	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ARHGAP20 mRNA	PMID:37019170
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1550452	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGAP20 mRNA	PMID:29950665
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1350363	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARHGAP20 mRNA	PMID:28628672
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550452	E	RGD:6480464	20200714	CTD	MESH:D019256	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of ARHGAP20 mRNA	PMID:31904401
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of ARHGAP20 mRNA	PMID:27387713
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1550452	E	RGD:6480464	20200714	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of ARHGAP20 mRNA	PMID:31904401
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550452	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ARHGAP20 mRNA	PMID:40194260
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550452	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGAP20 mRNA	PMID:17963808
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1350363	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of ARHGAP20 mRNA	PMID:27989131
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1350363	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of ARHGAP20 mRNA	PMID:25047013
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1350363	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARHGAP20 mRNA	PMID:28628672
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550452	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ARHGAP20 mRNA	PMID:28973697
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1350363	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARHGAP20 mRNA	PMID:38832940
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ARHGAP20 mRNA	PMID:33387578
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1350363	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ARHGAP20 mRNA	PMID:21420995|PMID:29067470
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1550452	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of ARHGAP20 mRNA	PMID:38723480
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550452	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of ARHGAP20 mRNA]	PMID:38723480
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:47381	diclofenac	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D004008	Diclofenac results in increased expression of ARHGAP20 mRNA	PMID:30723492
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1350363	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ARHGAP20 mRNA	PMID:31838189
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ARHGAP20 mRNA	PMID:29391264
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1350363	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGAP20 mRNA	PMID:22079256
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1350363	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARHGAP20 mRNA	PMID:28628672
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550452	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARHGAP20 mRNA; Nanotubes, Carbon results in decreased expression of ARHGAP20 mRNA	PMID:25554681
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1550452	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of ARHGAP20 mRNA	PMID:26377693
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1550452	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ARHGAP20 mRNA	PMID:20003209
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550452	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ARHGAP20 mRNA	PMID:22206623
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1350363	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ARHGAP20 mRNA	PMID:22079256
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1350363	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGAP20 mRNA	PMID:22079256
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of ARHGAP20 mRNA	PMID:26720608
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350363	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARHGAP20 gene]	PMID:28238834
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550452	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ARHGAP20 mRNA	PMID:38648751
1303160	Arhgap20	Rho GTPase activating protein 20	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARHGAP20 mRNA	PMID:24780913
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552956	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ST8SIA6 mRNA	PMID:33045310
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1605541	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of ST8SIA6 mRNA	PMID:34925699
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552956	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ST8SIA6 mRNA	PMID:26251327
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ST8SIA6 gene	PMID:20938992
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1552956	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of ST8SIA6 mRNA	PMID:36189433
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ST8SIA6 mRNA	PMID:36189433
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1605541	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ST8SIA6 mRNA	PMID:26516004
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552956	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ST8SIA6 mRNA	PMID:39241906
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552956	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ST8SIA6 mRNA	PMID:39298647
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ST8SIA6 gene	PMID:27618143
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ST8SIA6 gene	PMID:20938992
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]	PMID:37992649
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ST8SIA6 mRNA	PMID:36189433
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]	PMID:37992649
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ST8SIA6 mRNA	PMID:25378103
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605541	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ST8SIA6 gene	PMID:27153756
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605541	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ST8SIA6 intron	PMID:30157460
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ST8SIA6 mRNA	PMID:34911549
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ST8SIA6 mRNA	PMID:30779732
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:27086	tributylstannane	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in decreased expression of ST8SIA6 mRNA	PMID:31129395
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552956	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ST8SIA6 mRNA	PMID:25629700
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ST8SIA6 gene	PMID:20938992
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:27638	cobalt atom	increases expression	ISO	RGD:1552956	E	RGD:6480464	20220308	CTD	MESH:D003035	Cobalt results in increased expression of ST8SIA6 mRNA	PMID:34468815
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]	PMID:37992649
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ST8SIA6 mRNA	PMID:31881176
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ST8SIA6 mRNA	PMID:28374803
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1552956	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of ST8SIA6 mRNA	PMID:30807115
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ST8SIA6 mRNA	PMID:26033743
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]	PMID:37992649
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]	PMID:37992649
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552956	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of ST8SIA6 mRNA	PMID:39515575
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA6 mRNA	PMID:34876320
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA6 mRNA	PMID:34876320
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605541	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ST8SIA6 promoter	PMID:27901495
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ST8SIA6 mRNA	PMID:26033743
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552956	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ST8SIA6 mRNA	PMID:23557971|PMID:29264374
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552956	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ST8SIA6 gene	PMID:35295148
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of ST8SIA6 mRNA	PMID:23411599
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ST8SIA6 mRNA	PMID:25181051
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of ST8SIA6 mRNA	PMID:33296240
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552956	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ST8SIA6 mRNA	PMID:32156529
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ST8SIA6 gene	PMID:28505145
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1552956	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of ST8SIA6 mRNA	PMID:26377693
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605541	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ST8SIA6 mRNA	PMID:37042841
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552956	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ST8SIA6 mRNA	PMID:40194260
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1605541	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with ESR1 protein] results in increased expression of ST8SIA6 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ST8SIA6 mRNA]	PMID:18310284
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1605541	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ST8SIA6 gene	PMID:29154799
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552956	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ST8SIA6 mRNA	PMID:28973697
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ST8SIA6 mRNA]	PMID:37992649
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1552956	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of ST8SIA6 mRNA	PMID:30529165
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA6 mRNA	PMID:34876320
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552956	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ST8SIA6 mRNA; Nanotubes, Carbon results in increased expression of ST8SIA6 mRNA	PMID:25554681
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1605541	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ST8SIA6 mRNA	PMID:22714537
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1552956	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ST8SIA6 mRNA	PMID:20003209
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of ST8SIA6 mRNA	PMID:19564919
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of ST8SIA6 mRNA	PMID:19564919
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ST8SIA6 gene	PMID:35440735
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of ST8SIA6 mRNA	PMID:19564919
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552956	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ST8SIA6 mRNA	PMID:22206623
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1552956	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in decreased expression of ST8SIA6 mRNA	PMID:26655953
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552956	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ST8SIA6 mRNA	PMID:21795629
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1552956	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA6 mRNA	PMID:34876320
1303161	St8sia6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1605541	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ST8SIA6 mRNA	PMID:29301935
1303162	Ltb	lymphotoxin beta	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C007262	deoxynivalenol results in decreased expression of LTB mRNA	PMID:22968694
1303162	Ltb	lymphotoxin beta	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of LTB mRNA	PMID:35967413
1303162	Ltb	lymphotoxin beta	gene	CHEBI:119915	fentanyl	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D005283	Fentanyl results in increased expression of LTB mRNA	PMID:36032789
1303162	Ltb	lymphotoxin beta	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LTB mRNA	PMID:33045310
1303162	Ltb	lymphotoxin beta	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of LTB mRNA	PMID:25812627
1303162	Ltb	lymphotoxin beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D014212	Tretinoin results in decreased expression of LTB mRNA	PMID:16604517
1303162	Ltb	lymphotoxin beta	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTB mRNA	PMID:30529165
1303162	Ltb	lymphotoxin beta	gene	CHEBI:15414	S-adenosyl-L-methionine	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D012436	S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA]	PMID:17080400
1303162	Ltb	lymphotoxin beta	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of LTB protein	PMID:18951874
1303162	Ltb	lymphotoxin beta	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LTB mRNA	PMID:39241906
1303162	Ltb	lymphotoxin beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LTB mRNA	PMID:19428942|PMID:31059760
1303162	Ltb	lymphotoxin beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LTB mRNA; Lipopolysaccharides results in increased expression of LTB protein	PMID:14644621|PMID:21135813
1303162	Ltb	lymphotoxin beta	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of LTB mRNA	PMID:31059760
1303162	Ltb	lymphotoxin beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D004958	Estradiol results in increased expression of LTB mRNA	PMID:23373633
1303162	Ltb	lymphotoxin beta	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353964	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LTB mRNA	PMID:37042841
1303162	Ltb	lymphotoxin beta	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D001554	Benzene results in decreased expression of LTB mRNA	PMID:15120971
1303162	Ltb	lymphotoxin beta	gene	CHEBI:168396	mycophenolic acid	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D009173	Mycophenolic Acid results in increased expression of LTB mRNA	PMID:19818335
1303162	Ltb	lymphotoxin beta	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D011374	Progesterone results in increased expression of LTB mRNA	PMID:22615136
1303162	Ltb	lymphotoxin beta	gene	CHEBI:17183	sanguinarine	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:C005705	sanguinarine results in increased expression of LTB mRNA	PMID:24345465
1303162	Ltb	lymphotoxin beta	gene	CHEBI:17183	sanguinarine	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:C005705	[sanguinarine co-treated with arsenic trioxide] results in increased expression of LTB mRNA	PMID:24345465
1303162	Ltb	lymphotoxin beta	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTB mRNA	PMID:37992649
1303162	Ltb	lymphotoxin beta	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1551006	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of LTB mRNA	PMID:33848595
1303162	Ltb	lymphotoxin beta	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of LTB mRNA]	PMID:33848595
1303162	Ltb	lymphotoxin beta	gene	CHEBI:17509	5'-S-methyl-5'-thioadenosine	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C008500	5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA]	PMID:17080400
1303162	Ltb	lymphotoxin beta	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTB mRNA	PMID:37992649
1303162	Ltb	lymphotoxin beta	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D009538	Nicotine results in decreased expression of LTB mRNA	PMID:18247414
1303162	Ltb	lymphotoxin beta	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D002117	Calcitriol results in increased expression of LTB mRNA	PMID:22615136
1303162	Ltb	lymphotoxin beta	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D009538	Nicotine results in decreased expression of LTB mRNA	PMID:18247414
1303162	Ltb	lymphotoxin beta	gene	CHEBI:188851	Muraglitazar	affects expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar affects the expression of LTB mRNA	PMID:21515302
1303162	Ltb	lymphotoxin beta	gene	CHEBI:200715	Brevianamide A	increases expression	ISO	RGD:1551006	E	RGD:6480464	20231219	CTD	MESH:C006794	brevianamide A results in increased expression of LTB mRNA	PMID:19818335
1303162	Ltb	lymphotoxin beta	gene	CHEBI:211551	TMC-120A	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in decreased expression of LTB mRNA	PMID:19818335
1303162	Ltb	lymphotoxin beta	gene	CHEBI:25442	mycotoxin	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D009183	Mycotoxins results in increased expression of LTB mRNA	PMID:19818335
1303162	Ltb	lymphotoxin beta	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D010126	Ozone results in decreased expression of LTB mRNA	PMID:12763052|PMID:26342085|PMID:30848106
1303162	Ltb	lymphotoxin beta	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1353964	E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in increased expression of LTB mRNA	PMID:31476115
1303162	Ltb	lymphotoxin beta	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20191210	CTD	MESH:D010126	[Aripiprazole co-treated with Ozone] results in increased expression of LTB mRNA	PMID:31476115
1303162	Ltb	lymphotoxin beta	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D010126	[[LTA gene mutant form co-treated with TNF gene mutant form co-treated with LTB gene mutant form] co-treated with Ozone] results in decreased expression of H2-EB1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of LTB mRNA; [LTA gene mutant form co-treated with TNF gene mutant form co-treated with LTB gene mutant form] inhibits the reaction [Ozone results in increased expression of H2-EB2 mRNA]; [LTA gene mutant form co-treated with TNF gene mutant form co-treated with LTB gene mutant form] results in decreased susceptibility to Ozone	PMID:20032013|PMID:34911549
1303162	Ltb	lymphotoxin beta	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LTB mRNA	PMID:17125873|PMID:18395288
1303162	Ltb	lymphotoxin beta	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D002251	CCL2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of LTB mRNA]; CD44 protein affects the reaction [Carbon Tetrachloride results in increased expression of LTB mRNA]	PMID:17125873|PMID:18395288
1303162	Ltb	lymphotoxin beta	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D001151	Arsenic affects the expression of LTB protein	PMID:24675094
1303162	Ltb	lymphotoxin beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D001151	[Arsenic co-treated with Fluorides] results in decreased expression of LTB mRNA	PMID:19962721
1303162	Ltb	lymphotoxin beta	gene	CHEBI:27878	2-naphthylamine	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D015081	2-Naphthylamine results in decreased expression of LTB mRNA	PMID:18247414
1303162	Ltb	lymphotoxin beta	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1353964	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of LTB mRNA	PMID:27594783
1303162	Ltb	lymphotoxin beta	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D009532	Nickel results in increased expression of LTB mRNA	PMID:25583101
1303162	Ltb	lymphotoxin beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LTB mRNA	PMID:22298810
1303162	Ltb	lymphotoxin beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LTB mRNA	PMID:26377647
1303162	Ltb	lymphotoxin beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LTB mRNA	PMID:28351761
1303162	Ltb	lymphotoxin beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LTB mRNA	PMID:21851831
1303162	Ltb	lymphotoxin beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LTB mRNA	PMID:17942748
1303162	Ltb	lymphotoxin beta	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of LTB protein	PMID:18951874
1303162	Ltb	lymphotoxin beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of LTB mRNA	PMID:39631538
1303162	Ltb	lymphotoxin beta	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20170214	CTD	MESH:D004317	Doxorubicin inhibits the reaction [Fungal Polysaccharides results in increased expression of LTB mRNA]	PMID:27181935
1303162	Ltb	lymphotoxin beta	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTB mRNA	PMID:37992649
1303162	Ltb	lymphotoxin beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in increased expression of LTB mRNA	PMID:21911445|PMID:37682722
1303162	Ltb	lymphotoxin beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB mRNA	PMID:34876320
1303162	Ltb	lymphotoxin beta	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB mRNA	PMID:34876320
1303162	Ltb	lymphotoxin beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LTB mRNA	PMID:18247414|PMID:32234424
1303162	Ltb	lymphotoxin beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LTB mRNA	PMID:21569818|PMID:22610609|PMID:25908611
1303162	Ltb	lymphotoxin beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LTB mRNA	PMID:28351761
1303162	Ltb	lymphotoxin beta	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353964	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LTB promoter	PMID:27901495
1303162	Ltb	lymphotoxin beta	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of LTB mRNA	PMID:30171875
1303162	Ltb	lymphotoxin beta	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D012834	Silver results in decreased expression of LTB mRNA	PMID:27131904
1303162	Ltb	lymphotoxin beta	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LTB mRNA	PMID:22431001
1303162	Ltb	lymphotoxin beta	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of LTB mRNA; Silicon Dioxide results in increased expression of LTB mRNA	PMID:19428942|PMID:23806026
1303162	Ltb	lymphotoxin beta	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LTB mRNA	PMID:23221170|PMID:29341224
1303162	Ltb	lymphotoxin beta	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1353964	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of LTB mRNA	PMID:24345465
1303162	Ltb	lymphotoxin beta	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20191114	CTD	MESH:C006632	[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of LTB mRNA	PMID:24345465
1303162	Ltb	lymphotoxin beta	gene	CHEBI:31236	aripiprazole	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20191210	CTD	MESH:C094645	[Aripiprazole co-treated with Ozone] results in increased expression of LTB mRNA	PMID:31476115
1303162	Ltb	lymphotoxin beta	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1353964	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of LTB mRNA	PMID:37690743
1303162	Ltb	lymphotoxin beta	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D005897	Glafenine results in increased expression of LTB mRNA	PMID:24136188
1303162	Ltb	lymphotoxin beta	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:C030110	oxaliplatin results in increased expression of LTB mRNA	PMID:25729387
1303162	Ltb	lymphotoxin beta	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20170214	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of LTB mRNA	PMID:25729387
1303162	Ltb	lymphotoxin beta	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C009495	titanium dioxide results in decreased expression of LTB mRNA	PMID:27760801
1303162	Ltb	lymphotoxin beta	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551006	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LTB gene	PMID:35295148
1303162	Ltb	lymphotoxin beta	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of LTB mRNA	PMID:30012374
1303162	Ltb	lymphotoxin beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of LTB mRNA	PMID:18648102
1303162	Ltb	lymphotoxin beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of LTB mRNA	PMID:25380136
1303162	Ltb	lymphotoxin beta	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of LTB mRNA	PMID:19191707
1303162	Ltb	lymphotoxin beta	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20170214	CTD	MESH:C006780	bisphenol A affects the expression of LTB mRNA	PMID:25181051
1303162	Ltb	lymphotoxin beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of LTB mRNA	PMID:30816183|PMID:32528016
1303162	Ltb	lymphotoxin beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of LTB mRNA	PMID:41034487
1303162	Ltb	lymphotoxin beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551006	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LTB mRNA	PMID:32156529|PMID:38701888
1303162	Ltb	lymphotoxin beta	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C006780	[NR1H4 gene mutant form affects the susceptibility to bisphenol A] which results in decreased expression of LTB mRNA	PMID:30245210
1303162	Ltb	lymphotoxin beta	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D024502	Vitamin E results in increased expression of LTB mRNA	PMID:19244175
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:C032668	1-nitropyrene results in increased expression of LTB mRNA	PMID:19428942|PMID:19879285
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170613	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LTB mRNA	PMID:28351761
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34345	3-Nitrofluoranthene	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:C033643	3-nitrofluoranthene results in increased expression of LTB mRNA	PMID:19879285
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of LTB mRNA	PMID:40203079
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1551006	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of LTB promoter	PMID:33297965
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LTB mRNA	PMID:38685157
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C008745	bisphenol F results in increased expression of LTB mRNA	PMID:30951980
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of LTB mRNA	PMID:21241498
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of LTB mRNA	PMID:19647056
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of LTB mRNA	PMID:15765122|PMID:24535843
1303162	Ltb	lymphotoxin beta	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:C022838	nickel chloride results in increased expression of LTB mRNA	PMID:17312168
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353964	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LTB mRNA	PMID:37042841
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of LTB mRNA	PMID:35163327
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of LTB mRNA	PMID:25380136
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LTB mRNA	PMID:12160620
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20170214	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of LTB promoter	PMID:22457795
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LTB mRNA	PMID:25993096
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of LTB mRNA	PMID:25812627
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of LTB mRNA	PMID:27387713
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of LTB mRNA	PMID:25380136
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LTB mRNA	PMID:24449571
1303162	Ltb	lymphotoxin beta	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of LTB mRNA	PMID:25908611
1303162	Ltb	lymphotoxin beta	gene	CHEBI:3638	chloroquine	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D002738	Chloroquine results in increased expression of LTB	PMID:15139008
1303162	Ltb	lymphotoxin beta	gene	CHEBI:36706	resiquimod	increases expression	ISO	RGD:1551006	E	RGD:6480464	20260113	CTD	MESH:C402365	resiquimod results in increased expression of LTB mRNA	PMID:40651955
1303162	Ltb	lymphotoxin beta	gene	CHEBI:36706	resiquimod	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20260113	CTD	MESH:C402365	SAR131675 inhibits the reaction [resiquimod results in increased expression of LTB mRNA]	PMID:40651955
1303162	Ltb	lymphotoxin beta	gene	CHEBI:37288	gadolinium trichloride	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C038958	gadolinium chloride results in increased expression of LTB mRNA	PMID:15590129
1303162	Ltb	lymphotoxin beta	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D003010	Clorgyline results in increased expression of LTB mRNA	PMID:19691856
1303162	Ltb	lymphotoxin beta	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C056933	fumonisin B1 results in increased expression of LTB mRNA	PMID:15590129|PMID:17080400
1303162	Ltb	lymphotoxin beta	gene	CHEBI:38221	fumonisin B1	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C056933	5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA]	PMID:17080400
1303162	Ltb	lymphotoxin beta	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LTB mRNA	PMID:25812627
1303162	Ltb	lymphotoxin beta	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1551006	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LTB mRNA	PMID:40194260
1303162	Ltb	lymphotoxin beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LTB mRNA	PMID:25812627
1303162	Ltb	lymphotoxin beta	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C031763	1,3-butadiene results in decreased expression of LTB mRNA	PMID:29038090
1303162	Ltb	lymphotoxin beta	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D002737	Chloroprene results in decreased expression of LTB mRNA	PMID:23125180
1303162	Ltb	lymphotoxin beta	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D003474	Curcumin results in decreased expression of LTB mRNA	PMID:16751071
1303162	Ltb	lymphotoxin beta	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D003474	Curcumin results in increased expression of LTB mRNA	PMID:17198877
1303162	Ltb	lymphotoxin beta	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LTB mRNA	PMID:29154799
1303162	Ltb	lymphotoxin beta	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D003907	Dexamethasone results in decreased expression of LTB mRNA	PMID:12782123
1303162	Ltb	lymphotoxin beta	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D003907	Dexamethasone results in increased expression of LTB mRNA	PMID:21041162
1303162	Ltb	lymphotoxin beta	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTB mRNA	PMID:37992649
1303162	Ltb	lymphotoxin beta	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:C012589	trichostatin A results in increased expression of LTB mRNA	PMID:24935251|PMID:26272509
1303162	Ltb	lymphotoxin beta	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LTB mRNA	PMID:27188386
1303162	Ltb	lymphotoxin beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1353964	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen affects the expression of LTB mRNA	PMID:31059760
1303162	Ltb	lymphotoxin beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D000082	Acetaminophen affects the expression of LTB mRNA	PMID:17562736
1303162	Ltb	lymphotoxin beta	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of LTB mRNA	PMID:31059760
1303162	Ltb	lymphotoxin beta	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:C088658	zoledronic acid results in increased expression of LTB mRNA	PMID:24714768
1303162	Ltb	lymphotoxin beta	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D001151	Arsenic affects the expression of LTB protein	PMID:24675094
1303162	Ltb	lymphotoxin beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D001151	[Arsenic co-treated with Fluorides] results in decreased expression of LTB mRNA	PMID:19962721
1303162	Ltb	lymphotoxin beta	gene	CHEBI:47426	furosemide	affects expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D005665	Furosemide affects the expression of LTB mRNA	PMID:17497460
1303162	Ltb	lymphotoxin beta	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB mRNA	PMID:34876320
1303162	Ltb	lymphotoxin beta	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D018038	Sodium Selenite results in decreased expression of LTB mRNA	PMID:16705456
1303162	Ltb	lymphotoxin beta	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LTB mRNA	PMID:17942748
1303162	Ltb	lymphotoxin beta	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1353964	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of LTB mRNA	PMID:24345465
1303162	Ltb	lymphotoxin beta	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20191114	CTD	MESH:C032793	[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of LTB mRNA	PMID:24345465
1303162	Ltb	lymphotoxin beta	gene	CHEBI:50102	N-methyl-N-nitrosourea	decreases response to substance	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D008770	LTB protein results in decreased susceptibility to Methylnitrosourea	PMID:15240709
1303162	Ltb	lymphotoxin beta	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of LTB mRNA; Nanotubes, Carbon analog affects the expression of LTB mRNA	PMID:25554681
1303162	Ltb	lymphotoxin beta	gene	CHEBI:50924	sorafenib	increases expression	ISO	RGD:1551006	E	RGD:6480464	20260203	CTD	MESH:C471405	Sorafenib results in increased expression of LTB mRNA	PMID:40518001
1303162	Ltb	lymphotoxin beta	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LTB mRNA	PMID:35964746
1303162	Ltb	lymphotoxin beta	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D010081	Oxazolone results in increased expression of LTB mRNA	PMID:19647056
1303162	Ltb	lymphotoxin beta	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of LTB mRNA	PMID:11467998|PMID:12356572|PMID:19647056
1303162	Ltb	lymphotoxin beta	gene	CHEBI:53556	toluene 2,4-diisocyanate	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D014051	TNF protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of LTB mRNA]	PMID:12356572
1303162	Ltb	lymphotoxin beta	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1551006	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LTB mRNA	PMID:38701926
1303162	Ltb	lymphotoxin beta	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LTB mRNA	PMID:21641980
1303162	Ltb	lymphotoxin beta	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D019772	Topotecan results in increased expression of LTB mRNA	PMID:25729387
1303162	Ltb	lymphotoxin beta	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20170214	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of LTB mRNA	PMID:25729387
1303162	Ltb	lymphotoxin beta	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of LTB mRNA	PMID:19812364
1303162	Ltb	lymphotoxin beta	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of LTB mRNA	PMID:28988120
1303162	Ltb	lymphotoxin beta	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of LTB mRNA	PMID:36851058
1303162	Ltb	lymphotoxin beta	gene	CHEBI:67040	S-adenosyl-L-methioninate	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D012436	S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA]	PMID:17080400
1303162	Ltb	lymphotoxin beta	gene	CHEBI:68792	asperentin	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C000488	cladosporin results in increased expression of LTB mRNA	PMID:19818335
1303162	Ltb	lymphotoxin beta	gene	CHEBI:68794	neoechinulin A	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C490266	neoechinulin A results in increased expression of LTB mRNA	PMID:19818335
1303162	Ltb	lymphotoxin beta	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol inhibits the reaction [TNF protein results in increased expression of LTB mRNA]	PMID:31250491
1303162	Ltb	lymphotoxin beta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LTB mRNA	PMID:22206623
1303162	Ltb	lymphotoxin beta	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:C075117	squalestatin 1 results in decreased expression of LTB mRNA	PMID:27225895
1303162	Ltb	lymphotoxin beta	gene	CHEBI:75170	zaragozic acid A	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of LTB mRNA	PMID:27225895
1303162	Ltb	lymphotoxin beta	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1353964	E	RGD:6480464	20200714	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of LTB mRNA	PMID:32151702
1303162	Ltb	lymphotoxin beta	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20170214	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of LTB mRNA	PMID:21346803
1303162	Ltb	lymphotoxin beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LTB mRNA	PMID:27188386
1303162	Ltb	lymphotoxin beta	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1551006	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB mRNA	PMID:34876320
1303162	Ltb	lymphotoxin beta	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D011441	Propylthiouracil results in increased expression of LTB mRNA	PMID:24780913
1303162	Ltb	lymphotoxin beta	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of LTB mRNA	PMID:19429434
1303162	Ltb	lymphotoxin beta	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LTB mRNA	PMID:27188386
1303162	Ltb	lymphotoxin beta	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1551006	E	RGD:6480464	20210309	CTD	MESH:D012834	Silver results in decreased expression of LTB mRNA	PMID:27131904
1303162	Ltb	lymphotoxin beta	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20170328	CTD	MESH:D019821	Simvastatin results in decreased expression of LTB mRNA	PMID:17428261
1303162	Ltb	lymphotoxin beta	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20170214	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LTB mRNA	PMID:21346803
1303162	Ltb	lymphotoxin beta	gene	CHEBI:93751	PF-3758309	increases expression	ISO	RGD:1353964	E	RGD:6480464	20240806	CTD	MESH:C550923	PF 3758309 results in increased expression of LTB mRNA	PMID:29048629
1303162	Ltb	lymphotoxin beta	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1353964	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of LTB mRNA	PMID:29301935
1303162	Ltb	lymphotoxin beta	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20170214	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LTB mRNA	PMID:21346803
1303162	Ltb	lymphotoxin beta	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of LTB gene	PMID:31079544
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552966	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PPP1R11 mRNA	PMID:33045310
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1350582	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of PPP1R11 protein	PMID:39571964
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PPP1R11 gene	PMID:27618143
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552966	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PPP1R11 mRNA	PMID:33754040
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PPP1R11 mRNA	PMID:22061828
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1350582	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R11 mRNA	PMID:39836092
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552966	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PPP1R11 mRNA	PMID:22206623
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1350582	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R11 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP1R11 mRNA	PMID:39836092
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1350582	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PPP1R11 protein	PMID:35688186
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1350582	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PPP1R11 mRNA	PMID:23557933
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1350582	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of PPP1R11 gene	PMID:31636367
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1350582	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of PPP1R11 mRNA	PMID:19921347
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1350582	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of PPP1R11 mRNA	PMID:23300844
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552966	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPP1R11 mRNA	PMID:21570461
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPP1R11 mRNA	PMID:34747641
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552966	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPP1R11 mRNA	PMID:19465110|PMID:21354282
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1350582	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PPP1R11 mRNA	PMID:33212167
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1350582	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPP1R11 mRNA	PMID:29803840
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1350582	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PPP1R11 mRNA	PMID:38568856
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1350582	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R11 mRNA; [sodium arsenite co-treated with Tretinoin] results in decreased expression of PPP1R11 protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP1R11 mRNA	PMID:39571964|PMID:39836092
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350582	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PPP1R11 3' UTR; Benzo(a)pyrene results in increased methylation of PPP1R11 promoter	PMID:27901495
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1350582	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PPP1R11 mRNA	PMID:20018196
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PPP1R11 mRNA	PMID:25181051
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1350582	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PPP1R11 mRNA	PMID:30903817
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552966	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PPP1R11 mRNA	PMID:39298647
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552966	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PPP1R11 mRNA	PMID:37019170
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1552966	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of PPP1R11 mRNA	PMID:34813904
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1552966	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of PPP1R11 mRNA	PMID:34813904
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350582	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPP1R11 mRNA	PMID:37042841
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1350582	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R11 mRNA	PMID:39836092
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PPP1R11 promoter	PMID:22457795
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1350582	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PPP1R11 mRNA	PMID:38568856
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1350582	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PPP1R11 mRNA	PMID:24449571
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1350582	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of PPP1R11 mRNA	PMID:27989131
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552966	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPP1R11 mRNA	PMID:17562736
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1350582	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R11 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP1R11 mRNA	PMID:39836092
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1350582	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of PPP1R11 mRNA	PMID:23300844
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PPP1R11 mRNA	PMID:24136188
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552966	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PPP1R11 mRNA	PMID:35964746
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PPP1R11 mRNA	PMID:24136188
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1350582	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PPP1R11 protein	PMID:32959892
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1350582	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R11 mRNA	PMID:39836092
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552966	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of PPP1R11 mRNA	PMID:23650126
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1552966	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of PPP1R11 mRNA	PMID:28444820
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552966	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PPP1R11 mRNA	PMID:22206623
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1350582	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PPP1R11 mRNA	PMID:37199045
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of PPP1R11 mRNA	PMID:22124623
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PPP1R11 mRNA	PMID:24780913
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552966	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PPP1R11 mRNA	PMID:40826991
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PPP1R11 mRNA	PMID:21346803
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1552966	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of PPP1R11 mRNA	PMID:26217789
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PPP1R11 mRNA	PMID:21346803
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1552966	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PPP1R11 mRNA	PMID:32835833
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1552966	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of PPP1R11 mRNA	PMID:35537566
1303163	Ppp1r11	protein phosphatase 1, regulatory (inhibitor) subunit 11	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of PPP1R11 mRNA	PMID:23555832
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1623843	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ABHD16A mRNA	PMID:37995155
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABHD16A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABHD16A mRNA	PMID:32699268
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1623843	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of ABHD16A mRNA	PMID:40945087
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1623843	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ABHD16A mRNA	PMID:30319688
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1623843	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ABHD16A mRNA	PMID:30319688
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1351609	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ABHD16A mRNA	PMID:37042841
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABHD16A mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ABHD16A mRNA	PMID:39836092
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1623843	E	RGD:6480464	20151110	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of ABHD16A mRNA	PMID:19376150
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1351609	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ABHD16A exon	PMID:30157460
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in decreased expression of ABHD16A protein	PMID:33146391
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABHD16A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABHD16A mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ABHD16A mRNA	PMID:32699268
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1623843	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ABHD16A mRNA	PMID:34911549
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABHD16A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABHD16A mRNA	PMID:39836092
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623843	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ABHD16A mRNA	PMID:40504410
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1351609	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ABHD16A protein	PMID:35688186
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of ABHD16A gene	PMID:31011160
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1351609	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ABHD16A mRNA	PMID:27594783
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623843	E	RGD:6480464	20151110	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABHD16A mRNA	PMID:21570461
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1623843	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ABHD16A mRNA	PMID:19465110
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABHD16A mRNA	PMID:32109520
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1351609	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of ABHD16A protein	PMID:39603559
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1623843	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of ABHD16A mRNA	PMID:30807115
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1623843	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ABHD16A protein	PMID:28918527
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1351609	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ABHD16A mRNA	PMID:29803840
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABHD16A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABHD16A mRNA	PMID:39836092
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623843	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ABHD16A mRNA	PMID:40504410
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1351609	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ABHD16A gene	PMID:31601247
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ABHD16A gene	PMID:31601247
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1623843	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of ABHD16A mRNA	PMID:29264374
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1623843	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ABHD16A gene	PMID:35295148
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1623843	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ABHD16A mRNA	PMID:18648102
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C006253	pirinixic acid results in increased expression of ABHD16A mRNA	PMID:22484513
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1623843	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ABHD16A mRNA	PMID:19710929
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ABHD16A mRNA	PMID:25181051
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1351609	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ABHD16A gene	PMID:31601247
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD16A mRNA	PMID:34947998
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ABHD16A mRNA	PMID:36041667
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ABHD16A gene	PMID:31601247
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ABHD16A mRNA	PMID:36041667
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ABHD16A mRNA	PMID:36041667
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623843	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ABHD16A mRNA	PMID:37019170
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351609	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABHD16A mRNA	PMID:37042841
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABHD16A mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ABHD16A mRNA	PMID:39836092
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1351609	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ABHD16A mRNA	PMID:24449571
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABHD16A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABHD16A mRNA	PMID:32699268
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1351609	E	RGD:6480464	20151110	CTD	MESH:D003375	Coumestrol results in decreased expression of ABHD16A mRNA	PMID:19167446
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1351609	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ABHD16A mRNA	PMID:40419075
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351609	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABHD16A mRNA	PMID:25979313
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1351609	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ABHD16A mRNA	PMID:29154799
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ABHD16A mRNA	PMID:30047161|PMID:41580965
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1351609	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABHD16A mRNA	PMID:21420995
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABHD16A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABHD16A mRNA	PMID:39836092
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623843	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ABHD16A mRNA	PMID:40504410
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ABHD16A mRNA	PMID:24136188
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ABHD16A mRNA	PMID:30047161
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1351609	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of ABHD16A mRNA	PMID:20977926
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1351609	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ABHD16A protein	PMID:32959892
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D007649	Ketamine results in increased expression of ABHD16A mRNA	PMID:20080153
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABHD16A mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ABHD16A mRNA	PMID:39836092
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1351609	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ABHD16A mRNA	PMID:31758290
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351609	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ABHD16A gene]	PMID:28238834
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ABHD16A mRNA	PMID:30047161
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of ABHD16A mRNA	PMID:24136188
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:94686	orlistat	decreases activity	ISO	RGD:1351609	E	RGD:6480464	20170808	CTD	MESH:C055122	orlistat results in decreased activity of ABHD16A protein	PMID:18657971
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of ABHD16A protein	PMID:35544339
1303164	Abhd16a	abhydrolase domain containing 16A, phospholipase	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of ABHD16A gene	PMID:31079544
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1349303	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SLC44A4 mRNA	PMID:38218311
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1557086	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC44A4 mRNA	PMID:33045310
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC44A4 mRNA]	PMID:31150632
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1557086	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC44A4 mRNA	PMID:20938992
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1349303	E	RGD:6480464	20220607	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SLC44A4 mRNA; Oxygen deficiency results in decreased expression of SLC44A4 protein	PMID:34998824
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1349303	E	RGD:6480464	20220607	CTD	MESH:D010100	HIF1A protein affects the reaction [Oxygen deficiency results in decreased expression of SLC44A4 protein]	PMID:34998824
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1349303	E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SLC44A4 mRNA	PMID:21179406|PMID:23410634
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1557086	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of SLC44A4 mRNA	PMID:15289156
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1557086	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of SLC44A4 mRNA	PMID:33711761
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC44A4 mRNA	PMID:33387578
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1557086	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC44A4 mRNA	PMID:20938992
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1557086	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SLC44A4 mRNA	PMID:33848595
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1349303	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SLC44A4 mRNA	PMID:21592394
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1349303	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SLC44A4 mRNA	PMID:21592394
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1349303	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SLC44A4 mRNA	PMID:33647349
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SLC44A4 mRNA	PMID:26577399
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1349303	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SLC44A4 mRNA	PMID:21592394
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1349303	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SLC44A4 mRNA	PMID:21592394
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1349303	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SLC44A4 mRNA	PMID:28818685
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1557086	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of SLC44A4 mRNA	PMID:37748715
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:180654	N(4)-hydroxycytidine	multiple interactions	ISO	RGD:1557086	E	RGD:6480464	20240305	CTD	MESH:C010737	4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in decreased expression of SLC44A4 mRNA]	PMID:37748715
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1349303	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of SLC44A4 mRNA	PMID:24376830
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1557086	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC44A4 mRNA	PMID:29950665
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of SLC44A4 mRNA	PMID:21396975
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC44A4 mRNA	PMID:22129741
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1349303	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of SLC44A4 mRNA	PMID:25102026
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:2663	amiodarone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in decreased expression of SLC44A4 mRNA	PMID:17991464
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC44A4 mRNA	PMID:31150632
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC44A4 mRNA]	PMID:31150632
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557086	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC44A4 mRNA	PMID:20938992
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1349303	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SLC44A4 mRNA	PMID:19244175
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of SLC44A4 gene	PMID:31011160
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1349303	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC44A4 mRNA	PMID:23557933
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1349303	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of SLC44A4 promoter	PMID:22847954
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1557086	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of SLC44A4 mRNA	PMID:15289156
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557086	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC44A4 mRNA	PMID:21570461|PMID:26377647
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC44A4 mRNA	PMID:21215274|PMID:34747641
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC44A4 mRNA	PMID:33387578
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1349303	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC44A4 mRNA	PMID:33212167
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1349303	E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of SLC44A4 mRNA	PMID:23410634
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1349303	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC44A4 mRNA	PMID:29432896
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1557086	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC44A4 mRNA	PMID:37682722
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349303	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC44A4 mRNA	PMID:39719251
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1557086	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SLC44A4 mRNA	PMID:23557971
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1557086	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC44A4 mRNA	PMID:29950665
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC44A4 mRNA	PMID:34492290
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:32509	pirinixic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SLC44A4 mRNA	PMID:19162173
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1557086	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SLC44A4 mRNA	PMID:17426115
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557086	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SLC44A4 mRNA	PMID:20059764
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1557086	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of SLC44A4 mRNA]	PMID:20059764
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SLC44A4 mRNA	PMID:25181051
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1349303	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of SLC44A4 gene	PMID:31601247
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of SLC44A4 mRNA	PMID:27257137
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1557086	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SLC44A4 mRNA	PMID:34585602
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1557086	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SLC44A4 mRNA	PMID:26682919
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1557086	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of SLC44A4 exon	PMID:33297965
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1557086	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of SLC44A4 mRNA	PMID:26377693
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1557086	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC44A4 mRNA	PMID:29950665
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:34698	diethyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of SLC44A4 mRNA	PMID:32341500
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC44A4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC44A4 mRNA	PMID:18164116|PMID:22129741
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SLC44A4 promoter	PMID:22457795
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349303	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC44A4 mRNA	PMID:38568856
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of SLC44A4 mRNA	PMID:27387713
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1349303	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SLC44A4 mRNA	PMID:19244175
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:37825	p-toluidine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of SLC44A4 mRNA	PMID:27638505
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1349303	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of SLC44A4 promoter	PMID:22847954
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1349303	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of SLC44A4 promoter	PMID:22847954
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1349303	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of SLC44A4 mRNA	PMID:26352163|PMID:28476498
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1349303	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC44A4 mRNA	PMID:25562108
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1557086	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SLC44A4 mRNA	PMID:15289156
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1557086	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SLC44A4 mRNA	PMID:28973697
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:4356	desferrioxamine B	decreases expression	ISO	RGD:1349303	E	RGD:6480464	20220607	CTD	MESH:D003676	Deferoxamine results in decreased expression of SLC44A4 mRNA	PMID:34998824
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:46661	asbestos	affects expression	ISO	RGD:1349303	E	RGD:6480464	20120412	CTD	MESH:D001194	Asbestos affects the expression of SLC44A4 mRNA	PMID:17297452
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1557086	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of SLC44A4 mRNA	PMID:30529165
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SLC44A4 mRNA	PMID:29391264
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SLC44A4 mRNA	PMID:17557909
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1557086	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SLC44A4 mRNA	PMID:23608068
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	ISO	RGD:1349303	E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of SLC44A4 mRNA	PMID:23410634
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:68508	diethyl maleate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased expression of SLC44A4 mRNA	PMID:21161181
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC44A4 mRNA	PMID:18164116
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349303	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC44A4 gene]	PMID:28238834
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of SLC44A4 mRNA	PMID:32109520
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SLC44A4 mRNA	PMID:24780913|PMID:25825206
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SLC44A4 mRNA	PMID:21346803
1303167	Slc44a4	solute carrier family 44, member 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SLC44A4 mRNA	PMID:21346803
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1322029	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of IL22RA2 mRNA	PMID:22968694
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1322029	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of IL22RA2 mRNA	PMID:33045310
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IL22RA2 mRNA	PMID:33729688
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1322028	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of IL22RA2 mRNA	PMID:26079696
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:16494	lipoic acid	multiple interactions	ISO	RGD:1322029	E	RGD:6480464	20140610	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of IL22RA2 mRNA]	PMID:23608068
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of IL22RA2 mRNA	PMID:33387578
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1322029	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IL22RA2 mRNA	PMID:35550907
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IL22RA2 mRNA	PMID:33387578
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1322028	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL22RA2 mRNA	PMID:35301059
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1322028	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of IL22RA2 mRNA	PMID:41430723
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1322029	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of IL22RA2 mRNA; [MBL1 co-treated with MBL2] promotes the reaction [[Air Pollutants results in increased abundance of Ozone] which results in increased expression of IL22RA2 mRNA]	PMID:27106289
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of IL22RA2 mRNA	PMID:30779732
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1322028	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of IL22RA2 mRNA	PMID:31295307
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1322028	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL22RA2 mRNA	PMID:25583101
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IL22RA2 mRNA	PMID:33387578
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:28358	rac-lactic acid	affects expression	ISO	RGD:1322028	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of IL22RA2 mRNA	PMID:30851411
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:28812	(aminomethyl)phosphonic acid	decreases expression	ISO	RGD:1322028	E	RGD:6480464	20260407	CTD	MESH:C036423	1-aminomethylphosphonic acid results in decreased expression of IL22RA2 mRNA	PMID:31295307
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1322029	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of IL22RA2 mRNA	PMID:37682722
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1322029	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL22RA2 mRNA	PMID:34876320
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1322029	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL22RA2 mRNA	PMID:34876320
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1322028	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL22RA2 promoter	PMID:27901495
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1322028	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IL22RA2 3' UTR; Benzo(a)pyrene results in increased methylation of IL22RA2 exon	PMID:27901495
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	ISO	RGD:1322029	E	RGD:6480464	20140610	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of IL22RA2 mRNA]	PMID:23608068
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of IL22RA2 mRNA	PMID:30012374
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1322029	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of IL22RA2 mRNA	PMID:35295148
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1322028	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IL22RA2 mRNA	PMID:19710929
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IL22RA2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1322029	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of IL22RA2 mRNA	PMID:38701888
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1322029	E	RGD:6480464	20190702	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of IL22RA2 mRNA	PMID:27920257
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of IL22RA2 mRNA	PMID:35163327
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of IL22RA2 promoter	PMID:22457795
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1322028	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL22RA2 mRNA	PMID:35301059
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of IL22RA2 mRNA	PMID:27387713
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1322029	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IL22RA2 mRNA	PMID:40194260
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IL22RA2 mRNA	PMID:33387578
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1322029	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL22RA2 mRNA	PMID:34876320
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1322028	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of IL22RA2 mRNA	PMID:18175754
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of IL22RA2 mRNA	PMID:30307764
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1322029	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of IL22RA2 mRNA; Nanotubes, Carbon results in decreased expression of IL22RA2 mRNA	PMID:25554681
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1322029	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of IL22RA2 mRNA	PMID:19042947
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1322029	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of IL22RA2 mRNA	PMID:23608068
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1322029	E	RGD:6480464	20140610	CTD	MESH:D011192	Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of IL22RA2 mRNA]	PMID:23608068
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:53578	hexamethylene diisocyanate	increases methylation	ISO	RGD:1322028	E	RGD:6480464	20150414	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in increased methylation of IL22RA2 gene	PMID:25445006
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:63613	nevirapine	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D019829	Nevirapine metabolite results in increased expression of IL22RA2 mRNA	PMID:23947594
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	ISO	RGD:1322028	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of IL22RA2 mRNA	PMID:30851411
1303169	Il22ra2	interleukin 22 receptor subunit alpha 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1322029	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL22RA2 mRNA	PMID:34876320
1303170	Jph4	junctophilin 4	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1315305	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of JPH4 mRNA	PMID:27188386
1303170	Jph4	junctophilin 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1553007	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of JPH4 mRNA	PMID:37315490
1303170	Jph4	junctophilin 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1553007	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of JPH4 mRNA	PMID:20188158
1303170	Jph4	junctophilin 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1315305	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of JPH4 mRNA	PMID:21934132
1303170	Jph4	junctophilin 4	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1315305	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of JPH4 mRNA	PMID:26079696
1303170	Jph4	junctophilin 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1553007	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of JPH4 mRNA	PMID:30319688
1303170	Jph4	junctophilin 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1553007	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of JPH4 mRNA	PMID:30319688
1303170	Jph4	junctophilin 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315305	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of JPH4 mRNA	PMID:35811015
1303170	Jph4	junctophilin 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1315305	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of JPH4 mRNA]	PMID:35811015
1303170	Jph4	junctophilin 4	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1315305	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of JPH4 mRNA	PMID:26079696
1303170	Jph4	junctophilin 4	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1315305	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of JPH4 mRNA	PMID:33647349
1303170	Jph4	junctophilin 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of JPH4 mRNA	PMID:33387578
1303170	Jph4	junctophilin 4	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1315305	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of JPH4 mRNA	PMID:28818685
1303170	Jph4	junctophilin 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of JPH4 mRNA	PMID:31150632
1303170	Jph4	junctophilin 4	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1315305	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of JPH4 mRNA	PMID:26272509
1303170	Jph4	junctophilin 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1315305	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA	PMID:27188386
1303170	Jph4	junctophilin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of JPH4 mRNA	PMID:33387578
1303170	Jph4	junctophilin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of JPH4 mRNA	PMID:32109520
1303170	Jph4	junctophilin 4	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1315305	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of JPH4 mRNA	PMID:26272509
1303170	Jph4	junctophilin 4	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1315305	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA	PMID:27188386
1303170	Jph4	junctophilin 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1315305	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of JPH4 mRNA	PMID:32763439
1303170	Jph4	junctophilin 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1315305	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of JPH4 5' UTR	PMID:27901495
1303170	Jph4	junctophilin 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1315305	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of JPH4 promoter	PMID:27901495
1303170	Jph4	junctophilin 4	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1315305	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of JPH4 mRNA	PMID:37690743
1303170	Jph4	junctophilin 4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1315305	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of JPH4 gene	PMID:31601247
1303170	Jph4	junctophilin 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553007	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of JPH4 gene	PMID:35295148
1303170	Jph4	junctophilin 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1553007	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of JPH4 gene	PMID:35295148
1303170	Jph4	junctophilin 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of JPH4 mRNA	PMID:34492290
1303170	Jph4	junctophilin 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of JPH4 mRNA	PMID:30816183
1303170	Jph4	junctophilin 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of JPH4 mRNA	PMID:25181051
1303170	Jph4	junctophilin 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1315305	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of JPH4 gene	PMID:31601247
1303170	Jph4	junctophilin 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1315305	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of JPH4 gene	PMID:31601247
1303170	Jph4	junctophilin 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1553007	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of JPH4 exon; bisphenol S affects the methylation of JPH4 gene	PMID:31683443|PMID:33297965
1303170	Jph4	junctophilin 4	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1553007	E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride affects the expression of JPH4 mRNA	PMID:29408670
1303170	Jph4	junctophilin 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315305	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of JPH4 mRNA	PMID:25979313
1303170	Jph4	junctophilin 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1315305	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of JPH4 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1303170	Jph4	junctophilin 4	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1315305	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of JPH4 gene	PMID:29154799
1303170	Jph4	junctophilin 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1315305	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH4 mRNA	PMID:27188386
1303170	Jph4	junctophilin 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1315305	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of JPH4 mRNA	PMID:24935251
1303170	Jph4	junctophilin 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553007	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of JPH4 mRNA	PMID:17562736
1303170	Jph4	junctophilin 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of JPH4 mRNA	PMID:33387578
1303170	Jph4	junctophilin 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1315305	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of JPH4 mRNA]	PMID:35811015
1303170	Jph4	junctophilin 4	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1315305	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of JPH4 mRNA	PMID:26272509
1303170	Jph4	junctophilin 4	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1315305	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA	PMID:27188386
1303170	Jph4	junctophilin 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553007	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of JPH4 mRNA	PMID:22206623
1303170	Jph4	junctophilin 4	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1315305	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of JPH4 mRNA	PMID:36318118
1303170	Jph4	junctophilin 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1315305	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH4 mRNA	PMID:27188386
1303170	Jph4	junctophilin 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of JPH4 mRNA	PMID:32109520
1303170	Jph4	junctophilin 4	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1315305	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of JPH4 mRNA	PMID:26079696
1303170	Jph4	junctophilin 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1315305	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH4 mRNA	PMID:27188386
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606817	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CLCF1 mRNA	PMID:38218311
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1550082	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CLCF1 mRNA	PMID:37995155
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CLCF1 mRNA]	PMID:31150632
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CLCF1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLCF1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CLCF1 gene	PMID:20938992|PMID:33549593
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CLCF1 mRNA	PMID:33729688
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1606817	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CLCF1 mRNA	PMID:22378314
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1606817	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CLCF1 mRNA	PMID:20044591
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CLCF1 mRNA	PMID:39241906
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1606817	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CLCF1 mRNA	PMID:35811015
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CLCF1 mRNA]	PMID:35811015
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1606817	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CLCF1 mRNA	PMID:30510588
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of CLCF1 mRNA	PMID:32145629
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606817	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of CLCF1 mRNA	PMID:31614463
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in decreased expression of CLCF1 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of CLCF1 mRNA	PMID:20404318|PMID:30165855
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1606817	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CLCF1 mRNA	PMID:38568856
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CLCF1 gene	PMID:27618143
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CLCF1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLCF1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CLCF1 gene	PMID:20938992|PMID:33549593
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLCF1 mRNA	PMID:37992649
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:17439	cyanocob(III)alamin	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20210608	CTD	MESH:D014805	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CLCF1 mRNA	PMID:33549593
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLCF1 mRNA	PMID:37992649
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1606817	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CLCF1 mRNA	PMID:31163220
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:17750	glycine betaine	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20210608	CTD	MESH:D001622	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CLCF1 mRNA	PMID:33549593
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CLCF1 mRNA	PMID:26577399
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CLCF1 mRNA	PMID:27523638
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1606817	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CLCF1 mRNA	PMID:26485663
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CLCF1 mRNA	PMID:36331819
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLCF1 mRNA	PMID:39836092
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1606817	E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of CLCF1 mRNA	PMID:22562489
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1606817	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CLCF1 mRNA	PMID:19549813
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1550082	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CLCF1 mRNA	PMID:16377760
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20120412	CTD	MESH:D009151	Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of CLCF1 mRNA]; Indomethacin inhibits the reaction [Mustard Gas results in increased expression of CLCF1 mRNA]	PMID:16377760
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in decreased expression of CLCF1 mRNA	PMID:33026818
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CLCF1 mRNA	PMID:34911549
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CLCF1 mRNA	PMID:33549593
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CLCF1 mRNA	PMID:18593933
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CLCF1 mRNA	PMID:31150632
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CLCF1 mRNA]	PMID:31150632
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CLCF1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLCF1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CLCF1 gene	PMID:20938992|PMID:33549593
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLCF1 mRNA	PMID:40504410
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLCF1 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CLCF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLCF1 mRNA	PMID:32525701|PMID:39836092
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA	PMID:33854195
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CLCF1 mRNA	PMID:31881176
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1606817	E	RGD:6480464	20150310	CTD	MESH:C059514	resveratrol results in decreased expression of CLCF1 mRNA	PMID:23224687
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CLCF1 mRNA	PMID:23557933
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1606817	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CLCF1 mRNA	PMID:24768652|PMID:25583101
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550082	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLCF1 mRNA	PMID:21570461
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLCF1 mRNA	PMID:33387578
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CLCF1 mRNA	PMID:31378766
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CLCF1 mRNA	PMID:27862939
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1606817	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CLCF1 mRNA	PMID:29803840
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLCF1 mRNA	PMID:37992649
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CLCF1 mRNA	PMID:29432896
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLCF1 mRNA	PMID:37682722
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606817	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CLCF1 mRNA	PMID:29301061|PMID:38568856
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLCF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLCF1 mRNA	PMID:34876320|PMID:40504410
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLCF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLCF1 mRNA	PMID:39836092
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLCF1 mRNA	PMID:34876320
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLCF1 mRNA	PMID:19770486|PMID:22228805
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CLCF1 mRNA	PMID:33549593
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CLCF1 mRNA	PMID:18593933
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1550082	E	RGD:6480464	20190219	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of CLCF1 mRNA	PMID:30171875
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1550082	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CLCF1 mRNA	PMID:27131904
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1606817	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of CLCF1 mRNA	PMID:26014281
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of CLCF1 mRNA	PMID:38458666
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1550082	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CLCF1 mRNA	PMID:39716349
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of CLCF1 mRNA	PMID:24915197
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1606817	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of CLCF1 mRNA	PMID:38568856
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CLCF1 mRNA	PMID:32479839
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CLCF1 mRNA	PMID:29264374
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550082	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CLCF1 gene	PMID:35295148
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CLCF1 mRNA	PMID:23411599|PMID:34492290
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550082	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CLCF1 mRNA	PMID:18445702
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of CLCF1 mRNA	PMID:19167457
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CLCF1 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606817	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CLCF1 mRNA	PMID:25047013
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CLCF1 mRNA	PMID:25181051
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLCF1 mRNA	PMID:28628672
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1550082	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CLCF1 mRNA	PMID:25172293
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1550082	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CLCF1 mRNA	PMID:26682919
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550082	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CLCF1 mRNA	PMID:30951980|PMID:40203079
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CLCF1 mRNA	PMID:38685157
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1550082	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CLCF1 promoter	PMID:28392331
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA	PMID:33854195
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLCF1 mRNA	PMID:28628672
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550082	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CLCF1 mRNA	PMID:24535843
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of CLCF1 mRNA	PMID:22110744
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of CLCF1 mRNA	PMID:30589522
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of CLCF1 mRNA	PMID:38458666
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLCF1 mRNA	PMID:39836092
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606817	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CLCF1 mRNA	PMID:38174414|PMID:38568856
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CLCF1 mRNA	PMID:25539665
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of CLCF1 mRNA	PMID:30047161
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of CLCF1 mRNA	PMID:24386269
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:3647	chlorpromazine	increases expression	ISO	RGD:1550082	E	RGD:6480464	20120412	CTD	MESH:D002746	Chlorpromazine results in increased expression of CLCF1 mRNA	PMID:21683644
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CLCF1 mRNA	PMID:40194260
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CLCF1 mRNA	PMID:36331819
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of CLCF1 mRNA	PMID:29038090
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606817	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CLCF1 mRNA	PMID:29154799
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1606817	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CLCF1 gene	PMID:29154799
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CLCF1 mRNA	PMID:30047161
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606817	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CLCF1 mRNA	PMID:25562108
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA	PMID:33854195
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLCF1 mRNA	PMID:28628672
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLCF1 mRNA	PMID:37992649
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1606817	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of CLCF1 mRNA	PMID:24449571
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA	PMID:33854195
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLCF1 mRNA	PMID:33387578
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CLCF1 mRNA]	PMID:35811015
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLCF1 mRNA	PMID:40504410
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLCF1 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CLCF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLCF1 mRNA	PMID:32525701|PMID:39836092
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1550082	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of CLCF1 mRNA	PMID:31099283
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CLCF1 mRNA	PMID:29391264
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLCF1 mRNA	PMID:34876320
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1606817	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of CLCF1 mRNA	PMID:38568856
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin inhibits the reaction [Mustard Gas results in increased expression of CLCF1 mRNA]	PMID:16377760
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLCF1 mRNA	PMID:28628672
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1550082	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CLCF1 mRNA	PMID:39716349
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1606817	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of CLCF1 mRNA	PMID:19194470
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of CLCF1 mRNA	PMID:23962444
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CLCF1 mRNA	PMID:30047161
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA	PMID:33854195
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:59224	cetrorelix	decreases expression	ISO	RGD:1606817	E	RGD:6480464	20120412	CTD	MESH:C062876	cetrorelix results in decreased expression of CLCF1 mRNA	PMID:21062912
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLCF1 mRNA	PMID:39836092
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1606817	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CLCF1 mRNA	PMID:28988120
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1550082	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CLCF1 mRNA	PMID:36851058
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:64198	dimercaprol	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20120412	CTD	MESH:D004112	Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of CLCF1 mRNA]	PMID:16377760
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of CLCF1 mRNA	PMID:35283115
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20250902	CTD	MESH:D008687	[imeglimin co-treated with Metformin] results in decreased expression of CLCF1 mRNA	PMID:37314160
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1550082	E	RGD:6480464	20231031	CTD	MESH:C057862	cyanoginosin LR results in increased expression of CLCF1 mRNA	PMID:37342990
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1606817	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CLCF1 mRNA	PMID:31758290
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1606817	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CLCF1 mRNA	PMID:37199045
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20260714	CTD	MESH:C575881	[imeglimin co-treated with Metformin] results in decreased expression of CLCF1 mRNA	PMID:37314160
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1606817	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of CLCF1 mRNA	PMID:30559759
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CLCF1 mRNA	PMID:21346803
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of CLCF1 mRNA	PMID:23665939
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550082	E	RGD:6480464	20210608	CTD	MESH:D010634	Phenobarbital results in increased expression of CLCF1 mRNA	PMID:33549593
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20210608	CTD	MESH:D010634	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CLCF1 mRNA	PMID:33549593
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of CLCF1 mRNA	PMID:39847705
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1550082	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLCF1 mRNA	PMID:34876320
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CLCF1 mRNA	PMID:32525701
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1606817	E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of CLCF1 mRNA	PMID:35688559
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1550082	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CLCF1 mRNA	PMID:21278054
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of CLCF1 mRNA	PMID:24780913
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CLCF1 mRNA	PMID:25825206|PMID:30047161
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1550082	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of CLCF1 mRNA	PMID:40826991
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1606817	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of CLCF1 mRNA	PMID:31734321
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1550082	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CLCF1 mRNA	PMID:27131904
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1606817	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of CLCF1 mRNA	PMID:26014281
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CLCF1 mRNA	PMID:21346803
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1606817	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CLCF1 mRNA	PMID:38568856
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1606817	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CLCF1 mRNA	PMID:29301935
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CLCF1 mRNA	PMID:21346803
1303171	Clcf1	cardiotrophin-like cytokine factor 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1550082	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of CLCF1 mRNA	PMID:32835833
1303172	Fancd2	FA complementation group D2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FANCD2 mRNA	PMID:38218311
1303172	Fancd2	FA complementation group D2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1615723	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of FANCD2 mRNA	PMID:33045310
1303172	Fancd2	FA complementation group D2	gene	CHEBI:137392	chlormequat chloride	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of FANCD2 protein	PMID:34958886
1303172	Fancd2	FA complementation group D2	gene	CHEBI:15343	acetaldehyde	increases expression	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D000079	Acetaldehyde results in increased expression of FANCD2 protein	PMID:18482162
1303172	Fancd2	FA complementation group D2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FANCD2 mRNA	PMID:33167477
1303172	Fancd2	FA complementation group D2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FANCD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FANCD2 mRNA	PMID:32699268
1303172	Fancd2	FA complementation group D2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of FANCD2 mRNA; Oxygen deficiency results in decreased expression of FANCD2 protein	PMID:26516004|PMID:28472268
1303172	Fancd2	FA complementation group D2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FANCD2 mRNA	PMID:26079696
1303172	Fancd2	FA complementation group D2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in increased expression of FANCD2 mRNA; Ethanol results in increased expression of FANCD2 protein	PMID:18482162
1303172	Fancd2	FA complementation group D2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1615723	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in increased expression of FANCD2 mRNA; Ethanol results in increased expression of FANCD2 protein	PMID:18482162
1303172	Fancd2	FA complementation group D2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of FANCD2 mRNA	PMID:32145629
1303172	Fancd2	FA complementation group D2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1343234	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of FANCD2 mRNA	PMID:19167446
1303172	Fancd2	FA complementation group D2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1615723	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FANCD2 mRNA	PMID:25510870
1303172	Fancd2	FA complementation group D2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of FANCD2 mRNA	PMID:23649840
1303172	Fancd2	FA complementation group D2	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of FANCD2 mRNA	PMID:26079696
1303172	Fancd2	FA complementation group D2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of FANCD2 mRNA	PMID:21592394
1303172	Fancd2	FA complementation group D2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of FANCD2 mRNA	PMID:21592394
1303172	Fancd2	FA complementation group D2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1343234	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FANCD2 protein	PMID:31163220
1303172	Fancd2	FA complementation group D2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1615723	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FANCD2 mRNA	PMID:34319233
1303172	Fancd2	FA complementation group D2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1343234	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FANCD2 protein	PMID:37730182
1303172	Fancd2	FA complementation group D2	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of FANCD2 mRNA	PMID:21592394
1303172	Fancd2	FA complementation group D2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of FANCD2 mRNA	PMID:21592394
1303172	Fancd2	FA complementation group D2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of FANCD2 mRNA	PMID:28818685
1303172	Fancd2	FA complementation group D2	gene	CHEBI:180654	N(4)-hydroxycytidine	increases expression	ISO	RGD:1343234	E	RGD:6480464	20251202	CTD	MESH:C010737	N(4)-hydroxycytidine results in increased expression of FANCD2 mRNA	PMID:40692086
1303172	Fancd2	FA complementation group D2	gene	CHEBI:180664	4-hydroxy-TEMPO	decreases response to substance	ISO	RGD:1615723	E	RGD:6480464	20211109	CTD	MESH:C001803	tempol results in decreased susceptibility to FANCD2 gene mutant form	PMID:22628295
1303172	Fancd2	FA complementation group D2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1343234	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of FANCD2 intron	PMID:30157460
1303172	Fancd2	FA complementation group D2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FANCD2 mRNA	PMID:39836092
1303172	Fancd2	FA complementation group D2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1615723	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FANCD2 mRNA	PMID:25510870
1303172	Fancd2	FA complementation group D2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1615723	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FANCD2 mRNA	PMID:25510870
1303172	Fancd2	FA complementation group D2	gene	CHEBI:23704	diepoxybutane	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20141223	CTD	MESH:C007366	[Arsenic Trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to diepoxybutane; [monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to diepoxybutane	PMID:25092648
1303172	Fancd2	FA complementation group D2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FANCD2 protein	PMID:23301498
1303172	Fancd2	FA complementation group D2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1343234	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FANCD2 intron	PMID:30157460
1303172	Fancd2	FA complementation group D2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FANCD2 mRNA	PMID:23630614|PMID:25378103
1303172	Fancd2	FA complementation group D2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of FANCD2 mRNA	PMID:25102026
1303172	Fancd2	FA complementation group D2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1615723	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of FANCD2 mRNA	PMID:24336422
1303172	Fancd2	FA complementation group D2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FANCD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FANCD2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of FANCD2 mRNA	PMID:32699268
1303172	Fancd2	FA complementation group D2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1615723	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FANCD2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FANCD2 mRNA	PMID:34911549
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of FANCD2 mRNA	PMID:24657277
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27504	mitomycin C	increases ubiquitination	ISO	RGD:1343234	E	RGD:6480464	20160119	CTD	MESH:D016685	Mitomycin results in increased ubiquitination of FANCD2 protein	PMID:26208482
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27504	mitomycin C	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20141223	CTD	MESH:D016685	[arsenic trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to Mitomycin; [monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to Mitomycin; Curcumin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]; Digitoxin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]; Digoxin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]; Mitomycin results in increased expression of and results in increased ubiquitination of FANCD2 protein; Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]; SB 203580 inhibits the reaction [Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]]	PMID:24124520|PMID:25092648
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20220906	CTD	MESH:D001151	Arsenic affects the expression of and affects the localization of FANCD2 protein	PMID:32920123
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of FANCD2 mRNA	PMID:31881176
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of FANCD2 mRNA	PMID:33775663
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27881	resveratrol	decreases response to substance	ISO	RGD:1615723	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in decreased susceptibility to FANCD2 gene mutant form	PMID:22628295
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of FANCD2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of FANCD2 mRNA	PMID:19167446|PMID:23557933
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1343234	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of FANCD2 mRNA	PMID:28903495
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1343234	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of FANCD2 mRNA	PMID:27594783
1303172	Fancd2	FA complementation group D2	gene	CHEBI:27899	cisplatin	increases ubiquitination	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased ubiquitination of FANCD2 protein	PMID:21324906
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615723	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FANCD2 mRNA	PMID:21570461
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FANCD2 mRNA	PMID:32109520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1615723	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FANCD2 mRNA	PMID:19465110
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of FANCD2 protein	PMID:39603559
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of FANCD2 mRNA	PMID:18191903
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28544	digitoxin	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20140114	CTD	MESH:D004074	Digitoxin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]	PMID:24124520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of FANCD2 mRNA	PMID:28959563
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D004317	Doxorubicin results in decreased expression of FANCD2 mRNA	PMID:27181935
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FANCD2 mRNA	PMID:30031762|PMID:36634904
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D004317	Fungal Polysaccharides inhibits the reaction [Doxorubicin results in decreased expression of FANCD2 mRNA]	PMID:27181935
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20230704	CTD	MESH:D004317	[TP53 protein affects the susceptibility to Doxorubicin] which affects the expression of FANCD2 mRNA; TP53 protein affects the reaction [Doxorubicin results in decreased expression of FANCD2 mRNA]	PMID:36634904
1303172	Fancd2	FA complementation group D2	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1343234	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of FANCD2 protein	PMID:35688186
1303172	Fancd2	FA complementation group D2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FANCD2 mRNA; sodium arsenite results in decreased expression of FANCD2 protein	PMID:38228842|PMID:38568856
1303172	Fancd2	FA complementation group D2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1343234	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of FANCD2 mRNA	PMID:29301061
1303172	Fancd2	FA complementation group D2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20141223	CTD	MESH:C020300	[monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to diepoxybutane; [monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to Hydroxyurea; [monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to Mitomycin	PMID:25092648
1303172	Fancd2	FA complementation group D2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343234	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FANCD2 intron	PMID:30157460
1303172	Fancd2	FA complementation group D2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FANCD2 mRNA	PMID:20064835
1303172	Fancd2	FA complementation group D2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1615723	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FANCD2 mRNA	PMID:22228805
1303172	Fancd2	FA complementation group D2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1343234	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FANCD2 mRNA	PMID:32234424
1303172	Fancd2	FA complementation group D2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to FANCD2 mRNA]	PMID:32406909
1303172	Fancd2	FA complementation group D2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1343234	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of FANCD2 mRNA	PMID:25895662
1303172	Fancd2	FA complementation group D2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FANCD2 mRNA	PMID:20382639
1303172	Fancd2	FA complementation group D2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to diepoxybutane; [Arsenic Trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to Hydroxyurea; [Arsenic Trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to Mitomycin	PMID:25092648
1303172	Fancd2	FA complementation group D2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of FANCD2 mRNA	PMID:25729387
1303172	Fancd2	FA complementation group D2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1615723	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of FANCD2 mRNA	PMID:23557971
1303172	Fancd2	FA complementation group D2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013853	Thioacetamide results in increased expression of FANCD2 mRNA	PMID:22659510
1303172	Fancd2	FA complementation group D2	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1615723	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of FANCD2 mRNA	PMID:19191707
1303172	Fancd2	FA complementation group D2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:C074702	chromium hexavalent ion results in increased ubiquitination of and results in increased activity of FANCD2 protein	PMID:16893675
1303172	Fancd2	FA complementation group D2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of FANCD2 mRNA	PMID:32145629
1303172	Fancd2	FA complementation group D2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FANCD2 mRNA	PMID:25181051|PMID:26982218|PMID:30816183|PMID:32528016|PMID:34947998
1303172	Fancd2	FA complementation group D2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of FANCD2 mRNA	PMID:29275510
1303172	Fancd2	FA complementation group D2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1343234	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of FANCD2 mRNA	PMID:25979313
1303172	Fancd2	FA complementation group D2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1615723	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FANCD2 mRNA	PMID:25510870
1303172	Fancd2	FA complementation group D2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1615723	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FANCD2 mRNA	PMID:25510870
1303172	Fancd2	FA complementation group D2	gene	CHEBI:3423	carmustine	affects localization	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine affects the localization of FANCD2 protein	PMID:17221219
1303172	Fancd2	FA complementation group D2	gene	CHEBI:3423	carmustine	increases ubiquitination	ISO	RGD:1343234	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased ubiquitination of FANCD2 protein	PMID:17221219
1303172	Fancd2	FA complementation group D2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FANCD2 mRNA	PMID:23196670
1303172	Fancd2	FA complementation group D2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1615723	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of FANCD2 mRNA	PMID:40203079
1303172	Fancd2	FA complementation group D2	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1615723	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of FANCD2 mRNA	PMID:36464114
1303172	Fancd2	FA complementation group D2	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20171114	CTD	MESH:C022838	nickel chloride results in decreased expression of FANCD2 mRNA; nickel chloride results in decreased expression of FANCD2 protein	PMID:28472268
1303172	Fancd2	FA complementation group D2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1615723	E	RGD:6480464	20190219	CTD	MESH:D010269	[ATG7 protein affects the susceptibility to Paraquat] which affects the expression of FANCD2 mRNA	PMID:28012437
1303172	Fancd2	FA complementation group D2	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of FANCD2 mRNA	PMID:26678675
1303172	Fancd2	FA complementation group D2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FANCD2 mRNA	PMID:39836092
1303172	Fancd2	FA complementation group D2	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of FANCD2 mRNA	PMID:18500788
1303172	Fancd2	FA complementation group D2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of FANCD2 mRNA	PMID:30723492
1303172	Fancd2	FA complementation group D2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of FANCD2 mRNA	PMID:25539665
1303172	Fancd2	FA complementation group D2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FANCD2 mRNA	PMID:24449571
1303172	Fancd2	FA complementation group D2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FANCD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FANCD2 mRNA	PMID:32699268
1303172	Fancd2	FA complementation group D2	gene	CHEBI:37598	nitrogen mustard	increases expression	ISO	RGD:1343234	E	RGD:6480464	20170103	CTD	MESH:D009588	Nitrogen Mustard Compounds results in increased expression of FANCD2 mRNA; Nitrogen Mustard Compounds results in increased expression of FANCD2 protein	PMID:27342729
1303172	Fancd2	FA complementation group D2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1615723	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of FANCD2 mRNA	PMID:40194260
1303172	Fancd2	FA complementation group D2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1615723	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FANCD2 mRNA	PMID:40194260
1303172	Fancd2	FA complementation group D2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FANCD2 mRNA	PMID:31533062
1303172	Fancd2	FA complementation group D2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1343234	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of FANCD2 mRNA	PMID:19167446
1303172	Fancd2	FA complementation group D2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCD2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FANCD2 mRNA	PMID:19167446
1303172	Fancd2	FA complementation group D2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1615723	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of FANCD2 mRNA	PMID:39529242
1303172	Fancd2	FA complementation group D2	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20140114	CTD	MESH:D003474	Curcumin results in decreased expression of FANCD2 mRNA	PMID:24124520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20140114	CTD	MESH:D003474	Curcumin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]	PMID:24124520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of FANCD2 mRNA	PMID:28001369
1303172	Fancd2	FA complementation group D2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FANCD2 mRNA	PMID:25562108
1303172	Fancd2	FA complementation group D2	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of FANCD2 mRNA	PMID:24657277
1303172	Fancd2	FA complementation group D2	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of FANCD2 mRNA	PMID:24657277
1303172	Fancd2	FA complementation group D2	gene	CHEBI:44423	hydroxyurea	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20141223	CTD	MESH:D006918	[arsenic trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to Hydroxyurea; [monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to Hydroxyurea	PMID:25092648
1303172	Fancd2	FA complementation group D2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1343234	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of FANCD2 mRNA	PMID:38832940
1303172	Fancd2	FA complementation group D2	gene	CHEBI:4551	digoxin	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20140114	CTD	MESH:D004077	Digoxin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]	PMID:24124520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of FANCD2 mRNA	PMID:29067470
1303172	Fancd2	FA complementation group D2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1343234	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of FANCD2 mRNA	PMID:22230336
1303172	Fancd2	FA complementation group D2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FANCD2 mRNA	PMID:29523930
1303172	Fancd2	FA complementation group D2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20220906	CTD	MESH:D001151	Arsenic affects the expression of and affects the localization of FANCD2 protein	PMID:32920123
1303172	Fancd2	FA complementation group D2	gene	CHEBI:472805	ouabain	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20140114	CTD	MESH:D010042	Ouabain results in decreased expression of FANCD2 mRNA	PMID:24124520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:472805	ouabain	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20140114	CTD	MESH:D010042	Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]; SB 203580 inhibits the reaction [Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]]	PMID:24124520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1343234	E	RGD:6480464	20190219	CTD	MESH:D004726	Endosulfan affects the expression of FANCD2 mRNA	PMID:29705383
1303172	Fancd2	FA complementation group D2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20190219	CTD	MESH:D004726	Endosulfan results in decreased expression of FANCD2 mRNA	PMID:30090376|PMID:40706910
1303172	Fancd2	FA complementation group D2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1343234	E	RGD:6480464	20190219	CTD	MESH:D004726	Endosulfan results in increased expression of FANCD2 protein	PMID:29705383
1303172	Fancd2	FA complementation group D2	gene	CHEBI:4791	endosulfan	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20190219	CTD	MESH:D004726	2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Endosulfan affects the expression of FANCD2 mRNA]	PMID:29705383
1303172	Fancd2	FA complementation group D2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to diepoxybutane; [Arsenic Trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to Hydroxyurea; [Arsenic Trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to Mitomycin	PMID:25092648
1303172	Fancd2	FA complementation group D2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of FANCD2 mRNA	PMID:24793618
1303172	Fancd2	FA complementation group D2	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of FANCD2 mRNA; Bortezomib results in decreased expression of FANCD2 protein	PMID:19934314|PMID:21917757
1303172	Fancd2	FA complementation group D2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1615723	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of FANCD2 mRNA	PMID:19042947
1303172	Fancd2	FA complementation group D2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FANCD2 protein	PMID:32959892
1303172	Fancd2	FA complementation group D2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FANCD2 mRNA	PMID:39836092
1303172	Fancd2	FA complementation group D2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of FANCD2 mRNA	PMID:25729387
1303172	Fancd2	FA complementation group D2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of FANCD2 mRNA	PMID:25729387
1303172	Fancd2	FA complementation group D2	gene	CHEBI:6382	Lasiocarpine	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FANCD2 mRNA	PMID:33884520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:63924	riddelliine	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FANCD2 mRNA	PMID:33884520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of FANCD2 mRNA	PMID:28988120
1303172	Fancd2	FA complementation group D2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of FANCD2 mRNA	PMID:37269647
1303172	Fancd2	FA complementation group D2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of FANCD2 mRNA	PMID:35283115
1303172	Fancd2	FA complementation group D2	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of FANCD2 mRNA	PMID:36519830
1303172	Fancd2	FA complementation group D2	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of FANCD2 mRNA	PMID:33884520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:72564	temozolomide	affects localization	ISO	RGD:1343234	E	RGD:6480464	20130305	CTD	MESH:C047246	temozolomide affects the localization of FANCD2 protein	PMID:17221219
1303172	Fancd2	FA complementation group D2	gene	CHEBI:72564	temozolomide	increases ubiquitination	ISO	RGD:1343234	E	RGD:6480464	20130305	CTD	MESH:C047246	temozolomide results in increased ubiquitination of FANCD2 protein	PMID:17221219
1303172	Fancd2	FA complementation group D2	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1615723	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of FANCD2 mRNA	PMID:36464114
1303172	Fancd2	FA complementation group D2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1615723	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FANCD2 mRNA	PMID:22206623
1303172	Fancd2	FA complementation group D2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of FANCD2 mRNA	PMID:29522793
1303172	Fancd2	FA complementation group D2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1343234	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of FANCD2 mRNA	PMID:37199045
1303172	Fancd2	FA complementation group D2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCD2 mRNA	PMID:19167446
1303172	Fancd2	FA complementation group D2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of FANCD2 mRNA	PMID:32234424
1303172	Fancd2	FA complementation group D2	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of FANCD2 mRNA	PMID:26079696
1303172	Fancd2	FA complementation group D2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FANCD2 mRNA	PMID:24780913
1303172	Fancd2	FA complementation group D2	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1343234	E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]]	PMID:24124520
1303172	Fancd2	FA complementation group D2	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of FANCD2 mRNA	PMID:32419051
1303172	Fancd2	FA complementation group D2	gene	CHEBI:94287	erastin	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C477224	erastin results in decreased expression of FANCD2 protein	PMID:32937103
1303172	Fancd2	FA complementation group D2	gene	CHEBI:95060	dinaciclib	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20240806	CTD	MESH:C553669	dinaciclib results in decreased expression of FANCD2 protein	PMID:27880910
1303172	Fancd2	FA complementation group D2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1343234	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of FANCD2 mRNA	PMID:19140230
1303172	Fancd2	FA complementation group D2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1615723	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of FANCD2 mRNA	PMID:35537566
1303172	Fancd2	FA complementation group D2	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of FANCD2 gene	PMID:31682807
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1551064	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of UBE4A mRNA	PMID:33045310
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1351066	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of UBE4A mRNA	PMID:15928584
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1551064	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of UBE4A mRNA	PMID:30319688
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1351066	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of UBE4A mRNA	PMID:21179406
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551064	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UBE4A mRNA	PMID:36331819
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1351066	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of UBE4A gene	PMID:27153756
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1351066	E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in increased expression of UBE4A protein	PMID:18089832
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:27928	parathion	decreases methylation	ISO	RGD:1351066	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of UBE4A promoter	PMID:22847954
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551064	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE4A mRNA	PMID:21570461
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1351066	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBE4A mRNA	PMID:30851411
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1351066	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBE4A protein	PMID:38228842
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351066	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UBE4A mRNA	PMID:38568856
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1351066	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UBE4A 3' UTR	PMID:27901495
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351066	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of UBE4A promoter	PMID:27901495
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551064	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBE4A gene	PMID:35295148
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of UBE4A mRNA	PMID:34492290
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1551064	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of UBE4A mRNA	PMID:18648102
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1351066	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE4A protein	PMID:34186270
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551064	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE4A mRNA	PMID:26063408|PMID:32156529
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UBE4A mRNA	PMID:25181051
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1351066	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of UBE4A protein	PMID:34186270
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of UBE4A mRNA	PMID:21241498
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551064	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of UBE4A mRNA	PMID:37019170
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351066	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBE4A mRNA	PMID:37042841
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1351066	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of UBE4A mRNA	PMID:24449571
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1551064	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of UBE4A mRNA	PMID:18353800
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:38689	fonofos	decreases methylation	ISO	RGD:1351066	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of UBE4A promoter	PMID:22847954
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1351066	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of UBE4A mRNA	PMID:31533062
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:38960	terbufos	decreases methylation	ISO	RGD:1351066	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of UBE4A promoter	PMID:22847954
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551064	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UBE4A mRNA	PMID:36331819
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351066	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBE4A mRNA	PMID:25979313
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351066	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of UBE4A mRNA	PMID:29154799
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551064	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBE4A mRNA	PMID:17562736
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1551064	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of UBE4A mRNA	PMID:29279043
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1351066	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of UBE4A mRNA	PMID:31675489
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1551064	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of UBE4A mRNA	PMID:35436446
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of UBE4A mRNA	PMID:30307764
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of UBE4A mRNA	PMID:24136188
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBE4A mRNA	PMID:24136188
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of UBE4A mRNA	PMID:24140754
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1351066	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UBE4A protein	PMID:32959892
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of UBE4A mRNA	PMID:30467583
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of UBE4A mRNA	PMID:24136188
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1351066	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBE4A mRNA	PMID:30851411
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1551064	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of UBE4A mRNA	PMID:22538082
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1351066	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of UBE4A mRNA	PMID:38568856
1303173	Ube4a	ubiquitination factor E4A	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1551064	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of UBE4A mRNA	PMID:28973697
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PPID mRNA	PMID:38218311
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1553037	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PPID mRNA	PMID:37995155
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1553037	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PPID mRNA	PMID:30319688
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1553037	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PPID mRNA	PMID:30319688
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PPID mRNA	PMID:21632981
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553037	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PPID mRNA	PMID:39241906
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of PPID mRNA]	PMID:39241906
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:D004958	Estradiol affects the expression of PPID mRNA	PMID:15598610
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PPID mRNA	PMID:39298647
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of PPID mRNA	PMID:29980752
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1342741	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PPID mRNA	PMID:37042841
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16664	albendazole	multiple interactions	ISO	RGD:1342741	E	RGD:6480464	20130514	CTD	MESH:D015766	[Ivermectin co-treated with Albendazole] results in decreased expression of PPID mRNA	PMID:16861626
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PPID mRNA	PMID:23649840
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:16954	vitexin	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20180828	CTD	MESH:C032731	vitexin inhibits the reaction [APP protein modified form results in increased expression of PPID mRNA]	PMID:29545167
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:17158	methylglyoxal	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D011765	Pyruvaldehyde results in increased expression of PPID protein	PMID:34455488
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:17158	methylglyoxal	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:D011765	Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased expression of PPID protein]	PMID:34455488
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:C031280	pyrazole results in increased expression of PPID mRNA	PMID:17945193
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:17287	N-phosphocreatine	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:D010725	Phosphocreatine inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPID protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased expression of PPID protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased expression of PPID protein]	PMID:34455488
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1342741	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PPID protein	PMID:37730182
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PPID mRNA	PMID:33387578
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PPID mRNA	PMID:36331819
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1342741	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPID mRNA	PMID:39836092
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1342741	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in increased expression of PPID mRNA	PMID:23369406
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPID mRNA	PMID:37236586|PMID:37325564
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1342741	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PPID mRNA	PMID:35430440
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PPID mRNA	PMID:17484886
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PPID mRNA	PMID:21867686
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PPID mRNA	PMID:25629700
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPID mRNA	PMID:22206623
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1342741	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPID gene	PMID:25304211
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1342741	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPID mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPID mRNA	PMID:39836092
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPID mRNA	PMID:40504410
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1342741	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PPID protein	PMID:35688186
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1553037	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PPID mRNA	PMID:28960355
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:C059514	resveratrol results in increased expression of PPID mRNA	PMID:22610192
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:D002945	Cisplatin results in decreased expression of PPID mRNA; Cisplatin results in decreased expression of PPID protein	PMID:21151649|PMID:29733421
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1342741	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of PPID mRNA	PMID:18000554
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553037	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPID mRNA	PMID:21570461|PMID:24680724
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPID protein	PMID:19492234
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of PPID protein	PMID:39603559
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1342741	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of PPID mRNA; Rotenone results in increased expression of PPID protein	PMID:18614807
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PPID mRNA	PMID:28001369
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1342741	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PPID protein	PMID:33212167
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:28299	quercetin 3-O-beta-D-glucofuranoside	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C016527	isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA]	PMID:25129099
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PPID mRNA	PMID:30851411
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:28527	rutin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D012431	Rutin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA]	PMID:25129099
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1342741	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PPID mRNA	PMID:32763439
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1342741	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPID mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPID mRNA	PMID:39836092
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPID mRNA	PMID:40504410
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PPID mRNA	PMID:19770486
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PPID mRNA	PMID:23806026
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1342741	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PPID mRNA	PMID:25895662
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PPID mRNA	PMID:19150397
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPID mRNA	PMID:25729387
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PPID mRNA	PMID:34492290
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PPID mRNA	PMID:18648102
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:C006253	pirinixic acid results in increased expression of PPID mRNA	PMID:18301758
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of PPID mRNA	PMID:19191707
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:3312	calcium dichloride	increases expression	ISO	RGD:1342741	E	RGD:6480464	20120412	CTD	MESH:D002122	Calcium Chloride results in increased expression of PPID mRNA; Calcium Chloride results in increased expression of PPID protein	PMID:18614807
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PPID mRNA	PMID:33221593
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1342741	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PPID gene	PMID:31601247
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PPID mRNA	PMID:25181051|PMID:32145629
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PPID mRNA	PMID:36041667
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553037	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PPID mRNA	PMID:39298647
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PPID mRNA	PMID:36041667
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PPID mRNA	PMID:36041667
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PPID mRNA	PMID:37019170
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of PPID mRNA	PMID:17602206
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of PPID mRNA]	PMID:39241906
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1342741	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPID mRNA	PMID:39836092
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1342741	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PPID mRNA	PMID:38174414
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPID mRNA	PMID:37236586|PMID:37325564
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of PPID mRNA	PMID:25908611
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:D002922	Ciguatoxins affects the expression of PPID mRNA	PMID:18353800
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1342741	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PPID mRNA	PMID:31533062
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1342741	E	RGD:6480464	20211109	CTD	MESH:C076994	perfluorooctane sulfonic acid promotes the reaction [BAX protein binds to PPID protein]	PMID:34006824
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PPID mRNA	PMID:36331819
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1342741	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PPID mRNA	PMID:23179753|PMID:25192806|PMID:27188386|PMID:28001369
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of PPID mRNA	PMID:41580965
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1342741	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PPID mRNA	PMID:25562108
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1342741	E	RGD:6480464	20120412	CTD	MESH:D008727	PPID protein affects the susceptibility to Methotrexate	PMID:16217747
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1342741	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of PPID mRNA	PMID:21678067
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PPID mRNA	PMID:24136188
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1342741	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PPID mRNA	PMID:27188386
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1342741	E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of PPID mRNA	PMID:27188386
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of PPID mRNA	PMID:17562736
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPID mRNA	PMID:33387578
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPID mRNA	PMID:21420995
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1342741	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPID gene	PMID:25304211
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1342741	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPID mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPID mRNA	PMID:39836092
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPID mRNA	PMID:40504410
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1553037	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PPID mRNA	PMID:35436446
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PPID mRNA; Nanotubes, Carbon results in decreased expression of PPID mRNA	PMID:25620056
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553037	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PPID mRNA; Nanotubes, Carbon results in increased expression of PPID mRNA	PMID:25554681
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of PPID mRNA	PMID:40234311
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:C029938	nickel sulfate results in decreased expression of PPID mRNA	PMID:16100012
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PPID mRNA	PMID:19042947
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PPID protein	PMID:32959892
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:6078	ivermectin	multiple interactions	ISO	RGD:1342741	E	RGD:6480464	20130514	CTD	MESH:D007559	[Ivermectin co-treated with Albendazole] results in decreased expression of PPID mRNA	PMID:16861626
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1342741	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPID mRNA	PMID:39836092
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPID mRNA	PMID:25729387
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PPID mRNA	PMID:24136188
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PPID mRNA	PMID:23650126
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:65329	LY294002	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPID protein	PMID:34455488
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C085911	Phosphocreatine inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPID protein]	PMID:34455488
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:6773	Mesaconitine	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in increased expression of PPID protein	PMID:37182599
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:68352	quercetin 3-O-beta-D-glucopyranoside	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C016527	isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA]	PMID:25129099
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553037	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PPID mRNA	PMID:22206623
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPID mRNA	PMID:22206623
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of PPID mRNA	PMID:28960945
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1342741	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PPID mRNA	PMID:30851411
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:78741	oxidopamine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D016627	Oxidopamine results in increased expression of PPID mRNA	PMID:25129099
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:78741	oxidopamine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D016627	isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA]; Levodopa inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA]; Rutin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA]	PMID:25129099
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of PPID protein	PMID:19954255
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1553037	E	RGD:6480464	20130618	CTD	MESH:C045950	propiconazole results in increased expression of PPID mRNA	PMID:21278054
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1553037	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of PPID mRNA]	PMID:39241906
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PPID mRNA	PMID:21346803
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013311	Streptozocin results in increased expression of PPID protein	PMID:34455488
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:D013311	Phosphocreatine inhibits the reaction [Streptozocin results in increased expression of PPID protein]	PMID:34455488
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PPID mRNA	PMID:21346803
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of PPID protein	PMID:32519852
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1553037	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of PPID mRNA	PMID:35537566
1303174	Ppid	peptidylprolyl isomerase D	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of PPID gene	PMID:31682807
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NMT2 mRNA]	PMID:31150632
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552755	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NMT2 mRNA	PMID:20938992
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NMT2 mRNA	PMID:33167477
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552755	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NMT2 mRNA	PMID:36331819
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1349505	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of NMT2 mRNA	PMID:16823088
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552755	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of NMT2 mRNA	PMID:30319688
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NMT2 mRNA	PMID:21632981
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1349505	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of NMT2 protein	PMID:35688186
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552755	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NMT2 mRNA	PMID:39241906
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of NMT2 mRNA	PMID:35811015
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552755	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NMT2 mRNA	PMID:39298647
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NMT2 mRNA	PMID:33387578
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552755	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NMT2 mRNA	PMID:20938992
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349505	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NMT2 mRNA	PMID:37042841
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552755	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of NMT2 mRNA	PMID:23892564
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552755	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NMT2 mRNA	PMID:33754040
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1349505	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of NMT2 protein	PMID:37730182
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of NMT2 mRNA	PMID:22061828
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NMT2 mRNA	PMID:22061828|PMID:33387578
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1349505	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NMT2 mRNA	PMID:28818685
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552755	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NMT2 mRNA	PMID:36331819
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:18248	iron atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D007501	[Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of NMT2 mRNA	PMID:24619124
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NMT2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of NMT2 mRNA	PMID:39836092
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NMT2 mRNA	PMID:35301059
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NMT2 mRNA	PMID:19549813
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NMT2 mRNA	PMID:22129741
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1349505	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of NMT2 mRNA	PMID:16823088
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NMT2 mRNA	PMID:31150632
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552755	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NMT2 mRNA	PMID:31919559
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NMT2 mRNA]	PMID:31150632
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552755	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NMT2 mRNA	PMID:20938992
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1349505	E	RGD:6480464	20120412	CTD	MESH:D016685	NMT2 protein affects the susceptibility to Mitomycin	PMID:16217747
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1349505	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NMT2 gene	PMID:25304211
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NMT2 mRNA	PMID:39836092
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:27638	cobalt atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003035	[Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of NMT2 mRNA	PMID:24619124
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552755	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of NMT2 mRNA	PMID:28960355
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:27998	tungsten	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D014414	[Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of NMT2 mRNA; [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of NMT2 mRNA	PMID:24619124
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1552755	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of NMT2 mRNA	PMID:32186404
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D009532	[Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of NMT2 mRNA; [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of NMT2 mRNA	PMID:24619124
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552755	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NMT2 mRNA	PMID:21570461
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased activity of NMT2 protein	PMID:11731439
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NMT2 mRNA	PMID:11731439|PMID:26232522
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of NMT2 mRNA	PMID:19013527
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NMT2 mRNA	PMID:33212167
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NMT2 mRNA	PMID:30851411
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of NMT2 mRNA	PMID:30556269
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1349505	E	RGD:6480464	20120412	CTD	MESH:D004317	NMT2 protein affects the susceptibility to Doxorubicin	PMID:16217747
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NMT2 mRNA	PMID:38568856
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NMT2 mRNA	PMID:39836092
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1552755	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of NMT2 mRNA	PMID:17127020
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349505	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NMT2 3' UTR	PMID:27901495
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of NMT2 mRNA	PMID:30556269
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1349505	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of NMT2 mRNA; Silicon Dioxide results in increased expression of NMT2 mRNA	PMID:25351596|PMID:25895662
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1349505	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NMT2 mRNA	PMID:20458559
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552755	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NMT2 promoter	PMID:35295148
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552755	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NMT2 gene	PMID:35295148
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NMT2 mRNA	PMID:23411599|PMID:34492290
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552755	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NMT2 mRNA	PMID:17950772|PMID:18301758|PMID:20813756|PMID:23811191
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552755	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of NMT2 mRNA]	PMID:17950772
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552755	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of NMT2 mRNA	PMID:32156529
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NMT2 mRNA	PMID:36041667
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of NMT2 mRNA	PMID:36804509
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NMT2 mRNA	PMID:23196670
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552755	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of NMT2 mRNA	PMID:39298647
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NMT2 mRNA	PMID:36041667
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1349505	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of NMT2 protein	PMID:34186270
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NMT2 mRNA	PMID:36041667
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1349505	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of NMT2 protein	PMID:34186270
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552755	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NMT2 mRNA	PMID:37019170
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552755	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NMT2 mRNA	PMID:21266533
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NMT2 mRNA	PMID:22129741
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C022838	nickel chloride results in increased expression of NMT2 mRNA	PMID:24619124
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349505	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NMT2 mRNA	PMID:37042841
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NMT2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of NMT2 mRNA	PMID:39836092
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NMT2 mRNA	PMID:35301059
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of NMT2 mRNA	PMID:25539665
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552755	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NMT2 mRNA	PMID:28903501
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NMT2 mRNA	PMID:19320972
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NMT2 mRNA	PMID:19167446
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552755	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NMT2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NMT2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NMT2 mRNA	PMID:36331819
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1552755	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NMT2 mRNA]	PMID:18200517
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1349505	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of NMT2 gene	PMID:29154799
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349505	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of NMT2 mRNA	PMID:24935251
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NMT2 mRNA	PMID:20106945|PMID:25562108
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1349505	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of NMT2 mRNA	PMID:24935251
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552755	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NMT2 mRNA	PMID:17562736
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of NMT2 mRNA	PMID:35811015
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1349505	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NMT2 gene	PMID:25304211
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NMT2 mRNA	PMID:39836092
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1349505	E	RGD:6480464	20120412	CTD	MESH:D005047	NMT2 protein affects the susceptibility to Etoposide	PMID:16217747
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1349505	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NMT2 mRNA	PMID:20458559
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552755	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NMT2 mRNA; Nanotubes, Carbon results in increased expression of NMT2 mRNA	PMID:25554681
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of NMT2 mRNA	PMID:22714537
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1552755	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of NMT2 mRNA	PMID:18200517
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1552755	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NMT2 mRNA]	PMID:18200517
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NMT2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of NMT2 mRNA	PMID:39836092
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1349505	E	RGD:6480464	20120412	CTD	MESH:D019772	NMT2 protein affects the susceptibility to Topotecan	PMID:16217747
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:63940	sodium tungstate	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C025399	sodium tungstate(VI) results in increased expression of NMT2 mRNA	PMID:24619124
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of NMT2 mRNA	PMID:28988120
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1552755	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of NMT2 protein	PMID:36851058
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552755	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NMT2 mRNA	PMID:22206623
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NMT2 mRNA	PMID:22714537
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NMT2 mRNA	PMID:30851411
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552755	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of NMT2 mRNA	PMID:23091169
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1349505	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NMT2 mRNA	PMID:19167446
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1349505	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of NMT2 mRNA	PMID:21858171
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:82664	iron(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D007501	[Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of NMT2 mRNA	PMID:24619124
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1552755	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of NMT2 mRNA	PMID:21278054
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:9130	sevoflurane	increases methylation	ISO	RGD:1552755	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased methylation of NMT2 mRNA	PMID:35249202
1303175	Nmt2	N-myristoyltransferase 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of NMT2 mRNA	PMID:19015723
1303176	Tspan5	tetraspanin 5	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1621556	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TSPAN5 mRNA	PMID:37995155
1303176	Tspan5	tetraspanin 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1621556	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TSPAN5 mRNA	PMID:20188158
1303176	Tspan5	tetraspanin 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TSPAN5; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TSPAN5 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TSPAN5 mRNA	PMID:20938992
1303176	Tspan5	tetraspanin 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of TSPAN5 mRNA	PMID:21934132
1303176	Tspan5	tetraspanin 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1602132	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TSPAN5 mRNA	PMID:23724009
1303176	Tspan5	tetraspanin 5	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TSPAN5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TSPAN5 mRNA	PMID:32699268
1303176	Tspan5	tetraspanin 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1621556	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TSPAN5 mRNA	PMID:30319688
1303176	Tspan5	tetraspanin 5	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1602132	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TSPAN5 mRNA	PMID:20044591
1303176	Tspan5	tetraspanin 5	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1602132	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TSPAN5 mRNA	PMID:21632981
1303176	Tspan5	tetraspanin 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1621556	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TSPAN5 mRNA	PMID:39241906
1303176	Tspan5	tetraspanin 5	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1602132	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of TSPAN5 mRNA	PMID:30510588
1303176	Tspan5	tetraspanin 5	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1602132	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of TSPAN5 mRNA	PMID:14699072
1303176	Tspan5	tetraspanin 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1602132	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of TSPAN5 mRNA	PMID:24758408
1303176	Tspan5	tetraspanin 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20160412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of TSPAN5 mRNA; EGF protein promotes the reaction [Estradiol results in increased expression of TSPAN5 mRNA]	PMID:24758408|PMID:30165855
1303176	Tspan5	tetraspanin 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TSPAN5; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TSPAN5 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TSPAN5 mRNA	PMID:20938992
1303176	Tspan5	tetraspanin 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602132	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TSPAN5 mRNA	PMID:37042841
1303176	Tspan5	tetraspanin 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TSPAN5 mRNA	PMID:37992649
1303176	Tspan5	tetraspanin 5	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of TSPAN5 mRNA	PMID:33647349
1303176	Tspan5	tetraspanin 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TSPAN5 mRNA	PMID:37992649
1303176	Tspan5	tetraspanin 5	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of TSPAN5 mRNA	PMID:16002434
1303176	Tspan5	tetraspanin 5	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TSPAN5 mRNA	PMID:33387578
1303176	Tspan5	tetraspanin 5	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1602132	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TSPAN5 mRNA	PMID:28818685
1303176	Tspan5	tetraspanin 5	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1602132	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TSPAN5 mRNA	PMID:27153756
1303176	Tspan5	tetraspanin 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TSPAN5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TSPAN5 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of TSPAN5 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TSPAN5 mRNA	PMID:32699268|PMID:35430440
1303176	Tspan5	tetraspanin 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TSPAN5; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TSPAN5 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TSPAN5 mRNA	PMID:20938992
1303176	Tspan5	tetraspanin 5	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1602132	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TSPAN5 gene	PMID:25304211
1303176	Tspan5	tetraspanin 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of TSPAN5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSPAN5 mRNA	PMID:39836092|PMID:40512198
1303176	Tspan5	tetraspanin 5	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of TSPAN5 gene	PMID:35440735
1303176	Tspan5	tetraspanin 5	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TSPAN5 mRNA	PMID:31881176
1303176	Tspan5	tetraspanin 5	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1602132	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of TSPAN5 mRNA	PMID:28903495
1303176	Tspan5	tetraspanin 5	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of TSPAN5 mRNA	PMID:19561079
1303176	Tspan5	tetraspanin 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1602132	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TSPAN5 mRNA	PMID:22298810
1303176	Tspan5	tetraspanin 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TSPAN5 mRNA	PMID:17942748
1303176	Tspan5	tetraspanin 5	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TSPAN5 mRNA	PMID:15467011
1303176	Tspan5	tetraspanin 5	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1602132	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of TSPAN5 mRNA	PMID:29803840
1303176	Tspan5	tetraspanin 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TSPAN5 mRNA	PMID:37992649
1303176	Tspan5	tetraspanin 5	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1602132	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of TSPAN5 mRNA	PMID:20044591
1303176	Tspan5	tetraspanin 5	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1602132	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TSPAN5 gene	PMID:28589171
1303176	Tspan5	tetraspanin 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602132	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TSPAN5 mRNA	PMID:39719251
1303176	Tspan5	tetraspanin 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of TSPAN5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSPAN5 mRNA	PMID:39836092|PMID:40512198
1303176	Tspan5	tetraspanin 5	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1602132	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of TSPAN5 mRNA	PMID:20106945|PMID:22316170
1303176	Tspan5	tetraspanin 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TSPAN5 mRNA	PMID:20064835|PMID:21632981
1303176	Tspan5	tetraspanin 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602132	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TSPAN5 promoter	PMID:27901495
1303176	Tspan5	tetraspanin 5	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TSPAN5 mRNA	PMID:15467011
1303176	Tspan5	tetraspanin 5	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TSPAN5 mRNA	PMID:20382639
1303176	Tspan5	tetraspanin 5	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TSPAN5 gene	PMID:31601247
1303176	Tspan5	tetraspanin 5	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TSPAN5 mRNA	PMID:25729387
1303176	Tspan5	tetraspanin 5	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TSPAN5 mRNA	PMID:30047161
1303176	Tspan5	tetraspanin 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621556	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TSPAN5 gene	PMID:35295148
1303176	Tspan5	tetraspanin 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1621556	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TSPAN5 gene	PMID:35295148
1303176	Tspan5	tetraspanin 5	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TSPAN5 mRNA	PMID:34492290
1303176	Tspan5	tetraspanin 5	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1621556	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TSPAN5 mRNA	PMID:17426115
1303176	Tspan5	tetraspanin 5	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of TSPAN5 mRNA	PMID:30690063
1303176	Tspan5	tetraspanin 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of TSPAN5 mRNA	PMID:22576693
1303176	Tspan5	tetraspanin 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN5 mRNA	PMID:25181051|PMID:32145629|PMID:41034487
1303176	Tspan5	tetraspanin 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1621556	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN5 mRNA	PMID:32156529
1303176	Tspan5	tetraspanin 5	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TSPAN5 gene	PMID:28505145
1303176	Tspan5	tetraspanin 5	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1602132	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of TSPAN5 gene	PMID:31601247
1303176	Tspan5	tetraspanin 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TSPAN5 gene	PMID:31601247
1303176	Tspan5	tetraspanin 5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TSPAN5 mRNA	PMID:23196670
1303176	Tspan5	tetraspanin 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621556	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TSPAN5 mRNA	PMID:40203079
1303176	Tspan5	tetraspanin 5	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1621556	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of TSPAN5 intron	PMID:28392331
1303176	Tspan5	tetraspanin 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1621556	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TSPAN5 mRNA	PMID:17361019
1303176	Tspan5	tetraspanin 5	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of TSPAN5 mRNA	PMID:36117858
1303176	Tspan5	tetraspanin 5	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of TSPAN5 gene	PMID:33148267
1303176	Tspan5	tetraspanin 5	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in decreased expression of TSPAN5 mRNA]	PMID:19030233
1303176	Tspan5	tetraspanin 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602132	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TSPAN5 mRNA	PMID:37042841
1303176	Tspan5	tetraspanin 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TSPAN5 mRNA	PMID:38174414
1303176	Tspan5	tetraspanin 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TSPAN5 mRNA	PMID:33453195
1303176	Tspan5	tetraspanin 5	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TSPAN5 mRNA	PMID:27387713
1303176	Tspan5	tetraspanin 5	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TSPAN5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TSPAN5 mRNA	PMID:32699268
1303176	Tspan5	tetraspanin 5	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TSPAN5 mRNA	PMID:31533062
1303176	Tspan5	tetraspanin 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602132	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TSPAN5 mRNA	PMID:25979313
1303176	Tspan5	tetraspanin 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TSPAN5 mRNA	PMID:26272509
1303176	Tspan5	tetraspanin 5	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1602132	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TSPAN5 gene	PMID:29154799
1303176	Tspan5	tetraspanin 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602132	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of TSPAN5 mRNA	PMID:19101580|PMID:23179753|PMID:24935251|PMID:29154799
1303176	Tspan5	tetraspanin 5	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN5 mRNA	PMID:27188386
1303176	Tspan5	tetraspanin 5	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TSPAN5 mRNA	PMID:30047161
1303176	Tspan5	tetraspanin 5	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1602132	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TSPAN5 mRNA	PMID:25562108
1303176	Tspan5	tetraspanin 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1621556	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TSPAN5 mRNA	PMID:28973697
1303176	Tspan5	tetraspanin 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TSPAN5 mRNA	PMID:37992649
1303176	Tspan5	tetraspanin 5	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1602132	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TSPAN5 mRNA	PMID:38832940
1303176	Tspan5	tetraspanin 5	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of TSPAN5 mRNA	PMID:26272509
1303176	Tspan5	tetraspanin 5	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN5 mRNA	PMID:27188386
1303176	Tspan5	tetraspanin 5	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TSPAN5 mRNA	PMID:24935251|PMID:26272509
1303176	Tspan5	tetraspanin 5	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN5 mRNA	PMID:27188386
1303176	Tspan5	tetraspanin 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621556	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TSPAN5 mRNA	PMID:17562736
1303176	Tspan5	tetraspanin 5	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TSPAN5 mRNA	PMID:33387578
1303176	Tspan5	tetraspanin 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1602132	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TSPAN5 mRNA	PMID:29067470
1303176	Tspan5	tetraspanin 5	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1602132	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TSPAN5 gene	PMID:25304211
1303176	Tspan5	tetraspanin 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of TSPAN5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSPAN5 mRNA	PMID:39836092|PMID:40512198
1303176	Tspan5	tetraspanin 5	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TSPAN5 mRNA	PMID:29391264
1303176	Tspan5	tetraspanin 5	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TSPAN5 mRNA	PMID:22079256
1303176	Tspan5	tetraspanin 5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1621556	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TSPAN5 mRNA	PMID:17942748
1303176	Tspan5	tetraspanin 5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TSPAN5 mRNA	PMID:17942748
1303176	Tspan5	tetraspanin 5	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1602132	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of TSPAN5 mRNA	PMID:38568856
1303176	Tspan5	tetraspanin 5	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1621556	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TSPAN5 mRNA	PMID:25554681
1303176	Tspan5	tetraspanin 5	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D015735	Mifepristone results in decreased expression of TSPAN5 mRNA	PMID:25972201
1303176	Tspan5	tetraspanin 5	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1621556	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of TSPAN5 mRNA	PMID:36117858
1303176	Tspan5	tetraspanin 5	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1621556	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of TSPAN5 mRNA	PMID:20829426
1303176	Tspan5	tetraspanin 5	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of TSPAN5 mRNA	PMID:25729387
1303176	Tspan5	tetraspanin 5	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TSPAN5 mRNA	PMID:25729387
1303176	Tspan5	tetraspanin 5	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1602132	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TSPAN5 mRNA	PMID:15336504
1303176	Tspan5	tetraspanin 5	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TSPAN5 gene	PMID:35440735
1303176	Tspan5	tetraspanin 5	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of TSPAN5 gene	PMID:33148267
1303176	Tspan5	tetraspanin 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1621556	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TSPAN5 mRNA	PMID:22206623
1303176	Tspan5	tetraspanin 5	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TSPAN5 mRNA	PMID:22079256|PMID:22714537
1303176	Tspan5	tetraspanin 5	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TSPAN5 mRNA	PMID:22079256
1303176	Tspan5	tetraspanin 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN5 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN5 mRNA	PMID:27188386
1303176	Tspan5	tetraspanin 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TSPAN5 gene]	PMID:28238834
1303176	Tspan5	tetraspanin 5	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1621556	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of TSPAN5 mRNA	PMID:21795629|PMID:39847705
1303176	Tspan5	tetraspanin 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TSPAN5 mRNA	PMID:18077114|PMID:24780913
1303176	Tspan5	tetraspanin 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TSPAN5 mRNA	PMID:30047161
1303176	Tspan5	tetraspanin 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602132	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN5 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN5 mRNA	PMID:27188386
1303176	Tspan5	tetraspanin 5	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TSPAN5 mRNA	PMID:19281266
1303176	Tspan5	tetraspanin 5	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1602132	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TSPAN5 mRNA	PMID:29301935
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1331949	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TOP1MT mRNA	PMID:30529165
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1331949	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TOP1MT mRNA	PMID:36331819
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1331949	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TOP1MT mRNA	PMID:39241906
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1331949	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TOP1MT mRNA	PMID:39298647
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1331949	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TOP1MT mRNA	PMID:36331819
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1331949	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of TOP1MT mRNA	PMID:24489787
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1331949	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TOP1MT mRNA	PMID:22206623
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1351494	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TOP1MT mRNA	PMID:27392435
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1331949	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TOP1MT mRNA	PMID:21570461
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TOP1MT mRNA	PMID:33387578
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1351494	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TOP1MT mRNA	PMID:38568856
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1351494	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of TOP1MT mRNA	PMID:22378314
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1331949	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TOP1MT mRNA	PMID:22228805
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:3048	benzatropine	increases expression	ISO	RGD:1351494	E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of TOP1MT protein	PMID:34122009
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1351494	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TOP1MT gene	PMID:31601247
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of TOP1MT mRNA	PMID:24136188
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TOP1MT mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1331949	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TOP1MT mRNA	PMID:33221593
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1351494	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of TOP1MT mRNA	PMID:22576693
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TOP1MT mRNA	PMID:25181051
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TOP1MT gene	PMID:28505145
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1351494	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of TOP1MT gene	PMID:22576693
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1351494	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TOP1MT gene	PMID:31601247
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1331949	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of TOP1MT mRNA	PMID:25172293
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1351494	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TOP1MT mRNA	PMID:25979313
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1331949	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TOP1MT mRNA	PMID:39298647
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1351494	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TOP1MT mRNA	PMID:28628672
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1351494	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TOP1MT mRNA	PMID:28628672
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of TOP1MT gene	PMID:22079235
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1351494	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of TOP1MT protein	PMID:34122009
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1351494	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TOP1MT mRNA	PMID:31533062
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331949	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TOP1MT mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TOP1MT mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TOP1MT mRNA	PMID:36331819
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351494	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TOP1MT mRNA	PMID:25979313
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1351494	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of TOP1MT mRNA	PMID:29154799
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1351494	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TOP1MT gene	PMID:29154799
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1351494	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TOP1MT mRNA	PMID:28628672
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TOP1MT mRNA	PMID:33387578
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1351494	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of TOP1MT mRNA	PMID:29523930
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1351494	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TOP1MT mRNA	PMID:18175754
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1351494	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TOP1MT mRNA	PMID:28628672
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TOP1MT mRNA	PMID:24136188
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1331949	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TOP1MT mRNA	PMID:22206623
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TOP1MT mRNA	PMID:19281266
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1351494	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of TOP1MT mRNA	PMID:22378314
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TOP1MT mRNA	PMID:21346803
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of TOP1MT mRNA	PMID:22615374
1303177	Top1mt	DNA topoisomerase I mitochondrial	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of TOP1MT gene	PMID:31079544
1303178	Nanog	Nanog homeobox	gene	CHEBI:100241	ciprofloxacin	increases expression	ISO	RGD:1347686	E	RGD:6480464	20160510	CTD	MESH:D002939	Ciprofloxacin results in increased expression of NANOG protein	PMID:26947806
1303178	Nanog	Nanog homeobox	gene	CHEBI:113532	thymoquinone	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in decreased expression of NANOG protein	PMID:31298468
1303178	Nanog	Nanog homeobox	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1347686	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of NANOG mRNA	PMID:26272509
1303178	Nanog	Nanog homeobox	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA	PMID:27188386
1303178	Nanog	Nanog homeobox	gene	CHEBI:143794	3,5,6-trichloro-2-pyridinol	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20191114	CTD	MESH:C012587	3,5,6-trichloro-2-pyridinol results in decreased expression of NANOG mRNA	PMID:23220036
1303178	Nanog	Nanog homeobox	gene	CHEBI:145994	remdesivir	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20221101	CTD	MESH:C000606551	remdesivir results in decreased expression of NANOG mRNA	PMID:35605700
1303178	Nanog	Nanog homeobox	gene	CHEBI:147281	GS-441524	increases expression	ISO	RGD:1553059	E	RGD:6480464	20221101	CTD	MESH:C000710751	GS-441524 results in increased expression of NANOG mRNA	PMID:35605700
1303178	Nanog	Nanog homeobox	gene	CHEBI:149906	Tanshinone I	increases expression	ISO	RGD:1553059	E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone results in increased expression of NANOG mRNA	PMID:25186638
1303178	Nanog	Nanog homeobox	gene	CHEBI:149906	Tanshinone I	multiple interactions	EXP		E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone inhibits the reaction [Estrogens deficiency results in decreased expression of NANOG protein]	PMID:31108107
1303178	Nanog	Nanog homeobox	gene	CHEBI:15366	acetic acid	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20120717	CTD	MESH:D019342	Acetic Acid results in decreased expression of NANOG protein	PMID:21296659
1303178	Nanog	Nanog homeobox	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1347686	E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of NANOG mRNA	PMID:31600526
1303178	Nanog	Nanog homeobox	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20120613	CTD	MESH:D014212	Tretinoin results in decreased expression of NANOG mRNA	PMID:16168501|PMID:17138961|PMID:25566775
1303178	Nanog	Nanog homeobox	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20140610	CTD	MESH:D014212	Tretinoin results in decreased expression of NANOG mRNA	PMID:22466603
1303178	Nanog	Nanog homeobox	gene	CHEBI:15367	all-trans-retinoic acid	increases cleavage	ISO	RGD:1553059	E	RGD:6480464	20190219	CTD	MESH:D014212	Tretinoin results in increased cleavage of NANOG protein	PMID:29767511
1303178	Nanog	Nanog homeobox	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1553059	E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin results in increased expression of NANOG protein	PMID:30442713
1303178	Nanog	Nanog homeobox	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20190507	CTD	MESH:D014212	[Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of NANOG protein	PMID:30093655
1303178	Nanog	Nanog homeobox	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20120412	CTD	MESH:D014212	NR6A1 protein affects the reaction [Tretinoin results in decreased expression of NANOG mRNA]	PMID:16166633
1303178	Nanog	Nanog homeobox	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20250311	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NANOG protein	PMID:38909692
1303178	Nanog	Nanog homeobox	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20160210	CTD	MESH:D010100	Oxygen deficiency promotes the reaction [LIF protein affects the reaction NANOG mRNA]	PMID:26723917
1303178	Nanog	Nanog homeobox	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of NANOG mRNA	PMID:24763279
1303178	Nanog	Nanog homeobox	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of NANOG mRNA	PMID:26079696
1303178	Nanog	Nanog homeobox	gene	CHEBI:15866	2-deoxy-D-glucose	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20250902	CTD	MESH:D003847	Deoxyglucose results in decreased expression of NANOG protein	PMID:39617259
1303178	Nanog	Nanog homeobox	gene	CHEBI:15866	2-deoxy-D-glucose	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20250902	CTD	MESH:D003847	Deoxyglucose inhibits the reaction [ANP32E protein results in increased expression of NANOG protein]; Deoxyglucose inhibits the reaction [CALML3-AS1 results in increased expression of NANOG protein]	PMID:39617259|PMID:40557837
1303178	Nanog	Nanog homeobox	gene	CHEBI:16226	limonin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20200519	CTD	MESH:C001546	limonin results in decreased expression of NANOG mRNA; limonin results in decreased expression of NANOG protein	PMID:30738134
1303178	Nanog	Nanog homeobox	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D000431	Ethanol results in increased expression of NANOG mRNA	PMID:29769550
1303178	Nanog	Nanog homeobox	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1347686	E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in increased expression of NANOG mRNA	PMID:23378141
1303178	Nanog	Nanog homeobox	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20170110	CTD	MESH:D011794	Quercetin results in decreased expression of NANOG protein	PMID:22422628|PMID:23918355|PMID:27468969
1303178	Nanog	Nanog homeobox	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	NANOG inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; NANOG inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NANOG inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; NANOG inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; NANOG inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; NANOG inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:22200792
1303178	Nanog	Nanog homeobox	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20150127	CTD	MESH:D014260	Triclosan results in decreased expression of NANOG mRNA; Triclosan results in decreased expression of NANOG protein	PMID:24879426|PMID:36243240
1303178	Nanog	Nanog homeobox	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1347686	E	RGD:6480464	20150825	CTD	MESH:D004958	Estradiol results in increased expression of NANOG mRNA; Estradiol results in increased expression of NANOG protein	PMID:23391485|PMID:34719554
1303178	Nanog	Nanog homeobox	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1553059	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of NANOG mRNA	PMID:33711761
1303178	Nanog	Nanog homeobox	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NANOG mRNA	PMID:33387578
1303178	Nanog	Nanog homeobox	gene	CHEBI:167657	CHIR-98014	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20210406	CTD	MESH:C473710	Chir 98014 results in decreased expression of NANOG mRNA	PMID:22723015
1303178	Nanog	Nanog homeobox	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1553059	E	RGD:6480464	20241001	CTD	MESH:D005557	Formaldehyde results in increased expression of NANOG mRNA	PMID:33233951
1303178	Nanog	Nanog homeobox	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20240305	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of NANOG protein	PMID:37364752
1303178	Nanog	Nanog homeobox	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1347686	E	RGD:6480464	20220111	CTD	MESH:D013739	Testosterone results in increased expression of NANOG mRNA	PMID:34719554
1303178	Nanog	Nanog homeobox	gene	CHEBI:175901	gemcitabine	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in decreased expression of NANOG mRNA	PMID:25605917|PMID:35063459
1303178	Nanog	Nanog homeobox	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1347686	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of NANOG mRNA; Nicotine results in increased expression of NANOG protein	PMID:23219715
1303178	Nanog	Nanog homeobox	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1553059	E	RGD:6480464	20200804	CTD	MESH:D009538	Nicotine results in increased expression of NANOG protein	PMID:31507073
1303178	Nanog	Nanog homeobox	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of NANOG protein; SNAI1 mutant form inhibits the reaction [Nicotine results in increased expression of NANOG mRNA]	PMID:23219715|PMID:30259641
1303178	Nanog	Nanog homeobox	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NANOG mRNA	PMID:31163220
1303178	Nanog	Nanog homeobox	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20170613	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NANOG mRNA	PMID:28286118
1303178	Nanog	Nanog homeobox	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NANOG protein	PMID:37364752
1303178	Nanog	Nanog homeobox	gene	CHEBI:17846	(S)-naringenin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20170110	CTD	MESH:C005273	naringenin results in decreased expression of NANOG protein	PMID:27468969
1303178	Nanog	Nanog homeobox	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of NANOG mRNA	PMID:28818685
1303178	Nanog	Nanog homeobox	gene	CHEBI:18388	apigenin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20170110	CTD	MESH:D047310	Apigenin results in decreased expression of NANOG protein	PMID:27468969
1303178	Nanog	Nanog homeobox	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1347686	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of NANOG mRNA; Nicotine results in increased expression of NANOG protein	PMID:23219715
1303178	Nanog	Nanog homeobox	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1553059	E	RGD:6480464	20200804	CTD	MESH:D009538	Nicotine results in increased expression of NANOG protein	PMID:31507073
1303178	Nanog	Nanog homeobox	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of NANOG protein; SNAI1 mutant form inhibits the reaction [Nicotine results in increased expression of NANOG mRNA]	PMID:23219715|PMID:30259641
1303178	Nanog	Nanog homeobox	gene	CHEBI:210866	Antrocin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20231219	CTD	MESH:C558369	antrocin analog results in decreased expression of NANOG protein	PMID:36565974
1303178	Nanog	Nanog homeobox	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of NANOG mRNA	PMID:24376830
1303178	Nanog	Nanog homeobox	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20230801	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NANOG mRNA	PMID:36602393
1303178	Nanog	Nanog homeobox	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20260804	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NANOG protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased methylation of NANOG gene; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NANOG mRNA	PMID:35334236
1303178	Nanog	Nanog homeobox	gene	CHEBI:26267	proanthocyanidin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20240109	CTD	MESH:D044945	Proanthocyanidins results in decreased expression of NANOG protein	PMID:37551626
1303178	Nanog	Nanog homeobox	gene	CHEBI:26267	proanthocyanidin	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20240109	CTD	MESH:D044945	Lithium Chloride inhibits the reaction [Proanthocyanidins results in decreased expression of NANOG protein]	PMID:37551626
1303178	Nanog	Nanog homeobox	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1553059	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of NANOG mRNA	PMID:25629700
1303178	Nanog	Nanog homeobox	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1347686	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of NANOG mRNA	PMID:37624150
1303178	Nanog	Nanog homeobox	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of NANOG mRNA	PMID:28189721|PMID:28960355
1303178	Nanog	Nanog homeobox	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20141223	CTD	MESH:C059514	resveratrol results in decreased expression of NANOG mRNA; resveratrol results in decreased expression of NANOG protein	PMID:21304978|PMID:22692956|PMID:23651583
1303178	Nanog	Nanog homeobox	gene	CHEBI:27881	resveratrol	decreases response to substance	ISO	RGD:1347686	E	RGD:6480464	20130122	CTD	MESH:C059514	NANOG protein results in decreased susceptibility to resveratrol	PMID:21304978
1303178	Nanog	Nanog homeobox	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20141223	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of NANOG mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Resveratrol results in decreased expression of NANOG protein]; TP53 mutant form inhibits the reaction [Resveratrol results in decreased expression of NANOG protein]	PMID:23651583|PMID:41028656
1303178	Nanog	Nanog homeobox	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin results in decreased expression of NANOG mRNA	PMID:23300844
1303178	Nanog	Nanog homeobox	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1347686	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of NANOG mRNA; Cisplatin results in increased expression of NANOG protein	PMID:21618587
1303178	Nanog	Nanog homeobox	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with Paclitaxel] results in increased expression of NANOG mRNA; [Cisplatin co-treated with Paclitaxel] results in increased expression of NANOG protein; [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of NANOG mRNA; [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of NANOG protein; [NEAT1 protein affects the susceptibility to Cisplatin] which affects the expression of NANOG protein	PMID:20705681|PMID:21342274|PMID:30291867|PMID:30871063
1303178	Nanog	Nanog homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NANOG mRNA	PMID:33387578
1303178	Nanog	Nanog homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1347686	E	RGD:6480464	20190219	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NANOG mRNA	PMID:30203000
1303178	Nanog	Nanog homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553059	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NANOG mRNA	PMID:24058054
1303178	Nanog	Nanog homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20190219	CTD	MESH:D013749	N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NANOG mRNA]	PMID:30203000
1303178	Nanog	Nanog homeobox	gene	CHEBI:28171	5-hydroxytryptophan	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20211012	CTD	MESH:D006916	5-Hydroxytryptophan results in decreased expression of NANOG mRNA	PMID:32926198
1303178	Nanog	Nanog homeobox	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of NANOG mRNA	PMID:33512557
1303178	Nanog	Nanog homeobox	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20210608	CTD	MESH:D012402	Rotenone inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]	PMID:32949729
1303178	Nanog	Nanog homeobox	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1347686	E	RGD:6480464	20141014	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NANOG mRNA; methylmercuric chloride results in increased expression of NANOG protein	PMID:22555245|PMID:23903816|PMID:34328791
1303178	Nanog	Nanog homeobox	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20121009	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of NANOG mRNA	PMID:22105179
1303178	Nanog	Nanog homeobox	gene	CHEBI:28499	kaempferol	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20220607	CTD	MESH:C006552	kaempferol results in decreased expression of NANOG mRNA; kaempferol results in decreased expression of NANOG protein	PMID:35063459
1303178	Nanog	Nanog homeobox	gene	CHEBI:28499	kaempferol	increases expression	ISO	RGD:1553059	E	RGD:6480464	20170516	CTD	MESH:C006552	kaempferol results in increased expression of NANOG protein	PMID:26683311
1303178	Nanog	Nanog homeobox	gene	CHEBI:28499	kaempferol	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20220607	CTD	MESH:C006552	[Verapamil co-treated with kaempferol] results in decreased expression of NANOG mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of NANOG protein	PMID:35063459
1303178	Nanog	Nanog homeobox	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of NANOG mRNA	PMID:28959563
1303178	Nanog	Nanog homeobox	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of NANOG mRNA	PMID:41028656
1303178	Nanog	Nanog homeobox	gene	CHEBI:28824	stigmasterol	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20181113	CTD	MESH:D013265	Stigmasterol results in decreased expression of NANOG mRNA	PMID:30245210
1303178	Nanog	Nanog homeobox	gene	CHEBI:28824	stigmasterol	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20181113	CTD	MESH:D013265	[bisphenol A co-treated with Stigmasterol] results in decreased expression of NANOG mRNA; Stigmasterol inhibits the reaction [GW 4064 results in decreased expression of NANOG mRNA]	PMID:30245210
1303178	Nanog	Nanog homeobox	gene	CHEBI:28834	deoxycholic acid	increases expression	ISO	RGD:1553059	E	RGD:6480464	20180220	CTD	MESH:D003840	Deoxycholic Acid results in increased expression of NANOG mRNA	PMID:27151938
1303178	Nanog	Nanog homeobox	gene	CHEBI:28865	taurocholic acid	increases expression	ISO	RGD:1553059	E	RGD:6480464	20180220	CTD	MESH:D013656	Taurocholic Acid results in increased expression of NANOG mRNA	PMID:27151938
1303178	Nanog	Nanog homeobox	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20210406	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [ovatodiolide results in decreased expression of NANOG protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NANOG protein]	PMID:32745510|PMID:39276908
1303178	Nanog	Nanog homeobox	gene	CHEBI:28955	2-methoxy-17beta-estradiol	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20191114	CTD	MESH:C022830	2-Methoxyestradiol inhibits the reaction [Curcumin results in increased expression of NANOG mRNA]	PMID:25822711
1303178	Nanog	Nanog homeobox	gene	CHEBI:29014	cordycepin	affects expression	ISO	RGD:1347686	E	RGD:6480464	20231205	CTD	MESH:C058120	cordycepin affects the expression of NANOG mRNA	PMID:36881089
1303178	Nanog	Nanog homeobox	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1553059	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of NANOG protein	PMID:32042022
1303178	Nanog	Nanog homeobox	gene	CHEBI:29014	cordycepin	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20231205	CTD	MESH:C058120	sirtinol inhibits the reaction [cordycepin results in increased expression of NANOG mRNA]	PMID:36881089
1303178	Nanog	Nanog homeobox	gene	CHEBI:29014	cordycepin	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20240109	CTD	MESH:C058120	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [cordycepin results in increased expression of NANOG protein]	PMID:32042022
1303178	Nanog	Nanog homeobox	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1347686	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite affects the expression of NANOG mRNA	PMID:29301061
1303178	Nanog	Nanog homeobox	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1553059	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite affects the expression of NANOG mRNA	PMID:28370166
1303178	Nanog	Nanog homeobox	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of NANOG mRNA; sodium arsenite results in decreased expression of NANOG protein	PMID:19615344|PMID:23219847|PMID:32844245
1303178	Nanog	Nanog homeobox	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of NANOG protein	PMID:23143138|PMID:23219847
1303178	Nanog	Nanog homeobox	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347686	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of NANOG mRNA	PMID:24431212|PMID:31120745
1303178	Nanog	Nanog homeobox	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1553059	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of NANOG mRNA; sodium arsenite results in increased expression of NANOG protein	PMID:22641621|PMID:26438402
1303178	Nanog	Nanog homeobox	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Benzo(a)pyrene] results in increased expression of NANOG protein; METTL3 protein promotes the reaction [[sodium arsenite co-treated with Benzo(a)pyrene] results in increased expression of NANOG protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of NANOG mRNA]	PMID:19615344|PMID:37972769
1303178	Nanog	Nanog homeobox	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20161228	CTD	MESH:C017947	[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with sodium arsenite] results in decreased expression of NANOG protein; [OGG1 gene mutant form results in increased susceptibility to sodium arsenite] which affects the expression of NANOG mRNA	PMID:23143138|PMID:26438402
1303178	Nanog	Nanog homeobox	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347686	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NANOG promoter	PMID:27901495
1303178	Nanog	Nanog homeobox	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NANOG mRNA	PMID:22316170
1303178	Nanog	Nanog homeobox	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1347686	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NANOG 3' UTR	PMID:27901495
1303178	Nanog	Nanog homeobox	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20240430	CTD	MESH:D001564	[sodium arsenite co-treated with Benzo(a)pyrene] results in increased expression of NANOG protein; METTL3 protein promotes the reaction [[sodium arsenite co-treated with Benzo(a)pyrene] results in increased expression of NANOG protein]	PMID:37972769
1303178	Nanog	Nanog homeobox	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of NANOG mRNA	PMID:41028656
1303178	Nanog	Nanog homeobox	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20260303	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of NANOG mRNA	PMID:40049282
1303178	Nanog	Nanog homeobox	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20210810	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of NANOG mRNA; Arsenic Trioxide results in decreased expression of NANOG protein	PMID:33634982|PMID:38797699
1303178	Nanog	Nanog homeobox	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of NANOG mRNA	PMID:29767511
1303178	Nanog	Nanog homeobox	gene	CHEBI:30621	diarsenic trioxide	increases cleavage	ISO	RGD:1553059	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased cleavage of NANOG protein	PMID:29767511
1303178	Nanog	Nanog homeobox	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1347686	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NANOG mRNA; Arsenic Trioxide results in increased expression of NANOG protein	PMID:29396848
1303178	Nanog	Nanog homeobox	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of NANOG protein; ICG 001 affects the reaction [RORB protein affects the reaction [Arsenic Trioxide results in decreased expression of NANOG protein]]; PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]; RORB protein affects the reaction [Arsenic Trioxide results in decreased expression of NANOG protein]; SOX2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]; SOX2 protein affects the reaction [PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]]	PMID:29396848|PMID:30093655|PMID:38797699
1303178	Nanog	Nanog homeobox	gene	CHEBI:31355	carboplatin	increases expression	ISO	RGD:1347686	E	RGD:6480464	20171114	CTD	MESH:D016190	Carboplatin results in increased expression of NANOG mRNA	PMID:25605917
1303178	Nanog	Nanog homeobox	gene	CHEBI:31638	fulvestrant	increases expression	ISO	RGD:1347686	E	RGD:6480464	20180515	CTD	MESH:C070081	fulvestrant results in increased expression of NANOG protein	PMID:27581495
1303178	Nanog	Nanog homeobox	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in decreased expression of NANOG mRNA	PMID:25270620
1303178	Nanog	Nanog homeobox	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1553059	E	RGD:6480464	20200519	CTD	MESH:C008261	lead acetate results in increased expression of NANOG mRNA	PMID:31715224
1303178	Nanog	Nanog homeobox	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1347686	E	RGD:6480464	20180515	CTD	MESH:C015358	methylparaben results in increased expression of NANOG mRNA; methylparaben results in increased expression of NANOG protein	PMID:27581495
1303178	Nanog	Nanog homeobox	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1553059	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of NANOG mRNA	PMID:29264374
1303178	Nanog	Nanog homeobox	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in decreased expression of NANOG mRNA	PMID:25270620
1303178	Nanog	Nanog homeobox	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	ISO	RGD:1347686	E	RGD:6480464	20190312	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NANOG protein	PMID:30259641
1303178	Nanog	Nanog homeobox	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20190312	CTD	MESH:C016583	[Nicotine co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of NANOG protein	PMID:30259641
1303178	Nanog	Nanog homeobox	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1553059	E	RGD:6480464	20120515	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of NANOG mRNA	PMID:19654923
1303178	Nanog	Nanog homeobox	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20120515	CTD	MESH:C074702	MAP2K7 protein promotes the reaction [chromium hexavalent ion results in increased expression of NANOG mRNA]	PMID:19654923
1303178	Nanog	Nanog homeobox	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:C006780	bisphenol A results in decreased expression of NANOG mRNA; bisphenol A results in decreased expression of NANOG protein	PMID:24134786|PMID:25181051|PMID:41034487
1303178	Nanog	Nanog homeobox	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1347686	E	RGD:6480464	20140715	CTD	MESH:C006780	bisphenol A results in increased expression of NANOG mRNA; bisphenol A results in increased expression of NANOG protein	PMID:23391485|PMID:24424067|PMID:37610061|PMID:37834465
1303178	Nanog	Nanog homeobox	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553059	E	RGD:6480464	20140311	CTD	MESH:C006780	bisphenol A results in increased expression of NANOG mRNA; bisphenol A results in increased expression of NANOG protein	PMID:24090592|PMID:31288075
1303178	Nanog	Nanog homeobox	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20240206	CTD	MESH:C006780	[bisphenol A co-treated with perfluorooctane sulfonic acid] results in decreased expression of NANOG mRNA; [bisphenol A co-treated with perfluorooctanoic acid co-treated with bisphenol S co-treated with perfluorooctane sulfonic acid] results in decreased expression of NANOG mRNA	PMID:37834465
1303178	Nanog	Nanog homeobox	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20181113	CTD	MESH:C006780	[bisphenol A co-treated with Stigmasterol] results in decreased expression of NANOG mRNA; bisphenol A inhibits the reaction [GW 4064 results in decreased expression of NANOG mRNA]	PMID:30245210
1303178	Nanog	Nanog homeobox	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1347686	E	RGD:6480464	20230502	CTD	MESH:C543008	bisphenol S results in increased expression of NANOG mRNA	PMID:36565802
1303178	Nanog	Nanog homeobox	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20240206	CTD	MESH:C543008	[bisphenol A co-treated with perfluorooctanoic acid co-treated with bisphenol S co-treated with perfluorooctane sulfonic acid] results in decreased expression of NANOG mRNA; [bisphenol S co-treated with perfluorooctane sulfonic acid] results in decreased expression of NANOG mRNA	PMID:37834465
1303178	Nanog	Nanog homeobox	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20130611	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NANOG mRNA	PMID:23220036
1303178	Nanog	Nanog homeobox	gene	CHEBI:34696	dieldrin	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20210608	CTD	MESH:D004026	Dieldrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]	PMID:32949729
1303178	Nanog	Nanog homeobox	gene	CHEBI:34785	heptachlor	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20210608	CTD	MESH:D006533	Heptachlor inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]	PMID:32949729
1303178	Nanog	Nanog homeobox	gene	CHEBI:34892	nocodazole	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20120412	CTD	MESH:D015739	Nocodazole results in decreased expression of NANOG protein	PMID:21559451
1303178	Nanog	Nanog homeobox	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20210608	CTD	MESH:D026023	Permethrin promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]	PMID:32949729
1303178	Nanog	Nanog homeobox	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20230801	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NANOG mRNA	PMID:36602393
1303178	Nanog	Nanog homeobox	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20260804	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NANOG protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased methylation of NANOG gene; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NANOG mRNA	PMID:35334236
1303178	Nanog	Nanog homeobox	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1347686	E	RGD:6480464	20161025	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NANOG protein	PMID:27153767
1303178	Nanog	Nanog homeobox	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20240206	CTD	MESH:C023036	[bisphenol A co-treated with perfluorooctanoic acid co-treated with bisphenol S co-treated with perfluorooctane sulfonic acid] results in decreased expression of NANOG mRNA	PMID:37834465
1303178	Nanog	Nanog homeobox	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of NANOG mRNA	PMID:25539665
1303178	Nanog	Nanog homeobox	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20151013	CTD	MESH:C018021	[EPAS1 protein results in increased susceptibility to cobaltous chloride] which results in increased expression of NANOG mRNA; [HIF1A protein results in increased susceptibility to cobaltous chloride] which results in increased expression of NANOG mRNA	PMID:25805230
1303178	Nanog	Nanog homeobox	gene	CHEBI:3647	chlorpromazine	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20190312	CTD	MESH:D002746	Chlorpromazine results in decreased expression of NANOG mRNA	PMID:30703373
1303178	Nanog	Nanog homeobox	gene	CHEBI:38635	3-methyladenine	increases expression	ISO	RGD:1553059	E	RGD:6480464	20120412	CTD	MESH:C025946	3-methyladenine results in increased expression of NANOG mRNA	PMID:21681844
1303178	Nanog	Nanog homeobox	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NANOG mRNA	PMID:31533062
1303178	Nanog	Nanog homeobox	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1347686	E	RGD:6480464	20171114	CTD	MESH:C473478	sunitinib results in increased expression of NANOG mRNA	PMID:25605917
1303178	Nanog	Nanog homeobox	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20240206	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NANOG mRNA	PMID:37834465
1303178	Nanog	Nanog homeobox	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20140114	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NANOG mRNA; perfluorooctane sulfonic acid results in decreased expression of NANOG protein	PMID:24098361
1303178	Nanog	Nanog homeobox	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1347686	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NANOG protein	PMID:27153767
1303178	Nanog	Nanog homeobox	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1553059	E	RGD:6480464	20150414	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NANOG mRNA; perfluorooctane sulfonic acid results in increased expression of NANOG protein	PMID:25510869
1303178	Nanog	Nanog homeobox	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20240206	CTD	MESH:C076994	[bisphenol A co-treated with perfluorooctane sulfonic acid] results in decreased expression of NANOG mRNA; [bisphenol A co-treated with perfluorooctanoic acid co-treated with bisphenol S co-treated with perfluorooctane sulfonic acid] results in decreased expression of NANOG mRNA; [bisphenol S co-treated with perfluorooctane sulfonic acid] results in decreased expression of NANOG mRNA	PMID:37834465
1303178	Nanog	Nanog homeobox	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1553059	E	RGD:6480464	20170110	CTD	MESH:D003474	Curcumin results in increased expression of NANOG mRNA; Curcumin results in increased expression of NANOG protein	PMID:25822711|PMID:27237783
1303178	Nanog	Nanog homeobox	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20151013	CTD	MESH:D003474	2-methoxyestradiol inhibits the reaction [Curcumin results in increased expression of NANOG mRNA]	PMID:25822711
1303178	Nanog	Nanog homeobox	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of NANOG mRNA	PMID:23179753|PMID:27188386|PMID:29775723
1303178	Nanog	Nanog homeobox	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1347686	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of NANOG mRNA	PMID:22723015|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1303178	Nanog	Nanog homeobox	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; Valproic Acid inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]	PMID:27188386|PMID:32949729
1303178	Nanog	Nanog homeobox	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20260505	CTD	MESH:D016572	Cyclosporine results in decreased expression of NANOG mRNA	PMID:40119912
1303178	Nanog	Nanog homeobox	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1553059	E	RGD:6480464	20201103	CTD	MESH:C017160	cypermethrin results in increased expression of NANOG mRNA	PMID:32214279
1303178	Nanog	Nanog homeobox	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1347686	E	RGD:6480464	20180515	CTD	MESH:C016601	afimoxifene results in increased expression of NANOG protein	PMID:27581495
1303178	Nanog	Nanog homeobox	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of NANOG mRNA	PMID:27188386
1303178	Nanog	Nanog homeobox	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1347686	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of NANOG mRNA	PMID:26272509
1303178	Nanog	Nanog homeobox	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA	PMID:27188386
1303178	Nanog	Nanog homeobox	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161213	CTD	MESH:D017239	[Cisplatin co-treated with Paclitaxel] results in increased expression of NANOG mRNA; [Cisplatin co-treated with Paclitaxel] results in increased expression of NANOG protein	PMID:20705681
1303178	Nanog	Nanog homeobox	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1347686	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of NANOG mRNA	PMID:22723015|PMID:24935251|PMID:26272509
1303178	Nanog	Nanog homeobox	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA	PMID:27188386
1303178	Nanog	Nanog homeobox	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NANOG mRNA	PMID:33387578
1303178	Nanog	Nanog homeobox	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1553059	E	RGD:6480464	20120717	CTD	MESH:D005472	Fluorouracil affects the expression of NANOG protein	PMID:21296659
1303178	Nanog	Nanog homeobox	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20180703	CTD	MESH:D005472	Fluorouracil results in decreased expression of NANOG mRNA	PMID:24737281
1303178	Nanog	Nanog homeobox	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1553059	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of NANOG mRNA	PMID:29279043
1303178	Nanog	Nanog homeobox	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1347686	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of NANOG mRNA	PMID:37624150
1303178	Nanog	Nanog homeobox	gene	CHEBI:47575	ABT-737	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20210504	CTD	MESH:C501332	ABT-737 results in decreased expression of NANOG protein	PMID:23918355
1303178	Nanog	Nanog homeobox	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1347686	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in increased expression of NANOG mRNA	PMID:20069066
1303178	Nanog	Nanog homeobox	gene	CHEBI:48607	lithium chloride	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride inhibits the reaction [Proanthocyanidins results in decreased expression of NANOG protein]; SFRP2 protein affects the reaction [Lithium Chloride results in increased expression of NANOG mRNA]	PMID:20069066|PMID:37551626
1303178	Nanog	Nanog homeobox	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of NANOG mRNA	PMID:18175754
1303178	Nanog	Nanog homeobox	gene	CHEBI:4948	Evodiamine	increases expression	ISO	RGD:1347686	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in increased expression of NANOG mRNA	PMID:31835579
1303178	Nanog	Nanog homeobox	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20180703	CTD	MESH:D007213	Indomethacin results in decreased expression of NANOG mRNA	PMID:24737281
1303178	Nanog	Nanog homeobox	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20210810	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of NANOG mRNA; Arsenic Trioxide results in decreased expression of NANOG protein	PMID:33634982|PMID:38797699
1303178	Nanog	Nanog homeobox	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of NANOG mRNA	PMID:29767511
1303178	Nanog	Nanog homeobox	gene	CHEBI:49900	arsenous acid	increases cleavage	ISO	RGD:1553059	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased cleavage of NANOG protein	PMID:29767511
1303178	Nanog	Nanog homeobox	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1347686	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NANOG mRNA; Arsenic Trioxide results in increased expression of NANOG protein	PMID:29396848
1303178	Nanog	Nanog homeobox	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of NANOG protein; ICG 001 affects the reaction [RORB protein affects the reaction [Arsenic Trioxide results in decreased expression of NANOG protein]]; PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]; RORB protein affects the reaction [Arsenic Trioxide results in decreased expression of NANOG protein]; SOX2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]; SOX2 protein affects the reaction [PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]]	PMID:29396848|PMID:30093655|PMID:38797699
1303178	Nanog	Nanog homeobox	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of NANOG mRNA	PMID:23300844
1303178	Nanog	Nanog homeobox	gene	CHEBI:5118	fluoxetine	affects expression	ISO	RGD:1553059	E	RGD:6480464	20181113	CTD	MESH:D005473	Fluoxetine affects the expression of NANOG mRNA	PMID:29893963
1303178	Nanog	Nanog homeobox	gene	CHEBI:5693	hexachlorophene	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20210608	CTD	MESH:D006582	Hexachlorophene inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]	PMID:32949729
1303178	Nanog	Nanog homeobox	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20190219	CTD	MESH:D007559	Ivermectin results in decreased expression of NANOG mRNA; Ivermectin results in decreased expression of NANOG protein	PMID:29257278
1303178	Nanog	Nanog homeobox	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1347686	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of NANOG mRNA	PMID:26272509
1303178	Nanog	Nanog homeobox	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA	PMID:27188386
1303178	Nanog	Nanog homeobox	gene	CHEBI:62878	XAV939	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20240206	CTD	MESH:C544261	XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of NANOG protein]	PMID:37116855
1303178	Nanog	Nanog homeobox	gene	CHEBI:64206	bromochloroacetic acid	increases expression	ISO	RGD:1553059	E	RGD:6480464	20120717	CTD	MESH:C099813	bromochloroacetic acid results in increased expression of NANOG protein	PMID:21296659
1303178	Nanog	Nanog homeobox	gene	CHEBI:65242	sodium chlorate	increases expression	ISO	RGD:1553059	E	RGD:6480464	20130416	CTD	MESH:C032706	sodium chlorate results in increased expression of NANOG mRNA	PMID:19937756
1303178	Nanog	Nanog homeobox	gene	CHEBI:65329	LY294002	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20150414	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of NANOG protein	PMID:23143138
1303178	Nanog	Nanog homeobox	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20150414	CTD	MESH:C085911	[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with sodium arsenite] results in decreased expression of NANOG protein	PMID:23143138
1303178	Nanog	Nanog homeobox	gene	CHEBI:6570	lupeol	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20120412	CTD	MESH:C010480	lupeol results in decreased expression of NANOG protein	PMID:20979057
1303178	Nanog	Nanog homeobox	gene	CHEBI:67991	(20S)-ginsenoside Rg3	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20210406	CTD	MESH:C097367	ginsenoside Rg3 results in decreased expression of NANOG mRNA	PMID:31916386
1303178	Nanog	Nanog homeobox	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20200714	CTD	MESH:C054133	casticin results in decreased expression of NANOG mRNA	PMID:32268151
1303178	Nanog	Nanog homeobox	gene	CHEBI:69355	casticin	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20200714	CTD	MESH:C054133	casticin promotes the reaction [MIR148A mRNA results in decreased expression of NANOG mRNA]; DNMT1 protein inhibits the reaction [casticin results in decreased expression of NANOG protein]; MIR148A mRNA promotes the reaction [casticin results in decreased expression of NANOG mRNA]	PMID:32268151
1303178	Nanog	Nanog homeobox	gene	CHEBI:73158	sirtinol	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20231205	CTD	MESH:C439060	sirtinol inhibits the reaction [cordycepin results in increased expression of NANOG mRNA]	PMID:36881089
1303178	Nanog	Nanog homeobox	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of NANOG mRNA	PMID:27840820
1303178	Nanog	Nanog homeobox	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20260324	CTD	MESH:C554430	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA; decamethrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Dieldrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Heptachlor inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Hexachlorophene inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Permethrin promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Rotenone inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Valproic Acid inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]	PMID:32949729
1303178	Nanog	Nanog homeobox	gene	CHEBI:747490	teroxirone	increases expression	ISO	RGD:1347686	E	RGD:6480464	20260505	CTD	MESH:C028786	teroxirone results in increased expression of NANOG protein	PMID:29908167
1303178	Nanog	Nanog homeobox	gene	CHEBI:748285	napabucasin	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20260714	CTD	MESH:C000621033	napabucasin results in decreased expression of NANOG mRNA; napabucasin results in decreased expression of NANOG protein	PMID:25605917|PMID:26899963
1303178	Nanog	Nanog homeobox	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20141223	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of NANOG protein]	PMID:23651583
1303178	Nanog	Nanog homeobox	gene	CHEBI:752899	imetelstat	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20260714	CTD	MESH:C519562	imetelstat results in decreased expression of NANOG mRNA	PMID:20824134
1303178	Nanog	Nanog homeobox	gene	CHEBI:758254	ovatodiolide	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20260714	CTD	MESH:C432447	ovatodiolide results in decreased expression of NANOG protein	PMID:39276908
1303178	Nanog	Nanog homeobox	gene	CHEBI:758254	ovatodiolide	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20260714	CTD	MESH:C432447	Acetylcysteine inhibits the reaction [ovatodiolide results in decreased expression of NANOG protein]	PMID:39276908
1303178	Nanog	Nanog homeobox	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20240206	CTD	MESH:C560077	[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of NANOG protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of NANOG protein]	PMID:37116855
1303178	Nanog	Nanog homeobox	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20220607	CTD	MESH:D014700	[Verapamil co-treated with kaempferol] results in decreased expression of NANOG mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of NANOG protein	PMID:35063459
1303178	Nanog	Nanog homeobox	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20190219	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of NANOG mRNA; diallyl trisulfide results in decreased expression of NANOG protein	PMID:29626521|PMID:33751676|PMID:38821455
1303178	Nanog	Nanog homeobox	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1347686	E	RGD:6480464	20240604	CTD	MESH:C042577	diallyl trisulfide results in increased expression of NANOG protein	PMID:33751676
1303178	Nanog	Nanog homeobox	gene	CHEBI:78492	diallyl trisulfide	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20190219	CTD	MESH:C042577	diallyl trisulfide inhibits the reaction [CTNNB1 protein results in increased expression of NANOG protein]	PMID:29626521
1303178	Nanog	Nanog homeobox	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA	PMID:27188386
1303178	Nanog	Nanog homeobox	gene	CHEBI:78886	2-tert-butylhydroquinone	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20260505	CTD	MESH:C018855	2-tert-butylhydroquinone results in decreased expression of NANOG mRNA	PMID:40119912
1303178	Nanog	Nanog homeobox	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1553059	E	RGD:6480464	20191112	CTD	MESH:C025256	nonylphenol results in increased expression of NANOG mRNA	PMID:31288075
1303178	Nanog	Nanog homeobox	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20181113	CTD	MESH:C412815	GW 4064 results in decreased expression of NANOG mRNA	PMID:30245210
1303178	Nanog	Nanog homeobox	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1553059	E	RGD:6480464	20181113	CTD	MESH:C412815	bisphenol A inhibits the reaction [GW 4064 results in decreased expression of NANOG mRNA]; Stigmasterol inhibits the reaction [GW 4064 results in decreased expression of NANOG mRNA]	PMID:30245210
1303178	Nanog	Nanog homeobox	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1553059	E	RGD:6480464	20220111	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NANOG	PMID:34547414
1303178	Nanog	Nanog homeobox	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	increases expression	ISO	RGD:1347686	E	RGD:6480464	20230404	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in increased expression of NANOG mRNA	PMID:35687267
1303178	Nanog	Nanog homeobox	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20180515	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of NANOG mRNA	PMID:26206603
1303178	Nanog	Nanog homeobox	gene	CHEBI:83490	3,5,6-trichloropyridine-2-one	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20141202	CTD	MESH:C012587	3,5,6-trichloro-2-pyridinol results in decreased expression of NANOG mRNA	PMID:23220036
1303178	Nanog	Nanog homeobox	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1347686	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of NANOG mRNA	PMID:26272509
1303178	Nanog	Nanog homeobox	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA	PMID:27188386
1303178	Nanog	Nanog homeobox	gene	CHEBI:86290	6-bromoindirubin-3'-oxime	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20240206	CTD	MESH:C483321	[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of NANOG protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of NANOG protein]	PMID:37116855
1303178	Nanog	Nanog homeobox	gene	CHEBI:8890	(S)-ropivacaine	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20240806	CTD	MESH:C037663	Ropivacaine results in decreased expression of NANOG protein	PMID:36124980
1303178	Nanog	Nanog homeobox	gene	CHEBI:89188	2,4-di-tert-butylphenol	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20230801	CTD	MESH:C056559	[Chir 99021 co-treated with 2,4-di-tert-butylphenol] results in increased expression of NANOG mRNA	PMID:36682590
1303178	Nanog	Nanog homeobox	gene	CHEBI:91091	CHIR 99021	decreases expression	ISO	RGD:1347686	E	RGD:6480464	20200519	CTD	MESH:C473711	Chir 99021 results in decreased expression of NANOG mRNA	PMID:31711903
1303178	Nanog	Nanog homeobox	gene	CHEBI:91091	CHIR 99021	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20230801	CTD	MESH:C473711	[Chir 99021 co-treated with 2,4-di-tert-butylphenol] results in increased expression of NANOG mRNA	PMID:36682590
1303178	Nanog	Nanog homeobox	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20161220	CTD	MESH:C459179	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA; [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NANOG mRNA; decamethrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Dieldrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Heptachlor inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Hexachlorophene inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Permethrin promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Rotenone inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]; Valproic Acid inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of NANOG mRNA]	PMID:27188386|PMID:32949729
1303178	Nanog	Nanog homeobox	gene	CHEBI:9168	sirolimus	increases expression	ISO	RGD:1553059	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in increased expression of NANOG mRNA	PMID:21681844
1303178	Nanog	Nanog homeobox	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1553059	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of NANOG mRNA	PMID:26217789
1303178	Nanog	Nanog homeobox	gene	CHEBI:9948	verapamil	multiple interactions	ISO	RGD:1347686	E	RGD:6480464	20220607	CTD	MESH:D014700	[Verapamil co-treated with kaempferol] results in decreased expression of NANOG mRNA; [Verapamil co-treated with kaempferol] results in decreased expression of NANOG protein	PMID:35063459
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1352137	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in increased expression of BPI mRNA	PMID:15498508|PMID:33167477
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1551102	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of BPI mRNA	PMID:24205000
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1352137	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BPI mRNA	PMID:37042841
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1352137	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of BPI intron	PMID:30157460
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1352137	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of BPI intron	PMID:30157460
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1551102	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of BPI mRNA	PMID:28960355
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1551102	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of BPI protein	PMID:28918527
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1352137	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of BPI gene	PMID:28589171
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551102	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of BPI mRNA	PMID:37682722
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1352137	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BPI 3' UTR	PMID:27901495
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352137	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BPI promoter	PMID:27901495
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1352137	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of BPI mRNA	PMID:15761015|PMID:20458559
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1352137	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of BPI mRNA	PMID:15498508
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of BPI mRNA	PMID:25181051
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of BPI mRNA	PMID:23829299
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1551102	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of BPI exon	PMID:33297965
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1352137	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of BPI gene	PMID:22964155
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352137	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BPI mRNA	PMID:37042841
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of BPI mRNA	PMID:18500788
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551102	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of BPI mRNA	PMID:17292431
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1352137	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of BPI mRNA	PMID:17403535
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551102	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of BPI mRNA	PMID:17562736
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1352137	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of BPI mRNA	PMID:15761015|PMID:20458559
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1352137	E	RGD:6480464	20150310	CTD	MESH:C037123	cadmium sulfate results in increased expression of BPI mRNA	PMID:12064557|PMID:14676411
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1352137	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of BPI mRNA	PMID:26705709
1303179	Bpi	bactericidal/permeability-increasing protein	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1352137	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of BPI mRNA	PMID:30458266
1303180	Sfta2	surfactant associated 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1347220	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of SFTA2 mRNA	PMID:24763279
1303180	Sfta2	surfactant associated 2	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1347220	E	RGD:6480464	20130806	CTD	MESH:D011374	Progesterone results in decreased expression of SFTA2 mRNA	PMID:21540246
1303180	Sfta2	surfactant associated 2	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1347220	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of SFTA2 mRNA	PMID:31256213
1303180	Sfta2	surfactant associated 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1347220	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in increased expression of SFTA2 mRNA	PMID:23369406
1303180	Sfta2	surfactant associated 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1347220	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SFTA2 mRNA	PMID:23557933
1303180	Sfta2	surfactant associated 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347220	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SFTA2 promoter	PMID:27901495
1303180	Sfta2	surfactant associated 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347220	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SFTA2 3' UTR	PMID:27901495
1303180	Sfta2	surfactant associated 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1621901	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SFTA2 mRNA	PMID:32715474
1303180	Sfta2	surfactant associated 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SFTA2 mRNA	PMID:32680482
1303180	Sfta2	surfactant associated 2	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1347220	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of SFTA2 mRNA	PMID:37047231
1303180	Sfta2	surfactant associated 2	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of SFTA2 mRNA	PMID:33484710
1303180	Sfta2	surfactant associated 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347220	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SFTA2 gene]	PMID:28238834
1303180	Sfta2	surfactant associated 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SFTA2 mRNA	PMID:23640034
1303180	Sfta2	surfactant associated 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SFTA2 mRNA	PMID:23914054
1303181	Krt17	keratin 17	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of KRT17 mRNA	PMID:19371625
1303181	Krt17	keratin 17	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1353171	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KRT17 mRNA	PMID:38218311
1303181	Krt17	keratin 17	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1353171	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of KRT17 mRNA	PMID:27188386
1303181	Krt17	keratin 17	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1553073	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KRT17 mRNA	PMID:33045310
1303181	Krt17	keratin 17	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1553073	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of KRT17 mRNA	PMID:37995155
1303181	Krt17	keratin 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of KRT17 mRNA; Tretinoin results in decreased expression of KRT17 protein	PMID:15982314
1303181	Krt17	keratin 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1553073	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of KRT17 mRNA	PMID:16604517
1303181	Krt17	keratin 17	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin metabolite results in increased expression of KRT17 mRNA	PMID:15982314
1303181	Krt17	keratin 17	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KRT17 mRNA	PMID:36189433
1303181	Krt17	keratin 17	gene	CHEBI:15368	acrolein	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of KRT17 mRNA	PMID:38090360
1303181	Krt17	keratin 17	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1353171	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of KRT17 mRNA	PMID:22378314
1303181	Krt17	keratin 17	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1353171	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of KRT17 mRNA	PMID:35811015
1303181	Krt17	keratin 17	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KRT17 mRNA	PMID:35811015
1303181	Krt17	keratin 17	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1353171	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of KRT17 mRNA	PMID:30510588
1303181	Krt17	keratin 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of KRT17 mRNA	PMID:23019147
1303181	Krt17	keratin 17	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of KRT17 mRNA	PMID:19619570|PMID:31614463
1303181	Krt17	keratin 17	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553073	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of KRT17 mRNA	PMID:19484750
1303181	Krt17	keratin 17	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KRT17 mRNA	PMID:19619570
1303181	Krt17	keratin 17	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of KRT17 mRNA	PMID:38568856
1303181	Krt17	keratin 17	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1353171	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of KRT17 mRNA	PMID:23649840
1303181	Krt17	keratin 17	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of KRT17 mRNA	PMID:18037150
1303181	Krt17	keratin 17	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1553073	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of KRT17 mRNA	PMID:22238285
1303181	Krt17	keratin 17	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KRT17 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT17 mRNA	PMID:37567420
1303181	Krt17	keratin 17	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553073	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of KRT17 mRNA	PMID:36189433
1303181	Krt17	keratin 17	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KRT17 mRNA	PMID:36189433
1303181	Krt17	keratin 17	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1553073	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of KRT17 mRNA	PMID:19693291
1303181	Krt17	keratin 17	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of KRT17 mRNA	PMID:22967744
1303181	Krt17	keratin 17	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KRT17 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT17 mRNA	PMID:37567420
1303181	Krt17	keratin 17	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1353171	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KRT17 mRNA	PMID:31163220
1303181	Krt17	keratin 17	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of KRT17 protein	PMID:7508215
1303181	Krt17	keratin 17	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of KRT17 mRNA	PMID:33387578
1303181	Krt17	keratin 17	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KRT17 mRNA	PMID:28818685
1303181	Krt17	keratin 17	gene	CHEBI:194147	aristolochic acids	increases expression	EXP		E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in increased expression of KRT17 mRNA	PMID:21834575
1303181	Krt17	keratin 17	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in decreased expression of KRT17 mRNA	PMID:12634122
1303181	Krt17	keratin 17	gene	CHEBI:22977	cadmium atom	affects binding	ISO	RGD:1353171	E	RGD:6480464	20150512	CTD	MESH:D002104	KRT17 protein binds to Cadmium	PMID:23896426
1303181	Krt17	keratin 17	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1353171	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of KRT17 mRNA	PMID:24376830
1303181	Krt17	keratin 17	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1353171	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KRT17 mRNA	PMID:19549813
1303181	Krt17	keratin 17	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of KRT17 protein	PMID:23301498
1303181	Krt17	keratin 17	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1353171	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of KRT17 mRNA	PMID:23649840
1303181	Krt17	keratin 17	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1353171	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KRT17 mRNA	PMID:22100608
1303181	Krt17	keratin 17	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1353171	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KRT17 mRNA	PMID:23649840
1303181	Krt17	keratin 17	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases alkylation	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased alkylation of KRT17 protein	PMID:18342354
1303181	Krt17	keratin 17	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1553073	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of KRT17 mRNA	PMID:16377760
1303181	Krt17	keratin 17	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas promotes the reaction [CASP6 protein results in increased cleavage of KRT17 protein]	PMID:18342354
1303181	Krt17	keratin 17	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20120412	CTD	MESH:D009151	Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of KRT17 mRNA]	PMID:16377760
1303181	Krt17	keratin 17	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of KRT17 mRNA	PMID:19774075
1303181	Krt17	keratin 17	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT17 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT17 protein	PMID:38598786
1303181	Krt17	keratin 17	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of KRT17 mRNA	PMID:30779732
1303181	Krt17	keratin 17	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of KRT17 mRNA]	PMID:22206623
1303181	Krt17	keratin 17	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of KRT17 mRNA	PMID:19244175
1303181	Krt17	keratin 17	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1353171	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of KRT17 mRNA	PMID:33512557
1303181	Krt17	keratin 17	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1353171	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of KRT17 mRNA	PMID:26272509
1303181	Krt17	keratin 17	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT17 mRNA	PMID:27188386
1303181	Krt17	keratin 17	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KRT17 mRNA	PMID:37567420
1303181	Krt17	keratin 17	gene	CHEBI:27889	lead(0)	affects binding	ISO	RGD:1353171	E	RGD:6480464	20150512	CTD	MESH:D007854	KRT17 protein binds to Lead	PMID:23896426
1303181	Krt17	keratin 17	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D002945	KRT17 protein affects the susceptibility to Cisplatin	PMID:16217747
1303181	Krt17	keratin 17	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1353171	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of KRT17 mRNA	PMID:27594783
1303181	Krt17	keratin 17	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of KRT17 mRNA	PMID:19371625
1303181	Krt17	keratin 17	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1553073	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of KRT17 mRNA	PMID:32186404
1303181	Krt17	keratin 17	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D019833	[Genistein co-treated with vinclozolin] results in increased expression of KRT17 mRNA	PMID:23160963
1303181	Krt17	keratin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KRT17 mRNA	PMID:32109520|PMID:33387578
1303181	Krt17	keratin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1353171	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KRT17 mRNA	PMID:11489354|PMID:19619570|PMID:20106945|PMID:21632981
1303181	Krt17	keratin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553073	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KRT17 mRNA	PMID:17035482|PMID:17942748
1303181	Krt17	keratin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KRT17 mRNA	PMID:19619570
1303181	Krt17	keratin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KRT17 mRNA	PMID:17942748
1303181	Krt17	keratin 17	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KRT17 mRNA	PMID:30851411
1303181	Krt17	keratin 17	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of KRT17 mRNA	PMID:28959563
1303181	Krt17	keratin 17	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KRT17 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT17 mRNA	PMID:37567420
1303181	Krt17	keratin 17	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1353171	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of KRT17 mRNA	PMID:34032870
1303181	Krt17	keratin 17	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRT17 mRNA	PMID:22714537|PMID:39719251
1303181	Krt17	keratin 17	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1553073	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRT17 mRNA	PMID:37682722|PMID:39095385
1303181	Krt17	keratin 17	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353171	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT17 mRNA; sodium arsenite results in increased expression of KRT17 protein	PMID:19524636|PMID:38568856
1303181	Krt17	keratin 17	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT17 mRNA	PMID:34876320
1303181	Krt17	keratin 17	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT17 mRNA	PMID:34876320
1303181	Krt17	keratin 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353171	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KRT17 polyA tail	PMID:30157460
1303181	Krt17	keratin 17	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1553073	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KRT17 mRNA	PMID:22228805
1303181	Krt17	keratin 17	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1353171	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KRT17 5' UTR; Benzo(a)pyrene results in decreased methylation of KRT17 promoter	PMID:27901495
1303181	Krt17	keratin 17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1353171	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KRT17 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170
1303181	Krt17	keratin 17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553073	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KRT17 mRNA	PMID:23735875
1303181	Krt17	keratin 17	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to KRT17 mRNA]	PMID:32406909
1303181	Krt17	keratin 17	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of KRT17 mRNA	PMID:23806026
1303181	Krt17	keratin 17	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1353171	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of KRT17 mRNA	PMID:20382639
1303181	Krt17	keratin 17	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1353171	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of KRT17 mRNA	PMID:35984750
1303181	Krt17	keratin 17	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1353171	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of KRT17 mRNA	PMID:38568856
1303181	Krt17	keratin 17	gene	CHEBI:32063	propylparaben	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20240702	CTD	MESH:C006068	propylparaben results in decreased expression of KRT17 mRNA	PMID:38568856
1303181	Krt17	keratin 17	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1553073	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of KRT17 mRNA	PMID:23557971
1303181	Krt17	keratin 17	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT17 mRNA	PMID:25181051
1303181	Krt17	keratin 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT17 mRNA	PMID:19371625
1303181	Krt17	keratin 17	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1553073	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of KRT17 promoter	PMID:27312807
1303181	Krt17	keratin 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1353171	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of KRT17 mRNA	PMID:36232920
1303181	Krt17	keratin 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553073	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of KRT17 mRNA	PMID:32156529
1303181	Krt17	keratin 17	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in decreased expression of KRT17 mRNA	PMID:19371625
1303181	Krt17	keratin 17	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	affects expression	ISO	RGD:1353171	E	RGD:6480464	20240702	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl affects the expression of KRT17 mRNA	PMID:38568856
1303181	Krt17	keratin 17	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of KRT17 mRNA	PMID:15980968
1303181	Krt17	keratin 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553073	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of KRT17 mRNA	PMID:30951980
1303181	Krt17	keratin 17	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553073	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of KRT17 mRNA	PMID:30951980
1303181	Krt17	keratin 17	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1353171	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of KRT17 gene	PMID:22964155
1303181	Krt17	keratin 17	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1353171	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to KRT17 protein	PMID:32991956
1303181	Krt17	keratin 17	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT17 protein	PMID:38598786
1303181	Krt17	keratin 17	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of KRT17 mRNA	PMID:21527772
1303181	Krt17	keratin 17	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of KRT17 protein	PMID:20935162
1303181	Krt17	keratin 17	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KRT17 mRNA	PMID:38382870
1303181	Krt17	keratin 17	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1353171	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KRT17 mRNA	PMID:38568856
1303181	Krt17	keratin 17	gene	CHEBI:35546	perfluorodecanoic acid	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20240702	CTD	MESH:C036567	perfluorodecanoic acid results in decreased expression of KRT17 mRNA	PMID:38568856
1303181	Krt17	keratin 17	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of KRT17 mRNA	PMID:27387713
1303181	Krt17	keratin 17	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of KRT17 mRNA	PMID:19244175
1303181	Krt17	keratin 17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20240702	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of KRT17 mRNA	PMID:38568856|PMID:40419075
1303181	Krt17	keratin 17	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353171	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KRT17 mRNA	PMID:25979313
1303181	Krt17	keratin 17	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353171	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of KRT17 mRNA	PMID:23179753
1303181	Krt17	keratin 17	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1353171	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KRT17 gene	PMID:29154799
1303181	Krt17	keratin 17	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in decreased expression of KRT17 mRNA	PMID:17183730
1303181	Krt17	keratin 17	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1353171	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KRT17 mRNA	PMID:25562108
1303181	Krt17	keratin 17	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553073	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of KRT17 mRNA	PMID:17555576
1303181	Krt17	keratin 17	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in increased expression of KRT17 mRNA	PMID:19059307
1303181	Krt17	keratin 17	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of KRT17 mRNA	PMID:19371625
1303181	Krt17	keratin 17	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1553073	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in decreased expression of KRT17 mRNA	PMID:16467112
1303181	Krt17	keratin 17	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KRT17 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT17 mRNA	PMID:37567420
1303181	Krt17	keratin 17	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1353171	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of KRT17 mRNA	PMID:33512557
1303181	Krt17	keratin 17	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553073	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KRT17 mRNA	PMID:17562736
1303181	Krt17	keratin 17	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRT17 mRNA	PMID:33387578
1303181	Krt17	keratin 17	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of KRT17 mRNA	PMID:16584549
1303181	Krt17	keratin 17	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KRT17 mRNA	PMID:35811015
1303181	Krt17	keratin 17	gene	CHEBI:46680	serpentine asbestos	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of KRT17 mRNA	PMID:29523930
1303181	Krt17	keratin 17	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of KRT17 mRNA	PMID:31838189
1303181	Krt17	keratin 17	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KRT17 mRNA	PMID:29391264
1303181	Krt17	keratin 17	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT17 mRNA	PMID:34876320
1303181	Krt17	keratin 17	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1553073	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of KRT17 mRNA	PMID:17555576
1303181	Krt17	keratin 17	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553073	E	RGD:6480464	20120613	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of KRT17 mRNA	PMID:14976129|PMID:17942748
1303181	Krt17	keratin 17	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KRT17 mRNA	PMID:17942748
1303181	Krt17	keratin 17	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1353171	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of KRT17 mRNA	PMID:38568856
1303181	Krt17	keratin 17	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1353171	E	RGD:6480464	20150310	CTD	MESH:C037123	cadmium sulfate results in increased expression of KRT17 mRNA	PMID:12064557|PMID:14676411|PMID:21783983
1303181	Krt17	keratin 17	gene	CHEBI:50648	9-cis-retinoic acid	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in decreased expression of KRT17 mRNA	PMID:15982314
1303181	Krt17	keratin 17	gene	CHEBI:50749	calcipotriol	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20161213	CTD	MESH:C055085	calcipotriene results in decreased expression of KRT17 protein	PMID:7508215
1303181	Krt17	keratin 17	gene	CHEBI:50859	bexarotene	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in decreased expression of KRT17 mRNA; bexarotene results in decreased expression of KRT17 protein	PMID:17178900
1303181	Krt17	keratin 17	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of KRT17 mRNA	PMID:22714537
1303181	Krt17	keratin 17	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in decreased expression of KRT17 mRNA	PMID:17034753
1303181	Krt17	keratin 17	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1553073	E	RGD:6480464	20130723	CTD	MESH:D011192	Potassium Dichromate results in increased expression of KRT17 protein	PMID:19771553
1303181	Krt17	keratin 17	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in decreased expression of KRT17 mRNA	PMID:17183730
1303181	Krt17	keratin 17	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1553073	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of KRT17 mRNA	PMID:38701926
1303181	Krt17	keratin 17	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20120515	CTD	MESH:D015474	Isotretinoin results in decreased expression of KRT17 mRNA; Isotretinoin results in decreased expression of KRT17 protein	PMID:15982314|PMID:18769122
1303181	Krt17	keratin 17	gene	CHEBI:62878	XAV939	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20240206	CTD	MESH:C544261	XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of KRT17 protein]	PMID:37116855
1303181	Krt17	keratin 17	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1353171	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of KRT17 mRNA	PMID:28988120
1303181	Krt17	keratin 17	gene	CHEBI:64198	dimercaprol	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20120412	CTD	MESH:D004112	Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of KRT17 mRNA]	PMID:16377760
1303181	Krt17	keratin 17	gene	CHEBI:6651	malathion	increases expression	ISO	RGD:1353171	E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of KRT17 mRNA	PMID:37047231
1303181	Krt17	keratin 17	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1553073	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of KRT17 mRNA; Cannabidiol results in increased expression of KRT17 protein	PMID:31518892
1303181	Krt17	keratin 17	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553073	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KRT17 mRNA	PMID:22206623
1303181	Krt17	keratin 17	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of KRT17 mRNA]	PMID:22206623
1303181	Krt17	keratin 17	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1553073	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of KRT17 protein	PMID:19771553
1303181	Krt17	keratin 17	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of KRT17 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KRT17 mRNA	PMID:37567420
1303181	Krt17	keratin 17	gene	CHEBI:75408	sulindac sulfide	increases expression	ISO	RGD:1353171	E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in increased expression of KRT17 mRNA	PMID:16184548
1303181	Krt17	keratin 17	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20240206	CTD	MESH:C560077	[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of KRT17 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of KRT17 protein]	PMID:37116855
1303181	Krt17	keratin 17	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KRT17 mRNA	PMID:30851411
1303181	Krt17	keratin 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT17 mRNA	PMID:27188386
1303181	Krt17	keratin 17	gene	CHEBI:78671	sodium chromate	increases expression	ISO	RGD:1553073	E	RGD:6480464	20140708	CTD	MESH:C028982	sodium chromate(VI) results in increased expression of KRT17 protein	PMID:19771553
1303181	Krt17	keratin 17	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1553073	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of KRT17 mRNA	PMID:26655953
1303181	Krt17	keratin 17	gene	CHEBI:80656	all-trans-4-oxoretinoic acid	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20150120	CTD	MESH:C002202	4-oxoretinoic acid results in decreased expression of KRT17 mRNA	PMID:15982314
1303181	Krt17	keratin 17	gene	CHEBI:8069	phenobarbital	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of KRT17 protein	PMID:20935162
1303181	Krt17	keratin 17	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1553073	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of KRT17 mRNA	PMID:38648751
1303181	Krt17	keratin 17	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1353171	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of KRT17 mRNA	PMID:26705709
1303181	Krt17	keratin 17	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1553073	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT17 mRNA	PMID:34876320
1303181	Krt17	keratin 17	gene	CHEBI:86204	chromium trinitrate	increases expression	ISO	RGD:1553073	E	RGD:6480464	20170228	CTD	MESH:C041167	chromium nitrate results in increased expression of KRT17 protein	PMID:19771553
1303181	Krt17	keratin 17	gene	CHEBI:86290	6-bromoindirubin-3'-oxime	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20240206	CTD	MESH:C483321	[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of KRT17 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of KRT17 protein]	PMID:37116855
1303181	Krt17	keratin 17	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of KRT17 mRNA	PMID:19059307
1303181	Krt17	keratin 17	gene	CHEBI:91108	SB 431542	increases expression	ISO	RGD:1353171	E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of KRT17 protein	PMID:25670856
1303181	Krt17	keratin 17	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT17 mRNA	PMID:27188386
1303181	Krt17	keratin 17	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1353171	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of KRT17 mRNA	PMID:17428261
1303181	Krt17	keratin 17	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1353171	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KRT17 mRNA	PMID:38568856
1303181	Krt17	keratin 17	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1353171	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT17 protein	PMID:38598786
1303181	Krt17	keratin 17	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of KRT17 mRNA	PMID:23160963
1303181	Krt17	keratin 17	gene	CHEBI:9986	vinclozolin	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	[Genistein co-treated with vinclozolin] results in increased expression of KRT17 mRNA	PMID:23160963
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:10033	warfarin	decreases expression	ISO	RGD:1553080	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in decreased expression of DCTN2 mRNA	PMID:20493250
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DCTN2 protein]	PMID:38195004
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1352908	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DCTN2 mRNA	PMID:33167477
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DCTN2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of DCTN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DCTN2 mRNA	PMID:32699268|PMID:32845096
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1553080	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of DCTN2 mRNA	PMID:30319688
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553080	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DCTN2 mRNA	PMID:39241906
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553080	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DCTN2 mRNA	PMID:39298647
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1352908	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of DCTN2 protein	PMID:20109541
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1352908	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DCTN2 mRNA	PMID:37042841
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:16899	D-mannitol	increases expression	ISO	RGD:1553080	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in increased expression of DCTN2 mRNA	PMID:25270620
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1553080	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DCTN2 mRNA	PMID:23892564
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1352908	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DCTN2 protein	PMID:37730182
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DCTN2 mRNA	PMID:33387578
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553080	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DCTN2 mRNA	PMID:36331819
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D000517	alpha-Chlorohydrin analog results in decreased expression of DCTN2 protein; alpha-Chlorohydrin results in decreased expression of DCTN2 protein	PMID:26072098
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DCTN2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DCTN2 protein	PMID:38195004
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DCTN2 protein	PMID:23301498
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1352908	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DCTN2 mRNA	PMID:23649840
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DCTN2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of DCTN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DCTN2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DCTN2 mRNA	PMID:32699268|PMID:32845096
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of DCTN2 protein	PMID:38598786
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553080	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DCTN2 mRNA]	PMID:22206623
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553080	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCTN2 mRNA	PMID:40504410
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DCTN2 protein	PMID:38460933
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1352908	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DCTN2 protein	PMID:35688186
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1352908	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of DCTN2 mRNA	PMID:19921347
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553080	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DCTN2 mRNA	PMID:21570461
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DCTN2 mRNA	PMID:33387578|PMID:34747641
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553080	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DCTN2 mRNA	PMID:16467188
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1352908	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of DCTN2 protein	PMID:29385562
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1352908	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of DCTN2 mRNA	PMID:29803840
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553080	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCTN2 mRNA	PMID:40504410
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553080	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DCTN2 mRNA	PMID:22228805
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:3048	benzatropine	increases expression	ISO	RGD:1352908	E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of DCTN2 protein	PMID:34122009
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1553080	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DCTN2 gene	PMID:35295148
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DCTN2 mRNA	PMID:25181051
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1352908	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of DCTN2 mRNA; bisphenol A results in increased expression of DCTN2 protein	PMID:36232920|PMID:37567409
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553080	E	RGD:6480464	20150127	CTD	MESH:C006780	bisphenol A results in increased expression of DCTN2 mRNA	PMID:25270620
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1352908	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DCTN2 protein	PMID:31675489
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553080	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DCTN2 mRNA	PMID:39298647
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553080	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DCTN2 mRNA	PMID:37019170
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352908	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DCTN2 mRNA	PMID:37042841
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DCTN2 mRNA	PMID:33453195
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1352908	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DCTN2 mRNA	PMID:38568856
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DCTN2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DCTN2 protein	PMID:38195004
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DCTN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DCTN2 mRNA	PMID:32699268
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553080	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DCTN2 mRNA	PMID:36331819
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:40303	lovastatin	decreases expression	ISO	RGD:1553080	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in decreased expression of DCTN2 mRNA	PMID:20493250
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1352908	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DCTN2 mRNA	PMID:20106945|PMID:25562108
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553080	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DCTN2 mRNA	PMID:17555576
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553080	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DCTN2 mRNA	PMID:17562736
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DCTN2 protein	PMID:38460933
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553080	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCTN2 mRNA	PMID:40504410
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553080	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of DCTN2 mRNA	PMID:35436446
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1553080	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DCTN2 mRNA	PMID:17555576
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553080	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DCTN2 mRNA	PMID:16467188|PMID:17942748
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C017690	fenvalerate results in increased expression of DCTN2 protein	PMID:33656234
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1352908	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DCTN2 protein	PMID:32959892
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1553080	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DCTN2 mRNA	PMID:23650126
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:6842	methoxychlor	increases methylation	EXP		E	RGD:6480464	20130611	CTD	MESH:D008731	Methoxychlor results in increased methylation of DCTN2 gene	PMID:23303685
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553080	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DCTN2 mRNA	PMID:22206623
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553080	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DCTN2 mRNA]	PMID:22206623
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DCTN2 protein	PMID:37664457
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D012524	Sarin results in increased expression of DCTN2 protein	PMID:28973502
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DCTN2 gene]	PMID:28238834
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1352908	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of DCTN2 mRNA	PMID:18927307
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1352908	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of DCTN2 protein	PMID:31675489
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1553080	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of DCTN2 mRNA	PMID:40826991
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DCTN2 protein	PMID:37664457
1303182	Dctn2	dynactin subunit 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1352908	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of DCTN2 protein	PMID:38598786
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of SIPA1 mRNA	PMID:25152437
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1553084	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SIPA1 mRNA	PMID:33045310
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1346963	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in increased expression of SIPA1 mRNA	PMID:15498508|PMID:33167477
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1346963	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SIPA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of SIPA1 mRNA	PMID:32699268
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1346963	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SIPA1 mRNA	PMID:26079696
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of SIPA1 mRNA	PMID:36841081
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1553084	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SIPA1 mRNA	PMID:30319688
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SIPA1 mRNA	PMID:39241906
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SIPA1 mRNA	PMID:39298647
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1346963	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of SIPA1 mRNA	PMID:19162166
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SIPA1 mRNA	PMID:27523638
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1346963	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SIPA1 protein	PMID:37730182
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SIPA1 mRNA	PMID:33387578
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of SIPA1 mRNA	PMID:33914522
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SIPA1 mRNA	PMID:37236586
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SIPA1 mRNA	PMID:29950665
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1346963	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SIPA1 mRNA	PMID:19549813
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1346963	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SIPA1 intron	PMID:30157460
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1346963	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SIPA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of SIPA1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of SIPA1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of SIPA1 mRNA	PMID:32699268|PMID:35430440
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SIPA1 mRNA	PMID:34911549
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIPA1 mRNA	PMID:40504410
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1346963	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SIPA1 protein	PMID:35688186
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SIPA1 mRNA	PMID:31881176
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SIPA1 mRNA	PMID:30912803
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SIPA1 mRNA	PMID:34747641
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553084	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SIPA1 mRNA	PMID:21570461|PMID:24680724
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SIPA1 mRNA	PMID:32109520
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1346963	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SIPA1 mRNA	PMID:20106945
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SIPA1 mRNA	PMID:17942748
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346963	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SIPA1 mRNA	PMID:29803840
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SIPA1 mRNA	PMID:39631538
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1346963	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SIPA1 protein	PMID:35688186
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1346963	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SIPA1 mRNA	PMID:29432896
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:29365	phosgene	affects expression	ISO	RGD:1553084	E	RGD:6480464	20120515	CTD	MESH:D010705	Phosgene affects the expression of SIPA1 mRNA	PMID:16300373
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346963	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SIPA1 mRNA	PMID:38568856
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIPA1 mRNA	PMID:40504410
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346963	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SIPA1 3' UTR; Benzo(a)pyrene affects the methylation of SIPA1 5' UTR	PMID:27901495
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1346963	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of SIPA1 mRNA	PMID:20382639
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SIPA1 mRNA	PMID:30047161
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1346963	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of SIPA1 mRNA	PMID:15498508
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SIPA1 mRNA	PMID:23557971
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553084	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SIPA1 gene	PMID:35295148
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SIPA1 mRNA	PMID:29950665
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SIPA1 mRNA	PMID:34492290
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of SIPA1 mRNA	PMID:33914522
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SIPA1 mRNA	PMID:34947998
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553084	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SIPA1 mRNA	PMID:33221593
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SIPA1 gene	PMID:28505145
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1553084	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SIPA1 gene	PMID:31683443
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SIPA1 mRNA	PMID:39298647
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1553084	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SIPA1 exon	PMID:33297965
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SIPA1 mRNA	PMID:38685157
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SIPA1 mRNA	PMID:29950665
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of SIPA1 mRNA	PMID:22546817
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346963	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SIPA1 mRNA	PMID:37042841
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of SIPA1 mRNA	PMID:35163327
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1553084	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of SIPA1 mRNA	PMID:18974090
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346963	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SIPA1 mRNA	PMID:38568856
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SIPA1 mRNA	PMID:37236586
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1346963	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SIPA1 mRNA	PMID:19320972
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1346963	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SIPA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of SIPA1 mRNA	PMID:32699268
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:3764	clotrimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of SIPA1 mRNA	PMID:30047161
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1346963	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SIPA1 mRNA	PMID:31533062
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1346963	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SIPA1 gene	PMID:29154799
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SIPA1 mRNA	PMID:30047161
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346963	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SIPA1 mRNA	PMID:25562108
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of SIPA1 mRNA	PMID:17555576
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553084	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SIPA1 mRNA	PMID:17562736
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SIPA1 mRNA	PMID:33387578
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIPA1 mRNA	PMID:40504410
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SIPA1 mRNA	PMID:17942748
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SIPA1 mRNA	PMID:25554681
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SIPA1 mRNA	PMID:30047161
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1553084	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SIPA1 mRNA	PMID:35964746
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1346963	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SIPA1 protein	PMID:32959892
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553084	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SIPA1 mRNA	PMID:22206623
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1346963	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SIPA1 mRNA	PMID:37199045
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of SIPA1 mRNA	PMID:23665939
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1553084	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of SIPA1 mRNA	PMID:18958704
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1346963	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of SIPA1 mRNA	PMID:24247028
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SIPA1 mRNA	PMID:23640034
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SIPA1 mRNA	PMID:30047161
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SIPA1 mRNA	PMID:19281266
1303184	Sipa1	signal-induced proliferation-associated 1	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1346963	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SIPA1 mRNA	PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1346626	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TFAP2C mRNA	PMID:26272509|PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA	PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1551127	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TFAP2C mRNA	PMID:36189433
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	ISO	RGD:1346626	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of TFAP2C protein	PMID:28073184
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1346626	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TFAP2C mRNA	PMID:20044591
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1346626	E	RGD:6480464	20120515	CTD	MESH:D004958	Estradiol affects the expression of TFAP2C mRNA	PMID:21826169
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:16469	17beta-estradiol	increases activity	ISO	RGD:1346626	E	RGD:6480464	20170516	CTD	MESH:D004958	Estradiol results in increased activity of TFAP2C protein	PMID:27592001
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in increased expression of TFAP2C mRNA	PMID:26865669|PMID:28711546
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551127	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of TFAP2C mRNA	PMID:19484750
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of TFAP2C mRNA	PMID:30165855
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1551127	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA	PMID:25510870
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1551127	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of TFAP2C mRNA	PMID:22238285
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1551127	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TFAP2C mRNA	PMID:36189433
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:17263	estrone	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160705	CTD	MESH:D004970	Estrone results in increased expression of TFAP2C mRNA	PMID:26865669
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1346626	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TFAP2C exon	PMID:30157460
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:188855	Octicizer	decreases expression	ISO	RGD:1551127	E	RGD:6480464	20221004	CTD	MESH:C018535	2-ethylhexyldiphenylphosphate results in decreased expression of TFAP2C protein	PMID:35503735
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1551127	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA	PMID:25510870
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1551127	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA	PMID:25510870
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1346626	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TFAP2C promoter	PMID:30157460
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1346626	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of TFAP2C mRNA	PMID:19774075
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TFAP2C mRNA	PMID:18593933
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20120412	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of TFAP2C mRNA; Resveratrol results in increased localization of and results in increased activity of TFAP2C protein	PMID:16488535|PMID:23557933
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1346626	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of TFAP2C mRNA	PMID:23300844
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1346626	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of TFAP2C promoter	PMID:22847954
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28073	chromium atom	increases expression	ISO	RGD:1346626	E	RGD:6480464	20121113	CTD	MESH:D002857	Chromium results in increased expression of TFAP2C mRNA	PMID:21437242
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D019833	Genistein results in increased expression of TFAP2C mRNA	PMID:23160963
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160705	CTD	MESH:D019833	Genistein results in increased expression of TFAP2C mRNA	PMID:26865669
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551127	E	RGD:6480464	20120717	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TFAP2C mRNA	PMID:14708085|PMID:16962184
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TFAP2C mRNA	PMID:34747641
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551127	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TFAP2C mRNA	PMID:17035482|PMID:24058054
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551127	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TFAP2C mRNA; SRC protein promotes the reaction [Tetrachlorodibenzodioxin affects the expression of TFAP2C mRNA]	PMID:14708085|PMID:17942748
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TFAP2C mRNA	PMID:23179753|PMID:28001369
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TFAP2C mRNA	PMID:26272509
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA	PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TFAP2C mRNA; Copper results in increased expression of TFAP2C mRNA	PMID:26033743|PMID:30556269
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:28869	menadione	increases expression	ISO	RGD:1551127	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in increased expression of TFAP2C mRNA	PMID:25270620
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TFAP2C mRNA	PMID:38568856
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551127	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of TFAP2C mRNA	PMID:36209798
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346626	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TFAP2C exon; Benzo(a)pyrene affects the methylation of TFAP2C promoter	PMID:27901495|PMID:30157460
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551127	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TFAP2C mRNA	PMID:23735875
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1346626	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of TFAP2C promoter	PMID:23974009
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TFAP2C mRNA]	PMID:32406909
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TFAP2C mRNA; Copper results in increased expression of TFAP2C mRNA	PMID:26033743|PMID:30556269
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TFAP2C mRNA	PMID:18593933
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1346626	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TFAP2C mRNA	PMID:25351596
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TFAP2C mRNA	PMID:15761015
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:31638	fulvestrant	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant results in decreased expression of TFAP2C mRNA	PMID:26865669
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:31669	hexestrol	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160705	CTD	MESH:D006589	Hexestrol results in increased expression of TFAP2C mRNA	PMID:26865669
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551127	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TFAP2C gene; titanium dioxide results in decreased methylation of TFAP2C promoter	PMID:35295148
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:33090	picene	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20200609	CTD	MESH:C056699	picene results in decreased expression of TFAP2C mRNA	PMID:32251684
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1346626	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A affects the expression of TFAP2C mRNA	PMID:21826169
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TFAP2C mRNA	PMID:25181051
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TFAP2C mRNA	PMID:29275510
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of TFAP2C mRNA	PMID:41034487
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1346626	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TFAP2C mRNA	PMID:25979313
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1551127	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA	PMID:25510870
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1551127	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA	PMID:25510870
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:3423	carmustine	affects response to substance	ISO	RGD:1346626	E	RGD:6480464	20120412	CTD	MESH:D002330	TFAP2C mRNA affects the susceptibility to Carmustine	PMID:16365179
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1551127	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of TFAP2C exon	PMID:33297965
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1346626	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TFAP2C exon	PMID:30157460
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TFAP2C mRNA	PMID:38568856
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1551127	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of TFAP2C mRNA	PMID:17585979
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:3752	clomiphene	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20160705	CTD	MESH:D002996	Clomiphene results in decreased expression of TFAP2C mRNA	PMID:26865669
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1551127	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TFAP2C mRNA	PMID:40194260
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1346626	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of TFAP2C promoter	PMID:22847954
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1346626	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of TFAP2C promoter	PMID:22847954
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA	PMID:19167446
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TFAP2C mRNA	PMID:40419075
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346626	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TFAP2C mRNA	PMID:25979313
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:D014635	Valproic Acid results in decreased expression of TFAP2C mRNA	PMID:33150595
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TFAP2C mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA	PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160705	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TFAP2C mRNA	PMID:26865669
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1346626	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TFAP2C mRNA	PMID:38832940
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1346626	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TFAP2C mRNA	PMID:26272509
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA	PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of TFAP2C mRNA	PMID:19682730
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of TFAP2C mRNA	PMID:24935251|PMID:26272509
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20120412	CTD	MESH:C012589	[Decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein binds to ESR1 promoter]; [Decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein results in increased expression of ESR1 mRNA]; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [trichostatin A co-treated with TFAP2C protein] results in increased expression of ESR1 mRNA; [trichostatin A co-treated with TFAP2C protein] results in increased expression of RERG mRNA; TFAP2C protein promotes the reaction [[Decitabine co-treated with trichostatin A] results in increased expression of ESR1 mRNA]; TFAP2C protein promotes the reaction [[Decitabine co-treated with trichostatin A] results in increased expression of RERG mRNA]	PMID:19458056|PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20180703	CTD	MESH:D000082	Acetaminophen results in decreased expression of TFAP2C mRNA	PMID:29665328
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TFAP2C mRNA	PMID:29523930
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1551127	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TFAP2C mRNA	PMID:19446018
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1346626	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of TFAP2C mRNA	PMID:18687144
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TFAP2C mRNA	PMID:29391264
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551127	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TFAP2C mRNA	PMID:17942748
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA	PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TFAP2C mRNA	PMID:15761015
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1346626	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TFAP2C mRNA	PMID:23300844
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1346626	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of TFAP2C mRNA	PMID:16367923
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with TFAP2C protein] results in increased expression of ESR1 mRNA; [Decitabine co-treated with TFAP2C protein] results in increased expression of RERG mRNA; [Decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein binds to ESR1 promoter]; [Decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein results in increased expression of ESR1 mRNA]; TFAP2C protein promotes the reaction [[Decitabine co-treated with trichostatin A] results in increased expression of ESR1 mRNA]; TFAP2C protein promotes the reaction [[Decitabine co-treated with trichostatin A] results in increased expression of RERG mRNA]	PMID:19458056
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:50385	hemin	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D006427	Hemin results in decreased expression of TFAP2C mRNA	PMID:20016031
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of TFAP2C mRNA	PMID:22714537
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1346626	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of TFAP2C mRNA	PMID:31629900
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1346626	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of TFAP2C mRNA	PMID:26272509
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA	PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:6784	mestranol	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160705	CTD	MESH:D008656	Mestranol results in increased expression of TFAP2C mRNA	PMID:26865669
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1346626	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TFAP2C exon	PMID:30157460
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1346626	E	RGD:6480464	20130305	CTD	MESH:C047246	TFAP2C mRNA affects the susceptibility to temozolomide	PMID:16365179
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1346626	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TFAP2C mRNA	PMID:31758290
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:72754	bisphenol AF	affects expression	ISO	RGD:1551127	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the expression of TFAP2C mRNA	PMID:36464114
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1346626	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of TFAP2C mRNA	PMID:22714537
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1346626	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TFAP2C protein	PMID:31285264
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA	PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA	PMID:19167446
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1346626	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of TFAP2C mRNA	PMID:26705709
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1551127	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of TFAP2C mRNA	PMID:21195148
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1551127	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of TFAP2C mRNA	PMID:21195148
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20200609	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of TFAP2C mRNA	PMID:32251684
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TFAP2C mRNA	PMID:33150595|PMID:36843608
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:8502	6-propyl-2-thiouracil	increases methylation	EXP		E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in increased methylation of TFAP2C promoter	PMID:33150595
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1346626	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of TFAP2C mRNA	PMID:26272509
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA	PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of TFAP2C mRNA	PMID:26865669
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1346626	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of TFAP2C mRNA	PMID:24921660
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346626	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA	PMID:27188386
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1346626	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TFAP2C mRNA	PMID:38568856
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1551127	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of TFAP2C mRNA	PMID:21195148
1303185	Tfap2c	transcription factor AP-2 gamma	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TFAP2C mRNA	PMID:23034163
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1347481	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of ATP6V1G2 protein	PMID:39571964
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:16136	hydrogen sulfide	decreases expression	ISO	RGD:1551130	E	RGD:6480464	20181113	CTD	MESH:D006862	Hydrogen Sulfide results in decreased expression of ATP6V1G2 protein	PMID:29932956
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1551130	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ATP6V1G2 mRNA	PMID:30319688
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1551130	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ATP6V1G2 mRNA	PMID:30319688
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551130	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ATP6V1G2 mRNA	PMID:39241906
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ATP6V1G2 mRNA	PMID:23829299
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1551130	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of ATP6V1G2 mRNA	PMID:29980752
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ATP6V1G2 gene	PMID:27618143
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1347481	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATP6V1G2 mRNA	PMID:37042841
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1347481	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of ATP6V1G2 mRNA	PMID:27664576
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATP6V1G2 mRNA	PMID:33387578
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1347481	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ATP6V1G2 mRNA	PMID:28818685
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347481	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATP6V1G2 mRNA	PMID:35301059
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551130	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ATP6V1G2 mRNA]	PMID:22206623
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1347481	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ATP6V1G2 mRNA	PMID:28903495
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:27889	lead(0)	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in increased expression of ATP6V1G2 mRNA	PMID:36642386
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1347481	E	RGD:6480464	20120412	CTD	MESH:D002945	ATP6V1G2 protein affects the susceptibility to Cisplatin	PMID:16217747
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1347481	E	RGD:6480464	20190312	CTD	MESH:D012402	Rotenone affects the expression of ATP6V1G2 mRNA	PMID:29428530
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1347481	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ATP6V1G2 mRNA	PMID:28001369
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ATP6V1G2 mRNA	PMID:26033743
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347481	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATP6V1G2 mRNA	PMID:29803840
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1347481	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of ATP6V1G2 mRNA	PMID:36057382
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347481	E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of ATP6V1G2 protein	PMID:39571964
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1551130	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of ATP6V1G2 mRNA	PMID:17127020
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347481	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATP6V1G2 3' UTR	PMID:27901495
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1347481	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of ATP6V1G2 mRNA	PMID:36057382
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ATP6V1G2 mRNA	PMID:26033743
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1347481	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ATP6V1G2 mRNA	PMID:25895662
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of ATP6V1G2 mRNA	PMID:16483693
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in increased expression of ATP6V1G2 mRNA	PMID:36642386
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551130	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATP6V1G2 gene; titanium dioxide results in decreased methylation of ATP6V1G2 promoter alternative form	PMID:35295148
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP6V1G2 mRNA	PMID:25181051
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551130	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP6V1G2 mRNA	PMID:32156529
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1551130	E	RGD:6480464	20181113	CTD	MESH:C006780	[NR1H4 gene mutant form affects the susceptibility to bisphenol A] which results in increased expression of ATP6V1G2 mRNA	PMID:30245210
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ATP6V1G2 mRNA	PMID:28970181
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ATP6V1G2 promoter	PMID:22457795
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1551130	E	RGD:6480464	20181113	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATP6V1G2 mRNA	PMID:30030080
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347481	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATP6V1G2 mRNA	PMID:35301059
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1551130	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ATP6V1G2 mRNA	PMID:40194260
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347481	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ATP6V1G2 mRNA	PMID:31533062
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347481	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATP6V1G2 mRNA	PMID:25979313
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1347481	E	RGD:6480464	20170516	CTD	MESH:C017160	cypermethrin results in increased expression of ATP6V1G2 mRNA	PMID:27704156
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551130	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATP6V1G2 mRNA	PMID:17562736
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATP6V1G2 mRNA	PMID:33387578
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1347481	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ATP6V1G2 mRNA	PMID:18175754
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of ATP6V1G2 mRNA	PMID:36868495
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1551130	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ATP6V1G2 mRNA	PMID:23608068
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551130	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ATP6V1G2 mRNA	PMID:22206623
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551130	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ATP6V1G2 mRNA]	PMID:22206623
1303186	Atp6v1g2	ATPase H+ transporting V1 subunit G2	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1347481	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of ATP6V1G2 mRNA	PMID:28960945
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1615702	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PHACTR1 mRNA	PMID:33045310
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:15743	butanal	increases methylation	ISO	RGD:1353173	E	RGD:6480464	20190611	CTD	MESH:C018475	butyraldehyde results in increased methylation of PHACTR1 gene	PMID:30002397
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1615702	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PHACTR1 mRNA	PMID:30319688
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1353173	E	RGD:401900169|PMID:27187934	20231108	RGD	MESH:D008070	Lipopolysaccharide decreases expression of short length PHACTR1 mRNA in macrophages	
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1615702	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PHACTR1 mRNA	PMID:39241906
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1353173	E	RGD:401900169|PMID:27187934	20231108	RGD	MESH:D008070	Lipopolysaccharide increases expression of intermediate length PHACTR1 mRNA in macrophages	
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1615702	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of PHACTR1 mRNA	PMID:19484750
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1353173	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PHACTR1 mRNA	PMID:30165855
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1615702	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PHACTR1 mRNA	PMID:33711761
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PHACTR1 gene	PMID:27618143
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353173	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHACTR1 mRNA	PMID:37042841
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:17153	propanal	increases methylation	ISO	RGD:1353173	E	RGD:6480464	20190611	CTD	MESH:C005556	propionaldehyde results in increased methylation of PHACTR1 gene	PMID:30002397
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1353173	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PHACTR1 mRNA	PMID:31163220
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:17935	octanal	increases methylation	ISO	RGD:1353173	E	RGD:6480464	20190611	CTD	MESH:C031639	caprylic aldehyde results in increased methylation of PHACTR1 gene	PMID:30002397
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1353173	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PHACTR1 intron	PMID:30157460
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1615702	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of PHACTR1 mRNA	PMID:24067728
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1353173	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of PHACTR1 intron	PMID:30157460
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1353173	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PHACTR1 mRNA	PMID:41430723
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of PHACTR1 gene	PMID:35440735
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1615702	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of PHACTR1 mRNA	PMID:28960355
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PHACTR1 mRNA	PMID:31881176
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:28088	genistein	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in decreased methylation of PHACTR1 gene	PMID:28505145
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of PHACTR1 gene	PMID:28505145
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of PHACTR1 protein	PMID:35544339
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1353173	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PHACTR1 mRNA	PMID:33212167
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1353173	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHACTR1 mRNA	PMID:29803840
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353173	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PHACTR1 intron; Benzo(a)pyrene affects the methylation of PHACTR1 promoter	PMID:27901495|PMID:30157460
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1353173	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHACTR1 mRNA	PMID:32234424
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1615702	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHACTR1 mRNA	PMID:22228805
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1353173	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of PHACTR1 gene	PMID:25435355
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1615702	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PHACTR1 mRNA]	PMID:22228805
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1353173	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PHACTR1 mRNA	PMID:23806026
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1353173	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of PHACTR1 gene	PMID:31601247
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of PHACTR1 mRNA	PMID:30012374
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1615702	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of PHACTR1 mRNA	PMID:23557971
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615702	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHACTR1 gene	PMID:35295148
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1615702	E	RGD:6480464	20140513	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PHACTR1 mRNA	PMID:24374135
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PHACTR1 mRNA	PMID:30816183|PMID:41034487
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1353173	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PHACTR1 gene	PMID:31601247
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHACTR1 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PHACTR1 gene	PMID:28505145
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1615702	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of PHACTR1 mRNA	PMID:26682919
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1353173	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to PHACTR1 promoter]	PMID:20348232
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1353173	E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in decreased expression of PHACTR1 mRNA	PMID:30616060
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1615702	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PHACTR1 exon; bisphenol S results in decreased methylation of PHACTR1 promoter	PMID:33297965
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1353173	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of PHACTR1 gene	PMID:31601247
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1353173	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of PHACTR1 intron	PMID:30157460
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PHACTR1 protein	PMID:34896426
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1615702	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PHACTR1 intron	PMID:28392331
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1615702	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PHACTR1 mRNA	PMID:32715474
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:34787	heptanal	increases methylation	ISO	RGD:1353173	E	RGD:6480464	20190611	CTD	MESH:C046204	heptanal results in increased methylation of PHACTR1 gene	PMID:30002397
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353173	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHACTR1 mRNA	PMID:37042841
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1353173	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PHACTR1 mRNA	PMID:38174414
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1353173	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PHACTR1 mRNA	PMID:24449571
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1615702	E	RGD:6480464	20120412	CTD	MESH:D003024	Clozapine results in increased expression of PHACTR1 mRNA	PMID:14647396
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1615702	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PHACTR1 mRNA	PMID:40194260
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1353173	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PHACTR1 mRNA	PMID:31533062
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of PHACTR1 protein	PMID:34896426
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353173	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHACTR1 mRNA	PMID:25979313
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1353173	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of PHACTR1 mRNA	PMID:20106945
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PHACTR1 protein	PMID:34896426
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PHACTR1 protein	PMID:34896426
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1615702	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PHACTR1 mRNA	PMID:17562736
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1353173	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHACTR1 mRNA	PMID:22230336
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1353173	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of PHACTR1 mRNA	PMID:24714768
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1353173	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of PHACTR1 mRNA	PMID:38825487
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PHACTR1 protein	PMID:34896426
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615702	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PHACTR1 mRNA; Nanotubes, Carbon results in decreased expression of PHACTR1 mRNA	PMID:25554681
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1615702	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of PHACTR1 mRNA	PMID:19042947
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:5613	haloperidol	increases expression	ISO	RGD:1615702	E	RGD:6480464	20120412	CTD	MESH:D006220	Haloperidol results in increased expression of PHACTR1 mRNA	PMID:14647396
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:60151	oxidised LDL	decreases expression	ISO	RGD:1353173	E	RGD:401900169|PMID:27187934	20231108	RGD		Oxidized low density lipoprotein decreases expression of intermediate length PHACTR1 mRNA in macrophages	
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:60151	oxidised LDL	increases expression	ISO	RGD:1353173	E	RGD:401900131|PMID:36091033	20231107	RGD		Oxidized low-density lipoprotein increases expression of PHACTR1 mRNA in umbilical vein endothelial cells	
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:60151	oxidised LDL	increases expression	ISO	RGD:1353173	E	RGD:401900169|PMID:27187934	20231108	RGD		Oxidized low density lipoprotein increases expression of short length PHACTR1 mRNA in macrophages	
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1353173	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of PHACTR1 intron	PMID:30157460
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PHACTR1 gene	PMID:35440735
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1615702	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PHACTR1 mRNA	PMID:22206623
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of PHACTR1 promoter	PMID:27415467
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1353173	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PHACTR1 gene]	PMID:28238834
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:82036	prothioconazole	decreases expression	ISO	RGD:1353173	E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in decreased expression of PHACTR1 mRNA	PMID:35048155
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1615702	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PHACTR1 mRNA	PMID:27935865
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:84069	pentanal	increases methylation	ISO	RGD:1353173	E	RGD:6480464	20190611	CTD	MESH:C046012	pentanal results in increased methylation of PHACTR1 gene	PMID:30002397
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:84268	nonanal	increases methylation	ISO	RGD:1353173	E	RGD:6480464	20190611	CTD	MESH:C008664	nonanal results in increased methylation of PHACTR1 gene	PMID:30002397
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of PHACTR1 mRNA	PMID:26923065
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PHACTR1 mRNA	PMID:24780913
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:88528	hexanal	increases methylation	ISO	RGD:1353173	E	RGD:6480464	20190611	CTD	MESH:C010463	n-hexanal results in increased methylation of PHACTR1 gene	PMID:30002397
1303187	Phactr1	phosphatase and actin regulator 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PHACTR1 mRNA	PMID:21346803
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:15743	butanal	increases methylation	ISO	RGD:1342974	E	RGD:6480464	20190611	CTD	MESH:C018475	butyraldehyde results in increased methylation of SPINK4 gene	PMID:30002397
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:16348	3-nitropropanoic acid	decreases expression	ISO	RGD:1553095	E	RGD:6480464	20250603	CTD	MESH:C015392	3-nitropropionic acid results in decreased expression of SPINK4 mRNA	PMID:39832703
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1342974	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of SPINK4 mRNA	PMID:25321415
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPINK4 mRNA	PMID:33387578
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:17153	propanal	increases methylation	ISO	RGD:1342974	E	RGD:6480464	20190611	CTD	MESH:C005556	propionaldehyde results in increased methylation of SPINK4 gene	PMID:30002397
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1342974	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of SPINK4 mRNA	PMID:31256213
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553095	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SPINK4 mRNA	PMID:32235866
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:17935	octanal	increases methylation	ISO	RGD:1342974	E	RGD:6480464	20190611	CTD	MESH:C031639	caprylic aldehyde results in increased methylation of SPINK4 gene	PMID:30002397
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1342974	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of SPINK4 mRNA	PMID:15984569
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SPINK4 mRNA	PMID:33387578
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553095	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SPINK4 mRNA]	PMID:22206623
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553095	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPINK4 mRNA	PMID:21570461
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPINK4 mRNA	PMID:33387578
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SPINK4 mRNA	PMID:28959563
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SPINK4 mRNA	PMID:26033743
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1553095	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SPINK4 mRNA	PMID:39631538
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1553095	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of SPINK4 mRNA	PMID:16014739
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SPINK4 mRNA	PMID:26033743
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1342974	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of SPINK4 mRNA	PMID:15984569
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1553095	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SPINK4 mRNA	PMID:39716349
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of SPINK4 mRNA	PMID:22641619
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1553095	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SPINK4 mRNA	PMID:23557971
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553095	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SPINK4 mRNA	PMID:17426115
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPINK4 mRNA	PMID:25181051
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1342974	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of SPINK4 mRNA	PMID:31715268
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1553095	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of SPINK4 mRNA	PMID:26377693
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1553095	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SPINK4 mRNA	PMID:17361019|PMID:21266533
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:34787	heptanal	increases methylation	ISO	RGD:1342974	E	RGD:6480464	20190611	CTD	MESH:C046204	heptanal results in increased methylation of SPINK4 gene	PMID:30002397
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1342974	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SPINK4 mRNA	PMID:38382870
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SPINK4 promoter	PMID:22457795
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of SPINK4 mRNA	PMID:27387713
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SPINK4 mRNA	PMID:17005392
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:44423	hydroxyurea	increases mutagenesis	ISO	RGD:1553095	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased mutagenesis of SPINK4 gene	PMID:16868089
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SPINK4 mRNA	PMID:33387578
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1342974	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of SPINK4 mRNA	PMID:16584549
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1553095	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SPINK4 mRNA	PMID:39716349
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1553095	E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea results in increased mutagenesis of SPINK4 gene	PMID:16868089
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553095	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SPINK4 mRNA	PMID:25554681
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of SPINK4 mRNA	PMID:22504374
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1553095	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SPINK4 mRNA	PMID:23608068
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SPINK4 mRNA	PMID:28801915
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:6651	malathion	decreases expression	ISO	RGD:1342974	E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of SPINK4 mRNA	PMID:37047231
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553095	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SPINK4 mRNA	PMID:22206623
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of SPINK4 mRNA	PMID:27840820
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553095	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SPINK4 mRNA]	PMID:22206623
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:84069	pentanal	increases methylation	ISO	RGD:1342974	E	RGD:6480464	20190611	CTD	MESH:C046012	pentanal results in increased methylation of SPINK4 gene	PMID:30002397
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:84268	nonanal	increases methylation	ISO	RGD:1342974	E	RGD:6480464	20190611	CTD	MESH:C008664	nonanal results in increased methylation of SPINK4 gene	PMID:30002397
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of SPINK4 mRNA	PMID:22504374
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:88528	hexanal	increases methylation	ISO	RGD:1342974	E	RGD:6480464	20190611	CTD	MESH:C010463	n-hexanal results in increased methylation of SPINK4 gene	PMID:30002397
1303188	Spink4	serine peptidase inhibitor, Kazal type 4	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of SPINK4 gene	PMID:31079544
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1351952	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of NOX3 mRNA	PMID:23724009
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1351952	E	RGD:6480464	20240806	CTD	MESH:D019308	Palmitic Acid results in increased expression of NOX3 protein	PMID:38431059
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:15882	phenol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019800	Phenol results in increased expression of NOX3 mRNA	PMID:16785328
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1553107	E	RGD:6480464	20230606	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of NOX3 mRNA; [Lipopolysaccharides co-treated with Uric Acid] results in increased expression of NOX3 protein; diallyl trisulfide inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of NOX3 mRNA]; diallyl trisulfide inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of NOX3 protein]	PMID:36796188
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1351952	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of NOX3 mRNA	PMID:18070364
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	multiple interactions	ISO	RGD:1553107	E	RGD:6480464	20230606	CTD	MESH:D014527	[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of NOX3 mRNA; [Lipopolysaccharides co-treated with Uric Acid] results in increased expression of NOX3 protein; diallyl trisulfide inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of NOX3 mRNA]; diallyl trisulfide inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of NOX3 protein]	PMID:36796188
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:18421	superoxide	multiple interactions	ISO	RGD:1553107	E	RGD:6480464	20130122	CTD	MESH:D013481	[resveratrol results in decreased expression of and results in decreased activity of NOX3 protein] which results in decreased abundance of Superoxides	PMID:20675566
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1351952	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NOX3 intron	PMID:30157460
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:26523	reactive oxygen species	increases abundance	ISO	RGD:1553107	E	RGD:6480464	20170303	CTD	MESH:D017382	NOX3 results in increased abundance of Reactive Oxygen Species	PMID:20712533
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1553107	E	RGD:6480464	20170303	CTD	MESH:D017382	NOX3 mutant form inhibits the reaction [Capsaicin results in increased abundance of Reactive Oxygen Species]	PMID:20712533
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1553107	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in decreased expression of NOX3 mRNA	PMID:20675566
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1553107	E	RGD:6480464	20130122	CTD	MESH:C059514	[resveratrol results in decreased expression of and results in decreased activity of NOX3 protein] which results in decreased abundance of Superoxides; resveratrol results in decreased expression of and results in decreased activity of NOX3 protein	PMID:20675566
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553107	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NOX3 mRNA	PMID:21570461
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1553107	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of NOX3 mRNA	PMID:27862939
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1553107	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of NOX3 mRNA	PMID:37682722
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351952	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NOX3 promoter	PMID:27901495
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1351952	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NOX3 exon	PMID:27901495
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1553107	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NOX3 promoter	PMID:27901495
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1351952	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of NOX3 mRNA	PMID:25895662
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1553107	E	RGD:6480464	20230704	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NOX3 protein	PMID:37075931
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1351952	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of NOX3 mRNA	PMID:37690743
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1351952	E	RGD:6480464	20120412	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of NOX3 protein	PMID:21742780
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NOX3 mRNA	PMID:25181051
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:3374	capsaicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002211	Capsaicin results in increased expression of NOX3 mRNA; Capsaicin results in increased expression of NOX3 protein	PMID:20712533
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:3374	capsaicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002211	NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 protein]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOX3 mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOX3 protein]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 protein]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of TNF mRNA]; NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of TNF protein]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of NOX3 mRNA]; STAT1 mutant form inhibits the reaction [Capsaicin results in increased expression of NOX3 protein]	PMID:20712533
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:3374	capsaicin	multiple interactions	ISO	RGD:1553107	E	RGD:6480464	20120412	CTD	MESH:D002211	NOX3 mutant form inhibits the reaction [Capsaicin results in increased abundance of Reactive Oxygen Species]	PMID:20712533
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553107	E	RGD:6480464	20260707	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NOX3 mRNA	PMID:40643461
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:34631	chlorpyrifos	increases methylation	EXP		E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in increased methylation of NOX3 gene	PMID:32905263
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of NOX3 gene	PMID:33148267
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1351952	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NOX3 mRNA	PMID:25812627
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1351952	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NOX3 mRNA	PMID:25812627
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1351952	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NOX3 mRNA	PMID:25812627
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1553107	E	RGD:6480464	20150127	CTD	MESH:D004726	Endosulfan results in increased expression of NOX3 mRNA	PMID:25199686
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1553107	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of NOX3 mRNA	PMID:35436446
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of NOX3 gene	PMID:33148267
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:78492	diallyl trisulfide	multiple interactions	ISO	RGD:1553107	E	RGD:6480464	20230606	CTD	MESH:C042577	diallyl trisulfide inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of NOX3 mRNA]; diallyl trisulfide inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of NOX3 protein]	PMID:36796188
1303190	Nox3	NADPH oxidase 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351952	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NOX3 gene]	PMID:28238834
1303191	Snupn	snurportin 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1353124	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SNUPN mRNA	PMID:38218311
1303191	Snupn	snurportin 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SNUPN mRNA	PMID:33167477
1303191	Snupn	snurportin 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1615903	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNUPN mRNA	PMID:36331819
1303191	Snupn	snurportin 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353124	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNUPN mRNA	PMID:37042841
1303191	Snupn	snurportin 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1353124	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SNUPN mRNA	PMID:21179406
1303191	Snupn	snurportin 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1615903	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNUPN mRNA	PMID:34319233
1303191	Snupn	snurportin 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SNUPN mRNA	PMID:33387578
1303191	Snupn	snurportin 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1353124	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SNUPN mRNA	PMID:39836092
1303191	Snupn	snurportin 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SNUPN mRNA	PMID:19549813
1303191	Snupn	snurportin 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SNUPN mRNA	PMID:23649840
1303191	Snupn	snurportin 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1615903	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNUPN mRNA	PMID:22206623
1303191	Snupn	snurportin 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1353124	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SNUPN protein	PMID:35688186
1303191	Snupn	snurportin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615903	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNUPN mRNA	PMID:21570461
1303191	Snupn	snurportin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1615903	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNUPN mRNA	PMID:17942748
1303191	Snupn	snurportin 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNUPN mRNA	PMID:30851411
1303191	Snupn	snurportin 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNUPN mRNA	PMID:29803840
1303191	Snupn	snurportin 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1353124	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SNUPN protein	PMID:35688186
1303191	Snupn	snurportin 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1615903	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNUPN mRNA	PMID:22228805
1303191	Snupn	snurportin 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353124	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SNUPN promoter	PMID:27901495
1303191	Snupn	snurportin 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SNUPN mRNA	PMID:20458559
1303191	Snupn	snurportin 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SNUPN mRNA	PMID:34492290
1303191	Snupn	snurportin 1	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of SNUPN mRNA	PMID:30690063
1303191	Snupn	snurportin 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SNUPN protein	PMID:33376534
1303191	Snupn	snurportin 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1615903	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SNUPN mRNA	PMID:33221593
1303191	Snupn	snurportin 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1353124	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SNUPN gene	PMID:31601247
1303191	Snupn	snurportin 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNUPN mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303191	Snupn	snurportin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1615903	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SNUPN mRNA	PMID:39298647|PMID:40203079
1303191	Snupn	snurportin 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1615903	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SNUPN mRNA	PMID:37019170
1303191	Snupn	snurportin 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1615903	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SNUPN mRNA	PMID:17361019
1303191	Snupn	snurportin 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353124	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SNUPN mRNA	PMID:37042841
1303191	Snupn	snurportin 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1353124	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SNUPN mRNA	PMID:39836092
1303191	Snupn	snurportin 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SNUPN mRNA	PMID:33453195
1303191	Snupn	snurportin 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SNUPN mRNA	PMID:38568856
1303191	Snupn	snurportin 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1615903	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SNUPN mRNA	PMID:18353800
1303191	Snupn	snurportin 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1615903	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNUPN mRNA	PMID:36331819
1303191	Snupn	snurportin 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1615903	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SNUPN mRNA	PMID:17292431
1303191	Snupn	snurportin 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNUPN mRNA	PMID:29154799
1303191	Snupn	snurportin 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SNUPN mRNA	PMID:29067470
1303191	Snupn	snurportin 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNUPN mRNA	PMID:33387578
1303191	Snupn	snurportin 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1353124	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNUPN mRNA	PMID:22079256
1303191	Snupn	snurportin 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1615903	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SNUPN mRNA	PMID:35436446
1303191	Snupn	snurportin 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1353124	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SNUPN mRNA	PMID:18175754
1303191	Snupn	snurportin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1615903	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SNUPN mRNA	PMID:17942748
1303191	Snupn	snurportin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1615903	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNUPN mRNA	PMID:17942748
1303191	Snupn	snurportin 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SNUPN mRNA	PMID:20458559
1303191	Snupn	snurportin 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNUPN protein	PMID:32959892
1303191	Snupn	snurportin 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1353124	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SNUPN mRNA	PMID:39836092
1303191	Snupn	snurportin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1615903	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNUPN mRNA	PMID:22206623
1303191	Snupn	snurportin 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SNUPN mRNA	PMID:22079256|PMID:22714537
1303191	Snupn	snurportin 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1353124	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNUPN mRNA	PMID:22079256
1303191	Snupn	snurportin 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNUPN mRNA	PMID:30851411
1303191	Snupn	snurportin 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1615903	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SNUPN mRNA	PMID:31388691
1303191	Snupn	snurportin 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1615903	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SNUPN mRNA	PMID:30294300
1303191	Snupn	snurportin 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1353124	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SNUPN mRNA	PMID:38568856
1303191	Snupn	snurportin 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SNUPN mRNA	PMID:21346803
1303192	Klk1c12	kallikrein 1-related peptidase C12	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KLK1C12 gene	PMID:28505145
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1353653	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SUCNR1 mRNA	PMID:33167477
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550021	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SUCNR1 mRNA	PMID:36331819
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1353653	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SUCNR1 mRNA	PMID:35811015
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1353653	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SUCNR1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SUCNR1 mRNA	PMID:35811015
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of SUCNR1 mRNA	PMID:19484750|PMID:39298647
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1353653	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SUCNR1 mRNA	PMID:26079696
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1353653	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SUCNR1 gene	PMID:33872906
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SUCNR1 mRNA	PMID:28973375
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1353653	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SUCNR1 gene	PMID:33872906
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1353653	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SUCNR1 mRNA	PMID:19549813
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:234430	gardiquimod	increases expression	ISO	RGD:1353653	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of SUCNR1 mRNA	PMID:28003376
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1353653	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SUCNR1 mRNA]	PMID:28003376
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1353653	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SUCNR1 mRNA	PMID:27153756
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1353653	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SUCNR1 mRNA	PMID:41430723
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1353653	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SUCNR1 mRNA	PMID:18593933
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550021	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SUCNR1 mRNA	PMID:17484886
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SUCNR1 mRNA	PMID:27339419|PMID:31919559
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SUCNR1 mRNA	PMID:28189721|PMID:28960355
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1353653	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SUCNR1 mRNA	PMID:27594783
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1550021	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of SUCNR1 mRNA	PMID:18930951
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1353653	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of SUCNR1 mRNA	PMID:24768652
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550021	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SUCNR1 mRNA	PMID:26377647
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SUCNR1 mRNA	PMID:15652763
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SUCNR1 mRNA	PMID:28959563
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1353653	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SUCNR1 mRNA	PMID:32234424
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550021	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SUCNR1 mRNA	PMID:19770486
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1353653	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SUCNR1 mRNA	PMID:18593933
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:30563	silicon dioxide	affects expression	ISO	RGD:1353653	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog affects the expression of SUCNR1 mRNA	PMID:23806026
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SUCNR1 mRNA	PMID:23221170
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of SUCNR1 mRNA	PMID:22641619
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SUCNR1 mRNA	PMID:23557971
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SUCNR1 mRNA	PMID:30723492
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SUCNR1 mRNA	PMID:18445702
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1353653	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SUCNR1 mRNA	PMID:19710929
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SUCNR1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1353653	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SUCNR1 mRNA	PMID:25979313
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SUCNR1 mRNA	PMID:39298647|PMID:40203079
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of SUCNR1 mRNA	PMID:26377693
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SUCNR1 mRNA	PMID:35163327
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SUCNR1 mRNA	PMID:35163327
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in decreased expression of SUCNR1 mRNA	PMID:24183702
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SUCNR1 mRNA	PMID:28903501
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1550021	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SUCNR1 mRNA	PMID:18353800
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1353653	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SUCNR1 mRNA]	PMID:28003376
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550021	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SUCNR1 mRNA	PMID:36331819
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353653	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SUCNR1 mRNA	PMID:25979313
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550021	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SUCNR1 mRNA	PMID:17292431
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of SUCNR1 mRNA	PMID:29427782
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353653	E	RGD:6480464	20160210	CTD	MESH:D014635	Valproic Acid results in increased expression of SUCNR1 mRNA	PMID:26705709|PMID:29154799
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550021	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SUCNR1 mRNA	PMID:20937368
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of SUCNR1 mRNA	PMID:25123088
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SUCNR1 mRNA	PMID:28973697
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1550021	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SUCNR1 mRNA	PMID:18502557
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1353653	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SUCNR1 mRNA	PMID:38832940
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1353653	E	RGD:6480464	20160210	CTD	MESH:C012589	trichostatin A results in increased expression of SUCNR1 mRNA	PMID:26705709
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550021	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SUCNR1 mRNA	PMID:17562736
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1353653	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of SUCNR1 mRNA	PMID:24714768
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1353653	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SUCNR1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SUCNR1 mRNA	PMID:35811015
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of SUCNR1 mRNA	PMID:26934552
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1353653	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of SUCNR1 mRNA	PMID:26833863
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550021	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SUCNR1 mRNA	PMID:35436446
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1353653	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of SUCNR1 mRNA	PMID:32234424
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SUCNR1 mRNA; Nanotubes, Carbon results in decreased expression of SUCNR1 mRNA	PMID:25620056
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:6382	Lasiocarpine	decreases expression	ISO	RGD:1353653	E	RGD:6480464	20200714	CTD	MESH:C005136	lasiocarpine results in decreased expression of SUCNR1 mRNA	PMID:32234424
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SUCNR1 mRNA	PMID:22206623
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of SUCNR1 mRNA	PMID:19482888|PMID:23091169
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1550021	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SUCNR1 mRNA]	PMID:19482888
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1353653	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of SUCNR1 mRNA	PMID:26079696
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SUCNR1 mRNA	PMID:21278054
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in decreased expression of SUCNR1 mRNA	PMID:26141394
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1353653	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SUCNR1 mRNA	PMID:29301935
1303193	Sucnr1	succinate receptor 1	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1550021	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of SUCNR1 mRNA	PMID:32835833
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of HYAL4 mRNA	PMID:26496021
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1553131	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HYAL4 mRNA	PMID:37567420
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1553131	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HYAL4 mRNA	PMID:37567420
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1347409	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HYAL4 mRNA	PMID:31163220
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HYAL4 mRNA	PMID:39012411
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1553131	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of HYAL4 mRNA	PMID:28960355
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1347409	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of HYAL4 mRNA	PMID:30851411
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1553131	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HYAL4 mRNA	PMID:37567420
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347409	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HYAL4 mRNA	PMID:17879257
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1347409	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HYAL4 promoter	PMID:27901495
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HYAL4 mRNA	PMID:25181051
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of HYAL4 mRNA	PMID:26496021
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HYAL4 mRNA	PMID:39012411
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1553131	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HYAL4 mRNA	PMID:37567420
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1553131	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of HYAL4 mRNA	PMID:37567420
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1347409	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of HYAL4 mRNA	PMID:30851411
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1347409	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital affects the expression of HYAL4 mRNA	PMID:19084549
1303194	Hyal4	hyaluronidase 4	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1347409	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of HYAL4 mRNA	PMID:17440010
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1349129	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of DDX56 protein	PMID:39638853
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX56 mRNA]	PMID:31150632
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553134	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DDX56 gene	PMID:20938992
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DDX56 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of DDX56 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DDX56 mRNA	PMID:32699268|PMID:32845096
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1553134	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX56 mRNA	PMID:30529165
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1349129	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DDX56 mRNA	PMID:20044591
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553134	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DDX56 mRNA	PMID:39241906
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553134	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DDX56 mRNA	PMID:39298647
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553134	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DDX56 gene	PMID:20938992
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of DDX56 mRNA	PMID:27523638
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DDX56 mRNA	PMID:28818685
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DDX56 mRNA	PMID:39836092
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20250603	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DDX56 protein	PMID:39638853
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1349129	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DDX56 mRNA	PMID:22100608
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of DDX56 protein	PMID:39638853
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DDX56 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of DDX56 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DDX56 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DDX56 mRNA	PMID:32699268|PMID:32845096
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of DDX56 mRNA	PMID:30779732
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX56 mRNA	PMID:31150632
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX56 mRNA]	PMID:31150632
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553134	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DDX56 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DDX56 gene	PMID:20938992|PMID:22206623
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DDX56 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX56 mRNA	PMID:39836092
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553134	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX56 mRNA	PMID:40504410
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553134	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDX56 mRNA	PMID:20702594|PMID:24680724
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DDX56 mRNA	PMID:19684285
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DDX56 mRNA	PMID:33387578
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1349129	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DDX56 mRNA	PMID:19684285
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553134	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DDX56 mRNA	PMID:17942748
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1349129	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DDX56 mRNA	PMID:33212167
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1349129	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of DDX56 mRNA	PMID:39709020
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of DDX56 mRNA	PMID:32763439
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1553134	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of DDX56 mRNA	PMID:30807115
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of DDX56 mRNA	PMID:31162603
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DDX56 mRNA	PMID:38568856
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DDX56 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX56 mRNA	PMID:39836092
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553134	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX56 mRNA	PMID:40504410
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349129	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DDX56 promoter	PMID:27901495
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of DDX56 mRNA	PMID:31162603
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1349129	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of DDX56 gene	PMID:31601247
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553134	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of DDX56 mRNA	PMID:18301758
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DDX56 mRNA	PMID:25181051
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553134	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DDX56 mRNA	PMID:39298647
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DDX56 mRNA	PMID:17602206
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1553134	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DDX56 mRNA	PMID:21266533
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1349129	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to DDX56 protein	PMID:32991956
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DDX56 mRNA	PMID:17602206
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DDX56 mRNA	PMID:39836092
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DDX56 mRNA	PMID:19376846
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DDX56 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DDX56 mRNA	PMID:32699268
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1349129	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DDX56 mRNA	PMID:31533062
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1349129	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of DDX56 mRNA	PMID:19167446
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349129	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DDX56 mRNA	PMID:25979313
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of DDX56 mRNA; Valproic Acid results in decreased expression of DDX56 protein	PMID:29501571
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1349129	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DDX56 gene	PMID:29501571
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DDX56 mRNA	PMID:25562108
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553134	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DDX56 mRNA	PMID:17555576
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553134	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DDX56 mRNA	PMID:17562736
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1349129	E	RGD:6480464	20150825	CTD	MESH:D000082	DDX56 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of DDX56 mRNA	PMID:21420995
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DDX56 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX56 mRNA	PMID:39836092
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553134	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX56 mRNA	PMID:40504410
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of DDX56 mRNA	PMID:29391264
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1553134	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DDX56 mRNA	PMID:17555576
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553134	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DDX56 mRNA	PMID:17942748
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553134	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DDX56 mRNA	PMID:17942748
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DDX56 mRNA	PMID:24136188
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DDX56 protein	PMID:32959892
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DDX56 mRNA	PMID:39836092
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1349129	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of DDX56 mRNA	PMID:15336504
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553134	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DDX56 mRNA	PMID:22206623
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of DDX56 mRNA	PMID:24136188
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1349129	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of DDX56 protein	PMID:31285264
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1349129	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of DDX56 protein	PMID:39638853
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1349129	E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of DDX56 protein	PMID:39638853
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of DDX56 mRNA	PMID:39904859
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1553134	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of DDX56 mRNA	PMID:20702594
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1553134	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of DDX56 mRNA	PMID:39847705
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DDX56 mRNA	PMID:21346803
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1349129	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of DDX56 mRNA	PMID:34581912
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1349129	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DDX56 mRNA	PMID:38568856
1303195	Ddx56	DEAD-box helicase 56	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DDX56 mRNA	PMID:21346803
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1622348	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ST6GALNAC6 mRNA	PMID:33045310
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1622348	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ST6GALNAC6 mRNA	PMID:37995155
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ST6GALNAC6 mRNA]	PMID:31150632
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1622348	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of ST6GALNAC6 mRNA	PMID:40945087
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1622348	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ST6GALNAC6 mRNA	PMID:30319688
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1622348	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ST6GALNAC6 mRNA	PMID:39298647
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST6GALNAC6 mRNA	PMID:25510870
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ST6GALNAC6 mRNA	PMID:33387578
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D014050	Toluene results in decreased expression of ST6GALNAC6 mRNA	PMID:22967744
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1622348	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ST6GALNAC6 mRNA	PMID:34319233
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ST6GALNAC6 mRNA	PMID:36331819
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST6GALNAC6 mRNA	PMID:25510870
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST6GALNAC6 mRNA	PMID:25510870
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1354318	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ST6GALNAC6 mRNA	PMID:19549813
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ST6GALNAC6 mRNA	PMID:33354967
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1622348	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ST6GALNAC6 mRNA	PMID:19770486
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ST6GALNAC6 mRNA	PMID:31150632
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ST6GALNAC6 mRNA]	PMID:31150632
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1622348	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ST6GALNAC6 mRNA	PMID:25629700
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1354318	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ST6GALNAC6 mRNA	PMID:38460933
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1622348	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ST6GALNAC6 mRNA	PMID:28960355
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1354318	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ST6GALNAC6 mRNA	PMID:27392435
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622348	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ST6GALNAC6 mRNA	PMID:21570461|PMID:26377647
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ST6GALNAC6 mRNA	PMID:33387578
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1622348	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ST6GALNAC6 mRNA	PMID:26290441|PMID:28213091
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ST6GALNAC6 gene]	PMID:28213091
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ST6GALNAC6 mRNA	PMID:28959563
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1354318	E	RGD:6480464	20130806	CTD	MESH:D003561	Cytarabine results in decreased expression of ST6GALNAC6 mRNA	PMID:21198554
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1354318	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ST6GALNAC6 mRNA	PMID:29803840
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1622348	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ST6GALNAC6 mRNA	PMID:22228805
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1354318	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ST6GALNAC6 promoter	PMID:27901495
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:30778	gallic acid	increases expression	ISO	RGD:1354318	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of ST6GALNAC6 mRNA	PMID:34408198
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622348	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ST6GALNAC6 gene	PMID:35295148
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1622348	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ST6GALNAC6 gene	PMID:35295148
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ST6GALNAC6 mRNA	PMID:34492290
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1622348	E	RGD:6480464	20130806	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ST6GALNAC6 mRNA	PMID:18648102
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ST6GALNAC6 gene	PMID:23968726
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ST6GALNAC6 mRNA	PMID:25181051
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1622348	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of ST6GALNAC6 mRNA	PMID:37894381
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ST6GALNAC6 mRNA	PMID:34947998
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1354318	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of ST6GALNAC6 mRNA	PMID:36232920
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1354318	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of ST6GALNAC6 mRNA	PMID:36232920
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ST6GALNAC6 mRNA	PMID:36041667
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1354318	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST6GALNAC6 mRNA	PMID:28628672
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST6GALNAC6 mRNA	PMID:25510870
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST6GALNAC6 mRNA	PMID:25510870
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1622348	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ST6GALNAC6 exon	PMID:33297965
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ST6GALNAC6 mRNA	PMID:36041667
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1622348	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ST6GALNAC6 mRNA	PMID:38685157
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ST6GALNAC6 mRNA	PMID:36041667
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1354318	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ST6GALNAC6 mRNA	PMID:28628672
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1354318	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST6GALNAC6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ST6GALNAC6 mRNA	PMID:28628672
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ST6GALNAC6 gene	PMID:23968726
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1354318	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ST6GALNAC6 mRNA	PMID:32588087
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1354318	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ST6GALNAC6 mRNA	PMID:31533062
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ST6GALNAC6 mRNA	PMID:36331819
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ST6GALNAC6 mRNA	PMID:41580965
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1354318	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST6GALNAC6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ST6GALNAC6 mRNA	PMID:28628672
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1622348	E	RGD:6480464	20130806	CTD	MESH:D008727	Methotrexate affects the expression of ST6GALNAC6 mRNA	PMID:18502557
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1354318	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ST6GALNAC6 mRNA	PMID:38832940
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ST6GALNAC6 mRNA	PMID:33387578
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1354318	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ST6GALNAC6 mRNA	PMID:38460933
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1354318	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST6GALNAC6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ST6GALNAC6 mRNA	PMID:28628672
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ST6GALNAC6 mRNA	PMID:30307764
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1622348	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of ST6GALNAC6 mRNA	PMID:36907384
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1622348	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ST6GALNAC6 mRNA	PMID:22206623
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:749301	potassium perchlorate	decreases expression	ISO	RGD:1354318	E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of ST6GALNAC6 mRNA	PMID:29673971
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1622348	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital results in decreased expression of ST6GALNAC6 mRNA	PMID:19482888
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1622348	E	RGD:6480464	20130806	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ST6GALNAC6 mRNA]	PMID:19482888
1303196	St6galnac6	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1622348	E	RGD:6480464	20130806	CTD	MESH:C045950	propiconazole results in decreased expression of ST6GALNAC6 mRNA	PMID:21278054
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1553154	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GPAA1 mRNA	PMID:36331819
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1353728	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of GPAA1 mRNA	PMID:24763279
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1353728	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of GPAA1 mRNA	PMID:21632981
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553154	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GPAA1 mRNA	PMID:39241906
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of GPAA1 gene	PMID:27618143
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353728	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GPAA1 mRNA	PMID:37042841
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1553154	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of GPAA1 mRNA	PMID:17251523
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1553154	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of GPAA1 mRNA	PMID:28973375
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553154	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of GPAA1 mRNA	PMID:33754040
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553154	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPAA1 mRNA	PMID:36331819
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:18291	manganese atom	affects expression	ISO	RGD:1353728	E	RGD:6480464	20260203	CTD	MESH:D008345	Manganese affects the expression of GPAA1 protein	PMID:37834424
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GPAA1 mRNA	PMID:19549813
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of GPAA1 mRNA	PMID:35737395
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:27641	cycloheximide	increases expression	ISO	RGD:1353728	E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide results in increased expression of GPAA1 mRNA	PMID:19684285
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1353728	E	RGD:6480464	20120412	CTD	MESH:D003513	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of GPAA1 mRNA	PMID:19684285
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1353728	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of GPAA1 mRNA	PMID:19167446
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1353728	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of GPAA1 mRNA	PMID:28903495
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1353728	E	RGD:6480464	20120412	CTD	MESH:D002945	GPAA1 protein affects the susceptibility to Cisplatin	PMID:16217747
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1353728	E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in increased expression of GPAA1 mRNA	PMID:21858171
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553154	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPAA1 mRNA	PMID:21570461|PMID:24680724
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GPAA1 mRNA	PMID:16960034
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GPAA1 mRNA	PMID:33387578
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1353728	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GPAA1 mRNA	PMID:19684285
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553154	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GPAA1 mRNA	PMID:15667827|PMID:17942748
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1353728	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of GPAA1 mRNA	PMID:19684285
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553154	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GPAA1 mRNA	PMID:17942748
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GPAA1 mRNA	PMID:33212167
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of GPAA1 mRNA	PMID:32763439
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GPAA1 mRNA	PMID:38568856
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353728	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of GPAA1 mRNA	PMID:39719251
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1353728	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GPAA1 mRNA	PMID:22316170
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1553154	E	RGD:6480464	20120515	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of GPAA1 mRNA]; Benzo(a)pyrene promotes the reaction [AHR protein binds to GPAA1 promoter]	PMID:19654925|PMID:22228805
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of GPAA1 mRNA	PMID:35984750
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of GPAA1 mRNA	PMID:30047161
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553154	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GPAA1 promoter	PMID:35295148
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of GPAA1 mRNA	PMID:33296240|PMID:34947998
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GPAA1 mRNA	PMID:25181051
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553154	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GPAA1 mRNA	PMID:33221593
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553154	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GPAA1 mRNA	PMID:37019170
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:35154	manganese(0)	affects expression	ISO	RGD:1353728	E	RGD:6480464	20260203	CTD	MESH:D008345	Manganese affects the expression of GPAA1 protein	PMID:37834424
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GPAA1 mRNA	PMID:31533062
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1353728	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAA1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GPAA1 mRNA	PMID:19167446
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553154	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPAA1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GPAA1 mRNA	PMID:36331819
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353728	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GPAA1 mRNA	PMID:25979313
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353728	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of GPAA1 mRNA	PMID:23179753
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1353728	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GPAA1 gene	PMID:29154799
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1353728	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in decreased expression of GPAA1 mRNA	PMID:17183730
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of GPAA1 mRNA	PMID:20106945
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GPAA1 mRNA	PMID:33387578
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553154	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GPAA1 mRNA	PMID:35436446
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553154	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of GPAA1 mRNA	PMID:17942748
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553154	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GPAA1 mRNA	PMID:17942748
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553154	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GPAA1 mRNA; Nanotubes, Carbon results in increased expression of GPAA1 mRNA	PMID:25554681
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of GPAA1 mRNA	PMID:30047161
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1353728	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in decreased expression of GPAA1 mRNA	PMID:17183730
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GPAA1 protein	PMID:32959892
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of GPAA1 mRNA	PMID:22101062
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553154	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GPAA1 mRNA	PMID:22206623
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1353728	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of GPAA1 mRNA	PMID:19159669
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1353728	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAA1 mRNA	PMID:19167446
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1353728	E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of GPAA1 mRNA	PMID:21858171
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of GPAA1 mRNA	PMID:30047161
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GPAA1 mRNA	PMID:38568856
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1353728	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GPAA1 mRNA	PMID:29301935
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of GPAA1 mRNA	PMID:21346803
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of GPAA1 protein	PMID:32519852
1303197	Gpaa1	glycosylphosphatidylinositol anchor attachment 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1553154	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of GPAA1 mRNA	PMID:35537566
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of GCNT2 mRNA	PMID:25152437
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GCNT2 mRNA	PMID:20188158
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of GCNT2 mRNA	PMID:16604517
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1607088	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of GCNT2 mRNA	PMID:33167477
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1552410	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA	PMID:30951980
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552410	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GCNT2 mRNA	PMID:36331819
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20120515	CTD	MESH:D000431	Ethanol results in decreased expression of GCNT2 mRNA	PMID:21955143
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of GCNT2 mRNA	PMID:21632981
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552410	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GCNT2 mRNA	PMID:39241906
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GCNT2 mRNA	PMID:39298647
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GCNT2 mRNA	PMID:20823114
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of GCNT2 mRNA	PMID:20655997|PMID:23649840
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:17303	morphine	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20210309	CTD	MESH:D009020	Morphine deficiency results in decreased expression of GCNT2 mRNA	PMID:27126842
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:17303	morphine	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120515	CTD	MESH:D009020	Morphine results in increased expression of GCNT2 mRNA	PMID:21955143
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1552410	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of GCNT2 mRNA	PMID:33848595
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of GCNT2 mRNA	PMID:21955143
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1552410	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of GCNT2 mRNA	PMID:17997037
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of GCNT2 mRNA	PMID:27523638
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA	PMID:39836092
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of GCNT2 mRNA	PMID:21955143
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1552410	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of GCNT2 mRNA	PMID:17997037
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:2038	5-azacytidine	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in decreased expression of GCNT2 mRNA	PMID:20823114
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552410	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCNT2 mRNA	PMID:37236586
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1607088	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of GCNT2 mRNA	PMID:19549813
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of GCNT2 mRNA	PMID:23649840
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GCNT2 mRNA	PMID:19770486
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of GCNT2 mRNA	PMID:23649840
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of GCNT2 mRNA	PMID:19555225
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of GCNT2 mRNA	PMID:30779732
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GCNT2 mRNA	PMID:18593933
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of GCNT2 mRNA	PMID:17484886
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GCNT2 mRNA	PMID:31150632
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of GCNT2 mRNA	PMID:19654921
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCNT2 mRNA	PMID:39836092
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GCNT2 mRNA	PMID:23557933
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1607088	E	RGD:6480464	20120412	CTD	MESH:D002945	GCNT2 protein affects the susceptibility to Cisplatin	PMID:16217747
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1552410	E	RGD:6480464	20210309	CTD	MESH:D003042	Cocaine deficiency results in increased expression of GCNT2 mRNA	PMID:27126842
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552410	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GCNT2 mRNA	PMID:21570461
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GCNT2 mRNA	PMID:21215274|PMID:33387578
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GCNT2 mRNA	PMID:34747641
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GCNT2 mRNA	PMID:15800033
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552410	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GCNT2 promoter]	PMID:19654925
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of GCNT2 mRNA	PMID:28959563
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of GCNT2 mRNA	PMID:21198554
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GCNT2 mRNA	PMID:29803840
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552410	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of GCNT2 mRNA	PMID:39631538
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1552410	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of GCNT2 mRNA	PMID:32042022
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of GCNT2 mRNA	PMID:35314868
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552410	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of GCNT2 mRNA	PMID:18812580
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1607088	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GCNT2 mRNA	PMID:36989763|PMID:38568856
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCNT2 mRNA	PMID:39836092
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1607088	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GCNT2 5' UTR; Benzo(a)pyrene affects the methylation of GCNT2 promoter	PMID:27901495
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GCNT2 mRNA	PMID:21839799
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GCNT2 mRNA	PMID:19770486
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GCNT2 mRNA	PMID:32234424
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GCNT2 mRNA	PMID:22228805
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1607088	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GCNT2 mRNA	PMID:20106945|PMID:21632981
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1607088	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of GCNT2 promoter	PMID:23974009
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GCNT2 mRNA	PMID:18593933
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1607088	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of GCNT2 mRNA	PMID:26014281
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of GCNT2 mRNA	PMID:24915197
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of GCNT2 mRNA	PMID:24136188
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:31746	kainic acid	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in increased expression of GCNT2 mRNA	PMID:17997037
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of GCNT2 mRNA	PMID:25729387
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of GCNT2 mRNA	PMID:34492290
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of GCNT2 mRNA	PMID:23811191
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of GCNT2 mRNA	PMID:17426115|PMID:18445702
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of GCNT2 mRNA	PMID:30690063
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:33146	vanadyl sulfate	increases expression	ISO	RGD:1607088	E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in increased expression of GCNT2 mRNA	PMID:16330358
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GCNT2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of GCNT2 mRNA	PMID:33296240|PMID:34947998
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552410	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of GCNT2 mRNA	PMID:30951980|PMID:32156529
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GCNT2 gene	PMID:28505145
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1552410	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA	PMID:30951980
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of GCNT2 mRNA	PMID:28300664
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GCNT2 mRNA	PMID:23196670
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552410	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of GCNT2 gene	PMID:31683443
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552410	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of GCNT2 mRNA	PMID:30951980|PMID:40203079
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552410	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of GCNT2 exon	PMID:33297965
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1552410	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA	PMID:30951980
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552410	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of GCNT2 mRNA	PMID:30951980
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1552410	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA	PMID:30951980
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552410	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of GCNT2 exon; butylbenzyl phthalate results in increased methylation of GCNT2 intron	PMID:28392331
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of GCNT2 mRNA	PMID:37019170
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1607088	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of GCNT2 gene	PMID:22964155
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of GCNT2 mRNA	PMID:19638242
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of GCNT2 mRNA	PMID:30589522
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:35036	fentin chloride	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in increased expression of GCNT2 mRNA	PMID:37156404
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA	PMID:39836092
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GCNT2 mRNA	PMID:25993096
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1607088	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GCNT2 mRNA	PMID:38568856
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552410	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCNT2 mRNA	PMID:37236586
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of GCNT2 mRNA	PMID:19429403
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1552410	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of GCNT2 mRNA	PMID:24183702
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GCNT2 mRNA	PMID:31533062
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of GCNT2 mRNA	PMID:19429403
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552410	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GCNT2 mRNA	PMID:36331819
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1607088	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GCNT2 mRNA	PMID:25979313
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of GCNT2 mRNA	PMID:30047161
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1607088	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GCNT2 mRNA	PMID:25562108
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1552410	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of GCNT2 mRNA	PMID:22733784
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:42223	emodin	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:D004642	Emodin results in increased expression of GCNT2 mRNA	PMID:15612046
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552410	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of GCNT2 mRNA	PMID:28973697
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT2 mRNA	PMID:27188386
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GCNT2 mRNA	PMID:33387578
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of GCNT2 mRNA	PMID:21420995|PMID:29067470
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of GCNT2 mRNA	PMID:19654921
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCNT2 mRNA	PMID:39836092
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of GCNT2 mRNA	PMID:29391264
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GCNT2 mRNA	PMID:22079256
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GCNT2 mRNA	PMID:35436446
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:48981	quinolin-8-ol	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120412	CTD	MESH:D015125	Oxyquinoline results in increased expression of GCNT2 mRNA	PMID:15612046
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GCNT2 mRNA	PMID:20823114
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1552410	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of GCNT2 mRNA	PMID:25620056
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GCNT2 mRNA	PMID:25554681
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of GCNT2 mRNA	PMID:30047161
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1607088	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of GCNT2 mRNA	PMID:20977926
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1607088	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of GCNT2 mRNA	PMID:22714537
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:53070	2,4-dinitrobenzenesulfonic acid	increases expression	ISO	RGD:1552410	E	RGD:6480464	20190910	CTD	MESH:C001073	2,4-dinitrobenzenesulfonic acid results in increased expression of GCNT2 mRNA	PMID:30116771
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552410	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of GCNT2 mRNA	PMID:38701926
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA	PMID:39836092
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:63618	pravastatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of GCNT2 mRNA	PMID:27225895
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1552410	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of GCNT2 mRNA	PMID:27225895
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of GCNT2 mRNA	PMID:25729387
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of GCNT2 mRNA	PMID:25729387
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1552410	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of GCNT2 mRNA	PMID:20003209
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GCNT2 mRNA	PMID:20823114
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1607088	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of GCNT2 mRNA	PMID:31758290
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552410	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GCNT2 mRNA	PMID:22206623
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:75170	zaragozic acid A	affects expression	ISO	RGD:1552410	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 affects the expression of GCNT2 mRNA	PMID:27225895
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of GCNT2 mRNA	PMID:27225895
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1607088	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of GCNT2 mRNA	PMID:22079256|PMID:22714537
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GCNT2 mRNA	PMID:22079256
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of GCNT2 mRNA	PMID:26720608
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT2 mRNA	PMID:27188386
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GCNT2 gene]	PMID:28238834
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552410	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GCNT2 mRNA	PMID:23091169
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1552410	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of GCNT2 mRNA	PMID:38648751
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of GCNT2 mRNA	PMID:23640034
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of GCNT2 mRNA	PMID:39847705
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of GCNT2 mRNA	PMID:30047161
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GCNT2 mRNA	PMID:25825206
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of GCNT2 mRNA	PMID:30047161
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1607088	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT2 mRNA	PMID:27188386
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1607088	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of GCNT2 mRNA	PMID:26014281
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of GCNT2 mRNA	PMID:19281266
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	Streptozocin results in increased expression of GCNT2 mRNA	PMID:25905778
1303198	Gcnt2	glucosaminyl (N-acetyl) transferase 2	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1552410	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of GCNT2 mRNA	PMID:26217789
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D004237	Diuron results in decreased expression of CCL6 mRNA	PMID:21551480
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C000628730	graphene oxide analog results in increased expression of CCL6 mRNA; graphene oxide results in increased expression of CCL6 mRNA	PMID:33227293
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL6 mRNA	PMID:20938992
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCL6 mRNA	PMID:33729688
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CCL6 mRNA	PMID:30517762
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCL6 mRNA	PMID:39241906
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CCL6 mRNA	PMID:27339419
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D004958	Estradiol results in decreased expression of CCL6 mRNA	PMID:39298647
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D004958	Estradiol results in increased expression of CCL6 mRNA	PMID:32145629
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D004958	Estradiol results in increased expression of CCL6 mRNA	PMID:19484750
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL6 mRNA	PMID:32741896
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:16573	carbonyl sulfide	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C010063	carbonyl sulfide results in increased expression of CCL6 mRNA	PMID:19395590
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL6 mRNA	PMID:20938992
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:168396	mycophenolic acid	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D009173	Mycophenolic Acid results in decreased expression of CCL6 mRNA	PMID:19818335
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:168396	mycophenolic acid	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D009173	Mycophenolic Acid results in increased expression of CCL6 mRNA	PMID:19818335
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CCL6 mRNA	PMID:37992649
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL6 mRNA	PMID:32741896
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:17627	ferroheme b	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D006418	Heme metabolite results in increased expression of CCL6 mRNA	PMID:19191707
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CCL6 mRNA	PMID:37992649
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:17750	glycine betaine	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D001622	Betaine results in increased expression of CCL6 mRNA	PMID:26391144
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D003471	Cuprizone results in increased expression of CCL6 mRNA	PMID:26577399
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D005839	Gentamicins results in increased expression of CCL6 mRNA	PMID:22061828
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCL6 mRNA	PMID:36331819
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of CCL6 mRNA	PMID:28522335
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C500085	muraglitazar results in decreased expression of CCL6 mRNA	PMID:21515302
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:211551	TMC-120A	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C402696	TMC 120A results in increased expression of CCL6 mRNA	PMID:19818335
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCL6 mRNA	PMID:39012411
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CCL6 mRNA	PMID:33354967
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D009151	Mustard Gas results in decreased expression of CCL6 mRNA	PMID:19778212
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D009151	Mustard Gas results in increased expression of CCL6 mRNA	PMID:18955075
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:25442	mycotoxin	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D009183	Mycotoxins results in decreased expression of CCL6 mRNA	PMID:19818335
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CCL6 mRNA	PMID:19480007
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CCL6 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CCL6 mRNA	PMID:34911549
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:26355	heme b	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D006418	Heme metabolite results in increased expression of CCL6 mRNA	PMID:19191707
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D000661	Amphetamine results in increased expression of CCL6 mRNA	PMID:30779732
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D015032	Zinc deficiency results in increased expression of CCL6 mRNA	PMID:19111725
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCL6 mRNA	PMID:17484886|PMID:27339419|PMID:31919559
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CCL6 mRNA	PMID:30517762
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCL6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL6 mRNA	PMID:20938992|PMID:22206623
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:C059514	[Resveratrol co-treated with Streptozocin] results in increased expression of CCL6 mRNA	PMID:25905778
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D002945	Cisplatin results in decreased expression of CCL6 mRNA	PMID:22023808
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D014414	Tungsten results in decreased expression of CCL6 mRNA	PMID:30912803
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCL6 mRNA	PMID:28922406
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCL6 mRNA	PMID:15652763
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCL6 mRNA	PMID:22808131|PMID:23238561|PMID:34747641
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCL6 mRNA	PMID:23238561
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D012402	Rotenone results in increased expression of CCL6 mRNA	PMID:27900601
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D003300	Copper results in decreased expression of CCL6 mRNA	PMID:30556269
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CCL6 mRNA	PMID:21340527
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:D004317	Doxorubicin inhibits the reaction [Fungal Polysaccharides results in increased expression of CCL6 mRNA]	PMID:27181935
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CCL6 mRNA	PMID:37992649
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:29310	dichlorine	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D002713	Chlorine results in increased expression of CCL6 mRNA	PMID:30189237
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCL6 mRNA	PMID:21911445|PMID:37682722
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C017947	sodium arsenite results in increased expression of CCL6 mRNA	PMID:36209798
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCL6 mRNA	PMID:22228805
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:6904431	E	RGD:6480464	20220927	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCL15-CCL14 promoter	PMID:27901495
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCL6 mRNA	PMID:27858113
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C015001	arsenite results in decreased expression of CCL6 mRNA	PMID:18191166
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D003300	Copper results in decreased expression of CCL6 mRNA	PMID:30556269
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D015032	Zinc deficiency results in increased expression of CCL6 mRNA	PMID:19111725
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CCL6 mRNA	PMID:26345256|PMID:29341224
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C004312	glycidol results in increased expression of CCL6 mRNA	PMID:24395379|PMID:24915197
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D001761	Bleomycin results in increased expression of CCL6 protein	PMID:29175452
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C030110	Oxaliplatin results in increased expression of CCL6 mRNA	PMID:25729387
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in increased expression of CCL6 mRNA	PMID:25729387
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CCL6 mRNA	PMID:30047161
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C061133	tamibarotene results in decreased expression of CCL6 mRNA	PMID:20861477
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C501413	tesaglitazar results in decreased expression of CCL6 mRNA	PMID:21515302
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D002065	Buspirone results in decreased expression of CCL6 mRNA	PMID:24136188
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C009495	titanium dioxide results in increased expression of CCL6 mRNA	PMID:21259345|PMID:23557971|PMID:27760801
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D013853	Thioacetamide results in increased expression of CCL6 mRNA	PMID:34492290
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CCL6 mRNA	PMID:25380136
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C006253	pirinixic acid results in decreased expression of CCL6 mRNA	PMID:17426115
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C006253	pirinixic acid results in increased expression of CCL6 mRNA	PMID:18445702
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of CCL6 mRNA	PMID:19191707
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CCL6 mRNA	PMID:28472532
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C069837	fullerene C60 results in increased expression of CCL6 mRNA	PMID:20471445
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C006780	bisphenol A affects the expression of CCL6 mRNA	PMID:30903817
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C006780	bisphenol A results in decreased expression of CCL6 mRNA	PMID:25181051
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C006780	bisphenol A results in increased expression of CCL6 mRNA	PMID:32145629|PMID:41034487
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20251111	CTD	MESH:C006780	bisphenol A results in increased methylation of CCL6 gene	PMID:28505145
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CCL6 mRNA	PMID:28300664
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C029297	vinylidene chloride results in increased expression of CCL6 mRNA	PMID:26682919
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C543008	bisphenol S results in decreased expression of CCL6 mRNA	PMID:39298647
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C543008	bisphenol S results in increased expression of CCL6 mRNA	PMID:30951980
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCL6 mRNA	PMID:27858113
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of CCL6 mRNA	PMID:26377693
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C008745	bisphenol F results in increased expression of CCL6 mRNA	PMID:30951980|PMID:38685157
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CCL6 mRNA	PMID:32308655
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CCL6 mRNA	PMID:17602206
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of CCL6 mRNA	PMID:19645018
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D016264	Dextran Sulfate results in increased expression of CCL6 mRNA	PMID:35093514
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D003976	Diazinon affects the expression of CCL6 mRNA	PMID:22546817
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CCL6 mRNA	PMID:21266533
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34698	diethyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of CCL15-CCL14 mRNA	PMID:32341500
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D004137	Dinitrochlorobenzene affects the expression of CCL6 mRNA	PMID:22302311
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of CCL6 mRNA	PMID:19647056|PMID:21404309
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CCL6 mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CCL6 mRNA	PMID:17602206|PMID:18164116
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D010269	Paraquat results in decreased expression of CCL6 mRNA	PMID:32680482
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CCL6 mRNA	PMID:30589522
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CCL6 mRNA	PMID:25993096
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCL6 mRNA	PMID:39012411
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20251111	CTD	MESH:C039281	furan results in increased methylation of CCL6 gene	PMID:22079235
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CCL6 mRNA	PMID:28903501
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:35807	N-nitrosodimethylamine	affects expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D004128	Dimethylnitrosamine affects the expression of CCL6 mRNA	PMID:25380136
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCL6 mRNA	PMID:36331819
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C031763	1,3-butadiene results in increased expression of CCL6 mRNA	PMID:29038090
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:6904431	E	RGD:6480464	20220927	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CCL15-CCL14 gene	PMID:29154799
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D016572	Cyclosporine results in increased expression of CCL6 mRNA	PMID:21865292
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D003907	Dexamethasone results in increased expression of CCL6 mRNA	PMID:21041162
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CCL6 mRNA	PMID:37992649
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D008727	Methotrexate affects the expression of CCL6 mRNA	PMID:18502557
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C012655	nimesulide results in decreased expression of CCL6 mRNA	PMID:24136188
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D000082	Acetaminophen affects the expression of CCL6 mRNA	PMID:17562736
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CCL6 mRNA	PMID:23917077|PMID:29507420
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of CCL6 mRNA	PMID:16251409
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D004008	Diclofenac results in increased expression of CCL6 mRNA	PMID:26934552
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D004726	Endosulfan results in decreased expression of CCL6 mRNA	PMID:29391264
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CCL6 mRNA	PMID:17351261
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CCL6 mRNA; Nanotubes, Carbon results in increased expression of CCL6 mRNA	PMID:25620056
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D005485	Flutamide results in decreased expression of CCL6 mRNA	PMID:24136188
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCL6 mRNA	PMID:27858113
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCL6 mRNA	PMID:27858113
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:53050	trimellitic anhydride	affects expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C015559	trimellitic anhydride affects the expression of CCL6 mRNA	PMID:22302311
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CCL6 mRNA	PMID:16141432|PMID:19042947
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D010081	Oxazolone results in increased expression of CCL6 mRNA	PMID:19647056|PMID:21404309
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of CCL6 mRNA	PMID:19647056|PMID:21404309
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1553178	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CCL6 mRNA	PMID:38701926
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:61057	tacrolimus hydrate	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D016559	Tacrolimus results in increased expression of CCL6 mRNA	PMID:21865292
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D016559	Tacrolimus results in increased expression of CCL6 mRNA	PMID:29362864
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:63618	pravastatin	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D017035	Pravastatin results in decreased expression of CCL6 mRNA	PMID:27225895
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D017035	Pravastatin results in decreased expression of CCL6 mRNA	PMID:27225895
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL6 mRNA	PMID:21641980|PMID:26378955
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D019772	Topotecan results in increased expression of CCL6 mRNA	PMID:25729387
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in increased expression of CCL6 mRNA	PMID:25729387
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D007545	Isoproterenol results in increased expression of CCL6 mRNA	PMID:20003209
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D008012	Lidocaine results in increased expression of CCL6 mRNA	PMID:35283115
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D008694	Methamphetamine results in increased expression of CCL6 mRNA	PMID:36914120
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C057862	cyanoginosin LR results in increased expression of CCL6 mRNA	PMID:37342990
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D002185	Cannabidiol results in decreased expression of CCL6 mRNA	PMID:21542829
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:70851	phthalaldehyde	affects expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D009764	o-Phthalaldehyde affects the expression of CCL6 mRNA	PMID:22302311
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CCL6 mRNA	PMID:22206623
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCL6 mRNA	PMID:22206623
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C051752	nefazodone results in decreased expression of CCL6 mRNA	PMID:24136188
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C075117	squalestatin 1 results in decreased expression of CCL6 mRNA	PMID:27225895
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C075117	squalestatin 1 results in decreased expression of CCL6 mRNA	PMID:27225895
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C007350	nitrofen results in increased expression of CCL6 mRNA	PMID:33484710
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL6 mRNA	PMID:32741896
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CCL6 mRNA	PMID:18164116
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CCL6 mRNA	PMID:21346803
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:7852	oxycodone	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D010098	Oxycodone results in decreased expression of CCL6 mRNA	PMID:23439660
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D010634	Phenobarbital results in decreased expression of CCL6 mRNA	PMID:19482888
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of CCL6 mRNA]	PMID:19482888
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CCL6 mRNA	PMID:38648751
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CCL6 mRNA	PMID:23640034
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C009277	sodium arsenate affects the expression of CCL6 mRNA	PMID:39847705
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CCL6 mRNA	PMID:24780913|PMID:30047161
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:87368	diethyl malate	affects expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C058705	diethyl malate affects the expression of CCL6 mRNA	PMID:24814887
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:D020849	[APC protein affects the susceptibility to Raloxifene Hydrochloride] which affects the expression of CCL6 mRNA	PMID:24431404
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:D012999	Soman results in increased expression of CCL6 mRNA	PMID:19281266
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20251111	CTD	MESH:D013311	[Resveratrol co-treated with Streptozocin] results in increased expression of CCL6 mRNA	PMID:25905778
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1553178	E	RGD:6480464	20251111	CTD	MESH:C057693	Troglitazone results in increased expression of CCL6 mRNA	PMID:28973697
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C025643	vinclozolin affects the expression of CCL6 mRNA	PMID:19015723
1303200	Ccl6	C-C motif chemokine ligand 6	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20251111	CTD	MESH:C025643	vinclozolin results in increased expression of CCL6 mRNA	PMID:23034163
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1352882	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SGCE mRNA	PMID:38218311
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1553181	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SGCE mRNA	PMID:33045310
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1553181	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in increased expression of SGCE mRNA	PMID:16236135|PMID:16604517
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1553181	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SGCE mRNA	PMID:30319688
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553181	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SGCE mRNA	PMID:39241906
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1553181	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of SGCE mRNA]	PMID:39241906
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:164200	triclosan	increases methylation	ISO	RGD:1352882	E	RGD:6480464	20220607	CTD	MESH:D014260	Triclosan results in increased methylation of SGCE gene	PMID:34523531
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1553181	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SGCE mRNA	PMID:33711761
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553181	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SGCE mRNA	PMID:34319233
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1553181	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of SGCE gene	PMID:38833407
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553181	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SGCE mRNA	PMID:33754040
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553181	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SGCE mRNA	PMID:37236586
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1352882	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SGCE mRNA	PMID:19549813
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SGCE mRNA	PMID:30779732
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1553181	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SGCE mRNA	PMID:17484886
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1352882	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SGCE mRNA	PMID:21867686
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1352882	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SGCE gene	PMID:25304211
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352882	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SGCE mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SGCE mRNA	PMID:39836092|PMID:40512198
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1553181	E	RGD:6480464	20250311	CTD	MESH:D007854	Lead affects the methylation of SGCE gene	PMID:38833407
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SGCE mRNA	PMID:34747641
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1352882	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SGCE mRNA	PMID:33212167
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1352882	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SGCE mRNA	PMID:29803840
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352882	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SGCE mRNA	PMID:34032870
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352882	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SGCE mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SGCE mRNA	PMID:39836092|PMID:40512198
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1352882	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SGCE exon; Benzo(a)pyrene affects the methylation of SGCE promoter	PMID:27901495
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1553181	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SGCE intron	PMID:27901495
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:30778	gallic acid	increases expression	ISO	RGD:1352882	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of SGCE mRNA	PMID:34408198
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of SGCE mRNA	PMID:25729387
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SGCE mRNA	PMID:25729387
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SGCE mRNA	PMID:25181051
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553181	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SGCE mRNA	PMID:34585602
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SGCE gene	PMID:28505145
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of SGCE mRNA	PMID:21241498
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1553181	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of SGCE mRNA]	PMID:39241906
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553181	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SGCE mRNA	PMID:37236586
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1352882	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SGCE mRNA	PMID:24449571
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1553181	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SGCE mRNA	PMID:40194260
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1352882	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SGCE mRNA	PMID:28302478
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1352882	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SGCE mRNA	PMID:31533062
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1352882	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SGCE mRNA	PMID:25979313
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1352882	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SGCE mRNA	PMID:23179753|PMID:27188386
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1352882	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SGCE gene	PMID:29154799
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:4027	cyclophosphamide	affects response to substance	ISO	RGD:1352882	E	RGD:6480464	20120412	CTD	MESH:D003520	SGCE protein affects the susceptibility to Cyclophosphamide	PMID:16217747
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1352882	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SGCE mRNA	PMID:25562108|PMID:27989131
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1553181	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SGCE mRNA	PMID:28973697
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1352882	E	RGD:6480464	20120412	CTD	MESH:D008727	SGCE protein affects the susceptibility to Methotrexate	PMID:16217747
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1352882	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SGCE mRNA	PMID:38832940
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SGCE mRNA	PMID:20060208
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1352882	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SGCE mRNA	PMID:24935251
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553181	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SGCE mRNA	PMID:17562736
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SGCE mRNA	PMID:33387578
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1352882	E	RGD:6480464	20120412	CTD	MESH:D005472	SGCE protein affects the susceptibility to Fluorouracil	PMID:16217747
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1553181	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SGCE mRNA	PMID:29279043
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1553181	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of SGCE mRNA	PMID:29279043
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1352882	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SGCE gene	PMID:25304211
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352882	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SGCE mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SGCE mRNA	PMID:39836092|PMID:40512198
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1553181	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of SGCE mRNA	PMID:19042947
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of SGCE mRNA	PMID:25729387
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SGCE mRNA	PMID:25729387
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1352882	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SGCE mRNA	PMID:15336504
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1553181	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SGCE mRNA	PMID:27935865
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1352882	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of SGCE mRNA	PMID:33512557
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1553181	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SGCE mRNA	PMID:21795629
1303201	Sgce	sarcoglycan, epsilon	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1553181	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of SGCE mRNA]	PMID:39241906
1303202	Ns5atp4-ps3	NS5A transactivated protein 4, pseudogene 3	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NS5ATP4-PS3 mRNA	PMID:33387578
1303202	Ns5atp4-ps3	NS5A transactivated protein 4, pseudogene 3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of NS5ATP4-PS3 mRNA	PMID:31881176
1303202	Ns5atp4-ps3	NS5A transactivated protein 4, pseudogene 3	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of NS5ATP4-PS3 promoter	PMID:27415467
1303203	mt-Te	mitochondrially encoded tRNA glutamic acid	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D001280	Atrazine results in increased expression of TRNE mRNA	PMID:36841081
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1349532	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ARFIP2 mRNA	PMID:38218311
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1551239	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ARFIP2 mRNA	PMID:33045310
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1349532	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ARFIP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ARFIP2 mRNA	PMID:32699268
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1349532	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ARFIP2 mRNA	PMID:29581250
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551239	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ARFIP2 mRNA	PMID:39241906
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of ARFIP2 mRNA	PMID:32145629|PMID:35192832
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551239	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in increased expression of ARFIP2 protein	PMID:26903627
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1551239	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of ARFIP2 mRNA	PMID:28973375
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1551239	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of ARFIP2 mRNA	PMID:33848595
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1551239	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARFIP2 mRNA	PMID:28085963
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARFIP2 mRNA	PMID:33387578
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1349532	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of ARFIP2 mRNA	PMID:17103032
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1349532	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ARFIP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ARFIP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of ARFIP2 mRNA	PMID:32699268
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551239	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARFIP2 mRNA	PMID:22206623
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1349532	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ARFIP2 mRNA	PMID:19244175
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1349532	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ARFIP2 protein	PMID:35688186
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1551239	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ARFIP2 mRNA	PMID:28960355
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551239	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARFIP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ARFIP2 mRNA	PMID:17942748|PMID:25975270
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of ARFIP2 protein	PMID:35544339
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1349532	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of ARFIP2 mRNA	PMID:33512557
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ARFIP2 mRNA	PMID:30556269
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1551239	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ARFIP2 protein	PMID:28918527
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1349532	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ARFIP2 mRNA	PMID:29803840
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1349532	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ARFIP2 promoter	PMID:27901495
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ARFIP2 mRNA	PMID:30556269
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1551239	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ARFIP2 mRNA	PMID:23221170
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1349532	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ARFIP2 mRNA	PMID:25258189
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ARFIP2 mRNA	PMID:24136188
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ARFIP2 mRNA	PMID:34492290
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1551239	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ARFIP2 mRNA	PMID:18648102
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1349532	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARFIP2 mRNA	PMID:19710929
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ARFIP2 mRNA	PMID:19167457
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ARFIP2 mRNA	PMID:32145629|PMID:35192832
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1551239	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARFIP2 promoter	PMID:27312807
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ARFIP2 mRNA	PMID:25181051
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1551239	E	RGD:6480464	20250805	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of ARFIP2 protein	PMID:26903627
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1551239	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARFIP2 exon; bisphenol S results in decreased methylation of ARFIP2 promoter	PMID:33297965
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551239	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ARFIP2 mRNA	PMID:39298647
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1551239	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ARFIP2 mRNA	PMID:38685157
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1551239	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ARFIP2 mRNA	PMID:37019170
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349532	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARFIP2 mRNA	PMID:38174414|PMID:38568856
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1349532	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ARFIP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ARFIP2 mRNA	PMID:32699268
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1349532	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ARFIP2 mRNA	PMID:19244175
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1551239	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of ARFIP2 mRNA	PMID:31558096
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551239	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ARFIP2 mRNA	PMID:17292431
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1349532	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ARFIP2 mRNA	PMID:20106945
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1349532	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ARFIP2 mRNA	PMID:36621641
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1349532	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of ARFIP2 mRNA	PMID:16595896
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551239	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARFIP2 mRNA	PMID:17562736
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349532	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARFIP2 mRNA	PMID:26690555
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1551239	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ARFIP2 mRNA	PMID:35436446
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1551239	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARFIP2 mRNA	PMID:17555576|PMID:17942748
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551239	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARFIP2 mRNA	PMID:17942748
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1349532	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ARFIP2 mRNA	PMID:25258189
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1349532	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of ARFIP2 mRNA	PMID:18651567
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551239	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARFIP2 mRNA	PMID:22206623
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ARFIP2 mRNA	PMID:24136188
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1349532	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ARFIP2 mRNA	PMID:22714537
1303204	Arfip2	ARF interacting protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349532	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARFIP2 gene]	PMID:28238834
1303205	Phf1	PHD finger protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1344150	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PHF1 mRNA	PMID:38218311
1303205	Phf1	PHD finger protein 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1344150	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PHF1 mRNA	PMID:22378314
1303205	Phf1	PHD finger protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553204	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PHF1 mRNA	PMID:39241906
1303205	Phf1	PHD finger protein 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1344150	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PHF1 mRNA	PMID:38568856
1303205	Phf1	PHD finger protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344150	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHF1 mRNA	PMID:37042841
1303205	Phf1	PHD finger protein 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1344150	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PHF1 mRNA	PMID:23649840
1303205	Phf1	PHD finger protein 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1344150	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of PHF1 mRNA	PMID:21592394
1303205	Phf1	PHD finger protein 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of PHF1 mRNA	PMID:21592394
1303205	Phf1	PHD finger protein 1	gene	CHEBI:17447	geraniol	increases expression	ISO	RGD:1344150	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of PHF1 mRNA	PMID:27683099
1303205	Phf1	PHD finger protein 1	gene	CHEBI:17580	linalool	decreases expression	ISO	RGD:1344150	E	RGD:6480464	20190219	CTD	MESH:C018584	linalool results in decreased expression of PHF1 mRNA	PMID:27683099
1303205	Phf1	PHD finger protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1344150	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PHF1 protein	PMID:37730182
1303205	Phf1	PHD finger protein 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1344150	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of PHF1 mRNA	PMID:21592394
1303205	Phf1	PHD finger protein 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of PHF1 mRNA	PMID:21592394
1303205	Phf1	PHD finger protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PHF1 mRNA	PMID:33387578
1303205	Phf1	PHD finger protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553204	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PHF1 mRNA	PMID:36331819
1303205	Phf1	PHD finger protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553204	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PHF1 mRNA	PMID:37325564
1303205	Phf1	PHD finger protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1344150	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PHF1 mRNA	PMID:23649840
1303205	Phf1	PHD finger protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1344150	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PHF1 gene	PMID:27153756
1303205	Phf1	PHD finger protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1344150	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PHF1 mRNA	PMID:23649840
1303205	Phf1	PHD finger protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553204	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PHF1 mRNA	PMID:34911549
1303205	Phf1	PHD finger protein 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1553204	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PHF1 mRNA	PMID:17484886
1303205	Phf1	PHD finger protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF1 mRNA	PMID:40512198
1303205	Phf1	PHD finger protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553204	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF1 mRNA	PMID:40504410
1303205	Phf1	PHD finger protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1344150	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PHF1 protein	PMID:35688186
1303205	Phf1	PHD finger protein 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1344150	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PHF1 mRNA	PMID:28903495
1303205	Phf1	PHD finger protein 1	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of PHF1 mRNA	PMID:31734292
1303205	Phf1	PHD finger protein 1	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1344150	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PHF1 mRNA	PMID:30851411
1303205	Phf1	PHD finger protein 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of PHF1 mRNA	PMID:20971185
1303205	Phf1	PHD finger protein 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1344150	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of PHF1 mRNA	PMID:29319823
1303205	Phf1	PHD finger protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344150	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PHF1 mRNA	PMID:38568856
1303205	Phf1	PHD finger protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF1 mRNA	PMID:40512198
1303205	Phf1	PHD finger protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553204	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF1 mRNA	PMID:40504410
1303205	Phf1	PHD finger protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1344150	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PHF1 5' UTR	PMID:27901495
1303205	Phf1	PHD finger protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1344150	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHF1 mRNA	PMID:22316170
1303205	Phf1	PHD finger protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553204	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHF1 mRNA	PMID:21715664
1303205	Phf1	PHD finger protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of PHF1 mRNA	PMID:20971185
1303205	Phf1	PHD finger protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1344150	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PHF1 mRNA	PMID:25895662
1303205	Phf1	PHD finger protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1344150	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PHF1 mRNA	PMID:25258189
1303205	Phf1	PHD finger protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PHF1 mRNA	PMID:30047161
1303205	Phf1	PHD finger protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553204	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHF1 gene	PMID:35295148
1303205	Phf1	PHD finger protein 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1553204	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of PHF1 promoter	PMID:27334623
1303205	Phf1	PHD finger protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF1 mRNA	PMID:25181051
1303205	Phf1	PHD finger protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553204	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PHF1 mRNA	PMID:33221593
1303205	Phf1	PHD finger protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PHF1 mRNA	PMID:23196670
1303205	Phf1	PHD finger protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553204	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PHF1 mRNA	PMID:39298647
1303205	Phf1	PHD finger protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1553204	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PHF1 mRNA	PMID:38685157
1303205	Phf1	PHD finger protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PHF1 mRNA	PMID:28628672
1303205	Phf1	PHD finger protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1553204	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of PHF1 mRNA	PMID:28392331
1303205	Phf1	PHD finger protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PHF1 mRNA	PMID:28628672
1303205	Phf1	PHD finger protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344150	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHF1 mRNA	PMID:37042841
1303205	Phf1	PHD finger protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553204	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PHF1 mRNA	PMID:37325564
1303205	Phf1	PHD finger protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PHF1 mRNA	PMID:24386269
1303205	Phf1	PHD finger protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1344150	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PHF1 mRNA	PMID:19320972|PMID:19376846
1303205	Phf1	PHD finger protein 1	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of PHF1 mRNA	PMID:30047161
1303205	Phf1	PHD finger protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553204	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PHF1 mRNA	PMID:36331819
1303205	Phf1	PHD finger protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344150	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHF1 mRNA	PMID:25979313
1303205	Phf1	PHD finger protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1344150	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF1 mRNA	PMID:23179753|PMID:26272509
1303205	Phf1	PHD finger protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344150	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of PHF1 mRNA	PMID:29154799
1303205	Phf1	PHD finger protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF1 mRNA	PMID:27188386
1303205	Phf1	PHD finger protein 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PHF1 mRNA	PMID:30047161
1303205	Phf1	PHD finger protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1344150	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PHF1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303205	Phf1	PHD finger protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PHF1 mRNA	PMID:28628672
1303205	Phf1	PHD finger protein 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1344150	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PHF1 mRNA	PMID:27188386
1303205	Phf1	PHD finger protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553204	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PHF1 mRNA	PMID:17562736
1303205	Phf1	PHD finger protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PHF1 mRNA	PMID:33387578
1303205	Phf1	PHD finger protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF1 mRNA	PMID:40512198
1303205	Phf1	PHD finger protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553204	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF1 mRNA	PMID:40504410
1303205	Phf1	PHD finger protein 1	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1344150	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of PHF1 mRNA	PMID:22077320
1303205	Phf1	PHD finger protein 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PHF1 mRNA	PMID:28628672
1303205	Phf1	PHD finger protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1344150	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PHF1 mRNA	PMID:25258189
1303205	Phf1	PHD finger protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553204	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PHF1 mRNA; Nanotubes, Carbon results in decreased expression of PHF1 mRNA	PMID:25554681
1303205	Phf1	PHD finger protein 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PHF1 mRNA	PMID:30047161
1303205	Phf1	PHD finger protein 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of PHF1 mRNA	PMID:22504374
1303205	Phf1	PHD finger protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1553204	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PHF1 mRNA	PMID:35964746
1303205	Phf1	PHD finger protein 1	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1344150	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of PHF1 mRNA	PMID:20977926
1303205	Phf1	PHD finger protein 1	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1344150	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of PHF1 mRNA	PMID:22714537
1303205	Phf1	PHD finger protein 1	gene	CHEBI:53001	nickel sulfate	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of PHF1 mRNA	PMID:31734292
1303205	Phf1	PHD finger protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553204	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PHF1 mRNA	PMID:22206623
1303205	Phf1	PHD finger protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1344150	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PHF1 mRNA	PMID:30851411
1303205	Phf1	PHD finger protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF1 mRNA	PMID:27188386
1303205	Phf1	PHD finger protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1553204	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PHF1 mRNA	PMID:31388691
1303205	Phf1	PHD finger protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PHF1 mRNA	PMID:30047161
1303205	Phf1	PHD finger protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of PHF1 mRNA	PMID:22504374
1303205	Phf1	PHD finger protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1553204	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PHF1 mRNA	PMID:40826991
1303205	Phf1	PHD finger protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344150	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF1 mRNA	PMID:27188386
1303205	Phf1	PHD finger protein 1	gene	CHEBI:9130	sevoflurane	increases expression	ISO	RGD:1553204	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased expression of PHF1 protein	PMID:35575159
1303205	Phf1	PHD finger protein 1	gene	CHEBI:9130	sevoflurane	multiple interactions	ISO	RGD:1553204	E	RGD:6480464	20220809	CTD	MESH:C009250	APOE protein alternative form inhibits the reaction [Sevoflurane results in increased expression of PHF1 protein]	PMID:35575159
1303205	Phf1	PHD finger protein 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1344150	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PHF1 mRNA	PMID:38568856
1303205	Phf1	PHD finger protein 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1344150	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PHF1 mRNA	PMID:29301935
1303205	Phf1	PHD finger protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PHF1 mRNA	PMID:23034163
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1343407	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of USP54 mRNA	PMID:33167477
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1618263	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of USP54 mRNA	PMID:36331819
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1618263	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of USP54 mRNA	PMID:30319688
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1618263	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of USP54 mRNA	PMID:30319688
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1343407	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of USP54 protein	PMID:37730182
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of USP54 mRNA	PMID:33387578
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1618263	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of USP54 mRNA	PMID:27462272
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1618263	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of USP54 mRNA	PMID:19770486
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1343407	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of USP54 gene	PMID:27153756
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1343407	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of USP54 mRNA	PMID:23649840
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of USP54 mRNA	PMID:31150632
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1343407	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of USP54 protein	PMID:35688186
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1618263	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of USP54 mRNA	PMID:35897073
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1618263	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of USP54 mRNA	PMID:40618947
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1343407	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of USP54 mRNA	PMID:25583101
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618263	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USP54 mRNA	PMID:21570461
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1343407	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of USP54 mRNA	PMID:20106945
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1618263	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP54 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to USP54 promoter]	PMID:17942748|PMID:19654925
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1343407	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of USP54 mRNA	PMID:32763439
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1343407	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of USP54 mRNA	PMID:29803840
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1343407	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of USP54 mRNA	PMID:29319823
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343407	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of USP54 mRNA	PMID:34032870
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343407	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of USP54 exon	PMID:27901495
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1343407	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of USP54 mRNA	PMID:20106945
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1618263	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of USP54 mRNA	PMID:19770486
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1618263	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of USP54 exon; Benzo(a)pyrene results in decreased methylation of USP54 intron	PMID:27901495
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1343407	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USP54 mRNA	PMID:22316170|PMID:26238291
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1343407	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of USP54 promoter	PMID:27901495
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of USP54 mRNA	PMID:30047161
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1618263	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of USP54 mRNA	PMID:18648102
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1618263	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of USP54 mRNA	PMID:28329830
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of USP54 mRNA	PMID:30816183
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of USP54 mRNA	PMID:25181051
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1618263	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of USP54 mRNA	PMID:25594700
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of USP54 gene	PMID:28505145
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1618263	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of USP54 mRNA	PMID:40203079
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1343407	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of USP54 gene	PMID:31601247
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343407	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of USP54 mRNA	PMID:37042841
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of USP54 mRNA	PMID:30589522
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of USP54 mRNA	PMID:33453195
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1343407	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of USP54 mRNA	PMID:24449571
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1343407	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of USP54 mRNA	PMID:28302478
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1343407	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of USP54 mRNA	PMID:19167446
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618263	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of USP54 mRNA	PMID:36331819
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1343407	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of USP54 gene	PMID:29154799
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1343407	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of USP54 mRNA	PMID:29154799
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of USP54 mRNA	PMID:30047161
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1618263	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of USP54 mRNA	PMID:22733784
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1618263	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of USP54 mRNA	PMID:17562736
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of USP54 mRNA	PMID:33387578
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1618263	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of USP54 mRNA	PMID:17942748
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1618263	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP54 mRNA	PMID:17942748
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of USP54 mRNA	PMID:30047161
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of USP54 mRNA	PMID:24140754
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:6015	isoflurane	increases methylation	ISO	RGD:1618263	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in increased methylation of USP54 mRNA	PMID:35249202
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1618263	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of USP54 mRNA	PMID:19001666
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1618263	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of USP54 mRNA	PMID:22206623
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1343407	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to USP54 gene]	PMID:28238834
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:80799	Bufotalin	increases expression	ISO	RGD:1343407	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of USP54 mRNA	PMID:39904859
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of USP54 mRNA	PMID:27291303
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of USP54 mRNA	PMID:24780913|PMID:30047161
1303206	Usp54	ubiquitin specific peptidase 54	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1343407	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of USP54 mRNA	PMID:29301935
1303207	mt-Tl1	mitochondrially encoded tRNA leucine 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D001280	Atrazine results in increased expression of TRNL1 mRNA	PMID:36841081
1303208	mt-Tn	mitochondrially encoded tRNA asparagine	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013853	Thioacetamide results in decreased expression of TRNN mRNA	PMID:34492290
1303209	Pcdh7	protocadherin 7	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PCDH7 mRNA	PMID:33045310
1303209	Pcdh7	protocadherin 7	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PCDH7 mRNA	PMID:19074003
1303209	Pcdh7	protocadherin 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PCDH7 gene	PMID:20938992
1303209	Pcdh7	protocadherin 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1346973	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PCDH7 mRNA	PMID:23724009
1303209	Pcdh7	protocadherin 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PCDH7 mRNA	PMID:36331819
1303209	Pcdh7	protocadherin 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1616811	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PCDH7 mRNA	PMID:30319688
1303209	Pcdh7	protocadherin 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of PCDH7 mRNA	PMID:21185374|PMID:31614463
1303209	Pcdh7	protocadherin 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of PCDH7 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of PCDH7 mRNA	PMID:20660070|PMID:30165855
1303209	Pcdh7	protocadherin 7	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDH7 mRNA	PMID:33387578
1303209	Pcdh7	protocadherin 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PCDH7 gene	PMID:20938992
1303209	Pcdh7	protocadherin 7	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of PCDH7 mRNA	PMID:20660070
1303209	Pcdh7	protocadherin 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH7 mRNA	PMID:37992649
1303209	Pcdh7	protocadherin 7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1346973	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PCDH7 mRNA	PMID:36695872
1303209	Pcdh7	protocadherin 7	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of PCDH7 mRNA	PMID:26496021
1303209	Pcdh7	protocadherin 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH7 mRNA	PMID:37992649
1303209	Pcdh7	protocadherin 7	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1346973	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PCDH7 protein	PMID:37730182
1303209	Pcdh7	protocadherin 7	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of PCDH7 mRNA	PMID:16002434
1303209	Pcdh7	protocadherin 7	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PCDH7 mRNA	PMID:33387578
1303209	Pcdh7	protocadherin 7	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1346973	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PCDH7 intron	PMID:30157460
1303209	Pcdh7	protocadherin 7	gene	CHEBI:18291	manganese atom	increases expression	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of PCDH7 mRNA	PMID:17175027
1303209	Pcdh7	protocadherin 7	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in decreased expression of PCDH7 mRNA	PMID:12634122
1303209	Pcdh7	protocadherin 7	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PCDH7 protein	PMID:20106945
1303209	Pcdh7	protocadherin 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1346973	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PCDH7 intron	PMID:30157460
1303209	Pcdh7	protocadherin 7	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of PCDH7 mRNA	PMID:19774075
1303209	Pcdh7	protocadherin 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PCDH7 mRNA	PMID:31150632
1303209	Pcdh7	protocadherin 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PCDH7 gene	PMID:20938992
1303209	Pcdh7	protocadherin 7	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1346973	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PCDH7 mRNA	PMID:26272509
1303209	Pcdh7	protocadherin 7	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA	PMID:27188386
1303209	Pcdh7	protocadherin 7	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH7 mRNA]	PMID:37992649
1303209	Pcdh7	protocadherin 7	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1616811	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PCDH7 mRNA	PMID:28960355
1303209	Pcdh7	protocadherin 7	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PCDH7 mRNA	PMID:31881176
1303209	Pcdh7	protocadherin 7	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of PCDH7 mRNA	PMID:21603599
1303209	Pcdh7	protocadherin 7	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of PCDH7 mRNA	PMID:17898221
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of PCDH7 mRNA	PMID:24768652
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1346973	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PCDH7 mRNA	PMID:25583101
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1616811	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PCDH7 mRNA	PMID:24680724
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDH7 mRNA	PMID:32109520|PMID:33387578
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDH7 mRNA	PMID:21296121
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDH7 mRNA	PMID:16120747|PMID:19933214
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1346973	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PCDH7 mRNA	PMID:21296121
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PCDH7 mRNA; Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PCDH7 mRNA]	PMID:16054899|PMID:17942748
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PCDH7 mRNA	PMID:28001369
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1346973	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PCDH7 mRNA	PMID:23179753|PMID:28001369
1303209	Pcdh7	protocadherin 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PCDH7 mRNA	PMID:33212167
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1346973	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PCDH7 mRNA	PMID:30851411
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of PCDH7 mRNA	PMID:30807115
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of PCDH7 mRNA	PMID:21198554
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of PCDH7 mRNA	PMID:20971185
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH7 mRNA	PMID:37992649
1303209	Pcdh7	protocadherin 7	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH7 mRNA]	PMID:37992649
1303209	Pcdh7	protocadherin 7	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1346973	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of PCDH7 mRNA	PMID:29319823
1303209	Pcdh7	protocadherin 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346973	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of PCDH7 mRNA	PMID:28595984|PMID:34032870
1303209	Pcdh7	protocadherin 7	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of PCDH7 mRNA	PMID:17127020
1303209	Pcdh7	protocadherin 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346973	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDH7 intron	PMID:30157460
1303209	Pcdh7	protocadherin 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1616811	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PCDH7 mRNA	PMID:22228805|PMID:32417428
1303209	Pcdh7	protocadherin 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346973	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDH7 3' UTR; Benzo(a)pyrene results in increased methylation of PCDH7 exon	PMID:27901495
1303209	Pcdh7	protocadherin 7	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1346973	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of PCDH7 promoter	PMID:23974009
1303209	Pcdh7	protocadherin 7	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of PCDH7 mRNA	PMID:20971185
1303209	Pcdh7	protocadherin 7	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PCDH7 mRNA	PMID:27131904
1303209	Pcdh7	protocadherin 7	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1346973	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PCDH7 mRNA	PMID:25351596
1303209	Pcdh7	protocadherin 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PCDH7 mRNA	PMID:19150397
1303209	Pcdh7	protocadherin 7	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PCDH7 gene	PMID:31601247
1303209	Pcdh7	protocadherin 7	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1616811	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of PCDH7 mRNA	PMID:22609695
1303209	Pcdh7	protocadherin 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PCDH7 mRNA	PMID:25729387
1303209	Pcdh7	protocadherin 7	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1616811	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of PCDH7 mRNA	PMID:17656681
1303209	Pcdh7	protocadherin 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1616811	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PCDH7 gene	PMID:35295148
1303209	Pcdh7	protocadherin 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH7 mRNA	PMID:25181051
1303209	Pcdh7	protocadherin 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH7 mRNA	PMID:29275510
1303209	Pcdh7	protocadherin 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1346973	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PCDH7 gene	PMID:31601247
1303209	Pcdh7	protocadherin 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of PCDH7 mRNA	PMID:29097150
1303209	Pcdh7	protocadherin 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of PCDH7 mRNA	PMID:26496021
1303209	Pcdh7	protocadherin 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PCDH7 gene	PMID:31601247
1303209	Pcdh7	protocadherin 7	gene	CHEBI:34237	2,4-diaminotoluene	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in decreased expression of PCDH7 mRNA	PMID:20713471
1303209	Pcdh7	protocadherin 7	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of PCDH7 mRNA	PMID:20713471
1303209	Pcdh7	protocadherin 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1616811	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PCDH7 mRNA	PMID:30951980
1303209	Pcdh7	protocadherin 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1616811	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PCDH7 mRNA	PMID:30951980
1303209	Pcdh7	protocadherin 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PCDH7 mRNA	PMID:28392331
1303209	Pcdh7	protocadherin 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1616811	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of PCDH7 intron	PMID:28392331
1303209	Pcdh7	protocadherin 7	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1346973	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of PCDH7 gene	PMID:22964155
1303209	Pcdh7	protocadherin 7	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1616811	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PCDH7 mRNA	PMID:21266533
1303209	Pcdh7	protocadherin 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PCDH7 mRNA; Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PCDH7 mRNA]	PMID:16054899
1303209	Pcdh7	protocadherin 7	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20140408	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of PCDH7 mRNA; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of PCDH7 mRNA]	PMID:23963992
1303209	Pcdh7	protocadherin 7	gene	CHEBI:35154	manganese(0)	increases expression	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of PCDH7 mRNA	PMID:17175027
1303209	Pcdh7	protocadherin 7	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of PCDH7 mRNA	PMID:18500788
1303209	Pcdh7	protocadherin 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PCDH7 mRNA	PMID:38174414
1303209	Pcdh7	protocadherin 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1346973	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PCDH7 mRNA	PMID:38382870
1303209	Pcdh7	protocadherin 7	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1346973	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PCDH7 mRNA	PMID:24449571
1303209	Pcdh7	protocadherin 7	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PCDH7 mRNA	PMID:40194260
1303209	Pcdh7	protocadherin 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PCDH7 mRNA	PMID:36331819
1303209	Pcdh7	protocadherin 7	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of PCDH7 mRNA	PMID:23125180
1303209	Pcdh7	protocadherin 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1616811	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PCDH7 mRNA	PMID:17292431
1303209	Pcdh7	protocadherin 7	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PCDH7 mRNA	PMID:29427782
1303209	Pcdh7	protocadherin 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDH7 mRNA	PMID:29427782
1303209	Pcdh7	protocadherin 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDH7 mRNA	PMID:24935251
1303209	Pcdh7	protocadherin 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346973	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PCDH7 mRNA	PMID:23179753|PMID:25192806|PMID:26272509|PMID:28001369
1303209	Pcdh7	protocadherin 7	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1346973	E	RGD:6480464	20171114	CTD	MESH:D014635	Valproic Acid results in increased methylation of PCDH7 gene	PMID:28853863|PMID:29201983
1303209	Pcdh7	protocadherin 7	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA	PMID:27188386
1303209	Pcdh7	protocadherin 7	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PCDH7 mRNA	PMID:30047161
1303209	Pcdh7	protocadherin 7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCDH7 mRNA	PMID:20106945
1303209	Pcdh7	protocadherin 7	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in increased expression of PCDH7 mRNA	PMID:19059307
1303209	Pcdh7	protocadherin 7	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PCDH7 mRNA; Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PCDH7 mRNA]	PMID:16054899
1303209	Pcdh7	protocadherin 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PCDH7 mRNA	PMID:28973697
1303209	Pcdh7	protocadherin 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH7 mRNA	PMID:37992649
1303209	Pcdh7	protocadherin 7	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1346973	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of PCDH7 mRNA	PMID:24449571
1303209	Pcdh7	protocadherin 7	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1346973	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PCDH7 mRNA	PMID:26272509
1303209	Pcdh7	protocadherin 7	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of PCDH7 mRNA	PMID:24935251
1303209	Pcdh7	protocadherin 7	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1346973	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PCDH7 mRNA	PMID:24935251|PMID:26272509
1303209	Pcdh7	protocadherin 7	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA	PMID:27188386
1303209	Pcdh7	protocadherin 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCDH7 mRNA	PMID:30723492|PMID:33387578
1303209	Pcdh7	protocadherin 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCDH7 mRNA	PMID:17585979
1303209	Pcdh7	protocadherin 7	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PCDH7 mRNA]	PMID:18700144
1303209	Pcdh7	protocadherin 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of PCDH7 mRNA	PMID:33725128
1303209	Pcdh7	protocadherin 7	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1616811	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of PCDH7 mRNA	PMID:30529165
1303209	Pcdh7	protocadherin 7	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of PCDH7 mRNA	PMID:17557909
1303209	Pcdh7	protocadherin 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PCDH7 mRNA	PMID:29097150
1303209	Pcdh7	protocadherin 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1616811	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PCDH7 mRNA	PMID:17942748
1303209	Pcdh7	protocadherin 7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PCDH7 mRNA	PMID:17942748
1303209	Pcdh7	protocadherin 7	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1346973	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of PCDH7 mRNA	PMID:38568856
1303209	Pcdh7	protocadherin 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1616811	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PCDH7 mRNA; Nanotubes, Carbon results in increased expression of PCDH7 mRNA	PMID:25554681
1303209	Pcdh7	protocadherin 7	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PCDH7 mRNA	PMID:30047161
1303209	Pcdh7	protocadherin 7	gene	CHEBI:50819	ferric oxide	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in decreased expression of PCDH7 mRNA	PMID:25086211
1303209	Pcdh7	protocadherin 7	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20140408	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of PCDH7 mRNA; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of PCDH7 mRNA]	PMID:23963992
1303209	Pcdh7	protocadherin 7	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1616811	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PCDH7 mRNA	PMID:23608068
1303209	Pcdh7	protocadherin 7	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1346973	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of PCDH7 mRNA	PMID:31629900
1303209	Pcdh7	protocadherin 7	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of PCDH7 mRNA	PMID:27188386
1303209	Pcdh7	protocadherin 7	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in increased expression of PCDH7 mRNA	PMID:17175027
1303209	Pcdh7	protocadherin 7	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PCDH7 mRNA	PMID:25729387
1303209	Pcdh7	protocadherin 7	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PCDH7 mRNA	PMID:25729387
1303209	Pcdh7	protocadherin 7	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of PCDH7 mRNA	PMID:19751817
1303209	Pcdh7	protocadherin 7	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PCDH7 mRNA	PMID:36907384
1303209	Pcdh7	protocadherin 7	gene	CHEBI:6443	levonorgestrel	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PCDH7 mRNA	PMID:19074003
1303209	Pcdh7	protocadherin 7	gene	CHEBI:73458	NS-398	increases expression	ISO	RGD:1346973	E	RGD:6480464	20130604	CTD	MESH:C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of PCDH7 mRNA	PMID:11494140
1303209	Pcdh7	protocadherin 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1616811	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PCDH7 mRNA	PMID:22206623
1303209	Pcdh7	protocadherin 7	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PCDH7 mRNA	PMID:25566086
1303209	Pcdh7	protocadherin 7	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1616811	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PCDH7 mRNA]	PMID:25566086
1303209	Pcdh7	protocadherin 7	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of PCDH7 mRNA	PMID:33484710
1303209	Pcdh7	protocadherin 7	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1346973	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PCDH7 mRNA	PMID:30851411
1303209	Pcdh7	protocadherin 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA	PMID:27188386
1303209	Pcdh7	protocadherin 7	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1346973	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of PCDH7 mRNA	PMID:30928695
1303209	Pcdh7	protocadherin 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDH7 gene]	PMID:28238834
1303209	Pcdh7	protocadherin 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PCDH7 mRNA	PMID:32109520
1303209	Pcdh7	protocadherin 7	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1616811	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PCDH7 mRNA	PMID:38648751
1303209	Pcdh7	protocadherin 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PCDH7 mRNA	PMID:24780913|PMID:30047161
1303209	Pcdh7	protocadherin 7	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1346973	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PCDH7 mRNA	PMID:26272509
1303209	Pcdh7	protocadherin 7	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA	PMID:27188386
1303209	Pcdh7	protocadherin 7	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of PCDH7 mRNA	PMID:19059307
1303209	Pcdh7	protocadherin 7	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346973	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH7 mRNA	PMID:27188386
1303209	Pcdh7	protocadherin 7	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1616811	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PCDH7 mRNA	PMID:27131904
1303209	Pcdh7	protocadherin 7	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PCDH7 mRNA	PMID:19015723
1303209	Pcdh7	protocadherin 7	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of PCDH7 mRNA	PMID:23869203
1303209	Pcdh7	protocadherin 7	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PCDH7 mRNA	PMID:23034163
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1558316	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FARSB mRNA	PMID:33045310
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FARSB mRNA	PMID:33167477
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of FARSB mRNA	PMID:26516004
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1348852	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FARSB mRNA	PMID:20044591
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1558316	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FARSB mRNA	PMID:39241906
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1558316	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FARSB mRNA]	PMID:39241906
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1558316	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of FARSB mRNA	PMID:15598610
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1348852	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of FARSB mRNA	PMID:31614463
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1558316	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FARSB mRNA	PMID:39298647
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1348852	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of FARSB mRNA	PMID:38568856
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of FARSB mRNA	PMID:20655997
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of FARSB mRNA	PMID:28818685
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FARSB mRNA	PMID:19549813
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FARSB protein	PMID:23301498
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of FARSB mRNA	PMID:23649840
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of FARSB protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of FARSB protein	PMID:38598786
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of FARSB protein	PMID:38460933
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of FARSB mRNA	PMID:19921347
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of FARSB mRNA	PMID:27392435
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1348852	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of FARSB mRNA	PMID:24768652
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558316	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FARSB mRNA	PMID:21570461
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FARSB mRNA	PMID:33387578
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1558316	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FARSB mRNA	PMID:17942748
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FARSB mRNA	PMID:28001369
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FARSB mRNA	PMID:33212167
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FARSB mRNA	PMID:29803840
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1348852	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FARSB mRNA	PMID:20044591
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FARSB mRNA	PMID:38568856
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of and results in increased activity of FARSB protein	PMID:30528433
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FARSB mRNA	PMID:20064835
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1348852	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FARSB promoter	PMID:27901495
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to FARSB mRNA]	PMID:32406909
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of FARSB mRNA	PMID:24136188
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1558316	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FARSB gene	PMID:35295148
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of FARSB mRNA	PMID:23411599|PMID:34492290
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1558316	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of FARSB mRNA	PMID:18648102
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1558316	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of FARSB mRNA	PMID:18301758|PMID:23811191
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1558316	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of FARSB mRNA	PMID:28472532
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of FARSB mRNA	PMID:32145629
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1348852	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of FARSB mRNA	PMID:30903817
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FARSB mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of FARSB protein	PMID:34186270
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FARSB mRNA	PMID:25181051
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FARSB gene	PMID:28505145
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1348852	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of FARSB protein	PMID:34186270
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1558316	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FARSB mRNA	PMID:39298647
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1348852	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of FARSB protein	PMID:34186270
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1348852	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of FARSB protein	PMID:34186270
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FARSB mRNA	PMID:17602206
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1558316	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of FARSB mRNA	PMID:34813904
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of FARSB protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of FARSB protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of FARSB protein	PMID:38598786
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1558316	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of FARSB mRNA	PMID:34813904
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FARSB mRNA	PMID:17602206
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of FARSB mRNA	PMID:32680482
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1558316	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FARSB mRNA]	PMID:39241906
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348852	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FARSB mRNA	PMID:37042841
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FARSB mRNA	PMID:38568856
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FARSB mRNA	PMID:19320972
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1558316	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of FARSB mRNA	PMID:25908611
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1348852	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of FARSB protein	PMID:34122009
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1348852	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FARSB mRNA	PMID:32588087
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1348852	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FARSB mRNA	PMID:31533062
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1348852	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of FARSB mRNA	PMID:19167446
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1348852	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of FARSB mRNA	PMID:26352163
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1348852	E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of FARSB mRNA	PMID:36864359
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1348852	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FARSB mRNA	PMID:25979313
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1348852	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of FARSB mRNA	PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FARSB mRNA	PMID:27188386
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1348852	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FARSB mRNA	PMID:20106945|PMID:25562108
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:41500	4-phenylbutyric acid	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20120412	CTD	MESH:C075773	4-phenylbutyric acid results in decreased expression of FARSB mRNA	PMID:14583596
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of FARSB mRNA	PMID:36621641
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of FARSB mRNA	PMID:24136188
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1348852	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of FARSB mRNA	PMID:27188386
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1348852	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FARSB mRNA	PMID:24935251
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of FARSB protein	PMID:38460933
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1348852	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of FARSB mRNA	PMID:18175754
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1558316	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of FARSB mRNA	PMID:17942748
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1558316	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FARSB mRNA	PMID:17942748
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1558316	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FARSB mRNA; Nanotubes, Carbon results in increased expression of FARSB mRNA	PMID:25554681
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1558316	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FARSB mRNA	PMID:35964746
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of FARSB mRNA	PMID:24793618
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of FARSB mRNA	PMID:24136188
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1558316	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of FARSB mRNA	PMID:19042947
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FARSB protein	PMID:32959892
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1558316	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of FARSB protein	PMID:26558463
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:64153	tanespimycin	increases expression	ISO	RGD:1348852	E	RGD:6480464	20200804	CTD	MESH:C112765	tanespimycin analog results in increased expression of FARSB protein; tanespimycin results in increased expression of FARSB protein	PMID:31370342
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:64153	tanespimycin	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20200804	CTD	MESH:C112765	[tanespimycin co-treated with VER 155008] results in increased expression of FARSB protein	PMID:31370342
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1348852	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of FARSB protein	PMID:34186270
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1558316	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FARSB mRNA	PMID:22206623
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of FARSB mRNA	PMID:24136188
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of FARSB mRNA	PMID:28960945
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of FARSB mRNA	PMID:21346803
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FARSB mRNA	PMID:27188386
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of FARSB mRNA	PMID:18927307
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FARSB protein	PMID:31675489
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of FARSB protein	PMID:38348393
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1558316	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FARSB mRNA]	PMID:39241906
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1348852	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of FARSB mRNA	PMID:24921660
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FARSB mRNA	PMID:27188386
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FARSB mRNA	PMID:19281266
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FARSB mRNA	PMID:21346803
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1348852	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FARSB mRNA	PMID:38568856
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1348852	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of FARSB protein	PMID:38598786
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FARSB mRNA	PMID:21346803
1303210	Farsb	phenylalanyl-tRNA synthetase subunit beta	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FARSB mRNA	PMID:23034163
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of AURKAIP1 mRNA	PMID:22061828
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of AURKAIP1 mRNA	PMID:24136188
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of AURKAIP1 mRNA	PMID:30047161
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AURKAIP1 mRNA	PMID:34492290
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of AURKAIP1 mRNA	PMID:25181051
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of AURKAIP1 mRNA	PMID:33296240
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of AURKAIP1 mRNA	PMID:29427782
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of AURKAIP1 mRNA	PMID:30047161
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of AURKAIP1 mRNA	PMID:24136188
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of AURKAIP1 mRNA	PMID:30047161
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of AURKAIP1 mRNA	PMID:24136188
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of AURKAIP1 mRNA	PMID:30047161
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of AURKAIP1 mRNA	PMID:24136188
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of AURKAIP1 mRNA	PMID:21346803
1303211	Aurkaip1	aurora kinase A interacting protein 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of AURKAIP1 mRNA	PMID:22570695
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PGAP1 mRNA	PMID:26272509
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA	PMID:27188386
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1619812	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PGAP1 mRNA	PMID:37995155
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PGAP1 mRNA	PMID:33167477
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1605037	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PGAP1 mRNA	PMID:21632981
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PGAP1 mRNA	PMID:39298647
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of PGAP1 mRNA	PMID:20660070
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605037	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PGAP1 mRNA	PMID:37042841
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PGAP1 mRNA	PMID:20655997
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1605037	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PGAP1 mRNA	PMID:23649840
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of PGAP1 mRNA	PMID:20660070
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1619812	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PGAP1 mRNA	PMID:34319233
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PGAP1 mRNA	PMID:28818685
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1605037	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PGAP1 intron	PMID:30157460
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1619812	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PGAP1 mRNA	PMID:36331819
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1605037	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PGAP1 mRNA	PMID:23649840
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1605037	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PGAP1 protein	PMID:20106945
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1605037	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PGAP1 mRNA	PMID:21641981|PMID:22100608
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605037	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PGAP1 intron	PMID:30157460
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605037	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PGAP1 mRNA	PMID:23649840
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PGAP1 mRNA	PMID:31919559
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PGAP1 mRNA	PMID:25629700
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PGAP1 mRNA	PMID:19244175
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PGAP1 mRNA	PMID:38460933
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PGAP1 mRNA	PMID:26272509
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA	PMID:27188386
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1605037	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PGAP1 mRNA	PMID:27392435
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PGAP1 mRNA	PMID:27392435
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PGAP1 mRNA	PMID:22298810
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619812	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PGAP1 mRNA	PMID:26377647
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PGAP1 mRNA	PMID:20106945|PMID:21632981
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1619812	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PGAP1 mRNA	PMID:21889950
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1619812	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PGAP1 mRNA	PMID:25975270
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PGAP1 mRNA	PMID:26272509|PMID:28001369
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of PGAP1 mRNA	PMID:39709020
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PGAP1 protein	PMID:28918527
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PGAP1 mRNA	PMID:29803840
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1605037	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PGAP1 gene	PMID:28589171
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of PGAP1 mRNA	PMID:39719251
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605037	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PGAP1 intron	PMID:30157460
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PGAP1 mRNA	PMID:22316170
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PGAP1 mRNA	PMID:19770486
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605037	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PGAP1 3' UTR	PMID:27901495
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605037	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PGAP1 mRNA	PMID:32234424
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1619812	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of PGAP1 protein	PMID:37955338
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1619812	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of PGAP1 mRNA	PMID:27131904
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PGAP1 mRNA	PMID:23221170
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PGAP1 mRNA	PMID:29264374
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1619812	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PGAP1 promoter	PMID:35295148
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PGAP1 mRNA	PMID:23411599|PMID:34492290
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1619812	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PGAP1 mRNA	PMID:28472532
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PGAP1 mRNA	PMID:30816183|PMID:34947998
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PGAP1 mRNA	PMID:25181051|PMID:29097150
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1605037	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PGAP1 mRNA	PMID:29275510
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PGAP1 gene	PMID:28505145
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PGAP1 mRNA	PMID:39298647
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1605037	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of PGAP1 gene	PMID:31601247
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PGAP1 protein	PMID:34896426
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PGAP1 mRNA	PMID:37019170
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1619812	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of PGAP1 mRNA	PMID:36117858
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605037	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PGAP1 mRNA	PMID:37042841
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PGAP1 mRNA	PMID:35163327
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1605037	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PGAP1 mRNA	PMID:26472689
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PGAP1 mRNA	PMID:35163327
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of PGAP1 mRNA	PMID:27387713
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PGAP1 gene	PMID:22079235
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PGAP1 mRNA	PMID:28903501
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1605037	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PGAP1 mRNA	PMID:24449571
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PGAP1 mRNA	PMID:19244175
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PGAP1 mRNA	PMID:40194260
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:38757	isoflavones	increases expression	ISO	RGD:1605037	E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones results in increased expression of PGAP1 mRNA	PMID:17374662
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PGAP1 mRNA	PMID:31533062
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of PGAP1 protein	PMID:34896426
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1619812	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PGAP1 mRNA	PMID:36331819
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PGAP1 mRNA	PMID:29427782
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PGAP1 mRNA	PMID:29427782
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PGAP1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of PGAP1 mRNA	PMID:24896083
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA	PMID:27188386
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PGAP1 protein	PMID:34896426
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PGAP1 protein	PMID:34896426
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1619812	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PGAP1 mRNA	PMID:28973697
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1605037	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of PGAP1 mRNA	PMID:23649840
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PGAP1 mRNA	PMID:26272509
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1605037	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PGAP1 mRNA	PMID:24935251
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA	PMID:27188386
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605037	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of PGAP1 mRNA	PMID:26690555
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PGAP1 mRNA	PMID:33387578
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605037	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PGAP1 mRNA	PMID:22230336
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PGAP1 mRNA	PMID:38460933
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of PGAP1 mRNA	PMID:30529165
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PGAP1 mRNA	PMID:29097150
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PGAP1 protein	PMID:34896426
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PGAP1 mRNA	PMID:24793618
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1619812	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of PGAP1 mRNA	PMID:36117858
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1619812	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PGAP1 mRNA	PMID:38701926
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of PGAP1 mRNA	PMID:35283115
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of PGAP1 mRNA	PMID:27462272
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PGAP1 mRNA	PMID:22206623
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA	PMID:27188386
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PGAP1 gene]	PMID:28238834
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1619812	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PGAP1 mRNA	PMID:23091169
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PGAP1 mRNA	PMID:32109520
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PGAP1 mRNA	PMID:21278054
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1619812	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of PGAP1 mRNA	PMID:40826991
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605037	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGAP1 mRNA	PMID:27188386
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1619812	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of PGAP1 mRNA	PMID:27131904
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1619812	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of PGAP1 protein	PMID:24648495
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1605037	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of PGAP1 mRNA	PMID:27188386
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1619812	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PGAP1 mRNA	PMID:35537566
1303213	Pgap1	post-GPI attachment to proteins inositol deacylase 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of PGAP1 gene	PMID:31682807
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1602050	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of EMC10 mRNA	PMID:31863870
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1618341	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of EMC10 mRNA	PMID:30319688
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1618341	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EMC10 mRNA	PMID:39241906
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1618341	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of EMC10 mRNA	PMID:39298647
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602050	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EMC10 mRNA	PMID:37042841
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1618341	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EMC10 mRNA	PMID:33754040
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1618341	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EMC10 mRNA	PMID:36331819
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618341	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EMC10 mRNA	PMID:37236586
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1618341	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EMC10 mRNA	PMID:40504410
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1602050	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of EMC10 mRNA	PMID:19921347
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618341	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EMC10 mRNA	PMID:24680724
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EMC10 mRNA	PMID:33387578
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1602050	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of EMC10 protein	PMID:39603559
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602050	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EMC10 mRNA	PMID:29803840
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602050	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of EMC10 mRNA	PMID:39719251
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618341	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EMC10 mRNA	PMID:40504410
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1618341	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of EMC10 mRNA	PMID:29264374
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EMC10 mRNA	PMID:25181051
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1602050	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of EMC10 mRNA	PMID:25047013
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EMC10 mRNA	PMID:34947998
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602050	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EMC10 protein	PMID:33376534
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1618341	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of EMC10 mRNA	PMID:32156529
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1618341	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of EMC10 mRNA	PMID:39298647
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1602050	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of EMC10 protein	PMID:34186270
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1602050	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of EMC10 promoter	PMID:30157460
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1618341	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of EMC10 mRNA	PMID:38685157
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1602050	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of EMC10 protein	PMID:34186270
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1618341	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EMC10 mRNA	PMID:37019170
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1618341	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of EMC10 mRNA	PMID:34813904
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1618341	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of EMC10 mRNA	PMID:34813904
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618341	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EMC10 mRNA	PMID:37236586
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1602050	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EMC10 mRNA	PMID:31533062
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618341	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EMC10 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of EMC10 mRNA	PMID:36331819
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602050	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EMC10 mRNA	PMID:25979313
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602050	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of EMC10 mRNA	PMID:29154799|PMID:29501571
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1602050	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased methylation of EMC10 gene	PMID:29501571
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602050	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EMC10 mRNA	PMID:23179753
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602050	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of EMC10 gene	PMID:29154799
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1602050	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of EMC10 mRNA	PMID:17400583
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of EMC10 mRNA	PMID:24136188
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1618341	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EMC10 mRNA	PMID:40504410
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1602050	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of EMC10 mRNA	PMID:18175754
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1618341	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EMC10 mRNA	PMID:25554681
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1618341	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EMC10 mRNA	PMID:35964746
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EMC10 mRNA	PMID:24136188
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1602050	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EMC10 protein	PMID:32959892
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1602050	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of EMC10 promoter	PMID:30157460
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of EMC10 mRNA	PMID:24136188
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1602050	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of EMC10 protein	PMID:38348393
1303214	Emc10	ER membrane protein complex subunit 10	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EMC10 mRNA	PMID:23034163
1303215	Krt86	keratin 86	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1553237	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KRT86 mRNA	PMID:33045310
1303215	Krt86	keratin 86	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1348087	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of KRT86 mRNA	PMID:23724009
1303215	Krt86	keratin 86	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1348087	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of KRT86 mRNA	PMID:18951874
1303215	Krt86	keratin 86	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of KRT86 mRNA	PMID:25321415
1303215	Krt86	keratin 86	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1348087	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol promotes the reaction [ESR2 protein affects the expression of KRT86 mRNA]	PMID:20404318
1303215	Krt86	keratin 86	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1348087	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of KRT86 mRNA	PMID:21540246
1303215	Krt86	keratin 86	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1348087	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of KRT86 mRNA	PMID:26079696
1303215	Krt86	keratin 86	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D004051	[Genistein co-treated with Diethylhexyl Phthalate] results in decreased expression of KRT86 mRNA	PMID:36674726
1303215	Krt86	keratin 86	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1348087	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of KRT86 mRNA	PMID:36139627
1303215	Krt86	keratin 86	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of KRT86 mRNA	PMID:27153756
1303215	Krt86	keratin 86	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1553237	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KRT86 mRNA	PMID:25629700
1303215	Krt86	keratin 86	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1553237	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of KRT86 mRNA	PMID:28189721|PMID:28960355
1303215	Krt86	keratin 86	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of KRT86 mRNA	PMID:27392435
1303215	Krt86	keratin 86	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1348087	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of KRT86 mRNA	PMID:27392435
1303215	Krt86	keratin 86	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1553237	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of KRT86 mRNA	PMID:32186404
1303215	Krt86	keratin 86	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D019833	[Genistein co-treated with Diethylhexyl Phthalate] results in decreased expression of KRT86 mRNA	PMID:36674726
1303215	Krt86	keratin 86	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553237	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT86 mRNA	PMID:21570461
1303215	Krt86	keratin 86	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRT86 mRNA	PMID:38568856
1303215	Krt86	keratin 86	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348087	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KRT86 promoter	PMID:27901495
1303215	Krt86	keratin 86	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of KRT86 mRNA	PMID:25895662
1303215	Krt86	keratin 86	gene	CHEBI:33146	vanadyl sulfate	increases expression	ISO	RGD:1348087	E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in increased expression of KRT86 mRNA	PMID:16330358
1303215	Krt86	keratin 86	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT86 mRNA	PMID:25181051
1303215	Krt86	keratin 86	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1348087	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of KRT86 mRNA	PMID:22905168
1303215	Krt86	keratin 86	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KRT86 mRNA	PMID:35163327
1303215	Krt86	keratin 86	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT86 mRNA	PMID:35163327
1303215	Krt86	keratin 86	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT86 mRNA	PMID:35163327
1303215	Krt86	keratin 86	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1553237	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of KRT86 mRNA	PMID:17585979
1303215	Krt86	keratin 86	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of KRT86 mRNA	PMID:27989131
1303215	Krt86	keratin 86	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1348087	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KRT86 mRNA	PMID:25562108
1303215	Krt86	keratin 86	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of KRT86 mRNA	PMID:15590111
1303215	Krt86	keratin 86	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRT86 mRNA; Acetaminophen results in decreased expression of KRT86 protein	PMID:22230336
1303215	Krt86	keratin 86	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1348087	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of KRT86 mRNA; Acetaminophen results in increased expression of KRT86 protein	PMID:22230336|PMID:26690555
1303215	Krt86	keratin 86	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1348087	E	RGD:6480464	20120412	CTD	MESH:D005472	KRT86 protein affects the susceptibility to Fluorouracil	PMID:15352031
1303215	Krt86	keratin 86	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of KRT86 protein	PMID:15352031
1303215	Krt86	keratin 86	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of KRT86 mRNA	PMID:31838189
1303215	Krt86	keratin 86	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of KRT86 mRNA	PMID:30307764
1303215	Krt86	keratin 86	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1553237	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of KRT86 mRNA	PMID:23608068
1303215	Krt86	keratin 86	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1553237	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of KRT86 mRNA	PMID:38701926
1303215	Krt86	keratin 86	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1348087	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of KRT86 mRNA	PMID:31758290
1303215	Krt86	keratin 86	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1348087	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of KRT86 mRNA	PMID:28960945
1303215	Krt86	keratin 86	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1348087	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of KRT86 mRNA	PMID:36139627
1303215	Krt86	keratin 86	gene	CHEBI:91642	2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester	multiple interactions	ISO	RGD:1348087	E	RGD:6480464	20240702	CTD	MESH:C060446	[homosalate co-treated with Polystyrenes] results in decreased expression of KRT86 mRNA	PMID:38381479
1303215	Krt86	keratin 86	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1348087	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of KRT86 mRNA	PMID:29301935
1303216	Krt72	keratin 72	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1605869	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of KRT72 mRNA	PMID:22378314
1303216	Krt72	keratin 72	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1619907	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of KRT72 mRNA	PMID:39298647
1303216	Krt72	keratin 72	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1605869	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol promotes the reaction [ESR2 protein affects the expression of KRT72 mRNA]	PMID:20404318
1303216	Krt72	keratin 72	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KRT72 mRNA	PMID:33387578
1303216	Krt72	keratin 72	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	ISO	RGD:1605869	E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of KRT72 mRNA	PMID:39245080
1303216	Krt72	keratin 72	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605869	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KRT72 gene	PMID:27153756
1303216	Krt72	keratin 72	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1605869	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of KRT72 mRNA	PMID:21867686
1303216	Krt72	keratin 72	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of KRT72 mRNA	PMID:28959563
1303216	Krt72	keratin 72	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of KRT72 mRNA	PMID:26033743
1303216	Krt72	keratin 72	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605869	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT6 mRNA; sodium arsenite results in increased expression of KRT6 protein	PMID:19524636
1303216	Krt72	keratin 72	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605869	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KRT72 3' UTR	PMID:27901495
1303216	Krt72	keratin 72	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605869	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT72 promoter	PMID:27901495
1303216	Krt72	keratin 72	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of KRT72 mRNA	PMID:26033743
1303216	Krt72	keratin 72	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1619907	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of KRT72 mRNA	PMID:35295148
1303216	Krt72	keratin 72	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT72 mRNA	PMID:25181051
1303216	Krt72	keratin 72	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605869	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A promotes the reaction [KRT72 protein binds to ESR1 protein]	PMID:27156127
1303216	Krt72	keratin 72	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1619907	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of KRT72 mRNA	PMID:39298647
1303216	Krt72	keratin 72	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1605869	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of KRT72 gene	PMID:31601247
1303216	Krt72	keratin 72	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1619907	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of KRT72 mRNA	PMID:26377693
1303216	Krt72	keratin 72	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1619907	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of KRT72 intron	PMID:28392331
1303216	Krt72	keratin 72	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1619907	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of KRT72 mRNA	PMID:21266533
1303216	Krt72	keratin 72	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KRT72 mRNA	PMID:35163327
1303216	Krt72	keratin 72	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT72 mRNA	PMID:35163327
1303216	Krt72	keratin 72	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT72 mRNA	PMID:35163327
1303216	Krt72	keratin 72	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1605869	E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in decreased expression of KRT72 mRNA	PMID:26615145
1303216	Krt72	keratin 72	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1619907	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of KRT72 mRNA	PMID:35436446
1303216	Krt72	keratin 72	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1605869	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of KRT72 mRNA	PMID:18175754
1303216	Krt72	keratin 72	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605869	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT72 gene]	PMID:28238834
1303216	Krt72	keratin 72	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KRT72 mRNA	PMID:24780913
1303218	Emcn	endomucin	gene	CHEBI:10033	warfarin	decreases expression	ISO	RGD:1602001	E	RGD:6480464	20170613	CTD	MESH:D014859	Warfarin results in decreased expression of EMCN protein	PMID:26206560
1303218	Emcn	endomucin	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of EMCN mRNA	PMID:21551480
1303218	Emcn	endomucin	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of EMCN mRNA]	PMID:31150632
1303218	Emcn	endomucin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EMCN mRNA	PMID:30529165
1303218	Emcn	endomucin	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1558156	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EMCN mRNA	PMID:39241906
1303218	Emcn	endomucin	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1602001	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of EMCN mRNA	PMID:30510588
1303218	Emcn	endomucin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMCN mRNA	PMID:37992649
1303218	Emcn	endomucin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMCN mRNA	PMID:37992649
1303218	Emcn	endomucin	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1558156	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of EMCN mRNA	PMID:17456735
1303218	Emcn	endomucin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1558156	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of EMCN mRNA	PMID:34319233
1303218	Emcn	endomucin	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of EMCN mRNA	PMID:26577399
1303218	Emcn	endomucin	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1602001	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of EMCN protein	PMID:37730182
1303218	Emcn	endomucin	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of EMCN mRNA	PMID:28522335
1303218	Emcn	endomucin	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1558156	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of EMCN mRNA	PMID:17456735
1303218	Emcn	endomucin	gene	CHEBI:2208	purine-6-thiol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of EMCN mRNA	PMID:23358152
1303218	Emcn	endomucin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1602001	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EMCN mRNA	PMID:35301059
1303218	Emcn	endomucin	gene	CHEBI:24828	indoles	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in decreased expression of EMCN mRNA	PMID:20521778
1303218	Emcn	endomucin	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010126	Ozone results in decreased expression of EMCN mRNA	PMID:31397875
1303218	Emcn	endomucin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of EMCN mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of EMCN mRNA	PMID:34911549
1303218	Emcn	endomucin	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of EMCN mRNA	PMID:30779732
1303218	Emcn	endomucin	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EMCN mRNA	PMID:31150632
1303218	Emcn	endomucin	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of EMCN mRNA]	PMID:31150632
1303218	Emcn	endomucin	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1558156	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of EMCN mRNA	PMID:19654921
1303218	Emcn	endomucin	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1602001	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of EMCN mRNA	PMID:24768652|PMID:25583101
1303218	Emcn	endomucin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EMCN mRNA	PMID:32109520|PMID:34747641
1303218	Emcn	endomucin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1558156	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EMCN mRNA	PMID:15328365
1303218	Emcn	endomucin	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of EMCN mRNA	PMID:19013527
1303218	Emcn	endomucin	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1558156	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of EMCN mRNA	PMID:32937126
1303218	Emcn	endomucin	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of EMCN mRNA	PMID:30556269
1303218	Emcn	endomucin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMCN mRNA	PMID:37992649
1303218	Emcn	endomucin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602001	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EMCN 5' UTR; Benzo(a)pyrene affects the methylation of EMCN promoter	PMID:27901495
1303218	Emcn	endomucin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1558156	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EMCN mRNA	PMID:21569818|PMID:32417428
1303218	Emcn	endomucin	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EMCN mRNA	PMID:27858113
1303218	Emcn	endomucin	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of EMCN mRNA	PMID:30556269
1303218	Emcn	endomucin	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of EMCN mRNA	PMID:22431001
1303218	Emcn	endomucin	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1602001	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EMCN mRNA	PMID:26705709
1303218	Emcn	endomucin	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of EMCN mRNA	PMID:24915197
1303218	Emcn	endomucin	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1558156	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in increased expression of EMCN mRNA	PMID:30825431
1303218	Emcn	endomucin	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of EMCN mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of EMCN mRNA]	PMID:30825431
1303218	Emcn	endomucin	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1602001	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of EMCN gene	PMID:31601247
1303218	Emcn	endomucin	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of EMCN mRNA	PMID:22641619
1303218	Emcn	endomucin	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of EMCN mRNA	PMID:25729387
1303218	Emcn	endomucin	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of EMCN mRNA	PMID:25729387
1303218	Emcn	endomucin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of EMCN mRNA	PMID:41034487
1303218	Emcn	endomucin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1558156	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of EMCN mRNA	PMID:30951980
1303218	Emcn	endomucin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602001	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of EMCN gene	PMID:31601247
1303218	Emcn	endomucin	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1602001	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of EMCN mRNA	PMID:36804509
1303218	Emcn	endomucin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1558156	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of EMCN mRNA	PMID:30951980|PMID:39298647
1303218	Emcn	endomucin	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1558156	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of EMCN mRNA	PMID:26377693
1303218	Emcn	endomucin	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EMCN mRNA	PMID:27858113
1303218	Emcn	endomucin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1558156	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of EMCN mRNA	PMID:30951980
1303218	Emcn	endomucin	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1558156	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EMCN mRNA	PMID:37019170
1303218	Emcn	endomucin	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EMCN mRNA	PMID:21266533
1303218	Emcn	endomucin	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1558156	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of EMCN mRNA	PMID:24535843
1303218	Emcn	endomucin	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of EMCN mRNA	PMID:24535843
1303218	Emcn	endomucin	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of EMCN gene	PMID:33148267
1303218	Emcn	endomucin	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1558156	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of EMCN mRNA	PMID:26377693
1303218	Emcn	endomucin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1602001	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EMCN mRNA	PMID:35301059
1303218	Emcn	endomucin	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of EMCN mRNA	PMID:27387713
1303218	Emcn	endomucin	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1602001	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EMCN mRNA	PMID:19320972
1303218	Emcn	endomucin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1558156	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EMCN mRNA	PMID:40194260
1303218	Emcn	endomucin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1558156	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of EMCN mRNA	PMID:17292431
1303218	Emcn	endomucin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602001	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EMCN mRNA	PMID:25979313
1303218	Emcn	endomucin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1558156	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of EMCN mRNA	PMID:24896083
1303218	Emcn	endomucin	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of EMCN mRNA	PMID:41580965
1303218	Emcn	endomucin	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of EMCN mRNA	PMID:21865292
1303218	Emcn	endomucin	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of EMCN mRNA	PMID:21658437
1303218	Emcn	endomucin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1558156	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of EMCN mRNA	PMID:28973697
1303218	Emcn	endomucin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMCN mRNA	PMID:37992649
1303218	Emcn	endomucin	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1602001	E	RGD:6480464	20160210	CTD	MESH:C012589	trichostatin A results in decreased expression of EMCN mRNA	PMID:26705709
1303218	Emcn	endomucin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1558156	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EMCN mRNA	PMID:17562736
1303218	Emcn	endomucin	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1558156	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of EMCN mRNA	PMID:19654921
1303218	Emcn	endomucin	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1602001	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EMCN mRNA	PMID:26705709
1303218	Emcn	endomucin	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of EMCN mRNA	PMID:31881178
1303218	Emcn	endomucin	gene	CHEBI:50667	mercaptopurine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of EMCN mRNA	PMID:23358152
1303218	Emcn	endomucin	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EMCN mRNA	PMID:27858113
1303218	Emcn	endomucin	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EMCN mRNA	PMID:27858113
1303218	Emcn	endomucin	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1558156	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of EMCN mRNA	PMID:19042947
1303218	Emcn	endomucin	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of EMCN mRNA	PMID:25729387
1303218	Emcn	endomucin	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of EMCN mRNA	PMID:25729387
1303218	Emcn	endomucin	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1558156	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of EMCN protein	PMID:36851058
1303218	Emcn	endomucin	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of EMCN mRNA]	PMID:30825431
1303218	Emcn	endomucin	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of EMCN gene	PMID:33148267
1303218	Emcn	endomucin	gene	CHEBI:748998	lenabasum	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20260714	CTD	MESH:C471849	lenabasum inhibits the reaction [Bleomycin results in increased expression of EMCN mRNA]	PMID:30825431
1303218	Emcn	endomucin	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1558156	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of EMCN mRNA	PMID:25566086
1303218	Emcn	endomucin	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of EMCN mRNA	PMID:33484710
1303218	Emcn	endomucin	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1558156	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of EMCN mRNA	PMID:24535843
1303218	Emcn	endomucin	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1558156	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of EMCN mRNA	PMID:18958704
1303218	Emcn	endomucin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1602001	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of EMCN mRNA	PMID:26705709
1303218	Emcn	endomucin	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of EMCN mRNA	PMID:19281266
1303218	Emcn	endomucin	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of EMCN mRNA	PMID:23358152
1303218	Emcn	endomucin	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EMCN mRNA	PMID:21346803
1303218	Emcn	endomucin	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of EMCN mRNA	PMID:19015723
1303218	Emcn	endomucin	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of EMCN mRNA	PMID:23034163
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1332216	E	RGD:6480464	20141223	CTD	MESH:D015025	Zearalenone results in increased expression of SAMM50 protein	PMID:25058043
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SAMM50 mRNA	PMID:20938992
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SAMM50 mRNA	PMID:33167477
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SAMM50 gene	PMID:28931070|PMID:35440735
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332216	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SAMM50 mRNA	PMID:39241906
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SAMM50 mRNA	PMID:32145629
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SAMM50 mRNA	PMID:20938992
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604035	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SAMM50 mRNA	PMID:37042841
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1604035	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SAMM50 protein	PMID:37730182
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1332216	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of SAMM50 mRNA	PMID:37748715
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1604035	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SAMM50 intron	PMID:30157460
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SAMM50 mRNA	PMID:36331819
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SAMM50 mRNA	PMID:39836092
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1332216	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SAMM50 mRNA	PMID:27462272
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SAMM50 mRNA	PMID:19549813
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1604035	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SAMM50 intron	PMID:30157460
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332216	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SAMM50 mRNA	PMID:25629700
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SAMM50 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SAMM50 mRNA	PMID:20938992|PMID:22206623
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SAMM50 mRNA	PMID:40504410
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SAMM50 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SAMM50 mRNA	PMID:39836092
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of SAMM50 mRNA	PMID:19244175
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SAMM50 mRNA	PMID:23557933
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of SAMM50 mRNA	PMID:19921347
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1604035	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SAMM50 mRNA	PMID:23300844
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1604035	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SAMM50 mRNA	PMID:27392435
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SAMM50 mRNA	PMID:32109520
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SAMM50 mRNA	PMID:33387578
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of SAMM50 protein	PMID:35544339
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SAMM50 mRNA	PMID:38568856
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1332216	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of SAMM50 protein	PMID:29044176
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SAMM50 mRNA	PMID:40504410
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SAMM50 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SAMM50 mRNA	PMID:39836092
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1604035	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SAMM50 mRNA	PMID:22378314
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604035	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SAMM50 intron	PMID:30157460
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604035	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SAMM50 promoter	PMID:27901495
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:3016	Benoxacor	increases expression	ISO	RGD:1332216	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in increased expression of SAMM50 mRNA	PMID:34850242
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332216	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SAMM50 gene	PMID:35295148
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332216	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SAMM50 mRNA	PMID:18301758
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SAMM50 mRNA	PMID:32145629|PMID:34947998
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SAMM50 mRNA	PMID:25181051
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332216	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SAMM50 mRNA	PMID:33221593
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604035	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SAMM50 protein	PMID:37567409
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SAMM50 gene	PMID:28505145
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of SAMM50 mRNA	PMID:19244175
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332216	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SAMM50 mRNA	PMID:39298647
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1604035	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SAMM50 intron	PMID:30157460
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1604035	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SAMM50 protein	PMID:34186270
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332216	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SAMM50 mRNA	PMID:21266533
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1604035	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of SAMM50 mRNA	PMID:37047231
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SAMM50 mRNA	PMID:39836092
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SAMM50 mRNA	PMID:33453195
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SAMM50 mRNA	PMID:38568856
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1332216	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SAMM50 mRNA	PMID:28903501
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of SAMM50 mRNA	PMID:19244175
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of SAMM50 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SAMM50 mRNA]	PMID:17585979
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SAMM50 mRNA	PMID:31533062
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SAMM50 mRNA	PMID:36331819
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of SAMM50 mRNA	PMID:29501571
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1604035	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SAMM50 gene	PMID:29501571
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604035	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SAMM50 mRNA	PMID:23179753
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SAMM50 mRNA	PMID:17183730
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SAMM50 mRNA	PMID:20106945|PMID:25562108
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332216	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SAMM50 mRNA	PMID:28973697
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of SAMM50 mRNA	PMID:21346803
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SAMM50 mRNA	PMID:21420995|PMID:29067470
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of SAMM50 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SAMM50 mRNA]	PMID:17585979
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SAMM50 mRNA	PMID:40504410
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SAMM50 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SAMM50 mRNA	PMID:39836092
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1332216	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SAMM50 mRNA	PMID:35436446
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in increased expression of SAMM50 protein	PMID:39793947
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1604035	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SAMM50 mRNA	PMID:23300844
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332216	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SAMM50 mRNA	PMID:25554681
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SAMM50 mRNA	PMID:35964746
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SAMM50 mRNA	PMID:24793618
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SAMM50 mRNA	PMID:24136188
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SAMM50 mRNA	PMID:17183730
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of SAMM50 mRNA	PMID:20436886
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SAMM50 protein	PMID:32959892
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SAMM50 mRNA	PMID:39836092
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1604035	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SAMM50 intron	PMID:30157460
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SAMM50 gene	PMID:35440735
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1604035	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SAMM50 protein	PMID:34186270
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332216	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SAMM50 mRNA	PMID:22206623
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of SAMM50 mRNA	PMID:24136188
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604035	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SAMM50 gene]	PMID:28238834
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of SAMM50 protein	PMID:28903499
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of SAMM50 protein	PMID:38348393
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1604035	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SAMM50 mRNA	PMID:38568856
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1604035	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of SAMM50 mRNA	PMID:22378314
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SAMM50 mRNA	PMID:21346803
1303219	Samm50	SAMM50 sorting and assembly machinery component	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of SAMM50 protein	PMID:32519852
1303220	Klk1c6	kallikrein 1-related peptidase C6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[Testosterone co-treated with Estradiol] results in increased expression of KLK1C6 mRNA	PMID:32741896
1303220	Klk1c6	kallikrein 1-related peptidase C6	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of KLK1C6 gene	PMID:27618143
1303220	Klk1c6	kallikrein 1-related peptidase C6	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] results in increased expression of KLK1C6 mRNA	PMID:32741896
1303220	Klk1c6	kallikrein 1-related peptidase C6	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of KLK1C6 mRNA	PMID:21515302
1303220	Klk1c6	kallikrein 1-related peptidase C6	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of KLK1C6 gene	PMID:22079235
1303220	Klk1c6	kallikrein 1-related peptidase C6	gene	CHEBI:9753	troglitazone	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone affects the expression of KLK1C6 mRNA	PMID:21515302
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1344607	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PPIC mRNA	PMID:26272509
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA	PMID:27188386
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1551298	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PPIC mRNA	PMID:37995155
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1551298	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PPIC mRNA	PMID:20188158
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1344607	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PPIC mRNA	PMID:21934132|PMID:23724009
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of PPIC mRNA	PMID:30951980
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1344607	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PPIC mRNA	PMID:22378314
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551298	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PPIC mRNA	PMID:27339419
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1344607	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PPIC mRNA	PMID:21179406
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPIC mRNA	PMID:37992649
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1344607	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of PPIC mRNA	PMID:21592394
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of PPIC mRNA	PMID:21592394
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPIC mRNA	PMID:37992649
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1344607	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PPIC protein	PMID:31163220
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1344607	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PPIC mRNA	PMID:31163220
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551298	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PPIC mRNA	PMID:33754040
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PPIC mRNA	PMID:26577399|PMID:27523638
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1344607	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of PPIC mRNA	PMID:21592394
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of PPIC mRNA	PMID:21592394
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PPIC mRNA	PMID:36331819
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPIC mRNA	PMID:39012411
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1344607	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PPIC mRNA	PMID:19549813
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of PPIC mRNA	PMID:21396975
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1344607	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PPIC gene	PMID:27153756
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPIC mRNA	PMID:23630614|PMID:25378103|PMID:33354967
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PPIC mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PPIC mRNA	PMID:34911549
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1551298	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PPIC mRNA	PMID:17484886
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PPIC mRNA	PMID:31150632
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551298	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PPIC mRNA	PMID:27339419|PMID:29987408|PMID:31919559|PMID:34224798
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20211109	CTD	MESH:D002251	PPIC protein affects the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; PPIC protein affects the reaction [Carbon Tetrachloride results in increased expression of COL1A1 protein]; PPIC protein affects the reaction [Carbon Tetrachloride results in increased expression of COL3A1 protein]	PMID:34224798
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPIC mRNA	PMID:22206623
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1344607	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PPIC mRNA	PMID:26272509
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA	PMID:27188386
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PPIC mRNA	PMID:31881176
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1344607	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of PPIC gene	PMID:31636367
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1344607	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of PPIC mRNA	PMID:23300844
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPIC mRNA	PMID:22298810|PMID:34747641
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPIC mRNA	PMID:33387578
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1344607	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPIC mRNA	PMID:20106945
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPIC mRNA	PMID:17942748
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of PPIC mRNA	PMID:28374803
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1551298	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of PPIC mRNA	PMID:32937126
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1344607	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of PPIC mRNA	PMID:21198554
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551298	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPIC mRNA	PMID:39631538
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1344607	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PPIC mRNA	PMID:29803840
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPIC mRNA	PMID:37992649
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1344607	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PPIC mRNA	PMID:20044591
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344607	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPIC mRNA	PMID:34032870
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1551298	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of PPIC mRNA	PMID:39515575
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1344607	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of PPIC mRNA	PMID:22378314
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551298	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PPIC mRNA	PMID:32417428
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1551298	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of PPIC protein	PMID:37955338
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of PPIC mRNA	PMID:38458666
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of PPIC mRNA	PMID:24915197
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of PPIC mRNA	PMID:25729387
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of PPIC mRNA	PMID:25729387
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551298	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PPIC gene	PMID:35295148
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PPIC mRNA	PMID:23411599|PMID:34492290
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1551298	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PPIC mRNA	PMID:18648102
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551298	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PPIC mRNA	PMID:18301758|PMID:20059764|PMID:20813756|PMID:21318169|PMID:23811191
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of PPIC mRNA]; PPARA protein promotes the reaction [pirinixic acid results in increased expression of PPIC mRNA]	PMID:20059764|PMID:21318169
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PPIC mRNA	PMID:25181051
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PPIC mRNA	PMID:34947998|PMID:38750585
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPIC mRNA	PMID:28628672
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1344607	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of PPIC mRNA	PMID:19244175
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1551298	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of PPIC mRNA	PMID:26682919
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551298	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PPIC mRNA	PMID:30951980|PMID:40203079
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PPIC mRNA	PMID:28628672
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551298	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PPIC mRNA	PMID:30951980
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPIC mRNA	PMID:28628672
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of PPIC mRNA	PMID:30951980
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PPIC mRNA	PMID:21241498
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1551298	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PPIC mRNA	PMID:37019170
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1551298	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of PPIC protein	PMID:35362542
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PPIC protein]	PMID:35362542
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1551298	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PPIC mRNA	PMID:21266533
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPIC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPIC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PPIC mRNA	PMID:28628672
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1551298	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of PPIC protein	PMID:39748354
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of PPIC mRNA	PMID:38458666
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PPIC mRNA	PMID:35163327
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPIC mRNA	PMID:39012411
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PPIC mRNA	PMID:35163327
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of PPIC mRNA	PMID:26194646|PMID:27387713
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1344607	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PPIC mRNA	PMID:19320972|PMID:19376846
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1551298	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PPIC mRNA	PMID:18353800
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1344607	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PPIC mRNA	PMID:28302478
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PPIC mRNA	PMID:36331819
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344607	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PPIC mRNA	PMID:19101580|PMID:23179753|PMID:23527032|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1344607	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PPIC gene	PMID:29154799
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA	PMID:27188386
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of PPIC mRNA	PMID:41580965
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPIC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPIC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PPIC mRNA	PMID:28628672
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPIC mRNA	PMID:37992649
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1344607	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PPIC mRNA	PMID:24935251|PMID:26272509
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA	PMID:27188386
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551298	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPIC mRNA	PMID:17562736
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1344607	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPIC mRNA	PMID:26690555
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PPIC mRNA	PMID:33387578
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:46195	paracetamol	increases secretion	ISO	RGD:1551298	E	RGD:6480464	20180703	CTD	MESH:D000082	Acetaminophen results in increased secretion of PPIC protein	PMID:24038040
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PPIC mRNA	PMID:29432896
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPIC mRNA	PMID:17942748
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in increased expression of PPIC protein	PMID:39793947
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PPIC protein]	PMID:35362542
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1344607	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PPIC mRNA	PMID:26272509
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA	PMID:27188386
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPIC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPIC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PPIC mRNA	PMID:28628672
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1344607	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of PPIC mRNA	PMID:23300844
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1344607	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of PPIC mRNA	PMID:16367923
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PPIC mRNA	PMID:24793618
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1344607	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PPIC protein	PMID:32959892
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1344607	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of PPIC mRNA	PMID:26272509
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA	PMID:27188386
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of PPIC mRNA	PMID:25729387
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of PPIC mRNA	PMID:25729387
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1551298	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PPIC mRNA	PMID:23650126
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1551298	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in decreased expression of PPIC mRNA	PMID:36914120
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol promotes the reaction [MOG protein modified form results in increased expression of PPIC mRNA]	PMID:27256343
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1344607	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PPIC mRNA	PMID:31758290
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1344607	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PPIC protein	PMID:34186270
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551298	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPIC mRNA	PMID:22206623
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of PPIC mRNA	PMID:15215175
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA	PMID:27188386
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1344607	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of PPIC mRNA	PMID:19159669
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:82036	prothioconazole	increases expression	ISO	RGD:1344607	E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of PPIC mRNA	PMID:35048155
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1551298	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of PPIC mRNA	PMID:21795629
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PPIC mRNA	PMID:24780913
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1344607	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PPIC mRNA	PMID:26272509
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA	PMID:27188386
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344607	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA	PMID:27188386
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PPIC mRNA	PMID:19281266
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1344607	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PPIC mRNA	PMID:38568856
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1344607	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of PPIC mRNA	PMID:22378314
1303221	Ppic	peptidylprolyl isomerase C	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PPIC mRNA	PMID:23034163
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1347771	E	RGD:6480464	20170516	CTD	MESH:D015025	Zearalenone results in increased expression of AICDA mRNA	PMID:27757495
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1551301	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of AICDA mRNA	PMID:16093312
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551301	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of AICDA mRNA	PMID:25890327
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551301	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of AICDA mRNA	PMID:19139166
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1347771	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol promotes the reaction [ESR1 protein binds to AICDA promoter]; Tamoxifen inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to AICDA promoter]]	PMID:19139166
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1551301	E	RGD:6480464	20120412	CTD	MESH:D004958	[Dactinomycin co-treated with Alpha-Amanitin] inhibits the reaction [Estradiol results in increased expression of AICDA mRNA]; AICDA protein affects the reaction [Estradiol results in increased mutagenesis of MYC gene]; Tamoxifen inhibits the reaction [Estradiol results in increased expression of AICDA mRNA]	PMID:19139166
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1551301	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of AICDA mRNA; Progesterone results in decreased expression of AICDA protein	PMID:19139166|PMID:19553525
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of APOBEC3B mRNA	PMID:28522335
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D000661	Amphetamine results in decreased expression of APOBEC3B mRNA	PMID:30779732
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1347771	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AICDA gene	PMID:25304211
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1551301	E	RGD:6480464	20260811	CTD	MESH:D001151	Arsenic results in increased expression of APOBEC3B mRNA; Arsenic results in increased expression of APOBEC3B protein	PMID:34998823
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1551301	E	RGD:6480464	20120412	CTD	MESH:D003609	[Dactinomycin co-treated with Alpha-Amanitin] inhibits the reaction [Estradiol results in increased expression of AICDA mRNA]	PMID:19139166
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1551301	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of AICDA mRNA	PMID:28960355
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AICDA mRNA	PMID:32109520
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1347771	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of AICDA mRNA	PMID:33212167
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1347771	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of AICDA mRNA	PMID:24834073
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of AICDA mRNA	PMID:28959563
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:29019	nonanoic acid	affects expression	ISO	RGD:1551301	E	RGD:6480464	20120515	CTD	MESH:C008776	pelargonic acid affects the expression of AICDA mRNA	PMID:22302311
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347771	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of AICDA mRNA	PMID:38568856
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1551301	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of AICDA mRNA	PMID:25787150|PMID:39515575
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347771	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AICDA promoter	PMID:27901495
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1347771	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of AICDA mRNA	PMID:25895662
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1347771	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of AICDA protein	PMID:21570118
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1347771	E	RGD:6480464	20191114	CTD	MESH:C006632	Imatinib Mesylate promotes the reaction [Arsenic Trioxide results in decreased expression of AICDA protein]	PMID:21570118
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of APOBEC3B mRNA	PMID:30047161
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1551301	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of AICDA mRNA	PMID:35295148
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of AICDA mRNA	PMID:25181051
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects expression	ISO	RGD:1551301	E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene affects the expression of AICDA mRNA	PMID:22302311
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1347771	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of AICDA mRNA	PMID:36326898
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1347771	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of AICDA mRNA	PMID:24449571
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:37415	alpha-amanitin	multiple interactions	ISO	RGD:1551301	E	RGD:6480464	20170303	CTD	MESH:D053959	[Dactinomycin co-treated with Alpha-Amanitin] inhibits the reaction [Estradiol results in increased expression of AICDA mRNA]	PMID:19139166
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1551301	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of AICDA mRNA	PMID:40194260
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D000640	Amitrole results in increased expression of APOBEC3B mRNA	PMID:30047161
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1551301	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of AICDA mRNA	PMID:19139166
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1347771	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to AICDA promoter]]	PMID:19139166
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1551301	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen inhibits the reaction [Estradiol results in increased expression of AICDA mRNA]	PMID:19139166
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:4286	4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid	increases response to substance	ISO	RGD:1347771	E	RGD:6480464	20130514	CTD	MESH:D017878	AICDA results in increased susceptibility to 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid	PMID:23589568
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:4286	4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid	increases response to substance	ISO	RGD:1551301	E	RGD:6480464	20130514	CTD	MESH:D017878	AICDA results in increased susceptibility to 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid	PMID:23589568
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:4286	4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid	multiple interactions	ISO	RGD:1347771	E	RGD:6480464	20130514	CTD	MESH:D017878	[4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of RAD51 protein] which results in increased activity of AICDA protein	PMID:23589568
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:46938	zebularine	multiple interactions	ISO	RGD:1551301	E	RGD:6480464	20260811	CTD	MESH:C009131	[pyrimidin-2-one beta-ribofuranoside results in decreased activity of APOBEC3B protein] which results in increased susceptibility to Decitabine; pyrimidin-2-one beta-ribofuranoside inhibits the reaction [APOBEC3B protein results in decreased amination of Decitabine]	PMID:18398609
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1347771	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AICDA gene	PMID:25304211
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1551301	E	RGD:6480464	20260811	CTD	MESH:D001151	Arsenic results in increased expression of APOBEC3B mRNA; Arsenic results in increased expression of APOBEC3B protein	PMID:34998823
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D004726	Endosulfan results in decreased expression of APOBEC3B mRNA	PMID:29391264
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1347771	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of AICDA protein	PMID:21570118
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1347771	E	RGD:6480464	20191114	CTD	MESH:C032793	Imatinib Mesylate promotes the reaction [Arsenic Trioxide results in decreased expression of AICDA protein]	PMID:21570118
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1551301	E	RGD:6480464	20260811	CTD	MESH:C014347	[pyrimidin-2-one beta-ribofuranoside results in decreased activity of APOBEC3B protein] which results in increased susceptibility to Decitabine; pyrimidin-2-one beta-ribofuranoside inhibits the reaction [APOBEC3B protein results in decreased amination of Decitabine]	PMID:18398609
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D008713	Methimazole results in increased expression of APOBEC3B mRNA	PMID:30047161
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:53050	trimellitic anhydride	affects expression	ISO	RGD:1551301	E	RGD:6480464	20120515	CTD	MESH:C015559	trimellitic anhydride affects the expression of AICDA mRNA	PMID:22302311
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1551301	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of AICDA mRNA	PMID:19042947
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:55365	alpha-hexylcinnamaldehyde	affects expression	ISO	RGD:1551301	E	RGD:6480464	20120515	CTD	MESH:C080043	hexyl cinnamic aldehyde affects the expression of AICDA mRNA	PMID:22302311
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1551301	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of AICDA mRNA	PMID:38701926
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of AICDA mRNA	PMID:28801915
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1551301	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of AICDA mRNA	PMID:23650126
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1551301	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol results in increased expression of AICDA mRNA	PMID:30742662
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1551301	E	RGD:6480464	20201215	CTD	MESH:D002185	[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of AICDA mRNA	PMID:30742662
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:70851	phthalaldehyde	affects expression	ISO	RGD:1551301	E	RGD:6480464	20121218	CTD	MESH:D009764	o-Phthalaldehyde affects the expression of AICDA mRNA	PMID:22302311
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of AICDA mRNA	PMID:32109520
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1551301	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of AICDA mRNA	PMID:38648751
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:82163	rac-1,2-dichloropropane	affects expression	ISO	RGD:1347771	E	RGD:6480464	20190409	CTD	MESH:C004765	propylene dichloride affects the expression of AICDA mRNA	PMID:30452740
1303222	Aicda	activation-induced cytidine deaminase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D011441	Propylthiouracil results in increased expression of APOBEC3B mRNA	PMID:30047161
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:C084079	triptonide results in decreased expression of GPRASP3 mRNA	PMID:33045310
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BHLHB9 mRNA	PMID:20938992
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1347976	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of GPRASP3 mRNA	PMID:21934132
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of BHLHB9 mRNA	PMID:36331819
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20260707	CTD	MESH:D001280	Atrazine affects the methylation of GPRASP3 gene	PMID:35440735
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552602	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of BHLHB9 mRNA	PMID:30319688
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552602	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of BHLHB9 mRNA	PMID:30319688
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of BHLHB9 mRNA	PMID:39241906
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1347976	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of GPRASP3 mRNA	PMID:31614463
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D004958	Estradiol results in decreased expression of GPRASP3 mRNA	PMID:39298647
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BHLHB9 mRNA	PMID:20938992
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1347976	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of GPRASP3 mRNA	PMID:23649840
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BHLHB9 mRNA	PMID:37992649
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1552602	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of BHLHB9 mRNA	PMID:33848595
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BHLHB9 mRNA	PMID:37992649
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of BHLHB9 mRNA	PMID:34319233
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of GPRASP3 mRNA	PMID:33387578
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BHLHB9 mRNA	PMID:36331819
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of BHLHB9 mRNA	PMID:24067728
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347976	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPRASP3 mRNA	PMID:35301059
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPRASP3 mRNA	PMID:37236586
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1347976	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GPRASP3 mRNA	PMID:23649840
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of BHLHB9 mRNA	PMID:41580963
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of BHLHB9 mRNA	PMID:31919559
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552602	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BHLHB9 mRNA	PMID:17484886|PMID:27339419
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BHLHB9 mRNA	PMID:20938992
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1347976	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of GPRASP3 mRNA	PMID:26272509
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1347976	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPRASP3 mRNA	PMID:27188386
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA	PMID:33854195
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of BHLHB9 mRNA	PMID:28960355
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:C024565	ethylene dichloride results in increased expression of GPRASP3 mRNA	PMID:28960355
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552602	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BHLHB9 mRNA	PMID:21570461
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D020106	Acrylamide results in increased expression of GPRASP3 mRNA	PMID:28959563
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1347976	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of GPRASP3 mRNA	PMID:32763439
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D020106	Acrylamide results in increased expression of GPRASP3 mRNA	PMID:30807115
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BHLHB9 mRNA	PMID:37992649
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347976	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of GPRASP3 mRNA	PMID:39719251
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347976	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of GPRASP3 mRNA	PMID:25879800
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347976	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GPRASP3 5' UTR; Benzo(a)pyrene affects the methylation of GPRASP3 promoter	PMID:27901495
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1347976	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GPRASP3 mRNA	PMID:20106945
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BHLHB9 mRNA	PMID:19770486
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GPRASP3 intron	PMID:27901495
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of BHLHB9 mRNA	PMID:29264374
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552602	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BHLHB9 gene	PMID:35295148
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GPRASP3 mRNA	PMID:34492290
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013853	Thioacetamide results in increased expression of GPRASP3 mRNA	PMID:34492290
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1552602	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of BHLHB9 mRNA	PMID:19136022
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552602	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of BHLHB9 mRNA	PMID:18301758|PMID:23811191
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BHLHB9 mRNA	PMID:19710929
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of GPRASP3 mRNA	PMID:19167457
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A affects the expression of GPRASP3 mRNA	PMID:25181051
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of GPRASP3 mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:41034487
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1347976	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GPRASP3 gene	PMID:31601247
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552602	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of BHLHB9 mRNA	PMID:39298647
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA	PMID:33854195
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1552602	E	RGD:6480464	20190507	CTD	MESH:D026023	Permethrin results in increased expression of BHLHB9 mRNA	PMID:30629241
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347976	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BHLHB9 mRNA	PMID:37042841
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1347976	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of GPRASP3 mRNA	PMID:29024780
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347976	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPRASP3 mRNA	PMID:35301059
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPRASP3 mRNA	PMID:37236586
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1552602	E	RGD:6480464	20190312	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of BHLHB9 mRNA	PMID:30711707
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1347976	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of GPRASP3 mRNA	PMID:24449571
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1552602	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of BHLHB9 mRNA	PMID:28962523
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1552602	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of BHLHB9 mRNA	PMID:23811191
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GPRASP3 mRNA	PMID:40194260
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347976	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GPRASP3 mRNA	PMID:31533062
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BHLHB9 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of BHLHB9 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of BHLHB9 mRNA	PMID:36331819
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552602	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of BHLHB9 mRNA	PMID:17292431
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1347976	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of GPRASP3 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:28001369
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1347976	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GPRASP3 gene	PMID:29154799
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1347976	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of GPRASP3 mRNA	PMID:29154799
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347976	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPRASP3 mRNA	PMID:27188386
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1347976	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of GPRASP3 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of BHLHB9 mRNA	PMID:19770486
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA	PMID:33854195
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BHLHB9 mRNA	PMID:37992649
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA	PMID:33854195
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1347976	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of GPRASP3 mRNA	PMID:24935251
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GPRASP3 mRNA	PMID:33387578
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000082	Acetaminophen results in increased expression of GPRASP3 mRNA	PMID:33387578
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of BHLHB9 mRNA	PMID:29279043
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of GPRASP3 mRNA	PMID:29391264
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of GPRASP3 mRNA	PMID:24793618
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA	PMID:33854195
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of BHLHB9 mRNA	PMID:36907384
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GPRASP3 mRNA	PMID:27840820
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20260707	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GPRASP3 mRNA	PMID:22206623
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347976	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPRASP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPRASP3 mRNA	PMID:27188386
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347976	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GPRASP3 gene]	PMID:28238834
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552602	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of BHLHB9 mRNA	PMID:19136022|PMID:23091169
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GPRASP3 mRNA	PMID:30047161
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of GPRASP3 mRNA	PMID:24780913
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347976	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPRASP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPRASP3 mRNA	PMID:27188386
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GPRASP3 mRNA	PMID:21346803
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of GPRASP3 mRNA	PMID:21346803
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1552602	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of BHLHB9 mRNA	PMID:32835833
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1552602	E	RGD:6480464	20180220	CTD	MESH:C057693	Troglitazone results in increased expression of BHLHB9 mRNA	PMID:28973697
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C025643	vinclozolin results in decreased expression of GPRASP3 mRNA	PMID:23034163
1303224	Gprasp3	G protein-coupled receptor associated sorting protein family member 3	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of GPRASP3 mRNA	PMID:23034163
1303225	Ctsql2	cathepsin Q-like 2	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of CTSQL2 mRNA	PMID:23358152
1303225	Ctsql2	cathepsin Q-like 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CTSQL2 mRNA	PMID:25181051
1303225	Ctsql2	cathepsin Q-like 2	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of CTSQL2 mRNA	PMID:23358152
1303225	Ctsql2	cathepsin Q-like 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of CTSQL2 mRNA	PMID:22504374
1303225	Ctsql2	cathepsin Q-like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of CTSQL2 mRNA	PMID:22504374
1303225	Ctsql2	cathepsin Q-like 2	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of CTSQL2 mRNA	PMID:23358152
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1349384	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of DNAJC7 protein	PMID:39638853
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DNAJC7 mRNA	PMID:38218311
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1551318	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DNAJC7 mRNA	PMID:33045310
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1349384	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of DNAJC7 mRNA	PMID:26079696
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1551318	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DNAJC7 mRNA	PMID:30319688
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1349384	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DNAJC7 mRNA	PMID:20044591
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551318	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DNAJC7 mRNA	PMID:39241906
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:17627	ferroheme b	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006418	Heme results in decreased expression of DNAJC7 mRNA	PMID:15539406
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1349384	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of DNAJC7 promoter	PMID:30157460
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1349384	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DNAJC7 mRNA	PMID:19549813
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DNAJC7 protein	PMID:23301498
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DNAJC7 mRNA	PMID:35430440
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:26355	heme b	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D006418	Heme results in decreased expression of DNAJC7 mRNA	PMID:15539406
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of DNAJC7 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DNAJC7 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DNAJC7 protein	PMID:38598786
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551318	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNAJC7 mRNA	PMID:22206623
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of DNAJC7 mRNA	PMID:40512198
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551318	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJC7 mRNA	PMID:40504410
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC7 mRNA	PMID:19244175
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1551318	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of DNAJC7 mRNA	PMID:28960355
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJC7 mRNA	PMID:23557933
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1349384	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DNAJC7 mRNA	PMID:28903495
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551318	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNAJC7 mRNA	PMID:21570461
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1551318	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of DNAJC7 mRNA	PMID:23186747
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DNAJC7 mRNA	PMID:30851411
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1349384	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of DNAJC7 mRNA	PMID:23649840
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1349384	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DNAJC7 mRNA	PMID:32763439
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of DNAJC7 mRNA	PMID:40512198
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551318	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJC7 mRNA	PMID:40504410
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349384	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DNAJC7 3' UTR; Benzo(a)pyrene affects the methylation of DNAJC7 intron	PMID:27901495|PMID:30157460
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1349384	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DNAJC7 promoter	PMID:27901495
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1551318	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of DNAJC7 protein	PMID:37955338
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DNAJC7 protein	PMID:25419056
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DNAJC7 protein]	PMID:26598702
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551318	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DNAJC7 gene	PMID:35295148
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1551318	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of DNAJC7 mRNA	PMID:27760801
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DNAJC7 mRNA	PMID:19710929
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJC7 mRNA; bisphenol A results in decreased expression of DNAJC7 protein	PMID:29275510|PMID:37567409
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551318	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJC7 mRNA	PMID:32156529|PMID:33221593
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJC7 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1349384	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJC7 mRNA	PMID:33670352
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DNAJC7 gene	PMID:28505145
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DNAJC7 mRNA	PMID:36041667
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1349384	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of DNAJC7 mRNA	PMID:19244175
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC7 mRNA	PMID:19244175
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1349384	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of DNAJC7 mRNA	PMID:24752500
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DNAJC7 mRNA	PMID:36041667
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1349384	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of DNAJC7 intron	PMID:30157460
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DNAJC7 mRNA	PMID:36041667
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1551318	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of DNAJC7 mRNA	PMID:28392331
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551318	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of DNAJC7 mRNA	PMID:34813904
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of DNAJC7 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of DNAJC7 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DNAJC7 protein	PMID:38598786
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1551318	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of DNAJC7 mRNA	PMID:34813904
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNAJC7 mRNA	PMID:33453195
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of DNAJC7 mRNA	PMID:24449571
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC7 mRNA	PMID:19244175
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DNAJC7 mRNA	PMID:28302478
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349384	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DNAJC7 mRNA	PMID:25979313
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of DNAJC7 mRNA; Valproic Acid results in decreased expression of DNAJC7 protein	PMID:29501571
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1349384	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of DNAJC7 mRNA	PMID:23649840
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1349384	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of DNAJC7 mRNA	PMID:28542535
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DNAJC7 mRNA	PMID:33387578
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of DNAJC7 mRNA	PMID:29067470
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1349384	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJC7 mRNA	PMID:21420995
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of DNAJC7 mRNA	PMID:40512198
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551318	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJC7 mRNA	PMID:40504410
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1349384	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of DNAJC7 mRNA	PMID:24752500
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DNAJC7 protein	PMID:25419056
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DNAJC7 protein]	PMID:26598702
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:50102	N-methyl-N-nitrosourea	decreases expression	ISO	RGD:1551318	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in decreased expression of DNAJC7 mRNA	PMID:25270620
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551318	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DNAJC7 mRNA	PMID:35964746
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DNAJC7 mRNA	PMID:24136188
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DNAJC7 protein	PMID:32959892
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1551318	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DNAJC7 mRNA	PMID:23650126
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of DNAJC7 mRNA	PMID:37939859
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1349384	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of DNAJC7 intron	PMID:30157460
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551318	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNAJC7 mRNA	PMID:22206623
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases ubiquitination	ISO	RGD:1551318	E	RGD:6480464	20141014	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of DNAJC7 protein	PMID:24789201
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1551318	E	RGD:6480464	20141014	CTD	MESH:C072553	1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of DNAJC7 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [DNAJC7 protein results in increased expression of NR1I3 protein]; NR1I3 protein affects the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of DNAJC7 protein]]	PMID:24789201
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1349384	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of DNAJC7 mRNA	PMID:22714537
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1349384	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of DNAJC7 protein	PMID:39638853
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DNAJC7 mRNA	PMID:30851411
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNAJC7 mRNA	PMID:27291303
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1349384	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DNAJC7 protein	PMID:38348393
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DNAJC7 mRNA	PMID:21346803
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1349384	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of DNAJC7 mRNA	PMID:17440010
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1349384	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of DNAJC7 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DNAJC7 protein	PMID:38598786
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DNAJC7 mRNA	PMID:21346803
1303226	Dnajc7	DnaJ heat shock protein family (Hsp40) member C7	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DNAJC7 mRNA	PMID:19015723
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of FKBPL mRNA	PMID:32145629
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1353952	E	RGD:6480464	20120412	CTD	MESH:D004958	FKBPL protein inhibits the reaction [Estradiol results in increased phosphorylation of ESR1 protein]	PMID:20103631
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353952	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FKBPL mRNA	PMID:37042841
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1353952	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FKBPL mRNA	PMID:28818685
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1353952	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FKBPL mRNA	PMID:39836092
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1353952	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FKBPL mRNA	PMID:19549813
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1353952	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FKBPL mRNA	PMID:23649840
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1353952	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FKBPL gene	PMID:25304211
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1621552	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FKBPL mRNA	PMID:40504410
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1353952	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FKBPL mRNA	PMID:23557933
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1353952	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of FKBPL mRNA	PMID:27594783
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of FKBPL mRNA	PMID:20187946
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621552	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FKBPL mRNA	PMID:21570461
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1621552	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FKBPL mRNA	PMID:25975270
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1353952	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FKBPL mRNA	PMID:33212167
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1353952	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FKBPL mRNA	PMID:30851411
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353952	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FKBPL mRNA	PMID:38568856
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1621552	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FKBPL mRNA	PMID:40504410
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353952	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FKBPL promoter	PMID:27901495
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1621552	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FKBPL mRNA	PMID:22228805
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1353952	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FKBPL mRNA	PMID:35984750
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:31638	fulvestrant	increases response to substance	ISO	RGD:1353952	E	RGD:6480464	20120412	CTD	MESH:C070081	FKBPL protein results in increased susceptibility to fulvestrant	PMID:20103631
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FKBPL mRNA	PMID:34492290
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1353952	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FKBPL mRNA	PMID:19710929
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1621552	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of FKBPL mRNA	PMID:19191707
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of FKBPL mRNA	PMID:32145629
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1353952	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of FKBPL mRNA	PMID:27685785
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of FKBPL mRNA	PMID:36041667
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1621552	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of FKBPL gene	PMID:31683443
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621552	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of FKBPL mRNA	PMID:40203079
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of FKBPL mRNA	PMID:36041667
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of FKBPL mRNA	PMID:36041667
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353952	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FKBPL mRNA	PMID:37042841
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1353952	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FKBPL mRNA	PMID:39836092
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1353952	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FKBPL mRNA	PMID:38568856
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1353952	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FKBPL mRNA	PMID:28302478
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1353952	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of FKBPL mRNA	PMID:19167446
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1353952	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of FKBPL mRNA	PMID:14503796
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:41774	tamoxifen	increases response to substance	ISO	RGD:1353952	E	RGD:6480464	20120412	CTD	MESH:D013629	FKBPL protein results in increased susceptibility to Tamoxifen	PMID:20103631
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1353952	E	RGD:6480464	20120412	CTD	MESH:D013629	FKBPL protein inhibits the reaction [Tamoxifen results in increased phosphorylation of ESR1 protein]	PMID:20103631
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621552	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FKBPL mRNA	PMID:17562736
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1353952	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of FKBPL mRNA	PMID:14503796
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1353952	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FKBPL gene	PMID:25304211
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1621552	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FKBPL mRNA	PMID:40504410
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:47898	4'-epidoxorubicin	increases expression	ISO	RGD:1353952	E	RGD:6480464	20120412	CTD	MESH:D015251	Epirubicin results in increased expression of FKBPL mRNA	PMID:14503796
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1621552	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FKBPL mRNA	PMID:17942748
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1353952	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FKBPL mRNA	PMID:39836092
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1353952	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of FKBPL mRNA	PMID:28988120
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1353952	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of FKBPL mRNA	PMID:37199045
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1353952	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FKBPL mRNA	PMID:30851411
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FKBPL mRNA	PMID:19281266
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FKBPL mRNA	PMID:21346803
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FKBPL mRNA	PMID:21346803
1303227	Fkbpl	FKBP prolyl isomerase like	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1621552	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of FKBPL mRNA	PMID:35537566
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1551322	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of KLK4 mRNA	PMID:37995155
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1353266	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of KLK4 mRNA	PMID:29581250
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D013739	Testosterone results in increased expression of KLK4 mRNA	PMID:27684650
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D013739	bisphenol A inhibits the reaction [Testosterone results in increased expression of KLK4 protein]; vinclozolin inhibits the reaction [Testosterone results in increased expression of KLK4 protein]	PMID:27684650
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1353266	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KLK4 mRNA	PMID:31163220
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of KLK4 mRNA	PMID:26577399
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1353266	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KLK4 gene	PMID:25304211
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1353266	E	RGD:6480464	20120412	CTD	MESH:D002945	KLK4 protein affects the susceptibility to Cisplatin	PMID:16217747
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:28088	genistein	affects expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein affects the expression of KLK4	PMID:27352425
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:28741	sodium fluoride	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of KLK4 mRNA	PMID:27257137
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:28741	sodium fluoride	decreases secretion	ISO	RGD:1551322	E	RGD:6480464	20140311	CTD	MESH:D012969	Sodium Fluoride results in decreased secretion of KLK4 protein	PMID:21626649
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353266	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KLK4 intron; Benzo(a)pyrene affects the methylation of KLK4 promoter	PMID:27901495|PMID:30157460
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1353266	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KLK4 exon	PMID:27901495
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1353266	E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in increased expression of KLK4 mRNA	PMID:27188386
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the expression of KLK4	PMID:27352425
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KLK4 mRNA	PMID:25181051|PMID:27684650
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of KLK4 mRNA; bisphenol A results in increased expression of KLK4 protein	PMID:23764278
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551322	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of KLK4 mRNA	PMID:26063408
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:C006780	bisphenol A inhibits the reaction [Testosterone results in increased expression of KLK4 protein]	PMID:27684650
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1551322	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KLK4 mRNA	PMID:37019170
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1551322	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of KLK4 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KLK4 mRNA]	PMID:17585979
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1551322	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of KLK4 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KLK4 mRNA]	PMID:17585979
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1353266	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KLK4 gene	PMID:25304211
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551322	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KLK4 mRNA	PMID:22206623
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C025643	vinclozolin affects the expression of KLK4	PMID:27352425
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C025643	vinclozolin results in decreased expression of KLK4 mRNA	PMID:27684650
1303228	Klk4	kallikrein-related peptidase 4	gene	CHEBI:9986	vinclozolin	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:C025643	vinclozolin inhibits the reaction [Testosterone results in increased expression of KLK4 protein]	PMID:27684650
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of WFDC12 mRNA	PMID:30071829
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1349049	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of WFDC12 mRNA	PMID:31614463
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1349049	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of WFDC12 mRNA	PMID:33359661
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1349049	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of WFDC12 mRNA	PMID:31256213
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of WFDC12 protein	PMID:26597043
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1551325	E	RGD:6480464	20120515	CTD	MESH:D010126	Ozone results in increased expression of WFDC12 mRNA	PMID:21543283
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1349049	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of WFDC12 mRNA	PMID:21867686
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1349049	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC12 mRNA	PMID:32525701
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1349049	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of WFDC12 mRNA	PMID:23557933
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551325	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WFDC12 mRNA	PMID:21570461
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1349049	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WFDC12 mRNA	PMID:23152189
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1349049	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WFDC12 mRNA	PMID:30851411
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1551325	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of WFDC12 mRNA	PMID:30807115
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551325	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of WFDC12 mRNA	PMID:22228805
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349049	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WFDC12 exon; Benzo(a)pyrene results in increased methylation of WFDC12 promoter	PMID:27901495
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551325	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of WFDC12 mRNA	PMID:27858113
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of WFDC12 mRNA	PMID:25181051
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1551325	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of WFDC12 mRNA	PMID:26377693
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1551325	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of WFDC12 mRNA	PMID:27858113
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1551325	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of WFDC12 mRNA	PMID:24535843
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1551325	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of WFDC12 mRNA	PMID:26377693
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1551325	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of WFDC12 mRNA	PMID:28962523
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1551325	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of WFDC12 mRNA	PMID:15171707
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1551325	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of WFDC12 mRNA	PMID:28973697
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1349049	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC12 mRNA	PMID:32525701
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551325	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of WFDC12 mRNA; Nanotubes, Carbon results in increased expression of WFDC12 mRNA	PMID:25554681
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1551325	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of WFDC12 mRNA	PMID:26377693
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1551325	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of WFDC12 mRNA	PMID:27858113
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1551325	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of WFDC12 mRNA	PMID:27858113
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of WFDC12 mRNA	PMID:28801915
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of WFDC12 mRNA	PMID:28801915
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1349049	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WFDC12 mRNA	PMID:30851411
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349049	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WFDC12 gene]	PMID:28238834
1303229	Wfdc12	WAP four-disulfide core domain 12	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1349049	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC12 mRNA	PMID:32525701
1303230	Senp18	Sumo1/sentrin/SMT3 specific peptidase 18	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D011374	Progesterone results in increased expression of SENP18 mRNA	PMID:21770760
1303230	Senp18	Sumo1/sentrin/SMT3 specific peptidase 18	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of SENP18 gene	PMID:35440735
1303230	Senp18	Sumo1/sentrin/SMT3 specific peptidase 18	gene	CHEBI:34631	chlorpyrifos	increases methylation	EXP		E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in increased methylation of SENP18 gene	PMID:32905263
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1343885	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of RASL11A mRNA	PMID:25812627
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RASL11A mRNA	PMID:39752319
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1551355	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RASL11A mRNA	PMID:20188158
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASL11A mRNA	PMID:20938992
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RASL11A mRNA	PMID:33167477
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1343885	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of RASL11A mRNA	PMID:23830798
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1343885	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RASL11A mRNA	PMID:35811015
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RASL11A mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of RASL11A mRNA]	PMID:35811015
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1343885	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RASL11A mRNA	PMID:31614463
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASL11A mRNA	PMID:20938992
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1343885	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of RASL11A mRNA	PMID:20864642
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASL11A mRNA	PMID:37992649
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RASL11A mRNA	PMID:39752319
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RASL11A mRNA	PMID:21592394
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of RASL11A mRNA	PMID:21592394
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1343885	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of RASL11A mRNA	PMID:33647349
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASL11A mRNA	PMID:37992649
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of RASL11A mRNA	PMID:36139627
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of RASL11A mRNA	PMID:21592394
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of RASL11A mRNA	PMID:21592394
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RASL11A mRNA	PMID:33387578
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:17933	calcidiol	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D002112	Calcifediol deficiency results in decreased expression of RASL11A mRNA	PMID:17293106
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1343885	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RASL11A exon	PMID:30157460
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RASL11A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RASL11A mRNA	PMID:34911549
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASL11A mRNA	PMID:20938992
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RASL11A mRNA	PMID:19921347
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1343885	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RASL11A mRNA	PMID:27392435
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D003042	Cocaine results in increased expression of RASL11A mRNA	PMID:27899881
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551355	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASL11A mRNA	PMID:21570461
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASL11A mRNA	PMID:33387578|PMID:34747641
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1551355	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of RASL11A mRNA	PMID:32937126
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1343885	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RASL11A mRNA	PMID:28001369
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1343885	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RASL11A mRNA	PMID:33212167
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1343885	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of RASL11A mRNA	PMID:39709020
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1343885	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of RASL11A mRNA	PMID:32763439
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RASL11A mRNA	PMID:15467011
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASL11A mRNA	PMID:37992649
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1343885	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of RASL11A mRNA	PMID:20044591
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of RASL11A mRNA	PMID:29301061
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551355	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of RASL11A mRNA	PMID:37682722
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA	PMID:34876320
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of RASL11A mRNA	PMID:29453283
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA	PMID:34876320
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343885	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RASL11A exon	PMID:30157460
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RASL11A mRNA	PMID:32234424
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1343885	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RASL11A promoter	PMID:27901495
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1551355	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RASL11A 3' UTR; Benzo(a)pyrene results in decreased methylation of RASL11A exon	PMID:27901495
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RASL11A mRNA	PMID:27858113
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RASL11A mRNA	PMID:15467011
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1551355	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of RASL11A mRNA	PMID:39716349
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of RASL11A mRNA	PMID:24915197
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of RASL11A mRNA	PMID:30012374
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1551355	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of RASL11A mRNA	PMID:27760801
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551355	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RASL11A gene	PMID:35295148
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551355	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in decreased expression of RASL11A mRNA	PMID:35479511
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551355	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of RASL11A mRNA	PMID:32156529
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASL11A mRNA	PMID:28628672
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of RASL11A mRNA	PMID:23196670
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1551355	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of RASL11A mRNA	PMID:26377693
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RASL11A mRNA	PMID:27858113
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RASL11A mRNA	PMID:28628672
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1551355	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RASL11A mRNA	PMID:21266533
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASL11A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RASL11A mRNA	PMID:28628672
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343885	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RASL11A mRNA	PMID:37042841
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of RASL11A gene	PMID:22079235
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RASL11A mRNA	PMID:25812627
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1551355	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RASL11A mRNA	PMID:40194260
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1551355	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RASL11A mRNA	PMID:40194260
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RASL11A mRNA	PMID:31533062
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1551355	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RASL11A mRNA	PMID:39529242
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1343885	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of RASL11A mRNA	PMID:25812627
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1551355	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of RASL11A mRNA	PMID:23125180
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1343885	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of RASL11A mRNA	PMID:25047013
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASL11A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RASL11A mRNA	PMID:28628672
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551355	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RASL11A mRNA	PMID:28973697
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASL11A mRNA	PMID:37992649
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1343885	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RASL11A mRNA	PMID:38832940
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RASL11A mRNA	PMID:33387578
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RASL11A mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of RASL11A mRNA]	PMID:35811015
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1343885	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of RASL11A mRNA	PMID:25757056
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of RASL11A mRNA	PMID:31838189
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of RASL11A mRNA	PMID:29391264
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RASL11A mRNA	PMID:22079256
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA	PMID:34876320
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of RASL11A mRNA	PMID:32234424
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1343885	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of RASL11A mRNA	PMID:38568856
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASL11A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RASL11A mRNA	PMID:28628672
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1551355	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of RASL11A mRNA	PMID:39716349
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551355	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RASL11A mRNA; Nanotubes, Carbon results in increased expression of RASL11A mRNA	PMID:25554681
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of RASL11A mRNA	PMID:16648578
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:50859	bexarotene	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in increased expression of RASL11A mRNA	PMID:16648578
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RASL11A mRNA	PMID:27858113
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RASL11A mRNA	PMID:27858113
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1343885	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of RASL11A mRNA	PMID:31629900
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1551355	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of RASL11A mRNA	PMID:38701926
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of RASL11A mRNA	PMID:20080153
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of RASL11A mRNA	PMID:28801915
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of RASL11A mRNA	PMID:28801915
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of RASL11A mRNA	PMID:19564919
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of RASL11A mRNA	PMID:19564919
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RASL11A mRNA	PMID:39752319
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of RASL11A mRNA	PMID:19564919
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551355	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RASL11A mRNA	PMID:22206623
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1343885	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RASL11A mRNA	PMID:22079256
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RASL11A mRNA	PMID:22079256
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of RASL11A mRNA	PMID:36139627
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1343885	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RASL11A gene]	PMID:28238834
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1551355	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of RASL11A mRNA	PMID:38648751
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA	PMID:34876320
1303231	Rasl11a	RAS-like family 11 member A	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1551355	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RASL11A mRNA	PMID:39752319
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1353326	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PYROXD2 mRNA	PMID:27188386
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PYROXD2 mRNA	PMID:36331819
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of PYROXD2 gene	PMID:28931070|PMID:35440735
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553330	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PYROXD2 mRNA	PMID:39241906
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1353326	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PYROXD2 mRNA	PMID:35811015
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PYROXD2 mRNA]	PMID:39241906
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553330	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PYROXD2 mRNA	PMID:39298647
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353326	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PYROXD2 mRNA	PMID:37042841
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PYROXD2 mRNA	PMID:37992649
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1553330	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of PYROXD2 mRNA	PMID:28973375
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PYROXD2 mRNA	PMID:37992649
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1353326	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of PYROXD2 mRNA	PMID:26485663
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PYROXD2 protein	PMID:22061828
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PYROXD2 mRNA	PMID:36331819
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of PYROXD2 protein	PMID:34915118
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1353326	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PYROXD2 mRNA	PMID:35301059
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of PYROXD2 protein	PMID:33236894
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PYROXD2 mRNA	PMID:27153756
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1353326	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PYROXD2 gene	PMID:27153756
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PYROXD2 mRNA	PMID:30779732
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1353326	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PYROXD2 gene	PMID:25304211
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1353326	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PYROXD2 mRNA	PMID:32525701
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PYROXD2 mRNA	PMID:40504410
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PYROXD2 mRNA	PMID:31881176
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1353326	E	RGD:6480464	20150714	CTD	MESH:C059514	resveratrol results in increased expression of PYROXD2 mRNA	PMID:25888808
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PYROXD2 mRNA	PMID:24768652|PMID:25583101
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PYROXD2 mRNA	PMID:22298810
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PYROXD2 mRNA	PMID:33387578
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1353326	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PYROXD2 mRNA	PMID:33212167
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PYROXD2 mRNA	PMID:30556269
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PYROXD2 mRNA	PMID:29803840
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PYROXD2 mRNA	PMID:37992649
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of PYROXD2 protein	PMID:29459688
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PYROXD2 mRNA	PMID:40504410
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1353326	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PYROXD2 exon	PMID:27901495
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353326	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PYROXD2 promoter	PMID:27901495
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PYROXD2 mRNA	PMID:30556269
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PYROXD2 mRNA	PMID:25895662
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of PYROXD2 mRNA	PMID:22641619
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of PYROXD2 mRNA	PMID:23411599|PMID:34492290
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553330	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PYROXD2 mRNA	PMID:23811191
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1553330	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PYROXD2 mRNA	PMID:28472532
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PYROXD2 mRNA	PMID:25181051
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PYROXD2 mRNA	PMID:34947998
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1353326	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PYROXD2 gene	PMID:31601247
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553330	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PYROXD2 mRNA	PMID:33221593
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PYROXD2 gene	PMID:28505145
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553330	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PYROXD2 mRNA	PMID:39298647
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553330	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of PYROXD2 mRNA	PMID:40203079
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1353326	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of PYROXD2 gene	PMID:22964155
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PYROXD2 mRNA]	PMID:39241906
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1353326	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PYROXD2 mRNA	PMID:35301059
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PYROXD2 mRNA	PMID:24386269
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PYROXD2 mRNA	PMID:31533062
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1553330	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PYROXD2 mRNA	PMID:39529242
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PYROXD2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PYROXD2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PYROXD2 mRNA	PMID:36331819
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of PYROXD2 mRNA	PMID:25993096
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:39501	2,2,2-tetramine	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D014266	Trientine inhibits the reaction [Streptozocin results in increased expression of PYROXD2 protein]	PMID:19634143
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PYROXD2 mRNA	PMID:29154799
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1353326	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PYROXD2 gene	PMID:29154799
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1553330	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PYROXD2 mRNA	PMID:28973697
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PYROXD2 mRNA	PMID:37992649
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PYROXD2 mRNA	PMID:38832940
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PYROXD2 mRNA	PMID:26272509
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1353326	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PYROXD2 mRNA	PMID:27188386
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PYROXD2 mRNA	PMID:33387578
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of PYROXD2 mRNA	PMID:26690555
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1353326	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PYROXD2 mRNA	PMID:35811015
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1353326	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PYROXD2 gene	PMID:25304211
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1353326	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PYROXD2 mRNA	PMID:32525701
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PYROXD2 mRNA	PMID:40504410
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PYROXD2 mRNA	PMID:29391264
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553330	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PYROXD2 mRNA	PMID:35436446
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of PYROXD2 mRNA	PMID:17557909
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1553330	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of PYROXD2 mRNA	PMID:19042947
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1553330	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of PYROXD2 mRNA	PMID:38701926
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of PYROXD2 mRNA	PMID:27188386
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of PYROXD2 mRNA	PMID:24136188
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PYROXD2 mRNA	PMID:28801915
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1353326	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PYROXD2 mRNA	PMID:31758290
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553330	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PYROXD2 mRNA	PMID:22206623
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1353326	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PYROXD2 mRNA	PMID:27188386
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1353326	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PYROXD2 mRNA	PMID:32525701
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1553330	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PYROXD2 mRNA]	PMID:39241906
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:88542	Butylparaben	decreases expression	ISO	RGD:1353326	E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in decreased expression of PYROXD2 mRNA	PMID:17121429
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353326	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PYROXD2 mRNA	PMID:27188386
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D013311	Streptozocin results in increased expression of PYROXD2 protein	PMID:19634143
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D013311	Trientine inhibits the reaction [Streptozocin results in increased expression of PYROXD2 protein]	PMID:19634143
1303232	Pyroxd2	pyridine nucleotide-disulphide oxidoreductase domain 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of PYROXD2 mRNA	PMID:22570695
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332316	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FGFR1OP2 mRNA	PMID:33045310
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1348205	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FGFR1OP2 mRNA	PMID:25812627
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1332316	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FGFR1OP2 mRNA	PMID:30319688
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1348205	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of FGFR1OP2 mRNA	PMID:18951874
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1348205	E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in increased expression of FGFR1OP2 mRNA	PMID:30152185
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348205	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FGFR1OP2 mRNA	PMID:37042841
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1348205	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of FGFR1OP2 mRNA	PMID:33359661
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1332316	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of FGFR1OP2 mRNA	PMID:23892564
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1348205	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FGFR1OP2 mRNA	PMID:28818685
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1332316	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FGFR1OP2 mRNA	PMID:19770486
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1348205	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FGFR1OP2 gene	PMID:27153756
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1348205	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of FGFR1OP2 mRNA	PMID:23649840
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1348205	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of FGFR1OP2 mRNA	PMID:41430723
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1348205	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of FGFR1OP2 mRNA	PMID:19774075
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332316	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FGFR1OP2 mRNA	PMID:31919559
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332316	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FGFR1OP2 mRNA	PMID:25629700
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1348205	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FGFR1OP2 gene	PMID:25304211
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:27744	glyphosate	affects expression	ISO	RGD:1332316	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the expression of FGFR1OP2 mRNA	PMID:35489704
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1348205	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FGFR1OP2 mRNA	PMID:23557933
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1348205	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of FGFR1OP2 mRNA	PMID:28903495
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332316	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FGFR1OP2 mRNA	PMID:21570461
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FGFR1OP2 mRNA	PMID:34747641
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332316	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FGFR1OP2 mRNA	PMID:17949056
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332316	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FGFR1OP2 mRNA	PMID:17942748
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1348205	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of FGFR1OP2 mRNA	PMID:20971185
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1348205	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FGFR1OP2 mRNA	PMID:38568856
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1348205	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FGFR1OP2 5' UTR	PMID:27901495
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332316	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FGFR1OP2 mRNA	PMID:19770486|PMID:22228805
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1332316	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FGFR1OP2 mRNA	PMID:27858113
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1348205	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of FGFR1OP2 mRNA	PMID:20971185
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1332316	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of FGFR1OP2 mRNA	PMID:19073995
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1348205	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FGFR1OP2 mRNA	PMID:20018196
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1348205	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FGFR1OP2 mRNA	PMID:20458559
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1348205	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of FGFR1OP2 mRNA	PMID:31745603
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FGFR1OP2 mRNA	PMID:34492290
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1348205	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of FGFR1OP2 mRNA	PMID:22576693|PMID:29275510
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FGFR1OP2 mRNA	PMID:25181051|PMID:30816183
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332316	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of FGFR1OP2 mRNA	PMID:21932408
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1348205	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of FGFR1OP2 protein	PMID:33376534
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1348205	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of FGFR1OP2 gene	PMID:22576693
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1348205	E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in increased expression of FGFR1OP2 protein]	PMID:33376534
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1332316	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of FGFR1OP2 mRNA	PMID:26377693
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1332316	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FGFR1OP2 mRNA	PMID:27858113
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of FGFR1OP2 mRNA	PMID:21266533
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1332316	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of FGFR1OP2 mRNA	PMID:34813904
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348205	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FGFR1OP2 mRNA	PMID:37042841
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348205	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FGFR1OP2 mRNA	PMID:38382870
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1348205	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of FGFR1OP2 mRNA	PMID:25812627
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1348205	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FGFR1OP2 mRNA	PMID:28302478
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1348205	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FGFR1OP2 mRNA	PMID:31533062
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1348205	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of FGFR1OP2 mRNA	PMID:25812627
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1348205	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid affects the expression of FGFR1OP2 mRNA	PMID:23179753
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1348205	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of FGFR1OP2 mRNA	PMID:27188386|PMID:28001369
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1348205	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FGFR1OP2 gene	PMID:29154799
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1348205	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of FGFR1OP2 mRNA	PMID:29154799
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1348205	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FGFR1OP2 mRNA	PMID:20106945|PMID:25562108
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1332316	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of FGFR1OP2 mRNA	PMID:17555576
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1348205	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of FGFR1OP2 mRNA	PMID:27188386
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1348205	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of FGFR1OP2 mRNA	PMID:28542535
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1348205	E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of FGFR1OP2 mRNA	PMID:25458485
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1348205	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of FGFR1OP2 mRNA	PMID:21420995
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1348205	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FGFR1OP2 gene	PMID:25304211
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1332316	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of FGFR1OP2 mRNA	PMID:26934552
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1332316	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FGFR1OP2 mRNA	PMID:17555576
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1332316	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FGFR1OP2 mRNA	PMID:17942748
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1332316	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FGFR1OP2 mRNA	PMID:17942748
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1348205	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FGFR1OP2 mRNA	PMID:20458559
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332316	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FGFR1OP2 mRNA	PMID:25554681
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of FGFR1OP2 mRNA	PMID:24136188
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1332316	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of FGFR1OP2 mRNA	PMID:26377693
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1332316	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FGFR1OP2 mRNA	PMID:27858113
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1332316	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FGFR1OP2 mRNA	PMID:27858113
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1348205	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of FGFR1OP2 mRNA	PMID:20977926
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332316	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FGFR1OP2 mRNA	PMID:22206623
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1332316	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of FGFR1OP2 mRNA	PMID:23091169
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FGFR1OP2 mRNA	PMID:19281266
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FGFR1OP2 mRNA	PMID:21346803
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1348205	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of FGFR1OP2 mRNA	PMID:38568856
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1348205	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of FGFR1OP2 mRNA	PMID:27188386
1303233	Fgfr1op2	FGFR1 oncogene partner 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FGFR1OP2 mRNA	PMID:21346803
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:C084079	triptonide results in increased expression of CLCA4A mRNA	PMID:33045310
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of CLCA4 mRNA	PMID:32145629
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of CLCA4 mRNA	PMID:26496021
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1351138	E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of CLCA4 mRNA	PMID:17404688
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CLCA4 mRNA	PMID:33387578
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1351138	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of CLCA4 mRNA	PMID:17404688
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1351138	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of CLCA4 mRNA	PMID:31256213
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:17833	gentamycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein	PMID:30545405
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:18231	arsenic acid	multiple interactions	ISO	RGD:1351138	E	RGD:6480464	20250401	CTD	MESH:C025657	[sodium arsenate results in increased abundance of arsenic acid] which results in decreased expression of CLCA4 mRNA	PMID:38630284
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CLCA4A mRNA	PMID:18579281
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1351138	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CLCA4 gene	PMID:27153756
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1558268	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CLCA4 mRNA	PMID:27106289
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:C024565	ethylene dichloride results in increased expression of CLCA4 mRNA	PMID:28960355
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:27903	(2,4,5-trichlorophenoxy)acetic acid	decreases expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:D015085	2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of CLCA4A mRNA	PMID:18579281
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:28001	vancomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein	PMID:30545405
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1351138	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of CLCA4 mRNA	PMID:24768652
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLCA4 mRNA; Tetrachlorodibenzodioxin affects the expression of CLCA4A mRNA	PMID:21570461
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:28971	ampicillin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein	PMID:30545405
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1351138	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of CLCA4 gene	PMID:28589171
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1558268	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLCA4A mRNA	PMID:36209798
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351138	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of CLCA4 mRNA	PMID:34032870
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351138	E	RGD:6480464	20250401	CTD	MESH:C017947	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of CLCA4 mRNA	PMID:38630284
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:29852	methylarsonic acid	decreases expression	ISO	RGD:1351138	E	RGD:6480464	20250401	CTD	MESH:C020300	monomethylarsonic acid results in decreased expression of CLCA4 mRNA	PMID:38630284
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLCA4 mRNA	PMID:22228805
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1351138	E	RGD:6480464	20250401	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of CLCA4 mRNA	PMID:38630284
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1351138	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CLCA4 mRNA	PMID:25351596
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:C006253	pirinixic acid results in decreased expression of CLCA4 mRNA	PMID:17426115
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLCA4 mRNA	PMID:25181051
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:C006780	bisphenol A results in decreased methylation of CLCA4 promoter	PMID:27312807
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1351138	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CLCA4 gene	PMID:31601247
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of CLCA4 mRNA	PMID:26496021
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CLCA4 mRNA	PMID:28300664
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:C543008	bisphenol S results in decreased expression of CLCA4A mRNA	PMID:31881267
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:D016264	Dextran Sulfate results in increased expression of CLCA4 mRNA	PMID:23894361
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CLCA4 mRNA	PMID:27387713
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1351138	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CLCA4 mRNA	PMID:24449571
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CLCA4A mRNA]	PMID:18200517
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1351138	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CLCA4 gene	PMID:29154799
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1351138	E	RGD:6480464	20250401	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of CLCA4 mRNA	PMID:38630284
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20220913	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CLCA4A mRNA	PMID:17351261
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of CLCA4A mRNA	PMID:18200517
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CLCA4A mRNA]	PMID:18200517
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1558268	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of CLCA4A protein	PMID:35926579
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:6909	metronidazole	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein	PMID:30545405
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1558268	E	RGD:6480464	20220913	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CLCA4 mRNA	PMID:22206623
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:7507	neomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein	PMID:30545405
1303234	Clca4	chloride channel accessory 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1351138	E	RGD:6480464	20250401	CTD	MESH:C009277	[sodium arsenate results in increased abundance of arsenic acid] which results in decreased expression of CLCA4 mRNA	PMID:38630284
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:10106	zearalenone	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20141223	CTD	MESH:D015025	[Zearalenone co-treated with CGA protein] results in decreased expression of HSD17B11 protein	PMID:25058043
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of HSD17B11 mRNA	PMID:21551480
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HSD17B11 mRNA]	PMID:31150632
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of HSD17B11 mRNA]	PMID:19467301
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of HSD17B11 mRNA	PMID:16604517
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1352920	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of HSD17B11 mRNA	PMID:23724009
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSD17B11 mRNA	PMID:30529165
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of HSD17B11 mRNA	PMID:36331819
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:15743	butanal	increases methylation	ISO	RGD:1352920	E	RGD:6480464	20190611	CTD	MESH:C018475	butyraldehyde results in increased methylation of HSD17B11 gene	PMID:30002397
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:15846	NAD(+)	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20150414	CTD	MESH:D009243	NAD binds to and results in increased activity of HSD17B11 protein	PMID:25526675
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1352920	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of HSD17B11 mRNA	PMID:20044591|PMID:21179406
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:16240	hydrogen peroxide	increases secretion	ISO	RGD:1332160	E	RGD:6480464	20121218	CTD	MESH:D006861	Hydrogen Peroxide results in increased secretion of HSD17B11 mRNA	PMID:21179422
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1352920	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of HSD17B11 mRNA	PMID:29581250
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HSD17B11 mRNA	PMID:39241906
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of HSD17B11 mRNA	PMID:32145629
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of HSD17B11 mRNA	PMID:23019147|PMID:31614463
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of HSD17B11 mRNA	PMID:15289156|PMID:39298647
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20121113	CTD	MESH:D004958	[Raloxifene Hydrochloride co-treated with Estradiol] results in increased expression of HSD17B11 mRNA	PMID:21185374
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of HSD17B11 mRNA	PMID:33387578
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1332160	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of HSD17B11 mRNA	PMID:25549359|PMID:28973375
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1352920	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HSD17B11 mRNA	PMID:37042841
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1352920	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of HSD17B11 mRNA	PMID:18070364|PMID:20864642
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1352920	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of HSD17B11 mRNA	PMID:21179406
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17153	propanal	increases methylation	ISO	RGD:1352920	E	RGD:6480464	20190611	CTD	MESH:C005556	propionaldehyde results in increased methylation of HSD17B11 gene	PMID:30002397
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1332160	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of HSD17B11 mRNA	PMID:28973375
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1352920	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of HSD17B11 mRNA	PMID:21592394
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of HSD17B11 mRNA	PMID:21592394
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HSD17B11 mRNA	PMID:34319233
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HSD17B11 mRNA	PMID:26472102
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HSD17B11 mRNA	PMID:19850644
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD17B11 mRNA; PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of HSD17B11 mRNA]	PMID:19850644|PMID:39150890
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1352920	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of HSD17B11 protein	PMID:37730182
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1352920	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of HSD17B11 mRNA	PMID:21592394
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of HSD17B11 mRNA	PMID:21592394
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17935	octanal	increases methylation	ISO	RGD:1352920	E	RGD:6480464	20190611	CTD	MESH:C031639	caprylic aldehyde results in increased methylation of HSD17B11 gene	PMID:30002397
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1352920	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of HSD17B11 mRNA	PMID:28818685
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HSD17B11 mRNA	PMID:36331819
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of HSD17B11 mRNA	PMID:39836092
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HSD17B11 mRNA	PMID:19549813
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of HSD17B11 protein	PMID:33236894
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of HSD17B11 mRNA	PMID:35430440
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1332160	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of HSD17B11 mRNA	PMID:24535564
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of HSD17B11 mRNA	PMID:30779732
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HSD17B11 mRNA	PMID:31150632
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HSD17B11 mRNA	PMID:31919559
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HSD17B11 mRNA]	PMID:31150632
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HSD17B11 mRNA	PMID:40504410
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium deficiency results in increased expression of HSD17B11 mRNA; Selenium results in increased expression of HSD17B11 mRNA	PMID:16170372
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1332160	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of HSD17B11 mRNA	PMID:28189721|PMID:28960355
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of HSD17B11 mRNA	PMID:23625948
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in increased expression of HSD17B11 mRNA	PMID:21858171
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20160412	CTD	MESH:D019833	Genistein results in decreased expression of HSD17B11 mRNA	PMID:24967385
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of HSD17B11 mRNA	PMID:15289156
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HSD17B11 mRNA	PMID:34747641
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332160	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HSD17B11 mRNA	PMID:21570461
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HSD17B11 mRNA	PMID:21215274
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSD17B11 mRNA	PMID:33387578
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1352920	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSD17B11 mRNA	PMID:21632981
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1352920	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of HSD17B11 mRNA	PMID:33512557
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of HSD17B11 mRNA	PMID:28959563
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HSD17B11 mRNA	PMID:29803840
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1332160	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of HSD17B11 mRNA	PMID:39631538
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1352920	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of HSD17B11 mRNA	PMID:20044591
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of HSD17B11 protein	PMID:30557709
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of HSD17B11 mRNA	PMID:34032870|PMID:39719251
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HSD17B11 mRNA	PMID:40504410
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [HSD17B11 protein binds to CAPRIN1 protein]	PMID:33939924
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HSD17B11 mRNA	PMID:32234424
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HSD17B11 mRNA	PMID:19770486
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to HSD17B11 mRNA]	PMID:32406909
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of HSD17B11 mRNA	PMID:24136188
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HSD17B11 mRNA	PMID:34492290
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332160	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of HSD17B11 mRNA	PMID:17426115|PMID:17690133|PMID:20813756|PMID:23811191
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HSD17B11 mRNA	PMID:19710929
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of HSD17B11 mRNA	PMID:19191707
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of HSD17B11 mRNA	PMID:30903817
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of HSD17B11 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:37105472
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of HSD17B11 mRNA	PMID:26063408|PMID:33221593
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HSD17B11 mRNA	PMID:25181051
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332160	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of HSD17B11 mRNA	PMID:34585602
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:C006780	cyanidin-3-O-beta-glucopyranoside inhibits the reaction [bisphenol A results in decreased expression of HSD17B11 mRNA]; protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of HSD17B11 mRNA]	PMID:37105472
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332160	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of HSD17B11 mRNA	PMID:30951980|PMID:39298647|PMID:40203079
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of HSD17B11 mRNA	PMID:21241498
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of HSD17B11 mRNA	PMID:26472102
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD17B11 mRNA	PMID:39150890
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1332160	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of HSD17B11 mRNA	PMID:31558096
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of HSD17B11 mRNA	PMID:17602206
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34680	dipentyl phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C034171	di-n-pentyl phthalate results in increased expression of HSD17B11 mRNA	PMID:26472102
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HSD17B11 mRNA	PMID:26472102
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HSD17B11 mRNA	PMID:21266533
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD17B11 mRNA	PMID:39150890
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD17B11 mRNA	PMID:39150890
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1332160	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of HSD17B11 mRNA	PMID:34813904
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34787	heptanal	increases methylation	ISO	RGD:1352920	E	RGD:6480464	20190611	CTD	MESH:C046204	heptanal results in increased methylation of HSD17B11 gene	PMID:30002397
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of HSD17B11 mRNA	PMID:34813904
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of HSD17B11 mRNA	PMID:17942915
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of HSD17B11 mRNA]	PMID:17942915
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1352920	E	RGD:6480464	20220607	CTD	MESH:D010269	Paraquat results in increased expression of HSD17B11 mRNA	PMID:35182771
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352920	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HSD17B11 mRNA	PMID:37042841
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of HSD17B11 mRNA	PMID:39836092
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of HSD17B11 promoter	PMID:22457795
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD17B11 mRNA	PMID:39150890
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of HSD17B11 protein	PMID:34958885
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1332160	E	RGD:6480464	20190312	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of HSD17B11 mRNA	PMID:30711707
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20161025	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of HSD17B11 mRNA	PMID:27413110
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:36062	3,4-dihydroxybenzoic acid	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:C009091	protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of HSD17B11 mRNA]	PMID:37105472
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1332160	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of HSD17B11 mRNA	PMID:28962523
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium deficiency results in increased expression of HSD17B11 mRNA; Selenium results in increased expression of HSD17B11 mRNA	PMID:16170372
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1332160	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of HSD17B11 mRNA	PMID:17585979|PMID:23811191
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of HSD17B11 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HSD17B11 mRNA]	PMID:17585979
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1332160	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HSD17B11 mRNA	PMID:40194260
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of HSD17B11 mRNA	PMID:28302478
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HSD17B11 mRNA	PMID:31533062
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HSD17B11 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of HSD17B11 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of HSD17B11 mRNA	PMID:36331819
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1332160	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of HSD17B11 mRNA	PMID:31558096
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1332160	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of HSD17B11 mRNA	PMID:24535564
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1352920	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of HSD17B11 mRNA	PMID:23179753|PMID:27188386
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of HSD17B11 mRNA	PMID:41580965
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of HSD17B11 mRNA	PMID:19770486
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of HSD17B11 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1352920	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of HSD17B11 mRNA	PMID:33512557
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of HSD17B11 mRNA	PMID:15289156
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332160	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of HSD17B11 mRNA	PMID:28973697
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1352920	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of HSD17B11 mRNA	PMID:33512557
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:44215	NAD zwitterion	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20150414	CTD	MESH:D009243	NAD binds to and results in increased activity of HSD17B11 protein	PMID:25526675
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1332160	E	RGD:6480464	20230801	CTD	MESH:C016601	afimoxifene results in increased expression of HSD17B11 mRNA	PMID:26879975
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HSD17B11 mRNA	PMID:38832940
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in decreased expression of HSD17B11 mRNA	PMID:29246445
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of HSD17B11 mRNA	PMID:21420995|PMID:29067470
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1352920	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of HSD17B11 mRNA	PMID:22230336
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of HSD17B11 mRNA; PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of HSD17B11 mRNA]; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HSD17B11 mRNA]	PMID:17585979|PMID:29246445
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HSD17B11 mRNA	PMID:40504410
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in increased expression of HSD17B11 protein	PMID:39793947
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HSD17B11 mRNA; Nanotubes, Carbon results in decreased expression of HSD17B11 mRNA	PMID:25554681
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1352920	E	RGD:6480464	20161025	CTD	MESH:C082360	fipronil results in increased expression of HSD17B11 mRNA	PMID:27091632
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:5063	fipronil	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20161025	CTD	MESH:C082360	[fipronil co-treated with DEET] results in increased expression of HSD17B11 mRNA	PMID:27091632
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:50867	ciprofibrate	increases expression	ISO	RGD:1332160	E	RGD:6480464	20120412	CTD	MESH:C019304	ciprofibrate results in increased expression of HSD17B11 mRNA	PMID:12771043
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of HSD17B11 mRNA	PMID:24793618
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1352920	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of HSD17B11 protein	PMID:23718831
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HSD17B11 protein	PMID:32959892
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of HSD17B11 mRNA	PMID:39836092
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:63630	tolcapone	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to HSD17B11 protein	PMID:19783845
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD17B11 mRNA	PMID:25270620
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1352920	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of HSD17B11 mRNA	PMID:15336504
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20161025	CTD	MESH:D003671	[fipronil co-treated with DEET] results in increased expression of HSD17B11 mRNA	PMID:27091632
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HSD17B11 mRNA	PMID:22206623
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1332160	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD17B11 mRNA	PMID:39150890
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1332160	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in decreased expression of HSD17B11 mRNA	PMID:25270620
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1332160	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of HSD17B11 mRNA	PMID:30294300
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1332160	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of HSD17B11 mRNA	PMID:31558096
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of HSD17B11 mRNA	PMID:21858171
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:84069	pentanal	increases methylation	ISO	RGD:1352920	E	RGD:6480464	20190611	CTD	MESH:C046012	pentanal results in increased methylation of HSD17B11 gene	PMID:30002397
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1332160	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of HSD17B11 mRNA	PMID:39847705
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:84268	nonanal	increases methylation	ISO	RGD:1352920	E	RGD:6480464	20190611	CTD	MESH:C008664	nonanal results in increased methylation of HSD17B11 gene	PMID:30002397
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HSD17B11 mRNA	PMID:24780913
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1352920	E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with Estradiol] results in increased expression of HSD17B11 mRNA	PMID:21185374
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:88528	hexanal	increases methylation	ISO	RGD:1352920	E	RGD:6480464	20190611	CTD	MESH:C010463	n-hexanal results in increased methylation of HSD17B11 gene	PMID:30002397
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1352920	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of HSD17B11 mRNA	PMID:29301935
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of HSD17B11 mRNA	PMID:23034163
1303235	Hsd17b11	hydroxysteroid (17-beta) dehydrogenase 11	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of HSD17B11 gene	PMID:31079544
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:10101	zalcitabine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016047	[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of ESRRG mRNA	PMID:18606552
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ESRRG mRNA]	PMID:31150632
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1349366	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ESRRG mRNA	PMID:23724009
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1551381	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ESRRG mRNA	PMID:36331819
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ESRRG gene	PMID:28931070|PMID:35440735
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of ESRRG mRNA	PMID:36841081
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1551381	E	RGD:6480464	20200804	CTD	MESH:D000431	Ethanol results in increased expression of ESRRG mRNA; Ethanol results in increased expression of ESRRG protein	PMID:27455076|PMID:31912162
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1551381	E	RGD:6480464	20200804	CTD	MESH:D000431	CNR1 protein affects the reaction [Ethanol results in increased expression of ESRRG mRNA]; CNR1 protein affects the reaction [Ethanol results in increased expression of ESRRG protein]; GSK5182 inhibits the reaction [Ethanol results in increased expression of ESRRG mRNA]; GSK5182 inhibits the reaction [Ethanol results in increased expression of ESRRG protein]	PMID:31912162
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ESRRG mRNA	PMID:30510588
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:16469	17beta-estradiol	affects binding	ISO	RGD:1349366	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol binds to ESRRG protein	PMID:22935422
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551381	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ESRRG mRNA	PMID:39298647
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1349366	E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in increased expression of ESRRG mRNA	PMID:25878060
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551381	E	RGD:6480464	20181113	CTD	MESH:D004958	Estradiol results in increased expression of ESRRG mRNA	PMID:30196065
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ESRRG mRNA	PMID:26496021
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:165198	Bisphenol Z	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20250114	CTD	MESH:C517113	bisphenol Z inhibits the reaction [bisphenol A binds to ESRRG protein]	PMID:31195007
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1551381	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ESRRG mRNA	PMID:33711761
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ESRRG gene	PMID:27618143
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:167172	4-isopropylphenol	affects binding	ISO	RGD:1349366	E	RGD:6480464	20210202	CTD	MESH:C028690	4-isopropylphenol binds to ESRRG protein	PMID:27486708
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:167172	4-isopropylphenol	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20210202	CTD	MESH:C028690	4-isopropylphenol binds to and results in increased activity of ESRRG protein; 4-isopropylphenol inhibits the reaction [afimoxifene binds to and results in decreased activity of ESRRG protein]	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1349366	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ESRRG mRNA	PMID:21179406
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:17574	biochanin A	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:C004541	biochanin A promotes the reaction [ESRRG protein binds to PNRC1 protein]	PMID:14638870
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551381	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ESRRG mRNA	PMID:36331819
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:191854	arachidonyl-2'-chloroethylamide	increases expression	EXP		E	RGD:6480464	20220614	CTD	MESH:C119325	arachidonyl-2-chloroethylamide results in increased expression of ESRRG mRNA	PMID:27455076
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:191854	arachidonyl-2'-chloroethylamide	increases expression	ISO	RGD:1349366	E	RGD:6480464	20220614	CTD	MESH:C119325	arachidonyl-2-chloroethylamide results in increased expression of ESRRG mRNA	PMID:31912162
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:191854	arachidonyl-2'-chloroethylamide	increases expression	ISO	RGD:1551381	E	RGD:6480464	20220614	CTD	MESH:C119325	arachidonyl-2-chloroethylamide results in increased expression of ESRRG mRNA; arachidonyl-2-chloroethylamide results in increased expression of ESRRG protein	PMID:27455076|PMID:30019168|PMID:31912162
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:191854	arachidonyl-2'-chloroethylamide	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20220614	CTD	MESH:C119325	ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLA mRNA]; ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLB mRNA]; ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of FGF21 mRNA]	PMID:27455076|PMID:31912162
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:191854	arachidonyl-2'-chloroethylamide	multiple interactions	ISO	RGD:1551381	E	RGD:6480464	20220614	CTD	MESH:C119325	arachidonyl-2-chloroethylamide promotes the reaction [ESRRG protein binds to DAGLA promoter]; arachidonyl-2-chloroethylamide promotes the reaction [ESRRG protein binds to DAGLB promoter]; arachidonyl-2-chloroethylamide promotes the reaction [ESRRG protein binds to FGF21 promoter]; CNR1 protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of ESRRG mRNA]; ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLA mRNA]; ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLA protein]; ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLA]; ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLB mRNA]; ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLB]; ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of FGF21 mRNA]; ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased secretion of FGF21 protein]	PMID:27455076|PMID:31912162
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:22977	cadmium atom	affects localization	ISO	RGD:1349366	E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium affects the localization of ESRRG protein	PMID:39507056
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium promotes the reaction [ESRRG protein alternative form binds to G6PC1 enhancer]; Cadmium promotes the reaction [ESRRG protein alternative form binds to PDK4 enhancer]; Cadmium promotes the reaction [ESRRG protein alternative form binds to PEPCK1 enhancer]; Cadmium promotes the reaction [ESRRG protein alternative form binds to SLC2A2 enhancer]; Cadmium promotes the reaction [ESRRG protein binds to G6PC1 enhancer]; Cadmium promotes the reaction [ESRRG protein binds to PDK4 enhancer]; Cadmium promotes the reaction [ESRRG protein binds to SLC2A2 enhancer]	PMID:39507056
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:22984	calcium atom	affects localization	ISO	RGD:1349366	E	RGD:6480464	20251202	CTD	MESH:D002118	Calcium affects the localization of ESRRG protein	PMID:39507056
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:22984	calcium atom	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20251202	CTD	MESH:D002118	Calcium promotes the reaction [ESRRG protein alternative form binds to G6PC1 enhancer]; Calcium promotes the reaction [ESRRG protein alternative form binds to PDK4 enhancer]; Calcium promotes the reaction [ESRRG protein alternative form binds to PEPCK1 enhancer]; Calcium promotes the reaction [ESRRG protein alternative form binds to SLC2A2 enhancer]; Calcium promotes the reaction [ESRRG protein binds to G6PC1 enhancer]; Calcium promotes the reaction [ESRRG protein binds to PDK4 enhancer]; Calcium promotes the reaction [ESRRG protein binds to PEPCK1 enhancer]; Calcium promotes the reaction [ESRRG protein binds to SLC2A2 enhancer]	PMID:39507056
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ESRRG protein	PMID:20106945
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1349366	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ESRRG gene	PMID:27153756
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1349366	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ESRRG intron	PMID:30157460
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ESRRG mRNA	PMID:31150632
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551381	E	RGD:6480464	20211109	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ESRRG mRNA; Carbon Tetrachloride results in increased expression of ESRRG protein	PMID:34191077
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ESRRG mRNA]	PMID:31150632
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1551381	E	RGD:6480464	20211109	CTD	MESH:D002251	ESRRG protein affects the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA]; ESRRG protein affects the reaction [Carbon Tetrachloride results in increased expression of COL1A1 mRNA]; ESRRG protein affects the reaction [Carbon Tetrachloride results in increased expression of PDGFRB mRNA]; ESRRG protein affects the reaction [Carbon Tetrachloride results in increased expression of TGFB2 mRNA]; ESRRG protein affects the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]; ESRRG protein affects the reaction [Carbon Tetrachloride results in increased secretion of TGFB2 protein]; GSK5182 inhibits the reaction [Carbon Tetrachloride results in increased expression of ESRRG mRNA]	PMID:34191077
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551381	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ESRRG mRNA	PMID:25629700
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1349366	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ESRRG gene	PMID:25304211
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRRG mRNA	PMID:27188386
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of ESRRG gene	PMID:31011160
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1551381	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ESRRG mRNA	PMID:28960355
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein inhibits the reaction [bisphenol A results in increased expression of ESRRG mRNA]; Genistein inhibits the reaction [bisphenol A results in increased expression of ESRRG protein]; Genistein promotes the reaction [ESRRG protein binds to PNRC1 protein]	PMID:14638870|PMID:32963737
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ESRRG mRNA	PMID:24768652|PMID:25583101
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ESRRG mRNA	PMID:22298810
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551381	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ESRRG mRNA	PMID:26377647|PMID:28922406
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ESRRG mRNA	PMID:32109520
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551381	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ESRRG mRNA	PMID:24058054
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551381	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ESRRG mRNA	PMID:26290441|PMID:37172768
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551381	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of ESRRG mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ESRRG promoter]	PMID:16214954|PMID:19654925
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:C004742	daidzein inhibits the reaction [bisphenol A results in increased expression of ESRRG mRNA]; daidzein inhibits the reaction [bisphenol A results in increased expression of ESRRG protein]; daidzein promotes the reaction [ESRRG protein binds to PNRC1 protein]	PMID:14638870|PMID:32963737
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ESRRG mRNA	PMID:28001369
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ESRRG mRNA	PMID:33212167
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1349366	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of ESRRG mRNA	PMID:39709020
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ESRRG mRNA	PMID:29803840
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:29320	calcium(0)	affects localization	ISO	RGD:1349366	E	RGD:6480464	20251202	CTD	MESH:D002118	Calcium affects the localization of ESRRG protein	PMID:39507056
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:29320	calcium(0)	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20251202	CTD	MESH:D002118	Calcium promotes the reaction [ESRRG protein alternative form binds to G6PC1 enhancer]; Calcium promotes the reaction [ESRRG protein alternative form binds to PDK4 enhancer]; Calcium promotes the reaction [ESRRG protein alternative form binds to PEPCK1 enhancer]; Calcium promotes the reaction [ESRRG protein alternative form binds to SLC2A2 enhancer]; Calcium promotes the reaction [ESRRG protein binds to G6PC1 enhancer]; Calcium promotes the reaction [ESRRG protein binds to PDK4 enhancer]; Calcium promotes the reaction [ESRRG protein binds to PEPCK1 enhancer]; Calcium promotes the reaction [ESRRG protein binds to SLC2A2 enhancer]	PMID:39507056
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1349366	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ESRRG gene	PMID:28589171
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ESRRG mRNA	PMID:22378314
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349366	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ESRRG 5' UTR; Benzo(a)pyrene affects the methylation of ESRRG exon; Benzo(a)pyrene affects the methylation of ESRRG intron; Benzo(a)pyrene affects the methylation of ESRRG promoter	PMID:27901495|PMID:30157460
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ESRRG mRNA	PMID:20106945|PMID:32234424
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1551381	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ESRRG 3' UTR; Benzo(a)pyrene results in increased methylation of ESRRG exon; Benzo(a)pyrene results in increased methylation of ESRRG intron	PMID:27901495
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551381	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene affects the reaction [AHR protein binds to ESRRG promoter]	PMID:19654925
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1349366	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ESRRG mRNA	PMID:20458559
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:31575	ethylparaben	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20141111	CTD	MESH:C012313	ethyl-p-hydroxybenzoate inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]	PMID:23583298
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:31832	methyl salicylate	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20140211	CTD	MESH:C033069	methyl salicylate inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]	PMID:23583298
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:31835	methylparaben	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20140415	CTD	MESH:C015358	methylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]	PMID:23583298
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:31991	phenol red	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20200519	CTD	MESH:D010637	[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] inhibits the reaction [ESRRG protein binds to GJA1 protein binds to SNAI1 protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] inhibits the reaction [ESRRG protein binds to GJA1 protein binds to SNAI1 protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of ESRRG protein	PMID:31629898
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:32063	propylparaben	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20140211	CTD	MESH:C006068	propylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]	PMID:23583298
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ESRRG mRNA	PMID:34492290
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551381	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ESRRG mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ESRRG mRNA	PMID:19710929
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	affects binding	ISO	RGD:1349366	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A analog binds to ESRRG protein; bisphenol A binds to ESRRG protein	PMID:17761695|PMID:17964775|PMID:18005256|PMID:18197296|PMID:18582436|PMID:19304792|PMID:20542892|PMID:22298789|PMID:22935422|PMID:24978476|PMID:31195007
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ESRRG mRNA	PMID:32145629
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1349366	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A affects the expression of ESRRG mRNA; bisphenol A affects the expression of ESRRG protein	PMID:35220427
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1551381	E	RGD:6480464	20140812	CTD	MESH:C006780	bisphenol A affects the expression of ESRRG mRNA	PMID:23716699
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1349366	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of ESRRG gene	PMID:31601247
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1551381	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ESRRG promoter	PMID:27334623
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of ESRRG mRNA; bisphenol A results in decreased expression of ESRRG protein	PMID:24105817
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ESRRG mRNA	PMID:25181051|PMID:30580332
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1349366	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ESRRG mRNA; bisphenol A results in increased expression of ESRRG protein	PMID:22121209|PMID:25878060|PMID:26363202|PMID:27038254|PMID:30022450|PMID:32963737
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551381	E	RGD:6480464	20141223	CTD	MESH:C006780	bisphenol A results in increased expression of ESRRG mRNA	PMID:21123812|PMID:22707478|PMID:25111128|PMID:30149043|PMID:30196065
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ESRRG gene	PMID:28505145
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	increases response to substance	EXP		E	RGD:6480464	20120515	CTD	MESH:C006780	ESRRG protein results in increased susceptibility to bisphenol A	PMID:22281313
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ESRRG mRNA; afimoxifene inhibits the reaction [bisphenol A binds to and results in increased activity of ESRRG protein]; bisphenol A binds to and results in increased activity of ESRRG protein; bisphenol A inhibits the reaction [Dietary Fats results in increased expression of ESRRG mRNA]	PMID:23645310|PMID:26496021|PMID:30580332
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:C006780	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of ESRRG mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of ESRRG protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of ESRRG mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of ESRRG protein]; 4,4'-bisphenol F inhibits the reaction [bisphenol A binds to ESRRG protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] inhibits the reaction [ESRRG protein binds to GJA1 protein binds to SNAI1 protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] inhibits the reaction [ESRRG protein binds to GJA1 protein binds to SNAI1 protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of ESRRG protein; bisphenol A binds to and results in increased activity of ESRRG protein; bisphenol A inhibits the reaction [afimoxifene binds to and results in decreased activity of ESRRG protein]; bisphenol A inhibits the reaction [afimoxifene binds to ESRRG protein]; bisphenol A inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]; bisphenol A inhibits the reaction [afimoxifene results in decreased activity of ESRRG protein]; bisphenol A inhibits the reaction [Tamoxifen results in decreased expression of ESRRG mRNA]; bisphenol A results in increased expression of and affects the localization of ESRRG protein; bisphenol S inhibits the reaction [bisphenol A binds to ESRRG protein]; bisphenol Z inhibits the reaction [bisphenol A binds to ESRRG protein]; daidzein inhibits the reaction [bisphenol A results in increased expression of ESRRG mRNA]; daidzein inhibits the reaction [bisphenol A results in increased expression of ESRRG protein]; ESRRG protein affects the reaction [bisphenol A results in increased expression of MMP2 mRNA]; ESRRG protein affects the reaction [bisphenol A results in increased expression of MMP2 protein]; ESRRG protein affects the reaction [bisphenol A results in increased expression of MMP9 mRNA]; ESRRG protein affects the reaction [bisphenol A results in increased expression of MMP9 protein]; Genistein inhibits the reaction [bisphenol A results in increased expression of ESRRG mRNA]; Genistein inhibits the reaction [bisphenol A results in increased expression of ESRRG protein]	PMID:17964775|PMID:18197296|PMID:20427257|PMID:23583298|PMID:26363202|PMID:27038254|PMID:30467747|PMID:30951782|PMID:31127318|PMID:31195007|PMID:31629898|PMID:32963737
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1551381	E	RGD:6480464	20190219	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of ESRRG mRNA	PMID:30496566
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1349366	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ESRRG mRNA	PMID:25979313
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	affects binding	ISO	RGD:1349366	E	RGD:6480464	20200804	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane binds to ESRRG protein	PMID:32278787
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20191112	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane binds to and results in increased activity of ESRRG protein; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [afimoxifene binds to and results in decreased activity of ESRRG protein]	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1551381	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ESRRG mRNA	PMID:26682919
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ESRRG mRNA	PMID:23196670
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1551381	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ESRRG mRNA	PMID:39298647
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551381	E	RGD:6480464	20141223	CTD	MESH:C543008	bisphenol S results in decreased expression of ESRRG mRNA	PMID:25111128|PMID:33297965
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1551381	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ESRRG promoter	PMID:33297965
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1349366	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased expression of ESRRG mRNA	PMID:32155818
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551381	E	RGD:6480464	20181113	CTD	MESH:C543008	bisphenol S results in increased expression of ESRRG mRNA	PMID:30196065|PMID:30951980
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20191008	CTD	MESH:C543008	bisphenol S inhibits the reaction [bisphenol A binds to ESRRG protein]	PMID:31195007
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34395	4-chloro-m-cresol	affects binding	ISO	RGD:1349366	E	RGD:6480464	20141111	CTD	MESH:C006984	chlorocresol binds to ESRRG protein	PMID:17964775
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34395	4-chloro-m-cresol	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20141111	CTD	MESH:C006984	chlorocresol inhibits the reaction [afimoxifene binds to ESRRG protein]	PMID:17964775
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34444	4-tert-butylphenol	increases activity	ISO	RGD:1349366	E	RGD:6480464	20191112	CTD	MESH:C006862	butylphen results in increased activity of ESRRG protein	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34445	4-tert-Octylphenol	increases activity	ISO	RGD:1349366	E	RGD:6480464	20191112	CTD	MESH:C105260	4-tert-octylphenol results in increased activity of ESRRG protein	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34448	5,6,7,8-tetrahydro-2-naphthol	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20191112	CTD	MESH:C043496	5,6,7,8-tetrahydro-2-naphthol binds to and results in increased activity of ESRRG protein; 5,6,7,8-tetrahydro-2-naphthol inhibits the reaction [afimoxifene binds to and results in decreased activity of ESRRG protein]	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1349366	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ESRRG intron	PMID:30157460
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1551381	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of ESRRG mRNA	PMID:26377693
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34571	Benzyl parahydroxybenzoate	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20141111	CTD	MESH:C057775	benzylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]	PMID:23583298
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34575	bisphenol F	increases activity	ISO	RGD:1349366	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased activity of ESRRG protein	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551381	E	RGD:6480464	20181113	CTD	MESH:C008745	4,4'-bisphenol F results in increased expression of ESRRG mRNA	PMID:30196065
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20191008	CTD	MESH:C008745	4,4'-bisphenol F inhibits the reaction [bisphenol A binds to ESRRG protein]	PMID:31195007
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34581	Bisphenol B	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20191112	CTD	MESH:C492482	bisphenol B binds to and results in increased activity of ESRRG protein	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1551381	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ESRRG intron	PMID:28392331
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:34761	fenthion	increases activity	ISO	RGD:1349366	E	RGD:6480464	20120717	CTD	MESH:D005284	Fenthion results in increased activity of ESRRG protein	PMID:20143881
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:35096	p-tert-Amylphenol	increases activity	ISO	RGD:1349366	E	RGD:6480464	20191114	CTD	MESH:C019566	4-tert-octylphenol results in increased activity of ESRRG protein	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ESRRG gene	PMID:22079235
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1551381	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ESRRG mRNA	PMID:39529242
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551381	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ESRRG mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ESRRG mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ESRRG mRNA	PMID:36331819
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349366	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ESRRG mRNA	PMID:25979313
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1349366	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ESRRG gene	PMID:29154799
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349366	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ESRRG mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRRG mRNA	PMID:27188386
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ESRRG mRNA	PMID:20106945
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:41774	tamoxifen	affects binding	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen binds to ESRRG protein	PMID:11447273
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20191210	CTD	MESH:D013629	Tamoxifen results in decreased expression of ESRRG mRNA	PMID:30467747
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:D013629	bisphenol A inhibits the reaction [Tamoxifen results in decreased expression of ESRRG mRNA]; Tamoxifen binds to and affects the activity of ESRRG protein; Tamoxifen inhibits the reaction [PPARGC1A protein binds to ESRRG protein]	PMID:16889744|PMID:30467747
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:41922	diethylstilbestrol	affects binding	ISO	RGD:1349366	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol binds to ESRRG protein	PMID:11447273|PMID:17049190
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1551381	E	RGD:6480464	20130416	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ESRRG mRNA	PMID:22710028
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol binds to and affects the activity of ESRRG protein; Diethylstilbestrol binds to and results in decreased activity of ESRRG protein; Diethylstilbestrol binds to and results in increased activity of ESRRG protein; Diethylstilbestrol inhibits the reaction [ESRRG protein results in increased expression of TFF1 mRNA]	PMID:11559547|PMID:12579585|PMID:14751226|PMID:16889744
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	ISO	RGD:1551381	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol binds to and results in decreased activity of ESRRG protein; Diethylstilbestrol binds to and results in increased activity of ESRRG protein	PMID:12579585|PMID:15161930
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551381	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ESRRG mRNA	PMID:28973697
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:44616	afimoxifene	affects binding	ISO	RGD:1349366	E	RGD:6480464	20130122	CTD	MESH:C016601	afimoxifene binds to ESRRG protein	PMID:17964775|PMID:20542892
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:44616	afimoxifene	decreases activity	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased activity of ESRRG protein	PMID:15149736|PMID:30951782
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:C016601	afimoxifene binds to and results in decreased activity of ESRRG protein; afimoxifene inhibits the reaction [bisphenol A binds to and results in increased activity of ESRRG protein]	PMID:23645310
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:C016601	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [afimoxifene binds to and results in decreased activity of ESRRG protein]; 4-isopropylphenol inhibits the reaction [afimoxifene binds to and results in decreased activity of ESRRG protein]; 5,6,7,8-tetrahydro-2-naphthol inhibits the reaction [afimoxifene binds to and results in decreased activity of ESRRG protein]; afimoxifene binds to and affects the activity of ESRRG protein; afimoxifene binds to and results in decreased activity of [ESRRG protein binds to ESRRA protein]; afimoxifene binds to and results in decreased activity of ESRRG protein; afimoxifene inhibits the reaction [ESRRG protein binds to NCOA1 protein]; afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]; afimoxifene inhibits the reaction [PPARGC1A protein binds to ESRRG protein]; benzylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]; bisphenol A inhibits the reaction [afimoxifene binds to and results in decreased activity of ESRRG protein]; bisphenol A inhibits the reaction [afimoxifene binds to ESRRG protein]; bisphenol A inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]; bisphenol A inhibits the reaction [afimoxifene results in decreased activity of ESRRG protein]; butylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]; chlorocresol inhibits the reaction [afimoxifene binds to ESRRG protein]; ethyl salicylate inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]; ethyl-p-hydroxybenzoate inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]; methyl salicylate inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]; methylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]; N'-((1E)-(4-(diethylamino)phenyl)methylene)-4-hydroxybenzohydrazide inhibits the reaction [afimoxifene results in decreased activity of ESRRG protein]; propylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]	PMID:11447273|PMID:14751226|PMID:16889744|PMID:17049190|PMID:17964775|PMID:18197296|PMID:23583298|PMID:30951782|PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1551381	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene binds to and results in decreased activity of ESRRG protein	PMID:15161930
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ESRRG mRNA	PMID:38832940
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1349366	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ESRRG mRNA	PMID:26272509
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRRG mRNA	PMID:27188386
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:46024	trichostatin A	increases activity	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in increased activity of ESRRG protein	PMID:11705994
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1349366	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ESRRG mRNA	PMID:24935251
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551381	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ESRRG mRNA	PMID:17562736
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of ESRRG mRNA	PMID:32479839
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ESRRG mRNA	PMID:29067470
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ESRRG mRNA	PMID:24714768
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1349366	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of ESRRG mRNA	PMID:17331233
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1349366	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of ESRRG 5' UTR	PMID:29523930
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1349366	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ESRRG gene	PMID:25304211
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of ESRRG mRNA	PMID:29391264
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1551381	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ESRRG mRNA	PMID:35436446
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1349366	E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in increased expression of ESRRG mRNA	PMID:23527032
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ESRRG mRNA	PMID:32234424
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:49584	4-ethylphenol	increases activity	ISO	RGD:1349366	E	RGD:6480464	20191112	CTD	MESH:C042291	4-ethylphenol results in increased activity of ESRRG protein	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1349366	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ESRRG mRNA	PMID:20458559
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551381	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ESRRG mRNA; Nanotubes, Carbon results in decreased expression of ESRRG mRNA	PMID:25554681|PMID:25620056
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:52392	2-arachidonoylglycerol	increases abundance	ISO	RGD:1349366	E	RGD:6480464	20200804	CTD	MESH:C094503	ESRRG protein results in increased abundance of glyceryl 2-arachidonate	PMID:31912162
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:52392	2-arachidonoylglycerol	increases abundance	ISO	RGD:1551381	E	RGD:6480464	20200804	CTD	MESH:C094503	ESRRG protein results in increased abundance of glyceryl 2-arachidonate	PMID:31912162
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1551381	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of ESRRG mRNA	PMID:19042947
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ESRRG mRNA	PMID:22079614
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20160607	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of ESRRG mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of ESRRG protein]	PMID:27038254
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1349366	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ESRRG intron	PMID:30157460
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ESRRG gene	PMID:35440735
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1349366	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in increased expression of ESRRG mRNA	PMID:30559759
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRRG mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRRG mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRRG mRNA	PMID:27188386
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ESRRG gene]	PMID:28238834
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:80000	GSK 4716	increases activity	ISO	RGD:1349366	E	RGD:6480464	20191112	CTD	MESH:C545235	GSK 4716 results in increased activity of ESRRG protein	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:80774	tauroursodeoxycholic acid	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20190910	CTD	MESH:C031655	ursodoxicoltaurine inhibits the reaction [Dronabinol results in increased expression of ESRRG mRNA]	PMID:31054322
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ESRRG mRNA	PMID:32109520
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:88542	Butylparaben	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]	PMID:23583298
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:88839	Ethyl salicylate	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20151103	CTD	MESH:C041835	ethyl salicylate inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]	PMID:23583298
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:89188	2,4-di-tert-butylphenol	increases activity	ISO	RGD:1349366	E	RGD:6480464	20191112	CTD	MESH:C056559	2,4-di-tert-butylphenol results in increased activity of ESRRG protein	PMID:31127318
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349366	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRRG mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRRG mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRRG mRNA	PMID:27188386
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1349366	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ESRRG mRNA	PMID:17440010
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1349366	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of ESRRG mRNA	PMID:22378314
1303236	Esrrg	estrogen-related receptor gamma	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ESRRG mRNA	PMID:19015723
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ABHD5 mRNA	PMID:19074003
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1551382	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ABHD5 mRNA	PMID:22629407
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1551382	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ABHD5 mRNA]	PMID:22629407
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1551382	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ABHD5 mRNA	PMID:30319688
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1342875	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of ABHD5 mRNA	PMID:21632981
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ABHD5 mRNA	PMID:32145629
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1342875	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ABHD5 mRNA	PMID:38568856
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ABHD5 mRNA	PMID:33387578
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1342875	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ABHD5 mRNA	PMID:37042841
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1342875	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ABHD5 mRNA	PMID:23649840
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1342875	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of ABHD5 mRNA	PMID:20864642
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1342875	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ABHD5 mRNA	PMID:22017230
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ABHD5 mRNA	PMID:27523638
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ABHD5 mRNA	PMID:33387578
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1342875	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ABHD5 mRNA	PMID:28818685
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1342875	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of ABHD5 protein	PMID:28860664
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABHD5 mRNA	PMID:35301059
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1342875	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ABHD5 mRNA	PMID:19549813
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1342875	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ABHD5 mRNA	PMID:23649840
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1342875	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ABHD5 gene	PMID:27153756
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1342875	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABHD5 mRNA	PMID:22100608
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551382	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABHD5 mRNA	PMID:19770486
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1342875	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ABHD5 mRNA	PMID:23649840
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ABHD5 mRNA	PMID:41430723
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551382	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ABHD5 mRNA	PMID:25629700
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551382	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABHD5 mRNA	PMID:22206623
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1551382	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ABHD5 mRNA	PMID:28960355
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ABHD5 mRNA	PMID:31881176
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1342875	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ABHD5 mRNA	PMID:23300844
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of ABHD5 mRNA	PMID:22023808
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ABHD5 mRNA	PMID:27392435
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1342875	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ABHD5 mRNA	PMID:24768652
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551382	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABHD5 mRNA	PMID:21570461
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551382	E	RGD:6480464	20170613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ABHD5 mRNA	PMID:28238261
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABHD5 mRNA	PMID:34747641
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1342875	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABHD5 mRNA	PMID:19684285
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551382	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABHD5 mRNA	PMID:15328365|PMID:19684285
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551382	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ABHD5 mRNA	PMID:25975270
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1342875	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ABHD5 mRNA	PMID:28001369
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1342875	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ABHD5 mRNA; aristolochic acid I results in increased expression of ABHD5 protein	PMID:33212167
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1342875	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD5 mRNA	PMID:30851411
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1342875	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ABHD5 mRNA	PMID:32763439
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1551382	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of ABHD5 mRNA	PMID:30807115
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1342875	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABHD5 mRNA	PMID:29803840
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1342875	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ABHD5 mRNA	PMID:20044591
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1342875	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ABHD5 gene	PMID:28589171
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1342875	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ABHD5 mRNA	PMID:38568856|PMID:39719251
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551382	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ABHD5 mRNA	PMID:22228805
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1342875	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABHD5 mRNA	PMID:21632981|PMID:22316170|PMID:26238291
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551382	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABHD5 mRNA	PMID:19770486|PMID:21715664
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ABHD5 mRNA	PMID:22431001
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1342875	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ABHD5 mRNA	PMID:20018196
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1551382	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ABHD5 mRNA	PMID:39716349
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ABHD5 protein]	PMID:26598702
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ABHD5 mRNA	PMID:30047161
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551382	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABHD5 gene	PMID:35295148
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ABHD5 mRNA	PMID:23411599
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551382	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ABHD5 mRNA	PMID:23811191
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ABHD5 mRNA	PMID:19710929
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ABHD5 mRNA	PMID:32145629|PMID:35192832
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD5 mRNA	PMID:25181051
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551382	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD5 mRNA	PMID:34585602
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1342875	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ABHD5 gene	PMID:31601247
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA	PMID:28628672
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ABHD5 mRNA	PMID:23196670
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551382	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ABHD5 mRNA	PMID:39298647
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ABHD5 mRNA	PMID:28628672
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1342875	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ABHD5 protein	PMID:34186270
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ABHD5 mRNA	PMID:21241498
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ABHD5 mRNA	PMID:28628672
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1551382	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ABHD5 mRNA	PMID:24535843
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1342875	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABHD5 mRNA	PMID:37042841
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ABHD5 mRNA	PMID:30589522
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35176	zinc sulfate	decreases expression	ISO	RGD:1342875	E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of ABHD5 mRNA	PMID:16330358
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1551382	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of ABHD5 mRNA	PMID:26377693
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of ABHD5 mRNA	PMID:22110744
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1342875	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ABHD5 mRNA	PMID:38174414|PMID:38568856
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABHD5 mRNA	PMID:35301059
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551382	E	RGD:6480464	20140114	CTD	MESH:D019256	[MT1 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in increased expression of ABHD5 mRNA; [MT2 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in increased expression of ABHD5 mRNA	PMID:23921151
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1551382	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of ABHD5 mRNA	PMID:24183702
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ABHD5 mRNA	PMID:30047161
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ABHD5 mRNA	PMID:24386269
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1551382	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of ABHD5 mRNA	PMID:17585979
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1342875	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ABHD5 mRNA	PMID:28302478
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551382	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ABHD5 mRNA	PMID:36331819
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1342875	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABHD5 mRNA	PMID:25979313
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1342875	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ABHD5 mRNA; Valproic Acid results in decreased expression of ABHD5 protein	PMID:25716160|PMID:29501571
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1342875	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ABHD5 mRNA	PMID:23179753|PMID:26272509
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD5 mRNA	PMID:27188386
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ABHD5 mRNA	PMID:30047161
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1342875	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ABHD5 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1342875	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of ABHD5 mRNA	PMID:25047013
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ABHD5 mRNA	PMID:28628672
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1551382	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ABHD5 mRNA	PMID:28973697
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1342875	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ABHD5 mRNA	PMID:38832940
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551382	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ABHD5 mRNA	PMID:17562736
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABHD5 mRNA	PMID:33387578
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1342875	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ABHD5 mRNA	PMID:21420995
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1551382	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of ABHD5 mRNA	PMID:29279043
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ABHD5 mRNA	PMID:28628672
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1551382	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ABHD5 mRNA	PMID:39716349
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ABHD5 protein]	PMID:26598702
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1342875	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ABHD5 mRNA	PMID:23300844
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551382	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ABHD5 mRNA; Nanotubes, Carbon results in increased expression of ABHD5 mRNA	PMID:25554681
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ABHD5 mRNA	PMID:30047161
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1342875	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of ABHD5 mRNA	PMID:31629900
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1342875	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of ABHD5 mRNA	PMID:20436886
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of ABHD5 mRNA	PMID:20080153
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1551382	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ABHD5 mRNA	PMID:23650126
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:6443	levonorgestrel	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ABHD5 mRNA	PMID:19074003
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of ABHD5 mRNA	PMID:30467583
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1342875	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ABHD5 protein	PMID:34186270
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1551382	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ABHD5 mRNA	PMID:22206623
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551382	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABHD5 mRNA	PMID:22206623
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1342875	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD5 mRNA	PMID:30851411
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD5 mRNA	PMID:27188386
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1342875	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ABHD5 mRNA	PMID:19159669
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551382	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ABHD5 mRNA	PMID:23091169
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of ABHD5 mRNA	PMID:20345932
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1551382	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of ABHD5 mRNA	PMID:30953684
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1551382	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of ABHD5 mRNA	PMID:21278054
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ABHD5 mRNA	PMID:30047161
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1342875	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of ABHD5 mRNA	PMID:14699072
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1342875	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD5 mRNA	PMID:27188386
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1342875	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ABHD5 mRNA	PMID:38568856
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1551382	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of ABHD5 mRNA	PMID:32835833
1303237	Abhd5	abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ABHD5 mRNA	PMID:23034163
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ATP6V0E2 mRNA	PMID:38218311
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP6V0E2 mRNA	PMID:20938992
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550183	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ATP6V0E2 mRNA	PMID:30319688
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ATP6V0E2 mRNA	PMID:30319688
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ATP6V0E2 mRNA	PMID:32145629
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550183	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ATP6V0E2 mRNA	PMID:39298647
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ATP6V0E2 mRNA	PMID:30165855
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP6V0E2 mRNA	PMID:20938992
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606137	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATP6V0E2 mRNA	PMID:37042841
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP6V0E2 mRNA	PMID:37992649
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP6V0E2 mRNA	PMID:37992649
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550183	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATP6V0E2 mRNA	PMID:33754040
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ATP6V0E2 mRNA	PMID:28818685
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ATP6V0E2 mRNA	PMID:39836092
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1550183	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of ATP6V0E2 mRNA	PMID:27462272
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ATP6V0E2 mRNA	PMID:19549813
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1606137	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ATP6V0E2 protein	PMID:20106945
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ATP6V0E2 mRNA	PMID:27153756
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550183	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ATP6V0E2 mRNA	PMID:19770486
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ATP6V0E2 mRNA	PMID:34911549
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP6V0E2 mRNA	PMID:20938992
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATP6V0E2 mRNA	PMID:40504410
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ATP6V0E2 mRNA	PMID:32525701
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ATP6V0E2 mRNA	PMID:31881176
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP6V0E2 mRNA	PMID:23557933
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606137	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ATP6V0E2 mRNA	PMID:27392435
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ATP6V0E2 mRNA	PMID:27392435
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1550183	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of ATP6V0E2 mRNA	PMID:34813904
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550183	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATP6V0E2 mRNA	PMID:24680724
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1606137	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATP6V0E2 mRNA	PMID:22298810
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1606137	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATP6V0E2 mRNA	PMID:20106945|PMID:21632981
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1606137	E	RGD:6480464	20200519	CTD	MESH:D012402	Rotenone results in increased expression of ATP6V0E2 mRNA	PMID:31648047
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ATP6V0E2 mRNA	PMID:28001369
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ATP6V0E2 mRNA	PMID:32763439
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ATP6V0E2 mRNA	PMID:20971185
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550183	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATP6V0E2 mRNA	PMID:39631538
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATP6V0E2 mRNA	PMID:29803840
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP6V0E2 mRNA	PMID:37992649
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of ATP6V0E2 mRNA	PMID:22623647
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATP6V0E2 mRNA	PMID:38568856
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606137	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of ATP6V0E2 mRNA	PMID:28595984|PMID:34032870|PMID:39719251
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATP6V0E2 mRNA	PMID:40504410
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606137	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATP6V0E2 promoter	PMID:27901495
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATP6V0E2 mRNA	PMID:32234424
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1606137	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATP6V0E2 mRNA	PMID:20106945|PMID:21632981
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ATP6V0E2 mRNA	PMID:20971185
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ATP6V0E2 mRNA	PMID:25351596
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of ATP6V0E2 mRNA	PMID:34408198
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ATP6V0E2 mRNA	PMID:30047161
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550183	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of ATP6V0E2 mRNA	PMID:27760801
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ATP6V0E2 mRNA	PMID:34492290
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550183	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ATP6V0E2 mRNA	PMID:17426115
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ATP6V0E2 mRNA	PMID:19167457
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1606137	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ATP6V0E2 mRNA	PMID:30903817
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP6V0E2 mRNA	PMID:25181051
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1606137	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATP6V0E2 gene	PMID:31601247
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1606137	E	RGD:6480464	20120501	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ATP6V0E2 mRNA	PMID:19692669
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550183	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ATP6V0E2 mRNA	PMID:38685157
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1550183	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ATP6V0E2 mRNA	PMID:28392331
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ATP6V0E2 mRNA	PMID:21266533
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:34785	heptachlor	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D006533	Heptachlor results in decreased expression of ATP6V0E2 mRNA	PMID:23153324
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ATP6V0E2 mRNA	PMID:19638242
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1550183	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased expression of ATP6V0E2 mRNA	PMID:21371552
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ATP6V0E2 mRNA	PMID:39836092
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATP6V0E2 mRNA	PMID:38568856
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of ATP6V0E2 mRNA	PMID:26194646
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1550183	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of ATP6V0E2 mRNA	PMID:24183702
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ATP6V0E2 mRNA	PMID:32588087
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606137	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATP6V0E2 mRNA	PMID:25979313
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606137	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ATP6V0E2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1606137	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ATP6V0E2 gene	PMID:29154799
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0E2 mRNA	PMID:27188386
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ATP6V0E2 mRNA	PMID:30047161
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATP6V0E2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1606137	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of ATP6V0E2 promoter	PMID:27989131
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550183	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ATP6V0E2 mRNA	PMID:17555576
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550183	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ATP6V0E2 mRNA	PMID:28973697
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP6V0E2 mRNA	PMID:37992649
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ATP6V0E2 mRNA	PMID:24136188
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ATP6V0E2 mRNA	PMID:38832940
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of ATP6V0E2 mRNA	PMID:21346803
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1606137	E	RGD:6480464	20150825	CTD	MESH:D000082	ATP6V0E2 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATP6V0E2 mRNA	PMID:29067470
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ATP6V0E2 mRNA	PMID:25351596
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATP6V0E2 mRNA	PMID:40504410
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ATP6V0E2 mRNA	PMID:32525701
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1606137	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ATP6V0E2 mRNA	PMID:18175754
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550183	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ATP6V0E2 mRNA	PMID:17555576
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of ATP6V0E2 mRNA	PMID:36868495
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550183	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATP6V0E2 mRNA; Nanotubes, Carbon results in decreased expression of ATP6V0E2 mRNA	PMID:25554681
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ATP6V0E2 mRNA	PMID:30047161
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ATP6V0E2 mRNA	PMID:24136188
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1550183	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of ATP6V0E2 mRNA	PMID:26377693
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ATP6V0E2 mRNA	PMID:39836092
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:63598	levofloxacin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of ATP6V0E2 mRNA	PMID:24136188
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D008694	Methamphetamine results in increased expression of ATP6V0E2 mRNA	PMID:32035215
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:6980	monocrotaline	increases expression	ISO	RGD:1550183	E	RGD:6480464	20171114	CTD	MESH:D016686	Monocrotaline results in increased expression of ATP6V0E2 mRNA	PMID:28818515
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550183	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ATP6V0E2 mRNA	PMID:22206623
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ATP6V0E2 mRNA	PMID:21346803
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0E2 mRNA	PMID:27188386
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550183	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ATP6V0E2 mRNA	PMID:19482888
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1550183	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ATP6V0E2 mRNA]	PMID:19482888
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ATP6V0E2 mRNA	PMID:32525701
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of ATP6V0E2 mRNA	PMID:30047161
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606137	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0E2 mRNA	PMID:27188386
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ATP6V0E2 mRNA	PMID:19281266
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ATP6V0E2 mRNA	PMID:21346803
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1606137	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ATP6V0E2 mRNA	PMID:38568856
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:9763	trovafloxacin	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of ATP6V0E2 mRNA	PMID:24136188
1303238	Atp6v0e2	ATPase, H+ transporting V0 subunit e2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1550183	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of ATP6V0E2 mRNA	PMID:35537566
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1615141	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DNMT3L mRNA	PMID:37995155
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DNMT3L mRNA	PMID:36189433
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1343645	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DNMT3L mRNA	PMID:20044591
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:16412	lipopolysaccharide	affects expression	ISO	RGD:1615141	E	RGD:6480464	20190702	CTD	MESH:D008070	Lipopolysaccharides affects the expression of DNMT3L mRNA	PMID:30942577
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1343645	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DNMT3L mRNA	PMID:35811015
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DNMT3L mRNA	PMID:35811015
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DNMT3L mRNA	PMID:25510870
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DNMT3L mRNA	PMID:36189433
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D013739	[Testosterone co-treated with vinclozolin] results in decreased expression of DNMT3L mRNA; [Testosterone co-treated with vinclozolin] results in decreased expression of DNMT3L protein; [Testosterone co-treated with vinclozolin] results in increased expression of DNMT3L mRNA	PMID:20056826
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1615141	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNMT3L mRNA	PMID:34319233|PMID:36087924
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1343645	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DNMT3L mRNA	PMID:28818685
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DNMT3L mRNA	PMID:35301059
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DNMT3L mRNA	PMID:25510870
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DNMT3L mRNA	PMID:25510870
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1343645	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of DNMT3L mRNA	PMID:19549813
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1615141	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of DNMT3L mRNA	PMID:19376150
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1343645	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DNMT3L mRNA	PMID:22100608
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA	PMID:33656867
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D014501	Uranium affects the expression of DNMT3L mRNA	PMID:29024790
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNMT3L mRNA	PMID:22206623
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNMT3L mRNA	PMID:32045263
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1615141	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of DNMT3L mRNA	PMID:32186404
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615141	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNMT3L mRNA	PMID:21570461
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNMT3L mRNA	PMID:17942748
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:28216	methylmercury chloride	affects expression	ISO	RGD:1615141	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride affects the expression of DNMT3L mRNA	PMID:21613230
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:28824	stigmasterol	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20181113	CTD	MESH:D013265	[bisphenol A co-treated with Stigmasterol] results in increased expression of DNMT3L mRNA; NR1H4 gene mutant form inhibits the reaction [[bisphenol A co-treated with Stigmasterol] results in increased expression of DNMT3L mRNA]	PMID:30245210
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1615141	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of DNMT3L mRNA	PMID:25270620
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:29191	hydroxyl	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA	PMID:33656867
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343645	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of DNMT3L mRNA	PMID:29301061
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20220208	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNMT3L mRNA	PMID:32045263
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343645	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DNMT3L promoter	PMID:27901495
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1615141	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DNMT3L mRNA	PMID:15894712
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1343645	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNMT3L mRNA	PMID:22316170
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1615141	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNMT3L mRNA	PMID:23735875
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20120412	CTD	MESH:D001564	[arsenite co-treated with Benzo(a)pyrene] results in increased expression of DNMT3L mRNA	PMID:15894712
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1615141	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of DNMT3L mRNA	PMID:15894712
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20120412	CTD	MESH:C015001	[arsenite co-treated with Benzo(a)pyrene] results in increased expression of DNMT3L mRNA	PMID:15894712
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DNMT3L protein]	PMID:26598702
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1343645	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of DNMT3L mRNA	PMID:37690743
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20120515	CTD	MESH:C070081	fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT3L mRNA]	PMID:22131059
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:31767	lead diacetate	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:C008261	lead acetate results in increased methylation of DNMT3L gene	PMID:29571894
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1615141	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of DNMT3L mRNA	PMID:35295148
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1615141	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of DNMT3L mRNA	PMID:23557971
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DNMT3L mRNA	PMID:25181051
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1615141	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in decreased expression of DNMT3L mRNA	PMID:22131059
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20120515	CTD	MESH:C006780	[bisphenol A co-treated with Stigmasterol] results in increased expression of DNMT3L mRNA; Fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT3L mRNA]; NR1H4 gene mutant form inhibits the reaction [[bisphenol A co-treated with Stigmasterol] results in increased expression of DNMT3L mRNA]	PMID:22131059|PMID:30245210
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DNMT3L mRNA	PMID:25510870
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DNMT3L mRNA	PMID:25510870
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein]	PMID:23626723
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein]	PMID:23626723
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1615141	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DNMT3L mRNA	PMID:37019170
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:34631	chlorpyrifos	increases methylation	EXP		E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in increased methylation of DNMT3L gene	PMID:32905263
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of DNMT3L mRNA	PMID:35163327
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein; Wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein]	PMID:23626723
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of DNMT3L promoter	PMID:22457795
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1615141	E	RGD:6480464	20170516	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNMT3L mRNA; Cadmium Chloride results in increased expression of DNMT3L protein	PMID:27984135
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DNMT3L mRNA	PMID:35301059
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1343645	E	RGD:6480464	20120412	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DNMT3L mRNA	PMID:20105288
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1615141	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of DNMT3L mRNA	PMID:29038090
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343645	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DNMT3L mRNA	PMID:25979313
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1343645	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DNMT3L gene	PMID:29154799
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C017160	cypermethrin results in increased expression of DNMT3L mRNA	PMID:35605701
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1615141	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of DNMT3L mRNA	PMID:28973697
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:4610	dimethylselenide	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA	PMID:33656867
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1343645	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of DNMT3L mRNA	PMID:29067470
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DNMT3L mRNA	PMID:35811015
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNMT3L mRNA	PMID:32045263
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1343645	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of DNMT3L mRNA	PMID:40706910
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNMT3L mRNA	PMID:17942748
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DNMT3L protein]	PMID:26598702
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1615141	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DNMT3L mRNA; Nanotubes, Carbon results in increased expression of DNMT3L mRNA	PMID:25554681
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1343645	E	RGD:6480464	20140311	CTD	MESH:C009687	wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3L protein]	PMID:23626723
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DNMT3L mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DNMT3L mRNA	PMID:21641980|PMID:26378955
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1615141	E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol results in increased expression of DNMT3L mRNA	PMID:21542829
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNMT3L mRNA	PMID:22206623
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1615141	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of DNMT3L mRNA	PMID:25566086
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1615141	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of DNMT3L mRNA]	PMID:25566086
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1615141	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of DNMT3L mRNA	PMID:31388691
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1343645	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of DNMT3L mRNA	PMID:30458266
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1615141	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of DNMT3L mRNA	PMID:39847705
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1343645	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of DNMT3L mRNA	PMID:25572481
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1615141	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DNMT3L mRNA	PMID:35537566
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of DNMT3L mRNA; vinclozolin results in decreased expression of DNMT3L protein	PMID:20056826
1303239	Dnmt3l	DNA methyltransferase 3 like	gene	CHEBI:9986	vinclozolin	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	[Testosterone co-treated with vinclozolin] results in decreased expression of DNMT3L mRNA; [Testosterone co-treated with vinclozolin] results in decreased expression of DNMT3L protein; [Testosterone co-treated with vinclozolin] results in increased expression of DNMT3L mRNA	PMID:20056826
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KNSTRN mRNA	PMID:38218311
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614389	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KNSTRN mRNA	PMID:33045310
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KNSTRN mRNA	PMID:39752319
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of KNSTRN mRNA	PMID:33167477
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KNSTRN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KNSTRN mRNA	PMID:32699268
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KNSTRN mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KNSTRN mRNA	PMID:33729688
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614389	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of KNSTRN mRNA	PMID:39241906
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of KNSTRN mRNA	PMID:32145629
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of KNSTRN mRNA	PMID:39298647
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1344647	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of KNSTRN mRNA	PMID:19167446
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNSTRN mRNA	PMID:32741896
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KNSTRN mRNA	PMID:25510870
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1344647	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of KNSTRN mRNA	PMID:38568856
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1614389	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of KNSTRN mRNA	PMID:25549359
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of KNSTRN mRNA	PMID:23649840
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KNSTRN mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KNSTRN mRNA	PMID:37992649
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KNSTRN mRNA	PMID:39752319
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of KNSTRN mRNA	PMID:21592394
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNSTRN mRNA	PMID:32741896
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of KNSTRN mRNA	PMID:21592394
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KNSTRN mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KNSTRN mRNA	PMID:37992649
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of KNSTRN mRNA	PMID:26577399
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1344647	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of KNSTRN protein	PMID:37730182
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of KNSTRN mRNA	PMID:21592394
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of KNSTRN mRNA	PMID:21592394
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KNSTRN mRNA	PMID:33387578
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20150714	CTD	MESH:D002104	Cadmium results in decreased expression of KNSTRN mRNA	PMID:24376830
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KNSTRN mRNA	PMID:25510870
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KNSTRN mRNA	PMID:25510870
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KNSTRN mRNA	PMID:19549813
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KNSTRN mRNA	PMID:22129741
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KNSTRN mRNA	PMID:25378103
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of KNSTRN mRNA	PMID:23649840
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KNSTRN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KNSTRN mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of KNSTRN mRNA	PMID:32699268
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of KNSTRN mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of KNSTRN mRNA	PMID:34911549
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:27086	tributylstannane	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C011559	tributyltin results in decreased expression of KNSTRN mRNA	PMID:21683754
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1614389	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KNSTRN mRNA	PMID:17484886|PMID:27339419|PMID:29987408|PMID:31919559
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KNSTRN mRNA	PMID:25629700
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KNSTRN mRNA	PMID:27424125
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KNSTRN mRNA]	PMID:37992649
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of KNSTRN mRNA	PMID:31881176
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of KNSTRN mRNA	PMID:19167446
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of KNSTRN mRNA	PMID:27594783
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in decreased expression of KNSTRN mRNA	PMID:25270620
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KNSTRN mRNA	PMID:27424125
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KNSTRN mRNA	PMID:34747641
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614389	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KNSTRN mRNA	PMID:26377647
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1614389	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KNSTRN mRNA	PMID:19465110
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KNSTRN mRNA	PMID:27424125
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1344647	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of KNSTRN mRNA	PMID:33512557
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KNSTRN mRNA	PMID:30851411
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KNSTRN mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KNSTRN mRNA	PMID:37992649
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1344647	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of KNSTRN protein	PMID:35688186
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KNSTRN mRNA]	PMID:37992649
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of KNSTRN mRNA	PMID:38568856
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of KNSTRN mRNA	PMID:17998272
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of KNSTRN mRNA	PMID:29453283
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344647	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KNSTRN promoter	PMID:27901495
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614389	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KNSTRN mRNA	PMID:20713471|PMID:32417428
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to KNSTRN mRNA]	PMID:32406909
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1614389	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of KNSTRN mRNA	PMID:29341224
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KNSTRN mRNA	PMID:19150397|PMID:20382639
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of KNSTRN mRNA	PMID:24395379
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of KNSTRN mRNA	PMID:25729387
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of KNSTRN mRNA	PMID:25729387
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614389	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KNSTRN gene	PMID:35295148
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of KNSTRN mRNA	PMID:30012374
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1614389	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of KNSTRN mRNA	PMID:18301758|PMID:20813756
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of KNSTRN mRNA	PMID:38479592
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of KNSTRN mRNA	PMID:25181051|PMID:30816183|PMID:31129395|PMID:32528016|PMID:34947998
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of KNSTRN mRNA	PMID:29275510
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of KNSTRN mRNA	PMID:32145629
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1614389	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of KNSTRN mRNA	PMID:26063408
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1614389	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of KNSTRN mRNA	PMID:26682919
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KNSTRN mRNA	PMID:25510870
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KNSTRN mRNA	PMID:25510870
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KNSTRN mRNA	PMID:23196670
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1614389	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of KNSTRN mRNA	PMID:20713471
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of KNSTRN mRNA	PMID:39298647
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1614389	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of KNSTRN mRNA	PMID:26377693
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KNSTRN mRNA	PMID:21266533
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:34778	glycitein	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KNSTRN mRNA	PMID:27424125
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KNSTRN mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KNSTRN mRNA	PMID:18164116|PMID:22129741
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344647	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KNSTRN mRNA	PMID:37042841
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:35299	dibenz[a,h]anthracene	affects expression	ISO	RGD:1614389	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene affects the expression of KNSTRN mRNA	PMID:26377693
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of KNSTRN mRNA	PMID:18500788
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of KNSTRN mRNA	PMID:30723492
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KNSTRN mRNA	PMID:25993096
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KNSTRN mRNA	PMID:38568856
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of KNSTRN mRNA	PMID:25539665
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of KNSTRN mRNA	PMID:24386269
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1614389	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of KNSTRN mRNA	PMID:28962523
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KNSTRN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KNSTRN mRNA	PMID:32699268
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of KNSTRN mRNA	PMID:40194260
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614389	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KNSTRN mRNA	PMID:40194260
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of KNSTRN mRNA	PMID:28302478
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of KNSTRN mRNA	PMID:31533062
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1344647	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of KNSTRN mRNA	PMID:19167446
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNSTRN mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of KNSTRN mRNA	PMID:19167446
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of KNSTRN mRNA	PMID:39529242
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344647	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KNSTRN mRNA	PMID:25979313
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of KNSTRN mRNA	PMID:35594946
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344647	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of KNSTRN mRNA	PMID:29154799
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of KNSTRN mRNA	PMID:41580965
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KNSTRN mRNA	PMID:27424125
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1614389	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KNSTRN mRNA	PMID:28973697
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KNSTRN mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KNSTRN mRNA	PMID:37992649
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1344647	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KNSTRN mRNA	PMID:38832940
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KNSTRN mRNA	PMID:33387578
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1344647	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of KNSTRN mRNA	PMID:22230336
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of KNSTRN mRNA	PMID:22077320
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1344647	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of KNSTRN mRNA	PMID:31838189
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KNSTRN mRNA	PMID:22079256
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of KNSTRN mRNA	PMID:17351261
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20260707	CTD	MESH:C017690	fenvalerate results in decreased expression of KNSTRN mRNA	PMID:40043501
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of KNSTRN mRNA	PMID:30307764
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1614389	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of KNSTRN mRNA	PMID:25554681
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of KNSTRN mRNA	PMID:25554681
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1614389	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of KNSTRN mRNA	PMID:19042947
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1614389	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of KNSTRN mRNA	PMID:38701926
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KNSTRN protein	PMID:32959892
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of KNSTRN mRNA	PMID:20080153
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of KNSTRN mRNA	PMID:25729387
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of KNSTRN mRNA	PMID:25729387
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of KNSTRN mRNA	PMID:28988120
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of KNSTRN mRNA	PMID:37269647
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of KNSTRN mRNA	PMID:35283115
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D008694	Methamphetamine results in decreased expression of KNSTRN mRNA	PMID:28341135
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008701	Methapyrilene results in increased expression of KNSTRN mRNA	PMID:22484513
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KNSTRN mRNA	PMID:39752319
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KNSTRN mRNA	PMID:27840820
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1614389	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KNSTRN mRNA	PMID:22206623
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of KNSTRN mRNA	PMID:20061341
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of KNSTRN mRNA	PMID:22079256
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KNSTRN mRNA	PMID:22079256
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of KNSTRN mRNA	PMID:29522793
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1614389	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of KNSTRN mRNA	PMID:27858113
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1344647	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of KNSTRN mRNA	PMID:37199045
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNSTRN mRNA	PMID:32741896
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of KNSTRN mRNA	PMID:18164116
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KNSTRN mRNA	PMID:30851411
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of KNSTRN mRNA	PMID:34014027
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of KNSTRN mRNA	PMID:34995734
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:80373	glycitin	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KNSTRN mRNA	PMID:27424125
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in decreased expression of KNSTRN mRNA	PMID:20097248
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1614389	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of KNSTRN mRNA	PMID:19482888|PMID:23091169
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1344647	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNSTRN mRNA	PMID:19167446
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of KNSTRN mRNA	PMID:26377693
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1614389	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of KNSTRN mRNA	PMID:39847705
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of KNSTRN mRNA	PMID:24780913
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of KNSTRN mRNA	PMID:22869556
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1614389	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KNSTRN mRNA	PMID:39752319
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of KNSTRN mRNA	PMID:19281266
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1344647	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of KNSTRN mRNA	PMID:33512557
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1344647	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of KNSTRN mRNA	PMID:38568856
1303240	Knstrn	kinetochore-localized astrin/SPAG5 binding protein	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1614389	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of KNSTRN mRNA	PMID:35537566
1303241	Bace2	beta-secretase 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1350115	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of BACE2 mRNA	PMID:26272509|PMID:27188386
1303241	Bace2	beta-secretase 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA	PMID:27188386
1303241	Bace2	beta-secretase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BACE2 mRNA	PMID:36189433
1303241	Bace2	beta-secretase 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of BACE2 mRNA	PMID:32845096
1303241	Bace2	beta-secretase 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1350115	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of BACE2 mRNA	PMID:26516004
1303241	Bace2	beta-secretase 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1350115	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of BACE2 mRNA	PMID:30510588
1303241	Bace2	beta-secretase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1350115	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of BACE2 mRNA	PMID:21185374
1303241	Bace2	beta-secretase 2	gene	CHEBI:16598	DDE	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D003633	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA	PMID:25607892
1303241	Bace2	beta-secretase 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1350115	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of BACE2 mRNA	PMID:23649840
1303241	Bace2	beta-secretase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BACE2 mRNA	PMID:37992649
1303241	Bace2	beta-secretase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of BACE2 mRNA	PMID:36189433
1303241	Bace2	beta-secretase 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1551409	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of BACE2 mRNA	PMID:33848595
1303241	Bace2	beta-secretase 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of BACE2 mRNA]	PMID:33848595
1303241	Bace2	beta-secretase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BACE2 mRNA	PMID:37992649
1303241	Bace2	beta-secretase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551409	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of BACE2 mRNA	PMID:33754040
1303241	Bace2	beta-secretase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004051	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA	PMID:25607892
1303241	Bace2	beta-secretase 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of BACE2 mRNA	PMID:22061828|PMID:33387578
1303241	Bace2	beta-secretase 2	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1350115	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of BACE2 intron	PMID:30157460
1303241	Bace2	beta-secretase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BACE2 mRNA	PMID:37236586
1303241	Bace2	beta-secretase 2	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1551409	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of BACE2 mRNA	PMID:15664270
1303241	Bace2	beta-secretase 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1350115	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of BACE2 mRNA	PMID:23649840
1303241	Bace2	beta-secretase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1350115	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of BACE2 intron	PMID:30157460
1303241	Bace2	beta-secretase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1350115	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of BACE2 mRNA	PMID:23649840
1303241	Bace2	beta-secretase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of BACE2 mRNA	PMID:32845096
1303241	Bace2	beta-secretase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of BACE2 mRNA	PMID:34911549
1303241	Bace2	beta-secretase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1551409	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of BACE2 mRNA	PMID:17484886
1303241	Bace2	beta-secretase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551409	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of BACE2 mRNA	PMID:25629700
1303241	Bace2	beta-secretase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BACE2 mRNA	PMID:22206623
1303241	Bace2	beta-secretase 2	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1350115	E	RGD:6480464	20120412	CTD	MESH:D016685	BACE2 protein affects the susceptibility to Mitomycin	PMID:16217747
1303241	Bace2	beta-secretase 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1350115	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of BACE2 mRNA	PMID:26272509
1303241	Bace2	beta-secretase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA	PMID:27188386
1303241	Bace2	beta-secretase 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1551409	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of BACE2 mRNA	PMID:22610192
1303241	Bace2	beta-secretase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1350115	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of BACE2 mRNA	PMID:27392435
1303241	Bace2	beta-secretase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of BACE2 mRNA	PMID:27392435
1303241	Bace2	beta-secretase 2	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1350115	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of BACE2 promoter	PMID:22847954
1303241	Bace2	beta-secretase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551409	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BACE2 mRNA	PMID:21570461
1303241	Bace2	beta-secretase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BACE2 mRNA	PMID:33387578
1303241	Bace2	beta-secretase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1350115	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BACE2 mRNA	PMID:23152189
1303241	Bace2	beta-secretase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BACE2 mRNA	PMID:34747641
1303241	Bace2	beta-secretase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551409	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BACE2 mRNA	PMID:19770486
1303241	Bace2	beta-secretase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1350115	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of BACE2 mRNA	PMID:33212167
1303241	Bace2	beta-secretase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1350115	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of BACE2 mRNA	PMID:32763439
1303241	Bace2	beta-secretase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1350115	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BACE2 mRNA	PMID:29803840
1303241	Bace2	beta-secretase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551409	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of BACE2 mRNA	PMID:39631538
1303241	Bace2	beta-secretase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BACE2 mRNA	PMID:37992649
1303241	Bace2	beta-secretase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1350115	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of BACE2 mRNA	PMID:22714537|PMID:38568856
1303241	Bace2	beta-secretase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350115	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BACE2 intron	PMID:30157460
1303241	Bace2	beta-secretase 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1551409	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of BACE2 mRNA	PMID:27131904
1303241	Bace2	beta-secretase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BACE2 gene	PMID:31601247
1303241	Bace2	beta-secretase 2	gene	CHEBI:31823	mercury dichloride	affects expression	ISO	RGD:1350115	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride affects the expression of BACE2 mRNA	PMID:24118919
1303241	Bace2	beta-secretase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BACE2 mRNA	PMID:25181051
1303241	Bace2	beta-secretase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551409	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of BACE2 mRNA	PMID:26063408|PMID:32156529|PMID:34585602
1303241	Bace2	beta-secretase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BACE2 gene	PMID:31601247
1303241	Bace2	beta-secretase 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of BACE2 mRNA	PMID:28300664
1303241	Bace2	beta-secretase 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1551409	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of BACE2 mRNA	PMID:26682919
1303241	Bace2	beta-secretase 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of BACE2 mRNA	PMID:23196670
1303241	Bace2	beta-secretase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551409	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of BACE2 mRNA	PMID:30951980
1303241	Bace2	beta-secretase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1350115	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of BACE2 gene	PMID:31601247
1303241	Bace2	beta-secretase 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1551409	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of BACE2 mRNA	PMID:26377693
1303241	Bace2	beta-secretase 2	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1350115	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of BACE2 intron	PMID:30157460
1303241	Bace2	beta-secretase 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D003993	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA	PMID:25607892
1303241	Bace2	beta-secretase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350115	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BACE2 mRNA	PMID:37042841
1303241	Bace2	beta-secretase 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1551409	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of BACE2 mRNA	PMID:26377693
1303241	Bace2	beta-secretase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BACE2 mRNA	PMID:37236586
1303241	Bace2	beta-secretase 2	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of BACE2 gene	PMID:22079235
1303241	Bace2	beta-secretase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1350115	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of BACE2 mRNA	PMID:24449571
1303241	Bace2	beta-secretase 2	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1350115	E	RGD:6480464	20230502	CTD	MESH:D003024	Clozapine results in increased expression of BACE2 protein	PMID:36482696
1303241	Bace2	beta-secretase 2	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1350115	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of BACE2 promoter	PMID:22847954
1303241	Bace2	beta-secretase 2	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1350115	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of BACE2 promoter	PMID:22847954
1303241	Bace2	beta-secretase 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA	PMID:19167446
1303241	Bace2	beta-secretase 2	gene	CHEBI:39481	chloroprene	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of BACE2 mRNA	PMID:23125180
1303241	Bace2	beta-secretase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350115	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BACE2 mRNA	PMID:25979313
1303241	Bace2	beta-secretase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1350115	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of BACE2 gene	PMID:29154799
1303241	Bace2	beta-secretase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1350115	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of BACE2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1303241	Bace2	beta-secretase 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA	PMID:27188386
1303241	Bace2	beta-secretase 2	gene	CHEBI:40303	lovastatin	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D008148	Lovastatin results in increased expression of BACE2 protein	PMID:29341888
1303241	Bace2	beta-secretase 2	gene	CHEBI:40303	lovastatin	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20201103	CTD	MESH:D008148	[Lovastatin co-treated with APP protein] results in increased expression of BACE2 protein	PMID:29341888
1303241	Bace2	beta-secretase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1350115	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of BACE2 mRNA	PMID:27989131
1303241	Bace2	beta-secretase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551409	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of BACE2 mRNA	PMID:28973697
1303241	Bace2	beta-secretase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BACE2 mRNA	PMID:37992649
1303241	Bace2	beta-secretase 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1350115	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of BACE2 mRNA	PMID:24935251
1303241	Bace2	beta-secretase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA	PMID:27188386
1303241	Bace2	beta-secretase 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1350115	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of BACE2 mRNA	PMID:22230336
1303241	Bace2	beta-secretase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of BACE2 mRNA	PMID:33387578
1303241	Bace2	beta-secretase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of BACE2 mRNA	PMID:29391264
1303241	Bace2	beta-secretase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1551409	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of BACE2 mRNA	PMID:35436446
1303241	Bace2	beta-secretase 2	gene	CHEBI:4811	epoxiconazole	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C109476	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA	PMID:25607892
1303241	Bace2	beta-secretase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of BACE2 mRNA	PMID:17557909
1303241	Bace2	beta-secretase 2	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1350115	E	RGD:6480464	20120412	CTD	MESH:D005047	BACE2 protein affects the susceptibility to Etoposide	PMID:16217747
1303241	Bace2	beta-secretase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551409	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of BACE2 mRNA	PMID:25554681|PMID:25620056
1303241	Bace2	beta-secretase 2	gene	CHEBI:50729	mitoxantrone	affects response to substance	ISO	RGD:1350115	E	RGD:6480464	20120412	CTD	MESH:D008942	BACE2 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1303241	Bace2	beta-secretase 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1551409	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of BACE2 mRNA	PMID:19042947
1303241	Bace2	beta-secretase 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1551409	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of BACE2 mRNA	PMID:23608068
1303241	Bace2	beta-secretase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1350115	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of BACE2 mRNA	PMID:15336504
1303241	Bace2	beta-secretase 2	gene	CHEBI:6482	linuron	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D008044	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA	PMID:25607892
1303241	Bace2	beta-secretase 2	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1350115	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of BACE2 intron	PMID:30157460
1303241	Bace2	beta-secretase 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of BACE2 gene	PMID:35440735
1303241	Bace2	beta-secretase 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1350115	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of BACE2 mRNA	PMID:31758290
1303241	Bace2	beta-secretase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551409	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of BACE2 mRNA	PMID:22206623
1303241	Bace2	beta-secretase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551409	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BACE2 mRNA	PMID:22206623
1303241	Bace2	beta-secretase 2	gene	CHEBI:755912	aluminum chloride	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20260714	CTD	MESH:D000077410	[Aluminum Chloride co-treated with APP protein modified form] results in decreased expression of BACE2 mRNA; [Aluminum Chloride co-treated with APP protein modified form] results in decreased expression of BACE2 protein; [Aluminum Chloride co-treated with APP protein modified form] results in increased expression of BACE2 mRNA	PMID:20111991
1303241	Bace2	beta-secretase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA	PMID:27188386
1303241	Bace2	beta-secretase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BACE2 gene]	PMID:28238834
1303241	Bace2	beta-secretase 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA	PMID:19167446
1303241	Bace2	beta-secretase 2	gene	CHEBI:8434	prochloraz	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C045362	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA	PMID:25607892
1303241	Bace2	beta-secretase 2	gene	CHEBI:8450	procymidone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C035988	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA	PMID:25607892
1303241	Bace2	beta-secretase 2	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1350115	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of BACE2 mRNA	PMID:26272509
1303241	Bace2	beta-secretase 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA	PMID:27188386
1303241	Bace2	beta-secretase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1350115	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE2 mRNA	PMID:27188386
1303241	Bace2	beta-secretase 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1551409	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of BACE2 mRNA	PMID:27131904
1303241	Bace2	beta-secretase 2	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1350115	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of BACE2 mRNA	PMID:27188386
1303241	Bace2	beta-secretase 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1551409	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of BACE2 mRNA	PMID:28973697
1303241	Bace2	beta-secretase 2	gene	CHEBI:9986	vinclozolin	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C025643	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA	PMID:25607892
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606032	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KLK10 mRNA	PMID:38218311
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1606032	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of KLK10 mRNA	PMID:26272509|PMID:27188386
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLK10 mRNA	PMID:27188386
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1553373	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of KLK10 mRNA	PMID:37995155
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1606032	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of KLK10 mRNA	PMID:16249480|PMID:16800735
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KLK10 mRNA	PMID:35811015
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1606032	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of KLK10 mRNA	PMID:30510588
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of KLK10 mRNA	PMID:30165855
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KLK10 mRNA	PMID:33387578
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20130813	CTD	MESH:D011374	[Estrogens co-treated with Progesterone] results in increased expression of KLK10 mRNA	PMID:20686372
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1606032	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of KLK10 mRNA	PMID:26485663
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KLK10 mRNA	PMID:33387578
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1606032	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of KLK10 mRNA	PMID:21120746
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1553373	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of KLK10 mRNA	PMID:33026818
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553373	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of KLK10 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of KLK10 mRNA	PMID:34911549
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of KLK10 mRNA	PMID:19111725
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of KLK10 mRNA]	PMID:19111725
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KLK10 mRNA	PMID:32525701
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1606032	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of KLK10 mRNA	PMID:26272509
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK10 mRNA	PMID:27188386
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1606032	E	RGD:6480464	20120412	CTD	MESH:D002945	KLK10 protein affects the susceptibility to Cisplatin	PMID:16217747
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with panobinostat] affects the expression of KLK10 mRNA	PMID:21791302
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1606032	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of KLK10 promoter	PMID:22847954
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1606032	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of KLK10 mRNA	PMID:25583101
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1606032	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KLK10 mRNA	PMID:23152189
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606032	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KLK10 mRNA	PMID:28001369
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1606032	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KLK10 mRNA	PMID:30851411
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:28741	sodium fluoride	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of KLK10 mRNA	PMID:27257137
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1606032	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of KLK10 gene	PMID:28589171
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606032	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of KLK10 mRNA	PMID:39719251
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606032	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KLK10 promoter	PMID:27901495
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606032	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KLK10 5' UTR	PMID:27901495
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1606032	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLK10 mRNA	PMID:20064835
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of KLK10 mRNA	PMID:19111725
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of KLK10 mRNA]	PMID:19111725
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KLK10 mRNA	PMID:25181051
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1553373	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of KLK10 mRNA	PMID:26377693
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1553373	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of KLK10 exon	PMID:28392331
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1606032	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of KLK10 promoter	PMID:22847954
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1606032	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of KLK10 promoter	PMID:22847954
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of KLK10 mRNA	PMID:22561333
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606032	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLK10 mRNA	PMID:25979313
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:4488	diallyl disulfide	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide inhibits the reaction [tobacco tar analog results in decreased expression of KLK10 mRNA]	PMID:36758788
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KLK10 mRNA	PMID:33387578
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1606032	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of KLK10 mRNA	PMID:24714768
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KLK10 mRNA	PMID:35811015
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1606032	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of KLK10 mRNA	PMID:25351596
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KLK10 mRNA	PMID:32525701
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1606032	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of KLK10 mRNA	PMID:38825487
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	ISO	RGD:1606032	E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of KLK10 mRNA; Alitretinoin results in increased expression of KLK10 protein	PMID:16800735
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1606032	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of KLK10 mRNA	PMID:18651567
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1606032	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KLK10 mRNA	PMID:30851411
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLK10 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK10 mRNA	PMID:27188386
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KLK10 gene]	PMID:28238834
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KLK10 mRNA	PMID:23640034
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KLK10 mRNA	PMID:32525701
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20161228	CTD	MESH:C496932	[Cisplatin co-treated with panobinostat] affects the expression of KLK10 mRNA	PMID:21791302
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1606032	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of KLK10 mRNA	PMID:31734321
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606032	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLK10 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK10 mRNA	PMID:27188386
1303242	Klk10	kallikrein related-peptidase 10	gene	CHEBI:9944	venlafaxine hydrochloride	decreases expression	ISO	RGD:1606032	E	RGD:6480464	20170303	CTD	MESH:D000069470	Venlafaxine Hydrochloride results in decreased expression of KLK10 mRNA	PMID:16341940
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SPTB mRNA	PMID:23724009
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1557994	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SPTB mRNA	PMID:30319688
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1557994	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of SPTB mRNA	PMID:30319688
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557994	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SPTB mRNA	PMID:39241906
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SPTB mRNA	PMID:30510588
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SPTB mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SPTB mRNA	PMID:26496021|PMID:32741896
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1349727	E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [SPTB protein binds to ESR1 protein]	PMID:27156127
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349727	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SPTB mRNA	PMID:37042841
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1557994	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SPTB mRNA	PMID:33848595
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SPTB mRNA	PMID:32741896
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1349727	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPTB mRNA	PMID:36139627
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SPTB mRNA	PMID:33387578
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1557994	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of SPTB mRNA	PMID:39984025
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SPTB mRNA	PMID:19549813
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1349727	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SPTB gene	PMID:27153756
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SPTB mRNA	PMID:31150632
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SPTB mRNA	PMID:31881176
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1349727	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of SPTB mRNA	PMID:41028656
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1349727	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SPTB mRNA	PMID:28903495
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1557994	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SPTB mRNA	PMID:40618947
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:28077	rifampicin	increases expression	ISO	RGD:1349727	E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in increased expression of SPTB mRNA	PMID:24552687
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1557994	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of SPTB mRNA	PMID:32186404
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557994	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPTB mRNA	PMID:26377647
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPTB mRNA	PMID:33387578
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1349727	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SPTB mRNA	PMID:33212167
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SPTB mRNA	PMID:28959563
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1349727	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SPTB mRNA	PMID:41028656
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SPTB mRNA	PMID:29803840
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPTB mRNA; sodium arsenite results in decreased expression of SPTB protein	PMID:30528433|PMID:34032870
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1557994	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPTB mRNA	PMID:37682722
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349727	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPTB promoter	PMID:27901495
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1557994	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SPTB mRNA	PMID:22228805
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1349727	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SPTB 3' UTR	PMID:27901495
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1349727	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPTB mRNA	PMID:32234424
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349727	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPTB exon	PMID:27901495
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1349727	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of SPTB gene	PMID:25435355
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1557994	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of SPTB protein	PMID:37955338
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1349727	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SPTB mRNA	PMID:41028656
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SPTB mRNA	PMID:25895662
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1349727	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SPTB mRNA	PMID:20458559
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of SPTB mRNA	PMID:37690743
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1349727	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SPTB gene	PMID:31601247
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557994	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPTB gene; titanium dioxide results in decreased methylation of SPTB promoter	PMID:35295148
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SPTB mRNA	PMID:34492290
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPTB mRNA	PMID:25181051|PMID:30816183|PMID:41034487
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SPTB protein	PMID:31675489
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of SPTB mRNA; bisphenol A results in increased expression of SPTB protein	PMID:24552547|PMID:32145629
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1557994	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SPTB mRNA	PMID:30951980|PMID:32156529
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SPTB gene	PMID:28505145
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SPTB mRNA	PMID:26496021
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SPTB mRNA	PMID:19244175
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1557994	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SPTB gene	PMID:31683443
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1557994	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SPTB exon	PMID:33297965
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557994	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SPTB mRNA	PMID:30951980
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1557994	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SPTB mRNA	PMID:30951980
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1557994	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SPTB mRNA	PMID:21266533
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of SPTB gene	PMID:33148267
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349727	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SPTB mRNA	PMID:37042841
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1557994	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of SPTB mRNA	PMID:28962523
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1557994	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SPTB mRNA	PMID:40194260
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SPTB mRNA	PMID:29427782
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1557994	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SPTB mRNA	PMID:21427059
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1349727	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SPTB gene	PMID:29154799
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1349727	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SPTB mRNA	PMID:38832940
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SPTB mRNA	PMID:33387578
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SPTB mRNA	PMID:29391264
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of SPTB mRNA	PMID:32234424
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1349727	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SPTB mRNA	PMID:20458559
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1557994	E	RGD:6480464	20140715	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SPTB mRNA	PMID:23608068
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SPTB protein	PMID:32959892
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1557994	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of SPTB mRNA	PMID:19812364
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:64090	tert-butyl hydroperoxide	multiple interactions	ISO	RGD:1349727	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]	PMID:15040847
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SPTB mRNA	PMID:28801915
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1557994	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of SPTB mRNA	PMID:36907384
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SPTB gene	PMID:35440735
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of SPTB protein	PMID:34122009
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of SPTB gene	PMID:33148267
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1349727	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPTB mRNA	PMID:36139627
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SPTB mRNA	PMID:32741896
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349727	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPTB gene]	PMID:28238834
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SPTB mRNA	PMID:32109520
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1349727	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SPTB mRNA	PMID:29301935
1303243	Sptb	spectrin, beta, erythrocytic	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of SPTB protein	PMID:32519852
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1617925	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of KPRP mRNA	PMID:37995155
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1617925	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KPRP mRNA	PMID:19770486
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1353027	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KPRP mRNA	PMID:32525701
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1353027	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of KPRP protein	PMID:20884965
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1353027	E	RGD:6480464	20121113	CTD	MESH:D019833	ESR1 promotes the reaction [Genistein results in decreased expression of KPRP protein]	PMID:20884965
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1353027	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KPRP mRNA	PMID:23152189
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1353027	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KPRP mRNA	PMID:30851411
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of KPRP mRNA	PMID:28959563
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353027	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KPRP mRNA	PMID:38568856
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353027	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KPRP promoter	PMID:27901495
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353027	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KPRP 5' UTR	PMID:27901495
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KPRP mRNA	PMID:25181051
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1353027	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KPRP mRNA	PMID:38568856
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1353027	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KPRP mRNA	PMID:32525701
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1353027	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KPRP mRNA	PMID:30851411
1303244	Kprp	keratinocyte proline-rich protein	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1353027	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KPRP mRNA	PMID:32525701
1303245	Rtn2	reticulon 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1351891	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RTN2 mRNA	PMID:38218311
1303245	Rtn2	reticulon 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in decreased expression of RTN2 mRNA	PMID:20488242
1303245	Rtn2	reticulon 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1351891	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RTN2 mRNA	PMID:33167477
1303245	Rtn2	reticulon 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1553387	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RTN2 mRNA	PMID:30529165
1303245	Rtn2	reticulon 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1351891	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RTN2 mRNA	PMID:26079696
1303245	Rtn2	reticulon 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of RTN2 mRNA	PMID:36841081
1303245	Rtn2	reticulon 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1553387	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of RTN2 mRNA	PMID:40945087
1303245	Rtn2	reticulon 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1553387	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RTN2 mRNA	PMID:30319688
1303245	Rtn2	reticulon 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of RTN2 mRNA	PMID:32145629
1303245	Rtn2	reticulon 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1351891	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of RTN2 mRNA	PMID:31614463
1303245	Rtn2	reticulon 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553387	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of RTN2 mRNA	PMID:19484750
1303245	Rtn2	reticulon 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RTN2 gene	PMID:27618143
1303245	Rtn2	reticulon 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1351891	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of RTN2 mRNA	PMID:26079696
1303245	Rtn2	reticulon 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1553387	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RTN2 mRNA	PMID:37992649
1303245	Rtn2	reticulon 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1351891	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of RTN2 mRNA	PMID:21592394
1303245	Rtn2	reticulon 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of RTN2 mRNA	PMID:21592394
1303245	Rtn2	reticulon 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1553387	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RTN2 mRNA	PMID:37992649
1303245	Rtn2	reticulon 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553387	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RTN2 mRNA	PMID:34319233
1303245	Rtn2	reticulon 2	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RTN2 mRNA	PMID:36139627
1303245	Rtn2	reticulon 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1351891	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RTN2 mRNA	PMID:21592394
1303245	Rtn2	reticulon 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of RTN2 mRNA	PMID:21592394
1303245	Rtn2	reticulon 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RTN2 mRNA	PMID:33387578
1303245	Rtn2	reticulon 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RTN2 mRNA	PMID:39012411
1303245	Rtn2	reticulon 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1351891	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RTN2 mRNA	PMID:19549813
1303245	Rtn2	reticulon 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553387	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RTN2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RTN2 mRNA	PMID:34911549
1303245	Rtn2	reticulon 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1553387	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RTN2 mRNA	PMID:17484886
1303245	Rtn2	reticulon 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553387	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTN2 mRNA	PMID:40504410
1303245	Rtn2	reticulon 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1553387	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of RTN2 mRNA	PMID:28960355
1303245	Rtn2	reticulon 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RTN2 mRNA	PMID:23557933
1303245	Rtn2	reticulon 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1351891	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of RTN2 mRNA	PMID:27392435
1303245	Rtn2	reticulon 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1351891	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of RTN2 mRNA	PMID:25583101
1303245	Rtn2	reticulon 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553387	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RTN2 mRNA	PMID:21570461
1303245	Rtn2	reticulon 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RTN2 mRNA	PMID:33387578
1303245	Rtn2	reticulon 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553387	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RTN2 mRNA	PMID:19933214|PMID:33956508
1303245	Rtn2	reticulon 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1351891	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RTN2 mRNA	PMID:33212167
1303245	Rtn2	reticulon 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1553387	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RTN2 mRNA	PMID:37992649
1303245	Rtn2	reticulon 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553387	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTN2 mRNA	PMID:40504410
1303245	Rtn2	reticulon 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1351891	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RTN2 mRNA	PMID:32234424
1303245	Rtn2	reticulon 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351891	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RTN2 promoter	PMID:27901495
1303245	Rtn2	reticulon 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1351891	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RTN2 mRNA	PMID:25895662
1303245	Rtn2	reticulon 2	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1351891	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of RTN2 mRNA	PMID:34408198
1303245	Rtn2	reticulon 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553387	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RTN2 promoter	PMID:35295148
1303245	Rtn2	reticulon 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1553387	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RTN2 gene	PMID:35295148
1303245	Rtn2	reticulon 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RTN2 mRNA	PMID:34492290
1303245	Rtn2	reticulon 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RTN2 mRNA	PMID:25181051|PMID:32145629
1303245	Rtn2	reticulon 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RTN2 mRNA	PMID:34947998
1303245	Rtn2	reticulon 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RTN2 mRNA	PMID:36041667
1303245	Rtn2	reticulon 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1553387	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of RTN2 exon; bisphenol S affects the methylation of RTN2 gene	PMID:31683443|PMID:33297965
1303245	Rtn2	reticulon 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553387	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of RTN2 mRNA	PMID:40203079
1303245	Rtn2	reticulon 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RTN2 mRNA	PMID:36041667
1303245	Rtn2	reticulon 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RTN2 mRNA	PMID:36041667
1303245	Rtn2	reticulon 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RTN2 mRNA	PMID:28628672
1303245	Rtn2	reticulon 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1553387	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RTN2 promoter	PMID:28392331
1303245	Rtn2	reticulon 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553387	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RTN2 mRNA	PMID:37019170
1303245	Rtn2	reticulon 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RTN2 mRNA	PMID:21266533
1303245	Rtn2	reticulon 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RTN2 mRNA	PMID:28628672
1303245	Rtn2	reticulon 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of RTN2 mRNA	PMID:32680482
1303245	Rtn2	reticulon 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351891	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RTN2 mRNA	PMID:37042841
1303245	Rtn2	reticulon 2	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of RTN2 mRNA	PMID:35163327
1303245	Rtn2	reticulon 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RTN2 mRNA	PMID:35163327
1303245	Rtn2	reticulon 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RTN2 promoter	PMID:22457795
1303245	Rtn2	reticulon 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RTN2 mRNA	PMID:39012411
1303245	Rtn2	reticulon 2	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:1553387	E	RGD:6480464	20250204	CTD	MESH:C012125	diisononyl phthalate results in increased expression of RTN2 mRNA	PMID:33391822
1303245	Rtn2	reticulon 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RTN2 mRNA	PMID:35163327
1303245	Rtn2	reticulon 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1553387	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RTN2 mRNA	PMID:40194260
1303245	Rtn2	reticulon 2	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1351891	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of RTN2 mRNA	PMID:19167446
1303245	Rtn2	reticulon 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351891	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RTN2 mRNA	PMID:25979313
1303245	Rtn2	reticulon 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351891	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RTN2 mRNA	PMID:23179753|PMID:26272509|PMID:29154799
1303245	Rtn2	reticulon 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1553387	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of RTN2 mRNA	PMID:21427059
1303245	Rtn2	reticulon 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RTN2 mRNA	PMID:27188386
1303245	Rtn2	reticulon 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RTN2 mRNA	PMID:28628672
1303245	Rtn2	reticulon 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1553387	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RTN2 mRNA	PMID:37992649
1303245	Rtn2	reticulon 2	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1351891	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of RTN2 mRNA	PMID:33512557
1303245	Rtn2	reticulon 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1553387	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of RTN2 mRNA	PMID:18502557
1303245	Rtn2	reticulon 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1351891	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RTN2 mRNA	PMID:38832940
1303245	Rtn2	reticulon 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1351891	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RTN2 mRNA	PMID:24935251
1303245	Rtn2	reticulon 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RTN2 mRNA	PMID:33387578
1303245	Rtn2	reticulon 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1351891	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of RTN2 mRNA	PMID:29067470
1303245	Rtn2	reticulon 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553387	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTN2 mRNA	PMID:40504410
1303245	Rtn2	reticulon 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1351891	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of RTN2 mRNA	PMID:31838189
1303245	Rtn2	reticulon 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1553387	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RTN2 mRNA	PMID:17555576
1303245	Rtn2	reticulon 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RTN2 mRNA	PMID:28628672
1303245	Rtn2	reticulon 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553387	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RTN2 mRNA; Nanotubes, Carbon results in decreased expression of RTN2 mRNA	PMID:25554681
1303245	Rtn2	reticulon 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RTN2 mRNA	PMID:30047161
1303245	Rtn2	reticulon 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1553387	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of RTN2 mRNA	PMID:23608068
1303245	Rtn2	reticulon 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1553387	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of RTN2 mRNA	PMID:36907384
1303245	Rtn2	reticulon 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1351891	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RTN2 mRNA	PMID:31758290
1303245	Rtn2	reticulon 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553387	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RTN2 mRNA	PMID:22206623
1303245	Rtn2	reticulon 2	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RTN2 mRNA	PMID:36139627
1303245	Rtn2	reticulon 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RTN2 mRNA	PMID:27188386
1303245	Rtn2	reticulon 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RTN2 gene]	PMID:28238834
1303245	Rtn2	reticulon 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1553387	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RTN2 mRNA	PMID:27935865
1303245	Rtn2	reticulon 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1351891	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of RTN2 mRNA	PMID:32234424
1303245	Rtn2	reticulon 2	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1351891	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of RTN2 mRNA	PMID:33512557
1303245	Rtn2	reticulon 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1351891	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of RTN2 mRNA	PMID:26079696
1303245	Rtn2	reticulon 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1553387	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of RTN2 mRNA	PMID:21795629
1303245	Rtn2	reticulon 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1553387	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of RTN2 mRNA	PMID:30953684
1303245	Rtn2	reticulon 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RTN2 mRNA	PMID:30047161
1303245	Rtn2	reticulon 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1351891	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RTN2 mRNA	PMID:27188386
1303245	Rtn2	reticulon 2	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1553387	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of RTN2 mRNA	PMID:26217789
1303246	Dek	DEK proto-oncogene	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DEK mRNA	PMID:33045310
1303246	Dek	DEK proto-oncogene	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1553392	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of DEK mRNA	PMID:37995155
1303246	Dek	DEK proto-oncogene	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D002794	DEK protein results in decreased chemical synthesis of and results in increased secretion of Choline	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of DEK mRNA	PMID:15928584
1303246	Dek	DEK proto-oncogene	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of DEK mRNA	PMID:17218384
1303246	Dek	DEK proto-oncogene	gene	CHEBI:15428	glycine	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D005998	DEK protein results in decreased chemical synthesis of and results in increased uptake of Glycine	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:15600	(+)-catechin	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D002392	Catechin results in decreased expression of DEK mRNA	PMID:15465739
1303246	Dek	DEK proto-oncogene	gene	CHEBI:15741	succinic acid	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D019802	DEK protein affects the chemical synthesis of and affects the secretion of Succinic Acid	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:15846	NAD(+)	increases oxidation	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D009243	DEK protein results in increased oxidation of NAD	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:15891	taurine	increases chemical synthesis	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D013654	DEK protein results in increased chemical synthesis of Taurine	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DEK mRNA	PMID:22378314
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1553392	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DEK mRNA	PMID:30319688
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16236	ethanol	increases secretion	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D000431	DEK protein results in increased secretion of Ethanol	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16243	quercetin	affects phosphorylation	ISO	RGD:1349075	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin affects the phosphorylation of DEK protein	PMID:35688186
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DEK mRNA	PMID:21632981
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553392	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DEK mRNA	PMID:39241906
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1349075	E	RGD:6480464	20130416	CTD	MESH:D004958	Estradiol results in increased expression of DEK mRNA; Estradiol results in increased expression of DEK protein	PMID:23071688
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16469	17beta-estradiol	increases response to substance	ISO	RGD:1349075	E	RGD:6480464	20130416	CTD	MESH:D004958	DEK protein results in increased susceptibility to Estradiol	PMID:23071688
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20130416	CTD	MESH:D004958	1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [Estradiol results in increased expression of DEK protein]; Estradiol promotes the reaction [ESR1 protein binds to DEK promoter]; Estradiol promotes the reaction [MYC protein binds to DEK promoter]; fulvestrant inhibits the reaction [Estradiol results in increased expression of DEK protein]	PMID:23071688
1303246	Dek	DEK proto-oncogene	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of DEK mRNA	PMID:23829299
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DEK mRNA	PMID:33387578
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16797	1-methylnicotinamide	decreases chemical synthesis	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:C024058	DEK protein results in decreased chemical synthesis of N(1)-methylnicotinamide	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16856	glutathione	decreases chemical synthesis	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D005978	DEK protein results in decreased chemical synthesis of Glutathione	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16919	creatine	increases chemical synthesis	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D003401	DEK protein results in increased chemical synthesis of Creatine	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:16977	L-alanine	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D000409	DEK protein results in increased chemical synthesis of and results in increased secretion of Alanine	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1349075	E	RGD:6480464	20130416	CTD	MESH:D011374	Progesterone results in increased expression of DEK protein	PMID:23071688
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17170	dimethylamine	increases secretion	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:C034516	DEK protein results in increased secretion of dimethylamine	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D005947	DEK protein affects the chemical synthesis of and affects the uptake of Glucose	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of DEK mRNA	PMID:21592394
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of DEK mRNA	PMID:21592394
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of DEK mRNA	PMID:27683099
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D005947	DEK protein affects the chemical synthesis of and affects the uptake of Glucose	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of DEK mRNA	PMID:23892564
1303246	Dek	DEK proto-oncogene	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1349075	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DEK protein	PMID:37730182
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of DEK mRNA	PMID:21592394
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of DEK mRNA	PMID:21592394
1303246	Dek	DEK proto-oncogene	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DEK mRNA	PMID:33387578
1303246	Dek	DEK proto-oncogene	gene	CHEBI:18132	phosphocholine	decreases chemical synthesis	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D010767	DEK protein results in decreased chemical synthesis of Phosphorylcholine	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:18183	5-oxo-L-proline	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D011761	DEK protein results in decreased chemical synthesis of and results in increased uptake of Pyrrolidonecarboxylic Acid	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553392	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DEK mRNA	PMID:36331819
1303246	Dek	DEK proto-oncogene	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of DEK mRNA	PMID:12634122
1303246	Dek	DEK proto-oncogene	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DEK mRNA	PMID:19549813
1303246	Dek	DEK proto-oncogene	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DEK protein	PMID:23301498
1303246	Dek	DEK proto-oncogene	gene	CHEBI:24848	inositol	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D007294	DEK protein results in increased chemical synthesis of and results in decreased secretion of Inositol	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DEK protein	PMID:20106945
1303246	Dek	DEK proto-oncogene	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1349075	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DEK gene	PMID:27153756
1303246	Dek	DEK proto-oncogene	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of DEK mRNA	PMID:25102026
1303246	Dek	DEK proto-oncogene	gene	CHEBI:27470	folic acid	affects expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the expression of DEK mRNA	PMID:17320366
1303246	Dek	DEK proto-oncogene	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1349075	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of DEK mRNA	PMID:33512557
1303246	Dek	DEK proto-oncogene	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1349075	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DEK protein	PMID:35688186
1303246	Dek	DEK proto-oncogene	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of DEK mRNA	PMID:28960355
1303246	Dek	DEK proto-oncogene	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of DEK mRNA	PMID:12002526
1303246	Dek	DEK proto-oncogene	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DEK protein	PMID:25505154
1303246	Dek	DEK proto-oncogene	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of DEK mRNA	PMID:19167446
1303246	Dek	DEK proto-oncogene	gene	CHEBI:27899	cisplatin	decreases response to substance	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D002945	DEK protein results in decreased susceptibility to Cisplatin	PMID:21291860
1303246	Dek	DEK proto-oncogene	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1553392	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of DEK protein	PMID:22006019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in decreased expression of DEK mRNA	PMID:18922574
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DEK mRNA	PMID:34747641
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553392	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DEK mRNA	PMID:21570461|PMID:26377647
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DEK mRNA	PMID:32109520|PMID:33387578
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1349075	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of DEK mRNA	PMID:33512557
1303246	Dek	DEK proto-oncogene	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DEK mRNA	PMID:33212167
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28315	alloxanthine	increases secretion	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D010117	DEK protein results in increased secretion of Oxypurinol	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28358	rac-lactic acid	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D019344	DEK protein results in increased chemical synthesis of and results in increased secretion of Lactic Acid	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DEK mRNA	PMID:30556269
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DEK mRNA	PMID:29803840
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of DEK mRNA	PMID:16579640
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D005632	DEK protein results in decreased chemical synthesis of and results in decreased secretion of Fructose	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1349075	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of DEK protein	PMID:35688186
1303246	Dek	DEK proto-oncogene	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DEK mRNA	PMID:38568856
1303246	Dek	DEK proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553392	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DEK mRNA	PMID:22228805
1303246	Dek	DEK proto-oncogene	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DEK mRNA	PMID:30556269
1303246	Dek	DEK proto-oncogene	gene	CHEBI:30751	formic acid	decreases chemical synthesis	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:C030544	DEK protein results in decreased chemical synthesis of formic acid	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20130416	CTD	MESH:C070081	fulvestrant inhibits the reaction [Estradiol results in increased expression of DEK protein]	PMID:23071688
1303246	Dek	DEK proto-oncogene	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of DEK mRNA	PMID:24136188
1303246	Dek	DEK proto-oncogene	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of DEK mRNA	PMID:25729387
1303246	Dek	DEK proto-oncogene	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DEK mRNA	PMID:25729387
1303246	Dek	DEK proto-oncogene	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of DEK mRNA	PMID:24136188
1303246	Dek	DEK proto-oncogene	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1349075	E	RGD:6480464	20150714	CTD	MESH:C009495	titanium dioxide affects the expression of DEK mRNA	PMID:24023007
1303246	Dek	DEK proto-oncogene	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553392	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DEK promoter	PMID:35295148
1303246	Dek	DEK proto-oncogene	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1553392	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DEK gene	PMID:35295148
1303246	Dek	DEK proto-oncogene	gene	CHEBI:32816	pyruvic acid	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D019289	DEK protein results in decreased chemical synthesis of and results in decreased secretion of Pyruvic Acid	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of DEK mRNA	PMID:19167457
1303246	Dek	DEK proto-oncogene	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1349075	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DEK mRNA	PMID:30903817
1303246	Dek	DEK proto-oncogene	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DEK mRNA; bisphenol A results in decreased expression of DEK protein	PMID:29275510|PMID:31675489
1303246	Dek	DEK proto-oncogene	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DEK mRNA	PMID:33221593
1303246	Dek	DEK proto-oncogene	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DEK mRNA	PMID:25181051|PMID:30816183|PMID:32145629
1303246	Dek	DEK proto-oncogene	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DEK gene	PMID:28505145
1303246	Dek	DEK proto-oncogene	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1349075	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of DEK protein	PMID:31675489
1303246	Dek	DEK proto-oncogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553392	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DEK mRNA	PMID:39298647
1303246	Dek	DEK proto-oncogene	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DEK mRNA	PMID:37019170
1303246	Dek	DEK proto-oncogene	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DEK mRNA	PMID:21266533
1303246	Dek	DEK proto-oncogene	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1553392	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of DEK mRNA	PMID:34813904
1303246	Dek	DEK proto-oncogene	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1553392	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of DEK mRNA	PMID:17854601
1303246	Dek	DEK proto-oncogene	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1553392	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DEK mRNA]	PMID:17854601
1303246	Dek	DEK proto-oncogene	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349075	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DEK mRNA	PMID:37042841
1303246	Dek	DEK proto-oncogene	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DEK protein	PMID:33830842
1303246	Dek	DEK proto-oncogene	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349075	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DEK mRNA	PMID:26472689
1303246	Dek	DEK proto-oncogene	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of and results in increased methylation of DEK mRNA	PMID:33830842
1303246	Dek	DEK proto-oncogene	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of DEK gene	PMID:22079235
1303246	Dek	DEK proto-oncogene	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DEK mRNA	PMID:19320972
1303246	Dek	DEK proto-oncogene	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1349075	E	RGD:6480464	20130416	CTD	MESH:D015741	Metribolone results in increased expression of DEK mRNA; Metribolone results in increased expression of DEK protein	PMID:23071688
1303246	Dek	DEK proto-oncogene	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1349075	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of DEK mRNA	PMID:33512557
1303246	Dek	DEK proto-oncogene	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DEK mRNA	PMID:28302478
1303246	Dek	DEK proto-oncogene	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1349075	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of DEK mRNA	PMID:19167446
1303246	Dek	DEK proto-oncogene	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of DEK mRNA	PMID:19167446
1303246	Dek	DEK proto-oncogene	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of DEK mRNA	PMID:39529242
1303246	Dek	DEK proto-oncogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DEK mRNA	PMID:27153767|PMID:40419075
1303246	Dek	DEK proto-oncogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553392	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DEK mRNA	PMID:36331819
1303246	Dek	DEK proto-oncogene	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of DEK mRNA	PMID:23125180
1303246	Dek	DEK proto-oncogene	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of DEK mRNA	PMID:28001369
1303246	Dek	DEK proto-oncogene	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DEK mRNA	PMID:25562108
1303246	Dek	DEK proto-oncogene	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DEK mRNA	PMID:20106945
1303246	Dek	DEK proto-oncogene	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20130416	CTD	MESH:D013629	Tamoxifen results in decreased expression of DEK mRNA; Tamoxifen results in decreased expression of DEK protein	PMID:23071688
1303246	Dek	DEK proto-oncogene	gene	CHEBI:41774	tamoxifen	decreases response to substance	ISO	RGD:1349075	E	RGD:6480464	20130416	CTD	MESH:D013629	DEK protein results in decreased susceptibility to Tamoxifen	PMID:23071688
1303246	Dek	DEK proto-oncogene	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D005947	DEK protein affects the chemical synthesis of and affects the uptake of Glucose	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of DEK mRNA	PMID:16595896
1303246	Dek	DEK proto-oncogene	gene	CHEBI:44215	NAD zwitterion	increases oxidation	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D009243	DEK protein results in increased oxidation of NAD	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1349075	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of DEK mRNA	PMID:28542535
1303246	Dek	DEK proto-oncogene	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1349075	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of DEK mRNA	PMID:31675489
1303246	Dek	DEK proto-oncogene	gene	CHEBI:48430	4-methyl-2-oxopentanoic acid	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:C013082	DEK protein results in decreased chemical synthesis of and results in decreased secretion of alpha-ketoisocaproic acid	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DEK mRNA	PMID:17557909
1303246	Dek	DEK proto-oncogene	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553392	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DEK mRNA	PMID:25620056
1303246	Dek	DEK proto-oncogene	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1553392	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DEK mRNA	PMID:19042947
1303246	Dek	DEK proto-oncogene	gene	CHEBI:53374	gamma-poly(L-glutamic acid) macromolecule	decreases secretion	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D011099	DEK protein results in decreased secretion of Polyglutamic Acid	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DEK protein	PMID:32959892
1303246	Dek	DEK proto-oncogene	gene	CHEBI:61040	phosphorylcholine chloride	decreases chemical synthesis	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D010767	DEK protein results in decreased chemical synthesis of Phosphorylcholine	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of DEK mRNA	PMID:25729387
1303246	Dek	DEK proto-oncogene	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DEK mRNA	PMID:25729387
1303246	Dek	DEK proto-oncogene	gene	CHEBI:6773	Mesaconitine	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in increased expression of DEK protein	PMID:37182599
1303246	Dek	DEK proto-oncogene	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1349075	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DEK mRNA	PMID:31758290
1303246	Dek	DEK proto-oncogene	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1349075	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DEK protein	PMID:34186270
1303246	Dek	DEK proto-oncogene	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DEK mRNA	PMID:22206623
1303246	Dek	DEK proto-oncogene	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1349075	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of DEK protein	PMID:31285264
1303246	Dek	DEK proto-oncogene	gene	CHEBI:78320	2-hydroxypropanoic acid	multiple interactions	ISO	RGD:1349075	E	RGD:6480464	20180116	CTD	MESH:D019344	DEK protein results in increased chemical synthesis of and results in increased secretion of Lactic Acid	PMID:28558019
1303246	Dek	DEK proto-oncogene	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1349075	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of DEK protein	PMID:31675489
1303246	Dek	DEK proto-oncogene	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1349075	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of DEK mRNA	PMID:33512557
1303246	Dek	DEK proto-oncogene	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1349075	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DEK protein	PMID:38348393
1303246	Dek	DEK proto-oncogene	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DEK mRNA	PMID:24780913
1303246	Dek	DEK proto-oncogene	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1349075	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of DEK mRNA	PMID:33512557
1303246	Dek	DEK proto-oncogene	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of DEK protein	PMID:35544339
1303246	Dek	DEK proto-oncogene	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1553392	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DEK mRNA	PMID:35537566
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1616657	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SLC25A47 mRNA]	PMID:19467301
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1616657	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC25A47 mRNA	PMID:36331819
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1345966	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of SLC25A47 mRNA	PMID:22378314
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SLC25A47 mRNA	PMID:39298647
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SLC25A47 mRNA	PMID:32145629
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1616657	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC25A47 mRNA	PMID:25549359
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1345966	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of SLC25A47 mRNA	PMID:33359661
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:17578	toluene	decreases methylation	ISO	RGD:1345966	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased methylation of SLC25A47 gene	PMID:26717081
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1345966	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased expression of SLC25A47 mRNA	PMID:26717081
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1616657	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A47 mRNA	PMID:36331819
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of SLC25A47 mRNA	PMID:21396975
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC25A47 mRNA	PMID:22129741
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1345966	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC25A47 mRNA	PMID:22100608
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1616657	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SLC25A47 mRNA	PMID:31919559
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC25A47 mRNA	PMID:30690589
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC25A47 mRNA	PMID:27339419
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:27385	tetrachloromethane	increases methylation	EXP		E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in increased methylation of SLC25A47 promoter	PMID:30690589
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLC25A47 mRNA	PMID:28189721|PMID:28960355
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SLC25A47 mRNA	PMID:31881176
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1345966	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC25A47 mRNA	PMID:23557933
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC25A47 mRNA	PMID:22298810
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1345966	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC25A47 mRNA	PMID:22298810
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1616657	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC25A47 mRNA	PMID:26377647
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC25A47 mRNA	PMID:21724226
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20150127	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC25A47 mRNA	PMID:19770486|PMID:25270620
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC25A47 mRNA	PMID:26873546|PMID:36227756
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1616657	E	RGD:6480464	20160607	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of SLC25A47 mRNA	PMID:26873546
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC25A47 mRNA	PMID:22129741
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC25A47 mRNA	PMID:19770486|PMID:32417428
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1345966	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC25A47 mRNA	PMID:32234424
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1345966	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC25A47 promoter	PMID:27901495
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1345966	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SLC25A47 gene	PMID:31601247
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC25A47 mRNA	PMID:23411599|PMID:34492290
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SLC25A47 mRNA	PMID:28943392
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SLC25A47 mRNA	PMID:30903817
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1345966	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SLC25A47 gene	PMID:31601247
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1616657	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SLC25A47 gene	PMID:31683443
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SLC25A47 mRNA	PMID:39298647
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1345966	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SLC25A47 gene	PMID:22964155
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SLC25A47 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC25A47 mRNA	PMID:22129741|PMID:28943392
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1345966	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SLC25A47 mRNA	PMID:29024780
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SLC25A47 mRNA	PMID:28511854
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1345966	E	RGD:6480464	20161025	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SLC25A47 mRNA	PMID:27153767
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SLC25A47 gene	PMID:22079235
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1616657	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SLC25A47 mRNA	PMID:28903501
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1616657	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of SLC25A47 mRNA	PMID:28962523
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SLC25A47 mRNA	PMID:17585979
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1616657	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of SLC25A47 mRNA	PMID:39529242
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1345966	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SLC25A47 mRNA	PMID:27153767
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616657	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A47 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC25A47 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC25A47 mRNA	PMID:36331819
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of SLC25A47 mRNA	PMID:29038090
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1345966	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC25A47 gene	PMID:29154799
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1345966	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC25A47 mRNA	PMID:21420995|PMID:25704631
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC25A47 mRNA	PMID:29246445
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1616657	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of SLC25A47 mRNA]	PMID:29246445
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SLC25A47 mRNA	PMID:29391264
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC25A47 mRNA	PMID:35436446
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1616657	E	RGD:6480464	20170303	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of SLC25A47 mRNA	PMID:26873546
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin results in increased expression of SLC25A47 mRNA	PMID:31324951
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:8064	phenformin	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in increased expression of SLC25A47 mRNA	PMID:31324951
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of SLC25A47 mRNA	PMID:19482888
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1616657	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SLC25A47 mRNA]	PMID:19482888
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SLC25A47 mRNA	PMID:21724226
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:81508	2,3,4,7,8-Pentachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C038890	2,3,4,7,8-pentachlorodibenzofuran results in decreased expression of SLC25A47 mRNA	PMID:21724226
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1616657	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SLC25A47 mRNA	PMID:38648751
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1616657	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SLC25A47 mRNA	PMID:21278054
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of SLC25A47 mRNA	PMID:29162477
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1616657	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of SLC25A47 protein	PMID:35357534
1303247	Slc25a47	solute carrier family 25, member 47	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1616657	E	RGD:6480464	20120501	CTD	MESH:D013311	Streptozocin affects the expression of SLC25A47 mRNA	PMID:18583417
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551450	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of JAM3 mRNA	PMID:33045310
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1551450	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of JAM3 mRNA	PMID:37995155
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of JAM3 mRNA	PMID:39752319
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of JAM3 mRNA]	PMID:19467301
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551450	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of JAM3 mRNA	PMID:39241906
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of JAM3 mRNA]	PMID:39241906
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1346212	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of JAM3 mRNA	PMID:30510588
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of JAM3 mRNA	PMID:33387578
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1346212	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of JAM3 mRNA	PMID:37042841
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of JAM3 gene	PMID:30521419
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of JAM3 mRNA	PMID:37992649
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of JAM3 mRNA	PMID:39752319
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:175901	gemcitabine	decreases expression	ISO	RGD:1346212	E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in decreased expression of JAM3 mRNA	PMID:17039268
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of JAM3 mRNA	PMID:37992649
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551450	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of JAM3 mRNA	PMID:33754040
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of JAM3 mRNA	PMID:26577399
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of JAM3 protein	PMID:34122009
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1346212	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of JAM3 protein	PMID:37730182
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1346212	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of JAM3 mRNA	PMID:28818685
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1551450	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of JAM3 mRNA	PMID:37748715
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1551450	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of JAM3 mRNA	PMID:27462272
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of JAM3 mRNA	PMID:39012411
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of JAM3 mRNA	PMID:29950665
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:2422	acetohydrazide	decreases expression	ISO	RGD:1551450	E	RGD:6480464	20120412	CTD	MESH:C014949	acetylhydrazine results in decreased expression of JAM3 mRNA	PMID:15282401
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of JAM3 protein	PMID:33236894
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of JAM3 mRNA	PMID:23385219|PMID:23630614|PMID:25378103|PMID:33354967
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1346212	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of JAM3 intron	PMID:30157460
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of JAM3 mRNA	PMID:35737395
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1346212	E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in increased expression of JAM3 mRNA	PMID:31476115
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1346212	E	RGD:6480464	20160119	CTD	MESH:C011559	tributyltin results in increased expression of JAM3 mRNA	PMID:26314263
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1551450	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of JAM3 mRNA	PMID:17484886
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of JAM3 mRNA	PMID:32525701
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of JAM3 mRNA	PMID:31881176
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1346212	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of JAM3 mRNA	PMID:28903495
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1346212	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of JAM3 promoter	PMID:22847954
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of JAM3 mRNA	PMID:34747641
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of JAM3 mRNA	PMID:21215274
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of JAM3 mRNA	PMID:33387578
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346212	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of JAM3 mRNA	PMID:33212167
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1346212	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of JAM3 mRNA	PMID:32763439
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551450	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of JAM3 mRNA	PMID:39631538
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of JAM3 mRNA	PMID:37992649
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1551450	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of JAM3 gene	PMID:32068019
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1551450	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of JAM3 mRNA	PMID:17127020
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346212	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of JAM3 promoter	PMID:27901495
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551450	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of JAM3 mRNA	PMID:23735875
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1551450	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of JAM3 exon; Benzo(a)pyrene results in decreased methylation of JAM3 intron	PMID:27901495
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1346212	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of JAM3 mRNA	PMID:26314263
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551450	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of JAM3 mRNA	PMID:22228805
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346212	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of JAM3 exon	PMID:27901495
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of JAM3 protein	PMID:34122009
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of JAM3 gene	PMID:31601247
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of JAM3 mRNA	PMID:25729387
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of JAM3 mRNA	PMID:25729387
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551450	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of JAM3 gene	PMID:35295148
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of JAM3 mRNA	PMID:29950665
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of JAM3 mRNA	PMID:34492290
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of JAM3 mRNA	PMID:25181051
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551450	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of JAM3 mRNA	PMID:30951980
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of JAM3 gene	PMID:28505145
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of JAM3 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of JAM3 mRNA	PMID:28628672|PMID:31601247
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1551450	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of JAM3 mRNA	PMID:26682919
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34260	anthracen-2-amine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C006593	2-anthramine results in increased expression of JAM3 mRNA	PMID:23038007
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of JAM3 mRNA	PMID:23196670
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551450	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of JAM3 mRNA	PMID:30951980
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1346212	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of JAM3 intron	PMID:30157460
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551450	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of JAM3 mRNA	PMID:30951980
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of JAM3 mRNA	PMID:28628672
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of JAM3 mRNA	PMID:21241498
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of JAM3 mRNA	PMID:29950665
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of JAM3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of JAM3 mRNA	PMID:28628672
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of JAM3 mRNA]	PMID:39241906
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346212	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of JAM3 mRNA	PMID:37042841
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of JAM3 mRNA	PMID:30723492
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1346212	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of JAM3 mRNA	PMID:25851441
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of JAM3 promoter	PMID:22457795
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of JAM3 mRNA	PMID:39012411
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1346212	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of JAM3 mRNA	PMID:23146750
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1346212	E	RGD:6480464	20160119	CTD	MESH:C018021	cobaltous chloride results in increased expression of JAM3 mRNA	PMID:26314263
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1346212	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of JAM3 promoter	PMID:22847954
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1346212	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of JAM3 promoter	PMID:22847954
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346212	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of JAM3 mRNA	PMID:25979313
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1551450	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of JAM3 mRNA	PMID:17555576
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1346212	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of JAM3 mRNA	PMID:12782123
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of JAM3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of JAM3 mRNA	PMID:28628672
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551450	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of JAM3 mRNA	PMID:28973697
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of JAM3 mRNA	PMID:37992649
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551450	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of JAM3 mRNA	PMID:17562736
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of JAM3 mRNA	PMID:33387578
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of JAM3 mRNA	PMID:32525701
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of JAM3 mRNA	PMID:29391264
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of JAM3 mRNA	PMID:31464424
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1551450	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of JAM3 mRNA	PMID:35436446
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	EXP		E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of JAM3 gene	PMID:37958445
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of JAM3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of JAM3 mRNA	PMID:28628672
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:49747	methylmercury(1+)	increases expression	ISO	RGD:1346212	E	RGD:6480464	20160119	CTD	MESH:C030957	methylmercury II results in increased expression of JAM3 mRNA	PMID:26314263
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of JAM3 mRNA	PMID:31881178
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1551450	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of JAM3 mRNA	PMID:19042947
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:5643	Heliotrine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C010178	heliotrine results in increased expression of JAM3 mRNA	PMID:32419051
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of JAM3 mRNA	PMID:25729387
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of JAM3 mRNA	PMID:25729387
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:6382	Lasiocarpine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C005136	lasiocarpine results in increased expression of JAM3 mRNA	PMID:32419051
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1551450	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of JAM3 mRNA	PMID:14729362
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1346212	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of JAM3 intron	PMID:30157460
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:68508	diethyl maleate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased expression of JAM3 mRNA	PMID:21161181
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of JAM3 mRNA	PMID:39752319
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1346212	E	RGD:6480464	20160119	CTD	MESH:C025589	ochratoxin A metabolite results in increased expression of JAM3 mRNA; ochratoxin A results in increased expression of JAM3 mRNA	PMID:26314263
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1346212	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of JAM3 mRNA	PMID:26314263
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1346212	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of JAM3 mRNA	PMID:32525701
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of JAM3 mRNA	PMID:24780913|PMID:36843608
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of JAM3 mRNA]	PMID:39241906
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1551450	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of JAM3 mRNA	PMID:39752319
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of JAM3 mRNA	PMID:32419051
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1346212	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of JAM3 mRNA	PMID:31863870
1303248	Jam3	junctional adhesion molecule 3	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of JAM3 mRNA	PMID:23034163
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:10033	warfarin	multiple interactions	EXP		E	RGD:6480464	20170418	CTD	MESH:D014859	Warfarin affects the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]	PMID:23928358
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:10033	warfarin	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:D014859	Warfarin affects the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]; Warfarin binds to and results in decreased activity of VKORC1L1 protein; Warfarin inhibits the reaction [VKORC1L1 protein results in increased metabolism of vitamin K1 oxide]; Warfarin inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; Warfarin inhibits the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]	PMID:23710884|PMID:23928358|PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:134975	fluindione	decreases activity	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C017673	fluindione results in decreased activity of VKORC1L1 protein	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:134975	fluindione	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C017673	fluindione inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; fluindione inhibits the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:137426	dehydroacetic acid	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C027493	dehydroacetic acid results in decreased expression of VKORC1L1 protein	PMID:36403723|PMID:38103582
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:137426	dehydroacetic acid	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:C027493	FR 180204 inhibits the reaction [dehydroacetic acid results in decreased expression of VKORC1L1 protein]; VKORC1L1 protein inhibits the reaction [dehydroacetic acid results in decreased secretion of F9 protein]	PMID:36403723|PMID:38103582
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of VKORC1L1 mRNA	PMID:33167477
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in decreased expression of VKORC1L1 protein	PMID:40631627
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:15759	2,3-epoxyphylloquinone	increases metabolic processing	ISO	RGD:1353419	E	RGD:6480464	20240604	CTD	MESH:C016186	VKORC1L1 protein results in increased metabolism of vitamin K1 oxide	PMID:23710884
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:15759	2,3-epoxyphylloquinone	increases reduction	EXP		E	RGD:6480464	20240604	CTD	MESH:C016186	VKORC1L1 protein results in increased reduction of vitamin K1 oxide	PMID:23928358
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:15759	2,3-epoxyphylloquinone	increases reduction	ISO	RGD:1353419	E	RGD:6480464	20240604	CTD	MESH:C016186	VKORC1L1 protein results in increased reduction of vitamin K1 oxide	PMID:23928358|PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:15759	2,3-epoxyphylloquinone	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:C016186	Warfarin affects the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]	PMID:23928358
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:15759	2,3-epoxyphylloquinone	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20240604	CTD	MESH:C016186	[VKORC1L1 protein results in increased reduction of vitamin K1 oxide] which results in increased carboxylation of and results in increased activity of F9 protein; coumachlor inhibits the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]; fluindione inhibits the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]; Warfarin affects the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]; Warfarin inhibits the reaction [VKORC1L1 protein results in increased metabolism of vitamin K1 oxide]; Warfarin inhibits the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]	PMID:23710884|PMID:23928358|PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1551455	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of VKORC1L1 mRNA	PMID:30319688
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of VKORC1L1 mRNA	PMID:29432896
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551455	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of VKORC1L1 mRNA	PMID:39241906
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of VKORC1L1 protein	PMID:32145629
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551455	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of VKORC1L1 mRNA	PMID:39298647
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170418	CTD	MESH:D014241	Trichloroethylene results in increased methylation of VKORC1L1 gene	PMID:27618143
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353419	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of VKORC1L1 mRNA	PMID:37042841
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:D005557	Formaldehyde results in decreased expression of VKORC1L1 mRNA	PMID:23649840
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:C044887	beta-methylcholine affects the expression of VKORC1L1 mRNA	PMID:21179406
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of VKORC1L1 protein	PMID:40631627
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of VKORC1L1 mRNA	PMID:33359661
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1551455	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of VKORC1L1 mRNA	PMID:33848595
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of VKORC1L1 protein	PMID:40631627
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:18067	phylloquinone	increases reduction	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:D010837	VKORC1L1 protein results in increased reduction of Vitamin K 1	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:18067	phylloquinone	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:D010837	4-hydroxycoumarin inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; [VKORC1L1 protein results in increased reduction of Vitamin K 1] which results in increased carboxylation of and results in increased activity of F9 protein; Acenocoumarol inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; bromadiolone inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; bromfenacoum inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; coumachlor inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; coumatetralyl inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; Dicumarol inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; ferulenol inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; fluindione inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; Phenindione inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; Phenprocoumon inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; Warfarin inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of VKORC1L1 mRNA	PMID:39836092
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of VKORC1L1 mRNA	PMID:23649840
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1551455	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of VKORC1L1 mRNA	PMID:27776689
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20170418	CTD	MESH:C016517	indole-3-carbinol affects the expression of VKORC1L1 mRNA	PMID:21396975
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of VKORC1L1 mRNA	PMID:33354967
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of VKORC1L1 mRNA	PMID:23649840
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551455	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of VKORC1L1 mRNA	PMID:34911549
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1551455	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of VKORC1L1 mRNA	PMID:28960355
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D003042	Cocaine affects the expression of VKORC1L1 mRNA	PMID:20187946
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:D009532	Nickel results in decreased expression of VKORC1L1 mRNA	PMID:25583101
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VKORC1L1 mRNA	PMID:33387578|PMID:34747641
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of VKORC1L1 protein	PMID:39603559
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of VKORC1L1 mRNA	PMID:33212167
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:28371	vitamin K epoxide	increases metabolic processing	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:C016186	VKORC1L1 protein results in increased metabolism of vitamin K1 oxide	PMID:23710884
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:28371	vitamin K epoxide	increases reduction	EXP		E	RGD:6480464	20170418	CTD	MESH:C016186	VKORC1L1 protein results in increased reduction of vitamin K1 oxide	PMID:23928358
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:28371	vitamin K epoxide	increases reduction	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:C016186	VKORC1L1 protein results in increased reduction of vitamin K1 oxide	PMID:23928358|PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:28371	vitamin K epoxide	multiple interactions	EXP		E	RGD:6480464	20170418	CTD	MESH:C016186	Warfarin affects the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]	PMID:23928358
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:28371	vitamin K epoxide	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:C016186	[VKORC1L1 protein results in increased reduction of vitamin K1 oxide] which results in increased carboxylation of and results in increased activity of F9 protein; coumachlor inhibits the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]; fluindione inhibits the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]; Warfarin affects the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]; Warfarin inhibits the reaction [VKORC1L1 protein results in increased metabolism of vitamin K1 oxide]; Warfarin inhibits the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]	PMID:23710884|PMID:23928358|PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:28384	vitamin K	increases secretion	EXP		E	RGD:6480464	20230404	CTD	MESH:D014812	VKORC1L1 protein results in increased secretion of Vitamin K	PMID:36403723
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:D024483	Vitamin K 3 affects the expression of VKORC1L1 mRNA	PMID:20044591
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1551455	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of VKORC1L1 intron	PMID:27901495
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551455	E	RGD:6480464	20170411	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of VKORC1L1 mRNA	PMID:22228805
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of VKORC1L1 mRNA	PMID:19150397|PMID:20018196
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D005897	Glafenine results in increased expression of VKORC1L1 mRNA	PMID:24136188
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551455	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VKORC1L1 gene; titanium dioxide results in decreased methylation of VKORC1L1 promoter	PMID:35295148
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551455	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of VKORC1L1 gene	PMID:35295148
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of VKORC1L1 mRNA	PMID:29275510
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551455	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of VKORC1L1 mRNA	PMID:37894381
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:C006780	bisphenol A results in increased expression of VKORC1L1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of VKORC1L1 mRNA	PMID:23829299
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1353419	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of VKORC1L1 protein	PMID:34186270
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1353419	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of VKORC1L1 protein	PMID:34186270
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1551455	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of VKORC1L1 mRNA	PMID:28392331
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of VKORC1L1 mRNA	PMID:21241498
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1551455	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of VKORC1L1 intron	PMID:28392331
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of VKORC1L1 mRNA	PMID:21266533
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1551455	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of VKORC1L1 mRNA	PMID:34813904
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353419	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VKORC1L1 mRNA	PMID:37042841
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of VKORC1L1 mRNA	PMID:39836092
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of VKORC1L1 mRNA	PMID:40419075
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of VKORC1L1 mRNA	PMID:38685447|PMID:41580965
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:40070	4-hydroxycoumarin	decreases activity	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C068805	4-hydroxycoumarin results in decreased activity of VKORC1L1 protein	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:40070	4-hydroxycoumarin	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C068805	4-hydroxycoumarin inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of VKORC1L1 protein	PMID:40631627
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1551455	E	RGD:6480464	20170411	CTD	MESH:D008727	Methotrexate affects the expression of VKORC1L1 mRNA	PMID:18502557
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:C012655	nimesulide results in increased expression of VKORC1L1 mRNA	PMID:24136188
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:4513	dicoumarol	decreases activity	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:D001728	Dicumarol results in decreased activity of VKORC1L1 protein	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:4513	dicoumarol	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:D001728	Dicumarol inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VKORC1L1 mRNA	PMID:22079256
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:50438	phenprocoumon	decreases activity	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:D010644	Phenprocoumon results in decreased activity of VKORC1L1 protein	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:50438	phenprocoumon	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:D010644	Phenprocoumon inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551455	E	RGD:6480464	20170411	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of VKORC1L1 mRNA; Nanotubes, Carbon results in increased expression of VKORC1L1 mRNA	PMID:25554681|PMID:25620056
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of VKORC1L1 mRNA	PMID:38685447|PMID:41580965
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D005485	Flutamide results in increased expression of VKORC1L1 mRNA	PMID:24136188
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1551455	E	RGD:6480464	20170411	CTD	MESH:C015559	trimellitic anhydride results in increased expression of VKORC1L1 mRNA	PMID:19042947
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:53766	acenocoumarol	decreases activity	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:D000074	Acenocoumarol results in decreased activity of VKORC1L1 protein	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:53766	acenocoumarol	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:D000074	Acenocoumarol inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of VKORC1L1 protein	PMID:32959892
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of VKORC1L1 mRNA	PMID:39836092
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1353419	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of VKORC1L1 protein	PMID:34186270
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:C051752	nefazodone results in increased expression of VKORC1L1 mRNA	PMID:24136188
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of VKORC1L1 mRNA	PMID:22079256
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20170411	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VKORC1L1 mRNA	PMID:22079256
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:8066	phenindione	decreases activity	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:D010630	Phenindione results in decreased activity of VKORC1L1 protein	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:8066	phenindione	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:D010630	Phenindione inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:80741	Coumachlor	decreases activity	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C412550	coumachlor results in decreased activity of VKORC1L1 protein	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:80741	Coumachlor	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C412550	coumachlor inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]; coumachlor inhibits the reaction [VKORC1L1 protein results in increased reduction of vitamin K1 oxide]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:80742	Coumatetralyl	decreases activity	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C004699	coumatetralyl results in decreased activity of VKORC1L1 protein	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:80742	Coumatetralyl	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C004699	coumatetralyl inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:81855	Bromadiolone	decreases activity	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C021636	bromadiolone results in decreased activity of VKORC1L1 protein	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:81855	Bromadiolone	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C021636	bromadiolone inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:81892	Brodifacoum	decreases activity	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C013418	bromfenacoum results in decreased activity of VKORC1L1 protein	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:81892	Brodifacoum	multiple interactions	ISO	RGD:1353419	E	RGD:6480464	20191112	CTD	MESH:C013418	bromfenacoum inhibits the reaction [VKORC1L1 protein results in increased reduction of Vitamin K 1]	PMID:29581108
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1551455	E	RGD:6480464	20170411	CTD	MESH:C045950	propiconazole results in increased expression of VKORC1L1 mRNA	PMID:21278054
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D012999	Soman results in increased expression of VKORC1L1 mRNA	PMID:19281266
1303249	Vkorc1l1	vitamin K epoxide reductase complex subunit 1L1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of VKORC1L1 gene	PMID:31682807
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1351816	E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of ZMYND10 mRNA	PMID:19371625
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1351816	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ZMYND10 mRNA	PMID:27188386
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551456	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZMYND10 mRNA	PMID:33045310
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of ZMYND10 mRNA	PMID:35192832
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ZMYND10 mRNA	PMID:33387578
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1351816	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZMYND10 mRNA	PMID:37042841
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1351816	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ZMYND10 mRNA	PMID:36695872
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1351816	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ZMYND10 mRNA	PMID:33359661
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551456	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ZMYND10 mRNA	PMID:34319233
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ZMYND10 mRNA	PMID:26577399
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZMYND10 mRNA	PMID:33387578
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZMYND10 mRNA	PMID:39012411
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1351816	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZMYND10 gene	PMID:28458013
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551456	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ZMYND10 mRNA	PMID:34911549
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1351816	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ZMYND10 mRNA	PMID:19774075
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZMYND10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZMYND10 protein	PMID:38798119
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ZMYND10 mRNA	PMID:31881176
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1551456	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of ZMYND10 mRNA	PMID:18930951
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551456	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZMYND10 mRNA	PMID:26377647
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZMYND10 mRNA	PMID:33387578
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZMYND10 mRNA	PMID:32109520
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551456	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZMYND10 mRNA	PMID:17942748
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1351816	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZMYND10 mRNA	PMID:33212167
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ZMYND10 mRNA	PMID:28959563
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1351816	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased methylation of ZMYND10 gene	PMID:24570342
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZMYND10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZMYND10 protein	PMID:38798119
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351816	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZMYND10 exon	PMID:27901495
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351816	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZMYND10 promoter	PMID:27901495
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1551456	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of ZMYND10 mRNA	PMID:18929588
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of ZMYND10 mRNA	PMID:24395379
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:31767	lead diacetate	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C008261	lead acetate affects the expression of ZMYND10 mRNA	PMID:21864555
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1551456	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of ZMYND10 mRNA	PMID:23557971
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551456	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ZMYND10 mRNA	PMID:23811191
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZMYND10 mRNA	PMID:25181051
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1351816	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of ZMYND10 mRNA	PMID:20170705
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ZMYND10 mRNA	PMID:30816183|PMID:35192832
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1551456	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZMYND10 promoter	PMID:27312807
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1351816	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased methylation of ZMYND10 promoter	PMID:31610501
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ZMYND10 mRNA	PMID:36041667
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551456	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ZMYND10 mRNA	PMID:30951980
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ZMYND10 mRNA	PMID:36041667
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1551456	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ZMYND10 mRNA	PMID:38685157
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551456	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ZMYND10 mRNA	PMID:30951980
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ZMYND10 mRNA	PMID:36041667
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZMYND10 mRNA	PMID:39012411
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of ZMYND10 mRNA	PMID:25539665
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1351816	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ZMYND10 mRNA	PMID:31533062
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1551456	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ZMYND10 mRNA	PMID:23125180
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1351816	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZMYND10 gene	PMID:29154799
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1351816	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ZMYND10 mRNA	PMID:19371625
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1351816	E	RGD:6480464	20120412	CTD	MESH:C012589	[decitabine co-treated with trichostatin A] affects the expression of ZMYND10 mRNA	PMID:18819746
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZMYND10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZMYND10 protein	PMID:38798119
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551456	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZMYND10 mRNA	PMID:17942748
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	ISO	RGD:1351816	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of ZMYND10 mRNA	PMID:38825487
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1351816	E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with trichostatin A] affects the expression of ZMYND10 mRNA	PMID:18819746
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551456	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ZMYND10 mRNA; Nanotubes, Carbon results in decreased expression of ZMYND10 mRNA	PMID:25554681
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1551456	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of ZMYND10 mRNA	PMID:26377693
1303250	Zmynd10	zinc finger, MYND-type containing 10	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1551456	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ZMYND10 mRNA	PMID:38701926
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1347564	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MKRN1 mRNA	PMID:38218311
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MKRN1 mRNA	PMID:30071829
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1551460	E	RGD:6480464	20130806	CTD	MESH:D014212	Tretinoin results in decreased expression of MKRN1 mRNA	PMID:16604517
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1347564	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of MKRN1 mRNA	PMID:23724009|PMID:33167477
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1551460	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MKRN1 mRNA	PMID:30319688
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551460	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MKRN1 mRNA	PMID:39241906
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1347564	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of MKRN1 mRNA	PMID:31614463
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1347564	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MKRN1 mRNA	PMID:28818685
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1347564	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MKRN1 mRNA	PMID:23649840
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1347564	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MKRN1 intron	PMID:30157460
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1347564	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MKRN1 mRNA	PMID:23649840
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551460	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MKRN1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MKRN1 mRNA	PMID:34911549
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551460	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MKRN1 mRNA	PMID:22206623
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551460	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKRN1 mRNA	PMID:40504410
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1347564	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of MKRN1 gene	PMID:31636367
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551460	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MKRN1 mRNA	PMID:18343893|PMID:21570461
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1347564	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of MKRN1 mRNA	PMID:39709020
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1347564	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MKRN1 mRNA	PMID:30851411
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551460	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in decreased expression of MKRN1 mRNA	PMID:25896364
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1347564	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MKRN1 mRNA	PMID:29803840
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551460	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MKRN1 mRNA	PMID:25270620
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347564	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MKRN1 mRNA	PMID:38568856
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1551460	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MKRN1 mRNA	PMID:20883709
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551460	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKRN1 mRNA	PMID:40504410
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347564	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MKRN1 promoter	PMID:27901495
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551460	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MKRN1 mRNA	PMID:22228805
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551460	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MKRN1 gene	PMID:35295148
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MKRN1 mRNA	PMID:32145629|PMID:34947998
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347564	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MKRN1 mRNA	PMID:28628672
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1551460	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MKRN1 mRNA	PMID:17361019|PMID:21266533
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1347564	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MKRN1 mRNA	PMID:28628672
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347564	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MKRN1 mRNA	PMID:37042841
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1347564	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MKRN1 mRNA	PMID:38174414
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1551460	E	RGD:6480464	20130806	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MKRN1 mRNA	PMID:20883709
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1347564	E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in increased expression of MKRN1 mRNA	PMID:19320972|PMID:19376846
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1347564	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MKRN1 mRNA	PMID:31533062
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1347564	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of MKRN1 mRNA	PMID:26352163
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347564	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MKRN1 mRNA	PMID:25979313
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551460	E	RGD:6480464	20130806	CTD	MESH:D014635	Valproic Acid affects the expression of MKRN1 mRNA	PMID:17292431
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1347564	E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of MKRN1 mRNA	PMID:23179753|PMID:25192806
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1347564	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MKRN1 mRNA	PMID:25562108|PMID:27989131
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1347564	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MKRN1 mRNA	PMID:28628672
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551460	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MKRN1 mRNA	PMID:28973697
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1347564	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MKRN1 mRNA	PMID:26272509
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1347564	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MKRN1 mRNA	PMID:27188386
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551460	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKRN1 mRNA	PMID:40504410
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1347564	E	RGD:6480464	20130806	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MKRN1 mRNA	PMID:22079256
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1347564	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MKRN1 mRNA	PMID:28628672
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551460	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MKRN1 mRNA; Nanotubes, Carbon results in increased expression of MKRN1 mRNA	PMID:25554681|PMID:25620056
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of MKRN1 mRNA	PMID:34044035
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of MKRN1 mRNA	PMID:24136188
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of MKRN1 mRNA	PMID:24136188
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1551460	E	RGD:6480464	20130806	CTD	MESH:C017096	n-butoxyethanol results in increased expression of MKRN1 mRNA	PMID:19812364
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1551460	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MKRN1 mRNA	PMID:23650126
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1347564	E	RGD:6480464	20130806	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MKRN1 mRNA	PMID:15336504
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551460	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MKRN1 mRNA	PMID:22206623
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551460	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MKRN1 mRNA	PMID:22206623
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1347564	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MKRN1 mRNA	PMID:22079256
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1347564	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MKRN1 mRNA	PMID:22079256
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1347564	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MKRN1 mRNA	PMID:30851411
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347564	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MKRN1 mRNA	PMID:27188386
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551460	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of MKRN1 mRNA	PMID:23091169
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1551460	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in increased expression of MKRN1 mRNA	PMID:25270620
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1551460	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of MKRN1 mRNA	PMID:18343893
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347564	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MKRN1 mRNA	PMID:27188386
1303251	Mkrn1	makorin ring finger protein 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1551460	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of MKRN1 mRNA	PMID:28973697
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1606319	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ZMYND11 mRNA	PMID:38218311
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606319	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ZMYND11 mRNA	PMID:38218311
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1606319	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of ZMYND11 mRNA	PMID:27188386
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1553407	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ZMYND11 mRNA	PMID:33045310
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606319	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ZMYND11 mRNA	PMID:33167477
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of ZMYND11 mRNA	PMID:32845096
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1553407	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ZMYND11 mRNA	PMID:30319688
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553407	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZMYND11 mRNA	PMID:39241906
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ZMYND11 gene	PMID:27618143
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:17447	geraniol	increases expression	ISO	RGD:1606319	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of ZMYND11 mRNA	PMID:27683099
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553407	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ZMYND11 mRNA	PMID:33754040
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1606319	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ZMYND11 protein	PMID:37730182
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ZMYND11 mRNA	PMID:22061828|PMID:33387578
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553407	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of ZMYND11 mRNA	PMID:37236586
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of ZMYND11 mRNA	PMID:32845096
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1553407	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZMYND11 mRNA	PMID:25629700
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553407	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZMYND11 mRNA	PMID:22206623
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1553407	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in decreased expression of ZMYND11 mRNA	PMID:25270620
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553407	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZMYND11 mRNA	PMID:40504410
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1553407	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of ZMYND11 mRNA	PMID:32186404
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553407	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZMYND11 mRNA	PMID:21570461
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZMYND11 mRNA	PMID:34747641
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553407	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ZMYND11 mRNA	PMID:17942748
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of ZMYND11 mRNA	PMID:19013527
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606319	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZMYND11 mRNA	PMID:33212167
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ZMYND11 mRNA	PMID:30556269
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1553407	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ZMYND11 mRNA	PMID:27862939
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1553407	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of ZMYND11 mRNA	PMID:16508948
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553407	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZMYND11 mRNA	PMID:40504410
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606319	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZMYND11 promoter	PMID:27901495
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1553407	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZMYND11 intron	PMID:27901495
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606319	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZMYND11 5' UTR	PMID:27901495
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ZMYND11 mRNA	PMID:30556269
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1606319	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ZMYND11 mRNA	PMID:25895662
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1606319	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZMYND11 mRNA	PMID:19150397
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553407	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZMYND11 gene	PMID:35295148
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZMYND11 mRNA	PMID:25181051
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ZMYND11 mRNA	PMID:30816183|PMID:34947998
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606319	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of ZMYND11 mRNA	PMID:36232920
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZMYND11 gene	PMID:28505145
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZMYND11 mRNA	PMID:28628672
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1553407	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ZMYND11 intron	PMID:28392331
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ZMYND11 mRNA	PMID:17602206
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZMYND11 mRNA	PMID:21266533
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZMYND11 mRNA	PMID:28628672
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ZMYND11 mRNA	PMID:17602206
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606319	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZMYND11 mRNA	PMID:37042841
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553407	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of ZMYND11 mRNA	PMID:37236586
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606319	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZMYND11 mRNA	PMID:25979313
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606319	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZMYND11 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1606319	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZMYND11 gene	PMID:29154799
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZMYND11 mRNA	PMID:27188386
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553407	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ZMYND11 mRNA	PMID:17555576
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZMYND11 mRNA	PMID:28628672
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1606319	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of ZMYND11 mRNA	PMID:24449571
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1606319	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ZMYND11 mRNA	PMID:28542535
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1606319	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ZMYND11 mRNA	PMID:24935251|PMID:26272509
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZMYND11 mRNA	PMID:27188386
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZMYND11 mRNA	PMID:33387578
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553407	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZMYND11 mRNA	PMID:40504410
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1606319	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ZMYND11 mRNA	PMID:18175754
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1553407	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ZMYND11 mRNA	PMID:17555576
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553407	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ZMYND11 mRNA	PMID:17942748
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553407	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ZMYND11 mRNA	PMID:17942748
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZMYND11 mRNA	PMID:28628672
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553407	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ZMYND11 mRNA; Nanotubes, Carbon results in decreased expression of ZMYND11 mRNA	PMID:25554681
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1606319	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of ZMYND11 mRNA	PMID:20977926
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1606319	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of ZMYND11 mRNA	PMID:26705709
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1553407	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ZMYND11 mRNA	PMID:23650126
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553407	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZMYND11 mRNA	PMID:22206623
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1606319	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ZMYND11 protein	PMID:31285264
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZMYND11 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZMYND11 mRNA	PMID:27188386
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZMYND11 gene]	PMID:28238834
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1553407	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ZMYND11 mRNA	PMID:23091169
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of ZMYND11 mRNA	PMID:35688559
1303252	Zmynd11	zinc finger, MYND-type containing 11	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606319	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZMYND11 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZMYND11 mRNA	PMID:27188386
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1332116	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PYROXD1 mRNA	PMID:37995155
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PYROXD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PYROXD1 mRNA	PMID:32699268
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605346	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of PYROXD1 mRNA	PMID:31614463
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PYROXD1 gene	PMID:27618143
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605346	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PYROXD1 mRNA	PMID:37042841
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:17967	urethane	affects expression	ISO	RGD:1605346	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane affects the expression of PYROXD1 mRNA	PMID:28818685
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PYROXD1 mRNA	PMID:39836092
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332116	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PYROXD1 mRNA	PMID:37236586
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605346	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PYROXD1 mRNA	PMID:19549813
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of PYROXD1 mRNA	PMID:21396975
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PYROXD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PYROXD1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PYROXD1 mRNA	PMID:32699268
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332116	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PYROXD1 mRNA	PMID:31919559
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PYROXD1 mRNA	PMID:39836092
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1605346	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PYROXD1 mRNA	PMID:26272509
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PYROXD1 mRNA	PMID:27188386
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1605346	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of PYROXD1 mRNA	PMID:23300844
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332116	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PYROXD1 mRNA	PMID:21570461
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605346	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PYROXD1 mRNA	PMID:33212167
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1605346	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PYROXD1 mRNA	PMID:32763439
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605346	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PYROXD1 mRNA	PMID:22714537
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605346	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PYROXD1 mRNA	PMID:38568856
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PYROXD1 mRNA	PMID:39836092
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605346	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PYROXD1 promoter	PMID:27901495
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PYROXD1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PYROXD1 gene	PMID:28505145
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332116	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of PYROXD1 mRNA	PMID:33297965
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332116	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PYROXD1 mRNA	PMID:39298647
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1332116	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of PYROXD1 mRNA	PMID:28392331
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1332116	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PYROXD1 mRNA	PMID:37019170
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605346	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PYROXD1 mRNA	PMID:37042841
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PYROXD1 mRNA	PMID:39836092
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1605346	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PYROXD1 mRNA	PMID:38568856
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332116	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PYROXD1 mRNA	PMID:37236586
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1605346	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PYROXD1 mRNA	PMID:19376846
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1605346	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PYROXD1 mRNA	PMID:24449571
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PYROXD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PYROXD1 mRNA	PMID:32699268
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1605346	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PYROXD1 mRNA	PMID:32588087
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605346	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PYROXD1 mRNA	PMID:31533062
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PYROXD1 mRNA	PMID:19167446
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1605346	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PYROXD1 mRNA	PMID:27153767|PMID:40419075
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605346	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PYROXD1 mRNA	PMID:25979313
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1605346	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PYROXD1 gene	PMID:29154799
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605346	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of PYROXD1 mRNA	PMID:28001369
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605346	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PYROXD1 mRNA	PMID:25562108|PMID:27989131
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332116	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PYROXD1 mRNA	PMID:17562736
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PYROXD1 mRNA	PMID:33387578
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PYROXD1 mRNA	PMID:39836092
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1605346	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of PYROXD1 mRNA	PMID:23300844
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1332116	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of PYROXD1 mRNA	PMID:23608068
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605346	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PYROXD1 protein	PMID:32959892
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PYROXD1 mRNA	PMID:39836092
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1605346	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of PYROXD1 mRNA	PMID:28988120
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332116	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PYROXD1 mRNA	PMID:22206623
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PYROXD1 mRNA	PMID:27188386
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PYROXD1 mRNA	PMID:19167446
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605346	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PYROXD1 mRNA	PMID:27188386
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605346	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PYROXD1 mRNA	PMID:38568856
1303253	Pyroxd1	pyridine nucleotide-disulphide oxidoreductase domain 1	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1605346	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of PYROXD1 mRNA	PMID:27188386
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1618774	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZDHHC23 mRNA	PMID:33045310
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1345232	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of ZDHHC23 mRNA	PMID:23830798
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1345232	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of ZDHHC23 mRNA	PMID:21934132
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1345232	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ZDHHC23 mRNA	PMID:20044591
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1345232	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ZDHHC23 mRNA	PMID:21632981
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1345232	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ZDHHC23 mRNA	PMID:30510588
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ZDHHC23 mRNA	PMID:32145629
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1345232	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ZDHHC23 mRNA	PMID:30165855
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1618774	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZDHHC23 mRNA	PMID:39150890
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ZDHHC23 mRNA	PMID:26577399
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:195250	corn oil	affects expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D003314	Corn Oil affects the expression of ZDHHC23 mRNA	PMID:16360708
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZDHHC23 mRNA	PMID:33354967
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of ZDHHC23 mRNA	PMID:19483382
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZDHHC23 mRNA	PMID:31150632
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1345232	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZDHHC23 protein	PMID:35688186
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1618774	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ZDHHC23 mRNA	PMID:28960355
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ZDHHC23 mRNA	PMID:31881176
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in decreased expression of ZDHHC23 mRNA	PMID:25905778
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1345232	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ZDHHC23 mRNA	PMID:27392435
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1345232	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZDHHC23 mRNA	PMID:21632981
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ZDHHC23 mRNA	PMID:28374803
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1345232	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZDHHC23 mRNA	PMID:33212167
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZDHHC23 mRNA	PMID:21839799
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1618774	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZDHHC23 exon; Benzo(a)pyrene results in increased methylation of ZDHHC23 intron	PMID:27901495
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of ZDHHC23 mRNA	PMID:19483382
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1345232	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ZDHHC23 gene	PMID:31601247
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ZDHHC23 mRNA	PMID:30047161
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of ZDHHC23 mRNA	PMID:19483382
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ZDHHC23 mRNA	PMID:19483382
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZDHHC23 mRNA	PMID:25181051
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ZDHHC23 mRNA	PMID:32145629
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1618774	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ZDHHC23 mRNA	PMID:38074096|PMID:39742910
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1345232	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ZDHHC23 mRNA	PMID:29275510
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZDHHC23 gene	PMID:28505145
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1618774	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZDHHC23 gene	PMID:31683443
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1618774	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ZDHHC23 mRNA	PMID:26377693
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1618774	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZDHHC23 mRNA	PMID:39150890
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZDHHC23 mRNA	PMID:18668222
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1618774	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZDHHC23 mRNA	PMID:39150890
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1618774	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZDHHC23 mRNA	PMID:39150890
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1345232	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of ZDHHC23 mRNA	PMID:37047231
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1345232	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZDHHC23 mRNA	PMID:37042841
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of ZDHHC23 mRNA	PMID:30723492
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1618774	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZDHHC23 mRNA	PMID:39150890
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of ZDHHC23 mRNA	PMID:19483382
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1618774	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ZDHHC23 mRNA	PMID:40194260
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1345232	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZDHHC23 gene	PMID:29154799
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1345232	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZDHHC23 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:28001369
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1345232	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZDHHC23 mRNA	PMID:27188386
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ZDHHC23 mRNA	PMID:30047161
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1345232	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZDHHC23 mRNA	PMID:25562108
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1618774	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in increased expression of ZDHHC23 mRNA	PMID:35537566
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1345232	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of ZDHHC23 mRNA	PMID:40706910
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of ZDHHC23 mRNA	PMID:19483382
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ZDHHC23 mRNA	PMID:30047161
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1618774	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ZDHHC23 mRNA	PMID:38701926
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of ZDHHC23 mRNA	PMID:20080153
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1345232	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ZDHHC23 mRNA	PMID:28988120
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1345232	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ZDHHC23 mRNA	PMID:31758290
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of ZDHHC23 mRNA	PMID:19483382
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ZDHHC23 mRNA	PMID:21346803
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of ZDHHC23 mRNA	PMID:19483382
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1345232	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZDHHC23 mRNA	PMID:27188386
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1618774	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ZDHHC23 mRNA	PMID:39150890
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1345232	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZDHHC23 gene]	PMID:28238834
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D010634	Phenobarbital results in decreased expression of ZDHHC23 mRNA	PMID:28520973
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:C010902	[Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in increased expression of ZDHHC23 mRNA	PMID:32207525
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of ZDHHC23 mRNA	PMID:19483382
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZDHHC23 mRNA	PMID:30047161
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1345232	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of ZDHHC23 mRNA	PMID:31734321
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1345232	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZDHHC23 mRNA	PMID:27188386
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ZDHHC23 mRNA	PMID:21346803
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in decreased expression of ZDHHC23 mRNA	PMID:25905778
1303254	Zdhhc23	zDHHC palmitoyltransferase 23	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZDHHC23 mRNA	PMID:21346803
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1352969	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of EIF3D protein	PMID:39638853
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of EIF3D mRNA	PMID:25812627
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EIF3D mRNA]	PMID:31150632
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of EIF3D mRNA	PMID:33167477
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1352969	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of EIF3D mRNA	PMID:22378314
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551512	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EIF3D mRNA	PMID:39241906
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of EIF3D mRNA	PMID:15598610
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551512	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EIF3D mRNA	PMID:39298647
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of EIF3D mRNA	PMID:22061828|PMID:33387578
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1352969	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EIF3D protein	PMID:23301498
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1352969	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF3D protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EIF3D protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of EIF3D protein	PMID:38598786
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EIF3D mRNA	PMID:31150632
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551512	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EIF3D mRNA	PMID:27339419|PMID:31919559
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EIF3D mRNA]	PMID:31150632
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352969	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EIF3D mRNA	PMID:40512198
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551512	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIF3D mRNA	PMID:21570461
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EIF3D mRNA	PMID:33387578
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EIF3D mRNA	PMID:17942748
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF3D mRNA	PMID:17942748
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1352969	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of EIF3D mRNA	PMID:33512557
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1551512	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of EIF3D protein	PMID:28918527
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1352969	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of EIF3D mRNA	PMID:29803840
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1352969	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EIF3D mRNA	PMID:29432896
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of EIF3D protein	PMID:30528433
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352969	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EIF3D mRNA	PMID:40512198
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551512	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EIF3D gene; titanium dioxide results in decreased methylation of EIF3D promoter	PMID:35295148
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1551512	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of EIF3D mRNA	PMID:28472532
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1352969	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of EIF3D mRNA	PMID:30903817
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF3D mRNA	PMID:33296240
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF3D protein	PMID:37567409
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EIF3D mRNA	PMID:25181051|PMID:34947998
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551512	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EIF3D mRNA	PMID:39298647
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551512	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EIF3D mRNA	PMID:37019170
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1551512	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EIF3D mRNA	PMID:17361019
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1551512	E	RGD:6480464	20220607	CTD	MESH:D003993	[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of EIF3D protein	PMID:34864091
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551512	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of EIF3D mRNA	PMID:34813904
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1352969	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of EIF3D protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF3D protein	PMID:38598786
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1551512	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of EIF3D mRNA	PMID:34813904
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of EIF3D mRNA	PMID:32680482
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352969	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EIF3D mRNA	PMID:37042841
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EIF3D mRNA	PMID:21297351
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of EIF3D mRNA	PMID:25812627
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of EIF3D mRNA	PMID:19162173
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of EIF3D mRNA	PMID:24449571
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of EIF3D mRNA	PMID:25812627
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1352969	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EIF3D mRNA	PMID:31533062
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1352969	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of EIF3D mRNA	PMID:26352163
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of EIF3D mRNA	PMID:25812627
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of EIF3D mRNA	PMID:25993096
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1352969	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EIF3D mRNA	PMID:25979313
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of EIF3D mRNA	PMID:17292431
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of EIF3D mRNA	PMID:19101580|PMID:23179753
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of EIF3D mRNA	PMID:21427059
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1352969	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of EIF3D mRNA	PMID:20106945|PMID:25562108
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of EIF3D mRNA	PMID:17555576
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EIF3D mRNA	PMID:17562736
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352969	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EIF3D mRNA	PMID:40512198
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of EIF3D mRNA	PMID:31675489
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of EIF3D mRNA	PMID:17555576
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EIF3D mRNA	PMID:17942748
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF3D mRNA	PMID:17942748
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1551512	E	RGD:6480464	20220607	CTD	MESH:D037742	[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of EIF3D protein	PMID:34864091
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1551512	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of EIF3D mRNA	PMID:15375163
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551512	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EIF3D mRNA	PMID:35964746
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EIF3D mRNA	PMID:24136188
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1551512	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of EIF3D mRNA	PMID:26377693
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1352969	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EIF3D protein	PMID:32959892
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1352969	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EIF3D protein	PMID:37664457
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1352969	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of EIF3D protein	PMID:31285264
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1551512	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of EIF3D mRNA	PMID:30294300
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1352969	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of EIF3D mRNA	PMID:33512557
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1352969	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EIF3D protein	PMID:37664457
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EIF3D mRNA	PMID:21346803
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in increased expression of EIF3D mRNA	PMID:26141394
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1352969	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of EIF3D mRNA	PMID:38568856
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of EIF3D protein	PMID:35544339
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1352969	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of EIF3D protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EIF3D protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of EIF3D protein	PMID:38598786
1303255	Eif3d	eukaryotic translation initiation factor 3, subunit D	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EIF3D mRNA	PMID:21346803
1303256	Prss27	serine protease 27	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1353298	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PRSS27 mRNA	PMID:38218311
1303256	Prss27	serine protease 27	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of PRSS27 mRNA	PMID:21551480
1303256	Prss27	serine protease 27	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PRSS27 mRNA	PMID:33387578
1303256	Prss27	serine protease 27	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1353298	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRSS27 mRNA	PMID:39836092
1303256	Prss27	serine protease 27	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1353298	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of PRSS27 mRNA	PMID:38460933
1303256	Prss27	serine protease 27	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1353298	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PRSS27 mRNA	PMID:38460933
1303256	Prss27	serine protease 27	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1353298	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PRSS27 mRNA	PMID:23557933
1303256	Prss27	serine protease 27	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of PRSS27 gene	PMID:28505145
1303256	Prss27	serine protease 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551519	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRSS27 mRNA	PMID:21570461
1303256	Prss27	serine protease 27	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1353298	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of PRSS27 mRNA	PMID:29955902
1303256	Prss27	serine protease 27	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1353298	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PRSS27 mRNA	PMID:32763439
1303256	Prss27	serine protease 27	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353298	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PRSS27 mRNA	PMID:39719251
1303256	Prss27	serine protease 27	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1353298	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRSS27 mRNA	PMID:39836092
1303256	Prss27	serine protease 27	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353298	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRSS27 intron	PMID:30157460
1303256	Prss27	serine protease 27	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1353298	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PRSS27 exon	PMID:27901495
1303256	Prss27	serine protease 27	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1353298	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PRSS27 mRNA	PMID:25895662
1303256	Prss27	serine protease 27	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1551519	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PRSS27 mRNA	PMID:28472532
1303256	Prss27	serine protease 27	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRSS27 mRNA	PMID:25181051
1303256	Prss27	serine protease 27	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1353298	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PRSS27 gene	PMID:31601247
1303256	Prss27	serine protease 27	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of PRSS27 gene	PMID:28505145
1303256	Prss27	serine protease 27	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1353298	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in decreased expression of PRSS27 mRNA	PMID:27685785
1303256	Prss27	serine protease 27	gene	CHEBI:34682	diazinon	decreases methylation	ISO	RGD:1353298	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of PRSS27 gene	PMID:22964155
1303256	Prss27	serine protease 27	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PRSS27 promoter	PMID:22457795
1303256	Prss27	serine protease 27	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1353298	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRSS27 mRNA	PMID:38174414
1303256	Prss27	serine protease 27	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of PRSS27 mRNA	PMID:25539665
1303256	Prss27	serine protease 27	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PRSS27 gene	PMID:22079235
1303256	Prss27	serine protease 27	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1551519	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PRSS27 mRNA	PMID:18353800
1303256	Prss27	serine protease 27	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1353298	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PRSS27 gene	PMID:29154799
1303256	Prss27	serine protease 27	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1353298	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PRSS27 mRNA	PMID:38832940
1303256	Prss27	serine protease 27	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551519	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PRSS27 mRNA	PMID:17562736
1303256	Prss27	serine protease 27	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1353298	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRSS27 mRNA	PMID:22230336
1303256	Prss27	serine protease 27	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1353298	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PRSS27 mRNA	PMID:38460933
1303256	Prss27	serine protease 27	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1353298	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRSS27 mRNA	PMID:39836092
1303256	Prss27	serine protease 27	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551519	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PRSS27 mRNA	PMID:22206623
1303256	Prss27	serine protease 27	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of PRSS27 mRNA	PMID:23640034
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1602304	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ZC3H18 mRNA	PMID:38218311
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1553476	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZC3H18 mRNA	PMID:33045310
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1602304	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZC3H18 mRNA	PMID:26079696
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ZC3H18 gene	PMID:28931070
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1602304	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ZC3H18 mRNA	PMID:22378314
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of ZC3H18 gene	PMID:30207508
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1553476	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ZC3H18 mRNA	PMID:30319688
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1602304	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of ZC3H18 protein	PMID:35688186
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553476	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZC3H18 mRNA	PMID:39241906
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1602304	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ZC3H18 protein	PMID:37730182
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1602304	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ZC3H18 mRNA	PMID:39836092
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553476	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZC3H18 mRNA	PMID:28111341
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1553476	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ZC3H18 protein]	PMID:32272095
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1602304	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZC3H18 mRNA	PMID:22100608
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602304	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ZC3H18 mRNA	PMID:35430440
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1553476	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ZC3H18 mRNA	PMID:25629700
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602304	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ZC3H18 mRNA	PMID:40512198
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1602304	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ZC3H18 protein	PMID:35688186
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1602304	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ZC3H18 mRNA	PMID:27392435
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553476	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZC3H18 mRNA	PMID:21570461
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1602304	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZC3H18 mRNA	PMID:33212167
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602304	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZC3H18 mRNA	PMID:29803840
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1602304	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of ZC3H18 protein	PMID:35688186
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602304	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZC3H18 protein	PMID:38228842
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602304	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZC3H18 mRNA	PMID:38568856|PMID:39719251
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602304	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ZC3H18 mRNA	PMID:40512198
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553476	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZC3H18 mRNA	PMID:22228805
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602304	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZC3H18 3' UTR	PMID:27901495
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1553476	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of ZC3H18 protein	PMID:37955338
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553476	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZC3H18 gene	PMID:35295148
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1553476	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZC3H18 promoter	PMID:35295148
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZC3H18 mRNA	PMID:25181051
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553476	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZC3H18 mRNA	PMID:33221593
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ZC3H18 mRNA	PMID:30816183|PMID:32528016
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1602304	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of ZC3H18 protein	PMID:31945527
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1553476	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZC3H18 gene	PMID:31683443
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553476	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZC3H18 mRNA	PMID:37019170
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1553476	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of ZC3H18 protein	PMID:32272095
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1553476	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ZC3H18 protein]	PMID:32272095
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602304	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZC3H18 mRNA	PMID:37042841
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1602304	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ZC3H18 mRNA	PMID:39836092
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602304	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZC3H18 mRNA	PMID:38568856
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553476	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZC3H18 mRNA	PMID:28111341
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1553476	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of ZC3H18 mRNA	PMID:25908611
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1602304	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZC3H18 mRNA	PMID:28302478
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602304	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZC3H18 mRNA	PMID:31533062
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553476	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ZC3H18 mRNA	PMID:36331819
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602304	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZC3H18 gene	PMID:29154799
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602304	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ZC3H18 mRNA	PMID:40512198
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1602304	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of ZC3H18 mRNA	PMID:38568856
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1553476	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ZC3H18 mRNA	PMID:35964746
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1602304	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ZC3H18 mRNA	PMID:22714537
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1602304	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ZC3H18 mRNA	PMID:39836092
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553476	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ZC3H18 mRNA	PMID:22206623
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:756894	tak-243	affects sumoylation	ISO	RGD:1602304	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of ZC3H18 protein	PMID:31285264
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of ZC3H18 protein	PMID:28903499
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1553476	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ZC3H18 mRNA	PMID:40826991
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1602304	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of ZC3H18 mRNA	PMID:24921660
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ZC3H18 mRNA	PMID:21346803
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1602304	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZC3H18 mRNA	PMID:38568856
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of ZC3H18 protein	PMID:35544339
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZC3H18 mRNA	PMID:21346803
1303257	Zc3h18	zinc finger CCCH-type containing 18	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1553476	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ZC3H18 mRNA	PMID:28973697
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of MID1IP1 mRNA	PMID:21551480
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1344749	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MID1IP1 mRNA	PMID:26272509
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA	PMID:27188386
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MID1IP1 mRNA	PMID:33045310
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1553477	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MID1IP1 mRNA	PMID:37995155
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553477	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MID1IP1 gene	PMID:20938992
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1344749	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MID1IP1 mRNA	PMID:33167477
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1344749	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MID1IP1 mRNA	PMID:22378314
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1553477	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MID1IP1 mRNA	PMID:30319688
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1553477	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of MID1IP1 mRNA	PMID:19167417|PMID:30319688
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MID1IP1 mRNA	PMID:39241906
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MID1IP1 mRNA	PMID:32145629
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MID1IP1 mRNA	PMID:39298647
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1553477	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of MID1IP1 mRNA	PMID:33711761
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553477	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MID1IP1 gene	PMID:20938992
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D014050	Toluene results in decreased expression of MID1IP1 mRNA	PMID:22166486
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MID1IP1 mRNA	PMID:34319233
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of MID1IP1 mRNA	PMID:28522335
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553477	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MID1IP1 mRNA	PMID:37236586
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1344749	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MID1IP1 mRNA	PMID:23649840
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1344749	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MID1IP1 mRNA	PMID:27153756
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MID1IP1 mRNA	PMID:19770486
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1344749	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MID1IP1 mRNA	PMID:23649840
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MID1IP1-AS1 mRNA] which results in increased expression of MID1IP1 mRNA	PMID:33656867
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MID1IP1 mRNA	PMID:31919559
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553477	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MID1IP1 gene	PMID:20938992
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1344749	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MID1IP1 gene	PMID:25304211
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MID1IP1 mRNA	PMID:39836092
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MID1IP1 mRNA	PMID:31881176
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1344749	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of MID1IP1 mRNA	PMID:27392435|PMID:27594783
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1553477	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of MID1IP1 mRNA	PMID:40618947
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MID1IP1 mRNA	PMID:22298810
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553477	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MID1IP1 mRNA	PMID:21570461|PMID:26377647|PMID:28922406
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MID1IP1 mRNA	PMID:21215274|PMID:33387578
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1344749	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MID1IP1 mRNA	PMID:20106945|PMID:21632981
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MID1IP1 mRNA	PMID:19770486|PMID:19933214|PMID:26290441
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MID1IP1 mRNA	PMID:34747641
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of MID1IP1 protein	PMID:35544339
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:2825	aristolochic acid A	multiple interactions	EXP		E	RGD:6480464	20160510	CTD	MESH:C000228	[aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of MID1IP1 mRNA	PMID:23912714
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:1553477	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in increased expression of MID1IP1 mRNA	PMID:18579281
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of MID1IP1 mRNA	PMID:39631538
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MID1IP1 mRNA	PMID:39836092
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1344749	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of MID1IP1 mRNA	PMID:29453283
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344749	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MID1IP1 3' UTR; Benzo(a)pyrene affects the methylation of MID1IP1 5' UTR; Benzo(a)pyrene affects the methylation of MID1IP1 promoter	PMID:27901495
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1344749	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MID1IP1 mRNA	PMID:32234424
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MID1IP1 mRNA	PMID:19770486|PMID:21715664
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MID1IP1 mRNA	PMID:21839799
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1344749	E	RGD:6480464	20190910	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MID1IP1 mRNA	PMID:31255691
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553477	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MID1IP1 mRNA	PMID:22228805
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1553477	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MID1IP1 mRNA]	PMID:22228805
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1344749	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MID1IP1 mRNA	PMID:20018196|PMID:20382639
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1344749	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of MID1IP1 mRNA	PMID:38568856
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of MID1IP1 mRNA	PMID:32479839
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MID1IP1 mRNA	PMID:30047161
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of MID1IP1 mRNA	PMID:24136188
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553477	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MID1IP1 gene; titanium dioxide results in decreased methylation of MID1IP1 promoter	PMID:35295148
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1553477	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MID1IP1 promoter	PMID:35295148
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MID1IP1 mRNA	PMID:34492290
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MID1IP1 mRNA	PMID:25380136
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of MID1IP1 mRNA	PMID:18445702|PMID:23811191
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553477	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in increased expression of MID1IP1 mRNA	PMID:25270620
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MID1IP1 mRNA	PMID:19710929
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1553477	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MID1IP1 mRNA	PMID:28472532
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MID1IP1 mRNA	PMID:30816183
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of MID1IP1 mRNA	PMID:35598803
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MID1IP1 mRNA	PMID:25181051|PMID:32145629
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1344749	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MID1IP1 mRNA; bisphenol A results in increased expression of MID1IP1 protein	PMID:25047013|PMID:34186270
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1553477	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MID1IP1 mRNA	PMID:26682919
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1344749	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MID1IP1 mRNA	PMID:23146750
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MID1IP1 mRNA	PMID:40203079
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1344749	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MID1IP1 protein	PMID:34186270
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553477	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MID1IP1 mRNA	PMID:39298647
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1344749	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of MID1IP1 protein	PMID:34186270
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1344749	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MID1IP1 protein	PMID:34186270
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MID1IP1 mRNA	PMID:17361019|PMID:21266533
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of MID1IP1 mRNA	PMID:18164116
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344749	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MID1IP1 mRNA	PMID:37042841
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of MID1IP1 mRNA	PMID:30589522
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of MID1IP1 mRNA	PMID:25380136
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MID1IP1 mRNA	PMID:25993096|PMID:33453195
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553477	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MID1IP1 mRNA	PMID:37236586
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of MID1IP1 mRNA	PMID:26194646
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of MID1IP1 gene	PMID:22079235
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of MID1IP1 mRNA	PMID:25380136
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1344749	E	RGD:6480464	20190910	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of MID1IP1 mRNA	PMID:31255691
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1553477	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of MID1IP1 mRNA	PMID:28962523
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1553477	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of MID1IP1 mRNA	PMID:18353800
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1553477	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of MID1IP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MID1IP1 mRNA]	PMID:17585979
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344749	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MID1IP1 mRNA	PMID:25979313
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1553477	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MID1IP1 mRNA	PMID:17292431|PMID:17963808
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1344749	E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in decreased expression of MID1IP1 mRNA	PMID:22083351|PMID:23179753|PMID:29154799
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344749	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MID1IP1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA	PMID:27188386
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1344749	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of MID1IP1 mRNA	PMID:25562108
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1344749	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MID1IP1 mRNA	PMID:20106945|PMID:27989131
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553477	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MID1IP1 mRNA	PMID:20937368
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MID1IP1 mRNA	PMID:28973697
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1553477	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MID1IP1 mRNA	PMID:28973697
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D008727	Methotrexate results in decreased expression of MID1IP1 mRNA	PMID:24136188
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1344749	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of MID1IP1 mRNA	PMID:17379860
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of MID1IP1 mRNA	PMID:24136188
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1344749	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MID1IP1 mRNA	PMID:26272509
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA	PMID:27188386
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1344749	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MID1IP1 mRNA	PMID:28542535
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1344749	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MID1IP1 mRNA	PMID:24935251|PMID:26272509
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA	PMID:27188386
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20211109	CTD	MESH:C013503	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MID1IP1-AS1 mRNA] which results in increased expression of MID1IP1 mRNA	PMID:33656867
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553477	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MID1IP1 mRNA	PMID:17562736
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of MID1IP1 mRNA	PMID:32479839|PMID:33387578
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1553477	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of MID1IP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MID1IP1 mRNA]	PMID:17585979
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1344749	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MID1IP1 gene	PMID:25304211
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MID1IP1 mRNA	PMID:39836092
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MID1IP1 mRNA	PMID:35436446
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1344749	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of MID1IP1 mRNA	PMID:38568856
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MID1IP1 mRNA; Nanotubes, Carbon results in decreased expression of MID1IP1 mRNA	PMID:25554681|PMID:25620056
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MID1IP1 mRNA	PMID:30047161
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1553477	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MID1IP1 mRNA	PMID:35964746
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of MID1IP1 mRNA	PMID:24793618
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of MID1IP1 mRNA	PMID:24136188
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MID1IP1 mRNA	PMID:15003993
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of MID1IP1 mRNA	PMID:36907384
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin results in increased expression of MID1IP1 mRNA	PMID:31324951
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1553477	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in increased expression of MID1IP1 mRNA	PMID:36914120
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1344749	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MID1IP1 protein	PMID:34186270
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553477	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MID1IP1 mRNA	PMID:22206623
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of MID1IP1 mRNA	PMID:24136188
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1344749	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MID1IP1 mRNA	PMID:37199045
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of MID1IP1 mRNA	PMID:18164116
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of MID1IP1 mRNA	PMID:23665939
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA	PMID:27188386
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1553477	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MID1IP1 mRNA	PMID:23091169
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of MID1IP1 mRNA	PMID:30047161
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1553477	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MID1IP1 mRNA	PMID:39847705
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MID1IP1 mRNA	PMID:24780913
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MID1IP1 mRNA	PMID:30047161
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1344749	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of MID1IP1 mRNA	PMID:26272509
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA	PMID:27188386
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344749	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MID1IP1 mRNA	PMID:27188386
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MID1IP1 mRNA	PMID:19281266
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1344749	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MID1IP1 mRNA	PMID:38568856
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1344749	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MID1IP1 mRNA	PMID:29301935
1303258	Mid1ip1	MID1 interacting protein 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C025643	vinclozolin results in increased expression of MID1IP1 mRNA	PMID:30207508
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1352647	E	RGD:6480464	20120412	CTD	MESH:D015215	Zidovudine results in increased expression of ATP5MG mRNA	PMID:16894629
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1352647	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ATP5MG mRNA	PMID:38218311
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C084079	triptonide results in increased expression of ATP5MG mRNA	PMID:33045310
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1352647	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ATP5MG mRNA	PMID:22378314
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551535	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATP5MG mRNA	PMID:39241906
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1352647	E	RGD:6480464	20230704	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5MG mRNA	PMID:31059760
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004958	Estradiol results in decreased expression of ATP5MG protein	PMID:32145629
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP5MG mRNA	PMID:25510870
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1551535	E	RGD:6480464	20260707	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ATP5MG mRNA	PMID:35550907
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551535	E	RGD:6480464	20260707	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATP5MG mRNA	PMID:33754040
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:207229	dihydroartemisinin	affects binding	ISO	RGD:1352647	E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to ATP5MG protein	PMID:26340163
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP5MG mRNA	PMID:25510870
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP5MG mRNA	PMID:25510870
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1352647	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATP5MG gene	PMID:27153756
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATP5MG mRNA	PMID:34911549
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D005492	Folic Acid results in decreased expression of ATP5MG mRNA	PMID:25629700
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5MG mRNA	PMID:22206623
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352647	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATP5MG mRNA	PMID:40512198
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:27698	vanadium atom	increases expression	ISO	RGD:1352647	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of ATP5MG mRNA	PMID:19000753
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ATP5MG mRNA	PMID:31881176
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C059514	Resveratrol results in increased expression of ATP5MG mRNA	PMID:22610192
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1352647	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP5MG mRNA	PMID:23557933
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of ATP5MG protein	PMID:22023808
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D014414	Tungsten results in increased expression of ATP5MG mRNA	PMID:30912803
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATP5MG mRNA	PMID:21570461
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATP5MG mRNA	PMID:34747641
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATP5MG mRNA	PMID:20399798
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5MG mRNA	PMID:17942748
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1352647	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of ATP5MG mRNA	PMID:18191903
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1352647	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ATP5MG mRNA	PMID:28001369
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1352647	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ATP5MG mRNA	PMID:29803840
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of ATP5MG protein	PMID:29459688
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352647	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ATP5MG mRNA	PMID:34032870
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352647	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATP5MG mRNA	PMID:40512198
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352647	E	RGD:6480464	20230704	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATP5MG promoter	PMID:27901495
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C015001	arsenite results in decreased expression of ATP5MG mRNA	PMID:33053406
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1352647	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ATP5MG mRNA]; arsenite promotes the reaction [G3BP1 protein binds to ATP5MG protein]	PMID:32406909
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:3020	benzalkonium chloride	decreases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D001548	Benzalkonium Compounds results in decreased expression of ATP5MG mRNA	PMID:31199489
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1352647	E	RGD:6480464	20230704	CTD	MESH:C015358	methylparaben results in increased expression of ATP5MG mRNA	PMID:17121429
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ATP5MG mRNA	PMID:30047161
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1352647	E	RGD:6480464	20190910	CTD	MESH:C009495	titanium dioxide results in decreased expression of ATP5MG protein	PMID:30910687
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ATP5MG mRNA	PMID:34492290
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of ATP5MG mRNA	PMID:18648102
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C006780	bisphenol A affects the expression of ATP5MG mRNA	PMID:30903817
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1352647	E	RGD:6480464	20230704	CTD	MESH:C006780	bisphenol A affects the expression of ATP5MG mRNA	PMID:30903817
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ATP5MG mRNA; bisphenol A results in increased expression of ATP5MG protein	PMID:25181051|PMID:30816183|PMID:32145629
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1352647	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ATP5MG protein	PMID:37567409
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C006780	bisphenol A results in increased expression of ATP5MG mRNA	PMID:33221593|PMID:38074096
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP5MG mRNA	PMID:25510870
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP5MG mRNA	PMID:25510870
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551535	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ATP5MG mRNA	PMID:39298647
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ATP5MG mRNA	PMID:21266533
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D005284	Fenthion results in increased expression of ATP5MG mRNA	PMID:34813904
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352647	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATP5MG mRNA	PMID:37042841
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ATP5MG mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ATP5MG mRNA	PMID:35163327
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:351346	phenethyl isothiocyanate	affects binding	ISO	RGD:1352647	E	RGD:6480464	20120717	CTD	MESH:C058305	ATP5MG protein binds to phenethyl isothiocyanate	PMID:21838287
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:35170	vanadium(0)	increases expression	ISO	RGD:1352647	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of ATP5MG mRNA	PMID:19000753
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ATP5MG mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ATP5MG mRNA	PMID:35163327
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ATP5MG gene	PMID:22079235
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D002994	Clofibrate results in decreased expression of ATP5MG mRNA	PMID:17585979
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1352647	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ATP5MG mRNA	PMID:31533062
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1352647	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of ATP5MG mRNA	PMID:26352163
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ATP5MG mRNA	PMID:20936131
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ATP5MG mRNA; PPARA protein inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of ATP5MG mRNA]	PMID:20936131|PMID:36331819
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1352647	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATP5MG mRNA	PMID:25979313
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1352647	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ATP5MG mRNA	PMID:19101580
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000640	Amitrole results in increased expression of ATP5MG mRNA	PMID:30047161
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1352647	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATP5MG mRNA	PMID:20106945|PMID:22147139
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1352647	E	RGD:6480464	20230704	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATP5MG mRNA	PMID:31059760
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1352647	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of ATP5MG mRNA	PMID:25704631
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1352647	E	RGD:6480464	20230704	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5MG mRNA	PMID:31059760
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1352647	E	RGD:6480464	20230704	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ATP5MG mRNA	PMID:29432896
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352647	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATP5MG mRNA	PMID:40512198
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C109476	epoxiconazole results in increased expression of ATP5MG mRNA	PMID:35436446
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ATP5MG mRNA	PMID:17942748
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5MG mRNA	PMID:17942748
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in increased expression of ATP5MG protein	PMID:39793947
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ATP5MG mRNA; Nanotubes, Carbon results in increased expression of ATP5MG mRNA	PMID:25620056
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D008713	Methimazole results in increased expression of ATP5MG mRNA	PMID:30047161
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:C031180	chrysene results in decreased expression of ATP5MG mRNA	PMID:26377693
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:6030	isoniazide	increases expression	ISO	RGD:1352647	E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of ATP5MG mRNA; Isoniazid results in increased expression of ATP5MG protein	PMID:40015660
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1352647	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ATP5MG protein	PMID:32959892
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:63630	tolcapone	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to ATP5MG protein	PMID:19783845
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of ATP5MG mRNA	PMID:24136188
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ATP5MG protein	PMID:26558463
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:6773	Mesaconitine	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in increased expression of ATP5MG protein	PMID:37182599
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1352647	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ATP5MG mRNA	PMID:25912373
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ATP5MG mRNA	PMID:22206623
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551535	E	RGD:6480464	20230704	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5MG mRNA	PMID:22206623
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:749016	gossypol acetic acid	decreases expression	ISO	RGD:1352647	E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of ATP5MG protein	PMID:29938581
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1352647	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of ATP5MG mRNA	PMID:22576131
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352647	E	RGD:6480464	20230704	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATP5MG gene]	PMID:28238834
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATP5MG mRNA	PMID:30047161
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:88542	Butylparaben	increases expression	ISO	RGD:1352647	E	RGD:6480464	20230704	CTD	MESH:C038091	butylparaben results in increased expression of ATP5MG mRNA	PMID:17121429
1303259	Atp5mg	ATP synthase membrane subunit G	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ATP5MG mRNA	PMID:23034163
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20211109	CTD	MESH:C007262	deoxynivalenol results in decreased expression of TOMM22 protein	PMID:33890134
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TOMM22 mRNA	PMID:33167477
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TOMM22 mRNA	PMID:22378314
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TOMM22 mRNA	PMID:21632981
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1623801	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TOMM22 mRNA	PMID:39241906
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1342792	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TOMM22 mRNA	PMID:38568856
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TOMM22 mRNA	PMID:33387578
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1342792	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TOMM22 protein	PMID:37730182
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623801	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TOMM22 mRNA	PMID:36331819
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM22 mRNA	PMID:39836092
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TOMM22 protein	PMID:34915118
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1623801	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TOMM22 mRNA	PMID:37236586
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TOMM22 mRNA	PMID:23649840
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of TOMM22 protein	PMID:33236894
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1342792	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TOMM22 mRNA	PMID:27153756
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TOMM22 mRNA	PMID:23649840
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM22 mRNA	PMID:39836092
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1623801	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of TOMM22 mRNA	PMID:22610192
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1623801	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of TOMM22 mRNA	PMID:30912803
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623801	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TOMM22 mRNA	PMID:21570461
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TOMM22 mRNA	PMID:33387578
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TOMM22 mRNA	PMID:30851411
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1342792	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of TOMM22 protein	PMID:35688186
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1342792	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of TOMM22 mRNA	PMID:20044591
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TOMM22 mRNA	PMID:38568856
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in increased expression of TOMM22 protein	PMID:38266420
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1342792	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TOMM22 mRNA	PMID:34032870
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1623801	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of TOMM22 protein	PMID:29044176
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM22 mRNA	PMID:39836092
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of TOMM22 mRNA	PMID:22378314
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TOMM22 mRNA	PMID:20106945
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1623801	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TOMM22 mRNA	PMID:27195522
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1623801	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of TOMM22 mRNA	PMID:33053406
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TOMM22 mRNA]	PMID:32406909
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:3000	beauvericin	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20200915	CTD	MESH:C004456	[beauvericin co-treated with enniatins] results in decreased expression of TOMM22 protein	PMID:32407736
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1623801	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TOMM22 promoter	PMID:27334623
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TOMM22 mRNA	PMID:25181051|PMID:41034487
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1623801	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TOMM22 mRNA	PMID:39298647
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623801	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TOMM22 mRNA	PMID:37019170
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TOMM22 mRNA	PMID:17602206
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1623801	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TOMM22 mRNA	PMID:17361019|PMID:21266533
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TOMM22 mRNA	PMID:17602206
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM22 mRNA	PMID:39836092
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TOMM22 mRNA	PMID:30917596
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1623801	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TOMM22 mRNA	PMID:37236586
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of TOMM22 gene	PMID:22079235
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TOMM22 mRNA	PMID:19376846
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623801	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TOMM22 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TOMM22 mRNA	PMID:36331819
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1342792	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TOMM22 gene	PMID:29154799
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of TOMM22 mRNA	PMID:22230336|PMID:25704631
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:46680	serpentine asbestos	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of TOMM22 mRNA	PMID:21148743
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM22 mRNA	PMID:39836092
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in increased expression of TOMM22 protein	PMID:39793947
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TOMM22 mRNA	PMID:24136188
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TOMM22 protein	PMID:32959892
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOMM22 mRNA	PMID:39836092
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:64648	enniatin	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20200915	CTD	MESH:C100264	[beauvericin co-treated with enniatins] results in decreased expression of TOMM22 protein	PMID:32407736
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TOMM22 protein	PMID:37664457
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TOMM22 mRNA	PMID:30851411
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1623801	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TOMM22 mRNA	PMID:30294300
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1342792	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TOMM22 protein	PMID:37664457
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TOMM22 mRNA	PMID:19281266
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TOMM22 mRNA	PMID:38568856
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1342792	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TOMM22 mRNA	PMID:29301935
1303260	Tomm22	translocase of outer mitochondrial membrane 22	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TOMM22 mRNA	PMID:21346803
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1605075	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RTCB mRNA	PMID:38218311
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1332057	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RTCB mRNA	PMID:30319688
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol results in increased expression of RTCB protein	PMID:19609968
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332057	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RTCB mRNA	PMID:39241906
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332057	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RTCB mRNA	PMID:39298647
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605075	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RTCB mRNA	PMID:37042841
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1605075	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RTCB protein	PMID:37730182
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1332057	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of RTCB mRNA	PMID:27462272
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RTCB mRNA	PMID:35301059
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RTCB protein	PMID:23301498
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of RTCB protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of RTCB protein	PMID:38598786
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332057	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RTCB mRNA	PMID:22206623
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332057	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTCB mRNA	PMID:40504410
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of RTCB protein	PMID:38460933
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RTCB mRNA	PMID:23557933
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1605075	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RTCB mRNA	PMID:19921347
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RTCB mRNA	PMID:33387578
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332057	E	RGD:6480464	20131210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RTCB mRNA	PMID:18796159|PMID:19465110
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332057	E	RGD:6480464	20131210	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RTCB mRNA	PMID:16214954
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605075	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RTCB mRNA	PMID:38568856
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332057	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTCB mRNA	PMID:40504410
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [RTCB protein binds to CAPRIN1 protein]	PMID:33939924
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605075	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RTCB promoter	PMID:27901495
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332057	E	RGD:6480464	20131210	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RTCB mRNA	PMID:22228805
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RTCB mRNA]	PMID:32406909
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1605075	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of RTCB mRNA	PMID:31745603
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RTCB mRNA	PMID:30047161
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of RTCB mRNA	PMID:30816183
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605075	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of RTCB protein	PMID:34186270
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in increased expression of RTCB mRNA	PMID:25181051|PMID:34947998
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332057	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RTCB mRNA	PMID:39298647
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1605075	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of RTCB protein	PMID:34186270
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1332057	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RTCB mRNA	PMID:38685157
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1605075	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RTCB protein	PMID:34186270
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RTCB mRNA	PMID:28628672
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1605075	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RTCB protein	PMID:34186270
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1332057	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RTCB mRNA	PMID:37019170
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of RTCB protein	PMID:38598786
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RTCB mRNA	PMID:28628672
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RTCB mRNA	PMID:35301059
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of RTCB mRNA	PMID:30047161
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1605075	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of RTCB protein	PMID:34122009
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332057	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RTCB mRNA	PMID:36331819
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605075	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RTCB mRNA	PMID:25979313
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RTCB mRNA	PMID:30047161
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RTCB mRNA	PMID:28628672
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332057	E	RGD:6480464	20131210	CTD	MESH:D000082	Acetaminophen affects the expression of RTCB mRNA	PMID:17562736
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of RTCB protein	PMID:38460933
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332057	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTCB mRNA	PMID:40504410
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RTCB mRNA	PMID:28628672
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RTCB mRNA	PMID:30047161
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332057	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RTCB mRNA	PMID:35964746
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RTCB mRNA	PMID:24136188
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605075	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RTCB protein	PMID:32959892
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1605075	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RTCB protein	PMID:34186270
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332057	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RTCB mRNA	PMID:22206623
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332057	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RTCB mRNA	PMID:22206623
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RTCB protein	PMID:37664457
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RTCB mRNA	PMID:24136188
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1605075	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of RTCB protein	PMID:39638853
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RTCB gene]	PMID:28238834
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of RTCB protein	PMID:28903499
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1605075	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RTCB protein	PMID:38348393
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1332057	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RTCB mRNA	PMID:39847705
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of RTCB mRNA	PMID:30047161
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RTCB mRNA	PMID:30047161
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RTCB protein	PMID:37664457
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of RTCB protein	PMID:35544339
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1605075	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of RTCB protein	PMID:38598786
1303261	Rtcb	RNA 2',3'-cyclic phosphate and 5'-OH ligase	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of RTCB mRNA	PMID:23555832
1303262	Btnl3	butyrophilin-like 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in decreased expression of BTNL3 mRNA	PMID:25181051|PMID:41034487
1303262	Btnl3	butyrophilin-like 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of BTNL3 mRNA	PMID:19162173
1303262	Btnl3	butyrophilin-like 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BTNL1 mRNA	PMID:27291303
1303263	Gk2	glycerol kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1353777	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of GK2 mRNA	PMID:33167477
1303263	Gk2	glycerol kinase 2	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	ISO	RGD:1353777	E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of GK2 mRNA	PMID:39245080
1303263	Gk2	glycerol kinase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553485	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of GK2 mRNA	PMID:34319233
1303263	Gk2	glycerol kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1353777	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GK2 mRNA	PMID:35301059
1303263	Gk2	glycerol kinase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1353777	E	RGD:6480464	20131220	CTD	MESH:D019327	Copper Sulfate results in increased expression of GK2 mRNA	PMID:19549813
1303263	Gk2	glycerol kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553485	E	RGD:6480464	20140722	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GK2 mRNA	PMID:17942748
1303263	Gk2	glycerol kinase 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1553485	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of GK2 protein	PMID:28918527
1303263	Gk2	glycerol kinase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353777	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GK2 promoter	PMID:27901495
1303263	Gk2	glycerol kinase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553485	E	RGD:6480464	20140722	CTD	MESH:C006253	pirinixic acid results in increased expression of GK2 mRNA	PMID:23811191
1303263	Gk2	glycerol kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GK2 mRNA	PMID:25181051|PMID:41034487
1303263	Gk2	glycerol kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1353777	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GK2 mRNA	PMID:35301059
1303263	Gk2	glycerol kinase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1353777	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GK2 gene	PMID:29154799
1303263	Gk2	glycerol kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553485	E	RGD:6480464	20140722	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of GK2 mRNA	PMID:17942748
1303263	Gk2	glycerol kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553485	E	RGD:6480464	20140722	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GK2 mRNA	PMID:17942748
1303263	Gk2	glycerol kinase 2	gene	CHEBI:6651	malathion	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D008294	Malathion results in decreased expression of GK2 mRNA	PMID:25449180
1303263	Gk2	glycerol kinase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1353777	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GK2 gene]	PMID:28238834
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1347109	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TTC12 mRNA	PMID:38218311
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:137392	chlormequat chloride	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of TTC12 protein	PMID:34958886
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332282	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TTC12 mRNA	PMID:20938992
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TTC12 gene	PMID:35440735
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1332282	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TTC12 mRNA	PMID:30319688
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332282	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TTC12 mRNA	PMID:39241906
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of TTC12 mRNA	PMID:19619570
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TTC12 mRNA	PMID:19619570
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332282	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TTC12 mRNA	PMID:20938992
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1347109	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TTC12 mRNA	PMID:37042841
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332282	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTC12 mRNA	PMID:37992649
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332282	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTC12 mRNA	PMID:37992649
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332282	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TTC12 mRNA	PMID:34319233
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TTC12 mRNA	PMID:26577399|PMID:27523638
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TTC12 mRNA	PMID:39836092
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TTC12 mRNA	PMID:19549813
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TTC12 mRNA	PMID:23630614|PMID:25378103
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332282	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TTC12 mRNA	PMID:20938992
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1347109	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TTC12 gene	PMID:25304211
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TTC12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TTC12 mRNA	PMID:39836092
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TTC12 mRNA	PMID:31881176
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1347109	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TTC12 mRNA	PMID:27392435
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TTC12 mRNA	PMID:27392435
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TTC12 mRNA	PMID:24768652|PMID:25583101
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332282	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTC12 mRNA	PMID:21570461
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTC12 mRNA	PMID:33387578
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTC12 mRNA	PMID:19619570
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TTC12 mRNA	PMID:19619570
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TTC12 mRNA	PMID:28001369
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TTC12 mRNA	PMID:33212167
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TTC12 mRNA	PMID:32763439
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1332282	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of TTC12 mRNA	PMID:39631538
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1347109	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TTC12 mRNA	PMID:29803840
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332282	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTC12 mRNA	PMID:37992649
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TTC12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TTC12 mRNA	PMID:39836092
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTC12 mRNA	PMID:21632981
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1332282	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TTC12 intron	PMID:27901495
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347109	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TTC12 promoter	PMID:27901495
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TTC12 mRNA	PMID:25351596
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1347109	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TTC12 mRNA	PMID:20458559
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TTC12 mRNA	PMID:35984750
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1347109	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of TTC12 gene	PMID:31601247
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TTC12 gene	PMID:31601247
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TTC12 mRNA	PMID:30047161
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TTC12 mRNA	PMID:23411599
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1347109	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of TTC12 mRNA	PMID:20170705
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased expression of TTC12 mRNA	PMID:29097150
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TTC12 mRNA	PMID:25181051
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TTC12 gene	PMID:31601247
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332282	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TTC12 mRNA	PMID:40203079
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332282	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TTC12 mRNA	PMID:38685157
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332282	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TTC12 mRNA	PMID:21266533
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347109	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TTC12 mRNA	PMID:37042841
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TTC12 mRNA	PMID:35163327
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TTC12 mRNA	PMID:39836092
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TTC12 mRNA	PMID:35163327
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TTC12 mRNA	PMID:25539665
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TTC12 mRNA	PMID:24449571
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TTC12 mRNA	PMID:28302478
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TTC12 mRNA	PMID:31533062
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TTC12 mRNA	PMID:30047161
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332282	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTC12 mRNA	PMID:37992649
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TTC12 mRNA	PMID:38832940
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TTC12 mRNA	PMID:25351596
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1347109	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TTC12 gene	PMID:25304211
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TTC12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TTC12 mRNA	PMID:39836092
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TTC12 mRNA	PMID:29391264
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1347109	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TTC12 mRNA	PMID:20170705
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1347109	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TTC12 mRNA	PMID:20458559
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332282	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TTC12 mRNA; Nanotubes, Carbon results in decreased expression of TTC12 mRNA	PMID:25554681
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TTC12 mRNA	PMID:30047161
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1332282	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of TTC12 mRNA	PMID:23608068
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1332282	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TTC12 mRNA	PMID:38701926
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1347109	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TTC12 mRNA	PMID:39836092
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of TTC12 mRNA	PMID:23640034
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1332282	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TTC12 mRNA	PMID:39847705
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TTC12 mRNA	PMID:25825206|PMID:30047161
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TTC12 mRNA	PMID:38568856
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1347109	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TTC12 mRNA	PMID:29301935
1303264	Ttc12	tetratricopeptide repeat domain 12	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of TTC12 protein	PMID:32519852
1303266	mt-Ty	mitochondrially encoded tRNA tyrosine	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013853	Thioacetamide results in decreased expression of TRNY mRNA	PMID:34492290
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1619046	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DXO mRNA	PMID:33045310
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1348619	E	RGD:6480464	20130910	CTD	MESH:D004958	Estradiol results in increased expression of DXO mRNA	PMID:18692832
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1348619	E	RGD:6480464	20130910	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in increased expression of DXO mRNA	PMID:18692832
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DXO mRNA	PMID:33387578
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of DXO gene	PMID:27618143
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1348619	E	RGD:6480464	20130910	CTD	MESH:D011374	Progesterone results in increased expression of DXO mRNA	PMID:18692832
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1348619	E	RGD:6480464	20130910	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in increased expression of DXO mRNA	PMID:18692832
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1619046	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DXO mRNA	PMID:36331819
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1619046	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of DXO mRNA	PMID:37236586
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1348619	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DXO mRNA	PMID:35430440
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1619046	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DXO mRNA	PMID:22206623
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1619046	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DXO mRNA	PMID:40504410
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1348619	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DXO mRNA	PMID:19244175
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1348619	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of DXO mRNA	PMID:28711546
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1348619	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of DXO mRNA	PMID:19921347
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619046	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DXO mRNA	PMID:21570461
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DXO mRNA	PMID:33387578
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1348619	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DXO mRNA	PMID:29803840
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1619046	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DXO mRNA	PMID:40504410
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1348619	E	RGD:6480464	20150714	CTD	MESH:D014415	Tunicamycin results in increased expression of DXO mRNA	PMID:22378314
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1619046	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of DXO mRNA	PMID:34850242
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1348619	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DXO gene	PMID:31601247
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1619046	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DXO gene	PMID:35295148
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1619046	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of DXO mRNA	PMID:18648102
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1619046	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DXO mRNA	PMID:19710929
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A affects the expression of DXO mRNA	PMID:25181051
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DXO mRNA	PMID:30816183|PMID:32528016
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DXO mRNA	PMID:34947998
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1348619	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DXO gene	PMID:31601247
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1348619	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of DXO mRNA	PMID:19244175
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1619046	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DXO gene	PMID:31683443
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1619046	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of DXO exon	PMID:33297965
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1619046	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DXO mRNA	PMID:39298647
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1619046	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of DXO promoter	PMID:33297965
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1619046	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DXO mRNA	PMID:38685157
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1619046	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DXO mRNA	PMID:37019170
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DXO mRNA	PMID:18164116
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348619	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DXO mRNA	PMID:37042841
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348619	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DXO mRNA	PMID:38568856
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1619046	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of DXO mRNA	PMID:37236586
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1619046	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DXO mRNA	PMID:28903501
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1348619	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DXO mRNA	PMID:19320972
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1348619	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DXO mRNA	PMID:19244175
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1348619	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DXO mRNA	PMID:31533062
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1348619	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of DXO mRNA	PMID:40419075
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1619046	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DXO mRNA	PMID:36331819
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1348619	E	RGD:6480464	20160210	CTD	MESH:D008727	Methotrexate results in decreased expression of DXO mRNA	PMID:24449571
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of DXO mRNA	PMID:21346803
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1619046	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DXO mRNA	PMID:17562736
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1348619	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of DXO mRNA	PMID:26690555
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DXO mRNA	PMID:33387578
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1619046	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DXO mRNA	PMID:40504410
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of DXO mRNA	PMID:29391264
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1619046	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in increased expression of DXO mRNA	PMID:21335049
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1619046	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DXO mRNA	PMID:22206623
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DXO mRNA	PMID:18164116
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348619	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DXO gene]	PMID:28238834
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1348619	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DXO mRNA	PMID:38568856
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DXO mRNA	PMID:21346803
1303267	Dxo	decapping exoribonuclease	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of DXO mRNA	PMID:20566332
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1602480	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SLC38A7 mRNA	PMID:38218311
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC38A7 mRNA	PMID:33387578
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SLC38A7 mRNA	PMID:22061828|PMID:33387578
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:17883	hydrogen chloride	decreases expression	ISO	RGD:1619828	E	RGD:6480464	20190910	CTD	MESH:D006851	Hydrochloric Acid results in decreased expression of SLC38A7 mRNA	PMID:29618784
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1619828	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of SLC38A7 mRNA	PMID:37748715
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1602480	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SLC38A7 promoter	PMID:30157460
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of SLC38A7 mRNA	PMID:28522335
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602480	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SLC38A7 promoter	PMID:30157460
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1602480	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SLC38A7 mRNA	PMID:23649840
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602480	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SLC38A7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC38A7 mRNA	PMID:40512198
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1619828	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SLC38A7 mRNA	PMID:40504410
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1602480	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SLC38A7 protein	PMID:35688186
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SLC38A7 mRNA	PMID:31881176
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SLC38A7 mRNA	PMID:28374803
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602480	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC38A7 mRNA	PMID:29803840
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602480	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC38A7 mRNA	PMID:38568856
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602480	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SLC38A7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC38A7 mRNA	PMID:40512198
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1619828	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SLC38A7 mRNA	PMID:40504410
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602480	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC38A7 promoter	PMID:30157460
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602480	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC38A7 3' UTR	PMID:27901495
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1602480	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SLC38A7 mRNA	PMID:25895662
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1619828	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of SLC38A7 mRNA	PMID:29264374
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC38A7 mRNA	PMID:34492290
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC38A7 mRNA	PMID:25181051
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1602480	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SLC38A7 gene	PMID:31601247
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602480	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SLC38A7 mRNA	PMID:29275510
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602480	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC38A7 mRNA	PMID:28628672
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1619828	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SLC38A7 mRNA	PMID:39298647
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1602480	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of SLC38A7 gene	PMID:31601247
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SLC38A7 mRNA	PMID:21266533
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1619828	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of SLC38A7 mRNA	PMID:34813904
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1602480	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC38A7 mRNA	PMID:28628672
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1619828	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of SLC38A7 mRNA	PMID:34813904
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1602480	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SLC38A7 mRNA	PMID:28302478
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602480	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SLC38A7 mRNA	PMID:31533062
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1619828	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of SLC38A7 mRNA	PMID:39529242
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602480	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC38A7 mRNA	PMID:23179753
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1602480	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC38A7 mRNA	PMID:20106945
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1602480	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC38A7 mRNA	PMID:28628672
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1602480	E	RGD:6480464	20150825	CTD	MESH:D000082	SLC38A7 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602480	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SLC38A7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC38A7 mRNA	PMID:40512198
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1619828	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SLC38A7 mRNA	PMID:40504410
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1619828	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of SLC38A7 mRNA	PMID:35537566
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SLC38A7 mRNA	PMID:29391264
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1619828	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC38A7 mRNA	PMID:35436446
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1602480	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC38A7 mRNA	PMID:28628672
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:5643	Heliotrine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in increased expression of SLC38A7 mRNA	PMID:34185104
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1619828	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC38A7 mRNA	PMID:22206623
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1619828	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of SLC38A7 mRNA	PMID:38995820
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:83537	1-benzylpiperazine	increases expression	EXP		E	RGD:6480464	20170221	CTD	MESH:C006737	N-benzylpiperazine results in increased expression of SLC38A7 mRNA	PMID:26821219
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:9111	Senkirkine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C009238	senkirkine results in increased expression of SLC38A7 mRNA	PMID:34185104
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:9130	sevoflurane	decreases methylation	ISO	RGD:1619828	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased methylation of SLC38A7 mRNA	PMID:35249202
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1619828	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SLC38A7 mRNA	PMID:35537566
1303268	Slc38a7	solute carrier family 38, member 7	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of SLC38A7 mRNA	PMID:23555832
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:164200	triclosan	increases methylation	ISO	RGD:1354388	E	RGD:6480464	20220607	CTD	MESH:D014260	Triclosan results in increased methylation of MPIG6B gene	PMID:34523531
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MPIG6B mRNA	PMID:33387578
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1354388	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of MPIG6B mRNA	PMID:33647349
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1623045	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MPIG6B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MPIG6B mRNA	PMID:34911549
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1354388	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MPIG6B mRNA	PMID:27392435
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1354388	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MPIG6B mRNA	PMID:27392435
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MPIG6B mRNA	PMID:33387578
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1354388	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MPIG6B mRNA	PMID:33212167
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D003300	Copper deficiency results in increased expression of MPIG6B mRNA	PMID:26033743
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20171114	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of MPIG6B mRNA	PMID:26033743
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1354388	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MPIG6B promoter	PMID:27901495
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D003300	Copper deficiency results in increased expression of MPIG6B mRNA	PMID:26033743
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20171114	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of MPIG6B mRNA	PMID:26033743
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1354388	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of MPIG6B mRNA	PMID:23806026|PMID:25895662
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C006780	bisphenol A affects the expression of MPIG6B mRNA	PMID:25181051
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MPIG6B mRNA	PMID:30816183|PMID:32528016
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1623045	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MPIG6B protein	PMID:35999755
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1623045	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of MPIG6B exon	PMID:33297965
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1354388	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MPIG6B mRNA	PMID:28628672
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1623045	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of MPIG6B protein	PMID:35999755
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1354388	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MPIG6B mRNA	PMID:28628672
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1354388	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MPIG6B mRNA	PMID:37042841
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of MPIG6B promoter	PMID:22457795
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1623045	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MPIG6B mRNA	PMID:40194260
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1354388	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MPIG6B mRNA	PMID:28628672
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1354388	E	RGD:6480464	20130618	CTD	MESH:D005472	MPIG6B protein affects the susceptibility to Fluorouracil	PMID:16217747
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1354388	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MPIG6B mRNA	PMID:28628672
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1623045	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MPIG6B mRNA	PMID:35964746
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1623045	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of MPIG6B mRNA	PMID:38701926
1303269	Mpig6b	megakaryocyte and platelet inhibitory receptor G6b	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1354388	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MPIG6B mRNA	PMID:29301935
1303270	Prr3	proline rich 3	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1343981	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PRR3 mRNA	PMID:38218311
1303270	Prr3	proline rich 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1553544	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PRR3 mRNA	PMID:33045310
1303270	Prr3	proline rich 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1553544	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PRR3 mRNA	PMID:20188158
1303270	Prr3	proline rich 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PRR3 mRNA	PMID:33167477
1303270	Prr3	proline rich 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PRR3 mRNA	PMID:22378314
1303270	Prr3	proline rich 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PRR3 mRNA	PMID:32145629
1303270	Prr3	proline rich 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553544	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PRR3 mRNA	PMID:39298647
1303270	Prr3	proline rich 3	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1343981	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PRR3 mRNA	PMID:21179406
1303270	Prr3	proline rich 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PRR3 mRNA	PMID:21592394
1303270	Prr3	proline rich 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of PRR3 mRNA	PMID:21592394
1303270	Prr3	proline rich 3	gene	CHEBI:17558	quercitrin	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of PRR3 mRNA	PMID:25193878
1303270	Prr3	proline rich 3	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of PRR3 mRNA	PMID:21592394
1303270	Prr3	proline rich 3	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of PRR3 mRNA	PMID:21592394
1303270	Prr3	proline rich 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PRR3 mRNA	PMID:28818685
1303270	Prr3	proline rich 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PRR3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of PRR3 mRNA	PMID:39836092
1303270	Prr3	proline rich 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553544	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of PRR3 mRNA	PMID:28111341
1303270	Prr3	proline rich 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PRR3 mRNA	PMID:35430440
1303270	Prr3	proline rich 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553544	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PRR3 mRNA	PMID:27106289
1303270	Prr3	proline rich 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553544	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of PRR3 mRNA]	PMID:22206623
1303270	Prr3	proline rich 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PRR3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRR3 mRNA	PMID:39836092
1303270	Prr3	proline rich 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1553544	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PRR3 mRNA	PMID:28960355
1303270	Prr3	proline rich 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PRR3 mRNA	PMID:23557933
1303270	Prr3	proline rich 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553544	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRR3 mRNA	PMID:21570461
1303270	Prr3	proline rich 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PRR3 mRNA	PMID:33387578
1303270	Prr3	proline rich 3	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of PRR3 mRNA	PMID:23649840
1303270	Prr3	proline rich 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PRR3 mRNA	PMID:28959563
1303270	Prr3	proline rich 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PRR3 mRNA	PMID:29803840
1303270	Prr3	proline rich 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRR3 mRNA	PMID:38568856
1303270	Prr3	proline rich 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PRR3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRR3 mRNA	PMID:39836092
1303270	Prr3	proline rich 3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1553544	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PRR3 mRNA	PMID:27131904
1303270	Prr3	proline rich 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PRR3 mRNA	PMID:25351596
1303270	Prr3	proline rich 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1343981	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of PRR3 mRNA	PMID:20382639
1303270	Prr3	proline rich 3	gene	CHEBI:30621	diarsenic trioxide	increases response to substance	ISO	RGD:1343981	E	RGD:6480464	20191114	CTD	MESH:C006632	PRR3 protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1303270	Prr3	proline rich 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553544	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PRR3 promoter	PMID:35295148
1303270	Prr3	proline rich 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1553544	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PRR3 promoter	PMID:35295148
1303270	Prr3	proline rich 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PRR3 mRNA	PMID:19710929
1303270	Prr3	proline rich 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of PRR3 mRNA	PMID:31129395|PMID:32145629
1303270	Prr3	proline rich 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PRR3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1303270	Prr3	proline rich 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1553544	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PRR3 mRNA	PMID:38685157
1303270	Prr3	proline rich 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553544	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PRR3 mRNA	PMID:37019170
1303270	Prr3	proline rich 3	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1343981	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of PRR3 gene	PMID:22964155
1303270	Prr3	proline rich 3	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1553544	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of PRR3 mRNA	PMID:34813904
1303270	Prr3	proline rich 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PRR3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of PRR3 mRNA	PMID:39836092
1303270	Prr3	proline rich 3	gene	CHEBI:35176	zinc sulfate	increases expression	ISO	RGD:1343981	E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in increased expression of PRR3 mRNA	PMID:16330358
1303270	Prr3	proline rich 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PRR3 mRNA	PMID:38382870
1303270	Prr3	proline rich 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553544	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of PRR3 mRNA	PMID:28111341
1303270	Prr3	proline rich 3	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1343981	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PRR3 mRNA	PMID:28302478
1303270	Prr3	proline rich 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1343981	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PRR3 mRNA	PMID:31533062
1303270	Prr3	proline rich 3	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of PRR3 mRNA	PMID:17400583
1303270	Prr3	proline rich 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PRR3 mRNA	PMID:25351596
1303270	Prr3	proline rich 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PRR3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRR3 mRNA	PMID:39836092
1303270	Prr3	proline rich 3	gene	CHEBI:49900	arsenous acid	increases response to substance	ISO	RGD:1343981	E	RGD:6480464	20191114	CTD	MESH:C032793	PRR3 protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1303270	Prr3	proline rich 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1553544	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PRR3 mRNA	PMID:19042947
1303270	Prr3	proline rich 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1343981	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PRR3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of PRR3 mRNA	PMID:39836092
1303270	Prr3	proline rich 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1343981	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PRR3 mRNA	PMID:31758290
1303270	Prr3	proline rich 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553544	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PRR3 mRNA	PMID:22206623
1303270	Prr3	proline rich 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553544	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of PRR3 mRNA]	PMID:22206623
1303270	Prr3	proline rich 3	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1343981	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of PRR3 mRNA	PMID:24921660
1303270	Prr3	proline rich 3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1553544	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PRR3 mRNA	PMID:27131904
1303270	Prr3	proline rich 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1343981	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PRR3 mRNA	PMID:38568856
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1602654	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of KDF1 mRNA	PMID:26079696
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1623191	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of KDF1 mRNA	PMID:39298647
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1602654	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of KDF1 mRNA	PMID:33647349
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1602654	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KDF1 mRNA	PMID:28818685
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623191	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of KDF1 mRNA	PMID:36331819
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602654	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KDF1 mRNA	PMID:19549813
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602654	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KDF1 exon	PMID:30157460
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1602654	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KDF1 mRNA	PMID:23557933
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623191	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KDF1 mRNA	PMID:26377647
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of KDF1 mRNA	PMID:28959563
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602654	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of KDF1 mRNA	PMID:38568856
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602654	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KDF1 5' UTR	PMID:27901495
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KDF1 mRNA	PMID:21839799
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602654	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KDF1 promoter	PMID:27901495
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of KDF1 mRNA	PMID:24395379
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1623191	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of KDF1 mRNA	PMID:33221593
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in increased expression of KDF1 mRNA	PMID:25181051
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602654	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of KDF1 mRNA	PMID:31715268
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1623191	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of KDF1 mRNA	PMID:32156529
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1623191	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of KDF1 mRNA	PMID:30951980
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1623191	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of KDF1 mRNA	PMID:26377693
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1623191	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of KDF1 mRNA	PMID:30951980
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623191	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KDF1 mRNA	PMID:32715474
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602654	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KDF1 mRNA	PMID:38568856
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623191	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of KDF1 mRNA	PMID:36331819
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602654	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of KDF1 mRNA	PMID:26272509
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602654	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KDF1 gene	PMID:29154799
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602654	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDF1 mRNA	PMID:27188386
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1623191	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KDF1 mRNA	PMID:28973697
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602654	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDF1 mRNA	PMID:27188386
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1602654	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of KDF1 mRNA	PMID:26079696
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KDF1 mRNA	PMID:24780913
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602654	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDF1 mRNA	PMID:27188386
1303271	Kdf1	keratinocyte differentiation factor 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602654	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of KDF1 mRNA	PMID:38568856
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MMADHC mRNA	PMID:30071829
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of MMADHC gene	PMID:30207508
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1331945	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MMADHC mRNA	PMID:30319688
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of MMADHC mRNA	PMID:26496021
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1331945	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MMADHC mRNA	PMID:19850644
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1331945	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MMADHC mRNA]	PMID:19850644
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MMADHC mRNA	PMID:33387578
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1331945	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of MMADHC mRNA	PMID:27462272
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1346733	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMADHC mRNA	PMID:35301059
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1331945	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MMADHC mRNA	PMID:31919559
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1331945	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MMADHC mRNA	PMID:22206623
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1346733	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MMADHC gene	PMID:25304211
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346733	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MMADHC mRNA	PMID:23557933
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1346733	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MMADHC mRNA	PMID:30851411
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1331945	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of MMADHC mRNA	PMID:30807115
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346733	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MMADHC mRNA	PMID:39719251
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346733	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MMADHC mRNA	PMID:38568856
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1346733	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of MMADHC mRNA	PMID:22378314
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346733	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MMADHC promoter	PMID:27901495
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1346733	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MMADHC mRNA]	PMID:32406909
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MMADHC mRNA	PMID:25729387
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MMADHC mRNA	PMID:25729387
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MMADHC mRNA	PMID:12832660
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1331945	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MMADHC mRNA	PMID:20813756|PMID:23811191
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1346733	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of MMADHC mRNA	PMID:38479592
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MMADHC mRNA	PMID:25181051
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of MMADHC mRNA	PMID:12075121
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MMADHC mRNA	PMID:30816183
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1331945	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MMADHC mRNA	PMID:33221593
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MMADHC mRNA; [bisphenol A co-treated with Estradiol] results in decreased expression of MMADHC mRNA	PMID:26496021|PMID:36041667
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MMADHC mRNA	PMID:36041667
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MMADHC mRNA	PMID:36041667
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346733	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MMADHC mRNA	PMID:37042841
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1346733	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMADHC mRNA	PMID:35301059
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1331945	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of MMADHC mRNA	PMID:25908611
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1331945	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of MMADHC mRNA	PMID:28962523
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1346733	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MMADHC mRNA	PMID:28302478
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1346733	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of MMADHC mRNA	PMID:26352163
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1331945	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MMADHC mRNA	PMID:17292431
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1346733	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MMADHC gene	PMID:29154799
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346733	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MMADHC mRNA	PMID:25704631
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1331945	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MMADHC mRNA	PMID:29279043
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1346733	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MMADHC gene	PMID:25304211
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1346733	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MMADHC mRNA	PMID:18175754
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1331945	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MMADHC mRNA; Nanotubes, Carbon results in increased expression of MMADHC mRNA	PMID:25620056
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1331945	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of MMADHC mRNA	PMID:40234311
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MMADHC mRNA	PMID:24136188
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1346733	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of MMADHC protein	PMID:23718831
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of MMADHC mRNA	PMID:24136188
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MMADHC mRNA	PMID:25729387
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MMADHC mRNA	PMID:25729387
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of MMADHC mRNA	PMID:30467583
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MMADHC gene	PMID:35440735
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1331945	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MMADHC mRNA	PMID:22206623
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MMADHC mRNA	PMID:24136188
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1346733	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MMADHC mRNA	PMID:30851411
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1346733	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of MMADHC mRNA	PMID:30928695
1303272	Mmadhc	metabolism of cobalamin associated D	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1346733	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MMADHC mRNA	PMID:38568856
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1345737	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PARD6A mRNA	PMID:38218311
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1345737	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PARD6A mRNA	PMID:22378314
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1551602	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PARD6A mRNA	PMID:40945087
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1345737	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PARD6A mRNA	PMID:35811015
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1345737	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PARD6A mRNA	PMID:35811015
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1345737	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PARD6A mRNA	PMID:30165855
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PARD6A mRNA	PMID:33387578
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1345737	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PARD6A mRNA	PMID:21179406
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:17579	beta-carotene	multiple interactions	ISO	RGD:1551602	E	RGD:6480464	20140909	CTD	MESH:D019207	[BCO1 protein affects the susceptibility to beta Carotene] which affects the expression of PARD6A mRNA	PMID:24657404
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1345737	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PARD6A protein	PMID:37730182
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PARD6A mRNA	PMID:33387578
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1345737	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PARD6A mRNA	PMID:28818685
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:22977	cadmium atom	decreases methylation	ISO	RGD:1551602	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased methylation of PARD6A gene	PMID:37023889
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1345737	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PARD6A mRNA	PMID:19549813
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551602	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PARD6A mRNA	PMID:34911549
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1345737	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PARD6A mRNA	PMID:27392435
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1345737	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of PARD6A protein	PMID:16803524
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551602	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PARD6A mRNA	PMID:21570461
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PARD6A mRNA	PMID:33387578
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551602	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PARD6A mRNA	PMID:17942748
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1345737	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of PARD6A mRNA	PMID:24834073
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1345737	E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in decreased expression of PARD6A mRNA	PMID:19194470
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:28854	2,4-D	decreases expression	ISO	RGD:1345737	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of PARD6A mRNA	PMID:40294809
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1345737	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PARD6A mRNA	PMID:38568856
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1345737	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PARD6A mRNA	PMID:39719251
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551602	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PARD6A mRNA	PMID:22228805
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1551602	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PARD6A mRNA	PMID:27131904
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PARD6A mRNA	PMID:30047161
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PARD6A mRNA	PMID:23411599
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PARD6A mRNA	PMID:25181051
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PARD6A mRNA	PMID:34947998
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1551602	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of PARD6A promoter	PMID:27312807
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1551602	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PARD6A mRNA	PMID:37019170
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of PARD6A mRNA	PMID:22546817
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of PARD6A mRNA	PMID:22546817
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1551602	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PARD6A mRNA	PMID:17942915
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1551602	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PARD6A mRNA]	PMID:17942915
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of PARD6A mRNA	PMID:22546817
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1345737	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PARD6A mRNA	PMID:37042841
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PARD6A mRNA	PMID:30723492
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PARD6A mRNA	PMID:33387578
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1345737	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of PARD6A mRNA	PMID:24714768
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1345737	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PARD6A mRNA	PMID:35811015
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan affects the expression of PARD6A mRNA	PMID:31464424
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1551602	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PARD6A mRNA	PMID:17555576
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551602	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PARD6A mRNA	PMID:17942748
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PARD6A mRNA	PMID:30047161
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:82036	prothioconazole	increases expression	ISO	RGD:1345737	E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of PARD6A mRNA	PMID:35048155
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1551602	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PARD6A mRNA	PMID:39847705
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PARD6A mRNA	PMID:30047161
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1551602	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PARD6A mRNA	PMID:27131904
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PARD6A mRNA	PMID:19281266
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PARD6A mRNA	PMID:21346803
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PARD6A mRNA	PMID:21346803
1303273	Pard6a	par-6 family cell polarity regulator alpha	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1551602	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PARD6A mRNA	PMID:35537566
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20260407	CTD	MESH:C007262	deoxynivalenol results in decreased expression of DNMT3B mRNA; deoxynivalenol results in decreased expression of DNMT3B protein	PMID:40749799
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of DNMT3B protein	PMID:19679824
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1606037	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DNMT3B mRNA	PMID:26272509
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNMT3B mRNA	PMID:27188386
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DNMT3B mRNA	PMID:33045310
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:135338	guggulsterone	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20170307	CTD	MESH:C023617	pregna-4,17-diene-3,16-dione results in decreased expression of DNMT3B mRNA	PMID:23593078
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1551604	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DNMT3B mRNA	PMID:26251327
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:142921	3-phenylprop-2-enal	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in decreased expression of DNMT3B mRNA	PMID:17178418
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20121218	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3B protein	PMID:20548288
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20220705	CTD	MESH:D001241	Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3B mRNA]; Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3B protein]	PMID:34979192
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:15366	acetic acid	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120717	CTD	MESH:D019342	Acetic Acid results in decreased expression of DNMT3B protein	PMID:21296659
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of DNMT3B mRNA	PMID:16788091
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of DNMT3B mRNA	PMID:17273765|PMID:21934132|PMID:33167477
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of DNMT3B mRNA	PMID:24763279
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16118	berberine	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in decreased expression of DNMT3B mRNA	PMID:27311644
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D003634	DDT results in decreased expression of DNMT3B mRNA	PMID:19797855
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1606037	E	RGD:6480464	20220510	CTD	MESH:D000431	Ethanol affects the expression of DNMT3B protein	PMID:35149083
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20140211	CTD	MESH:D000431	Ethanol results in decreased expression of DNMT3B protein	PMID:23395981
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16236	ethanol	increases degradation	ISO	RGD:1551604	E	RGD:6480464	20140211	CTD	MESH:D000431	Ethanol results in increased degradation of DNMT3B protein	PMID:23395981
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1551604	E	RGD:6480464	20140211	CTD	MESH:D000431	Ethanol results in increased expression of DNMT3B mRNA	PMID:23395981
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20140211	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of DNMT3B mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Ethanol results in increased degradation of DNMT3B protein]	PMID:23395981|PMID:30517762
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16240	hydrogen peroxide	decreases response to substance	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D006861	DNMT3B protein results in decreased susceptibility to Hydrogen Peroxide	PMID:18314485
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1606037	E	RGD:6480464	20240702	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of DNMT3B mRNA	PMID:37940031
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551604	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DNMT3B mRNA	PMID:39298647
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606037	E	RGD:6480464	20190312	CTD	MESH:D004958	Estradiol results in increased expression of DNMT3B mRNA	PMID:30684530|PMID:32030086
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D004958	[Testosterone co-treated with Estradiol] affects the reaction [bisphenol A results in increased expression of DNMT3B mRNA]; [Testosterone co-treated with Estradiol] affects the reaction [estradiol-17 beta-benzoate results in increased expression of DNMT3B mRNA]	PMID:22109888
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20190312	CTD	MESH:D004958	Estradiol promotes the reaction [DNMT3B protein binds to COMT promoter]; sulforaphane inhibits the reaction [Estradiol promotes the reaction [DNMT3B protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Estradiol results in increased expression of DNMT3B mRNA]	PMID:30684530
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DNMT3B mRNA	PMID:25510870
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20170516	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DNMT3B mRNA	PMID:28013219
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16643	L-methionine	increases expression	ISO	RGD:1551604	E	RGD:6480464	20221206	CTD	MESH:D008715	Methionine results in increased expression of DNMT3B mRNA	PMID:35314295
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3B protein; Methionine inhibits the reaction [Cocaine results in decreased expression of DNMT3B mRNA]; Methionine inhibits the reaction [Cocaine results in decreased expression of DNMT3B protein]	PMID:20548288|PMID:22438930
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:167830	isorhapontigenin	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20240430	CTD	MESH:C432307	[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3B protein	PMID:37619952
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20120918	CTD	MESH:D005557	Formaldehyde results in decreased expression of DNMT3B mRNA; Formaldehyde results in decreased expression of DNMT3B protein	PMID:21745553
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17303	morphine	affects expression	ISO	RGD:1551604	E	RGD:6480464	20220111	CTD	MESH:D009020	Morphine affects the expression of DNMT3B mRNA	PMID:33891991
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of DNMT3B mRNA	PMID:21592394
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] affects the reaction [bisphenol A results in increased expression of DNMT3B mRNA]; [Testosterone co-treated with Estradiol] affects the reaction [estradiol-17 beta-benzoate results in increased expression of DNMT3B mRNA]; [Testosterone co-treated with vinclozolin] results in increased expression of DNMT3B mRNA; [Testosterone co-treated with vinclozolin] results in increased expression of DNMT3B protein	PMID:20056826|PMID:22109888
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of DNMT3B mRNA	PMID:21592394
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:175901	gemcitabine	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20230207	CTD	MESH:C056507	[Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of DNMT3B protein	PMID:25189999
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17594	hydroquinone	affects expression	ISO	RGD:1606037	E	RGD:6480464	20200609	CTD	MESH:C031927	hydroquinone affects the expression of DNMT3B mRNA	PMID:31899212
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20121009	CTD	MESH:C031927	hydroquinone results in decreased expression of DNMT3B mRNA	PMID:22245671|PMID:34612549
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17594	hydroquinone	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20200609	CTD	MESH:C031927	Decitabine affects the reaction [hydroquinone affects the expression of DNMT3B mRNA]; trichostatin A affects the reaction [hydroquinone affects the expression of DNMT3B mRNA]	PMID:31899212
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1551604	E	RGD:6480464	20201006	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of DNMT3B mRNA	PMID:32628958
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20191008	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DNMT3B mRNA	PMID:31211961
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DNMT3B mRNA	PMID:31163220
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	EXP		E	RGD:6480464	20260407	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of DNMT3B promoter	PMID:40618915
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNMT3B mRNA; Diethylhexyl Phthalate results in increased expression of DNMT3B protein	PMID:25280772|PMID:40618915
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551604	E	RGD:6480464	20121009	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNMT3B mRNA; Diethylhexyl Phthalate results in increased expression of DNMT3B protein	PMID:19912166|PMID:20335514
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1606037	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNMT3B protein	PMID:31163220
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17750	glycine betaine	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20150512	CTD	MESH:D001622	Betaine results in decreased expression of DNMT3B mRNA	PMID:22945834
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:177763	Diallyltetrasulfane	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C431585	diallyl tetrasulfide inhibits the reaction [cypermethrin results in decreased expression of DNMT3B protein]	PMID:34794910
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1606037	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DNMT3B protein	PMID:37730182
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of DNMT3B mRNA	PMID:21592394
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of DNMT3B mRNA	PMID:21592394
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DNMT3B mRNA	PMID:33387578
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:18346	vanillin	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20120613	CTD	MESH:C100058	vanillin results in decreased expression of DNMT3B mRNA	PMID:17178418
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:2038	5-azacytidine	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20250204	CTD	MESH:D001374	Azacitidine results in decreased expression of DNMT3B mRNA	PMID:39331569
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:2038	5-azacytidine	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20220906	CTD	MESH:D001374	Azacitidine inhibits the reaction [DNMT3B protein binds to MIR497 promoter]	PMID:35066776
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:22977	cadmium atom	affects expression	ISO	RGD:1606037	E	RGD:6480464	20170613	CTD	MESH:D002104	Cadmium affects the expression of DNMT3B mRNA	PMID:22382075
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1606037	E	RGD:6480464	20260407	CTD	MESH:D002104	Cadmium results in increased expression of DNMT3B mRNA; Cadmium results in increased expression of DNMT3B protein	PMID:40414543
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNMT3B mRNA	PMID:39012411
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20260407	CTD	MESH:D002104	[Cadmium co-treated with Decitabine] results in decreased expression of DNMT3B mRNA; Decitabine inhibits the reaction [Cadmium results in increased expression of DNMT3B protein]	PMID:40414543
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DNMT3B mRNA	PMID:25510870
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DNMT3B mRNA	PMID:25510870
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1606037	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DNMT3B mRNA	PMID:19549813
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of DNMT3B mRNA	PMID:21396975
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1606037	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DNMT3B exon	PMID:30157460
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1606037	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DNMT3B mRNA	PMID:23649840
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in decreased expression of DNMT3B mRNA	PMID:26392148
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1551604	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of DNMT3B mRNA	PMID:15674844
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:25812	ozone	affects response to substance	ISO	RGD:1606037	E	RGD:6480464	20161213	CTD	MESH:D010126	DNMT3B gene polymorphism affects the susceptibility to Ozone	PMID:27219456
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D010126	Ozone results in decreased expression of DNMT3B mRNA	PMID:29947284
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:25863	pelargonidin	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20190910	CTD	MESH:C066957	pelargonidin results in decreased expression of DNMT3B protein	PMID:31181187
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of DNMT3B mRNA	PMID:30779732
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in decreased expression of DNMT3B mRNA	PMID:31939706
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27214	uranium atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D014501	Uranium results in increased expression of DNMT3B mRNA	PMID:29024790
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27292	vinyl carbamate	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120412	CTD	MESH:C017963	vinyl carbamate results in decreased expression of DNMT3B mRNA	PMID:17849452
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551604	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNMT3B mRNA	PMID:31919559
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of DNMT3B mRNA	PMID:30517762
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27470	folic acid	affects expression	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the expression of DNMT3B mRNA; Folic Acid affects the expression of DNMT3B protein	PMID:17311948|PMID:26492244
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DNMT3B mRNA	PMID:25629700
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DNMT3B mRNA	PMID:21867686
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1551604	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of DNMT3B mRNA	PMID:26547318|PMID:39617304
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20121218	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3B protein; Decitabine inhibits the reaction [Folic Acid results in increased expression of DNMT3B mRNA]; Folic Acid affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of DNMT3B mRNA]; trichostatin A inhibits the reaction [Folic Acid results in increased expression of DNMT3B mRNA]	PMID:20548288|PMID:28475147|PMID:39617304
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20200804	CTD	MESH:D005492	APP protein affects the reaction [Folic Acid affects the expression of DNMT3B mRNA]; APP protein affects the reaction [Folic Acid affects the expression of DNMT3B protein]	PMID:26492244
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27563	arsenic atom	affects metabolic processing	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D001151	DNMT3B gene polymorphism affects the metabolism of Arsenic	PMID:21247820
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20190611	CTD	MESH:D001151	DNMT3B gene SNP affects the reaction [Arsenic affects the methylation of CDH1 promoter]	PMID:30220071
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of DNMT3B mRNA	PMID:26272509
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DNMT3B mRNA	PMID:27188386
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1606037	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DNMT3B protein	PMID:35688186
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D002110	Caffeine results in increased expression of DNMT3B mRNA	PMID:25868845|PMID:30423288
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of DNMT3B mRNA	PMID:34542374
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1606037	E	RGD:6480464	20260407	CTD	MESH:C010974	Glyphosate results in increased expression of DNMT3B mRNA	PMID:40578477
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27881	resveratrol	affects expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol affects the expression of DNMT3B mRNA	PMID:24447120
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol results in decreased expression of DNMT3B mRNA	PMID:23593078|PMID:26459286
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1606037	E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol results in increased expression of DNMT3B mRNA	PMID:26934322
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20130122	CTD	MESH:C059514	pterostilbene promotes the reaction [resveratrol results in decreased expression of DNMT3B mRNA]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3B protein binds to BRCA1 promoter]]	PMID:22197621|PMID:26459286
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1606037	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DNMT3B mRNA	PMID:28903495
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27899	cisplatin	decreases response to substance	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D002945	DNMT3B protein results in decreased susceptibility to Cisplatin	PMID:18314485
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1551604	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of DNMT3B protein	PMID:22006019
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of DNMT3B mRNA	PMID:27392435
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20121113	CTD	MESH:D003042	Cocaine results in decreased expression of DNMT3B mRNA; Cocaine results in decreased expression of DNMT3B protein	PMID:22438930
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20121113	CTD	MESH:D003042	Methionine inhibits the reaction [Cocaine results in decreased expression of DNMT3B mRNA]; Methionine inhibits the reaction [Cocaine results in decreased expression of DNMT3B protein]	PMID:22438930
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28073	chromium atom	increases expression	ISO	RGD:1606037	E	RGD:6480464	20260407	CTD	MESH:D002857	Chromium results in increased expression of DNMT3B mRNA; Chromium results in increased expression of DNMT3B protein	PMID:40414543
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28073	chromium atom	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20260407	CTD	MESH:D002857	[Chromium co-treated with Decitabine] results in decreased expression of DNMT3B mRNA; Decitabine inhibits the reaction [Chromium results in increased expression of DNMT3B protein]	PMID:40414543
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20141223	CTD	MESH:D019833	Genistein results in decreased expression of DNMT3B mRNA; Genistein results in decreased expression of DNMT3B protein	PMID:19221000|PMID:23593078
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20190312	CTD	MESH:D019833	Genistein promotes the reaction [DNMT3B protein binds to COMT promoter]	PMID:30684530
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNMT3B mRNA	PMID:33387578
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNMT3B mRNA	PMID:19770486|PMID:28922406
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNMT3B mRNA	PMID:20106945|PMID:21632981
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNMT3B mRNA	PMID:26455773|PMID:32109520
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20130122	CTD	MESH:D013749	Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3B protein binds to BRCA1 promoter]]; Tetrachlorodibenzodioxin promotes the reaction [DNMT3B protein binds to BRCA1 promoter]	PMID:22197621
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DNMT3B mRNA	PMID:19636072
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1606037	E	RGD:6480464	20211207	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DNMT3B mRNA; methylmercuric chloride results in increased expression of DNMT3B protein	PMID:33454822|PMID:34328791
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606037	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DNMT3B mRNA	PMID:33212167
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of DNMT3B mRNA	PMID:30807115|PMID:35032568
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of DNMT3B mRNA	PMID:32763439
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:2873	asiatic acid	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017032	asiatic acid inhibits the reaction [cypermethrin results in decreased expression of DNMT3B protein]	PMID:34794910
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28812	(aminomethyl)phosphonic acid	increases expression	ISO	RGD:1606037	E	RGD:6480464	20260407	CTD	MESH:C036423	1-aminomethylphosphonic acid results in increased expression of DNMT3B mRNA	PMID:40578477
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28833	gibberellin A3	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007842	gibberellic acid results in decreased expression of DNMT3B mRNA	PMID:31733319
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of DNMT3B mRNA	PMID:20044591
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20200310	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of DNMT3B protein]	PMID:31551408
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20180313	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of DNMT3B protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of DNMT3B protein]	PMID:26942697|PMID:31551408
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of DNMT3B mRNA	PMID:22623647
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DNMT3B mRNA	PMID:19615344|PMID:26581878|PMID:32844245
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606037	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNMT3B mRNA; sodium arsenite results in increased expression of DNMT3B protein	PMID:24570342|PMID:26409248|PMID:30191986|PMID:34032870|PMID:35850069|PMID:37894918|PMID:38146662
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20161228	CTD	MESH:C017947	Decitabine inhibits the reaction [sodium arsenite results in increased expression of DNMT3B protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of DNMT3B mRNA]	PMID:19615344|PMID:26409248|PMID:35850069
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606037	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DNMT3B promoter	PMID:27901495
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DNMT3B mRNA	PMID:19770486|PMID:21715664
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DNMT3B mRNA	PMID:27901495
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1551604	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DNMT3B intron	PMID:27901495
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606037	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DNMT3B 5' UTR	PMID:27901495
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551604	E	RGD:6480464	20220705	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNMT3B mRNA; Benzo(a)pyrene results in increased expression of DNMT3B protein	PMID:34979192
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1606037	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of DNMT3B gene	PMID:25435355
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20220705	CTD	MESH:D001564	Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3B mRNA]; Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3B protein]	PMID:34979192
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to DNMT3B mRNA]	PMID:32406909
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:30621	diarsenic trioxide	decreases activity	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased activity of DNMT3B protein	PMID:20596618
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DNMT3B mRNA	PMID:29223816
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DNMT3B protein	PMID:19679824
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DNMT3B; Arsenic Trioxide results in decreased expression of DNMT3B mRNA	PMID:12667347|PMID:12679007|PMID:17490527|PMID:20416177|PMID:20596618|PMID:21176356|PMID:29159499
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DNMT3B mRNA	PMID:25534098
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20120515	CTD	MESH:C070081	Fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT3B mRNA]; Fulvestrant inhibits the reaction [bisphenol A results in increased expression of DNMT3B mRNA]	PMID:22131059|PMID:30892605
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20220208	CTD	MESH:C070081	Fulvestrant inhibits the reaction [bisphenol A results in increased expression of DNMT3B protein]	PMID:34537452
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of DNMT3B mRNA	PMID:32479839
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DNMT3B mRNA	PMID:34492290
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DNMT3B mRNA	PMID:20813756
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A affects the expression of DNMT3B mRNA	PMID:36864339
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1551604	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of DNMT3B promoter	PMID:27334623
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of DNMT3B mRNA	PMID:25181051|PMID:25748669
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in decreased expression of DNMT3B mRNA; bisphenol A results in decreased expression of DNMT3B protein	PMID:22131059|PMID:23418087|PMID:27502578|PMID:30951980|PMID:31201698
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of DNMT3B protein	PMID:37567409
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1606037	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of DNMT3B promoter	PMID:27271280
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:C006780	bisphenol A results in increased expression of DNMT3B mRNA; bisphenol A results in increased expression of DNMT3B protein	PMID:21827818|PMID:22109888|PMID:23748860|PMID:26898831|PMID:36864339|PMID:39307384
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551604	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in increased expression of DNMT3B mRNA; bisphenol A results in increased expression of DNMT3B protein	PMID:23535407|PMID:30892605|PMID:31532523|PMID:32488702
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606037	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of DNMT3B mRNA; bisphenol A results in increased expression of DNMT3B protein	PMID:27685785|PMID:32030086|PMID:32105160|PMID:34537452
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DNMT3B gene	PMID:28505145
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:C006780	[Testosterone co-treated with Estradiol] affects the reaction [bisphenol A results in increased expression of DNMT3B mRNA]	PMID:22109888
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20120515	CTD	MESH:C006780	Drugs, Chinese Herbal inhibits the reaction [bisphenol A results in increased expression of DNMT3B protein]; Fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT3B mRNA]; Fulvestrant inhibits the reaction [bisphenol A results in increased expression of DNMT3B mRNA]	PMID:22131059|PMID:30892605|PMID:32488702
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20200804	CTD	MESH:C006780	bisphenol A promotes the reaction [ESR1 protein binds to DNMT3B promoter]; ESR1 protein promotes the reaction [bisphenol A results in increased expression of DNMT3B mRNA]; ESR1 protein promotes the reaction [bisphenol A results in increased expression of DNMT3B protein]; Fulvestrant inhibits the reaction [bisphenol A results in increased expression of DNMT3B protein]	PMID:32105160|PMID:34537452
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DNMT3B mRNA	PMID:25510870
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DNMT3B mRNA	PMID:25510870
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1551604	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of DNMT3B mRNA	PMID:37080397
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551604	E	RGD:6480464	20180703	CTD	MESH:C543008	bisphenol S results in increased expression of DNMT3B mRNA; bisphenol S results in increased expression of DNMT3B protein	PMID:29741722|PMID:31532523|PMID:39298647
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1606037	E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in increased expression of DNMT3B mRNA; bisphenol S results in increased expression of DNMT3B protein	PMID:25912373|PMID:32105160
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20200804	CTD	MESH:C543008	bisphenol S promotes the reaction [ESR1 protein binds to DNMT3B promoter]; ESR1 protein promotes the reaction [bisphenol S results in increased expression of DNMT3B mRNA]; ESR1 protein promotes the reaction [bisphenol S results in increased expression of DNMT3B protein]	PMID:32105160
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein]	PMID:23626723
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein]	PMID:23626723
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D000487	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT3B mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DNMT3B mRNA	PMID:38685157
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DNMT3B mRNA	PMID:40825503
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D004390	[Chlorpyrifos co-treated with Dimethoate] results in increased expression of DNMT3B mRNA	PMID:40825503
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DNMT3B protein	PMID:26745512
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DNMT3B mRNA; Dibutyl Phthalate results in decreased expression of DNMT3B protein	PMID:21266533|PMID:30952838
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1551604	E	RGD:6480464	20230801	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DNMT3B protein	PMID:36602389
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20250805	CTD	MESH:D003993	DNMT3B protein inhibits the reaction [Dibutyl Phthalate results in decreased methylation of PTEN promoter]	PMID:30952838
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34714	dimethoate	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D004117	Dimethoate results in increased expression of DNMT3B mRNA	PMID:40825503
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34714	dimethoate	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D004117	[Chlorpyrifos co-treated with Dimethoate] results in increased expression of DNMT3B mRNA	PMID:40825503
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20141223	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased expression of DNMT3B mRNA	PMID:25236440
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20200211	CTD	MESH:D015056	[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of DNMT3B mRNA	PMID:29094436
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1606037	E	RGD:6480464	20201215	CTD	MESH:D010269	Paraquat results in increased expression of DNMT3B	PMID:31189234
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606037	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DNMT3B mRNA	PMID:37042841
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein; Wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein]	PMID:23626723
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of DNMT3B mRNA	PMID:26377693
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DNMT3B mRNA; Cadmium Chloride results in decreased expression of DNMT3B protein	PMID:33865896
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1551604	E	RGD:6480464	20170516	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNMT3B protein	PMID:27984135
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606037	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNMT3B mRNA; Cadmium Chloride results in increased expression of DNMT3B protein	PMID:17938735|PMID:25448810|PMID:34520792
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNMT3B mRNA	PMID:39012411
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20200714	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DNMT3B mRNA	PMID:32068100
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1551604	E	RGD:6480464	20200804	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DNMT3B mRNA	PMID:32320774
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20200211	CTD	MESH:C023036	[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of DNMT3B mRNA	PMID:29094436
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:38221	fumonisin B1	decreases activity	ISO	RGD:1606037	E	RGD:6480464	20140513	CTD	MESH:C056933	fumonisin B1 results in decreased activity of DNMT3B protein	PMID:24280379
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:38518	benzophenanthridine	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20170117	CTD	MESH:D053119	Benzophenanthridines analog results in decreased expression of DNMT3B mRNA	PMID:23117580
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1606037	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of DNMT3B mRNA	PMID:28302478
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:38683	4-nitro-m-cresol	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20220906	CTD	MESH:C008636	4-nitro-3-cresol results in decreased expression of DNMT3B mRNA	PMID:35654127
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:39098	pyrethrins	affects expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins affects the expression of DNMT3B mRNA	PMID:34896426
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DNMT3B protein	PMID:26178269
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20191210	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DNMT3B mRNA; perfluorooctane sulfonic acid results in decreased expression of DNMT3B protein	PMID:31508952
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20190312	CTD	MESH:C031763	1,3-butadiene results in decreased expression of DNMT3B mRNA	PMID:30552462
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:39483	sodium dichromate	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20240430	CTD	MESH:C016104	[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3B protein	PMID:37619952
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20160510	CTD	MESH:D003474	Curcumin analog results in decreased expression of DNMT3B protein	PMID:26991801|PMID:29228771
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20141223	CTD	MESH:D003474	Curcumin results in decreased expression of DNMT3B mRNA	PMID:23593078
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551604	E	RGD:6480464	20150825	CTD	MESH:D014635	Valproic Acid affects the expression of DNMT3B mRNA	PMID:26072468
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606037	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DNMT3B mRNA	PMID:25979313|PMID:26072468
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of DNMT3B mRNA	PMID:21427059
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20240806	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of DNMT3B protein	PMID:34658283
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20240806	CTD	MESH:D003520	SGI-1027 promotes the reaction [Cyclophosphamide results in decreased expression of DNMT3B protein]	PMID:34658283
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:40304	8-hydroxy-2'-deoxyguanosine	affects abundance	ISO	RGD:1606037	E	RGD:6480464	20200211	CTD	MESH:C067134	DNMT3B gene SNP affects the abundance of 8-Hydroxy-2'-Deoxyguanosine	PMID:19896490
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of DNMT3B mRNA	PMID:20106945|PMID:27989131
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606037	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DNMT3B mRNA	PMID:25562108
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C037304	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT3B mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4042	cypermethrin	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	cypermethrin results in decreased expression of DNMT3B mRNA; cypermethrin results in decreased expression of DNMT3B protein	PMID:34794910
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C017160	cypermethrin results in increased expression of DNMT3B mRNA	PMID:35605701
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C017160	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT3B mRNA; [pyrazolanthrone co-treated with cypermethrin] results in decreased expression of DNMT3B protein; asiatic acid inhibits the reaction [cypermethrin results in decreased expression of DNMT3B protein]; cypermethrin results in decreased expression of and results in decreased activity of DNMT3B protein; diallyl tetrasulfide inhibits the reaction [cypermethrin results in decreased expression of DNMT3B protein]	PMID:33051911|PMID:33396045|PMID:34794910|PMID:34896426|PMID:36053783
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of DNMT3B mRNA	PMID:25123088
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of DNMT3B mRNA alternative form; Tamoxifen results in increased expression of DNMT3B protein alternative form	PMID:19019622
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D013629	DNMT3B protein affects the reaction [Tamoxifen results in decreased expression of CXCR4 mRNA]; DNMT3B protein affects the reaction [Tamoxifen results in decreased expression of CXCR4 protein]	PMID:19019622
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20200211	CTD	MESH:D003907	[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of DNMT3B mRNA	PMID:29094436
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of DNMT3B mRNA	PMID:37077353
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1551604	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of DNMT3B mRNA	PMID:16714842
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4356	desferrioxamine B	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine results in decreased expression of DNMT3B mRNA	PMID:23483119
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4356	desferrioxamine B	increases expression	ISO	RGD:1606037	E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine results in increased expression of DNMT3B mRNA	PMID:23483119
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1606037	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DNMT3B mRNA	PMID:38832940
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:C012589	[trichostatin A affects the expression of DNMT3B protein] which affects the expression of CDKN1A mRNA; [trichostatin A affects the expression of DNMT3B protein] which affects the expression of CDKN1B mRNA; [trichostatin A affects the expression of DNMT3B protein] which affects the expression of RB1 mRNA; trichostatin A affects the expression of DNMT3B mRNA	PMID:18544619
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20250902	CTD	MESH:C012589	trichostatin A inhibits the reaction [Folic Acid results in increased expression of DNMT3B mRNA]	PMID:39617304
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20200609	CTD	MESH:C012589	trichostatin A affects the reaction [hydroquinone affects the expression of DNMT3B mRNA]	PMID:31899212
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20180703	CTD	MESH:D000082	Acetaminophen results in decreased expression of DNMT3B mRNA	PMID:29665328
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DNMT3B mRNA	PMID:33387578
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1606037	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DNMT3B mRNA	PMID:22230336
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120717	CTD	MESH:D005472	Fluorouracil results in decreased expression of DNMT3B protein	PMID:21296659
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:46727	quartz	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20180220	CTD	MESH:D011791	Quartz results in decreased expression of DNMT3B mRNA	PMID:27917503
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:47217	arsane	affects metabolic processing	ISO	RGD:1606037	E	RGD:6480464	20140805	CTD	MESH:D001151	DNMT3B gene polymorphism affects the metabolism of Arsenic	PMID:21247820
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20190611	CTD	MESH:D001151	DNMT3B gene SNP affects the reaction [Arsenic affects the methylation of CDH1 promoter]	PMID:30220071
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in decreased expression of DNMT3B mRNA	PMID:37077353
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20140408	CTD	MESH:C016766	sulforaphane results in decreased expression of DNMT3B mRNA	PMID:24466240
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane inhibits the reaction [DNMT3B protein binds to COMT promoter]; sulforaphane inhibits the reaction [Estradiol promotes the reaction [DNMT3B protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Estradiol results in increased expression of DNMT3B mRNA]	PMID:30684530
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DNMT3B mRNA	PMID:29391264
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004726	Endosulfan results in increased expression of DNMT3B mRNA	PMID:35114330
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1606037	E	RGD:6480464	20180116	CTD	MESH:D004726	Endosulfan results in increased expression of DNMT3B mRNA; Endosulfan results in increased expression of DNMT3B protein	PMID:29054638
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1606037	E	RGD:6480464	20150609	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of DNMT3B mRNA	PMID:25839702
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNMT3B mRNA	PMID:22079256
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1551604	E	RGD:6480464	20240206	CTD	MESH:D018038	Sodium Selenite results in increased expression of DNMT3B mRNA	PMID:37142062
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:4911	etoposide	decreases response to substance	ISO	RGD:1606037	E	RGD:6480464	20120412	CTD	MESH:D005047	DNMT3B protein results in decreased susceptibility to Etoposide	PMID:18314485
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:49900	arsenous acid	decreases activity	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased activity of DNMT3B protein	PMID:20596618
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DNMT3B mRNA	PMID:29223816
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DNMT3B protein	PMID:19679824
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DNMT3B; Arsenic Trioxide results in decreased expression of DNMT3B mRNA	PMID:12667347|PMID:12679007|PMID:17490527|PMID:20416177|PMID:20596618|PMID:21176356|PMID:29159499
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DNMT3B mRNA	PMID:25534098
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of DNMT3B mRNA	PMID:24447120
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine affects the expression of DNMT3B protein] which affects the expression of CDKN1A mRNA; [Decitabine affects the expression of DNMT3B protein] which affects the expression of CDKN1B mRNA; [Decitabine affects the expression of DNMT3B protein] which affects the expression of RB1 mRNA; Decitabine affects the expression of DNMT3B mRNA	PMID:18544619
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects response to substance	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C014347	DNMT3B protein affects the susceptibility to Decitabine	PMID:17991895
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of DNMT3B protein	PMID:19679824
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of DNMT3B mRNA; Decitabine results in decreased expression of DNMT3B protein	PMID:17991895|PMID:18676679|PMID:19221000|PMID:19662370|PMID:19732952|PMID:21515334|PMID:21771726|PMID:22749965|PMID:40414543
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases response to substance	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C014347	DNMT3B gene mutant form results in decreased susceptibility to Decitabine	PMID:23300844
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Dust results in increased expression of DNMT3B mRNA]	PMID:30815999
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Folic Acid results in increased expression of DNMT3B mRNA]; Decitabine inhibits the reaction [Particulate Matter promotes the reaction [[ovalbumin-alum co-treated with Ovalbumin] results in increased expression of DNMT3B protein]]; Decitabine inhibits the reaction [Particulate Matter results in increased expression of DNMT3B protein]	PMID:30481581|PMID:39617304
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20191114	CTD	MESH:C014347	[Cadmium co-treated with Decitabine] results in decreased expression of DNMT3B mRNA; [Chromium co-treated with Decitabine] results in decreased expression of DNMT3B mRNA; Decitabine affects the reaction [hydroquinone affects the expression of DNMT3B mRNA]; Decitabine inhibits the reaction [Cadmium results in increased expression of DNMT3B protein]; Decitabine inhibits the reaction [Chromium results in increased expression of DNMT3B protein]; Decitabine inhibits the reaction [DNMT3B protein binds to GSTM2 promoter]; Decitabine inhibits the reaction [sodium arsenite results in increased expression of DNMT3B protein]; DNMT3B protein affects the reaction [Decitabine results in increased expression of CDH1 protein]; DNMT3B protein affects the reaction [Decitabine results in increased expression of JUP protein]	PMID:16887905|PMID:21246532|PMID:26409248|PMID:31899212|PMID:35850069|PMID:40414543
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C017690	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT3B mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50182	3,3'-diindolylmethane	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20140408	CTD	MESH:C016392	3,3'-diindolylmethane results in decreased expression of DNMT3B mRNA	PMID:24466240
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551604	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DNMT3B mRNA	PMID:25620056
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20140311	CTD	MESH:C009687	wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3B protein]	PMID:23626723
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:53074	diphenylcyclopropenone	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20141223	CTD	MESH:C029402	diphenylcyclopropenone results in decreased expression of DNMT3B mRNA	PMID:25236440
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:D011192	Potassium Dichromate results in increased expression of DNMT3B protein	PMID:37931768
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of DNMT3B mRNA	PMID:20080153
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of DNMT3B mRNA	PMID:28988120
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:64206	bromochloroacetic acid	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120717	CTD	MESH:C099813	bromochloroacetic acid results in decreased expression of DNMT3B protein	PMID:21296659
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1551604	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in increased expression of DNMT3B mRNA	PMID:21335049
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20180313	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Particulate Matter results in increased expression of DNMT3B protein]	PMID:26942697
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:6651	malathion	affects expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D008294	Malathion affects the expression of DNMT3B mRNA	PMID:36370973
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:6842	methoxychlor	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D008731	Methoxychlor results in increased expression of DNMT3B mRNA	PMID:19589859
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:69120	withaferin A	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20141223	CTD	MESH:C009684	withaferin A results in decreased expression of DNMT3B mRNA	PMID:23593078
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1606037	E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in increased expression of DNMT3B mRNA	PMID:29518473
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1606037	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DNMT3B mRNA	PMID:25912373
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DNMT3B protein	PMID:37664457
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:74926	patulin	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20250401	CTD	MESH:D010365	Patulin results in decreased expression of DNMT3B mRNA	PMID:38806716
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20140211	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Ethanol results in increased degradation of DNMT3B protein]	PMID:23395981
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DNMT3B mRNA	PMID:22079256
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNMT3B mRNA	PMID:22079256
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1606037	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DNMT3B mRNA	PMID:37199045
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:75632	procyanidin B2	increases expression	ISO	RGD:1606037	E	RGD:6480464	20150609	CTD	MESH:C479580	procyanidin B2 results in increased expression of DNMT3B mRNA	PMID:25839702
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1606037	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of DNMT3B protein	PMID:31285264
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNMT3B mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DNMT3B mRNA	PMID:27188386
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:7959	D-penicillamine	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20150512	CTD	MESH:D010396	Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of DNMT3B mRNA]	PMID:22945834
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DNMT3B gene]	PMID:28238834
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551604	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DNMT3B mRNA	PMID:23091169
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010634	Phenobarbital results in decreased expression of DNMT3B mRNA	PMID:28495587
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of DNMT3B mRNA	PMID:19270015
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DNMT3B mRNA	PMID:24780913
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:8630	pterostilbene	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20161025	CTD	MESH:C107773	pterostilbene promotes the reaction [resveratrol results in decreased expression of DNMT3B mRNA]	PMID:26459286
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20161025	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of DNMT3B protein	PMID:26745512
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:88542	Butylparaben	increases expression	EXP		E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of DNMT3B mRNA	PMID:26888303
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C432165	[pyrazolanthrone co-treated with cypermethrin] results in decreased expression of DNMT3B protein	PMID:34794910
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606037	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DNMT3B protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNMT3B mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DNMT3B mRNA	PMID:27188386|PMID:37664457
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:D013311	Streptozocin results in increased expression of DNMT3B mRNA	PMID:37081038
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1551604	E	RGD:6480464	20191008	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of DNMT3B mRNA; [Streptozocin co-treated with Dietary Fats] results in increased expression of DNMT3B protein	PMID:29127188
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:9400	tangeretin	decreases expression	ISO	RGD:1551604	E	RGD:6480464	20231003	CTD	MESH:C059006	tangeretin metabolite results in decreased expression of DNMT3B protein; tangeretin results in decreased expression of DNMT3B protein	PMID:37517432
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:9405	tartrazine	increases expression	ISO	RGD:1551604	E	RGD:6480464	20250506	CTD	MESH:D013645	Tartrazine results in increased expression of DNMT3B mRNA	PMID:37447272
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:9405	tartrazine	increases expression	ISO	RGD:1606037	E	RGD:6480464	20250506	CTD	MESH:D013645	Tartrazine results in increased expression of DNMT3B mRNA	PMID:40077783
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1606037	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of DNMT3B mRNA	PMID:29301935
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of DNMT3B mRNA; vinclozolin results in increased expression of DNMT3B protein	PMID:20056826
1303274	Dnmt3b	DNA methyltransferase 3 beta	gene	CHEBI:9986	vinclozolin	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	[Testosterone co-treated with vinclozolin] results in increased expression of DNMT3B mRNA; [Testosterone co-treated with vinclozolin] results in increased expression of DNMT3B protein	PMID:20056826
1303275	Eml5	EMAP like 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of EML5 mRNA	PMID:30071829
1303275	Eml5	EMAP like 5	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1551606	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of EML5 mRNA	PMID:29018328
1303275	Eml5	EMAP like 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of EML5 mRNA	PMID:35192832
1303275	Eml5	EMAP like 5	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EML5 mRNA	PMID:33387578
1303275	Eml5	EMAP like 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350172	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EML5 mRNA	PMID:37042841
1303275	Eml5	EMAP like 5	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1350172	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of EML5 mRNA	PMID:21179406
1303275	Eml5	EMAP like 5	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EML5 mRNA	PMID:33387578
1303275	Eml5	EMAP like 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551606	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EML5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EML5 mRNA	PMID:28111341|PMID:37236586
1303275	Eml5	EMAP like 5	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of EML5 mRNA	PMID:21396975
1303275	Eml5	EMAP like 5	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1551606	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of EML5 mRNA	PMID:28960355
1303275	Eml5	EMAP like 5	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1350172	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of EML5 mRNA	PMID:27392435
1303275	Eml5	EMAP like 5	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1350172	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of EML5 mRNA	PMID:27392435
1303275	Eml5	EMAP like 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551606	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EML5 mRNA	PMID:21570461
1303275	Eml5	EMAP like 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EML5 mRNA	PMID:33387578
1303275	Eml5	EMAP like 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EML5 mRNA	PMID:32109520
1303275	Eml5	EMAP like 5	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of EML5 mRNA	PMID:28374803
1303275	Eml5	EMAP like 5	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1350172	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of EML5 mRNA	PMID:28001369
1303275	Eml5	EMAP like 5	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1350172	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of EML5 protein	PMID:35688186
1303275	Eml5	EMAP like 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1350172	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of EML5 mRNA	PMID:34032870|PMID:38568856
1303275	Eml5	EMAP like 5	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1350172	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of EML5 gene	PMID:31601247
1303275	Eml5	EMAP like 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1551606	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of EML5 mRNA	PMID:29264374
1303275	Eml5	EMAP like 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551606	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EML5 gene	PMID:35295148
1303275	Eml5	EMAP like 5	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of EML5 mRNA	PMID:23411599|PMID:34492290
1303275	Eml5	EMAP like 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of EML5 mRNA	PMID:35192832
1303275	Eml5	EMAP like 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1350172	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of EML5 mRNA	PMID:29275510
1303275	Eml5	EMAP like 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551606	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of EML5 mRNA	PMID:32156529|PMID:33221593
1303275	Eml5	EMAP like 5	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1551606	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of EML5 promoter	PMID:27312807
1303275	Eml5	EMAP like 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EML5 mRNA	PMID:25181051|PMID:27571134|PMID:30816183|PMID:34947998
1303275	Eml5	EMAP like 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350172	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of EML5 gene	PMID:31601247
1303275	Eml5	EMAP like 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1551606	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of EML5 mRNA	PMID:38685157
1303275	Eml5	EMAP like 5	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of EML5 gene	PMID:33148267
1303275	Eml5	EMAP like 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350172	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EML5 mRNA	PMID:37042841
1303275	Eml5	EMAP like 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551606	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EML5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EML5 mRNA	PMID:28111341|PMID:37236586
1303275	Eml5	EMAP like 5	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of EML5 mRNA	PMID:26194646
1303275	Eml5	EMAP like 5	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1350172	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EML5 mRNA	PMID:31533062
1303275	Eml5	EMAP like 5	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of EML5 mRNA	PMID:29427782
1303275	Eml5	EMAP like 5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of EML5 mRNA	PMID:29427782
1303275	Eml5	EMAP like 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1350172	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EML5 mRNA	PMID:24383497
1303275	Eml5	EMAP like 5	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of EML5 mRNA	PMID:30047161
1303275	Eml5	EMAP like 5	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1350172	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of EML5 mRNA	PMID:27989131
1303275	Eml5	EMAP like 5	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1350172	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EML5 mRNA	PMID:38832940
1303275	Eml5	EMAP like 5	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EML5 mRNA	PMID:33387578
1303275	Eml5	EMAP like 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1350172	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of EML5 mRNA	PMID:29067470
1303275	Eml5	EMAP like 5	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of EML5 mRNA	PMID:29391264
1303275	Eml5	EMAP like 5	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1551606	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EML5 mRNA	PMID:35436446
1303275	Eml5	EMAP like 5	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of EML5 mRNA	PMID:30047161
1303275	Eml5	EMAP like 5	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1551606	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of EML5 mRNA	PMID:23608068
1303275	Eml5	EMAP like 5	gene	CHEBI:64153	tanespimycin	increases expression	ISO	RGD:1350172	E	RGD:6480464	20200804	CTD	MESH:C112765	tanespimycin analog results in increased expression of EML5 protein	PMID:31370342
1303275	Eml5	EMAP like 5	gene	CHEBI:64153	tanespimycin	multiple interactions	ISO	RGD:1350172	E	RGD:6480464	20200804	CTD	MESH:C112765	[tanespimycin co-treated with VER 155008] results in increased expression of EML5 protein	PMID:31370342
1303275	Eml5	EMAP like 5	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1551606	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of EML5 mRNA	PMID:36851058
1303275	Eml5	EMAP like 5	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of EML5 gene	PMID:33148267
1303275	Eml5	EMAP like 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551606	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EML5 mRNA	PMID:22206623
1303275	Eml5	EMAP like 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350172	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EML5 gene]	PMID:28238834
1303275	Eml5	EMAP like 5	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551606	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of EML5 mRNA	PMID:23091169
1303275	Eml5	EMAP like 5	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1551606	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of EML5 mRNA	PMID:31388691
1303275	Eml5	EMAP like 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EML5 mRNA	PMID:30047161
1303275	Eml5	EMAP like 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EML5 mRNA	PMID:21346803
1303275	Eml5	EMAP like 5	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1350172	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of EML5 mRNA	PMID:27188386
1303275	Eml5	EMAP like 5	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of EML5 mRNA	PMID:30047161
1303275	Eml5	EMAP like 5	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of EML5 mRNA	PMID:23034163|PMID:23555832
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1344113	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of USP19 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of USP19 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of USP19 mRNA	PMID:32699268|PMID:32845096
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1344113	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of USP19 mRNA	PMID:22378314
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1551608	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of USP19 mRNA	PMID:30319688
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551608	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of USP19 mRNA	PMID:34319233
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of USP19 mRNA	PMID:33387578
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1344113	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of USP19 protein	PMID:23301498
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551608	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of USP19 mRNA	PMID:19770486
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344113	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of USP19 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of USP19 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of USP19 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of USP19 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of USP19 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1551608	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of USP19 mRNA	PMID:25629700
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1344113	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP19 mRNA	PMID:40512198
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551608	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP19 mRNA	PMID:40504410
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1551608	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of USP19 mRNA	PMID:30912803
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551608	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USP19 mRNA	PMID:21570461
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1344113	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of USP19 protein	PMID:39603559
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344113	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of USP19 mRNA	PMID:33212167
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1551608	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of USP19 mRNA	PMID:30807115
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of USP19 mRNA	PMID:30556269
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:28854	2,4-D	increases expression	ISO	RGD:1344113	E	RGD:6480464	20120412	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in increased expression of USP19 mRNA	PMID:15878651
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344113	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of USP19 mRNA	PMID:38568856
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1551608	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of USP19 mRNA	PMID:16014739
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1344113	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP19 mRNA	PMID:40512198
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551608	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP19 mRNA	PMID:40504410
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1551608	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of USP19 mRNA	PMID:33053406
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of USP19 mRNA	PMID:30556269
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1344113	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of USP19 mRNA	PMID:34408198
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:30778	gallic acid	increases expression	ISO	RGD:1344113	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of USP19 mRNA	PMID:34408198
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551608	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USP19 gene	PMID:35295148
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551608	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of USP19 gene	PMID:35295148
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1551608	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of USP19 promoter	PMID:27312807
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of USP19 mRNA	PMID:25181051|PMID:30816183
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551608	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of USP19 mRNA	PMID:39298647
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551608	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of USP19 mRNA	PMID:34813904
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344113	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of USP19 mRNA	PMID:37042841
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1344113	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of USP19 mRNA	PMID:38568856
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of USP19 promoter	PMID:22457795
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of USP19 gene	PMID:22079235
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1344113	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of USP19 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of USP19 mRNA	PMID:32699268
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1551608	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of USP19 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of USP19 mRNA]	PMID:17585979
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1344113	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of USP19 mRNA	PMID:31533062
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1344113	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of USP19 mRNA	PMID:40419075
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551608	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of USP19 mRNA	PMID:17562736
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of USP19 mRNA	PMID:33387578
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1344113	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of USP19 mRNA	PMID:22230336
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1551608	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of USP19 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of USP19 mRNA]	PMID:17585979
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1344113	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP19 mRNA	PMID:40512198
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551608	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP19 mRNA	PMID:40504410
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1551608	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of USP19 mRNA	PMID:35436446
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1344113	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of USP19 protein	PMID:32959892
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551608	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of USP19 mRNA	PMID:22206623
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1551608	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of USP19 mRNA	PMID:22538082
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1551608	E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of USP19 mRNA	PMID:33269387
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of USP19 mRNA	PMID:21346803
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of USP19 mRNA	PMID:21346803
1303276	Usp19	ubiquitin specific peptidase 19	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of USP19 mRNA	PMID:23034163
1303277	Wfdc6b	WAP four-disulfide core domain 6B	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003471	Cuprizone results in increased expression of WFDC6B mRNA	PMID:26577399|PMID:27523638
1303277	Wfdc6b	WAP four-disulfide core domain 6B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of WFDC6B mRNA	PMID:25181051
1303277	Wfdc6b	WAP four-disulfide core domain 6B	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C039281	furan results in decreased expression of WFDC6B mRNA	PMID:25539665
1303277	Wfdc6b	WAP four-disulfide core domain 6B	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D007649	Ketamine results in increased expression of WFDC6B mRNA	PMID:20080153
1303277	Wfdc6b	WAP four-disulfide core domain 6B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D011441	Propylthiouracil results in increased expression of WFDC6B mRNA	PMID:24780913
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of TMPRSS11B mRNA	PMID:26496021
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of TMPRSS11B mRNA	PMID:26496021
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606722	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of TMPRSS11B mRNA	PMID:41430723
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1553560	E	RGD:6480464	20250401	CTD	MESH:C024565	ethylene dichloride affects the expression of TMPRSS11BNL mRNA	PMID:28960355
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:28741	sodium fluoride	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TMPRSS11BNL mRNA	PMID:27257137
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1553560	E	RGD:6480464	20190219	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of TMPRSS11B mRNA	PMID:30171875
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1606722	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TMPRSS11B mRNA	PMID:23806026
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of TMPRSS11BNL mRNA	PMID:25181051
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of TMPRSS11B mRNA; [bisphenol A co-treated with Testosterone] results in decreased expression of TMPRSS11B mRNA	PMID:26496021
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20130806	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of TMPRSS11B promoter	PMID:22457795
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1553560	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TMPRSS11B mRNA	PMID:40194260
1303278	Tmprss11b	transmembrane serine protease 11B	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1606722	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TMPRSS11B gene	PMID:29154799
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1553568	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ST3GAL6 mRNA	PMID:33045310
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1553568	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ST3GAL6 mRNA	PMID:37995155
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ST3GAL6 mRNA]	PMID:31150632
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1349452	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ST3GAL6 mRNA	PMID:21934132|PMID:23724009|PMID:33167477
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ST3GAL6 mRNA	PMID:22378314
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553568	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ST3GAL6 mRNA	PMID:39241906
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1349452	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ST3GAL6 mRNA	PMID:35811015
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of ST3GAL6 mRNA]	PMID:39241906
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553568	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of ST3GAL6 mRNA	PMID:19484750|PMID:39298647
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of ST3GAL6 mRNA	PMID:32145629
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1349452	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of ST3GAL6 mRNA	PMID:20660070
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1349452	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of ST3GAL6 mRNA	PMID:20660070
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1553568	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ST3GAL6 mRNA	PMID:21669218
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553568	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ST3GAL6 mRNA	PMID:33754040
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1349452	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ST3GAL6 mRNA	PMID:16002434
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ST3GAL6 mRNA	PMID:33387578
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ST3GAL6 mRNA	PMID:28818685
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1349452	E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in increased expression of ST3GAL6 mRNA	PMID:19194470
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ST3GAL6 mRNA	PMID:29950665
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ST3GAL6 mRNA	PMID:19549813
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ST3GAL6 mRNA	PMID:23649840
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1349452	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ST3GAL6 gene	PMID:27153756
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ST3GAL6 mRNA	PMID:23649840
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1349452	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ST3GAL6 mRNA	PMID:41430723
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ST3GAL6 mRNA	PMID:34911549
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of ST3GAL6 mRNA	PMID:19483382
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ST3GAL6 mRNA	PMID:31150632
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ST3GAL6 mRNA]	PMID:31150632
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ST3GAL6 mRNA	PMID:22206623
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1349452	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of ST3GAL6 mRNA	PMID:12629581
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ST3GAL6 mRNA	PMID:34747641
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553568	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ST3GAL6 mRNA	PMID:21570461|PMID:26377647
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ST3GAL6 mRNA	PMID:21215274
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1553568	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ST3GAL6 mRNA	PMID:28922406
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553568	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ST3GAL6 mRNA	PMID:19933214
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1349452	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of ST3GAL6 mRNA	PMID:39709020
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1349452	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ST3GAL6 mRNA	PMID:32763439
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of ST3GAL6 mRNA	PMID:21198554
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1349452	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of ST3GAL6 mRNA	PMID:29803840
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1349452	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ST3GAL6 mRNA	PMID:20044591
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1349452	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ST3GAL6 gene	PMID:28589171
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349452	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ST3GAL6 mRNA	PMID:22714537|PMID:28595984|PMID:34032870
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349452	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ST3GAL6 5' UTR	PMID:27901495
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1349452	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ST3GAL6 promoter	PMID:27901495
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of ST3GAL6 mRNA	PMID:19483382
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ST3GAL6 mRNA	PMID:25895662
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1349452	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ST3GAL6 mRNA	PMID:25351596
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1553568	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ST3GAL6 mRNA	PMID:39716349
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1349452	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ST3GAL6 gene	PMID:31601247
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553568	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ST3GAL6 gene; titanium dioxide results in decreased methylation of ST3GAL6 promoter	PMID:35295148
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ST3GAL6 mRNA	PMID:29950665
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of ST3GAL6 mRNA	PMID:19483382
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ST3GAL6 mRNA	PMID:34492290
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ST3GAL6 mRNA	PMID:19483382
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553568	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ST3GAL6 mRNA	PMID:17426115|PMID:18301758|PMID:20813756|PMID:23811191
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553568	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ST3GAL6 mRNA	PMID:26063408
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ST3GAL6 mRNA	PMID:25181051|PMID:32145629
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553568	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ST3GAL6 mRNA	PMID:30951980
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553568	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ST3GAL6 mRNA	PMID:30951980
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553568	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ST3GAL6 mRNA	PMID:37019170
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1553568	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ST3GAL6 protein	PMID:35362542
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ST3GAL6 mRNA; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ST3GAL6 protein]	PMID:29950665|PMID:35362542
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ST3GAL6 mRNA	PMID:21266533
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of ST3GAL6 mRNA]	PMID:39241906
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of ST3GAL6 mRNA]	PMID:19030233
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349452	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ST3GAL6 mRNA	PMID:37042841
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ST3GAL6 mRNA	PMID:33453195
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ST3GAL6 mRNA	PMID:38568856
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of ST3GAL6 mRNA	PMID:26194646
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1349452	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ST3GAL6 mRNA	PMID:24449571
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of ST3GAL6 mRNA	PMID:19483382
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1553568	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ST3GAL6 mRNA	PMID:40194260
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ST3GAL6 mRNA	PMID:31533062
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1349452	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ST3GAL6 mRNA	PMID:40419075
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349452	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ST3GAL6 mRNA	PMID:25979313
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ST3GAL6 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349452	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ST3GAL6 mRNA	PMID:29154799
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ST3GAL6 mRNA	PMID:20106945|PMID:25562108
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1553568	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ST3GAL6 mRNA	PMID:28973697
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ST3GAL6 mRNA	PMID:24136188
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ST3GAL6 mRNA	PMID:38832940
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1349452	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ST3GAL6 mRNA	PMID:26272509
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1349452	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST3GAL6 mRNA	PMID:27188386
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ST3GAL6 mRNA	PMID:33387578
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ST3GAL6 mRNA	PMID:29067470
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1349452	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ST3GAL6 mRNA	PMID:35811015
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1553568	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ST3GAL6 mRNA	PMID:29279043
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1349452	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ST3GAL6 mRNA	PMID:25351596
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:46938	zebularine	increases expression	ISO	RGD:1349452	E	RGD:6480464	20120412	CTD	MESH:C009131	pyrimidin-2-one beta-ribofuranoside results in increased expression of ST3GAL6 mRNA	PMID:19194470
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ST3GAL6 mRNA	PMID:29391264
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of ST3GAL6 mRNA	PMID:18175754
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of ST3GAL6 mRNA	PMID:19483382
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ST3GAL6 protein]	PMID:35362542
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1553568	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ST3GAL6 mRNA	PMID:39716349
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1349452	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of ST3GAL6 mRNA]	PMID:21095227
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553568	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ST3GAL6 mRNA; Nanotubes, Carbon results in decreased expression of ST3GAL6 mRNA	PMID:25554681
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1349452	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ST3GAL6 mRNA	PMID:22714537
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ST3GAL6 mRNA	PMID:21641980
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1553568	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of ST3GAL6 mRNA	PMID:19812364
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1349452	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ST3GAL6 mRNA	PMID:28988120
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ST3GAL6 mRNA	PMID:22079614
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ST3GAL6 mRNA	PMID:30467583
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553568	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ST3GAL6 mRNA	PMID:22206623
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ST3GAL6 mRNA	PMID:22206623
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1349452	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ST3GAL6 mRNA	PMID:37199045
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1349452	E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of ST3GAL6 mRNA	PMID:19737606
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of ST3GAL6 mRNA	PMID:19483382
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of ST3GAL6 mRNA	PMID:19483382
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1349452	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST3GAL6 mRNA	PMID:27188386
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1553568	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ST3GAL6 mRNA	PMID:39847705
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of ST3GAL6 mRNA	PMID:19483382
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1553568	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of ST3GAL6 mRNA]	PMID:39241906
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:88249	PD 0325901	decreases expression	ISO	RGD:1349452	E	RGD:6480464	20170303	CTD	MESH:C506614	mirdametinib results in decreased expression of ST3GAL6 mRNA	PMID:25119042
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:88249	PD 0325901	multiple interactions	ISO	RGD:1349452	E	RGD:6480464	20170303	CTD	MESH:C506614	[mirdametinib co-treated with (+)-JQ1 compound] results in decreased expression of ST3GAL6 mRNA	PMID:25119042
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349452	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST3GAL6 mRNA	PMID:27188386
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1349452	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ST3GAL6 mRNA	PMID:17440010
1303279	St3gal6	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ST3GAL6 mRNA	PMID:21346803
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1350737	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of BTLA mRNA	PMID:34925699
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BTLA mRNA	PMID:30529165
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1350737	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of BTLA mRNA	PMID:22378314
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BTLA mRNA	PMID:32741896
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of BTLA mRNA	PMID:33387578
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350737	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BTLA mRNA	PMID:37042841
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BTLA mRNA	PMID:32741896
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1350737	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of BTLA mRNA	PMID:33647349
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of BTLA mRNA	PMID:27523638
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1350737	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of BTLA mRNA	PMID:41430723
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BTLA mRNA	PMID:34911549
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of BTLA mRNA	PMID:30779732
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1551622	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of BTLA mRNA	PMID:30912803
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1551622	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of BTLA mRNA	PMID:32186404
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551622	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of BTLA mRNA	PMID:39631538
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1350737	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BTLA mRNA	PMID:38568856
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1551622	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of BTLA mRNA	PMID:36209798
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTLA mRNA	PMID:34876320
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTLA mRNA	PMID:34876320
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551622	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BTLA mRNA	PMID:21569818
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350737	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BTLA 3' UTR; Benzo(a)pyrene results in increased methylation of BTLA promoter	PMID:27901495
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20120918	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BTLA mRNA; AHR protein affects the reaction [Benzo(a)pyrene affects the expression of BTLA mRNA]	PMID:22228805|PMID:27858113
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1350737	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of BTLA gene	PMID:31601247
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1551622	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of BTLA mRNA	PMID:20542052
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BTLA mRNA	PMID:25181051
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1350737	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of BTLA gene	PMID:31601247
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350737	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of BTLA gene	PMID:31601247
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1551622	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of BTLA mRNA	PMID:26377693
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BTLA mRNA	PMID:27858113
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of BTLA mRNA	PMID:32680482
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350737	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BTLA mRNA	PMID:37042841
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of BTLA mRNA	PMID:35163327
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of BTLA mRNA	PMID:30723492
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1350737	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of BTLA mRNA	PMID:24449571
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1350737	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of BTLA mRNA	PMID:40334771
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1551622	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of BTLA mRNA	PMID:29038090
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1551622	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of BTLA mRNA	PMID:23125180
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1551622	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of BTLA mRNA	PMID:29279043
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTLA mRNA	PMID:34876320
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1551622	E	RGD:6480464	20130514	CTD	MESH:D018038	Sodium Selenite results in decreased expression of BTLA mRNA	PMID:23274088
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1551622	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of BTLA mRNA	PMID:25554681
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551622	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of BTLA mRNA	PMID:25554681
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1551622	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of BTLA mRNA	PMID:26377693
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BTLA mRNA	PMID:27858113
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BTLA mRNA	PMID:27858113
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1551622	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol results in increased expression of BTLA mRNA	PMID:27256343
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol promotes the reaction [MOG protein modified form results in increased expression of BTLA mRNA]	PMID:27256343
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BTLA mRNA	PMID:32741896
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350737	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BTLA gene]	PMID:28238834
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1551622	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTLA mRNA	PMID:34876320
1303280	Btla	B and T lymphocyte associated	gene	CHEBI:9130	sevoflurane	increases methylation	ISO	RGD:1551622	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased methylation of BTLA mRNA	PMID:35249202
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1616585	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of SCGN mRNA	PMID:37315490
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1347901	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SCGN mRNA	PMID:23724009
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:16170	mercury(0)	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20250311	CTD	MESH:D008628	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SCGN mRNA	PMID:32949613
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1347901	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SCGN mRNA	PMID:20044591
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SCGN mRNA	PMID:32949613
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SCGN mRNA	PMID:28818685
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1347901	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SCGN protein	PMID:20106945
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SCGN mRNA	PMID:22100608|PMID:32234424
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1347901	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SCGN gene	PMID:27153756
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:25195	mercury atom	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20250311	CTD	MESH:D008628	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SCGN mRNA	PMID:32949613
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1347901	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SCGN gene	PMID:25304211
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SCGN mRNA	PMID:20106945|PMID:21632981
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20160822	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SCGN mRNA	PMID:26159488
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1616585	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SCGN mRNA	PMID:17942748
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of SCGN protein	PMID:39603559
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SCGN mRNA	PMID:28959563
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1347901	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of SCGN gene	PMID:28589171
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1616585	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SCGN mRNA	PMID:37682722
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [SCGN protein binds to CAPRIN1 protein]	PMID:33939924
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCGN mRNA	PMID:32234424
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1347901	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SCGN mRNA	PMID:21632981
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347901	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SCGN exon; Benzo(a)pyrene results in increased methylation of SCGN promoter	PMID:27901495
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SCGN mRNA	PMID:25895662
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1347901	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SCGN mRNA	PMID:23806026
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SCGN mRNA	PMID:30047161
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1347901	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SCGN gene	PMID:31601247
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SCGN mRNA	PMID:28628672
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20250311	CTD	MESH:C027561	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SCGN mRNA	PMID:32949613
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SCGN mRNA	PMID:28628672
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20250311	CTD	MESH:C012125	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SCGN mRNA	PMID:32949613
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:37187	lead nitrate	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20250311	CTD	MESH:C017461	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SCGN mRNA	PMID:32949613
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1616585	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SCGN mRNA	PMID:40194260
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SCGN mRNA	PMID:28302478
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1347901	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SCGN mRNA	PMID:28001369
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SCGN mRNA	PMID:30047161
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SCGN mRNA	PMID:20106945|PMID:25562108
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1347901	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of SCGN mRNA	PMID:27989131
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SCGN mRNA	PMID:28628672
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SCGN mRNA	PMID:38832940
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCGN mRNA	PMID:27188386
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SCGN mRNA	PMID:29067470
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1347901	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SCGN gene	PMID:25304211
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:4791	endosulfan	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SCGN mRNA	PMID:26159488
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1616585	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of SCGN mRNA	PMID:35436446
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1616585	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SCGN mRNA	PMID:17942748
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of SCGN mRNA	PMID:32234424
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SCGN mRNA	PMID:28628672
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SCGN mRNA	PMID:30047161
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SCGN protein	PMID:32959892
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:756996	imeglimin	decreases expression	ISO	RGD:1616585	E	RGD:6480464	20260714	CTD	MESH:C575881	imeglimin results in decreased expression of SCGN mRNA	PMID:40713970
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCGN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCGN mRNA	PMID:27188386
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1347901	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SCGN mRNA	PMID:30928695
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SCGN mRNA	PMID:30047161
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SCGN mRNA	PMID:24780913
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCGN mRNA	PMID:27188386
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347901	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCGN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCGN mRNA	PMID:27188386
1303281	Scgn	secretagogin, EF-hand calcium binding protein	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1347901	E	RGD:6480464	20171114	CTD	MESH:C057693	troglitazone results in increased expression of SCGN mRNA	PMID:28934090
1303282	Notch4	notch receptor 4	gene	CHEBI:135937	enzacamene	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C038939	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NOTCH4 mRNA; [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1553588	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of NOTCH4 mRNA	PMID:16604517
1303282	Notch4	notch receptor 4	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D010100	Oxygen deficiency results in increased expression of NOTCH4 mRNA	PMID:26476374
1303282	Notch4	notch receptor 4	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D010100	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of NOTCH4 mRNA]	PMID:26476374
1303282	Notch4	notch receptor 4	gene	CHEBI:15553	prostaglandin F2alpha	decreases cleavage	EXP		E	RGD:6480464	20130723	CTD	MESH:D015237	Dinoprost results in decreased cleavage of NOTCH4 protein	PMID:21209419
1303282	Notch4	notch receptor 4	gene	CHEBI:15553	prostaglandin F2alpha	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D015237	Dinoprost results in decreased expression of NOTCH4 mRNA	PMID:21209419
1303282	Notch4	notch receptor 4	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of NOTCH4 mRNA	PMID:26079696
1303282	Notch4	notch receptor 4	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NOTCH4 mRNA	PMID:22378314
1303282	Notch4	notch receptor 4	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1553588	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of NOTCH4 mRNA	PMID:30319688
1303282	Notch4	notch receptor 4	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of NOTCH4 mRNA]	PMID:26476374
1303282	Notch4	notch receptor 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1354309	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of NOTCH4 mRNA	PMID:30165855
1303282	Notch4	notch receptor 4	gene	CHEBI:16598	DDE	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D003633	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:16684	atropine	multiple interactions	ISO	RGD:1354309	E	RGD:6480464	20130514	CTD	MESH:D001285	Atropine inhibits the reaction [Parathion results in increased expression of NOTCH4 protein]	PMID:17390078
1303282	Notch4	notch receptor 4	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of NOTCH4 mRNA	PMID:27905399
1303282	Notch4	notch receptor 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH4 protein	PMID:36988346
1303282	Notch4	notch receptor 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1354309	E	RGD:6480464	20240305	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH4 mRNA	PMID:38042133
1303282	Notch4	notch receptor 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553588	E	RGD:6480464	20250311	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH4 mRNA	PMID:33091777
1303282	Notch4	notch receptor 4	gene	CHEBI:172946	3-methylfuran	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C039851	3-methylfuran results in decreased expression of NOTCH4 mRNA	PMID:38160780
1303282	Notch4	notch receptor 4	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1354309	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of NOTCH4 mRNA	PMID:33647349
1303282	Notch4	notch receptor 4	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of NOTCH4 protein	PMID:20722969
1303282	Notch4	notch receptor 4	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of NOTCH4 protein; [Saquinavir co-treated with Nicotine] results in decreased expression of NOTCH4 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]	PMID:20722969
1303282	Notch4	notch receptor 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NOTCH4 mRNA; Diethylhexyl Phthalate results in increased expression of NOTCH4 protein	PMID:36988346
1303282	Notch4	notch receptor 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004051	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1553588	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOTCH4 mRNA	PMID:39150890
1303282	Notch4	notch receptor 4	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1354309	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NOTCH4 mRNA	PMID:36139627
1303282	Notch4	notch receptor 4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NOTCH4 mRNA	PMID:33387578
1303282	Notch4	notch receptor 4	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of NOTCH4 mRNA	PMID:28818685
1303282	Notch4	notch receptor 4	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of NOTCH4 mRNA	PMID:17175027
1303282	Notch4	notch receptor 4	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of NOTCH4 protein	PMID:20722969
1303282	Notch4	notch receptor 4	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of NOTCH4 protein; [Saquinavir co-treated with Nicotine] results in decreased expression of NOTCH4 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]	PMID:20722969
1303282	Notch4	notch receptor 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1354309	E	RGD:6480464	20230801	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOTCH4 mRNA	PMID:36602393
1303282	Notch4	notch receptor 4	gene	CHEBI:25812	ozone	decreases response to substance	ISO	RGD:1553588	E	RGD:6480464	20150609	CTD	MESH:D010126	NOTCH4 protein results in decreased susceptibility to Ozone	PMID:25658374
1303282	Notch4	notch receptor 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553588	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NOTCH4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NOTCH4 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of ATP6V0D2 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of AVPR1A mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of BCL2L15 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of CCL17 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of CCL7 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of CD200R4 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of CXCL3 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of DDC mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of DEPDC1A mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of ECM2 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of EREG mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of HAS2 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of HPX mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of LILRB4 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of LILRB4B mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of MFSD2 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of SERPINA3M mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of SLC26A4 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of SOCS3 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of SPC25 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of TEF mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of TFPI2 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of THBS3 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of TRIP13 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which results in decreased expression of LRG1 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which results in decreased expression of MT2 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which results in increased expression of CLEC3B mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which results in increased expression of RELA mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which results in increased expression of TNF mRNA; NOTCH4 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 mRNA]	PMID:25658374|PMID:34911549
1303282	Notch4	notch receptor 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1354309	E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the reaction [Cisplatin affects the expression of NOTCH4 mRNA]	PMID:16898872
1303282	Notch4	notch receptor 4	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1354309	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NOTCH4 gene	PMID:25304211
1303282	Notch4	notch receptor 4	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of NOTCH4 gene	PMID:31011160
1303282	Notch4	notch receptor 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1354309	E	RGD:6480464	20120412	CTD	MESH:D002945	Folic Acid affects the reaction [Cisplatin affects the expression of NOTCH4 mRNA]	PMID:16898872
1303282	Notch4	notch receptor 4	gene	CHEBI:27902	tetracycline	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20180116	CTD	MESH:D013752	Tetracycline results in decreased expression of NOTCH4 mRNA	PMID:28882639
1303282	Notch4	notch receptor 4	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1354309	E	RGD:6480464	20130514	CTD	MESH:D010278	Parathion results in increased expression of NOTCH4 protein	PMID:17390078
1303282	Notch4	notch receptor 4	gene	CHEBI:27928	parathion	multiple interactions	ISO	RGD:1354309	E	RGD:6480464	20130514	CTD	MESH:D010278	Atropine inhibits the reaction [Parathion results in increased expression of NOTCH4 protein]	PMID:17390078
1303282	Notch4	notch receptor 4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1553588	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of NOTCH4 mRNA	PMID:32186404
1303282	Notch4	notch receptor 4	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of NOTCH4 mRNA	PMID:25583101
1303282	Notch4	notch receptor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NOTCH4 mRNA	PMID:34747641
1303282	Notch4	notch receptor 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NOTCH4 mRNA	PMID:32763439
1303282	Notch4	notch receptor 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NOTCH4 mRNA	PMID:29803840
1303282	Notch4	notch receptor 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1553588	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of NOTCH4 mRNA	PMID:39631538
1303282	Notch4	notch receptor 4	gene	CHEBI:28940	calciol	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D002762	[Cholecalciferol co-treated with Dietary Fats co-treated with Particulate Matter] results in increased expression of NOTCH4 mRNA; [Cholecalciferol co-treated with Dietary Fats co-treated with Particulate Matter] results in increased expression of NOTCH4 protein	PMID:36603807
1303282	Notch4	notch receptor 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1354309	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NOTCH4 exon; Benzo(a)pyrene affects the methylation of NOTCH4 intron	PMID:27901495|PMID:30157460
1303282	Notch4	notch receptor 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553588	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NOTCH4 mRNA	PMID:22610609
1303282	Notch4	notch receptor 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1354309	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NOTCH4 promoter	PMID:27901495
1303282	Notch4	notch receptor 4	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1553588	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of NOTCH4 mRNA	PMID:36087614
1303282	Notch4	notch receptor 4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1553588	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of NOTCH4 mRNA	PMID:22609695
1303282	Notch4	notch receptor 4	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NOTCH4 mRNA	PMID:30047161
1303282	Notch4	notch receptor 4	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1553588	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of NOTCH4 mRNA	PMID:23557971
1303282	Notch4	notch receptor 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1553588	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of NOTCH4 mRNA	PMID:27760801
1303282	Notch4	notch receptor 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NOTCH4 mRNA	PMID:25181051
1303282	Notch4	notch receptor 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1354309	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of NOTCH4 gene	PMID:31601247
1303282	Notch4	notch receptor 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553588	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NOTCH4 mRNA	PMID:33221593
1303282	Notch4	notch receptor 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NOTCH4 mRNA; [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]	PMID:20722969
1303282	Notch4	notch receptor 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1553588	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of NOTCH4 gene	PMID:31683443
1303282	Notch4	notch receptor 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553588	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of NOTCH4 mRNA	PMID:39298647|PMID:40203079
1303282	Notch4	notch receptor 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1354309	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of NOTCH4 gene	PMID:31601247
1303282	Notch4	notch receptor 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553588	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of NOTCH4 mRNA	PMID:30951980
1303282	Notch4	notch receptor 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553588	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of NOTCH4 mRNA	PMID:30951980
1303282	Notch4	notch receptor 4	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1553588	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOTCH4 mRNA	PMID:39150890
1303282	Notch4	notch receptor 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553588	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NOTCH4 mRNA	PMID:37019170
1303282	Notch4	notch receptor 4	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D003993	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1553588	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOTCH4 mRNA	PMID:39150890
1303282	Notch4	notch receptor 4	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1553588	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOTCH4 mRNA	PMID:39150890
1303282	Notch4	notch receptor 4	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of NOTCH4 mRNA	PMID:17175027
1303282	Notch4	notch receptor 4	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of NOTCH4 promoter	PMID:22457795
1303282	Notch4	notch receptor 4	gene	CHEBI:35456	cadmium dichloride	increases cleavage	ISO	RGD:1354309	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased cleavage of NOTCH4 protein	PMID:25118938
1303282	Notch4	notch receptor 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1354309	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NOTCH4 mRNA	PMID:38568856
1303282	Notch4	notch receptor 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1354309	E	RGD:6480464	20230801	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOTCH4 mRNA	PMID:36602393
1303282	Notch4	notch receptor 4	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1553588	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOTCH4 mRNA	PMID:39150890
1303282	Notch4	notch receptor 4	gene	CHEBI:35497	androgen antagonist	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:D000726	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C039281	furan results in increased expression of NOTCH4 mRNA	PMID:38160780
1303282	Notch4	notch receptor 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1553588	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NOTCH4 mRNA	PMID:40194260
1303282	Notch4	notch receptor 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1354309	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NOTCH4 mRNA	PMID:40419075
1303282	Notch4	notch receptor 4	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NOTCH4 mRNA	PMID:30047161
1303282	Notch4	notch receptor 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1553588	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NOTCH4 mRNA	PMID:28973697
1303282	Notch4	notch receptor 4	gene	CHEBI:45409	ritonavir	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019438	Ritonavir results in decreased expression of NOTCH4 protein	PMID:20722969
1303282	Notch4	notch receptor 4	gene	CHEBI:45409	ritonavir	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019438	[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of NOTCH4 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]	PMID:20722969
1303282	Notch4	notch receptor 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553588	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NOTCH4 mRNA	PMID:17562736
1303282	Notch4	notch receptor 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of NOTCH4 mRNA	PMID:21420995
1303282	Notch4	notch receptor 4	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D000082	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1354309	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of NOTCH4 mRNA	PMID:17331233
1303282	Notch4	notch receptor 4	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1553588	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of NOTCH4 mRNA	PMID:29279043
1303282	Notch4	notch receptor 4	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1354309	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NOTCH4 gene	PMID:25304211
1303282	Notch4	notch receptor 4	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1553588	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of NOTCH4 mRNA	PMID:30529165
1303282	Notch4	notch receptor 4	gene	CHEBI:4811	epoxiconazole	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C109476	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553588	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of NOTCH4 mRNA	PMID:25554681
1303282	Notch4	notch receptor 4	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NOTCH4 mRNA	PMID:30047161
1303282	Notch4	notch receptor 4	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D015735	Mifepristone results in decreased expression of NOTCH4 mRNA	PMID:25972201
1303282	Notch4	notch receptor 4	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1354309	E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of NOTCH4 mRNA	PMID:17175027
1303282	Notch4	notch receptor 4	gene	CHEBI:63621	saquinavir	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019258	Saquinavir results in decreased expression of NOTCH4 protein	PMID:20722969
1303282	Notch4	notch receptor 4	gene	CHEBI:63621	saquinavir	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019258	[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of NOTCH4 protein; [Saquinavir co-treated with Nicotine] results in decreased expression of NOTCH4 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]	PMID:20722969
1303282	Notch4	notch receptor 4	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1553588	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of NOTCH4 mRNA	PMID:36907384
1303282	Notch4	notch receptor 4	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1553588	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of NOTCH4 mRNA	PMID:20003209
1303282	Notch4	notch receptor 4	gene	CHEBI:6482	linuron	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D008044	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553588	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NOTCH4 mRNA	PMID:22206623
1303282	Notch4	notch receptor 4	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1553588	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of NOTCH4 mRNA	PMID:27858113
1303282	Notch4	notch receptor 4	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1354309	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NOTCH4 mRNA	PMID:36139627
1303282	Notch4	notch receptor 4	gene	CHEBI:78734	tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate	multiple interactions	ISO	RGD:1354309	E	RGD:6480464	20140805	CTD	MESH:D001285	Atropine inhibits the reaction [Parathion results in increased expression of NOTCH4 protein]	PMID:17390078
1303282	Notch4	notch receptor 4	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1553588	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOTCH4 mRNA	PMID:39150890
1303282	Notch4	notch receptor 4	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of NOTCH4 mRNA	PMID:23914054
1303282	Notch4	notch receptor 4	gene	CHEBI:8434	prochloraz	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C045362	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:8450	procymidone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C035988	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NOTCH4 mRNA	PMID:30047161
1303282	Notch4	notch receptor 4	gene	CHEBI:86193	DAPT	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C419410	N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH4 protein	PMID:36988346
1303282	Notch4	notch receptor 4	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1553588	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of NOTCH4 mRNA	PMID:40826991
1303282	Notch4	notch receptor 4	gene	CHEBI:88542	Butylparaben	multiple interactions	EXP		E	RGD:6480464	20200407	CTD	MESH:C038091	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NOTCH4 mRNA; [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303282	Notch4	notch receptor 4	gene	CHEBI:9150	simvastatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin results in increased expression of NOTCH4 mRNA	PMID:19109527
1303282	Notch4	notch receptor 4	gene	CHEBI:9986	vinclozolin	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C025643	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA	PMID:25607892
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1346233	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of COG6 mRNA	PMID:20044591
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1346233	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of COG6 mRNA	PMID:18951874
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of COG6 mRNA	PMID:21632981
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1551639	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of COG6 mRNA	PMID:33848595
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551639	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of COG6 mRNA	PMID:34319233
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COG6 mRNA	PMID:19549813
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1346233	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of COG6 mRNA	PMID:23649840
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551639	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of COG6 mRNA	PMID:25629700
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551639	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COG6 mRNA	PMID:22206623
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346233	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG6 mRNA	PMID:39836092
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of COG6 mRNA	PMID:31881176
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346233	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of COG6 mRNA	PMID:23557933
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of COG6 mRNA	PMID:27594783
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of COG6 gene	PMID:28505145
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551639	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COG6 mRNA	PMID:21570461
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COG6 mRNA	PMID:17101203
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551639	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of COG6 mRNA	PMID:25975270
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of COG6 mRNA	PMID:33212167
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COG6 mRNA	PMID:30851411
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346233	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COG6 mRNA	PMID:38568856
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346233	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG6 mRNA	PMID:39836092
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1346233	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of COG6 mRNA	PMID:22378314
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1346233	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to COG6 mRNA]	PMID:32406909
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of COG6 mRNA	PMID:26238291
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1346233	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of COG6 gene	PMID:31601247
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COG6 mRNA	PMID:25181051
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of COG6 gene	PMID:28505145
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1346233	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of COG6 protein	PMID:31675489
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551639	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of COG6 mRNA	PMID:38685157
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551639	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of COG6 mRNA	PMID:37019170
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346233	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COG6 mRNA	PMID:37042841
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of COG6 promoter	PMID:22457795
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of COG6 gene	PMID:22079235
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1551639	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of COG6 mRNA	PMID:40194260
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of COG6 mRNA	PMID:28302478
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of COG6 mRNA	PMID:19167446
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1346233	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of COG6 mRNA	PMID:40419075
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551639	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of COG6 mRNA	PMID:17292431
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346233	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of COG6 mRNA	PMID:20106945
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of COG6 mRNA	PMID:21420995
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346233	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG6 mRNA	PMID:39836092
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1346233	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of COG6 mRNA	PMID:22079256
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1551639	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of COG6 mRNA	PMID:17942748
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of COG6 mRNA	PMID:24136188
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of COG6 mRNA	PMID:20080153
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551639	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of COG6 mRNA	PMID:22206623
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551639	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COG6 mRNA	PMID:22206623
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of COG6 mRNA	PMID:24136188
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of COG6 mRNA	PMID:22079256
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1346233	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of COG6 mRNA	PMID:22079256
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1346233	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COG6 mRNA	PMID:30851411
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1346233	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of COG6 protein	PMID:31675489
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1346233	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of COG6 mRNA	PMID:22378314
1303283	Cog6	component of oligomeric golgi complex 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of COG6 mRNA	PMID:21346803
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20150609	CTD	MESH:C007262	TRPA1 affects the reaction [deoxynivalenol results in increased secretion of CCK protein]	PMID:25787141
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:10319	1-naphthol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180703	CTD	MESH:C029350	1-naphthol analog results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1344231	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TRPA1 mRNA	PMID:27188386
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1553598	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TRPA1 mRNA	PMID:33045310
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:142921	3-phenylprop-2-enal	affects response to substance	ISO	RGD:1344231	E	RGD:6480464	20191114	CTD	MESH:C012843	TRPA1 mRNA affects the susceptibility to cinnamaldehyde	PMID:19507004
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:142921	3-phenylprop-2-enal	affects response to substance	ISO	RGD:1553598	E	RGD:6480464	20191114	CTD	MESH:C012843	TRPA1 affects the susceptibility to cinnamaldehyde	PMID:20442136
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:142921	3-phenylprop-2-enal	increases activity	EXP		E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased activity of TRPA1 protein	PMID:20720158
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:142921	3-phenylprop-2-enal	increases activity	ISO	RGD:1344231	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased activity of TRPA1 protein	PMID:20720158|PMID:22863862|PMID:22935519
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:142921	3-phenylprop-2-enal	increases activity	ISO	RGD:1553598	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased activity of TRPA1 protein	PMID:15046718|PMID:21353389|PMID:21689654|PMID:27735854
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:142921	3-phenylprop-2-enal	increases response to substance	ISO	RGD:1344231	E	RGD:6480464	20191114	CTD	MESH:C012843	TRPA1 protein results in increased susceptibility to cinnamaldehyde	PMID:15046718
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:142921	3-phenylprop-2-enal	increases response to substance	ISO	RGD:1553598	E	RGD:6480464	20191114	CTD	MESH:C012843	TRPA1 protein results in increased susceptibility to cinnamaldehyde	PMID:15046718
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:142921	3-phenylprop-2-enal	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20191114	CTD	MESH:C012843	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]; [cinnamaldehyde results in increased activity of TRPA1 protein] which results in increased transport of Calcium; edelfosine inhibits the reaction [F2RL1 protein promotes the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]]; F2RL1 protein promotes the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]; TRPA1 mRNA affects the reaction [cinnamaldehyde results in increased secretion of Serotonin]; TRPA1 mRNA affects the reaction [cinnamaldehyde results in increased uptake of Calcium]	PMID:17571167|PMID:19507004|PMID:20720158|PMID:22863862
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:142921	3-phenylprop-2-enal	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20191114	CTD	MESH:C012843	1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]; 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]; cinnamaldehyde binds to and results in increased activity of TRPA1 protein; isopentenyl pyrophosphate inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]	PMID:15046718|PMID:17991581|PMID:21353389|PMID:21689654
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15368	acrolein	affects response to substance	ISO	RGD:1344231	E	RGD:6480464	20120515	CTD	MESH:D000171	TRPA1 mRNA affects the susceptibility to Acrolein	PMID:19507004
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15368	acrolein	affects response to substance	ISO	RGD:1553598	E	RGD:6480464	20170516	CTD	MESH:D000171	TRPA1 gene mutant form affects the susceptibility to Acrolein; TRPA1 protein affects the susceptibility to Acrolein	PMID:27746315|PMID:30351402
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15368	acrolein	decreases response to substance	ISO	RGD:1553598	E	RGD:6480464	20180828	CTD	MESH:D000171	TRPA1 gene mutant form results in decreased susceptibility to Acrolein	PMID:29627347
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15368	acrolein	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D000171	Acrolein results in increased activity of TRPA1 protein	PMID:18568077
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15368	acrolein	increases activity	ISO	RGD:1344231	E	RGD:6480464	20120613	CTD	MESH:D000171	Acrolein results in increased activity of TRPA1 protein	PMID:21591660
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15368	acrolein	increases activity	ISO	RGD:1553598	E	RGD:6480464	20120412	CTD	MESH:D000171	Acrolein results in increased activity of TRPA1 protein	PMID:18568077|PMID:34271065
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15368	acrolein	increases response to substance	ISO	RGD:1553598	E	RGD:6480464	20170207	CTD	MESH:D000171	TRPA1 gene mutant form results in increased susceptibility to Acrolein	PMID:27592100
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20120515	CTD	MESH:D000171	TRPA1 mRNA affects the reaction [Acrolein results in increased secretion of Serotonin]; TRPA1 mRNA affects the reaction [Acrolein results in increased uptake of Calcium]	PMID:19507004
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20190312	CTD	MESH:D000171	TRPA1 gene mutant form affects the susceptibility to [Particulate Matter co-treated with Acrolein]	PMID:30351402
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15843	arachidonic acid	increases activity	ISO	RGD:1553598	E	RGD:6480464	20161213	CTD	MESH:D016718	Arachidonic Acid results in increased activity of TRPA1 protein	PMID:15046718
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:15843	arachidonic acid	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20161213	CTD	MESH:D016718	Ruthenium Red inhibits the reaction [Arachidonic Acid results in increased activity of TRPA1 protein]	PMID:15046718
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16011	2-ethylhexan-1-ol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20170516	CTD	MESH:C034017	2-ethylhexanol results in increased activity of TRPA1 protein	PMID:27545873
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16136	hydrogen sulfide	increases activity	ISO	RGD:1344231	E	RGD:6480464	20120515	CTD	MESH:D006862	Hydrogen Sulfide results in increased activity of TRPA1 protein	PMID:18031925
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16136	hydrogen sulfide	increases activity	ISO	RGD:1553598	E	RGD:6480464	20120515	CTD	MESH:D006862	Hydrogen Sulfide results in increased activity of TRPA1 protein	PMID:18031925
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1344231	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRPA1 mRNA	PMID:35811015
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRPA1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TRPA1 mRNA	PMID:35811015
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16482	naphthalene	increases response to substance	ISO	RGD:1553598	E	RGD:6480464	20120412	CTD	MESH:C031721	TRPA1 results in increased susceptibility to naphthalene	PMID:20176620
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16526	carbon dioxide	increases activity	EXP		E	RGD:6480464	20120515	CTD	MESH:D002245	Carbon Dioxide results in increased activity of TRPA1 protein	PMID:20881114
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16547	coniferyl aldehyde	increases activity	ISO	RGD:1344231	E	RGD:6480464	20140114	CTD	MESH:C075384	coniferaldehyde results in increased activity of TRPA1 protein	PMID:23541125
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16584	isopentenyl diphosphate	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20120515	CTD	MESH:C004809	isopentenyl pyrophosphate inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]	PMID:21353389
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16684	atropine	decreases response to substance	ISO	RGD:1553598	E	RGD:6480464	20180828	CTD	MESH:D001285	TRPA1 gene mutant form results in decreased susceptibility to Atropine	PMID:29627347
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16716	benzene	increases activity	ISO	RGD:1344231	E	RGD:6480464	20120613	CTD	MESH:D001554	Benzene results in increased activity of TRPA1 protein	PMID:21591660
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16842	formaldehyde	decreases response to substance	ISO	RGD:1553598	E	RGD:6480464	20241105	CTD	MESH:D005557	TRPA1 gene mutant form results in decreased susceptibility to Formaldehyde	PMID:39067042
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16842	formaldehyde	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased activity of TRPA1 protein	PMID:19847360
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16842	formaldehyde	increases activity	ISO	RGD:1344231	E	RGD:6480464	20120613	CTD	MESH:D005557	Formaldehyde results in increased activity of TRPA1 protein	PMID:21591660
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16842	formaldehyde	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [Formaldehyde results in increased activity of TRPA1 protein]	PMID:19847360
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16856	glutathione	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20140114	CTD	MESH:D005978	Glutathione inhibits the reaction [agathic acid results in increased activity of TRPA1 protein]; Glutathione inhibits the reaction [Particulate Matter results in increased activity of TRPA1 protein]; Glutathione inhibits the reaction [phenalen-1-one results in increased activity of TRPA1 protein]	PMID:23541125|PMID:30945539
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:16997	propane-1,2-diol	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20241105	CTD	MESH:D019946	TRPA1 gene mutant form results in decreased susceptibility to [Propylene Glycol co-treated with Glycerol]	PMID:39067042
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:17158	methylglyoxal	increases activity	ISO	RGD:1344231	E	RGD:6480464	20130312	CTD	MESH:D011765	Pyruvaldehyde results in increased activity of TRPA1 protein	PMID:22863862
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:17158	methylglyoxal	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20130312	CTD	MESH:D011765	[Pyruvaldehyde results in increased activity of TRPA1 protein] which results in increased transport of Calcium	PMID:22863862
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:17580	linalool	increases activity	ISO	RGD:1553598	E	RGD:6480464	20171010	CTD	MESH:C018584	linalool results in increased activity of TRPA1 protein	PMID:27735854
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:17594	hydroquinone	increases activity	ISO	RGD:1344231	E	RGD:6480464	20120613	CTD	MESH:C031927	hydroquinone results in increased activity of TRPA1 protein	PMID:21591660|PMID:28790335
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:17594	hydroquinone	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20220405	CTD	MESH:C031927	[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium; Dithiothreitol inhibits the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; Dithiothreitol inhibits the reaction [hydroquinone results in increased activity of TRPA1 protein]; mustard oil promotes the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; mustard oil promotes the reaction [hydroquinone results in increased activity of TRPA1 protein]	PMID:28790335
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:17754	glycerol	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20241105	CTD	MESH:D005990	TRPA1 gene mutant form results in decreased susceptibility to [Propylene Glycol co-treated with Glycerol]	PMID:39067042
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]	PMID:15843607
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:180557	2,6-Dimethylphenol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20211019	CTD	MESH:C036531	2,6-xylenol results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:182159	Cannabidivarin	increases activity	ISO	RGD:1344231	E	RGD:6480464	20211109	CTD	MESH:C580853	cannabidivarin results in increased activity of TRPA1 protein	PMID:30074247|PMID:31096838
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:182159	Cannabidivarin	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20211109	CTD	MESH:C580853	[cannabidivarin results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; TRPA1 mRNA promotes the reaction [cannabidivarin results in increased expression of MYOG mRNA]	PMID:30074247|PMID:31096838
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:18320	1,4-dithiothreitol	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20220405	CTD	MESH:D004229	Dithiothreitol inhibits the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; Dithiothreitol inhibits the reaction [hydroquinone results in increased activity of TRPA1 protein]	PMID:28790335
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:18388	apigenin	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20260113	CTD	MESH:D047310	Apigenin inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]	PMID:37375837
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:188094	1-Oleoyl-2-acetyl-sn-glycerol	increases activity	ISO	RGD:1553598	E	RGD:6480464	20220104	CTD	MESH:C038237	1-oleoyl-2-acetylglycerol results in increased activity of TRPA1 protein	PMID:15046718
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:188094	1-Oleoyl-2-acetyl-sn-glycerol	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20220104	CTD	MESH:C038237	Ruthenium Red inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPA1 protein]	PMID:15046718
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:191381	2,5-xylenol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20220614	CTD	MESH:C048893	2,5-xylenol results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:206827	Agathic acid	increases activity	ISO	RGD:1344231	E	RGD:6480464	20231219	CTD	MESH:C110795	agathic acid results in increased activity of TRPA1 protein	PMID:23541125
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:206827	Agathic acid	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20231219	CTD	MESH:C110795	Glutathione inhibits the reaction [agathic acid results in increased activity of TRPA1 protein]	PMID:23541125
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:228969	2,3-Dicresol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20240206	CTD	MESH:C054067	2,3-dimethylphenol results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRPA1 mRNA	PMID:35301059
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:22984	calcium atom	affects activity	ISO	RGD:1553598	E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the activity of TRPA1 protein	PMID:15843607
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:22984	calcium atom	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D002118	[allicin binds to and results in increased activity of TRPA1 protein] which results in increased transport of Calcium; [allyl isothiocyanate binds to and results in increased activity of TRPA1 protein] which results in increased transport of Calcium; [cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with TRPA1 protein] results in increased uptake of Calcium; Calcium affects the reaction [Capsaicin inhibits the reaction [TRPA1 protein affects the susceptibility to mustard oil]]; TRPA1 affects the reaction [AM 1241 results in increased abundance of Calcium]; TRPA1 promotes the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in increased abundance of Calcium]; TRPA1 promotes the reaction [mustard oil results in increased abundance of Calcium]	PMID:17314320|PMID:17590514|PMID:18234885|PMID:20086034
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:22984	calcium atom	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20120515	CTD	MESH:D002118	4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime inhibits the reaction [[2-chloroethyl ethyl sulfide results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; 4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime inhibits the reaction [[Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; [2-chloroethyl ethyl sulfide results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; [allyl isothiocyanate results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; [cannabidivarin results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; [Cannabinol results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; [cinnamaldehyde results in increased activity of TRPA1 protein] which results in increased transport of Calcium; [cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with TRPA1 protein] results in increased uptake of Calcium; [hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium; [Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; [Pyruvaldehyde results in increased activity of TRPA1 protein] which results in increased transport of Calcium; [Vehicle Emissions results in increased activity of TRPA1 protein] which results in increased import of Calcium; Acetylcysteine inhibits the reaction [[allyl isothiocyanate results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; Acetylcysteine inhibits the reaction [[Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; Dithiothreitol inhibits the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; mustard oil promotes the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; TRPA1 mRNA affects the reaction [Acrolein results in increased uptake of Calcium]; TRPA1 mRNA affects the reaction [allyl isothiocyanate results in increased uptake of Calcium]; TRPA1 mRNA affects the reaction [cinnamaldehyde results in increased uptake of Calcium]	PMID:17314320|PMID:19507004|PMID:22863862|PMID:27738742|PMID:28790335|PMID:30945539|PMID:31096838
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:233256	A-967079	decreases activity	ISO	RGD:1344231	E	RGD:6480464	20250408	CTD	MESH:C560402	A 967079 results in decreased activity of TRPA1 protein	PMID:28919489
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:233256	A-967079	decreases activity	ISO	RGD:1553598	E	RGD:6480464	20250408	CTD	MESH:C560402	A 967079 results in decreased activity of TRPA1 protein	PMID:34271065
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:233256	A-967079	increases response to substance	ISO	RGD:1344231	E	RGD:6480464	20250408	CTD	MESH:C560402	TRPA1 protein results in increased susceptibility to A 967079	PMID:28919489
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:233256	A-967079	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20250408	CTD	MESH:C560402	A 967079 inhibits the reaction [Ozone results in increased expression of TRPA1 protein]	PMID:35928613
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:2430	aconitine	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D000157	TRPA1 results in increased susceptibility to [Vehicle Emissions co-treated with Aconitine]	PMID:21377951
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1344231	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRPA1 mRNA	PMID:22100608|PMID:32234424
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:25187	p-menthan-3-ol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180515	CTD	MESH:D008610	Menthol results in increased activity of TRPA1 protein	PMID:29054683
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases activity	ISO	RGD:1344231	E	RGD:6480464	20170516	CTD	MESH:D009151	Mustard Gas results in increased activity of TRPA1 protein	PMID:27738742|PMID:36693442
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases alkylation	ISO	RGD:1344231	E	RGD:6480464	20230502	CTD	MESH:D009151	Mustard Gas results in increased alkylation of TRPA1 protein	PMID:36371551
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases response to substance	ISO	RGD:1344231	E	RGD:6480464	20231205	CTD	MESH:D009151	TRPA1 protein results in increased susceptibility to Mustard Gas	PMID:36693442
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20170516	CTD	MESH:D009151	4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime inhibits the reaction [[Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; 4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime inhibits the reaction [Mustard Gas results in increased activity of TRPA1 protein]; [Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; Acetylcysteine inhibits the reaction [[Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]	PMID:27738742|PMID:36693442
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:25812	ozone	affects response to substance	ISO	RGD:1553598	E	RGD:6480464	20120515	CTD	MESH:D010126	TRPA1 affects the susceptibility to Ozone	PMID:20008466
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:25812	ozone	increases activity	ISO	RGD:1344231	E	RGD:6480464	20120515	CTD	MESH:D010126	Ozone results in increased activity of TRPA1 protein	PMID:20008466
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1553598	E	RGD:6480464	20231031	CTD	MESH:D010126	Ozone results in increased expression of TRPA1 protein	PMID:35928613
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20231031	CTD	MESH:D010126	3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide inhibits the reaction [Ozone results in increased expression of TRPA1 protein]; A 967079 inhibits the reaction [Ozone results in increased expression of TRPA1 protein]	PMID:35928613
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:2639	amiloride	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20120412	CTD	MESH:D000584	Amiloride inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]	PMID:15843607
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:27363	zinc atom	affects response to substance	ISO	RGD:1553598	E	RGD:6480464	20231031	CTD	MESH:D015032	TRPA1 protein affects the susceptibility to Zinc	PMID:20133428
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:27452	styrene	increases response to substance	ISO	RGD:1553598	E	RGD:6480464	20120412	CTD	MESH:D020058	TRPA1 results in increased susceptibility to Styrene	PMID:20176620
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1553598	E	RGD:6480464	20160510	CTD	MESH:D005492	Folic Acid results in increased expression of TRPA1 mRNA	PMID:25006883
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:27632	acetophenone	increases activity	ISO	RGD:1344231	E	RGD:6480464	20170516	CTD	MESH:C038699	acetophenone results in increased activity of TRPA1 protein	PMID:27545873
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1553598	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of TRPA1 mRNA	PMID:28960355
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of TRPA1 mRNA	PMID:41028656
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:27899	cisplatin	increases response to substance	ISO	RGD:1553598	E	RGD:6480464	20120412	CTD	MESH:D002945	TRPA1 protein modified form results in increased susceptibility to Cisplatin	PMID:21481532
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:28235	p-methoxybenzaldehyde	increases activity	ISO	RGD:1344231	E	RGD:6480464	20141111	CTD	MESH:C024896	4-anisaldehyde results in increased activity of TRPA1 protein	PMID:21591660
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:28411	allicin	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C006452	allicin results in increased activity of TRPA1 protein	PMID:17684094
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:28411	allicin	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:C006452	[allicin binds to and results in increased activity of TRPA1 protein] which results in increased transport of Calcium; allicin binds to and results in increased activity of TRPA1 protein	PMID:20086034
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:28411	allicin	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20120412	CTD	MESH:C006452	allicin binds to and results in increased activity of TRPA1 protein	PMID:17825279
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1553598	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of TRPA1 mRNA	PMID:30807115
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TRPA1 mRNA	PMID:41028656
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:28790	serotonin	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20120515	CTD	MESH:D012701	TRPA1 mRNA affects the reaction [Acrolein results in increased secretion of Serotonin]; TRPA1 mRNA affects the reaction [allyl isothiocyanate results in increased secretion of Serotonin]; TRPA1 mRNA affects the reaction [cinnamaldehyde results in increased secretion of Serotonin]	PMID:19507004
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:28869	menadione	increases activity	ISO	RGD:1344231	E	RGD:6480464	20120613	CTD	MESH:D024483	Vitamin K 3 results in increased activity of TRPA1 protein	PMID:21591660
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:28925	mechlorethamine	increases response to substance	ISO	RGD:1344231	E	RGD:6480464	20231205	CTD	MESH:D008466	TRPA1 protein results in increased susceptibility to Mechlorethamine	PMID:36693442
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20170516	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[allyl isothiocyanate results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; Acetylcysteine inhibits the reaction [[Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]	PMID:27738742
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:2904	atenolol	decreases response to substance	ISO	RGD:1553598	E	RGD:6480464	20180828	CTD	MESH:D001262	TRPA1 gene mutant form results in decreased susceptibility to Atenolol	PMID:29627347
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	ISO	RGD:1553598	E	RGD:6480464	20120515	CTD	MESH:C028473	TRPA1 affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:20720158
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	increases activity	EXP		E	RGD:6480464	20120515	CTD	MESH:C028473	N-acetyl-4-benzoquinoneimine results in increased activity of TRPA1 protein	PMID:20720158
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	increases activity	ISO	RGD:1344231	E	RGD:6480464	20120515	CTD	MESH:C028473	N-acetyl-4-benzoquinoneimine results in increased activity of TRPA1 protein	PMID:20720158
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20120515	CTD	MESH:C028473	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased activity of TRPA1 protein]	PMID:20720158
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:29320	calcium(0)	affects activity	ISO	RGD:1553598	E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the activity of TRPA1 protein	PMID:15843607
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:29320	calcium(0)	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D002118	[allicin binds to and results in increased activity of TRPA1 protein] which results in increased transport of Calcium; [allyl isothiocyanate binds to and results in increased activity of TRPA1 protein] which results in increased transport of Calcium; [cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with TRPA1 protein] results in increased uptake of Calcium; Calcium affects the reaction [Capsaicin inhibits the reaction [TRPA1 protein affects the susceptibility to mustard oil]]; TRPA1 affects the reaction [AM 1241 results in increased abundance of Calcium]; TRPA1 promotes the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in increased abundance of Calcium]; TRPA1 promotes the reaction [mustard oil results in increased abundance of Calcium]	PMID:17314320|PMID:17590514|PMID:18234885|PMID:20086034
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:29320	calcium(0)	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20120515	CTD	MESH:D002118	4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime inhibits the reaction [[2-chloroethyl ethyl sulfide results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; 4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime inhibits the reaction [[Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; [2-chloroethyl ethyl sulfide results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; [allyl isothiocyanate results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; [cannabidivarin results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; [Cannabinol results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; [cinnamaldehyde results in increased activity of TRPA1 protein] which results in increased transport of Calcium; [cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with TRPA1 protein] results in increased uptake of Calcium; [hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium; [Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; [Pyruvaldehyde results in increased activity of TRPA1 protein] which results in increased transport of Calcium; [Vehicle Emissions results in increased activity of TRPA1 protein] which results in increased import of Calcium; Acetylcysteine inhibits the reaction [[allyl isothiocyanate results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; Acetylcysteine inhibits the reaction [[Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; Dithiothreitol inhibits the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; mustard oil promotes the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; TRPA1 mRNA affects the reaction [Acrolein results in increased uptake of Calcium]; TRPA1 mRNA affects the reaction [allyl isothiocyanate results in increased uptake of Calcium]; TRPA1 mRNA affects the reaction [cinnamaldehyde results in increased uptake of Calcium]	PMID:17314320|PMID:19507004|PMID:22863862|PMID:27738742|PMID:28790335|PMID:30945539|PMID:31096838
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1344231	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRPA1 mRNA	PMID:32234424
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1344231	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRPA1 exon; Benzo(a)pyrene results in increased methylation of TRPA1 promoter	PMID:27901495
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TRPA1 mRNA	PMID:41028656
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:30185	zinc(0)	affects response to substance	ISO	RGD:1553598	E	RGD:6480464	20231031	CTD	MESH:D015032	TRPA1 protein affects the susceptibility to Zinc	PMID:20133428
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1344231	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TRPA1 mRNA	PMID:20382639
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1553598	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TRPA1 mRNA	PMID:39716349
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:32585	4-hydroxynon-2-enal	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased activity of TRPA1 protein	PMID:17684094
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:32585	4-hydroxynon-2-enal	increases activity	ISO	RGD:1344231	E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased activity of TRPA1 protein	PMID:17684094
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:32585	4-hydroxynon-2-enal	increases activity	ISO	RGD:1553598	E	RGD:6480464	20120515	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased activity of TRPA1 protein	PMID:21689654
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:32585	4-hydroxynon-2-enal	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20120412	CTD	MESH:C027576	Ruthenium Red inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of TRPA1 protein]; TRPA1 gene mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of TRPA1 protein]	PMID:17684094
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:32585	4-hydroxynon-2-enal	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20120515	CTD	MESH:C027576	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of TRPA1 protein]	PMID:21689654
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TRPA1 mRNA	PMID:25181051|PMID:34947998
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:33375	gadolinium atom	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20120412	CTD	MESH:D005682	Gadolinium inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]	PMID:15843607
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:3357	Cannabichromene	increases activity	ISO	RGD:1344231	E	RGD:6480464	20201215	CTD	MESH:C010695	cannabichromene results in increased activity of TRPA1 protein	PMID:31096838
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:3359	cannabidiolic acid	increases activity	ISO	RGD:1344231	E	RGD:6480464	20201215	CTD	MESH:C006884	cannabidiolic acid results in increased activity of TRPA1 protein	PMID:31096838
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:3360	Cannabinol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20201215	CTD	MESH:D002187	Cannabinol results in increased activity of TRPA1 protein	PMID:31096838
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:3360	Cannabinol	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20201215	CTD	MESH:D002187	[Cannabinol results in increased activity of TRPA1 protein] which results in increased uptake of Calcium	PMID:31096838
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:3374	capsaicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002211	Capsaicin results in decreased expression of TRPA1 mRNA	PMID:18079164
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:3374	capsaicin	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180515	CTD	MESH:D002211	Capsaicin results in increased activity of TRPA1 protein	PMID:29054683
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:3374	capsaicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002211	Calcium affects the reaction [Capsaicin inhibits the reaction [TRPA1 protein affects the susceptibility to mustard oil]]	PMID:17590514
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34055	1,2-naphthoquinone	increases activity	ISO	RGD:1344231	E	RGD:6480464	20141111	CTD	MESH:C040756	1,2-naphthoquinone results in increased activity of TRPA1 protein	PMID:21591660
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34104	1-nitronaphthalene	increases activity	ISO	RGD:1344231	E	RGD:6480464	20120613	CTD	MESH:C016614	1-nitronaphthalene results in increased activity of TRPA1 protein	PMID:21591660
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34241	2,4-xylenol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180703	CTD	MESH:C027804	2,4-dimethylphenol results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34275	2-Ethylphenol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180703	CTD	MESH:C495777	2-ethylphenol results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34332	3-Ethylphenol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180703	CTD	MESH:C497701	3-ethylphenol results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553598	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TRPA1 mRNA	PMID:40203079
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:3440	carvacrol	increases activity	EXP		E	RGD:6480464	20120515	CTD	MESH:C073316	carvacrol results in increased activity of TRPA1 protein	PMID:16617338
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:3440	carvacrol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20130416	CTD	MESH:C073316	carvacrol results in increased activity of TRPA1 protein	PMID:22935519
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPA1 protein	PMID:34896426
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1553598	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TRPA1 promoter	PMID:28392331
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34687	dibutyl phthalate	increases activity	ISO	RGD:1344231	E	RGD:6480464	20130416	CTD	MESH:D003993	Dibutyl Phthalate results in increased activity of TRPA1 protein	PMID:22935519
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20130416	CTD	MESH:D003993	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [Dibutyl Phthalate results in increased activity of TRPA1 protein]	PMID:22935519
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34956	ruthenium red	decreases activity	ISO	RGD:1344231	E	RGD:6480464	20170303	CTD	MESH:D012430	Ruthenium Red results in decreased activity of TRPA1 protein	PMID:23994502
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34956	ruthenium red	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20170303	CTD	MESH:D012430	Ruthenium Red inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [[allyl isothiocyanate co-treated with TRPA1 protein] results in increased phosphorylation of MAPK1 protein]; Ruthenium Red inhibits the reaction [[allyl isothiocyanate co-treated with TRPA1 protein] results in increased phosphorylation of MAPK3 protein]	PMID:17684094|PMID:23994502
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:34956	ruthenium red	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20170303	CTD	MESH:D012430	Ruthenium Red inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [Arachidonic Acid results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]	PMID:15046718|PMID:15843607
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:35020	tributyrin	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180515	CTD	MESH:C005830	tributyrin results in increased activity of TRPA1 protein	PMID:29198882
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of TRPA1 promoter	PMID:22457795
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRPA1 mRNA	PMID:35301059
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20250805	CTD	MESH:C012125	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA]]; 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein]]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA]]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein]]	PMID:28240277
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	decreases expression	ISO	RGD:1344231	E	RGD:6480464	20230704	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in decreased expression of TRPA1 mRNA	PMID:36847817
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:37918	fluorescein 5-isothiocyanate	affects binding	ISO	RGD:1344231	E	RGD:6480464	20180116	CTD	MESH:D016650	Fluorescein-5-isothiocyanate binds to TRPA1 protein	PMID:27129696
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:37918	fluorescein 5-isothiocyanate	increases expression	ISO	RGD:1553598	E	RGD:6480464	20250805	CTD	MESH:D016650	Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA; Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein	PMID:28240277
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:37918	fluorescein 5-isothiocyanate	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20250805	CTD	MESH:D016650	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA]]; 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein]]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA]; diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA]]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein]]	PMID:28240277
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1553598	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TRPA1 mRNA	PMID:40194260
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:38572	3,5-xylenol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180703	CTD	MESH:C016834	3,5-xylenol results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of TRPA1 protein	PMID:34896426
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:39478	buta-1,3-diene	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20120613	CTD	MESH:C031763	1,3-butadiene binds to and results in increased activity of TRPA1 protein	PMID:21591660
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:39839	3,4-xylenol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20191114	CTD	MESH:C063628	3,4-dimethylphenol results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1344231	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TRPA1 gene	PMID:29154799
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344231	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TRPA1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPA1 mRNA	PMID:27188386
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:4027	cyclophosphamide	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D003520	[2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide binds to and results in decreased activity of TRPA1 protein] which results in decreased susceptibility to Cyclophosphamide	PMID:23523557
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPA1 protein	PMID:34896426
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPA1 protein	PMID:34896426
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:41607	crotonaldehyde	increases activity	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased activity of TRPA1 protein	PMID:18568077
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:41607	crotonaldehyde	increases activity	ISO	RGD:1553598	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased activity of TRPA1 protein	PMID:18568077|PMID:32634517
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:42106	L-1,4-dithiothreitol	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20220405	CTD	MESH:D004229	Dithiothreitol inhibits the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; Dithiothreitol inhibits the reaction [hydroquinone results in increased activity of TRPA1 protein]	PMID:28790335
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1344231	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TRPA1 mRNA	PMID:38832940
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1344231	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TRPA1 mRNA	PMID:24935251
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1553598	E	RGD:6480464	20120515	CTD	MESH:D000082	TRPA1 affects the susceptibility to Acetaminophen	PMID:20720158
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRPA1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TRPA1 mRNA	PMID:35811015
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:46936	nonivamide	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20230704	CTD	MESH:C040937	nonivamide inhibits the reaction [Smoke results in increased expression of TRPA1 mRNA]	PMID:36847817
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:47856	citronellal	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180410	CTD	MESH:C108217	citronellal results in increased activity of TRPA1 protein	PMID:26447139
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:4917	eugenol	increases activity	EXP		E	RGD:6480464	20120515	CTD	MESH:D005054	Eugenol results in increased activity of TRPA1 protein	PMID:22426238
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:4917	eugenol	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D005054	[2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide binds to and results in decreased activity of TRPA1 protein] which results in decreased susceptibility to Eugenol	PMID:22426238
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:49584	4-ethylphenol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180703	CTD	MESH:C042291	4-ethylphenol results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20171010	CTD	MESH:D007213	Indomethacin inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]	PMID:27735854
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1553598	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TRPA1 mRNA	PMID:39716349
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1344231	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of TRPA1 mRNA	PMID:38825487
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPA1 protein	PMID:34896426
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:53168	picrocrocin	increases activity	ISO	RGD:1344231	E	RGD:6480464	20190507	CTD	MESH:C087962	picrocrocin results in increased activity of TRPA1 protein	PMID:30636360
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:53168	picrocrocin	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20190507	CTD	MESH:C087962	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [picrocrocin results in increased activity of TRPA1 protein]	PMID:30636360
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:53169	safranal	increases activity	ISO	RGD:1344231	E	RGD:6480464	20190507	CTD	MESH:C087963	safranal results in increased activity of TRPA1 protein	PMID:30636360
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:53169	safranal	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20190507	CTD	MESH:C087963	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [safranal results in increased activity of TRPA1 protein]	PMID:30636360
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:53169	safranal	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20190507	CTD	MESH:C087963	TRPA1 gene mutant form inhibits the reaction [safranal results in increased secretion of CALCA protein]	PMID:30636360
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:53212	isocyanates	increases response to substance	ISO	RGD:1553598	E	RGD:6480464	20170131	CTD	MESH:D017953	TRPA1 protein results in increased susceptibility to Isocyanates	PMID:19036859
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:6382	Lasiocarpine	increases expression	ISO	RGD:1344231	E	RGD:6480464	20200714	CTD	MESH:C005136	lasiocarpine results in increased expression of TRPA1 mRNA	PMID:32234424
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1344231	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TRPA1 mRNA	PMID:22079614
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:6456	lidocaine	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D008012	Lidocaine results in increased activity of TRPA1 protein	PMID:18172555
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:6456	lidocaine	increases activity	ISO	RGD:1553598	E	RGD:6480464	20120412	CTD	MESH:D008012	Lidocaine results in increased activity of TRPA1 protein	PMID:18172555
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:69478	cannabidiol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20210209	CTD	MESH:D002185	Cannabidiol results in increased activity of TRPA1 protein	PMID:30074247
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1344231	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of TRPA1 mRNA	PMID:27918106
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol binds to and results in increased activity of TRPA1 protein	PMID:18550765
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:73224	allyl isothiocyanate	affects response to substance	ISO	RGD:1344231	E	RGD:6480464	20130702	CTD	MESH:C004471	TRPA1 mRNA affects the susceptibility to allyl isothiocyanate; TRPA1 protein polymorphism affects the susceptibility to allyl isothiocyanate	PMID:19507004|PMID:26039217
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:73224	allyl isothiocyanate	affects response to substance	ISO	RGD:1553598	E	RGD:6480464	20130702	CTD	MESH:C004471	TRPA1 affects the susceptibility to allyl isothiocyanate	PMID:20442136|PMID:20720158
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:73224	allyl isothiocyanate	increases activity	EXP		E	RGD:6480464	20130702	CTD	MESH:C004471	allyl isothiocyanate results in increased activity of TRPA1 protein	PMID:17314320
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:73224	allyl isothiocyanate	increases activity	ISO	RGD:1344231	E	RGD:6480464	20140311	CTD	MESH:C004471	allyl isothiocyanate results in increased activity of TRPA1 protein	PMID:22935519|PMID:23994502|PMID:27738742|PMID:29054683|PMID:30636360|PMID:36693442|PMID:37375837
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:73224	allyl isothiocyanate	increases activity	ISO	RGD:1553598	E	RGD:6480464	20130702	CTD	MESH:C004471	allyl isothiocyanate results in increased activity of TRPA1 protein	PMID:15046718|PMID:21689654|PMID:27735854
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:73224	allyl isothiocyanate	multiple interactions	EXP		E	RGD:6480464	20130702	CTD	MESH:C004471	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; [allyl isothiocyanate binds to and results in increased activity of TRPA1 protein] which results in increased transport of Calcium; allyl isothiocyanate binds to and results in increased activity of TRPA1 protein	PMID:20086034|PMID:27735854
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:73224	allyl isothiocyanate	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20130702	CTD	MESH:C004471	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; [allyl isothiocyanate co-treated with TRPA1 protein] results in increased phosphorylation of MAPK1 protein; [allyl isothiocyanate co-treated with TRPA1 protein] results in increased phosphorylation of MAPK3 protein; [allyl isothiocyanate results in increased activity of TRPA1 protein] which results in increased uptake of Calcium; Acetylcysteine inhibits the reaction [[allyl isothiocyanate results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; Apigenin inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; BDKRB2 protein promotes the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; edelfosine inhibits the reaction [F2RL1 protein promotes the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]]; F2RL1 protein promotes the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; Phosphatidylinositol 4,5-Diphosphate inhibits the reaction [F2RL1 protein promotes the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]]; Ruthenium Red inhibits the reaction [[allyl isothiocyanate co-treated with TRPA1 protein] results in increased phosphorylation of MAPK1 protein]; Ruthenium Red inhibits the reaction [[allyl isothiocyanate co-treated with TRPA1 protein] results in increased phosphorylation of MAPK3 protein]; TRPA1 mRNA affects the reaction [allyl isothiocyanate results in increased secretion of Serotonin]; TRPA1 mRNA affects the reaction [allyl isothiocyanate results in increased uptake of Calcium]; vasicine inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; vasicinone inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]	PMID:17571167|PMID:19507004|PMID:23994502|PMID:27738742|PMID:30636360|PMID:37375837
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:73224	allyl isothiocyanate	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20130702	CTD	MESH:C004471	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; [TRPA1 protein results in increased susceptibility to sodium persulfate] which affects the susceptibility to allyl isothiocyanate; allyl isothiocyanate binds to and results in increased activity of TRPA1 protein; Amiloride inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; Gadolinium inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; Gentamicins inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; Indomethacin inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]; TRPA1 gene mutant form inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]	PMID:15843607|PMID:17825279|PMID:21689654|PMID:27735854|PMID:30738091
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:73295	WIN 55212-2	increases response to substance	ISO	RGD:1553598	E	RGD:6480464	20170303	CTD	MESH:C070417	TRPA1 results in increased susceptibility to (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone	PMID:18234885
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:73295	WIN 55212-2	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C070417	(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone binds to and results in increased activity of TRPA1 protein; TRPA1 promotes the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in increased abundance of Calcium]	PMID:18234885|PMID:18550765
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:7549	N(gamma)-nitro-L-arginine methyl ester	decreases response to substance	ISO	RGD:1553598	E	RGD:6480464	20201006	CTD	MESH:D019331	TRPA1 gene mutant form results in decreased susceptibility to NG-Nitroarginine Methyl Ester	PMID:32634517
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:76537	1,2-dibutyrin	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180515	CTD	MESH:C063304	dibutyrylglycerol analog results in increased activity of TRPA1 protein	PMID:29198882
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPA1 mRNA	PMID:27188386
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:78649	edelfosine	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20170303	CTD	MESH:C026659	edelfosine inhibits the reaction [F2RL1 protein promotes the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]]; edelfosine inhibits the reaction [F2RL1 protein promotes the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]]	PMID:17571167
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:78734	tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate	decreases response to substance	ISO	RGD:1553598	E	RGD:6480464	20180828	CTD	MESH:D001285	TRPA1 gene mutant form results in decreased susceptibility to Atropine	PMID:29627347
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20250805	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 mRNA]]; pyrrolidine dithiocarbamic acid inhibits the reaction [diisononyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TRPA1 protein]]	PMID:28240277
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:7949	Peganine	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20260113	CTD	MESH:C019592	vasicine inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]	PMID:37375837
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRPA1 gene]	PMID:28238834
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1344231	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of TRPA1 mRNA	PMID:26705709
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:8809	resiniferatoxin	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:C024353	resiniferatoxin results in decreased expression of TRPA1 mRNA	PMID:25077949
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:89188	2,4-di-tert-butylphenol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20151103	CTD	MESH:C056559	2,4-di-tert-butylphenol results in increased activity of TRPA1 protein	PMID:21591660|PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:89886	2-Methoxy-4-methylphenol	increases activity	ISO	RGD:1344231	E	RGD:6480464	20180703	CTD	MESH:C025390	creosol results in increased activity of TRPA1 protein	PMID:29658714
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:90690	U-73122	multiple interactions	ISO	RGD:1553598	E	RGD:6480464	20160105	CTD	MESH:C060229	1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]	PMID:15046718
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPA1 mRNA	PMID:27188386
1303284	Trpa1	transient receptor potential cation channel, subfamily A, member 1	gene	CHEBI:9936	Vasicinone	multiple interactions	ISO	RGD:1344231	E	RGD:6480464	20260113	CTD	MESH:C052548	vasicinone inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]	PMID:37375837
1303285	Sirt5	sirtuin 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1351920	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SIRT5 mRNA	PMID:33167477
1303285	Sirt5	sirtuin 5	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SIRT5 mRNA	PMID:26079696
1303285	Sirt5	sirtuin 5	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SIRT5 mRNA	PMID:22378314
1303285	Sirt5	sirtuin 5	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of SIRT5 mRNA	PMID:25056781
1303285	Sirt5	sirtuin 5	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1351920	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of SIRT5 mRNA	PMID:22574217
1303285	Sirt5	sirtuin 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332358	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SIRT5 mRNA	PMID:39298647
1303285	Sirt5	sirtuin 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1351920	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SIRT5 mRNA	PMID:32030086
1303285	Sirt5	sirtuin 5	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SIRT5 mRNA	PMID:33387578
1303285	Sirt5	sirtuin 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1351920	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SIRT5 mRNA	PMID:37042841
1303285	Sirt5	sirtuin 5	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1351920	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SIRT5 mRNA	PMID:21179406
1303285	Sirt5	sirtuin 5	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20190910	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT5 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT5 protein	PMID:31016965
1303285	Sirt5	sirtuin 5	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of SIRT5 mRNA	PMID:23892564
1303285	Sirt5	sirtuin 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SIRT5 mRNA	PMID:33908429|PMID:35550907
1303285	Sirt5	sirtuin 5	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SIRT5 mRNA	PMID:33387578
1303285	Sirt5	sirtuin 5	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SIRT5 mRNA	PMID:28818685
1303285	Sirt5	sirtuin 5	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332358	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SIRT5 mRNA	PMID:36331819
1303285	Sirt5	sirtuin 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SIRT5 mRNA	PMID:19549813
1303285	Sirt5	sirtuin 5	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of SIRT5 mRNA	PMID:25056781
1303285	Sirt5	sirtuin 5	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SIRT5 mRNA	PMID:31919559
1303285	Sirt5	sirtuin 5	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20150310	CTD	MESH:C059514	resveratrol results in decreased expression of SIRT5 mRNA	PMID:23525482
1303285	Sirt5	sirtuin 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1351920	E	RGD:6480464	20130122	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SIRT5 mRNA; SIRT5 protein affects the reaction [Resveratrol results in decreased acetylation of CYP11A1 protein]; SIRT5 protein affects the reaction [Resveratrol results in increased expression of CYP11A1 protein]	PMID:22585829|PMID:23557933
1303285	Sirt5	sirtuin 5	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1351920	E	RGD:6480464	20200331	CTD	MESH:D002945	[Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of SIRT5 mRNA	PMID:30871063
1303285	Sirt5	sirtuin 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332358	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SIRT5 mRNA	PMID:21570461
1303285	Sirt5	sirtuin 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SIRT5 mRNA	PMID:33387578
1303285	Sirt5	sirtuin 5	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SIRT5 mRNA	PMID:28001369
1303285	Sirt5	sirtuin 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20250506	CTD	MESH:D004317	Doxorubicin results in decreased expression of SIRT5 protein	PMID:38943348
1303285	Sirt5	sirtuin 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SIRT5 mRNA	PMID:38568856
1303285	Sirt5	sirtuin 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SIRT5 mRNA	PMID:26238291|PMID:32234424
1303285	Sirt5	sirtuin 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1351920	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SIRT5 promoter	PMID:27901495
1303285	Sirt5	sirtuin 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SIRT5 mRNA	PMID:21839799
1303285	Sirt5	sirtuin 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332358	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SIRT5 mRNA	PMID:22228805
1303285	Sirt5	sirtuin 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1332358	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SIRT5 mRNA]	PMID:22228805
1303285	Sirt5	sirtuin 5	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of SIRT5 mRNA	PMID:26551752
1303285	Sirt5	sirtuin 5	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1351920	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SIRT5 protein]	PMID:26598702
1303285	Sirt5	sirtuin 5	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of SIRT5 mRNA	PMID:24136188
1303285	Sirt5	sirtuin 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332358	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SIRT5 promoter	PMID:35295148
1303285	Sirt5	sirtuin 5	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SIRT5 mRNA	PMID:34492290
1303285	Sirt5	sirtuin 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332358	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SIRT5 mRNA	PMID:18301758|PMID:23811191
1303285	Sirt5	sirtuin 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SIRT5 mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585
1303285	Sirt5	sirtuin 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20190910	CTD	MESH:C006780	bisphenol A results in decreased expression of SIRT5 mRNA	PMID:31016965
1303285	Sirt5	sirtuin 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SIRT5 mRNA	PMID:25181051
1303285	Sirt5	sirtuin 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1351920	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of SIRT5 mRNA	PMID:32030086
1303285	Sirt5	sirtuin 5	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SIRT5 gene	PMID:28505145
1303285	Sirt5	sirtuin 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332358	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SIRT5 mRNA	PMID:39298647
1303285	Sirt5	sirtuin 5	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of SIRT5 mRNA	PMID:17602206
1303285	Sirt5	sirtuin 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SIRT5 mRNA	PMID:21266533
1303285	Sirt5	sirtuin 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351920	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SIRT5 mRNA	PMID:37042841
1303285	Sirt5	sirtuin 5	gene	CHEBI:35459	diisononyl phthalate	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20191210	CTD	MESH:C012125	diisononyl phthalate results in decreased expression of SIRT5 mRNA	PMID:31423773
1303285	Sirt5	sirtuin 5	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1332358	E	RGD:6480464	20190910	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SIRT5 mRNA	PMID:31016965
1303285	Sirt5	sirtuin 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1332358	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SIRT5 mRNA	PMID:40194260
1303285	Sirt5	sirtuin 5	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1351920	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SIRT5 mRNA	PMID:31533062
1303285	Sirt5	sirtuin 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1332358	E	RGD:6480464	20190910	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SIRT5 mRNA	PMID:31016965
1303285	Sirt5	sirtuin 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1351920	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SIRT5 mRNA	PMID:40419075
1303285	Sirt5	sirtuin 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332358	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SIRT5 mRNA	PMID:36331819
1303285	Sirt5	sirtuin 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332358	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SIRT5 mRNA	PMID:17292431
1303285	Sirt5	sirtuin 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SIRT5 mRNA	PMID:23179753
1303285	Sirt5	sirtuin 5	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SIRT5 mRNA	PMID:27281708
1303285	Sirt5	sirtuin 5	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SIRT5 mRNA	PMID:25562108
1303285	Sirt5	sirtuin 5	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SIRT5 mRNA	PMID:38832940
1303285	Sirt5	sirtuin 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332358	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SIRT5 mRNA	PMID:17562736
1303285	Sirt5	sirtuin 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SIRT5 mRNA	PMID:33387578
1303285	Sirt5	sirtuin 5	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of SIRT5 mRNA	PMID:17557909
1303285	Sirt5	sirtuin 5	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1351920	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SIRT5 protein]	PMID:26598702
1303285	Sirt5	sirtuin 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SIRT5 mRNA	PMID:25620056
1303285	Sirt5	sirtuin 5	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1351920	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SIRT5 protein	PMID:23718831
1303285	Sirt5	sirtuin 5	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of SIRT5 mRNA	PMID:24136188
1303285	Sirt5	sirtuin 5	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20160412	CTD	MESH:D008687	Metformin results in decreased expression of SIRT5 protein	PMID:24687991
1303285	Sirt5	sirtuin 5	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in decreased expression of SIRT5 mRNA	PMID:25452209
1303285	Sirt5	sirtuin 5	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SIRT5 gene	PMID:35440735
1303285	Sirt5	sirtuin 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332358	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SIRT5 mRNA	PMID:22206623
1303285	Sirt5	sirtuin 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351920	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SIRT5 gene]	PMID:28238834
1303285	Sirt5	sirtuin 5	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SIRT5 mRNA	PMID:26079696
1303285	Sirt5	sirtuin 5	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of SIRT5 mRNA	PMID:26551752
1303285	Sirt5	sirtuin 5	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SIRT5 mRNA	PMID:38568856
1303285	Sirt5	sirtuin 5	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1351920	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SIRT5 mRNA	PMID:29301935
1303285	Sirt5	sirtuin 5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SIRT5 mRNA	PMID:21346803
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1348841	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ESAM mRNA	PMID:26079696
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1348841	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ESAM mRNA	PMID:21632981
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551659	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ESAM mRNA	PMID:39241906
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1348841	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ESAM mRNA	PMID:35811015
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1348841	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ESAM mRNA	PMID:26079696
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESAM mRNA	PMID:37992649
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of ESAM mRNA	PMID:22967744
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESAM mRNA	PMID:37992649
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ESAM mRNA	PMID:33387578
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1348841	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ESAM mRNA	PMID:28818685
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ESAM mRNA	PMID:39012411
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ESAM mRNA	PMID:29950665
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1348841	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ESAM mRNA	PMID:19549813
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of ESAM protein	PMID:33236894
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1348841	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ESAM gene	PMID:27153756
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ESAM mRNA	PMID:34911549
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1551659	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ESAM mRNA	PMID:17484886
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ESAM mRNA	PMID:31881176
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ESAM mRNA	PMID:22023808
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1348841	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ESAM mRNA	PMID:27392435
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1551659	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of ESAM protein	PMID:22006019
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1348841	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ESAM mRNA	PMID:27392435
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ESAM mRNA	PMID:34747641
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551659	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ESAM mRNA	PMID:21570461
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551659	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ESAM mRNA	PMID:17942748
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ESAM mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ESAM mRNA	PMID:17942748|PMID:25975270
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1348841	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ESAM mRNA	PMID:33212167
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ESAM mRNA	PMID:30556269
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1348841	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ESAM mRNA	PMID:29803840
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESAM mRNA	PMID:37992649
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1348841	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ESAM mRNA	PMID:34032870
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1348841	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ESAM mRNA	PMID:29301061
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1348841	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ESAM promoter	PMID:27901495
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1348841	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ESAM mRNA	PMID:20106945|PMID:21632981|PMID:32234424
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551659	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ESAM mRNA	PMID:21964900|PMID:22228805|PMID:32417428
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ESAM mRNA	PMID:30556269
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1348841	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of ESAM mRNA	PMID:37690743
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ESAM mRNA	PMID:24136188
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of ESAM mRNA	PMID:25729387
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ESAM mRNA	PMID:30047161
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ESAM mRNA	PMID:29950665
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ESAM mRNA	PMID:34492290
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ESAM mRNA	PMID:25181051
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ESAM mRNA	PMID:34947998
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1348841	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ESAM protein	PMID:31675489
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551659	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ESAM mRNA	PMID:32156529|PMID:33221593
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1348841	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ESAM protein	PMID:31675489
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551659	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ESAM mRNA	PMID:30951980
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1551659	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ESAM mRNA	PMID:26377693
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551659	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ESAM mRNA	PMID:30951980
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1551659	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ESAM mRNA	PMID:37019170
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ESAM mRNA	PMID:29950665
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348841	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ESAM mRNA	PMID:37042841
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1348841	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of ESAM mRNA	PMID:29024780
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ESAM mRNA	PMID:35163327
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348841	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ESAM mRNA	PMID:38382870
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ESAM mRNA	PMID:39012411
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ESAM mRNA	PMID:35163327
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ESAM mRNA	PMID:30047161
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1551659	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ESAM mRNA	PMID:28903501
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1348841	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ESAM mRNA	PMID:24449571
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1551659	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of ESAM mRNA	PMID:18353800
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:3764	clotrimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of ESAM mRNA	PMID:30047161
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ESAM mRNA	PMID:30047161
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1348841	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ESAM mRNA	PMID:21632981|PMID:25562108
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551659	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ESAM mRNA	PMID:28973697
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESAM mRNA	PMID:37992649
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1348841	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of ESAM mRNA	PMID:16595896
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1348841	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ESAM mRNA	PMID:38832940
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1348841	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ESAM mRNA	PMID:28542535
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551659	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ESAM mRNA	PMID:17562736
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ESAM mRNA	PMID:33387578
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1348841	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ESAM mRNA	PMID:35811015
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ESAM mRNA	PMID:29391264|PMID:31464424
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1551659	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ESAM mRNA	PMID:17942748
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ESAM mRNA	PMID:17942748
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1348841	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of ESAM mRNA	PMID:32234424
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1348841	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of ESAM mRNA	PMID:21856257
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ESAM mRNA	PMID:30047161
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ESAM mRNA	PMID:35964746
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of ESAM mRNA	PMID:25729387
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551659	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ESAM mRNA	PMID:22206623
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1348841	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of ESAM mRNA	PMID:32858204
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348841	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ESAM gene]	PMID:28238834
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1551659	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of ESAM mRNA	PMID:26655953
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1551659	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ESAM mRNA	PMID:19482888
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1551659	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ESAM mRNA]	PMID:19482888
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1348841	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ESAM protein	PMID:31675489
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1348841	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ESAM mRNA	PMID:26079696
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ESAM mRNA	PMID:30047161
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ESAM mRNA	PMID:30047161
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ESAM mRNA	PMID:19281266
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1348841	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ESAM mRNA	PMID:38568856
1303286	Esam	endothelial cell adhesion molecule	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of ESAM mRNA	PMID:30047161
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1348475	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of AGPAT1 mRNA	PMID:38218311
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20190312	CTD	MESH:D019301	[Farnesol analog co-treated with Oleic Acid] results in decreased expression of AGPAT1 mRNA; [GW 4064 co-treated with Oleic Acid] results in decreased expression of AGPAT1 mRNA	PMID:30611723
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1551668	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of AGPAT1 mRNA	PMID:30319688
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551668	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of AGPAT1 mRNA	PMID:39298647
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of AGPAT1 gene	PMID:27618143
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348475	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AGPAT1 mRNA	PMID:37042841
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of AGPAT1 promoter	PMID:33872906
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of AGPAT1 promoter	PMID:33872906
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1551668	E	RGD:6480464	20180116	CTD	MESH:D004051	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of AGPAT1 mRNA	PMID:28433925
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of AGPAT1 protein	PMID:34915118
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1551668	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of AGPAT1 mRNA	PMID:27462272
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:232796	cadmium acetate	increases expression	ISO	RGD:1348475	E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in increased expression of AGPAT1 mRNA	PMID:12965115
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1348475	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AGPAT1 gene	PMID:25304211
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551668	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AGPAT1 mRNA	PMID:40504410
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of AGPAT1 mRNA	PMID:31881176
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of AGPAT1 mRNA	PMID:23557933
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551668	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AGPAT1 mRNA	PMID:21570461|PMID:24680724
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1348475	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AGPAT1 mRNA	PMID:23152189
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551668	E	RGD:6480464	20170613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AGPAT1 mRNA	PMID:28213091|PMID:28238261
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551668	E	RGD:6480464	20170725	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of AGPAT1 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to AGPAT1 gene]	PMID:28213091|PMID:28433925
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1348475	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of AGPAT1 protein	PMID:39603559
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1348475	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of AGPAT1 mRNA	PMID:33212167
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:28600	farnesol	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20190312	CTD	MESH:D005204	[Farnesol analog co-treated with Oleic Acid] results in decreased expression of AGPAT1 mRNA	PMID:30611723
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1348475	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AGPAT1 mRNA	PMID:38568856
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551668	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AGPAT1 mRNA	PMID:40504410
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348475	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AGPAT1 3' UTR	PMID:27901495
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1348475	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AGPAT1 mRNA	PMID:20106945|PMID:32234424
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20120412	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of AGPAT1 mRNA	PMID:20146248
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of AGPAT1 gene	PMID:31601247
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1551668	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of AGPAT1 mRNA	PMID:23557971
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of AGPAT1 mRNA	PMID:23411599|PMID:34492290
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1551668	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of AGPAT1 mRNA	PMID:18648102
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20120412	CTD	MESH:C016583	[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of AGPAT1 mRNA	PMID:20146248
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1348475	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of AGPAT1 mRNA	PMID:30903817
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AGPAT1 mRNA	PMID:25181051|PMID:32145629
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGPAT1 mRNA	PMID:36041667
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of AGPAT1 gene	PMID:31601247
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1551668	E	RGD:6480464	20180116	CTD	MESH:C006780	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of AGPAT1 mRNA	PMID:28433925
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1551668	E	RGD:6480464	20180116	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of AGPAT1 mRNA	PMID:28433925
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1551668	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of AGPAT1 gene	PMID:31683443
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGPAT1 mRNA	PMID:36041667
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1551668	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of AGPAT1 mRNA	PMID:38685157
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGPAT1 mRNA	PMID:36041667
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AGPAT1 mRNA	PMID:28628672
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1551668	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of AGPAT1 mRNA	PMID:37019170
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AGPAT1 mRNA	PMID:28628672
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of AGPAT1 promoter	PMID:22457795
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1348475	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AGPAT1 mRNA	PMID:19376846
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1348475	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of AGPAT1 mRNA	PMID:24449571
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:3766	clozapine	decreases expression	ISO	RGD:1551668	E	RGD:6480464	20120412	CTD	MESH:D003024	Clozapine results in decreased expression of AGPAT1 mRNA	PMID:14647396
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1348475	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of AGPAT1 mRNA	PMID:32588087
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1348475	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of AGPAT1 mRNA	PMID:28302478
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1348475	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of AGPAT1 mRNA	PMID:40419075
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551668	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of AGPAT1 mRNA	PMID:17292431
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1348475	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AGPAT1 mRNA	PMID:20106945|PMID:25562108
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AGPAT1 mRNA	PMID:28628672
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551668	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of AGPAT1 mRNA	PMID:17562736
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1348475	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AGPAT1 gene	PMID:25304211
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551668	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AGPAT1 mRNA	PMID:40504410
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:47318	6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	increases expression	ISO	RGD:1348475	E	RGD:6480464	20190312	CTD	MESH:C475093	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of AGPAT1 mRNA	PMID:30611723
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of AGPAT1 mRNA	PMID:36868495
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AGPAT1 mRNA	PMID:28628672
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551668	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of AGPAT1 mRNA	PMID:25554681
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551668	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of AGPAT1 mRNA	PMID:35964746
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:5613	haloperidol	decreases expression	ISO	RGD:1551668	E	RGD:6480464	20120412	CTD	MESH:D006220	Haloperidol results in decreased expression of AGPAT1 mRNA	PMID:14647396
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1551668	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of AGPAT1 mRNA	PMID:15003993
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:70778	GW 7647	increases expression	ISO	RGD:1348475	E	RGD:6480464	20190312	CTD	MESH:C453899	GW 7647 results in increased expression of AGPAT1 mRNA	PMID:30611723
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551668	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AGPAT1 mRNA	PMID:22206623
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of AGPAT1 mRNA	PMID:26720608
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AGPAT1 gene]	PMID:28238834
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1348475	E	RGD:6480464	20190312	CTD	MESH:C412815	GW 4064 results in increased expression of AGPAT1 mRNA	PMID:30611723
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1348475	E	RGD:6480464	20190312	CTD	MESH:C412815	[GW 4064 co-treated with Oleic Acid] results in decreased expression of AGPAT1 mRNA	PMID:30611723
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1348475	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of AGPAT1 mRNA	PMID:19159669
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of AGPAT1 mRNA	PMID:27291303
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1348475	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AGPAT1 mRNA	PMID:38568856
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1348475	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of AGPAT1 mRNA	PMID:27188386
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of AGPAT1 mRNA	PMID:19015723
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of AGPAT1 mRNA	PMID:18042343
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of AGPAT1 mRNA	PMID:23034163
1303287	Agpat1	1-acylglycerol-3-phosphate O-acyltransferase 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased methylation of AGPAT1 promoter	PMID:22570695
1303288	Spink14	serine peptidase inhibitor, Kazal type 14	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621892	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPINK14 mRNA	PMID:36209798
1303288	Spink14	serine peptidase inhibitor, Kazal type 14	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601681	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of SPINK14 mRNA	PMID:29301061
1303288	Spink14	serine peptidase inhibitor, Kazal type 14	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPINK14 mRNA	PMID:25181051
1303288	Spink14	serine peptidase inhibitor, Kazal type 14	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1601681	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SPINK14 mRNA	PMID:26472689
1303288	Spink14	serine peptidase inhibitor, Kazal type 14	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPINK14 mRNA	PMID:30917596
1303288	Spink14	serine peptidase inhibitor, Kazal type 14	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SPINK14 mRNA	PMID:30047161
1303288	Spink14	serine peptidase inhibitor, Kazal type 14	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SPINK14 mRNA	PMID:30047161
1303288	Spink14	serine peptidase inhibitor, Kazal type 14	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1601681	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPINK14 gene]	PMID:28238834
1303288	Spink14	serine peptidase inhibitor, Kazal type 14	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPINK14 mRNA	PMID:30047161
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551689	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NENF mRNA	PMID:39241906
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1603399	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of NENF mRNA	PMID:23019147
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of NENF mRNA	PMID:32145629
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551689	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NENF mRNA	PMID:39298647
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603399	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of NENF mRNA	PMID:15223131
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NENF mRNA	PMID:19448997
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NENF mRNA	PMID:37992649
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NENF mRNA	PMID:37992649
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1551689	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NENF mRNA	PMID:34319233
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551689	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NENF mRNA	PMID:33754040
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of NENF mRNA	PMID:22061828
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1603399	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of NENF intron	PMID:30157460
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NENF mRNA	PMID:36331819
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1603399	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NENF mRNA	PMID:35301059
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of NENF mRNA	PMID:21396975
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NENF mRNA	PMID:33354967
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551689	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NENF mRNA	PMID:27339419
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NENF mRNA	PMID:22206623
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NENF mRNA	PMID:40504410
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NENF mRNA	PMID:31881176
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1603399	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of NENF mRNA	PMID:28903495
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1551689	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of NENF mRNA	PMID:40618947
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603399	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of NENF mRNA	PMID:27594783
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551689	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NENF mRNA	PMID:21570461
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NENF mRNA	PMID:34747641
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NENF mRNA	PMID:20959002|PMID:33387578
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1603399	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NENF mRNA	PMID:21296121
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NENF promoter]	PMID:19654925
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1603399	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of NENF mRNA	PMID:33512557
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1603399	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of NENF mRNA	PMID:30851411
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NENF mRNA	PMID:37992649
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NENF mRNA	PMID:40504410
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603399	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NENF promoter	PMID:27901495
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1603399	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to NENF mRNA]	PMID:32406909
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1603399	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NENF mRNA	PMID:19150397
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1551689	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of NENF mRNA	PMID:39716349
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NENF mRNA	PMID:30047161
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551689	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NENF gene	PMID:35295148
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551689	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NENF mRNA	PMID:18301758|PMID:23811191
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NENF mRNA	PMID:25181051
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NENF mRNA	PMID:30816183|PMID:32528016
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551689	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of NENF mRNA	PMID:30245210|PMID:35598803
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603399	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of NENF protein	PMID:34186270
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of NENF mRNA	PMID:32145629
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551689	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of NENF mRNA	PMID:32156529
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1603399	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of NENF mRNA	PMID:19244175
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1603399	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of NENF protein	PMID:31945527
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551689	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NENF mRNA	PMID:39298647|PMID:40203079
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1603399	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of NENF protein	PMID:34186270
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1603399	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of NENF intron	PMID:30157460
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1551689	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of NENF mRNA	PMID:38685157
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603399	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NENF mRNA	PMID:38568856
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1603399	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NENF mRNA	PMID:35301059
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1603399	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of NENF mRNA	PMID:19376846
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1603399	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of NENF mRNA	PMID:24449571
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1603399	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NENF mRNA	PMID:31533062
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NENF mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NENF mRNA	PMID:36331819
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603399	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NENF mRNA	PMID:25979313
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603399	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of NENF mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603399	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NENF mRNA	PMID:27188386
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NENF mRNA	PMID:30047161
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1603399	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of NENF mRNA	PMID:33512557
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1603399	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of NENF mRNA	PMID:36621641
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NENF mRNA	PMID:37992649
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1603399	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of NENF mRNA	PMID:27188386
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of NENF mRNA	PMID:21346803
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NENF mRNA	PMID:40504410
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1551689	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of NENF mRNA	PMID:39716349
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551689	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of NENF mRNA; Nanotubes, Carbon results in decreased expression of NENF mRNA	PMID:25554681
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of NENF mRNA	PMID:23962444
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NENF mRNA	PMID:30047161
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603399	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NENF protein	PMID:32959892
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1551689	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of NENF mRNA	PMID:23650126
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1603399	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of NENF intron	PMID:30157460
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NENF mRNA	PMID:22206623
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1603399	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of NENF mRNA	PMID:30851411
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603399	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NENF mRNA	PMID:27188386
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603399	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NENF gene]	PMID:28238834
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1551689	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of NENF mRNA	PMID:19482888
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1551689	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NENF mRNA]	PMID:19482888
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1603399	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of NENF mRNA	PMID:33512557
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1551689	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of NENF mRNA	PMID:39847705
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NENF mRNA	PMID:30047161
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603399	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NENF mRNA	PMID:27188386
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NENF mRNA	PMID:21346803
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NENF mRNA	PMID:21346803
1303289	Nenf	neudesin neurotrophic factor	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of NENF mRNA	PMID:23034163
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1553628	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KLHL10 mRNA	PMID:33045310
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KLHL10 mRNA	PMID:33387578
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1344199	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KLHL10 protein	PMID:31163220
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KLHL10 gene	PMID:33854195
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553628	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLHL10 mRNA	PMID:24680724
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344199	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of KLHL10 mRNA	PMID:33212167
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344199	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KLHL10 promoter	PMID:27901495
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KLHL10 mRNA	PMID:25181051
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1344199	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KLHL10 mRNA	PMID:28628672
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1344199	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of KLHL10 mRNA	PMID:28628672
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KLHL10 gene	PMID:33854195
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1344199	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KLHL10 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of KLHL10 mRNA	PMID:28628672
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1553628	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of KLHL10 mRNA	PMID:39529242
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KLHL10 gene	PMID:33854195
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553628	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of KLHL10 mRNA	PMID:17555576
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1344199	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KLHL10 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of KLHL10 mRNA	PMID:28628672
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1344199	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of KLHL10 mRNA	PMID:24449571
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:4488	diallyl disulfide	multiple interactions	ISO	RGD:1344199	E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide inhibits the reaction [tobacco tar analog results in increased expression of KLHL10 mRNA]	PMID:36758788
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:4489	Diallyl sulfide	multiple interactions	ISO	RGD:1344199	E	RGD:6480464	20230801	CTD	MESH:C038491	allyl sulfide inhibits the reaction [tobacco tar analog results in increased expression of KLHL10 mRNA]	PMID:36758788
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KLHL10 gene	PMID:33854195
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1553628	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of KLHL10 mRNA	PMID:17555576
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1344199	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KLHL10 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of KLHL10 mRNA	PMID:28628672
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KLHL10 gene	PMID:33854195
1303290	Klhl10	kelch-like family member 10	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of KLHL10 mRNA	PMID:28712647
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NDUFA11 mRNA	PMID:38218311
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NDUFA11 mRNA	PMID:22378314
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1553646	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of NDUFA11 mRNA	PMID:30319688
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553646	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDUFA11 mRNA	PMID:39241906
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1353803	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFA11 mRNA	PMID:31059760
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of NDUFA11 mRNA	PMID:32145629
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1553646	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of NDUFA11 mRNA	PMID:28973375
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:17578	toluene	affects expression	EXP		E	RGD:6480464	20130507	CTD	MESH:D014050	Toluene affects the expression of NDUFA11 mRNA	PMID:21827849
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of NDUFA11 mRNA	PMID:22967744
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553646	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NDUFA11 mRNA	PMID:33754040
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of NDUFA11 mRNA	PMID:28522335
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553646	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NDUFA11 mRNA	PMID:37236586
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NDUFA11 mRNA	PMID:33354967
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553646	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NDUFA11 mRNA	PMID:22206623
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1553646	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of NDUFA11 mRNA	PMID:28960355
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1553646	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NDUFA11 mRNA	PMID:30912803
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NDUFA11 mRNA	PMID:34747641
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFA11 mRNA	PMID:33387578
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553646	E	RGD:6480464	20130507	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFA11 mRNA	PMID:20399798
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NDUFA11 mRNA	PMID:32763439
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1553646	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of NDUFA11 protein	PMID:28918527
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1353803	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NDUFA11 mRNA	PMID:29803840
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1353803	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of NDUFA11 mRNA	PMID:29432896
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NDUFA11 mRNA	PMID:38568856
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in increased expression of NDUFA11 protein	PMID:38266420
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353803	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of NDUFA11 mRNA	PMID:39719251
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1553646	E	RGD:6480464	20190219	CTD	MESH:C017947	sodium arsenite results in increased expression of NDUFA11 mRNA	PMID:30130555
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NDUFA11 mRNA	PMID:22378314
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1553646	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of NDUFA11 mRNA	PMID:33053406
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1353803	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to NDUFA11 mRNA]	PMID:32406909
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20130507	CTD	MESH:D000643	Ammonium Chloride affects the expression of NDUFA11 mRNA	PMID:16483693
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553646	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NDUFA11 gene	PMID:35295148
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1553646	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of NDUFA11 mRNA	PMID:27760801
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NDUFA11 mRNA	PMID:34492290
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1553646	E	RGD:6480464	20130507	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NDUFA11 mRNA	PMID:19710929
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1353803	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NDUFA11 mRNA	PMID:30903817
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFA11 mRNA	PMID:32145629
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553646	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFA11 mRNA	PMID:35598803
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA11 mRNA	PMID:25181051
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553646	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA11 mRNA	PMID:33221593
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:34283	oxybenzone	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in decreased expression of NDUFA11 mRNA	PMID:30316929
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553646	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NDUFA11 mRNA	PMID:39298647
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1553646	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of NDUFA11 mRNA	PMID:38685157
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553646	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NDUFA11 mRNA	PMID:37019170
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1553646	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of NDUFA11 mRNA	PMID:34813904
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1553646	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of NDUFA11 mRNA	PMID:34813904
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFA11 mRNA	PMID:28659758
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353803	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NDUFA11 mRNA	PMID:37042841
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	multiple interactions	ISO	RGD:1353803	E	RGD:6480464	20260203	CTD	MESH:C031324	[Flame Retardants results in increased abundance of tris(chloroethyl)phosphate] which results in decreased expression of NDUFA11 mRNA	PMID:40518002
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	increases expression	ISO	RGD:1353803	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate results in increased expression of NDUFA11 mRNA	PMID:29024780
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NDUFA11 mRNA	PMID:38568856
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20130507	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of NDUFA11 promoter	PMID:22457795
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553646	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NDUFA11 mRNA	PMID:37236586
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1553646	E	RGD:6480464	20130507	CTD	MESH:D002994	Clofibrate results in decreased expression of NDUFA11 mRNA	PMID:17585979
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of NDUFA11 mRNA	PMID:26352163
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353803	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NDUFA11 mRNA	PMID:23179753
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NDUFA11 mRNA	PMID:25562108
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of NDUFA11 mRNA	PMID:31059760
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NDUFA11 mRNA	PMID:33387578
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1353803	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFA11 mRNA	PMID:31059760
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1553646	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of NDUFA11 mRNA	PMID:30529165
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1553646	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of NDUFA11 mRNA	PMID:35436446
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in increased expression of NDUFA11 protein	PMID:39793947
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1553646	E	RGD:6480464	20200714	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of NDUFA11 mRNA	PMID:31978390
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553646	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NDUFA11 mRNA; Nanotubes, Carbon results in increased expression of NDUFA11 mRNA	PMID:25554681
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1553646	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of NDUFA11 mRNA	PMID:23650126
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1553646	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of NDUFA11 protein	PMID:36851058
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:64317	isoprenaline	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFA11 mRNA	PMID:30303030
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D003671	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFA11 mRNA	PMID:28659758
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of NDUFA11 mRNA	PMID:31758290
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553646	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NDUFA11 mRNA	PMID:22206623
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFA11 mRNA	PMID:28659758
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1553646	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of NDUFA11 mRNA	PMID:40826991
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NDUFA11 mRNA	PMID:38568856
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1353803	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NDUFA11 mRNA	PMID:22378314
1303292	Ndufa11	NADH:ubiquinone oxidoreductase subunit A11	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of NDUFA11 mRNA	PMID:23034163
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1551722	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TBC1D20 mRNA	PMID:37995155
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TBC1D20 mRNA]	PMID:31150632
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346411	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TBC1D20 mRNA	PMID:33167477
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TBC1D20 mRNA	PMID:36331819
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551722	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TBC1D20 mRNA	PMID:39241906
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TBC1D20 mRNA	PMID:25510870
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1346411	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TBC1D20 mRNA	PMID:37042841
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1346411	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TBC1D20 mRNA	PMID:20655997
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TBC1D20 mRNA	PMID:25510870
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TBC1D20 mRNA	PMID:25510870
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TBC1D20 mRNA	PMID:31150632
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TBC1D20 mRNA]	PMID:31150632
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551722	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TBC1D20 mRNA	PMID:25629700
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TBC1D20 mRNA	PMID:40504410
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1346411	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of TBC1D20 protein	PMID:35688186
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of TBC1D20 mRNA	PMID:20187946
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551722	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBC1D20 mRNA	PMID:21570461
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TBC1D20 mRNA	PMID:33387578
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551722	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TBC1D20 mRNA	PMID:19770486|PMID:31961203
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1346411	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TBC1D20 mRNA	PMID:30851411
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346411	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TBC1D20 mRNA	PMID:22714537
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346411	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TBC1D20 mRNA	PMID:38568856
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TBC1D20 mRNA	PMID:40504410
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1346411	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TBC1D20 promoter	PMID:27901495
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1346411	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TBC1D20 mRNA	PMID:26238291
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1551722	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TBC1D20 mRNA	PMID:27131904
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1346411	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TBC1D20 mRNA	PMID:26238291
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551722	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TBC1D20 gene	PMID:35295148
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TBC1D20 mRNA	PMID:34492290
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551722	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TBC1D20 mRNA	PMID:18301758
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:33216	bisphenol A	affects response to substance	ISO	RGD:1551722	E	RGD:6480464	20191112	CTD	MESH:C006780	TBC1D20 mRNA alternative form affects the susceptibility to bisphenol A	PMID:31020848
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TBC1D20 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551722	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TBC1D20 mRNA alternative form	PMID:31020848
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TBC1D20 gene	PMID:28505145
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TBC1D20 mRNA	PMID:25510870
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TBC1D20 mRNA	PMID:25510870
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1551722	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TBC1D20 mRNA	PMID:37019170
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1551722	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of TBC1D20 mRNA	PMID:34813904
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1551722	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of TBC1D20 mRNA	PMID:34813904
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of TBC1D20 gene	PMID:22079235
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1346411	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TBC1D20 mRNA	PMID:31533062
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TBC1D20 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TBC1D20 mRNA	PMID:36331819
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346411	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TBC1D20 mRNA	PMID:23179753
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346411	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TBC1D20 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1346411	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of TBC1D20 mRNA	PMID:21420995|PMID:29067470
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TBC1D20 mRNA	PMID:40504410
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TBC1D20 mRNA	PMID:29391264
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551722	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TBC1D20 mRNA	PMID:35964746
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1346411	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of TBC1D20 mRNA	PMID:22714537
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1346411	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TBC1D20 mRNA	PMID:28988120
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1346411	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TBC1D20 mRNA	PMID:30851411
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1551722	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TBC1D20 mRNA	PMID:27131904
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1346411	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TBC1D20 mRNA	PMID:38568856
1303293	Tbc1d20	TBC1 domain family, member 20	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TBC1D20 mRNA	PMID:21346803
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ABCG3L1 mRNA	PMID:33387578
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ABCG3L1 mRNA	PMID:21396975
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ABCG3L1 mRNA	PMID:31150632
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of ABCG3L1 mRNA	PMID:25729387
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ABCG3L1 mRNA	PMID:30047161
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ABCG3L1 mRNA	PMID:30816183|PMID:32528016
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ABCG3L1 promoter	PMID:22457795
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ABCG3L1 mRNA	PMID:24386269
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ABCG3L1 mRNA	PMID:30047161
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:45285	pyrazinecarboxamide	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011718	Pyrazinamide results in decreased expression of ABCG3L1 mRNA	PMID:22431067
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ABCG3L1 mRNA	PMID:29391264
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ABCG3L1 mRNA	PMID:30047161
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of ABCG3L1 mRNA	PMID:25729387
1303294	Abcg3l1	ATP-binding cassette, subfamily G (WHITE), member 3-like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ABCG3L1 mRNA	PMID:24780913|PMID:30047161
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1323591	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of S100A11 mRNA	PMID:38218311
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of S100A11 mRNA]	PMID:31150632
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D002794	[Dietary Fats co-treated with Choline deficiency] results in increased expression of S100A11 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A11 mRNA; PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of S100A11 mRNA]	PMID:20938992|PMID:29246445
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D001241	Aspirin results in decreased expression of S100A11 mRNA	PMID:15928584
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D014212	Tretinoin results in increased expression of S100A11 mRNA	PMID:21934132|PMID:33167477
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of S100A11 protein	PMID:39571964
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of S100A11 mRNA	PMID:30951980
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:15422	ATP	increases expression	ISO	RGD:1323591	E	RGD:6480464	20201103	CTD	MESH:D000255	Adenosine Triphosphate results in increased expression of S100A11 mRNA	PMID:29733962
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of S100A11 mRNA	PMID:24763279
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D011794	Quercetin results in increased expression of S100A11 mRNA	PMID:21632981
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of S100A11 protein	PMID:16751997
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20161228	CTD	MESH:D008070	clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of S100A11 mRNA]	PMID:19172522
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D004958	Estradiol results in increased expression of S100A11 mRNA	PMID:20106945
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1323592	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of S100A11 mRNA	PMID:39298647
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of S100A11 mRNA	PMID:30165855
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA	PMID:25510870
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1323592	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of S100A11 mRNA	PMID:33711761
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1323592	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of S100A11 mRNA	PMID:25549359
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A11 mRNA	PMID:20938992
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1323591	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of S100A11 mRNA	PMID:37042841
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S100A11 mRNA	PMID:37992649
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1323592	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of S100A11 mRNA	PMID:33848595
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of S100A11 mRNA	PMID:17317680
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S100A11 mRNA	PMID:37992649
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1323591	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of S100A11 mRNA	PMID:31163220
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1323592	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of S100A11 mRNA	PMID:33754040
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of S100A11 mRNA	PMID:26577399
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1323591	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of S100A11 protein	PMID:37730182
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of S100A11 mRNA	PMID:22061828
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:17833	gentamycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein	PMID:30545405
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:18243	dopamine	increases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D004298	Dopamine results in increased expression of S100A11 mRNA	PMID:21983523
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of S100A11 mRNA	PMID:36331819
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:22977	cadmium atom	increases oxidation	ISO	RGD:1323592	E	RGD:6480464	20150310	CTD	MESH:D002104	Cadmium results in increased oxidation of S100A11 protein	PMID:24077948
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20210706	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of S100A11 protein	PMID:33040242
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA	PMID:25510870
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA	PMID:25510870
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of S100A11 protein]	PMID:32272095
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:2341	AACOCF3	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20160315	CTD	MESH:C081565	arachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to Cisplatin]; arachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to Oxaliplatin]	PMID:25940438
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D019327	Copper Sulfate results in increased expression of S100A11 mRNA	PMID:19549813
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of S100A11 protein	PMID:23301498
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20130115	CTD	MESH:C016517	indole-3-carbinol affects the expression of S100A11 mRNA	PMID:21396975
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D016604	Aflatoxin B1 affects the expression of S100A11 protein	PMID:20106945
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of S100A11 mRNA	PMID:33354967
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1323591	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of S100A11 mRNA	PMID:27153756
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1323591	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of S100A11 intron	PMID:30157460
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20250401	CTD	MESH:D015127	[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of S100A11 protein	PMID:39910959
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of S100A11 mRNA	PMID:35430440
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of S100A11 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of S100A11 mRNA	PMID:34911549
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of S100A11 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of S100A11 protein	PMID:38598786
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of S100A11 mRNA	PMID:30779732
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of S100A11 mRNA	PMID:33387578
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of S100A11 mRNA	PMID:16239168|PMID:31150632
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1323592	E	RGD:6480464	20181016	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of S100A11 mRNA	PMID:29987408
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of S100A11 mRNA]	PMID:31150632
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A11 mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of S100A11 mRNA]	PMID:20938992|PMID:22206623
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D016685	S100A11 protein affects the susceptibility to Mitomycin	PMID:16217747
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1323591	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of S100A11 gene	PMID:25304211
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A11 mRNA	PMID:39836092
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A11 mRNA	PMID:40504410
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D012643	Selenium results in increased expression of S100A11 mRNA	PMID:19244175
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1323591	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of S100A11 mRNA	PMID:26272509
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA	PMID:27188386
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of S100A11 mRNA	PMID:31881176
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1323591	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of S100A11 mRNA	PMID:23300844
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27899	cisplatin	increases response to substance	ISO	RGD:1323591	E	RGD:6480464	20160315	CTD	MESH:D002945	S100A11 mutant form results in increased susceptibility to Cisplatin	PMID:25940438
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20160315	CTD	MESH:D002945	[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein; [S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein; [S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein]; arachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to Cisplatin]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein]; S100A11 mutant form promotes the reaction [Cisplatin results in increased cleavage of PARP1 protein]; S100A11 mutant form promotes the reaction [Cisplatin results in increased expression of H2AX protein]	PMID:25940438
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of S100A11 mRNA	PMID:30912803
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D014640	Vancomycin results in decreased expression of S100A11 mRNA	PMID:18930951
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28001	vancomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein	PMID:30545405
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of S100A11 mRNA	PMID:23195993
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of S100A11 mRNA	PMID:21570461
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of S100A11 mRNA	PMID:32109520|PMID:34747641
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of S100A11 mRNA; Tetrachlorodibenzodioxin results in increased expression of S100A11 protein	PMID:20106945|PMID:21632981|PMID:37788135
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1323592	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of S100A11 mRNA	PMID:29673856
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of S100A11 mRNA	PMID:17942748
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28201	rotenone	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of S100A11 mRNA	PMID:28374803
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1323592	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in increased expression of S100A11 mRNA	PMID:23186747
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of S100A11 mRNA	PMID:23179753|PMID:34089799
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1323591	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of S100A11 mRNA	PMID:28001369
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of S100A11 mRNA	PMID:28959563
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of S100A11 mRNA	PMID:30556269
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of S100A11 protein	PMID:28918527
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1323592	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of S100A11 mRNA	PMID:27862939
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1323591	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of S100A11 protein	PMID:29385562
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of S100A11 mRNA	PMID:29803840
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28757	fructose	multiple interactions	EXP		E	RGD:6480464	20160510	CTD	MESH:D005632	[Fructose co-treated with bisphenol A] results in increased expression of S100A11 protein	PMID:26930160
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S100A11 mRNA	PMID:37992649
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20160315	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein]	PMID:25940438
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:28971	ampicillin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein	PMID:30545405
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1323591	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of S100A11 mRNA	PMID:22623647
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1323591	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of S100A11 mRNA	PMID:38568856
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of S100A11 protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A11 mRNA	PMID:39571964|PMID:39836092
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A11 mRNA	PMID:40504410
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of S100A11 mRNA	PMID:19770486|PMID:20127859
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of S100A11 mRNA	PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:32234424
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1323591	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of S100A11 promoter	PMID:27901495
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to S100A11 mRNA]	PMID:32406909
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of S100A11 mRNA	PMID:30556269
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of S100A11 protein	PMID:40770094
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of S100A11 protein	PMID:40770094
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1323592	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of S100A11 mRNA	PMID:23221170
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1323591	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of S100A11 mRNA	PMID:20458559
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:3139	bleomycin A2	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001761	Bleomycin results in increased expression of S100A11 protein	PMID:25933445
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of S100A11 mRNA	PMID:24136188
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1323591	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of S100A11 mRNA	PMID:38568856
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:31941	oxaliplatin	increases response to substance	ISO	RGD:1323591	E	RGD:6480464	20161213	CTD	MESH:C030110	S100A11 mutant form results in increased susceptibility to oxaliplatin	PMID:25940438
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20161213	CTD	MESH:C030110	[S100A11 mutant form results in increased susceptibility to oxaliplatin] which results in increased activity of CASP3 protein; [S100A11 mutant form results in increased susceptibility to oxaliplatin] which results in increased cleavage of PARP1 protein; arachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to oxaliplatin]	PMID:25940438
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1323592	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of S100A11 gene	PMID:35295148
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1323592	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of S100A11 mRNA	PMID:23557971|PMID:27760801
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of S100A11 mRNA	PMID:23411599|PMID:34492290
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of S100A11 mRNA	PMID:25380136|PMID:30723492
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of S100A11 mRNA	PMID:18648102
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:C006253	pirinixic acid results in decreased expression of S100A11 mRNA	PMID:17426115
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1323592	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of S100A11 mRNA	PMID:16221962|PMID:20813756|PMID:23811191
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of S100A11 mRNA	PMID:20813756
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of S100A11 mRNA	PMID:25181051|PMID:32145629
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1323591	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of S100A11 mRNA	PMID:30903817
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of S100A11 protein	PMID:31675489
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1323591	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of S100A11 protein	PMID:37567409
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1323592	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of S100A11 mRNA	PMID:30951980
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160510	CTD	MESH:C006780	[Fructose co-treated with bisphenol A] results in increased expression of S100A11 protein	PMID:26930160
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of S100A11 protein	PMID:31675489
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1323591	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of S100A11 mRNA	PMID:19244175
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:33418	graphite	increases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D006108	Graphite results in increased expression of S100A11 protein	PMID:22157353
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1323591	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of S100A11 mRNA	PMID:25979313
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1323592	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of S100A11 mRNA	PMID:26682919
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA	PMID:25510870
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA	PMID:25510870
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1323591	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of S100A11 protein	PMID:34186270
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1323592	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of S100A11 mRNA	PMID:30951980|PMID:39298647
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:3441	carvedilol	decreases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:C043211	carvedilol results in decreased expression of S100A11 protein	PMID:20403466
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of S100A11 mRNA	PMID:38685157
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1323592	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of S100A11 mRNA	PMID:30951980
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of S100A11 mRNA	PMID:30951980
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of S100A11 protein	PMID:32272095
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of S100A11 protein]	PMID:32272095
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of S100A11 protein	PMID:38598786
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of S100A11 mRNA	PMID:19638242
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1323592	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of S100A11 mRNA	PMID:24535843
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of S100A11 mRNA	PMID:24535843
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of S100A11 mRNA	PMID:32680482
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1323592	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of S100A11 protein	PMID:39748354
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1323591	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of S100A11 mRNA	PMID:37042841
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1323591	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of S100A11 mRNA	PMID:29024780
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of S100A11 mRNA	PMID:25380136|PMID:30723492
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D019256	Cadmium Chloride affects the expression of S100A11 mRNA	PMID:22110744
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20150609	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of S100A11 protein	PMID:24419708|PMID:33830842
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1323591	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of S100A11 mRNA; Cadmium Chloride results in increased expression of S100A11 protein	PMID:24527689|PMID:38185225|PMID:38382870|PMID:38568856
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20210706	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of S100A11 protein; Cadmium Chloride results in decreased expression of and results in decreased methylation of S100A11 mRNA	PMID:33040242|PMID:33830842
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of S100A11 mRNA	PMID:26194646
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:C018021	cobaltous chloride results in decreased expression of S100A11 mRNA	PMID:19376846
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of S100A11 mRNA	PMID:24386269
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of S100A11 mRNA	PMID:25380136
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of S100A11 mRNA	PMID:24449571
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D012643	Selenium results in increased expression of S100A11 mRNA	PMID:19244175
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:37941	clopidogrel	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20170303	CTD	MESH:C055162	clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of S100A11 mRNA]	PMID:19172522
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:C056933	fumonisin B1 results in increased expression of S100A11 mRNA	PMID:16221962
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1323591	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of S100A11 mRNA	PMID:26352163
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1323591	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of S100A11 mRNA	PMID:40419075
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of S100A11 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of S100A11 mRNA	PMID:36331819
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of S100A11 mRNA	PMID:29154799
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1323591	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of S100A11 mRNA	PMID:19101580|PMID:23179753|PMID:23527032|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1323592	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of S100A11 mRNA	PMID:24896083
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA	PMID:27188386
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1323591	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of S100A11 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of S100A11 mRNA	PMID:22733784
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of S100A11 mRNA	PMID:28973697
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S100A11 mRNA	PMID:37992649
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20130115	CTD	MESH:D008727	Methotrexate results in decreased expression of S100A11 mRNA	PMID:17400583
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1323591	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of S100A11 mRNA	PMID:38832940
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1323591	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of S100A11 mRNA	PMID:26272509
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA	PMID:27188386
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1323591	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of S100A11 mRNA	PMID:24935251|PMID:26272509
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA	PMID:27188386
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D000082	Acetaminophen affects the expression of S100A11 mRNA	PMID:17562736
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of S100A11 mRNA	PMID:33387578
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1323591	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of S100A11 mRNA	PMID:29067470
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1323592	E	RGD:6480464	20140812	CTD	MESH:D000082	Acetaminophen results in increased expression of S100A11 mRNA	PMID:24126418|PMID:29246445
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of S100A11 mRNA]	PMID:29246445
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D005472	Fluorouracil results in increased expression of S100A11 mRNA	PMID:19272435
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46345	5-fluorouracil	increases response to substance	ISO	RGD:1323591	E	RGD:6480464	20160315	CTD	MESH:D005472	S100A11 mutant form results in increased susceptibility to Fluorouracil	PMID:25940438
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20160315	CTD	MESH:D005472	[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased activity of CASP3 protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased expression of H2AX protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein]; S100A11 mutant form promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein]	PMID:25940438
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of S100A11 mRNA	PMID:29279043
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1323591	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of S100A11 protein	PMID:29553831
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1323591	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of S100A11 gene	PMID:25304211
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A11 mRNA	PMID:39836092
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A11 mRNA	PMID:40504410
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of S100A11 mRNA	PMID:31675489
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1323592	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of S100A11 mRNA	PMID:35436446
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of S100A11 mRNA	PMID:17942748
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of S100A11 mRNA	PMID:17942748
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1323591	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of S100A11 mRNA	PMID:32234424
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1323591	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of S100A11 mRNA	PMID:26272509
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA	PMID:27188386
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1323591	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of S100A11 mRNA	PMID:20458559
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:5002	fenoldopam	increases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D018818	Fenoldopam results in increased expression of S100A11 mRNA	PMID:21983523
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1323591	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of S100A11 mRNA	PMID:23300844
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects methylation	ISO	RGD:1323591	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the methylation of S100A11 gene	PMID:17579622
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1323591	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of S100A11 protein	PMID:22001959
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1323591	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of S100A11 protein	PMID:22157353
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1323592	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of S100A11 mRNA; Nanotubes, Carbon results in increased expression of S100A11 mRNA	PMID:25554681
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of S100A11 protein	PMID:32959892
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D007649	Ketamine results in decreased expression of S100A11 mRNA	PMID:20080153
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of S100A11 mRNA	PMID:24136188
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	ISO	RGD:1323591	E	RGD:6480464	20240206	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of S100A11 protein	PMID:37788135
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:64317	isoprenaline	increases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D007545	Isoproterenol results in increased expression of S100A11 protein	PMID:10886724
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of S100A11 mRNA	PMID:35283115
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of S100A11 protein	PMID:35926579
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of S100A11 mRNA	PMID:19564919
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of S100A11 mRNA	PMID:19564919
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:6909	metronidazole	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein	PMID:30545405
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1323592	E	RGD:6480464	20130115	CTD	MESH:C057862	cyanoginosin LR results in increased expression of S100A11 mRNA	PMID:17654400
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:6935	Miglitol	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20161213	CTD	MESH:C045621	miglitol results in decreased expression of S100A11 mRNA	PMID:20667563
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of S100A11 mRNA	PMID:31758290
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1323591	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of S100A11 protein	PMID:34186270
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:73297	SCH 23390	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in decreased expression of S100A11 mRNA	PMID:19564919
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of S100A11 mRNA	PMID:19564919
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1323592	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of S100A11 mRNA	PMID:22206623
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of S100A11 mRNA]	PMID:22206623
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of S100A11 protein	PMID:37664457
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:7507	neomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein	PMID:30545405
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of S100A11 mRNA	PMID:22714537
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1323591	E	RGD:6480464	20140610	CTD	MESH:C042577	diallyl trisulfide results in increased expression of S100A11 protein	PMID:16344271
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA	PMID:27188386
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to S100A11 gene]	PMID:28238834
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of S100A11 mRNA	PMID:24535843
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1323592	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of S100A11 mRNA	PMID:38648751
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1323592	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of S100A11 mRNA	PMID:30294300
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of S100A11 protein	PMID:31675489
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1323592	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of S100A11 mRNA	PMID:31558096
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1323591	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of S100A11 protein	PMID:31675489
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1323592	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of S100A11 mRNA	PMID:39847705
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of S100A11 mRNA	PMID:24780913
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1323591	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of S100A11 mRNA	PMID:26272509
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA	PMID:27188386
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:88212	lead(II) chloride	increases expression	ISO	RGD:1323591	E	RGD:6480464	20151103	CTD	MESH:C029891	lead chloride results in increased expression of S100A11 protein	PMID:24419708
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of S100A11 protein; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA	PMID:27188386|PMID:37664457
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:92181	lasalocid	increases expression	ISO	RGD:1323591	E	RGD:6480464	20240206	CTD	MESH:D007832	Lasalocid results in increased expression of S100A11 protein	PMID:37788135
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1323591	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of S100A11 protein	PMID:38598786
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of S100A11 protein	PMID:32519852
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1323592	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of S100A11 mRNA	PMID:18930950
1303295	S100a11	S100 calcium binding protein A11	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of S100A11 mRNA	PMID:19015723
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:38549391	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of HSPA14 mRNA	PMID:38218311
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D014212	Tretinoin results in decreased expression of HSPA14 mRNA	PMID:33167477
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D001280	Atrazine results in decreased expression of HSPA14 mRNA	PMID:22378314
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of HSPA14 mRNA	PMID:20044591
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D011794	Quercetin results in decreased expression of HSPA14 mRNA	PMID:21632981
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:38549391	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HSPA14 mRNA	PMID:37042841
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D005557	Formaldehyde results in increased expression of HSPA14 mRNA	PMID:23416264
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:38549391	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of HSPA14 protein	PMID:37730182
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of HSPA14 protein	PMID:34915118
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D019327	Copper Sulfate results in increased expression of HSPA14 mRNA	PMID:19549813
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of HSPA14 mRNA	PMID:23649840
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of HSPA14 mRNA	PMID:23649840
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D005492	Folic Acid results in decreased expression of HSPA14 mRNA	PMID:21867686
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:38549391	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSPA14 mRNA	PMID:39836092
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of HSPA14 mRNA	PMID:23557933
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in increased expression of HSPA14 mRNA]	PMID:21858171
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:2814	arecoline	increases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D001115	Arecoline results in increased expression of HSPA14 mRNA	PMID:17682004
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of HSPA14 protein	PMID:35544339
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:C000228	aristolochic acid I results in increased expression of HSPA14 mRNA	PMID:33212167
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D019344	Lactic Acid results in decreased expression of HSPA14 mRNA	PMID:30851411
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D014750	Vincristine results in decreased expression of HSPA14 mRNA	PMID:23649840
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D020106	Acrylamide results in increased expression of HSPA14 mRNA	PMID:32763439
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:C017947	sodium arsenite affects the expression of HSPA14 mRNA	PMID:34032870
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:C017947	sodium arsenite results in decreased expression of HSPA14 protein	PMID:30528433
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:C017947	sodium arsenite results in increased expression of HSPA14 mRNA	PMID:28595984
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:38549391	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSPA14 mRNA	PMID:39836092
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to HSPA14 mRNA]	PMID:32406909
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220614	CTD	MESH:C006780	bisphenol A results in increased expression of HSPA14 mRNA	PMID:25181051|PMID:32145629
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:38549391	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HSPA14 mRNA	PMID:37042841
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:38729	naled	affects expression	ISO	RGD:38549391	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of HSPA14 mRNA	PMID:40434365
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:C473478	Sunitinib results in increased expression of HSPA14 mRNA	PMID:31533062
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HSPA14 gene	PMID:29154799
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D014635	Valproic Acid results in increased expression of HSPA14 mRNA	PMID:23179753
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D016572	Cyclosporine results in decreased methylation of HSPA14 promoter	PMID:27989131
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D003703	Demecolcine results in decreased expression of HSPA14 mRNA	PMID:23649840
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:38549391	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HSPA14 mRNA	PMID:38832940
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20220614	CTD	MESH:D000082	Acetaminophen results in increased expression of HSPA14 mRNA	PMID:33387578
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:38549391	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSPA14 mRNA	PMID:39836092
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:C037123	cadmium sulfate results in increased expression of HSPA14 mRNA	PMID:12064557
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D007559	Ivermectin results in decreased expression of HSPA14 protein	PMID:32959892
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D019344	Lactic Acid results in decreased expression of HSPA14 mRNA	PMID:30851411
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HSPA14 gene]	PMID:28238834
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:8249	piroxicam	increases expression	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D010894	Piroxicam results in increased expression of HSPA14 mRNA	PMID:21858171
1303296	Hspa14	heat shock protein family A (Hsp70) member 14	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:38549391	E	RGD:6480464	20220614	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in increased expression of HSPA14 mRNA]	PMID:21858171
1303297	Krt2	keratin 2	gene	CHEBI:133296	microcystin RR	decreases expression	ISO	RGD:1342754	E	RGD:6480464	20161004	CTD	MESH:C063855	microcystin RR results in decreased expression of KRT2 protein	PMID:19111056
1303297	Krt2	keratin 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1342754	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of KRT2 mRNA	PMID:17034753
1303297	Krt2	keratin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553683	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in decreased expression of KRT2 protein	PMID:26903627
1303297	Krt2	keratin 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of KRT2 gene	PMID:27618143
1303297	Krt2	keratin 2	gene	CHEBI:17303	morphine	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine results in decreased expression of KRT2 protein	PMID:23056601
1303297	Krt2	keratin 2	gene	CHEBI:17303	morphine	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine deficiency affects the reaction [Morphine results in decreased expression of KRT2 protein]	PMID:23056601
1303297	Krt2	keratin 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1342754	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of KRT2 mRNA	PMID:21592394
1303297	Krt2	keratin 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1342754	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of KRT2 mRNA	PMID:21592394
1303297	Krt2	keratin 2	gene	CHEBI:17579	beta-carotene	increases expression	ISO	RGD:1342754	E	RGD:6480464	20120412	CTD	MESH:D019207	beta Carotene results in increased expression of KRT2 mRNA	PMID:17034753
1303297	Krt2	keratin 2	gene	CHEBI:17750	glycine betaine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in increased expression of KRT2 mRNA; Betaine results in increased expression of KRT2 protein	PMID:26391144
1303297	Krt2	keratin 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1342754	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of KRT2 mRNA	PMID:21592394
1303297	Krt2	keratin 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1342754	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of KRT2 mRNA	PMID:21592394
1303297	Krt2	keratin 2	gene	CHEBI:22977	cadmium atom	affects binding	ISO	RGD:1342754	E	RGD:6480464	20150512	CTD	MESH:D002104	KRT2 protein binds to Cadmium	PMID:23896426
1303297	Krt2	keratin 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1342754	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of KRT2 protein	PMID:23301498
1303297	Krt2	keratin 2	gene	CHEBI:27363	zinc atom	affects binding	ISO	RGD:1342754	E	RGD:6480464	20150512	CTD	MESH:D015032	KRT2 protein binds to Zinc	PMID:23896426
1303297	Krt2	keratin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1342754	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT2 mRNA	PMID:32525701
1303297	Krt2	keratin 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1553683	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of KRT2 mRNA	PMID:28960355
1303297	Krt2	keratin 2	gene	CHEBI:27889	lead(0)	affects binding	ISO	RGD:1342754	E	RGD:6480464	20150512	CTD	MESH:D007854	KRT2 protein binds to Lead	PMID:23896426
1303297	Krt2	keratin 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1553683	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of KRT2 mRNA	PMID:32186404
1303297	Krt2	keratin 2	gene	CHEBI:28112	nickel atom	affects binding	ISO	RGD:1342754	E	RGD:6480464	20150512	CTD	MESH:D009532	KRT2 protein binds to Nickel	PMID:23896426
1303297	Krt2	keratin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1342754	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KRT2 mRNA	PMID:21296121
1303297	Krt2	keratin 2	gene	CHEBI:28694	copper atom	affects binding	ISO	RGD:1342754	E	RGD:6480464	20150512	CTD	MESH:D003300	KRT2 protein binds to Copper	PMID:23896426
1303297	Krt2	keratin 2	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1342754	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of KRT2 protein	PMID:29385562
1303297	Krt2	keratin 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1553683	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT2 mRNA	PMID:16014739
1303297	Krt2	keratin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1342754	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KRT2 promoter	PMID:27901495
1303297	Krt2	keratin 2	gene	CHEBI:30052	copper(0)	affects binding	ISO	RGD:1342754	E	RGD:6480464	20150512	CTD	MESH:D003300	KRT2 protein binds to Copper	PMID:23896426
1303297	Krt2	keratin 2	gene	CHEBI:30185	zinc(0)	affects binding	ISO	RGD:1342754	E	RGD:6480464	20150512	CTD	MESH:D015032	KRT2 protein binds to Zinc	PMID:23896426
1303297	Krt2	keratin 2	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1553683	E	RGD:6480464	20190219	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRT2 mRNA	PMID:30171875
1303297	Krt2	keratin 2	gene	CHEBI:30563	silicon dioxide	affects secretion	ISO	RGD:1342754	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the secretion of KRT2 protein	PMID:25895662
1303297	Krt2	keratin 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1553683	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of KRT2 mRNA	PMID:29264374
1303297	Krt2	keratin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT2 mRNA	PMID:25181051
1303297	Krt2	keratin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553683	E	RGD:6480464	20250805	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT2 protein	PMID:26903627
1303297	Krt2	keratin 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1553683	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of KRT2 promoter	PMID:27312807
1303297	Krt2	keratin 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1553683	E	RGD:6480464	20250805	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of KRT2 protein	PMID:26903627
1303297	Krt2	keratin 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1342754	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of KRT2 protein	PMID:34186270
1303297	Krt2	keratin 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553683	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KRT2 mRNA	PMID:32715474
1303297	Krt2	keratin 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1342754	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to KRT2 protein	PMID:32991956
1303297	Krt2	keratin 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1553683	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of KRT2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KRT2 mRNA]	PMID:17585979
1303297	Krt2	keratin 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of KRT2 mRNA	PMID:30047161
1303297	Krt2	keratin 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRT2 mRNA	PMID:30723492
1303297	Krt2	keratin 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1553683	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of KRT2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KRT2 mRNA]	PMID:17585979
1303297	Krt2	keratin 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1342754	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT2 mRNA	PMID:32525701
1303297	Krt2	keratin 2	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	increases expression	ISO	RGD:1342754	E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in increased expression of KRT2 mRNA	PMID:17034753
1303297	Krt2	keratin 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1553683	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of KRT2 mRNA	PMID:23608068
1303297	Krt2	keratin 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1342754	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KRT2 protein	PMID:32959892
1303297	Krt2	keratin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1342754	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT2 gene]	PMID:28238834
1303297	Krt2	keratin 2	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1342754	E	RGD:6480464	20120412	CTD	MESH:D010672	Phenytoin results in increased expression of KRT2 mRNA	PMID:14741686
1303297	Krt2	keratin 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1342754	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT2 mRNA	PMID:32525701
1303297	Krt2	keratin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KRT2 mRNA	PMID:30047161
1303297	Krt2	keratin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of KRT2 mRNA	PMID:25825206
1303297	Krt2	keratin 2	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1342754	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of KRT2 mRNA	PMID:31734321
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1551746	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ARL10 mRNA	PMID:33045310
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ARL10 mRNA]	PMID:31150632
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551746	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARL10 gene	PMID:20938992
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1344087	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ARL10 mRNA	PMID:25596134
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551746	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARL10 mRNA	PMID:39241906
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1551746	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of ARL10 gene	PMID:21212295
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ARL10 mRNA	PMID:30510588
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1344087	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ARL10 mRNA	PMID:31614463
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551746	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ARL10 mRNA	PMID:39298647
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551746	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARL10 gene	PMID:20938992
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of ARL10 mRNA	PMID:27905399
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ARL10 mRNA	PMID:33359661
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ARL10 mRNA	PMID:33387578
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344087	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ARL10 mRNA	PMID:35430440
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARL10 mRNA	PMID:31150632
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ARL10 mRNA]	PMID:31150632
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551746	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARL10 gene	PMID:20938992
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551746	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARL10 mRNA	PMID:21570461
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARL10 mRNA	PMID:33387578
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551746	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of ARL10 gene	PMID:21212295
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARL10 mRNA	PMID:33212167
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of ARL10 mRNA	PMID:26272509
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1344087	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL10 mRNA	PMID:27188386
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ARL10 mRNA	PMID:32763439
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1551746	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ARL10 mRNA	PMID:15467011
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARL10 mRNA	PMID:29803840
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARL10 mRNA	PMID:22714537
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344087	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of ARL10 protein	PMID:39571964
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1344087	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ARL10 promoter	PMID:27901495
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1551746	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ARL10 mRNA	PMID:15467011
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551746	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARL10 gene; titanium dioxide results in decreased methylation of ARL10 promoter alternative form	PMID:35295148
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ARL10 mRNA	PMID:23411599
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1551746	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ARL10 mRNA	PMID:18648102
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1551746	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ARL10 mRNA	PMID:17950772
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARL10 mRNA	PMID:25181051
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ARL10 mRNA	PMID:30816183|PMID:32528016
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1551746	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ARL10 gene	PMID:31683443
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1551746	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ARL10 exon	PMID:33297965
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551746	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ARL10 mRNA	PMID:38685157
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344087	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARL10 mRNA	PMID:37042841
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1344087	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ARL10 mRNA	PMID:24449571
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1344087	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARL10 mRNA	PMID:31533062
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ARL10 mRNA	PMID:23125180
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344087	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ARL10 mRNA	PMID:23179753
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1344087	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ARL10 gene	PMID:29154799
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ARL10 mRNA	PMID:38832940
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551746	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARL10 mRNA	PMID:17562736
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARL10 mRNA	PMID:33387578
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1551746	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ARL10 mRNA	PMID:19446018
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ARL10 mRNA	PMID:29391264
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1551746	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ARL10 mRNA	PMID:35436446
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in decreased expression of ARL10 mRNA	PMID:22504374
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ARL10 mRNA	PMID:22714537
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551746	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ARL10 mRNA	PMID:22206623
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344087	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL10 mRNA	PMID:27188386
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ARL10 mRNA	PMID:23640034
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARL10 mRNA	PMID:22504374
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARL10 mRNA	PMID:24780913
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344087	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL10 mRNA	PMID:27188386
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1344087	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARL10 mRNA	PMID:38568856
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1344087	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ARL10 mRNA	PMID:29301935
1303298	Arl10	ARF like GTPase 10	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1551746	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of ARL10 mRNA	PMID:35537566
1303299	mt-Tp	mitochondrially encoded tRNA proline	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D001280	Atrazine results in increased expression of TRNP mRNA	PMID:36841081
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PAN2 mRNA	PMID:38218311
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1553696	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PAN2 mRNA	PMID:33045310
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PAN2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of PAN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PAN2 mRNA	PMID:32699268|PMID:32845096
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PAN2 mRNA	PMID:26079696
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1348496	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PAN2 mRNA	PMID:21179406
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1348496	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PAN2 mRNA	PMID:21632981
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1348496	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of PAN2 protein	PMID:35688186
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553696	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PAN2 mRNA	PMID:39241906
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of PAN2 mRNA	PMID:31614463
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348496	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PAN2 mRNA	PMID:37042841
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1348496	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PAN2 mRNA	PMID:23649840
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PAN2 mRNA	PMID:31163220
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553696	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PAN2 mRNA	PMID:34319233
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1348496	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PAN2 protein	PMID:37730182
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PAN2 mRNA	PMID:33387578
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PAN2 mRNA	PMID:39012411
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553696	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PAN2 mRNA	PMID:37236586
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PAN2 mRNA	PMID:19549813
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1348496	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PAN2 protein	PMID:20106945
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1348496	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PAN2 gene	PMID:27153756
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1348496	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PAN2 mRNA	PMID:23649840
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PAN2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of PAN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PAN2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of PAN2 mRNA	PMID:32699268|PMID:32845096
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PAN2 mRNA	PMID:18593933
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553696	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PAN2 mRNA	PMID:22206623
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553696	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PAN2 mRNA	PMID:40504410
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PAN2 mRNA	PMID:26272509
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAN2 mRNA	PMID:27188386
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1348496	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PAN2 protein	PMID:35688186
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PAN2 mRNA	PMID:23557933
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553696	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PAN2 mRNA	PMID:21570461
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553696	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PAN2 mRNA	PMID:17942748
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PAN2 mRNA	PMID:28001369
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PAN2 mRNA	PMID:33212167
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1348496	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PAN2 mRNA	PMID:29803840
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PAN2 mRNA	PMID:38568856
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553696	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PAN2 mRNA	PMID:40504410
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1348496	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of PAN2 mRNA	PMID:29453283
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PAN2 mRNA	PMID:26238291
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1348496	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PAN2 3' UTR	PMID:27901495
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553696	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PAN2 mRNA	PMID:22228805
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PAN2 mRNA	PMID:18593933
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PAN2 mRNA	PMID:27829220
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1348496	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of PAN2 gene	PMID:31601247
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PAN2 mRNA	PMID:25729387
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PAN2 mRNA	PMID:34492290
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PAN2 mRNA	PMID:19710929
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1553696	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of PAN2 mRNA	PMID:37894381
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PAN2 mRNA	PMID:25181051|PMID:30816183
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553696	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in increased expression of PAN2 mRNA	PMID:29165653
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1348496	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PAN2 mRNA	PMID:25979313
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1553696	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PAN2 mRNA	PMID:38685157
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553696	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PAN2 mRNA	PMID:37019170
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1553696	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PAN2 mRNA	PMID:34813904
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PAN2 mRNA	PMID:38568856
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PAN2 mRNA	PMID:39012411
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553696	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PAN2 mRNA	PMID:37236586
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in decreased methylation of PAN2 gene	PMID:22079235
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PAN2 mRNA	PMID:19376846
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PAN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PAN2 mRNA	PMID:32699268
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1348496	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of PAN2 mRNA	PMID:19167446
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1348496	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PAN2 mRNA	PMID:40419075
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1348496	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PAN2 mRNA	PMID:25979313
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PAN2 mRNA	PMID:23179753|PMID:26272509|PMID:29154799
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAN2 mRNA	PMID:27188386
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1348496	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of PAN2 mRNA	PMID:27989131
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553696	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PAN2 mRNA	PMID:17555576
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PAN2 mRNA	PMID:21420995
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553696	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PAN2 mRNA	PMID:40504410
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PAN2 mRNA	PMID:29391264
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1553696	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PAN2 mRNA	PMID:17555576
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553696	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PAN2 mRNA	PMID:17942748
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553696	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PAN2 mRNA	PMID:17942748
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PAN2 mRNA	PMID:27829220
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553696	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PAN2 mRNA	PMID:25554681
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1553696	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of PAN2 mRNA	PMID:40234311
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of PAN2 mRNA	PMID:24793618
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:51348	tetraphene	affects expression	ISO	RGD:1553696	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene affects the expression of PAN2 mRNA	PMID:26377693
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PAN2 mRNA	PMID:25729387
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1553696	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PAN2 mRNA	PMID:23650126
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PAN2 mRNA	PMID:15336504
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1348496	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PAN2 mRNA	PMID:31758290
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553696	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PAN2 mRNA	PMID:22206623
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAN2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAN2 mRNA	PMID:27188386
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PAN2 gene]	PMID:28238834
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1348496	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAN2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAN2 mRNA	PMID:27188386
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PAN2 mRNA	PMID:21346803
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1348496	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PAN2 mRNA	PMID:38568856
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1348496	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of PAN2 mRNA	PMID:22378314
1303301	Pan2	poly(A) specific ribonuclease subunit PAN2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1553696	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PAN2 mRNA	PMID:28973697
1303302	Nrg2	neuregulin 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1612360	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of NRG2 mRNA	PMID:33045310
1303302	Nrg2	neuregulin 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1606028	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NRG2 mRNA	PMID:35811015
1303302	Nrg2	neuregulin 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1606028	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NRG2 mRNA]	PMID:35811015
1303302	Nrg2	neuregulin 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1606028	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of NRG2 mRNA	PMID:30510588
1303302	Nrg2	neuregulin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606028	E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in increased expression of NRG2 mRNA	PMID:23373633
1303302	Nrg2	neuregulin 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NRG2 mRNA	PMID:33387578
1303302	Nrg2	neuregulin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1606028	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NRG2 mRNA	PMID:31163220
1303302	Nrg2	neuregulin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1612360	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of NRG2 intron	PMID:32864567
1303302	Nrg2	neuregulin 2	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1606028	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of NRG2 mRNA	PMID:16002434
1303302	Nrg2	neuregulin 2	gene	CHEBI:18291	manganese atom	increases expression	ISO	RGD:1606028	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of NRG2 mRNA	PMID:17175027
1303302	Nrg2	neuregulin 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1606028	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NRG2 intron	PMID:30157460
1303302	Nrg2	neuregulin 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1612360	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NRG2 mRNA	PMID:34911549
1303302	Nrg2	neuregulin 2	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1606028	E	RGD:6480464	20140610	CTD	MESH:D001151	Arsenic affects the expression of NRG2 protein	PMID:24675094
1303302	Nrg2	neuregulin 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1612360	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of NRG2 mRNA	PMID:28960355
1303302	Nrg2	neuregulin 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606028	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of NRG2 mRNA	PMID:23557933
1303302	Nrg2	neuregulin 2	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1606028	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of NRG2 promoter	PMID:22847954
1303302	Nrg2	neuregulin 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1606028	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of NRG2 mRNA	PMID:24768652|PMID:25583101
1303302	Nrg2	neuregulin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NRG2 mRNA	PMID:33387578
1303302	Nrg2	neuregulin 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606028	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NRG2 mRNA	PMID:28001369
1303302	Nrg2	neuregulin 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of NRG2 mRNA	PMID:28959563
1303302	Nrg2	neuregulin 2	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of NRG2 mRNA	PMID:30556269
1303302	Nrg2	neuregulin 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NRG2 mRNA	PMID:26033743
1303302	Nrg2	neuregulin 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of NRG2 mRNA	PMID:26033743
1303302	Nrg2	neuregulin 2	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1606028	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of NRG2 mRNA	PMID:22363485
1303302	Nrg2	neuregulin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606028	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of NRG2 mRNA	PMID:34032870
1303302	Nrg2	neuregulin 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1612360	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of NRG2 mRNA	PMID:37682722
1303302	Nrg2	neuregulin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606028	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NRG2 intron	PMID:30157460
1303302	Nrg2	neuregulin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606028	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NRG2 3' UTR	PMID:27901495
1303302	Nrg2	neuregulin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606028	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NRG2 promoter	PMID:27901495
1303302	Nrg2	neuregulin 2	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of NRG2 mRNA	PMID:30556269
1303302	Nrg2	neuregulin 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NRG2 mRNA	PMID:26033743
1303302	Nrg2	neuregulin 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of NRG2 mRNA	PMID:26033743
1303302	Nrg2	neuregulin 2	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1612360	E	RGD:6480464	20190219	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of NRG2 mRNA	PMID:30171875
1303302	Nrg2	neuregulin 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1606028	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NRG2 mRNA	PMID:34973136
1303302	Nrg2	neuregulin 2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of NRG2 mRNA	PMID:16483693
1303302	Nrg2	neuregulin 2	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1606028	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of NRG2 gene	PMID:31601247
1303302	Nrg2	neuregulin 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1606028	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NRG2 gene	PMID:31601247
1303302	Nrg2	neuregulin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1612360	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NRG2 gene; titanium dioxide results in decreased methylation of NRG2 promoter	PMID:35295148
1303302	Nrg2	neuregulin 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1612360	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of NRG2 mRNA	PMID:35295148
1303302	Nrg2	neuregulin 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1612360	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NRG2 gene	PMID:35295148
1303302	Nrg2	neuregulin 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1612360	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NRG2 mRNA	PMID:19710929
1303302	Nrg2	neuregulin 2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of NRG2 mRNA	PMID:19167457
1303302	Nrg2	neuregulin 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1606028	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of NRG2 gene	PMID:31601247
1303302	Nrg2	neuregulin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NRG2 mRNA	PMID:25181051
1303302	Nrg2	neuregulin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1612360	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of NRG2 mRNA	PMID:32156529
1303302	Nrg2	neuregulin 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NRG2 gene	PMID:28505145
1303302	Nrg2	neuregulin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606028	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NRG2 gene	PMID:31601247
1303302	Nrg2	neuregulin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1612360	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of NRG2 gene	PMID:31683443
1303302	Nrg2	neuregulin 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1606028	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NRG2 intron	PMID:30157460
1303302	Nrg2	neuregulin 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1612360	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NRG2 intron	PMID:28392331
1303302	Nrg2	neuregulin 2	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] affects the methylation of NRG2 gene	PMID:33148267
1303302	Nrg2	neuregulin 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of NRG2 mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of NRG2 mRNA	PMID:35163327
1303302	Nrg2	neuregulin 2	gene	CHEBI:35154	manganese(0)	increases expression	ISO	RGD:1606028	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of NRG2 mRNA	PMID:17175027
1303302	Nrg2	neuregulin 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of NRG2 mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of NRG2 mRNA	PMID:35163327
1303302	Nrg2	neuregulin 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1612360	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NRG2 mRNA	PMID:40194260
1303302	Nrg2	neuregulin 2	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1606028	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of NRG2 promoter	PMID:22847954
1303302	Nrg2	neuregulin 2	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1606028	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of NRG2 promoter	PMID:22847954
1303302	Nrg2	neuregulin 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606028	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NRG2 mRNA	PMID:25979313
1303302	Nrg2	neuregulin 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606028	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of NRG2 mRNA	PMID:26272509
1303302	Nrg2	neuregulin 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606028	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG2 mRNA	PMID:27188386
1303302	Nrg2	neuregulin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606028	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of NRG2 mRNA	PMID:20106945
1303302	Nrg2	neuregulin 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1606028	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of NRG2 mRNA	PMID:26272509
1303302	Nrg2	neuregulin 2	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1606028	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRG2 mRNA	PMID:27188386
1303302	Nrg2	neuregulin 2	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of NRG2 mRNA	PMID:21346803
1303302	Nrg2	neuregulin 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606028	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of NRG2 mRNA	PMID:22230336|PMID:29067470
1303302	Nrg2	neuregulin 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NRG2 mRNA	PMID:33387578
1303302	Nrg2	neuregulin 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1606028	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NRG2 mRNA]	PMID:35811015
1303302	Nrg2	neuregulin 2	gene	CHEBI:46661	asbestos	affects methylation	ISO	RGD:1606028	E	RGD:6480464	20210112	CTD	MESH:D001194	Asbestos affects the methylation of NRG2 gene	PMID:28722770
1303302	Nrg2	neuregulin 2	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1606028	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of NRG2 protein	PMID:24675094
1303302	Nrg2	neuregulin 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1612360	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of NRG2 mRNA	PMID:35436446
1303302	Nrg2	neuregulin 2	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of NRG2 mRNA	PMID:30307764
1303302	Nrg2	neuregulin 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1612360	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of NRG2 mRNA; Nanotubes, Carbon results in decreased expression of NRG2 mRNA	PMID:25554681
1303302	Nrg2	neuregulin 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of NRG2 mRNA	PMID:31881178
1303302	Nrg2	neuregulin 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1612360	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of NRG2 mRNA	PMID:23608068
1303302	Nrg2	neuregulin 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1606028	E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in increased expression of NRG2 mRNA	PMID:17175027
1303302	Nrg2	neuregulin 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] affects the methylation of NRG2 gene	PMID:33148267
1303302	Nrg2	neuregulin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606028	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRG2 mRNA	PMID:27188386
1303302	Nrg2	neuregulin 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NRG2 mRNA	PMID:32109520
1303302	Nrg2	neuregulin 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of NRG2 mRNA	PMID:23914054
1303302	Nrg2	neuregulin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NRG2 mRNA	PMID:24780913
1303302	Nrg2	neuregulin 2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1612360	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of NRG2 mRNA	PMID:40826991
1303302	Nrg2	neuregulin 2	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1606028	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of NRG2 mRNA	PMID:15849065
1303302	Nrg2	neuregulin 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606028	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRG2 mRNA	PMID:27188386
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1606812	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ELP5 mRNA	PMID:38218311
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1615924	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ELP5 mRNA	PMID:33045310
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606812	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ELP5 mRNA	PMID:33167477
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1606812	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of ELP5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of ELP5 mRNA	PMID:32699268
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1615924	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ELP5 mRNA	PMID:30319688
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1615924	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ELP5 mRNA	PMID:39241906
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1606812	E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in decreased expression of ELP5 protein	PMID:33181973
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606812	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ELP5 mRNA	PMID:37042841
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1615924	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ELP5 mRNA	PMID:33754040
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ELP5 mRNA	PMID:33387578
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1606812	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ELP5 mRNA	PMID:35301059
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606812	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of ELP5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of ELP5 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of ELP5 mRNA	PMID:32699268
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1615924	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ELP5 mRNA	PMID:31919559
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1615924	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ELP5 mRNA	PMID:22206623
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606812	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ELP5 mRNA	PMID:39836092
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1615924	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELP5 mRNA	PMID:40504410
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606812	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of ELP5 mRNA	PMID:19167446
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615924	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ELP5 mRNA	PMID:21570461|PMID:24680724
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ELP5 mRNA	PMID:21215274
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELP5 mRNA	PMID:33387578
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606812	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ELP5 mRNA	PMID:33212167
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606812	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ELP5 mRNA	PMID:29803840
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606812	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ELP5 mRNA	PMID:39836092
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1615924	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELP5 mRNA	PMID:40504410
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1615924	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELP5 mRNA	PMID:22228805
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1606812	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ELP5 mRNA	PMID:22521957
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ELP5 mRNA	PMID:30047161
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ELP5 mRNA	PMID:34492290
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ELP5 mRNA	PMID:25181051|PMID:32145629
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1615924	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ELP5 mRNA	PMID:33221593
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ELP5 gene	PMID:28505145
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1615924	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ELP5 gene	PMID:31683443
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1615924	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ELP5 mRNA	PMID:39298647
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1615924	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ELP5 mRNA	PMID:37019170
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ELP5 mRNA	PMID:21266533
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ELP5 mRNA	PMID:33453195
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of ELP5 promoter	PMID:22457795
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1606812	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ELP5 mRNA	PMID:35301059
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1606812	E	RGD:6480464	20151110	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ELP5 mRNA	PMID:19376846
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1606812	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of ELP5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of ELP5 mRNA	PMID:32699268
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1606812	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ELP5 mRNA	PMID:19167446
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1606812	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of ELP5 mRNA	PMID:19167446
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606812	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ELP5 mRNA	PMID:25979313
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606812	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ELP5 mRNA	PMID:23179753|PMID:24935251|PMID:27188386
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606812	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ELP5 mRNA	PMID:29154799
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ELP5 mRNA	PMID:30047161
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1615924	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ELP5 mRNA	PMID:17562736
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606812	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ELP5 mRNA	PMID:39836092
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1615924	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELP5 mRNA	PMID:40504410
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ELP5 mRNA	PMID:17557909
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1606812	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ELP5 mRNA	PMID:22521957
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1615924	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ELP5 mRNA	PMID:25554681
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ELP5 mRNA	PMID:30047161
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ELP5 mRNA	PMID:24136188
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1606812	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of ELP5 mRNA	PMID:20977926
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1606812	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ELP5 protein	PMID:32959892
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1606812	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ELP5 mRNA	PMID:28988120
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1615924	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ELP5 mRNA	PMID:22206623
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ELP5 mRNA	PMID:30047161
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D012999	Soman results in increased expression of ELP5 mRNA	PMID:19281266
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ELP5 mRNA	PMID:21346803
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1606812	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ELP5 mRNA	PMID:17440010
1303303	Elp5	elongator acetyltransferase complex subunit 5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ELP5 mRNA	PMID:21346803
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1321766	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of GPANK1 mRNA	PMID:33167477
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1321766	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of GPANK1 mRNA	PMID:22378314
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1321767	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of GPANK1 mRNA	PMID:30319688
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1321766	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of GPANK1 mRNA	PMID:20044591
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1321766	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of GPANK1 mRNA	PMID:21632981
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1321767	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GPANK1 mRNA	PMID:39298647
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GPANK1 mRNA	PMID:33387578
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of GPANK1 mRNA	PMID:33387578
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1321766	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GPANK1 mRNA	PMID:28818685
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1321767	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPANK1 mRNA	PMID:37236586
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1321766	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GPANK1 mRNA	PMID:19549813
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GPANK1 mRNA	PMID:33354967
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1321766	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GPANK1 mRNA	PMID:23649840
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1321766	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GPANK1 gene	PMID:25304211
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1321767	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of GPANK1 mRNA	PMID:30912803
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPANK1 mRNA	PMID:22298810
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1321767	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPANK1 mRNA	PMID:24680724
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GPANK1 mRNA	PMID:33387578
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1321766	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of GPANK1 mRNA	PMID:20044591
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1321766	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GPANK1 mRNA	PMID:38568856
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1321766	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GPANK1 5' UTR; Benzo(a)pyrene results in increased methylation of GPANK1 promoter	PMID:27901495
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GPANK1 mRNA	PMID:34492290
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GPANK1 mRNA	PMID:25181051
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1321767	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GPANK1 mRNA	PMID:39298647
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1321766	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of GPANK1 exon	PMID:30157460
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1321766	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GPANK1 mRNA	PMID:37042841
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1321767	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPANK1 mRNA	PMID:37236586
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1321766	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of GPANK1 mRNA	PMID:40419075
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1321767	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of GPANK1 mRNA	PMID:36331819
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1321767	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GPANK1 mRNA	PMID:17292431
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1321766	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of GPANK1 mRNA	PMID:20106945|PMID:27989131
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1321767	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GPANK1 mRNA	PMID:17562736
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1321766	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GPANK1 gene	PMID:25304211
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1321767	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GPANK1 mRNA	PMID:25554681
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1321766	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of GPANK1 mRNA	PMID:20977926
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1321766	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of GPANK1 exon	PMID:30157460
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1321766	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of GPANK1 protein	PMID:31285264
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of GPANK1 mRNA	PMID:19281266
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GPANK1 mRNA	PMID:21346803
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1321766	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GPANK1 mRNA	PMID:29301935
1303304	Gpank1	G patch domain and ankyrin repeats 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of GPANK1 mRNA	PMID:21346803
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1346513	E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of CUTA mRNA	PMID:19371625
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346513	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CUTA mRNA	PMID:33167477
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1346513	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CUTA mRNA	PMID:20044591
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553737	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CUTA mRNA	PMID:39241906
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553737	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CUTA mRNA	PMID:39298647
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CUTA gene	PMID:27618143
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553737	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CUTA mRNA	PMID:33754040
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1346513	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CUTA mRNA	PMID:35301059
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of CUTA protein	PMID:33236894
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346513	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CUTA gene	PMID:27153756
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1553737	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of CUTA mRNA	PMID:12763052
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:2654	aminoglutethimide	decreases expression	ISO	RGD:1346513	E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of CUTA protein	PMID:26102013
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1346513	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CUTA gene	PMID:25304211
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1346513	E	RGD:6480464	20241001	CTD	MESH:D001151	Arsenic results in increased methylation of CUTA gene	PMID:38030093
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553737	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CUTA mRNA	PMID:40504410
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1346513	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of CUTA mRNA	PMID:19371625
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553737	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CUTA mRNA	PMID:21570461|PMID:24680724
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CUTA mRNA	PMID:21215274
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1553737	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CUTA mRNA	PMID:19465110
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CUTA mRNA	PMID:33387578
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of CUTA mRNA	PMID:28374803
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1346513	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CUTA mRNA; aristolochic acid I results in increased expression of CUTA protein	PMID:33212167
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1346513	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of CUTA mRNA	PMID:24834073
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1346513	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of CUTA protein	PMID:29385562
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346513	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CUTA mRNA	PMID:17879257
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553737	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CUTA mRNA	PMID:40504410
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346513	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CUTA 3' UTR; Benzo(a)pyrene affects the methylation of CUTA promoter	PMID:27901495
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553737	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CUTA gene	PMID:35295148
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1346513	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CUTA mRNA	PMID:30903817
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1346513	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of CUTA protein	PMID:34186270
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553737	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of CUTA mRNA	PMID:35598803
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1346513	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CUTA gene	PMID:31601247
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CUTA mRNA	PMID:25181051|PMID:34947998
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1346513	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of CUTA protein	PMID:37567409
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553737	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of CUTA mRNA	PMID:37894381
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CUTA mRNA	PMID:36041667
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1346513	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CUTA protein	PMID:34186270
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CUTA mRNA	PMID:36041667
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CUTA mRNA	PMID:36041667
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553737	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CUTA mRNA	PMID:37019170
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CUTA mRNA	PMID:17602206
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CUTA mRNA	PMID:21266533
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1553737	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CUTA mRNA	PMID:21266533
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CUTA mRNA	PMID:17602206
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1346513	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CUTA mRNA	PMID:35301059
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of CUTA mRNA	PMID:19162173
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1346513	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CUTA mRNA	PMID:19376846
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1346513	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CUTA mRNA	PMID:24449571
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1553737	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of CUTA mRNA	PMID:17585979
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1553737	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of CUTA mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CUTA mRNA]	PMID:17585979
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1346513	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CUTA mRNA	PMID:31533062
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346513	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CUTA mRNA	PMID:25562108
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1553737	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of CUTA mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CUTA mRNA]	PMID:17585979
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1346513	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CUTA mRNA	PMID:29432896
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1553737	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CUTA mRNA	PMID:29279043
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1346513	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CUTA gene	PMID:25304211
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1346513	E	RGD:6480464	20241001	CTD	MESH:D001151	Arsenic results in increased methylation of CUTA gene	PMID:38030093
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553737	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CUTA mRNA	PMID:40504410
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1553737	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CUTA mRNA	PMID:35964746
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1346513	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CUTA protein	PMID:34186270
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346513	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CUTA gene]	PMID:28238834
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:82272	Erionite	increases expression	ISO	RGD:1553737	E	RGD:6480464	20200915	CTD	MESH:C083174	erionite results in increased expression of CUTA mRNA	PMID:29279043
1303306	Cuta	cutA divalent cation tolerance homolog	gene	CHEBI:90633	perfluorododecanoic acid	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in decreased expression of CUTA protein	PMID:19854247
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1349792	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of KIF13B mRNA	PMID:27188386
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of KIF13B mRNA	PMID:26079696
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1553738	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of KIF13B mRNA	PMID:30319688
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1349792	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of KIF13B mRNA	PMID:29581250
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553738	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KIF13B mRNA	PMID:39241906
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553738	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of KIF13B mRNA	PMID:39298647
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of KIF13B mRNA	PMID:38568856
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of KIF13B gene	PMID:27618143
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1553738	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of KIF13B mRNA	PMID:34673133
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1349792	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of KIF13B mRNA	PMID:21795739
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20170725	CTD	MESH:D014050	Toluene results in decreased expression of KIF13B mRNA	PMID:28245982
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553738	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KIF13B mRNA	PMID:33754040
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of KIF13B mRNA	PMID:26577399
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1349792	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KIF13B protein	PMID:37730182
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1349792	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KIF13B mRNA	PMID:28818685
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553738	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KIF13B mRNA	PMID:36331819
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1349792	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of KIF13B protein	PMID:20106945
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of KIF13B mRNA	PMID:22100608
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1349792	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KIF13B intron	PMID:30157460
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553738	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KIF13B mRNA	PMID:40504410
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of KIF13B mRNA	PMID:31881176
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of KIF13B mRNA	PMID:27392435
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KIF13B mRNA	PMID:33387578
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1553738	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KIF13B mRNA	PMID:19770486
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553738	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF13B mRNA	PMID:17942748
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1349792	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of KIF13B mRNA	PMID:39709020
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KIF13B mRNA	PMID:30851411
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of KIF13B mRNA	PMID:32763439
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1553738	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of KIF13B mRNA	PMID:27862939
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KIF13B mRNA	PMID:29803840
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1349792	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of KIF13B protein	PMID:35688186
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1349792	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of KIF13B mRNA	PMID:20044591
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349792	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KIF13B mRNA	PMID:38568856
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553738	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KIF13B mRNA	PMID:40504410
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KIF13B mRNA	PMID:20064835|PMID:32234424
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1349792	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KIF13B promoter	PMID:27901495
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1349792	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to KIF13B mRNA]	PMID:32406909
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of KIF13B mRNA	PMID:25895662
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1349792	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of KIF13B mRNA	PMID:20458559
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of KIF13B mRNA	PMID:24915197
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1349792	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of KIF13B gene	PMID:31601247
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1553738	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in increased expression of KIF13B mRNA	PMID:22613225
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of KIF13B mRNA	PMID:30012374
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553738	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KIF13B gene; titanium dioxide results in decreased methylation of KIF13B promoter	PMID:35295148
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1553738	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of KIF13B mRNA	PMID:29264374
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of KIF13B mRNA	PMID:32145629
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF13B mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1349792	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of KIF13B gene	PMID:31601247
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1349792	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of KIF13B mRNA	PMID:25979313
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1553738	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of KIF13B exon	PMID:33297965
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553738	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of KIF13B mRNA	PMID:40203079
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1349792	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of KIF13B gene	PMID:31601247
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553738	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KIF13B mRNA	PMID:37019170
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349792	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KIF13B mRNA	PMID:37042841
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KIF13B mRNA	PMID:38568856
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349792	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KIF13B mRNA	PMID:38174414
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1349792	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of KIF13B protein	PMID:34122009
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of KIF13B mRNA	PMID:31533062
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553738	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KIF13B mRNA	PMID:36331819
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of KIF13B mRNA	PMID:29427782
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349792	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of KIF13B mRNA	PMID:23527032
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1349792	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KIF13B gene	PMID:29154799
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1553738	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of KIF13B mRNA	PMID:19770486
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1349792	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of KIF13B mRNA	PMID:28542535
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553738	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KIF13B mRNA	PMID:17562736
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of KIF13B mRNA	PMID:21420995
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KIF13B mRNA	PMID:33387578
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553738	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KIF13B mRNA	PMID:40504410
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553738	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF13B mRNA	PMID:17942748
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:4953	exemestane	increases expression	ISO	RGD:1349792	E	RGD:6480464	20120412	CTD	MESH:C056516	exemestane results in increased expression of KIF13B mRNA	PMID:17254854
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1349792	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of KIF13B mRNA	PMID:20458559
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1553738	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of KIF13B mRNA	PMID:23608068
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KIF13B protein	PMID:32959892
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553738	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KIF13B mRNA	PMID:22206623
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KIF13B mRNA	PMID:30851411
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:79089	ceric oxide	increases expression	ISO	RGD:1349792	E	RGD:6480464	20150310	CTD	MESH:C030583	ceric oxide analog results in increased expression of KIF13B mRNA	PMID:24821434
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1349792	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of KIF13B mRNA	PMID:26079696
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KIF13B mRNA	PMID:24780913
1303307	Kif13b	kinesin family member 13B	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1553738	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of KIF13B mRNA	PMID:28973697
1303308	Tspan1	tetraspanin 1	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in increased expression of TSPAN1 mRNA	PMID:17557909
1303308	Tspan1	tetraspanin 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1354320	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TSPAN1 mRNA	PMID:38218311
1303308	Tspan1	tetraspanin 1	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1354320	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of TSPAN1 mRNA	PMID:31016361
1303308	Tspan1	tetraspanin 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1354320	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of TSPAN1 mRNA	PMID:22378314
1303308	Tspan1	tetraspanin 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1354320	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TSPAN1 mRNA	PMID:35811015
1303308	Tspan1	tetraspanin 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553747	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of TSPAN1 mRNA	PMID:19484750
1303308	Tspan1	tetraspanin 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1354320	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of TSPAN1 mRNA	PMID:19484750
1303308	Tspan1	tetraspanin 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1354320	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of TSPAN1 mRNA	PMID:30165855
1303308	Tspan1	tetraspanin 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of TSPAN1 mRNA	PMID:38568856
1303308	Tspan1	tetraspanin 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TSPAN1 mRNA	PMID:33387578
1303308	Tspan1	tetraspanin 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1354320	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of TSPAN1 mRNA	PMID:27664576
1303308	Tspan1	tetraspanin 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1553747	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of TSPAN1 mRNA	PMID:33848595
1303308	Tspan1	tetraspanin 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553747	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TSPAN1 mRNA	PMID:28085963|PMID:34319233
1303308	Tspan1	tetraspanin 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1354320	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of TSPAN1 mRNA	PMID:26485663
1303308	Tspan1	tetraspanin 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1354320	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TSPAN1 promoter	PMID:30157460
1303308	Tspan1	tetraspanin 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1354320	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TSPAN1 mRNA	PMID:21641981|PMID:30157460
1303308	Tspan1	tetraspanin 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1354320	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TSPAN1 mRNA	PMID:40512198
1303308	Tspan1	tetraspanin 1	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1354320	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of TSPAN1 mRNA	PMID:38460933
1303308	Tspan1	tetraspanin 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1354320	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of TSPAN1 mRNA	PMID:19167446
1303308	Tspan1	tetraspanin 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1354320	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TSPAN1 mRNA	PMID:27392435
1303308	Tspan1	tetraspanin 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1354320	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TSPAN1 mRNA	PMID:27392435
1303308	Tspan1	tetraspanin 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in decreased expression of TSPAN1 mRNA	PMID:26865667
1303308	Tspan1	tetraspanin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TSPAN1 mRNA	PMID:32109520
1303308	Tspan1	tetraspanin 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TSPAN1 mRNA	PMID:33212167
1303308	Tspan1	tetraspanin 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TSPAN1 mRNA	PMID:30851411
1303308	Tspan1	tetraspanin 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TSPAN1 mRNA	PMID:38568856
1303308	Tspan1	tetraspanin 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1553747	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TSPAN1 mRNA	PMID:17350061
1303308	Tspan1	tetraspanin 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1354320	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TSPAN1 mRNA	PMID:40512198
1303308	Tspan1	tetraspanin 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1354320	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TSPAN1 5' UTR	PMID:27901495
1303308	Tspan1	tetraspanin 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1354320	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TSPAN1 promoter	PMID:27901495
1303308	Tspan1	tetraspanin 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1354320	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TSPAN1 exon	PMID:27901495
1303308	Tspan1	tetraspanin 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of TSPAN1 mRNA	PMID:38568856
1303308	Tspan1	tetraspanin 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1553747	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in decreased expression of TSPAN1 mRNA	PMID:22609695
1303308	Tspan1	tetraspanin 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1553747	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of TSPAN1 mRNA	PMID:23557971
1303308	Tspan1	tetraspanin 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553747	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TSPAN1 mRNA	PMID:17426115
1303308	Tspan1	tetraspanin 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553747	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TSPAN1 mRNA	PMID:20813756
1303308	Tspan1	tetraspanin 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1354320	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TSPAN1 mRNA	PMID:19710929
1303308	Tspan1	tetraspanin 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1553747	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TSPAN1 mRNA	PMID:28472532
1303308	Tspan1	tetraspanin 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1354320	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of TSPAN1 mRNA	PMID:20170705
1303308	Tspan1	tetraspanin 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TSPAN1 mRNA	PMID:25181051
1303308	Tspan1	tetraspanin 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553747	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN1 mRNA	PMID:32156529
1303308	Tspan1	tetraspanin 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1553747	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TSPAN1 promoter	PMID:27312807
1303308	Tspan1	tetraspanin 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1553747	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of TSPAN1 mRNA	PMID:26682919
1303308	Tspan1	tetraspanin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553747	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TSPAN1 mRNA	PMID:40203079
1303308	Tspan1	tetraspanin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553747	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TSPAN1 mRNA	PMID:30951980
1303308	Tspan1	tetraspanin 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553747	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TSPAN1 mRNA	PMID:30951980
1303308	Tspan1	tetraspanin 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1553747	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TSPAN1 intron	PMID:28392331
1303308	Tspan1	tetraspanin 1	gene	CHEBI:34679	Di-n-octyl phthalate	increases expression	ISO	RGD:1553747	E	RGD:6480464	20240305	CTD	MESH:C010715	di-n-octyl phthalate results in increased expression of TSPAN1 mRNA	PMID:37810885
1303308	Tspan1	tetraspanin 1	gene	CHEBI:34698	diethyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of TSPAN1 mRNA	PMID:32341500
1303308	Tspan1	tetraspanin 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1354320	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of TSPAN1 mRNA	PMID:21527772
1303308	Tspan1	tetraspanin 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TSPAN1 mRNA	PMID:27387713
1303308	Tspan1	tetraspanin 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TSPAN1 mRNA	PMID:24449571
1303308	Tspan1	tetraspanin 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1553747	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TSPAN1 mRNA	PMID:40194260
1303308	Tspan1	tetraspanin 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TSPAN1 mRNA	PMID:28302478
1303308	Tspan1	tetraspanin 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TSPAN1 mRNA	PMID:31533062
1303308	Tspan1	tetraspanin 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1354320	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of TSPAN1 mRNA	PMID:19167446
1303308	Tspan1	tetraspanin 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1354320	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TSPAN1 mRNA	PMID:40419075
1303308	Tspan1	tetraspanin 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1553747	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TSPAN1 mRNA	PMID:17292431
1303308	Tspan1	tetraspanin 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TSPAN1 mRNA	PMID:30047161
1303308	Tspan1	tetraspanin 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1354320	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TSPAN1 mRNA	PMID:25562108
1303308	Tspan1	tetraspanin 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1354320	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TSPAN1 mRNA	PMID:38832940
1303308	Tspan1	tetraspanin 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553747	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TSPAN1 mRNA	PMID:17562736
1303308	Tspan1	tetraspanin 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1354320	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of TSPAN1 mRNA	PMID:35811015
1303308	Tspan1	tetraspanin 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1354320	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TSPAN1 mRNA	PMID:35811015
1303308	Tspan1	tetraspanin 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1354320	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TSPAN1 mRNA	PMID:40512198
1303308	Tspan1	tetraspanin 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1553747	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of TSPAN1 mRNA	PMID:30529165
1303308	Tspan1	tetraspanin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TSPAN1 mRNA	PMID:20170705|PMID:26865667
1303308	Tspan1	tetraspanin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1354320	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TSPAN1 mRNA	PMID:20170705|PMID:26865667
1303308	Tspan1	tetraspanin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TSPAN1 mRNA	PMID:18936297
1303308	Tspan1	tetraspanin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TSPAN1 mRNA	PMID:17351261|PMID:17557909
1303308	Tspan1	tetraspanin 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of TSPAN1 mRNA	PMID:38568856
1303308	Tspan1	tetraspanin 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TSPAN1 mRNA	PMID:30047161
1303308	Tspan1	tetraspanin 1	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1553747	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of TSPAN1 mRNA	PMID:26377693
1303308	Tspan1	tetraspanin 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TSPAN1 mRNA	PMID:28801915
1303308	Tspan1	tetraspanin 1	gene	CHEBI:64243	monosodium L-glutamate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:D012970	Sodium Glutamate results in increased expression of TSPAN1 mRNA	PMID:20928830
1303308	Tspan1	tetraspanin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553747	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TSPAN1 mRNA	PMID:22206623
1303308	Tspan1	tetraspanin 1	gene	CHEBI:756028	mivebresib	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of TSPAN1 mRNA	PMID:35486664
1303308	Tspan1	tetraspanin 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TSPAN1 mRNA	PMID:30851411
1303308	Tspan1	tetraspanin 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of TSPAN1 mRNA	PMID:23640034
1303308	Tspan1	tetraspanin 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TSPAN1 mRNA	PMID:24780913
1303308	Tspan1	tetraspanin 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1354320	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TSPAN1 mRNA	PMID:38568856
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1553762	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GTF2H4 mRNA	PMID:33045310
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1553762	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GTF2H4 mRNA	PMID:20188158
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1352501	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GTF2H4 mRNA	PMID:33167477
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1352501	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of GTF2H4 mRNA	PMID:22378314
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1352501	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of GTF2H4 mRNA	PMID:21632981
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553762	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GTF2H4 mRNA	PMID:39241906
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1553762	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of GTF2H4 mRNA	PMID:23892564
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1352501	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GTF2H4 mRNA	PMID:19549813
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553762	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF2H4 mRNA	PMID:22206623
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352501	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GTF2H4 mRNA	PMID:39836092
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1352501	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of GTF2H4 mRNA	PMID:12002526
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1553762	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of GTF2H4 mRNA	PMID:30912803
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553762	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GTF2H4 mRNA	PMID:21570461
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GTF2H4 mRNA	PMID:32109520
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GTF2H4 mRNA	PMID:33387578
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1352501	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of GTF2H4 mRNA	PMID:32763439
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1553762	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GTF2H4 mRNA	PMID:15467011
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1553762	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of GTF2H4 mRNA	PMID:16014739
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352501	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GTF2H4 mRNA	PMID:39836092
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1352501	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GTF2H4 promoter	PMID:27901495
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352501	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GTF2H4 3' UTR	PMID:27901495
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1553762	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GTF2H4 mRNA	PMID:15467011
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1352501	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GTF2H4 mRNA	PMID:19150397
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1352501	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of GTF2H4 mRNA	PMID:20018196
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1352501	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of GTF2H4 gene	PMID:31601247
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1352501	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GTF2H4 gene	PMID:31601247
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GTF2H4 mRNA	PMID:34492290
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1553762	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of GTF2H4 mRNA	PMID:18648102
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553762	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of GTF2H4 mRNA	PMID:18445702
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1553762	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of GTF2H4 promoter	PMID:27334623
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GTF2H4 mRNA	PMID:34947998
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1352501	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of GTF2H4 protein	PMID:31675489
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553762	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of GTF2H4 mRNA	PMID:35598803
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GTF2H4 mRNA	PMID:25181051|PMID:30816183
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1352501	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GTF2H4 protein	PMID:33376534
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553762	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of GTF2H4 mRNA	PMID:38074096
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1352501	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GTF2H4 gene; [ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in increased expression of GTF2H4 protein]; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GTF2H4 mRNA	PMID:28628672|PMID:31601247|PMID:33376534
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1352501	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of GTF2H4 protein	PMID:31675489
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1352501	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of GTF2H4 mRNA	PMID:24752500
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553762	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GTF2H4 mRNA	PMID:37019170
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1352501	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GTF2H4 mRNA	PMID:28628672
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1553762	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of GTF2H4 mRNA	PMID:34813904
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of GTF2H4 promoter	PMID:22457795
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1352501	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GTF2H4 protein	PMID:38185225
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:36704	imiquimod	decreases expression	ISO	RGD:1553762	E	RGD:6480464	20120412	CTD	MESH:C056493	imiquimod results in decreased expression of GTF2H4 mRNA	PMID:21878529
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1352501	E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of GTF2H4 mRNA	PMID:19031421
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1352501	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of GTF2H4 mRNA	PMID:19167446
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1352501	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GTF2H4 mRNA	PMID:20106945|PMID:25562108
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1352501	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GTF2H4 mRNA	PMID:28628672
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GTF2H4 mRNA	PMID:33387578
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352501	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GTF2H4 mRNA	PMID:39836092
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1352501	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of GTF2H4 mRNA	PMID:24752500
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1352501	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of GTF2H4 mRNA	PMID:31675489
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:4775	ellagic acid	increases expression	ISO	RGD:1352501	E	RGD:6480464	20120412	CTD	MESH:D004610	Ellagic Acid results in increased expression of GTF2H4 mRNA	PMID:12002526
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553762	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GTF2H4 mRNA	PMID:35436446
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1352501	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GTF2H4 mRNA	PMID:28628672
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1352501	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GTF2H4 protein	PMID:32959892
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1352501	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of GTF2H4 mRNA	PMID:31758290
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553762	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF2H4 mRNA	PMID:22206623
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1352501	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of GTF2H4 mRNA	PMID:36318118
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1352501	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of GTF2H4 mRNA	PMID:36318118
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352501	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GTF2H4 gene]	PMID:28238834
1303309	Gtf2h4	general transcription factor 2H subunit 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of GTF2H4 mRNA	PMID:32109520
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1551821	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of NFKBIL1 mRNA	PMID:37995155
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1551821	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NFKBIL1 mRNA	PMID:20188158
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1351897	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NFKBIL1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NFKBIL1 mRNA	PMID:32699268
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551821	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NFKBIL1 mRNA	PMID:39241906
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NFKBIL1 mRNA	PMID:33387578
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of NFKBIL1 gene	PMID:27618143
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1551821	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of NFKBIL1 mRNA	PMID:21549006
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1351897	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of NFKBIL1 protein	PMID:37730182
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NFKBIL1 mRNA	PMID:33387578
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:17846	(S)-naringenin	increases expression	ISO	RGD:1351897	E	RGD:6480464	20171010	CTD	MESH:C005273	naringenin results in increased expression of NFKBIL1 mRNA; naringenin results in increased expression of NFKBIL1 protein	PMID:27838343
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of NFKBIL1 mRNA	PMID:21396975
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1351897	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NFKBIL1 mRNA	PMID:23649840
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1351897	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NFKBIL1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NFKBIL1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of NFKBIL1 mRNA	PMID:32699268
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1351897	E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NFKBIL1 mRNA	PMID:16979875
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551821	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NFKBIL1 mRNA	PMID:40504410
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1351897	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of NFKBIL1 protein	PMID:35688186
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1351897	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of NFKBIL1 mRNA	PMID:27594783
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551821	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NFKBIL1 mRNA	PMID:21570461
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NFKBIL1 mRNA	PMID:33387578
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551821	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NFKBIL1 mRNA	PMID:17942748
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1351897	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NFKBIL1 mRNA	PMID:33212167
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351897	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NFKBIL1 mRNA	PMID:38568856
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551821	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NFKBIL1 mRNA	PMID:40504410
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551821	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NFKBIL1 mRNA	PMID:27195522
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1351897	E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NFKBIL1 mRNA	PMID:16979875
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of NFKBIL1 mRNA	PMID:16483693
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of NFKBIL1 mRNA	PMID:30047161
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551821	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NFKBIL1 gene	PMID:35295148
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NFKBIL1 mRNA	PMID:25181051
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551821	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of NFKBIL1 mRNA	PMID:39298647
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1551821	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of NFKBIL1 exon	PMID:33297965
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1551821	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of NFKBIL1 mRNA	PMID:35093514
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351897	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NFKBIL1 mRNA	PMID:37042841
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NFKBIL1 mRNA	PMID:33453195
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of NFKBIL1 promoter	PMID:22457795
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1351897	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NFKBIL1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NFKBIL1 mRNA	PMID:32699268
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1351897	E	RGD:6480464	20120412	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NFKBIL1 mRNA	PMID:16979875
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1351897	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NFKBIL1 mRNA	PMID:31533062
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551821	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NFKBIL1 mRNA	PMID:36331819
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351897	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NFKBIL1 mRNA	PMID:25979313
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of NFKBIL1 mRNA	PMID:30047161
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1351897	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of NFKBIL1 mRNA	PMID:25562108
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551821	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NFKBIL1 mRNA	PMID:17562736
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NFKBIL1 mRNA	PMID:33387578
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1351897	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NFKBIL1 mRNA	PMID:22230336
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551821	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NFKBIL1 mRNA	PMID:40504410
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NFKBIL1 mRNA	PMID:29391264
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551821	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NFKBIL1 mRNA	PMID:17942748
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of NFKBIL1 mRNA	PMID:30047161
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:6682	mangiferin	decreases expression	ISO	RGD:1551821	E	RGD:6480464	20120412	CTD	MESH:C013592	mangiferin results in decreased expression of NFKBIL1 mRNA	PMID:15135318
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551821	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NFKBIL1 mRNA	PMID:22206623
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1351897	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of NFKBIL1 mRNA	PMID:36318118
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NFKBIL1 mRNA	PMID:30047161
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1551821	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of NFKBIL1 mRNA	PMID:40826991
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in increased expression of NFKBIL1 mRNA	PMID:26141394
1303310	Nfkbil1	NFKB inhibitor like 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1351897	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NFKBIL1 mRNA	PMID:38568856
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602198	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRRC46 mRNA	PMID:37042841
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LRRC46 mRNA	PMID:26577399
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553771	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LRRC46 mRNA	PMID:36331819
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1602198	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of LRRC46 mRNA	PMID:23649840
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of LRRC46 mRNA	PMID:41580963
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553771	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LRRC46 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LRRC46 mRNA	PMID:34911549
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LRRC46 mRNA	PMID:31150632
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1602198	E	RGD:6480464	20260505	CTD	MESH:C010974	Glyphosate results in decreased expression of LRRC46 mRNA	PMID:40294809
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRRC46 mRNA	PMID:22298810
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRRC46 mRNA	PMID:33387578
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:28854	2,4-D	decreases expression	ISO	RGD:1602198	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of LRRC46 mRNA	PMID:40294809
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1553771	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of LRRC46 mRNA	PMID:36209798|PMID:37682722
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1553771	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased methylation of LRRC46 gene	PMID:39894169
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of LRRC46 mRNA	PMID:24395379
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1553771	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of LRRC46 mRNA	PMID:23557971
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553771	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRRC46 promoter alternative form	PMID:35295148
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRC46 mRNA	PMID:25181051|PMID:29097150
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of LRRC46 mRNA	PMID:34947998
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553771	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LRRC46 mRNA	PMID:30951980
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553771	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LRRC46 mRNA	PMID:30951980
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602198	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRRC46 mRNA	PMID:37042841
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of LRRC46 mRNA	PMID:25539665
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:37187	lead nitrate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate results in decreased expression of LRRC46 mRNA	PMID:21628963
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553771	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LRRC46 mRNA	PMID:36331819
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602198	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LRRC46 gene	PMID:29154799
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of LRRC46 mRNA	PMID:29097150
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553771	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of LRRC46 mRNA	PMID:25554681
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1553771	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of LRRC46 mRNA	PMID:22078008
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553771	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LRRC46 mRNA	PMID:22206623
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602198	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LRRC46 gene]	PMID:28238834
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of LRRC46 mRNA	PMID:24780913
1303311	Lrrc46	leucine rich repeat containing 46	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LRRC46 mRNA	PMID:25825206
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1557710	E	RGD:6480464	20141223	CTD	MESH:D015025	Zearalenone results in increased expression of ETFB protein	PMID:25058043
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ETFB mRNA]	PMID:31150632
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1347524	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ETFB mRNA	PMID:22378314|PMID:40865780
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of ETFB mRNA	PMID:16823088
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1347524	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ETFB mRNA	PMID:21632981
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20191008	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ETFB mRNA	PMID:31059760
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557710	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ETFB mRNA	PMID:39241906
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ETFB mRNA	PMID:31059760
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of ETFB mRNA	PMID:15223131
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ETFB mRNA	PMID:39298647
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:D004958	ESR1 protein affects the reaction [Estradiol results in decreased expression of ETFB mRNA]	PMID:15223131
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ETFB gene	PMID:27618143
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:17323	trans-pinosylvin	increases expression	ISO	RGD:1347524	E	RGD:6480464	20140805	CTD	MESH:C049032	pinosylvin results in increased expression of ETFB mRNA	PMID:23333577
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of ETFB mRNA	PMID:17997037
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:17712	9H-xanthine	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D019820	[Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of ETFB protein	PMID:19464573
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557710	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ETFB mRNA	PMID:33754040|PMID:35716406
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ETFB mRNA	PMID:28818685
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of ETFB mRNA	PMID:17997037
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ETFB mRNA	PMID:35301059
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557710	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ETFB mRNA	PMID:37236586
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ETFB mRNA	PMID:19549813
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:24858	iodide salt	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D007454	Iodides deficiency results in decreased expression of ETFB protein	PMID:26795019
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ETFB protein	PMID:20106945
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of ETFB mRNA	PMID:16823088
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of ETFB mRNA	PMID:19483382
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ETFB protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ETFB protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of ETFB protein	PMID:38598786
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:D014747	ETFB protein affects the susceptibility to Vinblastine	PMID:16217747
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ETFB mRNA	PMID:31150632
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ETFB mRNA]	PMID:31150632
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1557710	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ETFB mRNA	PMID:25629700
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1347524	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ETFB gene	PMID:25304211
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ETFB mRNA	PMID:32525701
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1557710	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ETFB mRNA	PMID:40504410
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ETFB protein	PMID:38460933
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1347524	E	RGD:6480464	20260804	CTD	MESH:C010974	Glyphosate results in increased expression of ETFB mRNA	PMID:40865780
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ETFB mRNA	PMID:31881176
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1557710	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of ETFB mRNA; resveratrol results in increased expression of ETFB protein	PMID:22610192|PMID:25505154
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1347524	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ETFB mRNA	PMID:27594783
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1557710	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ETFB mRNA	PMID:30912803
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557710	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ETFB mRNA	PMID:21570461
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ETFB mRNA	PMID:21215274|PMID:32109520|PMID:34747641
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1347524	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ETFB mRNA	PMID:11489354|PMID:20106945|PMID:21632981|PMID:26238291
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ETFB protein	PMID:39603559
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of ETFB protein	PMID:35544339
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1347524	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ETFB mRNA	PMID:33212167
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1347524	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of ETFB mRNA	PMID:39709020
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ETFB mRNA	PMID:30851411
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ETFB mRNA	PMID:20971185
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:D004317	ETFB protein affects the susceptibility to Doxorubicin	PMID:16217747
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ETFB mRNA	PMID:29803840
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:28918	(R)-adrenaline	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D004837	[Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of ETFB protein	PMID:19464573
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of ETFB protein	PMID:29459688
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347524	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ETFB mRNA	PMID:39719251
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1557710	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ETFB mRNA	PMID:40504410
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347524	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ETFB exon; Benzo(a)pyrene affects the methylation of ETFB promoter	PMID:27901495
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ETFB mRNA	PMID:32234424
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1347524	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ETFB mRNA; Benzo(a)pyrene results in increased expression of ETFB protein	PMID:18495319|PMID:22316170|PMID:30453624
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ETFB mRNA]	PMID:32406909
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ETFB mRNA	PMID:20971185
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:30145	lithium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of ETFB protein	PMID:18296634
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:30146	lithium hydride	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of ETFB protein	PMID:18296634
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of ETFB mRNA	PMID:19483382
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1347524	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ETFB mRNA	PMID:19150397
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1347524	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ETFB protein	PMID:25419056
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in decreased expression of ETFB mRNA	PMID:17997037
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of ETFB mRNA	PMID:22641619
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1557710	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of ETFB mRNA	PMID:20542052
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557710	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ETFB enhancer; titanium dioxide results in decreased methylation of ETFB gene	PMID:35295148
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of ETFB mRNA	PMID:19483382
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ETFB mRNA	PMID:34492290
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ETFB mRNA	PMID:19483382
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557710	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ETFB mRNA	PMID:17426115|PMID:18301758
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1557710	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ETFB mRNA	PMID:19710929
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1347524	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ETFB mRNA	PMID:30903817
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ETFB mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of ETFB mRNA; bisphenol A results in decreased expression of ETFB protein	PMID:15223131|PMID:31675489|PMID:34186270
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of ETFB protein	PMID:24909818
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ETFB mRNA	PMID:25181051
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1347524	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ETFB protein	PMID:37567409
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1557710	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ETFB mRNA	PMID:33221593
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:C006780	ESR1 protein affects the reaction [bisphenol A results in decreased expression of ETFB mRNA]	PMID:15223131
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ETFB protein	PMID:31675489
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1347524	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ETFB mRNA	PMID:25979313
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ETFB mRNA	PMID:26682919
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ETFB mRNA	PMID:40203079
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1347524	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ETFB protein	PMID:34186270
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557710	E	RGD:6480464	20200519	CTD	MESH:C543008	bisphenol S results in increased expression of ETFB mRNA	PMID:31881267|PMID:39298647
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ETFB mRNA	PMID:38685157
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1347524	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ETFB protein	PMID:34186270
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1347524	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ETFB protein	PMID:34186270
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1557710	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of ETFB mRNA	PMID:31558096
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ETFB mRNA	PMID:17361019|PMID:21266533
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ETFB protein	PMID:38598786
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347524	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ETFB mRNA	PMID:37042841
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ETFB mRNA	PMID:35163327
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1347524	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ETFB mRNA	PMID:26472689
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ETFB mRNA	PMID:35301059
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557710	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ETFB mRNA	PMID:37236586
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1347524	E	RGD:6480464	20240109	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ETFB mRNA	PMID:37738295
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ETFB mRNA	PMID:35163327
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ETFB mRNA	PMID:24386269
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ETFB mRNA	PMID:19376846
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:36011	pinosylvin	increases expression	ISO	RGD:1347524	E	RGD:6480464	20140311	CTD	MESH:C049032	pinosylvin results in increased expression of ETFB mRNA	PMID:23333577
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of ETFB mRNA	PMID:19483382
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1557710	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ETFB mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ETFB mRNA]	PMID:17585979
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1557710	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ETFB mRNA	PMID:40194260
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ETFB mRNA	PMID:31533062
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1557710	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of ETFB mRNA	PMID:31558096
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:39501	2,2,2-tetramine	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D014266	Trientine inhibits the reaction [Streptozocin results in decreased expression of ETFB protein]	PMID:19634143
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347524	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ETFB mRNA	PMID:25979313
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20140408	CTD	MESH:D016572	Cyclosporine results in decreased expression of ETFB mRNA	PMID:20106945|PMID:23830897
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20140408	CTD	MESH:D016572	Cyclosporine results in decreased expression of ETFB mRNA	PMID:23830897
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1347524	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of ETFB mRNA	PMID:33512557
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1557710	E	RGD:6480464	20210504	CTD	MESH:D003907	Dexamethasone results in increased expression of ETFB protein	PMID:33567340
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011692	Puromycin Aminonucleoside results in decreased expression of ETFB protein	PMID:19264907
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ETFB mRNA	PMID:38832940
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557710	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ETFB mRNA	PMID:17562736
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of ETFB mRNA	PMID:22230336|PMID:25704631|PMID:29067470|PMID:31059760
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ETFB mRNA	PMID:31059760
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1557710	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ETFB mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ETFB mRNA]	PMID:17585979
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:D005472	ETFB protein affects the susceptibility to Fluorouracil	PMID:15548681
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ETFB protein	PMID:38460933
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1347524	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ETFB gene	PMID:25304211
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ETFB mRNA	PMID:32525701
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1557710	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ETFB mRNA	PMID:40504410
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of ETFB mRNA	PMID:31675489
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1557710	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of ETFB mRNA	PMID:30529165
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:48517	7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D019820	[Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of ETFB protein	PMID:19464573
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ETFB mRNA	PMID:18175754
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of ETFB mRNA	PMID:19483382
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1347524	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ETFB protein	PMID:25419056
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of ETFB mRNA	PMID:23962444
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ETFB protein	PMID:32959892
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ETFB mRNA	PMID:15336504
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:64090	tert-butyl hydroperoxide	increases methylation	ISO	RGD:1347524	E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased methylation of ETFB gene	PMID:29432895
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1557710	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ETFB protein	PMID:26558463
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of ETFB protein	PMID:30467583
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ETFB mRNA	PMID:31758290
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1347524	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ETFB protein	PMID:34186270
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1347524	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of ETFB protein	PMID:18495319
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:75408	sulindac sulfide	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in decreased expression of ETFB mRNA	PMID:16184548
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:75701	sarin	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of ETFB mRNA	PMID:19522546
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:75701	sarin	increases expression	ISO	RGD:1347524	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of ETFB mRNA	PMID:19522546
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:76326	N-nitrosomorpholine	affects expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine affects the expression of ETFB protein	PMID:19716841
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of ETFB protein	PMID:39638853
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of ETFB mRNA	PMID:19483382
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of ETFB mRNA	PMID:19483382
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ETFB mRNA	PMID:30851411
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ETFB gene]	PMID:28238834
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1557710	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ETFB mRNA	PMID:38648751
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ETFB protein	PMID:31675489
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1557710	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of ETFB mRNA	PMID:31558096
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1347524	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ETFB protein	PMID:31675489
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1557710	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of ETFB mRNA	PMID:27029645
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ETFB mRNA	PMID:32525701
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of ETFB mRNA	PMID:19483382
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1557710	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ETFB mRNA	PMID:40826991
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:9288	streptozocin	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D013311	Streptozocin results in decreased expression of ETFB protein	PMID:19634143
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D013311	Trientine inhibits the reaction [Streptozocin results in decreased expression of ETFB protein]	PMID:19634143
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1347524	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ETFB mRNA	PMID:38568856
1303312	Etfb	electron transfer flavoprotein subunit beta	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1347524	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ETFB protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of ETFB protein	PMID:38598786
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1615128	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of UFC1 mRNA	PMID:39241906
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1615128	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of UFC1 mRNA	PMID:39298647
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1615128	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UFC1 mRNA	PMID:37236586
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1604819	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of UFC1 protein	PMID:23301498
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604819	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of UFC1 gene	PMID:27153756
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1615128	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of UFC1 mRNA	PMID:25629700
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1615128	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UFC1 mRNA	PMID:40504410
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1604819	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of UFC1 mRNA	PMID:27594783
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1615128	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of UFC1 mRNA	PMID:30912803
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615128	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UFC1 mRNA	PMID:21570461
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UFC1 mRNA	PMID:34747641
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1604819	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UFC1 mRNA	PMID:30851411
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of UFC1 mRNA	PMID:28959563
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1604819	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of UFC1 mRNA	PMID:29803840
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1615128	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UFC1 mRNA	PMID:40504410
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604819	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UFC1 promoter	PMID:27901495
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1604819	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to UFC1 mRNA]	PMID:32406909
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1615128	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of UFC1 mRNA	PMID:39716349
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of UFC1 mRNA	PMID:24136188
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615128	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UFC1 gene	PMID:35295148
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604819	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of UFC1 mRNA	PMID:29275510
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UFC1 mRNA	PMID:25181051
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1615128	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of UFC1 mRNA	PMID:33221593
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of UFC1 mRNA	PMID:36041667
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1604819	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of UFC1 protein	PMID:34186270
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1615128	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UFC1 mRNA	PMID:39298647|PMID:40203079
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of UFC1 mRNA	PMID:36041667
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of UFC1 mRNA	PMID:36041667
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604819	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UFC1 mRNA	PMID:37042841
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1615128	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UFC1 mRNA	PMID:37236586
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1604819	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of UFC1 mRNA	PMID:28302478
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1604819	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of UFC1 mRNA	PMID:31533062
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604819	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UFC1 mRNA	PMID:25979313
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1615128	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of UFC1 mRNA	PMID:17292431
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604819	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of UFC1 mRNA	PMID:19101580|PMID:23179753|PMID:25192806|PMID:27188386|PMID:28001369|PMID:29154799
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1604819	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of UFC1 gene	PMID:29154799
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1604819	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of UFC1 protein	PMID:17593366
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604819	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of UFC1 mRNA	PMID:29067470
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1604819	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of UFC1 mRNA	PMID:29523930
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1615128	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UFC1 mRNA	PMID:40504410
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1615128	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of UFC1 mRNA	PMID:35436446
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1615128	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of UFC1 mRNA	PMID:39716349
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1615128	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of UFC1 mRNA	PMID:40234311
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1615128	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of UFC1 mRNA	PMID:35964746
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604819	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UFC1 protein	PMID:32959892
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1604819	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of UFC1 protein	PMID:34186270
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1615128	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UFC1 mRNA	PMID:22206623
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1604819	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of UFC1 mRNA	PMID:22714537
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1604819	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UFC1 mRNA	PMID:30851411
1303313	Ufc1	ubiquitin-fold modifier conjugating enzyme 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1604819	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of UFC1 mRNA	PMID:19159669
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20211109	CTD	MESH:C007262	deoxynivalenol results in decreased expression of UQCRC1 protein	PMID:33890134
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20120501	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of UQCRC1 mRNA	PMID:17526437|PMID:18313992
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:141564	tert-butyl ethyl ether	increases expression	EXP		E	RGD:6480464	20180904	CTD	MESH:C098546	ethyl tert-butyl ether results in increased expression of UQCRC1 protein	PMID:24090815
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of UQCRC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of UQCRC1 mRNA	PMID:32699268
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D001280	Atrazine results in decreased expression of UQCRC1 mRNA	PMID:27114639
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20160705	CTD	MESH:D001280	Atrazine results in decreased expression of UQCRC1 mRNA	PMID:22378314|PMID:27114639
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551847	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of UQCRC1 mRNA	PMID:39241906
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of UQCRC1 protein	PMID:21673325
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1342599	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of UQCRC1 mRNA	PMID:37042841
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of UQCRC1 protein	PMID:32044396
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of UQCRC1 mRNA	PMID:20196124
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:177387	brequinar	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in decreased expression of UQCRC1 mRNA	PMID:39900124
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551847	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UQCRC1 mRNA	PMID:33754040
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1342599	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of UQCRC1 protein	PMID:37730182
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:17833	gentamycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein	PMID:30545405
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UQCRC1 mRNA	PMID:36331819
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UQCRC1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of UQCRC1 mRNA	PMID:39836092
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:189471	pseudolaric acid B	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20240109	CTD	MESH:C058391	pseudolaric acid B results in decreased expression of UQCRC1 mRNA	PMID:37244295
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1551847	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of UQCRC1 mRNA	PMID:27462272
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UQCRC1 mRNA	PMID:35301059
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20220308	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of UQCRC1 mRNA	PMID:33038468
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1342599	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of UQCRC1 gene	PMID:27153756
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of UQCRC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of UQCRC1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of UQCRC1 mRNA	PMID:32699268
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UQCRC1 protein	PMID:38598786
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UQCRC1 mRNA	PMID:22206623
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1342599	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of UQCRC1 protein	PMID:21514422
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UQCRC1 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of UQCRC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UQCRC1 mRNA	PMID:35809665|PMID:39836092
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UQCRC1 mRNA	PMID:40504410
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1342599	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of UQCRC1 mRNA	PMID:19244175
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1342599	E	RGD:6480464	20150414	CTD	MESH:C059514	resveratrol results in increased expression of UQCRC1 protein	PMID:24365713
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1551847	E	RGD:6480464	20141111	CTD	MESH:C059514	Resveratrol results in increased expression of UQCRC1 mRNA; Resveratrol results in increased expression of UQCRC1 protein	PMID:24041027|PMID:34216621
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20141111	CTD	MESH:C059514	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased expression of UQCRC1 protein]; HMOX1 mutant form inhibits the reaction [resveratrol results in increased expression of UQCRC1 protein]; lipopolysaccharide, E coli O55-B5 promotes the reaction [resveratrol results in increased expression of UQCRC1 protein]; resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of UQCRC1 protein]; tin protoporphyrin IX inhibits the reaction [lipopolysaccharide, E coli O55-B5 promotes the reaction [resveratrol results in increased expression of UQCRC1 protein]]; tin protoporphyrin IX inhibits the reaction [resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of UQCRC1 protein]]; tin protoporphyrin IX inhibits the reaction [resveratrol results in increased expression of UQCRC1 protein]	PMID:24041027
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20141111	CTD	MESH:C059514	Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of UQCRC1 protein]; SIRT1 protein affects the reaction [Resveratrol results in increased expression of UQCRC1 mRNA]; STK11 protein affects the reaction [Resveratrol results in increased expression of UQCRC1 mRNA]; tin protoporphyrin IX inhibits the reaction [Resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of UQCRC1 protein]]; tin protoporphyrin IX inhibits the reaction [Resveratrol results in increased expression of UQCRC1 protein]	PMID:24041027|PMID:34216621
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of UQCRC1 mRNA	PMID:19921347
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20150414	CTD	MESH:D002945	Cisplatin results in decreased expression of UQCRC1 protein	PMID:25450742
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of UQCRC1 protein	PMID:22023808
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28001	vancomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein	PMID:30545405
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551847	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UQCRC1 mRNA	PMID:21570461
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UQCRC1 mRNA	PMID:34747641
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UQCRC1 mRNA	PMID:33387578
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551847	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UQCRC1 mRNA	PMID:20399798
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UQCRC1 mRNA	PMID:17942748
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of UQCRC1 mRNA	PMID:23186747
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1342599	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of UQCRC1 mRNA	PMID:18191903
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of UQCRC1 mRNA	PMID:32763439
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28685	molybdenum atom	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20220308	CTD	MESH:D008982	[molybdenum trioxide results in increased abundance of Molybdenum] which results in decreased expression of UQCRC1 mRNA	PMID:33038468
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1551847	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper analog results in increased expression of UQCRC1 protein	PMID:23882024
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D004317	Doxorubicin results in decreased expression of UQCRC1 mRNA	PMID:28865727
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of UQCRC1 mRNA	PMID:26873546
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1342599	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of UQCRC1 mRNA	PMID:29803840
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1551847	E	RGD:6480464	20151013	CTD	MESH:D004317	Doxorubicin results in increased expression of UQCRC1 protein	PMID:21251210
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28748	doxorubicin	increases ubiquitination	ISO	RGD:1551847	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased ubiquitination of UQCRC1 protein	PMID:40035845
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20151013	CTD	MESH:D004317	sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of UQCRC1 protein]	PMID:21251210
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:28971	ampicillin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein	PMID:30545405
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of UQCRC1 mRNA; sodium arsenite results in decreased expression of UQCRC1 protein	PMID:15725613|PMID:38568856
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of UQCRC1 mRNA	PMID:38685555
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in increased expression of UQCRC1 protein	PMID:38266420
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UQCRC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UQCRC1 mRNA; sodium arsenite results in decreased expression of and affects the splicing of UQCRC1 mRNA	PMID:25879800|PMID:39836092
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UQCRC1 mRNA	PMID:40504410
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of UQCRC1 mRNA	PMID:22378314|PMID:39900124
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1342599	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UQCRC1 3' UTR; Benzo(a)pyrene results in decreased methylation of UQCRC1 promoter	PMID:27901495
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to UQCRC1 mRNA]	PMID:32406909
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1551847	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper analog results in increased expression of UQCRC1 protein	PMID:23882024
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:30627	molybdenum trioxide	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20220308	CTD	MESH:C082290	[molybdenum trioxide results in increased abundance of Molybdenum] which results in decreased expression of UQCRC1 mRNA	PMID:33038468
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:3139	bleomycin A2	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001761	Bleomycin results in decreased expression of UQCRC1 protein	PMID:25933445
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1551847	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of UQCRC1 protein	PMID:20797405
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551847	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UQCRC1 gene	PMID:35295148
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551847	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of UQCRC1 gene	PMID:35295148
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of UQCRC1 mRNA	PMID:33296240
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in decreased expression of UQCRC1 mRNA; bisphenol A results in decreased expression of UQCRC1 protein	PMID:30099677|PMID:34186270
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of UQCRC1 protein	PMID:24909818
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UQCRC1 mRNA	PMID:25181051
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1342599	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of UQCRC1 protein	PMID:37567409
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551847	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of UQCRC1 mRNA	PMID:32156529|PMID:33221593
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of UQCRC1 mRNA	PMID:36041667
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1342599	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of UQCRC1 mRNA	PMID:19244175
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of UQCRC1 mRNA	PMID:30316929
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551847	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UQCRC1 mRNA	PMID:39298647
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of UQCRC1 mRNA	PMID:36041667
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1342599	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of UQCRC1 protein	PMID:34186270
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of UQCRC1 mRNA	PMID:36041667
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1342599	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of UQCRC1 protein	PMID:34186270
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UQCRC1 protein	PMID:38598786
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20151013	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of UQCRC1 protein; Levodopa inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of UQCRC1 protein]; tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of UQCRC1 protein]	PMID:23562983
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of UQCRC1 mRNA	PMID:28659758
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1342599	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UQCRC1 mRNA	PMID:37042841
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UQCRC1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of UQCRC1 mRNA	PMID:39836092
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UQCRC1 mRNA	PMID:35301059
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20220308	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of UQCRC1 mRNA	PMID:33038468
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of UQCRC1 gene	PMID:22079235
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of UQCRC1 mRNA	PMID:19376846
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of UQCRC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of UQCRC1 mRNA	PMID:32699268
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1342599	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of UQCRC1 mRNA	PMID:19244175
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of UQCRC1 mRNA	PMID:17585979
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:3750	clofibrate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate results in increased expression of UQCRC1 protein	PMID:16470657
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of UQCRC1 mRNA	PMID:31533062
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UQCRC1 mRNA	PMID:36331819
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:39501	2,2,2-tetramine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D014266	Trientine inhibits the reaction [Streptozocin results in increased expression of UQCRC1 protein]	PMID:19634143|PMID:21136691
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1342599	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UQCRC1 mRNA	PMID:25979313
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1342599	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of UQCRC1 gene	PMID:29154799
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of UQCRC1 mRNA	PMID:20106945
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1551847	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of UQCRC1 mRNA	PMID:17555576
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1551847	E	RGD:6480464	20120717	CTD	MESH:D000082	Acetaminophen results in increased expression of UQCRC1 protein	PMID:21329376
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid results in decreased expression of UQCRC1 protein	PMID:28871336
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1342599	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of UQCRC1 protein	PMID:21514422
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UQCRC1 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of UQCRC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UQCRC1 mRNA	PMID:35809665|PMID:39836092
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UQCRC1 mRNA	PMID:40504410
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1551847	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide analog results in increased expression of UQCRC1 protein	PMID:23882024
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1551847	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of UQCRC1 mRNA	PMID:30529165
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20180515	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of UQCRC1 mRNA	PMID:29175576
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of UQCRC1 mRNA	PMID:35436446
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1342599	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of UQCRC1 mRNA	PMID:18175754
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1551847	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of UQCRC1 mRNA	PMID:17555576
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1551847	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UQCRC1 mRNA	PMID:17942748
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UQCRC1 mRNA	PMID:17942748
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1551847	E	RGD:6480464	20181016	CTD	MESH:C029892	cupric chloride results in increased expression of UQCRC1 protein	PMID:29617964
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551847	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UQCRC1 mRNA	PMID:25554681
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of UQCRC1 mRNA	PMID:23962444
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UQCRC1 mRNA	PMID:24136188
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20151013	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of UQCRC1 protein; Levodopa inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of UQCRC1 protein]; tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of UQCRC1 protein]	PMID:23562983
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of UQCRC1 mRNA	PMID:20436886
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UQCRC1 protein	PMID:32959892
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:63005	sodium nitrate	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20151013	CTD	MESH:C031618	sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of UQCRC1 protein]	PMID:21251210
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UQCRC1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of UQCRC1 mRNA	PMID:39836092
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of UQCRC1 mRNA	PMID:17526437|PMID:18313992
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:63952	arsenic trichloride	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of UQCRC1 mRNA	PMID:35809665
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:64108	8-bromo-3',5'-cyclic GMP	increases expression	ISO	RGD:1342599	E	RGD:6480464	20141111	CTD	MESH:C016276	8-bromocyclic GMP results in increased expression of UQCRC1 protein	PMID:24041027
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:64108	8-bromo-3',5'-cyclic GMP	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20141111	CTD	MESH:C016276	tin protoporphyrin IX inhibits the reaction [8-bromocyclic GMP results in increased expression of UQCRC1 protein]	PMID:24041027
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20141111	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin results in increased expression of UQCRC1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of UQCRC1 protein]	PMID:24041027
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:6909	metronidazole	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein	PMID:30545405
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D003671	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of UQCRC1 mRNA	PMID:28659758
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1342599	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of UQCRC1 protein	PMID:34186270
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UQCRC1 mRNA	PMID:22206623
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551847	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UQCRC1 mRNA	PMID:22206623
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of UQCRC1 mRNA	PMID:24136188
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:7507	neomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein	PMID:30545405
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of UQCRC1 protein	PMID:22144121
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:7602	nobiletin	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of UQCRC1 protein]	PMID:38348393
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of UQCRC1 protein	PMID:38348393
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1551847	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of UQCRC1 mRNA	PMID:30953684
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of UQCRC1 protein]	PMID:38348393
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:8489	propiconazole	increases metabolic processing	ISO	RGD:1551847	E	RGD:6480464	20130514	CTD	MESH:C045950	propiconazole results in increased metabolism of UQCRC1 protein	PMID:19714882
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:86204	chromium trinitrate	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20170228	CTD	MESH:C041167	chromium nitrate results in decreased expression of UQCRC1 protein	PMID:22144121
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of UQCRC1 mRNA	PMID:28659758
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:90633	perfluorododecanoic acid	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in increased expression of UQCRC1 protein	PMID:26168851
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:91215	1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one	multiple interactions	ISO	RGD:1342599	E	RGD:6480464	20170221	CTD	MESH:C095284	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased expression of UQCRC1 protein]	PMID:24041027
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D013311	Streptozocin results in increased expression of UQCRC1 protein	PMID:19634143|PMID:21136691
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013311	Trientine inhibits the reaction [Streptozocin results in increased expression of UQCRC1 protein]	PMID:19634143|PMID:21136691
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of UQCRC1 mRNA	PMID:38568856
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of UQCRC1 protein	PMID:35544339
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1342599	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of UQCRC1 mRNA	PMID:22378314
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1551847	E	RGD:6480464	20180828	CTD	MESH:C001899	triptolide results in decreased expression of UQCRC1 mRNA	PMID:29723566
1303314	Uqcrc1	ubiquinol-cytochrome c reductase core protein 1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1551847	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of UQCRC1 protein	PMID:18495193
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1345323	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of CDC50A mRNA	PMID:35967413
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1345323	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CDC50A mRNA	PMID:26079696
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1551850	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CDC50A mRNA	PMID:30319688
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1345323	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CDC50A mRNA	PMID:20044591
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551850	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CDC50A mRNA	PMID:39298647
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1345323	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDC50A mRNA	PMID:37042841
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1345323	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CDC50A mRNA	PMID:23649840
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CDC50A mRNA	PMID:36331819
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:211238	Torularhodin	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20250506	CTD	MESH:C078923	torularhodin inhibits the reaction [Dietary Fats results in decreased expression of CDC50A protein]	PMID:36234935
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDC50A mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC50A mRNA	PMID:28111341|PMID:37236586
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1345323	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CDC50A mRNA	PMID:19549813
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1345323	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CDC50A mRNA	PMID:23649840
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1345323	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CDC50A protein	PMID:20106945
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1345323	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CDC50A mRNA	PMID:23649840
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CDC50A mRNA]	PMID:22206623
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CDC50A mRNA	PMID:40504410
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C030686	acetamide results in decreased expression of CDC50A mRNA	PMID:31881176
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1345323	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CDC50A mRNA	PMID:28903495
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1551850	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of CDC50A mRNA	PMID:34813904
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC50A mRNA	PMID:33387578
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551850	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC50A mRNA	PMID:18796159
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDC50A mRNA	PMID:34747641
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1345323	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDC50A mRNA	PMID:19574409|PMID:20106945|PMID:21632981
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551850	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDC50A mRNA	PMID:19465110
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDC50A mRNA	PMID:15467011
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CDC50A mRNA	PMID:40504410
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551850	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDC50A mRNA	PMID:22228805
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDC50A mRNA	PMID:15467011
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1345323	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CDC50A mRNA	PMID:20018196
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1551850	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CDC50A mRNA	PMID:29264374
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1551850	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CDC50A mRNA	PMID:18445702
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C006780	bisphenol A results in decreased expression of CDC50A mRNA	PMID:34947998
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1345323	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CDC50A mRNA	PMID:29275510
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C006780	bisphenol A results in increased expression of CDC50A mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20260505	CTD	MESH:C006780	bisphenol A results in increased methylation of CDC50A gene	PMID:28505145
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1345323	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CDC50A gene	PMID:31601247
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC50A mRNA	PMID:36041667
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1345323	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene results in increased expression of CDC50A mRNA	PMID:20348232
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1345323	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to CDC50A promoter]	PMID:20348232
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551850	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CDC50A mRNA	PMID:39298647|PMID:40203079
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1345323	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of CDC50A gene	PMID:31601247
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC50A mRNA	PMID:36041667
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1345323	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CDC50A protein	PMID:34186270
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC50A mRNA	PMID:36041667
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1345323	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CDC50A protein	PMID:34186270
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDC50A mRNA	PMID:17602206
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1551850	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CDC50A mRNA	PMID:21266533
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551850	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CDC50A mRNA	PMID:34813904
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1551850	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CDC50A mRNA	PMID:34813904
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDC50A mRNA	PMID:17602206
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CDC50A mRNA	PMID:33453195
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDC50A mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC50A mRNA	PMID:28111341|PMID:37236586
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:37825	p-toluidine	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C029370	4-toluidine results in decreased expression of CDC50A mRNA	PMID:27638505
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1345323	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of CDC50A mRNA	PMID:19167446
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CDC50A mRNA	PMID:36331819
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1345323	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDC50A mRNA	PMID:25979313
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1345323	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CDC50A mRNA	PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1345323	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC50A mRNA	PMID:27188386
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1345323	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CDC50A mRNA	PMID:25562108
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1345323	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of CDC50A mRNA	PMID:36621641
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1345323	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of CDC50A mRNA	PMID:23649840
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1345323	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CDC50A mRNA	PMID:28542535
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1345323	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CDC50A mRNA	PMID:22230336
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1345323	E	RGD:6480464	20161213	CTD	MESH:C088658	Zoledronic Acid results in increased expression of CDC50A mRNA	PMID:20977926
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CDC50A mRNA	PMID:40504410
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551850	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CDC50A mRNA; Nanotubes, Carbon results in increased expression of CDC50A mRNA	PMID:25554681
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1345323	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CDC50A protein	PMID:32959892
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1551850	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CDC50A mRNA	PMID:23650126
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D008701	Methapyrilene results in decreased expression of CDC50A mRNA	PMID:30467583
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1551850	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of CDC50A mRNA	PMID:22470460
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1551850	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of CDC50A mRNA	PMID:27462272
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551850	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CDC50A mRNA	PMID:22206623
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551850	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CDC50A mRNA]	PMID:22206623
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1345323	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC50A mRNA	PMID:27188386
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1345323	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of CDC50A mRNA	PMID:30928695
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551850	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CDC50A mRNA	PMID:23091169
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1345323	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC50A mRNA	PMID:27188386
1303315	Cdc50a	cell division cycle 50 P4-ATPase accessory subunit A	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C001899	triptolide results in increased expression of CDC50A protein	PMID:32519852
1303316	Krt81	keratin 81	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1352979	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KRT81 mRNA	PMID:38218311
1303316	Krt81	keratin 81	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D000431	Ethanol results in decreased expression of KRT81 mRNA	PMID:31078653
1303316	Krt81	keratin 81	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1352979	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of KRT81 mRNA	PMID:19619570|PMID:21185374
1303316	Krt81	keratin 81	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1352979	E	RGD:6480464	20120522	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KRT81 mRNA	PMID:19619570
1303316	Krt81	keratin 81	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KRT81 mRNA	PMID:33387578
1303316	Krt81	keratin 81	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of KRT81 mRNA	PMID:28937961
1303316	Krt81	keratin 81	gene	CHEBI:17558	quercitrin	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of KRT81 mRNA	PMID:25193878
1303316	Krt81	keratin 81	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1352979	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of KRT81 mRNA	PMID:28860664
1303316	Krt81	keratin 81	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1352979	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of KRT81 mRNA	PMID:25102026
1303316	Krt81	keratin 81	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of KRT81 mRNA	PMID:27392435
1303316	Krt81	keratin 81	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1352979	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of KRT81 mRNA	PMID:27392435
1303316	Krt81	keratin 81	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1352979	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KRT81 mRNA	PMID:19619570|PMID:21296121
1303316	Krt81	keratin 81	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1352979	E	RGD:6480464	20120522	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KRT81 mRNA	PMID:19619570
1303316	Krt81	keratin 81	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1352979	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of KRT81 mRNA	PMID:20971185
1303316	Krt81	keratin 81	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRT81 mRNA	PMID:38568856
1303316	Krt81	keratin 81	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1352979	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KRT81 3' UTR	PMID:27901495
1303316	Krt81	keratin 81	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1352979	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased expression of KRT81 mRNA	PMID:23974009
1303316	Krt81	keratin 81	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1352979	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of KRT81 mRNA	PMID:20971185
1303316	Krt81	keratin 81	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1352979	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of KRT81 mRNA	PMID:38479592
1303316	Krt81	keratin 81	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT81 mRNA	PMID:25181051
1303316	Krt81	keratin 81	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT81 mRNA	PMID:27685785
1303316	Krt81	keratin 81	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1352979	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KRT81 gene	PMID:31601247
1303316	Krt81	keratin 81	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KRT81 mRNA	PMID:35163327
1303316	Krt81	keratin 81	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT81 mRNA	PMID:35163327
1303316	Krt81	keratin 81	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KRT81 mRNA	PMID:38382870
1303316	Krt81	keratin 81	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT81 mRNA	PMID:35163327
1303316	Krt81	keratin 81	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of KRT81 mRNA	PMID:25539665
1303316	Krt81	keratin 81	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of KRT81 mRNA	PMID:29154799
1303316	Krt81	keratin 81	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1352979	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KRT81 mRNA	PMID:25562108
1303316	Krt81	keratin 81	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1352979	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KRT81 mRNA	PMID:38832940
1303316	Krt81	keratin 81	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of KRT81 mRNA	PMID:24714768
1303316	Krt81	keratin 81	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1352979	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of KRT81 mRNA	PMID:29523930
1303316	Krt81	keratin 81	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of KRT81 mRNA	PMID:24389112
1303316	Krt81	keratin 81	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551851	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of KRT81 mRNA; Nanotubes, Carbon results in increased expression of KRT81 mRNA	PMID:25554681
1303316	Krt81	keratin 81	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of KRT81 mRNA	PMID:28801915
1303316	Krt81	keratin 81	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1352979	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of KRT81 mRNA	PMID:31758290
1303316	Krt81	keratin 81	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KRT81 mRNA	PMID:24780913
1303316	Krt81	keratin 81	gene	CHEBI:94686	orlistat	increases expression	ISO	RGD:1352979	E	RGD:6480464	20170808	CTD	MESH:C055122	orlistat results in increased expression of KRT81 mRNA	PMID:18796435
1303316	Krt81	keratin 81	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of KRT81 mRNA	PMID:38568856
1303316	Krt81	keratin 81	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1352979	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of KRT81 mRNA	PMID:29301935
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1551853	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ATF6B mRNA	PMID:37995155
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551853	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ATF6B gene	PMID:20938992
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1551853	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ATF6B mRNA	PMID:30319688
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1346168	E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in increased expression of ATF6B protein	PMID:30152185
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551853	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATF6B mRNA	PMID:39241906
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551853	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ATF6B mRNA	PMID:39298647
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ATF6B gene	PMID:27618143
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551853	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ATF6B gene	PMID:20938992
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:17115	L-serine	increases expression	ISO	RGD:1346168	E	RGD:6480464	20210608	CTD	MESH:D012694	Serine results in increased expression of ATF6B mRNA	PMID:29098664
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1551853	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of ATF6B mRNA	PMID:17945193
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1551853	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ATF6B mRNA	PMID:15788153
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551853	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATF6B mRNA	PMID:33754040
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATF6B mRNA	PMID:33387578
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1346168	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of ATF6B mRNA	PMID:17103032
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1346168	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATF6B mRNA	PMID:35301059
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1551853	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of ATF6B mRNA	PMID:12763052
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1346168	E	RGD:6480464	20180220	CTD	MESH:D010126	Ozone results in increased expression of ATF6B mRNA	PMID:27206323
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1346168	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ATF6B mRNA	PMID:19774075
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551853	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATF6B mRNA	PMID:27339419|PMID:31919559
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:27470	folic acid	affects expression	ISO	RGD:1346168	E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the expression of ATF6B mRNA	PMID:17320366
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551853	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ATF6B gene	PMID:20938992
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346168	E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to ATF6B promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of and results in increased cleavage of ATF6B protein; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATF6B mRNA; NFE2L2 protein affects the reaction [[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6B mRNA]	PMID:35625704|PMID:39836092
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1346168	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ATF6B mRNA	PMID:27392435
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551853	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATF6B mRNA	PMID:21570461
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551853	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATF6B mRNA	PMID:24058054
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATF6B mRNA	PMID:33387578|PMID:34747641
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346168	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ATF6B mRNA	PMID:33212167
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1346168	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ATF6B mRNA	PMID:30851411
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1346168	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ATF6B mRNA	PMID:32763439
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346168	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ATF6B mRNA	PMID:39719251
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346168	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATF6B mRNA	PMID:39836092
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346168	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATF6B promoter	PMID:27901495
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551853	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATF6B mRNA	PMID:22228805
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1346168	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATF6B protein	PMID:25258189
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551853	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ATF6B gene	PMID:35295148
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1551853	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATF6B mRNA	PMID:19710929
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1346168	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of ATF6B gene	PMID:31601247
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1551853	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ATF6B promoter	PMID:27334623
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ATF6B mRNA	PMID:30816183|PMID:32528016|PMID:33296240|PMID:34947998
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1551853	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ATF6B gene	PMID:31683443
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551853	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ATF6B mRNA	PMID:39298647
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551853	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ATF6B mRNA	PMID:34813904
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346168	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATF6B mRNA	PMID:37042841
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ATF6B promoter	PMID:22457795
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1346168	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATF6B mRNA	PMID:38382870
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1346168	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATF6B mRNA	PMID:35301059
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1346168	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ATF6B mRNA	PMID:28302478
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551853	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ATF6B mRNA	PMID:36331819
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551853	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ATF6B mRNA	PMID:17963808
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1346168	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ATF6B gene	PMID:29154799
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of ATF6B protein]	PMID:34214594
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:42567	fisetin	increases expression	ISO	RGD:1346168	E	RGD:6480464	20180116	CTD	MESH:C017875	fisetin results in increased expression of ATF6B protein	PMID:28181380
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:42567	fisetin	multiple interactions	ISO	RGD:1346168	E	RGD:6480464	20180116	CTD	MESH:C017875	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6B protein]	PMID:28181380
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1551853	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in decreased expression of ATF6B mRNA	PMID:16467112
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1346168	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of ATF6B mRNA	PMID:16595896
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1346168	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of ATF6B mRNA	PMID:24449571
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346168	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATF6B mRNA	PMID:29067470
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346168	E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to ATF6B promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of and results in increased cleavage of ATF6B protein; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATF6B mRNA; NFE2L2 protein affects the reaction [[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6B mRNA]	PMID:35625704|PMID:39836092
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:472805	ouabain	increases expression	ISO	RGD:1346168	E	RGD:6480464	20200609	CTD	MESH:D010042	Ouabain results in increased expression of ATF6B protein	PMID:31436044
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ATF6B mRNA	PMID:29391264
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1346168	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATF6B protein	PMID:25258189
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551853	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ATF6B mRNA	PMID:35964746
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:60888	BAPTA	increases expression	ISO	RGD:1346168	E	RGD:6480464	20180116	CTD	MESH:C025603	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of ATF6B protein	PMID:28181380
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:60888	BAPTA	multiple interactions	ISO	RGD:1346168	E	RGD:6480464	20180116	CTD	MESH:C025603	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6B protein]	PMID:28181380
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:63952	arsenic trichloride	multiple interactions	ISO	RGD:1346168	E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to ATF6B promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of and results in increased cleavage of ATF6B protein; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6B mRNA; NFE2L2 protein affects the reaction [[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6B mRNA]	PMID:35625704
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D008694	Methamphetamine results in increased expression of ATF6B protein	PMID:34214594
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D008694	4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of ATF6B protein]	PMID:34214594
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551853	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ATF6B mRNA	PMID:22206623
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1346168	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ATF6B protein	PMID:31285264
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1346168	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ATF6B mRNA	PMID:30851411
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:78708	Nonidet P-40	increases expression	ISO	RGD:1346168	E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in increased expression of ATF6B mRNA	PMID:26552463
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1346168	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ATF6B mRNA	PMID:38568856
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1551853	E	RGD:6480464	20170613	CTD	MESH:C001899	triptolide results in decreased expression of ATF6B protein	PMID:26990902
1303317	Atf6b	activating transcription factor 6 beta	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ATF6B mRNA	PMID:23034163
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUSC3 gene	PMID:20938992
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1606831	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TUSC3 mRNA	PMID:21632981
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551857	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TUSC3 mRNA	PMID:39298647
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUSC3 gene	PMID:20938992
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551857	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TUSC3 mRNA	PMID:33754040
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1606831	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TUSC3 mRNA	PMID:28818685
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TUSC3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TUSC3 mRNA	PMID:37236586|PMID:40850461
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1606831	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TUSC3 mRNA	PMID:19549813
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of TUSC3 mRNA	PMID:21396975
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1551857	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TUSC3 mRNA	PMID:19770486
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1606831	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TUSC3 mRNA	PMID:21641981
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TUSC3 mRNA	PMID:23630614|PMID:25378103
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1606831	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of TUSC3 mRNA	PMID:19774075
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TUSC3 mRNA	PMID:30779732
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551857	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TUSC3 mRNA	PMID:27339419|PMID:31919559
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TUSC3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUSC3 gene	PMID:20938992|PMID:22206623
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1606831	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TUSC3 gene	PMID:25304211
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TUSC3 mRNA	PMID:40504410
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of TUSC3 gene	PMID:35440735
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TUSC3 mRNA	PMID:31881176
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1606831	E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of TUSC3 mRNA	PMID:37386098
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1551857	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of TUSC3 mRNA	PMID:30912803
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TUSC3 mRNA	PMID:21215274|PMID:34747641
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551857	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TUSC3 mRNA	PMID:17942748
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TUSC3 mRNA	PMID:17942748
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:28177	theophylline	increases expression	ISO	RGD:1606831	E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of TUSC3 mRNA	PMID:16083514
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606831	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TUSC3 mRNA	PMID:28001369
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606831	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TUSC3 mRNA	PMID:33212167
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1606831	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of TUSC3 mRNA	PMID:22623647
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1606831	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TUSC3 gene	PMID:28589171
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606831	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of TUSC3 mRNA	PMID:39719251
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606831	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TUSC3 mRNA	PMID:38568856
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TUSC3 mRNA	PMID:40504410
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606831	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TUSC3 promoter	PMID:27901495
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551857	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TUSC3 mRNA	PMID:19770486
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1606831	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TUSC3 mRNA	PMID:21871943
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1606831	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TUSC3 mRNA	PMID:23806026
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1606831	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TUSC3 mRNA	PMID:20382639
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1606831	E	RGD:6480464	20240430	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TUSC3 mRNA	PMID:36801614
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TUSC3 mRNA	PMID:30047161
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551857	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TUSC3 gene	PMID:35295148
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551857	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TUSC3 gene	PMID:35295148
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TUSC3 mRNA	PMID:23411599|PMID:34492290
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of TUSC3 mRNA	PMID:28943392
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of TUSC3 mRNA	PMID:25380136
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1551857	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of TUSC3 mRNA	PMID:19136022
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of TUSC3 mRNA	PMID:22484513
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551857	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TUSC3 mRNA	PMID:18301758|PMID:23811191
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TUSC3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1606831	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TUSC3 promoter	PMID:30157460
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1551857	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of TUSC3 mRNA	PMID:26377693
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551857	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TUSC3 mRNA	PMID:38685157
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of TUSC3 mRNA	PMID:28943392
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TUSC3 mRNA	PMID:25380136|PMID:30723492
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TUSC3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TUSC3 mRNA	PMID:37236586|PMID:40850461
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of TUSC3 mRNA	PMID:25539665|PMID:26194646|PMID:27387713
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of TUSC3 mRNA	PMID:25380136
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of TUSC3 mRNA	PMID:25993096
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551857	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TUSC3 mRNA	PMID:17292431
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606831	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TUSC3 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TUSC3 mRNA	PMID:30047161
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606831	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of TUSC3 mRNA	PMID:27989131
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606831	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TUSC3 mRNA	PMID:20106945|PMID:25562108
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1551857	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TUSC3 mRNA	PMID:17555576
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551857	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TUSC3 mRNA	PMID:28973697
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TUSC3 mRNA	PMID:33387578
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1606831	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TUSC3 mRNA	PMID:29067470
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1606831	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TUSC3 gene	PMID:25304211
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TUSC3 mRNA	PMID:40504410
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1606831	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TUSC3 mRNA	PMID:18175754
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1551857	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TUSC3 mRNA	PMID:17555576
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1551857	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TUSC3 mRNA	PMID:17942748
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TUSC3 mRNA	PMID:17942748
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1606831	E	RGD:6480464	20240430	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TUSC3 mRNA	PMID:36801614
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1606831	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of TUSC3 mRNA]	PMID:21095227
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of TUSC3 mRNA	PMID:23962444
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1551857	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of TUSC3 mRNA	PMID:26377693
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1606831	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TUSC3 protein	PMID:32959892
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1606831	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TUSC3 mRNA	PMID:15336504
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1606831	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TUSC3 promoter	PMID:30157460
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1606831	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TUSC3 mRNA	PMID:31758290
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551857	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TUSC3 mRNA	PMID:22206623
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551857	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TUSC3 mRNA	PMID:22206623
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1606831	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of TUSC3 mRNA	PMID:29522793
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551857	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of TUSC3 mRNA	PMID:19136022
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1551857	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TUSC3 mRNA	PMID:19270015
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:83493	perfluoroundecanoic acid	multiple interactions	ISO	RGD:1606831	E	RGD:6480464	20210209	CTD	MESH:C101814	[perfluoroundecanoic acid affects the methylation of TUSC3 gene] which affects the expression of TUSC3 mRNA	PMID:32653021
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TUSC3 mRNA	PMID:24780913|PMID:30047161
1303318	Tusc3	tumor suppressor candidate 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TUSC3 mRNA	PMID:21346803
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1623173	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TMEM248 mRNA	PMID:37995155
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1623173	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM248 mRNA	PMID:36331819
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1623173	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TMEM248 mRNA	PMID:39241906
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1623173	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TMEM248 mRNA	PMID:39298647
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM248 mRNA	PMID:33387578
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602880	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TMEM248 mRNA	PMID:37042841
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1623173	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of TMEM248 mRNA	PMID:33848595
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TMEM248 mRNA	PMID:33387578
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1623173	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TMEM248 mRNA	PMID:27339419|PMID:31919559
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623173	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM248 mRNA	PMID:22206623
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1602880	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM248 gene	PMID:25304211
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602880	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM248 mRNA	PMID:39836092
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1623173	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of TMEM248 mRNA	PMID:40618947
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1602880	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TMEM248 mRNA	PMID:25583101
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM248 mRNA	PMID:33387578
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1602880	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TMEM248 mRNA	PMID:39709020
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1602880	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM248 mRNA	PMID:32763439
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1623173	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of TMEM248 mRNA	PMID:30807115
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602880	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM248 mRNA	PMID:39836092
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602880	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMEM248 mRNA	PMID:26238291
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602880	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMEM248 5' UTR	PMID:27901495
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1602880	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TMEM248 mRNA	PMID:19150397
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1602880	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TMEM248 gene	PMID:31601247
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TMEM248 mRNA	PMID:24136188
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1602880	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of TMEM248 mRNA	PMID:31745603
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TMEM248 mRNA	PMID:34492290
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1623173	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of TMEM248 mRNA	PMID:23811191
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM248 mRNA	PMID:32145629
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM248 mRNA	PMID:25181051
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMEM248 gene	PMID:28505145
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602880	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TMEM248 gene	PMID:31601247
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1623173	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TMEM248 mRNA	PMID:39298647
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1623173	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TMEM248 mRNA	PMID:38685157
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623173	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TMEM248 mRNA	PMID:37019170
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1602880	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of TMEM248 mRNA	PMID:19376846
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602880	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TMEM248 mRNA	PMID:31533062
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1602880	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TMEM248 mRNA	PMID:40419075
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623173	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM248 mRNA	PMID:36331819
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602880	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM248 mRNA	PMID:23179753
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602880	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TMEM248 mRNA	PMID:17183730
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TMEM248 mRNA	PMID:24136188
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1623173	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TMEM248 mRNA	PMID:29279043
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1602880	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM248 gene	PMID:25304211
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602880	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM248 mRNA	PMID:39836092
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1623173	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TMEM248 mRNA; Nanotubes, Carbon results in increased expression of TMEM248 mRNA	PMID:25554681|PMID:25620056
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TMEM248 mRNA	PMID:24136188
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1602880	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TMEM248 mRNA	PMID:17183730
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of TMEM248 mRNA	PMID:20080153
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1602880	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TMEM248 mRNA	PMID:15336504
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623173	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM248 mRNA	PMID:22206623
1303319	Tmem248	transmembrane protein 248	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TMEM248 mRNA	PMID:23034163
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1351629	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NQO2 mRNA	PMID:38218311
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1351629	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of NQO2 mRNA	PMID:26272509
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA	PMID:27188386
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NQO2 mRNA]	PMID:31150632
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of NQO2 mRNA	PMID:20488242
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1351629	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of NQO2 mRNA	PMID:33167477
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NQO2 mRNA	PMID:36331819
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:15927	N-ribosylnicotinamide	increases oxidation	ISO	RGD:1351629	E	RGD:6480464	20120501	CTD	MESH:C018613	NQO2 protein results in increased oxidation of nicotinamide-beta-riboside; NQO2 protein results in increased oxidation of nicotinamide-beta-riboside metabolite	PMID:20399199|PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:15927	N-ribosylnicotinamide	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120501	CTD	MESH:C018613	[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of 2,6-Dichloroindophenol; [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q1; [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2; [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]; Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]; N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]; resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]	PMID:20399199
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1551869	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of NQO2 mRNA	PMID:30319688
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of NQO2 protein	PMID:18951874
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16243	quercetin	affects binding	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin binds to NQO2 protein	PMID:15350128
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1351629	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NQO2 mRNA	PMID:21632981
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20170516	CTD	MESH:D011794	Quercetin inhibits the reaction [NQO2 protein results in increased reduction of estradiol-3,4-quinone]	PMID:18996184
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551869	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NQO2 mRNA	PMID:39241906
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NQO2 mRNA	PMID:39298647
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1351629	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of NQO2 mRNA	PMID:19167446
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of NQO2 mRNA	PMID:22217510
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16514	4',5,7-trihydroxy-3'-methoxyflavone	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120501	CTD	MESH:C007054	chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]	PMID:20399199
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20200804	CTD	MESH:D002635	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of NQO2 mRNA	PMID:32152650
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16794	scopolamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012601	Scopolamine results in increased expression of NQO2 mRNA	PMID:20861374
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16796	melatonin	affects activity	ISO	RGD:1351629	E	RGD:6480464	20170725	CTD	MESH:D008550	Melatonin affects the activity of NQO2 protein	PMID:22289031
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120501	CTD	MESH:D008550	Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]; Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]; Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]	PMID:20399199
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20200804	CTD	MESH:D006000	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of NQO2 mRNA	PMID:32152650
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20180116	CTD	MESH:D004051	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of NQO2 mRNA	PMID:28433925
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NQO2 mRNA	PMID:33387578
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NQO2 mRNA	PMID:36331819
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of NQO2 mRNA	PMID:28522335
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:194147	aristolochic acids	decreases expression	EXP		E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in decreased expression of NQO2 mRNA	PMID:19717638
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1351629	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of NQO2 mRNA	PMID:19549813
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of NQO2 protein	PMID:20106945
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NQO2 mRNA	PMID:19770486
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1351629	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NQO2 gene	PMID:27153756
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1351629	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NQO2 mRNA	PMID:23649840
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of NQO2 mRNA	PMID:34911549
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:2674	amodiaquine	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:D000655	Amodiaquine inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27363	zinc atom	affects expression	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of NQO2 mRNA	PMID:16979875
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NQO2 mRNA; [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NQO2 mRNA	PMID:16979875|PMID:18593933
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NQO2 mRNA	PMID:31150632
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NQO2 mRNA	PMID:27339419|PMID:31919559
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NQO2 mRNA]	PMID:31150632
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NQO2 mRNA	PMID:22206623
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20200804	CTD	MESH:D006002	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of NQO2 mRNA	PMID:32152650
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	increases expression	ISO	RGD:1351629	E	RGD:6480464	20180410	CTD	MESH:D000966	Antimony Potassium Tartrate results in increased expression of NQO2 mRNA	PMID:28713220
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1351629	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of NQO2 mRNA	PMID:26272509
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA	PMID:27188386
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of NQO2 mRNA	PMID:28960355
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27881	resveratrol	affects binding	ISO	RGD:1351629	E	RGD:6480464	20141111	CTD	MESH:C059514	resveratrol binds to NQO2 protein	PMID:24968355
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27881	resveratrol	decreases activity	ISO	RGD:1351629	E	RGD:6480464	20141223	CTD	MESH:C059514	resveratrol analog results in decreased activity of NQO2 protein	PMID:23953689
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of NQO2 protein	PMID:15993843
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20141223	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of NQO2 mRNA; [resveratrol binds to NQO2 protein] inhibits the reaction [NQO2 protein binds to AKT1 protein]; NQO2 protein inhibits the reaction [resveratrol results in decreased expression of AKT1 protein]; NQO2 protein promotes the reaction [resveratrol results in decreased expression of BCL2 protein]; NQO2 protein promotes the reaction [resveratrol results in decreased expression of RELA protein]; resveratrol binds to and results in decreased activity of NQO2 protein; resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2]; resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2]; resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; resveratrol inhibits the reaction [AKT1 protein binds to NQO2 protein]; resveratrol inhibits the reaction [NQO2 protein results in increased reduction of 2,6-Dichloroindophenol]; resveratrol inhibits the reaction [NQO2 protein results in increased reduction of thiazolyl blue]; resveratrol inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; resveratrol results in increased expression of and affects the localization of NQO2 protein	PMID:15350128|PMID:16759640|PMID:19167446|PMID:19661309|PMID:20399199|PMID:23953689|PMID:24968355|PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1351629	E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in decreased expression of NQO2 protein	PMID:37834424
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of NQO2 mRNA	PMID:21151649
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of NQO2 mRNA	PMID:17898221
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551869	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NQO2 mRNA	PMID:21570461
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NQO2 mRNA	PMID:18796159|PMID:21215274
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NQO2 mRNA; Tetrachlorodibenzodioxin results in increased expression of NQO2 protein	PMID:11154737|PMID:20106945|PMID:21632981
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551869	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NQO2 mRNA	PMID:21889950
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20120918	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of NQO2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NQO2 promoter]	PMID:21889950|PMID:28433925
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of NQO2 protein	PMID:18951874
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NQO2 mRNA	PMID:20061341
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1351629	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NQO2 mRNA	PMID:28001369
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28230	hesperetin	affects binding	ISO	RGD:1351629	E	RGD:6480464	20231003	CTD	MESH:C013015	hesperetin binds to NQO2 protein	PMID:37487865
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1351629	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NQO2 mRNA	PMID:30851411
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1551869	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of NQO2 protein	PMID:28918527
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in decreased expression of NQO2 mRNA	PMID:25896364
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20200804	CTD	MESH:D003840	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of NQO2 mRNA	PMID:32152650
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28869	menadione	affects response to substance	ISO	RGD:1551869	E	RGD:6480464	20120501	CTD	MESH:D024483	NQO2 affects the susceptibility to Vitamin K 3	PMID:12351651
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28869	menadione	decreases response to substance	ISO	RGD:1551869	E	RGD:6480464	20140812	CTD	MESH:D024483	NQO2 gene mutant form results in decreased susceptibility to Vitamin K 3	PMID:21859103
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28869	menadione	increases activity	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:D024483	NQO2 protein results in increased activity of Vitamin K 3	PMID:17762829
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28869	menadione	increases reduction	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:D024483	NQO2 protein results in increased reduction of Vitamin K 3	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28869	menadione	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120501	CTD	MESH:D024483	[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3; [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3; Amodiaquine inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; Clozapine inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; Mefenamic Acid inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; Resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; Resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; Resveratrol inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]	PMID:20399199|PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20240604	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [flutriafol results in increased expression of NQO2 mRNA]	PMID:34200939
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:C028473	NQO2 protein results in increased reduction of and results in decreased glutathionylation of N-acetyl-4-benzoquinoneimine; Tacrine inhibits the reaction [NQO2 protein results in increased reduction of N-acetyl-4-benzoquinoneimine]	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351629	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of NQO2 mRNA	PMID:22714537|PMID:24516582|PMID:25879800|PMID:28713220|PMID:38568856
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NQO2 mRNA	PMID:20127859
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1351629	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NQO2 promoter	PMID:27901495
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1351629	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NQO2 mRNA	PMID:20106945|PMID:21632981
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NQO2 mRNA	PMID:21715664
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351629	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NQO2 3' UTR	PMID:27901495
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20180116	CTD	MESH:D001564	[lipopolysaccharide, E coli O55-B5 co-treated with Benzo(a)pyrene] affects the expression of NQO2 mRNA	PMID:28987381
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:30185	zinc(0)	affects expression	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of NQO2 mRNA	PMID:16979875
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NQO2 mRNA; [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NQO2 mRNA	PMID:16979875|PMID:18593933
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of NQO2 mRNA	PMID:23221170
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1351629	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NQO2 mRNA	PMID:21461292
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of NQO2 mRNA	PMID:22641619
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of NQO2 mRNA	PMID:25729387
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1551869	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of NQO2 mRNA	PMID:35295148
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NQO2 mRNA	PMID:34492290
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NQO2 mRNA	PMID:18648102
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of NQO2 mRNA	PMID:18445702
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of NQO2 mRNA	PMID:28329830
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NQO2 mRNA	PMID:25181051
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NQO2 mRNA	PMID:34947998
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1351629	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of NQO2 protein	PMID:34186270|PMID:37567409
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20180116	CTD	MESH:C006780	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of NQO2 mRNA	PMID:28433925
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:3374	capsaicin	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin inhibits the reaction [Dietary Fats results in increased expression of NQO2 protein]	PMID:20359164
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:3387	carbamazepine	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:D002220	NQO2 protein results in increased reduction of and results in decreased glutathionylation of Carbamazepine metabolite	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20180116	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of NQO2 mRNA	PMID:28433925
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of NQO2 mRNA	PMID:20713471
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of NQO2 mRNA	PMID:39298647
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1351629	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of NQO2 protein	PMID:34186270
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1351629	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of NQO2 protein	PMID:34186270
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1351629	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of NQO2 protein	PMID:34186270
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of NQO2 mRNA	PMID:21241498
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NQO2 mRNA	PMID:21266533
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1551869	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of NQO2 mRNA	PMID:34813904
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34905	paraquat	increases activity	ISO	RGD:1351629	E	RGD:6480464	20170725	CTD	MESH:D010269	Paraquat results in increased activity of NQO2 protein	PMID:22289031
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34905	paraquat	increases response to substance	ISO	RGD:1351629	E	RGD:6480464	20170725	CTD	MESH:D010269	NQO2 protein results in increased susceptibility to Paraquat	PMID:22289031
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20170725	CTD	MESH:D010269	N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [Paraquat results in increased activity of NQO2 protein]	PMID:22289031
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351629	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NQO2 mRNA	PMID:37042841
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of NQO2 mRNA	PMID:35163327
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1351629	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NQO2 mRNA	PMID:38174414
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of NQO2 mRNA	PMID:35163327
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of NQO2 mRNA	PMID:25380136
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20200804	CTD	MESH:D005999	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of NQO2 mRNA	PMID:32152650
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20200331	CTD	MESH:D002738	Chloroquine binds to and results in decreased activity of NQO2 protein	PMID:15078100
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NQO2 mRNA	PMID:16979875
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:3766	clozapine	affects response to substance	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D003024	NQO2 gene SNP affects the susceptibility to Clozapine	PMID:14617031
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1351629	E	RGD:6480464	20260505	CTD	MESH:D003024	Clozapine results in increased expression of NQO2 mRNA	PMID:40311769
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:3766	clozapine	increases reduction	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:D003024	NQO2 protein results in increased reduction of Clozapine metabolite	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:3766	clozapine	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:D003024	Clozapine inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; Clozapine results in increased expression of and results in increased activity of NQO2 protein	PMID:29281794|PMID:40311769
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1351629	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NQO2 mRNA	PMID:19167446
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NQO2 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of NQO2 mRNA	PMID:19167446
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1351629	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NQO2 mRNA	PMID:40419075
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NQO2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NQO2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NQO2 mRNA	PMID:36331819
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351629	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NQO2 mRNA	PMID:25979313
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NQO2 mRNA	PMID:17292431
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1351629	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of NQO2 gene	PMID:29154799
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351629	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of NQO2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA	PMID:27188386
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1351629	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NQO2 mRNA	PMID:25562108
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of NQO2 mRNA	PMID:19770486
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of NQO2 mRNA	PMID:20106945|PMID:27989131|PMID:32152650
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of NQO2 mRNA	PMID:32152650
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1351629	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of NQO2 mRNA	PMID:36621641
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NQO2 mRNA	PMID:28973697
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1351629	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NQO2 mRNA	PMID:38832940
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1351629	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of NQO2 protein	PMID:17593366
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:45980	tacrine	decreases activity	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:D013619	Tacrine results in decreased activity of NQO2 protein	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:45980	tacrine	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:D013619	Tacrine inhibits the reaction [NQO2 protein results in increased reduction of 2,6-Dichloroindophenol]; Tacrine inhibits the reaction [NQO2 protein results in increased reduction of amodiaquine quinoneimine]; Tacrine inhibits the reaction [NQO2 protein results in increased reduction of N-acetyl-4-benzoquinoneimine]; Tacrine inhibits the reaction [NQO2 protein results in increased reduction of thiazolyl blue]	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1351629	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of NQO2 mRNA	PMID:28542535
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1351629	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of NQO2 mRNA	PMID:24935251
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551869	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NQO2 mRNA	PMID:17562736
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:46234	ubiquinone-1	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120501	CTD	MESH:C025203	[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q1; [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q1	PMID:20399199
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1351629	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of NQO2 mRNA; sulforaphane results in increased expression of NQO2 protein	PMID:26833863|PMID:40436238
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of NQO2 mRNA	PMID:29391264
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1351629	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NQO2 mRNA	PMID:21461292
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1551869	E	RGD:6480464	20200714	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of NQO2 mRNA	PMID:31978390
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of NQO2 mRNA; Nanotubes, Carbon results in decreased expression of NQO2 mRNA	PMID:25620056
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551869	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of NQO2 mRNA	PMID:25554681
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of NQO2 mRNA	PMID:24136188
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1351629	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of NQO2 mRNA	PMID:20977926
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1351629	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of NQO2 mRNA	PMID:22714537
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:53233	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide	increases reduction	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:C022616	NQO2 protein results in increased reduction of thiazolyl blue	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:53233	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:C022616	resveratrol inhibits the reaction [NQO2 protein results in increased reduction of thiazolyl blue]; Tacrine inhibits the reaction [NQO2 protein results in increased reduction of thiazolyl blue]	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:59613	4'-hydroxydiclofenac	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:C108036	NQO2 protein results in increased reduction of and results in decreased glutathionylation of 4'-hydroxydiclofenac	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of NQO2 mRNA	PMID:20436886
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1351629	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NQO2 protein	PMID:32959892
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of NQO2 mRNA	PMID:25729387
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of NQO2 mRNA	PMID:25729387
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1351629	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of NQO2 mRNA	PMID:15336504
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in decreased expression of NQO2 mRNA	PMID:21335049
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:6717	mefenamic acid	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:D008528	Mefenamic Acid inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; NQO2 protein results in increased reduction of and results in decreased glutathionylation of Mefenamic Acid metabolite	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of NQO2 mRNA	PMID:30467583
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1351629	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NQO2 protein	PMID:34186270
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NQO2 mRNA	PMID:22206623
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551869	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NQO2 mRNA	PMID:22206623
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:748040	tretazicar	increases reduction	ISO	RGD:1351629	E	RGD:6480464	20260714	CTD	MESH:C100099	NQO2 protein results in increased reduction of tretazicar	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of NQO2 mRNA	PMID:24136188
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:75701	sarin	decreases expression	ISO	RGD:1351629	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of NQO2 mRNA	PMID:19522546
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1351629	E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of NQO2 mRNA	PMID:19737606
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of NQO2 mRNA	PMID:19717638
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1351629	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NQO2 mRNA	PMID:30851411
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA	PMID:27188386
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:78741	oxidopamine	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20250401	CTD	MESH:D016627	Oxidopamine results in increased expression of and results in increased activity of NQO2 protein	PMID:39271030
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NQO2 gene]	PMID:28238834
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NQO2 mRNA	PMID:19167446
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:81923	flutriafol	increases expression	ISO	RGD:1351629	E	RGD:6480464	20240604	CTD	MESH:C543009	flutriafol results in increased expression of NQO2 mRNA	PMID:34200939
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:81923	flutriafol	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20240604	CTD	MESH:C543009	Acetylcysteine inhibits the reaction [flutriafol results in increased expression of NQO2 mRNA]	PMID:34200939
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:8405	primaquine	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20200331	CTD	MESH:D011319	Primaquine binds to and results in decreased activity of NQO2 protein	PMID:15078100
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NQO2 mRNA	PMID:24780913
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1351629	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of NQO2 mRNA	PMID:26272509
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA	PMID:27188386
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:8630	pterostilbene	increases expression	ISO	RGD:1351629	E	RGD:6480464	20150127	CTD	MESH:C107773	pterostilbene results in increased expression of NQO2 mRNA; pterostilbene results in increased expression of NQO2 protein	PMID:24936659
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:8711	quinacrine	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20200331	CTD	MESH:D011796	Quinacrine binds to and results in decreased activity of NQO2 protein	PMID:15078100
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO2 mRNA	PMID:27188386
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NQO2 mRNA	PMID:21346803
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1351629	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of NQO2 protein	PMID:34581912
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:945	2,6-dichloroindophenol	increases reduction	ISO	RGD:1351629	E	RGD:6480464	20180703	CTD	MESH:D015086	NQO2 protein results in increased reduction of 2,6-Dichloroindophenol	PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:945	2,6-dichloroindophenol	multiple interactions	ISO	RGD:1351629	E	RGD:6480464	20120501	CTD	MESH:D015086	[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of 2,6-Dichloroindophenol; [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of 2,6-Dichloroindophenol; resveratrol inhibits the reaction [NQO2 protein results in increased reduction of 2,6-Dichloroindophenol]; Tacrine inhibits the reaction [NQO2 protein results in increased reduction of 2,6-Dichloroindophenol]	PMID:20399199|PMID:29281794
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of NQO2 mRNA	PMID:26217789
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1551869	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of NQO2 mRNA	PMID:28973697
1303320	Nqo2	N-ribosyldihydronicotinamide:quinone dehydrogenase 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in decreased expression of NQO2 mRNA	PMID:22615374
1303321	Ier3	immediate early response 3	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1347080	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of IER3 mRNA	PMID:38218311
1303321	Ier3	immediate early response 3	gene	CHEBI:134767	valnoctamide	increases expression	ISO	RGD:1621625	E	RGD:6480464	20170307	CTD	MESH:C045179	valnoctamide results in increased expression of IER3 mRNA	PMID:15799026
1303321	Ier3	immediate early response 3	gene	CHEBI:135632	camostat	increases expression	ISO	RGD:1621625	E	RGD:6480464	20200915	CTD	MESH:C034532	camostat results in increased expression of IER3 mRNA	PMID:25104499
1303321	Ier3	immediate early response 3	gene	CHEBI:144400	dinophysistoxin 1	increases expression	ISO	RGD:1347080	E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of IER3 mRNA	PMID:28939011
1303321	Ier3	immediate early response 3	gene	CHEBI:144804	nickel subsulfide	affects expression	ISO	RGD:1621625	E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide affects the expression of IER3 mRNA	PMID:12729255
1303321	Ier3	immediate early response 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IER3 mRNA	PMID:20938992
1303321	Ier3	immediate early response 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014212	Tretinoin results in increased expression of IER3 mRNA	PMID:20488242|PMID:22664269
1303321	Ier3	immediate early response 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120613	CTD	MESH:D014212	Tretinoin results in increased expression of IER3 mRNA	PMID:15498508|PMID:21934132|PMID:33167477
1303321	Ier3	immediate early response 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin inhibits the reaction [Cisplatin results in increased expression of IER3 mRNA]	PMID:21532991
1303321	Ier3	immediate early response 3	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IER3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IER3 mRNA	PMID:32699268
1303321	Ier3	immediate early response 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1347080	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of IER3 mRNA	PMID:26516004
1303321	Ier3	immediate early response 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1621625	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of IER3 mRNA	PMID:20880076
1303321	Ier3	immediate early response 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IER3 mRNA	PMID:30529165
1303321	Ier3	immediate early response 3	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1347080	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IER3 mRNA	PMID:26079696
1303321	Ier3	immediate early response 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of IER3 mRNA	PMID:36841081
1303321	Ier3	immediate early response 3	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20190611	CTD	MESH:D000431	Ethanol results in decreased expression of IER3 mRNA	PMID:31059573
1303321	Ier3	immediate early response 3	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IER3 mRNA	PMID:29432896
1303321	Ier3	immediate early response 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of IER3 mRNA	PMID:20044591
1303321	Ier3	immediate early response 3	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of IER3 mRNA	PMID:12419474
1303321	Ier3	immediate early response 3	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of IER3	PMID:18687144
1303321	Ier3	immediate early response 3	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1347080	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of IER3 mRNA	PMID:21632981
1303321	Ier3	immediate early response 3	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D011794	[Quercetin co-treated with Ascorbic Acid] results in increased expression of IER3 mRNA	PMID:17639512
1303321	Ier3	immediate early response 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of IER3 mRNA	PMID:39241906
1303321	Ier3	immediate early response 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1347080	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IER3 mRNA	PMID:35811015
1303321	Ier3	immediate early response 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1621625	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IER3 mRNA	PMID:25890327|PMID:27339419
1303321	Ier3	immediate early response 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of IER3 mRNA; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IER3 mRNA	PMID:26667767|PMID:35811015
1303321	Ier3	immediate early response 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of IER3 mRNA]	PMID:39241906
1303321	Ier3	immediate early response 3	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in decreased expression of IER3 mRNA	PMID:34681664
1303321	Ier3	immediate early response 3	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of IER3 mRNA	PMID:15913882
1303321	Ier3	immediate early response 3	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of IER3 mRNA	PMID:15598610
1303321	Ier3	immediate early response 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in decreased expression of IER3 mRNA	PMID:15223131|PMID:23373633
1303321	Ier3	immediate early response 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of IER3 mRNA	PMID:32145629
1303321	Ier3	immediate early response 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of IER3 mRNA	PMID:20106945|PMID:32387340
1303321	Ier3	immediate early response 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1621625	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of IER3 mRNA	PMID:15289156|PMID:19484750
1303321	Ier3	immediate early response 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of IER3 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of IER3 mRNA; Estradiol inhibits the reaction [afimoxifene results in increased expression of IER3 mRNA]	PMID:16849584|PMID:20660070|PMID:30165855
1303321	Ier3	immediate early response 3	gene	CHEBI:16482	naphthalene	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C031721	naphthalene analog results in increased expression of IER3 mRNA	PMID:24976557
1303321	Ier3	immediate early response 3	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of IER3 mRNA	PMID:22579512
1303321	Ier3	immediate early response 3	gene	CHEBI:165198	Bisphenol Z	increases expression	ISO	RGD:1347080	E	RGD:6480464	20250114	CTD	MESH:C517113	bisphenol Z results in increased expression of IER3 mRNA	PMID:32387340
1303321	Ier3	immediate early response 3	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1621625	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of IER3 mRNA	PMID:29980752
1303321	Ier3	immediate early response 3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of IER3 mRNA	PMID:38568856
1303321	Ier3	immediate early response 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of IER3 mRNA	PMID:33387578
1303321	Ier3	immediate early response 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IER3 mRNA	PMID:20938992
1303321	Ier3	immediate early response 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1347080	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IER3 mRNA	PMID:37042841
1303321	Ier3	immediate early response 3	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20211012	CTD	MESH:D002635	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IER3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of IER3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IER3 mRNA	PMID:33819548
1303321	Ier3	immediate early response 3	gene	CHEBI:16827	corticosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003345	Corticosterone results in decreased expression of IER3 mRNA	PMID:15755911
1303321	Ier3	immediate early response 3	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1347080	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of IER3 mRNA	PMID:23649840
1303321	Ier3	immediate early response 3	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	ISO	RGD:1347080	E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of IER3 mRNA	PMID:39245080
1303321	Ier3	immediate early response 3	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of IER3 mRNA	PMID:20660070
1303321	Ier3	immediate early response 3	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1347080	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of IER3 mRNA	PMID:26079696
1303321	Ier3	immediate early response 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IER3 mRNA	PMID:37992649
1303321	Ier3	immediate early response 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of IER3 mRNA	PMID:16809437
1303321	Ier3	immediate early response 3	gene	CHEBI:17489	3',5'-cyclic AMP	affects response to substance	ISO	RGD:1621625	E	RGD:6480464	20130416	CTD	MESH:D000242	IER3 protein affects the susceptibility to Cyclic AMP	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000242	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of IER3 mRNA]	PMID:19414516
1303321	Ier3	immediate early response 3	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20130416	CTD	MESH:D000242	[[IER3 protein affects the chemical synthesis of Reactive Oxygen Species] which results in increased expression of GNAI2] which results in decreased chemical synthesis of Cyclic AMP; IER3 protein affects the reaction [Isoproterenol results in increased abundance of Cyclic AMP]; Pertussis Toxin affects the reaction [IER3 protein affects the reaction [Isoproterenol results in increased abundance of Cyclic AMP]]	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1347080	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of IER3 mRNA	PMID:31256213
1303321	Ier3	immediate early response 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IER3 mRNA	PMID:37992649
1303321	Ier3	immediate early response 3	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20211012	CTD	MESH:D006000	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IER3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of IER3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IER3 mRNA	PMID:33819548
1303321	Ier3	immediate early response 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1347080	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IER3 mRNA	PMID:31163220
1303321	Ier3	immediate early response 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1621625	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IER3 mRNA	PMID:35716406
1303321	Ier3	immediate early response 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1347080	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of IER3 protein	PMID:37730182
1303321	Ier3	immediate early response 3	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of IER3 mRNA	PMID:16002434
1303321	Ier3	immediate early response 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of IER3 mRNA	PMID:33387578
1303321	Ier3	immediate early response 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1347080	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of IER3 mRNA	PMID:28818685
1303321	Ier3	immediate early response 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IER3 mRNA	PMID:36331819
1303321	Ier3	immediate early response 3	gene	CHEBI:18421	superoxide	affects chemical synthesis	ISO	RGD:1621625	E	RGD:6480464	20130416	CTD	MESH:D013481	IER3 protein affects the chemical synthesis of Superoxides	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20120717	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of IER3 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of IER3 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IER3 mRNA	PMID:19840844
1303321	Ier3	immediate early response 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IER3 mRNA	PMID:35301059
1303321	Ier3	immediate early response 3	gene	CHEBI:233321	Mitoquinone	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20250408	CTD	MESH:C429014	mitoquinone affects the reaction [IER3 protein affects the expression of GNAI2 mRNA]	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:233415	Pf-06840003	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20250408	CTD	MESH:C000625742	PF-06840003 inhibits the reaction [MAPT protein mutant form results in decreased expression of IER3 mRNA]	PMID:39172838
1303321	Ier3	immediate early response 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of IER3 mRNA	PMID:19549813
1303321	Ier3	immediate early response 3	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of IER3 protein	PMID:20106945
1303321	Ier3	immediate early response 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1347080	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IER3 mRNA	PMID:21632981|PMID:21641981|PMID:22100608|PMID:27153756|PMID:32234424
1303321	Ier3	immediate early response 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of IER3 mRNA	PMID:15651846
1303321	Ier3	immediate early response 3	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1621625	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of IER3 mRNA	PMID:32553695
1303321	Ier3	immediate early response 3	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20201006	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of IER3 mRNA	PMID:32553695
1303321	Ier3	immediate early response 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IER3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IER3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of IER3 mRNA	PMID:32699268
1303321	Ier3	immediate early response 3	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20170303	CTD	MESH:D017382	[[IER3 protein affects the chemical synthesis of Reactive Oxygen Species] which results in increased expression of GNAI2] which results in decreased chemical synthesis of Cyclic AMP; [IER3 protein affects the chemical synthesis of Reactive Oxygen Species] which results in increased expression of GNAI2	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:27086	tributylstannane	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C011559	tributyltin results in increased expression of IER3 mRNA	PMID:21683754
1303321	Ier3	immediate early response 3	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of IER3 mRNA	PMID:18593933
1303321	Ier3	immediate early response 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1621625	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IER3 mRNA	PMID:27339419|PMID:31919559
1303321	Ier3	immediate early response 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IER3 mRNA	PMID:20938992
1303321	Ier3	immediate early response 3	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20211012	CTD	MESH:D006002	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IER3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of IER3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IER3 mRNA	PMID:33819548
1303321	Ier3	immediate early response 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1347080	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IER3 gene	PMID:25304211
1303321	Ier3	immediate early response 3	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of IER3 mRNA	PMID:16835338
1303321	Ier3	immediate early response 3	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1621625	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of IER3 mRNA	PMID:38723480
1303321	Ier3	immediate early response 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of IER3 mRNA]	PMID:38723480
1303321	Ier3	immediate early response 3	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of IER3 mRNA	PMID:17293063
1303321	Ier3	immediate early response 3	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1347080	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of IER3 mRNA	PMID:33512557
1303321	Ier3	immediate early response 3	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D003513	[afimoxifene co-treated with Cycloheximide] results in increased expression of IER3 mRNA	PMID:16849584
1303321	Ier3	immediate early response 3	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin inhibits the reaction [afimoxifene results in increased expression of IER3 mRNA]	PMID:16849584
1303321	Ier3	immediate early response 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1347080	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of IER3 mRNA	PMID:26272509
1303321	Ier3	immediate early response 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA	PMID:27188386
1303321	Ier3	immediate early response 3	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of IER3 mRNA	PMID:34850229
1303321	Ier3	immediate early response 3	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA	PMID:33854195
1303321	Ier3	immediate early response 3	gene	CHEBI:27779	griseofulvin	affects expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D006118	Griseofulvin affects the expression of IER3 mRNA	PMID:12735108
1303321	Ier3	immediate early response 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of IER3 mRNA	PMID:31881176
1303321	Ier3	immediate early response 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of IER3 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of IER3 mRNA	PMID:23557933|PMID:26667767
1303321	Ier3	immediate early response 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1347080	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin results in increased expression of IER3 mRNA	PMID:21532991|PMID:23300844|PMID:33545341|PMID:38498338
1303321	Ier3	immediate early response 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of IER3 mRNA	PMID:21151649
1303321	Ier3	immediate early response 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D002945	Tretinoin inhibits the reaction [Cisplatin results in increased expression of IER3 mRNA]	PMID:21532991
1303321	Ier3	immediate early response 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of IER3 mRNA	PMID:15289156
1303321	Ier3	immediate early response 3	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1621625	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in increased expression of IER3 mRNA	PMID:18922574
1303321	Ier3	immediate early response 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IER3 mRNA	PMID:22298810|PMID:34747641
1303321	Ier3	immediate early response 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621625	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IER3 mRNA	PMID:21570461|PMID:26377647
1303321	Ier3	immediate early response 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IER3 mRNA	PMID:33387578
1303321	Ier3	immediate early response 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IER3 mRNA	PMID:21632981
1303321	Ier3	immediate early response 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IER3 mRNA	PMID:16054898|PMID:19692669
1303321	Ier3	immediate early response 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1347080	E	RGD:6480464	20160822	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IER3 mRNA	PMID:20106945|PMID:21496263|PMID:22903824|PMID:26159488
1303321	Ier3	immediate early response 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1621625	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IER3 mRNA	PMID:14728982|PMID:15034205|PMID:18172886|PMID:18691609|PMID:19770486|PMID:19933214|PMID:21496263|PMID:21851831|PMID:21889950|PMID:25975270|PMID:26290441|PMID:32553695
1303321	Ier3	immediate early response 3	gene	CHEBI:28201	rotenone	affects response to substance	ISO	RGD:1621625	E	RGD:6480464	20130416	CTD	MESH:D012402	IER3 protein affects the susceptibility to Rotenone	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1621625	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in increased expression of IER3 mRNA	PMID:23186747
1303321	Ier3	immediate early response 3	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20130416	CTD	MESH:D012402	Rotenone affects the reaction [IER3 protein affects the expression of GNAI2 mRNA]	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of IER3 mRNA	PMID:34089799
1303321	Ier3	immediate early response 3	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1347080	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of IER3 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1303321	Ier3	immediate early response 3	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA	PMID:27188386
1303321	Ier3	immediate early response 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1347080	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of IER3 mRNA	PMID:33212167
1303321	Ier3	immediate early response 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1347080	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of IER3 mRNA	PMID:39709020
1303321	Ier3	immediate early response 3	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1347080	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of IER3 mRNA	PMID:30851411
1303321	Ier3	immediate early response 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1347080	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of IER3 mRNA	PMID:26272509
1303321	Ier3	immediate early response 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA	PMID:27188386
1303321	Ier3	immediate early response 3	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1347080	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of IER3 mRNA	PMID:23649840
1303321	Ier3	immediate early response 3	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1621625	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide affects the expression of IER3 mRNA	PMID:30807115
1303321	Ier3	immediate early response 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1347080	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of IER3 mRNA	PMID:32763439
1303321	Ier3	immediate early response 3	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of IER3 mRNA	PMID:19747488
1303321	Ier3	immediate early response 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120717	CTD	MESH:D003300	N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Copper results in increased expression of IER3 mRNA]; RELA mRNA affects the reaction [Copper results in increased expression of IER3 mRNA]	PMID:19747488
1303321	Ier3	immediate early response 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IER3 mRNA	PMID:29803840
1303321	Ier3	immediate early response 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1347080	E	RGD:6480464	20260203	CTD	MESH:D004317	Doxorubicin results in increased expression of IER3 mRNA	PMID:40854400
1303321	Ier3	immediate early response 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1621625	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of IER3 mRNA	PMID:39631538
1303321	Ier3	immediate early response 3	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20260203	CTD	MESH:D004317	FOXO3 protein affects the reaction [Doxorubicin results in increased expression of IER3 mRNA]	PMID:40854400
1303321	Ier3	immediate early response 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IER3 mRNA	PMID:37992649
1303321	Ier3	immediate early response 3	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20211012	CTD	MESH:D003840	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IER3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of IER3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IER3 mRNA	PMID:33819548
1303321	Ier3	immediate early response 3	gene	CHEBI:28851	phenanthrene	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20240702	CTD	MESH:C031181	phenanthrene results in decreased expression of IER3 mRNA	PMID:38568856
1303321	Ier3	immediate early response 3	gene	CHEBI:28851	phenanthrene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20121009	CTD	MESH:C031181	phenanthrene results in increased expression of IER3 mRNA	PMID:22579512
1303321	Ier3	immediate early response 3	gene	CHEBI:28876	melphalan	increases expression	ISO	RGD:1347080	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in increased expression of IER3 mRNA	PMID:22363485
1303321	Ier3	immediate early response 3	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IER3 mRNA	PMID:29432896
1303321	Ier3	immediate early response 3	gene	CHEBI:28939	N-acetyl-L-cysteine	affects response to substance	ISO	RGD:1621625	E	RGD:6480464	20130416	CTD	MESH:D000111	IER3 protein affects the susceptibility to Acetylcysteine	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20130416	CTD	MESH:D000111	Acetylcysteine affects the reaction [IER3 protein affects the expression of GNAI2 mRNA]	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:28940	calciol	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in decreased expression of IER3 mRNA	PMID:16508948
1303321	Ier3	immediate early response 3	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D001205	[Quercetin co-treated with Ascorbic Acid] results in increased expression of IER3 mRNA	PMID:17639512
1303321	Ier3	immediate early response 3	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1347080	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of IER3 mRNA	PMID:22623647
1303321	Ier3	immediate early response 3	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1347080	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of IER3 mRNA	PMID:34032870
1303321	Ier3	immediate early response 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of IER3 mRNA	PMID:39719251
1303321	Ier3	immediate early response 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347080	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of IER3 mRNA	PMID:12760830|PMID:22714537|PMID:29301061|PMID:38568856
1303321	Ier3	immediate early response 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621625	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of IER3 mRNA	PMID:36209798
1303321	Ier3	immediate early response 3	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of IER3 mRNA	PMID:29453283
1303321	Ier3	immediate early response 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347080	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IER3 promoter	PMID:27901495
1303321	Ier3	immediate early response 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20140909	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of IER3 mRNA	PMID:24356939
1303321	Ier3	immediate early response 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IER3 mRNA	PMID:19770486
1303321	Ier3	immediate early response 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IER3 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:22579512|PMID:26238291|PMID:30453624|PMID:32234424
1303321	Ier3	immediate early response 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1621625	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of IER3 mRNA; Benzo(a)pyrene results in increased expression of IER3 mRNA	PMID:15034205|PMID:15894712|PMID:20713471|PMID:21569818|PMID:32417428|PMID:32553695
1303321	Ier3	immediate early response 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D001564	[arsenite co-treated with Benzo(a)pyrene] results in increased expression of IER3 mRNA; [Benzo(a)pyrene results in increased activity of AHR protein] which results in increased expression of IER3 mRNA; AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of IER3 mRNA]	PMID:15034205|PMID:15894712|PMID:32553695
1303321	Ier3	immediate early response 3	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of IER3 mRNA	PMID:15894712
1303321	Ier3	immediate early response 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:C015001	[arsenite co-treated with Benzo(a)pyrene] results in increased expression of IER3 mRNA	PMID:15894712
1303321	Ier3	immediate early response 3	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of IER3 mRNA	PMID:19747488
1303321	Ier3	immediate early response 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120717	CTD	MESH:D003300	N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Copper results in increased expression of IER3 mRNA]; RELA mRNA affects the reaction [Copper results in increased expression of IER3 mRNA]	PMID:19747488
1303321	Ier3	immediate early response 3	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of IER3 mRNA	PMID:18593933
1303321	Ier3	immediate early response 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1347080	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of IER3 mRNA	PMID:25895662
1303321	Ier3	immediate early response 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1621625	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IER3 mRNA	PMID:19073995|PMID:23221170|PMID:33720480
1303321	Ier3	immediate early response 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1347080	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of IER3 mRNA	PMID:20382639
1303321	Ier3	immediate early response 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1347080	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of IER3 mRNA	PMID:26238291
1303321	Ier3	immediate early response 3	gene	CHEBI:30772	butyric acid	increases expression	ISO	RGD:1347080	E	RGD:6480464	20220607	CTD	MESH:D020148	Butyric Acid results in increased expression of IER3 mRNA	PMID:34581912
1303321	Ier3	immediate early response 3	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20211012	CTD	MESH:D000069446	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IER3 mRNA	PMID:33819548
1303321	Ier3	immediate early response 3	gene	CHEBI:31429	colforsin daropate hydrochloride	affects response to substance	ISO	RGD:1621625	E	RGD:6480464	20141111	CTD	MESH:D005576	IER3 protein affects the susceptibility to Colforsin	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:C070081	Fulvestrant inhibits the reaction [afimoxifene results in increased expression of IER3 mRNA]	PMID:16849584
1303321	Ier3	immediate early response 3	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of IER3 mRNA	PMID:24136188
1303321	Ier3	immediate early response 3	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of IER3 mRNA	PMID:20542052
1303321	Ier3	immediate early response 3	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1347080	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of IER3 mRNA	PMID:38568856
1303321	Ier3	immediate early response 3	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of IER3 mRNA	PMID:32479839
1303321	Ier3	immediate early response 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of IER3 mRNA	PMID:25729387
1303321	Ier3	immediate early response 3	gene	CHEBI:32145	sodium hydroxide	affects response to substance	ISO	RGD:1347080	E	RGD:6480464	20180220	CTD	MESH:D012972	IER3 SNP affects the susceptibility to Sodium Hydroxide	PMID:27258892
1303321	Ier3	immediate early response 3	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of IER3 mRNA	PMID:30047161
1303321	Ier3	immediate early response 3	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of IER3 mRNA	PMID:15498508
1303321	Ier3	immediate early response 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1621625	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of IER3 mRNA	PMID:23557971|PMID:27760801
1303321	Ier3	immediate early response 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of IER3 mRNA	PMID:23411599|PMID:34492290
1303321	Ier3	immediate early response 3	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of IER3 mRNA	PMID:12419474
1303321	Ier3	immediate early response 3	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of IER3 mRNA	PMID:19191707
1303321	Ier3	immediate early response 3	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	ISO	RGD:1347080	E	RGD:6480464	20140909	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of IER3 mRNA	PMID:24356939
1303321	Ier3	immediate early response 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1621625	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of IER3 mRNA	PMID:28472532
1303321	Ier3	immediate early response 3	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of IER3 mRNA	PMID:28329830
1303321	Ier3	immediate early response 3	gene	CHEBI:33090	picene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20200609	CTD	MESH:C056699	picene results in increased expression of IER3 mRNA	PMID:32251684
1303321	Ier3	immediate early response 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of IER3 mRNA	PMID:20170705|PMID:30903817
1303321	Ier3	immediate early response 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of IER3 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1303321	Ier3	immediate early response 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IER3 mRNA	PMID:25181051|PMID:32145629
1303321	Ier3	immediate early response 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1347080	E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A analog results in increased expression of IER3 mRNA; bisphenol A results in increased expression of IER3 mRNA	PMID:32387340
1303321	Ier3	immediate early response 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1621625	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of IER3 mRNA	PMID:30951980|PMID:32156529
1303321	Ier3	immediate early response 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1621625	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of IER3 mRNA	PMID:25172293
1303321	Ier3	immediate early response 3	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of IER3 mRNA]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of IER3 mRNA]	PMID:19414516
1303321	Ier3	immediate early response 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1347080	E	RGD:6480464	20240702	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of IER3 mRNA	PMID:38568856
1303321	Ier3	immediate early response 3	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of IER3 mRNA	PMID:15980968
1303321	Ier3	immediate early response 3	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1621625	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of IER3 mRNA	PMID:20713471
1303321	Ier3	immediate early response 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IER3 mRNA	PMID:19692669|PMID:20959002|PMID:32119087
1303321	Ier3	immediate early response 3	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20121009	CTD	MESH:D008748	Methylcholanthrene results in increased expression of IER3 mRNA	PMID:22579512
1303321	Ier3	immediate early response 3	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of IER3 mRNA	PMID:20713471
1303321	Ier3	immediate early response 3	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to IER3 promoter]	PMID:20348232
1303321	Ier3	immediate early response 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621625	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of IER3 mRNA	PMID:30951980|PMID:40203079
1303321	Ier3	immediate early response 3	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of IER3 mRNA	PMID:26377693
1303321	Ier3	immediate early response 3	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20141111	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of IER3 mRNA	PMID:22579512
1303321	Ier3	immediate early response 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1621625	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of IER3 mRNA	PMID:30951980
1303321	Ier3	immediate early response 3	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1347080	E	RGD:6480464	20201103	CTD	MESH:C492482	bisphenol B results in increased expression of IER3 mRNA	PMID:32387340
1303321	Ier3	immediate early response 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of IER3 mRNA	PMID:21241498
1303321	Ier3	immediate early response 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1621625	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of IER3 mRNA	PMID:32715474
1303321	Ier3	immediate early response 3	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA	PMID:33854195
1303321	Ier3	immediate early response 3	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1621625	E	RGD:6480464	20220809	CTD	MESH:D016264	Dextran Sulfate results in increased expression of IER3 mRNA	PMID:32033881
1303321	Ier3	immediate early response 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20220809	CTD	MESH:D016264	Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of IER3 mRNA]	PMID:32033881
1303321	Ier3	immediate early response 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20140211	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of IER3 mRNA	PMID:21266533|PMID:21745491
1303321	Ier3	immediate early response 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1621625	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of IER3 mRNA	PMID:17361019|PMID:21266533
1303321	Ier3	immediate early response 3	gene	CHEBI:34696	dieldrin	increases expression	ISO	RGD:1347080	E	RGD:6480464	20201215	CTD	MESH:D004026	Dieldrin results in increased expression of IER3 mRNA	PMID:31068361
1303321	Ier3	immediate early response 3	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of IER3 mRNA	PMID:17374397
1303321	Ier3	immediate early response 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of IER3 mRNA	PMID:28628672
1303321	Ier3	immediate early response 3	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1621625	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of IER3 mRNA	PMID:24535843
1303321	Ier3	immediate early response 3	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of IER3 mRNA	PMID:22110744
1303321	Ier3	immediate early response 3	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1621625	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of IER3 mRNA	PMID:12729255
1303321	Ier3	immediate early response 3	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20120717	CTD	MESH:C022838	HIF1A affects the reaction [nickel chloride results in increased expression of IER3 mRNA]	PMID:12729255
1303321	Ier3	immediate early response 3	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of IER3 mRNA	PMID:32680482
1303321	Ier3	immediate early response 3	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of IER3 mRNA	PMID:36117858
1303321	Ier3	immediate early response 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of IER3 mRNA]	PMID:39241906
1303321	Ier3	immediate early response 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347080	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IER3 mRNA	PMID:37042841
1303321	Ier3	immediate early response 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of IER3 mRNA	PMID:35163327
1303321	Ier3	immediate early response 3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20121009	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of IER3 mRNA	PMID:22579512
1303321	Ier3	immediate early response 3	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of IER3 mRNA	PMID:18500788
1303321	Ier3	immediate early response 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IER3 mRNA	PMID:12760830
1303321	Ier3	immediate early response 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of IER3 promoter	PMID:22457795
1303321	Ier3	immediate early response 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IER3 mRNA	PMID:35301059
1303321	Ier3	immediate early response 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20120717	CTD	MESH:D019256	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of IER3 mRNA	PMID:19840844
1303321	Ier3	immediate early response 3	gene	CHEBI:35546	perfluorodecanoic acid	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20240702	CTD	MESH:C036567	perfluorodecanoic acid results in decreased expression of IER3 mRNA	PMID:38568856
1303321	Ier3	immediate early response 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of IER3 mRNA	PMID:16221955
1303321	Ier3	immediate early response 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20240702	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of IER3 mRNA	PMID:38568856
1303321	Ier3	immediate early response 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of IER3 mRNA	PMID:35163327
1303321	Ier3	immediate early response 3	gene	CHEBI:35572	phorone	affects expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C018637	phorone affects the expression of IER3 mRNA	PMID:18198479
1303321	Ier3	immediate early response 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of IER3 mRNA	PMID:22698814
1303321	Ier3	immediate early response 3	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of IER3 mRNA	PMID:19376846
1303321	Ier3	immediate early response 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IER3 mRNA	PMID:24449571
1303321	Ier3	immediate early response 3	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20211012	CTD	MESH:D005999	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IER3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of IER3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IER3 mRNA	PMID:33819548
1303321	Ier3	immediate early response 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IER3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IER3 mRNA	PMID:32699268
1303321	Ier3	immediate early response 3	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of IER3 mRNA	PMID:17293063
1303321	Ier3	immediate early response 3	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1347080	E	RGD:6480464	20201215	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of IER3 mRNA	PMID:31068361
1303321	Ier3	immediate early response 3	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1621625	E	RGD:6480464	20121009	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of IER3 mRNA	PMID:19945525
1303321	Ier3	immediate early response 3	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20120717	CTD	MESH:D013755	[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IER3 mRNA	PMID:19840844
1303321	Ier3	immediate early response 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of IER3 mRNA	PMID:38568856
1303321	Ier3	immediate early response 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of IER3 mRNA	PMID:40194260
1303321	Ier3	immediate early response 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IER3 mRNA	PMID:31533062
1303321	Ier3	immediate early response 3	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1347080	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of IER3 mRNA	PMID:19167446
1303321	Ier3	immediate early response 3	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1621625	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of IER3 mRNA	PMID:39529242
1303321	Ier3	immediate early response 3	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of IER3 mRNA	PMID:26352163
1303321	Ier3	immediate early response 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1347080	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of IER3 mRNA	PMID:27153767|PMID:40419075
1303321	Ier3	immediate early response 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IER3 mRNA	PMID:36331819
1303321	Ier3	immediate early response 3	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:C016104	sodium bichromate results in decreased expression of IER3 mRNA	PMID:12760830
1303321	Ier3	immediate early response 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347080	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IER3 mRNA	PMID:25979313
1303321	Ier3	immediate early response 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of IER3 mRNA	PMID:17963808
1303321	Ier3	immediate early response 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1347080	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of IER3 mRNA	PMID:24383497|PMID:28001369|PMID:29154799
1303321	Ier3	immediate early response 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1621625	E	RGD:6480464	20120717	CTD	MESH:D014635	Valproic Acid results in increased expression of IER3 mRNA	PMID:15799026|PMID:19136453|PMID:21427059
1303321	Ier3	immediate early response 3	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of IER3 mRNA	PMID:30047161|PMID:41580965
1303321	Ier3	immediate early response 3	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20140909	CTD	MESH:D003520	Cyclophosphamide metabolite results in decreased expression of IER3 mRNA	PMID:24356939
1303321	Ier3	immediate early response 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of IER3 mRNA	PMID:27989131
1303321	Ier3	immediate early response 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1347080	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of IER3 mRNA	PMID:20106945|PMID:25562108
1303321	Ier3	immediate early response 3	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20211012	CTD	MESH:D016572	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of IER3 mRNA	PMID:33819548
1303321	Ier3	immediate early response 3	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1621625	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in increased expression of IER3 mRNA	PMID:40633821
1303321	Ier3	immediate early response 3	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA	PMID:33854195
1303321	Ier3	immediate early response 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of IER3 mRNA	PMID:14699072
1303321	Ier3	immediate early response 3	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of IER3 mRNA	PMID:15604281
1303321	Ier3	immediate early response 3	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of IER3 mRNA	PMID:25047013
1303321	Ier3	immediate early response 3	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of IER3 mRNA	PMID:22733784
1303321	Ier3	immediate early response 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of IER3 mRNA	PMID:28628672
1303321	Ier3	immediate early response 3	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of IER3 mRNA	PMID:15289156|PMID:16636312
1303321	Ier3	immediate early response 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1621625	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IER3 mRNA	PMID:28973697
1303321	Ier3	immediate early response 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IER3 mRNA	PMID:37992649
1303321	Ier3	immediate early response 3	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1347080	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of IER3 mRNA	PMID:23649840
1303321	Ier3	immediate early response 3	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of IER3 mRNA	PMID:12929121
1303321	Ier3	immediate early response 3	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in increased expression of IER3 mRNA; afimoxifene results in increased expression of IER3 protein	PMID:16849584
1303321	Ier3	immediate early response 3	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20200211	CTD	MESH:C016601	[afimoxifene co-treated with Cycloheximide] results in increased expression of IER3 mRNA; Dactinomycin inhibits the reaction [afimoxifene results in increased expression of IER3 mRNA]; ESR2 protein inhibits the reaction [afimoxifene results in increased expression of IER3 mRNA]; Estradiol inhibits the reaction [afimoxifene results in increased expression of IER3 mRNA]; Fulvestrant inhibits the reaction [afimoxifene results in increased expression of IER3 mRNA]	PMID:16849584
1303321	Ier3	immediate early response 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1347080	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IER3 mRNA	PMID:38832940
1303321	Ier3	immediate early response 3	gene	CHEBI:44658	okadaic acid	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20120717	CTD	MESH:D019319	[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of IER3 mRNA	PMID:19840844
1303321	Ier3	immediate early response 3	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1347080	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of IER3 mRNA	PMID:26272509
1303321	Ier3	immediate early response 3	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA	PMID:27188386
1303321	Ier3	immediate early response 3	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1621625	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of IER3 mRNA	PMID:12929121
1303321	Ier3	immediate early response 3	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA	PMID:33854195
1303321	Ier3	immediate early response 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1347080	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of IER3 mRNA	PMID:24935251|PMID:26272509
1303321	Ier3	immediate early response 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA	PMID:27188386
1303321	Ier3	immediate early response 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IER3 mRNA	PMID:17562736
1303321	Ier3	immediate early response 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of IER3 mRNA	PMID:32479839
1303321	Ier3	immediate early response 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1347080	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of IER3 mRNA	PMID:29067470
1303321	Ier3	immediate early response 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IER3 mRNA	PMID:35811015
1303321	Ier3	immediate early response 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of IER3 mRNA	PMID:29279043
1303321	Ier3	immediate early response 3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of IER3 mRNA	PMID:18687144
1303321	Ier3	immediate early response 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1347080	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IER3 gene	PMID:25304211
1303321	Ier3	immediate early response 3	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of IER3 mRNA	PMID:16835338
1303321	Ier3	immediate early response 3	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1621625	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of IER3 mRNA	PMID:38723480
1303321	Ier3	immediate early response 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of IER3 mRNA]	PMID:38723480
1303321	Ier3	immediate early response 3	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1621625	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of IER3 mRNA	PMID:26934552
1303321	Ier3	immediate early response 3	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1347080	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of IER3 mRNA	PMID:24383545
1303321	Ier3	immediate early response 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of IER3 mRNA	PMID:20170705
1303321	Ier3	immediate early response 3	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1347080	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of IER3 mRNA	PMID:32234424
1303321	Ier3	immediate early response 3	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1347080	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of IER3 mRNA	PMID:38568856
1303321	Ier3	immediate early response 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA	PMID:27188386
1303321	Ier3	immediate early response 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of IER3 mRNA	PMID:28628672
1303321	Ier3	immediate early response 3	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea results in increased expression of IER3 mRNA	PMID:17412507
1303321	Ier3	immediate early response 3	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1347080	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of IER3 mRNA	PMID:19117987|PMID:23300844
1303321	Ier3	immediate early response 3	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with TNF protein] promotes the reaction [GTF2H1 protein binds to IER3 promoter]; Decitabine promotes the reaction [NFKB1 protein binds to IER3 promoter]; Decitabine promotes the reaction [RELA protein binds to IER3 promoter]; TNF protein promotes the reaction [Decitabine promotes the reaction [NFKB1 protein binds to IER3 promoter]]; TNF protein promotes the reaction [Decitabine promotes the reaction [RELA protein binds to IER3 promoter]]; TNF protein promotes the reaction [Decitabine results in increased expression of IER3 mRNA]	PMID:19117987
1303321	Ier3	immediate early response 3	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate affects the reaction [MTF1 affects the expression of IER3 mRNA]	PMID:16221973
1303321	Ier3	immediate early response 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1621625	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of IER3 mRNA	PMID:25554681
1303321	Ier3	immediate early response 3	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of IER3 mRNA	PMID:30047161
1303321	Ier3	immediate early response 3	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of IER3 mRNA	PMID:24136188
1303321	Ier3	immediate early response 3	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20121009	CTD	MESH:C030935	benz(a)anthracene results in increased expression of IER3 mRNA	PMID:22579512
1303321	Ier3	immediate early response 3	gene	CHEBI:51397	1,3-dinitrobenzene	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C017906	3-dinitrobenzene affects the expression of IER3 mRNA	PMID:24140754
1303321	Ier3	immediate early response 3	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of IER3 mRNA	PMID:21983209
1303321	Ier3	immediate early response 3	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20121009	CTD	MESH:C031180	chrysene results in increased expression of IER3 mRNA	PMID:22579512
1303321	Ier3	immediate early response 3	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of IER3 mRNA	PMID:36117858
1303321	Ier3	immediate early response 3	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1347080	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of IER3 mRNA	PMID:17374397|PMID:18651567|PMID:22714537
1303321	Ier3	immediate early response 3	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120515	CTD	MESH:D010081	Oxazolone results in increased expression of IER3 mRNA	PMID:17374397
1303321	Ier3	immediate early response 3	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1347080	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of IER3 mRNA	PMID:31629900
1303321	Ier3	immediate early response 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1621625	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IER3 mRNA	PMID:38701926
1303321	Ier3	immediate early response 3	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA	PMID:33854195
1303321	Ier3	immediate early response 3	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of IER3 mRNA	PMID:20436886
1303321	Ier3	immediate early response 3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IER3 mRNA	PMID:21641980
1303321	Ier3	immediate early response 3	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of IER3 mRNA	PMID:25729387
1303321	Ier3	immediate early response 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of IER3 mRNA	PMID:25729387
1303321	Ier3	immediate early response 3	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of IER3 mRNA	PMID:19812364
1303321	Ier3	immediate early response 3	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1347080	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of IER3 mRNA	PMID:28988120
1303321	Ier3	immediate early response 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of IER3 mRNA	PMID:12419474
1303321	Ier3	immediate early response 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of IER3 mRNA	PMID:15336504
1303321	Ier3	immediate early response 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of IER3 mRNA	PMID:28801915
1303321	Ier3	immediate early response 3	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1347080	E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IER3 mRNA	PMID:20147733
1303321	Ier3	immediate early response 3	gene	CHEBI:64317	isoprenaline	affects response to substance	ISO	RGD:1621625	E	RGD:6480464	20130416	CTD	MESH:D007545	IER3 protein affects the susceptibility to Isoproterenol	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20130416	CTD	MESH:D007545	IER3 protein affects the reaction [Isoproterenol results in increased abundance of Cyclic AMP]; Pertussis Toxin affects the reaction [IER3 protein affects the reaction [Isoproterenol results in increased abundance of Cyclic AMP]]; Pertussis Toxin affects the reaction [IER3 protein affects the susceptibility to Isoproterenol]	PMID:20713914
1303321	Ier3	immediate early response 3	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1347080	E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in increased expression of IER3 mRNA	PMID:33244087
1303321	Ier3	immediate early response 3	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of IER3 mRNA]	PMID:27256343
1303321	Ier3	immediate early response 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1347080	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of IER3 mRNA	PMID:31758290
1303321	Ier3	immediate early response 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1621625	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IER3 mRNA	PMID:22206623
1303321	Ier3	immediate early response 3	gene	CHEBI:74562	valpromide	increases expression	ISO	RGD:1621625	E	RGD:6480464	20161213	CTD	MESH:C004651	dipropylacetamide results in increased expression of IER3 mRNA	PMID:15799026
1303321	Ier3	immediate early response 3	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of IER3 mRNA	PMID:24136188
1303321	Ier3	immediate early response 3	gene	CHEBI:7494	nefazodone	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20211012	CTD	MESH:C051752	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of IER3 mRNA	PMID:33819548
1303321	Ier3	immediate early response 3	gene	CHEBI:75441	gastrin-17	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20131008	CTD	MESH:C013550	[gastrin 17 co-treated with CCKBR protein] results in increased expression of IER3 mRNA	PMID:17704804
1303321	Ier3	immediate early response 3	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1347080	E	RGD:6480464	20200714	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of IER3 mRNA	PMID:32151702
1303321	Ier3	immediate early response 3	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20140909	CTD	MESH:C025589	ochratoxin A metabolite results in decreased expression of IER3 mRNA; ochratoxin A results in decreased expression of IER3 mRNA	PMID:24356939
1303321	Ier3	immediate early response 3	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20140805	CTD	MESH:D009853	[Omeprazole co-treated with CCKBR protein] results in increased expression of IER3	PMID:17704804
1303321	Ier3	immediate early response 3	gene	CHEBI:7772	omeprazole	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20120412	CTD	MESH:D009853	[Omeprazole co-treated with CCKBR protein] results in increased expression of IER3	PMID:17704804
1303321	Ier3	immediate early response 3	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1347080	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of IER3 mRNA	PMID:30851411
1303321	Ier3	immediate early response 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA	PMID:27188386
1303321	Ier3	immediate early response 3	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1347080	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of IER3 mRNA	PMID:20185912
1303321	Ier3	immediate early response 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1347080	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of IER3 mRNA	PMID:19159669
1303321	Ier3	immediate early response 3	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of IER3 mRNA	PMID:19270015
1303321	Ier3	immediate early response 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of IER3 mRNA	PMID:19482888
1303321	Ier3	immediate early response 3	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of IER3 mRNA]	PMID:19482888
1303321	Ier3	immediate early response 3	gene	CHEBI:8093	phenylephrine	affects localization	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine affects the localization of IER3 protein	PMID:11934837
1303321	Ier3	immediate early response 3	gene	CHEBI:8093	phenylephrine	decreases response to substance	ISO	RGD:1621625	E	RGD:6480464	20120412	CTD	MESH:D010656	IER3 protein results in decreased susceptibility to Phenylephrine	PMID:11934837
1303321	Ier3	immediate early response 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1621625	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of IER3 mRNA	PMID:38648751
1303321	Ier3	immediate early response 3	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1621625	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of IER3 mRNA	PMID:21195148
1303321	Ier3	immediate early response 3	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1621625	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of IER3 mRNA	PMID:21195148
1303321	Ier3	immediate early response 3	gene	CHEBI:81922	flusilazole	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole results in increased expression of IER3 mRNA	PMID:22664269
1303321	Ier3	immediate early response 3	gene	CHEBI:82288	o-anisidine	affects expression	ISO	RGD:1347080	E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine affects the expression of IER3 mRNA	PMID:28089782
1303321	Ier3	immediate early response 3	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	increases expression	ISO	RGD:1347080	E	RGD:6480464	20141111	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in increased expression of IER3 mRNA	PMID:22579512|PMID:32251684
1303321	Ier3	immediate early response 3	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1347080	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of IER3 mRNA	PMID:32234424
1303321	Ier3	immediate early response 3	gene	CHEBI:82388	p-anisidine	increases expression	ISO	RGD:1621625	E	RGD:6480464	20141111	CTD	MESH:C013813	4-anisidine results in increased expression of IER3 mRNA	PMID:12929121
1303321	Ier3	immediate early response 3	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1621625	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of IER3 mRNA	PMID:27029645
1303321	Ier3	immediate early response 3	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1621625	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of IER3 mRNA	PMID:39847705
1303321	Ier3	immediate early response 3	gene	CHEBI:85014	2,5-hexanedione	affects expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione affects the expression of IER3 mRNA	PMID:20616210
1303321	Ier3	immediate early response 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of IER3 mRNA	PMID:30047161
1303321	Ier3	immediate early response 3	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1347080	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of IER3 mRNA	PMID:26272509
1303321	Ier3	immediate early response 3	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA	PMID:27188386
1303321	Ier3	immediate early response 3	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1621625	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of IER3 mRNA]	PMID:39241906
1303321	Ier3	immediate early response 3	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1347080	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of IER3 mRNA	PMID:14699072
1303321	Ier3	immediate early response 3	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161213	CTD	MESH:D020849	ESR2 protein affects the reaction [Raloxifene Hydrochloride results in decreased expression of IER3 mRNA]	PMID:14699072
1303321	Ier3	immediate early response 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA	PMID:27188386
1303321	Ier3	immediate early response 3	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of IER3 mRNA	PMID:19281266
1303321	Ier3	immediate early response 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of IER3 mRNA	PMID:21346803
1303321	Ier3	immediate early response 3	gene	CHEBI:93310	N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20170303	CTD	MESH:C492919	N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Copper results in increased expression of IER3 mRNA]	PMID:19747488
1303321	Ier3	immediate early response 3	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1347080	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of IER3 mRNA	PMID:34581912
1303321	Ier3	immediate early response 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IER3 mRNA	PMID:38568856
1303321	Ier3	immediate early response 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1347080	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of IER3 mRNA	PMID:29301935
1303321	Ier3	immediate early response 3	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1621625	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of IER3 mRNA	PMID:21195148
1303321	Ier3	immediate early response 3	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1347080	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of IER3 mRNA	PMID:19140230
1303321	Ier3	immediate early response 3	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1621625	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of IER3 mRNA	PMID:35537566
1303321	Ier3	immediate early response 3	gene	CHEBI:9927	valsartan	multiple interactions	ISO	RGD:1347080	E	RGD:6480464	20170303	CTD	MESH:C081489	Valsartan inhibits the reaction [AGT protein results in increased expression of IER3 mRNA]	PMID:19225232
1303322	Krt26	keratin 26	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of KRT26 gene	PMID:27618143
1303322	Krt26	keratin 26	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1615562	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of KRT26 gene	PMID:34319233
1303322	Krt26	keratin 26	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1615562	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of KRT26 gene	PMID:34319233
1303322	Krt26	keratin 26	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of KRT26 mRNA	PMID:38314887
1303322	Krt26	keratin 26	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1615562	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of KRT26 mRNA	PMID:28960355
1303322	Krt26	keratin 26	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of KRT26 gene	PMID:28505145
1303322	Krt26	keratin 26	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615562	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT26 mRNA	PMID:21570461
1303322	Krt26	keratin 26	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KRT26 mRNA	PMID:32109520
1303322	Krt26	keratin 26	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343053	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRT26 mRNA	PMID:29301061
1303322	Krt26	keratin 26	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343053	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KRT26 promoter	PMID:27901495
1303322	Krt26	keratin 26	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1343053	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of KRT26 gene	PMID:31601247
1303322	Krt26	keratin 26	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT26 mRNA	PMID:25181051
1303322	Krt26	keratin 26	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of KRT26 gene	PMID:28505145
1303322	Krt26	keratin 26	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1343053	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of KRT26 gene	PMID:31601247
1303322	Krt26	keratin 26	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KRT26 mRNA	PMID:35163327
1303322	Krt26	keratin 26	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT26 mRNA	PMID:35163327
1303322	Krt26	keratin 26	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT26 mRNA	PMID:35163327
1303322	Krt26	keratin 26	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1343053	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT26 gene]	PMID:28238834
1303322	Krt26	keratin 26	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of KRT26 mRNA	PMID:32109520
1303322	Krt26	keratin 26	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of KRT26 mRNA	PMID:27291303
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1350768	E	RGD:6480464	20140909	CTD	MESH:D015215	Zidovudine results in increased expression of SLC67A1 mRNA	PMID:24292225
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D004237	Diuron results in increased expression of SLC67A1 mRNA	PMID:21551480
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC67A1 mRNA]	PMID:31150632
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of SLC67A1 mRNA	PMID:23830798
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1350768	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SLC67A1 mRNA	PMID:33167477
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC67A1 mRNA	PMID:36331819
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SLC67A1 mRNA	PMID:20044591
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D004958	Estradiol results in decreased expression of SLC67A1 mRNA	PMID:39298647
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1350768	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC67A1 mRNA	PMID:30165855
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC67A1 mRNA	PMID:33387578
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of SLC67A1 mRNA	PMID:18045764
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SLC67A1 mRNA	PMID:21592394
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SLC67A1 mRNA	PMID:21592394
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:17558	quercitrin	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of SLC67A1 mRNA	PMID:25193878
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SLC67A1 mRNA	PMID:23892564
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D003471	Cuprizone results in increased expression of SLC67A1 mRNA	PMID:26577399
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SLC67A1 mRNA	PMID:21592394
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SLC67A1 mRNA	PMID:21592394
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SLC67A1 mRNA	PMID:28818685
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1350768	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SLC67A1 promoter	PMID:30157460
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC67A1 mRNA	PMID:36331819
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC67A1 mRNA	PMID:37236586
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC67A1 mRNA	PMID:29950665
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1350768	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SLC67A1 mRNA	PMID:19549813
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLC67A1 mRNA	PMID:27153756
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1350768	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SLC67A1 intron; Aflatoxin B1 results in increased methylation of SLC67A1 promoter	PMID:30157460
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1350768	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SLC67A1 mRNA	PMID:35430440
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC67A1 mRNA	PMID:31150632
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC67A1 mRNA	PMID:31919559
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC67A1 mRNA]	PMID:31150632
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SLC67A1 mRNA	PMID:21867686
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1350768	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC67A1 gene	PMID:25304211
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC67A1 mRNA	PMID:40504410
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SLC67A1 mRNA	PMID:19244175
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1350768	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SLC67A1 mRNA	PMID:23300844
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1350768	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SLC67A1 mRNA	PMID:27392435
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D014640	Vancomycin results in increased expression of SLC67A1 mRNA	PMID:18930951
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1350768	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC67A1 mRNA	PMID:22298810
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC67A1 mRNA	PMID:32109520|PMID:33387578
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1350768	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of SLC67A1 mRNA	PMID:29803840
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1350768	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of SLC67A1 mRNA	PMID:22623647
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC67A1 mRNA	PMID:40504410
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350768	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC67A1 promoter	PMID:30157460
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC67A1 mRNA	PMID:32234424
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1350768	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC67A1 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C015001	arsenite results in decreased expression of SLC67A1 protein	PMID:37955338
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SLC67A1 mRNA	PMID:25895662
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1350768	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SLC67A1 mRNA	PMID:20382639
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SLC67A1 mRNA	PMID:15725085
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SLC67A1 mRNA	PMID:39716349
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1350768	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of SLC67A1 gene	PMID:31601247
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in increased expression of SLC67A1 mRNA	PMID:25729387
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide affects the expression of SLC67A1 mRNA	PMID:23557971
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC67A1 mRNA	PMID:29950665
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC67A1 mRNA	PMID:34492290
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC67A1 mRNA	PMID:19710929
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of SLC67A1 gene	PMID:23968726
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A affects the expression of SLC67A1 mRNA	PMID:21636974
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC67A1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1350768	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SLC67A1 gene	PMID:31601247
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1350768	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SLC67A1 mRNA	PMID:29275510
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in increased expression of SLC67A1 mRNA	PMID:32156529|PMID:33221593
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC67A1 gene	PMID:28505145
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC67A1 promoter	PMID:27312807
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SLC67A1 mRNA	PMID:26682919
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C543008	bisphenol S results in decreased expression of SLC67A1 mRNA	PMID:39298647
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C543008	bisphenol S results in increased expression of SLC67A1 mRNA	PMID:40203079
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1350768	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SLC67A1 polyA tail	PMID:30157460
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C008745	bisphenol F results in decreased expression of SLC67A1 mRNA	PMID:38685157
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1350768	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of SLC67A1 gene	PMID:31601247
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of SLC67A1 protein	PMID:35362542
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC67A1 mRNA; evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SLC67A1 protein]	PMID:29950665|PMID:35362542
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1350768	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SLC67A1 gene	PMID:22964155
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of SLC67A1 gene	PMID:23968726
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350768	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC67A1 mRNA	PMID:37042841
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC67A1 mRNA	PMID:37236586
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SLC67A1 mRNA	PMID:19162173
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SLC67A1 mRNA	PMID:24449571
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SLC67A1 mRNA	PMID:19244175
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D002994	Clofibrate results in decreased expression of SLC67A1 mRNA	PMID:17585979
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C056933	fumonisin B1 results in increased expression of SLC67A1 mRNA	PMID:16221962
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D000072318	Dibenzofurans results in increased expression of SLC67A1 mRNA	PMID:34254344
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1350768	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SLC67A1 mRNA	PMID:31533062
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of SLC22A18 mRNA	PMID:39529242
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC67A1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC67A1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SLC67A1 mRNA	PMID:36331819
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C016104	sodium bichromate affects the expression of SLC67A1 mRNA	PMID:22110744
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350768	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC67A1 mRNA	PMID:25979313
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1350768	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC67A1 mRNA	PMID:23179753|PMID:28001369
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1350768	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC67A1 gene	PMID:29154799
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000640	Amitrole results in increased expression of SLC67A1 mRNA	PMID:41580965
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine affects the expression of SLC67A1 mRNA	PMID:20106945
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1350768	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC67A1 mRNA	PMID:21632981|PMID:25562108
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:41500	4-phenylbutyric acid	increases expression	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:C075773	4-phenylbutyric acid results in increased expression of SLC67A1 mRNA	PMID:14583596
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC67A1 mRNA	PMID:38832940
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:45863	paclitaxel	decreases response to substance	ISO	RGD:1350768	E	RGD:6480464	20161213	CTD	MESH:D017239	SLC67A1 protein results in decreased susceptibility to Paclitaxel	PMID:16734730
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D014303	Trinitrotoluene affects the expression of SLC67A1 mRNA	PMID:21346803
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D000082	Acetaminophen affects the expression of SLC67A1 mRNA	PMID:17562736
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC67A1 mRNA	PMID:29067470
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC67A1 mRNA	PMID:33387578
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1350768	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC67A1 gene	PMID:25304211
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC67A1 mRNA	PMID:40504410
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D005047	SLC67A1 protein affects the susceptibility to Etoposide	PMID:16217747
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SLC67A1 protein]	PMID:35362542
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of SLC67A1 mRNA	PMID:38568856
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C029892	cupric chloride results in increased expression of SLC67A1 mRNA	PMID:17211630
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SLC67A1 mRNA	PMID:15725085
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SLC67A1 mRNA	PMID:39716349
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20260707	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of SLC67A1 mRNA	PMID:38825487
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1350768	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SLC67A1 mRNA	PMID:23300844
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SLC67A1 mRNA; Nanotubes, Carbon results in decreased expression of SLC67A1 mRNA	PMID:25554681
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D005485	Flutamide results in decreased expression of SLC67A1 mRNA	PMID:24793618
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of SLC67A1 mRNA	PMID:19042947
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of SLC67A1 mRNA	PMID:20436886
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SLC67A1 protein	PMID:32959892
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D019772	Topotecan results in increased expression of SLC67A1 mRNA	PMID:25729387
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in increased expression of SLC67A1 mRNA	PMID:25729387
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1350768	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SLC67A1 mRNA	PMID:15336504
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D012970	[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC67A1 mRNA	PMID:19001666
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1350768	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SLC67A1 polyA tail	PMID:30157460
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC67A1 mRNA	PMID:22206623
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C051752	nefazodone results in increased expression of SLC67A1 mRNA	PMID:24136188
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1350768	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SLC67A1 mRNA	PMID:36318118
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350768	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC67A1 gene]	PMID:28238834
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:D010634	Phenobarbital affects the expression of SLC67A1 mRNA	PMID:23091169
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of SLC67A1 mRNA	PMID:32109520
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SLC67A1 mRNA	PMID:38648751
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1553822	E	RGD:6480464	20260707	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SLC67A1 mRNA	PMID:30294300
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:82036	prothioconazole	increases expression	ISO	RGD:1350768	E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of SLC67A1 mRNA	PMID:35048155
1303323	Slc22a18	solute carrier family 22, member 18	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C001899	triptolide results in increased expression of SLC67A1 protein	PMID:32519852
1303324	Brd2	bromodomain containing 2	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D004002	Clodronic Acid results in decreased expression of BRD2 mRNA	PMID:25596134
1303324	Brd2	bromodomain containing 2	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:C014026	hexamethylene bisacetamide inhibits the reaction [BRD2 protein binds to SRM promoter]	PMID:26941288
1303324	Brd2	bromodomain containing 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:C084079	triptonide results in increased expression of BRD2 mRNA	PMID:33045310
1303324	Brd2	bromodomain containing 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BRD2 mRNA]	PMID:31150632
1303324	Brd2	bromodomain containing 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of BRD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of BRD2 mRNA	PMID:32699268
1303324	Brd2	bromodomain containing 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of BRD2 mRNA	PMID:25596134
1303324	Brd2	bromodomain containing 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D010100	Oxygen deficiency results in increased expression of BRD2	PMID:27292261
1303324	Brd2	bromodomain containing 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of BRD2 mRNA	PMID:36331819
1303324	Brd2	bromodomain containing 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of BRD2 mRNA	PMID:30319688
1303324	Brd2	bromodomain containing 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D011794	Quercetin results in increased expression of BRD2 mRNA	PMID:21632981
1303324	Brd2	bromodomain containing 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551876	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of BRD2 mRNA	PMID:39241906
1303324	Brd2	bromodomain containing 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BRD2 mRNA; Lipopolysaccharides results in increased expression of BRD2 protein	PMID:26349765
1303324	Brd2	bromodomain containing 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D004958	Estradiol results in increased expression of BRD2 mRNA	PMID:11179685
1303324	Brd2	bromodomain containing 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551876	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of BRD2 mRNA	PMID:39298647
1303324	Brd2	bromodomain containing 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D004958	3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of BRD2 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRD2 mRNA]	PMID:11179685
1303324	Brd2	bromodomain containing 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of BRD2 mRNA	PMID:38568856
1303324	Brd2	bromodomain containing 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of BRD2 mRNA	PMID:33387578
1303324	Brd2	bromodomain containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350574	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BRD2 mRNA	PMID:37042841
1303324	Brd2	bromodomain containing 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D010416	Pentachlorophenol results in increased expression of BRD2 mRNA	PMID:23892564
1303324	Brd2	bromodomain containing 2	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D009538	Nicotine results in increased expression of BRD2 mRNA	PMID:33640489
1303324	Brd2	bromodomain containing 2	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of BRD2 protein	PMID:34122009
1303324	Brd2	bromodomain containing 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1350574	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of BRD2 protein	PMID:37730182
1303324	Brd2	bromodomain containing 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D005839	Gentamicins results in decreased expression of BRD2 mRNA	PMID:22061828
1303324	Brd2	bromodomain containing 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of BRD2 mRNA	PMID:33387578
1303324	Brd2	bromodomain containing 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BRD2 mRNA	PMID:36331819
1303324	Brd2	bromodomain containing 2	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D009538	Nicotine results in increased expression of BRD2 mRNA	PMID:33640489
1303324	Brd2	bromodomain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BRD2 mRNA	PMID:37236586
1303324	Brd2	bromodomain containing 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D019327	Copper Sulfate results in increased expression of BRD2 mRNA	PMID:19549813
1303324	Brd2	bromodomain containing 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BRD2 mRNA	PMID:19770486
1303324	Brd2	bromodomain containing 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of BRD2 mRNA	PMID:23649840
1303324	Brd2	bromodomain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of BRD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of BRD2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of BRD2 mRNA	PMID:32699268
1303324	Brd2	bromodomain containing 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of BRD2 mRNA	PMID:30779732
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BRD2 mRNA	PMID:31150632
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BRD2 mRNA	PMID:31919559
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BRD2 mRNA]	PMID:31150632
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D005492	Folic Acid results in increased expression of BRD2 mRNA	PMID:25629700
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D012643	Selenium results in increased expression of BRD2 mRNA	PMID:19244175
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA	PMID:19244175
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1350574	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of BRD2 protein	PMID:35688186
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27871	chloroacetaldehyde	affects expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:C004656	chloroacetaldehyde affects the expression of BRD2 mRNA	PMID:25596134
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D002945	Cisplatin results in decreased expression of BRD2 mRNA	PMID:25596134
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D002945	Cisplatin results in decreased expression of BRD2 mRNA	PMID:21151649
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D002945	Cisplatin results in increased expression of BRD2 mRNA	PMID:19561079|PMID:38498338
1303324	Brd2	bromodomain containing 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D014414	Tungsten results in decreased expression of BRD2 mRNA	PMID:30912803
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BRD2 mRNA	PMID:33387578
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BRD2 mRNA	PMID:20702594|PMID:21570461
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BRD2 mRNA	PMID:34747641
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D013749	Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRD2 mRNA]	PMID:11179685
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of BRD2 mRNA	PMID:28001369
1303324	Brd2	bromodomain containing 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1350574	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of BRD2 mRNA	PMID:33212167
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1350574	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of BRD2 mRNA	PMID:39709020
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1350574	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of BRD2 mRNA	PMID:30851411
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1350574	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of BRD2 mRNA	PMID:32763439
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D012969	Sodium Fluoride results in increased expression of BRD2 mRNA	PMID:27862939
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BRD2 mRNA	PMID:29803840
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D004317	Doxorubicin results in decreased expression of BRD2 mRNA	PMID:19277126
1303324	Brd2	bromodomain containing 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1350574	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of BRD2 protein	PMID:35688186
1303324	Brd2	bromodomain containing 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1350574	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BRD2 mRNA	PMID:38568856
1303324	Brd2	bromodomain containing 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D014415	Tunicamycin results in increased expression of BRD2 mRNA	PMID:22378314
1303324	Brd2	bromodomain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BRD2 mRNA	PMID:19770486|PMID:20504355
1303324	Brd2	bromodomain containing 2	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of BRD2 protein	PMID:34122009
1303324	Brd2	bromodomain containing 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D012822	Silicon Dioxide results in increased expression of BRD2 mRNA	PMID:19073995
1303324	Brd2	bromodomain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of BRD2 mRNA	PMID:19150397
1303324	Brd2	bromodomain containing 2	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1350574	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of BRD2 mRNA	PMID:35984750
1303324	Brd2	bromodomain containing 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BRD2 gene	PMID:31601247
1303324	Brd2	bromodomain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551876	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BRD2 gene; titanium dioxide results in decreased methylation of BRD2 promoter	PMID:35295148
1303324	Brd2	bromodomain containing 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551876	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BRD2 promoter	PMID:35295148
1303324	Brd2	bromodomain containing 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of BRD2 mRNA	PMID:34492290
1303324	Brd2	bromodomain containing 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:C006253	pirinixic acid results in increased expression of BRD2 mRNA	PMID:16985257
1303324	Brd2	bromodomain containing 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1350574	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of BRD2 mRNA	PMID:30903817
1303324	Brd2	bromodomain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551876	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of BRD2 mRNA	PMID:33221593
1303324	Brd2	bromodomain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:C006780	bisphenol A results in increased expression of BRD2 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1303324	Brd2	bromodomain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1350574	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of BRD2 mRNA	PMID:29275510
1303324	Brd2	bromodomain containing 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of BRD2 gene	PMID:28505145
1303324	Brd2	bromodomain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BRD2 gene	PMID:31601247
1303324	Brd2	bromodomain containing 2	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D024502	Vitamin E results in decreased expression of BRD2 mRNA	PMID:19244175
1303324	Brd2	bromodomain containing 2	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D024502	Vitamin E results in increased expression of BRD2 mRNA	PMID:19244175
1303324	Brd2	bromodomain containing 2	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA	PMID:19244175
1303324	Brd2	bromodomain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551876	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of BRD2 mRNA	PMID:39298647
1303324	Brd2	bromodomain containing 2	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of BRD2 mRNA	PMID:26377693
1303324	Brd2	bromodomain containing 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of BRD2 mRNA	PMID:21241498
1303324	Brd2	bromodomain containing 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D003976	Diazinon results in increased methylation of BRD2 gene	PMID:22964155
1303324	Brd2	bromodomain containing 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1551876	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of BRD2 mRNA	PMID:34813904
1303324	Brd2	bromodomain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350574	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BRD2 mRNA	PMID:37042841
1303324	Brd2	bromodomain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BRD2 mRNA	PMID:25596134
1303324	Brd2	bromodomain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BRD2 mRNA	PMID:37236586
1303324	Brd2	bromodomain containing 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:C039281	furan results in increased expression of BRD2 mRNA	PMID:24183702
1303324	Brd2	bromodomain containing 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:C018021	cobaltous chloride results in increased expression of BRD2 mRNA	PMID:19320972
1303324	Brd2	bromodomain containing 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of BRD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of BRD2 mRNA	PMID:32699268
1303324	Brd2	bromodomain containing 2	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D012643	Selenium results in increased expression of BRD2 mRNA	PMID:19244175
1303324	Brd2	bromodomain containing 2	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA	PMID:19244175
1303324	Brd2	bromodomain containing 2	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of BRD2 mRNA	PMID:25596134
1303324	Brd2	bromodomain containing 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of BRD2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BRD2 mRNA]	PMID:17585979
1303324	Brd2	bromodomain containing 2	gene	CHEBI:38530	quinazolines	decreases splicing	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D011799	Quinazolines results in decreased splicing of BRD2 mRNA	PMID:25281741
1303324	Brd2	bromodomain containing 2	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:C100187	chloropicrin results in increased expression of BRD2 mRNA	PMID:26352163
1303324	Brd2	bromodomain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BRD2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of BRD2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of BRD2 mRNA	PMID:36331819
1303324	Brd2	bromodomain containing 2	gene	CHEBI:39447	pyrimidines	decreases splicing	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D011743	Pyrimidines results in decreased splicing of BRD2 mRNA	PMID:25281741
1303324	Brd2	bromodomain containing 2	gene	CHEBI:39867	valproic acid	affects localization	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D014635	Valproic Acid affects the localization of BRD2 protein	PMID:25769527
1303324	Brd2	bromodomain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of BRD2 mRNA	PMID:29154799
1303324	Brd2	bromodomain containing 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of BRD2 mRNA	PMID:30047161
1303324	Brd2	bromodomain containing 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D016572	Cyclosporine results in increased expression of BRD2 mRNA	PMID:25562108|PMID:25596134
1303324	Brd2	bromodomain containing 2	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1350574	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of BRD2 mRNA	PMID:33512557
1303324	Brd2	bromodomain containing 2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of BRD2 mRNA	PMID:36621641
1303324	Brd2	bromodomain containing 2	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1350574	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of BRD2 mRNA	PMID:33512557
1303324	Brd2	bromodomain containing 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D008727	Methotrexate affects the expression of BRD2 mRNA	PMID:18502557
1303324	Brd2	bromodomain containing 2	gene	CHEBI:44616	afimoxifene	decreases response to substance	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:C016601	BRD2 results in decreased susceptibility to afimoxifene	PMID:21233418
1303324	Brd2	bromodomain containing 2	gene	CHEBI:46024	trichostatin A	affects localization	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:C012589	trichostatin A affects the localization of BRD2 protein	PMID:25769527
1303324	Brd2	bromodomain containing 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:C012589	trichostatin A inhibits the reaction [IL3 protein promotes the reaction [BRD2 protein binds to CISH promoter]]	PMID:25769527
1303324	Brd2	bromodomain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D000082	Acetaminophen affects the expression of BRD2 mRNA	PMID:17562736
1303324	Brd2	bromodomain containing 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of BRD2 mRNA	PMID:33387578
1303324	Brd2	bromodomain containing 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D000082	Acetaminophen results in increased expression of BRD2 mRNA; Acetaminophen results in increased expression of BRD2 protein	PMID:21420995|PMID:26497421|PMID:26690555|PMID:40157625
1303324	Brd2	bromodomain containing 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1551876	E	RGD:6480464	20260113	CTD	MESH:D000082	Acetaminophen results in increased expression of BRD2 mRNA	PMID:40157625
1303324	Brd2	bromodomain containing 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of BRD2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BRD2 mRNA]	PMID:17585979
1303324	Brd2	bromodomain containing 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1551876	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of BRD2 mRNA	PMID:35436446
1303324	Brd2	bromodomain containing 2	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D011345	Fenofibrate results in decreased expression of BRD2 mRNA	PMID:25596134
1303324	Brd2	bromodomain containing 2	gene	CHEBI:50182	3,3'-diindolylmethane	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20180116	CTD	MESH:C016392	3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of BRD2 mRNA]	PMID:11179685
1303324	Brd2	bromodomain containing 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D008713	Methimazole results in decreased expression of BRD2 mRNA	PMID:22504374|PMID:30047161
1303324	Brd2	bromodomain containing 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551876	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of BRD2 mRNA	PMID:35964746
1303324	Brd2	bromodomain containing 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D005485	Flutamide results in increased expression of BRD2 mRNA	PMID:24136188
1303324	Brd2	bromodomain containing 2	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:C029938	nickel sulfate results in decreased expression of BRD2 mRNA	PMID:18651567
1303324	Brd2	bromodomain containing 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1350574	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of BRD2 mRNA	PMID:31629900
1303324	Brd2	bromodomain containing 2	gene	CHEBI:5864	ifosfamide	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:D007069	Ifosfamide results in decreased expression of BRD2 mRNA	PMID:25596134
1303324	Brd2	bromodomain containing 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of BRD2 protein	PMID:32959892
1303324	Brd2	bromodomain containing 2	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1350574	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of BRD2 mRNA	PMID:28988120
1303324	Brd2	bromodomain containing 2	gene	CHEBI:6801	metformin	affects expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D008687	Metformin affects the expression of BRD2 mRNA	PMID:25596134
1303324	Brd2	bromodomain containing 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D008694	Methamphetamine results in increased expression of BRD2 mRNA	PMID:26307267
1303324	Brd2	bromodomain containing 2	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of BRD2 mRNA	PMID:30467583
1303324	Brd2	bromodomain containing 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1350574	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of BRD2 mRNA	PMID:31758290
1303324	Brd2	bromodomain containing 2	gene	CHEBI:7438	N-methylformamide	increases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:C002950	methylformamide analog results in increased expression of BRD2 mRNA; methylformamide results in increased expression of BRD2 mRNA	PMID:17040096
1303324	Brd2	bromodomain containing 2	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1350574	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of BRD2 mRNA	PMID:30851411
1303324	Brd2	bromodomain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BRD2 gene]	PMID:28238834
1303324	Brd2	bromodomain containing 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D010634	Phenobarbital affects the expression of BRD2 mRNA	PMID:23091169
1303324	Brd2	bromodomain containing 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:D010634	Phenobarbital results in decreased expression of BRD2 mRNA	PMID:19270015
1303324	Brd2	bromodomain containing 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1551876	E	RGD:6480464	20211109	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of BRD2 mRNA	PMID:20702594
1303324	Brd2	bromodomain containing 2	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of BRD2 mRNA	PMID:36084822
1303324	Brd2	bromodomain containing 2	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1350574	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of BRD2 mRNA	PMID:33512557
1303324	Brd2	bromodomain containing 2	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of BRD2 mRNA	PMID:30047161
1303324	Brd2	bromodomain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20170418	CTD	MESH:D011441	Propylthiouracil results in decreased expression of BRD2 mRNA	PMID:22504374|PMID:30047161
1303324	Brd2	bromodomain containing 2	gene	CHEBI:87368	diethyl malate	increases expression	ISO	RGD:1350574	E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of BRD2 mRNA	PMID:38498338
1303324	Brd2	bromodomain containing 2	gene	CHEBI:90369	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	multiple interactions	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:C550547	BRD2 mutant form inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL8 protein]]	PMID:26212199
1303324	Brd2	bromodomain containing 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20170418	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of BRD2 mRNA	PMID:21346803
1303324	Brd2	bromodomain containing 2	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1350574	E	RGD:6480464	20170418	CTD	MESH:C004648	testosterone enanthate affects the expression of BRD2 mRNA	PMID:17440010
1303324	Brd2	bromodomain containing 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1350574	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of BRD2 mRNA	PMID:38568856
1303324	Brd2	bromodomain containing 2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1551876	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of BRD2 mRNA	PMID:35537566
1303324	Brd2	bromodomain containing 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20170418	CTD	MESH:C025643	vinclozolin affects the expression of BRD2 mRNA	PMID:19015723
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1344973	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NELFE mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NELFE mRNA	PMID:32699268
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1621569	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NELFE mRNA	PMID:22629407
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1621569	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of NELFE mRNA]	PMID:22629407
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1344973	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of NELFE protein	PMID:28073184
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1344973	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of NELFE mRNA	PMID:21632981
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1621569	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NELFE mRNA	PMID:39241906
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1344973	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of NELFE protein	PMID:20109541
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1621569	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of NELFE mRNA	PMID:19448997
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1344973	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NELFE protein	PMID:37730182
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1621569	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NELFE mRNA	PMID:36331819
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1344973	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NELFE protein	PMID:23301498
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1621569	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of NELFE mRNA	PMID:19376150
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NELFE mRNA	PMID:33354967
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1344973	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NELFE mRNA	PMID:23649840
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344973	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NELFE mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NELFE mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of NELFE mRNA	PMID:32699268
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1621569	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NELFE mRNA	PMID:22206623
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1344973	E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of NELFE gene	PMID:25304211
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1344973	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of NELFE protein	PMID:35688186
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1344973	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of NELFE mRNA	PMID:19921347
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1344973	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein promotes the reaction [NELFE protein binds to ESR1 protein]	PMID:27156127
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621569	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NELFE mRNA	PMID:21570461
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NELFE mRNA	PMID:32109520
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1621569	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NELFE mRNA	PMID:21354282
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NELFE mRNA	PMID:33387578
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases phosphorylation	EXP		E	RGD:6480464	20140715	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased phosphorylation of NELFE protein	PMID:23298284
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1621569	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NELFE mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NELFE promoter]	PMID:17942748|PMID:19654925
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1344973	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NELFE mRNA; aristolochic acid I results in decreased expression of NELFE protein	PMID:33212167
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1344973	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NELFE mRNA	PMID:29803840
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1344973	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of NELFE protein	PMID:35688186
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1621569	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of NELFE gene	PMID:39894169
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1344973	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NELFE 3' UTR	PMID:27901495
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1621569	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of NELFE mRNA	PMID:18648102
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of NELFE mRNA	PMID:33296240
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1344973	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of NELFE protein	PMID:31675489
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in increased expression of NELFE mRNA	PMID:25181051
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1344973	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of NELFE protein	PMID:31675489
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1621569	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of NELFE gene	PMID:31683443
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621569	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NELFE mRNA	PMID:39298647
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1621569	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NELFE mRNA	PMID:32715474
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1621569	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NELFE mRNA	PMID:21266533
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344973	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NELFE mRNA	PMID:37042841
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1344973	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NELFE mRNA	PMID:38568856
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1344973	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NELFE mRNA	PMID:19320972|PMID:19376846
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1344973	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NELFE mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NELFE mRNA	PMID:32699268
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621569	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NELFE mRNA	PMID:36331819
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344973	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of NELFE mRNA	PMID:29154799
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1344973	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of NELFE mRNA	PMID:20106945|PMID:27989131
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1621569	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of NELFE mRNA	PMID:17555576
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1344973	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of NELFE mRNA	PMID:25704631
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1344973	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NELFE mRNA	PMID:29432896
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1344973	E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of NELFE gene	PMID:25304211
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1344973	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of NELFE mRNA	PMID:31675489
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NELFE mRNA	PMID:29391264
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1621569	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NELFE mRNA	PMID:17942748
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1621569	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NELFE mRNA	PMID:17942748
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1621569	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NELFE mRNA	PMID:19042947
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1344973	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NELFE protein	PMID:32959892
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1344973	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NELFE mRNA	PMID:31758290
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1621569	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NELFE mRNA	PMID:22206623
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1344973	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NELFE protein	PMID:37664457
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of NELFE mRNA	PMID:21346803
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344973	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NELFE gene]	PMID:28238834
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1621569	E	RGD:6480464	20130723	CTD	MESH:D010634	Phenobarbital affects the expression of NELFE mRNA	PMID:23091169
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1344973	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NELFE protein	PMID:31675489
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344973	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NELFE protein	PMID:37664457
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NELFE mRNA	PMID:21346803
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1344973	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of NELFE mRNA	PMID:34581912
1303325	Nelfe	negative elongation factor complex member E	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NELFE mRNA	PMID:21346803
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1602903	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DHPS mRNA	PMID:38218311
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DHPS mRNA	PMID:33167477
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1602903	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of DHPS mRNA	PMID:17218384
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1602903	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of DHPS mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of DHPS mRNA	PMID:32699268
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D010100	DHPS protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D005947	DHPS protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D005947	DHPS protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of DHPS mRNA	PMID:16949557
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1602903	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DHPS protein	PMID:37730182
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of DHPS mRNA	PMID:16949557
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DHPS mRNA	PMID:19549813
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DHPS mRNA	PMID:23649840
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602903	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of DHPS mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of DHPS mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of DHPS mRNA	PMID:32699268
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551890	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DHPS mRNA	PMID:31919559
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551890	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DHPS mRNA	PMID:22206623
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1602903	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DHPS mRNA	PMID:19244175
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1602903	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of DHPS mRNA	PMID:19244175
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of DHPS mRNA	PMID:19921347
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DHPS mRNA	PMID:21215274
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHPS mRNA	PMID:33387578
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551890	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHPS mRNA	PMID:18796159|PMID:26290441
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551890	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of DHPS mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to DHPS promoter]	PMID:16214954|PMID:19654925
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1602903	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of DHPS protein	PMID:39603559
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DHPS mRNA	PMID:30851411
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of DHPS mRNA	PMID:28959563
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1602903	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of DHPS mRNA	PMID:16404146
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DHPS mRNA	PMID:38568856
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602903	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DHPS intron	PMID:30157460
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1551890	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of DHPS mRNA	PMID:18648102
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DHPS protein	PMID:31675489
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DHPS mRNA	PMID:34947998
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DHPS mRNA	PMID:36041667
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DHPS protein	PMID:31675489
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1602903	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of DHPS mRNA	PMID:19244175
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1602903	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of DHPS mRNA	PMID:19244175
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1602903	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of DHPS mRNA	PMID:25979313
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DHPS mRNA	PMID:36041667
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DHPS mRNA	PMID:36041667
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1551890	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DHPS exon	PMID:28392331
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1551890	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DHPS mRNA	PMID:21266533
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1602903	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to DHPS protein	PMID:32991956
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602903	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DHPS mRNA	PMID:37042841
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DHPS mRNA	PMID:38568856
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DHPS mRNA	PMID:24386269
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DHPS mRNA	PMID:19376846
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1602903	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of DHPS mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of DHPS mRNA	PMID:32699268
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1602903	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DHPS mRNA	PMID:19244175
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1602903	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of DHPS mRNA	PMID:19244175
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DHPS mRNA	PMID:31533062
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of DHPS mRNA	PMID:22561333
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602903	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DHPS mRNA	PMID:25979313
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of DHPS mRNA	PMID:23179753
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of DHPS mRNA	PMID:30047161
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1602903	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DHPS mRNA	PMID:25562108
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	DHPS protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1602903	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DHPS mRNA	PMID:29523930
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551890	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DHPS mRNA	PMID:25554681
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of DHPS mRNA	PMID:30047161
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DHPS protein	PMID:32959892
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of DHPS mRNA	PMID:15336504
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:67895	corosolic acid	increases expression	ISO	RGD:1602903	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of DHPS mRNA	PMID:37939859
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of DHPS mRNA	PMID:31758290
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551890	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DHPS mRNA	PMID:22206623
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551890	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DHPS mRNA	PMID:22206623
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1602903	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of DHPS protein	PMID:31285264
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1602903	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DHPS mRNA	PMID:30851411
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1551890	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of DHPS mRNA	PMID:19270015|PMID:19482888
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1551890	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of DHPS mRNA]	PMID:19482888
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1551890	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DHPS mRNA	PMID:30294300
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1602903	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DHPS protein	PMID:31675489
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	ISO	RGD:1602903	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of DHPS mRNA	PMID:24834073
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1602903	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of DHPS protein	PMID:31675489
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1551890	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of DHPS mRNA	PMID:39847705
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of DHPS mRNA	PMID:30047161
1303326	Dhps	deoxyhypusine synthase	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased methylation of DHPS promoter	PMID:22570695
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551901	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TMED3 mRNA	PMID:39241906
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of TMED3 mRNA	PMID:32145629
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551901	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of TMED3 mRNA	PMID:19484750|PMID:39298647
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of TMED3 mRNA	PMID:26496021
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMED3 mRNA	PMID:33387578
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1551901	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in decreased expression of TMED3 mRNA	PMID:17178593
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMED3 mRNA	PMID:37992649
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1551901	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of TMED3 mRNA	PMID:33848595
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of TMED3 mRNA	PMID:26496021
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1551901	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in decreased expression of TMED3 mRNA	PMID:17178593
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMED3 mRNA	PMID:37992649
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551901	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMED3 mRNA	PMID:33754040
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMED3 mRNA	PMID:36331819
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TMED3 mRNA	PMID:28522335
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1347293	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of TMED3 mRNA	PMID:20823114
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1551901	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of TMED3 mRNA	PMID:27462272
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347293	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMED3 mRNA	PMID:35301059
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1347293	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TMED3 mRNA	PMID:19549813
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TMED3 mRNA	PMID:30723492|PMID:31150632
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551901	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TMED3 mRNA	PMID:27339419|PMID:31919559
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMED3 mRNA	PMID:22206623
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of TMED3 mRNA	PMID:25905778
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1347293	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TMED3 mRNA	PMID:28903495
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1347293	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of TMED3 mRNA	PMID:23300844
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1347293	E	RGD:6480464	20220607	CTD	MESH:D002945	TMED3 protein affects the susceptibility to Cisplatin	PMID:34758370
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMED3 mRNA	PMID:34747641
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551901	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMED3 mRNA	PMID:21570461
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMED3 mRNA	PMID:32109520
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMED3 mRNA	PMID:21215274
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMED3 mRNA	PMID:25975270
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TMED3 mRNA	PMID:28959563
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1347293	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TMED3 mRNA	PMID:29803840
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMED3 mRNA	PMID:37992649
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:28794	coumarin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of TMED3 mRNA	PMID:18480146
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347293	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMED3 mRNA	PMID:38568856
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551901	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TMED3 mRNA	PMID:22228805
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347293	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMED3 promoter	PMID:27901495
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TMED3 mRNA	PMID:24136188
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TMED3 mRNA	PMID:25729387
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551901	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMED3 gene	PMID:35295148
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1551901	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TMED3 mRNA	PMID:23557971
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551901	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TMED3 gene	PMID:35295148
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TMED3 mRNA	PMID:34492290
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1551901	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of TMED3 mRNA	PMID:18445702|PMID:23811191
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TMED3 mRNA	PMID:19710929
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TMED3 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMED3 mRNA	PMID:25181051
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TMED3 mRNA; [bisphenol A co-treated with Estradiol] results in decreased expression of TMED3 mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of TMED3 mRNA	PMID:26496021|PMID:36041667
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1551901	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TMED3 mRNA	PMID:26682919
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TMED3 mRNA	PMID:36041667
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1551901	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of TMED3 mRNA	PMID:26377693
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TMED3 mRNA	PMID:36041667
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1551901	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TMED3 mRNA	PMID:37019170
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of TMED3 mRNA	PMID:19638242
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TMED3 mRNA	PMID:18164116
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347293	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMED3 mRNA	PMID:37042841
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of TMED3 mRNA	PMID:30589522
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TMED3 mRNA	PMID:30723492
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMED3 mRNA	PMID:25993096
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347293	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMED3 mRNA	PMID:35301059
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1551901	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of TMED3 mRNA	PMID:18353800
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1551901	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of TMED3 mRNA	PMID:23811191
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMED3 mRNA	PMID:36331819
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551901	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TMED3 mRNA	PMID:17292431
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347293	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TMED3 mRNA	PMID:17183730
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1551901	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of TMED3 mRNA	PMID:15331540
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1551901	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TMED3 mRNA	PMID:28973697
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1551901	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in decreased expression of TMED3 mRNA	PMID:17178593
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMED3 mRNA	PMID:37992649
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TMED3 mRNA	PMID:24136188
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of TMED3 mRNA	PMID:21346803
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551901	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMED3 mRNA	PMID:17562736
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1551901	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of TMED3 mRNA	PMID:29246445
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of TMED3 mRNA]	PMID:29246445
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TMED3 mRNA	PMID:29391264
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1551901	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TMED3 mRNA	PMID:35436446
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1551901	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of TMED3 mRNA	PMID:22334560
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1347293	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TMED3 mRNA	PMID:23300844
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551901	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TMED3 mRNA; Nanotubes, Carbon results in increased expression of TMED3 mRNA	PMID:25620056
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1347293	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TMED3 mRNA	PMID:17183730
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1347293	E	RGD:6480464	20131220	CTD	MESH:D015474	Isotretinoin results in decreased expression of P24B mRNA	PMID:20436886
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1347293	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TMED3 protein	PMID:32959892
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:62878	XAV939	multiple interactions	ISO	RGD:1347293	E	RGD:6480464	20220607	CTD	MESH:C544261	XAV939 inhibits the reaction [TMED3 protein results in increased expression of CTNNB1 protein]	PMID:34758370
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TMED3 mRNA	PMID:25729387
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:67271	MK-2206	multiple interactions	ISO	RGD:1347293	E	RGD:6480464	20220607	CTD	MESH:C548887	MK 2206 inhibits the reaction [TMED3 protein results in increased expression of CTNNB1 protein]; MK 2206 inhibits the reaction [TMED3 protein results in increased phosphorylation of AKT1 protein]; MK 2206 inhibits the reaction [TMED3 protein results in increased phosphorylation of GSK3B protein]	PMID:34758370
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551901	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMED3 mRNA	PMID:22206623
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:756996	imeglimin	decreases expression	ISO	RGD:1551901	E	RGD:6480464	20260714	CTD	MESH:C575881	imeglimin results in decreased expression of TMED3 mRNA	PMID:40713970
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TMED3 mRNA	PMID:18164116
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1551901	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TMED3 mRNA	PMID:19270015
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1551901	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TMED3 mRNA	PMID:30294300
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1551901	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of TMED3 mRNA	PMID:22334560
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1347293	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of TMED3 mRNA	PMID:30458266
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1551901	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of TMED3 mRNA	PMID:21278054|PMID:22334560
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of TMED3 mRNA	PMID:25905778
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TMED3 mRNA	PMID:21346803
1303327	Tmed3	transmembrane p24 trafficking protein 3	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1551901	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of TMED3 mRNA	PMID:28973697
1303328	Clint1	clathrin interactor 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1602726	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CLINT1 mRNA	PMID:38218311
1303328	Clint1	clathrin interactor 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1616577	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CLINT1 mRNA	PMID:37995155
1303328	Clint1	clathrin interactor 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CLINT1 mRNA]	PMID:31150632
1303328	Clint1	clathrin interactor 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1616577	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CLINT1 gene	PMID:20938992
1303328	Clint1	clathrin interactor 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1616577	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of CLINT1 mRNA	PMID:16169686
1303328	Clint1	clathrin interactor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1602726	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of CLINT1 mRNA	PMID:23830798
1303328	Clint1	clathrin interactor 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1616577	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CLINT1 mRNA	PMID:30319688
1303328	Clint1	clathrin interactor 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of CLINT1 mRNA	PMID:32145629
1303328	Clint1	clathrin interactor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1616577	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CLINT1 mRNA	PMID:39298647
1303328	Clint1	clathrin interactor 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1616577	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CLINT1 gene	PMID:20938992
1303328	Clint1	clathrin interactor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602726	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CLINT1 mRNA	PMID:37042841
1303328	Clint1	clathrin interactor 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1602726	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of CLINT1 mRNA	PMID:20655997
1303328	Clint1	clathrin interactor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1616577	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CLINT1 mRNA	PMID:33754040
1303328	Clint1	clathrin interactor 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CLINT1 mRNA	PMID:26577399|PMID:27523638
1303328	Clint1	clathrin interactor 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1602726	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CLINT1 protein	PMID:37730182
1303328	Clint1	clathrin interactor 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CLINT1 mRNA	PMID:22061828
1303328	Clint1	clathrin interactor 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1616577	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CLINT1 mRNA	PMID:36331819
1303328	Clint1	clathrin interactor 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1602726	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CLINT1 protein	PMID:23301498
1303328	Clint1	clathrin interactor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602726	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CLINT1 mRNA	PMID:35430440
1303328	Clint1	clathrin interactor 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1602726	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CLINT1 protein	PMID:38598786
1303328	Clint1	clathrin interactor 1	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1602726	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of CLINT1 mRNA	PMID:15672453
1303328	Clint1	clathrin interactor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CLINT1 mRNA	PMID:31150632
1303328	Clint1	clathrin interactor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1616577	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CLINT1 mRNA	PMID:31919559
1303328	Clint1	clathrin interactor 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CLINT1 mRNA]	PMID:31150632
1303328	Clint1	clathrin interactor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1616577	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CLINT1 mRNA	PMID:25629700
1303328	Clint1	clathrin interactor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616577	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CLINT1 gene	PMID:20938992
1303328	Clint1	clathrin interactor 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1602726	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CLINT1 protein	PMID:35688186
1303328	Clint1	clathrin interactor 1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1616577	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CLINT1 protein	PMID:36173347
1303328	Clint1	clathrin interactor 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1616577	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CLINT1 mRNA	PMID:28960355
1303328	Clint1	clathrin interactor 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1602726	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of CLINT1 mRNA	PMID:19921347
1303328	Clint1	clathrin interactor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1616577	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLINT1 mRNA	PMID:21570461
1303328	Clint1	clathrin interactor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1602726	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CLINT1 mRNA	PMID:33212167
1303328	Clint1	clathrin interactor 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1602726	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of CLINT1 mRNA	PMID:20971185
1303328	Clint1	clathrin interactor 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602726	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CLINT1 mRNA	PMID:38568856
1303328	Clint1	clathrin interactor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602726	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [CLINT1 protein binds to CAPRIN1 protein]	PMID:33939924
1303328	Clint1	clathrin interactor 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1602726	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of CLINT1 mRNA	PMID:20971185
1303328	Clint1	clathrin interactor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1602726	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CLINT1 mRNA	PMID:19150397
1303328	Clint1	clathrin interactor 1	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of CLINT1 mRNA	PMID:24915197
1303328	Clint1	clathrin interactor 1	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1602726	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of CLINT1 mRNA	PMID:31745603
1303328	Clint1	clathrin interactor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1616577	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CLINT1 gene	PMID:35295148
1303328	Clint1	clathrin interactor 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CLINT1 mRNA	PMID:34492290
1303328	Clint1	clathrin interactor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of CLINT1 mRNA	PMID:32145629
1303328	Clint1	clathrin interactor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CLINT1 mRNA	PMID:25181051|PMID:30816183
1303328	Clint1	clathrin interactor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1616577	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CLINT1 mRNA	PMID:39298647
1303328	Clint1	clathrin interactor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1616577	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CLINT1 mRNA	PMID:38685157
1303328	Clint1	clathrin interactor 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1602726	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CLINT1 protein	PMID:34186270
1303328	Clint1	clathrin interactor 1	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1616577	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of CLINT1 intron	PMID:28392331
1303328	Clint1	clathrin interactor 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1602726	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of CLINT1 protein	PMID:38598786
1303328	Clint1	clathrin interactor 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CLINT1 gene	PMID:33148267
1303328	Clint1	clathrin interactor 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CLINT1 promoter	PMID:22457795
1303328	Clint1	clathrin interactor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616577	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CLINT1 mRNA	PMID:36331819
1303328	Clint1	clathrin interactor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602726	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CLINT1 mRNA	PMID:25979313
1303328	Clint1	clathrin interactor 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1602726	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CLINT1 mRNA	PMID:20106945
1303328	Clint1	clathrin interactor 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1616577	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CLINT1 mRNA	PMID:17555576
1303328	Clint1	clathrin interactor 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602726	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLINT1 mRNA	PMID:21420995
1303328	Clint1	clathrin interactor 1	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C005219	methyl cellosolve results in increased expression of CLINT1 mRNA	PMID:19643169
1303328	Clint1	clathrin interactor 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1616577	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CLINT1 mRNA	PMID:35436446
1303328	Clint1	clathrin interactor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1616577	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CLINT1 mRNA	PMID:17555576
1303328	Clint1	clathrin interactor 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1616577	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CLINT1 mRNA	PMID:25620056
1303328	Clint1	clathrin interactor 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in decreased expression of CLINT1 mRNA	PMID:22504374
1303328	Clint1	clathrin interactor 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CLINT1 mRNA	PMID:24136188
1303328	Clint1	clathrin interactor 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1602726	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CLINT1 protein	PMID:32959892
1303328	Clint1	clathrin interactor 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1616577	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CLINT1 mRNA	PMID:23650126
1303328	Clint1	clathrin interactor 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CLINT1 gene	PMID:33148267
1303328	Clint1	clathrin interactor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1616577	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CLINT1 mRNA	PMID:22206623
1303328	Clint1	clathrin interactor 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1602726	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CLINT1 protein	PMID:37664457
1303328	Clint1	clathrin interactor 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1616577	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CLINT1 mRNA	PMID:21278054
1303328	Clint1	clathrin interactor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CLINT1 mRNA	PMID:22504374|PMID:24780913
1303328	Clint1	clathrin interactor 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602726	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CLINT1 protein	PMID:37664457
1303328	Clint1	clathrin interactor 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1602726	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of CLINT1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CLINT1 protein	PMID:38598786
1303328	Clint1	clathrin interactor 1	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1616577	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CLINT1 mRNA	PMID:18930950
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1604645	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of USH1C mRNA	PMID:27188386
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of USH1C mRNA	PMID:35811015
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of USH1C protein	PMID:32145629
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1553848	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of USH1C mRNA	PMID:25510870
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553848	E	RGD:6480464	20130402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of USH1C mRNA	PMID:22401849
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1553848	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of USH1C mRNA	PMID:36706583
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of USH1C mRNA	PMID:26577399
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1604645	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of USH1C intron	PMID:30157460
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of USH1C mRNA	PMID:21515302
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of USH1C mRNA	PMID:35301059
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1553848	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of USH1C mRNA	PMID:25510870
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1553848	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of USH1C mRNA	PMID:25510870
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20130402	CTD	MESH:C016517	indole-3-carbinol affects the expression of USH1C mRNA	PMID:21396975
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1604645	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of USH1C intron	PMID:30157460
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1604645	E	RGD:6480464	20130402	CTD	MESH:D015032	Zinc results in decreased expression of USH1C mRNA	PMID:15984569
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of USH1C mRNA	PMID:38460933
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of USH1C mRNA	PMID:38314887
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of USH1C mRNA	PMID:41028656
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1604645	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of USH1C mRNA	PMID:27392435
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of USH1C mRNA	PMID:27392435
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20130402	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USH1C mRNA	PMID:22298810
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1604645	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of USH1C mRNA	PMID:29955902
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of USH1C mRNA	PMID:41028656
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1604645	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of USH1C mRNA	PMID:20044591
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1604645	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of USH1C gene	PMID:28589171
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1553848	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of USH1C mRNA	PMID:36209798|PMID:37682722
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604645	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of USH1C intron; Benzo(a)pyrene affects the methylation of USH1C promoter	PMID:27901495|PMID:30157460
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604645	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of USH1C exon	PMID:27901495
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of USH1C mRNA	PMID:41028656
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1604645	E	RGD:6480464	20130402	CTD	MESH:D015032	Zinc results in decreased expression of USH1C mRNA	PMID:15984569
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1553848	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of USH1C mRNA	PMID:27131904
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1604645	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of USH1C mRNA	PMID:25895662
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of USH1C mRNA	PMID:21515302
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1553848	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of USH1C mRNA	PMID:28472532
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of USH1C mRNA	PMID:25181051
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553848	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of USH1C mRNA	PMID:26063408
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604645	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of USH1C gene	PMID:31601247
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of USH1C protein	PMID:32145629
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553848	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of USH1C mRNA	PMID:25594700
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of USH1C gene	PMID:28505145
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1553848	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of USH1C mRNA	PMID:25510870
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1553848	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of USH1C mRNA	PMID:25510870
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1553848	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of USH1C gene	PMID:31683443
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1604645	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of USH1C intron	PMID:30157460
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of USH1C mRNA	PMID:35301059
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of USH1C mRNA	PMID:27387713
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1604645	E	RGD:6480464	20130402	CTD	MESH:C018021	cobaltous chloride results in decreased expression of USH1C mRNA	PMID:19376846
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1604645	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of USH1C mRNA	PMID:28302478
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604645	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of USH1C mRNA	PMID:25979313
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604645	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of USH1C mRNA	PMID:29154799
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of USH1C mRNA	PMID:41580965
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1553848	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of USH1C mRNA	PMID:28973697
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1604645	E	RGD:6480464	20120412	CTD	MESH:D008727	USH1C protein affects the susceptibility to Methotrexate	PMID:16217747
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1604645	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in increased expression of USH1C mRNA	PMID:28542535
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of USH1C mRNA	PMID:35811015
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of USH1C mRNA	PMID:38460933
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1604645	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of USH1C mRNA	PMID:31838189
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1553848	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of USH1C mRNA	PMID:23608068
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1553848	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of USH1C mRNA	PMID:26307267
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1604645	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of USH1C intron	PMID:30157460
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of USH1C gene	PMID:35440735
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553848	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of USH1C mRNA	PMID:22206623
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604645	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to USH1C gene]	PMID:28238834
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1553848	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of USH1C mRNA	PMID:36706583
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1553848	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of USH1C mRNA	PMID:27131904
1303329	Ush1c	USH1 protein network component harmonin	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20130402	CTD	MESH:C057693	troglitazone results in decreased expression of USH1C mRNA	PMID:21515302
1303330	Prss57	serine protease 57	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621495	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PRSS57 mRNA	PMID:33045310
1303330	Prss57	serine protease 57	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1342482	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PRSS57 mRNA	PMID:33167477
1303330	Prss57	serine protease 57	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1342482	E	RGD:6480464	20170110	CTD	MESH:C018475	butyraldehyde results in increased expression of PRSS57 mRNA	PMID:26079696
1303330	Prss57	serine protease 57	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1342482	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PRSS57 mRNA	PMID:37042841
1303330	Prss57	serine protease 57	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1342482	E	RGD:6480464	20170110	CTD	MESH:C005556	propionaldehyde results in increased expression of PRSS57 mRNA	PMID:26079696
1303330	Prss57	serine protease 57	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PRSS57 promoter	PMID:23359474
1303330	Prss57	serine protease 57	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1342482	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PRSS57 intron	PMID:30157460
1303330	Prss57	serine protease 57	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1342482	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRSS57 mRNA	PMID:35301059
1303330	Prss57	serine protease 57	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1342482	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of PRSS57 mRNA	PMID:38460933
1303330	Prss57	serine protease 57	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1342482	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PRSS57 mRNA	PMID:27392435
1303330	Prss57	serine protease 57	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1342482	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PRSS57 mRNA	PMID:27392435
1303330	Prss57	serine protease 57	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1342482	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRSS57 intron; Benzo(a)pyrene affects the methylation of PRSS57 promoter	PMID:27901495|PMID:30157460
1303330	Prss57	serine protease 57	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1621495	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PRSS57 mRNA	PMID:29264374
1303330	Prss57	serine protease 57	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRSS57 mRNA	PMID:25181051
1303330	Prss57	serine protease 57	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621495	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of PRSS57 mRNA	PMID:29161229
1303330	Prss57	serine protease 57	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1621495	E	RGD:6480464	20170110	CTD	MESH:C006780	bisphenol A results in increased expression of PRSS57 mRNA	PMID:22687993|PMID:30951980
1303330	Prss57	serine protease 57	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PRSS57 promoter	PMID:23359474
1303330	Prss57	serine protease 57	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621495	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PRSS57 mRNA	PMID:30951980
1303330	Prss57	serine protease 57	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1621495	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PRSS57 mRNA	PMID:30951980
1303330	Prss57	serine protease 57	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PRSS57 promoter	PMID:23359474
1303330	Prss57	serine protease 57	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1342482	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PRSS57 mRNA	PMID:38382870
1303330	Prss57	serine protease 57	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of PRSS57 promoter	PMID:22457795
1303330	Prss57	serine protease 57	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1342482	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRSS57 mRNA	PMID:35301059
1303330	Prss57	serine protease 57	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of PRSS57 mRNA	PMID:35594946
1303330	Prss57	serine protease 57	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1621495	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PRSS57 mRNA	PMID:38701926
1303330	Prss57	serine protease 57	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1621495	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PRSS57 mRNA	PMID:38648751
1303330	Prss57	serine protease 57	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1342482	E	RGD:6480464	20170110	CTD	MESH:C046012	pentanal results in increased expression of PRSS57 mRNA	PMID:26079696
1303330	Prss57	serine protease 57	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1342482	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PRSS57 mRNA	PMID:29301935
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1344743	E	RGD:6480464	20140610	CTD	MESH:D015215	Zidovudine results in increased expression of PNKP mRNA	PMID:23675285
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PNKP mRNA	PMID:38218311
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:132098	methoxyacetic acid	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid affects the expression of PNKP mRNA	PMID:20864626
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1551919	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of PNKP mRNA	PMID:33045310
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1344743	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of PNKP protein	PMID:39571964
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1344743	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of PNKP protein	PMID:28073184
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20130312	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of PNKP mRNA	PMID:22539617
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of PNKP mRNA	PMID:17103110
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1344743	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PNKP mRNA	PMID:21632981
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551919	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PNKP mRNA	PMID:39298647
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PNKP mRNA	PMID:33387578
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344743	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PNKP mRNA	PMID:37042841
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20210608	CTD	MESH:D005947	Glucose results in decreased expression of PNKP mRNA	PMID:32942007
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20210608	CTD	MESH:D005947	Glucose results in decreased expression of PNKP mRNA	PMID:32942007
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1344743	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PNKP protein	PMID:37730182
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1344743	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PNKP exon	PMID:30157460
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1344743	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PNKP intron	PMID:30157460
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1344743	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PNKP mRNA	PMID:39836092
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344743	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PNKP mRNA	PMID:35430440
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551919	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PNKP mRNA]	PMID:22206623
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1344743	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PNKP gene	PMID:25304211
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1344743	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PNKP mRNA	PMID:39836092
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551919	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PNKP mRNA	PMID:40504410
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1344743	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PNKP mRNA	PMID:19244175
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1344743	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PNKP protein	PMID:35688186
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PNKP mRNA	PMID:27392435
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1551919	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of PNKP mRNA	PMID:21151649
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551919	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PNKP mRNA	PMID:21570461
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551919	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PNKP mRNA	PMID:28922406
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PNKP mRNA	PMID:33387578
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551919	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PNKP mRNA	PMID:17942748
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of PNKP mRNA	PMID:33512557
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PNKP mRNA	PMID:33212167
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1344743	E	RGD:6480464	20230704	CTD	MESH:D004317	[TP53 protein affects the susceptibility to Doxorubicin] which affects the expression of PNKP mRNA	PMID:36634904
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344743	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PNKP mRNA	PMID:38568856
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1344743	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PNKP mRNA; [sodium arsenite co-treated with Tretinoin] results in decreased expression of PNKP protein	PMID:39571964|PMID:39836092
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551919	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PNKP mRNA	PMID:40504410
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344743	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PNKP intron	PMID:30157460
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1344743	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PNKP 3' UTR	PMID:27901495
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551919	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PNKP gene	PMID:35295148
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PNKP mRNA	PMID:34492290
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of PNKP protein	PMID:31675489
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PNKP mRNA	PMID:25181051
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PNKP protein	PMID:31675489
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PNKP mRNA	PMID:19244175
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551919	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PNKP mRNA	PMID:39298647
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PNKP mRNA	PMID:21241498
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1551919	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of PNKP mRNA	PMID:31558096
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551919	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PNKP mRNA	PMID:34813904
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1551919	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PNKP mRNA	PMID:34813904
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344743	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PNKP mRNA	PMID:37042841
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of PNKP mRNA	PMID:30589522
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1344743	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PNKP mRNA	PMID:39836092
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:35458	cerium trichloride	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20180116	CTD	MESH:C026690	cerous chloride results in decreased expression of PNKP mRNA	PMID:28954213
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1344743	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PNKP mRNA	PMID:19376846
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1344743	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PNKP mRNA	PMID:19244175
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1551919	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of PNKP mRNA	PMID:23811191
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:38211	potassium bromate	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20130312	CTD	MESH:C019536	potassium bromate results in decreased expression of PNKP mRNA	PMID:22539617
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1551919	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of PNKP mRNA	PMID:31558096
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551919	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PNKP mRNA	PMID:17963808
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PNKP mRNA	PMID:29154799
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1344743	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PNKP mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of PNKP mRNA	PMID:33512557
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20210608	CTD	MESH:D005947	Glucose results in decreased expression of PNKP mRNA	PMID:32942007
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1344743	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PNKP gene	PMID:25304211
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1344743	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PNKP mRNA	PMID:39836092
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551919	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PNKP mRNA	PMID:40504410
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of PNKP mRNA	PMID:31675489
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551919	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PNKP mRNA	PMID:17942748
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551919	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PNKP mRNA	PMID:35964746
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PNKP protein	PMID:32959892
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1344743	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PNKP mRNA	PMID:39836092
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:68234	myristicin	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20141111	CTD	MESH:C005246	myristicin results in decreased expression of PNKP mRNA	PMID:24792648
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PNKP mRNA	PMID:31758290
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551919	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PNKP mRNA	PMID:22206623
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551919	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PNKP mRNA]	PMID:22206623
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1551919	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of PNKP mRNA	PMID:27858113
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1344743	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PNKP mRNA	PMID:37199045
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1344743	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of PNKP protein	PMID:31285264
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in decreased expression of PNKP mRNA	PMID:23358140
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344743	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PNKP gene]	PMID:28238834
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:80770	Brevetoxin B	increases expression	ISO	RGD:1344743	E	RGD:6480464	20170228	CTD	MESH:C043466	brevetoxin 2 results in increased expression of PNKP mRNA	PMID:20498034
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1551919	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of PNKP mRNA	PMID:31558096
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:8207	(+)-pilocarpine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in increased expression of PNKP mRNA	PMID:17971868
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PNKP protein	PMID:31675489
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of PNKP mRNA	PMID:33512557
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1344743	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of PNKP protein	PMID:38348393
1303331	Pnkp	polynucleotide kinase 3'-phosphatase	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PNKP mRNA	PMID:23034163
1303332	Cyp21a1-ps	cytochrome P450, family 21, subfamily a, polypeptide 1, pseudogene	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CYP21A1-PS gene	PMID:28931070
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LY6G6F mRNA	PMID:29945229
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LY6G6F mRNA	PMID:30779732
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of LY6G6F gene	PMID:31011160
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1622660	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of LY6G6F mRNA	PMID:40618947
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1622660	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of LY6G6F mRNA	PMID:32186404
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1342827	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LY6G6F promoter	PMID:27901495
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1622660	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of LY6G6F mRNA	PMID:35295148
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	ISO	RGD:1342827	E	RGD:6480464	20250708	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of LY6G6F gene	PMID:38723642
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LY6G6F mRNA	PMID:25181051
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1342827	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LY6G6F mRNA	PMID:37042841
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of LY6G6F promoter	PMID:22457795
1303333	Ly6g6f	lymphocyte antigen 6 family member G6F	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1622660	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of LY6G6F mRNA	PMID:38701926
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of HYAL3 mRNA	PMID:21551480
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1620668	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HYAL3 mRNA	PMID:20938992
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1344724	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HYAL3 mRNA	PMID:26079696
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1344724	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of HYAL3 mRNA	PMID:20044591
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of HYAL3 mRNA	PMID:33387578
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1620668	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HYAL3 mRNA	PMID:20938992
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:199329	Inotodiol	multiple interactions	ISO	RGD:1344724	E	RGD:6480464	20250114	CTD	MESH:C517091	inotodiol inhibits the reaction [TNF protein results in increased expression of HYAL3 mRNA]	PMID:37628993
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1344724	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HYAL3 mRNA	PMID:19549813
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1344724	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of HYAL3 mRNA	PMID:27153756
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HYAL3 mRNA	PMID:22484513
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620668	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HYAL3 mRNA	PMID:20938992
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of HYAL3 gene	PMID:31011160
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344724	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of HYAL3 mRNA	PMID:23557933
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1344724	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HYAL3 mRNA	PMID:27392435
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1620668	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of HYAL3 mRNA	PMID:32186404
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HYAL3 mRNA	PMID:33387578
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344724	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HYAL3 mRNA	PMID:33212167
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1344724	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of HYAL3 mRNA	PMID:30851411
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1344724	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of HYAL3 mRNA	PMID:34032870
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1344724	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of HYAL3 mRNA	PMID:35984750
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1344724	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HYAL3 gene	PMID:31601247
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of HYAL3 mRNA	PMID:24136188
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620668	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HYAL3 promoter	PMID:35295148
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1344724	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HYAL3 mRNA	PMID:19710929
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:32687	piperonyl butoxide	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in decreased expression of HYAL3 mRNA	PMID:22484513
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HYAL3 mRNA	PMID:25181051
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1620668	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of HYAL3 promoter	PMID:27312807
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1344724	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HYAL3 gene	PMID:31601247
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of HYAL3 mRNA	PMID:27914987
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344724	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HYAL3 mRNA	PMID:37042841
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HYAL3 mRNA	PMID:25993096
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1344724	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HYAL3 mRNA	PMID:31533062
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1344724	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HYAL3 mRNA	PMID:40419075
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620668	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of HYAL3 mRNA	PMID:36331819
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1620668	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of HYAL3 mRNA	PMID:17292431
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of HYAL3 mRNA	PMID:29427782
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of HYAL3 mRNA	PMID:24136188
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1344724	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HYAL3 mRNA	PMID:38832940
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:6015	isoflurane	increases methylation	ISO	RGD:1620668	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in increased methylation of HYAL3 mRNA	PMID:35249202
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of HYAL3 mRNA	PMID:24136188
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:63934	bathocuproine disulfonic acid	multiple interactions	ISO	RGD:1344724	E	RGD:6480464	20120814	CTD	MESH:C028559	[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of HYAL3 mRNA	PMID:15477007
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1344724	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of HYAL3 mRNA	PMID:31758290
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of HYAL3 mRNA	PMID:24136188
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of HYAL3 promoter	PMID:27415467
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1344724	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of HYAL3 mRNA	PMID:30851411
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	ISO	RGD:1344724	E	RGD:6480464	20140708	CTD	MESH:C020972	[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of HYAL3 mRNA	PMID:15477007
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1620668	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in increased expression of HYAL3 mRNA	PMID:35278568
1303334	Hyal3	hyaluronidase 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1344724	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of HYAL3 mRNA	PMID:38568856
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GGT6 mRNA	PMID:36331819
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1603275	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of GGT6 mRNA	PMID:26079696
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1551934	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of GGT6 mRNA	PMID:19167417
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551934	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of GGT6 mRNA	PMID:39298647
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603275	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of GGT6 mRNA	PMID:21185374
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1603275	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of GGT6 mRNA	PMID:30165855
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGT6 mRNA	PMID:25510870
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GGT6 mRNA	PMID:33387578
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1551934	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of GGT6 mRNA	PMID:22238285
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1603275	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GGT6 mRNA	PMID:28818685
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GGT6 mRNA	PMID:36331819
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGT6 mRNA	PMID:25510870
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGT6 mRNA	PMID:25510870
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1603275	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of GGT6 mRNA	PMID:19549813
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1551934	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GGT6 mRNA	PMID:31919559
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GGT6 mRNA	PMID:22206623
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603275	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGT6 mRNA	PMID:32525701
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1603275	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of GGT6 mRNA	PMID:38460933
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1551934	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of GGT6 mRNA	PMID:32186404
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551934	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GGT6 mRNA	PMID:21570461
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551934	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GGT6 mRNA	PMID:26290441
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GGT6 mRNA	PMID:25975270
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603275	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of GGT6 mRNA	PMID:34032870
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603275	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of GGT6 mRNA	PMID:39719251
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1603275	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GGT6 promoter	PMID:27901495
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551934	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GGT6 mRNA	PMID:19770486
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1551934	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of GGT6 mRNA	PMID:23557971
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	ISO	RGD:1603275	E	RGD:6480464	20250708	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of GGT6 gene	PMID:38723642
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in decreased expression of GGT6 mRNA	PMID:34973380
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551934	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GGT6 mRNA	PMID:33221593
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GGT6 gene	PMID:28505145
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGT6 mRNA	PMID:25510870
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGT6 mRNA	PMID:25510870
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551934	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of GGT6 mRNA	PMID:40203079
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551934	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GGT6 mRNA	PMID:39298647
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of GGT6 mRNA	PMID:35163327
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of GGT6 mRNA	PMID:35163327
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1551934	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of GGT6 mRNA	PMID:39529242
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GGT6 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GGT6 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of GGT6 mRNA	PMID:36331819
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551934	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GGT6 mRNA	PMID:17292431
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603275	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GGT6 gene	PMID:29154799
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551934	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GGT6 mRNA	PMID:17562736
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603275	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of GGT6 mRNA	PMID:26690555
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1603275	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of GGT6 mRNA	PMID:38460933
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603275	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGT6 mRNA	PMID:32525701
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1603275	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of GGT6 mRNA	PMID:38825487
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551934	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GGT6 mRNA	PMID:25620056
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1551934	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of GGT6 mRNA	PMID:19042947
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1551934	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of GGT6 mRNA	PMID:23608068
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1551934	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of GGT6 mRNA	PMID:36851058
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1603275	E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of GGT6 mRNA	PMID:33244087
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551934	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GGT6 mRNA	PMID:22206623
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551934	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GGT6 mRNA	PMID:22206623
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in decreased expression of GGT6 mRNA	PMID:17483316
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603275	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GGT6 gene]	PMID:28238834
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551934	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GGT6 mRNA	PMID:23091169
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1603275	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGT6 mRNA	PMID:32525701
1303335	Ggt6	gamma-glutamyl transferase 6	gene	CHEBI:87368	diethyl malate	affects expression	ISO	RGD:1551934	E	RGD:6480464	20170303	CTD	MESH:C058705	diethyl malate affects the expression of GGT6 mRNA	PMID:24814887
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20260407	CTD	MESH:C007262	deoxynivalenol results in decreased expression of DNMT3A mRNA; deoxynivalenol results in decreased expression of DNMT3A protein	PMID:40749799
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C007262	deoxynivalenol results in increased expression of DNMT3A mRNA; deoxynivalenol results in increased expression of DNMT3A protein	PMID:32738333
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DNMT3A mRNA	PMID:38218311
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606038	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DNMT3A mRNA	PMID:38218311
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:135338	guggulsterone	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20170307	CTD	MESH:C023617	pregna-4,17-diene-3,16-dione results in decreased expression of DNMT3A mRNA	PMID:23593078
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:135937	enzacamene	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C038939	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DNMT3A mRNA	PMID:25607892
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of DNMT3A mRNA	PMID:30071829
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1620920	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DNMT3A mRNA	PMID:20188158
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3A protein; [Methionine deficiency co-treated with Choline deficiency] results in increased expression of DNMT3A mRNA; [Methionine deficiency co-treated with Choline deficiency] results in increased expression of DNMT3A protein	PMID:20548288|PMID:20938992|PMID:25690533
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20220705	CTD	MESH:D001241	Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3A mRNA]; Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3A protein]	PMID:34979192
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of DNMT3A mRNA	PMID:17273765|PMID:21934132
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:15414	S-adenosyl-L-methionine	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20121113	CTD	MESH:D012436	S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in decreased expression of DNMT3A protein]	PMID:22558281
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:15414	S-adenosyl-L-methionine	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:D012436	S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of DNMT3A mRNA]	PMID:18098314
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D003634	DDT results in decreased expression of DNMT3A mRNA	PMID:19797855
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1606038	E	RGD:6480464	20220510	CTD	MESH:D000431	Ethanol affects the expression of DNMT3A protein	PMID:35149083
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1620920	E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol affects the expression of DNMT3A mRNA	PMID:26730594
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1620920	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DNMT3A mRNA	PMID:30319688
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20140211	CTD	MESH:D000431	Ethanol results in decreased expression of DNMT3A protein	PMID:23395981
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16236	ethanol	increases degradation	ISO	RGD:1620920	E	RGD:6480464	20140211	CTD	MESH:D000431	Ethanol results in increased degradation of DNMT3A protein	PMID:23395981
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1620920	E	RGD:6480464	20140211	CTD	MESH:D000431	Ethanol results in increased expression of DNMT3A mRNA	PMID:23395981
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20140211	CTD	MESH:D000431	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Ethanol results in increased degradation of DNMT3A protein]	PMID:23395981
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1606038	E	RGD:6480464	20180220	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of DNMT3A mRNA; Hydrogen Peroxide results in increased expression of DNMT3A protein	PMID:27655674|PMID:37940031
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of DNMT3A mRNA	PMID:22952798
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606038	E	RGD:6480464	20190312	CTD	MESH:D004958	Estradiol results in increased expression of DNMT3A mRNA	PMID:30684530
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D004958	[Testosterone co-treated with Estradiol] affects the reaction [bisphenol A results in increased expression of DNMT3A mRNA]; [Testosterone co-treated with Estradiol] affects the reaction [estradiol-17 beta-benzoate results in increased expression of DNMT3A mRNA]	PMID:22109888
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol inhibits the reaction [sodium arsenite results in decreased expression of DNMT3A mRNA]; sodium arsenite inhibits the reaction [Estradiol results in decreased expression of DNMT3A mRNA]	PMID:22952798
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of DNMT3A mRNA	PMID:30153481
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DNMT3A mRNA	PMID:27618143
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DNMT3A mRNA	PMID:22407948|PMID:25549359|PMID:27618143|PMID:28013219
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of DNMT3A gene	PMID:27618143
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20200609	CTD	MESH:D008715	[Methionine co-treated with 6-formylindolo(3,2-b)carbazole] results in increased expression of DNMT3A mRNA	PMID:31626383
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3A protein; [Methionine deficiency co-treated with Choline deficiency] results in increased expression of DNMT3A mRNA; [Methionine deficiency co-treated with Choline deficiency] results in increased expression of DNMT3A protein	PMID:20548288|PMID:20938992|PMID:25690533
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606038	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DNMT3A mRNA	PMID:37042841
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1606038	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of DNMT3A mRNA	PMID:21325737
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:167830	isorhapontigenin	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20240430	CTD	MESH:C432307	[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3A protein	PMID:37619952
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16827	corticosterone	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D003345	Corticosterone results in decreased expression of DNMT3A mRNA	PMID:30423288
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16827	corticosterone	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003345	Corticosterone results in increased expression of DNMT3A mRNA; Corticosterone results in increased expression of DNMT3A protein	PMID:37972751
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16827	corticosterone	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D003345	Mifepristone inhibits the reaction [Corticosterone results in increased expression of DNMT3A mRNA]	PMID:37972751
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20120918	CTD	MESH:D005557	Formaldehyde results in decreased expression of DNMT3A mRNA; Formaldehyde results in decreased expression of DNMT3A protein	PMID:21745553
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17303	morphine	affects expression	ISO	RGD:1620920	E	RGD:6480464	20220111	CTD	MESH:D009020	Morphine affects the expression of DNMT3A mRNA	PMID:33891991
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] affects the reaction [bisphenol A results in increased expression of DNMT3A mRNA]; [Testosterone co-treated with Estradiol] affects the reaction [estradiol-17 beta-benzoate results in increased expression of DNMT3A mRNA]; [Testosterone co-treated with vinclozolin] results in increased expression of DNMT3A mRNA	PMID:20056826|PMID:22109888
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17594	hydroquinone	affects expression	ISO	RGD:1606038	E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone affects the expression of DNMT3A mRNA	PMID:34612549
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20121009	CTD	MESH:C031927	hydroquinone results in decreased expression of DNMT3A mRNA; hydroquinone results in decreased expression of DNMT3A protein	PMID:22245671|PMID:27979589
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1606038	E	RGD:6480464	20200609	CTD	MESH:C031927	hydroquinone results in increased expression of DNMT3A mRNA	PMID:31899212
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1620920	E	RGD:6480464	20201006	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of DNMT3A mRNA	PMID:32628958
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects methylation	ISO	RGD:1620920	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate affects the methylation of DNMT3A gene	PMID:32864567
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20191008	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DNMT3A mRNA	PMID:31211961|PMID:34319233
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	EXP		E	RGD:6480464	20260407	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of DNMT3A promoter	PMID:40618915
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNMT3A mRNA; Diethylhexyl Phthalate results in increased expression of DNMT3A protein	PMID:25280772|PMID:40618915
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1606038	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNMT3A protein	PMID:31163220
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1620920	E	RGD:6480464	20121009	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNMT3A mRNA; Diethylhexyl Phthalate results in increased expression of DNMT3A protein	PMID:19912166|PMID:20335514|PMID:25351189
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DNMT3A promoter	PMID:23359474
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:177763	Diallyltetrasulfane	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C431585	diallyl tetrasulfide inhibits the reaction [cypermethrin results in decreased expression of DNMT3A protein]	PMID:34794910
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of DNMT3A mRNA	PMID:26577399
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1606038	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DNMT3A protein	PMID:37730182
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DNMT3A mRNA	PMID:33387578
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DNMT3A mRNA	PMID:28818685
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DNMT3A mRNA	PMID:36331819
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:2038	5-azacytidine	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20250204	CTD	MESH:D001374	Azacitidine results in decreased expression of DNMT3A mRNA	PMID:39331569
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:2038	5-azacytidine	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20220906	CTD	MESH:D001374	Azacitidine inhibits the reaction [DNMT3A protein binds to MIR497 promoter]	PMID:35066776
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of DNMT3A mRNA	PMID:39119833
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DNMT3A mRNA	PMID:19549813
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1620920	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DNMT3A mRNA	PMID:19770486
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1606038	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DNMT3A gene; Aflatoxin B1 results in increased methylation of DNMT3A intron	PMID:27153756|PMID:30157460
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in decreased expression of DNMT3A mRNA	PMID:26392148
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D010126	Ozone results in decreased expression of DNMT3A mRNA	PMID:29947284
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DNMT3A mRNA	PMID:35430440
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of DNMT3A mRNA	PMID:30779732
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27214	uranium atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D014501	Uranium results in increased expression of DNMT3A mRNA	PMID:29024790
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27292	vinyl carbamate	increases expression	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:C017963	vinyl carbamate results in increased expression of DNMT3A mRNA	PMID:17849452
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of DNMT3A mRNA; Zinc deficiency results in increased expression of DNMT3A protein	PMID:19111725
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of DNMT3A mRNA]	PMID:19111725
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20170516	CTD	MESH:D002251	DNMT3A protein affects the reaction [Carbon Tetrachloride results in decreased expression of SEPTIN9 protein]	PMID:27939986
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27470	folic acid	affects expression	ISO	RGD:1606038	E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the expression of DNMT3A mRNA	PMID:17311948
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27470	folic acid	affects expression	ISO	RGD:1620920	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid affects the expression of DNMT3A mRNA	PMID:29986310
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1620920	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of DNMT3A mRNA; Folic Acid results in increased expression of DNMT3A protein	PMID:30920123|PMID:39617304
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DNMT3A protein; [sodium arsenite co-treated with Folic Acid] results in decreased expression of DNMT3A mRNA; Decitabine inhibits the reaction [Folic Acid results in increased expression of DNMT3A mRNA]; Folic Acid affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of DNMT3A mRNA]; trichostatin A inhibits the reaction [Folic Acid results in increased expression of DNMT3A mRNA]	PMID:20548288|PMID:20938992|PMID:22959928|PMID:28475147|PMID:39617304
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20180313	CTD	MESH:D016685	Mitomycin results in decreased expression of DNMT3A protein	PMID:27032448
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C040641	[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA	PMID:28964809
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27563	arsenic atom	affects localization	ISO	RGD:1620920	E	RGD:6480464	20121009	CTD	MESH:D001151	Arsenic affects the localization of DNMT3A protein	PMID:22426358
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27563	arsenic atom	affects response to substance	ISO	RGD:1606038	E	RGD:6480464	20171114	CTD	MESH:D001151	DNMT3A gene SNP affects the susceptibility to Arsenic	PMID:27292127
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27563	arsenic atom	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D001151	Arsenic results in increased expression of DNMT3A mRNA; Arsenic results in increased expression of DNMT3A protein	PMID:36068745
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1620920	E	RGD:6480464	20121009	CTD	MESH:D001151	Arsenic results in increased expression of DNMT3A mRNA	PMID:22426358
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNMT3A mRNA	PMID:40512198
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20121009	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNMT3A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNMT3A mRNA; Arsenic promotes the reaction [DNMT3A protein binds to MYOG promoter]	PMID:22426358|PMID:40504410|PMID:40669674
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D003513	[Cycloheximide co-treated with FASLG protein] results in decreased expression of DNMT3A mRNA; [Cycloheximide co-treated with FASLG protein] results in decreased expression of DNMT3A protein	PMID:19833194
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D002110	Caffeine results in increased expression of DNMT3A mRNA	PMID:24717552
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1606038	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of DNMT3A protein	PMID:35688186
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of DNMT3A mRNA	PMID:26302742|PMID:33512083|PMID:34542374
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1606038	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of DNMT3A mRNA	PMID:33803994|PMID:40578477
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of DNMT3A gene	PMID:31011160
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DNMT3A mRNA	PMID:31881176
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20141223	CTD	MESH:C059514	resveratrol results in decreased expression of DNMT3A mRNA	PMID:23593078
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20130122	CTD	MESH:C059514	[resveratrol co-treated with pterostilbene] results in decreased expression of DNMT3A mRNA; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3A protein binds to BRCA1 promoter]]	PMID:22197621|PMID:26459286
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20151013	CTD	MESH:D007854	Lead results in decreased expression of DNMT3A mRNA; Lead results in decreased expression of DNMT3A protein	PMID:22272629
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20180703	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which affects the expression of DNMT3A protein	PMID:29481626
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of DNMT3A mRNA	PMID:30912803
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20141223	CTD	MESH:D019833	Genistein results in decreased expression of DNMT3A mRNA	PMID:23593078
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA	PMID:28964809
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNMT3A mRNA	PMID:22298810
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNMT3A mRNA	PMID:26455773
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNMT3A mRNA	PMID:19933214
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNMT3A mRNA	PMID:15328365
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20130122	CTD	MESH:D013749	resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3A protein binds to BRCA1 promoter]]; Tetrachlorodibenzodioxin promotes the reaction [DNMT3A protein binds to BRCA1 promoter]	PMID:22197621
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNMT3A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DNMT3A mRNA	PMID:17942748|PMID:25975270
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28197	daidzein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C004742	[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA	PMID:28964809
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1606038	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of DNMT3A protein	PMID:39603559
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1606038	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DNMT3A protein	PMID:33454822
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of DNMT3A mRNA	PMID:28959563
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20220705	CTD	MESH:D003300	Copper results in decreased expression of DNMT3A mRNA	PMID:34871762
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:2873	asiatic acid	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017032	asiatic acid inhibits the reaction [cypermethrin results in decreased expression of DNMT3A protein]	PMID:34794910
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1606038	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of DNMT3A mRNA	PMID:29803840
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1606038	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of DNMT3A protein	PMID:35688186
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28812	(aminomethyl)phosphonic acid	increases expression	ISO	RGD:1606038	E	RGD:6480464	20260407	CTD	MESH:C036423	1-aminomethylphosphonic acid results in increased expression of DNMT3A mRNA	PMID:40578477
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:28833	gibberellin A3	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007842	gibberellic acid results in decreased expression of DNMT3A mRNA	PMID:31733319
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29021	hexane	decreases methylation	EXP		E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of DNMT3A promoter	PMID:23740543
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1606038	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite affects the expression of DNMT3A mRNA	PMID:38146662
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of DNMT3A mRNA	PMID:35314868
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DNMT3A mRNA; sodium arsenite results in decreased expression of DNMT3A protein	PMID:17107663|PMID:22952798|PMID:24570342|PMID:26581878|PMID:29301061|PMID:32844245|PMID:37894918
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606038	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of DNMT3A mRNA; sodium arsenite results in increased expression of DNMT3A protein	PMID:26409248|PMID:30191986|PMID:35850069|PMID:38568856
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1620920	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNMT3A mRNA	PMID:19822182
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNMT3A mRNA; Decitabine inhibits the reaction [sodium arsenite results in increased expression of DNMT3A protein]; epigallocatechin gallate inhibits the reaction [sodium arsenite affects the expression of DNMT3A mRNA]; Estradiol inhibits the reaction [sodium arsenite results in decreased expression of DNMT3A mRNA]; sodium arsenite inhibits the reaction [Estradiol results in decreased expression of DNMT3A mRNA]	PMID:22952798|PMID:26409248|PMID:35850069|PMID:38146662|PMID:40512198
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Folic Acid] results in decreased expression of DNMT3A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNMT3A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNMT3A mRNA	PMID:22959928|PMID:40504410|PMID:40669674
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606038	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DNMT3A intron	PMID:30157460
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DNMT3A mRNA	PMID:20713471
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNMT3A mRNA; Benzo(a)pyrene results in increased expression of DNMT3A protein	PMID:39967322
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1606038	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNMT3A mRNA	PMID:17879257
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620920	E	RGD:6480464	20220705	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNMT3A mRNA; Benzo(a)pyrene results in increased expression of DNMT3A protein	PMID:34979192
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606038	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DNMT3A 3' UTR; Benzo(a)pyrene results in increased methylation of DNMT3A promoter	PMID:27901495
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20220705	CTD	MESH:D001564	Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3A mRNA]; Aspirin inhibits the reaction [Benzo(a)pyrene results in increased expression of DNMT3A protein]	PMID:34979192
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of DNMT3A mRNA	PMID:18191166
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20220705	CTD	MESH:D003300	Copper results in decreased expression of DNMT3A mRNA	PMID:34871762
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of DNMT3A mRNA; Zinc deficiency results in increased expression of DNMT3A protein	PMID:19111725
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of DNMT3A mRNA]	PMID:19111725
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide promotes the reaction [DNMT3A protein binds to RARB promoter]; DNMT3A protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of JUN protein]; DNMT3A protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MAPK1 protein modified form]; DNMT3A protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MAPK3 protein modified form]; DNMT3A protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PTGS2 protein modified form]	PMID:20426865
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:30621	diarsenic trioxide	decreases activity	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased activity of DNMT3A protein	PMID:20596618
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DNMT3A mRNA	PMID:29223816
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DNMT3A; Arsenic Trioxide results in decreased expression of DNMT3A mRNA; Arsenic Trioxide results in decreased expression of DNMT3A protein	PMID:12667347|PMID:12679007|PMID:17490527|PMID:20416177|PMID:20596618|PMID:21176356|PMID:22558281|PMID:29159499
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DNMT3A mRNA; Arsenic Trioxide results in increased expression of DNMT3A protein	PMID:25534098|PMID:37424815
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C006632	[[Arsenic Trioxide results in increased expression of DNMT3A protein] which results in increased methylation of MEG3 promoter] which results in decreased expression of MEG3 protein; S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in decreased expression of DNMT3A protein]	PMID:22558281|PMID:37424815
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:31236	aripiprazole	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C094645	Aripiprazole results in increased expression of DNMT3A mRNA	PMID:17868501
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20220208	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DNMT3A gene; Fulvestrant inhibits the reaction [bisphenol A results in increased expression of DNMT3A protein]	PMID:31601247|PMID:34537452
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20120515	CTD	MESH:C070081	fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA]	PMID:22131059
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:C008261	lead acetate results in decreased expression of DNMT3A protein	PMID:23246732
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:C008261	lead acetate results in increased expression of DNMT3A protein	PMID:23246732
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20180703	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which affects the expression of DNMT3A protein	PMID:29481626
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DNMT3A mRNA	PMID:34492290
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DNMT3A mRNA	PMID:18648102
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DNMT3A mRNA	PMID:18445702
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DNMT3A mRNA	PMID:19710929
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1620920	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A affects the expression of DNMT3A mRNA; bisphenol A affects the expression of DNMT3A protein	PMID:23418087|PMID:23716699
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1620920	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of DNMT3A promoter	PMID:27334623
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DNMT3A mRNA; bisphenol A results in decreased expression of DNMT3A protein	PMID:25181051|PMID:30816183|PMID:36864339
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20211207	CTD	MESH:C006780	bisphenol A results in decreased expression of DNMT3A mRNA; bisphenol A results in decreased expression of DNMT3A protein	PMID:28597690|PMID:31675489|PMID:37567409
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of DNMT3A mRNA; bisphenol A results in decreased expression of DNMT3A protein	PMID:22131059|PMID:23535407|PMID:27502578|PMID:31201698|PMID:31463084
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C006780	bisphenol A results in increased expression of DNMT3A mRNA; bisphenol A results in increased expression of DNMT3A protein	PMID:21827818|PMID:22109888|PMID:26898831|PMID:39307384
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606038	E	RGD:6480464	20200804	CTD	MESH:C006780	bisphenol A results in increased expression of DNMT3A mRNA; bisphenol A results in increased expression of DNMT3A protein	PMID:32105160|PMID:34537452
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620920	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of DNMT3A mRNA; bisphenol A results in increased expression of DNMT3A protein	PMID:21980460|PMID:28496034|PMID:31532523|PMID:32488702
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DNMT3A mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DNMT3A promoter; [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DNMT3A mRNA; [Testosterone co-treated with Estradiol] affects the reaction [bisphenol A results in increased expression of DNMT3A mRNA]	PMID:22109888|PMID:23359474|PMID:25607892|PMID:36041667
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20200804	CTD	MESH:C006780	[bisphenol A co-treated with decabromobiphenyl ether] results in decreased expression of DNMT3A mRNA; [bisphenol A co-treated with Fulvestrant] results in increased methylation of DNMT3A gene; DNMT3A protein promotes the reaction [bisphenol A results in decreased abundance of 5-hydroxymethylcytosine]; DNMT3A protein promotes the reaction [bisphenol A results in decreased expression of TET2 protein]; Fulvestrant inhibits the reaction [bisphenol A results in increased expression of DNMT3A protein]	PMID:28597690|PMID:31601247|PMID:32105160|PMID:34537452
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20120515	CTD	MESH:C006780	Drugs, Chinese Herbal inhibits the reaction [bisphenol A results in increased expression of DNMT3A protein]; Fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA]	PMID:22131059|PMID:32488702
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DNMT3A mRNA	PMID:19244175
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of DNMT3A mRNA	PMID:24096037
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1620920	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of DNMT3A mRNA	PMID:24096037
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1620920	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of DNMT3A mRNA	PMID:37080397
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D008748	[Diethylnitrosamine co-treated with Methylcholanthrene] affects the expression of and affects the localization of DNMT3A protein	PMID:21163286
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DNMT3A mRNA	PMID:39298647
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1606038	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of DNMT3A gene	PMID:31601247
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1620920	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of DNMT3A exon	PMID:33297965
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1606038	E	RGD:6480464	20200804	CTD	MESH:C543008	bisphenol S results in increased expression of DNMT3A mRNA; bisphenol S results in increased expression of DNMT3A protein	PMID:32105160|PMID:37834465
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620920	E	RGD:6480464	20200211	CTD	MESH:C543008	bisphenol S results in increased expression of DNMT3A protein	PMID:31532523
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DNMT3A mRNA	PMID:36041667
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20200804	CTD	MESH:C543008	[bisphenol S co-treated with perfluorooctanoic acid] results in increased expression of DNMT3A mRNA; DNMT3A protein promotes the reaction [bisphenol S results in decreased abundance of 5-hydroxymethylcytosine]; DNMT3A protein promotes the reaction [bisphenol S results in decreased expression of TET2 protein]	PMID:32105160|PMID:37834465
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein; wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein]	PMID:23626723
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein; Wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein]	PMID:23626723
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1620920	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of DNMT3A mRNA	PMID:26377693
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D000487	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3A mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of DNMT3A mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DNMT3A mRNA	PMID:36041667
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DNMT3A mRNA	PMID:37019170
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DNMT3A mRNA	PMID:40825503
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34631	chlorpyrifos	increases methylation	EXP		E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in increased methylation of DNMT3A gene	PMID:32905263
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D004390	[Chlorpyrifos co-treated with Dimethoate] results in increased expression of DNMT3A mRNA	PMID:40825503
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DNMT3A protein	PMID:26745512
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1620920	E	RGD:6480464	20230801	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DNMT3A protein	PMID:36602389
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DNMT3A promoter	PMID:23359474
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1620920	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of DNMT3A gene	PMID:38995845
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34714	dimethoate	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D004117	Dimethoate results in increased expression of DNMT3A mRNA	PMID:40825503
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34714	dimethoate	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D004117	[Chlorpyrifos co-treated with Dimethoate] results in increased expression of DNMT3A mRNA	PMID:40825503
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34778	glycitein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C086566	[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA	PMID:28964809
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20200211	CTD	MESH:D015056	[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of DNMT3A mRNA	PMID:29094436
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Methylcholanthrene] affects the expression of and affects the localization of DNMT3A protein	PMID:21163286
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20201215	CTD	MESH:D010269	Paraquat results in decreased expression of DNMT3A mRNA; Paraquat results in decreased expression of DNMT3A protein	PMID:31189234
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A mRNA; [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein; Wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein]	PMID:23626723
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DNMT3A mRNA	PMID:15913567
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35455	1-naphthyl isothiocyanate	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:D015058	O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of DNMT3A mRNA]	PMID:15913567
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019256	Cadmium Chloride affects the expression of DNMT3A mRNA; Cadmium Chloride affects the expression of DNMT3A protein	PMID:22957049|PMID:33865896|PMID:35525383
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DNMT3A mRNA	PMID:33865896
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNMT3A mRNA	PMID:37972751
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606038	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNMT3A mRNA; Cadmium Chloride results in increased expression of DNMT3A protein	PMID:22112500|PMID:25448810|PMID:34520792|PMID:38568856
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of DNMT3A mRNA	PMID:39119833
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20120918	CTD	MESH:D019256	[Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in decreased expression of ERCC1 mRNA; [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in decreased expression of MSH2 mRNA; [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in decreased expression of OGG1 mRNA; [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in decreased expression of XRCC1 mRNA; [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in increased methylation of ERCC1 promoter; [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in increased methylation of MSH2 promoter; [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in increased methylation of OGG1 promoter; [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in increased methylation of XRCC1 promoter; Cadmium Chloride results in increased activity of and results in increased expression of DNMT3A protein; decitabine inhibits the reaction [Cadmium Chloride results in increased expression of DNMT3A mRNA]; decitabine inhibits the reaction [Cadmium Chloride results in increased expression of DNMT3A protein]	PMID:22112500
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35497	androgen antagonist	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:D000726	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DNMT3A mRNA	PMID:25607892
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DNMT3A protein	PMID:26879310
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20200804	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DNMT3A mRNA	PMID:32320774
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1606038	E	RGD:6480464	20121009	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DNMT3A mRNA	PMID:22425687
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20240206	CTD	MESH:C023036	[bisphenol S co-treated with perfluorooctanoic acid] results in increased expression of DNMT3A mRNA	PMID:37834465
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20200211	CTD	MESH:C023036	[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of DNMT3A mRNA	PMID:29094436
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:37187	lead nitrate	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate results in decreased expression of DNMT3A mRNA; lead nitrate results in decreased expression of DNMT3A protein	PMID:24639330
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:37187	lead nitrate	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20170303	CTD	MESH:C017461	4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; E2F1 protein inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]	PMID:24639330
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:3723	citalopram	affects expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015283	Citalopram affects the expression of DNMT3A mRNA	PMID:21682946
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1620920	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of DNMT3A mRNA	PMID:17585979
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:38221	fumonisin B1	decreases activity	ISO	RGD:1606038	E	RGD:6480464	20140513	CTD	MESH:C056933	fumonisin B1 results in decreased activity of DNMT3A protein	PMID:24280379
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39098	pyrethrins	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011722	Pyrethrins results in increased expression of DNMT3A mRNA	PMID:34896426|PMID:36053783
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20191210	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DNMT3A mRNA; perfluorooctane sulfonic acid results in decreased expression of DNMT3A protein	PMID:31508952
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DNMT3A protein	PMID:26178269
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of DNMT3A protein	PMID:20621739
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DNMT3A mRNA	PMID:36331819
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20141223	CTD	MESH:C031763	1,3-butadiene results in decreased expression of DNMT3A mRNA	PMID:25237060|PMID:30552462
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of DNMT3A mRNA	PMID:23125180
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39483	sodium dichromate	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20240430	CTD	MESH:C016104	[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3A protein	PMID:37619952
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20141223	CTD	MESH:D003474	Curcumin results in decreased expression of DNMT3A mRNA	PMID:23593078
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20160510	CTD	MESH:D003474	Curcumin analog results in decreased expression of DNMT3A protein	PMID:26991801|PMID:29228771
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606038	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DNMT3A mRNA	PMID:25979313
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of DNMT3A mRNA	PMID:29427782
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606038	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of DNMT3A mRNA	PMID:28001369
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of DNMT3A mRNA	PMID:38685447|PMID:41580965
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1606038	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of DNMT3A promoter	PMID:27989131
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C037304	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3A mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of DNMT3A mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4042	cypermethrin	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	cypermethrin results in decreased expression of DNMT3A mRNA; cypermethrin results in decreased expression of DNMT3A protein	PMID:34794910
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C017160	cypermethrin results in increased expression of DNMT3A mRNA	PMID:35605701
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C017160	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3A mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of DNMT3A mRNA; [pyrazolanthrone co-treated with cypermethrin] results in decreased expression of DNMT3A protein; asiatic acid inhibits the reaction [cypermethrin results in decreased expression of DNMT3A protein]; cypermethrin results in decreased expression of and results in decreased activity of DNMT3A protein; diallyl tetrasulfide inhibits the reaction [cypermethrin results in decreased expression of DNMT3A protein]; DNMT3A protein inhibits the reaction [cypermethrin results in increased expression of MIR140 mRNA]; DNMT3A protein inhibits the reaction [cypermethrin results in increased expression of WWP2 mRNA]	PMID:33051911|PMID:33396045|PMID:34794910|PMID:34896426|PMID:36053783
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of DNMT3A mRNA	PMID:25123088
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20200211	CTD	MESH:D003907	[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of DNMT3A mRNA	PMID:29094436
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of DNMT3A mRNA	PMID:37077353
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of DNMT3A mRNA	PMID:35605701
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1620920	E	RGD:6480464	20140513	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of DNMT3A mRNA	PMID:16714842|PMID:24316720
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C013908	[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA	PMID:28964809
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of DNMT3A mRNA	PMID:28973697
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4356	desferrioxamine B	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine results in decreased expression of DNMT3A mRNA	PMID:23483119
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4356	desferrioxamine B	increases expression	ISO	RGD:1606038	E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine results in increased expression of DNMT3A mRNA	PMID:23483119
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1606038	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of DNMT3A mRNA	PMID:24449571
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:45453	sinefungin	decreases activity	ISO	RGD:1620920	E	RGD:6480464	20140211	CTD	MESH:C006235	sinefungin results in decreased activity of DNMT3A protein	PMID:23671287
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of DNMT3A mRNA	PMID:27188386
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20250902	CTD	MESH:C012589	trichostatin A inhibits the reaction [Folic Acid results in increased expression of DNMT3A mRNA]	PMID:39617304
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DNMT3A mRNA	PMID:17562736
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000082	Acetaminophen results in decreased expression of DNMT3A mRNA	PMID:29665328
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D000082	Acetaminophen results in increased expression of DNMT3A mRNA	PMID:25607892
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D000082	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DNMT3A mRNA	PMID:25607892
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:46727	quartz	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20180220	CTD	MESH:D011791	Quartz results in decreased expression of DNMT3A mRNA	PMID:27917503
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:47217	arsane	affects localization	ISO	RGD:1620920	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the localization of DNMT3A protein	PMID:22426358
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:47217	arsane	affects response to substance	ISO	RGD:1606038	E	RGD:6480464	20171114	CTD	MESH:D001151	DNMT3A gene SNP affects the susceptibility to Arsenic	PMID:27292127
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:47217	arsane	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D001151	Arsenic results in increased expression of DNMT3A mRNA; Arsenic results in increased expression of DNMT3A protein	PMID:36068745
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1620920	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of DNMT3A mRNA	PMID:22426358
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNMT3A mRNA	PMID:40512198
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20140805	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNMT3A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNMT3A mRNA; Arsenic promotes the reaction [DNMT3A protein binds to MYOG promoter]	PMID:22426358|PMID:40504410|PMID:40669674
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in decreased expression of DNMT3A mRNA	PMID:37077353
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of DNMT3A mRNA	PMID:37077353
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of DNMT3A mRNA	PMID:31675489
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1606038	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of DNMT3A mRNA	PMID:30684530
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004726	Endosulfan results in increased expression of DNMT3A mRNA	PMID:35114330
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1606038	E	RGD:6480464	20180116	CTD	MESH:D004726	Endosulfan results in increased expression of DNMT3A mRNA; Endosulfan results in increased expression of DNMT3A protein	PMID:29054638
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1606038	E	RGD:6480464	20150609	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of DNMT3A mRNA	PMID:25839702
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1620920	E	RGD:6480464	20230404	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of DNMT3A protein	PMID:35863485
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20251007	CTD	MESH:C045651	epigallocatechin gallate inhibits the reaction [sodium arsenite affects the expression of DNMT3A mRNA]	PMID:38146662
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of DNMT3A mRNA	PMID:18676679
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20240206	CTD	MESH:D018038	Sodium Selenite results in decreased expression of DNMT3A mRNA	PMID:37142062
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20191112	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DNMT3A mRNA	PMID:31463084
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DNMT3A mRNA	PMID:29097150
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNMT3A mRNA	PMID:17942748
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:49900	arsenous acid	decreases activity	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased activity of DNMT3A protein	PMID:20596618
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DNMT3A mRNA	PMID:29223816
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DNMT3A; Arsenic Trioxide results in decreased expression of DNMT3A mRNA; Arsenic Trioxide results in decreased expression of DNMT3A protein	PMID:12667347|PMID:12679007|PMID:17490527|PMID:20416177|PMID:20596618|PMID:21176356|PMID:22558281|PMID:29159499
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DNMT3A mRNA; Arsenic Trioxide results in increased expression of DNMT3A protein	PMID:25534098|PMID:37424815
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C032793	[[Arsenic Trioxide results in increased expression of DNMT3A protein] which results in increased methylation of MEG3 promoter] which results in decreased expression of MEG3 protein; S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in decreased expression of DNMT3A protein]	PMID:22558281|PMID:37424815
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of DNMT3A mRNA; Decitabine results in decreased expression of DNMT3A protein	PMID:17991895|PMID:18676679|PMID:19177197|PMID:19221000|PMID:21771726|PMID:22749965
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Dust results in increased expression of DNMT3A mRNA]	PMID:30815999
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Cadmium Chloride results in increased expression of DNMT3A mRNA]; Decitabine inhibits the reaction [Cadmium Chloride results in increased expression of DNMT3A protein]; Decitabine inhibits the reaction [DNMT3A protein binds to SPARC promoter]; Decitabine inhibits the reaction [sodium arsenite results in increased expression of DNMT3A protein]; DNMT3A protein affects the reaction [Decitabine results in increased expression of CDH1 mRNA]; DNMT3A protein affects the reaction [Decitabine results in increased expression of JUP mRNA]	PMID:16887905|PMID:19177197|PMID:22112500|PMID:26409248|PMID:35850069
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Folic Acid results in increased expression of DNMT3A mRNA]; Decitabine inhibits the reaction [Particulate Matter promotes the reaction [[ovalbumin-alum co-treated with Ovalbumin] results in increased expression of DNMT3A protein]]; Decitabine inhibits the reaction [Particulate Matter results in increased expression of DNMT3A protein]	PMID:30481581|PMID:39617304
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C017690	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3A mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of DNMT3A mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:50648	9-cis-retinoic acid	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20220208	CTD	MESH:C103303	[Arsenicals co-treated with Alitretinoin] results in increased expression of DNMT3A mRNA; [Arsenicals co-treated with Poly I-C co-treated with Alitretinoin] results in increased expression of DNMT3A mRNA	PMID:34303791
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of DNMT3A mRNA	PMID:41580965
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:50692	mifepristone	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D015735	Mifepristone inhibits the reaction [Corticosterone results in increased expression of DNMT3A mRNA]	PMID:37972751
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:50859	bexarotene	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in decreased expression of DNMT3A mRNA	PMID:17849452
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20140311	CTD	MESH:C009687	wortmannin inhibits the reaction [[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of DNMT3A protein]	PMID:23626723
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:52492	mancozeb	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20230905	CTD	MESH:C013099	mancozeb results in decreased expression of DNMT3A protein	PMID:36007320
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1620920	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DNMT3A mRNA	PMID:19042947
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:D011192	Potassium Dichromate results in increased expression of DNMT3A protein	PMID:37931768
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:5855	ibuprofen	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20180703	CTD	MESH:D007052	Ibuprofen results in decreased expression of DNMT3A mRNA	PMID:29665328
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1620920	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DNMT3A protein	PMID:26558463
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of DNMT3A mRNA	PMID:20003209
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:64317	isoprenaline	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D007545	Isoproterenol results in increased expression of DNMT3A protein	PMID:24945829
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:6651	malathion	affects expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D008294	Malathion affects the expression of DNMT3A mRNA	PMID:36370973
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:67040	S-adenosyl-L-methioninate	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20140805	CTD	MESH:D012436	S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in decreased expression of DNMT3A protein]	PMID:22558281
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:67040	S-adenosyl-L-methioninate	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20140805	CTD	MESH:D012436	S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of DNMT3A mRNA]	PMID:18098314
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DNMT3A gene	PMID:35440735
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:6842	methoxychlor	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D008731	Methoxychlor results in decreased expression of DNMT3A mRNA	PMID:23303685
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:69120	withaferin A	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20141223	CTD	MESH:C009684	withaferin A results in decreased expression of DNMT3A mRNA	PMID:23593078
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1606038	E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in increased expression of DNMT3A mRNA	PMID:29518473
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:69478	cannabidiol	decreases methylation	ISO	RGD:1620920	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased methylation of DNMT3A gene	PMID:32579259
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1620920	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DNMT3A mRNA	PMID:22206623
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:7438	N-methylformamide	affects expression	ISO	RGD:1620920	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide affects the expression of DNMT3A mRNA; methylformamide analog affects the expression of DNMT3A mRNA	PMID:17040096
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DNMT3A protein	PMID:37664457
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:74926	patulin	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20250401	CTD	MESH:D010365	Patulin results in decreased expression of DNMT3A mRNA	PMID:38806716
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20140211	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Ethanol results in increased degradation of DNMT3A protein]	PMID:23395981
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:75404	tyrphostin AG 1478	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20160405	CTD	MESH:C101044	RTKI cpd inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]	PMID:24639330
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:75632	procyanidin B2	increases expression	ISO	RGD:1606038	E	RGD:6480464	20150609	CTD	MESH:C479580	procyanidin B2 results in increased expression of DNMT3A mRNA	PMID:25839702
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:756894	tak-243	affects sumoylation	ISO	RGD:1606038	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of DNMT3A protein	PMID:31285264
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:76792	5-(hydroxymethyl)cytosine	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20200804	CTD	MESH:C011865	DNMT3A protein promotes the reaction [bisphenol A results in decreased abundance of 5-hydroxymethylcytosine]; DNMT3A protein promotes the reaction [bisphenol S results in decreased abundance of 5-hydroxymethylcytosine]	PMID:32105160
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:77397	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile	affects expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015283	Citalopram affects the expression of DNMT3A mRNA	PMID:21682946
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:7959	D-penicillamine	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20150512	CTD	MESH:D010396	Penicillamine results in decreased expression of DNMT3A mRNA	PMID:22945834
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of DNMT3A mRNA	PMID:19682730
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:80373	glycitin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C433283	[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA	PMID:28964809
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620920	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DNMT3A mRNA	PMID:19482888|PMID:23091169
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:80743	Difenacoum	affects binding	ISO	RGD:1606038	E	RGD:6480464	20201215	CTD	MESH:C012903	difenacoum binds to DNMT3A protein	PMID:31595789
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of DNMT3A mRNA	PMID:31388691
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNMT3A mRNA	PMID:40889571
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNMT3A protein	PMID:31675489
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20170303	CTD	MESH:C511295	[2,2',4,4'-tetrabromodiphenyl ether co-treated with MECP2 gene polymorphism] results in increased expression of DNMT3A mRNA	PMID:22343140
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:81892	Brodifacoum	affects binding	ISO	RGD:1606038	E	RGD:6480464	20201215	CTD	MESH:C013418	bromfenacoum binds to DNMT3A protein	PMID:31595789
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:81894	Flocoumafen	affects binding	ISO	RGD:1606038	E	RGD:6480464	20201215	CTD	MESH:C048069	flocoumafen binds to DNMT3A protein	PMID:31595789
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20211207	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of DNMT3A mRNA	PMID:28597690
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20211207	CTD	MESH:C010902	[bisphenol A co-treated with decabromobiphenyl ether] results in decreased expression of DNMT3A mRNA	PMID:28597690
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:83605	3,5-diethoxycarbonyl-1,4-dihydrocollidine	increases expression	ISO	RGD:1620920	E	RGD:6480464	20141202	CTD	MESH:D003997	Dicarbethoxydihydrocollidine results in increased expression of DNMT3A mRNA	PMID:18098314
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:83605	3,5-diethoxycarbonyl-1,4-dihydrocollidine	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20141202	CTD	MESH:D003997	S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of DNMT3A mRNA]	PMID:18098314
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20220208	CTD	MESH:D011070	[Arsenicals co-treated with Poly I-C co-treated with Alitretinoin] results in increased expression of DNMT3A mRNA; [Arsenicals co-treated with Poly I-C] results in increased expression of DNMT3A mRNA	PMID:34303791
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:8630	pterostilbene	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20161025	CTD	MESH:C107773	[resveratrol co-treated with pterostilbene] results in decreased expression of DNMT3A mRNA	PMID:26459286
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20161025	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of DNMT3A protein	PMID:26745512
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:88542	Butylparaben	increases expression	EXP		E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of DNMT3A mRNA	PMID:26888303
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:88542	Butylparaben	multiple interactions	EXP		E	RGD:6480464	20200407	CTD	MESH:C038091	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DNMT3A mRNA	PMID:25607892
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C432165	[pyrazolanthrone co-treated with cypermethrin] results in decreased expression of DNMT3A protein	PMID:34794910
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606038	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DNMT3A protein	PMID:37664457
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1620920	E	RGD:6480464	20191008	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of DNMT3A mRNA; [Streptozocin co-treated with Dietary Fats] results in increased expression of DNMT3A protein	PMID:29127188
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D013605	T-2 Toxin results in increased expression of DNMT3A mRNA; T-2 Toxin results in increased expression of DNMT3A protein	PMID:31279042
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9400	tangeretin	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20231003	CTD	MESH:C059006	tangeretin metabolite results in decreased expression of DNMT3A protein; tangeretin results in decreased expression of DNMT3A protein	PMID:37517432
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9405	tartrazine	increases expression	ISO	RGD:1606038	E	RGD:6480464	20250506	CTD	MESH:D013645	Tartrazine results in increased expression of DNMT3A mRNA	PMID:40077783
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9405	tartrazine	increases expression	ISO	RGD:1620920	E	RGD:6480464	20250506	CTD	MESH:D013645	Tartrazine results in increased expression of DNMT3A mRNA	PMID:37447272
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of DNMT3A protein	PMID:35544339
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1606038	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of DNMT3A mRNA	PMID:27188386
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1620920	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of DNMT3A mRNA	PMID:28973697
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9944	venlafaxine hydrochloride	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000069470	Venlafaxine Hydrochloride results in increased expression of DNMT3A mRNA	PMID:25423262
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of DNMT3A mRNA	PMID:18042343
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of DNMT3A mRNA	PMID:20056826
1303336	Dnmt3a	DNA methyltransferase 3 alpha	gene	CHEBI:9986	vinclozolin	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	[Testosterone co-treated with vinclozolin] results in increased expression of DNMT3A mRNA	PMID:20056826
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:135741	testosterone undecanoate	increases expression	ISO	RGD:1606161	E	RGD:6480464	20170307	CTD	MESH:C010792	testosterone undecanoate results in increased expression of ARL9 mRNA	PMID:19074003
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	ISO	RGD:1606161	E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ARL9 mRNA	PMID:19074003
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1606161	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ARL9 mRNA	PMID:30510588
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ARL9 gene	PMID:27618143
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1551947	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ARL9 mRNA	PMID:39922521
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1551947	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ARL9 mRNA	PMID:39922521
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551947	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ARL9 mRNA	PMID:25629700
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1606161	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ARL9 mRNA	PMID:26272509
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1606161	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA	PMID:27188386
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1606161	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ARL9 mRNA	PMID:23300844
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606161	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARL9 mRNA	PMID:33212167
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1606161	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of ARL9 mRNA	PMID:26272509
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1606161	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA	PMID:27188386
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ARL9 mRNA	PMID:26033743
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606161	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARL9 mRNA	PMID:38568856
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551947	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARL9 mRNA	PMID:34876320
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1551947	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARL9 mRNA	PMID:34876320
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ARL9 mRNA	PMID:26033743
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1551947	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ARL9 mRNA	PMID:29264374
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ARL9 mRNA	PMID:23411599
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARL9 mRNA	PMID:25181051
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551947	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ARL9 mRNA	PMID:32156529
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1551947	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ARL9 mRNA	PMID:35093514
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606161	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARL9 mRNA	PMID:25979313
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606161	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARL9 mRNA	PMID:28001369
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1551947	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ARL9 mRNA	PMID:39922521
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1551947	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARL9 mRNA	PMID:34876320
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1606161	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of ARL9 mRNA	PMID:26272509
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1606161	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA	PMID:27188386
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1606161	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ARL9 mRNA	PMID:23300844
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ARL9 mRNA	PMID:30307764
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of ARL9 mRNA	PMID:22504374
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:6443	levonorgestrel	multiple interactions	ISO	RGD:1606161	E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ARL9 mRNA	PMID:19074003
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606161	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA	PMID:27188386
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ARL9 mRNA	PMID:23914054
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1551947	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARL9 mRNA	PMID:34876320
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARL9 mRNA	PMID:22504374
1303337	Arl9	ARF like GTPase 9	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606161	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA	PMID:27188386
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1351307	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of SPINK6 mRNA	PMID:31016361
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1351307	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SPINK6 mRNA	PMID:26079696
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:16349	L-citrulline	increases expression	ISO	RGD:1351307	E	RGD:6480464	20250506	CTD	MESH:D002956	Citrulline results in increased expression of SPINK6 mRNA	PMID:38770826
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1621891	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SPINK6 mRNA	PMID:28973375
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1351307	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of SPINK6 mRNA	PMID:31256213
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1621891	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of SPINK6 mRNA	PMID:39984025
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351307	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPINK6 mRNA	PMID:32525701
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1351307	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPINK6 mRNA	PMID:30851411
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1351307	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of SPINK6 mRNA	PMID:34032870
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621891	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPINK6 mRNA	PMID:36209798
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351307	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of SPINK6 mRNA	PMID:25879800|PMID:28595984
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1351307	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SPINK6 exon	PMID:27901495
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150630	CTD	MESH:C006780	bisphenol A results in increased expression of SPINK6 mRNA	PMID:25181051
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SPINK6 gene	PMID:28505145
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621891	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SPINK6 mRNA	PMID:39298647
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SPINK6 mRNA	PMID:30047161
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351307	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPINK6 mRNA	PMID:32525701
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SPINK6 mRNA	PMID:30047161
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1621891	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of SPINK6 mRNA	PMID:36907384
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1351307	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPINK6 mRNA	PMID:30851411
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351307	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPINK6 gene]	PMID:28238834
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1351307	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPINK6 mRNA	PMID:32525701
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPINK6 mRNA	PMID:30047161
1303338	Spink6	serine peptidase inhibitor, Kazal type 6	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1351307	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of SPINK6 mRNA	PMID:31734321
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLEC4D mRNA	PMID:20938992
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1347298	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CLEC4D mRNA	PMID:33167477
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CLEC4D mRNA	PMID:33729688
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1347298	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CLEC4D mRNA	PMID:26079696
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1347298	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CLEC4D mRNA	PMID:18192897
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553885	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CLEC4D mRNA	PMID:21461237|PMID:25890327|PMID:39241906
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20161228	CTD	MESH:D008070	(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CLEC4D mRNA]	PMID:25890327
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553885	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CLEC4D mRNA	PMID:19484750
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4D mRNA	PMID:32741896
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLEC4D mRNA	PMID:20938992
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1347298	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CLEC4D mRNA	PMID:37042841
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1553885	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of CLEC4D mRNA	PMID:17251523
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLEC4D mRNA	PMID:37992649
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4D mRNA	PMID:32741896
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLEC4D mRNA	PMID:37992649
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of CLEC4D mRNA]	PMID:33484791
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of CLEC4D mRNA	PMID:23358152
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1553885	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of CLEC4D mRNA	PMID:19376150
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CLEC4D mRNA	PMID:30779732
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1553885	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CLEC4D mRNA	PMID:27339419|PMID:31919559
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLEC4D mRNA	PMID:20938992
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1347298	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CLEC4D gene	PMID:25304211
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1553885	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of CLEC4D mRNA	PMID:19654921
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1347298	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CLEC4D mRNA	PMID:25583101
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553885	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLEC4D mRNA	PMID:16114106
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLEC4D mRNA	PMID:17942748
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CLEC4D mRNA	PMID:28959563
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CLEC4D mRNA	PMID:26033743
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CLEC4D mRNA	PMID:26033743
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1553885	E	RGD:6480464	20200804	CTD	MESH:D004317	Doxorubicin results in increased expression of CLEC4D mRNA	PMID:28608983|PMID:36227756
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLEC4D mRNA	PMID:37992649
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:29310	dichlorine	increases expression	ISO	RGD:1553885	E	RGD:6480464	20190219	CTD	MESH:D002713	Chlorine results in increased expression of CLEC4D mRNA	PMID:30189237
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1553885	E	RGD:6480464	20150714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLEC4D mRNA	PMID:25908611
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553885	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLEC4D mRNA	PMID:22228805
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347298	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CLEC4D 3' UTR; Benzo(a)pyrene results in increased methylation of CLEC4D exon; Benzo(a)pyrene results in increased methylation of CLEC4D promoter	PMID:27901495
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CLEC4D mRNA	PMID:26033743
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CLEC4D mRNA	PMID:26033743
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	ISO	RGD:1347298	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of CLEC4D mRNA	PMID:25075043
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CLEC4D mRNA	PMID:21602193
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1553885	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CLEC4D mRNA	PMID:23221170|PMID:29341224
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1553885	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CLEC4D mRNA	PMID:23557971|PMID:27760801
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CLEC4D mRNA	PMID:34492290
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1553885	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of CLEC4D mRNA	PMID:19191707
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLEC4D mRNA	PMID:25181051
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1347298	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CLEC4D gene	PMID:31601247
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553885	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CLEC4D mRNA	PMID:32156529
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1553885	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CLEC4D mRNA	PMID:26682919
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553885	E	RGD:6480464	20240206	CTD	MESH:C543008	bisphenol S results in increased expression of CLEC4D mRNA	PMID:37611474|PMID:39298647
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1553885	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of CLEC4D mRNA	PMID:26377693
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553885	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CLEC4D mRNA	PMID:37019170
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1347298	E	RGD:6480464	20220111	CTD	MESH:D010269	Paraquat results in decreased expression of CLEC4D mRNA	PMID:34097952
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347298	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CLEC4D mRNA	PMID:37042841
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1553885	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of CLEC4D mRNA	PMID:26377693
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1553885	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of CLEC4D mRNA	PMID:22698814
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1347298	E	RGD:6480464	20130514	CTD	MESH:C018021	cobaltous chloride results in increased expression of CLEC4D mRNA	PMID:23052192
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1347298	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CLEC4D mRNA	PMID:24449571
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347298	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CLEC4D mRNA	PMID:25979313
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1347298	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of CLEC4D mRNA	PMID:23527032|PMID:28001369
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1553885	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CLEC4D mRNA	PMID:28973697
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLEC4D mRNA	PMID:37992649
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553885	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CLEC4D mRNA	PMID:17562736
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1347298	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CLEC4D gene	PMID:25304211
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1553885	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of CLEC4D mRNA	PMID:19654921
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1347298	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of CLEC4D mRNA	PMID:26833863
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLEC4D mRNA	PMID:17942748
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:50035	alpha-phellandrene	decreases expression	ISO	RGD:1347298	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of CLEC4D mRNA	PMID:25075043
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1553885	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of CLEC4D mRNA	PMID:25554681
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1347298	E	RGD:6480464	20191008	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CLEC4D mRNA	PMID:29348435
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553885	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CLEC4D mRNA	PMID:25554681
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of CLEC4D mRNA	PMID:23358152
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1553885	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CLEC4D mRNA	PMID:38701926
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1553885	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of CLEC4D mRNA	PMID:20003209
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CLEC4D mRNA	PMID:27935865
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1553885	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of CLEC4D mRNA	PMID:27858113
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4D mRNA	PMID:32741896
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347298	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CLEC4D gene]	PMID:28238834
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1553885	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CLEC4D mRNA	PMID:38648751
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1347298	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CLEC4D mRNA	PMID:23146750
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CLEC4D mRNA	PMID:27935865
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1553885	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of CLEC4D mRNA	PMID:39847705
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1553885	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of CLEC4D mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of CLEC4D mRNA]	PMID:33484791
1303339	Clec4d	C-type lectin domain family 4, member D	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of CLEC4D mRNA	PMID:23358152
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1623862	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of VMAC mRNA	PMID:37995155
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1623862	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VMAC mRNA	PMID:39241906
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of VMAC mRNA	PMID:33387578
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1606370	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of VMAC mRNA	PMID:28818685
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1623862	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VMAC mRNA	PMID:37236586
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606370	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of VMAC mRNA	PMID:35430440
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1606370	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of VMAC mRNA	PMID:19774075
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of VMAC mRNA	PMID:33387578
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1623862	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of VMAC mRNA	PMID:25629700
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623862	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VMAC mRNA	PMID:22206623
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of VMAC mRNA	PMID:31881176
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606370	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of VMAC mRNA	PMID:27392435
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1623862	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of VMAC mRNA	PMID:27862939
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623862	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VMAC promoter	PMID:35295148
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1623862	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of VMAC gene	PMID:35295148
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of VMAC mRNA	PMID:34492290
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of VMAC mRNA	PMID:19167457
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of VMAC mRNA	PMID:25181051
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of VMAC mRNA	PMID:34947998
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1623862	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of VMAC mRNA	PMID:32156529
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1623862	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of VMAC mRNA	PMID:25172293
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623862	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of VMAC mRNA	PMID:39298647
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1623862	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of VMAC mRNA	PMID:28392331
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1623862	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of VMAC mRNA	PMID:21266533
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1623862	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of VMAC mRNA	PMID:34813904
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of VMAC mRNA	PMID:30589522
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of VMAC promoter	PMID:22457795
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1623862	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VMAC mRNA	PMID:37236586
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1623862	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of VMAC mRNA	PMID:40194260
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606370	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of VMAC mRNA	PMID:31533062
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1606370	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of VMAC mRNA	PMID:38832940
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1606370	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of VMAC mRNA	PMID:38825487
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1623862	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of VMAC mRNA; Nanotubes, Carbon results in decreased expression of VMAC mRNA	PMID:25554681
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1623862	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of VMAC mRNA	PMID:35964746
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623862	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VMAC mRNA	PMID:22206623
1303340	Vmac	vimentin-type intermediate filament associated coiled-coil protein	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1606370	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of VMAC mRNA	PMID:29301935
1303341	Reg4	regenerating family member 4	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1352664	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of REG4 mRNA	PMID:27188386
1303341	Reg4	regenerating family member 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1352664	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of REG4 mRNA	PMID:25812627
1303341	Reg4	regenerating family member 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of REG4 mRNA]	PMID:31150632
1303341	Reg4	regenerating family member 4	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of REG4 gene	PMID:35440735
1303341	Reg4	regenerating family member 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1352664	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of REG4 mRNA	PMID:20044591
1303341	Reg4	regenerating family member 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of REG4 mRNA	PMID:32145629
1303341	Reg4	regenerating family member 4	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1352664	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of REG4 mRNA	PMID:26079696
1303341	Reg4	regenerating family member 4	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of REG4 mRNA	PMID:21515302
1303341	Reg4	regenerating family member 4	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of REG4 mRNA	PMID:21396975
1303341	Reg4	regenerating family member 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of REG4 mRNA	PMID:31150632
1303341	Reg4	regenerating family member 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of REG4 mRNA]	PMID:31150632
1303341	Reg4	regenerating family member 4	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1352664	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of REG4 gene	PMID:25304211
1303341	Reg4	regenerating family member 4	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1352664	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of REG4 promoter	PMID:22847954
1303341	Reg4	regenerating family member 4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1553892	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of REG4 mRNA	PMID:32186404
1303341	Reg4	regenerating family member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of REG4 mRNA	PMID:22298810
1303341	Reg4	regenerating family member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553892	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of REG4 mRNA	PMID:21570461
1303341	Reg4	regenerating family member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of REG4 mRNA	PMID:21724226
1303341	Reg4	regenerating family member 4	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of REG4 mRNA	PMID:28374803
1303341	Reg4	regenerating family member 4	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1352664	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of REG4 mRNA	PMID:20971185
1303341	Reg4	regenerating family member 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352664	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of REG4 3' UTR; Benzo(a)pyrene results in increased methylation of REG4 5' UTR; Benzo(a)pyrene results in increased methylation of REG4 promoter	PMID:27901495
1303341	Reg4	regenerating family member 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1553892	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of REG4 intron	PMID:27901495
1303341	Reg4	regenerating family member 4	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1352664	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of REG4 mRNA	PMID:20971185
1303341	Reg4	regenerating family member 4	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of REG4 mRNA	PMID:32479839
1303341	Reg4	regenerating family member 4	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of REG4 mRNA	PMID:21515302
1303341	Reg4	regenerating family member 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1553892	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of REG4 mRNA	PMID:35295148
1303341	Reg4	regenerating family member 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of REG4 mRNA	PMID:34492290
1303341	Reg4	regenerating family member 4	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1553892	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of REG4 mRNA	PMID:28472532
1303341	Reg4	regenerating family member 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of REG4 mRNA	PMID:25181051
1303341	Reg4	regenerating family member 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of REG4 mRNA	PMID:32145629
1303341	Reg4	regenerating family member 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of REG4 mRNA	PMID:18164116
1303341	Reg4	regenerating family member 4	gene	CHEBI:35036	fentin chloride	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in decreased expression of REG4 mRNA	PMID:37156404
1303341	Reg4	regenerating family member 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1352664	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of REG4 mRNA	PMID:25812627
1303341	Reg4	regenerating family member 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of REG4 mRNA	PMID:27387713
1303341	Reg4	regenerating family member 4	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1553892	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of REG4 mRNA	PMID:28962523
1303341	Reg4	regenerating family member 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1352664	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of REG4 mRNA	PMID:25812627
1303341	Reg4	regenerating family member 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1553892	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of REG4 mRNA	PMID:40194260
1303341	Reg4	regenerating family member 4	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1352664	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of REG4 promoter	PMID:22847954
1303341	Reg4	regenerating family member 4	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1352664	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of REG4 promoter	PMID:22847954
1303341	Reg4	regenerating family member 4	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of REG4 mRNA	PMID:22561333
1303341	Reg4	regenerating family member 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1553892	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of REG4 mRNA	PMID:18502557
1303341	Reg4	regenerating family member 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of REG4 mRNA	PMID:32479839|PMID:33387578
1303341	Reg4	regenerating family member 4	gene	CHEBI:46345	5-fluorouracil	decreases response to substance	ISO	RGD:1352664	E	RGD:6480464	20120412	CTD	MESH:D005472	REG4 protein results in decreased susceptibility to Fluorouracil	PMID:17237819
1303341	Reg4	regenerating family member 4	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1352664	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of REG4 gene	PMID:25304211
1303341	Reg4	regenerating family member 4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of REG4 mRNA	PMID:29391264
1303341	Reg4	regenerating family member 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553892	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of REG4 mRNA	PMID:22206623
1303341	Reg4	regenerating family member 4	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of REG4 mRNA	PMID:18164116
1303341	Reg4	regenerating family member 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352664	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to REG4 gene]	PMID:28238834
1303341	Reg4	regenerating family member 4	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of REG4 mRNA	PMID:21515302
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312052	E	RGD:6480464	20130312	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BOC mRNA	PMID:20938992
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of BOC mRNA	PMID:21934132
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312052	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of BOC mRNA	PMID:16788091
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of BOC gene	PMID:35440735
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312052	E	RGD:6480464	20210309	CTD	MESH:D001280	Atrazine results in decreased expression of BOC mRNA	PMID:33463082
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312052	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of BOC mRNA	PMID:30319688
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of BOC mRNA	PMID:35811015
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1605311	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of BOC mRNA	PMID:30510588
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605311	E	RGD:6480464	20130312	CTD	MESH:D004958	Estradiol results in increased expression of BOC mRNA	PMID:23019147
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of BOC mRNA	PMID:30165855
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312052	E	RGD:6480464	20130312	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BOC mRNA	PMID:20938992
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of BOC mRNA	PMID:33387578
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1605311	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of BOC exon	PMID:30157460
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312052	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BOC mRNA	PMID:36331819
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605311	E	RGD:6480464	20130312	CTD	MESH:D019327	Copper Sulfate results in increased expression of BOC mRNA	PMID:19549813
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605311	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of BOC exon	PMID:30157460
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312052	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BOC mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of BOC mRNA	PMID:27106289|PMID:34911549
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312052	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BOC mRNA	PMID:17484886
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312052	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of BOC mRNA	PMID:25629700
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312052	E	RGD:6480464	20130312	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BOC mRNA	PMID:20938992
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BOC mRNA	PMID:27188386
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of BOC mRNA	PMID:23557933
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of BOC mRNA	PMID:27392435
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of BOC mRNA	PMID:27392435
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of BOC mRNA	PMID:24768652
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312052	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BOC mRNA	PMID:21570461
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312052	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BOC mRNA	PMID:18691609
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BOC mRNA	PMID:27913140
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312052	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BOC mRNA	PMID:27913140
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1605311	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BOC mRNA	PMID:27913140
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28216	methylmercury chloride	affects expression	ISO	RGD:1312052	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride affects the expression of BOC mRNA	PMID:21613230
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of BOC mRNA	PMID:28001369
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1605311	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of BOC mRNA	PMID:28001369
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of BOC mRNA	PMID:28959563
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of BOC mRNA	PMID:31162603
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BOC mRNA	PMID:29803840
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605311	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of BOC mRNA	PMID:29301061
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605311	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BOC 5' UTR; Benzo(a)pyrene affects the methylation of BOC exon	PMID:27901495|PMID:30157460
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312052	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BOC mRNA	PMID:20713471
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605311	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of BOC exon; Benzo(a)pyrene results in decreased methylation of BOC promoter	PMID:27901495
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605311	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BOC mRNA	PMID:32234424
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312052	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to BOC promoter]	PMID:19654925
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of BOC mRNA	PMID:31162603
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of BOC mRNA	PMID:26705709
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1605311	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of BOC gene	PMID:31601247
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1605311	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of BOC gene	PMID:31601247
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of BOC mRNA	PMID:41034487
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312052	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of BOC mRNA	PMID:32156529
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1605311	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of BOC exon	PMID:30157460
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of BOC mRNA	PMID:35163327
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of BOC mRNA	PMID:30723492
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of BOC mRNA	PMID:35163327
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of BOC mRNA	PMID:31533062
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312052	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BOC mRNA	PMID:36331819
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of BOC mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605311	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of BOC mRNA	PMID:24935251
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1605311	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of BOC mRNA	PMID:24935251
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of BOC mRNA	PMID:33387578
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of BOC mRNA	PMID:35811015
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of BOC mRNA	PMID:35811015
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312052	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of BOC mRNA	PMID:29279043
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1605311	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of BOC gene	PMID:29523930
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of BOC mRNA	PMID:37567419
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of BOC mRNA	PMID:26272509
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BOC mRNA	PMID:27188386
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1605311	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of BOC mRNA	PMID:26705709
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312052	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of BOC mRNA	PMID:40234311
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312052	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of BOC mRNA	PMID:19042947
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312052	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of BOC mRNA	PMID:23608068
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312052	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of BOC mRNA	PMID:38701926
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1605311	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of BOC exon	PMID:30157460
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of BOC gene	PMID:35440735
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312052	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of BOC mRNA	PMID:22206623
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BOC mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BOC mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BOC mRNA	PMID:27188386
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1605311	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of BOC mRNA	PMID:26272509
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BOC mRNA	PMID:27188386
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605311	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BOC mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BOC mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BOC mRNA	PMID:27188386
1304550	Boc	BOC cell adhesion associated, oncogene regulated	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of BOC mRNA	PMID:19015723
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312053	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of USH1G mRNA	PMID:26079696
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312053	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of USH1G mRNA	PMID:22378314
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312053	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of USH1G mRNA	PMID:30165855
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of USH1G mRNA	PMID:23829299
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1549969	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of USH1G mRNA	PMID:36706583
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of USH1G mRNA	PMID:27523638
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312053	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of USH1G mRNA	PMID:36139627
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of USH1G mRNA	PMID:39012411
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of USH1G mRNA	PMID:21396975
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312053	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of USH1G mRNA	PMID:38460933
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312053	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of USH1G mRNA	PMID:23557933
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USH1G mRNA	PMID:22298810
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312053	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of USH1G mRNA	PMID:29301061|PMID:39719251
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1549969	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of USH1G mRNA	PMID:37682722
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312053	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USH1G mRNA	PMID:32234424
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1549969	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USH1G mRNA	PMID:23735875
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312053	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of USH1G gene	PMID:25435355
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312053	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of USH1G mRNA	PMID:35984750
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1549969	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USH1G gene	PMID:35295148
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1549969	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of USH1G promoter	PMID:35295148
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of USH1G mRNA	PMID:30816183|PMID:32528016
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of USH1G mRNA	PMID:23829299
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1549969	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of USH1G intron	PMID:28392331
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1549969	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of USH1G gene	PMID:38995845
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of USH1G mRNA	PMID:39012411
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312053	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of USH1G gene	PMID:29154799
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312053	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of USH1G mRNA	PMID:38460933
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312053	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of USH1G mRNA	PMID:24810058
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312053	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of USH1G mRNA	PMID:36139627
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of USH1G mRNA	PMID:32109520
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312053	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of USH1G mRNA	PMID:26079696
1304551	Ush1g	USH1 protein network component sans	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1549969	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of USH1G mRNA	PMID:36706583
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI35 mRNA	PMID:20370541
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IFI35 mRNA]	PMID:31150632
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of IFI35 protein	PMID:36641056
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312056	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in increased expression of IFI35 mRNA	PMID:15498508|PMID:33167477
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI35 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI35 mRNA	PMID:33729688
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312056	E	RGD:6480464	20190611	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IFI35 protein	PMID:30501627
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312057	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IFI35 mRNA	PMID:22687549|PMID:26582142|PMID:39241906
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20161228	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA]; genipin inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA]	PMID:22687549|PMID:39241906
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312056	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of IFI35 mRNA	PMID:30510588
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of IFI35 mRNA	PMID:39298647
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312056	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of IFI35 mRNA	PMID:21185374
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of IFI35 mRNA	PMID:30165855
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:16548	chlordecone	affects response to substance	ISO	RGD:1312056	E	RGD:6480464	20150609	CTD	MESH:D007631	IFI35 gene SNP affects the susceptibility to Chlordecone	PMID:25622337
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of IFI35 mRNA	PMID:28973375
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312056	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of IFI35 mRNA	PMID:21592394
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of IFI35 mRNA	PMID:21592394
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312057	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of IFI35 mRNA	PMID:23892564
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IFI35 mRNA	PMID:36139627
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312056	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of IFI35 mRNA	PMID:21592394
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of IFI35 mRNA	PMID:21592394
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of IFI35 mRNA	PMID:28818685
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1312057	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of IFI35 mRNA	PMID:39984025
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312056	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of IFI35 mRNA	PMID:23649840
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1312057	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of IFI35 gene	PMID:27776689
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IFI35 mRNA	PMID:31150632
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IFI35 mRNA]	PMID:31150632
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312057	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid deficiency results in increased expression of IFI35 mRNA	PMID:32304770
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IFI35 mRNA]	PMID:22206623
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IFI35 mRNA	PMID:40504410
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1312056	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of IFI35 mRNA	PMID:19244175
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1312056	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of IFI35 mRNA	PMID:38460933
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of IFI35 mRNA	PMID:38460933
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of IFI35 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of IFI35 mRNA	PMID:23557933
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312056	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of IFI35 mRNA; Cisplatin results in increased expression of IFI35 protein	PMID:27392435|PMID:40654249
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312057	E	RGD:6480464	20260602	CTD	MESH:D002945	Cisplatin results in increased expression of IFI35 protein	PMID:40654249
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of IFI35 mRNA; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]	PMID:27392435|PMID:40654249
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260602	CTD	MESH:D002945	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]; ML385 inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; ML385 inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]]; ML385 inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]]	PMID:40654249
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of IFI35 mRNA	PMID:18930951
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of IFI35 mRNA	PMID:23195993
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312056	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IFI35 mRNA	PMID:25583101
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312057	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IFI35 mRNA	PMID:21570461
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IFI35 mRNA	PMID:21215274|PMID:32109520
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of IFI35 mRNA	PMID:19013527
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of IFI35 mRNA	PMID:33212167
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IFI35 mRNA	PMID:29803840
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:28824	stigmasterol	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20181113	CTD	MESH:D013265	Stigmasterol results in decreased expression of IFI35 mRNA	PMID:30245210
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:28854	2,4-D	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of IFI35 mRNA	PMID:40294809
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:28984	aluminium atom	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20231031	CTD	MESH:D000535	Aluminum results in decreased expression of IFI35 mRNA	PMID:37544489
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20151013	CTD	MESH:D001379	Azathioprine results in decreased expression of IFI35 mRNA	PMID:19192274
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312056	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of IFI35 mRNA	PMID:38568856
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IFI35 mRNA	PMID:40504410
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312057	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IFI35 mRNA	PMID:23735875
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of IFI35 mRNA	PMID:27131904
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of IFI35 mRNA	PMID:20542052
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1312056	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of IFI35 mRNA	PMID:15498508
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of IFI35 mRNA	PMID:23411599|PMID:34492290
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312057	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of IFI35 mRNA	PMID:28472532
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of IFI35 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IFI35 mRNA	PMID:25181051
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312056	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of IFI35 mRNA	PMID:29275510
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312056	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of IFI35 mRNA	PMID:19244175
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:33629	aluminium(0)	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20231031	CTD	MESH:D000535	Aluminum results in decreased expression of IFI35 mRNA	PMID:37544489
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312057	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of IFI35 mRNA	PMID:30951980|PMID:39298647
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312057	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of IFI35 mRNA	PMID:30951980
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312057	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of IFI35 promoter	PMID:28392331
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of IFI35 mRNA	PMID:21266533
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:34696	dieldrin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D004026	Dieldrin results in decreased expression of IFI35 mRNA	PMID:34051100
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA]	PMID:39241906
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312056	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IFI35 mRNA	PMID:37042841
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20240109	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of IFI35 mRNA	PMID:37738295
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1312056	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of IFI35 mRNA	PMID:19244175
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of IFI35 mRNA	PMID:29154799
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of IFI35 mRNA	PMID:41580965
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of IFI35 mRNA	PMID:25562108
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312056	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of IFI35 mRNA	PMID:20106945|PMID:22147139|PMID:27989131
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312057	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of IFI35 mRNA	PMID:20937368
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in decreased expression of IFI35 mRNA	PMID:19192274
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312056	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IFI35 mRNA	PMID:38832940
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312057	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IFI35 mRNA	PMID:17562736
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1312056	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of IFI35 mRNA	PMID:16101138
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of IFI35 mRNA	PMID:38460933
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IFI35 mRNA	PMID:40504410
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac results in decreased expression of IFI35 mRNA	PMID:19192274
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312057	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IFI35 mRNA; Nanotubes, Carbon results in increased expression of IFI35 mRNA	PMID:25554681
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:5298	Genipin	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20141111	CTD	MESH:C007834	genipin inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA]	PMID:22687549
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:5516	sodium aurothiomalate	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20151013	CTD	MESH:D006052	Gold Sodium Thiomalate results in decreased expression of IFI35 mRNA	PMID:19192274
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1312056	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of IFI35 mRNA	PMID:20436886
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IFI35 protein	PMID:32959892
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI35 mRNA	PMID:21641980
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of IFI35 mRNA	PMID:15336504
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of IFI35 mRNA	PMID:28801915
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of IFI35 mRNA	PMID:30467583
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:6888	6alpha-methylprednisolone	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20151013	CTD	MESH:D008775	Methylprednisolone results in decreased expression of IFI35 mRNA	PMID:19192274
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:71200	tofacitinib	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20170516	CTD	MESH:C479163	tofacitinib results in decreased expression of IFI35 mRNA	PMID:25487280
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312056	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of IFI35 mRNA	PMID:31758290
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312057	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IFI35 mRNA	PMID:22206623
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IFI35 mRNA]	PMID:22206623
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of IFI35 mRNA	PMID:24136188
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IFI35 mRNA	PMID:36139627
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of IFI35 mRNA	PMID:22124623
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312057	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of IFI35 mRNA	PMID:30294300
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA]	PMID:39241906
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of IFI35 mRNA	PMID:31734321
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of IFI35 mRNA	PMID:27131904
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1312056	E	RGD:6480464	20260602	CTD	MESH:C477224	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]]	PMID:40654249
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260602	CTD	MESH:C477224	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]]	PMID:40654249
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312056	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of IFI35 mRNA	PMID:29301935
1304553	Ifi35	interferon-induced protein 35	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312057	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of IFI35 mRNA	PMID:35537566
1304554	Pate7	prostate and testis expressed 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C006780	bisphenol A results in decreased expression of PATE7 mRNA	PMID:25181051
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312060	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of COG3 mRNA	PMID:30319688
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312060	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of COG3 mRNA	PMID:39298647
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312059	E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [COG3 protein binds to ESR1 protein]	PMID:27156127
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312059	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COG3 mRNA	PMID:37042841
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312059	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of COG3 mRNA	PMID:20655997
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312060	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of COG3 mRNA	PMID:23892564
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312059	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of COG3 gene	PMID:27153756
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of COG3 mRNA	PMID:31150632
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312060	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of COG3 mRNA	PMID:27339419|PMID:31919559
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312060	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of COG3 mRNA	PMID:25629700
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312060	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COG3 mRNA	PMID:22206623
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312059	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of COG3 mRNA	PMID:23557933
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312060	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COG3 mRNA	PMID:21570461
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312060	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of COG3 mRNA	PMID:25975270
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312059	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of COG3 protein	PMID:39603559
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312059	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COG3 mRNA	PMID:30851411
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of COG3 mRNA	PMID:28959563
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312059	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COG3 mRNA	PMID:29803840
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312059	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of COG3 protein	PMID:30528433|PMID:38228842
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312060	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of COG3 mRNA	PMID:36209798
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312059	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of COG3 mRNA	PMID:22378314
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312060	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COG3 exon; Benzo(a)pyrene results in increased methylation of COG3 intron	PMID:27901495
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312059	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to COG3 mRNA]	PMID:32406909
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312060	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of COG3 mRNA	PMID:23221170
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312059	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of COG3 mRNA	PMID:26238291
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312059	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of COG3 gene	PMID:31601247
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of COG3 mRNA	PMID:24136188
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312060	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of COG3 gene	PMID:35295148
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312059	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of COG3 mRNA	PMID:19710929
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312059	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of COG3 protein	PMID:31675489
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312060	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of COG3 mRNA	PMID:33221593
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of COG3 mRNA	PMID:30816183
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312059	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of COG3 protein	PMID:37567409
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312059	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of COG3 gene	PMID:31601247
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312060	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of COG3 mRNA	PMID:39298647
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312060	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of COG3 mRNA	PMID:37019170
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312060	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of COG3 mRNA	PMID:34813904
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312059	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COG3 mRNA	PMID:38174414
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312059	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of COG3 mRNA	PMID:28302478
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312059	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of COG3 mRNA	PMID:31533062
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of COG3 mRNA	PMID:23125180
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312060	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of COG3 mRNA	PMID:17292431
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312059	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of COG3 mRNA	PMID:20106945|PMID:27989131
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312060	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of COG3 mRNA	PMID:18502557
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312060	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of COG3 mRNA	PMID:17562736
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COG3 mRNA	PMID:33387578
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312059	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of COG3 mRNA	PMID:21420995
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of COG3 mRNA	PMID:29391264
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312060	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of COG3 mRNA	PMID:35964746
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312059	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COG3 protein	PMID:32959892
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312060	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COG3 mRNA	PMID:22206623
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1312060	E	RGD:6480464	20220607	CTD	MESH:C038405	nivalenol results in increased expression of COG3 mRNA	PMID:35016910
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312059	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COG3 mRNA	PMID:30851411
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312059	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COG3 gene]	PMID:28238834
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312059	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COG3 protein	PMID:31675489
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of COG3 mRNA	PMID:21346803
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312059	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of COG3 mRNA	PMID:38568856
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312059	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of COG3 mRNA	PMID:22378314
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1312060	E	RGD:6480464	20140715	CTD	MESH:D013849	Thimerosal results in increased expression of COG3 mRNA	PMID:24675092
1304555	Cog3	component of oligomeric golgi complex 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of COG3 mRNA	PMID:21346803
1304556	Actg1	actin, gamma 1	gene	CHEBI:10093	yohimbine	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D015016	Yohimbine results in increased expression of ACTG1 mRNA	PMID:21983523
1304556	Actg1	actin, gamma 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ACTG1 mRNA	PMID:38218311
1304556	Actg1	actin, gamma 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312061	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ACTG1 mRNA	PMID:38218311
1304556	Actg1	actin, gamma 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ACTG1 mRNA	PMID:35967413
1304556	Actg1	actin, gamma 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ACTG1 mRNA	PMID:33045310
1304556	Actg1	actin, gamma 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTG1 mRNA]	PMID:31150632
1304556	Actg1	actin, gamma 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ACTG1 mRNA	PMID:20188158
1304556	Actg1	actin, gamma 1	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D014212	Tretinoin affects the expression of ACTG1 protein	PMID:15789344
1304556	Actg1	actin, gamma 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ACTG1 mRNA	PMID:23724009
1304556	Actg1	actin, gamma 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of ACTG1 protein	PMID:39571964
1304556	Actg1	actin, gamma 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ACTG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ACTG1 mRNA	PMID:32699268
1304556	Actg1	actin, gamma 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:D010100	ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1304556	Actg1	actin, gamma 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1549970	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ACTG1 mRNA	PMID:30319688
1304556	Actg1	actin, gamma 1	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D000431	Ethanol results in increased expression of ACTG1 protein	PMID:23702218
1304556	Actg1	actin, gamma 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ACTG1 mRNA	PMID:30319688
1304556	Actg1	actin, gamma 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D004958	Estradiol results in decreased expression of ACTG1 mRNA	PMID:11179685
1304556	Actg1	actin, gamma 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ACTG1 mRNA	PMID:39298647
1304556	Actg1	actin, gamma 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D004958	3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of ACTG1 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of ACTG1 mRNA]	PMID:11179685
1304556	Actg1	actin, gamma 1	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312061	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ACTG1 mRNA	PMID:38568856
1304556	Actg1	actin, gamma 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312061	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACTG1 mRNA	PMID:37042841
1304556	Actg1	actin, gamma 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D005557	Formaldehyde results in increased expression of ACTG1 mRNA	PMID:18045764
1304556	Actg1	actin, gamma 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:C044887	beta-methylcholine affects the expression of ACTG1 mRNA	PMID:21179406
1304556	Actg1	actin, gamma 1	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1304556	Actg1	actin, gamma 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACTG1 mRNA	PMID:37992649
1304556	Actg1	actin, gamma 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20240903	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased expression of ACTG1 mRNA	PMID:38730545
1304556	Actg1	actin, gamma 1	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1304556	Actg1	actin, gamma 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACTG1 mRNA	PMID:37992649
1304556	Actg1	actin, gamma 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ACTG1 mRNA	PMID:23892564
1304556	Actg1	actin, gamma 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ACTG1 mRNA	PMID:19850644
1304556	Actg1	actin, gamma 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased expression of ACTG1 mRNA; PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACTG1 mRNA]	PMID:19850644|PMID:38730545
1304556	Actg1	actin, gamma 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ACTG1 mRNA	PMID:22061828
1304556	Actg1	actin, gamma 1	gene	CHEBI:18243	dopamine	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D004298	Dopamine results in increased expression of ACTG1 mRNA	PMID:21983523
1304556	Actg1	actin, gamma 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of ACTG1 mRNA	PMID:27462272
1304556	Actg1	actin, gamma 1	gene	CHEBI:207229	dihydroartemisinin	affects binding	ISO	RGD:1312061	E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to ACTG1 protein	PMID:26340163
1304556	Actg1	actin, gamma 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D019327	Copper Sulfate results in increased expression of ACTG1 mRNA	PMID:19549813
1304556	Actg1	actin, gamma 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ACTG1 protein	PMID:23301498
1304556	Actg1	actin, gamma 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ACTG1 mRNA	PMID:33354967
1304556	Actg1	actin, gamma 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ACTG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ACTG1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ACTG1 mRNA	PMID:32699268
1304556	Actg1	actin, gamma 1	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ACTG1 mRNA	PMID:30779732
1304556	Actg1	actin, gamma 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ACTG1 mRNA	PMID:31150632
1304556	Actg1	actin, gamma 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ACTG1 mRNA	PMID:17084009
1304556	Actg1	actin, gamma 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTG1 mRNA]	PMID:31150632
1304556	Actg1	actin, gamma 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACTG1 mRNA]	PMID:22206623
1304556	Actg1	actin, gamma 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D012643	Selenium results in increased expression of ACTG1 mRNA	PMID:19244175
1304556	Actg1	actin, gamma 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1549970	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of ACTG1 mRNA	PMID:28189721|PMID:28960355
1304556	Actg1	actin, gamma 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ACTG1 mRNA	PMID:27392435
1304556	Actg1	actin, gamma 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ACTG1 mRNA	PMID:27392435
1304556	Actg1	actin, gamma 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of ACTG1 mRNA	PMID:22228119
1304556	Actg1	actin, gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACTG1 mRNA	PMID:34747641
1304556	Actg1	actin, gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACTG1 mRNA; Tetrachlorodibenzodioxin results in decreased expression of ACTG1 protein	PMID:16054898|PMID:16548065|PMID:33387578
1304556	Actg1	actin, gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACTG1 protein	PMID:19201780
1304556	Actg1	actin, gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of ACTG1 mRNA]	PMID:11179685
1304556	Actg1	actin, gamma 1	gene	CHEBI:28201	rotenone	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of ACTG1 mRNA	PMID:28374803
1304556	Actg1	actin, gamma 1	gene	CHEBI:28201	rotenone	increases oxidation	EXP		E	RGD:6480464	20190910	CTD	MESH:D012402	Rotenone results in increased oxidation of ACTG1 protein	PMID:30951809
1304556	Actg1	actin, gamma 1	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312061	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ACTG1 mRNA	PMID:30851411
1304556	Actg1	actin, gamma 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ACTG1 mRNA	PMID:32763439
1304556	Actg1	actin, gamma 1	gene	CHEBI:28694	copper atom	affects binding	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D003300	ACTG1 protein binds to Copper	PMID:15359738
1304556	Actg1	actin, gamma 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ACTG1 mRNA	PMID:30911355
1304556	Actg1	actin, gamma 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ACTG1 protein	PMID:27548804
1304556	Actg1	actin, gamma 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ACTG1 mRNA	PMID:39631538
1304556	Actg1	actin, gamma 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312061	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ACTG1 mRNA	PMID:29803840
1304556	Actg1	actin, gamma 1	gene	CHEBI:28748	doxorubicin	increases oxidation	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin results in increased oxidation of ACTG1 protein	PMID:28818578
1304556	Actg1	actin, gamma 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACTG1 mRNA	PMID:37992649
1304556	Actg1	actin, gamma 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACTG1 mRNA	PMID:35314868
1304556	Actg1	actin, gamma 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312061	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ACTG1 mRNA	PMID:38568856
1304556	Actg1	actin, gamma 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20210907	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of ACTG1 protein; [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of ACTG1 mRNA; sodium arsenite promotes the reaction [ACTG1 protein binds to CAPRIN1 protein]	PMID:32076005|PMID:33939924|PMID:39571964
1304556	Actg1	actin, gamma 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ACTG1 mRNA	PMID:22378314
1304556	Actg1	actin, gamma 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACTG1 mRNA	PMID:20064835
1304556	Actg1	actin, gamma 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312061	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ACTG1 3' UTR	PMID:27901495
1304556	Actg1	actin, gamma 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20210907	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of ACTG1 mRNA	PMID:32076005
1304556	Actg1	actin, gamma 1	gene	CHEBI:30052	copper(0)	affects binding	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D003300	ACTG1 protein binds to Copper	PMID:15359738
1304556	Actg1	actin, gamma 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ACTG1 mRNA	PMID:30911355
1304556	Actg1	actin, gamma 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ACTG1 mRNA	PMID:20458559
1304556	Actg1	actin, gamma 1	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1549970	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of ACTG1 mRNA	PMID:36087614
1304556	Actg1	actin, gamma 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ACTG1 mRNA	PMID:24136188
1304556	Actg1	actin, gamma 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ACTG1 mRNA	PMID:30047161
1304556	Actg1	actin, gamma 1	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of ACTG1 mRNA	PMID:24136188
1304556	Actg1	actin, gamma 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACTG1 mRNA	PMID:23557971
1304556	Actg1	actin, gamma 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1549970	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACTG1 promoter alternative form	PMID:35295148
1304556	Actg1	actin, gamma 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ACTG1 mRNA	PMID:34492290
1304556	Actg1	actin, gamma 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:C006253	pirinixic acid results in increased expression of ACTG1 mRNA	PMID:16221962|PMID:18445702
1304556	Actg1	actin, gamma 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ACTG1 mRNA	PMID:38479592
1304556	Actg1	actin, gamma 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ACTG1 mRNA	PMID:30903817
1304556	Actg1	actin, gamma 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312061	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ACTG1 mRNA	PMID:30903817
1304556	Actg1	actin, gamma 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ACTG1 protein	PMID:31675489
1304556	Actg1	actin, gamma 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ACTG1 mRNA	PMID:33221593
1304556	Actg1	actin, gamma 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACTG1 mRNA	PMID:25181051
1304556	Actg1	actin, gamma 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312061	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ACTG1 protein	PMID:37567409
1304556	Actg1	actin, gamma 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1549970	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of ACTG1 mRNA	PMID:35479511
1304556	Actg1	actin, gamma 1	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of ACTG1 mRNA	PMID:12082028
1304556	Actg1	actin, gamma 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ACTG1 mRNA	PMID:39298647
1304556	Actg1	actin, gamma 1	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ACTG1 mRNA	PMID:26377693
1304556	Actg1	actin, gamma 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1549970	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ACTG1 mRNA	PMID:38685157
1304556	Actg1	actin, gamma 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ACTG1 mRNA	PMID:21266533
1304556	Actg1	actin, gamma 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ACTG1 mRNA	PMID:17361019|PMID:21266533
1304556	Actg1	actin, gamma 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1549970	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ACTG1 mRNA	PMID:34813904
1304556	Actg1	actin, gamma 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ACTG1 mRNA	PMID:19638242
1304556	Actg1	actin, gamma 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in decreased expression of ACTG1 protein	PMID:39748354
1304556	Actg1	actin, gamma 1	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of ACTG1 mRNA	PMID:30589522
1304556	Actg1	actin, gamma 1	gene	CHEBI:35176	zinc sulfate	affects expression	ISO	RGD:1312061	E	RGD:6480464	20150127	CTD	MESH:D019287	Zinc Sulfate affects the expression of ACTG1 protein	PMID:25162517
1304556	Actg1	actin, gamma 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ACTG1 mRNA	PMID:30723492
1304556	Actg1	actin, gamma 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312061	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ACTG1 mRNA	PMID:38568856
1304556	Actg1	actin, gamma 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ACTG1 mRNA	PMID:19162173|PMID:30047161
1304556	Actg1	actin, gamma 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1549970	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of ACTG1 mRNA	PMID:28962523
1304556	Actg1	actin, gamma 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ACTG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ACTG1 mRNA	PMID:32699268
1304556	Actg1	actin, gamma 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D012643	Selenium results in increased expression of ACTG1 mRNA	PMID:19244175
1304556	Actg1	actin, gamma 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ACTG1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACTG1 mRNA]	PMID:17585979
1304556	Actg1	actin, gamma 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D015741	Metribolone results in increased expression of ACTG1 protein	PMID:17152098
1304556	Actg1	actin, gamma 1	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:C056933	fumonisin B1 results in increased expression of ACTG1 mRNA	PMID:16221962
1304556	Actg1	actin, gamma 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1549970	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACTG1 mRNA	PMID:40194260
1304556	Actg1	actin, gamma 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312061	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ACTG1 mRNA	PMID:28302478
1304556	Actg1	actin, gamma 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ACTG1 mRNA	PMID:40419075
1304556	Actg1	actin, gamma 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D014635	Valproic Acid affects the expression of ACTG1 mRNA	PMID:17292431
1304556	Actg1	actin, gamma 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ACTG1 mRNA	PMID:30047161
1304556	Actg1	actin, gamma 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312061	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ACTG1 mRNA	PMID:25562108
1304556	Actg1	actin, gamma 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D013629	Tamoxifen affects the expression of ACTG1 mRNA	PMID:20937368
1304556	Actg1	actin, gamma 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1304556	Actg1	actin, gamma 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACTG1 mRNA	PMID:37992649
1304556	Actg1	actin, gamma 1	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D011692	Puromycin Aminonucleoside results in decreased expression of ACTG1 protein	PMID:19264907
1304556	Actg1	actin, gamma 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D008727	Methotrexate affects the expression of ACTG1 mRNA	PMID:18502557
1304556	Actg1	actin, gamma 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D000082	Acetaminophen affects the expression of ACTG1 mRNA	PMID:17562736
1304556	Actg1	actin, gamma 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACTG1 protein	PMID:22230336
1304556	Actg1	actin, gamma 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D000082	Acetaminophen results in increased expression of ACTG1 mRNA	PMID:11264010|PMID:18544908
1304556	Actg1	actin, gamma 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ACTG1 mRNA; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ACTG1 mRNA]; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACTG1 mRNA]	PMID:17585979|PMID:18700144
1304556	Actg1	actin, gamma 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in decreased expression of ACTG1 mRNA	PMID:31464424
1304556	Actg1	actin, gamma 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ACTG1 mRNA	PMID:12082028
1304556	Actg1	actin, gamma 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ACTG1 mRNA	PMID:14976129
1304556	Actg1	actin, gamma 1	gene	CHEBI:4917	eugenol	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in decreased expression of ACTG1 protein	PMID:39793947
1304556	Actg1	actin, gamma 1	gene	CHEBI:4948	Evodiamine	increases expression	ISO	RGD:1312061	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in increased expression of ACTG1 mRNA	PMID:32057900
1304556	Actg1	actin, gamma 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ACTG1 mRNA	PMID:20458559
1304556	Actg1	actin, gamma 1	gene	CHEBI:5002	fenoldopam	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D018818	Fenoldopam results in increased expression of ACTG1 mRNA	PMID:21983523
1304556	Actg1	actin, gamma 1	gene	CHEBI:50182	3,3'-diindolylmethane	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20180116	CTD	MESH:C016392	3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of ACTG1 mRNA]	PMID:11179685
1304556	Actg1	actin, gamma 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ACTG1 mRNA	PMID:25620056
1304556	Actg1	actin, gamma 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1549970	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ACTG1 mRNA; Nanotubes, Carbon results in increased expression of ACTG1 mRNA	PMID:25554681
1304556	Actg1	actin, gamma 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ACTG1 mRNA	PMID:30047161
1304556	Actg1	actin, gamma 1	gene	CHEBI:50859	bexarotene	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in increased expression of ACTG1 mRNA	PMID:16648578
1304556	Actg1	actin, gamma 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ACTG1 mRNA	PMID:35964746
1304556	Actg1	actin, gamma 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ACTG1 mRNA	PMID:24136188
1304556	Actg1	actin, gamma 1	gene	CHEBI:517248	bufalin	increases expression	ISO	RGD:1312061	E	RGD:6480464	20151110	CTD	MESH:C022777	bufalin results in increased expression of ACTG1 protein	PMID:23091618
1304556	Actg1	actin, gamma 1	gene	CHEBI:52492	mancozeb	increases expression	ISO	RGD:1549970	E	RGD:6480464	20140708	CTD	MESH:C013099	mancozeb results in increased expression of ACTG1 protein	PMID:21375462
1304556	Actg1	actin, gamma 1	gene	CHEBI:529996	cytochalasin D	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20190219	CTD	MESH:D015638	Cytochalasin D inhibits the reaction [UPF1 protein binds to ACTG1 protein]; Cytochalasin D inhibits the reaction [UPF2 protein binds to ACTG1 protein]; Cytochalasin D inhibits the reaction [UPF3B protein binds to ACTG1 protein]	PMID:28743738
1304556	Actg1	actin, gamma 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1549970	E	RGD:6480464	20131220	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ACTG1 mRNA	PMID:19042947
1304556	Actg1	actin, gamma 1	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ACTG1 protein	PMID:18563748
1304556	Actg1	actin, gamma 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACTG1 protein	PMID:32959892
1304556	Actg1	actin, gamma 1	gene	CHEBI:63598	levofloxacin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of ACTG1 mRNA	PMID:24136188
1304556	Actg1	actin, gamma 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312061	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ACTG1 mRNA	PMID:28988120
1304556	Actg1	actin, gamma 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1549970	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ACTG1 protein	PMID:26558463
1304556	Actg1	actin, gamma 1	gene	CHEBI:66104	jaspamide	multiple interactions	ISO	RGD:1312061	E	RGD:6480464	20190219	CTD	MESH:C057531	jasplakinolide inhibits the reaction [UPF1 protein binds to ACTG1 protein]; jasplakinolide inhibits the reaction [UPF2 protein binds to ACTG1 protein]; jasplakinolide inhibits the reaction [UPF3B protein binds to ACTG1 protein]	PMID:28743738
1304556	Actg1	actin, gamma 1	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D008694	Methamphetamine results in decreased expression of ACTG1 protein	PMID:19826936
1304556	Actg1	actin, gamma 1	gene	CHEBI:6925	microcystin-LR	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C057862	cyanoginosin LR results in increased expression of ACTG1 protein	PMID:22430071
1304556	Actg1	actin, gamma 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1549970	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ACTG1 mRNA	PMID:22206623
1304556	Actg1	actin, gamma 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACTG1 mRNA]	PMID:22206623
1304556	Actg1	actin, gamma 1	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of ACTG1 mRNA	PMID:15215175
1304556	Actg1	actin, gamma 1	gene	CHEBI:76326	N-nitrosomorpholine	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C002741	N-nitrosomorpholine results in decreased expression of ACTG1 protein	PMID:19716841
1304556	Actg1	actin, gamma 1	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of ACTG1 protein	PMID:19716841
1304556	Actg1	actin, gamma 1	gene	CHEBI:76987	metacetamol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20140204	CTD	MESH:C026137	3-hydroxyacetanilide results in increased expression of ACTG1 mRNA	PMID:18544908
1304556	Actg1	actin, gamma 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312061	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ACTG1 mRNA	PMID:30851411
1304556	Actg1	actin, gamma 1	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20171010	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of ACTG1 protein	PMID:19550292
1304556	Actg1	actin, gamma 1	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 promotes the reaction [NR1H4 protein binds to ACTG1 gene]	PMID:20091679
1304556	Actg1	actin, gamma 1	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of ACTG1 mRNA	PMID:19682730
1304556	Actg1	actin, gamma 1	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of ACTG1 mRNA	PMID:31324951
1304556	Actg1	actin, gamma 1	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D010634	Phenobarbital results in decreased expression of ACTG1 mRNA	PMID:19162173
1304556	Actg1	actin, gamma 1	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D010634	Phenobarbital results in increased expression of ACTG1 mRNA	PMID:12082028
1304556	Actg1	actin, gamma 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1549970	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ACTG1 mRNA	PMID:31388691
1304556	Actg1	actin, gamma 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1549970	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ACTG1 mRNA	PMID:38648751
1304556	Actg1	actin, gamma 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1549970	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ACTG1 mRNA	PMID:30294300
1304556	Actg1	actin, gamma 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ACTG1 mRNA	PMID:24780913|PMID:30047161|PMID:36843608
1304556	Actg1	actin, gamma 1	gene	CHEBI:90633	perfluorododecanoic acid	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in decreased expression of ACTG1 protein	PMID:26168851
1304556	Actg1	actin, gamma 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312061	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ACTG1 mRNA	PMID:38568856
1304556	Actg1	actin, gamma 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of ACTG1 mRNA	PMID:22378314
1304556	Actg1	actin, gamma 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312061	E	RGD:6480464	20131220	CTD	MESH:C057693	troglitazone results in decreased expression of ACTG1 mRNA	PMID:19140230
1304556	Actg1	actin, gamma 1	gene	CHEBI:9763	trovafloxacin	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of ACTG1 mRNA	PMID:24136188
1304558	Dstnl1	destrin-like 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DSTNL1 mRNA	PMID:33387578
1304559	Wnt6	Wnt family member 6	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of WNT6 mRNA	PMID:38218311
1304559	Wnt6	Wnt family member 6	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of WNT6 mRNA	PMID:33045310
1304559	Wnt6	Wnt family member 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312068	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of WNT6 mRNA	PMID:37995155
1304559	Wnt6	Wnt family member 6	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1312067	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of WNT6 mRNA	PMID:34925699
1304559	Wnt6	Wnt family member 6	gene	CHEBI:144400	dinophysistoxin 1	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in decreased expression of WNT6 mRNA	PMID:28939011
1304559	Wnt6	Wnt family member 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of WNT6 mRNA	PMID:16604517
1304559	Wnt6	Wnt family member 6	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312067	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of WNT6 mRNA	PMID:20044591
1304559	Wnt6	Wnt family member 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of WNT6 mRNA	PMID:35811015
1304559	Wnt6	Wnt family member 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312067	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of WNT6 mRNA]	PMID:35811015
1304559	Wnt6	Wnt family member 6	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of WNT6 mRNA	PMID:30510588
1304559	Wnt6	Wnt family member 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312068	E	RGD:6480464	20130416	CTD	MESH:D004958	Estradiol results in increased expression of WNT6 mRNA	PMID:23144751
1304559	Wnt6	Wnt family member 6	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312067	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in increased expression of WNT6 mRNA	PMID:28937961
1304559	Wnt6	Wnt family member 6	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of WNT6 mRNA	PMID:26079696
1304559	Wnt6	Wnt family member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of WNT6 mRNA	PMID:34319233
1304559	Wnt6	Wnt family member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312067	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of WNT6 mRNA	PMID:31163220
1304559	Wnt6	Wnt family member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312068	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of WNT6 mRNA	PMID:33754040
1304559	Wnt6	Wnt family member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1304559	Wnt6	Wnt family member 6	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312067	E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of WNT6 mRNA	PMID:22562489
1304559	Wnt6	Wnt family member 6	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20241203	CTD	MESH:D001397	[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA]	PMID:31715269
1304559	Wnt6	Wnt family member 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20121218	CTD	MESH:D005492	[Folic Acid co-treated with sodium arsenite] results in increased methylation of WNT6 mRNA	PMID:22959928
1304559	Wnt6	Wnt family member 6	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312067	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of WNT6 mRNA	PMID:26272509
1304559	Wnt6	Wnt family member 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312067	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1304559	Wnt6	Wnt family member 6	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of WNT6 mRNA	PMID:32186404
1304559	Wnt6	Wnt family member 6	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in decreased expression of WNT6 mRNA	PMID:19130878
1304559	Wnt6	Wnt family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312068	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WNT6 mRNA	PMID:21570461
1304559	Wnt6	Wnt family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WNT6 mRNA	PMID:32109520
1304559	Wnt6	Wnt family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312067	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WNT6 mRNA	PMID:20106945|PMID:21296121|PMID:21632981
1304559	Wnt6	Wnt family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WNT6 mRNA	PMID:17942748
1304559	Wnt6	Wnt family member 6	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1312067	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of WNT6 mRNA	PMID:26272509
1304559	Wnt6	Wnt family member 6	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312067	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1304559	Wnt6	Wnt family member 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of WNT6 mRNA	PMID:37682722
1304559	Wnt6	Wnt family member 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312067	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of WNT6 mRNA	PMID:38568856
1304559	Wnt6	Wnt family member 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20161228	CTD	MESH:C017947	[Folic Acid co-treated with sodium arsenite] results in increased methylation of WNT6 mRNA	PMID:22959928
1304559	Wnt6	Wnt family member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312067	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WNT6 mRNA	PMID:21632981
1304559	Wnt6	Wnt family member 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312067	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WNT6 3' UTR; Benzo(a)pyrene results in increased methylation of WNT6 promoter	PMID:27901495
1304559	Wnt6	Wnt family member 6	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of WNT6 mRNA	PMID:25895662
1304559	Wnt6	Wnt family member 6	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312068	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of WNT6 mRNA	PMID:29341224
1304559	Wnt6	Wnt family member 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of WNT6 mRNA	PMID:29264374
1304559	Wnt6	Wnt family member 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312068	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of WNT6 promoter	PMID:35295148
1304559	Wnt6	Wnt family member 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of WNT6 mRNA	PMID:34492290
1304559	Wnt6	Wnt family member 6	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of WNT6 mRNA	PMID:17950772
1304559	Wnt6	Wnt family member 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20120412	CTD	MESH:C006253	NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of WNT6 mRNA]	PMID:17950772
1304559	Wnt6	Wnt family member 6	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312068	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of WNT6 mRNA	PMID:19191707
1304559	Wnt6	Wnt family member 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of WNT6 mRNA	PMID:25181051
1304559	Wnt6	Wnt family member 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of WNT6 mRNA	PMID:30816183|PMID:31129395|PMID:34947998|PMID:38750585
1304559	Wnt6	Wnt family member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312068	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of WNT6 mRNA	PMID:32156529
1304559	Wnt6	Wnt family member 6	gene	CHEBI:3390	carbaryl	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20170516	CTD	MESH:D012721	Carbaryl results in decreased expression of WNT6 mRNA	PMID:27829164
1304559	Wnt6	Wnt family member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312068	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of WNT6 mRNA	PMID:30951980|PMID:40203079
1304559	Wnt6	Wnt family member 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312068	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of WNT6 mRNA	PMID:30951980
1304559	Wnt6	Wnt family member 6	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1304559	Wnt6	Wnt family member 6	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20200519	CTD	MESH:D016264	[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA]	PMID:31715269
1304559	Wnt6	Wnt family member 6	gene	CHEBI:34682	diazinon	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in increased expression of WNT6 mRNA	PMID:19130878
1304559	Wnt6	Wnt family member 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of WNT6 mRNA	PMID:17361019|PMID:21266533
1304559	Wnt6	Wnt family member 6	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1304559	Wnt6	Wnt family member 6	gene	CHEBI:34696	dieldrin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004026	Dieldrin results in increased expression of WNT6 mRNA	PMID:19130878
1304559	Wnt6	Wnt family member 6	gene	CHEBI:34698	diethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1304559	Wnt6	Wnt family member 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312068	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of WNT6 mRNA	PMID:20478370
1304559	Wnt6	Wnt family member 6	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1304559	Wnt6	Wnt family member 6	gene	CHEBI:36791	escitalopram	decreases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D000089983	Escitalopram results in decreased expression of WNT6 mRNA	PMID:28467792
1304559	Wnt6	Wnt family member 6	gene	CHEBI:3723	citalopram	decreases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in decreased expression of WNT6 mRNA	PMID:28467792
1304559	Wnt6	Wnt family member 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of WNT6 mRNA	PMID:35594946
1304559	Wnt6	Wnt family member 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in increased expression of WNT6 mRNA	PMID:29427782
1304559	Wnt6	Wnt family member 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312067	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of WNT6 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1304559	Wnt6	Wnt family member 6	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312067	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1304559	Wnt6	Wnt family member 6	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of WNT6 mRNA	PMID:30047161
1304559	Wnt6	Wnt family member 6	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312067	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of WNT6 mRNA	PMID:24935251
1304559	Wnt6	Wnt family member 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of WNT6 mRNA	PMID:22230336|PMID:29067470
1304559	Wnt6	Wnt family member 6	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of WNT6 mRNA	PMID:33387578
1304559	Wnt6	Wnt family member 6	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312067	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of WNT6 mRNA]	PMID:35811015
1304559	Wnt6	Wnt family member 6	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of WNT6 mRNA	PMID:31838189
1304559	Wnt6	Wnt family member 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WNT6 mRNA	PMID:17942748
1304559	Wnt6	Wnt family member 6	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of WNT6 mRNA	PMID:32234424
1304559	Wnt6	Wnt family member 6	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312067	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1304559	Wnt6	Wnt family member 6	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of WNT6 mRNA	PMID:30307764
1304559	Wnt6	Wnt family member 6	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of WNT6 mRNA	PMID:30047161
1304559	Wnt6	Wnt family member 6	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of WNT6 mRNA	PMID:28801915
1304559	Wnt6	Wnt family member 6	gene	CHEBI:63959	celastrol	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20210608	CTD	MESH:C050414	celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA]	PMID:31715269
1304559	Wnt6	Wnt family member 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of WNT6 mRNA	PMID:28801915
1304559	Wnt6	Wnt family member 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312068	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of WNT6 mRNA	PMID:22206623
1304559	Wnt6	Wnt family member 6	gene	CHEBI:755665	etc-159	decreases expression	ISO	RGD:1312067	E	RGD:6480464	20260714	CTD	MESH:C000620782	ETC-159 results in decreased expression of WNT6 mRNA	PMID:39647516
1304559	Wnt6	Wnt family member 6	gene	CHEBI:755665	etc-159	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20260714	CTD	MESH:C000620782	ETC-159 results in decreased expression of WNT6 mRNA	PMID:39647516
1304559	Wnt6	Wnt family member 6	gene	CHEBI:77397	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile	decreases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in decreased expression of WNT6 mRNA	PMID:28467792
1304559	Wnt6	Wnt family member 6	gene	CHEBI:78030	LGK974	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20250902	CTD	MESH:C586458	LGK974 results in decreased expression of WNT6 mRNA	PMID:39647516
1304559	Wnt6	Wnt family member 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312067	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1304559	Wnt6	Wnt family member 6	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1304559	Wnt6	Wnt family member 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312067	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WNT6 gene]	PMID:28238834
1304559	Wnt6	Wnt family member 6	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of WNT6 mRNA	PMID:32109520
1304559	Wnt6	Wnt family member 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of WNT6 mRNA	PMID:24780913|PMID:30047161
1304559	Wnt6	Wnt family member 6	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312067	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1304559	Wnt6	Wnt family member 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312067	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1304559	Wnt6	Wnt family member 6	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312067	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of WNT6 mRNA	PMID:38568856
1304559	Wnt6	Wnt family member 6	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of WNT6 mRNA	PMID:20566332
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FAHD1 mRNA]	PMID:31150632
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of FAHD1 protein	PMID:32145629
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of FAHD1 mRNA	PMID:33387578
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348488	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FAHD1 mRNA	PMID:37042841
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:16856	glutathione	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D005978	Glutathione deficiency results in decreased expression of FAHD1 mRNA	PMID:20621112
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FAHD1 mRNA	PMID:33387578
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of FAHD1 mRNA	PMID:28818685
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553439	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAHD1 mRNA	PMID:36331819
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin analog results in decreased expression of FAHD1 protein	PMID:26597043
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of FAHD1 mRNA	PMID:21515302
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1348488	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of FAHD1 mRNA	PMID:24376830
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FAHD1 mRNA	PMID:19549813
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1348488	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FAHD1 gene	PMID:27153756
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FAHD1 mRNA	PMID:31150632|PMID:33387578
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1553439	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FAHD1 mRNA	PMID:27339419|PMID:31919559
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FAHD1 mRNA]	PMID:31150632
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1553439	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FAHD1 mRNA	PMID:25629700
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553439	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAHD1 mRNA	PMID:22206623
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FAHD1 mRNA	PMID:31881176
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1553439	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of FAHD1 mRNA	PMID:40618947
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D003042	Cocaine results in increased expression of FAHD1 protein	PMID:25100957
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1553439	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of FAHD1 mRNA	PMID:18930951
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:28112	nickel atom	affects expression	ISO	RGD:1348488	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel affects the expression of FAHD1 mRNA	PMID:14575637
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1348488	E	RGD:6480464	20120717	CTD	MESH:D009532	trichostatin A inhibits the reaction [Nickel affects the expression of FAHD1 mRNA]	PMID:14575637
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553439	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FAHD1 mRNA	PMID:21570461
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FAHD1 mRNA	PMID:21215274|PMID:33387578
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of FAHD1 protein	PMID:39603559
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FAHD1 mRNA; sodium arsenite results in decreased expression of FAHD1 protein	PMID:38228842|PMID:38568856
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of FAHD1 protein	PMID:29459688
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FAHD1 mRNA	PMID:32234424
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAHD1 mRNA	PMID:21839799
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1348488	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAHD1 3' UTR	PMID:27901495
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1553439	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of FAHD1 mRNA	PMID:23221170
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FAHD1 mRNA	PMID:19150397
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553439	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAHD1 gene	PMID:35295148
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of FAHD1 mRNA	PMID:23411599|PMID:34492290
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of FAHD1 mRNA	PMID:25380136
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553439	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of FAHD1 mRNA	PMID:18445702
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1553439	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FAHD1 mRNA; [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FAHD1 mRNA	PMID:19710929
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FAHD1 mRNA	PMID:30816183|PMID:32528016
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FAHD1 mRNA	PMID:33670352
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FAHD1 mRNA; bisphenol A results in increased expression of FAHD1 protein	PMID:25181051|PMID:32145629
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FAHD1 gene	PMID:28505145
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:3437	carteolol	affects expression	ISO	RGD:1348488	E	RGD:6480464	20240206	CTD	MESH:D002354	Carteolol affects the expression of FAHD1 mRNA	PMID:37120125
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553439	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FAHD1 mRNA	PMID:39298647
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1348488	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of FAHD1 protein	PMID:34186270
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1348488	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of FAHD1 protein	PMID:34186270
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1553439	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FAHD1 mRNA	PMID:21266533
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of FAHD1 mRNA	PMID:19638242
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348488	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FAHD1 mRNA	PMID:37042841
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of FAHD1 mRNA	PMID:25380136|PMID:30723492
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1348488	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of FAHD1 protein	PMID:26879310
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of FAHD1 mRNA	PMID:25539665|PMID:26194646
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1553439	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of FAHD1 mRNA	PMID:28903501
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FAHD1 mRNA	PMID:24386269
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of FAHD1 mRNA	PMID:25380136
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1553439	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of FAHD1 mRNA	PMID:18353800
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1553439	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of FAHD1 mRNA	PMID:17585979
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1348488	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FAHD1 mRNA	PMID:31533062
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553439	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAHD1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of FAHD1 mRNA	PMID:36331819
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1348488	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FAHD1 mRNA	PMID:25979313
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1348488	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of FAHD1 mRNA	PMID:23179753|PMID:27188386
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FAHD1 mRNA	PMID:25562108
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553439	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of FAHD1 mRNA	PMID:20937368
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1348488	E	RGD:6480464	20120717	CTD	MESH:C012589	trichostatin A inhibits the reaction [Nickel affects the expression of FAHD1 mRNA]	PMID:14575637
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553439	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FAHD1 mRNA	PMID:17562736
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of FAHD1 mRNA	PMID:32479839|PMID:33387578
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of FAHD1 mRNA	PMID:21420995|PMID:25704631
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of FAHD1 mRNA	PMID:29391264
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FAHD1 protein	PMID:32959892
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of FAHD1 mRNA	PMID:30467583
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1348488	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of FAHD1 protein	PMID:34186270
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553439	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FAHD1 mRNA	PMID:22206623
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553439	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAHD1 mRNA	PMID:22206623
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1553439	E	RGD:6480464	20160315	CTD	MESH:C072553	[MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of FAHD1 mRNA	PMID:25566086
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of FAHD1 protein	PMID:39638853
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of FAHD1 mRNA; ochratoxin A results in decreased expression of FAHD1 protein	PMID:22124623|PMID:39638853
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1348488	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of FAHD1 mRNA	PMID:19159669
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1553439	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of FAHD1 mRNA	PMID:19482888
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1553439	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of FAHD1 mRNA]	PMID:19482888
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1553439	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of FAHD1 mRNA	PMID:21278054
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FAHD1 mRNA	PMID:38568856
1304560	Fahd1	fumarylacetoacetate hydrolase domain containing 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1348488	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of FAHD1 mRNA	PMID:29301935
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312070	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CHCHD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CHCHD6 mRNA	PMID:32699268
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CHCHD6 mRNA	PMID:36331819
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1549972	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CHCHD6 mRNA	PMID:30319688
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1549972	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CHCHD6 mRNA	PMID:30319688
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312070	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CHCHD6 mRNA	PMID:21179406
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1549972	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CHCHD6 mRNA	PMID:39241906
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of CHCHD6 mRNA	PMID:32145629
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHCHD6 mRNA	PMID:37992649
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of CHCHD6 mRNA	PMID:36314267
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHCHD6 mRNA	PMID:37992649
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CHCHD6 mRNA	PMID:28818685
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312070	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CHCHD6 intron	PMID:30157460
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CHCHD6 mRNA	PMID:36331819
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of CHCHD6 mRNA	PMID:21346803
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CHCHD6 mRNA	PMID:21396975
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHCHD6 mRNA	PMID:22129741
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CHCHD6 mRNA	PMID:19770486
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312070	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CHCHD6 intron	PMID:30157460
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of CHCHD6 mRNA	PMID:25102026
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CHCHD6 mRNA	PMID:32553695
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312070	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CHCHD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CHCHD6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CHCHD6 mRNA	PMID:32699268
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CHCHD6 mRNA	PMID:31150632
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHCHD6 mRNA	PMID:22206623
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CHCHD6 mRNA	PMID:28960355
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312070	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CHCHD6 mRNA	PMID:28903495
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of CHCHD6 mRNA	PMID:22023808
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of CHCHD6 mRNA	PMID:24280081|PMID:27392435|PMID:27594783
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of CHCHD6 mRNA	PMID:24280081|PMID:25270620
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312070	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CHCHD6 mRNA	PMID:27392435
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27924	phenylhydrazine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030299	phenylhydrazine results in increased expression of CHCHD6 mRNA	PMID:17698508
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1549972	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHCHD6 mRNA	PMID:21570461
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHCHD6 mRNA	PMID:34747641
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CHCHD6 mRNA	PMID:17942748
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CHCHD6 mRNA	PMID:33212167
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHCHD6 mRNA	PMID:37992649
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CHCHD6 mRNA	PMID:38568856
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1549972	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of CHCHD6 gene	PMID:39894169
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312070	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHCHD6 intron; Benzo(a)pyrene affects the methylation of CHCHD6 promoter	PMID:27901495|PMID:30157460
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CHCHD6 mRNA	PMID:20064835|PMID:26238291
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CHCHD6 mRNA	PMID:19770486|PMID:21715664
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312070	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CHCHD6 3' UTR	PMID:27901495
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1549972	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CHCHD6 mRNA	PMID:22228805
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CHCHD6 mRNA]	PMID:22228805
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312070	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CHCHD6 gene	PMID:31601247
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of CHCHD6 mRNA	PMID:24136188
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CHCHD6 mRNA	PMID:23557971
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of CHCHD6 mRNA	PMID:19162173|PMID:22484513
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1549972	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CHCHD6 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of CHCHD6 mRNA	PMID:22484513
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1549972	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CHCHD6 mRNA	PMID:28472532
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CHCHD6 mRNA	PMID:32145629|PMID:34947998
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312070	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CHCHD6 gene	PMID:31601247
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CHCHD6 mRNA	PMID:25181051
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CHCHD6 gene	PMID:28505145
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312070	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CHCHD6 gene	PMID:31601247
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1549972	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CHCHD6 mRNA	PMID:39298647
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312070	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CHCHD6 intron	PMID:30157460
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CHCHD6 mRNA	PMID:32715474
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHCHD6 mRNA	PMID:17602206
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CHCHD6 mRNA	PMID:21266533
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CHCHD6 mRNA	PMID:34813904
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHCHD6 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHCHD6 mRNA	PMID:17602206|PMID:22129741
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of CHCHD6 mRNA	PMID:32680482
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CHCHD6 mRNA	PMID:19162173
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CHCHD6 mRNA	PMID:19162173
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312070	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CHCHD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CHCHD6 mRNA	PMID:32699268
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of CHCHD6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CHCHD6 mRNA]	PMID:17585979
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1549972	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CHCHD6 mRNA	PMID:40194260
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CHCHD6 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CHCHD6 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CHCHD6 mRNA	PMID:36331819
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312070	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CHCHD6 mRNA	PMID:25979313
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CHCHD6 mRNA	PMID:17963808
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312070	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CHCHD6 gene	PMID:29154799
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312070	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CHCHD6 mRNA	PMID:20106945
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHCHD6 mRNA	PMID:37992649
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CHCHD6 mRNA	PMID:24136188
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CHCHD6 mRNA	PMID:38832940
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of CHCHD6 mRNA	PMID:21346803
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CHCHD6 mRNA	PMID:17562736
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of CHCHD6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CHCHD6 mRNA]	PMID:17585979
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CHCHD6 mRNA	PMID:17942748
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CHCHD6 mRNA	PMID:17942748
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CHCHD6 mRNA	PMID:25554681
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1549972	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CHCHD6 mRNA; Nanotubes, Carbon results in increased expression of CHCHD6 mRNA	PMID:25620056
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CHCHD6 mRNA	PMID:24136188
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of CHCHD6 mRNA	PMID:23962444
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of CHCHD6 mRNA	PMID:19162173
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CHCHD6 mRNA	PMID:24136188
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CHCHD6 mRNA	PMID:24136188
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CHCHD6 mRNA	PMID:28801915
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312070	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CHCHD6 intron	PMID:30157460
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CHCHD6 gene	PMID:35440735
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CHCHD6 mRNA	PMID:31758290
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHCHD6 mRNA	PMID:22206623
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CHCHD6 mRNA	PMID:24136188
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of CHCHD6 mRNA	PMID:32858204
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CHCHD6 mRNA	PMID:21346803
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312070	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CHCHD6 gene]	PMID:28238834
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:8050	phenacetin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010615	Phenacetin results in increased expression of CHCHD6 mRNA	PMID:17698508
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of CHCHD6 mRNA	PMID:19162173
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:8093	phenylephrine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased expression of CHCHD6 mRNA	PMID:18158353
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:8228	pioglitazone	decreases expression	ISO	RGD:1312070	E	RGD:6480464	20181113	CTD	MESH:C060836	Pioglitazone results in decreased expression of CHCHD6 mRNA	PMID:30031879
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CHCHD6 mRNA	PMID:21346803
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of CHCHD6 protein	PMID:24648495
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CHCHD6 mRNA	PMID:21346803
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of CHCHD6 protein	PMID:32519852
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1549972	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of CHCHD6 mRNA	PMID:28973697
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of CHCHD6 mRNA	PMID:22615374
1304561	Chchd6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of CHCHD6 gene	PMID:31682807
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TBC1D1 mRNA	PMID:20938992
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1349688	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of TBC1D1 mRNA	PMID:23830798|PMID:33167477
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBC1D1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBC1D1 mRNA	PMID:32699268
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D019308	TBC1D1 protein results in decreased uptake of and results in decreased oxidation of Palmitic Acid	PMID:18931681
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of TBC1D1 gene	PMID:28931070
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312071	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of TBC1D1 mRNA	PMID:40945087
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1312071	E	RGD:6480464	20170207	CTD	MESH:D011794	Quercetin results in increased phosphorylation of TBC1D1 protein	PMID:26627467
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20170207	CTD	MESH:D011794	Quercetin inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D1 protein]	PMID:26627467
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1349688	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of TBC1D1 mRNA	PMID:29581250
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312071	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TBC1D1 mRNA	PMID:39241906
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of TBC1D1 mRNA	PMID:19619570
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TBC1D1 mRNA	PMID:19619570
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312071	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of TBC1D1 mRNA	PMID:33711761
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TBC1D1 mRNA	PMID:20938992
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349688	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TBC1D1 mRNA	PMID:37042841
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1349688	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TBC1D1 mRNA	PMID:23649840
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of TBC1D1 mRNA	PMID:18037150
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TBC1D1 mRNA	PMID:37992649
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of TBC1D1 gene	PMID:33872906
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of TBC1D1 mRNA	PMID:21592394
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of TBC1D1 mRNA	PMID:21592394
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TBC1D1 mRNA	PMID:37992649
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of TBC1D1 gene	PMID:33872906
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TBC1D1 mRNA	PMID:26577399
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TBC1D1 mRNA	PMID:27523638
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1349688	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TBC1D1 protein	PMID:37730182
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of TBC1D1 mRNA	PMID:21592394
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of TBC1D1 mRNA	PMID:21592394
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TBC1D1 mRNA	PMID:33387578
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TBC1D1 mRNA	PMID:36331819
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:18406	AICA ribonucleotide	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20170207	CTD	MESH:C031143	AICA ribonucleotide inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D1 protein]	PMID:26627467
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312071	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TBC1D1 mRNA	PMID:19770486
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1349688	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TBC1D1 gene	PMID:27153756
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBC1D1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBC1D1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of TBC1D1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TBC1D1 mRNA	PMID:32699268|PMID:35430440
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312071	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of TBC1D1 mRNA	PMID:25629700
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TBC1D1 mRNA	PMID:20938992
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312071	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TBC1D1 mRNA	PMID:28960355
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312071	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TBC1D1 mRNA	PMID:30912803
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1349688	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TBC1D1 mRNA	PMID:24768652|PMID:25583101
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBC1D1 mRNA	PMID:22298810
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312071	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBC1D1 mRNA	PMID:21570461
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TBC1D1 mRNA	PMID:34747641
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TBC1D1 mRNA	PMID:19619570
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312071	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBC1D1 mRNA	PMID:19933214
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBC1D1 mRNA	PMID:11489354
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TBC1D1 mRNA	PMID:25975270
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TBC1D1 mRNA	PMID:19619570
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TBC1D1 mRNA	PMID:28001369
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TBC1D1 mRNA	PMID:33212167
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TBC1D1 mRNA	PMID:32763439
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TBC1D1 mRNA	PMID:37992649
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TBC1D1 mRNA	PMID:20064835|PMID:26238291
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312071	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TBC1D1 mRNA	PMID:22228805
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349688	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TBC1D1 5' UTR	PMID:27901495
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TBC1D1 mRNA	PMID:26238291
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312071	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TBC1D1 mRNA	PMID:39716349
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1349688	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of TBC1D1 gene	PMID:31601247
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TBC1D1 mRNA	PMID:25729387
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312071	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TBC1D1 mRNA	PMID:29264374
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312071	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TBC1D1 gene; titanium dioxide results in decreased methylation of TBC1D1 promoter	PMID:35295148
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312071	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TBC1D1 gene; titanium dioxide results in increased methylation of TBC1D1 promoter	PMID:35295148
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TBC1D1 mRNA	PMID:23411599|PMID:34492290
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TBC1D1 mRNA	PMID:25181051|PMID:30816183
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TBC1D1 mRNA	PMID:29275510
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of TBC1D1 mRNA; bisphenol A results in increased expression of TBC1D1 protein	PMID:24552547|PMID:32528016
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1349688	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of TBC1D1 gene	PMID:31601247
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312071	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TBC1D1 mRNA	PMID:26682919
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TBC1D1 mRNA	PMID:32119087
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312071	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TBC1D1 mRNA	PMID:39298647
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1312071	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of TBC1D1 intron	PMID:28392331
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TBC1D1 mRNA	PMID:21266533
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of TBC1D1 gene	PMID:33148267
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349688	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TBC1D1 mRNA	PMID:37042841
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TBC1D1 mRNA	PMID:24386269
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TBC1D1 mRNA	PMID:19320972
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1349688	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TBC1D1 mRNA	PMID:24449571
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBC1D1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBC1D1 mRNA	PMID:32699268
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TBC1D1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TBC1D1 mRNA]	PMID:17585979
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TBC1D1 mRNA	PMID:31533062
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TBC1D1 mRNA	PMID:36331819
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of TBC1D1 mRNA	PMID:17198877
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312071	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TBC1D1 mRNA	PMID:17292431
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349688	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TBC1D1 mRNA	PMID:25979313
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349688	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TBC1D1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1349688	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TBC1D1 gene	PMID:29154799
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TBC1D1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TBC1D1 mRNA	PMID:17183730|PMID:27188386
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1312071	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TBC1D1 mRNA	PMID:15171707
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312071	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TBC1D1 mRNA	PMID:28973697
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TBC1D1 mRNA	PMID:37992649
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1349688	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TBC1D1 mRNA	PMID:24935251
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312071	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TBC1D1 mRNA	PMID:17562736
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TBC1D1 mRNA	PMID:33387578
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312071	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TBC1D1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TBC1D1 mRNA]	PMID:17585979
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TBC1D1 mRNA	PMID:29391264
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312071	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TBC1D1 mRNA	PMID:39716349
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312071	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TBC1D1 mRNA	PMID:25554681
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TBC1D1 mRNA	PMID:17183730
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312071	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TBC1D1 mRNA	PMID:38701926
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1349688	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of TBC1D1 mRNA	PMID:20436886
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TBC1D1 mRNA	PMID:25729387
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TBC1D1 gene	PMID:35440735
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of TBC1D1 gene	PMID:33148267
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312071	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TBC1D1 mRNA	PMID:22206623
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:7719	ochratoxin A	decreases methylation	EXP		E	RGD:6480464	20160210	CTD	MESH:C025589	ochratoxin A results in decreased methylation of TBC1D1 gene	PMID:26431795
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TBC1D1 mRNA	PMID:27188386
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349688	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TBC1D1 mRNA	PMID:27188386
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TBC1D1 mRNA	PMID:19281266
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1349688	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TBC1D1 mRNA	PMID:38568856
1304562	Tbc1d1	TBC1 domain family member 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TBC1D1 mRNA	PMID:23555832
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D014212	Tretinoin results in decreased expression of SYNE3 mRNA	PMID:23724009
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SYNE3 mRNA	PMID:26516004
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SYNE3 mRNA	PMID:35811015
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312072	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SYNE3 mRNA	PMID:31614463
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of SYNE3 mRNA	PMID:20404318
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312072	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SYNE3 mRNA	PMID:37042841
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312072	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of SYNE3 mRNA	PMID:27664576
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312072	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SYNE3 mRNA	PMID:36695872
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYNE3 mRNA	PMID:36139627
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SYNE3 mRNA	PMID:28818685
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312072	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SYNE3 3' UTR	PMID:30157460
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312073	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SYNE3 mRNA	PMID:37236586
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SYNE3 mRNA	PMID:33354967
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SYNE3 gene	PMID:27153756
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312072	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SYNE3 gene	PMID:25304211
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA	PMID:27188386
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312073	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of SYNE3 mRNA	PMID:35897073
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312073	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SYNE3 protein	PMID:25505154
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of SYNE3 gene	PMID:28505145
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SYNE3 mRNA	PMID:33387578
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SYNE3 mRNA	PMID:29803840
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D024483	Vitamin K 3 affects the expression of SYNE3 mRNA	PMID:20044591
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	ISO	RGD:1312072	E	RGD:6480464	20120522	CTD	MESH:C028473	SYNE3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312072	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SYNE3 promoter	PMID:27901495
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYNE3 mRNA	PMID:22316170|PMID:26238291
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312073	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SYNE3 mRNA	PMID:27195522
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312073	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SYNE3 mRNA	PMID:27131904
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SYNE3 mRNA	PMID:25351596
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SYNE3 mRNA	PMID:26238291
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of SYNE3 mRNA	PMID:24395379
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SYNE3 mRNA	PMID:25181051
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312072	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A analog results in increased expression of SYNE3 mRNA; bisphenol A results in increased expression of SYNE3 mRNA	PMID:29275510|PMID:32387340|PMID:36232920
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312073	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SYNE3 mRNA	PMID:32156529
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of SYNE3 gene	PMID:28505145
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312073	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of SYNE3 mRNA	PMID:33297965|PMID:39298647|PMID:40203079
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312072	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SYNE3 mRNA	PMID:37042841
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SYNE3 mRNA	PMID:38568856
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312073	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SYNE3 mRNA	PMID:37236586
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of SYNE3 mRNA	PMID:25539665
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312073	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SYNE3 mRNA	PMID:40194260
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312072	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SYNE3 mRNA	PMID:31533062
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D014635	Valproic Acid results in increased expression of SYNE3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312072	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SYNE3 gene	PMID:29154799
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA	PMID:27188386
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312072	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SYNE3 mRNA	PMID:25562108|PMID:27989131
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D003907	Dexamethasone results in increased expression of SYNE3 mRNA	PMID:25047013
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312073	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SYNE3 mRNA	PMID:28973697
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNE3 mRNA	PMID:33387578
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNE3 mRNA	PMID:21420995
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SYNE3 mRNA	PMID:35811015
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312072	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SYNE3 gene	PMID:25304211
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312073	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SYNE3 mRNA	PMID:25554681
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:5063	fipronil	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of SYNE3 mRNA	PMID:28991164
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SYNE3 mRNA	PMID:30047161
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of SYNE3 mRNA	PMID:28991164
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SYNE3 mRNA	PMID:31758290
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1312072	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of SYNE3 mRNA	PMID:29522793
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYNE3 mRNA	PMID:36139627
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA	PMID:27188386
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1312072	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of SYNE3 mRNA	PMID:26705709
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SYNE3 mRNA	PMID:24780913
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:C496932	panobinostat results in increased expression of SYNE3 mRNA	PMID:26272509
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA	PMID:27188386
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312072	E	RGD:6480464	20170110	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA	PMID:27188386
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312073	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SYNE3 mRNA	PMID:27131904
1304563	Syne3	spectrin repeat containing, nuclear envelope family member 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312072	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SYNE3 mRNA	PMID:29301935
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SENP6 mRNA	PMID:33045310
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SENP6 gene	PMID:20938992
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SENP6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SENP6 mRNA	PMID:32699268
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SENP6 mRNA	PMID:26079696
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SENP6 mRNA	PMID:22378314
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1312077	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of SENP6 mRNA	PMID:20362636
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1312076	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of SENP6 mRNA	PMID:16823088
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312077	E	RGD:6480464	20200331	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SENP6 mRNA; Lipopolysaccharides results in increased expression of SENP6 protein	PMID:26807181
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20200331	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Chloroquine] results in increased expression of SENP6 protein; [MIR669N mRNA results in decreased expression of SENP6 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]; [MIR669N mRNA results in decreased expression of SENP6 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; [MIR669N mRNA results in decreased expression of SENP6 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; MIR669N mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of SENP6 protein]; SENP6 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]; SENP6 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; SENP6 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]	PMID:26807181
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312077	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SENP6 mRNA	PMID:39298647
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of SENP6 gene	PMID:27618143
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SENP6 gene	PMID:20938992
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312076	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SENP6 mRNA	PMID:37042841
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of SENP6 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA]	PMID:20230807
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312076	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SENP6 protein	PMID:37730182
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1312077	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA	PMID:20230807
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of SENP6 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of SENP6 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA]	PMID:20230807
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of SENP6 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA]	PMID:20230807
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SENP6 mRNA	PMID:37236586
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SENP6 mRNA	PMID:19549813
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SENP6 protein	PMID:23301498
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1312076	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of SENP6 mRNA	PMID:16823088
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312076	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SENP6 mRNA	PMID:23649840
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SENP6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SENP6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of SENP6 mRNA	PMID:32699268
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SENP6 mRNA	PMID:25629700
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SENP6 gene	PMID:20938992
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of SENP6 mRNA	PMID:38723480
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20250902	CTD	MESH:D001151	SENP6 protein affects the reaction [Arsenic results in decreased expression of FTO protein]; SENP6 protein affects the reaction [Arsenic results in increased expression of GCLM protein]; SENP6 protein affects the reaction [Arsenic results in increased expression of HMOX1 protein]	PMID:38723480
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SENP6 mRNA	PMID:26272509
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA	PMID:27188386
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312076	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SENP6 protein	PMID:35688186
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of SENP6 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA]	PMID:20230807
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SENP6 mRNA	PMID:23557933
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SENP6 mRNA	PMID:30912803
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312077	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SENP6 mRNA	PMID:21570461
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SENP6 mRNA	PMID:34747641
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SENP6 mRNA	PMID:17942748
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312076	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of SENP6 mRNA	PMID:33512557
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SENP6 mRNA	PMID:28001369
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SENP6 mRNA	PMID:33212167
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SENP6 mRNA	PMID:15467011
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312076	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SENP6 protein	PMID:35688186
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SENP6 mRNA	PMID:20064835
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SENP6 mRNA	PMID:15467011
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SENP6 gene	PMID:31601247
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of SENP6 mRNA	PMID:22641619
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP6 mRNA	PMID:25729387
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SENP6 mRNA	PMID:30047161
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312077	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SENP6 gene	PMID:35295148
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SENP6 mRNA	PMID:34492290
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SENP6 mRNA	PMID:34947998
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of SENP6 mRNA	PMID:22576693
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SENP6 mRNA	PMID:33221593
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SENP6 mRNA	PMID:25181051|PMID:30816183
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312076	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of SENP6 gene	PMID:22576693
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SENP6 gene	PMID:31601247
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312077	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SENP6 intron	PMID:28392331
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SENP6 mRNA	PMID:33453195
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312076	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SENP6 mRNA	PMID:26472689
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SENP6 mRNA	PMID:37236586
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SENP6 mRNA	PMID:30047161
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20200331	CTD	MESH:D002738	[Lipopolysaccharides co-treated with Chloroquine] results in increased expression of SENP6 protein	PMID:26807181
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SENP6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SENP6 mRNA	PMID:32699268
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1312076	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of SENP6 mRNA	PMID:19691856
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312076	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SENP6 mRNA	PMID:31533062
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SENP6 mRNA	PMID:27153767
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312076	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SENP6 mRNA	PMID:25979313
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312077	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SENP6 mRNA	PMID:17963808
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SENP6 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SENP6 mRNA	PMID:21427059
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312076	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SENP6 gene	PMID:29154799
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA	PMID:27188386
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SENP6 mRNA	PMID:30047161
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SENP6 mRNA	PMID:25562108
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312076	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SENP6 mRNA	PMID:20106945
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1312076	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SENP6 mRNA	PMID:33512557
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:44485	N-ethylmaleimide	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20160607	CTD	MESH:D005033	Ethylmaleimide inhibits the reaction [SUMO2 protein binds to SENP6 protein]	PMID:26060329
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SENP6 mRNA	PMID:22083351
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312076	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of SENP6 mRNA	PMID:28542535
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SENP6 mRNA	PMID:24935251
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SENP6 mRNA	PMID:33387578
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SENP6 mRNA	PMID:21420995
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SENP6 mRNA	PMID:29279043
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of SENP6 mRNA	PMID:38723480
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20250902	CTD	MESH:D001151	SENP6 protein affects the reaction [Arsenic results in decreased expression of FTO protein]; SENP6 protein affects the reaction [Arsenic results in increased expression of GCLM protein]; SENP6 protein affects the reaction [Arsenic results in increased expression of HMOX1 protein]	PMID:38723480
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SENP6 mRNA	PMID:17942748
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SENP6 mRNA	PMID:30047161
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SENP6 mRNA	PMID:25729387
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP6 mRNA	PMID:25729387
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SENP6 mRNA	PMID:23650126
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312077	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SENP6 mRNA	PMID:22206623
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312076	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SENP6 protein	PMID:31285264
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA	PMID:27188386
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of SENP6 mRNA	PMID:18927307
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of SENP6 mRNA	PMID:31558096
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312076	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SENP6 mRNA	PMID:26079696
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SENP6 mRNA	PMID:30047161
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:85990	panobinostat	affects expression	ISO	RGD:1312076	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat affects the expression of SENP6 mRNA	PMID:26733615
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20161228	CTD	MESH:C496932	(+)-JQ1 compound promotes the reaction [panobinostat affects the expression of SENP6 mRNA]; panobinostat promotes the reaction [(+)-JQ1 compound affects the expression of SENP6 mRNA]	PMID:26733615
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312076	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA	PMID:27188386
1304565	Senp6	SUMO specific peptidase 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SENP6 mRNA	PMID:21346803
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in decreased expression of IGSF9 mRNA	PMID:36828454
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGSF9 mRNA	PMID:20938992
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IGSF9 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of IGSF9 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IGSF9 mRNA	PMID:32699268|PMID:32845096
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGSF9 mRNA	PMID:36331819
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312078	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IGSF9 mRNA	PMID:26079696
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312078	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of IGSF9 mRNA	PMID:20044591
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of IGSF9 mRNA	PMID:32145629|PMID:35192832
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20240206	CTD	MESH:D004958	Estradiol results in decreased expression of IGSF9 mRNA	PMID:36828454
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in decreased expression of IGSF9 mRNA	PMID:20404318
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA	PMID:25510870
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGSF9 mRNA	PMID:20938992
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312078	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of IGSF9 mRNA	PMID:21179406
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGSF9 mRNA	PMID:37992649
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of IGSF9 mRNA	PMID:21592394
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312079	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of IGSF9 mRNA	PMID:33848595
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of IGSF9 mRNA	PMID:21592394
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGSF9 mRNA	PMID:37992649
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IGSF9 mRNA	PMID:34319233
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of IGSF9 mRNA	PMID:21592394
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312078	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of IGSF9 mRNA	PMID:26485663
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of IGSF9 mRNA	PMID:21592394
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IGSF9 mRNA	PMID:33387578
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312078	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of IGSF9 intron	PMID:30157460
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IGSF9 mRNA	PMID:28111341
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA	PMID:25510870
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA	PMID:25510870
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312078	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of IGSF9 exon; Aflatoxin B1 results in decreased methylation of IGSF9 gene	PMID:27153756|PMID:30157460
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IGSF9 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of IGSF9 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IGSF9 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of IGSF9 mRNA	PMID:32699268|PMID:32845096
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312079	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of IGSF9 mRNA	PMID:31939706
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IGSF9 mRNA	PMID:31150632
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGSF9 mRNA	PMID:20938992
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of IGSF9 mRNA	PMID:40512198
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of IGSF9 mRNA	PMID:31881176
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of IGSF9 mRNA	PMID:23557933
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312078	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of IGSF9 mRNA	PMID:28903495
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312079	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IGSF9 mRNA	PMID:21570461
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IGSF9 mRNA	PMID:33387578
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IGSF9 mRNA	PMID:32763439
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IGSF9 mRNA	PMID:30031762
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGSF9 mRNA	PMID:37992649
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312078	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of IGSF9 mRNA	PMID:29301061
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of IGSF9 mRNA	PMID:40512198
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of IGSF9 mRNA	PMID:22378314
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312078	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IGSF9 3' UTR; Benzo(a)pyrene affects the methylation of IGSF9 5' UTR; Benzo(a)pyrene affects the methylation of IGSF9 intron	PMID:27901495|PMID:30157460
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IGSF9 mRNA	PMID:32234424
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312078	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of IGSF9 promoter	PMID:27901495
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312079	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IGSF9 mRNA	PMID:22228805|PMID:23735875
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of IGSF9 mRNA]	PMID:22228805
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of IGSF9 mRNA	PMID:18929588
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of IGSF9 mRNA]	PMID:18929588
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of IGSF9 mRNA	PMID:35984750
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312079	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IGSF9 promoter	PMID:35295148
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312079	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of IGSF9 mRNA	PMID:20813756
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of IGSF9 gene	PMID:23968726
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of IGSF9 mRNA	PMID:25181051
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of IGSF9 mRNA	PMID:32145629|PMID:35192832
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of IGSF9 mRNA	PMID:36828454
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312079	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of IGSF9 promoter	PMID:27312807
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312079	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in increased expression of IGSF9 mRNA	PMID:29165653|PMID:32156529
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA	PMID:25510870
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA	PMID:25510870
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of IGSF9 mRNA	PMID:40203079
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312078	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of IGSF9 exon; benzo(e)pyrene results in decreased methylation of IGSF9 promoter	PMID:30157460
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein	PMID:34896426
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312078	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of IGSF9 gene	PMID:22964155
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312079	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of IGSF9 mRNA	PMID:21266533
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of IGSF9 gene	PMID:23968726
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of IGSF9 mRNA	PMID:35163327
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IGSF9 mRNA	PMID:28111341
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of IGSF9 mRNA	PMID:35163327
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IGSF9 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IGSF9 mRNA	PMID:32699268
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IGSF9 mRNA	PMID:31533062
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of IGSF9 protein	PMID:34896426
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of IGSF9 mRNA	PMID:39529242
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGSF9 mRNA	PMID:36331819
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312078	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IGSF9 mRNA	PMID:25979313
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312078	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of IGSF9 mRNA	PMID:23179753|PMID:28001369
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312078	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IGSF9 gene	PMID:29154799
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20180220	CTD	MESH:D014635	KDM1A protein affects the reaction [Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]]; Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]	PMID:27645313
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein	PMID:34896426
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein	PMID:34896426
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20180220	CTD	MESH:D003907	Dexamethasone results in decreased expression of IGSF9 mRNA	PMID:27645313
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20180220	CTD	MESH:D003907	[HDAC1 protein co-treated with HDAC2 protein] affects the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]; apicidin inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]; HDAC1 protein affects the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]; KDM1A protein affects the reaction [Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]]; Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]	PMID:27645313
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGSF9 mRNA	PMID:37992649
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IGSF9 mRNA	PMID:33387578
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of IGSF9 mRNA	PMID:40512198
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of IGSF9 mRNA	PMID:32234424
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein	PMID:34896426
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of IGSF9 mRNA; Nanotubes, Carbon results in decreased expression of IGSF9 mRNA	PMID:25554681
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in increased expression of IGSF9 mRNA	PMID:41580965
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of IGSF9 mRNA	PMID:20080153
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:64648	enniatin	increases expression	ISO	RGD:1312078	E	RGD:6480464	20230502	CTD	MESH:C100264	enniatins results in increased expression of IGSF9 mRNA	PMID:36016515
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312078	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of IGSF9 exon; Methapyrilene results in decreased methylation of IGSF9 promoter	PMID:30157460
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312079	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IGSF9 mRNA	PMID:22206623
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of IGSF9 mRNA	PMID:27858113
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of IGSF9 promoter	PMID:27415467
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312078	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IGSF9 gene]	PMID:28238834
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1312078	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of IGSF9 mRNA	PMID:32234424
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312079	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of IGSF9 mRNA	PMID:39847705
1304566	Igsf9	immunoglobulin superfamily, member 9	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of IGSF9 mRNA	PMID:24780913
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1603248	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of C1ORF174 mRNA	PMID:35967413
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of C5H1ORF174 mRNA	PMID:32145629
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603248	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of C1ORF174 mRNA	PMID:37042841
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1603248	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of C1ORF174 mRNA	PMID:20655997
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of C5H1ORF174 mRNA	PMID:33387578
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1603248	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of C1ORF174 protein	PMID:23301498
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1603248	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of C1ORF174 intron	PMID:30157460
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1603248	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of C1ORF174 gene	PMID:25304211
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603248	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C1ORF174 mRNA	PMID:39836092
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1603248	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of C1ORF174 protein	PMID:35688186
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of C5H1ORF174 mRNA	PMID:33387578
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1603248	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of C1ORF174 protein	PMID:35688186
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603248	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of C1ORF174 mRNA	PMID:38568856
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603248	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C1ORF174 mRNA	PMID:39836092
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1603248	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of C1ORF174 mRNA	PMID:20382639
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	Oxaliplatin results in decreased expression of C5H1ORF174 mRNA	PMID:25729387
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in decreased expression of C5H1ORF174 mRNA	PMID:25729387
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of C1ORF174 mRNA; bisphenol A results in increased expression of C5H1ORF174 mRNA	PMID:25181051|PMID:32145629|PMID:34947998
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1603248	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of C1ORF174 gene	PMID:22964155
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603248	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of C1ORF174 mRNA	PMID:26472689
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1603248	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of C1ORF174 mRNA	PMID:31533062
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603248	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of C1ORF174 mRNA	PMID:25979313
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603248	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of C1ORF174 mRNA	PMID:23179753|PMID:27188386
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603248	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of C1ORF174 gene	PMID:29154799
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1603248	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of C1ORF174 mRNA	PMID:27188386
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of C5H1ORF174 mRNA	PMID:33387578
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1603248	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of C1ORF174 gene	PMID:25304211
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603248	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C1ORF174 mRNA	PMID:39836092
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1603248	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of C1ORF174 mRNA	PMID:36621641
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of C5H1ORF174 mRNA	PMID:24136188
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of C5H1ORF174 mRNA	PMID:24136188
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in decreased expression of C5H1ORF174 mRNA	PMID:25729387
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1603248	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of C1ORF174 mRNA	PMID:28988120
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1603248	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of C1ORF174 mRNA	PMID:31758290
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1603248	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of C1ORF174 mRNA	PMID:38568856
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1603248	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of C1ORF174 mRNA	PMID:29301935
1304567	C5h1orf174	similar to human chromosome 1 open reading frame 174	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1603248	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of C1ORF174 mRNA	PMID:27188386
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312081	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of P3H2 mRNA	PMID:26272509
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA	PMID:27188386
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312081	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of P3H2 mRNA	PMID:21934132
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312081	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of P3H2 mRNA	PMID:24236059
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312081	E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in increased expression of P3H2 mRNA	PMID:23378141
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20180703	CTD	MESH:D000431	[Ethanol co-treated with Folic Acid] results in increased expression of P3H2 mRNA	PMID:23378141
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of P3H2 mRNA	PMID:39241906
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312081	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of P3H2 mRNA	PMID:35811015
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of P3H2 mRNA]	PMID:35811015
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H2 mRNA]	PMID:39241906
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of P3H2 mRNA	PMID:26496021
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of P3H2 mRNA	PMID:20660070
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312081	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of P3H2 mRNA	PMID:21540246
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of P3H2 mRNA	PMID:20660070
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H2 mRNA	PMID:37992649
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312082	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of P3H2 mRNA	PMID:28973375
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of P3H2 mRNA	PMID:26496021
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H2 mRNA	PMID:37992649
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of P3H2 mRNA	PMID:36139627
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:17967	urethane	affects expression	ISO	RGD:1312081	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane affects the expression of P3H2 mRNA	PMID:28818685
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of P3H2 mRNA	PMID:37325564
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312081	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of P3H2 mRNA	PMID:27153756
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312081	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of P3H2 gene	PMID:27153756
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312082	E	RGD:6480464	20160705	CTD	MESH:D005492	Folic Acid results in increased expression of P3H2 mRNA	PMID:25006883
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20180703	CTD	MESH:D005492	[Ethanol co-treated with Folic Acid] results in increased expression of P3H2 mRNA	PMID:23378141
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of P3H2 mRNA	PMID:36861143
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312081	E	RGD:6480464	20160705	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of P3H2 mRNA	PMID:26272509
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA	PMID:27188386
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of P3H2 mRNA	PMID:31881176
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of P3H2 mRNA	PMID:19921347
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1312081	E	RGD:6480464	20120412	CTD	MESH:D002945	P3H2 protein affects the susceptibility to Cisplatin	PMID:16217747
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312081	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of P3H2 mRNA	PMID:27392435
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of P3H2 mRNA	PMID:23625948
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312082	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of P3H2 mRNA	PMID:18930951
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of P3H2 mRNA	PMID:32109520
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of P3H2 mRNA	PMID:21354282
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312082	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of P3H2 mRNA	PMID:19933214
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of P3H2 mRNA	PMID:28959563
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H2 mRNA	PMID:37992649
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of P3H2 mRNA	PMID:22714537|PMID:38568856
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312081	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of P3H2 5' UTR	PMID:27901495
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of P3H2 mRNA	PMID:21871943
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312082	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of P3H2 exon; Benzo(a)pyrene results in decreased methylation of P3H2 intron	PMID:27901495
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312081	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of P3H2 mRNA	PMID:20064835
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312082	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of P3H2 mRNA	PMID:22228805
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312081	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of P3H2 promoter	PMID:27901495
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of P3H2 mRNA	PMID:19150397
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of P3H2 mRNA	PMID:39716349
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312082	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of P3H2 gene	PMID:35295148
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312082	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of P3H2 mRNA	PMID:35295148
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of P3H2 mRNA	PMID:29275510
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312081	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of P3H2 gene	PMID:31601247
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of P3H2 gene	PMID:28505145
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of P3H2 mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of P3H2 mRNA	PMID:26496021
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of P3H2 mRNA	PMID:26682919
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1312081	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of P3H2 mRNA	PMID:36804509
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of P3H2 mRNA	PMID:23146750
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312081	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of P3H2 protein	PMID:31945527
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312082	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of P3H2 mRNA	PMID:30951980
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312081	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of P3H2 mRNA	PMID:21527772
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H2 mRNA]	PMID:39241906
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of P3H2 mRNA	PMID:38568856
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of P3H2 mRNA	PMID:37325564
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312081	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of P3H2 mRNA	PMID:24449571
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312081	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of P3H2 mRNA	PMID:31533062
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of P3H2 mRNA	PMID:40419075
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312082	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of P3H2 mRNA	PMID:17292431
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312081	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of P3H2 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of P3H2 mRNA	PMID:20106945
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of P3H2 mRNA	PMID:25047013
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H2 mRNA	PMID:37992649
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312081	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of P3H2 mRNA	PMID:29067470
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of P3H2 mRNA	PMID:24714768
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of P3H2 mRNA	PMID:35811015
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of P3H2 mRNA]	PMID:35811015
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of P3H2 mRNA	PMID:36861143
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of P3H2 mRNA	PMID:18936297
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of P3H2 mRNA	PMID:38568856
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of P3H2 mRNA	PMID:39716349
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of P3H2 mRNA	PMID:19042947
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of P3H2 protein	PMID:32959892
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312082	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of P3H2 mRNA	PMID:20003209
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312081	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of P3H2 mRNA	PMID:31758290
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of P3H2 mRNA	PMID:29522793
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of P3H2 mRNA	PMID:36139627
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of P3H2 mRNA	PMID:32858204
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of P3H2 mRNA	PMID:23665939
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA	PMID:27188386
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of P3H2 mRNA	PMID:23146750
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H2 mRNA]	PMID:39241906
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312081	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA	PMID:27188386
1304568	P3h2	prolyl 3-hydroxylase 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312081	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of P3H2 mRNA	PMID:38568856
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of FEM1B mRNA	PMID:21551480
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312083	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of FEM1B mRNA	PMID:22574217
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312084	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of FEM1B mRNA	PMID:39298647
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312083	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FEM1B mRNA	PMID:37042841
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312083	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of FEM1B mRNA	PMID:20655997
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FEM1B mRNA	PMID:33387578
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312083	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FEM1B mRNA	PMID:28818685
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312083	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of FEM1B mRNA	PMID:24376830
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FEM1B mRNA	PMID:39012411
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312083	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FEM1B gene	PMID:27153756
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312084	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FEM1B mRNA	PMID:19770486
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:D010126	pyrazolanthrone promotes the reaction [Ozone results in increased expression of FEM1B mRNA]	PMID:17460151
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of FEM1B gene	PMID:35440735
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312083	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FEM1B mRNA	PMID:23557933
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312083	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of FEM1B mRNA	PMID:28903495
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312084	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FEM1B mRNA	PMID:21570461|PMID:24680724
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FEM1B mRNA	PMID:33387578
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FEM1B mRNA	PMID:32109520
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FEM1B mRNA	PMID:19465110
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312083	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FEM1B mRNA	PMID:28001369
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312083	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of FEM1B mRNA	PMID:29803840
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:29014	cordycepin	affects expression	ISO	RGD:1312083	E	RGD:6480464	20240402	CTD	MESH:C058120	cordycepin affects the expression of FEM1B mRNA	PMID:28099944
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1312084	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased methylation of FEM1B gene	PMID:39894169
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312083	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FEM1B promoter	PMID:27901495
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312083	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FEM1B 3' UTR	PMID:27901495
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312084	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of FEM1B mRNA	PMID:19073995
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of FEM1B mRNA	PMID:30047161
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312084	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FEM1B gene; titanium dioxide results in decreased methylation of FEM1B promoter	PMID:35295148
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312084	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide analog results in increased expression of FEM1B mRNA; titanium dioxide results in increased expression of FEM1B mRNA	PMID:23557971|PMID:25111187
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of FEM1B mRNA	PMID:23411599|PMID:34492290
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of FEM1B mRNA	PMID:17426115
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of FEM1B mRNA	PMID:16985257
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FEM1B mRNA	PMID:26982218
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FEM1B mRNA	PMID:25181051|PMID:29097150
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312084	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of FEM1B mRNA	PMID:39298647
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein	PMID:34896426
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of FEM1B mRNA	PMID:22546817
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of FEM1B mRNA	PMID:22546817
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1312083	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of FEM1B mRNA	PMID:17312168
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312083	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FEM1B mRNA	PMID:37042841
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1312084	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of FEM1B mRNA	PMID:18974090
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312083	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FEM1B mRNA; Cadmium Chloride results in decreased expression of FEM1B protein	PMID:38185225|PMID:38568856
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FEM1B mRNA	PMID:33453195
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FEM1B mRNA	PMID:39012411
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of FEM1B mRNA	PMID:24386269
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312083	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of FEM1B mRNA	PMID:19376846
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312084	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of FEM1B mRNA	PMID:40194260
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312083	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FEM1B mRNA	PMID:31533062
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:39098	pyrethrins	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in increased expression of FEM1B protein	PMID:34896426
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312083	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FEM1B gene	PMID:29154799
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312083	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FEM1B mRNA	PMID:20106945|PMID:25562108
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein	PMID:34896426
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein	PMID:34896426
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312084	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FEM1B mRNA	PMID:28973697
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FEM1B mRNA	PMID:17562736
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FEM1B mRNA	PMID:33387578
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312083	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of FEM1B mRNA	PMID:20977926
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FEM1B mRNA	PMID:29097150
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein	PMID:34896426
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:50292	cadmium sulfate	decreases expression	ISO	RGD:1312083	E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in decreased expression of FEM1B mRNA	PMID:21783983
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of FEM1B mRNA	PMID:30047161
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of FEM1B mRNA	PMID:20080153
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of FEM1B mRNA	PMID:19812364
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312083	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of FEM1B mRNA	PMID:19159669
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1312083	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of FEM1B mRNA	PMID:19095052
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of FEM1B mRNA	PMID:30047161
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1312084	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone promotes the reaction [Ozone results in increased expression of FEM1B mRNA]	PMID:17460151
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FEM1B mRNA	PMID:21346803
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312083	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of FEM1B mRNA	PMID:38568856
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312083	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of FEM1B mRNA	PMID:29301935
1304569	Fem1b	fem-1 homolog B	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FEM1B mRNA	PMID:21346803
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312085	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of FN3KRP protein	PMID:36252740
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FN3KRP mRNA]	PMID:31150632
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FN3KRP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FN3KRP mRNA	PMID:32699268
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of FN3KRP mRNA	PMID:23829299
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606224	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FN3KRP mRNA	PMID:37042841
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of FN3KRP mRNA	PMID:22061828|PMID:33387578
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FN3KRP mRNA	PMID:39836092
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FN3KRP mRNA	PMID:35301059
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606224	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FN3KRP mRNA	PMID:19549813
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1606224	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FN3KRP mRNA	PMID:23649840
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FN3KRP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FN3KRP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of FN3KRP mRNA	PMID:32699268
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FN3KRP mRNA	PMID:31150632
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FN3KRP mRNA]	PMID:31150632
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FN3KRP mRNA	PMID:39836092
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of FN3KRP protein	PMID:38460933
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FN3KRP mRNA	PMID:23557933
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606224	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of FN3KRP mRNA	PMID:27594783
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606224	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FN3KRP mRNA	PMID:28001369
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606224	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FN3KRP protein	PMID:33212167
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1606224	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FN3KRP mRNA	PMID:20044591
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:29073	L-ascorbic acid	increases expression	ISO	RGD:1606224	E	RGD:6480464	20160705	CTD	MESH:D001205	Ascorbic Acid results in increased expression of FN3KRP mRNA	PMID:25555879
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312085	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of FN3KRP protein	PMID:29044176
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606224	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of FN3KRP mRNA	PMID:34032870
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FN3KRP mRNA	PMID:39836092
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606224	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FN3KRP promoter	PMID:27901495
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312085	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of FN3KRP protein	PMID:37955338
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to FN3KRP mRNA]	PMID:32406909
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1606224	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FN3KRP mRNA	PMID:25555879
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FN3KRP mRNA	PMID:24136188
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of FN3KRP mRNA	PMID:25729387
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of FN3KRP mRNA	PMID:25729387
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FN3KRP mRNA	PMID:34492290
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312085	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of FN3KRP mRNA	PMID:28329830
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1606224	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of FN3KRP mRNA	PMID:30903817
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FN3KRP mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606224	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FN3KRP protein	PMID:33376534
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606224	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of FN3KRP protein	PMID:34186270
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FN3KRP gene	PMID:28505145
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of FN3KRP mRNA	PMID:23829299
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1606224	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of FN3KRP protein	PMID:34186270
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312085	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of FN3KRP mRNA	PMID:38685157
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312085	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of FN3KRP mRNA	PMID:37019170
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of FN3KRP mRNA	PMID:30589522
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FN3KRP mRNA	PMID:39836092
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FN3KRP mRNA	PMID:35301059
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FN3KRP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FN3KRP mRNA	PMID:32699268
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606224	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FN3KRP mRNA	PMID:25562108
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1606224	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of FN3KRP mRNA	PMID:22230336
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of FN3KRP protein	PMID:38460933
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FN3KRP mRNA	PMID:39836092
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312085	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FN3KRP mRNA	PMID:35436446
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1606224	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FN3KRP mRNA	PMID:25555879
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312085	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of FN3KRP mRNA	PMID:40234311
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of FN3KRP mRNA	PMID:24793618
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:6015	isoflurane	decreases expression	ISO	RGD:1312085	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in decreased expression of FN3KRP protein	PMID:35249202
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1606224	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FN3KRP protein	PMID:32959892
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FN3KRP mRNA	PMID:39836092
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of FN3KRP mRNA	PMID:25729387
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of FN3KRP mRNA	PMID:25729387
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1606224	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of FN3KRP mRNA	PMID:31758290
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1606224	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of FN3KRP protein	PMID:34186270
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of FN3KRP protein	PMID:37664457
1304570	Fn3krp	fructosamine-3-kinase-related protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606224	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of FN3KRP protein	PMID:37664457
1304571	Ebpl	EBP like	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312086	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of EBPL mRNA	PMID:27188386
1304571	Ebpl	EBP like	gene	CHEBI:132098	methoxyacetic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of EBPL mRNA	PMID:20864626
1304571	Ebpl	EBP like	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EBPL gene	PMID:20938992
1304571	Ebpl	EBP like	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of EBPL mRNA	PMID:33167477
1304571	Ebpl	EBP like	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of EBPL mRNA	PMID:36331819
1304571	Ebpl	EBP like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of EBPL mRNA	PMID:39298647
1304571	Ebpl	EBP like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312086	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of EBPL mRNA	PMID:30165855
1304571	Ebpl	EBP like	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EBPL mRNA	PMID:33387578
1304571	Ebpl	EBP like	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EBPL gene	PMID:20938992
1304571	Ebpl	EBP like	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of EBPL mRNA	PMID:23649840
1304571	Ebpl	EBP like	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of EBPL mRNA	PMID:23892564
1304571	Ebpl	EBP like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312087	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EBPL mRNA	PMID:33754040
1304571	Ebpl	EBP like	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EBPL mRNA	PMID:28818685
1304571	Ebpl	EBP like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EBPL mRNA	PMID:36331819
1304571	Ebpl	EBP like	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of EBPL mRNA	PMID:23649840
1304571	Ebpl	EBP like	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EBPL mRNA	PMID:27339419|PMID:31919559
1304571	Ebpl	EBP like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EBPL gene	PMID:20938992
1304571	Ebpl	EBP like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312086	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EBPL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBPL mRNA	PMID:39836092|PMID:40512198
1304571	Ebpl	EBP like	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of EBPL mRNA	PMID:20864626
1304571	Ebpl	EBP like	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of EBPL mRNA	PMID:27594783
1304571	Ebpl	EBP like	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312087	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of EBPL mRNA	PMID:30912803
1304571	Ebpl	EBP like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312087	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EBPL mRNA	PMID:21570461|PMID:26377647
1304571	Ebpl	EBP like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EBPL mRNA	PMID:32109520
1304571	Ebpl	EBP like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EBPL mRNA	PMID:17949056
1304571	Ebpl	EBP like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EBPL mRNA	PMID:17942748
1304571	Ebpl	EBP like	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of EBPL mRNA	PMID:20864626
1304571	Ebpl	EBP like	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EBPL mRNA	PMID:33212167
1304571	Ebpl	EBP like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of EBPL mRNA	PMID:38568856
1304571	Ebpl	EBP like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312086	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EBPL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBPL mRNA	PMID:39836092|PMID:40512198
1304571	Ebpl	EBP like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EBPL mRNA	PMID:20064835
1304571	Ebpl	EBP like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312086	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EBPL promoter	PMID:27901495
1304571	Ebpl	EBP like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312087	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EBPL mRNA	PMID:22228805
1304571	Ebpl	EBP like	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of EBPL mRNA]	PMID:22228805
1304571	Ebpl	EBP like	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EBPL mRNA	PMID:39716349
1304571	Ebpl	EBP like	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of EBPL mRNA	PMID:34408198
1304571	Ebpl	EBP like	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of EBPL mRNA	PMID:22641619
1304571	Ebpl	EBP like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312087	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EBPL gene	PMID:35295148
1304571	Ebpl	EBP like	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312087	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of EBPL mRNA	PMID:18301758
1304571	Ebpl	EBP like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EBPL mRNA	PMID:25181051|PMID:34947998
1304571	Ebpl	EBP like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of EBPL mRNA	PMID:39298647
1304571	Ebpl	EBP like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312087	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of EBPL mRNA	PMID:40203079
1304571	Ebpl	EBP like	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of EBPL mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of EBPL promoter	PMID:25374375
1304571	Ebpl	EBP like	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in decreased expression of EBPL protein	PMID:39748354
1304571	Ebpl	EBP like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312086	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EBPL mRNA	PMID:37042841
1304571	Ebpl	EBP like	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EBPL mRNA	PMID:35163327
1304571	Ebpl	EBP like	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EBPL mRNA	PMID:35163327
1304571	Ebpl	EBP like	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312087	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EBPL mRNA	PMID:40194260
1304571	Ebpl	EBP like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EBPL mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of EBPL mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of EBPL mRNA	PMID:36331819
1304571	Ebpl	EBP like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of EBPL mRNA	PMID:23179753
1304571	Ebpl	EBP like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of EBPL mRNA	PMID:19770486
1304571	Ebpl	EBP like	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of EBPL mRNA	PMID:24136188
1304571	Ebpl	EBP like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312087	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EBPL mRNA	PMID:17562736
1304571	Ebpl	EBP like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of EBPL mRNA	PMID:29067470
1304571	Ebpl	EBP like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312086	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EBPL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBPL mRNA	PMID:39836092|PMID:40512198
1304571	Ebpl	EBP like	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312086	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of EBPL mRNA	PMID:18175754
1304571	Ebpl	EBP like	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EBPL mRNA	PMID:17557909
1304571	Ebpl	EBP like	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EBPL mRNA	PMID:17942748
1304571	Ebpl	EBP like	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EBPL mRNA	PMID:39716349
1304571	Ebpl	EBP like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EBPL mRNA; Nanotubes, Carbon results in decreased expression of EBPL mRNA	PMID:25554681
1304571	Ebpl	EBP like	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of EBPL mRNA	PMID:24793618
1304571	Ebpl	EBP like	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of EBPL mRNA	PMID:21983209
1304571	Ebpl	EBP like	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of EBPL mRNA	PMID:20080153
1304571	Ebpl	EBP like	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of EBPL mRNA	PMID:24136188
1304571	Ebpl	EBP like	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312087	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of EBPL mRNA	PMID:23650126
1304571	Ebpl	EBP like	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312086	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of EBPL mRNA	PMID:31758290
1304571	Ebpl	EBP like	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EBPL mRNA	PMID:22206623
1304571	Ebpl	EBP like	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of EBPL mRNA	PMID:24136188
1304571	Ebpl	EBP like	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312086	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EBPL gene]	PMID:28238834
1304571	Ebpl	EBP like	gene	CHEBI:8069	phenobarbital	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of EBPL mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of EBPL promoter	PMID:25374375
1304571	Ebpl	EBP like	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of EBPL mRNA	PMID:20345932
1304571	Ebpl	EBP like	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312087	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of EBPL mRNA	PMID:39847705
1304571	Ebpl	EBP like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EBPL mRNA	PMID:25825206
1304571	Ebpl	EBP like	gene	CHEBI:88522	Monobutylphthalate	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of EBPL mRNA	PMID:20864626
1304571	Ebpl	EBP like	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312086	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EBPL mRNA	PMID:38568856
1304571	Ebpl	EBP like	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of EBPL mRNA	PMID:22570695
1304572	Rnf150	ring finger protein 150	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1322589	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of RNF150 mRNA	PMID:27188386
1304572	Rnf150	ring finger protein 150	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1322589	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RNF150 mRNA	PMID:26272509
1304572	Rnf150	ring finger protein 150	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA	PMID:27188386
1304572	Rnf150	ring finger protein 150	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1322589	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of RNF150 mRNA	PMID:21934132
1304572	Rnf150	ring finger protein 150	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of RNF150 gene	PMID:30207508
1304572	Rnf150	ring finger protein 150	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1322589	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RNF150 mRNA	PMID:21179406
1304572	Rnf150	ring finger protein 150	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312088	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF150 mRNA	PMID:39241906
1304572	Rnf150	ring finger protein 150	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1322589	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RNF150 mRNA	PMID:31614463
1304572	Rnf150	ring finger protein 150	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of RNF150 mRNA	PMID:20660070
1304572	Rnf150	ring finger protein 150	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312088	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of RNF150 mRNA	PMID:22238285
1304572	Rnf150	ring finger protein 150	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of RNF150 mRNA	PMID:20660070
1304572	Rnf150	ring finger protein 150	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1322589	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RNF150 mRNA	PMID:21179406
1304572	Rnf150	ring finger protein 150	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1322589	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of RNF150 mRNA	PMID:26079696
1304572	Rnf150	ring finger protein 150	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312088	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNF150 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNF150 mRNA	PMID:37992649
1304572	Rnf150	ring finger protein 150	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1322589	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of RNF150 mRNA	PMID:33647349
1304572	Rnf150	ring finger protein 150	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312088	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNF150 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNF150 mRNA	PMID:37992649
1304572	Rnf150	ring finger protein 150	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RNF150 mRNA	PMID:33387578
1304572	Rnf150	ring finger protein 150	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1322589	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RNF150 mRNA	PMID:28818685
1304572	Rnf150	ring finger protein 150	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF150 mRNA	PMID:39836092
1304572	Rnf150	ring finger protein 150	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312088	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RNF150 mRNA	PMID:27106289
1304572	Rnf150	ring finger protein 150	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF150 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF150 mRNA	PMID:39836092
1304572	Rnf150	ring finger protein 150	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312088	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNF150 mRNA]	PMID:37992649
1304572	Rnf150	ring finger protein 150	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RNF150 mRNA	PMID:31881176
1304572	Rnf150	ring finger protein 150	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1322589	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RNF150 mRNA	PMID:27392435
1304572	Rnf150	ring finger protein 150	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of RNF150 gene	PMID:28505145
1304572	Rnf150	ring finger protein 150	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1322589	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of RNF150 mRNA	PMID:24768652|PMID:25583101
1304572	Rnf150	ring finger protein 150	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312088	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF150 mRNA	PMID:24680724
1304572	Rnf150	ring finger protein 150	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RNF150 mRNA	PMID:33387578
1304572	Rnf150	ring finger protein 150	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1322589	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RNF150 mRNA	PMID:28001369
1304572	Rnf150	ring finger protein 150	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1322589	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of RNF150 mRNA	PMID:32763439
1304572	Rnf150	ring finger protein 150	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312088	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF150 mRNA	PMID:39631538
1304572	Rnf150	ring finger protein 150	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312088	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNF150 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNF150 mRNA	PMID:37992649
1304572	Rnf150	ring finger protein 150	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312088	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNF150 mRNA]	PMID:37992649
1304572	Rnf150	ring finger protein 150	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312088	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNF150 mRNA	PMID:37682722|PMID:39515575
1304572	Rnf150	ring finger protein 150	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF150 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF150 mRNA	PMID:39836092
1304572	Rnf150	ring finger protein 150	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1322589	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF150 3' UTR; Benzo(a)pyrene results in increased methylation of RNF150 exon; Benzo(a)pyrene results in increased methylation of RNF150 promoter	PMID:27901495
1304572	Rnf150	ring finger protein 150	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1322589	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of RNF150 promoter	PMID:23974009
1304572	Rnf150	ring finger protein 150	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1322589	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RNF150 mRNA	PMID:25895662
1304572	Rnf150	ring finger protein 150	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1322589	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RNF150 mRNA	PMID:23806026
1304572	Rnf150	ring finger protein 150	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312088	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF150 gene	PMID:35295148
1304572	Rnf150	ring finger protein 150	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1322589	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF150 mRNA	PMID:27685785
1304572	Rnf150	ring finger protein 150	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RNF150 mRNA	PMID:25181051
1304572	Rnf150	ring finger protein 150	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF150 gene	PMID:28505145
1304572	Rnf150	ring finger protein 150	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1322589	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF150 gene	PMID:31601247
1304572	Rnf150	ring finger protein 150	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of RNF150 gene	PMID:28505145
1304572	Rnf150	ring finger protein 150	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1322589	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RNF150 mRNA	PMID:25979313
1304572	Rnf150	ring finger protein 150	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312088	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RNF150 mRNA	PMID:37019170
1304572	Rnf150	ring finger protein 150	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of RNF150 mRNA	PMID:28628672
1304572	Rnf150	ring finger protein 150	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312088	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of RNF150 mRNA	PMID:36117858
1304572	Rnf150	ring finger protein 150	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF150 mRNA	PMID:39836092
1304572	Rnf150	ring finger protein 150	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312088	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RNF150 mRNA	PMID:40194260
1304572	Rnf150	ring finger protein 150	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1322589	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RNF150 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1304572	Rnf150	ring finger protein 150	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA	PMID:27188386
1304572	Rnf150	ring finger protein 150	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of RNF150 mRNA	PMID:28628672
1304572	Rnf150	ring finger protein 150	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312088	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNF150 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RNF150 mRNA	PMID:37992649
1304572	Rnf150	ring finger protein 150	gene	CHEBI:44107	malachite green cation	affects response to substance	ISO	RGD:1322589	E	RGD:6480464	20150609	CTD	MESH:C005095	RNF150 gene SNP affects the susceptibility to malachite green	PMID:25622337
1304572	Rnf150	ring finger protein 150	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312088	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of RNF150 mRNA	PMID:18502557
1304572	Rnf150	ring finger protein 150	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1322589	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RNF150 mRNA	PMID:38832940
1304572	Rnf150	ring finger protein 150	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1322589	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RNF150 mRNA	PMID:24935251
1304572	Rnf150	ring finger protein 150	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RNF150 mRNA	PMID:33387578
1304572	Rnf150	ring finger protein 150	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF150 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF150 mRNA	PMID:39836092
1304572	Rnf150	ring finger protein 150	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1322589	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of RNF150 mRNA	PMID:31838189
1304572	Rnf150	ring finger protein 150	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RNF150 mRNA	PMID:29391264
1304572	Rnf150	ring finger protein 150	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of RNF150 mRNA	PMID:28628672
1304572	Rnf150	ring finger protein 150	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of RNF150 mRNA	PMID:23962444
1304572	Rnf150	ring finger protein 150	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312088	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of RNF150 mRNA	PMID:36117858
1304572	Rnf150	ring finger protein 150	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1322589	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of RNF150 mRNA	PMID:26272509
1304572	Rnf150	ring finger protein 150	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA	PMID:27188386
1304572	Rnf150	ring finger protein 150	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF150 mRNA	PMID:39836092
1304572	Rnf150	ring finger protein 150	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1322589	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of RNF150 mRNA	PMID:28988120
1304572	Rnf150	ring finger protein 150	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1312088	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of RNF150 mRNA	PMID:36907384
1304572	Rnf150	ring finger protein 150	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1322589	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RNF150 mRNA	PMID:31758290
1304572	Rnf150	ring finger protein 150	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312088	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RNF150 mRNA	PMID:22206623
1304572	Rnf150	ring finger protein 150	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA	PMID:27188386
1304572	Rnf150	ring finger protein 150	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RNF150 gene]	PMID:28238834
1304572	Rnf150	ring finger protein 150	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RNF150 mRNA	PMID:32109520
1304572	Rnf150	ring finger protein 150	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1322589	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of RNF150 mRNA	PMID:32234424
1304572	Rnf150	ring finger protein 150	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of RNF150 mRNA	PMID:23914054
1304572	Rnf150	ring finger protein 150	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312088	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RNF150 mRNA	PMID:39847705
1304572	Rnf150	ring finger protein 150	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1322589	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of RNF150 mRNA	PMID:26272509
1304572	Rnf150	ring finger protein 150	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA	PMID:27188386
1304572	Rnf150	ring finger protein 150	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1322589	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF150 mRNA	PMID:27188386
1304572	Rnf150	ring finger protein 150	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1322589	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RNF150 mRNA	PMID:38568856
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312089	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MAST2 mRNA	PMID:38218311
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312090	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MAST2 mRNA	PMID:33045310
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAST2 mRNA]	PMID:31150632
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312089	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MAST2 mRNA	PMID:33167477
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312090	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MAST2 mRNA	PMID:30319688
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1312089	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of MAST2 protein	PMID:35688186
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312090	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MAST2 mRNA	PMID:39241906
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312090	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MAST2 mRNA	PMID:39298647
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of MAST2 mRNA	PMID:33848595
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of MAST2 mRNA]	PMID:33848595
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312090	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MAST2 mRNA	PMID:23892564
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1312090	E	RGD:6480464	20210608	CTD	MESH:D009538	Nicotine results in increased expression of MAST2 mRNA	PMID:33640489
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312089	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MAST2 protein	PMID:37730182
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of MAST2 mRNA	PMID:22061828
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAST2 mRNA	PMID:36331819
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312089	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA	PMID:39836092
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1312090	E	RGD:6480464	20210608	CTD	MESH:D009538	Nicotine results in increased expression of MAST2 mRNA	PMID:33640489
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAST2 mRNA	PMID:28111341
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312089	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MAST2 mRNA	PMID:19549813
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of MAST2 mRNA	PMID:34911549
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAST2 mRNA	PMID:31150632
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312090	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAST2 mRNA	PMID:31919559
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAST2 mRNA]	PMID:31150632
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAST2 mRNA	PMID:22206623
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312089	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAST2 mRNA	PMID:39836092
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAST2 mRNA	PMID:40504410
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312089	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MAST2 protein	PMID:35688186
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MAST2 mRNA	PMID:30912803
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312089	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of MAST2 mRNA	PMID:26865667
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312090	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAST2 mRNA	PMID:21570461
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312089	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MAST2 mRNA	PMID:33212167
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MAST2 mRNA	PMID:15467011
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312089	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of MAST2 protein	PMID:35688186
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312089	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAST2 mRNA	PMID:39836092
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAST2 mRNA	PMID:40504410
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312089	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAST2 intron	PMID:30157460
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312090	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAST2 mRNA	PMID:22228805
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MAST2 mRNA	PMID:15467011
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of MAST2 mRNA	PMID:24915197
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312089	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of MAST2 gene	PMID:31601247
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312090	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of MAST2 mRNA	PMID:21829687
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312090	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MAST2 gene	PMID:35295148
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312090	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MAST2 mRNA	PMID:23811191
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of MAST2 mRNA	PMID:19167457
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MAST2 mRNA	PMID:25181051
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MAST2 mRNA	PMID:30816183|PMID:33296240
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of MAST2 mRNA	PMID:38074096
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312089	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MAST2 gene	PMID:31601247
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of MAST2 protein	PMID:24552547
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312089	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of MAST2 gene	PMID:31601247
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MAST2 mRNA	PMID:38685157
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312090	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MAST2 mRNA	PMID:21266533
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MAST2 mRNA	PMID:34813904
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of MAST2 mRNA	PMID:34813904
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312089	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA	PMID:39836092
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAST2 mRNA	PMID:28111341
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312089	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MAST2 mRNA	PMID:24449571
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312089	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MAST2 mRNA	PMID:28302478
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAST2 mRNA	PMID:36331819
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312090	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MAST2 mRNA	PMID:17292431
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of MAST2 mRNA	PMID:29427782
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312089	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MAST2 mRNA	PMID:38832940
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312090	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAST2 mRNA	PMID:17562736
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312089	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of MAST2 mRNA	PMID:29067470
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312089	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAST2 mRNA	PMID:39836092
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAST2 mRNA	PMID:40504410
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1312089	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of MAST2 mRNA	PMID:40706910
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MAST2 mRNA	PMID:26865667
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MAST2 mRNA	PMID:30307764
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312090	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MAST2 mRNA	PMID:25554681
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MAST2 mRNA	PMID:35964746
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312089	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA	PMID:39836092
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312090	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of MAST2 mRNA	PMID:26307267
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MAST2 mRNA	PMID:22206623
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAST2 mRNA	PMID:22206623
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:7599	Nivalenol	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20220607	CTD	MESH:C038405	nivalenol results in decreased expression of MAST2 mRNA	PMID:35016910
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312089	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MAST2 gene]	PMID:28238834
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312090	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MAST2 mRNA	PMID:23091169
1304573	Mast2	microtubule associated serine/threonine kinase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MAST2 mRNA	PMID:21346803
1304574	Selenon	selenoprotein N	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SELENON mRNA	PMID:20938992
1304574	Selenon	selenoprotein N	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603617	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SEPN1 mRNA	PMID:33167477
1304574	Selenon	selenoprotein N	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1603617	E	RGD:6480464	20120522	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SELENON mRNA	PMID:20044591
1304574	Selenon	selenoprotein N	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312091	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SELENON mRNA	PMID:39241906
1304574	Selenon	selenoprotein N	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1603617	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of SELENON mRNA	PMID:22574217
1304574	Selenon	selenoprotein N	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SELENON mRNA	PMID:20938992
1304574	Selenon	selenoprotein N	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SELENON mRNA	PMID:37992649
1304574	Selenon	selenoprotein N	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SELENON mRNA	PMID:37992649
1304574	Selenon	selenoprotein N	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1603617	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SELENON protein	PMID:37730182
1304574	Selenon	selenoprotein N	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SELENON mRNA	PMID:33387578
1304574	Selenon	selenoprotein N	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SELENON mRNA	PMID:39836092
1304574	Selenon	selenoprotein N	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1603617	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SELENON gene	PMID:27153756
1304574	Selenon	selenoprotein N	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SELENON mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SELENON mRNA	PMID:20938992|PMID:22206623
1304574	Selenon	selenoprotein N	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SELENON mRNA	PMID:40504410
1304574	Selenon	selenoprotein N	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SELENON mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SELENON mRNA	PMID:39836092
1304574	Selenon	selenoprotein N	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1603617	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SELENON protein	PMID:35688186
1304574	Selenon	selenoprotein N	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1603617	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of SELENON gene	PMID:31636367
1304574	Selenon	selenoprotein N	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1603617	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of SEPN1 mRNA	PMID:27594783
1304574	Selenon	selenoprotein N	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312091	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SELENON mRNA	PMID:21570461
1304574	Selenon	selenoprotein N	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312091	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of SEPN1 mRNA	PMID:32937126
1304574	Selenon	selenoprotein N	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1603617	E	RGD:6480464	20171114	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SELENON mRNA	PMID:28001369
1304574	Selenon	selenoprotein N	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1603617	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SELENON mRNA	PMID:33212167
1304574	Selenon	selenoprotein N	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1603617	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SELENON mRNA	PMID:32763439
1304574	Selenon	selenoprotein N	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SELENON mRNA	PMID:37992649
1304574	Selenon	selenoprotein N	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SEPN1 mRNA	PMID:29432896
1304574	Selenon	selenoprotein N	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1603617	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of SELENON mRNA	PMID:34032870
1304574	Selenon	selenoprotein N	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603617	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SELENON mRNA	PMID:38568856
1304574	Selenon	selenoprotein N	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SELENON mRNA	PMID:40504410
1304574	Selenon	selenoprotein N	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SELENON mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SELENON mRNA	PMID:39836092
1304574	Selenon	selenoprotein N	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1603617	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of SELENON mRNA	PMID:22378314
1304574	Selenon	selenoprotein N	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603617	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SEPN1 promoter	PMID:27901495
1304574	Selenon	selenoprotein N	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312091	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SELENON mRNA	PMID:27131904
1304574	Selenon	selenoprotein N	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SELENON mRNA	PMID:34492290
1304574	Selenon	selenoprotein N	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312091	E	RGD:6480464	20120522	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SELENON mRNA	PMID:18648102
1304574	Selenon	selenoprotein N	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1603617	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SELENON gene	PMID:31601247
1304574	Selenon	selenoprotein N	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SEPN1 mRNA	PMID:28628672
1304574	Selenon	selenoprotein N	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312091	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SELENON gene	PMID:31683443
1304574	Selenon	selenoprotein N	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SEPN1 mRNA	PMID:28628672
1304574	Selenon	selenoprotein N	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SELENON mRNA	PMID:39836092
1304574	Selenon	selenoprotein N	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1603617	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SELENON mRNA	PMID:38568856
1304574	Selenon	selenoprotein N	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603617	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SEPN1 mRNA	PMID:38382870
1304574	Selenon	selenoprotein N	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1603617	E	RGD:6480464	20171114	CTD	MESH:C000944	dicrotophos results in increased expression of SELENON mRNA	PMID:28302478
1304574	Selenon	selenoprotein N	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SEPN1 mRNA	PMID:28628672
1304574	Selenon	selenoprotein N	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SELENON mRNA	PMID:37992649
1304574	Selenon	selenoprotein N	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SELENON mRNA	PMID:33387578
1304574	Selenon	selenoprotein N	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603617	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SELENON mRNA	PMID:22230336
1304574	Selenon	selenoprotein N	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SEPN1 mRNA	PMID:29432896
1304574	Selenon	selenoprotein N	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SELENON mRNA	PMID:40504410
1304574	Selenon	selenoprotein N	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SELENON mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SELENON mRNA	PMID:39836092
1304574	Selenon	selenoprotein N	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SELENON mRNA	PMID:22079256
1304574	Selenon	selenoprotein N	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SEPN1 mRNA	PMID:28628672
1304574	Selenon	selenoprotein N	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312091	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of SELENON mRNA	PMID:40234311
1304574	Selenon	selenoprotein N	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SELENON mRNA	PMID:39836092
1304574	Selenon	selenoprotein N	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312091	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SEPN1 mRNA	PMID:22206623
1304574	Selenon	selenoprotein N	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312091	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SELENON mRNA	PMID:22206623
1304574	Selenon	selenoprotein N	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1603617	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of SELENON mRNA	PMID:22079256
1304574	Selenon	selenoprotein N	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SELENON mRNA	PMID:22079256
1304574	Selenon	selenoprotein N	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603617	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SELENON gene]; CGP 52608 promotes the reaction [RORA protein binds to SEPN1 gene]	PMID:28238834
1304574	Selenon	selenoprotein N	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1312091	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of SEPN1 mRNA	PMID:31558096
1304574	Selenon	selenoprotein N	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312091	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SELENON mRNA	PMID:27131904
1304574	Selenon	selenoprotein N	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1603617	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SELENON mRNA	PMID:38568856
1304574	Selenon	selenoprotein N	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1603617	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SEPN1 mRNA	PMID:29301935
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312093	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MAP3K3 mRNA	PMID:20188158
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312092	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MAP3K3 mRNA	PMID:33167477
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312092	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of MAP3K3 protein	PMID:23645742
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:16336	hyaluronic acid	multiple interactions	ISO	RGD:1312093	E	RGD:6480464	20130416	CTD	MESH:D006820	MAP3K3 protein promotes the reaction [TGFB2 protein results in increased abundance of Hyaluronic Acid]	PMID:20633555
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312092	E	RGD:6480464	20140408	CTD	MESH:D004958	Estradiol results in increased expression of MAP3K3 mRNA	PMID:23094148
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1312093	E	RGD:6480464	20120412	CTD	MESH:D014241	PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of MAP3K3 mRNA]	PMID:15363585
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312092	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAP3K3 mRNA	PMID:37042841
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of MAP3K3 gene	PMID:33872906
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of MAP3K3 gene	PMID:33872906
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312092	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MAP3K3 protein	PMID:37730182
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MAP3K3 mRNA	PMID:22061828
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312092	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MAP3K3 mRNA	PMID:28818685
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP3K3 mRNA	PMID:39836092
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:23643	depsipeptide	increases expression	ISO	RGD:1312092	E	RGD:6480464	20170110	CTD	MESH:D047630	Depsipeptides results in increased expression of MAP3K3 mRNA	PMID:17064661
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:23643	depsipeptide	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20170110	CTD	MESH:D047630	[decitabine co-treated with Depsipeptides] results in increased expression of MAP3K3 mRNA	PMID:17064661
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1312092	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of MAP3K3 mRNA	PMID:26760959
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312093	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAP3K3 mRNA	PMID:34911549
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MAP3K3 mRNA	PMID:30779732
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312092	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MAP3K3 protein	PMID:35688186
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312092	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MAP3K3 mRNA	PMID:31295307
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312093	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP3K3 mRNA	PMID:21570461
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312092	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MAP3K3 mRNA	PMID:30851411
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MAP3K3 mRNA	PMID:30911355
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MAP3K3 mRNA]	PMID:32406909
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MAP3K3 mRNA	PMID:30911355
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1312092	E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of MAP3K3 mRNA	PMID:27188386
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAP3K3 mRNA	PMID:25729387
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:32095	retinyl acetate	increases expression	ISO	RGD:1312093	E	RGD:6480464	20120412	CTD	MESH:C009166	retinol acetate results in increased expression of MAP3K3 mRNA	PMID:16772331
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312093	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MAP3K3 gene	PMID:35295148
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAP3K3 mRNA	PMID:19710929
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of MAP3K3 mRNA	PMID:19167457
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MAP3K3 mRNA	PMID:25181051
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP3K3 mRNA	PMID:30816183
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MAP3K3 gene	PMID:28505145
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312093	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MAP3K3 mRNA	PMID:21266533
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312093	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MAP3K3 mRNA	PMID:34813904
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312093	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of MAP3K3 mRNA	PMID:34813904
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312092	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MAP3K3 mRNA	PMID:37042841
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP3K3 mRNA	PMID:39836092
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAP3K3 mRNA	PMID:33453195
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:4357	deguelin	affects expression	ISO	RGD:1312092	E	RGD:6480464	20160705	CTD	MESH:C107676	deguelin affects the expression of MAP3K3 protein	PMID:25322282
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:4488	diallyl disulfide	affects expression	ISO	RGD:1312092	E	RGD:6480464	20140311	CTD	MESH:C028009	diallyl disulfide affects the expression of MAP3K3 protein	PMID:21695758
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:4489	Diallyl sulfide	affects expression	ISO	RGD:1312092	E	RGD:6480464	20141111	CTD	MESH:C038491	allyl sulfide affects the expression of MAP3K3 protein	PMID:21695758
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312092	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MAP3K3 mRNA	PMID:27188386
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312092	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MAP3K3 mRNA	PMID:22083351
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312093	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAP3K3 mRNA	PMID:17562736
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312092	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MAP3K3 mRNA	PMID:22230336
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with Depsipeptides] results in increased expression of MAP3K3 mRNA	PMID:17064661
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:517248	bufalin	decreases expression	ISO	RGD:1312092	E	RGD:6480464	20150714	CTD	MESH:C022777	bufalin results in decreased expression of MAP3K3 protein	PMID:23949904
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1312093	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of MAP3K3 mRNA	PMID:20829426
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312092	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP3K3 mRNA	PMID:39836092
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAP3K3 mRNA	PMID:25729387
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312093	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of MAP3K3 protein	PMID:36851058
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of MAP3K3 mRNA	PMID:28954212
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1312093	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of MAP3K3 mRNA	PMID:20829426
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312092	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MAP3K3 mRNA	PMID:31801206
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312093	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of MAP3K3 mRNA	PMID:22206623
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312092	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MAP3K3 mRNA	PMID:37199045
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312092	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MAP3K3 mRNA	PMID:30851411
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:78492	diallyl trisulfide	affects expression	ISO	RGD:1312092	E	RGD:6480464	20140610	CTD	MESH:C042577	diallyl trisulfide affects the expression of MAP3K3 protein	PMID:21695758
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312093	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of MAP3K3 mRNA	PMID:31388691
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MAP3K3 mRNA	PMID:23640034
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MAP3K3 mRNA	PMID:23914054
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312092	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MAP3K3 mRNA	PMID:27188386
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MAP3K3 mRNA	PMID:21346803
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MAP3K3 mRNA	PMID:23034163
1304575	Map3k3	mitogen activated protein kinase kinase kinase 3	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of MAP3K3 gene	PMID:31682807
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1605953	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of VPS37B mRNA	PMID:38218311
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of VPS37B mRNA	PMID:21551480
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1605953	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of VPS37B mRNA	PMID:25812627
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1614045	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of VPS37B mRNA	PMID:36331819
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1614045	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VPS37B mRNA	PMID:39241906
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of VPS37B mRNA	PMID:32145629
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1614045	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of VPS37B mRNA	PMID:39298647
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of VPS37B gene	PMID:27618143
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605953	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of VPS37B mRNA	PMID:37042841
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1605953	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of VPS37B mRNA	PMID:21179406
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614045	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of VPS37B mRNA	PMID:37992649
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614045	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of VPS37B mRNA	PMID:37992649
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of VPS37B mRNA	PMID:33387578
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1605953	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of VPS37B intron	PMID:30157460
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of VPS37B mRNA	PMID:39836092
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1614045	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of VPS37B mRNA	PMID:27462272
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1605953	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of VPS37B mRNA	PMID:24376830
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605953	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of VPS37B mRNA	PMID:19549813
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1605953	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of VPS37B mRNA	PMID:22100608
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1614045	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of VPS37B mRNA	PMID:19770486
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of VPS37B mRNA	PMID:35430440
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of VPS37B mRNA	PMID:18593933
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614045	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VPS37B mRNA	PMID:22206623
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of VPS37B mRNA	PMID:39836092
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1614045	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of VPS37B mRNA	PMID:35897073
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614045	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VPS37B mRNA	PMID:21570461
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VPS37B mRNA	PMID:33387578
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VPS37B mRNA	PMID:21215274
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1605953	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of VPS37B mRNA	PMID:33212167
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1605953	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of VPS37B mRNA	PMID:32763439
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of VPS37B mRNA	PMID:24690739
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614045	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of VPS37B mRNA	PMID:37992649
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605953	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of VPS37B protein	PMID:38228842
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1614045	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of VPS37B gene	PMID:39894169
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605953	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of VPS37B mRNA	PMID:38568856
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of VPS37B mRNA	PMID:39836092
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605953	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of VPS37B promoter	PMID:27901495
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614045	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of VPS37B mRNA	PMID:22228805
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605953	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of VPS37B 3' UTR	PMID:27901495
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of VPS37B mRNA	PMID:24690739
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of VPS37B mRNA	PMID:18593933
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1605953	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of VPS37B mRNA	PMID:26014281
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to VPS37B protein]	PMID:26598702
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of VPS37B mRNA	PMID:30047161
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of VPS37B mRNA	PMID:34492290
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1614045	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of VPS37B mRNA	PMID:23811191
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1614045	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of VPS37B mRNA	PMID:28329830
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1605953	E	RGD:6480464	20220607	CTD	MESH:C006780	bisphenol A affects the methylation of VPS37B gene	PMID:33391824
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of VPS37B mRNA	PMID:25181051
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of VPS37B gene	PMID:28505145
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VPS37B mRNA	PMID:36041667
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1614045	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of VPS37B gene	PMID:31683443
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1614045	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of VPS37B mRNA	PMID:39298647
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VPS37B mRNA	PMID:36041667
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VPS37B mRNA	PMID:36041667
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1614045	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of VPS37B intron	PMID:28392331
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1614045	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of VPS37B mRNA	PMID:37019170
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1614045	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of VPS37B mRNA	PMID:34813904
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605953	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VPS37B mRNA	PMID:37042841
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of VPS37B mRNA	PMID:39836092
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1605953	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of VPS37B mRNA	PMID:38568856
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1605953	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of VPS37B mRNA	PMID:25812627
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of VPS37B mRNA	PMID:26194646
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1614045	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of VPS37B mRNA	PMID:28903501
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1605953	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of VPS37B mRNA	PMID:19376846
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1614045	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of VPS37B mRNA	PMID:17585979
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1605953	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of VPS37B mRNA	PMID:25812627
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1614045	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of VPS37B mRNA	PMID:40194260
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1605953	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of VPS37B mRNA	PMID:31533062
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1605953	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of VPS37B mRNA	PMID:25812627
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1614045	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of VPS37B mRNA	PMID:36331819
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605953	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of VPS37B mRNA	PMID:25979313
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of VPS37B mRNA	PMID:30047161
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605953	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of VPS37B mRNA	PMID:20106945|PMID:25562108
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614045	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of VPS37B mRNA	PMID:37992649
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605953	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of VPS37B mRNA	PMID:38832940
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614045	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of VPS37B mRNA	PMID:17562736
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of VPS37B mRNA	PMID:33387578
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605953	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of VPS37B mRNA	PMID:21420995
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of VPS37B mRNA	PMID:24690739
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of VPS37B mRNA	PMID:29432896
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1605953	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of VPS37B mRNA	PMID:18687144
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of VPS37B mRNA	PMID:39836092
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of VPS37B mRNA	PMID:29391264
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1605953	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of VPS37B mRNA	PMID:38568856
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to VPS37B protein]	PMID:26598702
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614045	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of VPS37B mRNA; Nanotubes, Carbon results in increased expression of VPS37B mRNA	PMID:25620056
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of VPS37B mRNA	PMID:23962444
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of VPS37B mRNA	PMID:30047161
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605953	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of VPS37B protein	PMID:32959892
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of VPS37B mRNA	PMID:39836092
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of VPS37B mRNA	PMID:19564919
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1614045	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of VPS37B mRNA]	PMID:27256343
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614045	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VPS37B mRNA	PMID:22206623
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605953	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to VPS37B gene]	PMID:28238834
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1605953	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of VPS37B mRNA	PMID:19159669
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1614045	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of VPS37B mRNA	PMID:23091169
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1614045	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of VPS37B mRNA	PMID:38648751
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1614045	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of VPS37B mRNA	PMID:39847705
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of VPS37B mRNA	PMID:30047161
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of VPS37B mRNA	PMID:30047161
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1605953	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of VPS37B mRNA	PMID:26014281
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of VPS37B mRNA	PMID:19281266
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of VPS37B mRNA	PMID:21346803
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605953	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of VPS37B mRNA	PMID:38568856
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1605953	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of VPS37B mRNA	PMID:27188386
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1614045	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of VPS37B mRNA	PMID:32835833
1304576	Vps37b	VPS37B subunit of ESCRT-I	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of VPS37B mRNA	PMID:23034163
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312096	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP13 mRNA	PMID:20938992
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312095	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZNF205 mRNA	PMID:26079696
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312095	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ZNF205 mRNA	PMID:38568856
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312096	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP13 mRNA	PMID:20938992
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:16899	D-mannitol	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in decreased expression of ZFP13 mRNA	PMID:25270620
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312095	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ZNF205 mRNA	PMID:19774075
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312096	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP13 mRNA	PMID:20938992
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312095	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZNF205 protein	PMID:35688186
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of ZFP13 mRNA	PMID:35489704
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ZFP13 mRNA	PMID:28960355
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP13 mRNA	PMID:32109520
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312095	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF205 mRNA	PMID:33212167
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312095	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF205 mRNA	PMID:29803840
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZFP13 mRNA	PMID:39631538
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1312095	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of ZNF205 mRNA	PMID:34408198
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312096	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP13 gene	PMID:35295148
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312096	E	RGD:6480464	20131008	CTD	MESH:C009495	titanium dioxide results in increased expression of ZFP13 mRNA	PMID:23131501
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312096	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZFP13 gene	PMID:35295148
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ZFP13 mRNA	PMID:19167457
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF205 mRNA	PMID:25181051
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP13 mRNA	PMID:33221593
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP13 mRNA	PMID:34947998
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312096	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP13 mRNA	PMID:32156529
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZFP13 gene	PMID:28505145
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312096	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZFP13 gene	PMID:31683443
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZFP13 mRNA	PMID:39298647
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312096	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZFP13 mRNA	PMID:24982889
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of ZFP13 promoter	PMID:22457795
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312096	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ZFP13 mRNA	PMID:39529242
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312095	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZNF205 gene	PMID:29154799
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1312096	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of ZFP13 mRNA	PMID:22078008
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312095	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF205 protein	PMID:31285264
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in increased expression of ZFP13 mRNA	PMID:26720608
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312096	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ZFP13 mRNA	PMID:31388691
1304577	Zfp13	zinc finger protein 13	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ZFP13 mRNA	PMID:40826991
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TRIM5 mRNA	PMID:38218311
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1343210	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TRIM5 mRNA	PMID:38218311
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TRIM5 mRNA]	PMID:31150632
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1343210	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TRIM5 mRNA	PMID:33167477
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRIM5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRIM5 mRNA	PMID:32699268
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1616137	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of TRIM5 mRNA	PMID:40945087
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1343210	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of TRIM5 mRNA	PMID:29581250
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1616137	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TRIM5 mRNA	PMID:39241906
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1343210	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRIM5 mRNA	PMID:35811015
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRIM5 mRNA	PMID:35811015
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of TRIM5 mRNA	PMID:31614463
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1616137	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TRIM5 mRNA	PMID:39298647
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:16548	chlordecone	affects expression	ISO	RGD:1616137	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone affects the expression of TRIM5 mRNA	PMID:33711761
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1343210	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIM5 mRNA	PMID:37042841
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TRIM5 mRNA	PMID:26577399
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of TRIM5 mRNA	PMID:39836092
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TRIM5 mRNA	PMID:28522335
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRIM5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRIM5 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TRIM5 mRNA	PMID:32699268
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1616137	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TRIM5 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TRIM5 mRNA	PMID:34911549
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TRIM5 mRNA	PMID:31150632
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TRIM5 mRNA]	PMID:31150632
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM5 mRNA	PMID:39836092
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1343210	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TRIM5 mRNA	PMID:26272509
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM5 mRNA	PMID:27188386
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1616137	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TRIM5 mRNA	PMID:28960355
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TRIM5 mRNA	PMID:31881176
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TRIM5 mRNA	PMID:23557933
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1616137	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of TRIM5 mRNA	PMID:32186404
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRIM5 mRNA	PMID:33387578
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM5 mRNA	PMID:34747641
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TRIM5 mRNA	PMID:28374803
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of TRIM5 mRNA	PMID:21198554
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1616137	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRIM5 mRNA	PMID:39631538
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRIM5 mRNA	PMID:28595984|PMID:34032870
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1616137	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRIM5 mRNA	PMID:37682722
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM5 mRNA	PMID:39836092
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TRIM5 mRNA]	PMID:32406909
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1343210	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TRIM5 mRNA	PMID:25351596
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of TRIM5 mRNA	PMID:24136188
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of TRIM5 mRNA	PMID:27188386
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of TRIM5 mRNA	PMID:24136188
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TRIM5 mRNA	PMID:34492290
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM5 mRNA	PMID:34947998
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1343210	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TRIM5 gene	PMID:31601247
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TRIM5 mRNA	PMID:25181051|PMID:41034487
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1616137	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TRIM5 mRNA	PMID:37019170
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of TRIM5 mRNA	PMID:39836092
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRIM5 protein	PMID:38185225
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TRIM5 mRNA	PMID:33453195
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TRIM5 mRNA	PMID:19320972
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRIM5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRIM5 mRNA	PMID:32699268
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TRIM5 mRNA	PMID:31533062
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343210	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TRIM5 mRNA	PMID:25979313
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRIM5 mRNA	PMID:23179753
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of TRIM5 mRNA	PMID:41580965
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1343210	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TRIM5 mRNA	PMID:25562108
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1343210	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TRIM5 mRNA	PMID:36621641
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of TRIM5 mRNA	PMID:24136188
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIM5 mRNA	PMID:21420995
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1343210	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TRIM5 mRNA	PMID:22230336
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRIM5 mRNA	PMID:35811015
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM5 mRNA	PMID:39836092
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of TRIM5 mRNA	PMID:31838189
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIM5 mRNA	PMID:22079256
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1616137	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TRIM5 mRNA	PMID:35436446
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of TRIM5 mRNA	PMID:39836092
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM5 mRNA	PMID:26378955
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of TRIM5 mRNA	PMID:24136188
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of TRIM5 mRNA	PMID:30467583
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of TRIM5 mRNA	PMID:24136188
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1343210	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TRIM5 mRNA	PMID:22079256
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIM5 mRNA	PMID:22079256
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1343210	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of TRIM5 mRNA	PMID:19946333
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of TRIM5 mRNA]	PMID:19946333
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM5 mRNA	PMID:27188386
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TRIM5 mRNA	PMID:24780913
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1343210	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM5 mRNA	PMID:27188386
1304579	Trim5	tripartite motif-containing 5	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TRIM5 mRNA	PMID:19281266
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1331866	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SYNE4 mRNA	PMID:33045310
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1602427	E	RGD:6480464	20170411	CTD	MESH:D011794	Quercetin results in decreased expression of SYNE4 mRNA	PMID:21632981
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1331866	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SYNE4 mRNA	PMID:37992649
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1331866	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SYNE4 mRNA	PMID:37992649
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1331866	E	RGD:6480464	20170627	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SYNE4 mRNA	PMID:28085963
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SYNE4 mRNA	PMID:26577399
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1602427	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SYNE4 mRNA	PMID:28818685
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1331866	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SYNE4 mRNA	PMID:36331819
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1602427	E	RGD:6480464	20170411	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SYNE4 mRNA	PMID:27153756
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602427	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SYNE4 exon	PMID:30157460
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1331866	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SYNE4 mRNA	PMID:34911549
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SYNE4 mRNA	PMID:31150632
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602427	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SYNE4 mRNA	PMID:32525701
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20170411	CTD	MESH:C059514	resveratrol results in increased expression of SYNE4 mRNA	PMID:25905778
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1602427	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SYNE4 mRNA	PMID:27392435
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1602427	E	RGD:6480464	20170411	CTD	MESH:D009532	Nickel results in decreased expression of SYNE4 mRNA	PMID:24768652|PMID:25583101
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20170411	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SYNE4 mRNA	PMID:22298810
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1331866	E	RGD:6480464	20170627	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SYNE4 mRNA	PMID:26290441
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1602427	E	RGD:6480464	20170411	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SYNE4 mRNA	PMID:21632981
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1602427	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SYNE4 mRNA	PMID:33212167
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1331866	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SYNE4 mRNA	PMID:37992649
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:28794	coumarin	increases expression	EXP		E	RGD:6480464	20170411	CTD	MESH:C030123	coumarin results in increased expression of SYNE4 mRNA	PMID:18480146
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1331866	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SYNE4 mRNA	PMID:37682722
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602427	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SYNE4 promoter	PMID:27901495
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602427	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SYNE4 5' UTR	PMID:27901495
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1331866	E	RGD:6480464	20170627	CTD	MESH:D012834	Silver results in increased expression of SYNE4 mRNA	PMID:27131904
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SYNE4 mRNA	PMID:38458666
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D008627	Mercuric Chloride results in increased expression of SYNE4 mRNA	PMID:32599119
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1331866	E	RGD:6480464	20170627	CTD	MESH:C009495	titanium dioxide affects the expression of SYNE4 mRNA	PMID:23557971
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SYNE4 mRNA	PMID:34947998
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20170411	CTD	MESH:C006780	bisphenol A results in increased expression of SYNE4 mRNA	PMID:25181051
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1602427	E	RGD:6480464	20170411	CTD	MESH:D002220	Carbamazepine affects the expression of SYNE4 mRNA	PMID:25979313
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1602427	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SYNE4 exon	PMID:30157460
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1331866	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of SYNE4 mRNA	PMID:28392331
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SYNE4 mRNA	PMID:38458666
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SYNE4 mRNA	PMID:30723492
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20170411	CTD	MESH:C039281	furan results in decreased expression of SYNE4 mRNA	PMID:25539665|PMID:26194646
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20170411	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SYNE4 mRNA	PMID:24386269
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1331866	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SYNE4 mRNA	PMID:39529242
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331866	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SYNE4 mRNA	PMID:36331819
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602427	E	RGD:6480464	20170411	CTD	MESH:D014635	Valproic Acid affects the expression of SYNE4 mRNA	PMID:25979313
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602427	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYNE4 mRNA	PMID:28001369
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602427	E	RGD:6480464	20170411	CTD	MESH:D016572	Cyclosporine results in decreased expression of SYNE4 mRNA	PMID:25562108|PMID:27989131
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1331866	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SYNE4 mRNA	PMID:37992649
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNE4 mRNA	PMID:33387578
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602427	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SYNE4 mRNA	PMID:32525701
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:47381	diclofenac	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D004008	Diclofenac results in increased expression of SYNE4 mRNA	PMID:30723492
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1331866	E	RGD:6480464	20170627	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SYNE4 mRNA; Nanotubes, Carbon results in increased expression of SYNE4 mRNA	PMID:25554681|PMID:25620056
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of SYNE4 mRNA	PMID:28801915
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SYNE4 mRNA	PMID:28801915
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1602427	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SYNE4 exon	PMID:30157460
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of SYNE4 mRNA	PMID:33484710
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170411	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SYNE4 mRNA	PMID:27291303
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170411	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SYNE4 mRNA	PMID:23640034
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1602427	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SYNE4 mRNA	PMID:32525701
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20170411	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SYNE4 mRNA	PMID:24780913
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1331866	E	RGD:6480464	20170627	CTD	MESH:D012834	Silver results in increased expression of SYNE4 mRNA	PMID:27131904
1304580	Syne4	spectrin repeat containing nuclear envelope family member 4	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1331866	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of SYNE4 mRNA	PMID:32835833
1304581	Hebp1	heme binding protein 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312101	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of HEBP1 mRNA	PMID:27188386
1304581	Hebp1	heme binding protein 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HEBP1 mRNA]	PMID:31150632
1304581	Hebp1	heme binding protein 1	gene	CHEBI:144400	dinophysistoxin 1	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in decreased expression of HEBP1 mRNA	PMID:28939011
1304581	Hebp1	heme binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of HEBP1 mRNA	PMID:33167477
1304581	Hebp1	heme binding protein 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312101	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of HEBP1 mRNA	PMID:22378314
1304581	Hebp1	heme binding protein 1	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D000431	Ethanol results in decreased expression of HEBP1 protein	PMID:23702218
1304581	Hebp1	heme binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312102	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HEBP1 mRNA	PMID:39241906
1304581	Hebp1	heme binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of HEBP1 mRNA	PMID:19619570|PMID:21185374
1304581	Hebp1	heme binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of HEBP1 mRNA	PMID:19619570
1304581	Hebp1	heme binding protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of HEBP1 gene	PMID:33872906
1304581	Hebp1	heme binding protein 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312102	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of HEBP1 mRNA	PMID:33848595
1304581	Hebp1	heme binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of HEBP1 gene	PMID:33872906
1304581	Hebp1	heme binding protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HEBP1 mRNA	PMID:33387578
1304581	Hebp1	heme binding protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312101	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of HEBP1 mRNA	PMID:19549813
1304581	Hebp1	heme binding protein 1	gene	CHEBI:234430	gardiquimod	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in decreased expression of HEBP1 mRNA	PMID:28003376
1304581	Hebp1	heme binding protein 1	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of HEBP1 mRNA]	PMID:28003376
1304581	Hebp1	heme binding protein 1	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of HEBP1 protein	PMID:33236894
1304581	Hebp1	heme binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312101	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HEBP1 gene	PMID:27153756
1304581	Hebp1	heme binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HEBP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HEBP1 mRNA	PMID:34911549
1304581	Hebp1	heme binding protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HEBP1 mRNA	PMID:31150632
1304581	Hebp1	heme binding protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HEBP1 mRNA	PMID:27339419|PMID:31919559
1304581	Hebp1	heme binding protein 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HEBP1 mRNA]	PMID:31150632
1304581	Hebp1	heme binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of HEBP1 mRNA	PMID:40504410
1304581	Hebp1	heme binding protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of HEBP1 protein	PMID:38460933
1304581	Hebp1	heme binding protein 1	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA	PMID:33854195
1304581	Hebp1	heme binding protein 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of HEBP1 mRNA	PMID:31881176
1304581	Hebp1	heme binding protein 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of HEBP1 mRNA	PMID:19921347
1304581	Hebp1	heme binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of HEBP1 mRNA	PMID:40618947
1304581	Hebp1	heme binding protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312101	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of HEBP1 mRNA	PMID:27594783
1304581	Hebp1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HEBP1 mRNA	PMID:19619570
1304581	Hebp1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HEBP1 mRNA	PMID:19770486|PMID:28213091
1304581	Hebp1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HEBP1 mRNA	PMID:26232522|PMID:34747641
1304581	Hebp1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312102	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HEBP1 mRNA	PMID:19933214
1304581	Hebp1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of HEBP1 mRNA	PMID:19619570
1304581	Hebp1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to HEBP1 gene]	PMID:28213091
1304581	Hebp1	heme binding protein 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of HEBP1 mRNA	PMID:28959563
1304581	Hebp1	heme binding protein 1	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of HEBP1 mRNA	PMID:30556269
1304581	Hebp1	heme binding protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312102	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of HEBP1 mRNA	PMID:39631538
1304581	Hebp1	heme binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312101	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HEBP1 mRNA; sodium arsenite results in increased expression of HEBP1 protein	PMID:38568856|PMID:39571964
1304581	Hebp1	heme binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of HEBP1 mRNA	PMID:40504410
1304581	Hebp1	heme binding protein 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312101	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of HEBP1 mRNA	PMID:22378314
1304581	Hebp1	heme binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312101	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HEBP1 mRNA	PMID:20106945|PMID:21632981
1304581	Hebp1	heme binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312102	E	RGD:6480464	20240604	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HEBP1 mRNA	PMID:38641015
1304581	Hebp1	heme binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to HEBP1 mRNA]	PMID:32406909
1304581	Hebp1	heme binding protein 1	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of HEBP1 mRNA	PMID:30556269
1304581	Hebp1	heme binding protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HEBP1 mRNA	PMID:25729387
1304581	Hebp1	heme binding protein 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312102	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of HEBP1 mRNA	PMID:23557971
1304581	Hebp1	heme binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of HEBP1 mRNA	PMID:27760801
1304581	Hebp1	heme binding protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HEBP1 mRNA	PMID:34492290
1304581	Hebp1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of HEBP1 promoter	PMID:27415467
1304581	Hebp1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of HEBP1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304581	Hebp1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of HEBP1 protein	PMID:31675489
1304581	Hebp1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HEBP1 mRNA	PMID:25181051|PMID:32145629
1304581	Hebp1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312101	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of HEBP1 protein	PMID:37567409
1304581	Hebp1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312102	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of HEBP1 mRNA	PMID:32156529
1304581	Hebp1	heme binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312102	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of HEBP1 mRNA	PMID:40203079
1304581	Hebp1	heme binding protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20250311	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of HEBP1 mRNA	PMID:32308655
1304581	Hebp1	heme binding protein 1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1312102	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of HEBP1 mRNA	PMID:31558096
1304581	Hebp1	heme binding protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HEBP1 protein	PMID:34058248
1304581	Hebp1	heme binding protein 1	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA	PMID:33854195
1304581	Hebp1	heme binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312101	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HEBP1 mRNA	PMID:37042841
1304581	Hebp1	heme binding protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of HEBP1 mRNA	PMID:35163327
1304581	Hebp1	heme binding protein 1	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of HEBP1 mRNA	PMID:18500788
1304581	Hebp1	heme binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of HEBP1 mRNA	PMID:35163327
1304581	Hebp1	heme binding protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312101	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of HEBP1 mRNA	PMID:19376846
1304581	Hebp1	heme binding protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of HEBP1 mRNA	PMID:17585979
1304581	Hebp1	heme binding protein 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of HEBP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HEBP1 mRNA]	PMID:17585979
1304581	Hebp1	heme binding protein 1	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of HEBP1 mRNA]	PMID:28003376
1304581	Hebp1	heme binding protein 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312102	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HEBP1 mRNA	PMID:40194260
1304581	Hebp1	heme binding protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA	PMID:19167446
1304581	Hebp1	heme binding protein 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312102	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of HEBP1 mRNA	PMID:39529242
1304581	Hebp1	heme binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312101	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HEBP1 mRNA	PMID:40419075
1304581	Hebp1	heme binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312101	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HEBP1 mRNA	PMID:25979313
1304581	Hebp1	heme binding protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312101	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of HEBP1 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386
1304581	Hebp1	heme binding protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312102	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of HEBP1 mRNA	PMID:21427059
1304581	Hebp1	heme binding protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of HEBP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HEBP1 mRNA	PMID:17183730|PMID:27188386
1304581	Hebp1	heme binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of HEBP1 mRNA	PMID:19770486
1304581	Hebp1	heme binding protein 1	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA	PMID:33854195
1304581	Hebp1	heme binding protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of HEBP1 mRNA	PMID:28973697
1304581	Hebp1	heme binding protein 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HEBP1 mRNA	PMID:38832940
1304581	Hebp1	heme binding protein 1	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA	PMID:33854195
1304581	Hebp1	heme binding protein 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312101	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of HEBP1 mRNA	PMID:24935251
1304581	Hebp1	heme binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312102	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HEBP1 mRNA	PMID:17562736
1304581	Hebp1	heme binding protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20130416	CTD	MESH:D000082	Acetaminophen results in decreased expression of HEBP1 protein	PMID:22939915
1304581	Hebp1	heme binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HEBP1 mRNA	PMID:33387578
1304581	Hebp1	heme binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312101	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of HEBP1 mRNA	PMID:25704631
1304581	Hebp1	heme binding protein 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of HEBP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HEBP1 mRNA]	PMID:17585979
1304581	Hebp1	heme binding protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of HEBP1 protein	PMID:38460933
1304581	Hebp1	heme binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of HEBP1 mRNA	PMID:40504410
1304581	Hebp1	heme binding protein 1	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of HEBP1 mRNA	PMID:37077353
1304581	Hebp1	heme binding protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312102	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of HEBP1 mRNA	PMID:35436446
1304581	Hebp1	heme binding protein 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312102	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of HEBP1 mRNA	PMID:25554681
1304581	Hebp1	heme binding protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312102	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of HEBP1 mRNA	PMID:25554681
1304581	Hebp1	heme binding protein 1	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1312102	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in increased expression of HEBP1 mRNA	PMID:25086211
1304581	Hebp1	heme binding protein 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of HEBP1 mRNA	PMID:17183730
1304581	Hebp1	heme binding protein 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312102	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of HEBP1 mRNA	PMID:38701926
1304581	Hebp1	heme binding protein 1	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA	PMID:33854195
1304581	Hebp1	heme binding protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HEBP1 protein	PMID:32959892
1304581	Hebp1	heme binding protein 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HEBP1 mRNA	PMID:25729387
1304581	Hebp1	heme binding protein 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1312102	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of HEBP1 mRNA	PMID:19812364
1304581	Hebp1	heme binding protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312101	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of HEBP1 mRNA	PMID:24810058
1304581	Hebp1	heme binding protein 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312102	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of HEBP1 protein	PMID:36851058
1304581	Hebp1	heme binding protein 1	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1312102	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of HEBP1 mRNA	PMID:22078008
1304581	Hebp1	heme binding protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312101	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of HEBP1 protein	PMID:34186270
1304581	Hebp1	heme binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HEBP1 mRNA	PMID:27188386
1304581	Hebp1	heme binding protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HEBP1 gene]	PMID:28238834
1304581	Hebp1	heme binding protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312102	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of HEBP1 mRNA	PMID:19270015
1304581	Hebp1	heme binding protein 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA	PMID:19167446
1304581	Hebp1	heme binding protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312102	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of HEBP1 mRNA	PMID:38648751
1304581	Hebp1	heme binding protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HEBP1 protein	PMID:31675489
1304581	Hebp1	heme binding protein 1	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1312102	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of HEBP1 mRNA	PMID:31558096
1304581	Hebp1	heme binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of HEBP1 mRNA	PMID:24780913
1304581	Hebp1	heme binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312101	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HEBP1 mRNA	PMID:27188386
1304581	Hebp1	heme binding protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of HEBP1 mRNA	PMID:21346803
1304581	Hebp1	heme binding protein 1	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312101	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of HEBP1 mRNA	PMID:27188386
1304582	Mtm1	myotubularin 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA	PMID:25510870
1304582	Mtm1	myotubularin 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MTM1 mRNA	PMID:33387578
1304582	Mtm1	myotubularin 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312103	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MTM1 mRNA	PMID:37042841
1304582	Mtm1	myotubularin 1	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in decreased expression of MTM1 mRNA	PMID:17178593
1304582	Mtm1	myotubularin 1	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in decreased expression of MTM1 mRNA	PMID:17178593
1304582	Mtm1	myotubularin 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312103	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MTM1 protein	PMID:37730182
1304582	Mtm1	myotubularin 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MTM1 mRNA	PMID:33387578
1304582	Mtm1	myotubularin 1	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of MTM1 mRNA	PMID:17175027
1304582	Mtm1	myotubularin 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312103	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of MTM1 mRNA	PMID:28860664
1304582	Mtm1	myotubularin 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTM1 mRNA	PMID:37236586
1304582	Mtm1	myotubularin 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA	PMID:25510870
1304582	Mtm1	myotubularin 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA	PMID:25510870
1304582	Mtm1	myotubularin 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312103	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MTM1 gene	PMID:27153756
1304582	Mtm1	myotubularin 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312104	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MTM1 mRNA	PMID:31919559
1304582	Mtm1	myotubularin 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312103	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MTM1 protein	PMID:35688186
1304582	Mtm1	myotubularin 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312103	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MTM1 mRNA	PMID:23557933
1304582	Mtm1	myotubularin 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312104	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MTM1 mRNA	PMID:30912803
1304582	Mtm1	myotubularin 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312104	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of MTM1 mRNA	PMID:32186404
1304582	Mtm1	myotubularin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MTM1 mRNA	PMID:32109520|PMID:33387578
1304582	Mtm1	myotubularin 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MTM1 mRNA	PMID:28001369
1304582	Mtm1	myotubularin 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MTM1 mRNA	PMID:30851411
1304582	Mtm1	myotubularin 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MTM1 mRNA	PMID:39719251
1304582	Mtm1	myotubularin 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312103	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MTM1 5' UTR; Benzo(a)pyrene affects the methylation of MTM1 exon; Benzo(a)pyrene affects the methylation of MTM1 promoter	PMID:27901495
1304582	Mtm1	myotubularin 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MTM1 mRNA	PMID:19770486
1304582	Mtm1	myotubularin 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312103	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MTM1 mRNA]	PMID:32406909
1304582	Mtm1	myotubularin 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of MTM1 mRNA	PMID:18445702
1304582	Mtm1	myotubularin 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312104	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MTM1 mRNA	PMID:17950772|PMID:18301758|PMID:20813756|PMID:23811191
1304582	Mtm1	myotubularin 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of MTM1 mRNA]	PMID:17950772
1304582	Mtm1	myotubularin 1	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of MTM1 mRNA	PMID:30690063
1304582	Mtm1	myotubularin 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of MTM1 mRNA	PMID:19167457
1304582	Mtm1	myotubularin 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MTM1 mRNA	PMID:25181051
1304582	Mtm1	myotubularin 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MTM1 gene	PMID:28505145
1304582	Mtm1	myotubularin 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of MTM1 mRNA	PMID:19244175
1304582	Mtm1	myotubularin 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA	PMID:25510870
1304582	Mtm1	myotubularin 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA	PMID:25510870
1304582	Mtm1	myotubularin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312104	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MTM1 mRNA	PMID:39298647|PMID:40203079
1304582	Mtm1	myotubularin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of MTM1 mRNA]	PMID:40203079
1304582	Mtm1	myotubularin 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MTM1 mRNA	PMID:17361019|PMID:21266533
1304582	Mtm1	myotubularin 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312103	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MTM1 mRNA	PMID:37042841
1304582	Mtm1	myotubularin 1	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of MTM1 mRNA	PMID:17175027
1304582	Mtm1	myotubularin 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MTM1 mRNA	PMID:38568856
1304582	Mtm1	myotubularin 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTM1 mRNA	PMID:37236586
1304582	Mtm1	myotubularin 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MTM1 mRNA	PMID:28302478
1304582	Mtm1	myotubularin 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312103	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MTM1 mRNA	PMID:31533062
1304582	Mtm1	myotubularin 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312104	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of MTM1 mRNA	PMID:39529242
1304582	Mtm1	myotubularin 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312103	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MTM1 gene	PMID:29154799
1304582	Mtm1	myotubularin 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MTM1 mRNA	PMID:20106945
1304582	Mtm1	myotubularin 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312104	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MTM1 mRNA	PMID:28973697
1304582	Mtm1	myotubularin 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in decreased expression of MTM1 mRNA	PMID:17178593
1304582	Mtm1	myotubularin 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1312103	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of MTM1 mRNA	PMID:17400583
1304582	Mtm1	myotubularin 1	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312103	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTM1 mRNA	PMID:27188386
1304582	Mtm1	myotubularin 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MTM1 mRNA	PMID:26272509
1304582	Mtm1	myotubularin 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of MTM1 mRNA	PMID:31675489
1304582	Mtm1	myotubularin 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of MTM1 mRNA	PMID:31464424
1304582	Mtm1	myotubularin 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312103	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MTM1 mRNA	PMID:22079256
1304582	Mtm1	myotubularin 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of MTM1 mRNA	PMID:17175027
1304582	Mtm1	myotubularin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MTM1 mRNA	PMID:22206623
1304582	Mtm1	myotubularin 1	gene	CHEBI:749016	gossypol acetic acid	increases expression	ISO	RGD:1312103	E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in increased expression of MTM1 protein	PMID:29938581
1304582	Mtm1	myotubularin 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MTM1 mRNA	PMID:22079256|PMID:22714537
1304582	Mtm1	myotubularin 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312103	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MTM1 mRNA	PMID:22079256
1304582	Mtm1	myotubularin 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312103	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MTM1 mRNA	PMID:37199045
1304582	Mtm1	myotubularin 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MTM1 mRNA	PMID:30851411
1304582	Mtm1	myotubularin 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312103	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTM1 mRNA	PMID:27188386
1304582	Mtm1	myotubularin 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312104	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MTM1 mRNA	PMID:23091169
1304582	Mtm1	myotubularin 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312104	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of MTM1 mRNA	PMID:19270015
1304582	Mtm1	myotubularin 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MTM1 protein	PMID:31675489
1304582	Mtm1	myotubularin 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312103	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MTM1 protein	PMID:31675489
1304582	Mtm1	myotubularin 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312104	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of MTM1 mRNA	PMID:21795629
1304582	Mtm1	myotubularin 1	gene	CHEBI:85014	2,5-hexanedione	increases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in increased expression of MTM1 mRNA	PMID:22952946
1304582	Mtm1	myotubularin 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312103	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTM1 mRNA	PMID:27188386
1304582	Mtm1	myotubularin 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MTM1 mRNA	PMID:21346803
1304582	Mtm1	myotubularin 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MTM1 mRNA	PMID:23034163
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of AGO4 mRNA	PMID:26272509
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA	PMID:27188386
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AGO4 mRNA]	PMID:31150632
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312105	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of AGO4 mRNA	PMID:23724009
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20151013	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of AGO4 mRNA	PMID:24763279
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20151013	CTD	MESH:C018475	butyraldehyde results in decreased expression of AGO4 mRNA	PMID:26079696
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of AGO4 mRNA	PMID:39241906
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of AGO4 mRNA	PMID:32145629
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of AGO4 mRNA	PMID:31614463
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of AGO4 mRNA	PMID:22217510
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA	PMID:25510870
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of AGO4 mRNA	PMID:26577399
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AGO4 mRNA	PMID:37325564
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA	PMID:25510870
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA	PMID:25510870
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312105	E	RGD:6480464	20151013	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of AGO4 mRNA	PMID:23649840
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312105	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AGO4 intron	PMID:30157460
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312106	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AGO4 mRNA	PMID:19770486
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312105	E	RGD:6480464	20151013	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of AGO4 mRNA	PMID:23649840
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of AGO4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of AGO4 mRNA	PMID:35430440|PMID:41430723
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AGO4 mRNA	PMID:31150632
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AGO4 mRNA]	PMID:31150632
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of AGO4 mRNA	PMID:21867686
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AGO4 mRNA	PMID:39836092
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AGO4 mRNA	PMID:40504410
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of AGO4 mRNA	PMID:26272509
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA	PMID:27188386
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of AGO4 mRNA	PMID:23557933
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of AGO4 mRNA	PMID:27392435
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of AGO4 mRNA	PMID:27392435
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:27928	parathion	decreases methylation	ISO	RGD:1312105	E	RGD:6480464	20130514	CTD	MESH:D010278	Parathion results in decreased methylation of AGO4 promoter	PMID:22847954
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312106	E	RGD:6480464	20130319	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AGO4 mRNA	PMID:21570461
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of AGO4 mRNA	PMID:28001369
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of AGO4 mRNA	PMID:33212167
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of AGO4 mRNA	PMID:28959563
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AGO4 mRNA	PMID:29803840
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AGO4 mRNA	PMID:39836092
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AGO4 mRNA	PMID:40504410
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20130319	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AGO4 mRNA	PMID:22228805
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312106	E	RGD:6480464	20130319	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AGO4 mRNA	PMID:22228805
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312105	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AGO4 promoter	PMID:27901495
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20130319	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of AGO4 mRNA]	PMID:22228805
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312105	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of AGO4 mRNA	PMID:26014281
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of AGO4 mRNA	PMID:30047161
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312106	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AGO4 gene	PMID:35295148
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AGO4 mRNA	PMID:34492290
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312106	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of AGO4 mRNA	PMID:20813756
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312106	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of AGO4 mRNA	PMID:28472532
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AGO4 mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of AGO4 mRNA	PMID:34947998|PMID:41034487
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312105	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AGO4 mRNA	PMID:24752500
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA	PMID:25510870
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA	PMID:25510870
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of AGO4 mRNA	PMID:39298647
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1312106	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of AGO4 mRNA	PMID:36464114
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312105	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AGO4 mRNA	PMID:37042841
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AGO4 mRNA	PMID:37325564
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:38689	fonofos	decreases methylation	ISO	RGD:1312105	E	RGD:6480464	20130514	CTD	MESH:D004397	Fonofos results in decreased methylation of AGO4 promoter	PMID:22847954
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:38960	terbufos	decreases methylation	ISO	RGD:1312105	E	RGD:6480464	20130514	CTD	MESH:C012568	terbufos results in decreased methylation of AGO4 promoter	PMID:22847954
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312105	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AGO4 mRNA	PMID:25979313
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of AGO4 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA	PMID:27188386
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312106	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of AGO4 mRNA	PMID:18502557
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312105	E	RGD:6480464	20130319	CTD	MESH:D000082	Acetaminophen results in increased expression of AGO4 mRNA	PMID:22230336
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AGO4 mRNA	PMID:39836092
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AGO4 mRNA	PMID:40504410
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312105	E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac affects the expression of AGO4 mRNA	PMID:24752500
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of AGO4 mRNA	PMID:29391264
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of AGO4 mRNA; Nanotubes, Carbon results in decreased expression of AGO4 mRNA	PMID:25554681|PMID:25620056
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of AGO4 mRNA	PMID:30047161
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20160210	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of AGO4 mRNA	PMID:26377693
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of AGO4 mRNA	PMID:19042947
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20151013	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of AGO4 mRNA	PMID:23608068
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1312106	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of AGO4 mRNA	PMID:36464114
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312106	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of AGO4 mRNA	PMID:22206623
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA	PMID:27188386
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AGO4 gene]	PMID:28238834
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312106	E	RGD:6480464	20151013	CTD	MESH:D010634	Phenobarbital affects the expression of AGO4 mRNA	PMID:23091169
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312105	E	RGD:6480464	20151013	CTD	MESH:C046012	pentanal results in decreased expression of AGO4 mRNA	PMID:26079696
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AGO4 mRNA	PMID:30047161
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D011441	Propylthiouracil results in increased expression of AGO4 mRNA	PMID:24780913
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312105	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA	PMID:27188386
1304583	Ago4	argonaute RISC component 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312105	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of AGO4 mRNA	PMID:26014281
1304584	Fbxo28	F-box protein 28	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312107	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of FBXO28 mRNA	PMID:31863870
1304584	Fbxo28	F-box protein 28	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of FBXO28 mRNA	PMID:24763279
1304584	Fbxo28	F-box protein 28	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of FBXO28 mRNA	PMID:22378314
1304584	Fbxo28	F-box protein 28	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1549977	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FBXO28 mRNA	PMID:30319688
1304584	Fbxo28	F-box protein 28	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FBXO28 mRNA	PMID:21632981
1304584	Fbxo28	F-box protein 28	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in decreased expression of FBXO28 mRNA	PMID:16631469
1304584	Fbxo28	F-box protein 28	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1549977	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FBXO28 mRNA	PMID:34319233
1304584	Fbxo28	F-box protein 28	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312107	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FBXO28 protein	PMID:37730182
1304584	Fbxo28	F-box protein 28	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FBXO28 mRNA	PMID:33387578
1304584	Fbxo28	F-box protein 28	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1549977	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO28 mRNA	PMID:37236586
1304584	Fbxo28	F-box protein 28	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXO28 mRNA	PMID:18593933
1304584	Fbxo28	F-box protein 28	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO28 mRNA	PMID:39836092
1304584	Fbxo28	F-box protein 28	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FBXO28 mRNA	PMID:19244175
1304584	Fbxo28	F-box protein 28	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA	PMID:19244175
1304584	Fbxo28	F-box protein 28	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1549977	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO28 mRNA	PMID:21570461
1304584	Fbxo28	F-box protein 28	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1549977	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXO28 mRNA	PMID:24680724
1304584	Fbxo28	F-box protein 28	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FBXO28 mRNA	PMID:28001369
1304584	Fbxo28	F-box protein 28	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO28 mRNA	PMID:30851411
1304584	Fbxo28	F-box protein 28	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312107	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of FBXO28 mRNA	PMID:32763439
1304584	Fbxo28	F-box protein 28	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312107	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXO28 mRNA	PMID:38568856
1304584	Fbxo28	F-box protein 28	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO28 mRNA	PMID:39836092
1304584	Fbxo28	F-box protein 28	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312107	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXO28 promoter	PMID:27901495
1304584	Fbxo28	F-box protein 28	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXO28 mRNA	PMID:18593933
1304584	Fbxo28	F-box protein 28	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1312107	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of FBXO28 gene	PMID:31601247
1304584	Fbxo28	F-box protein 28	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO28 gene	PMID:31601247
1304584	Fbxo28	F-box protein 28	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of FBXO28 mRNA	PMID:23411599|PMID:34492290
1304584	Fbxo28	F-box protein 28	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO28 mRNA	PMID:25181051
1304584	Fbxo28	F-box protein 28	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of FBXO28 mRNA	PMID:30816183|PMID:32528016
1304584	Fbxo28	F-box protein 28	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312107	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of FBXO28 gene	PMID:31601247
1304584	Fbxo28	F-box protein 28	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO28 gene	PMID:31601247
1304584	Fbxo28	F-box protein 28	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA	PMID:19244175
1304584	Fbxo28	F-box protein 28	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312107	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FBXO28 mRNA	PMID:38174414|PMID:38568856
1304584	Fbxo28	F-box protein 28	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1549977	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO28 mRNA	PMID:37236586
1304584	Fbxo28	F-box protein 28	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of FBXO28 gene	PMID:22079235
1304584	Fbxo28	F-box protein 28	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FBXO28 mRNA	PMID:19244175
1304584	Fbxo28	F-box protein 28	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA	PMID:19244175
1304584	Fbxo28	F-box protein 28	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FBXO28 mRNA	PMID:28302478
1304584	Fbxo28	F-box protein 28	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312107	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO28 mRNA	PMID:25979313
1304584	Fbxo28	F-box protein 28	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXO28 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1304584	Fbxo28	F-box protein 28	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1549977	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXO28 mRNA	PMID:21427059
1304584	Fbxo28	F-box protein 28	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of FBXO28 mRNA	PMID:24935251
1304584	Fbxo28	F-box protein 28	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FBXO28 mRNA	PMID:21420995
1304584	Fbxo28	F-box protein 28	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312107	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO28 mRNA	PMID:39836092
1304584	Fbxo28	F-box protein 28	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1312107	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of FBXO28 mRNA	PMID:23228038
1304584	Fbxo28	F-box protein 28	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of FBXO28 mRNA	PMID:30307764
1304584	Fbxo28	F-box protein 28	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of FBXO28 mRNA	PMID:19564919
1304584	Fbxo28	F-box protein 28	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1549977	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FBXO28 mRNA	PMID:22206623
1304584	Fbxo28	F-box protein 28	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312107	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO28 mRNA	PMID:30851411
1304584	Fbxo28	F-box protein 28	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312107	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of FBXO28 mRNA	PMID:24921660
1304584	Fbxo28	F-box protein 28	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FBXO28 mRNA	PMID:21346803
1304584	Fbxo28	F-box protein 28	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FBXO28 mRNA	PMID:23034163
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:132098	methoxyacetic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of LYSMD2 mRNA	PMID:20864626
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LYSMD2 mRNA]	PMID:31150632
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1605838	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of LYSMD2 protein	PMID:36641056
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LYSMD2 mRNA	PMID:20938992
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605838	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of LYSMD2 mRNA	PMID:23724009
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1605838	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of LYSMD2 mRNA	PMID:21632981
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LYSMD2 mRNA	PMID:35811015
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of LYSMD2 mRNA	PMID:32145629
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605838	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LYSMD2 mRNA	PMID:31614463
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1605838	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of LYSMD2 mRNA	PMID:38568856
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1553061	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of LYSMD2 mRNA	PMID:25549359
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LYSMD2 mRNA	PMID:20938992
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LYSMD2 mRNA	PMID:37992649
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LYSMD2 mRNA	PMID:37992649
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1605838	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of LYSMD2 protein	PMID:37730182
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LYSMD2 mRNA	PMID:33387578
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LYSMD2 mRNA	PMID:36331819
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605838	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LYSMD2 gene	PMID:27153756
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1605838	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LYSMD2 mRNA	PMID:21641981
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1553061	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of LYSMD2 mRNA	PMID:12763052
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LYSMD2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of LYSMD2 mRNA	PMID:34911549
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LYSMD2 mRNA	PMID:31150632
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1553061	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LYSMD2 mRNA	PMID:31919559
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LYSMD2 mRNA]	PMID:31150632
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LYSMD2 mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of LYSMD2 mRNA]	PMID:20938992|PMID:22206623
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1605838	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LYSMD2 gene	PMID:25304211
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of LYSMD2 mRNA	PMID:38460933
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of LYSMD2 mRNA	PMID:20864626
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1605838	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of LYSMD2 mRNA	PMID:28903495
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1605838	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of LYSMD2 mRNA	PMID:27392435
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of LYSMD2 mRNA	PMID:27392435
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1605838	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LYSMD2 mRNA	PMID:24768652|PMID:25583101
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LYSMD2 mRNA	PMID:22298810|PMID:34747641
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553061	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LYSMD2 mRNA	PMID:21570461
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1605838	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LYSMD2 mRNA	PMID:20106945
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LYSMD2 mRNA	PMID:20864626
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of LYSMD2 mRNA	PMID:30556269
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1553061	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of LYSMD2 mRNA	PMID:27862939
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LYSMD2 mRNA	PMID:37992649
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1605838	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of LYSMD2 protein	PMID:35688186
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605838	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LYSMD2 mRNA	PMID:38568856
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605838	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LYSMD2 5' UTR	PMID:27901495
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1553061	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LYSMD2 mRNA	PMID:19770486
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605838	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LYSMD2 exon	PMID:27901495
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553061	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LYSMD2 mRNA	PMID:22228805|PMID:22610609|PMID:32417428
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605838	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LYSMD2 mRNA	PMID:21632981
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605838	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LYSMD2 promoter	PMID:27901495
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of LYSMD2 mRNA	PMID:30556269
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of LYSMD2 mRNA	PMID:24136188
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1553061	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of LYSMD2 mRNA	PMID:29264374
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LYSMD2 mRNA	PMID:23411599|PMID:34492290
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1553061	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of LYSMD2 mRNA	PMID:19136022
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553061	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of LYSMD2 mRNA	PMID:23811191
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LYSMD2 mRNA	PMID:25181051|PMID:32145629
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1605838	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of LYSMD2 gene	PMID:31601247
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1553061	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of LYSMD2 mRNA	PMID:24535843
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605838	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LYSMD2 mRNA	PMID:37042841
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1553061	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of LYSMD2 mRNA	PMID:26377693
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605838	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LYSMD2 mRNA	PMID:21457566
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1553061	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of LYSMD2 mRNA	PMID:24183702
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1605838	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LYSMD2 mRNA	PMID:24449571
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1553061	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of LYSMD2 mRNA	PMID:28962523
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1605838	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LYSMD2 mRNA	PMID:31533062
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:39178	clothianidin	decreases expression	ISO	RGD:1605838	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in decreased expression of LYSMD2 mRNA	PMID:31626844
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LYSMD2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of LYSMD2 mRNA	PMID:36331819
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of LYSMD2 mRNA	PMID:25993096
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605838	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of LYSMD2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYSMD2 mRNA	PMID:27188386
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1605838	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of LYSMD2 promoter	PMID:27989131
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605838	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of LYSMD2 mRNA	PMID:20106945|PMID:21632981
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1553061	E	RGD:6480464	20190219	CTD	MESH:C017160	cypermethrin results in increased expression of LYSMD2 mRNA	PMID:29020013
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553061	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of LYSMD2 mRNA	PMID:17555576
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1553061	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of LYSMD2 mRNA	PMID:25123088
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LYSMD2 mRNA	PMID:37992649
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1605838	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of LYSMD2 mRNA	PMID:26272509
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYSMD2 mRNA	PMID:27188386
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553061	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LYSMD2 mRNA	PMID:17562736
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LYSMD2 mRNA	PMID:33387578
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LYSMD2 mRNA	PMID:35811015
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of LYSMD2 mRNA	PMID:38460933
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1605838	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LYSMD2 gene	PMID:25304211
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1605838	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of LYSMD2 mRNA	PMID:31838189
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1553061	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of LYSMD2 mRNA	PMID:17555576
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of LYSMD2 mRNA	PMID:17557909
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553061	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of LYSMD2 mRNA	PMID:25554681
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of LYSMD2 mRNA	PMID:24793618
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of LYSMD2 mRNA	PMID:24136188
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of LYSMD2 mRNA	PMID:24136188
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1553061	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of LYSMD2 mRNA	PMID:36907384
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1605838	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of LYSMD2 mRNA	PMID:31758290
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553061	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LYSMD2 mRNA	PMID:22206623
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553061	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of LYSMD2 mRNA]	PMID:22206623
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYSMD2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYSMD2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYSMD2 mRNA	PMID:27188386
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LYSMD2 gene]	PMID:28238834
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1553061	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of LYSMD2 mRNA	PMID:19136022
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1553061	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of LYSMD2 mRNA	PMID:30294300
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1553061	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of LYSMD2 mRNA	PMID:21278054
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1605838	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of LYSMD2 mRNA	PMID:26272509
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYSMD2 mRNA	PMID:27188386
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:88522	Monobutylphthalate	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of LYSMD2 mRNA	PMID:20864626
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605838	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYSMD2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYSMD2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYSMD2 mRNA	PMID:27188386
1304585	Lysmd2	LysM domain containing 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LYSMD2 mRNA	PMID:21346803
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of ABCA12 mRNA	PMID:31016361
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ABCA12 mRNA	PMID:23724009
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1620735	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ABCA12 mRNA	PMID:36189433
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ABCA12 mRNA	PMID:26079696
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312110	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ABCA12 mRNA	PMID:22378314
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312110	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ABCA12 mRNA	PMID:21632981
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312110	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ABCA12 mRNA	PMID:35811015
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ABCA12 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ABCA12 mRNA	PMID:35811015
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of ABCA12 mRNA	PMID:19619570|PMID:21185374
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ABCA12 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of ABCA12 mRNA	PMID:19619570|PMID:30165855
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ABCA12 mRNA	PMID:38568856
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:16602	trichloroethene	affects response to substance	ISO	RGD:1312110	E	RGD:6480464	20140114	CTD	MESH:D014241	ABCA12 affects the susceptibility to Trichloroethylene	PMID:23994554
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312110	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ABCA12 mRNA	PMID:23649840
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1620735	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ABCA12 mRNA	PMID:22401849
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1620735	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ABCA12 mRNA	PMID:36189433
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ABCA12 mRNA	PMID:21592394
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of ABCA12 mRNA	PMID:21592394
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of ABCA12 mRNA	PMID:21592394
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of ABCA12 mRNA	PMID:21592394
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ABCA12 mRNA	PMID:33387578
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312110	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ABCA12 mRNA	PMID:23649840
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312110	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ABCA12 protein	PMID:20106945
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312110	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ABCA12 gene	PMID:27153756
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312110	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABCA12 mRNA	PMID:22100608|PMID:32234424
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312110	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ABCA12 mRNA	PMID:23649840
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of ABCA12 mRNA	PMID:28534445
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCA12 mRNA	PMID:32525701
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1312110	E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of ABCA12 mRNA	PMID:38460933
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ABCA12 mRNA	PMID:38460933
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312110	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ABCA12 mRNA	PMID:27392435
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ABCA12 mRNA	PMID:27392435
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ABCA12 mRNA	PMID:19619570|PMID:20106945
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312110	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABCA12 mRNA	PMID:23152189
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ABCA12 mRNA	PMID:19619570
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ABCA12 mRNA	PMID:33212167
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABCA12 mRNA	PMID:30851411
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1312110	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of ABCA12 mRNA	PMID:23649840
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:28445	vincristine	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20161213	CTD	MESH:D014750	[Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCA12 mRNA	PMID:19944135
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1312110	E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ABCA12 intron	PMID:32844245
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312110	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ABCA12 mRNA	PMID:29301061|PMID:32844245|PMID:39719251
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312110	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ABCA12 3' UTR	PMID:27901495
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312110	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCA12 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:32234424
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312110	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased expression of ABCA12 mRNA	PMID:23974009
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1312110	E	RGD:6480464	20170103	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of ABCA12 mRNA	PMID:25377654
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ABCA12 gene	PMID:31601247
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCA12 mRNA	PMID:25181051
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCA12 mRNA	PMID:22576693
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312110	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ABCA12 gene	PMID:31601247
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312110	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of ABCA12 gene	PMID:22576693
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ABCA12 gene	PMID:31601247
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1620735	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ABCA12 mRNA	PMID:26377693
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1620735	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ABCA12 intron	PMID:28392331
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ABCA12 mRNA	PMID:38568856
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312110	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ABCA12 mRNA	PMID:38174414
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:36015	1,1,1-trichloroethane	increases expression	ISO	RGD:1620735	E	RGD:6480464	20150127	CTD	MESH:C024566	1,1,1-trichloroethane results in increased expression of ABCA12 mRNA	PMID:25270620
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312110	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABCA12 mRNA	PMID:32588087
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620735	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABCA12 mRNA	PMID:40194260
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312110	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ABCA12 gene	PMID:29154799
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312110	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ABCA12 mRNA	PMID:20106945
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1312110	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ABCA12 mRNA	PMID:23649840
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCA12 mRNA	PMID:33387578
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCA12 mRNA	PMID:29067470
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312110	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ABCA12 mRNA	PMID:24714768
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ABCA12 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ABCA12 mRNA	PMID:35811015
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:46742	Nutlin-3	increases expression	ISO	RGD:1312110	E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of ABCA12 mRNA	PMID:38460933
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ABCA12 mRNA	PMID:38460933
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCA12 mRNA	PMID:32525701
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:51052	lucanthone	increases expression	ISO	RGD:1312110	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in increased expression of ABCA12 mRNA	PMID:21148553
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1620735	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ABCA12 mRNA	PMID:23608068
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1620735	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ABCA12 mRNA	PMID:22206623
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of ABCA12 mRNA	PMID:36318118
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20260714	CTD	MESH:D000077143	[Docetaxel results in decreased susceptibility to Docetaxel] which affects the expression of ABCA12 mRNA	PMID:19944135
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312110	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABCA12 mRNA	PMID:30851411
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ABCA12 gene]	PMID:28238834
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312110	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCA12 mRNA	PMID:32525701
1304586	Abca12	ATP binding cassette subfamily A member 12	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1312110	E	RGD:6480464	20150512	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of ABCA12 mRNA	PMID:25377654
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of C10H1ORF35 mRNA	PMID:22967744
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312112	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of C1ORF35 protein	PMID:37730182
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312112	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of C1ORF35 mRNA	PMID:19549813
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312112	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of C1ORF35 protein	PMID:23301498
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312112	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of C1ORF35 mRNA	PMID:35430440
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312112	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of C1ORF35 gene	PMID:25304211
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of C10H1ORF35 mRNA	PMID:22298810
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312112	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of C1ORF35 protein	PMID:33212167
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of C10H1ORF35 mRNA	PMID:28959563
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of C10H1ORF35 mRNA	PMID:30556269
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:28748	doxorubicin	increases oxidation	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin results in increased oxidation of C10H1ORF35 protein	PMID:28818578
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312112	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of C1ORF35 mRNA	PMID:39719251
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312112	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C1ORF35 promoter	PMID:27901495
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of C10H1ORF35 mRNA	PMID:30556269
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312112	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased expression of C1ORF35 mRNA	PMID:34973136
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of C1ORF35 mRNA	PMID:25181051
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1312112	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of C1ORF35 mRNA	PMID:16584549
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312112	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of C1ORF35 gene	PMID:25304211
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of C10H1ORF35 mRNA	PMID:29391264
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of C10H1ORF35 mRNA	PMID:17557909
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312112	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of C1ORF35 protein	PMID:32959892
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312112	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of C1ORF35 mRNA	PMID:37199045
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312112	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of C1ORF35 protein	PMID:31285264
1304587	C10h1orf35	similar to human chromosome 1 open reading frame 35	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of C10H1ORF35 mRNA	PMID:23034163
1304588	Lpin2	lipin 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of LPIN2 mRNA	PMID:33045310
1304588	Lpin2	lipin 2	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of LPIN2 mRNA	PMID:39506029
1304588	Lpin2	lipin 2	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1312114	E	RGD:6480464	20190312	CTD	MESH:D019301	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA; [GW 4064 co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA	PMID:30611723
1304588	Lpin2	lipin 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312115	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of LPIN2 mRNA	PMID:30319688
1304588	Lpin2	lipin 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LPIN2 mRNA	PMID:39241906
1304588	Lpin2	lipin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of LPIN2 mRNA	PMID:19484750|PMID:39298647
1304588	Lpin2	lipin 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312115	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of LPIN2 mRNA	PMID:25549359
1304588	Lpin2	lipin 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312115	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of LPIN2 mRNA	PMID:28973375
1304588	Lpin2	lipin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LPIN2 mRNA	PMID:19850644
1304588	Lpin2	lipin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20180116	CTD	MESH:D004051	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LPIN2 mRNA	PMID:28433925
1304588	Lpin2	lipin 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312114	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LPIN2 protein	PMID:37730182
1304588	Lpin2	lipin 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312114	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LPIN2 intron	PMID:30157460
1304588	Lpin2	lipin 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LPIN2 mRNA	PMID:36331819
1304588	Lpin2	lipin 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312114	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1304588	Lpin2	lipin 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LPIN2 mRNA	PMID:37236586
1304588	Lpin2	lipin 2	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of LPIN2 mRNA	PMID:21396975
1304588	Lpin2	lipin 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312114	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LPIN2 gene	PMID:27153756
1304588	Lpin2	lipin 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312114	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of LPIN2 mRNA	PMID:23649840
1304588	Lpin2	lipin 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312115	E	RGD:6480464	20120501	CTD	MESH:D010126	Ozone results in increased expression of LPIN2 mRNA	PMID:17095637|PMID:19555225
1304588	Lpin2	lipin 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LPIN2 mRNA	PMID:34911549
1304588	Lpin2	lipin 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of LPIN2 mRNA	PMID:17484886|PMID:31919559
1304588	Lpin2	lipin 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LPIN2 mRNA	PMID:25629700
1304588	Lpin2	lipin 2	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of LPIN2 mRNA	PMID:19654921
1304588	Lpin2	lipin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312114	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1304588	Lpin2	lipin 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312114	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of LPIN2 protein	PMID:35688186
1304588	Lpin2	lipin 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LPIN2 mRNA	PMID:28189721|PMID:28960355
1304588	Lpin2	lipin 2	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of LPIN2 mRNA	PMID:25905778
1304588	Lpin2	lipin 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312114	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of LPIN2 mRNA	PMID:27594783
1304588	Lpin2	lipin 2	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1312115	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of LPIN2 mRNA	PMID:34813904
1304588	Lpin2	lipin 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of LPIN2 mRNA	PMID:30912803
1304588	Lpin2	lipin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312115	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LPIN2 mRNA	PMID:21570461
1304588	Lpin2	lipin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LPIN2 mRNA	PMID:21215274|PMID:33387578
1304588	Lpin2	lipin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312115	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LPIN2 mRNA	PMID:15328365|PMID:15800033|PMID:16611356|PMID:19770486|PMID:21889950|PMID:23864506|PMID:23994337|PMID:25975270|PMID:26290441|PMID:28213091|PMID:28238261
1304588	Lpin2	lipin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20150825	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LPIN2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LPIN2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LPIN2 gene]	PMID:25975270|PMID:28213091|PMID:28433925
1304588	Lpin2	lipin 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of LPIN2 mRNA	PMID:28374803
1304588	Lpin2	lipin 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LPIN2 mRNA	PMID:30851411
1304588	Lpin2	lipin 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of LPIN2 mRNA	PMID:27862939
1304588	Lpin2	lipin 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LPIN2 mRNA	PMID:29803840
1304588	Lpin2	lipin 2	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312114	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of LPIN2 protein	PMID:35688186
1304588	Lpin2	lipin 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312114	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of LPIN2 mRNA	PMID:34032870
1304588	Lpin2	lipin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of LPIN2 mRNA	PMID:37956786
1304588	Lpin2	lipin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of LPIN2 mRNA	PMID:39515575
1304588	Lpin2	lipin 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312114	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LPIN2 mRNA	PMID:38568856
1304588	Lpin2	lipin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312114	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1304588	Lpin2	lipin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LPIN2 mRNA	PMID:32234424
1304588	Lpin2	lipin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312115	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LPIN2 mRNA	PMID:19770486|PMID:21569818|PMID:21964900
1304588	Lpin2	lipin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312114	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LPIN2 promoter	PMID:27901495
1304588	Lpin2	lipin 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312114	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LPIN2 mRNA]	PMID:32406909
1304588	Lpin2	lipin 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312114	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of LPIN2 mRNA	PMID:23806026
1304588	Lpin2	lipin 2	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312114	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of LPIN2 gene	PMID:31601247
1304588	Lpin2	lipin 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of LPIN2 mRNA	PMID:23557971
1304588	Lpin2	lipin 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of LPIN2 mRNA	PMID:34492290
1304588	Lpin2	lipin 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312115	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of LPIN2 mRNA	PMID:17426115|PMID:18301758|PMID:18445702|PMID:19850644|PMID:20813756|PMID:23811191
1304588	Lpin2	lipin 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LPIN2 mRNA; PPARA protein promotes the reaction [pirinixic acid results in decreased expression of LPIN2 mRNA]	PMID:19710929|PMID:19850644
1304588	Lpin2	lipin 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312114	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of LPIN2 mRNA	PMID:30903817
1304588	Lpin2	lipin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LPIN2 mRNA	PMID:25181051
1304588	Lpin2	lipin 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LPIN2 mRNA	PMID:30816183|PMID:32528016
1304588	Lpin2	lipin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312115	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of LPIN2 mRNA	PMID:34585602
1304588	Lpin2	lipin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20180116	CTD	MESH:C006780	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LPIN2 mRNA	PMID:28433925
1304588	Lpin2	lipin 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312114	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LPIN2 mRNA	PMID:25979313
1304588	Lpin2	lipin 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20180116	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LPIN2 mRNA	PMID:28433925
1304588	Lpin2	lipin 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1312115	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LPIN2 mRNA	PMID:23994337
1304588	Lpin2	lipin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LPIN2 mRNA	PMID:39298647
1304588	Lpin2	lipin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312115	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of LPIN2 mRNA	PMID:40203079
1304588	Lpin2	lipin 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of LPIN2 mRNA	PMID:28392331
1304588	Lpin2	lipin 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312115	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LPIN2 intron	PMID:28392331
1304588	Lpin2	lipin 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LPIN2 mRNA	PMID:32715474
1304588	Lpin2	lipin 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312114	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of LPIN2 gene	PMID:22964155
1304588	Lpin2	lipin 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LPIN2 mRNA	PMID:21266533
1304588	Lpin2	lipin 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312115	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of LPIN2 mRNA	PMID:34813904
1304588	Lpin2	lipin 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in decreased expression of LPIN2 mRNA	PMID:17215068
1304588	Lpin2	lipin 2	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of LPIN2 mRNA	PMID:12242611
1304588	Lpin2	lipin 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of LPIN2 mRNA	PMID:17215068
1304588	Lpin2	lipin 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312114	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LPIN2 mRNA	PMID:37042841
1304588	Lpin2	lipin 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of LPIN2 mRNA	PMID:30589522
1304588	Lpin2	lipin 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312114	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1304588	Lpin2	lipin 2	gene	CHEBI:35176	zinc sulfate	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of LPIN2 mRNA	PMID:16330358
1304588	Lpin2	lipin 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of LPIN2 mRNA	PMID:30723492
1304588	Lpin2	lipin 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LPIN2 mRNA	PMID:33453195
1304588	Lpin2	lipin 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LPIN2 mRNA	PMID:37236586
1304588	Lpin2	lipin 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312115	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of LPIN2 mRNA	PMID:28903501
1304588	Lpin2	lipin 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312115	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of LPIN2 mRNA	PMID:28962523
1304588	Lpin2	lipin 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312115	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of LPIN2 mRNA	PMID:18353800
1304588	Lpin2	lipin 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312115	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of LPIN2 mRNA	PMID:23811191
1304588	Lpin2	lipin 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of LPIN2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LPIN2 mRNA]	PMID:17585979
1304588	Lpin2	lipin 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312114	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LPIN2 mRNA	PMID:31533062
1304588	Lpin2	lipin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LPIN2 mRNA	PMID:36331819
1304588	Lpin2	lipin 2	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1312115	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of LPIN2 mRNA	PMID:29038090
1304588	Lpin2	lipin 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312115	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of LPIN2 mRNA	PMID:23125180
1304588	Lpin2	lipin 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of LPIN2 mRNA	PMID:38685447|PMID:41580965
1304588	Lpin2	lipin 2	gene	CHEBI:40303	lovastatin	decreases response to substance	ISO	RGD:1312114	E	RGD:6480464	20120501	CTD	MESH:D008148	LPIN2 SNP results in decreased susceptibility to Lovastatin	PMID:21483694
1304588	Lpin2	lipin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of LPIN2 mRNA	PMID:20106945
1304588	Lpin2	lipin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of LPIN2 mRNA	PMID:19770486
1304588	Lpin2	lipin 2	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1312114	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of LPIN2 promoter	PMID:27989131
1304588	Lpin2	lipin 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312114	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LPIN2 mRNA	PMID:25562108
1304588	Lpin2	lipin 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312115	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of LPIN2 mRNA	PMID:28973697
1304588	Lpin2	lipin 2	gene	CHEBI:43602	obeticholic acid	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of LPIN2 mRNA	PMID:27939613
1304588	Lpin2	lipin 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LPIN2 mRNA	PMID:38832940
1304588	Lpin2	lipin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LPIN2 mRNA	PMID:17562736
1304588	Lpin2	lipin 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of LPIN2 mRNA	PMID:21420995
1304588	Lpin2	lipin 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of LPIN2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LPIN2 mRNA]	PMID:17585979
1304588	Lpin2	lipin 2	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of LPIN2 mRNA	PMID:19654921
1304588	Lpin2	lipin 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312114	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1304588	Lpin2	lipin 2	gene	CHEBI:47318	6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	multiple interactions	ISO	RGD:1312114	E	RGD:6480464	20190312	CTD	MESH:C475093	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA	PMID:30611723
1304588	Lpin2	lipin 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of LPIN2 mRNA	PMID:30529165
1304588	Lpin2	lipin 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LPIN2 mRNA	PMID:29391264
1304588	Lpin2	lipin 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of LPIN2 mRNA	PMID:35436446
1304588	Lpin2	lipin 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LPIN2 mRNA; Nanotubes, Carbon results in decreased expression of LPIN2 mRNA	PMID:25554681|PMID:25620056
1304588	Lpin2	lipin 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of LPIN2 mRNA	PMID:41580965
1304588	Lpin2	lipin 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312114	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1304588	Lpin2	lipin 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of LPIN2 mRNA	PMID:15336504
1304588	Lpin2	lipin 2	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin results in decreased expression of LPIN2 mRNA	PMID:31324951
1304588	Lpin2	lipin 2	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of LPIN2 mRNA	PMID:30467583
1304588	Lpin2	lipin 2	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of LPIN2 mRNA	PMID:17383702
1304588	Lpin2	lipin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LPIN2 mRNA	PMID:22206623
1304588	Lpin2	lipin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LPIN2 mRNA	PMID:27840820
1304588	Lpin2	lipin 2	gene	CHEBI:7438	N-methylformamide	increases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in increased expression of LPIN2 mRNA; methylformamide results in increased expression of LPIN2 mRNA	PMID:17040096
1304588	Lpin2	lipin 2	gene	CHEBI:749301	potassium perchlorate	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of LPIN2 mRNA	PMID:29673971
1304588	Lpin2	lipin 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312115	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of LPIN2 mRNA	PMID:23994337
1304588	Lpin2	lipin 2	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of LPIN2 mRNA	PMID:23665939
1304588	Lpin2	lipin 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LPIN2 mRNA	PMID:30851411
1304588	Lpin2	lipin 2	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20190312	CTD	MESH:C412815	GW 4064 results in decreased expression of LPIN2 mRNA	PMID:30611723
1304588	Lpin2	lipin 2	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1312114	E	RGD:6480464	20190312	CTD	MESH:C412815	[GW 4064 co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA	PMID:30611723
1304588	Lpin2	lipin 2	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1312114	E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of LPIN2 mRNA	PMID:19682730
1304588	Lpin2	lipin 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of LPIN2 mRNA	PMID:19270015|PMID:19850644|PMID:23091169
1304588	Lpin2	lipin 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein promotes the reaction [Phenobarbital results in decreased expression of LPIN2 mRNA]	PMID:19850644
1304588	Lpin2	lipin 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of LPIN2 mRNA	PMID:27291303
1304588	Lpin2	lipin 2	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of LPIN2 mRNA	PMID:26377693
1304588	Lpin2	lipin 2	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	Streptozocin results in increased expression of LPIN2 mRNA	PMID:25905778
1304588	Lpin2	lipin 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LPIN2 mRNA	PMID:21346803
1304588	Lpin2	lipin 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of LPIN2 mRNA	PMID:28973697
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312116	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of SNAPC2 mRNA	PMID:22378314
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312116	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNAPC2 mRNA	PMID:37042841
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312117	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNAPC2 mRNA	PMID:33754040
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SNAPC2 mRNA	PMID:33387578
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312116	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SNAPC2 mRNA	PMID:28818685
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNAPC2 mRNA	PMID:36331819
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312116	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA	PMID:39836092
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312116	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of SNAPC2 mRNA	PMID:23369406
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNAPC2 mRNA	PMID:22206623
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312116	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC2 mRNA	PMID:39836092
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of SNAPC2 mRNA	PMID:20187946
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312117	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNAPC2 mRNA	PMID:21570461
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNAPC2 mRNA	PMID:16467188
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNAPC2 mRNA	PMID:33387578
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SNAPC2 mRNA	PMID:17942748
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312116	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNAPC2 mRNA	PMID:29803840
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312116	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SNAPC2 mRNA	PMID:38568856|PMID:39719251
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312116	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC2 mRNA	PMID:39836092
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312116	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SNAPC2 promoter	PMID:27901495
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312116	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SNAPC2 gene	PMID:31601247
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312117	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNAPC2 gene	PMID:35295148
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SNAPC2 mRNA	PMID:18648102
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312117	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SNAPC2 promoter	PMID:27334623
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SNAPC2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312117	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SNAPC2 gene	PMID:31683443
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312117	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SNAPC2 mRNA	PMID:39298647
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312117	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SNAPC2 mRNA	PMID:37019170
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312116	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SNAPC2 gene	PMID:22964155
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312117	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SNAPC2 mRNA	PMID:17361019|PMID:21266533
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312116	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA	PMID:39836092
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of SNAPC2 mRNA	PMID:18500788
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of SNAPC2 promoter	PMID:22457795
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNAPC2 mRNA	PMID:36331819
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312116	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SNAPC2 gene	PMID:29154799
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SNAPC2 mRNA	PMID:17555576
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNAPC2 mRNA	PMID:17562736
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNAPC2 mRNA	PMID:33387578
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312116	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of SNAPC2 mRNA	PMID:29067470
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312116	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC2 mRNA	PMID:39836092
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SNAPC2 mRNA	PMID:17555576
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1312117	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of SNAPC2 mRNA	PMID:16467188|PMID:17942748
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SNAPC2 mRNA	PMID:17942748
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SNAPC2 mRNA	PMID:35964746
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312116	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA	PMID:39836092
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312116	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SNAPC2 mRNA	PMID:31758290
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312117	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SNAPC2 mRNA	PMID:22206623
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNAPC2 mRNA	PMID:22206623
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SNAPC2 mRNA	PMID:23640034
1304589	Snapc2	small nuclear RNA activating complex, polypeptide 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SNAPC2 mRNA	PMID:23034163
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1346377	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RAP1GAP2 mRNA	PMID:26272509
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAP1GAP2 mRNA	PMID:27188386
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of RAP1GAP2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RAP1GAP2 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RAP1GAP2 mRNA	PMID:20938992
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312118	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of RAP1GAP2 mRNA	PMID:16169686
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1346377	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RAP1GAP2 mRNA	PMID:26516004
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1346377	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RAP1GAP2 mRNA	PMID:26079696
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of RAP1GAP2 gene	PMID:28931070
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of RAP1GAP2 mRNA	PMID:30319688
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312118	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAP1GAP2 mRNA	PMID:39241906
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of RAP1GAP2 mRNA	PMID:30165855
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312118	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of RAP1GAP2 mRNA	PMID:29980752
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RAP1GAP2 mRNA	PMID:33387578
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of RAP1GAP2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RAP1GAP2 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RAP1GAP2 mRNA	PMID:20938992
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1346377	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RAP1GAP2 mRNA	PMID:21179406
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAP1GAP2 mRNA	PMID:37992649
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312118	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of RAP1GAP2 mRNA	PMID:33848595
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAP1GAP2 mRNA	PMID:37992649
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1346377	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RAP1GAP2 mRNA	PMID:31163220
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of RAP1GAP2 mRNA	PMID:31606821
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1346377	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RAP1GAP2 protein	PMID:37730182
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1346377	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of RAP1GAP2 mRNA	PMID:26485663
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1346377	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of RAP1GAP2 intron	PMID:30157460
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAP1GAP2 mRNA	PMID:39836092
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1346377	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of RAP1GAP2 mRNA	PMID:28860664
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RAP1GAP2 mRNA	PMID:37236586
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1346377	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of RAP1GAP2 intron	PMID:30157460
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312118	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RAP1GAP2 mRNA	PMID:19770486
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1346377	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RAP1GAP2 exon	PMID:30157460
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RAP1GAP2 mRNA	PMID:35430440
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312118	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RAP1GAP2 mRNA	PMID:17484886
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of RAP1GAP2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RAP1GAP2 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RAP1GAP2 mRNA	PMID:20938992
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1346377	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RAP1GAP2 gene	PMID:25304211
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAP1GAP2 mRNA	PMID:40504410
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAP1GAP2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAP1GAP2 mRNA	PMID:32525701|PMID:39836092
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1346377	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RAP1GAP2 protein	PMID:35688186
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RAP1GAP2 mRNA	PMID:31881176
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1346377	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of RAP1GAP2 mRNA	PMID:27392435|PMID:27594783
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RAP1GAP2 mRNA	PMID:27392435
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312118	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAP1GAP2 mRNA	PMID:21570461|PMID:26377647
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAP1GAP2 mRNA	PMID:32109520
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAP1GAP2 mRNA	PMID:23238561
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312118	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAP1GAP2 mRNA	PMID:23238561
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of RAP1GAP2 intron] which results in decreased expression of RAP1GAP2 mRNA	PMID:33017471
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346377	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RAP1GAP2 mRNA	PMID:29803840
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAP1GAP2 mRNA	PMID:37992649
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1346377	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of RAP1GAP2 protein	PMID:35688186
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RAP1GAP2 mRNA	PMID:29432896
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	ISO	RGD:1346377	E	RGD:6480464	20120412	CTD	MESH:C028473	RAP1GAP2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312118	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite affects the methylation of RAP1GAP2 gene	PMID:39894169
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312118	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAP1GAP2 mRNA	PMID:37682722
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAP1GAP2 mRNA	PMID:40504410
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAP1GAP2 mRNA	PMID:39836092
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346377	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RAP1GAP2 exon; Benzo(a)pyrene affects the methylation of RAP1GAP2 intron; Benzo(a)pyrene affects the methylation of RAP1GAP2 promoter	PMID:27901495|PMID:30157460
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312118	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RAP1GAP2 mRNA	PMID:22228805
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1346377	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of RAP1GAP2 gene	PMID:25435355
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1346377	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RAP1GAP2 mRNA	PMID:25895662
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1346377	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RAP1GAP2 mRNA	PMID:19150397
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312118	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of RAP1GAP2 mRNA	PMID:39716349
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RAP1GAP2 mRNA	PMID:25729387
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RAP1GAP2 mRNA	PMID:30047161
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312118	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RAP1GAP2 gene	PMID:35295148
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312118	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RAP1GAP2 gene	PMID:35295148
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RAP1GAP2 mRNA	PMID:34492290
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RAP1GAP2 mRNA	PMID:19710929
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RAP1GAP2 mRNA	PMID:25181051
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1346377	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of RAP1GAP2 gene	PMID:31601247
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RAP1GAP2 mRNA	PMID:34947998
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1346377	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RAP1GAP2 mRNA	PMID:29275510
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RAP1GAP2 mRNA	PMID:29097150
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312118	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RAP1GAP2 mRNA	PMID:34585602
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1346377	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of RAP1GAP2 mRNA	PMID:36232920
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAP1GAP2 gene	PMID:28505145
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312118	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RAP1GAP2 mRNA	PMID:40203079
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1346377	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RAP1GAP2 intron	PMID:30157460
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1346377	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RAP1GAP2 exon	PMID:30157460
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RAP1GAP2 mRNA	PMID:21266533
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1346377	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RAP1GAP2 mRNA	PMID:29024780
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RAP1GAP2 mRNA	PMID:35163327
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAP1GAP2 mRNA	PMID:39836092
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RAP1GAP2 mRNA	PMID:37236586
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RAP1GAP2 mRNA	PMID:35163327
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1346377	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of RAP1GAP2 mRNA	PMID:28302478
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1346377	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RAP1GAP2 mRNA	PMID:31533062
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of RAP1GAP2 mRNA	PMID:29427782
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RAP1GAP2 mRNA	PMID:30047161
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346377	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RAP1GAP2 mRNA	PMID:25562108
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAP1GAP2 mRNA	PMID:37992649
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1346377	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RAP1GAP2 mRNA	PMID:38832940
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1346377	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of RAP1GAP2 mRNA	PMID:27188386
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RAP1GAP2 mRNA	PMID:33387578
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1346377	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of RAP1GAP2 mRNA	PMID:29067470
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1346377	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RAP1GAP2 gene	PMID:25304211
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAP1GAP2 mRNA	PMID:40504410
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAP1GAP2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAP1GAP2 mRNA	PMID:32525701|PMID:39836092
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312118	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of RAP1GAP2 mRNA	PMID:39716349
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of RAP1GAP2 mRNA	PMID:30307764
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312118	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RAP1GAP2 mRNA	PMID:38701926
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RAP1GAP2 mRNA	PMID:39836092
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of RAP1GAP2 mRNA	PMID:25729387
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RAP1GAP2 mRNA	PMID:25729387
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1312118	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of RAP1GAP2 mRNA	PMID:36907384
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1346377	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RAP1GAP2 intron	PMID:30157460
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1346377	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RAP1GAP2 exon	PMID:30157460
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RAP1GAP2 gene	PMID:35440735
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1346377	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RAP1GAP2 mRNA	PMID:31758290
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAP1GAP2 mRNA	PMID:27188386
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312118	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RAP1GAP2 mRNA	PMID:39847705
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAP1GAP2 mRNA	PMID:32525701
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of RAP1GAP2 mRNA	PMID:30047161
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346377	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAP1GAP2 mRNA	PMID:27188386
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312118	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of RAP1GAP2 mRNA	PMID:31606821
1304590	Rap1gap2	RAP1 GTPase activating protein 2	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of RAP1GAP2 gene	PMID:31079544
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312120	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ART1 mRNA	PMID:33045310
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:17323	trans-pinosylvin	increases expression	ISO	RGD:1312119	E	RGD:6480464	20140805	CTD	MESH:C049032	pinosylvin results in increased expression of ART1 mRNA	PMID:23333577
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in increased expression of ART1 mRNA]	PMID:20032058
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ART1 mRNA	PMID:26577399|PMID:27523638
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1312119	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of ART1 mRNA	PMID:20823114
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312119	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ART1 mRNA	PMID:35301059
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of ART1 mRNA	PMID:17074742
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312120	E	RGD:6480464	20240206	CTD	MESH:D002945	ART1 protein inhibits the reaction [Cisplatin results in increased cleavage of PARP1 protein]	PMID:24676941
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ART1 mRNA	PMID:22298810
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312119	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ART1 mRNA	PMID:33212167
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ART1 mRNA	PMID:28959563
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312119	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ART1 mRNA	PMID:29301061
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312119	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ART1 promoter	PMID:27901495
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312120	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ART1 mRNA	PMID:22228805
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312119	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ART1 5' UTR	PMID:27901495
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of ART1 mRNA	PMID:17074742
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312119	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ART1 gene	PMID:31601247
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312120	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ART1 mRNA	PMID:23557971
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312120	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ART1 mRNA	PMID:18648102
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1312120	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ART1 gene	PMID:23968726
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312119	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ART1 gene	PMID:31601247
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ART1 mRNA	PMID:25181051
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312119	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ART1 gene	PMID:31601247
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312120	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ART1 exon	PMID:33297965
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312120	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ART1 mRNA	PMID:21266533
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312120	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ART1 gene	PMID:23968726
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of ART1 mRNA	PMID:35163327
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ART1 mRNA	PMID:35163327
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:35176	zinc sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of ART1 mRNA	PMID:17074742
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312119	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ART1 mRNA	PMID:35301059
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ART1 mRNA	PMID:35163327
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:36011	pinosylvin	increases expression	ISO	RGD:1312119	E	RGD:6480464	20140311	CTD	MESH:C049032	pinosylvin results in increased expression of ART1 mRNA	PMID:23333577
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312120	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of ART1 mRNA	PMID:17555576
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of ART1 mRNA	PMID:20032058
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312120	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of ART1 mRNA	PMID:22733784
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in increased expression of ART1 mRNA]	PMID:20032058
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ART1 mRNA	PMID:30307764
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1312120	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ART1 mRNA	PMID:27935865
1304591	Art1	ADP-ribosyltransferase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ART1 mRNA	PMID:24780913
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:132098	methoxyacetic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in increased expression of C2CD5 mRNA	PMID:20864626
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312121	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of C2CD5 mRNA	PMID:33045310
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:736134	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of C2CD5 mRNA	PMID:33167477
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of C2CD5 gene	PMID:28931070
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:736134	E	RGD:6480464	20141111	CTD	MESH:D001280	Atrazine results in decreased expression of C2CD5 mRNA	PMID:22378314
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:736134	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of C2CD5 mRNA	PMID:20044591
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:736134	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of C2CD5 protein	PMID:18951874
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:736134	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of C2CD5 mRNA	PMID:21632981
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:736134	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of C2CD5 protein	PMID:35688186
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312121	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of C2CD5 mRNA	PMID:39298647
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of C2CD5 mRNA	PMID:22967744
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:736134	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of C2CD5 protein	PMID:37730182
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:736134	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of C2CD5 mRNA	PMID:19549813
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:736134	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C2CD5 mRNA	PMID:39836092|PMID:40512198
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:736134	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of C2CD5 mRNA	PMID:19244175
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:736134	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of C2CD5 mRNA	PMID:33512557
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:736134	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of C2CD5 protein	PMID:35688186
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in increased expression of C2CD5 mRNA	PMID:20864626
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of C2CD5 mRNA	PMID:31881176
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312121	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of C2CD5 mRNA	PMID:32186404
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:736134	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of C2CD5 mRNA	PMID:23195993
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of C2CD5 mRNA	PMID:33387578
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:736134	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of C2CD5 protein	PMID:18951874
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of C2CD5 mRNA	PMID:20864626
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:736134	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of C2CD5 mRNA	PMID:33212167
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:736134	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of C2CD5 protein	PMID:35688186
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:736134	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of C2CD5 mRNA	PMID:20044591
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:736134	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of C2CD5 mRNA	PMID:38568856
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:736134	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C2CD5 mRNA	PMID:39836092|PMID:40512198
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:736134	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of C2CD5 mRNA	PMID:20064835
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of C2CD5 mRNA	PMID:21839799
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312121	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C2CD5 intron	PMID:27901495
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:736134	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of C2CD5 mRNA	PMID:25351596
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of C2CD5 mRNA	PMID:25729387
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of C2CD5 mRNA	PMID:30047161
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of C2CD5 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312121	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of C2CD5 mRNA	PMID:36117858
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:736134	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of C2CD5 mRNA	PMID:37042841
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:736134	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of C2CD5 mRNA	PMID:38174414|PMID:38568856
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of C2CD5 mRNA	PMID:24386269
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:736134	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of C2CD5 mRNA	PMID:19244175
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312121	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of C2CD5 mRNA	PMID:40194260
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:38604	pyrimidifen	decreases expression	ISO	RGD:736134	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of C2CD5 mRNA	PMID:33512557
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:736134	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of C2CD5 mRNA	PMID:28302478
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of C2CD5 mRNA	PMID:29427782
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:736134	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of C2CD5 mRNA	PMID:23179753
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:736134	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of C2CD5 gene	PMID:29154799
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of C2CD5 mRNA	PMID:30047161
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:736134	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of C2CD5 mRNA	PMID:20106945|PMID:25562108
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:736134	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of C2CD5 mRNA	PMID:33512557
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312121	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of C2CD5 mRNA	PMID:28973697
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:736134	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of C2CD5 mRNA	PMID:33512557
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of C2CD5 mRNA	PMID:33387578
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:736134	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of C2CD5 mRNA	PMID:21420995|PMID:29067470
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:736134	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C2CD5 mRNA	PMID:39836092|PMID:40512198
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:736134	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of C2CD5 mRNA	PMID:22079256
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312121	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of C2CD5 mRNA	PMID:35436446
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:5011	fenpyroximate	decreases expression	ISO	RGD:736134	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of C2CD5 mRNA	PMID:33512557
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of C2CD5 mRNA	PMID:24793618
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312121	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of C2CD5 mRNA	PMID:36117858
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of C2CD5 mRNA	PMID:25729387
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:736134	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of C2CD5 mRNA	PMID:28988120
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:736134	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of C2CD5 mRNA	PMID:22079256
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:736134	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of C2CD5 mRNA	PMID:22079256
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:81794	thifluzamide	decreases expression	ISO	RGD:736134	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of C2CD5 mRNA	PMID:33512557
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:736134	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of C2CD5 mRNA	PMID:33512557
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of C2CD5 mRNA	PMID:30047161
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in increased expression of C2CD5 mRNA	PMID:20864626
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:9422	tebufenpyrad	decreases expression	ISO	RGD:736134	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of C2CD5 mRNA	PMID:33512557
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:736134	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of C2CD5 mRNA	PMID:38568856
1304592	C2cd5	C2 calcium-dependent domain containing 5	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312121	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of C2CD5 mRNA	PMID:35537566
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1331924	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of INTS3 mRNA	PMID:33045310
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1331924	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of INTS3 mRNA	PMID:37995155
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1331924	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of INTS3 mRNA	PMID:20188158
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1331924	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of INTS3 mRNA	PMID:30319688
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of INTS3 mRNA	PMID:32145629
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1331924	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of INTS3 mRNA	PMID:34319233
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1603299	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of INTS3 protein	PMID:37730182
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of INTS3 protein	PMID:23301498
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1603299	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of INTS3 3' UTR; Aflatoxin B1 results in increased methylation of INTS3 gene	PMID:27153756|PMID:30157460
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of INTS3 mRNA	PMID:35430440
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1603299	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of INTS3 mRNA	PMID:22171008
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of INTS3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of INTS3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INTS3 mRNA	PMID:39836092|PMID:40512198
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1603299	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of INTS3 mRNA	PMID:19244175
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1603299	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of INTS3 protein	PMID:35688186
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1331924	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of INTS3 mRNA	PMID:28960355
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1331924	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of INTS3 protein	PMID:25505154
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of INTS3 mRNA	PMID:23557933
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1331924	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of INTS3 mRNA	PMID:30912803
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1331924	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of INTS3 mRNA	PMID:21570461
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1603299	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of INTS3 mRNA	PMID:32763439
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of INTS3 mRNA	PMID:28959563
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603299	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of INTS3 mRNA	PMID:29803840
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1331924	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of INTS3 mRNA	PMID:39631538
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603299	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of INTS3 mRNA	PMID:38568856
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603299	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of INTS3 mRNA	PMID:39719251
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of INTS3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of INTS3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INTS3 mRNA	PMID:39836092|PMID:40512198
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1331924	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of INTS3 mRNA	PMID:22228805
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603299	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of INTS3 promoter	PMID:27901495
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1603299	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of INTS3 mRNA	PMID:22171008
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1331924	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of INTS3 promoter	PMID:35295148
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of INTS3 mRNA	PMID:38479592
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of INTS3 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1331924	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of INTS3 mRNA	PMID:33221593
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of INTS3 mRNA	PMID:28628672
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1331924	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of INTS3 mRNA	PMID:34813904
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of INTS3 mRNA	PMID:28628672
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1331924	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of INTS3 mRNA	PMID:34813904
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1603299	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of INTS3 mRNA	PMID:38568856
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1603299	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of INTS3 mRNA	PMID:19320972|PMID:19376846
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1603299	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of INTS3 mRNA	PMID:19244175
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1603299	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of INTS3 mRNA	PMID:28302478
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603299	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of INTS3 gene	PMID:29154799
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1603299	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of INTS3 mRNA	PMID:25562108
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of INTS3 mRNA	PMID:28628672
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1331924	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of INTS3 mRNA	PMID:17562736
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1603299	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of INTS3 mRNA	PMID:21420995
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of INTS3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of INTS3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INTS3 mRNA	PMID:39836092|PMID:40512198
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1331924	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of INTS3 mRNA	PMID:35436446
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1603299	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of INTS3 mRNA	PMID:28628672
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1331924	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of INTS3 mRNA	PMID:35964746
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603299	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of INTS3 protein	PMID:32959892
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of INTS3 mRNA	PMID:20080153
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1603299	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of INTS3 mRNA	PMID:28988120
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1331924	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of INTS3 mRNA	PMID:20003209
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1331924	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of INTS3 protein	PMID:35926579
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1603299	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of INTS3 mRNA	PMID:38568856
1304593	Ints3	integrator complex subunit 3	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of INTS3 mRNA	PMID:23034163
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312124	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COG1 mRNA	PMID:33045310
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COG1 gene	PMID:20938992
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of COG1 mRNA	PMID:39241906
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COG1 gene	PMID:20938992
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312123	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COG1 mRNA	PMID:37042841
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of COG1 protein	PMID:20463053
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312124	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of COG1 mRNA	PMID:23892564
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312123	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of COG1 protein	PMID:37730182
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of COG1 mRNA	PMID:33387578
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312123	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of COG1 mRNA	PMID:28818685
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COG1 protein]	PMID:32272095
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312123	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COG1 mRNA	PMID:19549813
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312123	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of COG1 mRNA	PMID:23649840
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312123	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COG1 mRNA	PMID:22100608
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COG1 gene	PMID:20938992
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312123	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of COG1 gene	PMID:25304211
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG1 mRNA	PMID:40504410
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of COG1 mRNA	PMID:30912803
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312123	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of COG1 mRNA	PMID:33212167
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:28748	doxorubicin	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of COG1 gene	PMID:28962528
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312123	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COG1 mRNA	PMID:29803840
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312124	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of COG1 mRNA	PMID:39631538
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312123	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of COG1 protein	PMID:35688186
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312123	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COG1 mRNA	PMID:38568856
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG1 mRNA	PMID:40504410
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312123	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COG1 promoter	PMID:27901495
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312124	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of COG1 gene	PMID:35295148
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of COG1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312123	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of COG1 protein	PMID:31675489
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COG1 mRNA	PMID:25181051
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of COG1 gene	PMID:28505145
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COG1 mRNA	PMID:36041667
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1312123	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of COG1 protein	PMID:31675489
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312123	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of COG1 gene	PMID:31601247
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COG1 mRNA	PMID:36041667
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COG1 mRNA	PMID:36041667
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312124	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COG1 mRNA	PMID:37019170
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of COG1 protein	PMID:32272095
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COG1 protein]	PMID:32272095
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COG1 mRNA	PMID:33453195
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of COG1 mRNA	PMID:17585979
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312123	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of COG1 mRNA	PMID:31533062
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312123	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COG1 mRNA	PMID:25979313
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312123	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of COG1 mRNA; Valproic Acid results in decreased expression of COG1 protein	PMID:29501571
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312123	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of COG1 gene	PMID:29154799|PMID:29501571
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312123	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of COG1 mRNA	PMID:20106945
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COG1 mRNA	PMID:33387578
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312123	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of COG1 mRNA	PMID:29523930
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312124	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of COG1 mRNA	PMID:19446018
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312123	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of COG1 gene	PMID:25304211
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG1 mRNA	PMID:40504410
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312123	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of COG1 mRNA	PMID:31675489
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of COG1 mRNA	PMID:35964746
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312123	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COG1 protein	PMID:32959892
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312123	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of COG1 mRNA	PMID:31758290
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312123	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of COG1 protein	PMID:31675489
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of COG1 mRNA	PMID:40826991
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312123	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of COG1 mRNA	PMID:22378314
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of COG1 mRNA	PMID:21346803
1304594	Cog1	component of oligomeric golgi complex 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of COG1 mRNA	PMID:23034163
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312125	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TMEM268 mRNA	PMID:26272509
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312125	E	RGD:6480464	20170110	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA	PMID:27188386
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312125	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TMEM268 mRNA	PMID:26079696
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312125	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TMEM268 mRNA	PMID:22378314
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312125	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TMEM268 mRNA	PMID:21632981
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312125	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of TMEM268 mRNA	PMID:29581250
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312126	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TMEM268 mRNA	PMID:39241906
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312125	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of TMEM268 mRNA	PMID:20106945|PMID:31614463
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312126	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TMEM268 mRNA	PMID:39298647
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM268 mRNA	PMID:33387578
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312126	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMEM268 mRNA	PMID:36331819
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312125	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TMEM268 mRNA	PMID:19549813
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312126	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TMEM268 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TMEM268 mRNA	PMID:34911549
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM268 mRNA	PMID:31150632
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA	PMID:33854195
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312125	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of TMEM268 mRNA	PMID:27594783
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM268 mRNA	PMID:32109520
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312125	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM268 mRNA	PMID:20106945|PMID:21632981
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312125	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TMEM268 mRNA	PMID:28001369
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1312125	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of TMEM268 mRNA	PMID:26272509
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312125	E	RGD:6480464	20170110	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA	PMID:27188386
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM268 mRNA	PMID:28959563
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312125	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM268 mRNA	PMID:29803840
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312125	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of TMEM268 mRNA	PMID:29453283
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312125	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM268 promoter	PMID:27901495
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1312125	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of TMEM268 mRNA	PMID:31745603
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TMEM268 mRNA	PMID:25181051
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM268 mRNA	PMID:34947998
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312125	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM268 mRNA	PMID:29275510
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMEM268 gene	PMID:28505145
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312125	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TMEM268 mRNA	PMID:25979313
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA	PMID:33854195
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312125	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TMEM268 gene	PMID:22964155
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TMEM268 mRNA	PMID:21266533
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312126	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TMEM268 mRNA	PMID:34813904
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of TMEM268 mRNA	PMID:30589522
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312125	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of TMEM268 mRNA	PMID:29024780
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312125	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMEM268 mRNA	PMID:26472689
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312125	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TMEM268 mRNA	PMID:32588087
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312125	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TMEM268 mRNA	PMID:28302478
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312125	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TMEM268 mRNA	PMID:31533062
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312126	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMEM268 mRNA	PMID:36331819
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312125	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM268 mRNA	PMID:25979313
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312125	E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM268 mRNA	PMID:22083351|PMID:28001369
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of TMEM268 mRNA	PMID:38685447|PMID:41580965
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312125	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TMEM268 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA	PMID:33854195
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312126	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TMEM268 mRNA	PMID:28973697
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312125	E	RGD:6480464	20170110	CTD	MESH:C111237	vorinostat results in decreased expression of TMEM268 mRNA	PMID:22083351|PMID:27188386
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA	PMID:33854195
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312125	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TMEM268 mRNA	PMID:28542535
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312125	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMEM268 mRNA	PMID:26690555
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM268 mRNA	PMID:33387578
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312125	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM268 mRNA	PMID:29067470
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of TMEM268 mRNA	PMID:38685447|PMID:41580965
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA	PMID:33854195
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312125	E	RGD:6480464	20170110	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA	PMID:27188386
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1312125	E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of TMEM268 mRNA	PMID:35688559
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312125	E	RGD:6480464	20170110	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA	PMID:27188386
1304595	Tmem268	transmembrane protein 268	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C025643	vinclozolin results in increased expression of TMEM268 mRNA	PMID:20566332
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NDUFA7 mRNA	PMID:38218311
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312128	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NDUFA7 mRNA	PMID:38218311
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of NDUFA7 mRNA	PMID:21551480
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20130507	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of NDUFA7 mRNA]	PMID:19467301
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312129	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDUFA7 mRNA	PMID:39241906
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312128	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFA7 mRNA	PMID:31059760
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NDUFA7 mRNA	PMID:39298647
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA	PMID:25510870
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20161025	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of NDUFA7 mRNA	PMID:27167697
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17578	toluene	affects expression	EXP		E	RGD:6480464	20130507	CTD	MESH:D014050	Toluene affects the expression of NDUFA7 mRNA	PMID:21827849
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of NDUFA7 mRNA	PMID:22967744
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20171010	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NDUFA7 mRNA	PMID:28412506|PMID:36774801
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NDUFA7 mRNA	PMID:35550907
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312129	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NDUFA7 mRNA	PMID:33754040
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NDUFA7 mRNA	PMID:33387578
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NDUFA7 mRNA	PMID:36331819
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA	PMID:25510870
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA	PMID:25510870
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312128	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NDUFA7 mRNA	PMID:23649840
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312128	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of NDUFA7 mRNA	PMID:35430440
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	ISO	RGD:1312128	E	RGD:6480464	20120412	CTD	MESH:D014747	NDUFA7 protein affects the susceptibility to Vinblastine	PMID:16217747
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NDUFA7 mRNA	PMID:33387578
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NDUFA7 mRNA	PMID:40504410
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312128	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of NDUFA7 mRNA	PMID:19244175
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312129	E	RGD:6480464	20130507	CTD	MESH:C059514	resveratrol results in increased expression of NDUFA7 mRNA	PMID:22610192
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312129	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NDUFA7 mRNA	PMID:30912803
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312129	E	RGD:6480464	20130507	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NDUFA7 mRNA	PMID:21570461
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFA7 mRNA	PMID:34747641
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFA7 mRNA	PMID:33387578
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312129	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFA7 mRNA	PMID:19770486|PMID:20399798
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20130507	CTD	MESH:D003300	Copper results in decreased expression of NDUFA7 mRNA	PMID:22465980
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of NDUFA7 mRNA	PMID:36989763
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of NDUFA7 mRNA	PMID:38685555
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NDUFA7 mRNA	PMID:40504410
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NDUFA7 mRNA	PMID:22378314
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NDUFA7 protein	PMID:32717239
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20130507	CTD	MESH:D003300	Copper results in decreased expression of NDUFA7 mRNA	PMID:22465980
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of NDUFA7 mRNA	PMID:16483693
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20130507	CTD	MESH:C008261	lead acetate results in decreased expression of NDUFA7 mRNA	PMID:21829687
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of NDUFA7 mRNA	PMID:24136188
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NDUFA7 mRNA	PMID:34492290
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312128	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NDUFA7 mRNA	PMID:30903817
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFA7 mRNA	PMID:25181051|PMID:32145629
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFA7 mRNA	PMID:25047013
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFA7 mRNA	PMID:35598803
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA7 mRNA	PMID:30816183|PMID:32528016
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312128	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA7 protein	PMID:37567409
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312129	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA7 mRNA	PMID:33221593|PMID:38074096
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NDUFA7 gene	PMID:28505145
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of NDUFA7 mRNA	PMID:19244175
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1312128	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of NDUFA7 mRNA	PMID:19244175
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA	PMID:25510870
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA	PMID:25510870
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312129	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NDUFA7 mRNA	PMID:39298647|PMID:40203079
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312129	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NDUFA7 mRNA	PMID:37019170
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20130507	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NDUFA7 mRNA	PMID:17361019
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312129	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of NDUFA7 mRNA	PMID:34813904
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312129	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NDUFA7 mRNA	PMID:17942915
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NDUFA7 mRNA]	PMID:17942915
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of NDUFA7 protein	PMID:26879310
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20130507	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NDUFA7 mRNA	PMID:19320972
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312128	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of NDUFA7 mRNA	PMID:19244175
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20130507	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NDUFA7 mRNA	PMID:20936131
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20130507	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NDUFA7 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NDUFA7 mRNA; PPARA protein inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of NDUFA7 mRNA]	PMID:20936131|PMID:36331819
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of NDUFA7 mRNA	PMID:41580965
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NDUFA7 mRNA	PMID:25562108
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of NDUFA7 mRNA	PMID:24136188
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NDUFA7 mRNA	PMID:33387578
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312128	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of NDUFA7 mRNA	PMID:25704631
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312128	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFA7 mRNA	PMID:31059760
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NDUFA7 mRNA	PMID:40504410
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20240702	CTD	MESH:D004008	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of NDUFA7 mRNA	PMID:37844793
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312129	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of NDUFA7 mRNA	PMID:35436446
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20240702	CTD	MESH:D004997	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of NDUFA7 mRNA	PMID:37844793
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of NDUFA7 mRNA	PMID:19194470
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20130507	CTD	MESH:D005485	Flutamide results in decreased expression of NDUFA7 mRNA	PMID:19442681
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20240702	CTD	MESH:D007052	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of NDUFA7 mRNA	PMID:37844793
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of NDUFA7 mRNA	PMID:24136188
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312129	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of NDUFA7 mRNA	PMID:23650126
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of NDUFA7 mRNA	PMID:15336504
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NDUFA7 mRNA	PMID:22206623
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of NDUFA7 mRNA	PMID:22576131
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1312128	E	RGD:6480464	20130507	CTD	MESH:C025589	ochratoxin A results in increased expression of NDUFA7 mRNA	PMID:17316727
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1312129	E	RGD:6480464	20130507	CTD	MESH:D010695	Phlorhizin results in increased expression of NDUFA7 mRNA	PMID:22538082
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:90943	osimertinib	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:C000603933	osimertinib results in increased expression of NDUFA7 protein	PMID:38734218
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NDUFA7 mRNA	PMID:19281266
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312128	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NDUFA7 mRNA	PMID:22378314
1304597	Ndufa7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of NDUFA7 protein	PMID:32519852
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1605591	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ABHD15 mRNA	PMID:27188386
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332503	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ABHD15 mRNA	PMID:33045310
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABHD15 mRNA]	PMID:31150632
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of ABHD15 mRNA	PMID:20488242
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1332503	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of ABHD15 mRNA	PMID:19167417
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ABHD15 mRNA	PMID:25890327
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ABHD15 mRNA	PMID:39298647
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605591	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ABHD15 mRNA	PMID:37042841
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1605591	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ABHD15 mRNA	PMID:23649840
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ABHD15 mRNA	PMID:33387578
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1605591	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ABHD15 mRNA	PMID:28818685
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1605591	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ABHD15 mRNA	PMID:23649840
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ABHD15 mRNA	PMID:33354967
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ABHD15 mRNA	PMID:19770486
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605591	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ABHD15 mRNA	PMID:23649840
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ABHD15 mRNA	PMID:31150632
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ABHD15 mRNA	PMID:27339419|PMID:31919559
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABHD15 mRNA]	PMID:31150632
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1332503	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ABHD15 mRNA	PMID:25629700
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332503	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABHD15 mRNA	PMID:40504410
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1332503	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of ABHD15 mRNA	PMID:35897073
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ABHD15 mRNA	PMID:31881176
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1605591	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of ABHD15 mRNA	PMID:19371625
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1605591	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ABHD15 mRNA	PMID:27392435
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605591	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ABHD15 mRNA	PMID:27392435
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ABHD15 mRNA	PMID:21215274
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332503	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABHD15 mRNA	PMID:19770486
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:28201	rotenone	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of ABHD15 mRNA	PMID:28374803
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605591	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ABHD15 mRNA	PMID:33212167
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20130514	CTD	MESH:D003300	Copper results in decreased expression of ABHD15 mRNA	PMID:18579281
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1332503	E	RGD:6480464	20130514	CTD	MESH:D003300	Copper results in increased expression of ABHD15 mRNA	PMID:18579281
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605591	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABHD15 mRNA	PMID:29803840
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABHD15 mRNA	PMID:39515575
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332503	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABHD15 mRNA	PMID:40504410
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605591	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ABHD15 mRNA	PMID:32234424
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1332503	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to ABHD15 promoter]	PMID:19654925
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1605591	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of ABHD15 promoter	PMID:23974009
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20130514	CTD	MESH:D003300	Copper results in decreased expression of ABHD15 mRNA	PMID:18579281
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1332503	E	RGD:6480464	20130514	CTD	MESH:D003300	Copper results in increased expression of ABHD15 mRNA	PMID:18579281
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1605591	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ABHD15 mRNA	PMID:35984750
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605591	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ABHD15 gene	PMID:31601247
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1332503	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of ABHD15 mRNA	PMID:22609695
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ABHD15 mRNA	PMID:32479839
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1332503	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of ABHD15 gene	PMID:35295148
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ABHD15 mRNA	PMID:35295148
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of ABHD15 mRNA	PMID:23411599|PMID:34492290
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332503	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ABHD15 mRNA	PMID:23811191
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1605591	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ABHD15 mRNA	PMID:19710929
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ABHD15 mRNA	PMID:25181051|PMID:41034487
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1605591	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ABHD15 gene	PMID:31601247
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332503	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD15 mRNA	PMID:33221593
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605591	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ABHD15 gene	PMID:31601247
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1332503	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ABHD15 gene	PMID:31683443
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ABHD15 mRNA	PMID:39298647
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1605591	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ABHD15 protein	PMID:34186270
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1332503	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ABHD15 mRNA	PMID:38685157
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1605591	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ABHD15 protein	PMID:34186270
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1332503	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ABHD15 intron	PMID:28392331
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332503	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ABHD15 mRNA	PMID:32715474
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of ABHD15 mRNA	PMID:24535843
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ABHD15 mRNA	PMID:35163327
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1332503	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of ABHD15 mRNA	PMID:26377693
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605591	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ABHD15 mRNA	PMID:38568856
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ABHD15 mRNA	PMID:35163327
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1332503	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABHD15 mRNA	PMID:40194260
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605591	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABHD15 mRNA	PMID:25979313
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605591	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ABHD15 mRNA	PMID:19101580|PMID:23179753|PMID:24383497
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605591	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ABHD15 gene	PMID:29154799
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605591	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ABHD15 mRNA	PMID:25562108
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of ABHD15 mRNA	PMID:25123088
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1605591	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ABHD15 mRNA	PMID:27188386
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1605591	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ABHD15 mRNA	PMID:24935251
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of ABHD15 mRNA	PMID:32479839|PMID:33387578
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332503	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABHD15 mRNA	PMID:40504410
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ABHD15 mRNA	PMID:35436446
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332503	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ABHD15 mRNA; Nanotubes, Carbon results in increased expression of ABHD15 mRNA	PMID:25620056
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ABHD15 mRNA	PMID:24136188
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1332503	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of ABHD15 mRNA	PMID:26377693
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1332503	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ABHD15 mRNA	PMID:38701926
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1605591	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ABHD15 mRNA	PMID:24810058
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1332503	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of ABHD15 mRNA	PMID:36851058
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1605591	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ABHD15 protein	PMID:34186270
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332503	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ABHD15 mRNA	PMID:22206623
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1332503	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of ABHD15 mRNA	PMID:26655953
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1332503	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ABHD15 mRNA	PMID:23091169
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ABHD15 mRNA	PMID:23914054
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1332503	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ABHD15 mRNA	PMID:39847705
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of ABHD15 mRNA	PMID:21278054
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1605591	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ABHD15 mRNA	PMID:29301935
1304598	Abhd15	abhydrolase domain containing 15	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1332503	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ABHD15 mRNA	PMID:35537566
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312132	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of POLRMT mRNA	PMID:33045310
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312131	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of POLRMT mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of POLRMT mRNA	PMID:32699268
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of POLRMT mRNA	PMID:36331819
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312131	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of POLRMT mRNA	PMID:22378314
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312132	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POLRMT mRNA	PMID:39241906
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312131	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of POLRMT mRNA	PMID:23019147
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312132	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of POLRMT mRNA	PMID:39298647
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312131	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of POLRMT mRNA	PMID:37042841
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:17558	quercitrin	decreases expression	ISO	RGD:1312131	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of POLRMT mRNA	PMID:25193878
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:17626	citraconic acid	increases expression	ISO	RGD:1312132	E	RGD:6480464	20180220	CTD	MESH:C073341	citraconic acid results in increased expression of POLRMT mRNA	PMID:27277809
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:17626	citraconic acid	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20180220	CTD	MESH:C073341	NFE2L2 protein affects the reaction [citraconic acid results in increased expression of POLRMT mRNA]	PMID:27277809
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312132	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of POLRMT mRNA	PMID:23892564
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312131	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of POLRMT protein	PMID:23301498
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312132	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of POLRMT mRNA	PMID:19770486
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312131	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of POLRMT mRNA	PMID:23649840
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312131	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of POLRMT mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of POLRMT mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of POLRMT mRNA	PMID:32699268
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of POLRMT mRNA	PMID:30779732
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POLRMT mRNA	PMID:22206623
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLRMT mRNA	PMID:40504410
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of POLRMT mRNA	PMID:30912803
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312131	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of POLRMT mRNA	PMID:23019147
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312132	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLRMT mRNA	PMID:21570461
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLRMT mRNA	PMID:21215274
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLRMT mRNA	PMID:19465110
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLRMT mRNA	PMID:33387578
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLRMT mRNA	PMID:17942748
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312131	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of POLRMT mRNA	PMID:32763439
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of POLRMT protein	PMID:18845810
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	HMOX1 protein inhibits the reaction [Doxorubicin results in decreased expression of POLRMT protein]	PMID:18845810
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312131	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of POLRMT mRNA	PMID:34032870
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLRMT mRNA	PMID:40504410
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312131	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POLRMT 3' UTR	PMID:27901495
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of POLRMT mRNA	PMID:19073995
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of POLRMT mRNA	PMID:30047161
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312132	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POLRMT gene	PMID:35295148
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of POLRMT mRNA	PMID:34492290
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of POLRMT gene	PMID:23968726
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of POLRMT mRNA	PMID:41034487
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of POLRMT mRNA	PMID:34813904
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of POLRMT mRNA	PMID:34813904
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of POLRMT gene	PMID:23968726
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of POLRMT mRNA	PMID:33453195
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312131	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of POLRMT mRNA	PMID:25812627
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312131	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of POLRMT mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of POLRMT mRNA	PMID:32699268
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312132	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of POLRMT mRNA	PMID:17585979
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312131	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of POLRMT mRNA	PMID:25812627
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312131	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of POLRMT mRNA	PMID:25812627
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of POLRMT mRNA	PMID:36331819
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312131	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of POLRMT gene	PMID:29154799
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of POLRMT mRNA	PMID:30047161
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312131	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of POLRMT mRNA	PMID:21420995|PMID:31059760
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in decreased expression of POLRMT mRNA	PMID:17585979
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLRMT mRNA	PMID:40504410
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLRMT mRNA	PMID:17942748
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1312131	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of POLRMT mRNA	PMID:38568856
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of POLRMT mRNA	PMID:30047161
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of POLRMT mRNA	PMID:22206623
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POLRMT mRNA	PMID:22206623
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:749635	bms-986094	decreases expression	ISO	RGD:1312131	E	RGD:6480464	20260714	CTD	MESH:C553340	BMS-986094 results in decreased expression of POLRMT protein	PMID:27466212
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:76004	dimethyl fumarate	increases expression	ISO	RGD:1312132	E	RGD:6480464	20180220	CTD	MESH:C056020	Dimethyl Fumarate results in increased expression of POLRMT mRNA	PMID:27277809
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:76004	dimethyl fumarate	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20180220	CTD	MESH:C056020	NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of POLRMT mRNA]	PMID:27277809
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of POLRMT mRNA	PMID:30047161
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312131	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of POLRMT mRNA	PMID:38568856
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312131	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of POLRMT mRNA	PMID:27188386
1304599	Polrmt	RNA polymerase mitochondrial	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of POLRMT mRNA	PMID:18930950
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of AMDHD2 mRNA	PMID:38218311
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1603049	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of AMDHD2 mRNA	PMID:38218311
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1603049	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AMDHD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AMDHD2 mRNA	PMID:32699268
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AMDHD2 mRNA	PMID:36331819
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1603049	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of AMDHD2 mRNA	PMID:26079696
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332011	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of AMDHD2 mRNA	PMID:39241906
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1603049	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of AMDHD2 mRNA	PMID:19162166
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of AMDHD2 mRNA	PMID:37992649
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of AMDHD2 mRNA	PMID:37992649
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of AMDHD2 mRNA	PMID:33387578
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of AMDHD2 mRNA	PMID:28818685
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AMDHD2 mRNA	PMID:36331819
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of AMDHD2 protein	PMID:34915118
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1603049	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of AMDHD2 mRNA	PMID:24376830
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AMDHD2 mRNA	PMID:37236586
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AMDHD2 mRNA	PMID:19549813
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of AMDHD2 mRNA	PMID:21396975
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of AMDHD2 mRNA	PMID:34911549
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603049	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AMDHD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AMDHD2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of AMDHD2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of AMDHD2 mRNA	PMID:32699268|PMID:35430440
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AMDHD2 mRNA	PMID:22206623
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1603049	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AMDHD2 gene	PMID:25304211
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1603049	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AMDHD2 mRNA	PMID:27392435
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1332011	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of AMDHD2 mRNA	PMID:30912803
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332011	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AMDHD2 mRNA	PMID:21570461
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AMDHD2 mRNA	PMID:33387578|PMID:34747641
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of AMDHD2 mRNA	PMID:33512557
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of AMDHD2 mRNA	PMID:33212167
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of AMDHD2 mRNA	PMID:32763439
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1332011	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of AMDHD2 protein	PMID:28918527
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AMDHD2 mRNA	PMID:29803840
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of AMDHD2 mRNA	PMID:37992649
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1332011	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of AMDHD2 mRNA	PMID:37682722
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603049	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of AMDHD2 mRNA	PMID:34032870|PMID:39719251
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603049	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AMDHD2 promoter	PMID:27901495
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1332011	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of AMDHD2 mRNA	PMID:29203145
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of AMDHD2 mRNA	PMID:30047161
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332011	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AMDHD2 gene	PMID:35295148
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1332011	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of AMDHD2 mRNA	PMID:23557971
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AMDHD2 mRNA	PMID:34492290
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1332011	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of AMDHD2 mRNA	PMID:23811191
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1332011	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of AMDHD2 mRNA	PMID:28472532
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of AMDHD2 mRNA	PMID:25181051
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of AMDHD2 protein	PMID:31675489
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1603049	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of AMDHD2 mRNA	PMID:27685785|PMID:29275510
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1603049	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of AMDHD2 gene	PMID:31601247
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332011	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of AMDHD2 mRNA	PMID:39298647|PMID:40203079
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1603049	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of AMDHD2 intron	PMID:30157460
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1603049	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of AMDHD2 protein	PMID:34186270
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1603049	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of AMDHD2 protein	PMID:34186270
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332011	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of AMDHD2 mRNA	PMID:37019170
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603049	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AMDHD2 mRNA	PMID:37042841
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of AMDHD2 promoter	PMID:22457795
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AMDHD2 mRNA	PMID:37236586
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1603049	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AMDHD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AMDHD2 mRNA	PMID:32699268
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1332011	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of AMDHD2 mRNA	PMID:23811191
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:38604	pyrimidifen	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of AMDHD2 mRNA	PMID:33512557
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AMDHD2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AMDHD2 mRNA	PMID:36331819
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603049	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of AMDHD2 mRNA	PMID:28001369
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603049	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of AMDHD2 gene	PMID:29154799
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of AMDHD2 mRNA	PMID:30047161
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of AMDHD2 mRNA	PMID:33512557
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of AMDHD2 mRNA	PMID:37992649
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of AMDHD2 mRNA	PMID:33512557
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332011	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of AMDHD2 mRNA	PMID:17562736
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1603049	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AMDHD2 gene	PMID:25304211
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of AMDHD2 mRNA	PMID:29391264
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332011	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AMDHD2 mRNA	PMID:25554681
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of AMDHD2 mRNA	PMID:30047161
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1332011	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of AMDHD2 mRNA	PMID:26377693
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of AMDHD2 mRNA	PMID:35283115
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of AMDHD2 mRNA	PMID:19564919
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1603049	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of AMDHD2 intron	PMID:30157460
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1603049	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AMDHD2 protein	PMID:34186270
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332011	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of AMDHD2 mRNA	PMID:22206623
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AMDHD2 mRNA	PMID:22206623
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603049	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AMDHD2 gene]	PMID:28238834
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1332011	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of AMDHD2 mRNA	PMID:19482888
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1332011	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of AMDHD2 mRNA]	PMID:19482888
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of AMDHD2 protein	PMID:31675489
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of AMDHD2 mRNA	PMID:27291303
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1332011	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of AMDHD2 mRNA	PMID:31558096
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1603049	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of AMDHD2 mRNA	PMID:33512557
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1332011	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of AMDHD2 mRNA	PMID:39847705
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of AMDHD2 mRNA	PMID:30047161
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of AMDHD2 mRNA	PMID:30047161
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1332011	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of AMDHD2 mRNA	PMID:40826991
1304601	Amdhd2	amidohydrolase domain containing 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1332011	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of AMDHD2 mRNA	PMID:35537566
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312136	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CRTAM mRNA	PMID:33045310
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:141319	metam	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20191114	CTD	MESH:C008435	methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in decreased expression of CRTAM mRNA]	PMID:24056979
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:149681	methcathinone	increases expression	ISO	RGD:1606263	E	RGD:6480464	20200602	CTD	MESH:C047806	monomethylpropion results in increased expression of CRTAM mRNA	PMID:22303338
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312136	E	RGD:6480464	20161025	CTD	MESH:D001280	Atrazine results in decreased expression of CRTAM mRNA	PMID:27655631
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:16136	hydrogen sulfide	increases expression	ISO	RGD:1312136	E	RGD:6480464	20200519	CTD	MESH:D006862	Hydrogen Sulfide results in increased expression of CRTAM mRNA	PMID:31843631
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312136	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CRTAM mRNA	PMID:24056979
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20161228	CTD	MESH:D008070	methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in decreased expression of CRTAM mRNA]	PMID:24056979
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606263	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of CRTAM mRNA	PMID:20660070
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRTAM mRNA	PMID:25510870
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CRTAM mRNA	PMID:33387578
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606263	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CRTAM mRNA	PMID:37042841
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1606263	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of CRTAM mRNA	PMID:20660070
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CRTAM mRNA	PMID:37992649
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CRTAM mRNA	PMID:37992649
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312136	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CRTAM mRNA	PMID:34319233
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1606263	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CRTAM intron	PMID:30157460
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1312136	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of CRTAM mRNA	PMID:39984025
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRTAM mRNA	PMID:25510870
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRTAM mRNA	PMID:25510870
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1606263	E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CRTAM mRNA	PMID:16979875
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1606263	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CRTAM gene	PMID:25304211
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1606263	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CRTAM mRNA	PMID:25583101
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606263	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CRTAM mRNA	PMID:33212167
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CRTAM mRNA	PMID:37992649
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRTAM mRNA	PMID:34876320
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRTAM mRNA	PMID:34876320
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606263	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CRTAM promoter	PMID:27901495
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1606263	E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CRTAM mRNA	PMID:16979875
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312136	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CRTAM mRNA	PMID:29341224
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CRTAM mRNA	PMID:34492290
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312136	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CRTAM mRNA	PMID:18648102
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CRTAM mRNA	PMID:25181051
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of CRTAM mRNA	PMID:41034487
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312136	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of CRTAM mRNA	PMID:35598803
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CRTAM gene	PMID:28505145
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRTAM mRNA	PMID:25510870
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRTAM mRNA	PMID:25510870
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312136	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CRTAM exon	PMID:33297965
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1606263	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CRTAM intron	PMID:30157460
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312136	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CRTAM mRNA	PMID:28392331
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606263	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CRTAM mRNA	PMID:37042841
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312136	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CRTAM mRNA	PMID:24982889
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1606263	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CRTAM mRNA	PMID:24449571
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1606263	E	RGD:6480464	20120412	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CRTAM mRNA	PMID:16979875
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312136	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CRTAM mRNA	PMID:40194260
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CRTAM mRNA	PMID:37992649
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312136	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CRTAM mRNA	PMID:29279043
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1606263	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CRTAM gene	PMID:25304211
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRTAM mRNA	PMID:34876320
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312136	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CRTAM mRNA	PMID:25554681
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312136	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CRTAM mRNA	PMID:38701926
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1312136	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of CRTAM mRNA	PMID:22078008
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1606263	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CRTAM intron	PMID:30157460
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312136	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CRTAM mRNA	PMID:22206623
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1606263	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CRTAM mRNA	PMID:37199045
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606263	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CRTAM gene]	PMID:28238834
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312136	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CRTAM mRNA	PMID:38648751
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312136	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRTAM mRNA	PMID:34876320
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CRTAM mRNA	PMID:24780913
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1606263	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of CRTAM mRNA	PMID:31734321
1304602	Crtam	cytotoxic and regulatory T cell molecule	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1606263	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CRTAM mRNA	PMID:29301935
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D015215	Zidovudine results in increased expression of NRF1 mRNA	PMID:17926646
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:132098	methoxyacetic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of NRF1 mRNA	PMID:20864626
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312138	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of NRF1 mRNA	PMID:33045310
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NRF1 mRNA]	PMID:31150632
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:134301	salvianolic acid B	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20240604	CTD	MESH:C076944	salvianolic acid B inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 mRNA]; salvianolic acid B inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 protein]	PMID:33994527
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NRF1 mRNA	PMID:20188158
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:142921	3-phenylprop-2-enal	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in decreased expression of NRF1 mRNA	PMID:28219650
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20231031	CTD	MESH:D001241	Aspirin inhibits the reaction [Cisplatin results in decreased expression of NRF1 protein]	PMID:37179038
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D014212	Tretinoin inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]]	PMID:23331247
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:15368	acrolein	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D000171	Acrolein results in decreased expression of NRF1 mRNA	PMID:35150775
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D010100	[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein]	PMID:36806343
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20171010	CTD	MESH:D010100	[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NRF1 protein; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NRF1 protein]	PMID:28477916
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1312137	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of NRF1 mRNA	PMID:39506029
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20201215	CTD	MESH:D019308	[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA]	PMID:26847930
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20160705	CTD	MESH:D001280	Atrazine results in decreased expression of NRF1 mRNA	PMID:27114639
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D001280	Atrazine results in increased expression of NRF1 mRNA	PMID:27114639
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20250204	CTD	MESH:C015329	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NRF1 mRNA]	PMID:33908429
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20201215	CTD	MESH:D019301	[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA]	PMID:26847930
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312137	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of NRF1 mRNA	PMID:20044591
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16240	hydrogen peroxide	affects response to substance	ISO	RGD:1312137	E	RGD:6480464	20170516	CTD	MESH:D006861	NRF1 protein affects the susceptibility to Hydrogen Peroxide	PMID:21051700
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20141223	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of NRF1 mRNA	PMID:23859249
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20141223	CTD	MESH:D006861	resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased expression of NRF1 mRNA]	PMID:23859249
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20160210	CTD	MESH:D011794	Quercetin inhibits the reaction [aluminum lactate results in decreased expression of NRF1 mRNA]; Quercetin inhibits the reaction [aluminum lactate results in decreased expression of NRF1 protein]; Quercetin inhibits the reaction [Atorvastatin affects the expression of NRF1 mRNA]	PMID:21775390|PMID:26493151
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NRF1 mRNA	PMID:39241906
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312137	E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in increased expression of NRF1 mRNA	PMID:20302909|PMID:22105178|PMID:33352482
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Norepinephrine] results in decreased expression of NRF1 mRNA	PMID:16954335
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20120412	CTD	MESH:D004958	ESR1 protein alternative form inhibits the reaction [Estradiol results in increased expression of NRF1 mRNA]; fulvestrant inhibits the reaction [Estradiol results in increased expression of NRF1 mRNA]; Vehicle Emissions inhibits the reaction [Estradiol results in increased expression of NRF1 mRNA]	PMID:20302909|PMID:22105178
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312137	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NRF1 mRNA	PMID:37042841
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16796	melatonin	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D008550	Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of NRF1 protein]	PMID:26882442
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of NRF1 mRNA	PMID:20655997|PMID:23649840
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17158	methylglyoxal	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D011765	Pyruvaldehyde results in increased expression of NRF1 mRNA	PMID:23331247
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17158	methylglyoxal	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D011765	monascin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]; Silymarin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]; Tretinoin inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]]	PMID:23331247
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein]	PMID:36806343
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1312138	E	RGD:6480464	20200915	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate affects the expression of NRF1 mRNA	PMID:32522588
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17245	carbon monoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002248	Carbon Monoxide results in increased expression of NRF1 protein	PMID:17179207
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17245	carbon monoxide	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D002248	Carbon Monoxide results in increased expression of NRF1 mRNA	PMID:17179207
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17245	carbon monoxide	increases localization	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D002248	Carbon Monoxide results in increased localization of NRF1 protein	PMID:18845810
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17245	carbon monoxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002248	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of NRF1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of NRF1 protein]; Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]; Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]; CAT protein inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]]	PMID:17179207
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17245	carbon monoxide	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D002248	AKT1 protein affects the reaction [Carbon Monoxide results in increased localization of NRF1 protein]; Carbon Monoxide promotes the reaction [NFE2L2 protein binds to NRF1 promoter]	PMID:18845810
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein]	PMID:36806343
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20220705	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NRF1 mRNA; Diethylhexyl Phthalate results in decreased expression of NRF1 protein	PMID:34822940
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312138	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NRF1 mRNA	PMID:33908429
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20250204	CTD	MESH:D004051	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NRF1 mRNA]	PMID:33908429
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17793	calycosin	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:C121707	7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of and affects the localization of NRF1 protein]; 7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NRF1 mRNA]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of ATP5F1A mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of ATP5F1A protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NDUFB8 mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NDUFB8 protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of SDHB mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of SDHB protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of UQCRC2 mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of UQCRC2 protein]]; SR18292 inhibits the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NRF1 mRNA]]	PMID:36436616
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312137	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of NRF1 protein	PMID:37730182
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D002117	Calcitriol results in increased expression of NRF1 protein	PMID:30194976
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20260804	CTD	MESH:D005839	Gentamicins results in decreased expression of NRF1 protein	PMID:42173392
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20260804	CTD	MESH:D005839	Formoterol Fumarate inhibits the reaction [Gentamicins results in decreased expression of NRF1 protein]	PMID:42173392
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20130416	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NRF1 protein	PMID:21856379
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312137	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NRF1 mRNA	PMID:28818685
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:18315	pyrroloquinoline quinone	increases expression	ISO	RGD:1312137	E	RGD:6480464	20171010	CTD	MESH:D045542	PQQ Cofactor results in increased expression of NRF1 mRNA	PMID:28578007
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:18357	(R)-noradrenaline	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D009638	[Estradiol co-treated with Norepinephrine] results in decreased expression of NRF1 mRNA	PMID:16954335
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:18406	AICA ribonucleotide	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C031143	AICA ribonucleotide results in increased expression of NRF1 mRNA	PMID:20438809
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:18406	AICA ribonucleotide	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C031143	dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of NRF1 mRNA]	PMID:20438809
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:18422	sulfur dioxide	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D013458	Sulfur Dioxide results in decreased expression of NRF1 mRNA; Sulfur Dioxide results in decreased expression of NRF1 protein	PMID:26980303
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:18422	sulfur dioxide	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013458	Sulfur Dioxide results in increased expression of NRF1 protein	PMID:22677886
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:191854	arachidonyl-2'-chloroethylamide	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20220614	CTD	MESH:C119325	arachidonyl-2-chloroethylamide results in decreased expression of NRF1 mRNA	PMID:26847930
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:191854	arachidonyl-2'-chloroethylamide	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20220614	CTD	MESH:C119325	FOXO1 protein affects the reaction [arachidonyl-2-chloroethylamide results in decreased expression of NRF1 mRNA]	PMID:26847930
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D002104	Cadmium results in increased expression of NRF1 mRNA	PMID:25388156
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:232424	MitoTEMPO	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20241203	CTD	MESH:C555916	MitoTEMPO inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]	PMID:29729358
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:232553	imisopasem manganese	increases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C121876	imisopasem manganese results in increased expression of NRF1 protein	PMID:28483572
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:232553	imisopasem manganese	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:C121876	Alloxan affects the reaction [imisopasem manganese results in increased expression of NRF1 protein]	PMID:28483572
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NRF1 mRNA	PMID:19549813
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20240903	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NRF1 mRNA; Copper Sulfate results in decreased expression of NRF1 protein	PMID:38124272
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NRF1 protein	PMID:23301498
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NRF1 mRNA	PMID:19770486
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312137	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NRF1 gene; Aflatoxin B1 results in increased methylation of NRF1 intron	PMID:27153756|PMID:30157460
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312138	E	RGD:6480464	20200519	CTD	MESH:D010126	Ozone results in increased expression of NRF1 mRNA	PMID:27240593
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20170303	CTD	MESH:D017382	NRF1 mutant form promotes the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]	PMID:21401886
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:26709	sodium hydrogensulfite	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C009279	sodium bisulfite results in decreased expression of NRF1 mRNA; sodium bisulfite results in decreased expression of NRF1 protein	PMID:26980303
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:26709	sodium hydrogensulfite	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C009279	Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of NRF1 mRNA]	PMID:26980303
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1312137	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of NRF1 mRNA	PMID:15672453
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NRF1 mRNA	PMID:18593933
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NRF1 protein	PMID:26882442
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NRF1 mRNA	PMID:31150632
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D002251	Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of NRF1 protein]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NRF1 mRNA]	PMID:26882442|PMID:31150632
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in decreased expression of NRF1 mRNA	PMID:25270620
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312137	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NRF1 gene	PMID:25304211
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1312137	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of NRF1 mRNA	PMID:21514422
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NRF1 mRNA	PMID:39836092
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NRF1 mRNA	PMID:17936198
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	NRF1 protein promotes the reaction [Selenium results in increased expression of TFAM mRNA]	PMID:17936198
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of NRF1 mRNA	PMID:20864626
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20120717	CTD	MESH:C059514	resveratrol results in decreased expression of NRF1 mRNA	PMID:21270273
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:C059514	Resveratrol results in increased expression of NRF1 mRNA; Resveratrol results in increased expression of NRF1 protein	PMID:20429690|PMID:20438809|PMID:32619457
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312137	E	RGD:6480464	20141111	CTD	MESH:C059514	resveratrol results in increased expression of NRF1 mRNA	PMID:22105178|PMID:24041027
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312138	E	RGD:6480464	20121218	CTD	MESH:C059514	Resveratrol results in increased expression of NRF1 mRNA; Resveratrol results in increased expression of NRF1 protein	PMID:20561979|PMID:24041027|PMID:34216621
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	dorsomorphin inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]; Resveratrol affects the reaction [Benzo(a)pyrene affects the expression of NRF1 mRNA]; Resveratrol affects the reaction [Benzo(a)pyrene affects the expression of NRF1 protein]; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of NRF1 mRNA]	PMID:20438809|PMID:21632075|PMID:32619457
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20141223	CTD	MESH:C059514	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]; [Plant Extracts co-treated with Resveratrol] results in increased expression of NRF1 mRNA; Fulvestrant inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]; HMOX1 mutant form inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased expression of NRF1 mRNA]; Resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NRF1 mRNA]; tin protoporphyrin IX inhibits the reaction [Resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NRF1 mRNA]]; tin protoporphyrin IX inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]	PMID:22105178|PMID:23557933|PMID:23859249|PMID:24041027
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20141111	CTD	MESH:C059514	[Dietary Fats co-treated with Resveratrol] results in increased expression of NRF1 mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Resveratrol] results in increased expression of NRF1 mRNA; SIRT1 protein affects the reaction [Resveratrol results in increased expression of NRF1 mRNA]; STK11 protein affects the reaction [Resveratrol results in increased expression of NRF1 mRNA]; tin protoporphyrin IX inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Resveratrol] results in increased expression of NRF1 mRNA]; tin protoporphyrin IX inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]	PMID:24041027|PMID:29197120|PMID:34216621
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in decreased expression of NRF1 mRNA; Cisplatin results in decreased expression of NRF1 protein	PMID:25270620|PMID:37179038
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20231031	CTD	MESH:D002945	Aspirin inhibits the reaction [Cisplatin results in decreased expression of NRF1 protein]	PMID:37179038
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20230801	CTD	MESH:D009532	[nickel chloride results in increased abundance of Nickel] which results in decreased expression of NRF1 mRNA	PMID:36794572
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312138	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NRF1 mRNA	PMID:21570461|PMID:24058054
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312137	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NRF1 mRNA	PMID:21296121
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312138	E	RGD:6480464	20171010	CTD	MESH:D012402	Rotenone results in increased expression of NRF1 mRNA	PMID:21536665
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20171010	CTD	MESH:D012402	PPARGC1A protein affects the reaction [Rotenone results in increased expression of NRF1 mRNA]	PMID:21536665
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NRF1 mRNA	PMID:20864626
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28498	acadesine	increases expression	ISO	RGD:1312137	E	RGD:6480464	20200310	CTD	MESH:C011651	acadesine results in increased expression of NRF1 protein	PMID:28556920
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28498	acadesine	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20200310	CTD	MESH:C011651	acadesine inhibits the reaction [Isoniazid results in decreased expression of NRF1 protein]	PMID:28556920
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28694	copper atom	decreases response to substance	ISO	RGD:1312138	E	RGD:6480464	20150512	CTD	MESH:D003300	NRF1 gene results in decreased susceptibility to Copper	PMID:24462598
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D003300	Copper deficiency results in increased expression of NRF1 protein	PMID:11694003
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20150512	CTD	MESH:D003300	NRF1 gene promotes the reaction [Copper results in increased expression of MT1 mRNA]	PMID:24462598
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20171010	CTD	MESH:D004317	Doxorubicin results in decreased expression of NRF1 protein	PMID:28456571|PMID:29729358
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20171010	CTD	MESH:D004317	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]; Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]; MitoTEMPO inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]; SIRT1 protein affects the reaction [Doxorubicin results in decreased expression of NRF1 protein]; SIRT1 protein affects the reaction [Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]]	PMID:28456571|PMID:29729358
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of NRF1 mRNA]	PMID:21775390|PMID:26980303|PMID:35403558|PMID:36493885
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312137	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of NRF1 mRNA	PMID:29319823
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:C017947	sodium arsenite results in decreased expression of NRF1 mRNA; sodium arsenite results in decreased expression of NRF1 protein	PMID:26767369|PMID:27425645|PMID:37730054
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of NRF1 protein	PMID:38228842
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312137	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of NRF1 mRNA	PMID:29301061|PMID:34032870
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20170207	CTD	MESH:C017947	sodium arsenite results in decreased expression of and affects the localization of NRF1 protein	PMID:27425645
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NRF1 mRNA	PMID:39836092
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NRF1 mRNA	PMID:22378314
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of NRF1 mRNA; Benzo(a)pyrene affects the expression of NRF1 protein	PMID:32619457
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312137	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NRF1 5' UTR	PMID:27901495
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NRF1 mRNA; Benzo(a)pyrene results in decreased expression of NRF1 protein	PMID:21401886|PMID:22865514
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312138	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NRF1 3' UTR; Benzo(a)pyrene results in decreased methylation of NRF1 exon	PMID:27901495
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NRF1 mRNA	PMID:22228805
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001564	Resveratrol affects the reaction [Benzo(a)pyrene affects the expression of NRF1 mRNA]; Resveratrol affects the reaction [Benzo(a)pyrene affects the expression of NRF1 protein]	PMID:32619457
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20121009	CTD	MESH:D001564	NRF1 mutant form inhibits the reaction [Benzo(a)pyrene results in decreased expression of TFAM protein]; NRF1 mutant form promotes the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]	PMID:21401886
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to NRF1 promoter]; Benzo(a)pyrene promotes the reaction [NRF1 protein binds to GSTA1 gene]	PMID:11961136|PMID:19654925
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:30052	copper(0)	decreases response to substance	ISO	RGD:1312138	E	RGD:6480464	20150512	CTD	MESH:D003300	NRF1 gene results in decreased susceptibility to Copper	PMID:24462598
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D003300	Copper deficiency results in increased expression of NRF1 protein	PMID:11694003
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20150512	CTD	MESH:D003300	NRF1 gene promotes the reaction [Copper results in increased expression of MT1 mRNA]	PMID:24462598
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NRF1 mRNA	PMID:18593933
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NRF1 mRNA	PMID:19150397
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:30621	diarsenic trioxide	affects methylation	ISO	RGD:1312137	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide affects the methylation of NRF1 promoter	PMID:26046465
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of NRF1 mRNA	PMID:16483693
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:31633	formoterol fumarate	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20260804	CTD	MESH:D000068759	Formoterol Fumarate inhibits the reaction [Gentamicins results in decreased expression of NRF1 protein]	PMID:42173392
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20121009	CTD	MESH:C070081	fulvestrant inhibits the reaction [afimoxifene results in increased expression of NRF1 mRNA]; fulvestrant inhibits the reaction [Estradiol results in increased expression of NRF1 mRNA]; fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of NRF1 mRNA]; fulvestrant inhibits the reaction [resveratrol results in increased expression of NRF1 mRNA]	PMID:22105178
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NRF1 mRNA	PMID:25729387
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312138	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NRF1 gene	PMID:35295148
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of NRF1 mRNA	PMID:18648102
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:32588	potassium chloride	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D011189	Potassium Chloride results in increased expression of NRF1 mRNA; Potassium Chloride results in increased expression of NRF1 protein	PMID:20438809
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	ISO	RGD:1312137	E	RGD:6480464	20140114	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of NRF1 mRNA	PMID:23777605
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of NRF1 mRNA	PMID:24105817
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NRF1 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:33375	gadolinium atom	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20260203	CTD	MESH:D005682	[gadolinium chloride results in increased abundance of Gadolinium] which results in decreased expression of NRF1 protein; [gadolinium oxide results in increased abundance of Gadolinium] which results in decreased expression of NRF1 protein	PMID:40796065
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of NRF1 mRNA	PMID:30316929
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20160210	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of NRF1 mRNA	PMID:26520405
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20170516	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of NRF1 mRNA	PMID:27923775
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:34679	Di-n-octyl phthalate	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20240206	CTD	MESH:C010715	di-n-octyl phthalate results in decreased expression of NRF1 mRNA; di-n-octyl phthalate results in decreased expression of NRF1 protein	PMID:34822940
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20170725	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased expression of NRF1 mRNA	PMID:28219650
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of NRF1 mRNA	PMID:34813904
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20180515	CTD	MESH:D015056	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of NRF1 mRNA; [Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of NRF1 mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of NRF1 mRNA	PMID:29288687|PMID:32417366
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of NRF1 mRNA	PMID:34813904
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20240702	CTD	MESH:C022838	nickel chloride results in decreased expression of NRF1 mRNA; nickel chloride results in decreased expression of NRF1 protein	PMID:38552765
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20230801	CTD	MESH:C022838	[nickel chloride results in increased abundance of Nickel] which results in decreased expression of NRF1 mRNA	PMID:36794572
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NRF1 mRNA	PMID:36493885
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:D019256	Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of NRF1 mRNA]	PMID:36493885
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NRF1 mRNA	PMID:19616056
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of NRF1 mRNA	PMID:30047161
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312137	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of NRF1 mRNA	PMID:24449571
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NRF1 mRNA	PMID:17936198
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	NRF1 protein promotes the reaction [Selenium results in increased expression of TFAM mRNA]	PMID:17936198
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:37288	gadolinium trichloride	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20260203	CTD	MESH:C038958	[gadolinium chloride results in increased abundance of Gadolinium] which results in decreased expression of NRF1 protein	PMID:40796065
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:37825	p-toluidine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of NRF1 mRNA	PMID:27638505
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:38630	indoxacarb	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C401104	indoxacarb results in decreased expression of NRF1 mRNA	PMID:41306723
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:38728	monocrotophos	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D008999	Monocrotophos results in decreased expression of NRF1 mRNA	PMID:35403558
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:38728	monocrotophos	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008999	Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of NRF1 mRNA]	PMID:35403558
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of NRF1 mRNA	PMID:36331819
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312137	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NRF1 mRNA	PMID:25979313
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of NRF1 mRNA	PMID:28001369
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of NRF1 mRNA	PMID:21427059
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of NRF1 mRNA	PMID:30047161
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1312137	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of NRF1 promoter	PMID:27989131
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:4045	cyprodinil	increases expression	ISO	RGD:1312137	E	RGD:6480464	20210810	CTD	MESH:C108338	cyprodinil results in increased expression of NRF1 mRNA	PMID:33352482
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20180515	CTD	MESH:D003907	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of NRF1 mRNA; [Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of NRF1 mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of NRF1 mRNA	PMID:29288687|PMID:32417366
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:42017	2,4-dinitrophenol	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D019297	2,4-Dinitrophenol results in increased expression of NRF1 mRNA	PMID:11784294
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:42478	ethidium	increases expression	ISO	RGD:1312137	E	RGD:6480464	20121009	CTD	MESH:D004996	Ethidium results in increased expression of NRF1 mRNA	PMID:22712077
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312138	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NRF1 mRNA	PMID:28973697
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein]	PMID:36806343
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011692	Puromycin Aminonucleoside affects the expression of NRF1 mRNA	PMID:16609681
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:44032	indinavir	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D019469	Indinavir results in increased expression of NRF1 mRNA	PMID:17926646
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1312137	E	RGD:6480464	20121009	CTD	MESH:C016601	afimoxifene results in increased expression of NRF1 mRNA	PMID:22105178
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20121009	CTD	MESH:C016601	fulvestrant inhibits the reaction [afimoxifene results in increased expression of NRF1 mRNA]; Vehicle Emissions inhibits the reaction [afimoxifene results in increased expression of NRF1 mRNA]	PMID:22105178
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312137	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NRF1 mRNA	PMID:38832940
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312137	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of NRF1 mRNA	PMID:29067470
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312138	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of NRF1 protein	PMID:28827156|PMID:33271250
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312137	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NRF1 gene	PMID:25304211
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1312137	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of NRF1 mRNA	PMID:21514422
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NRF1 mRNA	PMID:39836092
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312137	E	RGD:6480464	20170516	CTD	MESH:C016766	sulforaphane results in increased expression of NRF1 protein	PMID:27993529
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:4784	enalapril	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004656	Enalapril results in increased expression of NRF1 mRNA	PMID:18765277
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:49900	arsenous acid	affects methylation	ISO	RGD:1312137	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide affects the methylation of NRF1 promoter	PMID:26046465
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of NRF1 mRNA	PMID:30307764
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:50385	hemin	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:D006427	Hemin inhibits the reaction [manganese chloride affects the expression of NRF1 protein]	PMID:30040983
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of NRF1 mRNA	PMID:30047161
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:50686	atorvastatin calcium	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069059	Atorvastatin affects the expression of NRF1 mRNA	PMID:21775390
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069059	Atorvastatin results in increased expression of NRF1 mRNA	PMID:21775390
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:50686	atorvastatin calcium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069059	Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of NRF1 mRNA]; Quercetin inhibits the reaction [Atorvastatin affects the expression of NRF1 mRNA]	PMID:21775390
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NRF1 mRNA	PMID:35964746
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:5298	Genipin	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20171010	CTD	MESH:C007834	genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NRF1 protein]	PMID:28477916
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NRF1 mRNA	PMID:19042947
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:5352	Gingerenone A	increases expression	ISO	RGD:1312138	E	RGD:6480464	20240305	CTD	MESH:C000604237	gingerenone A results in increased expression of NRF1 mRNA	PMID:28556482
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:6030	isoniazide	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20200310	CTD	MESH:D007538	Isoniazid results in decreased expression of NRF1 protein	PMID:28556920
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:6030	isoniazide	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20200310	CTD	MESH:D007538	acadesine inhibits the reaction [Isoniazid results in decreased expression of NRF1 protein]	PMID:28556920
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:63041	manganese(II) chloride	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C025340	manganese chloride affects the expression of NRF1 protein	PMID:30040983
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:C025340	Hemin inhibits the reaction [manganese chloride affects the expression of NRF1 protein]	PMID:30040983
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:63581	stavudine	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D018119	Stavudine results in increased expression of NRF1 mRNA	PMID:17926646
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NRF1 mRNA	PMID:25729387
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NRF1 mRNA	PMID:25729387
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312137	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of NRF1 mRNA	PMID:16934159
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:63949	2,3-bis(4-hydroxyphenyl)propionitrile	increases expression	ISO	RGD:1312137	E	RGD:6480464	20220308	CTD	MESH:C486182	2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of NRF1 mRNA	PMID:22105178
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20190312	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 mRNA; 1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 protein	PMID:26141122
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20240604	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 mRNA; 1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 protein	PMID:33994527
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20190312	CTD	MESH:D015655	PPARGC1A protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 mRNA]; PPARGC1A protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 protein]	PMID:26141122
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20240604	CTD	MESH:D015655	salvianolic acid B inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 mRNA]; salvianolic acid B inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 protein]	PMID:33994527
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:64108	8-bromo-3',5'-cyclic GMP	increases expression	ISO	RGD:1312137	E	RGD:6480464	20141111	CTD	MESH:C016276	8-bromocyclic GMP results in increased expression of NRF1 mRNA	PMID:24041027
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:64108	8-bromo-3',5'-cyclic GMP	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20141111	CTD	MESH:C016276	tin protoporphyrin IX inhibits the reaction [8-bromocyclic GMP results in increased expression of NRF1 mRNA]	PMID:24041027
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:6451	Licarin A	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20180515	CTD	MESH:C432503	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of NRF1 mRNA	PMID:29288687
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:64648	enniatin	decreases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C100264	enniatins results in decreased expression of NRF1 mRNA	PMID:27163883
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of NRF1 protein]	PMID:17179207
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20141111	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin results in increased expression of NRF1 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of NRF1 mRNA]	PMID:24041027
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:6541	losartan	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019808	Losartan results in increased expression of NRF1 mRNA	PMID:18765277
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:6751	mepanipyrim	increases expression	ISO	RGD:1312137	E	RGD:6480464	20210810	CTD	MESH:C104083	mepanipyrim results in increased expression of NRF1 mRNA	PMID:33352482
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1312137	E	RGD:6480464	20120717	CTD	MESH:D008687	Metformin results in increased expression of NRF1 mRNA	PMID:16380484
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1312138	E	RGD:6480464	20160412	CTD	MESH:D008687	Metformin results in increased expression of NRF1 mRNA	PMID:24428821
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312138	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of NRF1 mRNA	PMID:26307267
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]	PMID:29729358
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:75633	procyanidin B1	increases expression	ISO	RGD:1312138	E	RGD:6480464	20260804	CTD	MESH:C479579	procyanidin B1 results in increased expression of NRF1 mRNA	PMID:42097479
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:756647	ripretinib	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20260714	CTD	MESH:C000707850	ripretinib results in decreased expression of NRF1 mRNA; ripretinib results in decreased expression of NRF1 protein	PMID:36933644
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:76451	alloxan	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D000496	Alloxan affects the reaction [imisopasem manganese results in increased expression of NRF1 protein]	PMID:28483572
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of NRF1 mRNA]; dorsomorphin inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]	PMID:20438809
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:81579	Erythropoietin	increases expression	ISO	RGD:1312137	E	RGD:6480464	20171010	CTD	MESH:D004921	Erythropoietin results in increased expression of NRF1 protein	PMID:28456571
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:81579	Erythropoietin	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20171010	CTD	MESH:D004921	Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]; SIRT1 protein affects the reaction [Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]]	PMID:28456571
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 mRNA; 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 protein	PMID:36269211
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:C511295	MIR128-1 promotes the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 mRNA]; MIR128-1 promotes the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 protein]; ZLN005 inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 mRNA]; ZLN005 inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 protein]	PMID:36269211
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:81763	fludioxonil	increases expression	ISO	RGD:1312137	E	RGD:6480464	20141104	CTD	MESH:C108339	fludioxonil results in increased expression of NRF1 mRNA	PMID:23436777
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:82008	Flumetralin	increases expression	ISO	RGD:1312137	E	RGD:6480464	20210810	CTD	MESH:C000617134	flumetralin results in increased expression of NRF1 mRNA	PMID:33352482
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:82035	propham	increases expression	ISO	RGD:1312137	E	RGD:6480464	20210810	CTD	MESH:C100175	propham results in increased expression of NRF1 mRNA	PMID:33352482
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:82621	monascin	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C517880	monascin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]; Tretinoin inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]]	PMID:23331247
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NRF1 mRNA	PMID:30047161
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:85994	lenvatinib	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C531958	lenvatinib affects the expression of NRF1 mRNA	PMID:34019861
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:8674	pyrimethanil	increases expression	ISO	RGD:1312137	E	RGD:6480464	20210810	CTD	MESH:C108337	pyrimethanil results in increased expression of NRF1 mRNA	PMID:33352482
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1312137	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of NRF1 mRNA	PMID:22105178
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20161213	CTD	MESH:D020849	fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of NRF1 mRNA]; Vehicle Emissions inhibits the reaction [Raloxifene Hydrochloride results in increased expression of NRF1 mRNA]	PMID:22105178
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:88522	Monobutylphthalate	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of NRF1 mRNA	PMID:20864626
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:90724	AM-251	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20201215	CTD	MESH:C103505	AM 251 inhibits the reaction [Dietary Fats results in decreased expression of NRF1 mRNA]	PMID:26847930
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:91091	CHIR 99021	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20190611	CTD	MESH:C473711	Chir 99021 results in decreased expression of NRF1 mRNA	PMID:29883716
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:91215	1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one	multiple interactions	EXP		E	RGD:6480464	20170221	CTD	MESH:C095284	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of NRF1 protein]	PMID:17179207
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:91215	1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20170221	CTD	MESH:C095284	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased expression of NRF1 mRNA]; 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [S-nitro-N-acetylpenicillamine results in increased expression of NRF1 mRNA]	PMID:24041027
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NRF1 mRNA	PMID:19281266
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9381	T-2 toxin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D013605	T-2 Toxin affects the expression of NRF1 mRNA	PMID:29870751
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20230404	CTD	MESH:D013605	T-2 Toxin results in decreased expression of NRF1 mRNA; T-2 Toxin results in decreased expression of NRF1 protein	PMID:35842139
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20170516	CTD	MESH:D013605	T-2 Toxin results in decreased expression of NRF1 protein	PMID:27363784
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9381	T-2 toxin	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20200114	CTD	MESH:D013605	NFE2L2 protein affects the reaction [T-2 Toxin results in decreased expression of NRF1 mRNA]; NFE2L2 protein affects the reaction [T-2 Toxin results in decreased expression of NRF1 protein]; T-2 Toxin promotes the reaction [NRF1 protein binds to CYP1A1 promoter]	PMID:31470059|PMID:35842139
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9381	T-2 toxin	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20170516	CTD	MESH:D013605	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [T-2 Toxin results in decreased expression of NRF1 protein]	PMID:27363784
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312137	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NRF1 mRNA	PMID:22378314
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1312137	E	RGD:6480464	20141014	CTD	MESH:D019284	NRF1 protein inhibits the reaction [Thapsigargin results in decreased phosphorylation of AKT1 protein]	PMID:22378314
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9747	Triptolide	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C001899	triptolide results in decreased expression of NRF1 mRNA	PMID:36436616
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20180828	CTD	MESH:C001899	triptolide results in decreased expression of NRF1 mRNA	PMID:29723566
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9747	Triptolide	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:C001899	7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of and affects the localization of NRF1 protein]; 7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NRF1 mRNA]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of ATP5F1A mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of ATP5F1A protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NDUFB8 mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NDUFB8 protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of SDHB mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of SDHB protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of UQCRC2 mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of UQCRC2 protein]]; SR18292 inhibits the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NRF1 mRNA]]; triptolide results in decreased expression of and affects the localization of NRF1 protein	PMID:36436616
1304603	Nrf1	nuclear respiratory factor 1	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of NRF1 mRNA	PMID:14563825
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:10101	zalcitabine	multiple interactions	EXP		E	RGD:6480464	20180918	CTD	MESH:D016047	[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of SENP5 mRNA	PMID:18606552
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20180918	CTD	MESH:D004237	Diuron results in increased expression of SENP5 mRNA	PMID:21551480
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312140	E	RGD:6480464	20180911	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SENP5 mRNA	PMID:26251327
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312139	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SENP5 mRNA	PMID:33167477
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312140	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SENP5 mRNA	PMID:39241906
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D004958	Estradiol results in increased expression of SENP5 mRNA	PMID:20106945
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312140	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SENP5 mRNA	PMID:39298647
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SENP5 mRNA	PMID:33387578
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312140	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SENP5 mRNA	PMID:33754040
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312139	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SENP5 intron	PMID:30157460
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D019327	Copper Sulfate results in increased expression of SENP5 mRNA	PMID:19549813
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SENP5 gene; Aflatoxin B1 results in increased methylation of SENP5 intron	PMID:27153756|PMID:30157460
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SENP5 mRNA	PMID:23649840
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SENP5 mRNA	PMID:18593933
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312139	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SENP5 protein	PMID:35688186
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312140	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SENP5 mRNA	PMID:28960355
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312139	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SENP5 mRNA	PMID:23557933
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312140	E	RGD:6480464	20180911	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SENP5 mRNA	PMID:21570461
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SENP5 mRNA	PMID:33387578
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312140	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SENP5 mRNA	PMID:31961203
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SENP5 mRNA	PMID:28001369
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312139	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SENP5 mRNA	PMID:29803840
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312139	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SENP5 mRNA	PMID:38568856
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312139	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SENP5 intron; Benzo(a)pyrene affects the methylation of SENP5 promoter	PMID:27901495|PMID:30157460
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SENP5 mRNA	PMID:18593933
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SENP5 mRNA	PMID:26238291
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20180918	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP5 mRNA	PMID:25729387
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SENP5 mRNA	PMID:34492290
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312140	E	RGD:6480464	20180911	CTD	MESH:C006253	pirinixic acid results in increased expression of SENP5 mRNA	PMID:23811191
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SENP5 mRNA	PMID:30816183|PMID:32528016
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312140	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SENP5 mRNA	PMID:33221593
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:3374	capsaicin	decreases expression	EXP		E	RGD:6480464	20180918	CTD	MESH:D002211	Capsaicin results in decreased expression of SENP5 mRNA	PMID:20349343
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312140	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SENP5 mRNA	PMID:39298647
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312139	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SENP5 intron	PMID:30157460
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20180918	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SENP5 mRNA	PMID:21266533
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312139	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SENP5 mRNA	PMID:37042841
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312139	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SENP5 mRNA	PMID:31533062
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D014635	Valproic Acid results in increased expression of SENP5 mRNA	PMID:29154799
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D016572	Cyclosporine results in increased expression of SENP5 mRNA	PMID:20106945
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312140	E	RGD:6480464	20180911	CTD	MESH:D008727	Methotrexate affects the expression of SENP5 mRNA	PMID:18502557
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:C012589	trichostatin A affects the expression of SENP5 mRNA	PMID:28542535
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312140	E	RGD:6480464	20180911	CTD	MESH:D000082	Acetaminophen affects the expression of SENP5 mRNA	PMID:17562736
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312140	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SENP5 mRNA	PMID:29279043
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:48981	quinolin-8-ol	decreases expression	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D015125	Oxyquinoline results in decreased expression of SENP5 mRNA	PMID:21632981
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20180918	CTD	MESH:D015735	Mifepristone results in decreased expression of SENP5 mRNA	PMID:25972201
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20180918	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP5 mRNA	PMID:25729387
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312139	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SENP5 intron	PMID:30157460
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312139	E	RGD:6480464	20180911	CTD	MESH:D010634	Phenobarbital affects the expression of SENP5 mRNA	PMID:19159669
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312139	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SENP5 mRNA	PMID:38568856
1304604	Senp5	SUMO specific peptidase 5	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20180918	CTD	MESH:C025643	vinclozolin affects the expression of SENP5 mRNA	PMID:19015723
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:15551	prostaglandin E2	affects binding	ISO	RGD:1312141	E	RGD:6480464	20211214	CTD	MESH:D015232	Dinoprostone binds to SLC22A22 protein	PMID:20448048
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:15551	prostaglandin E2	increases transport	ISO	RGD:1312141	E	RGD:6480464	20211214	CTD	MESH:D015232	SLC22A22 protein results in increased transport of Dinoprostone	PMID:20448048
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:15553	prostaglandin F2alpha	affects binding	ISO	RGD:1312141	E	RGD:6480464	20211214	CTD	MESH:D015237	Dinoprost binds to SLC22A22 protein	PMID:20448048
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:15555	prostaglandin D2	affects binding	ISO	RGD:1312141	E	RGD:6480464	20211214	CTD	MESH:D015230	Prostaglandin D2 binds to SLC22A22 protein	PMID:20448048
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312141	E	RGD:6480464	20211214	CTD	MESH:D007631	Chlordecone results in decreased expression of SLC22A22 mRNA	PMID:29980752
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SLC22A22 protein	PMID:34915118
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of SLC22A22 mRNA	PMID:21515302
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC22A10 gene	PMID:27153756
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312141	E	RGD:6480464	20211214	CTD	MESH:D005492	Folic Acid results in decreased expression of SLC22A22 mRNA	PMID:25629700
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:D005492	Folic Acid results in decreased expression of SLC22A10 mRNA	PMID:21867686
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1602951	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC22A10 mRNA	PMID:23557933
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC22A10 mRNA	PMID:26159488
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312141	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC22A22 mRNA	PMID:36209798
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602951	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC22A10 mRNA	PMID:38568856
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC22A10 mRNA	PMID:32234424
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC22A10 mRNA	PMID:22316170
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SLC22A10 mRNA	PMID:25895662
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1602951	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC22A10 gene	PMID:31601247
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20211214	CTD	MESH:C501413	tesaglitazar results in decreased expression of SLC22A22 mRNA	PMID:21515302
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC22A22 mRNA	PMID:25181051
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602951	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC22A10 gene	PMID:31601247
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312141	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of SLC22A22 intron	PMID:28392331
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SLC22A10 mRNA	PMID:32588087
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SLC22A10 mRNA	PMID:32588087
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SLC22A10 mRNA	PMID:32588087|PMID:36864359
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312141	E	RGD:6480464	20211214	CTD	MESH:D014635	Valproic Acid affects the expression of SLC22A22 mRNA	PMID:17963808
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:40279	allopurinol	decreases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:D000493	Allopurinol results in decreased expression of SLC22A22 mRNA	PMID:37876353
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1602951	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC22A10 mRNA	PMID:38832940
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:4791	endosulfan	multiple interactions	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC22A10 mRNA	PMID:26159488
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:C005223	methyleugenol results in decreased expression of SLC22A10 mRNA	PMID:32234424
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312141	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of SLC22A22 mRNA	PMID:36851058
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20211214	CTD	MESH:C025589	ochratoxin A results in decreased expression of SLC22A22 mRNA	PMID:30449730
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:82284	2-Amino-9H-pyrido[2,3-b]indole	decreases expression	ISO	RGD:1602951	E	RGD:6480464	20260113	CTD	MESH:C017822	2-amino-9H-pyrido(2,3-b)indole results in decreased expression of SLC22A10 mRNA	PMID:40713012
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20211214	CTD	MESH:C057693	Troglitazone results in decreased expression of SLC22A22 mRNA	PMID:21515302
1304605	Slc22a22	solute carrier family 22 member 22	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1602951	E	RGD:6480464	20220208	CTD	MESH:C057693	Troglitazone results in decreased expression of SLC22A10 mRNA	PMID:25572481
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312142	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of AGR2 mRNA	PMID:38218311
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312142	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of AGR2 mRNA	PMID:25812627
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of AGR2 protein	PMID:36641056
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of AGR2 mRNA	PMID:20044591
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312142	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of AGR2 mRNA	PMID:21632981
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	affects expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone affects the expression of AGR2 mRNA	PMID:17094431
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312142	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of AGR2 mRNA	PMID:29581250
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of AGR2 mRNA	PMID:23019147
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of AGR2 mRNA	PMID:32145629
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of AGR2 mRNA; Estradiol results in increased expression of AGR2 protein	PMID:16474171|PMID:19167446|PMID:20531310|PMID:21185374
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of AGR2 mRNA	PMID:26496021
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of AGR2 mRNA; Estradiol promotes the reaction [[ESR1 protein binds to AGR2 promoter] which results in increased expression of AGR2 mRNA]; Estradiol promotes the reaction [ESR1 protein binds to AGR2 promoter]	PMID:20531310|PMID:30165855
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312143	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of AGR2 mRNA	PMID:33711761
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of AGR2 mRNA	PMID:33387578
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17245	carbon monoxide	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20200310	CTD	MESH:D002248	[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of AGR2 mRNA	PMID:29621558
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17347	testosterone	affects expression	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone affects the expression of AGR2 mRNA	PMID:17003280
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of AGR2 mRNA	PMID:21592394
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of AGR2 mRNA	PMID:26496021
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of AGR2 mRNA	PMID:21592394
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of AGR2 mRNA	PMID:36139627
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of AGR2 mRNA	PMID:21592394
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of AGR2 mRNA	PMID:21592394
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:18422	sulfur dioxide	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20200310	CTD	MESH:D013458	[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of AGR2 mRNA	PMID:29621558
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGR2 mRNA	PMID:39012411
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of AGR2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of AGR2 mRNA	PMID:34911549
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312143	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of AGR2 mRNA	PMID:20857495
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid results in increased expression of AGR2 mRNA	PMID:17868486
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AGR2 mRNA	PMID:22206623
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AGR2 mRNA	PMID:32525701
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312143	E	RGD:6480464	20240604	CTD	MESH:C010974	Glyphosate results in decreased expression of AGR2 mRNA	PMID:33713393
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of AGR2 mRNA	PMID:19167446
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of AGR2 mRNA	PMID:27392435
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1312143	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein affects the expression of AGR2 mRNA	PMID:32186404
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of AGR2 mRNA	PMID:16474171
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312142	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AGR2 mRNA; Tetrachlorodibenzodioxin results in increased expression of AGR2 protein	PMID:18061397|PMID:20106945|PMID:20299546|PMID:21632981|PMID:26238291
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D013749	AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of AGR2 protein]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to AGR2 promoter]	PMID:20299546
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGR2 mRNA	PMID:17942748
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of AGR2 mRNA	PMID:39709020
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28689	dehydroepiandrosterone	affects expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D003687	Dehydroepiandrosterone affects the expression of AGR2 mRNA	PMID:17094431
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28842	octadecanoic acid	increases expression	ISO	RGD:1312142	E	RGD:6480464	20210706	CTD	MESH:C031183	stearic acid results in increased expression of AGR2 mRNA	PMID:32347412
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of AGR2 mRNA	PMID:20044591
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312142	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of AGR2 mRNA	PMID:39719251
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312143	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of AGR2 mRNA	PMID:17077188|PMID:17350061
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Diethylstilbestrol] results in increased expression of AGR2 mRNA	PMID:19665456
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AGR2 mRNA; Benzo(a)pyrene results in increased expression of AGR2 protein	PMID:18061397|PMID:20106945|PMID:20299546|PMID:21632981|PMID:21871943|PMID:22316170|PMID:26238291|PMID:32234424
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of AGR2 mRNA	PMID:18991936
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312143	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of AGR2 mRNA	PMID:20857495
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of AGR2 mRNA	PMID:25895662
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1312142	E	RGD:6480464	20191114	CTD	MESH:C006632	AGR2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312142	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of AGR2 mRNA	PMID:22521957
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:3090	bicalutamide	increases expression	ISO	RGD:1312142	E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of AGR2 mRNA	PMID:15638997
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:31348	capecitabine	increases response to substance	ISO	RGD:1312142	E	RGD:6480464	20170228	CTD	MESH:C110904	AGR2 protein results in increased susceptibility to Capecitabine	PMID:16734730
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:31521	doxifluridine	increases response to substance	ISO	RGD:1312142	E	RGD:6480464	20130806	CTD	MESH:C025034	AGR2 protein results in increased susceptibility to doxifluridine	PMID:16734730
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:31638	fulvestrant	affects response to substance	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:C070081	AGR2 protein affects the susceptibility to fulvestrant	PMID:20525379
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312143	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of AGR2 mRNA	PMID:23557971
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of AGR2 mRNA	PMID:17426115
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of AGR2 mRNA	PMID:25181051
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of AGR2 mRNA	PMID:16474171
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312143	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of AGR2 mRNA	PMID:32156529
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of AGR2 mRNA; [bisphenol A co-treated with Testosterone] results in decreased expression of AGR2 mRNA	PMID:26496021
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of AGR2 mRNA	PMID:28300664
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to AGR2 promoter]	PMID:20348232
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA	PMID:16997883
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312143	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in decreased expression of AGR2 protein	PMID:39748354
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312142	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of AGR2 mRNA	PMID:29024780
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312142	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AGR2 mRNA	PMID:38174414
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGR2 mRNA	PMID:39012411
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of AGR2 mRNA	PMID:27387713
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AGR2 mRNA	PMID:19376846
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312142	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of AGR2 mRNA	PMID:25812627
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of AGR2 mRNA	PMID:28302478
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312142	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of AGR2 mRNA	PMID:19167446
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AGR2 mRNA	PMID:19167446
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312143	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of AGR2 mRNA	PMID:23125180
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of AGR2 mRNA	PMID:17198877
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312142	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AGR2 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41774	tamoxifen	affects response to substance	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D013629	AGR2 protein affects the susceptibility to Tamoxifen	PMID:20525379
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41774	tamoxifen	decreases response to substance	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D013629	AGR2 protein results in decreased susceptibility to Tamoxifen	PMID:20531310
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of AGR2 mRNA; Tamoxifen results in increased expression of AGR2 protein	PMID:20531310
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen promotes the reaction [[ESR1 protein binds to AGR2 promoter] which results in increased expression of AGR2 mRNA]; Tamoxifen promotes the reaction [ESR1 protein binds to AGR2 promoter]	PMID:20531310
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA	PMID:16997883
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D004054	[sodium arsenite co-treated with Diethylstilbestrol] results in increased expression of AGR2 mRNA	PMID:19665456
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312142	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of AGR2 mRNA; Okadaic Acid results in increased expression of AGR2 protein	PMID:38832940
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of AGR2 mRNA]	PMID:15016801
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of AGR2 mRNA	PMID:24714768
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1312143	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of AGR2 mRNA	PMID:16251409
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AGR2 mRNA	PMID:32525701
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of AGR2 mRNA	PMID:18175754
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AGR2 mRNA	PMID:17557909
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AGR2 mRNA	PMID:17942748
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGR2 mRNA	PMID:17942748
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1312142	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of AGR2 mRNA	PMID:32234424
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1312142	E	RGD:6480464	20191114	CTD	MESH:C032793	AGR2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312142	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of AGR2 mRNA	PMID:22521957
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312143	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of AGR2 mRNA	PMID:25554681
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312143	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AGR2 mRNA	PMID:25554681
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in decreased expression of AGR2 mRNA	PMID:22504374
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of AGR2 mRNA	PMID:17982090
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of AGR2 mRNA	PMID:20436886
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312142	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AGR2 protein	PMID:32959892
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:64153	tanespimycin	increases expression	ISO	RGD:1312142	E	RGD:6480464	20200804	CTD	MESH:C112765	tanespimycin analog results in increased expression of AGR2 protein; tanespimycin results in increased expression of AGR2 protein	PMID:31370342
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:64153	tanespimycin	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20200804	CTD	MESH:C112765	[tanespimycin co-treated with VER 155008] results in increased expression of AGR2 protein	PMID:31370342
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:64211	8-Br-cAMP	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20120412	CTD	MESH:D015124	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA	PMID:16997883
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AGR2 mRNA	PMID:22206623
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of AGR2 mRNA	PMID:33484710
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of AGR2 mRNA	PMID:36139627
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA	PMID:19167446
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of AGR2 mRNA	PMID:36084822
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312142	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AGR2 mRNA	PMID:32525701
1304606	Agr2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AGR2 mRNA	PMID:22504374
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602714	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TMEM216 mRNA	PMID:33167477
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1602714	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TMEM216 mRNA	PMID:22378314
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602714	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TMEM216 mRNA	PMID:37042841
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of TMEM216 mRNA	PMID:26496021
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TMEM216 mRNA	PMID:26577399
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TMEM216 mRNA	PMID:33387578
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602714	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TMEM216 mRNA	PMID:19549813
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312144	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TMEM216 mRNA	PMID:19770486
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602714	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TMEM216 mRNA	PMID:35430440
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM216 mRNA	PMID:33387578
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312144	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TMEM216 mRNA	PMID:25629700
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312144	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM216 mRNA	PMID:22206623
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312144	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TMEM216 mRNA	PMID:28960355
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TMEM216 mRNA	PMID:31881176
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1602714	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of TMEM216 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of TMEM216 mRNA	PMID:23557933
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312144	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM216 mRNA	PMID:24680724
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM216 mRNA	PMID:33387578
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312144	E	RGD:6480464	20120522	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM216 mRNA	PMID:19770486
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602714	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMEM216 promoter	PMID:27901495
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1602714	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TMEM216 mRNA]	PMID:32406909
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TMEM216 mRNA	PMID:30047161
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312144	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM216 gene	PMID:35295148
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TMEM216 mRNA	PMID:34492290
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1602714	E	RGD:6480464	20120522	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TMEM216 mRNA	PMID:19710929
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM216 mRNA	PMID:25181051
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of TMEM216 mRNA	PMID:26496021
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602714	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMEM216 mRNA	PMID:37042841
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602714	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMEM216 mRNA	PMID:38568856
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1602714	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TMEM216 mRNA	PMID:19320972
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1602714	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TMEM216 mRNA	PMID:40419075
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602714	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM216 mRNA	PMID:25979313
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602714	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM216 mRNA	PMID:23179753
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TMEM216 mRNA	PMID:30047161
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312144	E	RGD:6480464	20120522	CTD	MESH:D016572	Cyclosporine results in decreased expression of TMEM216 mRNA	PMID:19770486
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMEM216 mRNA	PMID:33387578
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TMEM216 mRNA	PMID:29391264
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TMEM216 mRNA	PMID:30047161
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312144	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM216 mRNA	PMID:22206623
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TMEM216 mRNA	PMID:30047161
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1312144	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of TMEM216 mRNA	PMID:40826991
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TMEM216 mRNA	PMID:19281266
1304607	Tmem216	transmembrane protein 216	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312144	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TMEM216 mRNA	PMID:35537566
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312145	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TECRL mRNA	PMID:30529165
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1604717	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TECRL mRNA	PMID:26079696
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312145	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TECRL mRNA	PMID:22401849
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312145	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TECRL mRNA	PMID:28960355
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1604717	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TECRL mRNA	PMID:24768652|PMID:25583101
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TECRL mRNA	PMID:32109520
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TECRL mRNA	PMID:28374803
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TECRL mRNA	PMID:28959563
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1604717	E	RGD:6480464	20150127	CTD	MESH:D003561	Cytarabine results in decreased expression of TECRL mRNA	PMID:21198554
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312145	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TECRL mRNA	PMID:27862939
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604717	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TECRL mRNA	PMID:29803840
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312145	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of TECRL mRNA	PMID:39631538
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312145	E	RGD:6480464	20150127	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TECRL mRNA	PMID:20713471
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312145	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of TECRL mRNA	PMID:35295148
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TECRL mRNA	PMID:25181051
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of TECRL mRNA	PMID:41034487
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312145	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of TECRL mRNA	PMID:25594700
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:34237	2,4-diaminotoluene	decreases expression	ISO	RGD:1312145	E	RGD:6480464	20150127	CTD	MESH:C010914	2,4-diaminotoluene results in decreased expression of TECRL mRNA	PMID:20713471
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1604717	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TECRL mRNA	PMID:31533062
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312145	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of TECRL mRNA	PMID:23125180
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604717	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TECRL mRNA	PMID:25979313
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1604717	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TECRL mRNA	PMID:38832940
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312145	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of TECRL mRNA	PMID:30529165
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312145	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TECRL mRNA; Nanotubes, Carbon results in increased expression of TECRL mRNA	PMID:25554681
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312145	E	RGD:6480464	20150127	CTD	MESH:D007545	Isoproterenol results in increased expression of TECRL mRNA	PMID:20003209
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312145	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in increased expression of TECRL mRNA	PMID:36914120
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TECRL gene	PMID:35440735
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of TECRL mRNA	PMID:33484710
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of TECRL mRNA	PMID:32109520
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312145	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TECRL mRNA	PMID:31388691
1304608	Tecrl	trans-2,3-enoyl-CoA reductase-like	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1604717	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of TECRL mRNA	PMID:26079696
1304609	Actr6	actin related protein 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ACTR6 mRNA	PMID:26251327
1304609	Actr6	actin related protein 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312146	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ACTR6 mRNA	PMID:33167477
1304609	Actr6	actin related protein 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312147	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ACTR6 mRNA	PMID:30319688
1304609	Actr6	actin related protein 6	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312146	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ACTR6 mRNA	PMID:20044591
1304609	Actr6	actin related protein 6	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312146	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ACTR6 mRNA	PMID:21632981
1304609	Actr6	actin related protein 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ACTR6 mRNA	PMID:39298647
1304609	Actr6	actin related protein 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ACTR6 mRNA	PMID:26496021
1304609	Actr6	actin related protein 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312146	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACTR6 mRNA	PMID:37042841
1304609	Actr6	actin related protein 6	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312146	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ACTR6 mRNA	PMID:21179406
1304609	Actr6	actin related protein 6	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ACTR6 mRNA	PMID:39836092
1304609	Actr6	actin related protein 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACTR6 mRNA	PMID:35301059
1304609	Actr6	actin related protein 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312146	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ACTR6 gene	PMID:27153756
1304609	Actr6	actin related protein 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312147	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACTR6 mRNA	PMID:22206623
1304609	Actr6	actin related protein 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ACTR6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACTR6 mRNA	PMID:39836092|PMID:40512198
1304609	Actr6	actin related protein 6	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ACTR6 mRNA	PMID:28189721|PMID:28960355
1304609	Actr6	actin related protein 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ACTR6 mRNA	PMID:23557933
1304609	Actr6	actin related protein 6	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312147	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ACTR6 mRNA	PMID:30912803
1304609	Actr6	actin related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312147	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ACTR6 mRNA	PMID:25975270
1304609	Actr6	actin related protein 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312146	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACTR6 mRNA	PMID:30851411
1304609	Actr6	actin related protein 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312146	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACTR6 mRNA	PMID:39719251
1304609	Actr6	actin related protein 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312146	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ACTR6 mRNA	PMID:38568856
1304609	Actr6	actin related protein 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ACTR6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACTR6 mRNA	PMID:39836092|PMID:40512198
1304609	Actr6	actin related protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312147	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACTR6 mRNA	PMID:19770486
1304609	Actr6	actin related protein 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ACTR6 mRNA]	PMID:32406909
1304609	Actr6	actin related protein 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312147	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACTR6 gene	PMID:35295148
1304609	Actr6	actin related protein 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ACTR6 mRNA	PMID:23411599|PMID:34492290
1304609	Actr6	actin related protein 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312147	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ACTR6 mRNA	PMID:18301758
1304609	Actr6	actin related protein 6	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312146	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ACTR6 gene	PMID:31601247
1304609	Actr6	actin related protein 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312147	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ACTR6 mRNA	PMID:32156529|PMID:33221593|PMID:38074096
1304609	Actr6	actin related protein 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of ACTR6 mRNA	PMID:26496021
1304609	Actr6	actin related protein 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ACTR6 mRNA	PMID:39298647
1304609	Actr6	actin related protein 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312146	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ACTR6 gene	PMID:31601247
1304609	Actr6	actin related protein 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312147	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ACTR6 mRNA	PMID:38685157
1304609	Actr6	actin related protein 6	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR6 mRNA	PMID:28628672
1304609	Actr6	actin related protein 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ACTR6 mRNA	PMID:37019170
1304609	Actr6	actin related protein 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR6 mRNA	PMID:28628672
1304609	Actr6	actin related protein 6	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ACTR6 mRNA	PMID:39836092
1304609	Actr6	actin related protein 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312146	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ACTR6 mRNA	PMID:26472689
1304609	Actr6	actin related protein 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACTR6 mRNA	PMID:35301059
1304609	Actr6	actin related protein 6	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in decreased methylation of ACTR6 gene	PMID:22079235
1304609	Actr6	actin related protein 6	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312146	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ACTR6 mRNA	PMID:19376846
1304609	Actr6	actin related protein 6	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312146	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ACTR6 mRNA	PMID:28302478
1304609	Actr6	actin related protein 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312146	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ACTR6 mRNA	PMID:27153767
1304609	Actr6	actin related protein 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312147	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ACTR6 mRNA	PMID:17292431
1304609	Actr6	actin related protein 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312146	E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in increased expression of ACTR6 mRNA	PMID:22083351|PMID:29154799
1304609	Actr6	actin related protein 6	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR6 mRNA	PMID:28628672
1304609	Actr6	actin related protein 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312147	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACTR6 mRNA	PMID:17562736
1304609	Actr6	actin related protein 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ACTR6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACTR6 mRNA	PMID:39836092|PMID:40512198
1304609	Actr6	actin related protein 6	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR6 mRNA	PMID:28628672
1304609	Actr6	actin related protein 6	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of ACTR6 mRNA	PMID:40234311
1304609	Actr6	actin related protein 6	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312146	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACTR6 protein	PMID:32959892
1304609	Actr6	actin related protein 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312146	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ACTR6 mRNA	PMID:39836092
1304609	Actr6	actin related protein 6	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312146	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ACTR6 mRNA	PMID:31758290
1304609	Actr6	actin related protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACTR6 mRNA	PMID:22206623
1304609	Actr6	actin related protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312147	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACTR6 mRNA	PMID:22206623
1304609	Actr6	actin related protein 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312146	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACTR6 mRNA	PMID:30851411
1304609	Actr6	actin related protein 6	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312146	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ACTR6 mRNA	PMID:30928695
1304609	Actr6	actin related protein 6	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312147	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ACTR6 mRNA	PMID:19270015
1304609	Actr6	actin related protein 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312147	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ACTR6 mRNA	PMID:39847705
1304609	Actr6	actin related protein 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ACTR6 mRNA	PMID:21346803
1304609	Actr6	actin related protein 6	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of ACTR6 mRNA	PMID:26217789
1304609	Actr6	actin related protein 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ACTR6 mRNA	PMID:21346803
1304609	Actr6	actin related protein 6	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of ACTR6 mRNA	PMID:23555832
1304610	Atg14	autophagy related 14	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312148	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of ATG14 mRNA	PMID:31863870
1304610	Atg14	autophagy related 14	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312149	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ATG14 mRNA	PMID:33045310
1304610	Atg14	autophagy related 14	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATG14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATG14 mRNA	PMID:32699268
1304610	Atg14	autophagy related 14	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ATG14 mRNA	PMID:26079696
1304610	Atg14	autophagy related 14	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of ATG14 mRNA	PMID:36841081
1304610	Atg14	autophagy related 14	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312149	E	RGD:6480464	20201103	CTD	MESH:D001280	Atrazine results in increased expression of ATG14 mRNA	PMID:30360616
1304610	Atg14	autophagy related 14	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1312149	E	RGD:6480464	20201103	CTD	MESH:D001280	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG14 mRNA]	PMID:30360616
1304610	Atg14	autophagy related 14	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1312149	E	RGD:6480464	20201103	CTD	MESH:C015329	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG14 mRNA]	PMID:30360616
1304610	Atg14	autophagy related 14	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312149	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ATG14 mRNA	PMID:30319688
1304610	Atg14	autophagy related 14	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312149	E	RGD:6480464	20140513	CTD	MESH:D000431	Ethanol results in increased expression of ATG14 mRNA	PMID:24095927
1304610	Atg14	autophagy related 14	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312149	E	RGD:6480464	20140513	CTD	MESH:D000431	FOXO3 gene mutant form inhibits the reaction [Ethanol results in increased expression of ATG14 mRNA]	PMID:24095927
1304610	Atg14	autophagy related 14	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1312148	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of ATG14 protein	PMID:35688186
1304610	Atg14	autophagy related 14	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312149	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ATG14 mRNA	PMID:39241906
1304610	Atg14	autophagy related 14	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312149	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ATG14 mRNA	PMID:39298647
1304610	Atg14	autophagy related 14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312149	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATG14 mRNA	PMID:34319233
1304610	Atg14	autophagy related 14	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATG14 mRNA	PMID:33387578
1304610	Atg14	autophagy related 14	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312148	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ATG14 mRNA	PMID:28818685
1304610	Atg14	autophagy related 14	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312148	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ATG14 mRNA	PMID:19549813
1304610	Atg14	autophagy related 14	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312148	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATG14 gene	PMID:27153756
1304610	Atg14	autophagy related 14	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312148	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATG14 mRNA	PMID:23649840
1304610	Atg14	autophagy related 14	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATG14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATG14 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of ATG14 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ATG14 mRNA	PMID:32699268|PMID:35430440
1304610	Atg14	autophagy related 14	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312149	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of ATG14 mRNA	PMID:31919559
1304610	Atg14	autophagy related 14	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312149	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ATG14 mRNA	PMID:22206623
1304610	Atg14	autophagy related 14	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATG14 mRNA	PMID:39836092
1304610	Atg14	autophagy related 14	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20120522	CTD	MESH:D012643	Selenium results in decreased expression of ATG14 mRNA	PMID:19244175
1304610	Atg14	autophagy related 14	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312149	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of ATG14 mRNA	PMID:31352102
1304610	Atg14	autophagy related 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATG14 mRNA	PMID:33387578
1304610	Atg14	autophagy related 14	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATG14 mRNA	PMID:29803840
1304610	Atg14	autophagy related 14	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20220208	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]	PMID:34439521
1304610	Atg14	autophagy related 14	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312148	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ATG14 mRNA	PMID:38568856
1304610	Atg14	autophagy related 14	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATG14 mRNA	PMID:39836092
1304610	Atg14	autophagy related 14	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312148	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATG14 intron	PMID:30157460
1304610	Atg14	autophagy related 14	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ATG14 mRNA	PMID:30047161
1304610	Atg14	autophagy related 14	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of ATG14 mRNA	PMID:23146750
1304610	Atg14	autophagy related 14	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ATG14 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304610	Atg14	autophagy related 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312148	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ATG14 mRNA	PMID:34439521
1304610	Atg14	autophagy related 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312149	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ATG14 mRNA	PMID:33221593
1304610	Atg14	autophagy related 14	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATG14 gene	PMID:28505145
1304610	Atg14	autophagy related 14	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20220208	CTD	MESH:C006780	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]; astaxanthine inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]	PMID:34439521
1304610	Atg14	autophagy related 14	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of ATG14 mRNA	PMID:23146750
1304610	Atg14	autophagy related 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312149	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ATG14 mRNA	PMID:39298647
1304610	Atg14	autophagy related 14	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312149	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ATG14 intron	PMID:28392331
1304610	Atg14	autophagy related 14	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312148	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATG14 mRNA	PMID:37042841
1304610	Atg14	autophagy related 14	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATG14 mRNA	PMID:38568856
1304610	Atg14	autophagy related 14	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ATG14 mRNA	PMID:23146750
1304610	Atg14	autophagy related 14	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312149	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ATG14 mRNA	PMID:28903501
1304610	Atg14	autophagy related 14	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATG14 mRNA	PMID:24386269
1304610	Atg14	autophagy related 14	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312148	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATG14 mRNA	PMID:19320972|PMID:19376846
1304610	Atg14	autophagy related 14	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATG14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATG14 mRNA	PMID:32699268
1304610	Atg14	autophagy related 14	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20120522	CTD	MESH:D012643	Selenium results in decreased expression of ATG14 mRNA	PMID:19244175
1304610	Atg14	autophagy related 14	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1312148	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of ATG14 mRNA	PMID:40434365
1304610	Atg14	autophagy related 14	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312148	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ATG14 mRNA	PMID:31533062
1304610	Atg14	autophagy related 14	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ATG14 mRNA	PMID:19167446
1304610	Atg14	autophagy related 14	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATG14 mRNA	PMID:23179753
1304610	Atg14	autophagy related 14	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ATG14 mRNA	PMID:30047161
1304610	Atg14	autophagy related 14	gene	CHEBI:40968	astaxanthin	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20220208	CTD	MESH:C005948	astaxanthine inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]	PMID:34439521
1304610	Atg14	autophagy related 14	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D003907	Dexamethasone results in increased expression of ATG14 protein	PMID:33359579
1304610	Atg14	autophagy related 14	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312148	E	RGD:6480464	20210406	CTD	MESH:D003907	Dexamethasone results in increased expression of ATG14 protein	PMID:33359579
1304610	Atg14	autophagy related 14	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20210406	CTD	MESH:D003907	5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid inhibits the reaction [Dexamethasone results in increased expression of ATG14 protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of ATG14 protein]	PMID:33359579
1304610	Atg14	autophagy related 14	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ATG14 mRNA	PMID:36653537
1304610	Atg14	autophagy related 14	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312149	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of ATG14 mRNA	PMID:17562736
1304610	Atg14	autophagy related 14	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATG14 mRNA	PMID:39836092
1304610	Atg14	autophagy related 14	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312149	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATG14 mRNA; Nanotubes, Carbon results in decreased expression of ATG14 mRNA	PMID:25554681
1304610	Atg14	autophagy related 14	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ATG14 mRNA	PMID:30047161
1304610	Atg14	autophagy related 14	gene	CHEBI:50692	mifepristone	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20210406	CTD	MESH:D015735	Mifepristone inhibits the reaction [Dexamethasone results in increased expression of ATG14 protein]	PMID:33359579
1304610	Atg14	autophagy related 14	gene	CHEBI:50833	cadmium sulfide	increases expression	ISO	RGD:1312148	E	RGD:6480464	20170516	CTD	MESH:C034939	cadmium sulfide results in increased expression of ATG14 mRNA	PMID:27866839
1304610	Atg14	autophagy related 14	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of ATG14 mRNA	PMID:24793618
1304610	Atg14	autophagy related 14	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D008694	Methamphetamine results in increased expression of ATG14 mRNA	PMID:32676729
1304610	Atg14	autophagy related 14	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312149	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ATG14 mRNA	PMID:22206623
1304610	Atg14	autophagy related 14	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312149	E	RGD:6480464	20120522	CTD	MESH:D010634	Phenobarbital results in increased expression of ATG14 mRNA	PMID:19270015
1304610	Atg14	autophagy related 14	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312149	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ATG14 mRNA	PMID:31388691
1304610	Atg14	autophagy related 14	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ATG14 mRNA	PMID:23146750
1304610	Atg14	autophagy related 14	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312148	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ATG14 mRNA	PMID:26079696
1304610	Atg14	autophagy related 14	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312149	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ATG14 mRNA	PMID:39847705
1304610	Atg14	autophagy related 14	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATG14 mRNA	PMID:30047161
1304610	Atg14	autophagy related 14	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ATG14 mRNA	PMID:19281266
1304610	Atg14	autophagy related 14	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1312149	E	RGD:6480464	20150825	CTD	MESH:D013605	T-2 Toxin results in increased expression of ATG14 mRNA	PMID:26138683
1304610	Atg14	autophagy related 14	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312148	E	RGD:6480464	20210608	CTD	MESH:C080163	trovafloxacin results in increased expression of ATG14 mRNA	PMID:33609687
1304610	Atg14	autophagy related 14	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1312148	E	RGD:6480464	20210608	CTD	MESH:C080163	TNF protein inhibits the reaction [trovafloxacin results in increased expression of ATG14 mRNA]	PMID:33609687
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1549986	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ZKSCAN17 mRNA	PMID:33045310
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in increased expression of ZFP496 mRNA	PMID:35192832
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA	PMID:25510870
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ZNF496 mRNA	PMID:22061828
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZKSCAN17 mRNA	PMID:36331819
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of ZKSCAN17 mRNA	PMID:28111341
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA	PMID:25510870
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA	PMID:25510870
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZFP496 mRNA	PMID:33354967
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZFP496 mRNA	PMID:30779732
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZKSCAN17 mRNA	PMID:22206623
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1549986	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ZKSCAN17 mRNA	PMID:28960355
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312150	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ZNF496 mRNA	PMID:27392435
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1549986	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZKSCAN17 mRNA	PMID:21570461|PMID:24058054
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP496 mRNA	PMID:21215274
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP496 mRNA	PMID:33387578
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1549986	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZKSCAN17 mRNA	PMID:19465110
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312150	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ZNF496 mRNA	PMID:32763439
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312150	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZNF496 promoter	PMID:27901495
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312150	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of ZNF496 promoter	PMID:23974009
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1312150	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of ZNF496 gene	PMID:31601247
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312150	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ZNF496 gene	PMID:31601247
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ZFP496 mRNA	PMID:30047161
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1549986	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZKSCAN17 gene; titanium dioxide results in decreased methylation of ZKSCAN17 promoter	PMID:35295148
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1549986	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ZKSCAN17 mRNA	PMID:18301758
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF496 mRNA	PMID:25181051
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312150	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of ZNF496 mRNA	PMID:20170705
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1549986	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ZKSCAN17 promoter	PMID:27334623
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP496 mRNA	PMID:32145629
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP496 mRNA	PMID:34947998
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312150	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ZNF496 gene	PMID:31601247
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312150	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ZNF496 gene	PMID:31601247
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA	PMID:25510870
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA	PMID:25510870
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1549986	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZKSCAN17 mRNA	PMID:39298647
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1549986	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZKSCAN17 mRNA	PMID:37019170
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of ZKSCAN17 mRNA	PMID:28111341
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ZFP496 mRNA	PMID:24386269
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1549986	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of ZKSCAN17 mRNA	PMID:23811191
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312150	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ZNF496 mRNA	PMID:19167446
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZKSCAN17 mRNA	PMID:36331819
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312150	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF496 mRNA	PMID:23179753
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZFP496 mRNA	PMID:30047161
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312150	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF496 mRNA	PMID:25562108
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1549986	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZKSCAN17 mRNA	PMID:17562736
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312150	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZNF496 mRNA	PMID:22230336
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1549986	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ZKSCAN17 mRNA	PMID:35436446
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:4998	fenarimol	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C033789	fenarimol results in increased expression of ZFP496 mRNA	PMID:28970091
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1312150	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of ZNF496 mRNA]	PMID:21095227
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZFP496 mRNA	PMID:30047161
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZKSCAN17 mRNA	PMID:22206623
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312150	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF496 protein	PMID:31285264
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	affects expression	ISO	RGD:1549986	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the expression of ZKSCAN17 mRNA	PMID:31388691
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C045950	propiconazole results in increased expression of ZFP496 mRNA	PMID:28970091
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZFP496 mRNA	PMID:30047161
1304611	Zfp496	zinc finger protein 496	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1549986	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ZNF496 mRNA	PMID:28973697
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312152	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RASGRP3 mRNA	PMID:33167477
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASGRP3 mRNA	PMID:30529165
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of RASGRP3 mRNA	PMID:24763279
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RASGRP3 mRNA	PMID:26079696
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:16243	quercetin	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin affects the expression of RASGRP3 mRNA	PMID:18178720
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of RASGRP3 mRNA	PMID:22185406
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:22185406
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RASGRP3 mRNA	PMID:22185406|PMID:39241906
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RASGRP3 mRNA	PMID:35811015
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20161228	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]; Dexamethasone promotes the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]; Quercetin inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:22185406|PMID:39241906
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312152	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RASGRP3 mRNA	PMID:31614463
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASGRP3 mRNA	PMID:37992649
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASGRP3 mRNA	PMID:37992649
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RASGRP3 mRNA	PMID:27523638
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312152	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RASGRP3 protein	PMID:37730182
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RASGRP3 mRNA	PMID:33387578
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of RASGRP3 mRNA	PMID:28522335
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RASGRP3 mRNA	PMID:29950665
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RASGRP3 mRNA	PMID:27153756
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010126	Ozone results in decreased expression of RASGRP3 mRNA	PMID:31397875
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RASGRP3 mRNA	PMID:41430723
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RASGRP3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RASGRP3 mRNA	PMID:34911549
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312152	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RASGRP3 gene	PMID:25304211
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RASGRP3 mRNA	PMID:31881176
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of RASGRP3 mRNA	PMID:27392435
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RASGRP3 mRNA	PMID:27392435
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312153	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASGRP3 mRNA	PMID:21570461
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASGRP3 mRNA	PMID:34747641
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASGRP3 mRNA	PMID:19933214
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312152	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RASGRP3 mRNA	PMID:33212167
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RASGRP3 mRNA	PMID:28959563
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of RASGRP3 mRNA	PMID:30911355
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RASGRP3 mRNA	PMID:29803840
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of RASGRP3 mRNA	PMID:39631538
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASGRP3 mRNA	PMID:37992649
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of RASGRP3 mRNA	PMID:25879800
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA	PMID:34876320
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA	PMID:34876320
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312153	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RASGRP3 mRNA	PMID:22228805|PMID:22610609|PMID:32417428
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312152	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RASGRP3 5' UTR; Benzo(a)pyrene results in increased methylation of RASGRP3 promoter	PMID:27901495
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGRP3 mRNA	PMID:27858113
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of RASGRP3 mRNA	PMID:30911355
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312153	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of RASGRP3 mRNA	PMID:27131904
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RASGRP3 mRNA	PMID:25895662
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RASGRP3 gene	PMID:31601247
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RASGRP3 mRNA	PMID:25729387
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312153	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of RASGRP3 mRNA	PMID:23557971
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RASGRP3 mRNA	PMID:29950665
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RASGRP3 mRNA	PMID:18648102
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RASGRP3 mRNA	PMID:19710929
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312153	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of RASGRP3 mRNA	PMID:19191707
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312152	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RASGRP3 mRNA	PMID:30690063
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RASGRP3 mRNA	PMID:25181051|PMID:34947998
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RASGRP3 mRNA	PMID:29275510
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312153	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RASGRP3 mRNA	PMID:30951980
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RASGRP3 gene	PMID:28505145
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RASGRP3 gene	PMID:31601247
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:33276	delta-tocotrienol	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:C082097	tocotrienol, delta results in decreased expression of RASGRP3 mRNA	PMID:22185406
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:33276	delta-tocotrienol	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:C082097	tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:22185406
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312153	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RASGRP3 mRNA	PMID:30951980|PMID:39298647|PMID:40203079
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312153	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of RASGRP3 mRNA	PMID:26377693
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGRP3 mRNA	PMID:27858113
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312153	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RASGRP3 mRNA	PMID:30951980
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312153	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RASGRP3 intron	PMID:28392331
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RASGRP3 mRNA	PMID:29950665
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RASGRP3 mRNA	PMID:21266533
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:39241906
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312152	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RASGRP3 mRNA	PMID:37042841
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312153	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RASGRP3 mRNA	PMID:26377693
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RASGRP3 mRNA	PMID:38382870
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RASGRP3 mRNA	PMID:24386269
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RASGRP3 mRNA	PMID:19320972
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312152	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RASGRP3 mRNA	PMID:24449571
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:35842	antirheumatic drug	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20161228	CTD	MESH:D018501	[Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of RASGRP3 mRNA	PMID:16817978
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312153	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RASGRP3 mRNA	PMID:40194260
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of RASGRP3 mRNA	PMID:29038090
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of RASGRP3 mRNA	PMID:23125180
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312152	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RASGRP3 mRNA	PMID:25979313
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of RASGRP3 mRNA	PMID:29154799
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312152	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RASGRP3 gene	PMID:29154799
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:D003907	Dexamethasone results in decreased expression of RASGRP3 mRNA	PMID:22185406
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:D003907	Dexamethasone promotes the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:22185406
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312153	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RASGRP3 mRNA	PMID:28973697
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASGRP3 mRNA	PMID:37992649
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20151110	CTD	MESH:D008727	[Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of RASGRP3 mRNA	PMID:16817978
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RASGRP3 mRNA	PMID:38832940
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of RASGRP3 mRNA	PMID:33387578
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RASGRP3 mRNA	PMID:35811015
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312152	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RASGRP3 gene	PMID:25304211
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of RASGRP3 mRNA	PMID:31838189
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RASGRP3 mRNA	PMID:29391264
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RASGRP3 mRNA	PMID:22079256
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA	PMID:34876320
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RASGRP3 mRNA; Nanotubes, Carbon results in decreased expression of RASGRP3 mRNA	PMID:25554681
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RASGRP3 mRNA	PMID:35964746
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGRP3 mRNA	PMID:27858113
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGRP3 mRNA	PMID:27858113
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASGRP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RASGRP3 mRNA	PMID:21641980|PMID:26378955
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of RASGRP3 mRNA	PMID:25729387
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RASGRP3 mRNA	PMID:25729387
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of RASGRP3 mRNA	PMID:15336504
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312152	E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in increased expression of RASGRP3 mRNA	PMID:25290377
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312153	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RASGRP3 mRNA	PMID:22206623
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RASGRP3 mRNA	PMID:22079256
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312152	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RASGRP3 mRNA	PMID:22714537
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RASGRP3 mRNA	PMID:22079256
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312152	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RASGRP3 gene]	PMID:28238834
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of RASGRP3 mRNA	PMID:36084822
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312152	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of RASGRP3 mRNA	PMID:26079696
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312153	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RASGRP3 mRNA	PMID:39847705
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA	PMID:34876320
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RASGRP3 mRNA	PMID:25825206
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:39241906
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312152	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of RASGRP3 mRNA	PMID:24921660
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312153	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of RASGRP3 mRNA	PMID:27131904
1304612	Rasgrp3	RAS guanyl releasing protein 3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RASGRP3 mRNA	PMID:28973697
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1351787	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ALPK1 mRNA	PMID:26272509
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550001	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ALPK1 mRNA	PMID:33045310
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1351787	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ALPK1 mRNA	PMID:33167477
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ALPK1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ALPK1 mRNA	PMID:32699268
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1351787	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ALPK1 mRNA	PMID:26079696
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550001	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ALPK1 mRNA	PMID:39241906
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1351787	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ALPK1 mRNA	PMID:30510588
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of ALPK1 mRNA	PMID:22217510
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ALPK1 mRNA	PMID:33387578
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1351787	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ALPK1 mRNA	PMID:37042841
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1351787	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of ALPK1 mRNA	PMID:27664576
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ALPK1 mRNA	PMID:37992649
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of ALPK1 5' UTR	PMID:33872906
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1351787	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ALPK1 mRNA	PMID:31256213
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ALPK1 mRNA	PMID:37992649
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ALPK1 mRNA	PMID:29945229
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of ALPK1 5' UTR	PMID:33872906
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	increases expression	ISO	RGD:1351787	E	RGD:6480464	20180313	CTD	MESH:D014527	Uric Acid results in increased expression of ALPK1 mRNA	PMID:27542954
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	increases expression	ISO	RGD:1550001	E	RGD:6480464	20180313	CTD	MESH:D014527	Uric Acid results in increased expression of ALPK1 mRNA	PMID:27542954
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	increases response to substance	ISO	RGD:1351787	E	RGD:6480464	20180313	CTD	MESH:D014527	ALPK1 protein results in increased susceptibility to Uric Acid	PMID:27542954
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20180313	CTD	MESH:D014527	ALPK1 protein promotes the reaction [Uric Acid results in increased secretion of TGFB1 protein]	PMID:27542954
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ALPK1 mRNA	PMID:33387578
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ALPK1 mRNA	PMID:36331819
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ALPK1 mRNA	PMID:37236586
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ALPK1 mRNA	PMID:21396975
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1351787	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ALPK1 mRNA	PMID:21641981|PMID:22100608
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1351787	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ALPK1 gene	PMID:27153756
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ALPK1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ALPK1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of ALPK1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ALPK1 mRNA	PMID:32699268|PMID:35430440
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALPK1 mRNA	PMID:39836092
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ALPK1 mRNA	PMID:23557933
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550001	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ALPK1 mRNA	PMID:21889950
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALPK1 mRNA	PMID:33387578
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of ALPK1 mRNA	PMID:28374803
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1351787	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ALPK1 mRNA	PMID:33212167
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1351787	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ALPK1 mRNA	PMID:30851411
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1550001	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in increased expression of ALPK1 mRNA	PMID:35032568
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ALPK1 mRNA	PMID:20971185
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1351787	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ALPK1 mRNA	PMID:29803840
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ALPK1 mRNA	PMID:37992649
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1351787	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ALPK1 mRNA	PMID:34032870
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351787	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ALPK1 mRNA	PMID:38568856
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALPK1 mRNA	PMID:39836092
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ALPK1 mRNA	PMID:34876320
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ALPK1 mRNA	PMID:34876320
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1351787	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ALPK1 mRNA	PMID:20064835
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351787	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ALPK1 5' UTR	PMID:27901495
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1550001	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ALPK1 exon	PMID:27901495
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1351787	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ALPK1 gene	PMID:25435355
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ALPK1 mRNA]	PMID:32406909
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ALPK1 mRNA	PMID:20971185
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1351787	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ALPK1 mRNA	PMID:23806026|PMID:25895662
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ALPK1 gene	PMID:31601247
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1351787	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of ALPK1 mRNA	PMID:31745603
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ALPK1 mRNA	PMID:23411599
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ALPK1 mRNA	PMID:30723492
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1550001	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of ALPK1 mRNA	PMID:19191707
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ALPK1 mRNA	PMID:25181051
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550001	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ALPK1 mRNA	PMID:38074096
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1351787	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ALPK1 mRNA	PMID:29275510
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550001	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ALPK1 mRNA	PMID:30951980
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ALPK1 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALPK1 mRNA	PMID:28628672|PMID:31601247
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550001	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ALPK1 mRNA	PMID:40203079
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALPK1 mRNA	PMID:28628672
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550001	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ALPK1 mRNA	PMID:38685157
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ALPK1 mRNA	PMID:28628672
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550001	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ALPK1 intron	PMID:28392331
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALPK1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ALPK1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALPK1 mRNA	PMID:28628672
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351787	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ALPK1 mRNA	PMID:37042841
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1351787	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ALPK1 mRNA	PMID:38174414
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ALPK1 mRNA	PMID:37236586
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1351787	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ALPK1 mRNA	PMID:24449571
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ALPK1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ALPK1 mRNA	PMID:32699268
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550001	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ALPK1 mRNA	PMID:40194260
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ALPK1 mRNA	PMID:36331819
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1351787	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ALPK1 mRNA	PMID:28001369
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351787	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of ALPK1 mRNA	PMID:28001369|PMID:29154799
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ALPK1 mRNA	PMID:30047161
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1351787	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of ALPK1 mRNA	PMID:27989131
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALPK1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ALPK1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALPK1 mRNA	PMID:28628672
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ALPK1 mRNA	PMID:37992649
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ALPK1 mRNA	PMID:33387578
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1351787	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ALPK1 mRNA	PMID:26690555
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALPK1 mRNA	PMID:39836092
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ALPK1 mRNA	PMID:29391264
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ALPK1 mRNA	PMID:34876320
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALPK1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ALPK1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALPK1 mRNA	PMID:28628672
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550001	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ALPK1 mRNA; Nanotubes, Carbon results in increased expression of ALPK1 mRNA	PMID:25620056
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ALPK1 mRNA	PMID:30047161
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:52136	glufosinate	decreases expression	ISO	RGD:1550001	E	RGD:6480464	20230905	CTD	MESH:C003121	phosphinothricin results in decreased expression of ALPK1 mRNA	PMID:34597628
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1550001	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ALPK1 mRNA	PMID:23608068
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of ALPK1 mRNA	PMID:35283115
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:67977	Chikusetsusaponin-IVa	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20260303	CTD	MESH:C098580	chikusetsu saponin IVa inhibits the reaction [Paroxetine results in increased expression of ALPK1 mRNA]	PMID:40885343
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1351787	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ALPK1 mRNA	PMID:30851411
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:7936	paroxetine	increases expression	ISO	RGD:1550001	E	RGD:6480464	20260303	CTD	MESH:D017374	Paroxetine results in increased expression of ALPK1 mRNA	PMID:40885343
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:7936	paroxetine	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20260303	CTD	MESH:D017374	chikusetsu saponin IVa inhibits the reaction [Paroxetine results in increased expression of ALPK1 mRNA]	PMID:40885343
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ALPK1 gene]	PMID:28238834
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1550001	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ALPK1 mRNA	PMID:34876320
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ALPK1 mRNA	PMID:30047161
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:9288	streptozocin	increases response to substance	ISO	RGD:1351787	E	RGD:6480464	20180313	CTD	MESH:D013311	ALPK1 protein results in increased susceptibility to Streptozocin	PMID:27542954
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1351787	E	RGD:6480464	20180313	CTD	MESH:D013311	[ALPK1 protein results in increased susceptibility to Streptozocin] which results in decreased expression of PRKG2 mRNA; [ALPK1 protein results in increased susceptibility to Streptozocin] which results in increased expression of TGFB1 mRNA; [ALPK1 protein results in increased susceptibility to Streptozocin] which results in increased expression of TGFB1 protein; ALPK1 protein promotes the reaction [Streptozocin results in decreased secretion of INS1 protein]; ALPK1 protein promotes the reaction [Streptozocin results in increased abundance of Blood Glucose]	PMID:27542954
1304613	Alpk1	alpha-kinase 1	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of ALPK1 gene	PMID:31079544
1304614	Epha6	Eph receptor A6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312155	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of EPHA6 mRNA	PMID:36189433
1304614	Epha6	Eph receptor A6	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312155	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EPHA6 mRNA	PMID:36189433
1304614	Epha6	Eph receptor A6	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of EPHA6 gene	PMID:28931070
1304614	Epha6	Eph receptor A6	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312155	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of EPHA6 mRNA	PMID:29018328
1304614	Epha6	Eph receptor A6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312155	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EPHA6 mRNA	PMID:12057914
1304614	Epha6	Eph receptor A6	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1605546	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of EPHA6 mRNA	PMID:30510588
1304614	Epha6	Eph receptor A6	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D011374	Progesterone results in decreased expression of EPHA6 mRNA	PMID:21770760
1304614	Epha6	Eph receptor A6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312155	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of EPHA6 mRNA	PMID:36189433
1304614	Epha6	Eph receptor A6	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of EPHA6 mRNA	PMID:26577399
1304614	Epha6	Eph receptor A6	gene	CHEBI:196991	4-hydroperoxycyclophosphamide	decreases expression	ISO	RGD:1312155	E	RGD:6480464	20120814	CTD	MESH:C011272	perfosfamide results in decreased expression of EPHA6 mRNA	PMID:19429390
1304614	Epha6	Eph receptor A6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605546	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of EPHA6 mRNA	PMID:19549813
1304614	Epha6	Eph receptor A6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605546	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EPHA6 gene; Aflatoxin B1 results in decreased methylation of EPHA6 intron	PMID:27153756|PMID:30157460
1304614	Epha6	Eph receptor A6	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of EPHA6 gene	PMID:35440735
1304614	Epha6	Eph receptor A6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605546	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of EPHA6 mRNA	PMID:41028656
1304614	Epha6	Eph receptor A6	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312155	E	RGD:6480464	20120515	CTD	MESH:D019833	Genistein results in decreased expression of EPHA6 mRNA	PMID:21810550
1304614	Epha6	Eph receptor A6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605546	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EPHA6 mRNA	PMID:33212167
1304614	Epha6	Eph receptor A6	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1605546	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of EPHA6 mRNA	PMID:32763439
1304614	Epha6	Eph receptor A6	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of EPHA6 mRNA	PMID:26033743
1304614	Epha6	Eph receptor A6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1605546	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of EPHA6 mRNA	PMID:41028656
1304614	Epha6	Eph receptor A6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605546	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EPHA6 mRNA	PMID:38568856
1304614	Epha6	Eph receptor A6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605546	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EPHA6 exon; Benzo(a)pyrene results in increased methylation of EPHA6 promoter	PMID:27901495
1304614	Epha6	Eph receptor A6	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312155	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in increased expression of EPHA6 mRNA	PMID:33053406
1304614	Epha6	Eph receptor A6	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of EPHA6 mRNA	PMID:26033743
1304614	Epha6	Eph receptor A6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1605546	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of EPHA6 mRNA	PMID:41028656
1304614	Epha6	Eph receptor A6	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1605546	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of EPHA6 mRNA	PMID:35984750
1304614	Epha6	Eph receptor A6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312155	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EPHA6 promoter	PMID:35295148
1304614	Epha6	Eph receptor A6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EPHA6 mRNA	PMID:25181051|PMID:30816183|PMID:34947998|PMID:41034487
1304614	Epha6	Eph receptor A6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312155	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of EPHA6 mRNA	PMID:35598803
1304614	Epha6	Eph receptor A6	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1605546	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of EPHA6 mRNA	PMID:25979313
1304614	Epha6	Eph receptor A6	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA6 protein	PMID:34896426
1304614	Epha6	Eph receptor A6	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312155	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of EPHA6 intron	PMID:28392331
1304614	Epha6	Eph receptor A6	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1605546	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of EPHA6 mRNA	PMID:37047231
1304614	Epha6	Eph receptor A6	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of EPHA6 protein	PMID:34896426
1304614	Epha6	Eph receptor A6	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of EPHA6 mRNA	PMID:29427782
1304614	Epha6	Eph receptor A6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of EPHA6 mRNA	PMID:29427782
1304614	Epha6	Eph receptor A6	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1605546	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of EPHA6 gene	PMID:29154799
1304614	Epha6	Eph receptor A6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605546	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of EPHA6 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1304614	Epha6	Eph receptor A6	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605546	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA6 mRNA	PMID:27188386
1304614	Epha6	Eph receptor A6	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA6 protein	PMID:34896426
1304614	Epha6	Eph receptor A6	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA6 protein	PMID:34896426
1304614	Epha6	Eph receptor A6	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1605546	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of EPHA6 mRNA	PMID:38832940
1304614	Epha6	Eph receptor A6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1605546	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen affects the expression of EPHA6 mRNA	PMID:26690555
1304614	Epha6	Eph receptor A6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312155	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EPHA6 mRNA	PMID:35436446
1304614	Epha6	Eph receptor A6	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA6 protein	PMID:34896426
1304614	Epha6	Eph receptor A6	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of EPHA6 gene	PMID:35440735
1304614	Epha6	Eph receptor A6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605546	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA6 mRNA	PMID:27188386
1304614	Epha6	Eph receptor A6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605546	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPHA6 gene]	PMID:28238834
1304614	Epha6	Eph receptor A6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EPHA6 mRNA	PMID:24780913
1304614	Epha6	Eph receptor A6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of EPHA6 mRNA	PMID:36843608
1304614	Epha6	Eph receptor A6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605546	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA6 mRNA	PMID:27188386
1304614	Epha6	Eph receptor A6	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of EPHA6 gene	PMID:31079544
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CLYBL mRNA	PMID:25812627
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CLYBL gene	PMID:20938992
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CLYBL mRNA	PMID:33167477
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of CLYBL protein	PMID:39571964
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312157	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CLYBL mRNA	PMID:20880076
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CLYBL mRNA	PMID:36331819
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CLYBL gene	PMID:28931070
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312156	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CLYBL mRNA	PMID:22378314
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CLYBL mRNA	PMID:21632981
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312157	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CLYBL mRNA	PMID:39241906
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with resveratrol] results in increased expression of CLYBL mRNA	PMID:26667767
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CLYBL mRNA	PMID:30165855
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of CLYBL mRNA	PMID:33711761
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CLYBL gene	PMID:20938992
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of CLYBL mRNA	PMID:26496021
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CLYBL mRNA	PMID:31163220
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CLYBL mRNA	PMID:19850644
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of CLYBL mRNA]	PMID:19850644
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CLYBL mRNA	PMID:26577399
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CLYBL mRNA	PMID:28818685
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CLYBL mRNA	PMID:36331819
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CLYBL mRNA	PMID:28522335
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312157	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of CLYBL mRNA	PMID:27462272
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CLYBL mRNA	PMID:19549813
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CLYBL mRNA	PMID:21396975
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312156	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CLYBL protein	PMID:20106945
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CLYBL mRNA	PMID:33354967
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CLYBL mRNA	PMID:21641981|PMID:27153756
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CLYBL mRNA	PMID:19770486
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312156	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CLYBL intron	PMID:30157460
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CLYBL mRNA	PMID:23649840
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CLYBL mRNA	PMID:31150632
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CLYBL mRNA	PMID:31919559
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CLYBL mRNA	PMID:25629700
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CLYBL gene	PMID:20938992
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CLYBL mRNA	PMID:26272509
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CLYBL mRNA	PMID:27188386
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CLYBL mRNA	PMID:26302742
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CLYBL mRNA	PMID:31881176
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with resveratrol] results in increased expression of CLYBL mRNA	PMID:26667767
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of CLYBL mRNA	PMID:24280081|PMID:27594783
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of CLYBL mRNA	PMID:24280081
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D003042	Cocaine results in increased expression of CLYBL protein	PMID:25100957
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CLYBL mRNA	PMID:25583101
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLYBL mRNA	PMID:22298810
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLYBL mRNA	PMID:21215274
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLYBL mRNA	PMID:19770486
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312156	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLYBL mRNA	PMID:21802500
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CLYBL mRNA	PMID:33212167
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CLYBL mRNA	PMID:32763439
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CLYBL protein	PMID:28918527
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLYBL mRNA	PMID:37682722
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1312157	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of CLYBL gene	PMID:39894169
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312157	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CLYBL mRNA	PMID:20883709
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20251007	CTD	MESH:C017947	[sodium arsenite co-treated with lead acetate] results in increased expression of CLYBL protein; [sodium arsenite co-treated with Tretinoin] results in decreased expression of CLYBL protein	PMID:38072110|PMID:39571964
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLYBL mRNA	PMID:21632981|PMID:26238291|PMID:32234424
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLYBL mRNA	PMID:19770486
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312156	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CLYBL 3' UTR	PMID:27901495
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312156	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLYBL mRNA	PMID:21802500
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CLYBL mRNA	PMID:25895662
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CLYBL mRNA	PMID:26238291
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in increased expression of CLYBL protein	PMID:38072110
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CLYBL mRNA	PMID:23557971
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of CLYBL mRNA	PMID:23411599|PMID:34492290
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312157	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CLYBL mRNA	PMID:17426115|PMID:18301758|PMID:23811191
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20250708	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of CLYBL gene	PMID:38723642
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLYBL mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312156	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CLYBL gene	PMID:31601247
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CLYBL gene	PMID:28505145
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of CLYBL mRNA	PMID:26496021
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CLYBL mRNA	PMID:26682919
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312157	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CLYBL mRNA	PMID:39298647|PMID:40203079
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLYBL mRNA	PMID:17602206
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CLYBL mRNA	PMID:21266533
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CLYBL mRNA	PMID:21266533
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLYBL mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLYBL mRNA	PMID:17602206|PMID:18164116
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CLYBL mRNA	PMID:32680482
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312156	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CLYBL mRNA	PMID:37042841
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLYBL mRNA	PMID:25993096
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CLYBL mRNA	PMID:33453195
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CLYBL mRNA	PMID:20883709
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CLYBL mRNA	PMID:25812627
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312156	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CLYBL protein	PMID:26879310
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312157	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CLYBL mRNA	PMID:18353800
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CLYBL mRNA	PMID:25812627
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312157	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CLYBL mRNA	PMID:40194260
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CLYBL mRNA	PMID:25812627
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CLYBL mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CLYBL mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CLYBL mRNA	PMID:36331819
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312156	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CLYBL mRNA	PMID:25979313
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CLYBL mRNA	PMID:17292431
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312156	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CLYBL mRNA	PMID:19101580|PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312156	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CLYBL gene	PMID:29154799
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of CLYBL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLYBL mRNA	PMID:17183730|PMID:27188386
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of CLYBL mRNA	PMID:41580965
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CLYBL mRNA	PMID:20106945
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of CLYBL mRNA	PMID:19770486
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:41977	daunorubicin	affects response to substance	ISO	RGD:1312156	E	RGD:6480464	20120412	CTD	MESH:D003630	CLYBL affects the susceptibility to Daunorubicin	PMID:17545624
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CLYBL mRNA	PMID:28973697
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CLYBL mRNA	PMID:38832940
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312156	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CLYBL mRNA	PMID:24935251
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CLYBL mRNA	PMID:17562736
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CLYBL mRNA	PMID:33387578
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312156	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of CLYBL mRNA	PMID:25704631
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312157	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of CLYBL mRNA	PMID:30529165
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CLYBL mRNA	PMID:29391264
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CLYBL mRNA	PMID:32234424
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of CLYBL mRNA	PMID:17183730
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CLYBL gene	PMID:35440735
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CLYBL mRNA	PMID:31758290
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CLYBL mRNA	PMID:22206623
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:76604	MeIQx	decreases expression	ISO	RGD:1312156	E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in decreased expression of CLYBL mRNA	PMID:20816883
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLYBL mRNA	PMID:18164116
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CLYBL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLYBL mRNA	PMID:27188386
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of CLYBL mRNA	PMID:22538082
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312156	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CLYBL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLYBL mRNA	PMID:27188386
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CLYBL mRNA	PMID:21346803
1304615	Clybl	citramalyl-CoA lyase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CLYBL mRNA	PMID:21346803
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312158	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of NOP2 protein	PMID:39638853
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOP2 mRNA]	PMID:31150632
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D014212	Tretinoin results in decreased expression of NOL1 mRNA	PMID:16604517
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP2 mRNA	PMID:32699268
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NOP2 mRNA	PMID:26516004
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NOP2 mRNA	PMID:33729688
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP2 mRNA	PMID:30529165
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of NOP2 protein	PMID:31494107
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312159	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NOP2 mRNA	PMID:39241906
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP2 mRNA]	PMID:39241906
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312158	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of NOP2 mRNA	PMID:23019147|PMID:31614463
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312158	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NOP2 mRNA	PMID:37042841
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of NOP2 mRNA	PMID:26577399
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312158	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NOP2 protein	PMID:37730182
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA	PMID:39836092
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of NOP2 protein	PMID:34915118
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:22718	benzoates	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in decreased expression of NOP2 mRNA	PMID:29472718
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NOP2 mRNA	PMID:37236586
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312158	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NOP2 gene	PMID:27153756
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of NOP2 mRNA	PMID:32699268
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of NOP2 mRNA	PMID:30779732
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOP2 mRNA	PMID:31150632
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312159	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOP2 mRNA	PMID:27339419|PMID:31919559
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOP2 mRNA]	PMID:31150632
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NOP2 mRNA	PMID:22206623
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:39836092
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:40504410
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312158	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of NOP2 protein	PMID:35688186
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NOP2 mRNA	PMID:23557933
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of NOP2 mRNA	PMID:19921347
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of NOP2 mRNA	PMID:27594783
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312158	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of NOP2 mRNA	PMID:23019147
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312158	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NOP2 mRNA	PMID:24768652|PMID:25583101
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NOL1 mRNA	PMID:21570461
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312158	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NOP2 mRNA	PMID:22903824
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of NOP2 mRNA	PMID:28374803
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312158	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NOP2 mRNA	PMID:28001369
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312158	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of NOP2 mRNA	PMID:32763439
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NOP2 mRNA	PMID:29803840
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312158	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of NOP2 protein	PMID:35688186
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:39836092
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:40504410
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312158	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NOP2 mRNA	PMID:26238291
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of NOP2 mRNA	PMID:25075043
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of NOP2 mRNA	PMID:24136188
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NOP2 gene	PMID:35295148
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NOP2 promoter	PMID:35295148
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NOP2 mRNA	PMID:34492290
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NOL1 mRNA	PMID:18648102
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312159	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NOP2 mRNA	PMID:23811191
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NOP2 mRNA	PMID:25181051
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312158	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NOP2 mRNA	PMID:30903817
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of NOP2 protein	PMID:37567409
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of NOP2 mRNA	PMID:37894381
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312158	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of NOP2 gene	PMID:31601247
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NOP2 mRNA	PMID:36041667
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312159	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NOP2 mRNA	PMID:39298647
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NOP2 mRNA	PMID:36041667
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of NOP2 mRNA	PMID:38685157
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NOP2 mRNA	PMID:36041667
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOP2 mRNA	PMID:28628672
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312159	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NOP2 mRNA	PMID:37019170
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of NOP2 mRNA	PMID:22546817
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312158	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of NOP2 gene	PMID:22964155
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of NOP2 mRNA	PMID:22546817
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1312158	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to NOP2 protein	PMID:32991956
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOP2 mRNA	PMID:28628672
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of NOP2 mRNA	PMID:32680482
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP2 mRNA]	PMID:39241906
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA	PMID:39836092
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NOP2 mRNA	PMID:38174414
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312158	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NOP2 mRNA	PMID:12160620|PMID:38568856
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NOP2 mRNA	PMID:37236586
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312159	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NOP2 mRNA	PMID:28903501
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP2 mRNA	PMID:32699268
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312158	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NOP2 mRNA	PMID:32588087
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312158	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NOP2 mRNA	PMID:31533062
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312158	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NOP2 mRNA	PMID:25979313
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312159	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NOP2 mRNA	PMID:17292431
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D014635	Valproic Acid results in decreased expression of NOL1 mRNA	PMID:19136453|PMID:20546886
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312158	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NOP2 mRNA	PMID:23179753
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312158	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of NOP2 mRNA	PMID:25562108
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOP2 mRNA	PMID:28628672
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D008727	Methotrexate affects the expression of NOL1 mRNA	PMID:18502557
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NOP2 mRNA	PMID:25270620
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D000082	Acetaminophen affects the expression of NOL1 mRNA	PMID:17562736
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NOP2 mRNA	PMID:33387578
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:39836092
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:40504410
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of NOP2 mRNA	PMID:35436446
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NOL1 mRNA	PMID:17942748
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOP2 mRNA	PMID:28628672
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:50035	alpha-phellandrene	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of NOP2 mRNA	PMID:25075043
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312159	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NOP2 mRNA; Nanotubes, Carbon results in increased expression of NOP2 mRNA	PMID:25554681
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NOP2 mRNA	PMID:35964746
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NOP2 mRNA	PMID:24136188
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312159	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of NOP2 mRNA	PMID:26377693
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NOL1 mRNA	PMID:19042947
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NOP2 protein	PMID:32959892
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA	PMID:39836092
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312158	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NOP2 mRNA	PMID:31758290
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312158	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NOP2 protein	PMID:34186270
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NOP2 mRNA	PMID:22206623
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NOP2 protein	PMID:37664457
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312158	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of NOP2 protein	PMID:31285264
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312159	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NOP2 mRNA	PMID:30294300
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312158	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of NOP2 protein	PMID:38348393
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP2 mRNA]	PMID:39241906
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312158	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NOP2 protein	PMID:37664457
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1312158	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of NOP2 mRNA	PMID:34581912
1304616	Nop2	NOP2 nucleolar protein	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312159	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of NOP2 mRNA	PMID:32835833
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of KDELR2 mRNA	PMID:35967413
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KDELR2 mRNA	PMID:39752319
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of KDELR2 protein	PMID:40631627
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312161	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of KDELR2 mRNA	PMID:22378314
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1312162	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of KDELR2 mRNA	PMID:25056781
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312161	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of KDELR2 mRNA	PMID:29581250
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312162	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of KDELR2 mRNA	PMID:39241906
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312162	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of KDELR2 mRNA	PMID:39298647
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KDELR2 mRNA	PMID:19448997
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312161	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KDELR2 mRNA	PMID:37042841
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of KDELR2 mRNA	PMID:23649840
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312161	E	RGD:6480464	20130618	CTD	MESH:C044887	beta-methylcholine affects the expression of KDELR2 mRNA	PMID:21179406
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of KDELR2 protein	PMID:40631627
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KDELR2 mRNA	PMID:39752319
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of KDELR2 protein	PMID:40631627
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312161	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KDELR2 mRNA	PMID:31163220
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312162	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KDELR2 mRNA	PMID:33754040
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1312162	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of KDELR2 gene	PMID:32864567
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KDELR2 mRNA	PMID:33387578
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of KDELR2 mRNA	PMID:22061828
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:188855	Octicizer	multiple interactions	ISO	RGD:1312161	E	RGD:6480464	20260707	CTD	MESH:C018535	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of KDELR2 protein	PMID:42015365
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312162	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of KDELR2 mRNA	PMID:27462272
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20130618	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KDELR2 mRNA	PMID:19549813
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1312162	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of KDELR2 mRNA	PMID:25056781
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of KDELR2 mRNA	PMID:23649840
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of KDELR2 mRNA	PMID:19483382
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312162	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KDELR2 mRNA	PMID:27339419|PMID:31919559
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312162	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KDELR2 mRNA	PMID:25629700
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312161	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of KDELR2 mRNA	PMID:26272509
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312161	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA	PMID:27188386
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312161	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of KDELR2 mRNA	PMID:26865667
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312161	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of KDELR2 mRNA	PMID:24768652|PMID:25583101
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312162	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KDELR2 mRNA	PMID:21570461
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KDELR2 mRNA	PMID:17942748
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KDELR2 mRNA	PMID:17942748
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of KDELR2 mRNA	PMID:19013527
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312161	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KDELR2 mRNA	PMID:28001369
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28428	beta-hexachlorocyclohexane	increases expression	ISO	RGD:1312162	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in increased expression of KDELR2 mRNA	PMID:25270620
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312161	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KDELR2 mRNA	PMID:38568856|PMID:39719251
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312161	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of KDELR2 mRNA	PMID:22378314
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KDELR2 mRNA	PMID:26238291
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312161	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KDELR2 promoter	PMID:27901495
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of KDELR2 mRNA	PMID:19483382
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of KDELR2 mRNA	PMID:24136188
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312162	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KDELR2 promoter	PMID:35295148
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of KDELR2 mRNA	PMID:19483382
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of KDELR2 mRNA	PMID:19483382
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of KDELR2 mRNA	PMID:18445702
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312161	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of KDELR2 mRNA	PMID:30903817
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of KDELR2 mRNA	PMID:30816183|PMID:34947998
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312161	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of KDELR2 mRNA	PMID:25979313
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312162	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KDELR2 mRNA	PMID:37019170
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312162	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of KDELR2 mRNA	PMID:34813904
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:35033	triphenyl phosphate	multiple interactions	ISO	RGD:1312161	E	RGD:6480464	20260707	CTD	MESH:C005445	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of KDELR2 protein	PMID:42015365
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	multiple interactions	ISO	RGD:1312161	E	RGD:6480464	20260707	CTD	MESH:C031324	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of KDELR2 protein	PMID:42015365
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	multiple interactions	ISO	RGD:1312161	E	RGD:6480464	20260707	CTD	MESH:C013320	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of KDELR2 protein	PMID:42015365
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of KDELR2 mRNA	PMID:19483382
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1312161	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of KDELR2 mRNA	PMID:33512557
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of KDELR2 mRNA	PMID:29427782
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312161	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of KDELR2 mRNA	PMID:19101580|PMID:23179753|PMID:23527032|PMID:26272509
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312161	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA	PMID:27188386
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of KDELR2 mRNA	PMID:38685447|PMID:41580965
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of KDELR2 mRNA	PMID:25562108
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312161	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of KDELR2 mRNA	PMID:20106945|PMID:27989131
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of KDELR2 mRNA	PMID:17555576
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of KDELR2 protein	PMID:40631627
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312161	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of KDELR2 mRNA	PMID:24935251|PMID:26272509
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312161	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA	PMID:27188386
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KDELR2 mRNA	PMID:17562736
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312161	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of KDELR2 mRNA	PMID:18687144
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of KDELR2 mRNA	PMID:29391264
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D005001	Ethionine affects the expression of KDELR2 mRNA	PMID:19483382
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of KDELR2 mRNA	PMID:26865667
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312162	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of KDELR2 mRNA	PMID:17555576|PMID:17942748
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KDELR2 mRNA	PMID:17942748
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1312162	E	RGD:6480464	20130618	CTD	MESH:C037123	cadmium sulfate results in increased expression of KDELR2 mRNA	PMID:16221973
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312162	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of KDELR2 mRNA; Nanotubes, Carbon results in increased expression of KDELR2 mRNA	PMID:25554681|PMID:25620056
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of KDELR2 mRNA	PMID:41580965
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:50692	mifepristone	increases expression	ISO	RGD:1312161	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of KDELR2 mRNA	PMID:17584828
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of KDELR2 mRNA	PMID:35964746
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KDELR2 mRNA	PMID:24136188
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KDELR2 protein	PMID:32959892
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KDELR2 mRNA	PMID:39752319
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312161	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of KDELR2 mRNA	PMID:31758290
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312162	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KDELR2 mRNA	PMID:22206623
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1312161	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of KDELR2 mRNA	PMID:19946333
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1312161	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of KDELR2 mRNA]	PMID:19946333
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1312162	E	RGD:6480464	20220607	CTD	MESH:C038405	nivalenol results in increased expression of KDELR2 mRNA	PMID:35016910
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of KDELR2 mRNA	PMID:18548127
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of KDELR2 mRNA	PMID:19483382
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of KDELR2 mRNA	PMID:19483382
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312161	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA	PMID:27188386
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of KDELR2 mRNA	PMID:19682730
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312162	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of KDELR2 mRNA	PMID:31388691
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312162	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of KDELR2 mRNA	PMID:30294300
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1312161	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of KDELR2 mRNA	PMID:19095052
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of KDELR2 mRNA	PMID:38995820
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1312161	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of KDELR2 mRNA	PMID:33512557
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of KDELR2 mRNA	PMID:21858171
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1312161	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of KDELR2 mRNA	PMID:33512557
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of KDELR2 mRNA	PMID:21278054
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of KDELR2 mRNA	PMID:19483382
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KDELR2 mRNA	PMID:39752319
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312161	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA	PMID:27188386
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1312161	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of KDELR2 mRNA	PMID:31863870
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312161	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of KDELR2 mRNA	PMID:22378314
1304618	Kdelr2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of KDELR2 mRNA	PMID:23034163
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312164	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of AGO1 mRNA	PMID:33045310
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AGO1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGO1 gene	PMID:20938992
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312163	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of AGO1 mRNA	PMID:16140955|PMID:33167477
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AGO1 mRNA	PMID:30529165
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312163	E	RGD:6480464	20141111	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of AGO1 mRNA	PMID:24763279
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of AGO1 mRNA	PMID:39241906
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312163	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of AGO1 mRNA	PMID:22574217
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312164	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of AGO1 mRNA	PMID:39298647
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of AGO1 mRNA	PMID:26496021
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AGO1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGO1 gene	PMID:20938992
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312163	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AGO1 mRNA	PMID:37042841
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312163	E	RGD:6480464	20141111	CTD	MESH:D001554	Benzene results in increased expression of AGO1 mRNA	PMID:19162166
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of AGO1 mRNA	PMID:22061828
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312163	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of AGO1 mRNA	PMID:28818685
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AGO1 mRNA	PMID:36331819
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of AGO1 protein	PMID:33236894
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312163	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AGO1 gene	PMID:27153756
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312163	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of AGO1 exon	PMID:30157460
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of AGO1 mRNA	PMID:30779732
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AGO1 mRNA	PMID:31150632
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AGO1 mRNA	PMID:31919559
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AGO1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGO1 gene	PMID:20938992
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312163	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of AGO1 mRNA	PMID:28903495
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of AGO1 mRNA	PMID:27594783
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312163	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AGO1 mRNA	PMID:27392435
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of AGO1 mRNA	PMID:30912803
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of AGO1 mRNA	PMID:28001369
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of AGO1 mRNA	PMID:32763439
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312163	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of AGO1 mRNA	PMID:20044591
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AGO1 mRNA	PMID:38568856
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of AGO1 mRNA	PMID:16014739
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312163	E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite promotes the reaction [H3-3A protein binds to AGO1 protein]	PMID:37734572
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312164	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of AGO1 protein	PMID:37955338
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312164	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of AGO1 mRNA	PMID:23557971
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312164	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of AGO1 mRNA	PMID:18648102
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of AGO1 mRNA	PMID:32145629
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AGO1 mRNA	PMID:30816183|PMID:32528016
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of AGO1 mRNA; [bisphenol A co-treated with Estradiol] results in decreased expression of AGO1 mRNA	PMID:26496021|PMID:36041667
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312163	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AGO1 mRNA	PMID:25979313
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of AGO1 mRNA	PMID:39298647
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of AGO1 mRNA	PMID:36041667
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of AGO1 mRNA	PMID:36041667
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312164	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of AGO1 mRNA	PMID:37019170
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312163	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AGO1 mRNA	PMID:38382870
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312164	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of AGO1 mRNA	PMID:22698814
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AGO1 mRNA	PMID:19320972
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312163	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of AGO1 mRNA	PMID:28302478
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AGO1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of AGO1 mRNA	PMID:36331819
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of AGO1 mRNA	PMID:26272509
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of AGO1 mRNA	PMID:38685447|PMID:41580965
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of AGO1 mRNA	PMID:20106945
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of AGO1 mRNA	PMID:27188386
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AGO1 mRNA	PMID:29097150
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of AGO1 mRNA; Nanotubes, Carbon results in decreased expression of AGO1 mRNA	PMID:25554681
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of AGO1 mRNA	PMID:41580965
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AGO1 protein	PMID:32959892
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of AGO1 mRNA	PMID:22206623
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312163	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of AGO1 protein	PMID:37664457
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312163	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AGO1 gene]	PMID:28238834
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312163	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of AGO1 protein	PMID:37664457
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:94402	1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C084597	chlorcyclizine results in decreased expression of AGO1 mRNA	PMID:21058326
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AGO1 mRNA	PMID:38568856
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312163	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of AGO1 mRNA	PMID:27188386
1304619	Ago1	argonaute RISC component 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of AGO1 mRNA	PMID:28973697
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RABGAP1L mRNA	PMID:38218311
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1347519	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RABGAP1L mRNA	PMID:38218311
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of RABGAP1L mRNA	PMID:21551480
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of RABGAP1L mRNA	PMID:35967413
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1347519	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RABGAP1L mRNA	PMID:26272509
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA	PMID:27188386
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of RABGAP1L mRNA]	PMID:19467301
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RABGAP1L mRNA	PMID:26251327
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RABGAP1L mRNA	PMID:20938992
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RABGAP1L mRNA	PMID:23724009
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RABGAP1L mRNA	PMID:30529165
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312165	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RABGAP1L mRNA	PMID:30319688
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1347519	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of RABGAP1L mRNA	PMID:18951874
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1347519	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of RABGAP1L mRNA	PMID:21632981
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1347519	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of RABGAP1L mRNA	PMID:14699072
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RABGAP1L mRNA	PMID:39298647
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of RABGAP1L mRNA	PMID:23019147
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RABGAP1L mRNA	PMID:20938992
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of RABGAP1L mRNA	PMID:23649840
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of RABGAP1L mRNA	PMID:31256213
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1347519	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RABGAP1L mRNA	PMID:16002434
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RABGAP1L mRNA	PMID:22061828
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1347519	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RABGAP1L intron	PMID:30157460
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:22718	benzoates	increases expression	ISO	RGD:1347519	E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in increased expression of RABGAP1L mRNA	PMID:29472718
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RABGAP1L mRNA	PMID:39012411
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RABGAP1L mRNA	PMID:37236586
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RABGAP1L mRNA	PMID:19549813
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of RABGAP1L mRNA	PMID:23649840
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of RABGAP1L protein	PMID:33236894
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1347519	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of RABGAP1L protein	PMID:20106945
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1347519	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of RABGAP1L intron	PMID:30157460
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RABGAP1L mRNA	PMID:19770486
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RABGAP1L mRNA	PMID:21632981|PMID:21641981|PMID:22100608|PMID:27153756|PMID:30157460
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1347519	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RABGAP1L gene; Aflatoxin B1 results in increased methylation of RABGAP1L promoter	PMID:27153756|PMID:30157460
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RABGAP1L mRNA	PMID:23649840
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of RABGAP1L mRNA	PMID:32553695
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RABGAP1L mRNA	PMID:35430440
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312165	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RABGAP1L mRNA	PMID:17484886
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RABGAP1L mRNA	PMID:25629700
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RABGAP1L mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RABGAP1L mRNA]	PMID:20938992|PMID:22206623
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1347519	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RABGAP1L gene	PMID:25304211
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RABGAP1L mRNA	PMID:40504410
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RABGAP1L mRNA	PMID:40512198
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1312165	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of RABGAP1L mRNA	PMID:28960355
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20150714	CTD	MESH:C059514	resveratrol results in decreased expression of RABGAP1L mRNA	PMID:25888808
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1347519	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RABGAP1L mRNA	PMID:28903495
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of RABGAP1L mRNA	PMID:22023808
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of RABGAP1L mRNA	PMID:27594783
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312165	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RABGAP1L mRNA	PMID:24680724
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RABGAP1L mRNA	PMID:32109520
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RABGAP1L mRNA	PMID:34747641
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1347519	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RABGAP1L mRNA	PMID:21632981
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RABGAP1L mRNA	PMID:28001369
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RABGAP1L mRNA	PMID:33212167
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RABGAP1L mRNA	PMID:27188386
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RABGAP1L mRNA	PMID:29803840
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of RABGAP1L protein	PMID:21925251
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312165	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RABGAP1L mRNA	PMID:20883709
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347519	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RABGAP1L mRNA	PMID:38568856
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RABGAP1L mRNA	PMID:40504410
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RABGAP1L mRNA	PMID:40512198
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1347519	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of RABGAP1L mRNA	PMID:21714911
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347519	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RABGAP1L intron; Benzo(a)pyrene affects the methylation of RABGAP1L promoter	PMID:27901495|PMID:30157460
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RABGAP1L mRNA	PMID:15034205|PMID:19770486|PMID:20713471
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RABGAP1L mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291|PMID:32234424
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1347519	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of RABGAP1L mRNA	PMID:20382639
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RABGAP1L mRNA	PMID:26238291
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1347519	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of RABGAP1L gene	PMID:31601247
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RABGAP1L gene	PMID:31601247
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RABGAP1L mRNA	PMID:30047161
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312165	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RABGAP1L gene	PMID:35295148
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312165	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of RABGAP1L mRNA	PMID:23557971
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312165	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RABGAP1L promoter	PMID:35295148
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RABGAP1L mRNA	PMID:25380136
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of RABGAP1L mRNA	PMID:20813756|PMID:23811191
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in decreased expression of RABGAP1L mRNA	PMID:20813756
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of RABGAP1L mRNA	PMID:41034487
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of RABGAP1L mRNA	PMID:26063408|PMID:33221593
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of RABGAP1L protein	PMID:33181973
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1347519	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RABGAP1L gene	PMID:31601247
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of RABGAP1L mRNA	PMID:33296240
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312165	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RABGAP1L mRNA	PMID:30951980
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RABGAP1L gene	PMID:28505145
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RABGAP1L gene	PMID:31601247
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1347519	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RABGAP1L mRNA	PMID:25979313
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RABGAP1L mRNA	PMID:39298647
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312165	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RABGAP1L mRNA	PMID:30951980|PMID:40203079
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312165	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RABGAP1L mRNA	PMID:30951980
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312165	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RABGAP1L mRNA	PMID:17942915
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RABGAP1L mRNA]	PMID:17942915
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312165	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RABGAP1L mRNA	PMID:20883709
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RABGAP1L mRNA	PMID:39012411
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RABGAP1L mRNA	PMID:37236586
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of RABGAP1L mRNA	PMID:25380136
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312165	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of RABGAP1L mRNA	PMID:18353800
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:38561	fluvastatin	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20120412	CTD	MESH:C065180	[zoledronic acid co-treated with fluvastatin] results in increased expression of RABGAP1L mRNA	PMID:16996129
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RABGAP1L mRNA	PMID:31533062
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RABGAP1L mRNA	PMID:40419075
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of RABGAP1L mRNA	PMID:22110744
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312165	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RABGAP1L mRNA	PMID:17292431
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347519	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RABGAP1L mRNA	PMID:25979313
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of RABGAP1L mRNA	PMID:29427782
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of RABGAP1L mRNA	PMID:24935251
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1347519	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RABGAP1L mRNA	PMID:26272509
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA	PMID:27188386
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RABGAP1L mRNA	PMID:30047161
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of RABGAP1L mRNA	PMID:19770486
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1347519	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RABGAP1L mRNA	PMID:25562108
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of RABGAP1L mRNA	PMID:28973697
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of RABGAP1L mRNA	PMID:27188386
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1347519	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of RABGAP1L mRNA	PMID:24935251|PMID:26272509
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA	PMID:27188386
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of RABGAP1L mRNA	PMID:21420995
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid results in decreased expression of RABGAP1L protein	PMID:28871336
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:46557	zoledronic acid	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with fluvastatin] results in increased expression of RABGAP1L mRNA	PMID:16996129
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:46938	zebularine	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20120412	CTD	MESH:C009131	pyrimidin-2-one beta-ribofuranoside results in decreased expression of RABGAP1L mRNA	PMID:19194470
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1347519	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RABGAP1L gene	PMID:25304211
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RABGAP1L mRNA	PMID:40504410
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RABGAP1L mRNA	PMID:40512198
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RABGAP1L mRNA	PMID:29391264
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RABGAP1L mRNA	PMID:22079256
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:48981	quinolin-8-ol	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of RABGAP1L mRNA	PMID:21632981
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RABGAP1L mRNA	PMID:29097150
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of RABGAP1L mRNA	PMID:32234424
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RABGAP1L mRNA; Nanotubes, Carbon results in decreased expression of RABGAP1L mRNA	PMID:25554681|PMID:25620056
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RABGAP1L mRNA	PMID:30047161
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1347519	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of RABGAP1L mRNA	PMID:26272509
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA	PMID:27188386
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of RABGAP1L mRNA	PMID:19812364
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of RABGAP1L mRNA	PMID:15336504
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RABGAP1L gene	PMID:35440735
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of RABGAP1L mRNA	PMID:27462272
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RABGAP1L mRNA	PMID:31758290
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312165	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RABGAP1L mRNA	PMID:22206623
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312165	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RABGAP1L mRNA]	PMID:22206623
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1347519	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RABGAP1L mRNA	PMID:22079256
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RABGAP1L mRNA	PMID:22079256
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RABGAP1L mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA	PMID:27188386
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RABGAP1L gene]	PMID:28238834
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312165	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RABGAP1L mRNA	PMID:23091169
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RABGAP1L mRNA	PMID:32109520
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312165	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of RABGAP1L mRNA	PMID:31388691
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312165	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RABGAP1L mRNA	PMID:21795629|PMID:39847705
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1347519	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of RABGAP1L mRNA	PMID:26272509
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA	PMID:27188386
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347519	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RABGAP1L mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RABGAP1L mRNA	PMID:27188386
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RABGAP1L mRNA	PMID:19281266
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1347519	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RABGAP1L mRNA	PMID:38568856
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of RABGAP1L gene	PMID:31079544
1304620	Rabgap1l	RAB GTPase activating protein 1-like	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of RABGAP1L gene	PMID:31682807
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of URB1 mRNA]	PMID:31150632
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1353651	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of URB1 mRNA	PMID:33167477
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614214	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of URB1 mRNA	PMID:39241906
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1353651	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of URB1 mRNA	PMID:23019147|PMID:31614463
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1614214	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of URB1 mRNA	PMID:25510870
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1614214	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of URB1 mRNA	PMID:34319233
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of URB1 mRNA	PMID:33387578
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1614214	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of URB1 mRNA	PMID:25510870
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1614214	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of URB1 mRNA	PMID:25510870
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1353651	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of URB1 exon	PMID:30157460
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1353651	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of URB1 gene	PMID:27153756
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of URB1 mRNA	PMID:30779732
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of URB1 mRNA	PMID:31150632
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of URB1 mRNA]	PMID:31150632
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1614214	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of URB1 mRNA	PMID:28960355
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1353651	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of URB1 mRNA	PMID:27594783
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1614214	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of URB1 mRNA	PMID:30912803
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019833	Genistein results in decreased expression of URB1 protein	PMID:24552547
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1353651	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of URB1 mRNA	PMID:33212167
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1353651	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of URB1 mRNA	PMID:29803840
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353651	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of URB1 mRNA	PMID:38568856
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353651	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of URB1 3' UTR	PMID:27901495
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1614214	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of URB1 protein	PMID:37955338
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1614214	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of URB1 gene	PMID:35295148
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614214	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of URB1 promoter	PMID:35295148
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of URB1 mRNA	PMID:23411599|PMID:34492290
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of URB1 mRNA	PMID:30816183|PMID:32528016
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of URB1 mRNA	PMID:25181051
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of URB1 gene	PMID:28505145
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1353651	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of URB1 mRNA	PMID:28628672
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1614214	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of URB1 mRNA	PMID:25510870
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1614214	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of URB1 mRNA	PMID:25510870
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1353651	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of URB1 gene	PMID:31601247
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1353651	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of URB1 mRNA	PMID:28628672
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1353651	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of URB1 exon	PMID:30157460
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1353651	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of URB1 mRNA	PMID:28628672
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1353651	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to URB1 protein	PMID:32991956
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1353651	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of URB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of URB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of URB1 mRNA	PMID:28628672
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1614214	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of URB1 mRNA	PMID:36117858
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353651	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of URB1 mRNA	PMID:37042841
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1353651	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of URB1 mRNA	PMID:38174414
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:36009	omega-6 fatty acid	decreases expression	ISO	RGD:1353651	E	RGD:6480464	20170117	CTD	MESH:D043371	Fatty Acids, Omega-6 results in decreased expression of URB1 mRNA	PMID:16823509
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1353651	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of URB1 mRNA	PMID:28302478
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1353651	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of URB1 mRNA	PMID:31533062
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1614214	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of URB1 mRNA	PMID:36331819
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of URB1 mRNA	PMID:25993096
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1353651	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of URB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of URB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of URB1 mRNA	PMID:28628672
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614214	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of URB1 mRNA	PMID:17562736
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1614214	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of URB1 mRNA	PMID:19446018
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1614214	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of URB1 mRNA	PMID:35436446
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1353651	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of URB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of URB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of URB1 mRNA	PMID:28628672
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1614214	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of URB1 mRNA	PMID:36117858
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353651	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of URB1 protein	PMID:32959892
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1353651	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of URB1 exon	PMID:30157460
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of URB1 gene	PMID:35440735
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1353651	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of URB1 mRNA	PMID:22714537
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:757488	omega-3 fatty acids	increases expression	ISO	RGD:1353651	E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 results in increased expression of URB1 mRNA	PMID:16823509
1304621	Urb1	URB1 ribosome biogenesis factor	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1614214	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of URB1 mRNA	PMID:32835833
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1605647	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of KIAA1614 mRNA	PMID:34925699
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605647	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of KIAA1614 mRNA	PMID:35811015
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D014241	Trichloroethylene results in increased expression of KIAA1614 mRNA	PMID:33387578
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605647	E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA	PMID:33656867
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1605647	E	RGD:6480464	20211109	CTD	MESH:D017382	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of KIAA1614 mRNA	PMID:33656867
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605647	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KIAA1614 mRNA	PMID:23557933
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:29191	hydroxyl	multiple interactions	ISO	RGD:1605647	E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA	PMID:33656867
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605647	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KIAA1614 promoter	PMID:27901495
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1605647	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of KIAA1614 mRNA	PMID:37690743
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of KIAA1614 mRNA	PMID:30816183
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605647	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of KIAA1614 protein	PMID:31675489
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1605647	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KIAA1614 gene	PMID:31601247
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1605647	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of KIAA1614 protein	PMID:31675489
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D014635	Valproic Acid results in decreased expression of KIAA1614 mRNA	PMID:29427782
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312167	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KIAA1614 mRNA	PMID:28973697
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605647	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KIAA1614 mRNA	PMID:38832940
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:4610	dimethylselenide	multiple interactions	ISO	RGD:1605647	E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of KIAA1614 mRNA	PMID:33656867
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D000082	Acetaminophen results in increased expression of KIAA1614 mRNA	PMID:33387578
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1605647	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of KIAA1614 mRNA	PMID:35811015
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1605647	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of KIAA1614 mRNA	PMID:31675489
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1605647	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of KIAA1614 mRNA	PMID:36318118
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1605647	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of KIAA1614 protein	PMID:31675489
1304622	Kiaa1614	KIAA1614 homolog	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1605647	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of KIAA1614 protein	PMID:31675489
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CGNL1 mRNA	PMID:38218311
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of CGNL1 mRNA	PMID:21551480
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1353387	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CGNL1 mRNA	PMID:26272509
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1353387	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA	PMID:27188386
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CGNL1 mRNA]	PMID:31150632
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1620019	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CGNL1 mRNA	PMID:20938992
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of CGNL1 mRNA	PMID:23724009
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1353387	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of CGNL1 mRNA	PMID:21934132
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1353387	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CGNL1 mRNA	PMID:22378314
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1620019	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CGNL1 mRNA	PMID:30319688
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1620019	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CGNL1 mRNA	PMID:30319688
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CGNL1 mRNA	PMID:21632981
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of CGNL1 mRNA	PMID:30510588
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1620019	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CGNL1 mRNA	PMID:39298647
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1353387	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CGNL1 mRNA	PMID:30165855
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1620019	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CGNL1 mRNA	PMID:20938992
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1353387	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CGNL1 mRNA	PMID:26079696
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of CGNL1 mRNA	PMID:22967744
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of CGNL1 mRNA	PMID:16002434
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of CGNL1 mRNA	PMID:22061828
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1353387	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CGNL1 mRNA	PMID:28818685
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1620019	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CGNL1 mRNA	PMID:36331819
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CGNL1 mRNA	PMID:19549813
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1353387	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CGNL1 protein	PMID:20106945
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CGNL1 mRNA	PMID:21632981|PMID:21641981|PMID:22100608|PMID:27153756
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1353387	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CGNL1 gene	PMID:27153756
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CGNL1 mRNA	PMID:31150632
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1620019	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CGNL1 mRNA	PMID:17484886
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CGNL1 mRNA]	PMID:31150632
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620019	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CGNL1 mRNA	PMID:20938992
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1353387	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CGNL1 protein	PMID:35688186
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CGNL1 mRNA	PMID:24768652|PMID:25583101
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620019	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CGNL1 mRNA	PMID:21570461
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CGNL1 mRNA	PMID:34747641
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CGNL1 mRNA	PMID:20106945|PMID:21632981
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1620019	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CGNL1 mRNA	PMID:33956508
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CGNL1 mRNA	PMID:23179753
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CGNL1 mRNA	PMID:33212167
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CGNL1 mRNA	PMID:29803840
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1353387	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of CGNL1 mRNA	PMID:20044591
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353387	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CGNL1 5' UTR	PMID:27901495
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CGNL1 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291|PMID:32234424
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1620019	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CGNL1 mRNA	PMID:19770486
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620019	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CGNL1 mRNA	PMID:27195522
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1353387	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CGNL1 mRNA]	PMID:32406909
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CGNL1 mRNA	PMID:25895662
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CGNL1 mRNA	PMID:26705709
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620019	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CGNL1 gene	PMID:35295148
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1620019	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of CGNL1 mRNA	PMID:29264374|PMID:35295148
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1620019	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CGNL1 mRNA	PMID:18301758
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of CGNL1 mRNA	PMID:32145629
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CGNL1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1620019	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CGNL1 mRNA	PMID:33221593
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1353387	E	RGD:6480464	20181016	CTD	MESH:C006780	bisphenol A results in increased expression of CGNL1 mRNA; bisphenol A results in increased expression of CGNL1 protein	PMID:29718440|PMID:37567409
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620019	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of CGNL1 mRNA	PMID:30951980
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CGNL1 gene	PMID:28505145
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1620019	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CGNL1 gene	PMID:31683443
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620019	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CGNL1 mRNA	PMID:30951980
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1620019	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CGNL1 mRNA	PMID:30951980|PMID:38685157
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1620019	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CGNL1 mRNA	PMID:37019170
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1620019	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CGNL1 mRNA	PMID:21266533
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1620019	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CGNL1 mRNA	PMID:34813904
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1620019	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CGNL1 mRNA	PMID:34813904
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CGNL1 mRNA	PMID:24386269
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CGNL1 mRNA	PMID:19320972
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:37825	p-toluidine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of CGNL1 mRNA	PMID:27638505
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620019	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CGNL1 mRNA	PMID:40194260
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1353387	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CGNL1 mRNA	PMID:28302478
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CGNL1 mRNA	PMID:40419075
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620019	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CGNL1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CGNL1 mRNA	PMID:36331819
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353387	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CGNL1 mRNA	PMID:25979313
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of CGNL1 mRNA	PMID:29427782
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CGNL1 mRNA	PMID:29154799
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353387	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CGNL1 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1353387	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA	PMID:27188386
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of CGNL1 mRNA	PMID:41580965
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CGNL1 mRNA	PMID:20106945|PMID:25562108
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1353387	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CGNL1 protein	PMID:38832940
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1353387	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of CGNL1 mRNA	PMID:24935251|PMID:26272509
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1353387	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA	PMID:27188386
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1620019	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CGNL1 mRNA	PMID:17562736
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of CGNL1 mRNA	PMID:29067470
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of CGNL1 mRNA	PMID:24714768
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1620019	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CGNL1 mRNA	PMID:35436446
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CGNL1 mRNA	PMID:26705709
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CGNL1 mRNA	PMID:24136188|PMID:24793618
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CGNL1 mRNA	PMID:30467583
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1353387	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CGNL1 mRNA	PMID:31758290
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1620019	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CGNL1 mRNA	PMID:22206623
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1353387	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CGNL1 protein	PMID:37664457
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of CGNL1 mRNA	PMID:24136188
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1353387	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA	PMID:27188386
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1353387	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CGNL1 gene]	PMID:28238834
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of CGNL1 mRNA	PMID:26705709
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1353387	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of CGNL1 mRNA	PMID:26079696
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1353387	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of CGNL1 mRNA	PMID:26272509
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1353387	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA	PMID:27188386
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1620019	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of CGNL1 protein	PMID:35357534
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353387	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CGNL1 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGNL1 mRNA	PMID:27188386|PMID:37664457
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:9130	sevoflurane	decreases methylation	ISO	RGD:1620019	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased methylation of CGNL1 mRNA	PMID:35249202
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1353387	E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in decreased expression of CGNL1 mRNA	PMID:29453283
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1620019	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of CGNL1 protein	PMID:24648495
1304623	Cgnl1	cingulin-like 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CGNL1 mRNA	PMID:23034163
1304624	2700097O09Rikl	RIKEN cDNA 2700097009 gene like	gene	CHEBI:132098	methoxyacetic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in increased expression of 2700097O09RIKL mRNA	PMID:18199887
1304624	2700097O09Rikl	RIKEN cDNA 2700097009 gene like	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of 2700097O09RIKL mRNA	PMID:33387578
1304624	2700097O09Rikl	RIKEN cDNA 2700097009 gene like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of 2700097O09RIKL mRNA	PMID:33387578
1304624	2700097O09Rikl	RIKEN cDNA 2700097009 gene like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of 2700097O09RIKL mRNA	PMID:23411599|PMID:34492290
1304624	2700097O09Rikl	RIKEN cDNA 2700097009 gene like	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of 2700097O09RIKL mRNA	PMID:33387578
1304624	2700097O09Rikl	RIKEN cDNA 2700097009 gene like	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of 2700097O09RIKL mRNA	PMID:29391264
1304624	2700097O09Rikl	RIKEN cDNA 2700097009 gene like	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of 2700097O09RIKL gene	PMID:31682807
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312170	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MAP3K6 mRNA	PMID:27188386
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP3K6 mRNA]	PMID:31150632
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1312171	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in increased expression of MAP3K6 mRNA	PMID:33227293
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP3K6 mRNA	PMID:20938992
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MAP3K6 mRNA	PMID:33167477
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of MAP3K6 mRNA	PMID:20488242
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15368	acrolein	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of MAP3K6 mRNA	PMID:38090360
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MAP3K6 mRNA	PMID:33729688
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MAP3K6 mRNA	PMID:30529165
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MAP3K6 mRNA	PMID:22378314
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16136	hydrogen sulfide	increases expression	ISO	RGD:1312171	E	RGD:6480464	20200519	CTD	MESH:D006862	Hydrogen Sulfide results in increased expression of MAP3K6 mRNA	PMID:31843631
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312171	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MAP3K6 mRNA	PMID:30319688
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312170	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of MAP3K6 mRNA	PMID:29581250
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312170	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of MAP3K6 mRNA	PMID:30510588
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MAP3K6 mRNA	PMID:39298647
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312171	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of MAP3K6 mRNA	PMID:19484750
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of MAP3K6 mRNA	PMID:18978301
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP3K6 mRNA	PMID:20938992
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MAP3K6 gene	PMID:30521419
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAP3K6 mRNA	PMID:37992649
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAP3K6 mRNA	PMID:37992649
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MAP3K6 mRNA	PMID:33387578
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312170	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MAP3K6 mRNA	PMID:28818685
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1312171	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of MAP3K6 mRNA	PMID:39984025
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312170	E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of MAP3K6 mRNA	PMID:22562489
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAP3K6 mRNA	PMID:37236586
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:230826	AB-Fubinaca	increases expression	EXP		E	RGD:6480464	20240507	CTD	MESH:C000615602	AB-FUBINACA results in increased expression of MAP3K6 mRNA	PMID:26517302
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312170	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MAP3K6 gene	PMID:28458013
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120501	CTD	MESH:D010126	Ozone results in increased expression of MAP3K6 mRNA	PMID:17095637|PMID:19555225
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAP3K6 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MAP3K6 mRNA; pyrazolanthrone inhibits the reaction [Ozone results in increased expression of MAP3K6 mRNA]	PMID:17460151|PMID:27106289|PMID:34911549
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in decreased expression of MAP3K6 mRNA	PMID:31939706
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAP3K6 mRNA	PMID:31150632
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312171	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAP3K6 mRNA	PMID:27339419|PMID:31919559
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP3K6 mRNA]	PMID:31150632
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20180313	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of MAP3K6 mRNA	PMID:26778414
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP3K6 mRNA	PMID:20938992
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of MAP3K6 mRNA	PMID:19654921
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40512198
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40504410
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MAP3K6 mRNA	PMID:31881176
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312170	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of MAP3K6 mRNA	PMID:23300844
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312171	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of MAP3K6 mRNA	PMID:40618947
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MAP3K6 mRNA	PMID:27392435
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form] results in decreased expression of MAP3K6 mRNA	PMID:23625948
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312171	E	RGD:6480464	20160412	CTD	MESH:D019833	Genistein results in increased expression of MAP3K6 mRNA	PMID:24967385
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312171	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP3K6 mRNA	PMID:21570461
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312170	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAP3K6 mRNA	PMID:26238291
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAP3K6 mRNA	PMID:17035482
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAP3K6 mRNA	PMID:25975270
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MAP3K6 mRNA	PMID:32763439
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MAP3K6 mRNA	PMID:28959563
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MAP3K6 mRNA	PMID:30911355
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120918	CTD	MESH:D004317	Doxorubicin results in increased expression of MAP3K6 mRNA	PMID:21040762|PMID:39631538
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20120918	CTD	MESH:D004317	[[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of MAP3K6 mRNA	PMID:21040762
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAP3K6 mRNA	PMID:37992649
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28940	calciol	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in decreased expression of MAP3K6 mRNA	PMID:16508948
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312170	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of MAP3K6 mRNA	PMID:34032870
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40512198
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40504410
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312170	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAP3K6 promoter	PMID:27901495
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAP3K6 mRNA	PMID:21839799
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAP3K6 protein	PMID:32717239
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312170	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAP3K6 mRNA	PMID:26238291|PMID:32234424
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120717	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAP3K6 mRNA	PMID:20504355|PMID:21569818
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MAP3K6 mRNA	PMID:30911355
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312170	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MAP3K6 mRNA	PMID:26238291
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312171	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MAP3K6 mRNA	PMID:35676786
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:30778	gallic acid	increases expression	ISO	RGD:1312170	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of MAP3K6 mRNA	PMID:34408198
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of MAP3K6 mRNA	PMID:32479839
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MAP3K6 mRNA	PMID:19464567|PMID:23557971
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312171	E	RGD:6480464	20130611	CTD	MESH:C009495	titanium dioxide results in increased expression of MAP3K6 mRNA	PMID:27760801
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312171	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MAP3K6 gene	PMID:35295148
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MAP3K6 mRNA	PMID:23411599|PMID:34492290
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MAP3K6 mRNA	PMID:18445702
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312171	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MAP3K6 mRNA	PMID:28472532
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of MAP3K6 mRNA	PMID:19167457
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP3K6 mRNA	PMID:32145629|PMID:34947998
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MAP3K6 mRNA	PMID:25181051
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312171	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MAP3K6 mRNA	PMID:32156529
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA	PMID:28628672
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312171	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MAP3K6 gene	PMID:31683443
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312171	E	RGD:6480464	20240206	CTD	MESH:C543008	bisphenol S results in increased expression of MAP3K6 mRNA	PMID:37611474
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312171	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of MAP3K6 exon; bisphenol S results in increased methylation of MAP3K6 promoter	PMID:33297965
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MAP3K6 mRNA	PMID:26377693
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MAP3K6 mRNA	PMID:38685157
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA	PMID:28628672
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of MAP3K6 mRNA	PMID:22546817
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MAP3K6 mRNA	PMID:21266533
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of MAP3K6 mRNA	PMID:22546817
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA	PMID:28628672
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20180313	CTD	MESH:D004052	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of MAP3K6 mRNA	PMID:26778414
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of MAP3K6 mRNA	PMID:12595580|PMID:21463325
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312170	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MAP3K6 mRNA	PMID:37042841
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MAP3K6 mRNA	PMID:26377693
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MAP3K6 mRNA	PMID:30723492
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MAP3K6 mRNA	PMID:33453195
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MAP3K6 mRNA	PMID:38174414
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312170	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAP3K6 mRNA	PMID:38382870
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAP3K6 mRNA	PMID:37236586
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of MAP3K6 mRNA	PMID:25539665|PMID:26194646
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312171	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MAP3K6 mRNA	PMID:28903501
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MAP3K6 mRNA	PMID:24449571
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312171	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of MAP3K6 mRNA	PMID:18353800
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of MAP3K6 mRNA	PMID:29038090
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of MAP3K6 mRNA	PMID:23125180
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of MAP3K6 mRNA	PMID:21427059
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312170	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MAP3K6 gene	PMID:29154799
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312171	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of MAP3K6 mRNA	PMID:22733784
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA	PMID:28628672
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAP3K6 mRNA	PMID:37992649
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of MAP3K6 mRNA	PMID:18502557
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of MAP3K6 mRNA	PMID:24449571
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312170	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of MAP3K6 mRNA	PMID:24935251
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAP3K6 mRNA	PMID:17562736
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of MAP3K6 mRNA	PMID:32479839|PMID:33387578
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of MAP3K6 mRNA	PMID:19420014
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1312170	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of MAP3K6 mRNA	PMID:17331233
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1312170	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of MAP3K6 promoter	PMID:29626692
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1312170	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of MAP3K6 promoter	PMID:29626692
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1312170	E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of MAP3K6 promoter	PMID:29626692
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of MAP3K6 mRNA	PMID:19654921
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40512198
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40504410
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of MAP3K6 mRNA	PMID:30529165
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MAP3K6 mRNA	PMID:30529165
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of MAP3K6 mRNA	PMID:17441966
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312170	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA	PMID:28628672
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312171	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MAP3K6 mRNA	PMID:35676786
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312170	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MAP3K6 mRNA	PMID:23300844
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MAP3K6 mRNA	PMID:30307764
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312171	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of MAP3K6 mRNA; Nanotubes, Carbon analog affects the expression of MAP3K6 mRNA	PMID:25554681
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312171	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MAP3K6 mRNA; Nanotubes, Carbon results in increased expression of MAP3K6 mRNA	PMID:25620056
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:50845	doxycycline	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D004318	Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MAP3K6 mRNA]	PMID:18089841
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of MAP3K6 mRNA	PMID:24793618
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:52492	mancozeb	increases expression	ISO	RGD:1312171	E	RGD:6480464	20230905	CTD	MESH:C013099	mancozeb results in increased expression of MAP3K6 mRNA	PMID:36007320
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MAP3K6 mRNA	PMID:19042947
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of MAP3K6 mRNA	PMID:23537331
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MAP3K6 mRNA	PMID:15336504
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20160705	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MAP3K6 mRNA	PMID:25234470
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312171	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of MAP3K6 mRNA	PMID:36851058
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in decreased expression of MAP3K6 mRNA	PMID:16982809
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of MAP3K6 mRNA	PMID:18089841|PMID:20003209
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20120515	CTD	MESH:D007545	Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MAP3K6 mRNA]	PMID:18089841
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of MAP3K6 mRNA	PMID:28935588
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312171	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MAP3K6 mRNA	PMID:31052254
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312170	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MAP3K6 mRNA	PMID:37199045
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of MAP3K6 mRNA	PMID:20097248
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312170	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MAP3K6 mRNA	PMID:19159669
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MAP3K6 mRNA	PMID:27291303
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312171	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MAP3K6 mRNA	PMID:39847705
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MAP3K6 mRNA	PMID:24780913
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Ozone results in increased expression of MAP3K6 mRNA]	PMID:17460151
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MAP3K6 mRNA	PMID:21346803
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MAP3K6 mRNA	PMID:38568856
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MAP3K6 mRNA	PMID:29301935
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312170	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MAP3K6 mRNA	PMID:27188386
1304625	Map3k6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MAP3K6 mRNA	PMID:21346803
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312172	E	RGD:6480464	20160210	CTD	MESH:C018475	butyraldehyde results in decreased expression of CCSER2 mRNA	PMID:26079696
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CCSER2 mRNA	PMID:36841081
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20150127	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of CCSER2 protein	PMID:18951874
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551286	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCSER2 mRNA	PMID:39241906
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551286	E	RGD:6480464	20140715	CTD	MESH:D004958	Estradiol results in decreased expression of CCSER2 mRNA	PMID:19484750
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312172	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CCSER2 mRNA	PMID:38568856
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CCSER2 mRNA	PMID:33387578
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312172	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CCSER2 mRNA	PMID:37042841
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1551286	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CCSER2 mRNA	PMID:34319233
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CCSER2 mRNA	PMID:33387578
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312172	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CCSER2 mRNA	PMID:28818685
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCSER2 mRNA	PMID:35301059
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551286	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CCSER2 mRNA	PMID:19770486
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312172	E	RGD:6480464	20141111	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CCSER2 mRNA	PMID:23649840
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CCSER2 mRNA	PMID:18593933
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CCSER2 mRNA	PMID:22206623
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1312172	E	RGD:6480464	20260804	CTD	MESH:D001151	Arsenic results in increased expression of CCSER2 mRNA alternative form	PMID:42191081
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:27563	arsenic atom	increases response to substance	ISO	RGD:1312172	E	RGD:6480464	20260804	CTD	MESH:D001151	CCSER2 mRNA alternative form results in increased susceptibility to Arsenic	PMID:42191081
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20260804	CTD	MESH:D001151	[CCSER2 mRNA alternative form results in increased susceptibility to Arsenic] which results in increased expression of PIK3CA mRNA	PMID:42191081
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCSER2 mRNA	PMID:40504410
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312172	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CCSER2 mRNA	PMID:19244175
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312172	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CCSER2 protein	PMID:35688186
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312172	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of CCSER2 mRNA	PMID:28903495
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1551286	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of CCSER2 mRNA	PMID:18930951
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCSER2 mRNA	PMID:34747641
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551286	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCSER2 mRNA	PMID:21570461
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCSER2 mRNA	PMID:32109520|PMID:33387578
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551286	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCSER2 mRNA	PMID:15034205|PMID:21354282
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CCSER2 mRNA]	PMID:15034205
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20150127	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of CCSER2 protein	PMID:18951874
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312172	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CCSER2 mRNA	PMID:33212167
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312172	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CCSER2 mRNA	PMID:39709020
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312172	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CCSER2 mRNA	PMID:29803840
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312172	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CCSER2 mRNA	PMID:38568856
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCSER2 mRNA	PMID:40504410
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551286	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCSER2 mRNA	PMID:15034205|PMID:21715664
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312172	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCSER2 5' UTR; Benzo(a)pyrene results in increased methylation of CCSER2 promoter	PMID:27901495
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of CCSER2 mRNA]	PMID:15034205
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CCSER2 mRNA]	PMID:32406909
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CCSER2 mRNA	PMID:18593933
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CCSER2 mRNA	PMID:32479839
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of CCSER2 mRNA	PMID:30816183
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of CCSER2 mRNA	PMID:25181051
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of CCSER2 mRNA	PMID:29097150|PMID:41034487
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CCSER2 gene	PMID:33148267
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312172	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCSER2 mRNA	PMID:37042841
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of CCSER2 mRNA	PMID:30589522
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCSER2 mRNA	PMID:35301059
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312172	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CCSER2 mRNA	PMID:19376846
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312172	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CCSER2 mRNA	PMID:24449571
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312172	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CCSER2 mRNA	PMID:19244175
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312172	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CCSER2 mRNA	PMID:31533062
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002737	Chloroprene results in increased expression of CCSER2 mRNA	PMID:23125180
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of CCSER2 mRNA	PMID:29427782
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312172	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of CCSER2 mRNA	PMID:28001369|PMID:29154799
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312172	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CCSER2 gene	PMID:29154799
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312172	E	RGD:6480464	20160210	CTD	MESH:D016572	Cyclosporine results in increased expression of CCSER2 mRNA	PMID:20106945|PMID:25562108
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1551286	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CCSER2 mRNA	PMID:28973697
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CCSER2 mRNA	PMID:33387578
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312172	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CCSER2 mRNA	PMID:21420995|PMID:29067470
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1312172	E	RGD:6480464	20260804	CTD	MESH:D001151	Arsenic results in increased expression of CCSER2 mRNA alternative form	PMID:42191081
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:47217	arsane	increases response to substance	ISO	RGD:1312172	E	RGD:6480464	20260804	CTD	MESH:D001151	CCSER2 mRNA alternative form results in increased susceptibility to Arsenic	PMID:42191081
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20260804	CTD	MESH:D001151	[CCSER2 mRNA alternative form results in increased susceptibility to Arsenic] which results in increased expression of PIK3CA mRNA	PMID:42191081
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCSER2 mRNA	PMID:40504410
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCSER2 mRNA	PMID:22079256
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CCSER2 mRNA	PMID:29097150
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1312172	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of CCSER2 mRNA	PMID:23228038
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of CCSER2 mRNA	PMID:30307764
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551286	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCSER2 mRNA; Nanotubes, Carbon results in decreased expression of CCSER2 mRNA	PMID:25554681
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312172	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CCSER2 mRNA	PMID:28988120
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CCSER2 gene	PMID:33148267
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312172	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CCSER2 mRNA	PMID:31758290
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1551286	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of CCSER2 mRNA	PMID:22206623
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CCSER2 mRNA	PMID:22206623
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312172	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CCSER2 mRNA	PMID:22079256
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312172	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCSER2 mRNA	PMID:22079256
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551286	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CCSER2 mRNA	PMID:23091169
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CCSER2 mRNA	PMID:32109520
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1551286	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of CCSER2 mRNA	PMID:21795629
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312172	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CCSER2 mRNA	PMID:38568856
1304626	Ccser2	coiled-coil serine-rich protein 2	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312172	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CCSER2 mRNA	PMID:29301935
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:10138	[6]-Shogaol	increases expression	ISO	RGD:1549990	E	RGD:6480464	20141111	CTD	MESH:C040115	[shogaol results in increased expression of BDNF protein] which results in increased expression of CHAT protein; shogaol results in increased expression of CHAT protein	PMID:22381256
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:10138	[6]-Shogaol	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20141111	CTD	MESH:C040115	[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein; shogaol inhibits the reaction [Hydrogen Peroxide results in decreased expression of CHAT protein]; staurosporine aglycone inhibits the reaction [[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein]	PMID:22381256
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:116314	oleamide	increases activity	ISO	RGD:1312173	E	RGD:6480464	20120412	CTD	MESH:C029407	oleylamide results in increased activity of CHAT protein	PMID:12843655
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312173	E	RGD:6480464	20230704	CTD	MESH:D014212	Tretinoin results in decreased expression of CHAT protein	PMID:36805303
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312173	E	RGD:6480464	20241105	CTD	MESH:D014212	Tretinoin results in increased expression of CHAT mRNA	PMID:38070836
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of CHAT mRNA; Tretinoin results in increased expression of CHAT protein	PMID:17203487|PMID:19135036
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312173	E	RGD:6480464	20241105	CTD	MESH:D014212	anatoxin a promotes the reaction [Tretinoin results in increased expression of CHAT mRNA]	PMID:38070836
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D014212	[Bucladesine co-treated with Tretinoin] results in increased activity of CHAT protein; [Tretinoin co-treated with Bucladesine] results in increased activity of CHAT protein	PMID:16724269|PMID:29665406
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312173	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CHAT mRNA	PMID:26079696
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:15891	taurine	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D013654	Taurine inhibits the reaction [Manganese results in decreased activity of CHAT protein]	PMID:24885898
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16170	mercury(0)	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D008628	Mercury results in decreased expression of CHAT mRNA	PMID:7781173
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D000431	Ethanol results in decreased expression of CHAT mRNA; Ethanol results in decreased expression of CHAT protein	PMID:17045751|PMID:19100286
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20230502	CTD	MESH:D000431	Ethanol results in decreased expression of CHAT mRNA	PMID:35863473
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	Cyanamide affects the reaction [Ethanol results in decreased expression of CHAT mRNA]; Cyanamide affects the reaction [Ethanol results in decreased expression of CHAT protein]	PMID:17045751
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CHAT mRNA; Ethanol promotes the reaction [Dietary Fats results in decreased expression of CHAT mRNA]	PMID:30319688|PMID:35863473
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20121009	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of CHAT protein	PMID:22381256
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20121009	CTD	MESH:D006861	[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein; shogaol inhibits the reaction [Hydrogen Peroxide results in decreased expression of CHAT protein]; staurosporine aglycone inhibits the reaction [[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein]	PMID:22381256
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D011794	Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of CHAT mRNA]; Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of CHAT protein]	PMID:27389774
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312173	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CHAT mRNA	PMID:30510588
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid inhibits the reaction [aluminum chloride results in decreased expression of CHAT protein]	PMID:18482095
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16494	lipoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008063	[Thioctic Acid co-treated with Pilocarpine] results in increased activity of CHAT protein	PMID:19669875
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16675	quinolinic acid	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D017378	Quinolinic Acid results in decreased activity of CHAT protein	PMID:2976130
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16675	quinolinic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D017378	Dizocilpine Maleate inhibits the reaction [Quinolinic Acid results in decreased activity of CHAT protein]	PMID:2976130
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16698	cyanamide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003484	Cyanamide affects the reaction [Ethanol results in decreased expression of CHAT mRNA]; Cyanamide affects the reaction [Ethanol results in decreased expression of CHAT protein]	PMID:17045751
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in decreased expression of CHAT mRNA	PMID:37084897
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16794	scopolamine	decreases activity	ISO	RGD:1312173	E	RGD:6480464	20120412	CTD	MESH:D012601	Scopolamine results in decreased activity of CHAT protein	PMID:20694781
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16794	scopolamine	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20151110	CTD	MESH:D012601	Scopolamine results in decreased activity of CHAT protein	PMID:26408985|PMID:29133030
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16794	scopolamine	multiple interactions	ISO	RGD:1312173	E	RGD:6480464	20120412	CTD	MESH:D012601	kangshuai yizhi inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]	PMID:20694781
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:16794	scopolamine	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20151110	CTD	MESH:D012601	protopanaxadiol inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]; Serotonin analog inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]	PMID:26408985|PMID:29133030
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone inhibits the reaction [VPS54 gene mutant form results in decreased activity of CHAT protein]; Progesterone inhibits the reaction [VPS54 gene mutant form results in decreased expression of CHAT protein]; Progesterone inhibits the reaction [VPS54 mutant form results in decreased expression of CHAT protein]	PMID:17052708|PMID:19693665
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CHAT mRNA	PMID:21145954
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20130312	CTD	MESH:C040048	caffeic acid inhibits the reaction [aluminum chloride results in decreased expression of CHAT protein]	PMID:18482095
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:176788	dizocilpine maleate	multiple interactions	EXP		E	RGD:6480464	20210803	CTD	MESH:D016291	Dizocilpine Maleate inhibits the reaction [Quinolinic Acid results in decreased activity of CHAT protein]	PMID:2976130
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:17688	(S)-nicotine	decreases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased activity of CHAT protein	PMID:21633116
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:17688	(S)-nicotine	increases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased activity of CHAT protein	PMID:21633116|PMID:30247698
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [Vanadium results in decreased expression of CHAT protein]; Nicotine promotes the reaction [Bucladesine results in increased expression of CHAT protein]	PMID:20361958|PMID:22119111
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:D024502	[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein]	PMID:25891525
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:18291	manganese atom	decreases activity	EXP		E	RGD:6480464	20151013	CTD	MESH:D008345	Manganese results in decreased activity of CHAT protein	PMID:24885898
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D008345	Taurine inhibits the reaction [Manganese results in decreased activity of CHAT protein]	PMID:24885898
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20190910	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased activity of CHAT protein	PMID:30738988
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:18723	nicotine	decreases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased activity of CHAT protein	PMID:21633116
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:18723	nicotine	increases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased activity of CHAT protein	PMID:21633116|PMID:30247698
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [Vanadium results in decreased expression of CHAT protein]; Nicotine promotes the reaction [Bucladesine results in increased expression of CHAT protein]	PMID:20361958|PMID:22119111
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:201674	icaritin	increases expression	ISO	RGD:1549990	E	RGD:6480464	20231219	CTD	MESH:C499403	icaritin results in increased expression of CHAT protein	PMID:19135036
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in increased expression of CHAT mRNA; Azacitidine results in increased expression of CHAT protein	PMID:19151599
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312173	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of CHAT mRNA	PMID:24376830
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20200714	CTD	MESH:D002104	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CHAT mRNA	PMID:31904401
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:24527	herbicide	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20200804	CTD	MESH:D006540	Herbicides results in decreased expression of CHAT protein	PMID:31991143
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:24848	inositol	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D007294	Inositol inhibits the reaction [Streptozocin affects the localization of CHAT protein]	PMID:2431858
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CHAT mRNA	PMID:26260870
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:25195	mercury atom	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D008628	Mercury results in decreased expression of CHAT mRNA	PMID:7781173
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:2663	amiodarone	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D000638	Amiodarone results in decreased expression of CHAT protein	PMID:25659768
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:2666	amitriptyline	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D000639	Amitriptyline results in increased expression of CHAT mRNA	PMID:21820738
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:2706	Anatoxin a	multiple interactions	ISO	RGD:1312173	E	RGD:6480464	20241105	CTD	MESH:C509783	anatoxin a promotes the reaction [Tretinoin results in increased expression of CHAT mRNA]	PMID:38070836
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27086	tributylstannane	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:C011559	tributyltin results in decreased activity of CHAT protein	PMID:9015740
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312173	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of CHAT mRNA; Arsenic results in decreased expression of CHAT protein	PMID:37624150
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of CHAT protein	PMID:37624150
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27698	vanadium atom	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of CHAT protein	PMID:22119111
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27698	vanadium atom	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Nicotine inhibits the reaction [Vanadium results in decreased expression of CHAT protein]	PMID:22119111
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C059514	resveratrol results in increased expression of CHAT protein	PMID:23075401
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312173	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CHAT mRNA	PMID:23557933
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27928	parathion	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010278	Parathion affects the expression of CHAT protein	PMID:18941570|PMID:19590683
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27928	parathion	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D010278	Parathion results in decreased expression of CHAT protein	PMID:20015457
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27928	parathion	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D010278	Dietary Fats affects the reaction [Parathion affects the expression of CHAT protein]	PMID:19590683
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27953	physostigmine	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010830	Physostigmine results in decreased expression of CHAT protein	PMID:22640809
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27953	physostigmine	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010830	Physostigmine results in increased expression of CHAT protein	PMID:22640809
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1549990	E	RGD:6480464	20230404	CTD	MESH:D003042	Cocaine results in increased expression of CHAT protein	PMID:35597300
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28061	alpha-D-galactose	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20140805	CTD	MESH:D005690	Galactose results in decreased activity of CHAT protein	PMID:23612000
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28061	alpha-D-galactose	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140805	CTD	MESH:D005690	catalpol inhibits the reaction [Galactose results in decreased activity of CHAT protein]	PMID:23612000
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHAT mRNA	PMID:32109520
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28197	daidzein	increases activity	ISO	RGD:1312173	E	RGD:6480464	20120412	CTD	MESH:C004742	daidzein results in increased activity of CHAT protein	PMID:16428827
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20231003	CTD	MESH:D012402	Rotenone results in decreased expression of CHAT protein	PMID:35919817
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28260	galactose	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20140311	CTD	MESH:D005690	Galactose results in decreased activity of CHAT protein	PMID:23612000
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28260	galactose	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140311	CTD	MESH:D005690	catalpol inhibits the reaction [Galactose results in decreased activity of CHAT protein]	PMID:23612000
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28527	rutin	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D012431	Rutin inhibits the reaction [Acrylamide results in decreased expression of CHAT protein]	PMID:36657526
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28619	acrylamide	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D020106	Acrylamide results in decreased activity of CHAT protein	PMID:11779407
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CHAT mRNA; Acrylamide results in decreased expression of CHAT protein	PMID:28959563|PMID:36657526
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of CHAT mRNA	PMID:30807115
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28619	acrylamide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020106	NTF3 protein inhibits the reaction [Acrylamide results in decreased activity of CHAT protein]; Rutin inhibits the reaction [Acrylamide results in decreased expression of CHAT protein]	PMID:11779407|PMID:36657526
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28680	cytarabine	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in increased activity of CHAT protein	PMID:2900045
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28748	doxorubicin	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of CHAT gene	PMID:28962528
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of CHAT mRNA	PMID:39631538
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28790	serotonin	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20151110	CTD	MESH:D012701	Serotonin analog inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]	PMID:26408985
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28939	N-acetyl-L-cysteine	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D000111	Acetylcysteine results in increased expression of CHAT protein	PMID:25891525
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:D000111	[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein]	PMID:25891525
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28984	aluminium atom	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased activity of CHAT protein	PMID:16724269
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28984	aluminium atom	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased expression of CHAT protein	PMID:16928369
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:28984	aluminium atom	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	APP protein promotes the reaction [Aluminum results in decreased activity of CHAT protein]; meloxicam inhibits the reaction [Aluminum results in decreased expression of CHAT protein]	PMID:16724269|PMID:16928369
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:D001205	[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein]	PMID:25891525
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CHAT protein	PMID:21839772|PMID:24517892|PMID:30051311
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	increases activity	ISO	RGD:1549990	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased activity of CHAT protein	PMID:3437937
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312173	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CHAT mRNA	PMID:38568856
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	Curcumin inhibits the reaction [sodium arsenite results in decreased expression of CHAT protein]	PMID:21839772
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312173	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHAT promoter	PMID:27901495
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CHAT protein	PMID:28049045
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases activity	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene results in increased activity of CHAT protein	PMID:30247698
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312173	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CHAT exon	PMID:27901495
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312173	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CHAT promoter	PMID:23974009
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008063	[Thioctic Acid co-treated with Pilocarpine] results in increased activity of CHAT protein	PMID:19669875
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:3093	bifenthrin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C099952	bifenthrin results in decreased expression of CHAT mRNA	PMID:29775722
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CHAT mRNA	PMID:16483693
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312173	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CHAT gene	PMID:31601247
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312173	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CHAT gene	PMID:31601247
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of CHAT mRNA	PMID:23411599
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CHAT mRNA	PMID:25181051
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312173	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CHAT protein	PMID:31675489
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CHAT mRNA	PMID:32365465|PMID:34655688
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CHAT gene	PMID:28505145
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312173	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CHAT gene	PMID:31601247
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20220705	CTD	MESH:C006780	bisphenol A results in decreased expression of and results in decreased activity of CHAT protein; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of CHAT protein]	PMID:34655688
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312173	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CHAT protein	PMID:31675489
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20230704	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CHAT protein	PMID:35950316
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33629	aluminium(0)	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased activity of CHAT protein	PMID:16724269
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33629	aluminium(0)	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased expression of CHAT protein	PMID:16928369
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:33629	aluminium(0)	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	APP protein promotes the reaction [Aluminum results in decreased activity of CHAT protein]; meloxicam inhibits the reaction [Aluminum results in decreased expression of CHAT protein]	PMID:16724269|PMID:16928369
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312173	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CHAT gene	PMID:31601247
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34631	chlorpyrifos	affects activity	ISO	RGD:1549990	E	RGD:6480464	20210112	CTD	MESH:D004390	Chlorpyrifos affects the activity of CHAT protein	PMID:33007016
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CHAT mRNA	PMID:17452286|PMID:18812211
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34631	chlorpyrifos	increases activity	ISO	RGD:1549990	E	RGD:6480464	20210112	CTD	MESH:D004390	Chlorpyrifos results in increased activity of CHAT protein	PMID:33007016
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20151215	CTD	MESH:D004390	CHAT protein affects the reaction [Chlorpyrifos results in increased expression of ACHE mRNA]	PMID:26210949
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34682	diazinon	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in decreased activity of CHAT protein	PMID:16675431
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34682	diazinon	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in decreased expression of CHAT mRNA	PMID:17452286|PMID:18812211|PMID:29108742
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34690	dichlorvos	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D004006	Dichlorvos results in increased activity of CHAT protein	PMID:17722737
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of CHAT mRNA	PMID:19542621
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34905	paraquat	decreases activity	EXP		E	RGD:6480464	20150310	CTD	MESH:D010269	Paraquat results in decreased activity of CHAT protein	PMID:24521700
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D010269	Paraquat results in decreased expression of CHAT mRNA	PMID:28916328
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin co-treated with DEET] results in increased activity of CHAT protein	PMID:11248143
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:35154	manganese(0)	decreases activity	EXP		E	RGD:6480464	20151013	CTD	MESH:D008345	Manganese results in decreased activity of CHAT protein	PMID:24885898
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D008345	Taurine inhibits the reaction [Manganese results in decreased activity of CHAT protein]	PMID:24885898
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20190910	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased activity of CHAT protein	PMID:30738988
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:35170	vanadium(0)	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of CHAT protein	PMID:22119111
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:35170	vanadium(0)	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Nicotine inhibits the reaction [Vanadium results in decreased expression of CHAT protein]	PMID:22119111
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20141223	CTD	MESH:D019256	Cadmium Chloride results in decreased activity of CHAT protein	PMID:25201352
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CHAT mRNA; Cadmium Chloride results in decreased expression of CHAT protein	PMID:27389774
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20170110	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CHAT protein	PMID:27377441
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D019256	Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of CHAT mRNA]; Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of CHAT protein]	PMID:27389774
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20170110	CTD	MESH:D019256	[[Cadmium Chloride results in decreased activity of CHRM1 protein] which affects the expression of ACHE mRNA alternative form] which results in decreased expression of CHAT protein; [Cadmium Chloride results in decreased activity of CHRM1 protein] which results in decreased expression of CHAT protein; [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CHAT mRNA; ACHE mRNA promotes the reaction [Cadmium Chloride results in decreased expression of CHAT protein]; CHRM1 mRNA inhibits the reaction [Cadmium Chloride results in decreased expression of CHAT protein]	PMID:27377441|PMID:31904401
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20200714	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CHAT mRNA	PMID:31904401
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:39178	clothianidin	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20230905	CTD	MESH:C480342	clothianidin results in decreased expression of CHAT mRNA	PMID:35264496
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased activity of CHAT protein	PMID:12773772
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D003474	Curcumin inhibits the reaction [sodium arsenite results in decreased expression of CHAT protein]	PMID:21839772
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CHAT mRNA	PMID:30047161
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:4034	cyfluthrin	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C052570	cyfluthrin results in decreased expression of CHAT protein	PMID:26604153
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:4042	cypermethrin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C017160	cypermethrin results in decreased expression of CHAT mRNA; cypermethrin results in decreased expression of CHAT protein	PMID:26115703
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D003907	Dexamethasone results in decreased expression of CHAT protein	PMID:29524569
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:43931	methyllycaconitine	multiple interactions	ISO	RGD:1312173	E	RGD:6480464	20141111	CTD	MESH:C054634	methyllycaconitine inhibits the reaction [SLURP1 protein results in increased expression of CHAT]	PMID:24365495
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:44485	N-ethylmaleimide	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20121218	CTD	MESH:D005033	Ethylmaleimide results in decreased activity of CHAT protein	PMID:3437937
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:45980	tacrine	increases expression	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D013619	Tacrine results in increased expression of CHAT protein	PMID:15990178
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312173	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of CHAT mRNA; Arsenic results in decreased expression of CHAT protein	PMID:37624150
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of CHAT protein	PMID:37624150
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312173	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CHAT mRNA	PMID:31675489
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:48765	dimethylarsinic acid	increases activity	ISO	RGD:1549990	E	RGD:6480464	20121218	CTD	MESH:D002101	Cacodylic Acid results in increased activity of CHAT protein	PMID:21440049
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:50095	bucladesine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D003994	Bucladesine results in increased expression of CHAT protein	PMID:20361958
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D003994	Nicotine promotes the reaction [Bucladesine results in increased expression of CHAT protein]	PMID:20361958
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D003994	[Bucladesine co-treated with Tretinoin] results in increased activity of CHAT protein; [Tretinoin co-treated with Bucladesine] results in increased activity of CHAT protein	PMID:16724269|PMID:29665406
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:50648	9-cis-retinoic acid	decreases expression	ISO	RGD:1312173	E	RGD:6480464	20230704	CTD	MESH:C103303	Alitretinoin results in decreased expression of CHAT protein	PMID:36805303
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CHAT mRNA	PMID:30047161
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:5870	imidacloprid	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C082359	imidacloprid results in increased expression of CHAT mRNA	PMID:39002876
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:6015	isoflurane	decreases activity	EXP		E	RGD:6480464	20211207	CTD	MESH:D007530	Isoflurane results in decreased activity of CHAT protein	PMID:28084090
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:6015	isoflurane	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D007530	rhodioloside inhibits the reaction [Isoflurane results in decreased activity of CHAT protein]	PMID:28084090
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20190910	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased activity of CHAT protein	PMID:30738988
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:6741	meloxicam	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140107	CTD	MESH:C065757	meloxicam inhibits the reaction [Aluminum results in decreased expression of CHAT protein]	PMID:16928369
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:67988	ginsenoside Rd	increases expression	ISO	RGD:1549990	E	RGD:6480464	20140408	CTD	MESH:C049863	ginsenoside Rd results in increased expression of CHAT mRNA; ginsenoside Rd results in increased expression of CHAT protein	PMID:24599032
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:67988	ginsenoside Rd	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140408	CTD	MESH:C049863	staurosporine aglycone inhibits the reaction [ginsenoside Rd results in increased expression of CHAT mRNA]; staurosporine aglycone inhibits the reaction [ginsenoside Rd results in increased expression of CHAT protein]	PMID:24599032
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:6809	methamphetamine	decreases activity	ISO	RGD:1312173	E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in decreased activity of CHAT protein	PMID:10089005
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:69797	catalpol	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20141111	CTD	MESH:C078040	catalpol inhibits the reaction [Galactose results in decreased activity of CHAT protein]	PMID:23612000
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003671	[Pyridostigmine Bromide co-treated with Permethrin co-treated with DEET] results in increased activity of CHAT protein	PMID:11248143
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:755912	aluminum chloride	decreases activity	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in decreased activity of CHAT protein	PMID:2303807
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:755912	aluminum chloride	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in decreased expression of CHAT protein	PMID:18482095
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:755912	aluminum chloride	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20260714	CTD	MESH:D000077410	caffeic acid inhibits the reaction [Aluminum Chloride results in decreased expression of CHAT protein]	PMID:18482095
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:75701	sarin	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of CHAT protein	PMID:22640809
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:7596	nitroprusside	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D009599	Nitroprusside results in decreased activity of CHAT protein	PMID:16724269
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:7596	nitroprusside	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D009599	APP protein promotes the reaction [Nitroprusside results in decreased activity of CHAT protein]	PMID:16724269
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:76237	(20R)-protopanaxadiol	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20180410	CTD	MESH:C062916	protopanaxadiol inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]	PMID:29133030
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1312173	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CHAT mRNA	PMID:20816883
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:77148	ginsenoside Re	increases expression	ISO	RGD:1549990	E	RGD:6480464	20140408	CTD	MESH:C049864	ginsenoside Re results in increased expression of CHAT mRNA; ginsenoside Re results in increased expression of CHAT protein	PMID:24599032
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:77148	ginsenoside Re	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140408	CTD	MESH:C049864	staurosporine aglycone inhibits the reaction [ginsenoside Re results in increased expression of CHAT mRNA]; staurosporine aglycone inhibits the reaction [ginsenoside Re results in increased expression of CHAT protein]	PMID:24599032
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:77149	notoginsenoside R1	increases expression	ISO	RGD:1549990	E	RGD:6480464	20151110	CTD	MESH:C072936	notoginsenoside R1 results in increased expression of CHAT	PMID:25714973
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312173	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CHAT gene]	PMID:28238834
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CHAT mRNA	PMID:32109520
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312173	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CHAT protein	PMID:31675489
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:8207	(+)-pilocarpine	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in decreased activity of CHAT protein	PMID:19669875|PMID:19932735
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:8207	(+)-pilocarpine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in decreased expression of CHAT protein	PMID:19941057
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:8207	(+)-pilocarpine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010862	[Thioctic Acid co-treated with Pilocarpine] results in increased activity of CHAT protein	PMID:19669875
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312173	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CHAT protein	PMID:31675489
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20230704	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CHAT protein	PMID:35950316
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin co-treated with DEET] results in increased activity of CHAT protein	PMID:11248143
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:8874	rivastigmine	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C072506	Rivastigmine inhibits the reaction [Streptozocin results in decreased expression of CHAT protein]	PMID:32805344
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:9009	Salidroside	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:C009172	rhodioloside inhibits the reaction [Isoflurane results in decreased activity of CHAT protein]	PMID:28084090
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:9150	simvastatin	multiple interactions	ISO	RGD:1312173	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin inhibits the reaction [ITGAL affects the susceptibility to and affects the activity of CHAT protein]; Simvastatin inhibits the reaction [ITGAL affects the susceptibility to and affects the expression of CHAT mRNA]	PMID:16828882
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:9288	streptozocin	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D013311	Streptozocin affects the localization of CHAT protein	PMID:2431858
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:9288	streptozocin	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D013311	Streptozocin results in decreased expression of CHAT protein	PMID:32805344
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013311	Inositol inhibits the reaction [Streptozocin affects the localization of CHAT protein]; Phycocyanin inhibits the reaction [Streptozocin results in decreased expression of CHAT protein]; Rivastigmine inhibits the reaction [Streptozocin results in decreased expression of CHAT protein]	PMID:2431858|PMID:32805344
1304627	Chat	choline O-acetyltransferase	gene	CHEBI:9449	terbutaline	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D013726	Terbutaline results in decreased expression of CHAT protein	PMID:29524569
1304628	Exog	exo/endonuclease G	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312174	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of EXOG mRNA	PMID:38218311
1304628	Exog	exo/endonuclease G	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312175	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EXOG mRNA	PMID:33045310
1304628	Exog	exo/endonuclease G	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312175	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EXOG mRNA	PMID:20188158
1304628	Exog	exo/endonuclease G	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of EXOG mRNA	PMID:33167477
1304628	Exog	exo/endonuclease G	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312175	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of EXOG mRNA	PMID:39298647
1304628	Exog	exo/endonuclease G	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312174	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of EXOG mRNA	PMID:38568856
1304628	Exog	exo/endonuclease G	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312175	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EXOG mRNA	PMID:34319233
1304628	Exog	exo/endonuclease G	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EXOG mRNA	PMID:33387578
1304628	Exog	exo/endonuclease G	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of EXOG mRNA	PMID:21396975
1304628	Exog	exo/endonuclease G	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312175	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EXOG mRNA	PMID:19770486
1304628	Exog	exo/endonuclease G	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312174	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of EXOG mRNA	PMID:23649840
1304628	Exog	exo/endonuclease G	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312175	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EXOG mRNA	PMID:40504410
1304628	Exog	exo/endonuclease G	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312174	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of EXOG mRNA	PMID:23557933
1304628	Exog	exo/endonuclease G	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312174	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of EXOG mRNA	PMID:27594783
1304628	Exog	exo/endonuclease G	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312174	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of EXOG mRNA	PMID:25583101
1304628	Exog	exo/endonuclease G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312175	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EXOG mRNA	PMID:21570461
1304628	Exog	exo/endonuclease G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EXOG mRNA	PMID:19465110
1304628	Exog	exo/endonuclease G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EXOG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EXOG mRNA	PMID:17942748|PMID:25975270
1304628	Exog	exo/endonuclease G	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312175	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of EXOG mRNA	PMID:32937126
1304628	Exog	exo/endonuclease G	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D012402	[EXOG protein co-treated with Rotenone] results in decreased expression of PPARGC1A mRNA; [EXOG protein co-treated with Rotenone] results in decreased expression of PPARGC1A protein; [EXOG protein co-treated with Rotenone] results in decreased expression of SSBP1 protein; EXOG protein inhibits the reaction [Rotenone results in decreased expression of HSF1 protein]; EXOG protein inhibits the reaction [Rotenone results in decreased expression of TFAM mRNA]; EXOG protein inhibits the reaction [Rotenone results in decreased expression of TFAM protein]; EXOG protein inhibits the reaction [Rotenone results in decreased expression of TH protein]; Rotenone affects the expression of and affects the localization of EXOG protein; ZLN005 affects the reaction [Rotenone affects the expression of EXOG protein]	PMID:33515431
1304628	Exog	exo/endonuclease G	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of EXOG mRNA	PMID:23649840
1304628	Exog	exo/endonuclease G	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of EXOG mRNA	PMID:21198554
1304628	Exog	exo/endonuclease G	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EXOG mRNA	PMID:29803840
1304628	Exog	exo/endonuclease G	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312175	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EXOG mRNA	PMID:40504410
1304628	Exog	exo/endonuclease G	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312174	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EXOG promoter	PMID:27901495
1304628	Exog	exo/endonuclease G	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312174	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EXOG 3' UTR	PMID:27901495
1304628	Exog	exo/endonuclease G	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312175	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EXOG intron	PMID:27901495
1304628	Exog	exo/endonuclease G	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312174	E	RGD:6480464	20150310	CTD	MESH:D012834	Silver analog results in increased expression of EXOG mRNA; Silver results in increased expression of EXOG mRNA	PMID:24974767
1304628	Exog	exo/endonuclease G	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312175	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of EXOG mRNA	PMID:27131904
1304628	Exog	exo/endonuclease G	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of EXOG mRNA	PMID:25351596
1304628	Exog	exo/endonuclease G	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312174	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of EXOG mRNA	PMID:15761015
1304628	Exog	exo/endonuclease G	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EXOG mRNA	PMID:34492290
1304628	Exog	exo/endonuclease G	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EXOG mRNA	PMID:25181051
1304628	Exog	exo/endonuclease G	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of EXOG mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304628	Exog	exo/endonuclease G	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of EXOG gene	PMID:28505145
1304628	Exog	exo/endonuclease G	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EXOG mRNA	PMID:36041667
1304628	Exog	exo/endonuclease G	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EXOG mRNA	PMID:36041667
1304628	Exog	exo/endonuclease G	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312174	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of EXOG intron	PMID:30157460
1304628	Exog	exo/endonuclease G	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EXOG mRNA	PMID:36041667
1304628	Exog	exo/endonuclease G	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312175	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EXOG mRNA	PMID:37019170
1304628	Exog	exo/endonuclease G	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EXOG mRNA	PMID:21266533
1304628	Exog	exo/endonuclease G	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EXOG mRNA	PMID:21266533
1304628	Exog	exo/endonuclease G	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312174	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EXOG mRNA	PMID:37042841
1304628	Exog	exo/endonuclease G	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EXOG mRNA	PMID:33453195
1304628	Exog	exo/endonuclease G	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EXOG mRNA	PMID:19320972
1304628	Exog	exo/endonuclease G	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312174	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EXOG mRNA	PMID:24449571
1304628	Exog	exo/endonuclease G	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EXOG mRNA	PMID:31533062
1304628	Exog	exo/endonuclease G	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312174	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EXOG mRNA	PMID:25979313
1304628	Exog	exo/endonuclease G	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312174	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EXOG mRNA	PMID:23179753
1304628	Exog	exo/endonuclease G	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312175	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of EXOG mRNA	PMID:28973697
1304628	Exog	exo/endonuclease G	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of EXOG mRNA	PMID:23649840
1304628	Exog	exo/endonuclease G	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in decreased expression of EXOG mRNA	PMID:28542535
1304628	Exog	exo/endonuclease G	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EXOG mRNA	PMID:33387578
1304628	Exog	exo/endonuclease G	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312175	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EXOG mRNA	PMID:40504410
1304628	Exog	exo/endonuclease G	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of EXOG mRNA	PMID:18175754
1304628	Exog	exo/endonuclease G	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EXOG mRNA	PMID:17942748
1304628	Exog	exo/endonuclease G	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EXOG mRNA	PMID:17942748
1304628	Exog	exo/endonuclease G	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312174	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of EXOG mRNA	PMID:15761015
1304628	Exog	exo/endonuclease G	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312174	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of EXOG intron	PMID:30157460
1304628	Exog	exo/endonuclease G	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of EXOG gene	PMID:35440735
1304628	Exog	exo/endonuclease G	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1312175	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of EXOG mRNA	PMID:22470460
1304628	Exog	exo/endonuclease G	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1312174	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of EXOG mRNA	PMID:36318118
1304628	Exog	exo/endonuclease G	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312174	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EXOG gene]	PMID:28238834
1304628	Exog	exo/endonuclease G	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of EXOG mRNA	PMID:32109520
1304628	Exog	exo/endonuclease G	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312174	E	RGD:6480464	20150310	CTD	MESH:D012834	Silver analog results in increased expression of EXOG mRNA; Silver results in increased expression of EXOG mRNA	PMID:24974767
1304628	Exog	exo/endonuclease G	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312175	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of EXOG mRNA	PMID:27131904
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312176	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ACER2 mRNA	PMID:38218311
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of ACER2 mRNA	PMID:21551480
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622080	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ACER2 mRNA	PMID:33045310
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ACER2 mRNA	PMID:20188158
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACER2 mRNA	PMID:20938992
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312176	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ACER2 mRNA	PMID:33167477
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312176	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ACER2 mRNA	PMID:26516004
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ACER2 gene	PMID:28931070
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of ACER2 mRNA	PMID:32145629
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ACER2 mRNA	PMID:39298647
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1622080	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ACER2 mRNA	PMID:33711761
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACER2 mRNA	PMID:20938992
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACER2 mRNA	PMID:37992649
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of ACER2 mRNA	PMID:22967744
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACER2 mRNA	PMID:37992649
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312176	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ACER2 mRNA	PMID:28818685
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACER2 mRNA	PMID:36331819
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of ACER2 mRNA	PMID:23358152
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ACER2 mRNA	PMID:21396975
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ACER2 mRNA	PMID:23385219
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312176	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ACER2 mRNA	PMID:32234424
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:2564	aldrin	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in decreased expression of ACER2 mRNA	PMID:18579281
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of ACER2 mRNA	PMID:19555225
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of ACER2 mRNA	PMID:35737395
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ACER2 mRNA	PMID:34911549
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000638	Amiodarone results in increased expression of ACER2 mRNA	PMID:25580480
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ACER2 mRNA	PMID:30723492|PMID:31150632|PMID:33387578
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACER2 mRNA	PMID:20938992
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACER2 mRNA	PMID:40504410
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1312176	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ACER2 mRNA	PMID:38460933
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312176	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ACER2 mRNA	PMID:38460933
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ACER2 mRNA	PMID:25905778
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of ACER2 mRNA	PMID:25905778
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312176	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ACER2 mRNA	PMID:27392435
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1622080	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ACER2 mRNA	PMID:40618947
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312176	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ACER2 mRNA	PMID:27392435
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:27903	(2,4,5-trichlorophenoxy)acetic acid	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20130514	CTD	MESH:D015085	2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of ACER2 mRNA	PMID:18579281
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACER2 mRNA	PMID:34747641
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622080	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACER2 mRNA	PMID:21570461|PMID:26377647
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACER2 mRNA	PMID:32109520|PMID:33387578
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1622080	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACER2 mRNA	PMID:26290441
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ACER2 mRNA	PMID:28374803
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312176	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACER2 mRNA	PMID:30851411
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28509	chloroethene	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in decreased expression of ACER2 mRNA	PMID:18579281
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1622080	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in increased expression of ACER2 mRNA	PMID:35032568
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312176	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ACER2 mRNA	PMID:30031762
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1622080	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ACER2 mRNA	PMID:39631538
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACER2 mRNA	PMID:37992649
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312176	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACER2 mRNA	PMID:39719251
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACER2 mRNA	PMID:40504410
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312176	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ACER2 promoter	PMID:27901495
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312176	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACER2 mRNA	PMID:32234424
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1622080	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACER2 mRNA	PMID:27195522|PMID:32417428
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ACER2 mRNA	PMID:24136188
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of ACER2 mRNA	PMID:22641619
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ACER2 mRNA	PMID:32479839
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of ACER2 mRNA	PMID:25729387
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACER2 mRNA	PMID:30012374
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACER2 mRNA	PMID:23557971
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622080	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACER2 gene	PMID:35295148
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ACER2 mRNA	PMID:34492290
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1622080	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ACER2 mRNA	PMID:18301758|PMID:23811191
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ACER2 mRNA	PMID:19167457
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312176	E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A affects the expression of ACER2 mRNA	PMID:22574217
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312176	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ACER2 gene	PMID:31601247
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACER2 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:34947998
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1622080	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ACER2 mRNA	PMID:26063408|PMID:33221593
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ACER2 mRNA	PMID:26682919
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:3423	carmustine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of ACER2 mRNA	PMID:16005536
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ACER2 mRNA	PMID:39298647
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1622080	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ACER2 mRNA	PMID:37019170
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312176	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACER2 mRNA	PMID:37042841
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of ACER2 mRNA	PMID:30589522
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ACER2 mRNA	PMID:25993096
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ACER2 mRNA	PMID:35163327
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of ACER2 mRNA	PMID:26194646
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ACER2 mRNA	PMID:30047161
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1622080	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ACER2 mRNA	PMID:28903501
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312176	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ACER2 mRNA	PMID:31533062
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACER2 mRNA	PMID:36331819
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ACER2 mRNA	PMID:23125180
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20190219	CTD	MESH:C017160	cypermethrin results in decreased expression of ACER2 mRNA	PMID:29020013
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ACER2 mRNA	PMID:28973697
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACER2 mRNA	PMID:37992649
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased expression of ACER2 mRNA	PMID:16005536
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1312176	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of ACER2 mRNA	PMID:24657277
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312176	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ACER2 mRNA	PMID:38832940
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622080	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACER2 mRNA	PMID:17562736
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of ACER2 mRNA	PMID:32479839|PMID:33387578
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312176	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ACER2 mRNA	PMID:22230336|PMID:29067470
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ACER2 mRNA	PMID:29279043
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1622080	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of ACER2 mRNA	PMID:29279043
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:46742	Nutlin-3	increases expression	ISO	RGD:1312176	E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of ACER2 mRNA	PMID:38460933
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312176	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ACER2 mRNA	PMID:38460933
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACER2 mRNA	PMID:40504410
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of ACER2 mRNA	PMID:30529165
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ACER2 mRNA	PMID:35436446
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ACER2 mRNA	PMID:25554681
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1622080	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ACER2 mRNA	PMID:25620056
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of ACER2 mRNA	PMID:23962444
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of ACER2 mRNA	PMID:23358152
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ACER2 mRNA	PMID:30047161
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of ACER2 mRNA	PMID:25729387
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1622080	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ACER2 mRNA	PMID:20003209
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACER2 mRNA	PMID:22206623
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312176	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACER2 mRNA	PMID:30851411
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACER2 mRNA	PMID:27291303
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1312176	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of ACER2 mRNA	PMID:30458266
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1312176	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of ACER2 mRNA	PMID:32234424
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ACER2 mRNA	PMID:23640034
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ACER2 mRNA	PMID:24780913
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of ACER2 mRNA	PMID:25825206|PMID:30047161
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1312176	E	RGD:6480464	20121113	CTD	MESH:D020123	Sirolimus inhibits the reaction [TP73 protein results in decreased expression of ACER2 mRNA]	PMID:21245298
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of ACER2 mRNA	PMID:25905778
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of ACER2 mRNA	PMID:23358152
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:9555	tioguanine	increases expression	EXP		E	RGD:6480464	20130305	CTD	MESH:D013866	Thioguanine results in increased expression of ACER2 mRNA	PMID:16005536
1304629	Acer2	alkaline ceramidase 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ACER2 mRNA	PMID:19015723
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1551976	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ZFP169 mRNA	PMID:33045310
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ZFP169 mRNA	PMID:26496021
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP169 mRNA	PMID:33387578
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZFP169 mRNA	PMID:33354967
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZFP169 mRNA	PMID:30779732
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZFP169 mRNA	PMID:31150632
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312178	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF169 gene	PMID:25304211
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP169 mRNA	PMID:33387578
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ZFP169 mRNA	PMID:28959563
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312178	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ZNF169 mRNA	PMID:32763439
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312178	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZNF169 5' UTR	PMID:27901495
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1551976	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZFP169 mRNA	PMID:35295148
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551976	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP169 promoter	PMID:35295148
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF169 mRNA	PMID:25181051
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551976	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP169 mRNA	PMID:33221593|PMID:38074096
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312178	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZNF169 gene	PMID:31601247
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ZFP169 mRNA	PMID:26496021
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551976	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZFP169 mRNA	PMID:39298647
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:34575	bisphenol F	affects expression	ISO	RGD:1551976	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F affects the expression of ZFP169 mRNA	PMID:38685157
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312178	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF169 mRNA	PMID:38382870|PMID:38568856
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:4027	cyclophosphamide	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of ZFP169 mRNA	PMID:27281708
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312178	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ZNF169 mRNA	PMID:38832940
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312178	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF169 gene	PMID:25304211
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551976	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP169 mRNA	PMID:22206623
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312178	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF169 protein	PMID:31285264
1304631	Zfp169	zinc finger protein 169	gene	CHEBI:85014	2,5-hexanedione	decreases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in decreased expression of ZFP169 protein	PMID:19033394
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312181	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SOCS6 mRNA	PMID:33045310
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SOCS6 gene	PMID:20938992
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312180	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SOCS6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SOCS6 mRNA	PMID:32699268
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1312181	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of SOCS6 mRNA	PMID:20362636
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312180	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SOCS6 mRNA	PMID:21632981
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312180	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of SOCS6 mRNA	PMID:20106945
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SOCS6 gene	PMID:20938992
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312180	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of SOCS6 mRNA	PMID:20655997
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312181	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SOCS6 mRNA	PMID:23892564
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312180	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SOCS6 protein	PMID:37730182
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SOCS6 mRNA	PMID:33387578
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312180	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SOCS6 mRNA	PMID:28818685
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312180	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SOCS6 mRNA	PMID:35301059
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOCS6 mRNA	PMID:37236586
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312180	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SOCS6 mRNA	PMID:19549813
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312180	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SOCS6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SOCS6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SOCS6 mRNA	PMID:32699268
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312180	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of SOCS6 mRNA	PMID:19774075
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SOCS6 gene	PMID:20938992
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:27641	cycloheximide	increases expression	ISO	RGD:1312181	E	RGD:6480464	20130611	CTD	MESH:D003513	Cycloheximide results in increased expression of SOCS6 mRNA	PMID:23237828
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312180	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SOCS6 protein	PMID:35688186
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312180	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SOCS6 mRNA	PMID:27392435
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SOCS6 mRNA	PMID:22298810
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312181	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SOCS6 mRNA	PMID:21570461
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SOCS6 mRNA	PMID:33387578
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SOCS6 mRNA	PMID:19770486
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SOCS6 mRNA	PMID:17942748
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312180	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SOCS6 mRNA	PMID:33212167
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312180	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of SOCS6 mRNA	PMID:29803840
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312180	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SOCS6 mRNA	PMID:38568856
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312180	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SOCS6 promoter	PMID:27901495
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312181	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SOCS6 mRNA	PMID:22228805
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SOCS6 mRNA]	PMID:22228805
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SOCS6 mRNA	PMID:27131904
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1312180	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of SOCS6 mRNA	PMID:20382639
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312180	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SOCS6 mRNA	PMID:20018196
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312181	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SOCS6 gene	PMID:35295148
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SOCS6 mRNA	PMID:34492290
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312180	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SOCS6 mRNA	PMID:30903817
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SOCS6 mRNA	PMID:34947998
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SOCS6 mRNA	PMID:30816183
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SOCS6 gene	PMID:28505145
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312180	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of SOCS6 mRNA	PMID:24752500
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SOCS6 mRNA	PMID:34813904
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312180	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SOCS6 mRNA	PMID:37042841
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312180	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SOCS6 mRNA	PMID:35301059
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOCS6 mRNA	PMID:37236586
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312180	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SOCS6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SOCS6 mRNA	PMID:32699268
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312180	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SOCS6 mRNA	PMID:25979313
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312181	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SOCS6 mRNA	PMID:17963808
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312180	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SOCS6 mRNA	PMID:23179753|PMID:24935251|PMID:27188386
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312180	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SOCS6 gene	PMID:29154799
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SOCS6 mRNA	PMID:19770486
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312180	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SOCS6 mRNA	PMID:20106945|PMID:25562108
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312180	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SOCS6 mRNA	PMID:38832940
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312180	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SOCS6 mRNA	PMID:26272509
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312180	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOCS6 mRNA	PMID:27188386
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312181	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SOCS6 mRNA	PMID:17562736
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312180	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of SOCS6 mRNA	PMID:22230336
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312180	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of SOCS6 mRNA	PMID:24752500
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SOCS6 mRNA	PMID:35436446
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312181	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SOCS6 mRNA	PMID:17942748
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SOCS6 mRNA	PMID:17942748
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1312181	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of SOCS6 mRNA	PMID:21318169
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in increased expression of SOCS6 mRNA]	PMID:21318169
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312180	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SOCS6 mRNA	PMID:28988120
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312180	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of SOCS6 mRNA	PMID:15336504
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SOCS6 mRNA	PMID:22206623
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of SOCS6 mRNA	PMID:27840820
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312180	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SOCS6 mRNA	PMID:37199045
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312180	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOCS6 mRNA	PMID:27188386
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312180	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SOCS6 mRNA	PMID:19159669
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312181	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SOCS6 mRNA	PMID:23091169
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312181	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SOCS6 mRNA	PMID:31388691
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312180	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOCS6 mRNA	PMID:27188386
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SOCS6 mRNA	PMID:27131904
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SOCS6 mRNA	PMID:19281266
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SOCS6 mRNA	PMID:21346803
1304632	Socs6	suppressor of cytokine signaling 6	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312180	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SOCS6 mRNA	PMID:29301935
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TRAF3 mRNA	PMID:38218311
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TRAF3 mRNA	PMID:33045310
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:136185	VX nerve agent	increases expression	ISO	RGD:1312182	E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of TRAF3 mRNA	PMID:38555327
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312182	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TRAF3 mRNA	PMID:33167477
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRAF3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRAF3 mRNA	PMID:32699268
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TRAF3 gene	PMID:35440735
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of TRAF3 mRNA	PMID:40945087
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312183	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TRAF3 mRNA	PMID:30319688
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312183	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TRAF3 mRNA	PMID:30319688
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312183	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRAF3 mRNA	PMID:39241906
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20200331	CTD	MESH:D008070	Lipopolysaccharides promotes the reaction [APPL1 protein binds to TRAF3 protein]	PMID:25780039
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312182	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of TRAF3 mRNA	PMID:23019147|PMID:24758408|PMID:31614463
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein promotes the reaction [Estradiol results in increased expression of TRAF3 mRNA]	PMID:24758408
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of TRAF3 mRNA	PMID:19448997
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312182	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRAF3 mRNA	PMID:37042841
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312182	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of TRAF3 mRNA	PMID:19162166
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	Glucose results in increased expression of TRAF3 protein	PMID:25516495
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	tempol inhibits the reaction [Glucose results in increased expression of TRAF3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein]	PMID:25516495
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	Glucose results in increased expression of TRAF3 protein	PMID:25516495
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	tempol inhibits the reaction [Glucose results in increased expression of TRAF3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein]	PMID:25516495
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:D004051	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TRAF3 mRNA	PMID:26577399
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:17948	(+)-taxifolin	increases expression	ISO	RGD:1312182	E	RGD:6480464	20120412	CTD	MESH:C003377	taxifolin results in increased expression of TRAF3 mRNA	PMID:17541156
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014520	Urethane results in increased expression of TRAF3 mRNA	PMID:16978161
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:180664	4-hydroxy-TEMPO	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20211109	CTD	MESH:C001803	tempol inhibits the reaction [Glucose results in increased expression of TRAF3 protein]	PMID:25516495
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TRAF3 mRNA	PMID:36331819
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312182	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TRAF3 mRNA	PMID:19549813
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TRAF3 mRNA	PMID:23649840
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRAF3 mRNA	PMID:19770486
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:25187	p-menthan-3-ol	increases expression	ISO	RGD:1312182	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TRAF3 mRNA	PMID:26760959
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TRAF3 mRNA	PMID:23649840
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120515	CTD	MESH:D009151	Mustard Gas results in increased expression of TRAF3 mRNA	PMID:15674843|PMID:18955075
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRAF3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRAF3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TRAF3 mRNA	PMID:32699268
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TRAF3 mRNA	PMID:30779732
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRAF3 mRNA	PMID:31150632
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TRAF3 mRNA	PMID:22206623
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312182	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRAF3 gene	PMID:25304211
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TRAF3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:39836092|PMID:40512198
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:40504410
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312183	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of TRAF3 mRNA	PMID:35897073
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312183	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of TRAF3 mRNA	PMID:28189721|PMID:28960355
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TRAF3 mRNA	PMID:23557933
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312183	E	RGD:6480464	20160210	CTD	MESH:D002945	Cisplatin results in increased expression of TRAF3 mRNA	PMID:26546572
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20160210	CTD	MESH:D002945	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Cisplatin results in increased expression of TRAF3 mRNA]	PMID:26546572
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TRAF3 mRNA	PMID:30912803
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312182	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of TRAF3 mRNA	PMID:24768652
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRAF3 mRNA	PMID:22298810
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312183	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRAF3 mRNA	PMID:21570461
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRAF3 mRNA	PMID:19520675
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRAF3 mRNA	PMID:12167310|PMID:19770486
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRAF3 mRNA	PMID:17942748
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TRAF3 mRNA	PMID:28959563
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of TRAF3 mRNA	PMID:30911355
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20121009	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TRAF3 mRNA	PMID:21340527
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRAF3 mRNA	PMID:39631538
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312182	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TRAF3 gene	PMID:28589171
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRAF3 mRNA	PMID:12760830
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312182	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TRAF3 mRNA	PMID:34032870
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TRAF3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:39836092|PMID:40512198
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:40504410
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29852	methylarsonic acid	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:C020300	monomethylarsonic acid results in decreased expression of TRAF3 mRNA	PMID:15345372
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312182	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRAF3 intron	PMID:30157460
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRAF3 mRNA	PMID:19770486
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312182	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRAF3 5' UTR	PMID:27901495
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRAF3 mRNA	PMID:22228805
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312182	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRAF3 promoter	PMID:27901495
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of TRAF3 mRNA]	PMID:22228805
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of TRAF3 mRNA	PMID:30911355
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312182	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TRAF3 mRNA	PMID:25895662
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TRAF3 mRNA	PMID:19150397
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312182	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TRAF3 mRNA	PMID:17530438
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312183	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TRAF3 mRNA	PMID:23557971
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TRAF3 mRNA	PMID:23411599|PMID:34492290
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TRAF3 mRNA	PMID:19191707
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of TRAF3 mRNA	PMID:33312107|PMID:36232920
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TRAF3 mRNA	PMID:25181051
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TRAF3 gene	PMID:28505145
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:3374	capsaicin	increases expression	ISO	RGD:1312182	E	RGD:6480464	20120412	CTD	MESH:D002211	Capsaicin results in increased expression of TRAF3 mRNA	PMID:19502594
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of TRAF3 mRNA	PMID:22937105
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312182	E	RGD:6480464	20240305	CTD	MESH:C543008	bisphenol S results in increased expression of TRAF3 mRNA	PMID:33312107
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312183	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TRAF3 mRNA	PMID:39298647
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312182	E	RGD:6480464	20240305	CTD	MESH:C008745	bisphenol F results in increased expression of TRAF3 mRNA	PMID:33312107
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312183	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TRAF3 intron	PMID:28392331
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:C027561	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:D003993	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:C007379	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in decreased expression of TRAF3 mRNA	PMID:18836921
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of TRAF3 mRNA	PMID:32680482
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of TRAF3 gene	PMID:33148267
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRAF3 mRNA	PMID:38382870
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:C012125	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of TRAF3 mRNA	PMID:20562052|PMID:22079235
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TRAF3 mRNA	PMID:24449571
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRAF3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRAF3 mRNA	PMID:32699268
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:38319	usnic acid	increases expression	ISO	RGD:1312182	E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of TRAF3 mRNA	PMID:32508146
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TRAF3 mRNA	PMID:36331819
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1312182	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in increased expression of TRAF3 mRNA	PMID:16101141
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TRAF3 mRNA	PMID:29427782
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312182	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRAF3 gene	PMID:29154799
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of TRAF3 mRNA	PMID:38685447|PMID:41580965
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312182	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TRAF3 mRNA	PMID:15766595
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312183	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TRAF3 mRNA	PMID:28973697
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	Glucose results in increased expression of TRAF3 protein	PMID:25516495
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	tempol inhibits the reaction [Glucose results in increased expression of TRAF3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein]	PMID:25516495
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1312182	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of TRAF3 mRNA	PMID:17400583
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312182	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TRAF3 mRNA	PMID:38832940
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of TRAF3 mRNA	PMID:29309887
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRAF3 mRNA	PMID:21420995
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312182	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TRAF3 mRNA	PMID:22230336|PMID:29067470
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312182	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TRAF3 mRNA	PMID:19036117|PMID:24714768
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312182	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRAF3 gene	PMID:25304211
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TRAF3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:39836092|PMID:40512198
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:40504410
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of TRAF3 mRNA	PMID:15345372
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TRAF3 mRNA	PMID:17942748
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRAF3 mRNA	PMID:17942748
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312182	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TRAF3 mRNA	PMID:17530438
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of TRAF3 mRNA	PMID:38685447|PMID:41580965
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:5801	hydroxychloroquine	increases expression	ISO	RGD:1312182	E	RGD:6480464	20200519	CTD	MESH:D006886	Hydroxychloroquine results in increased expression of TRAF3 mRNA	PMID:25321315
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:5801	hydroxychloroquine	increases expression	ISO	RGD:1312183	E	RGD:6480464	20200519	CTD	MESH:D006886	Hydroxychloroquine results in increased expression of TRAF3 mRNA	PMID:25321315
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:6015	isoflurane	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007530	Isoflurane results in decreased expression of TRAF3 mRNA	PMID:16978161
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1312182	E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of TRAF3 mRNA	PMID:29309887
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TRAF3 gene	PMID:35440735
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:69478	cannabidiol	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D002185	Cannabidiol affects the methylation of TRAF3 gene	PMID:30521419
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of TRAF3 gene	PMID:33148267
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TRAF3 mRNA	PMID:22206623
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:76612	ibrutinib	decreases response to substance	ISO	RGD:1312182	E	RGD:6480464	20170110	CTD	MESH:C551803	TRAF3 protein mutant form results in decreased susceptibility to ibrutinib	PMID:26254443
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:C025605	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:7983	pentobarbital	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010424	Pentobarbital results in decreased expression of TRAF3 mRNA	PMID:16978161
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of TRAF3 mRNA	PMID:31388691
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TRAF3 mRNA	PMID:27291303
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:82288	o-anisidine	decreases expression	ISO	RGD:1312182	E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine results in decreased expression of TRAF3 mRNA	PMID:28089782
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TRAF3 mRNA	PMID:23640034
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:82577	Fusarenone X	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20150310	CTD	MESH:C002469	fusarenon-X results in decreased expression of TRAF3 mRNA	PMID:24983900
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of TRAF3 mRNA	PMID:21278054
1304633	Traf3	Tnf receptor-associated factor 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRAF3 mRNA	PMID:21346803
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312184	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DPH2 mRNA	PMID:38218311
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of DPH2 mRNA	PMID:23724009|PMID:33167477
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DPH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DPH2 mRNA	PMID:32699268
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPH2 mRNA	PMID:30529165
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DPH2 mRNA	PMID:22378314
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312184	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DPH2 mRNA	PMID:20044591
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1623210	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DPH2 mRNA	PMID:39241906
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312184	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of DPH2 mRNA	PMID:23019147|PMID:31614463
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312184	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DPH2 mRNA	PMID:37042841
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1623210	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DPH2 mRNA	PMID:23892564
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312184	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DPH2 protein	PMID:37730182
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DPH2 mRNA	PMID:33387578
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DPH2 mRNA	PMID:28818685
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DPH2 mRNA	PMID:36331819
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DPH2 protein	PMID:34915118
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPH2 mRNA	PMID:35301059
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DPH2 mRNA	PMID:19549813
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DPH2 protein	PMID:23301498
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of DPH2 mRNA	PMID:23649840
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DPH2 mRNA	PMID:23649840
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DPH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DPH2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DPH2 mRNA	PMID:32699268
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DPH2 mRNA]	PMID:22206623
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DPH2 mRNA	PMID:40504410
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of DPH2 mRNA	PMID:27594783
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1623210	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of DPH2 mRNA	PMID:30912803
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312184	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DPH2 mRNA	PMID:25583101
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623210	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DPH2 mRNA	PMID:21570461
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of DPH2 mRNA	PMID:32763439
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DPH2 mRNA	PMID:38568856
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DPH2 mRNA	PMID:40504410
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1623210	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DPH2 mRNA	PMID:19770486
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1623210	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DPH2 mRNA	PMID:22228805
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DPH2 protein]	PMID:26598702
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1623210	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of DPH2 mRNA	PMID:29264374
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623210	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DPH2 gene	PMID:35295148
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DPH2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1623210	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DPH2 mRNA	PMID:33221593
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623210	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of DPH2 mRNA	PMID:40203079
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312184	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of DPH2 gene	PMID:31601247
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623210	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DPH2 mRNA	PMID:37019170
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312184	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of DPH2 gene	PMID:22964155
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1623210	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DPH2 mRNA	PMID:21266533
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DPH2 mRNA	PMID:38568856
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPH2 mRNA	PMID:35301059
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of DPH2 mRNA	PMID:24386269
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DPH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DPH2 mRNA	PMID:32699268
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312184	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DPH2 mRNA	PMID:32588087
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312184	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of DPH2 mRNA	PMID:28302478
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DPH2 mRNA	PMID:36331819
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1623210	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of DPH2 mRNA	PMID:21427059
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312184	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DPH2 mRNA	PMID:23179753
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623210	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DPH2 mRNA	PMID:17562736
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DPH2 mRNA	PMID:33387578
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DPH2 mRNA	PMID:40504410
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of DPH2 mRNA	PMID:29391264
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DPH2 protein]	PMID:26598702
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1623210	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DPH2 mRNA; Nanotubes, Carbon results in increased expression of DPH2 mRNA	PMID:25554681
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312184	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312184	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DPH2 mRNA	PMID:31758290
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1623210	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DPH2 mRNA	PMID:22206623
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DPH2 mRNA]	PMID:22206623
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of DPH2 mRNA	PMID:18927307
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312184	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of DPH2 mRNA	PMID:24921660
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DPH2 mRNA	PMID:19281266
1304634	Dph2	diphthamide biosynthesis 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312184	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DPH2 mRNA	PMID:38568856
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ATP6V1G3 mRNA	PMID:30071829
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA	PMID:25510870
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312187	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of ATP6V1G3 mRNA	PMID:33711761
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ATP6V1G3 mRNA	PMID:22061828
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of ATP6V1G3 mRNA	PMID:20409345
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V1G3 mRNA	PMID:29950665
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA	PMID:25510870
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA	PMID:25510870
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312186	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATP6V1G3 gene	PMID:27153756
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATP6V1G3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ATP6V1G3 mRNA	PMID:27106289|PMID:34911549
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ATP6V1G3 mRNA	PMID:30779732
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ATP6V1G3 mRNA	PMID:26033743
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of ATP6V1G3 mRNA	PMID:26033743
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312186	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATP6V1G3 mRNA	PMID:22316170
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ATP6V1G3 mRNA	PMID:26033743
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of ATP6V1G3 mRNA	PMID:26033743
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312187	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ATP6V1G3 mRNA	PMID:35295148
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V1G3 mRNA	PMID:29950665
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP6V1G3 mRNA	PMID:25181051
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312186	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ATP6V1G3 gene	PMID:31601247
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA	PMID:25510870
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA	PMID:25510870
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V1G3 mRNA	PMID:29950665
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of ATP6V1G3 mRNA	PMID:36868495
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ATP6V1G3 mRNA	PMID:30307764
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of ATP6V1G3 mRNA	PMID:22504374
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312187	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of ATP6V1G3 mRNA	PMID:23650126
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312187	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of ATP6V1G3 protein	PMID:36851058
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312186	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATP6V1G3 gene]	PMID:28238834
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312187	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ATP6V1G3 mRNA	PMID:38648751
1304635	Atp6v1g3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATP6V1G3 mRNA	PMID:22504374|PMID:25825206
1304636	Sema4a	semaphorin 4A	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of SEMA4A mRNA	PMID:21551480
1304636	Sema4a	semaphorin 4A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312189	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SEMA4A mRNA	PMID:33045310
1304636	Sema4a	semaphorin 4A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312188	E	RGD:6480464	20260804	CTD	MESH:D014212	Tretinoin results in increased expression of SEMA4A mRNA	PMID:38091671
1304636	Sema4a	semaphorin 4A	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SEMA4A mRNA	PMID:33729688
1304636	Sema4a	semaphorin 4A	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312189	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of SEMA4A mRNA	PMID:30319688
1304636	Sema4a	semaphorin 4A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312188	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of SEMA4A mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of SEMA4A mRNA	PMID:22217510|PMID:30165855
1304636	Sema4a	semaphorin 4A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312188	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SEMA4A mRNA	PMID:37042841
1304636	Sema4a	semaphorin 4A	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312188	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SEMA4A mRNA	PMID:33647349
1304636	Sema4a	semaphorin 4A	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SEMA4A mRNA	PMID:33387578
1304636	Sema4a	semaphorin 4A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SEMA4A mRNA	PMID:22061828
1304636	Sema4a	semaphorin 4A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312188	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SEMA4A mRNA	PMID:28818685
1304636	Sema4a	semaphorin 4A	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of SEMA4A mRNA	PMID:21515302
1304636	Sema4a	semaphorin 4A	gene	CHEBI:192408	bromoacetate	increases expression	ISO	RGD:1312188	E	RGD:6480464	20220809	CTD	MESH:C016274	bromoacetate results in increased expression of SEMA4A mRNA	PMID:19753638
1304636	Sema4a	semaphorin 4A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312188	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SEMA4A exon	PMID:30157460
1304636	Sema4a	semaphorin 4A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312188	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SEMA4A mRNA	PMID:26035830
1304636	Sema4a	semaphorin 4A	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312188	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SEMA4A mRNA	PMID:22171008
1304636	Sema4a	semaphorin 4A	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SEMA4A mRNA	PMID:31150632
1304636	Sema4a	semaphorin 4A	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SEMA4A mRNA	PMID:31919559
1304636	Sema4a	semaphorin 4A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SEMA4A mRNA	PMID:22206623
1304636	Sema4a	semaphorin 4A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312188	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SEMA4A mRNA	PMID:32525701
1304636	Sema4a	semaphorin 4A	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SEMA4A mRNA	PMID:31881176
1304636	Sema4a	semaphorin 4A	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of SEMA4A mRNA	PMID:15691709
1304636	Sema4a	semaphorin 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEMA4A mRNA	PMID:34747641
1304636	Sema4a	semaphorin 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312189	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEMA4A mRNA	PMID:21570461
1304636	Sema4a	semaphorin 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEMA4A mRNA	PMID:17942748
1304636	Sema4a	semaphorin 4A	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312188	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SEMA4A mRNA	PMID:33212167
1304636	Sema4a	semaphorin 4A	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SEMA4A mRNA	PMID:28959563
1304636	Sema4a	semaphorin 4A	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SEMA4A mRNA	PMID:30556269
1304636	Sema4a	semaphorin 4A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SEMA4A mRNA	PMID:37682722|PMID:39515575
1304636	Sema4a	semaphorin 4A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312188	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEMA4A mRNA	PMID:38568856|PMID:39719251
1304636	Sema4a	semaphorin 4A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20210406	CTD	MESH:C017947	SEMA3A protein inhibits the reaction [sodium arsenite results in increased expression of SEMA4A protein]; SEMA4A protein promotes the reaction [sodium arsenite results in decreased expression of SEMA3A protein]; SEMA4A protein promotes the reaction [sodium arsenite results in increased expression of IL1B protein]; SEMA4A protein promotes the reaction [sodium arsenite results in increased expression of IL6 protein]; SEMA4A protein promotes the reaction [sodium arsenite results in increased expression of NLRP3 protein]; SEMA4A protein promotes the reaction [sodium arsenite results in increased expression of RELA protein]; SEMA4A protein promotes the reaction [sodium arsenite results in increased phosphorylation of AKT2 protein]; sodium arsenite results in increased expression of and results in increased secretion of SEMA4A protein	PMID:33290778
1304636	Sema4a	semaphorin 4A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312188	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SEMA4A 5' UTR	PMID:27901495
1304636	Sema4a	semaphorin 4A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SEMA4A mRNA	PMID:22228805
1304636	Sema4a	semaphorin 4A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312188	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SEMA4A promoter	PMID:27901495
1304636	Sema4a	semaphorin 4A	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312189	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in increased expression of SEMA4A mRNA	PMID:33053406
1304636	Sema4a	semaphorin 4A	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SEMA4A mRNA	PMID:30556269
1304636	Sema4a	semaphorin 4A	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312188	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SEMA4A mRNA	PMID:22171008
1304636	Sema4a	semaphorin 4A	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SEMA4A mRNA	PMID:19073995
1304636	Sema4a	semaphorin 4A	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SEMA4A mRNA	PMID:22431001
1304636	Sema4a	semaphorin 4A	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312188	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SEMA4A mRNA	PMID:25895662
1304636	Sema4a	semaphorin 4A	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SEMA4A mRNA	PMID:24136188
1304636	Sema4a	semaphorin 4A	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of SEMA4A mRNA	PMID:21515302
1304636	Sema4a	semaphorin 4A	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of SEMA4A mRNA	PMID:30012374
1304636	Sema4a	semaphorin 4A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312189	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SEMA4A mRNA	PMID:23557971
1304636	Sema4a	semaphorin 4A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SEMA4A mRNA	PMID:34492290
1304636	Sema4a	semaphorin 4A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SEMA4A mRNA	PMID:30723492
1304636	Sema4a	semaphorin 4A	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SEMA4A mRNA	PMID:18445702|PMID:20059764
1304636	Sema4a	semaphorin 4A	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of SEMA4A mRNA]	PMID:20059764
1304636	Sema4a	semaphorin 4A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SEMA4A mRNA	PMID:25181051
1304636	Sema4a	semaphorin 4A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312189	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SEMA4A mRNA	PMID:32156529|PMID:33221593|PMID:34585602|PMID:38701888
1304636	Sema4a	semaphorin 4A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SEMA4A mRNA	PMID:39298647|PMID:40203079
1304636	Sema4a	semaphorin 4A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312189	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SEMA4A promoter	PMID:28392331
1304636	Sema4a	semaphorin 4A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SEMA4A mRNA	PMID:21266533
1304636	Sema4a	semaphorin 4A	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SEMA4A mRNA	PMID:34813904
1304636	Sema4a	semaphorin 4A	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SEMA4A mRNA	PMID:34813904
1304636	Sema4a	semaphorin 4A	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SEMA4A mRNA	PMID:32680482
1304636	Sema4a	semaphorin 4A	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in decreased expression of SEMA4A mRNA	PMID:16797015
1304636	Sema4a	semaphorin 4A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312188	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEMA4A mRNA	PMID:37042841
1304636	Sema4a	semaphorin 4A	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SEMA4A mRNA	PMID:25993096
1304636	Sema4a	semaphorin 4A	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SEMA4A mRNA	PMID:24386269
1304636	Sema4a	semaphorin 4A	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312188	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SEMA4A mRNA	PMID:24449571
1304636	Sema4a	semaphorin 4A	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SEMA4A mRNA	PMID:40194260
1304636	Sema4a	semaphorin 4A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312188	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SEMA4A mRNA	PMID:31533062
1304636	Sema4a	semaphorin 4A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SEMA4A mRNA	PMID:17292431
1304636	Sema4a	semaphorin 4A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312188	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SEMA4A gene	PMID:29154799
1304636	Sema4a	semaphorin 4A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312188	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SEMA4A mRNA	PMID:17183730
1304636	Sema4a	semaphorin 4A	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1312188	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of SEMA4A mRNA	PMID:17400583
1304636	Sema4a	semaphorin 4A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SEMA4A mRNA	PMID:33387578
1304636	Sema4a	semaphorin 4A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312188	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SEMA4A mRNA	PMID:32525701
1304636	Sema4a	semaphorin 4A	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SEMA4A mRNA	PMID:29391264
1304636	Sema4a	semaphorin 4A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEMA4A mRNA	PMID:17942748
1304636	Sema4a	semaphorin 4A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312189	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SEMA4A mRNA	PMID:25554681
1304636	Sema4a	semaphorin 4A	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312188	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SEMA4A mRNA	PMID:17183730
1304636	Sema4a	semaphorin 4A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312189	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SEMA4A mRNA	PMID:38701926
1304636	Sema4a	semaphorin 4A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SEMA4A mRNA	PMID:21641980
1304636	Sema4a	semaphorin 4A	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of SEMA4A mRNA	PMID:19812364
1304636	Sema4a	semaphorin 4A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SEMA4A mRNA	PMID:22206623
1304636	Sema4a	semaphorin 4A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SEMA4A mRNA	PMID:22206623
1304636	Sema4a	semaphorin 4A	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1312188	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SEMA4A mRNA	PMID:36318118
1304636	Sema4a	semaphorin 4A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SEMA4A mRNA	PMID:39847705
1304636	Sema4a	semaphorin 4A	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312188	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SEMA4A mRNA	PMID:32525701
1304636	Sema4a	semaphorin 4A	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SEMA4A mRNA	PMID:21278054
1304636	Sema4a	semaphorin 4A	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SEMA4A mRNA	PMID:19281266
1304636	Sema4a	semaphorin 4A	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of SEMA4A mRNA	PMID:21515302
1304636	Sema4a	semaphorin 4A	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SEMA4A mRNA	PMID:23034163
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312191	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LTO1 mRNA	PMID:33045310
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312190	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ORAOV1 mRNA	PMID:33167477
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312190	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of LTO1 mRNA	PMID:22378314
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312191	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of LTO1 mRNA	PMID:33711761
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312190	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LTO1 mRNA	PMID:37042841
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312190	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of LTO1 mRNA	PMID:23649840
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312190	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of LTO1 mRNA	PMID:21179406
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LTO1 mRNA	PMID:33387578
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312190	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA	PMID:39836092
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312190	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LTO1 protein	PMID:23301498
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312190	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of LTO1 mRNA	PMID:23649840
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LTO1 mRNA	PMID:19770486
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312190	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LTO1 mRNA	PMID:23649840
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312190	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:39836092
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:40504410
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312191	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ORAOV1 mRNA	PMID:28960355
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LTO1 mRNA	PMID:21570461
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LTO1 mRNA	PMID:17942748
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312190	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LTO1 mRNA	PMID:33212167
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312190	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of LTO1 mRNA	PMID:23649840
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312190	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:39836092
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:40504410
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LTO1 mRNA	PMID:22228805
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312190	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ORAOV1 promoter	PMID:27901495
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312190	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of LTO1 mRNA	PMID:26014281
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LTO1 mRNA	PMID:23411599|PMID:34492290
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:C006253	pirinixic acid results in increased expression of LTO1 mRNA	PMID:18301758
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LTO1 mRNA	PMID:19710929
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312190	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LTO1 mRNA	PMID:29275510
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312190	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LTO1 gene	PMID:31601247
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LTO1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312191	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LTO1 mRNA	PMID:39298647
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ORAOV1 mRNA	PMID:32680482
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312190	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA	PMID:39836092
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312190	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LTO1 mRNA	PMID:38568856
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312190	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LTO1 mRNA	PMID:24449571
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312190	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LTO1 mRNA	PMID:20106945|PMID:25562108
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312190	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of LTO1 mRNA	PMID:24935251
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D000082	Acetaminophen affects the expression of LTO1 mRNA	PMID:17562736
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LTO1 mRNA	PMID:33387578
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312190	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:39836092
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:40504410
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LTO1 mRNA	PMID:29391264
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LTO1 mRNA	PMID:17942748
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LTO1 mRNA	PMID:17942748
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:5130	flurbiprofen	decreases expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D005480	Flurbiprofen results in decreased expression of LTO1 mRNA	PMID:16949054
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312190	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA	PMID:39836092
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of LTO1 mRNA	PMID:30467583
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312191	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ORAOV1 mRNA	PMID:22206623
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312190	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of LTO1 mRNA	PMID:37199045
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312190	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of LTO1 mRNA	PMID:26014281
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LTO1 mRNA	PMID:21346803
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LTO1 mRNA	PMID:21346803
1304637	Lto1	LTO1 maturation factor of ABCE1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312191	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of ORAOV1 mRNA	PMID:32835833
1304638	Coq4	coenzyme Q4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551979	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COQ4 mRNA	PMID:33045310
1304638	Coq4	coenzyme Q4	gene	CHEBI:137392	chlormequat chloride	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of COQ4 protein	PMID:34958886
1304638	Coq4	coenzyme Q4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of COQ4 mRNA	PMID:36331819
1304638	Coq4	coenzyme Q4	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312192	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of COQ4 mRNA	PMID:22378314
1304638	Coq4	coenzyme Q4	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1312192	E	RGD:6480464	20121009	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of COQ4 mRNA	PMID:18951874|PMID:21308897
1304638	Coq4	coenzyme Q4	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312192	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of COQ4 protein	PMID:18951874
1304638	Coq4	coenzyme Q4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312192	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COQ4 mRNA	PMID:37042841
1304638	Coq4	coenzyme Q4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of COQ4 mRNA	PMID:33387578
1304638	Coq4	coenzyme Q4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COQ4 mRNA	PMID:36331819
1304638	Coq4	coenzyme Q4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312192	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of COQ4 mRNA	PMID:39836092
1304638	Coq4	coenzyme Q4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312192	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COQ4 mRNA	PMID:19549813
1304638	Coq4	coenzyme Q4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312192	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of COQ4 mRNA	PMID:35430440
1304638	Coq4	coenzyme Q4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COQ4 mRNA	PMID:22206623
1304638	Coq4	coenzyme Q4	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312192	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of COQ4 gene	PMID:25304211
1304638	Coq4	coenzyme Q4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COQ4 mRNA	PMID:22298810
1304638	Coq4	coenzyme Q4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551979	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COQ4 mRNA	PMID:20702594|PMID:21570461
1304638	Coq4	coenzyme Q4	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1312192	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of COQ4 protein	PMID:18951874
1304638	Coq4	coenzyme Q4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312192	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of COQ4 mRNA	PMID:32763439
1304638	Coq4	coenzyme Q4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312192	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COQ4 mRNA	PMID:29803840
1304638	Coq4	coenzyme Q4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551979	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of COQ4 mRNA	PMID:26873546
1304638	Coq4	coenzyme Q4	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20160607	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of COQ4 mRNA	PMID:26873546
1304638	Coq4	coenzyme Q4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312192	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of COQ4 mRNA	PMID:38568856
1304638	Coq4	coenzyme Q4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551979	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of COQ4 mRNA	PMID:20883709
1304638	Coq4	coenzyme Q4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551979	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of COQ4 mRNA	PMID:22228805
1304638	Coq4	coenzyme Q4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to COQ4 promoter]	PMID:19654925
1304638	Coq4	coenzyme Q4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551979	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of COQ4 mRNA	PMID:17426115|PMID:18301758|PMID:20813756|PMID:23811191
1304638	Coq4	coenzyme Q4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of COQ4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304638	Coq4	coenzyme Q4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312192	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of COQ4 mRNA	PMID:33670352
1304638	Coq4	coenzyme Q4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551979	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of COQ4 mRNA	PMID:33297965
1304638	Coq4	coenzyme Q4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1551979	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of COQ4 mRNA	PMID:28392331
1304638	Coq4	coenzyme Q4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312192	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of COQ4 mRNA	PMID:39836092
1304638	Coq4	coenzyme Q4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1551979	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of COQ4 mRNA	PMID:20883709
1304638	Coq4	coenzyme Q4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of COQ4 mRNA	PMID:25539665
1304638	Coq4	coenzyme Q4	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of COQ4 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of COQ4 mRNA]	PMID:17585979
1304638	Coq4	coenzyme Q4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312192	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of COQ4 mRNA	PMID:40419075
1304638	Coq4	coenzyme Q4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COQ4 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of COQ4 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of COQ4 mRNA	PMID:36331819
1304638	Coq4	coenzyme Q4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312192	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of COQ4 mRNA	PMID:17183730
1304638	Coq4	coenzyme Q4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COQ4 mRNA	PMID:33387578
1304638	Coq4	coenzyme Q4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312192	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of COQ4 mRNA	PMID:25704631
1304638	Coq4	coenzyme Q4	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of COQ4 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of COQ4 mRNA]	PMID:17585979
1304638	Coq4	coenzyme Q4	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312192	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of COQ4 mRNA	PMID:20977926
1304638	Coq4	coenzyme Q4	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312192	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of COQ4 gene	PMID:25304211
1304638	Coq4	coenzyme Q4	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20170303	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of COQ4 mRNA	PMID:26873546
1304638	Coq4	coenzyme Q4	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of COQ4 mRNA	PMID:23962444
1304638	Coq4	coenzyme Q4	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312192	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of COQ4 mRNA	PMID:17183730
1304638	Coq4	coenzyme Q4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312192	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of COQ4 mRNA	PMID:39836092
1304638	Coq4	coenzyme Q4	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312192	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of COQ4 mRNA	PMID:28988120|PMID:29427785
1304638	Coq4	coenzyme Q4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COQ4 mRNA	PMID:22206623
1304638	Coq4	coenzyme Q4	gene	CHEBI:75458	carbonyl cyanide p-trifluoromethoxyphenylhydrazone	increases expression	ISO	RGD:1312192	E	RGD:6480464	20131008	CTD	MESH:D002259	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in increased expression of COQ4 mRNA	PMID:21308897
1304638	Coq4	coenzyme Q4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312192	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of COQ4 mRNA	PMID:19159669
1304638	Coq4	coenzyme Q4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1551979	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of COQ4 mRNA	PMID:20702594
1304638	Coq4	coenzyme Q4	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312192	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of COQ4 mRNA	PMID:38568856
1304639	Lig4	DNA ligase 4	gene	CHEBI:133326	barium sulfate	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D001466	Barium Sulfate results in increased expression of LIG4 mRNA	PMID:29463257
1304639	Lig4	DNA ligase 4	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of LIG4 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of LIG4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of LIG4 mRNA	PMID:32699268|PMID:32845096
1304639	Lig4	DNA ligase 4	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LIG4 mRNA	PMID:33729688
1304639	Lig4	DNA ligase 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LIG4 mRNA	PMID:36331819
1304639	Lig4	DNA ligase 4	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20180703	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of LIG4 mRNA	PMID:21751221
1304639	Lig4	DNA ligase 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of LIG4 mRNA	PMID:26496021
1304639	Lig4	DNA ligase 4	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312195	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of LIG4 mRNA	PMID:33711761
1304639	Lig4	DNA ligase 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LIG4 mRNA	PMID:33387578
1304639	Lig4	DNA ligase 4	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20241105	CTD	MESH:D008550	Melatonin promotes the reaction [bisphenol A results in increased expression of LIG4 mRNA]	PMID:36633214
1304639	Lig4	DNA ligase 4	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20241105	CTD	MESH:D008550	Melatonin promotes the reaction [bisphenol A results in increased expression of LIG4 mRNA]	PMID:36633214
1304639	Lig4	DNA ligase 4	gene	CHEBI:17356	2-acetamidofluorene	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D015073	2-Acetylaminofluorene results in decreased expression of LIG4 mRNA	PMID:19167416
1304639	Lig4	DNA ligase 4	gene	CHEBI:17521	(-)-quinic acid	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20191114	CTD	MESH:D011801	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of LIG4 mRNA	PMID:21751221
1304639	Lig4	DNA ligase 4	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1312194	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of LIG4 mRNA	PMID:16949557
1304639	Lig4	DNA ligase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LIG4 mRNA	PMID:37258237
1304639	Lig4	DNA ligase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312195	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LIG4 mRNA	PMID:34319233
1304639	Lig4	DNA ligase 4	gene	CHEBI:1784	biphenyl-4-amine	increases expression	ISO	RGD:1312194	E	RGD:6480464	20210406	CTD	MESH:C006757	4-biphenylamine results in increased expression of LIG4 mRNA	PMID:32905825
1304639	Lig4	DNA ligase 4	gene	CHEBI:1784	biphenyl-4-amine	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20210406	CTD	MESH:C006757	TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of LIG4 mRNA]	PMID:32905825
1304639	Lig4	DNA ligase 4	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LIG4 mRNA	PMID:28818685
1304639	Lig4	DNA ligase 4	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1312194	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of LIG4 mRNA	PMID:16949557
1304639	Lig4	DNA ligase 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312194	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LIG4 gene	PMID:27153756
1304639	Lig4	DNA ligase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LIG4 mRNA	PMID:33354967
1304639	Lig4	DNA ligase 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of LIG4 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of LIG4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of LIG4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of LIG4 mRNA	PMID:32699268|PMID:32845096
1304639	Lig4	DNA ligase 4	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of LIG4 mRNA; Arsenic results in decreased expression of LIG4 protein	PMID:21332098
1304639	Lig4	DNA ligase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20120412	CTD	MESH:D001151	Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 mRNA]; Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 protein]	PMID:21332098
1304639	Lig4	DNA ligase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIG4 mRNA	PMID:40504410
1304639	Lig4	DNA ligase 4	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312194	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of LIG4 mRNA	PMID:26272509
1304639	Lig4	DNA ligase 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIG4 mRNA	PMID:27188386
1304639	Lig4	DNA ligase 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LIG4 mRNA	PMID:23557933
1304639	Lig4	DNA ligase 4	gene	CHEBI:27889	lead(0)	affects response to substance	ISO	RGD:1312194	E	RGD:6480464	20140610	CTD	MESH:D007854	LIG4 gene polymorphism affects the susceptibility to Lead	PMID:22466227
1304639	Lig4	DNA ligase 4	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1312194	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of LIG4 promoter	PMID:22847954
1304639	Lig4	DNA ligase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of LIG4 mRNA	PMID:25975270
1304639	Lig4	DNA ligase 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LIG4 mRNA	PMID:28001369
1304639	Lig4	DNA ligase 4	gene	CHEBI:28553	selenocystine	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20241203	CTD	MESH:C009226	selenocystine results in decreased expression of LIG4 protein	PMID:39461470
1304639	Lig4	DNA ligase 4	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of LIG4 mRNA	PMID:30556269
1304639	Lig4	DNA ligase 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LIG4 mRNA	PMID:29803840
1304639	Lig4	DNA ligase 4	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20120412	CTD	MESH:D004317	LIG4 protein affects the reaction [Doxorubicin results in increased activity of CASP3 protein]; LIG4 protein affects the reaction [Doxorubicin results in increased activity of CASP8 protein]; LIG4 protein affects the reaction [Doxorubicin results in increased activity of CASP9 protein]	PMID:18508926
1304639	Lig4	DNA ligase 4	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which affects the expression of LIG4 mRNA	PMID:28433809
1304639	Lig4	DNA ligase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIG4 mRNA	PMID:40504410
1304639	Lig4	DNA ligase 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312194	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LIG4 5' UTR	PMID:27901495
1304639	Lig4	DNA ligase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312195	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LIG4 mRNA	PMID:22228805
1304639	Lig4	DNA ligase 4	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which affects the expression of LIG4 mRNA	PMID:28433809
1304639	Lig4	DNA ligase 4	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of LIG4 mRNA	PMID:30556269
1304639	Lig4	DNA ligase 4	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of LIG4 mRNA	PMID:34408198
1304639	Lig4	DNA ligase 4	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of LIG4 mRNA	PMID:22641619
1304639	Lig4	DNA ligase 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312195	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LIG4 gene	PMID:35295148
1304639	Lig4	DNA ligase 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312195	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LIG4 promoter alternative form	PMID:35295148
1304639	Lig4	DNA ligase 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LIG4 mRNA	PMID:23411599|PMID:34492290|PMID:37258237
1304639	Lig4	DNA ligase 4	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of LIG4 mRNA	PMID:38479592
1304639	Lig4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LIG4 mRNA	PMID:35192832
1304639	Lig4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312194	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of LIG4 mRNA	PMID:36633214
1304639	Lig4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312195	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of LIG4 mRNA	PMID:36633214
1304639	Lig4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of LIG4 mRNA	PMID:26496021
1304639	Lig4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20241105	CTD	MESH:C006780	Melatonin promotes the reaction [bisphenol A results in increased expression of LIG4 mRNA]	PMID:36633214
1304639	Lig4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20241105	CTD	MESH:C006780	Melatonin promotes the reaction [bisphenol A results in increased expression of LIG4 mRNA]	PMID:36633214
1304639	Lig4	DNA ligase 4	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1312194	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of LIG4 mRNA	PMID:19041380
1304639	Lig4	DNA ligase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312195	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LIG4 mRNA	PMID:39298647
1304639	Lig4	DNA ligase 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312195	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of LIG4 mRNA	PMID:26377693
1304639	Lig4	DNA ligase 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312195	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of LIG4 mRNA	PMID:38685157
1304639	Lig4	DNA ligase 4	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20171114	CTD	MESH:C022838	nickel chloride results in decreased expression of LIG4 mRNA	PMID:28472268
1304639	Lig4	DNA ligase 4	gene	CHEBI:35019	tributyl phosphate	increases expression	ISO	RGD:1312195	E	RGD:6480464	20260303	CTD	MESH:C009524	tributyl phosphate results in increased expression of LIG4 mRNA	PMID:40389058
1304639	Lig4	DNA ligase 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312194	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LIG4 mRNA	PMID:37042841
1304639	Lig4	DNA ligase 4	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	increases expression	ISO	RGD:1312195	E	RGD:6480464	20260303	CTD	MESH:C031324	tris(chloroethyl)phosphate results in increased expression of LIG4 mRNA	PMID:40389058
1304639	Lig4	DNA ligase 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20260203	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LIG4 mRNA	PMID:40054833
1304639	Lig4	DNA ligase 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LIG4 mRNA	PMID:24449571
1304639	Lig4	DNA ligase 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of LIG4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of LIG4 mRNA	PMID:32699268
1304639	Lig4	DNA ligase 4	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1312194	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of LIG4 mRNA	PMID:19691856
1304639	Lig4	DNA ligase 4	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1312194	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of LIG4 promoter	PMID:22847954
1304639	Lig4	DNA ligase 4	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1312194	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of LIG4 promoter	PMID:22847954
1304639	Lig4	DNA ligase 4	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of LIG4 mRNA	PMID:19167446
1304639	Lig4	DNA ligase 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LIG4 mRNA	PMID:27153767
1304639	Lig4	DNA ligase 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LIG4 mRNA	PMID:36331819
1304639	Lig4	DNA ligase 4	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 mRNA]; Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 protein]	PMID:21332098
1304639	Lig4	DNA ligase 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312194	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LIG4 mRNA	PMID:25979313
1304639	Lig4	DNA ligase 4	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of LIG4 mRNA	PMID:29427782
1304639	Lig4	DNA ligase 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312194	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of LIG4 mRNA	PMID:19101580|PMID:23179753|PMID:24935251
1304639	Lig4	DNA ligase 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LIG4 mRNA	PMID:25562108
1304639	Lig4	DNA ligase 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312194	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of LIG4 mRNA	PMID:24935251
1304639	Lig4	DNA ligase 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312195	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen affects the expression of LIG4 mRNA	PMID:29540258
1304639	Lig4	DNA ligase 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LIG4 mRNA	PMID:33387578
1304639	Lig4	DNA ligase 4	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312194	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of LIG4 mRNA	PMID:18687144
1304639	Lig4	DNA ligase 4	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of LIG4 mRNA; Arsenic results in decreased expression of LIG4 protein	PMID:21332098
1304639	Lig4	DNA ligase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20140805	CTD	MESH:D001151	Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 mRNA]; Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 protein]	PMID:21332098
1304639	Lig4	DNA ligase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIG4 mRNA	PMID:40504410
1304639	Lig4	DNA ligase 4	gene	CHEBI:48607	lithium chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in increased expression of LIG4 mRNA; Lithium Chloride results in increased expression of LIG4 protein	PMID:19285016
1304639	Lig4	DNA ligase 4	gene	CHEBI:5000	fenfluramine	increases expression	ISO	RGD:1312194	E	RGD:6480464	20231205	CTD	MESH:D005277	Fenfluramine results in increased expression of LIG4 mRNA	PMID:22140631
1304639	Lig4	DNA ligase 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312195	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of LIG4 mRNA	PMID:25620056
1304639	Lig4	DNA ligase 4	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1312194	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of LIG4 mRNA	PMID:20977926
1304639	Lig4	DNA ligase 4	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LIG4 mRNA	PMID:26378955
1304639	Lig4	DNA ligase 4	gene	CHEBI:6382	Lasiocarpine	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of LIG4 mRNA	PMID:40054833
1304639	Lig4	DNA ligase 4	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312195	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of LIG4 mRNA	PMID:19812364
1304639	Lig4	DNA ligase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312195	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LIG4 mRNA	PMID:22206623
1304639	Lig4	DNA ligase 4	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased expression of LIG4 mRNA	PMID:37162024
1304639	Lig4	DNA ligase 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIG4 mRNA	PMID:27188386
1304639	Lig4	DNA ligase 4	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of LIG4 mRNA	PMID:30928695
1304639	Lig4	DNA ligase 4	gene	CHEBI:79089	ceric oxide	affects expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C030583	ceric oxide affects the expression of LIG4 mRNA	PMID:29463257
1304639	Lig4	DNA ligase 4	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312195	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of LIG4 mRNA	PMID:21278054
1304639	Lig4	DNA ligase 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LIG4 mRNA	PMID:24780913
1304639	Lig4	DNA ligase 4	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312194	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of LIG4 mRNA	PMID:23726867
1304639	Lig4	DNA ligase 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312194	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIG4 mRNA	PMID:27188386
1304639	Lig4	DNA ligase 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LIG4 mRNA	PMID:21346803
1304639	Lig4	DNA ligase 4	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312194	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of LIG4 mRNA	PMID:29301935
1304639	Lig4	DNA ligase 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LIG4 mRNA	PMID:21346803
1304639	Lig4	DNA ligase 4	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of LIG4 mRNA	PMID:23034163
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1557044	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CPSF6 mRNA	PMID:33045310
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CPSF6 mRNA	PMID:26251327
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1557044	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of CPSF6 protein	PMID:31494107
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CPSF6 mRNA	PMID:33387578
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312196	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CPSF6 mRNA	PMID:37042841
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CPSF6 mRNA	PMID:23649840
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312196	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CPSF6 protein	PMID:37730182
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CPSF6 mRNA	PMID:22061828
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312196	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CPSF6 mRNA	PMID:28818685
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CPSF6 protein	PMID:34915118
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CPSF6 mRNA	PMID:23649840
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312196	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CPSF6 gene	PMID:27153756
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CPSF6 mRNA	PMID:23649840
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312196	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CPSF6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CPSF6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CPSF6 protein	PMID:38598786
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CPSF6 mRNA	PMID:31150632
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CPSF6 mRNA	PMID:25629700
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1557044	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF6 mRNA	PMID:40504410
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CPSF6 mRNA	PMID:26272509
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312196	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA	PMID:27188386
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312196	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CPSF6 protein	PMID:35688186
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CPSF6 mRNA	PMID:25905778
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557044	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CPSF6 mRNA	PMID:21570461
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CPSF6 mRNA	PMID:32109520|PMID:33387578
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CPSF6 mRNA	PMID:34747641
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1557044	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CPSF6 mRNA	PMID:19465110|PMID:19770486
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CPSF6 mRNA	PMID:33212167
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CPSF6 mRNA	PMID:23649840
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of CPSF6 mRNA	PMID:30556269
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312196	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CPSF6 mRNA	PMID:20971185
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312196	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of CPSF6 mRNA	PMID:29803840
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CPSF6 mRNA	PMID:38568856
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:29678	sodium arsenite	increases activity	ISO	RGD:1312196	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in increased activity of CPSF6 protein	PMID:30528433
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1557044	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF6 mRNA	PMID:40504410
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1557044	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CPSF6 mRNA	PMID:22228805
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312196	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CPSF6 promoter	PMID:27901495
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of CPSF6 mRNA	PMID:30556269
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312196	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CPSF6 mRNA	PMID:20971185
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CPSF6 mRNA	PMID:25729387
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557044	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CPSF6 gene	PMID:35295148
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CPSF6 mRNA	PMID:34492290
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312196	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of CPSF6 mRNA	PMID:20170705
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF6 mRNA; bisphenol A results in decreased expression of CPSF6 protein	PMID:29275510|PMID:31675489
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF6 mRNA	PMID:33221593
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CPSF6 mRNA	PMID:25181051|PMID:33296240|PMID:38750585
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312196	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of CPSF6 mRNA	PMID:36232920
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CPSF6 gene	PMID:28505145
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CPSF6 protein	PMID:31675489
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312196	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of CPSF6 mRNA	PMID:24752500
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557044	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CPSF6 mRNA	PMID:39298647
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CPSF6 mRNA	PMID:28392331
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312196	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CPSF6 protein	PMID:38598786
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1557044	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of CPSF6 mRNA	PMID:34813904
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of CPSF6 mRNA	PMID:30589522
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312196	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CPSF6 mRNA	PMID:37042841
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CPSF6 mRNA	PMID:19376846
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312196	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CPSF6 mRNA	PMID:24449571
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312196	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CPSF6 mRNA	PMID:25979313
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of CPSF6 mRNA	PMID:29427782
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CPSF6 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312196	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CPSF6 gene	PMID:29154799
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312196	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA	PMID:27188386
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of CPSF6 mRNA	PMID:38685447
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CPSF6 mRNA	PMID:25562108
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of CPSF6 mRNA	PMID:19770486
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of CPSF6 mRNA	PMID:23649840
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557044	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CPSF6 mRNA	PMID:17562736
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CPSF6 mRNA	PMID:33387578
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312196	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CPSF6 mRNA	PMID:21420995
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1557044	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF6 mRNA	PMID:40504410
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312196	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of CPSF6 mRNA	PMID:24752500
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of CPSF6 mRNA	PMID:16984733
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CPSF6 protein	PMID:32959892
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CPSF6 mRNA	PMID:25729387
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CPSF6 mRNA	PMID:28988120
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CPSF6 gene	PMID:35440735
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of CPSF6 mRNA	PMID:27462272
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CPSF6 mRNA	PMID:22206623
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312196	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA	PMID:27188386
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of CPSF6 mRNA	PMID:20345932
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CPSF6 mRNA	PMID:32109520
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CPSF6 protein	PMID:31675489
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of CPSF6 protein	PMID:28903499
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CPSF6 protein	PMID:31675489
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312196	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of CPSF6 mRNA	PMID:21858171
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of CPSF6 mRNA	PMID:21795629
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1557044	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of CPSF6 mRNA	PMID:21795629
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1557044	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CPSF6 mRNA	PMID:21278054
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312196	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA	PMID:27188386
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CPSF6 mRNA	PMID:21346803
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312196	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CPSF6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CPSF6 protein	PMID:38598786
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CPSF6 mRNA	PMID:21346803
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CPSF6 mRNA	PMID:22570695
1304640	Cpsf6	cleavage and polyadenylation specific factor 6	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CPSF6 mRNA	PMID:23034163
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of STIM2 mRNA	PMID:38218311
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312199	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of STIM2 mRNA]	PMID:19467301
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312199	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of STIM2 mRNA	PMID:20188158
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of STIM2 mRNA	PMID:22378314
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1312198	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of STIM2 mRNA	PMID:18951874
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1312198	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of STIM2 mRNA	PMID:21632981
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312199	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of STIM2 mRNA	PMID:39241906
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of STIM2 mRNA	PMID:39298647
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of STIM2 mRNA	PMID:34319233
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of STIM2 mRNA	PMID:26577399
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312198	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of STIM2 protein	PMID:37730182
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of STIM2 mRNA	PMID:33387578
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312198	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of STIM2 mRNA	PMID:28818685
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312199	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STIM2 mRNA	PMID:37236586
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312198	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STIM2 gene	PMID:27153756
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312198	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of STIM2 gene	PMID:25304211
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312198	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of STIM2 protein	PMID:35688186
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312198	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of STIM2 mRNA	PMID:28903495
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STIM2 mRNA	PMID:22298810
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STIM2 mRNA	PMID:21215274|PMID:33387578|PMID:34747641
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312198	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STIM2 mRNA	PMID:20106945|PMID:21632981
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312199	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STIM2 mRNA	PMID:28922406
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of STIM2 mRNA	PMID:28001369
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of STIM2 mRNA	PMID:33212167
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of STIM2 mRNA	PMID:30851411
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STIM2 mRNA	PMID:29803840
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312198	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of STIM2 protein	PMID:35688186
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STIM2 mRNA	PMID:21632981
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312199	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of STIM2 gene	PMID:35295148
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of STIM2 mRNA	PMID:23811191
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STIM2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of STIM2 mRNA	PMID:33670352
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of STIM2 mRNA	PMID:34947998
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312198	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of STIM2 mRNA	PMID:28628672
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of STIM2 mRNA	PMID:39298647
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312199	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of STIM2 exon	PMID:33297965
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of STIM2 mRNA	PMID:21266533
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312198	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of STIM2 mRNA	PMID:28628672
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:34967	rimonabant	affects expression	ISO	RGD:1312199	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant affects the expression of STIM2 mRNA	PMID:19030233
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312199	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of STIM2 mRNA]	PMID:19030233
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STIM2 mRNA	PMID:33453195
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312199	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STIM2 mRNA	PMID:37236586
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of STIM2 mRNA	PMID:24449571
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of STIM2 mRNA	PMID:23811191
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of STIM2 mRNA	PMID:40194260
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312198	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STIM2 mRNA	PMID:25979313
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312198	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of STIM2 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312198	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of STIM2 mRNA	PMID:28628672
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312198	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of STIM2 mRNA	PMID:38832940
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312199	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of STIM2 mRNA	PMID:17562736
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STIM2 mRNA	PMID:33387578
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312198	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of STIM2 mRNA	PMID:21420995
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312198	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of STIM2 gene	PMID:25304211
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1312199	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of STIM2 mRNA	PMID:35436446
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312198	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of STIM2 mRNA	PMID:28628672
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of STIM2 mRNA	PMID:20977926
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of STIM2 protein	PMID:32959892
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of STIM2 mRNA	PMID:22206623
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of STIM2 mRNA	PMID:30851411
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312199	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of STIM2 mRNA	PMID:19270015
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312198	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of STIM2 mRNA	PMID:26079696
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312199	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of STIM2 mRNA	PMID:21278054
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of STIM2 protein	PMID:24648495
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1312198	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of STIM2 mRNA	PMID:27188386
1304641	Stim2	stromal interaction molecule 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of STIM2 mRNA	PMID:22570695
1304642	Foxd2	forkhead box D2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312201	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FOXD2 mRNA	PMID:33045310
1304642	Foxd2	forkhead box D2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXD2 gene	PMID:20938992
1304642	Foxd2	forkhead box D2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of FOXD2 mRNA	PMID:30951980
1304642	Foxd2	forkhead box D2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312200	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FOXD2 mRNA	PMID:20044591
1304642	Foxd2	forkhead box D2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312200	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FOXD2 mRNA	PMID:31614463
1304642	Foxd2	forkhead box D2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FOXD2 mRNA	PMID:33387578
1304642	Foxd2	forkhead box D2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXD2 gene	PMID:20938992
1304642	Foxd2	forkhead box D2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20250902	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FOXD2 mRNA; [imeglimin co-treated with Glucose] results in increased expression of FOXD2 mRNA	PMID:34588186|PMID:37992649
1304642	Foxd2	forkhead box D2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20250902	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FOXD2 mRNA; [imeglimin co-treated with Glucose] results in increased expression of FOXD2 mRNA	PMID:34588186|PMID:37992649
1304642	Foxd2	forkhead box D2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FOXD2 mRNA	PMID:33387578
1304642	Foxd2	forkhead box D2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312200	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FOXD2 mRNA	PMID:19549813
1304642	Foxd2	forkhead box D2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD2 mRNA	PMID:22129741
1304642	Foxd2	forkhead box D2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXD2 gene	PMID:20938992
1304642	Foxd2	forkhead box D2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312200	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXD2 mRNA	PMID:23557933
1304642	Foxd2	forkhead box D2	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312200	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of FOXD2 mRNA	PMID:23300844
1304642	Foxd2	forkhead box D2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312200	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of FOXD2 mRNA	PMID:27392435
1304642	Foxd2	forkhead box D2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312201	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FOXD2 mRNA	PMID:24058054
1304642	Foxd2	forkhead box D2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FOXD2 mRNA	PMID:37992649
1304642	Foxd2	forkhead box D2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312200	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FOXD2 mRNA	PMID:20044591
1304642	Foxd2	forkhead box D2	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD2 mRNA	PMID:22129741
1304642	Foxd2	forkhead box D2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312200	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of FOXD2 mRNA	PMID:29453283
1304642	Foxd2	forkhead box D2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312200	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FOXD2 mRNA	PMID:32234424
1304642	Foxd2	forkhead box D2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312200	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FOXD2 3' UTR; Benzo(a)pyrene results in increased methylation of FOXD2 exon	PMID:27901495
1304642	Foxd2	forkhead box D2	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312200	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of FOXD2 promoter	PMID:23974009
1304642	Foxd2	forkhead box D2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312200	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of FOXD2 mRNA	PMID:25895662
1304642	Foxd2	forkhead box D2	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1312201	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of FOXD2 gene	PMID:35295148
1304642	Foxd2	forkhead box D2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312201	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FOXD2 enhancer	PMID:35295148
1304642	Foxd2	forkhead box D2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312201	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FOXD2 promoter	PMID:27334623
1304642	Foxd2	forkhead box D2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312201	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of FOXD2 mRNA	PMID:30951980
1304642	Foxd2	forkhead box D2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312200	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FOXD2 gene	PMID:31601247
1304642	Foxd2	forkhead box D2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312201	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FOXD2 mRNA	PMID:30951980
1304642	Foxd2	forkhead box D2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of FOXD2 mRNA	PMID:30951980
1304642	Foxd2	forkhead box D2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312201	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FOXD2 mRNA	PMID:30951980
1304642	Foxd2	forkhead box D2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312201	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of FOXD2 mRNA	PMID:32715474|PMID:37019170
1304642	Foxd2	forkhead box D2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD2 mRNA	PMID:22129741
1304642	Foxd2	forkhead box D2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312200	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FOXD2 mRNA	PMID:37042841
1304642	Foxd2	forkhead box D2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312200	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FOXD2 mRNA	PMID:24449571
1304642	Foxd2	forkhead box D2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312201	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FOXD2 mRNA	PMID:17292431
1304642	Foxd2	forkhead box D2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312200	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of FOXD2 mRNA	PMID:23527032
1304642	Foxd2	forkhead box D2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312200	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FOXD2 gene	PMID:29154799
1304642	Foxd2	forkhead box D2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20250902	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FOXD2 mRNA; [imeglimin co-treated with Glucose] results in increased expression of FOXD2 mRNA	PMID:34588186|PMID:37992649
1304642	Foxd2	forkhead box D2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FOXD2 mRNA	PMID:33387578
1304642	Foxd2	forkhead box D2	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1312200	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of FOXD2 promoter	PMID:29626692
1304642	Foxd2	forkhead box D2	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1312200	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of FOXD2 promoter	PMID:29626692
1304642	Foxd2	forkhead box D2	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1312200	E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of FOXD2 promoter	PMID:29626692
1304642	Foxd2	forkhead box D2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312200	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of FOXD2 mRNA	PMID:23300844
1304642	Foxd2	forkhead box D2	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312200	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of FOXD2 mRNA	PMID:28988120
1304642	Foxd2	forkhead box D2	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20260714	CTD	MESH:C575881	[imeglimin co-treated with Glucose] results in increased expression of FOXD2 mRNA	PMID:34588186
1304642	Foxd2	forkhead box D2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312201	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of FOXD2 mRNA	PMID:40826991
1304642	Foxd2	forkhead box D2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312200	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FOXD2 mRNA	PMID:38568856
1304642	Foxd2	forkhead box D2	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312200	E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in decreased expression of FOXD2 mRNA	PMID:29453283
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606299	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ASTE1 mRNA	PMID:33167477
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1606299	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ASTE1 mRNA	PMID:26079696
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1606299	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in decreased expression of ASTE1 mRNA	PMID:21632981
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ASTE1 mRNA	PMID:26496021
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ASTE1 gene	PMID:27618143
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606299	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ASTE1 mRNA	PMID:37042841
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1606299	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ASTE1 mRNA	PMID:33359661
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1312202	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of ASTE1 mRNA	PMID:29279043
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312202	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASTE1 mRNA	PMID:37236586
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606299	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ASTE1 mRNA	PMID:19549813
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1606299	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ASTE1 gene	PMID:27153756
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1606299	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ASTE1 mRNA	PMID:23649840
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312202	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ASTE1 mRNA	PMID:27106289
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606299	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ASTE1 mRNA	PMID:23557933
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312202	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASTE1 mRNA	PMID:21570461
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312202	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ASTE1 mRNA	PMID:25975270
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASTE1 mRNA	PMID:21839799
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312202	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ASTE1 promoter	PMID:35295148
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ASTE1 mRNA	PMID:34492290
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ASTE1 mRNA	PMID:25181051
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312202	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ASTE1 promoter	PMID:27312807
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ASTE1 gene	PMID:28505145
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of ASTE1 mRNA	PMID:26496021
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606299	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ASTE1 mRNA	PMID:37042841
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312202	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASTE1 mRNA	PMID:37236586
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1606299	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ASTE1 mRNA	PMID:28302478
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606299	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ASTE1 mRNA	PMID:25562108
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1606299	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ASTE1 mRNA	PMID:26690555
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312202	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ASTE1 mRNA	PMID:23608068
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of ASTE1 mRNA	PMID:28801915
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606299	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ASTE1 gene]	PMID:28238834
1304643	Aste1	asteroid structure-specific endonuclease 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1606299	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ASTE1 mRNA	PMID:29301935
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312203	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SLC52A3 mRNA	PMID:26272509
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312203	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA	PMID:27188386
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312204	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of SLC52A3 mRNA	PMID:36189433
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC52A3 mRNA	PMID:36189433
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of SLC52A3 mRNA	PMID:36841081
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312203	E	RGD:6480464	20160210	CTD	MESH:D001280	Atrazine results in increased expression of SLC52A3 mRNA	PMID:22378314
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:16238	FAD	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005182	Flavin-Adenine Dinucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]	PMID:19122205
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312204	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLC52A3 mRNA	PMID:39241906
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of SLC52A3 mRNA	PMID:26496021
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312203	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC52A3 mRNA	PMID:38568856
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC52A3 mRNA	PMID:33387578
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17015	riboflavin	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D012256	SLC52A3 protein results in increased transport of Riboflavin	PMID:19122205
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17015	riboflavin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012256	Acids promotes the reaction [SLC52A3 protein results in increased transport of Riboflavin]; Amiloride inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]; Flavin Mononucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]; Flavin-Adenine Dinucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]; lumiflavin inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]	PMID:19122205
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312203	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SLC52A3 mRNA	PMID:26079696
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC52A3 mRNA	PMID:37992649
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312204	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SLC52A3 mRNA	PMID:36189433
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC52A3 mRNA	PMID:36189433
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312203	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SLC52A3 mRNA	PMID:33359661
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312204	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SLC52A3 mRNA	PMID:33848595
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17621	FMN	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005486	Flavin Mononucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]	PMID:19122205
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC52A3 mRNA	PMID:37992649
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312204	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SLC52A3 mRNA	PMID:34319233
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SLC52A3 mRNA	PMID:33387578
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:2639	amiloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000584	Amiloride inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]	PMID:19122205
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312203	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC52A3 mRNA	PMID:40512198
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC52A3 mRNA	PMID:31881176
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312203	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC52A3 mRNA	PMID:23557933
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312203	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC52A3 mRNA	PMID:30851411
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SLC52A3 mRNA	PMID:28959563
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC52A3 mRNA	PMID:37992649
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:29021	hexane	decreases methylation	EXP		E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of SLC52A3 promoter	PMID:23740543
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1312203	E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased methylation of SLC52A3 intron	PMID:32844245
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312203	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC52A3 mRNA	PMID:29301061|PMID:32844245
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312203	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of SLC52A3 promoter; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC52A3 mRNA	PMID:18448484|PMID:40512198
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312203	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC52A3 exon; Benzo(a)pyrene results in decreased methylation of SLC52A3 promoter	PMID:27901495
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312203	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC52A3 mRNA	PMID:32234424
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312204	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SLC52A3 mRNA	PMID:27131904
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312203	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SLC52A3 mRNA	PMID:25895662
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312204	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SLC52A3 mRNA	PMID:23557971
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C006780	bisphenol A affects the expression of SLC52A3 mRNA	PMID:25181051
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC52A3 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312204	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC52A3 mRNA	PMID:30245210
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312203	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of SLC52A3 mRNA	PMID:31715268
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312204	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SLC52A3 mRNA	PMID:32156529
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of SLC52A3 mRNA	PMID:26496021
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312204	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SLC52A3 mRNA	PMID:26682919
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312203	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of SLC52A3 gene	PMID:31601247
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312204	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC52A3 mRNA	PMID:37019170
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SLC52A3 gene	PMID:22079235
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312203	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SLC52A3 mRNA	PMID:24449571
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312204	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC52A3 mRNA	PMID:40194260
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312203	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC52A3 mRNA	PMID:25979313
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312203	E	RGD:6480464	20160210	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC52A3 mRNA	PMID:23179753|PMID:23527032|PMID:26272509
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312203	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA	PMID:27188386
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312204	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SLC52A3 mRNA	PMID:28973697
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC52A3 mRNA	PMID:37992649
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:43661	lumiflavin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C001922	lumiflavin inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]	PMID:19122205
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC52A3 mRNA	PMID:33387578
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312203	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC52A3 mRNA	PMID:40512198
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SLC52A3 mRNA	PMID:30307764
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312204	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SLC52A3 mRNA	PMID:25554681
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312204	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC52A3 mRNA	PMID:22206623
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312203	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC52A3 mRNA	PMID:30851411
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312203	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA	PMID:27188386
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312203	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SLC52A3 mRNA	PMID:26272509
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312203	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA	PMID:27188386
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312203	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA	PMID:27188386
1304644	Slc52a3	solute carrier family 52 member 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312204	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SLC52A3 mRNA	PMID:27131904
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312206	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of DIS3 mRNA	PMID:26272509
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312206	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIS3 mRNA	PMID:27188386
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312207	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DIS3 mRNA	PMID:30529165
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312207	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DIS3 mRNA	PMID:39241906
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DIS3 mRNA	PMID:33387578
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312206	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DIS3 mRNA	PMID:37042841
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312207	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DIS3 mRNA	PMID:23892564
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1312206	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of DIS3 protein	PMID:34122009
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312206	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DIS3 protein	PMID:37730182
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of DIS3 mRNA	PMID:24067728
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312206	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of DIS3 mRNA	PMID:24376830
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312206	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DIS3 protein	PMID:23301498
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312206	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DIS3 gene	PMID:27153756
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DIS3 mRNA	PMID:31150632
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312207	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DIS3 mRNA	PMID:27339419|PMID:31919559
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312207	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DIS3 mRNA	PMID:22206623
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312207	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of DIS3 mRNA	PMID:28960355
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312206	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DIS3 mRNA	PMID:23557933
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312207	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of DIS3 mRNA	PMID:40618947
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312207	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DIS3 mRNA	PMID:21570461
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312206	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of DIS3 protein	PMID:39603559
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312206	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DIS3 mRNA	PMID:28001369
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312206	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of DIS3 mRNA	PMID:22378314
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312207	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of DIS3 protein	PMID:37955338
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312206	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DIS3 mRNA	PMID:25351596
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of DIS3 mRNA	PMID:23557971|PMID:29264374
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312207	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DIS3 promoter	PMID:35295148
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DIS3 mRNA	PMID:23411599|PMID:34492290
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312207	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DIS3 mRNA	PMID:23811191
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312206	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DIS3 protein	PMID:31675489|PMID:37567409
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DIS3 mRNA	PMID:33221593
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of DIS3 mRNA	PMID:40203079
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312207	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DIS3 mRNA	PMID:39298647
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DIS3 mRNA	PMID:37019170
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312206	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DIS3 mRNA	PMID:37042841
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312207	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DIS3 mRNA	PMID:28903501
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312206	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DIS3 mRNA	PMID:28302478
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of DIS3 mRNA	PMID:39529242
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of DIS3 mRNA	PMID:31558096
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312207	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DIS3 mRNA	PMID:17292431
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312206	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DIS3 gene	PMID:29154799
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312206	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of DIS3 mRNA	PMID:28542535
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312207	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DIS3 mRNA	PMID:17562736
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DIS3 mRNA	PMID:33387578
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of DIS3 mRNA	PMID:35436446
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312207	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DIS3 mRNA; Nanotubes, Carbon results in increased expression of DIS3 mRNA	PMID:25554681|PMID:25620056
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:50729	mitoxantrone	affects response to substance	ISO	RGD:1312206	E	RGD:6480464	20120412	CTD	MESH:D008942	DIS3 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312207	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DIS3 mRNA	PMID:19042947
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312206	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DIS3 protein	PMID:32959892
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DIS3 mRNA	PMID:19564919
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1312206	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of DIS3 protein	PMID:34122009
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312207	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DIS3 mRNA	PMID:22206623
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312207	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DIS3 mRNA	PMID:22206623
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312206	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DIS3 protein	PMID:37664457
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312206	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIS3 mRNA	PMID:27188386
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312207	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DIS3 mRNA	PMID:30294300
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312206	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DIS3 protein	PMID:31675489
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312206	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of DIS3 protein	PMID:31675489
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312206	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DIS3 protein	PMID:38348393
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312206	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DIS3 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIS3 mRNA	PMID:27188386|PMID:37664457
1304646	Dis3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of DIS3 mRNA	PMID:23555832
1304647	Snx6	sorting nexin 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312209	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of SNX6 mRNA	PMID:37995155
1304647	Snx6	sorting nexin 6	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312208	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of SNX6 mRNA	PMID:22378314
1304647	Snx6	sorting nexin 6	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312209	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SNX6 mRNA	PMID:23892564
1304647	Snx6	sorting nexin 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312209	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SNX6 mRNA	PMID:33754040
1304647	Snx6	sorting nexin 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SNX6 protein	PMID:22061828
1304647	Snx6	sorting nexin 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNX6 mRNA	PMID:36331819
1304647	Snx6	sorting nexin 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SNX6 mRNA	PMID:19549813
1304647	Snx6	sorting nexin 6	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312208	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SNX6 protein	PMID:23301498
1304647	Snx6	sorting nexin 6	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1312209	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of SNX6 mRNA	PMID:19376150
1304647	Snx6	sorting nexin 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312208	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SNX6 mRNA	PMID:35430440
1304647	Snx6	sorting nexin 6	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312208	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SNX6 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SNX6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SNX6 protein	PMID:38598786
1304647	Snx6	sorting nexin 6	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1312208	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of SNX6 mRNA	PMID:15672453
1304647	Snx6	sorting nexin 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312209	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNX6 mRNA	PMID:31919559
1304647	Snx6	sorting nexin 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX6 mRNA	PMID:22206623
1304647	Snx6	sorting nexin 6	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312209	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SNX6 mRNA	PMID:28960355
1304647	Snx6	sorting nexin 6	gene	CHEBI:27889	lead(0)	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of SNX6 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SNX6 protein	PMID:30738087
1304647	Snx6	sorting nexin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX6 mRNA	PMID:34747641
1304647	Snx6	sorting nexin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312209	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX6 mRNA	PMID:21570461
1304647	Snx6	sorting nexin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312209	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNX6 mRNA	PMID:15034205
1304647	Snx6	sorting nexin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SNX6 mRNA]	PMID:15034205
1304647	Snx6	sorting nexin 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNX6 mRNA	PMID:33212167
1304647	Snx6	sorting nexin 6	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SNX6 mRNA	PMID:25523186
1304647	Snx6	sorting nexin 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX6 protein	PMID:29459688
1304647	Snx6	sorting nexin 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX6 protein	PMID:38228842
1304647	Snx6	sorting nexin 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312208	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SNX6 mRNA	PMID:38568856
1304647	Snx6	sorting nexin 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312208	E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNX6 mRNA alternative form	PMID:40419235
1304647	Snx6	sorting nexin 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312209	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNX6 mRNA	PMID:15034205
1304647	Snx6	sorting nexin 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312208	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SNX6 promoter	PMID:27901495
1304647	Snx6	sorting nexin 6	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of SNX6 mRNA]	PMID:15034205
1304647	Snx6	sorting nexin 6	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SNX6 mRNA	PMID:25523186
1304647	Snx6	sorting nexin 6	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of SNX6 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SNX6 protein	PMID:30738087
1304647	Snx6	sorting nexin 6	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312209	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of SNX6 mRNA	PMID:17656681
1304647	Snx6	sorting nexin 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312209	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SNX6 gene	PMID:35295148
1304647	Snx6	sorting nexin 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SNX6 mRNA	PMID:23411599|PMID:34492290
1304647	Snx6	sorting nexin 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312209	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SNX6 mRNA	PMID:18648102
1304647	Snx6	sorting nexin 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX6 protein	PMID:31675489
1304647	Snx6	sorting nexin 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312208	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SNX6 protein	PMID:37567409
1304647	Snx6	sorting nexin 6	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312208	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SNX6 mRNA	PMID:19244175
1304647	Snx6	sorting nexin 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312208	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SNX6 protein	PMID:34186270
1304647	Snx6	sorting nexin 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312209	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of SNX6 mRNA	PMID:28392331
1304647	Snx6	sorting nexin 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312209	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SNX6 mRNA	PMID:17361019
1304647	Snx6	sorting nexin 6	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312208	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SNX6 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SNX6 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SNX6 protein	PMID:38598786
1304647	Snx6	sorting nexin 6	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312209	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SNX6 mRNA	PMID:34813904
1304647	Snx6	sorting nexin 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SNX6 mRNA	PMID:24449571
1304647	Snx6	sorting nexin 6	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1312208	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of SNX6 protein	PMID:34122009
1304647	Snx6	sorting nexin 6	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SNX6 mRNA	PMID:28302478
1304647	Snx6	sorting nexin 6	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SNX6 mRNA	PMID:31533062
1304647	Snx6	sorting nexin 6	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312208	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX6 mRNA	PMID:19167446
1304647	Snx6	sorting nexin 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNX6 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SNX6 mRNA	PMID:36331819
1304647	Snx6	sorting nexin 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNX6 mRNA	PMID:23179753|PMID:27188386
1304647	Snx6	sorting nexin 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SNX6 mRNA	PMID:21163907|PMID:27989131
1304647	Snx6	sorting nexin 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312209	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SNX6 mRNA	PMID:28973697
1304647	Snx6	sorting nexin 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312209	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNX6 mRNA	PMID:17562736
1304647	Snx6	sorting nexin 6	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1312208	E	RGD:6480464	20120412	CTD	MESH:D005472	SNX6 protein affects the susceptibility to Fluorouracil	PMID:16217747
1304647	Snx6	sorting nexin 6	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNX6 protein	PMID:32959892
1304647	Snx6	sorting nexin 6	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312209	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SNX6 mRNA	PMID:23650126
1304647	Snx6	sorting nexin 6	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312208	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SNX6 protein	PMID:34186270
1304647	Snx6	sorting nexin 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312209	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNX6 mRNA	PMID:22206623
1304647	Snx6	sorting nexin 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX6 mRNA	PMID:22206623
1304647	Snx6	sorting nexin 6	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1312208	E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of SNX6 mRNA	PMID:19682730
1304647	Snx6	sorting nexin 6	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312208	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX6 mRNA	PMID:19167446
1304647	Snx6	sorting nexin 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SNX6 mRNA	PMID:21346803
1304647	Snx6	sorting nexin 6	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312208	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SNX6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SNX6 protein	PMID:38598786
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1312210	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of PSKH1 mRNA	PMID:31016361
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PSKH1 mRNA	PMID:39241906
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PSKH1 mRNA	PMID:33387578
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312210	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PSKH1 mRNA	PMID:37042841
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PSKH1 mRNA	PMID:33387578
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551980	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PSKH1 mRNA	PMID:36331819
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312210	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PSKH1 mRNA	PMID:19549813
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PSKH1 mRNA	PMID:31150632
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551980	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSKH1 mRNA	PMID:21570461
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PSKH1 mRNA	PMID:33387578
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312210	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PSKH1 mRNA	PMID:29803840
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312210	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PSKH1 mRNA	PMID:38568856
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312210	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PSKH1 mRNA	PMID:39719251
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312210	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PSKH1 promoter	PMID:27901495
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312210	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PSKH1 mRNA	PMID:22316170|PMID:26238291
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312210	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PSKH1 5' UTR	PMID:27901495
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312210	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PSKH1 mRNA	PMID:35984750
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551980	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PSKH1 gene	PMID:35295148
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PSKH1 mRNA	PMID:34492290
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PSKH1 mRNA	PMID:20813756
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PSKH1 mRNA	PMID:34947998
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PSKH1 mRNA	PMID:25181051
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PSKH1 mRNA	PMID:39298647
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312210	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA	PMID:28628672
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PSKH1 mRNA	PMID:34813904
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312210	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA	PMID:28628672
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PSKH1 mRNA	PMID:34813904
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551980	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PSKH1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PSKH1 mRNA	PMID:36331819
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312210	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PSKH1 gene	PMID:29154799
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312210	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PSKH1 mRNA	PMID:25562108
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of PSKH1 mRNA	PMID:25123088
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312210	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA	PMID:28628672
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312210	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PSKH1 mRNA	PMID:38832940
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1312210	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of PSKH1 mRNA	PMID:22077320
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312210	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA	PMID:28628672
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312210	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of PSKH1 mRNA	PMID:28988120
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312210	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PSKH1 mRNA	PMID:37199045
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312210	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PSKH1 mRNA	PMID:29301935
1304648	Pskh1	protein serine kinase H1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PSKH1 mRNA	PMID:23034163
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of CDC14A mRNA	PMID:35967413
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CDC14A mRNA	PMID:26272509
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of CDC14A mRNA	PMID:23727915
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of CDC14A mRNA	PMID:30510588
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of CDC14A mRNA	PMID:26496021
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [CDC14A protein binds to ESR1 protein]	PMID:27156127
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312211	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDC14A mRNA	PMID:37042841
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDC14A mRNA	PMID:37992649
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312212	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of CDC14A mRNA	PMID:33848595
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of CDC14A mRNA]	PMID:33848595
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDC14A mRNA	PMID:37992649
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CDC14A mRNA	PMID:26577399
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312211	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CDC14A protein	PMID:37730182
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312211	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CDC14A mRNA	PMID:28818685
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDC14A mRNA	PMID:39012411
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CDC14A mRNA	PMID:35430440
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CDC14A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CDC14A mRNA	PMID:27106289|PMID:34911549
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of CDC14A mRNA	PMID:31129395
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CDC14A mRNA	PMID:26272509
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CDC14A mRNA	PMID:31881176
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CDC14A mRNA	PMID:27392435
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312212	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in increased expression of CDC14A mRNA	PMID:18922574
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC14A mRNA	PMID:22298810|PMID:32109520
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC14A mRNA	PMID:33387578
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDC14A mRNA	PMID:34747641
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CDC14A mRNA	PMID:30911355
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDC14A mRNA	PMID:29803840
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDC14A mRNA	PMID:37992649
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312211	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of CDC14A gene	PMID:28589171
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDC14A mRNA	PMID:34032870
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDC14A mRNA	PMID:37682722
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312211	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CDC14A mRNA	PMID:38568856
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDC14A mRNA	PMID:22316170
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDC14A mRNA	PMID:19770486
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CDC14A mRNA]	PMID:32406909
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CDC14A mRNA	PMID:30911355
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312211	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CDC14A gene	PMID:31601247
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CDC14A mRNA	PMID:25729387
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:32130	silver(1+) nitrate	increases expression	ISO	RGD:1312211	E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in increased expression of CDC14A mRNA	PMID:22831968
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CDC14A mRNA	PMID:23557971
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312212	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDC14A gene	PMID:35295148
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312212	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CDC14A mRNA	PMID:35295148
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312212	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CDC14A gene	PMID:35295148
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312212	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CDC14A mRNA	PMID:28472532
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CDC14A mRNA	PMID:25181051
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CDC14A mRNA	PMID:30816183|PMID:32528016
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312211	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CDC14A gene	PMID:31601247
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of CDC14A mRNA; [bisphenol A co-treated with tributyltin] results in decreased expression of CDC14A mRNA	PMID:26496021|PMID:31129395
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:3374	capsaicin	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in increased expression of CDC14A mRNA	PMID:20349343
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312212	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CDC14A gene	PMID:31683443
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312212	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CDC14A intron	PMID:28392331
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CDC14A mRNA	PMID:21266533
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312212	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CDC14A mRNA	PMID:21266533
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312211	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC14A mRNA	PMID:37042841
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDC14A mRNA	PMID:39012411
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CDC14A mRNA	PMID:24386269
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312211	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CDC14A mRNA	PMID:31533062
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312211	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDC14A mRNA	PMID:25979313
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDC14A mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDC14A mRNA	PMID:37992649
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:4356	desferrioxamine B	increases expression	ISO	RGD:1312211	E	RGD:6480464	20120412	CTD	MESH:D003676	Deferoxamine results in increased expression of CDC14A mRNA alternative form	PMID:16760464
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312211	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CDC14A mRNA	PMID:38832940
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CDC14A mRNA	PMID:24935251|PMID:26272509
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDC14A mRNA	PMID:33387578
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312211	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of CDC14A mRNA	PMID:24714768
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CDC14A mRNA	PMID:29391264
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CDC14A mRNA	PMID:32234424
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312211	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CDC14A mRNA	PMID:15585362
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CDC14A mRNA; Nanotubes, Carbon results in decreased expression of CDC14A mRNA	PMID:25554681
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CDC14A mRNA	PMID:24793618
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CDC14A mRNA	PMID:38701926
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of CDC14A mRNA	PMID:25729387
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CDC14A mRNA	PMID:25729387
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312211	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CDC14A mRNA	PMID:28988120
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CDC14A mRNA	PMID:27567155
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312212	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of CDC14A mRNA	PMID:22206623
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CDC14A gene]	PMID:28238834
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:79995	GW 3965	increases expression	ISO	RGD:1312211	E	RGD:6480464	20200915	CTD	MESH:C473027	GW 3965 results in increased expression of CDC14A mRNA	PMID:31437187
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of CDC14A mRNA	PMID:30953684
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312211	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1304649	Cdc14a	cell division cycle 14A	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CDC14A mRNA	PMID:19015723
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PPP1R13B mRNA	PMID:38218311
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of PPP1R13B mRNA	PMID:20488242
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312214	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PPP1R13B mRNA	PMID:21934132|PMID:23724009
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP1R13B mRNA	PMID:36331819
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PPP1R13B mRNA	PMID:22378314
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of PPP1R13B mRNA	PMID:30510588
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312215	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PPP1R13B mRNA	PMID:39298647
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312214	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PPP1R13B mRNA	PMID:21179406
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312214	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of PPP1R13B mRNA	PMID:33647349
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312215	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PPP1R13B mRNA	PMID:23892564
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312214	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PPP1R13B protein	PMID:37730182
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PPP1R13B mRNA	PMID:22061828
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PPP1R13B mRNA	PMID:33387578
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312214	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PPP1R13B mRNA	PMID:28818685
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312215	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPP1R13B mRNA	PMID:19770486
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312214	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PPP1R13B mRNA	PMID:23649840
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312214	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PPP1R13B mRNA	PMID:35430440
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PPP1R13B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PPP1R13B mRNA	PMID:34911549
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PPP1R13B mRNA	PMID:22206623
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312214	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPP1R13B gene	PMID:25304211
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312214	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PPP1R13B mRNA	PMID:40512198
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312214	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PPP1R13B protein	PMID:35688186
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PPP1R13B mRNA	PMID:27392435
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312214	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PPP1R13B mRNA	PMID:27392435
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312215	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPP1R13B mRNA	PMID:21570461|PMID:24680724
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPP1R13B mRNA	PMID:33387578
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPP1R13B mRNA	PMID:29803840
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPP1R13B mRNA	PMID:39900124
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312215	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPP1R13B protein	PMID:29044176
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312214	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PPP1R13B mRNA	PMID:38568856
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312214	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PPP1R13B mRNA	PMID:40512198
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20250902	CTD	MESH:D014415	Tunicamycin results in decreased expression of PPP1R13B mRNA	PMID:39900124
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312214	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPP1R13B promoter	PMID:27901495
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312215	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PPP1R13B intron	PMID:27901495
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312214	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PPP1R13B mRNA]	PMID:32406909
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PPP1R13B mRNA	PMID:21461292
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PPP1R13B mRNA	PMID:19710929
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of PPP1R13B mRNA	PMID:33296240
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312214	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PPP1R13B gene	PMID:31601247
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PPP1R13B mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312215	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PPP1R13B mRNA	PMID:26063408
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of PPP1R13B mRNA	PMID:36804509
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312215	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PPP1R13B mRNA	PMID:30951980|PMID:33297965
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312215	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of PPP1R13B promoter	PMID:33297965
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312215	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PPP1R13B mRNA	PMID:30951980
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1312215	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of PPP1R13B mRNA	PMID:31558096
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of PPP1R13B mRNA	PMID:22546817
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:34687	dibutyl phthalate	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D003993	Dibutyl Phthalate affects the expression of PPP1R13B mRNA	PMID:30934153
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of PPP1R13B mRNA	PMID:22546817
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of PPP1R13B mRNA	PMID:22546817
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312214	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPP1R13B mRNA	PMID:37042841
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1312214	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride affects the expression of PPP1R13B mRNA	PMID:23828170
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312214	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PPP1R13B mRNA	PMID:28302478
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312214	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PPP1R13B mRNA	PMID:31533062
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PPP1R13B mRNA	PMID:40419075
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP1R13B mRNA	PMID:36331819
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312215	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PPP1R13B mRNA	PMID:17963808
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312214	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PPP1R13B gene	PMID:29154799
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1312214	E	RGD:6480464	20230502	CTD	MESH:C017160	cypermethrin results in increased expression of PPP1R13B protein	PMID:36063984
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312215	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PPP1R13B mRNA	PMID:17555576
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312214	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PPP1R13B mRNA	PMID:38832940
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312215	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPP1R13B mRNA	PMID:17562736
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312214	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of PPP1R13B mRNA	PMID:26690555
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312214	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPP1R13B gene	PMID:25304211
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312214	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PPP1R13B mRNA	PMID:40512198
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312215	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PPP1R13B mRNA	PMID:17555576
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PPP1R13B mRNA	PMID:21461292
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312215	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PPP1R13B mRNA; Nanotubes, Carbon results in decreased expression of PPP1R13B mRNA	PMID:25554681
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PPP1R13B mRNA	PMID:35964746
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312214	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PPP1R13B mRNA	PMID:31758290
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312215	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PPP1R13B mRNA	PMID:22206623
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PPP1R13B mRNA	PMID:22206623
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PPP1R13B mRNA	PMID:32109520
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1312214	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of PPP1R13B mRNA	PMID:16202921
1304651	Ppp1r13b	protein phosphatase 1, regulatory subunit 13B	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312214	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PPP1R13B mRNA	PMID:38568856
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1603946	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of VMA22 mRNA	PMID:24763279
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of VMA22 mRNA	PMID:39241906
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1603946	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of VMA22 mRNA	PMID:22574217
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603946	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of VMA22 mRNA	PMID:37042841
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1603946	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of VMA22 mRNA	PMID:23649840
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of VMA22 mRNA	PMID:36331819
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of VMA22 protein	PMID:34915118
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1603946	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VMA22 mRNA	PMID:19549813
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of VMA22 mRNA	PMID:31150632
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of VMA22 mRNA]	PMID:22206623
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:C024565	ethylene dichloride results in decreased expression of VMA22 mRNA	PMID:28960355
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1603946	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of VMA22 mRNA	PMID:27392435
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D014414	Tungsten results in increased expression of VMA22 mRNA	PMID:30912803
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VMA22 mRNA	PMID:21570461
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VMA22 mRNA	PMID:33387578|PMID:34747641
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VMA22 mRNA	PMID:25975270
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D020106	Acrylamide results in increased expression of VMA22 mRNA	PMID:28959563
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D012969	Sodium Fluoride results in increased expression of VMA22 mRNA	PMID:27862939
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603946	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of VMA22 mRNA	PMID:22714537
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:C015001	arsenite results in decreased expression of VMA22 protein	PMID:37955338
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1603946	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to VMA22 mRNA]	PMID:32406909
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013853	Thioacetamide results in increased expression of VMA22 mRNA	PMID:34492290
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A affects the expression of VMA22 mRNA	PMID:25181051
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in decreased expression of VMA22 mRNA	PMID:33221593
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603946	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of VMA22 protein	PMID:32981897
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1603946	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of VMA22 mRNA	PMID:25047013
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of VMA22 mRNA	PMID:28392331
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D004390	Chlorpyrifos results in increased expression of VMA22 mRNA	PMID:37019170
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of VMA22 mRNA	PMID:21266533
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D019256	Cadmium Chloride results in increased expression of VMA22 mRNA	PMID:33453195
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C018021	cobaltous chloride results in increased expression of VMA22 mRNA	PMID:24386269
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1603946	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of VMA22 mRNA	PMID:28302478
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1603946	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of VMA22 mRNA	PMID:31533062
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of VMA22 mRNA	PMID:36331819
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603946	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of VMA22 mRNA	PMID:25979313
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603946	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of VMA22 mRNA	PMID:23179753
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1603946	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of VMA22 mRNA	PMID:25562108
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D000082	Acetaminophen affects the expression of VMA22 mRNA	PMID:17562736
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D004726	Endosulfan results in increased expression of VMA22 mRNA	PMID:29391264
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of VMA22 mRNA	PMID:17555576
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D007649	Ketamine results in increased expression of VMA22 mRNA	PMID:20080153
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1603946	E	RGD:6480464	20180410	CTD	MESH:C045463	Leflunomide results in decreased expression of VMA22 mRNA	PMID:28988120
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D004178	Diquat results in decreased expression of VMA22 protein	PMID:36851058
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VMA22 mRNA	PMID:22206623
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of VMA22 mRNA]	PMID:22206623
1304653	Vma22	vacuolar ATPase assembly factor VMA22	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312217	E	RGD:6480464	20260707	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of VMA22 mRNA	PMID:31388691
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623014	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TMPRSS7 mRNA	PMID:33045310
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1312220	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of TMPRSS7 mRNA	PMID:34925699
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1623014	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TMPRSS7 mRNA	PMID:20188158
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1623014	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMPRSS7 mRNA	PMID:36331819
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312220	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TMPRSS7 mRNA	PMID:26079696
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TMPRSS7 gene	PMID:35440735
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMPRSS7 mRNA	PMID:33387578
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312220	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TMPRSS7 mRNA	PMID:26079696
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1623014	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMPRSS7 mRNA	PMID:34319233
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TMPRSS7 mRNA	PMID:33387578
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623014	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMPRSS7 mRNA	PMID:36331819
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of TMPRSS7 mRNA	PMID:23358152
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1623014	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of TMPRSS7 mRNA	PMID:27776689
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMPRSS7 mRNA	PMID:22129741
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312220	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TMPRSS7 mRNA	PMID:27392435
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312220	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TMPRSS7 mRNA	PMID:27392435
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1623014	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of TMPRSS7 mRNA	PMID:32186404
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623014	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMPRSS7 mRNA	PMID:21570461
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMPRSS7 mRNA	PMID:32109520|PMID:33387578
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312220	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMPRSS7 mRNA	PMID:34032870
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312220	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of TMPRSS7 mRNA	PMID:29301061
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312220	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMPRSS7 5' UTR; Benzo(a)pyrene results in increased methylation of TMPRSS7 promoter	PMID:27901495
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1623014	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TMPRSS7 mRNA	PMID:29264374
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TMPRSS7 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMPRSS7 mRNA	PMID:22129741
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TMPRSS7 mRNA	PMID:27387713
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1623014	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TMPRSS7 mRNA	PMID:40194260
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623014	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMPRSS7 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMPRSS7 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TMPRSS7 mRNA	PMID:36331819
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623014	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of TMPRSS7 mRNA	PMID:17562736
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of TMPRSS7 mRNA	PMID:23358152
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:6456	lidocaine	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in decreased expression of TMPRSS7 mRNA	PMID:35283115
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of TMPRSS7 mRNA	PMID:27840820
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of TMPRSS7 mRNA	PMID:32109520
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312220	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of TMPRSS7 mRNA	PMID:26079696
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TMPRSS7 mRNA	PMID:24780913
1304655	Tmprss7	transmembrane serine protease 7	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of TMPRSS7 mRNA	PMID:23358152
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551983	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZDHHC6 mRNA	PMID:39241906
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312223	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZDHHC6 mRNA	PMID:37042841
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312223	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ZDHHC6 mRNA	PMID:21179406
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1551983	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ZDHHC6 mRNA	PMID:23892564
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZDHHC6 mRNA	PMID:33387578
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of ZDHHC6 mRNA	PMID:21346803
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZDHHC6 mRNA	PMID:39012411
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312223	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ZDHHC6 mRNA	PMID:35430440
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZDHHC6 mRNA	PMID:25629700
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551983	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZDHHC6 mRNA	PMID:22206623
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551983	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZDHHC6 mRNA	PMID:21570461
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312223	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZDHHC6 mRNA	PMID:33212167
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312223	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZDHHC6 mRNA	PMID:29803840
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312223	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ZDHHC6 gene	PMID:28589171
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZDHHC6 mRNA	PMID:20883709
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312223	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZDHHC6 mRNA	PMID:20458559
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551983	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZDHHC6 gene	PMID:35295148
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZDHHC6 mRNA	PMID:34492290
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1551983	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ZDHHC6 mRNA	PMID:18648102
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZDHHC6 mRNA	PMID:25181051
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551983	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZDHHC6 mRNA	PMID:33221593
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZDHHC6 gene	PMID:28505145
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551983	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ZDHHC6 mRNA	PMID:39298647
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZDHHC6 mRNA	PMID:37019170
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZDHHC6 mRNA	PMID:21266533
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZDHHC6 mRNA	PMID:20883709
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZDHHC6 mRNA	PMID:39012411
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ZDHHC6 mRNA	PMID:17585979
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312223	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ZDHHC6 mRNA	PMID:19167446
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312223	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZDHHC6 mRNA	PMID:25979313
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312223	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZDHHC6 mRNA	PMID:23179753|PMID:29154799
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312223	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZDHHC6 mRNA	PMID:25562108
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1312223	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of ZDHHC6 mRNA	PMID:33512557
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312223	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ZDHHC6 mRNA	PMID:22230336
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1551983	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ZDHHC6 mRNA]	PMID:18700144
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312223	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZDHHC6 mRNA	PMID:20458559
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:50292	cadmium sulfate	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in decreased expression of ZDHHC6 mRNA	PMID:19274763
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551983	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ZDHHC6 mRNA	PMID:25554681
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551983	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ZDHHC6 mRNA	PMID:35964746
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312223	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ZDHHC6 mRNA	PMID:28988120
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ZDHHC6 mRNA	PMID:15003993
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551983	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZDHHC6 mRNA	PMID:22206623
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of ZDHHC6 mRNA	PMID:30953684
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ZDHHC6 mRNA	PMID:19281266
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312223	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ZDHHC6 mRNA	PMID:38568856
1304657	Zdhhc6	zDHHC palmitoyltransferase 6	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ZDHHC6 mRNA	PMID:23034163
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312224	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TENM4 mRNA	PMID:27188386
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TENM4 mRNA	PMID:33045310
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TENM4 mRNA	PMID:30071829
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20130618	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TENM4; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TENM4 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TENM4 gene	PMID:20938992
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of TENM4 gene	PMID:28931070|PMID:35440735
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312225	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TENM4 mRNA	PMID:30319688
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312225	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TENM4 mRNA	PMID:30319688
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312224	E	RGD:6480464	20130618	CTD	MESH:D004958	Estradiol results in increased expression of TENM4 mRNA	PMID:19619570
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20130618	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of TENM4 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TENM4 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of TENM4 mRNA	PMID:19619570|PMID:20660070|PMID:30165855
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20130618	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TENM4; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TENM4 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TENM4 gene	PMID:20938992
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of TENM4 mRNA	PMID:34673133
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of TENM4 mRNA	PMID:20660070
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA	PMID:37992649
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1312224	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of TENM4 mRNA	PMID:31256213
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA	PMID:37992649
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1312225	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of TENM4 exon; Diethylhexyl Phthalate results in decreased methylation of TENM4 gene; Diethylhexyl Phthalate results in decreased methylation of TENM4 intron	PMID:32864567
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312225	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TENM4 mRNA	PMID:33754040
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TENM4 mRNA	PMID:33387578
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312224	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TENM4 intron	PMID:30157460
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:254496	7,12-dimethyltetraphene	affects expression	ISO	RGD:1312225	E	RGD:6480464	20130618	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene affects the expression of TENM4 mRNA	PMID:21785161
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TENM4 mRNA	PMID:30723492
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20130618	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TENM4; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TENM4 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TENM4 gene	PMID:20938992
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TENM4 mRNA	PMID:40512198
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of TENM4 gene	PMID:31011160
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]	PMID:37992649
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20130618	CTD	MESH:D003042	[Cocaine co-treated with FOS protein mutant form] results in increased expression of TENM4 mRNA	PMID:18355967
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312225	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TENM4 mRNA	PMID:21570461
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312224	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TENM4 mRNA	PMID:19619570
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20130618	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TENM4 mRNA	PMID:19619570
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of TENM4 intron] which results in decreased expression of TENM4 mRNA	PMID:33017471
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312224	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TENM4 mRNA	PMID:28001369
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312224	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TENM4 mRNA	PMID:33212167
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of TENM4 mRNA	PMID:30807115
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TENM4 mRNA	PMID:26033743
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20130618	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TENM4 mRNA	PMID:20971185
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312224	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TENM4 mRNA	PMID:29803840
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA	PMID:37992649
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]	PMID:37992649
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312224	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TENM4 gene	PMID:28589171
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312224	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TENM4 mRNA	PMID:34032870
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TENM4 mRNA	PMID:40512198
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1312225	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of TENM4 mRNA	PMID:22342234
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312224	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TENM4 5' UTR; Benzo(a)pyrene affects the methylation of TENM4 intron	PMID:27901495|PMID:30157460
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TENM4 mRNA	PMID:20713471|PMID:22228805|PMID:22610609
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312225	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TENM4 exon; Benzo(a)pyrene results in decreased methylation of TENM4 intron	PMID:27901495
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TENM4 mRNA	PMID:26033743
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20130618	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TENM4 mRNA	PMID:20971185
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TENM4 mRNA	PMID:27131904
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312224	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TENM4 mRNA	PMID:25351596
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312224	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TENM4 mRNA	PMID:35984750
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312224	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of TENM4 gene	PMID:31601247
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of TENM4 gene	PMID:31601247
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of TENM4 mRNA	PMID:23557971
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312225	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TENM4 gene; titanium dioxide results in decreased methylation of TENM4 promoter	PMID:35295148
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312225	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TENM4 promoter	PMID:35295148
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C069837	fullerene C60 results in decreased expression of TENM4 mRNA	PMID:19167457
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312224	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of TENM4 gene	PMID:31601247
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C006780	bisphenol A results in decreased expression of TENM4 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of TENM4 mRNA	PMID:29097150|PMID:41034487
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312224	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of TENM4 mRNA	PMID:27685785|PMID:29275510
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312225	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TENM4 mRNA	PMID:30951980|PMID:38701888
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TENM4 gene	PMID:28505145
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TENM4 mRNA	PMID:36041667
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of TENM4 gene	PMID:31601247
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1312225	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of TENM4 mRNA	PMID:20713471
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TENM4 mRNA	PMID:40203079
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312224	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TENM4 gene	PMID:31601247
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312225	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TENM4 mRNA	PMID:30951980
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312225	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of TENM4 exon	PMID:33297965
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TENM4 mRNA	PMID:36041667
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312224	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TENM4 intron	PMID:30157460
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TENM4 mRNA	PMID:38685157
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312225	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TENM4 mRNA	PMID:30951980
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TENM4 mRNA	PMID:36041667
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20130618	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TENM4 mRNA	PMID:21266533
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1312225	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of TENM4 gene	PMID:38995845
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C039281	furan results in decreased expression of TENM4 mRNA	PMID:25539665
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312225	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TENM4 mRNA	PMID:40194260
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312224	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TENM4 mRNA	PMID:31533062
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of TENM4 mRNA	PMID:39529242
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312224	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TENM4 mRNA	PMID:25979313
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of TENM4 mRNA	PMID:29427782
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312224	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TENM4 mRNA	PMID:23179753|PMID:25192806|PMID:26272509|PMID:27188386
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA	PMID:27188386
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TENM4 mRNA	PMID:28973697
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA	PMID:37992649
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312224	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of TENM4 mRNA	PMID:24935251|PMID:26272509
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA	PMID:27188386
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TENM4 mRNA	PMID:33387578
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312224	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TENM4 mRNA	PMID:24714768
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1312224	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of TENM4 5' UTR	PMID:29523930
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TENM4 mRNA	PMID:40512198
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TENM4 mRNA	PMID:29391264
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312225	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TENM4 mRNA	PMID:35436446
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TENM4 mRNA	PMID:29097150
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TENM4 mRNA; Nanotubes, Carbon results in decreased expression of TENM4 mRNA	PMID:25554681
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of TENM4 mRNA	PMID:34044035
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312225	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of TENM4 mRNA	PMID:26377693
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312224	E	RGD:6480464	20130618	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TENM4 mRNA	PMID:15336504
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TENM4 mRNA	PMID:28801915|PMID:37269647
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312224	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TENM4 intron	PMID:30157460
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TENM4 gene	PMID:35440735
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312224	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TENM4 mRNA	PMID:31758290
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of TENM4 mRNA	PMID:39938710
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312225	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TENM4 mRNA	PMID:22206623
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1312225	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TENM4 mRNA	PMID:25566086
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TENM4 mRNA]	PMID:25566086
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA	PMID:27188386
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of TENM4 mRNA	PMID:32109520
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1312224	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of TENM4 mRNA	PMID:26705709
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D011441	Propylthiouracil results in increased expression of TENM4 mRNA	PMID:24780913
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312224	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA	PMID:27188386
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TENM4 mRNA	PMID:27131904
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312224	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TENM4 mRNA	PMID:38568856
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of TENM4 gene	PMID:31079544
1304658	Tenm4	teneurin transmembrane protein 4	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TENM4 mRNA	PMID:23555832
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1312226	E	RGD:6480464	20250506	CTD	MESH:D015025	Zearalenone results in increased expression of ARHGEF2 protein	PMID:39306225
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312226	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ARHGEF2 mRNA	PMID:38218311
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312227	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ARHGEF2 mRNA	PMID:33045310
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGEF2 mRNA	PMID:20938992
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312226	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGEF2 mRNA	PMID:16054129|PMID:33167477
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312227	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARHGEF2 mRNA	PMID:30319688
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312226	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ARHGEF2 protein	PMID:22226621
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20161228	CTD	MESH:D008070	ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]; ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein]; ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]; ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]; Lipopolysaccharides promotes the reaction [TLR4 protein binds to ARHGEF2 protein]; TLR4 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of ARHGEF2 protein]	PMID:22226621
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312227	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGEF2 mRNA	PMID:39298647
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGEF2 mRNA	PMID:32741896
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ARHGEF2 mRNA	PMID:20823114
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ARHGEF2 mRNA	PMID:33387578
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGEF2 mRNA	PMID:20938992
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17151	xylitol	increases expression	ISO	RGD:1312226	E	RGD:6480464	20200804	CTD	MESH:D014993	Xylitol results in increased expression of ARHGEF2 mRNA	PMID:32275922
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGEF2 mRNA	PMID:37992649
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGEF2 mRNA	PMID:32741896
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1312226	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ARHGEF2 mRNA	PMID:31256213
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGEF2 mRNA	PMID:37992649
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312227	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ARHGEF2 mRNA	PMID:23892564
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1312227	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of ARHGEF2 gene	PMID:34319233
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312226	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ARHGEF2 protein	PMID:37730182
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARHGEF2 mRNA	PMID:33387578
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312226	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ARHGEF2 mRNA	PMID:28818685
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARHGEF2 mRNA	PMID:36331819
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of ARHGEF2 mRNA	PMID:17103032
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:187088	Muconic dialdehyde	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20250805	CTD	MESH:C034476	muconaldehyde results in decreased expression of ARHGEF2 mRNA	PMID:40300100
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:2038	5-azacytidine	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in decreased expression of ARHGEF2 mRNA	PMID:20823114
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ARHGEF2 mRNA	PMID:35430440
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGEF2 mRNA	PMID:20938992
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312226	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ARHGEF2 gene	PMID:25304211
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312226	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ARHGEF2 protein	PMID:35688186
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ARHGEF2 mRNA	PMID:31881176
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312227	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ARHGEF2 protein	PMID:25505154
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1312226	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of ARHGEF2 gene	PMID:31636367
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312226	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ARHGEF2 mRNA	PMID:23300844
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ARHGEF2 mRNA	PMID:22023808
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ARHGEF2 mRNA	PMID:27392435
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ARHGEF2 mRNA]; Cisplatin promotes the reaction [jinfukang results in decreased expression of ARHGEF2 mRNA]; jinfukang promotes the reaction [Cisplatin results in decreased expression of ARHGEF2 mRNA]	PMID:21858171|PMID:27392435
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312227	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ARHGEF2 mRNA	PMID:30912803
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ARHGEF2 mRNA	PMID:23195993
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGEF2 mRNA	PMID:34747641
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312227	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGEF2 mRNA	PMID:21570461
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGEF2 mRNA	PMID:21215274
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARHGEF2 mRNA	PMID:33387578
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of ARHGEF2 mRNA]	PMID:21215274
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ARHGEF2 protein	PMID:39603559
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312226	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARHGEF2 mRNA	PMID:33212167
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ARHGEF2 mRNA	PMID:20971185
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGEF2 mRNA	PMID:37992649
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312226	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of ARHGEF2 protein	PMID:35688186
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312226	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ARHGEF2 mRNA	PMID:34032870
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGEF2 mRNA	PMID:28595984
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312226	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGEF2 mRNA	PMID:29301061|PMID:38568856|PMID:39719251
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312226	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of ARHGEF2 mRNA; Tunicamycin results in increased expression of ARHGEF2 protein	PMID:22378314|PMID:29453283|PMID:33545341
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARHGEF2 protein	PMID:32717239
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312227	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARHGEF2 mRNA	PMID:19770486
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312226	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARHGEF2 mRNA	PMID:32234424
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ARHGEF2 mRNA	PMID:20971185
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312226	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ARHGEF2 mRNA	PMID:25895662
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312227	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARHGEF2 gene; titanium dioxide results in decreased methylation of ARHGEF2 promoter	PMID:35295148
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312227	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ARHGEF2 gene	PMID:35295148
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ARHGEF2 mRNA	PMID:34492290
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312227	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ARHGEF2 mRNA	PMID:23811191
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312227	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ARHGEF2 mRNA	PMID:28472532
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of ARHGEF2 mRNA	PMID:28329830
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312226	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ARHGEF2 mRNA	PMID:30903817
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF2 mRNA	PMID:30816183
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF2 mRNA	PMID:20678512
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGEF2 mRNA	PMID:34947998
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312226	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGEF2 mRNA; bisphenol A results in increased expression of ARHGEF2 protein	PMID:29275510|PMID:34186270
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312226	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of ARHGEF2 mRNA	PMID:24752500
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312227	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARHGEF2 exon	PMID:33297965
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGEF2 mRNA	PMID:28628672
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312226	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ARHGEF2 protein	PMID:34186270
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGEF2 mRNA	PMID:28628672
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARHGEF2 mRNA	PMID:18164116
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312226	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGEF2 mRNA	PMID:37042841
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ARHGEF2 mRNA	PMID:35163327
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312226	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARHGEF2 mRNA	PMID:25851441|PMID:38568856
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312226	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ARHGEF2 protein	PMID:26879310
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ARHGEF2 mRNA	PMID:35163327
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ARHGEF2 mRNA	PMID:24386269
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312226	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ARHGEF2 mRNA	PMID:19376846
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312226	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ARHGEF2 mRNA	PMID:32588087
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312226	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ARHGEF2 mRNA	PMID:28302478
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312226	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARHGEF2 mRNA	PMID:31533062
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1312226	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of ARHGEF2 mRNA	PMID:31626844
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1312226	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of ARHGEF2 mRNA	PMID:26352163
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312226	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ARHGEF2 mRNA	PMID:40419075
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARHGEF2 mRNA	PMID:36331819
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312226	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGEF2 mRNA	PMID:25979313
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARHGEF2 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF2 mRNA	PMID:27188386
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of ARHGEF2 mRNA	PMID:38685447|PMID:41580965
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312226	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ARHGEF2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312227	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of ARHGEF2 mRNA	PMID:19770486
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312227	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of ARHGEF2 mRNA	PMID:22733784
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGEF2 mRNA	PMID:28628672
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGEF2 mRNA	PMID:37992649
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1312226	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of ARHGEF2 mRNA	PMID:33512557
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312226	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARHGEF2 mRNA	PMID:38832940
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGEF2 mRNA	PMID:33387578
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312226	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ARHGEF2 mRNA	PMID:29067470
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1312226	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of ARHGEF2 mRNA	PMID:33725128
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312226	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ARHGEF2 gene	PMID:25304211
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312226	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of ARHGEF2 mRNA	PMID:24752500
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGEF2 mRNA	PMID:28628672
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ARHGEF2 mRNA	PMID:20823114
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312226	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ARHGEF2 mRNA	PMID:23300844
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312227	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARHGEF2 mRNA; Nanotubes, Carbon results in decreased expression of ARHGEF2 mRNA	PMID:25554681
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of ARHGEF2 mRNA	PMID:41580965
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312227	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of ARHGEF2 mRNA	PMID:40234311
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:D005485	Flutamide results in decreased expression of ARHGEF2 mRNA	PMID:40381864
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARHGEF2 protein	PMID:32959892
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312227	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ARHGEF2 mRNA	PMID:22776087
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ARHGEF2 mRNA	PMID:22079614
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:64227	ciglitazone	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ARHGEF2 mRNA	PMID:16197558
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6704	mebendazole	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20181016	CTD	MESH:D008463	Mebendazole results in decreased expression of ARHGEF2 protein	PMID:30075109
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ARHGEF2 mRNA	PMID:20823114
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312227	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ARHGEF2 mRNA	PMID:26307267
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ARHGEF2 mRNA	PMID:30467583
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1312227	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of ARHGEF2 mRNA	PMID:17654400
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312226	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ARHGEF2 protein	PMID:34186270
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312226	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ARHGEF2 mRNA	PMID:37199045
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGEF2 mRNA	PMID:32741896
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:77012	methylseleninic acid	increases expression	ISO	RGD:1312226	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of ARHGEF2 mRNA	PMID:18548127
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARHGEF2 mRNA	PMID:18164116
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:77095	flubendazole	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20181016	CTD	MESH:C018945	flubendazole results in decreased expression of ARHGEF2 protein	PMID:30075109
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:77131	sinapic acid	increases expression	ISO	RGD:1312227	E	RGD:6480464	20230404	CTD	MESH:C073734	sinapinic acid analog results in increased expression of ARHGEF2 mRNA	PMID:36279966
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF2 mRNA	PMID:27188386
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARHGEF2 gene]	PMID:28238834
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312227	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ARHGEF2 mRNA	PMID:31388691
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ARHGEF2 protein	PMID:31675489
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1312226	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of ARHGEF2 mRNA	PMID:33512557
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1312226	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ARHGEF2 protein	PMID:31675489
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of ARHGEF2 mRNA	PMID:21858171
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ARHGEF2 mRNA]	PMID:21858171
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1312226	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of ARHGEF2 mRNA	PMID:33512557
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARHGEF2 mRNA	PMID:33150595
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases methylation	EXP		E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in increased methylation of ARHGEF2 promoter	PMID:33150595
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312226	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF2 mRNA	PMID:27188386
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1312226	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of ARHGEF2 mRNA	PMID:14630613
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312226	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARHGEF2 mRNA	PMID:38568856
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312226	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of ARHGEF2 mRNA	PMID:22378314
1304659	Arhgef2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312226	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of ARHGEF2 mRNA	PMID:19140230
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1312229	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide analog results in increased expression of CCL27A mRNA; graphene oxide results in increased expression of CCL27A mRNA	PMID:33227293
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:15379	dioxygen	increases secretion	ISO	RGD:1312229	E	RGD:6480464	20260707	CTD	MESH:D010100	Oxygen deficiency results in increased secretion of CCL27A protein	PMID:41319837
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20260707	CTD	MESH:D010100	[Vehicle Emissions results in increased abundance of Air Pollutants] promotes the reaction [Oxygen deficiency results in increased secretion of CCL27A protein]	PMID:41319837
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:15551	prostaglandin E2	multiple interactions	ISO	RGD:1312228	E	RGD:6480464	20160510	CTD	MESH:D015232	Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]]; Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]]; Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]	PMID:16784723
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCL27A mRNA	PMID:39241906
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D004958	Estradiol results in decreased expression of CCL27 mRNA; Estradiol results in decreased expression of CCL27A mRNA	PMID:19693291|PMID:39298647
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:16548	chlordecone	affects expression	ISO	RGD:1312229	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone affects the expression of CCL27A mRNA	PMID:29980752
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CCL27 mRNA	PMID:33387578
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D013739	Testosterone results in decreased expression of CCL27 mRNA	PMID:19693291
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CCL27 mRNA	PMID:26577399
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:18224	isoeugenol	increases expression	ISO	RGD:1312228	E	RGD:6480464	20130312	CTD	MESH:C036643	isoeugenol results in increased expression of CCL27 mRNA	PMID:17936526
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCL27A mRNA	PMID:37236586
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CCL27 mRNA	PMID:19770486
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D015032	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:27638	cobalt atom	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D003035	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CCL27A mRNA	PMID:35897073
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CCL27A mRNA	PMID:28960355
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CCL27 mRNA	PMID:31881176
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:27928	parathion	decreases methylation	ISO	RGD:1312228	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of CCL27 promoter	PMID:22847954
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D009532	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCL27 mRNA	PMID:21570461
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCL27 mRNA	PMID:21215274
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312228	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of CCL27 mRNA	PMID:29955902
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CCL27 mRNA	PMID:28959563
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312228	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CCL27 promoter	PMID:27901495
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312228	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CCL27 mRNA	PMID:17879257
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCL27 mRNA	PMID:22228805
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312228	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CCL27 promoter	PMID:23974009
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D015032	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CCL27A mRNA	PMID:29095437
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20191114	CTD	MESH:C006632	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CCL27A mRNA]	PMID:29095437
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CCL27 mRNA	PMID:30047161
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CCL27A mRNA	PMID:29264374
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CCL27 mRNA	PMID:34492290
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CCL27 mRNA	PMID:18648102
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CCL27 mRNA	PMID:25181051
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CCL27 mRNA	PMID:30816183
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:33418	graphite	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite results in increased expression of CCL27 mRNA	PMID:29933104
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:3437	carteolol	increases expression	ISO	RGD:1312228	E	RGD:6480464	20240206	CTD	MESH:D002354	Carteolol results in increased expression of CCL27 mRNA	PMID:37120125
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CCL27A mRNA	PMID:39298647
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CCL27A mRNA	PMID:38685157
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312229	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CCL27A mRNA	PMID:37019170
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1312229	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of CCL27A mRNA	PMID:35093514
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D015056	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCL27A mRNA	PMID:37236586
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:38689	fonofos	decreases methylation	ISO	RGD:1312228	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of CCL27 promoter	PMID:22847954
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:38960	terbufos	decreases methylation	ISO	RGD:1312228	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of CCL27 promoter	PMID:22847954
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:39233	emamectin benzoate	increases expression	ISO	RGD:1312228	E	RGD:6480464	20230704	CTD	MESH:C108024	emamectin benzoate results in increased expression of CCL27 mRNA	PMID:36269090
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of CCL27 mRNA	PMID:25993096
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312228	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CCL27 gene	PMID:29154799
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CCL27 mRNA	PMID:30047161
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D016572	Cyclosporine results in decreased expression of CCL27 mRNA	PMID:19770486
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D003907	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D000082	Acetaminophen affects the expression of CCL27 mRNA	PMID:17562736
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CCL27 mRNA	PMID:33387578
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312229	E	RGD:6480464	20150721	CTD	MESH:D000082	Acetaminophen results in increased expression of CCL27A mRNA	PMID:17585979
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312229	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CCL27A mRNA	PMID:29279043
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:46790	2-methoxyethanol	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C005219	methyl cellosolve results in decreased expression of CCL27 mRNA	PMID:21061450
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:47519	ketoconazole	multiple interactions	ISO	RGD:1312228	E	RGD:6480464	20160510	CTD	MESH:D007654	Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]]; Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]; Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 protein]; PTGER2 protein promotes the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; PTGER3 protein promotes the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]	PMID:16784723
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CCL27 mRNA	PMID:29391264
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CCL27A mRNA	PMID:29095437
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20191114	CTD	MESH:C032793	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CCL27A mRNA]	PMID:29095437
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:50545	trans-isoeugenol	increases expression	ISO	RGD:1312228	E	RGD:6480464	20140805	CTD	MESH:C036643	isoeugenol results in increased expression of CCL27 mRNA	PMID:17936526
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCL27A mRNA; Nanotubes, Carbon results in decreased expression of CCL27A mRNA	PMID:25554681|PMID:25620056
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CCL27 mRNA	PMID:30047161
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of CCL27A mRNA	PMID:26377693
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:53001	nickel sulfate	increases secretion	ISO	RGD:1312228	E	RGD:6480464	20130312	CTD	MESH:C029938	nickel sulfate results in increased secretion of CCL27 protein	PMID:15679580
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of CCL27 mRNA	PMID:19042947
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:53444	potassium dichromate	increases secretion	ISO	RGD:1312228	E	RGD:6480464	20130312	CTD	MESH:D011192	Potassium Dichromate results in increased secretion of CCL27 protein	PMID:15679580
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CCL27A mRNA	PMID:38701926
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CCL27A mRNA]	PMID:29095437
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312229	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CCL27A mRNA	PMID:22206623
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312228	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCL27 gene]	PMID:28238834
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:8093	phenylephrine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D010656	Phenylephrine results in increased expression of CCL27 mRNA	PMID:18158353
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312229	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of CCL27A mRNA	PMID:39847705
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:8434	prochloraz	increases expression	ISO	RGD:1312229	E	RGD:6480464	20260707	CTD	MESH:C045362	prochloraz results in increased expression of CCL27A mRNA	PMID:39210919
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CCL27 mRNA	PMID:30047161
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:8984	sodium dodecyl sulfate	increases secretion	ISO	RGD:1312228	E	RGD:6480464	20130312	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased secretion of CCL27 protein	PMID:15679580
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CCL27 mRNA	PMID:19281266
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CCL27 mRNA	PMID:21346803
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:9448	terbinafine	multiple interactions	ISO	RGD:1312228	E	RGD:6480464	20161213	CTD	MESH:C041359	Dinoprostone deficiency inhibits the reaction [Terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]]; Dinoprostone deficiency inhibits the reaction [Terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; PTGER2 protein promotes the reaction [Terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; PTGER3 protein promotes the reaction [Terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; Terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]; Terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 protein]	PMID:16784723
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CCL27 mRNA	PMID:21346803
1304660	Ccl27	C-C motif chemokine ligand 27	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of CCL27 mRNA	PMID:22615374
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SERPINB13 gene	PMID:28931070
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SERPINB13 mRNA	PMID:35811015
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SERPINB13 mRNA	PMID:30165855
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312230	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SERPINB13 mRNA	PMID:38568856
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312230	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of SERPINB13 mRNA	PMID:16002434
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SERPINB13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SERPINB13 protein	PMID:38598786
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SERPINB13 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SERPINB13 mRNA	PMID:32525701|PMID:40512198
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312230	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SERPINB13 mRNA	PMID:25583101
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312231	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SERPINB13 mRNA	PMID:21570461
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312230	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SERPINB13 mRNA	PMID:23152189
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312230	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SERPINB13 mRNA	PMID:30851411
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312231	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SERPINB13 mRNA	PMID:27862939
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312230	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SERPINB13 mRNA	PMID:38568856
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312230	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SERPINB13 mRNA	PMID:39719251
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SERPINB13 mRNA	PMID:40512198
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312230	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SERPINB13 5' UTR	PMID:27901495
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312230	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SERPINB13 promoter	PMID:27901495
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312231	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to SERPINB13 promoter]	PMID:19654925
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1312231	E	RGD:6480464	20190219	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SERPINB13 mRNA	PMID:30171875
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312230	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SERPINB13 mRNA	PMID:25351596
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SERPINB13 mRNA	PMID:25181051|PMID:41034487
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312230	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of SERPINB13 gene	PMID:31601247
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1312230	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to SERPINB13 protein	PMID:32991956
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SERPINB13 protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SERPINB13 protein	PMID:38598786
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312230	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SERPINB13 mRNA	PMID:38174414
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of SERPINB13 promoter	PMID:22457795
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312230	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SERPINB13 mRNA	PMID:19376846
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SERPINB13 mRNA	PMID:35811015
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SERPINB13 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SERPINB13 mRNA	PMID:32525701|PMID:40512198
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312231	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SERPINB13 mRNA	PMID:35436446
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1312230	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of SERPINB13 mRNA	PMID:38568856
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312230	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SERPINB13 mRNA	PMID:30851411
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SERPINB13 gene]	PMID:28238834
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:81922	flusilazole	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C061365	flusilazole results in increased expression of SERPINB13 mRNA	PMID:33032228
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:81980	triticonazole	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C412303	triticonazole results in increased expression of SERPINB13 mRNA	PMID:33032228
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SERPINB13 mRNA	PMID:32525701
1304661	Serpinb13	serpin family B member 13	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312230	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SERPINB13 protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SERPINB13 protein	PMID:38598786
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:10093	yohimbine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20180116	CTD	MESH:D015016	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312232	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PLA2G12A mRNA	PMID:26272509|PMID:27188386
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA	PMID:27188386
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312233	E	RGD:6480464	20240903	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PLA2G12A mRNA	PMID:38458531
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312232	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of PLA2G12A mRNA	PMID:21934132
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLA2G12A mRNA	PMID:30529165
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLA2G12A mRNA	PMID:36331819
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of PLA2G12A gene	PMID:35440735
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:15950	(S)-coclaurine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20180116	CTD	MESH:C004690	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312233	E	RGD:6480464	20130806	CTD	MESH:D000431	Ethanol results in increased expression of PLA2G12A mRNA	PMID:19167417
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1312232	E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of PLA2G12A mRNA	PMID:39709020
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of PLA2G12A mRNA	PMID:32145629
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312232	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in increased expression of PLA2G12A mRNA	PMID:19167446
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312233	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PLA2G12A mRNA	PMID:33711761
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312232	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PLA2G12A mRNA	PMID:38568856
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of PLA2G12A mRNA	PMID:19448997
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312232	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PLA2G12A mRNA	PMID:37042841
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312232	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of PLA2G12A mRNA	PMID:38685446
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of PLA2G12A gene	PMID:33872906
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of PLA2G12A mRNA	PMID:17997037
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of PLA2G12A gene	PMID:33872906
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLA2G12A mRNA	PMID:36331819
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:18417	(RS)-coclaurine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20180116	CTD	MESH:C004690	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:18418	(RS)-norcoclaurine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20180116	CTD	MESH:C012348	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of PLA2G12A mRNA	PMID:17997037
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:196319	(+/-)-Aegeline	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20231003	CTD	MESH:C560978	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G12A mRNA	PMID:29950665
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312232	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PLA2G12A mRNA	PMID:19549813
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PLA2G12A mRNA	PMID:22129741
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLA2G12A mRNA	PMID:23385219|PMID:23630614|PMID:25378103
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of PLA2G12A mRNA	PMID:35737395
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PLA2G12A mRNA	PMID:34911549
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000638	Amiodarone results in increased expression of PLA2G12A mRNA	PMID:40216313
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312233	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PLA2G12A mRNA	PMID:27339419|PMID:31919559
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PLA2G12A mRNA	PMID:25629700
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLA2G12A mRNA	PMID:40504410
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312232	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PLA2G12A mRNA	PMID:19244175
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA	PMID:19244175
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20180116	CTD	MESH:D002110	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312232	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PLA2G12A mRNA	PMID:28903495
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of PLA2G12A mRNA	PMID:40618947
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLA2G12A mRNA	PMID:22298810|PMID:34747641
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312233	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLA2G12A mRNA	PMID:20702594|PMID:21570461|PMID:24680724|PMID:26377647
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA	PMID:21215274|PMID:23238561|PMID:32387183
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312233	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA	PMID:18796159|PMID:20005886|PMID:21851831|PMID:22230337|PMID:23238561|PMID:25975270|PMID:26290441
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA]	PMID:21215274
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:D013749	2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA]; [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of PLA2G12A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PLA2G12A mRNA; Tetrachlorodibenzodioxin promotes the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PLA2G12A mRNA]	PMID:16214954|PMID:21851831|PMID:25975270
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of PLA2G12A mRNA	PMID:28374803
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312232	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PLA2G12A mRNA	PMID:23179753
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28428	beta-hexachlorocyclohexane	increases expression	ISO	RGD:1312233	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in increased expression of PLA2G12A mRNA	PMID:25270620
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312233	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of PLA2G12A mRNA	PMID:39631538
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:28794	coumarin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of PLA2G12A mRNA	PMID:18480146
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLA2G12A mRNA	PMID:40504410
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312233	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLA2G12A mRNA	PMID:19770486
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLA2G12A gene	PMID:31601247
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of PLA2G12A mRNA	PMID:24136188
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312233	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLA2G12A promoter	PMID:35295148
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G12A mRNA	PMID:29950665
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PLA2G12A mRNA	PMID:23411599
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PLA2G12A mRNA	PMID:18648102
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PLA2G12A mRNA	PMID:25380136
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312233	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PLA2G12A mRNA	PMID:18445702|PMID:23811191
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of PLA2G12A mRNA	PMID:22484513
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312233	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PLA2G12A mRNA	PMID:28472532
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of PLA2G12A mRNA	PMID:32145629
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLA2G12A mRNA	PMID:25181051
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PLA2G12A gene	PMID:28505145
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLA2G12A gene	PMID:31601247
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312232	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PLA2G12A mRNA	PMID:19244175
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA	PMID:19244175
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312232	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of PLA2G12A mRNA	PMID:24752500
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1312233	E	RGD:6480464	20130806	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PLA2G12A mRNA	PMID:20005886|PMID:21851831
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20130806	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl affects the reaction [NR1I2 protein affects the expression of PLA2G12A mRNA]; 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA]; Tetrachlorodibenzodioxin promotes the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PLA2G12A mRNA]	PMID:21851831|PMID:32352317
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of PLA2G12A mRNA	PMID:20702594
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312233	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of PLA2G12A mRNA	PMID:40203079
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20241001	CTD	MESH:C008745	[Dietary Fats co-treated with bisphenol F] results in decreased expression of PLA2G12A mRNA	PMID:36632902
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312233	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLA2G12A mRNA	PMID:37019170
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G12A mRNA	PMID:29950665
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PLA2G12A mRNA	PMID:17361019|PMID:21266533
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1312233	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of PLA2G12A mRNA	PMID:25270620
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PLA2G12A mRNA	PMID:22129741
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312232	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLA2G12A mRNA	PMID:37042841
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PLA2G12A mRNA	PMID:25380136
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PLA2G12A mRNA	PMID:25993096
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of PLA2G12A mRNA	PMID:26194646
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PLA2G12A mRNA	PMID:30047161
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312233	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PLA2G12A mRNA	PMID:28903501
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312232	E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PLA2G12A mRNA	PMID:19376846
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of PLA2G12A mRNA	PMID:25380136
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312232	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PLA2G12A mRNA	PMID:24449571
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312232	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PLA2G12A mRNA	PMID:19244175
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA	PMID:19244175
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312232	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PLA2G12A mRNA	PMID:31533062
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLA2G12A mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLA2G12A mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PLA2G12A mRNA	PMID:36331819
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PLA2G12A mRNA	PMID:25993096
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312232	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLA2G12A mRNA	PMID:25979313
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312232	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PLA2G12A mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA	PMID:27188386
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312232	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of PLA2G12A mRNA	PMID:20106945
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1312232	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of PLA2G12A mRNA	PMID:24449571
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PLA2G12A mRNA	PMID:24136188
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312232	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PLA2G12A mRNA	PMID:24935251
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PLA2G12A mRNA	PMID:17562736
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of PLA2G12A mRNA	PMID:17202762
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312232	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in increased expression of PLA2G12A mRNA	PMID:21420995
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLA2G12A mRNA	PMID:40504410
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312232	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of PLA2G12A mRNA	PMID:24752500
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312233	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of PLA2G12A mRNA	PMID:22334560
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312233	E	RGD:6480464	20200714	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PLA2G12A mRNA	PMID:31978390
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312233	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PLA2G12A mRNA; Nanotubes, Carbon results in increased expression of PLA2G12A mRNA	PMID:25620056
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PLA2G12A mRNA	PMID:35964746
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PLA2G12A mRNA	PMID:24136188
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of PLA2G12A mRNA	PMID:17982090
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1312233	E	RGD:6480464	20150127	CTD	MESH:D016559	Tacrolimus results in increased expression of PLA2G12A mRNA	PMID:25270620
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:63598	levofloxacin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in increased expression of PLA2G12A mRNA	PMID:24136188
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:63613	nevirapine	increases expression	ISO	RGD:1312233	E	RGD:6480464	20240903	CTD	MESH:D019829	Nevirapine results in increased expression of PLA2G12A mRNA	PMID:38636494
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PLA2G12A mRNA	PMID:24136188
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312233	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of PLA2G12A mRNA	PMID:25270620
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of PLA2G12A mRNA	PMID:24136188
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312233	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of PLA2G12A mRNA	PMID:36851058
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:6801	metformin	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin affects the expression of PLA2G12A mRNA	PMID:31324951
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of PLA2G12A mRNA	PMID:28935588
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312233	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of PLA2G12A mRNA	PMID:31052254
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:72754	bisphenol AF	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20250114	CTD	MESH:C583074	[Dietary Fats co-treated with bisphenol AF] results in decreased expression of PLA2G12A mRNA	PMID:36632902
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312233	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PLA2G12A mRNA	PMID:22206623
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PLA2G12A mRNA	PMID:24136188
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:756996	imeglimin	increases expression	ISO	RGD:1312233	E	RGD:6480464	20260714	CTD	MESH:C575881	imeglimin results in increased expression of PLA2G12A mRNA	PMID:40713970
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of PLA2G12A mRNA	PMID:33484710
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA	PMID:27188386
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:8064	phenformin	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in increased expression of PLA2G12A mRNA	PMID:31324951
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312233	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in increased expression of PLA2G12A mRNA	PMID:19270015|PMID:19482888|PMID:23091169|PMID:25270620
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PLA2G12A mRNA]	PMID:19482888
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1312233	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of PLA2G12A mRNA	PMID:22334560
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:81760	difenoconazole	increases expression	ISO	RGD:1312233	E	RGD:6480464	20230905	CTD	MESH:C115058	difenoconazole results in increased expression of PLA2G12A mRNA	PMID:34425431
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312233	E	RGD:6480464	20130806	CTD	MESH:C045950	propiconazole results in increased expression of PLA2G12A mRNA	PMID:22334560
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLA2G12A mRNA	PMID:30047161
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312232	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA	PMID:27188386
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312232	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PLA2G12A mRNA	PMID:38568856
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PLA2G12A mRNA	PMID:21346803
1304662	Pla2g12a	phospholipase A2, group XIIA	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of PLA2G12A gene	PMID:31079544
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1312236	E	RGD:6480464	20180116	CTD	MESH:D015025	Zearalenone results in increased expression of SLC39A6 mRNA	PMID:28965971
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC39A6 mRNA]	PMID:31150632
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312237	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SLC39A6 mRNA	PMID:30319688
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC39A6 mRNA; Lipopolysaccharides results in decreased expression of SLC39A6 protein	PMID:16892068|PMID:17126599
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312237	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLC39A6 mRNA	PMID:39241906
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20161228	CTD	MESH:D008070	SLC39A6 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Zinc]; TICAM1 protein affects the reaction [Lipopolysaccharides results in decreased expression of SLC39A6 protein]	PMID:16892068
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312236	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of SLC39A6 mRNA	PMID:16514628
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC39A6 mRNA	PMID:33387578
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1312236	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SLC39A6 mRNA	PMID:16949557
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SLC39A6 mRNA	PMID:27523638
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312236	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SLC39A6 protein	PMID:37730182
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20130212	CTD	MESH:D002117	Calcitriol results in decreased expression of SLC39A6 mRNA	PMID:20089671
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1312236	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SLC39A6 mRNA	PMID:16949557
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:D002104	[zinc chloride co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] results in decreased expression of SLC39A6 mRNA	PMID:30714133
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:231505	gallium nitrate	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20240702	CTD	MESH:C027235	gallium nitrate results in decreased expression of SLC39A6 mRNA	PMID:18586083
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A6 mRNA	PMID:29950665
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312236	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SLC39A6 mRNA	PMID:19549813
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SLC39A6 protein	PMID:23301498
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of SLC39A6 mRNA	PMID:19376150
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312236	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SLC39A6 protein	PMID:20106945
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312236	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC39A6 mRNA	PMID:27153756
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312236	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SLC39A6 gene	PMID:27153756
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of SLC39A6 mRNA	PMID:15867272
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	affects uptake	ISO	RGD:1312236	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A6 protein affects the uptake of Zinc	PMID:18272141
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of SLC39A6 mRNA	PMID:17085522
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312237	E	RGD:6480464	20141223	CTD	MESH:D015032	Zinc deficiency results in increased expression of SLC39A6 protein	PMID:25088245
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	increases transport	ISO	RGD:1312236	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A6 protein results in increased transport of Zinc	PMID:18326752
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	increases uptake	ISO	RGD:1312236	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A6 protein results in increased uptake of Zinc	PMID:12839489
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20130212	CTD	MESH:D015032	Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]]	PMID:19887557
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A6 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Zinc]	PMID:16892068
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC39A6 mRNA	PMID:31150632
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312237	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC39A6 mRNA	PMID:27339419|PMID:31919559
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC39A6 mRNA]	PMID:31150632
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLC39A6 mRNA	PMID:28960355
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC39A6 mRNA	PMID:31881176
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of SLC39A6 mRNA	PMID:18930951
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312237	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC39A6 mRNA	PMID:21570461
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC39A6 mRNA	PMID:34747641
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC39A6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC39A6 mRNA	PMID:17942748|PMID:25975270
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312236	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SLC39A6 mRNA	PMID:39709020
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312236	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SLC39A6 mRNA	PMID:32763439
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC39A6 mRNA	PMID:29803840
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312237	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SLC39A6 mRNA	PMID:39631538
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312236	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC39A6 mRNA	PMID:32234424
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312237	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC39A6 mRNA	PMID:22228805|PMID:23735875
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312236	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of SLC39A6 promoter	PMID:23974009
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of SLC39A6 mRNA	PMID:15867272
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	affects uptake	ISO	RGD:1312236	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A6 protein affects the uptake of Zinc	PMID:18272141
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of SLC39A6 mRNA	PMID:17085522
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312237	E	RGD:6480464	20141223	CTD	MESH:D015032	Zinc deficiency results in increased expression of SLC39A6 protein	PMID:25088245
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	increases transport	ISO	RGD:1312236	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A6 protein results in increased transport of Zinc	PMID:18326752
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	increases uptake	ISO	RGD:1312236	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A6 protein results in increased uptake of Zinc	PMID:12839489
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20130212	CTD	MESH:D015032	Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]]	PMID:19887557
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A6 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Zinc]	PMID:16892068
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312236	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SLC39A6 mRNA	PMID:26238291
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:31638	fulvestrant	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of SLC39A6 mRNA	PMID:16514628
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SLC39A6 mRNA	PMID:30047161
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312237	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SLC39A6 gene	PMID:35295148
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A6 mRNA	PMID:29950665
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SLC39A6 mRNA	PMID:34492290
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SLC39A6 mRNA	PMID:25380136
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC39A6 mRNA	PMID:19710929
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of SLC39A6 mRNA	PMID:38479592
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SLC39A6 mRNA	PMID:25181051
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC39A6 mRNA	PMID:30816183|PMID:34947998
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312236	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SLC39A6 mRNA	PMID:26363213
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312237	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SLC39A6 mRNA	PMID:26682919
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312237	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SLC39A6 mRNA	PMID:38685157
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A6 mRNA	PMID:29950665
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SLC39A6 mRNA	PMID:21266533
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of SLC39A6 mRNA	PMID:36117858
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312236	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC39A6 mRNA	PMID:37042841
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SLC39A6 mRNA	PMID:25380136
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D019256	Cadmium Chloride affects the expression of SLC39A6 mRNA	PMID:29548726
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SLC39A6 mRNA	PMID:33453195
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:D019256	[zinc chloride co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] results in decreased expression of SLC39A6 mRNA	PMID:30714133
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SLC39A6 mRNA	PMID:30047161
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SLC39A6 mRNA	PMID:25380136
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SLC39A6 mRNA	PMID:28302478
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120515	CTD	MESH:C031763	1,3-butadiene results in increased expression of SLC39A6 mRNA	PMID:21147608
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312236	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC39A6 mRNA	PMID:25979313
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SLC39A6 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312236	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC39A6 mRNA	PMID:29154799
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA	PMID:27188386
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SLC39A6 mRNA	PMID:30047161
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SLC39A6 mRNA	PMID:27281708
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312236	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC39A6 mRNA	PMID:20106945
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of SLC39A6 mRNA	PMID:16514628
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312236	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SLC39A6 mRNA	PMID:38832940
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:45716	vorinostat	decreases response to substance	ISO	RGD:1312236	E	RGD:6480464	20161213	CTD	MESH:C111237	SLC39A6 mutant form results in decreased susceptibility to vorinostat	PMID:19887557
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SLC39A6 mRNA	PMID:24935251|PMID:26272509
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:46024	trichostatin A	decreases response to substance	ISO	RGD:1312236	E	RGD:6480464	20130212	CTD	MESH:C012589	SLC39A6 mutant form results in decreased susceptibility to trichostatin A	PMID:19887557
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312236	E	RGD:6480464	20130212	CTD	MESH:C012589	trichostatin A results in increased expression of SLC39A6 mRNA; trichostatin A results in increased expression of SLC39A6 protein	PMID:19887557
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20130212	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]; SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]; SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]; SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]; SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]]	PMID:19887557|PMID:27188386
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC39A6 mRNA	PMID:17562736
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312236	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC39A6 mRNA	PMID:29067470
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC39A6 mRNA	PMID:19420014
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1312236	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of SLC39A6 mRNA	PMID:21148743
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC39A6 mRNA	PMID:17942748
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1312236	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of SLC39A6 mRNA	PMID:23228038
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:49976	zinc dichloride	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:C016837	[zinc chloride co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] results in decreased expression of SLC39A6 mRNA	PMID:30714133
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SLC39A6 mRNA	PMID:30047161
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SLC39A6 mRNA	PMID:24793618
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of SLC39A6 mRNA	PMID:36117858
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1312236	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SLC39A6 mRNA	PMID:26705709
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SLC39A6 mRNA	PMID:19042947
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC39A6 mRNA	PMID:23650126
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of SLC39A6 mRNA	PMID:28935588
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312237	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of SLC39A6 mRNA	PMID:31052254
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of SLC39A6 mRNA	PMID:30559759
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA	PMID:27188386
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC39A6 gene]	PMID:28238834
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SLC39A6 mRNA	PMID:21278054
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SLC39A6 mRNA	PMID:24780913|PMID:30047161
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of SLC39A6 mRNA	PMID:26272509
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of SLC39A6 mRNA	PMID:16514628
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]]	PMID:19887557
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312236	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA	PMID:27188386
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SLC39A6 mRNA	PMID:19281266
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SLC39A6 mRNA	PMID:21346803
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312236	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SLC39A6 mRNA	PMID:38568856
1304664	Slc39a6	solute carrier family 39 member 6	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of SLC39A6 mRNA	PMID:22570695
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312238	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PCDHB4 mRNA	PMID:27188386
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D001280	Atrazine results in decreased expression of PCDHB4 mRNA	PMID:22378314
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20220913	CTD	MESH:D008628	Mercury results in decreased expression of PCDHB4 mRNA	PMID:22008530
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDHB4 mRNA	PMID:20823114
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of PCDHB4 gene	PMID:27618143
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PCDHB4 mRNA	PMID:34319233
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:2038	5-azacytidine	decreases expression	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D001374	Azacitidine results in decreased expression of PCDHB4 mRNA	PMID:20823114
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312238	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHB4 gene	PMID:27153756
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20220913	CTD	MESH:D008628	Mercury results in decreased expression of PCDHB4 mRNA	PMID:22008530
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20220913	CTD	MESH:D005492	Folic Acid results in decreased expression of PCDHB4 mRNA	PMID:25629700
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D009532	Nickel results in decreased expression of PCDHB4 mRNA	PMID:25583101
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDHB4 mRNA	PMID:33387578
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312238	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PCDHB4 mRNA	PMID:28001369
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:D003300	Copper deficiency results in increased expression of PCDHB4 mRNA	PMID:26033743
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312238	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDHB4 promoter	PMID:27901495
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312238	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDHB4 exon	PMID:27901495
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:D003300	Copper deficiency results in increased expression of PCDHB4 mRNA	PMID:26033743
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150721	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDHB4 mRNA	PMID:25181051|PMID:34947998
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20220913	CTD	MESH:C008745	bisphenol F results in decreased expression of PCDHB4 mRNA	PMID:30951980
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D014635	Valproic Acid affects the expression of PCDHB4 mRNA	PMID:25979313
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDHB4 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312238	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB4 mRNA	PMID:27188386
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCDHB4 mRNA	PMID:20106945
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312238	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PCDHB4 mRNA	PMID:27188386
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D018038	Sodium Selenite results in decreased expression of PCDHB4 mRNA	PMID:18175754
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDHB4 mRNA	PMID:20823114
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312239	E	RGD:6480464	20220913	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PCDHB4 mRNA	PMID:23608068
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:63618	pravastatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of PCDHB4 mRNA	PMID:27225895
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1312239	E	RGD:6480464	20220913	CTD	MESH:D017035	Pravastatin results in increased expression of PCDHB4 mRNA	PMID:27225895
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312238	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PCDHB4 mRNA	PMID:24810058
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PCDHB4 mRNA	PMID:20147733
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1312238	E	RGD:6480464	20160906	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDHB4 mRNA	PMID:20823114
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20220913	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PCDHB4 mRNA	PMID:22206623
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312238	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB4 mRNA	PMID:27188386
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312238	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDHB4 gene]	PMID:28238834
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1312239	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in increased expression of PCDHB4 mRNA	PMID:35278568
1304665	Pcdhb5	protocadherin beta 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312238	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB4 mRNA	PMID:27188386
1304666	Paip2l1	polyadenylate-binding protein-interacting protein 2-like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PAIP2L1 mRNA	PMID:25181051
1304666	Paip2l1	polyadenylate-binding protein-interacting protein 2-like 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of PAIP2L1 mRNA	PMID:35594946
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312242	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KCNA10 gene	PMID:27153756
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:26216	potassium atom	increases transport	ISO	RGD:1312242	E	RGD:6480464	20120412	CTD	MESH:D011188	KCNA10 protein results in increased transport of Potassium	PMID:10836990
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:26216	potassium atom	multiple interactions	ISO	RGD:1312242	E	RGD:6480464	20120412	CTD	MESH:D011188	4-Aminopyridine inhibits the reaction [KCNA10 protein results in increased transport of Potassium]; 4-O-methyl-12-O-tetradecanoylphorbol 13-acetate inhibits the reaction [KCNA10 protein results in increased transport of Potassium]; Barium inhibits the reaction [KCNA10 protein results in increased transport of Potassium]; Pimozide inhibits the reaction [KCNA10 protein results in increased transport of Potassium]; Verapamil inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312242	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KCNA10 gene	PMID:25304211
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312242	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KCNA10 mRNA	PMID:23557933
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312242	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of KCNA10 gene	PMID:28589171
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312242	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KCNA10 promoter	PMID:27901495
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:32595	barium(0)	multiple interactions	ISO	RGD:1312242	E	RGD:6480464	20120412	CTD	MESH:D001464	Barium inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in decreased expression of KCNA10 mRNA	PMID:25181051
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of KCNA10 mRNA	PMID:41034487
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1621289	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KCNA10 promoter	PMID:27312807
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:34385	4-aminopyridine	multiple interactions	ISO	RGD:1312242	E	RGD:6480464	20120412	CTD	MESH:D015761	4-Aminopyridine inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1621289	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of KCNA10 intron	PMID:28392331
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1621289	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KCNA10 mRNA	PMID:32715474
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312242	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KCNA10 mRNA	PMID:38832940
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312242	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KCNA10 gene	PMID:25304211
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	multiple interactions	ISO	RGD:1312242	E	RGD:6480464	20140805	CTD	MESH:D014700	Verapamil inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312242	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KCNA10 gene]	PMID:28238834
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:8212	pimozide	multiple interactions	ISO	RGD:1312242	E	RGD:6480464	20120412	CTD	MESH:D010868	Pimozide inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1304667	Kcna10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:9948	verapamil	multiple interactions	ISO	RGD:1312242	E	RGD:6480464	20120412	CTD	MESH:D014700	Verapamil inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of BLMH mRNA	PMID:33045310
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BLMH mRNA]	PMID:31150632
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein]	PMID:38195004
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of BLMH mRNA	PMID:14976132
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of BLMH mRNA	PMID:15498508|PMID:33167477
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312244	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of BLMH mRNA	PMID:16054129
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312245	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of BLMH mRNA	PMID:39298647
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312244	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of BLMH mRNA	PMID:38568856
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of BLMH mRNA	PMID:33387578
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein	PMID:38195004
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D015032	Zinc deficiency results in increased expression of BLMH mRNA	PMID:16140947
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20150623	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of BLMH mRNA]	PMID:16140947
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BLMH mRNA	PMID:31150632
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BLMH mRNA]	PMID:31150632
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of BLMH mRNA	PMID:32525701
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of BLMH protein	PMID:38460933
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D002945	Cisplatin results in decreased expression of BLMH mRNA	PMID:18172885
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312244	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of BLMH mRNA	PMID:27392435
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312245	E	RGD:6480464	20150623	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BLMH mRNA	PMID:21570461
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312244	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BLMH mRNA	PMID:23152189
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312244	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of BLMH protein	PMID:39603559
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of BLMH mRNA	PMID:32763439
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BLMH mRNA	PMID:29803840
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of BLMH mRNA	PMID:38568856|PMID:39719251
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of BLMH mRNA	PMID:36209798
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312244	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BLMH promoter	PMID:27901495
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D015032	Zinc deficiency results in increased expression of BLMH mRNA	PMID:16140947
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20150623	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of BLMH mRNA]	PMID:16140947
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BLMH mRNA	PMID:20382639
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D000643	Ammonium Chloride affects the expression of BLMH mRNA	PMID:16483693
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:31355	carboplatin	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D016190	Carboplatin results in decreased expression of BLMH mRNA	PMID:18172885
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:3139	bleomycin A2	affects response to substance	ISO	RGD:1312244	E	RGD:6480464	20120412	CTD	MESH:D001761	BLMH gene polymorphism affects the susceptibility to Bleomycin	PMID:12082022
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of BLMH mRNA	PMID:15498508
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312245	E	RGD:6480464	20150623	CTD	MESH:C006253	pirinixic acid results in increased expression of BLMH mRNA	PMID:18301758
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BLMH mRNA	PMID:19710929
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in decreased expression of BLMH mRNA	PMID:25181051|PMID:34947998
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of BLMH mRNA; bisphenol A results in decreased expression of BLMH protein	PMID:29275510|PMID:34186270
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312244	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of BLMH gene	PMID:31601247
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312245	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of BLMH mRNA	PMID:39298647
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of BLMH mRNA	PMID:26377693
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312245	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of BLMH mRNA	PMID:38685157
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of BLMH mRNA	PMID:37019170
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312244	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BLMH mRNA	PMID:37042841
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BLMH mRNA	PMID:26472689|PMID:38174414
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein	PMID:38195004
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312244	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of BLMH protein	PMID:26879310
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1312244	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of BLMH mRNA	PMID:40434365
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of BLMH mRNA	PMID:31533062
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C016104	sodium bichromate results in increased expression of BLMH mRNA	PMID:12325037
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312244	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BLMH mRNA	PMID:25979313
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312245	E	RGD:6480464	20150623	CTD	MESH:D014635	Valproic Acid affects the expression of BLMH mRNA	PMID:17292431
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312244	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of BLMH mRNA	PMID:29154799
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of BLMH mRNA	PMID:28973697
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312245	E	RGD:6480464	20150623	CTD	MESH:D000082	Acetaminophen affects the expression of BLMH mRNA	PMID:17562736
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of BLMH protein	PMID:38460933
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of BLMH mRNA	PMID:32525701
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312245	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of BLMH mRNA	PMID:25554681
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of BLMH mRNA	PMID:24136188
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D005485	Flutamide results in decreased expression of BLMH mRNA	PMID:24793618
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of BLMH mRNA	PMID:24136188
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of BLMH protein	PMID:32959892
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20150623	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of BLMH mRNA	PMID:23650126
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of BLMH gene	PMID:35440735
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312244	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of BLMH protein	PMID:34186270
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of BLMH protein	PMID:37664457
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312244	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of BLMH protein	PMID:39638853
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1312244	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of BLMH protein	PMID:39638853
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BLMH gene]	PMID:28238834
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of BLMH mRNA	PMID:19084549
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of BLMH protein	PMID:28903499
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1312244	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of BLMH mRNA	PMID:33512557
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312244	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of BLMH protein	PMID:38348393
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of BLMH mRNA	PMID:32525701
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in increased expression of BLMH mRNA	PMID:26923065
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312244	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of BLMH protein	PMID:37664457
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of BLMH mRNA	PMID:21346803
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of BLMH mRNA	PMID:24136188
1304668	Blmh	bleomycin hydrolase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of BLMH mRNA	PMID:21346803
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312246	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CCNDBP1 mRNA	PMID:38218311
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CCNDBP1 mRNA	PMID:21551480
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CCNDBP1 mRNA	PMID:26251327
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312246	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CCNDBP1 mRNA	PMID:23724009|PMID:33167477
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312246	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CCNDBP1 mRNA	PMID:26079696
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312247	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CCNDBP1 mRNA	PMID:30319688
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCNDBP1 mRNA	PMID:39241906
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312246	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of CCNDBP1 mRNA	PMID:23019147|PMID:31614463
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312246	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of CCNDBP1 mRNA	PMID:33359661
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312246	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CCNDBP1 mRNA	PMID:28818685
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312246	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CCNDBP1 mRNA	PMID:19549813
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312246	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CCNDBP1 mRNA	PMID:27153756
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312246	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CCNDBP1 gene	PMID:27153756
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312246	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CCNDBP1 mRNA	PMID:23649840
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:27385	tetrachloromethane	decreases response to substance	ISO	RGD:1312246	E	RGD:6480464	20120412	CTD	MESH:D002251	CCNDBP1 protein results in decreased susceptibility to Carbon Tetrachloride	PMID:16501603
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312247	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNDBP1 mRNA	PMID:22206623
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312246	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNDBP1 mRNA	PMID:40512198
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312246	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of CCNDBP1 mRNA	PMID:23300844
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312247	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCNDBP1 mRNA	PMID:21570461
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCNDBP1 mRNA	PMID:32109520
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312246	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CCNDBP1 mRNA	PMID:33212167
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1312246	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of CCNDBP1 mRNA	PMID:39709020
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312246	E	RGD:6480464	20120717	CTD	MESH:D003300	[Thiosemicarbazones binds to Copper] which results in increased expression of CCNDBP1 protein	PMID:20931265
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312247	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CCNDBP1 mRNA	PMID:27862939
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312246	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CCNDBP1 mRNA	PMID:38568856
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312246	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNDBP1 mRNA	PMID:40512198
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312247	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCNDBP1 mRNA	PMID:22228805
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312247	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCNDBP1 exon; Benzo(a)pyrene results in increased methylation of CCNDBP1 intron	PMID:27901495
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312246	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CCNDBP1 mRNA]	PMID:32406909
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312246	E	RGD:6480464	20120717	CTD	MESH:D003300	[Thiosemicarbazones binds to Copper] which results in increased expression of CCNDBP1 protein	PMID:20931265
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312247	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCNDBP1 gene	PMID:35295148
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312247	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CCNDBP1 mRNA	PMID:18648102
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CCNDBP1 mRNA	PMID:25181051
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CCNDBP1 mRNA	PMID:18668222
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	decreases response to substance	ISO	RGD:1312246	E	RGD:6480464	20120412	CTD	MESH:D004052	CCNDBP1 protein results in decreased susceptibility to Diethylnitrosamine	PMID:16501603
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312246	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCNDBP1 mRNA	PMID:37042841
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:35861	dibenzo[a,l]pyrene	affects expression	ISO	RGD:1312247	E	RGD:6480464	20160210	CTD	MESH:C041517	dibenzo(a,l)pyrene affects the expression of CCNDBP1 mRNA	PMID:26496743
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of CCNDBP1 mRNA	PMID:17585979|PMID:23811191
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312246	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CCNDBP1 mRNA	PMID:28302478
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312246	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CCNDBP1 mRNA	PMID:40419075
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312246	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CCNDBP1 mRNA	PMID:25979313
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312246	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CCNDBP1 mRNA	PMID:29154799
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312247	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CCNDBP1 mRNA	PMID:17555576
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312247	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CCNDBP1 mRNA	PMID:17562736
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312246	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNDBP1 mRNA	PMID:40512198
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312247	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CCNDBP1 mRNA	PMID:17555576
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312246	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of CCNDBP1 mRNA	PMID:23300844
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCNDBP1 mRNA; Nanotubes, Carbon results in decreased expression of CCNDBP1 mRNA	PMID:25554681
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of CCNDBP1 mRNA	PMID:26377693
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of CCNDBP1 mRNA	PMID:20080153
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1312246	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of CCNDBP1 mRNA	PMID:27918106
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312246	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CCNDBP1 mRNA	PMID:31758290
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CCNDBP1 mRNA	PMID:22206623
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312247	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNDBP1 mRNA	PMID:22206623
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312246	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of CCNDBP1 mRNA	PMID:26079696
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CCNDBP1 mRNA	PMID:21346803
1304669	Ccndbp1	cyclin D1 binding protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CCNDBP1 mRNA	PMID:23034163
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1350964	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CYB561A3 mRNA	PMID:38218311
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1615697	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CYB561A3 mRNA	PMID:39241906
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CYB561A3 mRNA	PMID:33387578
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350964	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CYB561A3 mRNA	PMID:37042841
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CYB561A3 mRNA	PMID:27523638
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CYB561A3 mRNA	PMID:33387578
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1615697	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYB561A3 mRNA	PMID:36331819
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1615697	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYB561A3 mRNA	PMID:37236586
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CYB561A3 mRNA	PMID:33354967
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1350964	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CYB561A3 mRNA	PMID:32234424
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CYB561A3 mRNA	PMID:31150632
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1350964	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYB561A3 mRNA	PMID:39836092
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1615697	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYB561A3 mRNA	PMID:40504410
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1615697	E	RGD:6480464	20260203	CTD	MESH:C024565	ethylene dichloride results in increased expression of CYB561A3 mRNA	PMID:28960355
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of CYB561A3 mRNA	PMID:19921347
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1350964	E	RGD:6480464	20260203	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CYB561A3 mRNA	PMID:27392435
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1350964	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYB561A3 mRNA	PMID:22298810
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615697	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYB561A3 mRNA	PMID:21570461
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1350964	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYB561A3 mRNA	PMID:20106945|PMID:26159488|PMID:30096437
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1350964	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CYB561A3 mRNA	PMID:33212167
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CYB561A3 mRNA	PMID:29803840
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CYB561A3 mRNA	PMID:38568856
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1615697	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of CYB561A3 mRNA	PMID:36209798
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1350964	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYB561A3 mRNA	PMID:39836092
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1615697	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYB561A3 mRNA	PMID:40504410
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1350964	E	RGD:6480464	20260203	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CYB561A3 5' UTR	PMID:27901495
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1350964	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYB561A3 mRNA	PMID:20106945
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CYB561A3 mRNA	PMID:34492290
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1615697	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in decreased expression of CYB561A3 mRNA	PMID:21932408
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C006780	bisphenol A results in increased expression of CYB561A3 mRNA	PMID:25181051
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CYB561A3 gene	PMID:28505145
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350964	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYB561A3 mRNA	PMID:28628672
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1615697	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CYB561A3 mRNA	PMID:39298647
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1615697	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CYB561A3 intron	PMID:28392331
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1615697	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CYB561A3 mRNA	PMID:21266533
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1615697	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CYB561A3 mRNA	PMID:34813904
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1350964	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYB561A3 mRNA	PMID:28628672
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1615697	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CYB561A3 mRNA	PMID:34813904
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350964	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CYB561A3 mRNA	PMID:37042841
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of CYB561A3 mRNA	PMID:35163327
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CYB561A3 mRNA	PMID:38174414
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1615697	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYB561A3 mRNA	PMID:37236586
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1615697	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CYB561A3 mRNA	PMID:18353800
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1615697	E	RGD:6480464	20141111	CTD	MESH:D002994	Clofibrate results in decreased expression of CYB561A3 mRNA	PMID:23811191
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CYB561A3 mRNA	PMID:32588087
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CYB561A3 mRNA	PMID:31533062
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20200915	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CYB561A3 mRNA	PMID:32588087
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1615697	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYB561A3 mRNA	PMID:36331819
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1350964	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CYB561A3 gene	PMID:29154799
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of CYB561A3 mRNA	PMID:41580965
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CYB561A3 mRNA	PMID:20106945|PMID:25562108
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1350964	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYB561A3 mRNA	PMID:28628672
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1350964	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CYB561A3 mRNA	PMID:22230336
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1350964	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYB561A3 mRNA	PMID:39836092
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1615697	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYB561A3 mRNA	PMID:40504410
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1350964	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYB561A3 mRNA	PMID:28628672
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615697	E	RGD:6480464	20260203	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CYB561A3 mRNA; Nanotubes, Carbon results in decreased expression of CYB561A3 mRNA	PMID:25554681
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1615697	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CYB561A3 mRNA	PMID:35964746
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CYB561A3 mRNA	PMID:28988120
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of CYB561A3 mRNA	PMID:31734321
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CYB561A3 mRNA	PMID:21346803
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CYB561A3 mRNA	PMID:38568856
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CYB561A3 mRNA	PMID:29301935
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1350964	E	RGD:6480464	20260203	CTD	MESH:C057693	Troglitazone results in decreased expression of CYB561A3 mRNA	PMID:25572481
1304670	Cyb561a3	cytochrome b561 family, member A3	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CYB561A3 mRNA	PMID:19015723
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1312249	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of SNAPC1 protein	PMID:36641056
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312249	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SNAPC1 mRNA	PMID:33167477
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312249	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SNAPC1 mRNA	PMID:24236059|PMID:26516004
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312249	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SNAPC1 mRNA	PMID:21179406
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312249	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of SNAPC1 mRNA	PMID:29581250
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312249	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SNAPC1 mRNA	PMID:31614463
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312249	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SNAPC1 mRNA	PMID:21592394
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312249	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SNAPC1 mRNA	PMID:21592394
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312250	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNAPC1 mRNA	PMID:34319233
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312249	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SNAPC1 mRNA	PMID:21592394
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312249	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SNAPC1 mRNA	PMID:21592394
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SNAPC1 mRNA	PMID:33387578
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D007501	Iron deficiency results in increased expression of SNAPC1 mRNA	PMID:16629162
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312250	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNAPC1 mRNA	PMID:37236586
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312249	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SNAPC1 mRNA	PMID:19549813
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312249	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SNAPC1 protein	PMID:20106945
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312250	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SNAPC1 mRNA	PMID:25629700
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312249	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SNAPC1 mRNA	PMID:32525701
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312249	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SNAPC1 mRNA	PMID:27392435
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312249	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SNAPC1 mRNA	PMID:27392435
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312250	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNAPC1 mRNA	PMID:21570461
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312249	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SNAPC1 mRNA	PMID:28001369
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312249	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNAPC1 mRNA	PMID:33212167
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:28358	rac-lactic acid	affects expression	ISO	RGD:1312249	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of SNAPC1 mRNA	PMID:30851411
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:28748	doxorubicin	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of SNAPC1 gene	PMID:28962528
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312249	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SNAPC1 promoter	PMID:27901495
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312250	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNAPC1 mRNA	PMID:22228805
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312249	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SNAPC1 mRNA	PMID:26014281
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312249	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SNAPC1 mRNA	PMID:19150397|PMID:20018196
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SNAPC1 mRNA	PMID:30047161
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312250	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SNAPC1 mRNA	PMID:29264374
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312250	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNAPC1 gene; titanium dioxide results in decreased methylation of SNAPC1 promoter	PMID:35295148
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SNAPC1 mRNA	PMID:23411599
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312250	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SNAPC1 mRNA	PMID:19710929
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312250	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SNAPC1 mRNA	PMID:26063408
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNAPC1 mRNA	PMID:25181051
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:3423	carmustine	increases expression	ISO	RGD:1312249	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of SNAPC1 mRNA	PMID:15980968
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1312249	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of SNAPC1 mRNA	PMID:17312168
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312249	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SNAPC1 mRNA	PMID:38382870
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312250	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNAPC1 mRNA	PMID:37236586
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SNAPC1 mRNA	PMID:30047161
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312250	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SNAPC1 mRNA	PMID:17292431
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312249	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SNAPC1 mRNA	PMID:28001369|PMID:29154799
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SNAPC1 mRNA	PMID:30047161
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312249	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SNAPC1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of SNAPC1 mRNA	PMID:36653537
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:45863	paclitaxel	increases response to substance	ISO	RGD:1312249	E	RGD:6480464	20161213	CTD	MESH:D017239	SNAPC1 protein results in increased susceptibility to Paclitaxel	PMID:16734730
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNAPC1 mRNA	PMID:33387578
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1312249	E	RGD:6480464	20120501	CTD	MESH:D005472	Fluorouracil results in decreased expression of SNAPC1 protein	PMID:15585135|PMID:16803524
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312249	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SNAPC1 mRNA	PMID:18687144
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312249	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SNAPC1 mRNA	PMID:32525701
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312250	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SNAPC1 mRNA	PMID:35436446
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1312249	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of SNAPC1 mRNA	PMID:23228038
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312250	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SNAPC1 mRNA	PMID:25554681
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SNAPC1 mRNA	PMID:30047161
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1312249	E	RGD:6480464	20120412	CTD	MESH:D019772	SNAPC1 protein affects the susceptibility to Topotecan	PMID:16217747
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312249	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SNAPC1 mRNA	PMID:28988120
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312250	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNAPC1 mRNA	PMID:22206623
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	ISO	RGD:1312249	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of SNAPC1 mRNA	PMID:30851411
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312249	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SNAPC1 mRNA	PMID:30928695
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312249	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SNAPC1 gene]	PMID:28238834
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312249	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SNAPC1 mRNA	PMID:19159669
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of SNAPC1 mRNA	PMID:16629162
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312249	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SNAPC1 mRNA	PMID:32525701
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312249	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SNAPC1 mRNA	PMID:26014281
1304671	Snapc1	small nuclear RNA activating complex, polypeptide 1	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1312249	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of SNAPC1 mRNA	PMID:17440010
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:2306471	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CASTOR2 mRNA	PMID:38218311
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312251	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CASTOR2 mRNA	PMID:33045310
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:2306471	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GATSL2 mRNA	PMID:33167477
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312251	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CASTOR2 mRNA	PMID:30529165
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312251	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CASTOR2 mRNA	PMID:30319688
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312251	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CASTOR2 mRNA	PMID:39241906
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:2306471	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of CASTOR2 mRNA	PMID:31614463
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:2306471	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of CASTOR2 mRNA	PMID:23019147
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:2306471	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CASTOR2 mRNA	PMID:38568856
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:2306471	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CASTOR2 mRNA	PMID:37042841
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CASTOR2 mRNA	PMID:33387578
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:2306471	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CASTOR2 mRNA	PMID:28818685
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GATSL2 mRNA	PMID:39012411
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312251	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASTOR2 mRNA	PMID:37236586
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312251	E	RGD:6480464	20180828	CTD	MESH:D019327	Copper Sulfate results in increased expression of CASTOR2 mRNA	PMID:18579281
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CASTOR2 mRNA	PMID:30779732
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D019833	Genistein results in increased methylation of CASTOR2 gene	PMID:28505145
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CASTOR2 mRNA	PMID:33387578
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312251	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CASTOR2 mRNA	PMID:28922406
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:2306471	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CASTOR2 mRNA	PMID:30851411
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CASTOR2 mRNA	PMID:26033743
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CASTOR2 mRNA	PMID:26033743
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:2306471	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CASTOR2 mRNA	PMID:29803840
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312251	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CASTOR2 mRNA	PMID:37682722
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:2306471	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of CASTOR2 mRNA; sodium arsenite results in increased expression of CASTOR2 protein	PMID:34032870|PMID:38568856|PMID:39571964
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312251	E	RGD:6480464	20180828	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CASTOR2 mRNA	PMID:22228805
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:2306471	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CASTOR2 promoter	PMID:27901495
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312251	E	RGD:6480464	20180828	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CASTOR2 mRNA]	PMID:22228805
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CASTOR2 mRNA	PMID:26033743
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CASTOR2 mRNA	PMID:26033743
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312251	E	RGD:6480464	20180828	CTD	MESH:D012834	Silver results in decreased expression of CASTOR2 mRNA	PMID:27131904
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312251	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of GATSL2 promoter	PMID:35295148
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150324	CTD	MESH:C006780	bisphenol A affects the expression of CASTOR2 mRNA	PMID:25181051
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CASTOR2 mRNA	PMID:30816183|PMID:32528016
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312251	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CASTOR2 intron	PMID:28392331
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312251	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of GATSL2 mRNA	PMID:36117858
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of CASTOR2 gene	PMID:33148267
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:2306471	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CASTOR2 mRNA	PMID:37042841
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GATSL2 mRNA	PMID:39012411
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312251	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASTOR2 mRNA	PMID:37236586
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312251	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CASTOR2 mRNA	PMID:40194260
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312251	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CASTOR2 mRNA	PMID:28973697
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:2306471	E	RGD:6480464	20180828	CTD	MESH:C012589	trichostatin A affects the expression of CASTOR2 mRNA	PMID:28542535
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CASTOR2 mRNA	PMID:33387578
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CASTOR2 mRNA	PMID:29097150
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312251	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of GATSL2 mRNA	PMID:36117858
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:53620	methylisothiazolinone	decreases expression	ISO	RGD:2306471	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of CASTOR2 mRNA	PMID:31629900
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of CASTOR2 gene	PMID:33148267
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312251	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GATSL2 mRNA	PMID:22206623
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:756996	imeglimin	decreases expression	ISO	RGD:1312251	E	RGD:6480464	20260714	CTD	MESH:C575881	imeglimin results in decreased expression of CASTOR2 mRNA	PMID:40713970
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:2306471	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CASTOR2 mRNA	PMID:30851411
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150324	CTD	MESH:D011441	Propylthiouracil results in increased expression of CASTOR2 mRNA	PMID:24780913
1304672	Castor2	cytosolic arginine sensor for mTORC1 subunit 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312251	E	RGD:6480464	20180828	CTD	MESH:D012834	Silver results in decreased expression of CASTOR2 mRNA	PMID:27131904
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312256	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PLCH2 mRNA	PMID:37995155
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1346590	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLCH2 mRNA	PMID:29432896
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLCH2 mRNA	PMID:25510870
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PLCH2 mRNA	PMID:33387578
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312256	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PLCH2 mRNA	PMID:34319233
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of PLCH2 mRNA	PMID:31606821
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1346590	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PLCH2 mRNA	PMID:28818685
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1346590	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PLCH2 3' UTR	PMID:30157460
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLCH2 mRNA	PMID:25510870
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLCH2 mRNA	PMID:25510870
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346590	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PLCH2 intron	PMID:30157460
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1346590	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PLCH2 3' UTR	PMID:30157460
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1312256	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of PLCH2 mRNA	PMID:18579281
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLCH2 mRNA	PMID:22206623
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312256	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PLCH2 mRNA	PMID:28960355
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLCH2 mRNA	PMID:32109520
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1346590	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PLCH2 mRNA	PMID:30851411
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:1312256	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in increased expression of PLCH2 mRNA	PMID:18579281
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1346590	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PLCH2 mRNA	PMID:32763439
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1346590	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLCH2 mRNA	PMID:29432896
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312256	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PLCH2 mRNA	PMID:37682722
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346590	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PLCH2 mRNA	PMID:38568856|PMID:39719251
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346590	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PLCH2 promoter	PMID:27901495
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312256	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of PLCH2 mRNA	PMID:33053406
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1346590	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PLCH2 mRNA]	PMID:32406909
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1346590	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PLCH2 mRNA	PMID:25895662
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1346590	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of PLCH2 mRNA	PMID:37690743
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1346590	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PLCH2 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of PLCH2 gene	PMID:31601247
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312256	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLCH2 gene	PMID:35295148
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312256	E	RGD:6480464	20160607	CTD	MESH:C006780	bisphenol A affects the expression of PLCH2 mRNA	PMID:27082013
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312256	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PLCH2 mRNA	PMID:32156529
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312256	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of PLCH2 promoter	PMID:27312807
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20160607	CTD	MESH:C006780	[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of PLCH2 mRNA]	PMID:27082013
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346590	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PLCH2 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PLCH2 mRNA	PMID:28628672|PMID:31601247
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLCH2 mRNA	PMID:25510870
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLCH2 mRNA	PMID:25510870
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312256	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PLCH2 gene	PMID:31683443
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312256	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PLCH2 exon	PMID:33297965
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1346590	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of PLCH2 gene	PMID:31601247
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1346590	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PLCH2 intron	PMID:30157460
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1346590	E	RGD:6480464	20180116	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of PLCH2 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PLCH2 mRNA	PMID:28628672|PMID:31601247
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1346590	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PLCH2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PLCH2 mRNA	PMID:28628672
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PLCH2 mRNA	PMID:32680482
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1346590	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of PLCH2 mRNA	PMID:29024780
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLCH2 mRNA	PMID:35163327
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLCH2 mRNA	PMID:35163327
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of PLCH2 mRNA	PMID:30047161
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:38211	potassium bromate	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20160607	CTD	MESH:C019536	[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of PLCH2 mRNA]	PMID:27082013
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312256	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PLCH2 mRNA	PMID:40194260
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PLCH2 mRNA	PMID:29427782
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1346590	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PLCH2 gene	PMID:29154799
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PLCH2 mRNA	PMID:30047161
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1346590	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of PLCH2 promoter	PMID:27989131
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346590	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PLCH2 mRNA	PMID:25562108
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1346590	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PLCH2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PLCH2 mRNA	PMID:28628672
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1346590	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of PLCH2 mRNA	PMID:31838189
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1346590	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of PLCH2 mRNA	PMID:18175754
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1346590	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PLCH2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PLCH2 mRNA	PMID:28628672
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312256	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PLCH2 mRNA; Nanotubes, Carbon results in decreased expression of PLCH2 mRNA	PMID:25554681
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PLCH2 mRNA	PMID:30047161
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:507499	tricetin	increases expression	ISO	RGD:1346590	E	RGD:6480464	20240903	CTD	MESH:C469689	tricetin results in increased expression of PLCH2 mRNA	PMID:38654487
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:51081	nitrates	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in increased expression of PLCH2 mRNA	PMID:30022042
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312256	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of PLCH2 mRNA	PMID:26377693
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1346590	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PLCH2 intron	PMID:30157460
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PLCH2 gene	PMID:35440735
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	decreases expression	ISO	RGD:1346590	E	RGD:6480464	20161025	CTD	MESH:D003671	DEET results in decreased expression of PLCH2 mRNA	PMID:27091632
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLCH2 mRNA	PMID:22206623
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:756028	mivebresib	decreases expression	ISO	RGD:1346590	E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of PLCH2 mRNA	PMID:35486664
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1346590	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PLCH2 mRNA	PMID:30851411
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLCH2 mRNA	PMID:30047161
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1312256	E	RGD:6480464	20250401	CTD	MESH:D013311	Streptozocin results in increased expression of PLCH2 mRNA	PMID:31606821
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312256	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of PLCH2 mRNA	PMID:31606821
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1346590	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PLCH2 mRNA	PMID:29301935
1304675	Plch2	phospholipase C, eta 2	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312256	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PLCH2 mRNA	PMID:32835833
1304676	Tollip	toll interacting protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312258	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TOLLIP mRNA	PMID:33045310
1304676	Tollip	toll interacting protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312258	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TOLLIP mRNA	PMID:20188158
1304676	Tollip	toll interacting protein	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312257	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TOLLIP mRNA	PMID:26079696
1304676	Tollip	toll interacting protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312258	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TOLLIP mRNA	PMID:30319688
1304676	Tollip	toll interacting protein	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312258	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased expression of TOLLIP protein	PMID:23353651
1304676	Tollip	toll interacting protein	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20161213	CTD	MESH:D011794	TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of RELA protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CD80 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CD86 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of NFKBIA protein]]	PMID:23353651
1304676	Tollip	toll interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TOLLIP mRNA	PMID:39241906
1304676	Tollip	toll interacting protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TOLLIP mRNA	PMID:39298647
1304676	Tollip	toll interacting protein	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TOLLIP mRNA	PMID:23829299
1304676	Tollip	toll interacting protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312257	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TOLLIP mRNA	PMID:37042841
1304676	Tollip	toll interacting protein	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of TOLLIP mRNA	PMID:38160208
1304676	Tollip	toll interacting protein	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of TOLLIP mRNA	PMID:21669218
1304676	Tollip	toll interacting protein	gene	CHEBI:17627	ferroheme b	increases expression	ISO	RGD:1312258	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in increased expression of TOLLIP mRNA	PMID:19191707
1304676	Tollip	toll interacting protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TOLLIP mRNA	PMID:33387578
1304676	Tollip	toll interacting protein	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TOLLIP mRNA	PMID:36331819
1304676	Tollip	toll interacting protein	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA	PMID:39836092
1304676	Tollip	toll interacting protein	gene	CHEBI:195250	corn oil	increases expression	ISO	RGD:1312258	E	RGD:6480464	20230704	CTD	MESH:D003314	Corn Oil results in increased expression of TOLLIP mRNA	PMID:33263755
1304676	Tollip	toll interacting protein	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312258	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of TOLLIP mRNA	PMID:27462272
1304676	Tollip	toll interacting protein	gene	CHEBI:211551	TMC-120A	increases expression	ISO	RGD:1312258	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in increased expression of TOLLIP mRNA	PMID:19818335
1304676	Tollip	toll interacting protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TOLLIP protein	PMID:23301498
1304676	Tollip	toll interacting protein	gene	CHEBI:24828	indoles	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in decreased expression of TOLLIP mRNA	PMID:20521778
1304676	Tollip	toll interacting protein	gene	CHEBI:24828	indoles	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in increased expression of TOLLIP mRNA	PMID:20521778
1304676	Tollip	toll interacting protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312257	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TOLLIP promoter	PMID:30157460
1304676	Tollip	toll interacting protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TOLLIP mRNA	PMID:35430440
1304676	Tollip	toll interacting protein	gene	CHEBI:26355	heme b	increases expression	ISO	RGD:1312258	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in increased expression of TOLLIP mRNA	PMID:19191707
1304676	Tollip	toll interacting protein	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of TOLLIP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TOLLIP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of TOLLIP protein	PMID:38598786
1304676	Tollip	toll interacting protein	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312257	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TOLLIP gene	PMID:25304211
1304676	Tollip	toll interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOLLIP mRNA	PMID:39836092
1304676	Tollip	toll interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312258	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TOLLIP mRNA	PMID:21570461
1304676	Tollip	toll interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TOLLIP mRNA	PMID:25975270
1304676	Tollip	toll interacting protein	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of TOLLIP protein	PMID:35544339
1304676	Tollip	toll interacting protein	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312257	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TOLLIP mRNA	PMID:33212167
1304676	Tollip	toll interacting protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312257	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TOLLIP mRNA	PMID:32763439
1304676	Tollip	toll interacting protein	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D004317	[Doxorubicin co-treated with Fungal Polysaccharides] results in decreased expression of TOLLIP mRNA	PMID:27181935
1304676	Tollip	toll interacting protein	gene	CHEBI:28783	zinc protoporphyrin	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C017803	zinc protoporphyrin results in decreased expression of TOLLIP protein	PMID:25780291
1304676	Tollip	toll interacting protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TOLLIP mRNA	PMID:21911445|PMID:31233874
1304676	Tollip	toll interacting protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312257	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TOLLIP mRNA	PMID:38568856
1304676	Tollip	toll interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOLLIP mRNA	PMID:39836092
1304676	Tollip	toll interacting protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312257	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TOLLIP 3' UTR; Benzo(a)pyrene affects the methylation of TOLLIP intron	PMID:27901495|PMID:30157460
1304676	Tollip	toll interacting protein	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312257	E	RGD:6480464	20121009	CTD	MESH:D012834	Silver results in increased expression of TOLLIP mRNA	PMID:22342292
1304676	Tollip	toll interacting protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312257	E	RGD:6480464	20120717	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TOLLIP mRNA	PMID:19428942
1304676	Tollip	toll interacting protein	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TOLLIP gene	PMID:31601247
1304676	Tollip	toll interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312257	E	RGD:6480464	20121009	CTD	MESH:C009495	titanium dioxide results in decreased expression of TOLLIP mRNA	PMID:22342292
1304676	Tollip	toll interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312258	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TOLLIP gene; titanium dioxide results in decreased methylation of TOLLIP promoter	PMID:35295148
1304676	Tollip	toll interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TOLLIP mRNA	PMID:34492290
1304676	Tollip	toll interacting protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312258	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of TOLLIP mRNA	PMID:18648102
1304676	Tollip	toll interacting protein	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20251202	CTD	MESH:D009585	TOLLIP gene SNP results in increased susceptibility to [Air Pollutants results in increased abundance of Nitrogen Dioxide]	PMID:39009092
1304676	Tollip	toll interacting protein	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TOLLIP mRNA	PMID:19167457
1304676	Tollip	toll interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TOLLIP mRNA	PMID:25181051
1304676	Tollip	toll interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312257	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of TOLLIP protein	PMID:31675489|PMID:34186270
1304676	Tollip	toll interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312257	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of TOLLIP mRNA	PMID:29275510
1304676	Tollip	toll interacting protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TOLLIP mRNA	PMID:36041667
1304676	Tollip	toll interacting protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TOLLIP gene	PMID:31601247
1304676	Tollip	toll interacting protein	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312257	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of TOLLIP protein	PMID:31675489
1304676	Tollip	toll interacting protein	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312257	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TOLLIP mRNA	PMID:25979313
1304676	Tollip	toll interacting protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of TOLLIP mRNA	PMID:23829299
1304676	Tollip	toll interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TOLLIP mRNA	PMID:39298647
1304676	Tollip	toll interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TOLLIP mRNA	PMID:36041667
1304676	Tollip	toll interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312257	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TOLLIP protein	PMID:34186270
1304676	Tollip	toll interacting protein	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TOLLIP mRNA	PMID:36041667
1304676	Tollip	toll interacting protein	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312257	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TOLLIP protein	PMID:34186270
1304676	Tollip	toll interacting protein	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20230404	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of TOLLIP protein	PMID:36543318
1304676	Tollip	toll interacting protein	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20230404	CTD	MESH:D016264	7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in decreased expression of TOLLIP protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in decreased expression of TOLLIP protein]	PMID:36543318
1304676	Tollip	toll interacting protein	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of TOLLIP protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of TOLLIP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TOLLIP protein	PMID:38598786
1304676	Tollip	toll interacting protein	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D010269	Paraquat results in increased expression of TOLLIP protein	PMID:24521700
1304676	Tollip	toll interacting protein	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312258	E	RGD:6480464	20220111	CTD	MESH:D010269	Paraquat results in increased expression of TOLLIP mRNA; Paraquat results in increased expression of TOLLIP protein	PMID:33838153
1304676	Tollip	toll interacting protein	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20220111	CTD	MESH:D010269	rhyncophylline promotes the reaction [Paraquat results in increased expression of TOLLIP mRNA]; rhyncophylline promotes the reaction [Paraquat results in increased expression of TOLLIP protein]; TOLLIP protein promotes the reaction [rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein]]	PMID:33838153
1304676	Tollip	toll interacting protein	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA	PMID:39836092
1304676	Tollip	toll interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TOLLIP mRNA	PMID:33453195
1304676	Tollip	toll interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312257	E	RGD:6480464	20211207	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TOLLIP mRNA	PMID:33129824
1304676	Tollip	toll interacting protein	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312257	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TOLLIP mRNA	PMID:31533062
1304676	Tollip	toll interacting protein	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312258	E	RGD:6480464	20260303	CTD	MESH:C473478	Sunitinib results in increased expression of TOLLIP protein	PMID:40449751
1304676	Tollip	toll interacting protein	gene	CHEBI:38940	sunitinib	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20260303	CTD	MESH:C473478	2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of TOLLIP protein]; N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of TOLLIP protein]]	PMID:40449751
1304676	Tollip	toll interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TOLLIP mRNA	PMID:36331819
1304676	Tollip	toll interacting protein	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of TOLLIP mRNA	PMID:23125180
1304676	Tollip	toll interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312258	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TOLLIP mRNA	PMID:17562736
1304676	Tollip	toll interacting protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TOLLIP mRNA	PMID:33387578
1304676	Tollip	toll interacting protein	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312257	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TOLLIP mRNA	PMID:20977926
1304676	Tollip	toll interacting protein	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1312257	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of TOLLIP mRNA	PMID:21148743
1304676	Tollip	toll interacting protein	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312257	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TOLLIP gene	PMID:25304211
1304676	Tollip	toll interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOLLIP mRNA	PMID:39836092
1304676	Tollip	toll interacting protein	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312257	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of TOLLIP mRNA	PMID:31675489
1304676	Tollip	toll interacting protein	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TOLLIP mRNA	PMID:29391264
1304676	Tollip	toll interacting protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TOLLIP mRNA	PMID:35436446
1304676	Tollip	toll interacting protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312258	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TOLLIP mRNA; Nanotubes, Carbon results in increased expression of TOLLIP mRNA	PMID:25554681|PMID:25620056
1304676	Tollip	toll interacting protein	gene	CHEBI:50834	cadmium selenide	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20121009	CTD	MESH:C058667	[cadmium selenide co-treated with zinc sulfide] results in increased expression of TOLLIP mRNA	PMID:22342292
1304676	Tollip	toll interacting protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TOLLIP mRNA	PMID:35964746
1304676	Tollip	toll interacting protein	gene	CHEBI:53509	erlotinib hydrochloride	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20180313	CTD	MESH:D000069347	[Erlotinib Hydrochloride results in decreased susceptibility to Erlotinib Hydrochloride] which results in increased expression of TOLLIP mRNA	PMID:27738319
1304676	Tollip	toll interacting protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312257	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TOLLIP protein	PMID:32959892
1304676	Tollip	toll interacting protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA	PMID:39836092
1304676	Tollip	toll interacting protein	gene	CHEBI:63948	trimethyltin	increases expression	ISO	RGD:1312258	E	RGD:6480464	20121113	CTD	MESH:C046488	trimethyltin results in increased expression of TOLLIP mRNA	PMID:21435392
1304676	Tollip	toll interacting protein	gene	CHEBI:6775	mesalamine	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20230404	CTD	MESH:D019804	Mesalamine inhibits the reaction [Dextran Sulfate results in decreased expression of TOLLIP protein]	PMID:36543318
1304676	Tollip	toll interacting protein	gene	CHEBI:68794	neoechinulin A	increases expression	ISO	RGD:1312258	E	RGD:6480464	20170228	CTD	MESH:C490266	neoechinulin A results in increased expression of TOLLIP mRNA	PMID:19818335
1304676	Tollip	toll interacting protein	gene	CHEBI:70069	Rhynchophylline	increases expression	ISO	RGD:1312258	E	RGD:6480464	20220111	CTD	MESH:C052714	rhyncophylline results in increased expression of TOLLIP mRNA; rhyncophylline results in increased expression of TOLLIP protein	PMID:33838153
1304676	Tollip	toll interacting protein	gene	CHEBI:70069	Rhynchophylline	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20220111	CTD	MESH:C052714	rhyncophylline promotes the reaction [Paraquat results in increased expression of TOLLIP mRNA]; rhyncophylline promotes the reaction [Paraquat results in increased expression of TOLLIP protein]; TOLLIP protein promotes the reaction [rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein]]	PMID:33838153
1304676	Tollip	toll interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TOLLIP mRNA	PMID:22206623
1304676	Tollip	toll interacting protein	gene	CHEBI:79089	ceric oxide	decreases expression	ISO	RGD:1312257	E	RGD:6480464	20150310	CTD	MESH:C030583	ceric oxide analog results in decreased expression of TOLLIP mRNA	PMID:24821434
1304676	Tollip	toll interacting protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312258	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TOLLIP mRNA	PMID:23091169
1304676	Tollip	toll interacting protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312257	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TOLLIP protein	PMID:31675489
1304676	Tollip	toll interacting protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of TOLLIP mRNA	PMID:38995820
1304676	Tollip	toll interacting protein	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312257	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of TOLLIP protein	PMID:31675489
1304676	Tollip	toll interacting protein	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312257	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of TOLLIP mRNA	PMID:26079696
1304676	Tollip	toll interacting protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312258	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TOLLIP mRNA	PMID:39847705
1304676	Tollip	toll interacting protein	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20251202	CTD	MESH:D011070	TOLLIP affects the reaction [[[Vehicle Emissions results in increased abundance of Particulate Matter] which co-treated with Poly I-C] results in increased secretion of CXCL8 protein]	PMID:39009092
1304676	Tollip	toll interacting protein	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of TOLLIP mRNA	PMID:21278054
1304676	Tollip	toll interacting protein	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312257	E	RGD:6480464	20121009	CTD	MESH:D012834	Silver results in increased expression of TOLLIP mRNA	PMID:22342292
1304676	Tollip	toll interacting protein	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312257	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TOLLIP mRNA	PMID:38568856
1304676	Tollip	toll interacting protein	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312257	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of TOLLIP mRNA	PMID:29301935
1304676	Tollip	toll interacting protein	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312257	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of TOLLIP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of TOLLIP protein	PMID:38598786
1304676	Tollip	toll interacting protein	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of TOLLIP mRNA	PMID:19015723
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312260	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PANK1 mRNA	PMID:33045310
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20171010	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PANK1 mRNA	PMID:28558994
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PANK1 mRNA]	PMID:31150632
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PANK1 mRNA	PMID:39752319
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:134964	perflubutane	increases expression	ISO	RGD:1312259	E	RGD:6480464	20170307	CTD	MESH:C108042	perfluorobutane results in increased expression of PANK1 mRNA	PMID:23567314
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PANK1 mRNA	PMID:33167477
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:15379	dioxygen	affects expression	ISO	RGD:1312259	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency affects the expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PANK1 mRNA	PMID:30529165
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PANK1 mRNA	PMID:36841081
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PANK1 mRNA	PMID:21632981
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312260	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of PANK1 mRNA	PMID:39298647
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of PANK1 mRNA	PMID:20106945
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of PANK1 mRNA	PMID:19484750
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PANK1 mRNA	PMID:32741896
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20130312	CTD	MESH:D005557	Formaldehyde results in decreased expression of PANK1 mRNA	PMID:20655997|PMID:23416264
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312259	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PANK1 mRNA	PMID:23649840
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312259	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PANK1 mRNA	PMID:21179406
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PANK1 mRNA	PMID:39752319
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1312260	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of PANK1 mRNA	PMID:17178593
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PANK1 mRNA	PMID:32741896
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312259	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PANK1 protein	PMID:37730182
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PANK1 mRNA	PMID:33387578
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PANK1 mRNA	PMID:28818685
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1312260	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of PANK1 mRNA	PMID:33914522
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1312260	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of PANK1 mRNA	PMID:17178593
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of PANK1 mRNA	PMID:34773240
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312259	E	RGD:6480464	20251007	CTD	MESH:D002104	Selenium inhibits the reaction [Cadmium results in decreased expression of PANK1 mRNA]	PMID:34773240
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PANK1 mRNA	PMID:19549813
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312259	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PANK1 mRNA	PMID:23649840
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PANK1 mRNA	PMID:27153756
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PANK1 mRNA	PMID:19770486
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312259	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PANK1 gene	PMID:27153756
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312259	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PANK1 mRNA	PMID:23649840
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PANK1 mRNA	PMID:31150632
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PANK1 mRNA	PMID:27339419|PMID:31919559
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PANK1 mRNA]	PMID:31150632
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PANK1 mRNA	PMID:25629700
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1312259	E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased methylation of PANK1 gene	PMID:24525453
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK1 mRNA	PMID:32045263
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312259	E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of PANK1 mRNA]	PMID:34773240
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1312259	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of PANK1 mRNA	PMID:38460933
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1312259	E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of PANK1 mRNA	PMID:38460933
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312259	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PANK1 mRNA	PMID:38460933
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PANK1 mRNA	PMID:31881176
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312259	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PANK1 mRNA	PMID:27392435
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312259	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PANK1 mRNA	PMID:27392435
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of PANK1 mRNA	PMID:18930951
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PANK1 mRNA	PMID:32186404
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PANK1 mRNA	PMID:24768652|PMID:25583101
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PANK1 mRNA	PMID:22298810
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312260	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PANK1 mRNA	PMID:21570461
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PANK1 mRNA	PMID:21215274|PMID:21724226|PMID:33387578
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PANK1 mRNA	PMID:17942748
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312260	E	RGD:6480464	20230905	CTD	MESH:D012402	Rotenone results in increased expression of PANK1 mRNA alternative form	PMID:35589691
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20230905	CTD	MESH:D012402	PANK1 mRNA alternative form affects the reaction [Rotenone results in decreased expression of TH protein]; PANK1 mRNA alternative form affects the reaction [Rotenone results in increased expression of SNCA mRNA]; PANK1 mRNA alternative form affects the reaction [Rotenone results in increased expression of SNCA protein]	PMID:35589691
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PANK1 mRNA	PMID:33212167
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1312260	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of PANK1 mRNA	PMID:17178593
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312259	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PANK1 protein	PMID:35688186
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of PANK1 mRNA	PMID:22623647
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PANK1 mRNA	PMID:38568856|PMID:39719251
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20220208	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK1 mRNA	PMID:32045263
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of PANK1 mRNA	PMID:17127020
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PANK1 mRNA	PMID:32234424
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312259	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PANK1 promoter	PMID:27901495
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PANK1 mRNA]	PMID:22228805
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of PANK1 mRNA	PMID:26014281
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PANK1 mRNA	PMID:19073995
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:31175	adefovir pivoxil	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in decreased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PANK1 mRNA	PMID:24136188
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PANK1 mRNA	PMID:29264374
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312260	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PANK1 promoter	PMID:35295148
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PANK1 mRNA	PMID:34492290
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PANK1 mRNA	PMID:16707586
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PANK1 mRNA	PMID:17426115|PMID:18301758|PMID:23811191
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312259	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PANK1 mRNA	PMID:19710929
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1312260	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of PANK1 mRNA	PMID:33914522
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PANK1 mRNA	PMID:32156529|PMID:37894381
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PANK1 mRNA	PMID:25181051
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312260	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PANK1 mRNA	PMID:33221593
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PANK1 mRNA	PMID:39298647
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PANK1 mRNA	PMID:28392331
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PANK1 mRNA	PMID:37019170
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of PANK1 mRNA	PMID:35093514
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of PANK1 mRNA	PMID:22110744
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PANK1 mRNA	PMID:32680482
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312259	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PANK1 mRNA	PMID:37042841
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PANK1 mRNA	PMID:28511854
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PANK1 mRNA	PMID:28558994
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PANK1 mRNA	PMID:24386269
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of PANK1 mRNA	PMID:28962523
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312259	E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of PANK1 mRNA]	PMID:34773240
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312260	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of PANK1 mRNA	PMID:23811191
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PANK1 mRNA	PMID:28558994
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:38397	perfluorononanoic acid	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20220111	CTD	MESH:C101816	PPARA protein affects the reaction [perfluoro-n-nonanoic acid results in increased expression of PANK1 mRNA]	PMID:28558994
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312259	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PANK1 mRNA	PMID:31533062
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20171010	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PANK1 mRNA	PMID:28558994
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312259	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PANK1 mRNA	PMID:25979313
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PANK1 mRNA	PMID:17963808
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PANK1 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of PANK1 mRNA	PMID:21427059
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312259	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PANK1 gene	PMID:29154799
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of PANK1 mRNA	PMID:38685447|PMID:41580965
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PANK1 mRNA	PMID:20106945|PMID:25562108|PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312260	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PANK1 mRNA	PMID:28973697
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PANK1 mRNA	PMID:38832940
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PANK1 mRNA	PMID:17562736
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PANK1 mRNA	PMID:33387578
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of PANK1 mRNA	PMID:29067470
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1312259	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of PANK1 mRNA	PMID:16557594
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of PANK1 mRNA	PMID:24714768|PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PANK1 mRNA	PMID:29523930
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312259	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PANK1 mRNA	PMID:38460933
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1312259	E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased methylation of PANK1 gene	PMID:24525453
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK1 mRNA	PMID:32045263
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1312260	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of PANK1 mRNA	PMID:17178593
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PANK1 mRNA	PMID:17942748
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of PANK1 mRNA	PMID:32234424
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of PANK1 mRNA	PMID:16984733
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of PANK1 mRNA	PMID:16707586|PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1312259	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of PANK1 mRNA	PMID:25572481|PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of PANK1 mRNA	PMID:25620056
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PANK1 mRNA	PMID:24136188
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of PANK1 mRNA	PMID:38685447|PMID:41580965
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of PANK1 mRNA	PMID:40234311
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PANK1 mRNA	PMID:24136188
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:5855	ibuprofen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:5855	ibuprofen	increases expression	ISO	RGD:1312259	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:5864	ifosfamide	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PANK1 protein	PMID:32959892
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PANK1 mRNA	PMID:20080153
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PANK1 mRNA	PMID:21641980
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PANK1 mRNA	PMID:24810058
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PANK1 mRNA	PMID:30467583
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PANK1 mRNA	PMID:39752319
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PANK1 mRNA	PMID:22206623
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of PANK1 mRNA	PMID:33484710
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PANK1 mRNA	PMID:32741896
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312260	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PANK1 mRNA	PMID:23091169
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312260	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PANK1 mRNA	PMID:38648751
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PANK1 mRNA	PMID:21278054
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PANK1 mRNA	PMID:39752319
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312259	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of PANK1 mRNA	PMID:26014281
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PANK1 mRNA	PMID:21346803
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of PANK1 mRNA	PMID:32835833
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in increased expression of PANK1 mRNA	PMID:25596134
1304677	Pank1	pantothenate kinase 1	gene	CHEBI:9986	vinclozolin	affects methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin affects the methylation of PANK1 gene	PMID:31682807
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312262	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GDF1 mRNA	PMID:33045310
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in increased expression of GDF1 mRNA; [bisphenol F co-treated with Tretinoin] results in increased expression of GDF1 mRNA; [bisphenol S co-treated with Tretinoin] results in increased expression of GDF1 mRNA	PMID:30951980
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1312261	E	RGD:6480464	20210810	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of GDF1 protein	PMID:33360347
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312261	E	RGD:6480464	20210810	CTD	MESH:D006861	Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of GDF1 protein]	PMID:33360347
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GDF1 mRNA	PMID:33387578
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20120522	CTD	MESH:D013739	Testosterone results in decreased expression of GDF1 mRNA	PMID:22138414
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312262	E	RGD:6480464	20120522	CTD	MESH:D013739	Testosterone results in increased expression of GDF1 mRNA	PMID:22138414
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1312261	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of GDF1 mRNA	PMID:18247414
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of GDF1 mRNA	PMID:22061828
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GDF1 mRNA	PMID:33387578
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1312261	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of GDF1 mRNA	PMID:18247414
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GDF1 mRNA	PMID:39012411
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	multiple interactions	ISO	RGD:1312261	E	RGD:6480464	20120522	CTD	MESH:D009151	TNF protein affects the reaction [Mustard Gas affects the expression of GDF1 mRNA]	PMID:16173061
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312261	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [sodium arsenite results in decreased expression of GDF1 mRNA]; Folic Acid inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]	PMID:26537450|PMID:33360347
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:27878	2-naphthylamine	increases expression	ISO	RGD:1312261	E	RGD:6480464	20120522	CTD	MESH:D015081	2-Naphthylamine results in increased expression of GDF1 mRNA	PMID:18247414
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312261	E	RGD:6480464	20120522	CTD	MESH:C059514	resveratrol results in decreased expression of GDF1 mRNA	PMID:12002526
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312261	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of GDF1 mRNA	PMID:28903495
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312261	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of GDF1 mRNA	PMID:27392435
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GDF1 mRNA	PMID:33387578
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312261	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GDF1 mRNA	PMID:29803840
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]	PMID:33360347
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1312261	E	RGD:6480464	20210810	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of GDF1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]	PMID:33360347
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C017947	sodium arsenite results in decreased expression of GDF1 mRNA; sodium arsenite results in decreased expression of GDF1 protein	PMID:33360347
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312261	E	RGD:6480464	20200804	CTD	MESH:C017947	sodium arsenite results in decreased expression of GDF1 mRNA; sodium arsenite results in decreased expression of GDF1 protein	PMID:26537450|PMID:33360347
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:C017947	Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]	PMID:33360347
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312261	E	RGD:6480464	20200804	CTD	MESH:C017947	Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]; Folic Acid inhibits the reaction [sodium arsenite results in decreased expression of GDF1 mRNA]; Folic Acid inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]; SHC1 protein affects the reaction [sodium arsenite results in decreased expression of GDF1 protein]; SHC1 protein inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]; SIRT1 protein inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]; sodium arsenite inhibits the reaction [SP1 protein binds to GDF1 promoter]; SP1 protein affects the reaction [sodium arsenite results in decreased expression of GDF1 protein]	PMID:26537450|PMID:33360347
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312261	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GDF1 promoter	PMID:27901495
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312261	E	RGD:6480464	20120522	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GDF1 mRNA	PMID:18247414
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GDF1 mRNA	PMID:29264374
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312262	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of GDF1 gene	PMID:35295148
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:33090	picene	increases expression	ISO	RGD:1312261	E	RGD:6480464	20200609	CTD	MESH:C056699	picene results in increased expression of GDF1 mRNA	PMID:32251684
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of GDF1 mRNA	PMID:26063408|PMID:30951980
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GDF1 mRNA	PMID:34947998
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in increased expression of GDF1 mRNA	PMID:30951980
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312262	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of GDF1 exon	PMID:33297965
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with LIF protein] results in decreased expression of GDF1 mRNA; [bisphenol S co-treated with Tretinoin] results in increased expression of GDF1 mRNA	PMID:30951980
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of GDF1 mRNA	PMID:30951980
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with LIF protein] results in decreased expression of GDF1 mRNA; [bisphenol F co-treated with Tretinoin] results in increased expression of GDF1 mRNA	PMID:30951980
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GDF1 mRNA	PMID:21266533
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GDF1 mRNA	PMID:21266533
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1312261	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of GDF1 mRNA	PMID:37047231
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of GDF1 mRNA	PMID:26377693
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GDF1 mRNA	PMID:39012411
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312262	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GDF1 mRNA	PMID:40194260
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312261	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GDF1 mRNA	PMID:31533062
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312261	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GDF1 gene	PMID:29154799
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:4469	(S)-amphetamine	increases expression	ISO	RGD:1312262	E	RGD:6480464	20120522	CTD	MESH:D003913	Dextroamphetamine results in increased expression of GDF1 mRNA	PMID:12205029
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:4469	(S)-amphetamine	multiple interactions	ISO	RGD:1312262	E	RGD:6480464	20120522	CTD	MESH:D003913	SOD1 inhibits the reaction [Dextroamphetamine results in increased expression of GDF1 mRNA]	PMID:12205029
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GDF1 mRNA	PMID:33387578
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1312261	E	RGD:6480464	20120522	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of GDF1 mRNA]	PMID:15016801
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GDF1 mRNA	PMID:29391264
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of GDF1 mRNA	PMID:17557909
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GDF1 mRNA; Nanotubes, Carbon results in decreased expression of GDF1 mRNA	PMID:25554681
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20120522	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of GDF1 mRNA	PMID:19042947
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of GDF1 mRNA	PMID:23608068
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:69478	cannabidiol	decreases methylation	ISO	RGD:1312262	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased methylation of GDF1 gene	PMID:33407853
1304678	Gdf1	growth differentiation factor 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of GDF1 mRNA	PMID:19015723
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312263	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of CHORDC1 mRNA; deoxynivalenol results in increased expression of CHORDC1 protein	PMID:31863870|PMID:39638853
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of CHORDC1 protein	PMID:36252740
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CHORDC1 mRNA	PMID:21551480
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312264	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CHORDC1 mRNA	PMID:37995155
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CHORDC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CHORDC1 mRNA	PMID:32699268
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312264	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CHORDC1 mRNA	PMID:24205000
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:15422	ATP	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20130514	CTD	MESH:D000255	Adenosine Triphosphate promotes the reaction [CHORDC1 protein binds to PPP5C protein]; Adenosine Triphosphate promotes the reaction [CHORDC1 protein binds to SUGT1 protein]	PMID:23184943
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:15422	ATP	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20130514	CTD	MESH:D000255	Adenosine Triphosphate binds to and affects the folding of CHORDC1 protein; Adenosine Triphosphate promotes the reaction [CHORDC1 protein binds to CHORDC1 protein]; Adenosine Triphosphate promotes the reaction [CHORDC1 protein binds to HSP90AA1 protein]; Adenosine Triphosphate promotes the reaction [ITGB1BP2 protein binds to CHORDC1 protein]	PMID:23184943
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of CHORDC1 mRNA	PMID:15282401
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of CHORDC1 mRNA	PMID:40865780
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312264	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CHORDC1 mRNA	PMID:30319688
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CHORDC1 mRNA	PMID:30319688
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CHORDC1 mRNA	PMID:21632981
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312264	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CHORDC1 mRNA	PMID:39241906
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CHORDC1 mRNA]	PMID:39241906
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312263	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CHORDC1 mRNA	PMID:20106945
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312264	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of CHORDC1 mRNA	PMID:33711761
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312263	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CHORDC1 mRNA	PMID:37042841
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:16761	ADP	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20130514	CTD	MESH:D000244	Adenosine Diphosphate binds to and affects the folding of CHORDC1 protein; Adenosine Diphosphate promotes the reaction [CHORDC1 protein binds to CHORDC1 protein]; Adenosine Diphosphate promotes the reaction [ITGB1BP2 protein binds to CHORDC1 protein]	PMID:23184943
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312263	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of CHORDC1 mRNA	PMID:18037150
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CHORDC1 mRNA	PMID:26577399
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CHORDC1 mRNA	PMID:33387578
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312263	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CHORDC1 mRNA	PMID:28818685
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA	PMID:39836092
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312263	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of CHORDC1 protein	PMID:28860664
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CHORDC1 mRNA	PMID:39012411
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312263	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CHORDC1 mRNA	PMID:19549813
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CHORDC1 protein	PMID:23301498
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of CHORDC1 mRNA	PMID:19376150
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312263	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CHORDC1 protein	PMID:20106945
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312263	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CHORDC1 mRNA	PMID:27153756
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CHORDC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CHORDC1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of CHORDC1 mRNA	PMID:32699268
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CHORDC1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of CHORDC1 protein	PMID:38598786
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CHORDC1 mRNA	PMID:18593933
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CHORDC1 mRNA	PMID:31150632
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312264	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CHORDC1 mRNA	PMID:27339419|PMID:31919559
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CHORDC1 mRNA	PMID:25629700
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1312263	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of CHORDC1 promoter	PMID:21291286
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CHORDC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA	PMID:32525701|PMID:39836092|PMID:40512198
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CHORDC1 mRNA	PMID:19244175
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CHORDC1 protein	PMID:38460933
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312263	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CHORDC1 protein	PMID:35688186
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CHORDC1 mRNA	PMID:23557933
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of CHORDC1 mRNA	PMID:27594783
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312264	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHORDC1 mRNA	PMID:21570461
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHORDC1 mRNA	PMID:21215274
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CHORDC1 mRNA	PMID:32109520|PMID:33387578
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312264	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CHORDC1 mRNA	PMID:15034205
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CHORDC1 mRNA]	PMID:15034205
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of CHORDC1 mRNA; Rotenone results in decreased expression of CHORDC1 protein	PMID:28374803|PMID:35544339
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CHORDC1 mRNA	PMID:33212167
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312263	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CHORDC1 mRNA	PMID:30851411
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA	PMID:27188386
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CHORDC1 mRNA	PMID:28959563
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312263	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CHORDC1 mRNA	PMID:32763439
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CHORDC1 mRNA	PMID:24690739
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CHORDC1 mRNA	PMID:25523186
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312263	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CHORDC1 mRNA	PMID:38568856
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA; [sodium arsenite co-treated with lead acetate] results in increased expression of CHORDC1 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CHORDC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA	PMID:38072110|PMID:39836092|PMID:40512198
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA	PMID:34876320
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA	PMID:34876320
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312263	E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CHORDC1 protein	PMID:33278487
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312264	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CHORDC1 mRNA	PMID:15034205|PMID:19770486|PMID:21569818|PMID:22228805
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of CHORDC1 mRNA]	PMID:15034205
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312263	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CHORDC1 promoter	PMID:23974009
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CHORDC1 mRNA]	PMID:32406909
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CHORDC1 mRNA	PMID:25523186
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CHORDC1 mRNA	PMID:24690739
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CHORDC1 mRNA	PMID:18593933
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312263	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of CHORDC1 mRNA	PMID:26014281|PMID:28959546
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312263	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CHORDC1 mRNA	PMID:25351596
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CHORDC1 protein]	PMID:26598702
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in increased expression of CHORDC1 protein	PMID:38072110
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CHORDC1 mRNA	PMID:16507785
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1312263	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of CHORDC1 mRNA	PMID:31745603
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CHORDC1 mRNA	PMID:23557971|PMID:29264374
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312264	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CHORDC1 gene	PMID:35295148
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CHORDC1 mRNA	PMID:23411599|PMID:34492290
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CHORDC1 mRNA	PMID:18648102
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CHORDC1 mRNA	PMID:18445702
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312264	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CHORDC1 mRNA	PMID:18301758|PMID:23811191
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CHORDC1 mRNA	PMID:30903817
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CHORDC1 mRNA	PMID:30816183
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CHORDC1 mRNA; bisphenol A results in decreased expression of CHORDC1 protein	PMID:29275510|PMID:37567409
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CHORDC1 mRNA	PMID:25181051|PMID:32145629
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of CHORDC1 mRNA	PMID:19244175
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312263	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CHORDC1 mRNA	PMID:25979313
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312264	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CHORDC1 mRNA	PMID:39298647
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312264	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CHORDC1 mRNA	PMID:38685157
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312263	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CHORDC1 protein	PMID:34186270
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CHORDC1 mRNA	PMID:28392331
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1312264	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of CHORDC1 protein	PMID:35362542
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of CHORDC1 protein]	PMID:35362542
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of CHORDC1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CHORDC1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of CHORDC1 protein	PMID:38598786
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CHORDC1 mRNA]	PMID:39241906
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312263	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHORDC1 mRNA	PMID:37042841
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA	PMID:39836092
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of CHORDC1 mRNA	PMID:26377693
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CHORDC1 mRNA	PMID:33453195
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CHORDC1 mRNA	PMID:19010381
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312263	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CHORDC1 mRNA	PMID:38568856
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CHORDC1 mRNA	PMID:39012411
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CHORDC1 mRNA	PMID:19162173
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312263	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CHORDC1 protein	PMID:26879310
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CHORDC1 mRNA	PMID:19162173
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of CHORDC1 mRNA	PMID:24386269
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312263	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of CHORDC1 mRNA	PMID:19376846
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312264	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CHORDC1 mRNA	PMID:18353800
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CHORDC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CHORDC1 mRNA	PMID:32699268
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CHORDC1 mRNA	PMID:19244175
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1312263	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of CHORDC1 protein	PMID:34122009
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CHORDC1 mRNA	PMID:28302478
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312263	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CHORDC1 mRNA	PMID:31533062
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of CHORDC1 mRNA	PMID:25993096
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CHORDC1 mRNA	PMID:17292431|PMID:17963808
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312263	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CHORDC1 gene	PMID:29154799
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312263	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CHORDC1 mRNA	PMID:29154799
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312263	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CHORDC1 mRNA	PMID:20106945|PMID:25562108
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CHORDC1 mRNA	PMID:20937368
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CHORDC1 mRNA	PMID:18502557
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CHORDC1 mRNA	PMID:24136188
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CHORDC1 mRNA	PMID:33387578
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312263	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CHORDC1 mRNA	PMID:21420995
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of CHORDC1 mRNA	PMID:24690739
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1312263	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of CHORDC1 mRNA	PMID:33725128
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CHORDC1 protein	PMID:38460933
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1312263	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of CHORDC1 promoter	PMID:21291286
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CHORDC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA	PMID:32525701|PMID:39836092|PMID:40512198
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312263	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of CHORDC1 mRNA	PMID:31838189
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1312263	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in increased expression of CHORDC1 mRNA	PMID:15711924
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA	PMID:34876320
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of CHORDC1 protein]	PMID:35362542
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1312263	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of CHORDC1 mRNA	PMID:17211630
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA	PMID:27188386
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CHORDC1 protein]	PMID:26598702
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1312264	E	RGD:6480464	20251104	CTD	MESH:C037123	cadmium sulfate results in increased expression of CHORDC1 mRNA	PMID:39152192
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CHORDC1 mRNA	PMID:25554681
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CHORDC1 mRNA	PMID:40234311
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of CHORDC1 mRNA	PMID:19162173
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CHORDC1 mRNA	PMID:35964746
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CHORDC1 mRNA	PMID:24136188
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of CHORDC1 mRNA	PMID:26377693
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312263	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of CHORDC1 mRNA	PMID:31629900
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:5613	haloperidol	increases expression	ISO	RGD:1312263	E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in increased expression of CHORDC1 protein	PMID:34122009
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CHORDC1 protein	PMID:32959892
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of CHORDC1 mRNA	PMID:20080153
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA	PMID:39836092
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CHORDC1 mRNA	PMID:24136188
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:63959	celastrol	increases expression	ISO	RGD:1312263	E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in increased expression of CHORDC1 mRNA	PMID:17010675
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312263	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CHORDC1 mRNA	PMID:28988120
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312263	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CHORDC1 mRNA	PMID:15336504
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:65954	gedunin	increases expression	ISO	RGD:1312263	E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in increased expression of CHORDC1 mRNA	PMID:17010675
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CHORDC1 mRNA	PMID:19564919
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of CHORDC1 mRNA	PMID:19564919
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312263	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CHORDC1 mRNA	PMID:31758290
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of CHORDC1 mRNA	PMID:39938710
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312263	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CHORDC1 mRNA; bisphenol AF results in increased expression of CHORDC1 protein	PMID:25912373|PMID:34186270
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of CHORDC1 mRNA	PMID:19564919
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CHORDC1 protein	PMID:37664457
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CHORDC1 mRNA	PMID:24136188
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312263	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CHORDC1 mRNA	PMID:22714537
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312263	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CHORDC1 mRNA	PMID:37199045
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312263	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CHORDC1 protein	PMID:31285264
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312263	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CHORDC1 protein	PMID:39638853
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1312263	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of CHORDC1 protein	PMID:39638853
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CHORDC1 mRNA	PMID:21346803
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312263	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CHORDC1 mRNA	PMID:30851411
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA	PMID:27188386
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:79369	elesclomol	increases expression	ISO	RGD:1312263	E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of CHORDC1 mRNA	PMID:18723479
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of CHORDC1 mRNA	PMID:19162173
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of CHORDC1 mRNA	PMID:26377693
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA	PMID:32525701
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA	PMID:34876320
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CHORDC1 mRNA	PMID:21278054
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CHORDC1 mRNA	PMID:24780913
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CHORDC1 mRNA]	PMID:39241906
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CHORDC1 protein; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA	PMID:27188386|PMID:37664457
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312263	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of CHORDC1 mRNA	PMID:26014281|PMID:28959546
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CHORDC1 mRNA	PMID:19281266
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CHORDC1 mRNA	PMID:21346803
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312263	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CHORDC1 mRNA	PMID:38568856
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312263	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CHORDC1 mRNA	PMID:29301935
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312263	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of CHORDC1 protein	PMID:38598786
1304679	Chordc1	cysteine and histidine rich domain containing 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CHORDC1 mRNA	PMID:21346803
1304680	Epha1	Eph receptor A1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of EPHA1 mRNA	PMID:38218311
1304680	Epha1	Eph receptor A1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312265	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of EPHA1 mRNA	PMID:26272509
1304680	Epha1	Eph receptor A1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1304680	Epha1	Eph receptor A1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312266	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EPHA1 mRNA	PMID:33045310
1304680	Epha1	Eph receptor A1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312265	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of EPHA1 mRNA	PMID:33167477
1304680	Epha1	Eph receptor A1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPHA1 mRNA	PMID:30529165
1304680	Epha1	Eph receptor A1	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20120412	CTD	MESH:D001280	[Atrazine co-treated with Arsenates] results in increased expression of EPHA1 mRNA	PMID:18585445
1304680	Epha1	Eph receptor A1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of EPHA1 mRNA	PMID:39298647
1304680	Epha1	Eph receptor A1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312265	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of EPHA1 mRNA	PMID:12154049
1304680	Epha1	Eph receptor A1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EPHA1 mRNA	PMID:33387578
1304680	Epha1	Eph receptor A1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312266	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of EPHA1 mRNA	PMID:39922521
1304680	Epha1	Eph receptor A1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of EPHA1 mRNA	PMID:19693291
1304680	Epha1	Eph receptor A1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312265	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of EPHA1 mRNA	PMID:21592394
1304680	Epha1	Eph receptor A1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312266	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in increased expression of EPHA1 mRNA	PMID:19693291
1304680	Epha1	Eph receptor A1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of EPHA1 mRNA	PMID:21592394
1304680	Epha1	Eph receptor A1	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of EPHA1 mRNA	PMID:17317680
1304680	Epha1	Eph receptor A1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312266	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of EPHA1 mRNA	PMID:39922521
1304680	Epha1	Eph receptor A1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312265	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of EPHA1 mRNA	PMID:21592394
1304680	Epha1	Eph receptor A1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of EPHA1 mRNA	PMID:21592394
1304680	Epha1	Eph receptor A1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EPHA1 mRNA	PMID:33387578
1304680	Epha1	Eph receptor A1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EPHA1 mRNA	PMID:28818685
1304680	Epha1	Eph receptor A1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312265	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of EPHA1 exon	PMID:30157460
1304680	Epha1	Eph receptor A1	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1312265	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of EPHA1 mRNA	PMID:12634122
1304680	Epha1	Eph receptor A1	gene	CHEBI:22727	benzopyran	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D001578	Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of and results in decreased activity of EPHA1 protein]; Benzopyrans results in increased expression of and results in increased activity of EPHA1 protein	PMID:25154877
1304680	Epha1	Eph receptor A1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EPHA1 mRNA	PMID:37236586
1304680	Epha1	Eph receptor A1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of EPHA1 mRNA	PMID:19549813
1304680	Epha1	Eph receptor A1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of EPHA1 mRNA	PMID:21396975
1304680	Epha1	Eph receptor A1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of EPHA1 mRNA	PMID:21641981|PMID:22100608|PMID:27153756
1304680	Epha1	Eph receptor A1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312265	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EPHA1 exon	PMID:30157460
1304680	Epha1	Eph receptor A1	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20150127	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of and results in decreased activity of EPHA1 protein; Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of and results in decreased activity of EPHA1 protein]	PMID:25154877
1304680	Epha1	Eph receptor A1	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of EPHA1 mRNA	PMID:30779732
1304680	Epha1	Eph receptor A1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312265	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EPHA1 gene	PMID:25304211
1304680	Epha1	Eph receptor A1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHA1 mRNA	PMID:32525701
1304680	Epha1	Eph receptor A1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20210907	CTD	MESH:D000966	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA1 protein	PMID:32076005
1304680	Epha1	Eph receptor A1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312265	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of EPHA1 protein	PMID:35688186
1304680	Epha1	Eph receptor A1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312265	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in increased expression of EPHA1 mRNA	PMID:12154049
1304680	Epha1	Eph receptor A1	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of EPHA1 mRNA	PMID:15691709
1304680	Epha1	Eph receptor A1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20120412	CTD	MESH:D019833	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA	PMID:16963248
1304680	Epha1	Eph receptor A1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPHA1 mRNA	PMID:19770486
1304680	Epha1	Eph receptor A1	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20120412	CTD	MESH:C004742	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA	PMID:16963248
1304680	Epha1	Eph receptor A1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EPHA1 mRNA	PMID:30851411
1304680	Epha1	Eph receptor A1	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in increased expression of EPHA1 mRNA	PMID:19695318
1304680	Epha1	Eph receptor A1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of EPHA1 mRNA	PMID:29301061|PMID:38568856
1304680	Epha1	Eph receptor A1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312265	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of EPHA1 mRNA	PMID:12760830
1304680	Epha1	Eph receptor A1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20210907	CTD	MESH:C017947	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of EPHA1 protein	PMID:32076005
1304680	Epha1	Eph receptor A1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of EPHA1 mRNA	PMID:17127020
1304680	Epha1	Eph receptor A1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312265	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EPHA1 exon	PMID:30157460
1304680	Epha1	Eph receptor A1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EPHA1 mRNA	PMID:32234424
1304680	Epha1	Eph receptor A1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EPHA1 mRNA	PMID:19770486|PMID:22228805
1304680	Epha1	Eph receptor A1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312265	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EPHA1 exon	PMID:27901495
1304680	Epha1	Eph receptor A1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA	PMID:27858113
1304680	Epha1	Eph receptor A1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20210907	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of EPHA1 protein	PMID:32076005
1304680	Epha1	Eph receptor A1	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in increased expression of EPHA1 mRNA	PMID:19695318
1304680	Epha1	Eph receptor A1	gene	CHEBI:30297	antimonite	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20210907	CTD	MESH:C061374	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA1 protein	PMID:32076005
1304680	Epha1	Eph receptor A1	gene	CHEBI:31638	fulvestrant	increases expression	ISO	RGD:1312265	E	RGD:6480464	20130122	CTD	MESH:C070081	fulvestrant results in increased expression of EPHA1 mRNA	PMID:12154049
1304680	Epha1	Eph receptor A1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of EPHA1 mRNA	PMID:29264374
1304680	Epha1	Eph receptor A1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of EPHA1 mRNA	PMID:34492290
1304680	Epha1	Eph receptor A1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of EPHA1 mRNA	PMID:18648102
1304680	Epha1	Eph receptor A1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of EPHA1 mRNA	PMID:18445702|PMID:23811191
1304680	Epha1	Eph receptor A1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EPHA1 mRNA	PMID:19710929
1304680	Epha1	Eph receptor A1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EPHA1 mRNA	PMID:25181051
1304680	Epha1	Eph receptor A1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312265	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EPHA1 gene	PMID:31601247
1304680	Epha1	Eph receptor A1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312266	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EPHA1 mRNA	PMID:32156529|PMID:34585602
1304680	Epha1	Eph receptor A1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of EPHA1 gene	PMID:28505145
1304680	Epha1	Eph receptor A1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312265	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of EPHA1 mRNA	PMID:25979313
1304680	Epha1	Eph receptor A1	gene	CHEBI:34283	oxybenzone	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20250311	CTD	MESH:C005290	oxybenzone results in decreased expression of EPHA1 mRNA	PMID:39343157
1304680	Epha1	Eph receptor A1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of EPHA1 mRNA	PMID:39298647
1304680	Epha1	Eph receptor A1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312266	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of EPHA1 mRNA	PMID:30951980
1304680	Epha1	Eph receptor A1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA	PMID:27858113
1304680	Epha1	Eph receptor A1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312265	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of EPHA1 exon	PMID:30157460
1304680	Epha1	Eph receptor A1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312266	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of EPHA1 mRNA	PMID:30951980
1304680	Epha1	Eph receptor A1	gene	CHEBI:34778	glycitein	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20141104	CTD	MESH:C086566	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA	PMID:16963248
1304680	Epha1	Eph receptor A1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312265	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EPHA1 mRNA	PMID:37042841
1304680	Epha1	Eph receptor A1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EPHA1 mRNA	PMID:35163327
1304680	Epha1	Eph receptor A1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EPHA1 mRNA	PMID:37236586
1304680	Epha1	Eph receptor A1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EPHA1 mRNA	PMID:35163327
1304680	Epha1	Eph receptor A1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of EPHA1 mRNA	PMID:28903501
1304680	Epha1	Eph receptor A1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312266	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of EPHA1 mRNA	PMID:18353800
1304680	Epha1	Eph receptor A1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of EPHA1 mRNA	PMID:23811191
1304680	Epha1	Eph receptor A1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of EPHA1 mRNA	PMID:32588087
1304680	Epha1	Eph receptor A1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EPHA1 mRNA	PMID:31533062
1304680	Epha1	Eph receptor A1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of EPHA1 mRNA	PMID:39529242
1304680	Epha1	Eph receptor A1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312265	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of EPHA1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1304680	Epha1	Eph receptor A1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1304680	Epha1	Eph receptor A1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of EPHA1 mRNA	PMID:25562108
1304680	Epha1	Eph receptor A1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312266	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of EPHA1 mRNA	PMID:28973697
1304680	Epha1	Eph receptor A1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312266	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of EPHA1 mRNA	PMID:39922521
1304680	Epha1	Eph receptor A1	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1312265	E	RGD:6480464	20130122	CTD	MESH:C016601	afimoxifene results in increased expression of EPHA1 mRNA	PMID:12154049
1304680	Epha1	Eph receptor A1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312265	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EPHA1 mRNA	PMID:38832940
1304680	Epha1	Eph receptor A1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312265	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of EPHA1 mRNA	PMID:24935251
1304680	Epha1	Eph receptor A1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EPHA1 mRNA	PMID:17562736
1304680	Epha1	Eph receptor A1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EPHA1 mRNA	PMID:33387578
1304680	Epha1	Eph receptor A1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312265	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EPHA1 gene	PMID:25304211
1304680	Epha1	Eph receptor A1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHA1 mRNA	PMID:32525701
1304680	Epha1	Eph receptor A1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of EPHA1 mRNA	PMID:29391264
1304680	Epha1	Eph receptor A1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	ISO	RGD:1312265	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of EPHA1 promoter	PMID:19277044
1304680	Epha1	Eph receptor A1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312265	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of EPHA1 mRNA; Decitabine results in increased expression of EPHA1 protein	PMID:19277044
1304680	Epha1	Eph receptor A1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EPHA1 mRNA; Nanotubes, Carbon results in decreased expression of EPHA1 mRNA	PMID:25554681
1304680	Epha1	Eph receptor A1	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312266	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of EPHA1 mRNA	PMID:26377693
1304680	Epha1	Eph receptor A1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA	PMID:27858113
1304680	Epha1	Eph receptor A1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA	PMID:27858113
1304680	Epha1	Eph receptor A1	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of EPHA1 mRNA	PMID:20977926
1304680	Epha1	Eph receptor A1	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1312265	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of EPHA1 mRNA	PMID:26272509
1304680	Epha1	Eph receptor A1	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1304680	Epha1	Eph receptor A1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	affects expression	ISO	RGD:1312265	E	RGD:6480464	20130611	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium affects the expression of EPHA1 mRNA	PMID:12710931
1304680	Epha1	Eph receptor A1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312265	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of EPHA1 exon	PMID:30157460
1304680	Epha1	Eph receptor A1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EPHA1 mRNA	PMID:22206623
1304680	Epha1	Eph receptor A1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EPHA1 mRNA	PMID:30851411
1304680	Epha1	Eph receptor A1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1304680	Epha1	Eph receptor A1	gene	CHEBI:78543	ponatinib	decreases activity	ISO	RGD:1312265	E	RGD:6480464	20170303	CTD	MESH:C545373	ponatinib results in decreased activity of EPHA1 protein	PMID:19878872
1304680	Epha1	Eph receptor A1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPHA1 gene]	PMID:28238834
1304680	Epha1	Eph receptor A1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHA1 mRNA	PMID:32525701
1304680	Epha1	Eph receptor A1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of EPHA1 mRNA	PMID:21278054
1304680	Epha1	Eph receptor A1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1304680	Epha1	Eph receptor A1	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1312265	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of EPHA1 mRNA	PMID:12154049
1304680	Epha1	Eph receptor A1	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1312266	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate affects the expression of EPHA1 mRNA	PMID:19162170
1304680	Epha1	Eph receptor A1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312265	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1304680	Epha1	Eph receptor A1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312265	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of EPHA1 mRNA	PMID:29301935
1304680	Epha1	Eph receptor A1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EPHA1 mRNA	PMID:23034163
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606493	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ABHD11 mRNA	PMID:38218311
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ABHD11 mRNA	PMID:35967413
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1615093	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ABHD11 mRNA	PMID:33045310
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1615093	E	RGD:6480464	20121204	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ABHD11 gene	PMID:20938992
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1606493	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ABHD11 mRNA	PMID:23724009
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ABHD11 gene	PMID:28931070
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20121204	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ABHD11 protein	PMID:18951874
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1615093	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ABHD11 mRNA	PMID:39241906
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1615093	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ABHD11 mRNA]	PMID:39241906
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606493	E	RGD:6480464	20121225	CTD	MESH:D004958	Estradiol results in increased expression of ABHD11 mRNA	PMID:23019147
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1615093	E	RGD:6480464	20121204	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ABHD11 gene	PMID:20938992
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606493	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ABHD11 mRNA	PMID:37042841
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ABHD11 mRNA	PMID:23649840
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20121204	CTD	MESH:D011374	Progesterone results in decreased expression of ABHD11 mRNA	PMID:18037150
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ABHD11 mRNA	PMID:36139627
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1615093	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ABHD11 mRNA	PMID:36331819
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1606493	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ABHD11 gene	PMID:28458013
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of ABHD11 protein	PMID:33146391
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1615093	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ABHD11 mRNA	PMID:34911549
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1615093	E	RGD:6480464	20121204	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ABHD11 mRNA	PMID:17484886|PMID:31919559
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1615093	E	RGD:6480464	20121204	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABHD11 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ABHD11 gene	PMID:20938992|PMID:22206623
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of ABHD11 mRNA	PMID:19167446
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1606493	E	RGD:6480464	20121204	CTD	MESH:D002945	ABHD11 protein affects the susceptibility to Cisplatin	PMID:16217747
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1606493	E	RGD:6480464	20121225	CTD	MESH:D019833	Genistein results in increased expression of ABHD11 mRNA	PMID:23019147
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615093	E	RGD:6480464	20121204	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABHD11 mRNA	PMID:21570461
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABHD11 mRNA	PMID:33387578
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20121204	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ABHD11 protein	PMID:18951874
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ABHD11 protein	PMID:39603559
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ABHD11 mRNA	PMID:33212167
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of ABHD11 mRNA	PMID:23649840
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20121204	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ABHD11 mRNA	PMID:20971185
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606493	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ABHD11 mRNA	PMID:34032870
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20121204	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ABHD11 mRNA	PMID:20971185
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of ABHD11 mRNA	PMID:34408198
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ABHD11 mRNA	PMID:30047161
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615093	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABHD11 gene; titanium dioxide results in decreased methylation of ABHD11 promoter alternative form	PMID:35295148
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ABHD11 mRNA	PMID:34492290
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1615093	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ABHD11 mRNA	PMID:18301758|PMID:23811191
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ABHD11 mRNA	PMID:38479592
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ABHD11 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606493	E	RGD:6480464	20121225	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD11 mRNA	PMID:23019147
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ABHD11 mRNA	PMID:36041667
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABHD11 mRNA	PMID:28628672
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1615093	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ABHD11 mRNA	PMID:39298647
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ABHD11 mRNA	PMID:36041667
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1615093	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ABHD11 mRNA	PMID:38685157
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ABHD11 mRNA	PMID:36041667
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1615093	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ABHD11 mRNA	PMID:28392331
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1615093	E	RGD:6480464	20121204	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ABHD11 mRNA	PMID:21266533
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1606493	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to ABHD11 protein	PMID:32991956
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABHD11 mRNA	PMID:28628672
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1615093	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ABHD11 mRNA]	PMID:39241906
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606493	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABHD11 mRNA	PMID:37042841
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606493	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ABHD11 mRNA; Cadmium Chloride results in increased expression of ABHD11 protein	PMID:24527689|PMID:26472689
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ABHD11 mRNA	PMID:24386269
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ABHD11 mRNA	PMID:24449571
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ABHD11 mRNA	PMID:31533062
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ABHD11 mRNA	PMID:19167446
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABHD11 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ABHD11 mRNA	PMID:19167446
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1615093	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ABHD11 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ABHD11 mRNA	PMID:36331819
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1615093	E	RGD:6480464	20121204	CTD	MESH:D014635	Valproic Acid affects the expression of ABHD11 mRNA	PMID:17292431
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606493	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ABHD11 mRNA	PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD11 mRNA	PMID:27188386
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ABHD11 mRNA	PMID:30047161
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABHD11 mRNA	PMID:28628672
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of ABHD11 mRNA	PMID:23649840
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1606493	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ABHD11 mRNA	PMID:38832940
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1615093	E	RGD:6480464	20121204	CTD	MESH:D000082	Acetaminophen affects the expression of ABHD11 mRNA	PMID:17562736
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1606493	E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in increased expression of ABHD11 mRNA	PMID:23527032
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:4917	eugenol	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in decreased expression of ABHD11 protein	PMID:39793947
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABHD11 mRNA	PMID:28628672
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1615093	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ABHD11 mRNA; Nanotubes, Carbon results in increased expression of ABHD11 mRNA	PMID:25554681
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ABHD11 mRNA	PMID:30047161
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ABHD11 mRNA	PMID:24793618
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ABHD11 mRNA	PMID:24136188
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ABHD11 protein	PMID:32959892
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:64153	tanespimycin	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20200804	CTD	MESH:C112765	[tanespimycin co-treated with VER 155008] results in decreased expression of ABHD11 protein	PMID:31370342
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:65585	carnosic acid	increases expression	ISO	RGD:1615093	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in increased expression of ABHD11 protein	PMID:35926579
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1615093	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABHD11 mRNA	PMID:22206623
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ABHD11 mRNA	PMID:36139627
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD11 mRNA	PMID:27188386
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABHD11 mRNA	PMID:19167446
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of ABHD11 protein	PMID:28903499
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1615093	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ABHD11 mRNA]	PMID:39241906
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1615093	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of ABHD11 protein	PMID:35357534
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606493	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD11 mRNA	PMID:27188386
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1606493	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ABHD11 mRNA	PMID:29301935
1304681	Abhd11	abhydrolase domain containing 11	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ABHD11 mRNA	PMID:23034163
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312270	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPTBN4 mRNA	PMID:33045310
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312270	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SPTBN4 mRNA	PMID:20188158
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312270	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SPTBN4 mRNA	PMID:30319688
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312270	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of SPTBN4 mRNA	PMID:30319688
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312270	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of SPTBN4 mRNA	PMID:39922521
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312270	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SPTBN4 mRNA	PMID:22401849
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312270	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of SPTBN4 mRNA	PMID:39922521
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312269	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPTBN4 mRNA	PMID:36139627
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312269	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SPTBN4 intron	PMID:30157460
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312270	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of SPTBN4 mRNA	PMID:31626304
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SPTBN4 mRNA	PMID:31150632
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312270	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SPTBN4 mRNA	PMID:22206623
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312269	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SPTBN4 mRNA	PMID:28903495
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312269	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SPTBN4 mRNA	PMID:27392435
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPTBN4 mRNA	PMID:22298810
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312270	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPTBN4 mRNA	PMID:21570461
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312269	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SPTBN4 mRNA	PMID:33212167
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312269	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPTBN4 mRNA	PMID:34032870
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312269	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SPTBN4 mRNA	PMID:38568856
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312269	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPTBN4 intron; Benzo(a)pyrene affects the methylation of SPTBN4 promoter	PMID:27901495|PMID:30157460
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312269	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPTBN4 5' UTR	PMID:27901495
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312269	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SPTBN4 mRNA	PMID:25895662
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312269	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SPTBN4 mRNA	PMID:20458559
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1312269	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of SPTBN4 mRNA	PMID:37690743
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312269	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPTBN4 gene	PMID:31601247
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312270	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPTBN4 gene	PMID:35295148
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312270	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SPTBN4 gene	PMID:35295148
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312270	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SPTBN4 mRNA	PMID:18648102
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312270	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SPTBN4 mRNA	PMID:17950772
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312270	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of SPTBN4 mRNA]	PMID:17950772
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPTBN4 mRNA	PMID:25181051
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312270	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SPTBN4 mRNA	PMID:32156529
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SPTBN4 mRNA	PMID:36041667
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312269	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPTBN4 gene	PMID:31601247
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312269	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of SPTBN4 gene	PMID:31601247
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312270	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of SPTBN4 exon	PMID:33297965
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SPTBN4 mRNA	PMID:36041667
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SPTBN4 mRNA	PMID:36041667
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312270	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SPTBN4 exon	PMID:28392331
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312269	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SPTBN4 gene	PMID:22964155
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of SPTBN4 mRNA	PMID:32680482
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SPTBN4 mRNA	PMID:35163327
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPTBN4 mRNA	PMID:36928142
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SPTBN4 mRNA	PMID:35163327
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of SPTBN4 mRNA	PMID:27387713
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312269	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SPTBN4 mRNA	PMID:24449571
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312270	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SPTBN4 mRNA	PMID:40194260
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SPTBN4 mRNA	PMID:29427782
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SPTBN4 mRNA	PMID:30047161
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312270	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of SPTBN4 mRNA	PMID:39922521
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312269	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SPTBN4 protein	PMID:38832940
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312270	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SPTBN4 mRNA	PMID:17562736
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312270	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SPTBN4 mRNA	PMID:19446018
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312269	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SPTBN4 mRNA	PMID:20458559
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SPTBN4 mRNA	PMID:30047161
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of SPTBN4 mRNA	PMID:21983209
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of SPTBN4 mRNA	PMID:20080153
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1312270	E	RGD:6480464	20150127	CTD	MESH:C014476	diethyl maleate results in increased expression of SPTBN4 mRNA	PMID:25270620
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312270	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SPTBN4 mRNA	PMID:22206623
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of SPTBN4 mRNA	PMID:27840820
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312270	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SPTBN4 mRNA	PMID:22206623
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1312269	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SPTBN4 mRNA	PMID:36318118
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312269	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPTBN4 mRNA	PMID:36139627
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312269	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPTBN4 gene]	PMID:28238834
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPTBN4 mRNA	PMID:30047161
1304682	Sptbn4	spectrin, beta, non-erythrocytic 4	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312270	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of SPTBN4 mRNA	PMID:35537566
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312272	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GNAT1 mRNA	PMID:33045310
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1312271	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of GNAT1 mRNA	PMID:34925699
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312271	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of GNAT1 mRNA	PMID:17218384
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:15368	acrolein	affects expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein affects the expression of GNAT1 mRNA	PMID:38090360
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GNAT1 mRNA	PMID:36331819
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of GNAT1 mRNA	PMID:36841081
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312271	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of GNAT1 mRNA	PMID:22378314
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of GNAT1 mRNA	PMID:32145629
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of GNAT1 mRNA	PMID:33387578
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of GNAT1 mRNA	PMID:21669218
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of GNAT1 mRNA	PMID:27523638
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of GNAT1 mRNA	PMID:26577399
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of GNAT1 mRNA	PMID:22061828|PMID:33387578
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GNAT1 mRNA	PMID:36331819
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GNAT1 mRNA	PMID:39012411
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312271	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GNAT1 mRNA	PMID:35301059
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GNAT1 mRNA	PMID:19770486
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1312271	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of GNAT1 mRNA	PMID:19921347
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D003042	Cocaine results in increased expression of GNAT1 mRNA	PMID:27899881
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312272	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GNAT1 mRNA	PMID:26377647|PMID:28922406
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GNAT1 mRNA	PMID:33387578
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GNAT1 mRNA	PMID:18172886|PMID:26290441
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GNAT1 mRNA	PMID:21215274
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312271	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GNAT1 mRNA	PMID:33212167
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312271	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GNAT1 mRNA	PMID:30851411
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of GNAT1 protein	PMID:29459688
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of GNAT1 mRNA	PMID:33933676
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA	PMID:34876320
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA	PMID:34876320
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312271	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GNAT1 promoter	PMID:27901495
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312271	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GNAT1 mRNA	PMID:32234424
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312272	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of GNAT1 mRNA	PMID:23221170
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312271	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GNAT1 gene	PMID:31601247
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of GNAT1 mRNA	PMID:24136188
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of GNAT1 mRNA	PMID:32479839
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of GNAT1 mRNA	PMID:30047161
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of GNAT1 mRNA	PMID:30012374
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312272	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GNAT1 gene	PMID:35295148
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GNAT1 mRNA	PMID:19710929
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GNAT1 mRNA	PMID:25181051|PMID:32145629
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GNAT1 mRNA	PMID:33221593
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312272	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GNAT1 promoter	PMID:27312807
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312271	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GNAT1 gene	PMID:31601247
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312271	E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in increased expression of GNAT1 mRNA	PMID:30616060
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312272	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GNAT1 mRNA	PMID:39298647
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312272	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of GNAT1 mRNA	PMID:26377693
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of GNAT1 mRNA	PMID:38685157
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon affects the expression of GNAT1 mRNA	PMID:17452286
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312272	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of GNAT1 mRNA	PMID:26377693
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of GNAT1 mRNA	PMID:30723492
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GNAT1 mRNA	PMID:39012411
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312271	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GNAT1 mRNA	PMID:35301059
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1312271	E	RGD:6480464	20260203	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of GNAT1 mRNA	PMID:40334771
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GNAT1 mRNA	PMID:28511854
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of GNAT1 mRNA	PMID:25539665
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1312272	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of GNAT1 mRNA	PMID:24183702
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312272	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of GNAT1 mRNA	PMID:28962523
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312272	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GNAT1 mRNA	PMID:40194260
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GNAT1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GNAT1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of GNAT1 mRNA	PMID:36331819
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of GNAT1 mRNA	PMID:25993096
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312271	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GNAT1 gene	PMID:29154799
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of GNAT1 mRNA	PMID:30047161
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of GNAT1 mRNA	PMID:20937368
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of GNAT1 mRNA	PMID:25123088
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of GNAT1 mRNA	PMID:18502557
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GNAT1 mRNA	PMID:17562736
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GNAT1 mRNA	PMID:33387578
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of GNAT1 mRNA	PMID:32479839
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1312272	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of GNAT1 mRNA	PMID:26934552
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GNAT1 mRNA	PMID:29391264
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA	PMID:34876320
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312272	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of GNAT1 mRNA	PMID:25620056
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312272	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GNAT1 mRNA	PMID:25620056
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of GNAT1 mRNA	PMID:30047161
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:5643	Heliotrine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in increased expression of GNAT1 mRNA	PMID:34185104
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312272	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of GNAT1 mRNA	PMID:36851058
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GNAT1 mRNA	PMID:22206623
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1312271	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of GNAT1 mRNA	PMID:20816883
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:76604	MeIQx	decreases expression	ISO	RGD:1312271	E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in decreased expression of GNAT1 mRNA	PMID:20816883
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312271	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GNAT1 mRNA	PMID:30851411
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312271	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GNAT1 gene]	PMID:28238834
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312272	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GNAT1 mRNA	PMID:23091169
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of GNAT1 mRNA	PMID:19482888
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of GNAT1 mRNA]	PMID:19482888
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:8264	Platyphylline	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C008937	platyphylline results in increased expression of GNAT1 mRNA	PMID:34185104
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA	PMID:34876320
1304683	Gnat1	G protein subunit alpha transducin 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of GNAT1 mRNA	PMID:24780913|PMID:30047161
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KDELC1 mRNA	PMID:38218311
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312274	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KDELC1 mRNA	PMID:36331819
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of POGLUT2 mRNA	PMID:21632981
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312274	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POGLUT2 mRNA	PMID:39241906
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312273	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of POGLUT2 mRNA	PMID:28818685
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1312273	E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of POGLUT2 mRNA	PMID:20368581
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	ISO	RGD:1312273	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of POGLUT2 mRNA	PMID:17103032
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of POGLUT2 protein	PMID:34915118
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POGLUT2 mRNA	PMID:19549813
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312273	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of POGLUT2 gene	PMID:27153756
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312274	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of POGLUT2 mRNA	PMID:31919559
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POGLUT2 mRNA	PMID:21570461
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POGLUT2 mRNA	PMID:20106945|PMID:21632981
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of POGLUT2 mRNA	PMID:17942748
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312273	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of POGLUT2 mRNA	PMID:39709020
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of POGLUT2 mRNA	PMID:32763439
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312273	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of POGLUT2 mRNA	PMID:20971185
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312273	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of POGLUT2 mRNA	PMID:29803840
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of POGLUT2 mRNA	PMID:22714537|PMID:38568856
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POGLUT2 mRNA	PMID:22228805
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312273	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of POGLUT2 mRNA	PMID:20971185
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D005897	Glafenine results in increased expression of POGLUT2 mRNA	PMID:24136188
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of POGLUT2 mRNA	PMID:34492290
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of POGLUT2 mRNA	PMID:29275510
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C006780	bisphenol A results in increased expression of POGLUT2 mRNA	PMID:25181051
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312273	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA	PMID:28628672
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312274	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of POGLUT2 mRNA	PMID:38685157
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312273	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA	PMID:28628672
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312274	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of POGLUT2 mRNA	PMID:28392331
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312273	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of POGLUT2 gene	PMID:22964155
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of POGLUT2 mRNA	PMID:21266533
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312273	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA	PMID:28628672
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of POGLUT2 mRNA	PMID:38174414|PMID:38568856
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of POGLUT2 mRNA	PMID:28302478
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of POGLUT2 mRNA	PMID:40419075
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312274	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KDELC1 mRNA	PMID:36331819
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312273	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of POGLUT2 mRNA	PMID:25979313
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D014635	Valproic Acid affects the expression of POGLUT2 mRNA	PMID:17292431
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312273	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of POGLUT2 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of POGLUT2 mRNA	PMID:25562108
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:41423	celecoxib	affects expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:C105934	Celecoxib affects the expression of POGLUT2 mRNA	PMID:20562220
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D013629	Tamoxifen affects the expression of POGLUT2 mRNA	PMID:17555576
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312273	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA	PMID:28628672
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1312273	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of POGLUT2 mRNA	PMID:16595896
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312273	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of POGLUT2 mRNA	PMID:38832940
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312273	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of POGLUT2 mRNA	PMID:22230336
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20161213	CTD	MESH:C088658	Zoledronic Acid results in decreased expression of POGLUT2 mRNA	PMID:24714768
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1312273	E	RGD:6480464	20210504	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of POGLUT2 mRNA	PMID:33581214
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of POGLUT2 mRNA	PMID:17555576
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of POGLUT2 mRNA	PMID:17557909
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of POGLUT2 mRNA	PMID:17942748
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312273	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA	PMID:28628672
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of POGLUT2 mRNA	PMID:25554681
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of POGLUT2 mRNA	PMID:22714537
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of POGLUT2 protein	PMID:32959892
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of POGLUT2 mRNA	PMID:23650126
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312273	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of POGLUT2 mRNA	PMID:15336504
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008701	Methapyrilene results in decreased expression of POGLUT2 mRNA	PMID:30467583
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312274	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KDELC1 mRNA	PMID:22206623
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312273	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KDELC1 gene]	PMID:28238834
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312274	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of POGLUT2 mRNA	PMID:31388691
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1312273	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of POGLUT2 mRNA	PMID:20368581
1304684	Poglut2	protein O-glucosyltransferase 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312274	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of KDELC1 mRNA	PMID:35537566
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312275	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of KLHL8 mRNA	PMID:24763279
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1312275	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of KLHL8 mRNA	PMID:18951874
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312276	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KLHL8 mRNA	PMID:39241906
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312275	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KLHL8 mRNA	PMID:37042841
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312276	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KLHL8 mRNA	PMID:34319233
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KLHL8 mRNA	PMID:33387578
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312276	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KLHL8 mRNA	PMID:19770486
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of KLHL8 mRNA	PMID:30779732
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312276	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of KLHL8 mRNA	PMID:17484886
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312275	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL8 mRNA	PMID:39836092
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312276	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KLHL8 mRNA	PMID:40504410
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of KLHL8 mRNA	PMID:31881176
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312275	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KLHL8 mRNA	PMID:23557933
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312275	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of KLHL8 mRNA	PMID:23195993
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312276	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLHL8 mRNA	PMID:21570461
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312275	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KLHL8 mRNA	PMID:17101203
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312275	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL8 mRNA	PMID:39836092
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312276	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KLHL8 mRNA	PMID:40504410
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312275	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KLHL8 promoter	PMID:27901495
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312275	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KLHL8 5' UTR	PMID:27901495
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312276	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLHL8 mRNA	PMID:22228805
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312276	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of KLHL8 mRNA]	PMID:22228805
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312275	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KLHL8 mRNA	PMID:20018196
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312275	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of KLHL8 mRNA	PMID:26238291
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312276	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KLHL8 gene	PMID:35295148
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of KLHL8 mRNA	PMID:23411599
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312276	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of KLHL8 mRNA	PMID:18648102
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312275	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of KLHL8 mRNA	PMID:19710929
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KLHL8 mRNA	PMID:25181051
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KLHL8 gene	PMID:28505145
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312276	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of KLHL8 intron	PMID:28392331
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KLHL8 mRNA	PMID:18668222
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312276	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of KLHL8 mRNA	PMID:39529242
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312275	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLHL8 mRNA	PMID:25979313
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312275	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of KLHL8 mRNA	PMID:19101580|PMID:29154799
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of KLHL8 mRNA	PMID:41580965
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312276	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of KLHL8 mRNA	PMID:28973697
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312275	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of KLHL8 mRNA	PMID:24935251
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KLHL8 mRNA	PMID:33387578
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312275	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL8 mRNA	PMID:39836092
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312276	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KLHL8 mRNA	PMID:40504410
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312276	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KLHL8 mRNA; Nanotubes, Carbon results in decreased expression of KLHL8 mRNA	PMID:25554681
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of KLHL8 mRNA	PMID:20080153
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312276	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of KLHL8 mRNA	PMID:22206623
1304685	Klhl8	kelch-like family member 8	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of KLHL8 mRNA	PMID:21346803
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1601944	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of EIF1AD mRNA	PMID:38218311
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EIF1AD mRNA]	PMID:31150632
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312277	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EIF1AD mRNA	PMID:39241906
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312277	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of EIF1AD mRNA]	PMID:39241906
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1601944	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of EIF1AD mRNA	PMID:22574217
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312277	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EIF1AD mRNA	PMID:39298647
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EIF1AD mRNA	PMID:33387578
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1601944	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of EIF1AD mRNA	PMID:39836092
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1601944	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of EIF1AD mRNA	PMID:19549813
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1601944	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of EIF1AD mRNA	PMID:18593933
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EIF1AD mRNA	PMID:31150632
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EIF1AD mRNA]	PMID:31150632
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EIF1AD mRNA	PMID:33387578|PMID:34747641
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312277	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EIF1AD mRNA	PMID:25975270
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1601944	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of EIF1AD mRNA	PMID:23649840
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1601944	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of EIF1AD mRNA	PMID:32763439
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1601944	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EIF1AD mRNA	PMID:29803840
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601944	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EIF1AD mRNA	PMID:38568856
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1601944	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of EIF1AD mRNA	PMID:18593933
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1601944	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of EIF1AD mRNA	PMID:26014281
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of EIF1AD mRNA	PMID:24136188
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312277	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EIF1AD gene	PMID:35295148
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EIF1AD mRNA	PMID:25181051
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312277	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EIF1AD mRNA	PMID:39298647
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1601944	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EIF1AD mRNA	PMID:28628672
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of EIF1AD mRNA	PMID:21241498
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1601944	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EIF1AD mRNA	PMID:28628672
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312277	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of EIF1AD mRNA]	PMID:39241906
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1601944	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of EIF1AD mRNA	PMID:39836092
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1601944	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of EIF1AD protein	PMID:24527689
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of EIF1AD mRNA	PMID:24386269
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1601944	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of EIF1AD mRNA	PMID:28302478
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1601944	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EIF1AD mRNA	PMID:23179753
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of EIF1AD mRNA	PMID:41580965
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1601944	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of EIF1AD mRNA	PMID:20106945
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1601944	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EIF1AD mRNA	PMID:28628672
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1601944	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of EIF1AD mRNA	PMID:36621641
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1601944	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of EIF1AD mRNA	PMID:23649840
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312277	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EIF1AD mRNA	PMID:17562736
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1601944	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of EIF1AD mRNA	PMID:36621641
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of EIF1AD mRNA	PMID:29391264
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1601944	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EIF1AD mRNA	PMID:28628672
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312277	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EIF1AD mRNA; Nanotubes, Carbon results in increased expression of EIF1AD mRNA	PMID:25554681|PMID:25620056
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of EIF1AD mRNA	PMID:41580965
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EIF1AD mRNA	PMID:24136188
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of EIF1AD mRNA	PMID:28801915
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1601944	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of EIF1AD mRNA	PMID:39836092
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1601944	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of EIF1AD mRNA	PMID:28988120
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of EIF1AD mRNA	PMID:28801915
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1601944	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of EIF1AD mRNA	PMID:31758290
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312277	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of EIF1AD mRNA	PMID:22206623
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of EIF1AD mRNA	PMID:24136188
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1601944	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of EIF1AD mRNA	PMID:37199045
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312277	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of EIF1AD mRNA]	PMID:39241906
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1601944	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of EIF1AD mRNA	PMID:26014281
1304686	Eif1ad	eukaryotic translation initiation factor 1A domain containing	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EIF1AD mRNA	PMID:23034163
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312278	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ALKBH8 mRNA	PMID:33045310
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ALKBH8 mRNA	PMID:30071829
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602194	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ALKBH8 mRNA	PMID:33167477
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1602194	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ALKBH8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ALKBH8 mRNA	PMID:32699268
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1602194	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ALKBH8 mRNA	PMID:26079696
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1602194	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ALKBH8 mRNA	PMID:31614463
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ALKBH8 mRNA	PMID:23829299
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1602194	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ALKBH8 mRNA	PMID:28818685
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602194	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ALKBH8 gene	PMID:27153756
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312278	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ALKBH8 mRNA	PMID:19770486
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602194	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ALKBH8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ALKBH8 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ALKBH8 mRNA	PMID:32699268
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ALKBH8 mRNA	PMID:30779732
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ALKBH8 mRNA	PMID:31150632
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312278	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ALKBH8 mRNA	PMID:25629700
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1602194	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ALKBH8 gene	PMID:25304211
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602194	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALKBH8 mRNA	PMID:39836092
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312278	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ALKBH8 mRNA	PMID:21570461
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ALKBH8 mRNA	PMID:32109520
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALKBH8 mRNA	PMID:33387578
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602194	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALKBH8 mRNA	PMID:39836092
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602194	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ALKBH8 promoter	PMID:27901495
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1602194	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of ALKBH8 mRNA	PMID:38568856
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ALKBH8 mRNA	PMID:23411599
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ALKBH8 mRNA	PMID:25181051
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312278	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ALKBH8 mRNA	PMID:26063408
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ALKBH8 gene	PMID:28505145
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1602194	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ALKBH8 gene	PMID:31601247
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of ALKBH8 mRNA	PMID:23829299
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1602194	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ALKBH8 gene	PMID:31601247
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1602194	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of ALKBH8 mRNA	PMID:27685785
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312278	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ALKBH8 mRNA	PMID:38685157
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312278	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased expression of ALKBH8 mRNA	PMID:21371552
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602194	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ALKBH8 mRNA	PMID:37042841
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ALKBH8 mRNA	PMID:35163327
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602194	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ALKBH8 mRNA	PMID:38568856
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ALKBH8 mRNA	PMID:33453195
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ALKBH8 mRNA	PMID:35163327
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1602194	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ALKBH8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ALKBH8 mRNA	PMID:32699268
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1602194	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ALKBH8 mRNA	PMID:32588087
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602194	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ALKBH8 mRNA	PMID:23179753|PMID:26272509|PMID:29154799
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602194	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALKBH8 mRNA	PMID:27188386
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ALKBH8 mRNA	PMID:33387578
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602194	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ALKBH8 mRNA	PMID:29067470
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1602194	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of ALKBH8 mRNA	PMID:16510598
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312278	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ALKBH8 mRNA	PMID:29279043
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1602194	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ALKBH8 gene	PMID:25304211
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602194	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALKBH8 mRNA	PMID:39836092
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312278	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ALKBH8 mRNA	PMID:23608068
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312278	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ALKBH8 mRNA	PMID:26378955
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312278	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ALKBH8 mRNA	PMID:22206623
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1602194	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ALKBH8 mRNA	PMID:22714537
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602194	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALKBH8 mRNA	PMID:27188386
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312278	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ALKBH8 mRNA	PMID:23091169
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1602194	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of ALKBH8 mRNA	PMID:24921660
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602194	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALKBH8 mRNA	PMID:27188386
1304687	Alkbh8	alkB homolog 8, tRNA methyltransferase	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312278	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ALKBH8 mRNA	PMID:28973697
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312279	E	RGD:6480464	20230404	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SLC49A3 mRNA	PMID:26251327
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312279	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC49A3 mRNA	PMID:36331819
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312279	E	RGD:6480464	20230404	CTD	MESH:D000431	Ethanol results in increased expression of SLC49A3 mRNA	PMID:19167417
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312279	E	RGD:6480464	20230404	CTD	MESH:D004958	Estradiol results in increased expression of SLC49A3 mRNA	PMID:19484750
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1604571	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC49A3 mRNA	PMID:38568856
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC49A3 mRNA	PMID:33387578
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SLC49A3 mRNA	PMID:26577399
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SLC49A3 mRNA	PMID:33387578
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312279	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC49A3 mRNA	PMID:36331819
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SLC49A3 protein	PMID:34915118
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604571	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC49A3 gene	PMID:25304211
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312279	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC49A3 mRNA	PMID:40504410
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC49A3 mRNA	PMID:31881176
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604571	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC49A3 mRNA	PMID:23557933
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1604571	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SLC49A3 mRNA	PMID:27392435
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312279	E	RGD:6480464	20230404	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC49A3 mRNA	PMID:21570461
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC49A3 mRNA	PMID:33387578
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604571	E	RGD:6480464	20190702	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC49A3 mRNA	PMID:29301061
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312279	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC49A3 mRNA	PMID:40504410
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604571	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC49A3 exon	PMID:30157460
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312279	E	RGD:6480464	20230404	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC49A3 mRNA	PMID:22228805
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1604571	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of SLC49A3 gene; [bisphenol S co-treated with Fulvestrant] results in increased methylation of SLC49A3 gene	PMID:31601247
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312279	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC49A3 gene	PMID:35295148
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC49A3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1604571	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of SLC49A3 gene	PMID:31601247
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1604571	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of SLC49A3 gene	PMID:31601247
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312279	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SLC49A3 promoter	PMID:28392331
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604571	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC49A3 mRNA	PMID:37042841
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SLC49A3 promoter	PMID:22457795
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1604571	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC49A3 mRNA	PMID:21457566
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312279	E	RGD:6480464	20230404	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SLC49A3 mRNA	PMID:28903501
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312279	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC49A3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC49A3 mRNA	PMID:36331819
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604571	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC49A3 gene	PMID:29154799
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1604571	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SLC49A3 mRNA	PMID:38832940
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312279	E	RGD:6480464	20230404	CTD	MESH:D000082	Acetaminophen affects the expression of SLC49A3 mRNA	PMID:17562736
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC49A3 mRNA	PMID:33387578
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604571	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC49A3 gene	PMID:25304211
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312279	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC49A3 mRNA	PMID:40504410
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312279	E	RGD:6480464	20230404	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SLC49A3 mRNA	PMID:25554681
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:C025340	manganese chloride results in increased expression of SLC49A3 mRNA	PMID:28801915
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312279	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SLC49A3 mRNA	PMID:39847705
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SLC49A3 mRNA	PMID:24780913
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1604571	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SLC49A3 mRNA	PMID:29301935
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:9747	Triptolide	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in decreased expression of MFSD7 protein	PMID:32519852
1304688	Slc49a3	solute carrier family 49 member 3	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312279	E	RGD:6480464	20230404	CTD	MESH:C080163	trovafloxacin results in increased expression of SLC49A3 mRNA	PMID:35537566
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312281	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TUBGCP5 mRNA	PMID:26251327
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TUBGCP5 gene	PMID:20938992
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TUBGCP5 mRNA	PMID:33167477
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312280	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TUBGCP5 mRNA	PMID:38568856
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TUBGCP5 gene	PMID:20938992
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312281	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TUBGCP5 mRNA	PMID:34319233
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TUBGCP5 mRNA	PMID:33387578
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TUBGCP5 mRNA	PMID:19549813
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312281	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TUBGCP5 mRNA	PMID:19770486
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312280	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TUBGCP5 mRNA	PMID:23649840
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TUBGCP5 gene	PMID:20938992
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUBGCP5 mRNA	PMID:40504410
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312280	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TUBGCP5 mRNA	PMID:22574217
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312281	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TUBGCP5 mRNA	PMID:24680724
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312281	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TUBGCP5 mRNA	PMID:21354282
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1312281	E	RGD:6480464	20120613	CTD	MESH:D012402	Rotenone affects the expression of TUBGCP5 mRNA	PMID:21893155
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20120613	CTD	MESH:D012402	TRP53 affects the reaction [Rotenone affects the expression of TUBGCP5 mRNA]	PMID:21893155
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TUBGCP5 mRNA; aristolochic acid I results in decreased expression of TUBGCP5 protein	PMID:33212167
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of TUBGCP5 mRNA	PMID:23649840
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TUBGCP5 mRNA	PMID:32763439
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312281	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TUBGCP5 mRNA	PMID:27862939
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TUBGCP5 mRNA	PMID:38568856
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TUBGCP5 mRNA	PMID:21297353
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312280	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TUBGCP5 mRNA	PMID:34032870
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUBGCP5 mRNA	PMID:40504410
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1312281	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of TUBGCP5 mRNA	PMID:34850242
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312281	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TUBGCP5 promoter	PMID:35295148
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TUBGCP5 mRNA	PMID:30816183|PMID:34947998
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA	PMID:28628672
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA	PMID:28628672
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312280	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TUBGCP5 mRNA	PMID:37042841
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TUBGCP5 mRNA	PMID:38174414|PMID:38568856
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TUBGCP5 mRNA	PMID:19376846
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TUBGCP5 mRNA	PMID:25562108
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA	PMID:28628672
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of TUBGCP5 mRNA	PMID:23649840
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TUBGCP5 mRNA	PMID:21420995
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUBGCP5 mRNA	PMID:40504410
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TUBGCP5 mRNA	PMID:22079256
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA	PMID:28628672
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312281	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TUBGCP5 mRNA	PMID:22206623
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TUBGCP5 mRNA	PMID:22079256
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312280	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TUBGCP5 mRNA	PMID:22079256
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312281	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of TUBGCP5 mRNA	PMID:39847705
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312281	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of TUBGCP5 mRNA	PMID:21795629
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TUBGCP5 mRNA	PMID:38568856
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312280	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TUBGCP5 mRNA	PMID:29301935
1304689	Tubgcp5	tubulin gamma complex component 5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TUBGCP5 mRNA	PMID:21346803
1304690	Eml4	EMAP like 4	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of EML4 mRNA	PMID:38218311
1304690	Eml4	EMAP like 4	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of EML4 mRNA	PMID:25152437
1304690	Eml4	EMAP like 4	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of EML4 mRNA	PMID:35967413
1304690	Eml4	EMAP like 4	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312282	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of EML4 mRNA	PMID:33045310
1304690	Eml4	EMAP like 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312282	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of EML4 mRNA	PMID:37995155
1304690	Eml4	EMAP like 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312282	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of EML4 mRNA	PMID:26251327
1304690	Eml4	EMAP like 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1351948	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of EML4 mRNA	PMID:33167477
1304690	Eml4	EMAP like 4	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of EML4 mRNA	PMID:26079696
1304690	Eml4	EMAP like 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1351948	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EML4 mRNA	PMID:21179406
1304690	Eml4	EMAP like 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312282	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EML4 mRNA	PMID:39298647
1304690	Eml4	EMAP like 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1351948	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of EML4 mRNA	PMID:31614463
1304690	Eml4	EMAP like 4	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EML4 mRNA	PMID:33387578
1304690	Eml4	EMAP like 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1351948	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EML4 mRNA	PMID:37042841
1304690	Eml4	EMAP like 4	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1351948	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of EML4 mRNA	PMID:19162166
1304690	Eml4	EMAP like 4	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of EML4 mRNA	PMID:12588870
1304690	Eml4	EMAP like 4	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20161213	CTD	MESH:D009538	alpha-cobratoxin inhibits the reaction [Nicotine results in decreased expression of EML4 mRNA]; Mecamylamine promotes the reaction [Nicotine results in decreased expression of EML4 mRNA]; Tubocurarine inhibits the reaction [Nicotine results in decreased expression of EML4 mRNA]	PMID:12588870
1304690	Eml4	EMAP like 4	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1351948	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EML4 protein	PMID:37730182
1304690	Eml4	EMAP like 4	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of EML4 mRNA	PMID:12588870
1304690	Eml4	EMAP like 4	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20161213	CTD	MESH:D009538	alpha-cobratoxin inhibits the reaction [Nicotine results in decreased expression of EML4 mRNA]; Mecamylamine promotes the reaction [Nicotine results in decreased expression of EML4 mRNA]; Tubocurarine inhibits the reaction [Nicotine results in decreased expression of EML4 mRNA]	PMID:12588870
1304690	Eml4	EMAP like 4	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1351948	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of EML4 mRNA	PMID:19549813
1304690	Eml4	EMAP like 4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EML4 protein	PMID:23301498
1304690	Eml4	EMAP like 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of EML4 mRNA	PMID:23630614
1304690	Eml4	EMAP like 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1351948	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EML4 gene	PMID:27153756
1304690	Eml4	EMAP like 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312282	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EML4 mRNA	PMID:25629700
1304690	Eml4	EMAP like 4	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of EML4 mRNA	PMID:26272509
1304690	Eml4	EMAP like 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EML4 mRNA	PMID:27188386
1304690	Eml4	EMAP like 4	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1351948	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of EML4 protein	PMID:35688186
1304690	Eml4	EMAP like 4	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312282	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of EML4 mRNA	PMID:30912803
1304690	Eml4	EMAP like 4	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1351948	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of EML4 mRNA	PMID:24768652
1304690	Eml4	EMAP like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EML4 mRNA	PMID:34747641
1304690	Eml4	EMAP like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312282	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EML4 mRNA	PMID:21570461|PMID:26377647
1304690	Eml4	EMAP like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EML4 mRNA	PMID:33387578
1304690	Eml4	EMAP like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EML4 mRNA	PMID:20106945|PMID:21632981
1304690	Eml4	EMAP like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EML4 mRNA	PMID:18796159|PMID:21215274|PMID:22342509|PMID:27136898
1304690	Eml4	EMAP like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312282	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EML4 mRNA	PMID:18796159|PMID:21889950|PMID:25975270|PMID:26290441
1304690	Eml4	EMAP like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312282	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of EML4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of EML4 mRNA	PMID:16214954|PMID:25975270
1304690	Eml4	EMAP like 4	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D012402	Rotenone results in increased expression of EML4 mRNA	PMID:27979718
1304690	Eml4	EMAP like 4	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1351948	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of EML4 mRNA	PMID:28001369
1304690	Eml4	EMAP like 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EML4 mRNA	PMID:33212167
1304690	Eml4	EMAP like 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1351948	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of EML4 protein	PMID:33212167
1304690	Eml4	EMAP like 4	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of EML4 mRNA	PMID:30556269
1304690	Eml4	EMAP like 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EML4 mRNA	PMID:29803840
1304690	Eml4	EMAP like 4	gene	CHEBI:28783	zinc protoporphyrin	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20150609	CTD	MESH:C017803	[lead acetate co-treated with zinc protoporphyrin] results in increased expression of EML4 mRNA	PMID:22839698
1304690	Eml4	EMAP like 4	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1351948	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of EML4 protein	PMID:35688186
1304690	Eml4	EMAP like 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of EML4 protein	PMID:38228842
1304690	Eml4	EMAP like 4	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1351948	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased methylation of EML4 gene	PMID:25199682
1304690	Eml4	EMAP like 4	gene	CHEBI:29678	sodium arsenite	increases stability	ISO	RGD:1351948	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased stability of EML4 mRNA	PMID:25493608
1304690	Eml4	EMAP like 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351948	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EML4 promoter	PMID:27901495
1304690	Eml4	EMAP like 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EML4 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1304690	Eml4	EMAP like 4	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of EML4 mRNA	PMID:30556269
1304690	Eml4	EMAP like 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of EML4 mRNA	PMID:25895662
1304690	Eml4	EMAP like 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EML4 mRNA	PMID:19150397|PMID:20018196|PMID:20382639
1304690	Eml4	EMAP like 4	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1351948	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of EML4 protein	PMID:25419056
1304690	Eml4	EMAP like 4	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20150609	CTD	MESH:C008261	[lead acetate co-treated with zinc protoporphyrin] results in increased expression of EML4 mRNA	PMID:22839698
1304690	Eml4	EMAP like 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of EML4 mRNA	PMID:25729387
1304690	Eml4	EMAP like 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of EML4 mRNA	PMID:30047161
1304690	Eml4	EMAP like 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312282	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EML4 promoter	PMID:35295148
1304690	Eml4	EMAP like 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1351948	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased methylation of EML4 promoter	PMID:34973136
1304690	Eml4	EMAP like 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of EML4 mRNA	PMID:30723492
1304690	Eml4	EMAP like 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EML4 mRNA	PMID:25181051
1304690	Eml4	EMAP like 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312282	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of EML4 mRNA	PMID:33221593
1304690	Eml4	EMAP like 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of EML4 mRNA	PMID:30816183|PMID:34947998
1304690	Eml4	EMAP like 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312282	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of EML4 mRNA	PMID:37894381
1304690	Eml4	EMAP like 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1351948	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of EML4 protein	PMID:37567409
1304690	Eml4	EMAP like 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EML4 mRNA	PMID:28628672
1304690	Eml4	EMAP like 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EML4 mRNA	PMID:27914987
1304690	Eml4	EMAP like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312282	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EML4 mRNA	PMID:39298647
1304690	Eml4	EMAP like 4	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1351948	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of EML4 intron	PMID:30157460
1304690	Eml4	EMAP like 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1351948	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of EML4 protein	PMID:34186270
1304690	Eml4	EMAP like 4	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1351948	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of EML4 protein	PMID:34186270
1304690	Eml4	EMAP like 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312282	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of EML4 intron	PMID:28392331
1304690	Eml4	EMAP like 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EML4 mRNA	PMID:28628672
1304690	Eml4	EMAP like 4	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of EML4 gene	PMID:33148267
1304690	Eml4	EMAP like 4	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of EML4 mRNA	PMID:30589522
1304690	Eml4	EMAP like 4	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of EML4 promoter	PMID:22457795
1304690	Eml4	EMAP like 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EML4 mRNA	PMID:24386269
1304690	Eml4	EMAP like 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of EML4 mRNA	PMID:24449571
1304690	Eml4	EMAP like 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312282	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of EML4 mRNA	PMID:36331819
1304690	Eml4	EMAP like 4	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of EML4 mRNA	PMID:23125180
1304690	Eml4	EMAP like 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351948	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of EML4 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1304690	Eml4	EMAP like 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EML4 mRNA	PMID:27188386
1304690	Eml4	EMAP like 4	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of EML4 mRNA	PMID:30047161
1304690	Eml4	EMAP like 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of EML4 mRNA	PMID:20106945|PMID:25562108
1304690	Eml4	EMAP like 4	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EML4 mRNA	PMID:28628672
1304690	Eml4	EMAP like 4	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of EML4 mRNA	PMID:24136188
1304690	Eml4	EMAP like 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1351948	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of EML4 mRNA	PMID:24935251|PMID:26272509
1304690	Eml4	EMAP like 4	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EML4 mRNA	PMID:27188386
1304690	Eml4	EMAP like 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312282	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EML4 mRNA	PMID:17562736
1304690	Eml4	EMAP like 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of EML4 mRNA	PMID:30723492
1304690	Eml4	EMAP like 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of EML4 mRNA	PMID:21420995
1304690	Eml4	EMAP like 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EML4 mRNA	PMID:33387578
1304690	Eml4	EMAP like 4	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1351948	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of EML4 mRNA	PMID:20977926
1304690	Eml4	EMAP like 4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of EML4 mRNA	PMID:29391264
1304690	Eml4	EMAP like 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EML4 mRNA	PMID:22079256
1304690	Eml4	EMAP like 4	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in decreased expression of EML4 mRNA	PMID:17211630
1304690	Eml4	EMAP like 4	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EML4 mRNA	PMID:28628672
1304690	Eml4	EMAP like 4	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1351948	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of EML4 protein	PMID:25419056
1304690	Eml4	EMAP like 4	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of EML4 mRNA	PMID:30047161
1304690	Eml4	EMAP like 4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EML4 protein	PMID:32959892
1304690	Eml4	EMAP like 4	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of EML4 mRNA	PMID:25729387
1304690	Eml4	EMAP like 4	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of EML4 mRNA	PMID:24136188
1304690	Eml4	EMAP like 4	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of EML4 mRNA	PMID:15336504
1304690	Eml4	EMAP like 4	gene	CHEBI:64310	crizotinib	decreases stability	ISO	RGD:1351948	E	RGD:6480464	20170303	CTD	MESH:C551994	crizotinib results in decreased stability of EML4 protein mutant form	PMID:22912387
1304690	Eml4	EMAP like 4	gene	CHEBI:64310	crizotinib	increases mutagenesis	ISO	RGD:1351948	E	RGD:6480464	20170303	CTD	MESH:C551994	crizotinib results in increased mutagenesis of EML4 gene mutant form	PMID:21502504
1304690	Eml4	EMAP like 4	gene	CHEBI:64310	crizotinib	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20170303	CTD	MESH:C551994	[crizotinib results in increased mutagenesis of EML4 gene mutant form] which results in decreased susceptibility to crizotinib	PMID:21502504
1304690	Eml4	EMAP like 4	gene	CHEBI:6706	Mecamylamine	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20141111	CTD	MESH:D008464	Mecamylamine results in decreased expression of EML4 mRNA	PMID:12588870
1304690	Eml4	EMAP like 4	gene	CHEBI:6706	Mecamylamine	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20141111	CTD	MESH:D008464	Mecamylamine promotes the reaction [Nicotine results in decreased expression of EML4 mRNA]	PMID:12588870
1304690	Eml4	EMAP like 4	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1351948	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of EML4 intron	PMID:30157460
1304690	Eml4	EMAP like 4	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of EML4 gene	PMID:33148267
1304690	Eml4	EMAP like 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312282	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EML4 mRNA	PMID:22206623
1304690	Eml4	EMAP like 4	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of EML4 mRNA	PMID:24136188
1304690	Eml4	EMAP like 4	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of EML4 mRNA	PMID:22079256
1304690	Eml4	EMAP like 4	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EML4 mRNA	PMID:22079256
1304690	Eml4	EMAP like 4	gene	CHEBI:7599	Nivalenol	decreases expression	ISO	RGD:1312282	E	RGD:6480464	20220607	CTD	MESH:C038405	nivalenol results in decreased expression of EML4 mRNA	PMID:35016910
1304690	Eml4	EMAP like 4	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1351948	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of EML4 protein	PMID:39638853
1304690	Eml4	EMAP like 4	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1351948	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of EML4 mRNA	PMID:19287073
1304690	Eml4	EMAP like 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EML4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EML4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EML4 mRNA	PMID:27188386
1304690	Eml4	EMAP like 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EML4 gene]	PMID:28238834
1304690	Eml4	EMAP like 4	gene	CHEBI:80630	irinotecan	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan affects the expression of EML4 mRNA	PMID:20097248
1304690	Eml4	EMAP like 4	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of EML4 mRNA	PMID:30047161
1304690	Eml4	EMAP like 4	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312282	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of EML4 mRNA	PMID:19270015
1304690	Eml4	EMAP like 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EML4 mRNA	PMID:30047161
1304690	Eml4	EMAP like 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EML4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EML4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EML4 mRNA	PMID:27188386
1304690	Eml4	EMAP like 4	gene	CHEBI:9774	tubocurarine	multiple interactions	ISO	RGD:1351948	E	RGD:6480464	20120515	CTD	MESH:D014403	Tubocurarine inhibits the reaction [Nicotine results in decreased expression of EML4 mRNA]	PMID:12588870
1304690	Eml4	EMAP like 4	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of EML4 mRNA	PMID:19015723|PMID:23034163
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1312284	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of RABGAP1 promoter	PMID:24205000
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312284	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RABGAP1 mRNA	PMID:24205000
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312284	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RABGAP1 mRNA	PMID:36331819
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:15996	GTP	affects binding	EXP		E	RGD:6480464	20181016	CTD	MESH:D006160	[RAB3A protein binds to Guanosine Triphosphate] which binds to RABGAP1 protein	PMID:29289693
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:15996	GTP	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D006160	manganese chloride inhibits the reaction [[RAB3A protein binds to Guanosine Triphosphate] which binds to RABGAP1 protein]; SNCA protein promotes the reaction [manganese chloride inhibits the reaction [[RAB3A protein binds to Guanosine Triphosphate] which binds to RABGAP1 protein]]	PMID:29289693
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312284	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of RABGAP1 mRNA	PMID:30319688
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RABGAP1 gene	PMID:27618143
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of RABGAP1 mRNA	PMID:17938736
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312283	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RABGAP1 mRNA	PMID:21179406
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312284	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RABGAP1 mRNA	PMID:33754040
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RABGAP1 mRNA	PMID:27523638
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312283	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RABGAP1 protein	PMID:37730182
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312283	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RABGAP1 mRNA	PMID:23649840
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312284	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RABGAP1 mRNA	PMID:19770486
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312283	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RABGAP1 mRNA	PMID:23649840
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312283	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of RABGAP1 protein	PMID:38598786
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312284	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of RABGAP1 mRNA	PMID:25629700
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of RABGAP1 mRNA	PMID:19244175
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312283	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RABGAP1 mRNA	PMID:23557933
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RABGAP1 mRNA	PMID:19921347
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RABGAP1 mRNA	PMID:21215274|PMID:33387578
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases phosphorylation	EXP		E	RGD:6480464	20140715	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased phosphorylation of RABGAP1 protein	PMID:23298284
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RABGAP1 mRNA	PMID:34747641
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312284	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of RABGAP1 mRNA	PMID:30807115
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of RABGAP1 protein	PMID:30528433
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312283	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RABGAP1 mRNA	PMID:17879257|PMID:38568856
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312283	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RABGAP1 mRNA]	PMID:32406909
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312283	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RABGAP1 mRNA	PMID:25895662
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RABGAP1 mRNA	PMID:19150397
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312284	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RABGAP1 gene; titanium dioxide results in decreased methylation of RABGAP1 promoter; titanium dioxide results in decreased methylation of RABGAP1 promoter alternative form	PMID:35295148
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312284	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RABGAP1 promoter	PMID:35295148
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312284	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RABGAP1 mRNA	PMID:18301758
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RABGAP1 mRNA	PMID:25181051
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of RABGAP1 protein	PMID:31675489
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of RABGAP1 mRNA	PMID:41034487
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312283	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of RABGAP1 mRNA	PMID:29275510
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1312283	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of RABGAP1 protein	PMID:31675489
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RABGAP1 mRNA	PMID:19244175
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312284	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of RABGAP1 promoter	PMID:33297965
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312284	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RABGAP1 mRNA	PMID:38685157
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312283	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of RABGAP1 protein	PMID:38598786
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312283	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RABGAP1 mRNA	PMID:37042841
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312283	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RABGAP1 mRNA	PMID:26472689|PMID:38174414
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of RABGAP1 gene	PMID:22079235
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312283	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RABGAP1 mRNA	PMID:24449571
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of RABGAP1 mRNA	PMID:19244175
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312283	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RABGAP1 mRNA	PMID:31533062
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312284	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RABGAP1 mRNA	PMID:36331819
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312284	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RABGAP1 mRNA	PMID:17292431
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RABGAP1 mRNA	PMID:23179753
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312283	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RABGAP1 gene	PMID:29154799
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312283	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RABGAP1 mRNA	PMID:22230336
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312283	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RABGAP1 mRNA	PMID:22079256
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of RABGAP1 mRNA	PMID:30307764
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312284	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RABGAP1 mRNA; Nanotubes, Carbon results in decreased expression of RABGAP1 mRNA	PMID:25554681
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RABGAP1 protein	PMID:32959892
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C025340	manganese chloride inhibits the reaction [[RAB3A protein binds to Guanosine Triphosphate] which binds to RABGAP1 protein]; SNCA protein promotes the reaction [manganese chloride inhibits the reaction [[RAB3A protein binds to Guanosine Triphosphate] which binds to RABGAP1 protein]]	PMID:29289693
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of RABGAP1 mRNA	PMID:15336504
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1312283	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RABGAP1 mRNA	PMID:22079614
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RABGAP1 mRNA	PMID:22079256
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312283	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RABGAP1 mRNA	PMID:22079256
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1312284	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of RABGAP1 mRNA	PMID:27858113
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312283	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RABGAP1 protein	PMID:31675489
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312284	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RABGAP1 mRNA	PMID:21795629
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RABGAP1 mRNA	PMID:25825206
1304691	Rabgap1	RAB GTPase activating protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312283	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of RABGAP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of RABGAP1 protein	PMID:38598786
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PUS7L mRNA]	PMID:31150632
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PUS7L mRNA	PMID:33167477
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1332437	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PUS7L mRNA	PMID:30529165
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PUS7L mRNA	PMID:22378314
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332437	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PUS7L mRNA	PMID:39241906
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606495	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PUS7L mRNA	PMID:23019147|PMID:31614463
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PUS7L mRNA	PMID:23649840
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PUS7L mRNA	PMID:33387578
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PUS7L mRNA	PMID:28818685
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1606495	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PUS7L mRNA	PMID:35301059
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PUS7L mRNA	PMID:19549813
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PUS7L mRNA	PMID:23649840
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1606495	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PUS7L gene	PMID:27153756
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PUS7L mRNA	PMID:31150632
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PUS7L mRNA]	PMID:31150632
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332437	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PUS7L mRNA	PMID:21570461
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PUS7L mRNA	PMID:33387578
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1332437	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of PUS7L mRNA	PMID:32937126
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1606495	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of PUS7L mRNA	PMID:39709020
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PUS7L mRNA	PMID:29803840
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1606495	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PUS7L protein	PMID:35688186
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PUS7L mRNA	PMID:38568856
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332437	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PUS7L mRNA	PMID:22228805
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of PUS7L mRNA	PMID:25075043
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332437	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PUS7L gene	PMID:35295148
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PUS7L mRNA	PMID:34492290
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1332437	E	RGD:6480464	20120522	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PUS7L mRNA	PMID:19710929
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332437	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PUS7L mRNA	PMID:40203079
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332437	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PUS7L mRNA	PMID:17361019|PMID:21266533
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1606495	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of PUS7L mRNA	PMID:37047231
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606495	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PUS7L mRNA	PMID:37042841
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PUS7L mRNA	PMID:38568856
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1606495	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PUS7L mRNA	PMID:35301059
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PUS7L mRNA	PMID:28302478
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PUS7L mRNA	PMID:31533062
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PUS7L mRNA	PMID:27153767
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332437	E	RGD:6480464	20120522	CTD	MESH:D014635	Valproic Acid affects the expression of PUS7L mRNA	PMID:17963808
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1606495	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PUS7L gene	PMID:29154799
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606495	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PUS7L mRNA	PMID:25562108|PMID:27989131
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20120522	CTD	MESH:C011890	kojic acid results in decreased expression of PUS7L mRNA	PMID:16595896
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1606495	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PUS7L mRNA	PMID:27188386
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PUS7L mRNA	PMID:33387578
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1606495	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PUS7L mRNA	PMID:22079256
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:50035	alpha-phellandrene	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of PUS7L mRNA	PMID:25075043
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332437	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PUS7L mRNA; Nanotubes, Carbon results in increased expression of PUS7L mRNA	PMID:25554681
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PUS7L mRNA	PMID:28801915
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1332437	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of PUS7L mRNA	PMID:22470460
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PUS7L mRNA	PMID:22079256
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1606495	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PUS7L mRNA	PMID:22079256
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1606495	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of PUS7L mRNA	PMID:30928695
1304692	Pus7l	pseudouridine synthase 7 like	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1332437	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PUS7L mRNA	PMID:32835833
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312286	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MMS22L mRNA	PMID:38218311
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MMS22L mRNA	PMID:33045310
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MMS22L mRNA	PMID:33167477
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MMS22L mRNA	PMID:26079696
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1620630	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MMS22L mRNA	PMID:39241906
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of MMS22L mRNA	PMID:32145629
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312286	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MMS22L mRNA	PMID:38568856
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312286	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MMS22L mRNA	PMID:37042841
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of MMS22L mRNA	PMID:26079696
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	ISO	RGD:1312286	E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of MMS22L mRNA	PMID:38160208
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MMS22L mRNA	PMID:21592394
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312286	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MMS22L mRNA	PMID:21592394
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MMS22L mRNA	PMID:26577399|PMID:27523638
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MMS22L mRNA	PMID:21592394
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312286	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MMS22L mRNA	PMID:21592394
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312286	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of MMS22L intron	PMID:30157460
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312286	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MMS22L mRNA	PMID:22100608
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312286	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MMS22L intron	PMID:30157460
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of MMS22L mRNA	PMID:24336422
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620630	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MMS22L mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MMS22L mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of MMS22L mRNA	PMID:25658374|PMID:27106289|PMID:34911549
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1620630	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of MMS22L mRNA	PMID:25629700
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MMS22L mRNA	PMID:31881176
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of MMS22L mRNA	PMID:22023808
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620630	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MMS22L mRNA	PMID:26377647
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MMS22L mRNA	PMID:32109520
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MMS22L mRNA	PMID:33212167
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MMS22L mRNA	PMID:28959563
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:28794	coumarin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of MMS22L mRNA	PMID:18480146
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of MMS22L mRNA	PMID:22363485
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MMS22L mRNA	PMID:38568856
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312286	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MMS22L intron	PMID:30157460
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MMS22L mRNA	PMID:20064835
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312286	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MMS22L mRNA	PMID:26238291|PMID:32234424
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312286	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MMS22L mRNA	PMID:26238291
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MMS22L mRNA	PMID:25729387
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MMS22L mRNA	PMID:25729387
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MMS22L mRNA	PMID:30047161
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620630	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MMS22L gene; titanium dioxide results in decreased methylation of MMS22L promoter	PMID:35295148
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of MMS22L mRNA	PMID:34492290
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1620630	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MMS22L mRNA	PMID:20813756
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1620630	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of MMS22L mRNA	PMID:20813756
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MMS22L mRNA	PMID:25181051|PMID:32145629
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MMS22L mRNA	PMID:29275510|PMID:33670352
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MMS22L mRNA	PMID:26063408
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of MMS22L mRNA	PMID:41034487
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MMS22L gene	PMID:28505145
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MMS22L mRNA	PMID:40203079
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MMS22L mRNA	PMID:28392331
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MMS22L mRNA	PMID:21266533
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312286	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MMS22L mRNA	PMID:37042841
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MMS22L mRNA	PMID:30723492
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MMS22L mRNA	PMID:33453195
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of MMS22L mRNA	PMID:25539665|PMID:26194646
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MMS22L mRNA	PMID:30047161
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of MMS22L mRNA	PMID:24386269
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MMS22L mRNA	PMID:40194260
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MMS22L mRNA	PMID:31533062
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MMS22L mRNA	PMID:39529242
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of MMS22L mRNA	PMID:22110744
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MMS22L mRNA	PMID:30047161
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:41607	crotonaldehyde	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of MMS22L mRNA	PMID:20471460
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MMS22L mRNA	PMID:33387578
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MMS22L mRNA	PMID:30047161
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1620630	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MMS22L mRNA	PMID:19042947
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1620630	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MMS22L mRNA	PMID:38701926
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MMS22L mRNA	PMID:25729387
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MMS22L mRNA	PMID:25729387
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of MMS22L mRNA	PMID:35283115
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of MMS22L mRNA	PMID:28960945
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312286	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of MMS22L mRNA	PMID:30928695
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620630	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MMS22L mRNA	PMID:23091169
1304693	Mms22l	MMS22-like, DNA repair protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MMS22L mRNA	PMID:24780913|PMID:30047161
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA0930 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA0930 mRNA	PMID:32699268
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1312287	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of KIAA0930 protein	PMID:35688186
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312287	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KIAA0930 mRNA	PMID:37042841
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312287	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KIAA0930 protein	PMID:37730182
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312287	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of KIAA0930 intron	PMID:30157460
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of KIAA0930 mRNA	PMID:28522335
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312287	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KIAA0930 intron	PMID:30157460
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA0930 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA0930 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of KIAA0930 mRNA	PMID:32699268
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312287	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KIAA0930 gene	PMID:25304211
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20120412	CTD	MESH:D003513	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of KIAA0930 mRNA	PMID:19684285
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312287	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of KIAA0930 protein	PMID:35688186
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312287	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of KIAA0930 mRNA	PMID:23300844
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312287	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of KIAA0930 mRNA	PMID:23195993
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIAA0930 mRNA	PMID:34747641
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312287	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIAA0930 mRNA	PMID:19684285|PMID:20106945
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20120412	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of KIAA0930 mRNA; [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of KIAA0930 mRNA	PMID:19684285|PMID:26159488
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D012402	Rotenone results in increased expression of KIAA0930 mRNA	PMID:28374803
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312287	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KIAA0930 mRNA	PMID:29803840
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312287	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of KIAA0930 mRNA	PMID:34032870
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312287	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KIAA0930 mRNA	PMID:20106945
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of KIAA0930 gene	PMID:31601247
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D013853	Thioacetamide results in increased expression of KIAA0930 mRNA	PMID:23411599
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312287	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KIAA0930 gene	PMID:31601247
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KIAA0930 mRNA	PMID:25181051
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of KIAA0930 gene	PMID:31601247
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312287	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of KIAA0930 mRNA	PMID:19244175
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312287	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of KIAA0930 intron	PMID:30157460
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312287	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KIAA0930 mRNA	PMID:38568856
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA0930 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA0930 mRNA	PMID:32699268
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312287	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of KIAA0930 mRNA	PMID:31533062
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312287	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KIAA0930 mRNA	PMID:25979313
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312287	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of KIAA0930 mRNA	PMID:19101580|PMID:23179753|PMID:26272509|PMID:28001369
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIAA0930 mRNA	PMID:27188386
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312287	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of KIAA0930 mRNA	PMID:28542535
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312287	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of KIAA0930 mRNA	PMID:21420995
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D000082	Acetaminophen results in increased expression of KIAA0930 mRNA	PMID:33387578
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312287	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of KIAA0930 mRNA	PMID:29067470
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312287	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of KIAA0930 mRNA	PMID:24714768
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312287	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KIAA0930 gene	PMID:25304211
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:4791	endosulfan	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of KIAA0930 mRNA	PMID:26159488
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312287	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of KIAA0930 mRNA	PMID:23300844
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312287	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of KIAA0930 mRNA	PMID:24810058
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312287	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of KIAA0930 intron	PMID:30157460
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIAA0930 mRNA	PMID:27188386
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of KIAA0930 mRNA	PMID:32109520
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of KIAA0930 mRNA	PMID:27291303
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KIAA0930 mRNA	PMID:23914054
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:85014	2,5-hexanedione	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C011269	2,5-hexanedione results in increased expression of KIAA0930 mRNA	PMID:22952946
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KIAA0930 mRNA	PMID:24780913
1304694	Kiaa0930	KIAA0930 homolog	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312287	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIAA0930 mRNA	PMID:27188386
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551989	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC39A13 mRNA	PMID:33045310
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1551989	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SLC39A13 mRNA	PMID:26251327
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551989	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC39A13 mRNA	PMID:39241906
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551989	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC39A13 mRNA	PMID:39298647
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312289	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC39A13 mRNA	PMID:37042841
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1551989	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SLC39A13 mRNA	PMID:23892564
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312289	E	RGD:6480464	20130212	CTD	MESH:D002117	Calcitriol results in decreased expression of SLC39A13 mRNA	PMID:20089671
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SLC39A13 mRNA	PMID:33387578
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551989	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC39A13 mRNA	PMID:19770486
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:27363	zinc atom	affects localization	ISO	RGD:1551989	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A13 protein affects the localization of Zinc	PMID:18985159
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SLC39A13 mRNA	PMID:20859692
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1551989	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in increased expression of SLC39A13 mRNA	PMID:22228435
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:27363	zinc atom	increases transport	ISO	RGD:1312289	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A13 protein results in increased transport of Zinc	PMID:18326752
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1551989	E	RGD:6480464	20130122	CTD	MESH:D015032	[[Zinc affects the localization of MTF1 protein] promotes the reaction [MTF1 protein binds to SLC39A13 promoter]] which results in increased expression of SLC39A13 mRNA; [Zinc affects the localization of MTF1 protein] promotes the reaction [MTF1 protein binds to SLC39A13 promoter]; [Zinc deficiency promotes the reaction [NFIC protein binds to SLC39A13 protein]] which results in decreased expression of SLC39A13 mRNA; Zinc deficiency promotes the reaction [NFIC protein binds to SLC39A13 protein]	PMID:22228435
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1551989	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SLC39A13 mRNA	PMID:28960355
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC39A13 mRNA	PMID:31881176
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551989	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC39A13 mRNA	PMID:20702594|PMID:21570461
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC39A13 mRNA	PMID:34747641
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC39A13 mRNA	PMID:26232522
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312289	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SLC39A13 mRNA	PMID:33212167
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312289	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SLC39A13 mRNA	PMID:32763439
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312289	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of SLC39A13 mRNA	PMID:29803840
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312289	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SLC39A13 mRNA	PMID:20044591
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312289	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC39A13 mRNA	PMID:39719251
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551989	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC39A13 mRNA	PMID:15034205
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312289	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC39A13 3' UTR	PMID:27901495
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551989	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC39A13 mRNA	PMID:20713471
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:30185	zinc(0)	affects localization	ISO	RGD:1551989	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A13 protein affects the localization of Zinc	PMID:18985159
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SLC39A13 mRNA	PMID:20859692
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1551989	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in increased expression of SLC39A13 mRNA	PMID:22228435
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:30185	zinc(0)	increases transport	ISO	RGD:1312289	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A13 protein results in increased transport of Zinc	PMID:18326752
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1551989	E	RGD:6480464	20130122	CTD	MESH:D015032	[[Zinc affects the localization of MTF1 protein] promotes the reaction [MTF1 protein binds to SLC39A13 promoter]] which results in increased expression of SLC39A13 mRNA; [Zinc affects the localization of MTF1 protein] promotes the reaction [MTF1 protein binds to SLC39A13 promoter]; [Zinc deficiency promotes the reaction [NFIC protein binds to SLC39A13 protein]] which results in decreased expression of SLC39A13 mRNA; Zinc deficiency promotes the reaction [NFIC protein binds to SLC39A13 protein]	PMID:22228435
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312289	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SLC39A13 mRNA	PMID:19128835
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551989	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC39A13 promoter	PMID:35295148
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551989	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SLC39A13 gene; titanium dioxide results in increased methylation of SLC39A13 promoter	PMID:35295148
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC39A13 mRNA	PMID:34492290
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC39A13 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SLC39A13 mRNA	PMID:25181051
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1551989	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SLC39A13 gene	PMID:31683443
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1551989	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC39A13 mRNA	PMID:37019170
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312289	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC39A13 mRNA	PMID:37042841
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC39A13 mRNA	PMID:35163327
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC39A13 mRNA	PMID:35163327
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SLC39A13 mRNA	PMID:24386269
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312289	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SLC39A13 mRNA	PMID:19320972
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312289	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SLC39A13 mRNA	PMID:40419075
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SLC39A13 mRNA	PMID:27281708
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551989	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC39A13 mRNA	PMID:17562736
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC39A13 mRNA	PMID:33387578
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1312289	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SLC39A13 mRNA	PMID:38568856
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312289	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SLC39A13 mRNA	PMID:19128835
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551989	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SLC39A13 mRNA	PMID:22206623
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1551989	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of SLC39A13 mRNA	PMID:20702594
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of SLC39A13 mRNA	PMID:32109520
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	ISO	RGD:1551989	E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SLC39A13 mRNA	PMID:22228435
1304695	Slc39a13	solute carrier family 39 member 13	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SLC39A13 mRNA	PMID:21346803
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312291	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TXNDC15 mRNA	PMID:37995155
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312290	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TXNDC15 mRNA	PMID:26079696
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312291	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TXNDC15 mRNA	PMID:30319688
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312290	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TXNDC15 mRNA	PMID:21632981
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312291	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TXNDC15 mRNA	PMID:39298647
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312290	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TXNDC15 mRNA	PMID:37042841
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312291	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TXNDC15 mRNA	PMID:33754040
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312291	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TXNDC15 mRNA	PMID:36331819
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312290	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312290	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TXNDC15 mRNA	PMID:19549813
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312290	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TXNDC15 gene	PMID:27153756
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TXNDC15 mRNA	PMID:31150632
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312291	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TXNDC15 mRNA	PMID:31919559
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312291	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TXNDC15 mRNA	PMID:22206623
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312290	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TXNDC15 mRNA	PMID:31881176
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of TXNDC15 mRNA	PMID:20187946
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312291	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TXNDC15 mRNA	PMID:21570461
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TXNDC15 mRNA	PMID:33387578
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of TXNDC15 mRNA	PMID:19013527
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312290	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TXNDC15 mRNA	PMID:39719251
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312290	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of TXNDC15 mRNA	PMID:24136188
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312291	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TXNDC15 gene	PMID:35295148
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	ISO	RGD:1312290	E	RGD:6480464	20250708	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of TXNDC15 gene	PMID:38723642
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of TXNDC15 mRNA	PMID:41034487
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TXNDC15 mRNA	PMID:25181051|PMID:34947998
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TXNDC15 gene	PMID:28505145
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312290	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TXNDC15 mRNA	PMID:33453195
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312290	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TXNDC15 mRNA	PMID:31533062
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312291	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TXNDC15 mRNA	PMID:36331819
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312290	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TXNDC15 mRNA	PMID:25979313
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312290	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TXNDC15 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:28001369|PMID:29154799
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312290	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNDC15 mRNA	PMID:27188386
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312290	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of TXNDC15 mRNA	PMID:20106945
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312290	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TXNDC15 mRNA	PMID:25562108|PMID:27989131
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312291	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TXNDC15 mRNA	PMID:17562736
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TXNDC15 mRNA	PMID:33387578
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312290	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of TXNDC15 mRNA	PMID:29067470
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312290	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312290	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TXNDC15 mRNA	PMID:18175754
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312291	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TXNDC15 mRNA; Nanotubes, Carbon results in decreased expression of TXNDC15 mRNA	PMID:25620056
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312290	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TXNDC15 protein	PMID:32959892
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312290	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312291	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TXNDC15 mRNA	PMID:21641980
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312291	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TXNDC15 mRNA	PMID:22206623
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312290	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNDC15 mRNA	PMID:27188386
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312291	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TXNDC15 mRNA	PMID:39847705
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312290	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNDC15 mRNA	PMID:27188386
1304696	Txndc15	thioredoxin domain containing 15	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312291	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TXNDC15 mRNA	PMID:35537566
1304697	Actl7a	actin-like 7a	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312292	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ACTL7A mRNA	PMID:20044591
1304697	Actl7a	actin-like 7a	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ACTL7A mRNA	PMID:33387578
1304697	Actl7a	actin-like 7a	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ACTL7A gene	PMID:27618143
1304697	Actl7a	actin-like 7a	gene	CHEBI:17578	toluene	decreases methylation	ISO	RGD:1312292	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased methylation of ACTL7A gene	PMID:26717081
1304697	Actl7a	actin-like 7a	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1312292	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased expression of ACTL7A mRNA	PMID:26717081
1304697	Actl7a	actin-like 7a	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312292	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ACTL7A mRNA	PMID:21867686
1304697	Actl7a	actin-like 7a	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ACTL7A mRNA	PMID:31881176
1304697	Actl7a	actin-like 7a	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312293	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACTL7A mRNA	PMID:21570461|PMID:24680724
1304697	Actl7a	actin-like 7a	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACTL7A mRNA	PMID:33387578
1304697	Actl7a	actin-like 7a	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312293	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACTL7A mRNA	PMID:17942748
1304697	Actl7a	actin-like 7a	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312292	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ACTL7A mRNA	PMID:33212167
1304697	Actl7a	actin-like 7a	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312293	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ACTL7A protein	PMID:28918527
1304697	Actl7a	actin-like 7a	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312292	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ACTL7A mRNA	PMID:38568856
1304697	Actl7a	actin-like 7a	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ACTL7A mRNA	PMID:19167457
1304697	Actl7a	actin-like 7a	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ACTL7A mRNA	PMID:25181051
1304697	Actl7a	actin-like 7a	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312292	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ACTL7A gene	PMID:31601247
1304697	Actl7a	actin-like 7a	gene	CHEBI:34750	Ethylenethiourea	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D005031	Ethylenethiourea results in decreased expression of ACTL7A mRNA	PMID:27905518
1304697	Actl7a	actin-like 7a	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312292	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ACTL7A gene	PMID:29154799
1304697	Actl7a	actin-like 7a	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312293	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACTL7A mRNA	PMID:17942748
1304697	Actl7a	actin-like 7a	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312293	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ACTL7A mRNA	PMID:23608068
1304697	Actl7a	actin-like 7a	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312292	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ACTL7A gene]	PMID:28238834
1304697	Actl7a	actin-like 7a	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1312292	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of ACTL7A mRNA	PMID:30458266
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1624076	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SRPRB mRNA	PMID:20188158
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312294	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SRPRB mRNA	PMID:33167477
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312294	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SRPRB mRNA	PMID:20044591
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1624076	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SRPRB mRNA	PMID:39241906
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312294	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SRPRB mRNA	PMID:31614463
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1624076	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SRPRB mRNA	PMID:39298647
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [SRPRB protein binds to ESR1 protein]	PMID:27156127
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312294	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SRPRB mRNA	PMID:37042841
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312294	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SRPRB mRNA	PMID:33359661
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SRPRB mRNA	PMID:33848595
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SRPRB mRNA	PMID:22061828
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SRPRB mRNA	PMID:36331819
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312294	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SRPRB mRNA	PMID:19549813
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SRPRB protein	PMID:23301498
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of SRPRB mRNA	PMID:19483382
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SRPRB mRNA	PMID:30723492
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1624076	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SRPRB mRNA	PMID:27339419|PMID:31919559
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPRB mRNA	PMID:40504410
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312294	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SRPRB protein	PMID:35688186
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1624076	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SRPRB mRNA	PMID:28960355
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1624076	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SRPRB protein	PMID:25505154
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of SRPRB mRNA	PMID:32186404
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1624076	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SRPRB mRNA	PMID:21570461
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SRPRB mRNA	PMID:21354282
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRPRB mRNA	PMID:17942748
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312294	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SRPRB mRNA	PMID:33212167
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SRPRB mRNA	PMID:39631538
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of SRPRB mRNA	PMID:19072884
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of SRPRB protein	PMID:29459688
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPRB mRNA	PMID:40504410
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312294	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SRPRB mRNA; Tunicamycin results in increased expression of SRPRB protein	PMID:22378314|PMID:29453283
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SRPRB mRNA	PMID:20127859
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of SRPRB mRNA	PMID:19483382
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1624076	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SRPRB mRNA	PMID:23221170
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312294	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SRPRB mRNA	PMID:19150397
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of SRPRB gene	PMID:31601247
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SRPRB mRNA	PMID:24136188
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of SRPRB mRNA	PMID:24136188
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1624076	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of SRPRB mRNA	PMID:27760801
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of SRPRB mRNA	PMID:19483382
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of SRPRB mRNA	PMID:19483382
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312294	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SRPRB mRNA	PMID:30903817
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SRPRB mRNA	PMID:34947998
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SRPRB mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312294	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SRPRB protein	PMID:34186270
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312294	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SRPRB mRNA	PMID:25979313
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of SRPRB mRNA	PMID:33297965
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1624076	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SRPRB mRNA	PMID:39298647
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of SRPRB gene	PMID:31601247
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312294	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SRPRB protein	PMID:34186270
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1624076	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SRPRB mRNA	PMID:37019170
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1624076	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of SRPRB mRNA	PMID:34813904
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312294	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SRPRB mRNA	PMID:37042841
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:35549	perfluorooctanoic acid	affects methylation	ISO	RGD:1312294	E	RGD:6480464	20220405	CTD	MESH:C023036	perfluorooctanoic acid affects the methylation of SRPRB gene	PMID:35266797
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SRPRB gene	PMID:22079235
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of SRPRB mRNA	PMID:19483382
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312294	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SRPRB mRNA	PMID:28302478
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312294	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SRPRB mRNA	PMID:19167446
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRPRB mRNA	PMID:19167446
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312294	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SRPRB mRNA	PMID:40419075
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SRPRB mRNA	PMID:36331819
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312294	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SRPRB gene	PMID:29154799
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312294	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SRPRB mRNA	PMID:23179753|PMID:29154799
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312294	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SRPRB mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1624076	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of SRPRB mRNA	PMID:19770486
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SRPRB mRNA	PMID:17555576
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312294	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of SRPRB mRNA	PMID:28542535
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SRPRB mRNA	PMID:17562736
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPRB mRNA	PMID:40504410
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SRPRB mRNA	PMID:35436446
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of SRPRB mRNA	PMID:19483382
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SRPRB mRNA	PMID:17555576
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SRPRB mRNA	PMID:17942748
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRPRB mRNA	PMID:17942748
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1624076	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SRPRB mRNA; Nanotubes, Carbon results in increased expression of SRPRB mRNA	PMID:25554681|PMID:25620056
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20161228	CTD	MESH:D037742	[Nanotubes, Carbon co-treated with calfactant] results in increased expression of SRPRB protein	PMID:23026733
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SRPRB mRNA	PMID:24793618
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312294	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SRPRB protein	PMID:32959892
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:63630	tolcapone	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to SRPRB protein	PMID:19783845
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312294	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SRPRB mRNA	PMID:31758290
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312294	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SRPRB protein	PMID:34186270
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1624076	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SRPRB mRNA	PMID:22206623
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:749466	calfactant	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20260721	CTD	MESH:C117342	[Nanotubes, Carbon co-treated with calfactant] results in increased expression of SRPRB protein	PMID:23026733
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312294	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SRPRB mRNA	PMID:37199045
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of SRPRB mRNA	PMID:19483382
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of SRPRB mRNA	PMID:19483382
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SRPRB gene]	PMID:28238834
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312294	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRPRB mRNA	PMID:19167446
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1624076	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SRPRB mRNA	PMID:30294300
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SRPRB mRNA	PMID:21278054
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of SRPRB mRNA	PMID:19483382
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SRPRB mRNA	PMID:19281266
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312294	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SRPRB mRNA	PMID:38568856
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of SRPRB protein	PMID:35544339
1304698	Srprb	SRP receptor subunit beta	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312294	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of SRPRB mRNA	PMID:22378314
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312295	E	RGD:6480464	20170725	CTD	MESH:C118739	entinostat results in increased expression of NAXE mRNA	PMID:27188386
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:133296	microcystin RR	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20161004	CTD	MESH:C063855	microcystin RR results in decreased expression of NAXE protein	PMID:19111056
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312296	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NAXE mRNA	PMID:36331819
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NAXE mRNA	PMID:22378314
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NAXE mRNA	PMID:39298647
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312295	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NAXE mRNA	PMID:37042841
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312296	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NAXE mRNA	PMID:33754040
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NAXE mRNA	PMID:22061828
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20221206	CTD	MESH:D014520	Urethane results in decreased expression of NAXE mRNA	PMID:28818685
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of NAXE mRNA	PMID:23649840
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312296	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAXE mRNA	PMID:22206623
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of NAXE protein	PMID:37834424
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312295	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NAXE protein	PMID:38460933
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of NAXE mRNA	PMID:31881176
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NAXE mRNA	PMID:21570461
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NAXE promoter]	PMID:19654925
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NAXE mRNA	PMID:33212167
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NAXE mRNA	PMID:32763439
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312295	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NAXE mRNA	PMID:29803840
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of APOA1BP protein; sodium arsenite results in decreased expression of NAXE mRNA	PMID:38228842|PMID:38568856
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312295	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of NAXE mRNA	PMID:34032870
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312295	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to NAXE mRNA]	PMID:32406909
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312296	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of APOA1BP gene	PMID:35295148
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NAXE mRNA	PMID:34492290
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of NAXE mRNA	PMID:19167457
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NAXE mRNA	PMID:33221593
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NAXE mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312295	E	RGD:6480464	20170725	CTD	MESH:C006780	bisphenol A results in increased expression of NAXE mRNA	PMID:25047013
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312296	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of NAXE mRNA	PMID:40203079
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312296	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NAXE mRNA	PMID:37019170
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAXE mRNA	PMID:21266533
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312296	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of NAXE mRNA	PMID:34813904
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312295	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NAXE protein	PMID:24527689
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NAXE mRNA	PMID:24982889
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312296	E	RGD:6480464	20171114	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NAXE protein	PMID:28126411|PMID:37422089
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NAXE mRNA	PMID:19320972
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312295	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of NAXE mRNA	PMID:24449571
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312296	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NAXE mRNA	PMID:40194260
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312295	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NAXE mRNA	PMID:40419075
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312296	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NAXE mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NAXE mRNA	PMID:36331819
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312295	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NAXE mRNA	PMID:25979313
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312295	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NAXE mRNA	PMID:23179753|PMID:27188386
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D014635	Valproic Acid results in increased expression of NAXE mRNA	PMID:21427059
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NAXE mRNA	PMID:20106945|PMID:25562108
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312295	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NAXE mRNA	PMID:22230336
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312295	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NAXE protein	PMID:38460933
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of NAXE protein	PMID:37834424
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NAXE protein	PMID:32959892
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20221206	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NAXE mRNA	PMID:22206623
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312296	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAXE mRNA	PMID:22206623
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312295	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NAXE protein	PMID:37664457
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in decreased expression of NAXE protein	PMID:35881160
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in decreased expression of NAXE protein	PMID:35881160
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312296	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of NAXE mRNA	PMID:31388691
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of NAXE mRNA	PMID:40826991
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312295	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NAXE protein	PMID:37664457
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D013605	T-2 Toxin results in increased expression of NAXE mRNA	PMID:42167635
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312295	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NAXE mRNA	PMID:38568856
1304699	Naxe	NAD(P)HX epimerase	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D013792	Thalidomide results in decreased expression of NAXE mRNA	PMID:26217789
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NDST2 mRNA	PMID:38218311
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NDST2 mRNA]	PMID:31150632
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:D001241	Aspirin results in increased expression of NDST2 mRNA	PMID:11906190
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NDST2 mRNA	PMID:36331819
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20170207	CTD	MESH:C029424	hydrazine results in decreased expression of NDST2 mRNA	PMID:15282401
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:C018475	butyraldehyde results in decreased expression of NDST2 mRNA	PMID:26079696
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312298	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of NDST2 mRNA	PMID:30319688
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312298	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDST2 mRNA	PMID:39241906
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312297	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NDST2 mRNA	PMID:37042841
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:C044887	beta-methylcholine affects the expression of NDST2 mRNA	PMID:21179406
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NDST2 mRNA	PMID:33387578
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NDST2 mRNA	PMID:36331819
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312297	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NDST2 mRNA	PMID:39836092
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NDST2 mRNA	PMID:39012411
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NDST2 mRNA	PMID:19549813
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312297	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of NDST2 mRNA	PMID:35430440
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NDST2 mRNA	PMID:34911549
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NDST2 mRNA	PMID:31150632
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NDST2 mRNA]	PMID:31150632
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312297	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NDST2 mRNA	PMID:39836092
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDST2 mRNA	PMID:33387578
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312298	E	RGD:6480464	20170207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDST2 mRNA	PMID:17942748
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20170207	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NDST2 mRNA	PMID:17942748
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NDST2 mRNA	PMID:28001369
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDST2 mRNA	PMID:30851411
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NDST2 mRNA	PMID:32763439
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28815	heparan sulfate	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20170207	CTD	MESH:D006497	Heparan Sulfate affects the susceptibility to [NDST1 protein co-treated with NDST2 protein]; Heparan Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK1 protein]; Heparan Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK3 protein]	PMID:19937756
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312297	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NDST2 mRNA	PMID:39836092
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312298	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NDST2 gene	PMID:35295148
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D013853	Thioacetamide results in decreased expression of NDST2 mRNA	PMID:23411599
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20170207	CTD	MESH:C006253	pirinixic acid results in decreased expression of NDST2 mRNA	PMID:20813756
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NDST2 mRNA	PMID:34947998
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:C006780	bisphenol A results in increased expression of NDST2 mRNA	PMID:25181051|PMID:30816183
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NDST2 mRNA	PMID:21266533
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of NDST2 mRNA	PMID:34813904
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312297	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NDST2 mRNA	PMID:39836092
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20170214	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of NDST2 promoter	PMID:22457795
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NDST2 mRNA	PMID:39012411
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NDST2 mRNA	PMID:19320972
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NDST2 mRNA	PMID:24449571
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NDST2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NDST2 mRNA	PMID:36331819
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:D014635	Valproic Acid affects the expression of NDST2 mRNA	PMID:25979313
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312298	E	RGD:6480464	20170207	CTD	MESH:D014635	Valproic Acid affects the expression of NDST2 mRNA	PMID:17292431
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20170207	CTD	MESH:D014635	Valproic Acid results in decreased expression of NDST2 mRNA	PMID:21427059
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312298	E	RGD:6480464	20170207	CTD	MESH:D014635	Valproic Acid results in increased expression of NDST2 mRNA	PMID:21427059
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312297	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NDST2 gene	PMID:29154799
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:D000082	Acetaminophen affects the expression of NDST2 mRNA	PMID:25458485
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of NDST2 mRNA	PMID:29279043
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312297	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NDST2 mRNA	PMID:39836092
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NDST2 mRNA	PMID:22079256
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312298	E	RGD:6480464	20170207	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NDST2 mRNA	PMID:17942748
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20170207	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NDST2 mRNA	PMID:17942748
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312297	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NDST2 mRNA	PMID:39836092
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D008694	Methamphetamine results in decreased expression of NDST2 mRNA	PMID:19564919
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:749301	potassium perchlorate	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of NDST2 mRNA	PMID:29673971
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NDST2 mRNA	PMID:22079256
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NDST2 mRNA	PMID:22079256
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDST2 mRNA	PMID:30851411
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:D012999	Soman results in decreased expression of NDST2 mRNA	PMID:19281266
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20170214	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NDST2 mRNA	PMID:21346803
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1312297	E	RGD:6480464	20170207	CTD	MESH:D013467	Sulindac results in decreased expression of NDST2 mRNA	PMID:11906190
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of NDST2 mRNA	PMID:28973697
1304700	Ndst2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170214	CTD	MESH:C025643	vinclozolin results in increased expression of NDST2 mRNA	PMID:23034163
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1312299	E	RGD:6480464	20200804	CTD	MESH:D015025	Zearalenone results in increased expression of PRMT6 mRNA	PMID:32119988
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PRMT6 mRNA	PMID:33045310
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PRMT6 mRNA]	PMID:31150632
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of PRMT6 mRNA	PMID:31016361
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PRMT6 mRNA	PMID:33167477
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550002	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRMT6 mRNA	PMID:30529165
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PRMT6 mRNA	PMID:22378314
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:16118	berberine	increases expression	ISO	RGD:1312299	E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in increased expression of PRMT6 mRNA	PMID:27311644
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550002	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PRMT6 mRNA	PMID:30319688
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PRMT6 mRNA	PMID:39241906
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312299	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of PRMT6 mRNA	PMID:31614463
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550002	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of PRMT6 mRNA	PMID:25210133
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312299	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PRMT6 mRNA	PMID:38568856
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312299	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PRMT6 mRNA	PMID:37042841
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:16680	S-adenosyl-L-homocysteine	decreases activity	ISO	RGD:1312299	E	RGD:6480464	20220111	CTD	MESH:D012435	S-Adenosylhomocysteine results in decreased activity of PRMT6 protein	PMID:33577917
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PRMT6 mRNA	PMID:20655997
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20241001	CTD	MESH:D005557	Formaldehyde results in decreased expression of PRMT6 mRNA; Formaldehyde results in decreased expression of PRMT6 protein	PMID:33233951
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312299	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PRMT6 mRNA	PMID:21179406
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1550002	E	RGD:6480464	20140916	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PRMT6 mRNA	PMID:23892564
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312299	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PRMT6 protein	PMID:37730182
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PRMT6 mRNA	PMID:33387578
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PRMT6 mRNA	PMID:28818685
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550002	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRMT6 mRNA	PMID:37236586
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PRMT6 mRNA	PMID:19549813
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PRMT6 mRNA	PMID:23649840
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550002	E	RGD:6480464	20140916	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PRMT6 mRNA	PMID:19770486
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312299	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PRMT6 gene	PMID:27153756
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PRMT6 mRNA	PMID:23649840
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PRMT6 mRNA	PMID:30779732
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PRMT6 mRNA	PMID:31150632
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PRMT6 mRNA]	PMID:31150632
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312299	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRMT6 gene	PMID:25304211
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312299	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PRMT6 mRNA	PMID:32525701
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550002	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PRMT6 mRNA	PMID:28960355
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of PRMT6 mRNA	PMID:19371625
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1312299	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of PRMT6 mRNA	PMID:19921347
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27958	cocaine	affects response to substance	ISO	RGD:1312299	E	RGD:6480464	20180220	CTD	MESH:D003042	PRMT6 protein affects the susceptibility to Cocaine	PMID:27506785
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:11561325|PMID:27506785	20250326	RGD	MESH:D003042	cocaine decreases expression of Prmt6 mRNA and protein in nucleus accumbens	
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20180220	CTD	MESH:D003042	Cocaine results in decreased expression of PRMT6 mRNA	PMID:27506785
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20180220	CTD	MESH:D003042	Cocaine results in decreased expression of PRMT6 mRNA; Cocaine results in decreased expression of PRMT6 protein	PMID:27506785
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1312299	E	RGD:6480464	20180220	CTD	MESH:D003042	PRMT6 protein inhibits the reaction [Cocaine results in increased expression of SRCIN1 protein]	PMID:27506785
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PRMT6 mRNA	PMID:32186404
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550002	E	RGD:6480464	20140916	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRMT6 mRNA	PMID:21570461
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PRMT6 mRNA	PMID:28001369
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PRMT6 mRNA	PMID:33212167
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PRMT6 mRNA	PMID:32763439
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRMT6 mRNA	PMID:38568856
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PRMT6 mRNA	PMID:22378314
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312299	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRMT6 3' UTR	PMID:27901495
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312299	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PRMT6 exon	PMID:27901495
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PRMT6 mRNA	PMID:20382639
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PRMT6 mRNA	PMID:35984750
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of PRMT6 mRNA	PMID:31745603
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PRMT6 mRNA	PMID:29264374
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PRMT6 mRNA	PMID:34492290
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRMT6 mRNA	PMID:25181051|PMID:34973380
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PRMT6 mRNA	PMID:29275510
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of PRMT6 mRNA	PMID:26063408|PMID:33221593
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1550002	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of PRMT6 promoter	PMID:27312807
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PRMT6 mRNA	PMID:30816183|PMID:34947998
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20140916	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PRMT6 mRNA	PMID:21266533
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20140408	CTD	MESH:D010269	Paraquat results in decreased expression of PRMT6 mRNA	PMID:23613995
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312299	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PRMT6 mRNA	PMID:37042841
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PRMT6 mRNA	PMID:38174414
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550002	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRMT6 mRNA	PMID:37236586
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PRMT6 mRNA	PMID:24386269
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PRMT6 mRNA	PMID:40194260
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312299	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PRMT6 mRNA	PMID:23179753
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PRMT6 mRNA	PMID:20106945|PMID:25562108
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1550002	E	RGD:6480464	20140916	CTD	MESH:D016572	Cyclosporine results in increased expression of PRMT6 mRNA	PMID:19770486
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312299	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PRMT6 mRNA	PMID:28542535
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550002	E	RGD:6480464	20140916	CTD	MESH:D000082	Acetaminophen affects the expression of PRMT6 mRNA	PMID:17562736
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRMT6 mRNA	PMID:33387578
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312299	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRMT6 gene	PMID:25304211
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312299	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PRMT6 mRNA	PMID:32525701
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PRMT6 mRNA	PMID:29391264
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:50819	ferric oxide	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in decreased expression of PRMT6 mRNA	PMID:25086211
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550002	E	RGD:6480464	20140916	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PRMT6 mRNA	PMID:19042947
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:63580	ribavirin	affects expression	ISO	RGD:1312299	E	RGD:6480464	20220607	CTD	MESH:D012254	Ribavirin affects the expression of PRMT6 protein	PMID:34919946
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of PRMT6 mRNA	PMID:39847705
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312299	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PRMT6 mRNA	PMID:32525701
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140916	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PRMT6 mRNA	PMID:21346803
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312299	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PRMT6 mRNA	PMID:29301935
1304701	Prmt6	protein arginine methyltransferase 6	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1550002	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of PRMT6 mRNA	PMID:35537566
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of COLGALT2 mRNA	PMID:38218311
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of COLGALT2 mRNA	PMID:26272509
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA	PMID:27188386
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552303	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COLGALT2 mRNA	PMID:33045310
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552303	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of COLGALT2 mRNA	PMID:37995155
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of COLGALT2 mRNA	PMID:21934132
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552303	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COLGALT2 mRNA	PMID:30529165
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of COLGALT2 gene	PMID:35440735
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of COLGALT2 mRNA	PMID:30510588
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552303	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of COLGALT2 mRNA	PMID:39298647
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of COLGALT2 mRNA	PMID:33387578
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of COLGALT2 mRNA	PMID:22017230
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of COLGALT2 mRNA	PMID:31163220
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1602008	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of COLGALT2 mRNA	PMID:19549813
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602008	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of COLGALT2 gene	PMID:27153756
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552303	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of COLGALT2 mRNA	PMID:34911549
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1602008	E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of COLGALT2 gene	PMID:25304211
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1602008	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of COLGALT2 mRNA	PMID:28903495
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552303	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COLGALT2 mRNA	PMID:28213091
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COLGALT2 mRNA	PMID:20106945|PMID:21632981
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552303	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to COLGALT2 gene]	PMID:28213091
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of COLGALT2 mRNA	PMID:26272509
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA	PMID:27188386
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:28741	sodium fluoride	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of COLGALT2 mRNA	PMID:27257137
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1602008	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of COLGALT2 mRNA	PMID:29453283
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552303	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COLGALT2 mRNA	PMID:22228805
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COLGALT2 mRNA	PMID:20106945|PMID:21632981
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602008	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of COLGALT2 promoter	PMID:27901495
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552303	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of COLGALT2 mRNA	PMID:32417428
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602008	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COLGALT2 5' UTR; Benzo(a)pyrene results in increased methylation of COLGALT2 exon	PMID:27901495
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of COLGALT2 gene	PMID:31601247
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552303	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of COLGALT2 mRNA	PMID:23557971|PMID:29264374
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552303	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of COLGALT2 gene	PMID:35295148
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552303	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of COLGALT2 gene	PMID:35295148
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of COLGALT2 mRNA	PMID:38479592
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of COLGALT2 mRNA	PMID:25181051
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552303	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of COLGALT2 mRNA	PMID:39742910
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COLGALT2 mRNA	PMID:28628672
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1602008	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of COLGALT2 mRNA	PMID:19244175
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1602008	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of COLGALT2 mRNA	PMID:25979313
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1602008	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of COLGALT2 gene	PMID:31601247
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of COLGALT2 gene	PMID:31601247
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552303	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of COLGALT2 mRNA	PMID:30951980
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COLGALT2 mRNA	PMID:28628672
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1552303	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of COLGALT2 intron	PMID:28392331
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COLGALT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COLGALT2 mRNA	PMID:28628672
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602008	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COLGALT2 mRNA	PMID:37042841
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1602008	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of COLGALT2 mRNA	PMID:29024780
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1602008	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COLGALT2 mRNA	PMID:38568856
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552303	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of COLGALT2 mRNA	PMID:22698814|PMID:28903501
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602008	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of COLGALT2 mRNA	PMID:31533062
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552303	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of COLGALT2 mRNA	PMID:36331819
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602008	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COLGALT2 mRNA	PMID:25979313
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of COLGALT2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA	PMID:27188386
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COLGALT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COLGALT2 mRNA	PMID:28628672
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20141111	CTD	MESH:C012589	trichostatin A results in decreased expression of COLGALT2 mRNA	PMID:24935251
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1602008	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of COLGALT2 mRNA	PMID:29067470
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:46661	asbestos	affects methylation	ISO	RGD:1602008	E	RGD:6480464	20210112	CTD	MESH:D001194	Asbestos affects the methylation of COLGALT2 gene	PMID:28722770
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1602008	E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of COLGALT2 gene	PMID:25304211
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of COLGALT2 mRNA	PMID:26272509
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA	PMID:27188386
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COLGALT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COLGALT2 mRNA	PMID:28628672
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552303	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COLGALT2 mRNA; Nanotubes, Carbon results in decreased expression of COLGALT2 mRNA	PMID:25554681
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1552303	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of COLGALT2 mRNA	PMID:19042947
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of COLGALT2 mRNA	PMID:26272509
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA	PMID:27188386
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1602008	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of COLGALT2 mRNA	PMID:24810058
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA	PMID:27188386
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COLGALT2 gene]	PMID:28238834
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552303	E	RGD:6480464	20130813	CTD	MESH:D010634	Phenobarbital affects the expression of COLGALT2 mRNA	PMID:23091169
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of COLGALT2 mRNA	PMID:32109520
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of COLGALT2 mRNA	PMID:26272509
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA	PMID:27188386
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602008	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA	PMID:27188386
1304702	Colgalt2	collagen beta(1-O)galactosyltransferase 2	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1602008	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in decreased expression of COLGALT2 mRNA	PMID:34581912
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312304	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TNFRSF17 mRNA	PMID:33045310
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312304	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TNFRSF17 mRNA	PMID:39241906
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TNFRSF17 mRNA	PMID:33387578
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312303	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TNFRSF17 mRNA	PMID:37042841
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312303	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TNFRSF17 mRNA	PMID:23649840
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312303	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TNFRSF17 mRNA	PMID:23649840
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:25187	p-menthan-3-ol	increases expression	ISO	RGD:1312303	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TNFRSF17 mRNA	PMID:26760959
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312303	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TNFRSF17 mRNA	PMID:23649840
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312303	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TNFRSF17 mRNA	PMID:22171008
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1312303	E	RGD:6480464	20140610	CTD	MESH:D001151	Arsenic affects the expression of TNFRSF17 protein	PMID:24675094
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:27924	phenylhydrazine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030299	phenylhydrazine results in decreased expression of TNFRSF17 mRNA	PMID:17698508
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312304	E	RGD:6480464	20140513	CTD	MESH:D019833	Genistein results in increased expression of TNFRSF17 mRNA	PMID:22553218
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312303	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of TNFRSF17 mRNA	PMID:23195993
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312304	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFRSF17 mRNA	PMID:21570461|PMID:26377647
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312303	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of TNFRSF17 mRNA	PMID:23649840
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312303	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TNFRSF17 promoter	PMID:27901495
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312303	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TNFRSF17 mRNA	PMID:22171008
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312303	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TNFRSF17 mRNA	PMID:17530438
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1312303	E	RGD:6480464	20120412	CTD	MESH:C061133	tamibarotene results in increased expression of TNFRSF17 mRNA	PMID:17229644
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TNFRSF17 mRNA	PMID:30012374
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312304	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TNFRSF17 mRNA	PMID:23557971
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of TNFRSF17 promoter	PMID:22457795
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TNFRSF17 mRNA	PMID:27387713
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1312303	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of TNFRSF17 mRNA	PMID:23649840
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1312303	E	RGD:6480464	20200331	CTD	MESH:D008727	[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of TNFRSF17 mRNA	PMID:28863153
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1312303	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of TNFRSF17 protein	PMID:24675094
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312303	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TNFRSF17 mRNA	PMID:17530438
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:50161	motexafin gadolinium	decreases expression	ISO	RGD:1312303	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in decreased expression of TNFRSF17 mRNA	PMID:16357179
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	ISO	RGD:1312303	E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TNFRSF17 mRNA	PMID:16357179
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312304	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TNFRSF17 mRNA	PMID:25554681
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:5801	hydroxychloroquine	multiple interactions	ISO	RGD:1312303	E	RGD:6480464	20200331	CTD	MESH:D006886	[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of TNFRSF17 mRNA	PMID:28863153
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312304	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TNFRSF17 mRNA	PMID:38701926
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:62984	zinc acetate	decreases expression	ISO	RGD:1312303	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of TNFRSF17 mRNA	PMID:16357179
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:62984	zinc acetate	multiple interactions	ISO	RGD:1312303	E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TNFRSF17 mRNA	PMID:16357179
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:8050	phenacetin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010615	Phenacetin results in decreased expression of TNFRSF17 mRNA	PMID:17698508
1304703	Tnfrsf17	TNF receptor superfamily member 17	gene	CHEBI:9334	sulfasalazine	multiple interactions	ISO	RGD:1312303	E	RGD:6480464	20200331	CTD	MESH:D012460	[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of TNFRSF17 mRNA	PMID:28863153
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RTRAF mRNA	PMID:33167477
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312305	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of RTRAF mRNA	PMID:24763279
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D000431	Ethanol results in increased expression of RTRAF protein	PMID:23702218
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312306	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RTRAF mRNA	PMID:39241906
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D005839	Gentamicins results in increased expression of RTRAF protein	PMID:22061828
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RTRAF mRNA	PMID:19549813
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312305	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RTRAF protein	PMID:23301498
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312305	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RTRAF gene	PMID:27153756
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:2654	aminoglutethimide	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of RTRAF protein	PMID:26102013
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:27086	tributylstannane	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in increased expression of RTRAF mRNA	PMID:31129395
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RTRAF mRNA	PMID:22206623
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of RTRAF protein	PMID:37834424
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTRAF mRNA	PMID:40504410
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312305	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RTRAF mRNA	PMID:23557933
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312305	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RTRAF mRNA	PMID:28903495
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312305	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RTRAF mRNA	PMID:27392435
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RTRAF mRNA	PMID:33387578
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RTRAF mRNA	PMID:29803840
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTRAF mRNA	PMID:40504410
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312305	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RTRAF promoter	PMID:27901495
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312305	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RTRAF mRNA]	PMID:32406909
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312305	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RTRAF gene	PMID:31601247
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:31739	josamycin	affects response to substance	ISO	RGD:1312305	E	RGD:6480464	20200609	CTD	MESH:D015570	RTRAF protein affects the susceptibility to Josamycin	PMID:31915244
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RTRAF mRNA; bisphenol A results in decreased expression of RTRAF protein	PMID:29275510|PMID:31675489
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312306	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RTRAF mRNA	PMID:33221593
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RTRAF mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312305	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RTRAF gene	PMID:31601247
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of RTRAF protein	PMID:31675489
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312306	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RTRAF mRNA	PMID:39298647
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:C041594	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:C105260	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:C027561	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:D003993	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:C019566	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312305	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RTRAF mRNA	PMID:24449571
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1312305	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of RTRAF mRNA	PMID:26352163
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312305	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RTRAF mRNA	PMID:20106945|PMID:25562108
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of RTRAF protein	PMID:37834424
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTRAF mRNA	PMID:40504410
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of RTRAF mRNA	PMID:31675489
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312306	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RTRAF mRNA	PMID:35436446
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312305	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RTRAF mRNA	PMID:18175754
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RTRAF mRNA	PMID:35964746
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D005485	Flutamide results in increased expression of RTRAF mRNA	PMID:24136188
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RTRAF protein	PMID:32959892
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RTRAF mRNA	PMID:22206623
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312305	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RTRAF protein	PMID:31675489
1304704	Rtraf	RNA transcription, translation and transport factor	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of RTRAF gene	PMID:31682807
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1607077	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TMEM147 mRNA	PMID:38218311
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1607077	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of TMEM147 mRNA	PMID:35967413
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312308	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of TMEM147 mRNA	PMID:30951980
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1607077	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TMEM147 mRNA	PMID:20044591
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312308	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TMEM147 mRNA	PMID:39241906
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312308	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TMEM147 mRNA	PMID:39298647
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1607077	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TMEM147 mRNA	PMID:37042841
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312308	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMEM147 mRNA	PMID:33754040
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1607077	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TMEM147 mRNA	PMID:19549813
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1607077	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TMEM147 mRNA	PMID:23649840
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1607077	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TMEM147 gene	PMID:27153756
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1607077	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TMEM147 mRNA	PMID:23649840
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312308	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM147 mRNA	PMID:31919559
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312308	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM147 mRNA	PMID:22206623
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1312308	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of TMEM147 mRNA	PMID:34813904
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM147 mRNA	PMID:22298810
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312308	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM147 mRNA	PMID:21570461
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM147 mRNA	PMID:21215274
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312308	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM147 mRNA	PMID:19465110
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM147 mRNA	PMID:33387578
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of TMEM147 mRNA]	PMID:21215274
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1607077	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM147 mRNA	PMID:30851411
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1607077	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TMEM147 mRNA	PMID:29803840
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1607077	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMEM147 mRNA	PMID:25879800|PMID:38568856
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TMEM147 mRNA	PMID:21839799
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1607077	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TMEM147 mRNA]	PMID:32406909
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312308	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM147 promoter	PMID:35295148
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312308	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of TMEM147 mRNA	PMID:15302862|PMID:20813756
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312308	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TMEM147 mRNA	PMID:28472532
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TMEM147 mRNA	PMID:19167457
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1607077	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TMEM147 mRNA	PMID:30903817
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM147 mRNA	PMID:34947998
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM147 mRNA	PMID:25181051
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312308	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM147 mRNA	PMID:33221593
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312308	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TMEM147 mRNA	PMID:39298647
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312308	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of TMEM147 mRNA	PMID:30951980
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312308	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TMEM147 mRNA	PMID:37019170
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1607077	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TMEM147 gene	PMID:22964155
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TMEM147 mRNA	PMID:18164116
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMEM147 mRNA	PMID:33453195
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312308	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TMEM147 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TMEM147 mRNA]	PMID:17585979
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1607077	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TMEM147 mRNA	PMID:40419075
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1607077	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM147 mRNA	PMID:23179753|PMID:27188386
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1607077	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TMEM147 gene	PMID:29154799
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1607077	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TMEM147 mRNA	PMID:20106945
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TMEM147 mRNA	PMID:24136188
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of TMEM147 mRNA	PMID:21346803
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312308	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMEM147 mRNA	PMID:17562736
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMEM147 mRNA	PMID:33387578
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312308	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TMEM147 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TMEM147 mRNA]	PMID:17585979
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312308	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TMEM147 mRNA	PMID:35436446
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TMEM147 mRNA	PMID:17351261
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312308	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TMEM147 mRNA	PMID:25554681
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TMEM147 mRNA	PMID:24136188
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312308	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TMEM147 mRNA	PMID:23650126
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of TMEM147 mRNA	PMID:30467583
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312308	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMEM147 mRNA	PMID:22206623
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312308	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM147 mRNA	PMID:22206623
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TMEM147 mRNA	PMID:24136188
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TMEM147 mRNA	PMID:18164116
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1607077	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM147 mRNA	PMID:30851411
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TMEM147 mRNA	PMID:21346803
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1607077	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TMEM147 mRNA	PMID:38568856
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TMEM147 mRNA	PMID:21346803
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TMEM147 mRNA	PMID:23034163
1304706	Tmem147	transmembrane protein 147	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TMEM147 mRNA	PMID:22570695
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312309	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of LRFN1 mRNA	PMID:27188386
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312310	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRFN1 gene	PMID:20938992
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312310	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of LRFN1 mRNA	PMID:30319688
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312309	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LRFN1 mRNA	PMID:31614463
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312310	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRFN1 gene	PMID:20938992
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312309	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LRFN1 mRNA	PMID:26079696
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1312309	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of LRFN1 mRNA	PMID:33647349
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312309	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LRFN1 mRNA	PMID:28818685
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312310	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of LRFN1 mRNA	PMID:37748715
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312309	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LRFN1 mRNA	PMID:32234424
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312309	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of LRFN1 mRNA	PMID:35430440
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312310	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRFN1 gene	PMID:20938992
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312309	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of LRFN1 mRNA	PMID:27392435
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRFN1 mRNA	PMID:33387578
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of LRFN1 mRNA	PMID:28959563
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29021	hexane	increases methylation	EXP		E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in increased methylation of LRFN1 promoter	PMID:23740543
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312309	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LRFN1 mRNA	PMID:38568856
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312310	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRFN1 mRNA	PMID:27195522
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312309	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRFN1 exon	PMID:27901495
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312310	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRFN1 5' UTR; Benzo(a)pyrene results in decreased methylation of LRFN1 exon	PMID:27901495
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312309	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRFN1 mRNA	PMID:32234424
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1312309	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of LRFN1 mRNA	PMID:37690743
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312309	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LRFN1 gene	PMID:31601247
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312310	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRFN1 gene	PMID:35295148
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of LRFN1 mRNA	PMID:19167457
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRFN1 mRNA	PMID:25181051
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312309	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of LRFN1 mRNA	PMID:23146750
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LRFN1 mRNA	PMID:30816183|PMID:34947998
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LRFN1 mRNA	PMID:36041667
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312309	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LRFN1 gene	PMID:31601247
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1312309	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LRFN1 mRNA	PMID:23146750
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LRFN1 mRNA	PMID:36041667
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LRFN1 mRNA	PMID:36041667
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312310	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LRFN1 intron	PMID:28392331
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRFN1 mRNA	PMID:20691718
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312310	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRFN1 mRNA	PMID:37019170
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312310	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of LRFN1 mRNA	PMID:36117858
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312309	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRFN1 mRNA	PMID:37042841
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312310	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRFN1 mRNA	PMID:40194260
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312309	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LRFN1 mRNA	PMID:31533062
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312309	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LRFN1 mRNA	PMID:25979313
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312309	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of LRFN1 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312309	E	RGD:6480464	20120522	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of LRFN1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRFN1 mRNA	PMID:17183730|PMID:27188386
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LRFN1 mRNA	PMID:33387578
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1312310	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of LRFN1 mRNA	PMID:29279043
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1312309	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of LRFN1 mRNA	PMID:32234424
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of LRFN1 mRNA	PMID:30307764
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312310	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of LRFN1 mRNA	PMID:36117858
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312309	E	RGD:6480464	20120522	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of LRFN1 mRNA	PMID:17183730
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312309	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRFN1 mRNA	PMID:27188386
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312309	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of LRFN1 mRNA	PMID:23146750
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1312309	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of LRFN1 mRNA	PMID:32234424
1304707	Lrfn1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312309	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRFN1 mRNA	PMID:27188386
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:137832	Cacalol	increases expression	ISO	RGD:1312311	E	RGD:6480464	20190219	CTD	MESH:C497192	cacalol results in increased expression of DAPK2 mRNA	PMID:20665104
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:145121	SKF-96365 hydrochloride	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:C063159	1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of DAPK2 protein]	PMID:32895711
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312311	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of DAPK2 mRNA; Tretinoin results in increased expression of DAPK2 protein	PMID:15498508|PMID:23830798|PMID:28978663|PMID:33167477
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20190409	CTD	MESH:D014212	DAPK2 protein affects the reaction [Tretinoin promotes the reaction [ATG5 protein binds to ATG12 protein]]; DAPK2 protein affects the reaction [Tretinoin promotes the reaction [bafilomycin A results in increased expression of MAP1LC3B protein modified form]]; TP73 protein affects the reaction [Tretinoin results in increased expression of DAPK2 mRNA]; TP73 protein affects the reaction [Tretinoin results in increased expression of DAPK2 protein]	PMID:28978663
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DAPK2 mRNA	PMID:30529165
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312311	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of DAPK2 mRNA	PMID:30510588
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in decreased expression of DAPK2 mRNA	PMID:19484750|PMID:39298647
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312311	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of DAPK2 mRNA	PMID:23373633|PMID:24758408|PMID:31614463
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein promotes the reaction [Estradiol results in increased expression of DAPK2 mRNA]	PMID:24758408
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312312	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of DAPK2 mRNA	PMID:33711761
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312311	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DAPK2 mRNA	PMID:37042841
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312311	E	RGD:6480464	20130806	CTD	MESH:D013739	Testosterone results in increased expression of DAPK2 mRNA	PMID:21592394
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20130806	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of DAPK2 mRNA	PMID:21592394
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of DAPK2 mRNA	PMID:27523638
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312311	E	RGD:6480464	20130806	CTD	MESH:D002117	Calcitriol results in increased expression of DAPK2 mRNA	PMID:21592394
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20130806	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of DAPK2 mRNA	PMID:21592394
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312311	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of DAPK2 intron	PMID:30157460
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312311	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in increased expression of DAPK2 mRNA	PMID:19549813
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312311	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DAPK2 mRNA	PMID:22100608|PMID:27153756
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312311	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DAPK2 intron	PMID:30157460
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1312311	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of DAPK2 mRNA	PMID:26760959
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312311	E	RGD:6480464	20130806	CTD	MESH:D000638	Amiodarone results in increased expression of DAPK2 mRNA	PMID:19774075
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312312	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of DAPK2 mRNA	PMID:25629700
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DAPK2 mRNA	PMID:22206623
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of DAPK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DAPK2 mRNA	PMID:40512198
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312311	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of DAPK2 mRNA	PMID:27392435
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of DAPK2 mRNA	PMID:40618947
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of DAPK2 mRNA	PMID:27392435
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DAPK2 mRNA	PMID:34747641
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DAPK2 mRNA	PMID:21215274
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DAPK2 mRNA	PMID:33387578
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312312	E	RGD:6480464	20150825	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DAPK2 mRNA	PMID:15310856|PMID:19770486|PMID:21889950|PMID:25975270
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of DAPK2 mRNA]	PMID:21215274
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DAPK2 mRNA	PMID:25975270
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312311	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DAPK2 mRNA	PMID:33212167
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of DAPK2 mRNA	PMID:28959563
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312311	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DAPK2 mRNA	PMID:29803840
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312311	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DAPK2 mRNA	PMID:38568856|PMID:39719251
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312312	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of DAPK2 mRNA	PMID:39515575
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of DAPK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DAPK2 mRNA	PMID:40512198
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312311	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DAPK2 intron	PMID:30157460
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of DAPK2 mRNA]	PMID:22228805
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312311	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DAPK2 mRNA; Arsenic Trioxide results in increased expression of DAPK2 protein	PMID:28978663
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20191114	CTD	MESH:C006632	DAPK2 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; TP73 protein affects the reaction [Arsenic Trioxide results in increased expression of DAPK2 mRNA]; TP73 protein affects the reaction [Arsenic Trioxide results in increased expression of DAPK2 protein]	PMID:28978663
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312311	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of DAPK2 mRNA	PMID:38568856
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DAPK2 mRNA	PMID:25729387
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1312311	E	RGD:6480464	20130806	CTD	MESH:C061133	tamibarotene results in increased expression of DAPK2 mRNA	PMID:15498508
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312312	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DAPK2 gene; titanium dioxide results in decreased methylation of DAPK2 promoter	PMID:35295148
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:C006253	pirinixic acid results in decreased expression of DAPK2 mRNA	PMID:17426115
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:C006253	pirinixic acid results in increased expression of DAPK2 mRNA	PMID:18301758
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DAPK2 mRNA	PMID:25181051|PMID:34947998
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DAPK2 mRNA	PMID:30816183|PMID:32528016
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312312	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of DAPK2 mRNA	PMID:32156529
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DAPK2 mRNA	PMID:25172293
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312312	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of DAPK2 mRNA	PMID:26682919
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20140715	CTD	MESH:D008748	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of DAPK2 mRNA	PMID:23519560
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DAPK2 mRNA	PMID:39298647
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312311	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of DAPK2 intron	PMID:30157460
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of DAPK2 mRNA	PMID:28392331
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312312	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DAPK2 intron	PMID:28392331
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312312	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DAPK2 mRNA	PMID:32715474
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312312	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of DAPK2 mRNA	PMID:24535843
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312311	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DAPK2 mRNA	PMID:37042841
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DAPK2 mRNA	PMID:35163327
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312311	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DAPK2 mRNA	PMID:38568856
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:D019256	MT3 affects the reaction [Cadmium Chloride affects the expression of DAPK2 mRNA]	PMID:20371981
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312311	E	RGD:6480464	20161025	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DAPK2 mRNA	PMID:27153767
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DAPK2 mRNA	PMID:35163327
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312312	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of DAPK2 mRNA	PMID:28962523
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:D002922	Ciguatoxins affects the expression of DAPK2 mRNA	PMID:18353800
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:D002994	Clofibrate results in decreased expression of DAPK2 mRNA	PMID:17585979
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20140715	CTD	MESH:D013755	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of DAPK2 mRNA	PMID:23519560
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:38319	usnic acid	increases expression	ISO	RGD:1312311	E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of DAPK2 mRNA	PMID:32508146
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312312	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DAPK2 mRNA	PMID:40194260
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312311	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DAPK2 mRNA	PMID:31533062
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312311	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of DAPK2 mRNA	PMID:26272509
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:D014635	Valproic Acid results in increased expression of DAPK2 mRNA	PMID:21427059
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312311	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DAPK2 gene	PMID:29154799
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA	PMID:27188386
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of DAPK2 mRNA	PMID:41580965
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in decreased expression of DAPK2 mRNA	PMID:19770486
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312312	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DAPK2 mRNA	PMID:28973697
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA	PMID:27188386
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312311	E	RGD:6480464	20130806	CTD	MESH:C012589	trichostatin A results in increased expression of DAPK2 mRNA	PMID:16865256
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of DAPK2 mRNA	PMID:17562736
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312312	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in increased expression of DAPK2 mRNA	PMID:17585979
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of DAPK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DAPK2 mRNA	PMID:40512198
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:47426	furosemide	affects expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D005665	Furosemide affects the expression of DAPK2 mRNA	PMID:17497460
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1312311	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of DAPK2 mRNA	PMID:38568856
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312311	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DAPK2 mRNA; Arsenic Trioxide results in increased expression of DAPK2 protein	PMID:28978663
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20191114	CTD	MESH:C032793	DAPK2 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; TP73 protein affects the reaction [Arsenic Trioxide results in increased expression of DAPK2 mRNA]; TP73 protein affects the reaction [Arsenic Trioxide results in increased expression of DAPK2 protein]	PMID:28978663
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312311	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of DAPK2 mRNA	PMID:19037991
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DAPK2 mRNA; Nanotubes, Carbon results in decreased expression of DAPK2 mRNA	PMID:25554681|PMID:25620056
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of DAPK2 mRNA	PMID:24136188
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:52717	bortezomib	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20170303	CTD	MESH:D000069286	[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of DAPK2 mRNA	PMID:25522274
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of DAPK2 mRNA	PMID:25729387
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DAPK2 mRNA	PMID:25729387
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312311	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of DAPK2 intron	PMID:30157460
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DAPK2 gene	PMID:35440735
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DAPK2 mRNA	PMID:22206623
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of DAPK2 mRNA	PMID:33484710
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of DAPK2 mRNA	PMID:21346803
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA	PMID:27188386
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:8107	phenytoin	decreases expression	ISO	RGD:1312311	E	RGD:6480464	20130806	CTD	MESH:D010672	Phenytoin results in decreased expression of DAPK2 mRNA	PMID:14741686
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the expression of DAPK2 protein	PMID:31020377
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of DAPK2 mRNA; 2,3',4,4',5-pentachlorobiphenyl results in increased expression of DAPK2 protein	PMID:31020377|PMID:32895711
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C070055	1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of DAPK2 protein]; 2,3',4,4',5-pentachlorobiphenyl promotes the reaction [TUBB3 protein binds to DAPK2 protein]; DAPK2 protein affects the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased phosphorylation of PIK3C3 protein]; DAPK2 protein affects the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased phosphorylation of PRKD1 protein]; TUBB3 protein promotes the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of DAPK2 protein]	PMID:31020377|PMID:32895711
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DAPK2 mRNA	PMID:24780913|PMID:25825206
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:87368	diethyl malate	affects expression	ISO	RGD:1312312	E	RGD:6480464	20170303	CTD	MESH:C058705	diethyl malate affects the expression of DAPK2 mRNA	PMID:24814887
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312311	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA	PMID:27188386
1304708	Dapk2	death-associated protein kinase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DAPK2 mRNA	PMID:21346803
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312313	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CA8 mRNA	PMID:33167477
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312313	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CA8 mRNA	PMID:35811015
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CA8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CA8 mRNA	PMID:35811015
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312313	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CA8 mRNA	PMID:30510588
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312313	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol affects the expression of CA8 mRNA	PMID:25321415
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CA8 mRNA	PMID:30165855
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312313	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CA8 mRNA	PMID:38568856
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312313	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CA8 mRNA	PMID:22100608
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CA8 mRNA	PMID:33354967
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312313	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CA8 intron	PMID:30157460
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CA8 mRNA	PMID:31150632
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312313	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of CA8 mRNA	PMID:26272509
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA	PMID:27188386
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312313	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CA8 mRNA	PMID:28903495
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312313	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CA8 mRNA	PMID:38568856
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1312313	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of CA8 mRNA	PMID:21714911
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312313	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CA8 3' UTR	PMID:27901495
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312313	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CA8 mRNA	PMID:22178795
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312313	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CA8 5' UTR; Benzo(a)pyrene results in increased methylation of CA8 promoter	PMID:27901495
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312313	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CA8 mRNA	PMID:23806026|PMID:25895662
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1312313	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of CA8 mRNA	PMID:37690743
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CA8 mRNA	PMID:34492290
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of CA8 mRNA	PMID:25181051
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312313	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of CA8 mRNA	PMID:27685785
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CA8 mRNA	PMID:34947998
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to CA8 promoter]	PMID:20348232
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:34698	diethyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of CA8 mRNA	PMID:32341500
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20250311	CTD	MESH:C007379	[diethyl phthalate results in increased abundance of monoethyl phthalate] which results in decreased expression of CA8 mRNA	PMID:32341500
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312313	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CA8 mRNA	PMID:24449571
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312313	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CA8 mRNA	PMID:31533062
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312313	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CA8 mRNA	PMID:25979313
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312313	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CA8 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in decreased expression of CA8 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA	PMID:17183730|PMID:27188386
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312313	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CA8 mRNA	PMID:20106945
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312314	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CA8 mRNA	PMID:28973697
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312313	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CA8 mRNA	PMID:38832940
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312313	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CA8 mRNA	PMID:24935251
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312313	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of CA8 mRNA	PMID:26690555
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CA8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CA8 mRNA	PMID:35811015
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in decreased expression of CA8 mRNA	PMID:17183730
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312313	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CA8 mRNA	PMID:15336504
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	ISO	RGD:1312313	E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of CA8 mRNA	PMID:20843944
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20250311	CTD	MESH:C581825	[diethyl phthalate results in increased abundance of monoethyl phthalate] which results in decreased expression of CA8 mRNA	PMID:32341500
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA	PMID:27188386
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CA8 mRNA	PMID:31826744
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312313	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of CA8 mRNA	PMID:26272509
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA	PMID:27188386
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312313	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA	PMID:27188386
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312313	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CA8 mRNA	PMID:38568856
1304709	Ca8	carbonic anhydrase 8	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312314	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CA8 mRNA	PMID:28973697
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASXL2 gene	PMID:20938992
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of ASXL2 mRNA	PMID:24763279
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1312315	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of ASXL2 protein	PMID:28073184
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312315	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ASXL2 mRNA	PMID:22378314
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASXL2 gene	PMID:20938992
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312315	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ASXL2 mRNA	PMID:37042841
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312315	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ASXL2 mRNA	PMID:21179406
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:17627	ferroheme b	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in decreased expression of ASXL2 mRNA	PMID:19191707
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312315	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ASXL2 protein	PMID:37730182
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ASXL2 mRNA	PMID:33387578
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASXL2 mRNA	PMID:35301059
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ASXL2 mRNA	PMID:28111341
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312315	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ASXL2 mRNA	PMID:19549813
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1614292	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ASXL2 mRNA	PMID:19770486
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312315	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ASXL2 gene	PMID:27153756
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312315	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ASXL2 mRNA	PMID:23649840
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ASXL2 mRNA	PMID:35430440
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:26355	heme b	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in decreased expression of ASXL2 mRNA	PMID:19191707
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ASXL2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASXL2 gene	PMID:20938992|PMID:22206623
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312315	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ASXL2 mRNA	PMID:19244175
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312315	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ASXL2 protein	PMID:35688186
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312315	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ASXL2 mRNA	PMID:27594783
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:27899	cisplatin	decreases phosphorylation	ISO	RGD:1614292	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased phosphorylation of ASXL2 protein	PMID:22006019
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ASXL2 mRNA	PMID:30912803
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614292	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASXL2 mRNA	PMID:21570461
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASXL2 mRNA	PMID:32109520
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312315	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ASXL2 mRNA	PMID:33212167
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312315	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASXL2 mRNA	PMID:30851411
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312315	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ASXL2 mRNA	PMID:38568856
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312315	E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ASXL2 mRNA	PMID:30453624
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614292	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASXL2 mRNA	PMID:22228805
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312315	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ASXL2 mRNA	PMID:26014281
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312315	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASXL2 mRNA	PMID:19150397|PMID:20018196
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312315	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ASXL2 mRNA	PMID:26238291
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312315	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ASXL2 mRNA	PMID:20458559
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614292	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ASXL2 gene	PMID:35295148
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1614292	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of ASXL2 mRNA	PMID:35598803
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:34093	1-Hydroxypyrene	decreases expression	ISO	RGD:1312315	E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in decreased expression of ASXL2 mRNA	PMID:21854004
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312315	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ASXL2 intron	PMID:30157460
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA	PMID:28628672
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ASXL2 mRNA	PMID:28392331
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA	PMID:28628672
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312315	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ASXL2 mRNA	PMID:37042841
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASXL2 mRNA	PMID:35301059
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ASXL2 mRNA	PMID:28111341
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312315	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ASXL2 mRNA	PMID:19244175
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ASXL2 mRNA	PMID:40194260
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312315	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ASXL2 mRNA	PMID:28302478
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of ASXL2 mRNA	PMID:29427782
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312315	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ASXL2 mRNA	PMID:23179753|PMID:26272509
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL2 mRNA	PMID:27188386
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA	PMID:28628672
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312315	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ASXL2 mRNA	PMID:24935251
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614292	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ASXL2 mRNA	PMID:17562736
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA	PMID:28628672
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312315	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ASXL2 mRNA	PMID:20458559
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ASXL2 mRNA; Nanotubes, Carbon results in decreased expression of ASXL2 mRNA	PMID:25554681
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312315	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ASXL2 intron	PMID:30157460
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ASXL2 mRNA	PMID:22206623
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ASXL2 mRNA	PMID:22206623
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312315	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASXL2 mRNA	PMID:30851411
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL2 mRNA	PMID:27188386
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ASXL2 gene]	PMID:28238834
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1614292	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ASXL2 mRNA	PMID:23091169
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1614292	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ASXL2 mRNA	PMID:31388691
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of ASXL2 mRNA	PMID:38995820
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312315	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL2 mRNA	PMID:27188386
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312315	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ASXL2 mRNA	PMID:26014281
1304710	Asxl2	ASXL transcriptional regulator 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ASXL2 mRNA	PMID:28973697
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1602701	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of INTS10 mRNA	PMID:38218311
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602701	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of INTS10 mRNA	PMID:33167477
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1602701	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of INTS10 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of INTS10 mRNA	PMID:32699268
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1602701	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of INTS10 mRNA	PMID:20044591
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1602701	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of INTS10 mRNA	PMID:29581250
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332281	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of INTS10 mRNA	PMID:39241906
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of INTS10 mRNA	PMID:32145629
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1602701	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of INTS10 mRNA	PMID:21179406
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1602701	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of INTS10 protein	PMID:37730182
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332281	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INTS10 mRNA	PMID:37236586
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602701	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of INTS10 mRNA	PMID:19549813
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1602701	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of INTS10 mRNA	PMID:23649840
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1602701	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of INTS10 mRNA	PMID:23649840
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602701	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of INTS10 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of INTS10 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of INTS10 mRNA	PMID:32699268
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1602701	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of INTS10 mRNA	PMID:23557933
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019833	Genistein results in increased expression of INTS10 protein	PMID:24552547
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of INTS10 mRNA	PMID:34747641
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of INTS10 mRNA	PMID:28959563
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602701	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of INTS10 mRNA	PMID:29803840
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1602701	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of INTS10 mRNA	PMID:20044591
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602701	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of INTS10 mRNA	PMID:38568856
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of INTS10 mRNA	PMID:30047161
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332281	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of INTS10 promoter	PMID:35295148
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of INTS10 mRNA	PMID:25181051
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of INTS10 mRNA	PMID:32145629
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332281	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of INTS10 mRNA	PMID:39298647
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1332281	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of INTS10 mRNA	PMID:34813904
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1332281	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of INTS10 mRNA	PMID:34813904
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602701	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of INTS10 mRNA	PMID:37042841
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602701	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of INTS10 mRNA	PMID:38568856
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332281	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INTS10 mRNA	PMID:37236586
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1602701	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of INTS10 mRNA	PMID:19320972
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1602701	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of INTS10 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of INTS10 mRNA	PMID:32699268
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602701	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of INTS10 mRNA	PMID:23179753
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of INTS10 mRNA	PMID:30047161
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1602701	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of INTS10 mRNA	PMID:28542535
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602701	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of INTS10 mRNA	PMID:22230336
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1602701	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of INTS10 mRNA	PMID:22079256
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of INTS10 mRNA	PMID:30047161
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of INTS10 mRNA	PMID:24136188
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1332281	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of INTS10 mRNA	PMID:23650126
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1602701	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of INTS10 mRNA	PMID:31758290
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1332281	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of INTS10 mRNA	PMID:22206623
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1602701	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of INTS10 mRNA	PMID:22079256
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1602701	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of INTS10 mRNA	PMID:22079256
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602701	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to INTS10 gene]	PMID:28238834
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of INTS10 mRNA	PMID:30047161
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of INTS10 mRNA	PMID:30047161
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of INTS10 mRNA	PMID:19281266
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602701	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of INTS10 mRNA	PMID:38568856
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1602701	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of INTS10 mRNA	PMID:27188386
1304711	Ints10	integrator complex subunit 10	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of INTS10 mRNA	PMID:19015723
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312321	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ERAL1 mRNA	PMID:33045310
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ERAL1 mRNA	PMID:39241906
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312320	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ERAL1 mRNA	PMID:37042841
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312321	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ERAL1 mRNA	PMID:34319233
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ERAL1 mRNA	PMID:26577399
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312320	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ERAL1 protein	PMID:37730182
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ERAL1 mRNA	PMID:33387578
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ERAL1 protein	PMID:34915118
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312320	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ERAL1 mRNA	PMID:19549813
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ERAL1 mRNA	PMID:21396975
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312321	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ERAL1 mRNA	PMID:22206623
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312320	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ERAL1 gene	PMID:25304211
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ERAL1 mRNA	PMID:22298810
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312321	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ERAL1 mRNA	PMID:21570461
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ERAL1 mRNA	PMID:33387578
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312321	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of ERAL1 mRNA	PMID:15251184
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312320	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ERAL1 mRNA	PMID:33212167
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312320	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ERAL1 protein	PMID:35688186
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312320	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ERAL1 mRNA	PMID:38568856
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312320	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ERAL1 promoter	PMID:27901495
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312320	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ERAL1 mRNA]	PMID:32406909
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ERAL1 mRNA	PMID:30047161
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312320	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ERAL1 mRNA	PMID:19710929
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ERAL1 mRNA	PMID:25181051
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ERAL1 mRNA	PMID:34947998
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312320	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of ERAL1 protein	PMID:31945527
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ERAL1 mRNA	PMID:38685157
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312320	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERAL1 mRNA	PMID:28628672
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ERAL1 mRNA	PMID:21266533
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of ERAL1 mRNA	PMID:22546817
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312320	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERAL1 mRNA	PMID:28628672
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of ERAL1 mRNA	PMID:22546817
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ERAL1 mRNA	PMID:17585979
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ERAL1 mRNA	PMID:30047161
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312320	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERAL1 mRNA	PMID:28628672
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312320	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ERAL1 gene	PMID:25304211
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in decreased expression of ERAL1 mRNA	PMID:36653537
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ERAL1 mRNA	PMID:35436446
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312320	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERAL1 mRNA	PMID:28628672
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312321	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of ERAL1 mRNA	PMID:15251184
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1312321	E	RGD:6480464	20191114	CTD	MESH:C014347	[Tetrachlorodibenzodioxin co-treated with Decitabine] results in increased expression of ERAL1 mRNA	PMID:15251184
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ERAL1 mRNA	PMID:22206623
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312321	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ERAL1 mRNA	PMID:22206623
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312320	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ERAL1 gene]	PMID:28238834
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of ERAL1 mRNA	PMID:30047161
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312321	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ERAL1 mRNA	PMID:31388691
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312321	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of ERAL1 mRNA	PMID:30953684
1304714	Eral1	Era-like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ERAL1 mRNA	PMID:30047161
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1603598	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RCSD1 mRNA	PMID:38218311
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621337	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RCSD1 mRNA	PMID:33045310
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1621337	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of RCSD1 mRNA	PMID:37995155
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1603598	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of RCSD1 mRNA	PMID:15894607|PMID:23830798|PMID:33167477
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of RCSD1 gene	PMID:35440735
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1603598	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of RCSD1 mRNA	PMID:29581250
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1621337	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RCSD1 mRNA	PMID:39241906
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1603598	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of RCSD1 mRNA	PMID:30510588
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603598	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RCSD1 mRNA	PMID:31614463
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1603598	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of RCSD1 mRNA	PMID:30165855
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RCSD1 mRNA	PMID:37992649
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RCSD1 mRNA	PMID:37992649
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RCSD1 mRNA	PMID:33387578
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1603598	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of RCSD1 exon	PMID:30157460
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RCSD1 mRNA	PMID:37325564
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1603598	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RCSD1 mRNA	PMID:23649840
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RCSD1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RCSD1 mRNA	PMID:34911549
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RCSD1 mRNA	PMID:40504410
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1603598	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of RCSD1 mRNA	PMID:38460933
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RCSD1 mRNA	PMID:31881176
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1603598	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of RCSD1 mRNA	PMID:27594783
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of RCSD1 mRNA	PMID:17898221
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1621337	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RCSD1 mRNA	PMID:30912803
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1603598	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RCSD1 mRNA	PMID:25583101
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621337	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RCSD1 mRNA	PMID:21570461|PMID:26377647
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RCSD1 mRNA	PMID:34747641
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1603598	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RCSD1 mRNA	PMID:17101203
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of RCSD1 mRNA	PMID:26033743
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603598	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RCSD1 mRNA	PMID:29803840
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RCSD1 mRNA	PMID:37992649
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621337	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of RCSD1 mRNA	PMID:39515575
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603598	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RCSD1 mRNA	PMID:38568856
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RCSD1 mRNA	PMID:40504410
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1603598	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RCSD1 promoter	PMID:27901495
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1621337	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RCSD1 mRNA	PMID:22228805
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of RCSD1 mRNA	PMID:26033743
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1621337	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of RCSD1 mRNA	PMID:27131904
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1603598	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RCSD1 mRNA	PMID:25895662
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RCSD1 mRNA	PMID:25729387
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1621337	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RCSD1 mRNA	PMID:28472532
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RCSD1 mRNA	PMID:25181051
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1603598	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of RCSD1 protein	PMID:37567409
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1621337	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RCSD1 mRNA	PMID:30951980|PMID:32156529
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RCSD1 gene	PMID:28505145
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1621337	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of RCSD1 gene	PMID:31683443
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621337	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RCSD1 mRNA	PMID:30951980
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1621337	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of RCSD1 mRNA	PMID:26377693
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1621337	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RCSD1 mRNA	PMID:30951980
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1621337	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RCSD1 mRNA	PMID:28392331
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RCSD1 mRNA	PMID:21266533
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603598	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RCSD1 mRNA	PMID:37042841
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of RCSD1 mRNA	PMID:35163327
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1621337	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RCSD1 mRNA	PMID:26377693
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603598	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RCSD1 mRNA	PMID:38568856
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RCSD1 mRNA	PMID:37325564
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of RCSD1 mRNA	PMID:25380136
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1603598	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RCSD1 mRNA	PMID:31533062
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603598	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RCSD1 mRNA	PMID:23179753|PMID:26272509
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603598	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RCSD1 mRNA	PMID:27188386
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1621337	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RCSD1 mRNA	PMID:28973697
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RCSD1 mRNA	PMID:37992649
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621337	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RCSD1 mRNA	PMID:17562736
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RCSD1 mRNA	PMID:33387578
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1603598	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of RCSD1 mRNA	PMID:38460933
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RCSD1 mRNA	PMID:40504410
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RCSD1 mRNA	PMID:29391264
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1621337	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RCSD1 mRNA	PMID:25554681
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1621337	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RCSD1 mRNA	PMID:35964746
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1621337	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RCSD1 mRNA	PMID:38701926
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of RCSD1 mRNA	PMID:25729387
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RCSD1 mRNA	PMID:25729387
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1621337	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of RCSD1 mRNA	PMID:19751817
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1621337	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of RCSD1 mRNA	PMID:36907384
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RCSD1 gene	PMID:35440735
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1621337	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RCSD1 mRNA	PMID:22206623
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of RCSD1 mRNA	PMID:33484710
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603598	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RCSD1 mRNA	PMID:27188386
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1621337	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RCSD1 mRNA	PMID:39847705
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603598	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RCSD1 mRNA	PMID:27188386
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1621337	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of RCSD1 mRNA	PMID:27131904
1304715	Rcsd1	RCSD domain containing 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RCSD1 mRNA	PMID:19281266
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312324	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CWF19L1 mRNA	PMID:20188158
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of CWF19L1 protein	PMID:40631627
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CWF19L1 mRNA	PMID:22378314
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CWF19L1 mRNA	PMID:39298647
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of CWF19L1 protein	PMID:40631627
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of CWF19L1 protein	PMID:40631627
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CWF19L1 mRNA	PMID:33387578
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312323	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CWF19L1 mRNA	PMID:35301059
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CWF19L1 mRNA	PMID:19549813
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312323	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CWF19L1 protein	PMID:23301498
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312323	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CWF19L1 mRNA	PMID:23557933
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1312323	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of CWF19L1 gene	PMID:31636367
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CWF19L1 mRNA	PMID:30851411
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CWF19L1 mRNA	PMID:29803840
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of CWF19L1 protein	PMID:38228842
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312323	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CWF19L1 mRNA]	PMID:32406909
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CWF19L1 mRNA	PMID:20458559
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CWF19L1 mRNA	PMID:34492290
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312323	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CWF19L1 mRNA	PMID:38479592
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CWF19L1 mRNA	PMID:25181051
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CWF19L1 mRNA	PMID:29275510
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CWF19L1 mRNA	PMID:34947998
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CWF19L1 mRNA	PMID:36041667
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CWF19L1 mRNA	PMID:39298647
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312324	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CWF19L1 exon	PMID:33297965
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CWF19L1 mRNA	PMID:36041667
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CWF19L1 mRNA	PMID:36041667
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312323	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CWF19L1 mRNA	PMID:28628672
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CWF19L1 mRNA	PMID:22546817
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312323	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CWF19L1 mRNA	PMID:28628672
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CWF19L1 mRNA	PMID:22546817
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312323	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CWF19L1 mRNA	PMID:37042841
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312323	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CWF19L1 mRNA	PMID:35301059
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CWF19L1 mRNA	PMID:24449571
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CWF19L1 mRNA	PMID:28302478
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312324	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CWF19L1 mRNA	PMID:36331819
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of CWF19L1 mRNA	PMID:38685447|PMID:41580965
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of CWF19L1 mRNA	PMID:25123088
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312323	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CWF19L1 mRNA	PMID:28628672
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of CWF19L1 protein	PMID:40631627
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312324	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CWF19L1 mRNA	PMID:17562736
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of CWF19L1 mRNA	PMID:40706910
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312323	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CWF19L1 mRNA	PMID:28628672
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CWF19L1 mRNA	PMID:20458559
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CWF19L1 mRNA; Nanotubes, Carbon results in decreased expression of CWF19L1 mRNA	PMID:25620056
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of CWF19L1 mRNA	PMID:38685447|PMID:41580965
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of CWF19L1 mRNA	PMID:24793618
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of CWF19L1 mRNA	PMID:20977926
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CWF19L1 mRNA	PMID:23608068
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CWF19L1 protein	PMID:32959892
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312324	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CWF19L1 protein	PMID:36851058
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312323	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CWF19L1 mRNA	PMID:30851411
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of CWF19L1 mRNA	PMID:36084822
1304716	Cwf19l1	CWF19 like cell cycle control factor 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CWF19L1 mRNA	PMID:28973697
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CXCL17 mRNA	PMID:33729688
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312325	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of CXCL17 mRNA	PMID:22238285
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1602051	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CXCL17 mRNA	PMID:26079696
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of CXCL17 mRNA	PMID:32533902
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CXCL17 mRNA	PMID:27523638
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1602051	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CXCL17 mRNA	PMID:26485663
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CXCL17 mRNA	PMID:33387578
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CXCL17 mRNA	PMID:21396975
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602051	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CXCL17 intron	PMID:30157460
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602051	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CXCL17 gene	PMID:27153756
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CXCL17 mRNA	PMID:30779732
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CXCL17 mRNA	PMID:31881176
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D019833	[Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of CXCL17 mRNA	PMID:32533902
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1602051	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CXCL17 mRNA	PMID:24768652|PMID:25583101
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312325	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CXCL17 mRNA	PMID:21570461
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CXCL17 mRNA	PMID:33387578
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312325	E	RGD:6480464	20140311	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CXCL17 mRNA	PMID:24213012
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1602051	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CXCL17 mRNA	PMID:30851411
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602051	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CXCL17 promoter	PMID:27901495
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312325	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CXCL17 mRNA	PMID:22228805
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CXCL17 mRNA	PMID:22431001
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of CXCL17 mRNA	PMID:22641619
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312325	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of CXCL17 mRNA	PMID:23557971
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312325	E	RGD:6480464	20131008	CTD	MESH:C009495	titanium dioxide results in decreased expression of CXCL17 mRNA	PMID:23131501|PMID:35295148
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312325	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of CXCL17 mRNA	PMID:27760801
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CXCL17 mRNA	PMID:25181051
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CXCL17 mRNA	PMID:34947998
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312325	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CXCL17 mRNA	PMID:32156529
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CXCL17 gene	PMID:28505145
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312325	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CXCL17 mRNA	PMID:40203079
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312325	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CXCL17 mRNA	PMID:30951980
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312325	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CXCL17 mRNA	PMID:38685157
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312325	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CXCL17 mRNA	PMID:24535843
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CXCL17 mRNA	PMID:32680482
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CXCL17 mRNA	PMID:35163327
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CXCL17 mRNA	PMID:35163327
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312325	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of CXCL17 mRNA	PMID:23125180
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of CXCL17 mRNA	PMID:35594946
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1602051	E	RGD:6480464	20241001	CTD	MESH:D003907	Dexamethasone inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CXCL17 mRNA]	PMID:32679548
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312325	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CXCL17 mRNA	PMID:28973697
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CXCL17 mRNA	PMID:33387578
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312325	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of CXCL17 mRNA	PMID:30529165
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CXCL17 mRNA	PMID:29391264
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1312325	E	RGD:6480464	20200804	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of CXCL17 mRNA	PMID:32052077
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312325	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CXCL17 mRNA; Nanotubes, Carbon results in increased expression of CXCL17 mRNA	PMID:25554681|PMID:27106021
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of CXCL17 mRNA	PMID:33484710
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:75902	hispidulin	multiple interactions	ISO	RGD:1602051	E	RGD:6480464	20241001	CTD	MESH:C055957	hispidulin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CXCL17 mRNA]	PMID:32679548
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1602051	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CXCL17 mRNA	PMID:30851411
1304717	Cxcl17	C-X-C motif chemokine ligand 17	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CXCL17 mRNA	PMID:24780913
1304718	Ifitm6	interferon induced transmembrane protein 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of IFITM6 mRNA	PMID:26496021
1304718	Ifitm6	interferon induced transmembrane protein 6	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003471	Cuprizone results in increased expression of IFITM6 mRNA	PMID:26577399
1304718	Ifitm6	interferon induced transmembrane protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of IFITM6 mRNA	PMID:25181051|PMID:32145629
1304718	Ifitm6	interferon induced transmembrane protein 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of IFITM6 mRNA	PMID:26496021
1304718	Ifitm6	interferon induced transmembrane protein 6	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D002509	Cephaloridine results in increased expression of IFITM6 mRNA	PMID:18500788
1304718	Ifitm6	interferon induced transmembrane protein 6	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C039281	furan results in increased expression of IFITM6 mRNA	PMID:26194646
1304718	Ifitm6	interferon induced transmembrane protein 6	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D008694	Methamphetamine results in decreased expression of IFITM6 mRNA	PMID:19564919
1304718	Ifitm6	interferon induced transmembrane protein 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D011441	Propylthiouracil results in decreased expression of IFITM6 mRNA	PMID:24780913
1304718	Ifitm6	interferon induced transmembrane protein 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of IFITM6 mRNA	PMID:21346803
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312327	E	RGD:6480464	20260804	CTD	MESH:C014638	beta-lapachone results in decreased expression of COA8 mRNA	PMID:38218311
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1620831	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of COA8 mRNA	PMID:39298647
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312327	E	RGD:6480464	20260804	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COA8 mRNA	PMID:37042841
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D005839	Gentamicins results in increased expression of COA8 mRNA	PMID:33387578
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312327	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of COA8 mRNA	PMID:23369406
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COA8 mRNA	PMID:37236586
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312327	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of COA8 mRNA	PMID:19549813
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312327	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of COA8 polyA tail	PMID:30157460
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312327	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of COA8 mRNA	PMID:23649840
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of COA8 mRNA	PMID:22206623
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of COA8 mRNA	PMID:40504410
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312327	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of COA8 mRNA	PMID:28903495
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1620831	E	RGD:6480464	20200331	CTD	MESH:D014414	Tungsten results in increased expression of COA8 mRNA	PMID:30912803
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COA8 mRNA	PMID:33387578
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312327	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of COA8 mRNA	PMID:29803840
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1312327	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of COA8 mRNA	PMID:29432896
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312327	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COA8 mRNA	PMID:38568856
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of COA8 mRNA	PMID:40504410
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312327	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COA8 polyA tail	PMID:30157460
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312327	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to COA8 mRNA]	PMID:32406909
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312327	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of COA8 gene	PMID:31601247
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1620831	E	RGD:6480464	20200331	CTD	MESH:C006780	bisphenol A results in decreased methylation of COA8 promoter	PMID:27312807
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COA8 mRNA	PMID:25181051|PMID:30816183
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620831	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of COA8 mRNA	PMID:37894381
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of COA8 mRNA	PMID:36041667
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312327	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of COA8 gene	PMID:31601247
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1620831	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S affects the methylation of COA8 gene	PMID:31683443
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620831	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of COA8 mRNA	PMID:39298647|PMID:40203079
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1620831	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of COA8 exon	PMID:33297965
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of COA8 mRNA	PMID:36041667
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1620831	E	RGD:6480464	20200331	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of COA8 mRNA	PMID:26377693
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of COA8 mRNA	PMID:36041667
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1620831	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COA8 mRNA	PMID:37019170
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312327	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of COA8 gene	PMID:22964155
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1620831	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of COA8 mRNA	PMID:34813904
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COA8 mRNA	PMID:37236586
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312327	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COA8 mRNA	PMID:31533062
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312327	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of COA8 mRNA	PMID:40419075
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312327	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of COA8 mRNA	PMID:20106945|PMID:25562108
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312327	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of COA8 mRNA	PMID:29523930
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of COA8 mRNA	PMID:40504410
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312327	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of COA8 mRNA	PMID:18175754
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620831	E	RGD:6480464	20200331	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COA8 mRNA; Nanotubes, Carbon results in decreased expression of COA8 mRNA	PMID:25554681
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312327	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of COA8 mRNA	PMID:31758290
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of COA8 mRNA	PMID:22206623
1304719	Coa8	cytochrome c oxidase assembly factor 8	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1620831	E	RGD:6480464	20200331	CTD	MESH:C057693	Troglitazone results in decreased expression of COA8 mRNA	PMID:28973697
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312331	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CADM4 mRNA	PMID:26272509
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312332	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CADM4 mRNA	PMID:20188158
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of CADM4 mRNA	PMID:24763279
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312332	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CADM4 mRNA	PMID:30319688
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CADM4 mRNA	PMID:30165855
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA	PMID:37992649
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA	PMID:37992649
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312331	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CADM4 protein	PMID:37730182
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CADM4 mRNA	PMID:36331819
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA	PMID:39836092
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CADM4 mRNA	PMID:31150632
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312332	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CADM4 mRNA	PMID:25629700
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CADM4 mRNA	PMID:39836092
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]	PMID:37992649
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CADM4 mRNA	PMID:28960355
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CADM4 mRNA	PMID:31881176
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CADM4 mRNA	PMID:28922406
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CADM4 mRNA	PMID:26033743
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CADM4 mRNA	PMID:26033743
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of CADM4 mRNA	PMID:39631538
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA	PMID:37992649
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]	PMID:37992649
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CADM4 mRNA	PMID:39836092
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312331	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CADM4 intron	PMID:30157460
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CADM4 mRNA	PMID:26033743
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CADM4 mRNA	PMID:26033743
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312332	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CADM4 mRNA	PMID:27131904
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312332	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CADM4 promoter	PMID:35295148
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312332	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CADM4 mRNA	PMID:23557971
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CADM4 mRNA	PMID:34492290
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312332	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CADM4 mRNA	PMID:18648102
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CADM4 mRNA	PMID:25181051
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CADM4 mRNA	PMID:30816183|PMID:34947998|PMID:38750585
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312332	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CADM4 mRNA	PMID:32156529
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CADM4 mRNA	PMID:26682919
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312332	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CADM4 gene	PMID:31683443
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312332	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CADM4 mRNA	PMID:39298647
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312332	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CADM4 intron	PMID:28392331
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312332	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CADM4 mRNA	PMID:37019170
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312331	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CADM4 mRNA	PMID:37042841
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CADM4 mRNA	PMID:35163327
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA	PMID:39836092
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CADM4 mRNA	PMID:35163327
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of CADM4 mRNA	PMID:28962523
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312331	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CADM4 mRNA	PMID:31533062
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CADM4 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CADM4 mRNA	PMID:36331819
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312331	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CADM4 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312331	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CADM4 gene	PMID:29154799
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312331	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CADM4 mRNA	PMID:23179753|PMID:27188386
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312332	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of CADM4 mRNA	PMID:21427059
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA	PMID:37992649
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312331	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CADM4 mRNA	PMID:28542535
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312331	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CADM4 mRNA	PMID:24935251|PMID:26272509
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CADM4 mRNA	PMID:39836092
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312332	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CADM4 mRNA; Nanotubes, Carbon results in increased expression of CADM4 mRNA	PMID:25620056
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312331	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CADM4 protein	PMID:32959892
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA	PMID:39836092
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312331	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CADM4 mRNA	PMID:15336504
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of CADM4 mRNA	PMID:20003209
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312331	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CADM4 mRNA	PMID:31758290
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312331	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CADM4 mRNA	PMID:22714537
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312332	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CADM4 mRNA	PMID:23091169
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CADM4 mRNA	PMID:32109520
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312332	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CADM4 mRNA	PMID:30294300
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312331	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of CADM4 mRNA	PMID:26079696
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1312331	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of CADM4 mRNA	PMID:26272509
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312331	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1304722	Cadm4	cell adhesion molecule 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312332	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CADM4 mRNA	PMID:27131904
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1603281	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of THEM4 mRNA	PMID:27188386
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:137392	chlormequat chloride	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of THEM4 protein	PMID:34958886
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of THEM4 mRNA	PMID:20488242
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312333	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of THEM4 mRNA	PMID:36331819
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1603281	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of THEM4 mRNA	PMID:26079696
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312333	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of THEM4 mRNA	PMID:30319688
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1603281	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of THEM4 mRNA	PMID:20660070
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312333	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of THEM4 mRNA	PMID:33711761
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1603281	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of THEM4 mRNA	PMID:20660070
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312333	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of THEM4 mRNA	PMID:34319233
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312333	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of THEM4 mRNA	PMID:36331819
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in decreased expression of THEM4 mRNA	PMID:19716837
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:22977	cadmium atom	increases methylation	ISO	RGD:1603281	E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in increased methylation of THEM4 promoter	PMID:19716837
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312333	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of THEM4 mRNA	PMID:37236586
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of THEM4 mRNA	PMID:19549813
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of THEM4 mRNA	PMID:23649840
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of THEM4 mRNA	PMID:23649840
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of THEM4 mRNA	PMID:21867686
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of THEM4 mRNA	PMID:26272509
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1603281	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of THEM4 mRNA	PMID:27188386
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of THEM4 mRNA	PMID:31295307
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of THEM4 mRNA	PMID:31881176
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of THEM4 mRNA	PMID:33387578
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312333	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of THEM4 mRNA	PMID:17949056
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of THEM4 mRNA	PMID:28001369
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1603281	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of THEM4 mRNA; aristolochic acid I results in increased expression of THEM4 protein	PMID:33212167
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1603281	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of THEM4 mRNA	PMID:30911355
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312333	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of THEM4 protein	PMID:28918527
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of THEM4 mRNA	PMID:29803840
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of THEM4 mRNA	PMID:38568856
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603281	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of THEM4 promoter	PMID:18448484
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603281	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of THEM4 promoter	PMID:27901495
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312333	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of THEM4 mRNA	PMID:19770486
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of THEM4 mRNA	PMID:19716837
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1603281	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased methylation of THEM4 promoter	PMID:19716837
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1603281	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of THEM4 mRNA	PMID:30911355
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of THEM4 mRNA	PMID:20018196
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of THEM4 mRNA	PMID:23411599|PMID:34492290
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312333	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of THEM4 mRNA	PMID:17426115
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312333	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of THEM4 mRNA	PMID:28329830
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of THEM4 mRNA	PMID:34947998
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of THEM4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of THEM4 gene	PMID:28505145
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1603281	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of THEM4 mRNA	PMID:25979313
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312333	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of THEM4 mRNA	PMID:34813904
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312333	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of THEM4 mRNA	PMID:34813904
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1603281	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of THEM4 mRNA	PMID:29024780
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of THEM4 mRNA	PMID:38568856
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312333	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of THEM4 mRNA	PMID:37236586
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1603281	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of THEM4 protein	PMID:26879310
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of THEM4 mRNA	PMID:31533062
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1603281	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of THEM4 mRNA	PMID:40419075
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312333	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of THEM4 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of THEM4 mRNA	PMID:36331819
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603281	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of THEM4 mRNA	PMID:25979313
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of THEM4 mRNA	PMID:28001369
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603281	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of THEM4 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1603281	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of THEM4 mRNA	PMID:38832940
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1603281	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of THEM4 mRNA	PMID:27188386
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1603281	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of THEM4 mRNA	PMID:27188386
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1603281	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of THEM4 mRNA	PMID:24935251
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of THEM4 mRNA	PMID:33387578
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312333	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of THEM4 mRNA	PMID:35436446
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312333	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of THEM4 mRNA	PMID:40234311
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603281	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of THEM4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of THEM4 mRNA	PMID:27188386
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of THEM4 mRNA	PMID:18927307
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312333	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of THEM4 mRNA	PMID:21278054
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603281	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of THEM4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of THEM4 mRNA	PMID:27188386
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1603281	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of THEM4 mRNA	PMID:29301935
1304723	Them4	thioesterase superfamily member 4	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1603281	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of THEM4 mRNA	PMID:27188386
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:132612	monobenzyl phthalate	decreases methylation	ISO	RGD:1312334	E	RGD:6480464	20260415	CTD	MESH:C103325	mono-benzyl phthalate results in decreased methylation of SOX21 gene	PMID:35032864
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312335	E	RGD:6480464	20140729	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SOX21 mRNA	PMID:20188158
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312334	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SOX21 mRNA	PMID:33359661
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of SOX21 mRNA	PMID:26496021
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312334	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SOX21 mRNA	PMID:31163220
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312334	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SOX21 mRNA	PMID:32525701
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312334	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SOX21 mRNA	PMID:26272509
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312334	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX21 mRNA	PMID:27188386
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:27889	lead(0)	increases methylation	ISO	RGD:1312335	E	RGD:6480464	20250311	CTD	MESH:D007854	Lead results in increased methylation of SOX21 gene	PMID:38833407
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312334	E	RGD:6480464	20140729	CTD	MESH:D002945	Cisplatin affects the expression of SOX21 mRNA	PMID:23300844
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312334	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SOX21 mRNA	PMID:27392435
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1312334	E	RGD:6480464	20140729	CTD	MESH:D010278	Parathion results in increased methylation of SOX21 promoter	PMID:22847954
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312335	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SOX21 mRNA	PMID:24058054
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312335	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SOX21 mRNA	PMID:31961203
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1312334	E	RGD:6480464	20140729	CTD	MESH:D003561	Cytarabine results in increased expression of SOX21 mRNA	PMID:21198554
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312334	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SOX21 exon	PMID:27901495
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312334	E	RGD:6480464	20140729	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SOX21 mRNA	PMID:22316170
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312335	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SOX21 mRNA	PMID:27195522
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312334	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SOX21 promoter	PMID:27901495
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312335	E	RGD:6480464	20140729	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SOX21 mRNA]	PMID:22228805
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1312335	E	RGD:6480464	20190219	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SOX21 mRNA	PMID:30171875
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312334	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SOX21 mRNA	PMID:25895662
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312334	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of SOX21 mRNA	PMID:35984750
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312335	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SOX21 enhancer; titanium dioxide results in decreased methylation of SOX21 gene	PMID:35295148
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312335	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SOX21 gene	PMID:35295148
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312335	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SOX21 promoter	PMID:27334623
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312334	E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in decreased expression of SOX21 mRNA	PMID:33476716
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of SOX21 mRNA	PMID:26496021
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312334	E	RGD:6480464	20210504	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SOX21 mRNA	PMID:33476716
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:34107	1-nitropyrene	decreases expression	ISO	RGD:1312334	E	RGD:6480464	20140729	CTD	MESH:C032668	1-nitropyrene results in decreased expression of SOX21 mRNA	PMID:19041380
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312334	E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SOX21 mRNA	PMID:22941251
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1312334	E	RGD:6480464	20140729	CTD	MESH:D004397	Fonofos results in increased methylation of SOX21 promoter	PMID:22847954
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1312334	E	RGD:6480464	20140729	CTD	MESH:C012568	terbufos results in increased methylation of SOX21 promoter	PMID:22847954
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312335	E	RGD:6480464	20140729	CTD	MESH:D000082	Acetaminophen affects the expression of SOX21 mRNA	PMID:17562736
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312334	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SOX21 mRNA	PMID:32525701
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312334	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SOX21 mRNA	PMID:23300844
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312334	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SOX21 mRNA	PMID:31758290
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312335	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SOX21 mRNA	PMID:22206623
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312334	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SOX21 mRNA	PMID:37199045
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312334	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX21 mRNA	PMID:27188386
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SOX21 mRNA	PMID:23914054
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312334	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SOX21 mRNA	PMID:32525701
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SOX21 mRNA	PMID:36843608
1304724	Sox21	SRY-box transcription factor 21	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312334	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX21 mRNA	PMID:27188386
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of DNAJB1 mRNA	PMID:21551480
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312337	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DNAJB1 mRNA	PMID:33045310
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin results in decreased expression of DNAJB1 mRNA	PMID:20117194
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312336	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of DNAJB1 mRNA	PMID:33167477
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:15368	acrolein	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of DNAJB1 mRNA	PMID:38090360
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB1 mRNA	PMID:32699268
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312337	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DNAJB1 mRNA	PMID:30319688
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16240	hydrogen peroxide	decreases response to substance	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D006861	DNAJB1 protein results in decreased susceptibility to Hydrogen Peroxide	PMID:11359866
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312337	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DNAJB1 mRNA	PMID:15919760|PMID:39241906
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of DNAJB1 mRNA	PMID:35877022
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DNAJB1 mRNA	PMID:20106945
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312336	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DNAJB1 mRNA	PMID:37042841
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16664	albendazole	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20130514	CTD	MESH:D015766	[Ivermectin co-treated with Albendazole] results in increased expression of DNAJB1 mRNA	PMID:16861626
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in decreased expression of DNAJB1 mRNA	PMID:19162166
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:167162	L-ascorbic acid 2-phosphate	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20220208	CTD	MESH:C011669	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA	PMID:34480604
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20200804	CTD	MESH:D002635	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of DNAJB1 mRNA	PMID:17572062
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16990	bilirubin IXalpha	affects expression	ISO	RGD:1312336	E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin affects the expression of DNAJB1 mRNA	PMID:20196124
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of DNAJB1 mRNA	PMID:18037150
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312336	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DNAJB1 mRNA	PMID:21179406
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of DNAJB1 mRNA	PMID:17945193
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312336	E	RGD:6480464	20140909	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of DNAJB1 mRNA	PMID:24356939
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312336	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of DNAJB1 mRNA	PMID:33647349
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D014050	Toluene results in decreased expression of DNAJB1 mRNA	PMID:22166486
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D014050	Toluene results in increased expression of DNAJB1 mRNA	PMID:22166486
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17580	linalool	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C018584	linalool results in increased expression of DNAJB1 mRNA	PMID:20536181
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:C031927	hydroquinone results in increased expression of DNAJB1 mRNA	PMID:15452088
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17650	cortisol	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20220208	CTD	MESH:D006854	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DNAJB1 mRNA	PMID:34480604
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20200804	CTD	MESH:D006000	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:177406	Bardoxolone methyl	affects expression	ISO	RGD:1312336	E	RGD:6480464	20220208	CTD	MESH:C445068	bardoxolone methyl affects the expression of DNAJB1 mRNA	PMID:34480604
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DNAJB1 mRNA	PMID:21318169
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNAJB1 mRNA	PMID:21318169
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312337	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNAJB1 mRNA	PMID:33754040
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Haloperidol] results in decreased expression of DNAJB1 protein	PMID:34122009
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312336	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DNAJB1 protein	PMID:37730182
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DNAJB1 mRNA	PMID:33387578
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312336	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DNAJB1 mRNA	PMID:28818685
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA	PMID:39836092
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DNAJB1 protein	PMID:34915118
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in increased expression of DNAJB1 protein	PMID:16729991
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312336	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of DNAJB1 mRNA; Cadmium results in increased expression of DNAJB1 protein	PMID:16020198|PMID:21120746|PMID:24284285|PMID:28860664|PMID:29993192|PMID:33559965
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:39012411
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20200609	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:31738976|PMID:35301059
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:37236586
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:232796	cadmium acetate	increases expression	ISO	RGD:1312336	E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in increased expression of DNAJB1 mRNA	PMID:18155341
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DNAJB1 mRNA	PMID:19549813
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312336	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DNAJB1 gene	PMID:27153756
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312336	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DNAJB1 mRNA	PMID:23649840
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:25712	organoselenium compound	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20170228	CTD	MESH:D016566	[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB1 mRNA	PMID:25167922
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of DNAJB1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DNAJB1 mRNA	PMID:32699268|PMID:35430440
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DNAJB1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DNAJB1 protein	PMID:38598786
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DNAJB1 mRNA	PMID:18593933
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNAJB1 mRNA	PMID:18346771|PMID:31150632
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312337	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNAJB1 mRNA	PMID:25270620|PMID:27339419|PMID:31919559
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20200804	CTD	MESH:D006002	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of DNAJB1 mRNA	PMID:35809665|PMID:39836092
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20210907	CTD	MESH:D000966	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DNAJB1 mRNA	PMID:32076005
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DNAJB1 protein	PMID:38460933
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA	PMID:33854195
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27810	resorcinol	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of DNAJB1 mRNA	PMID:22623647
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of DNAJB1 mRNA	PMID:31881176
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB1 mRNA]	PMID:31298478
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of DNAJB1 mRNA	PMID:40618947
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312336	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of DNAJB1 mRNA	PMID:27392435
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312336	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of DNAJB1 mRNA	PMID:23195993
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312337	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNAJB1 mRNA	PMID:21570461
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNAJB1 mRNA	PMID:21215274
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNAJB1 mRNA	PMID:33387578
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312336	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNAJB1 mRNA	PMID:20106945|PMID:21632981
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNAJB1 mRNA	PMID:17942748
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312336	E	RGD:6480464	20140909	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DNAJB1 mRNA	PMID:24356939|PMID:28001369
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312336	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of DNAJB1 mRNA	PMID:30851411
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA	PMID:27188386
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of DNAJB1 mRNA	PMID:23649840
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312336	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DNAJB1 mRNA	PMID:32763439
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of DNAJB1 mRNA; [Disulfiram binds to Copper] which results in decreased expression of DNAJB1 mRNA; [NSC 689534 binds to Copper] which results in increased expression of DNAJB1 mRNA; [Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB1 mRNA	PMID:20971185|PMID:24690739|PMID:25167922|PMID:35809665
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DNAJB1 mRNA	PMID:29803840
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of DNAJB1 mRNA	PMID:15033991
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20200804	CTD	MESH:D003840	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of DNAJB1 mRNA	PMID:20044591
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB1 mRNA]	PMID:18723479
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20220208	CTD	MESH:D001205	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA	PMID:34480604
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAJB1 protein	PMID:16729991
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312336	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAJB1 mRNA; sodium arsenite results in increased expression of DNAJB1 protein	PMID:12679051|PMID:12760830|PMID:16729991|PMID:24516582|PMID:38568856
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312337	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAJB1 mRNA	PMID:16014739|PMID:25270620
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20210907	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA; [sodium arsenite co-treated with lead acetate] results in increased expression of DNAJB1 protein; [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of DNAJB1 mRNA	PMID:32076005|PMID:38072110|PMID:39836092
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20121009	CTD	MESH:D014415	Tunicamycin results in decreased expression of DNAJB1 mRNA	PMID:20196124
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312336	E	RGD:6480464	20140909	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of DNAJB1 mRNA; Benzo(a)pyrene results in increased expression of DNAJB1 mRNA	PMID:24356939
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNAJB1 mRNA	PMID:19770486|PMID:21569818|PMID:21715664
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of DNAJB1 mRNA	PMID:33053406
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312336	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite results in increased expression of DNAJB1 mRNA	PMID:32406909
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20210907	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of DNAJB1 mRNA; arsenite promotes the reaction [G3BP1 protein binds to DNAJB1 mRNA]	PMID:32076005|PMID:32406909
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of DNAJB1 mRNA; [Disulfiram binds to Copper] which results in decreased expression of DNAJB1 mRNA; [NSC 689534 binds to Copper] which results in increased expression of DNAJB1 mRNA; [Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB1 mRNA	PMID:20971185|PMID:24690739|PMID:25167922|PMID:35809665
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DNAJB1 mRNA	PMID:18593933
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30297	antimonite	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20210907	CTD	MESH:C061374	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DNAJB1 mRNA	PMID:32076005
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312336	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of DNAJB1 mRNA	PMID:26014281|PMID:28959546
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312336	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DNAJB1 mRNA	PMID:25351596
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DNAJB1 mRNA	PMID:19073995
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312336	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DNAJB1 mRNA; Arsenic Trioxide results in increased expression of DNAJB1 protein	PMID:19417148|PMID:20458559|PMID:20724260|PMID:24356939
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20191114	CTD	MESH:C006632	KNK 437 inhibits the reaction [Arsenic Trioxide results in increased expression of DNAJB1 protein]	PMID:20724260
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1312336	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of DNAJB1 mRNA	PMID:35984750
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of DNAJB1 mRNA	PMID:21829687
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in increased expression of DNAJB1 protein	PMID:38072110
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32130	silver(1+) nitrate	increases expression	ISO	RGD:1312336	E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in increased expression of DNAJB1 mRNA	PMID:22831968
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of DNAJB1 mRNA	PMID:24136188
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of DNAJB1 mRNA	PMID:30012374
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of DNAJB1 mRNA	PMID:23557971|PMID:27760801|PMID:29128614|PMID:29264374
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312337	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DNAJB1 gene	PMID:35295148
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312337	E	RGD:6480464	20130611	CTD	MESH:C009495	titanium dioxide results in increased expression of DNAJB1 mRNA	PMID:31298478
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312337	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DNAJB1 gene	PMID:35295148
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20200211	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB1 mRNA]	PMID:31298478
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32497	thioacetamide	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased methylation of DNAJB1 promoter	PMID:27914986
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DNAJB1 mRNA	PMID:17426115
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C006253	pirinixic acid results in increased expression of DNAJB1 mRNA	PMID:19162173|PMID:21318169
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of DNAJB1 mRNA	PMID:18301758|PMID:21318169
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of DNAJB1 mRNA]	PMID:21318169
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312337	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DNAJB1 mRNA	PMID:28472532
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DNAJB1 mRNA	PMID:25181051|PMID:30903817
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJB1 protein	PMID:31675489
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJB1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312337	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJB1 mRNA	PMID:33221593|PMID:39742910
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312336	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of DNAJB1 mRNA	PMID:24752500
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312337	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DNAJB1 mRNA	PMID:39298647
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DNAJB1 mRNA	PMID:28628672
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of DNAJB1 mRNA	PMID:26377693
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DNAJB1 mRNA	PMID:20691718
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312337	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DNAJB1 mRNA	PMID:37019170
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA	PMID:33854195
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34682	diazinon	increases expression	ISO	RGD:1312336	E	RGD:6480464	20140909	CTD	MESH:D003976	Diazinon results in increased expression of DNAJB1 mRNA	PMID:24356939
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312336	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of DNAJB1 gene	PMID:22964155
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DNAJB1 mRNA	PMID:21266533
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34696	dieldrin	increases expression	ISO	RGD:1312336	E	RGD:6480464	20201215	CTD	MESH:D004026	Dieldrin results in increased expression of DNAJB1 mRNA	PMID:31068361
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DNAJB1 protein	PMID:38598786
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DNAJB1 mRNA	PMID:28628672
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of DNAJB1 mRNA	PMID:18691550
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of DNAJB1 mRNA	PMID:18253720
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004052	IKBKB protein inhibits the reaction [Diethylnitrosamine results in decreased expression of DNAJB1 mRNA]	PMID:18691550
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34905	paraquat	decreases response to substance	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D010269	DNAJB1 protein results in decreased susceptibility to Paraquat	PMID:11359866
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34936	propanil	increases expression	ISO	RGD:1312336	E	RGD:6480464	20141111	CTD	MESH:D011411	Propanil results in increased expression of DNAJB1 mRNA	PMID:24356939
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312336	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DNAJB1 mRNA	PMID:37042841
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA	PMID:39836092
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of DNAJB1 mRNA	PMID:26377693
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DNAJB1 mRNA	PMID:20551477
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35455	1-naphthyl isothiocyanate	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20160822	CTD	MESH:D015058	[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of DNAJB1 mRNA	PMID:27344345
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DNAJB1 mRNA	PMID:38382870
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNAJB1 mRNA; Cadmium Chloride results in increased expression of DNAJB1 protein	PMID:16729991|PMID:19010381|PMID:22110744
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312336	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNAJB1 mRNA	PMID:38568856
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:39012411
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20200609	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:31738976|PMID:35301059
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:37236586
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DNAJB1 mRNA	PMID:19162173|PMID:21318169
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312336	E	RGD:6480464	20150609	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DNAJB1 mRNA	PMID:25868421
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of DNAJB1 mRNA	PMID:24386269
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312336	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of DNAJB1 mRNA	PMID:19320972|PMID:19376846|PMID:24356939
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20200804	CTD	MESH:D005999	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312337	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of DNAJB1 mRNA	PMID:18353800
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB1 mRNA	PMID:32699268
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of DNAJB1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DNAJB1 mRNA]	PMID:17585979
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1312336	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of DNAJB1 mRNA	PMID:40434365
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312336	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DNAJB1 mRNA	PMID:31533062
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1312336	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of DNAJB1 mRNA	PMID:26352163
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312337	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of DNAJB1 mRNA	PMID:23125180
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:C016104	sodium bichromate results in decreased expression of DNAJB1 mRNA	PMID:12760830
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312336	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of DNAJB1 mRNA	PMID:29154799
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4027	cyclophosphamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide affects the expression of DNAJB1 mRNA	PMID:18246545
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1312336	E	RGD:6480464	20140909	CTD	MESH:D003520	Cyclophosphamide metabolite results in increased expression of DNAJB1 mRNA	PMID:24356939
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312336	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DNAJB1 mRNA	PMID:20106945|PMID:25562108|PMID:32152650
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA	PMID:33854195
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:41607	crotonaldehyde	increases expression	ISO	RGD:1312336	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased expression of DNAJB1 mRNA	PMID:20471460
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312337	E	RGD:6480464	20120717	CTD	MESH:D013629	Tamoxifen affects the expression of DNAJB1 mRNA	PMID:17555576|PMID:20937368
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DNAJB1 mRNA	PMID:28628672
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:42223	emodin	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D004642	Emodin results in increased expression of DNAJB1 mRNA	PMID:16045814
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4356	desferrioxamine B	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20250708	CTD	MESH:D003676	Deferoxamine results in decreased expression of DNAJB1 protein	PMID:39643152
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1312336	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of DNAJB1 mRNA	PMID:33512557
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of DNAJB1 mRNA	PMID:18502557
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of DNAJB1 mRNA	PMID:24136188
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312336	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DNAJB1 mRNA; Okadaic Acid results in increased expression of DNAJB1 protein	PMID:38832940
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA	PMID:33854195
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in increased expression of DNAJB1 mRNA	PMID:19606018
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DNAJB1 mRNA	PMID:18246545
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DNAJB1 mRNA	PMID:15606129|PMID:17562736
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJB1 mRNA	PMID:17202762|PMID:18246545|PMID:18346771|PMID:33387578
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312336	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJB1 mRNA	PMID:21420995|PMID:22230336|PMID:29067470
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120501	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJB1 mRNA	PMID:11264010|PMID:12540782|PMID:18544908
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of DNAJB1 mRNA; O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of DNAJB1 mRNA]; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DNAJB1 mRNA]	PMID:12540782|PMID:17585979
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of DNAJB1 mRNA	PMID:24690739
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312336	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DNAJB1 mRNA	PMID:25351596
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DNAJB1 protein	PMID:38460933
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of DNAJB1 mRNA	PMID:35809665|PMID:39836092
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1312336	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of DNAJB1 mRNA	PMID:22077320
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312336	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of DNAJB1 mRNA	PMID:24752500
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of DNAJB1 mRNA	PMID:31675489
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20190312	CTD	MESH:C016766	[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of DNAJB1 mRNA	PMID:30529165
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of DNAJB1 mRNA	PMID:31464424
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1312337	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of DNAJB1 mRNA	PMID:35436446
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4811	epoxiconazole	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C109476	epoxiconazole results in increased expression of DNAJB1 mRNA	PMID:29038839
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DNAJB1 mRNA	PMID:17555576
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DNAJB1 mRNA	PMID:17942748
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20160822	CTD	MESH:D004997	[Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of DNAJB1 mRNA	PMID:27344345
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNAJB1 mRNA	PMID:17942748
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of DNAJB1 mRNA	PMID:17211630
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA	PMID:27188386
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of DNAJB1 mRNA	PMID:18299717
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DNAJB1 mRNA	PMID:28628672
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49668	gefitinib	increases secretion	ISO	RGD:1312336	E	RGD:6480464	20210406	CTD	MESH:C419708	Gefitinib metabolite results in increased secretion of DNAJB1 protein	PMID:33132241
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312336	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DNAJB1 mRNA; Arsenic Trioxide results in increased expression of DNAJB1 protein	PMID:19417148|PMID:20458559|PMID:20724260|PMID:24356939
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20191114	CTD	MESH:C032793	KNK 437 inhibits the reaction [Arsenic Trioxide results in increased expression of DNAJB1 protein]	PMID:20724260
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:5001	fenofibrate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011345	[Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of DNAJB1 mRNA	PMID:18253720
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50161	motexafin gadolinium	increases expression	ISO	RGD:1312336	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of DNAJB1 mRNA	PMID:16357179
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium inhibits the reaction [Zinc Acetate results in decreased expression of DNAJB1 mRNA]	PMID:16357179
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate results in increased expression of DNAJB1 mRNA	PMID:12064557
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DNAJB1 mRNA	PMID:25620056
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312337	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DNAJB1 mRNA	PMID:25554681
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of DNAJB1 mRNA	PMID:40234311
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DNAJB1 mRNA	PMID:35964746
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DNAJB1 mRNA	PMID:24136188
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of DNAJB1 mRNA	PMID:26377693
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1312336	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of DNAJB1 mRNA	PMID:15509775
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312336	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DNAJB1 mRNA	PMID:31629900
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:5385	gliotoxin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005912	Gliotoxin results in increased expression of DNAJB1 mRNA	PMID:18346771
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:5613	haloperidol	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in decreased expression of DNAJB1 protein	PMID:34122009
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA	PMID:33854195
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DNAJB1 protein	PMID:32959892
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6078	ivermectin	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20130514	CTD	MESH:D007559	[Ivermectin co-treated with Albendazole] results in increased expression of DNAJB1 mRNA	PMID:16861626
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1312336	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of DNAJB1 mRNA	PMID:19606018
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:62878	XAV939	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20220208	CTD	MESH:C544261	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA	PMID:34480604
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:62984	zinc acetate	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of DNAJB1 mRNA	PMID:16357179
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:62984	zinc acetate	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20170303	CTD	MESH:D019345	motexafin gadolinium inhibits the reaction [Zinc Acetate results in decreased expression of DNAJB1 mRNA]	PMID:16357179
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA	PMID:39836092
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:63934	bathocuproine disulfonic acid	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20120814	CTD	MESH:C028559	[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of DNAJB1 mRNA	PMID:15477007
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:63952	arsenic trichloride	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20240402	CTD	MESH:C050510	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of DNAJB1 mRNA	PMID:35809665
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6402	leflunomide	affects expression	ISO	RGD:1312336	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide affects the expression of DNAJB1 mRNA	PMID:28988120
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of DNAJB1 mRNA	PMID:24136188
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of DNAJB1 mRNA	PMID:15336504
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20130514	CTD	MESH:D015655	DNAJB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SNCA mRNA]; DNAJB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SNCA protein]	PMID:16678164
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of DNAJB1 mRNA	PMID:37939859
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DNAJB1 mRNA	PMID:19564919
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of DNAJB1 mRNA; SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of DNAJB1 mRNA]	PMID:19564919
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1312336	E	RGD:6480464	20210608	CTD	MESH:C014476	diethyl maleate results in increased expression of DNAJB1 mRNA	PMID:33545341|PMID:34480604
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312336	E	RGD:6480464	20210209	CTD	MESH:D002185	Cannabidiol results in increased expression of DNAJB1 mRNA	PMID:26504004|PMID:31518892
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of DNAJB1 mRNA	PMID:31758290
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of DNAJB1 mRNA; SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of DNAJB1 mRNA]	PMID:19564919
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312337	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of DNAJB1 mRNA	PMID:22206623
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of DNAJB1 mRNA; [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DNAJB1 protein	PMID:34480604|PMID:37664457
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of DNAJB1 mRNA	PMID:24136188
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1312336	E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in increased expression of DNAJB1 mRNA	PMID:32152650
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:7494	nefazodone	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1312337	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of DNAJB1 mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of DNAJB1 protein	PMID:15525353|PMID:25566086
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:75261	arotinoid acid	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20220208	CTD	MESH:C038864	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DNAJB1 mRNA	PMID:34480604
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:75832	iron(2+) sulfate (anhydrous)	decreases response to substance	ISO	RGD:1312336	E	RGD:6480464	20161213	CTD	MESH:C020748	DNAJB1 protein results in decreased susceptibility to ferrous sulfate	PMID:11359866
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:76987	metacetamol	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20140204	CTD	MESH:C026137	3-hydroxyacetanilide results in decreased expression of DNAJB1 mRNA	PMID:18544908
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of DNAJB1 mRNA	PMID:21346803
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312336	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of DNAJB1 mRNA	PMID:30851411
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA	PMID:27188386
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:78782	pyrrolidine dithiocarbamate	increases expression	ISO	RGD:1312336	E	RGD:6480464	20140708	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid results in increased expression of DNAJB1 mRNA	PMID:15477007
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20140708	CTD	MESH:C020972	[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of DNAJB1 mRNA	PMID:15477007
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:79369	elesclomol	increases expression	ISO	RGD:1312336	E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of DNAJB1 mRNA	PMID:18723479
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:79369	elesclomol	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20170228	CTD	MESH:C512195	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB1 mRNA]	PMID:18723479
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of DNAJB1 mRNA	PMID:19162173
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of DNAJB1 mRNA	PMID:19270015
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312337	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of DNAJB1 mRNA	PMID:19482888|PMID:23091169
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of DNAJB1 mRNA]	PMID:19482888
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of DNAJB1 mRNA	PMID:22538082
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1312337	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of DNAJB1 mRNA	PMID:22538082
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312337	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DNAJB1 mRNA	PMID:38648751
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNAJB1 protein	PMID:31675489
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of DNAJB1 protein	PMID:31675489
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of DNAJB1 mRNA	PMID:21858171
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of DNAJB1 mRNA	PMID:39847705
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120501	CTD	MESH:C045950	propiconazole results in increased expression of DNAJB1 mRNA	PMID:19363144|PMID:21278054
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8493	Propiverine	affects localization	EXP		E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine affects the localization of DNAJB1 protein	PMID:29273565
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1312336	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of DNAJB1 mRNA	PMID:16497877
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:91091	CHIR 99021	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20220208	CTD	MESH:C473711	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DNAJB1 mRNA; [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA	PMID:34480604
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of DNAJB1 mRNA; [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DNAJB1 protein; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA	PMID:27188386|PMID:34480604|PMID:37664457
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312336	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of DNAJB1 mRNA	PMID:26014281|PMID:28959546
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DNAJB1 mRNA	PMID:19281266
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DNAJB1 mRNA	PMID:21346803
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1312336	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of DNAJB1 mRNA	PMID:33512557
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312336	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DNAJB1 mRNA	PMID:38568856
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9513	thalidomide	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D013792	Thalidomide analog results in increased expression of DNAJB1 mRNA	PMID:20525221
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1312336	E	RGD:6480464	20120412	CTD	MESH:D013849	Thimerosal results in increased expression of DNAJB1 mRNA	PMID:16870260
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312336	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DNAJB1 protein	PMID:38598786
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312337	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of DNAJB1 mRNA	PMID:28973697
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DNAJB1 mRNA	PMID:19015723
1304725	Dnajb1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of DNAJB1 mRNA	PMID:23034163
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313743	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of SMARCE1 protein	PMID:39638853
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SMARCE1 mRNA	PMID:38218311
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of SMARCE1 mRNA	PMID:21551480
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SMARCE1 mRNA	PMID:33167477
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SMARCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SMARCE1 mRNA	PMID:32699268
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313743	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SMARCE1 mRNA	PMID:20044591
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SMARCE1 gene	PMID:27618143
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313743	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SMARCE1 mRNA	PMID:37042841
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313743	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SMARCE1 mRNA	PMID:23649840
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SMARCE1 mRNA	PMID:37236586
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SMARCE1 mRNA	PMID:19549813
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313743	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SMARCE1 mRNA	PMID:23649840
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SMARCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SMARCE1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of SMARCE1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of SMARCE1 mRNA	PMID:32699268|PMID:35430440
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SMARCE1 mRNA	PMID:22171008
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SMARCE1 mRNA	PMID:31919559
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313743	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SMARCE1 protein	PMID:35688186
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SMARCE1 protein	PMID:25505154
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SMARCE1 mRNA	PMID:23557933
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313743	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SMARCE1 mRNA	PMID:28903495
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313744	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMARCE1 mRNA	PMID:21570461
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMARCE1 mRNA	PMID:17942748
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of SMARCE1 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCE1 mRNA	PMID:17942748|PMID:19465110
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SMARCE1 mRNA	PMID:28001369
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313743	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SMARCE1 mRNA	PMID:27188386
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMARCE1 protein	PMID:33212167
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of SMARCE1 mRNA	PMID:26272509
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA	PMID:27188386
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313744	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SMARCE1 mRNA	PMID:27862939
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMARCE1 mRNA	PMID:29803840
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29365	phosgene	affects expression	ISO	RGD:1313744	E	RGD:6480464	20120515	CTD	MESH:D010705	Phosgene affects the expression of SMARCE1 mRNA	PMID:16300373
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SMARCE1 mRNA	PMID:34032870|PMID:39719251
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313744	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of SMARCE1 mRNA	PMID:36209798
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMARCE1 mRNA	PMID:21632981|PMID:26238291
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313743	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SMARCE1 3' UTR; Benzo(a)pyrene results in decreased methylation of SMARCE1 promoter	PMID:27901495
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SMARCE1 mRNA	PMID:21839799
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SMARCE1 mRNA	PMID:22171008
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313743	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SMARCE1 mRNA	PMID:20382639
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of SMARCE1 mRNA	PMID:34408198
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313744	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SMARCE1 gene	PMID:35295148
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SMARCE1 mRNA	PMID:18648102
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SMARCE1 mRNA	PMID:25181051
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SMARCE1 mRNA	PMID:33221593
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313744	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SMARCE1 mRNA	PMID:26063408
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to SMARCE1 promoter]	PMID:20348232
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313744	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SMARCE1 mRNA	PMID:39298647
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMARCE1 mRNA	PMID:37019170
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313744	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of SMARCE1 protein	PMID:35362542
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SMARCE1 protein]	PMID:35362542
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313743	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SMARCE1 gene	PMID:22964155
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SMARCE1 mRNA	PMID:17361019|PMID:21266533
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313743	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SMARCE1 mRNA	PMID:37042841
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:351346	phenethyl isothiocyanate	affects binding	ISO	RGD:1313743	E	RGD:6480464	20120717	CTD	MESH:C058305	SMARCE1 protein binds to phenethyl isothiocyanate	PMID:21838287
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SMARCE1 mRNA	PMID:33453195
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SMARCE1 mRNA	PMID:38568856
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SMARCE1 mRNA	PMID:37236586
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of SMARCE1 mRNA	PMID:19429403
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313743	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SMARCE1 mRNA	PMID:24449571
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SMARCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SMARCE1 mRNA	PMID:32699268
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of SMARCE1 mRNA	PMID:19429403
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313743	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SMARCE1 mRNA	PMID:25979313
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCE1 mRNA	PMID:23179753
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCE1 mRNA	PMID:20546886|PMID:21427059
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of SMARCE1 mRNA	PMID:41580965
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMARCE1 mRNA	PMID:25562108|PMID:27989131
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of SMARCE1 mRNA	PMID:24136188
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313743	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SMARCE1 mRNA	PMID:27188386
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SMARCE1 mRNA	PMID:24935251|PMID:26272509
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA	PMID:27188386
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMARCE1 mRNA	PMID:33387578
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMARCE1 mRNA	PMID:21420995
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SMARCE1 mRNA	PMID:17942748
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCE1 mRNA	PMID:17942748
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SMARCE1 protein]	PMID:35362542
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SMARCE1 mRNA	PMID:24136188
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of SMARCE1 mRNA	PMID:34044035
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SMARCE1 mRNA	PMID:35964746
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of SMARCE1 mRNA	PMID:24793618
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SMARCE1 protein	PMID:32959892
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SMARCE1 mRNA	PMID:23650126
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313744	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SMARCE1 protein	PMID:26558463
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of SMARCE1 protein	PMID:36851058
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:73390	promegestone	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20130723	CTD	MESH:D011397	Promegestone promotes the reaction [SMARCE1 protein binds to PGR protein]	PMID:19609353
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313744	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SMARCE1 mRNA	PMID:22206623
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SMARCE1 protein	PMID:37664457
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313743	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SMARCE1 protein	PMID:31285264
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of SMARCE1 mRNA	PMID:12517777
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA	PMID:27188386
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SMARCE1 gene]	PMID:28238834
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313743	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of SMARCE1 mRNA	PMID:21858171
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SMARCE1 mRNA	PMID:24780913
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313743	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SMARCE1 protein; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA	PMID:27188386|PMID:37664457
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SMARCE1 mRNA	PMID:19281266
1304726	Smarce1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of SMARCE1 protein	PMID:35544339
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1605093	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MTF2 mRNA	PMID:38218311
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1332459	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MTF2 mRNA	PMID:33045310
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1332459	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MTF2 mRNA	PMID:30319688
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332459	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MTF2 mRNA	PMID:39241906
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MTF2 mRNA	PMID:20655997
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1605093	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of MTF2 mRNA	PMID:18070364
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1332459	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of MTF2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of MTF2 mRNA]	PMID:20230807
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1332459	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of MTF2 mRNA	PMID:20230807
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1332459	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of MTF2 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of MTF2 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of MTF2 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of MTF2 mRNA]	PMID:20230807
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1332459	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of MTF2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of MTF2 mRNA]	PMID:20230807
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of MTF2 protein	PMID:33236894
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605093	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MTF2 gene	PMID:27153756
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of MTF2 mRNA	PMID:28534445
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1605093	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of MTF2 mRNA	PMID:18356318
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1332459	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MTF2 mRNA	PMID:17484886
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1332459	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of MTF2 mRNA	PMID:25629700
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332459	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTF2 mRNA	PMID:22206623
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1605093	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MTF2 gene	PMID:25304211
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MTF2 mRNA	PMID:19244175
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605093	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTF2 mRNA	PMID:27188386
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1332459	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of MTF2 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of MTF2 mRNA]	PMID:20230807
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605093	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MTF2 mRNA	PMID:23557933
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332459	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MTF2 mRNA	PMID:21570461
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1332459	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MTF2 mRNA	PMID:19770486
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MTF2 protein	PMID:39603559
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MTF2 mRNA	PMID:28001369
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MTF2 mRNA	PMID:33212167
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1332459	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of MTF2 mRNA	PMID:32042022
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605093	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MTF2 mRNA	PMID:38568856
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332459	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MTF2 mRNA	PMID:19770486
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605093	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MTF2 promoter	PMID:27901495
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1605093	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of MTF2 mRNA	PMID:18356318
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MTF2 mRNA	PMID:19150397|PMID:26238291
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1332459	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MTF2 mRNA	PMID:35676786
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:30621	diarsenic trioxide	increases response to substance	ISO	RGD:1605093	E	RGD:6480464	20191114	CTD	MESH:C006632	MTF2 protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1605093	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MTF2 protein]	PMID:26598702
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MTF2 mRNA	PMID:25729387
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332459	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MTF2 gene	PMID:35295148
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MTF2 mRNA	PMID:34492290
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1332459	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MTF2 mRNA	PMID:18648102
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MTF2 mRNA	PMID:29275510
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MTF2 mRNA	PMID:30816183
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of MTF2 mRNA	PMID:19244175
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332459	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MTF2 mRNA	PMID:38685157
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1332459	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of MTF2 promoter	PMID:28392331
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332459	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MTF2 mRNA	PMID:21266533
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605093	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MTF2 mRNA	PMID:37042841
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of MTF2 mRNA	PMID:17616710
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1605093	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MTF2 mRNA	PMID:24449571
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MTF2 mRNA	PMID:19244175
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MTF2 mRNA	PMID:28302478
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MTF2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1605093	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MTF2 gene	PMID:29154799
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605093	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTF2 mRNA	PMID:27188386
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332459	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MTF2 mRNA	PMID:28973697
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1605093	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of MTF2 mRNA	PMID:33512557
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1605093	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MTF2 gene	PMID:25304211
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1332459	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MTF2 mRNA	PMID:35436446
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1332459	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MTF2 mRNA	PMID:35676786
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:49900	arsenous acid	increases response to substance	ISO	RGD:1605093	E	RGD:6480464	20191114	CTD	MESH:C032793	MTF2 protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1605093	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MTF2 protein]	PMID:26598702
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:49976	zinc dichloride	decreases expression	ISO	RGD:1605093	E	RGD:6480464	20130122	CTD	MESH:C016837	zinc chloride results in decreased expression of MTF2 mRNA	PMID:18947441
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:53001	nickel sulfate	affects expression	ISO	RGD:1332459	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate affects the expression of MTF2 mRNA	PMID:12718980
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:53351	chromium(3+) trichloride	increases expression	ISO	RGD:1332459	E	RGD:6480464	20130611	CTD	MESH:C022990	chromic chloride results in increased expression of MTF2 mRNA	PMID:12128095
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1332459	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MTF2 mRNA	PMID:26378955
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MTF2 mRNA	PMID:25729387
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1605093	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MTF2 mRNA	PMID:31758290
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1332459	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of MTF2 mRNA	PMID:22206623
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332459	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTF2 mRNA	PMID:22206623
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1605093	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MTF2 protein	PMID:31285264
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605093	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTF2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTF2 mRNA	PMID:27188386
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605093	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MTF2 gene]	PMID:28238834
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1332459	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MTF2 mRNA	PMID:23091169
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of MTF2 mRNA	PMID:20345932
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MTF2 mRNA	PMID:23640034
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605093	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTF2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTF2 mRNA	PMID:27188386
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MTF2 mRNA	PMID:21346803
1304727	Mtf2	metal response element binding transcription factor 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MTF2 mRNA	PMID:21346803
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1605106	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA0753 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA0753 mRNA	PMID:32699268
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1605106	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of KIAA0753 mRNA	PMID:22378314
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1605106	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of KIAA0753 mRNA	PMID:21632981
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1605106	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of KIAA0753 protein	PMID:37730182
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of 4933427D14RIKL mRNA	PMID:33387578
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1605106	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KIAA0753 mRNA	PMID:21641981
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605106	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA0753 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA0753 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of KIAA0753 mRNA	PMID:32699268
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605106	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KIAA0753 mRNA	PMID:39836092
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1605106	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of KIAA0753 mRNA	PMID:33512557
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1605106	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of KIAA0753 protein	PMID:35688186
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605106	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KIAA0753 mRNA	PMID:23557933
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1605106	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in increased expression of KIAA0753 protein	PMID:20884965
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1605106	E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in increased expression of KIAA0753 protein]	PMID:20884965
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1605106	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of KIAA0753 mRNA	PMID:33512557
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605106	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KIAA0753 mRNA	PMID:33212167
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1605106	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of KIAA0753 mRNA	PMID:29319823
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605106	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KIAA0753 mRNA	PMID:38568856
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605106	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KIAA0753 mRNA	PMID:39836092
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1605106	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of KIAA0753 mRNA	PMID:34408198
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605106	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of KIAA0753 gene	PMID:31601247
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of 4933427D14RIKL mRNA	PMID:30816183
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KIAA0753 mRNA	PMID:25181051
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of 4933427D14RIKL mRNA	PMID:32528016
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605106	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of KIAA0753 gene	PMID:31601247
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1605106	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA0753 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA0753 mRNA	PMID:32699268
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605106	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KIAA0753 mRNA	PMID:25979313
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of 4933427D14RIKL mRNA	PMID:29427782
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605106	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KIAA0753 gene	PMID:29154799
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of 4933427D14RIKL mRNA	PMID:33387578
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605106	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of KIAA0753 mRNA	PMID:22230336
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605106	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KIAA0753 mRNA	PMID:39836092
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1605106	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of KIAA0753 mRNA	PMID:33512557
1304728	4933427D14Rikl	RIKEN cDNA 4933427D14 gene like	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of 4933427D14RIKL mRNA	PMID:23034163
1304729	Sfn	stratifin	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312341	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SFN mRNA	PMID:38218311
1304729	Sfn	stratifin	gene	CHEBI:110423	clodronic acid	increases expression	ISO	RGD:1312341	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in increased expression of SFN mRNA	PMID:25596134
1304729	Sfn	stratifin	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312341	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SFN mRNA	PMID:27188386
1304729	Sfn	stratifin	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SFN mRNA	PMID:37995155
1304729	Sfn	stratifin	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1312341	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of SFN mRNA	PMID:34925699
1304729	Sfn	stratifin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFN mRNA	PMID:20938992
1304729	Sfn	stratifin	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of SFN mRNA	PMID:36189433
1304729	Sfn	stratifin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of SFN mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of SFN mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of SFN mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SFN mRNA	PMID:30951980|PMID:36189433
1304729	Sfn	stratifin	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312341	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SFN mRNA	PMID:25596134
1304729	Sfn	stratifin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SFN mRNA	PMID:30529165
1304729	Sfn	stratifin	gene	CHEBI:15864	luteolin	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D047311	Luteolin results in increased expression of SFN mRNA; Luteolin results in increased expression of SFN protein	PMID:18331776
1304729	Sfn	stratifin	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SFN mRNA	PMID:29432896
1304729	Sfn	stratifin	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312341	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SFN mRNA; Quercetin results in increased expression of SFN protein	PMID:14750173|PMID:18331776|PMID:21632981
1304729	Sfn	stratifin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SFN mRNA	PMID:35811015
1304729	Sfn	stratifin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20140408	CTD	MESH:D004958	Estradiol results in decreased expression of SFN mRNA	PMID:23019147|PMID:23094148
1304729	Sfn	stratifin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in decreased expression of SFN protein	PMID:26903627
1304729	Sfn	stratifin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312341	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of SFN mRNA	PMID:19167446
1304729	Sfn	stratifin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of SFN mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of SFN protein	PMID:22534328
1304729	Sfn	stratifin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of SFN mRNA	PMID:18556351
1304729	Sfn	stratifin	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312342	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of SFN mRNA	PMID:18978301
1304729	Sfn	stratifin	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SFN mRNA	PMID:33387578
1304729	Sfn	stratifin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFN mRNA	PMID:20938992
1304729	Sfn	stratifin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312341	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SFN mRNA	PMID:37042841
1304729	Sfn	stratifin	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312341	E	RGD:6480464	20210209	CTD	MESH:D001554	Benzene results in increased expression of SFN mRNA	PMID:33064461
1304729	Sfn	stratifin	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of SFN mRNA	PMID:34673133
1304729	Sfn	stratifin	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312341	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SFN mRNA	PMID:23649840
1304729	Sfn	stratifin	gene	CHEBI:169105	Ethyl maltol	increases expression	ISO	RGD:1312341	E	RGD:6480464	20240604	CTD	MESH:C052408	ethyl maltol results in increased expression of SFN mRNA	PMID:37606557
1304729	Sfn	stratifin	gene	CHEBI:169105	Ethyl maltol	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20240604	CTD	MESH:C052408	APP protein inhibits the reaction [ethyl maltol results in increased expression of SFN mRNA]	PMID:37606557
1304729	Sfn	stratifin	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of SFN mRNA	PMID:16966611
1304729	Sfn	stratifin	gene	CHEBI:17026	progesterone	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased phosphorylation of SFN protein	PMID:17303654
1304729	Sfn	stratifin	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20130910	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of SFN mRNA	PMID:18556351
1304729	Sfn	stratifin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SFN mRNA	PMID:36189433
1304729	Sfn	stratifin	gene	CHEBI:17356	2-acetamidofluorene	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of SFN mRNA	PMID:19167416|PMID:22213190
1304729	Sfn	stratifin	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312341	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SFN mRNA	PMID:33647349
1304729	Sfn	stratifin	gene	CHEBI:175901	gemcitabine	affects response to substance	ISO	RGD:1312341	E	RGD:6480464	20230207	CTD	MESH:C056507	SFN protein affects the susceptibility to Gemcitabine	PMID:26894857
1304729	Sfn	stratifin	gene	CHEBI:175901	gemcitabine	decreases response to substance	ISO	RGD:1312341	E	RGD:6480464	20230207	CTD	MESH:C056507	SFN protein results in decreased susceptibility to Gemcitabine	PMID:25189999|PMID:26894857
1304729	Sfn	stratifin	gene	CHEBI:175901	gemcitabine	increases methylation	ISO	RGD:1312341	E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased methylation of SFN gene	PMID:25189999
1304729	Sfn	stratifin	gene	CHEBI:175901	gemcitabine	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20230207	CTD	MESH:C056507	[DNMT1 protein binds to SFN promoter] inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; [Gemcitabine results in decreased susceptibility to Gemcitabine] inhibits the reaction [DNMT1 protein binds to SFN promoter]; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in decreased methylation of SFN gene; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of SFN mRNA; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of SFN protein; [UHRF1 protein promotes the reaction [DNMT1 protein binds to SFN promoter]] inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; SFN protein affects the reaction [YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]]; SFN protein inhibits the reaction [Gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein]; SFN protein inhibits the reaction [Gemcitabine results in increased cleavage of PARP1 protein]; SFN protein promotes the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]	PMID:25189999|PMID:26894857
1304729	Sfn	stratifin	gene	CHEBI:17594	hydroquinone	affects methylation	ISO	RGD:1312341	E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone affects the methylation of SFN promoter	PMID:23940045
1304729	Sfn	stratifin	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1312341	E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in increased expression of SFN mRNA	PMID:23940045
1304729	Sfn	stratifin	gene	CHEBI:17594	hydroquinone	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20220405	CTD	MESH:C031927	[hydroquinone affects the methylation of SFN promoter] which results in decreased abundance of 5-Methylcytosine; [hydroquinone affects the methylation of SFN promoter] which results in increased abundance of 5-hydroxymethylcytosine; TET1 protein affects the reaction [hydroquinone results in increased expression of SFN mRNA]	PMID:23940045
1304729	Sfn	stratifin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SFN protein	PMID:31163220
1304729	Sfn	stratifin	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SFN mRNA	PMID:36139627
1304729	Sfn	stratifin	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312341	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of SFN mRNA	PMID:26485663
1304729	Sfn	stratifin	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SFN mRNA	PMID:28818685
1304729	Sfn	stratifin	gene	CHEBI:20689	6-O-methylguanine	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20190910	CTD	MESH:C008449	[O(6)-benzylguanine co-treated with O-(6)-methylguanine] results in decreased expression of SFN mRNA	PMID:29666243
1304729	Sfn	stratifin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SFN mRNA	PMID:37325564
1304729	Sfn	stratifin	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SFN mRNA	PMID:19549813
1304729	Sfn	stratifin	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312341	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SFN mRNA	PMID:23649840
1304729	Sfn	stratifin	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SFN protein	PMID:20106945
1304729	Sfn	stratifin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312341	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SFN mRNA	PMID:21527772|PMID:21632981|PMID:22100608|PMID:32234424
1304729	Sfn	stratifin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312341	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SFN mRNA	PMID:21527772|PMID:23649840
1304729	Sfn	stratifin	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases alkylation	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased alkylation of SFN protein	PMID:18342354
1304729	Sfn	stratifin	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of SFN mRNA	PMID:21527772
1304729	Sfn	stratifin	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120515	CTD	MESH:D010126	Ozone results in increased expression of SFN mRNA	PMID:12763052|PMID:17095637|PMID:33026818
1304729	Sfn	stratifin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SFN mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SFN mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of SFN mRNA	PMID:25658374|PMID:27106289|PMID:34911549
1304729	Sfn	stratifin	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SFN protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SFN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SFN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SFN protein	PMID:38598786
1304729	Sfn	stratifin	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312342	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of SFN mRNA	PMID:31939706
1304729	Sfn	stratifin	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SFN mRNA	PMID:18593933
1304729	Sfn	stratifin	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SFN mRNA	PMID:30723492
1304729	Sfn	stratifin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFN mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SFN mRNA]	PMID:20938992|PMID:22206623
1304729	Sfn	stratifin	gene	CHEBI:27551	5-methylcytosine	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20220405	CTD	MESH:D044503	[hydroquinone affects the methylation of SFN promoter] which results in decreased abundance of 5-Methylcytosine	PMID:23940045
1304729	Sfn	stratifin	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of SFN mRNA	PMID:19945496
1304729	Sfn	stratifin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFN mRNA	PMID:40504410
1304729	Sfn	stratifin	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1312341	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of SFN mRNA	PMID:38460933
1304729	Sfn	stratifin	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of SFN mRNA	PMID:21527772
1304729	Sfn	stratifin	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of SFN mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of SFN protein	PMID:38460933
1304729	Sfn	stratifin	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312341	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SFN mRNA	PMID:26272509
1304729	Sfn	stratifin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1304729	Sfn	stratifin	gene	CHEBI:27871	chloroacetaldehyde	increases expression	ISO	RGD:1312341	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of SFN mRNA	PMID:25596134
1304729	Sfn	stratifin	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312341	E	RGD:6480464	20150414	CTD	MESH:D002945	Cisplatin affects the expression of SFN mRNA	PMID:25450742
1304729	Sfn	stratifin	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1312341	E	RGD:6480464	20180313	CTD	MESH:D002945	SFN protein affects the susceptibility to Cisplatin	PMID:26894857
1304729	Sfn	stratifin	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of SFN protein	PMID:21924258
1304729	Sfn	stratifin	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312341	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of SFN mRNA	PMID:21532991|PMID:25596134|PMID:27392435
1304729	Sfn	stratifin	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin promotes the reaction [jinfukang results in increased expression of SFN mRNA]; jinfukang promotes the reaction [Cisplatin results in increased expression of SFN mRNA]; SFN protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin]	PMID:15999354|PMID:27392435
1304729	Sfn	stratifin	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312341	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SFN mRNA	PMID:25583101
1304729	Sfn	stratifin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFN mRNA	PMID:21354282
1304729	Sfn	stratifin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312341	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SFN mRNA	PMID:27913140
1304729	Sfn	stratifin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SFN mRNA	PMID:19770486
1304729	Sfn	stratifin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFN mRNA	PMID:17942748
1304729	Sfn	stratifin	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312341	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SFN mRNA	PMID:28001369
1304729	Sfn	stratifin	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312341	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SFN mRNA; aristolochic acid I results in increased expression of SFN protein	PMID:33212167
1304729	Sfn	stratifin	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1312341	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of SFN mRNA	PMID:26272509
1304729	Sfn	stratifin	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1304729	Sfn	stratifin	gene	CHEBI:28499	kaempferol	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:C006552	kaempferol results in increased expression of SFN mRNA; kaempferol results in increased expression of SFN protein	PMID:18331776
1304729	Sfn	stratifin	gene	CHEBI:28680	cytarabine	decreases response to substance	ISO	RGD:1312341	E	RGD:6480464	20160315	CTD	MESH:D003561	SFN protein results in decreased susceptibility to Cytarabine	PMID:25189999
1304729	Sfn	stratifin	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SFN mRNA	PMID:22465980
1304729	Sfn	stratifin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which affects the expression of SFN mRNA	PMID:30911355
1304729	Sfn	stratifin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SFN mRNA	PMID:15467011
1304729	Sfn	stratifin	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312342	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SFN protein	PMID:27548804
1304729	Sfn	stratifin	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1312341	E	RGD:6480464	20180313	CTD	MESH:D004317	SFN protein affects the susceptibility to Doxorubicin	PMID:26894857
1304729	Sfn	stratifin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20160412	CTD	MESH:D004317	Doxorubicin results in decreased expression of SFN mRNA	PMID:24816189
1304729	Sfn	stratifin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312341	E	RGD:6480464	20160412	CTD	MESH:D004317	Doxorubicin results in increased expression of SFN protein	PMID:24816189
1304729	Sfn	stratifin	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20160412	CTD	MESH:D004317	TP53 protein mutant form affects the reaction [Doxorubicin results in decreased expression of SFN mRNA]; TP53 protein mutant form affects the reaction [Doxorubicin results in increased expression of SFN protein]	PMID:24816189
1304729	Sfn	stratifin	gene	CHEBI:28830	chlorambucil	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D002699	Chlorambucil results in increased expression of SFN mRNA	PMID:18092340
1304729	Sfn	stratifin	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SFN mRNA	PMID:29432896
1304729	Sfn	stratifin	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1312341	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of SFN mRNA	PMID:22623647
1304729	Sfn	stratifin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of SFN mRNA	PMID:12760830|PMID:38568856
1304729	Sfn	stratifin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312341	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of SFN mRNA	PMID:29301061|PMID:34032870|PMID:37939567|PMID:39719251
1304729	Sfn	stratifin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFN mRNA	PMID:40504410
1304729	Sfn	stratifin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312341	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SFN promoter	PMID:27901495
1304729	Sfn	stratifin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312341	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SFN mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:25690898|PMID:26238291|PMID:32234424|PMID:40280401
1304729	Sfn	stratifin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SFN mRNA	PMID:19770486
1304729	Sfn	stratifin	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312341	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of SFN gene	PMID:25435355
1304729	Sfn	stratifin	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20260407	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SFN mRNA	PMID:40280401
1304729	Sfn	stratifin	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SFN mRNA	PMID:22465980
1304729	Sfn	stratifin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which affects the expression of SFN mRNA	PMID:30911355
1304729	Sfn	stratifin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SFN mRNA	PMID:15467011
1304729	Sfn	stratifin	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1312342	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of SFN protein	PMID:24861204
1304729	Sfn	stratifin	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SFN mRNA	PMID:18593933
1304729	Sfn	stratifin	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1312342	E	RGD:6480464	20190219	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of SFN mRNA	PMID:30171875
1304729	Sfn	stratifin	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312342	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SFN mRNA	PMID:27131904
1304729	Sfn	stratifin	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1312341	E	RGD:6480464	20191114	CTD	MESH:C006632	SFN protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1304729	Sfn	stratifin	gene	CHEBI:30703	tetrathiomolybdate(2-)	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20240109	CTD	MESH:C020809	tetrathiomolybdate results in decreased expression of SFN mRNA	PMID:37290678
1304729	Sfn	stratifin	gene	CHEBI:31175	adefovir pivoxil	increases expression	ISO	RGD:1312341	E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of SFN mRNA	PMID:25596134
1304729	Sfn	stratifin	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of SFN mRNA	PMID:20680508
1304729	Sfn	stratifin	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312341	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of SFN mRNA	PMID:37939567|PMID:38568856
1304729	Sfn	stratifin	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SFN mRNA	PMID:30047161
1304729	Sfn	stratifin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312342	E	RGD:6480464	20130611	CTD	MESH:C009495	titanium dioxide results in increased expression of SFN mRNA	PMID:27760801
1304729	Sfn	stratifin	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312342	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SFN enhancer	PMID:35295148
1304729	Sfn	stratifin	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SFN mRNA	PMID:34492290
1304729	Sfn	stratifin	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SFN mRNA	PMID:17426115
1304729	Sfn	stratifin	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312341	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SFN mRNA	PMID:30903817
1304729	Sfn	stratifin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SFN mRNA	PMID:25181051
1304729	Sfn	stratifin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312342	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SFN promoter	PMID:27312807
1304729	Sfn	stratifin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312341	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SFN protein	PMID:37567409
1304729	Sfn	stratifin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312342	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SFN mRNA	PMID:32156529
1304729	Sfn	stratifin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of SFN mRNA	PMID:30951980
1304729	Sfn	stratifin	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312341	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SFN mRNA	PMID:25979313
1304729	Sfn	stratifin	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1312341	E	RGD:6480464	20240702	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SFN mRNA	PMID:38568856
1304729	Sfn	stratifin	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20140715	CTD	MESH:C014024	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of SFN protein	PMID:23457121
1304729	Sfn	stratifin	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20140715	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of SFN protein	PMID:23457121
1304729	Sfn	stratifin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SFN mRNA	PMID:30951980
1304729	Sfn	stratifin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312341	E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in increased methylation of SFN promoter	PMID:30616060
1304729	Sfn	stratifin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of SFN mRNA	PMID:30951980
1304729	Sfn	stratifin	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20260407	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SFN mRNA	PMID:40280401
1304729	Sfn	stratifin	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of SFN mRNA	PMID:26377693
1304729	Sfn	stratifin	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SFN mRNA	PMID:38685157
1304729	Sfn	stratifin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SFN mRNA	PMID:30951980
1304729	Sfn	stratifin	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of SFN mRNA	PMID:30951980
1304729	Sfn	stratifin	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SFN mRNA	PMID:21266533
1304729	Sfn	stratifin	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SFN protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SFN protein	PMID:38598786
1304729	Sfn	stratifin	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20140715	CTD	MESH:D004052	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of SFN protein	PMID:23457121
1304729	Sfn	stratifin	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of SFN mRNA	PMID:32680482
1304729	Sfn	stratifin	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312342	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of SFN protein	PMID:39748354
1304729	Sfn	stratifin	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312341	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SFN mRNA	PMID:37042841
1304729	Sfn	stratifin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SFN mRNA	PMID:35163327
1304729	Sfn	stratifin	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SFN mRNA	PMID:30723492
1304729	Sfn	stratifin	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312341	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SFN mRNA	PMID:12160620|PMID:25596134|PMID:38568856
1304729	Sfn	stratifin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of SFN mRNA	PMID:31077537
1304729	Sfn	stratifin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SFN mRNA	PMID:37325564
1304729	Sfn	stratifin	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20230207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SFN protein	PMID:36214631
1304729	Sfn	stratifin	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312342	E	RGD:6480464	20240206	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SFN protein	PMID:37422089
1304729	Sfn	stratifin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SFN mRNA	PMID:35163327
1304729	Sfn	stratifin	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SFN mRNA	PMID:17547211
1304729	Sfn	stratifin	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SFN mRNA	PMID:24449571
1304729	Sfn	stratifin	gene	CHEBI:3696	cidofovir anhydrous	increases expression	ISO	RGD:1312341	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of SFN mRNA	PMID:25596134
1304729	Sfn	stratifin	gene	CHEBI:38211	potassium bromate	increases expression	ISO	RGD:1312341	E	RGD:6480464	20190219	CTD	MESH:C019536	potassium bromate results in increased expression of SFN mRNA	PMID:30008028|PMID:30559759
1304729	Sfn	stratifin	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SFN mRNA	PMID:32588087
1304729	Sfn	stratifin	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312341	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SFN mRNA	PMID:19167446
1304729	Sfn	stratifin	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA	PMID:19167446
1304729	Sfn	stratifin	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of SFN mRNA	PMID:26352163
1304729	Sfn	stratifin	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312342	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of SFN mRNA	PMID:23125180
1304729	Sfn	stratifin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312341	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SFN mRNA	PMID:25979313
1304729	Sfn	stratifin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312341	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SFN mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799|PMID:30008028
1304729	Sfn	stratifin	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1304729	Sfn	stratifin	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SFN mRNA	PMID:30047161
1304729	Sfn	stratifin	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SFN mRNA	PMID:21527772
1304729	Sfn	stratifin	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312341	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SFN mRNA	PMID:20106945|PMID:25562108|PMID:25596134|PMID:27989131|PMID:30008028
1304729	Sfn	stratifin	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of SFN mRNA	PMID:17555576
1304729	Sfn	stratifin	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SFN mRNA	PMID:15171707|PMID:16636312
1304729	Sfn	stratifin	gene	CHEBI:43602	obeticholic acid	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of SFN mRNA	PMID:27939613
1304729	Sfn	stratifin	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1312341	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of SFN mRNA	PMID:17379860|PMID:21678067
1304729	Sfn	stratifin	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312341	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SFN mRNA	PMID:38832940
1304729	Sfn	stratifin	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:C028009	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of SFN mRNA	PMID:31077537
1304729	Sfn	stratifin	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1304729	Sfn	stratifin	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312341	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SFN mRNA	PMID:24935251|PMID:26272509
1304729	Sfn	stratifin	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1304729	Sfn	stratifin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SFN mRNA	PMID:21420995|PMID:29067470
1304729	Sfn	stratifin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312341	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SFN mRNA	PMID:22230336
1304729	Sfn	stratifin	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of SFN mRNA	PMID:16584549
1304729	Sfn	stratifin	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120501	CTD	MESH:D005472	Fluorouracil results in increased expression of SFN mRNA	PMID:16557594|PMID:17982676
1304729	Sfn	stratifin	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D005472	SFN protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SFN mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SFN mRNA]	PMID:15016801|PMID:15999354|PMID:17982676
1304729	Sfn	stratifin	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SFN mRNA	PMID:29432896
1304729	Sfn	stratifin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SFN mRNA	PMID:35811015
1304729	Sfn	stratifin	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312341	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SFN protein	PMID:29553831
1304729	Sfn	stratifin	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of SFN mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of SFN protein	PMID:38460933
1304729	Sfn	stratifin	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1312341	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of SFN mRNA	PMID:19945496
1304729	Sfn	stratifin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFN mRNA	PMID:40504410
1304729	Sfn	stratifin	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1312341	E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac results in increased expression of SFN mRNA	PMID:17379860
1304729	Sfn	stratifin	gene	CHEBI:47807	sulforaphane	affects binding	ISO	RGD:1312341	E	RGD:6480464	20120717	CTD	MESH:C016766	SFN protein binds to sulforaphane	PMID:21838287
1304729	Sfn	stratifin	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SFN mRNA	PMID:29391264
1304729	Sfn	stratifin	gene	CHEBI:49	(+)-Tetrandrine	increases expression	ISO	RGD:1312341	E	RGD:6480464	20160210	CTD	MESH:C009438	tetrandrine results in increased expression of SFN protein	PMID:26822499
1304729	Sfn	stratifin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SFN mRNA	PMID:17555576|PMID:17942748
1304729	Sfn	stratifin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFN mRNA	PMID:17942748
1304729	Sfn	stratifin	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of SFN mRNA	PMID:21527772
1304729	Sfn	stratifin	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1312341	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SFN mRNA	PMID:38568856
1304729	Sfn	stratifin	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1312341	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SFN mRNA	PMID:26272509
1304729	Sfn	stratifin	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1304729	Sfn	stratifin	gene	CHEBI:49668	gefitinib	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:C419708	gefitinib results in decreased expression of SFN mRNA	PMID:16685379
1304729	Sfn	stratifin	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1312341	E	RGD:6480464	20191114	CTD	MESH:C032793	SFN protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1304729	Sfn	stratifin	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1312342	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of SFN protein	PMID:24861204
1304729	Sfn	stratifin	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20130723	CTD	MESH:D003994	[Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of SFN mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of SFN protein	PMID:22534328
1304729	Sfn	stratifin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of SFN promoter	PMID:15979784
1304729	Sfn	stratifin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of SFN mRNA	PMID:15979784
1304729	Sfn	stratifin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312341	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of SFN protein	PMID:22534328|PMID:25189999
1304729	Sfn	stratifin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20191114	CTD	MESH:C014347	[Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with Decitabine] results in increased expression of SFN mRNA	PMID:22534328
1304729	Sfn	stratifin	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312341	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of SFN protein	PMID:22001959
1304729	Sfn	stratifin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312342	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SFN mRNA; Nanotubes, Carbon results in increased expression of SFN mRNA	PMID:25554681
1304729	Sfn	stratifin	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SFN mRNA	PMID:30047161
1304729	Sfn	stratifin	gene	CHEBI:50729	mitoxantrone	affects response to substance	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:D008942	SFN protein affects the susceptibility to Mitoxantrone	PMID:16217747
1304729	Sfn	stratifin	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SFN mRNA	PMID:35964746
1304729	Sfn	stratifin	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of SFN mRNA	PMID:26377693
1304729	Sfn	stratifin	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20260407	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SFN mRNA	PMID:40280401
1304729	Sfn	stratifin	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20260407	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SFN mRNA	PMID:40280401
1304729	Sfn	stratifin	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1312341	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of SFN mRNA	PMID:20977926
1304729	Sfn	stratifin	gene	CHEBI:52717	bortezomib	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20170303	CTD	MESH:D000069286	[irinotecan co-treated with Bortezomib] results in decreased expression of SFN protein	PMID:16373703
1304729	Sfn	stratifin	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of SFN mRNA	PMID:16100012|PMID:16166746
1304729	Sfn	stratifin	gene	CHEBI:5855	ibuprofen	increases expression	ISO	RGD:1312341	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of SFN mRNA	PMID:25596134
1304729	Sfn	stratifin	gene	CHEBI:5864	ifosfamide	increases expression	ISO	RGD:1312341	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of SFN mRNA	PMID:25596134
1304729	Sfn	stratifin	gene	CHEBI:6030	isoniazide	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20190219	CTD	MESH:D007538	Isoniazid results in decreased expression of SFN mRNA	PMID:30008028
1304729	Sfn	stratifin	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SFN protein	PMID:32959892
1304729	Sfn	stratifin	gene	CHEBI:6382	Lasiocarpine	increases expression	ISO	RGD:1312341	E	RGD:6480464	20200714	CTD	MESH:C005136	lasiocarpine results in increased expression of SFN mRNA	PMID:32234424
1304729	Sfn	stratifin	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SFN mRNA	PMID:28801915
1304729	Sfn	stratifin	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312342	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SFN protein	PMID:26558463
1304729	Sfn	stratifin	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	ISO	RGD:1312341	E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of SFN mRNA	PMID:17547211
1304729	Sfn	stratifin	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of SFN mRNA	PMID:28954212
1304729	Sfn	stratifin	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20140812	CTD	MESH:D007545	Isoproterenol results in decreased expression of SFN mRNA	PMID:24286936
1304729	Sfn	stratifin	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20130723	CTD	MESH:D017258	[Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of SFN mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of SFN protein	PMID:22534328
1304729	Sfn	stratifin	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of SFN mRNA	PMID:25596134
1304729	Sfn	stratifin	gene	CHEBI:68233	(Z)-3-butylidenephthalide	increases expression	ISO	RGD:1312341	E	RGD:6480464	20140311	CTD	MESH:C026105	butylidenephthalide results in increased expression of SFN protein	PMID:23770345
1304729	Sfn	stratifin	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312341	E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in increased expression of SFN mRNA	PMID:36519830
1304729	Sfn	stratifin	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312342	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SFN mRNA	PMID:22206623
1304729	Sfn	stratifin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SFN mRNA]	PMID:22206623
1304729	Sfn	stratifin	gene	CHEBI:748572	acyline	increases expression	ISO	RGD:1312341	E	RGD:6480464	20260714	CTD	MESH:C109238	acyline results in increased expression of SFN mRNA	PMID:17510436
1304729	Sfn	stratifin	gene	CHEBI:748866	6-o-benzylguanine	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20260714	CTD	MESH:C064976	[O(6)-benzylguanine co-treated with O-(6)-methylguanine] results in decreased expression of SFN mRNA	PMID:29666243
1304729	Sfn	stratifin	gene	CHEBI:75095	chrysin	increases expression	ISO	RGD:1312341	E	RGD:6480464	20130903	CTD	MESH:C043561	chrysin results in increased expression of SFN mRNA; chrysin results in increased expression of SFN protein	PMID:18331776
1304729	Sfn	stratifin	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312341	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SFN protein	PMID:31285264
1304729	Sfn	stratifin	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SFN mRNA	PMID:36139627
1304729	Sfn	stratifin	gene	CHEBI:76792	5-(hydroxymethyl)cytosine	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20220405	CTD	MESH:C011865	[hydroquinone affects the methylation of SFN promoter] which results in increased abundance of 5-hydroxymethylcytosine	PMID:23940045
1304729	Sfn	stratifin	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312341	E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of SFN mRNA; beta-Naphthoflavone results in increased expression of SFN protein	PMID:19737606|PMID:39638853
1304729	Sfn	stratifin	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312341	E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of SFN mRNA	PMID:30008028|PMID:30559759
1304729	Sfn	stratifin	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in increased expression of SFN mRNA	PMID:19237604
1304729	Sfn	stratifin	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1304729	Sfn	stratifin	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1312341	E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in increased expression of SFN mRNA	PMID:31437187
1304729	Sfn	stratifin	gene	CHEBI:80630	irinotecan	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20181113	CTD	MESH:D000077146	[Irinotecan co-treated with Bortezomib] results in decreased expression of SFN protein	PMID:16373703
1304729	Sfn	stratifin	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA	PMID:19167446
1304729	Sfn	stratifin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312342	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SFN mRNA	PMID:38648751
1304729	Sfn	stratifin	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1312341	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of SFN mRNA	PMID:32234424
1304729	Sfn	stratifin	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312342	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SFN mRNA	PMID:39847705
1304729	Sfn	stratifin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SFN mRNA	PMID:30047161
1304729	Sfn	stratifin	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312341	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SFN mRNA	PMID:26272509
1304729	Sfn	stratifin	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1304729	Sfn	stratifin	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	ISO	RGD:1312341	E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SFN mRNA	PMID:18778698
1304729	Sfn	stratifin	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20151103	CTD	MESH:C044387	TP53 mutant form inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SFN mRNA]	PMID:18778698
1304729	Sfn	stratifin	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1304729	Sfn	stratifin	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312342	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SFN mRNA	PMID:27131904
1304729	Sfn	stratifin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312341	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SFN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SFN protein	PMID:38598786
1304729	Sfn	stratifin	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312342	E	RGD:6480464	20170613	CTD	MESH:C001899	triptolide results in increased expression of SFN mRNA; triptolide results in increased expression of SFN protein	PMID:26990902|PMID:32835833
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1550323	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DCAF10 mRNA	PMID:37995155
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550323	E	RGD:6480464	20260707	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DCAF10 gene	PMID:20938992
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1352348	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DCAF10 mRNA	PMID:26079696
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1352348	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of DCAF10 mRNA	PMID:22378314
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of DCAF10 mRNA	PMID:32145629
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550323	E	RGD:6480464	20260707	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DCAF10 gene	PMID:20938992
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1352348	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DCAF10 protein	PMID:37730182
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of DCAF10 mRNA	PMID:22061828
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550323	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCAF10 mRNA	PMID:37236586
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550323	E	RGD:6480464	20260707	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DCAF10 mRNA	PMID:19770486
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DCAF10 mRNA	PMID:31150632
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550323	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DCAF10 mRNA	PMID:27339419|PMID:31919559
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550323	E	RGD:6480464	20260707	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DCAF10 gene	PMID:20938992
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1352348	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DCAF10 protein	PMID:35688186
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550323	E	RGD:6480464	20260707	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DCAF10 mRNA	PMID:21570461
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1352348	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DCAF10 mRNA	PMID:28001369
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1352348	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DCAF10 mRNA	PMID:29803840
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1352348	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of DCAF10 protein	PMID:35688186
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550323	E	RGD:6480464	20260707	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DCAF10 mRNA	PMID:22228805
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550323	E	RGD:6480464	20260707	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DCAF10 mRNA	PMID:19770486
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550323	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DCAF10 gene	PMID:35295148
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550323	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DCAF10 gene	PMID:35295148
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DCAF10 mRNA	PMID:25181051
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of DCAF10 mRNA	PMID:26982218|PMID:32145629
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DCAF10 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DCAF10 gene	PMID:28505145
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1352348	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of DCAF10 mRNA	PMID:25979313
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1550323	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of DCAF10 mRNA	PMID:39298647
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550323	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DCAF10 mRNA	PMID:38685157
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1550323	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of DCAF10 mRNA	PMID:28392331
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352348	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DCAF10 mRNA	PMID:37042841
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1352348	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DCAF10 mRNA	PMID:38568856
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of DCAF10 promoter	PMID:22457795
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550323	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCAF10 mRNA	PMID:37236586
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1352348	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DCAF10 mRNA	PMID:24449571
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1352348	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DCAF10 mRNA	PMID:31533062
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1352348	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of DCAF10 mRNA	PMID:23179753|PMID:24935251|PMID:27188386|PMID:29154799
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1352348	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of DCAF10 mRNA	PMID:27989131
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1352348	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of DCAF10 mRNA	PMID:24935251
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1352348	E	RGD:6480464	20260707	CTD	MESH:D000082	Acetaminophen results in increased expression of DCAF10 mRNA	PMID:22230336
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550323	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DCAF10 mRNA	PMID:29279043
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of DCAF10 mRNA	PMID:29391264
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1352348	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DCAF10 protein	PMID:32959892
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1352348	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of DCAF10 mRNA	PMID:28988120
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550323	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DCAF10 mRNA	PMID:22206623
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1352348	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DCAF10 mRNA	PMID:29301935
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DCAF10 mRNA	PMID:21346803
1304730	Dcaf10	DDB1 and CUL4 associated factor 10	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of DCAF10 mRNA	PMID:23034163
1304731	Oacyl	O-acyltransferase like	gene	CHEBI:27086	tributylstannane	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C011559	tributyltin results in decreased expression of OACYL mRNA	PMID:31129395
1304731	Oacyl	O-acyltransferase like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OACYL mRNA	PMID:33387578
1304731	Oacyl	O-acyltransferase like	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of OACYL mRNA	PMID:38458666
1304731	Oacyl	O-acyltransferase like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in increased expression of OACYL mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304731	Oacyl	O-acyltransferase like	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in increased methylation of OACYL gene	PMID:28505145
1304731	Oacyl	O-acyltransferase like	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of OACYL mRNA	PMID:38458666
1304731	Oacyl	O-acyltransferase like	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20250401	CTD	MESH:D008731	Methoxychlor affects the methylation of OACYL gene	PMID:35440735
1304731	Oacyl	O-acyltransferase like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D011441	Propylthiouracil results in decreased expression of OACYL mRNA	PMID:25825206
1304731	Oacyl	O-acyltransferase like	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D011441	Propylthiouracil results in increased expression of OACYL mRNA	PMID:24780913
1304731	Oacyl	O-acyltransferase like	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20250401	CTD	MESH:C025643	vinclozolin results in increased methylation of OACYL gene	PMID:31079544
1304733	Ep400	E1A binding protein p400	gene	CHEBI:10022	deoxynivalenol	decreases phosphorylation	ISO	RGD:1557068	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased phosphorylation of EP400 protein	PMID:23352502
1304733	Ep400	E1A binding protein p400	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of EP400 mRNA	PMID:25596134
1304733	Ep400	E1A binding protein p400	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1557068	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EP400 mRNA	PMID:33045310
1304733	Ep400	E1A binding protein p400	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of EP400 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of EP400 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of EP400 mRNA	PMID:32699268|PMID:32845096
1304733	Ep400	E1A binding protein p400	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of EP400 mRNA	PMID:25596134
1304733	Ep400	E1A binding protein p400	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of EP400 mRNA	PMID:26079696
1304733	Ep400	E1A binding protein p400	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of EP400 gene	PMID:35440735
1304733	Ep400	E1A binding protein p400	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1557068	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of EP400 mRNA	PMID:30319688
1304733	Ep400	E1A binding protein p400	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1312347	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of EP400 protein	PMID:35688186
1304733	Ep400	E1A binding protein p400	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312347	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of EP400 mRNA	PMID:31614463
1304733	Ep400	E1A binding protein p400	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA	PMID:25510870
1304733	Ep400	E1A binding protein p400	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of EP400 gene	PMID:27618143
1304733	Ep400	E1A binding protein p400	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of EP400 mRNA	PMID:23649840
1304733	Ep400	E1A binding protein p400	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312347	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EP400 protein	PMID:37730182
1304733	Ep400	E1A binding protein p400	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EP400 mRNA	PMID:33387578
1304733	Ep400	E1A binding protein p400	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EP400 mRNA	PMID:36331819
1304733	Ep400	E1A binding protein p400	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EP400 mRNA	PMID:35301059
1304733	Ep400	E1A binding protein p400	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EP400 mRNA	PMID:28111341
1304733	Ep400	E1A binding protein p400	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA	PMID:25510870
1304733	Ep400	E1A binding protein p400	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA	PMID:25510870
1304733	Ep400	E1A binding protein p400	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312347	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of EP400 mRNA	PMID:19549813
1304733	Ep400	E1A binding protein p400	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1557068	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EP400 mRNA	PMID:19770486
1304733	Ep400	E1A binding protein p400	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312347	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EP400 intron	PMID:30157460
1304733	Ep400	E1A binding protein p400	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of EP400 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of EP400 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of EP400 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of EP400 mRNA	PMID:32699268|PMID:32845096
1304733	Ep400	E1A binding protein p400	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312347	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of EP400 protein	PMID:35688186
1304733	Ep400	E1A binding protein p400	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of EP400 gene	PMID:35440735
1304733	Ep400	E1A binding protein p400	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of EP400 mRNA	PMID:25596134
1304733	Ep400	E1A binding protein p400	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of EP400 mRNA	PMID:25596134
1304733	Ep400	E1A binding protein p400	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1557068	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of EP400 mRNA	PMID:34813904
1304733	Ep400	E1A binding protein p400	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of EP400 mRNA	PMID:30912803
1304733	Ep400	E1A binding protein p400	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557068	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EP400 mRNA	PMID:21570461
1304733	Ep400	E1A binding protein p400	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EP400 mRNA	PMID:33387578
1304733	Ep400	E1A binding protein p400	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EP400 mRNA	PMID:34747641
1304733	Ep400	E1A binding protein p400	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EP400 mRNA	PMID:17942748
1304733	Ep400	E1A binding protein p400	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312347	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of EP400 mRNA	PMID:28001369
1304733	Ep400	E1A binding protein p400	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EP400 mRNA	PMID:33212167
1304733	Ep400	E1A binding protein p400	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312347	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of EP400 mRNA	PMID:30851411
1304733	Ep400	E1A binding protein p400	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312347	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of EP400 protein	PMID:35688186
1304733	Ep400	E1A binding protein p400	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312347	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of EP400 mRNA	PMID:29319823
1304733	Ep400	E1A binding protein p400	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312347	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EP400 mRNA	PMID:38568856
1304733	Ep400	E1A binding protein p400	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312347	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EP400 promoter	PMID:27901495
1304733	Ep400	E1A binding protein p400	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EP400 mRNA	PMID:26238291
1304733	Ep400	E1A binding protein p400	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1557068	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EP400 exon; Benzo(a)pyrene results in decreased methylation of EP400 intron	PMID:27901495
1304733	Ep400	E1A binding protein p400	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EP400 mRNA	PMID:20504355
1304733	Ep400	E1A binding protein p400	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to EP400 mRNA]	PMID:32406909
1304733	Ep400	E1A binding protein p400	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557068	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EP400 promoter	PMID:35295148
1304733	Ep400	E1A binding protein p400	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EP400 mRNA	PMID:25181051
1304733	Ep400	E1A binding protein p400	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312347	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EP400 gene	PMID:31601247
1304733	Ep400	E1A binding protein p400	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of EP400 mRNA	PMID:41034487
1304733	Ep400	E1A binding protein p400	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EP400 mRNA	PMID:28628672
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA	PMID:25510870
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA	PMID:25510870
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of EP400 mRNA	PMID:39298647
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EP400 mRNA	PMID:28628672
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312347	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of EP400 intron	PMID:30157460
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EP400 mRNA	PMID:28628672
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1557068	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of EP400 promoter	PMID:28392331
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EP400 mRNA	PMID:37019170
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of EP400 mRNA	PMID:34813904
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EP400 mRNA	PMID:28628672
1304733	Ep400	E1A binding protein p400	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1557068	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of EP400 mRNA	PMID:34813904
1304733	Ep400	E1A binding protein p400	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312347	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EP400 mRNA	PMID:37042841
1304733	Ep400	E1A binding protein p400	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of EP400 mRNA	PMID:25596134
1304733	Ep400	E1A binding protein p400	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EP400 mRNA	PMID:35301059
1304733	Ep400	E1A binding protein p400	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EP400 mRNA	PMID:28111341
1304733	Ep400	E1A binding protein p400	gene	CHEBI:35696	cobalt dichloride	affects expression	ISO	RGD:1312347	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride affects the expression of EP400 mRNA alternative form	PMID:19320972
1304733	Ep400	E1A binding protein p400	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of EP400 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of EP400 mRNA	PMID:32699268
1304733	Ep400	E1A binding protein p400	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of EP400 mRNA	PMID:25596134
1304733	Ep400	E1A binding protein p400	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312347	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of EP400 mRNA	PMID:28302478
1304733	Ep400	E1A binding protein p400	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312347	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EP400 mRNA	PMID:31533062
1304733	Ep400	E1A binding protein p400	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EP400 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of EP400 mRNA	PMID:36331819
1304733	Ep400	E1A binding protein p400	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1312347	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of EP400 promoter	PMID:27989131
1304733	Ep400	E1A binding protein p400	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of EP400 mRNA	PMID:17555576
1304733	Ep400	E1A binding protein p400	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EP400 mRNA	PMID:28628672
1304733	Ep400	E1A binding protein p400	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of EP400 mRNA	PMID:27188386
1304733	Ep400	E1A binding protein p400	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EP400 mRNA	PMID:17562736
1304733	Ep400	E1A binding protein p400	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of EP400 mRNA]	PMID:15016801
1304733	Ep400	E1A binding protein p400	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of EP400 mRNA	PMID:25596134
1304733	Ep400	E1A binding protein p400	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EP400 mRNA	PMID:35436446
1304733	Ep400	E1A binding protein p400	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EP400 mRNA	PMID:17942748
1304733	Ep400	E1A binding protein p400	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EP400 mRNA	PMID:17942748
1304733	Ep400	E1A binding protein p400	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1312347	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of EP400 mRNA	PMID:23228038
1304733	Ep400	E1A binding protein p400	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312347	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EP400 mRNA	PMID:28628672
1304733	Ep400	E1A binding protein p400	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of EP400 mRNA	PMID:25596134
1304733	Ep400	E1A binding protein p400	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1557068	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of EP400 mRNA	PMID:40234311
1304733	Ep400	E1A binding protein p400	gene	CHEBI:5864	ifosfamide	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of EP400 mRNA	PMID:25596134
1304733	Ep400	E1A binding protein p400	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of EP400 mRNA	PMID:25729387
1304733	Ep400	E1A binding protein p400	gene	CHEBI:6801	metformin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin affects the expression of EP400 mRNA	PMID:25596134
1304733	Ep400	E1A binding protein p400	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1557068	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of EP400 mRNA	PMID:26307267
1304733	Ep400	E1A binding protein p400	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312347	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of EP400 intron	PMID:30157460
1304733	Ep400	E1A binding protein p400	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of EP400 gene	PMID:35440735
1304733	Ep400	E1A binding protein p400	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312347	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of EP400 protein	PMID:31285264
1304733	Ep400	E1A binding protein p400	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of EP400 mRNA	PMID:21346803
1304733	Ep400	E1A binding protein p400	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312347	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of EP400 mRNA	PMID:30851411
1304733	Ep400	E1A binding protein p400	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of EP400 protein	PMID:38348393
1304733	Ep400	E1A binding protein p400	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of EP400 mRNA	PMID:21278054
1304733	Ep400	E1A binding protein p400	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312347	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of EP400 mRNA	PMID:38568856
1304733	Ep400	E1A binding protein p400	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1557068	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of EP400 protein	PMID:24648495
1304733	Ep400	E1A binding protein p400	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312347	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of EP400 mRNA	PMID:27188386
1304733	Ep400	E1A binding protein p400	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EP400 mRNA	PMID:21346803
1304733	Ep400	E1A binding protein p400	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of EP400 mRNA	PMID:28973697
1304733	Ep400	E1A binding protein p400	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of EP400 mRNA	PMID:23034163
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of ELMO3 mRNA	PMID:21551480
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of ELMO3 mRNA	PMID:36841081
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312348	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ELMO3 mRNA	PMID:29432896
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA	PMID:25510870
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312348	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ELMO3 mRNA	PMID:37042841
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ELMO3 mRNA	PMID:26577399
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ELMO3 mRNA	PMID:37236586
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA	PMID:25510870
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA	PMID:25510870
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312348	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ELMO3 gene	PMID:27153756
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312348	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ELMO3 mRNA	PMID:35430440
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312348	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ELMO3 mRNA	PMID:19774075
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ELMO3 mRNA	PMID:22206623
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312348	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ELMO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELMO3 mRNA	PMID:40512198
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312349	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ELMO3 mRNA	PMID:21570461
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312349	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ELMO3 mRNA	PMID:19770486
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELMO3 mRNA	PMID:32109520
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312348	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ELMO3 mRNA	PMID:33212167
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1312348	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ELMO3 mRNA	PMID:29432896
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312348	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELMO3 mRNA	PMID:38568856
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312348	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ELMO3 mRNA	PMID:39719251
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312349	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ELMO3 mRNA	PMID:16322246
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312348	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ELMO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELMO3 mRNA	PMID:40512198
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312348	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ELMO3 promoter	PMID:27901495
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312348	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ELMO3 mRNA	PMID:20106945
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312348	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ELMO3 exon	PMID:27901495
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312348	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELMO3 mRNA	PMID:26238291
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312349	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELMO3 mRNA	PMID:22228805
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312349	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of ELMO3 protein	PMID:37955338
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312348	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ELMO3 mRNA	PMID:35984750
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ELMO3 mRNA	PMID:25729387
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ELMO3 mRNA	PMID:25729387
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of ELMO3 mRNA	PMID:23411599|PMID:34492290
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312349	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ELMO3 mRNA	PMID:28472532
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ELMO3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312349	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ELMO3 mRNA	PMID:34585602
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ELMO3 gene	PMID:28505145
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA	PMID:25510870
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA	PMID:25510870
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312348	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ELMO3 mRNA	PMID:37042841
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312348	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ELMO3 mRNA	PMID:38568856
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ELMO3 mRNA	PMID:37236586
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ELMO3 mRNA	PMID:24386269
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312349	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of ELMO3 mRNA	PMID:23811191
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312349	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ELMO3 mRNA	PMID:40194260
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312348	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ELMO3 mRNA	PMID:31533062
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ELMO3 mRNA	PMID:36331819
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of ELMO3 mRNA	PMID:22110744
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312349	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ELMO3 mRNA	PMID:17292431|PMID:17963808
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312348	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ELMO3 mRNA	PMID:29154799
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312348	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ELMO3 gene	PMID:29154799
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312348	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ELMO3 mRNA	PMID:25562108
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312349	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ELMO3 mRNA	PMID:17555576
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1312348	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of ELMO3 protein	PMID:15907983
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ELMO3 mRNA	PMID:33387578
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312348	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ELMO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELMO3 mRNA	PMID:40512198
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312349	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ELMO3 mRNA	PMID:35436446
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312349	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ELMO3 mRNA	PMID:17555576
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ELMO3 mRNA	PMID:17557909
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	ISO	RGD:1312348	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of ELMO3 mRNA	PMID:38825487
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312349	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ELMO3 mRNA	PMID:25620056
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ELMO3 mRNA	PMID:25729387
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1312349	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of ELMO3 mRNA	PMID:22078008
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ELMO3 mRNA	PMID:30467583
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ELMO3 mRNA	PMID:22206623
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312348	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ELMO3 mRNA	PMID:38568856
1304734	Elmo3	engulfment and cell motility 3	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312349	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of ELMO3 mRNA	PMID:35537566
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312350	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MOV10L1 mRNA	PMID:37995155
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1345883	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of MOV10L1 mRNA	PMID:30510588
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1345883	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MOV10L1 mRNA	PMID:30165855
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MOV10L1 mRNA	PMID:33387578
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1345883	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of MOV10L1 mRNA	PMID:26079696
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312350	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MOV10L1 mRNA	PMID:22401849
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312350	E	RGD:6480464	20170613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MOV10L1 mRNA	PMID:28123099
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1345883	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of MOV10L1 intron	PMID:30157460
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1345883	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of MOV10L1 mRNA	PMID:20823114
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MOV10L1 mRNA	PMID:22129741
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1345883	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MOV10L1 gene; Aflatoxin B1 results in increased methylation of MOV10L1 intron	PMID:27153756|PMID:30157460
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312350	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MOV10L1 mRNA	PMID:16962184
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312350	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MOV10L1 mRNA	PMID:17942748
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312350	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of MOV10L1 mRNA	PMID:39631538
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MOV10L1 mRNA	PMID:22129741
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312350	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of MOV10L1 mRNA	PMID:37682722
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1345883	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of MOV10L1 mRNA	PMID:29301061|PMID:38568856
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1345883	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MOV10L1 promoter	PMID:27901495
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312350	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MOV10L1 mRNA	PMID:22228805
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312350	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MOV10L1 promoter alternative form	PMID:35295148
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of MOV10L1 mRNA	PMID:41034487
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1345883	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MOV10L1 gene	PMID:31601247
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MOV10L1 mRNA	PMID:22129741
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1345883	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MOV10L1 mRNA	PMID:38568856
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1345883	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MOV10L1 mRNA	PMID:19320972
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1345883	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MOV10L1 mRNA	PMID:38832940
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312350	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MOV10L1 mRNA	PMID:17942748
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312350	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MOV10L1 mRNA	PMID:17942748
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MOV10L1 gene	PMID:35440735
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:8093	phenylephrine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010656	MOV10L1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; MOV10L1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]	PMID:11854500
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:8093	phenylephrine	multiple interactions	ISO	RGD:1312350	E	RGD:6480464	20120412	CTD	MESH:D010656	MOV10L1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]	PMID:12754203
1304735	Mov10l1	Mov10 like RNA helicase 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1345883	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MOV10L1 mRNA	PMID:38568856
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of FNDC3A mRNA	PMID:27188386
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FNDC3A protein]	PMID:38195004
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1551997	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of FNDC3A mRNA	PMID:26251327
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1551997	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FNDC3A mRNA	PMID:20188158
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1354235	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of FNDC3A mRNA	PMID:33167477
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1551997	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FNDC3A mRNA	PMID:30319688
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1354235	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FNDC3A mRNA	PMID:20044591
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of FNDC3A mRNA	PMID:32145629
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551997	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FNDC3A mRNA	PMID:39298647
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1354235	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FNDC3A mRNA	PMID:37042841
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1354235	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of FNDC3A mRNA	PMID:18037150
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of FNDC3A mRNA	PMID:33359661
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1551997	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of FNDC3A mRNA	PMID:23892564
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1354235	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FNDC3A protein	PMID:37730182
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1354235	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of FNDC3A intron	PMID:30157460
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FNDC3A protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FNDC3A protein	PMID:38195004
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1354235	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FNDC3A gene	PMID:27153756
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551997	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FNDC3A mRNA	PMID:31919559
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FNDC3A mRNA	PMID:21867686
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FNDC3A mRNA	PMID:39836092
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1354235	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of FNDC3A protein	PMID:35688186
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FNDC3A mRNA	PMID:31881176
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FNDC3A mRNA	PMID:23557933
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FNDC3A mRNA	PMID:33212167
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FNDC3A mRNA	PMID:29803840
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1354235	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FNDC3A mRNA	PMID:20044591
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of FNDC3A mRNA	PMID:28595984|PMID:34032870
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1354235	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FNDC3A mRNA	PMID:38568856
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FNDC3A mRNA; sodium arsenite promotes the reaction [FNDC3A protein binds to CAPRIN1 protein]	PMID:33939924|PMID:39836092
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1354235	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FNDC3A promoter	PMID:27901495
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FNDC3A mRNA	PMID:21839799
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1354235	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of FNDC3A mRNA	PMID:25895662
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FNDC3A mRNA	PMID:19150397
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of FNDC3A gene	PMID:31601247
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1551997	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of FNDC3A mRNA	PMID:22609695
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1551997	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of FNDC3A promoter	PMID:35295148
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551997	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FNDC3A enhancer	PMID:35295148
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551997	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FNDC3A gene	PMID:35295148
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1551997	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of FNDC3A mRNA	PMID:18445702
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of FNDC3A mRNA	PMID:38479592
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1354235	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of FNDC3A gene	PMID:31601247
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FNDC3A mRNA	PMID:30816183|PMID:34947998
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FNDC3A mRNA	PMID:25047013
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FNDC3A mRNA	PMID:25181051|PMID:32145629
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of FNDC3A gene	PMID:31601247
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551997	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FNDC3A mRNA	PMID:39298647
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551997	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of FNDC3A mRNA	PMID:37019170
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1551997	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FNDC3A mRNA	PMID:24982889
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1354235	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FNDC3A mRNA	PMID:38174414|PMID:38568856
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FNDC3A protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FNDC3A protein	PMID:38195004
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of FNDC3A mRNA	PMID:27153767
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1354235	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FNDC3A mRNA	PMID:25979313
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FNDC3A mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1354235	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FNDC3A gene	PMID:29154799
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FNDC3A mRNA	PMID:27188386
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of FNDC3A mRNA	PMID:41580965
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in increased expression of FNDC3A mRNA	PMID:38685447
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1354235	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FNDC3A mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1551997	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of FNDC3A mRNA	PMID:19770486
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FNDC3A mRNA	PMID:24935251|PMID:26272509
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FNDC3A mRNA	PMID:27188386
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FNDC3A mRNA	PMID:21420995
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FNDC3A mRNA	PMID:39836092
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FNDC3A mRNA	PMID:22079256
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FNDC3A mRNA	PMID:29097150
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	ISO	RGD:1551997	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of FNDC3A gene	PMID:27923600
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:50729	mitoxantrone	affects response to substance	ISO	RGD:1354235	E	RGD:6480464	20120412	CTD	MESH:D008942	FNDC3A protein affects the susceptibility to Mitoxantrone	PMID:16217747
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of FNDC3A mRNA	PMID:24136188
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of FNDC3A mRNA	PMID:11114790
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FNDC3A protein	PMID:32959892
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1551997	E	RGD:6480464	20150127	CTD	MESH:D016559	Tacrolimus results in increased expression of FNDC3A mRNA	PMID:25270620
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of FNDC3A mRNA	PMID:30467583
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551997	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FNDC3A mRNA	PMID:22206623
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1354235	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FNDC3A mRNA	PMID:22079256
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FNDC3A mRNA	PMID:22079256
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FNDC3A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FNDC3A mRNA	PMID:27188386
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FNDC3A gene]	PMID:28238834
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of FNDC3A mRNA	PMID:20345932
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1354235	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FNDC3A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FNDC3A mRNA	PMID:27188386
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1354235	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of FNDC3A mRNA	PMID:38568856
1304736	Fndc3a	fibronectin type III domain containing 3a	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of FNDC3A gene	PMID:31079544
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312354	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ZFR2 mRNA	PMID:33045310
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312353	E	RGD:6480464	20120522	CTD	MESH:D014212	Tretinoin results in decreased expression of ZFR2 mRNA	PMID:21934132
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of ZFR2 mRNA	PMID:36841081
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFR2 mRNA	PMID:39241906
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312353	E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in increased expression of ZFR2 protein	PMID:33181973
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFR2 mRNA	PMID:37992649
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFR2 mRNA	PMID:37992649
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ZFR2 mRNA	PMID:33387578
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312353	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of ZFR2 intron	PMID:30157460
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ZFR2 mRNA	PMID:36331819
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1312353	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of ZFR2 intron	PMID:30157460
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312353	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZFR2 gene	PMID:25304211
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312353	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ZFR2 mRNA	PMID:26272509
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312353	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA	PMID:27188386
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312354	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ZFR2 mRNA	PMID:28960355
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFR2 mRNA	PMID:32109520
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFR2 mRNA	PMID:33387578
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312353	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ZFR2 mRNA	PMID:29955902
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312353	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZFR2 mRNA	PMID:33212167
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1312353	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of ZFR2 mRNA	PMID:26272509
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312353	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA	PMID:27188386
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFR2 mRNA	PMID:37992649
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312353	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZFR2 3' UTR; Benzo(a)pyrene affects the methylation of ZFR2 intron; Benzo(a)pyrene affects the methylation of ZFR2 promoter	PMID:27901495|PMID:30157460
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312353	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ZFR2 gene	PMID:31601247
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ZFR2 mRNA	PMID:30047161
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312354	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFR2 gene; titanium dioxide results in decreased methylation of ZFR2 promoter alternative form	PMID:35295148
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFR2 mRNA	PMID:34492290
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of ZFR2 mRNA	PMID:30816183
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312354	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFR2 mRNA	PMID:35598803
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312353	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZFR2 gene	PMID:31601247
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312353	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of ZFR2 protein	PMID:33181973
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312353	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ZFR2 gene	PMID:31601247
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312353	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ZFR2 mRNA	PMID:25979313
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312354	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZFR2 gene	PMID:31683443
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312354	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ZFR2 mRNA	PMID:40203079
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312353	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ZFR2 gene	PMID:31601247
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312354	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ZFR2 exon	PMID:33297965
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZFR2 mRNA	PMID:21266533
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312353	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZFR2 mRNA	PMID:38568856
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ZFR2 mRNA	PMID:25539665
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ZFR2 mRNA	PMID:39529242
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ZFR2 mRNA	PMID:36331819
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312353	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZFR2 mRNA	PMID:28001369
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312353	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZFR2 gene	PMID:29154799
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZFR2 mRNA	PMID:30047161
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFR2 mRNA	PMID:37992649
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312353	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZFR2 gene	PMID:25304211
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ZFR2 mRNA	PMID:29391264
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312354	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ZFR2 mRNA; Nanotubes, Carbon results in decreased expression of ZFR2 mRNA	PMID:25554681
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZFR2 mRNA	PMID:30047161
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ZFR2 mRNA	PMID:28801915
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312353	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA	PMID:27188386
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZFR2 mRNA	PMID:30047161
1304737	Zfr2	zinc finger RNA binding protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312353	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA	PMID:27188386
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312355	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of UBE4B mRNA	PMID:38218311
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312355	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of UBE4B mRNA	PMID:25812627
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of UBE4B mRNA	PMID:26251327
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE4B gene	PMID:20938992
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of UBE4B mRNA	PMID:26079696
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1312356	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of UBE4B mRNA	PMID:20362636
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312356	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of UBE4B mRNA	PMID:30319688
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of UBE4B mRNA	PMID:32145629
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE4B gene	PMID:20938992
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1312356	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of UBE4B mRNA	PMID:17945193
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of UBE4B protein	PMID:20463053
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of UBE4B mRNA	PMID:26577399
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312355	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of UBE4B protein	PMID:37730182
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312355	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UBE4B intron	PMID:30157460
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE4B mRNA	PMID:31150632
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312356	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of UBE4B mRNA	PMID:25629700
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of UBE4B mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE4B gene	PMID:20938992|PMID:22206623
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1312355	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of UBE4B mRNA	PMID:19244175
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312355	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of UBE4B protein	PMID:35688186
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of UBE4B mRNA	PMID:27594783
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of UBE4B mRNA	PMID:34813904
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE4B mRNA	PMID:22298810
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312355	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE4B mRNA	PMID:22574217
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312356	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE4B mRNA	PMID:21570461
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE4B mRNA	PMID:33387578
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE4B mRNA	PMID:18796159|PMID:22342509|PMID:32109520
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of UBE4B mRNA	PMID:33212167
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of UBE4B mRNA	PMID:28959563
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of UBE4B mRNA	PMID:29803840
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312355	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of UBE4B protein	PMID:35688186
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312355	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of UBE4B intron	PMID:30157460
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE4B mRNA	PMID:26238291
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312355	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of UBE4B promoter	PMID:27901495
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312355	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of UBE4B gene	PMID:25435355
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312355	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to UBE4B mRNA]	PMID:32406909
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312355	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UBE4B mRNA	PMID:20458559
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of UBE4B mRNA	PMID:30047161
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312356	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBE4B gene; titanium dioxide results in decreased methylation of UBE4B promoter	PMID:35295148
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312356	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of UBE4B mRNA	PMID:21318169
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of UBE4B mRNA]	PMID:21318169
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312356	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of UBE4B mRNA	PMID:19191707
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of UBE4B mRNA	PMID:25181051
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE4B mRNA	PMID:32145629
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE4B protein	PMID:31675489
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312355	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of UBE4B mRNA	PMID:29275510
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of UBE4B gene	PMID:28505145
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of UBE4B protein	PMID:31675489
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312355	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of UBE4B mRNA	PMID:19244175
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312355	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of UBE4B mRNA	PMID:25979313
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of UBE4B mRNA	PMID:33297965|PMID:39298647
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312355	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of UBE4B intron	PMID:30157460
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312356	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of UBE4B intron	PMID:28392331
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of UBE4B mRNA	PMID:37019170
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UBE4B mRNA	PMID:21266533
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of UBE4B mRNA	PMID:34813904
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of UBE4B mRNA	PMID:34813904
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312355	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBE4B mRNA	PMID:37042841
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312355	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE4B mRNA	PMID:38382870
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBE4B mRNA	PMID:24386269
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1312355	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of UBE4B mRNA	PMID:19244175
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312355	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of UBE4B mRNA	PMID:25812627
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312355	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of UBE4B gene	PMID:29154799
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of UBE4B mRNA	PMID:30047161|PMID:38685447|PMID:41580965
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of UBE4B mRNA	PMID:25562108
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in decreased expression of UBE4B mRNA	PMID:25270620
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312356	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBE4B mRNA	PMID:17562736
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of UBE4B mRNA	PMID:33387578
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of UBE4B mRNA	PMID:21420995
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of UBE4B mRNA	PMID:29279043
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in decreased expression of UBE4B mRNA	PMID:31464424
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of UBE4B mRNA	PMID:29391264
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of UBE4B mRNA	PMID:35436446
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312355	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UBE4B mRNA	PMID:20458559
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312356	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UBE4B mRNA; Nanotubes, Carbon results in increased expression of UBE4B mRNA	PMID:25554681|PMID:25620056
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of UBE4B mRNA	PMID:30047161|PMID:38685447|PMID:41580965
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of UBE4B mRNA	PMID:35964746
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBE4B mRNA	PMID:24136188
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UBE4B protein	PMID:32959892
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of UBE4B mRNA	PMID:24136188
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of UBE4B mRNA	PMID:28988120
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of UBE4B mRNA	PMID:24136188
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312355	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of UBE4B intron	PMID:30157460
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of UBE4B gene	PMID:35440735
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of UBE4B mRNA	PMID:31758290
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312356	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of UBE4B mRNA	PMID:22206623
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of UBE4B mRNA	PMID:22206623
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of UBE4B mRNA	PMID:24136188
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:77850	toxaphene	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014112	Toxaphene results in increased expression of UBE4B mRNA	PMID:23153324
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1312355	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of UBE4B protein	PMID:31675489
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of UBE4B mRNA	PMID:30047161
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:9123	sertraline	decreases expression	ISO	RGD:1312355	E	RGD:6480464	20140909	CTD	MESH:D020280	Sertraline results in decreased expression of UBE4B mRNA	PMID:24865413
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UBE4B mRNA	PMID:21346803
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of UBE4B mRNA	PMID:21346803
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of UBE4B mRNA	PMID:28973697
1304738	Ube4b	ubiquitination factor E4B	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of UBE4B mRNA	PMID:23034163
1304739	Exosc3	exosome component 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of EXOSC3 mRNA	PMID:21934132
1304739	Exosc3	exosome component 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of EXOSC3 protein	PMID:39571964
1304739	Exosc3	exosome component 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of EXOSC3 mRNA	PMID:22378314
1304739	Exosc3	exosome component 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312357	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EXOSC3 mRNA	PMID:20044591
1304739	Exosc3	exosome component 3	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of EXOSC3 protein	PMID:18951874
1304739	Exosc3	exosome component 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312358	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EXOSC3 mRNA	PMID:39241906
1304739	Exosc3	exosome component 3	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312357	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of EXOSC3 mRNA	PMID:21179406
1304739	Exosc3	exosome component 3	gene	CHEBI:17347	testosterone	affects expression	ISO	RGD:1312358	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone affects the expression of EXOSC3 mRNA	PMID:20403060
1304739	Exosc3	exosome component 3	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of EXOSC3 mRNA	PMID:31256213
1304739	Exosc3	exosome component 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312358	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of EXOSC3 mRNA	PMID:23892564
1304739	Exosc3	exosome component 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EXOSC3 mRNA	PMID:33387578
1304739	Exosc3	exosome component 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EXOSC3 mRNA	PMID:28818685
1304739	Exosc3	exosome component 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EXOSC3 protein	PMID:23301498
1304739	Exosc3	exosome component 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of EXOSC3 mRNA	PMID:35430440
1304739	Exosc3	exosome component 3	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of EXOSC3 mRNA	PMID:31129395
1304739	Exosc3	exosome component 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312358	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EXOSC3 mRNA	PMID:31919559
1304739	Exosc3	exosome component 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312358	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EXOSC3 mRNA	PMID:25629700
1304739	Exosc3	exosome component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312358	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EXOSC3 mRNA	PMID:21570461
1304739	Exosc3	exosome component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EXOSC3 mRNA	PMID:32109520
1304739	Exosc3	exosome component 3	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of EXOSC3 protein	PMID:18951874
1304739	Exosc3	exosome component 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of EXOSC3 mRNA	PMID:38568856
1304739	Exosc3	exosome component 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of EXOSC3 protein	PMID:39571964
1304739	Exosc3	exosome component 3	gene	CHEBI:29866	arsenite(3-)	affects expression	ISO	RGD:1312357	E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of EXOSC3 mRNA	PMID:22959463
1304739	Exosc3	exosome component 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312357	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of EXOSC3 mRNA	PMID:25895662
1304739	Exosc3	exosome component 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EXOSC3 mRNA	PMID:19150397|PMID:20382639
1304739	Exosc3	exosome component 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of EXOSC3 mRNA	PMID:29275510
1304739	Exosc3	exosome component 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EXOSC3 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1304739	Exosc3	exosome component 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of EXOSC3 mRNA	PMID:31129395
1304739	Exosc3	exosome component 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EXOSC3 mRNA	PMID:28628672
1304739	Exosc3	exosome component 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EXOSC3 mRNA	PMID:28628672
1304739	Exosc3	exosome component 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312357	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EXOSC3 mRNA	PMID:37042841
1304739	Exosc3	exosome component 3	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of EXOSC3 promoter	PMID:22457795
1304739	Exosc3	exosome component 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of EXOSC3 mRNA	PMID:28302478
1304739	Exosc3	exosome component 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312357	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EXOSC3 mRNA	PMID:31533062
1304739	Exosc3	exosome component 3	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312357	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of EXOSC3 mRNA	PMID:19167446
1304739	Exosc3	exosome component 3	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of EXOSC3 mRNA	PMID:26352163
1304739	Exosc3	exosome component 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of EXOSC3 mRNA	PMID:27188386
1304739	Exosc3	exosome component 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EXOSC3 mRNA	PMID:28628672
1304739	Exosc3	exosome component 3	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312357	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of EXOSC3 mRNA	PMID:27188386
1304739	Exosc3	exosome component 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EXOSC3 mRNA	PMID:33387578
1304739	Exosc3	exosome component 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EXOSC3 mRNA	PMID:28628672
1304739	Exosc3	exosome component 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312358	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of EXOSC3 mRNA	PMID:25554681
1304739	Exosc3	exosome component 3	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312358	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of EXOSC3 mRNA	PMID:40234311
1304739	Exosc3	exosome component 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312358	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EXOSC3 mRNA	PMID:35964746
1304739	Exosc3	exosome component 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312358	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of EXOSC3 mRNA	PMID:19042947
1304739	Exosc3	exosome component 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EXOSC3 protein	PMID:32959892
1304739	Exosc3	exosome component 3	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1312358	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of EXOSC3 mRNA	PMID:28444820
1304739	Exosc3	exosome component 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312358	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EXOSC3 mRNA	PMID:22206623
1304739	Exosc3	exosome component 3	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312357	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of EXOSC3 protein	PMID:31285264
1304739	Exosc3	exosome component 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312357	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EXOSC3 gene]	PMID:28238834
1304739	Exosc3	exosome component 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312358	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of EXOSC3 mRNA	PMID:30294300
1304739	Exosc3	exosome component 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312357	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EXOSC3 mRNA	PMID:38568856
1304739	Exosc3	exosome component 3	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of EXOSC3 mRNA	PMID:23034163
1304740	Tspan9	tetraspanin 9	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1553233	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TSPAN9 mRNA	PMID:37995155
1304740	Tspan9	tetraspanin 9	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1602896	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN9 protein]	PMID:38195004
1304740	Tspan9	tetraspanin 9	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1553233	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TSPAN9 mRNA	PMID:30319688
1304740	Tspan9	tetraspanin 9	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1553233	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TSPAN9 mRNA	PMID:30319688
1304740	Tspan9	tetraspanin 9	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1553233	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TSPAN9 mRNA	PMID:30319688
1304740	Tspan9	tetraspanin 9	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553233	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TSPAN9 mRNA	PMID:39241906
1304740	Tspan9	tetraspanin 9	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1602896	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TSPAN9 mRNA	PMID:35811015
1304740	Tspan9	tetraspanin 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1602896	E	RGD:6480464	20200714	CTD	MESH:D004958	Estradiol results in decreased expression of TSPAN9 mRNA	PMID:31614463|PMID:32234386|PMID:32387340
1304740	Tspan9	tetraspanin 9	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553233	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TSPAN9 mRNA	PMID:39298647
1304740	Tspan9	tetraspanin 9	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602896	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TSPAN9 mRNA	PMID:37042841
1304740	Tspan9	tetraspanin 9	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1602896	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TSPAN9 intron	PMID:30157460
1304740	Tspan9	tetraspanin 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1602896	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN9 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN9 protein	PMID:38195004
1304740	Tspan9	tetraspanin 9	gene	CHEBI:24556	1,3,5-trinitro-1,3,5-triazinane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009160	cyclonite results in decreased expression of TSPAN9 mRNA	PMID:25559034
1304740	Tspan9	tetraspanin 9	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602896	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TSPAN9 3' UTR; Aflatoxin B1 results in decreased methylation of TSPAN9 intron	PMID:30157460
1304740	Tspan9	tetraspanin 9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553233	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSPAN9 mRNA	PMID:40504410
1304740	Tspan9	tetraspanin 9	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1602896	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of TSPAN9 mRNA	PMID:19561079
1304740	Tspan9	tetraspanin 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TSPAN9 mRNA	PMID:22298810|PMID:34747641
1304740	Tspan9	tetraspanin 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1553233	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TSPAN9 mRNA	PMID:26290441
1304740	Tspan9	tetraspanin 9	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1602896	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TSPAN9 protein	PMID:33212167
1304740	Tspan9	tetraspanin 9	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602896	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TSPAN9 mRNA	PMID:38568856
1304740	Tspan9	tetraspanin 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553233	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSPAN9 mRNA	PMID:40504410
1304740	Tspan9	tetraspanin 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602896	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TSPAN9 3' UTR; Benzo(a)pyrene affects the methylation of TSPAN9 5' UTR	PMID:27901495|PMID:30157460
1304740	Tspan9	tetraspanin 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1553233	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TSPAN9 mRNA	PMID:19770486
1304740	Tspan9	tetraspanin 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602896	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TSPAN9 mRNA	PMID:22316170|PMID:32234424
1304740	Tspan9	tetraspanin 9	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602896	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TSPAN9 3' UTR	PMID:27901495
1304740	Tspan9	tetraspanin 9	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1602896	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TSPAN9 mRNA	PMID:25895662
1304740	Tspan9	tetraspanin 9	gene	CHEBI:30563	silicon dioxide	decreases methylation	ISO	RGD:1602896	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased methylation of TSPAN9 gene	PMID:34973136
1304740	Tspan9	tetraspanin 9	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1602896	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of TSPAN9 mRNA	PMID:34408198
1304740	Tspan9	tetraspanin 9	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TSPAN9 mRNA	PMID:30047161
1304740	Tspan9	tetraspanin 9	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1553233	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of TSPAN9 mRNA	PMID:17656681
1304740	Tspan9	tetraspanin 9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553233	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TSPAN9 gene	PMID:35295148
1304740	Tspan9	tetraspanin 9	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553233	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of TSPAN9 mRNA	PMID:23811191
1304740	Tspan9	tetraspanin 9	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1602896	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TSPAN9 mRNA	PMID:19710929
1304740	Tspan9	tetraspanin 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TSPAN9 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304740	Tspan9	tetraspanin 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1602896	E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A analog results in decreased expression of TSPAN9 mRNA	PMID:32387340
1304740	Tspan9	tetraspanin 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1602896	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TSPAN9 gene	PMID:31601247
1304740	Tspan9	tetraspanin 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN9 mRNA	PMID:34947998
1304740	Tspan9	tetraspanin 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553233	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN9 mRNA	PMID:32156529
1304740	Tspan9	tetraspanin 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602896	E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN9 mRNA	PMID:32387340
1304740	Tspan9	tetraspanin 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553233	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TSPAN9 mRNA	PMID:39298647
1304740	Tspan9	tetraspanin 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1602896	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TSPAN9 gene	PMID:31601247
1304740	Tspan9	tetraspanin 9	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1602896	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of TSPAN9 3' UTR	PMID:30157460
1304740	Tspan9	tetraspanin 9	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1602896	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TSPAN9 intron	PMID:30157460
1304740	Tspan9	tetraspanin 9	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1553233	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TSPAN9 promoter	PMID:28392331
1304740	Tspan9	tetraspanin 9	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TSPAN9 mRNA	PMID:21266533
1304740	Tspan9	tetraspanin 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602896	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TSPAN9 mRNA	PMID:37042841
1304740	Tspan9	tetraspanin 9	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1602896	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TSPAN9 mRNA	PMID:38174414
1304740	Tspan9	tetraspanin 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1602896	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN9 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN9 protein	PMID:38195004
1304740	Tspan9	tetraspanin 9	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1602896	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TSPAN9 protein	PMID:26879310
1304740	Tspan9	tetraspanin 9	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1602896	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TSPAN9 mRNA	PMID:24449571
1304740	Tspan9	tetraspanin 9	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1553233	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of TSPAN9 mRNA	PMID:17585979|PMID:23811191
1304740	Tspan9	tetraspanin 9	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1553233	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TSPAN9 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TSPAN9 mRNA]	PMID:17585979
1304740	Tspan9	tetraspanin 9	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602896	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TSPAN9 mRNA	PMID:31533062
1304740	Tspan9	tetraspanin 9	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602896	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TSPAN9 mRNA	PMID:23179753
1304740	Tspan9	tetraspanin 9	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602896	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TSPAN9 gene	PMID:29154799
1304740	Tspan9	tetraspanin 9	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TSPAN9 mRNA	PMID:30047161
1304740	Tspan9	tetraspanin 9	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602896	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TSPAN9 mRNA	PMID:25562108
1304740	Tspan9	tetraspanin 9	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1553233	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TSPAN9 mRNA	PMID:28973697
1304740	Tspan9	tetraspanin 9	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553233	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TSPAN9 mRNA	PMID:17562736
1304740	Tspan9	tetraspanin 9	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1553233	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TSPAN9 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TSPAN9 mRNA]	PMID:17585979
1304740	Tspan9	tetraspanin 9	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1602896	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TSPAN9 mRNA	PMID:29432896
1304740	Tspan9	tetraspanin 9	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1602896	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TSPAN9 mRNA	PMID:35811015
1304740	Tspan9	tetraspanin 9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553233	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSPAN9 mRNA	PMID:40504410
1304740	Tspan9	tetraspanin 9	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1602896	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of TSPAN9 mRNA	PMID:31675489
1304740	Tspan9	tetraspanin 9	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553233	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TSPAN9 mRNA	PMID:35436446
1304740	Tspan9	tetraspanin 9	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	EXP		E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of TSPAN9 gene	PMID:37958445
1304740	Tspan9	tetraspanin 9	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553233	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TSPAN9 mRNA	PMID:25554681
1304740	Tspan9	tetraspanin 9	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TSPAN9 mRNA	PMID:30047161
1304740	Tspan9	tetraspanin 9	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1553233	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TSPAN9 mRNA	PMID:35964746
1304740	Tspan9	tetraspanin 9	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1553233	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TSPAN9 mRNA	PMID:15003993
1304740	Tspan9	tetraspanin 9	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1602896	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of TSPAN9 3' UTR	PMID:30157460
1304740	Tspan9	tetraspanin 9	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1602896	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TSPAN9 intron	PMID:30157460
1304740	Tspan9	tetraspanin 9	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TSPAN9 gene	PMID:35440735
1304740	Tspan9	tetraspanin 9	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of TSPAN9 mRNA	PMID:27840820
1304740	Tspan9	tetraspanin 9	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1602896	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of TSPAN9 mRNA	PMID:22714537
1304740	Tspan9	tetraspanin 9	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1602896	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of TSPAN9 mRNA	PMID:32858204
1304740	Tspan9	tetraspanin 9	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602896	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TSPAN9 gene]	PMID:28238834
1304740	Tspan9	tetraspanin 9	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of TSPAN9 mRNA	PMID:30047161
1304740	Tspan9	tetraspanin 9	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TSPAN9 mRNA	PMID:24780913
1304740	Tspan9	tetraspanin 9	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TSPAN9 mRNA	PMID:30047161
1304740	Tspan9	tetraspanin 9	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of TSPAN9 mRNA	PMID:30047161
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of UST mRNA	PMID:36331819
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of UST mRNA	PMID:39506029
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of UST gene	PMID:28931070|PMID:35440735
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550016	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of UST mRNA	PMID:30319688
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312363	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of UST mRNA	PMID:35811015
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of UST mRNA	PMID:39298647
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312363	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of UST mRNA	PMID:30165855
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to UST gene]	PMID:31084621
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of UST mRNA	PMID:23649840
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312363	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of UST mRNA	PMID:20864642
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UST mRNA	PMID:37992649
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UST mRNA	PMID:37992649
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of UST mRNA	PMID:26577399
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312363	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of UST mRNA	PMID:16002434
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312363	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of UST intron	PMID:30157460
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312363	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UST mRNA	PMID:19549813
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of UST mRNA	PMID:23649840
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1312363	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of UST intron	PMID:30157460
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of UST mRNA	PMID:22100608
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of UST mRNA	PMID:23649840
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of UST mRNA	PMID:32553695
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1550016	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of UST mRNA	PMID:18579281
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of UST mRNA	PMID:30779732
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UST mRNA	PMID:25629700
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of UST gene	PMID:35440735
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of UST mRNA	PMID:31881176
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312363	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of UST mRNA	PMID:19371625
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312363	E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with panobinostat] affects the expression of UST mRNA	PMID:21791302
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UST mRNA	PMID:19933214
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UST mRNA	PMID:33387578
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of UST mRNA	PMID:33212167
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:1550016	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in increased expression of UST mRNA	PMID:18579281
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of UST mRNA	PMID:30807115
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of UST mRNA	PMID:29803840
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UST mRNA	PMID:37992649
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of UST mRNA	PMID:39515575
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312363	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UST mRNA	PMID:38568856
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312363	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of and affects the splicing of UST mRNA	PMID:25879800
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1550016	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UST 3' UTR; Benzo(a)pyrene results in decreased methylation of UST exon; Benzo(a)pyrene results in decreased methylation of UST intron	PMID:27901495
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1550016	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of UST mRNA	PMID:27131904
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312363	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of UST mRNA	PMID:25895662
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of UST mRNA	PMID:29264374
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550016	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UST gene	PMID:35295148
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of UST mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of UST mRNA	PMID:39742910
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312363	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of UST gene	PMID:31601247
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312363	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of UST mRNA	PMID:29275510
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of UST gene	PMID:28505145
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312363	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of UST mRNA	PMID:25979313
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312363	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of UST gene	PMID:31601247
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550016	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of UST intron	PMID:28392331
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312363	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UST mRNA	PMID:37042841
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of UST mRNA	PMID:24449571
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312363	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of UST mRNA	PMID:31533062
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312363	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UST mRNA	PMID:19167446
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1550016	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of UST mRNA	PMID:39529242
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312363	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of UST mRNA	PMID:40419075
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of UST mRNA	PMID:36331819
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of UST mRNA	PMID:28001369
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312363	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of UST mRNA	PMID:23179753|PMID:27188386
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312363	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of UST gene	PMID:29154799
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312363	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of UST mRNA	PMID:20106945
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UST mRNA	PMID:37992649
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of UST mRNA	PMID:33387578
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312363	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of UST mRNA	PMID:26690555|PMID:29067470
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of UST mRNA	PMID:35811015
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312363	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of UST mRNA	PMID:35811015
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of UST mRNA	PMID:29391264
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of UST mRNA	PMID:31758290
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1312363	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of UST mRNA	PMID:34995734
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312363	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of UST mRNA	PMID:30928695
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of UST mRNA	PMID:32109520
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312363	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UST mRNA	PMID:19167446
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of UST mRNA	PMID:24780913
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312363	E	RGD:6480464	20161228	CTD	MESH:C496932	[Cisplatin co-treated with panobinostat] affects the expression of UST mRNA	PMID:21791302
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1550016	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of UST mRNA	PMID:27131904
1304743	Ust	uronyl-2-sulfotransferase	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of UST gene	PMID:31079544
1304744	Stx11	syntaxin 11	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312365	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of STX11 mRNA	PMID:33167477
1304744	Stx11	syntaxin 11	gene	CHEBI:15767	dichloromethane	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120412	CTD	MESH:D008752	Methylene Chloride results in increased expression of STX11 mRNA	PMID:20359517
1304744	Stx11	syntaxin 11	gene	CHEBI:16101	ethylbenzene	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120412	CTD	MESH:C004912	ethylbenzene results in increased expression of STX11 mRNA	PMID:20359517
1304744	Stx11	syntaxin 11	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312365	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of STX11 mRNA	PMID:35811015
1304744	Stx11	syntaxin 11	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312366	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of STX11 mRNA	PMID:39241906
1304744	Stx11	syntaxin 11	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312365	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STX11 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of STX11 mRNA	PMID:35811015
1304744	Stx11	syntaxin 11	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312366	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of STX11 mRNA	PMID:39298647
1304744	Stx11	syntaxin 11	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312365	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of STX11 mRNA	PMID:31614463
1304744	Stx11	syntaxin 11	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STX11 mRNA	PMID:32741896
1304744	Stx11	syntaxin 11	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of STX11 mRNA	PMID:20359517
1304744	Stx11	syntaxin 11	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312365	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of STX11 mRNA	PMID:37042841
1304744	Stx11	syntaxin 11	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of STX11 mRNA	PMID:20359517
1304744	Stx11	syntaxin 11	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STX11 mRNA	PMID:37992649
1304744	Stx11	syntaxin 11	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STX11 mRNA	PMID:32741896
1304744	Stx11	syntaxin 11	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312365	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of STX11 mRNA	PMID:33647349
1304744	Stx11	syntaxin 11	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120412	CTD	MESH:D014050	Toluene results in increased expression of STX11 mRNA	PMID:20359517
1304744	Stx11	syntaxin 11	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STX11 mRNA	PMID:37992649
1304744	Stx11	syntaxin 11	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of STX11 mRNA	PMID:33387578
1304744	Stx11	syntaxin 11	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312365	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of STX11 mRNA	PMID:28818685
1304744	Stx11	syntaxin 11	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of STX11 mRNA	PMID:39012411
1304744	Stx11	syntaxin 11	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312365	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of STX11 mRNA	PMID:22100608
1304744	Stx11	syntaxin 11	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1312365	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of STX11 mRNA	PMID:26760959
1304744	Stx11	syntaxin 11	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312365	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of STX11 mRNA	PMID:23649840
1304744	Stx11	syntaxin 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312365	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of STX11 mRNA	PMID:41430723
1304744	Stx11	syntaxin 11	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of STX11 mRNA	PMID:19774075
1304744	Stx11	syntaxin 11	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of STX11 gene	PMID:35440735
1304744	Stx11	syntaxin 11	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312366	E	RGD:6480464	20240604	CTD	MESH:C010974	Glyphosate results in decreased expression of STX11 mRNA	PMID:33713393
1304744	Stx11	syntaxin 11	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312366	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of STX11 mRNA	PMID:28960355
1304744	Stx11	syntaxin 11	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of STX11 mRNA	PMID:31881176
1304744	Stx11	syntaxin 11	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312365	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of STX11 mRNA	PMID:27392435
1304744	Stx11	syntaxin 11	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312365	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of STX11 mRNA	PMID:27594783
1304744	Stx11	syntaxin 11	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312365	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of STX11 mRNA	PMID:27392435
1304744	Stx11	syntaxin 11	gene	CHEBI:28063	o-xylene	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120412	CTD	MESH:C026114	2-xylene results in increased expression of STX11 mRNA	PMID:20359517
1304744	Stx11	syntaxin 11	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312365	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of STX11 mRNA	PMID:24768652|PMID:25583101
1304744	Stx11	syntaxin 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STX11 mRNA	PMID:22298810
1304744	Stx11	syntaxin 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312365	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STX11 mRNA	PMID:22298810
1304744	Stx11	syntaxin 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312365	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STX11 mRNA	PMID:17101203
1304744	Stx11	syntaxin 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STX11 mRNA	PMID:33387578
1304744	Stx11	syntaxin 11	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312365	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of STX11 mRNA	PMID:33212167
1304744	Stx11	syntaxin 11	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STX11 mRNA	PMID:37992649
1304744	Stx11	syntaxin 11	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312365	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of STX11 mRNA	PMID:38568856
1304744	Stx11	syntaxin 11	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312365	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STX11 5' UTR	PMID:27901495
1304744	Stx11	syntaxin 11	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312366	E	RGD:6480464	20150602	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STX11 mRNA	PMID:21569818
1304744	Stx11	syntaxin 11	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312365	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of STX11 3' UTR	PMID:27901495
1304744	Stx11	syntaxin 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312365	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STX11 mRNA	PMID:32234424
1304744	Stx11	syntaxin 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312365	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STX11 promoter	PMID:27901495
1304744	Stx11	syntaxin 11	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312365	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of STX11 mRNA	PMID:25895662
1304744	Stx11	syntaxin 11	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of STX11 mRNA	PMID:34492290
1304744	Stx11	syntaxin 11	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1312365	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of STX11 mRNA	PMID:30690063
1304744	Stx11	syntaxin 11	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of STX11 mRNA	PMID:25181051
1304744	Stx11	syntaxin 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312365	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of STX11 mRNA	PMID:31715268
1304744	Stx11	syntaxin 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312366	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of STX11 mRNA	PMID:32156529
1304744	Stx11	syntaxin 11	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1312366	E	RGD:6480464	20150602	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of STX11 mRNA	PMID:25172293
1304744	Stx11	syntaxin 11	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312366	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of STX11 mRNA	PMID:26682919
1304744	Stx11	syntaxin 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312365	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of STX11 gene	PMID:31601247
1304744	Stx11	syntaxin 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312366	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of STX11 mRNA	PMID:40203079
1304744	Stx11	syntaxin 11	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of STX11 mRNA	PMID:21266533
1304744	Stx11	syntaxin 11	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of STX11 mRNA	PMID:17374397
1304744	Stx11	syntaxin 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312365	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STX11 mRNA	PMID:37042841
1304744	Stx11	syntaxin 11	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of STX11 mRNA	PMID:39012411
1304744	Stx11	syntaxin 11	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312365	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of STX11 mRNA	PMID:24449571
1304744	Stx11	syntaxin 11	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312365	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of STX11 mRNA	PMID:31533062
1304744	Stx11	syntaxin 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312365	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of STX11 mRNA	PMID:40419075
1304744	Stx11	syntaxin 11	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312366	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of STX11 mRNA	PMID:29038090
1304744	Stx11	syntaxin 11	gene	CHEBI:39481	chloroprene	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of STX11 mRNA	PMID:23125180
1304744	Stx11	syntaxin 11	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1312366	E	RGD:6480464	20150602	CTD	MESH:D002737	Chloroprene results in decreased expression of STX11 mRNA	PMID:23125180
1304744	Stx11	syntaxin 11	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312365	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of STX11 gene	PMID:29154799
1304744	Stx11	syntaxin 11	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312365	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of STX11 mRNA	PMID:17183730
1304744	Stx11	syntaxin 11	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STX11 mRNA	PMID:37992649
1304744	Stx11	syntaxin 11	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312365	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of STX11 mRNA	PMID:38832940
1304744	Stx11	syntaxin 11	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312366	E	RGD:6480464	20150602	CTD	MESH:D000082	Acetaminophen affects the expression of STX11 mRNA	PMID:17562736
1304744	Stx11	syntaxin 11	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STX11 mRNA	PMID:33387578
1304744	Stx11	syntaxin 11	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312365	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of STX11 mRNA	PMID:29067470
1304744	Stx11	syntaxin 11	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312365	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STX11 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of STX11 mRNA	PMID:35811015
1304744	Stx11	syntaxin 11	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of STX11 mRNA	PMID:29391264
1304744	Stx11	syntaxin 11	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312365	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STX11 mRNA	PMID:22079256
1304744	Stx11	syntaxin 11	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of STX11 mRNA	PMID:30307764
1304744	Stx11	syntaxin 11	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312366	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of STX11 mRNA	PMID:25554681
1304744	Stx11	syntaxin 11	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of STX11 mRNA	PMID:35964746
1304744	Stx11	syntaxin 11	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of STX11 mRNA	PMID:21983209
1304744	Stx11	syntaxin 11	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120515	CTD	MESH:C029938	nickel sulfate results in increased expression of STX11 mRNA	PMID:16780908|PMID:17374397
1304744	Stx11	syntaxin 11	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120515	CTD	MESH:D010081	Oxazolone results in increased expression of STX11 mRNA	PMID:17374397
1304744	Stx11	syntaxin 11	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312365	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of STX11 mRNA	PMID:31629900
1304744	Stx11	syntaxin 11	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312365	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of STX11 mRNA	PMID:17183730
1304744	Stx11	syntaxin 11	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20150602	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of STX11 mRNA	PMID:21641980
1304744	Stx11	syntaxin 11	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312366	E	RGD:6480464	20150602	CTD	MESH:D002185	Cannabidiol results in increased expression of STX11 mRNA	PMID:21542829
1304744	Stx11	syntaxin 11	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312365	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of STX11 mRNA	PMID:31758290
1304744	Stx11	syntaxin 11	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312366	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of STX11 mRNA	PMID:22206623
1304744	Stx11	syntaxin 11	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312365	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of STX11 mRNA	PMID:22079256|PMID:22714537
1304744	Stx11	syntaxin 11	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312365	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STX11 mRNA	PMID:22079256
1304744	Stx11	syntaxin 11	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STX11 mRNA	PMID:32741896
1304744	Stx11	syntaxin 11	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312365	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to STX11 gene]	PMID:28238834
1304744	Stx11	syntaxin 11	gene	CHEBI:8093	phenylephrine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine affects the expression of STX11 mRNA	PMID:18158353
1304744	Stx11	syntaxin 11	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312365	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of STX11 mRNA	PMID:38568856
1304744	Stx11	syntaxin 11	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312365	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of STX11 mRNA	PMID:19140230
1304745	Ubtfl1	upstream binding transcription factor like 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1622623	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of UBTFL1 mRNA	PMID:37315490
1304745	Ubtfl1	upstream binding transcription factor like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312367	E	RGD:6480464	20230905	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UBTFL1 exon	PMID:27901495
1304745	Ubtfl1	upstream binding transcription factor like 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1622623	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of UBTFL1 mRNA	PMID:40194260
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ADCY9 mRNA	PMID:33045310
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:132446	perfluorobutanesulfonic acid	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid results in decreased expression of ADCY9 mRNA	PMID:40334771
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:132446	perfluorobutanesulfonic acid	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20260203	CTD	MESH:C539348	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] affects the expression of ADCY9 mRNA	PMID:40334771
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADCY9 mRNA]	PMID:31150632
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ADCY9 mRNA	PMID:26079696
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312371	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ADCY9 mRNA	PMID:30319688
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312371	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ADCY9 mRNA	PMID:30319688
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D000431	Ethanol results in increased expression of ADCY9 mRNA	PMID:20655511
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312371	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ADCY9 mRNA	PMID:30319688
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADCY9 mRNA	PMID:39241906
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ADCY9 mRNA	PMID:30510588
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in increased expression of ADCY9 mRNA	PMID:35192832
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312370	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ADCY9 mRNA	PMID:31614463
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312371	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ADCY9 mRNA	PMID:39298647
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ADCY9 mRNA	PMID:26496021
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of ADCY9 gene	PMID:30521419
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D005557	Formaldehyde results in increased expression of ADCY9 mRNA	PMID:14756816
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ADCY9 mRNA	PMID:26577399
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312370	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ADCY9 protein	PMID:37730182
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:17833	gentamycin	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins affects the expression of ADCY9 mRNA	PMID:33387578
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ADCY9 mRNA	PMID:36331819
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20251104	CTD	MESH:D002104	Cadmium results in decreased expression of ADCY9 mRNA	PMID:29656123
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20251104	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADCY9 mRNA; Selenium inhibits the reaction [Cadmium results in decreased expression of ADCY9 mRNA]	PMID:29656123|PMID:38382403
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:22984	calcium atom	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20201103	CTD	MESH:D002118	Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]; Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]]	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312370	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ADCY9 intron	PMID:30157460
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADCY9 mRNA	PMID:31150632
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADCY9 mRNA	PMID:31919559
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADCY9 mRNA]	PMID:31150632
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ADCY9 mRNA]	PMID:22206623
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312370	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADCY9 gene	PMID:25304211
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADCY9 mRNA	PMID:39836092
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20251104	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of ADCY9 mRNA]	PMID:29656123
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312370	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ADCY9 protein	PMID:35688186
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:C059514	resveratrol results in decreased expression of ADCY9 mRNA	PMID:22610192
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312370	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ADCY9 mRNA	PMID:28903495
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ADCY9 mRNA	PMID:27392435
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADCY9 mRNA	PMID:20702594
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADCY9 mRNA	PMID:21215274|PMID:33387578
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312370	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADCY9 mRNA	PMID:20106945|PMID:21632981
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADCY9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ADCY9 mRNA	PMID:17942748|PMID:25975270
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D012402	Rotenone results in increased expression of ADCY9 mRNA	PMID:19013527|PMID:28374803
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312370	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ADCY9 protein	PMID:35688186
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:29320	calcium(0)	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20201103	CTD	MESH:D002118	Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]; Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]]	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADCY9 mRNA	PMID:35202923
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312371	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of ADCY9 mRNA	PMID:36209798
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADCY9 mRNA	PMID:39836092
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20240430	CTD	MESH:C017947	salvin inhibits the reaction [sodium arsenite results in decreased expression of ADCY9 mRNA]	PMID:35202923
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312370	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADCY9 3' UTR	PMID:27901495
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADCY9 mRNA	PMID:20064835
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312370	E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADCY9 mRNA	PMID:30453624
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADCY9 mRNA	PMID:22228805
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312371	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADCY9 3' UTR; Benzo(a)pyrene results in increased methylation of ADCY9 exon	PMID:27901495
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ADCY9 mRNA	PMID:25895662
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADCY9 mRNA	PMID:19150397|PMID:26238291
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ADCY9 mRNA	PMID:15761015
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:31429	colforsin daropate hydrochloride	increases activity	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D005576	Colforsin results in increased activity of ADCY9 protein	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:31429	colforsin daropate hydrochloride	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D005576	[Colforsin co-treated with Miconazole] results in increased activity of ADCY9 protein	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ADCY9 mRNA	PMID:34492290
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:C006253	pirinixic acid results in decreased expression of ADCY9 mRNA	PMID:15375163
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ADCY9 mRNA	PMID:32145629
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312370	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ADCY9 gene	PMID:31601247
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ADCY9 mRNA	PMID:25181051|PMID:29097150|PMID:41034487
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312370	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ADCY9 mRNA	PMID:29275510
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ADCY9 gene	PMID:28505145
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ADCY9 mRNA; [bisphenol A co-treated with Estradiol] results in increased expression of ADCY9 mRNA	PMID:26496021|PMID:36041667
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312370	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of ADCY9 mRNA	PMID:24752500
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ADCY9 mRNA	PMID:39298647
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312370	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ADCY9 gene	PMID:31601247
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312371	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ADCY9 mRNA	PMID:40203079
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ADCY9 mRNA	PMID:36041667
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ADCY9 mRNA	PMID:36041667
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ADCY9 mRNA	PMID:28392331
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312371	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ADCY9 intron	PMID:28392331
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ADCY9 mRNA	PMID:17452286
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34682	diazinon	decreases methylation	ISO	RGD:1312370	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of ADCY9 gene	PMID:22964155
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ADCY9 mRNA	PMID:21266533
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ADCY9 mRNA	PMID:34813904
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ADCY9 mRNA	PMID:32680482
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312370	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADCY9 mRNA	PMID:37042841
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20251104	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADCY9 mRNA	PMID:38382403
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20260203	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ADCY9 mRNA	PMID:40334771
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20260203	CTD	MESH:C023036	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] affects the expression of ADCY9 mRNA	PMID:40334771
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312370	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ADCY9 mRNA	PMID:24449571
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20251104	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of ADCY9 mRNA]	PMID:29656123
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:3764	clotrimazole	decreases activity	ISO	RGD:1312370	E	RGD:6480464	20201103	CTD	MESH:D003022	Clotrimazole results in decreased activity of ADCY9 protein	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:3764	clotrimazole	decreases activity	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D003022	Clotrimazole results in decreased activity of ADCY9 protein	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312371	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADCY9 mRNA	PMID:40194260
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312370	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ADCY9 mRNA	PMID:28302478
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312371	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ADCY9 mRNA	PMID:39529242
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ADCY9 mRNA	PMID:40334771
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20260203	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] affects the expression of ADCY9 mRNA	PMID:40334771
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ADCY9 mRNA	PMID:36331819
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20130312	CTD	MESH:D003474	Curcumin results in decreased expression of ADCY9 mRNA	PMID:15713895
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312370	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ADCY9 mRNA	PMID:25979313
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:D014635	Valproic Acid affects the expression of ADCY9 mRNA	PMID:17292431
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADCY9 mRNA	PMID:29427782
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312370	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ADCY9 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA	PMID:27188386
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of ADCY9 mRNA	PMID:38685447
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ADCY9 mRNA	PMID:41580965
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ADCY9 mRNA	PMID:20106945|PMID:25562108
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20130312	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of ADCY9 mRNA]	PMID:21233418
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:4469	(S)-amphetamine	increases expression	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:D003913	Dextroamphetamine results in increased expression of ADCY9 mRNA	PMID:12558987
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312370	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ADCY9 mRNA	PMID:24935251|PMID:26272509
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA	PMID:27188386
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:D000082	Acetaminophen affects the expression of ADCY9 mRNA	PMID:17562736
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20130312	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADCY9 mRNA	PMID:21420995
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20130312	CTD	MESH:D005472	Fluorouracil results in decreased expression of ADCY9 mRNA	PMID:19219653
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312370	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADCY9 gene	PMID:25304211
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADCY9 mRNA	PMID:39836092
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312370	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of ADCY9 mRNA	PMID:24752500
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of ADCY9 mRNA	PMID:26934552
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:4754	econazole	increases activity	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D004464	Econazole results in increased activity of ADCY9 protein	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ADCY9 mRNA	PMID:35436446
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADCY9 mRNA	PMID:29097150
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADCY9 mRNA	PMID:17942748
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADCY9 mRNA	PMID:17942748
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ADCY9 mRNA	PMID:15761015
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADCY9 mRNA; Nanotubes, Carbon results in decreased expression of ADCY9 mRNA	PMID:25554681|PMID:25620056
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:51081	nitrates	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in increased expression of ADCY9 mRNA	PMID:30022042
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ADCY9 mRNA	PMID:24136188
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of ADCY9 mRNA	PMID:19042947
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:61057	tacrolimus hydrate	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20201103	CTD	MESH:D016559	Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]]	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D007649	Ketamine results in increased expression of ADCY9 mRNA	PMID:20080153
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312370	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ADCY9 mRNA	PMID:28988120
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312370	E	RGD:6480464	20130312	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ADCY9 mRNA	PMID:15336504
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20201103	CTD	MESH:D007545	[Isoproterenol co-treated with Miconazole] results in increased activity of ADCY9 protein alternative form	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:65585	carnosic acid	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20240430	CTD	MESH:C018381	salvin inhibits the reaction [sodium arsenite results in decreased expression of ADCY9 mRNA]	PMID:35202923
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ADCY9 gene	PMID:35440735
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:6923	miconazole	increases activity	ISO	RGD:1312370	E	RGD:6480464	20201103	CTD	MESH:D008825	Miconazole results in increased activity of ADCY9 protein; Miconazole results in increased activity of ADCY9 protein alternative form	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:6923	miconazole	increases activity	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D008825	Miconazole results in increased activity of ADCY9 protein	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:6923	miconazole	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20201103	CTD	MESH:D008825	[Isoproterenol co-treated with Miconazole] results in increased activity of ADCY9 protein alternative form; Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]; Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]]	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:6923	miconazole	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D008825	[Colforsin co-treated with Miconazole] results in increased activity of ADCY9 protein	PMID:30607468
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:69477	cannabigerol	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20210112	CTD	MESH:C037036	cannabigerol results in decreased expression of ADCY9 mRNA	PMID:33019509
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20210112	CTD	MESH:D002185	Cannabidiol results in decreased expression of ADCY9 mRNA	PMID:33019509
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312371	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ADCY9 mRNA	PMID:22206623
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ADCY9 mRNA]	PMID:22206623
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA	PMID:27188386
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1312371	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of ADCY9 mRNA	PMID:20702594
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ADCY9 mRNA	PMID:32109520
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20130312	CTD	MESH:C045950	propiconazole results in decreased expression of ADCY9 mRNA	PMID:21278054
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADCY9 mRNA	PMID:24780913
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312370	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA	PMID:27188386
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ADCY9 mRNA	PMID:21346803
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ADCY9 mRNA	PMID:25603467
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ADCY9 mRNA	PMID:28973697
1304747	Adcy9	adenylate cyclase 9	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of ADCY9 gene	PMID:31079544
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:2299985	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of GGACT mRNA	PMID:31016361
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:2299985	E	RGD:6480464	20141111	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of GGACT mRNA	PMID:24763279
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312372	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGACT mRNA	PMID:25510870
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of GGACT mRNA	PMID:33387578
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:2299985	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GGACT mRNA	PMID:37042841
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	ISO	RGD:2299985	E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of GGACT mRNA	PMID:39245080
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of GGACT mRNA	PMID:33387578
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312372	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GGACT mRNA	PMID:36331819
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312372	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GGACT mRNA	PMID:37236586
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312372	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGACT mRNA	PMID:25510870
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312372	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGACT mRNA	PMID:25510870
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of GGACT mRNA	PMID:30779732
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of GGACT mRNA	PMID:31129395
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312372	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GGACT mRNA	PMID:27339419|PMID:31919559
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:2299985	E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of GGACT gene	PMID:25304211
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:2299985	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGACT mRNA	PMID:32525701
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312372	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GGACT mRNA	PMID:21570461
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:2299985	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GGACT mRNA	PMID:28001369
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312372	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GGACT mRNA	PMID:37682722
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:2299985	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GGACT mRNA	PMID:38568856
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:2299985	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of GGACT mRNA	PMID:29453283
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:2299985	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GGACT mRNA	PMID:32234424
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312372	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of GGACT protein	PMID:37955338
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:2299985	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of GGACT mRNA	PMID:35984750
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GGACT mRNA	PMID:34492290
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312372	E	RGD:6480464	20141111	CTD	MESH:C006253	pirinixic acid results in decreased expression of GGACT mRNA	PMID:17426115|PMID:23811191
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of GGACT mRNA	PMID:25181051
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GGACT mRNA; [bisphenol A co-treated with tributyltin] results in decreased expression of GGACT mRNA	PMID:31129395|PMID:36041667
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312372	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of GGACT mRNA	PMID:26682919
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312372	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGACT mRNA	PMID:25510870
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312372	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGACT mRNA	PMID:25510870
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312372	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GGACT mRNA	PMID:39298647
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GGACT mRNA	PMID:36041667
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GGACT mRNA	PMID:36041667
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:2299985	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GGACT mRNA	PMID:28628672
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:2299985	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GGACT mRNA	PMID:28628672
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:2299985	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GGACT mRNA	PMID:37042841
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312372	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GGACT mRNA	PMID:37236586
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1312372	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of GGACT mRNA	PMID:28903501
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GGACT mRNA	PMID:24386269
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312372	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GGACT mRNA	PMID:36331819
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:2299985	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GGACT mRNA	PMID:25979313
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:2299985	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of GGACT mRNA	PMID:28001369|PMID:29154799
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:2299985	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GGACT gene	PMID:29154799
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of GGACT mRNA	PMID:38685447|PMID:41580965
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312372	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of GGACT mRNA	PMID:19770486
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:2299985	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GGACT mRNA	PMID:28628672
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312372	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of GGACT mRNA	PMID:28973697
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GGACT mRNA	PMID:33387578
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:2299985	E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of GGACT gene	PMID:25304211
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:2299985	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGACT mRNA	PMID:32525701
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:2299985	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GGACT mRNA	PMID:28628672
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of GGACT mRNA	PMID:38685447|PMID:41580965
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of GGACT mRNA	PMID:20080153
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of GGACT mRNA	PMID:27840820
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312372	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GGACT mRNA	PMID:23091169
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of GGACT mRNA	PMID:36084822
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:2299985	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGACT mRNA	PMID:32525701
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312372	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of GGACT mRNA	PMID:21278054
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GGACT mRNA	PMID:24780913
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:2299985	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GGACT mRNA	PMID:29301935
1304748	Ggact	gamma-glutamylamine cyclotransferase	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of GGACT mRNA	PMID:23034163
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:10136	gingerol	increases expression	ISO	RGD:1312374	E	RGD:6480464	20170303	CTD	MESH:C007845	gingerol results in increased expression of LRP6 mRNA	PMID:26498061
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312373	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LRP6 mRNA	PMID:38218311
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of LRP6 mRNA	PMID:25152437
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of LRP6 mRNA	PMID:30071829
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of LRP6 mRNA	PMID:26251327
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of LRP6 mRNA	PMID:33167477
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312374	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of LRP6 mRNA	PMID:17064353
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312373	E	RGD:6480464	20211207	CTD	MESH:D010100	Oxygen deficiency results in increased expression of LRP6 protein	PMID:34648812
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20211207	CTD	MESH:D010100	[Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of LRP6 protein]	PMID:34648812
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of LRP6 mRNA	PMID:26079696
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of LRP6 mRNA	PMID:40945087
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:16236	ethanol	affects response to substance	ISO	RGD:1312374	E	RGD:6480464	20190910	CTD	MESH:D000431	LRP6 protein mutant form affects the susceptibility to Ethanol	PMID:30976847
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:16236	ethanol	decreases response to substance	ISO	RGD:1312373	E	RGD:6480464	20190910	CTD	MESH:D000431	LRP6 protein mutant form results in decreased susceptibility to Ethanol	PMID:30976847
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20190910	CTD	MESH:D000431	[LRP6 protein mutant form affects the susceptibility to Ethanol] which affects the expression of ALB protein; LRP6 protein affects the reaction [Ethanol results in increased activity of GPT protein]	PMID:30976847
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1312373	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of LRP6 mRNA	PMID:12414654
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LRP6 mRNA	PMID:39241906
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of LRP6 mRNA	PMID:32145629
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LRP6 mRNA	PMID:39298647
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of LRP6 gene	PMID:27618143
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312373	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRP6 mRNA	PMID:37042841
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:16827	corticosterone	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20260804	CTD	MESH:D003345	[Isoflurophate co-treated with Corticosterone] affects the methylation of LRP6	PMID:40606660
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of LRP6 mRNA	PMID:20655997
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312374	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LRP6 protein	PMID:35842051
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:17941	diisopropyl fluorophosphate	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20260804	CTD	MESH:D007531	[Isoflurophate co-treated with Corticosterone] affects the methylation of LRP6	PMID:40606660
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312373	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LRP6 mRNA	PMID:28818685
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LRP6 mRNA	PMID:36331819
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LRP6 mRNA	PMID:39836092
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of LRP6 mRNA	PMID:17103032
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of LRP6 mRNA	PMID:28522335
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP6 mRNA	PMID:39012411
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRP6 mRNA	PMID:35301059
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312373	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LRP6 gene	PMID:27153756
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312373	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LRP6 intron	PMID:30157460
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of LRP6 mRNA	PMID:30779732
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA	PMID:39836092
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of LRP6 mRNA	PMID:26272509
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA	PMID:27188386
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312373	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of LRP6 protein	PMID:35688186
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of LRP6 mRNA	PMID:31295307
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of LRP6 mRNA	PMID:31881176
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:28061	alpha-D-galactose	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20231205	CTD	MESH:D005690	[Galactose co-treated with gentiopicroside analog] results in increased expression of LRP6 protein	PMID:36878094
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312374	E	RGD:6480464	20230404	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRP6 mRNA	PMID:36222588
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRP6 mRNA	PMID:21215274|PMID:33387578
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRP6 mRNA	PMID:20106945|PMID:21632981
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRP6 mRNA	PMID:33956508
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRP6 mRNA	PMID:32109520
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312373	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRP6 mRNA	PMID:12377990
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LRP6 mRNA	PMID:28001369
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LRP6 mRNA	PMID:33212167
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:28260	galactose	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20231205	CTD	MESH:D005690	[Galactose co-treated with gentiopicroside analog] results in increased expression of LRP6 protein	PMID:36878094
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:28869	menadione	increases expression	ISO	RGD:1312373	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 results in increased expression of LRP6 mRNA	PMID:12414654
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312373	E	RGD:6480464	20220510	CTD	MESH:C017947	sodium arsenite results in increased expression of LRP6 mRNA; sodium arsenite results in increased expression of LRP6 mRNA alternative form	PMID:29216394|PMID:38568856
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312374	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of LRP6 mRNA	PMID:38906090
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:29678	sodium arsenite	increases phosphorylation	ISO	RGD:1312374	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased phosphorylation of LRP6 protein	PMID:38325618
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20220510	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA; LRP6 mRNA alternative form promotes the reaction [sodium arsenite results in decreased expression of CDH1 protein]; LRP6 mRNA alternative form promotes the reaction [sodium arsenite results in increased expression of VIM protein]; LRP6 mRNA alternative form promotes the reaction [sodium arsenite results in increased expression of ZEB1 protein]	PMID:29216394|PMID:39836092
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312373	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRP6 intron	PMID:30157460
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRP6 mRNA	PMID:20106945|PMID:21632981|PMID:32234424
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312374	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LRP6 exon; Benzo(a)pyrene results in increased methylation of LRP6 intron	PMID:27901495
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LRP6 mRNA	PMID:19150397
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of LRP6 mRNA	PMID:27188386
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:32026	Poloxamer	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D020442	Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]]	PMID:32961231
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of LRP6 mRNA	PMID:30047161
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D013853	Thioacetamide results in increased expression of LRP6 mRNA	PMID:32961231
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D013853	Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]]	PMID:32961231
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of LRP6 mRNA	PMID:30723492
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312374	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LRP6 mRNA	PMID:18301758
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LRP6 mRNA	PMID:19710929
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LRP6 mRNA	PMID:25181051|PMID:32145629
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of LRP6 mRNA	PMID:25381574|PMID:25963729
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LRP6 mRNA	PMID:33221593
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312373	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of LRP6 mRNA	PMID:29275510
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	Curcumin inhibits the reaction [bisphenol A results in decreased expression of LRP6 mRNA]	PMID:25963729
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LRP6 mRNA	PMID:39298647
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312374	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of LRP6 mRNA	PMID:40203079
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LRP6 mRNA	PMID:17602206
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312374	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LRP6 mRNA	PMID:21266533
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LRP6 mRNA	PMID:17602206
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LRP6 mRNA	PMID:39836092
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LRP6 mRNA	PMID:36928142
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LRP6 mRNA	PMID:38568856
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312374	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LRP6 mRNA	PMID:20478370
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP6 mRNA	PMID:39012411
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRP6 mRNA	PMID:35301059
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312373	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LRP6 mRNA	PMID:24449571
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRP6 mRNA	PMID:40194260
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LRP6 mRNA	PMID:36331819
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of LRP6 mRNA	PMID:23125180
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003474	Curcumin results in increased expression of LRP6 mRNA	PMID:25963729
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D003474	Curcumin inhibits the reaction [bisphenol A results in decreased expression of LRP6 mRNA]	PMID:25963729
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRP6 mRNA	PMID:23179753|PMID:27188386
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRP6 mRNA	PMID:19136453
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312373	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LRP6 gene	PMID:29154799
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of LRP6 mRNA	PMID:30047161
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LRP6 mRNA	PMID:20106945|PMID:25562108
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003907	Dexamethasone results in decreased expression of LRP6 mRNA	PMID:38971901
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of LRP6 mRNA	PMID:16595896
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312374	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of LRP6 mRNA	PMID:18502557
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of LRP6 mRNA	PMID:27188386
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20211207	CTD	MESH:D017239	[Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of LRP6 protein]	PMID:34648812
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of LRP6 mRNA	PMID:22723015|PMID:26272509
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA	PMID:27188386
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA	PMID:39836092
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1312373	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in increased expression of LRP6 mRNA	PMID:20069066
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:4887	ethosuximide	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D005013	Ethosuximide results in increased expression of LRP6 mRNA	PMID:26420483
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:4887	ethosuximide	multiple interactions	EXP		E	RGD:6480464	20160210	CTD	MESH:D005013	Ethosuximide inhibits the reaction [APP protein modified form results in decreased expression of LRP6 mRNA]	PMID:26420483
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LRP6 mRNA	PMID:29097150
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LRP6 mRNA; Nanotubes, Carbon results in decreased expression of LRP6 mRNA	PMID:25554681
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of LRP6 mRNA	PMID:30047161
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of LRP6 mRNA	PMID:24136188
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:51403	1,4-phenylenediamine	decreases phosphorylation	ISO	RGD:1312373	E	RGD:6480464	20170613	CTD	MESH:C029728	4-phenylenediamine results in decreased phosphorylation of LRP6 protein	PMID:26784575
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:5321	Gentiopicrin	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20231205	CTD	MESH:C012997	[Galactose co-treated with gentiopicroside analog] results in increased expression of LRP6 protein	PMID:36878094
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:53515	pluronic P-123	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D020442	Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]]	PMID:32961231
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LRP6 mRNA	PMID:39836092
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of LRP6 mRNA	PMID:24136188
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312373	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of LRP6 mRNA	PMID:12414654
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of LRP6 mRNA	PMID:30467583
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LRP6 gene	PMID:35440735
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312374	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of LRP6 mRNA	PMID:22206623
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of LRP6 mRNA	PMID:24136188
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide analog results in decreased expression of LRP6 protein; Niclosamide results in decreased expression of LRP6 protein	PMID:28284560
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:7553	niclosamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D009534	Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]]	PMID:32961231
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:7553	niclosamide	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of and results in decreased phosphorylation of LRP6 protein	PMID:24552774|PMID:24736023
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA	PMID:27188386
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312374	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of LRP6 mRNA	PMID:23091169
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of LRP6 mRNA	PMID:32109520
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of LRP6 mRNA	PMID:30047161
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312373	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA	PMID:27188386
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:9150	simvastatin	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D019821	Simvastatin results in decreased expression of LRP6 mRNA	PMID:25055962
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312373	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of LRP6 mRNA	PMID:27188386
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of LRP6 mRNA	PMID:28973697
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:9763	trovafloxacin	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in increased expression of LRP6 mRNA	PMID:24136188
1304749	Lrp6	LDL receptor related protein 6	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of LRP6 mRNA	PMID:19015723
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1604352	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of VPS50 protein]	PMID:38195004
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312377	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of VPS50 mRNA	PMID:30319688
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604352	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of VPS50 mRNA	PMID:37042841
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1604352	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of VPS50 protein	PMID:37730182
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312377	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VPS50 mRNA	PMID:37236586
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1604352	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of VPS50 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of VPS50 protein	PMID:38195004
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1604352	E	RGD:6480464	20161115	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of VPS50 gene	PMID:27153756
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604352	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of VPS50 mRNA	PMID:23649840
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312377	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of VPS50 mRNA	PMID:25629700
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312377	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VPS50 mRNA	PMID:22206623
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1604352	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of VPS50 protein	PMID:35688186
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604352	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of VPS50 mRNA	PMID:23557933
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312377	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VPS50 mRNA	PMID:21570461|PMID:24680724
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VPS50 mRNA	PMID:21215274
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of VPS50 mRNA	PMID:33212167
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of VPS50 mRNA	PMID:30851411
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1604352	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of VPS50 mRNA	PMID:32763439
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1604352	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of VPS50 protein	PMID:35688186
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of VPS50 mRNA	PMID:39719251
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of VPS50 mRNA	PMID:22316170
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of VPS50 mRNA	PMID:19150397
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D005897	Glafenine results in decreased expression of VPS50 mRNA	PMID:24136188
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of VPS50 mRNA	PMID:25729387
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1312377	E	RGD:6480464	20160119	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of VPS50 gene	PMID:23968726
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of VPS50 mRNA	PMID:25181051
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:C006780	bisphenol A results in increased methylation of VPS50 gene	PMID:28505145
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1604352	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of VPS50 protein	PMID:34186270
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1604352	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of VPS50 protein	PMID:34186270
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312377	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of VPS50 mRNA	PMID:37019170
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312377	E	RGD:6480464	20160119	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of VPS50 gene	PMID:23968726
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604352	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VPS50 mRNA	PMID:37042841
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1312377	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride affects the expression of VPS50 mRNA	PMID:16842966
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1604352	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of VPS50 mRNA	PMID:38174414
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312377	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VPS50 mRNA	PMID:37236586
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1604352	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of VPS50 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of VPS50 protein	PMID:38195004
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1604352	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of VPS50 mRNA	PMID:24449571
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20180410	CTD	MESH:C000944	dicrotophos results in decreased expression of VPS50 mRNA	PMID:28302478
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of VPS50 mRNA	PMID:31533062
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20161115	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of VPS50 mRNA	PMID:27153767
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of VPS50 mRNA	PMID:24935251
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604352	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of VPS50 mRNA	PMID:28001369
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20161115	CTD	MESH:C012589	trichostatin A results in decreased expression of VPS50 mRNA	PMID:24935251|PMID:26272509
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1604352	E	RGD:6480464	20161115	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VPS50 mRNA	PMID:27188386
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of VPS50 mRNA	PMID:33387578
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of VPS50 mRNA	PMID:21420995
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312377	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of VPS50 mRNA	PMID:29279043
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1604352	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VPS50 mRNA	PMID:22079256
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D005485	Flutamide results in increased expression of VPS50 mRNA	PMID:24136188
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1604352	E	RGD:6480464	20161115	CTD	MESH:C001277	geldanamycin results in increased expression of VPS50 mRNA	PMID:26705709
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of VPS50 protein	PMID:23718831
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312377	E	RGD:6480464	20160119	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VPS50 mRNA	PMID:21641980
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20161115	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of VPS50 mRNA	PMID:25729387
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of VPS50 gene	PMID:35440735
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312377	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of VPS50 mRNA	PMID:22206623
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312377	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VPS50 mRNA	PMID:22206623
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of VPS50 mRNA	PMID:22079256
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1604352	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VPS50 mRNA	PMID:22079256
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1604352	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of VPS50 protein	PMID:31285264
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20190702	CTD	MESH:C025589	ochratoxin A results in decreased expression of VPS50 mRNA	PMID:30559759
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1604352	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of VPS50 mRNA	PMID:30851411
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604352	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VPS50 mRNA	PMID:27188386
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of VPS50 protein	PMID:28903499
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of VPS50 mRNA	PMID:36843608
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604352	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VPS50 mRNA	PMID:27188386
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:9130	sevoflurane	decreases expression	ISO	RGD:1312377	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased expression of VPS50 protein	PMID:35249202
1304751	Vps50	VPS50 subunit of EARP/GARPII complex	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of VPS50 mRNA	PMID:19281266
1304753	Pcdh17	protocadherin 17	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312379	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PCDH17 mRNA	PMID:27188386
1304753	Pcdh17	protocadherin 17	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1617378	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PCDH17 mRNA	PMID:33045310
1304753	Pcdh17	protocadherin 17	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PCDH17 mRNA	PMID:30071829
1304753	Pcdh17	protocadherin 17	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1312379	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of PCDH17 mRNA	PMID:11906190
1304753	Pcdh17	protocadherin 17	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312379	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PCDH17 mRNA	PMID:21934132|PMID:23724009
1304753	Pcdh17	protocadherin 17	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1617378	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PCDH17 mRNA	PMID:30319688
1304753	Pcdh17	protocadherin 17	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1617378	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PCDH17 mRNA	PMID:30319688
1304753	Pcdh17	protocadherin 17	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312379	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PCDH17 mRNA	PMID:35811015
1304753	Pcdh17	protocadherin 17	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312379	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDH17 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PCDH17 mRNA	PMID:35811015
1304753	Pcdh17	protocadherin 17	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PCDH17 mRNA	PMID:32741896
1304753	Pcdh17	protocadherin 17	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PCDH17 mRNA	PMID:33387578
1304753	Pcdh17	protocadherin 17	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of PCDH17 mRNA	PMID:33448797
1304753	Pcdh17	protocadherin 17	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH17 mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA]	PMID:33448797|PMID:37992649
1304753	Pcdh17	protocadherin 17	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PCDH17 mRNA	PMID:32741896
1304753	Pcdh17	protocadherin 17	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of PCDH17 mRNA	PMID:33448797
1304753	Pcdh17	protocadherin 17	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH17 mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA]	PMID:33448797|PMID:37992649
1304753	Pcdh17	protocadherin 17	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PCDH17 mRNA	PMID:33387578
1304753	Pcdh17	protocadherin 17	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of PCDH17 mRNA	PMID:27462272
1304753	Pcdh17	protocadherin 17	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312379	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDH17 gene	PMID:27153756
1304753	Pcdh17	protocadherin 17	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PCDH17 mRNA	PMID:23630614
1304753	Pcdh17	protocadherin 17	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PCDH17 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PCDH17 mRNA	PMID:34911549
1304753	Pcdh17	protocadherin 17	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of PCDH17 mRNA	PMID:19654921
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1617378	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of PCDH17 mRNA	PMID:32186404
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1617378	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PCDH17 mRNA	PMID:21570461
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDH17 mRNA	PMID:32109520
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PCDH17 mRNA	PMID:33387578
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312379	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of PCDH17 mRNA	PMID:29955902
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312379	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PCDH17 mRNA	PMID:28001369
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PCDH17 mRNA	PMID:28959563
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PCDH17 mRNA	PMID:26033743
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PCDH17 mRNA	PMID:27862939
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312379	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDH17 mRNA	PMID:29803840
1304753	Pcdh17	protocadherin 17	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH17 mRNA	PMID:37992649
1304753	Pcdh17	protocadherin 17	gene	CHEBI:2896	astemizole	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016589	Astemizole results in decreased expression of PCDH17 mRNA	PMID:20221588
1304753	Pcdh17	protocadherin 17	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312379	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PCDH17 gene	PMID:28589171
1304753	Pcdh17	protocadherin 17	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PCDH17 mRNA	PMID:37682722
1304753	Pcdh17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312379	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDH17 promoter	PMID:27901495
1304753	Pcdh17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PCDH17 mRNA	PMID:21569818|PMID:22228805
1304753	Pcdh17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312379	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PCDH17 exon	PMID:27901495
1304753	Pcdh17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617378	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PCDH17 mRNA	PMID:21964900|PMID:22610609|PMID:32417428
1304753	Pcdh17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312379	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDH17 5' UTR	PMID:27901495
1304753	Pcdh17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA	PMID:27858113
1304753	Pcdh17	protocadherin 17	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312379	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of PCDH17 promoter	PMID:23974009
1304753	Pcdh17	protocadherin 17	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PCDH17 mRNA	PMID:26033743
1304753	Pcdh17	protocadherin 17	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312379	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCDH17 protein]	PMID:26598702
1304753	Pcdh17	protocadherin 17	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1312379	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of PCDH17 gene	PMID:31601247
1304753	Pcdh17	protocadherin 17	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of PCDH17 mRNA	PMID:30047161
1304753	Pcdh17	protocadherin 17	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617378	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PCDH17 gene	PMID:35295148
1304753	Pcdh17	protocadherin 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312379	E	RGD:6480464	20120918	CTD	MESH:C009495	titanium dioxide results in increased expression of PCDH17 mRNA	PMID:19695317
1304753	Pcdh17	protocadherin 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1617378	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of PCDH17 mRNA	PMID:23557971
1304753	Pcdh17	protocadherin 17	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1617378	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PCDH17 promoter	PMID:35295148
1304753	Pcdh17	protocadherin 17	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1617378	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PCDH17 mRNA	PMID:18301758|PMID:23811191
1304753	Pcdh17	protocadherin 17	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of PCDH17 mRNA	PMID:19167457
1304753	Pcdh17	protocadherin 17	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PCDH17 mRNA	PMID:25181051
1304753	Pcdh17	protocadherin 17	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH17 mRNA	PMID:30816183
1304753	Pcdh17	protocadherin 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH17 mRNA	PMID:26063408
1304753	Pcdh17	protocadherin 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1617378	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of PCDH17 mRNA	PMID:35479511|PMID:35598803
1304753	Pcdh17	protocadherin 17	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1617378	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PCDH17 mRNA	PMID:26377693
1304753	Pcdh17	protocadherin 17	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA	PMID:27858113
1304753	Pcdh17	protocadherin 17	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1617378	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PCDH17 mRNA	PMID:38685157
1304753	Pcdh17	protocadherin 17	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1617378	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PCDH17 mRNA	PMID:24535843
1304753	Pcdh17	protocadherin 17	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PCDH17 mRNA	PMID:24535843
1304753	Pcdh17	protocadherin 17	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1617378	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PCDH17 mRNA	PMID:26377693
1304753	Pcdh17	protocadherin 17	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PCDH17 mRNA	PMID:30723492
1304753	Pcdh17	protocadherin 17	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PCDH17 mRNA	PMID:25993096
1304753	Pcdh17	protocadherin 17	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312379	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PCDH17 mRNA	PMID:24449571
1304753	Pcdh17	protocadherin 17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PCDH17 mRNA	PMID:36331819
1304753	Pcdh17	protocadherin 17	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of PCDH17 mRNA	PMID:23125180
1304753	Pcdh17	protocadherin 17	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312379	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCDH17 mRNA	PMID:25979313
1304753	Pcdh17	protocadherin 17	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PCDH17 mRNA	PMID:29427782
1304753	Pcdh17	protocadherin 17	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312379	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDH17 mRNA	PMID:24383497
1304753	Pcdh17	protocadherin 17	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312379	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PCDH17 mRNA	PMID:19101580|PMID:23179753|PMID:28001369
1304753	Pcdh17	protocadherin 17	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PCDH17 mRNA	PMID:30047161
1304753	Pcdh17	protocadherin 17	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of PCDH17 mRNA	PMID:33448797
1304753	Pcdh17	protocadherin 17	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH17 mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA]	PMID:33448797|PMID:37992649
1304753	Pcdh17	protocadherin 17	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312379	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of PCDH17 mRNA	PMID:24935251
1304753	Pcdh17	protocadherin 17	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312379	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PCDH17 mRNA	PMID:24935251
1304753	Pcdh17	protocadherin 17	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1617378	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PCDH17 mRNA	PMID:17562736
1304753	Pcdh17	protocadherin 17	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PCDH17 mRNA	PMID:33387578
1304753	Pcdh17	protocadherin 17	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312379	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of PCDH17 mRNA	PMID:24714768
1304753	Pcdh17	protocadherin 17	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1312379	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of PCDH17 mRNA	PMID:35811015
1304753	Pcdh17	protocadherin 17	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312379	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDH17 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PCDH17 mRNA	PMID:35811015
1304753	Pcdh17	protocadherin 17	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of PCDH17 mRNA	PMID:19654921
1304753	Pcdh17	protocadherin 17	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PCDH17 mRNA	PMID:29097150
1304753	Pcdh17	protocadherin 17	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1312379	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PCDH17 mRNA	PMID:26272509
1304753	Pcdh17	protocadherin 17	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312379	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA	PMID:27188386
1304753	Pcdh17	protocadherin 17	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312379	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCDH17 protein]	PMID:26598702
1304753	Pcdh17	protocadherin 17	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of PCDH17 mRNA	PMID:25554681|PMID:25620056
1304753	Pcdh17	protocadherin 17	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1617378	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PCDH17 mRNA	PMID:25554681
1304753	Pcdh17	protocadherin 17	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of PCDH17 mRNA	PMID:30047161
1304753	Pcdh17	protocadherin 17	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA	PMID:27858113
1304753	Pcdh17	protocadherin 17	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA	PMID:27858113
1304753	Pcdh17	protocadherin 17	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA]	PMID:33448797
1304753	Pcdh17	protocadherin 17	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of PCDH17 mRNA	PMID:19042947
1304753	Pcdh17	protocadherin 17	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312379	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of PCDH17 mRNA	PMID:31629900
1304753	Pcdh17	protocadherin 17	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312379	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PCDH17 mRNA	PMID:24810058
1304753	Pcdh17	protocadherin 17	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PCDH17 mRNA	PMID:28801915
1304753	Pcdh17	protocadherin 17	gene	CHEBI:6716	medroxyprogesterone acetate	decreases expression	ISO	RGD:1312379	E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in decreased expression of PCDH17 mRNA	PMID:20843944
1304753	Pcdh17	protocadherin 17	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of PCDH17 mRNA	PMID:27462272
1304753	Pcdh17	protocadherin 17	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312379	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PCDH17 mRNA	PMID:31758290
1304753	Pcdh17	protocadherin 17	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PCDH17 mRNA	PMID:22206623
1304753	Pcdh17	protocadherin 17	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312379	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PCDH17 mRNA	PMID:22714537
1304753	Pcdh17	protocadherin 17	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PCDH17 mRNA	PMID:32741896
1304753	Pcdh17	protocadherin 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312379	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA	PMID:27188386
1304753	Pcdh17	protocadherin 17	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PCDH17 mRNA	PMID:24535843
1304753	Pcdh17	protocadherin 17	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PCDH17 mRNA	PMID:32109520
1304753	Pcdh17	protocadherin 17	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1617378	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PCDH17 mRNA	PMID:38648751
1304753	Pcdh17	protocadherin 17	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PCDH17 mRNA	PMID:21394737
1304753	Pcdh17	protocadherin 17	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of PCDH17 mRNA	PMID:23640034
1304753	Pcdh17	protocadherin 17	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of PCDH17 mRNA	PMID:30047161
1304753	Pcdh17	protocadherin 17	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PCDH17 mRNA	PMID:24780913|PMID:30047161
1304753	Pcdh17	protocadherin 17	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312379	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA	PMID:27188386
1304753	Pcdh17	protocadherin 17	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1312379	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of PCDH17 mRNA	PMID:11906190
1304753	Pcdh17	protocadherin 17	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1312379	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of PCDH17 mRNA	PMID:17440010
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1312380	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of HCLS1 mRNA	PMID:15928584
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312380	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of HCLS1 mRNA	PMID:33167477
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312380	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HCLS1 mRNA	PMID:26079696
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312381	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of HCLS1 mRNA	PMID:30319688
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312380	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of HCLS1 mRNA	PMID:21632981
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of HCLS1 mRNA	PMID:39298647
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HCLS1 mRNA	PMID:33387578
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312380	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of HCLS1 mRNA	PMID:21540246
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HCLS1 mRNA	PMID:37992649
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HCLS1 mRNA	PMID:37992649
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of HCLS1 mRNA	PMID:27523638
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1312380	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Clozapine] results in decreased expression of HCLS1 protein	PMID:34122009
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of HCLS1 mRNA	PMID:22061828
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312380	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of HCLS1 gene	PMID:27153756
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312380	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of HCLS1 mRNA	PMID:25102026
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312380	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of HCLS1 mRNA	PMID:35430440
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of HCLS1 mRNA	PMID:34911549
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	ISO	RGD:1312380	E	RGD:6480464	20120412	CTD	MESH:D014747	HCLS1 protein affects the susceptibility to Vinblastine	PMID:16217747
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HCLS1 mRNA	PMID:25629700
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1312380	E	RGD:6480464	20120412	CTD	MESH:D016685	HCLS1 protein affects the susceptibility to Mitomycin	PMID:16217747
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HCLS1 mRNA	PMID:40504410
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HCLS1 mRNA	PMID:31881176
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312380	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of HCLS1 mRNA	PMID:23557933
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312380	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of HCLS1 mRNA	PMID:19921347
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312380	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of HCLS1 mRNA	PMID:25583101
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HCLS1 mRNA	PMID:34747641
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312381	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HCLS1 mRNA	PMID:21570461
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312380	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HCLS1 mRNA	PMID:33212167
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1312380	E	RGD:6480464	20120412	CTD	MESH:D004317	HCLS1 protein affects the susceptibility to Doxorubicin	PMID:16217747
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HCLS1 mRNA	PMID:37992649
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312380	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of HCLS1 mRNA	PMID:34032870
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312380	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HCLS1 mRNA	PMID:22714537|PMID:38568856
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HCLS1 mRNA	PMID:34876320|PMID:40504410
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA	PMID:34876320
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312380	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HCLS1 exon; Benzo(a)pyrene affects the methylation of HCLS1 promoter	PMID:27901495
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312381	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HCLS1 mRNA	PMID:22228805
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to HCLS1 promoter]	PMID:19654925
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312380	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HCLS1 mRNA	PMID:26705709
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1312381	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in increased expression of HCLS1 mRNA	PMID:30825431
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA]	PMID:30825431
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1312380	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of HCLS1 mRNA	PMID:37690743
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312381	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of HCLS1 mRNA	PMID:23557971
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HCLS1 mRNA	PMID:34492290
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312381	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of HCLS1 promoter	PMID:27334623
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HCLS1 mRNA	PMID:25181051
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HCLS1 gene	PMID:28505145
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HCLS1 mRNA	PMID:39298647
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312381	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of HCLS1 mRNA	PMID:38685157
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312381	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of HCLS1 mRNA	PMID:28392331
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of HCLS1 protein	PMID:35362542
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of HCLS1 protein]	PMID:35362542
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312380	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HCLS1 mRNA	PMID:37042841
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of HCLS1 mRNA	PMID:35163327
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312380	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HCLS1 mRNA	PMID:25851441
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312380	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of HCLS1 mRNA	PMID:24449571
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:3766	clozapine	multiple interactions	ISO	RGD:1312380	E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in decreased expression of HCLS1 protein	PMID:34122009
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of HCLS1 mRNA	PMID:23125180
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312381	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of HCLS1 mRNA	PMID:17292431
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HCLS1 mRNA	PMID:37992649
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:4469	(S)-amphetamine	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20120412	CTD	MESH:D003913	Dextroamphetamine results in decreased expression of HCLS1 mRNA	PMID:12558987
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312381	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HCLS1 mRNA	PMID:17562736
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312380	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of HCLS1 mRNA	PMID:26690555
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HCLS1 mRNA	PMID:40504410
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA	PMID:34876320
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of HCLS1 protein]	PMID:35362542
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312380	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HCLS1 mRNA	PMID:26705709
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312381	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of HCLS1 mRNA; Nanotubes, Carbon results in increased expression of HCLS1 mRNA	PMID:25554681
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312381	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of HCLS1 mRNA	PMID:40234311
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of HCLS1 mRNA	PMID:35964746
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of HCLS1 mRNA	PMID:24136188
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312381	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of HCLS1 mRNA	PMID:38701926
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1312380	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of HCLS1 mRNA	PMID:20436886
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of HCLS1 mRNA	PMID:35283115
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA]	PMID:30825431
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312380	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of HCLS1 mRNA	PMID:31758290
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:72754	bisphenol AF	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in decreased expression of HCLS1 mRNA	PMID:39938710
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312381	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of HCLS1 mRNA	PMID:22206623
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:748998	lenabasum	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260714	CTD	MESH:C471849	lenabasum inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA]	PMID:30825431
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312380	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of HCLS1 mRNA	PMID:22714537
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA	PMID:34876320
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of HCLS1 mRNA	PMID:40826991
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1312380	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of HCLS1 mRNA	PMID:31734321
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of HCLS1 mRNA	PMID:19281266
1304754	Hcls1	hematopoietic cell specific Lyn substrate 1	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1312380	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of HCLS1 mRNA	PMID:17440010
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312382	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PHLDA2 mRNA	PMID:38218311
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312382	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PHLDA2 mRNA	PMID:26272509
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312383	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PHLDA2 mRNA	PMID:33045310
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	ISO	RGD:1312382	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of PHLDA2 mRNA	PMID:19524605
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:144400	dinophysistoxin 1	increases expression	ISO	RGD:1312382	E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of PHLDA2 mRNA	PMID:28939011
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of PHLDA2 mRNA	PMID:23830798
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of PHLDA2 mRNA	PMID:16788091
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PHLDA2 mRNA	PMID:36189433
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PHLDA2 mRNA	PMID:36331819
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312382	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PHLDA2 mRNA	PMID:26079696
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312382	E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PHLDA2 mRNA	PMID:20044591|PMID:23410634
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312382	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PHLDA2 mRNA	PMID:21632981
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D011794	[Quercetin co-treated with Ascorbic Acid] results in increased expression of PHLDA2 mRNA	PMID:17639512
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312382	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of PHLDA2 mRNA	PMID:22574217
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312382	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PHLDA2 mRNA	PMID:23019147|PMID:31614463
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PHLDA2 mRNA	PMID:30165855
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PHLDA2 mRNA	PMID:33387578
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312382	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PHLDA2 mRNA	PMID:23649840
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of PHLDA2 mRNA	PMID:18037150
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PHLDA2 mRNA	PMID:36189433
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312382	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of PHLDA2 mRNA	PMID:33647349
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312382	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PHLDA2 mRNA	PMID:31163220
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312382	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PHLDA2 protein	PMID:37730182
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PHLDA2 mRNA	PMID:36139627
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312382	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PHLDA2 mRNA	PMID:28818685
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PHLDA2 mRNA	PMID:36331819
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:2208	purine-6-thiol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of PHLDA2 mRNA	PMID:23358152
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PHLDA2 mRNA	PMID:35770551
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312382	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PHLDA2 mRNA	PMID:19549813
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PHLDA2 protein	PMID:20106945
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312382	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PHLDA2 mRNA	PMID:21641981|PMID:22100608|PMID:27153756|PMID:32234424
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of PHLDA2 mRNA	PMID:15674844
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of PHLDA2 mRNA	PMID:31626304
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PHLDA2 mRNA	PMID:34911549
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PHLDA2 mRNA	PMID:18593933
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312383	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PHLDA2 mRNA	PMID:31919559
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PHLDA2 mRNA	PMID:21867686
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312382	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PHLDA2 mRNA	PMID:26272509
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PHLDA2 mRNA	PMID:28960355
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PHLDA2 mRNA	PMID:31881176
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PHLDA2 mRNA	PMID:23557933
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:27899	cisplatin	increases response to substance	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D002945	PHLDA2 results in increased susceptibility to Cisplatin	PMID:22021909
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the reaction [Piroxicam results in decreased expression of PHLDA2 mRNA]	PMID:21858171
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312382	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of PHLDA2 mRNA	PMID:15256057|PMID:23019147
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHLDA2 mRNA	PMID:33387578
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312382	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHLDA2 mRNA	PMID:26238291
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of PHLDA2 mRNA	PMID:29704546
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHLDA2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PHLDA2 mRNA	PMID:17942748|PMID:25975270
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312382	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PHLDA2 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312382	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PHLDA2 mRNA	PMID:33212167
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1312382	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of PHLDA2 mRNA	PMID:26272509
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of PHLDA2 mRNA	PMID:24690739
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHLDA2 mRNA	PMID:29803840
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312382	E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of PHLDA2 mRNA	PMID:20044591|PMID:23410634
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D001205	[Quercetin co-treated with Ascorbic Acid] results in increased expression of PHLDA2 mRNA	PMID:17639512
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1312382	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of PHLDA2 mRNA	PMID:22623647
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312382	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of PHLDA2 mRNA	PMID:34032870
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of PHLDA2 mRNA	PMID:36209798|PMID:37682722
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312382	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PHLDA2 mRNA	PMID:21281968|PMID:38568856
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312382	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHLDA2 mRNA	PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:26238291|PMID:32234424
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312382	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PHLDA2 3' UTR; Benzo(a)pyrene results in increased methylation of PHLDA2 promoter	PMID:27901495
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of PHLDA2 mRNA	PMID:24690739
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PHLDA2 mRNA	PMID:18593933
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312382	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PHLDA2 mRNA	PMID:25895662
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312382	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PHLDA2 mRNA	PMID:19150397|PMID:26238291
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PHLDA2 mRNA	PMID:15761015
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1312382	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of PHLDA2 mRNA	PMID:35984750
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312382	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of PHLDA2 mRNA	PMID:38568856
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PHLDA2 mRNA	PMID:30047161
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PHLDA2 mRNA	PMID:29264374
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312383	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHLDA2 gene; titanium dioxide results in decreased methylation of PHLDA2 promoter	PMID:35295148
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PHLDA2 mRNA	PMID:23411599|PMID:34492290
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PHLDA2 mRNA	PMID:18648102
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312383	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PHLDA2 mRNA	PMID:28472532
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PHLDA2 mRNA	PMID:25181051
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312382	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PHLDA2 mRNA	PMID:30903817
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of PHLDA2 mRNA	PMID:26063408
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA	PMID:28628672
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312382	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PHLDA2 mRNA	PMID:25979313
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312383	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PHLDA2 mRNA	PMID:30951980
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312383	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PHLDA2 mRNA	PMID:30951980
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PHLDA2 mRNA	PMID:37019170
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312382	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of PHLDA2 gene	PMID:22964155
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA	PMID:28628672
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PHLDA2 mRNA	PMID:21527772
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PHLDA2 mRNA	PMID:24535843
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:C022838	nickel chloride results in increased expression of PHLDA2 mRNA	PMID:17547211
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of PHLDA2 mRNA	PMID:32680482
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312382	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PHLDA2 mRNA	PMID:38174414|PMID:38568856
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PHLDA2 mRNA	PMID:35770551
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of PHLDA2 mRNA	PMID:25539665|PMID:26194646
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PHLDA2 mRNA	PMID:19320972
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312382	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PHLDA2 mRNA	PMID:19376846
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of PHLDA2 mRNA	PMID:17547211
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PHLDA2 mRNA	PMID:24449571
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA	PMID:19167446
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PHLDA2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PHLDA2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PHLDA2 mRNA	PMID:36331819
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312382	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHLDA2 mRNA	PMID:25979313
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312382	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PHLDA2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312382	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PHLDA2 gene	PMID:29154799
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PHLDA2 mRNA	PMID:30047161
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of PHLDA2 mRNA	PMID:17403535
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312382	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PHLDA2 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA	PMID:28628672
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312382	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PHLDA2 mRNA	PMID:38832940
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312382	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PHLDA2 mRNA	PMID:26272509
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312382	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PHLDA2 mRNA	PMID:24935251|PMID:26272509
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PHLDA2 mRNA	PMID:17562736
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHLDA2 mRNA	PMID:26690555
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PHLDA2 mRNA	PMID:33387578
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312382	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of PHLDA2 mRNA	PMID:29067470
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of PHLDA2 mRNA	PMID:24690739
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:47898	4'-epidoxorubicin	increases response to substance	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D015251	PHLDA2 results in increased susceptibility to Epirubicin	PMID:22021909
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PHLDA2 mRNA	PMID:22079256
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHLDA2 mRNA	PMID:17942748
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1312382	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of PHLDA2 mRNA	PMID:38568856
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1312382	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PHLDA2 mRNA	PMID:26272509
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA	PMID:28628672
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:49668	gefitinib	affects response to substance	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:C419708	PHLDA2 protein affects the susceptibility to gefitinib	PMID:15496427
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PHLDA2 mRNA	PMID:15761015
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312382	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of PHLDA2 mRNA	PMID:21856257
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20181113	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of PHLDA2 mRNA	PMID:29906516
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:50667	mercaptopurine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of PHLDA2 mRNA	PMID:23358152
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PHLDA2 mRNA	PMID:30047161
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312382	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PHLDA2 protein	PMID:23718831
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312382	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of PHLDA2 mRNA	PMID:31629900
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of PHLDA2 mRNA	PMID:38701926
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of PHLDA2 mRNA	PMID:20436886
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1312382	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of PHLDA2 mRNA	PMID:26272509
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of PHLDA2 mRNA	PMID:25729387
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PHLDA2 mRNA	PMID:24136188
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	ISO	RGD:1312382	E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of PHLDA2 mRNA	PMID:23410634
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PHLDA2 mRNA	PMID:15336504
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in decreased expression of PHLDA2 mRNA	PMID:16982809
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312382	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PHLDA2 mRNA	PMID:31758290
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312383	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PHLDA2 mRNA	PMID:22206623
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312382	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PHLDA2 mRNA	PMID:22079256
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PHLDA2 mRNA	PMID:22079256
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312382	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PHLDA2 mRNA	PMID:37199045
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312382	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of PHLDA2 protein	PMID:31285264
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PHLDA2 mRNA	PMID:36139627
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of PHLDA2 mRNA	PMID:23665939
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1312383	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of PHLDA2 mRNA	PMID:26655953
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1312382	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of PHLDA2 mRNA	PMID:20185912
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PHLDA2 mRNA	PMID:19482888
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PHLDA2 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PHLDA2 mRNA]	PMID:19482888|PMID:24535843
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA	PMID:19167446
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1312382	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of PHLDA2 mRNA	PMID:32234424
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of PHLDA2 mRNA	PMID:21858171
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin affects the reaction [Piroxicam results in decreased expression of PHLDA2 mRNA]	PMID:21858171
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312382	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PHLDA2 mRNA	PMID:26079696
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PHLDA2 mRNA	PMID:24780913|PMID:25825206|PMID:30047161
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312382	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PHLDA2 mRNA	PMID:26272509
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312382	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of PHLDA2 mRNA	PMID:24921660
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312382	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PHLDA2 mRNA	PMID:19281266
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PHLDA2 mRNA	PMID:21346803
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of PHLDA2 mRNA	PMID:23358152
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312382	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PHLDA2 mRNA	PMID:38568856
1304755	Phlda2	pleckstrin homology-like domain, family A, member 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312382	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of PHLDA2 mRNA	PMID:19140230
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of FANK1 mRNA	PMID:26272509
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312384	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312384	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of FANK1 mRNA	PMID:23724009
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FANK1 mRNA	PMID:26079696
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312385	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FANK1 mRNA	PMID:30319688
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312384	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FANK1 mRNA	PMID:35811015
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312384	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of FANK1 mRNA	PMID:30510588
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of FANK1 mRNA	PMID:33387578
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312385	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FANK1 mRNA	PMID:34319233
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312384	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of FANK1 intron	PMID:30157460
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312384	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FANK1 gene; Aflatoxin B1 results in decreased methylation of FANK1 intron	PMID:27153756|PMID:30157460
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of FANK1 mRNA	PMID:27392435
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312384	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of FANK1 mRNA	PMID:27392435
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FANK1 mRNA	PMID:32109520
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312385	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FANK1 mRNA	PMID:17942748
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FANK1 mRNA	PMID:28001369
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of FANK1 mRNA	PMID:26272509
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312384	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312385	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of FANK1 protein	PMID:28918527
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of FANK1 mRNA	PMID:34032870
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312385	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of FANK1 mRNA	PMID:37682722
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of FANK1 mRNA	PMID:25895662
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of FANK1 mRNA	PMID:23557971
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of FANK1 mRNA	PMID:20813756
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FANK1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:3392	carbendazim	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006698	carbendazim results in increased expression of FANK1 mRNA	PMID:22952946
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312385	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FANK1 mRNA	PMID:30951980
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312385	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FANK1 mRNA	PMID:30951980
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1312384	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of FANK1 mRNA	PMID:37047231
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312385	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FANK1 mRNA	PMID:40194260
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312384	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of FANK1 mRNA	PMID:29154799
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312384	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FANK1 gene	PMID:29154799
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312385	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FANK1 mRNA	PMID:28973697
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FANK1 mRNA	PMID:38832940
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FANK1 mRNA	PMID:24935251|PMID:26272509
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312384	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312384	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FANK1 mRNA	PMID:35811015
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1312384	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of FANK1 mRNA	PMID:40706910
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312385	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FANK1 mRNA	PMID:17942748
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312385	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FANK1 mRNA	PMID:17942748
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of FANK1 mRNA	PMID:32234424
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FANK1 mRNA; Nanotubes, Carbon results in decreased expression of FANK1 mRNA	PMID:25554681
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of FANK1 mRNA	PMID:23608068
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of FANK1 mRNA	PMID:38701926
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of FANK1 mRNA	PMID:19564919
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of FANK1 mRNA	PMID:22470460
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FANK1 mRNA	PMID:22206623
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312384	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312384	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FANK1 gene]	PMID:28238834
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:80491	pinostrobin	increases expression	ISO	RGD:1312384	E	RGD:6480464	20240109	CTD	MESH:C411294	pinostrobin results in increased expression of FANK1 mRNA	PMID:37777166
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of FANK1 mRNA	PMID:26079696
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FANK1 mRNA	PMID:24780913
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1312384	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of FANK1 mRNA	PMID:26272509
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312384	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1304756	Fank1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312384	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ELAC1 mRNA	PMID:26251327
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ELAC1 mRNA	PMID:39241906
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312386	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ELAC1 mRNA	PMID:37042841
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ELAC1 mRNA	PMID:33387578
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312386	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ELAC1 mRNA	PMID:19549813
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312386	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ELAC1 gene	PMID:27153756
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312386	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ELAC1 mRNA	PMID:35430440
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1622152	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ELAC1 mRNA	PMID:34911549
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312386	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ELAC1 gene	PMID:25304211
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312386	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ELAC1 mRNA	PMID:23557933
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312386	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ELAC1 mRNA	PMID:28903495
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312386	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ELAC1 mRNA	PMID:27392435
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312386	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ELAC1 mRNA	PMID:27392435
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1622152	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ELAC1 promoter]	PMID:19654925
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312386	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ELAC1 mRNA	PMID:28001369
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312386	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELAC1 mRNA	PMID:38568856
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312386	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ELAC1 3' UTR	PMID:27901495
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312386	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ELAC1 mRNA	PMID:25351596
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312386	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ELAC1 mRNA	PMID:35984750
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ELAC1 mRNA	PMID:29264374
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622152	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ELAC1 promoter	PMID:35295148
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ELAC1 mRNA	PMID:25181051
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ELAC1 mRNA	PMID:33221593
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ELAC1 gene	PMID:28505145
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312386	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ELAC1 mRNA	PMID:28628672
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312386	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ELAC1 mRNA	PMID:25979313
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312386	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ELAC1 mRNA	PMID:28628672
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312386	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ELAC1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ELAC1 mRNA	PMID:28628672
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1622152	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of ELAC1 protein	PMID:39748354
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312386	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ELAC1 mRNA	PMID:37042841
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312386	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ELAC1 mRNA	PMID:38174414
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in decreased expression of ELAC1 mRNA	PMID:24183702
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ELAC1 gene	PMID:22079235
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:37918	fluorescein 5-isothiocyanate	affects binding	ISO	RGD:1312386	E	RGD:6480464	20180116	CTD	MESH:D016650	Fluorescein-5-isothiocyanate binds to ELAC1 protein	PMID:27129696
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1622152	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ELAC1 mRNA	PMID:40194260
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312386	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ELAC1 mRNA	PMID:28302478
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312386	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ELAC1 mRNA	PMID:25979313
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312386	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ELAC1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:28001369
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312386	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ELAC1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ELAC1 mRNA	PMID:28628672
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ELAC1 mRNA	PMID:28973697
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312386	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ELAC1 mRNA	PMID:24935251
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ELAC1 mRNA	PMID:29279043
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312386	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ELAC1 gene	PMID:25304211
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in increased expression of ELAC1 mRNA	PMID:36653537
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312386	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ELAC1 mRNA	PMID:22079256
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312386	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ELAC1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ELAC1 mRNA	PMID:28628672
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ELAC1 mRNA; Nanotubes, Carbon results in decreased expression of ELAC1 mRNA	PMID:25554681
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1622152	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ELAC1 mRNA	PMID:22206623
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312386	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ELAC1 mRNA	PMID:22079256
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312386	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ELAC1 mRNA	PMID:22079256
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of ELAC1 mRNA	PMID:25825206
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312386	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of ELAC1 mRNA	PMID:24921660
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312386	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ELAC1 mRNA	PMID:38568856
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312386	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ELAC1 mRNA	PMID:29301935
1304757	Elac1	elaC ribonuclease Z 1	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1312386	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of ELAC1 mRNA	PMID:27188386
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332244	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TMUB2 mRNA	PMID:39241906
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1604292	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of TMUB2 mRNA	PMID:31614463
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1604292	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of TMUB2 mRNA	PMID:38568856
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1604292	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TMUB2 mRNA	PMID:21179406
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1604292	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of TMUB2 mRNA	PMID:33359661
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604292	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TMUB2 gene	PMID:27153756
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604292	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TMUB2 mRNA	PMID:23649840
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604292	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TMUB2 mRNA	PMID:35430440
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1604292	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of TMUB2 mRNA	PMID:19774075
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TMUB2 mRNA	PMID:30779732
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332244	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of TMUB2 gene] which results in decreased expression of TMUB2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of TMUB2 gene	PMID:40504410
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1604292	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TMUB2 protein	PMID:35688186
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMUB2 mRNA	PMID:33387578
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332244	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of TMUB2 gene] which results in decreased expression of TMUB2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of TMUB2 gene	PMID:40504410
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332244	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMUB2 gene; titanium dioxide results in decreased methylation of TMUB2 promoter	PMID:35295148
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TMUB2 mRNA	PMID:34492290
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMUB2 mRNA	PMID:25181051
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332244	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TMUB2 mRNA	PMID:37019170
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1332244	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TMUB2 mRNA	PMID:21266533
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604292	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMUB2 mRNA	PMID:37042841
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMUB2 mRNA	PMID:33453195
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1604292	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMUB2 mRNA	PMID:38174414
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1604292	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TMUB2 mRNA	PMID:19376846
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1604292	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TMUB2 mRNA	PMID:29432896
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332244	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of TMUB2 gene] which results in decreased expression of TMUB2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of TMUB2 gene	PMID:40504410
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332244	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TMUB2 mRNA	PMID:22206623
1304758	Tmub2	transmembrane and ubiquitin-like domain containing 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1604292	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TMUB2 mRNA	PMID:38568856
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PALB2 mRNA	PMID:33167477
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312388	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PALB2 mRNA	PMID:39241906
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PALB2 mRNA	PMID:25510870
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:16708	adenine	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of PALB2 mRNA	PMID:24211769
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PALB2 mRNA	PMID:20655997
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1605949	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PALB2 mRNA	PMID:23649840
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PALB2 mRNA	PMID:37992649
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PALB2 mRNA	PMID:37992649
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312388	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PALB2 mRNA	PMID:34319233
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1605949	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PALB2 protein	PMID:37730182
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PALB2 mRNA	PMID:33387578
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PALB2 mRNA	PMID:28818685
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1605949	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PALB2 intron	PMID:30157460
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PALB2 mRNA	PMID:37236586
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PALB2 mRNA	PMID:25510870
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PALB2 mRNA	PMID:25510870
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PALB2 mRNA	PMID:19549813
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PALB2 mRNA	PMID:24211769
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1605949	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PALB2 mRNA	PMID:23649840
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605949	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PALB2 mRNA	PMID:23649840
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605949	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PALB2 mRNA	PMID:41430723
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of PALB2 mRNA	PMID:22171008
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20140513	CTD	MESH:D016685	Mitomycin results in decreased expression of PALB2 mRNA	PMID:24211769
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1605949	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PALB2 protein	PMID:35688186
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PALB2 mRNA	PMID:31881176
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:27882	(S)-colchicine	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of PALB2 mRNA	PMID:24211769
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin results in decreased expression of PALB2 mRNA	PMID:24211769
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1312388	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of PALB2 protein	PMID:22006019
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312388	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PALB2 mRNA	PMID:21570461
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1605949	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PALB2 mRNA	PMID:22574217
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PALB2 mRNA	PMID:29803840
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PALB2 mRNA	PMID:37992649
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PALB2 mRNA	PMID:38568856
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605949	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PALB2 intron	PMID:30157460
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of PALB2 mRNA	PMID:22171008
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of PALB2 mRNA	PMID:26014281
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PALB2 mRNA	PMID:35984750
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of PALB2 mRNA	PMID:34492290
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PALB2 mRNA	PMID:23411599
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312388	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PALB2 mRNA	PMID:20813756
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of PALB2 mRNA	PMID:20813756
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PALB2 mRNA	PMID:30816183|PMID:32528016
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PALB2 mRNA	PMID:25181051
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312388	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of PALB2 mRNA	PMID:40036665
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1605949	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PALB2 gene	PMID:31601247
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PALB2 mRNA	PMID:25510870
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PALB2 mRNA	PMID:25510870
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312388	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PALB2 mRNA	PMID:40203079
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312388	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PALB2 mRNA	PMID:37019170
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605949	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PALB2 mRNA	PMID:37042841
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of PALB2 mRNA	PMID:18500788
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PALB2 mRNA	PMID:37236586
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605949	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PALB2 mRNA	PMID:31533062
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312388	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PALB2 mRNA	PMID:39529242
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605949	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PALB2 mRNA	PMID:25979313
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PALB2 mRNA	PMID:25562108
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312388	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PALB2 mRNA	PMID:37992649
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of PALB2 mRNA	PMID:26690555
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PALB2 mRNA	PMID:33387578
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:46661	asbestos	affects response to substance	ISO	RGD:1605949	E	RGD:6480464	20201006	CTD	MESH:D001194	PALB2 alternative form affects the susceptibility to Asbestos	PMID:28687356
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20140513	CTD	MESH:D005047	Etoposide results in decreased expression of PALB2 mRNA	PMID:24211769
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of PALB2 mRNA	PMID:24793618
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312388	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PALB2 mRNA	PMID:19042947
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312388	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PALB2 mRNA	PMID:38701926
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases methylation	ISO	RGD:1605949	E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased methylation of PALB2 intron	PMID:29432895
1304759	Palb2	partner and localizer of BRCA2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1605949	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of PALB2 mRNA	PMID:26014281
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of PI16 mRNA	PMID:25152437
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PI16 mRNA	PMID:20188158
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1550019	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of PI16 promoter	PMID:26251327
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550019	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PI16 mRNA	PMID:26251327
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PI16 mRNA	PMID:33729688
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:15940	nicotinic acid	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20161213	CTD	MESH:D009525	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of PI16 mRNA]	PMID:16940432
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550019	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PI16 mRNA	PMID:39241906
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312389	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PI16 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PI16 mRNA	PMID:35811015
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of PI16 mRNA	PMID:19484750
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312389	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PI16 mRNA	PMID:26079696
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PI16 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA	PMID:37567420|PMID:37992649
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PI16 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA	PMID:37567420|PMID:37992649
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PI16 promoter	PMID:23359474
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PI16 mRNA	PMID:22061828|PMID:33387578
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of PI16 mRNA	PMID:23358152
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of PI16 mRNA	PMID:30779732
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PI16 mRNA	PMID:31881176
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231003	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 5' UTR; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 intron; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 promoter	PMID:33445541
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:28073	chromium atom	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20120412	CTD	MESH:D002857	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of PI16 mRNA]	PMID:16940432
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PI16 mRNA	PMID:32186404
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PI16 mRNA	PMID:34747641
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PI16 mRNA	PMID:28959563
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of PI16 mRNA	PMID:30556269
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312389	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PI16 mRNA	PMID:29803840
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PI16 mRNA	PMID:39631538
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PI16 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA	PMID:37567420|PMID:37992649
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of PI16 mRNA	PMID:39515575
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1550019	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of PI16 gene	PMID:39894169
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550019	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of PI16 mRNA	PMID:37682722
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PI16 mRNA	PMID:22610609
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550019	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PI16 mRNA	PMID:32417428
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of PI16 mRNA	PMID:30556269
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312389	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PI16 mRNA	PMID:23806026
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312389	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PI16 gene	PMID:31601247
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231003	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 5' UTR; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 intron; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 promoter	PMID:33445541
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of PI16 mRNA	PMID:23557971
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550019	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PI16 gene	PMID:35295148
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PI16 mRNA	PMID:34492290
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550019	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PI16 mRNA	PMID:20813756
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PI16 mRNA	PMID:25181051
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550019	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PI16 mRNA	PMID:32156529
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PI16 promoter	PMID:23359474
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312389	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PI16 gene	PMID:31601247
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1312389	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of PI16 mRNA; 2,5,2',5'-tetrachlorobiphenyl results in increased expression of PI16 mRNA	PMID:36804509
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550019	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PI16 mRNA	PMID:30951980
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550019	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PI16 exon; butylbenzyl phthalate results in increased methylation of PI16 intron	PMID:28392331
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PI16 promoter	PMID:23359474
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of PI16 mRNA	PMID:27387713
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550019	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PI16 mRNA	PMID:40194260
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1550019	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PI16 mRNA	PMID:39529242
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of PI16 mRNA	PMID:29038090
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of PI16 mRNA	PMID:22733784
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PI16 mRNA	PMID:28973697
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PI16 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA	PMID:37567420|PMID:37992649
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312389	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PI16 mRNA	PMID:22230336
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1312389	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of PI16 mRNA	PMID:35811015
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312389	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PI16 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PI16 mRNA	PMID:35811015
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PI16 mRNA; Nanotubes, Carbon results in decreased expression of PI16 mRNA	PMID:25554681|PMID:25620056
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550019	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PI16 mRNA	PMID:25620056
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of PI16 mRNA	PMID:23358152
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PI16 mRNA	PMID:36907384
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of PI16 mRNA	PMID:22078008
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA	PMID:37567420
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312389	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PI16 gene]	PMID:28238834
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550019	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PI16 mRNA	PMID:38648751
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PI16 mRNA	PMID:24780913
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PI16 mRNA	PMID:19281266
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of PI16 mRNA	PMID:23358152
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1550019	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of PI16 mRNA	PMID:28973697
1304760	Pi16	peptidase inhibitor 16	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PI16 mRNA	PMID:35537566
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	affects expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine affects the expression of IWS1 mRNA	PMID:30071829
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IWS1 gene	PMID:20938992
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IWS1 mRNA	PMID:36331819
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1604340	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of IWS1 mRNA	PMID:22378314
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of IWS1 mRNA	PMID:18951874
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IWS1 mRNA	PMID:25510870
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IWS1 gene	PMID:20938992
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1604340	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of IWS1 protein	PMID:37730182
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of IWS1 mRNA	PMID:33387578
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of IWS1 mRNA	PMID:39836092
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1331881	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of IWS1 mRNA	PMID:27462272
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IWS1 mRNA	PMID:37236586
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IWS1 mRNA	PMID:25510870
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IWS1 mRNA	PMID:25510870
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1331881	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IWS1 mRNA	PMID:19770486
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of IWS1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of IWS1 mRNA	PMID:35430440|PMID:41430723
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1331881	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of IWS1 mRNA	PMID:25629700
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IWS1 gene	PMID:20938992
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604340	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IWS1 gene	PMID:25304211
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of IWS1 mRNA	PMID:39836092
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1604340	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of IWS1 protein	PMID:35688186
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1331881	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of IWS1 protein	PMID:25505154
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of IWS1 mRNA	PMID:23557933
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1331881	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of IWS1 mRNA	PMID:30912803
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1331881	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IWS1 mRNA	PMID:21570461
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IWS1 mRNA	PMID:34747641
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1331881	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IWS1 mRNA	PMID:19770486
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of IWS1 protein	PMID:39603559
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of IWS1 mRNA	PMID:33212167
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1604340	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of IWS1 protein	PMID:35688186
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of IWS1 mRNA	PMID:39836092
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604340	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IWS1 promoter	PMID:27901495
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IWS1 mRNA	PMID:19150397
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1604340	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of IWS1 mRNA	PMID:31745603
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1331881	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IWS1 gene	PMID:35295148
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of IWS1 mRNA	PMID:25181051
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of IWS1 mRNA	PMID:34947998
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1331881	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of IWS1 mRNA	PMID:33221593
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of IWS1 protein	PMID:33376534|PMID:37567409
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1331881	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of IWS1 mRNA	PMID:40036665
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of IWS1 protein	PMID:31675489
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IWS1 mRNA	PMID:25510870
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IWS1 mRNA	PMID:25510870
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of IWS1 mRNA	PMID:28628672
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1331881	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of IWS1 mRNA	PMID:37019170
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of IWS1 mRNA	PMID:28628672
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of IWS1 mRNA	PMID:39836092
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IWS1 mRNA	PMID:37236586
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331881	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IWS1 mRNA	PMID:36331819
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1331881	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of IWS1 mRNA	PMID:17292431
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1604340	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of IWS1 gene	PMID:29154799
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1331881	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of IWS1 mRNA	PMID:19770486
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of IWS1 mRNA	PMID:28628672
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1331881	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IWS1 mRNA	PMID:28973697
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1604340	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of IWS1 mRNA	PMID:28542535
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604340	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IWS1 gene	PMID:25304211
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of IWS1 mRNA	PMID:39836092
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of IWS1 mRNA	PMID:31675489
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IWS1 mRNA	PMID:22079256
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1604340	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of IWS1 mRNA	PMID:23228038
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of IWS1 mRNA	PMID:28628672
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of IWS1 mRNA	PMID:24136188
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IWS1 protein	PMID:32959892
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of IWS1 mRNA	PMID:39836092
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of IWS1 mRNA	PMID:30467583
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1604340	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of IWS1 mRNA	PMID:27918106
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of IWS1 protein	PMID:37664457
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of IWS1 mRNA	PMID:22079256
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IWS1 mRNA	PMID:22079256
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1604340	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of IWS1 protein	PMID:31285264
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IWS1 protein	PMID:31675489
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of IWS1 protein	PMID:31675489
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604340	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of IWS1 protein	PMID:37664457
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of IWS1 mRNA	PMID:19281266
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of IWS1 mRNA	PMID:21346803
1304762	Iws1	interacts with SUPT6H, CTD assembly factor 1	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1604340	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of IWS1 mRNA	PMID:27188386
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:10033	warfarin	increases expression	ISO	RGD:1312395	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in increased expression of CCT6A mRNA	PMID:20493250
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312394	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CCT6A mRNA	PMID:38218311
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCT6A mRNA]	PMID:31150632
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CCT6A mRNA	PMID:33167477
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CCT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CCT6A mRNA	PMID:32699268
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312395	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CCT6A mRNA	PMID:30319688
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312394	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CCT6A mRNA	PMID:20044591
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16325	lithocholic acid	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20131210	CTD	MESH:D008095	Lithocholic Acid results in decreased expression of CCT6A protein	PMID:21224350
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312395	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CCT6A mRNA	PMID:39241906
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT6A mRNA]	PMID:39241906
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CCT6A mRNA	PMID:15598610
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312395	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CCT6A mRNA	PMID:39298647
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of CCT6A mRNA	PMID:26496021
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312394	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CCT6A mRNA	PMID:38568856
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CCT6A mRNA	PMID:33387578
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of CCT6A mRNA	PMID:15363585
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D014241	PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of CCT6A protein]	PMID:15363585
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312394	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CCT6A mRNA	PMID:37042841
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of CCT6A protein	PMID:32044396
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCT6A mRNA	PMID:21318169
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCT6A mRNA	PMID:21318169
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of CCT6A mRNA	PMID:27523638
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1312394	E	RGD:6480464	20211207	CTD	MESH:D003471	Cuprizone results in increased expression of CCT6A protein	PMID:34122009
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of CCT6A protein; [Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT6A protein	PMID:34122009
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312394	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CCT6A protein	PMID:37730182
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CCT6A mRNA; Gentamicins results in increased expression of CCT6A protein	PMID:22061828|PMID:33387578
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCT6A mRNA	PMID:36331819
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CCT6A mRNA	PMID:23649840
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CCT6A mRNA	PMID:33354967
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:2504	aflatoxin B1	increases mutagenesis	EXP		E	RGD:6480464	20240109	CTD	MESH:D016604	Aflatoxin B1 results in increased mutagenesis of CCT6A gene	PMID:36908029
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CCT6A mRNA	PMID:23649840
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CCT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CCT6A mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CCT6A mRNA	PMID:32699268
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:2654	aminoglutethimide	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of CCT6A protein	PMID:26102013
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CCT6A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CCT6A protein	PMID:38598786
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CCT6A mRNA	PMID:18593933
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCT6A mRNA	PMID:31150632
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312395	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCT6A mRNA	PMID:31919559
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCT6A mRNA]	PMID:31150632
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CCT6A mRNA]	PMID:22206623
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312394	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CCT6A protein	PMID:35688186
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312394	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CCT6A mRNA	PMID:28903495
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1312394	E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in increased expression of CCT6A protein	PMID:37834424
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of CCT6A mRNA	PMID:27594783
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312395	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCT6A mRNA	PMID:21570461
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCT6A mRNA	PMID:34747641
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CCT6A mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCT6A mRNA	PMID:16214954|PMID:17942748
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312394	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of CCT6A mRNA	PMID:33512557
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CCT6A mRNA	PMID:28959563
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312394	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CCT6A mRNA	PMID:32763439
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCT6A mRNA; sodium arsenite results in decreased expression of CCT6A protein	PMID:30528433|PMID:38568856
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of CCT6A mRNA	PMID:29453283
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCT6A mRNA	PMID:22228805
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312394	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCT6A 3' UTR; Benzo(a)pyrene results in increased methylation of CCT6A promoter	PMID:27901495
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CCT6A mRNA	PMID:18593933
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of CCT6A protein	PMID:34122009
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:30563	silicon dioxide	affects secretion	ISO	RGD:1312394	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the secretion of CCT6A protein	PMID:25895662
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312394	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CCT6A protein	PMID:19364129
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CCT6A mRNA	PMID:34492290
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C006253	pirinixic acid results in increased expression of CCT6A mRNA	PMID:19162173|PMID:21318169
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of CCT6A mRNA	PMID:15375163|PMID:18301758
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312395	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CCT6A mRNA	PMID:28472532
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:3312	calcium dichloride	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20150609	CTD	MESH:D002122	Calcium Chloride results in decreased expression of CCT6A protein	PMID:25824407
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of CCT6A mRNA	PMID:19167457
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CCT6A mRNA	PMID:25181051
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CCT6A mRNA; bisphenol A results in decreased expression of CCT6A protein	PMID:29275510|PMID:34186270
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312395	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of CCT6A promoter	PMID:27312807
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CCT6A mRNA	PMID:30816183|PMID:41034487
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of CCT6A mRNA	PMID:26496021
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312394	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CCT6A protein	PMID:34186270
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312395	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CCT6A mRNA	PMID:39298647
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312394	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CCT6A protein	PMID:34186270
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312394	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CCT6A protein	PMID:34186270
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1312395	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of CCT6A mRNA	PMID:31558096
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CCT6A protein	PMID:38598786
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of CCT6A mRNA	PMID:32680482
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT6A mRNA]	PMID:39241906
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312394	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCT6A mRNA	PMID:37042841
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CCT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CCT6A mRNA	PMID:32699268
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CCT6A mRNA	PMID:28302478
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCT6A mRNA	PMID:36331819
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1312395	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of CCT6A mRNA	PMID:31558096
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of CCT6A mRNA	PMID:25993096
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CCT6A mRNA	PMID:17292431
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of CCT6A mRNA	PMID:21318169
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of CCT6A mRNA	PMID:38685447|PMID:41580965
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:40303	lovastatin	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in increased expression of CCT6A mRNA	PMID:20493250
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312394	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CCT6A mRNA	PMID:20106945
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1312394	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of CCT6A mRNA	PMID:33512557
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CCT6A mRNA	PMID:24136188
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312394	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCT6A mRNA	PMID:38832940
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of CCT6A mRNA	PMID:21346803
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CCT6A mRNA	PMID:17562736
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CCT6A mRNA	PMID:21420995
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1312394	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of CCT6A protein	PMID:25470785
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of CCT6A protein	PMID:31195006
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312394	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of CCT6A mRNA	PMID:18175754
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CCT6A mRNA	PMID:17942748
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCT6A mRNA	PMID:17942748
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312394	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CCT6A protein	PMID:19364129
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312395	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CCT6A mRNA; Nanotubes, Carbon results in increased expression of CCT6A mRNA	PMID:25554681
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CCT6A mRNA	PMID:24136188
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of CCT6A mRNA	PMID:34044035
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of CCT6A mRNA	PMID:41580965
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312395	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CCT6A mRNA	PMID:40234311
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CCT6A mRNA	PMID:35964746
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CCT6A mRNA	PMID:24136188
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CCT6A mRNA	PMID:19042947
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CCT6A protein	PMID:32959892
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CCT6A mRNA	PMID:24136188
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:6723	megestrol acetate	increases expression	ISO	RGD:1312394	E	RGD:6480464	20170303	CTD	MESH:D019290	Megestrol Acetate results in increased expression of CCT6A protein	PMID:16939895
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312394	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of CCT6A protein	PMID:34122009
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT6A protein	PMID:34122009
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312394	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CCT6A protein	PMID:34186270
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312395	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CCT6A mRNA	PMID:22206623
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CCT6A mRNA]	PMID:22206623
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CCT6A mRNA	PMID:24136188
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of CCT6A protein	PMID:19716841
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312394	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CCT6A protein	PMID:39638853
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CCT6A mRNA	PMID:21346803
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1312394	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of CCT6A mRNA	PMID:18927307
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312395	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CCT6A mRNA	PMID:30294300
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1312395	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of CCT6A mRNA	PMID:31558096
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CCT6A mRNA	PMID:21278054
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT6A mRNA]	PMID:39241906
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CCT6A mRNA	PMID:21346803
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312394	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CCT6A protein	PMID:38598786
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CCT6A mRNA	PMID:21346803
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CCT6A mRNA	PMID:19015723
1304763	Cct6a	chaperonin containing TCP1 subunit 6A	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CCT6A mRNA	PMID:20566332
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552002	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PPP2R1B mRNA	PMID:33045310
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552002	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PPP2R1B mRNA	PMID:26251327
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of PPP2R1B mRNA	PMID:15498508
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552002	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PPP2R1B mRNA	PMID:30319688
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PPP2R1B mRNA	PMID:21632981
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552002	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PPP2R1B mRNA; Estradiol results in increased expression of PPP2R1B protein	PMID:26903627|PMID:39298647
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PPP2R1B protein	PMID:21673325
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PPP2R1B mRNA	PMID:23649840
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PPP2R1B mRNA	PMID:33359661
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552002	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PPP2R1B mRNA	PMID:23892564
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552002	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP2R1B mRNA	PMID:36331819
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of PPP2R1B mRNA	PMID:23369406
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312396	E	RGD:6480464	20251104	CTD	MESH:D002104	Cadmium results in increased expression of PPP2R1B mRNA	PMID:31463135
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552002	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPP2R1B mRNA	PMID:37236586
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PPP2R1B mRNA	PMID:19549813
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PPP2R1B mRNA	PMID:22100608
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312396	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PPP2R1B gene	PMID:27153756
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PPP2R1B mRNA	PMID:19502547
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000638	Amiodarone results in increased expression of PPP2R1B mRNA	PMID:40216313
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of PPP2R1B mRNA	PMID:31295307
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552002	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PPP2R1B mRNA	PMID:28960355
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552002	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPP2R1B mRNA	PMID:21570461
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of PPP2R1B mRNA	PMID:28374803
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1552002	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of PPP2R1B mRNA	PMID:30807115
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of PPP2R1B mRNA	PMID:30911355
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP2R1B protein]	PMID:18703135
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20120717	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP2R1B protein]	PMID:18703135
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPP2R1B mRNA; sodium arsenite results in decreased expression of PPP2R1B protein	PMID:38228842|PMID:38568856
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of PPP2R1B mRNA	PMID:30911355
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312396	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PPP2R1B mRNA	PMID:25351596
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of PPP2R1B mRNA	PMID:32479839
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of PPP2R1B mRNA	PMID:30047161
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:32181	tamibarotene	affects expression	ISO	RGD:1312396	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of PPP2R1B mRNA	PMID:15498508
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PPP2R1B mRNA	PMID:23411599|PMID:34492290
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552002	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PPP2R1B mRNA	PMID:18301758
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PPP2R1B mRNA	PMID:19167457
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PPP2R1B mRNA	PMID:25181051
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of PPP2R1B protein	PMID:37567409
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312396	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PPP2R1B gene	PMID:31601247
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PPP2R1B mRNA	PMID:34947998
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312396	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of PPP2R1B mRNA	PMID:27685785
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PPP2R1B gene	PMID:28505145
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PPP2R1B protein	PMID:31675489
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PPP2R1B mRNA	PMID:19244175
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312396	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of PPP2R1B mRNA	PMID:24752500
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552002	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PPP2R1B mRNA	PMID:39298647
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312396	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of PPP2R1B mRNA	PMID:27685785
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1312396	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to PPP2R1B protein	PMID:32991956
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312396	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPP2R1B mRNA	PMID:37042841
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of PPP2R1B mRNA	PMID:30589522
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:35176	zinc sulfate	affects expression	ISO	RGD:1312396	E	RGD:6480464	20150127	CTD	MESH:D019287	Zinc Sulfate affects the expression of PPP2R1B protein	PMID:25162517
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PPP2R1B mRNA; Cadmium Chloride results in decreased expression of PPP2R1B protein	PMID:18703135|PMID:33453195
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PPP2R1B protein	PMID:18703135
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP2R1B protein]	PMID:18703135
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20120717	CTD	MESH:D019256	Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP2R1B protein]	PMID:18703135
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552002	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPP2R1B mRNA	PMID:37236586
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PPP2R1B mRNA	PMID:28302478
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PPP2R1B mRNA	PMID:40419075
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552002	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP2R1B mRNA	PMID:36331819
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PPP2R1B mRNA	PMID:25993096
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312396	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PPP2R1B mRNA	PMID:25979313
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312396	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PPP2R1B mRNA	PMID:23179753|PMID:26272509
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of PPP2R1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA	PMID:17183730|PMID:27188386
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of PPP2R1B mRNA	PMID:41580965
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PPP2R1B mRNA	PMID:30047161
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of PPP2R1B mRNA	PMID:27989131
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:43602	obeticholic acid	increases expression	ISO	RGD:1312396	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in increased expression of PPP2R1B mRNA	PMID:27939613
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PPP2R1B mRNA	PMID:38832940
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:44975	1,10-phenanthroline	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20120501	CTD	MESH:C025205	1,10-phenanthroline results in decreased expression of PPP2R1B mRNA	PMID:19502547
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312396	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PPP2R1B mRNA	PMID:26272509
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA	PMID:27188386
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312396	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of PPP2R1B mRNA	PMID:24752500
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of PPP2R1B mRNA	PMID:31675489
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552002	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PPP2R1B mRNA	PMID:35436446
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552002	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PPP2R1B mRNA	PMID:25620056
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PPP2R1B mRNA	PMID:24136188
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of PPP2R1B mRNA	PMID:34044035
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of PPP2R1B mRNA	PMID:30047161
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PPP2R1B mRNA	PMID:24793618
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of PPP2R1B mRNA	PMID:22841810
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312396	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of PPP2R1B mRNA	PMID:16780908
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:53470	cobalt(2+) sulfate	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20120501	CTD	MESH:C026305	cobalt sulfate results in decreased expression of PPP2R1B mRNA	PMID:19502547
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of PPP2R1B mRNA	PMID:17183730
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PPP2R1B protein	PMID:32959892
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PPP2R1B mRNA	PMID:24136188
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:63924	riddelliine	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPP2R1B mRNA	PMID:33884520
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008701	Methapyrilene results in increased expression of PPP2R1B mRNA	PMID:22484513
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:747853	Gedatolisib	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20260714	CTD	MESH:C549060	gedatolisib inhibits the reaction [PIK3CA protein modified form results in increased expression of PPP2R1B mRNA]	PMID:27542212
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:7553	niclosamide	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide inhibits the reaction [PIK3CA protein modified form results in increased expression of PPP2R1B mRNA]	PMID:27542212
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of PPP2R1B mRNA	PMID:19287073
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA	PMID:27188386
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PPP2R1B gene]	PMID:28238834
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of PPP2R1B mRNA; 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PPP2R1B protein	PMID:19095052|PMID:31675489
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PPP2R1B protein	PMID:31675489
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of PPP2R1B mRNA	PMID:21858171
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of PPP2R1B mRNA	PMID:30047161
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:8493	Propiverine	affects binding	EXP		E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine binds to PPP2R1B protein	PMID:29273565
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of PPP2R1B mRNA	PMID:30047161
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:8687	pyrvinium	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20190219	CTD	MESH:C024631	pyrvinium inhibits the reaction [PIK3CA protein modified form results in increased expression of PPP2R1B mRNA]	PMID:27542212
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA	PMID:27188386
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1312396	E	RGD:6480464	20190219	CTD	MESH:D020123	Sirolimus inhibits the reaction [PIK3CA protein modified form results in increased expression of PPP2R1B mRNA]	PMID:27542212
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PPP2R1B mRNA	PMID:38568856
1304764	Ppp2r1b	protein phosphatase 2 scaffold subunit A beta	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312396	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PPP2R1B mRNA	PMID:29301935
1304765	Ano6	anoctamin 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312399	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ANO6 mRNA	PMID:37995155
1304765	Ano6	anoctamin 6	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein]	PMID:38195004
1304765	Ano6	anoctamin 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312399	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ANO6 mRNA	PMID:20188158
1304765	Ano6	anoctamin 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANO6 mRNA	PMID:20938992
1304765	Ano6	anoctamin 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312398	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of ANO6 mRNA	PMID:21934132
1304765	Ano6	anoctamin 6	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ANO6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ANO6 mRNA	PMID:32699268
1304765	Ano6	anoctamin 6	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312398	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ANO6 mRNA	PMID:26079696
1304765	Ano6	anoctamin 6	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ANO6 gene	PMID:28931070
1304765	Ano6	anoctamin 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ANO6 mRNA	PMID:26496021
1304765	Ano6	anoctamin 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ANO6 mRNA	PMID:30165855
1304765	Ano6	anoctamin 6	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312398	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ANO6 mRNA	PMID:38568856
1304765	Ano6	anoctamin 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANO6 mRNA	PMID:20938992
1304765	Ano6	anoctamin 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANO6 mRNA	PMID:37992649
1304765	Ano6	anoctamin 6	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of ANO6 mRNA	PMID:22967744
1304765	Ano6	anoctamin 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANO6 mRNA	PMID:37992649
1304765	Ano6	anoctamin 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312399	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ANO6 mRNA	PMID:33754040
1304765	Ano6	anoctamin 6	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312398	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ANO6 protein	PMID:37730182
1304765	Ano6	anoctamin 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ANO6 mRNA	PMID:33387578
1304765	Ano6	anoctamin 6	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20200519	CTD	MESH:D024502	alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of ANO6 mRNA]	PMID:27886375
1304765	Ano6	anoctamin 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein	PMID:38195004
1304765	Ano6	anoctamin 6	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANO6 mRNA	PMID:29950665
1304765	Ano6	anoctamin 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312398	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ANO6 mRNA	PMID:19549813
1304765	Ano6	anoctamin 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312398	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANO6 gene; Aflatoxin B1 results in increased methylation of ANO6 intron	PMID:27153756|PMID:30157460
1304765	Ano6	anoctamin 6	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312398	E	RGD:6480464	20200519	CTD	MESH:D010126	Ozone results in increased expression of ANO6 mRNA	PMID:27886375
1304765	Ano6	anoctamin 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20200519	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ANO6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ANO6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of ANO6 mRNA; alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of ANO6 mRNA]	PMID:27886375|PMID:32699268
1304765	Ano6	anoctamin 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANO6 mRNA	PMID:20938992
1304765	Ano6	anoctamin 6	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312398	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ANO6 gene	PMID:25304211
1304765	Ano6	anoctamin 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANO6 mRNA	PMID:40504410
1304765	Ano6	anoctamin 6	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312398	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ANO6 mRNA	PMID:26272509
1304765	Ano6	anoctamin 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANO6 mRNA	PMID:27188386
1304765	Ano6	anoctamin 6	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ANO6 mRNA	PMID:31881176
1304765	Ano6	anoctamin 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312398	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ANO6 mRNA	PMID:27392435
1304765	Ano6	anoctamin 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ANO6 mRNA	PMID:27392435
1304765	Ano6	anoctamin 6	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1312399	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of ANO6 mRNA	PMID:18930951
1304765	Ano6	anoctamin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ANO6 mRNA	PMID:33387578
1304765	Ano6	anoctamin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANO6 mRNA	PMID:34747641
1304765	Ano6	anoctamin 6	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312398	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of ANO6 protein	PMID:39603559
1304765	Ano6	anoctamin 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312398	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ANO6 mRNA	PMID:33212167
1304765	Ano6	anoctamin 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ANO6 mRNA	PMID:24690739
1304765	Ano6	anoctamin 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312398	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ANO6 mRNA	PMID:29803840
1304765	Ano6	anoctamin 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANO6 mRNA	PMID:37992649
1304765	Ano6	anoctamin 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANO6 mRNA	PMID:40504410
1304765	Ano6	anoctamin 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312399	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ANO6 mRNA	PMID:19770486
1304765	Ano6	anoctamin 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312399	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ANO6 intron	PMID:27901495
1304765	Ano6	anoctamin 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ANO6 mRNA]	PMID:32406909
1304765	Ano6	anoctamin 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ANO6 mRNA	PMID:24690739
1304765	Ano6	anoctamin 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312398	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANO6 mRNA	PMID:19150397
1304765	Ano6	anoctamin 6	gene	CHEBI:30814	digallic acid	decreases activity	ISO	RGD:1312399	E	RGD:6480464	20150127	CTD	MESH:C067648	digallic acid results in decreased activity of ANO6 protein	PMID:24478309
1304765	Ano6	anoctamin 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312399	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ANO6 gene	PMID:35295148
1304765	Ano6	anoctamin 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312399	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ANO6 gene; titanium dioxide results in increased methylation of ANO6 promoter	PMID:35295148
1304765	Ano6	anoctamin 6	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANO6 mRNA	PMID:29950665
1304765	Ano6	anoctamin 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ANO6 mRNA	PMID:34492290
1304765	Ano6	anoctamin 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ANO6 mRNA	PMID:25380136
1304765	Ano6	anoctamin 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312399	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ANO6 mRNA	PMID:18301758
1304765	Ano6	anoctamin 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ANO6 mRNA	PMID:25181051
1304765	Ano6	anoctamin 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ANO6 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304765	Ano6	anoctamin 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312398	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ANO6 protein	PMID:34186270
1304765	Ano6	anoctamin 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ANO6 gene	PMID:28505145
1304765	Ano6	anoctamin 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ANO6 mRNA	PMID:26496021
1304765	Ano6	anoctamin 6	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312398	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ANO6 mRNA	PMID:25979313
1304765	Ano6	anoctamin 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312399	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ANO6 mRNA	PMID:39298647
1304765	Ano6	anoctamin 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312398	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ANO6 protein	PMID:34186270
1304765	Ano6	anoctamin 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312399	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ANO6 mRNA	PMID:40203079
1304765	Ano6	anoctamin 6	gene	CHEBI:34457	5-Nitro-2-(3-phenylpropylamino)benzoic acid	decreases activity	ISO	RGD:1312399	E	RGD:6480464	20150127	CTD	MESH:C058176	5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of ANO6 protein	PMID:24478309
1304765	Ano6	anoctamin 6	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312398	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ANO6 protein	PMID:34186270
1304765	Ano6	anoctamin 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312399	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ANO6 intron	PMID:28392331
1304765	Ano6	anoctamin 6	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANO6 mRNA	PMID:29950665
1304765	Ano6	anoctamin 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312399	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ANO6 mRNA	PMID:21266533
1304765	Ano6	anoctamin 6	gene	CHEBI:34888	Niflumic acid	affects activity	ISO	RGD:1312399	E	RGD:6480464	20150127	CTD	MESH:D009544	Niflumic Acid affects the activity of ANO6 protein	PMID:24478309
1304765	Ano6	anoctamin 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312398	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANO6 mRNA	PMID:37042841
1304765	Ano6	anoctamin 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ANO6 mRNA	PMID:25380136
1304765	Ano6	anoctamin 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein	PMID:38195004
1304765	Ano6	anoctamin 6	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ANO6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ANO6 mRNA	PMID:32699268
1304765	Ano6	anoctamin 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312399	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ANO6 mRNA	PMID:40194260
1304765	Ano6	anoctamin 6	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312398	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ANO6 mRNA	PMID:19167446
1304765	Ano6	anoctamin 6	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA	PMID:19167446
1304765	Ano6	anoctamin 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312398	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ANO6 mRNA	PMID:25979313
1304765	Ano6	anoctamin 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANO6 mRNA	PMID:37992649
1304765	Ano6	anoctamin 6	gene	CHEBI:4286	4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid	decreases activity	ISO	RGD:1312399	E	RGD:6480464	20150127	CTD	MESH:D017878	4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of ANO6 protein	PMID:24478309
1304765	Ano6	anoctamin 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ANO6 mRNA	PMID:33387578
1304765	Ano6	anoctamin 6	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of ANO6 mRNA	PMID:24690739
1304765	Ano6	anoctamin 6	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312398	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ANO6 gene	PMID:25304211
1304765	Ano6	anoctamin 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANO6 mRNA	PMID:40504410
1304765	Ano6	anoctamin 6	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases activity	ISO	RGD:1312399	E	RGD:6480464	20150127	CTD	MESH:C045651	epigallocatechin gallate results in decreased activity of ANO6 protein	PMID:24478309
1304765	Ano6	anoctamin 6	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ANO6 mRNA	PMID:24793618
1304765	Ano6	anoctamin 6	gene	CHEBI:51876	auramine O	increases expression	ISO	RGD:1312398	E	RGD:6480464	20191114	CTD	MESH:D001576	Benzophenoneidum results in increased expression of ANO6 protein	PMID:28722353
1304765	Ano6	anoctamin 6	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312399	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ANO6 mRNA	PMID:26307267
1304765	Ano6	anoctamin 6	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312398	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ANO6 protein	PMID:34186270
1304765	Ano6	anoctamin 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312399	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ANO6 mRNA	PMID:22206623
1304765	Ano6	anoctamin 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312398	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ANO6 mRNA	PMID:37199045
1304765	Ano6	anoctamin 6	gene	CHEBI:7719	ochratoxin A	increases methylation	EXP		E	RGD:6480464	20160210	CTD	MESH:C025589	ochratoxin A results in increased methylation of ANO6 gene	PMID:26431795
1304765	Ano6	anoctamin 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANO6 mRNA	PMID:27188386
1304765	Ano6	anoctamin 6	gene	CHEBI:81555	Enterolactone	decreases expression	ISO	RGD:1312398	E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ANO6 mRNA	PMID:19167446
1304765	Ano6	anoctamin 6	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA	PMID:19167446
1304765	Ano6	anoctamin 6	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312398	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ANO6 mRNA	PMID:26079696
1304765	Ano6	anoctamin 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312398	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANO6 mRNA	PMID:27188386
1304765	Ano6	anoctamin 6	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ANO6 mRNA	PMID:19281266
1304765	Ano6	anoctamin 6	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312398	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ANO6 mRNA	PMID:38568856
1304765	Ano6	anoctamin 6	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of ANO6 protein	PMID:32519852
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ARHGEF19 mRNA	PMID:33045310
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550020	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ARHGEF19 mRNA	PMID:30319688
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550020	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ARHGEF19 mRNA	PMID:30319688
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312400	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGEF19 mRNA	PMID:31614463
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550020	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ARHGEF19 mRNA	PMID:39298647
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312400	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARHGEF19 mRNA	PMID:37042841
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ARHGEF19 mRNA	PMID:26577399|PMID:27523638
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312400	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of ARHGEF19 mRNA	PMID:26485663
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ARHGEF19 mRNA	PMID:22061828
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312400	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ARHGEF19 mRNA	PMID:28818685
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARHGEF19 mRNA	PMID:36331819
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312400	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGEF19 mRNA	PMID:35301059
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGEF19 mRNA	PMID:37236586
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:23115	chlorohydrocarbon	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D006843	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of ARHGEF19 mRNA	PMID:30744511
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312400	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARHGEF19 mRNA	PMID:22100608
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ARHGEF19 mRNA	PMID:31150632
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARHGEF19 mRNA	PMID:22206623
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550020	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of ARHGEF19 mRNA	PMID:28189721|PMID:28960355
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312400	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ARHGEF19 mRNA	PMID:27594783
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of ARHGEF19 protein	PMID:22006019
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312400	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ARHGEF19 mRNA	PMID:27392435
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGEF19 mRNA	PMID:22298810
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550020	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGEF19 mRNA	PMID:21570461
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGEF19 mRNA	PMID:21215274|PMID:21724226
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGEF19 mRNA	PMID:19770486|PMID:26290441
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARHGEF19 promoter]	PMID:19654925
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C004925	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of ARHGEF19 mRNA	PMID:30744511
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312400	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARHGEF19 mRNA	PMID:33212167
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ARHGEF19 mRNA	PMID:30556269
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGEF19 mRNA	PMID:39631538
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312400	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGEF19 mRNA	PMID:29301061|PMID:39719251
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550020	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGEF19 mRNA	PMID:37682722
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312400	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARHGEF19 5' UTR; Benzo(a)pyrene affects the methylation of ARHGEF19 promoter	PMID:27901495
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ARHGEF19 mRNA	PMID:30556269
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of ARHGEF19 mRNA	PMID:32479839
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550020	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ARHGEF19 gene	PMID:35295148
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ARHGEF19 mRNA	PMID:34492290
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ARHGEF19 mRNA	PMID:23811191
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARHGEF19 mRNA	PMID:19710929
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARHGEF19 mRNA	PMID:25181051
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF19 mRNA	PMID:32145629|PMID:34947998
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312400	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF19 mRNA	PMID:25047013
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGEF19 mRNA	PMID:30816183
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550020	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGEF19 mRNA	PMID:30951980|PMID:32156529
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1550020	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ARHGEF19 promoter	PMID:27312807
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ARHGEF19 mRNA	PMID:25172293
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312400	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ARHGEF19 mRNA	PMID:25979313
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550020	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ARHGEF19 gene	PMID:31683443
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ARHGEF19 mRNA	PMID:39298647
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312400	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARHGEF19 gene	PMID:31601247
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1550020	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARHGEF19 exon	PMID:33297965
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550020	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ARHGEF19 mRNA	PMID:30951980
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550020	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ARHGEF19 mRNA	PMID:30951980
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550020	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ARHGEF19 intron	PMID:28392331
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ARHGEF19 mRNA	PMID:34813904
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ARHGEF19 mRNA	PMID:34813904
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ARHGEF19 mRNA	PMID:17942915
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGEF19 mRNA]	PMID:17942915
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ARHGEF19 mRNA	PMID:32680482
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35036	fentin chloride	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in decreased expression of ARHGEF19 mRNA	PMID:37156404
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGEF19 mRNA	PMID:35163327
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312400	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGEF19 mRNA	PMID:35301059
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGEF19 mRNA	PMID:37236586
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312400	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ARHGEF19 mRNA	PMID:25812627
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGEF19 mRNA	PMID:35163327
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ARHGEF19 mRNA	PMID:28903501
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312400	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ARHGEF19 mRNA	PMID:25812627
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312400	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARHGEF19 mRNA	PMID:31533062
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312400	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ARHGEF19 mRNA	PMID:25812627
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312400	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ARHGEF19 mRNA	PMID:40419075
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARHGEF19 mRNA	PMID:36331819
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312400	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGEF19 mRNA	PMID:25979313
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312400	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGEF19 mRNA	PMID:24383497
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGEF19 mRNA	PMID:21427059
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312400	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ARHGEF19 gene	PMID:29154799
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARHGEF19 mRNA	PMID:19770486
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of ARHGEF19 mRNA	PMID:25123088
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550020	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ARHGEF19 mRNA	PMID:28973697
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ARHGEF19 mRNA	PMID:24136188
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARHGEF19 mRNA	PMID:17562736
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1550020	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of ARHGEF19 mRNA	PMID:35436446
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of ARHGEF19 mRNA	PMID:23962444
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ARHGEF19 mRNA	PMID:24136188
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ARHGEF19 mRNA	PMID:38701926
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of ARHGEF19 mRNA	PMID:24136188
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of ARHGEF19 mRNA	PMID:24136188
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	ISO	RGD:1312400	E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of ARHGEF19 mRNA	PMID:20843944
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20190910	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ARHGEF19 mRNA]	PMID:29891994
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARHGEF19 mRNA	PMID:22206623
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ARHGEF19 mRNA	PMID:24136188
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:77131	sinapic acid	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20230404	CTD	MESH:C073734	sinapinic acid analog results in decreased expression of ARHGEF19 mRNA	PMID:36279966
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312400	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARHGEF19 gene]	PMID:28238834
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of ARHGEF19 mRNA	PMID:19270015
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ARHGEF19 mRNA	PMID:21724226
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARHGEF19 mRNA	PMID:24780913
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ARHGEF19 mRNA	PMID:21346803
1304766	Arhgef19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ARHGEF19 mRNA	PMID:23034163
1304767	Tktl2	transketolase-like 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312402	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of TKTL2 mRNA	PMID:36189433
1304767	Tktl2	transketolase-like 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312402	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TKTL2 mRNA	PMID:36189433
1304767	Tktl2	transketolase-like 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312402	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TKTL2 mRNA	PMID:36189433
1304767	Tktl2	transketolase-like 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312402	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TKTL2 mRNA	PMID:34319233
1304767	Tktl2	transketolase-like 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1604771	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TKTL2 gene	PMID:27153756
1304767	Tktl2	transketolase-like 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604771	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of TKTL2 mRNA	PMID:41430723
1304767	Tktl2	transketolase-like 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312402	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TKTL2 mRNA	PMID:25629700
1304767	Tktl2	transketolase-like 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604771	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TKTL2 gene	PMID:25304211
1304767	Tktl2	transketolase-like 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312402	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TKTL2 protein	PMID:28918527
1304767	Tktl2	transketolase-like 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604771	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TKTL2 promoter	PMID:27901495
1304767	Tktl2	transketolase-like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604771	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TKTL2 exon	PMID:27901495
1304767	Tktl2	transketolase-like 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TKTL2 mRNA	PMID:25181051
1304767	Tktl2	transketolase-like 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604771	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TKTL2 gene	PMID:31601247
1304767	Tktl2	transketolase-like 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TKTL2 gene	PMID:28505145
1304767	Tktl2	transketolase-like 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312402	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of TKTL2 protein	PMID:39748354
1304767	Tktl2	transketolase-like 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604771	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TKTL2 gene	PMID:29154799
1304767	Tktl2	transketolase-like 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604771	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TKTL2 gene	PMID:25304211
1304767	Tktl2	transketolase-like 2	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of TKTL2 mRNA	PMID:29162477
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20250107	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MFSD4B2 mRNA]	PMID:31150632
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of MFSD4B2 protein	PMID:34915118
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:24527	herbicide	multiple interactions	ISO	RGD:1321427	E	RGD:6480464	20220906	CTD	MESH:D006540	[Herbicides results in increased abundance of mesotrione] which affects the methylation of SLC60A2 gene	PMID:34516295
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MFSD4B2 mRNA	PMID:31150632
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20250107	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MFSD4B2 mRNA]	PMID:31150632
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1321427	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of KIAA1919 mRNA	PMID:38460933
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1321427	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SLC60A2 protein	PMID:35688186
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:C030686	acetamide results in decreased expression of MFSD4B2 mRNA	PMID:31881176
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SLC60A2 mRNA	PMID:23557933
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:D002945	Cisplatin results in decreased expression of KIAA1919 mRNA	PMID:27594783
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:D020106	Acrylamide results in decreased expression of SLC60A2 mRNA	PMID:32763439
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SLC60A2 mRNA	PMID:20458559
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of SLC60A2 gene	PMID:31601247
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:D013853	Thioacetamide results in decreased expression of MFSD4B2 mRNA	PMID:23411599
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MFSD4B2 mRNA	PMID:25181051
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of SLC60A2 gene	PMID:31601247
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1321427	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SLC60A2 mRNA	PMID:38568856
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:38321	mesotrione	multiple interactions	ISO	RGD:1321427	E	RGD:6480464	20220906	CTD	MESH:C432907	[Herbicides results in increased abundance of mesotrione] which affects the methylation of SLC60A2 gene	PMID:34516295
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:C473478	Sunitinib results in increased expression of SLC60A2 mRNA	PMID:31533062
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:D014635	Valproic Acid affects the expression of SLC60A2 mRNA	PMID:25979313
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:D014635	Valproic Acid results in increased expression of KIAA1919 mRNA; Valproic Acid results in increased expression of SLC60A2 mRNA	PMID:23179753|PMID:29154799
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC60A2 mRNA	PMID:25562108
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:C012589	trichostatin A affects the expression of SLC60A2 mRNA	PMID:28542535
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1321427	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of KIAA1919 mRNA	PMID:38460933
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1321427	E	RGD:6480464	20220719	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SLC60A2 mRNA	PMID:20458559
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312406	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of SLC60A2-PS1 mRNA	PMID:38701926
1304770	Mfsd4b2	major facilitator superfamily domain containing 4B2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1321427	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SLC60A2 mRNA	PMID:38568856
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312407	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CNOT3 mRNA	PMID:26272509
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312407	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA	PMID:27188386
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CNOT3 mRNA	PMID:33045310
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CNOT3 mRNA	PMID:37995155
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312407	E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CNOT3 mRNA	PMID:32845096
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312407	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CNOT3 mRNA	PMID:22378314
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1312407	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of CNOT3 mRNA	PMID:19937285
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312407	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CNOT3 protein	PMID:37730182
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312407	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CNOT3 mRNA	PMID:28818685
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312408	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNOT3 mRNA	PMID:37236586
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1312407	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of CNOT3 mRNA	PMID:19937285
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312407	E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CNOT3 mRNA	PMID:32845096
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312407	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CNOT3 mRNA	PMID:28903495
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CNOT3 mRNA	PMID:30912803
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312408	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNOT3 mRNA	PMID:21570461
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312407	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CNOT3 mRNA	PMID:23179753|PMID:26272509
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1312407	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNOT3 mRNA	PMID:27188386
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312407	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CNOT3 mRNA	PMID:23649840
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312407	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of CNOT3 protein	PMID:38228842
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312407	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CNOT3 mRNA	PMID:20106945
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312407	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CNOT3 5' UTR	PMID:27901495
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312407	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CNOT3 mRNA	PMID:20018196
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1312407	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of CNOT3 mRNA	PMID:17762391
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312408	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CNOT3 gene	PMID:35295148
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312408	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CNOT3 promoter	PMID:35295148
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312408	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of CNOT3 mRNA	PMID:18648102
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CNOT3 mRNA	PMID:25181051
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312408	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CNOT3 mRNA	PMID:26063408
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312407	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CNOT3 exon	PMID:30157460
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312408	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of CNOT3 mRNA	PMID:34813904
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312407	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNOT3 mRNA	PMID:37042841
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312407	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CNOT3 mRNA	PMID:38568856
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312408	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNOT3 mRNA	PMID:37236586
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312407	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CNOT3 mRNA	PMID:24449571
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312407	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CNOT3 mRNA	PMID:28302478
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312407	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CNOT3 mRNA	PMID:24383497|PMID:24935251|PMID:26272509
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of CNOT3 mRNA	PMID:19136453|PMID:21427059
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312408	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of CNOT3 mRNA	PMID:21427059
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312407	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA	PMID:27188386
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1312407	E	RGD:6480464	20120412	CTD	MESH:D008727	CNOT3 protein affects the susceptibility to Methotrexate	PMID:16217747
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312407	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of CNOT3 mRNA	PMID:24935251
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:5613	haloperidol	decreases expression	ISO	RGD:1312407	E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in decreased expression of CNOT3 protein	PMID:34122009
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312407	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CNOT3 protein	PMID:32959892
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312407	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CNOT3 exon	PMID:30157460
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312408	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CNOT3 mRNA	PMID:22206623
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of CNOT3 mRNA	PMID:33484710
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312407	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNOT3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA	PMID:27188386
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312407	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CNOT3 gene]	PMID:28238834
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CNOT3 mRNA	PMID:19270015
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CNOT3 mRNA	PMID:21278054
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of CNOT3 mRNA	PMID:40826991
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312407	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNOT3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA	PMID:27188386
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1312407	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of CNOT3 mRNA	PMID:17440010
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312407	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CNOT3 mRNA	PMID:38568856
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312407	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CNOT3 mRNA	PMID:29301935
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CNOT3 mRNA	PMID:28973697
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CNOT3 mRNA	PMID:23555832
1304771	Cnot3	CCR4-NOT transcription complex, subunit 3	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CNOT3 mRNA	PMID:23034163
1304772	Tex9	testis expressed 9	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1606392	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TEX9 mRNA	PMID:38218311
1304772	Tex9	testis expressed 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1606392	E	RGD:6480464	20120522	CTD	MESH:D014212	Tretinoin results in increased expression of TEX9 mRNA	PMID:21934132
1304772	Tex9	testis expressed 9	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1606392	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TEX9 mRNA	PMID:21632981
1304772	Tex9	testis expressed 9	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1606392	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TEX9 mRNA	PMID:35811015
1304772	Tex9	testis expressed 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312409	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of TEX9 mRNA	PMID:19484750
1304772	Tex9	testis expressed 9	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1606392	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TEX9 mRNA	PMID:23649840
1304772	Tex9	testis expressed 9	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1606392	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TEX9 mRNA	PMID:36139627
1304772	Tex9	testis expressed 9	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1606392	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TEX9 mRNA	PMID:23649840
1304772	Tex9	testis expressed 9	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of TEX9 mRNA	PMID:21396975
1304772	Tex9	testis expressed 9	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1606392	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TEX9 protein	PMID:20106945
1304772	Tex9	testis expressed 9	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1606392	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TEX9 mRNA	PMID:23649840
1304772	Tex9	testis expressed 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312409	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TEX9 mRNA	PMID:22206623
1304772	Tex9	testis expressed 9	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606392	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TEX9 mRNA	PMID:27392435
1304772	Tex9	testis expressed 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312409	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TEX9 mRNA	PMID:21570461
1304772	Tex9	testis expressed 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TEX9 mRNA	PMID:34747641
1304772	Tex9	testis expressed 9	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606392	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TEX9 mRNA	PMID:33212167
1304772	Tex9	testis expressed 9	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TEX9 mRNA	PMID:28959563
1304772	Tex9	testis expressed 9	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1606392	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TEX9 mRNA	PMID:32763439
1304772	Tex9	testis expressed 9	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1606392	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TEX9 mRNA	PMID:30031762
1304772	Tex9	testis expressed 9	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1606392	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of TEX9 mRNA	PMID:22623647
1304772	Tex9	testis expressed 9	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1606392	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TEX9 gene	PMID:28589171
1304772	Tex9	testis expressed 9	gene	CHEBI:29866	arsenite(3-)	affects expression	ISO	RGD:1606392	E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of TEX9 mRNA	PMID:22959463
1304772	Tex9	testis expressed 9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312409	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TEX9 promoter	PMID:35295148
1304772	Tex9	testis expressed 9	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TEX9 mRNA	PMID:23411599
1304772	Tex9	testis expressed 9	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312409	E	RGD:6480464	20120522	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TEX9 mRNA	PMID:19710929
1304772	Tex9	testis expressed 9	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TEX9 mRNA	PMID:25181051
1304772	Tex9	testis expressed 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312409	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TEX9 mRNA	PMID:33221593
1304772	Tex9	testis expressed 9	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312409	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TEX9 mRNA	PMID:38685157
1304772	Tex9	testis expressed 9	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312409	E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TEX9 mRNA	PMID:21266533
1304772	Tex9	testis expressed 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606392	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TEX9 mRNA	PMID:37042841
1304772	Tex9	testis expressed 9	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606392	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TEX9 mRNA	PMID:38568856
1304772	Tex9	testis expressed 9	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1606392	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TEX9 mRNA	PMID:24449571
1304772	Tex9	testis expressed 9	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1606392	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of TEX9 mRNA	PMID:19691856
1304772	Tex9	testis expressed 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1606392	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TEX9 mRNA	PMID:27153767|PMID:40419075
1304772	Tex9	testis expressed 9	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606392	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TEX9 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:29154799
1304772	Tex9	testis expressed 9	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606392	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX9 mRNA	PMID:27188386
1304772	Tex9	testis expressed 9	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TEX9 mRNA	PMID:30047161
1304772	Tex9	testis expressed 9	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606392	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TEX9 mRNA	PMID:25562108
1304772	Tex9	testis expressed 9	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1606392	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of TEX9 promoter	PMID:27989131
1304772	Tex9	testis expressed 9	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606392	E	RGD:6480464	20120522	CTD	MESH:D016572	Cyclosporine results in increased expression of TEX9 mRNA	PMID:20106945
1304772	Tex9	testis expressed 9	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312409	E	RGD:6480464	20120522	CTD	MESH:D008727	Methotrexate affects the expression of TEX9 mRNA	PMID:18502557
1304772	Tex9	testis expressed 9	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312409	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in increased expression of TEX9 mRNA	PMID:25270620
1304772	Tex9	testis expressed 9	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1606392	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TEX9 mRNA	PMID:26272509
1304772	Tex9	testis expressed 9	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1606392	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX9 mRNA	PMID:27188386
1304772	Tex9	testis expressed 9	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1606392	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TEX9 mRNA	PMID:22230336
1304772	Tex9	testis expressed 9	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1606392	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of TEX9 mRNA	PMID:35811015
1304772	Tex9	testis expressed 9	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1606392	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TEX9 mRNA	PMID:35811015
1304772	Tex9	testis expressed 9	gene	CHEBI:48981	quinolin-8-ol	decreases expression	ISO	RGD:1606392	E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of TEX9 mRNA	PMID:21632981
1304772	Tex9	testis expressed 9	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TEX9 mRNA	PMID:30047161
1304772	Tex9	testis expressed 9	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312409	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TEX9 mRNA	PMID:22206623
1304772	Tex9	testis expressed 9	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1606392	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of TEX9 mRNA	PMID:29522793
1304772	Tex9	testis expressed 9	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1606392	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TEX9 mRNA	PMID:36139627
1304772	Tex9	testis expressed 9	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606392	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX9 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX9 mRNA	PMID:27188386
1304772	Tex9	testis expressed 9	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TEX9 mRNA	PMID:30047161
1304772	Tex9	testis expressed 9	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606392	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX9 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX9 mRNA	PMID:27188386
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1346229	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of COP1 mRNA	PMID:38218311
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1346229	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RFWD2 mRNA	PMID:33167477
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1346229	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of COP1 mRNA	PMID:22378314
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550065	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RFWD2 mRNA	PMID:30319688
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:165198	Bisphenol Z	increases expression	ISO	RGD:1346229	E	RGD:6480464	20260505	CTD	MESH:C517113	bisphenol Z results in increased expression of COP1 mRNA	PMID:40531193
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1550065	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to RFWD2 gene]	PMID:31084621
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1550065	E	RGD:6480464	20130806	CTD	MESH:D014241	Trichloroethylene results in increased expression of COP1 mRNA	PMID:19448997
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550065	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of COP1 mRNA	PMID:33754040
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1346229	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COP1 mRNA	PMID:35301059
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RFWD2 mRNA	PMID:30779732
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346229	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of COP1 mRNA	PMID:40512198
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1550065	E	RGD:6480464	20130806	CTD	MESH:D002945	Cisplatin results in increased expression of COP1 mRNA	PMID:21151649
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550065	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COP1 mRNA	PMID:21570461|PMID:24680724
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COP1 mRNA	PMID:34747641
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346229	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of COP1 mRNA	PMID:33212167
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1346229	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of RFWD2 mRNA	PMID:30911355
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346229	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COP1 mRNA	PMID:38568856
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346229	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of COP1 mRNA	PMID:40512198
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1550065	E	RGD:6480464	20130806	CTD	MESH:D014415	Tunicamycin results in increased expression of COP1 mRNA	PMID:17127020
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346229	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RFWD2 promoter	PMID:27901495
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1346229	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COP1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550065	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of COP1 mRNA	PMID:22228805
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1346229	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of RFWD2 mRNA	PMID:30911355
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550065	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RFWD2 promoter	PMID:35295148
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of COP1 mRNA	PMID:34947998
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of COP1 mRNA	PMID:25181051
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550065	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of COP1 mRNA	PMID:40036665
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:34321	3,3'-Dimethylbisphenol A	increases expression	ISO	RGD:1346229	E	RGD:6480464	20260505	CTD	MESH:C000730511	3,3'-dimethylbisphenol A results in increased expression of COP1 mRNA	PMID:40531193
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1346229	E	RGD:6480464	20260505	CTD	MESH:C543008	bisphenol S results in increased expression of COP1 mRNA	PMID:40531193
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1346229	E	RGD:6480464	20260505	CTD	MESH:C492482	bisphenol B results in increased expression of COP1 mRNA	PMID:40531193
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1550065	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of COP1 mRNA	PMID:28392331
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550065	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of COP1 mRNA	PMID:37019170
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346229	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COP1 mRNA	PMID:37042841
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346229	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of COP1 mRNA	PMID:38568856
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1346229	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COP1 mRNA	PMID:35301059
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1346229	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of COP1 mRNA	PMID:31533062
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1346229	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of COP1 mRNA	PMID:40419075
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1346229	E	RGD:6480464	20180515	CTD	MESH:D014635	Valproic Acid results in decreased methylation of COP1 gene	PMID:29154799
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346229	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in decreased expression of COP1 mRNA	PMID:21420995
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550065	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of COP1 mRNA	PMID:29279043
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346229	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of COP1 mRNA	PMID:40512198
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1346229	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of COP1 mRNA	PMID:36621641
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1346229	E	RGD:6480464	20130806	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of COP1 mRNA	PMID:22079256
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of COP1 mRNA	PMID:30307764
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550065	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COP1 mRNA	PMID:25554681
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550065	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RFWD2 mRNA	PMID:22206623
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1346229	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of COP1 mRNA	PMID:22079256
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1346229	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of COP1 mRNA	PMID:22079256
1304773	Cop1	COP1, E3 ubiquitin ligase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346229	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COP1 gene]; CGP 52608 promotes the reaction [RORA protein binds to RFWD2 gene]	PMID:28238834
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312411	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CASTOR1 mRNA	PMID:37995155
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312411	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CASTOR1 mRNA	PMID:36331819
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312411	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol affects the expression of CASTOR1 mRNA	PMID:19167417
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312411	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CASTOR1 mRNA	PMID:39241906
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:2306475	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of CASTOR1 mRNA	PMID:24758408
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:2306475	E	RGD:6480464	20160412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CASTOR1 mRNA; EGF protein inhibits the reaction [Estradiol results in increased expression of CASTOR1 mRNA]	PMID:24758408|PMID:30165855
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CASTOR1 mRNA	PMID:33387578
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312411	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CASTOR1 mRNA	PMID:37992649
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:2306475	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of GATSL3 mRNA	PMID:33359661
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:2306475	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of CASTOR1 mRNA	PMID:21592394
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:2306475	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CASTOR1 mRNA	PMID:21592394
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312411	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CASTOR1 mRNA	PMID:37992649
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:2306475	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CASTOR1 mRNA	PMID:21592394
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:2306475	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CASTOR1 mRNA	PMID:21592394
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CASTOR1 mRNA	PMID:23630614
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:2306475	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CASTOR1 gene	PMID:25304211
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:2306475	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CASTOR1 mRNA	PMID:32525701
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312411	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of CASTOR1 mRNA	PMID:35897073
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:2306475	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of CASTOR1 mRNA	PMID:23300844
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:2306475	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CASTOR1 mRNA	PMID:27392435
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of CASTOR1 mRNA	PMID:20187946
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CASTOR1 mRNA	PMID:33387578|PMID:34747641
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:2306475	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CASTOR1 mRNA	PMID:30851411
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312411	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of CASTOR1 mRNA	PMID:30807115
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312411	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CASTOR1 mRNA	PMID:37992649
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312411	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GATSL3 promoter	PMID:35295148
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312411	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CASTOR1 mRNA	PMID:35295148
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312411	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of GATSL3 gene	PMID:35295148
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CASTOR1 mRNA	PMID:23411599
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:2306475	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CASTOR1 mRNA	PMID:19710929
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CASTOR1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CASTOR1 mRNA	PMID:25181051
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312411	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of GATSL3 mRNA	PMID:30951980
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312411	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of CASTOR1 exon	PMID:33297965
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312411	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CASTOR1 mRNA	PMID:28392331
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312411	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CASTOR1 mRNA	PMID:37019170
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312411	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CASTOR1 mRNA	PMID:21266533
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CASTOR1 promoter	PMID:22457795
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:2306475	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CASTOR1 mRNA	PMID:31533062
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312411	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CASTOR1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CASTOR1 mRNA	PMID:36331819
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:2306475	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CASTOR1 mRNA	PMID:25979313
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of GATSL3 mRNA	PMID:30047161
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312411	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CASTOR1 mRNA	PMID:37992649
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:2306475	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CASTOR1 mRNA	PMID:38832940
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:2306475	E	RGD:6480464	20180828	CTD	MESH:C012589	trichostatin A affects the expression of CASTOR1 mRNA	PMID:28542535
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CASTOR1 mRNA	PMID:33387578
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:2306475	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of CASTOR1 mRNA	PMID:24714768
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:2306475	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CASTOR1 gene	PMID:25304211
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:2306475	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CASTOR1 mRNA	PMID:32525701
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CASTOR1 mRNA	PMID:29391264
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	ISO	RGD:2306475	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of CASTOR1 mRNA	PMID:38825487
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:2306475	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of CASTOR1 mRNA	PMID:23300844
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of GATSL3 mRNA	PMID:30047161
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1312411	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in increased expression of CASTOR1 mRNA	PMID:25086211
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:2306475	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CASTOR1 mRNA	PMID:30851411
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:2306475	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CASTOR1 mRNA	PMID:32525701
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CASTOR1 mRNA; Propylthiouracil results in decreased expression of GATSL3 mRNA	PMID:24780913|PMID:30047161
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1312411	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of CASTOR1 mRNA	PMID:26217789
1304774	Castor1	cytosolic arginine sensor for mTORC1 subunit 1	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of CASTOR1 protein	PMID:32519852
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CCDC150 mRNA	PMID:33167477
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1606406	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CCDC150 mRNA	PMID:20044591
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1606406	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CCDC150 mRNA	PMID:23649840
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312412	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CCDC150 mRNA	PMID:27106289
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1606406	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of CCDC150 promoter	PMID:21291286
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606406	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCDC150 mRNA	PMID:39836092
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCDC150 mRNA	PMID:33387578
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CCDC150 mRNA	PMID:28959563
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606406	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCDC150 mRNA	PMID:39836092
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606406	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCDC150 promoter	PMID:27901495
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CCDC150 mRNA	PMID:34973136
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1606406	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CCDC150 mRNA	PMID:25895662
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CCDC150 mRNA	PMID:21461292
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased expression of CCDC150 mRNA	PMID:34973136
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312412	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CCDC150 mRNA	PMID:23557971
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1606406	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCDC150 mRNA	PMID:19710929
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CCDC150 mRNA	PMID:25181051
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312412	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CCDC150 mRNA	PMID:32156529
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CCDC150 mRNA; Cadmium Chloride results in decreased expression of CCDC150 protein	PMID:38185225|PMID:38382870
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CCDC150 mRNA	PMID:36326898
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CCDC150 mRNA	PMID:28302478
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CCDC150 mRNA	PMID:31533062
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312412	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CCDC150 mRNA	PMID:17963808
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606406	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CCDC150 mRNA	PMID:25979313
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CCDC150 mRNA	PMID:29154799
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1606406	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CCDC150 gene	PMID:29154799
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CCDC150 mRNA	PMID:20106945|PMID:27989131
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1606406	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCDC150 mRNA	PMID:38832940
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1606406	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CCDC150 mRNA	PMID:27188386
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of CCDC150 mRNA	PMID:26690555|PMID:29067470
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CCDC150 mRNA	PMID:33387578
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1606406	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CCDC150 mRNA	PMID:22230336
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1606406	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of CCDC150 promoter	PMID:21291286
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606406	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCDC150 mRNA	PMID:39836092
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1606406	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CCDC150 mRNA	PMID:21461292
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312412	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CCDC150 mRNA	PMID:25554681
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312412	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CCDC150 mRNA	PMID:38701926
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312412	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CCDC150 mRNA	PMID:22206623
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of CCDC150 mRNA	PMID:27840820
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in increased expression of CCDC150 mRNA	PMID:26720608
1304775	Ccdc150	coiled-coil domain containing 150	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CCDC150 mRNA	PMID:24780913
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:100241	ciprofloxacin	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20180828	CTD	MESH:D002939	[Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of XIRP1 mRNA	PMID:29679711
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312414	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of XIRP1 mRNA	PMID:33045310
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312414	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of XIRP1 mRNA	PMID:37995155
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312413	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of XIRP1 mRNA	PMID:33167477
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of XIRP1 mRNA	PMID:33729688
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:15746	spermine	increases expression	ISO	RGD:1312414	E	RGD:6480464	20150324	CTD	MESH:D013096	Spermine results in increased expression of XIRP1 mRNA	PMID:18673383
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of XIRP1 mRNA	PMID:36841081
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312414	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of XIRP1 mRNA	PMID:30319688
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of XIRP1 mRNA	PMID:30517762
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312413	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of XIRP1 mRNA	PMID:35811015
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312413	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of XIRP1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of XIRP1 mRNA	PMID:35811015
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312413	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of XIRP1 mRNA	PMID:30510588
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of XIRP1 mRNA	PMID:37992649
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of XIRP1 mRNA	PMID:37992649
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of XIRP1 mRNA	PMID:27523638
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of XIRP1 mRNA	PMID:33387578
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of XIRP1 mRNA	PMID:21515302
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312413	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of XIRP1 gene	PMID:27153756
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of XIRP1 mRNA	PMID:30517762
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312413	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of XIRP1 mRNA	PMID:23557933
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312414	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of XIRP1 mRNA	PMID:32186404
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312414	E	RGD:6480464	20150324	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of XIRP1 mRNA	PMID:21570461
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XIRP1 mRNA	PMID:33387578
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:28216	methylmercury chloride	affects expression	EXP		E	RGD:6480464	20150324	CTD	MESH:C004925	methylmercuric chloride affects the expression of XIRP1 mRNA	PMID:20864626
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20180828	CTD	MESH:D019328	[Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of XIRP1 mRNA	PMID:29679711
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312413	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of XIRP1 mRNA	PMID:29803840
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312414	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of XIRP1 mRNA	PMID:39631538
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of XIRP1 mRNA	PMID:37992649
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:28838	lutein	increases expression	ISO	RGD:1312414	E	RGD:6480464	20150324	CTD	MESH:D014975	Lutein results in increased expression of XIRP1 mRNA	PMID:24865317
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312413	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of XIRP1 mRNA	PMID:38568856
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312413	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of XIRP1 5' UTR	PMID:27901495
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312414	E	RGD:6480464	20150324	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XIRP1 mRNA	PMID:22228805
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312413	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of XIRP1 promoter	PMID:27901495
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of XIRP1 mRNA	PMID:38458666
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312414	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of XIRP1 mRNA	PMID:29203145
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of XIRP1 mRNA	PMID:21515302
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312414	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of XIRP1 mRNA	PMID:35295148
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312414	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of XIRP1 enhancer	PMID:35295148
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150324	CTD	MESH:C006780	bisphenol A results in decreased expression of XIRP1 mRNA	PMID:25181051
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312414	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of XIRP1 promoter	PMID:27312807
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312413	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of XIRP1 protein	PMID:37567409
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312414	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of XIRP1 exon; bisphenol S affects the methylation of XIRP1 gene	PMID:31683443|PMID:33297965
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312414	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of XIRP1 mRNA	PMID:30951980
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312414	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of XIRP1 mRNA	PMID:30951980
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312414	E	RGD:6480464	20150324	CTD	MESH:D010269	Paraquat results in increased expression of XIRP1 mRNA	PMID:12595580
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of XIRP1 mRNA	PMID:38458666
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of XIRP1 mRNA	PMID:35163327
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of XIRP1 mRNA	PMID:35163327
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of XIRP1 mRNA	PMID:35163327
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of XIRP1 mRNA	PMID:35163327
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312413	E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in increased expression of XIRP1 mRNA	PMID:22941251
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312414	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of XIRP1 mRNA	PMID:28962523
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312414	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of XIRP1 mRNA	PMID:40194260
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312413	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of XIRP1 gene	PMID:29154799
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of XIRP1 mRNA	PMID:37992649
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312413	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of XIRP1 mRNA	PMID:38832940
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312413	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of XIRP1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of XIRP1 mRNA	PMID:35811015
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:50686	atorvastatin calcium	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20180828	CTD	MESH:D000069059	[Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of XIRP1 mRNA	PMID:29679711
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:D005485	Flutamide results in decreased expression of XIRP1 mRNA	PMID:40381864
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:51397	1,3-dinitrobenzene	affects expression	EXP		E	RGD:6480464	20150324	CTD	MESH:C017906	3-dinitrobenzene affects the expression of XIRP1 mRNA	PMID:24140754
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312413	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of XIRP1 mRNA	PMID:31629900
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of XIRP1 mRNA	PMID:37269647
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312414	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in increased expression of XIRP1 mRNA	PMID:36914120
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of XIRP1 gene	PMID:35440735
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1312413	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of XIRP1 mRNA	PMID:29522793
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of XIRP1 mRNA	PMID:32109520
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312414	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of XIRP1 mRNA	PMID:38648751
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of XIRP1 mRNA	PMID:27935865
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150324	CTD	MESH:D011441	Propylthiouracil results in decreased expression of XIRP1 mRNA	PMID:24780913
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20150324	CTD	MESH:D012999	Soman results in increased expression of XIRP1 mRNA	PMID:19281266
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312413	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of XIRP1 mRNA	PMID:38568856
1304776	Xirp1	xin actin-binding repeat containing 1	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20150324	CTD	MESH:C057693	troglitazone results in decreased expression of XIRP1 mRNA	PMID:21515302
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:10093	yohimbine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D015016	Yohimbine results in increased expression of NRIP3 mRNA	PMID:21983523
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of NRIP3 mRNA	PMID:26272509
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312415	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of NRIP3 mRNA	PMID:27188386
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312416	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NRIP3 mRNA	PMID:33045310
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NRIP3 mRNA]	PMID:31150632
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:144400	dinophysistoxin 1	increases expression	ISO	RGD:1312415	E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of NRIP3 mRNA	PMID:28939011
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRIP3 mRNA	PMID:30529165
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312415	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NRIP3 mRNA	PMID:26079696
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312415	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of NRIP3 mRNA	PMID:22378314
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of NRIP3 mRNA	PMID:30319688
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312415	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of NRIP3 mRNA	PMID:22574217
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of NRIP3 mRNA	PMID:30165855
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312416	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of NRIP3 mRNA	PMID:18978301
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NRIP3 mRNA	PMID:33387578
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312415	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of NRIP3 mRNA	PMID:19162166
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312416	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NRIP3 mRNA	PMID:39922521
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312416	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of NRIP3 mRNA	PMID:33848595
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of NRIP3 mRNA]	PMID:33848595
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312416	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NRIP3 mRNA	PMID:39922521
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NRIP3 mRNA	PMID:31163220
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of NRIP3 mRNA	PMID:26577399
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NRIP3 mRNA	PMID:33387578
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312415	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NRIP3 mRNA	PMID:28818685
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:18243	dopamine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004298	Dopamine results in increased expression of NRIP3 mRNA	PMID:21983523
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NRIP3 mRNA	PMID:39836092
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312415	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of NRIP3 mRNA	PMID:19549813
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NRIP3 mRNA	PMID:33354967
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312416	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NRIP3 mRNA	PMID:19770486
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NRIP3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NRIP3 mRNA	PMID:34911549
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NRIP3 mRNA	PMID:31150632
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NRIP3 mRNA]	PMID:31150632
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NRIP3 mRNA	PMID:21867686
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1312415	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of NRIP3 mRNA	PMID:18414638
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRIP3 mRNA	PMID:39836092
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of NRIP3 mRNA	PMID:26272509
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NRIP3 mRNA	PMID:31881176
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312415	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of NRIP3 mRNA	PMID:28903495
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312415	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of NRIP3 mRNA	PMID:27594783
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20120412	CTD	MESH:D003042	[Cocaine co-treated with FOS protein mutant form] results in increased expression of NRIP3 mRNA	PMID:18355967
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312415	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in increased expression of NRIP3 mRNA	PMID:20884965
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312416	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NRIP3 mRNA	PMID:21570461
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NRIP3 mRNA	PMID:33387578
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312416	E	RGD:6480464	20250708	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NRIP3 mRNA	PMID:39401686
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NRIP3 mRNA	PMID:17942748
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NRIP3 mRNA	PMID:28001369
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312415	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NRIP3 mRNA	PMID:33212167
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NRIP3 mRNA	PMID:30851411
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of NRIP3 mRNA	PMID:26272509
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of NRIP3 mRNA	PMID:28959563
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of NRIP3 mRNA	PMID:21198554
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NRIP3 mRNA	PMID:26033743
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312415	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NRIP3 mRNA	PMID:38568856
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRIP3 mRNA	PMID:39836092
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312415	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NRIP3 promoter	PMID:27901495
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NRIP3 mRNA	PMID:21839799
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312416	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NRIP3 mRNA	PMID:23735875
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312415	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NRIP3 5' UTR	PMID:27901495
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NRIP3 mRNA	PMID:26033743
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312416	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of NRIP3 mRNA	PMID:27131904
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312415	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of NRIP3 mRNA; Silicon Dioxide results in increased expression of NRIP3 mRNA	PMID:25351596|PMID:25895662
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312415	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NRIP3 mRNA	PMID:20458559
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1312416	E	RGD:6480464	20260407	CTD	MESH:D001761	Bleomycin results in increased expression of NRIP3 mRNA	PMID:40912499
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312416	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NRIP3 promoter	PMID:35295148
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NRIP3 mRNA	PMID:34492290
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NRIP3 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NRIP3 mRNA	PMID:29275510
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312416	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of NRIP3 mRNA	PMID:32156529
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NRIP3 mRNA	PMID:25181051
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of NRIP3 mRNA	PMID:32680482
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NRIP3 mRNA	PMID:39836092
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312415	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of NRIP3 mRNA	PMID:19320972|PMID:19376846
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312415	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NRIP3 mRNA	PMID:25979313
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of NRIP3 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312415	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of NRIP3 mRNA	PMID:19101580|PMID:23179753|PMID:27188386
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312416	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of NRIP3 mRNA	PMID:21427059
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of NRIP3 mRNA	PMID:38685447
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312416	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NRIP3 mRNA	PMID:39922521
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of NRIP3 mRNA	PMID:24935251|PMID:26272509
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NRIP3 mRNA	PMID:33387578
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312415	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of NRIP3 mRNA	PMID:24714768
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1312415	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of NRIP3 mRNA	PMID:18414638
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRIP3 mRNA	PMID:39836092
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in increased expression of NRIP3 mRNA	PMID:36653537
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NRIP3 mRNA	PMID:29391264
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NRIP3 mRNA	PMID:17942748
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of NRIP3 mRNA	PMID:26272509
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312415	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NRIP3 mRNA	PMID:20458559
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:5002	fenoldopam	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D018818	Fenoldopam results in increased expression of NRIP3 mRNA	PMID:21983523
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of NRIP3 mRNA	PMID:30307764
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312416	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NRIP3 mRNA; Nanotubes, Carbon results in increased expression of NRIP3 mRNA	PMID:25554681
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of NRIP3 mRNA	PMID:31881178
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of NRIP3 mRNA	PMID:21983209
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of NRIP3 mRNA	PMID:20830808
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of NRIP3 mRNA	PMID:20080153
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NRIP3 mRNA	PMID:39836092
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1312415	E	RGD:6480464	20120412	CTD	MESH:D019772	NRIP3 protein affects the susceptibility to Topotecan	PMID:16217747
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	ISO	RGD:1312415	E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in increased expression of NRIP3 mRNA	PMID:16982809
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:70778	GW 7647	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C453899	GW 7647 results in decreased expression of NRIP3 mRNA	PMID:31628012
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of NRIP3 mRNA	PMID:31758290
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312416	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NRIP3 mRNA	PMID:22206623
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20160315	CTD	MESH:C072553	[MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of NRIP3 mRNA	PMID:25566086
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312415	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of NRIP3 mRNA	PMID:22714537
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312415	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NRIP3 mRNA	PMID:37199045
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NRIP3 mRNA	PMID:30851411
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NRIP3 gene]	PMID:28238834
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NRIP3 mRNA	PMID:32109520
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312415	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of NRIP3 mRNA	PMID:26079696
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NRIP3 mRNA	PMID:24780913
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of NRIP3 mRNA	PMID:36843608
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1312415	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of NRIP3 mRNA	PMID:26272509
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of NRIP3 mRNA	PMID:29162477
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312415	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312416	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of NRIP3 mRNA	PMID:27131904
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NRIP3 mRNA	PMID:19281266
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1312415	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in increased expression of NRIP3 mRNA	PMID:31863870
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312415	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NRIP3 mRNA	PMID:38568856
1304777	Nrip3	nuclear receptor interacting protein 3	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of NRIP3 mRNA	PMID:22615374
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1312417	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of CERCAM mRNA	PMID:31863870
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of CERCAM mRNA	PMID:25152437
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1621421	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CERCAM mRNA	PMID:36331819
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312417	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CERCAM mRNA	PMID:30165855
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312417	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CERCAM mRNA	PMID:37042841
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1621421	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CERCAM mRNA	PMID:33754040
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CERCAM mRNA	PMID:33387578
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1621421	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of CERCAM mRNA	PMID:39984025
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312417	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of CERCAM mRNA	PMID:24376830
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CERCAM mRNA	PMID:19480007
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312417	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of CERCAM mRNA	PMID:24768652
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621421	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CERCAM mRNA	PMID:21570461
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CERCAM mRNA	PMID:34747641
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1621421	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CERCAM mRNA	PMID:19465110
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312417	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CERCAM mRNA	PMID:33212167
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CERCAM mRNA	PMID:28959563
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312417	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CERCAM mRNA	PMID:32763439
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of CERCAM mRNA	PMID:30556269
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312417	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CERCAM mRNA	PMID:29803840
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621421	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CERCAM mRNA	PMID:37682722
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312417	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CERCAM promoter	PMID:27901495
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of CERCAM mRNA	PMID:30556269
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1621421	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CERCAM promoter	PMID:35295148
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CERCAM mRNA	PMID:25181051
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312417	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CERCAM mRNA; bisphenol A results in decreased expression of CERCAM protein	PMID:31675489|PMID:36232920
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312417	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of CERCAM protein	PMID:34186270
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312417	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CERCAM mRNA	PMID:25979313
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312417	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CERCAM protein	PMID:34186270
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312417	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CERCAM protein	PMID:34186270
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CERCAM mRNA	PMID:21266533
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1621421	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of CERCAM mRNA	PMID:36117858
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312417	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CERCAM mRNA	PMID:37042841
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CERCAM mRNA	PMID:35163327
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CERCAM promoter	PMID:22457795
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CERCAM mRNA	PMID:33453195
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CERCAM mRNA	PMID:35163327
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CERCAM mRNA	PMID:27387713
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621421	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CERCAM mRNA	PMID:36331819
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1621421	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CERCAM mRNA	PMID:28973697
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CERCAM mRNA	PMID:33387578
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312417	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CERCAM mRNA	PMID:31675489
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1621421	E	RGD:6480464	20150127	CTD	MESH:D005047	Etoposide results in increased expression of CERCAM mRNA	PMID:25270620
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1621421	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of CERCAM mRNA	PMID:36117858
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312417	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CERCAM gene]	PMID:28238834
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1312417	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CERCAM protein	PMID:31675489
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1312417	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CERCAM protein	PMID:31675489
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1621421	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of CERCAM mRNA	PMID:27029645
1304778	Cercam	cerebral endothelial cell adhesion molecule	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CERCAM mRNA	PMID:24780913
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312419	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LRRC23 mRNA	PMID:33045310
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1604054	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of LRRC23 mRNA	PMID:22378314
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1604054	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of LRRC23 protein	PMID:18951874
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LRRC23 mRNA	PMID:33387578
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312419	E	RGD:6480464	20240806	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LRRC23 mRNA; Diethylhexyl Phthalate results in decreased expression of LRRC23 protein	PMID:36356568
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312419	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LRRC23 mRNA	PMID:34319233
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LRRC23 mRNA	PMID:26577399
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LRRC23 mRNA	PMID:33387578
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604054	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LRRC23 mRNA	PMID:19549813
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of LRRC23 mRNA	PMID:28623178
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312419	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LRRC23 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LRRC23 mRNA	PMID:34911549
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1604054	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of LRRC23 mRNA	PMID:28903495
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312419	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRRC23 mRNA	PMID:21570461
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312419	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRRC23 mRNA	PMID:33956508
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRRC23 mRNA	PMID:33387578
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1604054	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRRC23 mRNA	PMID:22903824
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1604054	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of LRRC23 protein	PMID:18951874
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of LRRC23 mRNA	PMID:26033743
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312419	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of LRRC23 protein	PMID:28918527
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604054	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LRRC23 mRNA	PMID:29803840
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604054	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRRC23 promoter	PMID:27901495
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604054	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRRC23 3' UTR	PMID:27901495
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRRC23 mRNA	PMID:21839799
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604054	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LRRC23 5' UTR	PMID:27901495
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of LRRC23 mRNA	PMID:26033743
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of LRRC23 mRNA	PMID:11578147
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312419	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of LRRC23 mRNA	PMID:23557971
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312419	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of LRRC23 mRNA	PMID:27760801|PMID:29264374
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LRRC23 mRNA	PMID:25181051
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRC23 mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:41034487
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312419	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of LRRC23 promoter	PMID:27312807
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604054	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LRRC23 gene	PMID:31601247
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of LRRC23 mRNA	PMID:41034487
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312419	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of LRRC23 mRNA	PMID:30951980
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LRRC23 gene	PMID:28505145
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312419	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LRRC23 mRNA	PMID:30951980
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312419	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LRRC23 mRNA	PMID:30951980
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1604054	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of LRRC23 mRNA	PMID:25812627
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1604054	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRRC23 mRNA	PMID:25812627
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312419	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LRRC23 mRNA	PMID:40194260
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1604054	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LRRC23 mRNA	PMID:25812627
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312419	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of LRRC23 mRNA	PMID:23125180
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1604054	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LRRC23 gene	PMID:29154799
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in increased expression of LRRC23 mRNA	PMID:38685447
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312419	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of LRRC23 mRNA	PMID:17555576
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312419	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of LRRC23 mRNA	PMID:28973697
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312419	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LRRC23 mRNA	PMID:17562736
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312419	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of LRRC23 mRNA	PMID:17555576
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1312419	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of LRRC23 mRNA	PMID:17942748
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1604054	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of LRRC23 mRNA	PMID:17908484
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312419	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LRRC23 mRNA; Nanotubes, Carbon results in decreased expression of LRRC23 mRNA	PMID:25554681
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of LRRC23 mRNA	PMID:22504374
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of LRRC23 protein	PMID:24140754
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312419	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of LRRC23 mRNA	PMID:38701926
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases methylation	ISO	RGD:1604054	E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased methylation of LRRC23 intron	PMID:29432895
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1604054	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of LRRC23 mRNA	PMID:37199045
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of LRRC23 mRNA	PMID:33484710
1304779	Lrrc23	leucine rich repeat containing 23	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of LRRC23 mRNA	PMID:22504374|PMID:24780913
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312421	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SPATS2 mRNA	PMID:20188158
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312421	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SPATS2 mRNA	PMID:30319688
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312420	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SPATS2 mRNA	PMID:37042841
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312420	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SPATS2 mRNA	PMID:23649840
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312420	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SPATS2 mRNA	PMID:21179406
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312420	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SPATS2 mRNA	PMID:28818685
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312421	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPATS2 mRNA	PMID:36331819
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312420	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SPATS2 mRNA	PMID:23649840
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312420	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SPATS2 mRNA	PMID:23649840
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312420	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SPATS2 mRNA	PMID:22171008
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312421	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPATS2 mRNA	PMID:25629700
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312420	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SPATS2 mRNA	PMID:23557933
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1312420	E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of SPATS2 mRNA	PMID:37386098
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPATS2 mRNA	PMID:34747641
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312421	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of SPATS2 mRNA	PMID:32937126
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312420	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SPATS2 mRNA	PMID:28001369
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312420	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SPATS2 mRNA	PMID:32763439
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312420	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPATS2 protein	PMID:30528433
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312421	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPATS2 protein	PMID:29044176
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312420	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SPATS2 mRNA	PMID:38568856
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312420	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite inhibits the reaction [SPATS2 protein binds to Ribonucleotides]	PMID:30528433
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312420	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SPATS2 promoter	PMID:27901495
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312421	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPATS2 mRNA	PMID:22228805
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312421	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to SPATS2 promoter]	PMID:19654925
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312420	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SPATS2 mRNA	PMID:22171008
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312420	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPATS2 gene; [bisphenol S co-treated with Fulvestrant] results in decreased methylation of SPATS2 gene	PMID:31601247
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312421	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPATS2 gene; titanium dioxide results in decreased methylation of SPATS2 promoter	PMID:35295148
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SPATS2 mRNA	PMID:23411599
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SPATS2 mRNA	PMID:34947998
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312420	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of SPATS2 mRNA	PMID:17989879
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SPATS2 gene	PMID:28505145
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312420	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPATS2 gene	PMID:31601247
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312421	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SPATS2 mRNA	PMID:39298647
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312420	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of SPATS2 gene	PMID:31601247
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312421	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of SPATS2 mRNA	PMID:36117858
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312420	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SPATS2 mRNA	PMID:37042841
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312420	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SPATS2 mRNA	PMID:24449571
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312420	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SPATS2 mRNA	PMID:31533062
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312421	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPATS2 mRNA	PMID:36331819
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SPATS2 mRNA	PMID:38685447|PMID:41580965
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1312421	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of SPATS2 mRNA	PMID:25123088
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312421	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SPATS2 mRNA	PMID:25554681
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of SPATS2 mRNA	PMID:41580965
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312421	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of SPATS2 mRNA	PMID:36117858
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312420	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SPATS2 protein	PMID:32959892
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312421	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SPATS2 mRNA	PMID:22206623
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312420	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SPATS2 mRNA	PMID:37199045
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312421	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SPATS2 mRNA	PMID:31388691
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SPATS2 mRNA	PMID:23640034
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312421	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SPATS2 mRNA	PMID:39847705
1304780	Spats2	spermatogenesis associated, serine-rich 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312420	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SPATS2 mRNA	PMID:38568856
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1312422	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of TRIT1 mRNA	PMID:11906190
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TRIT1 mRNA	PMID:33167477
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312423	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TRIT1 mRNA	PMID:36331819
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TRIT1 mRNA	PMID:22378314
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312423	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TRIT1 mRNA	PMID:39298647
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TRIT1 gene	PMID:27618143
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312422	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIT1 mRNA	PMID:37042841
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TRIT1 mRNA	PMID:36314267
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312423	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TRIT1 mRNA	PMID:34319233
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312422	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of TRIT1 protein	PMID:37730182
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TRIT1 mRNA	PMID:33387578
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312423	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRIT1 mRNA	PMID:37236586
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312423	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRIT1 mRNA	PMID:19770486
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1312423	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRIT1 protein	PMID:39910959
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312422	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TRIT1 mRNA	PMID:35430440
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRIT1 mRNA	PMID:31150632
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312422	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRIT1 gene	PMID:25304211
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TRIT1 mRNA	PMID:19244175
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312422	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TRIT1 protein	PMID:35688186
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312422	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TRIT1 mRNA	PMID:23557933
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312423	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIT1 mRNA	PMID:21570461
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIT1 mRNA	PMID:33387578
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312423	E	RGD:6480464	20120515	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TRIT1 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TRIT1 promoter]	PMID:19654925|PMID:25975270
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TRIT1 mRNA	PMID:30556269
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRIT1 mRNA	PMID:29803840
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRIT1 mRNA	PMID:38568856
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312422	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRIT1 promoter	PMID:27901495
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TRIT1 mRNA	PMID:30556269
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TRIT1 mRNA	PMID:23411599
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312423	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TRIT1 mRNA	PMID:18301758|PMID:23811191
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIT1 mRNA	PMID:25181051
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIT1 mRNA	PMID:20678512
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TRIT1 mRNA	PMID:30816183|PMID:34947998
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of TRIT1 mRNA	PMID:19244175
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312423	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TRIT1 mRNA	PMID:38685157
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312423	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of TRIT1 mRNA	PMID:34813904
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TRIT1 mRNA	PMID:33453195
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312423	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRIT1 mRNA	PMID:37236586
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312422	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of TRIT1 mRNA	PMID:19376846
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TRIT1 mRNA	PMID:19244175
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TRIT1 mRNA	PMID:28302478
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312422	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TRIT1 mRNA	PMID:31533062
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312423	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TRIT1 mRNA	PMID:36331819
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312423	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TRIT1 mRNA	PMID:17292431
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRIT1 mRNA	PMID:23179753
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312422	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of TRIT1 mRNA	PMID:29154799
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312423	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TRIT1 mRNA	PMID:28973697
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIT1 mRNA	PMID:25704631
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312423	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TRIT1 mRNA	PMID:29279043
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312422	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRIT1 gene	PMID:25304211
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TRIT1 mRNA	PMID:24136188
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312422	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRIT1 gene]	PMID:28238834
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:80799	Bufotalin	increases expression	ISO	RGD:1312422	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of TRIT1 mRNA	PMID:39904859
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRIT1 mRNA	PMID:21346803
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1312422	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of TRIT1 mRNA	PMID:11906190
1304781	Trit1	tRNA isopentenyltransferase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TRIT1 mRNA	PMID:21346803
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550090	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of RPRD1B mRNA	PMID:33045310
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1550090	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of RPRD1B mRNA	PMID:16604517
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA	PMID:25510870
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RPRD1B gene	PMID:27618143
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312424	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RPRD1B protein	PMID:37730182
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RPRD1B mRNA	PMID:36331819
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312424	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPRD1B mRNA	PMID:35301059
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA	PMID:25510870
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA	PMID:25510870
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312424	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RPRD1B mRNA	PMID:19549813
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312424	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RPRD1B mRNA	PMID:23649840
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312424	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RPRD1B mRNA	PMID:21867686
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312424	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RPRD1B protein	PMID:35688186
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1550090	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RPRD1B protein	PMID:25505154
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550090	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPRD1B mRNA	PMID:21570461
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312424	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of RPRD1B protein	PMID:35688186
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312424	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of RPRD1B mRNA	PMID:29319823
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312424	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RPRD1B protein	PMID:20097212
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550090	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RPRD1B mRNA	PMID:22228805
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312424	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of RPRD1B gene	PMID:31601247
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1312424	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of RPRD1B mRNA	PMID:31745603
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1550090	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of RPRD1B gene	PMID:35295148
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550090	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RPRD1B promoter	PMID:35295148
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550090	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of RPRD1B mRNA	PMID:29264374
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RPRD1B mRNA	PMID:25181051
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of RPRD1B mRNA	PMID:30816183
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312424	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of RPRD1B protein	PMID:37567409
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550090	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RPRD1B mRNA	PMID:26063408|PMID:33221593
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1312424	E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of RPRD1B mRNA	PMID:23146750
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA	PMID:25510870
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA	PMID:25510870
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550090	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of RPRD1B gene	PMID:31683443
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550090	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RPRD1B mRNA	PMID:39298647
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550090	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RPRD1B mRNA	PMID:38685157
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312424	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPRD1B mRNA	PMID:28628672
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1550090	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of RPRD1B mRNA	PMID:28392331
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550090	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RPRD1B mRNA	PMID:34813904
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312424	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPRD1B mRNA	PMID:28628672
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1550090	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of RPRD1B mRNA	PMID:34813904
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312424	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RPRD1B protein	PMID:24527689
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312424	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPRD1B mRNA	PMID:35301059
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RPRD1B mRNA	PMID:36331819
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312424	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RPRD1B mRNA	PMID:25979313
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312424	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of RPRD1B mRNA; Valproic Acid results in decreased expression of RPRD1B protein	PMID:29501571
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312424	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of RPRD1B gene	PMID:29501571
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312424	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPRD1B mRNA	PMID:28628672
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550090	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RPRD1B mRNA	PMID:17562736
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312424	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of RPRD1B mRNA	PMID:21420995
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1312424	E	RGD:6480464	20120412	CTD	MESH:D005472	RPRD1B protein affects the susceptibility to Fluorouracil	PMID:15331170
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1312424	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of RPRD1B mRNA	PMID:15331170
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312424	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPRD1B mRNA	PMID:28628672
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312424	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPRD1B protein	PMID:32959892
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550090	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RPRD1B mRNA	PMID:22206623
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of RPRD1B mRNA	PMID:27840820
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312424	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RPRD1B protein	PMID:37664457
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:7602	nobiletin	multiple interactions	ISO	RGD:1312424	E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in increased expression of RPRD1B protein]	PMID:38348393
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312424	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in increased expression of RPRD1B protein	PMID:38348393
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312424	E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in increased expression of RPRD1B protein]	PMID:38348393
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:8772	raloxifene	affects response to substance	ISO	RGD:1312424	E	RGD:6480464	20230801	CTD	MESH:D020849	RPRD1B protein affects the susceptibility to Raloxifene Hydrochloride	PMID:24452636
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312424	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RPRD1B protein	PMID:37664457
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550090	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RPRD1B mRNA	PMID:28973697
1304782	Rprd1b	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of RPRD1B mRNA	PMID:23869203
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1552021	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of DOHH protein	PMID:36252740
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552021	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of DOHH mRNA	PMID:33045310
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552021	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DOHH mRNA	PMID:20188158
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1552021	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of DOHH mRNA	PMID:40945087
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606491	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of DOHH mRNA	PMID:23019147
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1606491	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of DOHH mRNA	PMID:38568856
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606491	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DOHH mRNA	PMID:37042841
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1606491	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of DOHH mRNA	PMID:33359661
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DOHH mRNA	PMID:33387578
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1606491	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DOHH mRNA	PMID:22100608
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DOHH mRNA	PMID:31150632
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1552021	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of DOHH mRNA	PMID:25629700
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552021	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DOHH mRNA	PMID:22206623
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552021	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of DOHH mRNA	PMID:40504410
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1606491	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DOHH mRNA	PMID:19244175
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1606491	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of DOHH mRNA	PMID:19244175
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1606491	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of DOHH mRNA	PMID:27392435
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1606491	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of DOHH mRNA	PMID:23019147
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552021	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DOHH mRNA	PMID:24680724
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DOHH mRNA	PMID:33387578
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606491	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DOHH mRNA	PMID:33212167
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552021	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of DOHH mRNA	PMID:36209798
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606491	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of DOHH protein	PMID:38228842
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606491	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DOHH mRNA	PMID:38568856|PMID:39719251
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552021	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of DOHH mRNA	PMID:40504410
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552021	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DOHH mRNA	PMID:27195522
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1606491	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of DOHH mRNA	PMID:23806026|PMID:25895662
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1606491	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of DOHH mRNA	PMID:38568856
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1606491	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of DOHH mRNA	PMID:38568856
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552021	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of DOHH mRNA	PMID:27760801
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of DOHH mRNA	PMID:33296240
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552021	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of DOHH mRNA	PMID:35598803
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1606491	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DOHH gene	PMID:31601247
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DOHH mRNA	PMID:25181051|PMID:34947998
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DOHH mRNA	PMID:36041667
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1606491	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of DOHH mRNA	PMID:19244175
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1606491	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of DOHH mRNA	PMID:19244175
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DOHH mRNA	PMID:36041667
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DOHH mRNA	PMID:36041667
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1606491	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of DOHH gene	PMID:22964155
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of DOHH mRNA	PMID:32680482
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606491	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DOHH mRNA	PMID:38568856
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of DOHH promoter	PMID:22457795
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1606491	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of DOHH mRNA	PMID:19376846
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1606491	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DOHH mRNA	PMID:19244175
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1606491	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of DOHH mRNA	PMID:19244175
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552021	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of DOHH mRNA	PMID:17585979
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1606491	E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of DOHH mRNA	PMID:38568856
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1606491	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DOHH mRNA	PMID:40419075
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552021	E	RGD:6480464	20120515	CTD	MESH:D014635	Valproic Acid affects the expression of DOHH mRNA	PMID:17963808
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1606491	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DOHH gene	PMID:29154799
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1606491	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DOHH mRNA	PMID:38832940
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552021	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen affects the expression of DOHH mRNA	PMID:17562736
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552021	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of DOHH mRNA	PMID:40504410
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of DOHH mRNA	PMID:29391264
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1606491	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of DOHH mRNA	PMID:38568856
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1606491	E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in increased expression of DOHH mRNA	PMID:21783983
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552021	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DOHH mRNA	PMID:35964746
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DOHH mRNA	PMID:24136188
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552021	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DOHH mRNA	PMID:22206623
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of DOHH mRNA	PMID:24136188
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1606491	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DOHH mRNA	PMID:37199045
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1606491	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of DOHH mRNA	PMID:19946333
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1606491	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of DOHH mRNA]	PMID:19946333
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of DOHH mRNA	PMID:32109520
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552021	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DOHH mRNA	PMID:30294300
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552021	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of DOHH mRNA	PMID:40826991
1304783	Dohh	deoxyhypusine hydroxylase	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1606491	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DOHH mRNA	PMID:38568856
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312427	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LMX1A mRNA	PMID:33045310
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMX1A gene	PMID:20938992
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMX1A gene	PMID:20938992
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LMX1A mRNA	PMID:26577399
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312426	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LMX1A mRNA	PMID:35301059
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LMX1A mRNA	PMID:40850461
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312426	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LMX1A gene	PMID:27153756
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMX1A gene	PMID:20938992
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:27496	simazine	decreases expression	ISO	RGD:1312427	E	RGD:6480464	20220809	CTD	MESH:D012839	Simazine results in decreased expression of LMX1A mRNA; Simazine results in decreased expression of LMX1A protein	PMID:34936186
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:27496	simazine	increases expression	ISO	RGD:1312427	E	RGD:6480464	20210706	CTD	MESH:D012839	Simazine results in increased expression of LMX1A mRNA; Simazine results in increased expression of LMX1A protein	PMID:32822773
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:27496	simazine	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20210706	CTD	MESH:D012839	LMX1A protein promotes the reaction [Simazine results in increased expression of NR4A2 mRNA]; LMX1A protein promotes the reaction [Simazine results in increased expression of NR4A2 protein]; LMX1A protein promotes the reaction [Simazine results in increased expression of PITX3 mRNA]; LMX1A protein promotes the reaction [Simazine results in increased expression of PITX3 protein]; LMX1A protein promotes the reaction [Simazine results in increased expression of TH protein]; LMX1A protein promotes the reaction [Simazine results in increased expression of WNT1 mRNA]; LMX1A protein promotes the reaction [Simazine results in increased expression of WNT1 protein]	PMID:32822773
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312426	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LMX1A mRNA	PMID:23557933
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of LMX1A gene	PMID:28505145
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312427	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LMX1A mRNA	PMID:24058054
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312426	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LMX1A mRNA	PMID:28001369
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of LMX1A mRNA	PMID:28959563
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	ISO	RGD:1312426	E	RGD:6480464	20120412	CTD	MESH:C028473	LMX1A gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312426	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LMX1A mRNA	PMID:29301061
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312427	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of LMX1A mRNA	PMID:36209798
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312426	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LMX1A intron; Benzo(a)pyrene affects the methylation of LMX1A promoter	PMID:27901495|PMID:30157460
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312427	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LMX1A mRNA	PMID:27195522
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312426	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LMX1A 3' UTR; Benzo(a)pyrene results in increased methylation of LMX1A 5' UTR	PMID:27901495
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312426	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of LMX1A promoter	PMID:23974009
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312426	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of LMX1A mRNA	PMID:20458559
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of LMX1A mRNA	PMID:24395379
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312426	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of LMX1A gene	PMID:31601247
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312427	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LMX1A promoter	PMID:35295148
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312427	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of LMX1A mRNA	PMID:18648102
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312427	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of LMX1A promoter	PMID:27334623
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LMX1A mRNA	PMID:25181051
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LMX1A mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312427	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of LMX1A mRNA	PMID:30951980
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LMX1A gene	PMID:28505145
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of LMX1A gene	PMID:28505145
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312426	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of LMX1A gene	PMID:31601247
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312426	E	RGD:6480464	20191210	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of LMX1A mRNA	PMID:31326446
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312427	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of LMX1A mRNA	PMID:40203079
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312427	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LMX1A mRNA	PMID:30951980
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in decreased expression of LMX1A mRNA]	PMID:40203079
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312427	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LMX1A mRNA	PMID:30951980
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312427	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LMX1A intron	PMID:28392331
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35004	Tetrachlorobisphenol A	decreases expression	ISO	RGD:1312426	E	RGD:6480464	20191210	CTD	MESH:C041181	tetrachlorodian results in decreased expression of LMX1A mRNA	PMID:31326446
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LMX1A mRNA	PMID:35163327
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of LMX1A mRNA	PMID:30723492
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312426	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LMX1A mRNA	PMID:35301059
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LMX1A mRNA	PMID:40850461
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LMX1A mRNA	PMID:35163327
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312426	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LMX1A mRNA	PMID:25979313
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312426	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of LMX1A mRNA	PMID:26272509
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312426	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMX1A mRNA	PMID:27188386
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1312426	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of LMX1A promoter	PMID:29626692
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1312426	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of LMX1A promoter	PMID:29626692
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1312426	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of LMX1A gene	PMID:29523930
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312426	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of LMX1A mRNA	PMID:20458559
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312426	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMX1A mRNA	PMID:27188386
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312426	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LMX1A gene]	PMID:28238834
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312426	E	RGD:6480464	20191210	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of LMX1A mRNA	PMID:31326446
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312426	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of LMX1A mRNA	PMID:26079696
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LMX1A mRNA	PMID:25825206
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:8887	rofecoxib	increases expression	ISO	RGD:1312426	E	RGD:6480464	20170303	CTD	MESH:C116926	rofecoxib results in increased expression of LMX1A mRNA	PMID:17070997
1304784	Lmx1a	LIM homeobox transcription factor 1 alpha	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312426	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMX1A mRNA	PMID:27188386
1304785	Mospd4	motile sperm domain containing 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D014241	Trichloroethylene results in increased expression of MOSPD4 mRNA	PMID:33387578
1304785	Mospd4	motile sperm domain containing 4	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C010974	Glyphosate results in decreased expression of MOSPD4 mRNA	PMID:38314887
1304785	Mospd4	motile sperm domain containing 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of MOSPD4 mRNA	PMID:25181051
1304785	Mospd4	motile sperm domain containing 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MOSPD4 mRNA	PMID:21266533
1304785	Mospd4	motile sperm domain containing 4	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C017690	fenvalerate results in increased expression of MOSPD4 mRNA	PMID:30307764
1304785	Mospd4	motile sperm domain containing 4	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D005485	Flutamide results in increased expression of MOSPD4 mRNA	PMID:24793618
1304785	Mospd4	motile sperm domain containing 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MOSPD4 mRNA	PMID:24780913
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312430	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RBPJL mRNA	PMID:33045310
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RBPJL mRNA	PMID:36189433
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of RBPJL mRNA	PMID:36841081
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RBPJL mRNA	PMID:36189433
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:172946	3-methylfuran	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C039851	3-methylfuran results in increased expression of RBPJL mRNA	PMID:38160780
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312430	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RBPJL mRNA	PMID:33484791
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20210608	CTD	MESH:D004051	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in increased expression of RBPJL mRNA; [Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of RBPJL mRNA	PMID:31606821|PMID:33484791
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RBPJL mRNA	PMID:27523638
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RBPJL mRNA	PMID:30779732
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312430	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of RBPJL mRNA	PMID:25629700
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RBPJL mRNA	PMID:31881176
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312429	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RBPJL mRNA	PMID:23557933
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312430	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBPJL mRNA	PMID:24058054
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RBPJL mRNA	PMID:32109520|PMID:33387578
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312429	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RBPJL mRNA	PMID:33212167
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20231031	CTD	MESH:D015084	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312429	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RBPJL mRNA	PMID:38568856
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312429	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RBPJL 3' UTR	PMID:27901495
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312429	E	RGD:6480464	20160719	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of RBPJL gene	PMID:25435355
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RBPJL mRNA	PMID:30047161
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312430	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBPJL promoter	PMID:35295148
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RBPJL mRNA	PMID:34492290
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312430	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of RBPJL promoter	PMID:27334623
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RBPJL mRNA	PMID:25181051|PMID:34947998
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312430	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of RBPJL exon	PMID:33297965
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1312430	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of RBPJL mRNA	PMID:26377693
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312430	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of RBPJL mRNA	PMID:26377693
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of RBPJL mRNA	PMID:32680482
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of RBPJL mRNA	PMID:30723492
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RBPJL mRNA	PMID:33453195
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312429	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RBPJL mRNA	PMID:38568856
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312430	E	RGD:6480464	20220308	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RBPJL mRNA	PMID:34666113
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of RBPJL mRNA	PMID:25539665|PMID:38160780
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of RBPJL mRNA	PMID:30047161
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312430	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RBPJL mRNA	PMID:17963808
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312429	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RBPJL gene	PMID:29154799
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RBPJL mRNA	PMID:30047161|PMID:38685447
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of RBPJL mRNA	PMID:41580965
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312430	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of RBPJL mRNA	PMID:30529165
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RBPJL mRNA	PMID:29391264
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312430	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RBPJL mRNA	PMID:25554681
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RBPJL mRNA	PMID:30047161
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312430	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of RBPJL mRNA	PMID:26377693
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of RBPJL mRNA	PMID:28801915
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RBPJL mRNA	PMID:28801915
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1312430	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of RBPJL mRNA	PMID:22078008
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:6842	methoxychlor	increases methylation	EXP		E	RGD:6480464	20130611	CTD	MESH:D008731	Methoxychlor results in increased methylation of RBPJL gene	PMID:23303685
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in decreased methylation of RBPJL promoter	PMID:27415467
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312429	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RBPJL gene]	PMID:28238834
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of RBPJL mRNA	PMID:32109520
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RBPJL mRNA	PMID:30047161
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1312430	E	RGD:6480464	20250401	CTD	MESH:D013311	Streptozocin results in increased expression of RBPJL mRNA	PMID:31606821
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in increased expression of RBPJL mRNA; [Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of RBPJL mRNA	PMID:31606821|PMID:33484791
1304786	Rbpjl	recombination signal binding protein for immunoglobulin kappa J region-like	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of RBPJL mRNA	PMID:30047161
1304787	Fbxo42	F-box protein 42	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FBXO42 gene	PMID:20938992
1304787	Fbxo42	F-box protein 42	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550029	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FBXO42 mRNA	PMID:30319688
1304787	Fbxo42	F-box protein 42	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FBXO42 gene	PMID:20938992
1304787	Fbxo42	F-box protein 42	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312431	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FBXO42 mRNA	PMID:37042841
1304787	Fbxo42	F-box protein 42	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312431	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of FBXO42 mRNA	PMID:23649840
1304787	Fbxo42	F-box protein 42	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312431	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FBXO42 protein	PMID:37730182
1304787	Fbxo42	F-box protein 42	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312431	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA	PMID:39836092
1304787	Fbxo42	F-box protein 42	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FBXO42 gene	PMID:20938992
1304787	Fbxo42	F-box protein 42	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312431	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO42 mRNA	PMID:39836092
1304787	Fbxo42	F-box protein 42	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO42 mRNA	PMID:40504410
1304787	Fbxo42	F-box protein 42	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of FBXO42 gene	PMID:28505145
1304787	Fbxo42	F-box protein 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550029	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO42 mRNA	PMID:21570461
1304787	Fbxo42	F-box protein 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FBXO42 promoter]	PMID:19654925
1304787	Fbxo42	F-box protein 42	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312431	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO42 mRNA	PMID:30851411
1304787	Fbxo42	F-box protein 42	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312431	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FBXO42 mRNA	PMID:29803840
1304787	Fbxo42	F-box protein 42	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312431	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of FBXO42 protein	PMID:35688186
1304787	Fbxo42	F-box protein 42	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312431	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of FBXO42 gene	PMID:28589171
1304787	Fbxo42	F-box protein 42	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312431	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXO42 mRNA	PMID:38568856
1304787	Fbxo42	F-box protein 42	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312431	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO42 mRNA	PMID:39836092
1304787	Fbxo42	F-box protein 42	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO42 mRNA	PMID:40504410
1304787	Fbxo42	F-box protein 42	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312431	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXO42 promoter	PMID:27901495
1304787	Fbxo42	F-box protein 42	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312431	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to FBXO42 mRNA]	PMID:32406909
1304787	Fbxo42	F-box protein 42	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550029	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of FBXO42 mRNA	PMID:29264374
1304787	Fbxo42	F-box protein 42	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550029	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXO42 gene	PMID:35295148
1304787	Fbxo42	F-box protein 42	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550029	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FBXO42 promoter alternative form	PMID:35295148
1304787	Fbxo42	F-box protein 42	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FBXO42 mRNA	PMID:34492290
1304787	Fbxo42	F-box protein 42	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550029	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of FBXO42 mRNA	PMID:20813756|PMID:21318169
1304787	Fbxo42	F-box protein 42	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of FBXO42 mRNA]	PMID:21318169
1304787	Fbxo42	F-box protein 42	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FBXO42 mRNA	PMID:25181051
1304787	Fbxo42	F-box protein 42	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312431	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of FBXO42 mRNA	PMID:30903817
1304787	Fbxo42	F-box protein 42	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of FBXO42 mRNA	PMID:30816183|PMID:32528016
1304787	Fbxo42	F-box protein 42	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of FBXO42 gene	PMID:28505145
1304787	Fbxo42	F-box protein 42	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550029	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of FBXO42 gene	PMID:31683443
1304787	Fbxo42	F-box protein 42	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550029	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FBXO42 mRNA	PMID:37019170
1304787	Fbxo42	F-box protein 42	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312431	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FBXO42 mRNA	PMID:37042841
1304787	Fbxo42	F-box protein 42	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312431	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA	PMID:39836092
1304787	Fbxo42	F-box protein 42	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXO42 mRNA	PMID:33453195
1304787	Fbxo42	F-box protein 42	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312431	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXO42 mRNA	PMID:38568856
1304787	Fbxo42	F-box protein 42	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312431	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FBXO42 mRNA	PMID:24449571
1304787	Fbxo42	F-box protein 42	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312431	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXO42 mRNA	PMID:31533062
1304787	Fbxo42	F-box protein 42	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312431	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO42 mRNA	PMID:25979313
1304787	Fbxo42	F-box protein 42	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of FBXO42 mRNA	PMID:29427782
1304787	Fbxo42	F-box protein 42	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312431	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXO42 mRNA	PMID:29154799
1304787	Fbxo42	F-box protein 42	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of FBXO42 mRNA	PMID:30047161
1304787	Fbxo42	F-box protein 42	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312431	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FBXO42 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1304787	Fbxo42	F-box protein 42	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312431	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of FBXO42 mRNA	PMID:25047013
1304787	Fbxo42	F-box protein 42	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312431	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of FBXO42 mRNA	PMID:27188386
1304787	Fbxo42	F-box protein 42	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550029	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBXO42 mRNA	PMID:17562736
1304787	Fbxo42	F-box protein 42	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXO42 mRNA	PMID:33387578
1304787	Fbxo42	F-box protein 42	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312431	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXO42 mRNA	PMID:29067470
1304787	Fbxo42	F-box protein 42	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312431	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO42 mRNA	PMID:39836092
1304787	Fbxo42	F-box protein 42	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO42 mRNA	PMID:40504410
1304787	Fbxo42	F-box protein 42	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550029	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FBXO42 mRNA; Nanotubes, Carbon results in increased expression of FBXO42 mRNA	PMID:25554681|PMID:25620056
1304787	Fbxo42	F-box protein 42	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of FBXO42 mRNA	PMID:30047161
1304787	Fbxo42	F-box protein 42	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312431	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA	PMID:39836092
1304787	Fbxo42	F-box protein 42	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FBXO42 gene	PMID:35440735
1304787	Fbxo42	F-box protein 42	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550029	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FBXO42 mRNA	PMID:22206623
1304787	Fbxo42	F-box protein 42	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312431	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO42 mRNA	PMID:30851411
1304787	Fbxo42	F-box protein 42	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of FBXO42 mRNA	PMID:30047161
1304787	Fbxo42	F-box protein 42	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of FBXO42 mRNA	PMID:30047161
1304787	Fbxo42	F-box protein 42	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FBXO42 mRNA	PMID:21346803
1304787	Fbxo42	F-box protein 42	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1312431	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of FBXO42 mRNA	PMID:11906190
1304787	Fbxo42	F-box protein 42	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FBXO42 mRNA	PMID:21346803
1304787	Fbxo42	F-box protein 42	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of FBXO42 mRNA	PMID:30047161
1304787	Fbxo42	F-box protein 42	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550029	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FBXO42 mRNA	PMID:28973697
1304788	Lactb	lactamase, beta	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312433	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of LACTB mRNA	PMID:26272509|PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1312433	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of LACTB mRNA	PMID:31016361
1304788	Lactb	lactamase, beta	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312434	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of LACTB mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LACTB gene	PMID:20938992
1304788	Lactb	lactamase, beta	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312433	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of LACTB mRNA	PMID:33167477
1304788	Lactb	lactamase, beta	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312433	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of LACTB mRNA	PMID:22378314
1304788	Lactb	lactamase, beta	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LACTB mRNA	PMID:29432896
1304788	Lactb	lactamase, beta	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of LACTB mRNA	PMID:21632981
1304788	Lactb	lactamase, beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312434	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LACTB mRNA	PMID:39241906
1304788	Lactb	lactamase, beta	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312433	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of LACTB mRNA	PMID:22574217
1304788	Lactb	lactamase, beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of LACTB mRNA	PMID:19167446
1304788	Lactb	lactamase, beta	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312434	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of LACTB mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LACTB gene	PMID:20938992
1304788	Lactb	lactamase, beta	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312433	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LACTB mRNA	PMID:37042841
1304788	Lactb	lactamase, beta	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312433	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LACTB mRNA	PMID:26079696
1304788	Lactb	lactamase, beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LACTB mRNA	PMID:34319233
1304788	Lactb	lactamase, beta	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LACTB mRNA	PMID:33387578
1304788	Lactb	lactamase, beta	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LACTB mRNA	PMID:33354967
1304788	Lactb	lactamase, beta	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LACTB mRNA	PMID:23649840
1304788	Lactb	lactamase, beta	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312434	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LACTB mRNA	PMID:34911549
1304788	Lactb	lactamase, beta	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LACTB mRNA	PMID:30779732
1304788	Lactb	lactamase, beta	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LACTB mRNA	PMID:27339419|PMID:31919559
1304788	Lactb	lactamase, beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312434	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of LACTB mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LACTB gene	PMID:20938992
1304788	Lactb	lactamase, beta	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312433	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of LACTB mRNA	PMID:26272509
1304788	Lactb	lactamase, beta	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LACTB mRNA	PMID:23557933
1304788	Lactb	lactamase, beta	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1312433	E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of LACTB mRNA	PMID:37386098
1304788	Lactb	lactamase, beta	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312433	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of LACTB mRNA	PMID:23300844
1304788	Lactb	lactamase, beta	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312433	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LACTB mRNA	PMID:24768652|PMID:25583101
1304788	Lactb	lactamase, beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LACTB mRNA	PMID:34747641
1304788	Lactb	lactamase, beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312433	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LACTB mRNA	PMID:21632981
1304788	Lactb	lactamase, beta	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LACTB mRNA	PMID:23179753|PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312433	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LACTB mRNA	PMID:33212167
1304788	Lactb	lactamase, beta	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of LACTB protein	PMID:28918527
1304788	Lactb	lactamase, beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of LACTB mRNA	PMID:26873546
1304788	Lactb	lactamase, beta	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of LACTB protein	PMID:29459688
1304788	Lactb	lactamase, beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312433	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LACTB mRNA	PMID:38568856
1304788	Lactb	lactamase, beta	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312433	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LACTB promoter	PMID:27901495
1304788	Lactb	lactamase, beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LACTB mRNA	PMID:22228805
1304788	Lactb	lactamase, beta	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of LACTB mRNA	PMID:24136188
1304788	Lactb	lactamase, beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312434	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of LACTB mRNA	PMID:23557971
1304788	Lactb	lactamase, beta	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of LACTB mRNA	PMID:34492290
1304788	Lactb	lactamase, beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of LACTB mRNA	PMID:18648102
1304788	Lactb	lactamase, beta	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of LACTB mRNA	PMID:18445702
1304788	Lactb	lactamase, beta	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of LACTB mRNA	PMID:30690063
1304788	Lactb	lactamase, beta	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of LACTB mRNA	PMID:19167457
1304788	Lactb	lactamase, beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LACTB mRNA	PMID:34947998
1304788	Lactb	lactamase, beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LACTB mRNA	PMID:33221593
1304788	Lactb	lactamase, beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LACTB mRNA	PMID:30816183|PMID:32528016
1304788	Lactb	lactamase, beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312434	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LACTB mRNA	PMID:39298647
1304788	Lactb	lactamase, beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312434	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of LACTB mRNA	PMID:38685157
1304788	Lactb	lactamase, beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312433	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LACTB mRNA	PMID:37042841
1304788	Lactb	lactamase, beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LACTB mRNA	PMID:33453195
1304788	Lactb	lactamase, beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LACTB mRNA	PMID:38568856
1304788	Lactb	lactamase, beta	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LACTB mRNA	PMID:24449571
1304788	Lactb	lactamase, beta	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of LACTB mRNA	PMID:28302478
1304788	Lactb	lactamase, beta	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of LACTB mRNA	PMID:19167446
1304788	Lactb	lactamase, beta	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312433	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LACTB mRNA	PMID:25979313
1304788	Lactb	lactamase, beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312433	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of LACTB mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1304788	Lactb	lactamase, beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312434	E	RGD:6480464	20120918	CTD	MESH:D014635	Valproic Acid results in increased expression of LACTB mRNA	PMID:19136453|PMID:21427059
1304788	Lactb	lactamase, beta	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of LACTB mRNA	PMID:27989131
1304788	Lactb	lactamase, beta	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312433	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of LACTB mRNA	PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312433	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of LACTB mRNA	PMID:28542535
1304788	Lactb	lactamase, beta	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312433	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of LACTB mRNA	PMID:24935251|PMID:26272509
1304788	Lactb	lactamase, beta	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312434	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LACTB mRNA	PMID:17562736
1304788	Lactb	lactamase, beta	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LACTB mRNA	PMID:33387578
1304788	Lactb	lactamase, beta	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312433	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of LACTB mRNA	PMID:25704631
1304788	Lactb	lactamase, beta	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of LACTB mRNA	PMID:29523930
1304788	Lactb	lactamase, beta	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LACTB mRNA	PMID:29391264
1304788	Lactb	lactamase, beta	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LACTB mRNA	PMID:22079256
1304788	Lactb	lactamase, beta	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312433	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of LACTB mRNA	PMID:23300844
1304788	Lactb	lactamase, beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312434	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LACTB mRNA; Nanotubes, Carbon results in increased expression of LACTB mRNA	PMID:25554681
1304788	Lactb	lactamase, beta	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LACTB protein	PMID:32959892
1304788	Lactb	lactamase, beta	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1312433	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of LACTB mRNA	PMID:26272509
1304788	Lactb	lactamase, beta	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in increased expression of LACTB mRNA	PMID:19149911
1304788	Lactb	lactamase, beta	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312433	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of LACTB mRNA	PMID:27714895
1304788	Lactb	lactamase, beta	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312433	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LACTB protein	PMID:34186270
1304788	Lactb	lactamase, beta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312434	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LACTB mRNA	PMID:22206623
1304788	Lactb	lactamase, beta	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312433	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of LACTB mRNA	PMID:22079256|PMID:22714537
1304788	Lactb	lactamase, beta	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LACTB mRNA	PMID:22079256
1304788	Lactb	lactamase, beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:82341	Methylazoxymethanol acetate	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D008746	Methylazoxymethanol Acetate results in increased expression of LACTB mRNA	PMID:28349193
1304788	Lactb	lactamase, beta	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312433	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of LACTB mRNA	PMID:26272509
1304788	Lactb	lactamase, beta	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312433	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1304788	Lactb	lactamase, beta	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312433	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LACTB mRNA	PMID:38568856
1304788	Lactb	lactamase, beta	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LACTB mRNA	PMID:21346803
1304788	Lactb	lactamase, beta	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of LACTB mRNA	PMID:22570695
1304789	Serpina9	serpin family A member 9	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312435	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SERPINA9 mRNA	PMID:35811015
1304789	Serpina9	serpin family A member 9	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312435	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SERPINA9 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SERPINA9 mRNA	PMID:35811015
1304789	Serpina9	serpin family A member 9	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SERPINA9 mRNA	PMID:25549359
1304789	Serpina9	serpin family A member 9	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SERPINA9 mRNA	PMID:33387578
1304789	Serpina9	serpin family A member 9	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA	PMID:37992649
1304789	Serpina9	serpin family A member 9	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA	PMID:37992649
1304789	Serpina9	serpin family A member 9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SERPINA9 mRNA	PMID:34319233
1304789	Serpina9	serpin family A member 9	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SERPINA9 mRNA	PMID:33387578
1304789	Serpina9	serpin family A member 9	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SERPINA9 mRNA	PMID:36331819
1304789	Serpina9	serpin family A member 9	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312435	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SERPINA9 polyA tail	PMID:30157460
1304789	Serpina9	serpin family A member 9	gene	CHEBI:2663	amiodarone	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in decreased expression of SERPINA9 mRNA	PMID:24535564
1304789	Serpina9	serpin family A member 9	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312436	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SERPINA9 mRNA	PMID:31919559
1304789	Serpina9	serpin family A member 9	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of SERPINA9 gene	PMID:31011160
1304789	Serpina9	serpin family A member 9	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]	PMID:37992649
1304789	Serpina9	serpin family A member 9	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SERPINA9 mRNA	PMID:28189721|PMID:28960355
1304789	Serpina9	serpin family A member 9	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SERPINA9 mRNA	PMID:40618947
1304789	Serpina9	serpin family A member 9	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312436	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of SERPINA9 mRNA	PMID:32186404
1304789	Serpina9	serpin family A member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312435	E	RGD:6480464	20181016	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SERPINA9 mRNA	PMID:30096437
1304789	Serpina9	serpin family A member 9	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312435	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SERPINA9 mRNA	PMID:29803840
1304789	Serpina9	serpin family A member 9	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SERPINA9 mRNA	PMID:39631538
1304789	Serpina9	serpin family A member 9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA	PMID:37992649
1304789	Serpina9	serpin family A member 9	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]	PMID:37992649
1304789	Serpina9	serpin family A member 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312435	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SERPINA9 promoter	PMID:27901495
1304789	Serpina9	serpin family A member 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SERPINA9 mRNA	PMID:32417428
1304789	Serpina9	serpin family A member 9	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SERPINA9 mRNA	PMID:23221170
1304789	Serpina9	serpin family A member 9	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312436	E	RGD:6480464	20250401	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SERPINA9 mRNA	PMID:38811393
1304789	Serpina9	serpin family A member 9	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of SERPINA9 mRNA	PMID:16483693
1304789	Serpina9	serpin family A member 9	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312436	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of SERPINA9 mRNA	PMID:23557971
1304789	Serpina9	serpin family A member 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SERPINA9 mRNA	PMID:25181051
1304789	Serpina9	serpin family A member 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312436	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SERPINA9 promoter	PMID:27312807
1304789	Serpina9	serpin family A member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of SERPINA9 mRNA	PMID:40203079
1304789	Serpina9	serpin family A member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312436	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SERPINA9 mRNA	PMID:39298647
1304789	Serpina9	serpin family A member 9	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312436	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SERPINA9 mRNA	PMID:21266533
1304789	Serpina9	serpin family A member 9	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1312436	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of SERPINA9 mRNA	PMID:24183702
1304789	Serpina9	serpin family A member 9	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SERPINA9 mRNA	PMID:28903501
1304789	Serpina9	serpin family A member 9	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of SERPINA9 mRNA	PMID:28962523
1304789	Serpina9	serpin family A member 9	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312436	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SERPINA9 mRNA	PMID:40194260
1304789	Serpina9	serpin family A member 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SERPINA9 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SERPINA9 mRNA	PMID:36331819
1304789	Serpina9	serpin family A member 9	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312436	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of SERPINA9 mRNA	PMID:23125180
1304789	Serpina9	serpin family A member 9	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in decreased expression of SERPINA9 mRNA	PMID:24535564
1304789	Serpina9	serpin family A member 9	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA	PMID:37992649
1304789	Serpina9	serpin family A member 9	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312436	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SERPINA9 mRNA	PMID:17562736
1304789	Serpina9	serpin family A member 9	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SERPINA9 mRNA	PMID:33387578
1304789	Serpina9	serpin family A member 9	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312435	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SERPINA9 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SERPINA9 mRNA	PMID:35811015
1304789	Serpina9	serpin family A member 9	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of SERPINA9 mRNA	PMID:22334560
1304789	Serpina9	serpin family A member 9	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312436	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SERPINA9 mRNA	PMID:35436446
1304789	Serpina9	serpin family A member 9	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1312436	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate results in increased expression of SERPINA9 mRNA	PMID:16221973
1304789	Serpina9	serpin family A member 9	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312436	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of SERPINA9 mRNA	PMID:25554681
1304789	Serpina9	serpin family A member 9	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SERPINA9 mRNA; Nanotubes, Carbon results in decreased expression of SERPINA9 mRNA	PMID:25620056
1304789	Serpina9	serpin family A member 9	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312436	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SERPINA9 mRNA	PMID:25554681
1304789	Serpina9	serpin family A member 9	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20260113	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SERPINA9 mRNA	PMID:40930398
1304789	Serpina9	serpin family A member 9	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SERPINA9 mRNA	PMID:22206623
1304789	Serpina9	serpin family A member 9	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312435	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SERPINA9 mRNA	PMID:37199045
1304789	Serpina9	serpin family A member 9	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312435	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SERPINA9 gene]	PMID:28238834
1304789	Serpina9	serpin family A member 9	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of SERPINA9 mRNA	PMID:19270015|PMID:19482888|PMID:23091169
1304789	Serpina9	serpin family A member 9	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SERPINA9 mRNA]	PMID:19482888
1304789	Serpina9	serpin family A member 9	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of SERPINA9 mRNA	PMID:22334560
1304789	Serpina9	serpin family A member 9	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20131210	CTD	MESH:C045950	propiconazole results in decreased expression of SERPINA9 mRNA	PMID:22334560|PMID:23970803
1304789	Serpina9	serpin family A member 9	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in decreased expression of SERPINA9 mRNA	PMID:23970803
1304789	Serpina9	serpin family A member 9	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SERPINA9 mRNA	PMID:28973697
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FAM43A mRNA	PMID:38218311
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1343774	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FAM43A mRNA	PMID:26272509
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA	PMID:27188386
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of FAM43A mRNA	PMID:31016361
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	ISO	RGD:1343774	E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of FAM43A mRNA	PMID:23792671
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FAM43A mRNA	PMID:33167477
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1343774	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of FAM43A mRNA	PMID:26079696
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of FAM43A gene	PMID:35440735
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312437	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of FAM43A mRNA	PMID:40945087
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312437	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FAM43A mRNA	PMID:39241906
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312437	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FAM43A mRNA	PMID:27339419
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of FAM43A mRNA	PMID:19167446|PMID:31614463
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1343774	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of FAM43A mRNA	PMID:23019147
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of FAM43A mRNA	PMID:38568856
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FAM43A mRNA	PMID:33387578
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1343774	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FAM43A mRNA	PMID:37042841
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1343774	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of FAM43A mRNA	PMID:20655997
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of FAM43A mRNA	PMID:20864642
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1343774	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of FAM43A mRNA	PMID:26079696
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312437	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM43A mRNA	PMID:37992649
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1343774	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of FAM43A mRNA	PMID:33647349
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:17558	quercitrin	increases expression	ISO	RGD:1343774	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of FAM43A mRNA	PMID:25193878
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1343774	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of FAM43A mRNA	PMID:31256213
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312437	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM43A mRNA	PMID:37992649
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312437	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FAM43A mRNA	PMID:28085963
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FAM43A mRNA	PMID:33387578
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1343774	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FAM43A mRNA	PMID:28818685
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of FAM43A mRNA	PMID:28522335
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312437	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM43A mRNA	PMID:37325564
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1343774	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of FAM43A protein	PMID:20106945
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FAM43A mRNA	PMID:33354967
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312437	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FAM43A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FAM43A mRNA	PMID:34911549
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FAM43A mRNA	PMID:18593933
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312437	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FAM43A mRNA	PMID:25629700
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1343774	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FAM43A gene	PMID:25304211
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1343774	E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic results in increased expression of FAM43A mRNA	PMID:27838757
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FAM43A mRNA	PMID:32525701
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1343774	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of FAM43A mRNA	PMID:38460933
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of FAM43A mRNA	PMID:38460933
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1343774	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of FAM43A mRNA	PMID:26272509
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA	PMID:27188386
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of FAM43A mRNA	PMID:31881176
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in decreased expression of FAM43A mRNA	PMID:19167446
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of FAM43A mRNA	PMID:19167446
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1343774	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of FAM43A mRNA	PMID:28903495
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1343774	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of FAM43A mRNA	PMID:27594783
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1343774	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of FAM43A mRNA	PMID:23019147
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FAM43A mRNA	PMID:22298810
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FAM43A mRNA	PMID:21215274|PMID:34747641
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1343774	E	RGD:6480464	20150414	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM43A mRNA	PMID:25445724|PMID:30096437
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20150414	CTD	MESH:D013749	AHR gene SNP affects the reaction [Tetrachlorodibenzodioxin results in increased expression of FAM43A mRNA]	PMID:25445724
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1343774	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FAM43A mRNA	PMID:33212167
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FAM43A mRNA	PMID:30851411
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of FAM43A mRNA	PMID:28959563
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1343774	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of FAM43A mRNA	PMID:32763439
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FAM43A mRNA	PMID:29803840
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312437	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM43A mRNA	PMID:37992649
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1343774	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of FAM43A mRNA	PMID:22623647
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1312437	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased methylation of FAM43A gene	PMID:24118411
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1343774	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of FAM43A mRNA	PMID:34032870|PMID:38568856
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1343774	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM43A mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:32234424
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1343774	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM43A 3' UTR; Benzo(a)pyrene results in increased methylation of FAM43A exon; Benzo(a)pyrene results in increased methylation of FAM43A promoter	PMID:27901495
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1343774	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of FAM43A promoter	PMID:23974009
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FAM43A mRNA	PMID:18593933
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of FAM43A mRNA	PMID:38458666
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1343774	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FAM43A mRNA	PMID:19150397|PMID:20382639
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of FAM43A mRNA	PMID:24395379|PMID:24915197
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of FAM43A mRNA	PMID:25729387
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of FAM43A mRNA	PMID:25729387
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312437	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of FAM43A mRNA	PMID:29264374
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312437	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM43A gene	PMID:35295148
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FAM43A mRNA	PMID:34492290
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of FAM43A mRNA	PMID:25380136
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of FAM43A mRNA	PMID:38479592
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FAM43A mRNA	PMID:25181051
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM43A mRNA	PMID:34947998|PMID:38750585
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312437	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of FAM43A mRNA	PMID:32156529
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1343774	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of FAM43A mRNA	PMID:29275510
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312437	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of FAM43A mRNA	PMID:26377693
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1312437	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of FAM43A mRNA	PMID:26377693
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of FAM43A mRNA	PMID:38458666
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1343774	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of FAM43A mRNA	PMID:29024780
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of FAM43A mRNA	PMID:25380136
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312437	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM43A mRNA	PMID:37325564
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of FAM43A mRNA	PMID:27387713
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FAM43A mRNA	PMID:19320972
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of FAM43A mRNA	PMID:25380136
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FAM43A mRNA	PMID:31533062
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of FAM43A mRNA	PMID:19167446
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FAM43A mRNA	PMID:19167446
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343774	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FAM43A mRNA	PMID:25979313
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1343774	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of FAM43A mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA	PMID:27188386
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1343774	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of FAM43A mRNA	PMID:25562108
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1343774	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of FAM43A mRNA	PMID:20106945|PMID:21632981
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1343774	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of FAM43A mRNA	PMID:25047013
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312437	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FAM43A mRNA	PMID:28973697
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312437	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM43A mRNA	PMID:37992649
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1343774	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of FAM43A mRNA	PMID:24449571
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of FAM43A mRNA]	PMID:21233418
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1343774	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of FAM43A mRNA	PMID:38832940
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1343774	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of FAM43A mRNA	PMID:24935251|PMID:26272509
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA	PMID:27188386
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1343774	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of FAM43A mRNA	PMID:29067470
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of FAM43A mRNA	PMID:24714768
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FAM43A mRNA	PMID:29523930
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of FAM43A mRNA	PMID:38460933
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:46905	(R)-pantothenic acid	increases expression	ISO	RGD:1343774	E	RGD:6480464	20120515	CTD	MESH:D010205	Pantothenic Acid results in increased expression of FAM43A mRNA	PMID:19397697
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1343774	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FAM43A gene	PMID:25304211
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1343774	E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic results in increased expression of FAM43A mRNA	PMID:27838757
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FAM43A mRNA	PMID:32525701
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1343774	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of FAM43A mRNA	PMID:31838189
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of FAM43A mRNA	PMID:29391264
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FAM43A mRNA	PMID:25102311
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312437	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FAM43A mRNA	PMID:35964746
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of FAM43A mRNA	PMID:20977926
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1343774	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of FAM43A mRNA	PMID:22714537
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1343774	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of FAM43A mRNA	PMID:31629900
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1343774	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of FAM43A mRNA	PMID:26272509
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA	PMID:27188386
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of FAM43A mRNA	PMID:25729387
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of FAM43A mRNA	PMID:25729387
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1343774	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of FAM43A mRNA	PMID:28988120
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1343774	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of FAM43A mRNA	PMID:31758290
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1343774	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of FAM43A mRNA	PMID:37199045
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1343774	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of FAM43A mRNA	PMID:36318118
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of FAM43A mRNA	PMID:32858204
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FAM43A mRNA	PMID:30851411
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA	PMID:27188386
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:81555	Enterolactone	decreases expression	ISO	RGD:1343774	E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of FAM43A mRNA	PMID:19167446
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA	PMID:19167446
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1343774	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of FAM43A mRNA	PMID:26705709
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1343774	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of FAM43A mRNA	PMID:26079696
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312437	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of FAM43A mRNA	PMID:39847705
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FAM43A mRNA	PMID:32525701
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1343774	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of FAM43A mRNA	PMID:26272509
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA	PMID:27188386
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1343774	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA	PMID:27188386
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FAM43A mRNA	PMID:23034163
1304790	Fam43a	family with sequence similarity 43, member A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of FAM43A mRNA	PMID:23869203
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1312439	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in increased expression of BFAR protein	PMID:36252740
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312438	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of BFAR mRNA	PMID:38218311
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:136185	VX nerve agent	increases expression	ISO	RGD:1312438	E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of BFAR mRNA	PMID:38555327
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1312438	E	RGD:6480464	20210810	CTD	MESH:D019308	[Palmitic Acid co-treated with Arsenic] affects the expression of BFAR mRNA	PMID:33736254
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312439	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of BFAR mRNA	PMID:30319688
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312438	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of BFAR mRNA	PMID:21632981
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312439	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of BFAR mRNA	PMID:18978301
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312438	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of BFAR mRNA	PMID:21179406
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BFAR mRNA	PMID:37325564
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:24828	indoles	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in decreased expression of BFAR mRNA	PMID:20521778
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:24828	indoles	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in increased expression of BFAR mRNA	PMID:20521778
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312439	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BFAR mRNA	PMID:19770486
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1312438	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of BFAR mRNA	PMID:26760959
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312438	E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of BFAR mRNA	PMID:23033980
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312438	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of BFAR mRNA	PMID:35430440
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:27470	folic acid	affects expression	ISO	RGD:1312438	E	RGD:6480464	20120522	CTD	MESH:D005492	Folic Acid affects the expression of BFAR mRNA	PMID:16361273
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of BFAR mRNA	PMID:25629700
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312438	E	RGD:6480464	20210810	CTD	MESH:D001151	[Palmitic Acid co-treated with Arsenic] affects the expression of BFAR mRNA	PMID:33736254
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of BFAR mRNA	PMID:28189721|PMID:28960355
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312439	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BFAR mRNA	PMID:21570461
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312439	E	RGD:6480464	20120522	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BFAR mRNA	PMID:19770486
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312438	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BFAR mRNA	PMID:29803840
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1312439	E	RGD:6480464	20120522	CTD	MESH:D004317	BFAR protein results in decreased susceptibility to Doxorubicin	PMID:18805781
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312438	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BFAR mRNA	PMID:38568856|PMID:39719251
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA	PMID:34876320
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA	PMID:34876320
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of BFAR mRNA]	PMID:22228805
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:29866	arsenite(3-)	affects localization	ISO	RGD:1312439	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite affects the localization of BFAR protein alternative form	PMID:34175335
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of BFAR mRNA	PMID:19730151
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of BFAR mRNA	PMID:35676786
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312438	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of BFAR mRNA	PMID:20458559
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312439	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of BFAR mRNA	PMID:17426115|PMID:18301758|PMID:23811191
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BFAR mRNA	PMID:25181051
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of BFAR mRNA	PMID:30816183|PMID:32528016
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of BFAR mRNA	PMID:39298647
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of BFAR mRNA	PMID:38685157
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of BFAR mRNA	PMID:22546817
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of BFAR mRNA	PMID:21266533
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of BFAR mRNA	PMID:22546817
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312438	E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of BFAR mRNA	PMID:18836921
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312438	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BFAR mRNA	PMID:37042841
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:35456	cadmium dichloride	affects methylation	EXP		E	RGD:6480464	20161115	CTD	MESH:D019256	Cadmium Chloride affects the methylation of BFAR promoter	PMID:22457795
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312438	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BFAR mRNA	PMID:38568856
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20161115	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of BFAR promoter	PMID:22457795
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BFAR mRNA	PMID:37325564
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C018021	cobaltous chloride results in increased expression of BFAR mRNA	PMID:24386269
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:38319	usnic acid	increases expression	ISO	RGD:1312438	E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of BFAR mRNA	PMID:32508146
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312439	E	RGD:6480464	20120522	CTD	MESH:D016572	Cyclosporine results in increased expression of BFAR mRNA	PMID:19770486
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:42223	emodin	decreases expression	ISO	RGD:1312438	E	RGD:6480464	20120522	CTD	MESH:D004642	Emodin results in decreased expression of BFAR mRNA	PMID:16045814
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312438	E	RGD:6480464	20210810	CTD	MESH:D001151	[Palmitic Acid co-treated with Arsenic] affects the expression of BFAR mRNA	PMID:33736254
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA	PMID:34876320
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of BFAR mRNA	PMID:19730151
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of BFAR mRNA	PMID:35676786
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312438	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of BFAR mRNA	PMID:20458559
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of BFAR mRNA; Nanotubes, Carbon results in decreased expression of BFAR mRNA	PMID:25554681
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of BFAR mRNA	PMID:40234311
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312438	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of BFAR mRNA	PMID:31758290
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of BFAR mRNA	PMID:22206623
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA	PMID:34876320
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:85014	2,5-hexanedione	increases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in increased expression of BFAR mRNA	PMID:22952946
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of BFAR mRNA	PMID:19281266
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20120522	CTD	MESH:C057693	troglitazone results in decreased expression of BFAR mRNA	PMID:17569031
1304791	Bfar	bifunctional apoptosis regulator	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of BFAR mRNA	PMID:22615374
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312440	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GCFC2 mRNA	PMID:33167477
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312440	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of GCFC2 mRNA	PMID:21632981
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312440	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of GCFC2 mRNA	PMID:29581250
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312441	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GCFC2 mRNA	PMID:39241906
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312440	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of GCFC2 mRNA	PMID:38568856
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312440	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of GCFC2 protein	PMID:37730182
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GCFC2 mRNA	PMID:33387578
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312440	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of GCFC2 promoter	PMID:30157460
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1312440	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of GCFC2 mRNA	PMID:17175027
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA	PMID:39836092
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCFC2 mRNA	PMID:35301059
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GCFC2 protein	PMID:23301498
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GCFC2 mRNA	PMID:33354967
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312440	E	RGD:6480464	20160210	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GCFC2 mRNA	PMID:23649840
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312440	E	RGD:6480464	20160210	CTD	MESH:D001151	Arsenic affects the methylation of GCFC2 gene	PMID:25304211
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCFC2 mRNA	PMID:39836092
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of GCFC2 protein	PMID:38460933
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312440	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of GCFC2 protein	PMID:35688186
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312441	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of GCFC2 mRNA	PMID:28960355
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GCFC2 mRNA	PMID:31881176
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GCFC2 mRNA	PMID:23557933
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312441	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GCFC2 mRNA	PMID:24058054
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GCFC2 mRNA	PMID:33387578
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312440	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GCFC2 mRNA	PMID:38568856
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCFC2 mRNA	PMID:39836092
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312440	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GCFC2 promoter	PMID:27901495
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of GCFC2 gene	PMID:31601247
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312441	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GCFC2 mRNA	PMID:29264374
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of GCFC2 mRNA	PMID:23411599|PMID:34492290
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312441	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of GCFC2 promoter	PMID:27334623
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1312441	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of GCFC2 mRNA	PMID:37894381
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C006780	bisphenol A results in increased expression of GCFC2 mRNA	PMID:25181051
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312440	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of GCFC2 mRNA	PMID:19244175
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of GCFC2 gene	PMID:31601247
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312441	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of GCFC2 mRNA	PMID:38685157
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312440	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of GCFC2 gene	PMID:22964155
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312440	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GCFC2 mRNA	PMID:37042841
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1312440	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of GCFC2 mRNA	PMID:17175027
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA	PMID:39836092
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GCFC2 mRNA	PMID:33453195
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCFC2 mRNA	PMID:35301059
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312440	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of GCFC2 mRNA	PMID:24449571
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312440	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GCFC2 mRNA	PMID:31533062
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312440	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GCFC2 mRNA	PMID:25562108
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312440	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of GCFC2 mRNA	PMID:27188386
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of GCFC2 protein	PMID:38460933
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312440	E	RGD:6480464	20160210	CTD	MESH:D001151	Arsenic affects the methylation of GCFC2 gene	PMID:25304211
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCFC2 mRNA	PMID:39836092
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of GCFC2 mRNA	PMID:23962444
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of GCFC2 mRNA	PMID:30047161
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312441	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of GCFC2 mRNA	PMID:23608068
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312440	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GCFC2 protein	PMID:32959892
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1312440	E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of GCFC2 mRNA	PMID:17175027
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312440	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA	PMID:39836092
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:64153	tanespimycin	increases expression	ISO	RGD:1312440	E	RGD:6480464	20200804	CTD	MESH:C112765	tanespimycin analog results in increased expression of GCFC2 protein	PMID:31370342
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312440	E	RGD:6480464	20160210	CTD	MESH:C025589	ochratoxin A results in decreased expression of GCFC2 mRNA	PMID:19287073
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GCFC2 mRNA	PMID:30047161
1304792	Gcfc2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of GCFC2 mRNA	PMID:22570695|PMID:23034163
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:137392	chlormequat chloride	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of TMEM222 protein	PMID:34958886
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1604776	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TMEM222 mRNA	PMID:21632981
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of TMEM222 mRNA	PMID:32145629
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312442	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of TMEM222 mRNA	PMID:29980752
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604776	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TMEM222 mRNA	PMID:37042841
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:17688	(S)-nicotine	increases splicing	ISO	RGD:1604776	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased splicing of TMEM222 mRNA alternative form	PMID:23825647
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TMEM222 mRNA	PMID:33387578
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312442	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMEM222 mRNA	PMID:36331819
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:18723	nicotine	increases splicing	ISO	RGD:1604776	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased splicing of TMEM222 mRNA alternative form	PMID:23825647
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1604776	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TMEM222 mRNA	PMID:19244175
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1604776	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TMEM222 protein	PMID:35688186
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1604776	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of TMEM222 mRNA	PMID:23300844
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312442	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM222 mRNA	PMID:24680724
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604776	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TMEM222 mRNA	PMID:33212167
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TMEM222 mRNA	PMID:28959563
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604776	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMEM222 mRNA	PMID:38568856
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604776	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TMEM222 mRNA	PMID:39719251
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604776	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMEM222 promoter	PMID:27901495
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1604776	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TMEM222 mRNA	PMID:19150397
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TMEM222 mRNA	PMID:24136188
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312442	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM222 gene	PMID:35295148
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM222 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMEM222 gene	PMID:28505145
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1604776	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of TMEM222 mRNA	PMID:19244175
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312442	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TMEM222 mRNA	PMID:37019170
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604776	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMEM222 mRNA	PMID:37042841
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1604776	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TMEM222 mRNA	PMID:19376846
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1604776	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TMEM222 mRNA	PMID:19244175
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312442	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMEM222 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TMEM222 mRNA	PMID:36331819
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312442	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM222 mRNA	PMID:17292431
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604776	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TMEM222 gene	PMID:29154799
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:41791	calyculin A	decreases expression	ISO	RGD:1312442	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in decreased expression of TMEM222 mRNA	PMID:25270620
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1604776	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TMEM222 mRNA	PMID:36621641
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TMEM222 mRNA	PMID:29391264
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1604776	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TMEM222 mRNA	PMID:23300844
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of TMEM222 mRNA	PMID:34044035
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312442	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TMEM222 mRNA	PMID:35964746
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TMEM222 mRNA	PMID:24136188
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of TMEM222 mRNA	PMID:20080153
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	ISO	RGD:1604776	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of TMEM222 mRNA	PMID:24834073
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312442	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of TMEM222 mRNA	PMID:30953684
1304793	Tmem222	transmembrane protein 222	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312442	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of TMEM222 mRNA	PMID:32835833
1304794	Cenpb	centromere protein B	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CENPB mRNA	PMID:36841081
1304794	Cenpb	centromere protein B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312444	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CENPB mRNA	PMID:30319688
1304794	Cenpb	centromere protein B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312444	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CENPB mRNA	PMID:39241906
1304794	Cenpb	centromere protein B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312444	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CENPB mRNA	PMID:39298647
1304794	Cenpb	centromere protein B	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312444	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of CENPB mRNA	PMID:33711761
1304794	Cenpb	centromere protein B	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312443	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CENPB mRNA	PMID:38568856
1304794	Cenpb	centromere protein B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312443	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CENPB mRNA	PMID:37042841
1304794	Cenpb	centromere protein B	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of CENPB mRNA	PMID:22967744
1304794	Cenpb	centromere protein B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CENPB mRNA	PMID:33754040|PMID:36174316
1304794	Cenpb	centromere protein B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20250708	CTD	MESH:D004051	[[Polystyrenes results in increased abundance of Microplastics] which co-treated with Diethylhexyl Phthalate] results in decreased expression of CENPB mRNA	PMID:36174316
1304794	Cenpb	centromere protein B	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312443	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CENPB protein	PMID:37730182
1304794	Cenpb	centromere protein B	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of CENPB mRNA	PMID:22061828
1304794	Cenpb	centromere protein B	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CENPB mRNA	PMID:28818685
1304794	Cenpb	centromere protein B	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1312443	E	RGD:6480464	20250204	CTD	MESH:D016604	[CYP1A1 protein results in increased susceptibility to Aflatoxin B1] which results in increased expression of CENPB protein	PMID:38382706
1304794	Cenpb	centromere protein B	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20201006	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CENPB mRNA	PMID:32553695
1304794	Cenpb	centromere protein B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CENPB mRNA]	PMID:22206623
1304794	Cenpb	centromere protein B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CENPB mRNA	PMID:40504410
1304794	Cenpb	centromere protein B	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312443	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CENPB protein	PMID:35688186
1304794	Cenpb	centromere protein B	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of CENPB mRNA	PMID:19921347
1304794	Cenpb	centromere protein B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312443	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CENPB mRNA	PMID:27594783
1304794	Cenpb	centromere protein B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312444	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CENPB mRNA	PMID:21570461
1304794	Cenpb	centromere protein B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CENPB mRNA	PMID:32763439
1304794	Cenpb	centromere protein B	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312443	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of CENPB mRNA	PMID:34032870
1304794	Cenpb	centromere protein B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CENPB mRNA	PMID:38568856
1304794	Cenpb	centromere protein B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312443	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CENPB mRNA	PMID:38568856|PMID:39719251
1304794	Cenpb	centromere protein B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CENPB mRNA	PMID:40504410
1304794	Cenpb	centromere protein B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312444	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of CENPB mRNA; Benzo(a)pyrene results in increased expression of CENPB mRNA	PMID:22228805|PMID:32553695
1304794	Cenpb	centromere protein B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312443	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CENPB exon	PMID:27901495
1304794	Cenpb	centromere protein B	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312443	E	RGD:6480464	20230801	CTD	MESH:C015001	arsenite results in increased methylation of CENPB protein	PMID:23978223
1304794	Cenpb	centromere protein B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1312443	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CENPB mRNA	PMID:20382639
1304794	Cenpb	centromere protein B	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of CENPB mRNA	PMID:35984750
1304794	Cenpb	centromere protein B	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312443	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CENPB mRNA	PMID:38479592
1304794	Cenpb	centromere protein B	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312444	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of CENPB promoter	PMID:27334623
1304794	Cenpb	centromere protein B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CENPB mRNA	PMID:25181051
1304794	Cenpb	centromere protein B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CENPB mRNA	PMID:29275510
1304794	Cenpb	centromere protein B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312444	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CENPB mRNA	PMID:32156529
1304794	Cenpb	centromere protein B	gene	CHEBI:34107	1-nitropyrene	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of CENPB mRNA	PMID:19041380
1304794	Cenpb	centromere protein B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CENPB mRNA	PMID:39298647
1304794	Cenpb	centromere protein B	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CENPB mRNA	PMID:17361019
1304794	Cenpb	centromere protein B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CENPB mRNA	PMID:34813904
1304794	Cenpb	centromere protein B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CENPB mRNA	PMID:34813904
1304794	Cenpb	centromere protein B	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CENPB mRNA	PMID:24386269
1304794	Cenpb	centromere protein B	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CENPB mRNA	PMID:19320972|PMID:19376846
1304794	Cenpb	centromere protein B	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of CENPB mRNA	PMID:17585979
1304794	Cenpb	centromere protein B	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312443	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CENPB gene	PMID:29154799
1304794	Cenpb	centromere protein B	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312443	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CENPB mRNA	PMID:28542535
1304794	Cenpb	centromere protein B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CENPB mRNA	PMID:40504410
1304794	Cenpb	centromere protein B	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CENPB mRNA	PMID:35964746
1304794	Cenpb	centromere protein B	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312443	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CENPB protein	PMID:23718831
1304794	Cenpb	centromere protein B	gene	CHEBI:53620	methylisothiazolinone	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of CENPB mRNA	PMID:31629900
1304794	Cenpb	centromere protein B	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312443	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CENPB mRNA	PMID:31758290
1304794	Cenpb	centromere protein B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312444	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CENPB mRNA	PMID:22206623
1304794	Cenpb	centromere protein B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CENPB mRNA]	PMID:22206623
1304794	Cenpb	centromere protein B	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312443	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CENPB protein	PMID:31285264
1304794	Cenpb	centromere protein B	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CENPB mRNA	PMID:21278054
1304794	Cenpb	centromere protein B	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CENPB mRNA	PMID:19281266
1304794	Cenpb	centromere protein B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CENPB mRNA	PMID:21346803
1304794	Cenpb	centromere protein B	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CENPB mRNA	PMID:38568856
1304794	Cenpb	centromere protein B	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312443	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CENPB mRNA	PMID:29301935
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of APBB1IP mRNA	PMID:21551480|PMID:25152437
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312446	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of APBB1IP mRNA	PMID:20188158
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of APBB1IP mRNA	PMID:20938992
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312445	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of APBB1IP mRNA	PMID:33167477
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of APBB1IP mRNA	PMID:26079696
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312446	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of APBB1IP mRNA	PMID:30319688
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312446	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of APBB1IP mRNA	PMID:30319688
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of APBB1IP mRNA	PMID:35811015
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of APBB1IP mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of APBB1IP mRNA	PMID:35811015
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of APBB1IP mRNA	PMID:20938992
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of APBB1IP mRNA	PMID:27905399
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APBB1IP mRNA	PMID:37992649
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APBB1IP mRNA	PMID:37992649
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of APBB1IP mRNA	PMID:27523638
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of APBB1IP mRNA	PMID:22061828
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of APBB1IP mRNA	PMID:37748715
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312445	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of APBB1IP intron	PMID:30157460
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of APBB1IP mRNA	PMID:36331819
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of APBB1IP mRNA	PMID:28522335
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312445	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of APBB1IP protein	PMID:20106945
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312445	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of APBB1IP intron	PMID:30157460
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of APBB1IP mRNA	PMID:41430723
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of APBB1IP mRNA	PMID:34911549
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of APBB1IP mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of APBB1IP mRNA	PMID:20938992|PMID:22206623
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of APBB1IP mRNA	PMID:40504410
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of APBB1IP mRNA	PMID:31881176
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of APBB1IP mRNA	PMID:30912803
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312445	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of APBB1IP mRNA	PMID:25583101
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of APBB1IP mRNA	PMID:34747641
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of APBB1IP mRNA	PMID:20106945
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APBB1IP mRNA	PMID:37992649
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of APBB1IP mRNA	PMID:40504410
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312445	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of APBB1IP 5' UTR	PMID:27901495
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of APBB1IP mRNA	PMID:20064835|PMID:32234424
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of APBB1IP mRNA	PMID:22228805
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312445	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of APBB1IP mRNA	PMID:22316170
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312445	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of APBB1IP promoter	PMID:27901495
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312445	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of APBB1IP promoter	PMID:23974009
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in increased expression of APBB1IP mRNA	PMID:32721576
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312445	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of APBB1IP mRNA	PMID:20458559
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1312445	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of APBB1IP mRNA	PMID:37690743
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of APBB1IP gene	PMID:31601247
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of APBB1IP mRNA	PMID:25729387
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312446	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of APBB1IP mRNA	PMID:23557971
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of APBB1IP mRNA	PMID:34492290
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of APBB1IP mRNA	PMID:18648102
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of APBB1IP mRNA	PMID:25380136
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of APBB1IP mRNA	PMID:19710929
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of APBB1IP mRNA	PMID:38479592
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of APBB1IP mRNA	PMID:25181051
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of APBB1IP mRNA	PMID:24988533|PMID:30816183|PMID:32528016
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312445	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of APBB1IP gene	PMID:31601247
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312446	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of APBB1IP mRNA	PMID:32156529|PMID:38701888
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of APBB1IP gene	PMID:31601247
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of APBB1IP mRNA	PMID:39298647
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312445	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of APBB1IP protein	PMID:34186270
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312446	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of APBB1IP mRNA	PMID:30951980
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312445	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of APBB1IP protein	PMID:34186270
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312445	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of APBB1IP protein	PMID:34186270
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312445	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of APBB1IP mRNA	PMID:37042841
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of APBB1IP mRNA	PMID:25380136
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of APBB1IP mRNA	PMID:25380136
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of APBB1IP mRNA	PMID:24449571
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1312446	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of APBB1IP mRNA	PMID:38531469
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of APBB1IP mRNA	PMID:36331819
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of APBB1IP mRNA	PMID:29038090
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312446	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of APBB1IP mRNA	PMID:17292431
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312445	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of APBB1IP mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APBB1IP mRNA	PMID:27188386
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of APBB1IP mRNA	PMID:20106945
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APBB1IP mRNA	PMID:37992649
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of APBB1IP mRNA	PMID:18754875
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312446	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of APBB1IP mRNA	PMID:17562736
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of APBB1IP mRNA	PMID:21420995|PMID:29067470
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of APBB1IP mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of APBB1IP mRNA	PMID:35811015
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of APBB1IP mRNA	PMID:40504410
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of APBB1IP mRNA	PMID:31838189
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of APBB1IP mRNA	PMID:32234424
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312445	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of APBB1IP mRNA	PMID:20458559
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312446	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of APBB1IP mRNA	PMID:40234311
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1312446	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of APBB1IP mRNA	PMID:17982090
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of APBB1IP mRNA	PMID:23608068
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312446	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of APBB1IP mRNA	PMID:38701926
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of APBB1IP protein	PMID:32959892
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of APBB1IP mRNA	PMID:25729387
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of APBB1IP mRNA	PMID:25729387
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of APBB1IP mRNA	PMID:36851058
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1312445	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of APBB1IP mRNA	PMID:22079614
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of APBB1IP gene	PMID:35440735
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of APBB1IP mRNA	PMID:31758290
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312445	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of APBB1IP protein	PMID:34186270
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of APBB1IP mRNA	PMID:22206623
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312445	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of APBB1IP mRNA	PMID:22714537
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312445	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of APBB1IP mRNA	PMID:37199045
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APBB1IP mRNA	PMID:27188386
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to APBB1IP gene]	PMID:28238834
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312445	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of APBB1IP mRNA	PMID:19159669
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of APBB1IP mRNA	PMID:24780913
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312445	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APBB1IP mRNA	PMID:27188386
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of APBB1IP mRNA	PMID:19281266
1304795	Apbb1ip	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of APBB1IP mRNA	PMID:19015723
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312448	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MRPL15 mRNA	PMID:33045310
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPL15 mRNA	PMID:23724009|PMID:33167477
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPL15 mRNA	PMID:16788091
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL15 mRNA	PMID:36331819
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of MRPL15 protein	PMID:40631627
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPL15 mRNA	PMID:22378314
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312448	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MRPL15 mRNA	PMID:30319688
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312448	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL15 mRNA	PMID:39241906
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312448	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of MRPL15 mRNA	PMID:39298647
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312447	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MRPL15 mRNA	PMID:38568856
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312447	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPL15 mRNA	PMID:37042841
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of MRPL15 protein	PMID:40631627
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MRPL15 mRNA	PMID:21669218
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of MRPL15 protein	PMID:40631627
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MRPL15 mRNA	PMID:19850644
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of MRPL15 mRNA]	PMID:19850644
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL15 mRNA	PMID:36331819
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MRPL15 mRNA	PMID:39836092
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of MRPL15 protein	PMID:34915118
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPL15 mRNA	PMID:35301059
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRPL15 mRNA	PMID:19549813
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL15 mRNA	PMID:39836092
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312448	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of MRPL15 mRNA	PMID:28960355
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312448	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MRPL15 mRNA	PMID:22610192
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MRPL15 mRNA	PMID:23557933
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312447	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MRPL15 mRNA	PMID:28903495
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312448	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL15 mRNA	PMID:21570461
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL15 mRNA	PMID:33387578
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL15 mRNA	PMID:19465110
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL15 mRNA	PMID:17942748
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPL15 mRNA	PMID:30851411
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL15 mRNA	PMID:38568856|PMID:39719251
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL15 mRNA	PMID:16014739
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL15 mRNA	PMID:39836092
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312447	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MRPL15 promoter	PMID:27901495
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MRPL15 mRNA	PMID:19073995
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MRPL15 mRNA	PMID:20382639
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of MRPL15 mRNA	PMID:24136188
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL15 mRNA	PMID:34947998
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL15 mRNA	PMID:26063408
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL15 mRNA	PMID:25181051
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312447	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL15 protein	PMID:37567409
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MRPL15 mRNA	PMID:17316808
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312447	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of MRPL15 protein	PMID:31945527
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312448	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL15 mRNA	PMID:39298647
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPL15 mRNA	PMID:21266533
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312448	E	RGD:6480464	20210209	CTD	MESH:D010269	Paraquat results in increased expression of MRPL15 mRNA	PMID:21463325
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20130514	CTD	MESH:D010269	[Paraquat co-treated with Maneb] results in decreased expression of MRPL15 mRNA	PMID:18386188
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MRPL15 mRNA	PMID:39836092
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MRPL15 mRNA	PMID:38174414|PMID:38568856
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of MRPL15 promoter	PMID:22457795
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPL15 mRNA	PMID:35301059
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of MRPL15 mRNA	PMID:25908611
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MRPL15 mRNA	PMID:28302478
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312447	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MRPL15 mRNA	PMID:40419075
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL15 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL15 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MRPL15 mRNA	PMID:36331819
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPL15 mRNA	PMID:19101580
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312447	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MRPL15 mRNA	PMID:23179753|PMID:26272509
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRPL15 mRNA	PMID:27188386
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312448	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MRPL15 mRNA	PMID:28973697
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of MRPL15 protein	PMID:40631627
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312447	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MRPL15 mRNA	PMID:28542535
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRPL15 mRNA	PMID:17562736
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL15 mRNA	PMID:22230336|PMID:25704631|PMID:29067470
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MRPL15 mRNA	PMID:29279043
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL15 mRNA	PMID:39836092
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20240702	CTD	MESH:D004008	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL15 mRNA	PMID:37844793
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MRPL15 mRNA	PMID:17942748
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D004997	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL15 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL15 mRNA	PMID:17942748|PMID:37844793
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of MRPL15 mRNA	PMID:36868495
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MRPL15 mRNA; Nanotubes, Carbon results in decreased expression of MRPL15 mRNA	PMID:25620056
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312448	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MRPL15 mRNA; Nanotubes, Carbon results in increased expression of MRPL15 mRNA	PMID:25554681
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20130514	CTD	MESH:D008344	[Paraquat co-treated with Maneb] results in decreased expression of MRPL15 mRNA	PMID:18386188
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20240702	CTD	MESH:D007052	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL15 mRNA	PMID:37844793
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MRPL15 protein	PMID:32959892
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MRPL15 mRNA	PMID:39836092
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312447	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MRPL15 protein	PMID:34186270
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPL15 mRNA	PMID:22206623
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:749016	gossypol acetic acid	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of MRPL15 protein	PMID:29938581
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPL15 mRNA	PMID:30851411
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRPL15 mRNA	PMID:27188386
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312448	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MRPL15 mRNA	PMID:23091169
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of MRPL15 mRNA	PMID:21278054
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312447	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRPL15 mRNA	PMID:27188386
1304796	Mrpl15	mitochondrial ribosomal protein L15	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312447	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MRPL15 mRNA	PMID:38568856
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312449	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of B3GALNT1 mRNA	PMID:38218311
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of B3GALNT1 mRNA	PMID:25152437
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of B3GALNT1 mRNA	PMID:26272509|PMID:27188386
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:132446	perfluorobutanesulfonic acid	increases expression	ISO	RGD:1312449	E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid results in increased expression of B3GALNT1 mRNA	PMID:40885241
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312450	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of B3GALNT1 mRNA	PMID:37995155
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALNT1 mRNA	PMID:20938992
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312449	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of B3GALNT1 mRNA	PMID:21934132
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B3GALNT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B3GALNT1 mRNA	PMID:32699268
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of B3GALNT1 mRNA	PMID:35811015
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GALNT1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GALNT1 mRNA	PMID:35811015
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of B3GALNT1 mRNA	PMID:39298647
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312449	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of B3GALNT1 mRNA	PMID:31614463
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312450	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of B3GALNT1 mRNA	PMID:19484750
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALNT1 mRNA	PMID:20938992
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312449	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of B3GALNT1 mRNA	PMID:21179406
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA	PMID:37992649
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA	PMID:37992649
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of B3GALNT1 mRNA	PMID:31163220
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312450	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of B3GALNT1 mRNA	PMID:33754040|PMID:34319233
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of B3GALNT1 mRNA	PMID:33387578
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of B3GALNT1 mRNA	PMID:37748715
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA	PMID:39836092
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of B3GALNT1 mRNA	PMID:35301059
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of B3GALNT1 mRNA	PMID:37325564
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B3GALNT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B3GALNT1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of B3GALNT1 mRNA	PMID:32699268
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of B3GALNT1 mRNA	PMID:31129395
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of B3GALNT1 mRNA	PMID:31150632
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312450	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of B3GALNT1 mRNA	PMID:27339419|PMID:31919559
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of B3GALNT1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALNT1 mRNA	PMID:20938992|PMID:22206623
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B3GALNT1 mRNA	PMID:39836092
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312449	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of B3GALNT1 mRNA	PMID:26272509
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GALNT1 mRNA	PMID:27188386
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]	PMID:37992649
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of B3GALNT1 mRNA	PMID:31881176
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of B3GALNT1 mRNA	PMID:25905778
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312449	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of B3GALNT1 mRNA	PMID:28903495
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312450	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of B3GALNT1 mRNA	PMID:18930951
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of B3GALNT1 mRNA	PMID:22298810
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of B3GALNT1 mRNA	PMID:33387578
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of B3GALNT1 mRNA	PMID:28001369
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of B3GALNT1 mRNA	PMID:33212167
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of B3GALNT1 mRNA	PMID:29803840
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA	PMID:37992649
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]	PMID:37992649
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of B3GALNT1 mRNA	PMID:37682722
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B3GALNT1 mRNA	PMID:39836092
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of B3GALNT1 mRNA	PMID:21964900|PMID:23735875
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312449	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of B3GALNT1 5' UTR	PMID:27901495
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312449	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of B3GALNT1 mRNA	PMID:32234424
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312449	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of B3GALNT1 promoter	PMID:27901495
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of B3GALNT1 mRNA	PMID:32479839
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of B3GALNT1 mRNA	PMID:25729387
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of B3GALNT1 mRNA	PMID:25729387
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312450	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of B3GALNT1 gene	PMID:35295148
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of B3GALNT1 mRNA	PMID:34492290
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of B3GALNT1 mRNA	PMID:30723492
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of B3GALNT1 mRNA	PMID:20813756
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of B3GALNT1 mRNA	PMID:19710929
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of B3GALNT1 mRNA	PMID:30816183|PMID:32528016|PMID:33296240
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of B3GALNT1 mRNA	PMID:31129395
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of B3GALNT1 mRNA	PMID:39298647
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of B3GALNT1 mRNA	PMID:19638242
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of B3GALNT1 mRNA	PMID:18164116
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA	PMID:39836092
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of B3GALNT1 mRNA	PMID:30723492
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of B3GALNT1 mRNA	PMID:35301059
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of B3GALNT1 mRNA	PMID:37325564
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of B3GALNT1 mRNA	PMID:27387713
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of B3GALNT1 mRNA	PMID:28962523
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B3GALNT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B3GALNT1 mRNA	PMID:32699268
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA	PMID:19167446
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312449	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of B3GALNT1 mRNA	PMID:25979313
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of B3GALNT1 mRNA	PMID:23179753|PMID:25192806|PMID:27188386|PMID:28001369
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312449	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of B3GALNT1 gene	PMID:29154799
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of B3GALNT1 mRNA	PMID:27989131
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA	PMID:37992649
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312449	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of B3GALNT1 mRNA	PMID:38832940
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of B3GALNT1 mRNA	PMID:24935251|PMID:26272509
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of B3GALNT1 mRNA	PMID:33387578
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GALNT1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GALNT1 mRNA	PMID:35811015
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of B3GALNT1 mRNA	PMID:29279043
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B3GALNT1 mRNA	PMID:39836092
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312449	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of B3GALNT1 mRNA	PMID:17145863
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1312450	E	RGD:6480464	20150127	CTD	MESH:C000499	ferric oxide analog results in increased expression of B3GALNT1 mRNA	PMID:24525745
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of B3GALNT1 mRNA	PMID:21983209
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of B3GALNT1 mRNA	PMID:19042947
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA	PMID:39836092
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of B3GALNT1 mRNA	PMID:25729387
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of B3GALNT1 mRNA	PMID:25729387
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of B3GALNT1 mRNA	PMID:30467583
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of B3GALNT1 mRNA	PMID:22206623
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:7438	N-methylformamide	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in decreased expression of B3GALNT1 mRNA; methylformamide results in decreased expression of B3GALNT1 mRNA	PMID:17040096
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312449	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of B3GALNT1 mRNA	PMID:22714537
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of B3GALNT1 mRNA	PMID:18164116
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GALNT1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of B3GALNT1 mRNA	PMID:30928695
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of B3GALNT1 mRNA	PMID:23091169
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA	PMID:19167446
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312450	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of B3GALNT1 mRNA	PMID:39847705
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of B3GALNT1 mRNA	PMID:24780913
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312449	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GALNT1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of B3GALNT1 mRNA	PMID:25905778
1304797	B3galnt1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312449	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of B3GALNT1 mRNA	PMID:29301935
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312451	E	RGD:6480464	20140729	CTD	MESH:D011794	Quercetin results in decreased expression of ZNF184 mRNA	PMID:21632981
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552007	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP184 mRNA	PMID:39241906
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA	PMID:25510870
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312451	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF184 mRNA	PMID:37042841
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312451	E	RGD:6480464	20140729	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZNF184 mRNA	PMID:20655997
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of ZFP184 mRNA]	PMID:33484791
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312451	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZNF184 mRNA	PMID:28818685
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA	PMID:25510870
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA	PMID:25510870
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312451	E	RGD:6480464	20140729	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF184 mRNA	PMID:19549813
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312451	E	RGD:6480464	20140729	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ZNF184 mRNA	PMID:23649840
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312451	E	RGD:6480464	20140729	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNF184 mRNA	PMID:23649840
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552007	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ZFP184 mRNA	PMID:28960355
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1312451	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of ZNF184 gene	PMID:31636367
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312451	E	RGD:6480464	20140729	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZNF184 mRNA	PMID:22574217
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552007	E	RGD:6480464	20150602	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP184 mRNA	PMID:21570461
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312451	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ZNF184 mRNA	PMID:30851411
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1552007	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of ZFP184 mRNA	PMID:30807115
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312451	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF184 promoter	PMID:27901495
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312451	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF184 mRNA	PMID:20382639
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552007	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZFP184 mRNA	PMID:29264374
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20150602	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA	PMID:25510870
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20150602	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA	PMID:25510870
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552007	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ZFP184 mRNA	PMID:37019170
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552007	E	RGD:6480464	20150602	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ZFP184 mRNA	PMID:17361019
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312451	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF184 mRNA	PMID:37042841
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312451	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF184 mRNA	PMID:38568856
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312451	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF184 mRNA	PMID:25979313
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312451	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF184 gene	PMID:29154799
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312451	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ZNF184 mRNA	PMID:29154799
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312451	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF184 mRNA	PMID:20106945|PMID:25562108
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312451	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ZNF184 mRNA	PMID:22714537
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1552007	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ZFP184 mRNA	PMID:38701926
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312451	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ZNF184 mRNA	PMID:28988120
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552007	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ZFP184 mRNA	PMID:22206623
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312451	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF184 protein	PMID:31285264
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312451	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ZNF184 mRNA	PMID:30851411
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312451	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ZNF184 mRNA	PMID:30928695
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312451	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF184 gene]	PMID:28238834
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150602	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZFP184 mRNA	PMID:24780913
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of ZFP184 mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of ZFP184 mRNA]	PMID:33484791
1304798	Zfp184	zinc finger protein 184	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150602	CTD	MESH:C025643	vinclozolin results in decreased expression of ZFP184 mRNA	PMID:22570695
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312454	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of DGUOK mRNA	PMID:33045310
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312453	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of DGUOK mRNA	PMID:21934132
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of DGUOK mRNA	PMID:36331819
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of DGUOK gene	PMID:28931070
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DGUOK mRNA	PMID:39241906
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:16794	scopolamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012601	Scopolamine results in increased expression of DGUOK mRNA	PMID:17540011
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312453	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of DGUOK mRNA	PMID:33359661
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312453	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DGUOK mRNA	PMID:27153756
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DGUOK mRNA	PMID:31150632
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DGUOK mRNA	PMID:25629700
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DGUOK mRNA	PMID:22206623
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DGUOK mRNA	PMID:40504410
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312454	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of DGUOK mRNA	PMID:22610192
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312453	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of DGUOK mRNA	PMID:28903495
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312453	E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of DGUOK mRNA	PMID:22228119
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of DGUOK mRNA	PMID:32186404
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312454	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DGUOK mRNA	PMID:21570461
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DGUOK mRNA	PMID:21215274
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DGUOK mRNA	PMID:17942748
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312453	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DGUOK mRNA	PMID:30851411
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of DGUOK mRNA	PMID:27862939
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of DGUOK mRNA	PMID:26873546
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312453	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DGUOK mRNA	PMID:38568856
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DGUOK mRNA	PMID:40504410
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312453	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DGUOK promoter	PMID:27901495
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312454	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of DGUOK protein	PMID:37955338
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312453	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to DGUOK mRNA]	PMID:32406909
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312454	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DGUOK gene	PMID:35295148
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of DGUOK mRNA	PMID:23411599
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DGUOK mRNA	PMID:18648102
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DGUOK mRNA	PMID:25181051
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DGUOK mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DGUOK gene	PMID:28505145
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DGUOK mRNA	PMID:38685157
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DGUOK mRNA	PMID:32715474
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DGUOK mRNA	PMID:21266533
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of DGUOK mRNA	PMID:17942915
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DGUOK mRNA]	PMID:17942915
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312453	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DGUOK mRNA	PMID:37042841
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312453	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DGUOK mRNA	PMID:38568856
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DGUOK mRNA	PMID:24386269
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of DGUOK mRNA	PMID:36331819
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312453	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DGUOK mRNA	PMID:25979313
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312453	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of DGUOK mRNA	PMID:23179753
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DGUOK mRNA	PMID:17562736
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312453	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of DGUOK mRNA	PMID:21420995|PMID:25704631
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DGUOK mRNA	PMID:40504410
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DGUOK mRNA	PMID:17555576
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DGUOK mRNA	PMID:17942748
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of DGUOK mRNA	PMID:30307764
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DGUOK gene	PMID:35440735
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DGUOK mRNA	PMID:22206623
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DGUOK mRNA	PMID:22206623
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:75701	sarin	decreases expression	ISO	RGD:1312453	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of DGUOK mRNA	PMID:19522546
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:75701	sarin	increases expression	ISO	RGD:1312453	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of DGUOK mRNA	PMID:19522546
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312453	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DGUOK mRNA	PMID:30851411
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312454	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DGUOK mRNA	PMID:30294300
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of DGUOK mRNA	PMID:23914054
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1312454	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of DGUOK protein	PMID:35357534
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DGUOK mRNA	PMID:35537566
1304799	Dguok	deoxyguanosine kinase	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DGUOK mRNA	PMID:19015723
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312456	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of GGA2 mRNA	PMID:30319688
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GGA2 mRNA	PMID:39298647
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312455	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of GGA2 mRNA	PMID:19162166
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGA2 mRNA	PMID:37992649
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312456	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of GGA2 mRNA	PMID:22401849
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312455	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of GGA2 promoter	PMID:33872906
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of GGA2 mRNA	PMID:33848595
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGA2 mRNA	PMID:37992649
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312455	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of GGA2 promoter	PMID:33872906
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of GGA2 mRNA	PMID:22061828|PMID:33387578
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GGA2 protein	PMID:34915118
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GGA2 mRNA	PMID:37236586
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312456	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GGA2 mRNA	PMID:31919559
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GGA2 mRNA	PMID:25629700
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312455	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of GGA2 protein	PMID:35688186
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312455	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GGA2 mRNA	PMID:23557933
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312455	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of GGA2 protein	PMID:39603559
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of GGA2 mRNA	PMID:28959563
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGA2 mRNA	PMID:37992649
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of GGA2 mRNA	PMID:17127020
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312455	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GGA2 mRNA	PMID:26238291
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312455	E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GGA2 protein	PMID:32717239
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of GGA2 mRNA	PMID:24136188
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of GGA2 mRNA	PMID:25729387
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GGA2 mRNA	PMID:34492290
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312455	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of GGA2 mRNA	PMID:30903817
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312455	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of GGA2 mRNA	PMID:29275510
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GGA2 gene	PMID:28505145
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312455	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of GGA2 mRNA	PMID:25979313
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GGA2 mRNA	PMID:39298647
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of GGA2 mRNA	PMID:28392331
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312456	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GGA2 mRNA	PMID:37019170
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GGA2 mRNA	PMID:33453195
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312455	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GGA2 mRNA	PMID:38568856
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GGA2 mRNA	PMID:37236586
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312456	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GGA2 mRNA	PMID:40194260
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312455	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of GGA2 mRNA	PMID:19167446
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312455	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GGA2 mRNA	PMID:40419075
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312455	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GGA2 mRNA	PMID:25979313
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312455	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of GGA2 mRNA	PMID:23179753|PMID:26272509
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312455	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA	PMID:27188386
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGA2 mRNA	PMID:37992649
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1312455	E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in increased expression of GGA2 mRNA	PMID:16849584
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312455	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of GGA2 mRNA	PMID:24935251|PMID:26272509
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312455	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA	PMID:27188386
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312456	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GGA2 mRNA	PMID:17562736
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GGA2 mRNA	PMID:33387578
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GGA2 mRNA	PMID:29391264
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of GGA2 mRNA	PMID:24136188
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GGA2 mRNA	PMID:35964746
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312455	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of GGA2 protein	PMID:23718831
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:6015	isoflurane	decreases methylation	ISO	RGD:1312456	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in decreased methylation of GGA2 mRNA	PMID:35249202
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of GGA2 mRNA	PMID:25729387
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GGA2 gene	PMID:35440735
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312456	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GGA2 mRNA	PMID:22206623
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312455	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA	PMID:27188386
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312456	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of GGA2 mRNA	PMID:30294300
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of GGA2 mRNA	PMID:38995820
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	ISO	RGD:1312455	E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of GGA2 mRNA	PMID:12756304
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312455	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA	PMID:27188386
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312455	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GGA2 mRNA	PMID:38568856
1304800	Gga2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312455	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of GGA2 mRNA	PMID:29301935
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of S1PR4 mRNA	PMID:33729688
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of S1PR4 mRNA	PMID:30529165
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312457	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of S1PR4 mRNA	PMID:37042841
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D005947	Glucose results in decreased expression of S1PR4 mRNA	PMID:22406263
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S1PR4 mRNA	PMID:37992649
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D005947	Glucose results in decreased expression of S1PR4 mRNA	PMID:22406263
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S1PR4 mRNA	PMID:37992649
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of S1PR4 mRNA	PMID:36331819
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312457	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of S1PR4 mRNA	PMID:21641981|PMID:22100608
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of S1PR4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of S1PR4 mRNA	PMID:34911549
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312458	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of S1PR4 mRNA	PMID:25629700
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1312457	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of S1PR4 mRNA	PMID:18414638
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27698	vanadium atom	increases expression	ISO	RGD:1312457	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of S1PR4 mRNA	PMID:19000753
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312458	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of S1PR4 mRNA	PMID:28960355
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of S1PR4 mRNA	PMID:31881176
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312457	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of S1PR4 mRNA	PMID:27392435
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of S1PR4 mRNA	PMID:34747641
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S1PR4 mRNA	PMID:37992649
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA	PMID:34876320
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA	PMID:34876320
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312457	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of S1PR4 mRNA	PMID:21871943|PMID:22316170
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to S1PR4 promoter]	PMID:19654925
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of S1PR4 mRNA	PMID:34492290
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of S1PR4 mRNA	PMID:19167457
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of S1PR4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312458	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of S1PR4 mRNA	PMID:32156529
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312458	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of S1PR4 mRNA	PMID:37019170
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312457	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of S1PR4 mRNA	PMID:37042841
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of S1PR4 mRNA	PMID:35163327
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:35170	vanadium(0)	increases expression	ISO	RGD:1312457	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of S1PR4 mRNA	PMID:19000753
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of S1PR4 promoter	PMID:22457795
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312457	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of S1PR4 mRNA	PMID:24449571
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312458	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of S1PR4 mRNA	PMID:40194260
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of S1PR4 mRNA	PMID:36331819
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312457	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of S1PR4 gene	PMID:29154799
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D005947	Glucose results in decreased expression of S1PR4 mRNA	PMID:22406263
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S1PR4 mRNA	PMID:37992649
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312457	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of S1PR4 mRNA	PMID:26690555
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312458	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of S1PR4 mRNA	PMID:17585979
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1312457	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of S1PR4 mRNA	PMID:18414638
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA	PMID:34876320
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of S1PR4 mRNA	PMID:35964746
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312458	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of S1PR4 mRNA	PMID:38701926
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1312457	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of S1PR4 mRNA	PMID:28960945
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA	PMID:34876320
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D013311	Streptozocin results in increased expression of S1PR4 mRNA	PMID:22406263
1304801	S1pr4	sphingosine-1-phosphate receptor 4	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312457	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of S1PR4 mRNA	PMID:29301935
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312459	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of FRMD3 mRNA	PMID:23724009
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312460	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of FRMD3 mRNA	PMID:20880076
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FRMD3 mRNA	PMID:33729688
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of FRMD3 mRNA	PMID:30207508
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FRMD3 mRNA	PMID:21632981
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of FRMD3 mRNA	PMID:30510588
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312459	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of FRMD3 mRNA	PMID:23019147
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of FRMD3 mRNA	PMID:26496021
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of FRMD3 mRNA	PMID:20660070
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of FRMD3 mRNA	PMID:38568856
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312459	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of FRMD3 mRNA	PMID:23649840
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of FRMD3 mRNA	PMID:20660070
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA	PMID:37567420
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312459	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of FRMD3 mRNA	PMID:36695872
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312459	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of FRMD3 mRNA	PMID:33359661
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA	PMID:37567420
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312459	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FRMD3 protein	PMID:37730182
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312459	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of FRMD3 intron	PMID:30157460
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FRMD3 mRNA	PMID:35301059
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20200714	CTD	MESH:D002104	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of FRMD3 mRNA	PMID:31904401
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:234430	gardiquimod	increases expression	ISO	RGD:1312459	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of FRMD3 mRNA	PMID:28003376
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FRMD3 mRNA]	PMID:28003376
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FRMD3 mRNA	PMID:27106289
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312459	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of FRMD3 mRNA	PMID:19774075
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312460	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FRMD3 mRNA	PMID:25629700
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of FRMD3 mRNA	PMID:26272509
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA	PMID:27188386
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312460	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FRMD3 mRNA	PMID:28960355
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312459	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of FRMD3 mRNA	PMID:27392435
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of FRMD3 mRNA	PMID:27392435
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FRMD3 mRNA	PMID:28001369
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FRMD3 mRNA	PMID:33212167
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of FRMD3 mRNA	PMID:26272509
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA	PMID:27188386
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of FRMD3 mRNA	PMID:28959563
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312459	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of FRMD3 mRNA	PMID:32763439
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FRMD3 mRNA	PMID:29803840
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA	PMID:37567420
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312460	E	RGD:6480464	20220809	CTD	MESH:C017947	sodium arsenite affects the expression of FRMD3 mRNA	PMID:26674514
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of and affects the splicing of FRMD3 mRNA	PMID:25879800
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FRMD3 mRNA	PMID:20106945|PMID:21632981
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312459	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of FRMD3 promoter	PMID:23974009
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of FRMD3 mRNA	PMID:25895662
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FRMD3 mRNA	PMID:20018196
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312459	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of FRMD3 gene	PMID:31601247
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of FRMD3 gene	PMID:31601247
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312460	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of FRMD3 mRNA	PMID:22613225
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312460	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FRMD3 gene	PMID:35295148
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312460	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FRMD3 gene	PMID:35295148
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FRMD3 mRNA	PMID:19710929
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312460	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FRMD3 promoter	PMID:27334623
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FRMD3 mRNA	PMID:25181051
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of FRMD3 mRNA	PMID:31715268
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of FRMD3 mRNA	PMID:26496021
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1312459	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of FRMD3 mRNA	PMID:36804509
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of FRMD3 gene	PMID:31601247
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312459	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FRMD3 mRNA	PMID:37042841
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FRMD3 mRNA	PMID:35301059
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20200714	CTD	MESH:D019256	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of FRMD3 mRNA	PMID:31904401
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20200714	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of FRMD3 mRNA	PMID:31904401
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FRMD3 mRNA]	PMID:28003376
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312459	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FRMD3 mRNA	PMID:31533062
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of FRMD3 mRNA	PMID:19167446
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312459	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FRMD3 mRNA	PMID:25979313
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312460	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of FRMD3 mRNA	PMID:24896083
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312459	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of FRMD3 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRMD3 mRNA	PMID:27188386
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of FRMD3 mRNA	PMID:20106945|PMID:21632981
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA	PMID:37567420
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312459	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FRMD3 mRNA	PMID:24935251
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1312459	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of FRMD3 mRNA	PMID:26272509
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA	PMID:27188386
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312459	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of FRMD3 mRNA	PMID:22714537
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312459	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of FRMD3 mRNA	PMID:28988120
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312459	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of FRMD3 mRNA	PMID:31758290
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312460	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FRMD3 mRNA	PMID:22206623
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA	PMID:37567420
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1312459	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in increased expression of FRMD3 mRNA	PMID:30559759
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRMD3 mRNA	PMID:27188386
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FRMD3 gene]	PMID:28238834
1304802	Frmd3	FERM domain containing 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312459	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRMD3 mRNA	PMID:27188386
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1551186	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of WDR24 mRNA	PMID:20188158
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344935	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of WDR24 mRNA	PMID:37042841
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of WDR24 mRNA	PMID:33387578
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551186	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of WDR24 mRNA	PMID:25629700
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551186	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WDR24 mRNA	PMID:22206623
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:27698	vanadium atom	multiple interactions	ISO	RGD:1344935	E	RGD:6480464	20260203	CTD	MESH:D014639	[Metals, Heavy results in increased abundance of Vanadium] which results in increased methylation of WDR24 gene	PMID:39164771
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1344935	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of WDR24 protein	PMID:35688186
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551186	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDR24 mRNA	PMID:21570461
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1344935	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WDR24 mRNA	PMID:30851411
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1344935	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of WDR24 mRNA	PMID:32763439
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344935	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of WDR24 mRNA	PMID:38568856
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1344935	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of WDR24 mRNA	PMID:20106945
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1344935	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of WDR24 gene	PMID:31601247
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of WDR24 mRNA	PMID:34492290
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR24 mRNA	PMID:34947998
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1344935	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of WDR24 gene	PMID:31601247
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of WDR24 mRNA	PMID:25181051
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of WDR24 mRNA	PMID:36041667
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of WDR24 mRNA	PMID:36041667
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1344935	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of WDR24 intron	PMID:30157460
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of WDR24 mRNA	PMID:36041667
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:35170	vanadium(0)	multiple interactions	ISO	RGD:1344935	E	RGD:6480464	20260203	CTD	MESH:D014639	[Metals, Heavy results in increased abundance of Vanadium] which results in increased methylation of WDR24 gene	PMID:39164771
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1344935	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of WDR24 mRNA	PMID:31533062
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1344935	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of WDR24 mRNA	PMID:40419075
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1344935	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of WDR24 gene	PMID:29154799
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of WDR24 mRNA	PMID:21346803
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1551186	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of WDR24 mRNA	PMID:35436446
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of WDR24 mRNA	PMID:24136188
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1344935	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of WDR24 intron	PMID:30157460
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551186	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WDR24 mRNA	PMID:22206623
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1344935	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WDR24 mRNA	PMID:30851411
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of WDR24 mRNA	PMID:19281266
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of WDR24 mRNA	PMID:21346803
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of WDR24 mRNA	PMID:21346803
1304803	Wdr24	WD repeat domain 24	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of WDR24 mRNA	PMID:23034163
1304805	Krt12	keratin 12	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of KRT12 mRNA	PMID:21551480
1304805	Krt12	keratin 12	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312464	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KRT12 mRNA	PMID:35811015
1304805	Krt12	keratin 12	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312464	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of KRT12 mRNA]	PMID:35811015
1304805	Krt12	keratin 12	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of KRT12 mRNA	PMID:20884683
1304805	Krt12	keratin 12	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1618846	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of KRT12 mRNA	PMID:22238285
1304805	Krt12	keratin 12	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312464	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KRT12 mRNA	PMID:19549813
1304805	Krt12	keratin 12	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312464	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KRT12 gene	PMID:27153756
1304805	Krt12	keratin 12	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312464	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT12 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT12 protein	PMID:38598786
1304805	Krt12	keratin 12	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1618846	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of KRT12 mRNA	PMID:23625948
1304805	Krt12	keratin 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618846	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT12 mRNA	PMID:21570461
1304805	Krt12	keratin 12	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of KRT12 mRNA	PMID:28959563
1304805	Krt12	keratin 12	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of KRT12 mRNA	PMID:26033743
1304805	Krt12	keratin 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618846	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA	PMID:34876320
1304805	Krt12	keratin 12	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1618846	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA	PMID:34876320
1304805	Krt12	keratin 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1618846	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KRT12 mRNA	PMID:23735875
1304805	Krt12	keratin 12	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312464	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT12 exon; Benzo(a)pyrene results in increased methylation of KRT12 promoter	PMID:27901495
1304805	Krt12	keratin 12	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of KRT12 mRNA	PMID:26033743
1304805	Krt12	keratin 12	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1618846	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of KRT12 mRNA	PMID:29264374
1304805	Krt12	keratin 12	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1618846	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of KRT12 mRNA	PMID:17426115
1304805	Krt12	keratin 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT12 mRNA	PMID:25181051
1304805	Krt12	keratin 12	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of KRT12 mRNA	PMID:22561333
1304805	Krt12	keratin 12	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1618846	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of KRT12 mRNA	PMID:22155349
1304805	Krt12	keratin 12	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312464	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KRT12 gene	PMID:29154799
1304805	Krt12	keratin 12	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312464	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRT12 mRNA	PMID:22230336
1304805	Krt12	keratin 12	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312464	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of KRT12 mRNA]	PMID:35811015
1304805	Krt12	keratin 12	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1618846	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of KRT12 mRNA	PMID:29279043
1304805	Krt12	keratin 12	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1618846	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA	PMID:34876320
1304805	Krt12	keratin 12	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312464	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT12 gene]	PMID:28238834
1304805	Krt12	keratin 12	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1618846	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA	PMID:34876320
1304805	Krt12	keratin 12	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312464	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT12 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT12 protein	PMID:38598786
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of INO80D mRNA	PMID:27188386
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1616557	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of INO80D mRNA	PMID:33045310
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1616557	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of INO80D mRNA	PMID:39241906
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1616557	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INO80D mRNA	PMID:25510870
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606537	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of INO80D mRNA	PMID:37042841
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of INO80D mRNA	PMID:20655997
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1606537	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of INO80D protein	PMID:37730182
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1606537	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of INO80D mRNA	PMID:28818685
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1616557	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of INO80D mRNA	PMID:33914522
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1606537	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INO80D mRNA	PMID:35301059
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1616557	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INO80D mRNA	PMID:25510870
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1616557	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INO80D mRNA	PMID:25510870
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1606537	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of INO80D mRNA	PMID:23649840
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of INO80D mRNA	PMID:30779732
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of INO80D mRNA	PMID:26272509
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1606537	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INO80D mRNA	PMID:27188386
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1606537	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of INO80D protein	PMID:35688186
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of INO80D mRNA	PMID:26302742
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of INO80D mRNA	PMID:27392435|PMID:27594783
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606537	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of INO80D mRNA	PMID:27392435
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1616557	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of INO80D mRNA	PMID:30912803
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:28077	rifampicin	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in decreased expression of INO80D mRNA	PMID:24552687
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of INO80D mRNA	PMID:33212167
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1606537	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of INO80D mRNA	PMID:32763439
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of INO80D mRNA	PMID:29803840
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606537	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of INO80D mRNA	PMID:38568856
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of INO80D mRNA	PMID:20018196
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1616557	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of INO80D gene; titanium dioxide results in decreased methylation of INO80D promoter	PMID:35295148
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of INO80D mRNA	PMID:34492290
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1616557	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of INO80D mRNA	PMID:33914522
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of INO80D mRNA	PMID:25181051
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1616557	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of INO80D mRNA	PMID:32156529
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606537	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of INO80D mRNA	PMID:33670352
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of INO80D gene	PMID:28505145
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1616557	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INO80D mRNA	PMID:25510870
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1616557	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INO80D mRNA	PMID:25510870
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1616557	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of INO80D mRNA	PMID:28392331
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1616557	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of INO80D mRNA	PMID:37019170
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1616557	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of INO80D mRNA	PMID:34813904
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1616557	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of INO80D mRNA	PMID:34813904
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606537	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of INO80D mRNA	PMID:37042841
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1606537	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INO80D mRNA	PMID:35301059
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of INO80D mRNA	PMID:27153767
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616557	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of INO80D mRNA	PMID:36331819
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606537	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of INO80D mRNA	PMID:25979313
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of INO80D mRNA	PMID:29427782
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of INO80D mRNA	PMID:29427782
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of INO80D mRNA	PMID:23179753|PMID:24935251|PMID:27188386|PMID:28001369
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606537	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of INO80D mRNA	PMID:25562108
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20210608	CTD	MESH:C111237	Vorinostat results in decreased expression of INO80D mRNA	PMID:33770205
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1606537	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of INO80D mRNA	PMID:28542535
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of INO80D mRNA	PMID:22230336
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of INO80D mRNA	PMID:29097150
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1606537	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of INO80D mRNA	PMID:23228038
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1606537	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of INO80D mRNA	PMID:26272509
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1606537	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INO80D mRNA	PMID:27188386
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606537	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INO80D mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INO80D mRNA	PMID:27188386
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1616557	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of INO80D mRNA	PMID:23091169
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of INO80D mRNA	PMID:32109520
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1616557	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of INO80D mRNA	PMID:21795629
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606537	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INO80D mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INO80D mRNA	PMID:27188386
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1606537	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of INO80D mRNA	PMID:38568856
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1606537	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of INO80D mRNA	PMID:27188386
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1616557	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of INO80D mRNA	PMID:28973697
1304808	Ino80d	INO80 complex subunit D	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of INO80D mRNA	PMID:23034163
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312470	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ANKEF1 mRNA	PMID:26272509
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312470	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA	PMID:27188386
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312470	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ANKEF1 mRNA	PMID:21632981
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of ANKEF1 mRNA	PMID:21185374
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ANKEF1 mRNA	PMID:33387578
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312470	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ANKEF1 mRNA	PMID:37042841
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312470	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKEF1 mRNA	PMID:36139627
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ANKEF1 mRNA	PMID:28818685
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANKEF1 mRNA	PMID:39012411
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312470	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ANKEF1 mRNA	PMID:19549813
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312470	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ANKEF1 mRNA	PMID:23649840
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312471	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ANKEF1 mRNA	PMID:28960355
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ANKEF1 mRNA	PMID:31881176
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312470	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ANKEF1 mRNA	PMID:27594783
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ANKEF1 mRNA	PMID:28001369
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312470	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ANKEF1 mRNA	PMID:33212167
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ANKEF1 mRNA	PMID:29803840
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312470	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANKEF1 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312470	E	RGD:6480464	20161115	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ANKEF1 gene	PMID:25435355
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312470	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ANKEF1 mRNA]	PMID:32406909
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ANKEF1 mRNA	PMID:25351596
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312470	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ANKEF1 mRNA	PMID:19710929
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKEF1 mRNA	PMID:25181051
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312471	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of ANKEF1 mRNA	PMID:38701888
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312471	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ANKEF1 mRNA	PMID:40203079
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312470	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of ANKEF1 mRNA	PMID:27685785
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312471	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ANKEF1 exon	PMID:33297965
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ANKEF1 mRNA	PMID:21266533
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312470	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANKEF1 mRNA	PMID:37042841
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ANKEF1 mRNA	PMID:30723492
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ANKEF1 mRNA	PMID:38568856
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANKEF1 mRNA	PMID:39012411
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312470	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ANKEF1 mRNA	PMID:24935251|PMID:26272509|PMID:28001369
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312470	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA	PMID:27188386
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20160210	CTD	MESH:D016572	Cyclosporine results in decreased expression of ANKEF1 mRNA	PMID:25562108
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312470	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ANKEF1 mRNA	PMID:20106945
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312471	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ANKEF1 mRNA	PMID:28973697
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312471	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ANKEF1 mRNA	PMID:17562736
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312470	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ANKEF1 mRNA	PMID:20977926
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ANKEF1 mRNA	PMID:25351596
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ANKEF1 mRNA	PMID:30307764
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312471	E	RGD:6480464	20150512	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ANKEF1 mRNA	PMID:23608068
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ANKEF1 protein	PMID:32959892
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312471	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ANKEF1 mRNA	PMID:22206623
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312470	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKEF1 mRNA	PMID:36139627
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312470	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA	PMID:27188386
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of ANKEF1 mRNA	PMID:32109520
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:C010902	[Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of ANKEF1 mRNA	PMID:32207525
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312470	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA	PMID:27188386
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ANKEF1 mRNA	PMID:38568856
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ANKEF1 mRNA	PMID:29301935
1304809	Ankef1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312470	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ANKEF1 mRNA	PMID:27188386
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1602875	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of TRMT9B mRNA	PMID:21934132
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1602875	E	RGD:6480464	20210504	CTD	MESH:D014260	Triclosan results in decreased expression of TRMT9B mRNA	PMID:30510588
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312472	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TRMT9B mRNA	PMID:39298647
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TRMT9B mRNA	PMID:33387578
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1602875	E	RGD:6480464	20210504	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TRMT9B mRNA	PMID:31163220
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1602875	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TRMT9B mRNA	PMID:36139627
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1602875	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TRMT9B exon	PMID:30157460
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1602875	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TRMT9B mRNA	PMID:32234424
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602875	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TRMT9B gene	PMID:27153756
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1602875	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRMT9B gene	PMID:25304211
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRMT9B mRNA	PMID:22298810
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRMT9B mRNA	PMID:33387578
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312472	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of TRMT9B mRNA	PMID:30807115
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1602875	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TRMT9B mRNA	PMID:32763439
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602875	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRMT9B mRNA	PMID:29803840
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1602875	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TRMT9B gene	PMID:28589171
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602875	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRMT9B mRNA	PMID:34032870
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602875	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRMT9B exon; Benzo(a)pyrene affects the methylation of TRMT9B promoter	PMID:27901495|PMID:30157460
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602875	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRMT9B 5' UTR	PMID:27901495
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TRMT9B mRNA	PMID:25181051|PMID:33296240|PMID:34947998
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TRMT9B mRNA	PMID:30816183|PMID:32528016
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1602875	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TRMT9B mRNA	PMID:25979313
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312472	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of TRMT9B exon	PMID:33297965
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312472	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TRMT9B mRNA	PMID:30951980
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1602875	E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of TRMT9B mRNA	PMID:23626723
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1602875	E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of TRMT9B mRNA	PMID:23626723
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312472	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TRMT9B mRNA	PMID:30951980
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1602875	E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of TRMT9B mRNA	PMID:23626723
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TRMT9B mRNA	PMID:30723492
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20180515	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of TRMT9B promoter	PMID:22457795
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1602875	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TRMT9B mRNA	PMID:24449571
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312472	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TRMT9B mRNA	PMID:40194260
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602875	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TRMT9B mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602875	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMT9B mRNA	PMID:27188386
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1312472	E	RGD:6480464	20190219	CTD	MESH:C017160	cypermethrin results in increased expression of TRMT9B mRNA	PMID:29020013
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312472	E	RGD:6480464	20180313	CTD	MESH:D017313	Fenretinide results in increased expression of TRMT9B mRNA	PMID:28973697
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1602875	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TRMT9B mRNA	PMID:38832940
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1602875	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of TRMT9B mRNA	PMID:26272509
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1602875	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMT9B mRNA	PMID:27188386
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602875	E	RGD:6480464	20210504	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRMT9B mRNA	PMID:29067470
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TRMT9B mRNA	PMID:33387578
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1602875	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRMT9B gene	PMID:25304211
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TRMT9B mRNA	PMID:29391264
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TRMT9B mRNA	PMID:30307764
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312472	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TRMT9B mRNA	PMID:38701926
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1602875	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TRMT9B mRNA	PMID:36139627
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602875	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMT9B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMT9B mRNA	PMID:27188386
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1602875	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of TRMT9B mRNA	PMID:39904859
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312472	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of TRMT9B mRNA	PMID:31388691
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D011441	Propylthiouracil affects the expression of TRMT9B mRNA	PMID:24780913
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602875	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMT9B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMT9B mRNA	PMID:27188386
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602875	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TRMT9B mRNA	PMID:38568856
1304810	Trmt9b	tRNA methyltransferase 9B (putative)	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C025643	vinclozolin affects the expression of TRMT9B mRNA	PMID:19015723|PMID:23034163
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D004237	Diuron results in increased expression of TMC4 mRNA	PMID:21551480
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312474	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TMC4 mRNA	PMID:33045310
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312474	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TMC4 mRNA	PMID:37995155
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20150721	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMC4 mRNA	PMID:20938992
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMC4 mRNA	PMID:36331819
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312473	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TMC4 mRNA	PMID:26079696
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312473	E	RGD:6480464	20150707	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TMC4 mRNA	PMID:20044591
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312473	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TMC4 mRNA	PMID:35811015
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312473	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of TMC4 mRNA]	PMID:35811015
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312474	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TMC4 mRNA	PMID:39298647
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312473	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of TMC4 mRNA	PMID:30165855
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312474	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of TMC4 mRNA	PMID:33711761
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20150721	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMC4 mRNA	PMID:20938992
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312474	E	RGD:6480464	20150721	CTD	MESH:D011374	Progesterone results in increased expression of TMC4 mRNA	PMID:19693291
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312473	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TMC4 mRNA	PMID:26079696
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312473	E	RGD:6480464	20150707	CTD	MESH:D013739	Testosterone results in increased expression of TMC4 mRNA	PMID:21592394
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312474	E	RGD:6480464	20150721	CTD	MESH:D013739	Testosterone results in increased expression of TMC4 mRNA	PMID:19693291
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312473	E	RGD:6480464	20150707	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of TMC4 mRNA	PMID:21592394
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312473	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of TMC4 mRNA	PMID:21592394|PMID:26485663
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312473	E	RGD:6480464	20150707	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of TMC4 mRNA	PMID:21592394
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of TMC4 mRNA	PMID:28522335
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TMC4 mRNA	PMID:23630614
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312473	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TMC4 mRNA	PMID:35430440
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TMC4 mRNA	PMID:34911549
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TMC4 mRNA	PMID:30779732
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312474	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of TMC4 mRNA	PMID:31939706
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20150721	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMC4 mRNA	PMID:20938992
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMC4 mRNA	PMID:40504410
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312474	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of TMC4 mRNA	PMID:28960355
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312473	E	RGD:6480464	20150707	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of TMC4 mRNA	PMID:19167446
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of TMC4 gene	PMID:28505145
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312473	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TMC4 mRNA	PMID:24768652|PMID:25583101
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMC4 mRNA	PMID:32109520
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312473	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TMC4 mRNA	PMID:33212167
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312473	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TMC4 mRNA	PMID:32763439
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312473	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMC4 mRNA	PMID:34032870
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMC4 mRNA	PMID:40504410
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312473	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMC4 exon; Benzo(a)pyrene results in decreased methylation of TMC4 promoter	PMID:27901495
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312474	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TMC4 mRNA	PMID:27131904
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312473	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TMC4 mRNA	PMID:25895662
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of TMC4 mRNA	PMID:21515302
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TMC4 mRNA	PMID:30816183|PMID:32528016
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312474	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TMC4 mRNA	PMID:32156529
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMC4 mRNA	PMID:25181051
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of TMC4 gene	PMID:28505145
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312474	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TMC4 mRNA	PMID:30951980
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312473	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of TMC4 intron	PMID:30157460
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312474	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TMC4 mRNA	PMID:38685157
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:34698	diethyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of TMC4 mRNA	PMID:32341500
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312473	E	RGD:6480464	20250311	CTD	MESH:C007379	[diethyl phthalate results in increased abundance of monoethyl phthalate] which results in decreased expression of TMC4 mRNA	PMID:32341500
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of TMC4 mRNA	PMID:36117858
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312473	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMC4 mRNA	PMID:37042841
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TMC4 mRNA	PMID:35163327
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TMC4 mRNA	PMID:35163327
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TMC4 mRNA	PMID:27387713
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312473	E	RGD:6480464	20150707	CTD	MESH:D003375	Coumestrol results in decreased expression of TMC4 mRNA	PMID:19167446
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312473	E	RGD:6480464	20150707	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of TMC4 mRNA	PMID:19167446
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMC4 mRNA	PMID:36331819
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312473	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of TMC4 mRNA	PMID:28001369
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312473	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TMC4 gene	PMID:29154799
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312474	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TMC4 mRNA	PMID:28973697
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312474	E	RGD:6480464	20150721	CTD	MESH:D008727	Methotrexate affects the expression of TMC4 mRNA	PMID:18502557
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312473	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of TMC4 mRNA]	PMID:35811015
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMC4 mRNA	PMID:40504410
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TMC4 mRNA	PMID:17557909
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1312473	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of TMC4 mRNA	PMID:38825487
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:5118	fluoxetine	decreases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D005473	Fluoxetine results in decreased expression of TMC4 mRNA	PMID:17033635
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312474	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of TMC4 mRNA	PMID:26377693
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of TMC4 mRNA	PMID:36117858
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312474	E	RGD:6480464	20150721	CTD	MESH:D011192	Potassium Dichromate results in increased expression of TMC4 mRNA	PMID:23608068
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312473	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of TMC4 intron	PMID:30157460
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312473	E	RGD:6480464	20250311	CTD	MESH:C581825	[diethyl phthalate results in increased abundance of monoethyl phthalate] which results in decreased expression of TMC4 mRNA	PMID:32341500
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312474	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of TMC4 mRNA	PMID:22206623
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of TMC4 mRNA	PMID:32109520
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312474	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TMC4 mRNA	PMID:27131904
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:C057693	troglitazone results in decreased expression of TMC4 mRNA	PMID:21515302
1304811	Tmc4	transmembrane channel-like 4	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of TMC4 mRNA	PMID:19015723
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312476	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FCHSD2 mRNA	PMID:33045310
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FCHSD2 mRNA]	PMID:31150632
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FCHSD2 mRNA	PMID:33167477
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FCHSD2 mRNA	PMID:26079696
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of FCHSD2 protein	PMID:18951874
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FCHSD2 mRNA	PMID:21632981
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FCHSD2 mRNA	PMID:39241906
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of FCHSD2 mRNA	PMID:39298647
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FCHSD2 mRNA	PMID:33387578
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312475	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FCHSD2 mRNA	PMID:37042841
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in decreased expression of FCHSD2 mRNA	PMID:19162166
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of FCHSD2 mRNA	PMID:27664576
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312475	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FCHSD2 protein	PMID:37730182
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312475	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of FCHSD2 mRNA	PMID:16002434
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FCHSD2 mRNA	PMID:22061828
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FCHSD2 mRNA	PMID:36331819
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FCHSD2 mRNA	PMID:35301059
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FCHSD2 mRNA	PMID:37236586
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312475	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of FCHSD2 mRNA	PMID:19549813
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of FCHSD2 mRNA	PMID:15651846
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of FCHSD2 mRNA	PMID:30779732
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FCHSD2 mRNA	PMID:31150632
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FCHSD2 mRNA	PMID:17484886|PMID:31919559
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FCHSD2 mRNA]	PMID:31150632
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FCHSD2 mRNA	PMID:25629700
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FCHSD2 mRNA	PMID:22206623
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312475	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FCHSD2 gene	PMID:25304211
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA	PMID:27188386
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312475	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of FCHSD2 protein	PMID:35688186
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FCHSD2 mRNA	PMID:23557933
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312475	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of FCHSD2 mRNA	PMID:28903495
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of FCHSD2 mRNA	PMID:21603599
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312475	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of FCHSD2 mRNA	PMID:27392435
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of FCHSD2 mRNA	PMID:24768652
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FCHSD2 mRNA	PMID:22298810
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312475	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FCHSD2 mRNA	PMID:22298810
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312476	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FCHSD2 mRNA	PMID:21570461
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FCHSD2 mRNA	PMID:21215274
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FCHSD2 mRNA	PMID:20106945|PMID:21632981
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FCHSD2 mRNA	PMID:34747641
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312476	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FCHSD2 mRNA	PMID:21354282
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of FCHSD2 protein	PMID:18951874
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FCHSD2 mRNA	PMID:33212167
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312475	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of FCHSD2 mRNA	PMID:39709020
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FCHSD2 mRNA	PMID:30851411
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FCHSD2 mRNA	PMID:29803840
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of FCHSD2 mRNA	PMID:20371982
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FCHSD2 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312475	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FCHSD2 promoter	PMID:27901495
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312476	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FCHSD2 mRNA	PMID:22228805
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of FCHSD2 gene	PMID:31601247
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FCHSD2 mRNA	PMID:24136188
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of FCHSD2 mRNA	PMID:25729387
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312476	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FCHSD2 gene; titanium dioxide results in decreased methylation of FCHSD2 promoter	PMID:35295148
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FCHSD2 mRNA	PMID:34492290
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FCHSD2 mRNA	PMID:19710929
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of FCHSD2 mRNA	PMID:32145629
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of FCHSD2 gene	PMID:28505145
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312475	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FCHSD2 gene	PMID:31601247
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FCHSD2 mRNA	PMID:25181051
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FCHSD2 gene	PMID:28505145
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of FCHSD2 gene	PMID:31601247
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312476	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of FCHSD2 mRNA	PMID:20713471
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FCHSD2 mRNA	PMID:39298647
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312476	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of FCHSD2 mRNA	PMID:40203079
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312476	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of FCHSD2 mRNA	PMID:26377693
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312475	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of FCHSD2 gene	PMID:22964155
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312476	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of FCHSD2 mRNA	PMID:21266533
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of FCHSD2 mRNA	PMID:35163327
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FCHSD2 mRNA	PMID:35301059
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FCHSD2 mRNA	PMID:37236586
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FCHSD2 mRNA	PMID:19320972
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FCHSD2 mRNA	PMID:36331819
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of FCHSD2 mRNA	PMID:23179753
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FCHSD2 mRNA	PMID:25562108
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of FCHSD2 mRNA	PMID:24136188
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FCHSD2 mRNA	PMID:24935251|PMID:26272509
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA	PMID:27188386
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of FCHSD2 mRNA	PMID:21420995|PMID:22230336
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FCHSD2 mRNA	PMID:33387578
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312475	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of FCHSD2 mRNA	PMID:26690555
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FCHSD2 mRNA	PMID:29279043
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312475	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FCHSD2 gene	PMID:25304211
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of FCHSD2 mRNA	PMID:40706910
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FCHSD2 mRNA	PMID:22079256
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FCHSD2 mRNA; Nanotubes, Carbon results in decreased expression of FCHSD2 mRNA	PMID:25554681
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FCHSD2 mRNA	PMID:35964746
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of FCHSD2 mRNA	PMID:24136188
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312476	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FCHSD2 mRNA	PMID:23608068
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of FCHSD2 mRNA	PMID:25729387
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of FCHSD2 mRNA	PMID:25729387
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of FCHSD2 mRNA	PMID:19812364
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of FCHSD2 mRNA	PMID:30467583
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:72676	versicolorin A	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20210209	CTD	MESH:C029826	versicolorin A results in decreased expression of FCHSD2 mRNA	PMID:32106047
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FCHSD2 mRNA	PMID:22206623
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FCHSD2 mRNA	PMID:22206623
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FCHSD2 mRNA	PMID:22079256
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FCHSD2 mRNA	PMID:22079256
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312475	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FCHSD2 mRNA	PMID:30851411
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA	PMID:27188386
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FCHSD2 gene]	PMID:28238834
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312476	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of FCHSD2 mRNA	PMID:19270015
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FCHSD2 mRNA	PMID:24780913
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312475	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA	PMID:27188386
1304812	Fchsd2	FCH and double SH3 domains 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of FCHSD2 mRNA	PMID:22570695
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1312477	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of RBMS2 protein	PMID:36641056
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312477	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of RBMS2 mRNA	PMID:15309432
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312477	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of RBMS2 mRNA	PMID:30165855
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RBMS2 mRNA	PMID:33387578
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312477	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RBMS2 intron	PMID:30157460
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312477	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RBMS2 mRNA	PMID:35301059
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of RBMS2 mRNA	PMID:21396975
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312477	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RBMS2 mRNA	PMID:39836092
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312477	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RBMS2 protein	PMID:35688186
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312477	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RBMS2 mRNA	PMID:27392435
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550035	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RBMS2 mRNA	PMID:30912803
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550035	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBMS2 mRNA	PMID:21570461
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases phosphorylation	EXP		E	RGD:6480464	20140715	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased phosphorylation of RBMS2 protein	PMID:23298284
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312477	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RBMS2 mRNA	PMID:33212167
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312477	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RBMS2 mRNA	PMID:29803840
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312477	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RBMS2 mRNA	PMID:38568856
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312477	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RBMS2 mRNA	PMID:39836092
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1550035	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RBMS2 mRNA	PMID:18648102
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312477	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of RBMS2 mRNA	PMID:20170705
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RBMS2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312477	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RBMS2 mRNA	PMID:25979313
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1312477	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to RBMS2 promoter]	PMID:20348232
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1550035	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of RBMS2 intron	PMID:28392331
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550035	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RBMS2 mRNA	PMID:37019170
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550035	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RBMS2 mRNA	PMID:21266533
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312477	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RBMS2 mRNA	PMID:29024780
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312477	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RBMS2 mRNA	PMID:21457566
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of RBMS2 promoter	PMID:22457795
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312477	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RBMS2 mRNA	PMID:35301059
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312477	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RBMS2 mRNA	PMID:19320972
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312477	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RBMS2 mRNA	PMID:31533062
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312477	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RBMS2 mRNA	PMID:23179753|PMID:28001369
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312477	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RBMS2 mRNA	PMID:25562108
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550035	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of RBMS2 mRNA	PMID:28973697
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1550035	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of RBMS2 mRNA	PMID:18502557
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RBMS2 mRNA	PMID:33387578
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312477	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RBMS2 mRNA	PMID:39836092
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312477	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RBMS2 mRNA	PMID:31758290
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1312477	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of RBMS2 mRNA	PMID:34995734
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:82341	Methylazoxymethanol acetate	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D008746	Methylazoxymethanol Acetate results in decreased expression of RBMS2 mRNA	PMID:28349193
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550035	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RBMS2 mRNA	PMID:39847705
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RBMS2 mRNA	PMID:19281266
1304813	Rbms2	RNA binding motif, single stranded interacting protein 2	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of RBMS2 gene	PMID:31079544
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of KLHL9 mRNA	PMID:31016361
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of KLHL9 mRNA	PMID:26251327
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1347061	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of KLHL9 mRNA	PMID:23724009
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KLHL9 mRNA	PMID:21632981
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KLHL9 mRNA	PMID:39241906
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of KLHL9 mRNA	PMID:39298647
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KLHL9 mRNA	PMID:33387578
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KLHL9 mRNA	PMID:19448997
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1347061	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KLHL9 mRNA	PMID:37042841
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1347061	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of KLHL9 mRNA	PMID:21179406
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KLHL9 mRNA	PMID:28818685
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL9 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of KLHL9 mRNA	PMID:39836092
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLHL9 mRNA	PMID:35301059
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:27086	tributylstannane	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in increased expression of KLHL9 mRNA	PMID:31129395
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551887	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KLHL9 mRNA	PMID:22206623
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL9 mRNA	PMID:39836092
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of KLHL9 mRNA	PMID:19244175
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of KLHL9 mRNA	PMID:33512557
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1347061	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of KLHL9 protein	PMID:35688186
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of KLHL9 gene	PMID:31011160
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of KLHL9 mRNA	PMID:22023808
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551887	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLHL9 mRNA	PMID:21570461
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KLHL9 mRNA	PMID:33387578
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KLHL9 mRNA	PMID:32109520
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of KLHL9 mRNA	PMID:33512557
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KLHL9 mRNA	PMID:28001369
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KLHL9 mRNA	PMID:33212167
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of KLHL9 mRNA	PMID:20971185
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of KLHL9 mRNA	PMID:38568856
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1551887	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of KLHL9 mRNA	PMID:39095385
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL9 mRNA	PMID:39836092
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of KLHL9 mRNA	PMID:20971185
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551887	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KLHL9 gene	PMID:35295148
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of KLHL9 mRNA	PMID:18445702
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of KLHL9 mRNA	PMID:25181051
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of KLHL9 mRNA	PMID:32145629|PMID:34947998
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of KLHL9 mRNA	PMID:33296240
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KLHL9 mRNA	PMID:28628672
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of KLHL9 mRNA	PMID:19244175
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of KLHL9 mRNA	PMID:39298647
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of KLHL9 mRNA	PMID:31558096
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of KLHL9 mRNA	PMID:34813904
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KLHL9 mRNA	PMID:28628672
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of KLHL9 mRNA	PMID:34813904
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1551887	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of KLHL9 mRNA]	PMID:19030233
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347061	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KLHL9 mRNA	PMID:37042841
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL9 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of KLHL9 mRNA	PMID:39836092
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KLHL9 mRNA	PMID:38568856
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLHL9 mRNA	PMID:35301059
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of KLHL9 mRNA	PMID:19320972
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of KLHL9 mRNA	PMID:19244175
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of KLHL9 mRNA	PMID:28302478
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of KLHL9 mRNA	PMID:31558096
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347061	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLHL9 mRNA	PMID:25979313
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of KLHL9 mRNA	PMID:17183730
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KLHL9 mRNA	PMID:28628672
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1347061	E	RGD:6480464	20120412	CTD	MESH:D005472	KLHL9 protein affects the susceptibility to Fluorouracil	PMID:16217747
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:46666	crocidolite asbestos	increases methylation	ISO	RGD:1347061	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased methylation of KLHL9 promoter	PMID:29626692
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL9 mRNA	PMID:39836092
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KLHL9 mRNA	PMID:22079256
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of KLHL9 mRNA	PMID:29097150
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KLHL9 mRNA	PMID:28628672
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of KLHL9 mRNA	PMID:40234311
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of KLHL9 mRNA	PMID:17183730
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of KLHL9 mRNA	PMID:20080153
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL9 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of KLHL9 mRNA	PMID:39836092
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of KLHL9 mRNA	PMID:30467583
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1347061	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of KLHL9 mRNA	PMID:31758290
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551887	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KLHL9 mRNA	PMID:22206623
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of KLHL9 mRNA	PMID:22079256
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KLHL9 mRNA	PMID:22079256
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1347061	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of KLHL9 mRNA	PMID:37199045
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347061	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KLHL9 gene]	PMID:28238834
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1551887	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of KLHL9 mRNA	PMID:31558096
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:9422	tebufenpyrad	decreases expression	ISO	RGD:1347061	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of KLHL9 mRNA	PMID:33512557
1304814	Klhl9	kelch-like family member 9	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of KLHL9 mRNA	PMID:23555832
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614141	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LOXHD1 mRNA	PMID:33045310
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of LOXHD1 gene	PMID:35440735
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of LOXHD1 gene	PMID:30207508
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312479	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LOXHD1 mRNA	PMID:35811015
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1614141	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA	PMID:25510870
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of LOXHD1 gene	PMID:27618143
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1312479	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of LOXHD1 gene	PMID:30521419
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1614141	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of LOXHD1 gene	PMID:34319233
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1614141	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA	PMID:25510870
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1614141	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA	PMID:25510870
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614141	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LOXHD1 mRNA	PMID:25629700
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1614141	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LOXHD1 mRNA	PMID:28960355
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312479	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LOXHD1 mRNA	PMID:41028656
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LOXHD1 mRNA	PMID:32109520
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of LOXHD1 mRNA	PMID:28959563
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312479	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LOXHD1 mRNA	PMID:41028656
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312479	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LOXHD1 promoter	PMID:27901495
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1614141	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LOXHD1 intron	PMID:27901495
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312479	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LOXHD1 mRNA	PMID:41028656
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312479	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of LOXHD1 gene	PMID:31601247
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1614141	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of LOXHD1 mRNA	PMID:29264374
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LOXHD1 mRNA	PMID:25181051
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614141	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of LOXHD1 mRNA	PMID:32156529
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312479	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LOXHD1 gene	PMID:31601247
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312479	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of LOXHD1 gene	PMID:31601247
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1614141	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA	PMID:25510870
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1614141	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA	PMID:25510870
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1614141	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LOXHD1 intron	PMID:28392331
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] affects the methylation of LOXHD1 gene	PMID:33148267
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1312479	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of LOXHD1 mRNA	PMID:35811015
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312479	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LOXHD1 mRNA	PMID:35811015
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] affects the methylation of LOXHD1 gene	PMID:33148267
1304815	Loxhd1	lipoxygenase homology PLAT domains 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312479	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LOXHD1 gene]	PMID:28238834
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FKBP15 mRNA	PMID:37995155
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of FKBP15 mRNA	PMID:26251327
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1621210	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of FKBP15 promoter	PMID:26251327
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312480	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of FKBP15 mRNA	PMID:33167477
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1312480	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of FKBP15 protein	PMID:28073184
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FKBP15 mRNA	PMID:39241906
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312480	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FKBP15 mRNA	PMID:37042841
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312480	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of FKBP15 mRNA	PMID:23649840
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312480	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of FKBP15 mRNA	PMID:38685446
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of FKBP15 mRNA	PMID:26577399
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312480	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FKBP15 protein	PMID:37730182
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FKBP15 mRNA	PMID:39836092
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FKBP15 protein	PMID:23301498
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312480	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FKBP15 gene	PMID:27153756
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FKBP15 mRNA	PMID:39836092
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312480	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of FKBP15 protein	PMID:35688186
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of FKBP15 mRNA	PMID:30912803
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312480	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of FKBP15 mRNA	PMID:23195993
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FKBP15 mRNA	PMID:33387578
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312480	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FKBP15 mRNA	PMID:29803840
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312480	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of FKBP15 protein	PMID:35688186
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312480	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FKBP15 mRNA	PMID:38568856
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FKBP15 mRNA	PMID:39836092
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621210	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FKBP15 gene	PMID:35295148
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20130618	CTD	MESH:C006253	pirinixic acid results in decreased expression of FKBP15 mRNA	PMID:21318169
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1621210	E	RGD:6480464	20130618	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of FKBP15 mRNA]	PMID:21318169
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FKBP15 mRNA	PMID:25181051|PMID:30816183
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312480	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FKBP15 mRNA	PMID:25047013
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312480	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FKBP15 gene	PMID:31601247
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP15 mRNA	PMID:28628672
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FKBP15 mRNA	PMID:21266533
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP15 mRNA	PMID:28628672
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FKBP15 mRNA	PMID:39836092
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312480	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FKBP15 mRNA	PMID:38174414|PMID:38568856
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312480	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FKBP15 mRNA	PMID:24449571
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312480	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FKBP15 gene	PMID:29154799
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312480	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of FKBP15 mRNA	PMID:27989131
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP15 mRNA	PMID:28628672
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FKBP15 mRNA	PMID:39836092
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP15 mRNA	PMID:28628672
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1621210	E	RGD:6480464	20130618	CTD	MESH:D011345	Fenofibrate results in increased expression of FKBP15 mRNA	PMID:21318169
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1621210	E	RGD:6480464	20130618	CTD	MESH:D011345	[PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of FKBP15 mRNA	PMID:21318169
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1621210	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FKBP15 mRNA	PMID:35964746
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312480	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FKBP15 protein	PMID:32959892
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D007649	Ketamine results in increased expression of FKBP15 mRNA	PMID:20080153
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312480	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FKBP15 mRNA	PMID:39836092
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:6809	methamphetamine	affects response to substance	ISO	RGD:1312480	E	RGD:6480464	20130618	CTD	MESH:D008694	FKBP15 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FKBP15 mRNA	PMID:22206623
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1621210	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital affects the expression of FKBP15 mRNA	PMID:23091169
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of FKBP15 mRNA	PMID:27291303
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of FKBP15 protein	PMID:28903499
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of FKBP15 mRNA	PMID:23640034
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312480	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of FKBP15 protein	PMID:38348393
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1621210	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of FKBP15 mRNA	PMID:21795629
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20130618	CTD	MESH:C045950	propiconazole results in decreased expression of FKBP15 mRNA	PMID:21278054
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of FKBP15 mRNA	PMID:35537566
1304816	Fkbp15	FKBP prolyl isomerase family member 15	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of FKBP15 mRNA	PMID:23555832
1304817	Atg7	autophagy related 7	gene	CHEBI:10429	beta-lapachone	affects response to substance	ISO	RGD:1312481	E	RGD:6480464	20130409	CTD	MESH:C014638	ATG7 protein affects the susceptibility to beta-lapachone	PMID:21035436
1304817	Atg7	autophagy related 7	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312481	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ATG7 protein	PMID:38218311
1304817	Atg7	autophagy related 7	gene	CHEBI:10429	beta-lapachone	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20241001	CTD	MESH:C014638	3-methyladenine inhibits the reaction [beta-lapachone results in increased expression of ATG7 protein]	PMID:38218311
1304817	Atg7	autophagy related 7	gene	CHEBI:113532	thymoquinone	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in decreased expression of ATG7 protein	PMID:31298468
1304817	Atg7	autophagy related 7	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1558502	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ATG7 mRNA	PMID:33045310
1304817	Atg7	autophagy related 7	gene	CHEBI:141517	tyloxapol	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20240402	CTD	MESH:C016811	tyloxapol results in decreased expression of ATG7 protein	PMID:36905866
1304817	Atg7	autophagy related 7	gene	CHEBI:141517	tyloxapol	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20240402	CTD	MESH:C016811	Escin inhibits the reaction [tyloxapol results in decreased expression of ATG7 protein]; Fenofibrate inhibits the reaction [tyloxapol results in decreased expression of ATG7 protein]	PMID:36905866
1304817	Atg7	autophagy related 7	gene	CHEBI:145372	gilteritinib	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20260505	CTD	MESH:C000609080	ATG7 protein affects the reaction [gilteritinib results in increased expression of GPT protein]	PMID:40578406
1304817	Atg7	autophagy related 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312481	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ATG7 mRNA	PMID:33167477
1304817	Atg7	autophagy related 7	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20190409	CTD	MESH:D014212	HSF1 protein affects the reaction [Tretinoin inhibits the reaction [sodium arsenite results in increased expression of ATG7 protein]]; Tretinoin inhibits the reaction [sodium arsenite results in increased expression of ATG7 protein]	PMID:30309986
1304817	Atg7	autophagy related 7	gene	CHEBI:15368	acrolein	increases expression	ISO	RGD:1312481	E	RGD:6480464	20190219	CTD	MESH:D000171	Acrolein results in increased expression of ATG7 protein	PMID:30205151
1304817	Atg7	autophagy related 7	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20190219	CTD	MESH:D000171	Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG7 protein]; ATG7 protein affects the reaction [Acrolein results in increased expression of CASP1 protein]; ATG7 protein affects the reaction [Acrolein results in increased expression of IL1B protein]; ATG7 protein affects the reaction [Acrolein results in increased expression of NLRP3 protein]; ATG7 protein affects the reaction [Acrolein results in increased lipidation of MAP1LC3B protein]	PMID:30205151|PMID:34238121
1304817	Atg7	autophagy related 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ATG7 mRNA	PMID:36331819
1304817	Atg7	autophagy related 7	gene	CHEBI:15603	L-leucine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200519	CTD	MESH:D007930	Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]	PMID:31676321
1304817	Atg7	autophagy related 7	gene	CHEBI:15738	staurosporine	affects response to substance	ISO	RGD:1312481	E	RGD:6480464	20120412	CTD	MESH:D019311	ATG7 protein affects the susceptibility to Staurosporine	PMID:16497721
1304817	Atg7	autophagy related 7	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20190219	CTD	MESH:D019308	Palmitic Acid results in decreased expression of ATG7 protein	PMID:30208301
1304817	Atg7	autophagy related 7	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20190219	CTD	MESH:D019308	Palmitic Acid results in decreased expression of ATG7 protein	PMID:30208301
1304817	Atg7	autophagy related 7	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20190219	CTD	MESH:D019308	[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]]; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein]; trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein]	PMID:30208301|PMID:36905866
1304817	Atg7	autophagy related 7	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20190219	CTD	MESH:D019308	trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein]	PMID:30208301
1304817	Atg7	autophagy related 7	gene	CHEBI:15866	2-deoxy-D-glucose	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20120412	CTD	MESH:D003847	ATG7 protein inhibits the reaction [Deoxyglucose results in increased cleavage of CASP3 protein]; ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of DDIT3 protein]; ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein]; ATG7 protein promotes the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein]	PMID:20593179
1304817	Atg7	autophagy related 7	gene	CHEBI:15891	taurine	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180116	CTD	MESH:D013654	[Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]	PMID:29078374
1304817	Atg7	autophagy related 7	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1558502	E	RGD:6480464	20201103	CTD	MESH:D001280	Atrazine results in increased expression of ATG7 mRNA	PMID:30360616
1304817	Atg7	autophagy related 7	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20201103	CTD	MESH:D001280	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG7 mRNA]	PMID:30360616
1304817	Atg7	autophagy related 7	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20201103	CTD	MESH:C015329	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG7 mRNA]	PMID:30360616
1304817	Atg7	autophagy related 7	gene	CHEBI:16118	berberine	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D001599	Berberine inhibits the reaction [Glucose results in decreased expression of ATG7 protein]	PMID:39127087
1304817	Atg7	autophagy related 7	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20240402	CTD	MESH:D019301	[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein]	PMID:36905866
1304817	Atg7	autophagy related 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312481	E	RGD:6480464	20140513	CTD	MESH:D000431	Ethanol results in increased expression of ATG7 mRNA	PMID:24095927
1304817	Atg7	autophagy related 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1558502	E	RGD:6480464	20160510	CTD	MESH:D000431	Ethanol results in increased expression of ATG7 mRNA; Ethanol results in increased expression of ATG7 protein	PMID:24095927|PMID:24492484
1304817	Atg7	autophagy related 7	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20221206	CTD	MESH:D000431	Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]; HMGB1 protein affects the reaction [Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]]	PMID:35066094
1304817	Atg7	autophagy related 7	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20220607	CTD	MESH:D000431	ATG7 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]	PMID:34405320
1304817	Atg7	autophagy related 7	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20160510	CTD	MESH:D000431	ATG7 mutant form inhibits the reaction [Ethanol results in increased lipidation of MAP1LC3B protein]; Dactinomycin inhibits the reaction [Ethanol results in increased expression of ATG7 protein]; Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]; FOXO3 protein affects the reaction [Ethanol results in increased expression of ATG7 mRNA]	PMID:24095927|PMID:24492484|PMID:35066094
1304817	Atg7	autophagy related 7	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1312481	E	RGD:6480464	20140211	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ATG7 protein	PMID:23726866
1304817	Atg7	autophagy related 7	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312481	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased expression of ATG7 protein	PMID:25293876
1304817	Atg7	autophagy related 7	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:D011794	Quercetin inhibits the reaction [Levetiracetam results in decreased expression of ATG7 protein]	PMID:37098359
1304817	Atg7	autophagy related 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of ATG7 gene	PMID:21212295
1304817	Atg7	autophagy related 7	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in decreased expression of ATG7 mRNA	PMID:34681664
1304817	Atg7	autophagy related 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1558502	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ATG7 mRNA	PMID:39298647
1304817	Atg7	autophagy related 7	gene	CHEBI:16509	1,4-benzoquinone	increases expression	ISO	RGD:1312481	E	RGD:6480464	20260505	CTD	MESH:C004532	quinone results in increased expression of ATG7 protein	PMID:40854414
1304817	Atg7	autophagy related 7	gene	CHEBI:16598	DDE	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20201006	CTD	MESH:D003633	ATG7 protein affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein]	PMID:32721735
1304817	Atg7	autophagy related 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312481	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATG7 mRNA	PMID:37042841
1304817	Atg7	autophagy related 7	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1558502	E	RGD:6480464	20260505	CTD	MESH:D001554	Benzene results in increased expression of ATG7 protein	PMID:40854414
1304817	Atg7	autophagy related 7	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:D002635	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1304817	Atg7	autophagy related 7	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20221004	CTD	MESH:D008550	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]]; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]; Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 mRNA]; Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 protein]; TXNRD3 gene mutant form inhibits the reaction [Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 mRNA]]	PMID:35568058|PMID:36421005
1304817	Atg7	autophagy related 7	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:D005557	Formaldehyde results in increased expression of ATG7 mRNA; Formaldehyde results in increased expression of ATG7 protein	PMID:40164397
1304817	Atg7	autophagy related 7	gene	CHEBI:16856	glutathione	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180410	CTD	MESH:D005978	Glutathione inhibits the reaction [Apigenin results in increased expression of ATG7 protein]	PMID:29247770
1304817	Atg7	autophagy related 7	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of ATG7 protein	PMID:35243728|PMID:39127087
1304817	Atg7	autophagy related 7	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Berberine inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of ATG7 protein]	PMID:35243728|PMID:39127087
1304817	Atg7	autophagy related 7	gene	CHEBI:173086	ferrostatin-1	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20250401	CTD	MESH:C573944	ferrostatin-1 results in decreased expression of ATG7 protein	PMID:38896176
1304817	Atg7	autophagy related 7	gene	CHEBI:173086	ferrostatin-1	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20250401	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [ochratoxin A results in increased expression of ATG7 protein]	PMID:38896176
1304817	Atg7	autophagy related 7	gene	CHEBI:173719	Curcumol	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C022801	curcumol inhibits the reaction [VEGFA protein results in increased expression of ATG7 protein]	PMID:33549628
1304817	Atg7	autophagy related 7	gene	CHEBI:17447	geraniol	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20190702	CTD	MESH:C007836	geraniol inhibits the reaction [Rotenone results in decreased expression of ATG7 protein]	PMID:30141137
1304817	Atg7	autophagy related 7	gene	CHEBI:17548	alginic acid	increases expression	ISO	RGD:1558502	E	RGD:6480464	20220510	CTD	MESH:C008970	Alginic Acid results in increased expression of ATG7 protein	PMID:35066102
1304817	Atg7	autophagy related 7	gene	CHEBI:17558	quercitrin	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of ATG7 mRNA	PMID:25193878
1304817	Atg7	autophagy related 7	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1312481	E	RGD:6480464	20230404	CTD	MESH:C031927	hydroquinone results in increased expression of ATG7 protein	PMID:35302183
1304817	Atg7	autophagy related 7	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of ATG7 protein	PMID:35243728|PMID:39127087
1304817	Atg7	autophagy related 7	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Berberine inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of ATG7 protein]	PMID:35243728|PMID:39127087
1304817	Atg7	autophagy related 7	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:D006000	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1304817	Atg7	autophagy related 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATG7 protein	PMID:32710958
1304817	Atg7	autophagy related 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D004051	ATG7 protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of ACAA1A protein]	PMID:16332691
1304817	Atg7	autophagy related 7	gene	CHEBI:177680	onjisaponin B	decreases response to substance	ISO	RGD:1558502	E	RGD:6480464	20241203	CTD	MESH:C474233	ATG7 gene mutant form results in decreased susceptibility to onjisaponin B	PMID:24248062
1304817	Atg7	autophagy related 7	gene	CHEBI:17997	dinitrogen	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180313	CTD	MESH:D009584	ATG7 protein inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]; ATG7 protein promotes the reaction [bafilomycin A inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]]	PMID:27629431
1304817	Atg7	autophagy related 7	gene	CHEBI:18123	N-methylnicotinate	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20190219	CTD	MESH:C009560	ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]]; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein]	PMID:30208301
1304817	Atg7	autophagy related 7	gene	CHEBI:18123	N-methylnicotinate	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20190219	CTD	MESH:C009560	trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein]	PMID:30208301
1304817	Atg7	autophagy related 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATG7 mRNA	PMID:36331819
1304817	Atg7	autophagy related 7	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1558502	E	RGD:6480464	20200331	CTD	MESH:D014284	Triiodothyronine results in increased expression of ATG7 mRNA	PMID:30209975
1304817	Atg7	autophagy related 7	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA	PMID:39836092
1304817	Atg7	autophagy related 7	gene	CHEBI:18315	pyrroloquinoline quinone	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20190910	CTD	MESH:D045542	PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG7 protein]	PMID:31226464
1304817	Atg7	autophagy related 7	gene	CHEBI:18388	apigenin	increases expression	ISO	RGD:1312481	E	RGD:6480464	20180410	CTD	MESH:D047310	Apigenin results in increased expression of ATG7 protein	PMID:29247770
1304817	Atg7	autophagy related 7	gene	CHEBI:18388	apigenin	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180410	CTD	MESH:D047310	Acetylcysteine inhibits the reaction [Apigenin results in increased expression of ATG7 protein]; Glutathione inhibits the reaction [Apigenin results in increased expression of ATG7 protein]	PMID:29247770
1304817	Atg7	autophagy related 7	gene	CHEBI:191949	(+)-isoborneol	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20260602	CTD	MESH:C022871	isoborneol inhibits the reaction [[Thioacetamide co-treated with Dietary Fats co-treated with Fructose] results in decreased expression of ATG7 protein]	PMID:39967315
1304817	Atg7	autophagy related 7	gene	CHEBI:229049	Alpinetin	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20240206	CTD	MESH:C436748	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[alpinetin co-treated with TNF protein] results in increased expression of ATG7 mRNA]; [alpinetin co-treated with TNF protein] results in increased expression of ATG7 mRNA; AHR protein affects the reaction [[alpinetin co-treated with TNF protein] results in increased expression of ATG7 mRNA]; TSC2 protein affects the reaction [[alpinetin co-treated with TNF protein] results in increased expression of ATG7 mRNA]	PMID:31676321
1304817	Atg7	autophagy related 7	gene	CHEBI:229049	Alpinetin	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20240206	CTD	MESH:C436748	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]; alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]; Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]	PMID:31676321
1304817	Atg7	autophagy related 7	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium results in increased expression of ATG7 protein	PMID:26582496
1304817	Atg7	autophagy related 7	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1558502	E	RGD:6480464	20240109	CTD	MESH:D002104	Cadmium results in increased expression of ATG7 protein	PMID:37148155
1304817	Atg7	autophagy related 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200114	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]; NUPR1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]	PMID:31319114
1304817	Atg7	autophagy related 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA	PMID:37236586
1304817	Atg7	autophagy related 7	gene	CHEBI:231515	lanthanum trichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C028521	lanthanum chloride results in increased expression of ATG7 protein	PMID:35090998
1304817	Atg7	autophagy related 7	gene	CHEBI:24848	inositol	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D007294	Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein]	PMID:35243728
1304817	Atg7	autophagy related 7	gene	CHEBI:2500	Aescin	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20240402	CTD	MESH:D004928	Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein]	PMID:36905866
1304817	Atg7	autophagy related 7	gene	CHEBI:2500	Aescin	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20240402	CTD	MESH:D004928	Escin inhibits the reaction [Dietary Fats results in decreased expression of ATG7 protein]; Escin inhibits the reaction [tyloxapol results in decreased expression of ATG7 protein]; NFE2L2 protein affects the reaction [Escin inhibits the reaction [Dietary Fats results in decreased expression of ATG7 protein]]	PMID:36905866
1304817	Atg7	autophagy related 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ATG7 mRNA	PMID:22100608
1304817	Atg7	autophagy related 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312481	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ATG7 intron	PMID:30157460
1304817	Atg7	autophagy related 7	gene	CHEBI:25676	oligopeptide	increases expression	ISO	RGD:1312481	E	RGD:6480464	20170110	CTD	MESH:D009842	Oligopeptides analog results in increased expression of ATG7 protein	PMID:24875536
1304817	Atg7	autophagy related 7	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312481	E	RGD:6480464	20180220	CTD	MESH:D010126	Ozone results in increased expression of ATG7 mRNA	PMID:27206323
1304817	Atg7	autophagy related 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ATG7 mRNA	PMID:35430440
1304817	Atg7	autophagy related 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATG7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ATG7 mRNA	PMID:34911549
1304817	Atg7	autophagy related 7	gene	CHEBI:2663	amiodarone	affects response to substance	ISO	RGD:1312481	E	RGD:6480464	20131210	CTD	MESH:D000638	ATG7 protein affects the susceptibility to Amiodarone	PMID:23912912|PMID:32651653
1304817	Atg7	autophagy related 7	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312481	E	RGD:6480464	20131210	CTD	MESH:D000638	Amiodarone results in increased expression of ATG7 protein	PMID:23912912
1304817	Atg7	autophagy related 7	gene	CHEBI:2663	amiodarone	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20131210	CTD	MESH:D000638	ATG7 protein affects the reaction [Amiodarone results in increased cleavage of CASP3 protein]	PMID:23912912
1304817	Atg7	autophagy related 7	gene	CHEBI:2687	amsacrine	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20240206	CTD	MESH:D000677	Amsacrine results in decreased expression of ATG7 protein	PMID:37451322
1304817	Atg7	autophagy related 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200609	CTD	MESH:D002251	[TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of ATG7 protein	PMID:31513885
1304817	Atg7	autophagy related 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG7 mRNA	PMID:22206623
1304817	Atg7	autophagy related 7	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:D006002	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1304817	Atg7	autophagy related 7	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312481	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATG7 gene	PMID:25304211
1304817	Atg7	autophagy related 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA; ATG7 protein affects the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HMOX1 protein]	PMID:32525701|PMID:39836092
1304817	Atg7	autophagy related 7	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1312481	E	RGD:6480464	20190312	CTD	MESH:D002166	Camptothecin results in increased expression of ATG7 protein	PMID:30266318
1304817	Atg7	autophagy related 7	gene	CHEBI:27656	camptothecin	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20190312	CTD	MESH:D002166	Egtazic Acid inhibits the reaction [Camptothecin results in increased expression of ATG7 protein]; EIF2S1 protein affects the reaction [Camptothecin results in increased expression of ATG7 protein]; staurosporine aglycone inhibits the reaction [Camptothecin results in increased expression of ATG7 protein]	PMID:30266318
1304817	Atg7	autophagy related 7	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20140513	CTD	MESH:D003609	Dactinomycin inhibits the reaction [Ethanol results in increased expression of ATG7 protein]	PMID:24095927
1304817	Atg7	autophagy related 7	gene	CHEBI:27732	caffeine	increases response to substance	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D002110	ATG7 protein results in increased susceptibility to Caffeine; ATG7 results in increased susceptibility to Caffeine	PMID:21081844
1304817	Atg7	autophagy related 7	gene	CHEBI:27889	lead(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in increased expression of ATG7 mRNA	PMID:39276841
1304817	Atg7	autophagy related 7	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of ATG7 mRNA; Cisplatin results in decreased expression of ATG7 protein	PMID:19561079|PMID:28408137
1304817	Atg7	autophagy related 7	gene	CHEBI:27899	cisplatin	increases response to substance	ISO	RGD:1558502	E	RGD:6480464	20191008	CTD	MESH:D002945	ATG7 gene mutant form results in increased susceptibility to Cisplatin	PMID:29476062
1304817	Atg7	autophagy related 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20191008	CTD	MESH:D002945	ATG7 gene mutant form inhibits the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form]; ATG7 gene mutant form inhibits the reaction [trichostatin A inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]]; ATG7 gene mutant form inhibits the reaction [trichostatin A inhibits the reaction [Cisplatin results in increased expression of CASP3 protein modified form]]; ATG7 gene mutant form inhibits the reaction [trichostatin A promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form]]; ATG7 gene mutant form promotes the reaction [Cisplatin results in increased activity of CASP protein]; ATG7 gene mutant form promotes the reaction [Cisplatin results in increased expression of CASP protein modified form]	PMID:29476062
1304817	Atg7	autophagy related 7	gene	CHEBI:28061	alpha-D-galactose	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D005690	Galactose results in decreased expression of ATG7 protein	PMID:28302704
1304817	Atg7	autophagy related 7	gene	CHEBI:28061	alpha-D-galactose	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20181016	CTD	MESH:D005690	Galactose results in decreased expression of ATG7 protein	PMID:28302704
1304817	Atg7	autophagy related 7	gene	CHEBI:28061	alpha-D-galactose	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20181016	CTD	MESH:D005690	MIR34A mRNA promotes the reaction [Galactose results in decreased expression of ATG7 protein]	PMID:28302704
1304817	Atg7	autophagy related 7	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ATG7 mRNA	PMID:23195993
1304817	Atg7	autophagy related 7	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20151110	CTD	MESH:D009532	[Nickel co-treated with austenitic steel analog] results in increased expression of ATG7 mRNA	PMID:23638002
1304817	Atg7	autophagy related 7	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20221004	CTD	MESH:D009532	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]; [nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA; [nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]	PMID:35568058
1304817	Atg7	autophagy related 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558502	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATG7 mRNA	PMID:21570461
1304817	Atg7	autophagy related 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATG7 mRNA	PMID:32109520
1304817	Atg7	autophagy related 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases methylation	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased methylation of ATG7 gene	PMID:21212295
1304817	Atg7	autophagy related 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATG7 mRNA	PMID:33387578
1304817	Atg7	autophagy related 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATG7 mRNA; [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of ATG7 gene	PMID:17942748|PMID:21212295
1304817	Atg7	autophagy related 7	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20190702	CTD	MESH:D012402	Rotenone results in decreased expression of ATG7 protein	PMID:30141137
1304817	Atg7	autophagy related 7	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312481	E	RGD:6480464	20160315	CTD	MESH:D012402	Rotenone results in increased expression of ATG7 protein	PMID:25682864
1304817	Atg7	autophagy related 7	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20190702	CTD	MESH:D012402	geraniol inhibits the reaction [Rotenone results in decreased expression of ATG7 protein]	PMID:30141137
1304817	Atg7	autophagy related 7	gene	CHEBI:28260	galactose	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D005690	Galactose results in decreased expression of ATG7 protein	PMID:28302704
1304817	Atg7	autophagy related 7	gene	CHEBI:28260	galactose	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20181016	CTD	MESH:D005690	Galactose results in decreased expression of ATG7 protein	PMID:28302704
1304817	Atg7	autophagy related 7	gene	CHEBI:28260	galactose	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20181016	CTD	MESH:D005690	MIR34A mRNA promotes the reaction [Galactose results in decreased expression of ATG7 protein]	PMID:28302704
1304817	Atg7	autophagy related 7	gene	CHEBI:28741	sodium fluoride	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ATG7 mRNA	PMID:24296261
1304817	Atg7	autophagy related 7	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1558502	E	RGD:6480464	20141111	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ATG7 mRNA; Sodium Fluoride results in increased expression of ATG7 protein	PMID:24296261
1304817	Atg7	autophagy related 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATG7 mRNA	PMID:39631538
1304817	Atg7	autophagy related 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATG7 mRNA	PMID:29803840
1304817	Atg7	autophagy related 7	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312481	E	RGD:6480464	20190910	CTD	MESH:D004317	Doxorubicin results in increased expression of ATG7 protein	PMID:31226464
1304817	Atg7	autophagy related 7	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1558502	E	RGD:6480464	20250603	CTD	MESH:D004317	Doxorubicin results in increased expression of ATG7 mRNA	PMID:38324556
1304817	Atg7	autophagy related 7	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20140408	CTD	MESH:D004317	ATG7 mutant form inhibits the reaction [Doxorubicin results in increased degradation of SQSTM1 protein]; PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG7 protein]	PMID:22927544|PMID:31226464
1304817	Atg7	autophagy related 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20260602	CTD	MESH:D005632	[Thioacetamide co-treated with Dietary Fats co-treated with Fructose] results in decreased expression of ATG7 protein; isoborneol inhibits the reaction [[Thioacetamide co-treated with Dietary Fats co-treated with Fructose] results in decreased expression of ATG7 protein]	PMID:39967315
1304817	Atg7	autophagy related 7	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:D003840	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1304817	Atg7	autophagy related 7	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180410	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG7 protein]; Acetylcysteine inhibits the reaction [Apigenin results in increased expression of ATG7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:29247770|PMID:29307831|PMID:30205151|PMID:31319114
1304817	Atg7	autophagy related 7	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20210907	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:33462182
1304817	Atg7	autophagy related 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312481	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ATG7 mRNA; sodium arsenite results in increased expression of ATG7 protein	PMID:30309986|PMID:39536963
1304817	Atg7	autophagy related 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1558502	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ATG7 mRNA	PMID:30097599|PMID:39490100
1304817	Atg7	autophagy related 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	ATG7 mutant form inhibits the reaction [sodium arsenite results in decreased expression of SNCA]	PMID:25639566
1304817	Atg7	autophagy related 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20190409	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA; HSF1 protein affects the reaction [sodium arsenite results in increased expression of ATG7 protein]; HSF1 protein affects the reaction [Tretinoin inhibits the reaction [sodium arsenite results in increased expression of ATG7 protein]]; sodium arsenite results in increased expression of and results in increased methylation of ATG7 mRNA; Tretinoin inhibits the reaction [sodium arsenite results in increased expression of ATG7 protein]	PMID:30309986|PMID:39490100|PMID:39836092
1304817	Atg7	autophagy related 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20190409	CTD	MESH:C017947	[sodium arsenite co-treated with Dietary Fats] results in increased expression of ATG7 mRNA; ATG7 gene mutant form inhibits the reaction [sodium arsenite results in increased degradation of KEAP1 protein]; ATG7 gene mutant form inhibits the reaction [sodium arsenite results in increased degradation of SQSTM1 protein]; ATG7 gene mutant form inhibits the reaction [sodium arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein]	PMID:26483381|PMID:30097599
1304817	Atg7	autophagy related 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATG7 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:26238291
1304817	Atg7	autophagy related 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATG7 mRNA	PMID:19770486
1304817	Atg7	autophagy related 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1558502	E	RGD:6480464	20241203	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATG7 protein	PMID:39454710
1304817	Atg7	autophagy related 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1558502	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATG7 exon; Benzo(a)pyrene results in increased methylation of ATG7 intron	PMID:27901495
1304817	Atg7	autophagy related 7	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312481	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite results in increased expression of ATG7 mRNA; arsenite results in increased expression of ATG7 protein	PMID:34929507
1304817	Atg7	autophagy related 7	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312481	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATG7 mRNA; Arsenic Trioxide results in increased expression of ATG7 protein	PMID:29307831|PMID:32284743
1304817	Atg7	autophagy related 7	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1558502	E	RGD:6480464	20210810	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATG7 mRNA	PMID:32781346|PMID:33462182
1304817	Atg7	autophagy related 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20191114	CTD	MESH:C006632	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of BCR protein mutant form]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of FLT3 protein mutant form]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:22898604|PMID:29307831|PMID:32284743
1304817	Atg7	autophagy related 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20210907	CTD	MESH:C006632	3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:33462182
1304817	Atg7	autophagy related 7	gene	CHEBI:30740	ethylene glycol bis(2-aminoethyl)tetraacetic acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20190312	CTD	MESH:D004533	Egtazic Acid inhibits the reaction [Camptothecin results in increased expression of ATG7 protein]	PMID:30266318
1304817	Atg7	autophagy related 7	gene	CHEBI:31243	atazanavir sulfate	increases expression	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:D000069446	Atazanavir Sulfate results in increased expression of ATG7 mRNA	PMID:32152650
1304817	Atg7	autophagy related 7	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:D000069446	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1304817	Atg7	autophagy related 7	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in increased expression of ATG7 mRNA	PMID:39276841
1304817	Atg7	autophagy related 7	gene	CHEBI:3218	2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one	increases expression	ISO	RGD:1312481	E	RGD:6480464	20230905	CTD	MESH:C083997	buprofezin results in increased expression of ATG7 mRNA	PMID:36287832
1304817	Atg7	autophagy related 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1558502	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATG7 gene	PMID:35295148
1304817	Atg7	autophagy related 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1558502	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ATG7 gene	PMID:35295148
1304817	Atg7	autophagy related 7	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ATG7 mRNA	PMID:34492290
1304817	Atg7	autophagy related 7	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20260602	CTD	MESH:D013853	[Thioacetamide co-treated with Dietary Fats co-treated with Fructose] results in decreased expression of ATG7 protein; isoborneol inhibits the reaction [[Thioacetamide co-treated with Dietary Fats co-treated with Fructose] results in decreased expression of ATG7 protein]	PMID:39967315
1304817	Atg7	autophagy related 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1558502	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of ATG7 mRNA	PMID:21318169
1304817	Atg7	autophagy related 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of ATG7 mRNA]	PMID:21318169
1304817	Atg7	autophagy related 7	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312481	E	RGD:6480464	20220906	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of ATG7 mRNA	PMID:35550146
1304817	Atg7	autophagy related 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C006780	bisphenol A affects the expression of ATG7 mRNA	PMID:27539358
1304817	Atg7	autophagy related 7	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1558502	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of ATG7 mRNA	PMID:37894381
1304817	Atg7	autophagy related 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ATG7 mRNA	PMID:34947998
1304817	Atg7	autophagy related 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of ATG7 mRNA	PMID:29741722
1304817	Atg7	autophagy related 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312481	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ATG7 mRNA; bisphenol A results in increased expression of ATG7 protein	PMID:37257343
1304817	Atg7	autophagy related 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1558502	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ATG7 mRNA	PMID:26746108|PMID:34281243
1304817	Atg7	autophagy related 7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATG7 gene	PMID:28505145
1304817	Atg7	autophagy related 7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1558502	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATG7 promoter	PMID:27312807
1304817	Atg7	autophagy related 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20240206	CTD	MESH:C006780	2-(7-(3,4-dimethoxyphenyl)imidazo(1,2-c)pyrimidin-5-ylamino)nicotinamide inhibits the reaction [bisphenol A results in increased expression of ATG7 protein]; bisphenol A promotes the reaction [NFE2L2 protein binds to ATG7 promoter]; NFE2L2 protein affects the reaction [bisphenol A results in increased expression of ATG7 mRNA]; NFE2L2 protein affects the reaction [bisphenol A results in increased expression of ATG7 protein]	PMID:37257343
1304817	Atg7	autophagy related 7	gene	CHEBI:34107	1-nitropyrene	affects response to substance	ISO	RGD:1558502	E	RGD:6480464	20180116	CTD	MESH:C032668	ATG7 protein affects the susceptibility to 1-nitropyrene	PMID:29078374
1304817	Atg7	autophagy related 7	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1312481	E	RGD:6480464	20180116	CTD	MESH:C032668	1-nitropyrene results in increased expression of ATG7 mRNA; 1-nitropyrene results in increased expression of ATG7 protein	PMID:29078374
1304817	Atg7	autophagy related 7	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1558502	E	RGD:6480464	20180116	CTD	MESH:C032668	1-nitropyrene results in increased expression of ATG7 mRNA; 1-nitropyrene results in increased expression of ATG7 protein	PMID:29078374
1304817	Atg7	autophagy related 7	gene	CHEBI:34107	1-nitropyrene	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180116	CTD	MESH:C032668	3-methyladenine inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]; [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]; CEBPA protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 protein]; NDUFA1 protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]; NDUFA1 protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 protein]; NDUFA2 protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]; NDUFA2 protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 protein]	PMID:29078374
1304817	Atg7	autophagy related 7	gene	CHEBI:34107	1-nitropyrene	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20180116	CTD	MESH:C032668	ATG7 protein affects the reaction [1-nitropyrene results in increased expression of MAP1LC3B protein]; ATG7 protein affects the reaction [1-nitropyrene results in increased secretion of IL6 protein]	PMID:29078374
1304817	Atg7	autophagy related 7	gene	CHEBI:34211	2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20201006	CTD	MESH:C054919	ATG7 protein affects the reaction [2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in increased activity of CASP3 protein]	PMID:32721735
1304817	Atg7	autophagy related 7	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1558502	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of ATG7 mRNA	PMID:37080397
1304817	Atg7	autophagy related 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20180703	CTD	MESH:C543008	bisphenol S results in decreased expression of ATG7 mRNA	PMID:29741722
1304817	Atg7	autophagy related 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1558502	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ATG7 mRNA	PMID:39298647
1304817	Atg7	autophagy related 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1558502	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ATG7 exon	PMID:33297965
1304817	Atg7	autophagy related 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATG7 mRNA	PMID:28628672
1304817	Atg7	autophagy related 7	gene	CHEBI:34440	4-nonylphenol	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C041594	4-nonylphenol results in increased expression of ATG7 mRNA	PMID:28041982
1304817	Atg7	autophagy related 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312481	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ATG7 protein	PMID:34186270
1304817	Atg7	autophagy related 7	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312481	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ATG7 protein	PMID:34186270
1304817	Atg7	autophagy related 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1558502	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ATG7 intron	PMID:28392331
1304817	Atg7	autophagy related 7	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1558502	E	RGD:6480464	20200519	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ATG7 mRNA	PMID:31676321
1304817	Atg7	autophagy related 7	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200519	CTD	MESH:D016264	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]; alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]; Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]	PMID:31676321
1304817	Atg7	autophagy related 7	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1558502	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ATG7 mRNA	PMID:34813904
1304817	Atg7	autophagy related 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATG7 mRNA	PMID:28628672
1304817	Atg7	autophagy related 7	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1558502	E	RGD:6480464	20230606	CTD	MESH:C022838	nickel chloride results in increased expression of ATG7 mRNA; nickel chloride results in increased expression of ATG7 protein	PMID:36421005
1304817	Atg7	autophagy related 7	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20221004	CTD	MESH:C022838	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]; [nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA; [nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]; Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 mRNA]; Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 protein]; TXNRD3 gene mutant form inhibits the reaction [Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 mRNA]]; TXNRD3 gene mutant form promotes the reaction [nickel chloride results in increased expression of ATG7 mRNA]; TXNRD3 gene mutant form promotes the reaction [nickel chloride results in increased expression of ATG7 protein]	PMID:35568058|PMID:36421005
1304817	Atg7	autophagy related 7	gene	CHEBI:34905	paraquat	affects response to substance	ISO	RGD:1558502	E	RGD:6480464	20190219	CTD	MESH:D010269	ATG7 protein affects the susceptibility to Paraquat	PMID:28012437
1304817	Atg7	autophagy related 7	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20260113	CTD	MESH:D010269	Paraquat results in decreased expression of ATG7 protein	PMID:32517337
1304817	Atg7	autophagy related 7	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312481	E	RGD:6480464	20171114	CTD	MESH:D010269	Paraquat results in increased expression of ATG7 mRNA	PMID:27220436
1304817	Atg7	autophagy related 7	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1558502	E	RGD:6480464	20161115	CTD	MESH:D010269	Paraquat results in increased expression of ATG7 protein	PMID:27246695
1304817	Atg7	autophagy related 7	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20260113	CTD	MESH:D010269	3-methyladenine inhibits the reaction [vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG7 protein]]; vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG7 protein]	PMID:32517337
1304817	Atg7	autophagy related 7	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20161115	CTD	MESH:D010269	[ATG7 protein affects the susceptibility to Paraquat] which affects the expression of AKR1C3 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of ATM mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BACH1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BARD1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BLM mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BRCA1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BUB1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BUB1B mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CCNA2 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CCNB1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CCNB2 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CCNE1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CCNE2 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CDC20 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CDC25C mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CDK1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CDK2 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CDKN1A mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CHEK1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of FANCA mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of FANCB mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of FANCD2 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of KIF11 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of KIF14 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of KIF23 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of NBN mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of PLK1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of PLK4 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of PRC1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of SMC1A mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of STAT1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of TRP53 protein; ATG7 protein affects the reaction [Paraquat results in decreased expression of LMNB1 protein]; ATG7 protein affects the reaction [Paraquat results in increased expression of CDKN1A protein]; ATG7 protein affects the reaction [Paraquat results in increased expression of H2AX protein]; ATG7 protein affects the reaction [Paraquat results in increased expression of TRP53 mRNA]; Paraquat affects the reaction [ATG7 protein affects the expression of CDK1 mRNA]; Paraquat affects the reaction [ATG7 protein affects the expression of CDK1 protein]; Paraquat affects the reaction [ATG7 protein affects the expression of LMNB1 mRNA]; TLR4 protein affects the reaction [Paraquat results in increased expression of ATG7 protein]	PMID:27246695|PMID:28012437
1304817	Atg7	autophagy related 7	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ATG7 gene	PMID:33148267
1304817	Atg7	autophagy related 7	gene	CHEBI:34956	ruthenium red	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:D012430	Ruthenium Red inhibits the reaction [Cadmium Compounds results in increased expression of ATG7 protein]	PMID:34308505
1304817	Atg7	autophagy related 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312481	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATG7 mRNA	PMID:37042841
1304817	Atg7	autophagy related 7	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA	PMID:39836092
1304817	Atg7	autophagy related 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATG7 mRNA	PMID:33453195
1304817	Atg7	autophagy related 7	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATG7 protein	PMID:33127495
1304817	Atg7	autophagy related 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312481	E	RGD:6480464	20211012	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATG7 protein	PMID:33127495
1304817	Atg7	autophagy related 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200114	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]; NUPR1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]	PMID:31319114
1304817	Atg7	autophagy related 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA	PMID:37236586
1304817	Atg7	autophagy related 7	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20240305	CTD	MESH:C023036	[perfluorooctanoic acid co-treated with perfluorotetradecanoic acid] results in decreased expression of ATG7 mRNA	PMID:37806615
1304817	Atg7	autophagy related 7	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ATG7 mRNA	PMID:24449571
1304817	Atg7	autophagy related 7	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:D005999	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1304817	Atg7	autophagy related 7	gene	CHEBI:36560	zinc oxide	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D015034	Zinc Oxide results in increased expression of ATG7 mRNA	PMID:32951350
1304817	Atg7	autophagy related 7	gene	CHEBI:37415	alpha-amanitin	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D053959	Alpha-Amanitin results in increased expression of ATG7 protein	PMID:37329965
1304817	Atg7	autophagy related 7	gene	CHEBI:37415	alpha-amanitin	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20231205	CTD	MESH:D053959	3-methyladenine inhibits the reaction [Alpha-Amanitin results in increased expression of ATG7 protein]	PMID:37329965
1304817	Atg7	autophagy related 7	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ATG7 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATG7 mRNA]	PMID:17585979
1304817	Atg7	autophagy related 7	gene	CHEBI:38635	3-methyladenine	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20260113	CTD	MESH:C025946	3-methyladenine results in decreased expression of ATG7 protein	PMID:32517337
1304817	Atg7	autophagy related 7	gene	CHEBI:38635	3-methyladenine	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20140408	CTD	MESH:C025946	3-methyladenine inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]; 3-methyladenine inhibits the reaction [Alpha-Amanitin results in increased expression of ATG7 protein]; 3-methyladenine inhibits the reaction [beta-lapachone results in increased expression of ATG7 protein]; 3-methyladenine inhibits the reaction [rottlerin results in increased expression of ATG7 protein]; 3-methyladenine inhibits the reaction [vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG7 protein]]; [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]	PMID:22902833|PMID:29078374|PMID:32517337|PMID:37329965|PMID:38218311
1304817	Atg7	autophagy related 7	gene	CHEBI:38635	3-methyladenine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20210907	CTD	MESH:C025946	3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:33462182
1304817	Atg7	autophagy related 7	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1558502	E	RGD:6480464	20260303	CTD	MESH:C473478	Sunitinib results in increased expression of ATG7 protein	PMID:40449751
1304817	Atg7	autophagy related 7	gene	CHEBI:38940	sunitinib	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20260303	CTD	MESH:C473478	2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of ATG7 protein]; N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of ATG7 protein]]	PMID:40449751
1304817	Atg7	autophagy related 7	gene	CHEBI:39381	buprofezin	increases expression	ISO	RGD:1312481	E	RGD:6480464	20230905	CTD	MESH:C083997	buprofezin results in increased expression of ATG7 mRNA	PMID:36287832
1304817	Atg7	autophagy related 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATG7 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ATG7 mRNA	PMID:36331819
1304817	Atg7	autophagy related 7	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ATG7 mRNA	PMID:41580965
1304817	Atg7	autophagy related 7	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20200714	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of ATG7 protein	PMID:32151603
1304817	Atg7	autophagy related 7	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200714	CTD	MESH:D003520	Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of ATG7 protein]; Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of ATG7 protein]	PMID:32151603
1304817	Atg7	autophagy related 7	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:D016572	Cyclosporine results in increased expression of ATG7 mRNA	PMID:32152650|PMID:34681664
1304817	Atg7	autophagy related 7	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1304817	Atg7	autophagy related 7	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1312481	E	RGD:6480464	20170516	CTD	MESH:C017160	cypermethrin results in increased expression of ATG7 mRNA	PMID:27704156
1304817	Atg7	autophagy related 7	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ATG7 mRNA	PMID:17555576
1304817	Atg7	autophagy related 7	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATG7 mRNA	PMID:28628672
1304817	Atg7	autophagy related 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ATG7 mRNA	PMID:28973697
1304817	Atg7	autophagy related 7	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of ATG7 protein	PMID:35243728|PMID:39127087
1304817	Atg7	autophagy related 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Berberine inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of ATG7 protein]	PMID:35243728|PMID:39127087
1304817	Atg7	autophagy related 7	gene	CHEBI:45716	vorinostat	affects response to substance	ISO	RGD:1312481	E	RGD:6480464	20161213	CTD	MESH:C111237	ATG7 affects the susceptibility to vorinostat	PMID:21148553
1304817	Atg7	autophagy related 7	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312481	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ATG7 protein	PMID:20543569
1304817	Atg7	autophagy related 7	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20161213	CTD	MESH:C111237	ATG7 protein promotes the reaction [vorinostat results in increased cleavage of MAP1LC3B protein]	PMID:17881280
1304817	Atg7	autophagy related 7	gene	CHEBI:46024	trichostatin A	decreases response to substance	ISO	RGD:1558502	E	RGD:6480464	20191008	CTD	MESH:C012589	ATG7 gene mutant form results in decreased susceptibility to trichostatin A	PMID:29476062
1304817	Atg7	autophagy related 7	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20191008	CTD	MESH:C012589	ATG7 gene mutant form inhibits the reaction [trichostatin A inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]]; ATG7 gene mutant form inhibits the reaction [trichostatin A inhibits the reaction [Cisplatin results in increased expression of CASP3 protein modified form]]; ATG7 gene mutant form inhibits the reaction [trichostatin A promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form]]; ATG7 gene mutant form inhibits the reaction [trichostatin A results in increased expression of MAP1LC3B protein modified form]	PMID:29476062
1304817	Atg7	autophagy related 7	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ATG7 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATG7 mRNA]	PMID:17585979
1304817	Atg7	autophagy related 7	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of ATG7 mRNA	PMID:21061450
1304817	Atg7	autophagy related 7	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312481	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATG7 gene	PMID:25304211
1304817	Atg7	autophagy related 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA; ATG7 protein affects the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HMOX1 protein]	PMID:32525701|PMID:39836092
1304817	Atg7	autophagy related 7	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of ATG7 mRNA	PMID:31675489
1304817	Atg7	autophagy related 7	gene	CHEBI:47898	4'-epidoxorubicin	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20240604	CTD	MESH:D015251	[baicalein 5,6,7-trimethyl ether co-treated with Epirubicin] results in increased expression of ATG7 mRNA	PMID:38040128
1304817	Atg7	autophagy related 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ATG7 mRNA	PMID:35436446
1304817	Atg7	autophagy related 7	gene	CHEBI:49	(+)-Tetrandrine	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20170516	CTD	MESH:C009438	tetrandrine results in decreased expression of ATG7 protein	PMID:25266202
1304817	Atg7	autophagy related 7	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ATG7 mRNA	PMID:17555576
1304817	Atg7	autophagy related 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ATG7 mRNA	PMID:17942748
1304817	Atg7	autophagy related 7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATG7 mRNA	PMID:17942748
1304817	Atg7	autophagy related 7	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of ATG7 mRNA	PMID:36868495
1304817	Atg7	autophagy related 7	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATG7 mRNA	PMID:28628672
1304817	Atg7	autophagy related 7	gene	CHEBI:49668	gefitinib	increases expression	ISO	RGD:1312481	E	RGD:6480464	20120412	CTD	MESH:C419708	gefitinib results in increased expression of ATG7 protein	PMID:21655094
1304817	Atg7	autophagy related 7	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312481	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATG7 mRNA; Arsenic Trioxide results in increased expression of ATG7 protein	PMID:29307831|PMID:32284743
1304817	Atg7	autophagy related 7	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1558502	E	RGD:6480464	20210810	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATG7 mRNA	PMID:32781346|PMID:33462182
1304817	Atg7	autophagy related 7	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20191114	CTD	MESH:C032793	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of BCR protein mutant form]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of FLT3 protein mutant form]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:22898604|PMID:29307831|PMID:32284743
1304817	Atg7	autophagy related 7	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20210907	CTD	MESH:C032793	3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:33462182
1304817	Atg7	autophagy related 7	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1558502	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of ATG7 mRNA	PMID:21318169
1304817	Atg7	autophagy related 7	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate inhibits the reaction [tyloxapol results in decreased expression of ATG7 protein]; PPARA protein affects the reaction [Fenofibrate results in increased expression of ATG7 mRNA]	PMID:21318169|PMID:36905866
1304817	Atg7	autophagy related 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20190219	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATG7 mRNA; Nanotubes, Carbon results in decreased expression of ATG7 mRNA	PMID:30138652|PMID:30802478
1304817	Atg7	autophagy related 7	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ATG7 mRNA	PMID:32951350
1304817	Atg7	autophagy related 7	gene	CHEBI:50833	cadmium sulfide	increases expression	ISO	RGD:1312481	E	RGD:6480464	20170516	CTD	MESH:C034939	cadmium sulfide results in increased expression of ATG7 mRNA	PMID:27866839
1304817	Atg7	autophagy related 7	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ATG7 mRNA	PMID:35964746
1304817	Atg7	autophagy related 7	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1558502	E	RGD:6480464	20241105	CTD	MESH:D005485	Flutamide results in increased expression of ATG7 mRNA	PMID:32662666
1304817	Atg7	autophagy related 7	gene	CHEBI:5199	Fusaric acid	increases expression	ISO	RGD:1312481	E	RGD:6480464	20190312	CTD	MESH:D005669	Fusaric Acid results in increased expression of ATG7 mRNA	PMID:30582969
1304817	Atg7	autophagy related 7	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1558502	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ATG7 mRNA	PMID:19042947
1304817	Atg7	autophagy related 7	gene	CHEBI:53509	erlotinib hydrochloride	increases expression	ISO	RGD:1312481	E	RGD:6480464	20170303	CTD	MESH:D000069347	Erlotinib Hydrochloride results in increased expression of ATG7 protein	PMID:21655094
1304817	Atg7	autophagy related 7	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ATG7 protein	PMID:32959892
1304817	Atg7	autophagy related 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA	PMID:39836092
1304817	Atg7	autophagy related 7	gene	CHEBI:63112	fingolimod hydrochloride	increases expression	ISO	RGD:1312481	E	RGD:6480464	20170228	CTD	MESH:D000068876	Fingolimod Hydrochloride results in increased expression of ATG7 protein	PMID:25939952
1304817	Atg7	autophagy related 7	gene	CHEBI:64213	cantharidin	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D002193	Cantharidin results in increased expression of ATG7 protein	PMID:35398186
1304817	Atg7	autophagy related 7	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1312481	E	RGD:6480464	20221206	CTD	MESH:D002193	Cantharidin results in increased expression of ATG7 protein	PMID:35398186
1304817	Atg7	autophagy related 7	gene	CHEBI:6432	levamisole	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200714	CTD	MESH:D007978	Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of ATG7 protein]	PMID:32151603
1304817	Atg7	autophagy related 7	gene	CHEBI:6437	levetiracetam	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D000077287	Levetiracetam results in decreased expression of ATG7 protein	PMID:37098359
1304817	Atg7	autophagy related 7	gene	CHEBI:6437	levetiracetam	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:D000077287	Quercetin inhibits the reaction [Levetiracetam results in decreased expression of ATG7 protein]	PMID:37098359
1304817	Atg7	autophagy related 7	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20221004	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]	PMID:35568058
1304817	Atg7	autophagy related 7	gene	CHEBI:65899	flavokawain B	affects response to substance	ISO	RGD:1312481	E	RGD:6480464	20200331	CTD	MESH:C452039	ATG7 protein affects the susceptibility to flavokawain B	PMID:30025493
1304817	Atg7	autophagy related 7	gene	CHEBI:65899	flavokawain B	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200331	CTD	MESH:C452039	[ATG7 protein affects the susceptibility to flavokawain B] which affects the cleavage of CASP3 protein; [ATG7 protein affects the susceptibility to flavokawain B] which affects the cleavage of PARP1 protein; ATG7 protein affects the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]	PMID:30025493
1304817	Atg7	autophagy related 7	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312481	E	RGD:6480464	20240702	CTD	MESH:D002185	Cannabidiol results in increased expression of ATG7 protein	PMID:38583854
1304817	Atg7	autophagy related 7	gene	CHEBI:6950	mirtazapine	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:C035133	Mirtazapine results in increased expression of ATG7 mRNA	PMID:35066094
1304817	Atg7	autophagy related 7	gene	CHEBI:6950	mirtazapine	increases expression	ISO	RGD:1558502	E	RGD:6480464	20221206	CTD	MESH:C035133	Mirtazapine results in increased expression of ATG7 mRNA	PMID:35066094
1304817	Atg7	autophagy related 7	gene	CHEBI:6950	mirtazapine	multiple interactions	EXP		E	RGD:6480464	20221206	CTD	MESH:C035133	Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]; HMGB1 protein affects the reaction [Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]]; HMGB1 protein affects the reaction [Mirtazapine results in increased expression of ATG7 mRNA]	PMID:35066094
1304817	Atg7	autophagy related 7	gene	CHEBI:6950	mirtazapine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20221206	CTD	MESH:C035133	Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]	PMID:35066094
1304817	Atg7	autophagy related 7	gene	CHEBI:70436	platycodin D	increases expression	ISO	RGD:1312481	E	RGD:6480464	20190910	CTD	MESH:C108953	platycodin D results in increased expression of ATG7 protein	PMID:26078792
1304817	Atg7	autophagy related 7	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ATG7 gene	PMID:33148267
1304817	Atg7	autophagy related 7	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ATG7 mRNA	PMID:31758290
1304817	Atg7	autophagy related 7	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312481	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ATG7 protein	PMID:34186270
1304817	Atg7	autophagy related 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG7 mRNA	PMID:22206623
1304817	Atg7	autophagy related 7	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in increased expression of ATG7 mRNA	PMID:32152650
1304817	Atg7	autophagy related 7	gene	CHEBI:7494	nefazodone	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1304817	Atg7	autophagy related 7	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20180313	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [ATG7 protein results in decreased expression of SQSTM1 protein]	PMID:27629431
1304817	Atg7	autophagy related 7	gene	CHEBI:7602	nobiletin	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in increased expression of ATG7 protein]	PMID:38348393
1304817	Atg7	autophagy related 7	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1312481	E	RGD:6480464	20250401	CTD	MESH:C025589	ochratoxin A results in increased expression of ATG7 protein	PMID:38896176
1304817	Atg7	autophagy related 7	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20250401	CTD	MESH:C025589	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine promotes the reaction [ochratoxin A results in increased expression of ATG7 protein]; ferrostatin-1 inhibits the reaction [ochratoxin A results in increased expression of ATG7 protein]; tetrahydro-N, N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride inhibits the reaction [ochratoxin A results in increased expression of ATG7 protein]	PMID:38896176
1304817	Atg7	autophagy related 7	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ATG7 mRNA	PMID:21346803
1304817	Atg7	autophagy related 7	gene	CHEBI:78510	dorsomorphin	increases expression	ISO	RGD:1312481	E	RGD:6480464	20210706	CTD	MESH:C516138	dorsomorphin results in increased expression of ATG7 protein	PMID:31900833
1304817	Atg7	autophagy related 7	gene	CHEBI:78708	Nonidet P-40	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in decreased expression of ATG7 mRNA	PMID:26552463
1304817	Atg7	autophagy related 7	gene	CHEBI:7939	parthenolide	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20240206	CTD	MESH:C002669	parthenolide inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of ATG7 protein]	PMID:37858773
1304817	Atg7	autophagy related 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1558502	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ATG7 mRNA	PMID:23091169
1304817	Atg7	autophagy related 7	gene	CHEBI:8069	phenobarbital	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D010634	Phenobarbital inhibits the reaction [Dietary Fats results in increased expression of ATG7 mRNA]	PMID:36657701
1304817	Atg7	autophagy related 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ATG7 protein	PMID:31675489
1304817	Atg7	autophagy related 7	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1312481	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ATG7 protein	PMID:31675489
1304817	Atg7	autophagy related 7	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312481	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in increased expression of ATG7 protein	PMID:38348393
1304817	Atg7	autophagy related 7	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200915	CTD	MESH:C009277	ATG7 protein affects the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HMOX1 protein]; nobiletin inhibits the reaction [sodium arsenate results in increased expression of ATG7 protein]	PMID:32525701|PMID:38348393
1304817	Atg7	autophagy related 7	gene	CHEBI:8461	promethazine	decreases expression	ISO	RGD:1312481	E	RGD:6480464	20200519	CTD	MESH:D011398	Promethazine results in decreased expression of ATG7 protein	PMID:31682805
1304817	Atg7	autophagy related 7	gene	CHEBI:8630	pterostilbene	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20220607	CTD	MESH:C107773	ATG7 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]	PMID:34405320
1304817	Atg7	autophagy related 7	gene	CHEBI:8687	pyrvinium	increases expression	ISO	RGD:1312481	E	RGD:6480464	20260602	CTD	MESH:C024631	pyrvinium results in increased expression of ATG7 mRNA; pyrvinium results in increased expression of ATG7 protein	PMID:40976863
1304817	Atg7	autophagy related 7	gene	CHEBI:8899	rottlerin	increases expression	ISO	RGD:1312481	E	RGD:6480464	20140408	CTD	MESH:C085746	rottlerin results in increased expression of ATG7 protein	PMID:22902833
1304817	Atg7	autophagy related 7	gene	CHEBI:8899	rottlerin	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20140408	CTD	MESH:C085746	3-methyladenine inhibits the reaction [rottlerin results in increased expression of ATG7 protein]	PMID:22902833
1304817	Atg7	autophagy related 7	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20200519	CTD	MESH:D020123	[Sirolimus co-treated with TNF protein] results in increased expression of ATG7 mRNA	PMID:31676321
1304817	Atg7	autophagy related 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ATG7 mRNA	PMID:21346803
1304817	Atg7	autophagy related 7	gene	CHEBI:92519	1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	increases expression	ISO	RGD:1312481	E	RGD:6480464	20250401	CTD	MESH:C093337	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine results in increased expression of ATG7 protein	PMID:38896176
1304817	Atg7	autophagy related 7	gene	CHEBI:92519	1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20250401	CTD	MESH:C093337	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine promotes the reaction [ochratoxin A results in increased expression of ATG7 protein]	PMID:38896176
1304817	Atg7	autophagy related 7	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1558502	E	RGD:6480464	20170613	CTD	MESH:C001899	triptolide results in increased expression of ATG7 protein	PMID:26990902
1304817	Atg7	autophagy related 7	gene	CHEBI:9936	Vasicinone	multiple interactions	ISO	RGD:1312481	E	RGD:6480464	20260113	CTD	MESH:C052548	3-methyladenine inhibits the reaction [vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG7 protein]]; vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG7 protein]	PMID:32517337
1304817	Atg7	autophagy related 7	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ATG7 mRNA	PMID:23034163
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312483	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of HECA mRNA	PMID:38218311
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:132098	methoxyacetic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in increased expression of HECA mRNA	PMID:20864626
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312483	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of HECA mRNA	PMID:23724009
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1615528	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of HECA mRNA	PMID:30319688
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312483	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of HECA mRNA	PMID:31614463
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312483	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HECA mRNA	PMID:37042841
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312483	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of HECA mRNA	PMID:23649840
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1615528	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of HECA mRNA	PMID:28973375
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312483	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of HECA mRNA	PMID:33359661
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of HECA mRNA	PMID:26577399
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of HECA mRNA	PMID:22061828
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312483	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of HECA mRNA	PMID:28818685
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1615528	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HECA mRNA	PMID:36331819
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1615528	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HECA mRNA	PMID:37236586
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312483	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of HECA mRNA	PMID:19549813
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312483	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of HECA mRNA	PMID:23649840
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312483	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HECA mRNA	PMID:21641981
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312483	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of HECA mRNA	PMID:23649840
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312483	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of HECA mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HECA mRNA	PMID:35430440|PMID:41430723
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1615528	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HECA mRNA	PMID:27339419
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in increased expression of HECA mRNA	PMID:20864626
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of HECA mRNA	PMID:31881176
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HECA mRNA	PMID:34747641
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615528	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HECA mRNA	PMID:21570461
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of HECA mRNA	PMID:20864626
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312483	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HECA mRNA	PMID:33212167
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312483	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of HECA mRNA	PMID:20044591
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312483	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HECA mRNA	PMID:38568856
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1615528	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HECA mRNA	PMID:20883709
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312483	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HECA promoter	PMID:27901495
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HECA mRNA	PMID:21839799
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of HECA mRNA	PMID:27131904
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312483	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of HECA mRNA	PMID:25895662
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312483	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HECA mRNA	PMID:20458559
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of HECA mRNA	PMID:24136188
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of HECA mRNA	PMID:20813756
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312483	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HECA mRNA	PMID:19710929
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312483	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of HECA mRNA	PMID:38479592
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of HECA mRNA	PMID:25181051
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1615528	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of HECA mRNA	PMID:40036665
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HECA mRNA	PMID:39298647
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1615528	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of HECA mRNA	PMID:38685157
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HECA mRNA	PMID:21266533
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1615528	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HECA mRNA	PMID:21266533
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312483	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HECA mRNA	PMID:37042841
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312483	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HECA mRNA	PMID:38568856
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1615528	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HECA mRNA	PMID:20883709
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of HECA promoter	PMID:22457795
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1615528	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HECA mRNA	PMID:37236586
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312483	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of HECA mRNA	PMID:31533062
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312483	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of HECA mRNA	PMID:27153767
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1615528	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HECA mRNA	PMID:36331819
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312483	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HECA mRNA	PMID:25979313
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312483	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of HECA mRNA	PMID:19101580|PMID:23179753|PMID:24935251|PMID:27188386|PMID:29154799
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312483	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of HECA mRNA	PMID:20106945
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312483	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of HECA mRNA	PMID:24935251
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312483	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of HECA mRNA	PMID:29067470
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312483	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of HECA mRNA	PMID:22079256
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312483	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of HECA mRNA	PMID:18175754
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312483	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HECA mRNA	PMID:20458559
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HECA mRNA; Nanotubes, Carbon results in decreased expression of HECA mRNA	PMID:25554681
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1615528	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of HECA mRNA	PMID:20003209
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HECA mRNA	PMID:22206623
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312483	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of HECA mRNA	PMID:22079256
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312483	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of HECA mRNA	PMID:22079256
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312483	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of HECA mRNA	PMID:19159669
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1615528	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of HECA mRNA	PMID:23091169
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of HECA mRNA	PMID:21278054
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of HECA mRNA	PMID:24780913
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in increased expression of HECA mRNA	PMID:20864626
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of HECA mRNA	PMID:27131904
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312483	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of HECA mRNA	PMID:38568856
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312483	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of HECA mRNA	PMID:29301935
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of HECA mRNA	PMID:28973697
1304818	Heca	HECA ribonucleoprotein granule regulator	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of HECA mRNA	PMID:19015723
1304819	Cdc23	cell division cycle 23	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312485	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CDC23 mRNA	PMID:33045310
1304819	Cdc23	cell division cycle 23	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CDC23 mRNA	PMID:33167477
1304819	Cdc23	cell division cycle 23	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312485	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of CDC23 protein	PMID:31494107
1304819	Cdc23	cell division cycle 23	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D004958	Estradiol results in increased expression of CDC23 mRNA	PMID:20068009
1304819	Cdc23	cell division cycle 23	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CDC23 mRNA	PMID:33387578
1304819	Cdc23	cell division cycle 23	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312484	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDC23 mRNA	PMID:37042841
1304819	Cdc23	cell division cycle 23	gene	CHEBI:17315	D-glucosamine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of CDC23 mRNA	PMID:17109745
1304819	Cdc23	cell division cycle 23	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312485	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDC23 mRNA	PMID:34319233
1304819	Cdc23	cell division cycle 23	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312484	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CDC23 protein	PMID:37730182
1304819	Cdc23	cell division cycle 23	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in decreased expression of CDC23 mRNA	PMID:17109745
1304819	Cdc23	cell division cycle 23	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312484	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC23 mRNA	PMID:35301059
1304819	Cdc23	cell division cycle 23	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CDC23 mRNA	PMID:19549813
1304819	Cdc23	cell division cycle 23	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CDC23 mRNA	PMID:30779732
1304819	Cdc23	cell division cycle 23	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20120522	CTD	MESH:D012643	Selenium results in decreased expression of CDC23 mRNA	PMID:19244175
1304819	Cdc23	cell division cycle 23	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312484	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CDC23 mRNA	PMID:23557933
1304819	Cdc23	cell division cycle 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312485	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC23 mRNA	PMID:21570461
1304819	Cdc23	cell division cycle 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC23 mRNA	PMID:33387578
1304819	Cdc23	cell division cycle 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312485	E	RGD:6480464	20120522	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC23 mRNA	PMID:19770486
1304819	Cdc23	cell division cycle 23	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in decreased expression of CDC23 mRNA	PMID:17109745
1304819	Cdc23	cell division cycle 23	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDC23 mRNA	PMID:29803840
1304819	Cdc23	cell division cycle 23	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312484	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDC23 promoter	PMID:27901495
1304819	Cdc23	cell division cycle 23	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312484	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CDC23 mRNA	PMID:20862710
1304819	Cdc23	cell division cycle 23	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312485	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDC23 gene	PMID:35295148
1304819	Cdc23	cell division cycle 23	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CDC23 mRNA	PMID:25181051
1304819	Cdc23	cell division cycle 23	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC23 mRNA	PMID:36041667
1304819	Cdc23	cell division cycle 23	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CDC23 mRNA	PMID:27914987
1304819	Cdc23	cell division cycle 23	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC23 mRNA	PMID:36041667
1304819	Cdc23	cell division cycle 23	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC23 mRNA	PMID:36041667
1304819	Cdc23	cell division cycle 23	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312485	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CDC23 mRNA	PMID:20350560
1304819	Cdc23	cell division cycle 23	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CDC23 mRNA	PMID:22546817
1304819	Cdc23	cell division cycle 23	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312485	E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CDC23 mRNA	PMID:21266533
1304819	Cdc23	cell division cycle 23	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CDC23 mRNA	PMID:22546817
1304819	Cdc23	cell division cycle 23	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of CDC23 mRNA	PMID:17312168
1304819	Cdc23	cell division cycle 23	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312484	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC23 mRNA	PMID:37042841
1304819	Cdc23	cell division cycle 23	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312484	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC23 mRNA	PMID:35301059
1304819	Cdc23	cell division cycle 23	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20120522	CTD	MESH:D012643	Selenium results in decreased expression of CDC23 mRNA	PMID:19244175
1304819	Cdc23	cell division cycle 23	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CDC23 mRNA	PMID:28302478
1304819	Cdc23	cell division cycle 23	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312484	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CDC23 mRNA	PMID:31533062
1304819	Cdc23	cell division cycle 23	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312484	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDC23 mRNA	PMID:23179753|PMID:25979313
1304819	Cdc23	cell division cycle 23	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CDC23 mRNA	PMID:25562108
1304819	Cdc23	cell division cycle 23	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312484	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CDC23 mRNA	PMID:27188386
1304819	Cdc23	cell division cycle 23	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312485	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of CDC23 mRNA	PMID:17562736
1304819	Cdc23	cell division cycle 23	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDC23 mRNA	PMID:33387578
1304819	Cdc23	cell division cycle 23	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDC23 mRNA	PMID:21420995
1304819	Cdc23	cell division cycle 23	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312484	E	RGD:6480464	20240702	CTD	MESH:D000082	Acetaminophen results in increased expression of CDC23 mRNA	PMID:38614205
1304819	Cdc23	cell division cycle 23	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in decreased expression of CDC23 mRNA	PMID:17109745
1304819	Cdc23	cell division cycle 23	gene	CHEBI:48707	(-)-citrinin	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20190219	CTD	MESH:D002953	Citrinin results in decreased expression of CDC23 mRNA	PMID:30428381
1304819	Cdc23	cell division cycle 23	gene	CHEBI:48707	(-)-citrinin	multiple interactions	ISO	RGD:1312484	E	RGD:6480464	20190219	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC23 mRNA	PMID:30428381
1304819	Cdc23	cell division cycle 23	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312484	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CDC23 mRNA	PMID:20862710
1304819	Cdc23	cell division cycle 23	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1312484	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of CDC23 mRNA	PMID:20977926
1304819	Cdc23	cell division cycle 23	gene	CHEBI:6382	Lasiocarpine	multiple interactions	ISO	RGD:1312484	E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CDC23 mRNA	PMID:33884520
1304819	Cdc23	cell division cycle 23	gene	CHEBI:63924	riddelliine	multiple interactions	ISO	RGD:1312484	E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC23 mRNA	PMID:33884520
1304819	Cdc23	cell division cycle 23	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312485	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CDC23 mRNA	PMID:23650126
1304819	Cdc23	cell division cycle 23	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CDC23 mRNA	PMID:28988120
1304819	Cdc23	cell division cycle 23	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312485	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CDC23 mRNA	PMID:22206623
1304819	Cdc23	cell division cycle 23	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312484	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of CDC23 protein	PMID:31285264
1304819	Cdc23	cell division cycle 23	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312484	E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of CDC23 mRNA	PMID:30428381
1304819	Cdc23	cell division cycle 23	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1312484	E	RGD:6480464	20190219	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC23 mRNA	PMID:30428381
1304819	Cdc23	cell division cycle 23	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312484	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CDC23 gene]	PMID:28238834
1304819	Cdc23	cell division cycle 23	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CDC23 mRNA	PMID:23914054
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1349527	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of OMA1 mRNA	PMID:26272509
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1349527	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OMA1 mRNA	PMID:27188386
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of OMA1 mRNA]	PMID:31150632
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:136004	linsidomine	increases oxidation	EXP		E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of OMA1 protein	PMID:28086193
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of OMA1 mRNA	PMID:17347304
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of OMA1 protein	PMID:34971761
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D006861	Emodin inhibits the reaction [Hydrogen Peroxide results in increased expression of OMA1 protein]	PMID:34971761
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of OMA1 mRNA	PMID:21632981
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of OMA1 mRNA	PMID:33387578
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349527	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of OMA1 mRNA	PMID:37042841
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of OMA1 mRNA	PMID:23649840
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:17558	quercitrin	increases expression	ISO	RGD:1349527	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of OMA1 mRNA	PMID:25193878
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of OMA1 mRNA	PMID:26577399
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of OMA1 mRNA	PMID:33387578
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of OMA1 mRNA	PMID:19549813
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of OMA1 mRNA	PMID:23649840
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of OMA1 mRNA	PMID:31150632
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550363	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of OMA1 mRNA	PMID:31919559
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of OMA1 mRNA]	PMID:31150632
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of OMA1 mRNA	PMID:31881176
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1349527	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of OMA1 mRNA	PMID:23300844
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1349527	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of OMA1 mRNA	PMID:27392435
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550363	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of OMA1 mRNA	PMID:21570461
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OMA1 mRNA	PMID:11489354
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OMA1 mRNA	PMID:33387578
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of OMA1 mRNA	PMID:28001369
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of OMA1 mRNA	PMID:33212167
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of OMA1 mRNA	PMID:38568856
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349527	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OMA1 5' UTR; Benzo(a)pyrene results in increased methylation of OMA1 promoter	PMID:27901495
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1550363	E	RGD:6480464	20221004	CTD	MESH:C015001	arsenite results in increased expression of OMA1 mRNA	PMID:24960579
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550363	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of OMA1 gene; titanium dioxide results in decreased methylation of OMA1 promoter	PMID:35295148
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of OMA1 mRNA	PMID:19162173
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1550363	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of OMA1 mRNA	PMID:28329830
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OMA1 mRNA	PMID:25181051
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1349527	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of OMA1 mRNA	PMID:25979313
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550363	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of OMA1 mRNA	PMID:39298647|PMID:40203079
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550363	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of OMA1 mRNA	PMID:38685157
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550363	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of OMA1 mRNA	PMID:37019170
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of OMA1 mRNA	PMID:21266533
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550363	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of OMA1 mRNA	PMID:17361019|PMID:21266533
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1550363	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of OMA1 mRNA	PMID:34813904
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1550363	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of OMA1 mRNA	PMID:34813904
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1349527	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of OMA1 mRNA	PMID:29024780
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of OMA1 mRNA	PMID:38568856
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of OMA1 protein	PMID:34958885
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550363	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of OMA1 mRNA	PMID:40194260
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of OMA1 mRNA	PMID:28302478
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1349527	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of OMA1 mRNA	PMID:31533062
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349527	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of OMA1 mRNA	PMID:25979313
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550363	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of OMA1 mRNA	PMID:17292431
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1349527	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of OMA1 gene	PMID:29154799
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349527	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of OMA1 mRNA	PMID:26272509|PMID:28001369
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1349527	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OMA1 mRNA	PMID:27188386
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of OMA1 mRNA	PMID:20106945
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:42223	emodin	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D004642	Emodin inhibits the reaction [Hydrogen Peroxide results in increased expression of OMA1 protein]; Emodin inhibits the reaction [Oxidopamine results in increased expression of OMA1 protein]	PMID:34971761
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of OMA1 mRNA	PMID:38832940
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of OMA1 mRNA	PMID:21420995|PMID:29067470
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of OMA1 mRNA	PMID:33387578
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1550363	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of OMA1 mRNA	PMID:35436446
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1349527	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of OMA1 mRNA	PMID:23300844
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550363	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of OMA1 mRNA	PMID:25620056
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	ISO	RGD:1349527	E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in increased expression of OMA1 mRNA	PMID:16982809
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of OMA1 mRNA	PMID:19564919
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of OMA1 gene	PMID:35440735
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550363	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of OMA1 mRNA	PMID:22206623
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1349527	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OMA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OMA1 mRNA	PMID:27188386
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:78741	oxidopamine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D016627	Oxidopamine results in increased expression of OMA1 protein	PMID:34971761
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:78741	oxidopamine	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D016627	Emodin inhibits the reaction [Oxidopamine results in increased expression of OMA1 protein]	PMID:34971761
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349527	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to OMA1 gene]	PMID:28238834
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1349527	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of OMA1 mRNA	PMID:19159669
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of OMA1 mRNA	PMID:24780913
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349527	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OMA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OMA1 mRNA	PMID:27188386
1304821	Oma1	OMA1 zinc metallopeptidase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1349527	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of OMA1 mRNA	PMID:38568856
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1605646	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of METTL14 mRNA	PMID:31863870
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1605646	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of METTL14 mRNA	PMID:38218311
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of METTL14 mRNA	PMID:33045310
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of METTL14 mRNA	PMID:20488242
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1605646	E	RGD:6480464	20230404	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of METTL14 protein	PMID:35438468
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20230404	CTD	MESH:D008070	METTL14 protein affects the reaction [Lipopolysaccharides results in increased expression of MIR155HG]	PMID:35438468
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605646	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of METTL14 mRNA	PMID:37042841
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20200609	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of METTL14 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of METTL14 protein	PMID:31875672
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332193	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of METTL14 mRNA	PMID:36174712
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20200609	CTD	MESH:C016599	METTL14 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of SCARB1 mRNA]; mono-(2-ethylhexyl)phthalate affects the reaction [METTL14 protein affects the expression of SCARB1 mRNA]	PMID:31875672
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1605646	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of METTL14 mRNA	PMID:28818685
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1332193	E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium results in increased expression of METTL14 protein	PMID:36084736
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] promotes the reaction [METTL14 protein binds to FIS1 mRNA]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of METTL14 mRNA; [Cadmium co-treated with Dietary Fats] results in increased expression of METTL14 mRNA; [Cadmium co-treated with Dietary Fats] results in increased expression of METTL14 protein	PMID:36084736|PMID:36336035|PMID:37236586
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605646	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of METTL14 mRNA	PMID:19549813
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1605646	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of METTL14 mRNA	PMID:23649840
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605646	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of METTL14 mRNA	PMID:23649840
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1605646	E	RGD:6480464	20230307	CTD	MESH:D001151	Arsenic results in increased expression of METTL14	PMID:35363433
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA	PMID:33854195
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of METTL14 mRNA	PMID:23557933
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of METTL14 mRNA	PMID:32186404
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605646	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of METTL14 mRNA	PMID:33212167
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1605646	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of METTL14 protein	PMID:33212167
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D004317	METTL14 protein promotes the reaction [Doxorubicin results in increased abundance of Lipid Peroxides]	PMID:34648132
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20220510	CTD	MESH:D004317	METTL14 protein promotes the reaction [Doxorubicin results in decreased expression of MIR7-1 mRNA]; METTL14 protein promotes the reaction [Doxorubicin results in increased abundance of 4-hydroxy-2-nonenal]; METTL14 protein promotes the reaction [Doxorubicin results in increased abundance of Malondialdehyde]; METTL14 protein promotes the reaction [Doxorubicin results in increased expression of KCNQ1 protein]; METTL14 protein promotes the reaction [Doxorubicin results in increased expression of TFRC protein]	PMID:34648132
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20220510	CTD	MESH:D004317	[Doxorubicin results in decreased expression of MIR7-1 mRNA] which results in increased expression of METTL14 mRNA; [Doxorubicin results in decreased expression of MIR7-1 mRNA] which results in increased expression of METTL14 protein; METTL14 protein promotes the reaction [[[Doxorubicin results in increased methylation of and results in increased stability of KCNQ1OT1 mRNA] which results in decreased expression of MIR7-1 mRNA] which results in increased expression of TFRC mRNA]; METTL14 protein promotes the reaction [[[Doxorubicin results in increased methylation of and results in increased stability of KCNQ1OT1 mRNA] which results in decreased expression of MIR7-1 mRNA] which results in increased expression of TFRC protein]; METTL14 protein promotes the reaction [[Doxorubicin results in increased methylation of and results in increased stability of KCNQ1OT1 mRNA] which results in decreased expression of MIR7-1 mRNA]; METTL14 protein promotes the reaction [Doxorubicin results in increased abundance of Lipid Peroxides]; METTL14 protein promotes the reaction [Doxorubicin results in increased methylation of and results in increased stability of KCNQ1OT1 mRNA]	PMID:34648132
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:28755	2,4,6-trichlorophenol	increases expression	ISO	RGD:1332193	E	RGD:6480464	20240702	CTD	MESH:C024564	2,4,6-trichlorophenol results in increased expression of METTL14 mRNA	PMID:38157273
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20230905	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Paraquat results in increased expression of METTL14 mRNA]	PMID:34425375
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20210810	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 protein]	PMID:31004932
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1605646	E	RGD:6480464	20181113	CTD	MESH:C017947	sodium arsenite affects the expression of METTL14 mRNA; sodium arsenite affects the expression of METTL14 protein	PMID:29680375|PMID:30654086
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of METTL14 protein	PMID:39667319
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605646	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in decreased expression of METTL14 protein	PMID:39571964
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of METTL14 protein	PMID:37730054
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605646	E	RGD:6480464	20210810	CTD	MESH:C017947	sodium arsenite results in increased expression of METTL14 mRNA; sodium arsenite results in increased expression of METTL14 protein	PMID:31004932|PMID:39675544
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29678	sodium arsenite	increases localization	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased localization of METTL14 protein	PMID:38714084
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[METTL14 protein promotes the reaction [sodium arsenite results in increased methylation of TGFB1 mRNA]] which results in increased expression of TGFB1 protein; METTL14 promotes the reaction [sodium arsenite results in increased expression of ACTA2 protein]; METTL14 promotes the reaction [sodium arsenite results in increased expression of COL1A2 protein]; METTL14 promotes the reaction [sodium arsenite results in increased phosphorylation of SMAD2 protein]; METTL14 promotes the reaction [sodium arsenite results in increased phosphorylation of SMAD3 protein]; METTL14 protein promotes the reaction [sodium arsenite results in increased methylation of TGFB1 mRNA]; METTL14 protein promotes the reaction [sodium arsenite results in increased stability of TGFB1 mRNA]; sodium arsenite promotes the reaction [METTL14 protein binds to TGFB1 mRNA]	PMID:38714084
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20210810	CTD	MESH:C017947	Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 protein]	PMID:31004932
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of METTL14 mRNA	PMID:19770486
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605646	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of METTL14 promoter	PMID:27901495
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1332193	E	RGD:6480464	20251007	CTD	MESH:C015001	arsenite results in increased expression of METTL14 mRNA; arsenite results in increased expression of METTL14 protein	PMID:39405678
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to METTL14 mRNA]	PMID:32406909
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20240206	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of METTL14 mRNA	PMID:37979906
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605646	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of METTL14 mRNA	PMID:20018196
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1332193	E	RGD:6480464	20220906	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of METTL14 protein	PMID:35226250
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20220906	CTD	MESH:C006632	Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]	PMID:35226250
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20220906	CTD	MESH:C006632	Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]; AS3MT mRNA promotes the reaction [Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]]; METTL14 protein promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP1 protein modified form]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL18 protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL1B protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased stability of NLRP3 mRNA]	PMID:35226250
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332193	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of METTL14 gene	PMID:35295148
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:32585	4-hydroxynon-2-enal	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20220510	CTD	MESH:C027576	METTL14 protein promotes the reaction [Doxorubicin results in increased abundance of 4-hydroxy-2-nonenal]	PMID:34648132
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of METTL14 mRNA	PMID:34947998|PMID:41034487
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of METTL14 mRNA	PMID:33221593
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605646	E	RGD:6480464	20241001	CTD	MESH:C006780	bisphenol A results in decreased expression of METTL14 mRNA	PMID:38354435
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of METTL14 mRNA	PMID:25181051
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of METTL14 mRNA	PMID:40203079
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA	PMID:33854195
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of METTL14 mRNA	PMID:21266533
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1332193	E	RGD:6480464	20230905	CTD	MESH:D010269	Paraquat results in increased expression of METTL14 mRNA	PMID:34425375
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20230905	CTD	MESH:D010269	Acetylcysteine inhibits the reaction [Paraquat results in increased expression of METTL14 mRNA]	PMID:34425375
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605646	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of METTL14 mRNA	PMID:37042841
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] promotes the reaction [METTL14 protein binds to FIS1 mRNA]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of METTL14 mRNA	PMID:36336035|PMID:37236586
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1605646	E	RGD:6480464	20210608	CTD	MESH:C056933	fumonisin B1 results in increased expression of METTL14 mRNA	PMID:33496827
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1605646	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of METTL14 mRNA	PMID:28302478
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605646	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of METTL14 mRNA	PMID:23179753
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1605646	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of METTL14 gene	PMID:29154799
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA	PMID:33854195
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA	PMID:33854195
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of METTL14 mRNA	PMID:33387578
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1605646	E	RGD:6480464	20230307	CTD	MESH:D001151	Arsenic results in increased expression of METTL14	PMID:35363433
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1605646	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of METTL14 mRNA	PMID:22077320
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1332193	E	RGD:6480464	20240702	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of METTL14 mRNA	PMID:38157273
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of METTL14 mRNA	PMID:29391264
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1332193	E	RGD:6480464	20220906	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of METTL14 protein	PMID:35226250
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20220906	CTD	MESH:C032793	Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]	PMID:35226250
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20220906	CTD	MESH:C032793	Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]; AS3MT mRNA promotes the reaction [Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]]; METTL14 protein promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP1 protein modified form]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL18 protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL1B protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased stability of NLRP3 mRNA]	PMID:35226250
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20250506	CTD	MESH:C014347	Decitabine inhibits the reaction [[Docetaxel results in decreased susceptibility to Docetaxel] which results in increased expression of METTL14 mRNA]; Decitabine promotes the reaction [[Docetaxel results in decreased susceptibility to Docetaxel] promotes the reaction [E2F1 protein binds to METTL14 promoter]]	PMID:38546343
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1605646	E	RGD:6480464	20251007	CTD	MESH:C037123	cadmium sulfate results in increased expression of METTL14 mRNA	PMID:35794303
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:566274	malonaldehyde	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20220510	CTD	MESH:D008315	METTL14 protein promotes the reaction [Doxorubicin results in increased abundance of Malondialdehyde]	PMID:34648132
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA	PMID:33854195
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605646	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of METTL14 protein	PMID:32959892
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of METTL14 mRNA	PMID:30467583
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:75192	thallium(I) acetate	increases expression	ISO	RGD:1605646	E	RGD:6480464	20230905	CTD	MESH:C026995	thallium acetate results in increased expression of METTL14 protein	PMID:36745568
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:75192	thallium(I) acetate	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20230905	CTD	MESH:C026995	3-deazaadenosine inhibits the reaction [thallium acetate results in increased expression of METTL14 protein]; METTL14 protein affects the reaction [thallium acetate results in increased expression of ATP13A3 protein]	PMID:36745568
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:755540	docetaxel	decreases response to substance	ISO	RGD:1332193	E	RGD:6480464	20260714	CTD	MESH:D000077143	METTL14 protein results in decreased susceptibility to Docetaxel	PMID:38546343
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1332193	E	RGD:6480464	20260714	CTD	MESH:D000077143	METTL14 protein inhibits the reaction [Docetaxel results in decreased expression of MKI67 protein]	PMID:38546343
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1605646	E	RGD:6480464	20260714	CTD	MESH:D000077143	[[Docetaxel results in decreased susceptibility to Docetaxel] which results in increased methylation of METTL14 promoter] inhibits the reaction [E2F1 protein binds to METTL14 promoter]; [Docetaxel results in decreased susceptibility to Docetaxel] which results in increased expression of METTL14 mRNA; [Docetaxel results in decreased susceptibility to Docetaxel] which results in increased expression of METTL14 protein; [Docetaxel results in decreased susceptibility to Docetaxel] which results in increased methylation of METTL14 promoter; [METTL14 protein results in increased expression of CAMK2N1 mRNA] promotes the reaction [Docetaxel results in decreased susceptibility to Docetaxel]; Decitabine inhibits the reaction [[Docetaxel results in decreased susceptibility to Docetaxel] which results in increased expression of METTL14 mRNA]; Decitabine promotes the reaction [[Docetaxel results in decreased susceptibility to Docetaxel] promotes the reaction [E2F1 protein binds to METTL14 promoter]]; E2F1 protein inhibits the reaction [[Docetaxel results in decreased susceptibility to Docetaxel] which results in increased expression of METTL14 mRNA]; METTL14 protein promotes the reaction [Docetaxel results in decreased susceptibility to Docetaxel]; MIR129 promotes the reaction [METTL14 protein results in increased susceptibility to Docetaxel]	PMID:38546343
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1605646	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of METTL14 protein	PMID:31285264
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:81927	enilconazole	affects expression	ISO	RGD:1332193	E	RGD:6480464	20260804	CTD	MESH:C017435	enilconazole affects the expression of METTL14 mRNA	PMID:38232526
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:81927	enilconazole	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20260804	CTD	MESH:C017435	enilconazole results in decreased expression of METTL14 protein	PMID:38232526
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605646	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of METTL14 mRNA	PMID:38568856
1304822	Mettl14	methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1332193	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of METTL14 mRNA	PMID:28973697
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312489	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KDM8 gene	PMID:20938992
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602684	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of KDM8 mRNA	PMID:33167477
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312489	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KDM8 gene	PMID:20938992
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312489	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KDM8 mRNA	PMID:34319233
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1602684	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KDM8 mRNA	PMID:28818685
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1602684	E	RGD:6480464	20200310	CTD	MESH:D008769	Methylnitronitrosoguanidine inhibits the reaction [TP53 protein binds to KDM8 protein]	PMID:26025680
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602684	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of KDM8 mRNA	PMID:35430440
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312489	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KDM8 gene	PMID:20938992
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312489	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KDM8 mRNA	PMID:21570461
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KDM8 mRNA	PMID:21215274
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:28748	doxorubicin	affects localization	ISO	RGD:1602684	E	RGD:6480464	20200310	CTD	MESH:D004317	Doxorubicin affects the localization of KDM8 protein	PMID:26025680
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1602684	E	RGD:6480464	20200310	CTD	MESH:D004317	Doxorubicin inhibits the reaction [KDM8 protein binds to CDKN1A promoter]; Doxorubicin inhibits the reaction [KDM8 protein binds to RRM2B promoter]; Doxorubicin inhibits the reaction [TP53 protein binds to KDM8 protein]; KDM8 protein affects the reaction [Doxorubicin results in increased expression of CDKN1A protein]; KDM8 protein affects the reaction [Doxorubicin results in increased expression of RRM2B protein]	PMID:26025680
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602684	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KDM8 mRNA	PMID:22316170|PMID:32234424
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602684	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of JMJD5 promoter	PMID:27901495
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:3020	benzalkonium chloride	decreases expression	ISO	RGD:1312489	E	RGD:6480464	20190910	CTD	MESH:D001548	Benzalkonium Compounds results in decreased expression of KDM8 mRNA	PMID:31199489
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of KDM8 mRNA	PMID:30047161
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1602684	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of KDM8 mRNA	PMID:19710929
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A affects the expression of KDM8 mRNA	PMID:25181051
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KDM8 gene	PMID:28505145
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312489	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KDM8 promoter	PMID:27312807
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312489	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of KDM8 mRNA	PMID:40203079
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KDM8 mRNA	PMID:18668222
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1602684	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of KDM8 mRNA	PMID:32588087
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312489	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of KDM8 mRNA	PMID:39529242
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312489	E	RGD:6480464	20120515	CTD	MESH:D014635	Valproic Acid results in decreased expression of KDM8 mRNA	PMID:19136453|PMID:21427059
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602684	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of KDM8 mRNA	PMID:26272509
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1602684	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of KDM8 gene	PMID:29154799
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602684	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KDM8 mRNA	PMID:27188386
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of KDM8 mRNA	PMID:30047161
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1312489	E	RGD:6480464	20121009	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of KDM8 mRNA	PMID:22467019
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602684	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of KDM8 mRNA	PMID:29067470
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KDM8 mRNA	PMID:29391264
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1602684	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of KDM8 mRNA	PMID:32234424
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KDM8 mRNA	PMID:24136188|PMID:24793618
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1602684	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of KDM8 mRNA	PMID:28988120
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312489	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of JMJD5 mRNA	PMID:22206623
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602684	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KDM8 mRNA	PMID:27188386
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602684	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to JMJD5 gene]	PMID:28238834
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1602684	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of KDM8 mRNA	PMID:32234424
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of KDM8 mRNA	PMID:30047161
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of KDM8 mRNA	PMID:30047161
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602684	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KDM8 mRNA	PMID:27188386
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of KDM8 mRNA	PMID:19281266
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1602684	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of KDM8 mRNA	PMID:29301935
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of KDM8 mRNA	PMID:30047161
1304823	Kdm8	lysine demethylase 8	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of KDM8 mRNA	PMID:23034163
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D004237	Diuron results in increased expression of TIMCC mRNA	PMID:21551480
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMCC mRNA]	PMID:31150632
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TIMCC mRNA	PMID:33167477
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TIMCC mRNA	PMID:36331819
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D000431	Ethanol results in increased expression of TIMCC mRNA	PMID:30319688
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TIMCC mRNA	PMID:39241906
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TIMCC mRNA]	PMID:39241906
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of TIMCC protein	PMID:20109541
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1605923	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TIMCC mRNA	PMID:38568856
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TIMCC mRNA	PMID:33387578
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1605923	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TIMCC mRNA	PMID:21179406
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1605923	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TIMCC protein	PMID:37730182
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TIMCC mRNA	PMID:28818685
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TIMCC protein	PMID:34915118
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TIMCC mRNA	PMID:19549813
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605923	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TIMCC gene	PMID:27153756
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TIMCC mRNA	PMID:31150632
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMCC mRNA]	PMID:31150632
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TIMCC mRNA	PMID:40504410
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1605923	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TIMCC mRNA	PMID:22574217
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TIMCC mRNA	PMID:21215274|PMID:33387578
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1605923	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TIMCC mRNA	PMID:33212167
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TIMCC mRNA	PMID:30851411
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TIMCC mRNA	PMID:29803840
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TIMCC mRNA	PMID:38568856
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TIMCC mRNA	PMID:40504410
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605923	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TIMCC promoter	PMID:27901495
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in decreased expression of TIMCC mRNA	PMID:25729387
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TIMCC promoter	PMID:35295148
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013853	Thioacetamide results in increased expression of TIMCC mRNA	PMID:23411599|PMID:34492290
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of TIMCC mRNA	PMID:28329830
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A affects the expression of TIMCC mRNA	PMID:25181051
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:C543008	bisphenol S results in increased expression of TIMCC mRNA	PMID:39298647
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of TIMCC protein	PMID:35362542
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of TIMCC protein]	PMID:35362542
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TIMCC mRNA	PMID:21266533
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TIMCC mRNA]	PMID:39241906
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TIMCC mRNA	PMID:19376846
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of TIMCC mRNA	PMID:25908611
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TIMCC mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TIMCC mRNA	PMID:36331819
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605923	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TIMCC mRNA	PMID:25979313
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TIMCC mRNA	PMID:26272509|PMID:27188386
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605923	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIMCC mRNA	PMID:27188386
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TIMCC mRNA	PMID:25562108
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000082	Acetaminophen results in decreased expression of TIMCC mRNA	PMID:33387578
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of TIMCC mRNA	PMID:25704631
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TIMCC mRNA	PMID:40504410
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D004726	Endosulfan results in increased expression of TIMCC mRNA	PMID:29391264
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of TIMCC protein]	PMID:35362542
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D018120	Finasteride results in increased expression of TIMCC mRNA	PMID:24136188
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D005485	Flutamide results in increased expression of TIMCC mRNA	PMID:24136188
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TIMCC protein	PMID:32959892
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D007649	Ketamine results in decreased expression of TIMCC mRNA	PMID:20080153
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in decreased expression of TIMCC mRNA	PMID:25729387
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C406224	valdecoxib results in increased expression of TIMCC mRNA	PMID:24136188
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of TIMCC mRNA	PMID:37939859
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TIMCC mRNA	PMID:22206623
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C051752	nefazodone results in increased expression of TIMCC mRNA	PMID:24136188
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in decreased expression of TIMCC protein	PMID:39638853
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TIMCC mRNA	PMID:30851411
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605923	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIMCC mRNA	PMID:27188386
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:C045950	propiconazole results in increased expression of TIMCC mRNA	PMID:21278054
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D011441	Propylthiouracil results in increased expression of TIMCC mRNA	PMID:24780913|PMID:36843608
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312491	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TIMCC mRNA]	PMID:39241906
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605923	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIMCC mRNA	PMID:27188386
1304825	Timcc	TIM double twin CX3C motif chaperone	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1605923	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TIMCC mRNA	PMID:38568856
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622983	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ALG12 mRNA	PMID:33045310
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALG12 mRNA]	PMID:31150632
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:137392	chlormequat chloride	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of ALG12 protein	PMID:34958886
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1622983	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ALG12 mRNA	PMID:39241906
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1622983	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ALG12 mRNA	PMID:39298647
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120522	CTD	MESH:D005947	Glucose results in decreased expression of ALG12 mRNA	PMID:17178593
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of ALG12 mRNA	PMID:17178593
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120522	CTD	MESH:D005947	Glucose results in decreased expression of ALG12 mRNA	PMID:17178593
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ALG12 mRNA	PMID:22061828|PMID:33387578
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in decreased expression of ALG12 mRNA	PMID:17178593
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312492	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ALG12 mRNA	PMID:35301059
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:24897	isoindoles	affects response to substance	ISO	RGD:1312492	E	RGD:6480464	20170303	CTD	MESH:D054833	ALG12 gene SNP affects the susceptibility to Isoindoles analog	PMID:25622337
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312492	E	RGD:6480464	20120522	CTD	MESH:D000638	Amiodarone results in increased expression of ALG12 mRNA	PMID:19774075
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ALG12 mRNA	PMID:31150632
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALG12 mRNA]	PMID:31150632
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622983	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ALG12 mRNA	PMID:21570461
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120522	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ALG12 mRNA	PMID:19465110
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALG12 mRNA	PMID:33387578
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1622983	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALG12 mRNA	PMID:28213091
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1622983	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ALG12 gene]	PMID:28213091
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in decreased expression of ALG12 mRNA	PMID:17178593
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ALG12 mRNA	PMID:28959563
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312492	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ALG12 mRNA	PMID:29803840
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312492	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ALG12 mRNA	PMID:34032870
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1622983	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ALG12 mRNA	PMID:22228805
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312492	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ALG12 5' UTR	PMID:27901495
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1622983	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ALG12 mRNA	PMID:23221170
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312492	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ALG12 gene	PMID:31601247
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ALG12 mRNA	PMID:24136188
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622983	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ALG12 gene; titanium dioxide results in decreased methylation of ALG12 promoter alternative form	PMID:35295148
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ALG12 mRNA	PMID:23411599|PMID:34492290
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ALG12 mRNA	PMID:25181051
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ALG12 mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312492	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ALG12 mRNA	PMID:29275510
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1622983	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ALG12 mRNA	PMID:39298647
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ALG12 mRNA	PMID:38685157
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312492	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ALG12 gene	PMID:31601247
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ALG12 mRNA	PMID:32680482
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312492	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ALG12 mRNA	PMID:37042841
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312492	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ALG12 mRNA	PMID:35301059
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:37825	p-toluidine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of ALG12 mRNA	PMID:27638505
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1622983	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ALG12 mRNA	PMID:40194260
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312492	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ALG12 mRNA	PMID:31533062
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1622983	E	RGD:6480464	20120522	CTD	MESH:D014635	Valproic Acid affects the expression of ALG12 mRNA	PMID:17292431
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312492	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ALG12 mRNA	PMID:29154799
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312492	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ALG12 gene	PMID:29154799
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in decreased expression of ALG12 mRNA	PMID:17178593
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ALG12 mRNA	PMID:24136188
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622983	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of ALG12 mRNA	PMID:17562736
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in decreased expression of ALG12 mRNA	PMID:17178593
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ALG12 mRNA	PMID:35436446
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1622983	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ALG12 mRNA	PMID:25620056
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ALG12 mRNA	PMID:24136188
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1622983	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ALG12 mRNA	PMID:22206623
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ALG12 mRNA	PMID:24136188
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ALG12 mRNA	PMID:21346803
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:78160	bleomycin A5	decreases expression	ISO	RGD:1312492	E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in decreased expression of ALG12 mRNA	PMID:21040473
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1622983	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ALG12 mRNA	PMID:30294300
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1622983	E	RGD:6480464	20120522	CTD	MESH:C045950	propiconazole results in increased expression of ALG12 mRNA	PMID:21278054
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120522	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ALG12 mRNA	PMID:21346803
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312492	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ALG12 mRNA	PMID:38568856
1304826	Alg12	ALG12, alpha-1,6-mannosyltransferase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120522	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ALG12 mRNA	PMID:21346803
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of POMGNT2 mRNA]	PMID:31150632
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1606199	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of POMGNT2 mRNA	PMID:30510588
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332253	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of POMGNT2 mRNA	PMID:39298647
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of POMGNT2 mRNA	PMID:33387578
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606199	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of POMGNT2 mRNA	PMID:37042841
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1332253	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of POMGNT2 mRNA	PMID:33848595
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1332253	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of POMGNT2 mRNA]	PMID:33848595
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of POMGNT2 mRNA	PMID:33387578
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1606199	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of POMGNT2 mRNA	PMID:28818685
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606199	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of POMGNT2 mRNA	PMID:39836092
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606199	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POMGNT2 mRNA	PMID:19549813
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POMGNT2 mRNA	PMID:31150632
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of POMGNT2 mRNA]	PMID:31150632
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332253	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POMGNT2 mRNA	PMID:22206623
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of POMGNT2 mRNA	PMID:31881176
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606199	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of POMGNT2 mRNA	PMID:23557933
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606199	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of POMGNT2 mRNA	PMID:27392435
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606199	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of POMGNT2 mRNA	PMID:27392435
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POMGNT2 mRNA	PMID:22298810
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332253	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POMGNT2 mRNA	PMID:21570461
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1606199	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of POMGNT2 mRNA	PMID:32763439
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606199	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of POMGNT2 5' UTR	PMID:27901495
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of POMGNT2 mRNA	PMID:30047161
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of POMGNT2 mRNA	PMID:34492290
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1332253	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of POMGNT2 mRNA	PMID:28329830
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1606199	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of POMGNT2 gene	PMID:31601247
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of POMGNT2 mRNA	PMID:25181051
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of POMGNT2 mRNA	PMID:36041667
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606199	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POMGNT2 mRNA	PMID:28628672
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of POMGNT2 mRNA	PMID:36041667
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of POMGNT2 mRNA	PMID:36041667
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1606199	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POMGNT2 mRNA	PMID:28628672
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1332253	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of POMGNT2 intron	PMID:28392331
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332253	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of POMGNT2 mRNA	PMID:37019170
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1332253	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of POMGNT2 gene	PMID:38995845
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1606199	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POMGNT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POMGNT2 mRNA	PMID:28628672
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of POMGNT2 mRNA	PMID:32680482
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606199	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of POMGNT2 mRNA	PMID:39836092
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1606199	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of POMGNT2 mRNA	PMID:24449571
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332253	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of POMGNT2 mRNA	PMID:17292431
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606199	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of POMGNT2 mRNA	PMID:25979313
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606199	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of POMGNT2 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of POMGNT2 mRNA	PMID:30047161
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1332253	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of POMGNT2 mRNA	PMID:17555576
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1606199	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POMGNT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POMGNT2 mRNA	PMID:28628672
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1332253	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of POMGNT2 mRNA	PMID:28973697
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332253	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of POMGNT2 mRNA	PMID:17562736
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of POMGNT2 mRNA	PMID:33387578
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1332253	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of POMGNT2 mRNA	PMID:17555576
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1606199	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POMGNT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POMGNT2 mRNA	PMID:28628672
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332253	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of POMGNT2 mRNA	PMID:25554681
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of POMGNT2 mRNA	PMID:30047161
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606199	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of POMGNT2 mRNA	PMID:39836092
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1606199	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of POMGNT2 mRNA	PMID:28988120
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1332253	E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol results in decreased expression of POMGNT2 mRNA	PMID:21542829
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332253	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POMGNT2 mRNA	PMID:22206623
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of POMGNT2 mRNA	PMID:30047161
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1606199	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of POMGNT2 mRNA	PMID:38568856
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1606199	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of POMGNT2 mRNA	PMID:27188386
1304827	Pomgnt2	protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of POMGNT2 mRNA	PMID:23034163
1304829	Med13	mediator complex subunit 13	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312496	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of MED13 mRNA	PMID:16324150
1304829	Med13	mediator complex subunit 13	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312496	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MED13 mRNA	PMID:36331819
1304829	Med13	mediator complex subunit 13	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MED13 mRNA	PMID:26079696
1304829	Med13	mediator complex subunit 13	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of MED13 mRNA	PMID:40945087
1304829	Med13	mediator complex subunit 13	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1312495	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of MED13 protein	PMID:35688186
1304829	Med13	mediator complex subunit 13	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of MED13 mRNA	PMID:32145629
1304829	Med13	mediator complex subunit 13	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312495	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MED13 mRNA	PMID:37042841
1304829	Med13	mediator complex subunit 13	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312496	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MED13 mRNA	PMID:23892564
1304829	Med13	mediator complex subunit 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MED13 mRNA	PMID:33754040
1304829	Med13	mediator complex subunit 13	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312495	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MED13 protein	PMID:37730182
1304829	Med13	mediator complex subunit 13	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312496	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of MED13 mRNA	PMID:16324150
1304829	Med13	mediator complex subunit 13	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MED13 mRNA	PMID:33387578
1304829	Med13	mediator complex subunit 13	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312496	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MED13 mRNA	PMID:19770486
1304829	Med13	mediator complex subunit 13	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312495	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of MED13 mRNA	PMID:41430723
1304829	Med13	mediator complex subunit 13	gene	CHEBI:27086	tributylstannane	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C011559	tributyltin results in increased expression of MED13 mRNA	PMID:21683754
1304829	Med13	mediator complex subunit 13	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312496	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MED13 mRNA	PMID:31919559
1304829	Med13	mediator complex subunit 13	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312495	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MED13 protein	PMID:35688186
1304829	Med13	mediator complex subunit 13	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of MED13 mRNA	PMID:25905778
1304829	Med13	mediator complex subunit 13	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MED13 mRNA	PMID:19921347
1304829	Med13	mediator complex subunit 13	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MED13 mRNA	PMID:30912803
1304829	Med13	mediator complex subunit 13	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of MED13 mRNA	PMID:32186404
1304829	Med13	mediator complex subunit 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312496	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MED13 mRNA	PMID:21570461
1304829	Med13	mediator complex subunit 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MED13 mRNA	PMID:33387578
1304829	Med13	mediator complex subunit 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MED13 mRNA	PMID:32109520
1304829	Med13	mediator complex subunit 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312496	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MED13 mRNA	PMID:17942748
1304829	Med13	mediator complex subunit 13	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of MED13 mRNA	PMID:19013527
1304829	Med13	mediator complex subunit 13	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MED13 mRNA	PMID:28001369
1304829	Med13	mediator complex subunit 13	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MED13 mRNA	PMID:33212167
1304829	Med13	mediator complex subunit 13	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312495	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MED13 mRNA	PMID:32763439
1304829	Med13	mediator complex subunit 13	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MED13 mRNA	PMID:29803840
1304829	Med13	mediator complex subunit 13	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312495	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of MED13 protein	PMID:35688186
1304829	Med13	mediator complex subunit 13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312495	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MED13 mRNA	PMID:38568856
1304829	Med13	mediator complex subunit 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312495	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MED13 intron	PMID:30157460
1304829	Med13	mediator complex subunit 13	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312495	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MED13 mRNA]	PMID:32406909
1304829	Med13	mediator complex subunit 13	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MED13 mRNA	PMID:27131904
1304829	Med13	mediator complex subunit 13	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MED13 mRNA	PMID:19150397
1304829	Med13	mediator complex subunit 13	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312496	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MED13 mRNA	PMID:35676786
1304829	Med13	mediator complex subunit 13	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MED13 mRNA	PMID:30047161
1304829	Med13	mediator complex subunit 13	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of MED13 mRNA	PMID:35295148
1304829	Med13	mediator complex subunit 13	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312496	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MED13 gene; titanium dioxide results in decreased methylation of MED13 promoter	PMID:35295148
1304829	Med13	mediator complex subunit 13	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MED13 mRNA	PMID:23411599|PMID:34492290
1304829	Med13	mediator complex subunit 13	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of MED13 mRNA	PMID:23811191
1304829	Med13	mediator complex subunit 13	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of MED13 mRNA	PMID:19167457
1304829	Med13	mediator complex subunit 13	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of MED13 mRNA	PMID:32145629
1304829	Med13	mediator complex subunit 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MED13 mRNA	PMID:26063408
1304829	Med13	mediator complex subunit 13	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MED13 mRNA	PMID:30816183|PMID:33296240
1304829	Med13	mediator complex subunit 13	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312495	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of MED13 mRNA	PMID:24752500
1304829	Med13	mediator complex subunit 13	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:1312495	E	RGD:6480464	20230704	CTD	MESH:C005290	oxybenzone results in increased expression of MED13 mRNA	PMID:36581016
1304829	Med13	mediator complex subunit 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312496	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MED13 mRNA	PMID:39298647
1304829	Med13	mediator complex subunit 13	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312495	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MED13 intron	PMID:30157460
1304829	Med13	mediator complex subunit 13	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312496	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MED13 mRNA	PMID:38685157
1304829	Med13	mediator complex subunit 13	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MED13 mRNA	PMID:28392331
1304829	Med13	mediator complex subunit 13	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of MED13 mRNA	PMID:17312168
1304829	Med13	mediator complex subunit 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312495	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MED13 mRNA	PMID:37042841
1304829	Med13	mediator complex subunit 13	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312495	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MED13 mRNA	PMID:38174414
1304829	Med13	mediator complex subunit 13	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312495	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of MED13 mRNA	PMID:19320972|PMID:19376846
1304829	Med13	mediator complex subunit 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312496	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MED13 mRNA	PMID:36331819
1304829	Med13	mediator complex subunit 13	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312495	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MED13 mRNA	PMID:25979313
1304829	Med13	mediator complex subunit 13	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of MED13 mRNA	PMID:29427782
1304829	Med13	mediator complex subunit 13	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MED13 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1304829	Med13	mediator complex subunit 13	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312495	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MED13 gene	PMID:29154799
1304829	Med13	mediator complex subunit 13	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of MED13 mRNA	PMID:30047161
1304829	Med13	mediator complex subunit 13	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MED13 mRNA	PMID:25562108
1304829	Med13	mediator complex subunit 13	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MED13 mRNA	PMID:27188386
1304829	Med13	mediator complex subunit 13	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of MED13 mRNA	PMID:24935251
1304829	Med13	mediator complex subunit 13	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1312495	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of MED13 mRNA	PMID:22077320
1304829	Med13	mediator complex subunit 13	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312495	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of MED13 mRNA	PMID:24752500
1304829	Med13	mediator complex subunit 13	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MED13 mRNA	PMID:29097150
1304829	Med13	mediator complex subunit 13	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312496	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MED13 mRNA	PMID:17942748
1304829	Med13	mediator complex subunit 13	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312496	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MED13 mRNA	PMID:17942748
1304829	Med13	mediator complex subunit 13	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312496	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MED13 mRNA	PMID:35676786
1304829	Med13	mediator complex subunit 13	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1312495	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of MED13 mRNA	PMID:26705709
1304829	Med13	mediator complex subunit 13	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312496	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MED13 mRNA	PMID:21641980
1304829	Med13	mediator complex subunit 13	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312495	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MED13 intron	PMID:30157460
1304829	Med13	mediator complex subunit 13	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of MED13 mRNA	PMID:27462272
1304829	Med13	mediator complex subunit 13	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MED13 mRNA	PMID:22206623
1304829	Med13	mediator complex subunit 13	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of MED13 mRNA	PMID:18927307
1304829	Med13	mediator complex subunit 13	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of MED13 mRNA	PMID:19095052
1304829	Med13	mediator complex subunit 13	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312496	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of MED13 mRNA	PMID:21795629
1304829	Med13	mediator complex subunit 13	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MED13 mRNA	PMID:30047161
1304829	Med13	mediator complex subunit 13	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1312496	E	RGD:6480464	20230905	CTD	MESH:D011441	Propylthiouracil results in increased expression of MED13 protein	PMID:30769017
1304829	Med13	mediator complex subunit 13	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312495	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of MED13 mRNA	PMID:24921660
1304829	Med13	mediator complex subunit 13	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MED13 mRNA	PMID:27131904
1304829	Med13	mediator complex subunit 13	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MED13 mRNA	PMID:19281266
1304829	Med13	mediator complex subunit 13	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312495	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MED13 mRNA	PMID:38568856
1304829	Med13	mediator complex subunit 13	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312495	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MED13 mRNA	PMID:27188386
1304829	Med13	mediator complex subunit 13	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of MED13 mRNA	PMID:28973697
1304829	Med13	mediator complex subunit 13	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MED13 mRNA	PMID:23555832
1304830	Otop2	otopetrin 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312497	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of OTOP2 mRNA	PMID:38218311
1304830	Otop2	otopetrin 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623762	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of OTOP2 mRNA	PMID:33045310
1304830	Otop2	otopetrin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312497	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of OTOP2 mRNA	PMID:31614463
1304830	Otop2	otopetrin 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of OTOP2 mRNA	PMID:33387578
1304830	Otop2	otopetrin 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1623762	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of OTOP2 mRNA	PMID:31919559
1304830	Otop2	otopetrin 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312497	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of OTOP2 mRNA	PMID:23557933
1304830	Otop2	otopetrin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623762	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of OTOP2 mRNA	PMID:21570461
1304830	Otop2	otopetrin 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTOP2 mRNA	PMID:26033743
1304830	Otop2	otopetrin 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312497	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of OTOP2 mRNA	PMID:38568856
1304830	Otop2	otopetrin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312497	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of OTOP2 exon	PMID:30157460
1304830	Otop2	otopetrin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312497	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OTOP2 5' UTR; Benzo(a)pyrene results in increased methylation of OTOP2 promoter	PMID:27901495
1304830	Otop2	otopetrin 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTOP2 mRNA	PMID:26033743
1304830	Otop2	otopetrin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OTOP2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304830	Otop2	otopetrin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1623762	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of OTOP2 gene	PMID:31683443
1304830	Otop2	otopetrin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1623762	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of OTOP2 exon	PMID:33297965
1304830	Otop2	otopetrin 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312497	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of OTOP2 intron	PMID:30157460
1304830	Otop2	otopetrin 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312497	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of OTOP2 gene	PMID:22964155
1304830	Otop2	otopetrin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623762	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of OTOP2 mRNA	PMID:17562736
1304830	Otop2	otopetrin 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312497	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of OTOP2 mRNA	PMID:22230336
1304830	Otop2	otopetrin 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312497	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of OTOP2 intron	PMID:30157460
1304830	Otop2	otopetrin 2	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1623762	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of OTOP2 mRNA	PMID:27935865
1304830	Otop2	otopetrin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of OTOP2 mRNA	PMID:24780913
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312499	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of IL4I1 mRNA	PMID:37995155
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IL4I1 gene	PMID:20938992
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312498	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IL4I1 mRNA	PMID:26079696
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312498	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IL4I1 mRNA	PMID:35811015
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312498	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IL4I1 mRNA	PMID:35811015
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:C031721	naphthalene results in increased expression of IL4I1 mRNA	PMID:18978301
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IL4I1 gene	PMID:20938992
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312498	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of IL4I1 mRNA	PMID:26079696
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312498	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of IL4I1 mRNA	PMID:36314267
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312498	E	RGD:6480464	20140722	CTD	MESH:D019327	Copper Sulfate results in increased expression of IL4I1 mRNA	PMID:19549813
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312498	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of IL4I1 mRNA	PMID:35430440
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of IL4I1 mRNA	PMID:30779732
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IL4I1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IL4I1 gene	PMID:20938992|PMID:22206623
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20140722	CTD	MESH:D003042	Cocaine results in decreased expression of IL4I1 mRNA	PMID:17898221
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312498	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL4I1 mRNA	PMID:25583101
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IL4I1 mRNA	PMID:21570461
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IL4I1 mRNA	PMID:33387578
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IL4I1 mRNA	PMID:17942748
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D012402	Rotenone results in increased expression of IL4I1 mRNA	PMID:23186747
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D012969	Sodium Fluoride results in increased expression of IL4I1 protein	PMID:28918527
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312498	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the expression of IL4I1 mRNA	PMID:20816728
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312498	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL4I1 promoter	PMID:27901495
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312498	E	RGD:6480464	20140722	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IL4I1 mRNA	PMID:22316170
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of IL4I1 mRNA	PMID:19073995
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IL4I1 mRNA	PMID:26345256|PMID:38811393
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:30746	benzoic acid	decreases activity	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D019817	Benzoic Acid results in decreased activity of IL4I1 protein	PMID:15383589
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:30753	4-aminobenzoic acid	decreases activity	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D010129	4-Aminobenzoic Acid results in decreased activity of IL4I1 protein	PMID:15383589
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:31642	gadodiamide hydrate	increases expression	ISO	RGD:1312498	E	RGD:6480464	20161213	CTD	MESH:C064925	gadodiamide results in increased expression of IL4I1 mRNA	PMID:20959327
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:C009495	titanium dioxide results in decreased expression of IL4I1 mRNA	PMID:23131501
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312499	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IL4I1 gene	PMID:35295148
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:C009495	titanium dioxide results in increased expression of IL4I1 mRNA	PMID:19464567|PMID:21259345|PMID:23557971
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312499	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IL4I1 gene	PMID:35295148
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:C006780	bisphenol A results in decreased expression of IL4I1 mRNA	PMID:30951980
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312498	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of IL4I1 mRNA	PMID:27685785
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312499	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of IL4I1 gene	PMID:31683443
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312498	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of IL4I1 intron	PMID:30157460
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:C008745	bisphenol F results in decreased expression of IL4I1 mRNA	PMID:30951980
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of IL4I1 mRNA	PMID:35163327
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312498	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IL4I1 mRNA	PMID:24449571
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D002994	Clofibrate results in decreased expression of IL4I1 mRNA	PMID:17585979
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1312498	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of IL4I1 mRNA	PMID:40434365
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:C031763	1,3-butadiene results in decreased expression of IL4I1 mRNA	PMID:29038090
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312498	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IL4I1 gene	PMID:29154799
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D013629	Tamoxifen affects the expression of IL4I1 mRNA	PMID:17555576
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312498	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IL4I1 mRNA	PMID:38832940
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D000082	Acetaminophen results in increased expression of IL4I1 mRNA	PMID:17585979
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312498	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of IL4I1 mRNA	PMID:24714768
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312498	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IL4I1 mRNA	PMID:35811015
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1312498	E	RGD:6480464	20140722	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of IL4I1 mRNA	PMID:17331233
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of IL4I1 mRNA	PMID:17555576
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of IL4I1 mRNA	PMID:17942748
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IL4I1 mRNA	PMID:17942748
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IL4I1 mRNA; Nanotubes, Carbon results in increased expression of IL4I1 mRNA; Nanotubes, Carbon results in increased expression of IL4I1 protein	PMID:25554681|PMID:27106021
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:50819	ferric oxide	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:C000499	ferric oxide analog results in decreased expression of IL4I1 mRNA	PMID:25086211
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:C030935	benz(a)anthracene results in increased expression of IL4I1 mRNA	PMID:26377693
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL4I1 mRNA	PMID:21641980
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312498	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of IL4I1 intron	PMID:30157460
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IL4I1 mRNA	PMID:22206623
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IL4I1 mRNA	PMID:22206623
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of IL4I1 mRNA	PMID:33945839
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312499	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of IL4I1 mRNA	PMID:38648751
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312498	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of IL4I1 mRNA	PMID:26079696
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20220913	CTD	MESH:C009277	sodium arsenate results in decreased expression of IL4I1 mRNA	PMID:21795629
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:95077	GSK-J4	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of IL4I1 mRNA]; GSK-J4 inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of IL4I1 protein]	PMID:36537648
1304831	Il4i1	interleukin 4 induced 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of IL4I1 mRNA	PMID:23555832
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of AARS1 protein	PMID:39638853
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D015025	Zearalenone results in decreased expression of AARS1 protein	PMID:25058043|PMID:36252740
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of AARS1 mRNA	PMID:25596134
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of AARS1 mRNA	PMID:35967413
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312500	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of AARS1 mRNA	PMID:26272509
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AARS1 mRNA	PMID:27188386
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein]	PMID:38195004
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20230801	CTD	MESH:D014212	Tretinoin results in decreased expression of AARS1 mRNA	PMID:33167477
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of AARS1 mRNA	PMID:25596134
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:15545	prostaglandin A1	increases metabolic processing	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C100573	prostaglandin A1 analog results in increased metabolism of AARS1 protein	PMID:19800325
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D000431	Ethanol affects the splicing of AARS1 mRNA	PMID:30319688
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312501	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of AARS1 mRNA	PMID:39241906
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of AARS1 mRNA	PMID:35877022
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	Estradiol results in increased expression of AARS1 mRNA	PMID:32145629
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312501	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of AARS1 mRNA	PMID:39298647
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D014241	Trichloroethylene results in increased expression of AARS1 mRNA	PMID:33387578
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312500	E	RGD:6480464	20250805	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AARS1 mRNA	PMID:37042841
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20230801	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of AARS1 protein	PMID:32044396
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:177387	brequinar	increases expression	ISO	RGD:1312500	E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in increased expression of AARS1 mRNA	PMID:39900124
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312500	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of AARS1 protein	PMID:37730182
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D005839	Gentamicins results in increased expression of AARS1 mRNA	PMID:22061828|PMID:33387578
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:180654	N(4)-hydroxycytidine	increases expression	ISO	RGD:1312501	E	RGD:6480464	20250805	CTD	MESH:C010737	N(4)-hydroxycytidine results in increased expression of AARS1 mRNA	PMID:37748715
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AARS1 mRNA	PMID:36331819
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of AARS1 protein	PMID:34915118
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20221101	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AARS1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein	PMID:35301059|PMID:38195004
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AARS1 protein	PMID:23301498
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of AARS1 mRNA	PMID:27776689
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AARS1 mRNA	PMID:19770486
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of AARS1 protein	PMID:38598786
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312500	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of AARS1 mRNA	PMID:22171008
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of AARS1 mRNA]	PMID:22206623
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AARS1 mRNA	PMID:40504410
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312500	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of AARS1 protein	PMID:35688186
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C024565	ethylene dichloride results in decreased expression of AARS1 mRNA	PMID:28960355
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of AARS1 mRNA	PMID:25596134
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312500	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of AARS1 mRNA	PMID:23300844
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of AARS1 mRNA	PMID:25596134
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the reaction [Piroxicam results in decreased expression of AARS1 mRNA]	PMID:21858171
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D014414	Tungsten results in decreased expression of AARS1 mRNA	PMID:30912803
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312500	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of AARS1 mRNA	PMID:26865667
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of AARS1 mRNA	PMID:23195993
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AARS1 mRNA	PMID:21570461
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AARS1 mRNA	PMID:33387578
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AARS1 mRNA	PMID:16467188|PMID:17942748
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AARS1 mRNA	PMID:17942748
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of AARS1 mRNA	PMID:33512557
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of AARS1 mRNA	PMID:24690739
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:29073	L-ascorbic acid	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20120515	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of AARS1 mRNA	PMID:19197388
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of AARS1 mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312500	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of AARS1 mRNA	PMID:39719251
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AARS1 mRNA	PMID:40504410
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312500	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of AARS1 mRNA; Tunicamycin results in increased expression of AARS1 protein	PMID:22378314|PMID:29453283|PMID:33545341|PMID:36586010|PMID:38498338|PMID:39900124
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312500	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AARS1 3' UTR; Benzo(a)pyrene affects the methylation of AARS1 intron; Benzo(a)pyrene affects the methylation of AARS1 promoter	PMID:27901495|PMID:30157460
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20230801	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AARS1 protein	PMID:32717239
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to AARS1 protein]	PMID:32406909
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of AARS1 mRNA	PMID:24690739
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312500	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of AARS1 mRNA	PMID:22171008
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of AARS1 protein	PMID:19364129
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C008261	lead acetate results in increased expression of AARS1 mRNA	PMID:11578147
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1312500	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of AARS1 mRNA	PMID:31745603
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C009495	titanium dioxide results in increased expression of AARS1 mRNA	PMID:23557971|PMID:27760801
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AARS1 mRNA	PMID:34492290
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C006253	pirinixic acid affects the expression of AARS1 mRNA	PMID:17950772
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C006253	pirinixic acid results in decreased expression of AARS1 mRNA	PMID:23811191
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312500	E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A affects the expression of AARS1 mRNA	PMID:30903817
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of AARS1 mRNA	PMID:33296240|PMID:34947998
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of AARS1 protein	PMID:31675489|PMID:37567409
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A results in decreased expression of AARS1 mRNA	PMID:33221593
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A results in decreased methylation of AARS1 promoter	PMID:27312807
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A results in increased expression of AARS1 mRNA	PMID:25181051|PMID:32145629
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312500	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of AARS1 mRNA; bisphenol A results in increased expression of AARS1 protein	PMID:29275510|PMID:33670352|PMID:34186270
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312501	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of AARS1 mRNA	PMID:38074096
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:33418	graphite	affects expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D006108	Graphite affects the expression of AARS1 mRNA	PMID:29933104
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312500	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AARS1 mRNA	PMID:25979313
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C016340	o,p'-DDT results in increased expression of AARS1 mRNA	PMID:24096037
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C016340	o,p'-DDT results in increased expression of AARS1 mRNA	PMID:24096037
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312501	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of AARS1 mRNA	PMID:39298647
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312500	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of AARS1 protein	PMID:34186270
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312500	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of AARS1 protein	PMID:34186270
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of AARS1 mRNA	PMID:37019170
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of AARS1 mRNA	PMID:21266533
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1312500	E	RGD:6480464	20230801	CTD	MESH:D004137	Dinitrochlorobenzene binds to AARS1 protein	PMID:32991956
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D005284	Fenthion results in decreased expression of AARS1 mRNA	PMID:34813904
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C005828	methidathion results in decreased expression of AARS1 mRNA	PMID:34813904
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20250805	CTD	MESH:D010269	Paraquat results in decreased expression of AARS1 protein	PMID:34064677
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D010269	Paraquat results in increased expression of AARS1 mRNA	PMID:32680482
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312500	E	RGD:6480464	20250805	CTD	MESH:C005445	triphenyl phosphate affects the expression of AARS1 mRNA	PMID:37042841
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:35456	cadmium dichloride	affects localization	ISO	RGD:1312500	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the localization of AARS1 protein	PMID:18261755
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AARS1 mRNA	PMID:25596134|PMID:38568856
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20221101	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AARS1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein	PMID:35301059|PMID:38195004
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312500	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of AARS1 protein	PMID:26879310
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AARS1 mRNA	PMID:19320972
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C018021	cobaltous chloride results in increased expression of AARS1 protein	PMID:24386269
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of AARS1 mRNA	PMID:25596134
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1312500	E	RGD:6480464	20230801	CTD	MESH:D003024	Clozapine results in increased expression of AARS1 protein	PMID:34122009
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312500	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of AARS1 mRNA	PMID:32588087
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312500	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of AARS1 mRNA	PMID:31533062
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312500	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of AARS1 mRNA	PMID:19167446
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of AARS1 mRNA	PMID:26352163
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312500	E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of AARS1 mRNA	PMID:36864359|PMID:40419075
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AARS1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of AARS1 mRNA	PMID:36331819
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of AARS1 mRNA	PMID:17198877
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312500	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AARS1 mRNA	PMID:25979313
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D016572	Cyclosporine results in increased expression of AARS1 mRNA	PMID:25596134
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312500	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AARS1 mRNA	PMID:20106945|PMID:21632981|PMID:22147139|PMID:25224403|PMID:25562108|PMID:25596134|PMID:27989131
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D016572	Cyclosporine results in increased expression of AARS1 mRNA	PMID:25224403
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of AARS1 mRNA	PMID:33512557
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:41500	4-phenylbutyric acid	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20120412	CTD	MESH:C075773	4-phenylbutyric acid results in decreased expression of AARS1 mRNA	PMID:14583596
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:41500	4-phenylbutyric acid	increases expression	ISO	RGD:1312500	E	RGD:6480464	20120412	CTD	MESH:C075773	4-phenylbutyric acid results in increased expression of AARS1 mRNA	PMID:14583596
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D003907	Dexamethasone results in decreased expression of AARS1 mRNA	PMID:22733784
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D000082	Acetaminophen affects the expression of AARS1 mRNA	PMID:17562736
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D000082	Acetaminophen results in increased expression of AARS1 mRNA	PMID:33387578
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312500	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of AARS1 mRNA	PMID:29067470
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of AARS1 mRNA]	PMID:15016801
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20161213	CTD	MESH:C088658	Zoledronic Acid results in decreased expression of AARS1 mRNA	PMID:25596134
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of AARS1 mRNA	PMID:24690739
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AARS1 mRNA	PMID:40504410
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D004008	Diclofenac results in decreased expression of AARS1 mRNA	PMID:35537566
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D004726	Endosulfan results in increased expression of AARS1 mRNA	PMID:29391264
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of AARS1 mRNA	PMID:26865667
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AARS1 mRNA	PMID:24096037
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AARS1 mRNA	PMID:16467188|PMID:17942748|PMID:24096037
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AARS1 mRNA	PMID:17942748
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of AARS1 protein	PMID:19364129
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D011345	Fenofibrate results in increased expression of AARS1 mRNA	PMID:25596134
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312500	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of AARS1 mRNA	PMID:23300844
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AARS1 mRNA; Nanotubes, Carbon results in increased expression of AARS1 mRNA	PMID:25554681
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of AARS1 mRNA	PMID:35964746
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D005485	Flutamide results in increased expression of AARS1 mRNA	PMID:24136188
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C015559	trimellitic anhydride results in increased expression of AARS1 mRNA	PMID:19042947
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AARS1 protein	PMID:32959892
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:63630	tolcapone	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C066340	Tolcapone results in increased expression of AARS1 mRNA	PMID:24136188
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C017096	n-butoxyethanol results in increased expression of AARS1 mRNA	PMID:19812364
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of AARS1 mRNA	PMID:23650126
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of AARS1 mRNA	PMID:37269647
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312500	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of AARS1 mRNA	PMID:24810058
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D008687	Metformin results in increased expression of AARS1 mRNA	PMID:25596134
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312500	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AARS1 protein	PMID:34186270
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AARS1 mRNA	PMID:22206623
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of AARS1 mRNA]	PMID:22206623
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AARS1 protein	PMID:37664457
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of AARS1 mRNA	PMID:30559759
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AARS1 mRNA	PMID:27188386
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:80491	pinostrobin	increases expression	ISO	RGD:1312500	E	RGD:6480464	20240109	CTD	MESH:C411294	pinostrobin results in increased expression of AARS1 mRNA	PMID:37777166
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312500	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of AARS1 mRNA	PMID:19159669
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of AARS1 protein	PMID:31675489
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1312500	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of AARS1 mRNA	PMID:19095052
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1312500	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of AARS1 mRNA	PMID:33512557
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C013418	bromfenacoum results in increased expression of AARS1 protein	PMID:28903499
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of AARS1 mRNA	PMID:21858171
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin affects the reaction [Piroxicam results in decreased expression of AARS1 mRNA]	PMID:21858171
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of AARS1 mRNA	PMID:33512557
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of AARS1 mRNA	PMID:19013360
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AARS1 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AARS1 mRNA	PMID:27188386|PMID:37664457
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D013605	T-2 Toxin results in decreased expression of AARS1 mRNA	PMID:26141394
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20230801	CTD	MESH:D013605	T-2 Toxin results in decreased expression of AARS1 mRNA	PMID:34581912
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312500	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of AARS1 mRNA	PMID:29301935
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of AARS1 protein	PMID:35544339
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D019284	Thapsigargin results in increased expression of AARS1 protein	PMID:24648495
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312500	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of AARS1 protein	PMID:38598786
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C080163	trovafloxacin results in decreased expression of AARS1 mRNA	PMID:35537566
1304832	Aars1	alanyl-tRNA synthetase 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C025643	vinclozolin results in decreased expression of AARS1 mRNA	PMID:23034163
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:135947	bazedoxifene	decreases expression	ISO	RGD:1312502	E	RGD:6480464	20170307	CTD	MESH:C447119	bazedoxifene results in decreased expression of RC3H2 mRNA	PMID:19914376
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of RC3H2 mRNA	PMID:32145629
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312502	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of RC3H2 mRNA	PMID:23019147
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312502	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of RC3H2 mRNA	PMID:27664576
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312502	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RC3H2 mRNA	PMID:28818685
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312503	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RC3H2 mRNA	PMID:19770486
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312502	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RC3H2 gene	PMID:27153756
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312502	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RC3H2 mRNA	PMID:23649840
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312503	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RC3H2 mRNA	PMID:40504410
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312502	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RC3H2 protein	PMID:35688186
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312502	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RC3H2 mRNA	PMID:23557933
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RC3H2 mRNA	PMID:22298810
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312503	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RC3H2 mRNA	PMID:21354282
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312502	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RC3H2 mRNA	PMID:28001369
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312502	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of RC3H2 protein	PMID:35688186
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312503	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RC3H2 mRNA	PMID:40504410
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D008627	Mercuric Chloride results in increased expression of RC3H2 mRNA	PMID:32599119
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RC3H2 mRNA	PMID:34492290
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RC3H2 mRNA	PMID:25181051
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of RC3H2 mRNA	PMID:32145629
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312503	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RC3H2 mRNA	PMID:38685157
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312502	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RC3H2 mRNA	PMID:37042841
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312502	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RC3H2 mRNA	PMID:38568856
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312503	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of RC3H2 mRNA	PMID:18353800
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312502	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RC3H2 mRNA	PMID:31533062
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312502	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RC3H2 mRNA	PMID:23179753|PMID:25979313
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of RC3H2 mRNA	PMID:29427782
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of RC3H2 mRNA	PMID:29427782
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312502	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RC3H2 mRNA	PMID:24935251|PMID:27188386
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:4027	cyclophosphamide	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of RC3H2 mRNA	PMID:27281708
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312502	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of RC3H2 mRNA	PMID:24935251
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RC3H2 mRNA	PMID:33387578
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312503	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of RC3H2 mRNA	PMID:29279043
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312503	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RC3H2 mRNA	PMID:40504410
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1312502	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of RC3H2 mRNA	PMID:20436886
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312502	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RC3H2 protein	PMID:32959892
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312502	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RC3H2 mRNA	PMID:26378955
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312503	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RC3H2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RC3H2 mRNA	PMID:21641980|PMID:26378955
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312503	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RC3H2 mRNA	PMID:23091169
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312503	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of RC3H2 mRNA	PMID:21795629
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312503	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RC3H2 mRNA	PMID:21795629
1304833	Rc3h2	ring finger and CCCH-type domains 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312502	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RC3H2 mRNA	PMID:38568856
1304834	Rtkn2	rhotekin 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RTKN2 mRNA	PMID:38218311
1304834	Rtkn2	rhotekin 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312505	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RTKN2 mRNA	PMID:33045310
1304834	Rtkn2	rhotekin 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RTKN2 mRNA	PMID:33167477
1304834	Rtkn2	rhotekin 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312505	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RTKN2 mRNA	PMID:30529165
1304834	Rtkn2	rhotekin 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RTKN2 mRNA	PMID:26079696
1304834	Rtkn2	rhotekin 2	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1312504	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of RTKN2 mRNA	PMID:39506029
1304834	Rtkn2	rhotekin 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RTKN2 mRNA	PMID:21592394
1304834	Rtkn2	rhotekin 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of RTKN2 mRNA	PMID:21592394
1304834	Rtkn2	rhotekin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RTKN2 mRNA	PMID:32235866
1304834	Rtkn2	rhotekin 2	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of RTKN2 mRNA	PMID:21592394
1304834	Rtkn2	rhotekin 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of RTKN2 mRNA	PMID:21592394
1304834	Rtkn2	rhotekin 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1304834	Rtkn2	rhotekin 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RTKN2 mRNA	PMID:19549813
1304834	Rtkn2	rhotekin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RTKN2 mRNA	PMID:21641981
1304834	Rtkn2	rhotekin 2	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of RTKN2 mRNA	PMID:28623178
1304834	Rtkn2	rhotekin 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of RTKN2 mRNA	PMID:17095637
1304834	Rtkn2	rhotekin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1304834	Rtkn2	rhotekin 2	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312505	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RTKN2 mRNA	PMID:35897073
1304834	Rtkn2	rhotekin 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RTKN2 mRNA	PMID:28960355
1304834	Rtkn2	rhotekin 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RTKN2 mRNA	PMID:31881176
1304834	Rtkn2	rhotekin 2	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1312504	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of RTKN2 promoter	PMID:22847954
1304834	Rtkn2	rhotekin 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312504	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RTKN2 mRNA	PMID:24768652|PMID:25583101
1304834	Rtkn2	rhotekin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RTKN2 mRNA	PMID:32109520
1304834	Rtkn2	rhotekin 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312504	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RTKN2 mRNA	PMID:23179753
1304834	Rtkn2	rhotekin 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312505	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of RTKN2 mRNA	PMID:30807115
1304834	Rtkn2	rhotekin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1304834	Rtkn2	rhotekin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RTKN2 mRNA	PMID:21632981
1304834	Rtkn2	rhotekin 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RTKN2 mRNA	PMID:25895662
1304834	Rtkn2	rhotekin 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RTKN2 mRNA	PMID:23557971
1304834	Rtkn2	rhotekin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312505	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RTKN2 gene	PMID:35295148
1304834	Rtkn2	rhotekin 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312504	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased methylation of RTKN2 promoter	PMID:34973136
1304834	Rtkn2	rhotekin 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312505	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RTKN2 promoter	PMID:35295148
1304834	Rtkn2	rhotekin 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312505	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RTKN2 mRNA	PMID:20813756
1304834	Rtkn2	rhotekin 2	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of RTKN2 mRNA	PMID:30690063
1304834	Rtkn2	rhotekin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RTKN2 mRNA	PMID:25181051|PMID:34947998
1304834	Rtkn2	rhotekin 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RTKN2 gene	PMID:28505145
1304834	Rtkn2	rhotekin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RTKN2 mRNA	PMID:40203079
1304834	Rtkn2	rhotekin 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312504	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RTKN2 intron	PMID:30157460
1304834	Rtkn2	rhotekin 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RTKN2 mRNA	PMID:37019170
1304834	Rtkn2	rhotekin 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of RTKN2 mRNA	PMID:32680482
1304834	Rtkn2	rhotekin 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312504	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RTKN2 mRNA	PMID:37042841
1304834	Rtkn2	rhotekin 2	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of RTKN2 mRNA	PMID:26678675
1304834	Rtkn2	rhotekin 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1304834	Rtkn2	rhotekin 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312504	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RTKN2 mRNA	PMID:38568856
1304834	Rtkn2	rhotekin 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RTKN2 mRNA	PMID:36326898
1304834	Rtkn2	rhotekin 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RTKN2 mRNA	PMID:28302478
1304834	Rtkn2	rhotekin 2	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1312504	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of RTKN2 promoter	PMID:22847954
1304834	Rtkn2	rhotekin 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RTKN2 mRNA	PMID:31533062
1304834	Rtkn2	rhotekin 2	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1312504	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of RTKN2 promoter	PMID:22847954
1304834	Rtkn2	rhotekin 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RTKN2 mRNA	PMID:39529242
1304834	Rtkn2	rhotekin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RTKN2 mRNA	PMID:40419075
1304834	Rtkn2	rhotekin 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RTKN2 mRNA	PMID:23179753|PMID:24935251|PMID:27188386|PMID:28001369
1304834	Rtkn2	rhotekin 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312504	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RTKN2 gene	PMID:29154799
1304834	Rtkn2	rhotekin 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1312504	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of RTKN2 mRNA	PMID:24449571
1304834	Rtkn2	rhotekin 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312504	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RTKN2 mRNA	PMID:38832940
1304834	Rtkn2	rhotekin 2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312504	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RTKN2 mRNA	PMID:28542535
1304834	Rtkn2	rhotekin 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of RTKN2 mRNA	PMID:26272509
1304834	Rtkn2	rhotekin 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RTKN2 mRNA	PMID:27188386
1304834	Rtkn2	rhotekin 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RTKN2 mRNA	PMID:33387578
1304834	Rtkn2	rhotekin 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312504	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RTKN2 mRNA	PMID:22230336
1304834	Rtkn2	rhotekin 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1304834	Rtkn2	rhotekin 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RTKN2 mRNA	PMID:22079256
1304834	Rtkn2	rhotekin 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312505	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of RTKN2 mRNA	PMID:25554681
1304834	Rtkn2	rhotekin 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RTKN2 mRNA	PMID:25554681
1304834	Rtkn2	rhotekin 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1304834	Rtkn2	rhotekin 2	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RTKN2 mRNA	PMID:28988120
1304834	Rtkn2	rhotekin 2	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of RTKN2 mRNA	PMID:26307267
1304834	Rtkn2	rhotekin 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312504	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RTKN2 intron	PMID:30157460
1304834	Rtkn2	rhotekin 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RTKN2 gene	PMID:35440735
1304834	Rtkn2	rhotekin 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RTKN2 mRNA	PMID:22079256|PMID:22714537
1304834	Rtkn2	rhotekin 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RTKN2 mRNA	PMID:22079256
1304834	Rtkn2	rhotekin 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of RTKN2 mRNA	PMID:29522793
1304834	Rtkn2	rhotekin 2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312504	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RTKN2 protein	PMID:31285264
1304834	Rtkn2	rhotekin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RTKN2 mRNA	PMID:27188386
1304834	Rtkn2	rhotekin 2	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of RTKN2 mRNA	PMID:30928695
1304834	Rtkn2	rhotekin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RTKN2 gene]	PMID:28238834
1304834	Rtkn2	rhotekin 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1312504	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of RTKN2 mRNA	PMID:32234424
1304834	Rtkn2	rhotekin 2	gene	CHEBI:85014	2,5-hexanedione	increases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in increased expression of RTKN2 mRNA	PMID:22952946
1304834	Rtkn2	rhotekin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RTKN2 mRNA	PMID:25825206
1304834	Rtkn2	rhotekin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RTKN2 mRNA	PMID:24780913
1304834	Rtkn2	rhotekin 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312504	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RTKN2 mRNA	PMID:27188386
1304834	Rtkn2	rhotekin 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of RTKN2 mRNA	PMID:35537566
1304834	Rtkn2	rhotekin 2	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of RTKN2 gene	PMID:31682807
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1605771	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CALHM6 mRNA	PMID:27188386
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1605771	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of CALHM6 mRNA	PMID:31016361
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1605771	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CALHM6 mRNA	PMID:26516004
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312506	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CALHM6 mRNA	PMID:39241906
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312506	E	RGD:6480464	20180828	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CALHM6 mRNA	PMID:22687549|PMID:27339419
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312506	E	RGD:6480464	20180828	CTD	MESH:D008070	genipin inhibits the reaction [Lipopolysaccharides results in increased expression of CALHM6 mRNA]	PMID:22687549
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312506	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CALHM6 mRNA	PMID:39298647
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM26F mRNA	PMID:32741896
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605771	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of CALHM6 mRNA	PMID:27664576
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1605771	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of CALHM6 mRNA	PMID:21540246
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312506	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CALHM6 mRNA	PMID:37992649
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM26F mRNA	PMID:32741896
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1605771	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of CALHM6 mRNA	PMID:31256213
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312506	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CALHM6 mRNA	PMID:37992649
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1605771	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FAM26F mRNA	PMID:31163220
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of CALHM6 mRNA	PMID:21515302
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312506	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of CALHM6 mRNA	PMID:31919559
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CALHM6 mRNA	PMID:31150632
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312506	E	RGD:6480464	20180828	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CALHM6 mRNA	PMID:27339419
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1605771	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of CALHM6 mRNA	PMID:26272509
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605771	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALHM6 mRNA	PMID:27188386
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CALHM6 mRNA	PMID:31881176
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312506	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of CALHM6 mRNA	PMID:40618947
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1605771	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CALHM6 mRNA	PMID:24768652|PMID:25583101
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312506	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CALHM6 mRNA	PMID:26377647
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CALHM6 mRNA	PMID:34747641
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312506	E	RGD:6480464	20180828	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CALHM6 mRNA	PMID:25975270
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1605771	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CALHM6 mRNA	PMID:30851411
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312506	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of CALHM6 mRNA	PMID:39631538
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312506	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CALHM6 mRNA	PMID:37992649
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605771	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM26F promoter	PMID:27901495
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312506	E	RGD:6480464	20180828	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CALHM6 mRNA; Silicon Dioxide results in increased expression of FAM26F mRNA	PMID:23221170|PMID:29341224
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1605771	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CALHM6 mRNA	PMID:23806026
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of CALHM6 mRNA	PMID:25729387
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of CALHM6 mRNA	PMID:21515302
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312506	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CALHM6 mRNA	PMID:35295148
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312506	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FAM26F gene	PMID:35295148
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CALHM6 mRNA	PMID:25181051
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312506	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of CALHM6 mRNA	PMID:38074096
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312506	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CALHM6 mRNA	PMID:28392331
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605771	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CALHM6 mRNA	PMID:37042841
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of CALHM6 mRNA	PMID:35163327
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1605771	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CALHM6 mRNA	PMID:24449571
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312506	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CALHM6 mRNA	PMID:40194260
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1312506	E	RGD:6480464	20180828	CTD	MESH:D002737	Chloroprene results in decreased expression of CALHM6 mRNA	PMID:23125180
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605771	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CALHM6 mRNA	PMID:23179753|PMID:27188386
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605771	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of CALHM6 mRNA	PMID:28001369
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605771	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in increased methylation of CALHM6 gene	PMID:29154799
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312506	E	RGD:6480464	20180828	CTD	MESH:D017313	Fenretinide results in increased expression of CALHM6 mRNA	PMID:28973697
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312506	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CALHM6 mRNA	PMID:37992649
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CALHM6 mRNA	PMID:29391264
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CALHM6 mRNA	PMID:30307764
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312506	E	RGD:6480464	20180828	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CALHM6 mRNA; Nanotubes, Carbon results in increased expression of CALHM6 mRNA	PMID:25554681
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:5298	Genipin	multiple interactions	ISO	RGD:1312506	E	RGD:6480464	20180828	CTD	MESH:C007834	genipin inhibits the reaction [Lipopolysaccharides results in increased expression of CALHM6 mRNA]	PMID:22687549
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312506	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CALHM6 mRNA	PMID:38701926
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1605771	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of CALHM6 mRNA	PMID:27188386
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of CALHM6 mRNA	PMID:25729387
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1605771	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CALHM6 mRNA	PMID:37199045
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM26F mRNA	PMID:32741896
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1605771	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CALHM6 mRNA	PMID:30851411
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605771	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALHM6 mRNA	PMID:27188386
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312506	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CALHM6 mRNA	PMID:38648751
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312506	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of CALHM6 mRNA	PMID:39847705
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C028577	monobutyl phthalate results in increased expression of CALHM6 mRNA	PMID:29162477
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605771	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALHM6 mRNA	PMID:27188386
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of CALHM6 mRNA	PMID:21515302
1304835	Calhm6	calcium homeostasis modulator family member 6	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312506	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of FAM26F mRNA	PMID:35537566
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332465	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GATD1 mRNA	PMID:33045310
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20161018	CTD	MESH:D014212	Tretinoin results in decreased expression of GATD1 mRNA	PMID:23724009
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20161018	CTD	MESH:D001280	Atrazine results in decreased expression of GATD1 mRNA	PMID:22378314
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1604948	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GATD1 mRNA	PMID:29432896
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332465	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GATD1 mRNA	PMID:39241906
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332465	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of GATD1 mRNA	PMID:39298647
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GATD1 mRNA	PMID:33387578
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604948	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GATD1 mRNA	PMID:37042841
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1604948	E	RGD:6480464	20161018	CTD	MESH:C044887	beta-methylcholine affects the expression of GATD1 mRNA	PMID:21179406
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332465	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PDDC1 mRNA	PMID:34319233
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of GATD1 mRNA	PMID:33387578
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332465	E	RGD:6480464	20200714	CTD	MESH:D002104	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of GATD1 mRNA	PMID:31904401
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1604948	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GATD1 mRNA	PMID:35301059
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of GATD1 mRNA	PMID:23487506
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GATD1 mRNA	PMID:27153756
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332465	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PDDC1 mRNA	PMID:25629700
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332465	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GATD1 mRNA	PMID:22206623
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604948	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GATD1 mRNA	PMID:39836092
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20161018	CTD	MESH:D007854	Lead results in decreased expression of GATD1 mRNA	PMID:19921347
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20181016	CTD	MESH:D002945	Cisplatin results in decreased expression of GATD1 mRNA	PMID:27594783
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332465	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GATD1 mRNA	PMID:21570461
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1604948	E	RGD:6480464	20161018	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GATD1 mRNA	PMID:22298810
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GATD1 mRNA	PMID:33387578
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GATD1 mRNA	PMID:33212167
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of GATD1 mRNA	PMID:32763439
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GATD1 mRNA	PMID:29803840
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GATD1 mRNA	PMID:38568856
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604948	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of GATD1 mRNA	PMID:39719251
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604948	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GATD1 mRNA	PMID:39836092
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GATD1 mRNA	PMID:34492290
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604948	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GATD1 gene	PMID:31601247
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GATD1 mRNA	PMID:25181051
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332465	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GATD1 mRNA	PMID:33221593
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332465	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GATD1 mRNA	PMID:39298647
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1604948	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of GATD1 exon	PMID:30157460
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1604948	E	RGD:6480464	20161018	CTD	MESH:D003976	Diazinon results in increased methylation of GATD1 gene	PMID:22964155
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1332465	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of GATD1 mRNA	PMID:34813904
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1332465	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of GATD1 mRNA	PMID:34813904
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1604948	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PDDC1 mRNA	PMID:38382870
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332465	E	RGD:6480464	20200714	CTD	MESH:D019256	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of GATD1 mRNA	PMID:31904401
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1604948	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GATD1 mRNA	PMID:35301059
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20161018	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GATD1 mRNA	PMID:19320972
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1332465	E	RGD:6480464	20200714	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of GATD1 mRNA	PMID:31904401
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of GATD1 mRNA	PMID:29154799
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604948	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of GATD1 gene	PMID:29154799
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604948	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GATD1 mRNA	PMID:39836092
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of GATD1 mRNA	PMID:29391264
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332465	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GATD1 mRNA	PMID:35964746
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GATD1 protein	PMID:32959892
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1604948	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of GATD1 mRNA	PMID:37939859
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1604948	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of GATD1 exon	PMID:30157460
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332465	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GATD1 mRNA	PMID:22206623
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1332465	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 promotes the reaction [NR1H4 protein binds to GATD1 gene]	PMID:20091679
1304836	Gatd1	glutamine amidotransferase class 1 domain containing 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GATD1 mRNA	PMID:21346803
1304837	Gphra	golgi pH regulator A	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GPHR mRNA	PMID:36331819
1304837	Gphra	golgi pH regulator A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614355	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GPHR mRNA	PMID:39241906
1304837	Gphra	golgi pH regulator A	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of GPHRA protein	PMID:34122009
1304837	Gphra	golgi pH regulator A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GPHR mRNA	PMID:36331819
1304837	Gphra	golgi pH regulator A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPHR mRNA	PMID:37236586
1304837	Gphra	golgi pH regulator A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GPHRA gene	PMID:27153756
1304837	Gphra	golgi pH regulator A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GPHRA mRNA	PMID:23649840
1304837	Gphra	golgi pH regulator A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GPHRA mRNA	PMID:39836092
1304837	Gphra	golgi pH regulator A	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:C059514	Resveratrol results in increased expression of GPHR protein	PMID:25505154
1304837	Gphra	golgi pH regulator A	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:D014414	Tungsten results in increased expression of GPHR mRNA	PMID:30912803
1304837	Gphra	golgi pH regulator A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPHR mRNA	PMID:21570461
1304837	Gphra	golgi pH regulator A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GPHR mRNA	PMID:18796159
1304837	Gphra	golgi pH regulator A	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D012402	Rotenone results in increased expression of GPHRA mRNA	PMID:33512557
1304837	Gphra	golgi pH regulator A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GPHRA mRNA	PMID:33212167
1304837	Gphra	golgi pH regulator A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D020106	Acrylamide results in increased expression of GPHRA mRNA	PMID:32763439
1304837	Gphra	golgi pH regulator A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:C017947	sodium arsenite results in increased expression of GPHRA mRNA	PMID:38568856
1304837	Gphra	golgi pH regulator A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GPHRA mRNA	PMID:39836092
1304837	Gphra	golgi pH regulator A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GPHR mRNA	PMID:22228805
1304837	Gphra	golgi pH regulator A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GPHRA promoter	PMID:27901495
1304837	Gphra	golgi pH regulator A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in decreased expression of GPHR mRNA	PMID:25729387
1304837	Gphra	golgi pH regulator A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GPHR gene	PMID:35295148
1304837	Gphra	golgi pH regulator A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:C009495	titanium dioxide results in increased methylation of GPHR gene	PMID:35295148
1304837	Gphra	golgi pH regulator A	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20260602	CTD	MESH:D013853	Thioacetamide results in decreased expression of GPHR mRNA	PMID:34492290
1304837	Gphra	golgi pH regulator A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:C006780	bisphenol A results in decreased expression of GPHRA mRNA	PMID:27685785
1304837	Gphra	golgi pH regulator A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20260602	CTD	MESH:C006780	bisphenol A results in increased expression of GPHR mRNA	PMID:25181051
1304837	Gphra	golgi pH regulator A	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of GPHR mRNA	PMID:28392331
1304837	Gphra	golgi pH regulator A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GPHRA mRNA	PMID:38174414
1304837	Gphra	golgi pH regulator A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPHR mRNA	PMID:37236586
1304837	Gphra	golgi pH regulator A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GPHR mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GPHR mRNA	PMID:36331819
1304837	Gphra	golgi pH regulator A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1614355	E	RGD:6480464	20251223	CTD	MESH:D014635	Valproic Acid affects the expression of GPHR mRNA	PMID:17292431
1304837	Gphra	golgi pH regulator A	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GPHRA gene	PMID:29154799
1304837	Gphra	golgi pH regulator A	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:C107676	deguelin results in increased expression of GPHRA mRNA	PMID:33512557
1304837	Gphra	golgi pH regulator A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20260602	CTD	MESH:D000082	Acetaminophen results in increased expression of GPHR mRNA	PMID:33387578
1304837	Gphra	golgi pH regulator A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GPHRA mRNA	PMID:39836092
1304837	Gphra	golgi pH regulator A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in decreased expression of GPHR mRNA	PMID:25729387
1304837	Gphra	golgi pH regulator A	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of GPHRA protein	PMID:34122009
1304837	Gphra	golgi pH regulator A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:625785787	E	RGD:6480464	20251223	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GPHRA gene]	PMID:28238834
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312512	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTC34 gene	PMID:20938992
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312512	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTC34 gene	PMID:20938992
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:2293894	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TTC34 mRNA	PMID:37042841
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:2293894	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of TTC34 gene	PMID:33872906
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:2293894	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of TTC34 gene	PMID:33872906
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TTC34 mRNA	PMID:26577399
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:2293894	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TTC34 intron	PMID:30157460
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:2293894	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TTC34 mRNA	PMID:35430440
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312512	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTC34 gene	PMID:20938992
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TTC34 mRNA	PMID:32109520
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:28854	2,4-D	decreases expression	ISO	RGD:2293894	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of TTC34 mRNA	PMID:40294809
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TTC34 mRNA	PMID:19167457
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TTC34 mRNA	PMID:25181051
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312512	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of TTC34 promoter	PMID:27312807
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:2293894	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TTC34 gene	PMID:31601247
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312512	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of TTC34 exon	PMID:33297965
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:2293894	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TTC34 exon	PMID:30157460
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TTC34 mRNA	PMID:33453195
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:2293894	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TTC34 mRNA	PMID:38382870
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312512	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TTC34 mRNA; Nanotubes, Carbon results in decreased expression of TTC34 mRNA	PMID:25554681
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312512	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TTC34 mRNA	PMID:38701926
1304840	Ttc34	tetratricopeptide repeat domain 34	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:2293894	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TTC34 exon	PMID:30157460
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CTDSPL mRNA	PMID:38218311
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CTDSPL mRNA]	PMID:31150632
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312513	E	RGD:6480464	20130806	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CTDSPL mRNA	PMID:20188158
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:144441	triacsin C	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20190903	CTD	MESH:C034613	triacsin C results in decreased expression of CTDSPL mRNA	PMID:16704987
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CTDSPL mRNA	PMID:26079696
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:15843	arachidonic acid	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20161213	CTD	MESH:D016718	Arachidonic Acid results in decreased expression of CTDSPL mRNA	PMID:16704987
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312513	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CTDSPL mRNA	PMID:39241906
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CTDSPL mRNA	PMID:35811015
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1345284	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CTDSPL mRNA	PMID:38568856
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1345284	E	RGD:6480464	20130910	CTD	MESH:D011374	Progesterone results in increased expression of CTDSPL mRNA	PMID:18497975
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1345284	E	RGD:6480464	20130806	CTD	MESH:C044887	beta-methylcholine affects the expression of CTDSPL mRNA	PMID:21179406
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312513	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CTDSPL mRNA	PMID:33754040|PMID:34319233
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1345284	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CTDSPL protein	PMID:37730182
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CTDSPL mRNA	PMID:33387578
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CTDSPL mRNA	PMID:28818685
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1345284	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CTDSPL intron	PMID:30157460
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSPL mRNA	PMID:39836092
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312513	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CTDSPL mRNA	PMID:37236586
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CTDSPL mRNA	PMID:19549813
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312513	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CTDSPL mRNA	PMID:19770486
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1345284	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CTDSPL gene; Aflatoxin B1 results in increased methylation of CTDSPL intron	PMID:27153756|PMID:30157460
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CTDSPL mRNA	PMID:31150632|PMID:33387578
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CTDSPL mRNA]	PMID:31150632
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312513	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CTDSPL mRNA	PMID:25629700
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312513	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTDSPL mRNA	PMID:22206623
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1345284	E	RGD:6480464	20120412	CTD	MESH:D016685	CTDSPL protein affects the susceptibility to Mitomycin	PMID:16217747
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1345284	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CTDSPL gene	PMID:25304211
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSPL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTDSPL mRNA	PMID:39836092
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of CTDSPL gene	PMID:35440735
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1345284	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CTDSPL mRNA	PMID:27392435
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CTDSPL mRNA	PMID:27392435
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CTDSPL mRNA	PMID:24768652|PMID:25583101
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CTDSPL mRNA	PMID:34747641
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312513	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CTDSPL mRNA	PMID:26377647
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CTDSPL mRNA	PMID:33387578
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CTDSPL mRNA	PMID:21632981
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:28659	phosphorus atom	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20120412	CTD	MESH:D010758	[Phosphorus co-treated with paricalcitol] results in decreased expression of CTDSPL mRNA	PMID:17715259
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1345284	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CTDSPL protein	PMID:35688186
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1345284	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of CTDSPL gene	PMID:28589171
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CTDSPL mRNA	PMID:38568856
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSPL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTDSPL mRNA	PMID:39836092
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312513	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CTDSPL mRNA	PMID:19770486
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CTDSPL mRNA	PMID:20064835
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1345284	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CTDSPL promoter	PMID:27901495
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312513	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to CTDSPL promoter]	PMID:19654925
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:30207	phosphorus(.)	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20120412	CTD	MESH:D010758	[Phosphorus co-treated with paricalcitol] results in decreased expression of CTDSPL mRNA	PMID:17715259
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CTDSPL mRNA	PMID:25351596
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CTDSPL mRNA	PMID:25729387
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CTDSPL mRNA	PMID:34492290
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:32497	thioacetamide	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased methylation of CTDSPL promoter	PMID:27914986
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CTDSPL mRNA	PMID:19710929
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312513	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CTDSPL mRNA	PMID:28472532
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1345284	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CTDSPL mRNA	PMID:30903817
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CTDSPL mRNA	PMID:34947998
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1345284	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CTDSPL gene	PMID:31601247
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CTDSPL mRNA	PMID:25181051
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312513	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CTDSPL mRNA	PMID:32156529|PMID:37894381
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CTDSPL gene	PMID:28505145
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1345284	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of CTDSPL mRNA	PMID:19244175
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of CTDSPL mRNA	PMID:23829299
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312513	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CTDSPL mRNA	PMID:39298647
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312513	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CTDSPL exon	PMID:33297965
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312513	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CTDSPL mRNA	PMID:30951980
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1345284	E	RGD:6480464	20240702	CTD	MESH:C008745	bisphenol F results in increased expression of CTDSPL mRNA	PMID:38568856
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CTDSPL mRNA	PMID:28628672
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312513	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CTDSPL mRNA	PMID:28392331
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312513	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CTDSPL intron	PMID:28392331
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CTDSPL mRNA	PMID:28628672
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1345284	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CTDSPL mRNA	PMID:37042841
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSPL mRNA	PMID:39836092
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312513	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CTDSPL mRNA	PMID:37236586
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1345284	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CTDSPL mRNA	PMID:24449571
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1345284	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CTDSPL mRNA	PMID:31533062
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1345284	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CTDSPL mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1345284	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CTDSPL gene	PMID:29154799
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTDSPL mRNA	PMID:27188386
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CTDSPL mRNA	PMID:25562108
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312513	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CTDSPL mRNA	PMID:17555576
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CTDSPL mRNA	PMID:28628672
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312513	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CTDSPL mRNA	PMID:28973697
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CTDSPL mRNA	PMID:38832940
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1345284	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CTDSPL mRNA	PMID:24935251
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTDSPL mRNA	PMID:33387578
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTDSPL mRNA	PMID:21420995
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CTDSPL mRNA	PMID:35811015
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1345284	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CTDSPL gene	PMID:25304211
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSPL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTDSPL mRNA	PMID:39836092
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312513	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of CTDSPL mRNA	PMID:30529165
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312513	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CTDSPL mRNA	PMID:17555576
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312513	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CTDSPL mRNA	PMID:17942748
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CTDSPL mRNA	PMID:28628672
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CTDSPL mRNA	PMID:30307764
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312513	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CTDSPL mRNA; Nanotubes, Carbon results in decreased expression of CTDSPL mRNA	PMID:25554681
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of CTDSPL mRNA	PMID:41580965
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of CTDSPL mRNA	PMID:21983209
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSPL mRNA	PMID:39836092
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CTDSPL mRNA	PMID:25729387
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CTDSPL mRNA	PMID:15336504
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312513	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTDSPL mRNA	PMID:22206623
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CTDSPL mRNA	PMID:22714537
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTDSPL mRNA	PMID:27188386
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:7931	paricalcitol	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20161213	CTD	MESH:C084656	[Phosphorus co-treated with paricalcitol] results in decreased expression of CTDSPL mRNA	PMID:17715259
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CTDSPL gene]	PMID:28238834
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1345284	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of CTDSPL mRNA	PMID:19159669
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of CTDSPL mRNA	PMID:25825206
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1345284	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTDSPL mRNA	PMID:27188386
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CTDSPL mRNA	PMID:19281266
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CTDSPL mRNA	PMID:21346803
1304841	Ctdspl	CTD small phosphatase like	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1345284	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CTDSPL mRNA	PMID:38568856
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1332381	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MTMR14 mRNA	PMID:33045310
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605051	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MTMR14 mRNA	PMID:33167477
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1605051	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MTMR14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MTMR14 mRNA	PMID:32699268
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332381	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MTMR14 mRNA	PMID:39241906
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MTMR14 mRNA	PMID:25510870
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605051	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MTMR14 mRNA	PMID:37042841
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1605051	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of MTMR14 mRNA	PMID:19162166
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332381	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MTMR14 mRNA	PMID:34319233
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1605051	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MTMR14 protein	PMID:37730182
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1605051	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTMR14 mRNA	PMID:39836092
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTMR14 mRNA	PMID:37236586
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MTMR14 mRNA	PMID:25510870
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MTMR14 mRNA	PMID:25510870
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605051	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MTMR14 mRNA	PMID:19549813
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1332381	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MTMR14 mRNA	PMID:19770486
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605051	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MTMR14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MTMR14 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MTMR14 mRNA	PMID:32699268
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1605051	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MTMR14 mRNA	PMID:21867686
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MTMR14 mRNA	PMID:40504410
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605051	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTMR14 mRNA	PMID:39836092
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1605051	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MTMR14 protein	PMID:35688186
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MTMR14 mRNA	PMID:31881176
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1605051	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MTMR14 mRNA	PMID:19921347
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332381	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MTMR14 mRNA	PMID:21570461|PMID:24680724
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MTMR14 mRNA	PMID:21215274
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1605051	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MTMR14 mRNA	PMID:29704546
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1332381	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of MTMR14 mRNA	PMID:30807115
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1332381	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of MTMR14 mRNA	PMID:27862939
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1332381	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of MTMR14 mRNA	PMID:39631538
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605051	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MTMR14 mRNA	PMID:38568856
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MTMR14 mRNA	PMID:40504410
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605051	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTMR14 mRNA	PMID:39836092
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332381	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MTMR14 mRNA	PMID:22228805
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605051	E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MTMR14 protein	PMID:32717239
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332381	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MTMR14 gene	PMID:35295148
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MTMR14 mRNA	PMID:34492290
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of MTMR14 mRNA	PMID:19167457
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MTMR14 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605051	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MTMR14 protein	PMID:32981897
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1605051	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MTMR14 mRNA	PMID:25047013
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MTMR14 mRNA	PMID:25510870
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MTMR14 mRNA	PMID:25510870
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1332381	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MTMR14 gene	PMID:31683443
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MTMR14 mRNA	PMID:21266533
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605051	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MTMR14 mRNA	PMID:37042841
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1605051	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTMR14 mRNA	PMID:39836092
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTMR14 mRNA	PMID:37236586
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1605051	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MTMR14 mRNA	PMID:24449571
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1605051	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MTMR14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MTMR14 mRNA	PMID:32699268
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1332381	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of MTMR14 mRNA	PMID:23811191
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332381	E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid affects the expression of MTMR14 mRNA	PMID:17292431|PMID:17963808
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605051	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MTMR14 gene	PMID:29154799
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MTMR14 mRNA	PMID:40504410
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605051	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTMR14 mRNA	PMID:39836092
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of MTMR14 mRNA	PMID:31464424
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1605051	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of MTMR14 mRNA	PMID:40706910
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332381	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MTMR14 mRNA	PMID:35964746
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1332381	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MTMR14 mRNA	PMID:19042947
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1605051	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTMR14 mRNA	PMID:39836092
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1605051	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MTMR14 mRNA	PMID:37199045
1304842	Mtmr14	myotubularin related protein 14	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1332381	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of MTMR14 protein	PMID:24648495
1304843	Vill	villin-like	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1551799	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of VILL mRNA	PMID:33045310
1304843	Vill	villin-like	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1347824	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of VILL mRNA	PMID:25812627
1304843	Vill	villin-like	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1551799	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of VILL mRNA	PMID:37995155
1304843	Vill	villin-like	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VILL mRNA]	PMID:31150632
1304843	Vill	villin-like	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1347824	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of VILL protein	PMID:36641056
1304843	Vill	villin-like	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551799	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VILL mRNA	PMID:20938992
1304843	Vill	villin-like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1347824	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of VILL mRNA	PMID:33167477
1304843	Vill	villin-like	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1347824	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of VILL mRNA	PMID:26079696
1304843	Vill	villin-like	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551799	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of VILL mRNA	PMID:39241906
1304843	Vill	villin-like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551799	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of VILL mRNA	PMID:39298647
1304843	Vill	villin-like	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of VILL mRNA	PMID:32145629
1304843	Vill	villin-like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1347824	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of VILL mRNA	PMID:30165855
1304843	Vill	villin-like	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551799	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VILL mRNA	PMID:20938992
1304843	Vill	villin-like	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1347824	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of VILL mRNA	PMID:26079696
1304843	Vill	villin-like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551799	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VILL mRNA	PMID:37992649
1304843	Vill	villin-like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551799	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VILL mRNA	PMID:37992649
1304843	Vill	villin-like	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of VILL mRNA	PMID:33387578
1304843	Vill	villin-like	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1347824	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of VILL mRNA	PMID:28818685
1304843	Vill	villin-like	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of VILL protein	PMID:34915118
1304843	Vill	villin-like	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1551799	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of VILL mRNA	PMID:24067728
1304843	Vill	villin-like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1347824	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VILL mRNA	PMID:19549813
1304843	Vill	villin-like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551799	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of VILL mRNA	PMID:34911549
1304843	Vill	villin-like	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of VILL mRNA	PMID:31150632
1304843	Vill	villin-like	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VILL mRNA]	PMID:31150632
1304843	Vill	villin-like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551799	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VILL mRNA	PMID:20938992
1304843	Vill	villin-like	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1347824	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VILL mRNA	PMID:19244175
1304843	Vill	villin-like	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1551799	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of VILL mRNA	PMID:28960355
1304843	Vill	villin-like	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of VILL mRNA	PMID:31881176
1304843	Vill	villin-like	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1347824	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of VILL mRNA	PMID:27594783
1304843	Vill	villin-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VILL mRNA	PMID:22298810|PMID:32109520
1304843	Vill	villin-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VILL mRNA	PMID:21215274
1304843	Vill	villin-like	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1347824	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of VILL mRNA	PMID:33212167
1304843	Vill	villin-like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551799	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VILL mRNA	PMID:37992649
1304843	Vill	villin-like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1347824	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of VILL promoter	PMID:27901495
1304843	Vill	villin-like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of VILL mRNA	PMID:21839799
1304843	Vill	villin-like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347824	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of VILL 3' UTR	PMID:27901495
1304843	Vill	villin-like	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1347824	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of VILL promoter	PMID:23974009
1304843	Vill	villin-like	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1347824	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of VILL mRNA	PMID:25895662
1304843	Vill	villin-like	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1347824	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of VILL gene	PMID:31601247
1304843	Vill	villin-like	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1347824	E	RGD:6480464	20180828	CTD	MESH:C015358	methylparaben results in increased expression of VILL mRNA	PMID:17121429
1304843	Vill	villin-like	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1551799	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of VILL mRNA	PMID:23557971
1304843	Vill	villin-like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1551799	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of VILL mRNA	PMID:27760801
1304843	Vill	villin-like	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of VILL mRNA	PMID:23411599|PMID:34492290
1304843	Vill	villin-like	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1551799	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of VILL mRNA	PMID:19710929
1304843	Vill	villin-like	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of VILL mRNA	PMID:19167457
1304843	Vill	villin-like	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of VILL mRNA	PMID:25181051
1304843	Vill	villin-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of VILL mRNA	PMID:32145629
1304843	Vill	villin-like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551799	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of VILL mRNA	PMID:30951980
1304843	Vill	villin-like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347824	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of VILL gene	PMID:31601247
1304843	Vill	villin-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1551799	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of VILL gene	PMID:31683443
1304843	Vill	villin-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551799	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of VILL mRNA	PMID:30951980
1304843	Vill	villin-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1551799	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of VILL exon	PMID:33297965
1304843	Vill	villin-like	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551799	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of VILL mRNA	PMID:30951980
1304843	Vill	villin-like	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of VILL mRNA	PMID:35163327
1304843	Vill	villin-like	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1347824	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of VILL mRNA	PMID:25812627
1304843	Vill	villin-like	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1347824	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VILL mRNA	PMID:19244175
1304843	Vill	villin-like	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1347824	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of VILL mRNA	PMID:25812627
1304843	Vill	villin-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1347824	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of VILL mRNA	PMID:25812627
1304843	Vill	villin-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1347824	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of VILL mRNA	PMID:40419075
1304843	Vill	villin-like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1347824	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of VILL gene	PMID:29154799
1304843	Vill	villin-like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551799	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VILL mRNA	PMID:37992649
1304843	Vill	villin-like	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1347824	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of VILL mRNA	PMID:38832940
1304843	Vill	villin-like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551799	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of VILL mRNA	PMID:17562736
1304843	Vill	villin-like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of VILL mRNA	PMID:33387578
1304843	Vill	villin-like	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1551799	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of VILL mRNA	PMID:30529165
1304843	Vill	villin-like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551799	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of VILL mRNA; Nanotubes, Carbon results in increased expression of VILL mRNA	PMID:25554681|PMID:25620056
1304843	Vill	villin-like	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1551799	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of VILL protein	PMID:35926579
1304843	Vill	villin-like	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551799	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VILL mRNA	PMID:22206623
1304843	Vill	villin-like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of VILL mRNA	PMID:24780913
1304843	Vill	villin-like	gene	CHEBI:88542	Butylparaben	increases expression	ISO	RGD:1347824	E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of VILL mRNA	PMID:17121429
1304843	Vill	villin-like	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of VILL mRNA	PMID:21346803
1304843	Vill	villin-like	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1347824	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of VILL mRNA	PMID:29301935
1304843	Vill	villin-like	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of VILL mRNA	PMID:21346803
1304843	Vill	villin-like	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of VILL mRNA	PMID:19015723
1304845	Ercc4l1	excision repair cross-complementing rodent repair deficiency, complementation group 4-like 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C016517	indole-3-carbinol affects the expression of ERCC4L1 mRNA	PMID:21396975
1304845	Ercc4l1	excision repair cross-complementing rodent repair deficiency, complementation group 4-like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of ERCC4L1 mRNA	PMID:41034487
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1605392	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AMZ2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AMZ2 mRNA	PMID:32699268
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312519	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of AMZ2 mRNA	PMID:30319688
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312519	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of AMZ2 mRNA	PMID:33754040
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of AMZ2 promoter	PMID:23359474
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312519	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AMZ2 mRNA	PMID:36331819
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605392	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AMZ2 mRNA	PMID:19549813
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1605392	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of AMZ2 mRNA	PMID:23649840
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1605392	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AMZ2 mRNA	PMID:21641981|PMID:22100608|PMID:27153756
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605392	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of AMZ2 mRNA	PMID:23649840
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605392	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AMZ2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AMZ2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of AMZ2 mRNA	PMID:32699268
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AMZ2 mRNA	PMID:31150632
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312519	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AMZ2 mRNA	PMID:22206623
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1605392	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of AMZ2 mRNA	PMID:27392435
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605392	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AMZ2 mRNA	PMID:27392435
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312519	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AMZ2 mRNA	PMID:21570461
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1605392	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of AMZ2 mRNA	PMID:33512557
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605392	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AMZ2 mRNA	PMID:38568856
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605392	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AMZ2 intron	PMID:30157460
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605392	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to AMZ2 mRNA]	PMID:32406909
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312519	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AMZ2 gene	PMID:35295148
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AMZ2 mRNA	PMID:34492290
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312519	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of AMZ2 mRNA	PMID:23811191
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AMZ2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1605392	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of AMZ2 mRNA	PMID:36232920
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of AMZ2 promoter	PMID:23359474
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1605392	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of AMZ2 intron	PMID:30157460
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1605392	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of AMZ2 gene	PMID:22964155
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of AMZ2 promoter	PMID:23359474
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605392	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AMZ2 mRNA	PMID:38568856
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1605392	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AMZ2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AMZ2 mRNA	PMID:32699268
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312519	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AMZ2 mRNA	PMID:36331819
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605392	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AMZ2 mRNA	PMID:25979313
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605392	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of AMZ2 mRNA	PMID:23179753
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605392	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AMZ2 mRNA	PMID:25562108
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605392	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of AMZ2 mRNA	PMID:20106945
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1605392	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of AMZ2 mRNA	PMID:33512557
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312519	E	RGD:6480464	20120522	CTD	MESH:D013629	Tamoxifen affects the expression of AMZ2 mRNA	PMID:17555576
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312519	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of AMZ2 mRNA	PMID:17562736
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605392	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of AMZ2 mRNA	PMID:22230336
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312519	E	RGD:6480464	20120522	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of AMZ2 mRNA	PMID:17555576
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312519	E	RGD:6480464	20120522	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AMZ2 mRNA	PMID:17942748
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312519	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of AMZ2 mRNA	PMID:25554681
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of AMZ2 mRNA	PMID:24136188
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of AMZ2 mRNA	PMID:34044035
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of AMZ2 mRNA	PMID:24136188
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of AMZ2 mRNA	PMID:24136188
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of AMZ2 mRNA	PMID:30467583
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1605392	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of AMZ2 intron	PMID:30157460
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312519	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AMZ2 mRNA	PMID:22206623
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605392	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AMZ2 gene]	PMID:28238834
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of AMZ2 mRNA	PMID:19281266
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of AMZ2 mRNA	PMID:24136188
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1605392	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AMZ2 mRNA	PMID:38568856
1304846	Amz2	archaelysin family metallopeptidase 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of AMZ2 mRNA	PMID:20566332
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550044	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZFP444 mRNA	PMID:33045310
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ZFP444 mRNA	PMID:30071829
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550044	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP444 gene	PMID:20938992
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP444 mRNA	PMID:39241906
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312520	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ZNF444 mRNA	PMID:31614463
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312520	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ZNF444 mRNA	PMID:38568856
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550044	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP444 gene	PMID:20938992
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312520	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF444 mRNA	PMID:37042841
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312520	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF444 protein	PMID:37730182
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP444 mRNA	PMID:33387578
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312520	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZNF444 mRNA	PMID:28818685
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312520	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZNF444 gene	PMID:27153756
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550044	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP444 gene	PMID:20938992
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312520	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF444 gene	PMID:25304211
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312520	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ZNF444 mRNA	PMID:23557933
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP444 mRNA	PMID:19770486
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP444 mRNA	PMID:33387578
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:28794	coumarin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of ZFP444 mRNA	PMID:18480146
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312520	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF444 mRNA	PMID:38568856|PMID:39719251
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZFP444 mRNA	PMID:21839799
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312520	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZNF444 mRNA	PMID:32234424
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZFP444 mRNA	PMID:19770486|PMID:27195522
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1550044	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of ZFP444 gene	PMID:35295148
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550044	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of ZFP444 mRNA	PMID:29264374
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFP444 mRNA	PMID:34492290
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZFP444 mRNA	PMID:20813756
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of ZFP444 mRNA	PMID:22484513
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1550044	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ZFP444 promoter	PMID:27334623
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF444 mRNA	PMID:25181051
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP444 mRNA	PMID:34947998
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550044	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP444 mRNA	PMID:33221593
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of ZNF444 mRNA	PMID:23829299
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550044	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZFP444 gene	PMID:31683443
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZFP444 mRNA	PMID:39298647
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550044	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ZFP444 mRNA	PMID:37019170
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1550044	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ZFP444 mRNA	PMID:34813904
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312520	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNF444 mRNA	PMID:38174414|PMID:38568856
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ZFP444 mRNA	PMID:17585979
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312520	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ZNF444 mRNA	PMID:31533062
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312520	E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF444 mRNA	PMID:22083351
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZFP444 mRNA	PMID:21427059
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312520	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF444 gene	PMID:29154799
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1550044	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ZFP444 mRNA	PMID:21427059
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312520	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZNF444 mRNA	PMID:20106945
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZFP444 mRNA	PMID:19770486
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ZNF444 mRNA	PMID:28973697
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312520	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ZNF444 mRNA	PMID:38832940
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312520	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZNF444 mRNA	PMID:22230336|PMID:29067470
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312520	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF444 gene	PMID:25304211
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550044	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP444 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP444 mRNA	PMID:21641980|PMID:26378955
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ZFP444 mRNA	PMID:27840820
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1312520	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of ZNF444 mRNA	PMID:19946333
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1312520	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of ZNF444 mRNA]	PMID:19946333
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ZFP444 mRNA	PMID:21346803
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312520	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF444 mRNA	PMID:38568856
1304847	Zfp444	zinc finger protein 444	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZFP444 mRNA	PMID:21346803
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1604284	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of TRAF3IP3 mRNA	PMID:35967413
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1618179	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TRAF3IP3 mRNA	PMID:37995155
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1604284	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TRAF3IP3 mRNA	PMID:24763279
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1604284	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TRAF3IP3 mRNA	PMID:35811015
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1618179	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TRAF3IP3 mRNA	PMID:39241906
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1604284	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRAF3IP3 mRNA	PMID:35811015
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TRAF3IP3 mRNA	PMID:32741896
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TRAF3IP3 gene	PMID:27618143
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TRAF3IP3 mRNA	PMID:37992649
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TRAF3IP3 mRNA	PMID:32741896
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TRAF3IP3 mRNA	PMID:37992649
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TRAF3IP3 mRNA	PMID:33387578
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1604284	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRAF3IP3 mRNA	PMID:35301059
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAF3IP3 mRNA	PMID:37236586
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604284	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TRAF3IP3 gene	PMID:27153756
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1604284	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TRAF3IP3 mRNA	PMID:23649840
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TRAF3IP3 mRNA	PMID:34911549
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TRAF3IP3 mRNA	PMID:30779732
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604284	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRAF3IP3 gene	PMID:25304211
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TRAF3IP3 mRNA	PMID:31881176
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1618179	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TRAF3IP3 mRNA	PMID:30912803
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1604284	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of TRAF3IP3 mRNA	PMID:23195993
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1604284	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TRAF3IP3 mRNA	PMID:25583101
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRAF3IP3 mRNA	PMID:34747641
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1604284	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of TRAF3IP3 mRNA	PMID:23649840
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TRAF3IP3 mRNA	PMID:37992649
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604284	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRAF3IP3 mRNA	PMID:39719251
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604284	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TRAF3IP3 mRNA	PMID:38568856
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF3IP3 mRNA	PMID:34876320
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF3IP3 mRNA	PMID:34876320
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604284	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRAF3IP3 mRNA	PMID:20064835
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1618179	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRAF3IP3 mRNA	PMID:21569818
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604284	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRAF3IP3 5' UTR; Benzo(a)pyrene results in increased methylation of TRAF3IP3 exon; Benzo(a)pyrene results in increased methylation of TRAF3IP3 promoter	PMID:27901495
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRAF3IP3 mRNA	PMID:27858113
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1604284	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TRAF3IP3 mRNA	PMID:25351596
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of TRAF3IP3 mRNA	PMID:24915197
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1618179	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of TRAF3IP3 mRNA	PMID:27760801
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1618179	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TRAF3IP3 mRNA	PMID:23557971|PMID:35295148
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TRAF3IP3 mRNA	PMID:34492290
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TRAF3IP3 mRNA	PMID:25181051
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1618179	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TRAF3IP3 mRNA	PMID:32156529|PMID:38701888
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1618179	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of TRAF3IP3 mRNA	PMID:33297965
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1618179	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TRAF3IP3 mRNA	PMID:26377693
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRAF3IP3 mRNA	PMID:27858113
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604284	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRAF3IP3 mRNA	PMID:37042841
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of TRAF3IP3 mRNA	PMID:35163327
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1604284	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TRAF3IP3 mRNA	PMID:38568856
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1604284	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRAF3IP3 mRNA	PMID:35301059
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAF3IP3 mRNA	PMID:37236586
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1604284	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TRAF3IP3 mRNA	PMID:24449571
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1618179	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of TRAF3IP3 mRNA	PMID:29038090
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1618179	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of TRAF3IP3 mRNA	PMID:23125180
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TRAF3IP3 mRNA	PMID:37992649
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1604284	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TRAF3IP3 mRNA	PMID:38832940
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604284	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of TRAF3IP3 mRNA	PMID:26690555
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1604284	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRAF3IP3 mRNA	PMID:35811015
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1604284	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of TRAF3IP3 mRNA	PMID:25351596
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604284	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRAF3IP3 gene	PMID:25304211
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:47381	diclofenac	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D004008	Diclofenac results in increased expression of TRAF3IP3 mRNA	PMID:30723492
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF3IP3 mRNA	PMID:34876320
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1618179	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TRAF3IP3 mRNA; Nanotubes, Carbon results in decreased expression of TRAF3IP3 mRNA	PMID:25554681
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1618179	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of TRAF3IP3 mRNA	PMID:40234311
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TRAF3IP3 mRNA	PMID:35964746
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRAF3IP3 mRNA	PMID:27858113
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRAF3IP3 mRNA	PMID:27858113
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1618179	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TRAF3IP3 mRNA	PMID:38701926
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1604284	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of TRAF3IP3 mRNA	PMID:20436886
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1618179	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TRAF3IP3 mRNA	PMID:22206623
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TRAF3IP3 mRNA	PMID:32741896
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604284	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRAF3IP3 gene]	PMID:28238834
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1618179	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of TRAF3IP3 mRNA	PMID:39847705
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1618179	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF3IP3 mRNA	PMID:34876320
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1604284	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TRAF3IP3 mRNA	PMID:38568856
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1604284	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TRAF3IP3 mRNA	PMID:29301935
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1618179	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TRAF3IP3 mRNA	PMID:35537566
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of TRAF3IP3 mRNA	PMID:23034163
1304848	Traf3ip3	TRAF3 interacting protein 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TRAF3IP3 mRNA	PMID:23034163
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312522	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of ATAD2 protein	PMID:39638853
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ATAD2 mRNA	PMID:38218311
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:110423	clodronic acid	increases expression	ISO	RGD:1312522	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in increased expression of ATAD2 mRNA	PMID:25596134
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of ATAD2 mRNA	PMID:16249480|PMID:33167477
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ATAD2 mRNA	PMID:25596134
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of ATAD2 mRNA	PMID:29018328
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312522	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ATAD2 mRNA	PMID:29581250
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312523	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATAD2 mRNA	PMID:39241906
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ATAD2 mRNA	PMID:30510588
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312522	E	RGD:6480464	20130212	CTD	MESH:D004958	Estradiol results in increased expression of ATAD2 mRNA	PMID:16474171|PMID:18310284|PMID:19167446
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of ATAD2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA	PMID:17404688|PMID:20660070
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312522	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ATAD2 mRNA	PMID:38568856
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of ATAD2 gene	PMID:27618143
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312522	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of ATAD2 mRNA	PMID:17404688
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20120412	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of ATAD2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA	PMID:17404688|PMID:20660070
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312522	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ATAD2 mRNA	PMID:21179406
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:17270	glycerol 2-phosphate	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20151215	CTD	MESH:C031463	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA	PMID:26424790
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ATAD2 mRNA	PMID:33754040
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ATAD2 mRNA	PMID:27523638
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312522	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ATAD2 protein	PMID:37730182
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ATAD2 mRNA	PMID:22061828
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ATAD2 mRNA	PMID:28818685
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ATAD2 mRNA	PMID:19549813
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ATAD2 mRNA	PMID:21396975
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312522	E	RGD:6480464	20250603	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ATAD2 protein	PMID:39638853
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312522	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATAD2 mRNA	PMID:23649840
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312523	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ATAD2 mRNA	PMID:32553695
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATAD2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ATAD2 mRNA	PMID:34911549
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312523	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATAD2 mRNA	PMID:27339419|PMID:31919559
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312522	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATAD2 gene	PMID:25304211
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312522	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ATAD2 protein	PMID:35688186
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ATAD2 mRNA	PMID:31881176
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27871	chloroacetaldehyde	affects expression	ISO	RGD:1312522	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde affects the expression of ATAD2 mRNA	PMID:25596134
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312522	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in increased expression of ATAD2 mRNA	PMID:19167446
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of ATAD2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of ATAD2 mRNA	PMID:19167446|PMID:23557933
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ATAD2 mRNA	PMID:22023808
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ATAD2 mRNA	PMID:27392435
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27899	cisplatin	decreases phosphorylation	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased phosphorylation of ATAD2 protein	PMID:22006019
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312522	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of ATAD2 mRNA	PMID:25596134|PMID:27594783
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ATAD2 mRNA	PMID:27392435
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ATAD2 mRNA	PMID:30912803
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312522	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of ATAD2 mRNA	PMID:16474171
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312522	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ATAD2 mRNA	PMID:25583101
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312522	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATAD2 mRNA	PMID:22574217
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312523	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATAD2 mRNA	PMID:21570461|PMID:24680724
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATAD2 mRNA	PMID:32109520
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATAD2 mRNA	PMID:20106945|PMID:21632981|PMID:21802500
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATAD2 mRNA	PMID:34747641
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ATAD2 mRNA	PMID:25975270
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312522	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ATAD2 mRNA	PMID:28001369
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of ATAD2 mRNA	PMID:23649840
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ATAD2 mRNA	PMID:20971185
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATAD2 mRNA	PMID:29803840
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312522	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ATAD2 protein	PMID:35688186
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20151215	CTD	MESH:D001205	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA	PMID:26424790
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of ATAD2 mRNA	PMID:22623647
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATAD2 mRNA	PMID:29301061
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312522	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ATAD2 mRNA	PMID:34032870
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATAD2 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:21802500
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATAD2 mRNA	PMID:19770486
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATAD2 mRNA	PMID:20713471
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20201006	CTD	MESH:D001564	[Benzo(a)pyrene results in increased activity of AHR protein] which results in decreased expression of ATAD2 mRNA	PMID:32553695
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ATAD2 mRNA]	PMID:32406909
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ATAD2 mRNA	PMID:20971185
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ATAD2 mRNA	PMID:23806026
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATAD2 mRNA	PMID:19150397|PMID:20382639
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312522	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ATAD2 mRNA	PMID:26238291
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312522	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATAD2 mRNA	PMID:29266867
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20191114	CTD	MESH:C006632	[Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of ATAD2 mRNA	PMID:29266867
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:31175	adefovir pivoxil	increases expression	ISO	RGD:1312522	E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of ATAD2 mRNA	PMID:25596134
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATAD2 gene	PMID:31601247
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1312522	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of ATAD2 mRNA	PMID:38568856
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ATAD2 mRNA	PMID:25729387
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ATAD2 mRNA	PMID:25729387
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312523	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATAD2 promoter alternative form	PMID:35295148
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312523	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ATAD2 gene	PMID:35295148
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ATAD2 mRNA	PMID:34492290
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATAD2 mRNA	PMID:19710929
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312523	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ATAD2 mRNA	PMID:28472532
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ATAD2 mRNA	PMID:38479592
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312522	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ATAD2 mRNA	PMID:30903817
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATAD2 mRNA	PMID:25181051
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ATAD2 mRNA	PMID:29275510
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ATAD2 mRNA	PMID:26063408
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ATAD2 mRNA	PMID:32145629
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312522	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ATAD2 mRNA	PMID:16474171
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of ATAD2 protein; [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATAD2 gene	PMID:31601247|PMID:33376534
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312523	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of ATAD2 mRNA	PMID:26682919
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of ATAD2 mRNA	PMID:20713471
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ATAD2 mRNA	PMID:39298647|PMID:40203079
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ATAD2 mRNA	PMID:37019170
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ATAD2 mRNA	PMID:17361019|PMID:21266533
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of ATAD2 mRNA	PMID:36117858
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ATAD2 gene	PMID:33148267
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312522	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATAD2 mRNA	PMID:37042841
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of ATAD2 mRNA	PMID:18500788
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1312522	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride affects the expression of ATAD2 mRNA	PMID:25596134
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ATAD2 protein	PMID:26879310
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ATAD2 mRNA	PMID:19376846
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:3696	cidofovir anhydrous	increases expression	ISO	RGD:1312522	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of ATAD2 mRNA	PMID:25596134
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ATAD2 mRNA	PMID:32588087
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ATAD2 mRNA	PMID:40194260
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ATAD2 mRNA	PMID:28302478
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ATAD2 mRNA	PMID:31533062
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312522	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ATAD2 mRNA	PMID:19167446
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ATAD2 mRNA	PMID:19167446
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ATAD2 mRNA	PMID:39529242
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ATAD2 mRNA	PMID:40419075
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ATAD2 mRNA	PMID:17292431
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATAD2 mRNA	PMID:27188386
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATAD2 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20151215	CTD	MESH:D003907	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA	PMID:26424790
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312523	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ATAD2 mRNA	PMID:28973697
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of ATAD2 mRNA	PMID:23649840
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312522	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ATAD2 mRNA	PMID:38832940
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ATAD2 mRNA	PMID:26272509
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA	PMID:27188386
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ATAD2 mRNA	PMID:33387578
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312522	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ATAD2 mRNA	PMID:22230336
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312522	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATAD2 gene	PMID:25304211
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1312522	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of ATAD2 mRNA	PMID:36621641
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312522	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATAD2 mRNA	PMID:29266867
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20191114	CTD	MESH:C032793	[Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of ATAD2 mRNA	PMID:29266867
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of ATAD2 mRNA	PMID:21148553
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of ATAD2 mRNA	PMID:36117858
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312523	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ATAD2 mRNA	PMID:19042947
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ATAD2 protein	PMID:32959892
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATAD2 mRNA	PMID:21641980
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ATAD2 mRNA	PMID:25729387
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ATAD2 mRNA	PMID:15336504
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ATAD2 mRNA	PMID:37269647
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ATAD2 mRNA	PMID:24810058
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312523	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ATAD2 mRNA	PMID:20003209
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of ATAD2 mRNA	PMID:35283115
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ATAD2 gene	PMID:33148267
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of ATAD2 mRNA	PMID:29522793
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312522	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ATAD2 mRNA	PMID:37199045
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of ATAD2 mRNA	PMID:28960945
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312522	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ATAD2 protein	PMID:31285264
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:76989	phytoestrogen	increases expression	ISO	RGD:1312522	E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of ATAD2 mRNA	PMID:18310284
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA	PMID:27188386
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATAD2 gene]	PMID:28238834
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312523	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ATAD2 mRNA	PMID:23091169
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ATAD2 mRNA	PMID:19482888
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ATAD2 mRNA]	PMID:19482888
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:81555	Enterolactone	increases expression	ISO	RGD:1312522	E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ATAD2 mRNA	PMID:19167446
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA	PMID:19167446
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of ATAD2 mRNA	PMID:21858171
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of ATAD2 mRNA	PMID:24780913
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATAD2 mRNA	PMID:25825206
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of ATAD2 mRNA	PMID:32419051
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312522	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA	PMID:27188386
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:9111	Senkirkine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of ATAD2 mRNA	PMID:32419051
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312522	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of ATAD2 mRNA	PMID:22378314
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312523	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of ATAD2 protein	PMID:24648495
1304849	Atad2	ATPase family, AAA domain containing 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ATAD2 mRNA	PMID:23034163
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312524	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of SMARCC1 protein	PMID:39638853
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SMARCC1 mRNA	PMID:33045310
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SMARCC1 mRNA	PMID:26251327
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of SMARCC1 mRNA	PMID:15498508|PMID:33167477
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312524	E	RGD:6480464	20141014	CTD	MESH:D014212	Tretinoin results in increased expression of SMARCC1 mRNA	PMID:22906706
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312525	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SMARCC1 mRNA	PMID:30319688
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312525	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SMARCC1 mRNA	PMID:39298647
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312524	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SMARCC1 mRNA	PMID:38568856
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SMARCC1 mRNA	PMID:33387578
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312524	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SMARCC1 mRNA	PMID:37042841
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312525	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SMARCC1 mRNA	PMID:23892564
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SMARCC1 mRNA	PMID:33754040
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312524	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SMARCC1 protein	PMID:37730182
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SMARCC1 mRNA	PMID:33387578
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312524	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SMARCC1 protein	PMID:23301498
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	ISO	RGD:1312524	E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of SMARCC1 protein	PMID:19845377
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SMARCC1 mRNA	PMID:30779732
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1312524	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of SMARCC1 mRNA	PMID:15672453
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1312524	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of SMARCC1 mRNA	PMID:18414638
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312525	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCC1 mRNA	PMID:40504410
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SMARCC1 mRNA	PMID:19244175
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312524	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of SMARCC1 mRNA	PMID:19244175
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27690	acetazolamide	increases expression	ISO	RGD:1312525	E	RGD:6480464	20120717	CTD	MESH:D000086	Acetazolamide results in increased expression of SMARCC1 mRNA	PMID:19274763
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312524	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SMARCC1 protein	PMID:35688186
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of SMARCC1 protein	PMID:37208198
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312524	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SMARCC1 mRNA	PMID:28903495
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of SMARCC1 mRNA	PMID:27594783
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SMARCC1 mRNA	PMID:30912803
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312525	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMARCC1 mRNA	PMID:21570461
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMARCC1 mRNA	PMID:33387578
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312525	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCC1 mRNA	PMID:17942748
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMARCC1 mRNA	PMID:33212167
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312524	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SMARCC1 mRNA	PMID:39709020
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SMARCC1 mRNA	PMID:28959563
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312525	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SMARCC1 protein	PMID:28918527
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312524	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SMARCC1 protein	PMID:35688186
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312525	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCC1 mRNA	PMID:40504410
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMARCC1 mRNA	PMID:20064835
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMARCC1 mRNA	PMID:19770486
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:30621	diarsenic trioxide	increases response to substance	ISO	RGD:1312524	E	RGD:6480464	20191114	CTD	MESH:C006632	SMARCC1 protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:31638	fulvestrant	increases expression	ISO	RGD:1312524	E	RGD:6480464	20150414	CTD	MESH:C070081	fulvestrant results in increased expression of SMARCC1 protein	PMID:24169358
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMARCC1 mRNA	PMID:25729387
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:32181	tamibarotene	affects expression	ISO	RGD:1312524	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of SMARCC1 mRNA	PMID:15498508
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1312525	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of SMARCC1 promoter	PMID:35295148
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SMARCC1 mRNA	PMID:33221593
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SMARCC1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SMARCC1 gene	PMID:28505145
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SMARCC1 mRNA	PMID:19244175
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1312524	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of SMARCC1 mRNA	PMID:19244175
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of SMARCC1 mRNA	PMID:23829299
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312524	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of SMARCC1 gene	PMID:31601247
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312525	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SMARCC1 mRNA	PMID:38685157
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SMARCC1 mRNA	PMID:28392331
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMARCC1 mRNA	PMID:37019170
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SMARCC1 mRNA	PMID:21266533
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312524	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SMARCC1 mRNA	PMID:37042841
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SMARCC1 mRNA	PMID:19320972|PMID:19376846
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1312524	E	RGD:6480464	20190611	CTD	MESH:C018021	cobaltous chloride promotes the reaction [TP53 protein mutant form binds to SMARCC1 protein]	PMID:30381462
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SMARCC1 mRNA	PMID:25380136
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SMARCC1 mRNA	PMID:19244175
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312524	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of SMARCC1 mRNA	PMID:19244175
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312524	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SMARCC1 mRNA	PMID:25979313
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCC1 mRNA	PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCC1 mRNA	PMID:19136453
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312524	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SMARCC1 mRNA	PMID:17183730
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1312524	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SMARCC1 mRNA	PMID:33512557
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312525	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SMARCC1 mRNA	PMID:17562736
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMARCC1 mRNA	PMID:33387578
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1312524	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of SMARCC1 mRNA	PMID:18414638
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312525	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCC1 mRNA	PMID:40504410
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of SMARCC1 mRNA	PMID:36621641
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SMARCC1 mRNA	PMID:35436446
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312525	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SMARCC1 mRNA	PMID:17942748
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312525	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCC1 mRNA	PMID:17942748
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1312524	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of SMARCC1 mRNA	PMID:23228038
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:49900	arsenous acid	increases response to substance	ISO	RGD:1312524	E	RGD:6480464	20191114	CTD	MESH:C032793	SMARCC1 protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SMARCC1 mRNA	PMID:24793618
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312525	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SMARCC1 mRNA	PMID:19042947
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312524	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SMARCC1 mRNA	PMID:17183730
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMARCC1 mRNA	PMID:25729387
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:6382	Lasiocarpine	multiple interactions	ISO	RGD:1312524	E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMARCC1 mRNA	PMID:33884520
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:63924	riddelliine	multiple interactions	ISO	RGD:1312524	E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of SMARCC1 mRNA	PMID:33884520
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SMARCC1 mRNA	PMID:23650126
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312524	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SMARCC1 mRNA	PMID:15336504
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SMARCC1 mRNA	PMID:28801915
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1312524	E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of SMARCC1 mRNA	PMID:33884520
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312524	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SMARCC1 mRNA	PMID:31758290
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312525	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SMARCC1 mRNA	PMID:22206623
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of SMARCC1 mRNA	PMID:31558096
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SMARCC1 mRNA	PMID:24780913
1304850	Smarcc1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SMARCC1 mRNA	PMID:28973697
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312527	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CDK10 mRNA	PMID:33045310
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1312526	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin affects the expression of CDK10 mRNA	PMID:15498508
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CDK10 mRNA	PMID:26079696
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of CDK10 mRNA	PMID:12419474
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in decreased expression of CDK10 mRNA	PMID:30152185
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312527	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CDK10 mRNA	PMID:39241906
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312526	E	RGD:6480464	20120515	CTD	MESH:D004958	Estradiol affects the expression of CDK10 mRNA	PMID:21826169
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312526	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDK10 mRNA	PMID:37042841
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CDK10 mRNA	PMID:26079696
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CDK10 mRNA	PMID:31163220
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312526	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CDK10 protein	PMID:37730182
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CDK10 mRNA	PMID:28818685
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA	PMID:39836092
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312527	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CDK10 mRNA]	PMID:22206623
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK10 mRNA	PMID:39836092|PMID:40512198
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1312526	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CDK10 mRNA	PMID:19244175
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA	PMID:19244175
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CDK10 mRNA	PMID:23557933
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1312526	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CDK10 promoter	PMID:22847954
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312527	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDK10 mRNA	PMID:21570461
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDK10 mRNA	PMID:33387578
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CDK10 mRNA	PMID:23649840
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CDK10 mRNA	PMID:32763439
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312526	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of CDK10 mRNA	PMID:29803840
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312526	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of CDK10 mRNA	PMID:16404146
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CDK10 mRNA	PMID:29432896
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDK10 mRNA	PMID:38568856
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312526	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CDK10 mRNA	PMID:39719251
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK10 mRNA	PMID:39836092|PMID:40512198
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312526	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CDK10 promoter	PMID:27901495
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312527	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDK10 mRNA	PMID:22228805
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312527	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CDK10 mRNA	PMID:39716349
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312526	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CDK10 gene	PMID:31601247
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:32181	tamibarotene	affects expression	ISO	RGD:1312526	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of CDK10 mRNA	PMID:15498508
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312527	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDK10 gene	PMID:35295148
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CDK10 mRNA	PMID:34492290
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312526	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A affects the expression of CDK10 mRNA	PMID:21826169
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CDK10 mRNA	PMID:30816183|PMID:32528016|PMID:33296240
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA	PMID:19244175
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312527	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CDK10 exon	PMID:33297965
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312527	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of CDK10 mRNA	PMID:40203079
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312527	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CDK10 mRNA	PMID:38685157
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312526	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CDK10 mRNA	PMID:29024780
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA	PMID:39836092
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of CDK10 mRNA	PMID:30723492
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CDK10 mRNA	PMID:38174414|PMID:38568856
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CDK10 mRNA	PMID:24386269
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1312526	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CDK10 mRNA	PMID:19244175
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA	PMID:19244175
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312527	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CDK10 mRNA	PMID:40194260
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1312526	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CDK10 promoter	PMID:22847954
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312526	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CDK10 mRNA	PMID:31533062
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1312526	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CDK10 promoter	PMID:22847954
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312526	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CDK10 mRNA	PMID:40419075
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDK10 mRNA	PMID:29154799
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312526	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CDK10 mRNA	PMID:15766595
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of CDK10 mRNA	PMID:16595896
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CDK10 mRNA	PMID:38832940
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312526	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CDK10 mRNA	PMID:28542535
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312527	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CDK10 mRNA	PMID:17562736
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312526	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CDK10 mRNA	PMID:22230336
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK10 mRNA	PMID:39836092|PMID:40512198
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:48707	(-)-citrinin	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20190219	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDK10 mRNA	PMID:30428381
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312527	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CDK10 mRNA	PMID:39716349
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CDK10 mRNA	PMID:24793618
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312526	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of CDK10 mRNA	PMID:22714537
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA	PMID:39836092
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CDK10 mRNA	PMID:12419474
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of CDK10 mRNA	PMID:19564919
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CDK10 mRNA	PMID:30467583
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312527	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CDK10 mRNA	PMID:22206623
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312527	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CDK10 mRNA]	PMID:22206623
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312526	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CDK10 mRNA	PMID:22714537
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of CDK10 mRNA	PMID:11830524
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of CDK10 mRNA	PMID:30428381
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1312526	E	RGD:6480464	20190219	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDK10 mRNA	PMID:30428381
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312526	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of CDK10 mRNA	PMID:26079696
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312527	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CDK10 mRNA	PMID:21278054
1304851	Cdk10	cyclin-dependent kinase 10	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312527	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CDK10 mRNA	PMID:35537566
1304852	Defa24	defensin alpha 24	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003471	Cuprizone results in decreased expression of DEFA24 mRNA	PMID:27523638
1304852	Defa24	defensin alpha 24	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C004312	glycidol results in decreased expression of DEFA24 mRNA	PMID:24395379
1304852	Defa24	defensin alpha 24	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D000643	Ammonium Chloride affects the expression of DEFA24 mRNA	PMID:16483693
1304852	Defa24	defensin alpha 24	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DEFA24 mRNA	PMID:23196670
1304852	Defa24	defensin alpha 24	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C039281	furan results in increased expression of DEFA24 mRNA	PMID:27387713
1304852	Defa24	defensin alpha 24	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C016104	sodium bichromate results in decreased expression of DEFA24 mRNA	PMID:22561333
1304852	Defa24	defensin alpha 24	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C016104	sodium bichromate results in increased expression of DEFA24 mRNA	PMID:22561333
1304852	Defa24	defensin alpha 24	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of DEFA24 mRNA	PMID:15059925
1304852	Defa24	defensin alpha 24	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DEFA24 mRNA	PMID:24780913|PMID:25825206
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312530	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DLX2 mRNA	PMID:33045310
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	ISO	RGD:1312529	E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of DLX2 mRNA	PMID:23792671
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of DLX2 protein	PMID:17551590
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312529	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of DLX2 mRNA	PMID:21934132
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of DLX2 protein	PMID:16806298|PMID:17064353
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D014212	DKK1 protein promotes the reaction [Tretinoin results in increased expression of DLX2 protein]	PMID:17064353
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312529	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of DLX2 mRNA	PMID:26079696
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312529	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of DLX2 mRNA	PMID:22378314
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312529	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of DLX2 mRNA	PMID:21632981
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312529	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of DLX2 mRNA	PMID:29581250
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312529	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DLX2 mRNA	PMID:19619570
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DLX2 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of DLX2 mRNA	PMID:19619570|PMID:30165855
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312529	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DLX2 mRNA	PMID:20655997|PMID:23649840
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1312529	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of DLX2 mRNA	PMID:21795739
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312529	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of DLX2 mRNA	PMID:26079696
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312529	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of DLX2 mRNA	PMID:33647349
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:17579	beta-carotene	increases expression	ISO	RGD:1312529	E	RGD:6480464	20120412	CTD	MESH:D019207	beta Carotene results in increased expression of DLX2 mRNA	PMID:17034753
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:17750	glycine betaine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in increased expression of DLX2 mRNA	PMID:26391144
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of DLX2 mRNA	PMID:27523638
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DLX2 mRNA	PMID:33387578
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312529	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DLX2 mRNA	PMID:28818685
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	multiple interactions	ISO	RGD:1312530	E	RGD:6480464	20231205	CTD	MESH:D014284	[pyriproxyfen metabolite co-treated with Triiodothyronine] results in increased expression of DLX2 mRNA	PMID:34289950
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA	PMID:39836092
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DLX2 mRNA	PMID:35301059
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312529	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DLX2 mRNA	PMID:19549813
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312529	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DLX2 mRNA	PMID:21641981
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of DLX2 mRNA	PMID:15674843
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DLX2 mRNA	PMID:18593933
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DLX2 mRNA	PMID:25629700
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of DLX2 gene	PMID:39164771|PMID:39836092
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312529	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of DLX2 mRNA	PMID:26272509
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312529	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DLX2 protein	PMID:35688186
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of DLX2 mRNA	PMID:23557933
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of DLX2 mRNA	PMID:21151649
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312529	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of DLX2 mRNA	PMID:19561079
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312529	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of DLX2 mRNA	PMID:24768652
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312530	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DLX2 mRNA	PMID:21570461
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DLX2 mRNA	PMID:33387578
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312529	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DLX2 mRNA	PMID:16704738|PMID:19619570|PMID:20106945|PMID:21632981|PMID:22903824
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312530	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DLX2 mRNA	PMID:17586704|PMID:24058054
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DLX2 mRNA	PMID:19619570
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312529	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of DLX2 mRNA	PMID:29955902
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312529	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DLX2 mRNA	PMID:28001369
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312529	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DLX2 mRNA	PMID:33212167
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312529	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of DLX2 mRNA	PMID:39719251
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312529	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DLX2 mRNA	PMID:16966095|PMID:28595984|PMID:34032870|PMID:38568856
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA; TP53 protein promotes the reaction [sodium arsenite results in increased expression of DLX2 mRNA]	PMID:16966095|PMID:39836092
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312529	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DLX2 3' UTR	PMID:27901495
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312529	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DLX2 mRNA	PMID:20106945|PMID:21632981|PMID:21714911
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312529	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of DLX2 promoter	PMID:23974009
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DLX2 mRNA	PMID:18593933
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312529	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of DLX2 mRNA	PMID:26014281
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312529	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of DLX2 mRNA; Silicon Dioxide results in increased expression of DLX2 mRNA	PMID:22300531|PMID:23806026|PMID:25351596|PMID:25895662
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312529	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of DLX2 mRNA	PMID:20382639
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in decreased expression of DLX2 mRNA	PMID:33150645
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:30966	glycidol	increases methylation	EXP		E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in increased methylation of DLX2 promoter	PMID:33150595
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of DLX2 mRNA	PMID:16483693
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312529	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of DLX2 mRNA	PMID:38568856
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312530	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of DLX2 mRNA	PMID:22609695
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312529	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased expression of DLX2 mRNA	PMID:34973136
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312530	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DLX2 gene	PMID:35295148
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312530	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of DLX2 mRNA	PMID:28329830
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of DLX2 mRNA	PMID:19167457
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312530	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of DLX2 promoter	PMID:27334623
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of DLX2 mRNA	PMID:30951980
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1312529	E	RGD:6480464	20210504	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of DLX2 mRNA	PMID:33476716
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:33418	graphite	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of DLX2 mRNA	PMID:29933104
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of DLX2 mRNA	PMID:30951980
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312530	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of DLX2 mRNA	PMID:40203079
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of DLX2 mRNA	PMID:30951980
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312529	E	RGD:6480464	20210504	CTD	MESH:C008745	bisphenol F results in increased expression of DLX2 mRNA	PMID:33476716
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312530	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DLX2 mRNA	PMID:38685157
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA	PMID:39836092
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DLX2 mRNA	PMID:35301059
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA	PMID:19167446
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:39260	pyriproxyfen	increases expression	ISO	RGD:1312530	E	RGD:6480464	20231205	CTD	MESH:C055613	pyriproxyfen metabolite results in increased expression of DLX2 mRNA	PMID:34289950
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:39260	pyriproxyfen	multiple interactions	ISO	RGD:1312530	E	RGD:6480464	20231205	CTD	MESH:C055613	[pyriproxyfen metabolite co-treated with Triiodothyronine] results in increased expression of DLX2 mRNA	PMID:34289950
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312529	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DLX2 mRNA	PMID:25979313
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312529	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of DLX2 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312529	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DLX2 mRNA	PMID:25562108
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312529	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DLX2 mRNA	PMID:38832940
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312529	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of DLX2 mRNA	PMID:24935251|PMID:26272509
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DLX2 mRNA	PMID:33387578
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312529	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DLX2 mRNA	PMID:22230336
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312529	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DLX2 mRNA	PMID:18687144
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of DLX2 gene	PMID:39164771|PMID:39836092
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312529	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of DLX2 mRNA	PMID:21856257
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312529	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of DLX2 mRNA	PMID:22714537
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	increases expression	ISO	RGD:1312529	E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in increased expression of DLX2 mRNA	PMID:17034753
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312529	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DLX2 mRNA	PMID:31629900
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA	PMID:39836092
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312529	E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of DLX2 mRNA	PMID:29432895
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of DLX2 mRNA	PMID:14729362
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA	PMID:19167446
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DLX2 mRNA	PMID:21394737
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312529	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of DLX2 mRNA	PMID:24921660
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312529	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312529	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of DLX2 mRNA	PMID:26014281
1304853	Dlx2	distal-less homeobox 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312529	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DLX2 mRNA	PMID:38568856
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312531	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PLEKHH3 mRNA	PMID:36331819
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1602457	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PLEKHH3 mRNA	PMID:30165855
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1602457	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of PLEKHH3 mRNA	PMID:27905399
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PLEKHH3 promoter	PMID:23359474
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1602457	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PLEKHH3 protein	PMID:37730182
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PLEKHH3 mRNA	PMID:33387578
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1602457	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PLEKHH3 mRNA	PMID:28818685
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1312531	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of PLEKHH3 mRNA	PMID:33914522
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312531	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLEKHH3 mRNA	PMID:37236586
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1602457	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PLEKHH3 mRNA	PMID:19549813
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312531	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLEKHH3 mRNA	PMID:22206623
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PLEKHH3 mRNA	PMID:31881176
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1602457	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PLEKHH3 mRNA	PMID:27392435
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1602457	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLEKHH3 mRNA	PMID:22574217
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLEKHH3 mRNA	PMID:33387578|PMID:34747641
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1602457	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PLEKHH3 mRNA	PMID:33212167
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1602457	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PLEKHH3 mRNA	PMID:32763439
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1602457	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of PLEKHH3 mRNA	PMID:22378314
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1602457	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of PLEKHH3 gene	PMID:31601247
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312531	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLEKHH3 gene	PMID:35295148
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312531	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PLEKHH3 mRNA	PMID:23811191
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1312531	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of PLEKHH3 mRNA	PMID:33914522
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of PLEKHH3 mRNA	PMID:33296240
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLEKHH3 mRNA	PMID:25181051
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312531	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PLEKHH3 mRNA	PMID:34585602
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PLEKHH3 promoter	PMID:23359474
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312531	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PLEKHH3 gene	PMID:31683443
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312531	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PLEKHH3 exon	PMID:33297965
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1602457	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PLEKHH3 exon	PMID:30157460
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312531	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of PLEKHH3 mRNA	PMID:28392331
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312531	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PLEKHH3 intron	PMID:28392331
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312531	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLEKHH3 mRNA	PMID:37019170
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PLEKHH3 promoter	PMID:23359474
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602457	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PLEKHH3 mRNA	PMID:38568856
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312531	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLEKHH3 mRNA	PMID:37236586
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PLEKHH3 gene	PMID:22079235
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1312531	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PLEKHH3 mRNA	PMID:28903501
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1602457	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PLEKHH3 mRNA	PMID:24449571
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312531	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PLEKHH3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PLEKHH3 mRNA	PMID:36331819
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312531	E	RGD:6480464	20120918	CTD	MESH:D014635	Valproic Acid results in increased expression of PLEKHH3 mRNA	PMID:19136453|PMID:21427059
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602457	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PLEKHH3 gene	PMID:29154799
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312531	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PLEKHH3 mRNA	PMID:17562736
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312531	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PLEKHH3 mRNA	PMID:29279043
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312531	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PLEKHH3 mRNA	PMID:25554681
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312531	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of PLEKHH3 mRNA	PMID:26377693
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312531	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of PLEKHH3 mRNA	PMID:19042947
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1602457	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PLEKHH3 exon	PMID:30157460
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312531	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PLEKHH3 mRNA	PMID:22206623
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312531	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLEKHH3 mRNA	PMID:22206623
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1602457	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in increased expression of PLEKHH3 mRNA; Irinotecan results in increased expression of PLEKHH3 mRNA	PMID:15956246
1304854	Plekhh3	pleckstrin homology, MyTH4 and FERM domain containing H3	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1602457	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of PLEKHH3 mRNA	PMID:22378314
1304855	Capn7	calpain 7	gene	CHEBI:101381	aloxistatin	multiple interactions	ISO	RGD:1312532	E	RGD:6480464	20200331	CTD	MESH:C108192	aloxistatin inhibits the reaction [CAPN7 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]	PMID:30910806
1304855	Capn7	calpain 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312533	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CAPN7 mRNA	PMID:33045310
1304855	Capn7	calpain 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312533	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CAPN7 mRNA	PMID:37995155
1304855	Capn7	calpain 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CAPN7 mRNA	PMID:36331819
1304855	Capn7	calpain 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312532	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CAPN7 mRNA	PMID:37042841
1304855	Capn7	calpain 7	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312532	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CAPN7 mRNA	PMID:23649840
1304855	Capn7	calpain 7	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312532	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CAPN7 mRNA	PMID:16002434
1304855	Capn7	calpain 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CAPN7 mRNA	PMID:22061828
1304855	Capn7	calpain 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CAPN7 mRNA	PMID:19549813
1304855	Capn7	calpain 7	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312532	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CAPN7 mRNA	PMID:23649840
1304855	Capn7	calpain 7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312532	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CAPN7 mRNA	PMID:23649840
1304855	Capn7	calpain 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CAPN7 mRNA	PMID:25629700
1304855	Capn7	calpain 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAPN7 mRNA	PMID:22206623
1304855	Capn7	calpain 7	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CAPN7 mRNA	PMID:19244175
1304855	Capn7	calpain 7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CAPN7 mRNA	PMID:28960355
1304855	Capn7	calpain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312533	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CAPN7 mRNA	PMID:21570461
1304855	Capn7	calpain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312533	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CAPN7 mRNA	PMID:15034205
1304855	Capn7	calpain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CAPN7 mRNA]	PMID:15034205
1304855	Capn7	calpain 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CAPN7 mRNA	PMID:28001369
1304855	Capn7	calpain 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CAPN7 mRNA	PMID:29803840
1304855	Capn7	calpain 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312533	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CAPN7 mRNA	PMID:15034205
1304855	Capn7	calpain 7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of CAPN7 mRNA]	PMID:15034205
1304855	Capn7	calpain 7	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CAPN7 mRNA	PMID:19073995
1304855	Capn7	calpain 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CAPN7 mRNA	PMID:19150397
1304855	Capn7	calpain 7	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CAPN7 mRNA	PMID:30047161
1304855	Capn7	calpain 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312533	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CAPN7 gene	PMID:35295148
1304855	Capn7	calpain 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312533	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CAPN7 promoter	PMID:35295148
1304855	Capn7	calpain 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312532	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CAPN7 mRNA	PMID:19710929
1304855	Capn7	calpain 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPN7 protein	PMID:31675489
1304855	Capn7	calpain 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPN7 mRNA	PMID:33221593
1304855	Capn7	calpain 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CAPN7 mRNA	PMID:25181051
1304855	Capn7	calpain 7	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CAPN7 protein	PMID:31675489
1304855	Capn7	calpain 7	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of CAPN7 mRNA	PMID:19244175
1304855	Capn7	calpain 7	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CAPN7 mRNA	PMID:37019170
1304855	Capn7	calpain 7	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of CAPN7 mRNA]	PMID:19030233
1304855	Capn7	calpain 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312532	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CAPN7 mRNA	PMID:37042841
1304855	Capn7	calpain 7	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312532	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CAPN7 mRNA	PMID:24449571
1304855	Capn7	calpain 7	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CAPN7 mRNA	PMID:19244175
1304855	Capn7	calpain 7	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of CAPN7 mRNA	PMID:17585979
1304855	Capn7	calpain 7	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CAPN7 mRNA	PMID:28302478
1304855	Capn7	calpain 7	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312532	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CAPN7 mRNA	PMID:31533062
1304855	Capn7	calpain 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CAPN7 mRNA	PMID:36331819
1304855	Capn7	calpain 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CAPN7 mRNA	PMID:23179753
1304855	Capn7	calpain 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312532	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CAPN7 mRNA	PMID:29154799
1304855	Capn7	calpain 7	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CAPN7 mRNA	PMID:30047161
1304855	Capn7	calpain 7	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312532	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CAPN7 mRNA	PMID:20106945
1304855	Capn7	calpain 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CAPN7 mRNA	PMID:33387578
1304855	Capn7	calpain 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CAPN7 mRNA	PMID:29523930
1304855	Capn7	calpain 7	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CAPN7 mRNA	PMID:31675489
1304855	Capn7	calpain 7	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAPN7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAPN7 mRNA	PMID:21641980|PMID:26378955
1304855	Capn7	calpain 7	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CAPN7 mRNA	PMID:15336504
1304855	Capn7	calpain 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CAPN7 mRNA	PMID:22206623
1304855	Capn7	calpain 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAPN7 mRNA	PMID:22206623
1304855	Capn7	calpain 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312532	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CAPN7 gene]	PMID:28238834
1304855	Capn7	calpain 7	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CAPN7 mRNA	PMID:19363144
1304855	Capn7	calpain 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CAPN7 protein	PMID:31675489
1304855	Capn7	calpain 7	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312532	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of CAPN7 mRNA	PMID:21858171
1304855	Capn7	calpain 7	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CAPN7 mRNA	PMID:19363144
1304855	Capn7	calpain 7	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of CAPN7 mRNA	PMID:30047161
1304855	Capn7	calpain 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CAPN7 mRNA	PMID:30047161
1304855	Capn7	calpain 7	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in decreased expression of CAPN7 mRNA	PMID:19363144
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SLF1 mRNA	PMID:26516004
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312536	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLF1 mRNA	PMID:39241906
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SLF1 mRNA	PMID:33387578
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of SLF1 gene	PMID:27618143
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312535	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLF1 mRNA	PMID:37042841
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312535	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SLF1 mRNA	PMID:21179406
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SLF1 mRNA	PMID:26577399
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of SLF1 mRNA	PMID:37236586
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SLF1 mRNA	PMID:19549813
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312535	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SLF1 mRNA	PMID:23649840
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312535	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SLF1 protein	PMID:20106945
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312535	E	RGD:6480464	20161115	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLF1 gene	PMID:27153756
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312535	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SLF1 mRNA	PMID:23649840
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SLF1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLF1 mRNA	PMID:34911549
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312535	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLF1 gene	PMID:25304211
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20161115	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SLF1 mRNA	PMID:26272509
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312535	E	RGD:6480464	20161115	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA	PMID:27188386
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312535	E	RGD:6480464	20260505	CTD	MESH:C010974	Glyphosate results in increased expression of SLF1 mRNA	PMID:40294809
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLF1 mRNA	PMID:28960355
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312535	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of SLF1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of SLF1 mRNA	PMID:19167446|PMID:23557933
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SLF1 mRNA	PMID:27392435
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312535	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SLF1 mRNA	PMID:27594783
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312535	E	RGD:6480464	20161115	CTD	MESH:D009532	Nickel results in increased expression of SLF1 mRNA	PMID:25583101
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLF1 mRNA	PMID:20106945|PMID:21632981
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312536	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLF1 mRNA	PMID:19770486
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:28854	2,4-D	increases expression	ISO	RGD:1312535	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in increased expression of SLF1 mRNA	PMID:40294809
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of SLF1 mRNA	PMID:22623647
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312535	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of SLF1 gene	PMID:28589171
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312535	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLF1 5' UTR	PMID:27901495
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLF1 mRNA	PMID:19150397|PMID:20382639
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SLF1 mRNA	PMID:25181051
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312536	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of SLF1 mRNA	PMID:25594700
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SLF1 mRNA	PMID:21266533
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of SLF1 mRNA	PMID:36117858
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLF1 mRNA	PMID:33453195
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of SLF1 mRNA	PMID:37236586
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SLF1 mRNA	PMID:28302478
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SLF1 mRNA	PMID:31533062
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312535	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SLF1 mRNA	PMID:19167446
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312535	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLF1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of SLF1 mRNA	PMID:19167446
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SLF1 mRNA	PMID:39529242
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SLF1 mRNA	PMID:40419075
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312535	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLF1 mRNA	PMID:25979313
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312536	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SLF1 mRNA	PMID:17963808
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20161115	CTD	MESH:D014635	Valproic Acid results in decreased expression of SLF1 mRNA	PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of SLF1 mRNA	PMID:41580965
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1312535	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of SLF1 mRNA	PMID:25562108
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLF1 mRNA	PMID:20106945|PMID:21632981
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SLF1 mRNA	PMID:28973697
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312535	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SLF1 mRNA	PMID:38832940
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20161115	CTD	MESH:C012589	trichostatin A results in decreased expression of SLF1 mRNA	PMID:24935251|PMID:26272509
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312535	E	RGD:6480464	20161115	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA	PMID:27188386
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312535	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SLF1 mRNA	PMID:22230336
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312535	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLF1 gene	PMID:25304211
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of SLF1 mRNA	PMID:31838189
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:48981	quinolin-8-ol	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of SLF1 mRNA	PMID:21632981
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of SLF1 mRNA	PMID:36117858
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLF1 mRNA	PMID:21641980
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SLF1 mRNA	PMID:23650126
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SLF1 mRNA	PMID:24810058
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312535	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SLF1 mRNA	PMID:31758290
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLF1 mRNA	PMID:22206623
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312535	E	RGD:6480464	20161115	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SLF1 mRNA	PMID:22714537
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312535	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SLF1 protein	PMID:31285264
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312535	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA	PMID:27188386
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312535	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLF1 gene]	PMID:28238834
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312535	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLF1 mRNA	PMID:19167446
1304857	Slf1	SMC5/6 complex localization factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312535	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA	PMID:27188386
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312537	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of VPS39 mRNA	PMID:38218311
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of VPS39 mRNA	PMID:37995155
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312538	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of VPS39 mRNA	PMID:30319688
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of VPS39 mRNA	PMID:17103110
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VPS39 mRNA	PMID:39241906
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of VPS39 mRNA	PMID:39298647
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of VPS39 mRNA	PMID:20823114
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312537	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of VPS39 mRNA	PMID:21179406
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312538	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of VPS39 mRNA	PMID:34319233
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	ISO	RGD:1312537	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of VPS39 mRNA	PMID:17103032
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of VPS39 protein	PMID:34915118
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312537	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of VPS39 gene	PMID:27153756
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1312537	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VPS39 mRNA	PMID:19244175
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of VPS39 mRNA	PMID:19244175
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of VPS39 mRNA	PMID:30912803
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312538	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VPS39 mRNA	PMID:21570461
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312537	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of VPS39 mRNA	PMID:30851411
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of VPS39 mRNA	PMID:25270620
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312537	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of VPS39 mRNA	PMID:38568856
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312537	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of VPS39 promoter	PMID:27901495
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312538	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VPS39 mRNA	PMID:27858113
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of VPS39 mRNA	PMID:35676786
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312538	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VPS39 gene	PMID:35295148
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of VPS39 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312537	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of VPS39 mRNA	PMID:29275510
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VPS39 mRNA	PMID:36041667
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312537	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of VPS39 mRNA	PMID:19244175
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of VPS39 mRNA	PMID:19244175
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VPS39 mRNA	PMID:36041667
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS39 mRNA	PMID:28628672
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312538	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VPS39 mRNA	PMID:27858113
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VPS39 mRNA	PMID:36041667
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VPS39 mRNA	PMID:28628672
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of VPS39 mRNA	PMID:21241498
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312538	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of VPS39 mRNA	PMID:28392331
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of VPS39 mRNA	PMID:37019170
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VPS39 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS39 mRNA	PMID:28628672
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312537	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VPS39 mRNA	PMID:37042841
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:36015	1,1,1-trichloroethane	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20150127	CTD	MESH:C024566	1,1,1-trichloroethane results in decreased expression of VPS39 mRNA	PMID:25270620
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1312537	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VPS39 mRNA	PMID:19244175
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of VPS39 mRNA	PMID:19244175
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VPS39 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS39 mRNA	PMID:28628672
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312537	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of VPS39 mRNA	PMID:38832940
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312537	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of VPS39 mRNA	PMID:22230336
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of VPS39 mRNA	PMID:35436446
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VPS39 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS39 mRNA	PMID:28628672
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of VPS39 mRNA	PMID:35676786
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of VPS39 mRNA	PMID:20823114
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312538	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VPS39 mRNA	PMID:27858113
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312538	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VPS39 mRNA	PMID:27858113
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312537	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of VPS39 protein	PMID:32959892
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of VPS39 mRNA	PMID:20823114
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312538	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VPS39 mRNA	PMID:22206623
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312537	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of VPS39 mRNA	PMID:30851411
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312537	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to VPS39 gene]	PMID:28238834
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1312537	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of VPS39 mRNA	PMID:39904859
1304858	Vps39	VPS39 subunit of HOPS complex	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of VPS39 mRNA	PMID:23034163
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312540	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SH3GLB1 mRNA	PMID:33045310
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1312540	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of SH3GLB1 promoter	PMID:26251327
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312540	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SH3GLB1 mRNA	PMID:26251327
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312539	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SH3GLB1 mRNA	PMID:23724009
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312540	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SH3GLB1 mRNA	PMID:22629407
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SH3GLB1 mRNA]	PMID:22629407
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of SH3GLB1 mRNA	PMID:40945087
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SH3GLB1 mRNA	PMID:39241906
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312539	E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in decreased expression of SH3GLB1 mRNA	PMID:34681664
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SH3GLB1 protein	PMID:32145629
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in decreased expression of SH3GLB1 mRNA	PMID:22467019|PMID:39298647
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SH3GLB1 gene	PMID:27618143
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20200804	CTD	MESH:D002635	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312539	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SH3GLB1 mRNA	PMID:21592394
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SH3GLB1 mRNA	PMID:21592394
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20200804	CTD	MESH:D006000	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SH3GLB1 mRNA	PMID:33754040
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312539	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SH3GLB1 mRNA	PMID:21592394
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SH3GLB1 mRNA	PMID:21592394
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SH3GLB1 mRNA	PMID:37236586
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312539	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SH3GLB1 mRNA	PMID:19549813
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SH3GLB1 protein	PMID:23301498
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SH3GLB1 mRNA	PMID:19770486
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312539	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SH3GLB1 mRNA	PMID:23649840
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SH3GLB1 mRNA	PMID:25629700
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20200804	CTD	MESH:D006002	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SH3GLB1 mRNA	PMID:40504410
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312539	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SH3GLB1 mRNA	PMID:26272509
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of SH3GLB1 mRNA	PMID:25905778
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312540	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of SH3GLB1 mRNA	PMID:21151649
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SH3GLB1 mRNA	PMID:34747641
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312540	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SH3GLB1 mRNA	PMID:21570461
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3GLB1 mRNA	PMID:17942748
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SH3GLB1 mRNA	PMID:28374803
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312539	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SH3GLB1 mRNA	PMID:30851411
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312539	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of SH3GLB1 protein	PMID:29385562
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of SH3GLB1 mRNA	PMID:26873546
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20200804	CTD	MESH:D003840	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312539	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SH3GLB1 mRNA	PMID:38568856
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SH3GLB1 mRNA	PMID:40504410
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SH3GLB1 mRNA	PMID:19770486
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312539	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SH3GLB1 mRNA	PMID:26238291
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312539	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SH3GLB1 promoter	PMID:27901495
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SH3GLB1 mRNA	PMID:27131904
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:31243	atazanavir sulfate	increases expression	ISO	RGD:1312539	E	RGD:6480464	20200804	CTD	MESH:D000069446	Atazanavir Sulfate results in increased expression of SH3GLB1 mRNA	PMID:32152650
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20200804	CTD	MESH:D000069446	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3GLB1 mRNA; bisphenol A results in decreased expression of SH3GLB1 protein	PMID:32145629|PMID:34947998
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312539	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3GLB1 protein	PMID:31675489
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312540	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SH3GLB1 promoter	PMID:27312807
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SH3GLB1 mRNA	PMID:25181051|PMID:30816183
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312539	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SH3GLB1 protein	PMID:34186270
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1312539	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SH3GLB1 protein	PMID:31675489
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312539	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of SH3GLB1 mRNA	PMID:24752500
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312540	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SH3GLB1 mRNA	PMID:26682919
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of SH3GLB1 mRNA	PMID:30316929
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SH3GLB1 mRNA	PMID:39298647
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312539	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SH3GLB1 protein	PMID:34186270
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312540	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of SH3GLB1 exon	PMID:33297965
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312539	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SH3GLB1 protein	PMID:34186270
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SH3GLB1 mRNA	PMID:28392331
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of SH3GLB1 mRNA	PMID:22546817
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SH3GLB1 mRNA	PMID:21266533
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312539	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SH3GLB1 mRNA	PMID:37042841
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SH3GLB1 mRNA	PMID:30589522
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SH3GLB1 mRNA	PMID:37236586
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312539	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SH3GLB1 protein	PMID:26879310
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312539	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SH3GLB1 mRNA	PMID:19376846
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312539	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SH3GLB1 mRNA	PMID:24449571
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20200804	CTD	MESH:D005999	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SH3GLB1 mRNA	PMID:17585979
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312539	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SH3GLB1 mRNA	PMID:31533062
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SH3GLB1 mRNA	PMID:36331819
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312539	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SH3GLB1 mRNA	PMID:25979313
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SH3GLB1 mRNA	PMID:29427782
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312539	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SH3GLB1 mRNA	PMID:23179753
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SH3GLB1 mRNA	PMID:19770486
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312539	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SH3GLB1 mRNA	PMID:20106945|PMID:25562108|PMID:32152650|PMID:34681664
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SH3GLB1 mRNA	PMID:28973697
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1312539	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SH3GLB1 mRNA	PMID:33512557
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312539	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of SH3GLB1 mRNA	PMID:25704631|PMID:29067470
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SH3GLB1 mRNA	PMID:40504410
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312539	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of SH3GLB1 mRNA	PMID:24752500
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1312539	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of SH3GLB1 mRNA	PMID:31675489
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312540	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SH3GLB1 mRNA	PMID:35436446
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3GLB1 mRNA	PMID:17942748
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of SH3GLB1 mRNA	PMID:24136188
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312539	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SH3GLB1 protein	PMID:32959892
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SH3GLB1 mRNA	PMID:21641980
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SH3GLB1 mRNA	PMID:23650126
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312539	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SH3GLB1 mRNA	PMID:28988120|PMID:29427785
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312539	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SH3GLB1 mRNA	PMID:15336504
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:64648	enniatin	decreases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C100264	enniatins results in decreased expression of SH3GLB1 mRNA	PMID:27163883
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:6773	Mesaconitine	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in decreased expression of SH3GLB1 protein	PMID:37182599
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312539	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SH3GLB1 protein	PMID:34186270
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1312539	E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in increased expression of SH3GLB1 mRNA	PMID:32152650
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:7494	nefazodone	multiple interactions	ISO	RGD:1312539	E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312539	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SH3GLB1 mRNA	PMID:30851411
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312539	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SH3GLB1 mRNA	PMID:19159669
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1312539	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SH3GLB1 protein	PMID:31675489
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1312539	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SH3GLB1 protein	PMID:31675489
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312539	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of SH3GLB1 mRNA	PMID:21858171
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312539	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of SH3GLB1 protein	PMID:38348393
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312540	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SH3GLB1 mRNA	PMID:21795629
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SH3GLB1 mRNA	PMID:27131904
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SH3GLB1 mRNA	PMID:19281266
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SH3GLB1 mRNA	PMID:21346803
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of SH3GLB1 mRNA	PMID:25905778
1304859	Sh3glb1	SH3 domain -containing GRB2-like endophilin B1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312539	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SH3GLB1 mRNA	PMID:38568856
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of UBE2G2 mRNA	PMID:38218311
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:110423	clodronic acid	increases expression	ISO	RGD:1312541	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in increased expression of UBE2G2 mRNA	PMID:25596134
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBE2G2 mRNA]	PMID:31150632
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of UBE2G2 mRNA	PMID:33167477
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of UBE2G2 mRNA	PMID:25596134
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of UBE2G2 mRNA	PMID:22378314
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312542	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of UBE2G2 mRNA	PMID:39241906
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312541	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of UBE2G2 mRNA	PMID:31614463
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of UBE2G2 mRNA	PMID:39298647
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312541	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of UBE2G2 mRNA	PMID:38568856
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:17115	L-serine	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20210608	CTD	MESH:D012694	Serine results in decreased expression of UBE2G2 mRNA	PMID:29098664
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of UBE2G2 mRNA	PMID:33387578
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of UBE2G2 mRNA	PMID:28818685
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of UBE2G2 mRNA	PMID:27462272
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of UBE2G2 mRNA	PMID:23649840
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of UBE2G2 mRNA	PMID:19770486
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of UBE2G2 mRNA	PMID:23649840
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE2G2 mRNA	PMID:31150632
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312542	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE2G2 mRNA	PMID:31919559
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBE2G2 mRNA]	PMID:31150632
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312541	E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to UBE2G2 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of UBE2G2 protein	PMID:35625704
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of UBE2G2 mRNA	PMID:28960355
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of UBE2G2 mRNA	PMID:22610192
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312541	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of UBE2G2 mRNA	PMID:25596134
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2G2 mRNA	PMID:34747641
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312542	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2G2 mRNA	PMID:21570461
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE2G2 mRNA	PMID:21215274
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2G2 mRNA	PMID:33387578
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312541	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2G2 mRNA	PMID:22903824
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of UBE2G2 mRNA]	PMID:21215274
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2G2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of UBE2G2 mRNA	PMID:17942748|PMID:25975270
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of UBE2G2 mRNA	PMID:28959563
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of UBE2G2 mRNA	PMID:36057382
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBE2G2 mRNA	PMID:38568856
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE2G2 mRNA	PMID:22228805
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312541	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UBE2G2 5' UTR	PMID:27901495
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312542	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBE2G2 mRNA	PMID:21569818
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of UBE2G2 mRNA	PMID:36057382
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312541	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of UBE2G2 gene	PMID:31601247
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of UBE2G2 mRNA	PMID:24136188
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20180515	CTD	MESH:C009495	titanium dioxide results in decreased expression of UBE2G2 mRNA	PMID:29128614|PMID:29264374
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312542	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBE2G2 gene	PMID:35295148
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UBE2G2 mRNA	PMID:34492290
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of UBE2G2 mRNA	PMID:18445702
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2G2 mRNA	PMID:32145629
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2G2 mRNA	PMID:29275510
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2G2 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312541	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of UBE2G2 gene	PMID:31601247
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of UBE2G2 mRNA	PMID:19925653
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UBE2G2 mRNA	PMID:39298647
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312542	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of UBE2G2 mRNA	PMID:38685157
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312541	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of UBE2G2 protein	PMID:34186270
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:34679	Di-n-octyl phthalate	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20240305	CTD	MESH:C010715	di-n-octyl phthalate results in decreased expression of UBE2G2 mRNA	PMID:37810885
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312541	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBE2G2 mRNA	PMID:37042841
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:35176	zinc sulfate	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20130122	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of UBE2G2 mRNA	PMID:12756304
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UBE2G2 mRNA	PMID:25596134|PMID:38568856
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of UBE2G2 promoter	PMID:22457795
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE2G2 mRNA	PMID:33453195
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312541	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE2G2 mRNA	PMID:26472689
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of UBE2G2 mRNA	PMID:19320972
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of UBE2G2 mRNA	PMID:24449571
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:3696	cidofovir anhydrous	increases expression	ISO	RGD:1312541	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of UBE2G2 mRNA	PMID:25596134
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312541	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of UBE2G2 mRNA	PMID:28302478
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312541	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBE2G2 mRNA	PMID:25979313
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of UBE2G2 mRNA	PMID:17292431
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in decreased expression of UBE2G2 mRNA	PMID:23527032
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312541	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of UBE2G2 gene	PMID:29154799
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312541	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of UBE2G2 mRNA	PMID:23179753|PMID:27188386
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of UBE2G2 mRNA	PMID:25596134
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBE2G2 mRNA	PMID:17562736
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of UBE2G2 mRNA	PMID:33387578
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of UBE2G2 mRNA	PMID:29523930
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312541	E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to UBE2G2 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of UBE2G2 protein	PMID:35625704
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of UBE2G2 mRNA	PMID:29391264|PMID:31464424
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20130416	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of UBE2G2 mRNA	PMID:22246474
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UBE2G2 mRNA	PMID:17942748
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2G2 mRNA	PMID:17942748
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:5001	fenofibrate	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate affects the expression of UBE2G2 mRNA	PMID:25596134
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312542	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of UBE2G2 mRNA	PMID:25554681|PMID:25620056
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBE2G2 mRNA	PMID:24136188
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:5864	ifosfamide	increases expression	ISO	RGD:1312541	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of UBE2G2 mRNA	PMID:25596134
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:63952	arsenic trichloride	multiple interactions	ISO	RGD:1312541	E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to UBE2G2 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of UBE2G2 protein	PMID:35625704
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	affects expression	ISO	RGD:1312541	E	RGD:6480464	20160705	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium affects the expression of UBE2G2 mRNA	PMID:25234470
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of UBE2G2 mRNA	PMID:25596134
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312542	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of UBE2G2 mRNA	PMID:22206623
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312541	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to UBE2G2 gene]	PMID:28238834
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312542	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of UBE2G2 mRNA	PMID:31388691
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UBE2G2 mRNA	PMID:21346803
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312541	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of UBE2G2 mRNA	PMID:38568856
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312542	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of UBE2G2 mRNA	PMID:28973697
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312542	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of UBE2G2 mRNA	PMID:35537566
1304860	Ube2g2	ubiquitin-conjugating enzyme E2G 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of UBE2G2 mRNA	PMID:18042343
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1349850	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CUEDC1 mRNA	PMID:38218311
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550586	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CUEDC1 mRNA	PMID:33045310
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1550586	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CUEDC1 mRNA	PMID:37995155
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1550586	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of CUEDC1 mRNA	PMID:16788091
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1349850	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CUEDC1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CUEDC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CUEDC1 mRNA	PMID:32699268|PMID:32845096
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550586	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CUEDC1 mRNA	PMID:36331819
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1349850	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CUEDC1 mRNA	PMID:26079696
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1349850	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CUEDC1 mRNA	PMID:22378314
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550586	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CUEDC1 mRNA	PMID:30319688
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1349850	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of CUEDC1 mRNA	PMID:21632981
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1349850	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CUEDC1 intron	PMID:30157460
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1550586	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of CUEDC1 mRNA	PMID:27462272
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550586	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CUEDC1 mRNA	PMID:37236586
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1349850	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CUEDC1 mRNA	PMID:19549813
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1349850	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CUEDC1 3' UTR; Aflatoxin B1 results in increased methylation of CUEDC1 gene	PMID:27153756|PMID:30157460
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1349850	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CUEDC1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CUEDC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CUEDC1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of CUEDC1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of CUEDC1 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550586	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CUEDC1 mRNA	PMID:22206623
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550586	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CUEDC1 mRNA	PMID:40504410
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CUEDC1 mRNA	PMID:31881176
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1349850	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of CUEDC1 mRNA	PMID:19921347
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1550586	E	RGD:6480464	20120412	CTD	MESH:D003042	HDAC5 affects the reaction [Cocaine affects the expression of CUEDC1 mRNA]	PMID:17988634
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CUEDC1 mRNA	PMID:27913140
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1349850	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CUEDC1 mRNA	PMID:20106945|PMID:21632981
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550586	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CUEDC1 mRNA	PMID:40504410
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349850	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CUEDC1 5' UTR; Benzo(a)pyrene affects the methylation of CUEDC1 intron	PMID:27901495|PMID:30157460
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1349850	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CUEDC1 gene	PMID:31601247
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550586	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CUEDC1 gene	PMID:35295148
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550586	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of CUEDC1 mRNA	PMID:29264374
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550586	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CUEDC1 gene	PMID:35295148
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CUEDC1 mRNA	PMID:23411599
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of CUEDC1 mRNA	PMID:19167457
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CUEDC1 mRNA	PMID:25181051
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CUEDC1 mRNA	PMID:34947998
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550586	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CUEDC1 mRNA	PMID:26063408
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1349850	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CUEDC1 gene	PMID:31601247
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1349850	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to CUEDC1 promoter]	PMID:20348232
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550586	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of CUEDC1 exon; bisphenol S affects the methylation of CUEDC1 gene	PMID:31683443|PMID:33297965
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550586	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CUEDC1 mRNA	PMID:38685157
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349850	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CUEDC1 mRNA	PMID:37042841
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1349850	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CUEDC1 mRNA	PMID:38568856
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CUEDC1 mRNA	PMID:33453195
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550586	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CUEDC1 mRNA	PMID:37236586
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1349850	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CUEDC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CUEDC1 mRNA	PMID:32699268
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550586	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CUEDC1 mRNA	PMID:36331819
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349850	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CUEDC1 mRNA	PMID:25979313
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1349850	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CUEDC1 mRNA	PMID:25562108
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1349850	E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of CUEDC1 mRNA	PMID:19059307
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550586	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CUEDC1 mRNA	PMID:28973697
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1349850	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of CUEDC1 mRNA]	PMID:21233418
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CUEDC1 mRNA	PMID:33387578
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1349850	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CUEDC1 mRNA	PMID:29523930
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550586	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CUEDC1 mRNA	PMID:40504410
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550586	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CUEDC1 mRNA; Nanotubes, Carbon results in decreased expression of CUEDC1 mRNA	PMID:25554681
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1550586	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CUEDC1 mRNA	PMID:26307267
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1550586	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of CUEDC1 mRNA	PMID:22206623
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550586	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CUEDC1 mRNA	PMID:22206623
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550586	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of CUEDC1 mRNA	PMID:39847705
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1349850	E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of CUEDC1 mRNA	PMID:19059307
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550586	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CUEDC1 mRNA	PMID:28973697
1304861	Cuedc1	CUE domain containing 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased methylation of CUEDC1 promoter	PMID:22570695
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1347905	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TFAP2D gene	PMID:27153756
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312549	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TFAP2D mRNA	PMID:24058054
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TFAP2D mRNA	PMID:32109520
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1312549	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of TFAP2D gene	PMID:32068019
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347905	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TFAP2D promoter	PMID:27901495
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1347905	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of TFAP2D promoter	PMID:23974009
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1347905	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TFAP2D mRNA	PMID:25895662
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1347905	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of TFAP2D gene	PMID:31601247
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1347905	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TFAP2D gene	PMID:31601247
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:31767	lead diacetate	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:C008261	lead acetate results in increased methylation of TFAP2D gene	PMID:29571894
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312549	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TFAP2D promoter	PMID:27334623
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TFAP2D mRNA	PMID:25181051|PMID:34947998|PMID:38750585|PMID:41034487
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312549	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of TFAP2D mRNA	PMID:30951980
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TFAP2D mRNA	PMID:30816183|PMID:32528016
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347905	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TFAP2D gene	PMID:31601247
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312549	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of TFAP2D mRNA	PMID:30951980
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312549	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of TFAP2D mRNA	PMID:30951980
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312549	E	RGD:6480464	20250311	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TFAP2D mRNA	PMID:31841868
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of TFAP2D gene	PMID:33148267
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312549	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of TFAP2D mRNA	PMID:24896083
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D007649	Ketamine results in decreased expression of TFAP2D mRNA	PMID:20080153
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of TFAP2D gene	PMID:33148267
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of TFAP2D mRNA	PMID:32109520
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TFAP2D mRNA	PMID:21394737
1304864	Tfap2d	transcription factor AP-2 delta	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TFAP2D mRNA	PMID:24780913
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312550	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MUC20 mRNA	PMID:27188386
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312550	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of MUC20 mRNA	PMID:23830798
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312550	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MUC20 mRNA	PMID:22378314
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312550	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MUC20 mRNA	PMID:30165855
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312551	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of MUC20 mRNA	PMID:33711761
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MUC20 mRNA	PMID:33387578
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of MUC20 gene	PMID:27618143
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of MUC20 mRNA	PMID:22238285
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312550	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of MUC20 mRNA	PMID:33647349
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312550	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MUC20 mRNA	PMID:28818685
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of MUC20 mRNA	PMID:28522335
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MUC20 mRNA	PMID:30779732
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312550	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MUC20 mRNA	PMID:21867686
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312551	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of MUC20 mRNA	PMID:25629700
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312551	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MUC20 mRNA	PMID:22206623
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312550	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MUC20 mRNA	PMID:40512198
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of MUC20 mRNA	PMID:32186404
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312550	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MUC20 mRNA	PMID:25583101
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312550	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MUC20 mRNA	PMID:28001369
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312550	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MUC20 mRNA	PMID:33212167
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1312550	E	RGD:6480464	20231205	CTD	MESH:C058120	cordycepin results in increased expression of MUC20 mRNA	PMID:34858524
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1312550	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of MUC20 mRNA	PMID:22623647
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MUC20 mRNA	PMID:37682722
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312550	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MUC20 mRNA	PMID:38568856
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312550	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MUC20 mRNA	PMID:40512198
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312551	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of MUC20 mRNA	PMID:17127020
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MUC20 mRNA	PMID:21569818
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312550	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MUC20 promoter	PMID:27901495
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312551	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of MUC20 mRNA	PMID:23557971
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of MUC20 mRNA	PMID:30012374
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of MUC20 mRNA	PMID:32145629
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312550	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of MUC20 mRNA	PMID:31715268
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of MUC20 mRNA	PMID:38074096
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312550	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased expression of MUC20 mRNA	PMID:22576693
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312550	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MUC20 mRNA	PMID:24449571
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of MUC20 mRNA	PMID:29038090
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312550	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MUC20 gene	PMID:29154799
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312550	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MUC20 mRNA	PMID:25562108
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312550	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MUC20 mRNA	PMID:38832940
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312550	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MUC20 mRNA	PMID:21420995
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312550	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MUC20 mRNA	PMID:40512198
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MUC20 mRNA	PMID:25554681
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312551	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MUC20 mRNA	PMID:25554681
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312551	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MUC20 mRNA	PMID:21641980
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MUC20 mRNA	PMID:22206623
1304865	Muc20	mucin 20, cell surface associated	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312551	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MUC20 mRNA	PMID:22206623
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312553	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of LRRTM3 mRNA	PMID:36189433
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRTM3 mRNA	PMID:36189433
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312553	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of LRRTM3 mRNA	PMID:30319688
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312552	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LRRTM3 mRNA	PMID:35811015
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312552	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRRTM3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LRRTM3 mRNA	PMID:35811015
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312552	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of LRRTM3 mRNA	PMID:30510588
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA	PMID:25510870
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of LRRTM3 mRNA	PMID:33387578
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRTM3 mRNA	PMID:36189433
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA	PMID:25510870
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA	PMID:25510870
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312552	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LRRTM3 mRNA	PMID:22100608
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312552	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LRRTM3 gene	PMID:27153756
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312553	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LRRTM3 mRNA	PMID:28960355
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRRTM3 mRNA	PMID:32109520
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312553	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of LRRTM3 mRNA	PMID:36209798
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312552	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of LRRTM3 mRNA	PMID:25895662
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRTM3 mRNA	PMID:25181051|PMID:27178563
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312553	E	RGD:6480464	20140513	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRTM3 mRNA	PMID:24465770
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA	PMID:25510870
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA	PMID:25510870
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312553	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of LRRTM3 exon	PMID:33297965
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312552	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LRRTM3 intron	PMID:30157460
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312553	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LRRTM3 intron	PMID:28392331
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312553	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRRTM3 mRNA	PMID:32715474
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of LRRTM3 mRNA	PMID:36117858
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312553	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of LRRTM3 mRNA	PMID:28962523
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312552	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LRRTM3 mRNA	PMID:31533062
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312552	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRRTM3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LRRTM3 mRNA	PMID:35811015
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:46666	crocidolite asbestos	affects methylation	ISO	RGD:1312552	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite affects the methylation of LRRTM3 5' UTR; Asbestos, Crocidolite affects the methylation of LRRTM3 exon	PMID:29523930
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of LRRTM3 mRNA	PMID:36117858
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312552	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LRRTM3 intron	PMID:30157460
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312552	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of LRRTM3 mRNA	PMID:19084549
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of LRRTM3 mRNA	PMID:32109520
1304866	Lrrtm3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of LRRTM3 mRNA	PMID:19015723
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of PSMG2 protein	PMID:36252740
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312554	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PSMG2 mRNA	PMID:38218311
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312555	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PSMG2 mRNA	PMID:39241906
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312555	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PSMG2 mRNA	PMID:39298647
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312554	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PSMG2 mRNA	PMID:37042841
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of PSMG2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PSMG2 mRNA]	PMID:20230807
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1312555	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PSMG2 mRNA	PMID:20230807
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20120501	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of PSMG2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PSMG2 mRNA]	PMID:20230807
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of PSMG2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PSMG2 mRNA]	PMID:20230807
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMG2 mRNA	PMID:37236586
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312554	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PSMG2 gene	PMID:27153756
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312554	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PSMG2 mRNA	PMID:35430440
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PSMG2 mRNA	PMID:34911549
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PSMG2 mRNA	PMID:31150632
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMG2 mRNA	PMID:22206623
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312555	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMG2 mRNA	PMID:21570461
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PSMG2 mRNA	PMID:32109520
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMG2 mRNA	PMID:17942748
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312554	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PSMG2 mRNA	PMID:30851411
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PSMG2 mRNA	PMID:28959563
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PSMG2 mRNA	PMID:16014739
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312555	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PSMG2 mRNA	PMID:22228805
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312554	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PSMG2 mRNA	PMID:19150397
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PSMG2 mRNA	PMID:29264374
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PSMG2 mRNA	PMID:18445702
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312555	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PSMG2 mRNA	PMID:23811191
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312555	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PSMG2 mRNA	PMID:28472532
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMG2 mRNA	PMID:30816183|PMID:32528016
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312554	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMG2 mRNA; bisphenol A results in decreased expression of PSMG2 protein	PMID:29275510|PMID:37567409
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PSMG2 gene	PMID:28505145
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312554	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PSMG2 mRNA	PMID:28628672
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312555	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PSMG2 mRNA	PMID:39298647
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312555	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PSMG2 mRNA	PMID:37019170
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PSMG2 mRNA	PMID:21266533
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PSMG2 mRNA	PMID:34813904
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312554	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PSMG2 mRNA	PMID:28628672
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PSMG2 mRNA	PMID:34813904
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PSMG2 mRNA	PMID:35163327
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312554	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PSMG2 mRNA	PMID:38382870
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMG2 mRNA	PMID:37236586
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PSMG2 mRNA	PMID:35163327
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312554	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PSMG2 gene	PMID:29154799
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in increased expression of PSMG2 mRNA	PMID:38685447
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312554	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PSMG2 mRNA	PMID:28628672
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PSMG2 mRNA	PMID:24136188
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PSMG2 mRNA	PMID:17562736
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PSMG2 mRNA	PMID:33387578
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312554	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PSMG2 mRNA	PMID:21420995
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312554	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PSMG2 mRNA	PMID:29523930
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMG2 mRNA	PMID:17942748
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312554	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PSMG2 mRNA	PMID:28628672
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PSMG2 mRNA	PMID:35964746
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PSMG2 mRNA	PMID:24136188
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312555	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PSMG2 mRNA	PMID:19042947
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:6030	isoniazide	increases expression	ISO	RGD:1312554	E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of PSMG2 protein	PMID:40015660
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312554	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PSMG2 protein	PMID:32959892
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMG2 mRNA	PMID:22206623
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:749301	potassium perchlorate	decreases expression	ISO	RGD:1312554	E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of PSMG2 mRNA	PMID:29673971
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PSMG2 mRNA	PMID:24136188
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312554	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PSMG2 mRNA	PMID:30851411
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PSMG2 mRNA	PMID:19270015
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1312555	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of PSMG2 mRNA	PMID:40826991
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PSMG2 mRNA	PMID:19281266
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PSMG2 mRNA	PMID:21346803
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of PSMG2 protein	PMID:24648495
1304867	Psmg2	proteasome assembly chaperone 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PSMG2 mRNA	PMID:21346803
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312557	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DPH7 mRNA	PMID:33045310
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312556	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DPH7 mRNA	PMID:33167477
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312557	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DPH7 mRNA	PMID:36331819
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312556	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of DPH7 mRNA	PMID:39836092
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312556	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DPH7 mRNA	PMID:19549813
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312556	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DPH7 intron	PMID:30157460
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312556	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DPH7 gene	PMID:27153756
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312556	E	RGD:6480464	20150825	CTD	MESH:D001151	Arsenic affects the methylation of DPH7 gene	PMID:25304211
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312556	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA	PMID:39836092
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312557	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DPH7 mRNA	PMID:20702594|PMID:21570461
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DPH7 mRNA	PMID:33387578
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D012402	Rotenone results in decreased expression of DPH7 mRNA	PMID:19013527
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312556	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of DPH7 mRNA	PMID:29803840
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312556	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DPH7 mRNA	PMID:38568856
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312556	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA	PMID:39836092
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312556	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DPH7 promoter	PMID:27901495
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312557	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of DPH7 mRNA	PMID:29264374
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312557	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DPH7 gene	PMID:35295148
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312556	E	RGD:6480464	20130806	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DPH7 mRNA	PMID:19710929
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312557	E	RGD:6480464	20130806	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DPH7 mRNA	PMID:19710929
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of DPH7 mRNA	PMID:30816183
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of DPH7 mRNA	PMID:25181051
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312557	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DPH7 mRNA	PMID:21266533
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312556	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of DPH7 mRNA	PMID:39836092
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312556	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DPH7 mRNA	PMID:31533062
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312557	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DPH7 mRNA	PMID:36331819
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312556	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DPH7 mRNA	PMID:25979313
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312557	E	RGD:6480464	20130806	CTD	MESH:D014635	Valproic Acid results in decreased expression of DPH7 mRNA	PMID:21427059
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312556	E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in increased expression of DPH7 mRNA	PMID:37505509
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312556	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in increased expression of DPH7 mRNA	PMID:20106945
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312556	E	RGD:6480464	20150825	CTD	MESH:D001151	Arsenic affects the methylation of DPH7 gene	PMID:25304211
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312556	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA	PMID:39836092
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of DPH7 mRNA	PMID:30307764
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312556	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DPH7 mRNA	PMID:31629900
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312556	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of DPH7 mRNA	PMID:39836092
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1312557	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of DPH7 mRNA	PMID:27462272
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1312557	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of DPH7 mRNA	PMID:20702594
1304868	Dph7	diphthamide biosynthesis 7	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312556	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DPH7 mRNA	PMID:29301935
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312558	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PRMT7 mRNA	PMID:33045310
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312558	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRMT7 mRNA	PMID:30529165
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1601867	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PRMT7 mRNA	PMID:22378314
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:16118	berberine	increases expression	ISO	RGD:1601867	E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in increased expression of PRMT7 mRNA	PMID:27311644
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312558	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PRMT7 mRNA	PMID:39241906
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1601867	E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] affects the expression of PRMT7 mRNA	PMID:17404688
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1601867	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PRMT7 mRNA	PMID:38568856
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:16680	S-adenosyl-L-homocysteine	decreases activity	ISO	RGD:1601867	E	RGD:6480464	20220111	CTD	MESH:D012435	S-Adenosylhomocysteine results in decreased activity of PRMT7 protein	PMID:33577917
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1601867	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] affects the expression of PRMT7 mRNA	PMID:17404688
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312558	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PRMT7 mRNA	PMID:23892564
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PRMT7 mRNA	PMID:33387578
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312558	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PRMT7 mRNA	PMID:36331819
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1601867	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PRMT7 mRNA	PMID:19549813
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1601867	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PRMT7 gene	PMID:27153756
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312558	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in increased expression of PRMT7 mRNA	PMID:26392148
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312558	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PRMT7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PRMT7 mRNA	PMID:34911549
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312558	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of PRMT7 mRNA	PMID:25629700
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312558	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PRMT7 mRNA]	PMID:22206623
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312558	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PRMT7 mRNA	PMID:40504410
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1601867	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PRMT7 mRNA	PMID:23557933
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312558	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRMT7 mRNA	PMID:21570461
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1601867	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRMT7 mRNA	PMID:22574217
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRMT7 mRNA	PMID:33387578
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312558	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of PRMT7 mRNA	PMID:30807115
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1601867	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PRMT7 mRNA	PMID:20971185
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312558	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PRMT7 protein	PMID:28918527
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312558	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin affects the expression of PRMT7 mRNA	PMID:15699352
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1601867	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PRMT7 mRNA	PMID:29803840
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1312558	E	RGD:6480464	20120412	CTD	MESH:D004317	PRMT7 protein results in decreased susceptibility to Doxorubicin	PMID:15699352
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1601867	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of PRMT7 mRNA	PMID:34032870
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1601867	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRMT7 mRNA	PMID:38568856
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601867	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of PRMT7 mRNA	PMID:28595984
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312558	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PRMT7 mRNA	PMID:40504410
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312558	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PRMT7 mRNA	PMID:22228805
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1601867	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PRMT7 mRNA	PMID:20971185
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:30563	silicon dioxide	decreases methylation	ISO	RGD:1601867	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased methylation of PRMT7 gene	PMID:34973136
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of PRMT7 mRNA	PMID:32479839
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312558	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PRMT7 gene	PMID:35295148
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PRMT7 mRNA	PMID:23411599|PMID:34492290
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1601867	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PRMT7 mRNA	PMID:19710929
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312558	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PRMT7 mRNA	PMID:28472532
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PRMT7 mRNA	PMID:19167457
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PRMT7 mRNA	PMID:30816183|PMID:32528016
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312558	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PRMT7 mRNA	PMID:30303745
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312558	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PRMT7 mRNA	PMID:39298647
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PRMT7 mRNA	PMID:21241498
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of PRMT7 mRNA	PMID:32680482
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1601867	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PRMT7 mRNA	PMID:38568856
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312558	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PRMT7 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PRMT7 mRNA	PMID:36331819
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PRMT7 mRNA	PMID:25993096
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1601867	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PRMT7 mRNA	PMID:20106945
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312558	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PRMT7 mRNA	PMID:17555576
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312558	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PRMT7 mRNA	PMID:17562736
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312558	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PRMT7 mRNA	PMID:40504410
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312558	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PRMT7 mRNA	PMID:17555576
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312558	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PRMT7 mRNA; Nanotubes, Carbon results in increased expression of PRMT7 mRNA	PMID:25554681
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PRMT7 mRNA	PMID:24136188
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312558	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PRMT7 mRNA	PMID:19042947
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:63580	ribavirin	decreases expression	ISO	RGD:1601867	E	RGD:6480464	20220111	CTD	MESH:D012254	Ribavirin results in decreased expression of PRMT7 protein	PMID:33577917|PMID:34919946
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1601867	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of PRMT7 mRNA	PMID:28988120
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1601867	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PRMT7 mRNA	PMID:22079614
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312558	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PRMT7 mRNA	PMID:22206623
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312558	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PRMT7 mRNA]	PMID:22206623
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PRMT7 mRNA	PMID:19162173
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PRMT7 mRNA	PMID:27291303
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of PRMT7 mRNA	PMID:23640034
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1601867	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PRMT7 mRNA	PMID:38568856
1304869	Prmt7	protein arginine methyltransferase 7	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312558	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PRMT7 mRNA	PMID:32835833
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of IFIT1BL mRNA	PMID:32145629
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFIT1BL mRNA	PMID:32741896
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of IFIT1BL mRNA	PMID:33387578
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFIT1BL mRNA	PMID:32741896
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IFIT1BL mRNA	PMID:33387578
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of IFIT1BL mRNA	PMID:32145629
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IFIT1BL mRNA	PMID:33387578
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of IFIT1BL mRNA	PMID:29391264
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:6456	lidocaine	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in decreased expression of IFIT1BL mRNA	PMID:35283115
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFIT1BL mRNA	PMID:32741896
1304872	Ifit1bl	interferon-induced protein with tetratricopeptide repeats 1B-like	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of IFIT1BL mRNA	PMID:32109520
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312564	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MRTFA mRNA	PMID:27188386
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312565	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MRTFA mRNA	PMID:33045310
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312565	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of MRTFA mRNA	PMID:37995155
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312564	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of MKL1 mRNA; Tretinoin results in increased expression of MRTFA mRNA	PMID:23724009|PMID:33167477
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312564	E	RGD:6480464	20160822	CTD	MESH:D010100	Oxygen results in increased expression of MRTFA mRNA	PMID:23517783
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20160822	CTD	MESH:D010100	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Oxygen affects the localization of MRTFA protein]; Cytochalasin D inhibits the reaction [Oxygen affects the localization of MRTFA protein]; exoenzyme C3, Clostridium botulinum inhibits the reaction [Oxygen affects the localization of MRTFA protein]; MRTFA protein affects the reaction [Oxygen results in increased expression of ACTA2 mRNA]; MRTFA protein affects the reaction [Oxygen results in increased expression of ACTA2 protein]; Oxygen promotes the reaction [MRTFA protein binds to ACTA2 promoter]; Oxygen results in increased expression of and affects the localization of MRTFA protein	PMID:23517783
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of MRTFA mRNA	PMID:24763279
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312564	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MRTFA mRNA	PMID:26079696
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:15756	hexadecanoic acid	affects localization	ISO	RGD:1312564	E	RGD:6480464	20160412	CTD	MESH:D019308	Palmitic Acid affects the localization of MRTFA protein	PMID:21393865
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20160412	CTD	MESH:D019308	CCG 1423 inhibits the reaction [Palmitic Acid affects the localization of MRTFA protein]	PMID:21393865
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of MKL1 mRNA	PMID:30319688
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312564	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MRTFA mRNA	PMID:20044591
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312565	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MRTFA mRNA	PMID:39241906
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MRTFA mRNA]	PMID:39241906
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312564	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MRTFA mRNA	PMID:20655997
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MRTFA mRNA]	PMID:20032058
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312564	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MRTFA protein	PMID:37730182
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MRTFA mRNA	PMID:22061828
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312564	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MRTFA mRNA	PMID:28818685
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MRTFA mRNA	PMID:35301059
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312564	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MRTFA mRNA	PMID:19549813
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1312564	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of MRTFA intron	PMID:30157460
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312564	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MRTFA mRNA	PMID:23649840
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MKL1 mRNA	PMID:30779732
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312565	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MRTFA mRNA	PMID:17484886
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRTFA mRNA	PMID:22206623
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRTFA mRNA	PMID:40504410
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312564	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MRTFA protein	PMID:35688186
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MRTFA mRNA	PMID:23557933
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312564	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MRTFA mRNA	PMID:27392435|PMID:27594783
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MRTFA mRNA	PMID:27392435
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312565	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MKL1 mRNA	PMID:30912803
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312565	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRTFA mRNA	PMID:21570461
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects localization	ISO	RGD:1312564	E	RGD:6480464	20170207	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the localization of MRTFA protein	PMID:27697457
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRTFA mRNA	PMID:32109520
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312564	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MRTFA mRNA	PMID:29803840
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312564	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of MRTFA protein	PMID:35688186
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRTFA mRNA	PMID:40504410
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312564	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MKL1 promoter; Benzo(a)pyrene affects the methylation of MRTFA intron	PMID:27901495|PMID:30157460
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312564	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MKL1 5' UTR	PMID:27901495
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MRTFA gene	PMID:31601247
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRTFA mRNA	PMID:25181051
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MRTFA gene	PMID:31601247
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312564	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MRTFA gene	PMID:31601247
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312565	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of MRTFA promoter	PMID:33297965
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1312564	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of MRTFA intron	PMID:30157460
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of MRTFA mRNA	PMID:22546817
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of MRTFA mRNA	PMID:22546817
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MRTFA mRNA]	PMID:39241906
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312564	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MRTFA mRNA	PMID:37042841
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MRTFA mRNA	PMID:35301059
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312564	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MRTFA mRNA	PMID:28302478
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312564	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MRTFA mRNA	PMID:31533062
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312565	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of MRTFA mRNA	PMID:29038090
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312564	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRTFA mRNA	PMID:26272509
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MRTFA mRNA	PMID:27188386
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312564	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MRTFA mRNA	PMID:25562108
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in decreased expression of MRTFA mRNA	PMID:20032058
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MRTFA mRNA]	PMID:20032058
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312565	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRTFA mRNA	PMID:17562736
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312564	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MRTFA mRNA	PMID:22230336
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312564	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of MRTFA mRNA	PMID:24714768
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRTFA mRNA	PMID:40504410
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:472805	ouabain	decreases expression	ISO	RGD:1312564	E	RGD:6480464	20180116	CTD	MESH:D010042	Ouabain results in decreased expression of MRTFA mRNA	PMID:28795476
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312564	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MRTFA mRNA	PMID:18175754
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:529996	cytochalasin D	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20160822	CTD	MESH:D015638	Cytochalasin D inhibits the reaction [Oxygen affects the localization of MRTFA protein]	PMID:23517783
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:66104	jaspamide	affects localization	ISO	RGD:1312564	E	RGD:6480464	20160822	CTD	MESH:C057531	jasplakinolide affects the localization of MRTFA protein	PMID:23517783
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1312564	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of MRTFA intron	PMID:30157460
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MRTFA gene	PMID:35440735
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRTFA mRNA	PMID:22206623
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of MRTFA mRNA	PMID:23358140
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MRTFA mRNA	PMID:27188386
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MKL1 gene]	PMID:28238834
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MRTFA mRNA	PMID:32109520
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MRTFA mRNA]	PMID:39241906
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MRTFA mRNA	PMID:27188386
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MRTFA mRNA	PMID:19281266
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRTFA mRNA	PMID:21346803
1304873	Mrtfa	myocardin related transcription factor A	gene	CHEBI:9607	Tiron	multiple interactions	ISO	RGD:1312564	E	RGD:6480464	20160822	CTD	MESH:D014013	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Oxygen affects the localization of MRTFA protein]	PMID:23517783
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603665	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of REXO2 mRNA	PMID:33167477
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1603665	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of REXO2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of REXO2 mRNA	PMID:32699268
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1620676	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of REXO2 mRNA	PMID:36331819
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1620676	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of REXO2 mRNA	PMID:39241906
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of REXO2 mRNA	PMID:32145629
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1620676	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of REXO2 mRNA	PMID:39298647
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1603665	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of REXO2 mRNA	PMID:30165855
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1603665	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of REXO2 mRNA	PMID:21179406
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1620676	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of REXO2 mRNA	PMID:23892564
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1603665	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of REXO2 mRNA	PMID:31163220
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of REXO2 mRNA	PMID:22061828
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1620676	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of REXO2 mRNA	PMID:36331819
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1603665	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of REXO2 mRNA	PMID:19549813
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1603665	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of REXO2 mRNA	PMID:23649840
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603665	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of REXO2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of REXO2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of REXO2 mRNA	PMID:32699268
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620676	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of REXO2 mRNA	PMID:34911549
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1620676	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of REXO2 mRNA	PMID:31919559
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620676	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of REXO2 mRNA	PMID:22206623
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1603665	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of REXO2 mRNA	PMID:26272509
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1603665	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REXO2 mRNA	PMID:27188386
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of REXO2 mRNA	PMID:22298810|PMID:34747641
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620676	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of REXO2 mRNA	PMID:20702594|PMID:21570461
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of REXO2 mRNA	PMID:33387578
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1620676	E	RGD:6480464	20260804	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of REXO2 mRNA	PMID:17942748
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1620676	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of REXO2 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of REXO2 mRNA	PMID:16214954|PMID:17942748
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1603665	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of REXO2 protein	PMID:39603559
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1603665	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of REXO2 protein	PMID:33212167
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of REXO2 mRNA	PMID:28959563
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1603665	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of REXO2 mRNA	PMID:29803840
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1603665	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of REXO2 mRNA	PMID:20044591
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1603665	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of REXO2 promoter	PMID:27901495
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620676	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of REXO2 mRNA	PMID:22228805
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1603665	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to REXO2 mRNA]	PMID:32406909
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of REXO2 mRNA	PMID:24136188
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of REXO2 mRNA	PMID:30047161
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of REXO2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1620676	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of REXO2 mRNA	PMID:33221593
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of REXO2 mRNA	PMID:25181051|PMID:32145629
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of REXO2 gene	PMID:28505145
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1603665	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of REXO2 mRNA	PMID:25979313
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620676	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of REXO2 mRNA	PMID:39298647
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1603665	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of REXO2 protein	PMID:34186270
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1603665	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of REXO2 protein	PMID:34186270
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of REXO2 mRNA	PMID:17602206
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of REXO2 mRNA	PMID:17602206
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1620676	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of REXO2 protein	PMID:35362542
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1620676	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of REXO2 protein]	PMID:35362542
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of REXO2 mRNA	PMID:21266533
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of REXO2 mRNA	PMID:19638242
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of REXO2 mRNA	PMID:17602206
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603665	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of REXO2 mRNA	PMID:37042841
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603665	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of REXO2 mRNA	PMID:38568856
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1603665	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of REXO2 mRNA	PMID:25812627
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1603665	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of REXO2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of REXO2 mRNA	PMID:32699268
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1603665	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of REXO2 mRNA	PMID:25812627
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1603665	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of REXO2 mRNA	PMID:26352163
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1603665	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of REXO2 mRNA	PMID:25812627
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620676	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of REXO2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of REXO2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of REXO2 mRNA	PMID:36331819
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603665	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of REXO2 mRNA	PMID:25979313
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1603665	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of REXO2 gene	PMID:29154799
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603665	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of REXO2 mRNA	PMID:19101580|PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603665	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REXO2 mRNA	PMID:27188386
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of REXO2 mRNA	PMID:30047161
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603665	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of REXO2 mRNA	PMID:20106945|PMID:25562108
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1620676	E	RGD:6480464	20260804	CTD	MESH:D013629	Tamoxifen affects the expression of REXO2 mRNA	PMID:17555576
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of REXO2 mRNA	PMID:24136188
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1603665	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of REXO2 mRNA	PMID:24935251
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of REXO2 mRNA	PMID:33387578
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1603665	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of REXO2 mRNA	PMID:21420995|PMID:25704631
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1603665	E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in increased expression of REXO2 mRNA	PMID:23527032
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1620676	E	RGD:6480464	20260804	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of REXO2 mRNA	PMID:17555576
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1620676	E	RGD:6480464	20260804	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of REXO2 mRNA	PMID:17942748
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1620676	E	RGD:6480464	20260804	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of REXO2 mRNA	PMID:17942748
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1620676	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of REXO2 protein]	PMID:35362542
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1620676	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of REXO2 mRNA; Nanotubes, Carbon results in increased expression of REXO2 mRNA	PMID:25554681
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of REXO2 mRNA	PMID:24136188
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of REXO2 mRNA	PMID:30047161
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of REXO2 mRNA	PMID:24793618
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of REXO2 mRNA	PMID:24136188
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603665	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of REXO2 protein	PMID:32959892
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of REXO2 mRNA	PMID:24136188
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1620676	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of REXO2 mRNA	PMID:28444820
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1603665	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of REXO2 protein	PMID:34186270
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1620676	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of REXO2 mRNA	PMID:22206623
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1603665	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of REXO2 protein	PMID:37664457
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of REXO2 mRNA	PMID:24136188
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of REXO2 mRNA	PMID:21346803
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603665	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REXO2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REXO2 mRNA	PMID:27188386
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1620676	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of REXO2 mRNA	PMID:20702594
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1620676	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of REXO2 mRNA	PMID:38648751
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of REXO2 mRNA	PMID:30047161
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1620676	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of REXO2 mRNA	PMID:21278054
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of REXO2 mRNA	PMID:30047161
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603665	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of REXO2 protein; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REXO2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REXO2 mRNA	PMID:27188386|PMID:37664457
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of REXO2 mRNA	PMID:21346803
1304874	Rexo2	RNA exonuclease 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of REXO2 mRNA	PMID:21346803
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312568	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DLX3 mRNA	PMID:33045310
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312568	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DLX3 mRNA	PMID:37995155
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312567	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of DLX3 mRNA	PMID:26079696
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of DLX3 gene	PMID:28931070
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312567	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DLX3 mRNA	PMID:35811015
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DLX3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DLX3 mRNA	PMID:35811015
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of DLX3 mRNA	PMID:30165855
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of DLX3 mRNA	PMID:27523638
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:17833	gentamycin	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins affects the expression of DLX3 mRNA	PMID:33387578
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312568	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of DLX3 mRNA	PMID:27106289
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312568	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DLX3 mRNA	PMID:25629700
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DLX3 mRNA	PMID:32525701
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312567	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of DLX3 mRNA	PMID:26272509
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of DLX3 mRNA	PMID:23557933
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312568	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DLX3 mRNA	PMID:21570461
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DLX3 mRNA	PMID:33387578
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312567	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DLX3 mRNA	PMID:23152189
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312568	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DLX3 mRNA	PMID:24058054
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312567	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DLX3 mRNA	PMID:30851411
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1312567	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of DLX3 mRNA	PMID:26272509
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312567	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of DLX3 mRNA	PMID:34032870
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312567	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DLX3 3' UTR	PMID:30157460
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312567	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DLX3 3' UTR; Benzo(a)pyrene results in increased methylation of DLX3 exon	PMID:27901495
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312568	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of DLX3 mRNA	PMID:27131904
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312567	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DLX3 mRNA	PMID:20458559
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:32095	retinyl acetate	increases expression	ISO	RGD:1312568	E	RGD:6480464	20120412	CTD	MESH:C009166	retinol acetate results in increased expression of DLX3 mRNA	PMID:16772331
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1312568	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of DLX3 gene	PMID:35295148
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312568	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of DLX3 promoter	PMID:27334623
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DLX3 mRNA	PMID:36041667
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:34283	oxybenzone	affects expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone affects the expression of DLX3 mRNA	PMID:30316929
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312568	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DLX3 mRNA	PMID:30951980
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DLX3 mRNA	PMID:36041667
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312568	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DLX3 mRNA	PMID:38685157
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DLX3 mRNA	PMID:36041667
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of DLX3 mRNA	PMID:35163327
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DLX3 mRNA	PMID:35163327
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DLX3 mRNA	PMID:21297351
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DLX3 mRNA	PMID:35163327
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312567	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DLX3 mRNA	PMID:25979313
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312567	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of DLX3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1312567	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of DLX3 promoter	PMID:27989131
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of DLX3 mRNA	PMID:21658437
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312567	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of DLX3 mRNA	PMID:24935251|PMID:26272509
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312567	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of DLX3 mRNA	PMID:22230336
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1312567	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of DLX3 mRNA	PMID:35811015
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DLX3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DLX3 mRNA	PMID:35811015
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312568	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DLX3 mRNA	PMID:19446018
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DLX3 mRNA	PMID:32525701
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312567	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of DLX3 mRNA	PMID:31838189
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1312567	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of DLX3 mRNA	PMID:26272509
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312567	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DLX3 mRNA	PMID:20458559
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of DLX3 mRNA	PMID:30307764
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312567	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DLX3 mRNA	PMID:31629900
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DLX3 mRNA	PMID:28801915
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312567	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DLX3 mRNA	PMID:30851411
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DLX3 gene]	PMID:28238834
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DLX3 mRNA	PMID:27291303
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DLX3 mRNA	PMID:32525701
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312567	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of DLX3 mRNA	PMID:26272509
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312567	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1304875	Dlx3	distal-less homeobox 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312568	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of DLX3 mRNA	PMID:27131904
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312569	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of GGCT mRNA	PMID:38218311
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D004237	Diuron results in decreased expression of GGCT mRNA	PMID:21551480
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GGCT mRNA]	PMID:31150632
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312569	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GGCT mRNA	PMID:33167477
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GGCT mRNA	PMID:30529165
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GGCT mRNA	PMID:39241906
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of GGCT mRNA	PMID:35192832
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312569	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of GGCT mRNA	PMID:38568856
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GGCT mRNA	PMID:33387578
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312569	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GGCT mRNA	PMID:37042841
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGCT mRNA	PMID:37992649
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of GGCT mRNA	PMID:28973375
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGCT mRNA	PMID:37992649
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:17688	(S)-nicotine	increases splicing	ISO	RGD:1312569	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased splicing of GGCT mRNA alternative form	PMID:23825647
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of GGCT mRNA	PMID:36005737
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20180116	CTD	MESH:D004051	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GGCT mRNA	PMID:28433925
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of GGCT protein	PMID:34122009
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GGCT mRNA	PMID:33387578
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GGCT mRNA	PMID:36331819
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of GGCT mRNA	PMID:28522335
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:18723	nicotine	increases splicing	ISO	RGD:1312569	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased splicing of GGCT mRNA alternative form	PMID:23825647
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GGCT mRNA	PMID:29950665
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312569	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of GGCT mRNA	PMID:23649840
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GGCT mRNA	PMID:33354967
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312569	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GGCT mRNA	PMID:23649840
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	ISO	RGD:1312569	E	RGD:6480464	20130618	CTD	MESH:D014747	GGCT protein affects the susceptibility to Vinblastine	PMID:16217747
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GGCT mRNA	PMID:31150632
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:2302840	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GGCT mRNA	PMID:31919559
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GGCT mRNA]	PMID:31150632
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGCT mRNA	PMID:32525701
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:2302840	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of GGCT mRNA	PMID:28960355
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of GGCT mRNA	PMID:31881176
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312569	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of GGCT mRNA	PMID:27392435
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of GGCT mRNA	PMID:27392435
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2302840	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GGCT mRNA	PMID:26377647
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GGCT mRNA	PMID:34747641
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GGCT mRNA	PMID:33387578
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20180116	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GGCT mRNA	PMID:28433925
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of GGCT mRNA	PMID:28374803
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of GGCT mRNA	PMID:23186747
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of GGCT mRNA	PMID:28959563
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20130618	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GGCT mRNA	PMID:20971185
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGCT mRNA	PMID:37992649
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312569	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GGCT mRNA	PMID:37956786|PMID:38100851|PMID:38568856
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:2302840	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of GGCT mRNA	PMID:37682722
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:2302840	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GGCT mRNA	PMID:23735875
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312569	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GGCT promoter	PMID:27901495
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to GGCT mRNA]	PMID:32406909
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20130618	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GGCT mRNA	PMID:20971185
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of GGCT protein	PMID:34122009
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of GGCT mRNA	PMID:38458666
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of GGCT mRNA	PMID:24136188
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:2302840	E	RGD:6480464	20130618	CTD	MESH:C008261	lead acetate results in increased expression of GGCT mRNA	PMID:22609695
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GGCT mRNA	PMID:29264374
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:2302840	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GGCT gene	PMID:35295148
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GGCT mRNA	PMID:29950665
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GGCT mRNA	PMID:34492290
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of GGCT mRNA	PMID:18648102
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:2302840	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of GGCT mRNA	PMID:20813756|PMID:23811191
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:2302840	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of GGCT mRNA	PMID:28472532
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GGCT mRNA	PMID:25181051
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of GGCT mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312569	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of GGCT mRNA; bisphenol A results in decreased expression of GGCT protein	PMID:29275510|PMID:34186270|PMID:37664457
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20180116	CTD	MESH:C006780	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GGCT mRNA	PMID:28433925
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of GGCT mRNA	PMID:26682919
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20180116	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GGCT mRNA	PMID:28433925
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312569	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of GGCT protein	PMID:34186270
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:2302840	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GGCT mRNA	PMID:39298647
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312569	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of GGCT protein	PMID:34186270
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312569	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of GGCT protein	PMID:34186270
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:2302840	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of GGCT mRNA	PMID:28392331
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GGCT mRNA	PMID:29950665
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of GGCT mRNA	PMID:38458666
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312569	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GGCT mRNA	PMID:38568856
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GGCT mRNA	PMID:33453195
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of GGCT mRNA	PMID:25539665
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of GGCT mRNA	PMID:24386269
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	decreases expression	ISO	RGD:1312569	E	RGD:6480464	20130618	CTD	MESH:D015741	Metribolone results in decreased expression of GGCT protein	PMID:17152098
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312569	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GGCT mRNA	PMID:28302478
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312569	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GGCT mRNA	PMID:31533062
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20130618	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA	PMID:19167446
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GGCT mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of GGCT mRNA	PMID:36331819
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312569	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GGCT mRNA	PMID:25979313
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312569	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of GGCT mRNA	PMID:24383497|PMID:29154799
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1312569	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of GGCT mRNA	PMID:25562108
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:2302840	E	RGD:6480464	20130618	CTD	MESH:D013629	Tamoxifen affects the expression of GGCT mRNA	PMID:17555576|PMID:20937368
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:2302840	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of GGCT mRNA	PMID:25123088
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGCT mRNA	PMID:37992649
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of GGCT mRNA	PMID:24136188
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312569	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of GGCT mRNA	PMID:26690555
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGCT mRNA	PMID:32525701
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GGCT mRNA	PMID:29391264
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:2302840	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of GGCT mRNA	PMID:17555576
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GGCT mRNA	PMID:25620056
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:2302840	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GGCT mRNA; Nanotubes, Carbon results in increased expression of GGCT mRNA	PMID:25554681
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of GGCT mRNA	PMID:23962444
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of GGCT mRNA	PMID:24136188
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of GGCT mRNA	PMID:38701926
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312569	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GGCT protein	PMID:32959892
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of GGCT mRNA	PMID:25729387
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of GGCT mRNA	PMID:36851058
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:2302840	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of GGCT mRNA	PMID:27462272
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312569	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of GGCT mRNA	PMID:31758290
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312569	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GGCT protein	PMID:34186270
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GGCT mRNA	PMID:22206623
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:76290	PhIP	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of GGCT mRNA	PMID:33945839
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:76326	N-nitrosomorpholine	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in decreased expression of GGCT protein	PMID:19716841
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312569	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of GGCT protein	PMID:39638853
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:2302840	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital affects the expression of GGCT mRNA	PMID:23091169
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA	PMID:19167446
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312569	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGCT mRNA	PMID:32525701
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GGCT mRNA	PMID:24780913
1304876	Ggct	gamma-glutamyl cyclotransferase	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of GGCT protein	PMID:24648495
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TRIM44 mRNA	PMID:37995155
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1621436	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TRIM44 mRNA	PMID:20188158
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312571	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TRIM44 mRNA	PMID:26079696
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of TRIM44 mRNA	PMID:30319688
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312571	E	RGD:6480464	20251007	CTD	MESH:D006861	Hydrogen Peroxide promotes the reaction [TRIM44 protein promotes the reaction [SQSTM1 protein binds to SQSTM1 protein]]	PMID:39152142
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1621436	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRIM44 mRNA	PMID:39241906
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRIM44 mRNA]	PMID:39241906
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TRIM44 mRNA	PMID:39298647
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312571	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIM44 mRNA	PMID:37042841
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TRIM44 mRNA	PMID:33754040
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TRIM44 mRNA	PMID:36331819
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:22689	bafilomycin A1	multiple interactions	ISO	RGD:1312571	E	RGD:6480464	20251007	CTD	MESH:C040929	bafilomycin A1 promotes the reaction [TRIM44 protein promotes the reaction [SQSTM1 protein binds to SQSTM1 protein]]	PMID:39152142
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312571	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TRIM44 intron	PMID:30157460
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TRIM44 mRNA	PMID:30779732
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TRIM44 mRNA	PMID:22206623
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312571	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRIM44 gene	PMID:25304211
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM44 mRNA	PMID:40504410
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TRIM44 mRNA	PMID:31881176
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312571	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of TRIM44 mRNA	PMID:27594783
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TRIM44 mRNA	PMID:30912803
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM44 mRNA	PMID:22298810
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621436	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM44 mRNA	PMID:21570461
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRIM44 mRNA	PMID:33387578
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312571	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRIM44 mRNA	PMID:29803840
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1312571	E	RGD:6480464	20251007	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [TRIM44 protein promotes the reaction [SQSTM1 protein binds to SQSTM1 protein]]	PMID:39152142
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312571	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TRIM44 mRNA	PMID:38568856
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM44 mRNA	PMID:40504410
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312571	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRIM44 intron	PMID:30157460
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312571	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRIM44 mRNA	PMID:20064835
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRIM44 mRNA	PMID:19770486|PMID:21715664
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312571	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRIM44 promoter	PMID:27901495
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312571	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TRIM44 mRNA	PMID:19150397
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TRIM44 mRNA	PMID:39716349
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1312571	E	RGD:6480464	20251007	CTD	MESH:C006632	TRIM44 protein results in decreased susceptibility to Arsenic Trioxide	PMID:39152142
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312571	E	RGD:6480464	20251007	CTD	MESH:C006632	[TRIM44 protein results in decreased susceptibility to Arsenic Trioxide] which results in increased expression of TXN mRNA; Arsenic Trioxide inhibits the reaction [TRIM44 protein results in increased lipidation of MAP1LC3B protein]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of TXN mRNA]]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of TXN mRNA]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of SQSTM1 protein]	PMID:39152142
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621436	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRIM44 promoter	PMID:35295148
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRIM44 mRNA	PMID:25181051
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312571	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TRIM44 mRNA	PMID:30903817
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM44 mRNA	PMID:34947998
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM44 mRNA	PMID:33221593
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of TRIM44 mRNA	PMID:29097150|PMID:32145629
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TRIM44 gene	PMID:28505145
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TRIM44 mRNA	PMID:36041667
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312571	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of TRIM44 mRNA	PMID:19244175
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TRIM44 mRNA	PMID:39298647
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TRIM44 mRNA	PMID:36041667
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312571	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TRIM44 intron	PMID:30157460
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1621436	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TRIM44 mRNA	PMID:38685157
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TRIM44 mRNA	PMID:36041667
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRIM44 mRNA]	PMID:39241906
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312571	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRIM44 mRNA	PMID:37042841
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1312571	E	RGD:6480464	20251007	CTD	MESH:D002738	Chloroquine promotes the reaction [TRIM44 protein promotes the reaction [SQSTM1 protein binds to SQSTM1 protein]]	PMID:39152142
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TRIM44 mRNA	PMID:36331819
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TRIM44 mRNA	PMID:29427782
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312571	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TRIM44 gene	PMID:29154799
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TRIM44 mRNA	PMID:28973697
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312571	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TRIM44 mRNA	PMID:28542535
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIM44 mRNA	PMID:33387578
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312571	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIM44 mRNA	PMID:21420995
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312571	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRIM44 gene	PMID:25304211
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM44 mRNA	PMID:40504410
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312571	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIM44 mRNA	PMID:22079256
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TRIM44 mRNA	PMID:39716349
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1312571	E	RGD:6480464	20251007	CTD	MESH:C032793	TRIM44 protein results in decreased susceptibility to Arsenic Trioxide	PMID:39152142
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312571	E	RGD:6480464	20251007	CTD	MESH:C032793	[TRIM44 protein results in decreased susceptibility to Arsenic Trioxide] which results in increased expression of TXN mRNA; Arsenic Trioxide inhibits the reaction [TRIM44 protein results in increased lipidation of MAP1LC3B protein]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of TXN mRNA]]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of TXN mRNA]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of SQSTM1 protein]	PMID:39152142
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TRIM44 mRNA	PMID:35964746
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of TRIM44 mRNA	PMID:24793618
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIM44 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM44 mRNA	PMID:21641980|PMID:26378955
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TRIM44 mRNA	PMID:23650126
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312571	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TRIM44 intron	PMID:30157460
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TRIM44 mRNA	PMID:22206623
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312571	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TRIM44 mRNA	PMID:22079256
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312571	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIM44 mRNA	PMID:22079256
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRIM44 mRNA]	PMID:39241906
1304877	Trim44	tripartite motif-containing 44	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312571	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TRIM44 mRNA	PMID:38568856
1304878	Atg2b	autophagy related 2B	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ATG2B mRNA	PMID:37995155
1304878	Atg2b	autophagy related 2B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ATG2B mRNA	PMID:26251327
1304878	Atg2b	autophagy related 2B	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312572	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ATG2B mRNA	PMID:26079696
1304878	Atg2b	autophagy related 2B	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312573	E	RGD:6480464	20201103	CTD	MESH:D001280	Atrazine results in increased expression of ATG2B mRNA	PMID:30360616
1304878	Atg2b	autophagy related 2B	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20201103	CTD	MESH:D001280	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG2B mRNA]	PMID:30360616
1304878	Atg2b	autophagy related 2B	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20201103	CTD	MESH:C015329	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG2B mRNA]	PMID:30360616
1304878	Atg2b	autophagy related 2B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312573	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ATG2B mRNA	PMID:30319688
1304878	Atg2b	autophagy related 2B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ATG2B mRNA	PMID:39298647
1304878	Atg2b	autophagy related 2B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312572	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATG2B mRNA	PMID:37042841
1304878	Atg2b	autophagy related 2B	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312572	E	RGD:6480464	20140729	CTD	MESH:D011374	Progesterone results in increased expression of ATG2B mRNA	PMID:18070364
1304878	Atg2b	autophagy related 2B	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312572	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ATG2B protein	PMID:37730182
1304878	Atg2b	autophagy related 2B	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATG2B mRNA	PMID:33387578
1304878	Atg2b	autophagy related 2B	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312572	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ATG2B mRNA	PMID:28818685
1304878	Atg2b	autophagy related 2B	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312572	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ATG2B mRNA	PMID:39836092
1304878	Atg2b	autophagy related 2B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312572	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG2B mRNA	PMID:35301059
1304878	Atg2b	autophagy related 2B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATG2B mRNA	PMID:37236586
1304878	Atg2b	autophagy related 2B	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312572	E	RGD:6480464	20140729	CTD	MESH:D019327	Copper Sulfate results in increased expression of ATG2B mRNA	PMID:19549813
1304878	Atg2b	autophagy related 2B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312572	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATG2B gene	PMID:27153756
1304878	Atg2b	autophagy related 2B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312573	E	RGD:6480464	20140729	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ATG2B mRNA	PMID:19770486
1304878	Atg2b	autophagy related 2B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312572	E	RGD:6480464	20140729	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATG2B mRNA	PMID:23649840
1304878	Atg2b	autophagy related 2B	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ATG2B mRNA	PMID:31150632
1304878	Atg2b	autophagy related 2B	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312572	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ATG2B protein	PMID:35688186
1304878	Atg2b	autophagy related 2B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312572	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ATG2B mRNA	PMID:23557933
1304878	Atg2b	autophagy related 2B	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312572	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ATG2B mRNA	PMID:27594783
1304878	Atg2b	autophagy related 2B	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003042	Cocaine affects the expression of ATG2B mRNA	PMID:20187946
1304878	Atg2b	autophagy related 2B	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ATG2B mRNA	PMID:30912803
1304878	Atg2b	autophagy related 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312573	E	RGD:6480464	20140729	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATG2B mRNA	PMID:21570461
1304878	Atg2b	autophagy related 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATG2B mRNA	PMID:21215274
1304878	Atg2b	autophagy related 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ATG2B mRNA	PMID:25975270
1304878	Atg2b	autophagy related 2B	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ATG2B mRNA	PMID:28374803
1304878	Atg2b	autophagy related 2B	gene	CHEBI:2825	aristolochic acid A	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:C000228	[aristolochic acid I co-treated with Probenecid] results in decreased expression of ATG2B protein	PMID:38428544
1304878	Atg2b	autophagy related 2B	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ATG2B mRNA	PMID:28959563
1304878	Atg2b	autophagy related 2B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312572	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATG2B mRNA	PMID:29803840
1304878	Atg2b	autophagy related 2B	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312572	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ATG2B protein	PMID:35688186
1304878	Atg2b	autophagy related 2B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312573	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ATG2B intron	PMID:27901495
1304878	Atg2b	autophagy related 2B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312573	E	RGD:6480464	20140729	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATG2B mRNA	PMID:22228805
1304878	Atg2b	autophagy related 2B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312572	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATG2B 3' UTR	PMID:27901495
1304878	Atg2b	autophagy related 2B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312572	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ATG2B mRNA]	PMID:32406909
1304878	Atg2b	autophagy related 2B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312572	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ATG2B mRNA	PMID:26238291
1304878	Atg2b	autophagy related 2B	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ATG2B mRNA	PMID:24136188
1304878	Atg2b	autophagy related 2B	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of ATG2B mRNA	PMID:24136188
1304878	Atg2b	autophagy related 2B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312573	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATG2B gene	PMID:35295148
1304878	Atg2b	autophagy related 2B	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ATG2B mRNA	PMID:34492290
1304878	Atg2b	autophagy related 2B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20140729	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ATG2B mRNA	PMID:19710929
1304878	Atg2b	autophagy related 2B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATG2B mRNA	PMID:25181051
1304878	Atg2b	autophagy related 2B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ATG2B mRNA	PMID:30816183|PMID:32145629|PMID:34947998
1304878	Atg2b	autophagy related 2B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312572	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ATG2B mRNA	PMID:29275510
1304878	Atg2b	autophagy related 2B	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:1312572	E	RGD:6480464	20230704	CTD	MESH:C005290	oxybenzone results in increased expression of ATG2B mRNA	PMID:36581016
1304878	Atg2b	autophagy related 2B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ATG2B mRNA	PMID:39298647
1304878	Atg2b	autophagy related 2B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ATG2B mRNA	PMID:34813904
1304878	Atg2b	autophagy related 2B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ATG2B mRNA	PMID:34813904
1304878	Atg2b	autophagy related 2B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312572	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATG2B mRNA	PMID:37042841
1304878	Atg2b	autophagy related 2B	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312572	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ATG2B mRNA	PMID:39836092
1304878	Atg2b	autophagy related 2B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312572	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG2B mRNA	PMID:35301059
1304878	Atg2b	autophagy related 2B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATG2B mRNA	PMID:37236586
1304878	Atg2b	autophagy related 2B	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312572	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ATG2B mRNA	PMID:31533062
1304878	Atg2b	autophagy related 2B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312572	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATG2B mRNA	PMID:25979313
1304878	Atg2b	autophagy related 2B	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312572	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ATG2B gene	PMID:29154799
1304878	Atg2b	autophagy related 2B	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312573	E	RGD:6480464	20140729	CTD	MESH:D013629	Tamoxifen affects the expression of ATG2B mRNA	PMID:17555576
1304878	Atg2b	autophagy related 2B	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ATG2B mRNA	PMID:21658437
1304878	Atg2b	autophagy related 2B	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1312572	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of ATG2B mRNA	PMID:24449571
1304878	Atg2b	autophagy related 2B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312572	E	RGD:6480464	20140729	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATG2B mRNA	PMID:21420995
1304878	Atg2b	autophagy related 2B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312573	E	RGD:6480464	20140729	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ATG2B mRNA	PMID:17555576
1304878	Atg2b	autophagy related 2B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATG2B mRNA; Nanotubes, Carbon results in decreased expression of ATG2B mRNA	PMID:25554681
1304878	Atg2b	autophagy related 2B	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D008713	Methimazole results in increased expression of ATG2B mRNA	PMID:22504374
1304878	Atg2b	autophagy related 2B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312572	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ATG2B mRNA	PMID:39836092
1304878	Atg2b	autophagy related 2B	gene	CHEBI:63598	levofloxacin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in increased expression of ATG2B mRNA	PMID:24136188
1304878	Atg2b	autophagy related 2B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312573	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ATG2B mRNA	PMID:22206623
1304878	Atg2b	autophagy related 2B	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312573	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ATG2B mRNA	PMID:31388691
1304878	Atg2b	autophagy related 2B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ATG2B mRNA	PMID:23914054
1304878	Atg2b	autophagy related 2B	gene	CHEBI:8426	probenecid	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011339	[aristolochic acid I co-treated with Probenecid] results in decreased expression of ATG2B protein	PMID:38428544
1304878	Atg2b	autophagy related 2B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATG2B mRNA	PMID:22504374
1304878	Atg2b	autophagy related 2B	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312572	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ATG2B mRNA	PMID:29301935
1304878	Atg2b	autophagy related 2B	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312572	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ATG2B mRNA	PMID:27188386
1304878	Atg2b	autophagy related 2B	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ATG2B mRNA	PMID:28973697
1304878	Atg2b	autophagy related 2B	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312572	E	RGD:6480464	20210608	CTD	MESH:C080163	trovafloxacin results in increased expression of ATG2B mRNA	PMID:33609687
1304878	Atg2b	autophagy related 2B	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ATG2B mRNA	PMID:23034163
1304879	Zfp956	zinc finger protein 956	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D020106	Acrylamide results in increased expression of ZFP956 mRNA	PMID:28959563
1304879	Zfp956	zinc finger protein 956	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP956 mRNA	PMID:25181051
1304879	Zfp956	zinc finger protein 956	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP956 mRNA	PMID:30816183|PMID:32528016
1304879	Zfp956	zinc finger protein 956	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP956 mRNA	PMID:36041667
1304879	Zfp956	zinc finger protein 956	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP956 mRNA	PMID:36041667
1304879	Zfp956	zinc finger protein 956	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP956 mRNA	PMID:36041667
1304879	Zfp956	zinc finger protein 956	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C039281	furan results in increased expression of ZFP956 mRNA	PMID:25539665
1304879	Zfp956	zinc finger protein 956	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C018021	cobaltous chloride results in increased expression of ZFP956 mRNA	PMID:24386269
1304879	Zfp956	zinc finger protein 956	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFP956 mRNA	PMID:33387578
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SCUBE3 mRNA	PMID:26272509
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312575	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA	PMID:27188386
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614840	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SCUBE3 mRNA	PMID:33045310
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312575	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SCUBE3 mRNA	PMID:21934132
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SCUBE3 mRNA	PMID:37992649
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SCUBE3 mRNA	PMID:22017230
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SCUBE3 mRNA	PMID:37992649
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SCUBE3 mRNA	PMID:33387578
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D015122	Mercaptopurine results in increased expression of SCUBE3 mRNA	PMID:23358152
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1614840	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of SCUBE3 mRNA	PMID:39984025
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SCUBE3 mRNA	PMID:33354967
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SCUBE3 mRNA	PMID:34911549
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SCUBE3 mRNA	PMID:31150632
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312575	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SCUBE3 gene	PMID:25304211
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1614840	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of SCUBE3 mRNA	PMID:28960355
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SCUBE3 mRNA	PMID:31881176
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of SCUBE3 mRNA	PMID:24768652|PMID:25583101
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SCUBE3 mRNA	PMID:33387578
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SCUBE3 mRNA	PMID:33956508
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SCUBE3 mRNA	PMID:28001369
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of SCUBE3 mRNA	PMID:30807115
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SCUBE3 mRNA	PMID:37992649
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SCUBE3 mRNA	PMID:37682722
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312575	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SCUBE3 promoter	PMID:27901495
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614840	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SCUBE3 mRNA	PMID:22228805|PMID:27195522
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:3139	bleomycin A2	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20260113	CTD	MESH:D001761	Bleomycin results in decreased expression of SCUBE3 mRNA	PMID:40645554
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:3139	bleomycin A2	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in decreased expression of SCUBE3 mRNA	PMID:30825431
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SCUBE3 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of SCUBE3 mRNA]	PMID:30825431
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614840	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SCUBE3 promoter	PMID:35295148
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614840	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SCUBE3 promoter	PMID:35295148
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SCUBE3 mRNA	PMID:25181051
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SCUBE3 mRNA	PMID:34947998
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SCUBE3 mRNA	PMID:25172293
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SCUBE3 mRNA	PMID:26682919
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of SCUBE3 mRNA	PMID:36804509
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of SCUBE3 mRNA	PMID:32119087
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1614840	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SCUBE3 gene	PMID:31683443
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of SCUBE3 mRNA	PMID:30951980
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1614840	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SCUBE3 exon	PMID:33297965
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312575	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCUBE3 mRNA	PMID:28628672
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of SCUBE3 mRNA	PMID:30951980
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1614840	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SCUBE3 intron	PMID:28392331
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1614840	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SCUBE3 mRNA	PMID:37019170
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312575	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SCUBE3 gene	PMID:22964155
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312575	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCUBE3 mRNA	PMID:28628672
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312575	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SCUBE3 mRNA	PMID:37042841
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1312575	E	RGD:6480464	20230307	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SCUBE3 mRNA	PMID:35776891
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of SCUBE3 mRNA	PMID:26377693
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased expression of SCUBE3 mRNA	PMID:27387713
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614840	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SCUBE3 mRNA	PMID:40194260
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SCUBE3 mRNA	PMID:31533062
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312575	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SCUBE3 mRNA	PMID:25979313
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SCUBE3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312575	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA	PMID:27188386
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312575	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCUBE3 mRNA	PMID:28628672
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SCUBE3 mRNA	PMID:37992649
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312575	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA	PMID:27188386
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SCUBE3 mRNA	PMID:24935251|PMID:26272509
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of SCUBE3 mRNA	PMID:30723492|PMID:33387578
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312575	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SCUBE3 gene	PMID:25304211
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312575	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCUBE3 mRNA	PMID:28628672
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D015122	Mercaptopurine results in increased expression of SCUBE3 mRNA	PMID:23358152
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of SCUBE3 mRNA	PMID:40645554
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SCUBE3 mRNA	PMID:24810058
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20130806	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SCUBE3 mRNA	PMID:17475336
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SCUBE3 mRNA]	PMID:30825431
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:748998	lenabasum	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20260714	CTD	MESH:C471849	lenabasum inhibits the reaction [Bleomycin results in decreased expression of SCUBE3 mRNA]	PMID:30825431
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1312575	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of SCUBE3 mRNA	PMID:29522793
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of SCUBE3 mRNA	PMID:33484710
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1312575	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of SCUBE3 mRNA	PMID:34995734
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312575	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA	PMID:27188386
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312575	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SCUBE3 gene]	PMID:28238834
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312575	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA	PMID:27188386
1304880	Scube3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of SCUBE3 mRNA	PMID:23358152
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:2306328	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DCAF15 mRNA	PMID:38218311
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312576	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DCAF15 mRNA	PMID:33045310
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312576	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DCAF15 mRNA	PMID:39298647
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312576	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DCAF15 mRNA	PMID:23892564
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:2306328	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DCAF15 protein	PMID:37730182
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DCAF15 mRNA	PMID:33387578
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312576	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of DCAF15 mRNA	PMID:37748715
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:2306328	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of DCAF15 mRNA	PMID:26272509
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:2306328	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCAF15 mRNA	PMID:27188386
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:2306328	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DCAF15 protein	PMID:35688186
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DCAF15 mRNA	PMID:31881176
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:2306328	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DCAF15 mRNA	PMID:28903495
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DCAF15 mRNA	PMID:32109520
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DCAF15 mRNA	PMID:33387578
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:2306328	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DCAF15 mRNA	PMID:33212167
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:2306328	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DCAF15 intron	PMID:30157460
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:2306328	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DCAF15 mRNA	PMID:20018196
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:2306328	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of DCAF15 gene	PMID:31601247
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of DCAF15 mRNA	PMID:19167457
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of DCAF15 mRNA	PMID:33296240
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2306328	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DCAF15 mRNA; bisphenol A results in decreased expression of DCAF15 protein	PMID:29275510|PMID:33181973
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DCAF15 mRNA	PMID:25181051
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312576	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DCAF15 mRNA	PMID:38685157
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312576	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DCAF15 mRNA	PMID:37019170
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312576	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of DCAF15 mRNA	PMID:34813904
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312576	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of DCAF15 mRNA	PMID:34813904
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:2306328	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DCAF15 mRNA	PMID:37042841
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:2306328	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DCAF15 mRNA	PMID:38568856
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:2306328	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCAF15 mRNA	PMID:19167446
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312576	E	RGD:6480464	20120515	CTD	MESH:D014635	Valproic Acid affects the expression of DCAF15 mRNA	PMID:17292431|PMID:17963808
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:2306328	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DCAF15 mRNA	PMID:25979313
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:2306328	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DCAF15 gene	PMID:29154799
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:2306328	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DCAF15 mRNA	PMID:25562108
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DCAF15 mRNA	PMID:33387578
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:2306328	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of DCAF15 mRNA	PMID:20977926
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:2306328	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of DCAF15 mRNA	PMID:29432896
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312576	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DCAF15 mRNA	PMID:22206623
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:2306328	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCAF15 mRNA	PMID:27188386
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:2306328	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCAF15 mRNA	PMID:19167446
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:2306328	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCAF15 mRNA	PMID:27188386
1304881	Dcaf15	DDB1 and CUL4 associated factor 15	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of DCAF15 mRNA	PMID:18042343
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in decreased expression of CLPX mRNA	PMID:33227293
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CLPX mRNA	PMID:21632981
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of CLPX mRNA	PMID:32145629
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312579	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CLPX mRNA	PMID:39298647
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CLPX mRNA	PMID:37992649
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CLPX mRNA	PMID:37992649
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CLPX mRNA	PMID:33754040
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CLPX mRNA	PMID:36331819
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin analog results in decreased expression of CLPX protein	PMID:26597043
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CLPX protein	PMID:34915118
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of CLPX mRNA	PMID:21515302
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CLPX mRNA	PMID:37236586
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312579	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of CLPX mRNA	PMID:24535564
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in decreased expression of CLPX mRNA	PMID:31939706
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CLPX mRNA	PMID:27339419
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CLPX mRNA	PMID:25629700
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLPX mRNA	PMID:22206623
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CLPX protein	PMID:37208198
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312579	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of CLPX mRNA	PMID:28189721|PMID:28960355
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312578	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CLPX mRNA	PMID:23557933
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of CLPX mRNA	PMID:34813904
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312579	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLPX mRNA	PMID:21570461|PMID:28922406
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLPX mRNA	PMID:17101203
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20150825	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLPX mRNA	PMID:25975270
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLPX mRNA	PMID:33387578
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of CLPX mRNA	PMID:28374803
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of CLPX mRNA	PMID:28374803
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312578	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of CLPX mRNA	PMID:33512557
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CLPX mRNA	PMID:30851411
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312579	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of CLPX mRNA	PMID:25896364|PMID:39631538
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CLPX mRNA	PMID:37992649
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLPX mRNA	PMID:39095385
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLPX mRNA	PMID:19770486
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312579	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLPX mRNA	PMID:22228805
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312578	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CLPX mRNA]	PMID:32406909
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CLPX mRNA	PMID:19150397
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of CLPX mRNA	PMID:24136188
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:31739	josamycin	affects response to substance	ISO	RGD:1312578	E	RGD:6480464	20200609	CTD	MESH:D015570	CLPX protein affects the susceptibility to Josamycin	PMID:31915244
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312579	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CLPX gene	PMID:35295148
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312578	E	RGD:6480464	20190910	CTD	MESH:C009495	titanium dioxide results in increased expression of CLPX protein	PMID:30910687
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CLPX mRNA	PMID:18648102
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312579	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CLPX mRNA	PMID:18445702|PMID:20813756|PMID:23811191
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CLPX mRNA	PMID:19710929
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312578	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CLPX mRNA	PMID:38479592
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CLPX mRNA	PMID:30903817
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of CLPX mRNA	PMID:32145629
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of CLPX protein	PMID:34186270|PMID:37567409
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CLPX mRNA	PMID:26063408
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312579	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CLPX exon	PMID:33297965
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312579	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of CLPX mRNA	PMID:33297965|PMID:39298647
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312578	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CLPX protein	PMID:34186270
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312579	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CLPX mRNA	PMID:38685157
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312578	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CLPX protein	PMID:34186270
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CLPX mRNA	PMID:37019170
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CLPX mRNA	PMID:21266533
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLPX mRNA	PMID:18164116
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312579	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased expression of CLPX mRNA	PMID:21371552
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CLPX mRNA	PMID:30589522
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of CLPX mRNA	PMID:26377693
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of CLPX mRNA	PMID:30723492
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLPX mRNA	PMID:38568856
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CLPX mRNA	PMID:37236586
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CLPX gene	PMID:22079235
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CLPX mRNA	PMID:21139344
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of CLPX mRNA	PMID:17585979
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CLPX mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CLPX mRNA	PMID:36331819
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312578	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CLPX mRNA	PMID:25979313
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CLPX mRNA	PMID:17963808
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CLPX mRNA	PMID:23179753|PMID:27188386
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312579	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of CLPX mRNA	PMID:24535564
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of CLPX mRNA	PMID:19770486
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312578	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CLPX mRNA	PMID:25562108
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CLPX mRNA	PMID:37992649
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1312578	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of CLPX mRNA	PMID:33512557
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CLPX mRNA	PMID:18502557
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of CLPX mRNA	PMID:24136188
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1312578	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of CLPX protein	PMID:15907983
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312578	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CLPX mRNA	PMID:28542535
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CLPX mRNA	PMID:17562736
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLPX mRNA	PMID:33387578
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLPX mRNA	PMID:21420995|PMID:22230336|PMID:25704631|PMID:29067470
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1312579	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of CLPX mRNA	PMID:35436446
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312579	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CLPX mRNA	PMID:25620056
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CLPX mRNA	PMID:23608068
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CLPX mRNA	PMID:20436886
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CLPX protein	PMID:32959892
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLPX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CLPX mRNA	PMID:21641980|PMID:26378955
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CLPX mRNA	PMID:23650126
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312579	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CLPX protein	PMID:26558463
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in increased expression of CLPX mRNA	PMID:19149911
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CLPX mRNA	PMID:30467583
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:6887	methylphenidate	increases expression	ISO	RGD:1312579	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in increased expression of CLPX mRNA	PMID:22470460
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312578	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CLPX protein	PMID:34186270
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CLPX mRNA	PMID:22206623
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLPX mRNA	PMID:22206623
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312578	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CLPX protein	PMID:37664457
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLPX mRNA	PMID:18164116
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased expression of CLPX mRNA	PMID:37162024
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:7719	ochratoxin A	increases methylation	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased methylation of CLPX gene	PMID:37162024
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312578	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CLPX mRNA	PMID:30851411
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CLPX mRNA	PMID:19270015|PMID:19482888
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of CLPX mRNA]	PMID:19482888
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of CLPX protein	PMID:28903499
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1312578	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of CLPX mRNA	PMID:33512557
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of CLPX mRNA	PMID:39847705
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312579	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of CLPX mRNA	PMID:21795629
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CLPX mRNA	PMID:21278054
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312578	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CLPX protein	PMID:37664457
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CLPX mRNA	PMID:21346803
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:9747	Triptolide	affects expression	ISO	RGD:1312579	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide affects the expression of CLPX mRNA	PMID:32835833
1304883	Clpx	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of CLPX mRNA	PMID:21515302
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1351889	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of KIAA0513 protein	PMID:36641056
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1351889	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of KIAA0513 mRNA	PMID:23830798|PMID:33167477
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of 6430548M08RIKL gene	PMID:35440735
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of 6430548M08RIKL mRNA	PMID:36841081
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1351889	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of KIAA0513 mRNA	PMID:28986285
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1351889	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of KIAA0513 mRNA	PMID:20044591
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1351889	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KIAA0513 mRNA	PMID:35811015
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KIAA0513 mRNA	PMID:35811015
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of 6430548M08RIKL mRNA	PMID:33387578
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1351889	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of KIAA0513 mRNA	PMID:21592394
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of KIAA0513 mRNA	PMID:21592394
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1351889	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of KIAA0513 mRNA	PMID:26485663
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1351889	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of KIAA0513 mRNA	PMID:21592394
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of KIAA0513 mRNA	PMID:21592394
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of 6430548M08RIKL mRNA	PMID:33387578
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KIAA0513 mRNA	PMID:39836092
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1351889	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KIAA0513 mRNA	PMID:19549813
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1351889	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KIAA0513 intron	PMID:30157460
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KIAA0513 mRNA	PMID:39836092
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of 6430548M08RIKL mRNA	PMID:31881176
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of 6430548M08RIKL mRNA	PMID:33387578
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1351889	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KIAA0513 mRNA	PMID:30851411
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of 6430548M08RIKL mRNA	PMID:28959563
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1351889	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of KIAA0513 gene	PMID:28589171
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KIAA0513 mRNA	PMID:39836092
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351889	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KIAA0513 3' UTR; Benzo(a)pyrene affects the methylation of KIAA0513 5' UTR	PMID:27901495
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1351889	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KIAA0513 promoter	PMID:27901495
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1351889	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of KIAA0513 mRNA	PMID:25895662
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of 6430548M08RIKL mRNA	PMID:34492290
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of 6430548M08RIKL mRNA; bisphenol A results in decreased expression of KIAA0513 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1351889	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of KIAA0513 mRNA	PMID:27685785|PMID:29275510
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of 6430548M08RIKL mRNA	PMID:21266533
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351889	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KIAA0513 mRNA	PMID:37042841
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:351346	phenethyl isothiocyanate	increases expression	ISO	RGD:1351889	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in increased expression of KIAA0513 mRNA	PMID:26678675
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KIAA0513 mRNA	PMID:39836092
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of 6430548M08RIKL mRNA	PMID:33453195
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1351889	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KIAA0513 mRNA	PMID:31533062
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1351889	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of KIAA0513 mRNA	PMID:19167446
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA0513 mRNA	PMID:19167446
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351889	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KIAA0513 mRNA	PMID:25979313
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351889	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of KIAA0513 mRNA	PMID:19101580
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1351889	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of KIAA0513 mRNA	PMID:20106945
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1351889	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KIAA0513 mRNA	PMID:38832940
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of 6430548M08RIKL mRNA	PMID:33387578
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1351889	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of KIAA0513 mRNA	PMID:22230336|PMID:26690555|PMID:29067470
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KIAA0513 mRNA	PMID:35811015
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KIAA0513 mRNA	PMID:39836092
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1351889	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of KIAA0513 mRNA	PMID:31838189
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of 6430548M08RIKL mRNA	PMID:29391264
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KIAA0513 mRNA	PMID:39836092
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of 6430548M08RIKL gene	PMID:35440735
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1351889	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of KIAA0513 mRNA	PMID:31758290
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1351889	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of KIAA0513 mRNA	PMID:37199045
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:756028	mivebresib	increases expression	ISO	RGD:1351889	E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of KIAA0513 mRNA	PMID:35486664
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1351889	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KIAA0513 mRNA	PMID:30851411
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1351889	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA0513 mRNA	PMID:19167446
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312580	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of KIAA0513 mRNA	PMID:30294300
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of 6430548M08RIKL protein	PMID:28903499
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1351889	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of KIAA0513 mRNA	PMID:32234424
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of 6430548M08RIKL mRNA	PMID:24780913
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1351889	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KIAA0513 mRNA	PMID:38568856
1304884	6430548M08Rikl	RIKEN cDNA 6430548M08 gene like	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of 6430548M08RIKL mRNA	PMID:23034163
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SH3D19 mRNA	PMID:23724009
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1331895	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SH3D19 mRNA	PMID:30529165
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SH3D19 mRNA	PMID:21632981
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SH3D19 mRNA	PMID:32145629
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605862	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SH3D19 mRNA	PMID:31614463
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of SH3D19 mRNA	PMID:22967744
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:17688	(S)-nicotine	increases splicing	ISO	RGD:1605862	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased splicing of SH3D19 mRNA alternative form	PMID:23825647
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SH3D19 mRNA	PMID:34319233
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SH3D19 mRNA	PMID:26577399
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1605862	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SH3D19 exon	PMID:30157460
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:18723	nicotine	increases splicing	ISO	RGD:1605862	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased splicing of SH3D19 mRNA alternative form	PMID:23825647
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of SH3D19 mRNA	PMID:27462272
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1331895	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SH3D19 mRNA	PMID:37236586
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SH3D19 mRNA	PMID:19549813
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1331895	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SH3D19 mRNA	PMID:19770486
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SH3D19 mRNA	PMID:35430440
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SH3D19 mRNA	PMID:25629700
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1331895	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SH3D19 mRNA	PMID:21570461
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SH3D19 mRNA	PMID:33387578
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SH3D19 mRNA	PMID:33956508
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SH3D19 mRNA	PMID:20106945|PMID:21632981
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SH3D19 mRNA	PMID:32109520
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1331895	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SH3D19 mRNA	PMID:19770486
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SH3D19 mRNA	PMID:28374803
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SH3D19 mRNA	PMID:33212167
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SH3D19 mRNA	PMID:29803840
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of SH3D19 mRNA	PMID:39515575
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SH3D19 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605862	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SH3D19 exon; Benzo(a)pyrene results in decreased methylation of SH3D19 promoter	PMID:27901495
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1331895	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SH3D19 mRNA	PMID:19770486|PMID:27195522
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1331895	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SH3D19 mRNA	PMID:27858113
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SH3D19 mRNA]	PMID:32406909
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SH3D19 mRNA	PMID:19150397
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SH3D19 protein]	PMID:26598702
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1605862	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SH3D19 gene	PMID:31601247
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SH3D19 mRNA	PMID:23557971
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SH3D19 mRNA	PMID:18445702
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of SH3D19 mRNA	PMID:30690063
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of SH3D19 mRNA	PMID:30816183|PMID:32145629
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3D19 mRNA	PMID:25181051
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1331895	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SH3D19 mRNA	PMID:30951980
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1605862	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SH3D19 protein	PMID:34186270
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SH3D19 mRNA	PMID:28628672
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SH3D19 mRNA	PMID:27914987
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1605862	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SH3D19 mRNA	PMID:25979313
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1331895	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SH3D19 mRNA	PMID:30951980
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1605862	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SH3D19 protein	PMID:34186270
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of SH3D19 mRNA	PMID:26377693
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1331895	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SH3D19 mRNA	PMID:27858113
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1605862	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SH3D19 exon	PMID:30157460
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1331895	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SH3D19 mRNA	PMID:30951980|PMID:38685157
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1605862	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SH3D19 protein	PMID:34186270
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1605862	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SH3D19 protein	PMID:34186270
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SH3D19 mRNA	PMID:28392331
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SH3D19 mRNA	PMID:28628672
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of SH3D19 gene	PMID:33148267
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1331895	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SH3D19 mRNA	PMID:37236586
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1605862	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SH3D19 mRNA	PMID:24449571
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SH3D19 mRNA	PMID:31533062
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of SH3D19 mRNA	PMID:19167446
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605862	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SH3D19 mRNA	PMID:25979313
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605862	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of SH3D19 mRNA	PMID:23527032
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SH3D19 mRNA	PMID:25562108
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1605862	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of SH3D19 mRNA	PMID:25047013
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SH3D19 mRNA	PMID:28628672
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1605862	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SH3D19 mRNA	PMID:36621641
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SH3D19 mRNA	PMID:28973697
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1331895	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SH3D19 mRNA	PMID:18502557
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SH3D19 mRNA	PMID:26272509
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SH3D19 mRNA	PMID:27188386
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SH3D19 mRNA	PMID:21420995
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SH3D19 mRNA	PMID:33387578
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1605862	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of SH3D19 mRNA	PMID:36621641
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of SH3D19 mRNA	PMID:30529165
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SH3D19 mRNA	PMID:28628672
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SH3D19 protein]	PMID:26598702
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SH3D19 mRNA; Nanotubes, Carbon results in decreased expression of SH3D19 mRNA	PMID:25554681|PMID:25620056
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of SH3D19 mRNA	PMID:26377693
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1331895	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SH3D19 mRNA	PMID:27858113
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1331895	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SH3D19 mRNA	PMID:27858113
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1605862	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SH3D19 mRNA	PMID:28988120
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1331895	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of SH3D19 mRNA	PMID:20003209
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of SH3D19 mRNA	PMID:19564919
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1605862	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SH3D19 exon	PMID:30157460
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SH3D19 gene	PMID:35440735
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of SH3D19 gene	PMID:33148267
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SH3D19 mRNA	PMID:31758290
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1605862	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SH3D19 protein	PMID:34186270
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1605862	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SH3D19 mRNA	PMID:22714537
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SH3D19 mRNA	PMID:27188386
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of SH3D19 mRNA	PMID:31388691
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SH3D19 mRNA	PMID:25825206
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605862	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SH3D19 mRNA	PMID:27188386
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1605862	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SH3D19 mRNA	PMID:29301935
1304885	Sh3d19	SH3 domain containing 19	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1331895	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SH3D19 mRNA	PMID:28973697
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1606187	E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of TMEM54 mRNA	PMID:19371625
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1606187	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TMEM54 mRNA	PMID:27188386
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:144400	dinophysistoxin 1	decreases expression	ISO	RGD:1606187	E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in decreased expression of TMEM54 mRNA	PMID:28939011
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1606187	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM54 mRNA	PMID:23724009
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1614374	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM54 mRNA	PMID:36189433
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1614374	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM54 mRNA	PMID:36189433
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1606187	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of TMEM54 mRNA	PMID:22378314
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1606187	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TMEM54 mRNA	PMID:21632981
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1614374	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of TMEM54 mRNA	PMID:19484750
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM54 mRNA	PMID:33387578
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1614374	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of TMEM54 mRNA	PMID:22238285
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1614374	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM54 mRNA	PMID:36189433
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TMEM54 mRNA	PMID:26577399
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1614374	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of TMEM54 mRNA	PMID:29279043
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1606187	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TMEM54 mRNA	PMID:19549813
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614374	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TMEM54 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TMEM54 mRNA	PMID:34911549
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614374	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TMEM54 mRNA	PMID:25629700
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614374	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM54 mRNA	PMID:22206623
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1606187	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of TMEM54 mRNA	PMID:23300844
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1606187	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of TMEM54 mRNA	PMID:19371625
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1606187	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of TMEM54 mRNA	PMID:29955902
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TMEM54 mRNA	PMID:28959563
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606187	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM54 mRNA	PMID:29803840
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1606187	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TMEM54 mRNA	PMID:29432896
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606187	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TMEM54 mRNA	PMID:34032870|PMID:38568856|PMID:39719251
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606187	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMEM54 promoter	PMID:27901495
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1606187	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of TMEM54 mRNA	PMID:38568856
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TMEM54 mRNA	PMID:30047161
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1614374	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of TMEM54 mRNA	PMID:23557971
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1614374	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of TMEM54 mRNA	PMID:27760801
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614374	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TMEM54 gene; titanium dioxide results in increased methylation of TMEM54 promoter	PMID:35295148
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TMEM54 mRNA	PMID:23411599
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM54 mRNA	PMID:25181051
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMEM54 gene	PMID:28505145
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1614374	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TMEM54 gene	PMID:31683443
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1614374	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of TMEM54 exon; bisphenol S results in increased methylation of TMEM54 promoter	PMID:33297965
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of TMEM54 mRNA	PMID:32680482
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TMEM54 mRNA	PMID:30047161
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614374	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TMEM54 mRNA	PMID:40194260
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1606187	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TMEM54 mRNA	PMID:40419075
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1614374	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of TMEM54 mRNA	PMID:23125180
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606187	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM54 mRNA	PMID:25979313
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606187	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM54 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606187	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM54 mRNA	PMID:27188386
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TMEM54 mRNA	PMID:30047161
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606187	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of TMEM54 mRNA	PMID:20106945
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606187	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TMEM54 mRNA	PMID:25562108
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1606187	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TMEM54 mRNA	PMID:36621641
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1606187	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM54 mRNA	PMID:22230336
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1614374	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of TMEM54 mRNA]	PMID:18700144
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1606187	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TMEM54 mRNA	PMID:29432896
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:47519	ketoconazole	affects expression	ISO	RGD:1606187	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole affects the expression of TMEM54 mRNA	PMID:36621641
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1606187	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of TMEM54 mRNA	PMID:38568856
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1606187	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TMEM54 mRNA	PMID:23300844
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	ISO	RGD:1614374	E	RGD:6480464	20220510	CTD	MESH:C014347	Decitabine results in decreased methylation of TMEM54 gene	PMID:31215104
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1614374	E	RGD:6480464	20220510	CTD	MESH:C014347	Decitabine results in increased expression of TMEM54 mRNA	PMID:31215104
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614374	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TMEM54 mRNA; Nanotubes, Carbon results in increased expression of TMEM54 mRNA	PMID:25554681
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TMEM54 mRNA	PMID:30047161
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1614374	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of TMEM54 mRNA	PMID:19042947
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614374	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM54 mRNA	PMID:22206623
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606187	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM54 mRNA	PMID:27188386
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1606187	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of TMEM54 mRNA	PMID:26079696
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of TMEM54 mRNA	PMID:30047161
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TMEM54 mRNA	PMID:30047161
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606187	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM54 mRNA	PMID:27188386
1304886	Tmem54	transmembrane protein 54	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of TMEM54 mRNA	PMID:21515302
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1312583	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of DSCAML1 mRNA	PMID:34925699
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of DSCAML1 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DSCAML1 mRNA	PMID:30951980|PMID:36189433
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312583	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DSCAML1 mRNA	PMID:26079696
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of DSCAML1 gene	PMID:35440735
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312584	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DSCAML1 mRNA	PMID:30319688
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312583	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of DSCAML1 mRNA	PMID:30510588
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA	PMID:25510870
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DSCAML1 mRNA	PMID:33387578
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1312583	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of DSCAML1 mRNA	PMID:26079696
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA	PMID:37567420
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DSCAML1 mRNA	PMID:36189433
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:17303	morphine	increases expression	ISO	RGD:1312584	E	RGD:6480464	20120412	CTD	MESH:D009020	Morphine results in increased expression of DSCAML1 mRNA	PMID:20144693
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA	PMID:37567420
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312583	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DSCAML1 mRNA	PMID:31163220
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312583	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of DSCAML1 intron	PMID:30157460
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:18291	manganese atom	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in increased expression of DSCAML1 mRNA	PMID:26745496
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312583	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of DSCAML1 mRNA	PMID:24376830
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA	PMID:25510870
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA	PMID:25510870
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1312583	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of DSCAML1 intron	PMID:30157460
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312583	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DSCAML1 gene	PMID:28458013
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1312583	E	RGD:6480464	20260707	CTD	MESH:D000452	Aldrin results in increased expression of DSCAML1 mRNA	PMID:38723972
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312584	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of DSCAML1 mRNA	PMID:25629700
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases methylation	EXP		E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased methylation of DSCAML1 gene	PMID:26431795
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312583	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DSCAML1 mRNA	PMID:33212167
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:28748	doxorubicin	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of DSCAML1 gene	PMID:28962528
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA	PMID:37567420
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312583	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in increased expression of DSCAML1 mRNA	PMID:35954277
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312583	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DSCAML1 exon; Benzo(a)pyrene affects the methylation of DSCAML1 intron; Benzo(a)pyrene affects the methylation of DSCAML1 promoter	PMID:27901495|PMID:30157460
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312583	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DSCAML1 mRNA	PMID:21871943
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312583	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DSCAML1 3' UTR	PMID:27901495
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312584	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DSCAML1 intron	PMID:27901495
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312583	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DSCAML1 exon	PMID:27901495
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312583	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in increased expression of DSCAML1 mRNA	PMID:26551752
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312583	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DSCAML1 mRNA	PMID:25895662
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312583	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DSCAML1 gene	PMID:31601247
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312584	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DSCAML1 gene	PMID:35295148
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DSCAML1 mRNA	PMID:30816183
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312584	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of DSCAML1 mRNA	PMID:30951980|PMID:32156529
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312583	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DSCAML1 gene	PMID:31601247
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312583	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of DSCAML1 mRNA	PMID:31715268
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DSCAML1 gene	PMID:28505145
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DSCAML1 mRNA	PMID:36041667
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312583	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DSCAML1 gene	PMID:31601247
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA	PMID:25510870
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA	PMID:25510870
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312584	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DSCAML1 gene	PMID:31683443
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312584	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of DSCAML1 mRNA	PMID:30951980
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DSCAML1 mRNA	PMID:36041667
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of DSCAML1 mRNA	PMID:30951980
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312583	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of DSCAML1 exon; benzo(e)pyrene results in increased methylation of DSCAML1 intron	PMID:30157460
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312584	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of DSCAML1 mRNA	PMID:30951980
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DSCAML1 mRNA	PMID:36041667
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of DSCAML1 gene	PMID:33148267
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312583	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of DSCAML1 mRNA	PMID:29024780
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:35154	manganese(0)	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in increased expression of DSCAML1 mRNA	PMID:26745496
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312583	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DSCAML1 mRNA	PMID:25979313
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of DSCAML1 mRNA	PMID:29427782
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312583	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DSCAML1 gene	PMID:29154799
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA	PMID:37567420
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312584	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DSCAML1 mRNA	PMID:17562736
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1312584	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of DSCAML1 mRNA	PMID:23608068
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:53578	hexamethylene diisocyanate	increases methylation	ISO	RGD:1312583	E	RGD:6480464	20150414	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in increased methylation of DSCAML1 gene	PMID:25445006
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C025340	manganese chloride results in increased expression of DSCAML1 mRNA	PMID:26745496
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312583	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of DSCAML1 exon; Methapyrilene results in increased methylation of DSCAML1 intron	PMID:30157460
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DSCAML1 gene	PMID:35440735
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:69478	cannabidiol	increases methylation	ISO	RGD:1312584	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased methylation of DSCAML1 gene	PMID:32579259
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of DSCAML1 gene	PMID:33148267
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA	PMID:37567420
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of DSCAML1 mRNA	PMID:26720608
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312583	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DSCAML1 gene]	PMID:28238834
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DSCAML1 mRNA	PMID:21394737
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312583	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of DSCAML1 mRNA	PMID:26079696
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DSCAML1 mRNA	PMID:24780913
1304887	Dscaml1	DS cell adhesion molecule-like 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312583	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in increased expression of DSCAML1 mRNA	PMID:26551752
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of TRPM3 mRNA	PMID:26272509
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA	PMID:27188386
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312586	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TRPM3 mRNA	PMID:33045310
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of TRPM3 mRNA	PMID:21934132
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312586	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of TRPM3 mRNA	PMID:36189433
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312586	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TRPM3 mRNA	PMID:36189433
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TRPM3 gene	PMID:35440735
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312586	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TRPM3 mRNA	PMID:30319688
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312586	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of TRPM3 mRNA	PMID:33711761
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of TRPM3 mRNA	PMID:26079696
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312586	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TRPM3 mRNA	PMID:36189433
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TRPM3 mRNA	PMID:31163220
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TRPM3 mRNA	PMID:26577399|PMID:27523638
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312585	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TRPM3 gene	PMID:27153756
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRPM3 mRNA	PMID:33354967
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312585	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TRPM3 intron	PMID:30157460
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of TRPM3 mRNA	PMID:28534445
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312585	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TRPM3 mRNA	PMID:22171008
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of TRPM3 gene	PMID:31011160
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TRPM3 mRNA	PMID:28960355
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of TRPM3 mRNA	PMID:41028656
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of TRPM3 mRNA	PMID:32186404
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312586	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRPM3 mRNA	PMID:21570461
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRPM3 mRNA	PMID:33956508
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRPM3 mRNA	PMID:33387578
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TRPM3 mRNA	PMID:28001369
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312585	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TRPM3 mRNA	PMID:23179753|PMID:27188386
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TRPM3 mRNA	PMID:41028656
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D004317	Doxorubicin results in increased expression of TRPM3 mRNA	PMID:32289291
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:28777	liquiritigenin	decreases activity	ISO	RGD:1312586	E	RGD:6480464	20190702	CTD	MESH:C083152	liquiritigenin results in decreased activity of TRPM3 protein	PMID:25361167
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312585	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite affects the expression of TRPM3 mRNA	PMID:29301061
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRPM3 mRNA	PMID:36209798
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312585	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRPM3 promoter	PMID:27901495
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312586	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRPM3 intron	PMID:27901495
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312586	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRPM3 mRNA	PMID:27195522
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TRPM3 mRNA	PMID:41028656
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312585	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TRPM3 mRNA	PMID:22171008
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312585	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TRPM3 mRNA	PMID:20458559
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TRPM3 gene	PMID:31601247
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of TRPM3 mRNA	PMID:32479839
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TRPM3 mRNA	PMID:30047161
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312586	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRPM3 gene	PMID:35295148
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312586	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TRPM3 promoter	PMID:35295148
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TRPM3 mRNA	PMID:34492290
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRPM3 mRNA	PMID:25181051
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRPM3 mRNA	PMID:34947998|PMID:41034487
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312586	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of TRPM3 mRNA	PMID:35598803
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312585	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of TRPM3 gene	PMID:31601247
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TRPM3 gene	PMID:31601247
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312585	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TRPM3 mRNA	PMID:25979313
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1312585	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of TRPM3 mRNA	PMID:36804509
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312586	E	RGD:6480464	20121113	CTD	MESH:D010269	Paraquat results in increased expression of TRPM3 mRNA	PMID:22563483
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312586	E	RGD:6480464	20121113	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of TRPM3 mRNA; [Paraquat co-treated with Maneb] affects the expression of TRPM3 mRNA	PMID:22563483|PMID:36117858
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:35420	pregnenolone sulfate	multiple interactions	ISO	RGD:1312586	E	RGD:6480464	20190702	CTD	MESH:C018370	pregnenolone sulfate binds to and results in increased activity of TRPM3 protein	PMID:30883612
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TRPM3 mRNA	PMID:24449571
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:38626	pyridaben	increases expression	ISO	RGD:1312586	E	RGD:6480464	20121113	CTD	MESH:C428725	pyridaben results in increased expression of TRPM3 mRNA	PMID:22563483
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312586	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of TRPM3 mRNA	PMID:39529242
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TRPM3 mRNA	PMID:29427782
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRPM3 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRPM3 mRNA	PMID:24896083
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312585	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TRPM3 mRNA	PMID:23179753|PMID:27188386
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA	PMID:27188386
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TRPM3 mRNA	PMID:30047161
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312585	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of TRPM3 mRNA	PMID:22147139
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TRPM3 mRNA	PMID:38832940
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312585	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TRPM3 mRNA	PMID:26272509
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPM3 mRNA	PMID:27188386
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of TRPM3 mRNA	PMID:24935251
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312585	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TRPM3 mRNA	PMID:24935251
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRPM3 mRNA	PMID:32479839
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRPM3 mRNA	PMID:29067470
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TRPM3 mRNA	PMID:29391264
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1312585	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of TRPM3 mRNA	PMID:40706910
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312585	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TRPM3 mRNA	PMID:20458559
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312586	E	RGD:6480464	20121113	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of TRPM3 mRNA; [Paraquat co-treated with Maneb] affects the expression of TRPM3 mRNA	PMID:22563483|PMID:36117858
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TRPM3 mRNA	PMID:38701926
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:6809	methamphetamine	affects response to substance	ISO	RGD:1312585	E	RGD:6480464	20120412	CTD	MESH:D008694	TRPM3 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TRPM3 gene	PMID:35440735
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:75701	sarin	increases expression	ISO	RGD:1312585	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of TRPM3 mRNA	PMID:19522546
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPM3 mRNA	PMID:27188386
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRPM3 gene]	PMID:28238834
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TRPM3 mRNA	PMID:24780913|PMID:30047161
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312585	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPM3 mRNA	PMID:27188386
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1312585	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of TRPM3 mRNA	PMID:27188386
1304888	Trpm3	transient receptor potential cation channel, subfamily M, member 3	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of TRPM3 gene	PMID:31682807
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1344300	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of GPR18 mRNA	PMID:33167477
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312587	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GPR18 mRNA	PMID:39241906
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1344300	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GPR18 mRNA	PMID:35811015
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GPR18 mRNA	PMID:33387578
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344300	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GPR18 mRNA	PMID:37042841
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1344300	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of GPR18 mRNA	PMID:27905399
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of GPR18 mRNA	PMID:27523638
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in decreased expression of GPR18 mRNA	PMID:26745496
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:188851	Muraglitazar	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of GPR18 mRNA	PMID:21515302
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1344300	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of GPR18 mRNA	PMID:23649840
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1344300	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of GPR18 mRNA	PMID:23649840
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312587	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GPR18 mRNA	PMID:34911549
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344300	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of GPR18 mRNA	PMID:41430723
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GPR18 mRNA	PMID:31881176
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1344300	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of GPR18 mRNA	PMID:24768652|PMID:25583101
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312587	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPR18 mRNA	PMID:26377647
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1344300	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GPR18 mRNA	PMID:30851411
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312587	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR18 mRNA	PMID:34876320
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312587	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR18 mRNA	PMID:34876320
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1344300	E	RGD:6480464	20140909	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of GPR18 mRNA	PMID:24356939
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312587	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GPR18 mRNA	PMID:22228805
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1344300	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GPR18 mRNA	PMID:22316170
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312587	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of GPR18 mRNA]	PMID:22228805
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:3000	beauvericin	multiple interactions	ISO	RGD:1344300	E	RGD:6480464	20190910	CTD	MESH:C004456	[beauvericin co-treated with enniatins] results in decreased expression of GPR18 mRNA	PMID:31100301
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1344300	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of GPR18 mRNA	PMID:23824090|PMID:24356939|PMID:25424538
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of GPR18 mRNA	PMID:24915197
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:32195	Tesaglitazar	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of GPR18 mRNA	PMID:21515302
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312587	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of GPR18 mRNA	PMID:18648102
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1344300	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPR18 mRNA	PMID:19710929
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	ISO	RGD:1344300	E	RGD:6480464	20140909	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of GPR18 mRNA	PMID:23824090|PMID:24356939
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GPR18 mRNA	PMID:25181051
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of GPR18 mRNA	PMID:41034487
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312587	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of GPR18 mRNA	PMID:28392331
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1344300	E	RGD:6480464	20160705	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GPR18 mRNA	PMID:25424538
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344300	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GPR18 mRNA	PMID:37042841
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of GPR18 mRNA	PMID:35163327
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in decreased expression of GPR18 mRNA	PMID:26745496
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1344300	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of GPR18 mRNA	PMID:24449571
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312587	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of GPR18 mRNA	PMID:29038090
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1312587	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of GPR18 mRNA	PMID:23125180
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1344300	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GPR18 gene	PMID:29154799
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in increased expression of GPR18 mRNA	PMID:35594946
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1344300	E	RGD:6480464	20140909	CTD	MESH:D003520	Cyclophosphamide metabolite results in decreased expression of GPR18 mRNA	PMID:24356939
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1344300	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of GPR18 mRNA	PMID:35811015
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1344300	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GPR18 mRNA	PMID:35811015
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312587	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR18 mRNA	PMID:34876320
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1344300	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of GPR18 mRNA	PMID:23824090|PMID:24356939|PMID:25424538
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312587	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GPR18 mRNA	PMID:35964746
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:5277	gardenoside	increases expression	ISO	RGD:1344300	E	RGD:6480464	20251104	CTD	MESH:C056587	gardenoside results in increased expression of GPR18 mRNA	PMID:37588187
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312587	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of GPR18 mRNA	PMID:38701926
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C025340	manganese chloride results in decreased expression of GPR18 mRNA	PMID:26745496
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:64648	enniatin	multiple interactions	ISO	RGD:1344300	E	RGD:6480464	20190910	CTD	MESH:C100264	[beauvericin co-treated with enniatins] results in decreased expression of GPR18 mRNA	PMID:31100301
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312587	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GPR18 mRNA	PMID:22206623
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of GPR18 mRNA	PMID:27840820
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1344300	E	RGD:6480464	20140909	CTD	MESH:C025589	ochratoxin A metabolite results in decreased expression of GPR18 mRNA; ochratoxin A results in decreased expression of GPR18 mRNA	PMID:24356939
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1344300	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GPR18 mRNA	PMID:30851411
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344300	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GPR18 gene]	PMID:28238834
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:8060	Phenelzine	affects expression	ISO	RGD:1312587	E	RGD:6480464	20210504	CTD	MESH:D010624	Phenelzine affects the expression of GPR18 mRNA	PMID:31249575
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312587	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR18 mRNA	PMID:34876320
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:9168	sirolimus	increases expression	ISO	RGD:1344300	E	RGD:6480464	20140909	CTD	MESH:D020123	Sirolimus results in increased expression of GPR18 mRNA	PMID:24356939
1304889	Gpr18	G protein-coupled receptor 18	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of GPR18 mRNA	PMID:21515302
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of UFM1 mRNA	PMID:35967413
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550713	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of UFM1 mRNA	PMID:33045310
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550713	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of UFM1 mRNA	PMID:30319688
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of UFM1 protein	PMID:18951874
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1344837	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of UFM1 mRNA	PMID:21632981
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1344837	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of UFM1 mRNA	PMID:16631469
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550713	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of UFM1 mRNA	PMID:39241906
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1344837	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of UFM1 mRNA	PMID:23649840
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1550713	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of UFM1 mRNA	PMID:17945193
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1344837	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of UFM1 mRNA	PMID:16949557
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of UFM1 mRNA	PMID:33387578
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UFM1 mRNA	PMID:39836092
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1344837	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of UFM1 mRNA	PMID:16949557
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550713	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UFM1 mRNA	PMID:37325564
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1344837	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UFM1 mRNA	PMID:19549813
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1344837	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of UFM1 mRNA	PMID:23649840
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of UFM1 protein	PMID:33236894
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of UFM1 mRNA	PMID:21396975
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1344837	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UFM1 gene	PMID:27153756
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1344837	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of UFM1 mRNA	PMID:23649840
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UFM1 mRNA	PMID:31150632
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550713	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UFM1 mRNA	PMID:22206623
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UFM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UFM1 mRNA	PMID:39836092
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550713	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UFM1 mRNA	PMID:40504410
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of UFM1 protein	PMID:38460933
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1344837	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of UFM1 mRNA	PMID:26272509
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UFM1 mRNA	PMID:27188386
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of UFM1 mRNA	PMID:23557933
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550713	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UFM1 mRNA	PMID:21570461
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550713	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UFM1 mRNA	PMID:16891777
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UFM1 mRNA	PMID:34747641
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550713	E	RGD:6480464	20120412	CTD	MESH:D013749	AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of UFM1 mRNA]	PMID:16891777
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of UFM1 protein	PMID:18951874
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of UFM1 mRNA	PMID:28001369
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of UFM1 mRNA	PMID:33212167
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344837	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of UFM1 protein	PMID:33212167
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550713	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of UFM1 protein	PMID:28918527
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of UFM1 mRNA]	PMID:18723479
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of UFM1 mRNA; sodium arsenite results in decreased expression of UFM1 protein	PMID:30528433|PMID:34032870
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344837	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UFM1 mRNA	PMID:38568856
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UFM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UFM1 mRNA	PMID:39836092
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550713	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UFM1 mRNA	PMID:40504410
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1344837	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of UFM1 mRNA	PMID:22378314
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1550713	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of UFM1 mRNA	PMID:27131904
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of UFM1 mRNA	PMID:20018196
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of UFM1 mRNA	PMID:24136188
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1344837	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of UFM1 mRNA	PMID:31745603
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1344837	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of UFM1 mRNA	PMID:30903817
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UFM1 mRNA	PMID:25181051
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1344837	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of UFM1 protein	PMID:37567409
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1344837	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of UFM1 mRNA	PMID:25979313
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550713	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UFM1 mRNA	PMID:39298647
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344837	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UFM1 mRNA	PMID:37042841
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UFM1 mRNA	PMID:39836092
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UFM1 mRNA	PMID:38382870
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550713	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UFM1 mRNA	PMID:37325564
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1344837	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of UFM1 mRNA	PMID:19376846
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of UFM1 mRNA	PMID:28302478
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1344837	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of UFM1 mRNA	PMID:31533062
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of UFM1 mRNA	PMID:27153767
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550713	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of UFM1 mRNA	PMID:17292431
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of UFM1 mRNA	PMID:23179753|PMID:27188386
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344837	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of UFM1 mRNA	PMID:29154799
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1344837	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of UFM1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of UFM1 mRNA	PMID:24136188
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1344837	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of UFM1 mRNA	PMID:24935251
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550713	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UFM1 mRNA	PMID:17562736
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of UFM1 protein	PMID:38460933
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UFM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UFM1 mRNA	PMID:39836092
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550713	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UFM1 mRNA	PMID:40504410
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of UFM1 mRNA	PMID:40706910
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of UFM1 mRNA	PMID:29391264
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550713	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of UFM1 mRNA	PMID:35436446
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550713	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UFM1 mRNA; Nanotubes, Carbon results in increased expression of UFM1 mRNA	PMID:25554681|PMID:25620056
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of UFM1 mRNA	PMID:34044035
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UFM1 mRNA	PMID:24136188
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UFM1 protein	PMID:32959892
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UFM1 mRNA	PMID:39836092
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550713	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of UFM1 mRNA	PMID:23650126
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550713	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UFM1 mRNA	PMID:22206623
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550713	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UFM1 mRNA	PMID:22206623
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of UFM1 protein	PMID:37664457
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1344837	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of UFM1 protein	PMID:39638853
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UFM1 mRNA	PMID:27188386
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1344837	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of UFM1 mRNA	PMID:30928695
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:79369	elesclomol	increases expression	ISO	RGD:1344837	E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of UFM1 mRNA	PMID:18723479
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:79369	elesclomol	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20170228	CTD	MESH:C512195	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of UFM1 mRNA]	PMID:18723479
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1550713	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of UFM1 mRNA	PMID:30294300
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1344837	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of UFM1 mRNA	PMID:19095052
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1550713	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of UFM1 mRNA	PMID:21278054
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344837	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of UFM1 protein; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UFM1 mRNA	PMID:27188386|PMID:37664457
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1550713	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of UFM1 mRNA	PMID:27131904
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1344837	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of UFM1 mRNA	PMID:38568856
1304890	Ufm1	ubiquitin-fold modifier 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1344837	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of UFM1 mRNA	PMID:22378314
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D004237	Diuron results in decreased expression of KAT6A mRNA	PMID:25152437
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:136004	linsidomine	increases oxidation	EXP		E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of KAT6A protein	PMID:28086193
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KAT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KAT6A mRNA	PMID:32699268
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312591	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of KAT6A mRNA	PMID:30319688
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KAT6A mRNA	PMID:39241906
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of KAT6A mRNA	PMID:20068009|PMID:32145629
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312590	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KAT6A mRNA	PMID:37042841
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312590	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of KAT6A mRNA	PMID:19162166
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of KAT6A mRNA	PMID:20655997
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KAT6A mRNA	PMID:33754040
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312590	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KAT6A protein	PMID:37730182
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of KAT6A mRNA	PMID:22061828
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312590	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KAT6A mRNA	PMID:19549813
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of KAT6A protein	PMID:23301498
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312590	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KAT6A gene	PMID:27153756
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KAT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KAT6A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of KAT6A mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of KAT6A mRNA	PMID:32699268|PMID:41430723
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of KAT6A mRNA	PMID:26272509
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312590	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of KAT6A protein	PMID:35688186
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of KAT6A mRNA	PMID:27594783
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1312591	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of KAT6A protein	PMID:22006019
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of KAT6A mRNA	PMID:30912803
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KAT6A mRNA	PMID:33387578
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KAT6A mRNA	PMID:32109520|PMID:34747641
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of KAT6A mRNA	PMID:26272509
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312590	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of KAT6A protein	PMID:35688186
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312591	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of KAT6A mRNA	PMID:36209798
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to KAT6A mRNA]	PMID:32406909
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KAT6A mRNA	PMID:19150397
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312590	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of KAT6A mRNA	PMID:26238291
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of KAT6A mRNA	PMID:34408198
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1312590	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of KAT6A gene	PMID:31601247
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of KAT6A gene	PMID:31601247
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312591	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of KAT6A mRNA	PMID:20542052
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of KAT6A mRNA	PMID:27188386
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of KAT6A mRNA	PMID:25729387
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312591	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KAT6A promoter	PMID:35295148
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of KAT6A mRNA	PMID:34492290
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of KAT6A mRNA	PMID:32145629
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KAT6A mRNA	PMID:25181051
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of KAT6A mRNA	PMID:40036665
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312590	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KAT6A gene	PMID:31601247
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of KAT6A mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:36803626
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312590	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of KAT6A mRNA	PMID:36232920
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of KAT6A gene	PMID:31601247
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of KAT6A mRNA	PMID:23829299
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of KAT6A mRNA	PMID:39298647
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312591	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of KAT6A mRNA	PMID:38685157
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KAT6A mRNA	PMID:37019170
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KAT6A mRNA	PMID:21266533
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of KAT6A mRNA	PMID:34813904
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KAT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KAT6A mRNA	PMID:32699268
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312590	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of KAT6A mRNA	PMID:28302478
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of KAT6A mRNA	PMID:19167446
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312591	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of KAT6A mRNA	PMID:36331819
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D002737	Chloroprene results in increased expression of KAT6A mRNA	PMID:23125180
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of KAT6A mRNA	PMID:29427782
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20141111	CTD	MESH:D014635	Valproic Acid results in decreased expression of KAT6A mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312590	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of KAT6A gene	PMID:29154799
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1312590	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of KAT6A mRNA	PMID:33512557
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20141111	CTD	MESH:C012589	trichostatin A results in decreased expression of KAT6A mRNA	PMID:24935251
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of KAT6A mRNA	PMID:29523930
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of KAT6A mRNA	PMID:26272509
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of KAT6A mRNA	PMID:25554681
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1312590	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of KAT6A mRNA	PMID:26705709
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of KAT6A mRNA	PMID:25729387
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of KAT6A mRNA	PMID:25729387
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312591	E	RGD:6480464	20160210	CTD	MESH:D008694	Methamphetamine results in increased expression of KAT6A mRNA	PMID:26307267
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of KAT6A mRNA	PMID:30467583
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:80799	Bufotalin	increases expression	ISO	RGD:1312590	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of KAT6A mRNA	PMID:39904859
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312591	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of KAT6A mRNA	PMID:31388691
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of KAT6A mRNA	PMID:27291303
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1312591	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of KAT6A mRNA	PMID:31558096
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of KAT6A mRNA	PMID:23640034
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KAT6A mRNA	PMID:23640034
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of KAT6A mRNA	PMID:12756304
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312590	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of KAT6A mRNA	PMID:19281266
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312590	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of KAT6A mRNA	PMID:27188386
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of KAT6A mRNA	PMID:21346803
1304892	Kat6a	lysine acetyltransferase 6A	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of KAT6A mRNA	PMID:28973697
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	ISO	RGD:1312592	E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of CCR8 mRNA	PMID:39245080
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312592	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CCR8 intron	PMID:30157460
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:18227	sterigmatocystin	increases expression	ISO	RGD:1312593	E	RGD:6480464	20120501	CTD	MESH:D013241	Sterigmatocystin results in increased expression of CCR8 mRNA	PMID:19818335
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:211551	TMC-120A	increases expression	ISO	RGD:1312593	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in increased expression of CCR8 mRNA	PMID:19818335
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:22984	calcium atom	affects abundance	ISO	RGD:1312592	E	RGD:6480464	20120412	CTD	MESH:D002118	CCR8 protein affects the abundance of Calcium	PMID:12055238
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312593	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR8 mRNA	PMID:29950665
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312593	E	RGD:6480464	20180116	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CCR8 mRNA	PMID:28789997
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312592	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CCR8 intron	PMID:30157460
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:25442	mycotoxin	increases expression	ISO	RGD:1312593	E	RGD:6480464	20170228	CTD	MESH:D009183	Mycotoxins results in increased expression of CCR8 mRNA	PMID:19818335
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1312592	E	RGD:6480464	20140610	CTD	MESH:D001151	Arsenic affects the expression of CCR8 protein	PMID:24675094
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312593	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CCR8 mRNA	PMID:28960355
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1312592	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CCR8 promoter	PMID:22847954
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CCR8 mRNA	PMID:26033743
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CCR8 mRNA	PMID:26033743
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:29320	calcium(0)	affects abundance	ISO	RGD:1312592	E	RGD:6480464	20120412	CTD	MESH:D002118	CCR8 protein affects the abundance of Calcium	PMID:12055238
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312593	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCR8 mRNA	PMID:21911445
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312592	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCR8 promoter	PMID:27901495
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CCR8 mRNA	PMID:26033743
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CCR8 mRNA	PMID:26033743
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312592	E	RGD:6480464	20120717	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CCR8 mRNA	PMID:19428942
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312593	E	RGD:6480464	20250401	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CCR8 mRNA	PMID:38811393
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312592	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CCR8 mRNA	PMID:27829220
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312593	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of CCR8 mRNA	PMID:22609695
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312593	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CCR8 mRNA	PMID:29264374
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312593	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR8 mRNA	PMID:29950665
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CCR8 mRNA	PMID:25181051
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:34107	1-nitropyrene	decreases expression	ISO	RGD:1312592	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of CCR8 mRNA	PMID:19428942
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312592	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CCR8 intron	PMID:30157460
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312593	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR8 mRNA	PMID:29950665
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312593	E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CCR8 mRNA	PMID:29408670
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312592	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CCR8 mRNA	PMID:24449571
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1312592	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CCR8 promoter	PMID:22847954
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1312592	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CCR8 promoter	PMID:22847954
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1312592	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of CCR8 mRNA	PMID:17403535
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1312592	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of CCR8 promoter	PMID:27989131
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1312592	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of CCR8 protein	PMID:24675094
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312593	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CCR8 mRNA	PMID:35436446
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1312593	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of CCR8 mRNA	PMID:15885639
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312592	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CCR8 mRNA	PMID:27829220
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:49976	zinc dichloride	decreases expression	ISO	RGD:1312592	E	RGD:6480464	20120717	CTD	MESH:C016837	zinc chloride results in decreased expression of CCR8 mRNA	PMID:19428942
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312593	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CCR8 mRNA	PMID:25620056
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:53001	nickel sulfate	affects expression	ISO	RGD:1312592	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate affects the expression of CCR8 mRNA	PMID:18202158
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312592	E	RGD:6480464	20120814	CTD	MESH:C029938	nickel sulfate results in increased expression of CCR8 mRNA	PMID:11145678
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312593	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CCR8 mRNA	PMID:38701926
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312592	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CCR8 intron	PMID:30157460
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:75832	iron(2+) sulfate (anhydrous)	decreases expression	ISO	RGD:1312592	E	RGD:6480464	20161213	CTD	MESH:C020748	ferrous sulfate results in decreased expression of CCR8 mRNA	PMID:19428942
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312592	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCR8 gene]	PMID:28238834
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312593	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CCR8 mRNA	PMID:31388691
1304893	Ccr8	C-C motif chemokine receptor 8	gene	CHEBI:8207	(+)-pilocarpine	decreases expression	ISO	RGD:1312593	E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in decreased expression of CCR8 mRNA; Pilocarpine results in decreased expression of CCR8 protein	PMID:17181556
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552051	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CLCA2 mRNA	PMID:33045310
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312594	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CLCA2 mRNA	PMID:25812627
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLCA2 mRNA	PMID:20938992
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D010100	Oxygen results in increased expression of CLCA2 mRNA	PMID:22911455
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312594	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CLCA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CLCA2 mRNA	PMID:35811015
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D004958	Estradiol results in increased expression of CLCA2 mRNA	PMID:19484750
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20200211	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of CLCA2 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA2 mRNA	PMID:26496021|PMID:32741896
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312594	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CLCA2 mRNA	PMID:30165855
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CLCA2 mRNA	PMID:33387578
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CLCA2 gene	PMID:27618143
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLCA2 mRNA	PMID:20938992
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312594	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of CLCA2 mRNA	PMID:28937961
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312594	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CLCA2 mRNA	PMID:23649840
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA2 mRNA	PMID:32741896
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CLCA2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLCA2 mRNA]	PMID:20230807
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CLCA2 mRNA	PMID:33387578
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLCA2 mRNA	PMID:20230807
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CLCA2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLCA2 mRNA]	PMID:20230807
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CLCA2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLCA2 mRNA]	PMID:20230807
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312594	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of CLCA2 mRNA	PMID:21120746
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312594	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CLCA2 mRNA	PMID:23649840
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312594	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CLCA2 mRNA	PMID:22100608
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312594	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CLCA2 mRNA	PMID:23649840
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CLCA2 mRNA	PMID:30779732
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLCA2 mRNA	PMID:20938992
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D001151	Arsenic results in decreased expression of CLCA2 mRNA	PMID:19654921
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312594	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of CLCA2 mRNA	PMID:38460933
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312594	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CLCA2 mRNA	PMID:27392435
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312594	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CLCA2 mRNA	PMID:27392435
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1312594	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CLCA2 promoter	PMID:22847954
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLCA2 mRNA	PMID:18691609
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLCA2 mRNA	PMID:33387578
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CLCA2 mRNA	PMID:26033743
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CLCA2 mRNA	PMID:15467011
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312594	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLCA2 mRNA	PMID:38568856
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312594	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of CLCA2 mRNA	PMID:34032870|PMID:39719251
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312594	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLCA2 mRNA	PMID:22316170|PMID:32234424
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312594	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CLCA2 gene	PMID:25435355
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CLCA2 mRNA	PMID:26033743
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CLCA2 mRNA	PMID:15467011
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312594	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CLCA2 mRNA	PMID:26705709
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CLCA2 mRNA	PMID:16483693
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312594	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of CLCA2 mRNA	PMID:38568856
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552051	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of CLCA2 mRNA	PMID:27760801
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:C006253	pirinixic acid results in decreased expression of CLCA2 mRNA	PMID:17426115
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312594	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CLCA2 mRNA	PMID:38479592
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLCA2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552051	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CLCA2 mRNA	PMID:32156529
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1552051	E	RGD:6480464	20200211	CTD	MESH:C006780	bisphenol A results in increased methylation of CLCA2 promoter	PMID:27312807
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20200211	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of CLCA2 mRNA	PMID:26496021
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:3392	carbendazim	multiple interactions	EXP		E	RGD:6480464	20121106	CTD	MESH:C006698	[carbendazim co-treated with 2,5-hexanedione] results in decreased expression of CLCA2 mRNA	PMID:22382377
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1312594	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of CLCA2 mRNA	PMID:36804509
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of CLCA2 mRNA	PMID:26377693
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CLCA2 mRNA	PMID:30589522
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLCA2 mRNA	PMID:25993096
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312594	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLCA2 mRNA	PMID:38568856
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312594	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CLCA2 mRNA	PMID:25812627
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CLCA2 mRNA	PMID:27387713
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552051	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CLCA2 mRNA	PMID:40194260
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1312594	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CLCA2 promoter	PMID:22847954
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1312594	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CLCA2 promoter	PMID:22847954
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312594	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CLCA2 mRNA	PMID:40419075
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C016104	sodium bichromate results in decreased expression of CLCA2 mRNA	PMID:25993096
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CLCA2 mRNA	PMID:30047161
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312594	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CLCA2 mRNA	PMID:38832940
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of CLCA2 mRNA	PMID:33387578
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D000082	Acetaminophen affects the expression of CLCA2 mRNA	PMID:17562736
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312594	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CLCA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CLCA2 mRNA	PMID:35811015
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:46742	Nutlin-3	increases expression	ISO	RGD:1312594	E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of CLCA2 mRNA	PMID:38460933
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312594	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of CLCA2 mRNA	PMID:38460933
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1552051	E	RGD:6480464	20160301	CTD	MESH:D001151	Arsenic results in decreased expression of CLCA2 mRNA	PMID:19654921
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:D004726	Endosulfan results in increased expression of CLCA2 mRNA	PMID:29391264
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1312594	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of CLCA2 mRNA	PMID:38568856
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312594	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CLCA2 mRNA	PMID:26705709
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552051	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CLCA2 mRNA; Nanotubes, Carbon results in increased expression of CLCA2 mRNA	PMID:25554681|PMID:25620056
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CLCA2 mRNA	PMID:30047161
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:51052	lucanthone	increases expression	ISO	RGD:1312594	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in increased expression of CLCA2 mRNA	PMID:21148553
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:67251	beta-damascenone	increases expression	ISO	RGD:1552051	E	RGD:6480464	20161213	CTD	MESH:C075388	beta-damascenone results in increased expression of CLCA2 mRNA	PMID:22982537
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:75170	zaragozic acid A	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CLCA2 mRNA	PMID:27225895
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1552051	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CLCA2 mRNA	PMID:27225895
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1312594	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of CLCA2 mRNA	PMID:29522793
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA2 mRNA	PMID:32741896
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:85014	2,5-hexanedione	multiple interactions	EXP		E	RGD:6480464	20150303	CTD	MESH:C011269	[carbendazim co-treated with 2,5-hexanedione] results in decreased expression of CLCA2 mRNA	PMID:22382377
1304894	Clca2	chloride channel accessory 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CLCA2 mRNA	PMID:30047161
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:132098	methoxyacetic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of DDX31 mRNA	PMID:20864626
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX31 mRNA]	PMID:31150632
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312596	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DDX31 mRNA	PMID:33167477
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312597	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DDX31 mRNA	PMID:39241906
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312596	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of DDX31 mRNA	PMID:31614463
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312596	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DDX31 mRNA	PMID:37042841
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312597	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DDX31 mRNA	PMID:34319233
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of DDX31 mRNA	PMID:26577399
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312596	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DDX31 mRNA	PMID:28818685
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312596	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DDX31 mRNA	PMID:39836092
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312596	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DDX31 protein	PMID:23301498
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312596	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DDX31 mRNA	PMID:22100608
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312597	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DDX31 mRNA	PMID:19770486
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312596	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DDX31 gene	PMID:27153756
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312596	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of DDX31 mRNA	PMID:19774075
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX31 mRNA	PMID:31150632
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX31 mRNA]	PMID:31150632
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312597	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DDX31 mRNA	PMID:22206623
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312596	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DDX31 gene	PMID:25304211
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312596	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX31 mRNA	PMID:39836092
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of DDX31 mRNA	PMID:20864626
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DDX31 mRNA	PMID:33387578
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DDX31 mRNA	PMID:20864626
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312596	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of DDX31 mRNA	PMID:29803840
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:28794	coumarin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in decreased expression of DDX31 mRNA	PMID:18480146
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312596	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of DDX31 protein	PMID:35688186
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312596	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DDX31 mRNA	PMID:38568856
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312596	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX31 mRNA	PMID:39836092
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	ISO	RGD:1312596	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of DDX31 mRNA	PMID:25075043
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312596	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of DDX31 gene	PMID:31601247
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DDX31 mRNA	PMID:23411599|PMID:34492290
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312597	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DDX31 mRNA	PMID:19710929
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DDX31 mRNA	PMID:25181051
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DDX31 mRNA	PMID:30816183|PMID:32528016
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312597	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DDX31 mRNA	PMID:33221593
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DDX31 gene	PMID:28505145
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312597	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DDX31 mRNA	PMID:37019170
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of DDX31 mRNA	PMID:32680482
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312596	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DDX31 mRNA	PMID:37042841
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312596	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DDX31 mRNA	PMID:39836092
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312596	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DDX31 mRNA	PMID:38568856
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312596	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DDX31 mRNA	PMID:26472689
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312596	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of DDX31 mRNA	PMID:24449571
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312596	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DDX31 mRNA	PMID:23179753
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of DDX31 mRNA	PMID:21346803
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312597	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DDX31 mRNA	PMID:17562736
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312596	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DDX31 gene	PMID:25304211
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312596	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX31 mRNA	PMID:39836092
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312597	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of DDX31 mRNA	PMID:35436446
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:50035	alpha-phellandrene	decreases expression	ISO	RGD:1312596	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of DDX31 mRNA	PMID:25075043
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of DDX31 mRNA	PMID:20080153
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312596	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DDX31 mRNA	PMID:39836092
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312597	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DDX31 mRNA	PMID:22206623
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312596	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DDX31 gene]	PMID:28238834
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:88522	Monobutylphthalate	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of DDX31 mRNA	PMID:20864626
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DDX31 mRNA	PMID:21346803
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312596	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DDX31 mRNA	PMID:29301935
1304895	Ddx31	DEAD-box helicase 31	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of DDX31 mRNA	PMID:23034163
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GLT1D1 mRNA]	PMID:31150632
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1606714	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of GLT1D1 mRNA	PMID:34925699
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606714	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of GLT1D1 mRNA	PMID:23724009
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312598	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of GLT1D1 mRNA	PMID:36189433
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312598	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GLT1D1 mRNA	PMID:36189433
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1606714	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of GLT1D1 mRNA	PMID:22378314
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1606714	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GLT1D1 mRNA	PMID:35811015
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of GLT1D1 mRNA	PMID:32145629
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312598	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GLT1D1 mRNA	PMID:39298647
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GLT1D1 mRNA	PMID:32741896
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606714	E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of GLT1D1 mRNA	PMID:22217510
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312598	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GLT1D1 mRNA	PMID:25510870
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of GLT1D1 mRNA	PMID:33387578
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606714	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GLT1D1 mRNA	PMID:37042841
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1606714	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of GLT1D1 mRNA	PMID:21540246
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312598	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GLT1D1 mRNA	PMID:36189433
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312598	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of GLT1D1 mRNA	PMID:28973375
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GLT1D1 mRNA	PMID:32741896
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1606714	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of GLT1D1 intron	PMID:30157460
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312598	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GLT1D1 mRNA	PMID:25510870
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312598	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GLT1D1 mRNA	PMID:25510870
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of GLT1D1 mRNA	PMID:21396975
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GLT1D1 mRNA	PMID:33354967
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312598	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GLT1D1 mRNA	PMID:34911549
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606714	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of GLT1D1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of GLT1D1 mRNA	PMID:35430440|PMID:41430723
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GLT1D1 mRNA	PMID:31150632
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GLT1D1 mRNA]	PMID:31150632
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606714	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GLT1D1 mRNA	PMID:23557933
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1606714	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of GLT1D1 promoter	PMID:22847954
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1606714	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of GLT1D1 mRNA	PMID:23195993
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GLT1D1 mRNA	PMID:22298810|PMID:32109520
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of GLT1D1 mRNA	PMID:28374803
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606714	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GLT1D1 mRNA	PMID:28001369
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312598	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of GLT1D1 mRNA	PMID:37682722
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606714	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GLT1D1 promoter	PMID:27901495
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1606714	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GLT1D1 mRNA	PMID:20064835
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606714	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GLT1D1 3' UTR	PMID:27901495
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312598	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GLT1D1 gene; titanium dioxide results in decreased methylation of GLT1D1 promoter	PMID:35295148
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GLT1D1 mRNA	PMID:34492290
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of GLT1D1 mRNA	PMID:30816183
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GLT1D1 mRNA	PMID:25181051|PMID:32145629
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1606714	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GLT1D1 gene	PMID:31601247
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312598	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of GLT1D1 mRNA	PMID:30245210
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312598	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GLT1D1 mRNA	PMID:25510870
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312598	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GLT1D1 mRNA	PMID:25510870
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312598	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of GLT1D1 mRNA	PMID:33297965|PMID:39298647
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1606714	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of GLT1D1 intron	PMID:30157460
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312598	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of GLT1D1 intron	PMID:28392331
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606714	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GLT1D1 mRNA	PMID:37042841
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:35036	fentin chloride	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in increased expression of GLT1D1 mRNA	PMID:37156404
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312598	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of GLT1D1 mRNA	PMID:28903501
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1606714	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of GLT1D1 promoter	PMID:22847954
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1606714	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of GLT1D1 promoter	PMID:22847954
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606714	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GLT1D1 mRNA	PMID:25979313
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606714	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of GLT1D1 mRNA	PMID:26272509
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606714	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLT1D1 mRNA	PMID:27188386
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1606714	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GLT1D1 mRNA	PMID:38832940
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1606714	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of GLT1D1 mRNA	PMID:27188386
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1606714	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of GLT1D1 mRNA	PMID:24935251|PMID:26272509
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1606714	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLT1D1 mRNA	PMID:27188386
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312598	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GLT1D1 mRNA	PMID:17562736
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606714	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of GLT1D1 mRNA	PMID:21420995
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1606714	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GLT1D1 mRNA	PMID:35811015
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of GLT1D1 mRNA	PMID:29391264
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312598	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of GLT1D1 mRNA	PMID:38701926
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1606714	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of GLT1D1 intron	PMID:30157460
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312598	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GLT1D1 mRNA	PMID:22206623
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1312598	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of GLT1D1 mRNA	PMID:37699712
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GLT1D1 mRNA	PMID:32741896
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606714	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLT1D1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLT1D1 mRNA	PMID:27188386
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1606714	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in increased expression of GLT1D1 mRNA	PMID:19084549
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of GLT1D1 mRNA	PMID:32109520
1304896	Glt1d1	glycosyltransferase 1 domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606714	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLT1D1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLT1D1 mRNA	PMID:27188386
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1550053	E	RGD:6480464	20190219	CTD	MESH:D015025	Zearalenone results in decreased expression of RPL23A mRNA	PMID:30138655
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL23A mRNA	PMID:39752319
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:15368	acrolein	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of RPL23A mRNA	PMID:38090360
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPL23A mRNA	PMID:36331819
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550053	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RPL23A mRNA	PMID:39241906
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of RPL23A mRNA	PMID:35877022
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL23A mRNA	PMID:39752319
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550053	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RPL23A mRNA	PMID:33754040
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312599	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RPL23A protein	PMID:37730182
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL23A mRNA	PMID:36331819
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:207229	dihydroartemisinin	affects binding	ISO	RGD:1312599	E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to RPL23A protein	PMID:26340163
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312599	E	RGD:6480464	20130115	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RPL23A mRNA	PMID:19549813
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL23A protein	PMID:23301498
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of RPL23A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RPL23A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RPL23A protein	PMID:38598786
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL23A mRNA	PMID:22206623
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312599	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RPL23A mRNA	PMID:28903495
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312599	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RPL23A mRNA	PMID:27392435
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RPL23A mRNA	PMID:27392435
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1550053	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of RPL23A mRNA	PMID:34813904
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550053	E	RGD:6480464	20150728	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RPL23A mRNA	PMID:19465110|PMID:19770486
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPL23A mRNA	PMID:33387578|PMID:34747641
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20150728	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RPL23A mRNA	PMID:16214954
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312599	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RPL23A protein	PMID:39603559
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312599	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RPL23A mRNA; aristolochic acid I results in decreased expression of RPL23A protein	PMID:33212167
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312599	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RPL23A mRNA	PMID:30851411
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550053	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RPL23A protein	PMID:28918527
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312599	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RPL23A mRNA; sodium arsenite results in decreased expression of RPL23A protein	PMID:38228842|PMID:38568856|PMID:39719251
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312599	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RPL23A mRNA	PMID:21457566
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of and results in increased activity of RPL23A protein	PMID:30528433
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550053	E	RGD:6480464	20150728	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RPL23A mRNA	PMID:19770486
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RPL23A mRNA]; arsenite promotes the reaction [G3BP1 protein binds to RPL23A protein]	PMID:32406909
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20150728	CTD	MESH:D000643	Ammonium Chloride affects the expression of RPL23A mRNA	PMID:16483693
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of RPL23A mRNA	PMID:24136188
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RPL23A mRNA	PMID:34492290
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550053	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RPL23A mRNA	PMID:28472532
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150728	CTD	MESH:C006780	bisphenol A affects the expression of RPL23A mRNA	PMID:25181051
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312599	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL23A protein	PMID:34186270|PMID:37567409
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312599	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of RPL23A protein	PMID:34186270
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550053	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RPL23A mRNA	PMID:39298647
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312599	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RPL23A protein	PMID:34186270
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312599	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RPL23A protein	PMID:34186270
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20150728	CTD	MESH:D002995	Clofibric Acid affects the expression of RPL23A mRNA	PMID:17602206
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RPL23A protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RPL23A protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of RPL23A protein	PMID:38598786
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20150728	CTD	MESH:D002509	Cephaloridine results in increased expression of RPL23A mRNA	PMID:18500788
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312599	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of RPL23A protein	PMID:26879310
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of RPL23A mRNA	PMID:26194646
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312599	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RPL23A mRNA	PMID:24449571
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1312599	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of RPL23A mRNA	PMID:26352163
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL23A mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPL23A mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RPL23A mRNA	PMID:36331819
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312599	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RPL23A gene	PMID:29154799
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL23A mRNA	PMID:17183730
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1312599	E	RGD:6480464	20120412	CTD	MESH:D008727	RPL23A protein affects the susceptibility to Methotrexate	PMID:16217747
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:45863	paclitaxel	decreases response to substance	ISO	RGD:1312599	E	RGD:6480464	20161213	CTD	MESH:D017239	RPL23A mRNA results in decreased susceptibility to Paclitaxel	PMID:16322897
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550053	E	RGD:6480464	20150728	CTD	MESH:D000082	Acetaminophen affects the expression of RPL23A mRNA	PMID:17562736
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1312599	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of RPL23A protein	PMID:31195006
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of RPL23A mRNA	PMID:36868495
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1550053	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of RPL23A protein	PMID:21135415
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RPL23A mRNA	PMID:24136188
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL23A mRNA	PMID:17183730
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312599	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPL23A protein	PMID:32959892
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL23A mRNA	PMID:39752319
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312599	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RPL23A protein	PMID:34186270
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL23A mRNA	PMID:22206623
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL23A protein	PMID:37664457
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312599	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of RPL23A protein	PMID:31285264
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312599	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RPL23A mRNA	PMID:30851411
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1550053	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RPL23A mRNA	PMID:40826991
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1550053	E	RGD:6480464	20180703	CTD	MESH:C089595	cylindrospermopsin results in increased expression of RPL23A mRNA	PMID:20936652
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL23A mRNA	PMID:39752319
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL23A protein	PMID:37664457
1304897	Rpl23a	ribosomal protein L23A	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312599	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RPL23A protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RPL23A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RPL23A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RPL23A protein	PMID:38598786
1304898	Prtn3	proteinase 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312602	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PRTN3 mRNA	PMID:33045310
1304898	Prtn3	proteinase 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRTN3 gene	PMID:20938992
1304898	Prtn3	proteinase 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of PRTN3 mRNA; Tretinoin results in decreased expression of PRTN3 protein	PMID:26892147
1304898	Prtn3	proteinase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312601	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of PRTN3 mRNA	PMID:17218384|PMID:33167477
1304898	Prtn3	proteinase 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312601	E	RGD:6480464	20160607	CTD	MESH:D014212	arsenic trioxide promotes the reaction [Tretinoin results in decreased expression of PRTN3 mRNA]	PMID:26892147
1304898	Prtn3	proteinase 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312601	E	RGD:6480464	20120412	CTD	MESH:D001280	Atrazine results in increased expression of PRTN3 mRNA	PMID:18585445
1304898	Prtn3	proteinase 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312602	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PRTN3 mRNA	PMID:12057914|PMID:27339419
1304898	Prtn3	proteinase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312602	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of PRTN3 mRNA	PMID:19484750|PMID:39298647
1304898	Prtn3	proteinase 3	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312602	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of PRTN3 mRNA	PMID:18978301
1304898	Prtn3	proteinase 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PRTN3 mRNA	PMID:28973375
1304898	Prtn3	proteinase 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRTN3 mRNA	PMID:33387578
1304898	Prtn3	proteinase 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312602	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRTN3 mRNA	PMID:15363585|PMID:25549359
1304898	Prtn3	proteinase 3	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:D014241	PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of PRTN3 protein]	PMID:15363585
1304898	Prtn3	proteinase 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRTN3 gene	PMID:20938992
1304898	Prtn3	proteinase 3	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20140513	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of PRTN3 mRNA	PMID:24530881
1304898	Prtn3	proteinase 3	gene	CHEBI:16971	benzene-1,2,4-triol	multiple interactions	ISO	RGD:1312601	E	RGD:6480464	20140513	CTD	MESH:C013038	4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in decreased expression of PRTN3 mRNA]	PMID:24530881
1304898	Prtn3	proteinase 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1304898	Prtn3	proteinase 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1304898	Prtn3	proteinase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of PRTN3 mRNA]	PMID:33484791
1304898	Prtn3	proteinase 3	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PRTN3 mRNA	PMID:26577399
1304898	Prtn3	proteinase 3	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312601	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRTN3 mRNA	PMID:36139627
1304898	Prtn3	proteinase 3	gene	CHEBI:18185	gamma-tocopherol	increases expression	ISO	RGD:1312602	E	RGD:6480464	20180116	CTD	MESH:D024505	Tocopherols results in increased expression of PRTN3 mRNA	PMID:17056531
1304898	Prtn3	proteinase 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312601	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PRTN3 exon	PMID:30157460
1304898	Prtn3	proteinase 3	gene	CHEBI:18248	iron atom	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in decreased expression of PRTN3 mRNA	PMID:20368581
1304898	Prtn3	proteinase 3	gene	CHEBI:233355	4-aminobenzohydrazide	multiple interactions	ISO	RGD:1312601	E	RGD:6480464	20250408	CTD	MESH:C034343	4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in decreased expression of PRTN3 mRNA]	PMID:24530881
1304898	Prtn3	proteinase 3	gene	CHEBI:24527	herbicide	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20231031	CTD	MESH:D006540	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1304898	Prtn3	proteinase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PRTN3 mRNA	PMID:22100608
1304898	Prtn3	proteinase 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312601	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PRTN3 mRNA	PMID:22100608
1304898	Prtn3	proteinase 3	gene	CHEBI:27013	tocopherol	increases expression	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:D024505	Tocopherols results in increased expression of PRTN3 mRNA	PMID:17056531
1304898	Prtn3	proteinase 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312602	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PRTN3 mRNA	PMID:27339419|PMID:31919559
1304898	Prtn3	proteinase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRTN3 gene	PMID:20938992
1304898	Prtn3	proteinase 3	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1312601	E	RGD:6480464	20260203	CTD	MESH:D012643	Selenium results in increased expression of PRTN3 protein	PMID:37834424
1304898	Prtn3	proteinase 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of PRTN3 mRNA	PMID:27594783
1304898	Prtn3	proteinase 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312602	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of PRTN3 mRNA	PMID:40618947
1304898	Prtn3	proteinase 3	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1312601	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the reaction [Antibodies, Antineutrophil Cytoplasmic binds to PRTN3 protein]	PMID:18438818
1304898	Prtn3	proteinase 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PRTN3 mRNA	PMID:30912803
1304898	Prtn3	proteinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312602	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRTN3 mRNA	PMID:21570461|PMID:28922406
1304898	Prtn3	proteinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PRTN3 mRNA	PMID:19465110
1304898	Prtn3	proteinase 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PRTN3 mRNA	PMID:28959563
1304898	Prtn3	proteinase 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1304898	Prtn3	proteinase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRTN3 mRNA	PMID:33933676
1304898	Prtn3	proteinase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312601	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRTN3 3' UTR; Benzo(a)pyrene affects the methylation of PRTN3 promoter	PMID:27901495
1304898	Prtn3	proteinase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PRTN3 mRNA	PMID:32417428
1304898	Prtn3	proteinase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312601	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PRTN3 mRNA	PMID:22316170
1304898	Prtn3	proteinase 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PRTN3 mRNA	PMID:25895662
1304898	Prtn3	proteinase 3	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312601	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of PRTN3 mRNA]	PMID:26892147
1304898	Prtn3	proteinase 3	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of PRTN3 mRNA	PMID:16483693
1304898	Prtn3	proteinase 3	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1312601	E	RGD:6480464	20120412	CTD	MESH:C061133	tamibarotene results in increased expression of PRTN3 mRNA	PMID:17229644
1304898	Prtn3	proteinase 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PRTN3 mRNA	PMID:29264374
1304898	Prtn3	proteinase 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PRTN3 mRNA	PMID:18648102
1304898	Prtn3	proteinase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312601	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PRTN3 mRNA	PMID:19710929
1304898	Prtn3	proteinase 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PRTN3 mRNA	PMID:25181051
1304898	Prtn3	proteinase 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312602	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of PRTN3 mRNA	PMID:26682919
1304898	Prtn3	proteinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312602	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PRTN3 gene	PMID:31683443
1304898	Prtn3	proteinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PRTN3 mRNA	PMID:39298647
1304898	Prtn3	proteinase 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PRTN3 mRNA	PMID:38685157
1304898	Prtn3	proteinase 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PRTN3 mRNA	PMID:28392331
1304898	Prtn3	proteinase 3	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312602	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PRTN3 mRNA	PMID:24535843
1304898	Prtn3	proteinase 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312602	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of PRTN3 protein	PMID:39748354
1304898	Prtn3	proteinase 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PRTN3 promoter	PMID:22457795
1304898	Prtn3	proteinase 3	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of PRTN3 mRNA	PMID:28962523
1304898	Prtn3	proteinase 3	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1312601	E	RGD:6480464	20260203	CTD	MESH:D012643	Selenium results in increased expression of PRTN3 protein	PMID:37834424
1304898	Prtn3	proteinase 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312602	E	RGD:6480464	20260303	CTD	MESH:C473478	Sunitinib results in increased expression of PRTN3 protein	PMID:40449751
1304898	Prtn3	proteinase 3	gene	CHEBI:38940	sunitinib	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20260303	CTD	MESH:C473478	2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of PRTN3 protein]; N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of PRTN3 protein]]	PMID:40449751
1304898	Prtn3	proteinase 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PRTN3 mRNA	PMID:39529242
1304898	Prtn3	proteinase 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312601	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PRTN3 gene	PMID:29154799
1304898	Prtn3	proteinase 3	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of PRTN3 mRNA	PMID:17403535
1304898	Prtn3	proteinase 3	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1312602	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of PRTN3 mRNA	PMID:25123088
1304898	Prtn3	proteinase 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1304898	Prtn3	proteinase 3	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of PRTN3 mRNA	PMID:17400583
1304898	Prtn3	proteinase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PRTN3 mRNA	PMID:17562736
1304898	Prtn3	proteinase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRTN3 mRNA	PMID:22230336
1304898	Prtn3	proteinase 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312602	E	RGD:6480464	20220705	CTD	MESH:D000082	Acetaminophen results in increased expression of PRTN3 mRNA	PMID:34724096
1304898	Prtn3	proteinase 3	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1312602	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of PRTN3 mRNA	PMID:26934552
1304898	Prtn3	proteinase 3	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in decreased expression of PRTN3 mRNA	PMID:26833863
1304898	Prtn3	proteinase 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PRTN3 mRNA	PMID:35436446
1304898	Prtn3	proteinase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PRTN3 mRNA	PMID:12072388
1304898	Prtn3	proteinase 3	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312601	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of PRTN3 mRNA]	PMID:26892147
1304898	Prtn3	proteinase 3	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312602	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of PRTN3 mRNA	PMID:25620056
1304898	Prtn3	proteinase 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312602	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PRTN3 mRNA	PMID:25620056
1304898	Prtn3	proteinase 3	gene	CHEBI:50694	minocycline	increases expression	ISO	RGD:1312601	E	RGD:6480464	20120412	CTD	MESH:D008911	Minocycline results in increased expression of PRTN3 protein	PMID:12900849
1304898	Prtn3	proteinase 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312602	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PRTN3 mRNA	PMID:38701926
1304898	Prtn3	proteinase 3	gene	CHEBI:71219	pazopanib	increases expression	ISO	RGD:1312601	E	RGD:6480464	20210504	CTD	MESH:C516667	pazopanib results in increased expression of PRTN3 protein	PMID:33271325
1304898	Prtn3	proteinase 3	gene	CHEBI:72754	bisphenol AF	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of PRTN3 mRNA	PMID:27567155
1304898	Prtn3	proteinase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PRTN3 mRNA	PMID:22206623
1304898	Prtn3	proteinase 3	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1304898	Prtn3	proteinase 3	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312601	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRTN3 mRNA	PMID:36139627
1304898	Prtn3	proteinase 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312602	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PRTN3 mRNA	PMID:38648751
1304898	Prtn3	proteinase 3	gene	CHEBI:82664	iron(0)	decreases expression	ISO	RGD:1312601	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in decreased expression of PRTN3 mRNA	PMID:20368581
1304898	Prtn3	proteinase 3	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of PRTN3 mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of PRTN3 mRNA]	PMID:33484791
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312604	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYT1 mRNA	PMID:33045310
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312604	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of MYT1 mRNA	PMID:16169686
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312603	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of MYT1 mRNA	PMID:26079696
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:15743	butanal	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20190611	CTD	MESH:C018475	butyraldehyde results in increased methylation of MYT1 gene	PMID:30002397
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of MYT1 gene	PMID:35440735
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312603	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MYT1 mRNA	PMID:17268063
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312604	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of MYT1 mRNA	PMID:18978301
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA	PMID:25510870
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312603	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MYT1 mRNA	PMID:21179406
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312603	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of MYT1 mRNA	PMID:26079696
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:17153	propanal	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20190611	CTD	MESH:C005556	propionaldehyde results in increased methylation of MYT1 gene	PMID:30002397
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MYT1 mRNA	PMID:26577399
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:17935	octanal	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20190611	CTD	MESH:C031639	caprylic aldehyde results in increased methylation of MYT1 gene	PMID:30002397
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of MYT1 intron	PMID:30157460
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA	PMID:25510870
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA	PMID:25510870
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20171010	CTD	MESH:D005038	Ethylnitrosourea results in decreased expression of MYT1 protein	PMID:28549617
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312603	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MYT1 intron	PMID:30157460
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MYT1 gene	PMID:27153756
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MYT1 mRNA	PMID:27106289
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MYT1 mRNA	PMID:25629700
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312603	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MYT1 mRNA	PMID:26272509
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312603	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYT1 mRNA	PMID:27188386
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:27882	(S)-colchicine	increases phosphorylation	ISO	RGD:1312603	E	RGD:6480464	20120412	CTD	MESH:D003078	Colchicine results in increased phosphorylation of MYT1 protein	PMID:16611024
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312603	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MYT1 mRNA	PMID:28903495
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312603	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MYT1 mRNA	PMID:19921347
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312604	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MYT1 mRNA	PMID:24058054
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312603	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MYT1 mRNA	PMID:33212167
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MYT1 mRNA	PMID:28959563
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of MYT1 mRNA	PMID:26033743
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of MYT1 mRNA	PMID:26033743
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:28748	doxorubicin	increases phosphorylation	ISO	RGD:1312604	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased phosphorylation of MYT1 protein	PMID:15861398
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312603	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of MYT1 mRNA	PMID:29301061|PMID:32844245
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of MYT1 mRNA	PMID:36209798
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in increased methylation of MYT1 intron	PMID:32844245
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312603	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MYT1 5' UTR; Benzo(a)pyrene affects the methylation of MYT1 exon; Benzo(a)pyrene affects the methylation of MYT1 intron; Benzo(a)pyrene affects the methylation of MYT1 promoter	PMID:27901495|PMID:30157460
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312603	E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MYT1 mRNA	PMID:16120219
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MYT1 promoter	PMID:23974009
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of MYT1 mRNA	PMID:26033743
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of MYT1 mRNA	PMID:26033743
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312604	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of MYT1 promoter	PMID:27334623
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MYT1 mRNA	PMID:25181051
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MYT1 mRNA	PMID:32156529
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312603	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of MYT1 mRNA	PMID:17268063
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA	PMID:25510870
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA	PMID:25510870
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312604	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MYT1 gene	PMID:31683443
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of MYT1 mRNA	PMID:30951980
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312604	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of MYT1 exon	PMID:33297965
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MYT1 intron	PMID:30157460
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:34787	heptanal	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20190611	CTD	MESH:C046204	heptanal results in increased methylation of MYT1 gene	PMID:30002397
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:34892	nocodazole	increases phosphorylation	ISO	RGD:1312603	E	RGD:6480464	20120412	CTD	MESH:D015739	Nocodazole results in increased phosphorylation of MYT1 protein	PMID:16611024
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1312603	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of MYT1 mRNA	PMID:37047231
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312604	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MYT1 mRNA	PMID:40194260
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:3930	cryptolepine	decreases expression	ISO	RGD:1312603	E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of MYT1 mRNA	PMID:16120219
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312603	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MYT1 mRNA	PMID:25979313
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MYT1 gene	PMID:29154799
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312603	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MYT1 mRNA	PMID:27188386
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1312604	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of MYT1 mRNA	PMID:31099283
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1312603	E	RGD:6480464	20130416	CTD	MESH:D005047	Etoposide results in decreased expression of MYT1 mRNA	PMID:16120219
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of MYT1 mRNA	PMID:38701926
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:6076	itraconazole	increases expression	ISO	RGD:1312604	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of MYT1 mRNA	PMID:31099283
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of MYT1 mRNA	PMID:19564919
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MYT1 intron	PMID:30157460
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312603	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYT1 mRNA	PMID:27188386
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312603	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MYT1 gene]	PMID:28238834
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312603	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of MYT1 mRNA	PMID:26079696
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:84069	pentanal	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20190611	CTD	MESH:C046012	pentanal results in increased methylation of MYT1 gene	PMID:30002397
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:84268	nonanal	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20190611	CTD	MESH:C008664	nonanal results in increased methylation of MYT1 gene	PMID:30002397
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MYT1 mRNA	PMID:24780913
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:88528	hexanal	increases methylation	ISO	RGD:1312603	E	RGD:6480464	20190611	CTD	MESH:C010463	n-hexanal results in increased methylation of MYT1 gene	PMID:30002397
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312603	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYT1 mRNA	PMID:27188386
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MYT1 mRNA	PMID:19281266
1304899	Myt1	myelin transcription factor 1	gene	CHEBI:94366	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one	increases expression	ISO	RGD:1312604	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of MYT1 mRNA	PMID:31099283
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312605	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ZNF598 mRNA	PMID:38218311
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312606	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of ZFP598 mRNA	PMID:40945087
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312605	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ZNF598 mRNA	PMID:31614463
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312606	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ZFP598 mRNA	PMID:39298647
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312605	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ZNF598 mRNA	PMID:38568856
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP598 mRNA	PMID:22061828
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ZFP598 mRNA	PMID:33387578
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312606	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP598 mRNA	PMID:36331819
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312605	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ZNF598 protein	PMID:23301498
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312605	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ZNF598 mRNA	PMID:35430440
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZFP598 mRNA	PMID:31150632
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312605	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF598 gene	PMID:25304211
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312605	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZNF598 protein	PMID:35688186
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA	PMID:33854195
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312606	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of ZFP598 mRNA	PMID:28189721|PMID:28960355
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP598 mRNA	PMID:33387578
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312605	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF598 mRNA	PMID:33212167
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312605	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF598 mRNA	PMID:29803840
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1312605	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ZNF598 mRNA	PMID:29432896
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312605	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF598 protein	PMID:30528433
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312605	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF598 mRNA	PMID:38568856
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312605	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ZNF598 mRNA]	PMID:32406909
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312605	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of ZNF598 mRNA	PMID:38568856
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:32063	propylparaben	increases expression	ISO	RGD:1312605	E	RGD:6480464	20240702	CTD	MESH:C006068	propylparaben results in increased expression of ZNF598 mRNA	PMID:38568856
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312606	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP598 gene	PMID:35295148
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312606	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZFP598 mRNA	PMID:23811191
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF598 mRNA	PMID:25181051
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP598 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312606	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ZFP598 mRNA	PMID:39298647
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312606	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ZFP598 mRNA	PMID:37019170
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA	PMID:33854195
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312605	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF598 mRNA	PMID:38568856
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312606	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of ZFP598 mRNA	PMID:17585979|PMID:23811191
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312605	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZNF598 mRNA	PMID:31533062
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312606	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP598 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ZFP598 mRNA	PMID:36331819
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312606	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ZFP598 mRNA	PMID:17292431
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312605	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF598 mRNA	PMID:25562108
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA	PMID:33854195
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA	PMID:33854195
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFP598 mRNA	PMID:33387578
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312605	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ZNF598 mRNA	PMID:29067470
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312605	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF598 gene	PMID:25304211
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ZFP598 mRNA	PMID:29391264
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1312605	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of ZNF598 mRNA	PMID:38568856
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA	PMID:33854195
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312605	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ZNF598 protein	PMID:32959892
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312605	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ZNF598 mRNA	PMID:31758290
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ZFP598 mRNA	PMID:24136188
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:80799	Bufotalin	increases expression	ISO	RGD:1312605	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of ZNF598 mRNA	PMID:39904859
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ZFP598 mRNA	PMID:21346803
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312605	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF598 mRNA	PMID:38568856
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZFP598 mRNA	PMID:21346803
1304900	Zfp598	zinc finger protein 598	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ZNF598 mRNA	PMID:23034163
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312609	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NLRC3 mRNA	PMID:33045310
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRC3 mRNA	PMID:32741896
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NLRC3 mRNA	PMID:33387578
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604212	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NLRC3 mRNA	PMID:37042841
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1604212	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of NLRC3 mRNA	PMID:23649840
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:17230	homocysteine	increases expression	ISO	RGD:1312609	E	RGD:6480464	20170303	CTD	MESH:D006710	Homocysteine results in increased expression of NLRC3 mRNA	PMID:22647887
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:17230	homocysteine	multiple interactions	ISO	RGD:1312609	E	RGD:6480464	20170303	CTD	MESH:D006710	[Folic Acid deficiency results in increased abundance of Homocysteine] promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; CASP1 protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; PYCARD protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]	PMID:22647887
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRC3 mRNA	PMID:32741896
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1604212	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of NLRC3 mRNA	PMID:33647349
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1604212	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NLRC3 mRNA	PMID:31163220
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1604212	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of NLRC3 intron	PMID:30157460
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1604212	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of NLRC3 mRNA	PMID:23649840
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604212	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NLRC3 mRNA	PMID:23649840
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of NLRC3 mRNA	PMID:30779732
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312609	E	RGD:6480464	20140513	CTD	MESH:D005492	[Folic Acid deficiency results in increased abundance of Homocysteine] promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]	PMID:22647887
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604212	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NLRC3 gene	PMID:25304211
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NLRC3 mRNA	PMID:34747641
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604212	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NLRC3 mRNA	PMID:33212167
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312609	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of NLRC3 mRNA	PMID:36227756|PMID:39631538
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604212	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NLRC3 exon; Benzo(a)pyrene affects the methylation of NLRC3 promoter	PMID:27901495|PMID:30157460
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604212	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NLRC3 promoter	PMID:27901495
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1604212	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NLRC3 mRNA	PMID:32234424
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312609	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NLRC3 promoter	PMID:27901495
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312609	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NLRC3 mRNA	PMID:29341224
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1604212	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of NLRC3 mRNA	PMID:23806026
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of NLRC3 mRNA	PMID:41034487
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312609	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of NLRC3 mRNA	PMID:38074096
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of NLRC3 mRNA	PMID:41034487
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312609	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of NLRC3 mRNA	PMID:26682919
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312609	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of NLRC3 mRNA	PMID:40203079
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604212	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NLRC3 mRNA	PMID:37042841
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of NLRC3 mRNA	PMID:35163327
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NLRC3 mRNA	PMID:33453195
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312609	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NLRC3 mRNA	PMID:40194260
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312609	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of NLRC3 mRNA	PMID:29038090
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604212	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NLRC3 gene	PMID:29154799
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604212	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NLRC3 gene	PMID:25304211
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312609	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of NLRC3 mRNA	PMID:40234311
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312609	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of NLRC3 mRNA	PMID:38701926
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRC3 mRNA	PMID:32741896
1304902	Nlrc3	NLR family, CARD domain containing 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312609	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of NLRC3 mRNA	PMID:39847705
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312611	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of GPAT2 mRNA	PMID:20880076
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1601718	E	RGD:6480464	20260602	CTD	MESH:D019308	Palmitic Acid results in increased expression of GPAT2 mRNA	PMID:35933113
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1601718	E	RGD:6480464	20260602	CTD	MESH:D019308	cinnabarinic acid inhibits the reaction [Palmitic Acid results in increased expression of GPAT2 mRNA]	PMID:35933113
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:16196	oleic acid	increases expression	ISO	RGD:1601718	E	RGD:6480464	20260602	CTD	MESH:D019301	Oleic Acid results in increased expression of GPAT2 mRNA	PMID:35933113
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1601718	E	RGD:6480464	20260602	CTD	MESH:D019301	cinnabarinic acid inhibits the reaction [Oleic Acid results in increased expression of GPAT2 mRNA]	PMID:35933113
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1601718	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GPAT2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GPAT2 mRNA	PMID:35811015
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of GPAT2 mRNA	PMID:33387578
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1601718	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of GPAT2 mRNA	PMID:36314267
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1312611	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of GPAT2 gene	PMID:34319233
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312611	E	RGD:6480464	20180116	CTD	MESH:D004051	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GPAT2 mRNA	PMID:28433925
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:2663	amiodarone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000638	Amiodarone results in decreased expression of GPAT2 mRNA	PMID:40216313
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:27856	acetamide	affects expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide affects the expression of GPAT2 mRNA	PMID:31881176
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1601718	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of GPAT2 mRNA	PMID:24768652
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GPAT2 mRNA	PMID:21215274
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of GPAT2 mRNA]	PMID:21215274
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312611	E	RGD:6480464	20180116	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GPAT2 mRNA	PMID:28433925
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312611	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of GPAT2 mRNA	PMID:37682722
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312611	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GPAT2 mRNA	PMID:29264374
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GPAT2 mRNA	PMID:34492290
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312611	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of GPAT2 mRNA	PMID:23811191
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312611	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of GPAT2 mRNA	PMID:20739668|PMID:33221593
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312611	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GPAT2 promoter	PMID:27312807
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312611	E	RGD:6480464	20180116	CTD	MESH:C006780	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GPAT2 mRNA	PMID:28433925
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312611	E	RGD:6480464	20180116	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GPAT2 mRNA	PMID:28433925
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312611	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of GPAT2 gene	PMID:31683443
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312611	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GPAT2 mRNA	PMID:39298647
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312611	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of GPAT2 mRNA	PMID:38685157
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of GPAT2 mRNA	PMID:30723492
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1601718	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GPAT2 gene	PMID:29154799
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1601718	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of GPAT2 mRNA	PMID:35811015
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1601718	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GPAT2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GPAT2 mRNA	PMID:35811015
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312611	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GPAT2 mRNA; Nanotubes, Carbon results in decreased expression of GPAT2 mRNA	PMID:25620056
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312611	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GPAT2 mRNA	PMID:23091169
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1601718	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of GPAT2 mRNA	PMID:30458266
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of GPAT2 mRNA	PMID:23640034
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GPAT2 mRNA	PMID:24780913
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1601718	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GPAT2 mRNA	PMID:29301935
1304904	Gpat2	glycerol-3-phosphate acyltransferase 2, mitochondrial	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of GPAT2 mRNA	PMID:23555832
1304905	Hist1h2ao	histone cluster 1, H2ao	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HIST1H2AO mRNA; Trichloroethylene results in decreased expression of HIST2H4A mRNA	PMID:33387578
1304905	Hist1h2ao	histone cluster 1, H2ao	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of HIST1H2AO mRNA	PMID:26577399
1304905	Hist1h2ao	histone cluster 1, H2ao	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HIST1H2AO mRNA; Gentamicins results in increased expression of HIST2H4A mRNA	PMID:33387578
1304905	Hist1h2ao	histone cluster 1, H2ao	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HIST1H2AO mRNA; Tetrachlorodibenzodioxin results in increased expression of HIST2H4A mRNA	PMID:33387578
1304905	Hist1h2ao	histone cluster 1, H2ao	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D012402	Rotenone results in decreased expression of HIST1H2AO mRNA	PMID:28374803
1304905	Hist1h2ao	histone cluster 1, H2ao	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20240326	CTD	MESH:D000643	Ammonium Chloride affects the expression of HIST2H4A mRNA	PMID:16483693
1304905	Hist1h2ao	histone cluster 1, H2ao	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of HIST1H2AO mRNA; Acetaminophen affects the expression of HIST2H4A mRNA	PMID:33387578
1304905	Hist1h2ao	histone cluster 1, H2ao	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HIST1H2AO mRNA	PMID:24780913
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1604619	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of TRAPPC2L mRNA	PMID:30510588
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1604619	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TRAPPC2L mRNA	PMID:38568856
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of TRAPPC2L mRNA	PMID:22967744
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312614	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TRAPPC2L mRNA	PMID:33754040
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TRAPPC2L mRNA	PMID:33387578
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAPPC2L mRNA	PMID:35301059
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TRAPPC2L mRNA	PMID:30779732
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312614	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TRAPPC2L mRNA	PMID:22206623
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312614	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TRAPPC2L mRNA	PMID:40504410
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312614	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of TRAPPC2L mRNA	PMID:30912803
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312614	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRAPPC2L mRNA	PMID:21570461
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRAPPC2L mRNA	PMID:34747641
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRAPPC2L mRNA	PMID:33387578
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604619	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TRAPPC2L mRNA	PMID:33212167
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1604619	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TRAPPC2L mRNA	PMID:30851411
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1604619	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of TRAPPC2L mRNA	PMID:29803840
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604619	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRAPPC2L mRNA	PMID:38568856
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312614	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TRAPPC2L mRNA	PMID:40504410
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TRAPPC2L mRNA]	PMID:32406909
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312614	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TRAPPC2L gene	PMID:35295148
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TRAPPC2L mRNA	PMID:19167457
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRAPPC2L mRNA	PMID:25181051
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of TRAPPC2L mRNA	PMID:41034487
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRAPPC2L mRNA	PMID:28628672
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312614	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TRAPPC2L mRNA	PMID:40203079
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312614	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TRAPPC2L mRNA	PMID:28392331
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312614	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TRAPPC2L mRNA	PMID:37019170
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRAPPC2L mRNA	PMID:28628672
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TRAPPC2L mRNA	PMID:33453195
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAPPC2L mRNA	PMID:35301059
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1604619	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TRAPPC2L mRNA	PMID:19376846
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312614	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TRAPPC2L mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TRAPPC2L mRNA]	PMID:17585979
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604619	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TRAPPC2L mRNA	PMID:25979313
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604619	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TRAPPC2L mRNA	PMID:23179753|PMID:26272509
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604619	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRAPPC2L gene	PMID:29154799
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRAPPC2L mRNA	PMID:27188386
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604619	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TRAPPC2L mRNA	PMID:25562108
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRAPPC2L mRNA	PMID:28628672
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TRAPPC2L mRNA	PMID:24136188
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312614	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TRAPPC2L mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TRAPPC2L mRNA]	PMID:17585979
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312614	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TRAPPC2L mRNA	PMID:40504410
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TRAPPC2L mRNA	PMID:22079256
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312614	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TRAPPC2L mRNA	PMID:35436446
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRAPPC2L mRNA	PMID:28628672
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TRAPPC2L mRNA	PMID:24136188
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1604619	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of TRAPPC2L mRNA	PMID:22714537
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:6015	isoflurane	increases expression	ISO	RGD:1312614	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in increased expression of TRAPPC2L protein	PMID:35249202
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604619	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TRAPPC2L protein	PMID:32959892
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of TRAPPC2L mRNA	PMID:24136188
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312614	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TRAPPC2L mRNA	PMID:23650126
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of TRAPPC2L mRNA	PMID:24136188
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312614	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TRAPPC2L mRNA	PMID:22206623
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312614	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TRAPPC2L mRNA	PMID:22206623
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1604619	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of TRAPPC2L mRNA	PMID:22079256
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TRAPPC2L mRNA	PMID:22079256
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1604619	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TRAPPC2L mRNA	PMID:30851411
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRAPPC2L mRNA	PMID:27188386
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRAPPC2L gene]	PMID:28238834
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1604619	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of TRAPPC2L mRNA	PMID:24921660
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604619	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRAPPC2L mRNA	PMID:27188386
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1604619	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TRAPPC2L mRNA	PMID:38568856
1304906	Trappc2l	trafficking protein particle complex subunit 2L	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1312614	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of TRAPPC2L mRNA	PMID:26217789
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312619	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of DDX42 protein	PMID:39638853
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DDX42 mRNA	PMID:37995155
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX42 mRNA]	PMID:31150632
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312619	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DDX42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DDX42 mRNA	PMID:32699268
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312620	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DDX42 mRNA	PMID:30319688
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1312619	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of DDX42 mRNA	PMID:12414654
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1312619	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of DDX42 protein	PMID:35688186
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DDX42 mRNA	PMID:33387578
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312619	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DDX42 mRNA	PMID:37042841
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312619	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DDX42 mRNA	PMID:21179406
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DDX42 mRNA	PMID:33754040
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312620	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DDX42 mRNA	PMID:34319233
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312619	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DDX42 protein	PMID:37730182
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312619	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DDX42 mRNA	PMID:28818685
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312619	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DDX42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DDX42 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DDX42 mRNA	PMID:32699268
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX42 mRNA	PMID:31150632
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX42 mRNA]	PMID:31150632
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312619	E	RGD:6480464	20220405	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX42 protein	PMID:35072517
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312619	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DDX42 protein	PMID:38460933
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312619	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of DDX42 protein	PMID:35688186
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of DDX42 mRNA	PMID:28960355
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DDX42 protein	PMID:25505154
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312619	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DDX42 mRNA	PMID:23557933
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312619	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of DDX42 mRNA	PMID:19921347
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of DDX42 mRNA	PMID:30912803
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312620	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DDX42 mRNA	PMID:17942748
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312619	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of DDX42 mRNA	PMID:33512557
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312619	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of DDX42 protein	PMID:35688186
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:28869	menadione	increases expression	ISO	RGD:1312619	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 results in increased expression of DDX42 mRNA	PMID:12414654
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312619	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX42 protein	PMID:35072517
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DDX42 mRNA	PMID:21839799
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312619	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to DDX42 protein]	PMID:32406909
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312620	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DDX42 gene; titanium dioxide results in decreased methylation of DDX42 promoter alternative form	PMID:35295148
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of DDX42 mRNA	PMID:23811191
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX42 mRNA	PMID:33221593
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312619	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DDX42 gene	PMID:31601247
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DDX42 mRNA	PMID:25181051|PMID:30816183
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312619	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of DDX42 protein	PMID:34186270
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312620	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of DDX42 mRNA	PMID:40036665
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DDX42 gene	PMID:28505145
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312620	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DDX42 gene	PMID:31683443
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312619	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of DDX42 protein	PMID:34186270
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312620	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of DDX42 mRNA	PMID:28392331
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DDX42 mRNA	PMID:37019170
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312619	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DDX42 mRNA	PMID:37042841
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DDX42 mRNA	PMID:33453195
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312620	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of DDX42 mRNA	PMID:18353800
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312619	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DDX42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DDX42 mRNA	PMID:32699268
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:38604	pyrimidifen	decreases expression	ISO	RGD:1312619	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of DDX42 mRNA	PMID:33512557
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DDX42 protein	PMID:26178269
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312619	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DDX42 mRNA	PMID:25979313
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312619	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DDX42 gene	PMID:29154799
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1312619	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of DDX42 mRNA	PMID:15604281
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312619	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of DDX42 mRNA	PMID:27188386
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312619	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of DDX42 mRNA	PMID:20977926
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312619	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DDX42 protein	PMID:38460933
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312619	E	RGD:6480464	20220405	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX42 protein	PMID:35072517
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312620	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DDX42 mRNA	PMID:17942748
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312620	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DDX42 mRNA	PMID:17942748
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of DDX42 mRNA	PMID:19162173
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1312619	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of DDX42 mRNA	PMID:26705709
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312619	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DDX42 protein	PMID:32959892
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312619	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of DDX42 mRNA	PMID:12414654
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DDX42 protein	PMID:26558463
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312620	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of DDX42 mRNA	PMID:22206623
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:76604	MeIQx	increases expression	ISO	RGD:1312619	E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of DDX42 mRNA	PMID:20816883
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312619	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DDX42 protein	PMID:38348393
1304909	Ddx42	DEAD-box helicase 42	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of DDX42 mRNA	PMID:20566332
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1603510	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ZNF775 mRNA	PMID:38218311
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312621	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ZFP775 mRNA	PMID:33045310
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of ZFP775 mRNA	PMID:35192832
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603510	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF775 mRNA	PMID:37042841
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of ZFP775 mRNA	PMID:26496021
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1603510	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF775 protein	PMID:37730182
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP775 mRNA	PMID:33387578
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1603510	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZNF775 mRNA	PMID:28818685
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZFP775 mRNA	PMID:39012411
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1603510	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZNF775 mRNA	PMID:35301059
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1603510	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF775 mRNA	PMID:19549813
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1603510	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ZNF775 mRNA	PMID:26272509
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1603510	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF775 mRNA	PMID:27188386
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603510	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ZNF775 mRNA	PMID:23557933
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1603510	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ZNF775 mRNA	PMID:27392435
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1603510	E	RGD:6480464	20141223	CTD	MESH:D019833	Genistein results in decreased expression of ZNF775 mRNA	PMID:25136773
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1603510	E	RGD:6480464	20141223	CTD	MESH:D019833	[Dexamethasone co-treated with Genistein] results in decreased expression of ZNF775 mRNA	PMID:25136773
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZNF775 mRNA	PMID:22298810
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ZFP775 mRNA	PMID:28959563
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312621	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ZFP775 mRNA	PMID:39631538
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603510	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF775 mRNA	PMID:34032870
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ZFP775 mRNA	PMID:30047161
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312621	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZFP775 mRNA	PMID:35295148
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312621	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZFP775 gene	PMID:35295148
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFP775 mRNA	PMID:34492290
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312621	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ZFP775 mRNA	PMID:19710929
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ZFP775 mRNA	PMID:19167457
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF775 mRNA	PMID:25181051
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP775 mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:35192832
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of ZFP775 mRNA	PMID:26496021
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1603510	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ZNF775 intron	PMID:30157460
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ZFP775 mRNA	PMID:30589522
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZFP775 mRNA	PMID:39012411
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1603510	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZNF775 mRNA	PMID:35301059
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312621	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ZFP775 mRNA	PMID:17292431
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603510	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF775 mRNA	PMID:28001369
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZFP775 mRNA	PMID:30047161
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1603510	E	RGD:6480464	20141223	CTD	MESH:D003907	Dexamethasone results in decreased expression of ZNF775 mRNA	PMID:25136773
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1603510	E	RGD:6480464	20141223	CTD	MESH:D003907	[Dexamethasone co-treated with Genistein] results in decreased expression of ZNF775 mRNA	PMID:25136773
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312621	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZFP775 mRNA	PMID:17562736
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1603510	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ZNF775 mRNA	PMID:24714768
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZFP775 mRNA	PMID:30047161
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312621	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ZFP775 mRNA	PMID:26307267
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1603510	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ZNF775 intron	PMID:30157460
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1603510	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF775 protein	PMID:31285264
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603510	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF775 mRNA	PMID:27188386
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZFP775 mRNA	PMID:30047161
1304910	Zfp775	zinc finger protein 775	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603510	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF775 mRNA	PMID:27188386
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312622	E	RGD:6480464	20220308	CTD	MESH:C084079	triptonide results in increased expression of TRP53RKB mRNA	PMID:33045310
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312622	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TRP53RKB mRNA	PMID:36331819
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312622	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRP53RKB mRNA	PMID:37236586
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312622	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of TRP53RKB mRNA	PMID:40618947
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312622	E	RGD:6480464	20220308	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRP53RKB mRNA	PMID:20883709
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312622	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRP53RKB promoter	PMID:35295148
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312622	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TRP53RKB promoter	PMID:27312807
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312622	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TRP53RKB promoter	PMID:33297965
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:34709	Diisodecyl phthalate	increases expression	ISO	RGD:1312622	E	RGD:6480464	20220308	CTD	MESH:C042080	diisodecyl phthalate results in increased expression of TRP53RKB mRNA	PMID:25270620
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312622	E	RGD:6480464	20220308	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRP53RKB mRNA	PMID:20883709
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312622	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRP53RKB mRNA	PMID:37236586
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312622	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TRP53RKB mRNA	PMID:36331819
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312622	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of TRP53RKB mRNA	PMID:40234311
1304911	Tp53rkb	tumor protein p53 regulating kinase B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312622	E	RGD:6480464	20220308	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TRP53RKB mRNA	PMID:22206623
1304912	Lipm	lipase, family member M	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of LIPM mRNA	PMID:23358152
1304912	Lipm	lipase, family member M	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312623	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of LIPM mRNA	PMID:41430723
1304912	Lipm	lipase, family member M	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312623	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LIPM mRNA	PMID:32525701
1304912	Lipm	lipase, family member M	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312623	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LIPM mRNA	PMID:30851411
1304912	Lipm	lipase, family member M	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552056	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of LIPM mRNA	PMID:37682722
1304912	Lipm	lipase, family member M	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312623	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of LIPM mRNA	PMID:27685785
1304912	Lipm	lipase, family member M	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1552056	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of LIPM mRNA	PMID:26377693
1304912	Lipm	lipase, family member M	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of LIPM mRNA	PMID:35163327
1304912	Lipm	lipase, family member M	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of LIPM mRNA	PMID:35163327
1304912	Lipm	lipase, family member M	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of LIPM mRNA	PMID:35163327
1304912	Lipm	lipase, family member M	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312623	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LIPM mRNA	PMID:32525701
1304912	Lipm	lipase, family member M	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of LIPM mRNA	PMID:23358152
1304912	Lipm	lipase, family member M	gene	CHEBI:53050	trimellitic anhydride	increases methylation	ISO	RGD:1552056	E	RGD:6480464	20140610	CTD	MESH:C015559	trimellitic anhydride results in increased methylation of LIPM promoter	PMID:24675093
1304912	Lipm	lipase, family member M	gene	CHEBI:67251	beta-damascenone	increases expression	ISO	RGD:1552056	E	RGD:6480464	20161213	CTD	MESH:C075388	beta-damascenone results in increased expression of LIPM mRNA	PMID:22982537
1304912	Lipm	lipase, family member M	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312623	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LIPM mRNA	PMID:30851411
1304912	Lipm	lipase, family member M	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312623	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LIPM gene]	PMID:28238834
1304912	Lipm	lipase, family member M	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312623	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LIPM mRNA	PMID:32525701
1304912	Lipm	lipase, family member M	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of LIPM mRNA	PMID:23358152
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312626	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MRPL45 mRNA	PMID:33045310
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312625	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPL45 mRNA	PMID:33167477
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL45 mRNA	PMID:30529165
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL45 mRNA	PMID:36331819
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312625	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPL45 mRNA	PMID:22378314
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of MRPL45 mRNA	PMID:17347304
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312626	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL45 mRNA	PMID:39241906
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL45 mRNA	PMID:31059760
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of MRPL45 mRNA]	PMID:19442820
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of MRPL45 mRNA]	PMID:19442820
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MRPL45 mRNA	PMID:33387578
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL45 mRNA	PMID:36331819
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MRPL45 mRNA	PMID:35430440
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL45 mRNA	PMID:40504410
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312625	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MRPL45 mRNA	PMID:28903495
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312626	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL45 mRNA	PMID:21570461
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL45 mRNA	PMID:32109520
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL45 mRNA	PMID:33387578
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL45 mRNA	PMID:17942748
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312625	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MRPL45 mRNA	PMID:32763439
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MRPL45 mRNA	PMID:24690739
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312625	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL45 mRNA; sodium arsenite results in decreased expression of MRPL45 protein	PMID:39571964|PMID:39719251
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL45 mRNA	PMID:40504410
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312625	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of MRPL45 mRNA	PMID:22378314
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312625	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MRPL45 promoter	PMID:27901495
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRPL45 mRNA]	PMID:32406909
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MRPL45 mRNA	PMID:24690739
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1312625	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of MRPL45 mRNA	PMID:25075043
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312626	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MRPL45 mRNA	PMID:18648102
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312626	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPL45 mRNA	PMID:18301758|PMID:23811191
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL45 mRNA	PMID:24988533|PMID:25181051
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312625	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL45 mRNA	PMID:29275510
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312626	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL45 mRNA	PMID:33221593
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312626	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL45 mRNA	PMID:39298647
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312625	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of MRPL45 protein	PMID:34186270
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312626	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MRPL45 mRNA	PMID:37019170
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MRPL45 mRNA	PMID:33453195
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312625	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MRPL45 mRNA	PMID:38568856
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of MRPL45 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MRPL45 mRNA]	PMID:17585979
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312625	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MRPL45 mRNA	PMID:31533062
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL45 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL45 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MRPL45 mRNA	PMID:36331819
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312625	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPL45 mRNA	PMID:25979313
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312625	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPL45 mRNA	PMID:23179753|PMID:27188386
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL45 mRNA	PMID:17183730
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312626	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRPL45 mRNA	PMID:17562736
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL45 mRNA	PMID:33387578
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312625	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL45 mRNA	PMID:31059760
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL45 mRNA	PMID:31059760
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of MRPL45 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MRPL45 mRNA]	PMID:17585979
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of MRPL45 mRNA	PMID:24690739
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL45 mRNA	PMID:40504410
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312625	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MRPL45 mRNA	PMID:18175754
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312626	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MRPL45 mRNA	PMID:17942748
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL45 mRNA	PMID:17942748
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1312625	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of MRPL45 mRNA	PMID:25075043
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPL45 mRNA	PMID:24136188
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPL45 mRNA	PMID:24136188
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312626	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MRPL45 mRNA	PMID:19042947
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL45 mRNA	PMID:17183730
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312625	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MRPL45 protein	PMID:32959892
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1312626	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of MRPL45 mRNA	PMID:20003209
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of MRPL45 mRNA	PMID:30467583
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312626	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MRPL45 mRNA	PMID:22206623
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:7602	nobiletin	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of MRPL45 protein]	PMID:38348393
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MRPL45 gene]	PMID:28238834
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312626	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MRPL45 mRNA	PMID:31388691
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MRPL45 mRNA	PMID:23640034
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312625	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of MRPL45 protein	PMID:38348393
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of MRPL45 protein]	PMID:38348393
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRPL45 mRNA	PMID:21346803
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312625	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of MRPL45 mRNA	PMID:22378314
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1312625	E	RGD:6480464	20121113	CTD	MESH:D019284	4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of MRPL45 mRNA]; caffeic acid promotes the reaction [Thapsigargin results in decreased expression of MRPL45 mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in decreased expression of MRPL45 mRNA]	PMID:19442820
1304913	Mrpl45	mitochondrial ribosomal protein L45	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MRPL45 mRNA	PMID:21346803
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ADGRA3 mRNA	PMID:33045310
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550058	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ADGRA3 mRNA	PMID:30319688
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in decreased expression of ADGRA3 mRNA	PMID:21632981
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550058	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ADGRA3 mRNA	PMID:39241906
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312627	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol affects the expression of ADGRA3 mRNA	PMID:22574217
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ADGRA3 mRNA	PMID:32145629
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550058	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ADGRA3 mRNA	PMID:39298647
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312627	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADGRA3 mRNA	PMID:37042841
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ADGRA3 mRNA	PMID:23649840
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20260707	CTD	MESH:D013739	Testosterone results in decreased expression of ADGRA3 mRNA	PMID:33359661
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of ADGRA3 mRNA	PMID:37748715
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550058	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ADGRA3 mRNA	PMID:36331819
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312627	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRA3 mRNA	PMID:35301059
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ADGRA3 mRNA	PMID:19549813
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ADGRA3 mRNA	PMID:19770486
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ADGRA3 mRNA	PMID:23649840
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADGRA3 mRNA	PMID:31150632
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550058	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADGRA3 mRNA	PMID:22206623
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ADGRA3 mRNA	PMID:22023808
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADGRA3 mRNA	PMID:21215274|PMID:33387578
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADGRA3 mRNA	PMID:20106945|PMID:21632981
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ADGRA3 mRNA	PMID:33212167
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ADGRA3 mRNA	PMID:28959563
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADGRA3 mRNA	PMID:29803840
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312627	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ADGRA3 mRNA	PMID:20044591
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADGRA3 mRNA	PMID:38568856
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADGRA3 mRNA	PMID:20064835
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312627	E	RGD:6480464	20260707	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADGRA3 exon	PMID:27901495
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADGRA3 mRNA	PMID:19150397
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312627	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ADGRA3 gene	PMID:31601247
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312627	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ADGRA3 gene; [bisphenol S co-treated with Fulvestrant] affects the methylation of ADGRA3 gene	PMID:31601247
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550058	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADGRA3 gene	PMID:35295148
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550058	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in increased methylation of ADGRA3 gene; titanium dioxide results in increased methylation of ADGRA3 promoter	PMID:35295148
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ADGRA3 mRNA	PMID:34492290
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ADGRA3 mRNA	PMID:18445702
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550058	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ADGRA3 mRNA	PMID:18301758
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRA3 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312627	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ADGRA3 gene	PMID:31601247
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312627	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRA3 mRNA	PMID:29275510
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312627	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ADGRA3 gene	PMID:31601247
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ADGRA3 mRNA	PMID:26682919
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312627	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] affects the methylation of ADGRA3 gene	PMID:31601247
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550058	E	RGD:6480464	20160822	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ADGRA3 mRNA	PMID:26377693
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550058	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ADGRA3 mRNA	PMID:38685157
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ADGRA3 mRNA	PMID:28392331
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1550058	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ADGRA3 intron	PMID:28392331
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550058	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ADGRA3 mRNA	PMID:37019170
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of ADGRA3 gene	PMID:33148267
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312627	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADGRA3 mRNA	PMID:37042841
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADGRA3 mRNA	PMID:35163327
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ADGRA3 mRNA	PMID:38568856
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312627	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRA3 mRNA	PMID:35301059
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADGRA3 mRNA	PMID:35163327
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ADGRA3 mRNA	PMID:40194260
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550058	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ADGRA3 mRNA	PMID:36331819
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312627	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ADGRA3 mRNA	PMID:17183730
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20160822	CTD	MESH:D016572	Cyclosporine results in decreased expression of ADGRA3 mRNA	PMID:20106945|PMID:25562108
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of ADGRA3 mRNA	PMID:22733784
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ADGRA3 mRNA	PMID:38832940
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550058	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADGRA3 mRNA	PMID:17562736
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312627	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ADGRA3 mRNA	PMID:26690555
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ADGRA3 mRNA	PMID:29391264
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADGRA3 mRNA; Nanotubes, Carbon results in decreased expression of ADGRA3 mRNA	PMID:25554681
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312627	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ADGRA3 mRNA	PMID:17183730
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ADGRA3 gene	PMID:35440735
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of ADGRA3 gene	PMID:33148267
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20260707	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADGRA3 mRNA	PMID:22206623
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550058	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADGRA3 mRNA	PMID:22206623
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312627	E	RGD:6480464	20260707	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ADGRA3 gene]	PMID:28238834
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312627	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of ADGRA3 mRNA	PMID:19159669
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ADGRA3 mRNA	PMID:27291303
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ADGRA3 mRNA	PMID:23640034
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1312627	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of ADGRA3 mRNA	PMID:19429434
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312627	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of ADGRA3 mRNA	PMID:24921660
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ADGRA3 mRNA	PMID:19281266
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312627	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ADGRA3 mRNA	PMID:38568856
1304914	Adgra3	adhesion G protein-coupled receptor A3	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of ADGRA3 gene	PMID:31682807
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312629	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MRPL42 mRNA	PMID:38218311
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1616786	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MRPL42 mRNA	PMID:37995155
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPL42 mRNA	PMID:21934132|PMID:33167477
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312629	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MRPL42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MRPL42 mRNA	PMID:32699268
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPL42 mRNA	PMID:22378314
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312629	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MRPL42 mRNA	PMID:20044591
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1616786	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL42 mRNA	PMID:39241906
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MRPL42 mRNA	PMID:39298647
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312629	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPL42 mRNA	PMID:37042841
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312629	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MRPL42 mRNA	PMID:21179406
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20141007	CTD	MESH:D014050	Toluene results in decreased expression of MRPL42 mRNA	PMID:22967744
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1616786	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MRPL42 mRNA	PMID:33754040
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1616786	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL42 mRNA	PMID:36331819
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of MRPL42 mRNA	PMID:28522335
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312629	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRPL42 mRNA	PMID:27153756
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MRPL42 mRNA	PMID:23649840
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312629	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MRPL42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MRPL42 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of MRPL42 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of MRPL42 mRNA	PMID:32699268|PMID:35430440
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MRPL42 mRNA	PMID:25629700
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616786	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL42 mRNA	PMID:22206623
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MRPL42 mRNA	PMID:31881176
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20141007	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL42 mRNA	PMID:21215274
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of MRPL42 mRNA	PMID:39709020
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL42 mRNA	PMID:38568856|PMID:39719251
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MRPL42 mRNA	PMID:22378314
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312629	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRPL42 mRNA]	PMID:32406909
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MRPL42 mRNA	PMID:20458559
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL42 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL42 mRNA	PMID:29275510
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL42 mRNA	PMID:33221593
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL42 mRNA	PMID:25181051
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1616786	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL42 mRNA	PMID:39298647
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20250311	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MRPL42 mRNA	PMID:32308655
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20141007	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPL42 mRNA	PMID:17361019|PMID:21266533
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MRPL42 protein	PMID:26879310
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MRPL42 mRNA	PMID:19320972
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312629	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MRPL42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MRPL42 mRNA	PMID:32699268
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MRPL42 mRNA	PMID:28302478
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616786	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL42 mRNA	PMID:36331819
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312629	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPL42 mRNA	PMID:25979313
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPL42 mRNA	PMID:23179753|PMID:27188386
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1616786	E	RGD:6480464	20141007	CTD	MESH:D000082	Acetaminophen affects the expression of MRPL42 mRNA	PMID:17562736
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL42 mRNA	PMID:31059760
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPL42 mRNA	PMID:33387578
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MRPL42 mRNA	PMID:29279043
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1616786	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MRPL42 mRNA	PMID:35436446
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312629	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MRPL42 mRNA	PMID:18175754
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312629	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MRPL42 mRNA	PMID:20458559
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1616786	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MRPL42 mRNA; Nanotubes, Carbon results in increased expression of MRPL42 mRNA	PMID:25554681
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPL42 mRNA	PMID:24136188
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPL42 mRNA	PMID:24136188
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312629	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MRPL42 mRNA	PMID:31758290
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPL42 mRNA	PMID:22206623
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1616786	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL42 mRNA	PMID:22206623
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312629	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MRPL42 gene]	PMID:28238834
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of MRPL42 mRNA	PMID:30953684
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312629	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of MRPL42 mRNA	PMID:24921660
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1616786	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of MRPL42 protein	PMID:35357534
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20141007	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRPL42 mRNA	PMID:21346803
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1616786	E	RGD:6480464	20141007	CTD	MESH:D013311	Streptozocin affects the expression of MRPL42 mRNA	PMID:18583417
1304915	Mrpl42	mitochondrial ribosomal protein L42	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of MRPL42 mRNA	PMID:23034163
1304916	Optc	opticin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OPTC mRNA	PMID:36189433
1304916	Optc	opticin	gene	CHEBI:15379	dioxygen	increases degradation	ISO	RGD:1312631	E	RGD:6480464	20151013	CTD	MESH:D010100	Oxygen deficiency results in increased degradation of OPTC protein	PMID:22534113
1304916	Optc	opticin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312631	E	RGD:6480464	20151013	CTD	MESH:D010100	Edetic Acid inhibits the reaction [Oxygen deficiency results in increased degradation of OPTC protein]	PMID:22534113
1304916	Optc	opticin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312631	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of OPTC mRNA	PMID:31614463
1304916	Optc	opticin	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312632	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of OPTC mRNA	PMID:33711761
1304916	Optc	opticin	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of OPTC mRNA	PMID:33387578
1304916	Optc	opticin	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1312631	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of OPTC mRNA	PMID:26079696
1304916	Optc	opticin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OPTC mRNA	PMID:36189433
1304916	Optc	opticin	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of OPTC mRNA	PMID:36706583
1304916	Optc	opticin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312631	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of OPTC mRNA	PMID:31163220
1304916	Optc	opticin	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of OPTC mRNA	PMID:36331819
1304916	Optc	opticin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OPTC mRNA	PMID:28111341
1304916	Optc	opticin	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of OPTC mRNA	PMID:30779732
1304916	Optc	opticin	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of OPTC mRNA	PMID:31881176
1304916	Optc	opticin	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312631	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of OPTC mRNA	PMID:23557933
1304916	Optc	opticin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OPTC mRNA	PMID:32109520
1304916	Optc	opticin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312631	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OPTC 3' UTR; Benzo(a)pyrene results in increased methylation of OPTC promoter	PMID:27901495
1304916	Optc	opticin	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312632	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of OPTC mRNA	PMID:27131904
1304916	Optc	opticin	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1312631	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of OPTC mRNA	PMID:37690743
1304916	Optc	opticin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312632	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of OPTC mRNA	PMID:18648102
1304916	Optc	opticin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OPTC mRNA	PMID:25181051
1304916	Optc	opticin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312631	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of OPTC gene	PMID:31601247
1304916	Optc	opticin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312632	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of OPTC mRNA	PMID:32156529
1304916	Optc	opticin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312632	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of OPTC mRNA	PMID:30951980
1304916	Optc	opticin	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of OPTC promoter	PMID:22457795
1304916	Optc	opticin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OPTC mRNA	PMID:28111341
1304916	Optc	opticin	gene	CHEBI:35696	cobalt dichloride	increases degradation	ISO	RGD:1312631	E	RGD:6480464	20151013	CTD	MESH:C018021	cobaltous chloride results in increased degradation of OPTC protein	PMID:22534113
1304916	Optc	opticin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of OPTC mRNA	PMID:36331819
1304916	Optc	opticin	gene	CHEBI:4735	ethylenediaminetetraacetic acid	multiple interactions	ISO	RGD:1312631	E	RGD:6480464	20230207	CTD	MESH:D004492	Edetic Acid inhibits the reaction [Oxygen deficiency results in increased degradation of OPTC protein]; Edetic Acid inhibits the reaction [VEGFA protein results in increased degradation of OPTC protein]	PMID:22534113
1304916	Optc	opticin	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1312631	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of OPTC mRNA	PMID:18175754
1304916	Optc	opticin	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of OPTC mRNA	PMID:30307764
1304916	Optc	opticin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312632	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of OPTC mRNA	PMID:25554681
1304916	Optc	opticin	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of OPTC gene	PMID:35440735
1304916	Optc	opticin	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312632	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of OPTC mRNA	PMID:22206623
1304916	Optc	opticin	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312631	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to OPTC gene]	PMID:28238834
1304916	Optc	opticin	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of OPTC mRNA	PMID:32109520
1304916	Optc	opticin	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of OPTC mRNA	PMID:27935865
1304916	Optc	opticin	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of OPTC mRNA	PMID:36706583
1304916	Optc	opticin	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312632	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of OPTC mRNA	PMID:27131904
1304917	Arsl	arylsulfatase L	gene	CHEBI:10033	warfarin	decreases activity	ISO	RGD:1312633	E	RGD:6480464	20191112	CTD	MESH:D014859	Warfarin results in decreased activity of ARSL protein	PMID:7720070
1304917	Arsl	arylsulfatase L	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ARSL mRNA	PMID:21632981
1304917	Arsl	arylsulfatase L	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312633	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ARSL mRNA	PMID:30510588
1304917	Arsl	arylsulfatase L	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ARSE mRNA	PMID:33387578
1304917	Arsl	arylsulfatase L	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARSE mRNA	PMID:33387578
1304917	Arsl	arylsulfatase L	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ARSL mRNA	PMID:19549813
1304917	Arsl	arylsulfatase L	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312633	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ARSL protein	PMID:20106945
1304917	Arsl	arylsulfatase L	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ARSL mRNA	PMID:27153756
1304917	Arsl	arylsulfatase L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARSL mRNA	PMID:32109520
1304917	Arsl	arylsulfatase L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARSE mRNA	PMID:33387578
1304917	Arsl	arylsulfatase L	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ARSL mRNA	PMID:23179753
1304917	Arsl	arylsulfatase L	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312633	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARSL mRNA	PMID:38568856
1304917	Arsl	arylsulfatase L	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARSL mRNA	PMID:32234424
1304917	Arsl	arylsulfatase L	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312633	E	RGD:6480464	20211207	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ARSL 3' UTR; Benzo(a)pyrene results in decreased methylation of ARSL 5' UTR	PMID:27901495
1304917	Arsl	arylsulfatase L	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312633	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ARSL gene	PMID:25435355
1304917	Arsl	arylsulfatase L	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ARSL mRNA	PMID:25895662
1304917	Arsl	arylsulfatase L	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1312633	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of ARSL mRNA	PMID:37690743
1304917	Arsl	arylsulfatase L	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C069837	fullerene C60 results in increased expression of ARSL mRNA	PMID:19167457
1304917	Arsl	arylsulfatase L	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C006780	bisphenol A results in decreased expression of ARSE mRNA; bisphenol A results in decreased expression of ARSL mRNA	PMID:25181051|PMID:32145629
1304917	Arsl	arylsulfatase L	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ARSL mRNA	PMID:30589522
1304917	Arsl	arylsulfatase L	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARSL mRNA	PMID:24386269
1304917	Arsl	arylsulfatase L	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312633	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARSL mRNA	PMID:25979313
1304917	Arsl	arylsulfatase L	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARSL mRNA	PMID:29154799|PMID:29501571
1304917	Arsl	arylsulfatase L	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312633	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ARSL mRNA	PMID:24935251
1304917	Arsl	arylsulfatase L	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARSL mRNA	PMID:20106945|PMID:25562108
1304917	Arsl	arylsulfatase L	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ARSL mRNA	PMID:38832940
1304917	Arsl	arylsulfatase L	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ARSE mRNA	PMID:33387578
1304917	Arsl	arylsulfatase L	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARSL protein	PMID:32959892
1304917	Arsl	arylsulfatase L	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	decreases expression	ISO	RGD:1312633	E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of ARSL mRNA	PMID:17547211
1304917	Arsl	arylsulfatase L	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312633	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ARSL mRNA	PMID:19159669
1304917	Arsl	arylsulfatase L	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ARSL mRNA	PMID:21346803
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312635	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ASF1B mRNA	PMID:33045310
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ASF1B mRNA	PMID:39752319
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ASF1B; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASF1B gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ASF1B mRNA	PMID:20938992
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of ASF1B mRNA	PMID:16249480|PMID:33167477
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ASF1B mRNA	PMID:26516004
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312634	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ASF1B mRNA	PMID:21632981
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ASF1B mRNA	PMID:39241906
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ASF1B mRNA	PMID:30510588
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of ASF1B mRNA	PMID:32145629
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA	PMID:25510870
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312634	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ASF1B mRNA	PMID:38568856
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of ASF1B mRNA	PMID:25549359
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ASF1B gene	PMID:27618143
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ASF1B; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASF1B gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ASF1B mRNA	PMID:20938992
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ASF1B mRNA	PMID:26079696
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASF1B mRNA	PMID:37992649
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ASF1B mRNA	PMID:39752319
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ASF1B mRNA	PMID:21592394
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of ASF1B mRNA	PMID:21592394
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASF1B mRNA	PMID:37992649
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of ASF1B mRNA	PMID:21592394
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of ASF1B mRNA	PMID:21592394
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ASF1B mRNA	PMID:33387578
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312634	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ASF1B mRNA	PMID:28818685
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312634	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ASF1B intron	PMID:30157460
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASF1B mRNA	PMID:39836092
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA	PMID:25510870
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA	PMID:25510870
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312634	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ASF1B protein	PMID:20106945
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ASF1B mRNA	PMID:23630614|PMID:25378103
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ASF1B mRNA	PMID:19770486
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312634	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ASF1B gene; Aflatoxin B1 results in increased methylation of ASF1B intron	PMID:27153756|PMID:30157460
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ASF1B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ASF1B mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of ASF1B mRNA; TTPA protein affects the reaction [Ozone results in increased expression of ASF1B mRNA]	PMID:19555225|PMID:25658374|PMID:27106289|PMID:34911549
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ASF1B mRNA	PMID:17484886|PMID:31919559
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ASF1B mRNA	PMID:25629700
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of ASF1B mRNA	PMID:24657277
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ASF1B; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASF1B gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ASF1B mRNA	PMID:20938992
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASF1B mRNA	PMID:39836092
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ASF1B mRNA	PMID:31881176
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA	PMID:19167446
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ASF1B mRNA	PMID:22023808
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of ASF1B mRNA	PMID:40618947
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312634	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ASF1B mRNA	PMID:27594783|PMID:38498338
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312634	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ASF1B mRNA	PMID:25583101
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312634	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASF1B mRNA	PMID:22574217
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312635	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASF1B mRNA	PMID:21570461
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ASF1B mRNA	PMID:34747641
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASF1B mRNA	PMID:33387578
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312635	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASF1B mRNA	PMID:26290441
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASF1B mRNA	PMID:17942748
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of ASF1B mRNA	PMID:33512557
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312634	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ASF1B mRNA	PMID:33212167
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ASF1B mRNA	PMID:32763439
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ASF1B mRNA	PMID:28959563
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ASF1B mRNA	PMID:20971185
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ASF1B mRNA	PMID:30031762
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASF1B mRNA	PMID:37992649
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312634	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ASF1B mRNA	PMID:34032870
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ASF1B mRNA	PMID:38568856
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312634	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of ASF1B mRNA	PMID:28595984|PMID:29301061
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20220405	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASF1B mRNA; sodium arsenite promotes the reaction [ASF1B protein binds to CAPRIN1 protein]	PMID:33939924|PMID:39836092
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ASF1B mRNA	PMID:22378314
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312634	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ASF1B intron	PMID:30157460
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312634	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASF1B mRNA	PMID:32234424
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASF1B mRNA	PMID:20504355
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of ASF1B mRNA	PMID:18929588
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ASF1B mRNA]	PMID:32406909
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ASF1B mRNA	PMID:20971185
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312635	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ASF1B mRNA	PMID:29341224
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASF1B mRNA	PMID:20382639
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ASF1B mRNA	PMID:25729387
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ASF1B mRNA	PMID:25729387
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ASF1B mRNA	PMID:30047161
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312635	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ASF1B gene; titanium dioxide results in decreased methylation of ASF1B promoter	PMID:35295148
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of ASF1B mRNA	PMID:30012374
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312635	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ASF1B mRNA	PMID:23557971
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ASF1B mRNA	PMID:34492290
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of ASF1B mRNA	PMID:12832660|PMID:19162173
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ASF1B mRNA	PMID:17950772|PMID:18301758
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of ASF1B mRNA]	PMID:17950772
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of ASF1B mRNA	PMID:19191707
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of ASF1B mRNA	PMID:19191707
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ASF1B mRNA	PMID:38479592
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ASF1B mRNA	PMID:32145629
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312634	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ASF1B mRNA	PMID:30903817
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ASF1B mRNA	PMID:25181051
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ASF1B mRNA	PMID:29275510
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ASF1B mRNA	PMID:26063408
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ASF1B mRNA	PMID:20739668|PMID:30951980
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312634	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ASF1B mRNA	PMID:25979313
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA	PMID:25510870
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA	PMID:25510870
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of ASF1B mRNA	PMID:20713471
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of ASF1B mRNA	PMID:20713471
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312635	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ASF1B mRNA	PMID:30951980
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ASF1B mRNA	PMID:26377693
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312634	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ASF1B intron	PMID:30157460
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312635	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ASF1B mRNA	PMID:30951980
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ASF1B mRNA	PMID:17361019|PMID:21266533
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312634	E	RGD:6480464	20230704	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ASF1B mRNA	PMID:36828243
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20230704	CTD	MESH:D003993	N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of ASF1B mRNA]	PMID:36828243
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ASF1B mRNA	PMID:17854601
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ASF1B mRNA]	PMID:17854601
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20220607	CTD	MESH:D010269	Paraquat results in decreased expression of ASF1B mRNA	PMID:35182771
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312634	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ASF1B mRNA	PMID:37042841
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASF1B mRNA	PMID:39836092
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of ASF1B mRNA	PMID:26377693
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of ASF1B mRNA	PMID:18500788
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ASF1B mRNA	PMID:30723492
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312634	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ASF1B mRNA	PMID:26472689
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ASF1B mRNA	PMID:36326898
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ASF1B mRNA	PMID:25539665
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ASF1B mRNA	PMID:30047161
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312635	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ASF1B mRNA	PMID:22698814
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ASF1B mRNA	PMID:19320972|PMID:19376846
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ASF1B mRNA	PMID:24386269
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ASF1B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ASF1B mRNA]	PMID:17585979
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ASF1B mRNA	PMID:40194260
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ASF1B mRNA	PMID:31533062
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312634	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ASF1B mRNA	PMID:19167446
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA	PMID:19167446
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ASF1B mRNA	PMID:39529242
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of ASF1B mRNA	PMID:22110744
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of ASF1B mRNA	PMID:21427059
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of ASF1B mRNA	PMID:19136453|PMID:21427059
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of ASF1B mRNA	PMID:41580965
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ASF1B mRNA	PMID:30047161
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ASF1B mRNA	PMID:19159671|PMID:20106945|PMID:21632981|PMID:25562108
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of ASF1B mRNA	PMID:33512557
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ASF1B mRNA	PMID:17555576
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ASF1B mRNA	PMID:28973697
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312635	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ASF1B mRNA	PMID:28973697
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASF1B mRNA	PMID:37992649
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of ASF1B mRNA	PMID:33512557
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of ASF1B mRNA	PMID:24657277
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of ASF1B mRNA	PMID:24657277
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312634	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ASF1B mRNA	PMID:38832940
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312634	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ASF1B mRNA	PMID:28542535
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312634	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ASF1B mRNA	PMID:22230336
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ASF1B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ASF1B mRNA]	PMID:17585979
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASF1B mRNA	PMID:39836092
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ASF1B mRNA	PMID:29391264
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312635	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ASF1B mRNA	PMID:35436446
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ASF1B mRNA	PMID:17555576
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ASF1B mRNA	PMID:17942748
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASF1B mRNA	PMID:17942748
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312635	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ASF1B mRNA; Nanotubes, Carbon results in increased expression of ASF1B mRNA	PMID:25554681
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ASF1B mRNA	PMID:30047161
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ASF1B mRNA	PMID:19042947
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312634	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ASF1B protein	PMID:23718831
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ASF1B mRNA	PMID:38701926
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ASF1B protein	PMID:32959892
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASF1B mRNA	PMID:39836092
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ASF1B mRNA	PMID:25729387
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ASF1B mRNA	PMID:25729387
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ASF1B mRNA	PMID:28988120
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ASF1B mRNA	PMID:15336504
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ASF1B mRNA	PMID:37269647
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ASF1B mRNA	PMID:24810058
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312634	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ASF1B intron	PMID:30157460
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:68508	diethyl maleate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in increased expression of ASF1B mRNA	PMID:21161181
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ASF1B mRNA	PMID:39752319
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1312635	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of ASF1B mRNA	PMID:27858113
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of ASF1B mRNA	PMID:28960945
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of ASF1B mRNA	PMID:28284560
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ASF1B gene]	PMID:28238834
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ASF1B mRNA	PMID:12832660
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312635	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of ASF1B mRNA	PMID:19482888|PMID:20403969|PMID:23091169
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ASF1B mRNA]	PMID:19482888
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312635	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ASF1B mRNA	PMID:31388691
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312634	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA	PMID:19167446
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1312635	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of ASF1B mRNA	PMID:21195148
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1312635	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of ASF1B mRNA	PMID:21195148
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ASF1B mRNA	PMID:30047161
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ASF1B mRNA	PMID:24780913|PMID:30047161
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of ASF1B mRNA	PMID:22869556
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:87368	diethyl malate	increases expression	ISO	RGD:1312634	E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of ASF1B mRNA	PMID:38498338
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ASF1B mRNA	PMID:39752319
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ASF1B mRNA	PMID:38568856
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ASF1B mRNA	PMID:29301935
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312634	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of ASF1B mRNA	PMID:22378314
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1312635	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of ASF1B mRNA	PMID:21195148
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312635	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of ASF1B mRNA	PMID:28973697
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ASF1B mRNA	PMID:35537566
1304918	Asf1b	anti-silencing function 1B histone chaperone	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ASF1B mRNA	PMID:23555832
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312636	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of S100A13 mRNA	PMID:38218311
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312636	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of S100A13 mRNA	PMID:27188386
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of S100A13 mRNA	PMID:33167477
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of S100A13 mRNA	PMID:24763279
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of S100A13 gene	PMID:28931070
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312636	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of S100A13 mRNA	PMID:20044591
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312636	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of S100A13 mRNA	PMID:21632981
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of S100A13 mRNA	PMID:23019147
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312637	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of S100A13 mRNA	PMID:39298647
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of S100A13 mRNA	PMID:33387578
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of S100A13 mRNA	PMID:22967744
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312636	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of S100A13 protein	PMID:37730182
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of S100A13 mRNA	PMID:33387578
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:22984	calcium atom	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20120412	CTD	MESH:D002118	[Calcium co-treated with Copper] binds to and affects the folding of S100A13 protein; Calcium binds to and affects the folding of S100A13 protein	PMID:16766622
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312636	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of S100A13 mRNA	PMID:19549813
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of S100A13 mRNA	PMID:21396975
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312636	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of S100A13 protein	PMID:20106945
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312636	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of S100A13 gene	PMID:27153756
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312636	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of S100A13 mRNA	PMID:23649840
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of S100A13 mRNA	PMID:41580963
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of S100A13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of S100A13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of S100A13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of S100A13 protein	PMID:38598786
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of S100A13 mRNA	PMID:18356318
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312637	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of S100A13 mRNA	PMID:17484886
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of S100A13 mRNA	PMID:33387578
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312637	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of S100A13 mRNA	PMID:31919559
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312636	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of S100A13 gene	PMID:25304211
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A13 mRNA	PMID:40504410
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1312636	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of S100A13 mRNA	PMID:33512557
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of S100A13 protein	PMID:38460933
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312636	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of S100A13 protein	PMID:35688186
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312637	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of S100A13 protein	PMID:37208198
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312636	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of S100A13 mRNA	PMID:23300844
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312637	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of S100A13 mRNA	PMID:30912803
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of S100A13 mRNA	PMID:34747641
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312637	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of S100A13 mRNA	PMID:21570461
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1312637	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone affects the expression of S100A13 mRNA	PMID:23186747
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of S100A13 protein	PMID:39603559
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312636	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of S100A13 mRNA	PMID:33512557
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of S100A13 mRNA	PMID:23179753|PMID:27188386
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312636	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of S100A13 mRNA	PMID:33212167
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1312636	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of S100A13 mRNA	PMID:24834073
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20120412	CTD	MESH:D003300	[Calcium co-treated with Copper] binds to and affects the folding of S100A13 protein; Copper affects the secretion of [FGF1 protein binds to SYT1 protein binds to S100A13 protein]	PMID:16262243|PMID:16766622
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312636	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of S100A13 protein	PMID:29385562
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312636	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of S100A13 mRNA	PMID:29803840
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of S100A13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A13 mRNA	PMID:23783067
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:28851	phenanthrene	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20240702	CTD	MESH:C031181	phenanthrene results in decreased expression of S100A13 mRNA	PMID:38568856
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:29320	calcium(0)	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20120412	CTD	MESH:D002118	[Calcium co-treated with Copper] binds to and affects the folding of S100A13 protein; Calcium binds to and affects the folding of S100A13 protein	PMID:16766622
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of S100A13 protein	PMID:30528433
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of S100A13 mRNA	PMID:21297353
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312636	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of S100A13 mRNA	PMID:28595984|PMID:34032870
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A13 mRNA	PMID:40504410
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312636	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of S100A13 intron	PMID:30157460
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312636	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of S100A13 mRNA	PMID:20106945|PMID:21632981|PMID:32234424
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20120412	CTD	MESH:D003300	[Calcium co-treated with Copper] binds to and affects the folding of S100A13 protein; Copper affects the secretion of [FGF1 protein binds to SYT1 protein binds to S100A13 protein]	PMID:16262243|PMID:16766622
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of S100A13 mRNA	PMID:18356318
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of S100A13 mRNA	PMID:20018196
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312636	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of S100A13 mRNA	PMID:19150397
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of S100A13 mRNA	PMID:24915197
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of S100A13 mRNA	PMID:25729387
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312637	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of S100A13 mRNA	PMID:18648102
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312637	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of S100A13 mRNA	PMID:18301758|PMID:23811191
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:3312	calcium dichloride	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20120412	CTD	MESH:D002122	[Calcium Chloride co-treated with cuprous chloride] binds to and affects the folding of S100A13 protein; Calcium Chloride binds to and affects the folding of S100A13 protein	PMID:16766622
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312637	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of S100A13 mRNA	PMID:35598803
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312636	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of S100A13 protein	PMID:37567409
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312637	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of S100A13 mRNA	PMID:26682919
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312637	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of S100A13 mRNA	PMID:39298647
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312637	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of S100A13 mRNA	PMID:37019170
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of S100A13 mRNA	PMID:21266533
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312637	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of S100A13 mRNA	PMID:34813904
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of S100A13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of S100A13 protein	PMID:38598786
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of S100A13 mRNA	PMID:35163327
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312636	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of S100A13 mRNA	PMID:38568856
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312636	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of S100A13 protein	PMID:26879310
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of S100A13 mRNA	PMID:35163327
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312636	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of S100A13 mRNA	PMID:24449571
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312637	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of S100A13 mRNA	PMID:17585979
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of S100A13 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of S100A13 mRNA]	PMID:17585979
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1312636	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of S100A13 mRNA	PMID:33512557
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of S100A13 mRNA	PMID:28302478
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312637	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of S100A13 mRNA	PMID:19136453|PMID:21427059
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312636	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of S100A13 mRNA	PMID:25562108
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312637	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of S100A13 mRNA	PMID:17555576
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312637	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of S100A13 mRNA	PMID:17562736
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of S100A13 mRNA	PMID:33387578
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of S100A13 mRNA	PMID:21420995
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of S100A13 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of S100A13 mRNA]	PMID:17585979
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312636	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of S100A13 mRNA	PMID:29523930
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of S100A13 protein	PMID:38460933
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312636	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of S100A13 gene	PMID:25304211
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A13 mRNA	PMID:40504410
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:472805	ouabain	affects expression	ISO	RGD:1312636	E	RGD:6480464	20120412	CTD	MESH:D010042	Ouabain affects the expression of S100A13 protein	PMID:17268060
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of S100A13 mRNA	PMID:29391264
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312637	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of S100A13 mRNA	PMID:17555576
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1312636	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of S100A13 mRNA	PMID:33512557
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312636	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of S100A13 mRNA	PMID:23300844
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:53472	copper(I) chloride	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20120412	CTD	MESH:C028419	[Calcium Chloride co-treated with cuprous chloride] binds to and affects the folding of S100A13 protein; cuprous chloride binds to and affects the folding of S100A13 protein	PMID:16766622
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of S100A13 protein	PMID:32959892
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of S100A13 mRNA	PMID:25729387
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of S100A13 mRNA	PMID:23783067
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:69355	casticin	increases expression	ISO	RGD:1312637	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in increased expression of S100A13 mRNA	PMID:28444820
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312636	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of S100A13 protein	PMID:34186270
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to S100A13 gene]	PMID:28238834
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312637	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of S100A13 mRNA	PMID:40826991
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of S100A13 mRNA	PMID:21346803
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312636	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of S100A13 mRNA	PMID:38568856
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312636	E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in increased expression of S100A13 mRNA	PMID:19442820
1304919	S100a13	S100 calcium binding protein A13	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312636	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of S100A13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of S100A13 protein	PMID:38598786
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312638	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of UBQLN3 mRNA	PMID:31163220
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312638	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of UBQLN3 mRNA	PMID:41028656
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312638	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of UBQLN3 mRNA	PMID:41028656
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312638	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBQLN3 mRNA	PMID:29301061
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312638	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of UBQLN3 promoter	PMID:27901495
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312638	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of UBQLN3 3' UTR	PMID:27901495
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312638	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of UBQLN3 mRNA	PMID:41028656
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1615636	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of UBQLN3 mRNA	PMID:35295148
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of UBQLN3 mRNA	PMID:25181051
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1615636	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of UBQLN3 mRNA	PMID:32715474
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1312638	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of UBQLN3 mRNA	PMID:17400583
1304920	Ubqln3	ubiquilin 3	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of UBQLN3 mRNA	PMID:30307764
1304921	Cdc27	cell division cycle 27	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CDC27 mRNA	PMID:21934132
1304921	Cdc27	cell division cycle 27	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312639	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CDC27 mRNA	PMID:22378314
1304921	Cdc27	cell division cycle 27	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of CDC27 protein	PMID:31494107
1304921	Cdc27	cell division cycle 27	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CDC27 mRNA	PMID:21632981
1304921	Cdc27	cell division cycle 27	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312640	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CDC27 mRNA	PMID:39298647
1304921	Cdc27	cell division cycle 27	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CDC27 mRNA	PMID:23649840
1304921	Cdc27	cell division cycle 27	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of CDC27 protein	PMID:20463053
1304921	Cdc27	cell division cycle 27	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of CDC27 mRNA	PMID:26496021
1304921	Cdc27	cell division cycle 27	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312639	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CDC27 protein	PMID:37730182
1304921	Cdc27	cell division cycle 27	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312639	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CDC27 intron	PMID:30157460
1304921	Cdc27	cell division cycle 27	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC27 mRNA	PMID:28111341
1304921	Cdc27	cell division cycle 27	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312640	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDC27 mRNA	PMID:19770486
1304921	Cdc27	cell division cycle 27	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312639	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CDC27 gene	PMID:27153756
1304921	Cdc27	cell division cycle 27	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CDC27 mRNA	PMID:23649840
1304921	Cdc27	cell division cycle 27	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CDC27 mRNA	PMID:22206623
1304921	Cdc27	cell division cycle 27	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC27 mRNA	PMID:40504410
1304921	Cdc27	cell division cycle 27	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312639	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CDC27 protein	PMID:35688186
1304921	Cdc27	cell division cycle 27	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in decreased expression of CDC27 mRNA; resveratrol results in decreased expression of CDC27 protein	PMID:15767336|PMID:18089832
1304921	Cdc27	cell division cycle 27	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312640	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CDC27 protein	PMID:25505154
1304921	Cdc27	cell division cycle 27	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of CDC27 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CDC27 mRNA	PMID:19167446|PMID:23557933
1304921	Cdc27	cell division cycle 27	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312639	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CDC27 mRNA	PMID:28903495
1304921	Cdc27	cell division cycle 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312640	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC27 mRNA	PMID:21570461
1304921	Cdc27	cell division cycle 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDC27 mRNA	PMID:32109520
1304921	Cdc27	cell division cycle 27	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312639	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CDC27 protein	PMID:33212167
1304921	Cdc27	cell division cycle 27	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CDC27 mRNA	PMID:28959563
1304921	Cdc27	cell division cycle 27	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of CDC27 mRNA	PMID:30911355
1304921	Cdc27	cell division cycle 27	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312640	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CDC27 mRNA	PMID:27862939
1304921	Cdc27	cell division cycle 27	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDC27 mRNA	PMID:29803840
1304921	Cdc27	cell division cycle 27	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312639	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of CDC27 protein	PMID:35688186
1304921	Cdc27	cell division cycle 27	gene	CHEBI:29678	sodium arsenite	increases phosphorylation	ISO	RGD:1312639	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased phosphorylation of CDC27 protein	PMID:18501396
1304921	Cdc27	cell division cycle 27	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [CDC27 protein binds to CAPRIN1 protein]	PMID:33939924
1304921	Cdc27	cell division cycle 27	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC27 mRNA	PMID:40504410
1304921	Cdc27	cell division cycle 27	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312640	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of CDC27 mRNA	PMID:17127020
1304921	Cdc27	cell division cycle 27	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312640	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDC27 mRNA	PMID:20504355
1304921	Cdc27	cell division cycle 27	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of CDC27 mRNA	PMID:30911355
1304921	Cdc27	cell division cycle 27	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CDC27 mRNA	PMID:20018196
1304921	Cdc27	cell division cycle 27	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide co-treated with Paclitaxel] results in increased expression of CDC27 protein modified form	PMID:19781537
1304921	Cdc27	cell division cycle 27	gene	CHEBI:31206	ammonium chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of CDC27 protein	PMID:16483693
1304921	Cdc27	cell division cycle 27	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CDC27 mRNA	PMID:34492290
1304921	Cdc27	cell division cycle 27	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312640	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CDC27 mRNA	PMID:18301758|PMID:23811191
1304921	Cdc27	cell division cycle 27	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDC27 mRNA	PMID:25181051
1304921	Cdc27	cell division cycle 27	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CDC27 mRNA	PMID:30816183|PMID:32145629
1304921	Cdc27	cell division cycle 27	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CDC27 gene	PMID:28505145
1304921	Cdc27	cell division cycle 27	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of CDC27 mRNA	PMID:26496021
1304921	Cdc27	cell division cycle 27	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of CDC27 mRNA	PMID:19244175
1304921	Cdc27	cell division cycle 27	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312640	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CDC27 mRNA	PMID:39298647
1304921	Cdc27	cell division cycle 27	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312639	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CDC27 intron	PMID:30157460
1304921	Cdc27	cell division cycle 27	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312640	E	RGD:6480464	20190219	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CDC27 mRNA	PMID:29156651
1304921	Cdc27	cell division cycle 27	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CDC27 mRNA	PMID:22546817
1304921	Cdc27	cell division cycle 27	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312639	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC27 mRNA	PMID:37042841
1304921	Cdc27	cell division cycle 27	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20120717	CTD	MESH:D019256	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Cadmium Chloride promotes the reaction [CDC20 protein binds to CDC27 protein binds to MAD2L1 protein]]; Cadmium Chloride promotes the reaction [CDC20 protein binds to CDC27 protein binds to MAD2L1 protein]; CDC27 mutant form inhibits the reaction [Cadmium Chloride results in increased ubiquitination of and results in increased degradation of CDC20 protein]	PMID:20054826
1304921	Cdc27	cell division cycle 27	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC27 mRNA	PMID:28111341
1304921	Cdc27	cell division cycle 27	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CDC27 protein	PMID:26879310
1304921	Cdc27	cell division cycle 27	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312639	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CDC27 mRNA	PMID:19167446
1304921	Cdc27	cell division cycle 27	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC27 mRNA	PMID:19167446
1304921	Cdc27	cell division cycle 27	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDC27 mRNA	PMID:23179753|PMID:28001369
1304921	Cdc27	cell division cycle 27	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312640	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDC27 mRNA	PMID:21427059
1304921	Cdc27	cell division cycle 27	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312639	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CDC27 mRNA	PMID:20106945|PMID:25562108
1304921	Cdc27	cell division cycle 27	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of CDC27 mRNA	PMID:27188386
1304921	Cdc27	cell division cycle 27	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20161213	CTD	MESH:D017239	[arsenic trioxide co-treated with Paclitaxel] results in increased expression of CDC27 protein modified form	PMID:19781537
1304921	Cdc27	cell division cycle 27	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CDC27 mRNA	PMID:24935251|PMID:26272509
1304921	Cdc27	cell division cycle 27	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC27 mRNA	PMID:27188386
1304921	Cdc27	cell division cycle 27	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDC27 mRNA	PMID:33387578
1304921	Cdc27	cell division cycle 27	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312639	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CDC27 mRNA	PMID:22230336|PMID:38614205
1304921	Cdc27	cell division cycle 27	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC27 mRNA	PMID:40504410
1304921	Cdc27	cell division cycle 27	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDC27 mRNA	PMID:22079256
1304921	Cdc27	cell division cycle 27	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide co-treated with Paclitaxel] results in increased expression of CDC27 protein modified form	PMID:19781537
1304921	Cdc27	cell division cycle 27	gene	CHEBI:50161	motexafin gadolinium	increases expression	ISO	RGD:1312639	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of CDC27 mRNA	PMID:16357179
1304921	Cdc27	cell division cycle 27	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of CDC27 mRNA	PMID:16357179
1304921	Cdc27	cell division cycle 27	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1312639	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of CDC27 mRNA	PMID:26705709
1304921	Cdc27	cell division cycle 27	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CDC27 protein	PMID:23718831
1304921	Cdc27	cell division cycle 27	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CDC27 protein	PMID:32959892
1304921	Cdc27	cell division cycle 27	gene	CHEBI:62984	zinc acetate	increases expression	ISO	RGD:1312639	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of CDC27 mRNA	PMID:16357179
1304921	Cdc27	cell division cycle 27	gene	CHEBI:62984	zinc acetate	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of CDC27 mRNA	PMID:16357179
1304921	Cdc27	cell division cycle 27	gene	CHEBI:63618	pravastatin	affects expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of CDC27 mRNA	PMID:27225895
1304921	Cdc27	cell division cycle 27	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1312640	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of CDC27 mRNA	PMID:27225895
1304921	Cdc27	cell division cycle 27	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312639	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CDC27 mRNA	PMID:15336504
1304921	Cdc27	cell division cycle 27	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20130611	CTD	MESH:D015655	U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CDC27 mRNA]	PMID:12710931
1304921	Cdc27	cell division cycle 27	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312639	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CDC27 intron	PMID:30157460
1304921	Cdc27	cell division cycle 27	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312640	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CDC27 mRNA	PMID:22206623
1304921	Cdc27	cell division cycle 27	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CDC27 mRNA	PMID:22206623
1304921	Cdc27	cell division cycle 27	gene	CHEBI:75170	zaragozic acid A	affects expression	ISO	RGD:1312640	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 affects the expression of CDC27 mRNA	PMID:27225895
1304921	Cdc27	cell division cycle 27	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of CDC27 mRNA	PMID:27225895
1304921	Cdc27	cell division cycle 27	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CDC27 mRNA	PMID:22079256
1304921	Cdc27	cell division cycle 27	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDC27 mRNA	PMID:22079256
1304921	Cdc27	cell division cycle 27	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC27 mRNA	PMID:27188386
1304921	Cdc27	cell division cycle 27	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CDC27 gene]	PMID:28238834
1304921	Cdc27	cell division cycle 27	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312639	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CDC27 mRNA	PMID:19159669
1304921	Cdc27	cell division cycle 27	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA	PMID:19167446
1304921	Cdc27	cell division cycle 27	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312639	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC27 mRNA	PMID:27188386
1304921	Cdc27	cell division cycle 27	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CDC27 mRNA	PMID:21346803
1304921	Cdc27	cell division cycle 27	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312639	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of CDC27 mRNA	PMID:27188386
1304921	Cdc27	cell division cycle 27	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CDC27 mRNA	PMID:21346803
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1312641	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in increased expression of IRF2 mRNA	PMID:20370541
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of IRF2 mRNA	PMID:37995155
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of IRF2 mRNA	PMID:20188158
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312641	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of IRF2 mRNA	PMID:33167477
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:15422	ATP	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D000255	[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IRF2 mRNA; Hirudins inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IRF2 mRNA]	PMID:34212273
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312641	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of IRF2 mRNA	PMID:22378314
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of IRF2 mRNA	PMID:39241906
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312642	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IRF2 mRNA	PMID:10975854
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IRF2 mRNA; Hirudins inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IRF2 mRNA]; IRF2 protein affects the reaction [IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]]; IRF2 protein affects the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]; IRF2 protein affects the reaction [Lipopolysaccharides results in increased secretion of [IL12A protein binds to IL12B protein]]; IRF2 protein affects the reaction [Lipopolysaccharides results in increased secretion of IL12B protein]	PMID:10415056|PMID:34212273
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of IRF2 mRNA	PMID:31614463
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of IRF2 mRNA	PMID:39298647
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of IRF2 gene	PMID:27618143
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Glucose results in increased expression of IRF2 mRNA	PMID:34212273
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Hirudins inhibits the reaction [Glucose results in increased expression of IRF2 mRNA]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA]	PMID:34212273
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312642	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of IRF2 mRNA	PMID:28973375
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Glucose results in increased expression of IRF2 mRNA	PMID:34212273
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Hirudins inhibits the reaction [Glucose results in increased expression of IRF2 mRNA]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA]	PMID:34212273
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of IRF2 mRNA	PMID:33387578
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312641	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of IRF2 gene; Aflatoxin B1 results in increased methylation of IRF2 intron	PMID:27153756|PMID:30157460
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of IRF2 mRNA	PMID:23649840
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312641	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of IRF2 mRNA	PMID:35430440
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IRF2 mRNA	PMID:34911549
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IRF2 mRNA	PMID:31919559
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of IRF2 mRNA	PMID:25629700
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IRF2 mRNA	PMID:22206623
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of IRF2 mRNA	PMID:31881176
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312641	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of IRF2 mRNA	PMID:27392435
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of IRF2 mRNA	PMID:30912803
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of IRF2 mRNA	PMID:23195993
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312642	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IRF2 mRNA	PMID:21570461
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IRF2 mRNA	PMID:33387578|PMID:34747641
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312642	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IRF2 mRNA	PMID:24058054
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of IRF2 mRNA	PMID:28959563
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IRF2 mRNA	PMID:29803840
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of IRF2 mRNA	PMID:22363485
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IRF2 mRNA	PMID:38568856
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312641	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IRF2 5' UTR	PMID:27901495
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312642	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IRF2 mRNA	PMID:22228805
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of IRF2 mRNA	PMID:25895662
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of IRF2 mRNA	PMID:19073995
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IRF2 mRNA	PMID:19150397|PMID:20382639
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of IRF2 mRNA	PMID:25729387
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312642	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IRF2 gene	PMID:35295148
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312642	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IRF2 gene	PMID:35295148
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of IRF2 mRNA	PMID:18648102
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1312642	E	RGD:6480464	20120814	CTD	MESH:C006253	pirinixic acid affects the expression of IRF2 mRNA	PMID:17950772|PMID:19136022
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of IRF2 mRNA	PMID:17950772|PMID:23811191
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20120412	CTD	MESH:C006253	NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of IRF2 mRNA]	PMID:17950772
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF2 mRNA	PMID:28329830
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312642	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of IRF2 promoter	PMID:27334623
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IRF2 mRNA	PMID:25181051|PMID:34947998
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of IRF2 mRNA	PMID:32145629
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312641	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of IRF2 gene	PMID:31601247
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of IRF2 mRNA	PMID:39298647
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312641	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of IRF2 intron	PMID:30157460
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312642	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of IRF2 mRNA	PMID:34813904
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1312641	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of IRF2 mRNA	PMID:17312168
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312641	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IRF2 mRNA	PMID:37042841
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312641	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of IRF2 mRNA	PMID:29024780
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IRF2 mRNA	PMID:38568856
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of IRF2 promoter	PMID:22457795
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of IRF2 mRNA	PMID:23811191
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of IRF2 mRNA	PMID:29038090
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312641	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IRF2 mRNA	PMID:25979313
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of IRF2 mRNA	PMID:23179753|PMID:29154799
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312641	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of IRF2 gene	PMID:29154799
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of IRF2 mRNA	PMID:20106945|PMID:25562108
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312642	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of IRF2 mRNA	PMID:22733784
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Glucose results in increased expression of IRF2 mRNA	PMID:34212273
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Hirudins inhibits the reaction [Glucose results in increased expression of IRF2 mRNA]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA]	PMID:34212273
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1312641	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of IRF2 mRNA]	PMID:21233418
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of IRF2 mRNA	PMID:38832940
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of IRF2 mRNA	PMID:21420995|PMID:27761495
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of IRF2 mRNA	PMID:33387578
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312641	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of IRF2 mRNA	PMID:22230336
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312641	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of IRF2 mRNA	PMID:24714768
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312641	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IRF2 mRNA	PMID:22079256
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of IRF2 mRNA	PMID:28801915
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of IRF2 mRNA	PMID:25729387
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of IRF2 mRNA	PMID:28801915
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312641	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of IRF2 intron	PMID:30157460
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of IRF2 gene	PMID:35440735
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:6842	methoxychlor	increases methylation	EXP		E	RGD:6480464	20130611	CTD	MESH:D008731	Methoxychlor results in increased methylation of IRF2 gene	PMID:23303685
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:72544	flavonoids	increases expression	ISO	RGD:1312641	E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of IRF2 mRNA	PMID:15465739
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of IRF2 mRNA	PMID:22206623
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IRF2 mRNA	PMID:22206623
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of IRF2 mRNA	PMID:22079256
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312641	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IRF2 mRNA	PMID:22079256
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:753160	lard	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in decreased expression of IRF2 mRNA	PMID:26115784
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312641	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of IRF2 mRNA	PMID:37199045
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312641	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of IRF2 protein	PMID:31285264
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:75701	sarin	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of IRF2 mRNA	PMID:19522546
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of IRF2 mRNA	PMID:21346803
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312641	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IRF2 gene]	PMID:28238834
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312642	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of IRF2 mRNA	PMID:19136022
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:82577	Fusarenone X	increases expression	ISO	RGD:1312642	E	RGD:6480464	20150310	CTD	MESH:C002469	fusarenon-X results in increased expression of IRF2 mRNA	PMID:24983900
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of IRF2 mRNA	PMID:19281266
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D013311	Streptozocin results in increased expression of IRF2 mRNA	PMID:34212273
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D013311	Hirudins inhibits the reaction [Streptozocin results in increased expression of IRF2 mRNA]	PMID:34212273
1304922	Irf2	interferon regulatory factor 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312641	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IRF2 mRNA	PMID:38568856
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1312643	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of BATF mRNA	PMID:25596134
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312644	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of BATF mRNA	PMID:37995155
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BATF mRNA	PMID:20938992
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312643	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of BATF mRNA	PMID:33167477
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BATF mRNA	PMID:30529165
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1312643	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of BATF mRNA	PMID:39506029
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BATF mRNA	PMID:39241906
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BATF mRNA	PMID:20938992
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312643	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BATF mRNA	PMID:37042841
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BATF mRNA	PMID:37992649
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BATF mRNA	PMID:37992649
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BATF promoter	PMID:23359474
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312643	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of BATF mRNA	PMID:28818685
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312643	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BATF mRNA	PMID:19549813
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:234430	gardiquimod	increases expression	ISO	RGD:1312643	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of BATF mRNA	PMID:28003376
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1312643	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BATF mRNA]	PMID:28003376
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312643	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BATF mRNA	PMID:27153756
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312643	E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of BATF mRNA	PMID:23033980
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BATF mRNA	PMID:20938992
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1312643	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BATF mRNA	PMID:19244175
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of BATF mRNA	PMID:31881176
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312644	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of BATF mRNA	PMID:32186404
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312643	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of BATF mRNA	PMID:24768652|PMID:25583101
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312644	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BATF mRNA	PMID:24058054
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BATF mRNA	PMID:34747641
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312643	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BATF mRNA	PMID:22903824
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312644	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BATF mRNA	PMID:37172768
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1312643	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of BATF mRNA	PMID:23649840
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BATF mRNA	PMID:37992649
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28869	menadione	increases expression	ISO	RGD:1312644	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in increased expression of BATF mRNA	PMID:25270620
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312643	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BATF promoter	PMID:27901495
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312643	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of BATF 5' UTR	PMID:27901495
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312643	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BATF mRNA	PMID:21871943|PMID:22316170
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA	PMID:27858113
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of BATF mRNA	PMID:22431001
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312643	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of BATF mRNA	PMID:23806026
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312644	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of BATF mRNA	PMID:29341224
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312644	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of BATF mRNA	PMID:35295148
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of BATF mRNA	PMID:30012374
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312644	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of BATF mRNA	PMID:23557971
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of BATF mRNA	PMID:34492290
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312644	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of BATF mRNA	PMID:18648102
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312644	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of BATF mRNA	PMID:20813756
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of BATF mRNA	PMID:25181051
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312644	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of BATF promoter	PMID:27334623
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of BATF mRNA	PMID:34947998
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of BATF mRNA	PMID:30816183
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BATF promoter	PMID:23359474
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312643	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of BATF mRNA	PMID:19244175
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312644	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of BATF mRNA	PMID:30951980
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA	PMID:27858113
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312644	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of BATF promoter	PMID:28392331
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312644	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of BATF mRNA	PMID:28392331
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312644	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of BATF intron	PMID:28392331
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312644	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of BATF mRNA	PMID:37019170
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BATF promoter	PMID:23359474
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of BATF mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of BATF mRNA	PMID:35163327
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312644	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of BATF mRNA	PMID:26377693
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of BATF mRNA	PMID:18500788
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of BATF mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of BATF mRNA	PMID:35163327
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312643	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of BATF mRNA	PMID:24449571
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1312643	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BATF mRNA	PMID:19244175
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of BATF mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BATF mRNA]	PMID:17585979
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1312643	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BATF mRNA]	PMID:28003376
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312644	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of BATF mRNA	PMID:40194260
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312643	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of BATF mRNA	PMID:29154799
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312643	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of BATF mRNA	PMID:25562108
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BATF mRNA	PMID:37992649
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312643	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of BATF mRNA	PMID:38832940
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of BATF mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BATF mRNA]	PMID:17585979
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312644	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of BATF mRNA; Nanotubes, Carbon results in increased expression of BATF mRNA	PMID:25554681
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of BATF mRNA	PMID:35964746
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA	PMID:27858113
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA	PMID:27858113
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312644	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of BATF mRNA	PMID:19042947
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of BATF mRNA	PMID:38701926
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312644	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of BATF mRNA	PMID:22206623
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in decreased methylation of BATF promoter	PMID:27415467
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312643	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BATF gene]	PMID:28238834
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312644	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of BATF mRNA	PMID:38648751
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20230704	CTD	MESH:C041508	[indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of BATF mRNA	PMID:36975775
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312644	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of BATF mRNA	PMID:39847705
1304923	Batf	basic leucine zipper ATF-like transcription factor	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312643	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of BATF mRNA	PMID:24921660
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312645	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EME2 mRNA	PMID:33045310
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1344240	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of EME2 mRNA	PMID:26079696
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1344240	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of EME2 mRNA	PMID:22378314
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312645	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of EME2 mRNA	PMID:30319688
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312645	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EME2 mRNA	PMID:39298647
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1344240	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of EME2 mRNA	PMID:31614463
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1344240	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of EME2 mRNA	PMID:38568856
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344240	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EME2 mRNA	PMID:37042841
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1312645	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of EME2 mRNA	PMID:28973375
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of EME2 mRNA	PMID:22967744
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EME2 mRNA	PMID:33387578
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1344240	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of EME2 mRNA	PMID:39836092
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1344240	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of EME2 mRNA	PMID:26272509
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1344240	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EME2 mRNA	PMID:27188386
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344240	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of EME2 mRNA	PMID:23557933
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1344240	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of EME2 mRNA	PMID:19921347
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1344240	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of EME2 mRNA	PMID:27392435
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1344240	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of EME2 mRNA	PMID:23649840
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:28794	coumarin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of EME2 mRNA	PMID:18480146
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1344240	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of EME2 mRNA	PMID:25895662
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1344240	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of EME2 gene	PMID:31601247
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of EME2 mRNA	PMID:30047161
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of EME2 mRNA	PMID:34492290
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312645	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of EME2 mRNA	PMID:23811191
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EME2 mRNA	PMID:25181051
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1344240	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of EME2 gene	PMID:31601247
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312645	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EME2 mRNA	PMID:39298647
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344240	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EME2 mRNA	PMID:37042841
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1344240	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of EME2 mRNA	PMID:39836092
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1344240	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of EME2 mRNA	PMID:28302478
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312645	E	RGD:6480464	20130806	CTD	MESH:D014635	Valproic Acid affects the expression of EME2 mRNA	PMID:17963808
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1344240	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of EME2 gene	PMID:29154799
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of EME2 mRNA	PMID:30047161
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EME2 mRNA	PMID:33387578
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1344240	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of EME2 mRNA	PMID:22230336
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1312645	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of EME2 mRNA	PMID:26934552
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312645	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EME2 mRNA; Nanotubes, Carbon results in increased expression of EME2 mRNA	PMID:25620056
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of EME2 mRNA	PMID:30047161
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1344240	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of EME2 mRNA	PMID:39836092
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344240	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EME2 mRNA	PMID:27188386
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of EME2 mRNA	PMID:30047161
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344240	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EME2 mRNA	PMID:27188386
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of EME2 mRNA	PMID:30047161
1304924	Eme2	essential meiotic structure-specific endonuclease subunit 2	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312645	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of EME2 mRNA	PMID:32835833
1304925	Phf3	PHD finger protein 3	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312646	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PHF3 mRNA	PMID:38218311
1304925	Phf3	PHD finger protein 3	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of PHF3 mRNA	PMID:35967413
1304925	Phf3	PHD finger protein 3	gene	CHEBI:16130	DDT	decreases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased methylation of PHF3 gene	PMID:30207508
1304925	Phf3	PHD finger protein 3	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1312646	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of PHF3 protein	PMID:35688186
1304925	Phf3	PHD finger protein 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PHF3 mRNA	PMID:39241906
1304925	Phf3	PHD finger protein 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312646	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHF3 mRNA	PMID:37042841
1304925	Phf3	PHD finger protein 3	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1312646	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of PHF3 mRNA	PMID:16949557
1304925	Phf3	PHD finger protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PHF3 mRNA	PMID:33754040
1304925	Phf3	PHD finger protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312647	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PHF3 mRNA	PMID:34319233
1304925	Phf3	PHD finger protein 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312646	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PHF3 protein	PMID:37730182
1304925	Phf3	PHD finger protein 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PHF3 mRNA	PMID:33387578
1304925	Phf3	PHD finger protein 3	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1312646	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of PHF3 mRNA	PMID:16949557
1304925	Phf3	PHD finger protein 3	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of PHF3 mRNA	PMID:27462272
1304925	Phf3	PHD finger protein 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312646	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PHF3 protein	PMID:23301498
1304925	Phf3	PHD finger protein 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312647	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PHF3 mRNA	PMID:19770486
1304925	Phf3	PHD finger protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312646	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PHF3 mRNA	PMID:41430723
1304925	Phf3	PHD finger protein 3	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PHF3 mRNA	PMID:19244175
1304925	Phf3	PHD finger protein 3	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312646	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PHF3 protein	PMID:35688186
1304925	Phf3	PHD finger protein 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312646	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PHF3 mRNA	PMID:23557933
1304925	Phf3	PHD finger protein 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PHF3 mRNA	PMID:30912803
1304925	Phf3	PHD finger protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHF3 mRNA	PMID:32109520
1304925	Phf3	PHD finger protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312647	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHF3 mRNA	PMID:19465110
1304925	Phf3	PHD finger protein 3	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of PHF3 mRNA	PMID:19013527
1304925	Phf3	PHD finger protein 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PHF3 mRNA; aristolochic acid I results in decreased expression of PHF3 protein	PMID:33212167
1304925	Phf3	PHD finger protein 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PHF3 mRNA	PMID:27862939
1304925	Phf3	PHD finger protein 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHF3 mRNA	PMID:29803840
1304925	Phf3	PHD finger protein 3	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of PHF3 mRNA	PMID:22363485
1304925	Phf3	PHD finger protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312646	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PHF3 promoter	PMID:27901495
1304925	Phf3	PHD finger protein 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312646	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PHF3 mRNA]	PMID:32406909
1304925	Phf3	PHD finger protein 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PHF3 mRNA	PMID:19150397|PMID:26238291
1304925	Phf3	PHD finger protein 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312646	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PHF3 gene	PMID:31601247
1304925	Phf3	PHD finger protein 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312647	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of PHF3 mRNA	PMID:23557971
1304925	Phf3	PHD finger protein 3	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312646	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of PHF3 mRNA	PMID:38479592
1304925	Phf3	PHD finger protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PHF3 mRNA	PMID:33221593
1304925	Phf3	PHD finger protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304925	Phf3	PHD finger protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312646	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PHF3 mRNA	PMID:29275510
1304925	Phf3	PHD finger protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312647	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PHF3 mRNA	PMID:26063408
1304925	Phf3	PHD finger protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312646	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PHF3 gene	PMID:31601247
1304925	Phf3	PHD finger protein 3	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PHF3 mRNA	PMID:19244175
1304925	Phf3	PHD finger protein 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of PHF3 mRNA	PMID:23829299
1304925	Phf3	PHD finger protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PHF3 mRNA	PMID:39298647
1304925	Phf3	PHD finger protein 3	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of PHF3 gene	PMID:33148267
1304925	Phf3	PHD finger protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PHF3 mRNA	PMID:38568856
1304925	Phf3	PHD finger protein 3	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PHF3 mRNA	PMID:24386269
1304925	Phf3	PHD finger protein 3	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PHF3 mRNA	PMID:19244175
1304925	Phf3	PHD finger protein 3	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1312646	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of PHF3 mRNA	PMID:19691856
1304925	Phf3	PHD finger protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PHF3 mRNA	PMID:27153767
1304925	Phf3	PHD finger protein 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312647	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PHF3 mRNA	PMID:17963808
1304925	Phf3	PHD finger protein 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF3 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1304925	Phf3	PHD finger protein 3	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1312647	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine affects the expression of PHF3 mRNA	PMID:19770486
1304925	Phf3	PHD finger protein 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PHF3 mRNA	PMID:26272509
1304925	Phf3	PHD finger protein 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312646	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in increased expression of PHF3 mRNA	PMID:28542535
1304925	Phf3	PHD finger protein 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312646	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF3 mRNA	PMID:27188386
1304925	Phf3	PHD finger protein 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PHF3 mRNA; Nanotubes, Carbon results in decreased expression of PHF3 mRNA	PMID:25554681
1304925	Phf3	PHD finger protein 3	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PHF3 mRNA	PMID:24136188
1304925	Phf3	PHD finger protein 3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312647	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHF3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PHF3 mRNA	PMID:21641980|PMID:26378955
1304925	Phf3	PHD finger protein 3	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312646	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of PHF3 mRNA	PMID:28988120
1304925	Phf3	PHD finger protein 3	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312647	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of PHF3 mRNA	PMID:20003209
1304925	Phf3	PHD finger protein 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of PHF3 gene	PMID:33148267
1304925	Phf3	PHD finger protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312647	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of PHF3 mRNA	PMID:22206623
1304925	Phf3	PHD finger protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312647	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PHF3 mRNA	PMID:22206623
1304925	Phf3	PHD finger protein 3	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312646	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PHF3 protein	PMID:31285264
1304925	Phf3	PHD finger protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312646	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF3 mRNA	PMID:27188386
1304925	Phf3	PHD finger protein 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312646	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of PHF3 mRNA	PMID:19159669
1304925	Phf3	PHD finger protein 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312646	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of PHF3 protein	PMID:38348393
1304925	Phf3	PHD finger protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312646	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF3 mRNA	PMID:27188386
1304925	Phf3	PHD finger protein 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PHF3 mRNA	PMID:21346803
1304925	Phf3	PHD finger protein 3	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1312646	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of PHF3 mRNA	PMID:17440010
1304925	Phf3	PHD finger protein 3	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312646	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PHF3 mRNA	PMID:29301935
1304925	Phf3	PHD finger protein 3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PHF3 mRNA	PMID:28973697
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:132606	mono(2-ethyl-5-oxohexyl) phthalate	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20240402	CTD	MESH:C080276	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:132607	mono(2-ethyl-5-hydroxyhexyl) phthalate	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20240402	CTD	MESH:C479069	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:132611	mono(5-carboxy-2-ethylpentyl) phthalate	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20240402	CTD	MESH:C051450	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20240402	CTD	MESH:C103325	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PFAS mRNA	PMID:33167477
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of PFAS mRNA	PMID:26516004
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PFAS mRNA	PMID:22378314
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614154	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PFAS mRNA	PMID:39241906
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312648	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PFAS mRNA	PMID:23019147|PMID:31614463
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of PFAS mRNA	PMID:17404688
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312648	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PFAS mRNA	PMID:38568856
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PFAS mRNA	PMID:23649840
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of PFAS mRNA	PMID:17404688
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PFAS mRNA	PMID:21592394
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of PFAS mRNA	PMID:21592394
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of PFAS mRNA	PMID:21592394
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of PFAS mRNA	PMID:21592394
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PFAS mRNA	PMID:33387578
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PFAS mRNA	PMID:28818685
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PFAS protein	PMID:23301498
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PFAS mRNA	PMID:23649840
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312648	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PFAS gene	PMID:27153756
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PFAS mRNA	PMID:23649840
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of PFAS mRNA	PMID:25102026
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PFAS mRNA	PMID:30779732
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1614154	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PFAS mRNA	PMID:31919559
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PFAS mRNA	PMID:25629700
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312648	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PFAS gene	PMID:25304211
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1614154	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PFAS mRNA	PMID:40504410
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1614154	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PFAS mRNA	PMID:28960355
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312648	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of PFAS mRNA	PMID:23300844
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of PFAS mRNA	PMID:27594783
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PFAS mRNA	PMID:28001369
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of PFAS mRNA	PMID:23649840
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PFAS mRNA	PMID:32763439
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PFAS mRNA	PMID:20971185
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of PFAS protein	PMID:23736079
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PFAS mRNA	PMID:29803840
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1614154	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of PFAS mRNA	PMID:39631538
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29073	L-ascorbic acid	increases expression	ISO	RGD:1312648	E	RGD:6480464	20160705	CTD	MESH:D001205	Ascorbic Acid results in increased expression of PFAS mRNA	PMID:25555879
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20160705	CTD	MESH:D001205	[arsenic trioxide co-treated with Ascorbic Acid] results in increased expression of PFAS mRNA	PMID:25555879
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PFAS mRNA	PMID:38568856
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312648	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PFAS mRNA	PMID:34032870
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1614154	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PFAS mRNA	PMID:40504410
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PFAS mRNA	PMID:22378314
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PFAS mRNA	PMID:20064835
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PFAS mRNA]	PMID:32406909
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PFAS mRNA	PMID:20971185
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312648	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PFAS mRNA	PMID:25895662
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312648	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PFAS mRNA	PMID:25555879
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of PFAS mRNA	PMID:25555879
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of PFAS mRNA	PMID:25729387
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PFAS mRNA	PMID:25729387
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614154	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PFAS gene	PMID:35295148
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PFAS mRNA	PMID:34492290
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C069837	fullerene C60 results in decreased expression of PFAS mRNA	PMID:19167457
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PFAS mRNA	PMID:25181051
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PFAS mRNA	PMID:30816183|PMID:32528016
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PFAS mRNA; bisphenol A results in decreased expression of PFAS protein	PMID:29275510|PMID:31675489|PMID:37567409
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of PFAS mRNA	PMID:32145629
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1614154	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PFAS mRNA	PMID:33221593
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PFAS protein	PMID:31675489
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PFAS mRNA	PMID:39298647
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1614154	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PFAS promoter	PMID:33297965
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312648	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PFAS protein	PMID:34186270
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312648	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PFAS protein	PMID:34186270
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PFAS mRNA	PMID:28392331
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PFAS mRNA	PMID:37019170
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20150303	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PFAS mRNA	PMID:17361019|PMID:21266533
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PFAS mRNA	PMID:34813904
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of PFAS mRNA	PMID:17312168
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312648	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PFAS mRNA	PMID:37042841
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of PFAS mRNA	PMID:25539665
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PFAS mRNA	PMID:19376846
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:37825	p-toluidine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of PFAS mRNA	PMID:27638505
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312648	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PFAS mRNA	PMID:28302478
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312648	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PFAS mRNA	PMID:31533062
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PFAS mRNA	PMID:29154799
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312648	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PFAS mRNA	PMID:23179753
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PFAS mRNA	PMID:25562108
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of PFAS mRNA	PMID:23649840
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1312648	E	RGD:6480464	20151013	CTD	MESH:D008727	PFAS gene mutant form affects the susceptibility to Methotrexate	PMID:19426680
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PFAS mRNA	PMID:33387578
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PFAS mRNA	PMID:21420995
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312648	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PFAS gene	PMID:25304211
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1614154	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PFAS mRNA	PMID:40504410
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of PFAS mRNA	PMID:31675489
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:48707	(-)-citrinin	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20250603	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in increased expression of PFAS protein	PMID:39638853
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312648	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PFAS mRNA	PMID:25555879
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of PFAS mRNA	PMID:25555879
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312648	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of PFAS mRNA	PMID:23300844
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614154	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PFAS mRNA	PMID:25554681
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1614154	E	RGD:6480464	20150303	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PFAS mRNA	PMID:19042947
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PFAS protein	PMID:32959892
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PFAS mRNA	PMID:25729387
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20240402	CTD	MESH:C581825	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312648	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PFAS mRNA	PMID:31758290
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312648	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PFAS protein	PMID:34186270
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PFAS mRNA	PMID:22206623
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PFAS protein	PMID:37664457
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312648	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PFAS mRNA	PMID:22714537
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20250603	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in increased expression of PFAS protein	PMID:39638853
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PFAS gene]	PMID:28238834
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of PFAS mRNA	PMID:31388691
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PFAS protein	PMID:31675489
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PFAS protein	PMID:31675489
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PFAS mRNA	PMID:30047161
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20240402	CTD	MESH:C028577	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312648	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PFAS protein	PMID:37664457
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PFAS mRNA	PMID:29301935
1304926	Pfas	phosphoribosylformylglycinamidine synthase	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312648	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of PFAS mRNA	PMID:22378314
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of FAM135A mRNA	PMID:22378314
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312651	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FAM135A mRNA	PMID:30319688
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of FAM135A mRNA	PMID:29018328
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312650	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of FAM135A mRNA	PMID:21632981
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312650	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with resveratrol] results in decreased expression of FAM135A mRNA	PMID:26667767
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of FAM135A mRNA	PMID:32145629
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312651	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FAM135A mRNA	PMID:39298647
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312650	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FAM135A mRNA	PMID:37042841
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312650	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FAM135A protein	PMID:37730182
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312651	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM135A mRNA	PMID:37236586
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312650	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of FAM135A mRNA	PMID:19549813
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312650	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FAM135A gene	PMID:27153756
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312651	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FAM135A mRNA	PMID:19770486
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of FAM135A mRNA	PMID:23649840
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of FAM135A mRNA	PMID:30779732
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FAM135A mRNA	PMID:31150632
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312651	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FAM135A mRNA	PMID:31919559
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FAM135A mRNA	PMID:25629700
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312650	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of FAM135A protein	PMID:35688186
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA	PMID:33854195
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312650	E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with resveratrol] results in decreased expression of FAM135A mRNA	PMID:26667767
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of FAM135A mRNA	PMID:27392435
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312650	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of FAM135A mRNA	PMID:27594783
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312650	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of FAM135A mRNA	PMID:27392435
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312651	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FAM135A mRNA	PMID:24680724
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FAM135A mRNA	PMID:33387578
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FAM135A mRNA	PMID:33212167
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FAM135A mRNA	PMID:30851411
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of FAM135A mRNA	PMID:29301061
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312650	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FAM135A mRNA	PMID:38568856
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312650	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM135A 5' UTR	PMID:27901495
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312650	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM135A mRNA	PMID:26238291
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312651	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM135A mRNA	PMID:20127859
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of FAM135A mRNA	PMID:27188386
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312651	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM135A gene	PMID:35295148
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FAM135A mRNA	PMID:34492290
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM135A mRNA	PMID:32145629
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FAM135A mRNA	PMID:25181051
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312650	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of FAM135A mRNA	PMID:29275510
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312651	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FAM135A mRNA	PMID:39298647
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA	PMID:33854195
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312650	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FAM135A mRNA	PMID:37042841
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FAM135A mRNA	PMID:24982889
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312651	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM135A mRNA	PMID:37236586
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312650	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FAM135A mRNA	PMID:31533062
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FAM135A mRNA	PMID:24383497|PMID:26272509
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312650	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of FAM135A mRNA	PMID:24935251|PMID:29154799
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312650	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM135A mRNA	PMID:27188386
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312650	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FAM135A mRNA	PMID:25562108
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1312650	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of FAM135A promoter	PMID:27989131
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA	PMID:33854195
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312650	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of FAM135A mRNA	PMID:38832940
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:45716	vorinostat	affects expression	ISO	RGD:1312650	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat affects the expression of FAM135A mRNA	PMID:27188386
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA	PMID:33854195
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312650	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FAM135A mRNA	PMID:24935251
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FAM135A mRNA	PMID:21420995
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of FAM135A mRNA	PMID:40706910
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312651	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of FAM135A mRNA	PMID:35436446
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312651	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of FAM135A mRNA	PMID:26377693
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of FAM135A mRNA	PMID:19042947
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of FAM135A mRNA	PMID:23608068
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA	PMID:33854195
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FAM135A mRNA	PMID:22206623
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of FAM135A mRNA	PMID:33484710
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312650	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FAM135A mRNA	PMID:30851411
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312650	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM135A mRNA	PMID:27188386
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312650	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM135A mRNA	PMID:27188386
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:9546	thimerosal	affects expression	ISO	RGD:1312650	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal affects the expression of FAM135A mRNA	PMID:27188386
1304927	Fam135a	family with sequence similarity 135, member A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of FAM135A mRNA	PMID:23034163
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1312652	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of HMX1 mRNA	PMID:34925699
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312652	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HMX1 mRNA	PMID:26079696
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312652	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of HMX1 mRNA	PMID:27905399
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312652	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of HMX1 mRNA	PMID:26079696
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312652	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of HMX1 intron	PMID:30157460
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312652	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of HMX1 intron	PMID:30157460
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1312652	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HMX1 mRNA	PMID:19244175
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:28112	nickel atom	affects expression	ISO	RGD:1312652	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel affects the expression of HMX1 mRNA	PMID:14575637
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1312652	E	RGD:6480464	20120717	CTD	MESH:D009532	trichostatin A inhibits the reaction [Nickel affects the expression of HMX1 mRNA]	PMID:14575637
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312653	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HMX1 mRNA	PMID:24058054|PMID:26377647
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HMX1 mRNA	PMID:32109520
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312653	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HMX1 mRNA	PMID:37172768
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312652	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HMX1 mRNA	PMID:34089799
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312652	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of HMX1 mRNA	PMID:22378314
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312652	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HMX1 intron	PMID:30157460
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312653	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of HMX1 mRNA	PMID:27131904
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312653	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of HMX1 mRNA	PMID:22609695
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HMX1 mRNA	PMID:30047161
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312653	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of HMX1 mRNA	PMID:35295148
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312653	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HMX1 enhancer; titanium dioxide results in decreased methylation of HMX1 gene; titanium dioxide results in decreased methylation of HMX1 promoter	PMID:35295148
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HMX1 mRNA	PMID:34492290
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of HMX1 mRNA	PMID:25181051
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312653	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of HMX1 promoter	PMID:27334623
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312652	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of HMX1 intron; benzo(e)pyrene results in increased methylation of HMX1 polyA tail	PMID:30157460
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312653	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of HMX1 mRNA	PMID:32715474
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1312652	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HMX1 mRNA	PMID:19244175
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312652	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of HMX1 gene	PMID:29154799
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HMX1 mRNA	PMID:30047161
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312652	E	RGD:6480464	20120717	CTD	MESH:C012589	trichostatin A inhibits the reaction [Nickel affects the expression of HMX1 mRNA]	PMID:14575637
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	EXP		E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of HMX1 gene	PMID:37958445
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of HMX1 mRNA	PMID:30047161
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312652	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of HMX1 intron; Methapyrilene results in increased methylation of HMX1 polyA tail	PMID:30157460
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1312652	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of HMX1 mRNA	PMID:20185912
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HMX1 mRNA	PMID:27291303
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1312652	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of HMX1 mRNA	PMID:30458266
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of HMX1 mRNA	PMID:23640034
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312652	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of HMX1 mRNA	PMID:26079696
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of HMX1 mRNA	PMID:25825206|PMID:30047161
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312653	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of HMX1 mRNA	PMID:27131904
1304928	Hmx1	H6 family homeobox 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312652	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of HMX1 mRNA	PMID:22378314
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1312654	E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in increased expression of RUBCNL mRNA	PMID:36828454
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312654	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RUBCNL mRNA	PMID:27188386
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312654	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of RUBCNL mRNA	PMID:21934132|PMID:33167477
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of RUBCNL mRNA	PMID:33729688
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of RUBCNL mRNA	PMID:36841081
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1312654	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of RUBCNL mRNA	PMID:16823088
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312655	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RUBCNL mRNA	PMID:39241906
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312654	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of RUBCNL mRNA	PMID:21795739|PMID:31614463|PMID:36828454
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312654	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RUBCNL mRNA	PMID:37042841
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RUBCNL mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA	PMID:37567420|PMID:37992649
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RUBCNL mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA	PMID:37567420|PMID:37992649
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RUBCNL mRNA	PMID:27523638
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312654	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of RUBCNL mRNA	PMID:26485663
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RUBCNL mRNA	PMID:33387578
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312654	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RUBCNL promoter	PMID:30157460
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312654	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RUBCNL intron	PMID:30157460
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1312654	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of RUBCNL mRNA	PMID:16823088
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312654	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RUBCNL mRNA	PMID:41430723
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RUBCNL mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RUBCNL mRNA	PMID:34911549
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312654	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RUBCNL mRNA	PMID:26272509
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312654	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA	PMID:27188386
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312654	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RUBCNL mRNA	PMID:24768652|PMID:25583101
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RUBCNL mRNA	PMID:32109520
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RUBCNL mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA	PMID:37567420|PMID:37992649
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312654	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RUBCNL mRNA	PMID:38568856
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA	PMID:34876320
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA	PMID:34876320
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312654	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RUBCNL promoter	PMID:27901495
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1312654	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of RUBCNL mRNA	PMID:25075043
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312654	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of RUBCNL mRNA	PMID:28959546
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:30563	silicon dioxide	affects expression	ISO	RGD:1312654	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog affects the expression of RUBCNL mRNA	PMID:23806026
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RUBCNL mRNA	PMID:25181051
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312654	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of RUBCNL mRNA	PMID:20170705
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312654	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of RUBCNL mRNA	PMID:36828454
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312654	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of RUBCNL gene	PMID:31601247
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312654	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RUBCNL mRNA	PMID:37042841
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of RUBCNL mRNA	PMID:35163327
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312654	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RUBCNL mRNA	PMID:38568856
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312654	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RUBCNL mRNA	PMID:36326898
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312654	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RUBCNL mRNA	PMID:24449571
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312655	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RUBCNL mRNA	PMID:39529242
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312655	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of RUBCNL mRNA	PMID:29038090
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312654	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RUBCNL mRNA	PMID:25979313
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312654	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RUBCNL mRNA	PMID:23179753|PMID:26272509
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312654	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA	PMID:27188386
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RUBCNL mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA	PMID:37567420|PMID:37992649
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RUBCNL mRNA	PMID:33387578
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RUBCNL mRNA	PMID:29391264
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA	PMID:34876320
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312654	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RUBCNL mRNA	PMID:20170705
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1312654	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of RUBCNL mRNA	PMID:25075043
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RUBCNL mRNA	PMID:35964746
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312655	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RUBCNL mRNA	PMID:38701926
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA	PMID:37567420
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312654	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA	PMID:27188386
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA	PMID:34876320
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312654	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA	PMID:27188386
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312654	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of RUBCNL mRNA	PMID:28959546
1304929	Rubcnl	rubicon like autophagy enhancer	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312655	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of RUBCNL mRNA	PMID:35537566
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552794	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CNIH2 mRNA	PMID:20188158
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20120412	CTD	MESH:D001280	[Atrazine co-treated with Arsenates] results in increased expression of CNIH2 mRNA	PMID:18585445
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1352659	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CNIH2 mRNA	PMID:26079696
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1552794	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of CNIH2 mRNA	PMID:17178593
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1352659	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of CNIH2 mRNA	PMID:21592394
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of CNIH2 mRNA	PMID:21592394
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1552794	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of CNIH2 mRNA	PMID:17178593
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CNIH2 mRNA	PMID:26516888
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CNIH2 mRNA	PMID:26577399
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CNIH2 mRNA	PMID:36139627
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1352659	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of CNIH2 mRNA	PMID:21592394
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of CNIH2 mRNA	PMID:21592394
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CNIH2 mRNA	PMID:39836092
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552794	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNIH2 mRNA	PMID:28111341
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CNIH2 mRNA	PMID:35430440
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552794	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CNIH2 mRNA]	PMID:22206623
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1352659	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CNIH2 gene	PMID:25304211
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CNIH2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CNIH2 mRNA	PMID:39836092
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CNIH2 mRNA	PMID:23557933
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1552794	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of CNIH2 mRNA	PMID:32186404
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CNIH2 mRNA	PMID:33387578
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552794	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CNIH2 mRNA	PMID:17942748
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of CNIH2 mRNA	PMID:29704546
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552794	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNIH2 mRNA	PMID:17942748
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1352659	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CNIH2 mRNA	PMID:33212167
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1352659	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of CNIH2 mRNA	PMID:21198554
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CNIH2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CNIH2 mRNA	PMID:39836092
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352659	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CNIH2 5' UTR; Benzo(a)pyrene results in increased methylation of CNIH2 exon; Benzo(a)pyrene results in increased methylation of CNIH2 promoter	PMID:27901495
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CNIH2 mRNA	PMID:34492290
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552794	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CNIH2 mRNA	PMID:19710929
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CNIH2 mRNA	PMID:25181051
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552794	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CNIH2 mRNA	PMID:32156529
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of CNIH2 mRNA	PMID:38750585
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of CNIH2 mRNA	PMID:23829299
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552794	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of CNIH2 mRNA	PMID:40203079
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:34631	chlorpyrifos	affects expression	ISO	RGD:1552794	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos affects the expression of CNIH2 mRNA	PMID:37019170
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CNIH2 mRNA	PMID:21266533
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1552794	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of CNIH2 mRNA	PMID:36117858
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352659	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNIH2 mRNA	PMID:37042841
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1352659	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CNIH2 mRNA	PMID:29024780
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CNIH2 mRNA	PMID:39836092
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552794	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNIH2 mRNA	PMID:28111341
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1352659	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CNIH2 mRNA	PMID:31533062
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552794	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of CNIH2 mRNA	PMID:39529242
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1352659	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CNIH2 gene	PMID:29154799
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1552794	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of CNIH2 mRNA	PMID:17178593
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1352659	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CNIH2 mRNA	PMID:38832940
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CNIH2 mRNA	PMID:33387578
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1352659	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CNIH2 gene	PMID:25304211
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CNIH2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CNIH2 mRNA	PMID:39836092
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1352659	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of CNIH2 mRNA	PMID:31838189
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CNIH2 mRNA	PMID:29391264
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552794	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CNIH2 mRNA	PMID:17942748
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552794	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNIH2 mRNA	PMID:17942748
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1552794	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of CNIH2 mRNA	PMID:36117858
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CNIH2 mRNA	PMID:39836092
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1352659	E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of CNIH2 mRNA	PMID:33244087
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552794	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CNIH2 mRNA	PMID:22206623
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552794	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CNIH2 mRNA]	PMID:22206623
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1352659	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CNIH2 mRNA	PMID:36139627
1304930	Cnih2	cornichon family AMPA receptor auxiliary protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CNIH2 mRNA	PMID:24780913
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606208	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PERM1 mRNA	PMID:38218311
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606208	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PERM1 mRNA	PMID:33167477
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PERM1 mRNA	PMID:33729688
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312657	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PERM1 mRNA	PMID:39298647
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606208	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PERM1 mRNA	PMID:30165855
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PERM1 mRNA	PMID:33387578
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:17303	morphine	increases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D009020	Morphine results in increased expression of PERM1 protein	PMID:23056601
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:17303	morphine	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:D009020	Morphine deficiency affects the reaction [Morphine results in increased expression of PERM1 protein]	PMID:23056601
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PERM1 mRNA	PMID:33387578
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1606208	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of PERM1 mRNA	PMID:17103032
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1606208	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PERM1 mRNA	PMID:21641981
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312657	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PERM1 mRNA	PMID:34911549
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1606208	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PERM1 mRNA	PMID:21867686
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PERM1 mRNA	PMID:31881176
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PERM1 mRNA	PMID:32109520|PMID:33387578
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of PERM1 mRNA	PMID:28374803
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PERM1 mRNA	PMID:28959563
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312657	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PERM1 mRNA	PMID:39631538
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606208	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PERM1 promoter	PMID:27901495
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1606208	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PERM1 mRNA	PMID:32234424
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1606208	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PERM1 mRNA	PMID:25895662
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of PERM1 mRNA	PMID:24395379
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PERM1 mRNA	PMID:25181051
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312657	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PERM1 mRNA	PMID:32156529
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312657	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of PERM1 promoter	PMID:27312807
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PERM1 mRNA	PMID:36041667
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PERM1 mRNA	PMID:36041667
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PERM1 mRNA	PMID:36041667
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312657	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PERM1 mRNA	PMID:37019170
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1606208	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of PERM1 mRNA	PMID:29024780
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of PERM1 mRNA	PMID:35163327
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PERM1 mRNA	PMID:35163327
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606208	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PERM1 mRNA	PMID:38382870
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PERM1 mRNA	PMID:35163327
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312657	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PERM1 mRNA	PMID:39529242
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1606208	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PERM1 gene	PMID:29154799
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1606208	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of PERM1 mRNA	PMID:16595896
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1606208	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PERM1 mRNA	PMID:38832940
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PERM1 mRNA	PMID:29391264
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1606208	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of PERM1 mRNA	PMID:32234424
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1312657	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PERM1 mRNA	PMID:36907384
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1312657	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PERM1 mRNA	PMID:27935865
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1312657	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PERM1 mRNA	PMID:25566086
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1312657	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PERM1 mRNA]	PMID:25566086
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1312657	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PERM1 mRNA	PMID:27935865
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of PERM1 mRNA	PMID:25825206
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1312657	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of PERM1 mRNA	PMID:35278568
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:91091	CHIR 99021	increases expression	ISO	RGD:1312657	E	RGD:6480464	20190611	CTD	MESH:C473711	Chir 99021 results in increased expression of PERM1 mRNA	PMID:29883716
1304931	Perm1	PPARGC1 and ESRR induced regulator, muscle 1	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312657	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of PERM1 mRNA	PMID:35537566
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:10022	deoxynivalenol	affects phosphorylation	ISO	RGD:1312660	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol affects the phosphorylation of PDCD11 protein	PMID:23352502
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PDCD11 mRNA]	PMID:31150632
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PDCD11 mRNA	PMID:33167477
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PDCD11 mRNA	PMID:22378314
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312660	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PDCD11 mRNA	PMID:39241906
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1354347	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PDCD11 mRNA	PMID:23019147|PMID:31614463
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1354347	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PDCD11 mRNA	PMID:37042841
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PDCD11 promoter	PMID:23359474
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1354347	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PDCD11 protein	PMID:37730182
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PDCD11 protein	PMID:34915118
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PDCD11 mRNA	PMID:35301059
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PDCD11 protein	PMID:23301498
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:2422	acetohydrazide	decreases expression	ISO	RGD:1312660	E	RGD:6480464	20120412	CTD	MESH:C014949	acetylhydrazine results in decreased expression of PDCD11 mRNA	PMID:15282401
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of PDCD11 protein	PMID:39638853
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PDCD11 mRNA	PMID:23649840
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312660	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PDCD11 mRNA	PMID:27106289
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PDCD11 mRNA	PMID:30779732
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PDCD11 mRNA	PMID:31150632
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PDCD11 mRNA]	PMID:31150632
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312660	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PDCD11 mRNA	PMID:40504410
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of PDCD11 mRNA	PMID:40512198
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1354347	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PDCD11 protein	PMID:35688186
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312660	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of PDCD11 protein	PMID:25505154
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of PDCD11 mRNA	PMID:27594783
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of PDCD11 mRNA	PMID:17898221
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312660	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PDCD11 mRNA	PMID:30912803
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1354347	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of PDCD11 mRNA	PMID:23019147
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1354347	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PDCD11 mRNA	PMID:25583101
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PDCD11 mRNA	PMID:22298810
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312660	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PDCD11 mRNA	PMID:21570461
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PDCD11 mRNA	PMID:33387578
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1354347	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PDCD11 mRNA	PMID:33212167
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312660	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of PDCD11 mRNA	PMID:16243910
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1354347	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PDCD11 protein	PMID:35688186
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PDCD11 mRNA	PMID:38568856
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312660	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PDCD11 mRNA	PMID:40504410
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of PDCD11 mRNA	PMID:40512198
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312660	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PDCD11 mRNA	PMID:22228805
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312660	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PDCD11 mRNA]	PMID:22228805
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:3000	beauvericin	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20180515	CTD	MESH:C004456	beauvericin results in decreased expression of PDCD11 mRNA	PMID:29203277
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PDCD11 gene	PMID:31601247
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of PDCD11 mRNA	PMID:24136188
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PDCD11 mRNA	PMID:34492290
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312660	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PDCD11 mRNA	PMID:28472532
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PDCD11 mRNA	PMID:30816183|PMID:32528016
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of PDCD11 protein	PMID:37567409
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PDCD11 mRNA	PMID:25181051
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PDCD11 promoter	PMID:23359474
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PDCD11 gene	PMID:31601247
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of PDCD11 mRNA	PMID:30316929
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1354347	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of PDCD11 protein	PMID:31945527
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312660	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PDCD11 exon	PMID:33297965
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312660	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PDCD11 mRNA	PMID:39298647
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PDCD11 mRNA	PMID:17602206
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PDCD11 promoter	PMID:23359474
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PDCD11 mRNA	PMID:17602206
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1354347	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PDCD11 mRNA	PMID:37042841
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PDCD11 mRNA	PMID:33453195
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PDCD11 mRNA	PMID:35301059
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312660	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PDCD11 mRNA	PMID:28903501
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PDCD11 mRNA	PMID:24449571
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1354347	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of PDCD11 protein	PMID:34122009
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1354347	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PDCD11 mRNA	PMID:28302478
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1354347	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PDCD11 mRNA	PMID:25979313
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1354347	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PDCD11 mRNA	PMID:25562108
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312660	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PDCD11 mRNA	PMID:18502557
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1354347	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PDCD11 mRNA	PMID:38832940
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312660	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PDCD11 mRNA	PMID:40504410
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of PDCD11 mRNA	PMID:40512198
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312660	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PDCD11 mRNA	PMID:35436446
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:50161	motexafin gadolinium	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in decreased expression of PDCD11 mRNA	PMID:16357179
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312660	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PDCD11 mRNA	PMID:35964746
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PDCD11 mRNA	PMID:24136188
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312660	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PDCD11 mRNA	PMID:23608068
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PDCD11 protein	PMID:32959892
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:62984	zinc acetate	decreases expression	ISO	RGD:1354347	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of PDCD11 mRNA	PMID:16357179
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312660	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PDCD11 mRNA	PMID:23650126
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1354347	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of PDCD11 protein	PMID:34122009
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312660	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of PDCD11 mRNA	PMID:22206623
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PDCD11 protein	PMID:37664457
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PDCD11 mRNA	PMID:24136188
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1354347	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PDCD11 protein	PMID:31285264
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of PDCD11 protein	PMID:39638853
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of PDCD11 mRNA	PMID:21346803
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PDCD11 gene]	PMID:28238834
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of PDCD11 mRNA	PMID:36084822
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1354347	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PDCD11 protein	PMID:37664457
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PDCD11 mRNA	PMID:19281266
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PDCD11 mRNA	PMID:21346803
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PDCD11 mRNA	PMID:21346803
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312660	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PDCD11 mRNA	PMID:28973697
1304933	Pdcd11	programmed cell death 11	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PDCD11 mRNA	PMID:23034163
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552089	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RPUSD1 mRNA	PMID:20938992
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1344939	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of RPUSD1 mRNA	PMID:23019147
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552089	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RPUSD1 mRNA	PMID:20938992
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552089	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RPUSD1 mRNA	PMID:23892564
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552089	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RPUSD1 mRNA	PMID:34319233
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1344939	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of RPUSD1 mRNA	PMID:24376830
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1344939	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RPUSD1 gene	PMID:28458013
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552089	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RPUSD1 mRNA	PMID:20938992
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:27585	selenomethionine	affects expression	ISO	RGD:1344939	E	RGD:6480464	20120412	CTD	MESH:D012645	Selenomethionine affects the expression of RPUSD1 mRNA	PMID:17222674
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552089	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPUSD1 mRNA	PMID:21570461|PMID:24680724
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPUSD1 mRNA	PMID:33387578
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1344939	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RPUSD1 mRNA	PMID:29803840
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344939	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RPUSD1 mRNA	PMID:38568856
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344939	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of RPUSD1 mRNA	PMID:39719251
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344939	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RPUSD1 5' UTR	PMID:27901495
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1344939	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RPUSD1 3' UTR	PMID:27901495
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RPUSD1 mRNA	PMID:34492290
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1552089	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RPUSD1 mRNA	PMID:18648102
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RPUSD1 mRNA	PMID:25181051
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552089	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RPUSD1 mRNA	PMID:38685157
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552089	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RPUSD1 mRNA	PMID:37019170
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344939	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RPUSD1 mRNA	PMID:37042841
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1344939	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RPUSD1 gene	PMID:29154799
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RPUSD1 mRNA	PMID:33387578
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1344939	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RPUSD1 mRNA	PMID:18175754
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of RPUSD1 mRNA	PMID:30307764
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552089	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RPUSD1 mRNA	PMID:25554681
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1344939	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RPUSD1 mRNA	PMID:31758290
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of RPUSD1 mRNA	PMID:32109520
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RPUSD1 mRNA	PMID:21394737
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552089	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RPUSD1 mRNA	PMID:40826991
1304934	Rpusd1	RNA pseudouridine synthase domain containing 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1344939	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RPUSD1 mRNA	PMID:38568856
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1351016	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PLEKHH2 mRNA	PMID:27188386
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553122	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PLEKHH2 gene	PMID:20938992
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PLEKHH2 mRNA	PMID:33167477
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1351016	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PLEKHH2 mRNA	PMID:22378314
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of PLEKHH2 mRNA	PMID:24758408
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1351016	E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in decreased expression of PLEKHH2 mRNA]	PMID:24758408
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553122	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PLEKHH2 gene	PMID:20938992
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PLEKHH2 mRNA	PMID:33359661
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PLEKHH2 mRNA	PMID:31163220
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1351016	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PLEKHH2 intron	PMID:30157460
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of PLEKHH2 mRNA	PMID:24376830
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553122	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLEKHH2 mRNA	PMID:37236586
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of PLEKHH2 mRNA	PMID:23487506
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1351016	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of PLEKHH2 intron	PMID:30157460
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PLEKHH2 mRNA	PMID:31150632
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553122	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PLEKHH2 gene	PMID:20938992
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351016	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLEKHH2 mRNA	PMID:39836092
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1351016	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHH2 mRNA	PMID:27188386
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PLEKHH2 mRNA	PMID:31881176
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PLEKHH2 mRNA	PMID:27392435
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of PLEKHH2 mRNA	PMID:24768652
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553122	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLEKHH2 mRNA	PMID:21570461
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLEKHH2 mRNA	PMID:33387578
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLEKHH2 mRNA	PMID:27913140
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLEKHH2 mRNA	PMID:34747641
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553122	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLEKHH2 mRNA	PMID:19933214
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553122	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLEKHH2 mRNA	PMID:17942748
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PLEKHH2 mRNA	PMID:28001369
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PLEKHH2 mRNA	PMID:33212167
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PLEKHH2 mRNA	PMID:26033743
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PLEKHH2 mRNA	PMID:29803840
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351016	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PLEKHH2 mRNA	PMID:22714537
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351016	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLEKHH2 mRNA	PMID:39836092
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351016	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLEKHH2 3' UTR; Benzo(a)pyrene affects the methylation of PLEKHH2 promoter	PMID:27901495
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1553122	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PLEKHH2 exon; Benzo(a)pyrene results in increased methylation of PLEKHH2 intron	PMID:27901495
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PLEKHH2 mRNA	PMID:26033743
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1351016	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of PLEKHH2 mRNA	PMID:26014281
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PLEKHH2 mRNA; Silicon Dioxide results in decreased expression of PLEKHH2 mRNA	PMID:25895662|PMID:28425640
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1351016	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of PLEKHH2 gene	PMID:31601247
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PLEKHH2 mRNA	PMID:25181051|PMID:30816183|PMID:41034487
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1351016	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of PLEKHH2 mRNA	PMID:36232920
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553122	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of PLEKHH2 mRNA	PMID:30951980
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1553122	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PLEKHH2 mRNA	PMID:25172293
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1553122	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PLEKHH2 gene	PMID:31683443
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553122	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PLEKHH2 mRNA	PMID:30951980
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1351016	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of PLEKHH2 gene	PMID:31601247
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1351016	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PLEKHH2 intron	PMID:30157460
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553122	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PLEKHH2 mRNA	PMID:30951980
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1553122	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PLEKHH2 intron	PMID:28392331
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553122	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PLEKHH2 mRNA	PMID:37019170
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PLEKHH2 mRNA	PMID:32680482
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLEKHH2 mRNA	PMID:35163327
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of PLEKHH2 mRNA	PMID:17616710
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553122	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLEKHH2 mRNA	PMID:37236586
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLEKHH2 mRNA	PMID:35163327
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1553122	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PLEKHH2 mRNA	PMID:40194260
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PLEKHH2 mRNA	PMID:40419075
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1351016	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in increased expression of PLEKHH2 mRNA	PMID:18421014
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351016	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLEKHH2 mRNA	PMID:25979313
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351016	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PLEKHH2 mRNA	PMID:19101580|PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:37505509
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1351016	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHH2 mRNA	PMID:27188386
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1351016	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PLEKHH2 mRNA	PMID:25562108
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011692	Puromycin Aminonucleoside results in decreased expression of PLEKHH2 protein	PMID:20588063
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1351016	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PLEKHH2 mRNA	PMID:27188386
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1351016	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PLEKHH2 mRNA	PMID:28542535
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1351016	E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of PLEKHH2 mRNA	PMID:24935251|PMID:27188386
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PLEKHH2 mRNA	PMID:33387578
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1351016	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PLEKHH2 mRNA	PMID:22230336|PMID:29067470
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1351016	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of PLEKHH2 mRNA	PMID:24714768
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351016	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLEKHH2 mRNA	PMID:39836092
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1553122	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of PLEKHH2 mRNA	PMID:35537566
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of PLEKHH2 mRNA	PMID:37567419
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553122	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PLEKHH2 mRNA	PMID:17942748
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553122	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLEKHH2 mRNA	PMID:17942748
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PLEKHH2 mRNA	PMID:30307764
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1553122	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of PLEKHH2 mRNA	PMID:40234311
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1351016	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of PLEKHH2 mRNA	PMID:22714537
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1351016	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PLEKHH2 intron	PMID:30157460
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1351016	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of PLEKHH2 mRNA	PMID:29522793
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1351016	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHH2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHH2 mRNA	PMID:27188386
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLEKHH2 mRNA	PMID:24780913
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1351016	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHH2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHH2 mRNA	PMID:27188386
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1351016	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of PLEKHH2 mRNA	PMID:26014281
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PLEKHH2 mRNA	PMID:19281266
1304935	Plekhh2	pleckstrin homology, MyTH4 and FERM domain containing H2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1553122	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PLEKHH2 mRNA	PMID:35537566
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MTFR1 mRNA	PMID:38218311
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1605712	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MTFR1 mRNA	PMID:38218311
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of MTFR1 mRNA	PMID:21551480
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1615107	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MTFR1 mRNA	PMID:33045310
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:136004	linsidomine	increases oxidation	EXP		E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of MTFR1 protein	PMID:28086193
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1615107	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MTFR1 mRNA	PMID:26251327
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of MTFR1 mRNA	PMID:23724009|PMID:33167477
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1605712	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MTFR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MTFR1 mRNA	PMID:32699268
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1605712	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MTFR1 mRNA	PMID:22378314
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MTFR1 mRNA	PMID:21632981
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1605712	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of MTFR1 protein	PMID:35688186
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in decreased expression of MTFR1 protein	PMID:33181973
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1615107	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MTFR1 mRNA	PMID:39298647
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605712	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MTFR1 mRNA	PMID:37042841
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of MTFR1 mRNA	PMID:23649840
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1605712	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MTFR1 protein	PMID:37730182
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MTFR1 mRNA	PMID:33387578
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1605712	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTFR1 mRNA	PMID:39836092
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MTFR1 mRNA	PMID:23649840
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605712	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MTFR1 gene	PMID:27153756
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605712	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MTFR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MTFR1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MTFR1 mRNA	PMID:32699268
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1615107	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTFR1 mRNA	PMID:22206623
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605712	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTFR1 mRNA	PMID:39836092
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MTFR1 mRNA	PMID:31881176
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1605712	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MTFR1 mRNA	PMID:28903495
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1605712	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of MTFR1 mRNA	PMID:23300844
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1615107	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of MTFR1 mRNA	PMID:40618947
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615107	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MTFR1 mRNA	PMID:21570461
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MTFR1 mRNA	PMID:20106945|PMID:21632981
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1605712	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of MTFR1 mRNA	PMID:33512557
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MTFR1 mRNA	PMID:29803840
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605712	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTFR1 mRNA	PMID:39836092
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1605712	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of MTFR1 mRNA	PMID:22378314
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605712	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MTFR1 5' UTR	PMID:27901495
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1615107	E	RGD:6480464	20160210	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MTFR1 mRNA	PMID:26496743
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605712	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MTFR1 mRNA]	PMID:32406909
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MTFR1 mRNA	PMID:20018196
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MTFR1 mRNA	PMID:25729387
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MTFR1 mRNA	PMID:25729387
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615107	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MTFR1 gene	PMID:35295148
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MTFR1 mRNA	PMID:30723492
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1615107	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MTFR1 mRNA	PMID:17426115
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MTFR1 mRNA	PMID:25181051
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of MTFR1 protein	PMID:33181973
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MTFR1 mRNA	PMID:30816183|PMID:32145629
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of MTFR1 mRNA	PMID:19244175
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1605712	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MTFR1 intron	PMID:30157460
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1615107	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MTFR1 mRNA	PMID:38685157
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605712	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MTFR1 mRNA	PMID:37042841
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1605712	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTFR1 mRNA	PMID:39836092
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1615107	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of MTFR1 mRNA	PMID:21139344
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1605712	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MTFR1 mRNA	PMID:24449571
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1605712	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MTFR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MTFR1 mRNA	PMID:32699268
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605712	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MTFR1 mRNA	PMID:31533062
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605712	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MTFR1 mRNA	PMID:25979313
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605712	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MTFR1 mRNA	PMID:19101580|PMID:23179753|PMID:29154799
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605712	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MTFR1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MTFR1 mRNA	PMID:33387578
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605712	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTFR1 mRNA	PMID:39836092
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1615107	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MTFR1 mRNA	PMID:35436446
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1605712	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MTFR1 mRNA	PMID:23300844
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of MTFR1 mRNA	PMID:19162173
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:5118	fluoxetine	increases expression	ISO	RGD:1605712	E	RGD:6480464	20240206	CTD	MESH:D005473	Fluoxetine results in increased expression of MTFR1 mRNA	PMID:37386098
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1615107	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of MTFR1 mRNA	PMID:26377693
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1605712	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MTFR1 mRNA	PMID:39836092
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MTFR1 mRNA	PMID:25729387
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MTFR1 mRNA	PMID:25729387
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1615107	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MTFR1 mRNA	PMID:23650126
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1605712	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of MTFR1 mRNA	PMID:37939859
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1605712	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MTFR1 intron	PMID:30157460
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1615107	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MTFR1 mRNA	PMID:22206623
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1615107	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTFR1 mRNA	PMID:22206623
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:748435	pafuramidine	multiple interactions	ISO	RGD:1615107	E	RGD:6480464	20260714	CTD	MESH:C458513	MTFR1 affects the reaction [pafuramidine results in increased expression of HAVCR1 protein]	PMID:22940726
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:75408	sulindac sulfide	increases expression	ISO	RGD:1605712	E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in increased expression of MTFR1 mRNA	PMID:16184548
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1605712	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MTFR1 mRNA	PMID:37199045
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1615107	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MTFR1 mRNA	PMID:31388691
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1605712	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of MTFR1 mRNA	PMID:33512557
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MTFR1 mRNA	PMID:24780913
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1605712	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of MTFR1 mRNA	PMID:22378314
1304936	Mtfr1	mitochondrial fission regulator 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MTFR1 mRNA	PMID:21346803
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of ARAP3 mRNA	PMID:25152437
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621402	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ARAP3 mRNA	PMID:33045310
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of ARAP3 mRNA	PMID:21934132
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1621402	E	RGD:6480464	20130423	CTD	MESH:D014212	Tretinoin results in increased expression of ARAP3 mRNA	PMID:16604517
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of ARAP3 mRNA	PMID:36841081
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1621402	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ARAP3 mRNA	PMID:30319688
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:16240	hydrogen peroxide	decreases secretion	ISO	RGD:1621402	E	RGD:6480464	20130423	CTD	MESH:D006861	Hydrogen Peroxide results in decreased secretion of ARAP3 mRNA	PMID:21179422
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1621402	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARAP3 mRNA	PMID:39241906
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ARAP3 mRNA	PMID:35811015
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1621402	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ARAP3 mRNA	PMID:39298647
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of ARAP3 mRNA	PMID:17404688
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1347923	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARAP3 mRNA	PMID:37042841
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of ARAP3 mRNA	PMID:17404688
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1347923	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ARAP3 protein	PMID:37730182
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:187088	Muconic dialdehyde	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20250805	CTD	MESH:C034476	muconaldehyde results in decreased expression of ARAP3 mRNA	PMID:40300100
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1621402	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARAP3 mRNA	PMID:37325564
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1347923	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ARAP3 mRNA	PMID:19549813
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1347923	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARAP3 mRNA	PMID:21641981
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ARAP3 mRNA	PMID:35430440
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ARAP3 mRNA	PMID:30779732
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1621402	E	RGD:6480464	20130423	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ARAP3 mRNA	PMID:17484886
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ARAP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARAP3 mRNA	PMID:40512198
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1621402	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARAP3 mRNA	PMID:40504410
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1347923	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ARAP3 mRNA	PMID:27594783
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:27928	parathion	decreases methylation	ISO	RGD:1347923	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of ARAP3 promoter	PMID:22847954
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1347923	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARAP3 mRNA	PMID:33212167
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ARAP3 mRNA	PMID:30851411
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ARAP3 mRNA	PMID:32763439
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARAP3 mRNA	PMID:29803840
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ARAP3 mRNA	PMID:29432896
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1347923	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ARAP3 gene	PMID:28589171
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARAP3 mRNA	PMID:38568856
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ARAP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARAP3 mRNA	PMID:40512198
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1621402	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARAP3 mRNA	PMID:40504410
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1347923	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARAP3 mRNA	PMID:21871943
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ARAP3 mRNA	PMID:25895662
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of ARAP3 mRNA	PMID:25729387
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ARAP3 mRNA	PMID:38479592
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARAP3 mRNA	PMID:25181051
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ARAP3 mRNA	PMID:30816183|PMID:32528016
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1621402	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ARAP3 mRNA	PMID:30951980
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1621402	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of ARAP3 mRNA	PMID:25172293
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621402	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ARAP3 mRNA	PMID:40203079
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621402	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ARAP3 mRNA	PMID:30951980
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1621402	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ARAP3 exon	PMID:33297965
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1621402	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ARAP3 mRNA	PMID:38685157
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1621402	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ARAP3 mRNA	PMID:30951980
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1621402	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ARAP3 mRNA	PMID:28392331
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1621402	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ARAP3 mRNA	PMID:34289071|PMID:37019170
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347923	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARAP3 mRNA	PMID:37042841
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARAP3 mRNA	PMID:38568856
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARAP3 mRNA	PMID:33453195
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1621402	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARAP3 mRNA	PMID:37325564
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1347923	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ARAP3 mRNA	PMID:24449571
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:38689	fonofos	decreases methylation	ISO	RGD:1347923	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of ARAP3 promoter	PMID:22847954
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:38960	terbufos	decreases methylation	ISO	RGD:1347923	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of ARAP3 promoter	PMID:22847954
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621402	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ARAP3 mRNA	PMID:36331819
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARAP3 mRNA	PMID:23179753|PMID:26272509
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARAP3 mRNA	PMID:27188386
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ARAP3 mRNA	PMID:38832940
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of ARAP3 mRNA	PMID:27188386
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ARAP3 mRNA	PMID:29432896
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ARAP3 mRNA	PMID:35811015
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ARAP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARAP3 mRNA	PMID:40512198
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1621402	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARAP3 mRNA	PMID:40504410
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1347923	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of ARAP3 mRNA	PMID:40706910
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARAP3 mRNA	PMID:22079256
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1621402	E	RGD:6480464	20130423	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ARAP3 mRNA	PMID:17555576
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1621402	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARAP3 mRNA; Nanotubes, Carbon results in decreased expression of ARAP3 mRNA	PMID:25554681
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of ARAP3 mRNA	PMID:21983209
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of ARAP3 mRNA	PMID:27188386
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1621402	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ARAP3 mRNA	PMID:26378955
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1621402	E	RGD:6480464	20130423	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ARAP3 mRNA	PMID:22776087
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1621402	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of ARAP3 mRNA	PMID:22078008
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1621402	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ARAP3 mRNA	PMID:26307267
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1621402	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ARAP3 mRNA	PMID:22206623
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ARAP3 mRNA	PMID:22079256
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARAP3 mRNA	PMID:22079256
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ARAP3 mRNA	PMID:30851411
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARAP3 mRNA	PMID:27188386
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARAP3 gene]	PMID:28238834
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1621402	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of ARAP3 mRNA	PMID:39847705
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347923	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARAP3 mRNA	PMID:27188386
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ARAP3 mRNA	PMID:19281266
1304938	Arap3	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1347923	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ARAP3 mRNA	PMID:27188386
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of EXOC1 mRNA	PMID:33045310
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312668	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of EXOC1 mRNA	PMID:30529165
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:16136	hydrogen sulfide	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20181113	CTD	MESH:D006862	Hydrogen Sulfide results in decreased expression of EXOC1 protein	PMID:29932956
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312667	E	RGD:6480464	20130806	CTD	MESH:D001554	Benzene results in increased expression of EXOC1 mRNA	PMID:19162166
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of EXOC1 mRNA	PMID:22967744
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312667	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EXOC1 protein	PMID:37730182
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EXOC1 mRNA	PMID:33387578
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312667	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of EXOC1 mRNA	PMID:23649840
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312668	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of EXOC1 mRNA	PMID:25629700
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312667	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EXOC1 mRNA	PMID:40512198
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312667	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of EXOC1 protein	PMID:35688186
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312667	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of EXOC1 mRNA	PMID:23557933
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of EXOC1 gene	PMID:28505145
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312667	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of EXOC1 mRNA	PMID:23195993
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EXOC1 mRNA	PMID:21724226
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312667	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EXOC1 mRNA	PMID:33212167
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312667	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EXOC1 mRNA	PMID:30851411
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312667	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of EXOC1 protein	PMID:30528433
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312667	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EXOC1 mRNA	PMID:40512198
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312667	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EXOC1 promoter	PMID:27901495
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312667	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of EXOC1 mRNA	PMID:26238291
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of EXOC1 mRNA	PMID:30816183
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of EXOC1 mRNA	PMID:32156529
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312667	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EXOC1 gene	PMID:31601247
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of EXOC1 gene	PMID:28505145
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312667	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EXOC1 protein	PMID:31675489
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312668	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of EXOC1 gene	PMID:31683443
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312668	E	RGD:6480464	20200519	CTD	MESH:C543008	bisphenol S results in increased expression of EXOC1 mRNA	PMID:31881267|PMID:39298647
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1312667	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to EXOC1 protein	PMID:32991956
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312667	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of EXOC1 mRNA	PMID:28302478
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312668	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of EXOC1 mRNA	PMID:36331819
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312667	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of EXOC1 gene	PMID:29154799
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312667	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of EXOC1 mRNA	PMID:25562108
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312668	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of EXOC1 mRNA	PMID:17562736
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312667	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in increased expression of EXOC1 mRNA	PMID:22230336
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of EXOC1 mRNA	PMID:21061450
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312667	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EXOC1 mRNA	PMID:40512198
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1312668	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of EXOC1 mRNA	PMID:30529165
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312667	E	RGD:6480464	20130806	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EXOC1 mRNA	PMID:22079256
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EXOC1 mRNA	PMID:35436446
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312668	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of EXOC1 mRNA	PMID:23608068
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312667	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EXOC1 protein	PMID:32959892
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of EXOC1 mRNA	PMID:23650126
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of EXOC1 mRNA	PMID:30467583
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EXOC1 mRNA	PMID:22206623
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312667	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of EXOC1 mRNA	PMID:22079256
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312667	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EXOC1 mRNA	PMID:22079256
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312667	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EXOC1 mRNA	PMID:30851411
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312667	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of EXOC1 protein	PMID:31675489
1304939	Exoc1	exocyst complex component 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EXOC1 mRNA	PMID:21346803
1304940	Atf7	activating transcription factor 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312670	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ATF7 mRNA	PMID:33045310
1304940	Atf7	activating transcription factor 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312670	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ATF7 mRNA	PMID:20188158
1304940	Atf7	activating transcription factor 7	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1312669	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of ATF7 protein	PMID:28073184
1304940	Atf7	activating transcription factor 7	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312670	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of ATF7 mRNA	PMID:40945087
1304940	Atf7	activating transcription factor 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ATF7 mRNA	PMID:32145629
1304940	Atf7	activating transcription factor 7	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312669	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ATF7 protein	PMID:37730182
1304940	Atf7	activating transcription factor 7	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ATF7 mRNA	PMID:33387578
1304940	Atf7	activating transcription factor 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312669	E	RGD:6480464	20171010	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATF7 mRNA; ATF7 promotes the reaction [Cadmium results in increased expression of MT1A mRNA]	PMID:28632756|PMID:35301059
1304940	Atf7	activating transcription factor 7	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312669	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ATF7 protein	PMID:23301498
1304940	Atf7	activating transcription factor 7	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ATF7 mRNA	PMID:30779732
1304940	Atf7	activating transcription factor 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with baicalein] results in increased expression of ATF7 protein	PMID:33779329
1304940	Atf7	activating transcription factor 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312670	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ATF7 mRNA	PMID:22206623
1304940	Atf7	activating transcription factor 7	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312669	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of ATF7 protein	PMID:35688186
1304940	Atf7	activating transcription factor 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312669	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ATF7 mRNA	PMID:23557933
1304940	Atf7	activating transcription factor 7	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1312670	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of ATF7 mRNA	PMID:15681117
1304940	Atf7	activating transcription factor 7	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312669	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ATF7 mRNA	PMID:25583101
1304940	Atf7	activating transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATF7 mRNA	PMID:22298810
1304940	Atf7	activating transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312670	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATF7 mRNA	PMID:21570461
1304940	Atf7	activating transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATF7 mRNA	PMID:33387578
1304940	Atf7	activating transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312670	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATF7 mRNA	PMID:24058054
1304940	Atf7	activating transcription factor 7	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312669	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ATF7 mRNA	PMID:30851411
1304940	Atf7	activating transcription factor 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312669	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATF7 mRNA	PMID:29803840
1304940	Atf7	activating transcription factor 7	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312669	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ATF7 protein	PMID:35688186
1304940	Atf7	activating transcription factor 7	gene	CHEBI:2979	baicalein	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:C006680	[Carbon Tetrachloride co-treated with baicalein] results in increased expression of ATF7 protein	PMID:33779329
1304940	Atf7	activating transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312669	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATF7 promoter	PMID:27901495
1304940	Atf7	activating transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312669	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATF7 5' UTR	PMID:27901495
1304940	Atf7	activating transcription factor 7	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312670	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of ATF7 mRNA	PMID:22609695
1304940	Atf7	activating transcription factor 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312670	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATF7 promoter	PMID:35295148
1304940	Atf7	activating transcription factor 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATF7 mRNA	PMID:25181051|PMID:30816183|PMID:32145629
1304940	Atf7	activating transcription factor 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312669	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATF7 gene	PMID:31601247
1304940	Atf7	activating transcription factor 7	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312669	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of ATF7 mRNA	PMID:29024780
1304940	Atf7	activating transcription factor 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312669	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATF7 mRNA	PMID:38568856
1304940	Atf7	activating transcription factor 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312669	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATF7 mRNA	PMID:35301059
1304940	Atf7	activating transcription factor 7	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312669	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ATF7 mRNA	PMID:28302478
1304940	Atf7	activating transcription factor 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312670	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ATF7 mRNA	PMID:17963808
1304940	Atf7	activating transcription factor 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312669	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATF7 mRNA	PMID:24935251
1304940	Atf7	activating transcription factor 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312669	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ATF7 mRNA	PMID:23179753
1304940	Atf7	activating transcription factor 7	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312669	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ATF7 gene	PMID:29154799
1304940	Atf7	activating transcription factor 7	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1312669	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of ATF7 promoter	PMID:27989131
1304940	Atf7	activating transcription factor 7	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312669	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ATF7 mRNA	PMID:27188386
1304940	Atf7	activating transcription factor 7	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312669	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ATF7 mRNA	PMID:24935251
1304940	Atf7	activating transcription factor 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312670	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATF7 mRNA	PMID:17562736
1304940	Atf7	activating transcription factor 7	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312670	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of ATF7 mRNA	PMID:25554681
1304940	Atf7	activating transcription factor 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312670	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATF7 mRNA	PMID:25554681
1304940	Atf7	activating transcription factor 7	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ATF7 mRNA	PMID:28801915
1304940	Atf7	activating transcription factor 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312670	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ATF7 mRNA	PMID:22206623
1304940	Atf7	activating transcription factor 7	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312669	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ATF7 protein	PMID:31285264
1304940	Atf7	activating transcription factor 7	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312669	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ATF7 mRNA	PMID:30851411
1304940	Atf7	activating transcription factor 7	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312670	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ATF7 mRNA	PMID:31388691
1304940	Atf7	activating transcription factor 7	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ATF7 mRNA	PMID:19281266
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of HIPK1 mRNA	PMID:33045310
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312671	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of HIPK1 mRNA	PMID:15498508
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312672	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of HIPK1 mRNA	PMID:30319688
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312672	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of HIPK1 mRNA	PMID:30319688
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312671	E	RGD:6480464	20230704	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HIPK1 protein	PMID:36052886
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20230704	CTD	MESH:D008070	HIPK1 protein inhibits the reaction [MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in decreased expression of CCND1 protein]]; HIPK1 protein inhibits the reaction [MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of BAX protein]]; HIPK1 protein inhibits the reaction [MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; HIPK1 protein inhibits the reaction [MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of HIPK1 protein]; ZNF644 mRNA alternative form inhibits the reaction [MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of HIPK1 protein]]; ZNF644 mRNA alternative form promotes the reaction [Lipopolysaccharides results in increased expression of HIPK1 protein]	PMID:36052886
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312671	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of HIPK1 mRNA	PMID:22574217
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of HIPK1 mRNA	PMID:39298647
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312671	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of HIPK1 mRNA	PMID:23019147
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312671	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HIPK1 mRNA	PMID:37042841
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1312672	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HIPK1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HIPK1 mRNA]	PMID:20230807
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312671	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of HIPK1 protein	PMID:37730182
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1312672	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HIPK1 mRNA	PMID:20230807
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1312672	E	RGD:6480464	20120501	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HIPK1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HIPK1 mRNA]	PMID:20230807
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312671	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of HIPK1 mRNA	PMID:28818685
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA	PMID:39836092
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1312672	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HIPK1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HIPK1 mRNA]	PMID:20230807
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312671	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of HIPK1 mRNA	PMID:19549813
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312671	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of HIPK1 mRNA	PMID:23649840
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1312671	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of HIPK1 mRNA	PMID:28534445
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312671	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HIPK1 gene	PMID:25304211
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA	PMID:39836092
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of HIPK1 mRNA	PMID:25905778
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of HIPK1 mRNA	PMID:30912803
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312672	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HIPK1 mRNA	PMID:21570461
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HIPK1 mRNA	PMID:33387578
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HIPK1 mRNA	PMID:34747641
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312672	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of HIPK1 mRNA	PMID:25896364|PMID:39631538
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312671	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of HIPK1 protein	PMID:35688186
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312671	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HIPK1 mRNA	PMID:38568856
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20171114	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA; [sodium arsenite results in increased stability of and affects the localization of HIPK1 protein] which results in increased phosphorylation of CREB1 protein; sodium arsenite results in increased stability of and affects the localization of HIPK1 protein	PMID:27884605|PMID:39836092
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312671	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HIPK1 3' UTR	PMID:27901495
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312671	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HIPK1 5' UTR	PMID:27901495
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:29866	arsenite(3-)	affects expression	ISO	RGD:1312671	E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of HIPK1 mRNA	PMID:22959463
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to HIPK1 mRNA]	PMID:32406909
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312671	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HIPK1 mRNA	PMID:20018196
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312671	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HIPK1 mRNA	PMID:20458559
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HIPK1 gene	PMID:31601247
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HIPK1 mRNA	PMID:25729387
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1312671	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of HIPK1 mRNA	PMID:15498508
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312672	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of HIPK1 mRNA	PMID:17656681
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HIPK1 mRNA	PMID:29264374
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312672	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HIPK1 gene; titanium dioxide results in decreased methylation of HIPK1 promoter	PMID:35295148
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of HIPK1 mRNA	PMID:25181051
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HIPK1 gene	PMID:31601247
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HIPK1 mRNA	PMID:39298647
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HIPK1 mRNA	PMID:28628672
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312672	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HIPK1 mRNA	PMID:21266533
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of HIPK1 mRNA	PMID:22546817
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of HIPK1 mRNA	PMID:34813904
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HIPK1 mRNA	PMID:28628672
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of HIPK1 mRNA	PMID:34813904
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of HIPK1 mRNA	PMID:22546817
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA	PMID:39836092
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312671	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HIPK1 mRNA	PMID:38568856
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312671	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of HIPK1 mRNA	PMID:19320972
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312671	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of HIPK1 mRNA	PMID:31533062
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312671	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of HIPK1 mRNA	PMID:19167446
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of HIPK1 mRNA	PMID:29427782
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312671	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of HIPK1 mRNA	PMID:23179753
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of HIPK1 mRNA	PMID:19136453
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312671	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HIPK1 gene	PMID:29154799
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of HIPK1 mRNA	PMID:41580965
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312671	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of HIPK1 mRNA	PMID:25562108
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HIPK1 mRNA	PMID:28628672
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312672	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HIPK1 mRNA	PMID:17562736
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312672	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of HIPK1 mRNA	PMID:17585979
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312671	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HIPK1 gene	PMID:25304211
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA	PMID:39836092
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HIPK1 mRNA	PMID:28628672
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312671	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HIPK1 mRNA	PMID:20458559
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:50161	motexafin gadolinium	increases expression	ISO	RGD:1312671	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of HIPK1 mRNA	PMID:16357179
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of HIPK1 mRNA]	PMID:16357179
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:62984	zinc acetate	increases expression	ISO	RGD:1312671	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of HIPK1 mRNA	PMID:16357179
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:62984	zinc acetate	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20170303	CTD	MESH:D019345	motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of HIPK1 mRNA]	PMID:16357179
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA	PMID:39836092
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of HIPK1 mRNA	PMID:25729387
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HIPK1 mRNA	PMID:25729387
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of HIPK1 mRNA	PMID:23650126
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312672	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of HIPK1 mRNA	PMID:20003209
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of HIPK1 mRNA	PMID:30467583
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312671	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of HIPK1 mRNA	PMID:37199045
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312671	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of HIPK1 protein	PMID:31285264
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312671	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HIPK1 gene]	PMID:28238834
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HIPK1 mRNA	PMID:24780913
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1312671	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of HIPK1 mRNA	PMID:17440010
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312671	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of HIPK1 mRNA	PMID:38568856
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312671	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of HIPK1 mRNA	PMID:29301935
1304941	Hipk1	homeodomain interacting protein kinase 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of HIPK1 mRNA	PMID:23869203
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312673	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of ABCF2 protein	PMID:39638853
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1312673	E	RGD:6480464	20140909	CTD	MESH:D015215	Zidovudine results in increased expression of ABCF2 mRNA	PMID:24292225
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312674	E	RGD:6480464	20130806	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ABCF2 mRNA	PMID:20188158
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ABCF2 gene	PMID:20938992
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ABCF2 mRNA	PMID:33167477
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312673	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ABCF2 mRNA	PMID:20044591
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312674	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ABCF2 mRNA	PMID:39241906
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312673	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ABCF2 mRNA	PMID:31614463
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312673	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ABCF2 mRNA	PMID:38568856
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of ABCF2 gene	PMID:27618143
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ABCF2 gene	PMID:20938992
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312673	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ABCF2 mRNA	PMID:37042841
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312673	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ABCF2 mRNA	PMID:23649840
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:17558	quercitrin	increases expression	ISO	RGD:1312673	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of ABCF2 mRNA	PMID:25193878
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ABCF2 mRNA	PMID:36331819
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ABCF2 protein]	PMID:32272095
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ABCF2 mRNA	PMID:23649840
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312673	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABCF2 mRNA	PMID:22100608
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ABCF2 mRNA	PMID:23649840
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1312673	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of ABCF2 mRNA	PMID:15672453
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312673	E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in increased expression of ABCF2 mRNA	PMID:18356318
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ABCF2 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ABCF2 mRNA]	PMID:20938992|PMID:22206623
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312673	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ABCF2 gene	PMID:25304211
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABCF2 mRNA	PMID:40504410
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312674	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ABCF2 protein	PMID:25505154
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ABCF2 mRNA	PMID:23195993
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312673	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ABCF2 mRNA	PMID:24768652|PMID:25583101
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312674	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCF2 mRNA	PMID:21570461
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABCF2 mRNA	PMID:33387578
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABCF2 mRNA	PMID:17942748
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABCF2 mRNA	PMID:17942748
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ABCF2 protein	PMID:39603559
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312673	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ABCF2 mRNA	PMID:33212167
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:28618	1,4-dichlorobenzene	increases expression	ISO	RGD:1312674	E	RGD:6480464	20171114	CTD	MESH:C018511	4-dichlorobenzene results in increased expression of ABCF2 mRNA	PMID:26975756
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312673	E	RGD:6480464	20130806	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ABCF2 mRNA	PMID:20971185
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312673	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ABCF2 mRNA	PMID:34032870
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABCF2 mRNA; sodium arsenite results in decreased expression of ABCF2 protein	PMID:30528433|PMID:38568856
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABCF2 mRNA	PMID:40504410
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312674	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCF2 mRNA	PMID:22228805
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312673	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ABCF2 promoter	PMID:27901495
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312673	E	RGD:6480464	20130806	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ABCF2 mRNA	PMID:20971185
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312673	E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in increased expression of ABCF2 mRNA	PMID:18356318
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ABCF2 mRNA	PMID:20018196
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312674	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABCF2 gene	PMID:35295148
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ABCF2 mRNA	PMID:25181051
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312673	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ABCF2 mRNA	PMID:30903817
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCF2 protein	PMID:37567409
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312673	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ABCF2 protein	PMID:34186270
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCF2 mRNA	PMID:17602206
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312674	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of ABCF2 protein	PMID:32272095
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ABCF2 protein]	PMID:32272095
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCF2 mRNA	PMID:17602206
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCF2 mRNA	PMID:17917374
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ABCF2 mRNA	PMID:33453195
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20130806	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of ABCF2 promoter	PMID:22457795
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ABCF2 mRNA	PMID:19376846
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312674	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ABCF2 mRNA	PMID:40194260
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ABCF2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ABCF2 mRNA	PMID:36331819
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312673	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABCF2 mRNA	PMID:25979313
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312673	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in increased expression of ABCF2 mRNA	PMID:22147139
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:41423	celecoxib	affects expression	ISO	RGD:1312674	E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib affects the expression of ABCF2 mRNA	PMID:20562220
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ABCF2 mRNA	PMID:17555576
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:43572	kojic acid	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:C011890	[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCF2 mRNA	PMID:17917374
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of ABCF2 mRNA	PMID:24449571
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312673	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ABCF2 mRNA	PMID:38832940
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ABCF2 mRNA	PMID:17562736
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABCF2 mRNA	PMID:33387578
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312673	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ABCF2 gene	PMID:25304211
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABCF2 mRNA	PMID:40504410
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ABCF2 mRNA	PMID:29391264
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312674	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ABCF2 mRNA	PMID:35436446
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ABCF2 mRNA	PMID:17555576
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ABCF2 mRNA	PMID:17942748
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABCF2 mRNA	PMID:17942748
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312674	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ABCF2 mRNA; Nanotubes, Carbon results in increased expression of ABCF2 mRNA	PMID:25554681
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ABCF2 mRNA	PMID:30047161
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ABCF2 mRNA	PMID:24136188
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312674	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ABCF2 mRNA	PMID:19042947
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ABCF2 protein	PMID:32959892
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312674	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ABCF2 protein	PMID:26558463
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312674	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ABCF2 mRNA	PMID:22206623
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ABCF2 mRNA]	PMID:22206623
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312673	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ABCF2 protein	PMID:31285264
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:75701	sarin	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of ABCF2 mRNA	PMID:19522546
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:75701	sarin	increases expression	ISO	RGD:1312673	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of ABCF2 mRNA	PMID:19522546
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ABCF2 mRNA	PMID:21346803
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312673	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ABCF2 gene]	PMID:28238834
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ABCF2 mRNA	PMID:30047161
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ABCF2 mRNA	PMID:21346803
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312673	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ABCF2 mRNA	PMID:38568856
1304942	Abcf2	ATP binding cassette subfamily F member 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ABCF2 mRNA	PMID:21346803
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA	PMID:27188386
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:132098	methoxyacetic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in increased expression of LRP12 mRNA	PMID:18199887
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRP12 mRNA]	PMID:31150632
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	ISO	RGD:1312675	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of LRP12 mRNA	PMID:19524605
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LRP12 mRNA	PMID:20938992
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of LRP12 mRNA	PMID:32845096
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRP12 mRNA	PMID:30529165
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550067	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of LRP12 mRNA	PMID:30319688
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550067	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LRP12 mRNA	PMID:39241906
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LRP12 mRNA	PMID:39298647
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312675	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LRP12 mRNA	PMID:31614463
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of LRP12 mRNA	PMID:30165855
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LRP12 mRNA	PMID:20938992
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312675	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of LRP12 protein	PMID:37730182
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312675	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LRP12 mRNA	PMID:28818685
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA	PMID:39836092
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP12 mRNA	PMID:39012411
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRP12 mRNA	PMID:35301059
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312675	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LRP12 mRNA	PMID:19549813
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312675	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of LRP12 protein	PMID:20106945
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312675	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LRP12 mRNA	PMID:27153756
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of LRP12 mRNA	PMID:32845096
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LRP12 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LRP12 mRNA	PMID:34911549
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LRP12 mRNA	PMID:30779732
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LRP12 mRNA	PMID:31150632
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550067	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LRP12 mRNA	PMID:27339419|PMID:31919559
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRP12 mRNA]	PMID:31150632
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LRP12 mRNA	PMID:25629700
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRP12 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LRP12 mRNA	PMID:20938992|PMID:22206623
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP12 mRNA	PMID:39836092
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312675	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of LRP12 mRNA	PMID:27594783
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550067	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRP12 mRNA	PMID:21570461
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312675	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LRP12 mRNA	PMID:28001369
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312675	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LRP12 mRNA	PMID:29803840
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312675	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LRP12 mRNA	PMID:38568856
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP12 mRNA	PMID:39836092
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550067	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRP12 mRNA	PMID:22228805
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550067	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LRP12 mRNA	PMID:29203145
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of LRP12 mRNA	PMID:29264374
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550067	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of LRP12 mRNA	PMID:23557971|PMID:27760801
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550067	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LRP12 gene	PMID:35295148
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LRP12 mRNA	PMID:34492290
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550067	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LRP12 mRNA	PMID:28472532
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LRP12 mRNA	PMID:33221593
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LRP12 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LRP12 gene	PMID:28505145
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:34093	1-Hydroxypyrene	decreases expression	ISO	RGD:1312675	E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in decreased expression of LRP12 mRNA	PMID:21854004
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LRP12 mRNA	PMID:39298647
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LRP12 mRNA	PMID:37019170
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312675	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRP12 mRNA	PMID:37042841
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA	PMID:39836092
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LRP12 mRNA	PMID:21297351
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP12 mRNA	PMID:39012411
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRP12 mRNA	PMID:35301059
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRP12 mRNA	PMID:40194260
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312675	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LRP12 mRNA	PMID:31533062
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:39472	1,3,4-thiadiazole	affects expression	EXP		E	RGD:6480464	20250204	CTD	MESH:C058949	1,3,4-thiadiazole analog affects the expression of LRP12 mRNA	PMID:30905023
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550067	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LRP12 mRNA	PMID:17292431
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312675	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRP12 mRNA	PMID:24935251
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312675	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LRP12 gene	PMID:29154799
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312675	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of LRP12 mRNA	PMID:24935251|PMID:29154799
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of LRP12 mRNA	PMID:38685447
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312675	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of LRP12 mRNA	PMID:20106945
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312675	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LRP12 mRNA	PMID:38832940
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312675	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of LRP12 mRNA	PMID:24935251|PMID:26272509
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA	PMID:27188386
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LRP12 mRNA	PMID:33387578
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312675	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of LRP12 mRNA	PMID:29067470
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP12 mRNA	PMID:39836092
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312675	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of LRP12 mRNA	PMID:26833863
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LRP12 mRNA	PMID:29391264
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1312675	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of LRP12 mRNA	PMID:18175754
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1312675	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of LRP12 mRNA	PMID:23228038
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550067	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LRP12 mRNA; Nanotubes, Carbon results in increased expression of LRP12 mRNA	PMID:25554681
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1550067	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of LRP12 mRNA	PMID:26377693
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1312675	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of LRP12 mRNA	PMID:22714537
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA	PMID:39836092
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LRP12 mRNA	PMID:22206623
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRP12 mRNA	PMID:22206623
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312675	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of LRP12 mRNA	PMID:22714537
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA	PMID:27188386
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LRP12 gene]	PMID:28238834
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1312675	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of LRP12 mRNA	PMID:26272509
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA	PMID:27188386
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312675	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA	PMID:27188386
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of LRP12 mRNA	PMID:19281266
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LRP12 mRNA	PMID:21346803
1304943	Lrp12	LDL receptor related protein 12	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of LRP12 mRNA	PMID:22615374
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312679	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of DDX17 protein	PMID:39638853
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DDX17 mRNA	PMID:38218311
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312679	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DDX17 mRNA	PMID:38218311
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of DDX17 mRNA	PMID:25596134
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of DDX17 mRNA	PMID:27188386
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in decreased expression of DDX17 mRNA	PMID:33227293
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D014212	Tretinoin results in decreased expression of DDX17 mRNA	PMID:10718294
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D014212	Tretinoin results in decreased expression of DDX17 mRNA	PMID:10718294
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:15367	all-trans-retinoic acid	increases acetylation	ISO	RGD:1312679	E	RGD:6480464	20171010	CTD	MESH:D014212	Tretinoin results in increased acetylation of DDX17 protein	PMID:28053092
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of DDX17 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of and results in increased oxidation of DDX17 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of DDX17 mRNA	PMID:32699268|PMID:32845096
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312679	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of DDX17 mRNA	PMID:25596134
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DDX17 mRNA	PMID:36331819
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DDX17 mRNA	PMID:26079696
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1312679	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of DDX17 protein	PMID:28073184
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DDX17 mRNA	PMID:21179406
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in decreased expression of DDX17 mRNA	PMID:21632981
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DDX17 mRNA	PMID:39241906
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of DDX17 mRNA	PMID:32145629
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in decreased expression of DDX17 mRNA	PMID:21795739
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DDX17 mRNA	PMID:39298647
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1550068	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of DDX17 mRNA	PMID:33711761
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DDX17 mRNA	PMID:33387578
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312679	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DDX17 mRNA	PMID:37042841
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:C044887	beta-methylcholine affects the expression of DDX17 mRNA	PMID:21179406
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1312679	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of DDX17 mRNA	PMID:16949557
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DDX17 mRNA	PMID:33754040
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of DDX17 protein	PMID:34122009
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312679	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of DDX17 protein	PMID:37730182
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of DDX17 mRNA	PMID:22061828
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DDX17 mRNA	PMID:28818685
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DDX17 mRNA	PMID:36331819
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1312679	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of DDX17 mRNA	PMID:16949557
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DDX17 mRNA	PMID:28111341|PMID:37325564
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of DDX17 mRNA	PMID:23487506
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DDX17 protein	PMID:23301498
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DDX17 mRNA	PMID:23649840
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of DDX17 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of and results in increased oxidation of DDX17 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of DDX17 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of DDX17 mRNA	PMID:32699268|PMID:32845096
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D000638	Amiodarone results in increased expression of DDX17 mRNA	PMID:19774075
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in decreased expression of DDX17 mRNA	PMID:18593933
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DDX17 mRNA	PMID:22206623
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27563	arsenic atom	decreases response to substance	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D001151	DDX17 mRNA results in decreased susceptibility to Arsenic	PMID:17976673
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D012643	Selenium results in decreased expression of DDX17 mRNA	PMID:19244175
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA	PMID:19244175
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312679	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DDX17 protein	PMID:35688186
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550068	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of DDX17 mRNA	PMID:28960355
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of DDX17 mRNA	PMID:25596134
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DDX17 protein	PMID:25505154
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312679	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DDX17 mRNA	PMID:28903495
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of DDX17 mRNA	PMID:25596134|PMID:27594783
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of DDX17 mRNA	PMID:31734292
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDX17 mRNA	PMID:22574217
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550068	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDX17 mRNA	PMID:21570461
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DDX17 mRNA	PMID:15328365
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DDX17 mRNA	PMID:34747641
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to DDX17 promoter]	PMID:19654925
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of DDX17 mRNA	PMID:29955902
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312679	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DDX17 mRNA	PMID:26272509
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DDX17 mRNA	PMID:33212167
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DDX17 mRNA	PMID:30556269
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of DDX17 protein	PMID:28918527
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312679	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of DDX17 protein	PMID:35688186
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DDX17 mRNA; sodium arsenite results in decreased expression of DDX17 protein	PMID:38228842|PMID:38568856
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550068	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of DDX17 mRNA	PMID:36209798
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DDX17 mRNA; Benzo(a)pyrene results in decreased expression of DDX17 protein	PMID:20064835|PMID:20106945|PMID:21632981|PMID:33278487
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to DDX17 protein]	PMID:32406909
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DDX17 mRNA	PMID:30556269
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in decreased expression of DDX17 mRNA	PMID:18593933
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of DDX17 protein	PMID:34122009
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DDX17 mRNA	PMID:19150397|PMID:20018196
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of DDX17 mRNA	PMID:27760801
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550068	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DDX17 gene	PMID:35295148
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550068	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of DDX17 mRNA	PMID:29264374
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20130806	CTD	MESH:C006253	pirinixic acid results in decreased expression of DDX17 mRNA	PMID:18445702
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of DDX17 mRNA	PMID:32145629
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX17 mRNA	PMID:25181051
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX17 mRNA	PMID:40036665
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DDX17 gene	PMID:28505145
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX17 mRNA	PMID:28628672
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DDX17 protein	PMID:31675489
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DDX17 mRNA	PMID:19244175
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA	PMID:19244175
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1550068	E	RGD:6480464	20180515	CTD	MESH:D008748	Methylcholanthrene results in increased expression of DDX17 mRNA	PMID:25926378
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in decreased expression of DDX17 mRNA	PMID:25912373
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DDX17 mRNA	PMID:39298647
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of DDX17 mRNA	PMID:28628672
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312679	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of DDX17 gene	PMID:22964155
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DDX17 mRNA	PMID:24893172
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550068	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DDX17 mRNA	PMID:21266533
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of DDX17 mRNA	PMID:34813904
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of DDX17 mRNA	PMID:28628672
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:C022838	nickel chloride results in decreased expression of DDX17 mRNA	PMID:17312168
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312679	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DDX17 mRNA	PMID:25596134
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DDX17 mRNA	PMID:28111341|PMID:37325564
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312679	E	RGD:6480464	20150609	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DDX17 mRNA	PMID:25868421
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of DDX17 gene	PMID:22079235
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DDX17 mRNA	PMID:19320972
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of DDX17 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of DDX17 mRNA	PMID:32699268
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D012643	Selenium results in decreased expression of DDX17 mRNA	PMID:19244175
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA	PMID:19244175
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of DDX17 mRNA	PMID:25596134
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of DDX17 mRNA	PMID:23811191
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312679	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DDX17 mRNA	PMID:31533062
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DDX17 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DDX17 mRNA	PMID:36331819
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550068	E	RGD:6480464	20130806	CTD	MESH:D014635	Valproic Acid affects the expression of DDX17 mRNA	PMID:17292431
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of DDX17 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA	PMID:27188386
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of DDX17 mRNA	PMID:30047161
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DDX17 mRNA	PMID:25562108
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in increased expression of DDX17 mRNA	PMID:21163907
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of DDX17 mRNA	PMID:28628672
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550068	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DDX17 mRNA	PMID:28973697
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of DDX17 mRNA	PMID:23649840
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of DDX17 mRNA	PMID:24136188
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D019319	Okadaic Acid results in decreased expression of DDX17 protein	PMID:19397276
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of DDX17 mRNA	PMID:22083351|PMID:27188386
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312679	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of DDX17 mRNA	PMID:28542535
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of DDX17 mRNA	PMID:24935251|PMID:26272509
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA	PMID:27188386
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550068	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of DDX17 mRNA	PMID:17562736
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DDX17 mRNA	PMID:33387578
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in decreased expression of DDX17 mRNA	PMID:21420995
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:47217	arsane	decreases response to substance	ISO	RGD:1312679	E	RGD:6480464	20140805	CTD	MESH:D001151	DDX17 mRNA results in decreased susceptibility to Arsenic	PMID:17976673
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of DDX17 mRNA	PMID:31675489
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of DDX17 mRNA	PMID:28628672
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of DDX17 mRNA	PMID:30307764
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DDX17 mRNA; Nanotubes, Carbon results in decreased expression of DDX17 mRNA	PMID:25554681|PMID:25620056
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of DDX17 mRNA	PMID:34044035
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of DDX17 mRNA	PMID:30047161
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DDX17 mRNA	PMID:35964746
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of DDX17 mRNA	PMID:24136188
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of DDX17 mRNA	PMID:26377693
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1312679	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of DDX17 mRNA	PMID:26705709
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:53001	nickel sulfate	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of DDX17 mRNA	PMID:31734292
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:5864	ifosfamide	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of DDX17 mRNA	PMID:25596134
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DDX17 protein	PMID:32959892
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DDX17 mRNA	PMID:23650126
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DDX17 mRNA	PMID:24810058
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of DDX17 mRNA	PMID:25596134
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1550068	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DDX17 mRNA	PMID:26307267
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of DDX17 mRNA	PMID:30467583
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of DDX17 mRNA	PMID:31758290
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:72754	bisphenol AF	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of DDX17 mRNA	PMID:25912373
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DDX17 mRNA	PMID:22206623
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DDX17 mRNA	PMID:22206623
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DDX17 protein	PMID:37664457
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of DDX17 mRNA	PMID:24136188
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312679	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of DDX17 protein	PMID:31285264
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA	PMID:27188386
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DDX17 gene]	PMID:28238834
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in decreased expression of DDX17 mRNA	PMID:20185912
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of DDX17 mRNA	PMID:30047161
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312679	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DDX17 protein	PMID:31675489
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DDX17 mRNA	PMID:30047161
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of DDX17 mRNA	PMID:40826991
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312679	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DDX17 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA	PMID:27188386|PMID:37664457
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1312679	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of DDX17 mRNA	PMID:17440010
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1550068	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of DDX17 mRNA	PMID:32835833
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of DDX17 mRNA	PMID:28973697
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of DDX17 mRNA	PMID:18930950
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DDX17 mRNA	PMID:19015723
1304945	Ddx17	DEAD-box helicase 17	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of DDX17 mRNA	PMID:23034163
1304946	Vom2r26	vomeronasal 2 receptor, 26	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of VOM2R26 mRNA	PMID:33387578
1304946	Vom2r26	vomeronasal 2 receptor, 26	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of VOM2R26 gene	PMID:33148267
1304946	Vom2r26	vomeronasal 2 receptor, 26	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of VOM2R26 gene	PMID:35440735
1304946	Vom2r26	vomeronasal 2 receptor, 26	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of VOM2R26 gene	PMID:33148267
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312685	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CARD10 mRNA	PMID:27188386
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CARD10 gene	PMID:20938992
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312685	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of CARD10 mRNA	PMID:21934132
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312685	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CARD10 mRNA	PMID:22378314
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312685	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CARD10 mRNA	PMID:20044591
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CARD10 mRNA	PMID:35811015
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20161228	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CARD10 mRNA; CARD10 protein affects the reaction [Lipopolysaccharides results in increased localization of RELA protein]	PMID:24863965|PMID:35811015
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in decreased expression of CARD10 mRNA	PMID:19426747|PMID:23373633
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CARD10 mRNA	PMID:39298647
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312685	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of CARD10 mRNA	PMID:23019147|PMID:31614463
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol inhibits the reaction [Etoposide results in increased expression of CARD10 mRNA]	PMID:19426747
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:16598	DDE	affects expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene affects the expression of CARD10 mRNA	PMID:24576310
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CARD10 mRNA	PMID:33387578
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CARD10 gene	PMID:20938992
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CARD10 mRNA	PMID:37992649
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CARD10 mRNA	PMID:37992649
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312685	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CARD10 protein	PMID:37730182
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312685	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CARD10 mRNA	PMID:26485663
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CARD10 mRNA	PMID:33387578
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20150310	CTD	MESH:D015632	[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased expression of CARD10 mRNA	PMID:25406165
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:188106	Myrtucommulone A	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20220104	CTD	MESH:C455139	myrtucommulone A results in decreased expression of CARD10 mRNA	PMID:26032814
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CARD10 mRNA	PMID:35301059
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CARD10 mRNA	PMID:37325564
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312686	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CARD10 mRNA	PMID:19770486
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312685	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CARD10 intron	PMID:30157460
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of CARD10 mRNA	PMID:26760959
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CARD10 mRNA	PMID:34911549
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CARD10 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CARD10 mRNA]	PMID:20938992|PMID:22206623
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1312685	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of CARD10 mRNA	PMID:19945496
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARD10 mRNA	PMID:40504410
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312686	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of CARD10 mRNA	PMID:35897073
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312686	E	RGD:6480464	20160210	CTD	MESH:D002945	Cisplatin results in increased expression of CARD10 mRNA	PMID:26546572
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CARD10 mRNA	PMID:27392435
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20160210	CTD	MESH:D002945	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Cisplatin results in increased expression of CARD10 mRNA]	PMID:26546572
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312685	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of CARD10 mRNA	PMID:23019147|PMID:26865667
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CARD10 mRNA	PMID:22298810
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312686	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CARD10 mRNA	PMID:21570461
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CARD10 mRNA	PMID:19933214
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312685	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CARD10 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CARD10 mRNA	PMID:17942748
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312685	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CARD10 mRNA	PMID:33212167
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of CARD10 mRNA	PMID:30911355
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CARD10 mRNA	PMID:37992649
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CARD10 mRNA	PMID:29432896
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CARD10 mRNA	PMID:34032870
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312685	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CARD10 mRNA	PMID:39719251
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARD10 mRNA	PMID:40504410
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312685	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CARD10 promoter	PMID:27901495
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312685	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CARD10 mRNA	PMID:20064835
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of CARD10 mRNA	PMID:30911355
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312685	E	RGD:6480464	20220809	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CARD10 mRNA	PMID:34766707
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CARD10 mRNA	PMID:19150397
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312686	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of CARD10 mRNA	PMID:17656681
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CARD10 mRNA	PMID:23557971
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312686	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CARD10 gene	PMID:35295148
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of CARD10 mRNA	PMID:19167457
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CARD10 mRNA	PMID:25181051
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312685	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of CARD10 mRNA	PMID:23019147|PMID:27685785
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312686	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CARD10 mRNA	PMID:32156529
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CARD10 gene	PMID:28505145
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CARD10 mRNA	PMID:25172293
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of CARD10 mRNA	PMID:22937105
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CARD10 mRNA	PMID:39298647
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CARD10 mRNA	PMID:38685157
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312686	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CARD10 mRNA	PMID:37019170
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CARD10 mRNA	PMID:28628672
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CARD10 mRNA	PMID:18691550
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D004052	IKBKB protein inhibits the reaction [Diethylnitrosamine results in increased expression of CARD10 mRNA]; MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CARD10 mRNA]	PMID:18691550
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CARD10 mRNA	PMID:22546817
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CARD10 mRNA	PMID:35301059
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CARD10 mRNA	PMID:37325564
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of CARD10 mRNA	PMID:22079235
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312685	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CARD10 mRNA	PMID:24449571
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CARD10 mRNA	PMID:40419075
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312685	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CARD10 mRNA	PMID:25979313
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312685	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of CARD10 mRNA	PMID:19101580|PMID:23179753|PMID:28001369
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CARD10 mRNA	PMID:20106945
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CARD10 mRNA	PMID:17555576
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CARD10 mRNA	PMID:28628672
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CARD10 mRNA	PMID:37992649
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CARD10 mRNA	PMID:17562736
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CARD10 mRNA	PMID:33387578
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CARD10 mRNA	PMID:21420995
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of CARD10 mRNA	PMID:32479839
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of CARD10 mRNA	PMID:24714768
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CARD10 mRNA	PMID:29432896
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CARD10 mRNA	PMID:35811015
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1312685	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of CARD10 mRNA	PMID:19945496
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARD10 mRNA	PMID:40504410
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of CARD10 mRNA	PMID:29391264
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CARD10 mRNA	PMID:17555576
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CARD10 mRNA	PMID:17942748
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CARD10 mRNA	PMID:17942748
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1312685	E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of CARD10 mRNA	PMID:19426747
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20120412	CTD	MESH:D005047	Estradiol inhibits the reaction [Etoposide results in increased expression of CARD10 mRNA]	PMID:19426747
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CARD10 mRNA	PMID:28628672
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CARD10 mRNA	PMID:25554681|PMID:25620056
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:51081	nitrates	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in decreased expression of CARD10 mRNA	PMID:30022042
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312685	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of CARD10 mRNA	PMID:18651567
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of CARD10 mRNA	PMID:19042947
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of CARD10 mRNA	PMID:27188386
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CARD10 mRNA	PMID:16934159
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CARD10 mRNA	PMID:37269647
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20190910	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CARD10 mRNA]	PMID:29891994
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312686	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CARD10 mRNA	PMID:22206623
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CARD10 mRNA]	PMID:22206623
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:755208	eprenetapopt	increases expression	ISO	RGD:1312685	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt results in increased expression of CARD10 mRNA	PMID:19946333
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt results in increased expression of CARD10 mRNA]	PMID:19946333
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312685	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CARD10 gene]	PMID:28238834
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of CARD10 mRNA	PMID:19482888
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CARD10 mRNA]	PMID:19482888
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:82288	o-anisidine	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine results in decreased expression of CARD10 mRNA	PMID:28089782
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:8426	probenecid	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20150310	CTD	MESH:D011339	[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased expression of CARD10 mRNA	PMID:25406165
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CARD10 mRNA	PMID:21278054
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1312685	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of CARD10 mRNA	PMID:14699072
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:8922	Rutecarpine	increases expression	ISO	RGD:1312685	E	RGD:6480464	20250114	CTD	MESH:C028632	rutecarpine results in increased expression of CARD10 mRNA	PMID:34955744
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CARD10 mRNA	PMID:21346803
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312685	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of CARD10 mRNA	PMID:27188386
1304949	Card10	caspase recruitment domain family, member 10	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of CARD10 gene	PMID:31079544
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in increased expression of IL21R mRNA; [bisphenol F co-treated with Tretinoin] results in increased expression of IL21R mRNA; [bisphenol S co-treated with Tretinoin] results in increased expression of IL21R mRNA	PMID:30951980
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312687	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IL21R mRNA	PMID:26079696
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	ISO	RGD:1312687	E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of IL21R mRNA]	PMID:19442820
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL21R mRNA	PMID:32741896
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of IL21R mRNA	PMID:33387578
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312687	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IL21R mRNA	PMID:37042841
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312687	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of IL21R mRNA	PMID:19162166
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312687	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of IL21R mRNA	PMID:23649840
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312687	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of IL21R mRNA	PMID:26079696
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL21R mRNA	PMID:37992649
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL21R mRNA	PMID:32741896
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	ISO	RGD:1312687	E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of IL21R mRNA]	PMID:19442820
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL21R mRNA	PMID:37992649
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312688	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IL21R mRNA	PMID:35550907
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IL21R mRNA	PMID:27523638
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL21R mRNA	PMID:37325564
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312687	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of IL21R mRNA	PMID:23649840
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312687	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of IL21R intron	PMID:30157460
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312687	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IL21R mRNA	PMID:32234424
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of IL21R mRNA	PMID:30779732
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IL21R mRNA	PMID:31150632
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of IL21R mRNA	PMID:31881176
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312688	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of IL21R mRNA	PMID:32186404
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312687	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL21R mRNA	PMID:25583101
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IL21R mRNA	PMID:33387578
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of IL21R mRNA	PMID:26033743
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL21R mRNA	PMID:37992649
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312687	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of IL21R mRNA	PMID:29301061|PMID:38568856
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA	PMID:34876320
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA	PMID:34876320
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312687	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL21R 3' UTR; Benzo(a)pyrene affects the methylation of IL21R promoter	PMID:27901495
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312687	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IL21R mRNA	PMID:32234424
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312688	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IL21R mRNA	PMID:32417428
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of IL21R mRNA	PMID:26033743
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312687	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of IL21R mRNA	PMID:25895662
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312688	E	RGD:6480464	20250401	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IL21R mRNA	PMID:38811393
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312687	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IL21R gene	PMID:31601247
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of IL21R mRNA	PMID:34492290
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of IL21R mRNA	PMID:19167457
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IL21R mRNA	PMID:25181051
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312687	E	RGD:6480464	20250204	CTD	MESH:C006780	bisphenol A results in decreased methylation of IL21R gene	PMID:38338858
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312688	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of IL21R mRNA	PMID:38701888
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312687	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IL21R gene	PMID:31601247
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in increased expression of IL21R mRNA	PMID:30951980
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312687	E	RGD:6480464	20250204	CTD	MESH:C543008	bisphenol S results in decreased methylation of IL21R gene	PMID:38338858
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312687	E	RGD:6480464	20210504	CTD	MESH:C543008	bisphenol S results in increased expression of IL21R mRNA	PMID:33476716
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in increased expression of IL21R mRNA	PMID:30951980
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:34575	bisphenol F	decreases methylation	ISO	RGD:1312687	E	RGD:6480464	20250204	CTD	MESH:C008745	bisphenol F results in decreased methylation of IL21R gene	PMID:38338858
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in increased expression of IL21R mRNA	PMID:30951980
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312688	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of IL21R mRNA	PMID:37019170
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312687	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IL21R mRNA	PMID:37042841
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of IL21R mRNA	PMID:35163327
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL21R mRNA	PMID:37325564
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312687	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of IL21R mRNA	PMID:36326898
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312687	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IL21R mRNA	PMID:24449571
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312688	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of IL21R mRNA	PMID:29038090
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312687	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IL21R gene	PMID:29154799
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1312687	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of IL21R promoter	PMID:27989131
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312687	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of IL21R mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312687	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of IL21R mRNA	PMID:25047013
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL21R mRNA	PMID:37992649
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1312687	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of IL21R mRNA	PMID:24449571
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312687	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IL21R mRNA	PMID:38832940
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of IL21R mRNA	PMID:29391264
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA	PMID:34876320
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312688	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of IL21R mRNA	PMID:23845593
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312688	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IL21R mRNA; Nanotubes, Carbon results in increased expression of IL21R mRNA	PMID:25554681
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of IL21R mRNA	PMID:35964746
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312688	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IL21R mRNA	PMID:38701926
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312688	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of IL21R mRNA	PMID:36851058
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL21R mRNA	PMID:32741896
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1312687	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of IL21R mRNA	PMID:32234424
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA	PMID:34876320
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1312687	E	RGD:6480464	20121113	CTD	MESH:D019284	4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of IL21R mRNA]; caffeic acid promotes the reaction [Thapsigargin results in decreased expression of IL21R mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in decreased expression of IL21R mRNA]	PMID:19442820
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312688	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of IL21R mRNA	PMID:35537566
1304950	Il21r	interleukin 21 receptor	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of IL21R gene	PMID:31682807
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550072	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TSSK2 mRNA	PMID:33045310
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1550072	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of TSSK2 mRNA	PMID:31525975
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1550072	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of TSSK2 mRNA	PMID:31525975
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:2682	amphotericin B	increases expression	ISO	RGD:1606567	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in increased expression of TSSK2 mRNA	PMID:28534445
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1606567	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TSSK2 mRNA	PMID:27392435
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606567	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TSSK2 mRNA	PMID:27392435
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of TSSK2 mRNA	PMID:20187946
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550072	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TSSK2 mRNA	PMID:21570461
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550072	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TSSK2 mRNA	PMID:17942748
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606567	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TSSK2 exon; Benzo(a)pyrene affects the methylation of TSSK2 promoter	PMID:27901495
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550072	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TSSK2 mRNA	PMID:20504355
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550072	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TSSK2 mRNA	PMID:19710929
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TSSK2 mRNA	PMID:25181051
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1606567	E	RGD:6480464	20210504	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of TSSK2 mRNA	PMID:33476716
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:37187	lead nitrate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate results in decreased expression of TSSK2 mRNA	PMID:21628963
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1550072	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of TSSK2 mRNA	PMID:31525975
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550072	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TSSK2 mRNA	PMID:17942748
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550072	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TSSK2 mRNA	PMID:17942748
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:5118	fluoxetine	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D005473	Fluoxetine results in decreased expression of TSSK2 mRNA	PMID:17033635
1304951	Tssk2	testis-specific serine kinase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606567	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TSSK2 gene]	PMID:28238834
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312691	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PIANP mRNA	PMID:37995155
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PIANP mRNA	PMID:36841081
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1606434	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PIANP mRNA	PMID:22378314
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312691	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PIANP mRNA	PMID:30319688
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312691	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PIANP mRNA	PMID:39298647
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PIANP mRNA	PMID:23829299
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1312691	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to PIANP gene]	PMID:31084621
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1606434	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PIANP mRNA	PMID:26079696
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312691	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PIANP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PIANP mRNA	PMID:37567420|PMID:37992649
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of PIANP mRNA	PMID:22967744
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312691	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PIANP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PIANP mRNA	PMID:37567420|PMID:37992649
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1606434	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PIANP mRNA	PMID:31163220
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PIANP mRNA	PMID:31150632
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606434	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PIANP mRNA	PMID:23557933
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of PIANP mRNA	PMID:20187946
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312691	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PIANP mRNA	PMID:24680724
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PIANP mRNA	PMID:33387578
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of PIANP mRNA	PMID:28959563
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1606434	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PIANP mRNA	PMID:32763439
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312691	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PIANP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PIANP mRNA	PMID:37567420|PMID:37992649
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606434	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PIANP 5' UTR	PMID:27901495
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PIANP mRNA	PMID:21839799
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312691	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PIANP mRNA	PMID:23735875
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606434	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PIANP promoter	PMID:27901495
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1312691	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of PIANP mRNA	PMID:27131904
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312691	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PIANP mRNA	PMID:27131904
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1606434	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PIANP mRNA	PMID:25895662
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1606434	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of PIANP mRNA	PMID:37690743
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PIANP mRNA	PMID:25181051
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PIANP mRNA	PMID:34947998
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312691	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PIANP mRNA	PMID:32156529
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606434	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of PIANP mRNA	PMID:27685785
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312691	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PIANP promoter	PMID:27312807
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PIANP mRNA	PMID:36041667
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PIANP mRNA	PMID:23196670
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312691	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PIANP mRNA	PMID:39298647
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PIANP mRNA	PMID:36041667
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1312691	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of PIANP mRNA	PMID:26377693
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PIANP mRNA	PMID:36041667
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312691	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of PIANP mRNA	PMID:28392331
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312691	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PIANP mRNA	PMID:37019170
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606434	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PIANP mRNA	PMID:38382870
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312691	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of PIANP mRNA	PMID:28962523
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312691	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PIANP mRNA	PMID:40194260
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of PIANP mRNA	PMID:21658437
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312691	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PIANP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PIANP mRNA	PMID:37567420|PMID:37992649
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PIANP mRNA	PMID:33387578
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1606434	E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in decreased expression of PIANP mRNA	PMID:26615145
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312691	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of PIANP mRNA	PMID:40234311
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:6015	isoflurane	decreases methylation	ISO	RGD:1312691	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in decreased methylation of PIANP mRNA	PMID:35249202
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312691	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of PIANP mRNA	PMID:36851058
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312691	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PIANP mRNA	PMID:37567420
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1312691	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in decreased expression of PIANP mRNA	PMID:26655953
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1606434	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PIANP mRNA	PMID:26079696
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312691	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PIANP mRNA	PMID:39847705
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PIANP mRNA	PMID:24780913
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1312691	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of PIANP mRNA	PMID:27131904
1304952	Pianp	PILR alpha associated neural protein	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312691	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PIANP mRNA	PMID:27131904
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1604756	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TSACC mRNA	PMID:35811015
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TSACC mRNA	PMID:33387578
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TSACC mRNA	PMID:33387578
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1604756	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TSACC mRNA	PMID:28818685
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1331902	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TSACC mRNA	PMID:22206623
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1331902	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSACC mRNA	PMID:40504410
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1604756	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TSACC mRNA	PMID:27392435
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1604756	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TSACC mRNA	PMID:27913140
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TSACC mRNA	PMID:33387578
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TSACC mRNA	PMID:28959563
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1331902	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TSACC mRNA	PMID:37682722
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1331902	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSACC mRNA	PMID:40504410
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1604756	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of TSACC mRNA	PMID:22316170
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1331902	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TSACC mRNA	PMID:32156529
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1331902	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of TSACC mRNA	PMID:38074096
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1604756	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TSACC mRNA	PMID:38382870
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of TSACC promoter	PMID:22457795
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331902	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TSACC mRNA	PMID:36331819
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1604756	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TSACC gene	PMID:29154799
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1604756	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TSACC mRNA	PMID:38832940
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1604756	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TSACC mRNA	PMID:35811015
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1331902	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSACC mRNA	PMID:40504410
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1331902	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TSACC mRNA; Nanotubes, Carbon results in decreased expression of TSACC mRNA	PMID:25554681
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1331902	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TSACC mRNA	PMID:38701926
1304953	Tsacc	TSSK6 activating co-chaperone	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1331902	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TSACC mRNA	PMID:22206623
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of POLD2 mRNA	PMID:33045310
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of POLD2 mRNA	PMID:33167477
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of POLD2 mRNA	PMID:26516004
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16170	mercury(0)	affects expression	ISO	RGD:1312693	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury affects the expression of POLD2 mRNA	PMID:16823088
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16235	guanine	multiple interactions	ISO	RGD:1312693	E	RGD:6480464	20150825	CTD	MESH:D006147	Guanine metabolite results in decreased activity of [POLD1 protein binds to POLD2 protein binds to POLD3 protein binds to POLD4 protein]; Guanine metabolite results in decreased activity of [POLD1 protein binds to POLD2 protein binds to POLD4 protein]	PMID:26010525
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312693	E	RGD:6480464	20130723	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of POLD2 mRNA; chromium histidinate inhibits the reaction [Hydrogen Peroxide results in increased expression of POLD2 mRNA]	PMID:19902159|PMID:21751221
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of POLD2 mRNA	PMID:15309432
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312694	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POLD2 mRNA	PMID:39241906
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of POLD2 mRNA]	PMID:39241906
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312693	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of POLD2 mRNA	PMID:19167446
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312693	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of POLD2 mRNA	PMID:38568856
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of POLD2 mRNA	PMID:33387578
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312693	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of POLD2 mRNA	PMID:37042841
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	ISO	RGD:1312693	E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of POLD2 mRNA	PMID:38160208
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:17521	(-)-quinic acid	multiple interactions	ISO	RGD:1312693	E	RGD:6480464	20191114	CTD	MESH:D011801	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of POLD2 mRNA	PMID:21751221
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of POLD2 mRNA	PMID:19850644
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of POLD2 mRNA]	PMID:19850644
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of POLD2 mRNA	PMID:26577399
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POLD2 mRNA	PMID:36331819
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of POLD2 mRNA	PMID:19770486
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of POLD2 mRNA	PMID:23630614
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:25195	mercury atom	affects expression	ISO	RGD:1312693	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury affects the expression of POLD2 mRNA	PMID:16823088
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of POLD2 mRNA	PMID:31881176
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312693	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of POLD2 mRNA	PMID:19167446
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312694	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLD2 mRNA	PMID:21570461
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLD2 mRNA	PMID:21215274
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLD2 mRNA	PMID:33387578
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLD2 mRNA	PMID:17942748
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of POLD2 mRNA]	PMID:21215274
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLD2 mRNA	PMID:17942748
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of POLD2 protein	PMID:39603559
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of POLD2 protein	PMID:33212167
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of POLD2 mRNA	PMID:32763439
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28794	coumarin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of POLD2 mRNA	PMID:18480146
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLD2 mRNA	PMID:35314868
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLD2 mRNA	PMID:38568856
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312693	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of POLD2 mRNA	PMID:39719251
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312693	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POLD2 promoter	PMID:27901495
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of POLD2 mRNA	PMID:25729387
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312694	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POLD2 promoter	PMID:35295148
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of POLD2 mRNA	PMID:23411599|PMID:34492290
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of POLD2 mRNA	PMID:18648102
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of POLD2 mRNA	PMID:18445702
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of POLD2 mRNA	PMID:17950772|PMID:18301758
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of POLD2 mRNA]	PMID:17950772
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of POLD2 mRNA	PMID:25181051|PMID:32145629
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of POLD2 mRNA	PMID:34947998
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of POLD2 mRNA	PMID:29275510
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of POLD2 mRNA	PMID:40203079
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312693	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of POLD2 exon	PMID:30157460
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1312694	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of POLD2 mRNA	PMID:36464114
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of POLD2 mRNA	PMID:17361019|PMID:21266533
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312694	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of POLD2 mRNA	PMID:34813904
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312694	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of POLD2 mRNA	PMID:34813904
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of POLD2 mRNA]	PMID:39241906
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in decreased expression of POLD2 mRNA]	PMID:19030233
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of POLD2 mRNA	PMID:35163327
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of POLD2 mRNA	PMID:25539665
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of POLD2 gene	PMID:22079235
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of POLD2 mRNA	PMID:19320972|PMID:19376846
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312693	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of POLD2 mRNA	PMID:19167446
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312693	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of POLD2 mRNA	PMID:19167446
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of POLD2 mRNA	PMID:39529242
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POLD2 mRNA	PMID:36331819
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of POLD2 mRNA	PMID:22110744|PMID:25993096
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of POLD2 mRNA	PMID:17555576
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of POLD2 mRNA	PMID:17562736
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of POLD2 mRNA	PMID:33387578
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of POLD2 mRNA	PMID:17555576
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of POLD2 mRNA	PMID:17942748
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLD2 mRNA	PMID:17942748
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312694	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of POLD2 mRNA; Nanotubes, Carbon results in increased expression of POLD2 mRNA	PMID:25554681
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:50692	mifepristone	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of POLD2 mRNA	PMID:17584828
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of POLD2 mRNA	PMID:35964746
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312694	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of POLD2 mRNA	PMID:19042947
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of POLD2 protein	PMID:32959892
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of POLD2 mRNA	PMID:25729387
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312693	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of POLD2 exon	PMID:30157460
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1312694	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of POLD2 mRNA	PMID:27462272
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1312694	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of POLD2 mRNA	PMID:36464114
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312694	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of POLD2 mRNA	PMID:22206623
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312693	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of POLD2 protein	PMID:37664457
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312693	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of POLD2 protein	PMID:31285264
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312693	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA	PMID:19167446
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312694	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of POLD2 mRNA	PMID:30294300
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of POLD2 protein	PMID:38348393
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of POLD2 mRNA]	PMID:39241906
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312693	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of POLD2 protein	PMID:37664457
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:9168	sirolimus	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased expression of POLD2 mRNA	PMID:11355896
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of POLD2 mRNA	PMID:21346803
1304954	Pold2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312693	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of POLD2 mRNA	PMID:38568856
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of EBF3 mRNA	PMID:25152437
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1346410	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of EBF3 mRNA	PMID:27188386
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346410	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of EBF3 mRNA	PMID:33167477
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of EBF3 gene	PMID:35440735
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312697	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EBF3 mRNA	PMID:39241906
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBF3 mRNA	PMID:32741896
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312697	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EBF3 mRNA	PMID:25510870
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:167162	L-ascorbic acid 2-phosphate	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20220208	CTD	MESH:C011669	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mRNA	PMID:34480604
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312697	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EBF3 mRNA	PMID:37992649
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312697	E	RGD:6480464	20141021	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of EBF3 mRNA	PMID:22401849
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBF3 mRNA	PMID:32741896
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312697	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EBF3 mRNA	PMID:37992649
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:17650	cortisol	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20220208	CTD	MESH:D006854	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EBF3 mRNA	PMID:34480604
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312697	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of EBF3 mRNA	PMID:34319233
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1346410	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of EBF3 mRNA	PMID:31163220
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EBF3 mRNA	PMID:33387578
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1346410	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of EBF3 intron	PMID:30157460
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312697	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EBF3 mRNA	PMID:25510870
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312697	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EBF3 mRNA	PMID:25510870
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1346410	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of EBF3 intron	PMID:30157460
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346410	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EBF3 gene	PMID:27153756
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312697	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of EBF3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of EBF3 mRNA	PMID:27106289|PMID:34911549
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312697	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of EBF3 mRNA	PMID:28960355
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1346410	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of EBF3 mRNA	PMID:28903495
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312697	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of EBF3 mRNA	PMID:32186404
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1346410	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of EBF3 mRNA	PMID:24768652|PMID:25583101
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of EBF3 mRNA	PMID:28959563
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312697	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of EBF3 mRNA	PMID:27862939
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346410	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EBF3 mRNA	PMID:29803840
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312697	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EBF3 mRNA	PMID:37992649
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20220208	CTD	MESH:D001205	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mRNA	PMID:34480604
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346410	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EBF3 intron	PMID:30157460
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346410	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EBF3 5' UTR; Benzo(a)pyrene results in increased methylation of EBF3 promoter	PMID:27901495
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1346410	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of EBF3 promoter	PMID:23974009
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of EBF3 gene	PMID:31601247
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of EBF3 mRNA	PMID:25729387
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] affects the expression of EBF3 mRNA	PMID:25729387
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312697	E	RGD:6480464	20141021	CTD	MESH:C009495	titanium dioxide results in decreased expression of EBF3 mRNA	PMID:23557971
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312697	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EBF3 promoter	PMID:35295148
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312697	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of EBF3 gene	PMID:35295148
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1346410	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of EBF3 gene	PMID:31601247
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of EBF3 mRNA	PMID:34947998
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312697	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of EBF3 promoter	PMID:27312807
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of EBF3 mRNA	PMID:30816183|PMID:32528016|PMID:41034487
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of EBF3 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EBF3 mRNA	PMID:28628672|PMID:31601247
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312697	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EBF3 mRNA	PMID:25510870
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312697	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EBF3 mRNA	PMID:25510870
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312697	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of EBF3 mRNA	PMID:30951980
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1346410	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of EBF3 gene	PMID:31601247
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1346410	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of EBF3 intron	PMID:30157460
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EBF3 mRNA	PMID:28628672
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312697	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EBF3 mRNA	PMID:37019170
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312697	E	RGD:6480464	20141021	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EBF3 mRNA	PMID:21266533
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EBF3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EBF3 mRNA	PMID:28628672
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of EBF3 gene	PMID:33148267
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EBF3 mRNA	PMID:35163327
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EBF3 mRNA	PMID:35163327
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1346410	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EBF3 mRNA	PMID:24449571
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312697	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EBF3 mRNA	PMID:40194260
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346410	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EBF3 mRNA	PMID:25979313
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346410	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of EBF3 mRNA	PMID:19101580
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1346410	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of EBF3 gene	PMID:29154799
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346410	E	RGD:6480464	20210608	CTD	MESH:D016572	Cyclosporine results in decreased expression of EBF3 mRNA	PMID:33631201
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346410	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of EBF3 mRNA	PMID:20106945
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EBF3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EBF3 mRNA	PMID:28628672
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312697	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EBF3 mRNA	PMID:37992649
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EBF3 mRNA	PMID:33387578
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EBF3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EBF3 mRNA	PMID:28628672
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312697	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of EBF3 mRNA	PMID:38701926
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:62878	XAV939	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20220208	CTD	MESH:C544261	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mRNA	PMID:34480604
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:63632	topotecan	affects expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan affects the expression of EBF3 mRNA	PMID:25729387
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] affects the expression of EBF3 mRNA	PMID:25729387
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1346410	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of EBF3 intron	PMID:30157460
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of EBF3 gene	PMID:33148267
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of EBF3 mRNA	PMID:39938710
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of EBF3 mRNA	PMID:34480604
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:75261	arotinoid acid	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20220208	CTD	MESH:C038864	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EBF3 mRNA	PMID:34480604
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBF3 mRNA	PMID:32741896
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of EBF3 mRNA	PMID:32109520
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:91091	CHIR 99021	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20220208	CTD	MESH:C473711	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EBF3 mRNA; [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mRNA	PMID:34480604
1304956	Ebf3	EBF transcription factor 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346410	E	RGD:6480464	20220208	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of EBF3 mRNA	PMID:34480604
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312699	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ATOH7 mRNA	PMID:33045310
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ATOH7 mRNA	PMID:20188158
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312698	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ATOH7 mRNA	PMID:30510588
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ATOH7 mRNA	PMID:33387578
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	EXP		E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of ATOH7 gene	PMID:33923623
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312698	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATOH7 gene	PMID:27153756
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312699	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of ATOH7 mRNA	PMID:15674844
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ATOH7 mRNA	PMID:25629700
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312699	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ATOH7 mRNA	PMID:40618947
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ATOH7 mRNA	PMID:32186404
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATOH7 mRNA	PMID:22228805
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312698	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATOH7 exon; Benzo(a)pyrene results in increased methylation of ATOH7 promoter	PMID:27901495
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of ATOH7 mRNA	PMID:24395379
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ATOH7 mRNA	PMID:18648102
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATOH7 mRNA	PMID:25181051
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312699	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ATOH7 mRNA	PMID:37019170
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312699	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ATOH7 mRNA	PMID:40194260
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:38626	pyridaben	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20121113	CTD	MESH:C428725	pyridaben results in decreased expression of ATOH7 mRNA	PMID:22563483
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312698	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATOH7 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312698	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATOH7 mRNA	PMID:27188386
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312698	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ATOH7 mRNA	PMID:26272509
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312698	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATOH7 mRNA	PMID:27188386
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312698	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ATOH7 mRNA	PMID:24935251
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of ATOH7 mRNA	PMID:22504374
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312698	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATOH7 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATOH7 mRNA	PMID:27188386
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312698	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATOH7 gene]	PMID:28238834
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATOH7 mRNA	PMID:24780913
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATOH7 mRNA	PMID:22504374
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312698	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATOH7 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATOH7 mRNA	PMID:27188386
1304957	Atoh7	atonal bHLH transcription factor 7	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ATOH7 mRNA	PMID:19281266
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1343247	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TBC1D19 mRNA	PMID:38218311
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1343247	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TBC1D19 mRNA	PMID:38218311
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1553444	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of TBC1D19 mRNA	PMID:33045310
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1343247	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TBC1D19 mRNA	PMID:33167477
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1343247	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of TBC1D19 mRNA	PMID:22378314
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553444	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TBC1D19 mRNA	PMID:39241906
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of TBC1D19 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of TBC1D19 mRNA	PMID:17404688|PMID:30165855
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of TBC1D19 mRNA	PMID:17404688
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1553444	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TBC1D19 mRNA	PMID:37992649
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1553444	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TBC1D19 mRNA	PMID:37992649
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1343247	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TBC1D19 mRNA	PMID:28818685
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TBC1D19 mRNA	PMID:39836092
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1343247	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TBC1D19 mRNA	PMID:22100608
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1553444	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TBC1D19 mRNA	PMID:19770486
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TBC1D19 mRNA	PMID:23630614
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1343247	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TBC1D19 mRNA	PMID:23649840
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1553444	E	RGD:6480464	20150127	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TBC1D19 mRNA	PMID:25270620
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TBC1D19 mRNA	PMID:39836092
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553444	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TBC1D19 mRNA	PMID:40504410
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TBC1D19 mRNA	PMID:31881176
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1343247	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TBC1D19 mRNA	PMID:27392435
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TBC1D19 mRNA	PMID:27392435
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1553444	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of TBC1D19 mRNA	PMID:30912803
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBC1D19 mRNA	PMID:33387578
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553444	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBC1D19 mRNA	PMID:21354282
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1343247	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TBC1D19 mRNA	PMID:33212167
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1553444	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TBC1D19 mRNA	PMID:37992649
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TBC1D19 mRNA	PMID:39836092
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553444	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TBC1D19 mRNA	PMID:40504410
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553444	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TBC1D19 mRNA	PMID:22228805
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1343247	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TBC1D19 promoter	PMID:27901495
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553444	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TBC1D19 gene	PMID:35295148
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TBC1D19 mRNA	PMID:23411599
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1343247	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of TBC1D19 mRNA	PMID:30690063
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TBC1D19 mRNA	PMID:25181051
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1553444	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TBC1D19 mRNA	PMID:38685157
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343247	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TBC1D19 mRNA	PMID:37042841
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TBC1D19 mRNA	PMID:39836092
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1343247	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TBC1D19 mRNA	PMID:38382870
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TBC1D19 mRNA	PMID:25539665
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1343247	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TBC1D19 mRNA	PMID:24449571
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1343247	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TBC1D19 mRNA	PMID:28302478
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1343247	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TBC1D19 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1343247	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TBC1D19 mRNA	PMID:25562108
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1553444	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TBC1D19 mRNA	PMID:37992649
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TBC1D19 mRNA	PMID:39836092
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553444	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TBC1D19 mRNA	PMID:40504410
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TBC1D19 mRNA	PMID:29391264
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TBC1D19 mRNA	PMID:22079256
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of TBC1D19 mRNA	PMID:24793618
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1553444	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TBC1D19 mRNA	PMID:38701926
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TBC1D19 mRNA	PMID:39836092
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1553444	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TBC1D19 mRNA	PMID:23650126
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1343247	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TBC1D19 mRNA	PMID:31758290
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553444	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TBC1D19 mRNA	PMID:22206623
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1343247	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TBC1D19 mRNA	PMID:22079256|PMID:22714537
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1343247	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TBC1D19 mRNA	PMID:22079256
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1553444	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TBC1D19 mRNA	PMID:39847705
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1553444	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of TBC1D19 mRNA	PMID:21278054
1304958	Tbc1d19	TBC1 domain family, member 19	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TBC1D19 mRNA	PMID:21346803
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of RDH13 mRNA]	PMID:19467301
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312701	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RDH13 mRNA	PMID:26516004
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RDH13 mRNA	PMID:36331819
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of RDH13 gene	PMID:28931070
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312701	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RDH13 mRNA	PMID:38568856
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312701	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RDH13 mRNA	PMID:37042841
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312701	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RDH13 mRNA	PMID:33359661
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:18009	NADP(+)	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of RDH13 protein	PMID:25526675
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of RDH13 mRNA	PMID:39836092
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312702	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RDH13 mRNA	PMID:19770486
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RDH13 mRNA	PMID:30779732
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RDH13 mRNA	PMID:31150632
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:27385	tetrachloromethane	increases response to substance	ISO	RGD:1312702	E	RGD:6480464	20170516	CTD	MESH:D002251	RDH13 results in increased susceptibility to Carbon Tetrachloride	PMID:27865848
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20170516	CTD	MESH:D002251	RDH13 protein promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; RDH13 protein promotes the reaction [Carbon Tetrachloride results in increased expression of COL1A1 mRNA]; RDH13 protein promotes the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]; RDH13 protein promotes the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]; RDH13 protein promotes the reaction [Carbon Tetrachloride results in increased expression of TIMP1 protein]	PMID:27865848
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312702	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of RDH13 protein	PMID:25505154
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312701	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RDH13 mRNA	PMID:19921347
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312702	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of RDH13 mRNA	PMID:32186404
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RDH13 mRNA	PMID:32109520
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RDH13 mRNA	PMID:33387578
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RDH13 mRNA	PMID:25975270
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312701	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RDH13 mRNA	PMID:33212167
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312701	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RDH13 mRNA	PMID:38568856
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312701	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RDH13 exon; Benzo(a)pyrene affects the methylation of RDH13 intron; Benzo(a)pyrene affects the methylation of RDH13 promoter	PMID:27901495|PMID:30157460
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312701	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RDH13 mRNA	PMID:19150397
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:31767	lead diacetate	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:C008261	lead acetate results in increased methylation of RDH13 gene	PMID:29571894
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RDH13 mRNA	PMID:34492290
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RDH13 mRNA	PMID:19710929
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which affects the expression of RDH13 mRNA	PMID:38479592
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RDH13 mRNA	PMID:25181051|PMID:30816183
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312701	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RDH13 protein	PMID:33376534|PMID:34186270
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312702	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RDH13 mRNA	PMID:33221593
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RDH13 mRNA	PMID:28628672
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312702	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RDH13 mRNA	PMID:40203079
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312702	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RDH13 mRNA	PMID:39298647
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RDH13 mRNA	PMID:28628672
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312701	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RDH13 intron	PMID:30157460
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312701	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RDH13 protein	PMID:34186270
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RDH13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RDH13 mRNA	PMID:28628672
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of RDH13 mRNA	PMID:39836092
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RDH13 mRNA	PMID:33453195
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312701	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of RDH13 mRNA	PMID:19167446
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RDH13 mRNA	PMID:36331819
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312701	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RDH13 mRNA	PMID:25979313
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312702	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RDH13 mRNA	PMID:17963808
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RDH13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RDH13 mRNA	PMID:28628672
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:44409	NADP zwitterion	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of RDH13 protein	PMID:25526675
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RDH13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RDH13 mRNA	PMID:28628672
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1312701	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of RDH13 mRNA	PMID:20977926
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312701	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of RDH13 mRNA	PMID:39836092
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312701	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RDH13 intron	PMID:30157460
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312702	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RDH13 mRNA	PMID:22206623
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1312701	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of RDH13 protein	PMID:39638853
1304959	Rdh13	retinol dehydrogenase 13	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312701	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RDH13 protein	PMID:38348393
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312703	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GDAP1L1 mRNA	PMID:26272509
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312703	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA	PMID:27188386
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623785	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GDAP1L1 mRNA	PMID:33045310
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:16136	hydrogen sulfide	decreases expression	ISO	RGD:1623785	E	RGD:6480464	20181113	CTD	MESH:D006862	Hydrogen Sulfide results in decreased expression of GDAP1L1 protein	PMID:29932956
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1623785	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of GDAP1L1 mRNA	PMID:30319688
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312703	E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in decreased expression of GDAP1L1 protein	PMID:33181973
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1623785	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of GDAP1L1 mRNA	PMID:26445464
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GDAP1L1 mRNA	PMID:39012411
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312703	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of GDAP1L1 mRNA	PMID:26272509
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312703	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA	PMID:27188386
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312703	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of GDAP1L1 mRNA	PMID:23557933
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1312703	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of GDAP1L1 promoter	PMID:22847954
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D003042	Cocaine results in decreased expression of GDAP1L1 protein	PMID:25100957
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1623785	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of GDAP1L1 mRNA	PMID:32186404
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of GDAP1L1 mRNA	PMID:26033743
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312703	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of GDAP1L1 gene	PMID:28589171
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312703	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GDAP1L1 mRNA	PMID:38568856
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312703	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GDAP1L1 promoter	PMID:27901495
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of GDAP1L1 mRNA	PMID:26033743
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1312703	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of GDAP1L1 mRNA	PMID:37690743
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of GDAP1L1 mRNA	PMID:30047161
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623785	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GDAP1L1 gene	PMID:35295148
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1623785	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of GDAP1L1 mRNA	PMID:32156529
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GDAP1L1 mRNA	PMID:25181051|PMID:34947998
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312703	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of GDAP1L1 mRNA	PMID:19244175
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623785	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of GDAP1L1 mRNA	PMID:30951980
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of GDAP1L1 mRNA	PMID:36117858
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GDAP1L1 mRNA	PMID:39012411
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1312703	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of GDAP1L1 promoter	PMID:22847954
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1312703	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of GDAP1L1 promoter	PMID:22847954
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1623785	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of GDAP1L1 mRNA	PMID:39529242
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312703	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GDAP1L1 mRNA	PMID:25979313
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312703	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of GDAP1L1 mRNA	PMID:24935251|PMID:28001369
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of GDAP1L1 mRNA	PMID:30047161
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623785	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GDAP1L1 mRNA	PMID:17562736
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	EXP		E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of GDAP1L1 gene	PMID:37958445
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312703	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA	PMID:27188386
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of GDAP1L1 mRNA	PMID:30047161
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of GDAP1L1 mRNA	PMID:36117858
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1312703	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of GDAP1L1 mRNA	PMID:20436886
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1312703	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA	PMID:27188386
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of GDAP1L1 mRNA	PMID:20080153
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1623785	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of GDAP1L1 mRNA	PMID:19751817
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1623785	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GDAP1L1 mRNA	PMID:22776087
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312703	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA	PMID:27188386
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312703	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GDAP1L1 gene]	PMID:28238834
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GDAP1L1 mRNA	PMID:30047161
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312703	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA	PMID:27188386
1304960	Gdap1l1	ganglioside-induced differentiation-associated protein 1-like 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of GDAP1L1 mRNA	PMID:23869203
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312705	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of WBP1 mRNA	PMID:38218311
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of WBP1 mRNA	PMID:21551480
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312706	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of WBP1 mRNA	PMID:20188158
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312705	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of WBP1 mRNA	PMID:23724009
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of WBP1 mRNA	PMID:30951980
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WBP1 mRNA	PMID:30529165
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of WBP1 mRNA	PMID:36331819
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of WBP1 mRNA	PMID:39241906
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of WBP1 gene	PMID:21212295
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of WBP1 mRNA	PMID:39298647
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of WBP1 mRNA	PMID:17251523
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312706	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of WBP1 mRNA	PMID:33754040
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312705	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of WBP1 protein	PMID:37730182
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of WBP1 mRNA	PMID:22061828
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312705	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of WBP1 mRNA	PMID:19549813
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of WBP1 mRNA	PMID:19376150
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of WBP1 mRNA	PMID:31150632
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of WBP1 mRNA	PMID:31919559
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WBP1 mRNA	PMID:22206623
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of WBP1 mRNA	PMID:40512198
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of WBP1 mRNA	PMID:28960355
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of WBP1 mRNA	PMID:23557933
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:28112	nickel atom	affects expression	ISO	RGD:1312705	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel affects the expression of WBP1 mRNA	PMID:14575637
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20120717	CTD	MESH:D009532	trichostatin A inhibits the reaction [Nickel affects the expression of WBP1 mRNA]	PMID:14575637
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312706	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WBP1 mRNA	PMID:21570461
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases methylation	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased methylation of WBP1 gene	PMID:21212295
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of WBP1 gene	PMID:21212295
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of WBP1 mRNA	PMID:30556269
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312705	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of WBP1 mRNA	PMID:20044591
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of WBP1 mRNA	PMID:40512198
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312705	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of WBP1 promoter	PMID:27901495
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of WBP1 mRNA	PMID:30556269
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312705	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of WBP1 mRNA	PMID:25895662
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of WBP1 mRNA	PMID:23811191
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of WBP1 mRNA	PMID:19710929
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of WBP1 mRNA	PMID:28329830
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of WBP1 mRNA	PMID:25181051
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312705	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of WBP1 mRNA	PMID:30903817
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of WBP1 mRNA	PMID:30816183|PMID:38750585
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312705	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of WBP1 mRNA	PMID:25912373
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312705	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of WBP1 mRNA	PMID:29275510
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of WBP1 mRNA	PMID:28628672
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of WBP1 mRNA	PMID:30951980
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of WBP1 mRNA	PMID:28628672
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of WBP1 mRNA	PMID:17361019|PMID:21266533
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312706	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of WBP1 mRNA	PMID:34813904
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of WBP1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of WBP1 mRNA	PMID:28628672
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312705	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of WBP1 mRNA	PMID:37042841
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of WBP1 mRNA	PMID:35163327
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of WBP1 mRNA	PMID:35163327
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of WBP1 mRNA	PMID:24386269
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of WBP1 mRNA	PMID:23811191
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of WBP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of WBP1 mRNA]	PMID:17585979
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312705	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of WBP1 mRNA	PMID:28302478
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312705	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of WBP1 mRNA	PMID:31533062
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312705	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of WBP1 mRNA	PMID:19167446
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of WBP1 mRNA	PMID:36331819
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of WBP1 mRNA	PMID:17292431
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of WBP1 mRNA	PMID:41580965
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312705	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of WBP1 mRNA	PMID:25562108
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of WBP1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of WBP1 mRNA	PMID:28628672
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20120717	CTD	MESH:C012589	trichostatin A inhibits the reaction [Nickel affects the expression of WBP1 mRNA]	PMID:14575637
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of WBP1 mRNA	PMID:17562736
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312705	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of WBP1 mRNA	PMID:22230336
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of WBP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of WBP1 mRNA]	PMID:17585979
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of WBP1 mRNA	PMID:40512198
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of WBP1 mRNA	PMID:35436446
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312705	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of WBP1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of WBP1 mRNA	PMID:28628672
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of WBP1 mRNA; Nanotubes, Carbon results in decreased expression of WBP1 mRNA	PMID:25554681|PMID:25620056
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of WBP1 mRNA	PMID:22206623
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WBP1 mRNA	PMID:22206623
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1312705	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of WBP1 mRNA	PMID:28960945
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of WBP1 mRNA	PMID:24780913
1304961	Wbp1	WW domain binding protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of WBP1 mRNA	PMID:40826991
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of LARS1 mRNA	PMID:35967413
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LARS1 mRNA]	PMID:31150632
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein]	PMID:38195004
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of LARS1 mRNA	PMID:23724009|PMID:33167477
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of LARS1 gene	PMID:35440735
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312707	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LARS1 mRNA	PMID:21179406
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550076	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LARS1 mRNA	PMID:39241906
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of LARS1 mRNA	PMID:28973375
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:17750	glycine betaine	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D001622	Betaine results in decreased expression of LARS1 mRNA	PMID:26391144
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D005839	Gentamicins results in increased expression of LARS1 mRNA	PMID:22061828
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of LARS1 protein	PMID:34915118
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein	PMID:38195004
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LARS1 protein	PMID:23301498
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312707	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LARS1 intron	PMID:30157460
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LARS1 mRNA	PMID:23649840
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of LARS1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of LARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of LARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of LARS1 protein	PMID:38598786
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LARS1 mRNA	PMID:31150632
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LARS1 mRNA	PMID:27339419|PMID:31919559
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LARS1 mRNA]	PMID:31150632
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of LARS1 protein	PMID:38460933
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312707	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of LARS1 protein	PMID:35688186
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of LARS1 mRNA	PMID:25596134
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LARS1 mRNA	PMID:23557933
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of LARS1 mRNA	PMID:25596134
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LARS1 mRNA	PMID:21570461
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LARS1 mRNA	PMID:34747641
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LARS1 mRNA	PMID:20106945|PMID:21632981
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LARS1 mRNA	PMID:28001369
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20230801	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LARS1 mRNA	PMID:33212167
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LARS1 mRNA	PMID:22228805
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LARS1 mRNA]	PMID:32406909
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LARS1 mRNA	PMID:20018196
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:32509	pirinixic acid	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C006253	pirinixic acid results in decreased expression of LARS1 mRNA	PMID:16940010
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:C006253	pirinixic acid results in increased expression of LARS1 mRNA	PMID:18301758
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LARS1 mRNA	PMID:28472532
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312707	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of LARS1 mRNA	PMID:30903817
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of LARS1 mRNA	PMID:30816183|PMID:32528016
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of LARS1 protein	PMID:34186270|PMID:37567409
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A results in increased expression of LARS1 mRNA	PMID:25181051
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312707	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LARS1 mRNA	PMID:25979313
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312707	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of LARS1 protein	PMID:34186270
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312707	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of LARS1 protein	PMID:34186270
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LARS1 mRNA	PMID:37019170
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LARS1 mRNA	PMID:24893172
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D005284	Fenthion results in decreased expression of LARS1 mRNA	PMID:34813904
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of LARS1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of LARS1 protein	PMID:38598786
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:C005828	methidathion results in increased expression of LARS1 mRNA	PMID:34813904
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D010269	Paraquat results in increased expression of LARS1 mRNA	PMID:32680482
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of LARS1 mRNA	PMID:17616710
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D002509	Cephaloridine results in decreased expression of LARS1 mRNA	PMID:18500788
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312707	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LARS1 mRNA	PMID:25596134
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein	PMID:38195004
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of LARS1 mRNA	PMID:25596134
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312707	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LARS1 mRNA	PMID:31533062
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312707	E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of LARS1 mRNA	PMID:36864359
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312707	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LARS1 mRNA	PMID:25979313
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of LARS1 mRNA	PMID:23179753|PMID:26272509
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	PMID:27188386
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D016572	Cyclosporine results in increased expression of LARS1 mRNA	PMID:25596134
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312707	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LARS1 mRNA	PMID:20106945|PMID:25562108|PMID:25596134|PMID:27989131
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D003907	Dexamethasone results in decreased expression of LARS1 mRNA	PMID:22733784
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20161213	CTD	MESH:C111237	Vorinostat results in decreased expression of LARS1 mRNA	PMID:27188386
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of LARS1 mRNA	PMID:26272509
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	PMID:27188386
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D000082	Acetaminophen affects the expression of LARS1 mRNA	PMID:17562736
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of LARS1 mRNA	PMID:29279043
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312707	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of LARS1 mRNA	PMID:29523930
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of LARS1 protein	PMID:38460933
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1312707	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of LARS1 mRNA	PMID:23228038
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D011345	Fenofibrate results in decreased expression of LARS1 mRNA	PMID:25596134
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1312707	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of LARS1 mRNA	PMID:25596134
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LARS1 mRNA; Nanotubes, Carbon results in increased expression of LARS1 mRNA	PMID:25620056
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D005485	Flutamide results in decreased expression of LARS1 mRNA	PMID:24793618
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D005485	Flutamide results in increased expression of LARS1 mRNA	PMID:24136188
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1312707	E	RGD:6480464	20230801	CTD	MESH:C001277	geldanamycin results in increased expression of LARS1 mRNA	PMID:26705709
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:5855	ibuprofen	increases expression	ISO	RGD:1312707	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of LARS1 mRNA	PMID:25596134
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LARS1 protein	PMID:32959892
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of LARS1 mRNA	PMID:28801915
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D008687	Metformin results in increased expression of LARS1 mRNA	PMID:25596134
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D008701	Methapyrilene results in decreased expression of LARS1 mRNA	PMID:30467583
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312707	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of LARS1 mRNA	PMID:31758290
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312707	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LARS1 protein	PMID:34186270
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of LARS1 protein	PMID:37664457
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312707	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of LARS1 protein	PMID:31285264
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of LARS1 mRNA	PMID:30559759
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	PMID:27188386
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20230801	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LARS1 gene]	PMID:28238834
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of LARS1 protein	PMID:31675489
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of LARS1 mRNA	PMID:23914054
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of LARS1 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	PMID:27188386|PMID:37664457
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D013605	T-2 Toxin results in decreased expression of LARS1 mRNA	PMID:26141394
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312707	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of LARS1 mRNA	PMID:27188386
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312707	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of LARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of LARS1 protein	PMID:38598786
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LARS1 mRNA	PMID:21346803
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:C080163	trovafloxacin results in decreased expression of LARS1 mRNA	PMID:35537566
1304962	Lars1	leucyl-tRNA synthetase 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C025643	vinclozolin affects the expression of LARS1 mRNA	PMID:23034163
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:2298744	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of PCARE mRNA	PMID:30510588
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:2298744	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PCARE gene	PMID:27153756
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:2298744	E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in decreased expression of PCARE protein	PMID:31195006
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:2298744	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of PCARE mRNA	PMID:41028656
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:2298744	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of PCARE mRNA	PMID:41028656
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PCARE mRNA	PMID:21839799
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:2298744	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCARE promoter	PMID:27901495
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:2298744	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of PCARE mRNA	PMID:41028656
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of PCARE mRNA	PMID:25181051
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:2298744	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PCARE gene	PMID:31601247
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:2298744	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PCARE mRNA	PMID:31533062
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:2298744	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of PCARE protein	PMID:31195006
1304963	Pcare	photoreceptor cilium actin regulator	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1312708	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of PCARE mRNA	PMID:22078008
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:110423	clodronic acid	affects expression	ISO	RGD:1312709	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid affects the expression of AIFM2 mRNA	PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of AIFM2 mRNA	PMID:37995155
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of AIFM2 mRNA]	PMID:19467301
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of AIFM2 mRNA	PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AIFM2 mRNA	PMID:36331819
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312710	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of AIFM2 mRNA	PMID:30319688
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312709	E	RGD:6480464	20171010	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of AIFM2 mRNA	PMID:20044591
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16240	hydrogen peroxide	increases secretion	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased secretion of AIFM2 protein	PMID:14987999
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of AIFM2 protein]	PMID:14987999
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of AIFM2 mRNA	PMID:39298647
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of AIFM2 mRNA	PMID:30165855
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312710	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of AIFM2 mRNA	PMID:33711761
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312710	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of AIFM2 mRNA	PMID:25549359
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312709	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AIFM2 mRNA	PMID:37042841
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:17158	methylglyoxal	increases expression	ISO	RGD:1312709	E	RGD:6480464	20190219	CTD	MESH:D011765	Pyruvaldehyde results in increased expression of AIFM2 mRNA	PMID:30447388
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312709	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of AIFM2 mRNA	PMID:22017230
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:173086	ferrostatin-1	increases expression	ISO	RGD:1312709	E	RGD:6480464	20250401	CTD	MESH:C573944	ferrostatin-1 results in increased expression of AIFM2 protein	PMID:38896176
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:173086	ferrostatin-1	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20250401	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [ochratoxin A results in decreased expression of AIFM2 protein]	PMID:38896176
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1312709	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of AIFM2 mRNA	PMID:31256213
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of AIFM2 mRNA	PMID:26577399
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of AIFM2 mRNA	PMID:28818685
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AIFM2 mRNA	PMID:36331819
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA	PMID:39836092
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of AIFM2 mRNA	PMID:24067728
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AIFM2 mRNA	PMID:35301059
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AIFM2 mRNA	PMID:37236586
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312709	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of AIFM2 mRNA	PMID:19549813
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312709	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of AIFM2 mRNA	PMID:23649840
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AIFM2 mRNA	PMID:33354967
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312709	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of AIFM2 mRNA	PMID:23649840
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:2564	aldrin	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in decreased expression of AIFM2 mRNA	PMID:18579281
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312710	E	RGD:6480464	20141014	CTD	MESH:C011559	tributyltin results in increased expression of AIFM2 mRNA	PMID:24848799
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AIFM2 mRNA	PMID:31150632
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:39836092
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:40504410
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of AIFM2 protein	PMID:38460933
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312709	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of AIFM2 mRNA	PMID:26272509
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIFM2 mRNA	PMID:27188386
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27871	chloroacetaldehyde	increases expression	ISO	RGD:1312709	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of AIFM2 mRNA	PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27889	lead(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of AIFM2 mRNA	PMID:39276841
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of AIFM2 mRNA; Cisplatin results in decreased expression of AIFM2 protein	PMID:25596134|PMID:40654249
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20260602	CTD	MESH:D002945	Cisplatin results in decreased expression of AIFM2 protein	PMID:40654249
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312709	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of AIFM2 mRNA; Cisplatin results in increased expression of AIFM2 protein	PMID:27392435
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AIFM2 mRNA; [Cisplatin co-treated with jinfukang] results in increased expression of AIFM2 protein; Cisplatin promotes the reaction [jinfukang results in increased expression of AIFM2 mRNA]; Cisplatin promotes the reaction [jinfukang results in increased expression of AIFM2 protein]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]; jinfukang promotes the reaction [Cisplatin results in increased expression of AIFM2 mRNA]; jinfukang promotes the reaction [Cisplatin results in increased expression of AIFM2 protein]	PMID:27392435|PMID:40654249
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260602	CTD	MESH:D002945	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]; ML385 inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]	PMID:40654249
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D003042	Cocaine affects the expression of AIFM2 mRNA	PMID:15681117
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312710	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AIFM2 mRNA	PMID:21570461
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AIFM2 mRNA	PMID:19770486
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AIFM2 mRNA	PMID:34747641
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312709	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AIFM2 mRNA	PMID:20106945|PMID:21632981
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AIFM2 mRNA	PMID:17942748
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D012402	Rotenone results in decreased expression of AIFM2 mRNA	PMID:19013527
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312709	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of AIFM2 mRNA	PMID:33212167
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312709	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of AIFM2 mRNA	PMID:32763439
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of AIFM2 mRNA	PMID:20971185
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004317	Doxorubicin results in decreased expression of AIFM2 mRNA	PMID:19915844
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28783	zinc protoporphyrin	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260602	CTD	MESH:C017803	zinc protoporphyrin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of AIFM2 protein]	PMID:39959930
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312709	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of AIFM2 mRNA	PMID:21281968|PMID:25493608|PMID:38568856|PMID:39900124
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:39836092
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:40504410
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312709	E	RGD:6480464	20250902	CTD	MESH:D014415	Tunicamycin results in increased expression of AIFM2 mRNA	PMID:39900124
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312709	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AIFM2 intron	PMID:30157460
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312709	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AIFM2 mRNA	PMID:21632981|PMID:26238291
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312709	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AIFM2 5' UTR	PMID:27901495
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of AIFM2 mRNA	PMID:20971185
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312709	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of AIFM2 gene	PMID:31601247
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312709	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of AIFM2 mRNA	PMID:38568856
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of AIFM2 mRNA	PMID:39276841
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of AIFM2 mRNA	PMID:30047161
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of AIFM2 mRNA	PMID:23557971
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312710	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AIFM2 promoter	PMID:35295148
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312710	E	RGD:6480464	20131220	CTD	MESH:C006253	pirinixic acid results in increased expression of AIFM2 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of AIFM2 mRNA	PMID:19167457
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312709	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of AIFM2 mRNA	PMID:30903817
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of AIFM2 promoter	PMID:27415467
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of AIFM2 protein	PMID:33376534
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AIFM2 mRNA	PMID:25181051
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312709	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of AIFM2 protein	PMID:34186270
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of AIFM2 protein]	PMID:33376534
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene inhibits the reaction [ganglioside, GD3 results in increased secretion of AIFM2 protein]; Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of AIFM2 protein]	PMID:14987999
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of AIFM2 mRNA	PMID:39298647
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312710	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of AIFM2 exon; bisphenol S results in decreased methylation of AIFM2 promoter	PMID:33297965
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312709	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of AIFM2 protein	PMID:34186270
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312709	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of AIFM2 protein	PMID:34186270
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312709	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of AIFM2 protein	PMID:34186270
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312710	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of AIFM2 mRNA	PMID:37019170
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of AIFM2 mRNA	PMID:21266533
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of AIFM2 mRNA	PMID:22546817
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20141014	CTD	MESH:D015056	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of AIFM2 mRNA	PMID:24848799
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of AIFM2 mRNA	PMID:22546817
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312709	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AIFM2 mRNA	PMID:37042841
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA	PMID:39836092
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312710	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of AIFM2 mRNA	PMID:26377693
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AIFM2 mRNA	PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312709	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AIFM2 mRNA	PMID:38174414
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AIFM2 mRNA	PMID:35301059
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AIFM2 mRNA	PMID:37236586
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of AIFM2 mRNA	PMID:19162173|PMID:30047161
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312709	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of AIFM2 mRNA	PMID:19320972
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312710	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of AIFM2 mRNA	PMID:28962523
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of AIFM2 mRNA	PMID:40194260
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of AIFM2 mRNA	PMID:31533062
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AIFM2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AIFM2 mRNA	PMID:36331819
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312710	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of AIFM2 mRNA	PMID:17292431
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20260602	CTD	MESH:D014635	Valproic Acid results in decreased expression of AIFM2 protein	PMID:40990894
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20260602	CTD	MESH:D014635	Valproic Acid results in decreased expression of AIFM2 protein	PMID:40990894
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of AIFM2 mRNA	PMID:30047161
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of AIFM2 mRNA	PMID:41580965
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AIFM2 mRNA	PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312709	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AIFM2 mRNA	PMID:20106945|PMID:25562108|PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312709	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of AIFM2 mRNA	PMID:25047013
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20141014	CTD	MESH:D003907	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of AIFM2 mRNA	PMID:24848799
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of AIFM2 mRNA	PMID:28973697
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D008727	Methotrexate affects the expression of AIFM2 mRNA	PMID:18502557
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312709	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of AIFM2 mRNA	PMID:38832940
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of AIFM2 mRNA	PMID:25704631|PMID:26690555
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of AIFM2 protein	PMID:38460933
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:39836092
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:40504410
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1312709	E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of AIFM2 mRNA	PMID:26722802
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of AIFM2 mRNA	PMID:35436446
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AIFM2 mRNA	PMID:17942748
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AIFM2 mRNA	PMID:17942748
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1312709	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of AIFM2 mRNA	PMID:38568856
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of AIFM2 mRNA	PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1312709	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of AIFM2 mRNA	PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of AIFM2 mRNA	PMID:30047161
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:50833	cadmium sulfide	increases expression	ISO	RGD:1312709	E	RGD:6480464	20170516	CTD	MESH:C034939	cadmium sulfide results in increased expression of AIFM2 mRNA	PMID:27866839
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1312709	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of AIFM2 mRNA	PMID:20977926
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:5855	ibuprofen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of AIFM2 mRNA	PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:5855	ibuprofen	increases expression	ISO	RGD:1312709	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of AIFM2 mRNA	PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA	PMID:39836092
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of AIFM2 mRNA	PMID:25596134
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:69832	osthole	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20260407	CTD	MESH:C046627	osthol results in decreased expression of AIFM2 protein	PMID:40446951
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:69832	osthole	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20260407	CTD	MESH:C046627	TFRC protein promotes the reaction [osthol results in decreased expression of AIFM2 protein]	PMID:40446951
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312709	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AIFM2 protein	PMID:34186270
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:76004	dimethyl fumarate	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C056020	Dimethyl Fumarate inhibits the reaction [Matrines results in decreased expression of AIFM2 mRNA]; Dimethyl Fumarate inhibits the reaction [Matrines results in decreased expression of AIFM2 protein]	PMID:38723914
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312709	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of AIFM2 protein	PMID:39638853
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20250401	CTD	MESH:C025589	ochratoxin A results in decreased expression of AIFM2 protein	PMID:38896176
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20250401	CTD	MESH:C025589	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine promotes the reaction [ochratoxin A results in decreased expression of AIFM2 protein]; ferrostatin-1 inhibits the reaction [ochratoxin A results in decreased expression of AIFM2 protein]; tetrahydro-N, N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride inhibits the reaction [ochratoxin A results in decreased expression of AIFM2 protein]	PMID:38896176
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIFM2 mRNA	PMID:27188386
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AIFM2 gene]	PMID:28238834
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of AIFM2 mRNA	PMID:19162173
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AIFM2 mRNA	PMID:30047161
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of AIFM2 mRNA	PMID:24780913
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIFM2 mRNA	PMID:27188386
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:92519	1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20250401	CTD	MESH:C093337	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine results in decreased expression of AIFM2 protein	PMID:38896176
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:92519	1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20250401	CTD	MESH:C093337	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine promotes the reaction [ochratoxin A results in decreased expression of AIFM2 protein]	PMID:38896176
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1312709	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of AIFM2 mRNA	PMID:11906190
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1312709	E	RGD:6480464	20260602	CTD	MESH:C477224	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]	PMID:40654249
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260602	CTD	MESH:C477224	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]	PMID:40654249
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312709	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of AIFM2 mRNA	PMID:29301935
1304964	Aifm2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in increased expression of AIFM2 mRNA	PMID:25596134
1304965	Rhoc	ras homolog family member C	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RHOC mRNA	PMID:38218311
1304965	Rhoc	ras homolog family member C	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of RHOC mRNA	PMID:35967413
1304965	Rhoc	ras homolog family member C	gene	CHEBI:141524	ochratoxin B	affects binding	ISO	RGD:1312711	E	RGD:6480464	20260505	CTD	MESH:C045354	RHOC protein binds to ochratoxin B	PMID:40952447
1304965	Rhoc	ras homolog family member C	gene	CHEBI:144400	dinophysistoxin 1	increases expression	ISO	RGD:1312711	E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of RHOC mRNA	PMID:28939011
1304965	Rhoc	ras homolog family member C	gene	CHEBI:149906	Tanshinone I	increases expression	ISO	RGD:1312711	E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone results in increased expression of RHOC mRNA	PMID:15849732
1304965	Rhoc	ras homolog family member C	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RHOC mRNA	PMID:20938992
1304965	Rhoc	ras homolog family member C	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312711	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of RHOC mRNA	PMID:23724009
1304965	Rhoc	ras homolog family member C	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of RHOC protein	PMID:39571964
1304965	Rhoc	ras homolog family member C	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of RHOC mRNA	PMID:30951980
1304965	Rhoc	ras homolog family member C	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RHOC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RHOC mRNA	PMID:32699268
1304965	Rhoc	ras homolog family member C	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RHOC mRNA	PMID:30529165
1304965	Rhoc	ras homolog family member C	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RHOC mRNA	PMID:36331819
1304965	Rhoc	ras homolog family member C	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312711	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RHOC mRNA	PMID:22378314
1304965	Rhoc	ras homolog family member C	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312711	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RHOC mRNA	PMID:21632981
1304965	Rhoc	ras homolog family member C	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RHOC mRNA	PMID:39241906
1304965	Rhoc	ras homolog family member C	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312712	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of RHOC mRNA	PMID:15598610
1304965	Rhoc	ras homolog family member C	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of RHOC protein	PMID:32145629
1304965	Rhoc	ras homolog family member C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312712	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RHOC mRNA	PMID:39298647
1304965	Rhoc	ras homolog family member C	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312711	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of RHOC mRNA	PMID:22579512
1304965	Rhoc	ras homolog family member C	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312712	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of RHOC mRNA	PMID:33711761
1304965	Rhoc	ras homolog family member C	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RHOC mRNA	PMID:20938992
1304965	Rhoc	ras homolog family member C	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312711	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RHOC mRNA	PMID:37042841
1304965	Rhoc	ras homolog family member C	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312711	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RHOC mRNA	PMID:23649840
1304965	Rhoc	ras homolog family member C	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHOC mRNA	PMID:37992649
1304965	Rhoc	ras homolog family member C	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine analog results in decreased expression of RHOC mRNA	PMID:16142878
1304965	Rhoc	ras homolog family member C	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHOC mRNA	PMID:37992649
1304965	Rhoc	ras homolog family member C	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312711	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RHOC mRNA	PMID:28818685
1304965	Rhoc	ras homolog family member C	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RHOC mRNA	PMID:36331819
1304965	Rhoc	ras homolog family member C	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog results in decreased expression of RHOC mRNA	PMID:16142878
1304965	Rhoc	ras homolog family member C	gene	CHEBI:22977	cadmium atom	increases oxidation	ISO	RGD:1312712	E	RGD:6480464	20150310	CTD	MESH:D002104	Cadmium results in increased oxidation of RHOC protein	PMID:24077948
1304965	Rhoc	ras homolog family member C	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312711	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RHOC mRNA	PMID:19549813
1304965	Rhoc	ras homolog family member C	gene	CHEBI:24229	geranylgeraniol	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20190702	CTD	MESH:C017338	geranylgeraniol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein]	PMID:24587105
1304965	Rhoc	ras homolog family member C	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312711	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of RHOC protein	PMID:20106945
1304965	Rhoc	ras homolog family member C	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RHOC mRNA	PMID:23630614|PMID:25378103|PMID:33354967
1304965	Rhoc	ras homolog family member C	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312711	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RHOC mRNA	PMID:21632981|PMID:21641981|PMID:27153756
1304965	Rhoc	ras homolog family member C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RHOC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RHOC mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RHOC mRNA	PMID:32699268
1304965	Rhoc	ras homolog family member C	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RHOC mRNA	PMID:30779732
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312712	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RHOC mRNA	PMID:27339419|PMID:31919559
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the reaction [Cisplatin affects the expression of RHOC mRNA]	PMID:16898872
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RHOC mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RHOC mRNA	PMID:20938992|PMID:22206623
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHOC mRNA	PMID:40504410
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27641	cycloheximide	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20220809	CTD	MESH:D003513	Cycloheximide results in decreased expression of RHOC protein	PMID:34873829
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20220809	CTD	MESH:D003513	RNF168 protein promotes the reaction [Cycloheximide results in decreased expression of RHOC protein]	PMID:34873829
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1312711	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of RHOC mRNA	PMID:38460933
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1312711	E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of RHOC mRNA	PMID:38460933
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of RHOC mRNA	PMID:38460933
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312711	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RHOC mRNA	PMID:26272509
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOC mRNA	PMID:27188386
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RHOC mRNA	PMID:31881176
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312712	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of RHOC protein	PMID:25505154
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312711	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RHOC mRNA	PMID:28903495
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312711	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of RHOC mRNA	PMID:23300844
1304965	Rhoc	ras homolog family member C	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20120412	CTD	MESH:D002945	Folic Acid affects the reaction [Cisplatin affects the expression of RHOC mRNA]	PMID:16898872
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of RHOC mRNA	PMID:18930951
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RHOC mRNA	PMID:34747641
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312712	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RHOC mRNA	PMID:21570461
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312711	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RHOC mRNA	PMID:20106945|PMID:21632981
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312712	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RHOC mRNA	PMID:19770486
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog results in decreased expression of RHOC mRNA	PMID:16142878
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28600	farnesol	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20190702	CTD	MESH:D005204	Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein]	PMID:24587105
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RHOC mRNA	PMID:28959563
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of RHOC mRNA	PMID:21198554
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312711	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RHOC mRNA	PMID:29803840
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHOC mRNA	PMID:37992649
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28851	phenanthrene	increases expression	ISO	RGD:1312711	E	RGD:6480464	20121009	CTD	MESH:C031181	phenanthrene results in increased expression of RHOC mRNA	PMID:22579512
1304965	Rhoc	ras homolog family member C	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312711	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of RHOC mRNA	PMID:20044591
1304965	Rhoc	ras homolog family member C	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1312711	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of RHOC mRNA	PMID:22623647
1304965	Rhoc	ras homolog family member C	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312711	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RHOC mRNA	PMID:20886546|PMID:38568856
1304965	Rhoc	ras homolog family member C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of RHOC protein	PMID:39571964
1304965	Rhoc	ras homolog family member C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHOC mRNA	PMID:40504410
1304965	Rhoc	ras homolog family member C	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of RHOC mRNA	PMID:29453283
1304965	Rhoc	ras homolog family member C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RHOC mRNA	PMID:19770486
1304965	Rhoc	ras homolog family member C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312711	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RHOC mRNA	PMID:21632981|PMID:22316170|PMID:22579512|PMID:26238291
1304965	Rhoc	ras homolog family member C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312712	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RHOC mRNA	PMID:22228805
1304965	Rhoc	ras homolog family member C	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312712	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RHOC mRNA	PMID:19073995|PMID:33720480
1304965	Rhoc	ras homolog family member C	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of RHOC mRNA	PMID:26238599
1304965	Rhoc	ras homolog family member C	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RHOC mRNA	PMID:16483693
1304965	Rhoc	ras homolog family member C	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of RHOC mRNA	PMID:25729387
1304965	Rhoc	ras homolog family member C	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RHOC mRNA	PMID:25729387
1304965	Rhoc	ras homolog family member C	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RHOC mRNA	PMID:30047161
1304965	Rhoc	ras homolog family member C	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312712	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of RHOC mRNA	PMID:23557971
1304965	Rhoc	ras homolog family member C	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312712	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RHOC promoter	PMID:35295148
1304965	Rhoc	ras homolog family member C	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RHOC mRNA	PMID:23411599|PMID:34492290
1304965	Rhoc	ras homolog family member C	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RHOC mRNA	PMID:30723492
1304965	Rhoc	ras homolog family member C	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312712	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of RHOC mRNA	PMID:18301758|PMID:23811191
1304965	Rhoc	ras homolog family member C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RHOC mRNA	PMID:29275510
1304965	Rhoc	ras homolog family member C	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312712	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RHOC promoter	PMID:27312807
1304965	Rhoc	ras homolog family member C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RHOC mRNA; bisphenol A results in increased expression of RHOC protein	PMID:25181051|PMID:32145629
1304965	Rhoc	ras homolog family member C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312712	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RHOC mRNA	PMID:32156529|PMID:34585602
1304965	Rhoc	ras homolog family member C	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RHOC mRNA	PMID:28628672
1304965	Rhoc	ras homolog family member C	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of RHOC protein	PMID:31675489
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312712	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of RHOC mRNA	PMID:26682919
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312711	E	RGD:6480464	20121009	CTD	MESH:D008748	Methylcholanthrene results in increased expression of RHOC mRNA	PMID:22579512
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312712	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of RHOC mRNA	PMID:39298647
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312712	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of RHOC mRNA	PMID:26377693
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1312711	E	RGD:6480464	20141111	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of RHOC mRNA	PMID:22579512
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312711	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RHOC protein	PMID:34186270
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312712	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RHOC mRNA	PMID:30951980
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHOC mRNA	PMID:28628672
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of RHOC mRNA	PMID:30951980
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312712	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RHOC intron	PMID:28392331
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312712	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RHOC mRNA	PMID:37019170
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RHOC mRNA	PMID:21266533
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1312711	E	RGD:6480464	20120412	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of RHOC mRNA	PMID:16314067
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312712	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of RHOC mRNA	PMID:34813904
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RHOC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHOC mRNA	PMID:28628672
1304965	Rhoc	ras homolog family member C	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312712	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RHOC mRNA	PMID:24535843
1304965	Rhoc	ras homolog family member C	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312711	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RHOC mRNA	PMID:29024780
1304965	Rhoc	ras homolog family member C	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312711	E	RGD:6480464	20121009	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RHOC mRNA	PMID:22579512
1304965	Rhoc	ras homolog family member C	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312712	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RHOC mRNA	PMID:26377693
1304965	Rhoc	ras homolog family member C	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of RHOC mRNA	PMID:30723492
1304965	Rhoc	ras homolog family member C	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20160210	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RHOC mRNA	PMID:26238599
1304965	Rhoc	ras homolog family member C	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312711	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RHOC mRNA	PMID:38568856
1304965	Rhoc	ras homolog family member C	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of RHOC gene	PMID:27387713
1304965	Rhoc	ras homolog family member C	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of RHOC mRNA	PMID:26194646|PMID:27387713
1304965	Rhoc	ras homolog family member C	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RHOC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RHOC mRNA	PMID:32699268
1304965	Rhoc	ras homolog family member C	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of RHOC mRNA	PMID:17585979
1304965	Rhoc	ras homolog family member C	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1312712	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in increased expression of RHOC mRNA	PMID:16221962
1304965	Rhoc	ras homolog family member C	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RHOC mRNA	PMID:31533062
1304965	Rhoc	ras homolog family member C	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of RHOC mRNA	PMID:26352163
1304965	Rhoc	ras homolog family member C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RHOC protein	PMID:26178269
1304965	Rhoc	ras homolog family member C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RHOC mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RHOC mRNA	PMID:36331819
1304965	Rhoc	ras homolog family member C	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312711	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of RHOC mRNA	PMID:28001369
1304965	Rhoc	ras homolog family member C	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RHOC mRNA	PMID:30047161
1304965	Rhoc	ras homolog family member C	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312711	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RHOC mRNA	PMID:25562108
1304965	Rhoc	ras homolog family member C	gene	CHEBI:41423	celecoxib	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib promotes the reaction [Atorvastatin results in decreased localization of RHOC protein]; Celecoxib promotes the reaction [Atorvastatin results in increased expression of RHOC protein]	PMID:18172863
1304965	Rhoc	ras homolog family member C	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RHOC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHOC mRNA	PMID:28628672
1304965	Rhoc	ras homolog family member C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312712	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RHOC mRNA	PMID:28973697
1304965	Rhoc	ras homolog family member C	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHOC mRNA	PMID:37992649
1304965	Rhoc	ras homolog family member C	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312711	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RHOC protein	PMID:38832940
1304965	Rhoc	ras homolog family member C	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312712	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RHOC mRNA	PMID:17562736
1304965	Rhoc	ras homolog family member C	gene	CHEBI:46557	zoledronic acid	affects localization	ISO	RGD:1312711	E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid affects the localization of RHOC protein	PMID:28871336
1304965	Rhoc	ras homolog family member C	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of RHOC mRNA	PMID:38460933
1304965	Rhoc	ras homolog family member C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHOC mRNA	PMID:40504410
1304965	Rhoc	ras homolog family member C	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of RHOC mRNA	PMID:31675489
1304965	Rhoc	ras homolog family member C	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RHOC mRNA	PMID:29391264
1304965	Rhoc	ras homolog family member C	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog results in decreased expression of RHOC mRNA	PMID:16142878
1304965	Rhoc	ras homolog family member C	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RHOC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHOC mRNA	PMID:28628672
1304965	Rhoc	ras homolog family member C	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of RHOC mRNA	PMID:26238599
1304965	Rhoc	ras homolog family member C	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312711	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of RHOC mRNA	PMID:23300844
1304965	Rhoc	ras homolog family member C	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312712	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RHOC mRNA; Nanotubes, Carbon results in increased expression of RHOC mRNA	PMID:25554681
1304965	Rhoc	ras homolog family member C	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RHOC mRNA	PMID:30047161
1304965	Rhoc	ras homolog family member C	gene	CHEBI:50686	atorvastatin calcium	decreases localization	ISO	RGD:1312711	E	RGD:6480464	20170303	CTD	MESH:D000069059	Atorvastatin results in decreased localization of RHOC protein	PMID:18172863
1304965	Rhoc	ras homolog family member C	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312711	E	RGD:6480464	20170303	CTD	MESH:D000069059	Atorvastatin results in increased expression of RHOC protein	PMID:18172863
1304965	Rhoc	ras homolog family member C	gene	CHEBI:50686	atorvastatin calcium	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20170303	CTD	MESH:D000069059	Celecoxib promotes the reaction [Atorvastatin results in decreased localization of RHOC protein]; Celecoxib promotes the reaction [Atorvastatin results in increased expression of RHOC protein]	PMID:18172863
1304965	Rhoc	ras homolog family member C	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312711	E	RGD:6480464	20121009	CTD	MESH:C030935	benz(a)anthracene results in increased expression of RHOC mRNA	PMID:22579512
1304965	Rhoc	ras homolog family member C	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312711	E	RGD:6480464	20121009	CTD	MESH:C031180	chrysene results in increased expression of RHOC mRNA	PMID:22579512
1304965	Rhoc	ras homolog family member C	gene	CHEBI:52288	1-octadec-9-enoylglycero-3-phosphate	increases activity	ISO	RGD:1312711	E	RGD:6480464	20190702	CTD	MESH:C032881	lysophosphatidic acid results in increased activity of RHOC protein	PMID:24587105
1304965	Rhoc	ras homolog family member C	gene	CHEBI:52288	1-octadec-9-enoylglycero-3-phosphate	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20190702	CTD	MESH:C032881	Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein]; geranylgeraniol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein]	PMID:24587105
1304965	Rhoc	ras homolog family member C	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312711	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of RHOC mRNA	PMID:16314067
1304965	Rhoc	ras homolog family member C	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RHOC protein	PMID:32959892
1304965	Rhoc	ras homolog family member C	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RHOC mRNA	PMID:21641980
1304965	Rhoc	ras homolog family member C	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of RHOC mRNA	PMID:25729387
1304965	Rhoc	ras homolog family member C	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RHOC mRNA	PMID:25729387
1304965	Rhoc	ras homolog family member C	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1312712	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of RHOC mRNA	PMID:17654400
1304965	Rhoc	ras homolog family member C	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RHOC mRNA	PMID:22206623
1304965	Rhoc	ras homolog family member C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RHOC mRNA	PMID:22206623
1304965	Rhoc	ras homolog family member C	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20220809	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [RNF168 protein results in decreased expression of RHOC protein]	PMID:34873829
1304965	Rhoc	ras homolog family member C	gene	CHEBI:7719	ochratoxin A	affects binding	ISO	RGD:1312711	E	RGD:6480464	20260505	CTD	MESH:C025589	RHOC protein binds to ochratoxin A	PMID:40952447
1304965	Rhoc	ras homolog family member C	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of RHOC mRNA	PMID:23665939
1304965	Rhoc	ras homolog family member C	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOC mRNA	PMID:27188386
1304965	Rhoc	ras homolog family member C	gene	CHEBI:81525	2,3,3',4,4',5,5'-Heptachlorobiphenyl	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20170303	CTD	MESH:C034559	2,2',3,3',4,4',5-heptachlorobiphenyl results in decreased expression of RHOC mRNA	PMID:26238599
1304965	Rhoc	ras homolog family member C	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RHOC protein	PMID:31675489
1304965	Rhoc	ras homolog family member C	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RHOC mRNA	PMID:21394737
1304965	Rhoc	ras homolog family member C	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20160210	CTD	MESH:C093628	cyproconazole results in decreased expression of RHOC mRNA	PMID:26238599
1304965	Rhoc	ras homolog family member C	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	increases expression	ISO	RGD:1312711	E	RGD:6480464	20141111	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in increased expression of RHOC mRNA	PMID:22579512
1304965	Rhoc	ras homolog family member C	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of RHOC protein	PMID:31675489
1304965	Rhoc	ras homolog family member C	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1312712	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of RHOC mRNA	PMID:27029645
1304965	Rhoc	ras homolog family member C	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312712	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RHOC mRNA	PMID:39847705
1304965	Rhoc	ras homolog family member C	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RHOC mRNA	PMID:30047161
1304965	Rhoc	ras homolog family member C	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RHOC mRNA	PMID:40826991
1304965	Rhoc	ras homolog family member C	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of RHOC protein	PMID:20553848
1304965	Rhoc	ras homolog family member C	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312711	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOC mRNA	PMID:27188386
1304965	Rhoc	ras homolog family member C	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1312711	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of RHOC mRNA	PMID:14630613
1304965	Rhoc	ras homolog family member C	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RHOC mRNA	PMID:19281266
1304965	Rhoc	ras homolog family member C	gene	CHEBI:9448	terbinafine	increases localization	ISO	RGD:1312711	E	RGD:6480464	20161213	CTD	MESH:C041359	terbinafine results in increased localization of RHOC protein	PMID:17172416
1304965	Rhoc	ras homolog family member C	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1312711	E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon analog results in decreased expression of RHOC mRNA; triadimefon results in decreased expression of RHOC mRNA	PMID:26238599
1304965	Rhoc	ras homolog family member C	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of RHOC mRNA	PMID:23034163
1304966	Cutc	cutC copper transporter	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CUTC mRNA	PMID:21632981
1304966	Cutc	cutC copper transporter	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CUTC gene	PMID:27618143
1304966	Cutc	cutC copper transporter	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CUTC mRNA	PMID:23649840
1304966	Cutc	cutC copper transporter	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312714	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CUTC mRNA	PMID:34319233
1304966	Cutc	cutC copper transporter	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CUTC mRNA	PMID:33387578
1304966	Cutc	cutC copper transporter	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CUTC mRNA	PMID:36331819
1304966	Cutc	cutC copper transporter	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CUTC mRNA	PMID:37236586
1304966	Cutc	cutC copper transporter	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CUTC mRNA	PMID:19549813|PMID:20599845
1304966	Cutc	cutC copper transporter	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312713	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CUTC protein	PMID:23301498
1304966	Cutc	cutC copper transporter	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CUTC mRNA	PMID:23649840
1304966	Cutc	cutC copper transporter	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312714	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CUTC mRNA	PMID:31919559
1304966	Cutc	cutC copper transporter	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CUTC mRNA	PMID:19244175
1304966	Cutc	cutC copper transporter	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312713	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA	PMID:19244175
1304966	Cutc	cutC copper transporter	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312713	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CUTC mRNA	PMID:27392435
1304966	Cutc	cutC copper transporter	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1312714	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of CUTC mRNA	PMID:34813904
1304966	Cutc	cutC copper transporter	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312714	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CUTC mRNA	PMID:21570461
1304966	Cutc	cutC copper transporter	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUTC mRNA	PMID:17942748
1304966	Cutc	cutC copper transporter	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CUTC mRNA	PMID:33212167
1304966	Cutc	cutC copper transporter	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312714	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CUTC mRNA	PMID:27862939
1304966	Cutc	cutC copper transporter	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312714	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of CUTC mRNA	PMID:39631538
1304966	Cutc	cutC copper transporter	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CUTC mRNA	PMID:38568856
1304966	Cutc	cutC copper transporter	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312713	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CUTC mRNA	PMID:17879257
1304966	Cutc	cutC copper transporter	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312714	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CUTC mRNA	PMID:21715664|PMID:22228805
1304966	Cutc	cutC copper transporter	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312713	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CUTC mRNA	PMID:25351596
1304966	Cutc	cutC copper transporter	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CUTC mRNA	PMID:20382639
1304966	Cutc	cutC copper transporter	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312714	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CUTC gene	PMID:35295148
1304966	Cutc	cutC copper transporter	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312714	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CUTC gene	PMID:35295148
1304966	Cutc	cutC copper transporter	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CUTC mRNA	PMID:34492290
1304966	Cutc	cutC copper transporter	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CUTC mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1304966	Cutc	cutC copper transporter	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312713	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CUTC mRNA	PMID:28628672
1304966	Cutc	cutC copper transporter	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of CUTC mRNA	PMID:19244175
1304966	Cutc	cutC copper transporter	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1312713	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA	PMID:19244175
1304966	Cutc	cutC copper transporter	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CUTC mRNA	PMID:21266533
1304966	Cutc	cutC copper transporter	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312713	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CUTC mRNA	PMID:28628672
1304966	Cutc	cutC copper transporter	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312713	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CUTC mRNA	PMID:37042841
1304966	Cutc	cutC copper transporter	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CUTC mRNA	PMID:38568856
1304966	Cutc	cutC copper transporter	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CUTC mRNA	PMID:37236586
1304966	Cutc	cutC copper transporter	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CUTC mRNA	PMID:24386269
1304966	Cutc	cutC copper transporter	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CUTC mRNA	PMID:19244175
1304966	Cutc	cutC copper transporter	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312713	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA	PMID:19244175
1304966	Cutc	cutC copper transporter	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CUTC mRNA	PMID:28302478
1304966	Cutc	cutC copper transporter	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312713	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CUTC mRNA	PMID:31533062
1304966	Cutc	cutC copper transporter	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CUTC mRNA	PMID:36331819
1304966	Cutc	cutC copper transporter	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of CUTC mRNA	PMID:22110744
1304966	Cutc	cutC copper transporter	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312713	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CUTC mRNA	PMID:29154799
1304966	Cutc	cutC copper transporter	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1312713	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CUTC promoter	PMID:27989131
1304966	Cutc	cutC copper transporter	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CUTC mRNA	PMID:17555576
1304966	Cutc	cutC copper transporter	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312713	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of CUTC mRNA	PMID:25047013
1304966	Cutc	cutC copper transporter	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312713	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CUTC mRNA	PMID:28628672
1304966	Cutc	cutC copper transporter	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312713	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CUTC mRNA	PMID:28542535
1304966	Cutc	cutC copper transporter	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CUTC mRNA	PMID:17562736
1304966	Cutc	cutC copper transporter	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of CUTC mRNA	PMID:29067470
1304966	Cutc	cutC copper transporter	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CUTC mRNA	PMID:33387578
1304966	Cutc	cutC copper transporter	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1312713	E	RGD:6480464	20120412	CTD	MESH:D005472	CUTC protein affects the susceptibility to Fluorouracil	PMID:16217747
1304966	Cutc	cutC copper transporter	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1312713	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of CUTC mRNA]	PMID:15016801
1304966	Cutc	cutC copper transporter	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CUTC mRNA	PMID:29391264
1304966	Cutc	cutC copper transporter	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CUTC mRNA	PMID:17555576
1304966	Cutc	cutC copper transporter	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CUTC mRNA	PMID:17942748
1304966	Cutc	cutC copper transporter	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUTC mRNA	PMID:17942748
1304966	Cutc	cutC copper transporter	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312713	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CUTC mRNA	PMID:28628672
1304966	Cutc	cutC copper transporter	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CUTC mRNA	PMID:35964746
1304966	Cutc	cutC copper transporter	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CUTC mRNA	PMID:24793618
1304966	Cutc	cutC copper transporter	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CUTC mRNA	PMID:24136188
1304966	Cutc	cutC copper transporter	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of CUTC mRNA	PMID:21983209
1304966	Cutc	cutC copper transporter	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CUTC protein	PMID:32959892
1304966	Cutc	cutC copper transporter	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CUTC mRNA	PMID:28988120
1304966	Cutc	cutC copper transporter	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312714	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CUTC mRNA	PMID:22206623
1304966	Cutc	cutC copper transporter	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CUTC mRNA	PMID:21346803
1304966	Cutc	cutC copper transporter	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312713	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CUTC mRNA	PMID:38568856
1304966	Cutc	cutC copper transporter	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CUTC mRNA	PMID:21346803
1304966	Cutc	cutC copper transporter	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312714	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CUTC mRNA	PMID:35537566
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LSM1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LSM1 mRNA	PMID:32699268
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312715	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LSM1 mRNA	PMID:20044591
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1558112	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of LSM1 mRNA	PMID:39298647
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312715	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LSM1 mRNA	PMID:37042841
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LSM1 mRNA	PMID:39836092
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LSM1 mRNA	PMID:35301059
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312715	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LSM1 gene	PMID:27153756
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LSM1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LSM1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of LSM1 mRNA	PMID:32699268
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1558112	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LSM1 mRNA	PMID:25629700
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM1 mRNA	PMID:22206623
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSM1 mRNA	PMID:39836092
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM1 mRNA	PMID:40504410
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558112	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LSM1 mRNA	PMID:17949056
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312715	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of LSM1 mRNA	PMID:33512557
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312715	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LSM1 mRNA	PMID:33212167
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312715	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LSM1 mRNA	PMID:32763439
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1558112	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of LSM1 mRNA	PMID:27862939
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LSM1 mRNA	PMID:29432896
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSM1 mRNA	PMID:39836092
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM1 mRNA	PMID:40504410
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to LSM1 mRNA]	PMID:32406909
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1558112	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of LSM1 mRNA	PMID:27131904
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1558112	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LSM1 mRNA	PMID:18301758
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312715	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LSM1 mRNA	PMID:29275510
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LSM1 mRNA	PMID:25181051
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1558112	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LSM1 mRNA	PMID:39298647
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312715	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of LSM1 mRNA alternative form	PMID:17064354
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LSM1 mRNA	PMID:39836092
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LSM1 mRNA	PMID:35301059
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LSM1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LSM1 mRNA	PMID:32699268
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1312715	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of LSM1 mRNA	PMID:17010196
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312715	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of LSM1 mRNA	PMID:28302478
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSM1 mRNA	PMID:39836092
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM1 mRNA	PMID:40504410
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1558112	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of LSM1 mRNA	PMID:25554681
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of LSM1 mRNA	PMID:34044035
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LSM1 mRNA	PMID:35964746
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of LSM1 mRNA	PMID:24136188
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312715	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of LSM1 protein	PMID:23718831
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312715	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LSM1 protein	PMID:32959892
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312715	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LSM1 mRNA	PMID:39836092
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSM1 mRNA	PMID:21641980
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:6437	levetiracetam	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077287	Levetiracetam results in increased expression of LSM1 mRNA	PMID:20345932
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM1 mRNA	PMID:22206623
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:8107	phenytoin	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in decreased expression of LSM1 mRNA	PMID:20345932
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1558112	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of LSM1 mRNA	PMID:30294300
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312715	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of LSM1 protein	PMID:38348393
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1558112	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of LSM1 mRNA	PMID:27131904
1304967	Lsm1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LSM1 mRNA	PMID:21346803
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1602488	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of RSRC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of RSRC1 mRNA	PMID:32699268
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RSRC1 mRNA	PMID:21632981
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RSRC1 gene	PMID:27618143
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of RSRC1 mRNA	PMID:23649840
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1602488	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RSRC1 mRNA	PMID:21179406
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1602488	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RSRC1 protein	PMID:37730182
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:D024502	[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in decreased expression of RSRC1 mRNA]; [Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [sodium arsenite results in decreased expression of RSRC1 mRNA]	PMID:37704839|PMID:39325335
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1602488	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of RSRC1 protein	PMID:20106945
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RSRC1 mRNA	PMID:19770486
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RSRC1 mRNA	PMID:22100608
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D016604	[sulforaphane co-treated with Aflatoxin B1] affects the expression of RSRC1 mRNA	PMID:25450479
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RSRC1 mRNA	PMID:23649840
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602488	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of RSRC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of RSRC1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RSRC1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of RSRC1 mRNA	PMID:32699268|PMID:41430723
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of RSRC1 mRNA	PMID:31129395
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RSRC1 mRNA	PMID:31919559
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RSRC1 mRNA	PMID:25629700
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1602488	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of RSRC1 mRNA	PMID:19167446
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of RSRC1 mRNA	PMID:24280081
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of RSRC1 mRNA	PMID:24280081
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1602488	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of RSRC1 mRNA	PMID:19561079
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RSRC1 mRNA	PMID:30912803
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551518	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RSRC1 mRNA	PMID:21570461
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RSRC1 mRNA	PMID:33212167
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RSRC1 mRNA	PMID:28959563
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:D001205	[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in decreased expression of RSRC1 mRNA]; [Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [sodium arsenite results in decreased expression of RSRC1 mRNA]	PMID:37704839|PMID:39325335
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of RSRC1 mRNA	PMID:37704839|PMID:39325335
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in decreased expression of RSRC1 mRNA]; [Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [sodium arsenite results in decreased expression of RSRC1 mRNA]	PMID:37704839|PMID:39325335
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RSRC1 mRNA	PMID:19770486|PMID:21715664
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RSRC1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RSRC1 mRNA	PMID:19073995
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RSRC1 mRNA	PMID:26238291
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RSRC1 mRNA	PMID:25729387
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RSRC1 mRNA	PMID:30047161
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551518	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RSRC1 gene	PMID:35295148
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1551518	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of RSRC1 mRNA	PMID:23557971
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RSRC1 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RSRC1 mRNA	PMID:33221593
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1602488	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RSRC1 gene	PMID:31601247
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551518	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of RSRC1 mRNA	PMID:40036665
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602488	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of RSRC1 mRNA	PMID:36232920
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of RSRC1 mRNA	PMID:31129395
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1602488	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RSRC1 gene	PMID:31601247
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551518	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RSRC1 mRNA	PMID:39298647
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602488	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RSRC1 mRNA	PMID:37042841
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of RSRC1 gene	PMID:22079235
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1602488	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of RSRC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of RSRC1 mRNA	PMID:32699268
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RSRC1 mRNA	PMID:28302478
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1602488	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RSRC1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of RSRC1 mRNA	PMID:19167446
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RSRC1 mRNA	PMID:23179753
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RSRC1 mRNA	PMID:30047161
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of RSRC1 mRNA	PMID:19770486
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1602488	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RSRC1 mRNA	PMID:25562108
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of RSRC1 mRNA	PMID:28973697
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551518	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RSRC1 mRNA	PMID:17562736
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of RSRC1 mRNA	PMID:20977926
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:47807	sulforaphane	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:C016766	[sulforaphane co-treated with Aflatoxin B1] affects the expression of RSRC1 mRNA	PMID:25450479
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of RSRC1 mRNA	PMID:32234424
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1602488	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of RSRC1 mRNA	PMID:23228038
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RSRC1 mRNA	PMID:30047161
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RSRC1 mRNA	PMID:25729387
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551518	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RSRC1 mRNA	PMID:22206623
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:7719	ochratoxin A	increases methylation	EXP		E	RGD:6480464	20160210	CTD	MESH:C025589	ochratoxin A results in increased methylation of RSRC1 gene	PMID:26431795
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:8107	phenytoin	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in decreased expression of RSRC1 mRNA	PMID:20345932
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1602488	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RSRC1 mRNA	PMID:19167446
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1602488	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of RSRC1 mRNA	PMID:32234424
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RSRC1 mRNA	PMID:24780913
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RSRC1 mRNA	PMID:30047161
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RSRC1 mRNA	PMID:21346803
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1602488	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of RSRC1 mRNA	PMID:17440010
1304968	Rsrc1	arginine and serine rich coiled-coil 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RSRC1 mRNA	PMID:21346803
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621515	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EEF2KMT mRNA	PMID:33045310
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603258	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of EEF2KMT mRNA	PMID:23724009|PMID:33167477
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1621515	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of EEF2KMT mRNA	PMID:36331819
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1621515	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EEF2KMT mRNA	PMID:39241906
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603258	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of EEF2KMT mRNA	PMID:31614463
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1621515	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EEF2KMT mRNA	PMID:39298647
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1603258	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of EEF2KMT mRNA	PMID:38568856
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603258	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EEF2KMT mRNA	PMID:37042841
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EEF2KMT mRNA	PMID:33387578
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1603258	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EEF2KMT mRNA	PMID:28818685
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1621515	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EEF2KMT mRNA	PMID:36331819
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1603258	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of EEF2KMT mRNA	PMID:19549813
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EEF2KMT mRNA	PMID:31150632
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in increased expression of EEF2KMT mRNA	PMID:38314887
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EEF2KMT mRNA	PMID:33387578
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1621515	E	RGD:6480464	20150127	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to EEF2KMT promoter]	PMID:19654925
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1603258	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of EEF2KMT mRNA	PMID:20971185
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603258	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of EEF2KMT mRNA	PMID:38568856
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603258	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of EEF2KMT mRNA	PMID:21457566
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603258	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EEF2KMT exon; Benzo(a)pyrene results in increased methylation of EEF2KMT promoter	PMID:27901495
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1603258	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of EEF2KMT mRNA	PMID:20971185
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1603258	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of EEF2KMT mRNA	PMID:25895662
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621515	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EEF2KMT gene	PMID:35295148
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of EEF2KMT mRNA	PMID:34492290
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of EEF2KMT mRNA	PMID:34947998
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1603258	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased methylation of EEF2KMT gene	PMID:22576693
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1603258	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased expression of EEF2KMT mRNA	PMID:22576693
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1621515	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of EEF2KMT gene	PMID:31683443
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621515	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of EEF2KMT mRNA	PMID:40203079
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603258	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EEF2KMT mRNA	PMID:37042841
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1603258	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of EEF2KMT mRNA	PMID:29024780
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of EEF2KMT mRNA	PMID:17616710
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1603258	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of EEF2KMT mRNA	PMID:38174414|PMID:38382870
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of EEF2KMT promoter	PMID:22457795
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1603258	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EEF2KMT mRNA	PMID:32588087
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1603258	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of EEF2KMT mRNA	PMID:28302478
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621515	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EEF2KMT mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of EEF2KMT mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of EEF2KMT mRNA	PMID:36331819
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603258	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EEF2KMT mRNA	PMID:23179753
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of EEF2KMT mRNA	PMID:29391264
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1621515	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EEF2KMT mRNA	PMID:22206623
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1603258	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of EEF2KMT mRNA	PMID:24921660
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1603258	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EEF2KMT mRNA	PMID:38568856
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1603258	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of EEF2KMT mRNA	PMID:29301935
1304969	Eef2kmt	eukaryotic elongation factor 2 lysine methyltransferase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1621515	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of EEF2KMT mRNA	PMID:35537566
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of STIL mRNA	PMID:38218311
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312721	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of STIL mRNA	PMID:33045310
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of STIL mRNA	PMID:33167477
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of STIL mRNA	PMID:26516004
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312720	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of STIL mRNA	PMID:24763279
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of STIL mRNA	PMID:21632981
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312721	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of STIL mRNA	PMID:39241906
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312720	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of STIL mRNA	PMID:19167446|PMID:20106945
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312721	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of STIL mRNA	PMID:25210133
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of STIL mRNA	PMID:26496021
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of STIL mRNA]	PMID:25210133
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA	PMID:25510870
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of STIL mRNA	PMID:20655997
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of STIL mRNA	PMID:21592394
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312720	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of STIL mRNA	PMID:21592394
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:176335	SP2509	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20210706	CTD	MESH:C000594309	SP2509 results in decreased expression of STIL mRNA	PMID:29581250
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of STIL mRNA	PMID:21592394
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312720	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of STIL mRNA	PMID:21592394
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312720	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of STIL mRNA	PMID:28818685
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of STIL mRNA	PMID:37748715
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of STIL mRNA	PMID:36331819
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA	PMID:25510870
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA	PMID:25510870
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312720	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of STIL protein	PMID:20106945
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312720	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of STIL mRNA	PMID:23649840
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of STIL mRNA	PMID:25102026
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of STIL mRNA	PMID:24336422
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312721	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of STIL mRNA	PMID:33026818
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of STIL mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of STIL mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of STIL mRNA	PMID:25658374|PMID:34911549
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312721	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of STIL mRNA	PMID:31919559
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of STIL mRNA	PMID:25629700
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of STIL mRNA	PMID:15767336
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312720	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of STIL mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of STIL mRNA	PMID:19167446|PMID:23557933
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of STIL mRNA	PMID:30912803
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312720	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STIL mRNA	PMID:22574217
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STIL mRNA	PMID:32109520
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STIL mRNA	PMID:20106945|PMID:21632981|PMID:21802500
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of STIL mRNA	PMID:33212167
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of STIL mRNA	PMID:22623647
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of STIL mRNA	PMID:17998272
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312720	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STIL intron; Benzo(a)pyrene affects the methylation of STIL promoter	PMID:30157460
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STIL mRNA	PMID:21802500
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312720	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STIL mRNA	PMID:32234424
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312721	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STIL mRNA	PMID:32417428
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312720	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to STIL mRNA]	PMID:32406909
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312721	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of STIL mRNA	PMID:29341224
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of STIL mRNA	PMID:20382639
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of STIL mRNA	PMID:35295148
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312721	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STIL gene; titanium dioxide results in decreased methylation of STIL promoter	PMID:35295148
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312721	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of STIL mRNA	PMID:23557971
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of STIL mRNA	PMID:20813756
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312721	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of STIL mRNA	PMID:20059764
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of STIL mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of STIL mRNA]	PMID:19710929|PMID:20059764
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312720	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of STIL mRNA	PMID:38479592
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STIL mRNA	PMID:25181051
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of STIL mRNA	PMID:29275510
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of STIL mRNA	PMID:32145629
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312720	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of STIL gene	PMID:31601247
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STIL mRNA; [bisphenol A co-treated with Estradiol] results in increased expression of STIL mRNA	PMID:26496021|PMID:36041667
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA	PMID:25510870
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA	PMID:25510870
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of STIL mRNA	PMID:40203079
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STIL mRNA	PMID:36041667
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STIL mRNA	PMID:36041667
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of STIL mRNA	PMID:30723492
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STIL mRNA	PMID:38174414
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312721	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of STIL mRNA	PMID:28962523
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of STIL mRNA	PMID:40194260
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312721	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of STIL mRNA	PMID:40194260
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of STIL mRNA	PMID:31533062
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312720	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of STIL mRNA	PMID:19167446
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312720	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STIL mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of STIL mRNA	PMID:19167446
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of STIL mRNA	PMID:39529242
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of STIL mRNA	PMID:40419075
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of STIL mRNA	PMID:36331819
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312721	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of STIL mRNA	PMID:23125180
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of STIL mRNA	PMID:20106945|PMID:21632981
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312720	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of STIL mRNA	PMID:38832940
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312720	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of STIL mRNA	PMID:22230336
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:47381	diclofenac	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D004008	Diclofenac results in increased expression of STIL mRNA	PMID:30723492
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in decreased expression of STIL mRNA	PMID:24383545
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:48981	quinolin-8-ol	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of STIL mRNA	PMID:21632981
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312721	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of STIL mRNA; Nanotubes, Carbon results in increased expression of STIL mRNA	PMID:25554681
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312721	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of STIL mRNA	PMID:19042947
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312721	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of STIL mRNA	PMID:38701926
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of STIL mRNA	PMID:37269647
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of STIL mRNA	PMID:36851058
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of STIL mRNA	PMID:35283115
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of STIL mRNA	PMID:29522793
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312720	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of STIL mRNA	PMID:37199045
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of STIL mRNA	PMID:34995734
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312720	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STIL mRNA	PMID:19167446
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of STIL mRNA	PMID:22869556
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of STIL mRNA	PMID:32419051
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312720	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of STIL mRNA	PMID:19140230
1304972	Stil	STIL, centriolar assembly protein	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of STIL mRNA	PMID:35537566
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MOSPD3 mRNA	PMID:38218311
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of MOSPD3 mRNA	PMID:35967413
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312723	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MOSPD3 mRNA	PMID:33045310
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MOSPD3 mRNA]	PMID:31150632
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:137392	chlormequat chloride	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of MOSPD3 protein	PMID:34958886
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MOSPD3 mRNA	PMID:20938992
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312722	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MOSPD3 mRNA	PMID:22378314
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of MOSPD3 mRNA	PMID:31614463
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of MOSPD3 gene	PMID:27618143
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MOSPD3 mRNA	PMID:20938992
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312722	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MOSPD3 mRNA	PMID:37042841
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MOSPD3 mRNA	PMID:36331819
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312722	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MOSPD3 mRNA	PMID:35430440
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MOSPD3 mRNA	PMID:31150632
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MOSPD3 mRNA]	PMID:31150632
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MOSPD3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MOSPD3 mRNA	PMID:20938992|PMID:22206623
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312722	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MOSPD3 mRNA	PMID:23557933
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312722	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MOSPD3 mRNA	PMID:27392435
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312723	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MOSPD3 mRNA	PMID:21570461
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of MOSPD3 mRNA	PMID:28374803
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MOSPD3 mRNA	PMID:38568856
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312722	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MOSPD3 promoter	PMID:27901495
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312723	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of MOSPD3 mRNA	PMID:27131904
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MOSPD3 mRNA	PMID:25895662
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of MOSPD3 mRNA	PMID:24136188
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312723	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MOSPD3 gene	PMID:35295148
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MOSPD3 mRNA	PMID:34492290
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of MOSPD3 mRNA	PMID:28329830
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MOSPD3 mRNA	PMID:25181051
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312723	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in decreased expression of MOSPD3 mRNA	PMID:21932408
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312722	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOSPD3 mRNA	PMID:28628672
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312723	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MOSPD3 mRNA	PMID:25172293
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312723	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MOSPD3 mRNA	PMID:38685157
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312723	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of MOSPD3 intron	PMID:28392331
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312723	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MOSPD3 mRNA	PMID:37019170
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MOSPD3 mRNA	PMID:21266533
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312723	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MOSPD3 mRNA	PMID:34813904
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312722	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOSPD3 mRNA	PMID:28628672
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312723	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of MOSPD3 mRNA	PMID:34813904
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312722	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MOSPD3 mRNA	PMID:37042841
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20121009	CTD	MESH:D019256	MT3 affects the reaction [Cadmium Chloride affects the expression of MOSPD3 mRNA]	PMID:20371981
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MOSPD3 mRNA	PMID:32588087
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MOSPD3 mRNA	PMID:31533062
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MOSPD3 mRNA	PMID:36331819
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312722	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MOSPD3 mRNA	PMID:25979313
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MOSPD3 mRNA	PMID:20106945
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312722	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOSPD3 mRNA	PMID:28628672
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312723	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MOSPD3 mRNA	PMID:17562736
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312723	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MOSPD3 mRNA	PMID:29279043
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of MOSPD3 mRNA	PMID:38568856
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312722	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOSPD3 mRNA	PMID:28628672
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MOSPD3 mRNA	PMID:35964746
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312723	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of MOSPD3 mRNA	PMID:23650126
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of MOSPD3 mRNA	PMID:24136188
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312723	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MOSPD3 mRNA	PMID:22206623
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MOSPD3 mRNA	PMID:22206623
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of MOSPD3 mRNA	PMID:24136188
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312723	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of MOSPD3 mRNA	PMID:27131904
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MOSPD3 mRNA	PMID:38568856
1304973	Mospd3	motile sperm domain containing 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312722	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MOSPD3 mRNA	PMID:29301935
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312725	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RAD52 mRNA	PMID:38218311
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of RAD52 mRNA	PMID:36841081
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAD52 mRNA	PMID:12057914|PMID:39241906
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RAD52 mRNA	PMID:33387578
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312725	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RAD52 mRNA	PMID:37042841
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20230502	CTD	MESH:D001554	Benzene results in decreased expression of RAD52 mRNA	PMID:35963423
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1312726	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of RAD52 mRNA	PMID:17945193
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RAD52 mRNA	PMID:39836092
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312725	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RAD52 mRNA	PMID:23649840
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312726	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RAD52 mRNA	PMID:19770486
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312725	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RAD52 gene	PMID:27153756
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312725	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RAD52 mRNA	PMID:19799994|PMID:23649840
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20240206	CTD	MESH:D009151	Mustard Gas results in decreased expression of RAD52 mRNA	PMID:19778212
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RAD52 mRNA	PMID:33387578
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:39836092
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312726	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:40504410
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RAD52 mRNA	PMID:28960355
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of RAD52 mRNA	PMID:33775663
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312726	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAD52 mRNA	PMID:21570461
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAD52 mRNA	PMID:33387578
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312725	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of RAD52 mRNA	PMID:29955902
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312726	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of RAD52 mRNA	PMID:39631538
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312725	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RAD52 gene	PMID:28589171
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312725	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAD52 mRNA	PMID:38568856
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:39836092
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312726	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:40504410
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RAD52 mRNA	PMID:20504355
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312726	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RAD52 mRNA	PMID:22228805
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312725	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RAD52 5' UTR; Benzo(a)pyrene results in increased methylation of RAD52 promoter	PMID:27901495
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RAD52 mRNA]	PMID:32406909
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RAD52 mRNA	PMID:19073995
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of RAD52 mRNA	PMID:15073043
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RAD52 mRNA	PMID:25729387
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RAD52 mRNA	PMID:30047161
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312726	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RAD52 mRNA	PMID:18648102
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312725	E	RGD:6480464	20220607	CTD	MESH:C006780	bisphenol A affects the methylation of RAD52 gene	PMID:33391824
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RAD52 mRNA	PMID:32156529
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAD52 mRNA	PMID:25181051
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312726	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RAD52 mRNA	PMID:26063408
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAD52 gene	PMID:28505145
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RAD52 mRNA	PMID:28628672
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RAD52 mRNA	PMID:38685157
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1312726	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of RAD52 mRNA	PMID:36464114
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RAD52 mRNA	PMID:21266533
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RAD52 mRNA	PMID:28628672
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of RAD52 mRNA	PMID:22110744
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:35019	tributyl phosphate	increases expression	ISO	RGD:1312726	E	RGD:6480464	20260303	CTD	MESH:C009524	tributyl phosphate results in increased expression of RAD52 mRNA	PMID:40389058
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312725	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAD52 mRNA	PMID:37042841
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	increases expression	ISO	RGD:1312726	E	RGD:6480464	20260303	CTD	MESH:C031324	tris(chloroethyl)phosphate results in increased expression of RAD52 mRNA	PMID:40389058
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RAD52 mRNA	PMID:39836092
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312725	E	RGD:6480464	20121113	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RAD52 mRNA	PMID:16269432
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C039281	furan results in decreased expression of RAD52 mRNA	PMID:22507866
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312725	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RAD52 mRNA	PMID:24449571
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of RAD52 mRNA	PMID:17585979
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312725	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RAD52 mRNA	PMID:24383497
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RAD52 mRNA	PMID:30047161
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1312725	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of RAD52 promoter	PMID:27989131
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RAD52 mRNA	PMID:28628672
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312726	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RAD52 mRNA	PMID:28973697
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312725	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RAD52 mRNA	PMID:38832940
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312726	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAD52 mRNA	PMID:17562736
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RAD52 mRNA	PMID:33387578
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:39836092
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312726	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:40504410
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1312725	E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of RAD52 mRNA; Etoposide results in increased expression of RAD52 protein	PMID:16417649|PMID:19799994
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20120412	CTD	MESH:D005047	BRCA1 protein mutant form inhibits the reaction [Etoposide results in increased expression of RAD52 protein]	PMID:16417649
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C005223	methyleugenol results in decreased expression of RAD52 mRNA	PMID:21659616
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RAD52 mRNA	PMID:28628672
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of RAD52 mRNA	PMID:15073043
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RAD52 mRNA	PMID:30047161
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312725	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RAD52 mRNA	PMID:39836092
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RAD52 mRNA	PMID:25729387
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312726	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of RAD52 mRNA	PMID:20003209
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of RAD52 mRNA	PMID:19564919
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1312726	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of RAD52 mRNA	PMID:36464114
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312726	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RAD52 mRNA	PMID:22206623
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312725	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RAD52 mRNA	PMID:37199045
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of RAD52 mRNA	PMID:19162173
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312726	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RAD52 mRNA	PMID:30294300
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of RAD52 mRNA	PMID:30047161
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RAD52 mRNA	PMID:30047161
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RAD52 mRNA	PMID:19281266
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RAD52 mRNA	PMID:21346803
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RAD52 mRNA	PMID:28973697
1304975	Rad52	RAD52 DNA repair protein	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of RAD52 mRNA	PMID:23869203
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614770	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CIMAP1C mRNA	PMID:33045310
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1348133	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CIMAP1C mRNA	PMID:26079696
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1348133	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CIMAP1C mRNA	PMID:35811015
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614770	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA	PMID:37567420
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614770	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA	PMID:37567420
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1348133	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CIMAP1C mRNA	PMID:23649840
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1348133	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CIMAP1C exon	PMID:30157460
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1348133	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CIMAP1C mRNA	PMID:21641981|PMID:22100608
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1348133	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CIMAP1C gene	PMID:27153756
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1348133	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CIMAP1C mRNA	PMID:23649840
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1348133	E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of CIMAP1C mRNA	PMID:33656867
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1348133	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CIMAP1C mRNA	PMID:23557933
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1348133	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of CIMAP1C mRNA	PMID:19921347
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1348133	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CIMAP1C mRNA	PMID:27392435
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1348133	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CIMAP1C mRNA	PMID:27392435
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614770	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA	PMID:37567420
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1614770	E	RGD:6480464	20231031	CTD	MESH:D015084	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA	PMID:37567420
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:29191	hydroxyl	multiple interactions	ISO	RGD:1348133	E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of CIMAP1C mRNA	PMID:33656867
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1348133	E	RGD:6480464	20230801	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CIMAP1C mRNA	PMID:35870112
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1614770	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CIMAP1C mRNA	PMID:22228805
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1348133	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CIMAP1C promoter	PMID:27901495
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1614770	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CIMAP1C exon	PMID:27901495
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1614770	E	RGD:6480464	20120515	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CIMAP1C mRNA]; Benzo(a)pyrene promotes the reaction [AHR protein binds to CIMAP1C promoter]	PMID:19654925|PMID:22228805
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CIMAP1C mRNA	PMID:25181051
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:3764	clotrimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of CIMAP1C mRNA	PMID:30047161
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1348133	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CIMAP1C gene	PMID:29154799
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CIMAP1C mRNA	PMID:30047161
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614770	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA	PMID:37567420
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1348133	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of CIMAP1C mRNA	PMID:23649840
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1348133	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CIMAP1C mRNA	PMID:38832940
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:4610	dimethylselenide	multiple interactions	ISO	RGD:1348133	E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of CIMAP1C mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of CIMAP1C mRNA	PMID:33656867
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1348133	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CIMAP1C mRNA	PMID:35811015
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1614770	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA	PMID:37567420
1304976	Cimap1c	ciliary microtubule associated protein 1C	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348133	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CIMAP1C gene]	PMID:28238834
1304977	Nup214	nucleoporin 214	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1316779	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of NUP214 protein	PMID:39638853
1304977	Nup214	nucleoporin 214	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622085	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NUP214 mRNA	PMID:33045310
1304977	Nup214	nucleoporin 214	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1622085	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of NUP214 mRNA	PMID:37995155
1304977	Nup214	nucleoporin 214	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of NUP214 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of NUP214 mRNA	PMID:32699268
1304977	Nup214	nucleoporin 214	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1622085	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NUP214 mRNA	PMID:36331819
1304977	Nup214	nucleoporin 214	gene	CHEBI:15948	lycopene	decreases expression	ISO	RGD:1316779	E	RGD:6480464	20120412	CTD	MESH:C015329	lycopene results in decreased expression of NUP214 mRNA	PMID:16886892
1304977	Nup214	nucleoporin 214	gene	CHEBI:16243	quercetin	affects phosphorylation	ISO	RGD:1316779	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin affects the phosphorylation of NUP214 protein	PMID:35688186
1304977	Nup214	nucleoporin 214	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1622085	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NUP214 mRNA	PMID:39241906
1304977	Nup214	nucleoporin 214	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in increased expression of NUP214 protein	PMID:34122009
1304977	Nup214	nucleoporin 214	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1316779	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NUP214 protein	PMID:37730182
1304977	Nup214	nucleoporin 214	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20120412	CTD	MESH:D014284	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of NUP214 mRNA	PMID:14761676
1304977	Nup214	nucleoporin 214	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUP214 mRNA	PMID:35301059
1304977	Nup214	nucleoporin 214	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1622085	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUP214 mRNA	PMID:37236586
1304977	Nup214	nucleoporin 214	gene	CHEBI:234430	gardiquimod	decreases expression	ISO	RGD:1316779	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in decreased expression of NUP214 mRNA	PMID:28003376
1304977	Nup214	nucleoporin 214	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of NUP214 mRNA]	PMID:28003376
1304977	Nup214	nucleoporin 214	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP214 protein	PMID:23301498
1304977	Nup214	nucleoporin 214	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1622085	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NUP214 mRNA	PMID:19770486
1304977	Nup214	nucleoporin 214	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1316779	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NUP214 intron	PMID:30157460
1304977	Nup214	nucleoporin 214	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of NUP214 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of NUP214 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of NUP214 mRNA	PMID:32699268
1304977	Nup214	nucleoporin 214	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1622085	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUP214 mRNA	PMID:40504410
1304977	Nup214	nucleoporin 214	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NUP214 protein	PMID:38460933
1304977	Nup214	nucleoporin 214	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1316779	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of NUP214 protein	PMID:35688186
1304977	Nup214	nucleoporin 214	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1622085	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of NUP214 protein	PMID:36173347
1304977	Nup214	nucleoporin 214	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1622085	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of NUP214 mRNA	PMID:30912803
1304977	Nup214	nucleoporin 214	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1316779	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NUP214 mRNA	PMID:24768652|PMID:25583101
1304977	Nup214	nucleoporin 214	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in increased expression of NUP214 mRNA	PMID:31734292
1304977	Nup214	nucleoporin 214	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUP214 mRNA	PMID:22298810
1304977	Nup214	nucleoporin 214	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20120412	CTD	MESH:D013749	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of NUP214 mRNA	PMID:14761676
1304977	Nup214	nucleoporin 214	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUP214 mRNA	PMID:20971185
1304977	Nup214	nucleoporin 214	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1316779	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NUP214 mRNA	PMID:29803840
1304977	Nup214	nucleoporin 214	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1316779	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of NUP214 protein	PMID:35688186
1304977	Nup214	nucleoporin 214	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1622085	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUP214 mRNA	PMID:40504410
1304977	Nup214	nucleoporin 214	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1316779	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NUP214 3' UTR; Benzo(a)pyrene affects the methylation of NUP214 promoter	PMID:27901495|PMID:30157460
1304977	Nup214	nucleoporin 214	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUP214 mRNA	PMID:20971185
1304977	Nup214	nucleoporin 214	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1316779	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP214 mRNA	PMID:19150397
1304977	Nup214	nucleoporin 214	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622085	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NUP214 gene	PMID:35295148
1304977	Nup214	nucleoporin 214	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NUP214 mRNA	PMID:19710929
1304977	Nup214	nucleoporin 214	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1316779	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of NUP214 protein	PMID:37567409
1304977	Nup214	nucleoporin 214	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of NUP214 mRNA	PMID:29097150|PMID:30816183
1304977	Nup214	nucleoporin 214	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1316779	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of NUP214 mRNA	PMID:25979313
1304977	Nup214	nucleoporin 214	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1622085	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of NUP214 mRNA	PMID:39298647
1304977	Nup214	nucleoporin 214	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1622085	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NUP214 mRNA	PMID:37019170
1304977	Nup214	nucleoporin 214	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1316779	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NUP214 mRNA	PMID:37042841
1304977	Nup214	nucleoporin 214	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1316779	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NUP214 protein	PMID:24527689
1304977	Nup214	nucleoporin 214	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUP214 mRNA	PMID:35301059
1304977	Nup214	nucleoporin 214	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1622085	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUP214 mRNA	PMID:37236586
1304977	Nup214	nucleoporin 214	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of NUP214 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of NUP214 mRNA	PMID:32699268
1304977	Nup214	nucleoporin 214	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of NUP214 mRNA]	PMID:28003376
1304977	Nup214	nucleoporin 214	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1316779	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of NUP214 mRNA	PMID:28302478
1304977	Nup214	nucleoporin 214	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1622085	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NUP214 mRNA	PMID:36331819
1304977	Nup214	nucleoporin 214	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of NUP214 mRNA	PMID:29427782
1304977	Nup214	nucleoporin 214	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1316779	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of NUP214 mRNA	PMID:25562108
1304977	Nup214	nucleoporin 214	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of NUP214 mRNA	PMID:36653537
1304977	Nup214	nucleoporin 214	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622085	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NUP214 mRNA	PMID:17562736
1304977	Nup214	nucleoporin 214	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NUP214 mRNA	PMID:33387578
1304977	Nup214	nucleoporin 214	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1316779	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NUP214 mRNA	PMID:22230336
1304977	Nup214	nucleoporin 214	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NUP214 protein	PMID:38460933
1304977	Nup214	nucleoporin 214	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1622085	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUP214 mRNA	PMID:40504410
1304977	Nup214	nucleoporin 214	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in decreased expression of NUP214 mRNA	PMID:36653537
1304977	Nup214	nucleoporin 214	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of NUP214 mRNA	PMID:30307764
1304977	Nup214	nucleoporin 214	gene	CHEBI:53001	nickel sulfate	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in increased expression of NUP214 mRNA	PMID:31734292
1304977	Nup214	nucleoporin 214	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1622085	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of NUP214 mRNA	PMID:23608068
1304977	Nup214	nucleoporin 214	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1316779	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NUP214 protein	PMID:32959892
1304977	Nup214	nucleoporin 214	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of NUP214 gene	PMID:35440735
1304977	Nup214	nucleoporin 214	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1316779	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in increased expression of NUP214 protein	PMID:34122009
1304977	Nup214	nucleoporin 214	gene	CHEBI:72544	flavonoids	increases expression	ISO	RGD:1316779	E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of NUP214 mRNA	PMID:15465739
1304977	Nup214	nucleoporin 214	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622085	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NUP214 mRNA	PMID:22206623
1304977	Nup214	nucleoporin 214	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1316779	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of NUP214 protein	PMID:31285264
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1604216	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of METTL15 mRNA	PMID:38218311
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1604216	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of METTL15 mRNA	PMID:22378314
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20130806	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of METTL15 protein	PMID:18951874
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of METTL15 mRNA	PMID:33387578
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of METTL15 gene	PMID:33872906
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of METTL15 gene	PMID:33872906
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of METTL15 mRNA	PMID:33387578
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1604216	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of METTL15 mRNA	PMID:28818685
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553712	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of METTL15 mRNA	PMID:36331819
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of METTL15 mRNA	PMID:39836092
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of METTL15 protein	PMID:34915118
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604216	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of METTL15 mRNA	PMID:19549813
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:24527	herbicide	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20220906	CTD	MESH:D006540	[Herbicides results in increased abundance of Picloram] which affects the methylation of METTL15 gene	PMID:34516295
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1553712	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of METTL15 mRNA	PMID:19770486
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1604216	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of METTL15 mRNA	PMID:27153756
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604216	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of METTL15 gene	PMID:27153756
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604216	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of METTL15 mRNA	PMID:23649840
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553712	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of METTL15 mRNA	PMID:34911549
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1553712	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of METTL15 mRNA	PMID:31919559
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of METTL15 mRNA	PMID:31150632
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553712	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of METTL15 mRNA	PMID:22206623
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of METTL15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of METTL15 mRNA	PMID:39836092
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of METTL15 mRNA	PMID:32109520
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of METTL15 mRNA	PMID:33387578
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20130806	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of METTL15 protein	PMID:18951874
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1604216	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of METTL15 protein	PMID:39603559
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1604216	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of METTL15 mRNA	PMID:33212167
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604216	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of METTL15 mRNA	PMID:29803840
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of METTL15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of METTL15 mRNA	PMID:39836092
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1553712	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of METTL15 mRNA	PMID:21715664
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553712	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of METTL15 mRNA	PMID:32417428
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604216	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of METTL15 5' UTR	PMID:27901495
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of METTL15 mRNA	PMID:34492290
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of METTL15 mRNA	PMID:25181051
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604216	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of METTL15 protein	PMID:33376534
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of METTL15 mRNA	PMID:27905518
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:34922	picloram	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20220906	CTD	MESH:D010846	[Herbicides results in increased abundance of Picloram] which affects the methylation of METTL15 gene	PMID:34516295
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604216	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of METTL15 mRNA	PMID:37042841
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of METTL15 mRNA	PMID:30589522
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of METTL15 mRNA	PMID:39836092
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1604216	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of METTL15 mRNA	PMID:27153767
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553712	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of METTL15 mRNA	PMID:36331819
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1604216	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of METTL15 gene	PMID:29154799
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604216	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of METTL15 mRNA	PMID:29154799
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553712	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of METTL15 mRNA	PMID:17562736
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of METTL15 mRNA	PMID:33387578
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of METTL15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of METTL15 mRNA	PMID:39836092
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20130806	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of METTL15 mRNA	PMID:22079256
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of METTL15 mRNA	PMID:39836092
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553712	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of METTL15 mRNA	PMID:22206623
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553712	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of METTL15 mRNA	PMID:22206623
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1604216	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of METTL15 mRNA	PMID:22079256
1304978	Mettl15	methyltransferase 15, mitochondrial 12S rRNA N4-cytidine	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1604216	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of METTL15 mRNA	PMID:22079256
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of USP8 mRNA	PMID:33045310
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of USP8 mRNA]	PMID:31150632
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of USP8 gene	PMID:20938992
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312731	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of USP8 mRNA	PMID:30319688
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of USP8 mRNA	PMID:39298647
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of USP8 gene	PMID:20938992
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312730	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of USP8 mRNA	PMID:37042841
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of USP8 mRNA	PMID:33754040
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312730	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of USP8 protein	PMID:37730182
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of USP8 protein	PMID:34915118
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:22689	bafilomycin A1	multiple interactions	ISO	RGD:1312730	E	RGD:6480464	20220906	CTD	MESH:C040929	[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein]; bafilomycin A1 promotes the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]	PMID:35022897
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of USP8 mRNA	PMID:28111341
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	ISO	RGD:1312730	E	RGD:6480464	20240409	CTD	MESH:C121565	pifithrin inhibits the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]; pifithrin inhibits the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased expression of BAX protein]; pifithrin inhibits the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased expression of BBC3 protein]; pifithrin inhibits the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased expression of CDKN1A protein]; pifithrin inhibits the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased expression of PMAIP1 protein]	PMID:35022897
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312730	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of USP8 mRNA	PMID:23649840
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312730	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of USP8 mRNA	PMID:41430723
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of USP8 mRNA	PMID:31150632
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of USP8 mRNA]	PMID:31150632
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of USP8 gene	PMID:20938992
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP8 mRNA	PMID:40504410
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312730	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of USP8 protein	PMID:35688186
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312730	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of USP8 mRNA	PMID:23557933
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of USP8 mRNA	PMID:30912803
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312731	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USP8 mRNA	PMID:21570461
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of USP8 mRNA	PMID:34747641
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312730	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of USP8 mRNA	PMID:30851411
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312730	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of USP8 mRNA	PMID:29803840
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312730	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of USP8 protein	PMID:35688186
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:29019	nonanoic acid	increases expression	ISO	RGD:1312731	E	RGD:6480464	20120412	CTD	MESH:C008776	pelargonic acid results in increased expression of USP8 mRNA	PMID:11379042
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312730	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of USP8 mRNA	PMID:12016162|PMID:38568856
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP8 mRNA	PMID:40504410
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312730	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USP8 mRNA	PMID:17879257
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312731	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USP8 gene	PMID:35295148
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312731	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of USP8 promoter	PMID:27334623
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of USP8 mRNA	PMID:33221593
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of USP8 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312730	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of USP8 mRNA	PMID:28628672
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312730	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of USP8 mRNA	PMID:28628672
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of USP8 mRNA	PMID:28111341
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1312730	E	RGD:6480464	20220906	CTD	MESH:D002738	[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] promotes the reaction [Chloroquine results in increased cleavage of PARP1 protein]; Chloroquine promotes the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]	PMID:35022897
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312730	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of USP8 mRNA	PMID:28302478
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312730	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of USP8 mRNA	PMID:25979313
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312731	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of USP8 mRNA	PMID:17555576
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312730	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of USP8 mRNA	PMID:28628672
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312731	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of USP8 mRNA	PMID:17562736
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of USP8 mRNA	PMID:33387578
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP8 mRNA	PMID:40504410
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312731	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of USP8 mRNA	PMID:17555576
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312730	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of USP8 mRNA	PMID:28628672
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of USP8 mRNA	PMID:23537331
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:53556	toluene 2,4-diisocyanate	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20120412	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in decreased expression of USP8 mRNA	PMID:11379042
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of USP8 mRNA	PMID:23650126
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of USP8 mRNA	PMID:30467583
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of USP8 mRNA	PMID:22206623
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312730	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of USP8 mRNA	PMID:30851411
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of USP8 mRNA	PMID:21795629
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312731	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of USP8 mRNA	PMID:21795629
1304979	Usp8	ubiquitin specific peptidase 8	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of USP8 mRNA	PMID:33269387
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312732	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MAPKAPK3 mRNA	PMID:38218311
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:132098	methoxyacetic acid	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid affects the expression of MAPKAPK3 mRNA	PMID:20864626
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1312732	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of MAPKAPK3 mRNA	PMID:15928584
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312732	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MAPKAPK3 mRNA	PMID:33167477
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MAPKAPK3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MAPKAPK3 mRNA	PMID:32699268
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAPKAPK3 mRNA	PMID:36331819
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MAPKAPK3 mRNA	PMID:39241906
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20161228	CTD	MESH:D008070	MAPKAPK3 protein affects the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA]; MAPKAPK3 protein affects the reaction [MAPKAPK2 protein affects the reaction [Lipopolysaccharides affects the localization of RELA protein]]; MAPKAPK3 protein affects the reaction [MAPKAPK2 protein affects the reaction [Lipopolysaccharides results in increased activity of STAT3 protein]]; MAPKAPK3 protein affects the reaction [MAPKAPK2 protein affects the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]]	PMID:21586572
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312732	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MAPKAPK3 mRNA	PMID:38568856
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20200804	CTD	MESH:D002635	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650|PMID:33819548
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAPKAPK3 mRNA	PMID:37992649
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MAPKAPK3 mRNA	PMID:22401849
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of MAPKAPK3 mRNA	PMID:22967744
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAPKAPK3 mRNA	PMID:37992649
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20200804	CTD	MESH:D006000	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650|PMID:33819548
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MAPKAPK3 mRNA	PMID:34319233
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MAPKAPK3 mRNA	PMID:33387578
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312732	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MAPKAPK3 mRNA	PMID:28818685
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of MAPKAPK3 mRNA	PMID:24067728
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of MAPKAPK3 mRNA	PMID:21396975
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA]	PMID:22129741
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312732	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MAPKAPK3 mRNA	PMID:22100608
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552084	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MAPKAPK3 mRNA	PMID:19770486
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MAPKAPK3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MAPKAPK3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of MAPKAPK3 mRNA	PMID:32699268
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552084	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAPKAPK3 mRNA	PMID:31919559
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MAPKAPK3 mRNA	PMID:25629700
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20200804	CTD	MESH:D006002	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650|PMID:33819548
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1552084	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of MAPKAPK3 mRNA	PMID:25270620
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAPKAPK3 mRNA	PMID:40504410
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27641	cycloheximide	affects response to substance	ISO	RGD:1312732	E	RGD:6480464	20150609	CTD	MESH:D003513	MAPKAPK3 gene SNP affects the susceptibility to Cycloheximide	PMID:25622337
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27698	vanadium atom	increases expression	ISO	RGD:1312732	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of MAPKAPK3 mRNA	PMID:19000753
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312732	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MAPKAPK3 protein	PMID:35688186
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of MAPKAPK3 gene	PMID:35440735
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312732	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of MAPKAPK3 mRNA	PMID:27392435
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552084	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in increased expression of MAPKAPK3 mRNA	PMID:25270620
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MAPKAPK3 mRNA	PMID:27392435
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312732	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MAPKAPK3 mRNA	PMID:25583101
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552084	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAPKAPK3 mRNA	PMID:21570461
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAPKAPK3 mRNA	PMID:21215274
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAPKAPK3 mRNA	PMID:32109520|PMID:33387578
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of MAPKAPK3 mRNA	PMID:19013527
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312732	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MAPKAPK3 mRNA	PMID:28001369
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312732	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MAPKAPK3 mRNA	PMID:33212167
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312732	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MAPKAPK3 mRNA	PMID:32763439
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MAPKAPK3 mRNA	PMID:30911355
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of MAPKAPK3 mRNA	PMID:39631538
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAPKAPK3 mRNA	PMID:37992649
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20200804	CTD	MESH:D003840	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650|PMID:33819548
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA]	PMID:22129741
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312732	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MAPKAPK3 mRNA	PMID:12760830|PMID:38568856
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MAPKAPK3 mRNA	PMID:37682722
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:29678	sodium arsenite	increases activity	ISO	RGD:1312732	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased activity of MAPKAPK3 protein	PMID:12547826
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20161228	CTD	MESH:C017947	SB 203580 inhibits the reaction [sodium arsenite results in increased activity of MAPKAPK3 protein]	PMID:12547826
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAPKAPK3 mRNA	PMID:40504410
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAPKAPK3 mRNA	PMID:22228805
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312732	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAPKAPK3 mRNA	PMID:32234424
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552084	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAPKAPK3 mRNA	PMID:19770486
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of MAPKAPK3 protein	PMID:37955338
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MAPKAPK3 mRNA	PMID:30911355
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:31243	atazanavir sulfate	increases expression	ISO	RGD:1312732	E	RGD:6480464	20200804	CTD	MESH:D000069446	Atazanavir Sulfate results in increased expression of MAPKAPK3 mRNA	PMID:32152650
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20200804	CTD	MESH:D000069446	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of MAPKAPK3 gene	PMID:31601247
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of MAPKAPK3 mRNA	PMID:32479839
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552084	E	RGD:6480464	20180515	CTD	MESH:C009495	titanium dioxide results in increased expression of MAPKAPK3 mRNA	PMID:29128614|PMID:29264374
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MAPKAPK3 mRNA	PMID:34492290
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of MAPKAPK3 mRNA	PMID:19167457
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MAPKAPK3 mRNA	PMID:25181051|PMID:30816183
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312732	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of MAPKAPK3 mRNA	PMID:29275510
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MAPKAPK3 mRNA	PMID:23196670
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312732	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MAPKAPK3 gene	PMID:31601247
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552084	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of MAPKAPK3 exon	PMID:33297965
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of MAPKAPK3 gene	PMID:31601247
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAPKAPK3 mRNA	PMID:17602206
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312732	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of MAPKAPK3 gene	PMID:22964155
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MAPKAPK3 mRNA	PMID:21266533
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAPKAPK3 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA]	PMID:17602206|PMID:22129741
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MAPKAPK3 mRNA	PMID:32680482
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312732	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MAPKAPK3 mRNA	PMID:37042841
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:35170	vanadium(0)	increases expression	ISO	RGD:1312732	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of MAPKAPK3 mRNA	PMID:19000753
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312732	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MAPKAPK3 mRNA	PMID:24449571
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20200804	CTD	MESH:D005999	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650|PMID:33819548
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MAPKAPK3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MAPKAPK3 mRNA	PMID:32699268
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MAPKAPK3 mRNA	PMID:39529242
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAPKAPK3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MAPKAPK3 mRNA	PMID:36331819
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1552084	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of MAPKAPK3 mRNA	PMID:31558096
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312732	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAPKAPK3 mRNA	PMID:25979313
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312732	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MAPKAPK3 mRNA	PMID:19101580|PMID:23179753
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312732	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MAPKAPK3 mRNA	PMID:20106945|PMID:32152650|PMID:34681664
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1552084	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of MAPKAPK3 mRNA	PMID:19770486
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAPKAPK3 mRNA	PMID:37992649
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552084	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAPKAPK3 mRNA	PMID:17562736
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAPKAPK3 mRNA	PMID:33387578
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312732	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAPKAPK3 mRNA	PMID:21420995
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20211012	CTD	MESH:D000082	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA	PMID:33819548
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312732	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of MAPKAPK3 mRNA	PMID:24714768
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAPKAPK3 mRNA	PMID:40504410
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1552084	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of MAPKAPK3 mRNA	PMID:26934552
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of MAPKAPK3 mRNA	PMID:29391264
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MAPKAPK3 mRNA	PMID:15576828
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1552084	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of MAPKAPK3 mRNA	PMID:25270620
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MAPKAPK3 mRNA	PMID:25620056
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:5130	flurbiprofen	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20120412	CTD	MESH:D005480	MAPKAPK3 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]	PMID:18056468
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312732	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of MAPKAPK3 mRNA	PMID:18651567
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312732	E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in increased expression of MAPKAPK3 mRNA	PMID:11678601
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20120412	CTD	MESH:D007052	MAPKAPK3 protein promotes the reaction [Ibuprofen results in increased expression of NGFR protein]	PMID:18056468
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312732	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MAPKAPK3 mRNA	PMID:31758290
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MAPKAPK3 mRNA	PMID:22206623
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1312732	E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in increased expression of MAPKAPK3 mRNA	PMID:32152650
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:7494	nefazodone	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MAPKAPK3 mRNA	PMID:27291303
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MAPKAPK3 mRNA	PMID:23640034
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1552084	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of MAPKAPK3 mRNA	PMID:27029645
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [sodium arsenite results in increased activity of MAPKAPK3 protein]	PMID:12547826
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MAPKAPK3 mRNA	PMID:19281266
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MAPKAPK3 mRNA	PMID:21346803
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:9405	tartrazine	multiple interactions	ISO	RGD:1312732	E	RGD:6480464	20211012	CTD	MESH:D013645	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA	PMID:33819548
1304980	Mapkapk3	MAPK activated protein kinase 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312732	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MAPKAPK3 mRNA	PMID:29301935
1304981	Lpxn	leupaxin	gene	CHEBI:10022	deoxynivalenol	decreases phosphorylation	ISO	RGD:1312735	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased phosphorylation of LPXN protein	PMID:23352502
1304981	Lpxn	leupaxin	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of LPXN mRNA	PMID:35967413
1304981	Lpxn	leupaxin	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LPXN mRNA	PMID:33045310
1304981	Lpxn	leupaxin	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in increased expression of LPXN mRNA	PMID:33227293
1304981	Lpxn	leupaxin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPXN mRNA	PMID:20938992
1304981	Lpxn	leupaxin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312734	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of LPXN mRNA	PMID:33167477
1304981	Lpxn	leupaxin	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of LPXN mRNA	PMID:22378314
1304981	Lpxn	leupaxin	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312734	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of LPXN mRNA	PMID:21632981
1304981	Lpxn	leupaxin	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312734	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of LPXN mRNA	PMID:29581250
1304981	Lpxn	leupaxin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LPXN mRNA	PMID:39241906
1304981	Lpxn	leupaxin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LPXN mRNA]	PMID:39241906
1304981	Lpxn	leupaxin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of LPXN mRNA	PMID:31614463
1304981	Lpxn	leupaxin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of LPXN mRNA	PMID:30165855
1304981	Lpxn	leupaxin	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LPXN mRNA	PMID:33387578
1304981	Lpxn	leupaxin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPXN mRNA	PMID:20938992
1304981	Lpxn	leupaxin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312734	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LPXN mRNA	PMID:37042841
1304981	Lpxn	leupaxin	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312734	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of LPXN mRNA	PMID:19162166
1304981	Lpxn	leupaxin	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312734	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of LPXN mRNA	PMID:23649840
1304981	Lpxn	leupaxin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LPXN mRNA	PMID:37992649
1304981	Lpxn	leupaxin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LPXN mRNA	PMID:37992649
1304981	Lpxn	leupaxin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312735	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LPXN mRNA	PMID:34319233
1304981	Lpxn	leupaxin	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312734	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of LPXN protein	PMID:37730182
1304981	Lpxn	leupaxin	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of LPXN mRNA	PMID:22061828|PMID:33387578
1304981	Lpxn	leupaxin	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312734	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LPXN mRNA	PMID:19549813
1304981	Lpxn	leupaxin	gene	CHEBI:234430	gardiquimod	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in decreased expression of LPXN mRNA	PMID:28003376
1304981	Lpxn	leupaxin	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of LPXN mRNA]	PMID:28003376
1304981	Lpxn	leupaxin	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312734	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of LPXN mRNA	PMID:23649840
1304981	Lpxn	leupaxin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312734	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LPXN mRNA	PMID:22100608|PMID:27153756
1304981	Lpxn	leupaxin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312735	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LPXN mRNA	PMID:19770486
1304981	Lpxn	leupaxin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312734	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of LPXN mRNA	PMID:23649840
1304981	Lpxn	leupaxin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of LPXN mRNA	PMID:35430440
1304981	Lpxn	leupaxin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312735	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LPXN mRNA	PMID:27339419|PMID:31919559
1304981	Lpxn	leupaxin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPXN mRNA	PMID:20938992
1304981	Lpxn	leupaxin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of LPXN mRNA	PMID:40512198
1304981	Lpxn	leupaxin	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LPXN mRNA]	PMID:11007951
1304981	Lpxn	leupaxin	gene	CHEBI:27810	resorcinol	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of LPXN mRNA	PMID:22623647
1304981	Lpxn	leupaxin	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of LPXN mRNA	PMID:31881176
1304981	Lpxn	leupaxin	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of LPXN mRNA	PMID:19921347
1304981	Lpxn	leupaxin	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of LPXN mRNA	PMID:23195993
1304981	Lpxn	leupaxin	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312734	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LPXN mRNA	PMID:24768652|PMID:25583101
1304981	Lpxn	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312735	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LPXN mRNA	PMID:21570461
1304981	Lpxn	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LPXN mRNA	PMID:33387578|PMID:34747641
1304981	Lpxn	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312734	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LPXN mRNA	PMID:11007951|PMID:20106945|PMID:21632981
1304981	Lpxn	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312735	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LPXN mRNA	PMID:26290441
1304981	Lpxn	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20120412	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LPXN mRNA]	PMID:11007951
1304981	Lpxn	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LPXN mRNA	PMID:17942748
1304981	Lpxn	leupaxin	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LPXN mRNA	PMID:28001369
1304981	Lpxn	leupaxin	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312734	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LPXN mRNA	PMID:33212167
1304981	Lpxn	leupaxin	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312734	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LPXN mRNA	PMID:32763439
1304981	Lpxn	leupaxin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of LPXN mRNA	PMID:20971185
1304981	Lpxn	leupaxin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312735	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of LPXN mRNA	PMID:39631538
1304981	Lpxn	leupaxin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LPXN mRNA	PMID:37992649
1304981	Lpxn	leupaxin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312735	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of LPXN mRNA	PMID:39515575
1304981	Lpxn	leupaxin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312734	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of LPXN mRNA	PMID:22714537|PMID:38568856
1304981	Lpxn	leupaxin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of LPXN mRNA	PMID:40512198
1304981	Lpxn	leupaxin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA	PMID:34876320
1304981	Lpxn	leupaxin	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312734	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of LPXN mRNA	PMID:22378314
1304981	Lpxn	leupaxin	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA	PMID:34876320
1304981	Lpxn	leupaxin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312734	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LPXN mRNA	PMID:20106945|PMID:21632981|PMID:30453624
1304981	Lpxn	leupaxin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312735	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LPXN mRNA	PMID:22228805
1304981	Lpxn	leupaxin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312734	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LPXN 3' UTR	PMID:27901495
1304981	Lpxn	leupaxin	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of LPXN mRNA]	PMID:22228805
1304981	Lpxn	leupaxin	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312734	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of LPXN promoter	PMID:23974009
1304981	Lpxn	leupaxin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to LPXN mRNA]	PMID:32406909
1304981	Lpxn	leupaxin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of LPXN mRNA	PMID:20971185
1304981	Lpxn	leupaxin	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312735	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LPXN mRNA	PMID:27131904
1304981	Lpxn	leupaxin	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LPXN mRNA	PMID:29341224
1304981	Lpxn	leupaxin	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of LPXN mRNA	PMID:35984750
1304981	Lpxn	leupaxin	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1312735	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in increased expression of LPXN mRNA	PMID:30825431
1304981	Lpxn	leupaxin	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of LPXN mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of LPXN mRNA]	PMID:30825431
1304981	Lpxn	leupaxin	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312734	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of LPXN mRNA	PMID:38568856
1304981	Lpxn	leupaxin	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of LPXN mRNA	PMID:25729387
1304981	Lpxn	leupaxin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of LPXN mRNA	PMID:23557971|PMID:27760801
1304981	Lpxn	leupaxin	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LPXN mRNA	PMID:23411599|PMID:34492290
1304981	Lpxn	leupaxin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of LPXN mRNA	PMID:25380136
1304981	Lpxn	leupaxin	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LPXN mRNA	PMID:19710929
1304981	Lpxn	leupaxin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LPXN mRNA	PMID:25181051
1304981	Lpxn	leupaxin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LPXN mRNA	PMID:29275510
1304981	Lpxn	leupaxin	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LPXN mRNA	PMID:28628672
1304981	Lpxn	leupaxin	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LPXN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of LPXN mRNA	PMID:28628672
1304981	Lpxn	leupaxin	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LPXN mRNA]	PMID:39241906
1304981	Lpxn	leupaxin	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of LPXN mRNA	PMID:35163327
1304981	Lpxn	leupaxin	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312734	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LPXN mRNA	PMID:38174414|PMID:38568856
1304981	Lpxn	leupaxin	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of LPXN mRNA	PMID:27387713
1304981	Lpxn	leupaxin	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of LPXN mRNA	PMID:25380136
1304981	Lpxn	leupaxin	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LPXN mRNA	PMID:24449571
1304981	Lpxn	leupaxin	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of LPXN mRNA]	PMID:28003376
1304981	Lpxn	leupaxin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312735	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LPXN mRNA	PMID:40194260
1304981	Lpxn	leupaxin	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1312734	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of LPXN mRNA	PMID:26352163
1304981	Lpxn	leupaxin	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20171010	CTD	MESH:C100187	chloropicrin results in decreased expression of LPXN mRNA	PMID:28476498
1304981	Lpxn	leupaxin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312735	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LPXN mRNA	PMID:17292431
1304981	Lpxn	leupaxin	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LPXN mRNA	PMID:29154799
1304981	Lpxn	leupaxin	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LPXN mRNA	PMID:25562108|PMID:27989131
1304981	Lpxn	leupaxin	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LPXN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of LPXN mRNA	PMID:28628672
1304981	Lpxn	leupaxin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LPXN mRNA	PMID:37992649
1304981	Lpxn	leupaxin	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1312734	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of LPXN mRNA	PMID:23649840
1304981	Lpxn	leupaxin	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312734	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of LPXN mRNA	PMID:27188386
1304981	Lpxn	leupaxin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312735	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LPXN mRNA	PMID:17562736
1304981	Lpxn	leupaxin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of LPXN mRNA	PMID:21420995
1304981	Lpxn	leupaxin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LPXN mRNA	PMID:33387578
1304981	Lpxn	leupaxin	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1312734	E	RGD:6480464	20120412	CTD	MESH:D005472	LPXN protein affects the susceptibility to Fluorouracil	PMID:15548681
1304981	Lpxn	leupaxin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of LPXN mRNA	PMID:40512198
1304981	Lpxn	leupaxin	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LPXN mRNA	PMID:29391264
1304981	Lpxn	leupaxin	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA	PMID:34876320
1304981	Lpxn	leupaxin	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312734	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of LPXN mRNA	PMID:24383545
1304981	Lpxn	leupaxin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LPXN mRNA	PMID:17942748
1304981	Lpxn	leupaxin	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LPXN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of LPXN mRNA	PMID:28628672
1304981	Lpxn	leupaxin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312734	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of LPXN mRNA	PMID:19194470
1304981	Lpxn	leupaxin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312735	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LPXN mRNA; Nanotubes, Carbon results in increased expression of LPXN mRNA	PMID:25554681
1304981	Lpxn	leupaxin	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of LPXN mRNA	PMID:34044035
1304981	Lpxn	leupaxin	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312735	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of LPXN mRNA	PMID:19042947
1304981	Lpxn	leupaxin	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312734	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LPXN mRNA	PMID:31629900
1304981	Lpxn	leupaxin	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LPXN mRNA	PMID:38701926
1304981	Lpxn	leupaxin	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of LPXN mRNA	PMID:25729387
1304981	Lpxn	leupaxin	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of LPXN mRNA	PMID:19751817
1304981	Lpxn	leupaxin	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of LPXN mRNA	PMID:35283115
1304981	Lpxn	leupaxin	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of LPXN mRNA	PMID:19564919
1304981	Lpxn	leupaxin	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of LPXN mRNA]	PMID:30825431
1304981	Lpxn	leupaxin	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of LPXN mRNA	PMID:31758290
1304981	Lpxn	leupaxin	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312735	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LPXN mRNA	PMID:22206623
1304981	Lpxn	leupaxin	gene	CHEBI:748998	lenabasum	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260714	CTD	MESH:C471849	lenabasum inhibits the reaction [Bleomycin results in increased expression of LPXN mRNA]	PMID:30825431
1304981	Lpxn	leupaxin	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of LPXN mRNA	PMID:22714537
1304981	Lpxn	leupaxin	gene	CHEBI:753051	incobotulinumtoxina	affects expression	ISO	RGD:1312734	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA affects the expression of LPXN mRNA	PMID:29522793
1304981	Lpxn	leupaxin	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312734	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of LPXN mRNA	PMID:37199045
1304981	Lpxn	leupaxin	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of LPXN mRNA	PMID:21346803
1304981	Lpxn	leupaxin	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1312734	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of LPXN mRNA	PMID:19095052
1304981	Lpxn	leupaxin	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA	PMID:34876320
1304981	Lpxn	leupaxin	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LPXN mRNA]	PMID:39241906
1304981	Lpxn	leupaxin	gene	CHEBI:88249	PD 0325901	decreases expression	ISO	RGD:1312734	E	RGD:6480464	20170303	CTD	MESH:C506614	mirdametinib results in decreased expression of LPXN mRNA	PMID:25119042
1304981	Lpxn	leupaxin	gene	CHEBI:88249	PD 0325901	multiple interactions	ISO	RGD:1312734	E	RGD:6480464	20170303	CTD	MESH:C506614	[(+)-JQ1 compound co-treated with mirdametinib] results in decreased expression of LPXN mRNA	PMID:25119042
1304981	Lpxn	leupaxin	gene	CHEBI:8922	Rutecarpine	increases expression	ISO	RGD:1312734	E	RGD:6480464	20250114	CTD	MESH:C028632	rutecarpine results in increased expression of LPXN mRNA	PMID:34955744
1304981	Lpxn	leupaxin	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312735	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LPXN mRNA	PMID:27131904
1304981	Lpxn	leupaxin	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312734	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LPXN mRNA	PMID:38568856
1304981	Lpxn	leupaxin	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of LPXN mRNA	PMID:32835833
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:13439143	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CRYZL2P mRNA	PMID:38218311
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1621341	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CRYZL2 mRNA	PMID:39241906
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1621341	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CRYZL2 mRNA	PMID:39298647
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621341	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CRYZL2 mRNA	PMID:37992649
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621341	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CRYZL2 mRNA	PMID:37992649
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1621341	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CRYZL2 mRNA	PMID:36331819
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1621341	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CRYZL2 mRNA	PMID:34911549
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1621341	E	RGD:6480464	20220222	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CRYZL2 mRNA	PMID:31919559
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:13439143	E	RGD:6480464	20220222	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CRYZL2P mRNA	PMID:33212167
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1621341	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CRYZL2 mRNA	PMID:37992649
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:13439143	E	RGD:6480464	20220222	CTD	MESH:C017947	sodium arsenite results in increased expression of CRYZL2P mRNA	PMID:34032870
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1621341	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CRYZL2P mRNA	PMID:39716349
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1621341	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CRYZL2 mRNA	PMID:37019170
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621341	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CRYZL2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CRYZL2 mRNA	PMID:36331819
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621341	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CRYZL2 mRNA	PMID:37992649
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:13439143	E	RGD:6480464	20220222	CTD	MESH:D000082	Acetaminophen results in decreased expression of CRYZL2P mRNA	PMID:26690555
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1621341	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CRYZL2P mRNA	PMID:39716349
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:13439143	E	RGD:6480464	20220222	CTD	MESH:C082360	fipronil results in decreased expression of CRYZL2P mRNA	PMID:28991164
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:5063	fipronil	multiple interactions	ISO	RGD:13439143	E	RGD:6480464	20220222	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of CRYZL2P mRNA	PMID:28991164
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:13439143	E	RGD:6480464	20220222	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of CRYZL2P mRNA	PMID:28991164
1304982	Cryzl2	crystallin zeta like 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1621341	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of CRYZL2 mRNA	PMID:39847705
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312739	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SEC63 mRNA	PMID:33045310
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of SEC63 mRNA	PMID:16604517
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SEC63 mRNA	PMID:26079696
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312739	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SEC63 mRNA	PMID:30319688
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312739	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SEC63 mRNA	PMID:39241906
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312739	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SEC63 mRNA	PMID:39298647
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312738	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SEC63 mRNA	PMID:37042841
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SEC63 mRNA	PMID:23649840
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SEC63 mRNA	PMID:33848595
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SEC63 mRNA	PMID:33754040
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312738	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SEC63 protein	PMID:37730182
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SEC63 mRNA	PMID:36331819
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SEC63 mRNA	PMID:19549813
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312738	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SEC63 protein	PMID:23301498
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of SEC63 mRNA	PMID:19376150
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SEC63 mRNA	PMID:21641981
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SEC63 mRNA	PMID:19770486
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312738	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SEC63 mRNA	PMID:39836092
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312738	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SEC63 protein	PMID:35688186
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312738	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SEC63 mRNA	PMID:23557933
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312739	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEC63 mRNA	PMID:21570461
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SEC63 mRNA	PMID:18796159
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEC63 mRNA	PMID:17942748
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SEC63 mRNA	PMID:33212167
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SEC63 mRNA	PMID:28959563
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SEC63 mRNA	PMID:29803840
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312739	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SEC63 mRNA	PMID:39631538
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312738	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SEC63 mRNA	PMID:20044591
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of SEC63 mRNA	PMID:28595984|PMID:34032870
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312738	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEC63 mRNA	PMID:38568856
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312738	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SEC63 mRNA	PMID:39836092
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312738	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SEC63 mRNA; Tunicamycin results in increased expression of SEC63 protein	PMID:22378314|PMID:29453283
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SEC63 mRNA	PMID:19770486|PMID:20127859
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SEC63 mRNA	PMID:22228805
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:3048	benzatropine	increases expression	ISO	RGD:1312738	E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of SEC63 protein	PMID:34122009
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SEC63 mRNA	PMID:19073995
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of SEC63 mRNA	PMID:24136188
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312739	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SEC63 gene; titanium dioxide results in decreased methylation of SEC63 promoter	PMID:35295148
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312739	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of SEC63 mRNA	PMID:35295148
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SEC63 mRNA	PMID:34492290
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of SEC63 mRNA	PMID:21318169|PMID:23811191
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of SEC63 mRNA]	PMID:21318169
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC63 mRNA	PMID:34947998
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC63 protein	PMID:37567409
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC63 mRNA	PMID:33221593
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SEC63 mRNA	PMID:25181051
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312738	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SEC63 mRNA	PMID:28628672
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SEC63 mRNA	PMID:19244175
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312738	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SEC63 protein	PMID:34186270
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312739	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SEC63 mRNA	PMID:39298647
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312738	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SEC63 protein	PMID:34186270
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312738	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SEC63 protein	PMID:34186270
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SEC63 mRNA	PMID:18668222
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SEC63 mRNA	PMID:34813904
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312738	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SEC63 mRNA	PMID:28628672
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of SEC63 mRNA]	PMID:19030233
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312738	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEC63 mRNA	PMID:37042841
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of SEC63 mRNA	PMID:17585979
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1312738	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of SEC63 protein	PMID:34122009
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312738	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SEC63 mRNA	PMID:31533062
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SEC63 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SEC63 mRNA	PMID:36331819
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312738	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SEC63 mRNA	PMID:23179753
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SEC63 mRNA	PMID:21427059
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SEC63 mRNA	PMID:25562108
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312738	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of SEC63 mRNA	PMID:20106945|PMID:21632981|PMID:27989131
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312739	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of SEC63 mRNA	PMID:25270620
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SEC63 mRNA	PMID:17555576
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312738	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SEC63 mRNA	PMID:28628672
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of SEC63 mRNA	PMID:24136188
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20180116	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SEC63 mRNA	PMID:28939011
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312738	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SEC63 mRNA	PMID:39836092
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of SEC63 mRNA	PMID:31464424
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312738	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SEC63 mRNA	PMID:18175754
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SEC63 mRNA	PMID:17555576
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SEC63 mRNA	PMID:17942748
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEC63 mRNA	PMID:17942748
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of SEC63 mRNA	PMID:16984733
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312738	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SEC63 mRNA	PMID:28628672
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of SEC63 mRNA	PMID:21318169
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20120613	CTD	MESH:D011345	[PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of SEC63 mRNA	PMID:21318169
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312739	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of SEC63 mRNA	PMID:25554681
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312739	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SEC63 mRNA	PMID:25554681
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SEC63 mRNA	PMID:24136188
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:5613	haloperidol	increases expression	ISO	RGD:1312738	E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in increased expression of SEC63 protein	PMID:34122009
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:6030	isoniazide	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of SEC63 protein	PMID:40015660
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SEC63 protein	PMID:32959892
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SEC63 mRNA	PMID:23650126
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312738	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SEC63 protein	PMID:34186270
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312739	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SEC63 mRNA	PMID:22206623
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of SEC63 mRNA	PMID:24136188
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312738	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SEC63 mRNA	PMID:30928695
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312739	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SEC63 mRNA	PMID:23091169
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of SEC63 mRNA	PMID:30953684
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SEC63 mRNA	PMID:19281266
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SEC63 mRNA	PMID:21346803
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of SEC63 mRNA	PMID:24136188
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312738	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of SEC63 mRNA	PMID:22378314
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SEC63 mRNA	PMID:21346803
1304984	Sec63	SEC63 protein translocation regulator	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SEC63 mRNA	PMID:23034163
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312740	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NKX2-4 mRNA	PMID:36189433
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1343785	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NKX2-4 mRNA	PMID:26079696
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NKX2-4 mRNA	PMID:33387578
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312740	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NKX2-4 mRNA	PMID:36189433
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312740	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NKX2-4 mRNA	PMID:34319233
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1343785	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of NKX2-4 protein	PMID:37730182
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NKX2-4 mRNA	PMID:33387578
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1343785	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of NKX2-4 mRNA	PMID:24376830
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NKX2-4 mRNA	PMID:22129741
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1343785	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NKX2-4 gene	PMID:27153756
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312740	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NKX2-4 mRNA	PMID:24058054
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NKX2-4 mRNA	PMID:33387578
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1343785	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NKX2-4 promoter	PMID:27901495
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312740	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NKX2-4 gene	PMID:35295148
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312740	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of NKX2-4 promoter	PMID:27334623
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312740	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of NKX2-4 promoter	PMID:27312807
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312740	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NKX2-4 mRNA	PMID:32715474
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NKX2-4 mRNA	PMID:22129741
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1343785	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NKX2-4 gene	PMID:29154799
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NKX2-4 mRNA	PMID:33387578
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312740	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of NKX2-4 mRNA	PMID:23608068
1304985	Nkx2-4	NK2 homeobox 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312740	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NKX2-4 mRNA	PMID:22206623
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of WFDC5 mRNA	PMID:23829299
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312741	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of WFDC5 mRNA	PMID:23649840
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312741	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of WFDC5 mRNA	PMID:23649840
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312741	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of WFDC5 mRNA	PMID:21867686
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312741	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC5 mRNA	PMID:32525701
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312741	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of WFDC5 mRNA	PMID:38460933
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312741	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WFDC5 mRNA	PMID:30851411
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of WFDC5 mRNA	PMID:28959563
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550079	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of WFDC5 mRNA	PMID:37682722
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312741	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of WFDC5 promoter	PMID:27901495
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312741	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WFDC5 3' UTR	PMID:27901495
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312741	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of WFDC5 mRNA	PMID:25895662
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of WFDC5 mRNA	PMID:25181051
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of WFDC5 mRNA	PMID:41034487
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550079	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of WFDC5 3' UTR	PMID:28392331
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312741	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of WFDC5 mRNA	PMID:24714768
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312741	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of WFDC5 mRNA	PMID:38460933
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312741	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC5 mRNA	PMID:32525701
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of WFDC5 mRNA	PMID:30307764
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1550079	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of WFDC5 mRNA	PMID:22078008
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312741	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WFDC5 mRNA	PMID:30851411
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312741	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WFDC5 gene]	PMID:28238834
1304986	Wfdc5	WAP four-disulfide core domain 5	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312741	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC5 mRNA	PMID:32525701
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312744	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of WNT10B mRNA	PMID:25812627
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT10B mRNA	PMID:39752319
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312744	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of WNT10B mRNA	PMID:33167477
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:15640	5-formyltetrahydrofolic acid	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D002955	[Methotrexate co-treated with Leucovorin] results in increased expression of WNT10B mRNA	PMID:25187349
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312744	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of WNT10B mRNA	PMID:26079696
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of WNT10B gene	PMID:28931070
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312744	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of WNT10B mRNA	PMID:12437293|PMID:23019147|PMID:31614463
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312745	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of WNT10B mRNA	PMID:25210133
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of WNT10B mRNA]	PMID:25210133
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT10B mRNA	PMID:39752319
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:17351	linoleic acid	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20170303	CTD	MESH:D019787	Linoleic Acid results in decreased expression of WNT10B mRNA	PMID:12021203
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of WNT10B promoter	PMID:23359474
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of WNT10B mRNA	PMID:26577399
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WNT10B mRNA	PMID:36139627
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D001374	Azacitidine results in increased expression of WNT10B mRNA	PMID:27415467
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:2208	purine-6-thiol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of WNT10B mRNA	PMID:23358152
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT10B mRNA	PMID:35301059
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312744	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WNT10B mRNA	PMID:22100608
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in decreased expression of WNT10B mRNA	PMID:33026818
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of WNT10B mRNA	PMID:27106289
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20130122	CTD	MESH:D015032	[Zinc deficiency promotes the reaction [TRP53 gene mutant form results in increased susceptibility to nitrosobenzylmethylamine]] which results in decreased expression of WNT10B mRNA	PMID:12517797
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT10B mRNA	PMID:40504410
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312745	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of WNT10B mRNA	PMID:28960355
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20191008	CTD	MESH:C059514	[Dietary Fats co-treated with Resveratrol] results in increased expression of WNT10B mRNA	PMID:29197120
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312744	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of WNT10B mRNA	PMID:28903495
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312744	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of WNT10B mRNA	PMID:27392435
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D019833	Genistein results in decreased expression of WNT10B mRNA	PMID:24361872
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20140408	CTD	MESH:D019833	Genistein results in increased methylation of WNT10B promoter	PMID:24361872
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312745	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WNT10B mRNA	PMID:21570461
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to WNT10B promoter]	PMID:19654925
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of WNT10B mRNA; [NSC 689534 binds to Copper] which results in decreased expression of WNT10B mRNA	PMID:20971185|PMID:30911355
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312745	E	RGD:6480464	20181016	CTD	MESH:D012969	Sodium Fluoride results in increased expression of WNT10B mRNA	PMID:29447955
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:28741	sodium fluoride	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D012969	PTH protein promotes the reaction [Sodium Fluoride results in increased expression of WNT10B mRNA]	PMID:29447955
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20181016	CTD	MESH:D012969	PTH protein promotes the reaction [Sodium Fluoride results in increased expression of WNT10B mRNA]; Sodium Fluoride affects the reaction [PTH protein results in increased expression of WNT10B mRNA]	PMID:29447955
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312745	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of WNT10B mRNA	PMID:37682722
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT10B mRNA	PMID:40504410
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312744	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of WNT10B promoter	PMID:27901495
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312744	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WNT10B mRNA	PMID:32234424
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of WNT10B mRNA; [NSC 689534 binds to Copper] which results in decreased expression of WNT10B mRNA	PMID:20971185|PMID:30911355
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20130122	CTD	MESH:D015032	[Zinc deficiency promotes the reaction [TRP53 gene mutant form results in increased susceptibility to nitrosobenzylmethylamine]] which results in decreased expression of WNT10B mRNA	PMID:12517797
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312744	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of WNT10B mRNA	PMID:25895662
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312744	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WNT10B mRNA	PMID:19150397
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20251007	CTD	MESH:C006632	[Arsenic Trioxide co-treated with apatinib] results in decreased expression of WNT10B mRNA	PMID:39223679
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1312745	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of WNT10B gene; titanium dioxide affects the methylation of WNT10B promoter	PMID:35295148
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of WNT10B mRNA	PMID:29264374
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of WNT10B mRNA	PMID:25181051
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of WNT10B mRNA	PMID:30951980|PMID:32156529
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of WNT10B gene	PMID:28505145
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of WNT10B promoter	PMID:23359474
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312744	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of WNT10B mRNA	PMID:25979313
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34159	15-deoxy-Delta(12,14)-prostaglandin J2	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20170303	CTD	MESH:C097240	15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of WNT10B mRNA	PMID:12021203
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312744	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of WNT10B gene	PMID:31601247
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of WNT10B mRNA	PMID:26377693
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of WNT10B mRNA	PMID:26377693
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34572	allethrin	increases expression	ISO	RGD:1312744	E	RGD:6480464	20120412	CTD	MESH:D000487	Allethrins results in increased expression of WNT10B mRNA	PMID:12437293
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of WNT10B mRNA	PMID:30951980
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34631	chlorpyrifos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004390	Chlorpyrifos affects the expression of WNT10B mRNA	PMID:18502319
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of WNT10B promoter	PMID:23359474
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20171010	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B mRNA; APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B protein]	PMID:28242765
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1312744	E	RGD:6480464	20120412	CTD	MESH:D026023	Permethrin results in increased expression of WNT10B mRNA	PMID:12437293
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:34916	phenothrin	increases expression	ISO	RGD:1312744	E	RGD:6480464	20161213	CTD	MESH:C006166	phenothrin results in increased expression of WNT10B mRNA	PMID:12437293
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20120918	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of WNT10B mRNA	PMID:19818801
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT10B mRNA	PMID:35301059
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312744	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of WNT10B mRNA	PMID:25812627
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA]	PMID:17585979
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312744	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of WNT10B mRNA	PMID:25812627
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312745	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of WNT10B mRNA	PMID:40194260
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312744	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of WNT10B mRNA	PMID:25812627
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312745	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of WNT10B mRNA	PMID:17292431
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312744	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of WNT10B mRNA	PMID:15590111
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20171010	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B mRNA; APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B protein]	PMID:28242765
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312745	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of WNT10B mRNA	PMID:18502557
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	[Methotrexate co-treated with Leucovorin] results in increased expression of WNT10B mRNA	PMID:25187349
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312744	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of WNT10B mRNA	PMID:38832940
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312744	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of WNT10B mRNA	PMID:24935251
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA]	PMID:17585979
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:4629	diosgenin	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20151215	CTD	MESH:D004144	Diosgenin results in decreased expression of WNT10B mRNA	PMID:26408789
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT10B mRNA	PMID:40504410
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1312744	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of WNT10B mRNA	PMID:32234424
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20251007	CTD	MESH:C032793	[Arsenic Trioxide co-treated with apatinib] results in decreased expression of WNT10B mRNA	PMID:39223679
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1312744	E	RGD:6480464	20120412	CTD	MESH:C017690	fenvalerate results in increased expression of WNT10B mRNA	PMID:12437293
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of WNT10B mRNA; Nanotubes, Carbon results in decreased expression of WNT10B mRNA	PMID:25554681
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:50667	mercaptopurine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of WNT10B mRNA	PMID:23358152
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of WNT10B mRNA	PMID:28801915
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT10B mRNA	PMID:39752319
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:755665	etc-159	decreases expression	ISO	RGD:1312744	E	RGD:6480464	20260714	CTD	MESH:C000620782	ETC-159 results in decreased expression of WNT10B mRNA	PMID:39647516
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WNT10B mRNA	PMID:36139627
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in decreased methylation of WNT10B promoter	PMID:27415467
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased expression of WNT10B mRNA	PMID:27415467
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:78030	LGK974	decreases expression	ISO	RGD:1312744	E	RGD:6480464	20250902	CTD	MESH:C586458	LGK974 results in decreased expression of WNT10B mRNA	PMID:39647516
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:78030	LGK974	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20250902	CTD	MESH:C586458	LGK974 results in decreased expression of WNT10B mRNA	PMID:39647516
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT10B mRNA	PMID:27188386
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:80799	Bufotalin	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20250603	CTD	MESH:C004600	bufotalin inhibits the reaction [TGFB1 protein results in increased expression of WNT10B mRNA]	PMID:38158113
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1312744	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of WNT10B mRNA	PMID:32234424
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of WNT10B mRNA	PMID:24780913
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312744	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of WNT10B mRNA	PMID:26272509
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT10B mRNA	PMID:27188386
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT10B mRNA	PMID:39752319
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312744	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT10B mRNA	PMID:27188386
1304988	Wnt10b	Wnt family member 10B	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of WNT10B mRNA	PMID:23358152
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of KCTD5 mRNA	PMID:21551480
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312748	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KCTD5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KCTD5 mRNA	PMID:32699268
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312748	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of KCTD5 mRNA	PMID:24763279
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312749	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of KCTD5 mRNA	PMID:30319688
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312748	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of KCTD5 mRNA	PMID:21179406
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312748	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of KCTD5 mRNA	PMID:33647349
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312748	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KCTD5 protein	PMID:37730182
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312748	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KCTD5 mRNA	PMID:28818685
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312749	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of KCTD5 mRNA	PMID:27462272
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312748	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KCTD5 mRNA	PMID:19549813
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312748	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KCTD5 intron	PMID:30157460
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312748	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KCTD5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KCTD5 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of KCTD5 mRNA	PMID:32699268
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1312748	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of KCTD5 mRNA	PMID:22171008
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312748	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of KCTD5 mRNA	PMID:18593933
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20150127	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of KCTD5 mRNA	PMID:25270620
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KCTD5 mRNA	PMID:25629700
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312748	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KCTD5 mRNA	PMID:23557933
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of KCTD5 mRNA	PMID:40618947
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312748	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of KCTD5 mRNA	PMID:25583101
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312749	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KCTD5 mRNA	PMID:21570461
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KCTD5 mRNA	PMID:19770486
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312748	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of KCTD5 mRNA	PMID:33512557
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312748	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of KCTD5 mRNA	PMID:33212167
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312748	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of KCTD5 mRNA	PMID:32763439
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312748	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KCTD5 mRNA	PMID:38568856
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312748	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KCTD5 promoter	PMID:27901495
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1312748	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of KCTD5 mRNA	PMID:22171008
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312748	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of KCTD5 mRNA	PMID:18593933
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312748	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KCTD5 mRNA	PMID:19150397
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312748	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to KCTD5 protein]	PMID:26598702
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of KCTD5 mRNA	PMID:30047161
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of KCTD5 mRNA	PMID:24136188
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312749	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KCTD5 promoter	PMID:35295148
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of KCTD5 mRNA	PMID:18648102
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312749	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of KCTD5 mRNA	PMID:28472532
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KCTD5 mRNA	PMID:25181051
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312748	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of KCTD5 mRNA	PMID:29275510
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of KCTD5 mRNA	PMID:30816183|PMID:34947998
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of KCTD5 mRNA	PMID:27914987
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of KCTD5 mRNA	PMID:20713471
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312749	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of KCTD5 promoter	PMID:33297965
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312748	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of KCTD5 intron	PMID:30157460
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312748	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KCTD5 mRNA	PMID:37042841
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of KCTD5 promoter	PMID:22457795
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312748	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KCTD5 mRNA	PMID:38174414|PMID:38568856
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312748	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of KCTD5 mRNA	PMID:19320972|PMID:19376846
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312748	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KCTD5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KCTD5 mRNA	PMID:32699268
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of KCTD5 mRNA	PMID:21427059
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312748	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KCTD5 gene	PMID:29154799
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of KCTD5 mRNA	PMID:30047161
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of KCTD5 mRNA	PMID:19770486
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312748	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of KCTD5 mRNA	PMID:20106945
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of KCTD5 mRNA	PMID:24136188
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312748	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KCTD5 mRNA	PMID:38832940
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312749	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KCTD5 mRNA	PMID:17562736
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312748	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of KCTD5 mRNA	PMID:20977926
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312748	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to KCTD5 protein]	PMID:26598702
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of KCTD5 mRNA	PMID:24136188
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of KCTD5 mRNA	PMID:30047161
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312749	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of KCTD5 mRNA	PMID:35964746
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KCTD5 mRNA	PMID:24136188
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312749	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of KCTD5 mRNA	PMID:19042947
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312748	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KCTD5 protein	PMID:32959892
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312748	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of KCTD5 intron	PMID:30157460
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of KCTD5 mRNA	PMID:24136188
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of KCTD5 mRNA	PMID:21346803
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312748	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KCTD5 gene]	PMID:28238834
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of KCTD5 mRNA	PMID:30047161
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KCTD5 mRNA	PMID:21346803
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of KCTD5 mRNA	PMID:24136188
1304990	Kctd5	potassium channel tetramerization domain containing 5	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312748	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KCTD5 mRNA	PMID:38568856
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1349222	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of THOC5 mRNA	PMID:38218311
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349222	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of THOC5 mRNA	PMID:33167477
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1349222	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of THOC5 mRNA	PMID:22378314
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1349222	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of THOC5 protein	PMID:35688186
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312750	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of THOC5 mRNA	PMID:39241906
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1349222	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of THOC5 mRNA	PMID:21179406
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1349222	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of THOC5 protein	PMID:37730182
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312750	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of THOC5 mRNA	PMID:37236586
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312750	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of THOC5 mRNA	PMID:40504410
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1349222	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of THOC5 protein	PMID:35688186
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1349222	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of THOC5 mRNA	PMID:28903495
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312750	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of THOC5 mRNA	PMID:21570461
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of THOC5 mRNA	PMID:33387578
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312750	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of THOC5 mRNA	PMID:17942748
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of THOC5 mRNA	PMID:28959563
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1349222	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of THOC5 mRNA	PMID:32763439
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312750	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of THOC5 mRNA	PMID:40504410
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349222	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of THOC5 promoter	PMID:27901495
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1349222	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of THOC5 mRNA	PMID:25351596
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312750	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of THOC5 mRNA	PMID:20542052
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312750	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of THOC5 gene	PMID:35295148
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312750	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of THOC5 mRNA	PMID:23811191
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of THOC5 mRNA	PMID:25181051|PMID:34947998
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312750	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of THOC5 mRNA	PMID:39298647
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1349222	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of THOC5 protein	PMID:34186270
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1349222	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THOC5 mRNA	PMID:28628672
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1349222	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of THOC5 protein	PMID:34186270
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312750	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of THOC5 intron	PMID:28392331
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312750	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of THOC5 mRNA	PMID:37019170
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1349222	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THOC5 mRNA	PMID:28628672
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349222	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of THOC5 mRNA	PMID:37042841
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312750	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of THOC5 mRNA	PMID:37236586
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1349222	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of THOC5 mRNA	PMID:19167446
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312750	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of THOC5 mRNA	PMID:17292431
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349222	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of THOC5 mRNA	PMID:25979313
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1349222	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THOC5 mRNA	PMID:28628672
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of THOC5 mRNA	PMID:33387578
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312750	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of THOC5 mRNA	PMID:40504410
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312750	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of THOC5 mRNA	PMID:17942748
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1349222	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THOC5 mRNA	PMID:28628672
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of THOC5 mRNA	PMID:24136188
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312750	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of THOC5 mRNA	PMID:19042947
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349222	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of THOC5 protein	PMID:32959892
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1349222	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of THOC5 protein	PMID:34186270
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312750	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of THOC5 mRNA	PMID:22206623
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312750	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of THOC5 mRNA	PMID:31388691
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of THOC5 mRNA	PMID:21346803
1304991	Thoc5	THO complex subunit 5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of THOC5 mRNA	PMID:21346803
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FKBP3 gene	PMID:20938992
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of FKBP3 protein	PMID:39571964
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312752	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FKBP3 mRNA	PMID:39241906
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FKBP3 mRNA]	PMID:39241906
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of FKBP3 mRNA	PMID:23019147
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in decreased expression of FKBP3 protein	PMID:26903627
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FKBP3 gene	PMID:20938992
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312751	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FKBP3 mRNA	PMID:37042841
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312751	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of FKBP3 mRNA	PMID:21179406
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312751	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FKBP3 protein	PMID:37730182
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312751	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of FKBP3 mRNA	PMID:28860664
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FKBP3 mRNA	PMID:19549813
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FKBP3 protein	PMID:23301498
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of FKBP3 mRNA	PMID:21396975
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312751	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FKBP3 gene	PMID:27153756
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of FKBP3 mRNA	PMID:15674844
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312752	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of FKBP3 protein	PMID:39910959
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:2567	alendronic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019386	Alendronate affects the expression of FKBP3 mRNA	PMID:16079270
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of FKBP3 mRNA	PMID:35430440
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of FKBP3 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of FKBP3 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of FKBP3 protein	PMID:38598786
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of FKBP3 mRNA	PMID:16140947
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of FKBP3 mRNA]	PMID:16140947
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FKBP3 mRNA	PMID:31919559
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FKBP3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FKBP3 gene	PMID:20938992|PMID:22206623
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of FKBP3 gene	PMID:39164771
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FKBP3 mRNA	PMID:40504410
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FKBP3 mRNA	PMID:19244175
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of FKBP3 protein	PMID:38460933
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312751	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of FKBP3 protein	PMID:35688186
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FKBP3 mRNA	PMID:31881176
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of FKBP3 protein	PMID:25505154
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312752	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FKBP3 mRNA	PMID:24680724
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKBP3 mRNA	PMID:33387578
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312752	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKBP3 mRNA	PMID:15034205|PMID:17942748
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKBP3 mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FKBP3 mRNA]	PMID:15034205|PMID:17942748
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FKBP3 mRNA	PMID:33212167
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FKBP3 mRNA	PMID:30851411
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312751	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of FKBP3 protein	PMID:35688186
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of FKBP3 mRNA; sodium arsenite results in decreased expression of FKBP3 protein	PMID:30528433|PMID:38568856
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of FKBP3 protein	PMID:39571964
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FKBP3 mRNA	PMID:40504410
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FKBP3 mRNA	PMID:15034205
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of FKBP3 mRNA]	PMID:15034205
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of FKBP3 protein	PMID:40770094
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of FKBP3 protein	PMID:40770094
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of FKBP3 mRNA	PMID:16140947
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of FKBP3 mRNA]	PMID:16140947
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of FKBP3 mRNA	PMID:18648102
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of FKBP3 mRNA	PMID:18445702
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:32888	gamma-hexachlorocyclohexane	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane affects the expression of FKBP3 mRNA	PMID:17785943
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FKBP3 mRNA	PMID:25181051
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312751	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of FKBP3 mRNA	PMID:30903817
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of FKBP3 mRNA	PMID:29275510
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312751	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of FKBP3 protein	PMID:34186270
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312751	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of FKBP3 protein	PMID:34186270
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of FKBP3 mRNA	PMID:17602206
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of FKBP3 protein	PMID:38598786
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FKBP3 mRNA]	PMID:39241906
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312751	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FKBP3 mRNA	PMID:37042841
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312751	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FKBP3 protein	PMID:33830842
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of and results in increased methylation of FKBP3 mRNA	PMID:33830842
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FKBP3 mRNA	PMID:19320972|PMID:19376846
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FKBP3 mRNA	PMID:19244175
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312752	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of FKBP3 mRNA	PMID:17585979
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FKBP3 mRNA	PMID:28302478
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FKBP3 mRNA	PMID:31533062
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:39096	alpha-hexachlorocyclohexane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C040534	alpha-hexachlorocyclohexane results in increased expression of FKBP3 mRNA	PMID:17785943
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312751	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FKBP3 gene	PMID:29154799
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of FKBP3 mRNA	PMID:41580965
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FKBP3 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of FKBP3 mRNA	PMID:12929121
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of FKBP3 mRNA	PMID:24136188
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1312752	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of FKBP3 mRNA	PMID:12929121
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FKBP3 mRNA	PMID:33387578
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of FKBP3 protein	PMID:38460933
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of FKBP3 gene	PMID:39164771
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FKBP3 mRNA	PMID:40504410
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312752	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of FKBP3 mRNA	PMID:35436446
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FKBP3 mRNA	PMID:16079270
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of FKBP3 mRNA	PMID:17557909
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FKBP3 mRNA	PMID:17942748
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKBP3 mRNA	PMID:17942748
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of FKBP3 mRNA	PMID:24136188
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of FKBP3 mRNA	PMID:24136188
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312752	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of FKBP3 mRNA	PMID:26377693
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FKBP3 protein	PMID:32959892
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of FKBP3 mRNA	PMID:24136188
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312751	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of FKBP3 protein	PMID:34186270
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FKBP3 mRNA	PMID:22206623
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FKBP3 mRNA	PMID:22206623
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of FKBP3 mRNA	PMID:24136188
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FKBP3 mRNA	PMID:30851411
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:82388	p-anisidine	increases expression	ISO	RGD:1312752	E	RGD:6480464	20141111	CTD	MESH:C013813	4-anisidine results in increased expression of FKBP3 mRNA	PMID:12929121
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FKBP3 mRNA]	PMID:39241906
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of FKBP3 mRNA	PMID:16079270
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FKBP3 mRNA	PMID:21346803
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312751	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FKBP3 mRNA	PMID:38568856
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of FKBP3 protein	PMID:24648495
1304992	Fkbp3	FKBP prolyl isomerase 3	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312751	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of FKBP3 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of FKBP3 protein	PMID:38598786
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312753	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DRG1 mRNA	PMID:38218311
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312754	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DRG1 mRNA	PMID:30319688
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312754	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DRG1 mRNA	PMID:30319688
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312754	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DRG1 mRNA	PMID:39241906
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DRG1 mRNA	PMID:20068009
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312753	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DRG1 mRNA	PMID:37042841
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of DRG1 promoter	PMID:33872906
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312754	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DRG1 mRNA	PMID:33754040
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of DRG1 promoter	PMID:33872906
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312753	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DRG1 mRNA	PMID:19549813
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DRG1 protein	PMID:23301498
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of DRG1 mRNA	PMID:21396975
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DRG1 mRNA	PMID:35430440
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312754	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DRG1 mRNA	PMID:25629700
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312754	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DRG1 mRNA	PMID:22206623
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DRG1 protein	PMID:38460933
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:27812	Se-methyl-L-selenocysteine	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20120412	CTD	MESH:C002979	[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of DRG1	PMID:15897249
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of DRG1 mRNA	PMID:27392435
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312754	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DRG1 mRNA	PMID:21570461
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DRG1 mRNA	PMID:21215274
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DRG1 mRNA	PMID:33387578
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312754	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DRG1 mRNA	PMID:17942748
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312753	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of DRG1 protein	PMID:30528433
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite inhibits the reaction [DRG1 protein binds to Ribonucleotides]	PMID:30528433
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312754	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DRG1 mRNA	PMID:22228805
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to DRG1 mRNA]	PMID:32406909
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312754	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DRG1 mRNA	PMID:39716349
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312754	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DRG1 gene	PMID:35295148
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312753	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of DRG1 protein	PMID:37567409
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312754	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of DRG1 mRNA	PMID:29161229
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DRG1 mRNA	PMID:25181051
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312753	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DRG1 protein	PMID:31675489
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312754	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DRG1 mRNA	PMID:39298647
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312753	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of DRG1 protein	PMID:34186270
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312753	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DRG1 protein	PMID:26879310
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312754	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DRG1 mRNA	PMID:28903501
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312753	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DRG1 mRNA	PMID:28302478
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312754	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DRG1 mRNA	PMID:17292431
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of DRG1 mRNA	PMID:38685447|PMID:41580965
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DRG1 protein	PMID:38460933
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312754	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DRG1 mRNA	PMID:17942748
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312754	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DRG1 mRNA	PMID:17942748
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312754	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DRG1 mRNA	PMID:39716349
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of DRG1 mRNA	PMID:38685447|PMID:41580965
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of DRG1 mRNA	PMID:24793618
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DRG1 mRNA	PMID:24136188
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312753	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DRG1 protein	PMID:32959892
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312753	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DRG1 mRNA	PMID:31758290
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312753	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DRG1 protein	PMID:34186270
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312754	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DRG1 mRNA	PMID:22206623
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DRG1 protein	PMID:37664457
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:80630	irinotecan	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20181113	CTD	MESH:D000077146	[selenomethylselenocysteine co-treated with Irinotecan] results in decreased expression of DRG1	PMID:15897249
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312753	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DRG1 protein	PMID:31675489
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:9068	Se-methylselenocysteine	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20120412	CTD	MESH:C002979	[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of DRG1	PMID:15897249
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312753	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DRG1 protein	PMID:37664457
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312753	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DRG1 mRNA	PMID:38568856
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312753	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DRG1 mRNA	PMID:29301935
1304993	Drg1	developmentally regulated GTP binding protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of DRG1 mRNA	PMID:23555832
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312755	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CEBPZ mRNA	PMID:26272509
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312755	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPZ mRNA	PMID:27188386
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CEBPZ mRNA]	PMID:31150632
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of CEBPZ mRNA	PMID:16054129
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312755	E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of CEBPZ mRNA	PMID:15894607
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312756	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CEBPZ mRNA	PMID:39241906
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CEBPZ mRNA	PMID:15598610
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312755	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of CEBPZ mRNA	PMID:31614463
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312755	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CEBPZ mRNA	PMID:20823114
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312755	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CEBPZ mRNA	PMID:38568856
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of and results in increased activity of CEBPZ protein	PMID:35842051
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312755	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CEBPZ protein	PMID:37730182
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CEBPZ mRNA	PMID:22061828|PMID:33387578
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPZ mRNA	PMID:37236586
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CEBPZ mRNA	PMID:31150632
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CEBPZ mRNA]	PMID:31150632
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CEBPZ mRNA	PMID:25629700
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:27656	camptothecin	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20120412	CTD	MESH:D002166	Camptothecin results in decreased expression of CEBPZ mRNA	PMID:17374387
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CEBPZ mRNA	PMID:30912803
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEBPZ mRNA	PMID:19684285
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312756	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CEBPZ mRNA	PMID:17942748|PMID:19684285
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CEBPZ mRNA	PMID:17942748
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CEBPZ mRNA	PMID:33212167
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312756	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of CEBPZ mRNA	PMID:39631538
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312755	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CEBPZ mRNA	PMID:20458559
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312756	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CEBPZ gene	PMID:35295148
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CEBPZ mRNA	PMID:23411599|PMID:34492290
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CEBPZ mRNA	PMID:18648102
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312756	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CEBPZ mRNA	PMID:23811191
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPZ mRNA	PMID:28329830
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CEBPZ protein	PMID:37567409
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CEBPZ mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312756	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CEBPZ mRNA	PMID:39298647
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CEBPZ mRNA	PMID:37019170
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1312755	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to CEBPZ protein	PMID:32991956
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CEBPZ mRNA	PMID:19041683
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312755	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEBPZ mRNA	PMID:37042841
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CEBPZ mRNA	PMID:38568856
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CEBPZ promoter	PMID:22457795
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312756	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CEBPZ mRNA	PMID:18974090
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPZ mRNA	PMID:37236586
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CEBPZ mRNA	PMID:24449571
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CEBPZ mRNA	PMID:28302478
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of CEBPZ mRNA	PMID:25993096
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEBPZ mRNA	PMID:23179753|PMID:27188386
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEBPZ mRNA	PMID:21427059
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312755	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CEBPZ mRNA	PMID:20106945|PMID:25562108
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:41977	daunorubicin	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20120412	CTD	MESH:D003630	Daunorubicin results in decreased expression of CEBPZ mRNA	PMID:17374387
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of CEBPZ mRNA	PMID:22334560
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CEBPZ mRNA	PMID:17942748
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CEBPZ mRNA	PMID:17942748
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in decreased expression of CEBPZ mRNA	PMID:17374387
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312755	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CEBPZ mRNA	PMID:20458559
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1312755	E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CEBPZ mRNA	PMID:20823114
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CEBPZ mRNA	PMID:24136188
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CEBPZ protein	PMID:32959892
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1312755	E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CEBPZ mRNA	PMID:20823114
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312755	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CEBPZ mRNA	PMID:31758290
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312756	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CEBPZ mRNA	PMID:22206623
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312755	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CEBPZ protein	PMID:37664457
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312755	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CEBPZ protein	PMID:31285264
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in decreased expression of CEBPZ mRNA	PMID:18417182
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312755	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPZ mRNA	PMID:27188386
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312755	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of CEBPZ mRNA	PMID:30928695
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of CEBPZ mRNA	PMID:22334560
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in decreased expression of CEBPZ mRNA	PMID:22334560
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312755	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CEBPZ protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPZ mRNA	PMID:27188386|PMID:37664457
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:9150	simvastatin	multiple interactions	ISO	RGD:1312755	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin inhibits the reaction [CEBPZ binds to COL1A1 promoter]	PMID:16575855
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CEBPZ mRNA	PMID:19281266
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CEBPZ mRNA	PMID:21346803
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CEBPZ mRNA	PMID:21346803
1304994	Cebpz	CCAAT/enhancer binding protein zeta	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of CEBPZ mRNA	PMID:23555832
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NEK4 gene	PMID:20938992
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312757	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NEK4 mRNA	PMID:33167477
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NEK4 mRNA	PMID:36331819
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312757	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of NEK4 mRNA	PMID:26079696
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312757	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NEK4 mRNA	PMID:21632981
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312757	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of NEK4 mRNA	PMID:22574217
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NEK4 gene	PMID:20938992
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312757	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of NEK4 mRNA	PMID:27905399
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312757	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of NEK4 protein	PMID:37730182
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NEK4 mRNA	PMID:33387578
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312757	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA	PMID:39836092
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NEK4 mRNA	PMID:37236586
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312757	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NEK4 mRNA	PMID:19549813
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of NEK4 mRNA	PMID:21396975
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NEK4 mRNA	PMID:22129741
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312758	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NEK4 mRNA	PMID:19770486
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312757	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NEK4 mRNA	PMID:23649840
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312757	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of NEK4 mRNA	PMID:35430440
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NEK4 mRNA	PMID:25629700
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NEK4 gene	PMID:20938992
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312757	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NEK4 gene	PMID:25304211
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312757	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NEK4 mRNA	PMID:39836092
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312757	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of NEK4 protein	PMID:35688186
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312757	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NEK4 mRNA	PMID:23557933
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312757	E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in decreased expression of NEK4 mRNA	PMID:19031421
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312757	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NEK4 mRNA	PMID:11007951|PMID:17101203
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NEK4 mRNA	PMID:19770486
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NEK4 mRNA	PMID:17942748
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NEK4 mRNA	PMID:17942748
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NEK4 mRNA	PMID:22129741
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of NEK4 mRNA	PMID:16014739
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312757	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NEK4 mRNA	PMID:39836092
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NEK4 mRNA	PMID:20504355
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312757	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NEK4 mRNA	PMID:26238291
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312758	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NEK4 gene	PMID:35295148
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NEK4 mRNA	PMID:34492290
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NEK4 mRNA	PMID:25181051
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NEK4 mRNA	PMID:30816183|PMID:32528016
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NEK4 mRNA	PMID:33221593
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NEK4 mRNA	PMID:37019170
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NEK4 mRNA	PMID:21266533
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NEK4 mRNA	PMID:22129741
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312757	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NEK4 mRNA	PMID:37042841
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312757	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA	PMID:39836092
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1312758	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of NEK4 mRNA	PMID:18974090
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NEK4 mRNA	PMID:37236586
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312758	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of NEK4 mRNA	PMID:18353800
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NEK4 mRNA	PMID:36331819
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312757	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of NEK4 mRNA	PMID:29154799
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312757	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of NEK4 mRNA	PMID:27989131
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of NEK4 mRNA	PMID:17555576
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NEK4 mRNA	PMID:17562736
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NEK4 mRNA	PMID:33387578
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312757	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NEK4 mRNA	PMID:22230336
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1312757	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of NEK4 mRNA	PMID:16709241
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312757	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NEK4 gene	PMID:25304211
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312757	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NEK4 mRNA	PMID:39836092
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NEK4 mRNA	PMID:17555576
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NEK4 mRNA	PMID:17942748
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NEK4 mRNA	PMID:17942748
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of NEK4 mRNA	PMID:22504374
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312757	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA	PMID:39836092
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	decreases expression	ISO	RGD:1312757	E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of NEK4 mRNA	PMID:19031421
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of NEK4 mRNA	PMID:21346803
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312757	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NEK4 gene]	PMID:28238834
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of NEK4 mRNA	PMID:21278054
1304995	Nek4	NIMA-related kinase 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of NEK4 mRNA	PMID:22504374
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312759	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KIF1A mRNA	PMID:38218311
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312759	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of KIF1A mRNA	PMID:26272509
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312759	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312760	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KIF1A mRNA	PMID:33045310
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312760	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of KIF1A mRNA	PMID:26251327
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF1A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KIF1A gene	PMID:20938992
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:D014212	Tretinoin results in decreased expression of KIF1A mRNA	PMID:21934132
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312759	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of KIF1A mRNA	PMID:25014914|PMID:26079696
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of KIF1A gene	PMID:28931070
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of KIF1A mRNA	PMID:36841081
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312760	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of KIF1A mRNA	PMID:30319688
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of KIF1A mRNA	PMID:29018328
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312760	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of KIF1A mRNA	PMID:30319688
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312759	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of KIF1A mRNA	PMID:30510588
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in decreased expression of KIF1A mRNA	PMID:20068009
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of KIF1A mRNA	PMID:39298647
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312760	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of KIF1A mRNA	PMID:33711761
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KIF1A mRNA	PMID:33387578
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF1A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KIF1A gene	PMID:20938992
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:C044887	beta-methylcholine affects the expression of KIF1A mRNA	PMID:21179406
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312759	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of KIF1A mRNA	PMID:25014914|PMID:26079696
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20140211	CTD	MESH:D005947	Glucose results in increased expression of KIF1A protein	PMID:23776493
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of KIF1A mRNA]	PMID:20032058
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20140211	CTD	MESH:D005947	Glucose results in increased expression of KIF1A protein	PMID:23776493
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of KIF1A mRNA	PMID:22061828
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20150714	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of KIF1A mRNA	PMID:15329391
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312759	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KIF1A gene; Aflatoxin B1 results in increased methylation of KIF1A intron	PMID:27153756|PMID:30157460
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KIF1A mRNA	PMID:21527772
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D009151	Mustard Gas results in decreased expression of KIF1A mRNA	PMID:15674843
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of KIF1A mRNA	PMID:21527772
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of KIF1A mRNA	PMID:17484886
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF1A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KIF1A gene	PMID:20938992
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:D003609	Dactinomycin results in increased expression of KIF1A mRNA	PMID:21527772
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312759	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of KIF1A mRNA	PMID:26272509
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312759	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312760	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of KIF1A mRNA	PMID:28960355
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:D010278	Parathion results in increased methylation of KIF1A promoter	PMID:22847954
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D012402	Rotenone results in increased expression of KIF1A mRNA	PMID:19013527
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312759	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KIF1A mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1312759	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1312759	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of KIF1A mRNA	PMID:26272509
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312759	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312759	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KIF1A mRNA	PMID:29803840
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:29323	methylazoxymethanol	increases expression	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:C030667	methylazoxymethanol results in increased expression of KIF1A mRNA	PMID:17107856
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312759	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KIF1A mRNA	PMID:38568856
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312759	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KIF1A 5' UTR; Benzo(a)pyrene affects the methylation of KIF1A intron	PMID:27901495|PMID:30157460
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312759	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KIF1A 3' UTR	PMID:27901495
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312760	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KIF1A intron	PMID:27901495
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KIF1A mRNA	PMID:22610609
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312759	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KIF1A promoter	PMID:27901495
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to KIF1A promoter]	PMID:19654925
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312760	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KIF1A gene	PMID:35295148
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312760	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KIF1A promoter	PMID:35295148
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF1A mRNA	PMID:25181051
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF1A mRNA	PMID:32156529
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312759	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KIF1A gene	PMID:31601247
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of KIF1A mRNA	PMID:29097150
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312759	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of KIF1A mRNA	PMID:25912373
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KIF1A mRNA	PMID:36041667
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KIF1A mRNA	PMID:36041667
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312759	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of KIF1A intron	PMID:30157460
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of KIF1A mRNA	PMID:38685157
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KIF1A mRNA	PMID:36041667
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312760	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of KIF1A intron	PMID:28392331
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KIF1A mRNA	PMID:21266533
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KIF1A mRNA	PMID:21266533
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of KIF1A mRNA	PMID:21527772
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312759	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KIF1A mRNA	PMID:38568856
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D002994	Clofibrate results in increased expression of KIF1A mRNA	PMID:17585979
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:D004397	Fonofos results in increased methylation of KIF1A promoter	PMID:22847954
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312759	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KIF1A mRNA	PMID:31533062
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:C012568	terbufos results in increased methylation of KIF1A promoter	PMID:22847954
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312759	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KIF1A mRNA	PMID:25979313
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D014635	Valproic Acid affects the expression of KIF1A mRNA	PMID:17292431
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of KIF1A mRNA	PMID:29427782
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312759	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of KIF1A mRNA	PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312759	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KIF1A gene	PMID:29154799
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D003907	Dexamethasone results in decreased expression of KIF1A mRNA	PMID:20032058
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of KIF1A mRNA]	PMID:20032058
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:41977	daunorubicin	affects response to substance	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:D003630	KIF1A affects the susceptibility to Daunorubicin	PMID:17545624
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of KIF1A protein	PMID:23776493
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312759	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of KIF1A mRNA	PMID:27188386
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KIF1A mRNA	PMID:29391264
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:D005047	Etoposide results in increased expression of KIF1A mRNA	PMID:21527772
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312759	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312759	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of KIF1A protein	PMID:23718831
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312760	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of KIF1A mRNA	PMID:23608068
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312759	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of KIF1A intron	PMID:30157460
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1312760	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of KIF1A mRNA	PMID:25566086
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of KIF1A mRNA]	PMID:25566086
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312759	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital results in increased expression of KIF1A mRNA	PMID:19482888
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20130806	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of KIF1A mRNA]	PMID:19482888
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of KIF1A mRNA	PMID:23914054
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312759	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of KIF1A mRNA	PMID:25014914|PMID:26079696
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312759	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of KIF1A protein	PMID:35544339
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312759	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of KIF1A mRNA	PMID:27188386
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312759	E	RGD:6480464	20130806	CTD	MESH:C057693	troglitazone results in increased expression of KIF1A mRNA	PMID:19140230
1304996	Kif1a	kinesin family member 1A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of KIF1A mRNA	PMID:22570695
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:10022	deoxynivalenol	decreases phosphorylation	ISO	RGD:1312762	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased phosphorylation of SEC61B protein	PMID:23352502
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312761	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SEC61B mRNA	PMID:38218311
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61B mRNA	PMID:39752319
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312761	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of SEC61B mRNA	PMID:17218384
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SEC61B mRNA	PMID:36331819
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312761	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of SEC61B mRNA	PMID:29581250
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312762	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SEC61B mRNA	PMID:39241906
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SEC61B mRNA	PMID:39298647
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SEC61B mRNA	PMID:32145629
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61B mRNA	PMID:39752319
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SEC61B mRNA	PMID:28973375
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312762	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SEC61B mRNA	PMID:33754040
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312761	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SEC61B protein	PMID:37730182
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SEC61B mRNA	PMID:36331819
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SEC61B mRNA	PMID:39836092
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312762	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SEC61B mRNA	PMID:27462272
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:211238	Torularhodin	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20250506	CTD	MESH:C078923	torularhodin inhibits the reaction [Dietary Fats results in decreased expression of SEC61B protein]	PMID:36234935
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SEC61B mRNA	PMID:35301059
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SEC61B mRNA	PMID:37236586
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SEC61B protein	PMID:23301498
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SEC61B protein	PMID:38598786
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SEC61B mRNA	PMID:30779732
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SEC61B mRNA	PMID:22206623
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEC61B mRNA	PMID:40504410
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312761	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SEC61B protein	PMID:35688186
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312761	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SEC61B mRNA	PMID:27392435|PMID:27594783
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of SEC61B mRNA	PMID:34813904
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312762	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SEC61B mRNA	PMID:30912803
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312761	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of SEC61B mRNA	PMID:26865667
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEC61B mRNA	PMID:34747641
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312762	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEC61B mRNA	PMID:21570461|PMID:24680724
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SEC61B mRNA	PMID:19770486
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SEC61B mRNA	PMID:28374803
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312761	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SEC61B mRNA	PMID:30851411
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SEC61B mRNA	PMID:30556269
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SEC61B mRNA	PMID:24690739
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312761	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEC61B mRNA	PMID:38568856
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312762	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of SEC61B mRNA	PMID:37682722
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEC61B mRNA	PMID:40504410
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312761	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SEC61B mRNA	PMID:22378314|PMID:29453283
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SEC61B mRNA	PMID:30556269
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SEC61B mRNA	PMID:24690739
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:3048	benzatropine	increases expression	ISO	RGD:1312761	E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of SEC61B protein	PMID:34122009
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SEC61B mRNA	PMID:24136188
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312762	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SEC61B mRNA	PMID:23557971
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312761	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC61B protein	PMID:34186270
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SEC61B mRNA	PMID:25181051|PMID:32145629
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312761	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SEC61B protein	PMID:33376534
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312762	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SEC61B mRNA	PMID:33221593|PMID:38074096
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312762	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SEC61B mRNA	PMID:39298647|PMID:40203079
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312761	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SEC61B protein	PMID:34186270
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312762	E	RGD:6480464	20230207	CTD	MESH:C008745	bisphenol F results in increased expression of SEC61B mRNA	PMID:35387338
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312761	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SEC61B protein	PMID:34186270
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312762	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SEC61B mRNA	PMID:37019170
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312761	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEC61B mRNA	PMID:37042841
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SEC61B mRNA	PMID:35163327
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SEC61B mRNA	PMID:39836092
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SEC61B mRNA	PMID:33453195
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312761	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SEC61B mRNA	PMID:38568856
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SEC61B mRNA	PMID:35301059
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SEC61B mRNA	PMID:37236586
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SEC61B mRNA	PMID:35163327
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SEC61B gene	PMID:22079235
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SEC61B mRNA	PMID:17585979
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of SEC61B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SEC61B mRNA]	PMID:17585979
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1312761	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of SEC61B protein	PMID:34122009
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312761	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SEC61B mRNA	PMID:31533062
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1312761	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of SEC61B mRNA	PMID:26352163
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SEC61B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SEC61B mRNA	PMID:36331819
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312761	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SEC61B gene	PMID:29154799
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312761	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SEC61B mRNA	PMID:23179753|PMID:26272509
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEC61B mRNA	PMID:27188386
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312761	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SEC61B mRNA	PMID:20106945|PMID:25562108
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312762	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of SEC61B mRNA	PMID:19770486|PMID:25270620
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312762	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SEC61B mRNA	PMID:17562736
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SEC61B mRNA	PMID:33387578
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of SEC61B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SEC61B mRNA]	PMID:17585979
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of SEC61B mRNA	PMID:24690739
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEC61B mRNA	PMID:40504410
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SEC61B mRNA	PMID:29391264|PMID:31464424
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312762	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of SEC61B mRNA	PMID:22334560
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SEC61B mRNA	PMID:26865667
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312762	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SEC61B mRNA	PMID:17942748
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1312761	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SEC61B mRNA	PMID:38568856
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312762	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SEC61B mRNA; Nanotubes, Carbon results in increased expression of SEC61B mRNA	PMID:25554681
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of SEC61B mRNA	PMID:26377693
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312761	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of SEC61B mRNA	PMID:18651567
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312761	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SEC61B protein	PMID:32959892
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SEC61B mRNA	PMID:39836092
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312761	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of SEC61B protein	PMID:34122009
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61B mRNA	PMID:39752319
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312761	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SEC61B protein	PMID:34186270
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SEC61B mRNA	PMID:22206623
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SEC61B protein	PMID:37664457
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312761	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SEC61B mRNA	PMID:30851411
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEC61B mRNA	PMID:27188386
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312762	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SEC61B mRNA	PMID:38648751
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312762	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SEC61B mRNA	PMID:30294300
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1312762	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of SEC61B mRNA	PMID:22334560
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312762	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of SEC61B mRNA	PMID:21278054|PMID:22334560
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61B mRNA	PMID:39752319
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SEC61B protein; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEC61B mRNA	PMID:27188386|PMID:37664457
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SEC61B mRNA	PMID:21346803
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312761	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SEC61B mRNA	PMID:38568856
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312761	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of SEC61B mRNA	PMID:22378314
1304997	Sec61b	SEC61 translocon subunit beta	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312761	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SEC61B protein	PMID:38598786
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:2293814	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FAM161A mRNA	PMID:33167477
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312765	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FAM161A mRNA	PMID:36331819
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:2293814	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of FAM161A mRNA	PMID:21632981
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312765	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of FAM161A mRNA	PMID:39298647
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:2293814	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of FAM161A mRNA	PMID:24758408
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of FAM161A mRNA	PMID:26496021
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:2293814	E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in increased expression of FAM161A mRNA]	PMID:24758408
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of FAM161A mRNA	PMID:26577399
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:2293814	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FAM161A protein	PMID:37730182
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312765	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM161A mRNA	PMID:37236586
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:2293814	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FAM161A gene	PMID:27153756
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:2293814	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FAM161A mRNA	PMID:23649840
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312765	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FAM161A mRNA	PMID:34911549
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:2293814	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of FAM161A mRNA	PMID:40512198
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312765	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FAM161A mRNA	PMID:28960355
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:2293814	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of FAM161A mRNA	PMID:28001369
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:2293814	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FAM161A mRNA	PMID:33212167
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of FAM161A mRNA	PMID:26033743
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of FAM161A mRNA	PMID:26033743
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:2293814	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of FAM161A mRNA	PMID:22623647
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:2293814	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of FAM161A mRNA	PMID:40512198
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of FAM161A mRNA	PMID:26033743
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of FAM161A mRNA	PMID:26033743
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:2293814	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FAM161A mRNA	PMID:26238291
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of FAM161A mRNA	PMID:24395379
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:2293814	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of FAM161A mRNA	PMID:31745603
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of FAM161A mRNA	PMID:30047161
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312765	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of FAM161A mRNA	PMID:23557971
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312765	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of FAM161A mRNA	PMID:23811191
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM161A mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312765	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM161A mRNA	PMID:32156529
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2293814	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM161A mRNA	PMID:33670352
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of FAM161A mRNA	PMID:26496021
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312765	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FAM161A mRNA	PMID:30951980
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312765	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of FAM161A mRNA	PMID:37019170
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:2293814	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FAM161A mRNA	PMID:37042841
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:2293814	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FAM161A mRNA	PMID:26472689|PMID:38568856
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312765	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM161A mRNA	PMID:37236586
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312765	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of FAM161A mRNA	PMID:23811191
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312765	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FAM161A mRNA	PMID:36331819
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:2293814	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of FAM161A mRNA	PMID:29154799
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of FAM161A mRNA	PMID:30047161
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:2293814	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FAM161A mRNA	PMID:21632981|PMID:25562108
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:2293814	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of FAM161A mRNA	PMID:20106945
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312765	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FAM161A mRNA	PMID:17562736
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:2293814	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of FAM161A mRNA	PMID:22230336
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:2293814	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of FAM161A mRNA	PMID:40512198
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:2293814	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in decreased expression of FAM161A mRNA	PMID:26833863
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312765	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FAM161A mRNA; Nanotubes, Carbon results in decreased expression of FAM161A mRNA	PMID:25554681
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of FAM161A mRNA	PMID:30047161
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312765	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of FAM161A mRNA	PMID:19042947
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312765	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FAM161A mRNA	PMID:23608068
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312765	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of FAM161A mRNA	PMID:38701926
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312765	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FAM161A mRNA	PMID:22206623
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:2293814	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of FAM161A mRNA	PMID:19946333
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:2293814	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of FAM161A mRNA]	PMID:19946333
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:2293814	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of FAM161A protein	PMID:31285264
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FAM161A mRNA	PMID:25825206|PMID:30047161
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FAM161A mRNA	PMID:24780913
1304999	Fam161a	FAM161 centrosomal protein A	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:2293814	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of FAM161A mRNA	PMID:29301935
1305000	Cldn19	claudin 19	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1312766	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of CLDN19 mRNA	PMID:31016361
1305000	Cldn19	claudin 19	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1312766	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of CLDN19 mRNA	PMID:34925699
1305000	Cldn19	claudin 19	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312766	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CLDN19 mRNA	PMID:30165855
1305000	Cldn19	claudin 19	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CLDN19 mRNA	PMID:33387578
1305000	Cldn19	claudin 19	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312766	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of CLDN19 mRNA	PMID:33647349
1305000	Cldn19	claudin 19	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CLDN19 mRNA	PMID:26577399
1305000	Cldn19	claudin 19	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CLDN19 mRNA	PMID:33387578
1305000	Cldn19	claudin 19	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312766	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CLDN19 mRNA	PMID:19549813
1305000	Cldn19	claudin 19	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312766	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CLDN19 mRNA	PMID:23557933
1305000	Cldn19	claudin 19	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1312766	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CLDN19 promoter	PMID:22847954
1305000	Cldn19	claudin 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLDN19 mRNA	PMID:33387578
1305000	Cldn19	claudin 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312766	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLDN19 mRNA	PMID:26238291
1305000	Cldn19	claudin 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312767	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CLDN19 promoter]	PMID:19654925
1305000	Cldn19	claudin 19	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CLDN19 mRNA	PMID:26033743
1305000	Cldn19	claudin 19	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312767	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLDN19 mRNA	PMID:36209798
1305000	Cldn19	claudin 19	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312766	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CLDN19 exon	PMID:27901495
1305000	Cldn19	claudin 19	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312766	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLDN19 mRNA	PMID:22316170|PMID:26238291|PMID:32234424
1305000	Cldn19	claudin 19	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312767	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLDN19 mRNA	PMID:22228805
1305000	Cldn19	claudin 19	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312766	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CLDN19 promoter	PMID:27901495
1305000	Cldn19	claudin 19	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CLDN19 mRNA	PMID:26033743
1305000	Cldn19	claudin 19	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of CLDN19 mRNA	PMID:38458666
1305000	Cldn19	claudin 19	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of CLDN19 mRNA	PMID:24395379
1305000	Cldn19	claudin 19	gene	CHEBI:31767	lead diacetate	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C008261	lead acetate affects the expression of CLDN19 mRNA	PMID:21864555
1305000	Cldn19	claudin 19	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312767	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CLDN19 mRNA	PMID:35295148
1305000	Cldn19	claudin 19	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312767	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CLDN19 mRNA	PMID:20813756
1305000	Cldn19	claudin 19	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312766	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CLDN19 mRNA	PMID:30903817
1305000	Cldn19	claudin 19	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLDN19 mRNA	PMID:25181051
1305000	Cldn19	claudin 19	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312767	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of CLDN19 promoter	PMID:27312807
1305000	Cldn19	claudin 19	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CLDN19 gene	PMID:28505145
1305000	Cldn19	claudin 19	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of CLDN19 mRNA	PMID:38458666
1305000	Cldn19	claudin 19	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312766	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CLDN19 mRNA	PMID:29024780
1305000	Cldn19	claudin 19	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of CLDN19 mRNA	PMID:25539665
1305000	Cldn19	claudin 19	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312767	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CLDN19 mRNA	PMID:40194260
1305000	Cldn19	claudin 19	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1312766	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CLDN19 promoter	PMID:22847954
1305000	Cldn19	claudin 19	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1312766	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CLDN19 promoter	PMID:22847954
1305000	Cldn19	claudin 19	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312766	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CLDN19 gene	PMID:29154799
1305000	Cldn19	claudin 19	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312766	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CLDN19 mRNA	PMID:38832940
1305000	Cldn19	claudin 19	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLDN19 mRNA	PMID:33387578
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1553236	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of RRN3 mRNA	PMID:37995155
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RRN3 mRNA]	PMID:31150632
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1553236	E	RGD:6480464	20141014	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RRN3 mRNA	PMID:20188158
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1347637	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RRN3 mRNA	PMID:26079696
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1553236	E	RGD:6480464	20160705	CTD	MESH:D001280	Atrazine results in increased expression of RRN3 mRNA	PMID:26518232
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553236	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RRN3 mRNA	PMID:39241906
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:16469	17beta-estradiol	decreases phosphorylation	ISO	RGD:1347637	E	RGD:6480464	20160607	CTD	MESH:D004958	Estradiol results in decreased phosphorylation of RRN3 protein	PMID:27026707
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1347637	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RRN3 protein	PMID:37730182
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RRN3 mRNA	PMID:39836092
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RRN3 mRNA	PMID:35301059
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1347637	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RRN3 mRNA	PMID:19549813
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1347637	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RRN3 gene	PMID:27153756
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20141021	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RRN3 mRNA	PMID:23630614
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1553236	E	RGD:6480464	20141014	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RRN3 mRNA	PMID:19770486
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1347637	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RRN3 mRNA	PMID:23649840
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1553236	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RRN3 mRNA	PMID:31919559
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RRN3 mRNA	PMID:31150632
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1553236	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RRN3 mRNA	PMID:27339419
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RRN3 mRNA]	PMID:31150632
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553236	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RRN3 mRNA	PMID:22206623
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1347637	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RRN3 gene	PMID:25304211
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RRN3 mRNA	PMID:39836092
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553236	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RRN3 mRNA	PMID:40504410
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1553236	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RRN3 mRNA	PMID:28960355
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RRN3 mRNA	PMID:31881176
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RRN3 mRNA	PMID:23557933
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RRN3 mRNA	PMID:27392435
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553236	E	RGD:6480464	20141014	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RRN3 mRNA	PMID:21570461
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RRN3 mRNA	PMID:32109520
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of RRN3 mRNA	PMID:28374803
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1347637	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of RRN3 protein	PMID:35688186
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347637	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RRN3 mRNA	PMID:38568856
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RRN3 mRNA	PMID:39836092
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553236	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RRN3 mRNA	PMID:40504410
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553236	E	RGD:6480464	20141014	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RRN3 mRNA	PMID:19770486|PMID:22228805
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347637	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RRN3 promoter	PMID:27901495
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RRN3 mRNA]	PMID:32406909
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RRN3 mRNA	PMID:30047161
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553236	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RRN3 promoter	PMID:35295148
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RRN3 mRNA	PMID:34492290
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RRN3 mRNA	PMID:19710929
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RRN3 mRNA	PMID:25181051
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553236	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RRN3 mRNA	PMID:39298647
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347637	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RRN3 mRNA	PMID:37042841
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RRN3 mRNA	PMID:39836092
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1553236	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RRN3 mRNA	PMID:26377693
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347637	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RRN3 mRNA	PMID:38382870
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1347637	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RRN3 protein	PMID:33830842
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RRN3 mRNA; Cadmium Chloride results in decreased expression of and results in increased methylation of RRN3 mRNA	PMID:33830842|PMID:35301059
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of RRN3 mRNA	PMID:30047161
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1347637	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RRN3 mRNA	PMID:32588087
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1347637	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RRN3 mRNA	PMID:28302478
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1347637	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RRN3 mRNA	PMID:31533062
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347637	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RRN3 mRNA	PMID:25979313
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1347637	E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in decreased expression of RRN3 mRNA	PMID:37505509
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1553236	E	RGD:6480464	20141014	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RRN3 mRNA	PMID:22467019
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1347637	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of RRN3 mRNA	PMID:26690555
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1347637	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of RRN3 mRNA	PMID:18687144
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1347637	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RRN3 gene	PMID:25304211
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RRN3 mRNA	PMID:39836092
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553236	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RRN3 mRNA	PMID:40504410
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553236	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of RRN3 mRNA	PMID:35436446
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553236	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RRN3 mRNA	PMID:25554681
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of RRN3 mRNA	PMID:34044035
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1553236	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of RRN3 mRNA	PMID:26377693
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1347637	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RRN3 mRNA	PMID:39836092
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1347637	E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of RRN3 mRNA	PMID:29432895
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RRN3 gene	PMID:35440735
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553236	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RRN3 mRNA	PMID:22206623
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RRN3 mRNA	PMID:24136188
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1553236	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of RRN3 mRNA	PMID:31388691
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RRN3 mRNA	PMID:30047161
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1553236	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of RRN3 protein	PMID:35357534
1305001	Rrn3	RNA polymerase I transcription factor RRN3	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1553236	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of RRN3 mRNA	PMID:32835833
1305002	Ccng2	cyclin G2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312769	E	RGD:6480464	20190219	CTD	MESH:C007262	deoxynivalenol results in increased expression of CCNG2 mRNA	PMID:30169763
1305002	Ccng2	cyclin G2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312769	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CCNG2 mRNA	PMID:38218311
1305002	Ccng2	cyclin G2	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of CCNG2 mRNA	PMID:25596134
1305002	Ccng2	cyclin G2	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CCNG2 mRNA	PMID:26272509
1305002	Ccng2	cyclin G2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1305002	Ccng2	cyclin G2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CCNG2 mRNA	PMID:33045310
1305002	Ccng2	cyclin G2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312770	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CCNG2 mRNA	PMID:37995155
1305002	Ccng2	cyclin G2	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1312769	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of CCNG2 mRNA	PMID:31016361
1305002	Ccng2	cyclin G2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CCNG2 mRNA	PMID:26251327
1305002	Ccng2	cyclin G2	gene	CHEBI:144804	nickel subsulfide	affects expression	ISO	RGD:1312770	E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide affects the expression of CCNG2 mRNA	PMID:12729255
1305002	Ccng2	cyclin G2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CCNG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CCNG2 mRNA	PMID:32699268
1305002	Ccng2	cyclin G2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CCNG2 mRNA	PMID:20042640|PMID:24236059|PMID:25596134
1305002	Ccng2	cyclin G2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312770	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CCNG2 mRNA	PMID:20880076
1305002	Ccng2	cyclin G2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CCNG2 mRNA	PMID:26079696
1305002	Ccng2	cyclin G2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312770	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CCNG2 mRNA	PMID:30319688
1305002	Ccng2	cyclin G2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312769	E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in increased expression of CCNG2 mRNA	PMID:23378141
1305002	Ccng2	cyclin G2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20180703	CTD	MESH:D000431	[Ethanol co-treated with Folic Acid] results in increased expression of CCNG2 mRNA	PMID:23378141
1305002	Ccng2	cyclin G2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CCNG2 mRNA	PMID:21632981
1305002	Ccng2	cyclin G2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCNG2 mRNA	PMID:39241906
1305002	Ccng2	cyclin G2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312769	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CCNG2 mRNA	PMID:30510588
1305002	Ccng2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312769	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of CCNG2 mRNA	PMID:22574217
1305002	Ccng2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CCNG2 mRNA	PMID:15598610
1305002	Ccng2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in decreased expression of CCNG2 mRNA	PMID:26865669|PMID:28711546|PMID:31614463|PMID:32387340
1305002	Ccng2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of CCNG2 mRNA	PMID:14664709|PMID:39298647
1305002	Ccng2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CCNG2 mRNA	PMID:19619570
1305002	Ccng2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20140513	CTD	MESH:D004958	[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CCNG2 mRNA; Estradiol inhibits the reaction [NCOA3 protein binds to CCNG2 promoter]; FOXA1 protein affects the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]; FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]]; Tetrachlorodibenzodioxin inhibits the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol inhibits the reaction [NCOA3 protein binds to CCNG2 promoter]]	PMID:19619570|PMID:22596188
1305002	Ccng2	cyclin G2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CCNG2 mRNA	PMID:38568856
1305002	Ccng2	cyclin G2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312769	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CCNG2 mRNA	PMID:37042841
1305002	Ccng2	cyclin G2	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1312770	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of CCNG2 mRNA	PMID:34673133
1305002	Ccng2	cyclin G2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CCNG2 mRNA	PMID:23649840
1305002	Ccng2	cyclin G2	gene	CHEBI:17263	estrone	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160705	CTD	MESH:D004970	Estrone results in decreased expression of CCNG2 mRNA	PMID:26865669
1305002	Ccng2	cyclin G2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312770	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of CCNG2 mRNA	PMID:28973375
1305002	Ccng2	cyclin G2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of CCNG2 mRNA	PMID:26496021
1305002	Ccng2	cyclin G2	gene	CHEBI:175901	gemcitabine	increases expression	ISO	RGD:1312769	E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased expression of CCNG2 mRNA	PMID:17039268
1305002	Ccng2	cyclin G2	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1312769	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CCNG2 mRNA	PMID:23416264
1305002	Ccng2	cyclin G2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312769	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCNG2 mRNA	PMID:31163220
1305002	Ccng2	cyclin G2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CCNG2 mRNA	PMID:16002434
1305002	Ccng2	cyclin G2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CCNG2 mRNA	PMID:33387578
1305002	Ccng2	cyclin G2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CCNG2 mRNA	PMID:22061828
1305002	Ccng2	cyclin G2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312769	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CCNG2 mRNA	PMID:28818685
1305002	Ccng2	cyclin G2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCNG2 mRNA	PMID:36331819
1305002	Ccng2	cyclin G2	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of CCNG2 mRNA	PMID:20368581
1305002	Ccng2	cyclin G2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA	PMID:39836092
1305002	Ccng2	cyclin G2	gene	CHEBI:18320	1,4-dithiothreitol	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D004229	Dithiothreitol results in increased expression of CCNG2 mRNA	PMID:17332266
1305002	Ccng2	cyclin G2	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1312769	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CCNG2 mRNA	PMID:23416264
1305002	Ccng2	cyclin G2	gene	CHEBI:2038	5-azacytidine	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20121113	CTD	MESH:D001374	Azacitidine results in decreased expression of CCNG2 mRNA	PMID:21245298
1305002	Ccng2	cyclin G2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCNG2 mRNA	PMID:37236586
1305002	Ccng2	cyclin G2	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20240409	CTD	MESH:C121565	[pifithrin co-treated with Arsenic Trioxide] results in increased expression of CCNG2 mRNA	PMID:35030298
1305002	Ccng2	cyclin G2	gene	CHEBI:23115	chlorohydrocarbon	increases expression	ISO	RGD:1312769	E	RGD:6480464	20170228	CTD	MESH:D006843	Hydrocarbons, Chlorinated results in increased expression of CCNG2 mRNA	PMID:14757120
1305002	Ccng2	cyclin G2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CCNG2 mRNA	PMID:19549813
1305002	Ccng2	cyclin G2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CCNG2 mRNA	PMID:23649840
1305002	Ccng2	cyclin G2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CCNG2 protein	PMID:20106945
1305002	Ccng2	cyclin G2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312769	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CCNG2 gene	PMID:27153756
1305002	Ccng2	cyclin G2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CCNG2 mRNA	PMID:23649840
1305002	Ccng2	cyclin G2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CCNG2 mRNA	PMID:15674843
1305002	Ccng2	cyclin G2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CCNG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CCNG2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CCNG2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of CCNG2 mRNA	PMID:32699268|PMID:41430723
1305002	Ccng2	cyclin G2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CCNG2 mRNA	PMID:27106289
1305002	Ccng2	cyclin G2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CCNG2 mRNA	PMID:31150632
1305002	Ccng2	cyclin G2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCNG2 mRNA	PMID:17484886|PMID:31919559
1305002	Ccng2	cyclin G2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20180703	CTD	MESH:D005492	[Ethanol co-treated with Folic Acid] results in increased expression of CCNG2 mRNA	PMID:23378141
1305002	Ccng2	cyclin G2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNG2 mRNA	PMID:22206623
1305002	Ccng2	cyclin G2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNG2 mRNA	PMID:39836092
1305002	Ccng2	cyclin G2	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1312769	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of CCNG2 mRNA	PMID:38460933
1305002	Ccng2	cyclin G2	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1312769	E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of CCNG2 mRNA	PMID:38460933
1305002	Ccng2	cyclin G2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of CCNG2 mRNA	PMID:38460933
1305002	Ccng2	cyclin G2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CCNG2 mRNA	PMID:26272509
1305002	Ccng2	cyclin G2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1305002	Ccng2	cyclin G2	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of CCNG2 mRNA	PMID:25596134
1305002	Ccng2	cyclin G2	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D002945	CCNG2 protein affects the susceptibility to Cisplatin	PMID:16217747
1305002	Ccng2	cyclin G2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of CCNG2 mRNA	PMID:25596134
1305002	Ccng2	cyclin G2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312769	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CCNG2 mRNA	PMID:27594783
1305002	Ccng2	cyclin G2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CCNG2 mRNA	PMID:27392435
1305002	Ccng2	cyclin G2	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312770	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of CCNG2 mRNA	PMID:30912803
1305002	Ccng2	cyclin G2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160705	CTD	MESH:D019833	Genistein results in decreased expression of CCNG2 mRNA	PMID:26865669
1305002	Ccng2	cyclin G2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CCNG2 mRNA	PMID:24768652|PMID:25583101
1305002	Ccng2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCNG2 mRNA	PMID:22298810
1305002	Ccng2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312770	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCNG2 mRNA	PMID:21570461
1305002	Ccng2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA	PMID:34747641
1305002	Ccng2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140513	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA; Tetrachlorodibenzodioxin results in increased expression of CCNG2 protein	PMID:19574409|PMID:19619570|PMID:20348232|PMID:22596188
1305002	Ccng2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D013749	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA]; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CCNG2 mRNA; AHR protein promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CCNG2 gene]]; ESR1 protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA]; FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]]; FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CCNG2 promoter]]; FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [NCOA3 protein binds to CCNG2 promoter]]; FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol inhibits the reaction [NCOA3 protein binds to CCNG2 promoter]]; Tetrachlorodibenzodioxin promotes the reaction [[[AHR protein binds to FOXA1 protein] which binds to CCNG2 promoter] which results in increased expression of CCNG2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [[[AHR protein binds to NCOA3 protein binds to FOXA1 protein] which binds to CCNG2 promoter] which results in increased expression of CCNG2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [[[AHR protein binds to NCOA3 protein binds to FOXA1 protein] which binds to CCNG2 promoter] which results in increased expression of CCNG2 protein]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CCNG2 gene]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CCNG2 promoter]; Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CCNG2 gene]; Tetrachlorodibenzodioxin promotes the reaction [FOXA1 protein binds to CCNG2 enhancer]; Tetrachlorodibenzodioxin promotes the reaction [FOXA1 protein binds to CCNG2 promoter]; Tetrachlorodibenzodioxin promotes the reaction [NCOA3 protein binds to CCNG2 promoter]	PMID:19574409|PMID:19619570|PMID:22596188
1305002	Ccng2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CCNG2 mRNA	PMID:25975270
1305002	Ccng2	cyclin G2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CCNG2 mRNA	PMID:28001369
1305002	Ccng2	cyclin G2	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312769	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CCNG2 mRNA	PMID:30851411
1305002	Ccng2	cyclin G2	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of CCNG2 mRNA	PMID:26272509
1305002	Ccng2	cyclin G2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1305002	Ccng2	cyclin G2	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of CCNG2 mRNA	PMID:28959563
1305002	Ccng2	cyclin G2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CCNG2 mRNA	PMID:30911355
1305002	Ccng2	cyclin G2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312770	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of CCNG2 mRNA	PMID:39631538
1305002	Ccng2	cyclin G2	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20140513	CTD	MESH:D004317	Doxorubicin inhibits the reaction [NR1I3 protein results in increased expression of CCNG2 mRNA]	PMID:21557330
1305002	Ccng2	cyclin G2	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of CCNG2 mRNA	PMID:16508948
1305002	Ccng2	cyclin G2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCNG2 mRNA	PMID:34032870
1305002	Ccng2	cyclin G2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312769	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CCNG2 mRNA	PMID:20886546|PMID:38568856
1305002	Ccng2	cyclin G2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNG2 mRNA	PMID:39836092
1305002	Ccng2	cyclin G2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312769	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CCNG2 promoter	PMID:27901495
1305002	Ccng2	cyclin G2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312769	E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCNG2 mRNA	PMID:30453624
1305002	Ccng2	cyclin G2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCNG2 mRNA	PMID:20504355|PMID:22228805
1305002	Ccng2	cyclin G2	gene	CHEBI:3000	beauvericin	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20190910	CTD	MESH:C004456	[beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA	PMID:31100301
1305002	Ccng2	cyclin G2	gene	CHEBI:30045	divanadium pentaoxide	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:C066075	vanadium pentoxide results in decreased expression of CCNG2 mRNA	PMID:17459161
1305002	Ccng2	cyclin G2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CCNG2 mRNA	PMID:30911355
1305002	Ccng2	cyclin G2	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1312769	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CCNG2 mRNA	PMID:25075043
1305002	Ccng2	cyclin G2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CCNG2 mRNA	PMID:27131904
1305002	Ccng2	cyclin G2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CCNG2 mRNA	PMID:25895662
1305002	Ccng2	cyclin G2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CCNG2 mRNA	PMID:20018196
1305002	Ccng2	cyclin G2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312769	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CCNG2 mRNA	PMID:26238291
1305002	Ccng2	cyclin G2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312769	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CCNG2 mRNA	PMID:20458559|PMID:24356939|PMID:25424538
1305002	Ccng2	cyclin G2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20240402	CTD	MESH:C006632	[pifithrin co-treated with Arsenic Trioxide] results in increased expression of CCNG2 mRNA	PMID:35030298
1305002	Ccng2	cyclin G2	gene	CHEBI:3090	bicalutamide	increases expression	ISO	RGD:1312769	E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of CCNG2 mRNA	PMID:15790403
1305002	Ccng2	cyclin G2	gene	CHEBI:31638	fulvestrant	increases expression	ISO	RGD:1312769	E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant results in increased expression of CCNG2 mRNA	PMID:26865669
1305002	Ccng2	cyclin G2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of CCNG2 mRNA	PMID:24136188
1305002	Ccng2	cyclin G2	gene	CHEBI:31669	hexestrol	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160705	CTD	MESH:D006589	Hexestrol results in decreased expression of CCNG2 mRNA	PMID:26865669
1305002	Ccng2	cyclin G2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CCNG2 mRNA	PMID:30047161
1305002	Ccng2	cyclin G2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of CCNG2 mRNA	PMID:27760801
1305002	Ccng2	cyclin G2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312770	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCNG2 gene	PMID:35295148
1305002	Ccng2	cyclin G2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CCNG2 mRNA	PMID:34492290
1305002	Ccng2	cyclin G2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CCNG2 mRNA	PMID:18648102
1305002	Ccng2	cyclin G2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312770	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CCNG2 mRNA	PMID:18301758|PMID:20059764|PMID:23811191
1305002	Ccng2	cyclin G2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CCNG2 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of CCNG2 mRNA]	PMID:19710929|PMID:20059764
1305002	Ccng2	cyclin G2	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of CCNG2 mRNA	PMID:19191707
1305002	Ccng2	cyclin G2	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140909	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of CCNG2 mRNA	PMID:24356939
1305002	Ccng2	cyclin G2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312770	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CCNG2 mRNA	PMID:28472532
1305002	Ccng2	cyclin G2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CCNG2 mRNA	PMID:38479592
1305002	Ccng2	cyclin G2	gene	CHEBI:33090	picene	increases expression	ISO	RGD:1312769	E	RGD:6480464	20200609	CTD	MESH:C056699	picene results in increased expression of CCNG2 mRNA	PMID:32251684
1305002	Ccng2	cyclin G2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CCNG2 mRNA	PMID:26982218
1305002	Ccng2	cyclin G2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20171010	CTD	MESH:C006780	bisphenol A results in decreased expression of CCNG2 mRNA	PMID:28711546
1305002	Ccng2	cyclin G2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CCNG2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305002	Ccng2	cyclin G2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312769	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of CCNG2 mRNA	PMID:29275510
1305002	Ccng2	cyclin G2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312770	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CCNG2 mRNA	PMID:33221593
1305002	Ccng2	cyclin G2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of CCNG2 mRNA	PMID:26496021
1305002	Ccng2	cyclin G2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CCNG2 mRNA	PMID:25172293
1305002	Ccng2	cyclin G2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312769	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CCNG2 mRNA	PMID:25979313
1305002	Ccng2	cyclin G2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	affects expression	ISO	RGD:1312770	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT affects the expression of CCNG2 mRNA	PMID:18925944
1305002	Ccng2	cyclin G2	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312769	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene results in increased expression of CCNG2 mRNA	PMID:20348232
1305002	Ccng2	cyclin G2	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to CCNG2 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to CCNG2 promoter]; Methylcholanthrene promotes the reaction [Methylcholanthrene results in increased expression of CCNG2 mRNA]	PMID:20348232
1305002	Ccng2	cyclin G2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CCNG2 mRNA	PMID:39298647
1305002	Ccng2	cyclin G2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312770	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of CCNG2 mRNA	PMID:40203079
1305002	Ccng2	cyclin G2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312770	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CCNG2 mRNA	PMID:28392331
1305002	Ccng2	cyclin G2	gene	CHEBI:34682	diazinon	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140909	CTD	MESH:D003976	Diazinon results in increased expression of CCNG2 mRNA	PMID:24356939
1305002	Ccng2	cyclin G2	gene	CHEBI:34709	Diisodecyl phthalate	increases expression	ISO	RGD:1312770	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in increased expression of CCNG2 mRNA	PMID:25270620
1305002	Ccng2	cyclin G2	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CCNG2 mRNA	PMID:22546817
1305002	Ccng2	cyclin G2	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120814	CTD	MESH:C022838	nickel chloride results in increased expression of CCNG2 mRNA	PMID:17312168|PMID:21455298
1305002	Ccng2	cyclin G2	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of CCNG2 mRNA	PMID:12729255
1305002	Ccng2	cyclin G2	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20120717	CTD	MESH:C022838	HIF1A affects the reaction [nickel chloride results in increased expression of CCNG2 mRNA]	PMID:12729255
1305002	Ccng2	cyclin G2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCNG2 mRNA	PMID:30589522
1305002	Ccng2	cyclin G2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312769	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCNG2 mRNA	PMID:37042841
1305002	Ccng2	cyclin G2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA	PMID:39836092
1305002	Ccng2	cyclin G2	gene	CHEBI:35456	cadmium dichloride	affects methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the methylation of CCNG2 promoter	PMID:22457795
1305002	Ccng2	cyclin G2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CCNG2 mRNA	PMID:25596134|PMID:38568856
1305002	Ccng2	cyclin G2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCNG2 mRNA	PMID:37236586
1305002	Ccng2	cyclin G2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140909	CTD	MESH:C018021	cobaltous chloride results in increased expression of CCNG2 mRNA	PMID:19376846|PMID:22202117|PMID:24356939
1305002	Ccng2	cyclin G2	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20120717	CTD	MESH:C018021	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CCNG2 mRNA]	PMID:22202117
1305002	Ccng2	cyclin G2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312769	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CCNG2 mRNA	PMID:24449571
1305002	Ccng2	cyclin G2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CCNG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CCNG2 mRNA	PMID:32699268
1305002	Ccng2	cyclin G2	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of CCNG2 mRNA	PMID:25596134
1305002	Ccng2	cyclin G2	gene	CHEBI:3752	clomiphene	increases expression	ISO	RGD:1312769	E	RGD:6480464	20160705	CTD	MESH:D002996	Clomiphene results in increased expression of CCNG2 mRNA	PMID:26865669
1305002	Ccng2	cyclin G2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CCNG2 mRNA	PMID:28302478
1305002	Ccng2	cyclin G2	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of CCNG2 mRNA	PMID:19167446
1305002	Ccng2	cyclin G2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CCNG2 mRNA	PMID:40419075
1305002	Ccng2	cyclin G2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCNG2 mRNA	PMID:36331819
1305002	Ccng2	cyclin G2	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of CCNG2 mRNA	PMID:25993096
1305002	Ccng2	cyclin G2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312769	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CCNG2 mRNA	PMID:25979313
1305002	Ccng2	cyclin G2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CCNG2 mRNA	PMID:17292431
1305002	Ccng2	cyclin G2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CCNG2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1305002	Ccng2	cyclin G2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1305002	Ccng2	cyclin G2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CCNG2 mRNA	PMID:30047161
1305002	Ccng2	cyclin G2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CCNG2 mRNA	PMID:25562108|PMID:25596134|PMID:27989131
1305002	Ccng2	cyclin G2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CCNG2 mRNA	PMID:20106945
1305002	Ccng2	cyclin G2	gene	CHEBI:41977	daunorubicin	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D003630	Daunorubicin results in increased expression of CCNG2 mRNA	PMID:18754885
1305002	Ccng2	cyclin G2	gene	CHEBI:42106	L-1,4-dithiothreitol	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140805	CTD	MESH:D004229	Dithiothreitol results in increased expression of CCNG2 mRNA	PMID:17332266
1305002	Ccng2	cyclin G2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CCNG2 mRNA	PMID:28973697
1305002	Ccng2	cyclin G2	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of CCNG2 mRNA	PMID:23649840
1305002	Ccng2	cyclin G2	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of CCNG2 mRNA	PMID:12929121
1305002	Ccng2	cyclin G2	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of CCNG2 mRNA]	PMID:21233418
1305002	Ccng2	cyclin G2	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1312770	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of CCNG2 mRNA	PMID:12929121
1305002	Ccng2	cyclin G2	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of CCNG2 mRNA	PMID:29309887
1305002	Ccng2	cyclin G2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312769	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CCNG2 mRNA	PMID:28542535
1305002	Ccng2	cyclin G2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CCNG2 mRNA	PMID:24935251|PMID:26272509
1305002	Ccng2	cyclin G2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1305002	Ccng2	cyclin G2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312770	E	RGD:6480464	20120613	CTD	MESH:D000082	Acetaminophen affects the expression of CCNG2 mRNA	PMID:15606129|PMID:17562736
1305002	Ccng2	cyclin G2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D005472	CCNG2 affects the susceptibility to Fluorouracil	PMID:15067352
1305002	Ccng2	cyclin G2	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20121009	CTD	MESH:D005472	Fluorouracil results in decreased expression of CCNG2 mRNA	PMID:19272435
1305002	Ccng2	cyclin G2	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120918	CTD	MESH:D005472	Fluorouracil results in increased expression of CCNG2 mRNA	PMID:16510598|PMID:16557594|PMID:17039268|PMID:18754885
1305002	Ccng2	cyclin G2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of CCNG2 mRNA	PMID:38460933
1305002	Ccng2	cyclin G2	gene	CHEBI:46936	nonivamide	increases expression	ISO	RGD:1312769	E	RGD:6480464	20170303	CTD	MESH:C040937	nonivamide results in increased expression of CCNG2 mRNA	PMID:17332266
1305002	Ccng2	cyclin G2	gene	CHEBI:46936	nonivamide	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20170303	CTD	MESH:C040937	[nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of CCNG2 mRNA	PMID:17332266
1305002	Ccng2	cyclin G2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNG2 mRNA	PMID:39836092
1305002	Ccng2	cyclin G2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CCNG2 mRNA	PMID:29391264
1305002	Ccng2	cyclin G2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of CCNG2 mRNA	PMID:18851785
1305002	Ccng2	cyclin G2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312770	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CCNG2 mRNA	PMID:35436446
1305002	Ccng2	cyclin G2	gene	CHEBI:48607	lithium chloride	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in decreased expression of CCNG2 mRNA	PMID:15711924
1305002	Ccng2	cyclin G2	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in increased expression of CCNG2 mRNA	PMID:17440966
1305002	Ccng2	cyclin G2	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of CCNG2 mRNA	PMID:18754885
1305002	Ccng2	cyclin G2	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of CCNG2 mRNA	PMID:26272509
1305002	Ccng2	cyclin G2	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1305002	Ccng2	cyclin G2	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of CCNG2 mRNA	PMID:16984733
1305002	Ccng2	cyclin G2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312769	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CCNG2 mRNA	PMID:20458559|PMID:24356939|PMID:25424538
1305002	Ccng2	cyclin G2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20240402	CTD	MESH:C032793	[pifithrin co-treated with Arsenic Trioxide] results in increased expression of CCNG2 mRNA	PMID:35030298
1305002	Ccng2	cyclin G2	gene	CHEBI:49976	zinc dichloride	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20120717	CTD	MESH:C016837	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CCNG2 mRNA]	PMID:22202117
1305002	Ccng2	cyclin G2	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of CCNG2 mRNA	PMID:25596134
1305002	Ccng2	cyclin G2	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of CCNG2 mRNA	PMID:25596134
1305002	Ccng2	cyclin G2	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1312769	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CCNG2 mRNA	PMID:25075043
1305002	Ccng2	cyclin G2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCNG2 mRNA	PMID:25554681
1305002	Ccng2	cyclin G2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312769	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CCNG2 mRNA	PMID:15585362
1305002	Ccng2	cyclin G2	gene	CHEBI:50845	doxycycline	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D004318	Doxycycline inhibits the reaction [Isoproterenol results in increased expression of CCNG2 mRNA]	PMID:18089841
1305002	Ccng2	cyclin G2	gene	CHEBI:5118	fluoxetine	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140909	CTD	MESH:D005473	Fluoxetine results in increased expression of CCNG2 mRNA	PMID:24356939
1305002	Ccng2	cyclin G2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CCNG2 mRNA	PMID:24136188
1305002	Ccng2	cyclin G2	gene	CHEBI:52717	bortezomib	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20170303	CTD	MESH:D000069286	[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of CCNG2 mRNA	PMID:25522274
1305002	Ccng2	cyclin G2	gene	CHEBI:5864	ifosfamide	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of CCNG2 mRNA	PMID:25596134
1305002	Ccng2	cyclin G2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA	PMID:39836092
1305002	Ccng2	cyclin G2	gene	CHEBI:63112	fingolimod hydrochloride	increases expression	ISO	RGD:1312769	E	RGD:6480464	20170228	CTD	MESH:D000068876	Fingolimod Hydrochloride results in increased expression of CCNG2 mRNA	PMID:24356939
1305002	Ccng2	cyclin G2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNG2 mRNA	PMID:21641980
1305002	Ccng2	cyclin G2	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D019772	CCNG2 protein affects the susceptibility to Topotecan	PMID:16217747
1305002	Ccng2	cyclin G2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of CCNG2 mRNA	PMID:19812364
1305002	Ccng2	cyclin G2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CCNG2 mRNA	PMID:15336504
1305002	Ccng2	cyclin G2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CCNG2 mRNA	PMID:28801915
1305002	Ccng2	cyclin G2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of CCNG2 mRNA	PMID:18089841|PMID:20003209
1305002	Ccng2	cyclin G2	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20120515	CTD	MESH:D007545	Doxycycline inhibits the reaction [Isoproterenol results in increased expression of CCNG2 mRNA]	PMID:18089841
1305002	Ccng2	cyclin G2	gene	CHEBI:64648	enniatin	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20190910	CTD	MESH:C100264	[beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA	PMID:31100301
1305002	Ccng2	cyclin G2	gene	CHEBI:6784	mestranol	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20160705	CTD	MESH:D008656	Mestranol results in decreased expression of CCNG2 mRNA	PMID:26865669
1305002	Ccng2	cyclin G2	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of CCNG2 mRNA	PMID:25596134
1305002	Ccng2	cyclin G2	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of CCNG2 mRNA	PMID:25596134
1305002	Ccng2	cyclin G2	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of CCNG2 mRNA	PMID:29309887
1305002	Ccng2	cyclin G2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	increases expression	ISO	RGD:1312769	E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in increased expression of CCNG2 mRNA	PMID:22101062
1305002	Ccng2	cyclin G2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CCNG2 mRNA	PMID:22206623
1305002	Ccng2	cyclin G2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNG2 mRNA	PMID:22206623
1305002	Ccng2	cyclin G2	gene	CHEBI:747853	Gedatolisib	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20260714	CTD	MESH:C549060	gedatolisib inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA]	PMID:27542212
1305002	Ccng2	cyclin G2	gene	CHEBI:7507	neomycin	increases expression	ISO	RGD:1312770	E	RGD:6480464	20190507	CTD	MESH:D009355	Neomycin results in increased expression of CCNG2 mRNA	PMID:30626089
1305002	Ccng2	cyclin G2	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1312769	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of CCNG2 mRNA	PMID:36318118
1305002	Ccng2	cyclin G2	gene	CHEBI:7553	niclosamide	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA]	PMID:27542212
1305002	Ccng2	cyclin G2	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20140909	CTD	MESH:C025589	ochratoxin A results in decreased expression of CCNG2 mRNA	PMID:24356939
1305002	Ccng2	cyclin G2	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312769	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CCNG2 mRNA	PMID:30851411
1305002	Ccng2	cyclin G2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1305002	Ccng2	cyclin G2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCNG2 gene]	PMID:28238834
1305002	Ccng2	cyclin G2	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1312769	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of CCNG2 mRNA	PMID:18927307
1305002	Ccng2	cyclin G2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312770	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CCNG2 mRNA	PMID:23091169
1305002	Ccng2	cyclin G2	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of CCNG2 mRNA	PMID:18958704
1305002	Ccng2	cyclin G2	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1312770	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of CCNG2 mRNA	PMID:21195148
1305002	Ccng2	cyclin G2	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1312770	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of CCNG2 mRNA	PMID:21195148
1305002	Ccng2	cyclin G2	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	increases expression	ISO	RGD:1312769	E	RGD:6480464	20200609	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in increased expression of CCNG2 mRNA	PMID:32251684
1305002	Ccng2	cyclin G2	gene	CHEBI:82388	p-anisidine	increases expression	ISO	RGD:1312770	E	RGD:6480464	20141111	CTD	MESH:C013813	4-anisidine results in increased expression of CCNG2 mRNA	PMID:12929121
1305002	Ccng2	cyclin G2	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of CCNG2 mRNA	PMID:20368581
1305002	Ccng2	cyclin G2	gene	CHEBI:8378	prednisolone	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140909	CTD	MESH:D011239	Prednisolone results in increased expression of CCNG2 mRNA	PMID:24356939
1305002	Ccng2	cyclin G2	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of CCNG2 mRNA	PMID:26079696
1305002	Ccng2	cyclin G2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CCNG2 mRNA	PMID:30047161
1305002	Ccng2	cyclin G2	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of CCNG2 mRNA	PMID:26272509
1305002	Ccng2	cyclin G2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1305002	Ccng2	cyclin G2	gene	CHEBI:8687	pyrvinium	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20190219	CTD	MESH:C024631	pyrvinium inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA]	PMID:27542212
1305002	Ccng2	cyclin G2	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1312769	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of CCNG2 mRNA	PMID:16497877|PMID:26865669
1305002	Ccng2	cyclin G2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1305002	Ccng2	cyclin G2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CCNG2 mRNA	PMID:27131904
1305002	Ccng2	cyclin G2	gene	CHEBI:9168	sirolimus	increases expression	ISO	RGD:1312769	E	RGD:6480464	20140909	CTD	MESH:D020123	Sirolimus results in increased expression of CCNG2 mRNA	PMID:24356939
1305002	Ccng2	cyclin G2	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D020123	[cotylenin A co-treated with Sirolimus] results in increased expression of CCNG2 mRNA; Sirolimus inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA]; Sirolimus inhibits the reaction [TP73 protein results in increased expression of CCNG2 mRNA]	PMID:18754885|PMID:21245298|PMID:27542212
1305002	Ccng2	cyclin G2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CCNG2 mRNA	PMID:19281266
1305002	Ccng2	cyclin G2	gene	CHEBI:92658	kenpaullone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C119620	kenpaullone results in decreased expression of CCNG2 mRNA	PMID:17993264
1305002	Ccng2	cyclin G2	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1312769	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in decreased expression of CCNG2 mRNA	PMID:34581912
1305002	Ccng2	cyclin G2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312769	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CCNG2 mRNA	PMID:38568856
1305002	Ccng2	cyclin G2	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312769	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CCNG2 mRNA	PMID:29301935
1305002	Ccng2	cyclin G2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312769	E	RGD:6480464	20120412	CTD	MESH:D019284	Thapsigargin results in increased expression of CCNG2 mRNA	PMID:17332266
1305002	Ccng2	cyclin G2	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1312770	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of CCNG2 mRNA	PMID:21195148
1305002	Ccng2	cyclin G2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CCNG2 mRNA	PMID:35537566
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312772	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of PKNOX1 mRNA	PMID:33045310
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PKNOX1 mRNA]	PMID:31150632
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PKNOX1 mRNA	PMID:26251327
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312772	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PKNOX1 mRNA	PMID:20188158
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1312772	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of PKNOX1 promoter	PMID:26251327
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312772	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PKNOX1 mRNA	PMID:30319688
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PKNOX1 mRNA	PMID:39241906
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312771	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PKNOX1 mRNA	PMID:37042841
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:17303	morphine	increases expression	ISO	RGD:1312772	E	RGD:6480464	20120412	CTD	MESH:D009020	Morphine results in increased expression of PKNOX1 mRNA	PMID:21178816
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312772	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PKNOX1 mRNA	PMID:23892564
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312771	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PKNOX1 protein	PMID:37730182
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PKNOX1 mRNA	PMID:33387578
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312771	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PKNOX1 mRNA	PMID:28818685
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312771	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PKNOX1 mRNA	PMID:23649840
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312771	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PKNOX1 promoter	PMID:30157460
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312771	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PKNOX1 mRNA	PMID:18593933
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312772	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PKNOX1 mRNA	PMID:17484886
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PKNOX1 mRNA	PMID:31150632
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PKNOX1 mRNA]	PMID:31150632
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PKNOX1 mRNA	PMID:25629700
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312771	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PKNOX1 mRNA	PMID:23557933
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312772	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PKNOX1 mRNA	PMID:21570461|PMID:24058054
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312771	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PKNOX1 mRNA	PMID:32763439
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312771	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PKNOX1 mRNA	PMID:38568856
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312772	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PKNOX1 mRNA	PMID:22228805
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312771	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PKNOX1 mRNA	PMID:18593933
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312771	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PKNOX1 mRNA	PMID:15761015
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312772	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PKNOX1 gene; titanium dioxide results in decreased methylation of PKNOX1 promoter	PMID:35295148
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312772	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PKNOX1 mRNA	PMID:18648102
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PKNOX1 mRNA	PMID:23811191
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312771	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PKNOX1 gene	PMID:31601247
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PKNOX1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312772	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PKNOX1 mRNA	PMID:26063408
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312772	E	RGD:6480464	20240206	CTD	MESH:C543008	bisphenol S results in increased expression of PKNOX1 mRNA	PMID:37611474
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1312772	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of PKNOX1 mRNA	PMID:18974090
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PKNOX1 promoter	PMID:22457795
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312771	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PKNOX1 mRNA	PMID:19320972
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312771	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PKNOX1 mRNA	PMID:25979313
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312772	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PKNOX1 mRNA	PMID:28973697
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PKNOX1 mRNA	PMID:33387578
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312771	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of PKNOX1 mRNA	PMID:21420995
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312771	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PKNOX1 mRNA	PMID:15761015
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of PKNOX1 mRNA	PMID:30307764
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1312772	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of PKNOX1 mRNA	PMID:36907384
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:6980	monocrotaline	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20171114	CTD	MESH:D016686	Monocrotaline results in decreased expression of PKNOX1 mRNA	PMID:28818515
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312772	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PKNOX1 mRNA	PMID:22206623
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312771	E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PKNOX1 mRNA	PMID:19737606
1305003	Pknox1	PBX/knotted 1 homeobox 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PKNOX1 mRNA	PMID:28973697
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SFSWAP mRNA	PMID:33045310
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SFSWAP mRNA	PMID:39241906
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312773	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SFSWAP mRNA	PMID:37042841
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312774	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SFSWAP mRNA	PMID:34319233
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312773	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SFSWAP protein	PMID:37730182
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1312773	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of SFSWAP intron	PMID:30157460
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312773	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SFSWAP protein	PMID:23301498
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312773	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SFSWAP intron	PMID:30157460
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SFSWAP mRNA	PMID:25629700
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFSWAP mRNA	PMID:40504410
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312773	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SFSWAP protein	PMID:35688186
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312774	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SFSWAP mRNA	PMID:21570461
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFSWAP mRNA	PMID:33387578
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFSWAP mRNA	PMID:19933214
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFSWAP mRNA	PMID:17942748
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312773	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SFSWAP mRNA	PMID:29803840
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312773	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SFSWAP protein	PMID:35688186
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312773	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SFSWAP mRNA	PMID:38568856
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFSWAP mRNA	PMID:40504410
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312773	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SFSWAP intron	PMID:30157460
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312773	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SFSWAP gene	PMID:31601247
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312774	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SFSWAP gene	PMID:35295148
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312774	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SFSWAP mRNA	PMID:23557971
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SFSWAP mRNA	PMID:18648102
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SFSWAP mRNA	PMID:25181051|PMID:34947998
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SFSWAP gene	PMID:28505145
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312773	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFSWAP mRNA	PMID:28628672
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312773	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SFSWAP mRNA	PMID:19244175
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312774	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SFSWAP mRNA	PMID:39298647
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312773	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SFSWAP mRNA	PMID:28628672
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SFSWAP mRNA	PMID:38685157
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312774	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of SFSWAP intron	PMID:28392331
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312773	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFSWAP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SFSWAP mRNA	PMID:28628672
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312773	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SFSWAP mRNA	PMID:38568856
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20121009	CTD	MESH:D019256	MT3 affects the reaction [Cadmium Chloride affects the expression of SFSWAP mRNA]	PMID:20371981
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312773	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SFSWAP mRNA	PMID:19376846
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SFSWAP mRNA	PMID:17292431
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312773	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SFSWAP mRNA	PMID:23179753
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312773	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SFSWAP gene	PMID:29154799
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312773	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFSWAP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SFSWAP mRNA	PMID:28628672
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SFSWAP mRNA	PMID:18502557
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312773	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SFSWAP mRNA	PMID:27188386
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SFSWAP mRNA	PMID:33387578
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1312773	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of SFSWAP gene	PMID:29523930
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFSWAP mRNA	PMID:40504410
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SFSWAP mRNA	PMID:17942748
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFSWAP mRNA	PMID:17942748
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312773	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFSWAP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SFSWAP mRNA	PMID:28628672
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SFSWAP mRNA	PMID:25554681
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312773	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SFSWAP protein	PMID:32959892
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312774	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SFSWAP mRNA	PMID:22206623
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312773	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SFSWAP protein	PMID:31285264
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312773	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SFSWAP mRNA	PMID:19159669
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312774	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SFSWAP mRNA	PMID:23091169
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SFSWAP mRNA	PMID:23640034
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312773	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SFSWAP mRNA	PMID:38568856
1305004	Sfswap	splicing factor SWAP	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of SFSWAP gene	PMID:31682807
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312775	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of LAMTOR5 mRNA	PMID:33167477
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LAMTOR5 mRNA	PMID:39298647
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312775	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LAMTOR5 mRNA	PMID:37042841
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312776	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LAMTOR5 mRNA	PMID:33754040
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312775	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of LAMTOR5 protein	PMID:37730182
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312776	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of LAMTOR5 mRNA	PMID:27462272
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312775	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of LAMTOR5 mRNA	PMID:23369406
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LAMTOR5 mRNA	PMID:35301059
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312775	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LAMTOR5 mRNA	PMID:19549813
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LAMTOR5 mRNA	PMID:22206623
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LAMTOR5 mRNA	PMID:39836092
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LAMTOR5 mRNA	PMID:40504410
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LAMTOR5 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of LAMTOR5 mRNA	PMID:23557933
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LAMTOR5 mRNA	PMID:32109520
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of LAMTOR5 mRNA]; MT2 affects the reaction [Copper results in increased expression of LAMTOR5 mRNA]	PMID:16629173
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312775	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of LAMTOR5 mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LAMTOR5 mRNA	PMID:39836092
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LAMTOR5 mRNA	PMID:40504410
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of LAMTOR5 mRNA]; MT2 affects the reaction [Copper results in increased expression of LAMTOR5 mRNA]	PMID:16629173
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312775	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of LAMTOR5 mRNA	PMID:20458559
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1312775	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of LAMTOR5 mRNA	PMID:38568856
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312776	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LAMTOR5 gene	PMID:35295148
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of LAMTOR5 mRNA	PMID:18445702
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of LAMTOR5 mRNA	PMID:35598803
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of LAMTOR5 mRNA	PMID:25181051
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312775	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of LAMTOR5 protein	PMID:37567409
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LAMTOR5 mRNA	PMID:28628672
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LAMTOR5 mRNA	PMID:28628672
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312776	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LAMTOR5 mRNA	PMID:37019170
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of LAMTOR5 mRNA	PMID:17361019
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LAMTOR5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LAMTOR5 mRNA	PMID:28628672
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312775	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LAMTOR5 mRNA	PMID:37042841
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LAMTOR5 mRNA	PMID:33453195
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of LAMTOR5 promoter	PMID:22457795
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LAMTOR5 mRNA	PMID:35301059
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:36791	escitalopram	increases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D000089983	Escitalopram results in increased expression of LAMTOR5 mRNA	PMID:28467792
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:3723	citalopram	increases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in increased expression of LAMTOR5 mRNA	PMID:28467792
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of LAMTOR5 mRNA	PMID:17585979
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312775	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LAMTOR5 mRNA	PMID:25812627
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312775	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of LAMTOR5 mRNA	PMID:28302478
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1312775	E	RGD:6480464	20161025	CTD	MESH:C100187	chloropicrin results in increased expression of LAMTOR5 mRNA	PMID:26352163
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312775	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of LAMTOR5 mRNA	PMID:25812627
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LAMTOR5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LAMTOR5 mRNA	PMID:28628672
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LAMTOR5 mRNA	PMID:33387578
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LAMTOR5 mRNA	PMID:39836092
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LAMTOR5 mRNA	PMID:40504410
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of LAMTOR5 mRNA	PMID:29097150
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LAMTOR5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LAMTOR5 mRNA	PMID:28628672
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312775	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of LAMTOR5 mRNA	PMID:20458559
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of LAMTOR5 mRNA	PMID:24136188
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LAMTOR5 mRNA	PMID:35964746
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312775	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LAMTOR5 protein	PMID:32959892
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312776	E	RGD:6480464	20161025	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of LAMTOR5 mRNA	PMID:23650126
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LAMTOR5 mRNA	PMID:22206623
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LAMTOR5 mRNA	PMID:22206623
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of LAMTOR5 protein	PMID:37664457
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312775	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of LAMTOR5 protein	PMID:31285264
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:77397	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile	increases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in increased expression of LAMTOR5 mRNA	PMID:28467792
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1312775	E	RGD:6480464	20191112	CTD	MESH:C042577	diallyl trisulfide results in increased expression of LAMTOR5 mRNA	PMID:11925594
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312775	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of LAMTOR5 protein	PMID:37664457
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LAMTOR5 mRNA	PMID:21346803
1305005	Lamtor5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C025643	vinclozolin results in increased expression of LAMTOR5 mRNA	PMID:23034163|PMID:23869203
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1343978	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of GNL2 protein	PMID:39638853
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1343978	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GNL2 mRNA	PMID:33167477
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GNL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GNL2 mRNA	PMID:32699268
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1343978	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of GNL2 mRNA	PMID:20044591
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553517	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GNL2 mRNA	PMID:39241906
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of GNL2 mRNA]	PMID:39241906
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1343978	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of GNL2 mRNA	PMID:22574217
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1343978	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of GNL2 mRNA	PMID:31614463
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553517	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of GNL2 mRNA	PMID:39298647
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20130611	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of GNL2 mRNA	PMID:21453500
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1343978	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of GNL2 mRNA	PMID:38568856
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1343978	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GNL2 mRNA	PMID:37042841
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20130611	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of GNL2 mRNA	PMID:21453500
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GNL2 mRNA	PMID:33387578
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GNL2 mRNA	PMID:36331819
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNL2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of GNL2 mRNA	PMID:39836092
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	ISO	RGD:1343978	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of GNL2 mRNA	PMID:17103032
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GNL2 mRNA	PMID:37236586
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1343978	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of GNL2 mRNA	PMID:19549813
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1343978	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GNL2 gene	PMID:27153756
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of GNL2 protein	PMID:39638853
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GNL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GNL2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of GNL2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of GNL2 mRNA	PMID:32699268|PMID:41430723
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GNL2 mRNA	PMID:31150632
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1553517	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GNL2 mRNA	PMID:27339419|PMID:31919559
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1553517	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of GNL2 mRNA	PMID:25629700
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of GNL2 mRNA]	PMID:22206623
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNL2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNL2 mRNA	PMID:39836092
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNL2 mRNA	PMID:40504410
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1553517	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of GNL2 protein	PMID:25505154
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1553517	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of GNL2 mRNA	PMID:30912803
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553517	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GNL2 mRNA	PMID:21570461
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GNL2 mRNA	PMID:33387578
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1553517	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of GNL2 mRNA	PMID:39631538
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNL2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNL2 mRNA	PMID:39836092
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNL2 mRNA	PMID:40504410
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343978	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GNL2 promoter	PMID:27901495
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553517	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GNL2 mRNA	PMID:22228805
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to GNL2 promoter]	PMID:19654925
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1343978	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GNL2 mRNA	PMID:26238291
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of GNL2 mRNA	PMID:23411599|PMID:34492290
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553517	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of GNL2 mRNA	PMID:18445702
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1343978	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of GNL2 mRNA	PMID:30903817
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of GNL2 mRNA	PMID:32145629
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553517	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GNL2 mRNA	PMID:33221593|PMID:37894381
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GNL2 mRNA	PMID:25181051
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553517	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GNL2 mRNA	PMID:39298647
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1553517	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of GNL2 mRNA	PMID:38685157
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1553517	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GNL2 mRNA	PMID:21266533
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of GNL2 mRNA]	PMID:39241906
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNL2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of GNL2 mRNA	PMID:39836092
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GNL2 mRNA	PMID:37236586
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1553517	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of GNL2 mRNA	PMID:28903501
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1343978	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GNL2 mRNA	PMID:19320972
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GNL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GNL2 mRNA	PMID:32699268
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1343978	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GNL2 mRNA	PMID:28302478
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GNL2 mRNA	PMID:36331819
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of GNL2 mRNA	PMID:25993096
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343978	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GNL2 mRNA	PMID:25979313
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1343978	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GNL2 mRNA	PMID:20106945|PMID:25562108
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1343978	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GNL2 mRNA	PMID:38832940
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553517	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GNL2 mRNA	PMID:17562736
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNL2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNL2 mRNA	PMID:39836092
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNL2 mRNA	PMID:40504410
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of GNL2 mRNA	PMID:29097150
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553517	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GNL2 mRNA; Nanotubes, Carbon results in increased expression of GNL2 mRNA	PMID:25620056
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of GNL2 mRNA	PMID:24136188
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNL2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of GNL2 mRNA	PMID:39836092
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1553517	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of GNL2 mRNA	PMID:23650126
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553517	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GNL2 mRNA	PMID:22206623
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of GNL2 mRNA]	PMID:22206623
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of GNL2 protein	PMID:37664457
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of GNL2 protein	PMID:39638853
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of GNL2 mRNA	PMID:20345932
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1553517	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of GNL2 mRNA]	PMID:39241906
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1343978	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of GNL2 protein	PMID:37664457
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of GNL2 mRNA	PMID:19281266
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GNL2 mRNA	PMID:21346803
1305006	Gnl2	G protein nucleolar 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of GNL2 mRNA	PMID:21346803
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1332449	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of OGFOD3 mRNA	PMID:37995155
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of OGFOD3 gene	PMID:30207508
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1602867	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of OGFOD3 mRNA	PMID:29432896
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332449	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of OGFOD3 mRNA	PMID:39241906
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602867	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of OGFOD3 mRNA	PMID:37042841
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1602867	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of OGFOD3 mRNA	PMID:23649840
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of OGFOD3 mRNA	PMID:26577399
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602867	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of OGFOD3 mRNA	PMID:19549813
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1602867	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of OGFOD3 mRNA	PMID:23649840
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of OGFOD3 protein	PMID:33236894
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1602867	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of OGFOD3 mRNA	PMID:23649840
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of OGFOD3 mRNA	PMID:31150632
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332449	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of OGFOD3 mRNA	PMID:22206623
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OGFOD3 mRNA	PMID:32109520
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of OGFOD3 protein	PMID:35544339
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1602867	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of OGFOD3 mRNA	PMID:33212167
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of OGFOD3 mRNA	PMID:28959563
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1602867	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of OGFOD3 mRNA	PMID:32763439
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1602867	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of OGFOD3 mRNA	PMID:20044591
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602867	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of OGFOD3 mRNA	PMID:38568856
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602867	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of OGFOD3 promoter	PMID:27901495
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1332449	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of OGFOD3 3' UTR; Benzo(a)pyrene results in decreased methylation of OGFOD3 exon; Benzo(a)pyrene results in decreased methylation of OGFOD3 intron	PMID:27901495
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in decreased expression of OGFOD3 mRNA	PMID:27914986|PMID:34492290
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:32497	thioacetamide	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased methylation of OGFOD3 promoter	PMID:27914986
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1332449	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of OGFOD3 mRNA	PMID:28472532
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of OGFOD3 mRNA	PMID:30816183
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332449	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of OGFOD3 mRNA	PMID:33221593
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of OGFOD3 mRNA	PMID:25181051
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332449	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of OGFOD3 mRNA	PMID:26063408
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1332449	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of OGFOD3 promoter	PMID:27312807
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332449	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of OGFOD3 mRNA	PMID:40203079
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1602867	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of OGFOD3 intron	PMID:30157460
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1332449	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of OGFOD3 mRNA	PMID:34813904
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1332449	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of OGFOD3 mRNA	PMID:34813904
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of OGFOD3 mRNA	PMID:33453195
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1602867	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of OGFOD3 protein	PMID:38185225
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1602867	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of OGFOD3 mRNA	PMID:24449571
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602867	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of OGFOD3 mRNA	PMID:25979313
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602867	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of OGFOD3 mRNA	PMID:29154799
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602867	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of OGFOD3 gene	PMID:29154799
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1332449	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of OGFOD3 mRNA	PMID:35436446
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1602867	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of OGFOD3 mRNA	PMID:15336504
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1602867	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of OGFOD3 intron	PMID:30157460
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332449	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of OGFOD3 mRNA	PMID:22206623
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1332449	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of OGFOD3 mRNA	PMID:39847705
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of OGFOD3 mRNA	PMID:24780913
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of OGFOD3 mRNA	PMID:23034163
1305007	Ogfod3	2-oxoglutarate and iron-dependent oxygenase domain containing 3	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:C025643	vinclozolin results in increased methylation of OGFOD3 gene	PMID:30207508
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SUCLG2 mRNA	PMID:38218311
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SUCLG2 mRNA	PMID:20938992
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SUCLG2 mRNA	PMID:32699268
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SUCLG2 mRNA	PMID:36331819
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SUCLG2 mRNA	PMID:22378314
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312780	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SUCLG2 mRNA	PMID:30319688
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SUCLG2 mRNA	PMID:21632981
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312780	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SUCLG2 mRNA	PMID:39241906
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SUCLG2 mRNA	PMID:32145629
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SUCLG2 mRNA	PMID:26496021
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SUCLG2 mRNA	PMID:20938992
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SUCLG2 mRNA	PMID:23649840
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312780	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of SUCLG2 mRNA	PMID:33848595
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of SUCLG2 mRNA]	PMID:33848595
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17712	9H-xanthine	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D019820	[Xanthine co-treated with XDH protein] results in decreased expression of SUCLG2 protein	PMID:19464573
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SUCLG2 mRNA; Gentamicins results in increased expression of SUCLG2 protein	PMID:22061828
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SUCLG2 mRNA	PMID:28818685
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUCLG2 mRNA	PMID:36331819
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA	PMID:39836092
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312780	E	RGD:6480464	20151110	CTD	MESH:D002104	Cadmium results in increased expression of SUCLG2 mRNA	PMID:26187450
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SUCLG2 mRNA	PMID:35301059
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SUCLG2 mRNA	PMID:29950665
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SUCLG2 mRNA	PMID:23649840
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312779	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SUCLG2 protein	PMID:20106945
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SUCLG2 mRNA	PMID:19770486
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312779	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SUCLG2 gene	PMID:27153756
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SUCLG2 mRNA	PMID:23649840
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SUCLG2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA	PMID:32699268
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SUCLG2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of SUCLG2 protein	PMID:38598786
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SUCLG2 mRNA	PMID:31150632
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SUCLG2 mRNA	PMID:31919559
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SUCLG2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SUCLG2 mRNA	PMID:20938992|PMID:22206623
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SUCLG2 mRNA	PMID:39836092
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SUCLG2 mRNA	PMID:26272509
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA	PMID:27188386
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of SUCLG2 mRNA	PMID:26302742
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SUCLG2 mRNA	PMID:31881176
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312780	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SUCLG2 protein	PMID:25505154
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form] results in decreased expression of SUCLG2 mRNA	PMID:23625948
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312780	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SUCLG2 mRNA	PMID:21570461
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312780	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SUCLG2 mRNA	PMID:19465110
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SUCLG2 mRNA	PMID:33212167
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SUCLG2 mRNA	PMID:32763439
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SUCLG2 mRNA	PMID:29803840
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of SUCLG2 mRNA; Doxorubicin results in decreased expression of SUCLG2 protein	PMID:21251210|PMID:26873546
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20151013	CTD	MESH:D004317	sodium nitrate inhibits the reaction [Doxorubicin results in decreased expression of SUCLG2 protein]	PMID:21251210
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28918	(R)-adrenaline	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D004837	Epinephrine results in increased expression of SUCLG2 protein	PMID:19464573
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29073	L-ascorbic acid	affects expression	ISO	RGD:1312780	E	RGD:6480464	20120501	CTD	MESH:D001205	Ascorbic Acid affects the expression of SUCLG2 protein	PMID:19224539
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SUCLG2 mRNA	PMID:38568856
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SUCLG2 mRNA	PMID:39836092
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SUCLG2 mRNA	PMID:21632981
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312780	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SUCLG2 mRNA	PMID:22228805
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SUCLG2 mRNA]	PMID:32406909
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312779	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SUCLG2 mRNA	PMID:19150397
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SUCLG2 mRNA	PMID:29633893
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312779	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SUCLG2 protein	PMID:25419056
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of SUCLG2 mRNA	PMID:21515302
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312780	E	RGD:6480464	20180515	CTD	MESH:C009495	titanium dioxide results in increased expression of SUCLG2 mRNA	PMID:29128614|PMID:29264374
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SUCLG2 mRNA	PMID:29950665
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SUCLG2 mRNA	PMID:34492290
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312780	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SUCLG2 mRNA	PMID:18301758|PMID:23811191
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312779	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SUCLG2 mRNA	PMID:30903817
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312780	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SUCLG2 promoter	PMID:27334623
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SUCLG2 mRNA	PMID:34947998
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SUCLG2 mRNA	PMID:25181051
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312779	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SUCLG2 protein	PMID:37567409
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SUCLG2 mRNA	PMID:26496021
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312779	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SUCLG2 protein	PMID:34186270
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312779	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SUCLG2 protein	PMID:34186270
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312779	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SUCLG2 protein	PMID:34186270
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SUCLG2 mRNA	PMID:17602206
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SUCLG2 mRNA	PMID:29950665
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SUCLG2 mRNA	PMID:21266533
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SUCLG2 mRNA	PMID:17361019|PMID:21266533
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SUCLG2 protein	PMID:38598786
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SUCLG2 mRNA	PMID:17602206
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312779	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SUCLG2 mRNA	PMID:37042841
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:351346	phenethyl isothiocyanate	affects binding	ISO	RGD:1312779	E	RGD:6480464	20120717	CTD	MESH:C058305	SUCLG2 protein binds to phenethyl isothiocyanate	PMID:21838287
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA	PMID:39836092
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SUCLG2 mRNA	PMID:38568856
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312779	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SUCLG2 protein	PMID:24527689
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SUCLG2 mRNA	PMID:35301059
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SUCLG2 mRNA	PMID:19376846
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SUCLG2 mRNA	PMID:32699268
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:3750	clofibrate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate results in increased expression of SUCLG2 protein	PMID:16470657
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:38221	fumonisin B1	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in decreased expression of SUCLG2 mRNA	PMID:16221962
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SUCLG2 mRNA	PMID:31533062
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39096	alpha-hexachlorocyclohexane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C040534	alpha-hexachlorocyclohexane results in increased expression of SUCLG2 mRNA	PMID:16940010
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUCLG2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SUCLG2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SUCLG2 mRNA	PMID:36331819
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312779	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SUCLG2 mRNA	PMID:25979313
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SUCLG2 mRNA	PMID:23179753|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29501571
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312779	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SUCLG2 gene	PMID:29501571
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA	PMID:27188386
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SUCLG2 mRNA	PMID:20106945
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312779	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of SUCLG2 mRNA	PMID:25047013
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312780	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SUCLG2 mRNA	PMID:28973697
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1312779	E	RGD:6480464	20120412	CTD	MESH:D008727	SUCLG2 protein affects the susceptibility to Methotrexate	PMID:16217747
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SUCLG2 mRNA	PMID:38832940
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SUCLG2 mRNA	PMID:25270620
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312780	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SUCLG2 mRNA	PMID:17562736
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SUCLG2 mRNA	PMID:33387578
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of SUCLG2 mRNA	PMID:25704631|PMID:29067470
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1312780	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of SUCLG2 mRNA	PMID:19446018
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SUCLG2 mRNA	PMID:39836092
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:48517	7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D019820	[Xanthine co-treated with XDH protein] results in decreased expression of SUCLG2 protein	PMID:19464573
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SUCLG2 mRNA	PMID:29633893
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312779	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SUCLG2 protein	PMID:25419056
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:6030	isoniazide	increases expression	ISO	RGD:1312779	E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of SUCLG2 protein	PMID:40015660
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SUCLG2 protein	PMID:32959892
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:63005	sodium nitrate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20151013	CTD	MESH:C031618	sodium nitrate inhibits the reaction [Doxorubicin results in decreased expression of SUCLG2 protein]	PMID:21251210
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA	PMID:39836092
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:6382	Lasiocarpine	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of SUCLG2 mRNA	PMID:40054833
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of SUCLG2 protein	PMID:30467583
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of SUCLG2 mRNA	PMID:17383702
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SUCLG2 mRNA	PMID:31758290
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312779	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SUCLG2 protein	PMID:34186270
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SUCLG2 mRNA	PMID:22206623
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SUCLG2 mRNA	PMID:22206623
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SUCLG2 protein	PMID:22144121
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:7602	nobiletin	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of SUCLG2 protein]	PMID:38348393
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:76326	N-nitrosomorpholine	affects expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine affects the expression of SUCLG2 protein	PMID:19716841
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA	PMID:27188386
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of SUCLG2 mRNA	PMID:22538082
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of SUCLG2 protein	PMID:38348393
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of SUCLG2 protein]	PMID:38348393
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:86204	chromium trinitrate	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20170228	CTD	MESH:C041167	chromium nitrate results in decreased expression of SUCLG2 protein	PMID:22144121
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:90633	perfluorododecanoic acid	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in increased expression of SUCLG2 protein	PMID:26168851
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1312780	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of SUCLG2 protein	PMID:35357534
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA	PMID:27188386
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SUCLG2 mRNA	PMID:21346803
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:94688	5-methyl-4-oxido-2-pyrazin-4-iumcarboxylic acid	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20170307	CTD	MESH:C027696	acipimox results in decreased expression of SUCLG2 mRNA	PMID:25352640
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312779	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SUCLG2 mRNA	PMID:38568856
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312779	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of SUCLG2 protein	PMID:38598786
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SUCLG2 mRNA	PMID:21346803
1305008	Suclg2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of SUCLG2 gene	PMID:31079544
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312782	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of DNAJC9 mRNA	PMID:37995155
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1312781	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of DNAJC9 protein	PMID:36641056
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of DNAJC9 mRNA	PMID:26516004
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of DNAJC9 mRNA	PMID:24763279
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DNAJC9 mRNA	PMID:22378314
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312782	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DNAJC9 mRNA	PMID:39241906
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of DNAJC9 mRNA	PMID:32145629
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of DNAJC9 mRNA	PMID:20660070
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312781	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of DNAJC9 mRNA	PMID:38568856
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DNAJC9 mRNA	PMID:33387578
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20200804	CTD	MESH:D002635	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:32152650|PMID:33819548
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of DNAJC9 mRNA	PMID:20660070
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of DNAJC9 mRNA	PMID:21592394
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of DNAJC9 mRNA	PMID:21592394
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20200804	CTD	MESH:D006000	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:32152650|PMID:33819548
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of DNAJC9 mRNA	PMID:21592394
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of DNAJC9 mRNA	PMID:21592394
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA	PMID:39836092
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJC9 mRNA	PMID:35301059
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DNAJC9 mRNA	PMID:19549813
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DNAJC9 protein	PMID:23301498
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312782	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DNAJC9 mRNA	PMID:19770486
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312781	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DNAJC9 mRNA	PMID:23649840
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of DNAJC9 mRNA	PMID:25102026
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312782	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DNAJC9 mRNA	PMID:32553695
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DNAJC9 mRNA	PMID:34911549
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1312781	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of DNAJC9 mRNA	PMID:15672453
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312782	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNAJC9 mRNA	PMID:27339419
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNAJC9 mRNA	PMID:22206623
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20200804	CTD	MESH:D006002	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:32152650|PMID:33819548
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1312782	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of DNAJC9 mRNA	PMID:25270620
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNAJC9 mRNA	PMID:39836092
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJC9 mRNA	PMID:40504410
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DNAJC9 mRNA	PMID:19244175
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of DNAJC9 mRNA	PMID:19167446
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312782	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in increased expression of DNAJC9 mRNA	PMID:25270620
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in increased expression of DNAJC9 mRNA]	PMID:21858171
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312781	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNAJC9 mRNA	PMID:22574217
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNAJC9 mRNA	PMID:34747641
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312782	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of DNAJC9 protein	PMID:28918527
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312781	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of DNAJC9 mRNA	PMID:29803840
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312781	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of DNAJC9 protein	PMID:35688186
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20200804	CTD	MESH:D003840	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:32152650|PMID:33819548
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DNAJC9 mRNA	PMID:38568856
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNAJC9 mRNA	PMID:39836092
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJC9 mRNA	PMID:40504410
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312781	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNAJC9 mRNA	PMID:32234424
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312782	E	RGD:6480464	20120717	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of DNAJC9 mRNA; Benzo(a)pyrene results in increased expression of DNAJC9 mRNA	PMID:19770486|PMID:21715664|PMID:32553695
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DNAJC9 mRNA	PMID:20382639
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312781	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DNAJC9 mRNA	PMID:15761015
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:31243	atazanavir sulfate	increases expression	ISO	RGD:1312781	E	RGD:6480464	20200804	CTD	MESH:D000069446	Atazanavir Sulfate results in increased expression of DNAJC9 mRNA	PMID:32152650
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of DNAJC9 mRNA	PMID:25729387
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DNAJC9 mRNA	PMID:25729387
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of DNAJC9 mRNA	PMID:24136188
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312782	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DNAJC9 gene	PMID:35295148
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312782	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DNAJC9 mRNA	PMID:18301758|PMID:21318169|PMID:23811191
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of DNAJC9 mRNA]	PMID:21318169
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJC9 mRNA	PMID:34947998
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJC9 mRNA	PMID:26063408
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJC9 mRNA	PMID:25181051|PMID:32145629
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DNAJC9 gene	PMID:28505145
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312781	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of DNAJC9 mRNA	PMID:24752500
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312782	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of DNAJC9 mRNA	PMID:20713471
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DNAJC9 mRNA	PMID:39298647
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DNAJC9 mRNA	PMID:37019170
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DNAJC9 mRNA	PMID:21266533
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312782	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of DNAJC9 mRNA	PMID:17854601
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DNAJC9 mRNA]	PMID:17854601
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312781	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DNAJC9 mRNA	PMID:37042841
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA	PMID:39836092
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35456	cadmium dichloride	affects methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the methylation of DNAJC9 promoter	PMID:22457795
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DNAJC9 protein	PMID:33830842
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1312781	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of DNAJC9 mRNA	PMID:33830842
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJC9 mRNA	PMID:35301059
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:1312782	E	RGD:6480464	20250204	CTD	MESH:C012125	diisononyl phthalate results in increased expression of DNAJC9 mRNA	PMID:33391822
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DNAJC9 protein	PMID:26879310
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20200804	CTD	MESH:D005999	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:32152650|PMID:33819548
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DNAJC9 mRNA	PMID:19244175
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DNAJC9 mRNA	PMID:28302478
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DNAJC9 mRNA	PMID:31533062
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312781	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of DNAJC9 mRNA	PMID:19167446
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DNAJC9 mRNA	PMID:19167446
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of DNAJC9 mRNA	PMID:39529242
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312781	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DNAJC9 mRNA	PMID:23179753
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of DNAJC9 mRNA	PMID:41580965
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20200804	CTD	MESH:D016572	Cyclosporine results in decreased expression of DNAJC9 mRNA	PMID:32152650
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA	PMID:32152650
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312782	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DNAJC9 mRNA	PMID:28973697
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312781	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DNAJC9 mRNA	PMID:38832940
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312782	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DNAJC9 mRNA	PMID:17562736
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJC9 mRNA	PMID:33387578
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312781	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJC9 mRNA	PMID:22230336
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DNAJC9 mRNA	PMID:29279043
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNAJC9 mRNA	PMID:39836092
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJC9 mRNA	PMID:40504410
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1312781	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of DNAJC9 mRNA	PMID:24752500
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312781	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DNAJC9 mRNA	PMID:15761015
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DNAJC9 mRNA	PMID:35964746
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:6030	isoniazide	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of DNAJC9 protein	PMID:40015660
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DNAJC9 protein	PMID:32959892
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA	PMID:39836092
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:63598	levofloxacin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of DNAJC9 mRNA	PMID:24136188
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DNAJC9 mRNA	PMID:25729387
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of DNAJC9 mRNA	PMID:24136188
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312782	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DNAJC9 mRNA	PMID:22206623
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNAJC9 mRNA	PMID:22206623
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DNAJC9 protein	PMID:37664457
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312781	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DNAJC9 mRNA	PMID:37199045
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of DNAJC9 mRNA	PMID:36318118
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312782	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DNAJC9 mRNA	PMID:23091169
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA	PMID:19167446
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:8249	piroxicam	increases expression	ISO	RGD:1312781	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of DNAJC9 mRNA	PMID:21858171
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in increased expression of DNAJC9 mRNA]	PMID:21858171
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20211012	CTD	MESH:C005842	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA	PMID:33819548
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DNAJC9 protein	PMID:38348393
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DNAJC9 protein	PMID:37664457
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DNAJC9 mRNA	PMID:19281266
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:9405	tartrazine	multiple interactions	ISO	RGD:1312781	E	RGD:6480464	20211012	CTD	MESH:D013645	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:33819548
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312781	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DNAJC9 mRNA	PMID:38568856
1305009	Dnajc9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DNAJC9 mRNA	PMID:21346803
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312783	E	RGD:6480464	20130115	CTD	MESH:D014212	Tretinoin results in increased expression of C1QTNF3 mRNA	PMID:21934132
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C1QTNF3 mRNA	PMID:30529165
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of C1QTNF3 mRNA	PMID:36331819
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:C029424	hydrazine results in decreased expression of C1QTNF3 mRNA	PMID:15282401
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of C1QTNF3 mRNA	PMID:26079696
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312783	E	RGD:6480464	20130115	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of C1QTNF3 mRNA	PMID:20044591
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312783	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of C1QTNF3 mRNA	PMID:30510588
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of C1QTNF3 mRNA	PMID:31614463
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of C1QTNF3 mRNA	PMID:19484750
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of C1QTNF3 mRNA	PMID:31525975
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20130115	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of C1QTNF3 mRNA]	PMID:20032058
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of C1QTNF3 mRNA	PMID:31525975
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of C1QTNF3 mRNA	PMID:26577399
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of C1QTNF3 mRNA	PMID:28818685
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of C1QTNF3 mRNA	PMID:37325564
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20130115	CTD	MESH:D019327	Copper Sulfate results in decreased expression of C1QTNF3 mRNA	PMID:19549813
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of C1QTNF3 mRNA	PMID:27153756
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of C1QTNF3 mRNA	PMID:27106289
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312784	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of C1QTNF3 mRNA	PMID:25629700
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of C1QTNF3 mRNA	PMID:38314887
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312784	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of C1QTNF3 mRNA	PMID:28960355
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D014640	Vancomycin results in increased expression of C1QTNF3 mRNA	PMID:18930951
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312784	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of C1QTNF3 mRNA	PMID:32186404
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of C1QTNF3 mRNA	PMID:24768652|PMID:25583101
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of C1QTNF3 mRNA	PMID:32109520
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of C1QTNF3 mRNA	PMID:22808131
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of C1QTNF3 mRNA	PMID:19933214
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of C1QTNF3 mRNA	PMID:28959563
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of C1QTNF3 mRNA	PMID:34032870
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of C1QTNF3 mRNA	PMID:37682722
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312783	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of C1QTNF3 mRNA	PMID:29301061
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA	PMID:34876320
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA	PMID:34876320
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of C1QTNF3 mRNA	PMID:21839799
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of C1QTNF3 mRNA	PMID:32234424
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of C1QTNF3 mRNA	PMID:22228805
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312784	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of C1QTNF3 mRNA	PMID:23735875
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312783	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C1QTNF3 promoter	PMID:27901495
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312784	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C1QTNF3 3' UTR; Benzo(a)pyrene results in increased methylation of C1QTNF3 exon; Benzo(a)pyrene results in increased methylation of C1QTNF3 intron	PMID:27901495
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of C1QTNF3 mRNA]	PMID:22228805
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:3000	beauvericin	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20180515	CTD	MESH:C004456	beauvericin results in decreased expression of C1QTNF3 mRNA	PMID:29203277
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:C006253	pirinixic acid results in increased expression of C1QTNF3 mRNA	PMID:18301758
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of C1QTNF3 gene	PMID:23968726
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of C1QTNF3 mRNA	PMID:25181051|PMID:38750585
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of C1QTNF3 protein	PMID:31675489
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of C1QTNF3 mRNA	PMID:37105096
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of C1QTNF3 mRNA	PMID:33296240
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of C1QTNF3 protein	PMID:31675489
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312784	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of C1QTNF3 exon; bisphenol S results in decreased methylation of C1QTNF3 promoter	PMID:33297965
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312784	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of C1QTNF3 promoter	PMID:28392331
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of C1QTNF3 mRNA	PMID:21266533
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of C1QTNF3 gene	PMID:23968726
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of C1QTNF3 mRNA	PMID:35163327
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of C1QTNF3 mRNA	PMID:35163327
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of C1QTNF3 mRNA	PMID:37325564
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of C1QTNF3 mRNA	PMID:35163327
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of C1QTNF3 mRNA	PMID:25539665
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312784	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of C1QTNF3 mRNA	PMID:40194260
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312783	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of C1QTNF3 mRNA	PMID:31533062
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of C1QTNF3 mRNA	PMID:36331819
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of C1QTNF3 mRNA	PMID:29038090
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of C1QTNF3 mRNA	PMID:29154799
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of C1QTNF3 mRNA	PMID:30047161
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D003907	Dexamethasone results in decreased expression of C1QTNF3 mRNA	PMID:20032058
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20130115	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of C1QTNF3 mRNA]	PMID:20032058
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of C1QTNF3 mRNA	PMID:31525975
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of C1QTNF3 mRNA	PMID:38832940
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of C1QTNF3 mRNA	PMID:27188386
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312783	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of C1QTNF3 mRNA	PMID:26690555
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of C1QTNF3 mRNA	PMID:31675489
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of C1QTNF3 mRNA	PMID:37567419
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA	PMID:34876320
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of C1QTNF3 mRNA	PMID:17942748
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of C1QTNF3 mRNA	PMID:30047161
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of C1QTNF3 mRNA	PMID:36851058
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of C1QTNF3 gene	PMID:35440735
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of C1QTNF3 mRNA	PMID:22206623
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:748790	exenatide	increases expression	ISO	RGD:1312784	E	RGD:6480464	20260714	CTD	MESH:D000077270	Exenatide results in increased expression of C1QTNF3 mRNA	PMID:36152787
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1312783	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of C1QTNF3 mRNA	PMID:29522793
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:76290	PhIP	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of C1QTNF3 mRNA	PMID:20816883
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1312784	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of C1QTNF3 mRNA	PMID:26655953
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of C1QTNF3 mRNA	PMID:32109520
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of C1QTNF3 protein	PMID:31675489
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of C1QTNF3 protein	PMID:31675489
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of C1QTNF3 mRNA	PMID:26079696
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA	PMID:34876320
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of C1QTNF3 mRNA	PMID:24780913|PMID:30047161
1305010	C1qtnf3	C1q and TNF related 3	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312783	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of C1QTNF3 mRNA	PMID:27188386
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:16118	berberine	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D001599	Berberine results in decreased expression of H2BC7 mRNA	PMID:27311644
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of HIST1H2BQ mRNA; Estradiol results in increased expression of HIST1H2BQ protein	PMID:32145629
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D005557	Formaldehyde results in increased expression of H2BC7 mRNA	PMID:23649840
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1346859	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of H2BC7 mRNA	PMID:33647349
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:177387	brequinar	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in decreased expression of H2BC7 mRNA	PMID:39900124
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of HIST1H2BQ mRNA	PMID:27523638
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D019327	Copper Sulfate results in increased expression of H2BC7 mRNA	PMID:19549813
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of H2BC7 gene	PMID:27153756
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of H2BC7 mRNA	PMID:27153756
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of HIST1H2BQ protein	PMID:22248470
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	EXP		E	RGD:6480464	20200310	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HIST1H2BQ protein	PMID:22248470
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D000661	Amphetamine results in increased expression of HIST1H2BQ mRNA	PMID:30779732
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HIST1H2BQ mRNA	PMID:31150632
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:C004925	methylmercuric chloride results in increased expression of H2BC7 mRNA	PMID:28001369
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1346859	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of H2BC7 mRNA	PMID:39709020
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D019344	Lactic Acid results in increased expression of H2BC7 mRNA	PMID:30851411
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D014750	Vincristine results in increased expression of H2BC7 mRNA	PMID:23649840
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of H2BC7 mRNA	PMID:20971185
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D004317	Doxorubicin results in decreased expression of H2BC7 mRNA	PMID:29803840
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D024483	Vitamin K 3 affects the expression of H2BC7 mRNA	PMID:20044591
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of H2BC7 mRNA	PMID:38568856
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of H2BC7 mRNA	PMID:20106945
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HIST1H2BQ mRNA	PMID:21839799
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of H2BC7 mRNA	PMID:20971185
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of H2BC7 mRNA; Silicon Dioxide results in increased expression of H2BC7 mRNA	PMID:23806026|PMID:25351596
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of H2BC7 mRNA	PMID:20382639
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C004312	glycidol results in decreased expression of HIST1H2BQ mRNA	PMID:24915197
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D000643	Ammonium Chloride affects the expression of HIST1H2BQ mRNA	PMID:16483693
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of HIST1H2BQ protein	PMID:32145629
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:C006780	bisphenol A results in decreased expression of H2BC7 mRNA	PMID:29275510
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:33418	graphite	affects expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D006108	Graphite affects the expression of HIST1H2BQ mRNA	PMID:29933104
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:34445	4-tert-Octylphenol	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C105260	4-tert-octylphenol results in decreased expression of HIST1H2BQ mRNA	PMID:17011747
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:34445	4-tert-Octylphenol	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C105260	4-tert-octylphenol results in increased expression of HIST1H2BQ mRNA	PMID:17011747
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D002995	Clofibric Acid affects the expression of HIST1H2BQ mRNA	PMID:17602206
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:35096	p-tert-Amylphenol	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C019566	4-tert-octylphenol results in decreased expression of HIST1H2BQ mRNA	PMID:17011747
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:35096	p-tert-Amylphenol	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C019566	4-tert-octylphenol results in increased expression of HIST1H2BQ mRNA	PMID:17011747
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of H2BC7 mRNA	PMID:26678675
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:C018021	cobaltous chloride results in decreased expression of H2BC7 mRNA	PMID:19320972
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:38757	isoflavones	multiple interactions	EXP		E	RGD:6480464	20200310	CTD	MESH:D007529	[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HIST1H2BQ protein; [ENNG co-treated with Isoflavones] results in increased expression of HIST1H2BQ protein	PMID:22248470
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D003375	Coumestrol results in decreased expression of H2BC7 mRNA	PMID:19167446
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C016104	sodium bichromate results in decreased expression of HIST1H2BQ mRNA	PMID:25993096
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D003474	Curcumin results in increased expression of HIST1H2BQ mRNA	PMID:18299980
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D014635	Valproic Acid results in decreased expression of H2BC7 mRNA	PMID:29154799
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D014635	Valproic Acid results in increased expression of H2BC7 mRNA	PMID:28001369
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of HIST1H2BQ mRNA	PMID:38685447
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of HIST1H2BQ mRNA	PMID:41580965
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D016572	Cyclosporine results in decreased expression of H2BC7 mRNA	PMID:20106945|PMID:27989131
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of HIST1H2BQ mRNA	PMID:17011747
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D003703	Demecolcine results in increased expression of H2BC7 mRNA	PMID:23649840
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of HIST1H2BQ mRNA	PMID:33387578
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D004726	Endosulfan results in increased expression of HIST1H2BQ mRNA	PMID:29391264
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D008154	Lucanthone results in decreased expression of H2BC7 mRNA	PMID:21148553
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C025340	manganese chloride results in decreased expression of HIST1H2BQ mRNA	PMID:28801915
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D019772	Topotecan results in increased expression of HIST1H2BQ mRNA	PMID:25729387
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of HIST1H2BQ mRNA	PMID:28801915
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of H2BC7 mRNA	PMID:29522793
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C025589	ochratoxin A results in increased expression of HIST1H2BQ mRNA	PMID:22124623
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:D019344	Lactic Acid results in increased expression of H2BC7 mRNA	PMID:30851411
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1346859	E	RGD:6480464	20200901	CTD	MESH:C046012	pentanal results in decreased expression of H2BC7 mRNA	PMID:26079696
1305011	Hist1h2bq	histone cluster 1 H2B family member Q	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HIST1H2BQ mRNA	PMID:24780913|PMID:25825206
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1312788	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in decreased expression of IRAK1BP1 mRNA	PMID:33227293
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of IRAK1BP1 mRNA	PMID:33167477
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312788	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of IRAK1BP1 mRNA	PMID:30319688
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of IRAK1BP1 mRNA	PMID:21632981
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA	PMID:32741896
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of IRAK1BP1 mRNA	PMID:30165855
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of IRAK1BP1 mRNA	PMID:33387578
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA	PMID:32741896
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of IRAK1BP1 mRNA	PMID:33387578
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312788	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of IRAK1BP1 mRNA	PMID:37748715
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IRAK1BP1 mRNA	PMID:36331819
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312787	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of IRAK1BP1 mRNA	PMID:23649840
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IRAK1BP1 mRNA	PMID:34911549
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of IRAK1BP1 mRNA	PMID:18593933
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IRAK1BP1 mRNA	PMID:40504410
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of IRAK1BP1 mRNA	PMID:26272509
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA	PMID:27188386
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:27810	resorcinol	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of IRAK1BP1 mRNA	PMID:22623647
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312787	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of IRAK1BP1 mRNA	PMID:28903495
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IRAK1BP1 mRNA	PMID:33387578
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IRAK1BP1 mRNA	PMID:25975270
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of IRAK1BP1 mRNA	PMID:19013527
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of IRAK1BP1 mRNA	PMID:33212167
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IRAK1BP1 mRNA	PMID:32763439
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of IRAK1BP1 mRNA	PMID:30556269
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IRAK1BP1 mRNA	PMID:29803840
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of IRAK1BP1 mRNA	PMID:22623647
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312787	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of IRAK1BP1 gene	PMID:28589171
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IRAK1BP1 mRNA	PMID:38568856
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IRAK1BP1 mRNA	PMID:40504410
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IRAK1BP1 mRNA	PMID:20106945|PMID:21632981
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312788	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IRAK1BP1 mRNA	PMID:19770486|PMID:22228805
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of IRAK1BP1 mRNA	PMID:30556269
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of IRAK1BP1 mRNA	PMID:18593933
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312788	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IRAK1BP1 gene	PMID:35295148
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312788	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of IRAK1BP1 mRNA	PMID:18648102
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312788	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of IRAK1BP1 mRNA	PMID:20813756
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IRAK1BP1 mRNA	PMID:19710929
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312787	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of IRAK1BP1 mRNA	PMID:30690063
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of IRAK1BP1 mRNA	PMID:19167457
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of IRAK1BP1 mRNA	PMID:34947998|PMID:41034487
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312787	E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A results in increased expression of IRAK1BP1 mRNA	PMID:32387340
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312788	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of IRAK1BP1 mRNA	PMID:32156529
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of IRAK1BP1 mRNA	PMID:18668222
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of IRAK1BP1 mRNA	PMID:30589522
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312787	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IRAK1BP1 mRNA	PMID:37042841
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IRAK1BP1 mRNA	PMID:33453195
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of IRAK1BP1 mRNA	PMID:25539665
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312787	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of IRAK1BP1 mRNA	PMID:24449571
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312787	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of IRAK1BP1 mRNA	PMID:31533062
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IRAK1BP1 mRNA	PMID:36331819
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of IRAK1BP1 mRNA	PMID:38832940
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of IRAK1BP1 mRNA	PMID:26272509
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA	PMID:27188386
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IRAK1BP1 mRNA	PMID:33387578
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of IRAK1BP1 mRNA	PMID:32479839
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312788	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of IRAK1BP1 mRNA	PMID:29279043
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IRAK1BP1 mRNA	PMID:40504410
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IRAK1BP1 mRNA	PMID:22079256
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:48981	quinolin-8-ol	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of IRAK1BP1 mRNA	PMID:21632981
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:52774	pentane-2,3-dione	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in decreased expression of IRAK1BP1 mRNA	PMID:25710175
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of IRAK1BP1 gene	PMID:35440735
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of IRAK1BP1 mRNA	PMID:22079256
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312787	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of IRAK1BP1 mRNA	PMID:22714537
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IRAK1BP1 mRNA	PMID:22079256
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA	PMID:32741896
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA	PMID:27188386
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IRAK1BP1 gene]	PMID:28238834
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:82288	o-anisidine	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine results in decreased expression of IRAK1BP1 mRNA	PMID:28089782
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312788	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of IRAK1BP1 mRNA	PMID:39847705
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1312788	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of IRAK1BP1 mRNA	PMID:40826991
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312787	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA	PMID:27188386
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of IRAK1BP1 mRNA	PMID:19281266
1305012	Irak1bp1	interleukin-1 receptor-associated kinase 1 binding protein 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312787	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IRAK1BP1 mRNA	PMID:38568856
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TMEM143 mRNA]	PMID:31150632
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312789	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM143 mRNA	PMID:36331819
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TMEM143 mRNA	PMID:26079696
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM143 mRNA	PMID:33387578
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TMEM143 mRNA	PMID:28818685
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TMEM143 mRNA	PMID:22100608
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM143 mRNA	PMID:31150632
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TMEM143 mRNA]	PMID:31150632
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602477	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TMEM143 mRNA	PMID:40512198
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1602477	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TMEM143 mRNA	PMID:27392435
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312789	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM143 mRNA	PMID:21570461
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM143 mRNA	PMID:33387578
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312789	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TMEM143 mRNA	PMID:27862939
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM143 mRNA	PMID:29803840
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMEM143 mRNA	PMID:25879800|PMID:38568856
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602477	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TMEM143 mRNA	PMID:40512198
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312789	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMEM143 mRNA	PMID:22228805
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMEM143 mRNA	PMID:32234424
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312789	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMEM143 intron	PMID:27901495
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1602477	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of TMEM143 gene	PMID:25435355
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TMEM143 mRNA	PMID:34492290
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1602477	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TMEM143 mRNA	PMID:19710929
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TMEM143 mRNA	PMID:25181051
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1312789	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of TMEM143 mRNA	PMID:37894381
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312789	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM143 mRNA	PMID:35598803
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312789	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM143 mRNA	PMID:33221593
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TMEM143 mRNA	PMID:36041667
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312789	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TMEM143 mRNA	PMID:39298647
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TMEM143 mRNA	PMID:36041667
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TMEM143 mRNA	PMID:36041667
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMEM143 mRNA	PMID:38568856
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMEM143 mRNA	PMID:33453195
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312789	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TMEM143 mRNA	PMID:40194260
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1602477	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TMEM143 mRNA	PMID:28302478
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602477	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TMEM143 mRNA	PMID:31533062
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312789	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM143 mRNA	PMID:36331819
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM143 mRNA	PMID:29154799
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312789	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TMEM143 mRNA	PMID:28973697
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TMEM143 mRNA	PMID:38832940
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM143 mRNA	PMID:33387578
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1602477	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM143 mRNA	PMID:25704631
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602477	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TMEM143 mRNA	PMID:40512198
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TMEM143 mRNA	PMID:28988120
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312789	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of TMEM143 protein	PMID:36851058
1305013	Tmem143	transmembrane protein 143	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602477	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TMEM143 mRNA	PMID:38568856
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312790	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of C10ORF88 mRNA	PMID:33167477
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of C1H10ORF88 mRNA	PMID:33387578
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312790	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of C10ORF88 mRNA	PMID:19549813
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312790	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of C10ORF88 mRNA	PMID:23649840
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312790	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of C10ORF88 mRNA	PMID:23649840
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312790	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of C10ORF88 mRNA	PMID:23557933
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312790	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of C10ORF88 mRNA	PMID:33212167
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312790	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of C10ORF88 mRNA	PMID:30851411
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312790	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of C10ORF88 mRNA	PMID:29803840
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312790	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of C10ORF88 mRNA	PMID:38568856
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312790	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of C10ORF88 mRNA	PMID:20106945|PMID:21632981
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312790	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C10ORF88 promoter	PMID:27901495
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of C1H10ORF88 mRNA	PMID:34492290
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of C10ORF88 mRNA	PMID:25181051
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312790	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of C10ORF88 gene	PMID:31601247
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312790	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of C10ORF88 mRNA	PMID:37042841
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312790	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of C10ORF88 mRNA	PMID:28302478
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312790	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of C10ORF88 mRNA	PMID:25979313
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312790	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of C10ORF88 mRNA	PMID:23179753|PMID:24935251
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of C1H10ORF88 mRNA	PMID:33387578
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312790	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of C10ORF88 mRNA	PMID:26690555
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of C1H10ORF88 gene	PMID:35440735
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312790	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of C10ORF88 mRNA	PMID:30851411
1305014	C1h10orf88	similar to human chromosome 10 open reading frame 88	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of C1H10ORF88 mRNA	PMID:23034163
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of PABPC4 mRNA	PMID:35967413
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PABPC4 mRNA]	PMID:31150632
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:137392	chlormequat chloride	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of PABPC4 protein	PMID:34958886
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PABPC4 mRNA	PMID:26251327
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PABPC4 mRNA	PMID:33167477
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PABPC4 mRNA	PMID:30529165
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312793	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PABPC4 mRNA	PMID:39298647
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312793	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of PABPC4 mRNA	PMID:19448997
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312792	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PABPC4 mRNA	PMID:37042841
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312793	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of PABPC4 mRNA	PMID:28973375
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PABPC4 mRNA	PMID:26577399
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312792	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PABPC4 mRNA	PMID:28818685
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PABPC4 protein	PMID:34915118
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PABPC4 mRNA	PMID:28111341|PMID:37236586
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:232796	cadmium acetate	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in decreased expression of PABPC4 mRNA	PMID:18155341
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PABPC4 mRNA	PMID:19549813
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312792	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PABPC4 protein	PMID:23301498
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PABPC4 mRNA	PMID:23649840
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of PABPC4 protein	PMID:33236894
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PABPC4 mRNA	PMID:23649840
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of PABPC4 mRNA	PMID:19483382
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PABPC4 mRNA	PMID:31150632
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PABPC4 mRNA]	PMID:31150632
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PABPC4 mRNA	PMID:40504410
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312793	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PABPC4 mRNA	PMID:21570461
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PABPC4 mRNA	PMID:34747641
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of PABPC4 mRNA	PMID:19013527|PMID:28374803
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PABPC4 mRNA	PMID:33212167
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312792	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of PABPC4 mRNA	PMID:39709020
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312792	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PABPC4 mRNA	PMID:30851411
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PABPC4 mRNA	PMID:28959563
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PABPC4 mRNA; sodium arsenite results in decreased expression of PABPC4 protein	PMID:25879800|PMID:30528433|PMID:38568856
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PABPC4 mRNA	PMID:25270620
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312792	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [PABPC4 protein binds to CAPRIN1 protein]	PMID:33939924
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PABPC4 mRNA	PMID:40504410
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PABPC4 mRNA	PMID:21632981
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PABPC4 mRNA	PMID:22228805
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of PABPC4 mRNA	PMID:19483382
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312792	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PABPC4 protein]	PMID:26598702
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1312792	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of PABPC4 mRNA	PMID:31745603
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of PABPC4 mRNA	PMID:25729387
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PABPC4 mRNA	PMID:25729387
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of PABPC4 mRNA	PMID:19483382
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PABPC4 mRNA	PMID:34492290
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312793	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PABPC4 mRNA	PMID:18648102
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of PABPC4 mRNA	PMID:19483382
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312793	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PABPC4 mRNA	PMID:18301758
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of PABPC4 protein	PMID:34186270
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PABPC4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:41034487
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PABPC4 gene	PMID:28505145
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312792	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of PABPC4 gene	PMID:31601247
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312792	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PABPC4 protein	PMID:34186270
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312793	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PABPC4 mRNA	PMID:39298647|PMID:40203079
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312792	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PABPC4 protein	PMID:34186270
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312792	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PABPC4 protein	PMID:34186270
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PABPC4 mRNA	PMID:28392331
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PABPC4 mRNA	PMID:37019170
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of PABPC4 mRNA	PMID:32680482
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of PABPC4 mRNA	PMID:17616710
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PABPC4 mRNA	PMID:38174414
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PABPC4 mRNA	PMID:28111341|PMID:37236586
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of PABPC4 mRNA	PMID:26194646
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of PABPC4 mRNA	PMID:19483382
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312792	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PABPC4 mRNA	PMID:28302478
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of PABPC4 mRNA	PMID:26352163
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312792	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PABPC4 mRNA	PMID:40419075
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PABPC4 mRNA	PMID:25993096
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312792	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PABPC4 mRNA	PMID:25979313
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312793	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PABPC4 mRNA	PMID:17292431
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of PABPC4 mRNA	PMID:19101580
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312792	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PABPC4 gene	PMID:29154799
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312793	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PABPC4 mRNA	PMID:18502557
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PABPC4 mRNA	PMID:33387578
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312792	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of PABPC4 mRNA	PMID:29067470
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PABPC4 mRNA	PMID:40504410
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of PABPC4 mRNA	PMID:40706910
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312792	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PABPC4 mRNA	PMID:22079256
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of PABPC4 mRNA	PMID:19483382
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312792	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PABPC4 protein]	PMID:26598702
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312793	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PABPC4 mRNA	PMID:25554681
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312793	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PABPC4 mRNA	PMID:19042947
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PABPC4 protein	PMID:32959892
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PABPC4 mRNA	PMID:25729387
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PABPC4 mRNA	PMID:25729387
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PABPC4 protein	PMID:26558463
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PABPC4 gene	PMID:35440735
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312792	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PABPC4 protein	PMID:34186270
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312792	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PABPC4 mRNA	PMID:22079256
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312792	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PABPC4 mRNA	PMID:22079256
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312792	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PABPC4 protein	PMID:31285264
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312792	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PABPC4 protein	PMID:39638853
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of PABPC4 mRNA	PMID:19483382
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of PABPC4 mRNA	PMID:21346803
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of PABPC4 mRNA	PMID:19483382
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312792	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PABPC4 mRNA	PMID:30851411
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312793	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PABPC4 mRNA	PMID:30294300
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312792	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PABPC4 protein	PMID:31675489
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of PABPC4 mRNA	PMID:19483382
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PABPC4 mRNA	PMID:24780913
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PABPC4 mRNA	PMID:40826991
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PABPC4 mRNA	PMID:21346803
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PABPC4 mRNA	PMID:21346803
1305015	Pabpc4	poly(A) binding protein, cytoplasmic 4	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PABPC4 mRNA	PMID:23034163
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312795	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PARD6G mRNA	PMID:37995155
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of PARD6G mRNA	PMID:26496021
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1312794	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of PARD6G gene	PMID:30521419
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312794	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PARD6G intron	PMID:30157460
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312795	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PARD6G mRNA	PMID:32553695
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312795	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PARD6G mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PARD6G mRNA	PMID:34911549
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312794	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PARD6G mRNA	PMID:18593933
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312794	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PARD6G gene	PMID:25304211
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312794	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PARD6G mRNA	PMID:38460933
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312795	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of PARD6G mRNA	PMID:40618947
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312794	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PARD6G mRNA	PMID:27392435
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312794	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PARD6G mRNA	PMID:27392435
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312795	E	RGD:6480464	20201006	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PARD6G mRNA	PMID:32553695
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312794	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PARD6G mRNA	PMID:33212167
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1312794	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PARD6G mRNA	PMID:30851411
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312794	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PARD6G mRNA	PMID:32763439
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312794	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PARD6G intron	PMID:30157460
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312795	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of PARD6G mRNA	PMID:32553695
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312795	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of PARD6G mRNA	PMID:18191166
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312794	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PARD6G mRNA	PMID:18593933
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312795	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of PARD6G mRNA	PMID:23557971
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312795	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PARD6G gene	PMID:35295148
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PARD6G mRNA	PMID:25181051
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312794	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of PARD6G mRNA	PMID:22576693
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312794	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PARD6G mRNA	PMID:29275510
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312795	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of PARD6G mRNA	PMID:35479511
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312794	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of PARD6G gene	PMID:22576693|PMID:31601247
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of PARD6G mRNA	PMID:26496021
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312794	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of PARD6G gene	PMID:31601247
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PARD6G mRNA	PMID:35163327
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PARD6G mRNA	PMID:35163327
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312794	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PARD6G mRNA	PMID:31533062
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312794	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PARD6G mRNA	PMID:25979313
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312794	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PARD6G gene	PMID:29154799
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312794	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PARD6G mRNA	PMID:22230336
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312794	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PARD6G mRNA	PMID:38460933
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312794	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PARD6G gene	PMID:25304211
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312795	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PARD6G mRNA; Nanotubes, Carbon results in decreased expression of PARD6G mRNA	PMID:25554681
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PARD6G mRNA	PMID:20080153
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:6809	methamphetamine	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine affects the expression of PARD6G mRNA	PMID:19564919
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] affects the expression of PARD6G mRNA	PMID:19564919
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:73297	SCH 23390	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 affects the expression of PARD6G mRNA	PMID:19564919
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] affects the expression of PARD6G mRNA	PMID:19564919
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1312794	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PARD6G mRNA	PMID:30851411
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312794	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PARD6G gene]	PMID:28238834
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of PARD6G mRNA	PMID:20345932
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of PARD6G mRNA	PMID:26923065
1305016	Pard6g	par-6 family cell polarity regulator gamma	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PARD6G mRNA	PMID:24780913
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1312796	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of DHRSX mRNA	PMID:28973375
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DHRSX mRNA	PMID:33387578
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1344855	E	RGD:6480464	20130618	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DHRSX mRNA	PMID:19549813
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20130618	CTD	MESH:C016517	indole-3-carbinol affects the expression of DHRSX mRNA	PMID:21396975
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1344855	E	RGD:6480464	20130618	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DHRSX mRNA	PMID:21641981|PMID:22100608
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344855	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DHRSX mRNA	PMID:35430440
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312796	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DHRSX mRNA	PMID:25629700
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312796	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DHRSX mRNA	PMID:21570461
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DHRSX mRNA	PMID:21215274|PMID:32109520
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHRSX mRNA	PMID:33387578|PMID:34747641
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1344855	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DHRSX mRNA	PMID:28001369
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1344855	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DHRSX mRNA	PMID:29803840
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312796	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of DHRSX mRNA	PMID:37682722
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312796	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DHRSX mRNA	PMID:27195522
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1344855	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DHRSX mRNA	PMID:20064835|PMID:22316170|PMID:26238291|PMID:32234424
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1344855	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DHRSX mRNA	PMID:25895662
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1344855	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DHRSX mRNA	PMID:26238291
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1344855	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DHRSX mRNA	PMID:26705709
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of DHRSX mRNA	PMID:30047161
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312796	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DHRSX gene; titanium dioxide results in decreased methylation of DHRSX promoter	PMID:35295148
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312796	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of DHRSX mRNA	PMID:29264374
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312796	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DHRSX gene	PMID:35295148
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of DHRSX mRNA	PMID:34492290
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DHRSX mRNA	PMID:25181051
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1344855	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of DHRSX mRNA	PMID:25047013
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DHRSX mRNA	PMID:36041667
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DHRSX mRNA	PMID:36041667
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312796	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DHRSX mRNA	PMID:38685157
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DHRSX mRNA	PMID:36041667
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1312796	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of DHRSX mRNA	PMID:35093514
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312796	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of DHRSX mRNA	PMID:34813904
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312796	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of DHRSX mRNA	PMID:34813904
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1344855	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DHRSX mRNA	PMID:37042841
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312796	E	RGD:6480464	20130618	CTD	MESH:D002994	Clofibrate results in decreased expression of DHRSX mRNA	PMID:17585979
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1344855	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DHRSX mRNA	PMID:31533062
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1344855	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of DHRSX mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369|PMID:29154799
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344855	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DHRSX mRNA	PMID:27188386
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of DHRSX mRNA	PMID:30047161
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1344855	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of DHRSX mRNA	PMID:24935251
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DHRSX mRNA	PMID:33387578
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of DHRSX mRNA	PMID:29391264
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1344855	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of DHRSX mRNA	PMID:32234424
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1344855	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DHRSX mRNA	PMID:26705709
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of DHRSX mRNA	PMID:24136188
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of DHRSX mRNA	PMID:30047161
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312796	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DHRSX mRNA	PMID:22206623
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of DHRSX mRNA	PMID:27840820
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344855	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DHRSX mRNA	PMID:27188386
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DHRSX mRNA	PMID:30047161
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344855	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DHRSX mRNA	PMID:27188386
1305017	Dhrsx	dehydrogenase/reductase X-linked	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of DHRSX mRNA	PMID:30047161
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1312797	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of WNT9A mRNA	PMID:31016361
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:144804	nickel subsulfide	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in decreased expression of WNT9A mRNA	PMID:24952340
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20130402	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of WNT9A mRNA	PMID:20880076
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312798	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of WNT9A mRNA	PMID:30319688
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312797	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of WNT9A mRNA	PMID:30510588
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of WNT9A mRNA	PMID:30165855
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312797	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of WNT9A mRNA	PMID:38568856
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of WNT9A gene	PMID:30521419
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20240305	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of WNT9A protein	PMID:37364752
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312797	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of WNT9A mRNA	PMID:21592394
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of WNT9A mRNA	PMID:21592394
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1312797	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of WNT9A mRNA	PMID:33647349
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of WNT9A mRNA	PMID:36706583
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312797	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of WNT9A mRNA	PMID:21592394
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of WNT9A mRNA	PMID:21592394
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of WNT9A mRNA	PMID:33387578
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT9A mRNA	PMID:37325564
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312798	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WNT9A mRNA	PMID:19770486
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20211109	CTD	MESH:D017382	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of WNT9A mRNA	PMID:33656867
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312798	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of WNT9A mRNA	PMID:17484886
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1312798	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of WNT9A mRNA	PMID:25270620
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of WNT9A mRNA	PMID:38460933
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of WNT9A mRNA	PMID:35897073
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of WNT9A mRNA	PMID:28960355
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312797	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of WNT9A mRNA	PMID:27392435
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of WNT9A mRNA	PMID:27392435
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:28112	nickel atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel affects the expression of WNT9A mRNA	PMID:19130878
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312798	E	RGD:6480464	20130402	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WNT9A mRNA	PMID:21570461|PMID:36222588
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WNT9A mRNA	PMID:19933214
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WNT9A mRNA	PMID:32109520|PMID:33387578
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to WNT9A promoter]	PMID:19654925
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312797	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of WNT9A mRNA	PMID:33212167
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of WNT9A mRNA	PMID:30911355
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312797	E	RGD:6480464	20210907	CTD	MESH:D012969	Sodium Fluoride results in increased expression of WNT9A mRNA; Sodium Fluoride results in increased expression of WNT9A protein	PMID:33982124
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312797	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of WNT9A mRNA	PMID:38568856
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312797	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of WNT9A intron	PMID:30157460
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312798	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WNT9A mRNA	PMID:19770486
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312797	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WNT9A 3' UTR; Benzo(a)pyrene results in increased methylation of WNT9A promoter	PMID:27901495
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene affects the reaction [AHR protein binds to WNT9A promoter]	PMID:19654925
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of WNT9A mRNA	PMID:30911355
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in decreased expression of WNT9A mRNA	PMID:33150645
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:30966	glycidol	increases methylation	EXP		E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in increased methylation of WNT9A promoter	PMID:33150595
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1312798	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of WNT9A mRNA	PMID:36087614
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20130423	CTD	MESH:C008261	lead acetate results in decreased expression of WNT9A mRNA	PMID:22609695
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312798	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of WNT9A promoter	PMID:35295148
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of WNT9A mRNA	PMID:34492290
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:33083	fluoranthene	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20170725	CTD	MESH:C007738	fluoranthene results in decreased expression of WNT9A mRNA	PMID:28329830
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of WNT9A mRNA	PMID:28329830
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of WNT9A mRNA	PMID:25181051
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of WNT9A mRNA	PMID:34947998
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312797	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of WNT9A mRNA	PMID:33670352
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312798	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of WNT9A mRNA	PMID:30951980|PMID:32156529
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of WNT9A mRNA	PMID:25172293
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312798	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of WNT9A gene	PMID:31683443
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312798	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of WNT9A mRNA	PMID:30951980|PMID:40203079
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312798	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of WNT9A exon	PMID:33297965
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312797	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of WNT9A 3' UTR	PMID:30157460
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312798	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of WNT9A mRNA	PMID:30951980
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of WNT9A intron	PMID:28392331
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of WNT9A mRNA	PMID:18502319
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon affects the expression of WNT9A mRNA	PMID:19130878
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34682	diazinon	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in decreased expression of WNT9A mRNA	PMID:18502319
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004026	Dieldrin affects the expression of WNT9A mRNA	PMID:19130878
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312798	E	RGD:6480464	20130402	CTD	MESH:D019256	Cadmium Chloride results in increased expression of WNT9A mRNA	PMID:20478370
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT9A mRNA	PMID:37325564
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312798	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of WNT9A mRNA	PMID:17292431
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312797	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of WNT9A gene	PMID:29154799
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of WNT9A mRNA	PMID:28973697
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1312797	E	RGD:6480464	20201006	CTD	MESH:C107676	deguelin results in decreased expression of WNT9A mRNA	PMID:19861542
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:4610	dimethylselenide	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20211109	CTD	MESH:C013503	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of WNT9A mRNA	PMID:33656867
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of WNT9A mRNA	PMID:33387578
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312797	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of WNT9A mRNA	PMID:38460933
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312798	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of WNT9A mRNA	PMID:35436446
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312798	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of WNT9A mRNA	PMID:27915011
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312798	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of WNT9A mRNA	PMID:25554681
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312798	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of WNT9A mRNA	PMID:23608068
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312797	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of WNT9A 3' UTR	PMID:30157460
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1312798	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of WNT9A mRNA	PMID:27029645
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of WNT9A mRNA	PMID:25825206|PMID:33150595
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:8502	6-propyl-2-thiouracil	increases methylation	EXP		E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in increased methylation of WNT9A promoter	PMID:33150595
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of WNT9A mRNA	PMID:36706583
1305018	Wnt9a	Wnt family member 9A	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of WNT9A mRNA	PMID:19281266
1305019	Cerk	ceramide kinase	gene	CHEBI:132446	perfluorobutanesulfonic acid	increases expression	ISO	RGD:1312799	E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid results in increased expression of CERK mRNA	PMID:40885241
1305019	Cerk	ceramide kinase	gene	CHEBI:13956	ceramide 1-phosphate	affects abundance	ISO	RGD:1312799	E	RGD:6480464	20170303	CTD	MESH:C065576	CERK protein affects the abundance of ceramide 1-phosphate	PMID:15899891
1305019	Cerk	ceramide kinase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CERK mRNA	PMID:36331819
1305019	Cerk	ceramide kinase	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312799	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CERK mRNA	PMID:22378314
1305019	Cerk	ceramide kinase	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1312799	E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CERK mRNA	PMID:39709020
1305019	Cerk	ceramide kinase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CERK mRNA	PMID:39241906
1305019	Cerk	ceramide kinase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of CERK mRNA	PMID:20660070
1305019	Cerk	ceramide kinase	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1312799	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CERK mRNA	PMID:38568856
1305019	Cerk	ceramide kinase	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312799	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of CERK mRNA	PMID:19162166
1305019	Cerk	ceramide kinase	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of CERK mRNA	PMID:20660070
1305019	Cerk	ceramide kinase	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312799	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CERK mRNA	PMID:21179406
1305019	Cerk	ceramide kinase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CERK mRNA	PMID:37992649
1305019	Cerk	ceramide kinase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CERK mRNA	PMID:37992649
1305019	Cerk	ceramide kinase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1305019	Cerk	ceramide kinase	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CERK mRNA	PMID:33387578
1305019	Cerk	ceramide kinase	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of CERK mRNA	PMID:39836092
1305019	Cerk	ceramide kinase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CERK mRNA	PMID:39012411
1305019	Cerk	ceramide kinase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CERK mRNA	PMID:37776818
1305019	Cerk	ceramide kinase	gene	CHEBI:22984	calcium atom	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the reaction [CERK protein results in increased phosphorylation of Ceramides]	PMID:16269826
1305019	Cerk	ceramide kinase	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312799	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CERK mRNA	PMID:19549813
1305019	Cerk	ceramide kinase	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of CERK mRNA	PMID:19376150
1305019	Cerk	ceramide kinase	gene	CHEBI:25107	magnesium atom	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20120412	CTD	MESH:D008274	Magnesium affects the reaction [CERK protein results in increased phosphorylation of Ceramides]	PMID:16269826
1305019	Cerk	ceramide kinase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312799	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CERK mRNA	PMID:23649840
1305019	Cerk	ceramide kinase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312800	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CERK mRNA	PMID:27339419
1305019	Cerk	ceramide kinase	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1312799	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the expression of CERK mRNA	PMID:25304211
1305019	Cerk	ceramide kinase	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312799	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CERK gene	PMID:25304211
1305019	Cerk	ceramide kinase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CERK mRNA	PMID:39836092
1305019	Cerk	ceramide kinase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CERK mRNA	PMID:40504410
1305019	Cerk	ceramide kinase	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of CERK gene	PMID:35440735
1305019	Cerk	ceramide kinase	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA	PMID:33854195
1305019	Cerk	ceramide kinase	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CERK mRNA	PMID:31881176
1305019	Cerk	ceramide kinase	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CERK mRNA	PMID:23557933
1305019	Cerk	ceramide kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CERK mRNA	PMID:34747641
1305019	Cerk	ceramide kinase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312799	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of CERK mRNA	PMID:29955902
1305019	Cerk	ceramide kinase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312800	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of CERK mRNA	PMID:32937126
1305019	Cerk	ceramide kinase	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312799	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CERK mRNA	PMID:39709020
1305019	Cerk	ceramide kinase	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312799	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CERK mRNA	PMID:30851411
1305019	Cerk	ceramide kinase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CERK mRNA	PMID:37992649
1305019	Cerk	ceramide kinase	gene	CHEBI:29320	calcium(0)	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the reaction [CERK protein results in increased phosphorylation of Ceramides]	PMID:16269826
1305019	Cerk	ceramide kinase	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1312800	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of CERK gene	PMID:32068019
1305019	Cerk	ceramide kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CERK mRNA	PMID:39836092
1305019	Cerk	ceramide kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CERK mRNA	PMID:40504410
1305019	Cerk	ceramide kinase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312799	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CERK 3' UTR; Benzo(a)pyrene affects the methylation of CERK intron	PMID:27901495|PMID:30157460
1305019	Cerk	ceramide kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CERK mRNA	PMID:19770486
1305019	Cerk	ceramide kinase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CERK mRNA]	PMID:32406909
1305019	Cerk	ceramide kinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312800	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CERK gene	PMID:35295148
1305019	Cerk	ceramide kinase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CERK mRNA	PMID:34492290
1305019	Cerk	ceramide kinase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CERK mRNA	PMID:25380136
1305019	Cerk	ceramide kinase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CERK mRNA	PMID:17426115
1305019	Cerk	ceramide kinase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312800	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CERK mRNA	PMID:23811191
1305019	Cerk	ceramide kinase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CERK mRNA	PMID:19710929
1305019	Cerk	ceramide kinase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CERK mRNA	PMID:25181051
1305019	Cerk	ceramide kinase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312800	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CERK mRNA	PMID:26063408|PMID:32156529
1305019	Cerk	ceramide kinase	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312799	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of CERK mRNA	PMID:19244175
1305019	Cerk	ceramide kinase	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312800	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CERK mRNA	PMID:26682919
1305019	Cerk	ceramide kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312800	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CERK gene	PMID:31683443
1305019	Cerk	ceramide kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312800	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CERK exon	PMID:33297965
1305019	Cerk	ceramide kinase	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312799	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CERK intron	PMID:30157460
1305019	Cerk	ceramide kinase	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1305019	Cerk	ceramide kinase	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA	PMID:33854195
1305019	Cerk	ceramide kinase	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CERK mRNA	PMID:21266533
1305019	Cerk	ceramide kinase	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1305019	Cerk	ceramide kinase	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1305019	Cerk	ceramide kinase	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CERK gene	PMID:33148267
1305019	Cerk	ceramide kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312799	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CERK mRNA	PMID:37042841
1305019	Cerk	ceramide kinase	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of CERK mRNA	PMID:39836092
1305019	Cerk	ceramide kinase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CERK mRNA	PMID:39012411
1305019	Cerk	ceramide kinase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CERK mRNA	PMID:37776818
1305019	Cerk	ceramide kinase	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1305019	Cerk	ceramide kinase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CERK mRNA	PMID:40194260
1305019	Cerk	ceramide kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CERK mRNA	PMID:36331819
1305019	Cerk	ceramide kinase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312799	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CERK mRNA	PMID:25979313
1305019	Cerk	ceramide kinase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312799	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CERK mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305019	Cerk	ceramide kinase	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA	PMID:27188386
1305019	Cerk	ceramide kinase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CERK mRNA	PMID:30047161
1305019	Cerk	ceramide kinase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312799	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CERK mRNA	PMID:20106945
1305019	Cerk	ceramide kinase	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA	PMID:33854195
1305019	Cerk	ceramide kinase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CERK mRNA	PMID:37992649
1305019	Cerk	ceramide kinase	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312799	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CERK mRNA	PMID:38832940
1305019	Cerk	ceramide kinase	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA	PMID:33854195
1305019	Cerk	ceramide kinase	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312799	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CERK mRNA	PMID:24935251|PMID:26272509
1305019	Cerk	ceramide kinase	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA	PMID:27188386
1305019	Cerk	ceramide kinase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312800	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CERK mRNA	PMID:17562736
1305019	Cerk	ceramide kinase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CERK mRNA	PMID:33387578
1305019	Cerk	ceramide kinase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312799	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CERK mRNA	PMID:21420995
1305019	Cerk	ceramide kinase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312799	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CERK mRNA	PMID:22230336
1305019	Cerk	ceramide kinase	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1312799	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the expression of CERK mRNA	PMID:25304211
1305019	Cerk	ceramide kinase	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312799	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CERK gene	PMID:25304211
1305019	Cerk	ceramide kinase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CERK mRNA	PMID:39836092
1305019	Cerk	ceramide kinase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CERK mRNA	PMID:40504410
1305019	Cerk	ceramide kinase	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CERK mRNA	PMID:29391264
1305019	Cerk	ceramide kinase	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CERK mRNA	PMID:30047161
1305019	Cerk	ceramide kinase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CERK mRNA	PMID:35964746
1305019	Cerk	ceramide kinase	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA	PMID:33854195
1305019	Cerk	ceramide kinase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of CERK mRNA	PMID:39836092
1305019	Cerk	ceramide kinase	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CERK mRNA	PMID:21641980
1305019	Cerk	ceramide kinase	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CERK mRNA	PMID:23650126
1305019	Cerk	ceramide kinase	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312799	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CERK intron	PMID:30157460
1305019	Cerk	ceramide kinase	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CERK gene	PMID:35440735
1305019	Cerk	ceramide kinase	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CERK gene	PMID:33148267
1305019	Cerk	ceramide kinase	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312799	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CERK mRNA	PMID:31758290
1305019	Cerk	ceramide kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312800	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CERK mRNA	PMID:22206623
1305019	Cerk	ceramide kinase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312799	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CERK mRNA	PMID:30851411
1305019	Cerk	ceramide kinase	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA	PMID:27188386
1305019	Cerk	ceramide kinase	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1305019	Cerk	ceramide kinase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CERK mRNA	PMID:30047161
1305019	Cerk	ceramide kinase	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1312799	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of CERK mRNA	PMID:31734321
1305019	Cerk	ceramide kinase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312799	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA	PMID:27188386
1305019	Cerk	ceramide kinase	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CERK mRNA	PMID:23034163
1305020	Phf20	PHD finger protein 20	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1623787	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PHF20 mRNA	PMID:37995155
1305020	Phf20	PHD finger protein 20	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PHF20 mRNA	PMID:30071829
1305020	Phf20	PHD finger protein 20	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1605683	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PHF20 mRNA	PMID:22378314
1305020	Phf20	PHD finger protein 20	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1623787	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PHF20 mRNA	PMID:30319688
1305020	Phf20	PHD finger protein 20	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1623787	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PHF20 mRNA	PMID:39298647
1305020	Phf20	PHD finger protein 20	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1605683	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PHF20 protein	PMID:37730182
1305020	Phf20	PHD finger protein 20	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PHF20 mRNA	PMID:33387578
1305020	Phf20	PHD finger protein 20	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605683	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PHF20 mRNA	PMID:19549813
1305020	Phf20	PHD finger protein 20	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1605683	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of PHF20 promoter	PMID:21291286
1305020	Phf20	PHD finger protein 20	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605683	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PHF20 mRNA	PMID:23557933
1305020	Phf20	PHD finger protein 20	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1605683	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of PHF20 mRNA	PMID:19921347
1305020	Phf20	PHD finger protein 20	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1623787	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PHF20 mRNA	PMID:30912803
1305020	Phf20	PHD finger protein 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHF20 mRNA	PMID:22298810
1305020	Phf20	PHD finger protein 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PHF20 mRNA	PMID:33387578
1305020	Phf20	PHD finger protein 20	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PHF20 mRNA	PMID:28959563
1305020	Phf20	PHD finger protein 20	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1605683	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PHF20 gene	PMID:28589171
1305020	Phf20	PHD finger protein 20	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1623787	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PHF20 mRNA	PMID:22700541
1305020	Phf20	PHD finger protein 20	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605683	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PHF20 promoter	PMID:27901495
1305020	Phf20	PHD finger protein 20	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605683	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PHF20 mRNA	PMID:20064835
1305020	Phf20	PHD finger protein 20	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605683	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PHF20 3' UTR	PMID:27901495
1305020	Phf20	PHD finger protein 20	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1623787	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PHF20 intron	PMID:27901495
1305020	Phf20	PHD finger protein 20	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605683	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PHF20 mRNA]	PMID:32406909
1305020	Phf20	PHD finger protein 20	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605683	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PHF20 mRNA	PMID:19150397
1305020	Phf20	PHD finger protein 20	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1605683	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of PHF20 gene	PMID:31601247
1305020	Phf20	PHD finger protein 20	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PHF20 mRNA	PMID:25729387
1305020	Phf20	PHD finger protein 20	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623787	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHF20 gene	PMID:35295148
1305020	Phf20	PHD finger protein 20	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1623787	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PHF20 mRNA	PMID:20813756
1305020	Phf20	PHD finger protein 20	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of PHF20 mRNA	PMID:32145629
1305020	Phf20	PHD finger protein 20	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF20 mRNA	PMID:25181051
1305020	Phf20	PHD finger protein 20	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1623787	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PHF20 mRNA	PMID:26063408
1305020	Phf20	PHD finger protein 20	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1605683	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PHF20 mRNA	PMID:19244175
1305020	Phf20	PHD finger protein 20	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623787	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PHF20 mRNA	PMID:39298647
1305020	Phf20	PHD finger protein 20	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1605683	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PHF20 intron	PMID:30157460
1305020	Phf20	PHD finger protein 20	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623787	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PHF20 mRNA	PMID:37019170
1305020	Phf20	PHD finger protein 20	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHF20 mRNA	PMID:30589522
1305020	Phf20	PHD finger protein 20	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1605683	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PHF20 mRNA	PMID:19376846
1305020	Phf20	PHD finger protein 20	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1623787	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PHF20 mRNA	PMID:17963808
1305020	Phf20	PHD finger protein 20	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605683	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF20 mRNA	PMID:23179753
1305020	Phf20	PHD finger protein 20	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605683	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PHF20 mRNA	PMID:21420995|PMID:22230336
1305020	Phf20	PHD finger protein 20	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1605683	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of PHF20 promoter	PMID:21291286
1305020	Phf20	PHD finger protein 20	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of PHF20 mRNA	PMID:34044035
1305020	Phf20	PHD finger protein 20	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PHF20 mRNA	PMID:24136188
1305020	Phf20	PHD finger protein 20	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PHF20 mRNA	PMID:25729387
1305020	Phf20	PHD finger protein 20	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1605683	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of PHF20 mRNA	PMID:16934159
1305020	Phf20	PHD finger protein 20	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1605683	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PHF20 intron	PMID:30157460
1305020	Phf20	PHD finger protein 20	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PHF20 gene	PMID:35440735
1305020	Phf20	PHD finger protein 20	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1605683	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of PHF20 protein	PMID:31285264
1305020	Phf20	PHD finger protein 20	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605683	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PHF20 gene]	PMID:28238834
1305020	Phf20	PHD finger protein 20	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1623787	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of PHF20 mRNA	PMID:23091169
1305020	Phf20	PHD finger protein 20	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1605683	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of PHF20 mRNA	PMID:19095052
1305020	Phf20	PHD finger protein 20	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1605683	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of PHF20 mRNA	PMID:27188386
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312803	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PPFIA2 mRNA	PMID:27188386
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPFIA2 mRNA]	PMID:31150632
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1621980	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PPFIA2 mRNA	PMID:30319688
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312803	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PPFIA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PPFIA2 mRNA	PMID:35811015
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of PPFIA2 mRNA	PMID:26496021
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1621980	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PPFIA2 mRNA	PMID:34319233
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312803	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PPFIA2 mRNA	PMID:28818685
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312803	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PPFIA2 gene	PMID:27153756
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PPFIA2 mRNA	PMID:31150632
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPFIA2 mRNA]	PMID:31150632
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312803	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PPFIA2 mRNA	PMID:28903495
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1621980	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PPFIA2 mRNA	PMID:32186404
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1621980	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPFIA2 mRNA	PMID:39631538
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312803	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PPFIA2 gene	PMID:28589171
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621980	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPFIA2 mRNA	PMID:36209798|PMID:37682722
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312803	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPFIA2 5' UTR; Benzo(a)pyrene affects the methylation of PPFIA2 promoter	PMID:27901495
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312803	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPFIA2 mRNA	PMID:32234424
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312803	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PPFIA2 3' UTR	PMID:27901495
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312803	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PPFIA2 mRNA	PMID:22316170
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312803	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PPFIA2 exon	PMID:27901495
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1621980	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PPFIA2 mRNA	PMID:20813756
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PPFIA2 mRNA	PMID:19167457
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PPFIA2 mRNA	PMID:25181051|PMID:30816183|PMID:41034487
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621980	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PPFIA2 mRNA	PMID:32156529
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of PPFIA2 mRNA	PMID:26496021
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of PPFIA2 mRNA	PMID:25539665
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1621980	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PPFIA2 mRNA	PMID:40194260
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312803	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of PPFIA2 mRNA	PMID:26690555
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1312803	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of PPFIA2 mRNA	PMID:35811015
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312803	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PPFIA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PPFIA2 mRNA	PMID:35811015
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PPFIA2 mRNA	PMID:29391264
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1312803	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of PPFIA2 mRNA	PMID:32234424
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PPFIA2 mRNA	PMID:30307764
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PPFIA2 gene	PMID:35440735
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312803	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of PPFIA2 mRNA	PMID:30879928
1305021	Ppfia2	PPFI scaffold protein A2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1312803	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of PPFIA2 mRNA	PMID:32234424
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HEYL mRNA	PMID:39752319
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HEYL mRNA	PMID:20938992
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312806	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of HEYL mRNA	PMID:30319688
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312805	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of HEYL mRNA	PMID:20044591
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312805	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of HEYL mRNA	PMID:30510588
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312806	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of HEYL mRNA	PMID:25210133
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HEYL mRNA	PMID:32741896
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HEYL mRNA	PMID:33387578
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HEYL mRNA	PMID:20938992
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HEYL mRNA	PMID:37992649
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HEYL mRNA	PMID:39752319
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HEYL mRNA	PMID:32741896
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of HEYL mRNA	PMID:22967744
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HEYL mRNA	PMID:37992649
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312805	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HEYL mRNA	PMID:31163220
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of HEYL mRNA	PMID:26577399|PMID:27523638
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312805	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HEYL mRNA	PMID:36139627
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312805	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HEYL mRNA	PMID:35301059
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HEYL mRNA	PMID:33354967
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HEYL mRNA	PMID:20938992
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312805	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of HEYL mRNA	PMID:38460933
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312805	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HEYL mRNA	PMID:27188386
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HEYL mRNA	PMID:31881176
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312805	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HEYL mRNA	PMID:27392435
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of HEYL mRNA	PMID:30912803
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HEYL mRNA	PMID:22298810
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312806	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HEYL mRNA	PMID:24058054
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HEYL mRNA	PMID:34747641
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312805	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HEYL mRNA	PMID:28001369
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20180410	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HEYL mRNA	PMID:29104120
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312805	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HEYL mRNA	PMID:29803840
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of HEYL mRNA	PMID:39631538
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HEYL mRNA	PMID:37992649
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312805	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HEYL 3' UTR	PMID:27901495
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312806	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HEYL mRNA	PMID:22228805|PMID:32417428
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312805	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HEYL exon; Benzo(a)pyrene results in increased methylation of HEYL promoter	PMID:27901495
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1312805	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of HEYL mRNA	PMID:37690743
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of HEYL mRNA	PMID:22613225
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HEYL mRNA	PMID:30047161
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HEYL mRNA	PMID:29264374
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312806	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of HEYL mRNA	PMID:23557971
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HEYL mRNA	PMID:25181051|PMID:34947998
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312805	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of HEYL mRNA	PMID:27685785
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312805	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of HEYL gene	PMID:31601247
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of HEYL mRNA	PMID:30816183|PMID:32528016
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312806	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of HEYL mRNA	PMID:30951980
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HEYL mRNA	PMID:36041667
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312806	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of HEYL mRNA	PMID:30951980
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HEYL mRNA	PMID:36041667
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312806	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of HEYL mRNA	PMID:30951980
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HEYL mRNA	PMID:36041667
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312806	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of HEYL promoter	PMID:28392331
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312805	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of HEYL gene	PMID:22964155
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312806	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HEYL mRNA	PMID:17361019|PMID:21266533
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20130416	CTD	MESH:D010269	[SNCA protein co-treated with Maneb co-treated with Paraquat] results in decreased expression of HEYL mRNA	PMID:23017109
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312806	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of HEYL mRNA	PMID:26377693
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312805	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HEYL mRNA	PMID:35301059
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of HEYL mRNA	PMID:29038090
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312805	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of HEYL mRNA	PMID:23179753
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HEYL mRNA	PMID:30047161
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312806	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of HEYL mRNA	PMID:17555576
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HEYL mRNA	PMID:37992649
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312805	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of HEYL mRNA	PMID:27188386
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312805	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in increased expression of HEYL mRNA	PMID:28542535
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312805	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of HEYL mRNA	PMID:38460933
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312806	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of HEYL mRNA	PMID:17555576
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HEYL mRNA	PMID:25620056
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312806	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of HEYL mRNA	PMID:25554681
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20130416	CTD	MESH:D008344	[SNCA protein co-treated with Maneb co-treated with Paraquat] results in decreased expression of HEYL mRNA	PMID:23017109
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of HEYL mRNA	PMID:23608068
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of HEYL mRNA	PMID:36907384
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of HEYL mRNA	PMID:22078008
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HEYL mRNA	PMID:39752319
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of HEYL mRNA	PMID:33484710
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312805	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HEYL mRNA	PMID:36139627
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HEYL mRNA	PMID:32741896
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312805	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HEYL mRNA	PMID:27188386
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312805	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HEYL gene]	PMID:28238834
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1312806	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of HEYL mRNA	PMID:26655953
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HEYL mRNA	PMID:24780913
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of HEYL mRNA	PMID:30047161
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HEYL mRNA	PMID:39752319
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312805	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HEYL mRNA	PMID:27188386
1305022	Heyl	hes-related family bHLH transcription factor with YRPW motif-like	gene	CHEBI:9130	sevoflurane	decreases methylation	ISO	RGD:1312806	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased methylation of HEYL mRNA	PMID:35249202
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1551204	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of DEGS2 mRNA	PMID:37995155
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DEGS2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DEGS2 gene	PMID:20938992
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1352357	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of DEGS2 mRNA	PMID:23019147
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DEGS2 mRNA	PMID:33387578
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DEGS2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DEGS2 gene	PMID:20938992
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1352357	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DEGS2 mRNA	PMID:37042841
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DEGS2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DEGS2 mRNA	PMID:37992649
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of DEGS2 mRNA	PMID:22967744
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DEGS2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DEGS2 mRNA	PMID:37992649
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DEGS2 mRNA	PMID:33387578
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DEGS2 mRNA	PMID:39012411
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DEGS2 mRNA	PMID:23630614
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of DEGS2 mRNA	PMID:30779732
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1551204	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of DEGS2 mRNA	PMID:31939706
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DEGS2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DEGS2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DEGS2 gene	PMID:20938992|PMID:22206623
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DEGS2 mRNA]	PMID:37992649
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1352357	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of DEGS2 mRNA	PMID:23557933
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1551204	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of DEGS2 mRNA	PMID:32186404
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1352357	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of DEGS2 mRNA	PMID:23019147
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DEGS2 mRNA	PMID:33387578
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1352357	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DEGS2 mRNA	PMID:23152189
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551204	E	RGD:6480464	20170613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DEGS2 mRNA	PMID:28238261
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DEGS2 mRNA	PMID:17942748
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1352357	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DEGS2 mRNA	PMID:30851411
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DEGS2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DEGS2 mRNA	PMID:37992649
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DEGS2 mRNA]	PMID:37992649
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352357	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of DEGS2 mRNA	PMID:39719251
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1352357	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DEGS2 mRNA	PMID:22316170
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352357	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DEGS2 promoter	PMID:27901495
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DEGS2 mRNA	PMID:22431001
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1551204	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of DEGS2 mRNA	PMID:23131501|PMID:23557971
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551204	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DEGS2 gene	PMID:35295148
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of DEGS2 mRNA	PMID:30012374
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DEGS2 mRNA	PMID:25181051|PMID:32145629
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1352357	E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A results in increased expression of DEGS2 mRNA	PMID:23019147
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551204	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DEGS2 mRNA	PMID:37019170
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352357	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DEGS2 mRNA	PMID:37042841
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1352357	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DEGS2 mRNA	PMID:38568856
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DEGS2 mRNA	PMID:39012411
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of DEGS2 gene	PMID:27387713
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of DEGS2 mRNA	PMID:27387713
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1551204	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of DEGS2 mRNA	PMID:21427059
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551204	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DEGS2 mRNA	PMID:28973697
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DEGS2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DEGS2 mRNA	PMID:37992649
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1352357	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of DEGS2 mRNA	PMID:38832940
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1352357	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of DEGS2 mRNA	PMID:22230336
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1551204	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DEGS2 mRNA	PMID:29279043
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DEGS2 mRNA	PMID:17942748
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1551204	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of DEGS2 mRNA	PMID:23608068
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of DEGS2 mRNA	PMID:27935865
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551204	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DEGS2 mRNA	PMID:22206623
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DEGS2 mRNA	PMID:22206623
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in decreased expression of DEGS2 mRNA	PMID:32741896
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1352357	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DEGS2 mRNA	PMID:30851411
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20180220	CTD	MESH:C412815	GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of DEGS2 mRNA]	PMID:28223344
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:8062	phenethyl caffeate	multiple interactions	ISO	RGD:1551204	E	RGD:6480464	20180220	CTD	MESH:C055494	[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of DEGS2 mRNA; GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of DEGS2 mRNA]; NR1H4 protein affects the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of DEGS2 mRNA]	PMID:28223344
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DEGS2 mRNA	PMID:24780913
1305023	Degs2	delta(4)-desaturase, sphingolipid 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of DEGS2 mRNA	PMID:19281266
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623055	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZFP575 mRNA	PMID:33045310
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312810	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZNF575 mRNA	PMID:26079696
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312810	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF575 mRNA	PMID:37042841
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of ZNF575 mRNA	PMID:22967744
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312810	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF575 mRNA	PMID:19549813
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312810	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZNF575 mRNA	PMID:22100608
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312810	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ZNF575 mRNA	PMID:23557933
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312810	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ZNF575 mRNA	PMID:27392435
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1312810	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ZNF575 gene	PMID:24570342
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312810	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF575 mRNA	PMID:24570342
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312810	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZNF575 5' UTR	PMID:27901495
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1623055	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ZFP575 mRNA	PMID:27131904
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623055	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP575 promoter	PMID:35295148
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312810	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ZNF575 mRNA	PMID:19710929
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ZFP575 mRNA	PMID:19167457
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF575 mRNA	PMID:25181051
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP575 mRNA	PMID:30816183|PMID:34947998
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP575 mRNA	PMID:36041667
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1623055	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ZFP575 exon	PMID:33297965
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP575 mRNA	PMID:36041667
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP575 mRNA	PMID:36041667
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312810	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNF575 mRNA	PMID:38382870
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312810	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ZNF575 mRNA	PMID:24449571
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:46905	(R)-pantothenic acid	decreases expression	ISO	RGD:1312810	E	RGD:6480464	20120515	CTD	MESH:D010205	Pantothenic Acid results in decreased expression of ZNF575 mRNA	PMID:19397697
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312810	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF575 gene]	PMID:28238834
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZFP575 mRNA	PMID:24780913
1305025	Zfp575	zinc finger protein 575	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1623055	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ZFP575 mRNA	PMID:27131904
1305026	Tnks2	tankyrase 2	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:D004237	Diuron results in increased expression of TNKS2 mRNA	PMID:21551480
1305026	Tnks2	tankyrase 2	gene	CHEBI:132098	methoxyacetic acid	increases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:C013598	methoxyacetic acid results in increased expression of TNKS2 mRNA	PMID:20864626
1305026	Tnks2	tankyrase 2	gene	CHEBI:134689	rucaparib	affects binding	ISO	RGD:1312811	E	RGD:6480464	20200211	CTD	MESH:C531549	rucaparib binds to TNKS2 protein	PMID:28001384
1305026	Tnks2	tankyrase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552096	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TNKS2 mRNA	PMID:30319688
1305026	Tnks2	tankyrase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20180626	CTD	MESH:D004958	Estradiol results in decreased expression of TNKS2 mRNA	PMID:19484750
1305026	Tnks2	tankyrase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312811	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TNKS2 mRNA	PMID:37042841
1305026	Tnks2	tankyrase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TNKS2 mRNA	PMID:33754040|PMID:34319233
1305026	Tnks2	tankyrase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:D005839	Gentamicins results in increased expression of TNKS2 mRNA	PMID:22061828
1305026	Tnks2	tankyrase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552096	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TNKS2 mRNA	PMID:36331819
1305026	Tnks2	tankyrase 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TNKS2 mRNA	PMID:28522335
1305026	Tnks2	tankyrase 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TNKS2 mRNA	PMID:23649840
1305026	Tnks2	tankyrase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TNKS2 gene	PMID:27153756
1305026	Tnks2	tankyrase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552096	E	RGD:6480464	20180626	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TNKS2 mRNA	PMID:19770486
1305026	Tnks2	tankyrase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TNKS2 mRNA	PMID:23649840
1305026	Tnks2	tankyrase 2	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:D002110	Caffeine results in increased expression of TNKS2 mRNA	PMID:20864626
1305026	Tnks2	tankyrase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312811	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TNKS2 mRNA	PMID:23557933
1305026	Tnks2	tankyrase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552096	E	RGD:6480464	20180626	CTD	MESH:D002945	Cisplatin results in increased expression of TNKS2 mRNA	PMID:21151649
1305026	Tnks2	tankyrase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNKS2 mRNA	PMID:21215274
1305026	Tnks2	tankyrase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNKS2 mRNA	PMID:17101203
1305026	Tnks2	tankyrase 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TNKS2 mRNA	PMID:28374803
1305026	Tnks2	tankyrase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TNKS2 mRNA	PMID:20864626
1305026	Tnks2	tankyrase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TNKS2 mRNA	PMID:26272509
1305026	Tnks2	tankyrase 2	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNKS2 mRNA	PMID:27188386
1305026	Tnks2	tankyrase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312811	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TNKS2 mRNA	PMID:30851411
1305026	Tnks2	tankyrase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNKS2 mRNA	PMID:28595984|PMID:39719251
1305026	Tnks2	tankyrase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312811	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TNKS2 mRNA	PMID:38568856
1305026	Tnks2	tankyrase 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of TNKS2 gene	PMID:25435355
1305026	Tnks2	tankyrase 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312811	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TNKS2 mRNA]	PMID:32406909
1305026	Tnks2	tankyrase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TNKS2 mRNA	PMID:19150397
1305026	Tnks2	tankyrase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1552096	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TNKS2 mRNA	PMID:35676786
1305026	Tnks2	tankyrase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552096	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TNKS2 gene	PMID:35295148
1305026	Tnks2	tankyrase 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312811	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of TNKS2 mRNA	PMID:38479592
1305026	Tnks2	tankyrase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TNKS2 mRNA	PMID:34947998
1305026	Tnks2	tankyrase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:C006780	bisphenol A results in increased expression of TNKS2 mRNA	PMID:25181051
1305026	Tnks2	tankyrase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TNKS2 mRNA	PMID:39298647
1305026	Tnks2	tankyrase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552096	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TNKS2 intron	PMID:28392331
1305026	Tnks2	tankyrase 2	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20180626	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TNKS2 mRNA	PMID:17602206
1305026	Tnks2	tankyrase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TNKS2 mRNA	PMID:21266533
1305026	Tnks2	tankyrase 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TNKS2 mRNA	PMID:34813904
1305026	Tnks2	tankyrase 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TNKS2 mRNA	PMID:34813904
1305026	Tnks2	tankyrase 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20180626	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TNKS2 mRNA	PMID:17602206
1305026	Tnks2	tankyrase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312811	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TNKS2 mRNA	PMID:37042841
1305026	Tnks2	tankyrase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TNKS2 mRNA	PMID:19162173
1305026	Tnks2	tankyrase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TNKS2 mRNA	PMID:19162173
1305026	Tnks2	tankyrase 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:C000944	dicrotophos results in decreased expression of TNKS2 mRNA	PMID:28302478
1305026	Tnks2	tankyrase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312811	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TNKS2 mRNA	PMID:31533062
1305026	Tnks2	tankyrase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552096	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TNKS2 mRNA	PMID:36331819
1305026	Tnks2	tankyrase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TNKS2 gene	PMID:29154799
1305026	Tnks2	tankyrase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:D016572	Cyclosporine results in increased expression of TNKS2 mRNA	PMID:20106945
1305026	Tnks2	tankyrase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552096	E	RGD:6480464	20180626	CTD	MESH:D000082	Acetaminophen affects the expression of TNKS2 mRNA	PMID:17562736
1305026	Tnks2	tankyrase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20180626	CTD	MESH:C109476	epoxiconazole results in decreased expression of TNKS2 mRNA	PMID:22334560
1305026	Tnks2	tankyrase 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1552096	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TNKS2 mRNA	PMID:35676786
1305026	Tnks2	tankyrase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552096	E	RGD:6480464	20180626	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TNKS2 mRNA	PMID:25554681
1305026	Tnks2	tankyrase 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of TNKS2 mRNA	PMID:19162173
1305026	Tnks2	tankyrase 2	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:C001277	geldanamycin results in increased expression of TNKS2 mRNA	PMID:26705709
1305026	Tnks2	tankyrase 2	gene	CHEBI:62878	XAV939	multiple interactions	ISO	RGD:1312811	E	RGD:6480464	20200211	CTD	MESH:C544261	XAV939 binds to and results in decreased activity of TNKS2 protein	PMID:28001384
1305026	Tnks2	tankyrase 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNKS2 mRNA	PMID:26378955
1305026	Tnks2	tankyrase 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of TNKS2 mRNA	PMID:39938710
1305026	Tnks2	tankyrase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TNKS2 mRNA	PMID:22206623
1305026	Tnks2	tankyrase 2	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in increased expression of TNKS2 mRNA	PMID:26720608
1305026	Tnks2	tankyrase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312811	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TNKS2 mRNA	PMID:30851411
1305026	Tnks2	tankyrase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNKS2 mRNA	PMID:27188386
1305026	Tnks2	tankyrase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552096	E	RGD:6480464	20180626	CTD	MESH:D010634	Phenobarbital affects the expression of TNKS2 mRNA	PMID:23091169
1305026	Tnks2	tankyrase 2	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20180626	CTD	MESH:C093628	cyproconazole results in decreased expression of TNKS2 mRNA	PMID:22334560
1305026	Tnks2	tankyrase 2	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of TNKS2 mRNA	PMID:26923065
1305026	Tnks2	tankyrase 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20180626	CTD	MESH:C045950	propiconazole results in decreased expression of TNKS2 mRNA	PMID:21278054|PMID:22334560
1305026	Tnks2	tankyrase 2	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:C028577	monobutyl phthalate results in increased expression of TNKS2 mRNA	PMID:20864626
1305026	Tnks2	tankyrase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312811	E	RGD:6480464	20180626	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNKS2 mRNA	PMID:27188386
1305026	Tnks2	tankyrase 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:D012999	Soman results in decreased expression of TNKS2 mRNA	PMID:19281266
1305026	Tnks2	tankyrase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20180626	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TNKS2 mRNA	PMID:21346803
1305026	Tnks2	tankyrase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20180626	CTD	MESH:C057693	troglitazone results in decreased expression of TNKS2 mRNA	PMID:28973697
1305026	Tnks2	tankyrase 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20180626	CTD	MESH:C025643	vinclozolin results in increased expression of TNKS2 mRNA	PMID:20566332
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312812	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SFMBT2 mRNA	PMID:26272509|PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SFMBT2 mRNA	PMID:33045310
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SFMBT2 mRNA	PMID:25812627
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1616410	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SFMBT2 gene	PMID:20938992
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312812	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SFMBT2 mRNA	PMID:23724009
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312812	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SFMBT2 mRNA	PMID:26516004
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312812	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SFMBT2 mRNA	PMID:26079696
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SFMBT2 mRNA	PMID:22378314
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of SFMBT2 mRNA	PMID:24758408
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in decreased expression of SFMBT2 mRNA]	PMID:24758408
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1616410	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SFMBT2 gene	PMID:20938992
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312812	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SFMBT2 mRNA	PMID:26079696
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SFMBT2 mRNA	PMID:33387578
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312812	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SFMBT2 mRNA	PMID:28818685
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312812	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SFMBT2 intron	PMID:30157460
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312812	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SFMBT2 intron	PMID:30157460
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SFMBT2 mRNA	PMID:41430723
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1616410	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SFMBT2 mRNA	PMID:34911549
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SFMBT2 mRNA	PMID:25629700
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616410	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SFMBT2 gene	PMID:20938992
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312812	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SFMBT2 mRNA	PMID:26272509
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:27690	acetazolamide	increases expression	ISO	RGD:1616410	E	RGD:6480464	20120717	CTD	MESH:D000086	Acetazolamide results in increased expression of SFMBT2 mRNA	PMID:19274763
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SFMBT2 mRNA	PMID:28960355
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312812	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SFMBT2 mRNA	PMID:28903495
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312812	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SFMBT2 mRNA	PMID:24768652|PMID:25583101
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFMBT2 mRNA	PMID:29704546
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFMBT2 mRNA	PMID:19933214|PMID:27913140
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of SFMBT2 mRNA	PMID:29704546
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312812	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SFMBT2 mRNA	PMID:32763439
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SFMBT2 mRNA	PMID:26033743
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SFMBT2 mRNA	PMID:29803840
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of SFMBT2 mRNA	PMID:39719251
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of SFMBT2 mRNA	PMID:36209798
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1616410	E	RGD:6480464	20180410	CTD	MESH:C017947	sodium arsenite results in increased expression of SFMBT2	PMID:29121352
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312812	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SFMBT2 promoter	PMID:27901495
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312812	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SFMBT2 5' UTR	PMID:27901495
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SFMBT2 mRNA	PMID:26033743
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SFMBT2 mRNA	PMID:19150397
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of SFMBT2 mRNA	PMID:35984750
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SFMBT2 gene	PMID:31601247
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1616410	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SFMBT2 gene	PMID:35295148
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1616410	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SFMBT2 mRNA	PMID:20813756
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SFMBT2 mRNA	PMID:25181051
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SFMBT2 mRNA	PMID:32145629|PMID:41034487
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1616410	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SFMBT2 mRNA	PMID:26063408|PMID:35598803
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SFMBT2 gene	PMID:28505145
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SFMBT2 gene	PMID:31601247
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1616410	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SFMBT2 mRNA	PMID:30951980
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312812	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SFMBT2 intron	PMID:30157460
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SFMBT2 mRNA	PMID:32715474
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312812	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SFMBT2 mRNA	PMID:37042841
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SFMBT2 mRNA	PMID:25812627
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SFMBT2 mRNA	PMID:25812627
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SFMBT2 mRNA	PMID:31533062
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SFMBT2 mRNA	PMID:25812627
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SFMBT2 mRNA	PMID:21427059
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312812	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SFMBT2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312812	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SFMBT2 mRNA	PMID:26272509|PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312812	E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of SFMBT2 mRNA	PMID:24935251|PMID:26272509|PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1616410	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SFMBT2 mRNA	PMID:17562736
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SFMBT2 mRNA	PMID:33387578
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SFMBT2 mRNA	PMID:29391264
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of SFMBT2 mRNA	PMID:40706910
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SFMBT2 mRNA; Nanotubes, Carbon results in decreased expression of SFMBT2 mRNA	PMID:25554681
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SFMBT2 mRNA	PMID:24793618
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1616410	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of SFMBT2 mRNA	PMID:23608068
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1616410	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SFMBT2 mRNA	PMID:38701926
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1312812	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of SFMBT2 mRNA	PMID:26272509
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SFMBT2 mRNA	PMID:24810058
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312812	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SFMBT2 intron	PMID:30157460
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312812	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SFMBT2 mRNA	PMID:31758290
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SFMBT2 mRNA	PMID:22206623
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312812	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SFMBT2 mRNA	PMID:22714537
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312812	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SFMBT2 mRNA	PMID:37199045
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312812	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of SFMBT2 mRNA	PMID:26079696
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312812	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SFMBT2 mRNA	PMID:26272509
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312812	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1616410	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of SFMBT2 protein	PMID:24648495
1305027	Sfmbt2	Scm-like with four mbt domains 2	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of SFMBT2 gene	PMID:31079544
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of EZH1 mRNA	PMID:25152437
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1312813	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of EZH1 mRNA	PMID:16823088
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EZH1 mRNA	PMID:39241906
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of EZH1 mRNA]	PMID:39241906
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312814	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of EZH1 mRNA	PMID:15598610
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16480	nitric oxide	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide deficiency results in decreased expression of EZH1 mRNA	PMID:15878706
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of EZH1 gene	PMID:27618143
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312813	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EZH1 mRNA	PMID:37042841
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:17270	glycerol 2-phosphate	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20151215	CTD	MESH:C031463	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of EZH1 mRNA	PMID:26424790
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312813	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of EZH1 protein	PMID:37730182
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312813	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EZH1 mRNA	PMID:28818685
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA	PMID:39836092
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312813	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of EZH1 mRNA	PMID:23649840
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1312813	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of EZH1 mRNA	PMID:16823088
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of EZH1 mRNA	PMID:34911549
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EZH1 mRNA	PMID:17484886
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EZH1 mRNA	PMID:25629700
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EZH1 mRNA	PMID:22206623
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EZH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EZH1 mRNA	PMID:39836092|PMID:40512198
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312813	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of EZH1 mRNA	PMID:26272509
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA	PMID:27188386
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312813	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of EZH1 mRNA	PMID:12002526
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312813	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of EZH1 mRNA	PMID:27594783
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312813	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of EZH1 mRNA	PMID:27392435
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of EZH1 mRNA	PMID:30912803
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312813	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of EZH1 mRNA	PMID:25583101
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312814	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EZH1 mRNA	PMID:21570461
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EZH1 mRNA	PMID:32109520
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20120412	CTD	MESH:D019328	Buthionine Sulfoximine results in decreased expression of EZH1 mRNA	PMID:15878706
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312813	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EZH1 mRNA	PMID:29803840
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312814	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of EZH1 mRNA	PMID:39631538
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20151215	CTD	MESH:D001205	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of EZH1 mRNA	PMID:26424790
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312813	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of EZH1 mRNA	PMID:39719251
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312814	E	RGD:6480464	20221101	CTD	MESH:C017947	sodium arsenite results in increased expression of EZH1 mRNA	PMID:35364107
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EZH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EZH1 mRNA	PMID:39836092|PMID:40512198
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20221101	CTD	MESH:C017947	GSK-2816126 promotes the reaction [sodium arsenite results in increased expression of EZH1 mRNA]	PMID:35364107
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312813	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EZH1 promoter	PMID:27901495
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EZH1 mRNA	PMID:21839799
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EZH1 mRNA	PMID:22228805
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of EZH1 mRNA	PMID:30047161
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312814	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EZH1 gene	PMID:35295148
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312814	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of EZH1 mRNA	PMID:29264374
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of EZH1 mRNA	PMID:23411599
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EZH1 mRNA	PMID:25181051|PMID:30816183
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312813	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of EZH1 mRNA	PMID:20170705
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312813	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of EZH1 mRNA	PMID:29275510
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312813	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of EZH1 mRNA	PMID:19244175
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EZH1 mRNA	PMID:37019170
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EZH1 mRNA	PMID:21266533
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312814	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EZH1 mRNA	PMID:21266533
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of EZH1 mRNA]	PMID:39241906
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312813	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EZH1 mRNA	PMID:37042841
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA	PMID:39836092
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312813	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of EZH1 mRNA	PMID:38568856
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312813	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EZH1 mRNA	PMID:38174414
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312813	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EZH1 mRNA	PMID:24449571
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312813	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EZH1 mRNA	PMID:25979313
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312813	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of EZH1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA	PMID:27188386
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of EZH1 mRNA	PMID:30047161
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of EZH1 mRNA	PMID:41580965
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312813	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of EZH1 mRNA	PMID:25562108
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20151215	CTD	MESH:D003907	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of EZH1 mRNA	PMID:26424790
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of EZH1 mRNA	PMID:37077353
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312813	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of EZH1 mRNA	PMID:38832940
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312813	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of EZH1 mRNA	PMID:24935251
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of EZH1 mRNA	PMID:29279043
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EZH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EZH1 mRNA	PMID:39836092|PMID:40512198
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of EZH1 mRNA	PMID:37077353
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:4775	ellagic acid	increases expression	ISO	RGD:1312813	E	RGD:6480464	20120412	CTD	MESH:D004610	Ellagic Acid results in increased expression of EZH1 mRNA	PMID:12002526
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312813	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of EZH1 mRNA	PMID:18175754
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EZH1 mRNA; Nanotubes, Carbon results in decreased expression of EZH1 mRNA	PMID:25554681
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of EZH1 mRNA	PMID:30047161
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EZH1 mRNA	PMID:35964746
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1312813	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of EZH1 mRNA	PMID:27188386
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of EZH1 mRNA	PMID:20080153
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA	PMID:39836092
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of EZH1 mRNA	PMID:22078008
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312814	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of EZH1 mRNA	PMID:20003209
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of EZH1 mRNA	PMID:30467583
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312814	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EZH1 mRNA	PMID:22206623
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EZH1 mRNA	PMID:22206623
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA	PMID:27188386
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EZH1 mRNA	PMID:30047161
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of EZH1 mRNA]	PMID:39241906
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312813	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA	PMID:27188386
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EZH1 mRNA	PMID:21346803
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312813	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of EZH1 mRNA	PMID:38568856
1305028	Ezh1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EZH1 mRNA	PMID:21346803
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of IL27RA mRNA	PMID:15784690
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312815	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of IL27RA mRNA	PMID:26272509|PMID:27188386
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA	PMID:27188386
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312816	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of IL27RA mRNA	PMID:33045310
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312816	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of IL27RA mRNA	PMID:36189433
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of IL27RA mRNA	PMID:36189433
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312815	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of IL27RA mRNA	PMID:22378314
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of IL27RA mRNA	PMID:30510588
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312815	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of IL27RA mRNA	PMID:19619570|PMID:21185374|PMID:31614463
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL27RA mRNA	PMID:32741896
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of IL27RA mRNA	PMID:19619570
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312815	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IL27RA mRNA	PMID:37042841
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL27RA mRNA	PMID:37992649
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312816	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of IL27RA mRNA	PMID:22401849
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of IL27RA mRNA	PMID:36189433
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL27RA mRNA	PMID:32741896
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL27RA mRNA	PMID:37992649
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312816	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IL27RA mRNA	PMID:35550907
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IL27RA mRNA	PMID:27523638
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of IL27RA mRNA	PMID:22061828
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA	PMID:39836092
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of IL27RA mRNA	PMID:21120746
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312815	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of IL27RA mRNA	PMID:19549813
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312815	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of IL27RA intron	PMID:30157460
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of IL27RA mRNA	PMID:30779732
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL27RA mRNA	PMID:39836092
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1312815	E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of IL27RA mRNA	PMID:21527772
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of IL27RA mRNA	PMID:23557933
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312815	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of IL27RA mRNA	PMID:23300844
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312815	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of IL27RA mRNA	PMID:27594783
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312815	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL27RA mRNA	PMID:25583101
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312816	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IL27RA mRNA	PMID:21570461|PMID:26377647
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IL27RA mRNA	PMID:19619570
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of IL27RA mRNA	PMID:19619570
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IL27RA mRNA	PMID:29803840
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL27RA mRNA	PMID:37992649
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:28939	N-acetyl-L-cysteine	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine results in decreased expression of IL27RA mRNA	PMID:16084531
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312815	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of IL27RA mRNA	PMID:34032870
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IL27RA mRNA	PMID:38568856|PMID:39719251
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312816	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of IL27RA mRNA	PMID:37682722
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL27RA mRNA	PMID:39836092
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA	PMID:34876320
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA	PMID:34876320
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312815	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL27RA 3' UTR	PMID:27901495
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312815	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of IL27RA promoter	PMID:27901495
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312815	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IL27RA mRNA	PMID:32234424
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312816	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IL27RA mRNA	PMID:29341224
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of IL27RA mRNA	PMID:19128835
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312816	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IL27RA gene	PMID:35295148
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IL27RA mRNA	PMID:25181051
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of IL27RA mRNA	PMID:30816183|PMID:32528016
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312816	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of IL27RA mRNA	PMID:38701888
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312815	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of IL27RA mRNA	PMID:25979313
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312816	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of IL27RA mRNA	PMID:28392331
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:34674	dextran sulfate	decreases response to substance	ISO	RGD:1312816	E	RGD:6480464	20120412	CTD	MESH:D016264	IL27RA protein results in decreased susceptibility to Dextran Sulfate	PMID:16306766
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312815	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IL27RA mRNA	PMID:37042841
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of IL27RA mRNA	PMID:35163327
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA	PMID:39836092
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IL27RA mRNA	PMID:38568856
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20210309	CTD	MESH:C023036	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of IL27RA mRNA	PMID:33325755
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IL27RA mRNA	PMID:24449571
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312816	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IL27RA mRNA	PMID:40194260
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:38757	isoflavones	affects expression	ISO	RGD:1312815	E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones affects the expression of IL27RA mRNA	PMID:16365062
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IL27RA mRNA	PMID:31533062
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of IL27RA mRNA	PMID:40419075
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312816	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of IL27RA mRNA	PMID:29038090
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312815	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IL27RA mRNA	PMID:25979313
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312816	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of IL27RA mRNA	PMID:17292431
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of IL27RA mRNA	PMID:29154799
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of IL27RA mRNA	PMID:27989131
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312815	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of IL27RA mRNA	PMID:22147139
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL27RA mRNA	PMID:37992649
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312815	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of IL27RA mRNA	PMID:24935251|PMID:26272509
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA	PMID:27188386
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1312815	E	RGD:6480464	20120412	CTD	MESH:D005472	IL27RA protein affects the susceptibility to Fluorouracil	PMID:16217747
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL27RA mRNA	PMID:39836092
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of IL27RA mRNA	PMID:29391264
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20120412	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of IL27RA mRNA	PMID:16084531
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of IL27RA mRNA	PMID:22079256
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA	PMID:34876320
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1312815	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of IL27RA mRNA	PMID:38568856
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of IL27RA mRNA	PMID:19128835
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312815	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of IL27RA mRNA	PMID:23300844
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312816	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IL27RA mRNA	PMID:38701926
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA	PMID:39836092
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of IL27RA mRNA	PMID:15784690
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1312815	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL27RA mRNA	PMID:22079614
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312815	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of IL27RA mRNA	PMID:31758290
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312816	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IL27RA mRNA	PMID:22206623
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312815	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of IL27RA mRNA	PMID:22079256
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of IL27RA mRNA	PMID:22079256
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:75701	sarin	increases expression	ISO	RGD:1312815	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of IL27RA mRNA	PMID:19522546
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:76989	phytoestrogen	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20210309	CTD	MESH:D048789	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of IL27RA mRNA	PMID:33325755
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL27RA mRNA	PMID:32741896
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA	PMID:27188386
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1312815	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of IL27RA mRNA	PMID:32234424
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA	PMID:34876320
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312815	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of IL27RA mRNA	PMID:26272509
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA	PMID:27188386
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312815	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA	PMID:27188386
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IL27RA mRNA	PMID:38568856
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of IL27RA mRNA	PMID:29301935
1305029	Il27ra	interleukin 27 receptor subunit alpha	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312815	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of IL27RA mRNA	PMID:27188386
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312818	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACBD6 gene	PMID:20938992
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312817	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ACBD6 mRNA	PMID:33167477
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in decreased expression of ACBD6 protein	PMID:40631627
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312818	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of ACBD6 mRNA	PMID:40945087
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312817	E	RGD:6480464	20160712	CTD	MESH:D011794	Quercetin results in decreased expression of ACBD6 mRNA	PMID:21632981
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312818	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of ACBD6 mRNA	PMID:19484750
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312818	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACBD6 gene	PMID:20938992
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312817	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACBD6 mRNA	PMID:37042841
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of ACBD6 protein	PMID:40631627
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:17558	quercitrin	decreases expression	ISO	RGD:1312817	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of ACBD6 mRNA	PMID:25193878
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of ACBD6 protein	PMID:40631627
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312817	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312818	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACBD6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACBD6 gene	PMID:20938992|PMID:22206623
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312817	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312817	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ACBD6 mRNA	PMID:23557933
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312818	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ACBD6 mRNA	PMID:30912803
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312818	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACBD6 mRNA	PMID:21570461
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACBD6 mRNA	PMID:21215274
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACBD6 mRNA	PMID:33387578
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312817	E	RGD:6480464	20160712	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACBD6 mRNA	PMID:20106945
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312817	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ACBD6 mRNA	PMID:33212167
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312817	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312817	E	RGD:6480464	20160712	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACBD6 mRNA	PMID:20064835
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312818	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACBD6 mRNA	PMID:21715664
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312817	E	RGD:6480464	20160712	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACBD6 mRNA	PMID:21632981
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ACBD6 mRNA	PMID:25729387
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ACBD6 mRNA	PMID:34947998
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312817	E	RGD:6480464	20160712	CTD	MESH:C006780	bisphenol A results in increased expression of ACBD6 mRNA	PMID:25047013
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312818	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ACBD6 mRNA	PMID:32156529
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ACBD6 mRNA	PMID:21241498
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312818	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ACBD6 mRNA	PMID:34813904
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312818	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ACBD6 mRNA	PMID:34813904
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312817	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312817	E	RGD:6480464	20160712	CTD	MESH:D014635	Valproic Acid affects the expression of ACBD6 mRNA	PMID:25979313
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312817	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ACBD6 mRNA	PMID:29154799
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312817	E	RGD:6480464	20160712	CTD	MESH:D016572	Cyclosporine results in increased expression of ACBD6 mRNA	PMID:20106945
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of ACBD6 protein	PMID:40631627
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312817	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ACBD6 mRNA	PMID:24136188
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312817	E	RGD:6480464	20160712	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ACBD6 protein	PMID:23718831
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312817	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ACBD6 mRNA	PMID:25729387
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of ACBD6 mRNA	PMID:24136188
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312818	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACBD6 mRNA	PMID:22206623
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312817	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ACBD6 mRNA	PMID:37199045
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312817	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ACBD6 gene]	PMID:28238834
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312818	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ACBD6 mRNA	PMID:40826991
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	Streptozocin results in increased expression of ACBD6 mRNA	PMID:25905778
1305030	Acbd6	acyl-CoA binding domain containing 6	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312817	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ACBD6 mRNA	PMID:38568856
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of VTA1 mRNA	PMID:22378314
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552739	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VTA1 mRNA	PMID:39241906
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312819	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of VTA1 mRNA	PMID:37042841
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552739	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of VTA1 mRNA	PMID:33754040
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VTA1 mRNA	PMID:19549813
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312819	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of VTA1 gene	PMID:27153756
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1312819	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of VTA1 mRNA	PMID:15672453
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of VTA1 mRNA	PMID:22171008
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552739	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of VTA1 mRNA	PMID:25629700
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of VTA1 protein	PMID:37834424
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552739	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of VTA1 mRNA	PMID:28960355
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VTA1 mRNA	PMID:33387578
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VTA1 mRNA	PMID:29803840
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of VTA1 mRNA	PMID:39719251
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312819	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to VTA1 mRNA]	PMID:32406909
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of VTA1 mRNA	PMID:22171008
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312819	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of VTA1 gene	PMID:31601247
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of VTA1 mRNA	PMID:30047161
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552739	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VTA1 gene; titanium dioxide results in decreased methylation of VTA1 promoter	PMID:35295148
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of VTA1 mRNA	PMID:29275510
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of VTA1 mRNA	PMID:25181051|PMID:34947998
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312819	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of VTA1 protein	PMID:37567409
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VTA1 mRNA	PMID:36041667
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312819	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of VTA1 gene	PMID:31601247
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312819	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of VTA1 protein	PMID:34186270
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552739	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of VTA1 mRNA	PMID:39298647
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VTA1 mRNA	PMID:36041667
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312819	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of VTA1 protein	PMID:34186270
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VTA1 mRNA	PMID:36041667
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312819	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VTA1 mRNA	PMID:28628672
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of VTA1 mRNA	PMID:21241498
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312819	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VTA1 mRNA	PMID:28628672
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of VTA1 promoter	PMID:22457795
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of VTA1 mRNA	PMID:30047161
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552739	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of VTA1 mRNA	PMID:17585979
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in decreased expression of VTA1 protein	PMID:17152098
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of VTA1 mRNA	PMID:28302478
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552739	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of VTA1 mRNA	PMID:17292431
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1552739	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of VTA1 mRNA	PMID:21427059
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552739	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of VTA1 mRNA	PMID:21427059
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of VTA1 mRNA	PMID:30047161
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of VTA1 mRNA	PMID:25562108
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312819	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VTA1 mRNA	PMID:28628672
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of VTA1 protein	PMID:37834424
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of VTA1 mRNA	PMID:40706910
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312819	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VTA1 mRNA	PMID:28628672
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552739	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of VTA1 mRNA; Nanotubes, Carbon results in increased expression of VTA1 mRNA	PMID:25554681
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of VTA1 mRNA	PMID:30047161
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of VTA1 mRNA	PMID:24136188
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of VTA1 protein	PMID:32959892
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312819	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of VTA1 mRNA	PMID:31758290
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of VTA1 protein	PMID:31675489
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of VTA1 protein	PMID:31675489
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of VTA1 mRNA	PMID:30047161
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312819	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of VTA1 mRNA	PMID:24921660
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1312819	E	RGD:6480464	20180703	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of VTA1 protein	PMID:21469165
1305031	Vta1	vesicle trafficking 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312819	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of VTA1 mRNA	PMID:38568856
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312821	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TMPRSS4 mRNA	PMID:38218311
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMPRSS4 mRNA	PMID:20938992
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312821	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of TMPRSS4 mRNA	PMID:23830798
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312821	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TMPRSS4 mRNA	PMID:26079696
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312821	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of TMPRSS4 mRNA	PMID:19619570|PMID:21185374
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312821	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TMPRSS4 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of TMPRSS4 mRNA	PMID:19619570|PMID:30165855
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMPRSS4 mRNA	PMID:33387578
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMPRSS4 mRNA	PMID:20938992
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMPRSS4 mRNA	PMID:36331819
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMPRSS4 mRNA	PMID:37236586|PMID:37325564
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TMPRSS4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TMPRSS4 mRNA	PMID:34911549
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312822	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of TMPRSS4 mRNA	PMID:31939706
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMPRSS4 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMPRSS4 mRNA	PMID:20938992|PMID:22206623
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1312821	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of TMPRSS4 mRNA	PMID:26865667
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312821	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TMPRSS4 mRNA	PMID:25583101
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312822	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMPRSS4 mRNA	PMID:26377647
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMPRSS4 mRNA	PMID:20159946
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312821	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMPRSS4 mRNA	PMID:19619570
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312821	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TMPRSS4 mRNA	PMID:19619570
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TMPRSS4 mRNA	PMID:17942748
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of TMPRSS4 mRNA	PMID:30556269
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TMPRSS4 mRNA	PMID:26033743
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMPRSS4 mRNA	PMID:37682722
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312821	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMPRSS4 promoter	PMID:27901495
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312821	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMPRSS4 5' UTR	PMID:27901495
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of TMPRSS4 mRNA	PMID:30556269
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TMPRSS4 mRNA	PMID:26033743
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312822	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of TMPRSS4 mRNA	PMID:22609695
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TMPRSS4 mRNA	PMID:30012374
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312822	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TMPRSS4 mRNA	PMID:23557971|PMID:27760801
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TMPRSS4 mRNA	PMID:19710929
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TMPRSS4 mRNA	PMID:25181051
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312822	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TMPRSS4 mRNA	PMID:32156529
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of TMPRSS4 mRNA	PMID:30316929
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TMPRSS4 mRNA	PMID:40203079
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312822	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TMPRSS4 mRNA	PMID:26377693
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of TMPRSS4 mRNA	PMID:32680482
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMPRSS4 mRNA	PMID:37236586|PMID:37325564
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TMPRSS4 mRNA	PMID:27387713
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMPRSS4 mRNA	PMID:36331819
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312821	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TMPRSS4 mRNA	PMID:24383497
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of TMPRSS4 mRNA	PMID:25123088
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of TMPRSS4 mRNA	PMID:18502557
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312821	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TMPRSS4 mRNA	PMID:38832940
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMPRSS4 mRNA	PMID:17562736
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1312822	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of TMPRSS4 mRNA	PMID:29279043
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312822	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TMPRSS4 mRNA	PMID:35436446
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312821	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TMPRSS4 mRNA	PMID:26865667
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TMPRSS4 mRNA	PMID:17942748
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TMPRSS4 mRNA	PMID:25620056
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312822	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TMPRSS4 mRNA; Nanotubes, Carbon results in increased expression of TMPRSS4 mRNA	PMID:25554681
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1312821	E	RGD:6480464	20161025	CTD	MESH:C082360	fipronil results in increased expression of TMPRSS4 mRNA	PMID:27091632
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:5855	ibuprofen	affects expression	ISO	RGD:1312821	E	RGD:6480464	20120412	CTD	MESH:D007052	Ibuprofen affects the expression of TMPRSS4 mRNA	PMID:17070997
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TMPRSS4 mRNA	PMID:26378955
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:67251	beta-damascenone	increases expression	ISO	RGD:1312822	E	RGD:6480464	20161213	CTD	MESH:C075388	beta-damascenone results in increased expression of TMPRSS4 mRNA	PMID:22982537
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMPRSS4 mRNA	PMID:22206623
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMPRSS4 mRNA	PMID:22206623
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312821	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TMPRSS4 gene]	PMID:28238834
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:80491	pinostrobin	increases phosphorylation	ISO	RGD:1312821	E	RGD:6480464	20240206	CTD	MESH:C411294	pinostrobin results in increased phosphorylation of TMPRSS4 protein	PMID:37164308
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:82036	prothioconazole	decreases expression	ISO	RGD:1312821	E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in decreased expression of TMPRSS4 mRNA	PMID:35048155
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:8887	rofecoxib	increases expression	ISO	RGD:1312821	E	RGD:6480464	20170303	CTD	MESH:C116926	rofecoxib results in increased expression of TMPRSS4 mRNA	PMID:17070997
1305033	Tmprss4	transmembrane serine protease 4	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TMPRSS4 mRNA	PMID:23869203
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NET1 mRNA	PMID:33167477
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312823	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of NET1 mRNA	PMID:16249480|PMID:21934132
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NET1 mRNA	PMID:33729688
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:15940	nicotinic acid	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20161213	CTD	MESH:D009525	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of NET1 mRNA]	PMID:16940432
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NET1 mRNA	PMID:21632981
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312824	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NET1 mRNA	PMID:39241906
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of NET1 mRNA	PMID:15598610
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of NET1 mRNA	PMID:32145629
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312824	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NET1 mRNA	PMID:39298647
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of NET1 mRNA	PMID:30165855
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NET1 mRNA	PMID:33387578
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312823	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of NET1 mRNA	PMID:16002434
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA	PMID:39836092
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312823	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in increased expression of NET1 mRNA	PMID:23369406
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NET1 mRNA	PMID:37236586
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NET1 mRNA	PMID:19549813
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased expression of NET1 mRNA	PMID:19100860
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NET1 mRNA	PMID:22100608
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312823	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NET1 gene	PMID:27153756
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NET1 mRNA	PMID:19770486
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of NET1 mRNA	PMID:12763052
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NET1 mRNA	PMID:31150632
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312824	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NET1 mRNA	PMID:31919559
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NET1 mRNA	PMID:22206623
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NET1 mRNA	PMID:39836092
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312823	E	RGD:6480464	20240702	CTD	MESH:D002945	Cisplatin results in increased expression of NET1 mRNA	PMID:38498338
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:28073	chromium atom	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D002857	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of NET1 mRNA]	PMID:16940432
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312824	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NET1 mRNA	PMID:21570461
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NET1 mRNA	PMID:21215274
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NET1 mRNA	PMID:20106945|PMID:21632981
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NET1 mRNA	PMID:19933214|PMID:28922406
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312823	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of NET1 mRNA	PMID:39709020
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NET1 mRNA	PMID:29803840
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312823	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of NET1 mRNA	PMID:20044591
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NET1 mRNA	PMID:38568856
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NET1 mRNA	PMID:39836092
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NET1 mRNA	PMID:20106945|PMID:21632981
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NET1 mRNA	PMID:19770486
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312824	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NET1 exon; Benzo(a)pyrene results in decreased methylation of NET1 intron	PMID:27901495
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312824	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NET1 mRNA	PMID:15034205|PMID:27195522
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312823	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NET1 promoter	PMID:27901495
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of NET1 mRNA]	PMID:15034205
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NET1 mRNA	PMID:22431001
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NET1 mRNA	PMID:20382639
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of NET1 mRNA	PMID:22641619
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of NET1 mRNA	PMID:25729387
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NET1 mRNA	PMID:25729387
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312824	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NET1 gene	PMID:35295148
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NET1 mRNA	PMID:23411599|PMID:34492290
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of NET1 mRNA	PMID:16221962|PMID:18301758
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NET1 mRNA	PMID:30903817
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312823	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NET1 mRNA	PMID:30903817
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NET1 mRNA	PMID:25181051|PMID:32145629
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NET1 mRNA	PMID:30816183|PMID:32528016|PMID:33296240
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312824	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of NET1 promoter	PMID:33297965
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312824	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of NET1 mRNA	PMID:30951980|PMID:33297965|PMID:39298647
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NET1 mRNA	PMID:28628672
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312824	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of NET1 mRNA	PMID:30951980
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312824	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NET1 promoter	PMID:28392331
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1312824	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of NET1 mRNA	PMID:31558096
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34682	diazinon	decreases methylation	ISO	RGD:1312823	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of NET1 gene	PMID:22964155
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NET1 mRNA	PMID:21266533
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34709	Diisodecyl phthalate	increases expression	ISO	RGD:1312824	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in increased expression of NET1 mRNA	PMID:25270620
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NET1 mRNA	PMID:28628672
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NET1 mRNA	PMID:19100860
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of NET1 mRNA	PMID:36117858
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312823	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NET1 mRNA	PMID:37042841
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:35036	fentin chloride	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in increased expression of NET1 mRNA	PMID:37156404
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of NET1 mRNA	PMID:17616710
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA	PMID:39836092
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of NET1 mRNA	PMID:26377693
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NET1 mRNA	PMID:25993096
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NET1 mRNA	PMID:37236586
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of NET1 mRNA	PMID:25539665
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of NET1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NET1 mRNA]	PMID:17585979
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312824	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NET1 mRNA	PMID:40194260
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NET1 mRNA	PMID:31533062
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1312823	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of NET1 mRNA	PMID:26352163
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NET1 mRNA	PMID:27153767
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1312824	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of NET1 mRNA	PMID:31558096
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312823	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NET1 mRNA	PMID:25979313
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NET1 mRNA	PMID:17963808
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of NET1 mRNA	PMID:21427059
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312823	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of NET1 gene	PMID:29154799
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312823	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NET1 mRNA	PMID:23179753
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312824	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of NET1 mRNA	PMID:24896083
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in decreased expression of NET1 mRNA	PMID:17183730
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NET1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312824	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of NET1 mRNA	PMID:22733784
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NET1 mRNA	PMID:28628672
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312823	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of NET1 mRNA	PMID:36621641
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NET1 mRNA	PMID:28973697
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of NET1 mRNA	PMID:18502557
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NET1 mRNA	PMID:33387578
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of NET1 mRNA	PMID:22230336|PMID:29067470
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of NET1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NET1 mRNA]	PMID:17585979
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NET1 mRNA	PMID:39836092
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1312823	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of NET1 mRNA	PMID:36621641
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of NET1 mRNA	PMID:29391264
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312824	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of NET1 mRNA	PMID:35436446
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312823	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of NET1 mRNA	PMID:18175754
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NET1 mRNA	PMID:17108234
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1312823	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of NET1 mRNA	PMID:16984733
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NET1 mRNA	PMID:28628672
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of NET1 mRNA; Nanotubes, Carbon results in decreased expression of NET1 mRNA	PMID:25554681
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312824	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of NET1 mRNA	PMID:25620056
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of NET1 mRNA	PMID:34044035
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of NET1 mRNA	PMID:36117858
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312823	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of NET1 mRNA	PMID:16780908
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of NET1 mRNA	PMID:23608068
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in decreased expression of NET1 mRNA	PMID:17183730
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312823	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA	PMID:39836092
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NET1 mRNA	PMID:25729387
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NET1 mRNA	PMID:25729387
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312823	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of NET1 mRNA	PMID:28988120
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of NET1 mRNA	PMID:30467583
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of NET1 mRNA	PMID:17654400
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312823	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NET1 mRNA	PMID:31758290
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NET1 mRNA	PMID:22206623
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of NET1 mRNA	PMID:24136188
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of NET1 mRNA	PMID:29522793
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312823	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NET1 mRNA	PMID:37199045
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312823	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of NET1 protein	PMID:31285264
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of NET1 mRNA	PMID:19482888
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NET1 mRNA]	PMID:19482888
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1312824	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of NET1 mRNA	PMID:31558096
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1312823	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of NET1 mRNA	PMID:21858171
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of NET1 mRNA	PMID:39847705
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312824	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of NET1 mRNA	PMID:21795629
1305034	Net1	neuroepithelial cell transforming 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of NET1 mRNA	PMID:19015723
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MMAA mRNA	PMID:26272509
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312825	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAA mRNA	PMID:27188386
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MMAA mRNA	PMID:26079696
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MMAA mRNA	PMID:39241906
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MMAA mRNA	PMID:39298647
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312825	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MMAA mRNA	PMID:37042841
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MMAA mRNA	PMID:20655997
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MMAA mRNA	PMID:28085963
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MMAA mRNA	PMID:33387578
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MMAA mRNA	PMID:28818685
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MMAA mRNA	PMID:19549813
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MMAA mRNA	PMID:23649840
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312825	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MMAA gene	PMID:27153756
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MMAA mRNA	PMID:23649840
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312826	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MMAA mRNA	PMID:22206623
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312825	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MMAA protein	PMID:35688186
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312826	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of MMAA mRNA	PMID:28960355
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of MMAA mRNA	PMID:27594783
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312825	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of MMAA mRNA	PMID:27392435
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312825	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MMAA mRNA	PMID:24768652|PMID:25583101
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MMAA mRNA	PMID:21215274
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MMAA mRNA	PMID:33387578
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312826	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MMAA mRNA	PMID:21354282
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MMAA mRNA	PMID:28001369
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MMAA mRNA	PMID:33212167
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MMAA mRNA	PMID:30851411
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MMAA mRNA	PMID:29803840
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312825	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MMAA 5' UTR	PMID:27901495
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312826	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MMAA promoter	PMID:35295148
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MMAA mRNA	PMID:34492290
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312825	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of MMAA mRNA	PMID:38479592
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MMAA mRNA	PMID:30816183
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312826	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of MMAA mRNA	PMID:40203079
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MMAA mRNA	PMID:38685157
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312825	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MMAA protein	PMID:34186270
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312825	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MMAA mRNA	PMID:37042841
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MMAA mRNA	PMID:38568856
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MMAA mRNA	PMID:24386269
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312826	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MMAA mRNA	PMID:40194260
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312825	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MMAA mRNA	PMID:31533062
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312825	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MMAA mRNA	PMID:25979313
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312826	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MMAA mRNA	PMID:17292431
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of MMAA mRNA	PMID:23179753|PMID:24935251
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312825	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of MMAA mRNA	PMID:28001369
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of MMAA mRNA	PMID:41580965
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of MMAA mRNA	PMID:24935251
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of MMAA mRNA	PMID:21346803
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312826	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MMAA mRNA	PMID:17562736
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MMAA mRNA	PMID:21420995
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MMAA mRNA	PMID:33387578
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MMAA mRNA	PMID:29279043
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MMAA mRNA	PMID:25620056
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of MMAA mRNA	PMID:40234311
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of MMAA mRNA	PMID:38701926
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312826	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MMAA mRNA	PMID:22206623
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312825	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MMAA mRNA	PMID:30851411
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312825	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAA mRNA	PMID:27188386
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1312825	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of MMAA mRNA	PMID:31734321
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312825	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAA mRNA	PMID:27188386
1305035	Mmaa	metabolism of cobalamin associated A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MMAA mRNA	PMID:21346803
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1603936	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of INTS4 mRNA	PMID:38218311
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1603936	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of INTS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of INTS4 mRNA	PMID:32699268
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of INTS4 gene	PMID:35440735
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1603936	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of INTS4 mRNA	PMID:22378314
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1603936	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of INTS4 mRNA	PMID:17254854
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1603936	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of INTS4 mRNA	PMID:19549813
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of INTS4 mRNA	PMID:33354967
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1603936	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of INTS4 gene; Aflatoxin B1 results in increased methylation of INTS4 intron	PMID:27153756|PMID:30157460
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1603936	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of INTS4 mRNA	PMID:23649840
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603936	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of INTS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of INTS4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of INTS4 mRNA	PMID:32699268
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312827	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of INTS4 mRNA	PMID:40504410
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312827	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of INTS4 protein	PMID:25505154
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312827	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of INTS4 mRNA	PMID:21570461
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of INTS4 mRNA	PMID:33387578
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1603936	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of INTS4 mRNA	PMID:33212167
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312827	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of INTS4 mRNA	PMID:40504410
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1603936	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of INTS4 promoter	PMID:27901495
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of INTS4 mRNA	PMID:34492290
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1603936	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of INTS4 mRNA	PMID:19710929
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of INTS4 mRNA	PMID:22484513
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of INTS4 mRNA	PMID:34947998
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312827	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of INTS4 mRNA	PMID:33221593
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of INTS4 mRNA	PMID:25181051
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1603936	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of INTS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of INTS4 mRNA	PMID:32699268
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603936	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of INTS4 mRNA	PMID:24935251
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603936	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of INTS4 mRNA	PMID:20106945
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1603936	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of INTS4 mRNA	PMID:38832940
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1603936	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of INTS4 mRNA	PMID:24935251
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312827	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of INTS4 mRNA	PMID:40504410
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:4953	exemestane	increases expression	ISO	RGD:1603936	E	RGD:6480464	20120412	CTD	MESH:C056516	exemestane results in increased expression of INTS4 mRNA	PMID:17254854
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of INTS4 mRNA	PMID:24136188
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312827	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of INTS4 mRNA	PMID:35964746
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of INTS4 mRNA	PMID:24136188
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312827	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of INTS4 mRNA	PMID:23608068
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312827	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of INTS4 mRNA	PMID:23650126
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312827	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of INTS4 mRNA	PMID:22206623
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:756894	tak-243	affects sumoylation	ISO	RGD:1603936	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of INTS4 protein	PMID:31285264
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603936	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to INTS4 gene]	PMID:28238834
1305036	Ints4	integrator complex subunit 4	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312827	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of INTS4 protein	PMID:24648495
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552099	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of BAZ2A mRNA	PMID:33045310
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BAZ2A gene	PMID:20938992
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312828	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of BAZ2A mRNA	PMID:33167477
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312828	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of BAZ2A mRNA	PMID:20044591
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552099	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of BAZ2A mRNA	PMID:39241906
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of BAZ2A mRNA	PMID:32145629
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312828	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of BAZ2A mRNA	PMID:16705744
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BAZ2A gene	PMID:20938992
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312828	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BAZ2A mRNA	PMID:37042841
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312828	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of BAZ2A mRNA	PMID:33359661
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312828	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of BAZ2A protein	PMID:37730182
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312828	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of BAZ2A mRNA	PMID:16002434
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312828	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of BAZ2A mRNA	PMID:28818685
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312828	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of BAZ2A mRNA	PMID:39836092
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312828	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of BAZ2A mRNA	PMID:35430440
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of BAZ2A mRNA	PMID:30779732
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of BAZ2A mRNA	PMID:31129395
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552099	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of BAZ2A mRNA	PMID:25629700
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BAZ2A gene	PMID:20938992
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAZ2A mRNA	PMID:40504410
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312828	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of BAZ2A protein	PMID:35688186
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of BAZ2A mRNA	PMID:26302742
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312828	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of BAZ2A mRNA	PMID:27594783
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552099	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of BAZ2A mRNA	PMID:30912803
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312828	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of BAZ2A mRNA	PMID:16705744
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552099	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BAZ2A mRNA	PMID:21570461|PMID:24680724
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312828	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BAZ2A mRNA	PMID:21296121
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BAZ2A mRNA	PMID:17942748
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312828	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of BAZ2A protein	PMID:35688186
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C017947	sodium arsenite results in increased expression of BAZ2A mRNA; sodium arsenite results in increased expression of BAZ2A protein	PMID:37757915|PMID:39354181
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552099	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of BAZ2A mRNA	PMID:36209798
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of BAZ2A mRNA]; Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of BAZ2A protein]	PMID:39354181
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAZ2A mRNA	PMID:40504410
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552099	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BAZ2A gene	PMID:35295148
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552099	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of BAZ2A mRNA	PMID:23557971
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552099	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BAZ2A gene	PMID:35295148
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of BAZ2A mRNA	PMID:19167457
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of BAZ2A mRNA	PMID:25181051|PMID:30816183|PMID:32145629
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552099	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of BAZ2A mRNA	PMID:26063408
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BAZ2A mRNA; [bisphenol A co-treated with tributyltin] results in increased expression of BAZ2A mRNA	PMID:31129395|PMID:36041667
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BAZ2A mRNA	PMID:36041667
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BAZ2A mRNA	PMID:36041667
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312828	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BAZ2A mRNA	PMID:28628672
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312828	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BAZ2A mRNA	PMID:28628672
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552099	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of BAZ2A mRNA	PMID:34813904
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312828	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of BAZ2A mRNA	PMID:39836092
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of BAZ2A promoter	PMID:22457795
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312828	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of BAZ2A protein	PMID:26879310
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312828	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of BAZ2A mRNA	PMID:28302478
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312828	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of BAZ2A mRNA	PMID:31533062
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312828	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of BAZ2A mRNA	PMID:19167446
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312828	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BAZ2A mRNA	PMID:28628672
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAZ2A mRNA	PMID:40504410
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:48843	disodium selenite	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D018038	Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of BAZ2A mRNA]; Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of BAZ2A protein]	PMID:39354181
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BAZ2A mRNA	PMID:17942748
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312828	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BAZ2A mRNA	PMID:28628672
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312828	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of BAZ2A mRNA	PMID:39836092
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1552099	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of BAZ2A mRNA	PMID:26307267
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1312828	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of BAZ2A protein	PMID:31285264
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of BAZ2A mRNA	PMID:26720608
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:81980	triticonazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in increased expression of BAZ2A mRNA	PMID:36084822
1305037	Baz2a	bromodomain adjacent to zinc finger domain, 2A	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of BAZ2A gene	PMID:31079544
1305038	Plk5	polo-like kinase 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312829	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PLK5 mRNA	PMID:33045310
1305038	Plk5	polo-like kinase 5	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312829	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PLK5 mRNA	PMID:36189433
1305038	Plk5	polo-like kinase 5	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312829	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PLK5 mRNA	PMID:36331819
1305038	Plk5	polo-like kinase 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312829	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PLK5 mRNA	PMID:39298647
1305038	Plk5	polo-like kinase 5	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:2302687	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PLK5 mRNA	PMID:38568856
1305038	Plk5	polo-like kinase 5	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PLK5 mRNA	PMID:33387578
1305038	Plk5	polo-like kinase 5	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312829	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PLK5 mRNA	PMID:36189433
1305038	Plk5	polo-like kinase 5	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:2302687	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of PLK5 mRNA	PMID:33647349
1305038	Plk5	polo-like kinase 5	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PLK5 mRNA	PMID:26577399
1305038	Plk5	polo-like kinase 5	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PLK5 mRNA	PMID:33387578
1305038	Plk5	polo-like kinase 5	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312829	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PLK5 mRNA	PMID:36331819
1305038	Plk5	polo-like kinase 5	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLK5 mRNA	PMID:23630614
1305038	Plk5	polo-like kinase 5	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:2302687	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of PLK5 mRNA	PMID:36861143
1305038	Plk5	polo-like kinase 5	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PLK5 mRNA	PMID:31881176
1305038	Plk5	polo-like kinase 5	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312829	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PLK5 mRNA	PMID:32186404
1305038	Plk5	polo-like kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312829	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLK5 mRNA	PMID:33956508
1305038	Plk5	polo-like kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLK5 mRNA	PMID:33387578
1305038	Plk5	polo-like kinase 5	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PLK5 mRNA	PMID:28959563
1305038	Plk5	polo-like kinase 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:2302687	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PLK5 mRNA	PMID:38568856
1305038	Plk5	polo-like kinase 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:2302687	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PLK5 promoter	PMID:27901495
1305038	Plk5	polo-like kinase 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312829	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK5 mRNA	PMID:27858113
1305038	Plk5	polo-like kinase 5	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312829	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of PLK5 mRNA	PMID:23557971
1305038	Plk5	polo-like kinase 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312829	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLK5 gene; titanium dioxide results in decreased methylation of PLK5 promoter alternative form	PMID:35295148
1305038	Plk5	polo-like kinase 5	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PLK5 mRNA	PMID:34492290
1305038	Plk5	polo-like kinase 5	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312829	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PLK5 mRNA	PMID:23811191
1305038	Plk5	polo-like kinase 5	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of PLK5 mRNA	PMID:19167457
1305038	Plk5	polo-like kinase 5	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PLK5 mRNA	PMID:25181051
1305038	Plk5	polo-like kinase 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312829	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of PLK5 mRNA	PMID:39742910
1305038	Plk5	polo-like kinase 5	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:2302687	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PLK5 gene	PMID:31601247
1305038	Plk5	polo-like kinase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312829	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PLK5 mRNA	PMID:39298647
1305038	Plk5	polo-like kinase 5	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312829	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK5 mRNA	PMID:27858113
1305038	Plk5	polo-like kinase 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312829	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PLK5 mRNA	PMID:38685157
1305038	Plk5	polo-like kinase 5	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312829	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PLK5 mRNA	PMID:26377693
1305038	Plk5	polo-like kinase 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:2302687	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PLK5 mRNA	PMID:38382870
1305038	Plk5	polo-like kinase 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312829	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PLK5 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PLK5 mRNA	PMID:36331819
1305038	Plk5	polo-like kinase 5	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:2302687	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PLK5 gene	PMID:29154799
1305038	Plk5	polo-like kinase 5	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PLK5 mRNA	PMID:33387578
1305038	Plk5	polo-like kinase 5	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:2302687	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of PLK5 mRNA	PMID:36861143
1305038	Plk5	polo-like kinase 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312829	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PLK5 mRNA; Nanotubes, Carbon results in decreased expression of PLK5 mRNA	PMID:25554681|PMID:25620056
1305038	Plk5	polo-like kinase 5	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312829	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK5 mRNA	PMID:27858113
1305038	Plk5	polo-like kinase 5	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312829	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK5 mRNA	PMID:27858113
1305038	Plk5	polo-like kinase 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLK5 mRNA	PMID:24780913|PMID:25825206
1305038	Plk5	polo-like kinase 5	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PLK5 mRNA	PMID:19281266
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312831	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ICAM5 mRNA	PMID:33045310
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ICAM5 gene	PMID:20938992
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ICAM5 mRNA	PMID:33729688
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312830	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ICAM5 mRNA	PMID:26079696
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ICAM5 mRNA	PMID:30319688
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312830	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ICAM5 mRNA	PMID:30510588
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in decreased expression of ICAM5 mRNA	PMID:26789235
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICAM5 mRNA	PMID:32741896
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20160705	CTD	MESH:D004958	bisphenol A inhibits the reaction [Estradiol results in decreased expression of ICAM5 mRNA]; fulvestrant inhibits the reaction [Estradiol results in decreased expression of ICAM5 mRNA]	PMID:26789235
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ICAM5 gene	PMID:20938992
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312830	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ICAM5 mRNA	PMID:26079696
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ICAM5 mRNA	PMID:33448797
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA]	PMID:33448797
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICAM5 mRNA	PMID:32741896
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ICAM5 mRNA	PMID:33448797
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA]	PMID:33448797
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ICAM5 mRNA	PMID:26577399
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ICAM5 mRNA	PMID:25378103
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312830	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ICAM5 gene	PMID:28458013
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312830	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ICAM5 mRNA	PMID:41430723
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ICAM5 gene	PMID:20938992
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1312830	E	RGD:6480464	20140610	CTD	MESH:D001151	Arsenic affects the expression of ICAM5 mRNA; Arsenic affects the expression of ICAM5 protein	PMID:24675094|PMID:28793237
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312830	E	RGD:6480464	20180515	CTD	MESH:D001151	[Arsenic results in increased abundance of Arsenicals] which affects the expression of ICAM5 mRNA; [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of ICAM5 mRNA	PMID:28793237
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312830	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ICAM5 mRNA	PMID:28903495
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ICAM5 mRNA	PMID:33387578
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312830	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ICAM5 mRNA	PMID:33212167
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312830	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ICAM5 mRNA	PMID:32763439
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312831	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ICAM5 mRNA	PMID:27862939
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312830	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ICAM5 mRNA	PMID:38568856|PMID:39719251
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312830	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ICAM5 3' UTR; Benzo(a)pyrene affects the methylation of ICAM5 promoter	PMID:27901495
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312830	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ICAM5 exon	PMID:27901495
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312830	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ICAM5 mRNA	PMID:32234424
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312830	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of ICAM5 promoter	PMID:23974009
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312830	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ICAM5 mRNA	PMID:23806026
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1312830	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ICAM5 mRNA	PMID:37690743
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant inhibits the reaction [Estradiol results in decreased expression of ICAM5 mRNA]	PMID:26789235
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ICAM5 promoter	PMID:35295148
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ICAM5 gene	PMID:35295148
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ICAM5 mRNA	PMID:34492290
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ICAM5 mRNA	PMID:30816183|PMID:34947998|PMID:35192832
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312830	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ICAM5 protein	PMID:33376534
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ICAM5 mRNA	PMID:26789235
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ICAM5 mRNA	PMID:25181051|PMID:32145629
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ICAM5 gene	PMID:28505145
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ICAM5 mRNA	PMID:36041667
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A inhibits the reaction [Estradiol results in decreased expression of ICAM5 mRNA]	PMID:26789235
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1312830	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of ICAM5 mRNA	PMID:15980968
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1312830	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ICAM5 mRNA	PMID:23146750
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312831	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ICAM5 gene	PMID:31683443
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312831	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ICAM5 exon	PMID:33297965
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ICAM5 mRNA	PMID:36041667
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ICAM5 mRNA	PMID:36041667
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:34682	diazinon	decreases methylation	ISO	RGD:1312830	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of ICAM5 gene	PMID:22964155
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of ICAM5 mRNA	PMID:30723492
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ICAM5 mRNA	PMID:33453195
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312831	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ICAM5 mRNA	PMID:24982889
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312830	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ICAM5 mRNA	PMID:31533062
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ICAM5 mRNA	PMID:39529242
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ICAM5 mRNA	PMID:33448797
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA]	PMID:33448797
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ICAM5 mRNA	PMID:33387578
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1312830	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of ICAM5 5' UTR	PMID:29523930
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1312830	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of ICAM5 mRNA; Arsenic affects the expression of ICAM5 protein	PMID:24675094|PMID:28793237
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312830	E	RGD:6480464	20180515	CTD	MESH:D001151	[Arsenic results in increased abundance of Arsenicals] which affects the expression of ICAM5 mRNA; [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of ICAM5 mRNA	PMID:28793237
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312830	E	RGD:6480464	20180515	CTD	MESH:D002101	[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of ICAM5 mRNA	PMID:28793237
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:5118	fluoxetine	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D005473	Fluoxetine results in decreased expression of ICAM5 mRNA	PMID:17033635
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA]	PMID:33448797
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of ICAM5 mRNA	PMID:20080153
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312830	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ICAM5 mRNA	PMID:24810058
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:6682	mangiferin	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20120412	CTD	MESH:C013592	mangiferin results in decreased expression of ICAM5 mRNA	PMID:15135318
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ICAM5 mRNA	PMID:22206623
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1312830	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ICAM5 mRNA	PMID:36318118
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICAM5 mRNA	PMID:32741896
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1312831	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of ICAM5 mRNA	PMID:26655953
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ICAM5 mRNA	PMID:24780913
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ICAM5 mRNA	PMID:19281266
1305039	Icam5	intercellular adhesion molecule 5	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ICAM5 mRNA	PMID:19015723
1305040	Six5	SIX homeobox 5	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SIX5 mRNA	PMID:38218311
1305040	Six5	SIX homeobox 5	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312832	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SIX5 mRNA	PMID:38218311
1305040	Six5	SIX homeobox 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SIX5 gene	PMID:20938992
1305040	Six5	SIX homeobox 5	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SIX5 mRNA	PMID:30529165
1305040	Six5	SIX homeobox 5	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SIX5 mRNA	PMID:26079696
1305040	Six5	SIX homeobox 5	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312832	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol affects the expression of SIX5 mRNA	PMID:22574217
1305040	Six5	SIX homeobox 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312833	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SIX5 mRNA	PMID:39298647
1305040	Six5	SIX homeobox 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SIX5 gene	PMID:20938992
1305040	Six5	SIX homeobox 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312832	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SIX5 mRNA	PMID:37042841
1305040	Six5	SIX homeobox 5	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312832	E	RGD:6480464	20130806	CTD	MESH:C044887	beta-methylcholine affects the expression of SIX5 mRNA	PMID:21179406
1305040	Six5	SIX homeobox 5	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SIX5 mRNA	PMID:28973375
1305040	Six5	SIX homeobox 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SIX5 promoter	PMID:23359474
1305040	Six5	SIX homeobox 5	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SIX5 mRNA	PMID:26577399
1305040	Six5	SIX homeobox 5	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SIX5 mRNA	PMID:22061828
1305040	Six5	SIX homeobox 5	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SIX5 mRNA	PMID:28818685
1305040	Six5	SIX homeobox 5	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of SIX5 mRNA	PMID:21120746
1305040	Six5	SIX homeobox 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SIX5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SIX5 mRNA	PMID:37236586|PMID:37325564
1305040	Six5	SIX homeobox 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SIX5 gene	PMID:20938992
1305040	Six5	SIX homeobox 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIX5 mRNA	PMID:40504410
1305040	Six5	SIX homeobox 5	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SIX5 mRNA	PMID:26272509
1305040	Six5	SIX homeobox 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312832	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA	PMID:27188386
1305040	Six5	SIX homeobox 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312832	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SIX5 mRNA	PMID:23557933
1305040	Six5	SIX homeobox 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312833	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SIX5 mRNA	PMID:21570461|PMID:24058054
1305040	Six5	SIX homeobox 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SIX5 mRNA	PMID:29803840
1305040	Six5	SIX homeobox 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIX5 mRNA	PMID:40504410
1305040	Six5	SIX homeobox 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SIX5 mRNA	PMID:23735875
1305040	Six5	SIX homeobox 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20130806	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SIX5 mRNA]	PMID:22228805
1305040	Six5	SIX homeobox 5	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of SIX5 mRNA	PMID:35984750
1305040	Six5	SIX homeobox 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312833	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SIX5 gene	PMID:35295148
1305040	Six5	SIX homeobox 5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SIX5 mRNA	PMID:19710929
1305040	Six5	SIX homeobox 5	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312833	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SIX5 promoter	PMID:27334623
1305040	Six5	SIX homeobox 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SIX5 mRNA	PMID:30816183
1305040	Six5	SIX homeobox 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20130806	CTD	MESH:C006780	bisphenol A results in decreased expression of SIX5 mRNA	PMID:23146750
1305040	Six5	SIX homeobox 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SIX5 promoter	PMID:23359474
1305040	Six5	SIX homeobox 5	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SIX5 mRNA	PMID:25172293
1305040	Six5	SIX homeobox 5	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20130806	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of SIX5 mRNA	PMID:23146750
1305040	Six5	SIX homeobox 5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20130806	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of SIX5 mRNA	PMID:23146750
1305040	Six5	SIX homeobox 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SIX5 mRNA	PMID:21266533
1305040	Six5	SIX homeobox 5	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SIX5 promoter	PMID:23359474
1305040	Six5	SIX homeobox 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312832	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SIX5 mRNA	PMID:37042841
1305040	Six5	SIX homeobox 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SIX5 mRNA	PMID:38568856
1305040	Six5	SIX homeobox 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SIX5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SIX5 mRNA	PMID:37236586|PMID:37325564
1305040	Six5	SIX homeobox 5	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20130806	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SIX5 mRNA	PMID:23146750
1305040	Six5	SIX homeobox 5	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312832	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SIX5 mRNA	PMID:24449571
1305040	Six5	SIX homeobox 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SIX5 mRNA	PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799
1305040	Six5	SIX homeobox 5	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312832	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA	PMID:27188386
1305040	Six5	SIX homeobox 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312833	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SIX5 mRNA	PMID:17562736
1305040	Six5	SIX homeobox 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIX5 mRNA	PMID:40504410
1305040	Six5	SIX homeobox 5	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of SIX5 mRNA	PMID:26272509
1305040	Six5	SIX homeobox 5	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312832	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA	PMID:27188386
1305040	Six5	SIX homeobox 5	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of SIX5 mRNA	PMID:19042947
1305040	Six5	SIX homeobox 5	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of SIX5 mRNA	PMID:38701926
1305040	Six5	SIX homeobox 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312833	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SIX5 mRNA	PMID:22206623
1305040	Six5	SIX homeobox 5	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1312832	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SIX5 mRNA	PMID:36318118
1305040	Six5	SIX homeobox 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312832	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA	PMID:27188386
1305040	Six5	SIX homeobox 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312832	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SIX5 gene]	PMID:28238834
1305040	Six5	SIX homeobox 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SIX5 mRNA	PMID:23146750
1305040	Six5	SIX homeobox 5	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of SIX5 mRNA	PMID:40826991
1305040	Six5	SIX homeobox 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312832	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA	PMID:27188386
1305040	Six5	SIX homeobox 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SIX5 mRNA	PMID:21346803
1305040	Six5	SIX homeobox 5	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312832	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of SIX5 mRNA	PMID:22378314
1305040	Six5	SIX homeobox 5	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312832	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SIX5 mRNA	PMID:27188386
1305040	Six5	SIX homeobox 5	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312833	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of SIX5 mRNA	PMID:35537566
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1603796	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of GIMAP6 mRNA	PMID:33167477
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550092	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GIMAP6 mRNA	PMID:39241906
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1603796	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GIMAP6 mRNA	PMID:35811015
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1603796	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GIMAP6 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GIMAP6 mRNA	PMID:35811015
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GIMAP6 mRNA	PMID:32741896
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603796	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GIMAP6 mRNA	PMID:37042841
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GIMAP6 mRNA	PMID:32741896
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:17558	quercitrin	increases expression	ISO	RGD:1603796	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of GIMAP6 mRNA	PMID:25193878
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of GIMAP6 mRNA	PMID:22061828
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1603796	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GIMAP6 gene	PMID:27153756
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1550092	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of GIMAP6 mRNA	PMID:33026818
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550092	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GIMAP6 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GIMAP6 mRNA	PMID:34911549
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of GIMAP6 mRNA	PMID:30779732
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550092	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of GIMAP6 mRNA	PMID:22206623
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603796	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of GIMAP6 mRNA	PMID:27594783
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1603796	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of GIMAP6 mRNA	PMID:23195993
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GIMAP6 mRNA	PMID:32109520|PMID:34747641
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1550092	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in increased expression of GIMAP6 mRNA	PMID:35032568
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550092	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of GIMAP6 mRNA	PMID:39631538
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603796	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GIMAP6 mRNA	PMID:29803840
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550092	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP6 mRNA	PMID:34876320
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1550092	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP6 mRNA	PMID:34876320
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550092	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GIMAP6 mRNA	PMID:21715664
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550092	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GIMAP6 mRNA	PMID:21964900|PMID:22610609
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1550092	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of GIMAP6 mRNA	PMID:27131904
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1603796	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of GIMAP6 mRNA	PMID:15761015
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550092	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of GIMAP6 mRNA	PMID:28472532
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GIMAP6 mRNA	PMID:25181051
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of GIMAP6 gene	PMID:28505145
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of GIMAP6 mRNA	PMID:30816183|PMID:32528016
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550092	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of GIMAP6 mRNA	PMID:30951980
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:34093	1-Hydroxypyrene	increases expression	ISO	RGD:1603796	E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in increased expression of GIMAP6 mRNA	PMID:21854004
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550092	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of GIMAP6 mRNA	PMID:30951980
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550092	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of GIMAP6 mRNA	PMID:26377693
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550092	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of GIMAP6 mRNA	PMID:30951980
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1550092	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of GIMAP6 mRNA	PMID:28392331
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1550092	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of GIMAP6 mRNA	PMID:31558096
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550092	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GIMAP6 mRNA	PMID:34289071|PMID:37019170
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550092	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of GIMAP6 mRNA	PMID:34813904
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1550092	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of GIMAP6 mRNA	PMID:34813904
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603796	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GIMAP6 mRNA	PMID:37042841
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of GIMAP6 mRNA	PMID:35163327
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1603796	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GIMAP6 mRNA	PMID:19320972
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550092	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GIMAP6 mRNA	PMID:40194260
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1550092	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of GIMAP6 mRNA	PMID:31558096
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550092	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of GIMAP6 mRNA	PMID:28973697
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1550092	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in increased expression of GIMAP6 mRNA	PMID:25270620
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550092	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GIMAP6 mRNA	PMID:17562736
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1603796	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of GIMAP6 mRNA	PMID:21420995
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603796	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of GIMAP6 mRNA	PMID:26690555
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1603796	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GIMAP6 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GIMAP6 mRNA	PMID:35811015
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:46661	asbestos	affects expression	ISO	RGD:1603796	E	RGD:6480464	20120412	CTD	MESH:D001194	Asbestos affects the expression of GIMAP6 mRNA	PMID:17297452
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1550092	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP6 mRNA	PMID:34876320
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1603796	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of GIMAP6 mRNA	PMID:15761015
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550092	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GIMAP6 mRNA	PMID:35964746
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of GIMAP6 mRNA	PMID:24136188
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550092	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of GIMAP6 mRNA	PMID:38701926
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1550092	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of GIMAP6 mRNA	PMID:36851058
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550092	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GIMAP6 mRNA	PMID:22206623
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550092	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of GIMAP6 mRNA	PMID:22206623
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GIMAP6 mRNA	PMID:32741896
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550092	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of GIMAP6 mRNA	PMID:19482888
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1550092	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of GIMAP6 mRNA]	PMID:19482888
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1550092	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of GIMAP6 mRNA	PMID:31558096
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550092	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of GIMAP6 mRNA	PMID:30953684
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1550092	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP6 mRNA	PMID:34876320
1305041	Gimap6	GTPase, IMAP family member 6	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1550092	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of GIMAP6 mRNA	PMID:27131904
1305042	Snx22	sorting nexin 22	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SNX22 mRNA	PMID:37995155
1305042	Snx22	sorting nexin 22	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1614769	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX22 gene	PMID:20938992
1305042	Snx22	sorting nexin 22	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312835	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SNX22 mRNA	PMID:23724009
1305042	Snx22	sorting nexin 22	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1614769	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SNX22 mRNA	PMID:24205000
1305042	Snx22	sorting nexin 22	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312835	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SNX22 mRNA	PMID:26079696
1305042	Snx22	sorting nexin 22	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614769	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SNX22 mRNA	PMID:39241906
1305042	Snx22	sorting nexin 22	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SNX22 mRNA	PMID:33387578
1305042	Snx22	sorting nexin 22	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1614769	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX22 gene	PMID:20938992
1305042	Snx22	sorting nexin 22	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312835	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNX22 mRNA	PMID:37042841
1305042	Snx22	sorting nexin 22	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312835	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SNX22 mRNA	PMID:26079696
1305042	Snx22	sorting nexin 22	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SNX22 mRNA	PMID:28973375
1305042	Snx22	sorting nexin 22	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1614769	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SNX22 mRNA	PMID:23892564
1305042	Snx22	sorting nexin 22	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312835	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SNX22 mRNA	PMID:28818685
1305042	Snx22	sorting nexin 22	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1614769	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of SNX22 mRNA	PMID:39984025
1305042	Snx22	sorting nexin 22	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614769	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX22 gene	PMID:20938992
1305042	Snx22	sorting nexin 22	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1312835	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of SNX22 mRNA	PMID:38460933
1305042	Snx22	sorting nexin 22	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312835	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of SNX22 mRNA	PMID:38460933
1305042	Snx22	sorting nexin 22	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SNX22 mRNA	PMID:40618947
1305042	Snx22	sorting nexin 22	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312835	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SNX22 mRNA	PMID:27392435
1305042	Snx22	sorting nexin 22	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1614769	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SNX22 mRNA	PMID:30912803
1305042	Snx22	sorting nexin 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNX22 mRNA	PMID:32109520
1305042	Snx22	sorting nexin 22	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312835	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX22 mRNA	PMID:34032870
1305042	Snx22	sorting nexin 22	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312835	E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SNX22 mRNA	PMID:40419235
1305042	Snx22	sorting nexin 22	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614769	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNX22 gene	PMID:35295148
1305042	Snx22	sorting nexin 22	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1614769	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of SNX22 mRNA	PMID:29264374
1305042	Snx22	sorting nexin 22	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614769	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SNX22 gene	PMID:35295148
1305042	Snx22	sorting nexin 22	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SNX22 mRNA	PMID:25181051
1305042	Snx22	sorting nexin 22	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX22 mRNA	PMID:29161229|PMID:32156529
1305042	Snx22	sorting nexin 22	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SNX22 mRNA	PMID:34947998
1305042	Snx22	sorting nexin 22	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312835	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SNX22 mRNA	PMID:36326898
1305042	Snx22	sorting nexin 22	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312835	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SNX22 mRNA	PMID:31533062
1305042	Snx22	sorting nexin 22	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312835	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SNX22 mRNA	PMID:25979313
1305042	Snx22	sorting nexin 22	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312835	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SNX22 mRNA	PMID:38832940
1305042	Snx22	sorting nexin 22	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614769	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNX22 mRNA	PMID:17562736
1305042	Snx22	sorting nexin 22	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312835	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of SNX22 mRNA	PMID:38460933
1305042	Snx22	sorting nexin 22	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1312835	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of SNX22 mRNA]	PMID:21095227
1305042	Snx22	sorting nexin 22	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SNX22 mRNA	PMID:25554681
1305042	Snx22	sorting nexin 22	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of SNX22 mRNA	PMID:22470460
1305042	Snx22	sorting nexin 22	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNX22 mRNA	PMID:22206623
1305042	Snx22	sorting nexin 22	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312835	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SNX22 gene]	PMID:28238834
1305042	Snx22	sorting nexin 22	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1614769	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SNX22 mRNA	PMID:38648751
1305042	Snx22	sorting nexin 22	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1614769	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of SNX22 mRNA	PMID:35537566
1305043	Clrn3	clarin 3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CLRN3 mRNA	PMID:27188386
1305043	Clrn3	clarin 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312836	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CLRN3 mRNA	PMID:37995155
1305043	Clrn3	clarin 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of CLRN3 mRNA	PMID:20106945
1305043	Clrn3	clarin 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312836	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLRN3 mRNA	PMID:25510870
1305043	Clrn3	clarin 3	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CLRN3 mRNA	PMID:26079696
1305043	Clrn3	clarin 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of CLRN3 protein	PMID:34915118
1305043	Clrn3	clarin 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CLRN3 mRNA	PMID:28522335
1305043	Clrn3	clarin 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312836	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLRN3 mRNA	PMID:25510870
1305043	Clrn3	clarin 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312836	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLRN3 mRNA	PMID:25510870
1305043	Clrn3	clarin 3	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1603923	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CLRN3 protein	PMID:20106945
1305043	Clrn3	clarin 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CLRN3 mRNA	PMID:27153756
1305043	Clrn3	clarin 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1603923	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CLRN3 gene	PMID:25304211
1305043	Clrn3	clarin 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603923	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CLRN3 mRNA	PMID:23557933
1305043	Clrn3	clarin 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312836	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLRN3 mRNA	PMID:37682722
1305043	Clrn3	clarin 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLRN3 mRNA	PMID:29301061
1305043	Clrn3	clarin 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603923	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CLRN3 promoter	PMID:27901495
1305043	Clrn3	clarin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLRN3 mRNA	PMID:32234424
1305043	Clrn3	clarin 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603923	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CLRN3 3' UTR	PMID:27901495
1305043	Clrn3	clarin 3	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1603923	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CLRN3 gene	PMID:31601247
1305043	Clrn3	clarin 3	gene	CHEBI:32509	pirinixic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CLRN3 mRNA	PMID:19162173
1305043	Clrn3	clarin 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312836	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CLRN3 mRNA	PMID:28472532
1305043	Clrn3	clarin 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLRN3 mRNA	PMID:25181051
1305043	Clrn3	clarin 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CLRN3 gene	PMID:28505145
1305043	Clrn3	clarin 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312836	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLRN3 mRNA	PMID:25510870
1305043	Clrn3	clarin 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312836	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLRN3 mRNA	PMID:25510870
1305043	Clrn3	clarin 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312836	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CLRN3 intron	PMID:28392331
1305043	Clrn3	clarin 3	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of CLRN3 mRNA	PMID:22110744
1305043	Clrn3	clarin 3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CLRN3 mRNA	PMID:27387713
1305043	Clrn3	clarin 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312836	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CLRN3 mRNA	PMID:21139344
1305043	Clrn3	clarin 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CLRN3 mRNA	PMID:32588087
1305043	Clrn3	clarin 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312836	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CLRN3 mRNA	PMID:40194260
1305043	Clrn3	clarin 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CLRN3 mRNA	PMID:20106945
1305043	Clrn3	clarin 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312836	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CLRN3 mRNA	PMID:28973697
1305043	Clrn3	clarin 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CLRN3 mRNA	PMID:38832940
1305043	Clrn3	clarin 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLRN3 mRNA	PMID:29067470
1305043	Clrn3	clarin 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1603923	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CLRN3 gene	PMID:25304211
1305043	Clrn3	clarin 3	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CLRN3 mRNA	PMID:32234424
1305043	Clrn3	clarin 3	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1603923	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of CLRN3 mRNA	PMID:27188386
1305043	Clrn3	clarin 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312836	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CLRN3 mRNA	PMID:22206623
1305043	Clrn3	clarin 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1603923	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CLRN3 mRNA	PMID:19159669
1305044	Zan	zonadhesin	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312838	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZAN mRNA	PMID:33045310
1305044	Zan	zonadhesin	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZAN mRNA]	PMID:31150632
1305044	Zan	zonadhesin	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20140729	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ZAN mRNA	PMID:20188158
1305044	Zan	zonadhesin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312838	E	RGD:6480464	20140729	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ZAN mRNA	PMID:22401849
1305044	Zan	zonadhesin	gene	CHEBI:17558	quercitrin	increases expression	ISO	RGD:1312837	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of ZAN mRNA	PMID:25193878
1305044	Zan	zonadhesin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312838	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ZAN mRNA	PMID:34319233
1305044	Zan	zonadhesin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312838	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZAN mRNA	PMID:37325564
1305044	Zan	zonadhesin	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20140729	CTD	MESH:C016517	indole-3-carbinol affects the expression of ZAN mRNA	PMID:21396975
1305044	Zan	zonadhesin	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312837	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZAN intron	PMID:30157460
1305044	Zan	zonadhesin	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZAN mRNA	PMID:31150632
1305044	Zan	zonadhesin	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZAN mRNA]	PMID:31150632
1305044	Zan	zonadhesin	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312837	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ZAN mRNA	PMID:23557933
1305044	Zan	zonadhesin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312838	E	RGD:6480464	20140729	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZAN mRNA	PMID:21570461
1305044	Zan	zonadhesin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312838	E	RGD:6480464	20140729	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ZAN promoter]	PMID:19654925
1305044	Zan	zonadhesin	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1312837	E	RGD:6480464	20161025	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of ZAN mRNA	PMID:27188386
1305044	Zan	zonadhesin	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312838	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ZAN protein	PMID:28918527
1305044	Zan	zonadhesin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZAN mRNA	PMID:36209798
1305044	Zan	zonadhesin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312838	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ZAN mRNA	PMID:37682722
1305044	Zan	zonadhesin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312838	E	RGD:6480464	20140729	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZAN mRNA	PMID:20504355
1305044	Zan	zonadhesin	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312837	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ZAN gene	PMID:25435355
1305044	Zan	zonadhesin	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZAN mRNA	PMID:23411599
1305044	Zan	zonadhesin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312837	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZAN mRNA	PMID:28628672
1305044	Zan	zonadhesin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312838	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZAN gene	PMID:31683443
1305044	Zan	zonadhesin	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312837	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZAN mRNA	PMID:28628672
1305044	Zan	zonadhesin	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZAN mRNA	PMID:24982889
1305044	Zan	zonadhesin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312838	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZAN mRNA	PMID:37325564
1305044	Zan	zonadhesin	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312837	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ZAN mRNA	PMID:24449571
1305044	Zan	zonadhesin	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312838	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of ZAN mRNA	PMID:28962523
1305044	Zan	zonadhesin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312838	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ZAN mRNA	PMID:40194260
1305044	Zan	zonadhesin	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312837	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZAN mRNA	PMID:28302478
1305044	Zan	zonadhesin	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ZAN mRNA	PMID:39529242
1305044	Zan	zonadhesin	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of ZAN mRNA	PMID:29038090
1305044	Zan	zonadhesin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312838	E	RGD:6480464	20140729	CTD	MESH:D014635	Valproic Acid affects the expression of ZAN mRNA	PMID:17963808
1305044	Zan	zonadhesin	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312837	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZAN mRNA	PMID:28628672
1305044	Zan	zonadhesin	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312837	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZAN mRNA	PMID:28628672
1305044	Zan	zonadhesin	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312838	E	RGD:6480464	20140729	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ZAN mRNA	PMID:19042947
1305044	Zan	zonadhesin	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of ZAN mRNA	PMID:24136188
1305044	Zan	zonadhesin	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ZAN mRNA	PMID:28801915
1305044	Zan	zonadhesin	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ZAN mRNA	PMID:35537566
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312839	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of EMC7 mRNA	PMID:38218311
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312840	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of EMC7 mRNA	PMID:37995155
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312840	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of EMC7 mRNA	PMID:30319688
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312840	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EMC7 mRNA	PMID:33754040|PMID:34319233
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of EMC7 protein	PMID:34915118
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312840	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of EMC7 mRNA	PMID:27462272
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312839	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EMC7 mRNA	PMID:27153756
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312840	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EMC7 mRNA	PMID:22206623
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312839	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EMC7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:39836092|PMID:40512198
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312840	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:40504410
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of EMC7 mRNA	PMID:26302742
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312839	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of EMC7 protein	PMID:39603559
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312839	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of EMC7 mRNA	PMID:33212167
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312839	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EMC7 mRNA	PMID:30851411
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of EMC7 mRNA	PMID:28959563
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312839	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in decreased expression of EMC7 protein	PMID:39571964
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312839	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EMC7 mRNA	PMID:38568856
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312839	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EMC7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:39836092|PMID:40512198
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312840	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:40504410
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312839	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to EMC7 mRNA]	PMID:32406909
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312839	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of EMC7 mRNA	PMID:38479592
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312839	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of EMC7 mRNA	PMID:30903817
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312839	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of EMC7 protein	PMID:34186270
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312840	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of EMC7 mRNA	PMID:26512966
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EMC7 mRNA	PMID:25181051
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312840	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of EMC7 mRNA	PMID:40203079
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312839	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of EMC7 protein	PMID:34186270
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312839	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of EMC7 protein	PMID:34186270
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EMC7 mRNA	PMID:21266533
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312839	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EMC7 mRNA	PMID:37042841
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312839	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of EMC7 protein	PMID:26879310
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312839	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EMC7 mRNA	PMID:31533062
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1312839	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of EMC7 mRNA	PMID:26352163
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312839	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EMC7 mRNA	PMID:23179753|PMID:29154799
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of EMC7 mRNA	PMID:24136188
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312839	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EMC7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:39836092|PMID:40512198
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312840	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:40504410
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EMC7 mRNA	PMID:24136188
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312839	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EMC7 protein	PMID:32959892
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312840	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EMC7 mRNA	PMID:22206623
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of EMC7 mRNA	PMID:24136188
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:78160	bleomycin A5	decreases expression	ISO	RGD:1312839	E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in decreased expression of EMC7 mRNA	PMID:21040473
1305045	Emc7	ER membrane protein complex subunit 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312839	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EMC7 mRNA	PMID:30851411
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of STK11IP mRNA	PMID:33045310
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STK11IP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STK11IP gene	PMID:20938992
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312841	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of STK11IP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of STK11IP mRNA	PMID:32699268
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of STK11IP gene	PMID:30207508
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312842	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of STK11IP mRNA	PMID:30319688
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of STK11IP mRNA	PMID:39241906
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of STK11IP mRNA]	PMID:39241906
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STK11IP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STK11IP gene	PMID:20938992
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312842	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of STK11IP mRNA	PMID:34319233
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312841	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of STK11IP protein	PMID:37730182
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of STK11IP mRNA	PMID:33387578
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312841	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of STK11IP intron	PMID:30157460
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312841	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of STK11IP mRNA	PMID:23649840
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312841	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of STK11IP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of STK11IP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of STK11IP mRNA	PMID:32699268
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312842	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of STK11IP mRNA	PMID:17484886
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STK11IP mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STK11IP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STK11IP gene	PMID:20938992|PMID:22206623
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312841	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40512198
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40504410
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312841	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of STK11IP protein	PMID:35688186
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312841	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of STK11IP mRNA	PMID:23300844
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312841	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of STK11IP mRNA	PMID:27392435
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STK11IP mRNA	PMID:22298810
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312842	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STK11IP mRNA	PMID:21570461
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to STK11IP promoter]	PMID:19654925
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312841	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STK11IP mRNA	PMID:29803840
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312841	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of STK11IP protein	PMID:35688186
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312841	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40512198
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40504410
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of STK11IP mRNA	PMID:35295148
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312842	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STK11IP gene	PMID:35295148
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of STK11IP mRNA	PMID:23411599
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of STK11IP mRNA	PMID:25181051
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of STK11IP mRNA	PMID:38685157
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of STK11IP mRNA]	PMID:39241906
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312841	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STK11IP mRNA	PMID:37042841
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312841	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of STK11IP mRNA	PMID:38568856
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of STK11IP mRNA	PMID:24386269
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312841	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of STK11IP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of STK11IP mRNA	PMID:32699268
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of STK11IP mRNA	PMID:23811191
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312842	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of STK11IP mRNA	PMID:40194260
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312842	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of STK11IP mRNA	PMID:17963808
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312841	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of STK11IP mRNA	PMID:29154799
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312842	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of STK11IP mRNA	PMID:17562736
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312841	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40512198
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40504410
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of STK11IP mRNA	PMID:29391264
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312841	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of STK11IP mRNA	PMID:23300844
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312842	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of STK11IP mRNA	PMID:26307267
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STK11IP mRNA	PMID:22206623
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20200519	CTD	MESH:D010634	Phenobarbital results in decreased expression of STK11IP mRNA	PMID:31836555
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of STK11IP mRNA]	PMID:39241906
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of STK11IP mRNA	PMID:21346803
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312841	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of STK11IP mRNA	PMID:29301935
1305046	Stk11ip	serine/threonine kinase 11 interacting protein	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of STK11IP mRNA	PMID:23034163
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CYFIP2 mRNA	PMID:38218311
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312846	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CYFIP2 mRNA	PMID:33045310
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CYFIP2 mRNA	PMID:39752319
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYFIP2 mRNA	PMID:20938992
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312845	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CYFIP2 mRNA	PMID:15894607|PMID:23724009|PMID:33167477
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of CYFIP2 mRNA	PMID:15894607
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CYFIP2 mRNA	PMID:22378314
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CYFIP2 mRNA	PMID:30319688
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1312845	E	RGD:6480464	20250805	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CYFIP2 mRNA; Hydrogen Peroxide results in increased expression of CYFIP2 protein	PMID:39667565
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20250805	CTD	MESH:D006861	CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]]; CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT2 protein]]; CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT3 protein]]; CYFIP2 protein promotes the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]; CYFIP2 protein promotes the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT2 protein]; CYFIP2 protein promotes the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT3 protein]; epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased expression of CYFIP2 mRNA]; epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased expression of CYFIP2 protein]	PMID:39667565
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312846	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CYFIP2 mRNA	PMID:39241906
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of CYFIP2 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of CYFIP2 mRNA	PMID:20660070|PMID:30165855
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of CYFIP2 mRNA	PMID:33711761
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CYFIP2 mRNA	PMID:38568856
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYFIP2 mRNA	PMID:20938992
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312845	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CYFIP2 mRNA	PMID:23649840
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D011374	Progesterone results in decreased expression of CYFIP2 mRNA	PMID:20864642
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of CYFIP2 mRNA	PMID:20660070
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:C044887	beta-methylcholine affects the expression of CYFIP2 mRNA	PMID:21179406
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312845	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CYFIP2 mRNA	PMID:26079696
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CYFIP2 mRNA	PMID:39922521
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CYFIP2 mRNA	PMID:39752319
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CYFIP2 mRNA	PMID:39922521
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CYFIP2 mRNA	PMID:22061828
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312845	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CYFIP2 intron	PMID:30157460
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of CYFIP2 mRNA	PMID:28522335
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:211249	Ampullosporin	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C109004	[ampullosporin co-treated with Ketamine] results in decreased expression of CYFIP2 mRNA	PMID:16635253
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP2 mRNA	PMID:29950665
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312845	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CYFIP2 mRNA	PMID:23649840
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYFIP2 mRNA	PMID:22129741
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CYFIP2 protein	PMID:20106945
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CYFIP2 mRNA	PMID:21632981|PMID:21641981
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312845	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CYFIP2 gene; Aflatoxin B1 results in increased methylation of CYFIP2 intron	PMID:27153756|PMID:30157460
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312845	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CYFIP2 mRNA	PMID:23649840
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYFIP2 mRNA	PMID:20938992
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYFIP2 mRNA	PMID:32525701
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CYFIP2 protein	PMID:38460933
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CYFIP2 mRNA	PMID:31881176
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of CYFIP2 mRNA	PMID:27594783
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312845	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CYFIP2 mRNA	PMID:27392435
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in decreased expression of CYFIP2 mRNA	PMID:21858171
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CYFIP2 mRNA	PMID:30912803
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:D014640	Vancomycin results in increased expression of CYFIP2 mRNA	PMID:18930951
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312845	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CYFIP2 mRNA	PMID:24768652|PMID:25583101
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312846	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYFIP2 mRNA	PMID:26377647
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYFIP2 mRNA	PMID:34747641
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYFIP2 mRNA	PMID:20959002|PMID:21215274|PMID:32109520
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312846	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYFIP2 mRNA	PMID:19759094|PMID:19770486|PMID:19933214|PMID:25270620|PMID:26290441
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CYFIP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CYFIP2 mRNA; AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYFIP2 mRNA]	PMID:16214954|PMID:19759094|PMID:25975270
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of CYFIP2 mRNA	PMID:28374803
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CYFIP2 mRNA	PMID:28001369
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20180703	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CYFIP2 mRNA	PMID:29261810
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CYFIP2 mRNA	PMID:33212167
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20180703	CTD	MESH:D020106	Acrylamide results in decreased expression of CYFIP2 mRNA	PMID:29261810
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CYFIP2 mRNA	PMID:28959563
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312845	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CYFIP2 mRNA	PMID:29803840
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of CYFIP2 mRNA; sodium arsenite results in decreased expression of CYFIP2 protein	PMID:30528433|PMID:38568856
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312845	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CYFIP2 5' UTR; Benzo(a)pyrene affects the methylation of CYFIP2 promoter	PMID:27901495
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312845	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CYFIP2 exon	PMID:27901495
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYFIP2 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYFIP2 mRNA	PMID:19770486|PMID:21715664|PMID:32417428
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1312845	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CYFIP2 mRNA	PMID:25075043
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312846	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CYFIP2 mRNA	PMID:29203145
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312845	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CYFIP2 mRNA	PMID:20382639
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYFIP2 mRNA	PMID:15894607
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of CYFIP2 mRNA	PMID:38568856
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CYFIP2 mRNA	PMID:25729387
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of CYFIP2 mRNA	PMID:30012374
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP2 mRNA	PMID:29950665
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CYFIP2 mRNA	PMID:23411599|PMID:34492290
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C006253	pirinixic acid results in increased expression of CYFIP2 mRNA	PMID:19162173
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:C006253	pirinixic acid results in increased expression of CYFIP2 mRNA	PMID:20813756
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYFIP2 mRNA	PMID:19710929
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CYFIP2 mRNA	PMID:25181051
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of CYFIP2 mRNA; bisphenol A results in decreased expression of CYFIP2 protein	PMID:24552547|PMID:35192832
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of CYFIP2 mRNA	PMID:39742910
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312845	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CYFIP2 gene	PMID:31601247
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of CYFIP2 mRNA	PMID:32145629
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CYFIP2 gene	PMID:28505145
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312845	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CYFIP2 mRNA	PMID:25979313
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CYFIP2 mRNA	PMID:26682919
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYFIP2 mRNA	PMID:20959002
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1312845	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of CYFIP2 intron	PMID:30157460
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP2 mRNA	PMID:29950665
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYFIP2 mRNA	PMID:22129741
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CYFIP2 gene	PMID:33148267
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312845	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CYFIP2 mRNA	PMID:37042841
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CYFIP2 mRNA	PMID:30589522
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of CYFIP2 mRNA	PMID:35163327
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CYFIP2 mRNA	PMID:38568856
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CYFIP2 mRNA	PMID:19320972
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CYFIP2 mRNA	PMID:24449571
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312846	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CYFIP2 mRNA	PMID:40194260
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1312846	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of CYFIP2 mRNA	PMID:34254344
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D003375	Coumestrol results in decreased expression of CYFIP2 mRNA	PMID:19167446
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of CYFIP2 mRNA	PMID:29038090
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312845	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CYFIP2 mRNA	PMID:25979313
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312845	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CYFIP2 mRNA	PMID:19101580|PMID:23179753|PMID:27188386
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:D014635	Valproic Acid results in increased expression of CYFIP2 mRNA	PMID:21427059
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312845	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CYFIP2 gene	PMID:29154799
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of CYFIP2 mRNA	PMID:17183730
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CYFIP2 mRNA	PMID:25562108|PMID:27989131
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in increased expression of CYFIP2 mRNA	PMID:19159671|PMID:22147139
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CYFIP2 mRNA	PMID:39922521
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CYFIP2 mRNA	PMID:26272509
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYFIP2 mRNA	PMID:27188386
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in increased expression of CYFIP2 mRNA	PMID:22230336
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D005472	CYFIP2 protein affects the susceptibility to Fluorouracil	PMID:16217747
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D005472	Fluorouracil results in increased expression of CYFIP2 mRNA	PMID:17039268|PMID:17982676
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA]	PMID:15016801|PMID:17982676
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of CYFIP2 mRNA	PMID:24714768
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46742	Nutlin-3	increases expression	ISO	RGD:1312845	E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of CYFIP2 mRNA	PMID:38460933
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CYFIP2 protein	PMID:38460933
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYFIP2 mRNA	PMID:32525701
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312846	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of CYFIP2 mRNA	PMID:30529165
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CYFIP2 mRNA	PMID:29391264
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20250805	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of CYFIP2 mRNA	PMID:39667565
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20250805	CTD	MESH:C045651	CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]]; CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT2 protein]]; CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT3 protein]]; epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased expression of CYFIP2 mRNA]; epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased expression of CYFIP2 protein]	PMID:39667565
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CYFIP2 mRNA	PMID:35436446
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of CYFIP2 mRNA	PMID:37567419
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:C029892	cupric chloride results in decreased expression of CYFIP2 mRNA	PMID:17211630|PMID:38568856
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYFIP2 mRNA	PMID:15894607
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1312845	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CYFIP2 mRNA	PMID:25075043
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CYFIP2 mRNA; Nanotubes, Carbon results in decreased expression of CYFIP2 mRNA	PMID:25554681
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CYFIP2 mRNA	PMID:19042947
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of CYFIP2 mRNA	PMID:17183730
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CYFIP2 protein	PMID:32959892
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:6121	ketamine	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D007649	[ampullosporin co-treated with Ketamine] results in decreased expression of CYFIP2 mRNA	PMID:16635253
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CYFIP2 mRNA	PMID:25729387
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of CYFIP2 mRNA	PMID:19812364
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312846	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CYFIP2 mRNA	PMID:25270620
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CYFIP2 mRNA	PMID:24136188
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1312845	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of CYFIP2 intron	PMID:30157460
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CYFIP2 gene	PMID:33148267
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CYFIP2 mRNA	PMID:39752319
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312846	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CYFIP2 mRNA	PMID:22206623
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312845	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CYFIP2 mRNA	PMID:22714537
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of CYFIP2 mRNA	PMID:32858204
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYFIP2 mRNA	PMID:27188386
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CYFIP2 gene]	PMID:28238834
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312846	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital results in increased expression of CYFIP2 mRNA	PMID:19482888
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20130806	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in decreased expression of CYFIP2 mRNA	PMID:21858171
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYFIP2 mRNA	PMID:32525701
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of CYFIP2 mRNA	PMID:26923065
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CYFIP2 mRNA	PMID:24780913
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CYFIP2 mRNA	PMID:39752319
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312845	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYFIP2 mRNA	PMID:27188386
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312845	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CYFIP2 mRNA	PMID:38568856
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CYFIP2 mRNA	PMID:21346803
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CYFIP2 mRNA	PMID:35537566
1305048	Cyfip2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of CYFIP2 mRNA	PMID:23869203
1305049	Fbxo16	F-box protein 16	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312847	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FBXO16 mRNA	PMID:27188386
1305049	Fbxo16	F-box protein 16	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312848	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FBXO16 mRNA	PMID:33045310
1305049	Fbxo16	F-box protein 16	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FBXO16 mRNA	PMID:33167477
1305049	Fbxo16	F-box protein 16	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312847	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of FBXO16 mRNA	PMID:26079696
1305049	Fbxo16	F-box protein 16	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXO16 mRNA	PMID:35811015
1305049	Fbxo16	F-box protein 16	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312847	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FBXO16 mRNA	PMID:35811015
1305049	Fbxo16	F-box protein 16	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FBXO16 mRNA	PMID:31614463
1305049	Fbxo16	F-box protein 16	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FBXO16 mRNA	PMID:32741896
1305049	Fbxo16	F-box protein 16	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312848	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of FBXO16 mRNA	PMID:33711761
1305049	Fbxo16	F-box protein 16	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FBXO16 mRNA	PMID:33387578
1305049	Fbxo16	F-box protein 16	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of FBXO16 mRNA	PMID:27905399
1305049	Fbxo16	F-box protein 16	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FBXO16 mRNA	PMID:32741896
1305049	Fbxo16	F-box protein 16	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of FBXO16 mRNA	PMID:26577399
1305049	Fbxo16	F-box protein 16	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	ISO	RGD:1312847	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of FBXO16 mRNA	PMID:17103032
1305049	Fbxo16	F-box protein 16	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FBXO16 mRNA	PMID:19549813
1305049	Fbxo16	F-box protein 16	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312847	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of FBXO16 mRNA	PMID:23649840
1305049	Fbxo16	F-box protein 16	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FBXO16 mRNA	PMID:22100608
1305049	Fbxo16	F-box protein 16	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312847	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FBXO16 mRNA	PMID:23649840
1305049	Fbxo16	F-box protein 16	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312847	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of FBXO16 mRNA	PMID:19774075
1305049	Fbxo16	F-box protein 16	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312847	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1305049	Fbxo16	F-box protein 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO16 mRNA	PMID:22298810
1305049	Fbxo16	F-box protein 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXO16 mRNA	PMID:33387578
1305049	Fbxo16	F-box protein 16	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FBXO16 mRNA	PMID:28001369
1305049	Fbxo16	F-box protein 16	gene	CHEBI:28741	sodium fluoride	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of FBXO16 mRNA	PMID:27257137
1305049	Fbxo16	F-box protein 16	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBXO16 mRNA	PMID:34032870
1305049	Fbxo16	F-box protein 16	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312848	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXO16 mRNA	PMID:37682722
1305049	Fbxo16	F-box protein 16	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312847	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of FBXO16 mRNA	PMID:22378314
1305049	Fbxo16	F-box protein 16	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312847	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of FBXO16 gene	PMID:31601247
1305049	Fbxo16	F-box protein 16	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312848	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of FBXO16 mRNA	PMID:18648102
1305049	Fbxo16	F-box protein 16	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312847	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FBXO16 gene	PMID:31601247
1305049	Fbxo16	F-box protein 16	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FBXO16 gene	PMID:28505145
1305049	Fbxo16	F-box protein 16	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312847	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of FBXO16 gene	PMID:31601247
1305049	Fbxo16	F-box protein 16	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312848	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of FBXO16 intron	PMID:28392331
1305049	Fbxo16	F-box protein 16	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312848	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FBXO16 mRNA	PMID:21266533
1305049	Fbxo16	F-box protein 16	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXO16 mRNA	PMID:38382870
1305049	Fbxo16	F-box protein 16	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FBXO16 mRNA	PMID:31533062
1305049	Fbxo16	F-box protein 16	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312847	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO16 mRNA	PMID:25979313
1305049	Fbxo16	F-box protein 16	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXO16 mRNA	PMID:23179753|PMID:26272509
1305049	Fbxo16	F-box protein 16	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312847	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FBXO16 gene	PMID:29154799
1305049	Fbxo16	F-box protein 16	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312847	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXO16 mRNA	PMID:29154799
1305049	Fbxo16	F-box protein 16	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312847	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1305049	Fbxo16	F-box protein 16	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312847	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FBXO16 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1305049	Fbxo16	F-box protein 16	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1312847	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of FBXO16 mRNA	PMID:16595896
1305049	Fbxo16	F-box protein 16	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of FBXO16 mRNA	PMID:26272509
1305049	Fbxo16	F-box protein 16	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312847	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1305049	Fbxo16	F-box protein 16	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312847	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of FBXO16 mRNA	PMID:28542535
1305049	Fbxo16	F-box protein 16	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312847	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FBXO16 mRNA	PMID:24935251|PMID:26272509
1305049	Fbxo16	F-box protein 16	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312847	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1305049	Fbxo16	F-box protein 16	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FBXO16 mRNA	PMID:33387578
1305049	Fbxo16	F-box protein 16	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312847	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FBXO16 mRNA	PMID:35811015
1305049	Fbxo16	F-box protein 16	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FBXO16 mRNA	PMID:29391264
1305049	Fbxo16	F-box protein 16	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312848	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of FBXO16 mRNA	PMID:38701926
1305049	Fbxo16	F-box protein 16	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FBXO16 mRNA	PMID:32741896
1305049	Fbxo16	F-box protein 16	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312847	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1305049	Fbxo16	F-box protein 16	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1312847	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of FBXO16 mRNA	PMID:19095052
1305049	Fbxo16	F-box protein 16	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of FBXO16 mRNA	PMID:29162477
1305049	Fbxo16	F-box protein 16	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312847	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1305049	Fbxo16	F-box protein 16	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of FBXO16 mRNA	PMID:22570695
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CHMP2A mRNA	PMID:21551480
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550598	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CHMP2A mRNA	PMID:33045310
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CHMP2A gene	PMID:20938992
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1603659	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CHMP2A mRNA	PMID:33167477
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550598	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CHMP2A mRNA	PMID:39241906
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1603659	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of CHMP2A mRNA	PMID:23019147
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1603659	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CHMP2A mRNA	PMID:38568856
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CHMP2A gene	PMID:20938992
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CHMP2A mRNA	PMID:37236586
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CHMP2A protein]	PMID:32272095
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CHMP2A mRNA	PMID:30779732
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1603659	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CHMP2A mRNA	PMID:21867686
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHMP2A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CHMP2A gene	PMID:20938992|PMID:22206623
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHMP2A mRNA	PMID:40504410
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1603659	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CHMP2A mRNA	PMID:19244175
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550598	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHMP2A mRNA	PMID:21570461
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CHMP2A mRNA	PMID:33387578
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1603659	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CHMP2A mRNA; aristolochic acid I results in decreased expression of CHMP2A protein	PMID:33212167
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1603659	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CHMP2A mRNA	PMID:29803840
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:29021	hexane	decreases methylation	EXP		E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of CHMP2A promoter	PMID:23740543
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHMP2A mRNA	PMID:40504410
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603659	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHMP2A 5' UTR; Benzo(a)pyrene affects the methylation of CHMP2A promoter	PMID:27901495
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550598	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CHMP2A mRNA	PMID:22228805
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550598	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CHMP2A gene	PMID:35295148
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CHMP2A mRNA	PMID:34492290
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550598	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CHMP2A mRNA	PMID:33221593
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CHMP2A mRNA	PMID:25181051
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CHMP2A mRNA	PMID:36041667
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1603659	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CHMP2A mRNA	PMID:25979313
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1550598	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CHMP2A promoter	PMID:33297965
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550598	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CHMP2A mRNA	PMID:39298647|PMID:40203079
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CHMP2A mRNA	PMID:36041667
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1603659	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CHMP2A protein	PMID:34186270
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CHMP2A mRNA	PMID:36041667
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1550598	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of CHMP2A protein	PMID:32272095
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CHMP2A protein]	PMID:32272095
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1550598	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of CHMP2A mRNA	PMID:34813904
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603659	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHMP2A mRNA	PMID:37042841
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CHMP2A mRNA	PMID:33453195
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CHMP2A mRNA	PMID:37236586
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1603659	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CHMP2A mRNA	PMID:19320972
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1603659	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CHMP2A mRNA	PMID:19244175
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603659	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CHMP2A mRNA	PMID:25979313
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603659	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CHMP2A mRNA	PMID:23179753|PMID:23527032|PMID:27188386
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603659	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CHMP2A gene	PMID:29154799
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603659	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CHMP2A mRNA	PMID:25562108
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550598	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CHMP2A mRNA	PMID:17555576
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHMP2A mRNA	PMID:40504410
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1603659	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of CHMP2A mRNA	PMID:18175754
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550598	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CHMP2A mRNA	PMID:17555576
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CHMP2A mRNA	PMID:24136188
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CHMP2A mRNA	PMID:24136188|PMID:24793618
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603659	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CHMP2A protein	PMID:32959892
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1603659	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CHMP2A mRNA	PMID:15336504
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CHMP2A mRNA	PMID:30467583
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1603659	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CHMP2A mRNA	PMID:31758290
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1603659	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CHMP2A protein	PMID:34186270
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550598	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHMP2A mRNA	PMID:22206623
1305050	Chmp2a	charged multivesicular body protein 2A	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of CHMP2A mRNA	PMID:24136188
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1601976	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of AEN mRNA	PMID:38218311
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1601976	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of AEN mRNA	PMID:35967413
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551717	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of AEN mRNA	PMID:33045310
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of AEN mRNA]	PMID:31150632
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of AEN gene	PMID:20938992
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1601976	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of AEN mRNA	PMID:33167477
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of AEN mRNA	PMID:20488242
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AEN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AEN mRNA	PMID:32699268
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AEN mRNA	PMID:30529165
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1601976	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of AEN mRNA	PMID:26079696
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16037	2-nitropropane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016617	2-nitropropane results in increased expression of AEN mRNA	PMID:17070881
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1601976	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of AEN mRNA	PMID:21632981
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551717	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of AEN mRNA	PMID:39241906
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1601976	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of AEN mRNA	PMID:35811015
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of AEN mRNA]	PMID:39241906
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of AEN mRNA	PMID:35811015
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551717	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of AEN mRNA	PMID:39298647
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1601976	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of AEN mRNA	PMID:23019147|PMID:31614463
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of AEN mRNA	PMID:33387578
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of AEN gene	PMID:20938992
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1601976	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of AEN mRNA	PMID:23649840
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:17356	2-acetamidofluorene	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of AEN mRNA	PMID:17070881|PMID:22584684
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1551717	E	RGD:6480464	20121113	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of AEN mRNA	PMID:21607683
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1601976	E	RGD:6480464	20130312	CTD	MESH:C031927	hydroquinone results in increased expression of AEN mRNA	PMID:23416264
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of AEN mRNA	PMID:22584684
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of AEN mRNA	PMID:26577399|PMID:27523638
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of AEN mRNA	PMID:33387578
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1601976	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of AEN mRNA	PMID:28818685
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AEN mRNA	PMID:39836092
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AEN mRNA	PMID:37236586
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1601976	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AEN mRNA	PMID:19549813
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1601976	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of AEN mRNA	PMID:23649840
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases expression	ISO	RGD:1551717	E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased expression of AEN mRNA	PMID:19100860
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1601976	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of AEN protein	PMID:20106945
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AEN mRNA	PMID:23385219|PMID:23630614|PMID:25378103
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551717	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AEN mRNA	PMID:19770486
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1601976	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AEN mRNA	PMID:21632981|PMID:22100608|PMID:27153756
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1601976	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of AEN mRNA	PMID:23649840
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:2533	alachlor	affects expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C000188	alachlor affects the expression of AEN mRNA	PMID:19425180
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1551717	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of AEN mRNA	PMID:32553695
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1601976	E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in increased expression of AEN mRNA	PMID:28652203
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AEN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AEN mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of AEN mRNA	PMID:32699268
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of AEN mRNA	PMID:18593933
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of AEN mRNA	PMID:31150632
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of AEN mRNA]	PMID:31150632
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1551717	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of AEN mRNA	PMID:25629700
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of AEN mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of AEN gene	PMID:20938992|PMID:22206623
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AEN mRNA	PMID:40504410
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AEN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AEN mRNA	PMID:39836092
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1601976	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of AEN mRNA	PMID:33512557
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of AEN mRNA	PMID:31881176
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1601976	E	RGD:6480464	20210608	CTD	MESH:D002945	Cisplatin results in increased expression of AEN mRNA	PMID:33545341
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1601976	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of AEN mRNA	PMID:24768652|PMID:25583101
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551717	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AEN mRNA	PMID:21570461
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AEN mRNA	PMID:33387578
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1601976	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of AEN mRNA	PMID:33212167
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1601976	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of AEN mRNA	PMID:30851411
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1601976	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of AEN mRNA	PMID:29803840
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AEN mRNA	PMID:40504410
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AEN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AEN mRNA	PMID:39836092
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1601976	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of AEN mRNA	PMID:22378314
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1601976	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AEN promoter	PMID:27901495
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551717	E	RGD:6480464	20150714	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of AEN mRNA; Benzo(a)pyrene results in increased expression of AEN mRNA	PMID:19770486|PMID:21569818|PMID:21964900|PMID:22610609|PMID:25908611|PMID:32553695
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1601976	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AEN mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:32234424
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1601976	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AEN 5' UTR	PMID:27901495
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AEN mRNA	PMID:27858113
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:3000	beauvericin	decreases expression	ISO	RGD:1601976	E	RGD:6480464	20180515	CTD	MESH:C004456	beauvericin results in decreased expression of AEN mRNA	PMID:29203277
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of AEN mRNA	PMID:18593933
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1601976	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of AEN mRNA	PMID:25351596
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1601976	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of AEN mRNA	PMID:19150397
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1551717	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of AEN mRNA	PMID:29095437
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20191114	CTD	MESH:C006632	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of AEN mRNA]	PMID:29095437
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of AEN mRNA	PMID:25729387
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of AEN mRNA	PMID:25729387
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:3218	2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one	increases expression	ISO	RGD:1601976	E	RGD:6480464	20230905	CTD	MESH:C083997	buprofezin results in increased expression of AEN mRNA	PMID:36287832
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of AEN mRNA	PMID:23411599|PMID:34492290
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1551717	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of AEN mRNA	PMID:28472532
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AEN mRNA	PMID:25181051|PMID:34947998
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1601976	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of AEN mRNA	PMID:19244175
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1601976	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AEN mRNA	PMID:25979313
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	EXP		E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of AEN mRNA	PMID:17070881
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:34260	anthracen-2-amine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C006593	2-anthramine results in increased expression of AEN mRNA	PMID:23038007
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551717	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of AEN mRNA	PMID:39298647
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1551717	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of AEN mRNA	PMID:26377693
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AEN mRNA	PMID:27858113
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551717	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of AEN mRNA	PMID:37019170
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of AEN mRNA	PMID:21266533
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1551717	E	RGD:6480464	20121113	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of AEN mRNA	PMID:19100860|PMID:21607683
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of AEN mRNA	PMID:32680482
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of AEN mRNA]	PMID:39241906
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AEN mRNA	PMID:39836092
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1551717	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of AEN mRNA	PMID:26377693
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1601976	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AEN mRNA	PMID:38382870|PMID:38568856
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AEN mRNA	PMID:37236586
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1551717	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of AEN mRNA	PMID:24183702|PMID:37517673
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1551717	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of AEN mRNA	PMID:28903501
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of AEN mRNA	PMID:25380136
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1551717	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of AEN mRNA	PMID:28962523
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AEN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AEN mRNA	PMID:32699268
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1551717	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of AEN mRNA	PMID:39529242
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:39381	buprofezin	increases expression	ISO	RGD:1601976	E	RGD:6480464	20230905	CTD	MESH:C083997	buprofezin results in increased expression of AEN mRNA	PMID:36287832
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1551717	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of AEN mRNA	PMID:29038090
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of AEN mRNA	PMID:25993096
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551717	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of AEN mRNA	PMID:17292431
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1601976	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AEN mRNA	PMID:25979313
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1551717	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of AEN mRNA	PMID:21427059
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1601976	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of AEN mRNA	PMID:29154799
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1601976	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AEN mRNA	PMID:20106945|PMID:25562108
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1601976	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of AEN mRNA	PMID:33512557
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551717	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of AEN mRNA	PMID:28973697
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1601976	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of AEN mRNA	PMID:33512557
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1601976	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of AEN mRNA	PMID:38832940
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1601976	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of AEN mRNA	PMID:28542535
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of AEN mRNA	PMID:33387578
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of AEN mRNA	PMID:35811015
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AEN mRNA	PMID:40504410
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AEN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AEN mRNA	PMID:39836092
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1551717	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in increased expression of AEN mRNA	PMID:35537566
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of AEN mRNA	PMID:29391264
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1551717	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of AEN mRNA	PMID:29095437
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20191114	CTD	MESH:C032793	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of AEN mRNA]	PMID:29095437
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551717	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AEN mRNA; Nanotubes, Carbon results in increased expression of AEN mRNA	PMID:25554681|PMID:25620056
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of AEN mRNA	PMID:23962444
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of AEN mRNA	PMID:24136188
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AEN mRNA	PMID:27858113
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1551717	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of AEN mRNA	PMID:26377693
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AEN mRNA	PMID:27858113
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of AEN mRNA	PMID:28801915
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1601976	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AEN mRNA	PMID:39836092
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of AEN mRNA	PMID:25729387
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of AEN mRNA	PMID:25729387
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of AEN mRNA	PMID:28801915
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1551717	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of AEN mRNA	PMID:20003209
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:67116	4-nitro-1,2-phenylenediamine	decreases expression	EXP		E	RGD:6480464	20120904	CTD	MESH:C012277	1,2-diamino-4-nitrobenzene results in decreased expression of AEN mRNA	PMID:17070881
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of AEN mRNA]	PMID:29095437
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1601976	E	RGD:6480464	20210608	CTD	MESH:C014476	diethyl maleate results in increased expression of AEN mRNA	PMID:33545341
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551717	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AEN mRNA	PMID:22206623
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of AEN mRNA	PMID:22206623
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1551717	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of AEN mRNA	PMID:27858113
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1601976	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of AEN mRNA	PMID:28960945
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:76261	1-nitropropane	increases expression	EXP		E	RGD:6480464	20161220	CTD	MESH:C035314	1-nitropropane results in increased expression of AEN mRNA	PMID:17070881
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:76288	2,6-diaminotoluene	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C025235	2,6-diaminotoluene results in increased expression of AEN mRNA	PMID:17070881
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:76343	4-acetylaminofluorene	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C028676	4-acetylaminofluorene results in decreased expression of AEN mRNA	PMID:17070881
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:76394	2-nitro-p-phenylenediamine	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C014706	2-nitro-4-phenylenediamine results in increased expression of AEN mRNA	PMID:17070881
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1601976	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of AEN mRNA	PMID:30851411
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1601976	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of AEN mRNA	PMID:19159669
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1601976	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of AEN mRNA	PMID:32234424
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of AEN mRNA	PMID:23640034
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1551717	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of AEN mRNA]	PMID:39241906
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1601976	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of AEN mRNA	PMID:24921660
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of AEN mRNA	PMID:21346803
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1601976	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of AEN mRNA	PMID:38568856
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of AEN mRNA	PMID:21346803
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1551717	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of AEN mRNA	PMID:32835833
1305051	Aen	apoptosis enhancing nuclease	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1551717	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of AEN mRNA	PMID:35537566
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606322	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PGS1 mRNA	PMID:38218311
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PGS1 mRNA]	PMID:31150632
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312851	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGS1 mRNA	PMID:30529165
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312851	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PGS1 mRNA	PMID:30319688
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1606322	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PGS1 mRNA	PMID:21632981
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312851	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PGS1 mRNA	PMID:39241906
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606322	E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of PGS1 mRNA	PMID:22217510
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606322	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PGS1 mRNA	PMID:37042841
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PGS1 mRNA	PMID:22061828|PMID:33387578
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312851	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PGS1 mRNA	PMID:19770486
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D000638	Amiodarone results in increased expression of PGS1 mRNA	PMID:22291062
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of PGS1 mRNA	PMID:30779732
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PGS1 mRNA	PMID:31150632
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312851	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PGS1 mRNA	PMID:31919559
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PGS1 mRNA]	PMID:31150632
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312851	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of PGS1 mRNA	PMID:25629700
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1606322	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PGS1 gene	PMID:25304211
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312851	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PGS1 mRNA	PMID:40504410
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312851	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PGS1 mRNA	PMID:28960355
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606322	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PGS1 mRNA	PMID:23557933
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312851	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PGS1 mRNA	PMID:21570461|PMID:28238261
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PGS1 mRNA	PMID:33387578
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606322	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PGS1 mRNA	PMID:33212167
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606322	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PGS1 mRNA	PMID:29803840
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606322	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PGS1 mRNA	PMID:38568856
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312851	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PGS1 mRNA	PMID:40504410
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312851	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PGS1 mRNA	PMID:19770486
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606322	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PGS1 3' UTR	PMID:27901495
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of PGS1 mRNA	PMID:24136188
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PGS1 mRNA	PMID:34492290
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312851	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PGS1 mRNA	PMID:18301758|PMID:20813756
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1312851	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of PGS1 mRNA	PMID:19191707
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PGS1 mRNA	PMID:25181051
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312851	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PGS1 mRNA	PMID:33221593
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1606322	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PGS1 gene	PMID:31601247
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312851	E	RGD:6480464	20130514	CTD	MESH:D010269	[Paraquat co-treated with Maneb] results in decreased expression of PGS1 mRNA	PMID:18386188
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606322	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PGS1 mRNA	PMID:37042841
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PGS1 mRNA	PMID:33453195
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606322	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PGS1 mRNA	PMID:38568856
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:3750	clofibrate	increases activity	EXP		E	RGD:6480464	20120613	CTD	MESH:D002994	Clofibrate results in increased activity of PGS1 protein	PMID:14594999
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:3750	clofibrate	increases activity	ISO	RGD:1312851	E	RGD:6480464	20120613	CTD	MESH:D002994	Clofibrate results in increased activity of PGS1 protein	PMID:14594999
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312851	E	RGD:6480464	20120613	CTD	MESH:D002994	PPARA affects the reaction [Clofibrate results in increased activity of PGS1 protein]	PMID:14594999
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1312851	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PGS1 mRNA]	PMID:18200517
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312851	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PGS1 mRNA	PMID:17555576
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312851	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PGS1 mRNA	PMID:17562736
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of PGS1 mRNA	PMID:21061450
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1606322	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PGS1 gene	PMID:25304211
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312851	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PGS1 mRNA	PMID:40504410
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312851	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PGS1 mRNA	PMID:35436446
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312851	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PGS1 mRNA	PMID:17555576
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PGS1 mRNA	PMID:24136188
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312851	E	RGD:6480464	20130514	CTD	MESH:D008344	[Paraquat co-treated with Maneb] results in decreased expression of PGS1 mRNA	PMID:18386188
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1312851	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of PGS1 mRNA	PMID:18200517
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1312851	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PGS1 mRNA]	PMID:18200517
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312851	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PGS1 mRNA	PMID:26307267
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PGS1 gene	PMID:35440735
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1606322	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PGS1 mRNA	PMID:37199045
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606322	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PGS1 gene]	PMID:28238834
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312851	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PGS1 mRNA	PMID:19482888
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312851	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PGS1 mRNA]	PMID:19482888
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1606322	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of PGS1 mRNA	PMID:24921660
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1606322	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PGS1 mRNA	PMID:38568856
1305052	Pgs1	phosphatidylglycerophosphate synthase 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312851	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PGS1 mRNA	PMID:32835833
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ARHGAP18 mRNA	PMID:33045310
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of ARHGAP18 mRNA	PMID:21934132
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312852	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGAP18 mRNA	PMID:33167477
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312853	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ARHGAP18 mRNA	PMID:30319688
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1312852	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ARHGAP18 mRNA	PMID:18951874
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20130312	CTD	MESH:D011794	Quercetin results in decreased expression of ARHGAP18 mRNA	PMID:21632981
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARHGAP18 mRNA	PMID:35811015
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARHGAP18 mRNA	PMID:39241906
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARHGAP18 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ARHGAP18 mRNA	PMID:35811015
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGAP18 mRNA	PMID:31614463
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20130312	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of ARHGAP18 mRNA	PMID:20404318
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312853	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ARHGAP18 mRNA	PMID:33711761
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16602	trichloroethene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014241	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ARHGAP18 mRNA	PMID:17905399
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312852	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARHGAP18 mRNA	PMID:37042841
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16716	benzene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ARHGAP18 mRNA	PMID:17905399
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ARHGAP18 mRNA	PMID:23649840
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of ARHGAP18 mRNA	PMID:20864642
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ARHGAP18 mRNA	PMID:33359661
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARHGAP18 mRNA	PMID:34319233
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312852	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ARHGAP18 mRNA; Diethylhexyl Phthalate results in increased expression of ARHGAP18 protein	PMID:31163220
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ARHGAP18 mRNA	PMID:22061828
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20130312	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ARHGAP18 mRNA	PMID:19549813
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ARHGAP18 mRNA	PMID:23649840
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C016517	indole-3-carbinol affects the expression of ARHGAP18 mRNA	PMID:21396975
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ARHGAP18 mRNA	PMID:23649840
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ARHGAP18 mRNA	PMID:30779732
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARHGAP18 mRNA	PMID:17484886
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP18 mRNA	PMID:39836092
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312852	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ARHGAP18 mRNA	PMID:26272509
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312852	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ARHGAP18 protein	PMID:35688186
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ARHGAP18 mRNA	PMID:30912803
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of ARHGAP18 mRNA	PMID:18930951
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28088	genistein	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in decreased methylation of ARHGAP18 gene	PMID:28505145
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of ARHGAP18 gene	PMID:28505145
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGAP18 mRNA	PMID:34747641
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGAP18 mRNA	PMID:20106945
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGAP18 mRNA	PMID:19933214
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ARHGAP18 mRNA	PMID:17942748
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ARHGAP18 mRNA	PMID:28001369
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of ARHGAP18 mRNA	PMID:23649840
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of ARHGAP18 mRNA	PMID:30556269
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGAP18 mRNA	PMID:29803840
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGAP18 mRNA	PMID:39631538
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312852	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of ARHGAP18 protein	PMID:35688186
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20130312	CTD	MESH:D008558	Melphalan results in decreased expression of ARHGAP18 mRNA	PMID:22363485
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGAP18 mRNA	PMID:20371982|PMID:38568856
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312852	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGAP18 mRNA	PMID:22714537
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP18 mRNA	PMID:39836092
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARHGAP18 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of ARHGAP18 mRNA	PMID:30556269
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ARHGAP18 mRNA	PMID:25895662
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1312852	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of ARHGAP18 mRNA	PMID:20382639
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARHGAP18 mRNA	PMID:19150397
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ARHGAP18 mRNA	PMID:27829220
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ARHGAP18 gene	PMID:31601247
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ARHGAP18 mRNA	PMID:24136188
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ARHGAP18 mRNA	PMID:34492290
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ARHGAP18 mRNA	PMID:23411599
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARHGAP18 mRNA	PMID:19710929
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312853	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ARHGAP18 mRNA	PMID:28472532
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARHGAP18 mRNA	PMID:25181051
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312852	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ARHGAP18 mRNA	PMID:30903817
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312852	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of ARHGAP18 gene	PMID:31601247
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP18 mRNA	PMID:34947998
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP18 mRNA	PMID:29275510
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312852	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP18 protein	PMID:34186270
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312853	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP18 mRNA	PMID:34585602
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ARHGAP18 gene	PMID:28505145
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ARHGAP18 gene	PMID:31601247
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312852	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ARHGAP18 mRNA	PMID:25979313
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARHGAP18 mRNA	PMID:21266533
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312853	E	RGD:6480464	20130312	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARHGAP18 mRNA	PMID:17361019|PMID:21266533
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312852	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGAP18 mRNA	PMID:37042841
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312852	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARHGAP18 mRNA	PMID:26472689
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ARHGAP18 protein	PMID:26879310
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ARHGAP18 mRNA	PMID:25539665
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARHGAP18 mRNA	PMID:24386269
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARHGAP18 mRNA	PMID:19320972
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ARHGAP18 mRNA	PMID:24449571
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:37825	p-toluidine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of ARHGAP18 mRNA	PMID:27638505
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312853	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ARHGAP18 mRNA	PMID:40194260
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ARHGAP18 mRNA	PMID:28302478
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ARHGAP18 mRNA	PMID:31533062
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312852	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGAP18 mRNA	PMID:25979313
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312852	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGAP18 mRNA	PMID:23179753|PMID:23527032|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARHGAP18 mRNA	PMID:25562108
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ARHGAP18 mRNA	PMID:17555576
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312853	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ARHGAP18 mRNA	PMID:28973697
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of ARHGAP18 mRNA	PMID:23649840
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312852	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ARHGAP18 mRNA	PMID:26272509|PMID:27188386
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312852	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ARHGAP18 mRNA	PMID:24935251|PMID:26272509
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGAP18 mRNA	PMID:33387578
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20130312	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGAP18 mRNA	PMID:21420995
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ARHGAP18 mRNA	PMID:20977926
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARHGAP18 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ARHGAP18 mRNA	PMID:35811015
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP18 mRNA	PMID:39836092
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ARHGAP18 mRNA	PMID:29391264
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20130312	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGAP18 mRNA	PMID:22079256
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ARHGAP18 mRNA	PMID:17555576
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARHGAP18 mRNA	PMID:17942748
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ARHGAP18 mRNA	PMID:17942748
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1312852	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of ARHGAP18 mRNA	PMID:26272509
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:49747	methylmercury(1+)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C030957	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ARHGAP18 mRNA	PMID:17905399
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ARHGAP18 mRNA	PMID:27829220
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARHGAP18 mRNA; Nanotubes, Carbon results in decreased expression of ARHGAP18 mRNA	PMID:25620056
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312852	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ARHGAP18 mRNA	PMID:22714537
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARHGAP18 protein	PMID:32959892
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20130312	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARHGAP18 mRNA	PMID:21641980
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of ARHGAP18 mRNA	PMID:20003209
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ARHGAP18 gene	PMID:35440735
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312852	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ARHGAP18 protein	PMID:34186270
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ARHGAP18 mRNA	PMID:22206623
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ARHGAP18 mRNA	PMID:22079256
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGAP18 mRNA	PMID:22079256
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of ARHGAP18 mRNA	PMID:33484710
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312853	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ARHGAP18 mRNA	PMID:23091169
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ARHGAP18 mRNA	PMID:31388691
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1312853	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of ARHGAP18 mRNA	PMID:27029645
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312852	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of ARHGAP18 mRNA	PMID:26272509
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312852	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ARHGAP18 mRNA	PMID:21346803
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in decreased expression of ARHGAP18 mRNA	PMID:26141394
1305053	Arhgap18	Rho GTPase activating protein 18	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312852	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ARHGAP18 mRNA	PMID:27188386
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312855	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DNTT mRNA	PMID:33045310
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DNTT mRNA	PMID:36331819
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DNTT mRNA	PMID:39298647
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DNTT mRNA	PMID:37992649
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of DNTT mRNA	PMID:21669218
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DNTT mRNA	PMID:37992649
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DNTT mRNA	PMID:36331819
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of DNTT mRNA	PMID:15674844
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of DNTT mRNA	PMID:12763052
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of DNTT mRNA	PMID:40618947
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312855	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNTT mRNA	PMID:26377647
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20130416	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNTT mRNA	PMID:16102516|PMID:8122269
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNTT mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to DNTT promoter]	PMID:17942748|PMID:19654925
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DNTT mRNA	PMID:37992649
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312854	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DNTT 3' UTR; Benzo(a)pyrene results in increased methylation of DNTT promoter	PMID:27901495
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312854	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of DNTT gene	PMID:31601247
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in decreased expression of DNTT mRNA	PMID:22609695
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of DNTT mRNA	PMID:27760801
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of DNTT mRNA	PMID:20813756|PMID:23811191
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of DNTT mRNA	PMID:20813756
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DNTT mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DNTT mRNA	PMID:39298647
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312854	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of DNTT gene	PMID:31601247
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of DNTT mRNA	PMID:28392331
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312855	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of DNTT mRNA	PMID:24535843
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of DNTT mRNA	PMID:17585979
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312855	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DNTT mRNA	PMID:40194260
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DNTT mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DNTT mRNA	PMID:36331819
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of DNTT mRNA	PMID:21041162
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of DNTT mRNA	PMID:25123088
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of DNTT mRNA	PMID:21041162
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of DNTT mRNA	PMID:21041162
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DNTT mRNA	PMID:37992649
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DNTT mRNA	PMID:17942748
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNTT mRNA	PMID:17942748
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312855	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DNTT mRNA	PMID:25620056
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:5277	gardenoside	decreases expression	ISO	RGD:1312854	E	RGD:6480464	20251104	CTD	MESH:C056587	gardenoside results in decreased expression of DNTT mRNA	PMID:37588187
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:5277	gardenoside	multiple interactions	ISO	RGD:1312854	E	RGD:6480464	20251104	CTD	MESH:C056587	gardenoside inhibits the reaction [FOXO3A protein binds to DNTT promoter]	PMID:37588187
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in decreased expression of DNTT mRNA	PMID:21404309
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:53556	toluene 2,4-diisocyanate	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in decreased expression of DNTT mRNA	PMID:21404309
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of DNTT mRNA	PMID:19812364
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312854	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DNTT gene]	PMID:28238834
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of DNTT mRNA	PMID:19482888
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of DNTT mRNA]	PMID:19482888
1305054	Dntt	DNA nucleotidylexotransferase	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312855	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DNTT mRNA	PMID:38648751
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312856	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ATP6V0A4 mRNA	PMID:38218311
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312856	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ATP6V0A4 mRNA	PMID:38218311
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ATP6V0A4 mRNA	PMID:36189433
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312856	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of ATP6V0A4 mRNA	PMID:25321415|PMID:31614463
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ATP6V0A4 mRNA	PMID:33387578
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312856	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ATP6V0A4 mRNA	PMID:26079696
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ATP6V0A4 mRNA	PMID:36189433
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ATP6V0A4 mRNA	PMID:36189433
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of ATP6V0A4 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of ATP6V0A4 mRNA]	PMID:20230807
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ATP6V0A4 mRNA	PMID:27523638
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ATP6V0A4 mRNA	PMID:26577399
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ATP6V0A4 mRNA	PMID:22061828
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of ATP6V0A4 mRNA	PMID:20230807
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20120501	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of ATP6V0A4 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of ATP6V0A4 mRNA]	PMID:20230807
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATP6V0A4 mRNA	PMID:36331819
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of ATP6V0A4 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of ATP6V0A4 mRNA]	PMID:20230807
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0A4 mRNA	PMID:29950665
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312856	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ATP6V0A4 gene; Aflatoxin B1 results in increased methylation of ATP6V0A4 promoter	PMID:27153756|PMID:30157460
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312856	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ATP6V0A4 mRNA	PMID:21867686
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312856	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP6V0A4 mRNA	PMID:23557933
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ATP6V0A4 mRNA	PMID:32186404
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312856	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ATP6V0A4 mRNA	PMID:24768652|PMID:25583101
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312856	E	RGD:6480464	20200519	CTD	MESH:D012402	Rotenone results in increased expression of ATP6V0A4 mRNA	PMID:31648047
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312856	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ATP6V0A4 mRNA	PMID:33212167
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATP6V0A4 mRNA	PMID:37682722
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312856	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ATP6V0A4 mRNA	PMID:29301061|PMID:38568856
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312856	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATP6V0A4 5' UTR; Benzo(a)pyrene affects the methylation of ATP6V0A4 intron	PMID:27901495|PMID:30157460
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312856	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ATP6V0A4 exon	PMID:27901495
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312857	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ATP6V0A4 exon; Benzo(a)pyrene results in decreased methylation of ATP6V0A4 intron	PMID:27901495
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312857	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ATP6V0A4 mRNA	PMID:35295148
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0A4 mRNA	PMID:29950665
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312857	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ATP6V0A4 mRNA	PMID:20813756
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATP6V0A4 mRNA	PMID:25181051
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP6V0A4 mRNA	PMID:38701888
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ATP6V0A4 mRNA	PMID:34947998
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312857	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ATP6V0A4 mRNA	PMID:32156529
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATP6V0A4 gene	PMID:28505145
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ATP6V0A4 mRNA	PMID:26682919
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ATP6V0A4 mRNA	PMID:40203079
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in decreased expression of ATP6V0A4 mRNA]	PMID:40203079
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312856	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ATP6V0A4 intron	PMID:30157460
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1312857	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of ATP6V0A4 mRNA	PMID:26377693
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0A4 mRNA	PMID:29950665
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	increases expression	ISO	RGD:1312856	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate results in increased expression of ATP6V0A4 mRNA	PMID:29024780
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1312856	E	RGD:6480464	20210309	CTD	MESH:C023036	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of ATP6V0A4 mRNA	PMID:33325755
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312857	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ATP6V0A4 mRNA	PMID:28903501
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312857	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ATP6V0A4 mRNA	PMID:40194260
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ATP6V0A4 mRNA	PMID:39529242
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATP6V0A4 mRNA	PMID:36331819
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312856	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ATP6V0A4 mRNA	PMID:24383497|PMID:26272509
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312856	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA	PMID:27188386
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ATP6V0A4 mRNA	PMID:41580965
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312856	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ATP6V0A4 mRNA	PMID:24935251
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312856	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ATP6V0A4 mRNA	PMID:24714768
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1312856	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of ATP6V0A4 mRNA	PMID:40706910
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1312857	E	RGD:6480464	20200804	CTD	MESH:D002101	Cacodylic Acid results in increased expression of ATP6V0A4 mRNA	PMID:32052077
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1312856	E	RGD:6480464	20120412	CTD	MESH:D005047	ATP6V0A4 protein affects the susceptibility to Etoposide	PMID:16217747
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ATP6V0A4 mRNA	PMID:30307764
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312857	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ATP6V0A4 mRNA; Nanotubes, Carbon results in increased expression of ATP6V0A4 mRNA	PMID:25554681
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312857	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of ATP6V0A4 mRNA	PMID:26377693
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ATP6V0A4 mRNA	PMID:23608068
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312857	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of ATP6V0A4 mRNA	PMID:36851058
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312856	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ATP6V0A4 intron	PMID:30157460
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ATP6V0A4 gene	PMID:35440735
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1312856	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ATP6V0A4 mRNA	PMID:22714537
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1312857	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of ATP6V0A4 mRNA	PMID:37699712
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:76989	phytoestrogen	multiple interactions	ISO	RGD:1312856	E	RGD:6480464	20210309	CTD	MESH:D048789	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of ATP6V0A4 mRNA	PMID:33325755
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312856	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA	PMID:27188386
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312856	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATP6V0A4 gene]	PMID:28238834
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312857	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ATP6V0A4 mRNA	PMID:38648751
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATP6V0A4 mRNA	PMID:24780913
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312856	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of ATP6V0A4 mRNA	PMID:26272509
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312856	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA	PMID:27188386
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312856	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA	PMID:27188386
1305055	Atp6v0a4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of ATP6V0A4 protein	PMID:32519852
1305056	Angel2	angel homolog 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1551319	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ANGEL2 mRNA	PMID:33045310
1305056	Angel2	angel homolog 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1601837	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ANGEL2 mRNA	PMID:33167477
1305056	Angel2	angel homolog 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1601837	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ANGEL2 mRNA	PMID:26079696
1305056	Angel2	angel homolog 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1551319	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ANGEL2 mRNA	PMID:30319688
1305056	Angel2	angel homolog 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551319	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ANGEL2 mRNA	PMID:39241906
1305056	Angel2	angel homolog 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551319	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ANGEL2 mRNA	PMID:39298647
1305056	Angel2	angel homolog 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551319	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ANGEL2 mRNA	PMID:34319233
1305056	Angel2	angel homolog 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551319	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ANGEL2 mRNA	PMID:28111341
1305056	Angel2	angel homolog 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1601837	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ANGEL2 mRNA	PMID:19549813
1305056	Angel2	angel homolog 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1601837	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ANGEL2 protein	PMID:23301498
1305056	Angel2	angel homolog 2	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1551319	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of ANGEL2 mRNA	PMID:19376150
1305056	Angel2	angel homolog 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551319	E	RGD:6480464	20150127	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ANGEL2 mRNA	PMID:17484886|PMID:25270620
1305056	Angel2	angel homolog 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1601837	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANGEL2 mRNA	PMID:38568856
1305056	Angel2	angel homolog 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551319	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANGEL2 mRNA	PMID:22228805
1305056	Angel2	angel homolog 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1601837	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ANGEL2 mRNA	PMID:25351596
1305056	Angel2	angel homolog 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1601837	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ANGEL2 mRNA	PMID:26238291
1305056	Angel2	angel homolog 2	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1601837	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of ANGEL2 mRNA	PMID:31745603
1305056	Angel2	angel homolog 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ANGEL2 mRNA	PMID:25729387
1305056	Angel2	angel homolog 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1551319	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ANGEL2 mRNA	PMID:19136022
1305056	Angel2	angel homolog 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ANGEL2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305056	Angel2	angel homolog 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ANGEL2 mRNA	PMID:25181051
1305056	Angel2	angel homolog 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ANGEL2 mRNA	PMID:36041667
1305056	Angel2	angel homolog 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551319	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ANGEL2 mRNA	PMID:39298647
1305056	Angel2	angel homolog 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ANGEL2 mRNA	PMID:36041667
1305056	Angel2	angel homolog 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ANGEL2 mRNA	PMID:36041667
1305056	Angel2	angel homolog 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551319	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ANGEL2 mRNA	PMID:37019170
1305056	Angel2	angel homolog 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1551319	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ANGEL2 mRNA	PMID:34813904
1305056	Angel2	angel homolog 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1601837	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANGEL2 mRNA	PMID:37042841
1305056	Angel2	angel homolog 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1601837	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ANGEL2 mRNA	PMID:38382870
1305056	Angel2	angel homolog 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551319	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ANGEL2 mRNA	PMID:28111341
1305056	Angel2	angel homolog 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1601837	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ANGEL2 mRNA	PMID:25979313
1305056	Angel2	angel homolog 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1551319	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of ANGEL2 mRNA	PMID:21427059
1305056	Angel2	angel homolog 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1601837	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ANGEL2 mRNA	PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1305056	Angel2	angel homolog 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1601837	E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in increased expression of ANGEL2 mRNA	PMID:37505509
1305056	Angel2	angel homolog 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1551319	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ANGEL2 mRNA	PMID:17555576
1305056	Angel2	angel homolog 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1601837	E	RGD:6480464	20130806	CTD	MESH:D008727	Methotrexate results in increased expression of ANGEL2 mRNA	PMID:17400583
1305056	Angel2	angel homolog 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551319	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ANGEL2 mRNA	PMID:17562736
1305056	Angel2	angel homolog 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1551319	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ANGEL2 mRNA	PMID:29279043
1305056	Angel2	angel homolog 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1551319	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ANGEL2 mRNA	PMID:35436446
1305056	Angel2	angel homolog 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1551319	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ANGEL2 mRNA	PMID:17555576
1305056	Angel2	angel homolog 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D008713	Methimazole results in increased expression of ANGEL2 mRNA	PMID:22504374
1305056	Angel2	angel homolog 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551319	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ANGEL2 mRNA	PMID:35964746
1305056	Angel2	angel homolog 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ANGEL2 mRNA	PMID:25729387
1305056	Angel2	angel homolog 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551319	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ANGEL2 mRNA	PMID:22206623
1305056	Angel2	angel homolog 2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1601837	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ANGEL2 protein	PMID:31285264
1305056	Angel2	angel homolog 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551319	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of ANGEL2 mRNA	PMID:19136022
1305056	Angel2	angel homolog 2	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of ANGEL2 protein	PMID:28903499
1305056	Angel2	angel homolog 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ANGEL2 mRNA	PMID:23640034
1305056	Angel2	angel homolog 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D011441	Propylthiouracil results in increased expression of ANGEL2 mRNA	PMID:22504374
1305056	Angel2	angel homolog 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ANGEL2 mRNA	PMID:21346803
1305056	Angel2	angel homolog 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1551319	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ANGEL2 mRNA	PMID:35537566
1305056	Angel2	angel homolog 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ANGEL2 mRNA	PMID:23555832
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312859	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NAGK mRNA	PMID:38218311
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312860	E	RGD:6480464	20171010	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of NAGK mRNA	PMID:28558994
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312859	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of NAGK mRNA	PMID:33167477
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NAGK mRNA	PMID:36331819
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NAGK mRNA	PMID:39241906
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAGK mRNA]	PMID:39241906
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312859	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of NAGK mRNA	PMID:23649840
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAGK mRNA	PMID:37992649
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAGK mRNA	PMID:37992649
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312860	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of NAGK mRNA	PMID:23892564
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312859	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of NAGK protein	PMID:37730182
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NAGK mRNA	PMID:33387578
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NAGK mRNA	PMID:36331819
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312859	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NAGK mRNA	PMID:19549813
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312859	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of NAGK mRNA	PMID:23649840
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312859	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NAGK mRNA	PMID:23649840
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of NAGK protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of NAGK protein	PMID:38598786
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312860	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NAGK mRNA	PMID:31919559
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NAGK mRNA	PMID:40504410
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1312859	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NAGK mRNA	PMID:19244175
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312859	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of NAGK mRNA	PMID:26272509
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA	PMID:27188386
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NAGK mRNA	PMID:23557933
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312859	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of NAGK mRNA	PMID:27594783
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312859	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of NAGK mRNA	PMID:23195993
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312860	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NAGK mRNA	PMID:21570461
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NAGK mRNA	PMID:32109520
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NAGK mRNA	PMID:33387578
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312859	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NAGK mRNA	PMID:20106945|PMID:21632981
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAGK mRNA	PMID:17942748
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of NAGK protein	PMID:35544339
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312860	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of NAGK mRNA	PMID:30807115
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAGK mRNA	PMID:37992649
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312859	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of NAGK protein	PMID:35688186
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312859	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NAGK mRNA	PMID:38568856
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NAGK mRNA	PMID:40504410
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312859	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NAGK promoter	PMID:27901495
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312859	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NAGK mRNA	PMID:21632981
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312860	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NAGK mRNA	PMID:20713471|PMID:22228805
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to NAGK promoter]	PMID:19654925
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312860	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NAGK gene; titanium dioxide results in decreased methylation of NAGK promoter	PMID:35295148
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NAGK mRNA	PMID:34492290
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NAGK mRNA	PMID:25380136
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312860	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NAGK mRNA	PMID:18301758|PMID:23811191
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NAGK mRNA	PMID:19710929
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NAGK mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NAGK mRNA	PMID:25181051
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312859	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of NAGK protein	PMID:37567409
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312859	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of NAGK mRNA	PMID:19244175
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of NAGK mRNA	PMID:17602206
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1312860	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of NAGK protein	PMID:35362542
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NAGK protein]	PMID:35362542
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAGK mRNA	PMID:21266533
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312860	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAGK mRNA	PMID:17361019
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1312859	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to NAGK protein	PMID:32991956
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of NAGK protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of NAGK protein	PMID:38598786
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAGK mRNA]	PMID:39241906
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312859	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NAGK mRNA	PMID:37042841
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of NAGK mRNA	PMID:25380136
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312860	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NAGK mRNA	PMID:28558994
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20171010	CTD	MESH:C023036	PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of NAGK mRNA]	PMID:28558994
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312859	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NAGK mRNA	PMID:19376846
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of NAGK mRNA	PMID:25380136
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1312859	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NAGK mRNA	PMID:19244175
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312860	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NAGK mRNA	PMID:28558994|PMID:40194260
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312859	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NAGK mRNA	PMID:40419075
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312860	E	RGD:6480464	20171010	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NAGK mRNA	PMID:28558994
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NAGK mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NAGK mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NAGK mRNA	PMID:36331819
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312859	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NAGK mRNA	PMID:25979313
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NAGK mRNA	PMID:17963808
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312859	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of NAGK mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA	PMID:27188386
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of NAGK mRNA	PMID:41580965
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312859	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of NAGK mRNA	PMID:20106945
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAGK mRNA	PMID:37992649
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312859	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NAGK mRNA	PMID:38832940
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NAGK mRNA	PMID:17562736
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312859	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NAGK mRNA	PMID:22230336
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NAGK mRNA	PMID:40504410
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NAGK mRNA	PMID:22079256
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312860	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of NAGK mRNA	PMID:22334560
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAGK mRNA	PMID:17942748
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NAGK protein]	PMID:35362542
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312860	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of NAGK mRNA	PMID:25620056
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of NAGK mRNA	PMID:24136188
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of NAGK mRNA	PMID:24793618
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312859	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NAGK protein	PMID:32959892
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1312859	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of NAGK mRNA	PMID:28988120
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312860	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of NAGK mRNA	PMID:22776087
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312859	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NAGK protein	PMID:34186270
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312860	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NAGK mRNA	PMID:22206623
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312859	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NAGK mRNA	PMID:22079256
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NAGK mRNA	PMID:22079256
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of NAGK mRNA	PMID:22124623
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312859	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of NAGK mRNA	PMID:22124623
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA	PMID:27188386
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of NAGK mRNA	PMID:19482888
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NAGK mRNA]	PMID:19482888
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1312860	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of NAGK mRNA	PMID:22334560
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312860	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of NAGK mRNA	PMID:22334560
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAGK mRNA]	PMID:39241906
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA	PMID:27188386
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of NAGK mRNA	PMID:19281266
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312859	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of NAGK protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of NAGK protein	PMID:38598786
1305057	Nagk	N-acetylglucosamine kinase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NAGK mRNA	PMID:21346803
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of RAB34 mRNA	PMID:33045310
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312862	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of RAB34 mRNA	PMID:37995155
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312861	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RAB34 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of RAB34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RAB34 mRNA	PMID:32699268|PMID:32845096
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RAB34 mRNA	PMID:36331819
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAB34 mRNA	PMID:39241906
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312862	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RAB34 mRNA	PMID:39298647
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of RAB34 mRNA	PMID:26496021
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAB34 mRNA	PMID:37992649
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAB34 mRNA	PMID:37992649
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312861	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RAB34 protein	PMID:37730182
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of RAB34 mRNA	PMID:22061828
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of RAB34 protein	PMID:34915118
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312861	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of RAB34 mRNA	PMID:23369406
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312861	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RAB34 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of RAB34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RAB34 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RAB34 mRNA	PMID:32699268|PMID:32845096
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312862	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RAB34 mRNA	PMID:31919559
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RAB34 mRNA	PMID:22206623
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312861	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RAB34 gene	PMID:25304211
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RAB34 mRNA	PMID:31881176
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312862	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAB34 mRNA	PMID:21570461
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAB34 mRNA	PMID:34747641
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAB34 mRNA	PMID:23238561
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAB34 mRNA	PMID:23238561|PMID:33387578
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312861	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RAB34 mRNA	PMID:33212167
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RAB34 mRNA	PMID:28959563
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAB34 mRNA	PMID:37992649
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312861	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAB34 mRNA	PMID:38568856
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312862	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RAB34 mRNA	PMID:22228805
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of RAB34 mRNA	PMID:24136188
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of RAB34 mRNA	PMID:20542052
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of RAB34 mRNA	PMID:25729387
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RAB34 mRNA	PMID:25729387
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of RAB34 mRNA	PMID:24136188
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312862	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RAB34 gene	PMID:35295148
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RAB34 mRNA	PMID:34492290
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RAB34 mRNA	PMID:12832660
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312862	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of RAB34 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:32888	gamma-hexachlorocyclohexane	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane affects the expression of RAB34 mRNA	PMID:17785943
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RAB34 mRNA	PMID:25181051
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RAB34 mRNA	PMID:34947998
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312862	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RAB34 mRNA	PMID:33221593
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAB34 gene	PMID:28505145
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of RAB34 mRNA	PMID:26496021
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312861	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RAB34 mRNA	PMID:25979313
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:34107	1-nitropyrene	decreases expression	ISO	RGD:1312861	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of RAB34 mRNA	PMID:19041380
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312862	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RAB34 mRNA	PMID:39298647
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RAB34 mRNA	PMID:21266533
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312862	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RAB34 mRNA	PMID:24535843
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312861	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAB34 mRNA	PMID:37042841
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312861	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RAB34 mRNA	PMID:38568856
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312861	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RAB34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RAB34 mRNA	PMID:32699268
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RAB34 mRNA	PMID:36331819
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312861	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAB34 mRNA	PMID:25979313
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312861	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of RAB34 mRNA	PMID:23179753|PMID:24935251
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312861	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RAB34 gene	PMID:29154799
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAB34 mRNA	PMID:37992649
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1312862	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of RAB34 mRNA	PMID:12929121
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of RAB34 mRNA	PMID:24136188
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1312862	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of RAB34 mRNA	PMID:12929121
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312862	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAB34 mRNA	PMID:17562736
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RAB34 mRNA	PMID:33387578
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312861	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RAB34 gene	PMID:25304211
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312862	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RAB34 mRNA	PMID:25620056
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RAB34 mRNA	PMID:24136188
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312861	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RAB34 protein	PMID:32959892
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of RAB34 mRNA	PMID:25729387
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RAB34 mRNA	PMID:25729387
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of RAB34 mRNA	PMID:24136188
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RAB34 mRNA	PMID:22206623
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312861	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RAB34 protein	PMID:37664457
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RAB34 mRNA	PMID:24136188
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:77850	toxaphene	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014112	Toxaphene results in decreased expression of RAB34 mRNA	PMID:23153324
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of RAB34 mRNA	PMID:31388691
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:82388	p-anisidine	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20141111	CTD	MESH:C013813	4-anisidine results in decreased expression of RAB34 mRNA	PMID:12929121
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312862	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RAB34 mRNA	PMID:39847705
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312861	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RAB34 protein	PMID:37664457
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RAB34 mRNA	PMID:19281266
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312861	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RAB34 mRNA	PMID:38568856
1305058	Rab34	RAB34, member RAS oncogene family	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of RAB34 mRNA	PMID:23034163
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of RBM5 mRNA	PMID:21551480
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312864	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RBM5 mRNA	PMID:33045310
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1312863	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of RBM5 mRNA	PMID:31016361
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RBM5 mRNA	PMID:36331819
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312864	E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol affects the expression of RBM5 mRNA	PMID:26730594
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312864	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RBM5 mRNA	PMID:30319688
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RBM5 mRNA	PMID:39241906
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RBM5 mRNA]	PMID:39241906
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RBM5 mRNA	PMID:39298647
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	ISO	RGD:1312863	E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of RBM5 mRNA	PMID:20196124
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312863	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RBM5 protein	PMID:37730182
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RBM5 mRNA	PMID:22061828|PMID:33387578
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBM5 mRNA	PMID:36331819
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RBM5 mRNA	PMID:37325564
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312863	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RBM5 mRNA	PMID:19549813
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312864	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RBM5 mRNA	PMID:19770486
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312864	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of RBM5 mRNA	PMID:25629700
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312863	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RBM5 gene	PMID:25304211
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBM5 mRNA	PMID:40504410
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1312863	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RBM5 mRNA	PMID:19244175
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312863	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RBM5 protein	PMID:35688186
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RBM5 mRNA	PMID:25905778
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RBM5 protein	PMID:25505154
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312863	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RBM5 mRNA	PMID:23557933
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312863	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of RBM5 mRNA	PMID:28903495
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RBM5 mRNA	PMID:30912803
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312864	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBM5 mRNA	PMID:21570461|PMID:26377647
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RBM5 mRNA	PMID:34747641
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20131210	CTD	MESH:D013749	RBM5 promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]	PMID:23997114
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312863	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of RBM5 mRNA	PMID:23649840
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RBM5 mRNA	PMID:30556269
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312864	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of RBM5 protein	PMID:28918527
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312863	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RBM5 mRNA	PMID:29803840
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312864	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of RBM5 mRNA	PMID:25896364
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBM5 mRNA	PMID:40504410
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312864	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RBM5 mRNA	PMID:20504355|PMID:22228805
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312863	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBM5 promoter	PMID:27901495
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RBM5 mRNA	PMID:30556269
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312863	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of RBM5 mRNA	PMID:26014281
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RBM5 mRNA	PMID:30047161
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RBM5 mRNA	PMID:23557971
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312864	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBM5 gene	PMID:35295148
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312864	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of RBM5 mRNA	PMID:18648102
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RBM5 mRNA	PMID:18445702
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RBM5 mRNA	PMID:25181051|PMID:30816183
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RBM5 mRNA	PMID:32156529
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312863	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RBM5 gene	PMID:31601247
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RBM5 mRNA	PMID:27571134
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312864	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of RBM5 mRNA	PMID:40036665
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312863	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RBM5 mRNA	PMID:19244175
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:3374	capsaicin	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in increased expression of RBM5 mRNA	PMID:20349343
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312863	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of RBM5 protein	PMID:31945527
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RBM5 mRNA	PMID:38685157
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RBM5 mRNA	PMID:20350560|PMID:37019170
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RBM5 mRNA	PMID:21266533
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of RBM5 mRNA	PMID:34813904
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RBM5 mRNA]	PMID:39241906
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312863	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RBM5 mRNA	PMID:37042841
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of RBM5 mRNA	PMID:30723492
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RBM5 mRNA	PMID:37325564
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312863	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RBM5 mRNA	PMID:24449571
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1312863	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RBM5 mRNA	PMID:19244175
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBM5 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RBM5 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RBM5 mRNA	PMID:36331819
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of RBM5 mRNA	PMID:23125180
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312863	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RBM5 mRNA	PMID:25979313
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312863	E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in decreased expression of RBM5 mRNA	PMID:22083351|PMID:23179753|PMID:29154799
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of RBM5 mRNA	PMID:24136188
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312863	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of RBM5 mRNA	PMID:22083351
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312863	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RBM5 mRNA	PMID:28542535
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of RBM5 mRNA	PMID:21346803
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RBM5 mRNA	PMID:33387578
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1312863	E	RGD:6480464	20120412	CTD	MESH:D005472	RBM5 protein affects the susceptibility to Fluorouracil	PMID:15548681
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1312863	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RBM5 mRNA	PMID:29432896
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312863	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RBM5 gene	PMID:25304211
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBM5 mRNA	PMID:40504410
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of RBM5 mRNA	PMID:17557909
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RBM5 mRNA; Nanotubes, Carbon results in decreased expression of RBM5 mRNA	PMID:25554681
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RBM5 mRNA	PMID:30047161
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of RBM5 mRNA	PMID:24136188
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:53074	diphenylcyclopropenone	decreases expression	ISO	RGD:1312863	E	RGD:6480464	20141223	CTD	MESH:C029402	diphenylcyclopropenone results in decreased expression of RBM5 mRNA	PMID:25236440
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312863	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of RBM5 protein	PMID:23718831
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312863	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RBM5 protein	PMID:32959892
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RBM5 mRNA	PMID:21641980|PMID:26378955
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of RBM5 mRNA	PMID:24136188
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:6809	methamphetamine	decreases methylation	ISO	RGD:1312864	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased methylation of RBM5 promoter	PMID:26307267
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312864	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of RBM5 mRNA	PMID:26307267
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RBM5 mRNA	PMID:22206623
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of RBM5 mRNA	PMID:23091169
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of RBM5 mRNA	PMID:21795629|PMID:39847705
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312864	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RBM5 mRNA	PMID:21795629
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RBM5 mRNA	PMID:30047161
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RBM5 mRNA]	PMID:39241906
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312863	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of RBM5 mRNA	PMID:26014281
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RBM5 mRNA	PMID:19281266
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312863	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of RBM5 mRNA	PMID:29301935
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312864	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of RBM5 protein	PMID:24648495
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RBM5 mRNA	PMID:19015723
1305059	Rbm5	RNA binding motif protein 5	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of RBM5 mRNA	PMID:20566332|PMID:23034163
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312865	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CTNNA2 mRNA	PMID:26272509
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA	PMID:27188386
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein]	PMID:38195004
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTNNA2 mRNA	PMID:20938992
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin affects the expression of CTNNA2 mRNA	PMID:16211290
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of CTNNA2 mRNA	PMID:30207508
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312865	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of CTNNA2 mRNA	PMID:29581250
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312865	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of CTNNA2 mRNA	PMID:30510588
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1619285	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CTNNA2 mRNA	PMID:19484750
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of CTNNA2 mRNA	PMID:20660070
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CTNNA2 mRNA	PMID:33387578
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTNNA2 mRNA	PMID:20938992
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of CTNNA2 gene	PMID:30521419
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:16899	D-mannitol	decreases expression	ISO	RGD:1619285	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in decreased expression of CTNNA2 mRNA	PMID:25270620
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of CTNNA2 mRNA	PMID:20660070
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312865	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of CTNNA2 mRNA	PMID:21592394
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CTNNA2 mRNA	PMID:21592394
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312865	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CTNNA2 mRNA	PMID:31163220
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312865	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CTNNA2 protein	PMID:37730182
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312865	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CTNNA2 mRNA	PMID:21592394
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CTNNA2 mRNA	PMID:21592394
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein	PMID:38195004
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312865	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CTNNA2 gene	PMID:27153756
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CTNNA2 mRNA	PMID:15674843
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of CTNNA2 mRNA	PMID:12763052
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CTNNA2 mRNA	PMID:27106289
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CTNNA2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of CTNNA2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNNA2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CTNNA2 protein	PMID:38598786
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTNNA2 mRNA	PMID:20938992
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA	PMID:27188386
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312865	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CTNNA2 protein	PMID:35688186
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of CTNNA2 gene	PMID:35440735
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CTNNA2 mRNA	PMID:22298810
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619285	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CTNNA2 mRNA	PMID:21570461
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNA2 mRNA	PMID:17942748
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312865	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of CTNNA2 protein	PMID:39603559
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312865	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CTNNA2 mRNA	PMID:28001369
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312865	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of CTNNA2 gene	PMID:28589171
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312865	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CTNNA2 mRNA	PMID:38568856
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312865	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CTNNA2 5' UTR; Benzo(a)pyrene affects the methylation of CTNNA2 promoter	PMID:27901495
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312865	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CTNNA2 exon	PMID:27901495
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312865	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CTNNA2 gene	PMID:25435355
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20251007	CTD	MESH:C006632	[Arsenic Trioxide co-treated with apatinib] results in increased expression of CTNNA2 mRNA	PMID:39223679
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of CTNNA2 gene; [bisphenol F co-treated with Fulvestrant] results in decreased methylation of CTNNA2 gene	PMID:31601247
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1619285	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CTNNA2 promoter	PMID:35295148
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1619285	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CTNNA2 gene	PMID:35295148
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CTNNA2 mRNA	PMID:18648102
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CTNNA2 mRNA	PMID:25181051
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312865	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CTNNA2 gene	PMID:31601247
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312865	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CTNNA2 protein	PMID:31675489
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1619285	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CTNNA2 mRNA	PMID:32156529
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of CTNNA2 mRNA	PMID:38750585
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of CTNNA2 gene	PMID:31601247
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1312865	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CTNNA2 protein	PMID:31675489
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312865	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of CTNNA2 gene	PMID:31601247
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of CTNNA2 gene	PMID:31601247
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1619285	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CTNNA2 intron	PMID:28392331
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CTNNA2 mRNA	PMID:21266533
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1312865	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to CTNNA2 protein	PMID:32991956
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNNA2 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CTNNA2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of CTNNA2 protein	PMID:38598786
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312865	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CTNNA2 protein	PMID:24527689
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CTNNA2 mRNA	PMID:30917596
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein	PMID:38195004
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CTNNA2 mRNA	PMID:25539665
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1619285	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CTNNA2 mRNA	PMID:40194260
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312865	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CTNNA2 mRNA	PMID:25979313
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312865	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CTNNA2 gene	PMID:29154799
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312865	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of CTNNA2 mRNA	PMID:23179753
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312865	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CTNNA2 protein	PMID:38832940
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312865	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTNNA2 mRNA	PMID:22230336
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1312865	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of CTNNA2 mRNA	PMID:31675489
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CTNNA2 mRNA	PMID:29391264
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	EXP		E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of CTNNA2 gene	PMID:37958445
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CTNNA2 mRNA	PMID:17942748
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNA2 mRNA	PMID:17942748
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20251007	CTD	MESH:C032793	[Arsenic Trioxide co-treated with apatinib] results in increased expression of CTNNA2 mRNA	PMID:39223679
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1619285	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CTNNA2 mRNA	PMID:38701926
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1619285	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of CTNNA2 mRNA	PMID:36851058
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1312865	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CTNNA2 mRNA	PMID:22079614
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CTNNA2 gene	PMID:35440735
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:756894	tak-243	affects sumoylation	ISO	RGD:1312865	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of CTNNA2 protein	PMID:31285264
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA	PMID:27188386
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CTNNA2 gene]	PMID:28238834
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1312865	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CTNNA2 protein	PMID:31675489
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA	PMID:27188386
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CTNNA2 mRNA	PMID:19281266
1305060	Ctnna2	catenin alpha 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312865	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNNA2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNNA2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CTNNA2 protein	PMID:38598786
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of TPPP3 mRNA	PMID:25152437
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of TPPP3 mRNA	PMID:21551480
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312867	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TPPP3 mRNA	PMID:33045310
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1604620	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TPPP3 mRNA	PMID:33167477
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TPPP3 mRNA	PMID:30529165
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of TPPP3 mRNA	PMID:36841081
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312867	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of TPPP3 mRNA	PMID:40945087
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312867	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TPPP3 mRNA	PMID:39241906
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of TPPP3 mRNA	PMID:30510588
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of TPPP3 mRNA	PMID:32145629
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312867	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of TPPP3 mRNA	PMID:19484750
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312867	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of TPPP3 mRNA	PMID:33711761
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:16573	carbonyl sulfide	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C010063	carbonyl sulfide results in decreased expression of TPPP3 mRNA	PMID:19395590
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TPPP3 mRNA	PMID:33387578
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312867	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of TPPP3 mRNA	PMID:22238285
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TPPP3 mRNA	PMID:37992649
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TPPP3 mRNA	PMID:37992649
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TPPP3 mRNA	PMID:26577399|PMID:27523638
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TPPP3 mRNA	PMID:36331819
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D007501	Iron deficiency results in increased expression of TPPP3 mRNA	PMID:16629162
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TPPP3 mRNA	PMID:37325564
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TPPP3 mRNA	PMID:19480007
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20250401	CTD	MESH:D015127	[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of TPPP3 protein	PMID:39910959
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312867	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of TPPP3 mRNA	PMID:31626304
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TPPP3 mRNA	PMID:34911549
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TPPP3 mRNA	PMID:30779732
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604620	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TPPP3 gene	PMID:25304211
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20260203	CTD	MESH:D012643	Selenium results in decreased expression of TPPP3 protein	PMID:37834424
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TPPP3 mRNA	PMID:27392435
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1604620	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TPPP3 mRNA	PMID:27392435
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312867	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TPPP3 mRNA	PMID:21570461
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TPPP3 mRNA	PMID:34747641
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TPPP3 promoter]	PMID:19654925
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TPPP3 mRNA	PMID:28374803
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312867	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TPPP3 protein	PMID:28918527
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TPPP3 mRNA	PMID:37992649
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312867	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TPPP3 mRNA	PMID:37682722
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TPPP3 mRNA; sodium arsenite results in decreased expression of TPPP3 protein	PMID:34032870|PMID:39571964|PMID:39719251
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604620	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TPPP3 mRNA	PMID:38568856
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604620	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TPPP3 5' UTR; Benzo(a)pyrene affects the methylation of TPPP3 promoter	PMID:27901495
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TPPP3 mRNA	PMID:21871943
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TPPP3 mRNA	PMID:25895662
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312867	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TPPP3 mRNA	PMID:39716349
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:3139	bleomycin A2	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001761	Bleomycin results in decreased expression of TPPP3 protein	PMID:25933445
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312867	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TPPP3 promoter	PMID:35295148
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1604620	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TPPP3 mRNA	PMID:19710929
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of TPPP3 mRNA	PMID:32145629
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1604620	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of TPPP3 mRNA	PMID:20170705
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of TPPP3 mRNA	PMID:32145629
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of TPPP3 protein	PMID:37664457
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TPPP3 mRNA	PMID:25181051
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312867	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TPPP3 mRNA	PMID:30951980
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312867	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TPPP3 mRNA	PMID:30951980
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312867	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TPPP3 mRNA	PMID:17361019|PMID:21266533
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604620	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TPPP3 mRNA	PMID:37042841
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TPPP3 mRNA	PMID:35163327
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TPPP3 mRNA	PMID:38382870
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TPPP3 mRNA	PMID:37325564
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TPPP3 mRNA	PMID:35163327
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TPPP3 mRNA	PMID:27387713
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20260203	CTD	MESH:D012643	Selenium results in decreased expression of TPPP3 protein	PMID:37834424
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312867	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TPPP3 mRNA	PMID:40194260
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312867	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of TPPP3 mRNA	PMID:39529242
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TPPP3 mRNA	PMID:36331819
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312867	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of TPPP3 mRNA	PMID:21427059
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of TPPP3 mRNA	PMID:41580965
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1604620	E	RGD:6480464	20210608	CTD	MESH:D016572	Cyclosporine results in increased expression of TPPP3 mRNA	PMID:33631201
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TPPP3 mRNA	PMID:21658437
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312867	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TPPP3 mRNA	PMID:28973697
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312867	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TPPP3 mRNA	PMID:37992649
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of TPPP3 mRNA	PMID:33512557
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of TPPP3 mRNA	PMID:30723492
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of TPPP3 mRNA	PMID:26690555
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604620	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TPPP3 gene	PMID:25304211
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312867	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TPPP3 mRNA	PMID:39716349
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312867	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TPPP3 mRNA; Nanotubes, Carbon results in decreased expression of TPPP3 mRNA	PMID:25554681
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of TPPP3 mRNA	PMID:23962444
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312867	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TPPP3 mRNA	PMID:38701926
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1604620	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TPPP3 mRNA	PMID:24810058
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1312867	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of TPPP3 mRNA	PMID:36907384
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1312867	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of TPPP3 mRNA	PMID:22078008
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312867	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TPPP3 mRNA	PMID:22206623
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1604620	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of TPPP3 mRNA	PMID:32858204
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312867	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TPPP3 mRNA	PMID:38648751
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:C010902	[Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of TPPP3 mRNA	PMID:32207525
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of TPPP3 mRNA	PMID:16629162
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312867	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TPPP3 mRNA	PMID:39847705
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TPPP3 mRNA	PMID:24780913|PMID:25825206
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TPPP3 mRNA	PMID:19281266
1305061	Tppp3	tubulin polymerization-promoting protein family member 3	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of TPPP3 mRNA	PMID:19015723
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:132098	methoxyacetic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of RWDD2B mRNA	PMID:20864626
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312868	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RWDD2B mRNA	PMID:21632981
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312869	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RWDD2B mRNA	PMID:39241906
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312868	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RWDD2B mRNA	PMID:37042841
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312868	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RWDD2B mRNA	PMID:33359661
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312869	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RWDD2B mRNA	PMID:34319233
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312868	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RWDD2B protein	PMID:37730182
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RWDD2B mRNA	PMID:28818685
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RWDD2B mRNA	PMID:19549813
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312869	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RWDD2B mRNA	PMID:25629700
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312869	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RWDD2B mRNA	PMID:22206623
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312868	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RWDD2B mRNA	PMID:39836092
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of RWDD2B mRNA	PMID:20864626
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RWDD2B mRNA	PMID:31881176
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312868	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RWDD2B mRNA	PMID:27392435
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312868	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RWDD2B mRNA	PMID:27392435
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312869	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RWDD2B mRNA	PMID:21570461
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RWDD2B mRNA	PMID:32109520
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312869	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RWDD2B mRNA	PMID:18796159
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312869	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RWDD2B mRNA	PMID:16214954
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of RWDD2B mRNA	PMID:19013527
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RWDD2B mRNA	PMID:20864626
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RWDD2B mRNA	PMID:30851411
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RWDD2B mRNA	PMID:29803840
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RWDD2B mRNA	PMID:38568856
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312868	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RWDD2B mRNA	PMID:39836092
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312868	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RWDD2B mRNA	PMID:21632981
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312868	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RWDD2B promoter	PMID:27901495
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312868	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RWDD2B mRNA]	PMID:32406909
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RWDD2B mRNA	PMID:25351596
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312869	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RWDD2B mRNA	PMID:17426115
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RWDD2B mRNA	PMID:25181051
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RWDD2B mRNA	PMID:30816183|PMID:32528016
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of RWDD2B mRNA	PMID:32145629
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RWDD2B mRNA	PMID:17602206
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RWDD2B mRNA	PMID:17602206
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312868	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RWDD2B mRNA	PMID:37042841
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of RWDD2B promoter	PMID:22457795
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RWDD2B mRNA	PMID:19320972
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312868	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RWDD2B mRNA	PMID:24449571
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:38845	profenofos	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C024273	profenofos results in increased expression of RWDD2B mRNA	PMID:17569032
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of RWDD2B mRNA	PMID:29154799
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312869	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of RWDD2B mRNA	PMID:21427059
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RWDD2B mRNA	PMID:25562108
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RWDD2B mRNA	PMID:21658437
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RWDD2B mRNA	PMID:38832940
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312869	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RWDD2B mRNA	PMID:17562736
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RWDD2B mRNA	PMID:33387578
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312868	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RWDD2B mRNA	PMID:39836092
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312869	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RWDD2B mRNA; Nanotubes, Carbon results in increased expression of RWDD2B mRNA	PMID:25554681
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312869	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RWDD2B mRNA	PMID:19042947
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312869	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RWDD2B mRNA	PMID:22206623
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312869	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RWDD2B mRNA	PMID:22206623
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RWDD2B mRNA	PMID:30851411
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:82036	prothioconazole	increases expression	ISO	RGD:1312868	E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of RWDD2B mRNA	PMID:35048155
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:88522	Monobutylphthalate	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of RWDD2B mRNA	PMID:20864626
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of RWDD2B mRNA	PMID:31734321
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RWDD2B mRNA	PMID:19281266
1305062	Rwdd2b	RWD domain containing 2B	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312868	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RWDD2B mRNA	PMID:29301935
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1348691	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RAB11FIP4 mRNA	PMID:26272509|PMID:27188386
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA	PMID:27188386
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550606	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RAB11FIP4 mRNA	PMID:33045310
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of RAB11FIP4 mRNA	PMID:25812627
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1550606	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of RAB11FIP4 mRNA	PMID:37995155
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RAB11FIP4 mRNA]	PMID:31150632
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1348691	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of RAB11FIP4 mRNA	PMID:31016361
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550606	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RAB11FIP4 mRNA	PMID:20188158
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of RAB11FIP4 mRNA	PMID:20488242
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1348691	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RAB11FIP4 mRNA	PMID:26079696
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550606	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of RAB11FIP4 mRNA	PMID:30319688
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1348691	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RAB11FIP4 mRNA	PMID:20044591
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RAB11FIP4 mRNA	PMID:21632981
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAB11FIP4 mRNA	PMID:35811015
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RAB11FIP4 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RAB11FIP4 mRNA	PMID:35811015
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1348691	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of RAB11FIP4 mRNA	PMID:30510588
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550606	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RAB11FIP4 mRNA	PMID:39298647
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RAB11FIP4 gene	PMID:27618143
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348691	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RAB11FIP4 mRNA	PMID:37042841
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1348691	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of RAB11FIP4 mRNA	PMID:19162166
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1550606	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RAB11FIP4 mRNA	PMID:39922521
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1550606	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RAB11FIP4 mRNA	PMID:39922521
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RAB11FIP4 mRNA	PMID:36139627
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RAB11FIP4 mRNA	PMID:33387578
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RAB11FIP4 mRNA	PMID:28818685
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RAB11FIP4 mRNA	PMID:19549813
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RAB11FIP4 mRNA	PMID:21641981
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550606	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RAB11FIP4 mRNA	PMID:34911549
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RAB11FIP4 mRNA	PMID:30779732
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1348691	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of RAB11FIP4 mRNA	PMID:15672453
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RAB11FIP4 mRNA	PMID:31150632
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RAB11FIP4 mRNA]	PMID:31150632
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550606	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of RAB11FIP4 mRNA	PMID:28189721|PMID:28960355
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1348691	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RAB11FIP4 mRNA	PMID:28903495
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1550606	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of RAB11FIP4 mRNA	PMID:18930951
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550606	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAB11FIP4 mRNA	PMID:26377647
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550606	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAB11FIP4 mRNA	PMID:28922406
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RAB11FIP4 mRNA	PMID:30851411
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1348691	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of RAB11FIP4 mRNA	PMID:20044591
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of RAB11FIP4 mRNA	PMID:22623647
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550606	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAB11FIP4 mRNA	PMID:37682722
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1348691	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of RAB11FIP4 mRNA	PMID:39719251
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550606	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of RAB11FIP4 mRNA	PMID:39515575
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348691	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RAB11FIP4 intron; Benzo(a)pyrene affects the methylation of RAB11FIP4 promoter	PMID:27901495|PMID:30157460
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RAB11FIP4 mRNA	PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:26238291
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RAB11FIP4 mRNA	PMID:25895662
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RAB11FIP4 mRNA	PMID:26238291
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RAB11FIP4 gene	PMID:31601247
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of RAB11FIP4 mRNA	PMID:25729387
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RAB11FIP4 mRNA	PMID:30047161
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550606	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RAB11FIP4 gene; titanium dioxide results in decreased methylation of RAB11FIP4 promoter	PMID:35295148
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RAB11FIP4 mRNA	PMID:34492290
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RAB11FIP4 mRNA	PMID:25181051
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1348691	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RAB11FIP4 mRNA	PMID:30903817
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550606	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in decreased expression of RAB11FIP4 mRNA	PMID:21932408
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1348691	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RAB11FIP4 gene	PMID:31601247
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of RAB11FIP4 mRNA	PMID:30816183
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RAB11FIP4 gene	PMID:31601247
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550606	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of RAB11FIP4 mRNA	PMID:26682919
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1348691	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of RAB11FIP4 intron	PMID:30157460
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550606	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RAB11FIP4 mRNA	PMID:38685157
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1550606	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RAB11FIP4 mRNA	PMID:28392331
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550606	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RAB11FIP4 mRNA	PMID:17361019|PMID:21266533
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348691	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAB11FIP4 mRNA	PMID:37042841
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RAB11FIP4 mRNA	PMID:38568856
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RAB11FIP4 mRNA	PMID:25812627
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RAB11FIP4 mRNA	PMID:24449571
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:3764	clotrimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of RAB11FIP4 mRNA	PMID:30047161
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RAB11FIP4 mRNA	PMID:25812627
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RAB11FIP4 mRNA	PMID:31533062
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RAB11FIP4 mRNA	PMID:25812627
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1348691	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAB11FIP4 mRNA	PMID:25979313
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1348691	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of RAB11FIP4 mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1348691	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RAB11FIP4 gene	PMID:29154799
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA	PMID:27188386
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of RAB11FIP4 mRNA	PMID:38685447
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RAB11FIP4 mRNA	PMID:30047161
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RAB11FIP4 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550606	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RAB11FIP4 mRNA	PMID:28973697
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1550606	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RAB11FIP4 mRNA	PMID:39922521
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1348691	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of RAB11FIP4 mRNA	PMID:24935251|PMID:26272509
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA	PMID:27188386
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550606	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAB11FIP4 mRNA	PMID:17562736
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RAB11FIP4 mRNA	PMID:33387578
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RAB11FIP4 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RAB11FIP4 mRNA	PMID:35811015
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550606	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RAB11FIP4 mRNA	PMID:25620056
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RAB11FIP4 mRNA	PMID:30047161
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1348691	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RAB11FIP4 mRNA	PMID:24810058
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1348691	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of RAB11FIP4 intron	PMID:30157460
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RAB11FIP4 gene	PMID:35440735
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RAB11FIP4 mRNA	PMID:36139627
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1348691	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RAB11FIP4 mRNA	PMID:30851411
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA	PMID:27188386
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RAB11FIP4 gene]	PMID:28238834
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1550606	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of RAB11FIP4 mRNA	PMID:26655953
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1348691	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of RAB11FIP4 mRNA	PMID:26079696
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RAB11FIP4 mRNA	PMID:30047161
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1348691	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of RAB11FIP4 mRNA	PMID:26272509
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA	PMID:27188386
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1348691	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB11FIP4 mRNA	PMID:27188386
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1348691	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of RAB11FIP4 mRNA	PMID:29301935
1305063	Rab11fip4	RAB11 family interacting protein 4	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550606	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of RAB11FIP4 mRNA	PMID:35537566
1305064	Scrn3	secernin 3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SCRN3 mRNA	PMID:38218311
1305064	Scrn3	secernin 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312871	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SCRN3 mRNA	PMID:23724009
1305064	Scrn3	secernin 3	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SCRN3 gene	PMID:28931070
1305064	Scrn3	secernin 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550100	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SCRN3 mRNA	PMID:30319688
1305064	Scrn3	secernin 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SCRN3 mRNA	PMID:39241906
1305064	Scrn3	secernin 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SCRN3 mRNA	PMID:32145629
1305064	Scrn3	secernin 3	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312871	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SCRN3 mRNA	PMID:23649840
1305064	Scrn3	secernin 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SCRN3 mRNA	PMID:33359661
1305064	Scrn3	secernin 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SCRN3 mRNA	PMID:33387578
1305064	Scrn3	secernin 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550100	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SCRN3 mRNA	PMID:36331819
1305064	Scrn3	secernin 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312871	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SCRN3 mRNA	PMID:39836092
1305064	Scrn3	secernin 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550100	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SCRN3 mRNA	PMID:37236586
1305064	Scrn3	secernin 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312871	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SCRN3 mRNA	PMID:23649840
1305064	Scrn3	secernin 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550100	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SCRN3 mRNA	PMID:27106289
1305064	Scrn3	secernin 3	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550100	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SCRN3 mRNA	PMID:17484886
1305064	Scrn3	secernin 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SCRN3 mRNA	PMID:31919559
1305064	Scrn3	secernin 3	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1550100	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of SCRN3 mRNA	PMID:18930951
1305064	Scrn3	secernin 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SCRN3 mRNA	PMID:28001369
1305064	Scrn3	secernin 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312871	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SCRN3 protein	PMID:33212167
1305064	Scrn3	secernin 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SCRN3 mRNA	PMID:29803840
1305064	Scrn3	secernin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCRN3 mRNA	PMID:32234424
1305064	Scrn3	secernin 3	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of SCRN3 protein	PMID:40770094
1305064	Scrn3	secernin 3	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of SCRN3 protein	PMID:40770094
1305064	Scrn3	secernin 3	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of SCRN3 mRNA	PMID:34408198
1305064	Scrn3	secernin 3	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of SCRN3 mRNA	PMID:22641619
1305064	Scrn3	secernin 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SCRN3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305064	Scrn3	secernin 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of SCRN3 mRNA	PMID:35598803
1305064	Scrn3	secernin 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SCRN3 mRNA	PMID:32145629
1305064	Scrn3	secernin 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550100	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of SCRN3 mRNA	PMID:25594700|PMID:40036665
1305064	Scrn3	secernin 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550100	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SCRN3 mRNA	PMID:39298647
1305064	Scrn3	secernin 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SCRN3 mRNA	PMID:21266533
1305064	Scrn3	secernin 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312871	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SCRN3 mRNA	PMID:39836092
1305064	Scrn3	secernin 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of SCRN3 mRNA	PMID:30723492
1305064	Scrn3	secernin 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SCRN3 mRNA	PMID:24982889
1305064	Scrn3	secernin 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550100	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SCRN3 mRNA	PMID:37236586
1305064	Scrn3	secernin 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312871	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SCRN3 mRNA	PMID:24449571
1305064	Scrn3	secernin 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550100	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SCRN3 mRNA	PMID:36331819
1305064	Scrn3	secernin 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SCRN3 mRNA	PMID:19770486
1305064	Scrn3	secernin 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SCRN3 mRNA	PMID:28973697
1305064	Scrn3	secernin 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SCRN3 mRNA	PMID:38832940
1305064	Scrn3	secernin 3	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312871	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SCRN3 mRNA	PMID:27188386
1305064	Scrn3	secernin 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SCRN3 mRNA	PMID:26272509
1305064	Scrn3	secernin 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550100	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SCRN3 mRNA	PMID:17562736
1305064	Scrn3	secernin 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SCRN3 mRNA	PMID:21420995|PMID:29067470
1305064	Scrn3	secernin 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312871	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SCRN3 mRNA	PMID:22079256
1305064	Scrn3	secernin 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SCRN3 mRNA; Nanotubes, Carbon results in decreased expression of SCRN3 mRNA	PMID:25554681
1305064	Scrn3	secernin 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550100	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SCRN3 mRNA; Nanotubes, Carbon results in increased expression of SCRN3 mRNA	PMID:25620056
1305064	Scrn3	secernin 3	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of SCRN3 mRNA	PMID:23962444
1305064	Scrn3	secernin 3	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1312871	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SCRN3 mRNA	PMID:26705709
1305064	Scrn3	secernin 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312871	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SCRN3 mRNA	PMID:39836092
1305064	Scrn3	secernin 3	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1550100	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of SCRN3 mRNA	PMID:19812364
1305064	Scrn3	secernin 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SCRN3 mRNA	PMID:22206623
1305064	Scrn3	secernin 3	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SCRN3 mRNA	PMID:22079256
1305064	Scrn3	secernin 3	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312871	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SCRN3 mRNA	PMID:22079256
1305064	Scrn3	secernin 3	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SCRN3 mRNA	PMID:26079696
1305064	Scrn3	secernin 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550100	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SCRN3 mRNA	PMID:39847705
1305064	Scrn3	secernin 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SCRN3 mRNA	PMID:38568856
1305064	Scrn3	secernin 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SCRN3 mRNA	PMID:29301935
1305064	Scrn3	secernin 3	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312871	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SCRN3 mRNA	PMID:27188386
1305064	Scrn3	secernin 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SCRN3 mRNA	PMID:21346803
1305064	Scrn3	secernin 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of SCRN3 mRNA	PMID:22570695
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TNFSF18 mRNA	PMID:39241906
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312876	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFSF18 protein	PMID:21951872
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:16412	lipopolysaccharide	increases response to substance	ISO	RGD:1312876	E	RGD:6480464	20161228	CTD	MESH:D008070	TNFSF18 results in increased susceptibility to Lipopolysaccharides	PMID:21951872
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20161228	CTD	MESH:D008070	Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFSF18 protein]; TNFSF18 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; TNFSF18 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:21951872
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TNFSF18 mRNA	PMID:33387578
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of TNFSF18 mRNA	PMID:34673133
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF18 mRNA	PMID:37992649
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF18 mRNA	PMID:37992649
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TNFSF18 mRNA	PMID:33387578
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312875	E	RGD:6480464	20260113	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TNFSF18 mRNA	PMID:40288432
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:25187	p-menthan-3-ol	increases expression	ISO	RGD:1312875	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TNFSF18 mRNA	PMID:26760959
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312875	E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in increased expression of TNFSF18 mRNA	PMID:31476115
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312875	E	RGD:6480464	20191210	CTD	MESH:D010126	[Aripiprazole co-treated with Ozone] results in increased expression of TNFSF18 mRNA	PMID:31476115
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of TNFSF18 mRNA	PMID:27106289
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFSF18 mRNA	PMID:33387578
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312875	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TNFSF18 mRNA	PMID:20971185
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF18 mRNA	PMID:37992649
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312875	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNFSF18 mRNA	PMID:34032870
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312875	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TNFSF18 mRNA	PMID:38568856
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312875	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TNFSF18 mRNA	PMID:20971185
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312875	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TNFSF18 mRNA	PMID:23806026
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312875	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TNFSF18 mRNA	PMID:17530438|PMID:21461292
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:31236	aripiprazole	multiple interactions	ISO	RGD:1312875	E	RGD:6480464	20191210	CTD	MESH:C094645	[Aripiprazole co-treated with Ozone] results in increased expression of TNFSF18 mRNA	PMID:31476115
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TNFSF18 mRNA	PMID:34492290
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in decreased expression of TNFSF18 mRNA	PMID:29552716
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1312876	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of TNFSF18 mRNA	PMID:38531469
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TNFSF18 mRNA	PMID:40194260
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFSF18 protein]	PMID:21951872
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF18 mRNA	PMID:37992649
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312875	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TNFSF18 mRNA	PMID:38832940
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TNFSF18 mRNA	PMID:33387578
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1312875	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of TNFSF18 mRNA	PMID:35811015
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of TNFSF18 mRNA	PMID:35537566
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of TNFSF18 mRNA	PMID:29391264
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TNFSF18 mRNA	PMID:35436446
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312875	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of TNFSF18 mRNA	PMID:24383545
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312875	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TNFSF18 mRNA	PMID:17530438|PMID:21461292
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312876	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TNFSF18 mRNA; Nanotubes, Carbon results in increased expression of TNFSF18 mRNA	PMID:25554681
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TNFSF18 mRNA	PMID:38701926
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:63618	pravastatin	affects expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of TNFSF18 mRNA	PMID:27225895
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:63618	pravastatin	affects expression	ISO	RGD:1312876	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of TNFSF18 mRNA	PMID:27225895
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of TNFSF18 mRNA	PMID:27225895
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of TNFSF18 mRNA	PMID:27225895
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1312875	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of TNFSF18 mRNA	PMID:29522793
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:93751	PF-3758309	decreases expression	ISO	RGD:1312875	E	RGD:6480464	20240806	CTD	MESH:C550923	PF 3758309 results in decreased expression of TNFSF18 mRNA	PMID:29048629
1305066	Tnfsf18	TNF superfamily member 18	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TNFSF18 mRNA	PMID:35537566
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of UBE2J1 mRNA	PMID:26272509
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312877	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA	PMID:27188386
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBE2J1 mRNA]	PMID:31150632
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2J1 mRNA	PMID:39752319
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:D014212	Tretinoin results in increased expression of UBE2J1 mRNA	PMID:21934132|PMID:33167477
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of UBE2J1 mRNA	PMID:26079696
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of UBE2J1 mRNA	PMID:22378314
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312877	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of UBE2J1 mRNA	PMID:29581250
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312878	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of UBE2J1 mRNA	PMID:39241906
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312878	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of UBE2J1 mRNA	PMID:39298647
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of UBE2J1 gene	PMID:27618143
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:D005557	Formaldehyde results in decreased expression of UBE2J1 mRNA	PMID:23649840
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2J1 mRNA	PMID:39752319
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20140729	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in increased expression of UBE2J1 mRNA]	PMID:20032058
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of UBE2J1 protein	PMID:31163220
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312877	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of UBE2J1 protein	PMID:37730182
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of UBE2J1 mRNA	PMID:22061828
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of UBE2J1 mRNA	PMID:22061828
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312877	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of UBE2J1 mRNA	PMID:28818685
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D002104	Cadmium results in decreased expression of UBE2J1 mRNA	PMID:24067728
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of UBE2J1 mRNA	PMID:37236586
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of UBE2J1 mRNA	PMID:23649840
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C016517	indole-3-carbinol affects the expression of KRTAP5-2 mRNA	PMID:21396975
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of UBE2J1 mRNA	PMID:23649840
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:D015032	Zinc deficiency results in increased expression of UBE2J1 mRNA	PMID:22171008
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of UBE2J1 mRNA	PMID:33387578
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE2J1 mRNA	PMID:31150632
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312878	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE2J1 mRNA	PMID:31919559
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBE2J1 mRNA]	PMID:31150632
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312878	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UBE2J1 mRNA	PMID:25629700
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312877	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of UBE2J1 mRNA	PMID:27293554
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2J1 mRNA	PMID:22206623
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UBE2J1 mRNA	PMID:40504410
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2J1 mRNA	PMID:21570461
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2J1 mRNA	PMID:17942748
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:C004925	methylmercuric chloride results in increased expression of UBE2J1 mRNA	PMID:20061341
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBE2J1 mRNA	PMID:30851411
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of UBE2J1 mRNA	PMID:26272509
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1312877	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA	PMID:27188386
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of UBE2J1 mRNA	PMID:23649840
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of UBE2J1 mRNA	PMID:15467011
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312878	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of UBE2J1 protein	PMID:28918527
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312877	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of UBE2J1 protein	PMID:35688186
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312877	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UBE2J1 mRNA	PMID:38568856|PMID:39719251
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UBE2J1 mRNA	PMID:40504410
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312877	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of UBE2J1 mRNA	PMID:22378314|PMID:29453283
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBE2J1 mRNA	PMID:22228805
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of UBE2J1 mRNA	PMID:15467011
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:D015032	Zinc deficiency results in increased expression of UBE2J1 mRNA	PMID:22171008
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:31429	colforsin daropate hydrochloride	increases expression	ISO	RGD:1312877	E	RGD:6480464	20141111	CTD	MESH:D005576	Colforsin results in increased expression of UBE2J1 mRNA	PMID:16751804
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of UBE2J1 mRNA	PMID:24136188
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312878	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of UBE2J1 mRNA	PMID:27760801
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UBE2J1 mRNA	PMID:34492290
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312877	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of UBE2J1 mRNA	PMID:30903817
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in decreased expression of KRTAP5-4 mRNA	PMID:25181051
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312878	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2J1 mRNA	PMID:26063408
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2J1 mRNA	PMID:29097150
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312877	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of UBE2J1 mRNA	PMID:25979313
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312878	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UBE2J1 mRNA	PMID:39298647
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UBE2J1 mRNA	PMID:21266533
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE2J1 mRNA	PMID:20061341
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of UBE2J1 mRNA	PMID:37236586
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:C018021	cobaltous chloride results in decreased expression of UBE2J1 mRNA	PMID:19320972
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBE2J1 mRNA	PMID:24386269
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:3750	clofibrate	decreases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D002994	Clofibrate results in decreased expression of UBE2J1 mRNA	PMID:12851107
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:D015741	Metribolone results in increased expression of UBE2J1 mRNA	PMID:16751804
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2J1 mRNA	PMID:19167446
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312877	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBE2J1 mRNA	PMID:25979313
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of UBE2J1 mRNA	PMID:23179753|PMID:27188386
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:D014635	Valproic Acid results in increased expression of UBE2J1 mRNA	PMID:23179753
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312877	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of UBE2J1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D013629	Tamoxifen affects the expression of UBE2J1 mRNA	PMID:17555576
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D003907	Dexamethasone results in increased expression of UBE2J1 mRNA	PMID:20032058
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20140729	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in increased expression of UBE2J1 mRNA]	PMID:20032058
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of UBE2J1 mRNA	PMID:36621641
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20140729	CTD	MESH:D003703	Demecolcine results in decreased expression of UBE2J1 mRNA	PMID:23649840
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of UBE2J1 mRNA	PMID:26272509
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312877	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA	PMID:27188386
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D000082	Acetaminophen affects the expression of UBE2J1 mRNA	PMID:17562736
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1312877	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of UBE2J1 mRNA	PMID:29432896
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UBE2J1 mRNA	PMID:40504410
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of UBE2J1 mRNA	PMID:29391264
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of UBE2J1 mRNA	PMID:17555576
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UBE2J1 mRNA	PMID:29097150
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UBE2J1 mRNA	PMID:17942748
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2J1 mRNA	PMID:17942748
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D008770	Methylnitrosourea results in increased expression of UBE2J1 mRNA	PMID:17412507
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312878	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UBE2J1 mRNA; Nanotubes, Carbon results in increased expression of UBE2J1 mRNA	PMID:25554681
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBE2J1 mRNA	PMID:24136188
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2J1 mRNA	PMID:39752319
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of UBE2J1 mRNA	PMID:31758290
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2J1 mRNA	PMID:22206623
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312877	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBE2J1 mRNA	PMID:30851411
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312877	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA	PMID:27188386
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312877	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2J1 mRNA	PMID:19167446
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312878	E	RGD:6480464	20140729	CTD	MESH:C045950	propiconazole results in increased expression of UBE2J1 mRNA	PMID:21278054
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2J1 mRNA	PMID:39752319
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312877	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA	PMID:27188386
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of UBE2J1 mRNA	PMID:19281266
1305067	Ube2j1	ubiquitin-conjugating enzyme E2, J1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312877	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of UBE2J1 mRNA	PMID:22378314
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1606288	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of YBX2 mRNA	PMID:38218311
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332070	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of YBX2 mRNA	PMID:33045310
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of YBX2 gene	PMID:20938992
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1606288	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of YBX2 mRNA	PMID:26079696
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of YBX2 mRNA	PMID:26496021
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1606288	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of YBX2 mRNA	PMID:38568856
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1332070	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of YBX2 mRNA	PMID:25549359
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of YBX2 mRNA	PMID:33387578
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of YBX2 gene	PMID:20938992
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1332070	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of YBX2 mRNA	PMID:39922521
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]	PMID:37992649
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1332070	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of YBX2 mRNA	PMID:39922521
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]	PMID:37992649
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332070	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of YBX2 mRNA	PMID:33162236|PMID:33754040
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332070	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of YBX2 mRNA	PMID:34319233
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:17750	glycine betaine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in decreased expression of YBX2 mRNA	PMID:26391144
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1606288	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of YBX2 intron	PMID:30157460
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1332070	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of YBX2 protein	PMID:39910959
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20250401	CTD	MESH:D015127	[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of YBX2 protein	PMID:39910959
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of YBX2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of YBX2 mRNA	PMID:34911549
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of YBX2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of YBX2 gene	PMID:20938992|PMID:22206623
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1606288	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of YBX2 promoter	PMID:21291286
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606288	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of YBX2 mRNA	PMID:40512198
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]	PMID:37992649
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1332070	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of YBX2 mRNA	PMID:28189721|PMID:28960355
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1332070	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of YBX2 mRNA	PMID:40618947
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1332070	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of YBX2 mRNA	PMID:18930951
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1606288	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of YBX2 mRNA	PMID:24768652|PMID:25583101
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332070	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of YBX2 mRNA	PMID:21570461
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606288	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of YBX2 protein	PMID:33212167
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]	PMID:37992649
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]	PMID:37992649
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606288	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of YBX2 mRNA	PMID:40512198
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606288	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of YBX2 exon; Benzo(a)pyrene affects the methylation of YBX2 promoter	PMID:27901495
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332070	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of YBX2 mRNA	PMID:20504355
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1606288	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of YBX2 mRNA	PMID:25895662
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1606288	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of YBX2 mRNA	PMID:37690743
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1606288	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of YBX2 gene	PMID:31601247
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332070	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of YBX2 gene; titanium dioxide results in decreased methylation of YBX2 promoter	PMID:35295148
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of YBX2 mRNA	PMID:25181051|PMID:30816183
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of YBX2 mRNA	PMID:26496021
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332070	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of YBX2 mRNA	PMID:30951980|PMID:33297965
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1332070	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of YBX2 exon	PMID:33297965
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:34572	allethrin	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D000487	Allethrins results in decreased expression of YBX2 mRNA	PMID:28181402
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D000487	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of YBX2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of YBX2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of YBX2 mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332070	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of YBX2 mRNA	PMID:37019170
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1332070	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of YBX2 mRNA	PMID:35093514
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:35036	fentin chloride	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in decreased expression of YBX2 mRNA	PMID:37156404
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1606288	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of YBX2 mRNA	PMID:28302478
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606288	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of YBX2 mRNA	PMID:31533062
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:39098	pyrethrins	affects expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins affects the expression of YBX2 mRNA	PMID:34896426
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011722	Pyrethrins results in decreased expression of YBX2 mRNA	PMID:36053783
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1332070	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of YBX2 mRNA	PMID:21427059
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606288	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of YBX2 mRNA	PMID:19101580
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C037304	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of YBX2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of YBX2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of YBX2 mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C017160	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of YBX2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of YBX2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of YBX2 mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332070	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of YBX2 mRNA	PMID:28973697
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1332070	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of YBX2 mRNA	PMID:39922521
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of YBX2 mRNA]	PMID:37992649
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of YBX2 mRNA	PMID:33387578
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1606288	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of YBX2 promoter	PMID:21291286
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606288	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of YBX2 mRNA	PMID:40512198
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of YBX2 mRNA	PMID:29391264
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C017690	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of YBX2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of YBX2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of YBX2 mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332070	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of YBX2 mRNA	PMID:22206623
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332070	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of YBX2 mRNA	PMID:22206623
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	ISO	RGD:1606288	E	RGD:6480464	20220405	CTD	MESH:C045338	YBX2 protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of YBX2 mRNA	PMID:28712647
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1606288	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of YBX2 mRNA	PMID:26079696
1305068	Ybx2	Y box binding protein 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of YBX2 mRNA	PMID:23555832|PMID:30207508
1305069	Smad6	SMAD family member 6	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SMAD6 mRNA	PMID:38218311
1305069	Smad6	SMAD family member 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SMAD6 gene	PMID:20938992
1305069	Smad6	SMAD family member 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of SMAD6 protein	PMID:19058293
1305069	Smad6	SMAD family member 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312880	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SMAD6 mRNA	PMID:21934132
1305069	Smad6	SMAD family member 6	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of SMAD6 mRNA	PMID:30951980
1305069	Smad6	SMAD family member 6	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SMAD6 mRNA	PMID:26476374
1305069	Smad6	SMAD family member 6	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D010100	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of SMAD6 mRNA]	PMID:26476374
1305069	Smad6	SMAD family member 6	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of SMAD6 mRNA	PMID:36841081
1305069	Smad6	SMAD family member 6	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of SMAD6 mRNA]	PMID:26476374
1305069	Smad6	SMAD family member 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides results in increased phosphorylation of SMAD3 protein] promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; IRAK1 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]; MAP2K1 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; MAPK1 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; MAPK3 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; SMAD3 protein modified form promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; TLR4 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; U 0126 inhibits the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]	PMID:21295571
1305069	Smad6	SMAD family member 6	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SMAD6 mRNA	PMID:30510588
1305069	Smad6	SMAD family member 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SMAD6 mRNA	PMID:30165855
1305069	Smad6	SMAD family member 6	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SMAD6 gene	PMID:27618143
1305069	Smad6	SMAD family member 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SMAD6 gene	PMID:20938992
1305069	Smad6	SMAD family member 6	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:D001554	TRP53 protein inhibits the reaction [Benzene results in increased expression of SMAD6]	PMID:15935813
1305069	Smad6	SMAD family member 6	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of SMAD6 mRNA	PMID:21795739
1305069	Smad6	SMAD family member 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SMAD6 mRNA	PMID:36695872
1305069	Smad6	SMAD family member 6	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of SMAD6 mRNA	PMID:27683099
1305069	Smad6	SMAD family member 6	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of SMAD6 mRNA	PMID:16002434
1305069	Smad6	SMAD family member 6	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SMAD6 mRNA	PMID:33387578
1305069	Smad6	SMAD family member 6	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA	PMID:39836092
1305069	Smad6	SMAD family member 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312880	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SMAD6 intron	PMID:30157460
1305069	Smad6	SMAD family member 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312880	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SMAD6 gene	PMID:27153756
1305069	Smad6	SMAD family member 6	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of SMAD6 mRNA	PMID:15674844
1305069	Smad6	SMAD family member 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SMAD6 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SMAD6 mRNA	PMID:34911549
1305069	Smad6	SMAD family member 6	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312880	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SMAD6 mRNA	PMID:18356318
1305069	Smad6	SMAD family member 6	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SMAD6 mRNA	PMID:17484886
1305069	Smad6	SMAD family member 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMAD6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SMAD6 gene	PMID:20938992|PMID:22206623
1305069	Smad6	SMAD family member 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMAD6 mRNA	PMID:39836092
1305069	Smad6	SMAD family member 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SMAD6 mRNA	PMID:27392435
1305069	Smad6	SMAD family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312881	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMAD6 mRNA	PMID:21570461|PMID:24058054
1305069	Smad6	SMAD family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMAD6 mRNA	PMID:19933214
1305069	Smad6	SMAD family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMAD6 mRNA	PMID:33387578
1305069	Smad6	SMAD family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312881	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMAD6 mRNA	PMID:37172768
1305069	Smad6	SMAD family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SMAD6 promoter]	PMID:19654925
1305069	Smad6	SMAD family member 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SMAD6 mRNA	PMID:23179753
1305069	Smad6	SMAD family member 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMAD6 mRNA	PMID:33212167
1305069	Smad6	SMAD family member 6	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SMAD6 mRNA	PMID:28959563
1305069	Smad6	SMAD family member 6	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of SMAD6 mRNA	PMID:21198554
1305069	Smad6	SMAD family member 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SMAD6 mRNA	PMID:38568856|PMID:39719251
1305069	Smad6	SMAD family member 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312880	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of SMAD6 mRNA	PMID:12016162|PMID:16966095|PMID:28595984|PMID:34032870
1305069	Smad6	SMAD family member 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMAD6 mRNA	PMID:39836092
1305069	Smad6	SMAD family member 6	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of SMAD6 mRNA	PMID:29453283
1305069	Smad6	SMAD family member 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20230704	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMAD6 mRNA	PMID:35870112
1305069	Smad6	SMAD family member 6	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312880	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SMAD6 mRNA	PMID:18356318
1305069	Smad6	SMAD family member 6	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SMAD6 mRNA	PMID:20458559
1305069	Smad6	SMAD family member 6	gene	CHEBI:30769	citric acid	increases expression	ISO	RGD:1312880	E	RGD:6480464	20240604	CTD	MESH:D019343	Citric Acid results in increased expression of SMAD6 mRNA	PMID:37149095
1305069	Smad6	SMAD family member 6	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of SMAD6 mRNA	PMID:35984750
1305069	Smad6	SMAD family member 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SMAD6 mRNA	PMID:25729387
1305069	Smad6	SMAD family member 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SMAD6 mRNA	PMID:23557971
1305069	Smad6	SMAD family member 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312881	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SMAD6 promoter	PMID:35295148
1305069	Smad6	SMAD family member 6	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of SMAD6 mRNA	PMID:30690063
1305069	Smad6	SMAD family member 6	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of SMAD6 mRNA	PMID:28329830
1305069	Smad6	SMAD family member 6	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of SMAD6 mRNA	PMID:19167457
1305069	Smad6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312880	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of SMAD6 mRNA	PMID:20170705
1305069	Smad6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312881	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SMAD6 promoter	PMID:27334623
1305069	Smad6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SMAD6 mRNA	PMID:26982218|PMID:30816183
1305069	Smad6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SMAD6 mRNA	PMID:25181051
1305069	Smad6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312880	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SMAD6 mRNA	PMID:29275510
1305069	Smad6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312881	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SMAD6 mRNA	PMID:32156529
1305069	Smad6	SMAD family member 6	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SMAD6 mRNA	PMID:25172293
1305069	Smad6	SMAD family member 6	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1312880	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of SMAD6 mRNA	PMID:36804509
1305069	Smad6	SMAD family member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312881	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SMAD6 mRNA	PMID:30951980
1305069	Smad6	SMAD family member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of SMAD6 mRNA	PMID:30951980
1305069	Smad6	SMAD family member 6	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312880	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SMAD6 intron	PMID:30157460
1305069	Smad6	SMAD family member 6	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1312881	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of SMAD6 mRNA	PMID:26377693
1305069	Smad6	SMAD family member 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312881	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SMAD6 mRNA	PMID:30951980
1305069	Smad6	SMAD family member 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312881	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SMAD6 intron	PMID:28392331
1305069	Smad6	SMAD family member 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312881	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SMAD6 mRNA	PMID:37019170
1305069	Smad6	SMAD family member 6	gene	CHEBI:34905	paraquat	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat affects the expression of SMAD6 mRNA	PMID:16854511
1305069	Smad6	SMAD family member 6	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA	PMID:39836092
1305069	Smad6	SMAD family member 6	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of SMAD6 mRNA	PMID:26194646
1305069	Smad6	SMAD family member 6	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of SMAD6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SMAD6 mRNA]	PMID:17585979
1305069	Smad6	SMAD family member 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SMAD6 mRNA	PMID:40194260
1305069	Smad6	SMAD family member 6	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312880	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SMAD6 mRNA	PMID:31533062
1305069	Smad6	SMAD family member 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMAD6 mRNA	PMID:28001369
1305069	Smad6	SMAD family member 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312880	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of SMAD6 mRNA	PMID:24935251
1305069	Smad6	SMAD family member 6	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312880	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SMAD6 gene	PMID:29154799
1305069	Smad6	SMAD family member 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMAD6 mRNA	PMID:27989131
1305069	Smad6	SMAD family member 6	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of SMAD6 mRNA	PMID:24449571
1305069	Smad6	SMAD family member 6	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312880	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SMAD6 mRNA	PMID:38832940
1305069	Smad6	SMAD family member 6	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312880	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SMAD6 mRNA	PMID:24935251
1305069	Smad6	SMAD family member 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMAD6 mRNA	PMID:33387578
1305069	Smad6	SMAD family member 6	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of SMAD6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SMAD6 mRNA]	PMID:17585979
1305069	Smad6	SMAD family member 6	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20161213	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SMAD6 mRNA	PMID:23634900
1305069	Smad6	SMAD family member 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMAD6 mRNA	PMID:39836092
1305069	Smad6	SMAD family member 6	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMAD6 mRNA	PMID:22079256
1305069	Smad6	SMAD family member 6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SMAD6 mRNA	PMID:35436446
1305069	Smad6	SMAD family member 6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312880	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SMAD6 mRNA	PMID:20170705
1305069	Smad6	SMAD family member 6	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of SMAD6 mRNA	PMID:38568856
1305069	Smad6	SMAD family member 6	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SMAD6 mRNA	PMID:20458559
1305069	Smad6	SMAD family member 6	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20120412	CTD	MESH:D003994	Bucladesine inhibits the reaction [BMP4 protein results in increased expression of SMAD6 mRNA]	PMID:20522807
1305069	Smad6	SMAD family member 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SMAD6 mRNA; Nanotubes, Carbon results in decreased expression of SMAD6 mRNA	PMID:25554681
1305069	Smad6	SMAD family member 6	gene	CHEBI:5262	galangin	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20141223	CTD	MESH:C037032	galangin results in decreased expression of SMAD6 mRNA	PMID:25268046
1305069	Smad6	SMAD family member 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA	PMID:39836092
1305069	Smad6	SMAD family member 6	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD6 mRNA	PMID:26378955
1305069	Smad6	SMAD family member 6	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMAD6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD6 mRNA	PMID:21641980|PMID:26378955
1305069	Smad6	SMAD family member 6	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SMAD6 mRNA	PMID:25729387
1305069	Smad6	SMAD family member 6	gene	CHEBI:63916	iloprost	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20120412	CTD	MESH:D016285	Iloprost inhibits the reaction [BMP4 protein results in increased expression of SMAD6 mRNA]	PMID:20522807
1305069	Smad6	SMAD family member 6	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312880	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SMAD6 intron	PMID:30157460
1305069	Smad6	SMAD family member 6	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SMAD6 gene	PMID:35440735
1305069	Smad6	SMAD family member 6	gene	CHEBI:72312	pasireotide	decreases expression	EXP		E	RGD:6480464	20170103	CTD	MESH:C517782	pasireotide results in decreased expression of SMAD6 mRNA	PMID:23137853
1305069	Smad6	SMAD family member 6	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312880	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SMAD6 mRNA	PMID:31758290
1305069	Smad6	SMAD family member 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMAD6 mRNA	PMID:22206623
1305069	Smad6	SMAD family member 6	gene	CHEBI:7507	neomycin	increases expression	ISO	RGD:1312881	E	RGD:6480464	20190507	CTD	MESH:D009355	Neomycin results in increased expression of SMAD6 mRNA	PMID:30626089
1305069	Smad6	SMAD family member 6	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SMAD6 mRNA	PMID:22079256|PMID:22714537
1305069	Smad6	SMAD family member 6	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMAD6 mRNA	PMID:22079256
1305069	Smad6	SMAD family member 6	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of SMAD6 mRNA	PMID:32858204
1305069	Smad6	SMAD family member 6	gene	CHEBI:7726	octreotide	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D015282	Octreotide results in decreased expression of SMAD6 mRNA	PMID:23137853
1305069	Smad6	SMAD family member 6	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of SMAD6 mRNA	PMID:23665939
1305069	Smad6	SMAD family member 6	gene	CHEBI:78420	icariin	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20140520	CTD	MESH:C056599	SMAD6 protein inhibits the reaction [icariin results in increased expression of BGLAP mRNA]; SMAD6 protein inhibits the reaction [icariin results in increased expression of SPP1 mRNA]	PMID:18295595
1305069	Smad6	SMAD family member 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312880	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SMAD6 gene]	PMID:28238834
1305069	Smad6	SMAD family member 6	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SMAD6 mRNA	PMID:21278054
1305069	Smad6	SMAD family member 6	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013311	Streptozocin results in increased expression of SMAD6 protein	PMID:17437042
1305069	Smad6	SMAD family member 6	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312880	E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in decreased expression of SMAD6 mRNA	PMID:29453283
1305069	Smad6	SMAD family member 6	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312881	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of SMAD6 mRNA	PMID:28973697
1305069	Smad6	SMAD family member 6	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SMAD6 mRNA	PMID:35537566
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1614145	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DLEU7 mRNA	PMID:30319688
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1605843	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DLEU7 mRNA	PMID:35811015
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605843	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DLEU7 mRNA	PMID:35811015
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1614145	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DLEU7 mRNA	PMID:25510870
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1614145	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of DLEU7 mRNA	PMID:22238285
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of DLEU7 mRNA	PMID:27523638
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1614145	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DLEU7 mRNA	PMID:25510870
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1614145	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DLEU7 mRNA	PMID:25510870
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614145	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DLEU7 mRNA	PMID:25629700
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of DLEU7 gene	PMID:31011160
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DLEU7 mRNA	PMID:32109520|PMID:34747641
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605843	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DLEU7 exon; Benzo(a)pyrene results in increased methylation of DLEU7 promoter	PMID:27901495
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1605843	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of DLEU7 mRNA	PMID:37690743
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1614145	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of DLEU7 mRNA	PMID:20542052
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614145	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DLEU7 gene; titanium dioxide results in decreased methylation of DLEU7 promoter	PMID:35295148
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DLEU7 mRNA	PMID:25181051|PMID:29097150|PMID:30816183|PMID:32528016
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1614145	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of DLEU7 mRNA	PMID:26682919
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1614145	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DLEU7 mRNA	PMID:25510870
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1614145	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DLEU7 mRNA	PMID:25510870
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1614145	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of DLEU7 mRNA	PMID:30951980
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1614145	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of DLEU7 mRNA	PMID:21427059
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1605843	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DLEU7 mRNA	PMID:35811015
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DLEU7 gene	PMID:35440735
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605843	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DLEU7 gene]	PMID:28238834
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of DLEU7 mRNA	PMID:32109520
1305071	Dleu7	deleted in lymphocytic leukemia, 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DLEU7 mRNA	PMID:24780913
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SLC25A46 mRNA	PMID:38218311
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1606754	E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of SLC25A46 mRNA	PMID:32845096
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1332229	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SLC25A46 mRNA	PMID:30319688
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SLC25A46 mRNA	PMID:21632981
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606754	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC25A46 mRNA	PMID:37042841
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:17303	morphine	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine results in decreased expression of SLC25A46 protein	PMID:23056601
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:17303	morphine	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine deficiency promotes the reaction [Morphine results in decreased expression of SLC25A46 protein]	PMID:23056601
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1606754	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SLC25A46 protein	PMID:37730182
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SLC25A46 mRNA	PMID:33387578
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SLC25A46 mRNA	PMID:19549813
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of SLC25A46 protein	PMID:33146391
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606754	E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of SLC25A46 mRNA	PMID:32845096
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332229	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SLC25A46 mRNA	PMID:25629700
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332229	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A46 mRNA	PMID:22206623
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1606754	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC25A46 gene	PMID:25304211
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1606754	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SLC25A46 protein	PMID:35688186
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SLC25A46 mRNA	PMID:27392435
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1332229	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of SLC25A46 mRNA	PMID:32186404
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332229	E	RGD:6480464	20150825	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC25A46 mRNA	PMID:15328365|PMID:25270620|PMID:25975270
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332229	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of SLC25A46 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC25A46 mRNA	PMID:16214954|PMID:25975270
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1606754	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of SLC25A46 mRNA	PMID:33512557
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SLC25A46 mRNA	PMID:28001369
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC25A46 mRNA	PMID:30851411
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606754	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC25A46 intron	PMID:30157460
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC25A46 mRNA	PMID:21839799
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SLC25A46 mRNA	PMID:25729387
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332229	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SLC25A46 gene	PMID:35295148
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332229	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SLC25A46 mRNA	PMID:17426115|PMID:23811191
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1332229	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC25A46 mRNA	PMID:19710929
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC25A46 mRNA	PMID:36232920
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SLC25A46 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606754	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of SLC25A46 mRNA	PMID:36232920
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1606754	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SLC25A46 mRNA	PMID:25979313
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1332229	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SLC25A46 mRNA	PMID:38685157
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1606754	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SLC25A46 protein	PMID:34186270
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1606754	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SLC25A46 protein	PMID:34186270
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:34696	dieldrin	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20260707	CTD	MESH:D004026	Dieldrin results in decreased expression of SLC25A46 mRNA	PMID:38723972
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:34785	heptachlor	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20260707	CTD	MESH:D006533	Heptachlor results in decreased expression of SLC25A46 mRNA	PMID:38723972
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1332229	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SLC25A46 mRNA	PMID:34813904
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606754	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC25A46 mRNA	PMID:37042841
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SLC25A46 mRNA	PMID:28302478
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SLC25A46 mRNA	PMID:27153767
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606754	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC25A46 mRNA	PMID:23179753|PMID:24935251
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1606754	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SLC25A46 mRNA	PMID:24935251
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC25A46 mRNA	PMID:21420995
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1606754	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC25A46 gene	PMID:25304211
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1606754	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC25A46 mRNA	PMID:22079256
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SLC25A46 mRNA	PMID:24136188
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SLC25A46 mRNA	PMID:25729387
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1332229	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC25A46 mRNA	PMID:23650126
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1332229	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of SLC25A46 mRNA	PMID:25270620
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of SLC25A46 mRNA	PMID:24136188
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1332229	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of SLC25A46 protein	PMID:36851058
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of SLC25A46 mRNA	PMID:30467583
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332229	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC25A46 mRNA	PMID:22206623
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332229	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A46 mRNA	PMID:22206623
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SLC25A46 mRNA	PMID:22079256
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1606754	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC25A46 mRNA	PMID:22079256
1305072	Slc25a46	solute carrier family 25, member 46	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1606754	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC25A46 mRNA	PMID:30851411
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312888	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TRIM69 mRNA	PMID:26272509
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312889	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TRIM69 mRNA	PMID:33045310
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1312888	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of TRIM69 mRNA	PMID:31016361
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:149681	methcathinone	increases expression	ISO	RGD:1312888	E	RGD:6480464	20200602	CTD	MESH:C047806	monomethylpropion results in increased expression of TRIM69 mRNA	PMID:22303338
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312888	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TRIM69 mRNA	PMID:33167477
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312888	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TRIM69 mRNA	PMID:25596134
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312888	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRIM69 mRNA	PMID:35811015
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRIM69 mRNA	PMID:35811015
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312888	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of TRIM69 mRNA	PMID:30510588
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of TRIM69 mRNA	PMID:30165855
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312888	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIM69 mRNA	PMID:37042841
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA	PMID:37567420
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312888	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of TRIM69 mRNA	PMID:33359661
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA	PMID:37567420
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TRIM69 mRNA	PMID:33387578
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312888	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRIM69 mRNA	PMID:21641981
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of TRIM69 mRNA	PMID:41580963
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of TRIM69 mRNA	PMID:41430723
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312888	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TRIM69 mRNA	PMID:26272509
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312889	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of TRIM69 mRNA	PMID:28189721|PMID:28960355
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TRIM69 mRNA	PMID:31881176
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:27871	chloroacetaldehyde	increases expression	ISO	RGD:1312888	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of TRIM69 mRNA	PMID:25596134
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312888	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TRIM69 mRNA	PMID:24768652|PMID:25583101
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20151110	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM69 mRNA	PMID:17942748
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312888	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TRIM69 mRNA	PMID:28001369
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312889	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TRIM69 protein	PMID:28918527
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312888	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRIM69 mRNA	PMID:29803840
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA	PMID:37567420
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312888	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRIM69 mRNA	PMID:38568856
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312889	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of TRIM69 mRNA	PMID:37682722
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312888	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRIM69 5' UTR	PMID:27901495
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312888	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRIM69 promoter	PMID:27901495
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TRIM69 mRNA]	PMID:32406909
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1312888	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of TRIM69 mRNA	PMID:37690743
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM69 mRNA	PMID:25181051
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312888	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM69 mRNA	PMID:22576693
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312888	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TRIM69 gene	PMID:31601247
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312888	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of TRIM69 gene	PMID:22576693
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312888	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRIM69 mRNA	PMID:38568856
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TRIM69 mRNA	PMID:25539665
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312889	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TRIM69 mRNA	PMID:40194260
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312888	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TRIM69 mRNA	PMID:26272509
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA	PMID:37567420
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312888	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TRIM69 mRNA	PMID:24935251
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312889	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TRIM69 mRNA	PMID:17562736
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIM69 mRNA	PMID:33387578
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312888	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIM69 mRNA	PMID:21420995
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRIM69 mRNA	PMID:35811015
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312889	E	RGD:6480464	20151110	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TRIM69 mRNA	PMID:17942748
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20151110	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM69 mRNA	PMID:17942748
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1312888	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of TRIM69 mRNA	PMID:38825487
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA	PMID:37567420
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of TRIM69 mRNA	PMID:21346803
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRIM69 gene]	PMID:28238834
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1312888	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of TRIM69 mRNA	PMID:26272509
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312888	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312888	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TRIM69 mRNA	PMID:29301935
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TRIM69 mRNA	PMID:21346803
1305074	Trim69	tripartite motif-containing 69	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312889	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of TRIM69 mRNA	PMID:32835833
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312890	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RHBDF1 mRNA	PMID:38218311
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312890	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of RHBDF1 mRNA	PMID:23724009
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312890	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RHBDF1 mRNA	PMID:22378314
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312891	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RHBDF1 mRNA	PMID:30319688
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RHBDF1 mRNA	PMID:39241906
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in decreased expression of RHBDF1 mRNA	PMID:19167446|PMID:26865669|PMID:28711546
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RHBDF1 mRNA	PMID:39298647
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312890	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RHBDF1 mRNA	PMID:21179406
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHBDF1 mRNA	PMID:37992649
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:17263	estrone	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20160705	CTD	MESH:D004970	Estrone results in decreased expression of RHBDF1 mRNA	PMID:26865669
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHBDF1 mRNA	PMID:37992649
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312891	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RHBDF1 mRNA	PMID:23892564
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312890	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RHBDF1 protein	PMID:37730182
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312890	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RHBDF1 mRNA	PMID:28818685
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RHBDF1 mRNA	PMID:36331819
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RHBDF1 mRNA	PMID:37236586
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312890	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RHBDF1 mRNA	PMID:19549813
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312890	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RHBDF1 mRNA	PMID:21641981
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312891	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RHBDF1 mRNA	PMID:19770486
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RHBDF1 mRNA	PMID:34911549
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RHBDF1 mRNA	PMID:31150632
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312891	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RHBDF1 mRNA	PMID:27339419|PMID:31919559
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1312890	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of RHBDF1 promoter	PMID:21291286
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RHBDF1 mRNA	PMID:40512198
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHBDF1 mRNA	PMID:40504410
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312890	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RHBDF1 mRNA	PMID:26272509
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA	PMID:27188386
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312890	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RHBDF1 protein	PMID:35688186
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of RHBDF1 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of RHBDF1 mRNA	PMID:19167446|PMID:23557933
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20160705	CTD	MESH:D019833	Genistein results in decreased expression of RHBDF1 mRNA	PMID:26865669
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312891	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RHBDF1 mRNA	PMID:21570461
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RHBDF1 mRNA	PMID:32109520
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RHBDF1 mRNA	PMID:33387578
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312890	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of RHBDF1 mRNA	PMID:29955902
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RHBDF1 mRNA	PMID:28959563
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of RHBDF1 mRNA	PMID:24690739
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RHBDF1 mRNA	PMID:29803840
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHBDF1 mRNA	PMID:37992649
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312890	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of RHBDF1 mRNA	PMID:29319823
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312890	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RHBDF1 mRNA	PMID:38568856|PMID:39719251
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RHBDF1 mRNA	PMID:40512198
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHBDF1 mRNA	PMID:40504410
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312890	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of RHBDF1 mRNA	PMID:22378314
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312890	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RHBDF1 5' UTR	PMID:27901495
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312890	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RHBDF1 mRNA	PMID:32234424
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312891	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RHBDF1 mRNA	PMID:22228805
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312890	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RHBDF1 promoter	PMID:27901495
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of RHBDF1 mRNA	PMID:24690739
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:31638	fulvestrant	increases expression	ISO	RGD:1312890	E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant results in increased expression of RHBDF1 mRNA	PMID:26865669
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312891	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RHBDF1 gene	PMID:35295148
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RHBDF1 mRNA	PMID:34492290
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312891	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RHBDF1 mRNA	PMID:18648102
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312891	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of RHBDF1 mRNA	PMID:17426115|PMID:18301758|PMID:20813756|PMID:23811191
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20171010	CTD	MESH:C006780	bisphenol A results in decreased expression of RHBDF1 mRNA	PMID:28711546
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RHBDF1 mRNA	PMID:25181051
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RHBDF1 mRNA	PMID:39298647
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RHBDF1 mRNA	PMID:38685157
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHBDF1 mRNA	PMID:28628672
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of RHBDF1 mRNA	PMID:21241498
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312891	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RHBDF1 mRNA	PMID:21266533
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RHBDF1 mRNA	PMID:34813904
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHBDF1 mRNA	PMID:28628672
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of RHBDF1 mRNA	PMID:34813904
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312891	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RHBDF1 mRNA	PMID:24535843
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of RHBDF1 promoter	PMID:22457795
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20121009	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RHBDF1 mRNA; MT3 affects the reaction [Cadmium Chloride affects the expression of RHBDF1 mRNA]	PMID:20371981|PMID:37236586
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312890	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of RHBDF1 mRNA	PMID:19376846
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312890	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RHBDF1 mRNA	PMID:24449571
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RHBDF1 mRNA	PMID:31533062
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of RHBDF1 mRNA	PMID:19167446
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHBDF1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of RHBDF1 mRNA	PMID:19167446
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RHBDF1 mRNA	PMID:36331819
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312890	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RHBDF1 mRNA	PMID:25979313
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312890	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of RHBDF1 mRNA	PMID:28001369
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312890	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RHBDF1 gene	PMID:29154799
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312890	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RHBDF1 mRNA	PMID:25562108
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of RHBDF1 mRNA	PMID:25047013
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHBDF1 mRNA	PMID:28628672
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20160705	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of RHBDF1 mRNA	PMID:26865669
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHBDF1 mRNA	PMID:37992649
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of RHBDF1 mRNA]	PMID:21233418
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312890	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of RHBDF1 mRNA	PMID:24935251|PMID:26272509
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA	PMID:27188386
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312890	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RHBDF1 mRNA	PMID:22230336
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of RHBDF1 mRNA	PMID:24690739
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1312890	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of RHBDF1 promoter	PMID:21291286
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RHBDF1 mRNA	PMID:40512198
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHBDF1 mRNA	PMID:40504410
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RHBDF1 mRNA	PMID:29391264
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHBDF1 mRNA	PMID:28628672
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of RHBDF1 mRNA	PMID:30307764
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312890	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RHBDF1 mRNA	PMID:24810058
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:6784	mestranol	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20160705	CTD	MESH:D008656	Mestranol results in decreased expression of RHBDF1 mRNA	PMID:26865669
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of RHBDF1 mRNA	PMID:19564919
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of RHBDF1 mRNA	PMID:19564919
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:73297	SCH 23390	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in decreased expression of RHBDF1 mRNA	PMID:19564919
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of RHBDF1 mRNA	PMID:19564919
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312891	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RHBDF1 mRNA	PMID:22206623
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of RHBDF1 mRNA	PMID:21346803
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA	PMID:27188386
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312891	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of RHBDF1 mRNA	PMID:19482888
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RHBDF1 mRNA]	PMID:19482888
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312891	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of RHBDF1 mRNA	PMID:31388691
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHBDF1 mRNA	PMID:19167446
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RHBDF1 mRNA	PMID:24780913|PMID:25825206
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1312890	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of RHBDF1 mRNA	PMID:26865669
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1312890	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of RHBDF1 mRNA	PMID:31734321
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312890	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA	PMID:27188386
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312890	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RHBDF1 mRNA	PMID:38568856
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312890	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of RHBDF1 mRNA	PMID:22378314
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312891	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of RHBDF1 mRNA	PMID:35537566
1305075	Rhbdf1	rhomboid 5 homolog 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of RHBDF1 mRNA	PMID:22570695
1305076	Cdc16	cell division cycle 16	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312892	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CDC16 mRNA	PMID:38218311
1305076	Cdc16	cell division cycle 16	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CDC16 mRNA	PMID:30529165
1305076	Cdc16	cell division cycle 16	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312893	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CDC16 mRNA	PMID:30319688
1305076	Cdc16	cell division cycle 16	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312892	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CDC16 mRNA	PMID:20044591
1305076	Cdc16	cell division cycle 16	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of CDC16 mRNA	PMID:14715546
1305076	Cdc16	cell division cycle 16	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312892	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CDC16 protein	PMID:37730182
1305076	Cdc16	cell division cycle 16	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CDC16 protein	PMID:34915118
1305076	Cdc16	cell division cycle 16	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDC16 mRNA	PMID:37236586
1305076	Cdc16	cell division cycle 16	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312893	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CDC16 mRNA	PMID:31919559
1305076	Cdc16	cell division cycle 16	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312892	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CDC16 gene	PMID:25304211
1305076	Cdc16	cell division cycle 16	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC16 mRNA	PMID:39836092
1305076	Cdc16	cell division cycle 16	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CDC16 mRNA	PMID:19244175
1305076	Cdc16	cell division cycle 16	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312892	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CDC16 protein	PMID:35688186
1305076	Cdc16	cell division cycle 16	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312893	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CDC16 mRNA	PMID:28960355
1305076	Cdc16	cell division cycle 16	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312892	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of CDC16 mRNA	PMID:28903495
1305076	Cdc16	cell division cycle 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312893	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC16 mRNA	PMID:21570461
1305076	Cdc16	cell division cycle 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDC16 mRNA	PMID:17942748
1305076	Cdc16	cell division cycle 16	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CDC16 mRNA	PMID:30911355
1305076	Cdc16	cell division cycle 16	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDC16 mRNA	PMID:29803840
1305076	Cdc16	cell division cycle 16	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312893	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDC16 mRNA	PMID:16014739
1305076	Cdc16	cell division cycle 16	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC16 mRNA; sodium arsenite promotes the reaction [CDC16 protein binds to CAPRIN1 protein]	PMID:33939924|PMID:39836092
1305076	Cdc16	cell division cycle 16	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312893	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDC16 mRNA	PMID:22228805
1305076	Cdc16	cell division cycle 16	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CDC16 mRNA	PMID:30911355
1305076	Cdc16	cell division cycle 16	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1312892	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of CDC16 mRNA	PMID:31745603
1305076	Cdc16	cell division cycle 16	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312893	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CDC16 mRNA	PMID:18648102
1305076	Cdc16	cell division cycle 16	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312892	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CDC16 mRNA	PMID:30903817
1305076	Cdc16	cell division cycle 16	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CDC16 mRNA	PMID:25181051
1305076	Cdc16	cell division cycle 16	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of CDC16 mRNA	PMID:19244175
1305076	Cdc16	cell division cycle 16	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312892	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CDC16 mRNA	PMID:25979313
1305076	Cdc16	cell division cycle 16	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312893	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CDC16 mRNA	PMID:39298647
1305076	Cdc16	cell division cycle 16	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312893	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CDC16 mRNA	PMID:37019170
1305076	Cdc16	cell division cycle 16	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of CDC16 mRNA	PMID:17602206
1305076	Cdc16	cell division cycle 16	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CDC16 mRNA	PMID:21266533
1305076	Cdc16	cell division cycle 16	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312893	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CDC16 mRNA	PMID:34813904
1305076	Cdc16	cell division cycle 16	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312892	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC16 mRNA	PMID:37042841
1305076	Cdc16	cell division cycle 16	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CDC16 mRNA	PMID:33453195
1305076	Cdc16	cell division cycle 16	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDC16 mRNA	PMID:37236586
1305076	Cdc16	cell division cycle 16	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312892	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CDC16 mRNA	PMID:24449571
1305076	Cdc16	cell division cycle 16	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CDC16 mRNA	PMID:19244175
1305076	Cdc16	cell division cycle 16	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312893	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of CDC16 mRNA	PMID:17585979
1305076	Cdc16	cell division cycle 16	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CDC16 mRNA	PMID:28302478
1305076	Cdc16	cell division cycle 16	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312892	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDC16 mRNA	PMID:25979313
1305076	Cdc16	cell division cycle 16	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312892	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CDC16 mRNA	PMID:20106945|PMID:25562108
1305076	Cdc16	cell division cycle 16	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of CDC16 mRNA	PMID:29309887
1305076	Cdc16	cell division cycle 16	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDC16 mRNA	PMID:33387578
1305076	Cdc16	cell division cycle 16	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312892	E	RGD:6480464	20240702	CTD	MESH:D000082	Acetaminophen results in increased expression of CDC16 mRNA	PMID:38614205
1305076	Cdc16	cell division cycle 16	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312892	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CDC16 gene	PMID:25304211
1305076	Cdc16	cell division cycle 16	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC16 mRNA	PMID:39836092
1305076	Cdc16	cell division cycle 16	gene	CHEBI:4744	Echimidine	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of CDC16 mRNA	PMID:33884520
1305076	Cdc16	cell division cycle 16	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CDC16 mRNA	PMID:30529165
1305076	Cdc16	cell division cycle 16	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312893	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CDC16 mRNA	PMID:17942748
1305076	Cdc16	cell division cycle 16	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDC16 mRNA	PMID:17942748
1305076	Cdc16	cell division cycle 16	gene	CHEBI:50161	motexafin gadolinium	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in decreased expression of CDC16 mRNA	PMID:16357179
1305076	Cdc16	cell division cycle 16	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDC16 mRNA	PMID:16357179
1305076	Cdc16	cell division cycle 16	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CDC16 mRNA	PMID:35964746
1305076	Cdc16	cell division cycle 16	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CDC16 mRNA	PMID:24136188
1305076	Cdc16	cell division cycle 16	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of CDC16 mRNA	PMID:22841810
1305076	Cdc16	cell division cycle 16	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CDC16 protein	PMID:32959892
1305076	Cdc16	cell division cycle 16	gene	CHEBI:62984	zinc acetate	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of CDC16 mRNA	PMID:16357179
1305076	Cdc16	cell division cycle 16	gene	CHEBI:62984	zinc acetate	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDC16 mRNA	PMID:16357179
1305076	Cdc16	cell division cycle 16	gene	CHEBI:6382	Lasiocarpine	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC16 mRNA	PMID:33884520
1305076	Cdc16	cell division cycle 16	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312893	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CDC16 mRNA	PMID:23650126
1305076	Cdc16	cell division cycle 16	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CDC16 mRNA	PMID:15336504
1305076	Cdc16	cell division cycle 16	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1312892	E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of CDC16 mRNA	PMID:29309887
1305076	Cdc16	cell division cycle 16	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312892	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CDC16 mRNA	PMID:31758290
1305076	Cdc16	cell division cycle 16	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312893	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CDC16 mRNA	PMID:22206623
1305076	Cdc16	cell division cycle 16	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312892	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of CDC16 protein	PMID:31285264
1305076	Cdc16	cell division cycle 16	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CDC16 mRNA	PMID:21346803
1305076	Cdc16	cell division cycle 16	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CDC16 mRNA	PMID:21346803
1305076	Cdc16	cell division cycle 16	gene	CHEBI:9747	Triptolide	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C001899	triptolide results in decreased expression of CDC16 mRNA	PMID:23639586
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of PIBF1 mRNA	PMID:25152437
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1624034	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PIBF1 mRNA	PMID:39241906
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312894	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PIBF1 mRNA	PMID:37042841
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312894	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of PIBF1 mRNA; Progesterone results in increased expression of PIBF1 protein	PMID:17701593
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312894	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PIBF1 mRNA	PMID:19549813
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of PIBF1 mRNA	PMID:21396975
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312894	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PIBF1 mRNA	PMID:23649840
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312894	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PIBF1 gene	PMID:25304211
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of PIBF1 gene	PMID:35440735
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1624034	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PIBF1 mRNA	PMID:28960355
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312894	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PIBF1 mRNA	PMID:27392435
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312894	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PIBF1 mRNA	PMID:27392435
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1624034	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PIBF1 mRNA	PMID:21570461
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1624034	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PIBF1 mRNA	PMID:15034205
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312894	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PIBF1 mRNA	PMID:33212167
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312894	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PIBF1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1624034	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PIBF1 mRNA	PMID:15034205
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:31527	dydrogesterone	affects expression	ISO	RGD:1312894	E	RGD:6480464	20120412	CTD	MESH:D004394	Dydrogesterone affects the expression of PIBF1 protein	PMID:15760377
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:31527	dydrogesterone	increases expression	ISO	RGD:1312894	E	RGD:6480464	20120412	CTD	MESH:D004394	Dydrogesterone results in increased expression of PIBF1 protein	PMID:16045524
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of PIBF1 mRNA	PMID:22641619
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1624034	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PIBF1 promoter	PMID:35295148
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PIBF1 mRNA	PMID:34492290
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PIBF1 mRNA	PMID:25181051
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of PIBF1 mRNA	PMID:41034487
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312894	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PIBF1 gene	PMID:31601247
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1624034	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of PIBF1 mRNA	PMID:36464114
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312894	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PIBF1 mRNA	PMID:37042841
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312894	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PIBF1 mRNA	PMID:28302478
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312894	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PIBF1 mRNA	PMID:25979313
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312894	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PIBF1 mRNA	PMID:23179753
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312894	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PIBF1 gene	PMID:29154799
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312894	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PIBF1 mRNA	PMID:20106945|PMID:25562108
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312894	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PIBF1 mRNA	PMID:21420995
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312894	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PIBF1 gene	PMID:25304211
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312894	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PIBF1 mRNA	PMID:22079256
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:50692	mifepristone	decreases expression	ISO	RGD:1312894	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of PIBF1 mRNA; Mifepristone results in decreased expression of PIBF1 protein	PMID:17701593
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PIBF1 mRNA	PMID:20080153
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PIBF1 gene	PMID:35440735
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1624034	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of PIBF1 mRNA	PMID:36464114
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1624034	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PIBF1 mRNA	PMID:22206623
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312894	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PIBF1 mRNA	PMID:22079256
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312894	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PIBF1 mRNA	PMID:22079256
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1312894	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of PIBF1 mRNA	PMID:30928695
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1624034	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PIBF1 mRNA	PMID:31388691
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1624034	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of PIBF1 mRNA	PMID:40826991
1305077	Pibf1	progesterone immunomodulatory binding factor 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PIBF1 mRNA	PMID:23034163
1305078	Sulf2	sulfatase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312895	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SULF2 mRNA	PMID:38218311
1305078	Sulf2	sulfatase 2	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SULF2 mRNA]	PMID:31150632
1305078	Sulf2	sulfatase 2	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SULF2 mRNA	PMID:39752319
1305078	Sulf2	sulfatase 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SULF2 mRNA]	PMID:19467301
1305078	Sulf2	sulfatase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SULF2 mRNA	PMID:23724009
1305078	Sulf2	sulfatase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of SULF2 mRNA	PMID:20488242
1305078	Sulf2	sulfatase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312895	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SULF2 mRNA	PMID:21934132|PMID:33167477
1305078	Sulf2	sulfatase 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20150825	CTD	MESH:D010100	[Oxygen deficiency co-treated with Oxygen] results in decreased expression of SULF2 mRNA; SULT1E1 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of SULF2 mRNA]	PMID:25922074
1305078	Sulf2	sulfatase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SULF2 mRNA	PMID:36331819
1305078	Sulf2	sulfatase 2	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of SULF2 mRNA	PMID:39506029
1305078	Sulf2	sulfatase 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of SULF2 mRNA	PMID:36841081
1305078	Sulf2	sulfatase 2	gene	CHEBI:16037	2-nitropropane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016617	2-nitropropane results in increased expression of SULF2 mRNA	PMID:17070881
1305078	Sulf2	sulfatase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312896	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SULF2 mRNA	PMID:30319688
1305078	Sulf2	sulfatase 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312896	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SULF2 mRNA	PMID:30319688
1305078	Sulf2	sulfatase 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312895	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SULF2 mRNA	PMID:21632981
1305078	Sulf2	sulfatase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SULF2 mRNA	PMID:39241906
1305078	Sulf2	sulfatase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SULF2 mRNA	PMID:32145629
1305078	Sulf2	sulfatase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SULF2 mRNA	PMID:39298647
1305078	Sulf2	sulfatase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312895	E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in increased expression of SULF2 mRNA	PMID:20106945|PMID:21632981
1305078	Sulf2	sulfatase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SULF2 mRNA	PMID:32741896
1305078	Sulf2	sulfatase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SULF2 mRNA	PMID:30165855
1305078	Sulf2	sulfatase 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312896	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SULF2 mRNA	PMID:33711761
1305078	Sulf2	sulfatase 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SULF2 mRNA	PMID:38568856
1305078	Sulf2	sulfatase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312895	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SULF2 mRNA	PMID:37042841
1305078	Sulf2	sulfatase 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of SULF2 mRNA	PMID:28937961
1305078	Sulf2	sulfatase 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312895	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SULF2 mRNA	PMID:23649840
1305078	Sulf2	sulfatase 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312895	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of SULF2 mRNA	PMID:20864642
1305078	Sulf2	sulfatase 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312895	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SULF2 mRNA	PMID:21179406
1305078	Sulf2	sulfatase 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SULF2 mRNA	PMID:26079696
1305078	Sulf2	sulfatase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULF2 mRNA	PMID:37992649
1305078	Sulf2	sulfatase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SULF2 mRNA	PMID:39752319
1305078	Sulf2	sulfatase 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of SULF2 mRNA	PMID:21592394
1305078	Sulf2	sulfatase 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SULF2 mRNA	PMID:32741896
1305078	Sulf2	sulfatase 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SULF2 mRNA	PMID:21592394
1305078	Sulf2	sulfatase 2	gene	CHEBI:17356	2-acetamidofluorene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of SULF2 mRNA	PMID:17070881
1305078	Sulf2	sulfatase 2	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20121113	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of SULF2 mRNA	PMID:21607683
1305078	Sulf2	sulfatase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULF2 mRNA	PMID:37992649
1305078	Sulf2	sulfatase 2	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SULF2 mRNA	PMID:36139627
1305078	Sulf2	sulfatase 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312895	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SULF2 mRNA	PMID:21592394
1305078	Sulf2	sulfatase 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SULF2 mRNA	PMID:21592394
1305078	Sulf2	sulfatase 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312895	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SULF2 intron	PMID:30157460
1305078	Sulf2	sulfatase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SULF2 mRNA	PMID:36331819
1305078	Sulf2	sulfatase 2	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1312895	E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of SULF2 mRNA	PMID:20368581
1305078	Sulf2	sulfatase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA	PMID:39836092
1305078	Sulf2	sulfatase 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased expression of SULF2 mRNA	PMID:28860664
1305078	Sulf2	sulfatase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SULF2 mRNA	PMID:37236586
1305078	Sulf2	sulfatase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SULF2 mRNA	PMID:19549813
1305078	Sulf2	sulfatase 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312895	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SULF2 mRNA	PMID:23649840
1305078	Sulf2	sulfatase 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312895	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SULF2 protein	PMID:20106945
1305078	Sulf2	sulfatase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SULF2 mRNA	PMID:22484513|PMID:33354967
1305078	Sulf2	sulfatase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312895	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SULF2 mRNA	PMID:21632981|PMID:21641981
1305078	Sulf2	sulfatase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312896	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SULF2 mRNA	PMID:19770486
1305078	Sulf2	sulfatase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312895	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SULF2 gene; Aflatoxin B1 results in increased methylation of SULF2 intron	PMID:27153756|PMID:30157460
1305078	Sulf2	sulfatase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312895	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SULF2 mRNA	PMID:23649840
1305078	Sulf2	sulfatase 2	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SULF2 mRNA	PMID:32553695
1305078	Sulf2	sulfatase 2	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20201006	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SULF2 mRNA	PMID:32553695
1305078	Sulf2	sulfatase 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312896	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of SULF2 mRNA	PMID:24535564
1305078	Sulf2	sulfatase 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SULF2 mRNA	PMID:30779732
1305078	Sulf2	sulfatase 2	gene	CHEBI:27300	vitamin D	affects expression	ISO	RGD:1312895	E	RGD:6480464	20170303	CTD	MESH:D014807	Vitamin D affects the expression of SULF2 mRNA	PMID:20368581
1305078	Sulf2	sulfatase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SULF2 mRNA	PMID:31150632
1305078	Sulf2	sulfatase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SULF2 mRNA]	PMID:31150632
1305078	Sulf2	sulfatase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SULF2 mRNA]	PMID:22206623
1305078	Sulf2	sulfatase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA	PMID:32525701|PMID:39836092
1305078	Sulf2	sulfatase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SULF2 mRNA	PMID:40504410
1305078	Sulf2	sulfatase 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312895	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SULF2 mRNA	PMID:26272509
1305078	Sulf2	sulfatase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA	PMID:27188386
1305078	Sulf2	sulfatase 2	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of SULF2 gene	PMID:31011160
1305078	Sulf2	sulfatase 2	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312895	E	RGD:6480464	20150714	CTD	MESH:C059514	resveratrol results in increased expression of SULF2 mRNA	PMID:25888808
1305078	Sulf2	sulfatase 2	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1312895	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SULF2 mRNA	PMID:23300844
1305078	Sulf2	sulfatase 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312895	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SULF2 mRNA	PMID:27392435
1305078	Sulf2	sulfatase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SULF2 mRNA; [Cisplatin co-treated with panobinostat] affects the expression of SULF2 mRNA	PMID:21791302|PMID:27392435
1305078	Sulf2	sulfatase 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312895	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of SULF2 mRNA	PMID:18847459
1305078	Sulf2	sulfatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SULF2 mRNA	PMID:34747641
1305078	Sulf2	sulfatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312896	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SULF2 mRNA	PMID:28213091
1305078	Sulf2	sulfatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SULF2 mRNA	PMID:21215274
1305078	Sulf2	sulfatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SULF2 mRNA	PMID:26290441
1305078	Sulf2	sulfatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SULF2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SULF2 gene]	PMID:17942748|PMID:28213091
1305078	Sulf2	sulfatase 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of SULF2 mRNA	PMID:29955902
1305078	Sulf2	sulfatase 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SULF2 mRNA	PMID:28374803
1305078	Sulf2	sulfatase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312895	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SULF2 mRNA	PMID:23179753|PMID:26272509
1305078	Sulf2	sulfatase 2	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA	PMID:27188386
1305078	Sulf2	sulfatase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312895	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SULF2 mRNA	PMID:33212167
1305078	Sulf2	sulfatase 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SULF2 mRNA	PMID:32763439
1305078	Sulf2	sulfatase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SULF2 mRNA	PMID:20971185
1305078	Sulf2	sulfatase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SULF2 mRNA	PMID:39631538
1305078	Sulf2	sulfatase 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312895	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SULF2 mRNA	PMID:29803840|PMID:30031762
1305078	Sulf2	sulfatase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULF2 mRNA	PMID:37992649
1305078	Sulf2	sulfatase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of SULF2 mRNA	PMID:20371982|PMID:38568856
1305078	Sulf2	sulfatase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA	PMID:39836092
1305078	Sulf2	sulfatase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SULF2 mRNA	PMID:40504410
1305078	Sulf2	sulfatase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312895	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SULF2 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1305078	Sulf2	sulfatase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of SULF2 mRNA; Benzo(a)pyrene results in increased expression of SULF2 mRNA	PMID:19770486|PMID:22610609|PMID:32553695
1305078	Sulf2	sulfatase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312895	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SULF2 promoter	PMID:27901495
1305078	Sulf2	sulfatase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SULF2 mRNA	PMID:20971185
1305078	Sulf2	sulfatase 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SULF2 mRNA	PMID:25895662
1305078	Sulf2	sulfatase 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SULF2 mRNA	PMID:22521957
1305078	Sulf2	sulfatase 2	gene	CHEBI:31175	adefovir pivoxil	increases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SULF2 mRNA	PMID:30047161
1305078	Sulf2	sulfatase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SULF2 mRNA	PMID:23557971
1305078	Sulf2	sulfatase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SULF2 mRNA	PMID:34492290
1305078	Sulf2	sulfatase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312896	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SULF2 mRNA	PMID:17426115|PMID:18301758|PMID:18445702|PMID:20813756|PMID:23811191
1305078	Sulf2	sulfatase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SULF2 mRNA	PMID:19710929
1305078	Sulf2	sulfatase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SULF2 mRNA	PMID:25181051
1305078	Sulf2	sulfatase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of SULF2 mRNA	PMID:32145629
1305078	Sulf2	sulfatase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SULF2 mRNA	PMID:25047013
1305078	Sulf2	sulfatase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SULF2 mRNA	PMID:33221593
1305078	Sulf2	sulfatase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312896	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of SULF2 mRNA	PMID:35479511
1305078	Sulf2	sulfatase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312896	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SULF2 promoter	PMID:27312807
1305078	Sulf2	sulfatase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SULF2 mRNA	PMID:28628672
1305078	Sulf2	sulfatase 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312895	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SULF2 mRNA	PMID:25979313
1305078	Sulf2	sulfatase 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SULF2 mRNA	PMID:26682919
1305078	Sulf2	sulfatase 2	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	EXP		E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of SULF2 mRNA	PMID:17070881
1305078	Sulf2	sulfatase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SULF2 mRNA	PMID:39298647
1305078	Sulf2	sulfatase 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SULF2 mRNA	PMID:26377693
1305078	Sulf2	sulfatase 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1312895	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SULF2 intron	PMID:30157460
1305078	Sulf2	sulfatase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SULF2 mRNA	PMID:28628672
1305078	Sulf2	sulfatase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312896	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SULF2 intron	PMID:28392331
1305078	Sulf2	sulfatase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SULF2 mRNA	PMID:21266533
1305078	Sulf2	sulfatase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SULF2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SULF2 mRNA	PMID:28628672
1305078	Sulf2	sulfatase 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312896	E	RGD:6480464	20121113	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SULF2 mRNA	PMID:21607683
1305078	Sulf2	sulfatase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312895	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SULF2 mRNA	PMID:37042841
1305078	Sulf2	sulfatase 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312895	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SULF2 mRNA	PMID:29024780
1305078	Sulf2	sulfatase 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SULF2 mRNA	PMID:35163327
1305078	Sulf2	sulfatase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA	PMID:39836092
1305078	Sulf2	sulfatase 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of SULF2 mRNA	PMID:26377693
1305078	Sulf2	sulfatase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SULF2 mRNA	PMID:37236586
1305078	Sulf2	sulfatase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SULF2 mRNA	PMID:35163327
1305078	Sulf2	sulfatase 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of SULF2 mRNA	PMID:26194646
1305078	Sulf2	sulfatase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312896	E	RGD:6480464	20161025	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SULF2 mRNA	PMID:27413110|PMID:28903501
1305078	Sulf2	sulfatase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SULF2 mRNA	PMID:24386269
1305078	Sulf2	sulfatase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SULF2 mRNA	PMID:19320972
1305078	Sulf2	sulfatase 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SULF2 mRNA	PMID:24449571
1305078	Sulf2	sulfatase 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312896	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of SULF2 mRNA	PMID:28962523
1305078	Sulf2	sulfatase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312896	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SULF2 mRNA	PMID:18353800
1305078	Sulf2	sulfatase 2	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312896	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of SULF2 mRNA	PMID:17585979
1305078	Sulf2	sulfatase 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1312895	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SULF2 mRNA	PMID:28302478
1305078	Sulf2	sulfatase 2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312895	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SULF2 mRNA	PMID:19167446
1305078	Sulf2	sulfatase 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SULF2 mRNA	PMID:19167446
1305078	Sulf2	sulfatase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SULF2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SULF2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SULF2 mRNA	PMID:36331819
1305078	Sulf2	sulfatase 2	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SULF2 mRNA]	PMID:18200517
1305078	Sulf2	sulfatase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312895	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SULF2 mRNA	PMID:25979313
1305078	Sulf2	sulfatase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SULF2 mRNA	PMID:17963808
1305078	Sulf2	sulfatase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312895	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SULF2 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1305078	Sulf2	sulfatase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312896	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of SULF2 mRNA	PMID:24535564
1305078	Sulf2	sulfatase 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SULF2 mRNA	PMID:30047161
1305078	Sulf2	sulfatase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SULF2 mRNA	PMID:25562108|PMID:25596134|PMID:27989131
1305078	Sulf2	sulfatase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SULF2 mRNA	PMID:17555576
1305078	Sulf2	sulfatase 2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1312896	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of SULF2 mRNA	PMID:25123088
1305078	Sulf2	sulfatase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SULF2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SULF2 mRNA	PMID:28628672
1305078	Sulf2	sulfatase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SULF2 mRNA	PMID:28973697
1305078	Sulf2	sulfatase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULF2 mRNA	PMID:37992649
1305078	Sulf2	sulfatase 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1312895	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of SULF2 mRNA	PMID:23649840
1305078	Sulf2	sulfatase 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SULF2 mRNA	PMID:38832940
1305078	Sulf2	sulfatase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312895	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SULF2 mRNA	PMID:22230336
1305078	Sulf2	sulfatase 2	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312895	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:46680	serpentine asbestos	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of SULF2 mRNA	PMID:29523930
1305078	Sulf2	sulfatase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA	PMID:32525701|PMID:39836092
1305078	Sulf2	sulfatase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SULF2 mRNA	PMID:40504410
1305078	Sulf2	sulfatase 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312895	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of SULF2 mRNA	PMID:26833863
1305078	Sulf2	sulfatase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SULF2 mRNA	PMID:29391264
1305078	Sulf2	sulfatase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SULF2 mRNA	PMID:17555576
1305078	Sulf2	sulfatase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SULF2 mRNA	PMID:17942748
1305078	Sulf2	sulfatase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SULF2 mRNA	PMID:17942748
1305078	Sulf2	sulfatase 2	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1312895	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SULF2 mRNA	PMID:26272509
1305078	Sulf2	sulfatase 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA	PMID:27188386
1305078	Sulf2	sulfatase 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SULF2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SULF2 mRNA	PMID:28628672
1305078	Sulf2	sulfatase 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SULF2 mRNA	PMID:22521957
1305078	Sulf2	sulfatase 2	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1312895	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SULF2 mRNA	PMID:23300844
1305078	Sulf2	sulfatase 2	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SULF2 mRNA	PMID:30307764
1305078	Sulf2	sulfatase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SULF2 mRNA; Nanotubes, Carbon results in decreased expression of SULF2 mRNA	PMID:25620056
1305078	Sulf2	sulfatase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312896	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SULF2 mRNA	PMID:25554681
1305078	Sulf2	sulfatase 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SULF2 mRNA	PMID:30047161
1305078	Sulf2	sulfatase 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312896	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of SULF2 mRNA	PMID:40234311
1305078	Sulf2	sulfatase 2	gene	CHEBI:51052	lucanthone	increases expression	ISO	RGD:1312895	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in increased expression of SULF2 mRNA	PMID:21148553
1305078	Sulf2	sulfatase 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of SULF2 mRNA	PMID:24136188
1305078	Sulf2	sulfatase 2	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of SULF2 mRNA	PMID:22714537
1305078	Sulf2	sulfatase 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of SULF2 mRNA	PMID:18200517
1305078	Sulf2	sulfatase 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SULF2 mRNA]	PMID:18200517
1305078	Sulf2	sulfatase 2	gene	CHEBI:5855	ibuprofen	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:5864	ifosfamide	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA	PMID:39836092
1305078	Sulf2	sulfatase 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SULF2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SULF2 mRNA	PMID:21641980|PMID:26378955
1305078	Sulf2	sulfatase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SULF2 mRNA	PMID:28801915
1305078	Sulf2	sulfatase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased methylation of SULF2 gene	PMID:28801915
1305078	Sulf2	sulfatase 2	gene	CHEBI:67116	4-nitro-1,2-phenylenediamine	affects expression	EXP		E	RGD:6480464	20120904	CTD	MESH:C012277	1,2-diamino-4-nitrobenzene affects the expression of SULF2 mRNA	PMID:17070881
1305078	Sulf2	sulfatase 2	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1312895	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SULF2 intron	PMID:30157460
1305078	Sulf2	sulfatase 2	gene	CHEBI:68508	diethyl maleate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased expression of SULF2 mRNA	PMID:21161181
1305078	Sulf2	sulfatase 2	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SULF2 mRNA	PMID:39752319
1305078	Sulf2	sulfatase 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312895	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SULF2 mRNA	PMID:31758290
1305078	Sulf2	sulfatase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SULF2 mRNA	PMID:27840820
1305078	Sulf2	sulfatase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312896	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SULF2 mRNA	PMID:22206623
1305078	Sulf2	sulfatase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SULF2 mRNA]	PMID:22206623
1305078	Sulf2	sulfatase 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of SULF2 mRNA	PMID:24136188
1305078	Sulf2	sulfatase 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312895	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SULF2 mRNA	PMID:22714537
1305078	Sulf2	sulfatase 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312895	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SULF2 mRNA	PMID:37199045
1305078	Sulf2	sulfatase 2	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SULF2 mRNA	PMID:36139627
1305078	Sulf2	sulfatase 2	gene	CHEBI:76261	1-nitropropane	increases expression	EXP		E	RGD:6480464	20161220	CTD	MESH:C035314	1-nitropropane results in increased expression of SULF2 mRNA	PMID:17070881
1305078	Sulf2	sulfatase 2	gene	CHEBI:76288	2,6-diaminotoluene	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C025235	2,6-diaminotoluene results in increased expression of SULF2 mRNA	PMID:17070881
1305078	Sulf2	sulfatase 2	gene	CHEBI:76343	4-acetylaminofluorene	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C028676	4-acetylaminofluorene results in decreased expression of SULF2 mRNA	PMID:17070881
1305078	Sulf2	sulfatase 2	gene	CHEBI:76394	2-nitro-p-phenylenediamine	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C014706	2-nitro-4-phenylenediamine results in decreased expression of SULF2 mRNA	PMID:17070881
1305078	Sulf2	sulfatase 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SULF2 mRNA	PMID:32741896
1305078	Sulf2	sulfatase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA	PMID:27188386
1305078	Sulf2	sulfatase 2	gene	CHEBI:7852	oxycodone	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in increased expression of SULF2 mRNA	PMID:23439660
1305078	Sulf2	sulfatase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SULF2 gene]	PMID:28238834
1305078	Sulf2	sulfatase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312895	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SULF2 mRNA	PMID:19159669
1305078	Sulf2	sulfatase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312896	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SULF2 mRNA	PMID:31388691
1305078	Sulf2	sulfatase 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SULF2 mRNA	PMID:19167446
1305078	Sulf2	sulfatase 2	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1312895	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of SULF2 mRNA	PMID:20368581
1305078	Sulf2	sulfatase 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312895	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of SULF2 mRNA	PMID:26079696
1305078	Sulf2	sulfatase 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of SULF2 mRNA	PMID:30953684
1305078	Sulf2	sulfatase 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312896	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SULF2 mRNA	PMID:39847705
1305078	Sulf2	sulfatase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA	PMID:32525701
1305078	Sulf2	sulfatase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SULF2 mRNA	PMID:25825206
1305078	Sulf2	sulfatase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SULF2 mRNA	PMID:30047161
1305078	Sulf2	sulfatase 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20161228	CTD	MESH:C496932	[Cisplatin co-treated with panobinostat] affects the expression of SULF2 mRNA	PMID:21791302
1305078	Sulf2	sulfatase 2	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SULF2 mRNA	PMID:39752319
1305078	Sulf2	sulfatase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312895	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA	PMID:27188386
1305078	Sulf2	sulfatase 2	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D013605	T-2 Toxin results in increased expression of SULF2 mRNA	PMID:42167635
1305078	Sulf2	sulfatase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SULF2 mRNA	PMID:21346803
1305078	Sulf2	sulfatase 2	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of SULF2 mRNA	PMID:25596134
1305078	Sulf2	sulfatase 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312896	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of SULF2 mRNA	PMID:28973697
1305078	Sulf2	sulfatase 2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312896	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of SULF2 mRNA	PMID:35537566
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312897	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of DSE mRNA	PMID:33167477
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312897	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of DSE mRNA	PMID:21632981
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312897	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of DSE mRNA	PMID:22574217
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DSE mRNA	PMID:39298647
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DSE mRNA	PMID:33387578
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312897	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DSE mRNA	PMID:23649840
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312897	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DSE mRNA	PMID:21179406
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DSE mRNA	PMID:37992649
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312897	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of DSE gene	PMID:33872906
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DSE mRNA	PMID:37992649
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DSE mRNA	PMID:34319233
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312897	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of DSE gene	PMID:33872906
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DSE mRNA	PMID:39012411
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312897	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DSE protein	PMID:20106945
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312897	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DSE gene	PMID:27153756
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312897	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DSE mRNA	PMID:22100608
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312897	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of DSE mRNA	PMID:41430723
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312898	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DSE mRNA	PMID:31919559
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1312897	E	RGD:6480464	20120412	CTD	MESH:D016685	DSE protein affects the susceptibility to Mitomycin	PMID:16217747
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DSE mRNA	PMID:40504410
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DSE mRNA	PMID:19244175
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of DSE mRNA	PMID:28960355
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DSE mRNA	PMID:31881176
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312897	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of DSE mRNA	PMID:27392435|PMID:27594783
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DSE mRNA	PMID:33387578
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DSE mRNA	PMID:34747641
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of DSE mRNA	PMID:29955902
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DSE mRNA	PMID:33212167
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312897	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DSE mRNA	PMID:32763439
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312897	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of DSE mRNA	PMID:24690739
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DSE mRNA	PMID:37992649
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DSE mRNA	PMID:38568856
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DSE mRNA	PMID:40504410
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1312897	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of DSE mRNA	PMID:20106945
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312897	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DSE 5' UTR; Benzo(a)pyrene affects the methylation of DSE promoter	PMID:27901495
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DSE mRNA	PMID:21632981|PMID:21871943
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312897	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DSE mRNA	PMID:32234424
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312897	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of DSE mRNA	PMID:24690739
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DSE mRNA	PMID:19150397
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:31348	capecitabine	decreases response to substance	ISO	RGD:1312897	E	RGD:6480464	20170228	CTD	MESH:C110904	DSE protein results in decreased susceptibility to Capecitabine	PMID:16734730
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:31521	doxifluridine	decreases response to substance	ISO	RGD:1312897	E	RGD:6480464	20130806	CTD	MESH:C025034	DSE protein results in decreased susceptibility to doxifluridine	PMID:16734730
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312898	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of DSE mRNA	PMID:35295148
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DSE mRNA	PMID:34492290
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312898	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DSE mRNA	PMID:18648102
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DSE mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of DSE mRNA	PMID:41034487
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312897	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of DSE mRNA	PMID:25979313
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312898	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of DSE mRNA	PMID:26682919
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DSE mRNA	PMID:39298647
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312897	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of DSE gene	PMID:31601247
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312898	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DSE mRNA	PMID:30951980
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312898	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of DSE mRNA	PMID:30951980
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased expression of DSE mRNA	PMID:17374397
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312897	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of DSE mRNA	PMID:29024780
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DSE mRNA	PMID:39012411
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:35842	antirheumatic drug	affects expression	ISO	RGD:1312897	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents affects the expression of DSE mRNA	PMID:24449571
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DSE mRNA	PMID:19244175
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DSE mRNA	PMID:40419075
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312897	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DSE mRNA	PMID:25979313
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312897	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of DSE mRNA	PMID:29154799
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312897	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DSE mRNA	PMID:20106945
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of DSE mRNA	PMID:28973697
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DSE mRNA	PMID:37992649
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DSE mRNA	PMID:33387578
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312897	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DSE mRNA	PMID:22230336|PMID:29067470
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1312897	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of DSE mRNA	PMID:24714768
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1312897	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of DSE mRNA	PMID:24690739
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DSE mRNA	PMID:40504410
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DSE mRNA	PMID:29391264
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312897	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DSE mRNA	PMID:22079256
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:48981	quinolin-8-ol	increases expression	ISO	RGD:1312897	E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in increased expression of DSE mRNA	PMID:21632981
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of DSE mRNA	PMID:23962444
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20120515	CTD	MESH:C029938	nickel sulfate results in decreased expression of DSE mRNA	PMID:17374397
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20120515	CTD	MESH:D010081	Oxazolone results in decreased expression of DSE mRNA	PMID:17374397
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1312897	E	RGD:6480464	20120412	CTD	MESH:D019772	DSE protein affects the susceptibility to Topotecan	PMID:16217747
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DSE mRNA	PMID:22079256
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312897	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DSE mRNA	PMID:22079256
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312897	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DSE gene]	PMID:28238834
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312898	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DSE mRNA	PMID:23091169
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312898	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of DSE mRNA	PMID:31388691
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312897	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DSE mRNA	PMID:38568856
1305079	Dse	dermatan sulfate epimerase	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of DSE protein	PMID:24648495
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CDKL1 mRNA	PMID:30071829
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312900	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CDKL1 mRNA	PMID:22629407
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CDKL1 mRNA]	PMID:22629407
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1312900	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of CDKL1 mRNA	PMID:17556502
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20120412	CTD	MESH:D011374	NCOA2 protein affects the reaction [Progesterone results in decreased expression of CDKL1 mRNA]	PMID:17556502
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312900	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDKL1 mRNA	PMID:34319233
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312899	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CDKL1 protein	PMID:37730182
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312899	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CDKL1 mRNA	PMID:28818685
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312899	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CDKL1 mRNA	PMID:19549813
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDKL1 mRNA	PMID:33354967
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312899	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CDKL1 mRNA	PMID:26272509
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312899	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDKL1 mRNA	PMID:27188386
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CDKL1 mRNA	PMID:31881176
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312899	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CDKL1 mRNA	PMID:27392435
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312900	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of CDKL1 mRNA	PMID:18930951
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:28009	N-acetyl-beta-D-glucosamine	decreases expression	ISO	RGD:1312899	E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of CDKL1 mRNA	PMID:18047607
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312900	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDKL1 mRNA	PMID:21570461
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDKL1 mRNA	PMID:33387578
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312900	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of CDKL1 mRNA	PMID:39631538
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312899	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDKL1 mRNA	PMID:38568856
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA	PMID:34876320
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA	PMID:34876320
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312899	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDKL1 mRNA	PMID:32234424
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312899	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDKL1 exon	PMID:27901495
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1312899	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of CDKL1 mRNA	PMID:37690743
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of CDKL1 mRNA	PMID:16507785
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CDKL1 mRNA	PMID:30047161
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312900	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CDKL1 mRNA	PMID:23557971|PMID:29264374
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDKL1 mRNA	PMID:25181051|PMID:30816183
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312899	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of CDKL1 mRNA	PMID:29275510
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312900	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CDKL1 mRNA	PMID:32156529
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDKL1 mRNA	PMID:36041667
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312900	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CDKL1 mRNA	PMID:26682919
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312900	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CDKL1 gene	PMID:31683443
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312900	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CDKL1 mRNA	PMID:40203079
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDKL1 mRNA	PMID:36041667
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDKL1 mRNA	PMID:36041667
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312899	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDKL1 mRNA	PMID:37042841
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of CDKL1 mRNA	PMID:18500788
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CDKL1 mRNA	PMID:25539665
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CDKL1 gene	PMID:22079235
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312899	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CDKL1 mRNA	PMID:31533062
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CDKL1 mRNA	PMID:30047161
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312900	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CDKL1 mRNA	PMID:28973697
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312899	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CDKL1 mRNA	PMID:38832940
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CDKL1 mRNA	PMID:33387578
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA	PMID:34876320
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312900	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CDKL1 mRNA	PMID:25554681
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:506227	N-acetyl-D-glucosamine	decreases expression	ISO	RGD:1312899	E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of CDKL1 mRNA	PMID:18047607
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CDKL1 mRNA	PMID:30047161
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1312899	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of CDKL1 mRNA	PMID:11830524
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312899	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDKL1 mRNA	PMID:27188386
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CDKL1 mRNA	PMID:32109520
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CDKL1 mRNA	PMID:27935865
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:C010902	[Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of CDKL1 mRNA	PMID:32207525
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA	PMID:34876320
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CDKL1 mRNA	PMID:30047161
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CDKL1 mRNA	PMID:24780913
1305080	Cdkl1	cyclin dependent kinase like 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312899	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDKL1 mRNA	PMID:27188386
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312902	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of AIF1L mRNA	PMID:37995155
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of AIF1L mRNA	PMID:31016361
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1312901	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of AIF1L mRNA	PMID:11906190
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of AIF1L mRNA	PMID:21934132
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of AIF1L mRNA	PMID:20488242
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AIF1L mRNA	PMID:30529165
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AIF1L mRNA	PMID:36331819
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312901	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of AIF1L mRNA	PMID:26079696
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1312901	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of AIF1L mRNA	PMID:39506029
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312902	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of AIF1L mRNA	PMID:30319688
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312902	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of AIF1L mRNA	PMID:19484750
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of AIF1L mRNA	PMID:30165855
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of AIF1L mRNA	PMID:38568856
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of AIF1L mRNA	PMID:33387578
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312901	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of AIF1L mRNA	PMID:26079696
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312902	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of AIF1L mRNA	PMID:33848595
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of AIF1L mRNA]	PMID:33848595
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of AIF1L mRNA	PMID:26577399
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312901	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of AIF1L protein	PMID:37730182
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of AIF1L mRNA	PMID:33387578
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of AIF1L mRNA	PMID:28818685
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AIF1L mRNA	PMID:39012411
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AIF1L mRNA	PMID:19549813
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AIF1L protein	PMID:23301498
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AIF1L mRNA	PMID:21641981
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1312902	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of AIF1L mRNA	PMID:18579281
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312901	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of AIF1L protein	PMID:35688186
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312902	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of AIF1L protein	PMID:25505154
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of AIF1L mRNA	PMID:22023808
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312901	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of AIF1L mRNA	PMID:27392435
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AIF1L mRNA	PMID:27392435
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of AIF1L mRNA	PMID:15009677
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AIF1L mRNA	PMID:32109520|PMID:33387578
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312902	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AIF1L mRNA	PMID:16611356
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of AIF1L mRNA	PMID:28959563
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of AIF1L mRNA	PMID:32763439
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1312901	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of AIF1L mRNA	PMID:21198554
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of AIF1L mRNA	PMID:20971185
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of AIF1L mRNA	PMID:15467011
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1312901	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of AIF1L protein	PMID:35688186
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of AIF1L mRNA	PMID:29432896
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AIF1L mRNA	PMID:38568856
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312901	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of AIF1L mRNA	PMID:29301061
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312901	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AIF1L intron	PMID:30157460
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AIF1L mRNA	PMID:26238291
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312902	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AIF1L mRNA	PMID:21569818
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312901	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AIF1L promoter	PMID:27901495
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of AIF1L mRNA	PMID:20971185
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of AIF1L mRNA	PMID:15467011
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of AIF1L gene	PMID:31601247
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of AIF1L mRNA	PMID:38568856
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312902	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of AIF1L mRNA	PMID:29264374
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312902	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AIF1L gene	PMID:35295148
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312902	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of AIF1L mRNA	PMID:27760801
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of AIF1L mRNA	PMID:25181051|PMID:30816183
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of AIF1L protein	PMID:37567409
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of AIF1L mRNA	PMID:33296240
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AIF1L gene	PMID:28505145
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of AIF1L gene	PMID:31601247
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312901	E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in increased expression of AIF1L mRNA	PMID:25912373
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of AIF1L mRNA	PMID:35163327
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312901	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AIF1L mRNA	PMID:38174414
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AIF1L mRNA	PMID:39012411
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of AIF1L protein	PMID:26879310
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of AIF1L mRNA	PMID:35163327
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312901	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of AIF1L mRNA	PMID:24449571
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312902	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of AIF1L mRNA	PMID:40194260
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of AIF1L mRNA	PMID:31533062
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of AIF1L mRNA	PMID:40419075
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AIF1L mRNA	PMID:36331819
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312901	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AIF1L mRNA	PMID:25979313
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of AIF1L mRNA	PMID:28001369
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312901	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of AIF1L mRNA	PMID:19101580|PMID:26272509
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312901	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of AIF1L gene	PMID:29154799
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIF1L mRNA	PMID:27188386
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of AIF1L mRNA	PMID:38685447|PMID:41580965
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of AIF1L mRNA	PMID:21865292
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AIF1L mRNA	PMID:25562108
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312902	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of AIF1L mRNA	PMID:22733784
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of AIF1L mRNA	PMID:36653537
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of AIF1L mRNA	PMID:33387578
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of AIF1L mRNA	PMID:29391264
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of AIF1L mRNA	PMID:18175754
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of AIF1L mRNA	PMID:30307764
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312902	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AIF1L mRNA	PMID:25554681
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of AIF1L mRNA	PMID:41580965
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312902	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of AIF1L mRNA	PMID:23608068
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AIF1L mRNA	PMID:26378955
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312901	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of AIF1L mRNA	PMID:24810058
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312901	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of AIF1L mRNA	PMID:31758290
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312901	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AIF1L mRNA	PMID:25912373
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312902	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AIF1L mRNA	PMID:22206623
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AIF1L protein	PMID:37664457
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIF1L mRNA	PMID:27188386
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312901	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of AIF1L mRNA	PMID:26079696
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of AIF1L mRNA	PMID:30047161
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312901	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AIF1L protein; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIF1L mRNA	PMID:27188386|PMID:37664457
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of AIF1L mRNA	PMID:11906190
1305081	Aif1l	allograft inflammatory factor 1-like	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312901	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AIF1L mRNA	PMID:38568856
1305082	Prp2	proline rich protein 2	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20230516	CTD	MESH:D003042	Cocaine results in increased expression of PRP2 mRNA	PMID:17898221
1305082	Prp2	proline rich protein 2	gene	CHEBI:28794	coumarin	decreases expression	EXP		E	RGD:6480464	20230516	CTD	MESH:C030123	coumarin results in decreased expression of PRP2 mRNA	PMID:18480146
1305082	Prp2	proline rich protein 2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20230516	CTD	MESH:D000643	Ammonium Chloride affects the expression of PRP2 mRNA	PMID:16483693
1305082	Prp2	proline rich protein 2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20230516	CTD	MESH:C069837	fullerene C60 results in decreased expression of PRP2 mRNA	PMID:19167457
1305082	Prp2	proline rich protein 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PRP2 mRNA	PMID:30047161
1305082	Prp2	proline rich protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312903	E	RGD:6480464	20230516	CTD	MESH:D000082	Acetaminophen affects the expression of PRP2 mRNA	PMID:17562736
1305082	Prp2	proline rich protein 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312903	E	RGD:6480464	20230516	CTD	MESH:C109476	epoxiconazole results in increased expression of PRP2 mRNA	PMID:35436446
1305082	Prp2	proline rich protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312903	E	RGD:6480464	20230516	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of PRP2 mRNA	PMID:22206623
1305082	Prp2	proline rich protein 2	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20230516	CTD	MESH:D009966	Orphenadrine affects the expression of PRP2 mRNA	PMID:23665939
1305082	Prp2	proline rich protein 2	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of PRP2 mRNA	PMID:30047161
1305082	Prp2	proline rich protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PRP2 mRNA	PMID:30047161
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of RO60 mRNA	PMID:25596134
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RO60 gene	PMID:20938992
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TROVE2 mRNA	PMID:33167477
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312904	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of RO60 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of RO60 mRNA	PMID:32699268
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312904	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RO60 mRNA	PMID:25596134
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of RO60 mRNA	PMID:40945087
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312904	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RO60 mRNA	PMID:21179406
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RO60 mRNA	PMID:39241906
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RO60 gene	PMID:20938992
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312904	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RO60 mRNA	PMID:21179406
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RO60 mRNA	PMID:27523638
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1312904	E	RGD:6480464	20211207	CTD	MESH:D003471	Cuprizone results in increased expression of TROVE2 protein	PMID:34122009
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312904	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RO60 protein	PMID:37730182
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TROVE2 mRNA	PMID:33387578
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312904	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RO60 mRNA	PMID:28818685
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of RO60 mRNA	PMID:27462272
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312904	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RO60 protein	PMID:23301498
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RO60 mRNA	PMID:33354967
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312904	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RO60 gene	PMID:27153756
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RO60 mRNA	PMID:19770486
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of RO60 mRNA	PMID:41580963
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312904	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of RO60 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of RO60 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of RO60 mRNA	PMID:32699268
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of RO60 mRNA	PMID:15226459
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TROVE2 mRNA	PMID:25629700
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RO60 gene	PMID:20938992
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312904	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RO60 gene	PMID:25304211
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RO60 mRNA	PMID:40504410
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of RO60 mRNA	PMID:19244175
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1312904	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of RO60 protein	PMID:38460933
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RO60 mRNA	PMID:31881176
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of RO60 mRNA	PMID:25596134
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312904	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RO60 mRNA	PMID:23557933
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of RO60 mRNA	PMID:25596134
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of RO60 mRNA	PMID:17898221
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RO60 mRNA	PMID:21570461
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RO60 mRNA; Tetrachlorodibenzodioxin results in decreased expression of TROVE2 mRNA	PMID:32109520|PMID:33387578
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RO60 mRNA	PMID:19465110
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RO60 mRNA	PMID:28001369
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RO60 mRNA	PMID:28959563
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RO60 mRNA	PMID:25523186
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RO60 mRNA	PMID:40504410
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RO60 mRNA	PMID:25523186
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of RO60 mRNA	PMID:15226459
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1312904	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of RO60 mRNA	PMID:35984750
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RO60 mRNA	PMID:34492290
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RO60 mRNA	PMID:25181051
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RO60 mRNA	PMID:30816183|PMID:34947998
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RO60 mRNA	PMID:29097150|PMID:33296240
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312904	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of RO60 protein	PMID:37567409
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RO60 mRNA	PMID:19244175
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RO60 mRNA	PMID:39298647
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312904	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RO60 protein	PMID:34186270
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1624075	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RO60 mRNA	PMID:38685157
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RO60 mRNA	PMID:37019170
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of RO60 mRNA	PMID:17312168
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312904	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TROVE2 mRNA	PMID:37042841
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:35176	zinc sulfate	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of RO60 mRNA	PMID:15226459
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RO60 mRNA	PMID:38568856
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312904	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RO60 protein	PMID:24527689
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:36009	omega-6 fatty acid	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20170117	CTD	MESH:D043371	Fatty Acids, Omega-6 results in decreased expression of RO60 mRNA	PMID:16823509
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312904	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of RO60 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of RO60 mRNA	PMID:32699268
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of RO60 mRNA	PMID:19244175
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of RO60 mRNA	PMID:25596134
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RO60 mRNA	PMID:40194260
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RO60 mRNA	PMID:28302478
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of RO60 mRNA	PMID:23125180
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of RO60 mRNA	PMID:29427782
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of RO60 mRNA	PMID:29427782
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RO60 mRNA	PMID:23179753
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312904	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RO60 gene	PMID:29154799
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312904	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RO60 mRNA	PMID:25596134
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:41607	crotonaldehyde	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of RO60 mRNA	PMID:20471460
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of RO60 mRNA	PMID:24935251
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1312904	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of RO60 protein	PMID:38460933
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312904	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RO60 gene	PMID:25304211
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RO60 mRNA	PMID:40504410
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RO60 mRNA	PMID:29097150
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of RO60 mRNA	PMID:16984733
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of RO60 mRNA	PMID:25596134
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1312904	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of TROVE2 mRNA	PMID:26705709
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:5864	ifosfamide	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of RO60 mRNA	PMID:25596134
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of RO60 mRNA	PMID:20436886
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RO60 protein	PMID:32959892
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] affects the expression of RO60 mRNA	PMID:26378955
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D007545	Isoproterenol results in increased expression of RO60 mRNA	PMID:20003209
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:6801	metformin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin affects the expression of RO60 mRNA	PMID:25596134
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of RO60 mRNA	PMID:27462272
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TROVE2 mRNA	PMID:22206623
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312904	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RO60 protein	PMID:37664457
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:757488	omega-3 fatty acids	increases expression	ISO	RGD:1312904	E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 results in increased expression of RO60 mRNA	PMID:16823509
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D010634	Phenobarbital affects the expression of RO60 mRNA	PMID:23091169
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RO60 mRNA	PMID:32109520
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312904	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RO60 protein	PMID:38348393
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:C009277	sodium arsenate results in increased expression of RO60 mRNA	PMID:21795629
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312904	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RO60 protein	PMID:37664457
1305083	Ro60	Ro60, Y RNA binding protein	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of RO60 mRNA	PMID:23555832
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1352232	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ZNF473 mRNA	PMID:38218311
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552774	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ZFP473 mRNA	PMID:33045310
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1352232	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ZNF473 mRNA	PMID:23724009
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1352232	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZNF473 mRNA	PMID:22378314
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1352232	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ZNF473 mRNA	PMID:20044591
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552774	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP473 mRNA	PMID:25510870
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ZFP473 mRNA	PMID:33387578
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1352232	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ZNF473 mRNA	PMID:23649840
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1352232	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ZNF473 mRNA	PMID:21179406
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1352232	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of ZNF473 mRNA	PMID:33647349
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF473 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ZNF473 mRNA	PMID:39836092
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552774	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP473 mRNA	PMID:25510870
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552774	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP473 mRNA	PMID:25510870
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1352232	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZNF473 mRNA	PMID:19549813
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1352232	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ZNF473 mRNA	PMID:23649840
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1352232	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZNF473 mRNA	PMID:22100608
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1352232	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZNF473 gene	PMID:27153756
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1352232	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNF473 mRNA	PMID:23649840
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZNF473 mRNA	PMID:18593933
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF473 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF473 mRNA	PMID:39836092
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of ZFP473 mRNA	PMID:38314887
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1552774	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of ZFP473 mRNA	PMID:28960355
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552774	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP473 mRNA	PMID:16962184|PMID:21570461
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP473 mRNA	PMID:33387578
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1352232	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF473 mRNA	PMID:33212167
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1352232	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZNF473 mRNA	PMID:32763439
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ZNF473 mRNA	PMID:20971185
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1352232	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF473 mRNA	PMID:29803840
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352232	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF473 mRNA	PMID:38568856
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF473 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF473 mRNA	PMID:39836092
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552774	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZFP473 mRNA	PMID:22228805
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352232	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZNF473 3' UTR	PMID:27901495
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ZNF473 mRNA	PMID:20971185
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZNF473 mRNA	PMID:18593933
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1352232	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ZNF473 mRNA	PMID:26014281
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1352232	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ZNF473 mRNA	PMID:35984750
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552774	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP473 gene	PMID:35295148
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFP473 mRNA	PMID:34492290
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1352232	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of ZNF473 mRNA	PMID:36232920
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552774	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP473 mRNA	PMID:25510870
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552774	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP473 mRNA	PMID:25510870
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ZFP473 mRNA	PMID:32119087
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552774	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ZFP473 mRNA	PMID:40203079
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF473 mRNA	PMID:28628672
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552774	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP473 mRNA	PMID:37019170
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF473 mRNA	PMID:28628672
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1352232	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF473 mRNA	PMID:37042841
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF473 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ZNF473 mRNA	PMID:39836092
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1352232	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ZNF473 mRNA	PMID:19320972
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552774	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ZFP473 mRNA	PMID:39529242
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1352232	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF473 mRNA	PMID:28001369
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1352232	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ZNF473 mRNA	PMID:29154799
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1352232	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZNF473 gene	PMID:29154799
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1352232	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF473 mRNA	PMID:20106945|PMID:25562108
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF473 mRNA	PMID:28628672
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFP473 mRNA	PMID:33387578
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1352232	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ZNF473 mRNA	PMID:21420995|PMID:22230336
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1352232	E	RGD:6480464	20120412	CTD	MESH:D005472	ZNF473 protein affects the susceptibility to Fluorouracil	PMID:15331170
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1352232	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of ZNF473 mRNA	PMID:15331170
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF473 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF473 mRNA	PMID:39836092
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1352232	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of ZNF473 mRNA	PMID:22077320
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ZNF473 mRNA	PMID:22079256
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF473 mRNA	PMID:28628672
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552774	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ZFP473 mRNA	PMID:19042947
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1552774	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ZFP473 mRNA	PMID:23608068
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ZNF473 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ZNF473 mRNA	PMID:39836092
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552774	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP473 mRNA	PMID:22206623
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1352232	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ZNF473 mRNA	PMID:22079256
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ZNF473 mRNA	PMID:22079256
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1352232	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of ZNF473 mRNA	PMID:19946333
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of ZNF473 mRNA]	PMID:19946333
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1352232	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF473 protein	PMID:31285264
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352232	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF473 gene]	PMID:28238834
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of ZFP473 mRNA	PMID:32109520
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1352232	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ZNF473 mRNA	PMID:26014281
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1352232	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF473 mRNA	PMID:38568856
1305084	Zfp473	zinc finger protein 473	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552774	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ZFP473 mRNA	PMID:35537566
1305085	Matn3	matrilin 3	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in decreased expression of MATN3 mRNA	PMID:24172598
1305085	Matn3	matrilin 3	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1312907	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MATN3 mRNA	PMID:26272509|PMID:27188386
1305085	Matn3	matrilin 3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA	PMID:27188386
1305085	Matn3	matrilin 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312907	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MATN3 mRNA	PMID:25812627
1305085	Matn3	matrilin 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312907	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MATN3 mRNA	PMID:22378314
1305085	Matn3	matrilin 3	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20120918	CTD	MESH:D000431	Ethanol results in decreased expression of MATN3 protein	PMID:20621659
1305085	Matn3	matrilin 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312907	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MATN3 mRNA	PMID:20044591
1305085	Matn3	matrilin 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MATN3 mRNA	PMID:30165855
1305085	Matn3	matrilin 3	gene	CHEBI:16767	3,4-dichloroaniline	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in decreased expression of MATN3 mRNA	PMID:24172598
1305085	Matn3	matrilin 3	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312907	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of MATN3 mRNA	PMID:21592394
1305085	Matn3	matrilin 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of MATN3 mRNA	PMID:21592394
1305085	Matn3	matrilin 3	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312907	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of MATN3 mRNA	PMID:21592394
1305085	Matn3	matrilin 3	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of MATN3 mRNA	PMID:21592394
1305085	Matn3	matrilin 3	gene	CHEBI:18088	formononetin	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20240402	CTD	MESH:C007768	formononetin results in decreased expression of MATN3 mRNA	PMID:37793997
1305085	Matn3	matrilin 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA	PMID:39836092
1305085	Matn3	matrilin 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MATN3 mRNA	PMID:19549813
1305085	Matn3	matrilin 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312907	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MATN3 mRNA	PMID:21632981
1305085	Matn3	matrilin 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312907	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MATN3 gene	PMID:25304211
1305085	Matn3	matrilin 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN3 mRNA	PMID:39836092
1305085	Matn3	matrilin 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of MATN3 mRNA	PMID:19167446
1305085	Matn3	matrilin 3	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1312907	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of MATN3 promoter	PMID:22847954
1305085	Matn3	matrilin 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312907	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of MATN3 mRNA	PMID:26865667
1305085	Matn3	matrilin 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MATN3 mRNA	PMID:24768652|PMID:25583101
1305085	Matn3	matrilin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MATN3 mRNA	PMID:32109520
1305085	Matn3	matrilin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MATN3 mRNA	PMID:20106945|PMID:21632981
1305085	Matn3	matrilin 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MATN3 mRNA	PMID:33212167
1305085	Matn3	matrilin 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MATN3 mRNA	PMID:28959563
1305085	Matn3	matrilin 3	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of MATN3 mRNA	PMID:22623647
1305085	Matn3	matrilin 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of MATN3 mRNA	PMID:34032870
1305085	Matn3	matrilin 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN3 mRNA	PMID:39836092
1305085	Matn3	matrilin 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312907	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MATN3 intron	PMID:30157460
1305085	Matn3	matrilin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MATN3 mRNA	PMID:21632981
1305085	Matn3	matrilin 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312907	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MATN3 mRNA	PMID:22316170
1305085	Matn3	matrilin 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MATN3 mRNA	PMID:25895662
1305085	Matn3	matrilin 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of MATN3 gene	PMID:31601247
1305085	Matn3	matrilin 3	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of MATN3 mRNA	PMID:25729387
1305085	Matn3	matrilin 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of MATN3 mRNA	PMID:25729387
1305085	Matn3	matrilin 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312908	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MATN3 mRNA	PMID:18648102
1305085	Matn3	matrilin 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312907	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MATN3 mRNA	PMID:30903817
1305085	Matn3	matrilin 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MATN3 mRNA	PMID:25181051
1305085	Matn3	matrilin 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MATN3 mRNA	PMID:34947998
1305085	Matn3	matrilin 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MATN3 gene	PMID:28505145
1305085	Matn3	matrilin 3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312907	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MATN3 intron	PMID:30157460
1305085	Matn3	matrilin 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of MATN3 gene	PMID:31601247
1305085	Matn3	matrilin 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA	PMID:39836092
1305085	Matn3	matrilin 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MATN3 mRNA	PMID:26472689|PMID:38568856
1305085	Matn3	matrilin 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MATN3 mRNA	PMID:24386269
1305085	Matn3	matrilin 3	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312908	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of MATN3 mRNA	PMID:17585979
1305085	Matn3	matrilin 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MATN3 mRNA	PMID:28302478
1305085	Matn3	matrilin 3	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1312907	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of MATN3 promoter	PMID:22847954
1305085	Matn3	matrilin 3	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1312907	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of MATN3 promoter	PMID:22847954
1305085	Matn3	matrilin 3	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of MATN3 mRNA	PMID:19167446
1305085	Matn3	matrilin 3	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MATN3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of MATN3 mRNA	PMID:19167446
1305085	Matn3	matrilin 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312908	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MATN3 mRNA	PMID:39529242
1305085	Matn3	matrilin 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312907	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MATN3 mRNA	PMID:25812627
1305085	Matn3	matrilin 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312907	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MATN3 mRNA	PMID:25979313
1305085	Matn3	matrilin 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312907	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MATN3 gene	PMID:29154799
1305085	Matn3	matrilin 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312907	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MATN3 mRNA	PMID:26272509|PMID:28001369
1305085	Matn3	matrilin 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA	PMID:27188386
1305085	Matn3	matrilin 3	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1312907	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of MATN3 mRNA	PMID:25562108
1305085	Matn3	matrilin 3	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312907	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of MATN3 mRNA	PMID:24714768
1305085	Matn3	matrilin 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312907	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MATN3 gene	PMID:25304211
1305085	Matn3	matrilin 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN3 mRNA	PMID:39836092
1305085	Matn3	matrilin 3	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312907	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MATN3 mRNA	PMID:22714537
1305085	Matn3	matrilin 3	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of MATN3 mRNA	PMID:28801915
1305085	Matn3	matrilin 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA	PMID:39836092
1305085	Matn3	matrilin 3	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MATN3 mRNA	PMID:25729387
1305085	Matn3	matrilin 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of MATN3 mRNA	PMID:25729387
1305085	Matn3	matrilin 3	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312907	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MATN3 intron	PMID:30157460
1305085	Matn3	matrilin 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA	PMID:27188386
1305085	Matn3	matrilin 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MATN3 mRNA	PMID:32109520
1305085	Matn3	matrilin 3	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MATN3 mRNA	PMID:19167446
1305085	Matn3	matrilin 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312907	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA	PMID:27188386
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1613934	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KBTBD6 mRNA	PMID:33045310
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of KBTBD6 mRNA	PMID:33167477
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D001280	Atrazine results in decreased expression of KBTBD6 mRNA	PMID:22378314
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D011794	Quercetin results in decreased expression of KBTBD6 mRNA	PMID:21632981
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1613934	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of KBTBD6 mRNA	PMID:39241906
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D004958	Estradiol results in increased expression of KBTBD6 mRNA	PMID:24758408
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in increased expression of KBTBD6 mRNA]	PMID:24758408
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1346287	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of KBTBD6 mRNA	PMID:38568856
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KBTBD6 mRNA	PMID:33387578
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1346287	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KBTBD6 mRNA	PMID:37042841
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of KBTBD6 mRNA	PMID:20655997|PMID:27664576
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D005557	Formaldehyde results in increased expression of KBTBD6 mRNA	PMID:23649840
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:17323	trans-pinosylvin	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:C049032	pinosylvin results in decreased expression of KBTBD6 mRNA	PMID:23333577
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of KBTBD6 mRNA	PMID:31256213
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1613934	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KBTBD6 mRNA	PMID:34319233
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KBTBD6 mRNA	PMID:33387578
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KBTBD6 mRNA	PMID:28818685
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1613934	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of KBTBD6 mRNA	PMID:39984025
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1346287	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KBTBD6 mRNA	PMID:35301059
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1613934	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KBTBD6 mRNA	PMID:28111341
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346287	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KBTBD6 gene	PMID:27153756
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KBTBD6 mRNA	PMID:23649840
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1613934	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of KBTBD6 mRNA	PMID:34911549
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D015032	Zinc deficiency results in decreased expression of KBTBD6 mRNA	PMID:22171008
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1613934	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of KBTBD6 mRNA	PMID:30912803
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KBTBD6 mRNA	PMID:20106945|PMID:21632981
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1613934	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KBTBD6 mRNA	PMID:31961203
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KBTBD6 mRNA	PMID:33387578
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KBTBD6 mRNA	PMID:28001369
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KBTBD6 mRNA	PMID:29803840
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of KBTBD6 mRNA	PMID:38568856
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346287	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of KBTBD6 protein	PMID:21925251
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1346287	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KBTBD6 3' UTR; Benzo(a)pyrene results in decreased methylation of KBTBD6 exon	PMID:27901495
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D015032	Zinc deficiency results in decreased expression of KBTBD6 mRNA	PMID:22171008
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:33146	vanadyl sulfate	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:C034028	vanadyl sulfate results in decreased expression of KBTBD6 mRNA	PMID:16330358
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KBTBD6 mRNA	PMID:25181051
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1613934	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of KBTBD6 mRNA	PMID:33221593
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1613934	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of KBTBD6 mRNA	PMID:39298647
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1613934	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of KBTBD6 mRNA	PMID:26377693
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346287	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KBTBD6 mRNA	PMID:37042841
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KBTBD6 mRNA	PMID:18560533|PMID:38568856
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1346287	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KBTBD6 mRNA	PMID:35301059
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1613934	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KBTBD6 mRNA	PMID:28111341
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:36011	pinosylvin	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:C049032	pinosylvin results in decreased expression of KBTBD6 mRNA	PMID:23333577
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D014635	Valproic Acid affects the expression of KBTBD6 mRNA	PMID:25979313
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D014635	Valproic Acid results in decreased expression of KBTBD6 mRNA	PMID:23179753|PMID:28001369
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20160719	CTD	MESH:D016572	Cyclosporine results in decreased expression of KBTBD6 mRNA	PMID:25562108
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KBTBD6 mRNA	PMID:33387578
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KBTBD6 mRNA	PMID:29391264
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of KBTBD6 mRNA	PMID:30307764
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1613934	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of KBTBD6 mRNA; Nanotubes, Carbon results in increased expression of KBTBD6 mRNA	PMID:25554681
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1613934	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of KBTBD6 mRNA	PMID:38701926
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of KBTBD6 mRNA	PMID:28988120
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346287	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KBTBD6 gene]	PMID:28238834
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1346287	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of KBTBD6 mRNA	PMID:38568856
1305086	Kbtbd6	kelch repeat and BTB domain containing 6	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1613934	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of KBTBD6 mRNA	PMID:35537566
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1605279	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SLC9B1 mRNA	PMID:26516004
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SLC9B1 mRNA	PMID:33387578
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605279	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC9B1 gene	PMID:27153756
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC9B1 mRNA	PMID:33387578
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SLC9B1 mRNA	PMID:28959563
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:28854	2,4-D	decreases expression	ISO	RGD:1605279	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of SLC9B1 mRNA	PMID:40294809
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312910	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC9B1 mRNA	PMID:39490100
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605279	E	RGD:6480464	20231205	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC9B1 5' UTR; Benzo(a)pyrene results in increased methylation of SLC9B1 promoter	PMID:27901495
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312910	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SLC9B1 mRNA	PMID:20813756
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312910	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC9B1 mRNA	PMID:19710929
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC9B1 mRNA	PMID:25181051
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605279	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC9B1 mRNA	PMID:27685785
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1605279	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SLC9B1 gene	PMID:31601247
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC9B1 gene	PMID:28505145
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1605279	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in decreased expression of SLC9B1 mRNA	PMID:27685785
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1605279	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SLC9B1 intron	PMID:30157460
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1605279	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of SLC9B1 mRNA	PMID:37047231
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605279	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SLC9B1 mRNA	PMID:38382870
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605279	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC9B1 mRNA	PMID:26690555
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1605279	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SLC9B1 intron	PMID:30157460
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SLC9B1 gene	PMID:35440735
1305087	Slc9b1	solute carrier family 9 member B1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312910	E	RGD:6480464	20231205	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC9B1 mRNA	PMID:22206623
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312911	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PURG mRNA	PMID:26272509
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312911	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PURG mRNA	PMID:20938992
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312911	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PURG mRNA	PMID:23724009
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312911	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PURG mRNA	PMID:26516004
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PURG mRNA	PMID:30529165
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312911	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PURG mRNA	PMID:26079696
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PURG mRNA	PMID:23829299
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PURG mRNA	PMID:20938992
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312911	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PURG mRNA	PMID:31163220
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PURG mRNA	PMID:37325564
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312912	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PURG mRNA	PMID:19770486
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PURG mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PURG mRNA	PMID:20938992|PMID:22206623
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312911	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312912	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PURG mRNA	PMID:28960355
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312912	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PURG mRNA	PMID:21570461
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PURG mRNA	PMID:33387578
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312911	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PURG mRNA	PMID:29301061
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312911	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PURG 3' UTR; Benzo(a)pyrene affects the methylation of PURG promoter	PMID:27901495
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312911	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PURG mRNA	PMID:32234424
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312911	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PURG exon	PMID:27901495
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312911	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PURG mRNA	PMID:15761015
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PURG mRNA	PMID:30047161
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312912	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of PURG mRNA	PMID:23557971
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312912	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PURG promoter alternative form	PMID:35295148
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312912	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in increased expression of PURG mRNA	PMID:25270620
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PURG mRNA	PMID:19167457
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312912	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of PURG mRNA	PMID:35598803
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PURG gene	PMID:28505145
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl affects the expression of PURG mRNA	PMID:23829299
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312912	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PURG gene	PMID:31683443
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312912	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PURG mRNA	PMID:37019170
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PURG mRNA	PMID:37325564
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312911	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PURG mRNA	PMID:31533062
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312912	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PURG mRNA	PMID:39529242
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312911	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PURG mRNA	PMID:25979313
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PURG mRNA	PMID:29427782
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312911	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PURG mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:28001369
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312911	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PURG gene	PMID:29154799
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312911	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of PURG mRNA	PMID:24935251
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312911	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PURG mRNA	PMID:30047161
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312911	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PURG mRNA	PMID:28542535
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312911	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PURG mRNA	PMID:24935251|PMID:26272509
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312911	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PURG mRNA	PMID:24935251
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312911	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PURG mRNA	PMID:33387578
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1312911	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of PURG mRNA]	PMID:15016801
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:48607	lithium chloride	decreases expression	ISO	RGD:1312911	E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in decreased expression of PURG mRNA	PMID:23527032
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312911	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PURG mRNA	PMID:15761015
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PURG mRNA	PMID:30307764
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312912	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PURG mRNA	PMID:25554681
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PURG mRNA	PMID:30047161
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PURG mRNA	PMID:22206623
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312911	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1312911	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of PURG mRNA	PMID:30458266
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PURG mRNA	PMID:30047161
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1312911	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of PURG mRNA	PMID:26272509
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312911	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312911	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1305088	Purg	purine-rich element binding protein G	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of PURG mRNA	PMID:23555832
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312913	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRORP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRORP mRNA	PMID:32699268
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312914	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of PRORP mRNA	PMID:40945087
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PRORP mRNA	PMID:21632981
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in decreased expression of PRORP protein	PMID:33181973
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PRORP mRNA	PMID:23829299
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PRORP mRNA	PMID:28818685
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PRORP mRNA	PMID:19549813
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312913	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PRORP protein	PMID:20106945
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312913	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRORP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRORP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PRORP mRNA	PMID:32699268
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312914	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PRORP mRNA	PMID:34911549
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PRORP mRNA	PMID:21867686
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of PRORP protein	PMID:39603559
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D020106	Acrylamide results in increased expression of PRORP mRNA	PMID:28959563
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PRORP mRNA	PMID:29803840
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PRORP mRNA	PMID:22378314
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312913	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRORP intron	PMID:30157460
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PRORP mRNA	PMID:20064835|PMID:21632981
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in decreased expression of PRORP mRNA	PMID:25729387
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PRORP mRNA	PMID:34492290
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312914	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PRORP mRNA	PMID:32156529|PMID:33221593
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PRORP mRNA	PMID:25181051
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20191008	CTD	MESH:C006780	bisphenol A results in increased methylation of PRORP gene	PMID:28505145
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of PRORP mRNA	PMID:23829299
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312913	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PRORP intron	PMID:30157460
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312914	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PRORP mRNA	PMID:34813904
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PRORP mRNA	PMID:38568856
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PRORP promoter	PMID:22457795
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20191008	CTD	MESH:C039281	furan results in increased methylation of PRORP gene	PMID:22079235
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312913	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRORP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRORP mRNA	PMID:32699268
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PRORP mRNA	PMID:28302478
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PRORP mRNA	PMID:20106945
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312913	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PRORP mRNA	PMID:25562108
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRORP mRNA	PMID:33387578
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRORP mRNA	PMID:21420995|PMID:25704631|PMID:29067470
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312913	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRORP mRNA	PMID:22079256
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D018120	Finasteride results in increased expression of PRORP mRNA	PMID:24136188
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:51876	auramine O	increases expression	ISO	RGD:1312913	E	RGD:6480464	20191114	CTD	MESH:D001576	Benzophenoneidum results in increased expression of PRORP protein	PMID:28722353
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in decreased expression of PRORP mRNA	PMID:25729387
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of PRORP mRNA	PMID:37939859
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312913	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PRORP intron	PMID:30157460
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PRORP mRNA	PMID:22079256
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312913	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRORP mRNA	PMID:22079256
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in decreased expression of PRORP protein	PMID:39638853
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D013467	Sulindac results in increased expression of PRORP mRNA	PMID:24136188
1305089	Prorp	protein only RNase P catalytic subunit	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312913	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of PRORP mRNA	PMID:22378314
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312915	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of MNMIP1 mRNA	PMID:37995155
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605948	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MNMIP1 mRNA	PMID:33167477
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1605948	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MNMIP1 mRNA	PMID:26516004
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MNMIP1 mRNA	PMID:36331819
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1605948	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of MNMIP1 mRNA	PMID:26079696
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312915	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MNMIP1 mRNA	PMID:39241906
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312915	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MNMIP1 mRNA	PMID:39298647
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1605948	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MNMIP1 mRNA	PMID:30165855
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MNMIP1 mRNA	PMID:33387578
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605948	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MNMIP1 mRNA	PMID:37042841
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3D21 mRNA	PMID:37992649
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1605948	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of MNMIP1 mRNA	PMID:21592394
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1605948	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of MNMIP1 mRNA	PMID:21592394
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1605948	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of MNMIP1 mRNA	PMID:33647349
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3D21 mRNA	PMID:37992649
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1605948	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MNMIP1 protein	PMID:37730182
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1605948	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MNMIP1 mRNA	PMID:36139627
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1605948	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of MNMIP1 mRNA	PMID:21592394
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1605948	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of MNMIP1 mRNA	PMID:21592394
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MNMIP1 mRNA	PMID:33387578
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1605948	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MNMIP1 mRNA	PMID:28818685
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1605948	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of MNMIP1 promoter	PMID:30157460
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of MNMIP1 mRNA	PMID:28522335
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605948	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MNMIP1 mRNA	PMID:19549813
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605948	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MNMIP1 promoter	PMID:30157460
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MNMIP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MNMIP1 mRNA	PMID:34911549
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605948	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MNMIP1 mRNA	PMID:35430440
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MNMIP1 mRNA	PMID:31150632
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1605948	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MNMIP1 gene	PMID:25304211
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1605948	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MNMIP1 protein	PMID:35688186
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MNMIP1 mRNA	PMID:31881176
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605948	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MNMIP1 mRNA	PMID:23557933
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MNMIP1 mRNA	PMID:33387578
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1605948	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MNMIP1 mRNA	PMID:30851411
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:28428	beta-hexachlorocyclohexane	decreases expression	ISO	RGD:1312915	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in decreased expression of MNMIP1 mRNA	PMID:25270620
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312915	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of MNMIP1 mRNA	PMID:27862939
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3D21 mRNA	PMID:37992649
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605948	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of MNMIP1 mRNA	PMID:39719251
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MNMIP1 mRNA	PMID:34876320
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MNMIP1 mRNA	PMID:34876320
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605948	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MNMIP1 promoter	PMID:27901495|PMID:30157460
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605948	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MNMIP1 5' UTR	PMID:27901495
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605948	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MNMIP1 mRNA]	PMID:32406909
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1605948	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of MNMIP1 mRNA	PMID:25895662
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:30621	diarsenic trioxide	affects expression	ISO	RGD:1312915	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide affects the expression of MNMIP1 mRNA	PMID:39716349
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of MNMIP1 gene	PMID:23968726
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MNMIP1 mRNA	PMID:25181051
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312915	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MNMIP1 mRNA	PMID:34585602
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MNMIP1 gene	PMID:28505145
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312915	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MNMIP1 promoter	PMID:27312807
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1605948	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in decreased expression of MNMIP1 mRNA	PMID:27685785
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1312915	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of MNMIP1 mRNA	PMID:26377693
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312915	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MNMIP1 mRNA	PMID:38685157
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312915	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of MNMIP1 mRNA	PMID:30951980
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312915	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of MNMIP1 promoter	PMID:28392331
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312915	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MNMIP1 mRNA	PMID:37019170
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of MNMIP1 gene	PMID:23968726
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605948	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MNMIP1 mRNA	PMID:37042841
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of MNMIP1 mRNA	PMID:35163327
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MNMIP1 mRNA	PMID:33453195
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of MNMIP1 mRNA	PMID:35163327
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605948	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MNMIP1 mRNA	PMID:31533062
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MNMIP1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MNMIP1 mRNA	PMID:36331819
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312915	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of MNMIP1 mRNA	PMID:23125180
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312915	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MNMIP1 mRNA	PMID:28973697
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3D21 mRNA	PMID:37992649
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1605948	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MNMIP1 mRNA	PMID:38832940
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MNMIP1 mRNA	PMID:33387578
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1605948	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MNMIP1 gene	PMID:25304211
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MNMIP1 mRNA	PMID:34876320
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:49900	arsenous acid	affects expression	ISO	RGD:1312915	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide affects the expression of MNMIP1 mRNA	PMID:39716349
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MNMIP1 mRNA	PMID:30307764
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312915	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of MNMIP1 mRNA	PMID:25554681
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312915	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MNMIP1 mRNA	PMID:25620056
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312915	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MNMIP1 mRNA	PMID:25554681
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1605948	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MNMIP1 mRNA	PMID:36139627
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1605948	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MNMIP1 mRNA	PMID:30851411
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312915	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MNMIP1 mRNA	PMID:34876320
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1605948	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of MNMIP1 mRNA	PMID:31734321
1305090	Mnmip1	manchette microtubule inner protein 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MNMIP1 mRNA	PMID:23869203
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1605059	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of LRRC59 protein	PMID:39638853
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1332550	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of LRRC59 mRNA	PMID:37995155
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRRC59 mRNA]	PMID:31150632
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of LRRC59 mRNA	PMID:39752319
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LRRC59 protein]	PMID:38195004
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRRC59 mRNA	PMID:30529165
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LRRC59 mRNA	PMID:36331819
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1332550	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of LRRC59 mRNA	PMID:30319688
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1605059	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of LRRC59 mRNA	PMID:29581250
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332550	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LRRC59 mRNA	PMID:39241906
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of LRRC59 mRNA]	PMID:39241906
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of LRRC59 mRNA	PMID:32145629
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332550	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of LRRC59 mRNA	PMID:39298647
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605059	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LRRC59 mRNA	PMID:31614463
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1332550	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of LRRC59 mRNA	PMID:19448997
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605059	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of LRRC59 mRNA	PMID:23649840
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of LRRC59 mRNA	PMID:39752319
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1332550	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of LRRC59 mRNA	PMID:33848595
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1605059	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of LRRC59 protein	PMID:37730182
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20221101	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LRRC59 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRRC59 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LRRC59 protein	PMID:35301059|PMID:38195004
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LRRC59 protein	PMID:23301498
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1332550	E	RGD:6480464	20240604	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LRRC59 protein	PMID:38307155
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LRRC59 mRNA	PMID:34911549
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of LRRC59 protein	PMID:38598786
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LRRC59 mRNA	PMID:31150632
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332550	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LRRC59 mRNA	PMID:27339419|PMID:31919559
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRRC59 mRNA]	PMID:31150632
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of LRRC59 mRNA]	PMID:22206623
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRRC59 mRNA	PMID:40504410
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1332550	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of LRRC59 mRNA	PMID:28960355
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of LRRC59 mRNA	PMID:27392435
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1605059	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LRRC59 mRNA	PMID:24768652|PMID:25583101
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332550	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRRC59 mRNA	PMID:18343893|PMID:21570461
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRRC59 mRNA	PMID:34747641
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332550	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRRC59 mRNA	PMID:16611356
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of LRRC59 mRNA	PMID:28959563
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1332550	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of LRRC59 protein	PMID:28918527
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1332550	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of LRRC59 protein	PMID:27548804
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1605059	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of LRRC59 mRNA	PMID:29803840
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605059	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LRRC59 mRNA	PMID:38568856|PMID:39719251
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRRC59 mRNA	PMID:40504410
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1332550	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LRRC59 mRNA	PMID:23221170
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1605059	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of LRRC59 protein	PMID:25419056
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of LRRC59 mRNA	PMID:24136188
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1605059	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of LRRC59 mRNA	PMID:38568856
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1605059	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of LRRC59 mRNA	PMID:38568856
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of LRRC59 mRNA	PMID:30047161
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of LRRC59 mRNA	PMID:24136188
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332550	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRRC59 gene; titanium dioxide results in decreased methylation of LRRC59 promoter	PMID:35295148
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1332550	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of LRRC59 mRNA	PMID:27760801
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LRRC59 mRNA	PMID:23411599|PMID:34492290
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332550	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LRRC59 mRNA	PMID:18301758
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:32585	4-hydroxynon-2-enal	affects binding	ISO	RGD:1605059	E	RGD:6480464	20120717	CTD	MESH:C027576	LRRC59 protein binds to 4-hydroxy-2-nonenal	PMID:20043646
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1605059	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of LRRC59 mRNA	PMID:30903817
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRC59 mRNA	PMID:32145629
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605059	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRC59 mRNA	PMID:29275510|PMID:33670352
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LRRC59 mRNA	PMID:25181051
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1332550	E	RGD:6480464	20250805	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of LRRC59 protein	PMID:26903627
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332550	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LRRC59 mRNA	PMID:39298647
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1605059	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of LRRC59 protein	PMID:34186270
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LRRC59 mRNA	PMID:28628672
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1605059	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of LRRC59 protein	PMID:34186270
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1332550	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of LRRC59 mRNA	PMID:28392331
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1332550	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LRRC59 mRNA	PMID:37019170
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LRRC59 mRNA	PMID:21266533
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1332550	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of LRRC59 mRNA	PMID:34813904
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of LRRC59 protein	PMID:38598786
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LRRC59 mRNA	PMID:28628672
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of LRRC59 mRNA	PMID:19041683
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of LRRC59 mRNA	PMID:32680482
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of LRRC59 mRNA]	PMID:39241906
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605059	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRRC59 mRNA	PMID:37042841
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1605059	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LRRC59 mRNA	PMID:38568856
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20221101	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LRRC59 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRRC59 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LRRC59 protein	PMID:35301059|PMID:38195004
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of LRRC59 mRNA	PMID:25539665|PMID:26194646
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of LRRC59 mRNA	PMID:19162173
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of LRRC59 mRNA	PMID:24386269
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1605059	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LRRC59 mRNA	PMID:24449571
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LRRC59 mRNA	PMID:36331819
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332550	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LRRC59 mRNA	PMID:17292431
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605059	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of LRRC59 mRNA	PMID:23179753
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of LRRC59 mRNA	PMID:30047161
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605059	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of LRRC59 mRNA	PMID:20106945
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LRRC59 mRNA	PMID:28628672
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605059	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LRRC59 mRNA; Okadaic Acid results in increased expression of LRRC59 protein	PMID:38832940
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of LRRC59 mRNA	PMID:21346803
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332550	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LRRC59 mRNA	PMID:17562736
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605059	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of LRRC59 mRNA	PMID:25704631
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRRC59 mRNA	PMID:40504410
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1605059	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of LRRC59 protein	PMID:25470785
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1605059	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of LRRC59 mRNA	PMID:31675489
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LRRC59 mRNA	PMID:29391264
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1332550	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of LRRC59 mRNA	PMID:35436446
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1605059	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of LRRC59 mRNA	PMID:38568856
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LRRC59 mRNA	PMID:28628672
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1605059	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of LRRC59 protein	PMID:25419056
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332550	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LRRC59 mRNA; Nanotubes, Carbon results in increased expression of LRRC59 mRNA	PMID:25554681|PMID:25620056
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of LRRC59 mRNA	PMID:34044035
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of LRRC59 mRNA	PMID:30047161
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LRRC59 mRNA	PMID:35964746
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of LRRC59 mRNA	PMID:24136188
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1332550	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of LRRC59 mRNA	PMID:19042947
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1605059	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LRRC59 mRNA	PMID:31629900
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605059	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LRRC59 protein	PMID:32959892
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:63630	tolcapone	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to LRRC59 protein	PMID:19783845
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of LRRC59 mRNA	PMID:39752319
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1605059	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LRRC59 protein	PMID:34186270
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332550	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LRRC59 mRNA	PMID:22206623
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of LRRC59 mRNA]	PMID:22206623
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of LRRC59 protein	PMID:37664457
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of LRRC59 mRNA	PMID:24136188
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LRRC59 gene]	PMID:28238834
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of LRRC59 mRNA	PMID:19162173|PMID:30047161
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1332550	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of LRRC59 mRNA	PMID:18343893
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1332550	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of LRRC59 mRNA	PMID:30294300
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1605059	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of LRRC59 protein	PMID:31675489
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of LRRC59 protein	PMID:28903499
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1605059	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of LRRC59 protein	PMID:38348393
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1332550	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of LRRC59 mRNA	PMID:21278054
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of LRRC59 mRNA	PMID:30047161
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of LRRC59 mRNA]	PMID:39241906
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1332550	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of LRRC59 mRNA	PMID:39752319
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1332550	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of LRRC59 protein	PMID:35357534
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605059	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of LRRC59 protein	PMID:37664457
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LRRC59 mRNA	PMID:21346803
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605059	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LRRC59 mRNA	PMID:38568856
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of LRRC59 protein	PMID:35544339
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LRRC59 mRNA	PMID:21346803
1305092	Lrrc59	leucine rich repeat containing 59	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of LRRC59 mRNA	PMID:23034163
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MXD4 mRNA]	PMID:31150632
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MXD4 mRNA	PMID:20188158
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MXD4 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MXD4 mRNA	PMID:33729688
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D010100	Oxygen affects the reaction [AHR protein results in decreased expression of MXD4 mRNA]	PMID:27103661
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:C018475	butyraldehyde results in decreased expression of MXD4 mRNA	PMID:26079696
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312920	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MXD4 mRNA	PMID:30319688
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312920	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MXD4 mRNA	PMID:30319688
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MXD4 mRNA	PMID:39241906
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MXD4 mRNA]	PMID:39241906
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D004958	Estradiol affects the expression of MXD4 mRNA	PMID:15598610
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D004958	Estradiol results in decreased expression of MXD4 mRNA	PMID:16474171|PMID:31614463
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D004958	Estradiol results in decreased expression of MXD4 mRNA	PMID:14664709|PMID:39298647
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of MXD4 mRNA	PMID:38568856
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:17447	geraniol	increases expression	ISO	RGD:1312919	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of MXD4 mRNA	PMID:27683099
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MXD4 mRNA	PMID:33387578
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312919	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MXD4 mRNA	PMID:28818685
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MXD4 mRNA	PMID:36331819
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MXD4 mRNA	PMID:39012411
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MXD4 mRNA	PMID:19549813
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MXD4 mRNA	PMID:23649840
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MXD4 mRNA	PMID:19770486
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MXD4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MXD4 mRNA	PMID:34911549
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of MXD4 mRNA	PMID:31129395
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MXD4 mRNA	PMID:17484886
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MXD4 mRNA	PMID:31150632
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MXD4 mRNA]	PMID:31150632
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MXD4 mRNA	PMID:22206623
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MXD4 mRNA	PMID:40504410
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MXD4 mRNA	PMID:28189721|PMID:28960355
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312919	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MXD4 mRNA	PMID:27392435
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D019833	Genistein results in decreased expression of MXD4 mRNA	PMID:16474171
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312920	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MXD4 mRNA	PMID:21570461|PMID:24680724
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MXD4 mRNA	PMID:33387578|PMID:34747641
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MXD4 mRNA	PMID:32109520
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of MXD4 mRNA	PMID:29955902
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312919	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MXD4 mRNA	PMID:33212167
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312919	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of MXD4 mRNA	PMID:39709020
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312920	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of MXD4 mRNA	PMID:39631538
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1312919	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MXD4 mRNA	PMID:29432896
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MXD4 mRNA	PMID:38568856
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312919	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of MXD4 mRNA	PMID:39719251
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MXD4 mRNA	PMID:40504410
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MXD4 mRNA	PMID:19770486
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312919	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MXD4 promoter	PMID:27901495
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MXD4 mRNA	PMID:27131904
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MXD4 mRNA	PMID:25895662
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MXD4 mRNA	PMID:29203145
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of MXD4 mRNA	PMID:38568856
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312920	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MXD4 gene	PMID:35295148
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D013853	Thioacetamide results in decreased expression of MXD4 mRNA	PMID:23411599
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MXD4 mRNA	PMID:18648102
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1312919	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MXD4 mRNA	PMID:30903817
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MXD4 mRNA	PMID:25181051
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:C006780	bisphenol A results in decreased expression of MXD4 mRNA	PMID:16474171
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:C006780	bisphenol A results in increased expression of MXD4 mRNA	PMID:20678512|PMID:29275510
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of MXD4 mRNA	PMID:31129395
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MXD4 mRNA	PMID:25172293
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:C543008	bisphenol S results in decreased expression of MXD4 mRNA	PMID:25912373
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MXD4 mRNA	PMID:39298647
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312919	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MXD4 mRNA	PMID:28628672
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D003976	Diazinon results in increased methylation of MXD4 gene	PMID:22964155
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MXD4 mRNA	PMID:21266533
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MXD4 mRNA	PMID:34813904
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312919	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MXD4 mRNA	PMID:28628672
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of MXD4 mRNA	PMID:34813904
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312920	E	RGD:6480464	20210209	CTD	MESH:D010269	Paraquat results in increased expression of MXD4 mRNA	PMID:21463325
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MXD4 mRNA]	PMID:39241906
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312919	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MXD4 mRNA	PMID:37042841
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312919	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of MXD4 mRNA	PMID:29024780
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MXD4 mRNA	PMID:38568856
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MXD4 mRNA	PMID:39012411
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MXD4 mRNA	PMID:19162173
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MXD4 mRNA	PMID:24449571
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D002994	Clofibrate results in decreased expression of MXD4 mRNA	PMID:23811191
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1312919	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of MXD4 mRNA	PMID:40434365
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D003375	Coumestrol results in decreased expression of MXD4 mRNA	PMID:19167446
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MXD4 mRNA	PMID:19167446
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MXD4 mRNA	PMID:36331819
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1312920	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of MXD4 mRNA	PMID:29038090
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D002737	Chloroprene results in increased expression of MXD4 mRNA	PMID:23125180
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D014635	Valproic Acid affects the expression of MXD4 mRNA	PMID:17963808
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D014635	Valproic Acid results in decreased expression of MXD4 mRNA	PMID:23527032|PMID:24935251|PMID:29154799
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312919	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MXD4 gene	PMID:29154799
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:D016572	Cyclosporine results in decreased expression of MXD4 mRNA	PMID:25562108
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D003907	Dexamethasone results in increased expression of MXD4 mRNA	PMID:22733784
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312919	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MXD4 mRNA	PMID:28628672
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of MXD4 mRNA	PMID:15171707
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:C111237	vorinostat results in decreased expression of MXD4 mRNA	PMID:27188386
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MXD4 mRNA	PMID:33387578
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of MXD4 mRNA	PMID:29279043
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MXD4 mRNA	PMID:40504410
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of MXD4 mRNA	PMID:31838189
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MXD4 mRNA	PMID:29391264
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of MXD4 mRNA	PMID:38568856
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312919	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MXD4 mRNA	PMID:28628672
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MXD4 mRNA	PMID:25554681
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of MXD4 mRNA	PMID:28801915
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20140729	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MXD4 mRNA	PMID:21641980
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MXD4 mRNA	PMID:28801915
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in decreased expression of MXD4 mRNA	PMID:36914120
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:70778	GW 7647	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C453899	GW 7647 results in decreased expression of MXD4 mRNA	PMID:31628012
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:72754	bisphenol AF	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of MXD4 mRNA	PMID:25912373
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MXD4 mRNA	PMID:22206623
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MXD4 mRNA	PMID:22714537
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312919	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MXD4 mRNA	PMID:37199045
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1312919	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of MXD4 mRNA	PMID:28960945
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312919	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MXD4 gene]	PMID:28238834
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MXD4 mRNA	PMID:19167446
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312920	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MXD4 mRNA	PMID:39847705
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:85993	palbociclib	increases expression	ISO	RGD:1312919	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in increased expression of MXD4 mRNA	PMID:22869556
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MXD4 mRNA]	PMID:39241906
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MXD4 mRNA	PMID:27131904
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MXD4 mRNA	PMID:19281266
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:C004648	testosterone enanthate affects the expression of MXD4 mRNA	PMID:17440010
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312919	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MXD4 mRNA	PMID:38568856
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312919	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MXD4 mRNA	PMID:29301935
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312919	E	RGD:6480464	20170221	CTD	MESH:C057693	troglitazone results in increased expression of MXD4 mRNA	PMID:19140230
1305093	Mxd4	Max dimerization protein 4	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of MXD4 mRNA	PMID:19015723
1305095	Fbxo24	F-box protein 24	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312923	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of FBXO24 mRNA	PMID:33045310
1305095	Fbxo24	F-box protein 24	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312923	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXO24 mRNA	PMID:39241906
1305095	Fbxo24	F-box protein 24	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312922	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FBXO24 mRNA	PMID:35811015
1305095	Fbxo24	F-box protein 24	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312922	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of FBXO24 mRNA	PMID:30510588
1305095	Fbxo24	F-box protein 24	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FBXO24 mRNA	PMID:31614463
1305095	Fbxo24	F-box protein 24	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of FBXO24 mRNA	PMID:38568856
1305095	Fbxo24	F-box protein 24	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of FBXO24 mRNA	PMID:33387578
1305095	Fbxo24	F-box protein 24	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of FBXO24 mRNA	PMID:26079696
1305095	Fbxo24	F-box protein 24	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312922	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FBXO24 mRNA	PMID:28818685
1305095	Fbxo24	F-box protein 24	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FBXO24 mRNA	PMID:22100608
1305095	Fbxo24	F-box protein 24	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312923	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of FBXO24 mRNA	PMID:25629700
1305095	Fbxo24	F-box protein 24	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312923	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of FBXO24 mRNA	PMID:28960355
1305095	Fbxo24	F-box protein 24	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312923	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA	PMID:34876320
1305095	Fbxo24	F-box protein 24	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312923	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA	PMID:34876320
1305095	Fbxo24	F-box protein 24	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312922	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of FBXO24 gene	PMID:31601247
1305095	Fbxo24	F-box protein 24	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312923	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of FBXO24 mRNA	PMID:29264374
1305095	Fbxo24	F-box protein 24	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312923	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of FBXO24 mRNA	PMID:21318169
1305095	Fbxo24	F-box protein 24	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312923	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of FBXO24 mRNA]	PMID:21318169
1305095	Fbxo24	F-box protein 24	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO24 mRNA	PMID:25181051
1305095	Fbxo24	F-box protein 24	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO24 mRNA	PMID:23146750
1305095	Fbxo24	F-box protein 24	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of FBXO24 mRNA	PMID:30816183|PMID:32528016
1305095	Fbxo24	F-box protein 24	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of FBXO24 mRNA	PMID:23146750
1305095	Fbxo24	F-box protein 24	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FBXO24 mRNA	PMID:23146750
1305095	Fbxo24	F-box protein 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312923	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of FBXO24 gene	PMID:31683443
1305095	Fbxo24	F-box protein 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312923	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of FBXO24 mRNA	PMID:40203079
1305095	Fbxo24	F-box protein 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312922	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FBXO24 gene	PMID:31601247
1305095	Fbxo24	F-box protein 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312922	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of FBXO24 gene	PMID:31601247
1305095	Fbxo24	F-box protein 24	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXO24 mRNA	PMID:33453195
1305095	Fbxo24	F-box protein 24	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of FBXO24 mRNA	PMID:23146750
1305095	Fbxo24	F-box protein 24	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312922	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FBXO24 gene	PMID:29154799
1305095	Fbxo24	F-box protein 24	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of FBXO24 mRNA	PMID:20106945
1305095	Fbxo24	F-box protein 24	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FBXO24 mRNA	PMID:38832940
1305095	Fbxo24	F-box protein 24	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312922	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXO24 mRNA	PMID:26690555
1305095	Fbxo24	F-box protein 24	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312922	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FBXO24 mRNA	PMID:35811015
1305095	Fbxo24	F-box protein 24	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of FBXO24 mRNA	PMID:29391264
1305095	Fbxo24	F-box protein 24	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1312922	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of FBXO24 mRNA	PMID:40706910
1305095	Fbxo24	F-box protein 24	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312923	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA	PMID:34876320
1305095	Fbxo24	F-box protein 24	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1312923	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of FBXO24 mRNA	PMID:23608068
1305095	Fbxo24	F-box protein 24	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312922	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FBXO24 mRNA	PMID:23146750
1305095	Fbxo24	F-box protein 24	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312923	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA	PMID:34876320
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1616771	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PDRG1 mRNA	PMID:33045310
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PDRG1 mRNA]	PMID:31150632
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1349373	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of PDRG1 protein	PMID:36641056
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PDRG1 mRNA	PMID:36331819
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1349373	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PDRG1 mRNA	PMID:26079696
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of PDRG1 mRNA	PMID:26496021
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1616771	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of PDRG1 mRNA	PMID:33711761
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349373	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PDRG1 mRNA	PMID:37042841
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PDRG1 mRNA	PMID:33387578
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1349373	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PDRG1 mRNA	PMID:28818685
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PDRG1 mRNA	PMID:36331819
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PDRG1 mRNA	PMID:35301059
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1349373	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PDRG1 mRNA	PMID:19549813
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PDRG1 protein	PMID:23301498
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1349373	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PDRG1 mRNA	PMID:27153756
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1616771	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PDRG1 mRNA	PMID:19770486
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1349373	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PDRG1 mRNA	PMID:23649840
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PDRG1 mRNA	PMID:18593933
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PDRG1 mRNA	PMID:31150632
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PDRG1 mRNA]	PMID:31150632
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PDRG1 mRNA	PMID:22206623
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PDRG1 mRNA	PMID:40504410
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1349373	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of PDRG1 mRNA	PMID:27594783
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1616771	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in increased expression of PDRG1 mRNA	PMID:25270620
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PDRG1 mRNA	PMID:27392435
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1616771	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PDRG1 mRNA	PMID:21570461
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PDRG1 mRNA	PMID:33387578
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1349373	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of PDRG1 mRNA	PMID:29955902
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1349373	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PDRG1 mRNA	PMID:33212167
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1349373	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of PDRG1 mRNA	PMID:39709020
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of PDRG1 mRNA	PMID:24690739
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1349373	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PDRG1 mRNA	PMID:29803840
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1349373	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PDRG1 mRNA	PMID:20044591
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349373	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PDRG1 mRNA	PMID:38568856
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PDRG1 mRNA	PMID:40504410
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1616771	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of PDRG1 mRNA	PMID:22641617
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1349373	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PDRG1 promoter	PMID:27901495
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1616771	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PDRG1 mRNA	PMID:19770486
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of PDRG1 mRNA	PMID:24690739
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PDRG1 mRNA	PMID:18593933
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1616771	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PDRG1 mRNA	PMID:29095437
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20191114	CTD	MESH:C006632	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PDRG1 mRNA]	PMID:29095437
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PDRG1 mRNA	PMID:30047161
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1616771	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PDRG1 gene; titanium dioxide results in decreased methylation of PDRG1 promoter	PMID:35295148
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PDRG1 mRNA	PMID:34492290
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349373	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PDRG1 protein	PMID:33376534
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PDRG1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of PDRG1 mRNA	PMID:26496021
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1616771	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of PDRG1 mRNA	PMID:20713471
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1616771	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PDRG1 mRNA	PMID:39298647|PMID:40203079
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1616771	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PDRG1 mRNA	PMID:38685157
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1616771	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of PDRG1 mRNA	PMID:28392331
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PDRG1 mRNA	PMID:33453195
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349373	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PDRG1 mRNA	PMID:38174414
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PDRG1 mRNA	PMID:35301059
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1349373	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PDRG1 mRNA	PMID:31533062
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1349373	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PDRG1 mRNA	PMID:40419075
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PDRG1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PDRG1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PDRG1 mRNA	PMID:36331819
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PDRG1 mRNA	PMID:30047161
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1349373	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of PDRG1 mRNA	PMID:20106945
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PDRG1 mRNA	PMID:33387578
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of PDRG1 mRNA	PMID:24690739
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1349373	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PDRG1 mRNA	PMID:18687144
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PDRG1 mRNA	PMID:40504410
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PDRG1 mRNA	PMID:29391264
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PDRG1 mRNA	PMID:22079256
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of PDRG1 mRNA	PMID:29097150
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1616771	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PDRG1 mRNA	PMID:29095437
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20191114	CTD	MESH:C032793	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PDRG1 mRNA]	PMID:29095437
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1616771	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in decreased expression of PDRG1 mRNA	PMID:21318169
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in decreased expression of PDRG1 mRNA]	PMID:21318169
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PDRG1 mRNA	PMID:30047161
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1616771	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of PDRG1 mRNA	PMID:40234311
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PDRG1 mRNA	PMID:35964746
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PDRG1 mRNA	PMID:24136188
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of PDRG1 mRNA	PMID:20080153
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PDRG1 mRNA]	PMID:29095437
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of PDRG1 mRNA	PMID:30467583
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1616771	E	RGD:6480464	20150127	CTD	MESH:C014476	diethyl maleate results in increased expression of PDRG1 mRNA	PMID:25270620
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1616771	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PDRG1 mRNA	PMID:22206623
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1349373	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PDRG1 mRNA	PMID:22079256
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1349373	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PDRG1 mRNA	PMID:22079256
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:8069	phenobarbital	decreases methylation	ISO	RGD:1616771	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased methylation of PDRG1 gene	PMID:19233941
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1349373	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PDRG1 mRNA	PMID:26079696
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PDRG1 mRNA	PMID:30047161
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PDRG1 mRNA	PMID:21346803
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in increased expression of PDRG1 mRNA	PMID:26141394
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1349373	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PDRG1 mRNA	PMID:38568856
1305096	Pdrg1	p53 and DNA damage regulated 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PDRG1 mRNA	PMID:21346803
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550113	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PCGF2 mRNA	PMID:33045310
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550113	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PCGF2 mRNA	PMID:36331819
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550113	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PCGF2 mRNA	PMID:39298647
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of PCGF2 mRNA	PMID:26496021
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20140916	CTD	MESH:D005557	Formaldehyde results in decreased expression of PCGF2 mRNA	PMID:23649840
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1550113	E	RGD:6480464	20150602	CTD	MESH:D011374	Progesterone affects the expression of PCGF2 mRNA	PMID:17251523
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1352511	E	RGD:6480464	20140916	CTD	MESH:C044887	beta-methylcholine affects the expression of PCGF2 mRNA	PMID:21179406
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PCGF2 mRNA	PMID:33387578
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1352511	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PCGF2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PCGF2 mRNA	PMID:29093498|PMID:35301059
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of PCGF2 mRNA	PMID:23487506
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1550113	E	RGD:6480464	20150602	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of PCGF2 mRNA	PMID:19376150
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in decreased expression of PCGF2 mRNA	PMID:23033980
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PCGF2 mRNA	PMID:30779732
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PCGF2 mRNA	PMID:26272509
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1352511	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCGF2 mRNA	PMID:27188386
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1550113	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of PCGF2 mRNA	PMID:35897073
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550113	E	RGD:6480464	20150602	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PCGF2 promoter]	PMID:19654925
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of PCGF2 mRNA	PMID:23649840
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of PCGF2 mRNA	PMID:39719251
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550113	E	RGD:6480464	20221101	CTD	MESH:C017947	sodium arsenite results in increased expression of PCGF2 mRNA	PMID:35364107|PMID:37682722
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550113	E	RGD:6480464	20150602	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to PCGF2 promoter]	PMID:19654925
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550113	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PCGF2 gene	PMID:35295148
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A affects the expression of PCGF2 mRNA	PMID:25181051
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1550113	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of PCGF2 promoter	PMID:27334623
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of PCGF2 mRNA	PMID:26496021
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550113	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PCGF2 mRNA	PMID:38685157
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550113	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PCGF2 mRNA	PMID:37019170
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1550113	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of PCGF2 mRNA	PMID:36117858
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PCGF2 mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PCGF2 mRNA	PMID:35163327
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PCGF2 mRNA	PMID:38568856
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1352511	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PCGF2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PCGF2 mRNA	PMID:29093498|PMID:35301059
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PCGF2 mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PCGF2 mRNA	PMID:35163327
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1352511	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PCGF2 mRNA	PMID:28302478
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550113	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PCGF2 mRNA	PMID:36331819
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1352511	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCGF2 mRNA	PMID:25979313
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCGF2 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1352511	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PCGF2 gene	PMID:29154799
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1352511	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCGF2 mRNA	PMID:27188386
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20140916	CTD	MESH:D003703	Demecolcine results in decreased expression of PCGF2 mRNA	PMID:23649840
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PCGF2 mRNA	PMID:27188386
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20140916	CTD	MESH:C012589	trichostatin A results in decreased expression of PCGF2 mRNA	PMID:24935251
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCGF2 mRNA	PMID:33387578
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20140916	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCGF2 mRNA	PMID:22230336
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1352511	E	RGD:6480464	20140916	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PCGF2 mRNA	PMID:22079256
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1550113	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of PCGF2 mRNA	PMID:36117858
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1352511	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCGF2 mRNA	PMID:26378955
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20140916	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PCGF2 mRNA	PMID:16934159
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1352511	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of PCGF2 mRNA	PMID:27918106
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1352511	E	RGD:6480464	20140916	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PCGF2 mRNA	PMID:22079256
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1352511	E	RGD:6480464	20140916	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PCGF2 mRNA	PMID:22079256
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1352511	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCGF2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCGF2 mRNA	PMID:27188386
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352511	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCGF2 gene]	PMID:28238834
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PCGF2 mRNA	PMID:27291303
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:8249	piroxicam	increases expression	ISO	RGD:1352511	E	RGD:6480464	20140916	CTD	MESH:D010894	Piroxicam results in increased expression of PCGF2 mRNA	PMID:21858171
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1550113	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PCGF2 mRNA	PMID:40826991
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1352511	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCGF2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCGF2 mRNA	PMID:27188386
1305097	Pcgf2	polycomb group ring finger 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C025643	vinclozolin results in increased expression of PCGF2 mRNA	PMID:18042343
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC30A10 mRNA]	PMID:31150632
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SLC30A10 mRNA	PMID:23724009
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312928	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SLC30A10 mRNA	PMID:30319688
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312928	E	RGD:6480464	20220308	CTD	MESH:D000431	Ethanol results in increased expression of SLC30A10 mRNA	PMID:34590183
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SLC30A10 mRNA	PMID:21632981
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of SLC30A10 mRNA	PMID:32145629
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in decreased expression of SLC30A10 mRNA	PMID:20106945|PMID:21632981
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312928	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC30A10 mRNA	PMID:39298647
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of SLC30A10 mRNA; [Testosterone co-treated with Estradiol] results in increased expression of SLC30A10 mRNA	PMID:26496021|PMID:32741896
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SLC30A10 mRNA	PMID:37992649
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SLC30A10 mRNA	PMID:28973375
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SLC30A10 mRNA	PMID:33848595
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] results in increased expression of SLC30A10 mRNA	PMID:32741896
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SLC30A10 mRNA	PMID:37992649
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1604615	E	RGD:6480464	20180313	CTD	MESH:D002117	Calcitriol results in increased expression of SLC30A10 mRNA; Calcitriol results in increased expression of SLC30A10 protein	PMID:27107558
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20180313	CTD	MESH:D002117	[Calcitriol results in increased activity of VDR protein] which results in increased expression of SLC30A10 mRNA; Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to SLC30A10 promoter]	PMID:27107558
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1312928	E	RGD:6480464	20190219	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SLC30A10 protein	PMID:28688763
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC30A10 mRNA	PMID:36331819
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:18291	manganese atom	affects transport	ISO	RGD:1604615	E	RGD:6480464	20151013	CTD	MESH:D008345	SLC30A10 gene SNP affects the transport of Manganese	PMID:26025379
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:18291	manganese atom	decreases abundance	ISO	RGD:1604615	E	RGD:6480464	20160315	CTD	MESH:D008345	SLC30A10 gene SNP results in decreased abundance of Manganese	PMID:26628504
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20180703	CTD	MESH:D008345	Manganese results in decreased expression of SLC30A10 mRNA	PMID:29020610
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:18291	manganese atom	increases abundance	ISO	RGD:1604615	E	RGD:6480464	20160315	CTD	MESH:D008345	SLC30A10 gene mutant form results in increased abundance of Manganese; SLC30A10 gene SNP results in increased abundance of Manganese	PMID:22926781|PMID:26628504
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:18291	manganese atom	increases secretion	ISO	RGD:1604615	E	RGD:6480464	20180515	CTD	MESH:D008345	SLC30A10 protein results in increased secretion of Manganese	PMID:28860195
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20220308	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 protein	PMID:34590183
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20151013	CTD	MESH:D008345	[IL6 protein results in decreased expression of SLC30A10 mRNA] which results in decreased export of Manganese; [IL6 protein results in decreased expression of SLC30A10 protein] which results in decreased export of Manganese; Edetic Acid inhibits the reaction [SLC30A10 gene mutant form results in increased abundance of Manganese]	PMID:22926781|PMID:24576911
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20220809	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC30A10 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC30A10 mRNA	PMID:35212737|PMID:37236586
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20251202	CTD	MESH:D002104	[APOE protein alternative form results in increased susceptibility to Cadmium] which affects the expression of SLC30A10 mRNA	PMID:35878927
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SLC30A10 mRNA	PMID:19549813
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1604615	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SLC30A10 protein	PMID:20106945
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLC30A10 mRNA	PMID:21632981|PMID:21641981|PMID:22100608
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1604615	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC30A10 gene	PMID:27153756
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:26523	reactive oxygen species	decreases abundance	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	SLC30A10 protein results in decreased abundance of Reactive Oxygen Species	PMID:22427991
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	[SLC30A10 protein affects the expression of CAT protein] which affects the abundance of Reactive Oxygen Species	PMID:22427991
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27363	zinc atom	affects abundance	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	SLC30A10 protein affects the abundance of Zinc	PMID:22427991
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of SLC30A10 mRNA	PMID:22427991
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27363	zinc atom	decreases response to substance	ISO	RGD:1604615	E	RGD:6480464	20130122	CTD	MESH:D015032	SLC30A10 protein results in decreased susceptibility to Zinc	PMID:22427991
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[SLC30A10 protein affects the abundance of Zinc] which affects the expression of CDKN1A protein; [SLC30A10 protein affects the abundance of Zinc] which affects the expression of TP53 protein	PMID:22427991
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC30A10 mRNA	PMID:31150632
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC30A10 mRNA]	PMID:31150632
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SLC30A10 mRNA	PMID:25629700
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1604615	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SLC30A10 mRNA	PMID:26272509
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA	PMID:27188386
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SLC30A10 mRNA	PMID:31881176
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC30A10 mRNA	PMID:23557933
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of SLC30A10 mRNA	PMID:34813904
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:28077	rifampicin	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20180313	CTD	MESH:D012293	Rifampin results in decreased expression of SLC30A10 mRNA	PMID:27199754
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC30A10 mRNA	PMID:22298810
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312928	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC30A10 mRNA	PMID:28922406
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC30A10 mRNA	PMID:19770486|PMID:26290441|PMID:28213091
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC30A10 mRNA	PMID:21632981|PMID:21998131
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SLC30A10 gene]	PMID:28213091
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SLC30A10 mRNA	PMID:28374803
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312928	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SLC30A10 mRNA	PMID:19465457
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604615	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC30A10 mRNA	PMID:33212167
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SLC30A10 mRNA	PMID:37992649
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of SLC30A10 mRNA	PMID:22623647
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC30A10 mRNA	PMID:37682722
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC30A10 mRNA	PMID:29301061
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1604615	E	RGD:6480464	20190219	CTD	MESH:D014415	Tunicamycin results in increased expression of SLC30A10 mRNA	PMID:28688763
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604615	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC30A10 5' UTR; Benzo(a)pyrene affects the methylation of SLC30A10 promoter	PMID:27901495
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC30A10 mRNA	PMID:19770486
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC30A10 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291|PMID:32234424
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604615	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC30A10 exon	PMID:27901495
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:30185	zinc(0)	affects abundance	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	SLC30A10 protein affects the abundance of Zinc	PMID:22427991
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of SLC30A10 mRNA	PMID:22427991
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:30185	zinc(0)	decreases response to substance	ISO	RGD:1604615	E	RGD:6480464	20130122	CTD	MESH:D015032	SLC30A10 protein results in decreased susceptibility to Zinc	PMID:22427991
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[SLC30A10 protein affects the abundance of Zinc] which affects the expression of CDKN1A protein; [SLC30A10 protein affects the abundance of Zinc] which affects the expression of TP53 protein	PMID:22427991
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:30660	thyroxine	decreases chemical synthesis	ISO	RGD:1312928	E	RGD:6480464	20180515	CTD	MESH:D013974	SLC30A10 gene mutant form results in decreased chemical synthesis of Thyroxine	PMID:28860195
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312928	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC30A10 gene	PMID:35295148
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC30A10 mRNA	PMID:23411599
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of SLC30A10 mRNA	PMID:20813756|PMID:23811191
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in decreased expression of SLC30A10 mRNA	PMID:20813756
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC30A10 mRNA	PMID:19710929
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312928	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SLC30A10 mRNA	PMID:28472532
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of SLC30A10 mRNA	PMID:32145629
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1604615	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SLC30A10 mRNA	PMID:30903817
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC30A10 mRNA	PMID:25181051|PMID:34947998
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC30A10 mRNA	PMID:32156529
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of SLC30A10 mRNA	PMID:26496021
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312928	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of SLC30A10 mRNA	PMID:33297965|PMID:39298647
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:34785	heptachlor	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20260707	CTD	MESH:D006533	Heptachlor results in decreased expression of SLC30A10 mRNA	PMID:38723972
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35154	manganese(0)	affects transport	ISO	RGD:1604615	E	RGD:6480464	20151013	CTD	MESH:D008345	SLC30A10 gene SNP affects the transport of Manganese	PMID:26025379
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35154	manganese(0)	decreases abundance	ISO	RGD:1604615	E	RGD:6480464	20160315	CTD	MESH:D008345	SLC30A10 gene SNP results in decreased abundance of Manganese	PMID:26628504
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20180703	CTD	MESH:D008345	Manganese results in decreased expression of SLC30A10 mRNA	PMID:29020610
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35154	manganese(0)	increases abundance	ISO	RGD:1604615	E	RGD:6480464	20160315	CTD	MESH:D008345	SLC30A10 gene mutant form results in increased abundance of Manganese; SLC30A10 gene SNP results in increased abundance of Manganese	PMID:22926781|PMID:26628504
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35154	manganese(0)	increases secretion	ISO	RGD:1604615	E	RGD:6480464	20180515	CTD	MESH:D008345	SLC30A10 protein results in increased secretion of Manganese	PMID:28860195
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20220308	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 protein	PMID:34590183
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20151013	CTD	MESH:D008345	[IL6 protein results in decreased expression of SLC30A10 mRNA] which results in decreased export of Manganese; [IL6 protein results in decreased expression of SLC30A10 protein] which results in decreased export of Manganese; Edetic Acid inhibits the reaction [SLC30A10 gene mutant form results in increased abundance of Manganese]	PMID:22926781|PMID:24576911
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of SLC30A10 mRNA	PMID:26377693
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20220809	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC30A10 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC30A10 mRNA	PMID:35212737|PMID:37236586
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1312928	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of SLC30A10 mRNA	PMID:24183702
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20161025	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SLC30A10 mRNA	PMID:27413110
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:37825	p-toluidine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of SLC30A10 mRNA	PMID:27638505
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312928	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC30A10 mRNA	PMID:40194260
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC30A10 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC30A10 mRNA	PMID:36331819
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of SLC30A10 mRNA]	PMID:18200517
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312928	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SLC30A10 mRNA	PMID:17963808
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC30A10 mRNA	PMID:19770486
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC30A10 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SLC30A10 mRNA	PMID:28973697
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SLC30A10 mRNA	PMID:37992649
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC30A10 mRNA	PMID:38832940
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1604615	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SLC30A10 mRNA	PMID:26272509
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA	PMID:27188386
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1604615	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SLC30A10 mRNA	PMID:24935251|PMID:26272509
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA	PMID:27188386
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC30A10 mRNA	PMID:29067470
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:4735	ethylenediaminetetraacetic acid	increases expression	ISO	RGD:1604615	E	RGD:6480464	20230207	CTD	MESH:D004492	Edetic Acid results in increased expression of SLC30A10 mRNA; Edetic Acid results in increased expression of SLC30A10 protein	PMID:22341971
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:4735	ethylenediaminetetraacetic acid	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20230207	CTD	MESH:D004492	Edetic Acid inhibits the reaction [SLC30A10 gene mutant form results in increased abundance of Manganese]	PMID:22926781
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SLC30A10 mRNA	PMID:29391264
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1312928	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of SLC30A10 mRNA	PMID:35436446
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:48981	quinolin-8-ol	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of SLC30A10 mRNA	PMID:21632981
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SLC30A10 mRNA	PMID:25620056
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312928	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SLC30A10 mRNA	PMID:25620056
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of SLC30A10 mRNA	PMID:18200517
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of SLC30A10 mRNA]	PMID:18200517
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of SLC30A10 mRNA	PMID:20436886
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20220308	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 protein	PMID:34590183
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases response to substance	ISO	RGD:1604615	E	RGD:6480464	20190219	CTD	MESH:D015655	SLC30A10 protein results in decreased susceptibility to 1-Methyl-4-phenylpyridinium	PMID:28688763
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1604615	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SLC30A10 mRNA	PMID:28688763
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20190219	CTD	MESH:D015655	ATF4 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SLC30A10 mRNA]	PMID:28688763
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:64227	ciglitazone	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SLC30A10 mRNA; [ciglitazone binds to PPARG protein] which results in increased expression of SLC30A10 mRNA	PMID:16197558
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:73726	GW 501516	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20170303	CTD	MESH:C425931	[GW 501516 binds to PPARD protein] which results in increased expression of SLC30A10 mRNA	PMID:16197558
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1604615	E	RGD:6480464	20200211	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of SLC30A10 mRNA	PMID:31588062
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA	PMID:27188386
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20120515	CTD	MESH:D010634	Phenobarbital results in decreased expression of SLC30A10 mRNA	PMID:19270015|PMID:19482888
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312928	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SLC30A10 mRNA]	PMID:19482888
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SLC30A10 mRNA	PMID:32109520
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SLC30A10 mRNA	PMID:24780913
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:8872	ritodrine	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20141111	CTD	MESH:D012312	Ritodrine results in decreased expression of SLC30A10 mRNA	PMID:23370008
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:89700	3-iodothyronamine	affects uptake	ISO	RGD:1604615	E	RGD:6480464	20170110	CTD	MESH:C487948	SLC30A10 mRNA affects the uptake of 3-iodothyronamine	PMID:19074582
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1312928	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of SLC30A10 protein	PMID:35357534
1305098	Slc30a10	solute carrier family 30, member 10	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604615	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA	PMID:27188386
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312929	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RUFY1 mRNA	PMID:38218311
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312930	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RUFY1 mRNA	PMID:26251327
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312929	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY1 mRNA	PMID:32699268
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312930	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RUFY1 mRNA	PMID:30319688
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RUFY1 mRNA	PMID:21632981
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312930	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RUFY1 mRNA	PMID:39298647
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312929	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RUFY1 mRNA	PMID:37042841
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in decreased expression of RUFY1 mRNA	PMID:19162166
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of RUFY1 mRNA	PMID:38685446
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312930	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RUFY1 mRNA	PMID:34319233
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RUFY1 mRNA	PMID:33387578
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1312929	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of RUFY1 intron	PMID:30157460
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312929	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of RUFY1 mRNA	PMID:24376830
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RUFY1 mRNA	PMID:19549813
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312929	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RUFY1 protein	PMID:23301498
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312929	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RUFY1 intron	PMID:30157460
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312929	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the methylation of RUFY1 gene; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RUFY1 mRNA	PMID:32699268|PMID:35835166
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312930	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RUFY1 mRNA]	PMID:22206623
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312929	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RUFY1 gene	PMID:25304211
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312929	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RUFY1 mRNA	PMID:40512198
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312929	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RUFY1 protein	PMID:35688186
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312929	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of RUFY1 mRNA	PMID:28903495
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RUFY1 mRNA	PMID:19921347
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312930	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RUFY1 mRNA	PMID:21570461
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RUFY1 mRNA	PMID:33387578
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312930	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RUFY1 mRNA	PMID:19933214
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RUFY1 protein	PMID:39603559
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RUFY1 mRNA	PMID:33212167
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RUFY1 mRNA	PMID:28959563
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RUFY1 mRNA	PMID:29803840
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312929	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RUFY1 mRNA	PMID:40512198
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312929	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RUFY1 3' UTR; Benzo(a)pyrene results in increased methylation of RUFY1 promoter	PMID:27901495
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RUFY1 mRNA	PMID:25181051
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of RUFY1 mRNA	PMID:22576693
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312930	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RUFY1 mRNA	PMID:33221593
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RUFY1 gene	PMID:28505145
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RUFY1 gene	PMID:28505145
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312929	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of RUFY1 gene	PMID:22576693
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RUFY1 mRNA	PMID:19244175
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312929	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RUFY1 gene	PMID:31601247
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312930	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RUFY1 intron	PMID:28392331
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312929	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RUFY1 mRNA	PMID:37042841
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RUFY1 mRNA	PMID:33453195
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RUFY1 mRNA	PMID:24386269
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RUFY1 mRNA	PMID:24449571
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312929	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY1 mRNA	PMID:32699268
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312929	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RUFY1 mRNA	PMID:31533062
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312929	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RUFY1 mRNA	PMID:25979313
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RUFY1 mRNA	PMID:23179753
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312930	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RUFY1 mRNA	PMID:28973697
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RUFY1 mRNA	PMID:33387578
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312929	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RUFY1 gene	PMID:25304211
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312929	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RUFY1 mRNA	PMID:40512198
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312929	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RUFY1 mRNA	PMID:22079256
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of RUFY1 mRNA	PMID:29097150
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312930	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RUFY1 mRNA	PMID:35964746
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RUFY1 protein	PMID:32959892
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312930	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RUFY1 mRNA	PMID:23650126
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312930	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RUFY1 mRNA	PMID:22206623
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312930	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RUFY1 mRNA]	PMID:22206623
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RUFY1 mRNA	PMID:22079256
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312929	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RUFY1 mRNA	PMID:22079256
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312929	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RUFY1 mRNA	PMID:37199045
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1312929	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of RUFY1 mRNA	PMID:22124623
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312929	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RUFY1 gene]	PMID:28238834
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1312930	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in increased expression of RUFY1 protein	PMID:26903627
1305099	Rufy1	RUN and FYVE domain containing 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RUFY1 mRNA	PMID:21346803
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1623092	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PBX4 mRNA	PMID:37995155
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1345476	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of PBX4 mRNA	PMID:34925699
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of PBX4 mRNA	PMID:20488242
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1345476	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PBX4 mRNA	PMID:26079696
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of PBX4 mRNA	PMID:36841081
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1345476	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PBX4 mRNA	PMID:20044591
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1345476	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PBX4 mRNA	PMID:35811015
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1345476	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PBX4 mRNA	PMID:35811015
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PBX4 mRNA	PMID:33387578
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PBX4 gene	PMID:27618143
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1345476	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PBX4 mRNA	PMID:26079696
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1623092	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of PBX4 mRNA	PMID:39922521
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1623092	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PBX4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PBX4 mRNA	PMID:37567420|PMID:37992649
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1623092	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of PBX4 mRNA	PMID:39922521
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1623092	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PBX4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PBX4 mRNA	PMID:37567420|PMID:37992649
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1623092	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PBX4 mRNA	PMID:34319233
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PBX4 mRNA	PMID:33387578
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1345476	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PBX4 intron	PMID:30157460
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1345476	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PBX4 mRNA	PMID:23649840
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1623092	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PBX4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PBX4 mRNA	PMID:34911549
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1345476	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PBX4 gene	PMID:25304211
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PBX4 mRNA	PMID:31881176
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623092	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PBX4 mRNA	PMID:24058054
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PBX4 mRNA	PMID:33387578
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1345476	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PBX4 mRNA	PMID:33212167
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1345476	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PBX4 mRNA	PMID:32763439
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1623092	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PBX4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PBX4 mRNA	PMID:37567420|PMID:37992649
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1345476	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PBX4 exon; Benzo(a)pyrene results in increased methylation of PBX4 promoter	PMID:27901495
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1623092	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in decreased expression of PBX4 mRNA	PMID:22609695
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623092	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PBX4 gene; titanium dioxide results in decreased methylation of PBX4 promoter	PMID:35295148
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1345476	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased methylation of PBX4 gene	PMID:34973136
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1345476	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PBX4 mRNA	PMID:19710929
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PBX4 mRNA	PMID:25181051
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PBX4 mRNA	PMID:34947998
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1345476	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PBX4 gene	PMID:31601247
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PBX4 mRNA	PMID:30816183|PMID:32528016
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1623092	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PBX4 mRNA	PMID:38685157
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1345476	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PBX4 mRNA	PMID:24449571
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1623092	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of PBX4 mRNA	PMID:21427059
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1623092	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of PBX4 mRNA	PMID:39922521
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1623092	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PBX4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PBX4 mRNA	PMID:37567420|PMID:37992649
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PBX4 mRNA	PMID:33387578
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1345476	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PBX4 mRNA	PMID:35811015
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1345476	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PBX4 gene	PMID:25304211
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1623092	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of PBX4 mRNA	PMID:36851058
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1345476	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PBX4 mRNA	PMID:22079614
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1345476	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PBX4 mRNA	PMID:31758290
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1623092	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PBX4 mRNA	PMID:37567420
1305100	Pbx4	PBX homeobox 4	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1623092	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of PBX4 mRNA	PMID:32835833
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344399	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PUDP mRNA	PMID:37042841
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PUDP mRNA	PMID:28818685
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:188855	Octicizer	multiple interactions	ISO	RGD:1344399	E	RGD:6480464	20260707	CTD	MESH:C018535	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of PUDP protein	PMID:42015365
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PUDP mRNA	PMID:19549813
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1344399	E	RGD:6480464	20161115	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PUDP gene	PMID:27153756
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PUDP mRNA	PMID:23649840
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1344399	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of PUDP protein	PMID:38460933
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1344399	E	RGD:6480464	20161115	CTD	MESH:D009532	Nickel results in increased expression of PUDP mRNA	PMID:24768652|PMID:25583101
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550115	E	RGD:6480464	20170725	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PUDP mRNA	PMID:17942748
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PUDP mRNA	PMID:28001369
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1344399	E	RGD:6480464	20170725	CTD	MESH:D024483	Vitamin K 3 affects the expression of PUDP mRNA	PMID:20044591
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PUDP mRNA	PMID:38568856
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1550115	E	RGD:6480464	20170725	CTD	MESH:D012834	Silver results in increased expression of PUDP mRNA	PMID:27131904
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20170725	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PUDP mRNA	PMID:19150397|PMID:20382639
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1344399	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PUDP gene	PMID:31601247
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550115	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of PUDP mRNA	PMID:35295148
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PUDP mRNA	PMID:25181051
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PUDP gene	PMID:28505145
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1344399	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PUDP gene	PMID:31601247
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1344399	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PUDP intron	PMID:30157460
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:35033	triphenyl phosphate	multiple interactions	ISO	RGD:1344399	E	RGD:6480464	20260707	CTD	MESH:C005445	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of PUDP protein	PMID:42015365
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	multiple interactions	ISO	RGD:1344399	E	RGD:6480464	20260707	CTD	MESH:C031324	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of PUDP protein	PMID:42015365
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	multiple interactions	ISO	RGD:1344399	E	RGD:6480464	20260707	CTD	MESH:C013320	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of PUDP protein	PMID:42015365
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20170725	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PUDP mRNA	PMID:19320972
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344399	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PUDP mRNA	PMID:25979313
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PUDP mRNA	PMID:20106945|PMID:25562108
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550115	E	RGD:6480464	20170725	CTD	MESH:D013629	Tamoxifen affects the expression of PUDP mRNA	PMID:17555576
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1344399	E	RGD:6480464	20170725	CTD	MESH:D008727	PUDP protein affects the susceptibility to Methotrexate	PMID:16217747
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1344399	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of PUDP protein	PMID:38460933
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1344399	E	RGD:6480464	20170725	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PUDP mRNA	PMID:22079256
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550115	E	RGD:6480464	20170725	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PUDP mRNA	PMID:17555576
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550115	E	RGD:6480464	20170725	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PUDP mRNA	PMID:17942748
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550115	E	RGD:6480464	20170725	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PUDP mRNA	PMID:17942748
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PUDP protein	PMID:32959892
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1344399	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PUDP intron	PMID:30157460
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PUDP mRNA	PMID:31758290
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1344399	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PUDP protein	PMID:34186270
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20170725	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PUDP mRNA	PMID:22079256
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1344399	E	RGD:6480464	20170725	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PUDP mRNA	PMID:22079256
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1344399	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PUDP mRNA	PMID:37199045
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1550115	E	RGD:6480464	20170725	CTD	MESH:D012834	Silver results in increased expression of PUDP mRNA	PMID:27131904
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PUDP mRNA	PMID:38568856
1305101	Pudp	pseudouridine 5'-phosphatase	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1344399	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PUDP mRNA	PMID:29301935
1305102	Scel	sciellin	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312935	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SCEL mRNA	PMID:38218311
1305102	Scel	sciellin	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312935	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in decreased expression of SCEL mRNA	PMID:24172598
1305102	Scel	sciellin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312935	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of SCEL mRNA	PMID:16249480
1305102	Scel	sciellin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312935	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of SCEL mRNA	PMID:23019147
1305102	Scel	sciellin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312935	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SCEL mRNA	PMID:30165855
1305102	Scel	sciellin	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312936	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SCEL mRNA	PMID:33711761
1305102	Scel	sciellin	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SCEL mRNA	PMID:33387578
1305102	Scel	sciellin	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1312935	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of SCEL mRNA	PMID:16002434
1305102	Scel	sciellin	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312935	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of SCEL mRNA	PMID:21120746
1305102	Scel	sciellin	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312935	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SCEL mRNA	PMID:19549813
1305102	Scel	sciellin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SCEL mRNA	PMID:34911549
1305102	Scel	sciellin	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312935	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SCEL protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SCEL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SCEL protein	PMID:38598786
1305102	Scel	sciellin	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312936	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SCEL mRNA	PMID:17484886
1305102	Scel	sciellin	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of SCEL mRNA	PMID:19654921
1305102	Scel	sciellin	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1312936	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of SCEL mRNA	PMID:38723480
1305102	Scel	sciellin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of SCEL mRNA]	PMID:38723480
1305102	Scel	sciellin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312935	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCEL mRNA	PMID:27188386
1305102	Scel	sciellin	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312935	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in decreased expression of SCEL mRNA	PMID:23019147
1305102	Scel	sciellin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312936	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SCEL mRNA	PMID:21570461
1305102	Scel	sciellin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SCEL mRNA	PMID:33387578
1305102	Scel	sciellin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312936	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SCEL mRNA	PMID:17035482|PMID:19933214
1305102	Scel	sciellin	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312935	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SCEL mRNA; aristolochic acid I results in decreased expression of SCEL protein	PMID:33212167
1305102	Scel	sciellin	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SCEL mRNA	PMID:28959563
1305102	Scel	sciellin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312935	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SCEL mRNA	PMID:20971185
1305102	Scel	sciellin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312935	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of SCEL mRNA	PMID:28595984|PMID:34032870
1305102	Scel	sciellin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SCEL mRNA	PMID:37682722
1305102	Scel	sciellin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312935	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SCEL mRNA	PMID:39719251
1305102	Scel	sciellin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA	PMID:34876320
1305102	Scel	sciellin	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA	PMID:34876320
1305102	Scel	sciellin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312935	E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCEL mRNA	PMID:40419235
1305102	Scel	sciellin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312935	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SCEL promoter	PMID:27901495
1305102	Scel	sciellin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312935	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SCEL 3' UTR	PMID:27901495
1305102	Scel	sciellin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312935	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SCEL mRNA	PMID:20971185
1305102	Scel	sciellin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SCEL mRNA	PMID:29203145
1305102	Scel	sciellin	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1312935	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of SCEL mRNA	PMID:37690743
1305102	Scel	sciellin	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C009495	titanium dioxide results in decreased expression of SCEL mRNA	PMID:28181387
1305102	Scel	sciellin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SCEL mRNA	PMID:23557971
1305102	Scel	sciellin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SCEL mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305102	Scel	sciellin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312935	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SCEL mRNA	PMID:29275510
1305102	Scel	sciellin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312936	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SCEL mRNA	PMID:32156529
1305102	Scel	sciellin	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SCEL gene	PMID:28505145
1305102	Scel	sciellin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312936	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of SCEL mRNA	PMID:40203079
1305102	Scel	sciellin	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of SCEL mRNA	PMID:26377693
1305102	Scel	sciellin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312936	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SCEL mRNA	PMID:30951980
1305102	Scel	sciellin	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312936	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SCEL intron	PMID:28392331
1305102	Scel	sciellin	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312936	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SCEL mRNA	PMID:37019170
1305102	Scel	sciellin	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312935	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SCEL protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SCEL protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SCEL protein	PMID:38598786
1305102	Scel	sciellin	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312936	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SCEL mRNA	PMID:24535843
1305102	Scel	sciellin	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312935	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SCEL mRNA	PMID:38174414
1305102	Scel	sciellin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312936	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SCEL mRNA	PMID:40194260
1305102	Scel	sciellin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312935	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SCEL mRNA	PMID:27188386
1305102	Scel	sciellin	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312935	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of SCEL mRNA	PMID:16144937
1305102	Scel	sciellin	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312935	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SCEL mRNA	PMID:38832940
1305102	Scel	sciellin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SCEL mRNA	PMID:33387578
1305102	Scel	sciellin	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1312935	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of SCEL mRNA	PMID:24714768
1305102	Scel	sciellin	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SCEL mRNA	PMID:29279043
1305102	Scel	sciellin	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of SCEL mRNA	PMID:19654921
1305102	Scel	sciellin	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1312936	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of SCEL mRNA	PMID:38723480
1305102	Scel	sciellin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of SCEL mRNA]	PMID:38723480
1305102	Scel	sciellin	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of SCEL mRNA	PMID:30529165
1305102	Scel	sciellin	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA	PMID:34876320
1305102	Scel	sciellin	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SCEL mRNA	PMID:30307764
1305102	Scel	sciellin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SCEL mRNA; Nanotubes, Carbon results in decreased expression of SCEL mRNA	PMID:25554681
1305102	Scel	sciellin	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of SCEL promoter	PMID:27415467
1305102	Scel	sciellin	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312935	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCEL mRNA	PMID:27188386
1305102	Scel	sciellin	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312935	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SCEL gene]	PMID:28238834
1305102	Scel	sciellin	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SCEL mRNA	PMID:27291303
1305102	Scel	sciellin	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SCEL mRNA	PMID:23640034
1305102	Scel	sciellin	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA	PMID:34876320
1305102	Scel	sciellin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SCEL mRNA	PMID:24780913
1305102	Scel	sciellin	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1312935	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of SCEL mRNA	PMID:24921660
1305102	Scel	sciellin	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312935	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCEL mRNA	PMID:27188386
1305102	Scel	sciellin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312935	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SCEL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SCEL protein	PMID:38598786
1305102	Scel	sciellin	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SCEL mRNA	PMID:35537566
1305102	Scel	sciellin	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of SCEL gene	PMID:31079544
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312938	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CSMD1 mRNA	PMID:33045310
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CSMD1 mRNA	PMID:37995155
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CSMD1 mRNA]	PMID:31150632
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	ISO	RGD:1312937	E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CSMD1 mRNA	PMID:19074003
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CSMD1 mRNA	PMID:20188158
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CSMD1 gene	PMID:28931070|PMID:35440735
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of CSMD1 mRNA	PMID:29018328
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312938	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CSMD1 mRNA	PMID:30319688
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CSMD1 mRNA	PMID:33387578
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1312937	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of CSMD1 intron	PMID:30157460
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CSMD1 mRNA	PMID:21396975
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CSMD1 mRNA	PMID:22129741
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312937	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CSMD1 gene	PMID:27153756
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CSMD1 mRNA	PMID:23630614|PMID:25378103
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312937	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CSMD1 intron	PMID:30157460
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CSMD1 mRNA	PMID:31150632
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CSMD1 mRNA]	PMID:31150632
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312937	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CSMD1 mRNA	PMID:24768652|PMID:25583101
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312938	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CSMD1 mRNA	PMID:21570461
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of CSMD1 mRNA	PMID:36209798
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312937	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CSMD1 exon; Benzo(a)pyrene affects the methylation of CSMD1 intron	PMID:30157460
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312937	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CSMD1 3' UTR; Benzo(a)pyrene results in decreased methylation of CSMD1 promoter	PMID:27901495
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1312937	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CSMD1 gene	PMID:25435355
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312938	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CSMD1 mRNA	PMID:29341224|PMID:38811393
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1312937	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of CSMD1 gene	PMID:31601247
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312937	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CSMD1 gene; [bisphenol F co-treated with Fulvestrant] results in decreased methylation of CSMD1 gene	PMID:31601247
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CSMD1 mRNA	PMID:32479839
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CSMD1 mRNA	PMID:32599119
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CSMD1 mRNA	PMID:29264374
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312938	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CSMD1 gene	PMID:35295148
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312937	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CSMD1 gene	PMID:31601247
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CSMD1 mRNA	PMID:25181051|PMID:30816183
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CSMD1 mRNA	PMID:32156529
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312938	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of CSMD1 mRNA	PMID:35598803
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CSMD1 gene	PMID:28505145
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312937	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CSMD1 gene	PMID:31601247
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1312937	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of CSMD1 intron	PMID:30157460
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312937	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of CSMD1 gene	PMID:31601247
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CSMD1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CSMD1 mRNA	PMID:18164116|PMID:22129741
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CSMD1 promoter	PMID:22457795
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CSMD1 mRNA	PMID:25539665
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1312937	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of CSMD1 mRNA	PMID:31626844
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of CSMD1 mRNA	PMID:29427782
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in increased expression of CSMD1 mRNA	PMID:30723492
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CSMD1 mRNA	PMID:29391264
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:63618	pravastatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of CSMD1 mRNA	PMID:27225895
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of CSMD1 mRNA	PMID:27225895
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:6443	levonorgestrel	multiple interactions	ISO	RGD:1312937	E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CSMD1 mRNA	PMID:19074003
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:6809	methamphetamine	affects response to substance	ISO	RGD:1312937	E	RGD:6480464	20120412	CTD	MESH:D008694	CSMD1 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1312937	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of CSMD1 intron	PMID:30157460
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:75170	zaragozic acid A	affects expression	ISO	RGD:1312938	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 affects the expression of CSMD1 mRNA	PMID:27225895
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:75170	zaragozic acid A	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CSMD1 mRNA	PMID:27225895
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:756028	mivebresib	decreases expression	ISO	RGD:1312937	E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of CSMD1 mRNA	PMID:35486664
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CSMD1 mRNA	PMID:18164116
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of CSMD1 mRNA	PMID:23665939
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312937	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CSMD1 gene]	PMID:28238834
1305103	Csmd1	CUB and Sushi multiple domains 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CSMD1 mRNA	PMID:24780913|PMID:25825206
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312940	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ANKRD2 mRNA	PMID:33045310
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312939	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of ANKRD2 mRNA	PMID:23830798
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ANKRD2 mRNA	PMID:33729688
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312939	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ANKRD2 mRNA	PMID:26079696
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:15746	spermine	increases expression	ISO	RGD:1312940	E	RGD:6480464	20120412	CTD	MESH:D013096	Spermine results in increased expression of ANKRD2 mRNA	PMID:18673383
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312939	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ANKRD2 mRNA	PMID:31614463
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312939	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ANKRD2 mRNA	PMID:30165855
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of ANKRD2 mRNA	PMID:27664576
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312939	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ANKRD2 mRNA	PMID:26079696
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA	PMID:37992649
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312939	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ANKRD2 mRNA	PMID:21475673
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA	PMID:37992649
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20210608	CTD	MESH:D004051	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of ANKRD2 mRNA	PMID:33484791
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312939	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKRD2 mRNA	PMID:36139627
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ANKRD2 mRNA	PMID:33387578
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312939	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ANKRD2 promoter	PMID:30157460
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ANKRD2 mRNA	PMID:32234424
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312939	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANKRD2 gene	PMID:27153756
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312940	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in increased expression of ANKRD2 mRNA	PMID:31626304
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ANKRD2 mRNA	PMID:27392435
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312940	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANKRD2 mRNA	PMID:26377647
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312940	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ANKRD2 mRNA	PMID:26290441
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANKRD2 mRNA	PMID:33387578
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ANKRD2 promoter]	PMID:19654925
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312939	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ANKRD2 mRNA	PMID:33212167
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ANKRD2 mRNA	PMID:30851411
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312940	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of ANKRD2 mRNA	PMID:30807115
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ANKRD2 mRNA	PMID:29803840
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312940	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of ANKRD2 mRNA	PMID:36227756
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20260707	CTD	MESH:D005632	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA	PMID:37992649
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20260707	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA]	PMID:37992649
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANKRD2 mRNA	PMID:38568856
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312939	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ANKRD2 mRNA	PMID:39719251
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312939	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ANKRD2 promoter	PMID:27901495
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to ANKRD2 promoter]	PMID:19654925
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312940	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ANKRD2 mRNA	PMID:23221170
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1312939	E	RGD:6480464	20191114	CTD	MESH:C006632	ANKRD2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:3160	Botulinum toxin type A	increases expression	EXP		E	RGD:6480464	20170117	CTD	MESH:D019274	Botulinum Toxins, Type A results in increased expression of ANKRD2 mRNA	PMID:18603602
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of ANKRD2 mRNA	PMID:38568856
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312940	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ANKRD2 mRNA	PMID:35295148
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKRD2 mRNA	PMID:25181051
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312939	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ANKRD2 gene	PMID:31601247
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ANKRD2 gene	PMID:28505145
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312940	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ANKRD2 mRNA	PMID:30951980
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312940	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ANKRD2 mRNA	PMID:37019170
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1312940	E	RGD:6480464	20120918	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of ANKRD2 mRNA	PMID:19647056
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312940	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ANKRD2 mRNA	PMID:40194260
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ANKRD2 mRNA	PMID:40419075
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312939	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ANKRD2 mRNA	PMID:27153767
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ANKRD2 mRNA	PMID:36331819
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312939	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ANKRD2 gene	PMID:29154799
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of ANKRD2 mRNA	PMID:27989131
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1312940	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in increased expression of ANKRD2 mRNA	PMID:40633821
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA	PMID:37992649
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ANKRD2 mRNA	PMID:38832940
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ANKRD2 mRNA	PMID:31838189
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ANKRD2 mRNA	PMID:32234424
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1312939	E	RGD:6480464	20191114	CTD	MESH:C032793	ANKRD2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312940	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ANKRD2 mRNA; Nanotubes, Carbon results in increased expression of ANKRD2 mRNA	PMID:25620056
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of ANKRD2 protein	PMID:24140754
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1312940	E	RGD:6480464	20120918	CTD	MESH:D010081	Oxazolone results in increased expression of ANKRD2 mRNA	PMID:19647056
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1312940	E	RGD:6480464	20120918	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of ANKRD2 mRNA	PMID:19647056
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ANKRD2 protein	PMID:32959892
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:60799	esketamine	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20240702	CTD	MESH:C000629870	Esketamine results in decreased expression of ANKRD2 mRNA	PMID:38219984
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ANKRD2 mRNA	PMID:15336504
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:64310	crizotinib	increases expression	ISO	RGD:1312940	E	RGD:6480464	20260303	CTD	MESH:C551994	Crizotinib results in increased expression of ANKRD2 mRNA; Crizotinib results in increased expression of ANKRD2 protein	PMID:41183147
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312939	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKRD2 mRNA	PMID:36139627
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:7719	ochratoxin A	decreases methylation	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased methylation of ANKRD2 gene	PMID:37162024
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased expression of ANKRD2 mRNA	PMID:37162024
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ANKRD2 mRNA	PMID:30851411
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of ANKRD2 mRNA	PMID:32234424
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1312939	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ANKRD2 mRNA	PMID:26079696
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of ANKRD2 mRNA	PMID:33484791
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1312939	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ANKRD2 mRNA	PMID:17440010
1305104	Ankrd2	ankyrin repeat domain 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312939	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ANKRD2 mRNA	PMID:38568856
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552115	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SMYD1 mRNA	PMID:33045310
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:15746	spermine	increases expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D013096	Spermine results in increased expression of SMYD1 mRNA	PMID:18673383
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312941	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SMYD1 mRNA	PMID:30510588
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552115	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SMYD1 mRNA	PMID:39298647
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312941	E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [SMYD1 protein binds to ESR1 protein]	PMID:27156127
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA	PMID:25510870
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:16643	L-methionine	increases expression	ISO	RGD:1552115	E	RGD:6480464	20221206	CTD	MESH:D008715	Methionine deficiency results in increased expression of SMYD1 mRNA	PMID:35314295
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of SMYD1 mRNA	PMID:31525975
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of SMYD1 mRNA	PMID:31525975
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SMYD1 mRNA	PMID:33387578
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SMYD1 mRNA	PMID:36331819
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of SMYD1 mRNA	PMID:39984025
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA	PMID:25510870
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA	PMID:25510870
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of SMYD1 mRNA	PMID:19376150
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1552115	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in increased expression of SMYD1 mRNA	PMID:26392148
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SMYD1 mRNA	PMID:34911549
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312941	E	RGD:6480464	20220308	CTD	MESH:D005492	Folic Acid results in increased expression of SMYD1 mRNA	PMID:34742744
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMYD1 mRNA	PMID:22206623
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SMYD1 mRNA	PMID:28189721|PMID:28960355
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMYD1 mRNA	PMID:18343893
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMYD1 mRNA	PMID:32109520
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMYD1 mRNA	PMID:19770486
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SMYD1 mRNA	PMID:28374803
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312941	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMYD1 mRNA	PMID:29803840
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312941	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SMYD1 promoter	PMID:27901495
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SMYD1 mRNA	PMID:29264374
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SMYD1 mRNA	PMID:18301758
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SMYD1 mRNA	PMID:25181051
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SMYD1 mRNA	PMID:41034487
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312941	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SMYD1 protein	PMID:37567409
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552115	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SMYD1 mRNA	PMID:30951980|PMID:32156529
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SMYD1 gene	PMID:28505145
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA	PMID:25510870
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA	PMID:25510870
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of SMYD1 mRNA	PMID:40203079
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552115	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SMYD1 mRNA	PMID:30951980|PMID:39298647
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552115	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SMYD1 mRNA	PMID:30951980
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of SMYD1 mRNA	PMID:35163327
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SMYD1 mRNA	PMID:35163327
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of SMYD1 mRNA	PMID:18500788
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SMYD1 mRNA	PMID:35163327
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312941	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SMYD1 mRNA	PMID:31533062
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SMYD1 mRNA	PMID:39529242
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SMYD1 mRNA	PMID:22237054
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SMYD1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SMYD1 mRNA	PMID:36331819
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMYD1 mRNA	PMID:15799026
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in increased expression of SMYD1 mRNA	PMID:35594946
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312941	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SMYD1 mRNA	PMID:28001369
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of SMYD1 mRNA	PMID:31525975
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SMYD1 mRNA	PMID:17562736
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1552115	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of SMYD1 mRNA	PMID:30529165
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of SMYD1 mRNA	PMID:22504374
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:50845	doxycycline	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D004318	Doxycycline inhibits the reaction [Isoproterenol results in decreased expression of SMYD1 mRNA]	PMID:18089841
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of SMYD1 mRNA	PMID:36907384
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of SMYD1 mRNA	PMID:18089841|PMID:20003209
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20120515	CTD	MESH:D007545	Doxycycline inhibits the reaction [Isoproterenol results in decreased expression of SMYD1 mRNA]	PMID:18089841
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SMYD1 mRNA	PMID:22206623
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMYD1 mRNA	PMID:22206623
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1312941	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of SMYD1 mRNA	PMID:29522793
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312941	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SMYD1 gene]	PMID:28238834
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1552115	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of SMYD1 mRNA	PMID:18343893
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SMYD1 mRNA	PMID:32109520
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SMYD1 mRNA	PMID:23914054
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SMYD1 mRNA	PMID:21278054
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SMYD1 mRNA	PMID:24780913
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of SMYD1 mRNA	PMID:22504374
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of SMYD1 mRNA	PMID:26006729|PMID:26217789
1305105	Smyd1	SET and MYND domain containing 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1552115	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of SMYD1 mRNA	PMID:32835833
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of CIDEA mRNA	PMID:25152437
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:136185	VX nerve agent	increases expression	ISO	RGD:1312942	E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of CIDEA mRNA	PMID:38555327
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20191008	CTD	MESH:D002794	[Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CIDEA mRNA	PMID:29127188
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of CIDEA mRNA	PMID:16604517|PMID:16788091|PMID:36189433
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CIDEA mRNA	PMID:36189433
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312943	E	RGD:6480464	20140610	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CIDEA mRNA	PMID:23539316
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CIDEA mRNA	PMID:36331819
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20260407	CTD	MESH:D019308	Palmitic Acid results in decreased expression of CIDEA mRNA	PMID:40449640
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:15940	nicotinic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20161213	CTD	MESH:D009525	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of CIDEA mRNA]	PMID:16940432
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:15956	biotin	multiple interactions	ISO	RGD:1312942	E	RGD:6480464	20220111	CTD	MESH:D001710	[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA	PMID:34323617
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of CIDEA mRNA	PMID:19484750
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of CIDEA mRNA	PMID:26496021
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of CIDEA mRNA	PMID:17905399
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20191008	CTD	MESH:D008715	[Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CIDEA mRNA	PMID:29127188
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312943	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CIDEA mRNA	PMID:39922521
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CIDEA mRNA	PMID:37992649
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312943	E	RGD:6480464	20200915	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CIDEA mRNA	PMID:32522588
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CIDEA mRNA	PMID:36189433
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in increased expression of CIDEA mRNA]	PMID:20032058
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:17488	scopoletin	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D012603	Scopoletin inhibits the reaction [Alcohols affects the expression of CIDEA mRNA]	PMID:26115886
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312943	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CIDEA mRNA	PMID:39922521
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CIDEA mRNA	PMID:37992649
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D009538	Nicotine results in decreased expression of CIDEA mRNA	PMID:33091441
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CIDEA mRNA	PMID:31706747|PMID:34319233
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CIDEA mRNA	PMID:26577399
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:1784	biphenyl-4-amine	decreases expression	ISO	RGD:1312942	E	RGD:6480464	20140909	CTD	MESH:C006757	4-biphenylamine results in decreased expression of CIDEA mRNA	PMID:24857880
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D009538	Nicotine results in decreased expression of CIDEA mRNA	PMID:33091441
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:23115	chlorohydrocarbon	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D006843	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CIDEA mRNA	PMID:30744511
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CIDEA mRNA	PMID:21396975
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CIDEA mRNA	PMID:22129741
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CIDEA mRNA	PMID:33354967
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312942	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CIDEA intron	PMID:30157460
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312942	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CIDEA gene	PMID:27153756
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:25187	p-menthan-3-ol	increases expression	ISO	RGD:1312942	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of CIDEA mRNA	PMID:26760959
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Ozone co-treated with Fructose] results in decreased expression of CIDEA mRNA; [Particulate Matter co-treated with Ozone co-treated with Fructose] results in decreased expression of CIDEA mRNA	PMID:23968387
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CIDEA mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CIDEA mRNA	PMID:34911549
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000638	Amiodarone results in increased expression of CIDEA mRNA	PMID:40216313
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312943	E	RGD:6480464	20171114	CTD	MESH:D000638	Amiodarone results in increased expression of CIDEA mRNA	PMID:28962527
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:2663	amiodarone	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20171114	CTD	MESH:D000638	1-(3,4-dihydroxyphenyl)-2-thiocyanate-ethanone inhibits the reaction [Amiodarone results in increased expression of CIDEA mRNA]; DDIT3 gene mutant form inhibits the reaction [Amiodarone results in increased expression of CIDEA mRNA]	PMID:28962527
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312943	E	RGD:6480464	20141014	CTD	MESH:C011559	tributyltin results in increased expression of CIDEA mRNA	PMID:24848799
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20191008	CTD	MESH:D005492	[Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CIDEA mRNA	PMID:29127188
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312942	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of CIDEA mRNA	PMID:19962721
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312942	E	RGD:6480464	20120412	CTD	MESH:D001151	[Arsenic co-treated with Fluorides] results in decreased expression of CIDEA mRNA	PMID:19962721
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CIDEA mRNA	PMID:28960355
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CIDEA mRNA	PMID:31881176
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312943	E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol results in increased expression of CIDEA mRNA	PMID:25761413
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of CIDEA mRNA	PMID:25905778
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:C059514	PRKAA1 gene mutant form inhibits the reaction [resveratrol results in increased expression of CIDEA mRNA]; resveratrol inhibits the reaction [Dietary Fats affects the expression of CIDEA mRNA]	PMID:17086191|PMID:25761413
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of CIDEA mRNA	PMID:15681117
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28073	chromium atom	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D002857	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of CIDEA mRNA]	PMID:16940432
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312942	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of CIDEA mRNA	PMID:24768652
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CIDEA mRNA	PMID:21215274
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CIDEA mRNA	PMID:17942748
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28121	harmine	increases expression	ISO	RGD:1312943	E	RGD:6480464	20171114	CTD	MESH:D006247	Harmine results in increased expression of CIDEA protein	PMID:27805061
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28121	harmine	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20171114	CTD	MESH:D006247	Harmine affects the reaction [Dietary Fats affects the expression of CIDEA mRNA]	PMID:27805061
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of CIDEA mRNA	PMID:28374803
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C004925	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CIDEA mRNA	PMID:30744511
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312942	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CIDEA mRNA	PMID:30851411
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28436	delphinidin	increases expression	ISO	RGD:1312942	E	RGD:6480464	20120814	CTD	MESH:C017185	delphinidin results in increased expression of CIDEA mRNA	PMID:19182879
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312943	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of CIDEA mRNA	PMID:39631538
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28757	fructose	decreases expression	EXP		E	RGD:6480464	20210112	CTD	MESH:D005632	Fructose results in decreased expression of CIDEA mRNA	PMID:23968387
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28757	fructose	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D005632	[Ozone co-treated with Fructose] results in decreased expression of CIDEA mRNA; [Particulate Matter co-treated with Fructose] results in decreased expression of CIDEA mRNA; [Particulate Matter co-treated with Ozone co-treated with Fructose] results in decreased expression of CIDEA mRNA	PMID:23968387
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CIDEA mRNA	PMID:37992649
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312942	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of CIDEA mRNA	PMID:29301061
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CIDEA mRNA	PMID:21839799
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312942	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CIDEA mRNA	PMID:22316170
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312943	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CIDEA mRNA	PMID:22610609
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312942	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CIDEA promoter	PMID:27901495
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1312942	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CIDEA promoter	PMID:23974009
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312942	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CIDEA mRNA	PMID:17530438
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:30660	thyroxine	multiple interactions	ISO	RGD:1312942	E	RGD:6480464	20220111	CTD	MESH:D013974	[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA	PMID:34323617
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:30879	alcohol	affects expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D000438	Alcohols affects the expression of CIDEA mRNA	PMID:26115886
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:30879	alcohol	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:D000438	Scopoletin inhibits the reaction [Alcohols affects the expression of CIDEA mRNA]	PMID:26115886
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of CIDEA mRNA	PMID:24915197
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CIDEA mRNA	PMID:30047161
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CIDEA mRNA	PMID:23557971
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312943	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CIDEA gene	PMID:35295148
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CIDEA mRNA	PMID:23411599
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CIDEA mRNA	PMID:25380136
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of CIDEA mRNA	PMID:19162173|PMID:22484513
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312943	E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of CIDEA mRNA; pirinixic acid results in increased expression of CIDEA protein	PMID:12727805|PMID:17690133|PMID:17950772|PMID:18301758|PMID:20059764
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CIDEA mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of CIDEA mRNA]	PMID:17950772|PMID:19710929|PMID:20059764
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of CIDEA mRNA	PMID:22484513
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:32888	gamma-hexachlorocyclohexane	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane results in decreased expression of CIDEA mRNA	PMID:17785943
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CIDEA mRNA	PMID:34947998|PMID:35192832
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of CIDEA mRNA	PMID:30245210|PMID:39537008
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CIDEA mRNA	PMID:25181051
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CIDEA gene	PMID:28505145
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of CIDEA mRNA	PMID:26496021
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:33418	graphite	increases expression	ISO	RGD:1312943	E	RGD:6480464	20180515	CTD	MESH:D006108	Graphite results in increased expression of CIDEA mRNA	PMID:27440207
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of CIDEA mRNA	PMID:22937105
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CIDEA mRNA	PMID:16984957|PMID:20959002
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CIDEA mRNA	PMID:20959002
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CIDEA mRNA	PMID:37019170
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CIDEA mRNA	PMID:22546817
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312943	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CIDEA mRNA	PMID:17361019|PMID:21266533
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CIDEA mRNA	PMID:22546817
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312942	E	RGD:6480464	20220111	CTD	MESH:D015056	[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with bisphenol AF] results in increased expression of CIDEA mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of CIDEA mRNA	PMID:31596606|PMID:34323617
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20141014	CTD	MESH:D015056	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CIDEA mRNA; [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Roscovitine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEA mRNA	PMID:24848799|PMID:29288687|PMID:32417366|PMID:34323617
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312943	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CIDEA mRNA	PMID:24535843
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CIDEA mRNA	PMID:22129741
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CIDEA mRNA	PMID:22546817
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312942	E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of CIDEA mRNA	PMID:18836921
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of CIDEA gene	PMID:33148267
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of CIDEA mRNA	PMID:30589522
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CIDEA mRNA	PMID:35163327
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CIDEA mRNA	PMID:25380136
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312942	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CIDEA mRNA	PMID:38174414
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CIDEA mRNA	PMID:19162173
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312942	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CIDEA mRNA	PMID:25812627
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CIDEA mRNA	PMID:35163327
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CIDEA mRNA	PMID:19162173
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312943	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CIDEA mRNA	PMID:18353800
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312943	E	RGD:6480464	20210608	CTD	MESH:D002994	Clofibrate results in increased expression of CIDEA mRNA	PMID:33549593
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:38319	usnic acid	increases expression	ISO	RGD:1312942	E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of CIDEA mRNA	PMID:32508146
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312942	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CIDEA mRNA	PMID:25812627
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312943	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CIDEA mRNA	PMID:40194260
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:38397	perfluorononanoic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20220111	CTD	MESH:C101816	[Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in increased expression of CIDEA mRNA	PMID:33483757
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CIDEA mRNA	PMID:19162173
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20210209	CTD	MESH:C076994	[Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of CIDEA mRNA; [perfluorooctane sulfonic acid co-treated with Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of CIDEA mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CIDEA mRNA	PMID:32979393|PMID:32991729|PMID:36331819
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of CIDEA mRNA	PMID:35594946
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CIDEA mRNA	PMID:30047161
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of CIDEA mRNA	PMID:41580965
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of CIDEA mRNA	PMID:20032058
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312942	E	RGD:6480464	20130416	CTD	MESH:D003907	Dexamethasone results in increased expression of CIDEA mRNA	PMID:19853017
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in increased expression of CIDEA mRNA]	PMID:20032058
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312942	E	RGD:6480464	20220111	CTD	MESH:D003907	[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with bisphenol AF] results in increased expression of CIDEA mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of CIDEA mRNA	PMID:31596606|PMID:34323617
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20141014	CTD	MESH:D003907	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CIDEA mRNA; [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Roscovitine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEA mRNA	PMID:24848799|PMID:29288687|PMID:32417366|PMID:34323617
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CIDEA mRNA	PMID:36653537|PMID:37077353
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:42017	2,4-dinitrophenol	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20150127	CTD	MESH:D019297	[2,4-Dinitrophenol co-treated with Dietary Fats] affects the expression of CIDEA mRNA	PMID:24872412
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312943	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CIDEA mRNA	PMID:28973697
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312943	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CIDEA mRNA	PMID:39922521
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CIDEA mRNA	PMID:37992649
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CIDEA mRNA	PMID:24136188
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:46905	(R)-pantothenic acid	multiple interactions	ISO	RGD:1312942	E	RGD:6480464	20220111	CTD	MESH:D010205	[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA	PMID:34323617
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312942	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of CIDEA mRNA	PMID:19962721
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312942	E	RGD:6480464	20140805	CTD	MESH:D001151	[Arsenic co-treated with Fluorides] results in decreased expression of CIDEA mRNA	PMID:19962721
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:47426	furosemide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005665	Furosemide affects the expression of CIDEA mRNA	PMID:17497460
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of CIDEA mRNA	PMID:36653537|PMID:37077353
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312943	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of CIDEA mRNA	PMID:30529165
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CIDEA mRNA	PMID:17942748
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312942	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CIDEA mRNA	PMID:17530438
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	ISO	RGD:1312942	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of CIDEA promoter	PMID:18033804
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312942	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of CIDEA mRNA	PMID:18033804
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1312942	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine promotes the reaction [SP1 protein binds to CIDEA promoter]; Decitabine promotes the reaction [SP3 protein binds to CIDEA promoter]	PMID:18033804
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CIDEA mRNA	PMID:25620056
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312943	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CIDEA mRNA	PMID:25620056
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of CIDEA mRNA	PMID:23962444
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CIDEA mRNA	PMID:30047161
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CIDEA mRNA	PMID:24136188
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:5299	Geniposide	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20220111	CTD	MESH:C007835	geniposide results in decreased expression of CIDEA mRNA	PMID:34718029
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20150609	CTD	MESH:C029938	nickel sulfate results in decreased expression of CIDEA mRNA	PMID:23126276
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:53001	nickel sulfate	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20150609	CTD	MESH:C029938	[nickel sulfate co-treated with Particulate Matter] results in decreased expression of CIDEA mRNA	PMID:23126276
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20240702	CTD	MESH:C082359	[imidacloprid co-treated with Dietary Fats] results in increased expression of CIDEA mRNA	PMID:33487623
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:6015	isoflurane	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007530	Isoflurane results in decreased expression of CIDEA mRNA	PMID:16978161
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1312942	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CIDEA mRNA	PMID:20436886
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:63630	tolcapone	increases expression	ISO	RGD:1312942	E	RGD:6480464	20181016	CTD	MESH:C066340	tolcapone results in increased expression of CIDEA mRNA	PMID:29688484
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1312942	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CIDEA mRNA	PMID:22079614
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CIDEA mRNA	PMID:19001666
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:6451	Licarin A	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20180515	CTD	MESH:C432503	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA	PMID:29288687
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:6682	mangiferin	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20200915	CTD	MESH:C013592	[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA	PMID:32417366
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D008694	Methamphetamine results in increased expression of CIDEA mRNA; Methamphetamine results in increased expression of CIDEA protein	PMID:28341135
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of CIDEA gene	PMID:33148267
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:72754	bisphenol AF	multiple interactions	ISO	RGD:1312942	E	RGD:6480464	20250114	CTD	MESH:C583074	[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with bisphenol AF] results in increased expression of CIDEA mRNA	PMID:31596606
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CIDEA mRNA	PMID:24136188
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CIDEA mRNA	PMID:25566086
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of CIDEA mRNA	PMID:23665939
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:7823	oxazepam	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D010076	Oxazepam results in decreased expression of CIDEA mRNA	PMID:12727805
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312942	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CIDEA mRNA	PMID:30851411
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312942	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CIDEA gene]	PMID:28238834
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of CIDEA mRNA	PMID:19162173
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1312943	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of CIDEA mRNA	PMID:18958704
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of CIDEA mRNA	PMID:26377693
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CIDEA mRNA	PMID:25825206|PMID:30047161
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CIDEA mRNA	PMID:24780913
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of CIDEA mRNA	PMID:25905778
1305106	Cidea	cell death-inducing DFFA-like effector a	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20191008	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of CIDEA mRNA	PMID:29127188
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of SRPK2 mRNA	PMID:16788091
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of SRPK2 protein	PMID:39571964
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312945	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SRPK2 mRNA	PMID:12057914
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SRPK2 mRNA	PMID:32145629
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SRPK2 gene	PMID:27618143
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312944	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SRPK2 mRNA	PMID:37042841
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D014050	Toluene results in decreased expression of SRPK2 mRNA	PMID:22166486
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D014050	Toluene results in increased expression of SRPK2 mRNA	PMID:22166486
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SRPK2 mRNA	PMID:22061828
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20150714	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SRPK2 mRNA	PMID:15329391
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SRPK2 mRNA	PMID:39836092
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312945	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SRPK2 mRNA	PMID:28111341
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SRPK2 protein	PMID:23301498
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SRPK2 mRNA	PMID:19770486
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of SRPK2 mRNA	PMID:15674843
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312945	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SRPK2 mRNA	PMID:20857495
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312945	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SRPK2 mRNA	PMID:17484886
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312944	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SRPK2 gene	PMID:25304211
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPK2 mRNA	PMID:39836092
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312944	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SRPK2 protein	PMID:35688186
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312944	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SRPK2 mRNA	PMID:28903495
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:27899	cisplatin	affects localization	ISO	RGD:1312944	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the localization of SRPK2 protein	PMID:21157427
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin affects the localization of SRPK2 protein] which results in increased phosphorylation of SRSF2 protein; Cisplatin affects the localization of and results in increased phosphorylation of SRPK2 protein	PMID:21157427|PMID:23613995
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SRPK2 mRNA	PMID:30912803
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SRPK2 mRNA	PMID:34747641
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312944	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SRPK2 mRNA	PMID:33212167
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20250401	CTD	MESH:D004317	Doxorubicin results in decreased expression of SRPK2 mRNA; Doxorubicin results in decreased expression of SRPK2 protein	PMID:38244039|PMID:39631538
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312944	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of SRPK2 protein	PMID:35688186
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312944	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of SRPK2 protein	PMID:30528433
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of SRPK2 mRNA	PMID:36209798
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312944	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SRPK2 mRNA	PMID:38568856
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312945	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of SRPK2 mRNA	PMID:32068019
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20220405	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [sodium arsenite co-treated with Tretinoin] results in increased expression of SRPK2 protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPK2 mRNA; sodium arsenite inhibits the reaction [SRPK2 protein binds to Ribonucleotides]	PMID:30528433|PMID:39571964|PMID:39836092
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312944	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SRPK2 mRNA	PMID:20064835|PMID:20106945
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of SRPK2 protein	PMID:37955338
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:29866	arsenite(3-)	decreases methylation	ISO	RGD:1312944	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of SRPK2 promoter	PMID:23974009
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312945	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SRPK2 mRNA	PMID:20857495
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312944	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SRPK2 mRNA	PMID:19150397
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:30772	butyric acid	affects localization	ISO	RGD:1312944	E	RGD:6480464	20120412	CTD	MESH:D020148	Butyric Acid affects the localization of SRPK2 protein	PMID:21555914
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of SRPK2 gene	PMID:31601247
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SRPK2 mRNA	PMID:34492290
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312945	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of SRPK2 mRNA	PMID:19191707
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SRPK2 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998|PMID:41034487
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SRPK2 mRNA	PMID:33221593
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312944	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SRPK2 gene	PMID:31601247
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SRPK2 mRNA	PMID:25181051
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312945	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of SRPK2 mRNA	PMID:25594700
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SRPK2 gene	PMID:28505145
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of SRPK2 gene	PMID:31601247
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1312944	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SRPK2 mRNA	PMID:19244175
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312945	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SRPK2 gene	PMID:31683443
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SRPK2 mRNA	PMID:39298647
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SRPK2 mRNA	PMID:38685157
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312945	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SRPK2 intron	PMID:28392331
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SRPK2 mRNA	PMID:18668222
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SRPK2 mRNA	PMID:37019170
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1312944	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of SRPK2 mRNA	PMID:21527772
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20140408	CTD	MESH:D010269	Paraquat affects the localization of and results in increased phosphorylation of SRPK2 protein; SRPK2 protein affects the reaction [Paraquat results in increased phosphorylation of SRSF3 protein]; SRPK2 protein affects the reaction [Paraquat results in increased phosphorylation of SRSF5 protein]; SRPK2 protein affects the reaction [Paraquat results in increased phosphorylation of SRSF6 protein]	PMID:23613995
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312944	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SRPK2 mRNA	PMID:37042841
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SRPK2 mRNA	PMID:30589522
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SRPK2 mRNA	PMID:39836092
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312944	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SRPK2 mRNA	PMID:26472689
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312945	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SRPK2 mRNA	PMID:28111341
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312944	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SRPK2 mRNA	PMID:24449571
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312945	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SRPK2 mRNA	PMID:18353800
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of SRPK2 mRNA	PMID:23125180
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312944	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SRPK2 mRNA	PMID:25979313
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312944	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SRPK2 gene	PMID:29154799
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312944	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SRPK2 mRNA	PMID:19101580|PMID:23179753
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SRPK2 mRNA	PMID:28973697
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1312944	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of SRPK2 mRNA	PMID:24449571
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312944	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SRPK2 mRNA	PMID:22230336
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SRPK2 mRNA	PMID:29279043
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312944	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SRPK2 gene	PMID:25304211
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPK2 mRNA	PMID:39836092
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SRPK2 mRNA	PMID:22079256
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SRPK2 mRNA	PMID:25554681
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SRPK2 mRNA	PMID:24136188
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312945	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SRPK2 mRNA	PMID:23608068
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312944	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SRPK2 protein	PMID:32959892
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SRPK2 mRNA	PMID:39836092
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312945	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRPK2 mRNA	PMID:21641980
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312944	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SRPK2 mRNA	PMID:15336504
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SRPK2 gene	PMID:35440735
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of SRPK2 mRNA	PMID:27462272
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	increases expression	ISO	RGD:1312944	E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in increased expression of SRPK2 mRNA	PMID:22101062
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312945	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SRPK2 mRNA	PMID:22206623
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:7438	N-methylformamide	increases expression	ISO	RGD:1312945	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in increased expression of SRPK2 mRNA; methylformamide results in increased expression of SRPK2 mRNA	PMID:17040096
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312944	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SRPK2 mRNA	PMID:22079256
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312944	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SRPK2 mRNA	PMID:22079256
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of SRPK2 mRNA	PMID:22124623
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312944	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SRPK2 mRNA	PMID:19159669
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of SRPK2 mRNA	PMID:23091169
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312945	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in increased expression of SRPK2 mRNA	PMID:25270620
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SRPK2 mRNA	PMID:21278054
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of SRPK2 mRNA	PMID:16079270
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SRPK2 mRNA	PMID:21346803
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1312944	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of SRPK2 mRNA	PMID:17440010
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SRPK2 mRNA	PMID:21346803
1305107	Srpk2	SRSF protein kinase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SRPK2 mRNA	PMID:28973697
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552117	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PCDHGA7 mRNA	PMID:30319688
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312946	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PCDHGA7 mRNA	PMID:35811015
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D014241	Trichloroethylene results in increased expression of PCDHGB4 mRNA	PMID:33387578
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312946	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHGA7 gene	PMID:27153756
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312946	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PCDHGA7 mRNA	PMID:27392435
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312946	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PCDHGA7 mRNA	PMID:27392435
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312946	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PCDHGA7 mRNA	PMID:33212167
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312946	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PCDHGA7 mRNA	PMID:32763439
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:28748	doxorubicin	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of PCDHGA7 gene	PMID:28962528
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312946	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDHGA7 mRNA	PMID:29803840
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552117	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PCDHGA7 mRNA	PMID:22228805
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of PCDHGA7 mRNA	PMID:24915197
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PCDHGA7 mRNA	PMID:30047161
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1552117	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of PCDHGA7 mRNA	PMID:23557971
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PCDHGA7 mRNA	PMID:25181051
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312946	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PCDHGA7 gene	PMID:29154799
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PCDHGA7 mRNA	PMID:30047161
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312946	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PCDHGA7 mRNA	PMID:38832940
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1312946	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of PCDHGA7 mRNA	PMID:35811015
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312946	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PCDHGA7 mRNA	PMID:35811015
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1312946	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of PCDHGA7 promoter	PMID:29626692
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1312946	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of PCDHGA7 promoter	PMID:29626692
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1312946	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of PCDHGA7 mRNA	PMID:38825487
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PCDHGA7 mRNA	PMID:30047161
1305108	Pcdhga7	protocadherin gamma subfamily A, 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PCDHGA7 mRNA	PMID:30047161
1305109	Stom	stomatin	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312947	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of STOM protein	PMID:39638853
1305109	Stom	stomatin	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of STOM mRNA	PMID:35967413
1305109	Stom	stomatin	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of STOM mRNA	PMID:21551480
1305109	Stom	stomatin	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of STOM protein	PMID:36641056
1305109	Stom	stomatin	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550119	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of STOM mRNA	PMID:20188158
1305109	Stom	stomatin	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of STOM mRNA	PMID:23830798
1305109	Stom	stomatin	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of STOM mRNA	PMID:36841081
1305109	Stom	stomatin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of STOM mRNA	PMID:39241906
1305109	Stom	stomatin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550119	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of STOM mRNA	PMID:39298647
1305109	Stom	stomatin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of STOM mRNA	PMID:30165855
1305109	Stom	stomatin	gene	CHEBI:16602	trichloroethene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014241	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of STOM mRNA	PMID:17905399
1305109	Stom	stomatin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312947	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of STOM mRNA	PMID:37042841
1305109	Stom	stomatin	gene	CHEBI:16716	benzene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of STOM mRNA	PMID:17905399
1305109	Stom	stomatin	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312947	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of STOM mRNA	PMID:23649840
1305109	Stom	stomatin	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of STOM mRNA	PMID:21669218
1305109	Stom	stomatin	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of STOM mRNA	PMID:22967744
1305109	Stom	stomatin	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of STOM mRNA	PMID:23892564
1305109	Stom	stomatin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550119	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of STOM mRNA	PMID:34319233
1305109	Stom	stomatin	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312947	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of STOM protein	PMID:37730182
1305109	Stom	stomatin	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STOM mRNA	PMID:36139627
1305109	Stom	stomatin	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of STOM mRNA	PMID:33387578
1305109	Stom	stomatin	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of STOM mRNA	PMID:19549813
1305109	Stom	stomatin	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312947	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of STOM mRNA	PMID:23649840
1305109	Stom	stomatin	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1312947	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of STOM protein	PMID:20106945
1305109	Stom	stomatin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312947	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STOM gene	PMID:27153756
1305109	Stom	stomatin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312947	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of STOM mRNA; Aflatoxin B1 results in increased expression of STOM protein	PMID:21632981|PMID:39638853
1305109	Stom	stomatin	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of STOM protein	PMID:39638853
1305109	Stom	stomatin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312947	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of STOM mRNA	PMID:21527772|PMID:23649840
1305109	Stom	stomatin	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of STOM mRNA	PMID:17484886
1305109	Stom	stomatin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550119	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STOM mRNA	PMID:22206623
1305109	Stom	stomatin	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of STOM mRNA	PMID:19654921
1305109	Stom	stomatin	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1312947	E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of STOM mRNA	PMID:21527772
1305109	Stom	stomatin	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of STOM mRNA	PMID:26272509
1305109	Stom	stomatin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STOM mRNA	PMID:27188386
1305109	Stom	stomatin	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of STOM mRNA	PMID:28960355
1305109	Stom	stomatin	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of STOM mRNA	PMID:31881176
1305109	Stom	stomatin	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of STOM mRNA	PMID:25905778
1305109	Stom	stomatin	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of STOM mRNA	PMID:40618947
1305109	Stom	stomatin	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of STOM gene	PMID:28505145
1305109	Stom	stomatin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STOM mRNA	PMID:34747641
1305109	Stom	stomatin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550119	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to STOM promoter]	PMID:19654925
1305109	Stom	stomatin	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312947	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of STOM mRNA	PMID:39709020
1305109	Stom	stomatin	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of STOM mRNA	PMID:28959563
1305109	Stom	stomatin	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of STOM mRNA	PMID:21198554
1305109	Stom	stomatin	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550119	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of STOM mRNA	PMID:27862939
1305109	Stom	stomatin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STOM mRNA	PMID:29803840
1305109	Stom	stomatin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of STOM mRNA	PMID:38568856|PMID:39719251
1305109	Stom	stomatin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of STOM mRNA	PMID:39515575
1305109	Stom	stomatin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312947	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of STOM mRNA	PMID:34032870
1305109	Stom	stomatin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550119	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of STOM mRNA; sodium arsenite results in increased expression of STOM protein	PMID:29044176|PMID:39095385
1305109	Stom	stomatin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of STOM mRNA	PMID:12634122
1305109	Stom	stomatin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STOM mRNA	PMID:19770486
1305109	Stom	stomatin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312947	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STOM mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1305109	Stom	stomatin	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of STOM mRNA	PMID:18929588
1305109	Stom	stomatin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of STOM mRNA]	PMID:18929588
1305109	Stom	stomatin	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of STOM mRNA	PMID:38458666
1305109	Stom	stomatin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of STOM mRNA	PMID:25895662
1305109	Stom	stomatin	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312947	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of STOM mRNA	PMID:20382639|PMID:26238291
1305109	Stom	stomatin	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1550119	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of STOM mRNA	PMID:22609695
1305109	Stom	stomatin	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20120412	CTD	MESH:C008261	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of STOM mRNA	PMID:12634122
1305109	Stom	stomatin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of STOM mRNA	PMID:23557971
1305109	Stom	stomatin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550119	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STOM gene	PMID:35295148
1305109	Stom	stomatin	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of STOM mRNA	PMID:34492290
1305109	Stom	stomatin	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of STOM mRNA	PMID:17426115
1305109	Stom	stomatin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of STOM mRNA	PMID:18301758
1305109	Stom	stomatin	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of STOM mRNA	PMID:38479592
1305109	Stom	stomatin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STOM mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305109	Stom	stomatin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of STOM protein	PMID:31675489|PMID:34186270
1305109	Stom	stomatin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of STOM mRNA	PMID:20739668
1305109	Stom	stomatin	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of STOM gene	PMID:28505145
1305109	Stom	stomatin	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1312947	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of STOM mRNA	PMID:19244175
1305109	Stom	stomatin	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312947	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of STOM mRNA	PMID:25979313
1305109	Stom	stomatin	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1550119	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of STOM mRNA	PMID:26682919
1305109	Stom	stomatin	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of STOM mRNA	PMID:19925653
1305109	Stom	stomatin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of STOM mRNA	PMID:39298647
1305109	Stom	stomatin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312947	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of STOM protein	PMID:34186270
1305109	Stom	stomatin	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1312947	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of STOM protein	PMID:34186270
1305109	Stom	stomatin	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of STOM mRNA	PMID:21266533
1305109	Stom	stomatin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550119	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of STOM mRNA	PMID:17361019|PMID:21266533
1305109	Stom	stomatin	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312947	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STOM mRNA	PMID:37042841
1305109	Stom	stomatin	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of STOM mRNA	PMID:38458666
1305109	Stom	stomatin	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312947	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of STOM mRNA	PMID:29024780
1305109	Stom	stomatin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of STOM mRNA	PMID:35163327
1305109	Stom	stomatin	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STOM mRNA	PMID:38568856
1305109	Stom	stomatin	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312947	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of STOM mRNA	PMID:26472689
1305109	Stom	stomatin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20120412	CTD	MESH:D019256	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of STOM mRNA	PMID:12634122
1305109	Stom	stomatin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of STOM mRNA	PMID:35163327
1305109	Stom	stomatin	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of STOM mRNA	PMID:23811191
1305109	Stom	stomatin	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1312947	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of STOM mRNA	PMID:40434365
1305109	Stom	stomatin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312947	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STOM mRNA	PMID:25979313
1305109	Stom	stomatin	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of STOM mRNA	PMID:29154799
1305109	Stom	stomatin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312947	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of STOM mRNA	PMID:23179753|PMID:24935251
1305109	Stom	stomatin	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1312947	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of STOM mRNA	PMID:21527772
1305109	Stom	stomatin	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of STOM mRNA	PMID:25562108|PMID:27989131
1305109	Stom	stomatin	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of STOM mRNA	PMID:17555576
1305109	Stom	stomatin	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312947	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of STOM mRNA	PMID:25047013
1305109	Stom	stomatin	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of STOM mRNA]	PMID:21233418
1305109	Stom	stomatin	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of STOM mRNA	PMID:18769122
1305109	Stom	stomatin	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1312947	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of STOM mRNA	PMID:24935251
1305109	Stom	stomatin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of STOM mRNA	PMID:17562736
1305109	Stom	stomatin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of STOM mRNA	PMID:29067470
1305109	Stom	stomatin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STOM mRNA	PMID:33387578
1305109	Stom	stomatin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312947	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of STOM mRNA	PMID:22230336
1305109	Stom	stomatin	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20180703	CTD	MESH:D005472	Fluorouracil results in decreased expression of STOM mRNA	PMID:24737281
1305109	Stom	stomatin	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of STOM mRNA	PMID:29279043
1305109	Stom	stomatin	gene	CHEBI:46680	serpentine asbestos	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of STOM mRNA	PMID:21148743
1305109	Stom	stomatin	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of STOM mRNA	PMID:19654921
1305109	Stom	stomatin	gene	CHEBI:48242	dichromium trioxide	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20120412	CTD	MESH:C023600	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of STOM mRNA	PMID:12634122
1305109	Stom	stomatin	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312947	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of STOM mRNA	PMID:24383545
1305109	Stom	stomatin	gene	CHEBI:48981	quinolin-8-ol	increases expression	ISO	RGD:1312947	E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in increased expression of STOM mRNA	PMID:21632981
1305109	Stom	stomatin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of STOM mRNA	PMID:17555576
1305109	Stom	stomatin	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1312947	E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of STOM mRNA	PMID:21527772
1305109	Stom	stomatin	gene	CHEBI:49747	methylmercury(1+)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C030957	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of STOM mRNA	PMID:17905399
1305109	Stom	stomatin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of STOM mRNA; Nanotubes, Carbon results in decreased expression of STOM mRNA	PMID:25620056
1305109	Stom	stomatin	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550119	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of STOM mRNA	PMID:35964746
1305109	Stom	stomatin	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of STOM protein	PMID:32959892
1305109	Stom	stomatin	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1550119	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of STOM protein	PMID:26558463
1305109	Stom	stomatin	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of STOM mRNA	PMID:36907384
1305109	Stom	stomatin	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	ISO	RGD:1312947	E	RGD:6480464	20130910	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of STOM mRNA	PMID:18497975
1305109	Stom	stomatin	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312947	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of STOM protein	PMID:34186270
1305109	Stom	stomatin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550119	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STOM mRNA	PMID:22206623
1305109	Stom	stomatin	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STOM mRNA	PMID:36139627
1305109	Stom	stomatin	gene	CHEBI:77012	methylseleninic acid	increases expression	ISO	RGD:1312947	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of STOM mRNA	PMID:18548127
1305109	Stom	stomatin	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of STOM protein	PMID:39638853
1305109	Stom	stomatin	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STOM mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STOM mRNA	PMID:27188386
1305109	Stom	stomatin	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550119	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of STOM mRNA	PMID:31388691
1305109	Stom	stomatin	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STOM mRNA	PMID:27188386
1305109	Stom	stomatin	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312947	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STOM mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STOM mRNA	PMID:27188386
1305109	Stom	stomatin	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of STOM mRNA	PMID:19281266
1305109	Stom	stomatin	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of STOM mRNA	PMID:38568856
1305109	Stom	stomatin	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1312947	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of STOM mRNA	PMID:29301935
1305109	Stom	stomatin	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of STOM mRNA	PMID:19015723
1305109	Stom	stomatin	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of STOM mRNA	PMID:23034163
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:10101	zalcitabine	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D016047	[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of SANBR mRNA	PMID:18606552
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606998	E	RGD:6480464	20230307	CTD	MESH:D014212	Tretinoin results in decreased expression of SANBR mRNA	PMID:33167477
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312949	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SANBR mRNA	PMID:39241906
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312949	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SANBR mRNA]	PMID:39241906
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SANBR mRNA	PMID:30165855
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SANBR mRNA	PMID:39836092
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SANBR mRNA	PMID:23630614
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SANBR mRNA	PMID:39836092
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SANBR mRNA	PMID:23557933
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1606998	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SANBR mRNA	PMID:28903495
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606998	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SANBR mRNA	PMID:27594783
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606998	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SANBR mRNA	PMID:33212167
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1606998	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SANBR mRNA	PMID:30851411
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SANBR mRNA	PMID:39836092
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606998	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SANBR promoter	PMID:27901495
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1606998	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of SANBR gene	PMID:31601247
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SANBR gene	PMID:31601247
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C006780	bisphenol A results in decreased expression of SANBR mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1606998	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of SANBR gene	PMID:31601247
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SANBR gene	PMID:31601247
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312949	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SANBR mRNA	PMID:39298647
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312949	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SANBR mRNA	PMID:38685157
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of SANBR gene	PMID:33148267
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312949	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SANBR mRNA]	PMID:39241906
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SANBR mRNA	PMID:39836092
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1606998	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SANBR mRNA	PMID:24449571
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1606998	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SANBR mRNA	PMID:31533062
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312949	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SANBR mRNA	PMID:28973697
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1606998	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SANBR mRNA	PMID:38832940
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SANBR mRNA	PMID:39836092
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SANBR mRNA	PMID:22079256
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C025340	manganese chloride results in increased expression of SANBR mRNA	PMID:28801915
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SANBR mRNA	PMID:39836092
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of SANBR gene	PMID:33148267
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1606998	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SANBR mRNA	PMID:22079256
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1606998	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SANBR mRNA	PMID:22079256
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1606998	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SANBR mRNA	PMID:30851411
1305110	Sanbr	SANT and BTB domain regulator of CSR	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312949	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SANBR mRNA]	PMID:39241906
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ARHGEF12 mRNA	PMID:33045310
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	affects methylation	ISO	RGD:1312951	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine affects the methylation of ARHGEF12 promoter	PMID:26251327
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312951	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ARHGEF12 mRNA	PMID:20188158|PMID:26251327
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312950	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ARHGEF12 mRNA	PMID:26079696
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:15756	hexadecanoic acid	affects phosphorylation	ISO	RGD:1312950	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid affects the phosphorylation of ARHGEF12 protein	PMID:28073184
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of ARHGEF12 mRNA	PMID:40945087
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312951	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARHGEF12 mRNA	PMID:30319688
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312951	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ARHGEF12 mRNA	PMID:30319688
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGEF12 mRNA	PMID:39298647
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARHGEF12 mRNA	PMID:33754040
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312950	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ARHGEF12 protein	PMID:37730182
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ARHGEF12 mRNA	PMID:22061828
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGEF12 mRNA	PMID:29950665
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312950	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ARHGEF12 gene	PMID:27153756
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARHGEF12 mRNA	PMID:34911549
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ARHGEF12 mRNA	PMID:22206623
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:27563	arsenic atom	increases response to substance	ISO	RGD:1312950	E	RGD:6480464	20120412	CTD	MESH:D001151	ARHGEF12 mRNA results in increased susceptibility to Arsenic	PMID:17976673
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312950	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ARHGEF12 protein	PMID:35688186
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of ARHGEF12 gene	PMID:31011160
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312950	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of ARHGEF12 mRNA	PMID:28903495
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312950	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ARHGEF12 mRNA	PMID:24768652
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGEF12 mRNA	PMID:33387578
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARHGEF12 mRNA	PMID:32109520
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGEF12 mRNA	PMID:17942748
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312950	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARHGEF12 mRNA	PMID:33212167
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ARHGEF12 mRNA	PMID:30556269
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312950	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of ARHGEF12 protein	PMID:35688186
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1312950	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ARHGEF12 gene	PMID:28589171
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312950	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGEF12 mRNA	PMID:38568856
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312950	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ARHGEF12 mRNA]	PMID:32406909
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ARHGEF12 mRNA	PMID:30556269
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1312950	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of ARHGEF12 mRNA	PMID:25075043
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312950	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ARHGEF12 gene; [bisphenol S co-treated with Fulvestrant] results in decreased methylation of ARHGEF12 gene	PMID:31601247
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ARHGEF12 mRNA	PMID:30047161
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312951	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of ARHGEF12 mRNA	PMID:17656681
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312951	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARHGEF12 gene; titanium dioxide results in decreased methylation of ARHGEF12 promoter	PMID:35295148
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGEF12 mRNA	PMID:29950665
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARHGEF12 mRNA	PMID:19710929
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ARHGEF12 mRNA	PMID:19167457
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ARHGEF12 mRNA	PMID:32145629
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF12 mRNA	PMID:25181051
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312950	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARHGEF12 gene	PMID:31601247
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ARHGEF12 gene	PMID:28505145
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312950	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ARHGEF12 mRNA	PMID:25979313
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ARHGEF12 mRNA	PMID:39298647
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312950	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARHGEF12 gene	PMID:31601247
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312951	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ARHGEF12 mRNA	PMID:40203079
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312950	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of ARHGEF12 gene	PMID:31601247
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312951	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ARHGEF12 mRNA	PMID:38685157
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312950	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ARHGEF12 gene	PMID:31601247
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ARHGEF12 mRNA	PMID:28392331
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312951	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ARHGEF12 intron	PMID:28392331
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGEF12 mRNA	PMID:29950665
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312951	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARHGEF12 mRNA	PMID:21266533
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of ARHGEF12 gene	PMID:33148267
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34967	rimonabant	affects expression	ISO	RGD:1312951	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant affects the expression of ARHGEF12 mRNA	PMID:19030233
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of ARHGEF12 mRNA]	PMID:19030233
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312950	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGEF12 mRNA	PMID:37042841
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ARHGEF12 mRNA	PMID:30047161
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ARHGEF12 mRNA	PMID:40194260
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:38561	fluvastatin	multiple interactions	ISO	RGD:1312950	E	RGD:6480464	20120412	CTD	MESH:C065180	[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF12 mRNA	PMID:16996129
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312950	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGEF12 mRNA	PMID:17183730
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ARHGEF12 mRNA	PMID:30047161
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARHGEF12 mRNA	PMID:19770486
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1312950	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ARHGEF12 mRNA	PMID:28542535
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312950	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGEF12 mRNA	PMID:21420995
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:46557	zoledronic acid	multiple interactions	ISO	RGD:1312950	E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF12 mRNA	PMID:16996129
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:47217	arsane	increases response to substance	ISO	RGD:1312950	E	RGD:6480464	20140805	CTD	MESH:D001151	ARHGEF12 mRNA results in increased susceptibility to Arsenic	PMID:17976673
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ARHGEF12 mRNA	PMID:29391264
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312951	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARHGEF12 mRNA	PMID:17942748
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGEF12 mRNA	PMID:17942748
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1312950	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of ARHGEF12 mRNA	PMID:25075043
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARHGEF12 mRNA; Nanotubes, Carbon results in decreased expression of ARHGEF12 mRNA	PMID:25554681
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ARHGEF12 mRNA	PMID:30047161
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312950	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGEF12 mRNA	PMID:17183730
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312950	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARHGEF12 protein	PMID:32959892
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of ARHGEF12 gene	PMID:33148267
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1312950	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ARHGEF12 mRNA	PMID:31758290
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ARHGEF12 mRNA	PMID:22206623
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1312950	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of ARHGEF12 mRNA	PMID:18927307
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:8093	phenylephrine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in decreased expression of ARHGEF12 mRNA	PMID:18158353
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1312950	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ARHGEF12 mRNA	PMID:26079696
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312951	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ARHGEF12 mRNA	PMID:39847705
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of ARHGEF12 mRNA	PMID:26923065
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARHGEF12 mRNA	PMID:30047161
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ARHGEF12 mRNA	PMID:19281266
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312950	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARHGEF12 mRNA	PMID:38568856
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1312950	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of ARHGEF12 mRNA	PMID:27188386
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ARHGEF12 mRNA	PMID:21346803
1305111	Arhgef12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ARHGEF12 mRNA	PMID:28973697
1305112	Tex2	testis expressed 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1603633	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TEX2 mRNA	PMID:38218311
1305112	Tex2	testis expressed 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1603633	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of TEX2 mRNA	PMID:21934132
1305112	Tex2	testis expressed 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312952	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TEX2 mRNA	PMID:30319688
1305112	Tex2	testis expressed 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1603633	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of TEX2 mRNA	PMID:29581250
1305112	Tex2	testis expressed 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312952	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TEX2 mRNA	PMID:39241906
1305112	Tex2	testis expressed 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312952	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of TEX2 mRNA	PMID:19484750
1305112	Tex2	testis expressed 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312952	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TEX2 mRNA	PMID:39298647
1305112	Tex2	testis expressed 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603633	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TEX2 mRNA	PMID:31614463
1305112	Tex2	testis expressed 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of TEX2 mRNA	PMID:26496021
1305112	Tex2	testis expressed 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312952	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TEX2 mRNA	PMID:25510870
1305112	Tex2	testis expressed 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1603633	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of TEX2 mRNA	PMID:38568856
1305112	Tex2	testis expressed 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1603633	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TEX2 mRNA	PMID:21179406
1305112	Tex2	testis expressed 2	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1312952	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of TEX2 mRNA	PMID:23892564
1305112	Tex2	testis expressed 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1603633	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TEX2 mRNA	PMID:31163220
1305112	Tex2	testis expressed 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1603633	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TEX2 protein	PMID:37730182
1305112	Tex2	testis expressed 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TEX2 mRNA	PMID:33387578
1305112	Tex2	testis expressed 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1603633	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TEX2 intron	PMID:30157460
1305112	Tex2	testis expressed 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312952	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TEX2 mRNA	PMID:25510870
1305112	Tex2	testis expressed 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312952	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TEX2 mRNA	PMID:25510870
1305112	Tex2	testis expressed 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1603633	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TEX2 mRNA	PMID:19549813
1305112	Tex2	testis expressed 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1603633	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TEX2 gene	PMID:27153756
1305112	Tex2	testis expressed 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TEX2 mRNA	PMID:31150632
1305112	Tex2	testis expressed 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312952	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TEX2 mRNA	PMID:25629700
1305112	Tex2	testis expressed 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312952	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TEX2 mRNA	PMID:22206623
1305112	Tex2	testis expressed 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603633	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TEX2 mRNA	PMID:39836092
1305112	Tex2	testis expressed 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1603633	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of TEX2 protein	PMID:35688186
1305112	Tex2	testis expressed 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312952	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TEX2 mRNA	PMID:21570461
1305112	Tex2	testis expressed 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1603633	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TEX2 mRNA	PMID:33212167
1305112	Tex2	testis expressed 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1603633	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TEX2 mRNA	PMID:30851411
1305112	Tex2	testis expressed 2	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1603633	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of TEX2 protein	PMID:35688186
1305112	Tex2	testis expressed 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603633	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TEX2 mRNA	PMID:39836092
1305112	Tex2	testis expressed 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603633	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TEX2 3' UTR; Benzo(a)pyrene affects the methylation of TEX2 5' UTR	PMID:27901495
1305112	Tex2	testis expressed 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312952	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TEX2 mRNA	PMID:22228805
1305112	Tex2	testis expressed 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603633	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TEX2 promoter	PMID:27901495
1305112	Tex2	testis expressed 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312952	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of TEX2 mRNA]	PMID:22228805
1305112	Tex2	testis expressed 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312952	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of TEX2 protein	PMID:37955338
1305112	Tex2	testis expressed 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1603633	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TEX2 mRNA]	PMID:32406909
1305112	Tex2	testis expressed 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1603633	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TEX2 mRNA	PMID:19150397
1305112	Tex2	testis expressed 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of TEX2 mRNA	PMID:24136188
1305112	Tex2	testis expressed 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312952	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TEX2 gene	PMID:35295148
1305112	Tex2	testis expressed 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of TEX2 mRNA	PMID:23411599|PMID:34492290
1305112	Tex2	testis expressed 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TEX2 mRNA	PMID:25181051
1305112	Tex2	testis expressed 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TEX2 mRNA	PMID:30816183
1305112	Tex2	testis expressed 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of TEX2 mRNA	PMID:41034487
1305112	Tex2	testis expressed 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of TEX2 mRNA	PMID:26496021
1305112	Tex2	testis expressed 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312952	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TEX2 mRNA	PMID:25510870
1305112	Tex2	testis expressed 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312952	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TEX2 mRNA	PMID:25510870
1305112	Tex2	testis expressed 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TEX2 mRNA	PMID:32119087
1305112	Tex2	testis expressed 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312952	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TEX2 gene	PMID:31683443
1305112	Tex2	testis expressed 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1603633	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TEX2 gene	PMID:31601247
1305112	Tex2	testis expressed 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1603633	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TEX2 intron	PMID:30157460
1305112	Tex2	testis expressed 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312952	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TEX2 mRNA	PMID:38685157
1305112	Tex2	testis expressed 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312952	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TEX2 intron	PMID:28392331
1305112	Tex2	testis expressed 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312952	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of TEX2 mRNA	PMID:34813904
1305112	Tex2	testis expressed 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603633	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TEX2 mRNA	PMID:37042841
1305112	Tex2	testis expressed 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1603633	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TEX2 mRNA	PMID:40419075
1305112	Tex2	testis expressed 2	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of TEX2 mRNA	PMID:25993096
1305112	Tex2	testis expressed 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603633	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TEX2 mRNA	PMID:25979313
1305112	Tex2	testis expressed 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1603633	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TEX2 gene	PMID:29154799
1305112	Tex2	testis expressed 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603633	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TEX2 mRNA	PMID:23179753|PMID:28001369
1305112	Tex2	testis expressed 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1603633	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TEX2 mRNA	PMID:20106945|PMID:25562108
1305112	Tex2	testis expressed 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TEX2 mRNA	PMID:24136188
1305112	Tex2	testis expressed 2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1603633	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TEX2 mRNA	PMID:28542535
1305112	Tex2	testis expressed 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TEX2 mRNA	PMID:33387578
1305112	Tex2	testis expressed 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603633	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TEX2 mRNA	PMID:39836092
1305112	Tex2	testis expressed 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1603633	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TEX2 mRNA	PMID:22079256
1305112	Tex2	testis expressed 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312952	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TEX2 mRNA	PMID:35436446
1305112	Tex2	testis expressed 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of TEX2 mRNA	PMID:23962444
1305112	Tex2	testis expressed 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TEX2 mRNA	PMID:24136188
1305112	Tex2	testis expressed 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312952	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of TEX2 mRNA	PMID:23608068
1305112	Tex2	testis expressed 2	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of TEX2 mRNA	PMID:24136188
1305112	Tex2	testis expressed 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TEX2 mRNA	PMID:28801915
1305112	Tex2	testis expressed 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1603633	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TEX2 intron	PMID:30157460
1305112	Tex2	testis expressed 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TEX2 gene	PMID:35440735
1305112	Tex2	testis expressed 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312952	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TEX2 mRNA	PMID:22206623
1305112	Tex2	testis expressed 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312952	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TEX2 mRNA	PMID:22206623
1305112	Tex2	testis expressed 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1603633	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TEX2 mRNA	PMID:22079256
1305112	Tex2	testis expressed 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1603633	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TEX2 mRNA	PMID:22079256
1305112	Tex2	testis expressed 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1603633	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TEX2 mRNA	PMID:30851411
1305112	Tex2	testis expressed 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603633	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TEX2 gene]	PMID:28238834
1305112	Tex2	testis expressed 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TEX2 mRNA	PMID:31826744
1305112	Tex2	testis expressed 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TEX2 mRNA	PMID:21346803
1305112	Tex2	testis expressed 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TEX2 mRNA	PMID:21346803
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312954	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of NUBP2 protein	PMID:36252740
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NUBP2 mRNA	PMID:38218311
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20120613	CTD	MESH:D001241	Aspirin results in decreased expression of NUBP2 mRNA	PMID:15456535|PMID:15928584
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312953	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NUBP2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NUBP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NUBP2 mRNA	PMID:32699268|PMID:32845096
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312954	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NUBP2 mRNA	PMID:39241906
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312954	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NUBP2 mRNA	PMID:39298647
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of NUBP2 protein	PMID:20109541
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312953	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NUBP2 mRNA	PMID:37042841
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312953	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of NUBP2 gene	PMID:33872906
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312953	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of NUBP2 gene	PMID:33872906
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312954	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of NUBP2 mRNA	PMID:27462272
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUBP2 mRNA	PMID:37236586
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312953	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NUBP2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NUBP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NUBP2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of NUBP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of NUBP2 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NUBP2 mRNA	PMID:34911549
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312954	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NUBP2 mRNA	PMID:31919559
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUBP2 mRNA	PMID:22206623
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUBP2 mRNA	PMID:40504410
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312954	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of NUBP2 protein	PMID:25505154
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312954	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUBP2 mRNA	PMID:21570461
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUBP2 mRNA	PMID:33387578
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of NUBP2 protein	PMID:39603559
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312953	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NUBP2 mRNA	PMID:33212167
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of NUBP2 mRNA	PMID:28959563
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NUBP2 mRNA	PMID:38568856
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUBP2 mRNA	PMID:40504410
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of NUBP2 mRNA	PMID:25729387
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NUBP2 mRNA	PMID:30047161
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312954	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NUBP2 gene	PMID:35295148
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NUBP2 mRNA	PMID:25181051
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of NUBP2 mRNA	PMID:33296240
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of NUBP2 protein	PMID:31675489
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NUBP2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NUBP2 gene	PMID:28505145
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of NUBP2 protein	PMID:31675489
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312954	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NUBP2 mRNA	PMID:39298647
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312954	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NUBP2 mRNA	PMID:21266533
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NUBP2 mRNA	PMID:38568856
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUBP2 mRNA	PMID:37236586
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of NUBP2 mRNA	PMID:25812627
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312953	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NUBP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NUBP2 mRNA	PMID:32699268
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of NUBP2 mRNA	PMID:25812627
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NUBP2 mRNA	PMID:25812627
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312953	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NUBP2 gene	PMID:29154799
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NUBP2 mRNA	PMID:30047161
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of NUBP2 mRNA	PMID:24136188
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUBP2 mRNA	PMID:40504410
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of NUBP2 mRNA	PMID:31675489
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312953	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of NUBP2 mRNA	PMID:18175754
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312953	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of NUBP2 mRNA	PMID:17908484
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312954	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NUBP2 mRNA; Nanotubes, Carbon results in increased expression of NUBP2 mRNA	PMID:25554681
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NUBP2 mRNA	PMID:30047161
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:50692	mifepristone	increases expression	ISO	RGD:1312953	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of NUBP2 mRNA	PMID:17584828
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NUBP2 mRNA	PMID:35964746
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NUBP2 mRNA	PMID:24136188
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NUBP2 protein	PMID:32959892
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of NUBP2 mRNA	PMID:25729387
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of NUBP2 mRNA	PMID:24136188
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312954	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of NUBP2 protein	PMID:36851058
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1312954	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of NUBP2 mRNA	PMID:27462272
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUBP2 mRNA	PMID:22206623
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of NUBP2 mRNA	PMID:24136188
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NUBP2 protein	PMID:31675489
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of NUBP2 protein	PMID:31675489
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NUBP2 mRNA	PMID:30047161
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NUBP2 mRNA	PMID:21346803
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312953	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NUBP2 mRNA	PMID:38568856
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NUBP2 mRNA	PMID:21346803
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312954	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of NUBP2 mRNA	PMID:32835833
1305113	Nubp2	NUBP iron-sulfur cluster assembly factor 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of NUBP2 mRNA	PMID:22570695
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of MOB1B mRNA	PMID:25152437
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312955	E	RGD:6480464	20141111	CTD	MESH:D011794	Quercetin results in decreased expression of MOB1B mRNA	PMID:21632981
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MOB1B mRNA	PMID:32145629
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1312955	E	RGD:6480464	20170725	CTD	MESH:D014050	Toluene results in increased expression of MOB1B mRNA	PMID:28245982
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312955	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MOB1B protein	PMID:37730182
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MOB1B mRNA	PMID:33387578
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312955	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MOB1B mRNA	PMID:28818685
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1617540	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MOB1B mRNA	PMID:36331819
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617540	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MOB1B mRNA	PMID:37236586
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312955	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MOB1B mRNA	PMID:19549813
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312955	E	RGD:6480464	20141111	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MOB1B mRNA	PMID:23649840
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1617540	E	RGD:6480464	20141111	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MOB1B mRNA	PMID:19770486
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312955	E	RGD:6480464	20141111	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MOB1B mRNA	PMID:23649840
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MOB1B mRNA	PMID:25629700
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MOB1B mRNA	PMID:31881176
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MOB1B mRNA	PMID:32109520|PMID:33387578
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312955	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MOB1B mRNA	PMID:33212167
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312955	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MOB1B mRNA	PMID:29803840
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1312955	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MOB1B mRNA	PMID:25523186
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MOB1B mRNA	PMID:37682722
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312955	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MOB1B mRNA	PMID:21457566
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1312955	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MOB1B mRNA	PMID:25523186
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MOB1B mRNA	PMID:27131904
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312955	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MOB1B mRNA	PMID:19150397
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1312955	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of MOB1B gene	PMID:31601247
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1617540	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MOB1B gene; titanium dioxide results in increased methylation of MOB1B promoter	PMID:35295148
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MOB1B mRNA	PMID:34492290
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of MOB1B mRNA	PMID:32145629
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MOB1B mRNA	PMID:25181051
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312955	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of MOB1B protein	PMID:34186270
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312955	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MOB1B gene	PMID:31601247
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312955	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MOB1B protein	PMID:34186270
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1617540	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MOB1B mRNA	PMID:38685157
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MOB1B mRNA	PMID:28392331
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1312955	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to MOB1B protein	PMID:32991956
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312955	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MOB1B mRNA	PMID:37042841
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MOB1B mRNA	PMID:33453195
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617540	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MOB1B mRNA	PMID:37236586
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1617540	E	RGD:6480464	20230307	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MOB1B mRNA	PMID:36152675
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1312955	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of MOB1B mRNA	PMID:19691856
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MOB1B mRNA	PMID:40194260
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312955	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MOB1B mRNA	PMID:40419075
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617540	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MOB1B mRNA	PMID:36331819
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D002737	Chloroprene results in increased expression of MOB1B mRNA	PMID:23125180
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312955	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of MOB1B mRNA	PMID:23179753
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:41607	crotonaldehyde	decreases expression	ISO	RGD:1312955	E	RGD:6480464	20141111	CTD	MESH:C012796	2-butenal results in decreased expression of MOB1B mRNA	PMID:20471460
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C005219	methyl cellosolve results in increased expression of MOB1B mRNA	PMID:21061450
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1617540	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MOB1B mRNA	PMID:17555576
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MOB1B mRNA	PMID:29097150
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MOB1B mRNA	PMID:25729387
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MOB1B mRNA	PMID:22206623
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1617540	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of MOB1B mRNA	PMID:21795629
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1617540	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of MOB1B mRNA	PMID:40826991
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MOB1B mRNA	PMID:27131904
1305114	Mob1b	MOB kinase activator 1B	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MOB1B mRNA	PMID:19281266
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312957	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of HBE1 mRNA	PMID:27188386
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312957	E	RGD:6480464	20131220	CTD	MESH:D014212	Tretinoin results in increased expression of HBE1 mRNA	PMID:21934132
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1312957	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HBE1 mRNA	PMID:26079696
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of HBE1 gene	PMID:35440735
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1312957	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of HBE1 mRNA	PMID:30510588
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of HBE1 mRNA	PMID:32145629
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HBE1 mRNA	PMID:23829299
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HBE1 mRNA	PMID:33387578
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of HBE1 gene	PMID:27618143
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312957	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of HBE1 mRNA	PMID:23649840|PMID:27905399
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1312957	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of HBE1 mRNA	PMID:26079696
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312957	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HBE1 gene	PMID:27153756
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312957	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HBE1 mRNA	PMID:21867686
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550121	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of HBB-Y mRNA	PMID:28960355
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HBE1 mRNA	PMID:31881176
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HBE1 mRNA	PMID:33387578
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of HBE1 protein	PMID:29459688
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550121	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of HBB-Y mRNA	PMID:37682722
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312957	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HBE1 promoter	PMID:27901495
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312957	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HBE1 exon	PMID:27901495
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312957	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of HBE1 mRNA	PMID:20382639
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20140722	CTD	MESH:D000643	Ammonium Chloride affects the expression of HBE1 mRNA	PMID:16483693
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312957	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of HBE1 gene; [bisphenol F co-treated with Fulvestrant] results in decreased methylation of HBE1 gene	PMID:31601247
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of HBE1 mRNA	PMID:25729387
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1550121	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of HBB-Y mRNA	PMID:18648102
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20140722	CTD	MESH:C069837	fullerene C60 results in decreased expression of HBE1 mRNA	PMID:19167457
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HBE1 mRNA	PMID:25181051|PMID:32145629
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20140722	CTD	MESH:C006780	bisphenol A results in increased expression of HBE1 mRNA	PMID:15901920
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1550121	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HBB-Y promoter	PMID:27312807
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312957	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of HBE1 gene	PMID:31601247
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140722	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of HBE1 mRNA	PMID:23829299
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550121	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of HBB-Y mRNA	PMID:30951980
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312957	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of HBE1 gene	PMID:31601247
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550121	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of HBB-Y mRNA	PMID:30951980
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312957	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of HBE1 gene	PMID:31601247
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of HBE1 mRNA	PMID:32680482
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1312957	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of HBE1 mRNA	PMID:29024780
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1550121	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of HBB-Y mRNA	PMID:19429403
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1550121	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of HBB-Y mRNA	PMID:28962523
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1550121	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of HBB-Y mRNA	PMID:19429403
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312957	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of HBE1 mRNA	PMID:28001369
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of HBE1 mRNA	PMID:41580965
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1550121	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of HBB-Y mRNA	PMID:18502557
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312957	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HBE1 mRNA	PMID:38832940
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312957	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HBE1 protein	PMID:38832940
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550121	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HBB-Y mRNA	PMID:17562736
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312957	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of HBE1 mRNA	PMID:26690555
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1312957	E	RGD:6480464	20131220	CTD	MESH:D005472	HBE1 protein affects the susceptibility to Fluorouracil	PMID:15352031
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1312957	E	RGD:6480464	20131220	CTD	MESH:D005472	Fluorouracil results in decreased expression of HBE1 protein	PMID:15352031
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1312957	E	RGD:6480464	20131220	CTD	MESH:D018038	Sodium Selenite results in decreased expression of HBE1 mRNA	PMID:18175754
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of HBE1 mRNA	PMID:30307764
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550121	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in decreased expression of HBB-Y mRNA	PMID:35964746
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1312957	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of HBE1 mRNA	PMID:27188386
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550121	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HBB-Y mRNA	PMID:26378955
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of HBE1 mRNA	PMID:25729387
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of HBE1 mRNA	PMID:25729387
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312957	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of HBE1 mRNA	PMID:31758290
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312957	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of HBE1 mRNA	PMID:37199045
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of HBE1 mRNA	PMID:33484710
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312957	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HBE1 gene]	PMID:28238834
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1550121	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of HBE1 mRNA	PMID:30294300
1305115	Hbe1	hemoglobin subunit epsilon 1	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of HBE1 gene	PMID:31682807
1305116	Churc1	churchill domain containing 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CHURC1 mRNA	PMID:21551480
1305116	Churc1	churchill domain containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CHURC1 gene	PMID:20938992
1305116	Churc1	churchill domain containing 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1550122	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of CHURC1 mRNA	PMID:40945087
1305116	Churc1	churchill domain containing 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA	PMID:25510870
1305116	Churc1	churchill domain containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CHURC1 gene	PMID:20938992
1305116	Churc1	churchill domain containing 1	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of CHURC1 mRNA	PMID:22967744
1305116	Churc1	churchill domain containing 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312958	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CHURC1 mRNA	PMID:28818685
1305116	Churc1	churchill domain containing 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA	PMID:25510870
1305116	Churc1	churchill domain containing 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA	PMID:25510870
1305116	Churc1	churchill domain containing 1	gene	CHEBI:27214	uranium atom	increases expression	ISO	RGD:1312958	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium results in increased expression of CHURC1 mRNA	PMID:15672453
1305116	Churc1	churchill domain containing 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CHURC1 mRNA	PMID:33387578
1305116	Churc1	churchill domain containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550122	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CHURC1 mRNA	PMID:25629700
1305116	Churc1	churchill domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHURC1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CHURC1 gene	PMID:20938992|PMID:22206623
1305116	Churc1	churchill domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CHURC1 mRNA	PMID:40504410
1305116	Churc1	churchill domain containing 1	gene	CHEBI:27808	heroin	decreases expression	ISO	RGD:1312958	E	RGD:6480464	20120412	CTD	MESH:D003932	Heroin results in decreased expression of CHURC1 mRNA	PMID:16710320
1305116	Churc1	churchill domain containing 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CHURC1 mRNA	PMID:31881176
1305116	Churc1	churchill domain containing 1	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1312958	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of CHURC1 mRNA	PMID:15009677|PMID:16710320
1305116	Churc1	churchill domain containing 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1550122	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of CHURC1 mRNA	PMID:30912803
1305116	Churc1	churchill domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550122	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHURC1 mRNA	PMID:21570461
1305116	Churc1	churchill domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHURC1 mRNA	PMID:34747641
1305116	Churc1	churchill domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312958	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CHURC1 mRNA	PMID:28001369
1305116	Churc1	churchill domain containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1312958	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CHURC1 mRNA	PMID:33212167
1305116	Churc1	churchill domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CHURC1 mRNA	PMID:40504410
1305116	Churc1	churchill domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312958	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHURC1 promoter	PMID:27901495
1305116	Churc1	churchill domain containing 1	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1312958	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of CHURC1 mRNA	PMID:31745603
1305116	Churc1	churchill domain containing 1	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of CHURC1 mRNA	PMID:24136188
1305116	Churc1	churchill domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550122	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CHURC1 gene; titanium dioxide results in decreased methylation of CHURC1 promoter	PMID:35295148
1305116	Churc1	churchill domain containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CHURC1 mRNA	PMID:34492290
1305116	Churc1	churchill domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CHURC1 mRNA	PMID:25181051
1305116	Churc1	churchill domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550122	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CHURC1 mRNA	PMID:32156529
1305116	Churc1	churchill domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550122	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CHURC1 mRNA	PMID:33221593|PMID:38074096
1305116	Churc1	churchill domain containing 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA	PMID:25510870
1305116	Churc1	churchill domain containing 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA	PMID:25510870
1305116	Churc1	churchill domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550122	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CHURC1 mRNA	PMID:39298647
1305116	Churc1	churchill domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550122	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CHURC1 mRNA	PMID:40194260
1305116	Churc1	churchill domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312958	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CHURC1 mRNA	PMID:31533062
1305116	Churc1	churchill domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312958	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CHURC1 mRNA	PMID:25979313
1305116	Churc1	churchill domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312958	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CHURC1 mRNA	PMID:23179753|PMID:27188386
1305116	Churc1	churchill domain containing 1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CHURC1 mRNA	PMID:24136188
1305116	Churc1	churchill domain containing 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312958	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CHURC1 mRNA	PMID:38832940
1305116	Churc1	churchill domain containing 1	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1550122	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of CHURC1 mRNA	PMID:29279043
1305116	Churc1	churchill domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CHURC1 mRNA	PMID:40504410
1305116	Churc1	churchill domain containing 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1312958	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of CHURC1 mRNA	PMID:18175754
1305116	Churc1	churchill domain containing 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1550122	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CHURC1 mRNA	PMID:40234311
1305116	Churc1	churchill domain containing 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of CHURC1 mRNA	PMID:19162173
1305116	Churc1	churchill domain containing 1	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of CHURC1 mRNA	PMID:24136188
1305116	Churc1	churchill domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CHURC1 mRNA	PMID:24136188
1305116	Churc1	churchill domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550122	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CHURC1 mRNA	PMID:22206623
1305116	Churc1	churchill domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHURC1 mRNA	PMID:22206623
1305116	Churc1	churchill domain containing 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CHURC1 mRNA	PMID:24136188
1305116	Churc1	churchill domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312958	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CHURC1 gene]	PMID:28238834
1305116	Churc1	churchill domain containing 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1550122	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of CHURC1 mRNA	PMID:40826991
1305116	Churc1	churchill domain containing 1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1550122	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of CHURC1 mRNA	PMID:26217789
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of JPT2 mRNA	PMID:37995155
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JPT2 mRNA	PMID:30529165
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312961	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of JPT2 mRNA	PMID:39241906
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312961	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of JPT2 mRNA	PMID:39298647
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20230307	CTD	MESH:D004958	Estradiol promotes the reaction [JPT2 protein binds to ESR1 protein]	PMID:27156127
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of JPT2 protein	PMID:20109541
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of JPT2 gene	PMID:27618143
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312960	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of JPT2 mRNA	PMID:37042841
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:17558	quercitrin	increases expression	ISO	RGD:1312960	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of JPT2 mRNA	PMID:25193878
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312961	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of JPT2 mRNA	PMID:23892564
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of JPT2 mRNA	PMID:26577399
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20230307	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in increased expression of JPT2 protein	PMID:34122009
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1312960	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of JPT2 protein	PMID:37730182
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of JPT2 protein	PMID:23301498
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312960	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of JPT2 gene	PMID:27153756
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312961	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of JPT2 protein	PMID:39910959
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312961	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of JPT2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of JPT2 mRNA	PMID:34911549
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of JPT2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of JPT2 protein	PMID:38598786
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of JPT2 mRNA	PMID:31150632
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312961	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of JPT2 mRNA	PMID:27339419|PMID:31919559
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:D005492	Folic Acid results in decreased expression of JPT2 mRNA	PMID:25629700
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1312960	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of JPT2 gene	PMID:25304211
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:C024565	ethylene dichloride results in increased expression of JPT2 mRNA	PMID:28960355
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312960	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the expression of JPT2 mRNA	PMID:28903495
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312961	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of JPT2 mRNA	PMID:21570461|PMID:24680724
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of JPT2 mRNA	PMID:33387578
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of JPT2 mRNA	PMID:30851411
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of JPT2 mRNA	PMID:20971185
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of JPT2 mRNA	PMID:29803840
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of JPT2 mRNA	PMID:39631538
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of JPT2 mRNA	PMID:38568856
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of JPT2 promoter	PMID:27901495
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of JPT2 mRNA	PMID:20971185
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20230307	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in increased expression of JPT2 protein	PMID:34122009
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of JPT2 mRNA	PMID:24915197
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of JPT2 mRNA	PMID:24136188
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of JPT2 mRNA	PMID:22613225
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HN1L mRNA	PMID:30047161
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of JPT2 mRNA	PMID:24136188
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:C009495	titanium dioxide results in decreased expression of JPT2 mRNA	PMID:29264374
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312961	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HN1L gene; titanium dioxide results in decreased methylation of HN1L promoter	PMID:35295148
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312961	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of JPT2 mRNA	PMID:23557971
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of JPT2 protein	PMID:37567409
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of JPT2 mRNA	PMID:25181051
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312960	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of JPT2 mRNA	PMID:20678512
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312960	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of JPT2 mRNA	PMID:25979313
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JPT2 mRNA	PMID:23196670
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of JPT2 mRNA	PMID:40203079
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312961	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of JPT2 mRNA	PMID:39298647
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312961	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of JPT2 mRNA	PMID:38685157
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1312960	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of JPT2 gene	PMID:22964155
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of JPT2 mRNA	PMID:21266533
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of JPT2 protein	PMID:38598786
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312960	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of JPT2 mRNA	PMID:37042841
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C005445	triphenyl phosphate results in increased expression of JPT2 mRNA	PMID:30589522
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of JPT2 mRNA	PMID:38568856
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of JPT2 promoter	PMID:22457795
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of JPT2 mRNA	PMID:35163327
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of JPT2 gene	PMID:22079235
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of JPT2 mRNA	PMID:31533062
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of JPT2 mRNA	PMID:39529242
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312960	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of JPT2 mRNA	PMID:25979313
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of JPT2 mRNA	PMID:26272509
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA	PMID:27188386
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HN1L mRNA	PMID:30047161
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of JPT2 mRNA	PMID:25562108
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of JPT2 mRNA	PMID:28973697
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1312960	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of JPT2 mRNA	PMID:24449571
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of JPT2 mRNA	PMID:24136188
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of JPT2 mRNA	PMID:24935251|PMID:26272509
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA	PMID:27188386
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312961	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of JPT2 mRNA	PMID:17562736
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:D000082	Acetaminophen results in increased expression of JPT2 mRNA	PMID:29246445
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of JPT2 mRNA]	PMID:29246445
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1312960	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of JPT2 gene	PMID:25304211
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1312960	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of JPT2 mRNA	PMID:23228038
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312961	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of JPT2 mRNA; Nanotubes, Carbon results in increased expression of JPT2 mRNA	PMID:25554681
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of JPT2 mRNA	PMID:34044035
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of HN1L mRNA	PMID:30047161
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312961	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of JPT2 mRNA	PMID:35964746
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of JPT2 mRNA	PMID:24136188
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of JPT2 protein	PMID:32959892
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1312960	E	RGD:6480464	20120412	CTD	MESH:D019772	JPT2 protein affects the susceptibility to Topotecan	PMID:16217747
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of JPT2 mRNA	PMID:15336504
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of JPT2 protein	PMID:30467583
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1312961	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of JPT2 mRNA	PMID:27462272
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of JPT2 protein	PMID:37664457
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of JPT2 mRNA	PMID:29522793
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312960	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of JPT2 protein	PMID:39638853
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of JPT2 mRNA	PMID:30851411
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA	PMID:27188386
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of HN1L mRNA	PMID:30047161
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312961	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of JPT2 mRNA	PMID:19270015
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:C009277	sodium arsenate results in increased expression of JPT2 mRNA	PMID:30953684
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of HN1L mRNA; Propylthiouracil results in increased expression of JPT2 mRNA	PMID:24780913|PMID:30047161
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of JPT2 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA	PMID:27188386|PMID:37664457
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312960	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of JPT2 mRNA	PMID:38568856
1305117	Jpt2	Jupiter microtubule associated homolog 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1312960	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of JPT2 protein	PMID:38598786
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of DAAM1 mRNA	PMID:15498508
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312963	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DAAM1 mRNA	PMID:30319688
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DAAM1 mRNA	PMID:39298647
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of DAAM1 mRNA	PMID:19167446
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of DAAM1 mRNA	PMID:30165855
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1312963	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to DAAM1 gene]	PMID:31084621
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DAAM1 mRNA	PMID:33754040
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1346826	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of DAAM1 protein	PMID:37730182
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DAAM1 mRNA	PMID:33387578
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1346826	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DAAM1 mRNA	PMID:28818685
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312963	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DAAM1 mRNA	PMID:36331819
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DAAM1 mRNA	PMID:39836092
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1346826	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DAAM1 mRNA	PMID:19549813
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of DAAM1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of DAAM1 protein	PMID:38598786
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DAAM1 mRNA	PMID:31150632
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DAAM1 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DAAM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DAAM1 mRNA	PMID:32525701|PMID:39836092
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DAAM1 mRNA	PMID:19244175
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of DAAM1 mRNA	PMID:33512557
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1346826	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DAAM1 protein	PMID:35688186
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of DAAM1 mRNA	PMID:31295307
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1346826	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of DAAM1 mRNA	PMID:28903495
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of DAAM1 mRNA	PMID:27392435
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DAAM1 mRNA	PMID:22298810
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312963	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DAAM1 mRNA	PMID:21570461
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DAAM1 mRNA	PMID:18796159|PMID:21215274|PMID:33387578
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DAAM1 mRNA	PMID:19933214
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DAAM1 mRNA	PMID:29704546
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DAAM1 mRNA	PMID:34747641
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of DAAM1 mRNA	PMID:29704546
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of DAAM1 mRNA	PMID:33512557
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DAAM1 mRNA	PMID:28001369
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DAAM1 mRNA	PMID:33212167
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DAAM1 mRNA	PMID:30851411
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1346826	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of DAAM1 mRNA	PMID:23649840
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of DAAM1 mRNA	PMID:39631538
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DAAM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DAAM1 mRNA	PMID:39836092
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346826	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DAAM1 5' UTR	PMID:27901495
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DAAM1 mRNA	PMID:19770486
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312963	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DAAM1 mRNA	PMID:22228805
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to DAAM1 mRNA]	PMID:32406909
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DAAM1 gene	PMID:31601247
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DAAM1 mRNA	PMID:25729387
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of DAAM1 mRNA	PMID:15498508
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of DAAM1 mRNA	PMID:24136188
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312963	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DAAM1 gene	PMID:35295148
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312963	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DAAM1 gene	PMID:35295148
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of DAAM1 mRNA	PMID:18648102
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of DAAM1 mRNA	PMID:23811191
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of DAAM1 mRNA	PMID:30690063
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DAAM1 mRNA	PMID:33221593
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of DAAM1 mRNA	PMID:25912373
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1346826	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DAAM1 gene	PMID:31601247
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DAAM1 mRNA	PMID:25181051|PMID:30816183
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DAAM1 gene	PMID:31601247
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DAAM1 mRNA	PMID:19244175
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312963	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DAAM1 gene	PMID:31683443
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DAAM1 mRNA	PMID:39298647
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DAAM1 mRNA	PMID:21266533
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of DAAM1 protein	PMID:38598786
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346826	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DAAM1 mRNA	PMID:37042841
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DAAM1 mRNA	PMID:39836092
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DAAM1 mRNA	PMID:18560533
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of DAAM1 mRNA	PMID:28903501
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1346826	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DAAM1 mRNA	PMID:24449571
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DAAM1 mRNA	PMID:19244175
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:38604	pyrimidifen	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of DAAM1 mRNA	PMID:33512557
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DAAM1 mRNA	PMID:31533062
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of DAAM1 mRNA	PMID:19167446
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312963	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DAAM1 mRNA	PMID:36331819
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346826	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of DAAM1 mRNA	PMID:19101580
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346826	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DAAM1 mRNA	PMID:25562108
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of DAAM1 mRNA	PMID:33512557
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of DAAM1 mRNA	PMID:28973697
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of DAAM1 mRNA	PMID:33512557
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1346826	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of DAAM1 mRNA	PMID:23649840
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of DAAM1 mRNA	PMID:24136188
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1346826	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of DAAM1 mRNA	PMID:28542535
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1346826	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of DAAM1 mRNA	PMID:24935251
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DAAM1 mRNA	PMID:33387578
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1346826	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of DAAM1 mRNA	PMID:21420995
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DAAM1 mRNA	PMID:29279043
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1346826	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DAAM1 mRNA	PMID:18687144
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DAAM1 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DAAM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DAAM1 mRNA	PMID:32525701|PMID:39836092
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DAAM1 mRNA	PMID:29391264
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DAAM1 mRNA	PMID:22079256
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:5011	fenpyroximate	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of DAAM1 mRNA	PMID:33512557
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DAAM1 mRNA	PMID:25554681
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of DAAM1 mRNA	PMID:24136188
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DAAM1 mRNA	PMID:39836092
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312963	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DAAM1 mRNA	PMID:21641980
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DAAM1 mRNA	PMID:25729387
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of DAAM1 mRNA	PMID:24136188
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of DAAM1 mRNA	PMID:30467583
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of DAAM1 mRNA	PMID:24136188
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DAAM1 mRNA	PMID:22079256|PMID:22714537
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DAAM1 mRNA	PMID:22079256
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DAAM1 mRNA	PMID:30851411
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312963	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DAAM1 mRNA	PMID:23091169
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:81794	thifluzamide	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of DAAM1 mRNA	PMID:33512557
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of DAAM1 mRNA	PMID:33512557
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DAAM1 mRNA	PMID:32525701
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of DAAM1 mRNA	PMID:21278054
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DAAM1 mRNA	PMID:21346803
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:9422	tebufenpyrad	decreases expression	ISO	RGD:1346826	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of DAAM1 mRNA	PMID:33512557
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1346826	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DAAM1 mRNA	PMID:29301935
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1346826	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of DAAM1 protein	PMID:38598786
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DAAM1 mRNA	PMID:21346803
1305119	Daam1	dishevelled associated activator of morphogenesis 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312963	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of DAAM1 mRNA	PMID:28973697
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1619128	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DENND2D gene	PMID:20938992
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of DENND2D mRNA	PMID:20488242
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of DENND2D mRNA	PMID:32145629
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of DENND2D mRNA	PMID:30165855
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1619128	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of DENND2D mRNA	PMID:33711761
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of DENND2D mRNA	PMID:38568856
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1619128	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DENND2D gene	PMID:20938992
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602459	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DENND2D mRNA	PMID:37042841
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1619128	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of DENND2D mRNA	PMID:22238285
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1602459	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of DENND2D mRNA	PMID:26079696
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1619128	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DENND2D mRNA	PMID:37992649
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1619128	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DENND2D mRNA	PMID:37992649
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DENND2D mRNA	PMID:33387578
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1619128	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DENND2D mRNA	PMID:36331819
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1602459	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DENND2D protein	PMID:20106945
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DENND2D mRNA	PMID:25378103
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602459	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DENND2D gene	PMID:27153756
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DENND2D mRNA	PMID:35430440
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1619128	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DENND2D mRNA	PMID:25629700
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1619128	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DENND2D gene	PMID:20938992
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of DENND2D mRNA	PMID:27424125
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of DENND2D mRNA	PMID:38460933
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DENND2D mRNA	PMID:31881176
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of DENND2D mRNA	PMID:27424125
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of DENND2D mRNA	PMID:23195993
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1602459	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DENND2D mRNA	PMID:25583101
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DENND2D mRNA	PMID:22298810
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DENND2D mRNA	PMID:21215274|PMID:32109520
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DENND2D mRNA	PMID:33387578
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of DENND2D mRNA]	PMID:21215274
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of DENND2D mRNA	PMID:27424125
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of DENND2D mRNA	PMID:29955902
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DENND2D mRNA	PMID:33212167
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DENND2D mRNA	PMID:30851411
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of DENND2D mRNA	PMID:28959563
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1619128	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DENND2D mRNA	PMID:37992649
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DENND2D mRNA	PMID:38568856
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602459	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DENND2D exon; Benzo(a)pyrene results in decreased methylation of DENND2D promoter	PMID:27901495
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1602459	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DENND2D mRNA	PMID:22316170
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1619128	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DENND2D intron	PMID:27901495
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DENND2D mRNA	PMID:25895662
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of DENND2D mRNA	PMID:30047161
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1619128	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DENND2D gene	PMID:35295148
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of DENND2D mRNA	PMID:30012374
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1619128	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of DENND2D mRNA	PMID:23557971
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DENND2D mRNA	PMID:23411599|PMID:34492290
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DENND2D mRNA	PMID:30723492
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1602459	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DENND2D mRNA	PMID:30690063
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DENND2D mRNA	PMID:25181051
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DENND2D mRNA	PMID:30816183|PMID:32145629|PMID:34947998
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1619128	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of DENND2D mRNA	PMID:25172293
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DENND2D mRNA	PMID:19244175
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1619128	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DENND2D mRNA	PMID:38685157
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:34778	glycitein	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of DENND2D mRNA	PMID:27424125
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602459	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DENND2D mRNA	PMID:37042841
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of DENND2D mRNA	PMID:25539665
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DENND2D mRNA	PMID:24386269
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of DENND2D mRNA	PMID:24449571
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1619128	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of DENND2D mRNA	PMID:18353800
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1602459	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of DENND2D mRNA	PMID:40434365
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1619128	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DENND2D mRNA	PMID:36331819
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of DENND2D mRNA	PMID:29154799
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of DENND2D mRNA	PMID:30047161
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1619128	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of DENND2D mRNA	PMID:25123088
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of DENND2D mRNA	PMID:27424125
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1619128	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of DENND2D mRNA	PMID:28973697
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1619128	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DENND2D mRNA	PMID:37992649
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of DENND2D mRNA	PMID:24449571
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1619128	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DENND2D mRNA	PMID:17562736
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DENND2D mRNA	PMID:33387578
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of DENND2D mRNA	PMID:21420995
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1602459	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of DENND2D mRNA	PMID:24714768
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of DENND2D mRNA	PMID:38460933
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1619128	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of DENND2D mRNA	PMID:35537566
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DENND2D mRNA	PMID:29391264
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DENND2D mRNA	PMID:22079256
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DENND2D mRNA	PMID:17557909
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1619128	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DENND2D mRNA	PMID:25554681
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of DENND2D mRNA	PMID:30047161
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of DENND2D mRNA	PMID:22714537
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of DENND2D mRNA	PMID:35283115
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DENND2D mRNA	PMID:22079256
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1602459	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of DENND2D mRNA	PMID:22714537
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DENND2D mRNA	PMID:22079256
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1602459	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DENND2D mRNA	PMID:37199045
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DENND2D mRNA	PMID:30851411
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DENND2D gene]	PMID:28238834
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:80373	glycitin	multiple interactions	ISO	RGD:1602459	E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of DENND2D mRNA	PMID:27424125
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1619128	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of DENND2D mRNA	PMID:19482888
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1619128	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of DENND2D mRNA]	PMID:19482888
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1619128	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of DENND2D mRNA	PMID:21795629
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of DENND2D mRNA	PMID:30047161
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DENND2D mRNA	PMID:24780913|PMID:30047161
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of DENND2D mRNA	PMID:31734321
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DENND2D mRNA	PMID:21346803
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602459	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DENND2D mRNA	PMID:38568856
1305120	Dennd2d	DENN domain containing 2D	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1619128	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DENND2D mRNA	PMID:35537566
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:135466	nafamostat	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20190219	CTD	MESH:C032855	nafamostat binds to and results in decreased activity of FTO protein	PMID:30393114
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1621572	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FTO mRNA	PMID:20188158
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FTO mRNA	PMID:33167477
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FTO mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FTO mRNA	PMID:32699268
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FTO mRNA	PMID:26079696
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1621572	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FTO mRNA	PMID:30319688
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1621572	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FTO mRNA	PMID:39298647
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:16509	1,4-benzoquinone	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20230404	CTD	MESH:C004532	quinone results in decreased expression of FTO mRNA	PMID:36306860
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:16509	1,4-benzoquinone	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20241203	CTD	MESH:C004532	quinone results in decreased expression of FTO mRNA	PMID:38367942
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of FTO mRNA	PMID:23649840
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of FTO mRNA	PMID:36174712
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FTO mRNA	PMID:31923814
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FTO mRNA	PMID:36423848
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1625089	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of FTO intron	PMID:30157460
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:207229	dihydroartemisinin	affects binding	ISO	RGD:1625089	E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to FTO protein	PMID:26340163
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:21891	N(6)-methyladenosine	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20230704	CTD	MESH:C010223	[FTO results in decreased abundance of N-methyladenosine] which results in decreased methylation of SETD2 mRNA alternative form	PMID:36260529
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20260303	CTD	MESH:D002104	Cadmium results in decreased expression of FTO protein	PMID:40334773
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1621572	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FTO mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FTO protein; [Cadmium co-treated with Dietary Fats co-treated with Dietary Sugars] results in decreased expression of FTO protein; Cadmium promotes the reaction [[Dietary Fats co-treated with Dietary Sugars] results in decreased expression of FTO protein]	PMID:37236586|PMID:40334773
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20250603	CTD	MESH:D002104	[cadmium sulfate results in increased abundance of Cadmium] which results in decreased expression of FTO mRNA; [cadmium sulfate results in increased abundance of Cadmium] which results in decreased expression of FTO protein	PMID:39725363
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:234558	ML-792	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20250902	CTD	MESH:C000716071	ML-792 inhibits the reaction [Arsenic results in decreased expression of FTO protein]; ML-792 promotes the reaction [FTO protein inhibits the reaction [Arsenic results in increased expression of GCLM protein]]; ML-792 promotes the reaction [FTO protein inhibits the reaction [Arsenic results in increased expression of H2AX protein]]; ML-792 promotes the reaction [FTO protein inhibits the reaction [Arsenic results in increased expression of HMOX1 protein]]	PMID:38723480
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FTO protein	PMID:23301498
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of FTO protein	PMID:33236894
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1625089	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of FTO protein	PMID:20106945
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1625089	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FTO gene	PMID:27153756
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1625089	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FTO intron	PMID:30157460
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1621572	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FTO mRNA	PMID:27106289
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FTO mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FTO mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of FTO mRNA	PMID:32699268
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of FTO protein	PMID:38723480
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of FTO protein	PMID:38723480
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1625089	E	RGD:6480464	20221101	CTD	MESH:D001151	Arsenic results in increased expression of FTO; Arsenic results in increased expression of FTO protein	PMID:34998823|PMID:35363433
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1621572	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in decreased expression of ACTA1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ACTN3 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ANK1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of APOBEC2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ARNTL mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ASB5 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ATP2A1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of CACNA1S mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of CCL21D mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of CKM mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of EGLN3 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of H19 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of IGKV6-15 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of KLHL41 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MIR142HG mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYBPC2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYH1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYH8 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYL1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYL3 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYLPF mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYOZ1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of NEB mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of NPAS2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PDE3B mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PDK4 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PGAM2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PLCB1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PPP1R3A mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PTPRD mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of SBK2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of SFRP2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of SMTNL1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of TGM3 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of TNNC2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of TNNT3 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ZBTB16 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of ACKR4 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of ARHGAP20 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of BDNF mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of CES1G mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of COL12A1 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of GCLM protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of GLIS2 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of HMOX1 protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of IER3 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of KALRN mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of LMO2 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of LRTM2 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of MCC mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of MISP3 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of OGG1 protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of RAI2 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of RND1 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of SCEL mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of SH3RF2 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of WNT7A mRNA]	PMID:38723480
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20221101	CTD	MESH:D001151	Arsenic promotes the reaction [FTO protein binds to SUMO1 protein]; FTO protein affects the reaction [APOBEC3B protein affects the reaction [Arsenic results in increased mutagenesis of TP53 gene]]; FTO protein affects the reaction [Arsenic results in decreased methylation of APOBEC3B 3' UTR]; FTO protein affects the reaction [Arsenic results in increased expression of APOBEC3B protein]; FTO protein affects the reaction [Arsenic results in increased expression of H2AX protein]; FTO protein affects the reaction [Arsenic results in increased expression of TP53 protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of GCLM protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of H2AX protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of HMOX1 protein]; ML-792 inhibits the reaction [Arsenic results in decreased expression of FTO protein]; ML-792 promotes the reaction [FTO protein inhibits the reaction [Arsenic results in increased expression of GCLM protein]]; ML-792 promotes the reaction [FTO protein inhibits the reaction [Arsenic results in increased expression of H2AX protein]]; ML-792 promotes the reaction [FTO protein inhibits the reaction [Arsenic results in increased expression of HMOX1 protein]]; SENP1 protein affects the reaction [Arsenic results in decreased expression of FTO protein]; SENP6 protein affects the reaction [Arsenic results in decreased expression of FTO protein]; YTHDF2 protein affects the reaction [FTO protein affects the reaction [APOBEC3B protein affects the reaction [Arsenic results in increased mutagenesis of TP53 gene]]]; YTHDF2 protein affects the reaction [FTO protein affects the reaction [Arsenic results in increased expression of H2AX protein]]	PMID:34998823|PMID:38723480
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27638	cobalt atom	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20231031	CTD	MESH:D003035	Cobalt results in decreased expression of FTO mRNA; Cobalt results in decreased expression of FTO protein	PMID:32827984
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27638	cobalt atom	increases expression	ISO	RGD:1621572	E	RGD:6480464	20231031	CTD	MESH:D003035	Cobalt results in increased expression of FTO mRNA; Cobalt results in increased expression of FTO protein	PMID:32827984
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FTO mRNA	PMID:31881176
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of FTO mRNA	PMID:19921347
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D007854	Lead results in increased expression of FTO mRNA; Lead results in increased expression of FTO protein	PMID:37269892
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of FTO mRNA	PMID:19561079|PMID:27594783
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621572	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FTO mRNA	PMID:21570461
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1625089	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of FTO protein	PMID:39603559
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FTO mRNA	PMID:33212167
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1625089	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FTO protein	PMID:33212167
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28741	sodium fluoride	decreases expression	EXP		E	RGD:6480464	20260602	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of FTO mRNA; Sodium Fluoride results in decreased expression of FTO protein	PMID:41830162
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20260602	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of FTO mRNA; Sodium Fluoride results in decreased expression of FTO protein	PMID:41830162
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28741	sodium fluoride	decreases response to substance	EXP		E	RGD:6480464	20260602	CTD	MESH:D012969	FTO gene results in decreased susceptibility to Sodium Fluoride	PMID:41830162
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28741	sodium fluoride	decreases response to substance	ISO	RGD:1625089	E	RGD:6480464	20260602	CTD	MESH:D012969	FTO protein results in decreased susceptibility to Sodium Fluoride	PMID:41830162
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1621572	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of FTO protein	PMID:28918527
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20260602	CTD	MESH:D012969	FTO protein inhibits the reaction [Sodium Fluoride results in decreased expression of DLG1 protein]; FTO protein inhibits the reaction [Sodium Fluoride results in decreased expression of FTO mRNA]; FTO protein inhibits the reaction [Sodium Fluoride results in decreased expression of FTO protein]; FTO protein inhibits the reaction [Sodium Fluoride results in decreased expression of GRIA2 mRNA]; FTO protein inhibits the reaction [Sodium Fluoride results in decreased expression of GRIA2 protein]	PMID:41830162
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28755	2,4,6-trichlorophenol	increases expression	ISO	RGD:1621572	E	RGD:6480464	20240702	CTD	MESH:C024564	2,4,6-trichlorophenol results in increased expression of FTO mRNA	PMID:38157273
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1625089	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of FTO protein	PMID:35688186
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1621572	E	RGD:6480464	20230905	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of FTO mRNA]	PMID:34425375
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20210810	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of FTO mRNA]	PMID:31004932
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1625089	E	RGD:6480464	20181113	CTD	MESH:C017947	sodium arsenite affects the expression of FTO mRNA; sodium arsenite affects the expression of FTO protein	PMID:29680375|PMID:30654086
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite results in decreased expression of FTO protein	PMID:37061066
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite results in decreased expression of FTO mRNA; sodium arsenite results in decreased expression of FTO protein	PMID:37061066|PMID:38568856|PMID:39265400|PMID:39675544
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1625089	E	RGD:6480464	20210810	CTD	MESH:C017947	sodium arsenite results in increased expression of FTO mRNA	PMID:31004932
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20210810	CTD	MESH:C017947	[sodium arsenite co-treated with FTO] results in increased expression of IFI44 mRNA; [sodium arsenite co-treated with FTO] results in increased expression of IFI6 mRNA; [sodium arsenite co-treated with FTO] results in increased expression of IFIT1 mRNA; [sodium arsenite co-treated with FTO] results in increased expression of IFIT2 mRNA; [sodium arsenite co-treated with FTO] results in increased expression of IFIT3 mRNA; [sodium arsenite co-treated with FTO] results in increased expression of IRF7 mRNA; [sodium arsenite co-treated with FTO] results in increased expression of ISG15 mRNA; [sodium arsenite co-treated with FTO] results in increased expression of OASL mRNA; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of FTO mRNA]; FTO inhibits the reaction [sodium arsenite results in decreased expression of ATF3 mRNA]; FTO inhibits the reaction [sodium arsenite results in decreased expression of ATF3 protein]; FTO inhibits the reaction [sodium arsenite results in decreased expression of DUSP5 mRNA]; FTO inhibits the reaction [sodium arsenite results in decreased expression of JUN mRNA]; FTO inhibits the reaction [sodium arsenite results in decreased expression of KLF6 mRNA]; FTO inhibits the reaction [sodium arsenite results in decreased expression of PPP1R15A mRNA]; FTO promotes the reaction [sodium arsenite results in increased expression of GCLM protein]; FTO promotes the reaction [sodium arsenite results in increased expression of HMOX1 protein]; FTO promotes the reaction [sodium arsenite results in increased phosphorylation of H2AX protein]; FTO protein affects the reaction [sodium arsenite results in increased expression of AKT1 protein]; FTO protein affects the reaction [sodium arsenite results in increased expression of and results in increased methylation of AKT1 mRNA]; FTO protein affects the reaction [sodium arsenite results in increased methylation of RPS21 mRNA]; FTO protein affects the reaction [sodium arsenite results in increased methylation of UBA52 3' UTR]; sodium arsenite promotes the reaction [FTO protein binds to AKT1 mRNA]; sodium arsenite promotes the reaction [FTO protein binds to PHLPP2 mRNA]	PMID:31004932|PMID:36444808|PMID:37061066|PMID:39265400
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1625089	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FTO intron	PMID:30157460
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FTO mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1621572	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FTO intron	PMID:27901495
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:29866	arsenite(3-)	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C015001	arsenite results in decreased expression of FTO protein	PMID:29982692
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20181113	CTD	MESH:C015001	arsenite results in decreased expression of FTO mRNA; arsenite results in decreased expression of FTO protein	PMID:29982692|PMID:39405678
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of FTO mRNA	PMID:34850242
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20240206	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of FTO mRNA	PMID:37979906
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FTO mRNA	PMID:26238291
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of FTO mRNA	PMID:25729387
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621572	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FTO gene	PMID:35295148
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FTO mRNA	PMID:34492290
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20231205	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of FTO mRNA	PMID:36739042
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1625089	E	RGD:6480464	20241001	CTD	MESH:C006780	bisphenol A affects the expression of FTO mRNA	PMID:38354435
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FTO mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:41034487
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FTO mRNA; bisphenol A results in decreased expression of FTO protein	PMID:26063408|PMID:36451259
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1621572	E	RGD:6480464	20240305	CTD	MESH:C006780	bisphenol A results in decreased methylation of FTO intron	PMID:36469784
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of FTO mRNA; bisphenol A results in increased expression of FTO protein	PMID:34947998|PMID:37495067|PMID:41034487
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1621572	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of FTO mRNA	PMID:26063408
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FTO gene	PMID:28505145
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	[Dietary Fats co-treated with bisphenol A] results in increased expression of FTO mRNA; [Dietary Fats co-treated with bisphenol A] results in increased expression of FTO protein	PMID:35945320
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1621572	E	RGD:6480464	20240305	CTD	MESH:C006780	bisphenol A promotes the reaction [CTCF protein binds to FTO intron]; FTO intron mutant form inhibits the reaction [bisphenol A results in increased expression of LEP protein]	PMID:36469784
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FTO mRNA	PMID:28628672
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621572	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FTO mRNA	PMID:39298647
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1625089	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of FTO intron	PMID:30157460
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FTO mRNA	PMID:28628672
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1621572	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of FTO intron	PMID:28392331
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of FTO mRNA	PMID:28392331
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FTO mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FTO mRNA	PMID:28628672
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20230905	CTD	MESH:D010269	Paraquat results in decreased expression of FTO mRNA	PMID:34425375
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1621572	E	RGD:6480464	20230905	CTD	MESH:D010269	Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of FTO mRNA]	PMID:34425375
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1625089	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FTO mRNA	PMID:37042841
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1625089	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FTO mRNA	PMID:38174414
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1621572	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FTO mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FTO protein	PMID:37236586
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1625089	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FTO mRNA	PMID:24449571
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FTO mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FTO mRNA	PMID:32699268
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:38221	fumonisin B1	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20210608	CTD	MESH:C056933	fumonisin B1 results in decreased expression of FTO mRNA	PMID:33496827
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1625089	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of FTO mRNA	PMID:28302478
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1625089	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FTO mRNA	PMID:25979313
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1625089	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FTO gene	PMID:29154799
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1625089	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of FTO mRNA	PMID:23179753|PMID:27188386
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FTO mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FTO mRNA	PMID:28628672
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FTO mRNA	PMID:38832940
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of FTO protein	PMID:38723480
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of FTO protein	PMID:38723480
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1625089	E	RGD:6480464	20221101	CTD	MESH:D001151	Arsenic results in increased expression of FTO; Arsenic results in increased expression of FTO protein	PMID:34998823|PMID:35363433
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1621572	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in decreased expression of ACTA1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ACTN3 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ANK1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of APOBEC2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ARNTL mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ASB5 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ATP2A1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of CACNA1S mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of CCL21D mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of CKM mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of EGLN3 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of H19 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of IGKV6-15 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of KLHL41 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MIR142HG mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYBPC2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYH1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYH8 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYL1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYL3 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYLPF mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of MYOZ1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of NEB mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of NPAS2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PDE3B mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PDK4 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PGAM2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PLCB1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PPP1R3A mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of PTPRD mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of SBK2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of SFRP2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of SMTNL1 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of TGM3 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of TNNC2 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of TNNT3 mRNA]; FTO protein inhibits the reaction [Arsenic results in decreased expression of ZBTB16 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of ACKR4 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of ARHGAP20 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of BDNF mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of CES1G mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of COL12A1 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of GCLM protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of GLIS2 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of HMOX1 protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of IER3 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of KALRN mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of LMO2 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of LRTM2 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of MCC mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of MISP3 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of OGG1 protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of RAI2 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of RND1 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of SCEL mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of SH3RF2 mRNA]; FTO protein inhibits the reaction [Arsenic results in increased expression of WNT7A mRNA]	PMID:38723480
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20221101	CTD	MESH:D001151	Arsenic promotes the reaction [FTO protein binds to SUMO1 protein]; FTO protein affects the reaction [APOBEC3B protein affects the reaction [Arsenic results in increased mutagenesis of TP53 gene]]; FTO protein affects the reaction [Arsenic results in decreased methylation of APOBEC3B 3' UTR]; FTO protein affects the reaction [Arsenic results in increased expression of APOBEC3B protein]; FTO protein affects the reaction [Arsenic results in increased expression of H2AX protein]; FTO protein affects the reaction [Arsenic results in increased expression of TP53 protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of GCLM protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of H2AX protein]; FTO protein inhibits the reaction [Arsenic results in increased expression of HMOX1 protein]; ML-792 inhibits the reaction [Arsenic results in decreased expression of FTO protein]; ML-792 promotes the reaction [FTO protein inhibits the reaction [Arsenic results in increased expression of GCLM protein]]; ML-792 promotes the reaction [FTO protein inhibits the reaction [Arsenic results in increased expression of H2AX protein]]; ML-792 promotes the reaction [FTO protein inhibits the reaction [Arsenic results in increased expression of HMOX1 protein]]; SENP1 protein affects the reaction [Arsenic results in decreased expression of FTO protein]; SENP6 protein affects the reaction [Arsenic results in decreased expression of FTO protein]; YTHDF2 protein affects the reaction [FTO protein affects the reaction [APOBEC3B protein affects the reaction [Arsenic results in increased mutagenesis of TP53 gene]]]; YTHDF2 protein affects the reaction [FTO protein affects the reaction [Arsenic results in increased expression of H2AX protein]]	PMID:34998823|PMID:38723480
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1621572	E	RGD:6480464	20240702	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of FTO mRNA	PMID:38157273
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1625089	E	RGD:6480464	20240702	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of FTO mRNA	PMID:38157273
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FTO mRNA	PMID:35436446
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of FTO mRNA	PMID:32234424
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FTO mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FTO mRNA	PMID:28628672
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:50292	cadmium sulfate	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20251007	CTD	MESH:C037123	cadmium sulfate results in decreased expression of FTO protein	PMID:35794303
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1625089	E	RGD:6480464	20251007	CTD	MESH:C037123	cadmium sulfate results in increased expression of FTO mRNA	PMID:35794303
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1625089	E	RGD:6480464	20250603	CTD	MESH:C037123	[cadmium sulfate results in increased abundance of Cadmium] which results in decreased expression of FTO mRNA; [cadmium sulfate results in increased abundance of Cadmium] which results in decreased expression of FTO protein	PMID:39725363
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:6015	isoflurane	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in decreased expression of FTO protein	PMID:35249202
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FTO protein	PMID:32959892
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of FTO mRNA	PMID:25729387
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1625089	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of FTO intron	PMID:30157460
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FTO gene	PMID:35440735
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of FTO mRNA	PMID:31758290
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1625089	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of FTO protein	PMID:31285264
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of FTO mRNA	PMID:18927307
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:81927	enilconazole	affects expression	ISO	RGD:1621572	E	RGD:6480464	20260804	CTD	MESH:C017435	enilconazole affects the expression of FTO mRNA	PMID:38232526
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of FTO mRNA	PMID:26079696
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1621572	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of FTO mRNA	PMID:21795629
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:9130	sevoflurane	decreases expression	ISO	RGD:1621572	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased expression of FTO protein	PMID:35249202
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FTO mRNA	PMID:19281266
1305121	Fto	FTO, alpha-ketoglutarate dependent dioxygenase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1625089	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FTO mRNA	PMID:38568856
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TBRG1 mRNA]	PMID:31150632
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TBRG1 mRNA	PMID:20188158
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312969	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of TBRG1 mRNA	PMID:29581250
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312970	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TBRG1 mRNA	PMID:39298647
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312969	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TBRG1 mRNA	PMID:37042841
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312970	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of TBRG1 mRNA	PMID:23892564
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312969	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TBRG1 protein	PMID:37730182
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TBRG1 mRNA	PMID:22061828
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1312969	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TBRG1 gene	PMID:27153756
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312969	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TBRG1 mRNA	PMID:23649840
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TBRG1 mRNA	PMID:31150632
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312970	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TBRG1 mRNA	PMID:27339419|PMID:31919559
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TBRG1 mRNA]	PMID:31150632
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TBRG1 mRNA	PMID:40504410
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1312969	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of TBRG1 protein	PMID:35688186
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1312969	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TBRG1 mRNA	PMID:28903495
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1312969	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of TBRG1 mRNA	PMID:19921347
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312970	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBRG1 mRNA	PMID:21570461
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBRG1 mRNA	PMID:34747641
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBRG1 mRNA	PMID:19465110
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TBRG1 mRNA	PMID:17942748
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312969	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TBRG1 mRNA	PMID:28001369
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312969	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TBRG1 mRNA	PMID:28001369
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1312969	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TBRG1 mRNA	PMID:39709020
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312969	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TBRG1 mRNA	PMID:20971185
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312969	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TBRG1 mRNA	PMID:29803840
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312969	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TBRG1 mRNA	PMID:38568856
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TBRG1 mRNA	PMID:40504410
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312970	E	RGD:6480464	20150714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TBRG1 mRNA	PMID:25908611
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TBRG1 mRNA	PMID:22228805
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of TBRG1 mRNA]	PMID:22228805
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312969	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TBRG1 mRNA	PMID:20971185
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of TBRG1 mRNA	PMID:20542052
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312970	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TBRG1 gene	PMID:35295148
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TBRG1 mRNA	PMID:23411599
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TBRG1 mRNA	PMID:18445702
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TBRG1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312970	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TBRG1 mRNA	PMID:33221593
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TBRG1 mRNA	PMID:25181051
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TBRG1 gene	PMID:28505145
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312969	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TBRG1 mRNA	PMID:25979313
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312970	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TBRG1 mRNA	PMID:39298647
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312970	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of TBRG1 mRNA	PMID:34813904
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312970	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of TBRG1 mRNA	PMID:34813904
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TBRG1 mRNA	PMID:33453195
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312969	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TBRG1 mRNA	PMID:38568856
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1312970	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of TBRG1 mRNA	PMID:25908611
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312970	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of TBRG1 mRNA	PMID:17585979
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312969	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TBRG1 mRNA	PMID:32588087
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312969	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TBRG1 mRNA	PMID:31533062
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312969	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TBRG1 mRNA	PMID:40419075
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of TBRG1 mRNA	PMID:25993096
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312969	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TBRG1 mRNA	PMID:23179753
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312969	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TBRG1 gene	PMID:29154799
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312969	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TBRG1 mRNA	PMID:17183730
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312969	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TBRG1 mRNA	PMID:20106945|PMID:25562108
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312969	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of TBRG1 mRNA	PMID:27188386
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TBRG1 mRNA	PMID:17562736
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TBRG1 mRNA	PMID:33387578
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TBRG1 mRNA	PMID:40504410
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1312969	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of TBRG1 mRNA	PMID:36621641
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TBRG1 mRNA	PMID:29391264
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312970	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TBRG1 mRNA	PMID:35436446
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TBRG1 mRNA	PMID:17942748
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312970	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TBRG1 mRNA; Nanotubes, Carbon results in increased expression of TBRG1 mRNA	PMID:25554681|PMID:25620056
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TBRG1 mRNA	PMID:24136188
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312969	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of TBRG1 mRNA	PMID:31629900
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312969	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TBRG1 mRNA	PMID:17183730
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TBRG1 mRNA	PMID:14729362
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	increases expression	ISO	RGD:1312969	E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in increased expression of TBRG1 mRNA	PMID:22101062
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TBRG1 mRNA	PMID:21346803
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TBRG1 mRNA	PMID:21346803
1305123	Tbrg1	transforming growth factor beta regulator 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TBRG1 mRNA	PMID:23034163
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312972	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CILP mRNA	PMID:33045310
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CILP mRNA	PMID:35811015
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312971	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of CILP mRNA	PMID:23019147
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312972	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CILP mRNA	PMID:19484750
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of CILP mRNA	PMID:20660070
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA	PMID:25510870
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CILP mRNA	PMID:33387578
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of CILP mRNA	PMID:20660070
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312972	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CILP mRNA	PMID:34319233
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312971	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CILP mRNA	PMID:26485663
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CILP mRNA	PMID:33387578
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA	PMID:25510870
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA	PMID:25510870
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312971	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CILP gene	PMID:27153756
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CILP mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CILP mRNA	PMID:27106289|PMID:34911549
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312972	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CILP mRNA	PMID:25629700
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of CILP mRNA	PMID:38314887
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CILP mRNA	PMID:23557933
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1312971	E	RGD:6480464	20120412	CTD	MESH:D002945	CILP protein affects the susceptibility to Cisplatin	PMID:16217747
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312972	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of CILP mRNA	PMID:32186404
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312971	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of CILP mRNA	PMID:19371625|PMID:23019147
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312971	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CILP mRNA	PMID:24768652|PMID:25583101
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CILP mRNA	PMID:33387578
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CILP mRNA	PMID:34747641
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312971	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CILP mRNA	PMID:28001369
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CILP mRNA	PMID:28959563
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CILP mRNA	PMID:24690739
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312971	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CILP mRNA	PMID:29803840
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312971	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CILP mRNA	PMID:38568856
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA	PMID:34876320
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA	PMID:34876320
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to CILP promoter]	PMID:19654925
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CILP mRNA	PMID:24690739
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312972	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CILP mRNA	PMID:29341224|PMID:38811393
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of CILP mRNA	PMID:24395379
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CILP mRNA	PMID:30047161
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CILP mRNA	PMID:34492290
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CILP mRNA	PMID:19710929
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CILP mRNA	PMID:25181051|PMID:34947998
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312971	E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A results in increased expression of CILP mRNA	PMID:23019147
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312972	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of CILP mRNA	PMID:30951980|PMID:32156529
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CILP mRNA	PMID:28628672
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA	PMID:25510870
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA	PMID:25510870
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312972	E	RGD:6480464	20241001	CTD	MESH:C543008	bisphenol S results in decreased expression of CILP mRNA	PMID:38908815
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312972	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CILP mRNA	PMID:30951980
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CILP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CILP mRNA	PMID:28628672
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CILP mRNA	PMID:32680482
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CILP mRNA	PMID:35163327
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of CILP mRNA	PMID:18500788
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CILP mRNA	PMID:30917596
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312971	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CILP mRNA	PMID:25812627
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CILP mRNA	PMID:35163327
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CILP mRNA	PMID:27387713
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312971	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CILP mRNA	PMID:25812627
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1312971	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CILP gene	PMID:29154799
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CILP mRNA	PMID:30047161
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312971	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of CILP mRNA	PMID:25047013
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CILP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CILP mRNA	PMID:28628672
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312971	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CILP mRNA	PMID:19371625
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312972	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CILP mRNA	PMID:28973697
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CILP mRNA	PMID:33387578
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312971	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of CILP mRNA	PMID:26690555
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of CILP mRNA	PMID:24690739
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CILP mRNA	PMID:35811015
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA	PMID:34876320
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312971	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CILP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CILP mRNA	PMID:28628672
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CILP mRNA	PMID:30047161
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312972	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of CILP mRNA	PMID:20003209
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:6716	medroxyprogesterone acetate	decreases expression	ISO	RGD:1312971	E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in decreased expression of CILP mRNA	PMID:20843944
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:6925	microcystin-LR	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C057862	cyanoginosin LR results in increased expression of CILP mRNA	PMID:34740672
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312972	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CILP mRNA	PMID:22206623
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312972	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CILP mRNA	PMID:38648751
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of CILP mRNA	PMID:36084822
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA	PMID:34876320
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CILP mRNA	PMID:24780913
1305124	Cilp	cartilage intermediate layer protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CILP mRNA	PMID:30047161
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1312973	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of ATL2 protein	PMID:39638853
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ATL2 mRNA	PMID:38218311
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1312973	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ATL2 mRNA	PMID:38218311
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of ATL2 mRNA]	PMID:19467301
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ATL2 mRNA	PMID:33167477
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ATL2 mRNA	PMID:36331819
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312973	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ATL2 mRNA	PMID:22378314
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312974	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ATL2 mRNA	PMID:30319688
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312973	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ATL2 mRNA	PMID:21632981
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1312973	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of ATL2 protein	PMID:35688186
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312974	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATL2 mRNA	PMID:39241906
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ATL2 mRNA	PMID:39298647
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of ATL2 mRNA	PMID:32145629
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312973	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATL2 mRNA	PMID:37042841
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ATL2 mRNA	PMID:26577399
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATL2 mRNA	PMID:33387578
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATL2 mRNA	PMID:36331819
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of ATL2 mRNA	PMID:33914522
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATL2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATL2 mRNA	PMID:37236586|PMID:37325564
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ATL2 mRNA	PMID:19549813
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ATL2 mRNA	PMID:23649840
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312973	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATL2 mRNA	PMID:39836092
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312973	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ATL2 protein	PMID:35688186
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ATL2 mRNA	PMID:31881176
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312974	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ATL2 protein	PMID:25505154
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312973	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ATL2 mRNA	PMID:23557933
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312974	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ATL2 mRNA	PMID:30912803
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312974	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATL2 mRNA	PMID:24680724
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATL2 mRNA	PMID:21215274|PMID:33387578
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATL2 mRNA	PMID:34747641
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312974	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATL2 mRNA	PMID:15034205
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ATL2 mRNA]	PMID:15034205
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of ATL2 mRNA	PMID:28959563
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATL2 mRNA	PMID:15467011
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATL2 mRNA	PMID:29803840
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:29021	hexane	decreases methylation	EXP		E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of ATL2 promoter	PMID:23740543
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ATL2 mRNA	PMID:25523186
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATL2 mRNA	PMID:38568856
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312973	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATL2 mRNA	PMID:39836092
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of ATL2 mRNA	PMID:29453283
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATL2 mRNA	PMID:22228805
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312974	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATL2 mRNA	PMID:15034205|PMID:20127859|PMID:22228805
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of ATL2 mRNA]	PMID:15034205
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of ATL2 protein	PMID:37955338
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ATL2 mRNA	PMID:25523186
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATL2 mRNA	PMID:15467011
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATL2 mRNA	PMID:19150397|PMID:20382639
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ATL2 mRNA	PMID:24136188
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ATL2 mRNA	PMID:25729387
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ATL2 mRNA	PMID:25729387
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of ATL2 mRNA	PMID:24136188
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312974	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATL2 gene; titanium dioxide results in decreased methylation of ATL2 promoter	PMID:35295148
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ATL2 mRNA	PMID:34492290
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312974	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of ATL2 mRNA	PMID:18648102
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312974	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ATL2 mRNA	PMID:18445702
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1312974	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of ATL2 mRNA	PMID:33914522
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ATL2 protein	PMID:31675489|PMID:33376534|PMID:37567409
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ATL2 mRNA	PMID:25181051|PMID:32145629
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312973	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ATL2 protein	PMID:34186270
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATL2 gene	PMID:28505145
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312973	E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of ATL2 protein]	PMID:33376534
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312973	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ATL2 mRNA	PMID:25979313
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312974	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ATL2 mRNA	PMID:39298647
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312974	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ATL2 mRNA	PMID:38685157
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATL2 mRNA	PMID:17602206
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312974	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ATL2 mRNA	PMID:17361019|PMID:21266533
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATL2 mRNA	PMID:17602206
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATL2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATL2 mRNA	PMID:37236586|PMID:37325564
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ATL2 protein	PMID:26879310
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312974	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ATL2 mRNA	PMID:28903501
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1312973	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ATL2 mRNA	PMID:24449571
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ATL2 mRNA	PMID:17585979
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATL2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ATL2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ATL2 mRNA	PMID:36331819
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312973	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATL2 mRNA	PMID:25979313
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312973	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ATL2 gene	PMID:29154799
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATL2 mRNA	PMID:25562108
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATL2 mRNA	PMID:19770486
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ATL2 mRNA	PMID:28973697
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312974	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ATL2 mRNA	PMID:18502557
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ATL2 mRNA	PMID:24136188
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312974	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATL2 mRNA	PMID:17562736
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:46661	asbestos	affects expression	ISO	RGD:1312973	E	RGD:6480464	20120412	CTD	MESH:D001194	Asbestos affects the expression of ATL2 mRNA	PMID:17297452
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312973	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATL2 mRNA	PMID:39836092
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of ATL2 mRNA	PMID:31675489
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312974	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ATL2 mRNA; Nanotubes, Carbon results in increased expression of ATL2 mRNA	PMID:25620056
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1312973	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of ATL2 protein	PMID:32959892
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ATL2 mRNA	PMID:25729387
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ATL2 mRNA	PMID:25729387
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312973	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ATL2 mRNA	PMID:31758290
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312974	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ATL2 mRNA	PMID:22206623
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312973	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ATL2 protein	PMID:37664457
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ATL2 mRNA	PMID:24136188
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312973	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of ATL2 protein	PMID:39638853
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1312973	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of ATL2 mRNA	PMID:18927307
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312974	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ATL2 mRNA	PMID:23091169
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312974	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ATL2 mRNA	PMID:19270015
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312973	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ATL2 protein	PMID:31675489
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1312973	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ATL2 protein	PMID:31675489
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1312974	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of ATL2 mRNA	PMID:40826991
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312973	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ATL2 protein	PMID:37664457
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312973	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ATL2 mRNA	PMID:29301935
1305125	Atl2	atlastin GTPase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ATL2 mRNA	PMID:28973697
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of KIF21A mRNA	PMID:33045310
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1312975	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of KIF21A mRNA	PMID:11906190
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312976	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of KIF21A mRNA	PMID:30319688
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1312975	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of KIF21A mRNA	PMID:21179406
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KIF21A mRNA	PMID:21632981
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of KIF21A mRNA	PMID:30510588
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312975	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of KIF21A mRNA	PMID:31614463
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of KIF21A mRNA	PMID:26496021
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312975	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol promotes the reaction [ESR2 protein affects the expression of KIF21A mRNA]	PMID:20404318
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312975	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of KIF21A mRNA	PMID:22017230
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of KIF21A mRNA	PMID:26496021
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1312975	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KIF21A protein	PMID:37730182
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of KIF21A mRNA	PMID:33387578
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312975	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KIF21A mRNA	PMID:35301059
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1312976	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of KIF21A mRNA	PMID:15664270
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of KIF21A mRNA	PMID:33354967
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312975	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KIF21A gene; Aflatoxin B1 results in increased methylation of KIF21A intron	PMID:28458013|PMID:30157460
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312976	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of KIF21A mRNA	PMID:32553695
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of KIF21A mRNA	PMID:27106289
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KIF21A mRNA	PMID:22206623
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KIF21A mRNA	PMID:40504410
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312975	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of KIF21A protein	PMID:35688186
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312975	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of KIF21A mRNA	PMID:28903495
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312975	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of KIF21A mRNA	PMID:27594783
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312976	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of KIF21A mRNA	PMID:18930951
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312976	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of KIF21A mRNA	PMID:32186404
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312976	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KIF21A mRNA	PMID:18343893|PMID:21570461
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KIF21A mRNA	PMID:17337447
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312976	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIF21A mRNA	PMID:18691609|PMID:32553695
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF21A mRNA	PMID:17942748
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KIF21A mRNA	PMID:33212167
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KIF21A mRNA	PMID:29803840
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1312975	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of KIF21A protein	PMID:35688186
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of KIF21A mRNA	PMID:29301061
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KIF21A mRNA	PMID:40504410
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KIF21A mRNA	PMID:22228805
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312976	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KIF21A mRNA	PMID:15034205|PMID:20713471
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312975	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KIF21A promoter	PMID:27901495
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of KIF21A mRNA]	PMID:22228805
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312976	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of KIF21A protein	PMID:37955338
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KIF21A mRNA	PMID:19150397
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of KIF21A mRNA	PMID:31745603
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312976	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KIF21A gene; titanium dioxide results in decreased methylation of KIF21A promoter	PMID:35295148
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312976	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KIF21A promoter	PMID:35295148
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of KIF21A mRNA	PMID:30816183
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF21A mRNA	PMID:32145629
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF21A mRNA	PMID:33221593
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312975	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of KIF21A mRNA	PMID:27685785
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of KIF21A mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of KIF21A mRNA	PMID:26496021
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of KIF21A mRNA	PMID:28392331
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of KIF21A gene	PMID:33148267
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312975	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KIF21A mRNA	PMID:37042841
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of KIF21A mRNA	PMID:30589522
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312975	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KIF21A mRNA	PMID:35301059
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1312975	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of KIF21A mRNA	PMID:19320972
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312976	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KIF21A mRNA	PMID:40194260
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of KIF21A mRNA	PMID:27153767
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312975	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KIF21A mRNA	PMID:20106945|PMID:25562108
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312975	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KIF21A mRNA	PMID:38832940
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of KIF21A mRNA	PMID:26272509
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312975	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF21A mRNA	PMID:27188386
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KIF21A mRNA	PMID:33387578
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of KIF21A mRNA	PMID:21061450
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KIF21A mRNA	PMID:40504410
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF21A mRNA	PMID:17942748
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KIF21A mRNA; Nanotubes, Carbon results in decreased expression of KIF21A mRNA	PMID:25554681
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of KIF21A mRNA	PMID:24136188
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KIF21A mRNA	PMID:24136188
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KIF21A protein	PMID:32959892
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of KIF21A mRNA	PMID:24136188
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of KIF21A gene	PMID:33148267
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312976	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of KIF21A mRNA	PMID:22206623
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KIF21A mRNA	PMID:22206623
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312975	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of KIF21A protein	PMID:37664457
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312975	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of KIF21A mRNA	PMID:37199045
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312975	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF21A mRNA	PMID:27188386
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1312976	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of KIF21A mRNA	PMID:18343893
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1312975	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of KIF21A mRNA	PMID:26705709
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of KIF21A mRNA	PMID:38995820
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of KIF21A protein	PMID:28903499
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312975	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of KIF21A protein	PMID:38348393
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312976	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of KIF21A mRNA	PMID:21795629|PMID:30953684
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312975	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of KIF21A protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF21A mRNA	PMID:27188386|PMID:37664457
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1312975	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KIF21A mRNA	PMID:38568856
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of KIF21A mRNA	PMID:21346803
1305126	Kif21a	kinesin family member 21A	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of KIF21A protein	PMID:32519852
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1344635	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TXNL4B mRNA	PMID:38218311
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1344635	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TXNL4B mRNA	PMID:38218311
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TXNL4B mRNA]	PMID:31150632
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552589	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TXNL4B mRNA	PMID:26251327
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1552589	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of TXNL4B promoter	PMID:26251327
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1344635	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TXNL4B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TXNL4B mRNA	PMID:32699268
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TXNL4B gene	PMID:27618143
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344635	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TXNL4B mRNA	PMID:37042841
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1344635	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TXNL4B mRNA	PMID:23649840
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1344635	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TXNL4B mRNA	PMID:28818685
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1344635	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TXNL4B mRNA	PMID:23649840
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1344635	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TXNL4B gene	PMID:27153756
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1344635	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TXNL4B mRNA	PMID:23649840
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1344635	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TXNL4B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TXNL4B mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TXNL4B mRNA	PMID:32699268
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TXNL4B mRNA	PMID:31150632
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TXNL4B mRNA]	PMID:31150632
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1552589	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of TXNL4B mRNA	PMID:35897073
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552589	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TXNL4B mRNA	PMID:28960355
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1344635	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin promotes the reaction [jinfukang results in decreased expression of TXNL4B mRNA]; jinfukang promotes the reaction [Cisplatin results in decreased expression of TXNL4B mRNA]	PMID:27392435
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of TXNL4B gene	PMID:28505145
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1344635	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TXNL4B mRNA	PMID:24768652|PMID:25583101
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552589	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TXNL4B mRNA	PMID:21570461
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1344635	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of TXNL4B mRNA; Rotenone results in decreased expression of TXNL4B protein	PMID:29955902|PMID:33512557|PMID:39603559
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1344635	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TXNL4B mRNA	PMID:28001369
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1344635	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TXNL4B mRNA; aristolochic acid I results in increased expression of TXNL4B protein	PMID:33212167
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1344635	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TXNL4B mRNA	PMID:39709020
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1344635	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TXNL4B mRNA	PMID:32763439
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1344635	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TXNL4B mRNA	PMID:29803840
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344635	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TXNL4B mRNA	PMID:38568856
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TXNL4B mRNA	PMID:30047161
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552589	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TXNL4B promoter alternative form	PMID:35295148
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TXNL4B mRNA	PMID:34492290
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1344635	E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A affects the expression of TXNL4B mRNA	PMID:22574217
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TXNL4B mRNA	PMID:34947998
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TXNL4B mRNA	PMID:25181051
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1552589	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TXNL4B promoter	PMID:27312807
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of TXNL4B gene	PMID:28505145
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552589	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TXNL4B mRNA	PMID:34813904
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552589	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TXNL4B mRNA	PMID:34813904
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1344635	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TXNL4B mRNA	PMID:38568856
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in decreased methylation of TXNL4B gene	PMID:22079235
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1344635	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TXNL4B mRNA	PMID:24449571
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1344635	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TXNL4B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TXNL4B mRNA	PMID:32699268
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:38214	monuron	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C100088	monuron results in increased expression of TXNL4B mRNA	PMID:22584684
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344635	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TXNL4B mRNA	PMID:25979313
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344635	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TXNL4B mRNA	PMID:23179753|PMID:26272509
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344635	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNL4B mRNA	PMID:27188386
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TXNL4B mRNA	PMID:30047161
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1344635	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of TXNL4B promoter	PMID:27989131
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1344635	E	RGD:6480464	20170516	CTD	MESH:C017160	cypermethrin results in increased expression of TXNL4B mRNA	PMID:27704156
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:41308	benzophenone	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C047723	benzophenone results in increased expression of TXNL4B mRNA	PMID:22584684
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:42223	emodin	decreases expression	ISO	RGD:1344635	E	RGD:6480464	20120412	CTD	MESH:D004642	Emodin results in decreased expression of TXNL4B mRNA	PMID:16045814
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TXNL4B mRNA	PMID:33387578
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1344635	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of TXNL4B mRNA	PMID:26690555
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TXNL4B mRNA	PMID:29391264
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1344635	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TXNL4B mRNA	PMID:22079256
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552589	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TXNL4B mRNA; Nanotubes, Carbon results in decreased expression of TXNL4B mRNA	PMID:25620056
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TXNL4B mRNA	PMID:30047161
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of TXNL4B mRNA	PMID:24793618
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1344635	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of TXNL4B mRNA	PMID:31629900
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:6382	Lasiocarpine	decreases expression	ISO	RGD:1344635	E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of TXNL4B mRNA	PMID:40054833
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1344635	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TXNL4B mRNA	PMID:28988120
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D008701	Methapyrilene results in increased expression of TXNL4B mRNA	PMID:22584684
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552589	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TXNL4B mRNA	PMID:22206623
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1344635	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of TXNL4B mRNA	PMID:22079256
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1344635	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TXNL4B mRNA	PMID:22079256
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344635	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNL4B mRNA	PMID:27188386
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344635	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TXNL4B gene]	PMID:28238834
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1344635	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of TXNL4B mRNA	PMID:33512557
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TXNL4B mRNA	PMID:30047161
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344635	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNL4B mRNA	PMID:27188386
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TXNL4B mRNA	PMID:21346803
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1344635	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of TXNL4B mRNA	PMID:34581912
1305127	Txnl4b	thioredoxin-like 4B	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1344635	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TXNL4B mRNA	PMID:38568856
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312979	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of POLG2 mRNA	PMID:33045310
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of POLG2 mRNA]	PMID:31150632
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312978	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of POLG2 mRNA	PMID:22378314
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of POLG2 mRNA	PMID:39241906
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312978	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of POLG2 mRNA	PMID:31059760
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20150609	CTD	MESH:D004958	Estradiol results in decreased expression of POLG2 mRNA	PMID:25575267|PMID:39298647
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of POLG2 mRNA	PMID:33387578
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312978	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of POLG2 intron	PMID:30157460
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312978	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POLG2 mRNA	PMID:19549813
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312979	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of POLG2 mRNA	PMID:19770486
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312978	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of POLG2 intron	PMID:30157460
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POLG2 mRNA	PMID:31150632
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POLG2 mRNA	PMID:31919559
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of POLG2 mRNA]	PMID:31150632
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312978	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POLG2 mRNA	PMID:39836092
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of POLG2 mRNA	PMID:28960355
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of POLG2 mRNA	PMID:31881176
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312978	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of POLG2 mRNA	PMID:23557933
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312978	E	RGD:6480464	20210608	CTD	MESH:D002945	Cisplatin results in increased expression of POLG2 mRNA	PMID:33545341|PMID:38498338
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27974	estriol	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20150609	CTD	MESH:D004964	Estriol results in decreased expression of POLG2 mRNA	PMID:25575267
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312979	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLG2 mRNA	PMID:21570461
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLG2 mRNA	PMID:21215274|PMID:21724226
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLG2 mRNA	PMID:33387578
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLG2 mRNA	PMID:17942748
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312978	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of POLG2 mRNA	PMID:33212167
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312978	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of POLG2 mRNA	PMID:32763439
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312978	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of POLG2 mRNA	PMID:29803840
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1312978	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of POLG2 protein	PMID:35688186
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312978	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLG2 mRNA	PMID:38568856
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312978	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POLG2 mRNA	PMID:39836092
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312978	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of POLG2 mRNA	PMID:22378314
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312978	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of POLG2 intron	PMID:30157460
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312978	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POLG2 promoter	PMID:27901495
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of POLG2 mRNA	PMID:23221170
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312978	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of POLG2 mRNA	PMID:20382639
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312978	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of POLG2 mRNA	PMID:27829220
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:31341	calcium dihydroxide	affects expression	ISO	RGD:1312979	E	RGD:6480464	20190507	CTD	MESH:D002126	Calcium Hydroxide affects the expression of POLG2 mRNA	PMID:30615914
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of POLG2 mRNA	PMID:32479839
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1312978	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of POLG2 mRNA	PMID:31745603
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of POLG2 mRNA	PMID:25729387
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of POLG2 mRNA	PMID:24136188
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312979	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POLG2 promoter	PMID:35295148
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of POLG2 mRNA	PMID:34492290
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:32509	pirinixic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of POLG2 mRNA	PMID:19162173
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of POLG2 mRNA	PMID:17426115
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of POLG2 mRNA	PMID:17785943
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of POLG2 mRNA	PMID:32145629|PMID:34947998
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20150609	CTD	MESH:C006780	bisphenol A results in decreased expression of POLG2 mRNA	PMID:25575267
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20150609	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased expression of POLG2 mRNA	PMID:25575267
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:3423	carmustine	affects response to substance	ISO	RGD:1312978	E	RGD:6480464	20120412	CTD	MESH:D002330	POLG2 mRNA affects the susceptibility to Carmustine	PMID:16365179
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of POLG2 mRNA	PMID:20959002
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of POLG2 mRNA	PMID:17602206
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of POLG2 mRNA	PMID:17602206
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312978	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of POLG2 mRNA	PMID:37042841
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312978	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of POLG2 mRNA	PMID:38568856
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of POLG2 mRNA	PMID:19162173
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312978	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of POLG2 mRNA	PMID:19376846
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of POLG2 mRNA	PMID:23811191
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1312978	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of POLG2 mRNA	PMID:28302478
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of POLG2 mRNA	PMID:17292431
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312978	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of POLG2 mRNA	PMID:23179753
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312978	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of POLG2 mRNA	PMID:29154799
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20150609	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of POLG2 mRNA	PMID:25575267
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of POLG2 mRNA	PMID:33387578
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in decreased expression of POLG2 mRNA	PMID:17585979
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of POLG2 mRNA	PMID:32479839
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312978	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of POLG2 mRNA	PMID:22230336|PMID:31059760
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312978	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of POLG2 mRNA	PMID:31059760
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312978	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POLG2 mRNA	PMID:39836092
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of POLG2 mRNA	PMID:29391264
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of POLG2 mRNA	PMID:17942748
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLG2 mRNA	PMID:17942748
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312978	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of POLG2 mRNA	PMID:27829220
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of POLG2 mRNA; Nanotubes, Carbon results in decreased expression of POLG2 mRNA	PMID:25554681
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of POLG2 mRNA	PMID:19162173
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of POLG2 mRNA	PMID:24793618
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312979	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of POLG2 mRNA	PMID:26377693
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1312978	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of POLG2 mRNA	PMID:31629900
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:63598	levofloxacin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in increased expression of POLG2 mRNA	PMID:24136188
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of POLG2 mRNA	PMID:25729387
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of POLG2 mRNA	PMID:25729387
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1312978	E	RGD:6480464	20130305	CTD	MESH:C047246	POLG2 mRNA affects the susceptibility to temozolomide	PMID:16365179
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312978	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of POLG2 mRNA	PMID:31758290
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of POLG2 mRNA	PMID:22206623
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of POLG2 mRNA	PMID:24136188
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:76004	dimethyl fumarate	increases expression	ISO	RGD:1312979	E	RGD:6480464	20180220	CTD	MESH:C056020	Dimethyl Fumarate results in increased expression of POLG2 mRNA	PMID:27277809
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:76004	dimethyl fumarate	multiple interactions	ISO	RGD:1312979	E	RGD:6480464	20180220	CTD	MESH:C056020	NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of POLG2 mRNA]	PMID:27277809
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:76326	N-nitrosomorpholine	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in decreased expression of POLG2 mRNA	PMID:19716841
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of POLG2 mRNA	PMID:23665939
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of POLG2 mRNA	PMID:19162173
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312979	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of POLG2 mRNA	PMID:39847705
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of POLG2 mRNA	PMID:21278054
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of POLG2 mRNA	PMID:21346803
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1312979	E	RGD:6480464	20120501	CTD	MESH:D013311	Streptozocin affects the expression of POLG2 mRNA	PMID:18583417
1305128	Polg2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of POLG2 mRNA	PMID:21346803
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of MAMDC2 mRNA	PMID:25152437
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MAMDC2 mRNA	PMID:26272509
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA	PMID:27188386
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312981	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MAMDC2 mRNA	PMID:37995155
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in decreased expression of MAMDC2 mRNA	PMID:33227293
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAMDC2 mRNA	PMID:20938992
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAMDC2 mRNA	PMID:30529165
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAMDC2 mRNA	PMID:36331819
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MAMDC2 mRNA	PMID:30165855
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAMDC2 mRNA	PMID:20938992
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of MAMDC2 mRNA	PMID:39245080
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312980	E	RGD:6480464	20130806	CTD	MESH:D011374	Progesterone results in increased expression of MAMDC2 mRNA	PMID:21795739
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of MAMDC2 mRNA	PMID:31525975|PMID:33448797
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:17234	glucose	increases methylation	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased methylation of MAMDC2 gene	PMID:33448797
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAMDC2 mRNA]	PMID:33448797
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MAMDC2 mRNA	PMID:22017230
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MAMDC2 mRNA	PMID:26445464
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of MAMDC2 mRNA	PMID:31525975|PMID:33448797
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:17634	D-glucose	increases methylation	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased methylation of MAMDC2 gene	PMID:33448797
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAMDC2 mRNA]	PMID:33448797
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAMDC2 mRNA	PMID:37325564
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312980	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MAMDC2 intron	PMID:30157460
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in decreased expression of MAMDC2 mRNA	PMID:33026818
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAMDC2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MAMDC2 mRNA	PMID:27106289|PMID:34911549
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MAMDC2 mRNA	PMID:17484886
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MAMDC2 mRNA	PMID:25629700
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAMDC2 mRNA	PMID:20938992
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1312980	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MAMDC2 mRNA	PMID:26272509
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAMDC2 mRNA	PMID:27188386
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of MAMDC2 mRNA	PMID:40618947
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MAMDC2 mRNA	PMID:25583101
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAMDC2 mRNA	PMID:34747641
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MAMDC2 promoter]	PMID:19654925
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312980	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MAMDC2 mRNA	PMID:28001369
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1312980	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of MAMDC2 mRNA	PMID:29803840
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of MAMDC2 mRNA	PMID:34032870|PMID:39719251
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAMDC2 mRNA	PMID:22316170
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312981	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAMDC2 mRNA	PMID:27195522
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312980	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MAMDC2 exon	PMID:27901495
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to MAMDC2 promoter]	PMID:19654925
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MAMDC2 mRNA	PMID:22431001
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MAMDC2 mRNA	PMID:23221170
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1312980	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MAMDC2 mRNA	PMID:20382639
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MAMDC2 mRNA	PMID:26705709
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of MAMDC2 mRNA	PMID:24395379
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1312980	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of MAMDC2 mRNA	PMID:37690743
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of MAMDC2 gene	PMID:31601247
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C008261	lead acetate results in increased expression of MAMDC2 mRNA	PMID:22641619
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MAMDC2 mRNA	PMID:23557971|PMID:27760801
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MAMDC2 mRNA	PMID:34492290
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of MAMDC2 mRNA	PMID:19136022
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of MAMDC2 mRNA	PMID:20813756|PMID:23811191
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MAMDC2 mRNA	PMID:19710929
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MAMDC2 mRNA	PMID:25181051|PMID:30816183
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of MAMDC2 mRNA	PMID:27685785|PMID:31715268
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MAMDC2 mRNA	PMID:32156529
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of MAMDC2 gene	PMID:31601247
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1312980	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MAMDC2 mRNA	PMID:25979313
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312980	E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in increased expression of MAMDC2 mRNA	PMID:25912373
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312981	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of MAMDC2 mRNA	PMID:40203079
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of MAMDC2 mRNA]	PMID:40203079
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312981	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MAMDC2 mRNA	PMID:26377693
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAMDC2 mRNA	PMID:28628672
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAMDC2 mRNA	PMID:28628672
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of MAMDC2 mRNA	PMID:24535843
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of MAMDC2 mRNA	PMID:24535843
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of MAMDC2 mRNA	PMID:32680482
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of MAMDC2 mRNA	PMID:30589522
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of MAMDC2 mRNA	PMID:30723492
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAMDC2 mRNA	PMID:37325564
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312981	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MAMDC2 mRNA	PMID:40194260
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MAMDC2 mRNA	PMID:40419075
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAMDC2 mRNA	PMID:36331819
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312980	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAMDC2 mRNA	PMID:25979313
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of MAMDC2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312980	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of MAMDC2 mRNA	PMID:23179753|PMID:27188386
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA	PMID:27188386
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAMDC2 mRNA	PMID:28628672
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of MAMDC2 mRNA	PMID:31525975|PMID:33448797
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	increases methylation	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased methylation of MAMDC2 gene	PMID:33448797
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAMDC2 mRNA]	PMID:33448797
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1312980	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MAMDC2 mRNA	PMID:38832940
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1312980	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MAMDC2 mRNA	PMID:27188386
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MAMDC2 mRNA	PMID:24935251|PMID:26272509
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA	PMID:27188386
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAMDC2 mRNA	PMID:17562736
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1312980	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of MAMDC2 mRNA	PMID:16510598
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MAMDC2 mRNA	PMID:29279043
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of MAMDC2 mRNA	PMID:31838189
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of MAMDC2 mRNA	PMID:17351261|PMID:17557909
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAMDC2 mRNA	PMID:28628672
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MAMDC2 mRNA	PMID:26705709
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MAMDC2 mRNA; Nanotubes, Carbon results in decreased expression of MAMDC2 mRNA	PMID:25554681
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAMDC2 mRNA]	PMID:33448797
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MAMDC2 mRNA	PMID:19042947
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of MAMDC2 mRNA	PMID:37269647
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1312980	E	RGD:6480464	20130806	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MAMDC2 mRNA	PMID:22079614
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1312980	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MAMDC2 mRNA	PMID:31758290
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1312980	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MAMDC2 mRNA	PMID:25912373
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:753051	incobotulinumtoxina	affects expression	ISO	RGD:1312980	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA affects the expression of MAMDC2 mRNA	PMID:29522793
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAMDC2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA	PMID:27188386
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MAMDC2 gene]	PMID:28238834
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312981	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of MAMDC2 mRNA	PMID:19136022|PMID:23091169
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of MAMDC2 mRNA	PMID:19482888
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of MAMDC2 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of MAMDC2 mRNA]	PMID:19482888|PMID:24535843
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of MAMDC2 mRNA	PMID:26705709
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312981	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MAMDC2 mRNA	PMID:39847705
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MAMDC2 mRNA	PMID:24780913
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312980	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAMDC2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA	PMID:27188386
1305129	Mamdc2	MAM domain containing 2	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1312980	E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon results in decreased expression of MAMDC2 mRNA	PMID:26705709
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZKSCAN6 mRNA	PMID:36331819
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1312982	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ZNF18 mRNA	PMID:29581250
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312983	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZKSCAN6 mRNA	PMID:39241906
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312982	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ZNF18 mRNA	PMID:33359661
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312982	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZNF18 mRNA	PMID:28818685
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZKSCAN6 mRNA	PMID:36331819
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312982	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF18 mRNA	PMID:19549813
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1312982	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF18 mRNA	PMID:27188386
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312982	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ZNF18 mRNA	PMID:27392435
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312982	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ZNF18 mRNA	PMID:27392435
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312983	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZKSCAN6 mRNA	PMID:21570461
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312983	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZKSCAN6 mRNA	PMID:24058054
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZKSCAN6 mRNA	PMID:17942748
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ZFP18 mRNA	PMID:28959563
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312982	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF18 mRNA	PMID:29803840
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312982	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF18 mRNA	PMID:38568856
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312983	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZKSCAN6 promoter	PMID:35295148
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312983	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ZKSCAN6 promoter	PMID:27334623
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP18 mRNA	PMID:34947998
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312982	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF18 mRNA	PMID:37042841
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312982	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF18 mRNA	PMID:38568856
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312982	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ZNF18 mRNA	PMID:36326898
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ZKSCAN6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ZKSCAN6 mRNA]	PMID:17585979
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:39178	clothianidin	decreases expression	ISO	RGD:1312982	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in decreased expression of ZNF18 mRNA	PMID:31626844
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZKSCAN6 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZKSCAN6 mRNA	PMID:36331819
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312983	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ZKSCAN6 mRNA	PMID:17963808
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312982	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF18 mRNA	PMID:23179753
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312982	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in decreased expression of ZNF18 mRNA	PMID:17183730
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312983	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZKSCAN6 mRNA	PMID:17562736
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ZKSCAN6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ZKSCAN6 mRNA]	PMID:17585979
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312983	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ZKSCAN6 mRNA	PMID:17942748
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZKSCAN6 mRNA	PMID:17942748
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate affects the reaction [MTF1 affects the expression of ZKSCAN6 mRNA]	PMID:16221973
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ZKSCAN6 mRNA	PMID:35964746
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of ZFP18 mRNA	PMID:24793618
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1312982	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in decreased expression of ZNF18 mRNA	PMID:17183730
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1312982	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ZNF18 mRNA	PMID:36318118
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312982	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF18 protein	PMID:31285264
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312982	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF18 mRNA	PMID:27188386
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312982	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF18 gene]	PMID:28238834
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312983	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ZKSCAN6 mRNA	PMID:39847705
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312982	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF18 mRNA	PMID:27188386
1305130	Zfp18	zinc finger protein 18	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZNF18 mRNA	PMID:21346803
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1605377	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of KLHDC8A mRNA	PMID:26272509
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA	PMID:27188386
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605377	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of KLHDC8A mRNA	PMID:21934132
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605377	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of KLHDC8A mRNA	PMID:23724009
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1332094	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLHDC8A mRNA	PMID:30529165
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1605377	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of KLHDC8A mRNA	PMID:26079696
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332094	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of KLHDC8A mRNA	PMID:39298647
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of KLHDC8A mRNA	PMID:30165855
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1605377	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of KLHDC8A mRNA	PMID:26079696
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332094	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of KLHDC8A mRNA	PMID:37992649
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1605377	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of KLHDC8A mRNA	PMID:36314267
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332094	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of KLHDC8A mRNA	PMID:37992649
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332094	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KLHDC8A mRNA	PMID:34319233
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1605377	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KLHDC8A mRNA	PMID:31163220
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KLHDC8A mRNA	PMID:33387578
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332094	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KLHDC8A mRNA	PMID:36331819
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLHDC8A mRNA	PMID:35301059
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of KLHDC8A mRNA	PMID:23630614
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605377	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KLHDC8A gene	PMID:27153756
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1332094	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of KLHDC8A mRNA	PMID:34911549
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1605377	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KLHDC8A gene	PMID:25304211
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA	PMID:27188386
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of KLHDC8A mRNA	PMID:31881176
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KLHDC8A mRNA	PMID:23557933
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332094	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLHDC8A mRNA	PMID:28922406
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KLHDC8A mRNA	PMID:32109520
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1332094	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KLHDC8A mRNA	PMID:19770486
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605377	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KLHDC8A mRNA	PMID:28001369
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1605377	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KLHDC8A mRNA	PMID:34089799
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1605377	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of KLHDC8A mRNA	PMID:26272509
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA	PMID:27188386
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1332094	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of KLHDC8A mRNA	PMID:39631538
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332094	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of KLHDC8A mRNA	PMID:37992649
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605377	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of KLHDC8A mRNA	PMID:37939567
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605377	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KLHDC8A 5' UTR; Benzo(a)pyrene results in increased methylation of KLHDC8A promoter	PMID:27901495
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1605377	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of KLHDC8A mRNA	PMID:21461292
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of KLHDC8A mRNA	PMID:30047161
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1332094	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of KLHDC8A mRNA	PMID:27760801
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332094	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KLHDC8A gene	PMID:35295148
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of KLHDC8A mRNA	PMID:23411599|PMID:34492290
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of KLHDC8A mRNA	PMID:34947998
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KLHDC8A mRNA	PMID:25181051
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KLHDC8A gene	PMID:28505145
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1332094	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of KLHDC8A mRNA	PMID:20713471
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332094	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of KLHDC8A mRNA	PMID:30951980
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332094	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of KLHDC8A mRNA	PMID:39298647|PMID:40203079
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KLHDC8A mRNA	PMID:21266533
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:34911	permethrin	affects expression	ISO	RGD:1605377	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin affects the expression of KLHDC8A mRNA	PMID:37047231
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of KLHDC8A mRNA	PMID:30589522
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KLHDC8A mRNA	PMID:35163327
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of KLHDC8A mRNA	PMID:30723492
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1605377	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KLHDC8A mRNA	PMID:38568856
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLHDC8A mRNA	PMID:35301059
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332094	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KLHDC8A mRNA	PMID:36331819
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605377	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of KLHDC8A mRNA	PMID:23179753|PMID:26272509
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605377	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of KLHDC8A mRNA	PMID:23179753
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA	PMID:27188386
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of KLHDC8A mRNA	PMID:30047161
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1332094	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of KLHDC8A mRNA	PMID:40633821
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332094	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of KLHDC8A mRNA	PMID:37992649
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1605377	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of KLHDC8A mRNA	PMID:24935251|PMID:26272509
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA	PMID:27188386
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KLHDC8A mRNA	PMID:33387578
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1605377	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KLHDC8A gene	PMID:25304211
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of KLHDC8A mRNA	PMID:29391264
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1605377	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of KLHDC8A mRNA	PMID:26272509
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA	PMID:27188386
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1605377	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of KLHDC8A mRNA	PMID:21461292
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of KLHDC8A mRNA	PMID:28801915
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1605377	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of KLHDC8A mRNA	PMID:24810058
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1332094	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of KLHDC8A mRNA	PMID:20003209
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332094	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KLHDC8A mRNA	PMID:22206623
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1605377	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of KLHDC8A mRNA	PMID:36318118
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in increased expression of KLHDC8A mRNA	PMID:26720608
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA	PMID:27188386
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KLHDC8A gene]	PMID:28238834
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of KLHDC8A mRNA	PMID:30047161
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1605377	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of KLHDC8A mRNA	PMID:26079696
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of KLHDC8A mRNA	PMID:24780913
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605377	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA	PMID:27188386
1305132	Klhdc8a	kelch domain containing 8A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of KLHDC8A mRNA	PMID:22570695
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of MPHOSPH8 mRNA	PMID:21551480
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1603305	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of MPHOSPH8 mRNA	PMID:35967413
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1332275	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of MPHOSPH8 mRNA	PMID:40945087
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1603305	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of MPHOSPH8 mRNA	PMID:19167446
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332275	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MPHOSPH8 mRNA	PMID:33754040
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1603305	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MPHOSPH8 protein	PMID:37730182
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MPHOSPH8 mRNA	PMID:33387578
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1332275	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MPHOSPH8 mRNA	PMID:19770486
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1603305	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MPHOSPH8 mRNA	PMID:23649840
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1603305	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of MPHOSPH8 mRNA	PMID:28534445
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MPHOSPH8 mRNA	PMID:30690589
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:27385	tetrachloromethane	increases methylation	EXP		E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in increased methylation of MPHOSPH8 promoter	PMID:30690589
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332275	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MPHOSPH8 mRNA	PMID:22206623
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603305	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MPHOSPH8 mRNA	PMID:39836092
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1603305	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MPHOSPH8 protein	PMID:35688186
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603305	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MPHOSPH8 mRNA	PMID:23557933
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1603305	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MPHOSPH8 mRNA	PMID:22574217
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MPHOSPH8 mRNA	PMID:21215274|PMID:33387578
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1332275	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MPHOSPH8 mRNA	PMID:19770486
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of MPHOSPH8 mRNA	PMID:19013527
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1603305	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MPHOSPH8 mRNA	PMID:28001369
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1603305	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MPHOSPH8 mRNA	PMID:28001369
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1603305	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MPHOSPH8 mRNA	PMID:27188386
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1603305	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of MPHOSPH8 protein	PMID:35688186
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1332275	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of MPHOSPH8 mRNA	PMID:36209798
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603305	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MPHOSPH8 mRNA	PMID:38568856
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603305	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MPHOSPH8 mRNA	PMID:39836092
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1603305	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MPHOSPH8 mRNA	PMID:22316170
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1603305	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MPHOSPH8 mRNA	PMID:19150397
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332275	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MPHOSPH8 gene	PMID:35295148
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1332275	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MPHOSPH8 mRNA	PMID:19710929
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MPHOSPH8 mRNA	PMID:34947998
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332275	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MPHOSPH8 mRNA	PMID:26063408
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603305	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MPHOSPH8 mRNA	PMID:25047013
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MPHOSPH8 mRNA	PMID:25181051
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603305	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MPHOSPH8 mRNA	PMID:37042841
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of MPHOSPH8 mRNA	PMID:19162173
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:38561	fluvastatin	multiple interactions	ISO	RGD:1603305	E	RGD:6480464	20120412	CTD	MESH:C065180	[zoledronic acid co-treated with fluvastatin] results in increased expression of MPHOSPH8 mRNA	PMID:16996129
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of MPHOSPH8 mRNA	PMID:23125180
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603305	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MPHOSPH8 mRNA	PMID:23179753|PMID:25979313
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of MPHOSPH8 mRNA	PMID:41580965
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1603305	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MPHOSPH8 mRNA	PMID:21420995
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:46557	zoledronic acid	multiple interactions	ISO	RGD:1603305	E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with fluvastatin] results in increased expression of MPHOSPH8 mRNA	PMID:16996129
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1332275	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MPHOSPH8 mRNA	PMID:29279043
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603305	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MPHOSPH8 mRNA	PMID:39836092
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of MPHOSPH8 mRNA	PMID:19162173
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MPHOSPH8 mRNA	PMID:24136188
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603305	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MPHOSPH8 protein	PMID:32959892
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of MPHOSPH8 mRNA	PMID:24136188
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1603305	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MPHOSPH8 mRNA	PMID:15336504
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332275	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MPHOSPH8 mRNA	PMID:22206623
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603305	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MPHOSPH8 mRNA	PMID:27188386
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1603305	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of MPHOSPH8 mRNA	PMID:19095052
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MPHOSPH8 mRNA	PMID:25825206
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603305	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MPHOSPH8 mRNA	PMID:27188386
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1332275	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of MPHOSPH8 mRNA	PMID:28973697
1305133	Mphosph8	M-phase phosphoprotein 8	gene	CHEBI:9763	trovafloxacin	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in increased expression of MPHOSPH8 mRNA	PMID:24136188
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:2308242	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of PAKAP mRNA	PMID:33045310
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PAKAP mRNA]	PMID:31150632
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1603446	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of PALM2AKAP2 protein	PMID:36641056
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D014212	Tretinoin results in decreased expression of PALM2AKAP2 mRNA	PMID:15498508|PMID:33167477
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D014212	Tretinoin results in decreased expression of PAKAP mRNA	PMID:16604517
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in increased expression of PAKAP mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of PAKAP mRNA	PMID:30951980
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of PALM2AKAP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of PALM2AKAP2 mRNA	PMID:32699268
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20240109	CTD	MESH:D001280	Atrazine affects the methylation of PAKAP	PMID:28931070
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PALM2AKAP2 mRNA	PMID:35811015
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D014260	Triclosan results in decreased expression of PALM2AKAP2 mRNA	PMID:30510588
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D004958	Estradiol results in decreased expression of PAKAP mRNA	PMID:20068009|PMID:32145629
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D004958	Estradiol results in decreased expression of PAKAP mRNA	PMID:19484750
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PALM2AKAP2 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of PALM2AKAP2 mRNA	PMID:20823114|PMID:30165855
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PAKAP mRNA	PMID:33387578
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PAKAP mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PAKAP mRNA	PMID:37992649
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PAKAP mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PAKAP mRNA	PMID:37992649
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1603446	E	RGD:6480464	20191008	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PALM2AKAP2 mRNA	PMID:31163220
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20240109	CTD	MESH:D003471	[Cuprizone co-treated with Clozapine] results in decreased expression of PALM2AKAP2 protein	PMID:34122009
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1603446	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PALM2AKAP2 protein	PMID:37730182
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D005839	Gentamicins results in decreased expression of PAKAP mRNA	PMID:22061828|PMID:33387578
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D005839	Gentamicins results in increased expression of PAKAP mRNA	PMID:33387578
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1603446	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PALM2AKAP2 intron	PMID:30157460
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PAKAP mRNA	PMID:37236586
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PALM2AKAP2 protein	PMID:23301498
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PALM2AKAP2 protein	PMID:20106945
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PAKAP mRNA	PMID:19770486
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PALM2AKAP2; Aflatoxin B1 results in decreased methylation of PALM2AKAP2 gene	PMID:27153756
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of PALM2AKAP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of PALM2AKAP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of PALM2AKAP2 mRNA	PMID:32699268
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D000661	Amphetamine results in decreased expression of PAKAP mRNA	PMID:30779732
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PALM2AKAP2 mRNA	PMID:18593933
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PAKAP mRNA	PMID:31150632
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PAKAP mRNA]	PMID:31150632
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20240109	CTD	MESH:D005492	Folic Acid results in decreased expression of PAKAP mRNA	PMID:25629700
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D001151	Arsenic affects the methylation of PALM2AKAP2	PMID:25304211
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PAKAP mRNA	PMID:40504410
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D012643	Selenium results in increased expression of PALM2AKAP2 mRNA	PMID:19244175
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PALM2AKAP2 mRNA	PMID:26272509
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1603446	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PALM2AKAP2 protein	PMID:35688186
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1603446	E	RGD:6480464	20260804	CTD	MESH:C010974	Glyphosate results in increased expression of PALM2AKAP2 mRNA	PMID:40865780
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:2308242	E	RGD:6480464	20240109	CTD	MESH:C024565	ethylene dichloride affects the expression of PAKAP mRNA	PMID:28960355
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20240109	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PAKAP mRNA	PMID:28960355
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C030686	acetamide results in decreased expression of PAKAP mRNA	PMID:31881176
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D007854	Lead affects the expression of PALM2AKAP2 mRNA	PMID:28903495
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D002945	Cisplatin results in decreased expression of PALM2AKAP2 mRNA	PMID:19561079|PMID:27392435
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PALM2AKAP2 mRNA	PMID:27392435
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PAKAP mRNA	PMID:34747641
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PAKAP mRNA	PMID:21570461
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PAKAP mRNA	PMID:32109520|PMID:33387578
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PAKAP mRNA	PMID:19770486|PMID:25270620
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PAKAP mRNA	PMID:17942748
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PALM2AKAP2 mRNA	PMID:28001369
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D020106	Acrylamide results in decreased expression of PAKAP mRNA	PMID:28959563
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PAKAP mRNA	PMID:27862939
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20260707	CTD	MESH:D005632	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PAKAP mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PAKAP mRNA	PMID:37992649
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1603446	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PALM2AKAP2 protein	PMID:35688186
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20260707	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PAKAP mRNA]	PMID:37992649
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:2308242	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of PAKAP mRNA	PMID:36209798
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PAKAP mRNA	PMID:40504410
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PALM2AKAP2 intron	PMID:30157460
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PALM2AKAP2 mRNA	PMID:20106945|PMID:22178795
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PAKAP mRNA	PMID:19770486
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:2308242	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PAKAP mRNA	PMID:32417428
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603446	E	RGD:6480464	20240109	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PALM2AKAP2 3' UTR	PMID:27901495
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PALM2AKAP2 mRNA]; arsenite inhibits the reaction [G3BP1 protein binds to PALM2AKAP2 protein]	PMID:32406909
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PALM2AKAP2 mRNA	PMID:18593933
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D012834	Silver results in increased expression of PALM2AKAP2 mRNA	PMID:28959546
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PALM2AKAP2 mRNA	PMID:25895662
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PAKAP mRNA	PMID:23221170|PMID:29203145
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PALM2AKAP2 mRNA	PMID:20018196
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PALM2AKAP2 mRNA	PMID:20458559
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1603446	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of PALM2AKAP2 mRNA	PMID:37690743
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PALM2AKAP2 gene; [bisphenol S co-treated with Fulvestrant] results in increased methylation of PALM2AKAP2 gene	PMID:31601247
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:32181	tamibarotene	affects expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:C061133	tamibarotene affects the expression of PALM2AKAP2 mRNA	PMID:15498508
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:C009495	titanium dioxide affects the expression of PAKAP mRNA	PMID:23557971
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D013853	Thioacetamide affects the expression of PAKAP mRNA	PMID:34492290
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D013853	Thioacetamide results in increased expression of PAKAP mRNA	PMID:34492290
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:C006253	pirinixic acid results in decreased expression of PAKAP mRNA	PMID:25270620
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:C006253	pirinixic acid results in increased expression of PAKAP mRNA	PMID:23811191
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C069837	fullerene C60 results in increased expression of PAKAP mRNA	PMID:19167457
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:2308242	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PAKAP mRNA	PMID:30951980
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C006780	bisphenol A results in decreased expression of PAKAP mRNA	PMID:30816183|PMID:32145629|PMID:34947998
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C006780	bisphenol A results in increased expression of PAKAP mRNA	PMID:25181051|PMID:27178563
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1603446	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of PALM2AKAP2 protein	PMID:34186270|PMID:37567409
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2308242	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of PAKAP mRNA	PMID:30951980
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PALM2AKAP2 gene	PMID:31601247
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D024502	Vitamin E results in decreased expression of PALM2AKAP2 mRNA	PMID:19244175
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D024502	Vitamin E results in increased expression of PALM2AKAP2 mRNA	PMID:19244175
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:2308242	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of PAKAP mRNA	PMID:30951980
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1603446	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of PALM2AKAP2 gene	PMID:31601247
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1603446	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PALM2AKAP2 protein	PMID:34186270
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:2308242	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PAKAP mRNA	PMID:30951980|PMID:39298647
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of PALM2AKAP2 gene	PMID:31601247
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with LIF protein] results in decreased expression of PAKAP mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of PAKAP mRNA	PMID:30951980
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PALM2AKAP2 intron	PMID:30157460
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34575	bisphenol F	affects expression	ISO	RGD:2308242	E	RGD:6480464	20240109	CTD	MESH:C008745	bisphenol F affects the expression of PAKAP mRNA	PMID:30951980
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1603446	E	RGD:6480464	20240109	CTD	MESH:C008745	bisphenol F results in increased expression of PALM2AKAP2 protein	PMID:34186270
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:2308242	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PAKAP mRNA	PMID:30951980
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PALM2AKAP2 mRNA	PMID:28628672
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in increased expression of PAKAP mRNA	PMID:30951980
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1603446	E	RGD:6480464	20240109	CTD	MESH:C492482	bisphenol B results in increased expression of PALM2AKAP2 protein	PMID:34186270
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:2308242	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of PAKAP intron	PMID:28392331
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PAKAP mRNA	PMID:21266533
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PALM2AKAP2 mRNA	PMID:28628672
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34967	rimonabant	affects expression	ISO	RGD:2308242	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant affects the expression of PAKAP mRNA	PMID:19030233
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of PAKAP mRNA]	PMID:19030233
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of PAKAP mRNA	PMID:30589522
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603446	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PALM2AKAP2 mRNA	PMID:38568856
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PAKAP mRNA	PMID:37236586
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PALM2AKAP2 mRNA	PMID:19320972
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of PALM2AKAP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of PALM2AKAP2 mRNA	PMID:32699268
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D012643	Selenium results in increased expression of PALM2AKAP2 mRNA	PMID:19244175
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:3766	clozapine	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20240109	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in decreased expression of PALM2AKAP2 protein	PMID:34122009
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1603446	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PALM2AKAP2 mRNA	PMID:40419075
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D002737	Chloroprene results in increased expression of PAKAP mRNA	PMID:23125180
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PALM2AKAP2; Valproic Acid results in decreased methylation of PALM2AKAP2 gene	PMID:29154799
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D014635	Valproic Acid results in increased expression of PALM2AKAP2 mRNA	PMID:19101580|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D014635	Valproic Acid results in increased methylation of PALM2AKAP2	PMID:29154799
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALM2AKAP2 mRNA	PMID:27188386
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D003520	Cyclophosphamide results in increased expression of PALM2AKAP2 mRNA	PMID:17403535
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D016572	Cyclosporine results in decreased expression of PALM2AKAP2 mRNA	PMID:20106945
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D016572	Cyclosporine results in decreased expression of PAKAP mRNA	PMID:19770486
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D016572	Cyclosporine results in increased expression of PALM2AKAP2 mRNA	PMID:25562108
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D003907	Dexamethasone results in increased expression of PALM2AKAP2 mRNA	PMID:12782123
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PALM2AKAP2 mRNA	PMID:28628672
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D017313	Fenretinide results in increased expression of PAKAP mRNA	PMID:28973697
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PAKAP mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PAKAP mRNA	PMID:37992649
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:C111237	Vorinostat results in increased expression of PALM2AKAP2 mRNA	PMID:18769122
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:C012589	trichostatin A results in increased expression of PALM2AKAP2 mRNA	PMID:24935251|PMID:26272509
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALM2AKAP2 mRNA	PMID:27188386
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen affects the expression of PAKAP mRNA	PMID:17562736
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D000082	Acetaminophen results in decreased expression of PAKAP mRNA	PMID:33387578
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D000082	Acetaminophen results in decreased expression of PALM2AKAP2 mRNA	PMID:21420995
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PALM2AKAP2 mRNA	PMID:35811015
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PALM2AKAP2 mRNA	PMID:18687144
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D001151	Arsenic affects the methylation of PALM2AKAP2	PMID:25304211
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PAKAP mRNA	PMID:40504410
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D004726	Endosulfan results in decreased expression of PAKAP mRNA	PMID:29391264
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PAKAP mRNA	PMID:17942748
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PALM2AKAP2 mRNA	PMID:28628672
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PALM2AKAP2 mRNA	PMID:20458559
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PALM2AKAP2 mRNA	PMID:20823114
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C017690	fenvalerate results in increased expression of PAKAP mRNA	PMID:30307764
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PAKAP protein	PMID:21135415
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PAKAP mRNA; Nanotubes, Carbon results in decreased expression of PAKAP mRNA	PMID:25554681
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C082360	fipronil results in increased expression of PAKAP mRNA	PMID:23962444
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D008713	Methimazole results in increased expression of PAKAP mRNA	PMID:22504374
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D005485	Flutamide results in decreased expression of PAKAP mRNA	PMID:24793618
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:C017096	n-butoxyethanol results in increased expression of PAKAP mRNA	PMID:19812364
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:63959	celastrol	decreases expression	ISO	RGD:1603446	E	RGD:6480464	20250311	CTD	MESH:C050414	celastrol results in decreased expression of PALM2AKAP2 mRNA	PMID:39181414
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:C045463	Leflunomide results in increased expression of PALM2AKAP2 mRNA	PMID:28988120
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PALM2AKAP2 mRNA	PMID:22079614
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:64227	ciglitazone	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PALM2AKAP2 mRNA	PMID:16197558
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PALM2AKAP2 mRNA	PMID:20823114
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:D008701	Methapyrilene results in increased methylation of PALM2AKAP2 intron	PMID:30157460
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1603446	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PALM2AKAP2 protein	PMID:34186270
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:2308242	E	RGD:6480464	20240109	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of PAKAP mRNA	PMID:22206623
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:77012	methylseleninic acid	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:C008493	methylselenic acid results in increased expression of PALM2AKAP2 mRNA	PMID:18548127
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1603446	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of PALM2AKAP2 mRNA	PMID:34995734
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALM2AKAP2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALM2AKAP2 mRNA	PMID:27188386
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PALM2AKAP2 gene]; CGP 52608 promotes the reaction [RORA protein binds to PALM2AKAP2]	PMID:28238834
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:2308242	E	RGD:6480464	20191008	CTD	MESH:D010634	Phenobarbital affects the expression of PAKAP mRNA	PMID:23091169
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:2308242	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PAKAP mRNA	PMID:31388691
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PAKAP mRNA	PMID:27291303
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C013418	bromfenacoum results in decreased expression of PAKAP protein	PMID:28903499
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C412303	triticonazole results in decreased expression of PAKAP mRNA	PMID:36084822
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D011441	Propylthiouracil results in increased expression of PAKAP mRNA	PMID:22504374
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALM2AKAP2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALM2AKAP2 mRNA	PMID:27188386
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1603446	E	RGD:6480464	20190528	CTD	MESH:D012834	Silver results in increased expression of PALM2AKAP2 mRNA	PMID:28959546
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D012999	Soman results in increased expression of PAKAP mRNA	PMID:19281266
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1603446	E	RGD:6480464	20190702	CTD	MESH:C004648	testosterone enanthate affects the expression of PALM2AKAP2 mRNA	PMID:17440010
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1603446	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PALM2AKAP2 mRNA	PMID:38568856
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C025643	vinclozolin affects the expression of PAKAP	PMID:19015723
1305135	Palm2akap2	PALM2 and AKAP2 fusion	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C025643	vinclozolin results in decreased expression of PAKAP mRNA	PMID:23034163
1305137	Med25	mediator complex subunit 25	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1347126	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MED25 mRNA	PMID:38218311
1305137	Med25	mediator complex subunit 25	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553314	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MED25 mRNA	PMID:20938992
1305137	Med25	mediator complex subunit 25	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1553314	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MED25 mRNA	PMID:30319688
1305137	Med25	mediator complex subunit 25	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1553314	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of MED25 mRNA	PMID:29018328
1305137	Med25	mediator complex subunit 25	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553314	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MED25 mRNA	PMID:39241906
1305137	Med25	mediator complex subunit 25	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553314	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MED25 mRNA	PMID:39298647
1305137	Med25	mediator complex subunit 25	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1347126	E	RGD:6480464	20161025	CTD	MESH:D004958	[ESR1 protein co-treated with MED25 protein co-treated with Estradiol] results in increased activity of CYP2C9 protein; [ESR1 protein co-treated with MED25 protein co-treated with Estradiol] results in increased expression of CYP2C9 mRNA; Estradiol promotes the reaction [MED25 protein binds to ESR1 protein]	PMID:27273787
1305137	Med25	mediator complex subunit 25	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553314	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MED25 mRNA	PMID:20938992
1305137	Med25	mediator complex subunit 25	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1347126	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MED25 mRNA	PMID:37042841
1305137	Med25	mediator complex subunit 25	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1553314	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of MED25 mRNA	PMID:24067728
1305137	Med25	mediator complex subunit 25	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1347126	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MED25 mRNA	PMID:35430440
1305137	Med25	mediator complex subunit 25	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553314	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MED25 mRNA	PMID:20938992
1305137	Med25	mediator complex subunit 25	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1347126	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MED25 mRNA	PMID:23557933
1305137	Med25	mediator complex subunit 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553314	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MED25 mRNA	PMID:21570461
1305137	Med25	mediator complex subunit 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MED25 mRNA	PMID:33387578
1305137	Med25	mediator complex subunit 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553314	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MED25 mRNA	PMID:17942748
1305137	Med25	mediator complex subunit 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553314	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MED25 mRNA	PMID:17942748
1305137	Med25	mediator complex subunit 25	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1347126	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of MED25 mRNA	PMID:20971185
1305137	Med25	mediator complex subunit 25	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347126	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MED25 mRNA	PMID:29803840
1305137	Med25	mediator complex subunit 25	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1347126	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MED25 promoter	PMID:27901495
1305137	Med25	mediator complex subunit 25	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1347126	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of MED25 mRNA	PMID:20971185
1305137	Med25	mediator complex subunit 25	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1347126	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of MED25 mRNA	PMID:34408198
1305137	Med25	mediator complex subunit 25	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1347126	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of MED25 mRNA	PMID:38568856
1305137	Med25	mediator complex subunit 25	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553314	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MED25 gene; titanium dioxide results in decreased methylation of MED25 promoter alternative form	PMID:35295148
1305137	Med25	mediator complex subunit 25	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of MED25 mRNA	PMID:32145629
1305137	Med25	mediator complex subunit 25	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MED25 mRNA	PMID:25181051
1305137	Med25	mediator complex subunit 25	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MED25 mRNA	PMID:36041667
1305137	Med25	mediator complex subunit 25	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347126	E	RGD:6480464	20161025	CTD	MESH:C006780	[ESR1 protein co-treated with MED25 protein co-treated with bisphenol A] results in increased activity of CYP2C9 protein; [ESR1 protein co-treated with MED25 protein co-treated with bisphenol A] results in increased expression of CYP2C9 mRNA; bisphenol A promotes the reaction [MED25 protein binds to ESR1 protein]	PMID:27273787
1305137	Med25	mediator complex subunit 25	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553314	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MED25 mRNA	PMID:39298647
1305137	Med25	mediator complex subunit 25	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MED25 mRNA	PMID:36041667
1305137	Med25	mediator complex subunit 25	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MED25 mRNA	PMID:36041667
1305137	Med25	mediator complex subunit 25	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553314	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MED25 mRNA	PMID:37019170
1305137	Med25	mediator complex subunit 25	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347126	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MED25 mRNA	PMID:37042841
1305137	Med25	mediator complex subunit 25	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347126	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MED25 mRNA	PMID:38568856
1305137	Med25	mediator complex subunit 25	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1347126	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MED25 mRNA	PMID:38382870
1305137	Med25	mediator complex subunit 25	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1347126	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MED25 mRNA	PMID:28302478
1305137	Med25	mediator complex subunit 25	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1347126	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MED25 mRNA	PMID:21420995
1305137	Med25	mediator complex subunit 25	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1553314	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MED25 mRNA	PMID:29279043
1305137	Med25	mediator complex subunit 25	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553314	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MED25 mRNA	PMID:35436446
1305137	Med25	mediator complex subunit 25	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553314	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MED25 mRNA	PMID:17942748
1305137	Med25	mediator complex subunit 25	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553314	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MED25 mRNA	PMID:17942748
1305137	Med25	mediator complex subunit 25	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of MED25 mRNA	PMID:34044035
1305137	Med25	mediator complex subunit 25	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1347126	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MED25 mRNA	PMID:28988120
1305137	Med25	mediator complex subunit 25	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1553314	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of MED25 mRNA	PMID:22206623
1305137	Med25	mediator complex subunit 25	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1347126	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MED25 protein	PMID:31285264
1305137	Med25	mediator complex subunit 25	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1347126	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MED25 gene]	PMID:28238834
1305137	Med25	mediator complex subunit 25	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1347126	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MED25 mRNA	PMID:38568856
1305137	Med25	mediator complex subunit 25	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1347126	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MED25 mRNA	PMID:27188386
1305137	Med25	mediator complex subunit 25	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MED25 mRNA	PMID:23034163
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1605912	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SLC61A1 mRNA	PMID:22378314
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312995	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLC61A1 mRNA	PMID:39241906
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1605912	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of SLC61A1 mRNA	PMID:22574217
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605912	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC61A1 mRNA	PMID:37042841
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1605912	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of SLC61A1 mRNA	PMID:19162166
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1605912	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC61A1 mRNA	PMID:39836092
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605912	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SLC61A1 mRNA	PMID:19549813
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SLC61A1 mRNA]	PMID:22206623
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC61A1 mRNA	PMID:40504410
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1605912	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of SLC61A1 mRNA	PMID:19561079|PMID:27392435
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC61A1 mRNA	PMID:33387578
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605912	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SLC61A1 mRNA	PMID:28001369
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1605912	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SLC61A1 mRNA	PMID:23649840
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D020106	Acrylamide results in increased expression of SLC61A1 mRNA	PMID:28959563
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1605912	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SLC61A1 mRNA	PMID:20044591
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC61A1 mRNA	PMID:40504410
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC61A1 mRNA	PMID:22228805
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605912	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC61A1 mRNA	PMID:20064835
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1605912	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of SLC61A1 mRNA	PMID:26014281
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SLC61A1 mRNA	PMID:30047161
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:C009495	titanium dioxide affects the methylation of SLC61A1 gene	PMID:35295148
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C006780	bisphenol A results in increased expression of SLC61A1 mRNA	PMID:25181051
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1605912	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SLC61A1 mRNA	PMID:25979313
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC61A1 mRNA	PMID:37019170
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D005284	Fenthion results in decreased expression of SLC61A1 mRNA	PMID:34813904
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1605912	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC61A1 mRNA	PMID:39836092
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D002994	Clofibrate results in decreased expression of SLC61A1 mRNA	PMID:17585979
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605912	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC61A1 mRNA	PMID:23179753
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605912	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC61A1 gene	PMID:29154799
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605912	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SLC61A1 mRNA	PMID:17183730
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D000640	Amitrole results in increased expression of SLC61A1 mRNA	PMID:30047161
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D000082	Acetaminophen affects the expression of SLC61A1 mRNA	PMID:17562736
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC61A1 mRNA	PMID:33387578
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605912	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC61A1 mRNA	PMID:21420995
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC61A1 mRNA	PMID:40504410
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D004726	Endosulfan results in increased expression of SLC61A1 mRNA	PMID:29391264
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLC61A1 mRNA	PMID:25554681
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D018120	Finasteride results in increased expression of SLC61A1 mRNA	PMID:24136188
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D008713	Methimazole results in increased expression of SLC61A1 mRNA	PMID:30047161
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D005485	Flutamide results in increased expression of SLC61A1 mRNA	PMID:24136188
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1605912	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SLC61A1 mRNA	PMID:17183730
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605912	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SLC61A1 protein	PMID:32959892
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1605912	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC61A1 mRNA	PMID:39836092
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C066340	Tolcapone results in decreased expression of SLC61A1 mRNA	PMID:24136188
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1605912	E	RGD:6480464	20180410	CTD	MESH:C045463	Leflunomide results in decreased expression of SLC61A1 mRNA	PMID:28988120
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SLC61A1 mRNA	PMID:22206623
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312995	E	RGD:6480464	20260804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SLC61A1 mRNA]	PMID:22206623
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C045950	propiconazole results in increased expression of SLC61A1 mRNA	PMID:30047161
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D011441	Propylthiouracil results in increased expression of SLC61A1 mRNA	PMID:30047161
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1605912	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of SLC61A1 mRNA	PMID:26014281
1305138	Slc61a1	solute carrier family 61 member 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1605912	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SLC61A1 mRNA	PMID:38568856
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ZFP281 mRNA	PMID:26251327
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312996	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of ZNF281 mRNA	PMID:22574217
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ZFP281 mRNA	PMID:32145629
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1312996	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF281 mRNA	PMID:37042841
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ZNF281 mRNA	PMID:33359661
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:17447	geraniol	increases expression	ISO	RGD:1312996	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of ZNF281 mRNA	PMID:27683099
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312996	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF281 protein	PMID:37730182
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZNF281 mRNA	PMID:28818685
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312997	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZFP281 mRNA	PMID:37236586
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1312996	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZNF281 mRNA	PMID:19549813
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZFP281 mRNA	PMID:33354967
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312996	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ZNF281 mRNA	PMID:41430723
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of ZFP281 mRNA	PMID:31129395
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1312996	E	RGD:6480464	20120412	CTD	MESH:D016685	ZNF281 protein affects the susceptibility to Mitomycin	PMID:16217747
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312997	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZFP281 mRNA	PMID:40504410
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1312996	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ZNF281 protein	PMID:35688186
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312997	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ZFP281 mRNA	PMID:40618947
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312997	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP281 mRNA	PMID:21570461|PMID:24058054
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP281 mRNA	PMID:19770486
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312997	E	RGD:6480464	20150127	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP281 mRNA	PMID:25270620
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of ZNF281 mRNA	PMID:29955902
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZNF281 mRNA	PMID:33212167
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312996	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF281 mRNA	PMID:38568856
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312997	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of ZFP281 mRNA	PMID:36209798
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312997	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZFP281 mRNA	PMID:40504410
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312997	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFP281 mRNA	PMID:22228805
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312996	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ZNF281 mRNA	PMID:26014281
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:30621	diarsenic trioxide	increases sumoylation	ISO	RGD:1312996	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased sumoylation of ZNF281 protein	PMID:28318385
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZFP281 mRNA	PMID:18445702
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ZFP281 mRNA	PMID:32145629
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF281 protein	PMID:31675489
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZNF281 mRNA	PMID:25181051
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312997	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP281 mRNA	PMID:33221593
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of ZFP281 mRNA	PMID:31129395
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ZNF281 protein	PMID:31675489
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1312996	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to ZNF281 promoter]	PMID:20348232
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312996	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF281 mRNA	PMID:28628672
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP281 mRNA	PMID:37019170
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312996	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF281 mRNA	PMID:28628672
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312996	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF281 mRNA	PMID:37042841
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312997	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZFP281 mRNA	PMID:37236586
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312996	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZNF281 mRNA	PMID:31533062
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF281 mRNA	PMID:23179753
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1312996	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF281 gene	PMID:29154799
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZFP281 mRNA	PMID:19770486
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312997	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of ZFP281 mRNA	PMID:22733784
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312996	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF281 mRNA	PMID:28628672
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312997	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ZNF281 mRNA	PMID:28973697
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312997	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZFP281 mRNA	PMID:17562736
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZNF281 mRNA	PMID:21420995
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ZFP281 mRNA	PMID:29279043
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312997	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZFP281 mRNA	PMID:40504410
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of ZNF281 mRNA	PMID:31675489
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1312996	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF281 mRNA	PMID:28628672
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:49900	arsenous acid	increases sumoylation	ISO	RGD:1312996	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased sumoylation of ZNF281 protein	PMID:28318385
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ZFP281 mRNA	PMID:24136188
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of ZFP281 mRNA	PMID:40234311
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:6456	lidocaine	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in decreased expression of ZFP281 mRNA	PMID:35283115
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1312996	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF281 protein	PMID:31285264
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312997	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ZFP281 mRNA	PMID:23091169
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ZNF281 protein	PMID:31675489
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312996	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ZNF281 protein	PMID:31675489
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312996	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ZNF281 mRNA	PMID:26014281
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ZFP281 mRNA	PMID:19281266
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ZFP281 mRNA	PMID:21346803
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of ZFP281 mRNA	PMID:24136188
1305139	Zfp281	zinc finger protein 281	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZFP281 mRNA	PMID:21346803
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553300	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DCAF7 mRNA	PMID:20938992
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1553300	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DCAF7 mRNA	PMID:30529165
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1604053	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DCAF7 mRNA	PMID:21179406
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553300	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DCAF7 mRNA	PMID:39298647
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of DCAF7 protein	PMID:20109541
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553300	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DCAF7 mRNA	PMID:20938992
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604053	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DCAF7 mRNA	PMID:37042841
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1604053	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DCAF7 mRNA	PMID:21179406
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553300	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DCAF7 mRNA	PMID:34319233
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DCAF7 mRNA	PMID:19549813
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1604053	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DCAF7 protein	PMID:23301498
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1553300	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DCAF7 mRNA	PMID:19770486
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604053	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DCAF7 mRNA	PMID:35430440
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553300	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DCAF7 mRNA	PMID:20938992
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1604053	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of DCAF7 mRNA	PMID:18414638
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604053	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DCAF7 gene	PMID:25304211
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1604053	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of DCAF7 gene	PMID:31636367
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of DCAF7 mRNA	PMID:23195993
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1604053	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DCAF7 mRNA	PMID:25583101
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553300	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DCAF7 mRNA	PMID:21570461
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DCAF7 mRNA	PMID:33387578
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1604053	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DCAF7 mRNA	PMID:23179753
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of DCAF7 mRNA	PMID:28959563
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604053	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of DCAF7 protein	PMID:38228842
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604053	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DCAF7 promoter	PMID:27901495
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DCAF7 mRNA	PMID:20018196
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1604053	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DCAF7 gene	PMID:31601247
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553300	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DCAF7 gene	PMID:35295148
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DCAF7 mRNA	PMID:23411599
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DCAF7 mRNA	PMID:25181051
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DCAF7 gene	PMID:28505145
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1604053	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DCAF7 gene	PMID:31601247
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553300	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DCAF7 mRNA	PMID:38685157
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553300	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DCAF7 mRNA	PMID:37019170
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1553300	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DCAF7 mRNA	PMID:21266533
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1553300	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of DCAF7 mRNA	PMID:34813904
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604053	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DCAF7 mRNA	PMID:37042841
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1553300	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DCAF7 mRNA	PMID:17963808
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604053	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DCAF7 mRNA	PMID:25979313
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of DCAF7 mRNA	PMID:23179753
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DCAF7 mRNA	PMID:25562108
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1553300	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DCAF7 mRNA	PMID:28973697
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of DCAF7 mRNA	PMID:27188386
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1604053	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCAF7 mRNA	PMID:27188386
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553300	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DCAF7 mRNA	PMID:17562736
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DCAF7 mRNA	PMID:33387578
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1604053	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of DCAF7 mRNA	PMID:18414638
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604053	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DCAF7 gene	PMID:25304211
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1553300	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DCAF7 mRNA	PMID:30529165
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1604053	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of DCAF7 mRNA	PMID:23228038
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553300	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DCAF7 mRNA; Nanotubes, Carbon results in increased expression of DCAF7 mRNA	PMID:25554681|PMID:25620056
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1553300	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DCAF7 mRNA	PMID:35964746
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DCAF7 protein	PMID:32959892
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1604053	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of DCAF7 mRNA	PMID:27188386
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of DCAF7 mRNA	PMID:15336504
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1553300	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of DCAF7 mRNA	PMID:27462272
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553300	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DCAF7 mRNA	PMID:22206623
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1604053	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DCAF7 protein	PMID:37664457
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1604053	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of DCAF7 mRNA	PMID:19946333
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1604053	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of DCAF7 mRNA]	PMID:19946333
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604053	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCAF7 mRNA	PMID:27188386
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of DCAF7 mRNA	PMID:19682730
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1553300	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DCAF7 mRNA	PMID:23091169
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DCAF7 mRNA	PMID:24780913
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604053	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DCAF7 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCAF7 mRNA	PMID:27188386|PMID:37664457
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DCAF7 mRNA	PMID:21346803
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1604053	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of DCAF7 mRNA	PMID:27188386
1305140	Dcaf7	DDB1 and CUL4 associated factor 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1553300	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of DCAF7 mRNA	PMID:28973697
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1553369	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of WDR45B mRNA	PMID:33045310
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of WDR45B mRNA	PMID:20938992
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1350558	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of WDR45B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of WDR45B mRNA	PMID:32699268
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553369	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of WDR45B mRNA	PMID:39298647
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of WDR45B mRNA	PMID:25510870
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of WDR45B mRNA	PMID:20938992
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350558	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of WDR45B mRNA	PMID:37042841
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of WDR45B mRNA	PMID:25510870
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of WDR45B mRNA	PMID:25510870
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1350558	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of WDR45B mRNA	PMID:19549813
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1350558	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of WDR45B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of WDR45B mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of WDR45B mRNA	PMID:32699268
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of WDR45B mRNA	PMID:20938992
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of WDR45B mRNA	PMID:40504410
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1553369	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of WDR45B mRNA	PMID:28960355
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1350558	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of WDR45B mRNA	PMID:28903495
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553369	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDR45B mRNA	PMID:21570461
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20161115	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of WDR45B mRNA	PMID:25975270
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1350558	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of WDR45B mRNA	PMID:29803840
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of WDR45B mRNA	PMID:40504410
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1553369	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of WDR45B mRNA	PMID:39716349
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1350558	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of WDR45B gene	PMID:31601247
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1553369	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of WDR45B promoter	PMID:35295148
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D013853	Thioacetamide affects the expression of WDR45B mRNA	PMID:25151969
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:32497	thioacetamide	affects methylation	EXP		E	RGD:6480464	20141223	CTD	MESH:D013853	Thioacetamide affects the methylation of WDR45B promoter	PMID:25151969
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of WDR45B mRNA	PMID:34492290
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in increased expression of WDR45B mRNA	PMID:25181051
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of WDR45B gene	PMID:28505145
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350558	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of WDR45B gene	PMID:31601247
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of WDR45B mRNA	PMID:25510870
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of WDR45B mRNA	PMID:25510870
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1553369	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of WDR45B mRNA	PMID:39298647
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1553369	E	RGD:6480464	20161115	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of WDR45B mRNA	PMID:26377693
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1553369	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of WDR45B intron	PMID:28392331
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553369	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of WDR45B mRNA	PMID:37019170
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1350558	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of WDR45B gene	PMID:22964155
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350558	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of WDR45B mRNA	PMID:37042841
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1350558	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of WDR45B mRNA	PMID:19376846
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1350558	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of WDR45B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of WDR45B mRNA	PMID:32699268
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1350558	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of WDR45B mRNA	PMID:31533062
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1350558	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of WDR45B promoter	PMID:27989131
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1350558	E	RGD:6480464	20161115	CTD	MESH:D008727	Methotrexate results in decreased expression of WDR45B mRNA	PMID:17400583|PMID:24449571
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553369	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of WDR45B mRNA	PMID:17562736
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553369	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of WDR45B mRNA	PMID:40504410
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1553369	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of WDR45B mRNA	PMID:39716349
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553369	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of WDR45B mRNA; Nanotubes, Carbon results in increased expression of WDR45B mRNA	PMID:25620056
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1350558	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of WDR45B protein	PMID:32959892
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1553369	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of WDR45B mRNA	PMID:22206623
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:9130	sevoflurane	increases expression	ISO	RGD:1553369	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased expression of WDR45B protein	PMID:35249202
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of WDR45B mRNA	PMID:19281266
1305141	Wdr45b	WD repeat domain 45B	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1553369	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of WDR45B mRNA	PMID:35537566
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313000	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of TBL3 protein	PMID:39638853
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TBL3 mRNA	PMID:38218311
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313001	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TBL3 mRNA	PMID:33045310
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TBL3 mRNA]	PMID:31150632
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313000	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBL3 mRNA	PMID:32699268
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313001	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of TBL3 mRNA	PMID:30529165
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313001	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TBL3 mRNA	PMID:39241906
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313001	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TBL3 mRNA	PMID:39298647
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313000	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TBL3 mRNA	PMID:38568856
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TBL3 mRNA	PMID:23649840
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TBL3 protein	PMID:34915118
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TBL3 mRNA	PMID:19549813
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TBL3 mRNA	PMID:23649840
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313000	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TBL3 intron	PMID:30157460
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TBL3 mRNA	PMID:23649840
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313000	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBL3 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of TBL3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TBL3 mRNA	PMID:32699268|PMID:35430440
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TBL3 mRNA	PMID:31150632
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TBL3 mRNA]	PMID:31150632
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313001	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TBL3 mRNA	PMID:25629700
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313000	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TBL3 gene	PMID:25304211
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313000	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TBL3 mRNA	PMID:19244175
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of TBL3 mRNA	PMID:27594783
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313001	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBL3 mRNA	PMID:21570461
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313000	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TBL3 mRNA	PMID:39709020
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TBL3 mRNA	PMID:32763439
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313001	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of TBL3 mRNA]; MT2 affects the reaction [Copper results in increased expression of TBL3 mRNA]	PMID:16629173
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TBL3 mRNA	PMID:38568856
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313000	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TBL3 mRNA	PMID:34032870|PMID:39719251
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313001	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of TBL3 mRNA]; MT2 affects the reaction [Copper results in increased expression of TBL3 mRNA]	PMID:16629173
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313001	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of TBL3 mRNA	PMID:27760801
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TBL3 mRNA	PMID:23411599|PMID:34492290
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of TBL3 mRNA	PMID:33296240
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of TBL3 protein	PMID:37567409
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313000	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TBL3 gene	PMID:31601247
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TBL3 mRNA	PMID:25181051|PMID:34947998
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TBL3 gene	PMID:28505145
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313000	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of TBL3 protein	PMID:31945527
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313001	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TBL3 mRNA	PMID:39298647
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313001	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TBL3 intron	PMID:28392331
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313001	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TBL3 mRNA	PMID:37019170
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TBL3 mRNA	PMID:17602206
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TBL3 mRNA	PMID:17602206
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313000	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TBL3 mRNA	PMID:37042841
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TBL3 mRNA	PMID:19376846
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313000	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBL3 mRNA	PMID:32699268
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313000	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TBL3 mRNA	PMID:19244175
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313001	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of TBL3 mRNA	PMID:17585979
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1313000	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of TBL3 protein	PMID:34122009
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313000	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TBL3 mRNA	PMID:31533062
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313001	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid affects the expression of TBL3 mRNA	PMID:17292431|PMID:17963808
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313000	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TBL3 gene	PMID:29154799
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313000	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TBL3 mRNA	PMID:25562108
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TBL3 mRNA	PMID:33387578
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TBL3 mRNA	PMID:21420995
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313000	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TBL3 gene	PMID:25304211
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313001	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of TBL3 mRNA	PMID:30529165
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313001	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TBL3 mRNA; Nanotubes, Carbon results in increased expression of TBL3 mRNA	PMID:25554681
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TBL3 mRNA	PMID:24136188
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313001	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TBL3 mRNA	PMID:19042947
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313000	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TBL3 protein	PMID:32959892
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of TBL3 mRNA	PMID:24136188
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313001	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TBL3 mRNA	PMID:22206623
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313000	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TBL3 protein	PMID:31285264
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of TBL3 mRNA	PMID:32109520
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TBL3 mRNA	PMID:21346803
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TBL3 mRNA	PMID:21346803
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313001	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TBL3 mRNA	PMID:35537566
1305142	Tbl3	transducin (beta)-like 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TBL3 mRNA	PMID:23034163
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550129	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SDHAF3 mRNA	PMID:30319688
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313002	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SDHAF3 mRNA	PMID:21179406
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SDHAF3 mRNA	PMID:28818685
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SDHAF3 mRNA	PMID:28522335
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SDHAF3 mRNA	PMID:19549813
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313002	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SDHAF3 gene	PMID:27153756
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SDHAF3 mRNA	PMID:33387578
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550129	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SDHAF3 mRNA	PMID:25629700
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313002	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SDHAF3 gene	PMID:25304211
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SDHAF3 mRNA	PMID:31881176
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313002	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SDHAF3 mRNA	PMID:27392435
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1550129	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SDHAF3 mRNA	PMID:30912803
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550129	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SDHAF3 mRNA	PMID:21570461
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SDHAF3 mRNA	PMID:21215274
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SDHAF3 mRNA	PMID:20106945|PMID:21632981
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SDHAF3 mRNA	PMID:30851411
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28618	1,4-dichlorobenzene	increases expression	ISO	RGD:1550129	E	RGD:6480464	20171114	CTD	MESH:C018511	4-dichlorobenzene results in increased expression of SDHAF3 mRNA	PMID:26975756
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SDHAF3 mRNA	PMID:28959563
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SDHAF3 mRNA	PMID:29803840
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313002	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SDHAF3 mRNA	PMID:29432896
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SDHAF3 mRNA	PMID:38568856
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SDHAF3 mRNA	PMID:21839799
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313002	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SDHAF3 mRNA]	PMID:32406909
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550129	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACN9 gene	PMID:35295148
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SDHAF3 mRNA	PMID:34492290
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1550129	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of SDHAF3 mRNA	PMID:18648102
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SDHAF3 mRNA	PMID:30723492
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SDHAF3 mRNA	PMID:25181051
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of SDHAF3 mRNA	PMID:36232920
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550129	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SDHAF3 mRNA	PMID:33221593
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313002	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SDHAF3 mRNA	PMID:28628672
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313002	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SDHAF3 mRNA	PMID:28628672
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550129	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SDHAF3 mRNA	PMID:37019170
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SDHAF3 mRNA	PMID:21266533
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313002	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SDHAF3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SDHAF3 mRNA	PMID:28628672
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SDHAF3 mRNA	PMID:24386269
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SDHAF3 mRNA	PMID:19376846
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550129	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SDHAF3 mRNA	PMID:36331819
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313002	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SDHAF3 mRNA	PMID:25979313
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313002	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SDHAF3 gene	PMID:29154799
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313002	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SDHAF3 mRNA	PMID:23179753|PMID:28001369|PMID:29154799|PMID:37505509
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313002	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SDHAF3 mRNA	PMID:17183730
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SDHAF3 mRNA	PMID:20106945|PMID:25562108
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313002	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SDHAF3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SDHAF3 mRNA	PMID:28628672
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313002	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SDHAF3 mRNA	PMID:27188386
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SDHAF3 mRNA	PMID:33387578
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313002	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SDHAF3 gene	PMID:25304211
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313002	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SDHAF3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SDHAF3 mRNA	PMID:28628672
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SDHAF3 mRNA	PMID:24136188
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1550129	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of SDHAF3 mRNA	PMID:40234311
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SDHAF3 mRNA	PMID:24136188
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313002	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SDHAF3 mRNA	PMID:17183730
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of SDHAF3 mRNA	PMID:37939859
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313002	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SDHAF3 mRNA	PMID:31758290
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550129	E	RGD:6480464	20221206	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SDHAF3 mRNA	PMID:22206623
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SDHAF3 mRNA	PMID:30851411
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313002	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SDHAF3 mRNA	PMID:19159669
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550129	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SDHAF3 mRNA	PMID:31388691
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SDHAF3 mRNA	PMID:19281266
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of SDHAF3 mRNA	PMID:24136188
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SDHAF3 mRNA	PMID:38568856
1305143	Sdhaf3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313002	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SDHAF3 mRNA	PMID:29301935
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313003	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RPS6KB2 mRNA	PMID:38218311
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RPS6KB2 mRNA	PMID:20188158
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313003	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RPS6KB2 mRNA	PMID:22378314
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:16337	phosphatidic acid	increases activity	ISO	RGD:1313003	E	RGD:6480464	20170103	CTD	MESH:D010712	Phosphatidic Acids results in increased activity of RPS6KB2 protein	PMID:12087098
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:16337	phosphatidic acid	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20170103	CTD	MESH:D010712	MTOR protein affects the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein]; Sirolimus inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein]; wortmannin inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein]	PMID:12087098
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313004	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RPS6KB2 mRNA	PMID:39298647
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of RPS6KB2 mRNA	PMID:28973375
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of RPS6KB2 mRNA	PMID:11478936
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313003	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RPS6KB2 protein	PMID:37730182
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RPS6KB2 mRNA	PMID:33387578
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:18152	myricetin	increases expression	ISO	RGD:1313003	E	RGD:6480464	20180828	CTD	MESH:C040015	myricetin results in increased expression of RPS6KB2 protein	PMID:29698783
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of RPS6KB2 mRNA	PMID:33914522
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of RPS6KB2 protein	PMID:34915118
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of RPS6KB2 mRNA	PMID:11478936
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313004	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RPS6KB2 mRNA	PMID:37236586
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of RPS6KB2 mRNA	PMID:19376150
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of RPS6KB2 mRNA	PMID:32186404
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPS6KB2 mRNA	PMID:21570461
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPS6KB2 mRNA	PMID:19770486
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of RPS6KB2 mRNA	PMID:30911355
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:28748	doxorubicin	decreases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased phosphorylation of RPS6KB2 protein	PMID:19801490
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	NRG1 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of RPS6KB2 protein]	PMID:19801490
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313003	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of RPS6KB2 protein	PMID:35688186
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:28885	butan-1-ol	decreases activity	ISO	RGD:1313003	E	RGD:6480464	20120412	CTD	MESH:D020001	1-Butanol results in decreased activity of RPS6KB2 protein	PMID:12087098
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RPS6KB2 mRNA	PMID:29432896
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313003	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RPS6KB2 gene	PMID:28589171
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313003	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of RPS6KB2 mRNA	PMID:34032870|PMID:39719251
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313003	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RPS6KB2 3' UTR	PMID:27901495
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of RPS6KB2 mRNA	PMID:30911355
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RPS6KB2 protein]	PMID:26598702
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RPS6KB2 gene	PMID:31601247
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RPS6KB2 mRNA	PMID:30047161
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RPS6KB2 mRNA	PMID:19710929
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RPS6KB2 mRNA	PMID:18180321|PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313004	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in increased expression of RPS6KB2 mRNA	PMID:29165653
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RPS6KB2 gene	PMID:31601247
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313004	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S results in decreased methylation of RPS6KB2 gene	PMID:31683443
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RPS6KB2 mRNA	PMID:38685157
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313004	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RPS6KB2 mRNA	PMID:37019170
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313003	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RPS6KB2 mRNA	PMID:37042841
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313004	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RPS6KB2 mRNA	PMID:37236586
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of RPS6KB2 mRNA	PMID:30047161
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of RPS6KB2 mRNA	PMID:17963808
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313003	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RPS6KB2 gene	PMID:29154799
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RPS6KB2 mRNA	PMID:30047161
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:41072	3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C070515	bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]	PMID:12720544
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RPS6KB2 mRNA	PMID:33387578
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313003	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RPS6KB2 mRNA	PMID:18175754
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RPS6KB2 protein]	PMID:26598702
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RPS6KB2 mRNA	PMID:30047161
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein]	PMID:12087098
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:52646	leptomycin B	decreases activity	ISO	RGD:1313003	E	RGD:6480464	20120412	CTD	MESH:C038753	leptomycin B results in decreased activity of RPS6KB2 protein	PMID:12087098
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313003	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of RPS6KB2 mRNA	PMID:18651567
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313003	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPS6KB2 protein	PMID:32959892
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:6482	linuron	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D008044	Linuron results in decreased expression of RPS6KB2 mRNA	PMID:28705778
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:6651	malathion	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20260804	CTD	MESH:D008294	Malathion results in decreased expression of RPS6KB2 mRNA	PMID:39476999
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D008694	Methamphetamine results in decreased expression of RPS6KB2 mRNA	PMID:32035215
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cannabidiol co-treated with moringin] results in increased expression of RPS6KB2 mRNA	PMID:30096889
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313003	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RPS6KB2 mRNA	PMID:31758290
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313004	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RPS6KB2 mRNA	PMID:22206623
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:8093	phenylephrine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010656	bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]; rottlerin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]	PMID:12720544
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:8364	prazosin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011224	Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]	PMID:12720544
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in increased expression of RPS6KB2 mRNA	PMID:26923065
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RPS6KB2 mRNA	PMID:30047161
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:8899	rottlerin	decreases activity	EXP		E	RGD:6480464	20131008	CTD	MESH:C085746	rottlerin results in decreased activity of RPS6KB2 protein	PMID:12720544
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:8899	rottlerin	multiple interactions	EXP		E	RGD:6480464	20131008	CTD	MESH:C085746	rottlerin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]	PMID:12720544
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:9168	sirolimus	decreases activity	ISO	RGD:1313003	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased activity of RPS6KB2 protein	PMID:12087098
1305144	Rps6kb2	ribosomal protein S6 kinase B2	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1313003	E	RGD:6480464	20120412	CTD	MESH:D020123	MTOR protein inhibits the reaction [Sirolimus results in decreased activity of RPS6KB2 protein]; Sirolimus inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein]	PMID:12087098
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313005	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of NARS2 mRNA	PMID:37995155
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313005	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NARS2 mRNA	PMID:20938992
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NARS2 mRNA	PMID:33167477
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313005	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NARS2 mRNA	PMID:39241906
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605947	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of NARS2 mRNA	PMID:31059760
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313005	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NARS2 mRNA	PMID:20938992
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of NARS2 mRNA	PMID:23649840
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1605947	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of NARS2 mRNA	PMID:21179406
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NARS2 mRNA	PMID:19549813
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of NARS2 mRNA	PMID:23649840
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605947	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NARS2 gene	PMID:27153756
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of NARS2 mRNA	PMID:23649840
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313005	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NARS2 mRNA	PMID:20938992
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1605947	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NARS2 gene	PMID:25304211
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of NARS2 mRNA	PMID:31881176
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605947	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NARS2 mRNA	PMID:23557933
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313005	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NARS2 mRNA	PMID:21570461
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NARS2 mRNA	PMID:33387578
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1605947	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NARS2 mRNA	PMID:29803840
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NARS2 mRNA	PMID:38568856
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NARS2 mRNA	PMID:20064835
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313005	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NARS2 mRNA	PMID:22228805
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313005	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of NARS2 protein	PMID:37955338
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:3000	beauvericin	multiple interactions	ISO	RGD:1605947	E	RGD:6480464	20200915	CTD	MESH:C004456	[beauvericin co-treated with enniatins] results in increased expression of NARS2 protein	PMID:32407736
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NARS2 mRNA	PMID:25181051
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of NARS2 protein	PMID:34186270
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1605947	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of NARS2 mRNA	PMID:25979313
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313005	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NARS2 mRNA	PMID:39298647
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313005	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of NARS2 mRNA	PMID:38685157
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1605947	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of NARS2 protein	PMID:34186270
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34682	diazinon	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D003976	Diazinon results in increased expression of NARS2 mRNA	PMID:29108742
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605947	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NARS2 mRNA	PMID:37042841
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1605947	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NARS2 protein	PMID:26879310
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NARS2 mRNA	PMID:19320972
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313005	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NARS2 mRNA	PMID:40194260
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605947	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NARS2 mRNA	PMID:31533062
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313005	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NARS2 mRNA	PMID:17963808
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605947	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NARS2 mRNA	PMID:25979313
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NARS2 mRNA	PMID:25562108
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of NARS2 mRNA	PMID:22230336|PMID:25704631
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NARS2 mRNA	PMID:33387578
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605947	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in increased expression of NARS2 mRNA	PMID:31059760
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1605947	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of NARS2 mRNA	PMID:31059760
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1605947	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NARS2 gene	PMID:25304211
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1605947	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NARS2 mRNA	PMID:22079256
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:64648	enniatin	multiple interactions	ISO	RGD:1605947	E	RGD:6480464	20200915	CTD	MESH:C100264	[beauvericin co-treated with enniatins] results in increased expression of NARS2 protein	PMID:32407736
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1605947	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NARS2 mRNA	PMID:31758290
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1605947	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NARS2 protein	PMID:34186270
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313005	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NARS2 mRNA	PMID:22206623
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1605947	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NARS2 mRNA	PMID:22079256
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1605947	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NARS2 mRNA	PMID:22079256
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of NARS2 mRNA	PMID:33484710
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605947	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NARS2 gene]	PMID:28238834
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of NARS2 mRNA	PMID:23640034
1305145	Nars2	asparaginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NARS2 mRNA	PMID:19281266
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1617582	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TMX4 gene	PMID:20938992
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TMX4 mRNA	PMID:33167477
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1603023	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TMX4 mRNA	PMID:23724009
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TMX4 mRNA	PMID:26079696
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1617582	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of TMX4 mRNA	PMID:30319688
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1617582	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TMX4 mRNA	PMID:39241906
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of TMX4 mRNA	PMID:32145629
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1617582	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TMX4 gene	PMID:20938992
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603023	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TMX4 mRNA	PMID:37042841
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TMX4 mRNA	PMID:23649840
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1617582	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TMX4 mRNA	PMID:33754040
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1603023	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TMX4 protein	PMID:37730182
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1603023	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TMX4 mRNA	PMID:28818685
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1617582	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMX4 mRNA	PMID:36331819
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20120814	CTD	MESH:D002104	Cadmium results in decreased expression of TMX4 mRNA	PMID:16439709
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617582	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TMX4 mRNA	PMID:37236586
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1603023	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TMX4 gene	PMID:27153756
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TMX4 mRNA	PMID:30779732
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1617582	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TMX4 gene	PMID:20938992
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603023	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMX4 mRNA	PMID:39836092
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603023	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of TMX4 mRNA	PMID:19167446
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1603023	E	RGD:6480464	20120412	CTD	MESH:D002945	TMX4 protein affects the susceptibility to Cisplatin	PMID:16217747
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of TMX4 mRNA	PMID:22023808
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603023	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of TMX4 mRNA	PMID:27594783
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1617582	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMX4 mRNA	PMID:21570461
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1603023	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMX4 mRNA	PMID:21632981
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of TMX4 mRNA	PMID:39709020
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of TMX4 mRNA	PMID:23649840
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1617582	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TMX4 protein	PMID:28918527
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMX4 mRNA	PMID:29803840
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMX4 mRNA	PMID:22714537|PMID:38568856
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1617582	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TMX4 mRNA	PMID:20883709
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603023	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMX4 mRNA	PMID:39836092
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617582	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TMX4 mRNA	PMID:22228805
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603023	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMX4 3' UTR	PMID:27901495
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1603023	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of TMX4 promoter	PMID:23974009
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:30145	lithium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of TMX4 protein	PMID:18296634
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:30146	lithium hydride	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of TMX4 protein	PMID:18296634
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1603023	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TMX4 mRNA	PMID:26238291
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617582	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMX4 promoter	PMID:35295148
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1617582	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TMX4 gene	PMID:35295148
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TMX4 mRNA	PMID:34492290
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1603023	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TMX4 mRNA	PMID:30690063
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TMX4 mRNA	PMID:25181051
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TMX4 mRNA	PMID:30816183
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMX4 gene	PMID:28505145
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1617582	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TMX4 mRNA	PMID:38685157
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603023	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMX4 mRNA	PMID:37042841
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMX4 mRNA	PMID:38568856
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1617582	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMX4 mRNA	PMID:20883709
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617582	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TMX4 mRNA	PMID:37236586
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TMX4 mRNA	PMID:19376846
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:38757	isoflavones	affects expression	ISO	RGD:1603023	E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones affects the expression of TMX4 mRNA	PMID:16365062
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1603023	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of TMX4 mRNA	PMID:19167446
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617582	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMX4 mRNA	PMID:36331819
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603023	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMX4 mRNA	PMID:25979313
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603023	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TMX4 mRNA	PMID:23179753
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TMX4 mRNA	PMID:33387578
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603023	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of TMX4 mRNA	PMID:25704631
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603023	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMX4 mRNA	PMID:39836092
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1603023	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TMX4 mRNA	PMID:22079256
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1617582	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TMX4 mRNA	PMID:25620056
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of TMX4 mRNA	PMID:22714537
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TMX4 mRNA	PMID:15336504
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TMX4 mRNA	PMID:28801915
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1603023	E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TMX4 mRNA	PMID:20147733
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1617582	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMX4 mRNA	PMID:22206623
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of TMX4 mRNA	PMID:27840820
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TMX4 mRNA	PMID:22714537
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1603023	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of TMX4 mRNA	PMID:22079256
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1603023	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TMX4 mRNA	PMID:22079256
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1617582	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TMX4 mRNA	PMID:38648751
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of TMX4 protein	PMID:28903499
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1617582	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TMX4 mRNA	PMID:39847705
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TMX4 mRNA	PMID:24780913
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TMX4 mRNA	PMID:21346803
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1603023	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TMX4 mRNA	PMID:38568856
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:9763	trovafloxacin	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in increased expression of TMX4 mRNA	PMID:24136188
1305146	Tmx4	thioredoxin-related transmembrane protein 4	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of TMX4 mRNA	PMID:23034163
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:15354	choline	affects expression	ISO	RGD:1354489	E	RGD:6480464	20120412	CTD	MESH:D002794	Choline affects the expression of MARCHF1 mRNA	PMID:17616785
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of MARCHF1 mRNA	PMID:21934132
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:D000431	Ethanol affects the splicing of MARCHF1 mRNA	PMID:30319688
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MARCHF1 mRNA	PMID:35811015
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1354489	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MARCHF1 mRNA	PMID:35811015
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:16548	chlordecone	affects response to substance	ISO	RGD:1354489	E	RGD:6480464	20150609	CTD	MESH:D007631	MARCHF1 gene SNP affects the susceptibility to Chlordecone	PMID:25622337
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MARCHF1 mRNA	PMID:33387578
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552868	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MARCHF1 mRNA	PMID:37992649
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of MARCHF1 mRNA	PMID:33647349
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552868	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MARCHF1 mRNA	PMID:37992649
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MARCHF1 mRNA	PMID:26577399|PMID:27523638
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1354489	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of MARCHF1 mRNA	PMID:16002434
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1354489	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of MARCHF1 intron	PMID:30157460
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MARCHF1 mRNA	PMID:22100608
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1354489	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MARCHF1 gene	PMID:27153756
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1354489	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MARCHF1 intron	PMID:30157460
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1552868	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of MARCHF1 mRNA	PMID:31626304
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552868	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MARCHF1 mRNA	PMID:34911549
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1354489	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MARCHF1 gene	PMID:25304211
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MARCHF1 mRNA	PMID:28189721
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MARCHF1 mRNA	PMID:31881176
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1354489	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MARCHF1 mRNA	PMID:27392435
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1354489	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MARCHF1 mRNA	PMID:24768652|PMID:25583101
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MARCHF1 mRNA	PMID:26377647
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MARCHF1 mRNA	PMID:21215274|PMID:32109520
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MARCHF1 mRNA	PMID:28001369
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of MARCHF1 mRNA	PMID:26272509
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1354489	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MARCHF1 mRNA	PMID:27188386
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552868	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MARCHF1 mRNA	PMID:37992649
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1354489	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MARCHF1 intron; Benzo(a)pyrene affects the methylation of MARCHF1 promoter	PMID:27901495|PMID:30157460
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MARCHF1 mRNA	PMID:32234424
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1354489	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MARCHF1 5' UTR; Benzo(a)pyrene results in decreased methylation of MARCHF1 exon	PMID:27901495
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MARCHF1 mRNA	PMID:22228805
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MARCHF1 mRNA]	PMID:22228805
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1354489	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MARCHF1 mRNA]	PMID:32406909
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of MARCHF1 mRNA	PMID:32479839
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:C009495	titanium dioxide results in increased expression of MARCHF1 mRNA	PMID:23557971|PMID:29264374
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MARCHF1 mRNA	PMID:34492290
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MARCHF1 mRNA	PMID:30723492
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C006780	bisphenol A results in decreased expression of MARCHF1 mRNA	PMID:25181051|PMID:32145629
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of MARCHF1 mRNA	PMID:41034487
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552868	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of MARCHF1 mRNA	PMID:38701888
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20200114	CTD	MESH:C006780	bisphenol A results in increased methylation of MARCHF1 gene	PMID:28505145
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1354489	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MARCHF1 mRNA	PMID:25979313
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552868	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MARCHF1 mRNA	PMID:39298647
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1354489	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MARCHF1 intron	PMID:30157460
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of MARCHF1 mRNA	PMID:26377693
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552868	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MARCHF1 mRNA	PMID:38685157
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552868	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of MARCHF1 intron	PMID:28392331
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C039281	furan results in decreased expression of MARCHF1 mRNA	PMID:25539665
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1354489	E	RGD:6480464	20130514	CTD	MESH:C018021	cobaltous chloride results in increased expression of MARCHF1 mRNA	PMID:23052192
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MARCHF1 mRNA	PMID:24449571
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:D002737	Chloroprene results in decreased expression of MARCHF1 mRNA	PMID:23125180
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1354489	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MARCHF1 mRNA	PMID:25979313
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:D014635	Valproic Acid results in decreased expression of MARCHF1 mRNA	PMID:24896083
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552868	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MARCHF1 mRNA	PMID:37992649
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MARCHF1 mRNA	PMID:38832940
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:D000082	Acetaminophen affects the expression of MARCHF1 mRNA	PMID:17562736
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of MARCHF1 mRNA	PMID:29067470
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1354489	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MARCHF1 mRNA	PMID:35811015
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1354489	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MARCHF1 gene	PMID:25304211
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:D004008	Diclofenac results in increased expression of MARCHF1 mRNA	PMID:26934552|PMID:35537566
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of MARCHF1 mRNA	PMID:32234424
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1552868	E	RGD:6480464	20200114	CTD	MESH:C030935	benz(a)anthracene results in increased expression of MARCHF1 mRNA	PMID:26377693
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552868	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MARCHF1 mRNA	PMID:38701926
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MARCHF1 mRNA	PMID:24810058
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1354489	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MARCHF1 intron	PMID:30157460
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552868	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MARCHF1 mRNA	PMID:22206623
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1354489	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MARCHF1 mRNA	PMID:22714537
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1354489	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MARCHF1 mRNA	PMID:27188386
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1354489	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MARCHF1 gene]	PMID:28238834
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MARCHF1 mRNA	PMID:32109520
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D011441	Propylthiouracil results in increased expression of MARCHF1 mRNA	PMID:24780913
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1354489	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MARCHF1 mRNA	PMID:27188386
1305148	Marchf1	membrane associated ring-CH-type finger 1	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1354489	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of MARCHF1 mRNA	PMID:27188386
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313009	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of IL15RA mRNA	PMID:38218311
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of IL15RA mRNA	PMID:33045310
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313009	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IL15RA mRNA	PMID:26079696
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of IL15RA gene	PMID:28931070
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20250401	CTD	MESH:D011794	[Quercetin co-treated with Lipopolysaccharides] results in decreased expression of IL15RA mRNA	PMID:38823456
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313009	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IL15RA mRNA	PMID:35811015
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313010	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IL15RA mRNA	PMID:26582142|PMID:39241906
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313009	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of IL15RA mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL15RA mRNA]	PMID:35811015
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20161228	CTD	MESH:D008070	(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of IL15RA mRNA]; [Quercetin co-treated with Lipopolysaccharides] results in decreased expression of IL15RA mRNA	PMID:26582142|PMID:38823456
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of IL15RA mRNA	PMID:39298647
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313009	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of IL15RA mRNA	PMID:24758408|PMID:31614463
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313009	E	RGD:6480464	20160412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in increased expression of IL15RA mRNA; EGF protein promotes the reaction [Estradiol results in increased expression of IL15RA mRNA]	PMID:18692832|PMID:24758408
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of IL15RA mRNA	PMID:33387578
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313009	E	RGD:6480464	20130910	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in increased expression of IL15RA mRNA	PMID:18692832
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:17489	3',5'-cyclic AMP	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D000242	Cyclic AMP results in decreased expression of IL15RA mRNA	PMID:22117073
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D000242	[Metformin co-treated with Cyclic AMP] results in decreased expression of IL15RA mRNA; PPARGC1A mutant form inhibits the reaction [Cyclic AMP results in decreased expression of IL15RA mRNA]	PMID:22117073
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IL15RA mRNA	PMID:36331819
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of IL15RA mRNA	PMID:33914522
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313009	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL15RA mRNA	PMID:35301059
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL15RA mRNA	PMID:37236586
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IL15RA mRNA	PMID:19770486
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313009	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of IL15RA mRNA	PMID:23649840
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IL15RA mRNA	PMID:34911549
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of IL15RA mRNA	PMID:17484886
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IL15RA mRNA	PMID:31919559
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313009	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IL15RA gene	PMID:25304211
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of IL15RA mRNA	PMID:28960355
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form] results in decreased expression of IL15RA mRNA	PMID:23625948
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313009	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL15RA mRNA	PMID:24768652|PMID:25583101
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IL15RA mRNA	PMID:34747641
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IL15RA mRNA	PMID:21570461
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IL15RA mRNA	PMID:25975270
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313009	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IL15RA mRNA	PMID:29803840
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313009	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IL15RA mRNA	PMID:38568856
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of IL15RA mRNA	PMID:37682722
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313010	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of IL15RA gene	PMID:39894169
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313009	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL15RA promoter	PMID:27901495
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IL15RA mRNA	PMID:22228805
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of IL15RA mRNA	PMID:35295148
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of IL15RA mRNA	PMID:23411599
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of IL15RA mRNA	PMID:20813756|PMID:23811191
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:C006253	pirinixic acid results in increased expression of IL15RA mRNA	PMID:18301758
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of IL15RA mRNA	PMID:33914522
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of IL15RA mRNA	PMID:25181051
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1313010	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of IL15RA mRNA	PMID:37894381
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:C006780	bisphenol A results in decreased expression of IL15RA mRNA	PMID:21932408|PMID:32156529
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313009	E	RGD:6480464	20250204	CTD	MESH:C006780	bisphenol A results in decreased methylation of IL15RA gene	PMID:38338858
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313010	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of IL15RA mRNA	PMID:38074096
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of IL15RA mRNA	PMID:36041667
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313009	E	RGD:6480464	20250204	CTD	MESH:C543008	bisphenol S results in decreased methylation of IL15RA gene	PMID:38338858
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of IL15RA mRNA	PMID:36041667
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of IL15RA mRNA	PMID:38685157
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:34575	bisphenol F	decreases methylation	ISO	RGD:1313009	E	RGD:6480464	20250204	CTD	MESH:C008745	bisphenol F results in decreased methylation of IL15RA gene	PMID:38338858
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of IL15RA mRNA	PMID:36041667
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313010	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of IL15RA intron	PMID:28392331
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1313009	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of IL15RA mRNA	PMID:37047231
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of IL15RA gene	PMID:33148267
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313009	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IL15RA mRNA	PMID:37042841
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313009	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL15RA mRNA	PMID:35301059
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL15RA mRNA	PMID:37236586
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313010	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of IL15RA mRNA	PMID:28903501
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313009	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IL15RA mRNA	PMID:24449571
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313009	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IL15RA mRNA	PMID:32588087
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313010	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IL15RA mRNA	PMID:40194260
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IL15RA mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of IL15RA mRNA	PMID:36331819
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D003520	Cyclophosphamide results in increased expression of IL15RA mRNA	PMID:21041162
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313009	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of IL15RA mRNA	PMID:20106945
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313010	E	RGD:6480464	20140114	CTD	MESH:D016572	Cyclosporine results in increased expression of IL15RA mRNA	PMID:23958496
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D003907	Dexamethasone results in increased expression of IL15RA mRNA	PMID:21041162
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of IL15RA mRNA	PMID:21041162
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313010	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IL15RA mRNA	PMID:28973697
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313009	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of IL15RA mRNA	PMID:17400583|PMID:24449571
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313009	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of IL15RA mRNA	PMID:21420995
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of IL15RA mRNA	PMID:33387578
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313009	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of IL15RA mRNA	PMID:29067470
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1313009	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of IL15RA mRNA	PMID:33725128
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313009	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of IL15RA mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL15RA mRNA]	PMID:35811015
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313009	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IL15RA gene	PMID:25304211
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of IL15RA mRNA	PMID:29391264
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol inhibits the reaction [IL1B protein results in increased expression of IL15RA mRNA]	PMID:12072388
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of IL15RA mRNA	PMID:25620056
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:53049	1-fluoro-2,4-dinitrobenzene	increases response to substance	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D004139	IL15RA protein results in increased susceptibility to Dinitrofluorobenzene	PMID:15719370
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313010	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IL15RA mRNA	PMID:38701926
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1313010	E	RGD:6480464	20140114	CTD	MESH:D016559	Tacrolimus results in increased expression of IL15RA mRNA	PMID:23958496
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D008687	Metformin results in decreased expression of IL15RA mRNA	PMID:22117073
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D008687	[Metformin co-treated with Cyclic AMP] results in decreased expression of IL15RA mRNA; Metformin promotes the reaction [GCG protein results in decreased expression of IL15RA mRNA]	PMID:22117073
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of IL15RA gene	PMID:33148267
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:7438	N-methylformamide	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:C002950	methylformamide analog results in decreased expression of IL15RA mRNA; methylformamide results in decreased expression of IL15RA mRNA	PMID:17040096
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313009	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IL15RA gene]	PMID:28238834
1305149	Il15ra	interleukin 15 receptor subunit alpha	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital results in increased expression of IL15RA mRNA	PMID:19270015
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:138858	Azaspiracid	increases expression	ISO	RGD:1313012	E	RGD:6480464	20190219	CTD	MESH:C406592	azaspiracid results in increased expression of B3GNT3 mRNA	PMID:28939011
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of B3GNT3 mRNA	PMID:36331819
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313012	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of B3GNT3 mRNA	PMID:20044591
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313012	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of B3GNT3 mRNA	PMID:35811015
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of B3GNT3 mRNA	PMID:39241906
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313012	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GNT3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GNT3 mRNA	PMID:35811015
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313012	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of B3GNT3 mRNA	PMID:38568856
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of B3GNT3 mRNA	PMID:33387578
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GNT3 mRNA	PMID:37992649
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GNT3 mRNA	PMID:37992649
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of B3GNT3 mRNA	PMID:27523638
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1313013	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of B3GNT3 mRNA	PMID:39984025
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of B3GNT3 mRNA	PMID:29950665
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313012	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of B3GNT3 mRNA	PMID:19549813
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313013	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of B3GNT3 mRNA	PMID:31939706
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313013	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of B3GNT3 mRNA	PMID:25629700
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313012	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of B3GNT3 mRNA	PMID:23557933
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313012	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of B3GNT3 mRNA	PMID:27392435
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313013	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of B3GNT3 mRNA	PMID:32186404
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313012	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of B3GNT3 mRNA	PMID:30851411
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313013	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of B3GNT3 mRNA	PMID:30807115
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of B3GNT3 mRNA	PMID:30556269
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GNT3 mRNA	PMID:37992649
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313012	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of B3GNT3 mRNA	PMID:29301061|PMID:32844245|PMID:38568856
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313012	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of B3GNT3 mRNA	PMID:39719251
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1313012	E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in increased methylation of B3GNT3 intron	PMID:32844245
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313012	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of B3GNT3 5' UTR; Benzo(a)pyrene affects the methylation of B3GNT3 promoter	PMID:27901495
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313012	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of B3GNT3 mRNA	PMID:22316170|PMID:26238291
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313013	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of B3GNT3 mRNA	PMID:32417428
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313012	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of B3GNT3 3' UTR	PMID:27901495
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of B3GNT3 mRNA	PMID:30556269
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313012	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of B3GNT3 mRNA	PMID:25895662
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1313012	E	RGD:6480464	20191114	CTD	MESH:C006632	B3GNT3 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313012	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of B3GNT3 mRNA	PMID:38568856
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313013	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of B3GNT3 gene	PMID:35295148
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313013	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of B3GNT3 gene	PMID:35295148
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of B3GNT3 mRNA	PMID:29950665
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of B3GNT3 mRNA	PMID:25181051
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313013	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of B3GNT3 mRNA	PMID:34585602
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1313012	E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of B3GNT3 mRNA	PMID:23626723
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1313012	E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of B3GNT3 mRNA	PMID:23626723
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of B3GNT3 mRNA	PMID:29950665
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313012	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of B3GNT3 mRNA	PMID:29024780
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1313012	E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of B3GNT3 mRNA	PMID:23626723
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313012	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of B3GNT3 mRNA	PMID:38382870
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of B3GNT3 mRNA	PMID:36331819
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313012	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of B3GNT3 mRNA	PMID:25562108
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GNT3 mRNA	PMID:37992649
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1313012	E	RGD:6480464	20120412	CTD	MESH:D008727	B3GNT3 protein affects the susceptibility to Methotrexate	PMID:16217747
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of B3GNT3 mRNA	PMID:33387578
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313012	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of B3GNT3 mRNA	PMID:29067470
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313012	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GNT3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GNT3 mRNA	PMID:35811015
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313013	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of B3GNT3 mRNA	PMID:35436446
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of B3GNT3 mRNA	PMID:17557909
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1313012	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of B3GNT3 mRNA	PMID:32234424
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1313012	E	RGD:6480464	20191114	CTD	MESH:C032793	B3GNT3 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313013	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of B3GNT3 mRNA; Nanotubes, Carbon results in increased expression of B3GNT3 mRNA	PMID:25554681
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of B3GNT3 mRNA	PMID:38701926
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313012	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of B3GNT3 mRNA	PMID:28988120
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313012	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of B3GNT3 mRNA	PMID:30851411
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1313012	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of B3GNT3 mRNA	PMID:31734321
1305151	B3gnt3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313012	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of B3GNT3 mRNA	PMID:38568856
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of ITGA10 mRNA	PMID:31863870
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313015	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ITGA10 mRNA	PMID:33045310
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313014	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ITGA10 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of ITGA10 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ITGA10 mRNA	PMID:32699268|PMID:32845096
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ITGA10 mRNA	PMID:26079696
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313014	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ITGA10 mRNA	PMID:22378314
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313014	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ITGA10 mRNA	PMID:21632981
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ITGA10 mRNA	PMID:30510588
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ITGA10 mRNA	PMID:33387578
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313014	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ITGA10 mRNA	PMID:37042841
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of ITGA10 mRNA	PMID:34673133
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313014	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of ITGA10 mRNA	PMID:20864642|PMID:21795739
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ITGA10 mRNA	PMID:22017230
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:17650	cortisol	increases expression	ISO	RGD:1313014	E	RGD:6480464	20121113	CTD	MESH:D006854	Hydrocortisone results in increased expression of ITGA10 mRNA	PMID:21267416
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ITGA10 mRNA	PMID:26577399|PMID:27523638
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1313014	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ITGA10 mRNA	PMID:36139627
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of ITGA10 mRNA	PMID:26485663
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGA10 mRNA	PMID:29950665
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313015	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ITGA10 mRNA	PMID:19770486
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313014	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ITGA10 gene	PMID:27153756
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313014	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ITGA10 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of ITGA10 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ITGA10 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of ITGA10 mRNA	PMID:32699268|PMID:32845096
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene] which results in increased expression of ITGA10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGA10 mRNA	PMID:40504410
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:27698	vanadium atom	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of ITGA10 mRNA	PMID:19000753
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313015	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ITGA10 mRNA	PMID:40618947
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ITGA10 mRNA	PMID:20106945|PMID:21632981
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ITGA10 mRNA	PMID:33956508
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313014	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ITGA10 mRNA	PMID:16704738
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of ITGA10 mRNA	PMID:29955902
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313014	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ITGA10 mRNA	PMID:33212167
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ITGA10 mRNA	PMID:26033743
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313014	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ITGA10 mRNA	PMID:30911355
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ITGA10 mRNA	PMID:30031762
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313014	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ITGA10 mRNA	PMID:29803840
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ITGA10 mRNA	PMID:24431212|PMID:38568856
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20220405	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene] which results in increased expression of ITGA10 mRNA; [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGA10 mRNA	PMID:34876320|PMID:40504410
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA	PMID:34876320
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ITGA10 mRNA	PMID:26033743
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313014	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ITGA10 mRNA	PMID:30911355
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of ITGA10 mRNA	PMID:24915197
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ITGA10 mRNA	PMID:29264374
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGA10 mRNA	PMID:29950665
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ITGA10 mRNA	PMID:34492290
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ITGA10 mRNA	PMID:25181051|PMID:31129395|PMID:34947998
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ITGA10 mRNA	PMID:32156529|PMID:37894381|PMID:38074096
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313015	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of ITGA10 mRNA	PMID:20713471
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ITGA10 mRNA	PMID:39298647
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1313015	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of ITGA10 mRNA	PMID:26377693
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ITGA10 mRNA	PMID:38685157
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGA10 mRNA	PMID:29950665
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:35170	vanadium(0)	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of ITGA10 mRNA	PMID:19000753
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ITGA10 mRNA	PMID:38568856
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313014	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ITGA10 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ITGA10 mRNA	PMID:32699268
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ITGA10 mRNA	PMID:20106945
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313015	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of ITGA10 mRNA	PMID:22733784
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ITGA10 mRNA	PMID:38832940
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene] which results in increased expression of ITGA10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGA10 mRNA	PMID:40504410
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA	PMID:34876320
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:50091	S-nitrosoglutathione	affects expression	ISO	RGD:1313014	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione affects the expression of ITGA10 mRNA	PMID:38825487
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ITGA10 mRNA	PMID:38701926
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of ITGA10 mRNA	PMID:28801915
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ITGA10 mRNA	PMID:37269647
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:756028	mivebresib	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of ITGA10 mRNA	PMID:35486664
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313014	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ITGA10 mRNA	PMID:36139627
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA	PMID:34876320
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of ITGA10 mRNA	PMID:24780913
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of ITGA10 mRNA	PMID:31863870
1305152	Itga10	integrin subunit alpha 10	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313014	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ITGA10 mRNA	PMID:29301935
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C084079	triptonide results in increased expression of CFAP184 mRNA	PMID:33045310
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CFAP184 gene	PMID:20938992
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1603873	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CFAP184 mRNA	PMID:23724009
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D001280	Atrazine results in decreased expression of CFAP184 mRNA	PMID:36841081
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CFAP184 gene	PMID:20938992
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603873	E	RGD:6480464	20260707	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CFAP184 mRNA	PMID:37042841
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate affects the expression of CFAP184 mRNA	PMID:21195148
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1603873	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of CFAP184 mRNA	PMID:33647349
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D003471	Cuprizone results in increased expression of CFAP184 mRNA	PMID:26577399
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1603873	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CFAP184 mRNA	PMID:36139627
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1603873	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of CFAP184 mRNA	PMID:24376830
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1603873	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CFAP184 mRNA	PMID:21641981
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1603873	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CFAP184 mRNA	PMID:23649840
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CFAP184 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CFAP184 mRNA	PMID:34911549
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603873	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CFAP184 mRNA	PMID:35430440
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1603873	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of CFAP184 mRNA	PMID:19774075
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000661	Amphetamine results in increased expression of CFAP184 mRNA	PMID:30779732
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CFAP184 gene	PMID:20938992
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1603873	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of CFAP184 mRNA	PMID:27392435
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CFAP184 mRNA	PMID:22298810
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1603873	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of CFAP184 mRNA	PMID:29955902
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603873	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CFAP184 mRNA	PMID:34032870
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603873	E	RGD:6480464	20260707	CTD	MESH:C017947	sodium arsenite results in increased expression of CFAP184 mRNA	PMID:38568856
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1603873	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CFAP184 exon	PMID:27901495
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1603873	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of CFAP184 mRNA	PMID:37690743
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C032036	bromobenzene results in increased expression of CFAP184 mRNA	PMID:32479839
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in decreased expression of CFAP184 mRNA	PMID:23557971
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CFAP184 gene	PMID:35295148
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013853	Thioacetamide results in increased expression of CFAP184 mRNA	PMID:34492290
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CFAP184 mRNA	PMID:19710929
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in decreased expression of CFAP184 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in increased expression of CFAP184 mRNA	PMID:30951980
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1603873	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CFAP184 mRNA	PMID:25979313
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C543008	bisphenol S results in increased expression of CFAP184 mRNA	PMID:30951980
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C008745	bisphenol F results in increased expression of CFAP184 mRNA	PMID:30951980|PMID:38685157
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:D016264	Dextran Sulfate results in increased expression of CFAP184 mRNA	PMID:35093514
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603873	E	RGD:6480464	20260707	CTD	MESH:C005445	triphenyl phosphate affects the expression of CFAP184 mRNA	PMID:37042841
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CFAP184 mRNA	PMID:40194260
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1603873	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CFAP184 mRNA	PMID:31533062
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:D002737	Chloroprene results in increased expression of CFAP184 mRNA	PMID:23125180
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603873	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CFAP184 gene	PMID:29154799
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1603873	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CFAP184 mRNA	PMID:38832940
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1603873	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CFAP184 mRNA	PMID:28542535
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000082	Acetaminophen results in increased expression of CFAP184 mRNA	PMID:33387578
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CFAP184 mRNA	PMID:38701926
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C025340	manganese chloride results in increased expression of CFAP184 mRNA	PMID:28801915
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1603873	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CFAP184 mRNA	PMID:37199045
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1603873	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CFAP184 mRNA	PMID:36139627
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603873	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CFAP184 gene]	PMID:28238834
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C028577	monobutyl phthalate affects the expression of CFAP184 mRNA	PMID:21195148
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D012999	Soman results in decreased expression of CFAP184 mRNA	PMID:19281266
1305153	Cfap184	cilia and flagella associated protein 184	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1332091	E	RGD:6480464	20260707	CTD	MESH:C080163	trovafloxacin results in increased expression of CFAP184 mRNA	PMID:35537566
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ASB7 mRNA	PMID:26251327
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313017	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ASB7 mRNA	PMID:20655997
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ASB7 mRNA	PMID:33387578
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313017	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ASB7 intron	PMID:30157460
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1619902	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ASB7 mRNA	PMID:36331819
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ASB7 mRNA	PMID:39836092
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313017	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ASB7 mRNA	PMID:19549813
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1619902	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ASB7 mRNA	PMID:19770486
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313017	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ASB7 mRNA	PMID:19774075
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313017	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ASB7 gene	PMID:25304211
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ASB7 mRNA	PMID:39836092
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA	PMID:33854195
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ASB7 mRNA	PMID:23557933
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ASB7 mRNA	PMID:32186404
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619902	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASB7 mRNA	PMID:21570461
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313017	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASB7 mRNA	PMID:30851411
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ASB7 mRNA	PMID:26033743
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of ASB7 mRNA	PMID:26033743
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313017	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ASB7 mRNA	PMID:29803840
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ASB7 mRNA	PMID:39836092
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ASB7 mRNA	PMID:26033743
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of ASB7 mRNA	PMID:26033743
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1619902	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ASB7 mRNA	PMID:35295148
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ASB7 mRNA	PMID:18648102
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1619902	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ASB7 mRNA	PMID:19136022
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of ASB7 mRNA	PMID:21318169
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1619902	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of ASB7 mRNA]	PMID:21318169
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313017	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ASB7 gene	PMID:31601247
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ASB7 mRNA	PMID:32145629
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ASB7 mRNA	PMID:39298647
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASB7 mRNA	PMID:28628672
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313017	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ASB7 intron	PMID:30157460
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASB7 mRNA	PMID:28628672
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA	PMID:33854195
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASB7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASB7 mRNA	PMID:28628672
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ASB7 mRNA	PMID:39836092
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ASB7 gene	PMID:22079235
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1619902	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ASB7 mRNA	PMID:36331819
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1619902	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ASB7 mRNA	PMID:17292431
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313017	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ASB7 mRNA	PMID:23179753
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ASB7 mRNA	PMID:17183730
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA	PMID:33854195
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASB7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASB7 mRNA	PMID:28628672
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1619902	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ASB7 mRNA	PMID:18502557
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA	PMID:33854195
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313017	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ASB7 mRNA	PMID:21420995
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ASB7 mRNA	PMID:29279043
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313017	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ASB7 gene	PMID:25304211
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ASB7 mRNA	PMID:39836092
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ASB7 mRNA	PMID:35436446
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASB7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASB7 mRNA	PMID:28628672
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1619902	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ASB7 mRNA	PMID:25554681
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ASB7 mRNA	PMID:17183730
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA	PMID:33854195
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313017	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ASB7 mRNA	PMID:39836092
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313017	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ASB7 intron	PMID:30157460
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ASB7 mRNA	PMID:22206623
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313017	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASB7 mRNA	PMID:30851411
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1619902	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ASB7 mRNA	PMID:19136022|PMID:23091169
1305154	Asb7	ankyrin repeat and SOCS box-containing 7	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of ASB7 mRNA	PMID:21278054
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:119915	fentanyl	affects expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D005283	Fentanyl affects the expression of ADAMTSL3 mRNA	PMID:36032789
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313018	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ADAMTSL3 mRNA	PMID:27188386
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAMTSL3 mRNA	PMID:36331819
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ADAMTSL3 mRNA	PMID:26079696
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313019	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ADAMTSL3 mRNA	PMID:30319688
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313018	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of ADAMTSL3 protein	PMID:18951874
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ADAMTSL3 mRNA	PMID:30510588
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ADAMTSL3 mRNA	PMID:26079696
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL3 mRNA	PMID:37992649
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ADAMTSL3 mRNA	PMID:26717081
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:17578	toluene	increases methylation	ISO	RGD:1313018	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ADAMTSL3 gene	PMID:26717081
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL3 mRNA	PMID:37992649
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ADAMTSL3 mRNA	PMID:34319233
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ADAMTSL3 mRNA	PMID:33387578
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313018	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ADAMTSL3 intron	PMID:30157460
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313018	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ADAMTSL3 mRNA	PMID:19549813
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ADAMTSL3 mRNA	PMID:22100608
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313018	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ADAMTSL3 mRNA	PMID:40512198
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene	PMID:33854195
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313018	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of ADAMTSL3 mRNA	PMID:41028656
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of ADAMTSL3 mRNA	PMID:40618947
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1313018	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of ADAMTSL3 protein	PMID:18951874
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313018	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ADAMTSL3 mRNA	PMID:41028656
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADAMTSL3 mRNA	PMID:29803840
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADAMTSL3 mRNA	PMID:39631538
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL3 mRNA	PMID:37992649
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAMTSL3 mRNA	PMID:22714537|PMID:29301061
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAMTSL3 mRNA	PMID:37682722
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313018	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ADAMTSL3 mRNA	PMID:40512198
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313018	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADAMTSL3 intron	PMID:30157460
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADAMTSL3 mRNA	PMID:32234424
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313018	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADAMTSL3 3' UTR; Benzo(a)pyrene results in increased methylation of ADAMTSL3 5' UTR; Benzo(a)pyrene results in increased methylation of ADAMTSL3 exon; Benzo(a)pyrene results in increased methylation of ADAMTSL3 promoter	PMID:27901495
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313018	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ADAMTSL3 mRNA]	PMID:32406909
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313018	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ADAMTSL3 mRNA	PMID:41028656
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ADAMTSL3 mRNA	PMID:27131904
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ADAMTSL3 mRNA	PMID:26705709
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313019	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADAMTSL3 gene; titanium dioxide results in decreased methylation of ADAMTSL3 promoter	PMID:35295148
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313019	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ADAMTSL3 mRNA	PMID:35295148
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313019	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ADAMTSL3 promoter	PMID:35295148
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTSL3 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ADAMTSL3 gene	PMID:28505145
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ADAMTSL3 mRNA	PMID:32119087
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313019	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ADAMTSL3 gene	PMID:31683443
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313019	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ADAMTSL3 mRNA	PMID:30951980
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313018	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ADAMTSL3 intron	PMID:30157460
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313019	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ADAMTSL3 mRNA	PMID:30951980
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313019	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ADAMTSL3 intron	PMID:28392331
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene	PMID:33854195
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ADAMTSL3 mRNA	PMID:32680482
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ADAMTSL3 gene	PMID:33148267
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313018	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ADAMTSL3 mRNA	PMID:38382870
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ADAMTSL3 mRNA	PMID:40194260
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAMTSL3 mRNA	PMID:36331819
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313018	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ADAMTSL3 gene	PMID:29154799
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene	PMID:33854195
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ADAMTSL3 mRNA	PMID:28973697
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL3 mRNA	PMID:37992649
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene	PMID:33854195
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADAMTSL3 mRNA	PMID:33387578
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADAMTSL3 mRNA	PMID:21420995
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ADAMTSL3 mRNA	PMID:24714768
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313018	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ADAMTSL3 mRNA	PMID:40512198
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ADAMTSL3 mRNA	PMID:29391264
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ADAMTSL3 mRNA	PMID:32234424
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ADAMTSL3 mRNA	PMID:26705709
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ADAMTSL3 mRNA	PMID:22714537
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of ADAMTSL3 mRNA	PMID:19042947
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene	PMID:33854195
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of ADAMTSL3 mRNA	PMID:22078008
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313018	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ADAMTSL3 intron	PMID:30157460
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ADAMTSL3 gene	PMID:33148267
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ADAMTSL3 mRNA	PMID:22714537
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313018	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ADAMTSL3 gene]	PMID:28238834
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313018	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of ADAMTSL3 mRNA	PMID:32234424
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ADAMTSL3 mRNA	PMID:24780913
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1313018	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of ADAMTSL3 mRNA	PMID:14699072
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ADAMTSL3 mRNA	PMID:27131904
1305155	Adamtsl3	ADAMTS-like 3	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1313018	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ADAMTSL3 mRNA	PMID:17440010
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606915	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NSMCE2 mRNA	PMID:38218311
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1331905	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NSMCE2 mRNA	PMID:39241906
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1606915	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of NSMCE2 mRNA	PMID:31614463
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of NSMCE2 gene	PMID:27618143
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of NSMCE2 mRNA	PMID:27523638
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of NSMCE2 mRNA	PMID:26577399
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1606915	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NSMCE2 mRNA	PMID:28818685
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1331905	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NSMCE2 mRNA	PMID:37236586
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1606915	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NSMCE2 mRNA	PMID:22100608
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1331905	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NSMCE2 mRNA	PMID:34911549
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1331905	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NSMCE2 mRNA	PMID:25629700
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606915	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NSMCE2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of NSMCE2 mRNA	PMID:32525701|PMID:40512198
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606915	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NSMCE2 mRNA	PMID:23557933
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606915	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of NSMCE2 mRNA	PMID:19561079
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1331905	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NSMCE2 mRNA	PMID:21570461
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1331905	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NSMCE2 mRNA	PMID:19465110
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606915	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NSMCE2 mRNA	PMID:33212167
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1606915	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of NSMCE2 mRNA	PMID:32763439
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606915	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NSMCE2 mRNA	PMID:29803840
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606915	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NSMCE2 mRNA	PMID:38568856
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606915	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NSMCE2 mRNA	PMID:40512198
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1606915	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NSMCE2 mRNA	PMID:20064835|PMID:26238291
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606915	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NSMCE2 5' UTR	PMID:27901495
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1331905	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NSMCE2 mRNA	PMID:22228805
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1331905	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of NSMCE2 mRNA]	PMID:22228805
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1606915	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to NSMCE2 mRNA]	PMID:32406909
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1331905	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of NSMCE2 mRNA	PMID:27131904
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1606915	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NSMCE2 gene	PMID:31601247
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NSMCE2 mRNA	PMID:25729387
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1331905	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of NSMCE2 mRNA	PMID:21318169
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1331905	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of NSMCE2 mRNA]	PMID:21318169
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NSMCE2 gene	PMID:28505145
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1606915	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of NSMCE2 gene	PMID:31601247
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606915	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NSMCE2 gene	PMID:31601247
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1606915	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of NSMCE2 gene	PMID:31601247
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1331905	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NSMCE2 mRNA	PMID:39298647
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1331905	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NSMCE2 intron	PMID:28392331
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1331905	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NSMCE2 mRNA	PMID:37019170
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606915	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NSMCE2 mRNA	PMID:37042841
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606915	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NSMCE2 mRNA	PMID:38568856
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1331905	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NSMCE2 mRNA	PMID:37236586
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1606915	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NSMCE2 mRNA	PMID:28302478
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606915	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NSMCE2 mRNA	PMID:31533062
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606915	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of NSMCE2 mRNA	PMID:20106945
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1331905	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NSMCE2 mRNA]	PMID:18700144
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606915	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NSMCE2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of NSMCE2 mRNA	PMID:32525701|PMID:40512198
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1606915	E	RGD:6480464	20121009	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of NSMCE2 mRNA	PMID:22079256
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1606915	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NSMCE2 mRNA	PMID:22079256
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1331905	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of NSMCE2 mRNA	PMID:25554681|PMID:25620056
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of NSMCE2 mRNA	PMID:24136188
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NSMCE2 mRNA	PMID:24136188
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of NSMCE2 mRNA	PMID:20080153
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NSMCE2 mRNA	PMID:25729387
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1331905	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NSMCE2 mRNA	PMID:22206623
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1606915	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NSMCE2 mRNA	PMID:22079256
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1606915	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NSMCE2 mRNA	PMID:22079256
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1606915	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of NSMCE2 protein	PMID:31285264
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1606915	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of NSMCE2 mRNA	PMID:32525701
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1331905	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of NSMCE2 mRNA	PMID:27131904
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1606915	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NSMCE2 mRNA	PMID:38568856
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1606915	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of NSMCE2 mRNA	PMID:29301935
1305156	Nsmce2	NSE2 SUMO ligase component of SMC5/6 complex	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of NSMCE2 mRNA	PMID:23034163
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1606802	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of GASK1A mRNA	PMID:26272509|PMID:27188386
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1606802	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GASK1A mRNA	PMID:27188386
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313021	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM198A mRNA	PMID:36189433
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313021	E	RGD:6480464	20191112	CTD	MESH:D000431	Ethanol results in increased expression of GASK1A mRNA	PMID:30319688
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1606802	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GASK1A mRNA	PMID:35811015
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313021	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GASK1A mRNA	PMID:39241906
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1606802	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GASK1A mRNA	PMID:35811015
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1606802	E	RGD:6480464	20191112	CTD	MESH:D014260	Triclosan results in increased expression of GASK1A mRNA	PMID:30510588
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313021	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GASK1A mRNA	PMID:39298647
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM198A mRNA	PMID:32741896
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313021	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FAM198A mRNA	PMID:36189433
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM198A mRNA	PMID:32741896
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313021	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GASK1A mRNA	PMID:37236586
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606802	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GASK1A mRNA	PMID:19549813
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1606802	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GASK1A gene	PMID:27153756
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1606802	E	RGD:6480464	20190409	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GASK1A intron	PMID:30157460
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GASK1A mRNA	PMID:30723492|PMID:31150632
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1606802	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of GASK1A mRNA	PMID:26272509
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1606802	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GASK1A mRNA	PMID:27188386
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606802	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of GASK1A mRNA	PMID:23557933
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313021	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of GASK1A mRNA	PMID:40618947
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313021	E	RGD:6480464	20190409	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GASK1A mRNA	PMID:26377647
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of FAM198A mRNA	PMID:28374803
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606802	E	RGD:6480464	20190409	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM198A promoter; Benzo(a)pyrene affects the methylation of GASK1A exon	PMID:27901495|PMID:30157460
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606802	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM198A 5' UTR	PMID:27901495
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GASK1A mRNA	PMID:34492290
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM198A mRNA	PMID:32145629
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313021	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GASK1A mRNA	PMID:33221593
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313021	E	RGD:6480464	20190409	CTD	MESH:C006780	bisphenol A results in increased methylation of GASK1A promoter	PMID:27312807
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313021	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GASK1A mRNA	PMID:39298647
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of FAM198A mRNA	PMID:32680482
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of GASK1A mRNA	PMID:30723492
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606802	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GASK1A mRNA	PMID:26472689|PMID:38568856
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313021	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GASK1A mRNA	PMID:37236586
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of GASK1A mRNA	PMID:26194646
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1606802	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of FAM198A mRNA	PMID:31626844
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606802	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GASK1A mRNA	PMID:25979313
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606802	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of GASK1A mRNA	PMID:24935251|PMID:28001369
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1606802	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of GASK1A promoter	PMID:27989131
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1606802	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GASK1A mRNA	PMID:38832940
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1606802	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GASK1A mRNA	PMID:35811015
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313021	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of GASK1A mRNA	PMID:35436446
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313021	E	RGD:6480464	20190409	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GASK1A mRNA; Nanotubes, Carbon results in decreased expression of GASK1A mRNA	PMID:25620056
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of GASK1A mRNA	PMID:23962444
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313021	E	RGD:6480464	20190409	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of GASK1A mRNA	PMID:23608068
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313021	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of GASK1A mRNA	PMID:38701926
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GASK1A gene	PMID:35440735
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1313021	E	RGD:6480464	20190409	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GASK1A mRNA	PMID:27935865
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM198A mRNA	PMID:32741896
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606802	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GASK1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GASK1A mRNA	PMID:27188386
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606802	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GASK1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GASK1A mRNA	PMID:27188386
1305157	Gask1a	golgi associated kinase 1A	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1313021	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of FAM198A mRNA	PMID:32835833
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614364	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SMIM8 mRNA	PMID:33045310
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SMIM8 mRNA]	PMID:31150632
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SMIM8 mRNA	PMID:33167477
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:D001280	Atrazine results in decreased expression of SMIM8 mRNA	PMID:22378314
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313022	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SMIM8 mRNA	PMID:37042841
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1614364	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SMIM8 mRNA	PMID:35716406
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SMIM8 mRNA	PMID:33387578
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SMIM8 mRNA	PMID:28818685
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SMIM8 mRNA	PMID:19549813
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313022	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SMIM8 gene	PMID:27153756
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614364	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SMIM8 mRNA	PMID:34911549
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SMIM8 mRNA	PMID:31150632
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1614364	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SMIM8 mRNA	PMID:31919559
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SMIM8 mRNA]	PMID:31150632
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614364	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMIM8 mRNA	PMID:22206623
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:D001151	Arsenic affects the methylation of SMIM8 gene	PMID:25304211
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313022	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SMIM8 mRNA	PMID:23557933
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1614364	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SMIM8 mRNA	PMID:30912803
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:D009532	Nickel results in decreased expression of SMIM8 mRNA	PMID:25583101
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SMIM8 mRNA	PMID:28001369
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SMIM8 mRNA	PMID:30851411
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMIM8 mRNA	PMID:29803840
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMIM8 mRNA	PMID:20064835
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313022	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SMIM8 promoter	PMID:27901495
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMIM8 mRNA	PMID:25729387
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SMIM8 mRNA	PMID:34492290
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614364	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SMIM8 mRNA	PMID:33221593
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SMIM8 mRNA	PMID:36041667
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1614364	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SMIM8 mRNA	PMID:39298647
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SMIM8 mRNA	PMID:36041667
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SMIM8 mRNA	PMID:36041667
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1614364	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMIM8 mRNA	PMID:37019170
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1614364	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of SMIM8 protein	PMID:39748354
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of SMIM8 promoter	PMID:22457795
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313022	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SMIM8 mRNA	PMID:24449571
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614364	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SMIM8 mRNA	PMID:40194260
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SMIM8 mRNA	PMID:28302478
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SMIM8 mRNA	PMID:31533062
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:D014635	Valproic Acid affects the expression of SMIM8 mRNA	PMID:25979313
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313022	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SMIM8 mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMIM8 mRNA	PMID:20106945
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:C011890	kojic acid results in decreased expression of SMIM8 mRNA	PMID:16595896
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313022	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SMIM8 mRNA	PMID:27188386
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:C012589	trichostatin A results in increased expression of SMIM8 mRNA	PMID:24935251
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313022	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM8 mRNA	PMID:27188386
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SMIM8 mRNA	PMID:33387578
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:D001151	Arsenic affects the methylation of SMIM8 gene	PMID:25304211
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMIM8 mRNA	PMID:22079256
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1614364	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SMIM8 mRNA	PMID:35436446
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMIM8 mRNA	PMID:25729387
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614364	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMIM8 mRNA	PMID:22206623
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SMIM8 mRNA	PMID:22079256
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313022	E	RGD:6480464	20161018	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMIM8 mRNA	PMID:22079256
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313022	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SMIM8 mRNA	PMID:30851411
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313022	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM8 mRNA	PMID:27188386
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1614364	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SMIM8 mRNA	PMID:31388691
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1614364	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of SMIM8 mRNA	PMID:40826991
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313022	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM8 mRNA	PMID:27188386
1305158	Smim8	small integral membrane protein 8	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of SMIM8 mRNA	PMID:23034163
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1349800	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of WDR5 mRNA	PMID:19438726
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of WDR5 mRNA	PMID:21551480
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313023	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of WDR5 mRNA	PMID:37995155
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of WDR5 mRNA]	PMID:31150632
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1349800	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of WDR5 protein]	PMID:38195004
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349800	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of WDR5 mRNA	PMID:33167477
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313023	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WDR5 mRNA	PMID:30529165
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1349800	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of WDR5 mRNA	PMID:18951874
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313023	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of WDR5 mRNA	PMID:39241906
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1349800	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of WDR5 mRNA	PMID:22574217
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313023	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone results in increased expression of WDR5 mRNA	PMID:31084621
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of WDR5 gene	PMID:27618143
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349800	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of WDR5 mRNA	PMID:37042841
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1349800	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of WDR5 mRNA	PMID:21179406
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of WDR5 mRNA	PMID:22061828
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1349800	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of WDR5 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of WDR5 protein	PMID:38195004
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of WDR5 mRNA	PMID:31150632
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of WDR5 mRNA]	PMID:31150632
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1349800	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of WDR5 gene	PMID:25304211
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1349800	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of WDR5 mRNA	PMID:24768652|PMID:25583101
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313023	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDR5 mRNA	PMID:21570461
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WDR5 mRNA	PMID:33387578
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313023	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WDR5 mRNA	PMID:17942748
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1349800	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of WDR5 mRNA	PMID:29803840
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349800	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of WDR5 mRNA	PMID:38568856
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349800	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of WDR5 mRNA	PMID:34032870
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313023	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WDR5 mRNA	PMID:22228805
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313023	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WDR5 intron	PMID:27901495
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313023	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to WDR5 promoter]	PMID:19654925
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1349800	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of WDR5 promoter	PMID:23974009
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1349800	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to WDR5 protein]	PMID:32406909
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:31642	gadodiamide hydrate	increases expression	ISO	RGD:1349800	E	RGD:6480464	20161213	CTD	MESH:C064925	gadodiamide results in increased expression of WDR5 mRNA	PMID:20959327
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313023	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of WDR5 enhancer; titanium dioxide results in decreased methylation of WDR5 promoter	PMID:35295148
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of WDR5 mRNA	PMID:23411599|PMID:34492290
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313023	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of WDR5 mRNA	PMID:18301758
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1349800	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of WDR5 mRNA	PMID:38479592
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349800	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR5 mRNA; bisphenol A results in decreased expression of WDR5 protein	PMID:29275510|PMID:33376534
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of WDR5 mRNA	PMID:25181051
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313023	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of WDR5 protein	PMID:33022573
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1349800	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of WDR5 mRNA; bisphenol A results in increased expression of WDR5 protein	PMID:33022573
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313023	E	RGD:6480464	20220208	CTD	MESH:C006780	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [bisphenol A results in increased expression of WDR5 protein]	PMID:33022573
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1349800	E	RGD:6480464	20220208	CTD	MESH:C006780	[bisphenol A promotes the reaction [WDR5 protein binds to TET2 protein]] which binds to ESR2 exon; [bisphenol A promotes the reaction [WDR5 protein binds to TET2 protein]] which binds to ESR2 promoter; bisphenol A promotes the reaction [WDR5 protein binds to TET2 protein]; GPER1 protein affects the reaction [bisphenol A results in increased expression of WDR5 protein]; TET2 protein inhibits the reaction [[bisphenol A promotes the reaction [WDR5 protein binds to TET2 protein]] which binds to ESR2 exon]; TET2 protein inhibits the reaction [[bisphenol A promotes the reaction [WDR5 protein binds to TET2 protein]] which binds to ESR2 promoter]; TET2 protein inhibits the reaction [bisphenol A promotes the reaction [WDR5 protein binds to TET2 protein]]; WDR5 protein affects the reaction [bisphenol A results in increased expression of ESR2 protein]	PMID:33022573
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1349800	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of WDR5 protein	PMID:31675489
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1349800	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of WDR5 protein	PMID:31945527
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:34432	4-octylphenol	increases expression	ISO	RGD:1349800	E	RGD:6480464	20140204	CTD	MESH:C080417	4-octylphenol results in increased expression of WDR5 protein	PMID:20056579
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313023	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of WDR5 mRNA	PMID:28392331
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of WDR5 mRNA	PMID:17602206
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313023	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of WDR5 protein	PMID:35362542
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313023	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of WDR5 protein]	PMID:35362542
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313023	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of WDR5 mRNA	PMID:34813904
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of WDR5 mRNA	PMID:17602206
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1349800	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of WDR5 mRNA	PMID:38568856
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1349800	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of WDR5 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of WDR5 protein	PMID:38195004
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1349800	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of WDR5 mRNA	PMID:28302478
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349800	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of WDR5 mRNA	PMID:25979313
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349800	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of WDR5 mRNA	PMID:23179753
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1349800	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of WDR5 gene	PMID:25304211
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313023	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of WDR5 mRNA	PMID:17555576|PMID:17942748
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313023	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WDR5 mRNA	PMID:17942748
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313023	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of WDR5 protein]	PMID:35362542
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of WDR5 mRNA	PMID:24136188
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313023	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of WDR5 mRNA	PMID:19042947
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1349800	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of WDR5 protein	PMID:32959892
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313023	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of WDR5 protein	PMID:26558463
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1313023	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of WDR5 protein	PMID:35926579
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313023	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of WDR5 mRNA	PMID:22206623
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1349800	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of WDR5 protein	PMID:37664457
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1349800	E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in increased expression of WDR5 protein	PMID:20056579
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1349800	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of WDR5 mRNA	PMID:19159669
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1349800	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of WDR5 protein	PMID:31675489
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of WDR5 mRNA	PMID:36084822
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1349800	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of WDR5 protein	PMID:31675489
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1349800	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of WDR5 protein	PMID:38348393
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349800	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of WDR5 protein	PMID:37664457
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of WDR5 mRNA	PMID:21346803
1305159	Wdr5	WD repeat domain 5	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of WDR5 mRNA	PMID:23034163
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:C084079	triptonide results in increased expression of NTAN1 mRNA	PMID:33045310
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:C018475	butyraldehyde results in increased expression of NTAN1 mRNA	PMID:26079696
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D011794	Quercetin results in increased expression of NTAN1 mRNA	PMID:21632981
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D004958	Estradiol results in decreased expression of NTAN1 mRNA	PMID:30077407
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D004958	[Polyphenols co-treated with Estradiol] results in decreased expression of NTAN1 mRNA	PMID:30077407
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20170530	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of NTAN1 mRNA	PMID:26496021
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	EXP		E	RGD:6480464	20170530	CTD	MESH:D000242	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of NTAN1 mRNA]	PMID:19414516
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1350127	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of NTAN1 intron	PMID:30157460
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of NTAN1 protein	PMID:34915118
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D019327	Copper Sulfate results in increased expression of NTAN1 mRNA	PMID:19549813
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of NTAN1 mRNA	PMID:23649840
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NTAN1 mRNA	PMID:23649840
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NTAN1 mRNA	PMID:31919559
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of NTAN1 mRNA]	PMID:22206623
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D002945	Cisplatin results in increased expression of NTAN1 mRNA	PMID:27392435|PMID:27594783
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of NTAN1 mRNA	PMID:27392435
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NTAN1 mRNA	PMID:21570461|PMID:24680724
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NTAN1 mRNA	PMID:17942748
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of NTAN1 mRNA	PMID:28374803
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1350127	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NTAN1 mRNA	PMID:38568856
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350127	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NTAN1 intron	PMID:30157460
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NTAN1 mRNA	PMID:22228805
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1350127	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NTAN1 mRNA	PMID:32234424
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NTAN1 mRNA	PMID:19150397
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332072	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NTAN1 promoter	PMID:35295148
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332072	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NTAN1 gene	PMID:35295148
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of NTAN1 mRNA	PMID:18648102
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NTAN1 mRNA	PMID:19710929
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20170530	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of NTAN1 mRNA	PMID:26496021
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	multiple interactions	EXP		E	RGD:6480464	20170530	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of NTAN1 mRNA]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of NTAN1 mRNA]	PMID:19414516
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1332072	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of NTAN1 promoter	PMID:33297965
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1350127	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NTAN1 intron	PMID:30157460
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1332072	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of NTAN1 mRNA	PMID:28392331
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NTAN1 mRNA	PMID:21266533
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350127	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NTAN1 mRNA	PMID:37042841
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D014635	Valproic Acid affects the expression of NTAN1 mRNA	PMID:25979313
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1350127	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of NTAN1 gene	PMID:29154799
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of NTAN1 mRNA	PMID:17183730
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D016572	Cyclosporine results in decreased expression of NTAN1 mRNA	PMID:25562108|PMID:27989131
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D013629	Tamoxifen affects the expression of NTAN1 mRNA	PMID:17555576
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D000082	Acetaminophen affects the expression of NTAN1 mRNA	PMID:17562736
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D000082	Acetaminophen results in decreased expression of NTAN1 mRNA	PMID:17585979
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NTAN1 mRNA	PMID:17555576
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NTAN1 mRNA	PMID:17942748
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NTAN1 mRNA	PMID:17942748
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20170530	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of NTAN1 mRNA	PMID:19162173
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332072	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NTAN1 mRNA	PMID:35964746
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of NTAN1 mRNA	PMID:17183730
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:D015474	Isotretinoin results in decreased expression of NTAN1 mRNA	PMID:20436886
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1350127	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NTAN1 protein	PMID:32959892
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1350127	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of NTAN1 intron	PMID:30157460
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NTAN1 mRNA	PMID:22206623
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of NTAN1 mRNA]	PMID:22206623
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1350127	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NTAN1 mRNA	PMID:37199045
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1350127	E	RGD:6480464	20170530	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of NTAN1 mRNA	PMID:19095052
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:90633	perfluorododecanoic acid	increases expression	EXP		E	RGD:6480464	20170530	CTD	MESH:C522391	perfluorododecanoic acid results in increased expression of NTAN1 protein	PMID:19854247
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1350127	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of NTAN1 mRNA	PMID:29301935
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1332072	E	RGD:6480464	20211116	CTD	MESH:D013792	Thalidomide results in decreased expression of NTAN1 mRNA	PMID:26217789
1305160	Ntan1	N-terminal asparagine amidase	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20170530	CTD	MESH:C057693	troglitazone results in increased expression of NTAN1 protein	PMID:21315101
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313026	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ATPAF2 mRNA	PMID:20188158
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1313025	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin affects the expression of ATPAF2 mRNA	PMID:15498508
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313025	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ATPAF2 protein	PMID:18951874
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313026	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATPAF2 mRNA	PMID:39241906
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313026	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of ATPAF2 mRNA	PMID:29980752
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313025	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATPAF2 mRNA	PMID:37042841
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATPAF2 mRNA	PMID:33387578
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313026	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATPAF2 mRNA	PMID:37236586
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of ATPAF2 protein	PMID:33236894
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313025	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATPAF2 mRNA	PMID:23649840
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313026	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ATPAF2 mRNA	PMID:25629700
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313026	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATPAF2 mRNA	PMID:22206623
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313026	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ATPAF2 protein	PMID:25505154
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313026	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATPAF2 mRNA	PMID:21570461
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313026	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATPAF2 mRNA	PMID:20399798
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATPAF2 mRNA	PMID:33387578
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1313025	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ATPAF2 protein	PMID:18951874
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313026	E	RGD:6480464	20121009	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ATPAF2 mRNA	PMID:21340527
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313025	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATPAF2 mRNA	PMID:29803840
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313026	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATPAF2 mRNA	PMID:26873546
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313025	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ATPAF2 mRNA	PMID:34032870
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313025	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of ATPAF2 protein	PMID:39571964
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313026	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATPAF2 exon; Benzo(a)pyrene results in increased methylation of ATPAF2 intron	PMID:27901495
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ATPAF2 mRNA	PMID:30047161
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:32181	tamibarotene	affects expression	ISO	RGD:1313025	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of ATPAF2 mRNA	PMID:15498508
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313026	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ATPAF2 mRNA	PMID:23811191
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313025	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATPAF2 gene	PMID:31601247
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ATPAF2 mRNA	PMID:25181051
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313026	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ATPAF2 mRNA	PMID:39298647
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ATPAF2 mRNA	PMID:21266533
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313026	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ATPAF2 mRNA	PMID:34813904
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313026	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ATPAF2 mRNA	PMID:34813904
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313025	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATPAF2 mRNA	PMID:37042841
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313026	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATPAF2 mRNA	PMID:37236586
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:3764	clotrimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of ATPAF2 mRNA	PMID:30047161
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313025	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ATPAF2 gene	PMID:29154799
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313025	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ATPAF2 mRNA	PMID:23179753
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ATPAF2 mRNA	PMID:30047161
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313025	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ATPAF2 mRNA	PMID:38832940
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ATPAF2 mRNA	PMID:33387578
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313025	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of ATPAF2 mRNA	PMID:25704631
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ATPAF2 mRNA	PMID:30047161
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ATPAF2 mRNA	PMID:24793618
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ATPAF2 mRNA	PMID:24136188
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313025	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ATPAF2 protein	PMID:23718831
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1313025	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of ATPAF2 mRNA	PMID:37939859
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313026	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATPAF2 mRNA	PMID:22206623
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313025	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATPAF2 gene]	PMID:28238834
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATPAF2 mRNA	PMID:30047161
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1313026	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of ATPAF2 protein	PMID:35357534
1305161	Atpaf2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ATPAF2 mRNA	PMID:19281266
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1604511	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FAM76A mRNA	PMID:26079696
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313027	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FAM76A mRNA	PMID:39241906
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313027	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of FAM76A mRNA	PMID:39298647
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313027	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAM76A mRNA	PMID:36331819
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313027	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FAM76A mRNA	PMID:19770486
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604511	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FAM76A 3' UTR	PMID:30157460
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604511	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FAM76A mRNA	PMID:23649840
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1604511	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of FAM76A protein	PMID:35688186
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604511	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FAM76A mRNA	PMID:23557933
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of FAM76A mRNA	PMID:19013527
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604511	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FAM76A mRNA	PMID:29803840
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1604511	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of FAM76A gene	PMID:28589171
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604511	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FAM76A mRNA	PMID:38568856
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604511	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM76A intron; Benzo(a)pyrene affects the methylation of FAM76A promoter	PMID:27901495|PMID:30157460
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313027	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FAM76A promoter	PMID:35295148
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of FAM76A mRNA	PMID:23411599
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FAM76A mRNA	PMID:25181051
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313027	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FAM76A mRNA	PMID:39298647
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1604511	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM76A mRNA	PMID:28628672
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1604511	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM76A mRNA	PMID:28628672
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604511	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FAM76A mRNA	PMID:37042841
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of FAM76A mRNA	PMID:30589522
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313027	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of FAM76A mRNA	PMID:26377693
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1604511	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FAM76A mRNA	PMID:24449571
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1604511	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FAM76A mRNA	PMID:31533062
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313027	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAM76A mRNA	PMID:36331819
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of FAM76A mRNA	PMID:23125180
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1604511	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM76A mRNA	PMID:28628672
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FAM76A mRNA	PMID:33387578
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604511	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of FAM76A mRNA	PMID:22230336
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FAM76A mRNA	PMID:29391264
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1604511	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FAM76A mRNA	PMID:22079256
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1604511	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM76A mRNA	PMID:28628672
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313027	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FAM76A mRNA; Nanotubes, Carbon results in decreased expression of FAM76A mRNA	PMID:25554681
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1604511	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of FAM76A mRNA	PMID:20977926
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313027	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FAM76A mRNA	PMID:22206623
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1604511	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FAM76A mRNA	PMID:22079256
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1604511	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FAM76A mRNA	PMID:22079256
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1313027	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of FAM76A mRNA	PMID:31388691
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313027	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of FAM76A mRNA	PMID:21278054
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FAM76A mRNA	PMID:19281266
1305162	Fam76a	family with sequence similarity 76, member A	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313027	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FAM76A mRNA	PMID:28973697
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IRGM mRNA]	PMID:31150632
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:141319	metam	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20191114	CTD	MESH:C008435	methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of IRGM1 mRNA]	PMID:24056979
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	ISO	RGD:1601797	E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of IRGM mRNA	PMID:23792671
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IRGM mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IRGM mRNA	PMID:33729688
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1601797	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IRGM mRNA	PMID:26079696
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1621624	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IRGM1 mRNA	PMID:24056979|PMID:25890327|PMID:38969277|PMID:39241906
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20161228	CTD	MESH:D008070	(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of IRGM1 mRNA]; [Lipopolysaccharides co-treated with bavachinin] results in increased expression of IRGM1 mRNA; [Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IRGM1 mRNA]; methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of IRGM1 mRNA]	PMID:24056979|PMID:25890327|PMID:38969277|PMID:39241906
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1621624	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of IRGM1 mRNA	PMID:39298647
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRGM mRNA	PMID:32741896
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1621624	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of IRGM1 mRNA	PMID:34673133
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1601797	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of IRGM mRNA	PMID:26079696
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRGM1 mRNA	PMID:37567420
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRGM mRNA	PMID:32741896
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRGM1 mRNA	PMID:37567420
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1621624	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of IRGM1 mRNA	PMID:23892564
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGM1 mRNA	PMID:39150890
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IRGM mRNA	PMID:26577399|PMID:27523638
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of IRGM mRNA	PMID:22061828|PMID:33387578
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:184255	Bavachinin	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20250114	CTD	MESH:C468752	[Lipopolysaccharides co-treated with bavachinin] results in increased expression of IRGM1 mRNA	PMID:38969277
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IRGM1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IRGM1 mRNA	PMID:37236586|PMID:37325564
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of IRGM mRNA	PMID:21396975
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of IRGM mRNA	PMID:33354967
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of IRGM mRNA	PMID:19770486
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010126	Ozone results in decreased expression of IRGM mRNA	PMID:31397875
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20130618	CTD	MESH:D010126	Ozone results in decreased expression of IRGM1 mRNA	PMID:16183385
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IRGM mRNA	PMID:31150632
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IRGM mRNA]	PMID:31150632
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IRGM1 mRNA	PMID:22206623
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IRGM1 mRNA	PMID:40504410
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1601797	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of IRGM mRNA	PMID:31874349
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRGM1 mRNA	PMID:37567420
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of IRGM mRNA	PMID:31881176
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1621624	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of IRGM1 protein	PMID:25505154
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1621624	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of IRGM1 mRNA	PMID:30912803
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of IRGM mRNA	PMID:18930951
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621624	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IRGM1 mRNA	PMID:21570461|PMID:26377647
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IRGM mRNA	PMID:22808131|PMID:33387578
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20130618	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IRGM1 mRNA	PMID:17942748
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1601797	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of IRGM mRNA	PMID:24834073
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of IRGM mRNA	PMID:28959563
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of IRGM1 mRNA	PMID:39631538
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1621624	E	RGD:6480464	20250603	CTD	MESH:D004317	Doxorubicin results in increased expression of IRGM1 mRNA	PMID:38324556
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRGM1 mRNA	PMID:37567420
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601797	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of IRGM mRNA	PMID:38568856
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621624	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of IRGM1 protein	PMID:29044176
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IRGM1 mRNA	PMID:40504410
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IRGM mRNA	PMID:19770486
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1621624	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IRGM1 mRNA	PMID:22228805|PMID:23735875
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1601797	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IRGM 5' UTR	PMID:27901495
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1601797	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of IRGM2 mRNA	PMID:25075043
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of IRGM1 mRNA	PMID:34850242
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of IRGM1 mRNA	PMID:27131904
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of IRGM mRNA	PMID:25729387
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of IRGM mRNA	PMID:25729387
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of IRGM mRNA	PMID:24136188
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of IRGM mRNA	PMID:27760801
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1621624	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of IRGM1 mRNA	PMID:23557971
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of IRGM mRNA; pirinixic acid results in decreased expression of IRGM1 mRNA	PMID:17426115|PMID:18445702|PMID:23811191
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of IRGM mRNA	PMID:19191707
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of IRGM1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of IRGM1 mRNA]	PMID:28329830
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IRGM mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1621624	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of IRGM1 mRNA	PMID:35479511
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of IRGM mRNA	PMID:28970181
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1621624	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of IRGM1 mRNA	PMID:39298647
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621624	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of IRGM1 mRNA	PMID:30951980
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1621624	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of IRGM1 mRNA	PMID:30951980
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGM1 mRNA	PMID:39150890
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGM1 mRNA	PMID:39150890
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:34696	dieldrin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D004026	Dieldrin results in decreased expression of IRGM mRNA	PMID:34051100
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGM1 mRNA	PMID:39150890
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IRGM1 mRNA]	PMID:39241906
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IRGM mRNA	PMID:33453195
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of IRGM mRNA	PMID:25993096
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1601797	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of IRGM mRNA	PMID:38568856
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IRGM1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IRGM1 mRNA	PMID:37236586|PMID:37325564
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGM1 mRNA	PMID:39150890
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1621624	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of IRGM mRNA	PMID:18353800
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:37825	p-toluidine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of IRGM mRNA	PMID:27638505
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of IRGM1 protein	PMID:26178269
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of IRGM1 mRNA	PMID:36331819
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:39481	chloroprene	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of IRGM mRNA	PMID:23125180
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1621624	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of IRGM1 mRNA	PMID:17292431
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1621624	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of IRGM1 mRNA	PMID:24896083
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1601797	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IRGM gene	PMID:29154799
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of IRGM mRNA	PMID:19770486
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1621624	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of IRGM mRNA	PMID:20937368
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of IRGM1 mRNA	PMID:22733784
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1621624	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IRGM mRNA; Fenretinide results in increased expression of IRGM1 mRNA	PMID:28973697
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRGM1 mRNA	PMID:37567420
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1601797	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IRGM mRNA	PMID:38832940
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1601797	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of IRGM mRNA	PMID:28542535
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621624	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IRGM mRNA	PMID:17562736
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IRGM mRNA	PMID:33387578
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1621624	E	RGD:6480464	20130618	CTD	MESH:D005472	IRGM1 protein affects the susceptibility to Fluorouracil	PMID:18371424
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IRGM1 mRNA	PMID:40504410
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1621624	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of IRGM1 mRNA	PMID:26934552
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of IRGM mRNA	PMID:29391264
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20130618	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IRGM1 mRNA	PMID:17942748
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1601797	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of IRGM2 mRNA	PMID:25075043
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of IRGM1 mRNA	PMID:25620056
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1621624	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IRGM1 mRNA; Nanotubes, Carbon results in increased expression of IRGM1 mRNA	PMID:25554681
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of IRGM mRNA	PMID:24793618
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:53050	trimellitic anhydride	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C015559	trimellitic anhydride results in increased expression of IRGM mRNA	PMID:21893156
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D010081	Oxazolone results in increased expression of IRGM mRNA	PMID:21893156
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1621624	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of IRGM mRNA	PMID:23608068
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1621624	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IRGM1 mRNA	PMID:38701926
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:63613	nevirapine	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D019829	Nevirapine results in decreased expression of IRGM mRNA	PMID:23947594
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20130618	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRGM1 mRNA	PMID:21641980
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of IRGM mRNA	PMID:25729387
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of IRGM mRNA	PMID:25729387
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of IRGM mRNA	PMID:23650126
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1621624	E	RGD:6480464	20120515	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of IRGM mRNA	PMID:14729362|PMID:15003993
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:68508	diethyl maleate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased expression of IRGM mRNA	PMID:21161181
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:69478	cannabidiol	affects expression	ISO	RGD:1601797	E	RGD:6480464	20250708	CTD	MESH:D002185	Cannabidiol affects the expression of IRGM mRNA	PMID:39894194
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20250708	CTD	MESH:D002185	Cannabidiol results in decreased expression of IRGM1 mRNA	PMID:39894194
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of IRGM1 mRNA	PMID:22206623
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IRGM1 mRNA	PMID:22206623
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of IRGM mRNA	PMID:24136188
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IRGM1 mRNA	PMID:37567420
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRGM mRNA	PMID:32741896
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20140715	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of IRGM mRNA	PMID:22234961
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20140715	CTD	MESH:D019324	AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of IRGM mRNA]	PMID:22234961
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:77148	ginsenoside Re	decreases expression	ISO	RGD:1601797	E	RGD:6480464	20140408	CTD	MESH:C049864	ginsenoside Re results in decreased expression of IRGM protein	PMID:20230918
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of IRGM mRNA	PMID:21346803
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGM1 mRNA	PMID:39150890
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1621624	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital affects the expression of IRGM1 mRNA	PMID:23091169
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1621624	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of IRGM1 mRNA	PMID:21195148
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1621624	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of IRGM1 mRNA	PMID:21195148
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1621624	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of IRGM mRNA; propiconazole results in increased expression of IRGM1 mRNA	PMID:21278054
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of IRGM mRNA	PMID:24780913
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IRGM1 mRNA]	PMID:39241906
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1621624	E	RGD:6480464	20170725	CTD	MESH:C093642	SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of IRGM1 mRNA]	PMID:28329830
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1621624	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of IRGM1 mRNA	PMID:27131904
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of IRGM mRNA	PMID:19281266
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of IRGM mRNA	PMID:21346803
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1601797	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of IRGM mRNA	PMID:38568856
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1621624	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of IRGM1 mRNA	PMID:21195148
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of IRGM protein	PMID:32519852
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1621624	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of IRGM1 mRNA	PMID:35537566
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of IRGM mRNA	PMID:22570695
1305163	Irgm	immunity-related GTPase M	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of IRGM gene	PMID:31682807
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:16412	lipopolysaccharide	affects localization	ISO	RGD:1622291	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides affects the localization of PDIA2 protein	PMID:17475668
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1622291	E	RGD:6480464	20161228	CTD	MESH:D008070	Vaticanol B inhibits the reaction [Lipopolysaccharides affects the localization of PDIA2 protein]	PMID:17475668
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313029	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of PDIA2 mRNA	PMID:30510588
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1622291	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PDIA2 mRNA	PMID:33711761
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PDIA2 mRNA	PMID:29945229
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PDIA2 mRNA	PMID:31163220
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1622291	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of PDIA2 mRNA	PMID:31606821
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in decreased expression of PDIA2 protein	PMID:16440303
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of PDIA2 mRNA	PMID:36861143
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1622291	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PDIA2 mRNA	PMID:28960355
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313029	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PDIA2 mRNA	PMID:23557933
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PDIA2 mRNA	PMID:27392435
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1622291	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of PDIA2 mRNA	PMID:40618947
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313029	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PDIA2 mRNA	PMID:27392435
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:D012402	Ellagic Acid inhibits the reaction [Rotenone results in increased nitrosation of and results in decreased activity of PDIA2 protein]; Rotenone results in increased nitrosation of and results in decreased activity of PDIA2 protein	PMID:25247703
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PDIA2 mRNA	PMID:32763439
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:29073	L-ascorbic acid	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20120515	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of PDIA2 mRNA	PMID:19197388
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PDIA2 protein	PMID:19294697
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1622291	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of PDIA2 mRNA	PMID:17127020
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313029	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PDIA2 5' UTR	PMID:27901495
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313029	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PDIA2 mRNA	PMID:22316170
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1622291	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of PDIA2 mRNA	PMID:35295148
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PDIA2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PDIA2 gene	PMID:28505145
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1622291	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of PDIA2 mRNA	PMID:40203079
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PDIA2 protein	PMID:16440303
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PDIA2 gene	PMID:22079235
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313029	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PDIA2 mRNA	PMID:24449571
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1622291	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PDIA2 mRNA	PMID:18353800
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:3647	chlorpromazine	increases expression	ISO	RGD:1313029	E	RGD:6480464	20120412	CTD	MESH:D002746	Chlorpromazine analog results in increased expression of PDIA2 mRNA	PMID:15924885
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of PDIA2 mRNA	PMID:22561333
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PDIA2 mRNA	PMID:29427782
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313029	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PDIA2 gene	PMID:29154799
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313029	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PDIA2 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of PDIA2 mRNA	PMID:36861143
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:4775	ellagic acid	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:D004610	Ellagic Acid inhibits the reaction [Rotenone results in increased nitrosation of and results in decreased activity of PDIA2 protein]	PMID:25247703
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of PDIA2 mRNA	PMID:40706910
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1622291	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PDIA2 mRNA	PMID:25620056
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1622291	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PDIA2 mRNA; Nanotubes, Carbon results in decreased expression of PDIA2 mRNA	PMID:25554681|PMID:25620056
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1622291	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of PDIA2 mRNA	PMID:26377693
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:52722	lactacystin	increases expression	ISO	RGD:1313029	E	RGD:6480464	20130611	CTD	MESH:C067713	lactacystin results in increased expression of PDIA2 mRNA; lactacystin results in increased expression of PDIA2 protein	PMID:15353226
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1622291	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PDIA2 mRNA	PMID:23608068
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1622291	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of PDIA2 mRNA	PMID:38701926
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PDIA2 mRNA	PMID:20080153
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313029	E	RGD:6480464	20130611	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PDIA2 mRNA; 1-Methyl-4-phenylpyridinium results in increased expression of PDIA2 protein	PMID:15353226
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:6651	malathion	decreases expression	ISO	RGD:1313029	E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of PDIA2 mRNA	PMID:37047231
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PDIA2 mRNA	PMID:24780913
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1622291	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of PDIA2 protein	PMID:35357534
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1622291	E	RGD:6480464	20250401	CTD	MESH:D013311	Streptozocin results in increased expression of PDIA2 mRNA	PMID:31606821
1305164	Pdia2	protein disulfide isomerase family A, member 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1622291	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of PDIA2 mRNA	PMID:31606821
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313032	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RANBP6 mRNA	PMID:33045310
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of RANBP6 mRNA	PMID:31016361
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313032	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RANBP6 gene	PMID:20938992
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of RANBP6 mRNA	PMID:22378314
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RANBP6 mRNA	PMID:21632981
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313032	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RANBP6 gene	PMID:20938992
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RANBP6 mRNA	PMID:26577399
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RANBP6 mRNA	PMID:28818685
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313032	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RANBP6 mRNA	PMID:36331819
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313032	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RANBP6 gene	PMID:20938992
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1313031	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of RANBP6 mRNA	PMID:18414638
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RANBP6 mRNA	PMID:28960355
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313031	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RANBP6 mRNA	PMID:22574217
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RANBP6 protein	PMID:39603559
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RANBP6 mRNA	PMID:28001369
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RANBP6 mRNA	PMID:30851411
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RANBP6 mRNA	PMID:38568856
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RANBP6 mRNA	PMID:30047161
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of RANBP6 mRNA	PMID:29264374
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313032	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RANBP6 promoter	PMID:35295148
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313032	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RANBP6 promoter	PMID:35295148
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RANBP6 mRNA	PMID:20813756
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of RANBP6 protein	PMID:31675489
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RANBP6 mRNA	PMID:25181051|PMID:29097150
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of RANBP6 protein	PMID:31675489
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1313031	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of RANBP6 mRNA	PMID:19041380
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313031	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RANBP6 protein	PMID:34186270
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313031	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RANBP6 protein	PMID:34186270
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RANBP6 mRNA	PMID:37019170
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of RANBP6 mRNA	PMID:17312168
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313031	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RANBP6 mRNA	PMID:37042841
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RANBP6 mRNA	PMID:24982889
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of RANBP6 mRNA	PMID:25539665|PMID:26194646
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RANBP6 mRNA	PMID:40194260
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RANBP6 mRNA	PMID:28302478
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RANBP6 mRNA	PMID:31533062
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313032	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RANBP6 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RANBP6 mRNA	PMID:36331819
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313031	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RANBP6 gene	PMID:29154799
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313031	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of RANBP6 mRNA	PMID:29154799
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RANBP6 mRNA	PMID:30047161
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of RANBP6 mRNA	PMID:19770486
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313032	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RANBP6 mRNA	PMID:17562736
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of RANBP6 mRNA	PMID:21420995
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1313031	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of RANBP6 mRNA	PMID:18414638
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of RANBP6 mRNA	PMID:31675489
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RANBP6 mRNA	PMID:29097150
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of RANBP6 mRNA	PMID:40234311
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of RANBP6 mRNA	PMID:22714537
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:53620	methylisothiazolinone	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of RANBP6 mRNA	PMID:31629900
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RANBP6 protein	PMID:32959892
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of RANBP6 mRNA	PMID:30467583
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RANBP6 mRNA	PMID:30851411
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of RANBP6 mRNA	PMID:20345932
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1313031	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RANBP6 protein	PMID:31675489
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of RANBP6 mRNA	PMID:26079696
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313031	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in increased expression of RANBP6 protein	PMID:38348393
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of RANBP6 mRNA	PMID:30047161
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RANBP6 mRNA	PMID:30047161|PMID:36843608
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RANBP6 mRNA	PMID:21346803
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RANBP6 mRNA	PMID:38568856
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313031	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RANBP6 mRNA	PMID:29301935
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RANBP6 mRNA	PMID:21346803
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of RANBP6 mRNA	PMID:30047161
1305165	Ranbp6	RAN binding protein 6	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313032	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of RANBP6 mRNA	PMID:35537566
1305166	Tctn3	tectonic family member 3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313033	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TCTN3 mRNA	PMID:38218311
1305166	Tctn3	tectonic family member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313033	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TCTN3 mRNA	PMID:33167477
1305166	Tctn3	tectonic family member 3	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313033	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCTN3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCTN3 mRNA	PMID:32699268
1305166	Tctn3	tectonic family member 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313034	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TCTN3 mRNA	PMID:39241906
1305166	Tctn3	tectonic family member 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313033	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TCTN3 mRNA	PMID:37042841
1305166	Tctn3	tectonic family member 3	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313034	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of TCTN3 mRNA	PMID:33914522
1305166	Tctn3	tectonic family member 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313033	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TCTN3 mRNA	PMID:19549813
1305166	Tctn3	tectonic family member 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313033	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCTN3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCTN3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TCTN3 mRNA	PMID:32699268
1305166	Tctn3	tectonic family member 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313034	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of TCTN3 mRNA	PMID:27106289
1305166	Tctn3	tectonic family member 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TCTN3 mRNA	PMID:30779732
1305166	Tctn3	tectonic family member 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313034	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TCTN3 mRNA	PMID:25629700
1305166	Tctn3	tectonic family member 3	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1313033	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of TCTN3 mRNA	PMID:18414638
1305166	Tctn3	tectonic family member 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313033	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TCTN3 mRNA	PMID:23557933
1305166	Tctn3	tectonic family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313034	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TCTN3 mRNA	PMID:21570461|PMID:26377647
1305166	Tctn3	tectonic family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TCTN3 mRNA	PMID:33387578
1305166	Tctn3	tectonic family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313034	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TCTN3 mRNA	PMID:28922406
1305166	Tctn3	tectonic family member 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313033	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TCTN3 mRNA	PMID:25879800|PMID:38568856
1305166	Tctn3	tectonic family member 3	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1313033	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of TCTN3 mRNA	PMID:25075043
1305166	Tctn3	tectonic family member 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313034	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TCTN3 promoter	PMID:35295148
1305166	Tctn3	tectonic family member 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20150707	CTD	MESH:D013853	Thioacetamide results in increased expression of TCTN3 mRNA	PMID:23411599
1305166	Tctn3	tectonic family member 3	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1313034	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of TCTN3 mRNA	PMID:33914522
1305166	Tctn3	tectonic family member 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313034	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TCTN3 mRNA	PMID:38685157
1305166	Tctn3	tectonic family member 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313034	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TCTN3 mRNA	PMID:37019170
1305166	Tctn3	tectonic family member 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313033	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TCTN3 mRNA	PMID:37042841
1305166	Tctn3	tectonic family member 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313033	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TCTN3 mRNA	PMID:38174414
1305166	Tctn3	tectonic family member 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313033	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TCTN3 mRNA	PMID:19376846
1305166	Tctn3	tectonic family member 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313033	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TCTN3 mRNA	PMID:24449571
1305166	Tctn3	tectonic family member 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313033	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCTN3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCTN3 mRNA	PMID:32699268
1305166	Tctn3	tectonic family member 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313034	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TCTN3 mRNA	PMID:40194260
1305166	Tctn3	tectonic family member 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313033	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TCTN3 mRNA	PMID:31533062
1305166	Tctn3	tectonic family member 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313033	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TCTN3 mRNA	PMID:25979313
1305166	Tctn3	tectonic family member 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313033	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TCTN3 mRNA	PMID:23179753|PMID:29154799
1305166	Tctn3	tectonic family member 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313033	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TCTN3 mRNA	PMID:25562108
1305166	Tctn3	tectonic family member 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TCTN3 mRNA	PMID:33387578
1305166	Tctn3	tectonic family member 3	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1313033	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of TCTN3 mRNA	PMID:18414638
1305166	Tctn3	tectonic family member 3	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1313033	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of TCTN3 mRNA	PMID:25075043
1305166	Tctn3	tectonic family member 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313034	E	RGD:6480464	20150707	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TCTN3 mRNA	PMID:19042947
1305166	Tctn3	tectonic family member 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313033	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TCTN3 mRNA	PMID:38568856
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1346005	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FSD2 mRNA	PMID:35811015
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1346005	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of FSD2 mRNA]	PMID:35811015
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1346005	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of FSD2 mRNA	PMID:30510588
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of FSD2 mRNA	PMID:33387578
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FSD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FSD2 mRNA	PMID:37992649
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FSD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FSD2 mRNA	PMID:37992649
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FSD2 mRNA	PMID:26472102
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FSD2 mRNA	PMID:34911549
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FSD2 mRNA	PMID:40504410
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FSD2 mRNA]	PMID:37992649
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313035	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FSD2 mRNA	PMID:28960355
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FSD2 mRNA	PMID:32109520
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of FSD2 mRNA	PMID:28374803
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1346005	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FSD2 mRNA	PMID:33212167
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346005	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FSD2 mRNA	PMID:29803840
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FSD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FSD2 mRNA	PMID:37992649
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FSD2 mRNA]	PMID:37992649
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313035	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of FSD2 mRNA	PMID:36209798|PMID:37682722
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346005	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of FSD2 mRNA	PMID:34032870
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FSD2 mRNA	PMID:40504410
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313035	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FSD2 mRNA	PMID:22228805
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346005	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FSD2 5' UTR; Benzo(a)pyrene results in increased methylation of FSD2 promoter	PMID:27901495
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FSD2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:41034487
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313035	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of FSD2 gene	PMID:31683443
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313035	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of FSD2 mRNA	PMID:40203079
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313035	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FSD2 mRNA	PMID:30951980
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1346005	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of FSD2 intron	PMID:30157460
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of FSD2 mRNA	PMID:26472102
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of FSD2 mRNA	PMID:26472102
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313035	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of FSD2 mRNA	PMID:28392331
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313035	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of FSD2 intron	PMID:28392331
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34680	dipentyl phthalate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C034171	di-n-pentyl phthalate results in decreased expression of FSD2 mRNA	PMID:26472102
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FSD2 mRNA	PMID:26472102
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:34698	diethyl phthalate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C007379	diethyl phthalate results in increased expression of FSD2 mRNA	PMID:26472102
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of FSD2 mRNA	PMID:35163327
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FSD2 mRNA	PMID:35163327
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FSD2 mRNA	PMID:35163327
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313035	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of FSD2 mRNA	PMID:28973697
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FSD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FSD2 mRNA	PMID:37992649
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1346005	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of FSD2 mRNA]	PMID:35811015
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FSD2 mRNA	PMID:40504410
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313035	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of FSD2 mRNA	PMID:38701926
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1346005	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of FSD2 intron	PMID:30157460
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1313035	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of FSD2 mRNA	PMID:25566086
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of FSD2 mRNA	PMID:32109520
1305167	Fsd2	fibronectin type III and SPRY domain containing 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313035	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FSD2 mRNA	PMID:27935865
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20170228	CTD	MESH:C014026	hexamethylene bisacetamide results in decreased expression of MCM3 mRNA	PMID:26941288
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:132238	iron(III) nitrilotriacetate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C020326	ferric nitrilotriacetate results in increased expression of MCM3 mRNA	PMID:23208426
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MCM3 mRNA	PMID:37995155
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MCM3 mRNA	PMID:39752319
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:134355	auraptene	affects expression	ISO	RGD:1313036	E	RGD:6480464	20170509	CTD	MESH:C105832	aurapten affects the expression of MCM3 mRNA	PMID:23320178
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:146207	palytoxin	increases expression	ISO	RGD:1313037	E	RGD:6480464	20200303	CTD	MESH:C010272	palytoxin results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MCM3 mRNA	PMID:16054129|PMID:33167477
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of MCM3 mRNA	PMID:26516004
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313036	E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MCM3 mRNA	PMID:23410634
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of MCM3 mRNA	PMID:23727915
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16359	cholic acid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D019826	Cholic Acid results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MCM3 mRNA	PMID:39241906
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of MCM3 mRNA	PMID:35877022
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MCM3 mRNA	PMID:32145629
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16469	17beta-estradiol	affects localization	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the localization of MCM3 protein	PMID:16966611
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313036	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of MCM3 mRNA	PMID:19167446|PMID:20049119|PMID:22494775
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MCM3 mRNA	PMID:32741896
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of MCM3 protein; Estradiol promotes the reaction [Progesterone affects the localization of MCM3 protein]	PMID:16966611
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA	PMID:25510870
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313036	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MCM3 mRNA	PMID:38568856
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313036	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MCM3 mRNA	PMID:37042841
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16827	corticosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003345	Corticosterone results in decreased expression of MCM3 mRNA	PMID:15755911
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of MCM3 mRNA	PMID:34673133
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17026	progesterone	affects localization	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the localization of MCM3 protein	PMID:16966611
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of MCM3 mRNA	PMID:16966611
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of MCM3 protein; Estradiol promotes the reaction [Progesterone affects the localization of MCM3 protein]	PMID:16966611
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of MCM3 mRNA	PMID:38160208
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM3 mRNA	PMID:37992649
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20250311	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MCM3 mRNA	PMID:33162236
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MCM3 mRNA	PMID:39752319
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MCM3 mRNA	PMID:21592394
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MCM3 mRNA	PMID:32741896
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM3 mRNA	PMID:21592394
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM3 mRNA	PMID:37992649
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313037	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MCM3 mRNA	PMID:23892564
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17750	glycine betaine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in decreased expression of MCM3 mRNA	PMID:26391144
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MCM3 mRNA	PMID:26577399
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313036	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MCM3 protein	PMID:37730182
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MCM3 mRNA	PMID:21592394
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM3 mRNA	PMID:21592394
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17907	styrene oxide	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:C013690	styrene oxide results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MCM3 mRNA	PMID:28818685
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MCM3 mRNA	PMID:39836092
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA	PMID:25510870
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA	PMID:25510870
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MCM3 mRNA	PMID:19549813
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MCM3 protein	PMID:23301498
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MCM3 mRNA	PMID:21641981
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MCM3 mRNA	PMID:19770486
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM3 mRNA	PMID:23630614
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313036	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM3 mRNA	PMID:22100608
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of MCM3 mRNA	PMID:25102026
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	ISO	RGD:1313036	E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of MCM3 protein	PMID:19845377
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MCM3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MCM3 mRNA	PMID:27106289|PMID:34911549
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:2654	aminoglutethimide	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of MCM3 protein	PMID:26102013
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MCM3 mRNA	PMID:30779732
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313037	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MCM3 mRNA	PMID:27339419|PMID:31919559
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:2756	anthracene-1,8,9-triol	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D000875	Anthralin results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MCM3 mRNA	PMID:39836092
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MCM3 mRNA	PMID:40504410
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D002110	Caffeine results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MCM3 mRNA	PMID:31295307
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MCM3 mRNA	PMID:31881176
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of MCM3 mRNA	PMID:19167446
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313036	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MCM3 mRNA	PMID:28903495
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MCM3 mRNA	PMID:19921347
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of MCM3 mRNA	PMID:22023808
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313036	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of MCM3 mRNA	PMID:27594783
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1313036	E	RGD:6480464	20130514	CTD	MESH:D010278	Parathion results in increased expression of MCM3 mRNA	PMID:17390078
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of MCM3 mRNA	PMID:23195993
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313036	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM3 mRNA	PMID:22574217
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313037	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM3 mRNA	PMID:21570461|PMID:26377647
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM3 mRNA	PMID:34747641
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM3 mRNA	PMID:19770486
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of MCM3 mRNA	PMID:33512557
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MCM3 mRNA	PMID:33212167
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of MCM3 mRNA	PMID:39709020
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MCM3 mRNA	PMID:32763439
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D020106	Acrylamide results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of MCM3 mRNA	PMID:22465980
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MCM3 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MCM3 mRNA	PMID:20971185|PMID:30911355
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313037	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of MCM3 protein	PMID:28918527
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20250204	CTD	MESH:D004317	[VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of MCM3 protein	PMID:38367682
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM3 mRNA	PMID:37992649
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28794	coumarin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of MCM3 mRNA	PMID:18480146
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313036	E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of MCM3 mRNA	PMID:20044591|PMID:23410634
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of MCM3 mRNA	PMID:22623647
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCM3 mRNA	PMID:38568856
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313037	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of MCM3 gene	PMID:32068019
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313036	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of MCM3 mRNA	PMID:28595984|PMID:34032870
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MCM3 mRNA	PMID:39836092
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MCM3 mRNA	PMID:40504410
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MCM3 mRNA	PMID:22378314
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM3 mRNA	PMID:20064835
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM3 mRNA	PMID:19770486
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313036	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCM3 mRNA	PMID:32234424|PMID:33411230
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCM3 mRNA	PMID:20713471
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of MCM3 mRNA	PMID:22465980
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MCM3 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MCM3 mRNA	PMID:20971185|PMID:30911355
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of MCM3 mRNA	PMID:26014281
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MCM3 mRNA	PMID:20382639
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MCM3 mRNA	PMID:34413873
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:30808	iron trichloride	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:C024555	ferric chloride results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:C029451	ferrous chloride results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of MCM3 mRNA	PMID:32479839
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MCM3 mRNA	PMID:25729387
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM3 mRNA	PMID:25729387
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:32111	saccharin	increases expression	ISO	RGD:1313037	E	RGD:6480464	20121009	CTD	MESH:D012439	Saccharin results in increased expression of MCM3 mRNA	PMID:19000923
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:32130	silver(1+) nitrate	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in decreased expression of MCM3 mRNA	PMID:22831968
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1313037	E	RGD:6480464	20121009	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MCM3 mRNA	PMID:19000923
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313037	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MCM3 mRNA	PMID:23557971
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MCM3 mRNA	PMID:23411599|PMID:34492290
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of MCM3 mRNA	PMID:19136022
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MCM3 mRNA	PMID:17950772|PMID:18301758|PMID:19136022|PMID:20813756|PMID:23811191
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of MCM3 mRNA]	PMID:17950772
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MCM3 mRNA	PMID:38479592
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of MCM3 mRNA	PMID:32145629
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313036	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MCM3 mRNA	PMID:30903817
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM3 mRNA; bisphenol A results in decreased expression of MCM3 protein	PMID:29275510|PMID:31675489|PMID:37567409
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313036	E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A results in increased expression of MCM3 mRNA; bisphenol A results in increased expression of MCM3 protein	PMID:22494775|PMID:33516137
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MCM3 protein	PMID:31675489
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313036	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MCM3 mRNA	PMID:25979313
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MCM3 mRNA	PMID:26682919
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA	PMID:25510870
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA	PMID:25510870
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of MCM3 mRNA	PMID:20713471
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1313037	E	RGD:6480464	20121009	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of MCM3 mRNA	PMID:19000923
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of MCM3 mRNA	PMID:20713471
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MCM3 mRNA	PMID:40203079
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MCM3 mRNA	PMID:26377693
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D016264	Dextran Sulfate results in increased expression of MCM3 protein	PMID:20025956|PMID:35362542
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MCM3 protein]	PMID:35362542
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MCM3 mRNA	PMID:17361019|PMID:21266533
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1313036	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to MCM3 protein	PMID:32991956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20180703	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of MCM3 mRNA	PMID:21404309
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MCM3 mRNA	PMID:17854601
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MCM3 mRNA]	PMID:17854601
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of MCM3 protein	PMID:39748354
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313036	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MCM3 mRNA	PMID:37042841
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MCM3 mRNA	PMID:39836092
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MCM3 mRNA	PMID:26377693
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of MCM3 mRNA	PMID:18500788
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MCM3 mRNA	PMID:30723492
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MCM3 mRNA	PMID:38174414|PMID:38568856
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MCM3 protein	PMID:26879310
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of MCM3 mRNA	PMID:25539665
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20140311	CTD	MESH:D011285	[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM3 mRNA	PMID:23626729
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MCM3 mRNA	PMID:19320972|PMID:19376846
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:3647	chlorpromazine	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D002746	Chlorpromazine analog results in decreased expression of MCM3 mRNA	PMID:15924885
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1313037	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of MCM3 mRNA	PMID:38531469
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1313037	E	RGD:6480464	20121009	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of MCM3 mRNA	PMID:19000923
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MCM3 mRNA	PMID:40194260
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MCM3 mRNA	PMID:31533062
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313036	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MCM3 mRNA	PMID:19167446
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MCM3 mRNA	PMID:19167446
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MCM3 mRNA	PMID:39529242
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of MCM3 mRNA	PMID:22110744
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of MCM3 mRNA	PMID:21427059
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of MCM3 mRNA	PMID:21427059
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of MCM3 mRNA	PMID:41580965
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MCM3 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313037	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MCM3 mRNA	PMID:28973697
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM3 mRNA	PMID:37992649
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of MCM3 mRNA	PMID:33512557
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20140408	CTD	MESH:C012589	trichostatin A results in decreased expression of MCM3 mRNA	PMID:19606018|PMID:23770000
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MCM3 mRNA	PMID:17562736
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of MCM3 mRNA	PMID:32479839|PMID:33387578
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313036	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MCM3 mRNA	PMID:22230336
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of MCM3 mRNA	PMID:16709241
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM3 mRNA]	PMID:15016801
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:47032	1,4-dioxane	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:C025223	1,4-dioxane results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MCM3 mRNA	PMID:39836092
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MCM3 mRNA	PMID:40504410
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MCM3 protein]	PMID:35362542
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MCM3 mRNA	PMID:34413873
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:49976	zinc dichloride	increases expression	ISO	RGD:1313037	E	RGD:6480464	20121009	CTD	MESH:C016837	zinc chloride results in increased expression of MCM3 mRNA	PMID:19000923
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313037	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MCM3 mRNA; Nanotubes, Carbon results in increased expression of MCM3 mRNA	PMID:25554681|PMID:25620056
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313037	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MCM3 mRNA	PMID:40234311
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MCM3 mRNA	PMID:35964746
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MCM3 mRNA	PMID:19042947
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1313037	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in increased expression of MCM3 mRNA	PMID:21404309
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1313037	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of MCM3 mRNA	PMID:21404309
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MCM3 mRNA	PMID:38701926
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MCM3 protein	PMID:32959892
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of MCM3 mRNA	PMID:19606018
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of MCM3 mRNA	PMID:20080153
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MCM3 mRNA	PMID:39836092
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MCM3 mRNA	PMID:25729387
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM3 mRNA	PMID:25729387
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	ISO	RGD:1313036	E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of MCM3 mRNA	PMID:23410634
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MCM3 mRNA	PMID:15336504
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of MCM3 mRNA	PMID:35283115
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:6918	Mezerein	increases expression	ISO	RGD:1313037	E	RGD:6480464	20141111	CTD	MESH:C011309	mezerein results in increased expression of MCM3 mRNA	PMID:19000923
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313037	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of MCM3 mRNA	PMID:27462272
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of MCM3 mRNA	PMID:36519830
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of MCM3 mRNA	PMID:22101062
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MCM3 mRNA	PMID:39752319
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313037	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MCM3 mRNA	PMID:22206623
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MCM3 protein	PMID:37664457
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of MCM3 mRNA	PMID:29522793
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:754951	siponimod	increases expression	ISO	RGD:1313037	E	RGD:6480464	20260714	CTD	MESH:C578989	siponimod results in increased expression of MCM3 mRNA	PMID:29556671
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313036	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MCM3 protein	PMID:31285264
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MCM3 mRNA	PMID:32741896
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of MCM3 mRNA	PMID:12517777
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C025589	ochratoxin A results in increased expression of MCM3 mRNA	PMID:23208426
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:78870	sodium nitrite	increases expression	ISO	RGD:1313037	E	RGD:6480464	20140708	CTD	MESH:D012977	Sodium Nitrite results in increased expression of MCM3 protein	PMID:20025956
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1313036	E	RGD:6480464	20220208	CTD	MESH:C025256	nonylphenol results in increased expression of MCM3 mRNA; nonylphenol results in increased expression of MCM3 protein	PMID:33516137
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MCM3 gene]	PMID:28238834
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:79995	GW 3965	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20200915	CTD	MESH:C473027	GW 3965 results in decreased expression of MCM3 mRNA	PMID:31437187
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313036	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MCM3 mRNA	PMID:19159669
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of MCM3 mRNA	PMID:19136022
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313037	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of MCM3 mRNA	PMID:19136022|PMID:23091169
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of MCM3 mRNA	PMID:18958704
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:81543	Tributyltin oxide	decreases phosphorylation	ISO	RGD:1313037	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased phosphorylation of MCM3 protein	PMID:22174045
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM3 mRNA	PMID:19167446
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1313036	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MCM3 protein	PMID:31675489
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of MCM3 mRNA	PMID:21858171
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:82615	diminazene diaceturate	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20240604	CTD	MESH:C003915	diminazene aceturate results in decreased expression of MCM3 mRNA	PMID:37681557
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of MCM3 mRNA	PMID:33512557
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313037	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MCM3 mRNA	PMID:39847705
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MCM3 mRNA	PMID:24780913
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MCM3 mRNA	PMID:39752319
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:90724	AM-251	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20170303	CTD	MESH:C103505	AM 251 results in decreased expression of MCM3 mRNA	PMID:16500647
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of MCM3 mRNA	PMID:32419051
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313036	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MCM3 protein	PMID:37664457
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of MCM3 mRNA	PMID:26014281
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MCM3 mRNA	PMID:38568856
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of MCM3 mRNA	PMID:22378314
1305168	Mcm3	minichromosome maintenance complex component 3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313036	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of MCM3 mRNA	PMID:19140230
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313039	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of PANK2 mRNA	PMID:33045310
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PANK2 mRNA	PMID:30071829
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313038	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of PANK2 mRNA	PMID:33167477
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313038	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PANK2 mRNA	PMID:21632981
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313038	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA	PMID:39836092
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:18388	apigenin	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20121113	CTD	MESH:D047310	Apigenin results in decreased expression of PANK2 mRNA	PMID:22359648
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PANK2 mRNA	PMID:37236586
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313038	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PANK2 mRNA	PMID:23649840
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313038	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PANK2 gene	PMID:27153756
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313038	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PANK2 mRNA	PMID:23649840
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313038	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PANK2 mRNA	PMID:35430440
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313038	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PANK2 mRNA	PMID:18593933
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PANK2 mRNA	PMID:25629700
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PANK2 mRNA	PMID:22206623
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313038	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PANK2 gene	PMID:25304211
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313038	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK2 mRNA	PMID:39836092
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313038	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PANK2 protein	PMID:35688186
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313038	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of PANK2 mRNA	PMID:27594783
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313038	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PANK2 mRNA	PMID:24768652|PMID:25583101
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313039	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PANK2 mRNA	PMID:21570461
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20120522	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PANK2 mRNA	PMID:17942748
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313038	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PANK2 mRNA	PMID:28001369
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313038	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PANK2 mRNA	PMID:33212167
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313038	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of PANK2 mRNA	PMID:23649840
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313038	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PANK2 mRNA	PMID:32763439
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313038	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PANK2 mRNA	PMID:38568856
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313038	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK2 mRNA	PMID:39836092
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313038	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PANK2 mRNA	PMID:18593933
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313038	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PANK2 mRNA	PMID:19150397
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313039	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PANK2 mRNA	PMID:39716349
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313039	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of PANK2 mRNA	PMID:17656681
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313039	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PANK2 promoter	PMID:35295148
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20120522	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PANK2 mRNA	PMID:18648102
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313039	E	RGD:6480464	20120522	CTD	MESH:C006253	pirinixic acid results in increased expression of PANK2 mRNA	PMID:18301758
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PANK2 mRNA	PMID:25181051|PMID:30816183
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313038	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PANK2 mRNA	PMID:25979313
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PANK2 mRNA	PMID:39298647
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PANK2 mRNA	PMID:21266533
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313038	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PANK2 mRNA	PMID:37042841
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313038	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA	PMID:39836092
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PANK2 mRNA	PMID:37236586
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313038	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PANK2 mRNA	PMID:19376846
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313038	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PANK2 mRNA	PMID:28302478
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313038	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PANK2 mRNA	PMID:31533062
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313038	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PANK2 mRNA	PMID:27188386
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313038	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PANK2 gene	PMID:29154799
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313039	E	RGD:6480464	20120522	CTD	MESH:D014635	Valproic Acid results in increased expression of PANK2 mRNA	PMID:19136453
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20120522	CTD	MESH:D016572	Cyclosporine results in decreased expression of PANK2 mRNA	PMID:19770486
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1313038	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of PANK2 mRNA	PMID:23649840
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313038	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PANK2 mRNA	PMID:27188386
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313038	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of PANK2 mRNA	PMID:25704631
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313038	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PANK2 gene	PMID:25304211
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313038	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK2 mRNA	PMID:39836092
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20120522	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PANK2 mRNA	PMID:17942748
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313039	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PANK2 mRNA	PMID:39716349
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of PANK2 mRNA	PMID:34044035
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313038	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA	PMID:39836092
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313038	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PANK2 mRNA	PMID:31758290
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PANK2 mRNA	PMID:22206623
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PANK2 mRNA	PMID:22206623
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of PANK2 mRNA	PMID:31558096
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:8249	piroxicam	increases expression	ISO	RGD:1313038	E	RGD:6480464	20120522	CTD	MESH:D010894	Piroxicam results in increased expression of PANK2 mRNA	PMID:21858171
1305169	Pank2	pantothenate kinase 2	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313038	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of PANK2 mRNA	PMID:27188386
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551729	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CPN2 mRNA	PMID:33045310
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CPN2 mRNA]	PMID:31150632
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of CPN2 mRNA	PMID:24205000
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1551729	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CPN2 mRNA	PMID:36331819
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:16170	mercury(0)	affects expression	ISO	RGD:1346122	E	RGD:6480464	20120814	CTD	MESH:D008628	Mercury affects the expression of CPN2 protein	PMID:22030286
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CPN2 mRNA	PMID:21632981
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of CPN2 mRNA	PMID:30510588
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of CPN2 mRNA	PMID:19484750
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of CPN2 mRNA	PMID:32145629
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551729	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CPN2 mRNA	PMID:39298647
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1346122	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of CPN2 mRNA	PMID:20404318
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CPN2 mRNA	PMID:33387578
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of CPN2 mRNA	PMID:27905399
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551729	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CPN2 mRNA	PMID:36331819
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CPN2 mRNA	PMID:19549813
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1346122	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CPN2 protein	PMID:20106945
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CPN2 mRNA	PMID:27153756
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CPN2 mRNA	PMID:19770486
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:25195	mercury atom	affects expression	ISO	RGD:1346122	E	RGD:6480464	20120814	CTD	MESH:D008628	Mercury affects the expression of CPN2 protein	PMID:22030286
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:27363	zinc atom	affects binding	ISO	RGD:1346122	E	RGD:6480464	20150512	CTD	MESH:D015032	CPN2 protein binds to Zinc	PMID:23896426
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of CPN2 mRNA	PMID:18356318
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CPN2 mRNA	PMID:31150632
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CPN2 mRNA	PMID:27339419|PMID:31919559
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CPN2 mRNA]	PMID:31150632
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20160510	CTD	MESH:D005492	Folic Acid results in decreased expression of CPN2 mRNA	PMID:25006883
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1551729	E	RGD:6480464	20200114	CTD	MESH:D002945	Cisplatin results in increased expression of CPN2 protein	PMID:31493026
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of CPN2 mRNA	PMID:32186404
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CPN2 mRNA	PMID:22298810
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CPN2 mRNA	PMID:19770486|PMID:26290441
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551729	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of CPN2 mRNA	PMID:16214954
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:28659	phosphorus atom	multiple interactions	ISO	RGD:1346122	E	RGD:6480464	20120412	CTD	MESH:D010758	[Phosphorus co-treated with paricalcitol] results in decreased expression of CPN2 mRNA	PMID:17715259
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of CPN2 mRNA	PMID:39631538
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346122	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CPN2 intron	PMID:30157460
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CPN2 mRNA	PMID:32234424
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CPN2 mRNA	PMID:19770486
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346122	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CPN2 promoter	PMID:27901495
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:30185	zinc(0)	affects binding	ISO	RGD:1346122	E	RGD:6480464	20150512	CTD	MESH:D015032	CPN2 protein binds to Zinc	PMID:23896426
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of CPN2 mRNA	PMID:18356318
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:30207	phosphorus(.)	multiple interactions	ISO	RGD:1346122	E	RGD:6480464	20120412	CTD	MESH:D010758	[Phosphorus co-treated with paricalcitol] results in decreased expression of CPN2 mRNA	PMID:17715259
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1346122	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CPN2 gene	PMID:31601247
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of CPN2 mRNA	PMID:23411599|PMID:34492290
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of CPN2 mRNA	PMID:23811191
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CPN2 mRNA	PMID:25181051
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CPN2 protein	PMID:31675489
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in decreased expression of CPN2 mRNA	PMID:35479511
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of CPN2 mRNA	PMID:32145629|PMID:41034487
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551729	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of CPN2 mRNA	PMID:25594700|PMID:30245210
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346122	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CPN2 gene	PMID:31601247
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CPN2 protein	PMID:31675489
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CPN2 mRNA	PMID:30744511
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1551729	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of CPN2 mRNA	PMID:39298647
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1551729	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of CPN2 exon	PMID:33297965
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551729	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CPN2 mRNA	PMID:38685157
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1551729	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CPN2 3' UTR	PMID:28392331
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CPN2 mRNA	PMID:37019170
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CPN2 mRNA	PMID:34813904
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CPN2 mRNA	PMID:34813904
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of CPN2 mRNA	PMID:25539665
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CPN2 gene	PMID:22079235
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1551729	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CPN2 mRNA	PMID:40194260
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1346122	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CPN2 mRNA	PMID:28302478
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551729	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CPN2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CPN2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CPN2 mRNA	PMID:36331819
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of CPN2 mRNA	PMID:29038090
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CPN2 mRNA	PMID:29154799
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CPN2 mRNA	PMID:20106945|PMID:25562108
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346122	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of CPN2 mRNA	PMID:27989131
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551729	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CPN2 mRNA	PMID:28973697
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CPN2 mRNA	PMID:38832940
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551729	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CPN2 mRNA	PMID:17562736
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CPN2 mRNA	PMID:21420995|PMID:29067470
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1346122	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of CPN2 mRNA	PMID:26690555
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in decreased expression of CPN2 mRNA	PMID:31099283
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CPN2 mRNA	PMID:29391264
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CPN2 mRNA	PMID:24793618
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1346122	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of CPN2 mRNA	PMID:31629900
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:6076	itraconazole	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in decreased expression of CPN2 mRNA	PMID:31099283
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of CPN2 mRNA	PMID:33484710
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:7931	paricalcitol	multiple interactions	ISO	RGD:1346122	E	RGD:6480464	20161213	CTD	MESH:C084656	[Phosphorus co-treated with paricalcitol] results in decreased expression of CPN2 mRNA	PMID:17715259
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346122	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CPN2 gene]	PMID:28238834
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:81517	3,4,5,3',4',5'-Hexachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C027309	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CPN2 mRNA	PMID:30744511
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1551729	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CPN2 mRNA	PMID:38648751
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CPN2 mRNA	PMID:27291303
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CPN2 mRNA	PMID:23640034
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1346122	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CPN2 protein	PMID:31675489
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:94366	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one	decreases expression	ISO	RGD:1551729	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in decreased expression of CPN2 mRNA	PMID:31099283
1305170	Cpn2	carboxypeptidase N subunit 2	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of CPN2 gene	PMID:31079544
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313042	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PCDHB3 mRNA	PMID:37995155
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313041	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PCDHB3 mRNA	PMID:22378314
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDHB3 mRNA	PMID:33387578
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PCDHB3 mRNA	PMID:33387578
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313041	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHB3 gene	PMID:27153756
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313041	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PCDHB3 exon	PMID:30157460
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313042	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PCDHB3 mRNA	PMID:25629700
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDHB3 mRNA	PMID:33387578
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313041	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PCDHB3 mRNA	PMID:22378314
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313041	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDHB3 exon	PMID:27901495
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313042	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PCDHB3 mRNA	PMID:22228805
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313041	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDHB3 promoter	PMID:27901495
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of PCDHB3 mRNA	PMID:32479839
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313042	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PCDHB3 mRNA	PMID:19710929
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PCDHB3 mRNA	PMID:19167457
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDHB3 mRNA	PMID:34947998
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PCDHB3 mRNA	PMID:25181051
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313041	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of PCDHB3 gene	PMID:31601247
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PCDHB3 gene	PMID:22079235
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313041	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PCDHB3 mRNA	PMID:31533062
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313042	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PCDHB3 mRNA	PMID:17292431
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313041	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PCDHB3 mRNA	PMID:38832940
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCDHB3 mRNA	PMID:33387578
1305171	Pcdhb3	protocadherin beta 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313041	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDHB3 gene]	PMID:28238834
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313043	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SNAPC3 mRNA	PMID:26272509
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA	PMID:27188386
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313044	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SNAPC3 mRNA	PMID:33045310
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313044	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNAPC3 gene	PMID:20938992
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313044	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SNAPC3 mRNA	PMID:30529165
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313043	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SNAPC3 mRNA	PMID:22378314
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313043	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of SNAPC3 mRNA	PMID:18951874
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SNAPC3 mRNA	PMID:33387578
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313044	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNAPC3 gene	PMID:20938992
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313043	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SNAPC3 mRNA	PMID:16949557
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA	PMID:39836092
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313043	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SNAPC3 mRNA	PMID:16949557
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313043	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SNAPC3 gene	PMID:27153756
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313043	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SNAPC3 mRNA	PMID:27153756
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313044	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SNAPC3 mRNA	PMID:19770486
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313043	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SNAPC3 intron	PMID:30157460
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313044	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNAPC3 gene	PMID:20938992
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC3 mRNA	PMID:39836092
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:27899	cisplatin	increases response to substance	ISO	RGD:1313043	E	RGD:6480464	20120412	CTD	MESH:D002945	SNAPC3 protein results in increased susceptibility to Cisplatin	PMID:16734730
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of SNAPC3 gene	PMID:28505145
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313043	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of SNAPC3 mRNA	PMID:23195993
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313044	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNAPC3 mRNA	PMID:21570461
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313044	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNAPC3 mRNA	PMID:15034205|PMID:21354282
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313043	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SNAPC3 mRNA	PMID:28001369
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313043	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNAPC3 mRNA	PMID:33212167
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313043	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SNAPC3 mRNA	PMID:39709020
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313043	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SNAPC3 mRNA	PMID:23649840
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313043	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNAPC3 mRNA	PMID:29803840
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313043	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of SNAPC3 mRNA	PMID:29319823
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC3 mRNA	PMID:39836092
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SNAPC3 mRNA	PMID:15034205
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313043	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SNAPC3 promoter	PMID:27901495
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313044	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNAPC3 mRNA	PMID:22228805
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SNAPC3 mRNA	PMID:19073995
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313043	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased expression of SNAPC3 mRNA	PMID:34973136
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313044	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNAPC3 gene	PMID:35295148
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SNAPC3 mRNA	PMID:34492290
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SNAPC3 mRNA	PMID:20813756
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SNAPC3 mRNA	PMID:32156529
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNAPC3 mRNA	PMID:25181051|PMID:30816183
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:3423	carmustine	increases expression	ISO	RGD:1313043	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of SNAPC3 mRNA	PMID:15980968
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SNAPC3 mRNA	PMID:28628672
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SNAPC3 mRNA	PMID:28628672
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313043	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SNAPC3 mRNA	PMID:37042841
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA	PMID:39836092
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313043	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SNAPC3 mRNA	PMID:24449571
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313043	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SNAPC3 mRNA	PMID:31533062
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313043	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of SNAPC3 mRNA	PMID:19167446
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313043	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNAPC3 mRNA	PMID:23179753|PMID:26272509
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313043	E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of SNAPC3 mRNA	PMID:25192806|PMID:28001369
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA	PMID:27188386
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SNAPC3 mRNA	PMID:28628672
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SNAPC3 mRNA	PMID:33387578
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SNAPC3 mRNA	PMID:29279043
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC3 mRNA	PMID:39836092
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of SNAPC3 mRNA	PMID:30529165
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313044	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SNAPC3 mRNA	PMID:30529165
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SNAPC3 mRNA	PMID:28628672
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313044	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SNAPC3 mRNA; Nanotubes, Carbon results in increased expression of SNAPC3 mRNA	PMID:25554681
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of SNAPC3 mRNA	PMID:23962444
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of SNAPC3 mRNA	PMID:20080153
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA	PMID:39836092
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313043	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SNAPC3 mRNA	PMID:31758290
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA	PMID:27188386
1305172	Snapc3	small nuclear RNA activating complex, polypeptide 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313043	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA	PMID:27188386
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313045	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GTF3C5 mRNA	PMID:38218311
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313046	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GTF3C5 mRNA	PMID:39241906
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313046	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of GTF3C5 mRNA	PMID:34319233
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313045	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GTF3C5 mRNA	PMID:23649840
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313046	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF3C5 mRNA	PMID:22206623
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313045	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GTF3C5 mRNA	PMID:39836092
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313045	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of GTF3C5 protein	PMID:35688186
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313045	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of GTF3C5 mRNA	PMID:27594783
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313046	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GTF3C5 mRNA	PMID:21570461
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GTF3C5 mRNA	PMID:21215274
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313045	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GTF3C5 mRNA	PMID:33212167
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313045	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of GTF3C5 protein	PMID:21925251
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313045	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite co-treated with lead acetate] results in decreased expression of GTF3C5 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GTF3C5 mRNA	PMID:38072110|PMID:39836092
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313045	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GTF3C5 promoter	PMID:27901495
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313046	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GTF3C5 exon; Benzo(a)pyrene results in increased methylation of GTF3C5 intron	PMID:27901495
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1313045	E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in decreased expression of GTF3C5 protein	PMID:38072110
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313046	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GTF3C5 gene	PMID:35295148
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313046	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of GTF3C5 mRNA	PMID:18648102
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GTF3C5 mRNA	PMID:25181051
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313046	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of GTF3C5 mRNA	PMID:37019170
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313045	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GTF3C5 mRNA	PMID:37042841
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1313045	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of GTF3C5 mRNA	PMID:31626844
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313046	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GTF3C5 mRNA	PMID:17292431|PMID:17963808
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313045	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GTF3C5 gene	PMID:29154799
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313045	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GTF3C5 mRNA	PMID:38832940
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313046	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GTF3C5 mRNA	PMID:17562736
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313045	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of GTF3C5 mRNA	PMID:22230336
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313045	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GTF3C5 mRNA	PMID:39836092
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313045	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GTF3C5 protein	PMID:32959892
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313046	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF3C5 mRNA	PMID:22206623
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313045	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of GTF3C5 protein	PMID:37664457
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313045	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of GTF3C5 mRNA	PMID:30559759
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313046	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of GTF3C5 mRNA	PMID:30294300
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of GTF3C5 mRNA	PMID:23640034
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:90724	AM-251	decreases expression	ISO	RGD:1313045	E	RGD:6480464	20170303	CTD	MESH:C103505	AM 251 results in decreased expression of GTF3C5 mRNA	PMID:16500647
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313045	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of GTF3C5 protein	PMID:37664457
1305173	Gtf3c5	general transcription factor IIIC subunit 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GTF3C5 mRNA	PMID:21346803
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAGOH mRNA]	PMID:31150632
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313047	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of MAGOH mRNA	PMID:16249480|PMID:21934132
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313048	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MAGOH mRNA	PMID:30319688
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313048	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MAGOH mRNA	PMID:30319688
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313048	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MAGOH mRNA	PMID:39241906
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [MAGOH protein binds to ESR1 protein]	PMID:27156127
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MAGOH mRNA	PMID:33387578
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:166595	Yessotoxin	decreases expression	ISO	RGD:1313047	E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of MAGOH mRNA	PMID:30679557
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313048	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MAGOH mRNA	PMID:23892564
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MAGOH mRNA	PMID:22061828
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAGOH mRNA	PMID:36331819
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA	PMID:39836092
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of MAGOH mRNA	PMID:21396975
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MAGOH mRNA	PMID:19770486
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAGOH mRNA	PMID:31150632
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313048	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAGOH mRNA	PMID:27339419|PMID:31919559
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAGOH mRNA]	PMID:31150632
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAGOH mRNA	PMID:22206623
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1313047	E	RGD:6480464	20120412	CTD	MESH:D016685	MAGOH protein affects the susceptibility to Mitomycin	PMID:16217747
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAGOH mRNA	PMID:39836092
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MAGOH mRNA	PMID:23557933
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313048	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MAGOH mRNA	PMID:30912803
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313048	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAGOH mRNA	PMID:21570461
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313047	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAGOH mRNA	PMID:17101203
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAGOH mRNA	PMID:34747641
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAGOH mRNA	PMID:17942748
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAGOH mRNA	PMID:17942748
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MAGOH mRNA	PMID:24690739
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313047	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MAGOH mRNA	PMID:38568856
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAGOH mRNA	PMID:39836092
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAGOH mRNA	PMID:20504355
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313047	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MAGOH promoter	PMID:27901495
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAGOH mRNA	PMID:22228805
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MAGOH mRNA	PMID:24690739
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313047	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAGOH mRNA	PMID:20018196
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of MAGOH mRNA	PMID:24136188
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of MAGOH mRNA	PMID:21829687
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAGOH mRNA	PMID:25729387
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MAGOH mRNA	PMID:30047161
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313048	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MAGOH promoter	PMID:35295148
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MAGOH mRNA	PMID:34492290
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MAGOH mRNA	PMID:18648102
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313047	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MAGOH mRNA; bisphenol A results in decreased expression of MAGOH protein	PMID:29275510|PMID:31675489
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MAGOH mRNA	PMID:33221593
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MAGOH mRNA	PMID:25181051|PMID:32145629
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313047	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of MAGOH protein	PMID:34186270
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313048	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MAGOH mRNA	PMID:32156529
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313047	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of MAGOH protein	PMID:31675489
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313047	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MAGOH protein	PMID:34186270
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313048	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MAGOH mRNA	PMID:39298647
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MAGOH mRNA	PMID:38685157
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MAGOH mRNA	PMID:37019170
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MAGOH mRNA	PMID:17361019
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313048	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MAGOH mRNA	PMID:34813904
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313047	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MAGOH mRNA	PMID:37042841
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA	PMID:39836092
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313047	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAGOH mRNA	PMID:38568856
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313047	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MAGOH mRNA	PMID:19376846
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313047	E	RGD:6480464	20170110	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MAGOH mRNA	PMID:24449571
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MAGOH protein	PMID:26178269
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAGOH mRNA	PMID:36331819
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313047	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAGOH mRNA	PMID:25979313
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313047	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of MAGOH mRNA	PMID:29154799
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MAGOH mRNA	PMID:30047161
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313047	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MAGOH mRNA	PMID:20106945
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MAGOH mRNA	PMID:17555576
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MAGOH mRNA	PMID:24136188
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313047	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MAGOH mRNA	PMID:27188386
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAGOH mRNA	PMID:17562736
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of MAGOH mRNA	PMID:24690739
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAGOH mRNA	PMID:39836092
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1313047	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of MAGOH mRNA	PMID:22077320
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1313047	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of MAGOH mRNA	PMID:31675489
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313048	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MAGOH mRNA	PMID:35436446
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MAGOH mRNA	PMID:17555576
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MAGOH mRNA	PMID:17942748
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAGOH mRNA	PMID:17942748
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MAGOH mRNA	PMID:24136188
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MAGOH mRNA	PMID:30047161
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MAGOH mRNA	PMID:35964746
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MAGOH mRNA	PMID:24136188
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MAGOH mRNA	PMID:19042947
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313047	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA	PMID:39836092
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of MAGOH mRNA	PMID:24136188
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAGOH mRNA	PMID:25729387
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of MAGOH mRNA	PMID:28444820
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAGOH mRNA	PMID:22206623
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MAGOH mRNA	PMID:24136188
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313048	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of MAGOH mRNA	PMID:30294300
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1313047	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MAGOH protein	PMID:31675489
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1313047	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MAGOH protein	PMID:31675489
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:8249	piroxicam	increases expression	ISO	RGD:1313047	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of MAGOH mRNA	PMID:21858171
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of MAGOH mRNA	PMID:21278054
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MAGOH mRNA	PMID:30047161
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313047	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MAGOH mRNA	PMID:38568856
1305174	Magoh	mago homolog, exon junction complex subunit	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of MAGOH mRNA	PMID:30047161
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313049	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of DCAF1 mRNA	PMID:26251327
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DCAF1 mRNA	PMID:26079696
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313049	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DCAF1 mRNA	PMID:39241906
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1605417	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DCAF1 protein	PMID:37730182
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of DCAF1 mRNA	PMID:23649840
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DCAF1 mRNA	PMID:23649840
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1605417	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DCAF1 protein	PMID:35688186
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313049	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of DCAF1 mRNA	PMID:28960355
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1605417	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DCAF1 mRNA	PMID:22574217
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DCAF1 mRNA	PMID:33387578
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DCAF1 mRNA	PMID:33212167
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DCAF1 mRNA	PMID:38568856
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DCAF1 mRNA	PMID:22316170
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DCAF1 mRNA	PMID:19150397
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313049	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DCAF1 gene; titanium dioxide results in decreased methylation of DCAF1 promoter	PMID:35295148
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1605417	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DCAF1 gene	PMID:34973136
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of DCAF1 mRNA	PMID:19167457
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of DCAF1 mRNA	PMID:26982218
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1605417	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DCAF1 gene	PMID:31601247
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DCAF1 gene	PMID:28505145
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313049	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DCAF1 mRNA	PMID:39298647
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313049	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DCAF1 mRNA	PMID:37019170
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605417	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DCAF1 mRNA	PMID:37042841
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DCAF1 mRNA	PMID:38568856
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of DCAF1 mRNA	PMID:28001369
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of DCAF1 mRNA	PMID:24449571
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of DCAF1 mRNA	PMID:31675489
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313049	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DCAF1 mRNA	PMID:17555576
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DCAF1 protein	PMID:32959892
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313049	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DCAF1 mRNA	PMID:22206623
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:76290	PhIP	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of DCAF1 mRNA	PMID:20816883
1305176	Dcaf1	DDB1 and CUL4 associated factor 1	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1605417	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of DCAF1 mRNA	PMID:26079696
1305177	Lctl	lactase-like	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of LCTL mRNA	PMID:26272509
1305177	Lctl	lactase-like	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1602287	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA	PMID:27188386
1305177	Lctl	lactase-like	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of LCTL mRNA	PMID:21934132
1305177	Lctl	lactase-like	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of LCTL mRNA	PMID:26079696
1305177	Lctl	lactase-like	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1602287	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of LCTL mRNA	PMID:30510588
1305177	Lctl	lactase-like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313050	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in decreased expression of LCTL mRNA	PMID:19484750
1305177	Lctl	lactase-like	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LCTL mRNA	PMID:33387578
1305177	Lctl	lactase-like	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LCTL mRNA	PMID:33387578
1305177	Lctl	lactase-like	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of LCTL mRNA	PMID:17103032
1305177	Lctl	lactase-like	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1602287	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of LCTL mRNA	PMID:19774075
1305177	Lctl	lactase-like	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of LCTL mRNA	PMID:26272509
1305177	Lctl	lactase-like	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1602287	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA	PMID:27188386
1305177	Lctl	lactase-like	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of LCTL mRNA	PMID:31881176
1305177	Lctl	lactase-like	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LCTL mRNA	PMID:28001369
1305177	Lctl	lactase-like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LCTL mRNA	PMID:34032870
1305177	Lctl	lactase-like	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313050	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of LCTL mRNA	PMID:23557971
1305177	Lctl	lactase-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LCTL mRNA	PMID:25181051
1305177	Lctl	lactase-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313050	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of LCTL mRNA	PMID:40203079
1305177	Lctl	lactase-like	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313050	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LCTL mRNA	PMID:32715474
1305177	Lctl	lactase-like	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313050	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of LCTL mRNA	PMID:39529242
1305177	Lctl	lactase-like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of LCTL mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305177	Lctl	lactase-like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602287	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LCTL gene	PMID:29154799
1305177	Lctl	lactase-like	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602287	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA	PMID:27188386
1305177	Lctl	lactase-like	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313050	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of LCTL mRNA	PMID:40633821
1305177	Lctl	lactase-like	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of LCTL mRNA	PMID:24935251|PMID:26272509
1305177	Lctl	lactase-like	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1602287	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA	PMID:27188386
1305177	Lctl	lactase-like	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LCTL mRNA	PMID:33387578
1305177	Lctl	lactase-like	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of LCTL mRNA	PMID:26272509
1305177	Lctl	lactase-like	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1602287	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA	PMID:27188386
1305177	Lctl	lactase-like	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602287	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA	PMID:27188386
1305177	Lctl	lactase-like	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of LCTL mRNA	PMID:30458266
1305177	Lctl	lactase-like	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1602287	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of LCTL mRNA	PMID:26272509
1305177	Lctl	lactase-like	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1602287	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA	PMID:27188386
1305177	Lctl	lactase-like	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602287	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA	PMID:27188386
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313051	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of C9ORF78 mRNA	PMID:22378314
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1313051	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of C9ORF78 protein	PMID:35688186
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313051	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of C9ORF78 protein	PMID:37730182
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313051	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of C9ORF78 mRNA	PMID:28818685
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313051	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313051	E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in decreased expression of C9ORF78 mRNA	PMID:22171008
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313051	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313051	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of C9ORF78 protein	PMID:35688186
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313051	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of C9ORF78 mRNA	PMID:27392435
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313051	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of C9ORF78 mRNA	PMID:33212167
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313051	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313051	E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in decreased expression of C9ORF78 mRNA	PMID:22171008
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of C3H9ORF78 mRNA	PMID:34492290
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of C9ORF78 mRNA	PMID:25181051
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313051	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313051	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of C9ORF78 mRNA	PMID:28302478
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313051	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of C9ORF78 mRNA	PMID:31533062
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313051	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of C9ORF78 mRNA	PMID:25562108
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313051	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in increased expression of C9ORF78 mRNA	PMID:22230336
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313051	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313051	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of C9ORF78 protein	PMID:32959892
1305178	C3h9orf78	similar to human chromosome 9 open reading frame 78	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313051	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of N4BP1 mRNA	PMID:25152437
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of N4BP1 mRNA	PMID:30071829
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605706	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of N4BP1 mRNA	PMID:33167477
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313053	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of N4BP1 mRNA	PMID:30319688
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313053	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of N4BP1 mRNA	PMID:25510870
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605706	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of N4BP1 mRNA	PMID:37042841
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of N4BP1 mRNA	PMID:20655997
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313053	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of N4BP1 mRNA	PMID:20463053
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313053	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of N4BP1 mRNA	PMID:23892564
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313053	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of N4BP1 mRNA	PMID:33754040
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1605706	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of N4BP1 protein	PMID:37730182
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605706	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of N4BP1 mRNA	PMID:35301059
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313053	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of N4BP1 mRNA	PMID:25510870
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313053	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of N4BP1 mRNA	PMID:25510870
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1605706	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of N4BP1 mRNA	PMID:23649840
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605706	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of N4BP1 intron	PMID:30157460
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313053	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of N4BP1 mRNA	PMID:19770486
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605706	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of N4BP1 polyA tail	PMID:30157460
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605706	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of N4BP1 mRNA	PMID:23649840
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313053	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of N4BP1 mRNA	PMID:32553695
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of N4BP1 mRNA	PMID:30779732
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of N4BP1 mRNA	PMID:31150632
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1605706	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of N4BP1 protein	PMID:35688186
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of N4BP1 mRNA	PMID:31881176
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in decreased expression of N4BP1 mRNA	PMID:19167446
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313053	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of N4BP1 mRNA	PMID:30912803
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1605706	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of N4BP1 mRNA	PMID:24768652|PMID:25583101
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of N4BP1 mRNA	PMID:34747641
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of N4BP1 mRNA	PMID:28001369
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of N4BP1 mRNA	PMID:30851411
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of N4BP1 mRNA	PMID:29803840
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1605706	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of N4BP1 protein	PMID:35688186
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605706	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of N4BP1 promoter	PMID:27901495
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of N4BP1 mRNA	PMID:22316170
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313053	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of N4BP1 mRNA	PMID:19770486
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605706	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of N4BP1 3' UTR	PMID:27901495
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605706	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to N4BP1 mRNA]	PMID:32406909
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of N4BP1 mRNA	PMID:19150397
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1605706	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of N4BP1 mRNA	PMID:15761015
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of N4BP1 mRNA	PMID:23411599|PMID:34492290
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of N4BP1 mRNA	PMID:20678512
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1605706	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of N4BP1 gene	PMID:31601247
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of N4BP1 mRNA	PMID:25181051|PMID:30816183|PMID:32145629
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of N4BP1 mRNA	PMID:19244175
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313053	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of N4BP1 mRNA	PMID:25510870
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313053	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of N4BP1 mRNA	PMID:25510870
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313053	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of N4BP1 mRNA	PMID:39298647
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313053	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of N4BP1 exon	PMID:33297965
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313053	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of N4BP1 intron	PMID:28392331
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313053	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of N4BP1 mRNA	PMID:37019170
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605706	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of N4BP1 mRNA	PMID:37042841
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605706	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of N4BP1 mRNA	PMID:35301059
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313053	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of N4BP1 mRNA	PMID:22698814
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1605706	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of N4BP1 mRNA	PMID:19376846
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605706	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of N4BP1 mRNA	PMID:31533062
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of N4BP1 mRNA	PMID:19167446
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1605706	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of N4BP1 mRNA	PMID:19167446
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of N4BP1 mRNA	PMID:23125180
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of N4BP1 mRNA	PMID:26272509
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605706	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of N4BP1 mRNA	PMID:27188386
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of N4BP1 mRNA	PMID:38685447
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:41607	crotonaldehyde	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of N4BP1 mRNA	PMID:20471460
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313053	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of N4BP1 mRNA	PMID:28973697
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of N4BP1 mRNA	PMID:24935251|PMID:26272509
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1605706	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of N4BP1 mRNA	PMID:27188386
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1605706	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of N4BP1 mRNA	PMID:15761015
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of N4BP1 mRNA	PMID:41580965
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313053	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of N4BP1 mRNA	PMID:19042947
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of N4BP1 mRNA	PMID:15336504
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of N4BP1 mRNA	PMID:19564919
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313053	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of N4BP1 mRNA	PMID:22206623
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:76290	PhIP	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of N4BP1 mRNA	PMID:20816883
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of N4BP1 mRNA	PMID:30851411
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605706	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of N4BP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of N4BP1 mRNA	PMID:27188386
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605706	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to N4BP1 gene]	PMID:28238834
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1605706	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of N4BP1 mRNA	PMID:18927307
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1605706	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of N4BP1 mRNA	PMID:19167446
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605706	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of N4BP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of N4BP1 mRNA	PMID:27188386
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of N4BP1 mRNA	PMID:19281266
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313053	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of N4BP1 mRNA	PMID:28973697
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of N4BP1 mRNA	PMID:23034163
1305179	N4bp1	Nedd4 binding protein 1	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of N4BP1 gene	PMID:31079544
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of PBXIP1 protein	PMID:39638853
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313055	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PBXIP1 mRNA	PMID:33045310
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PBXIP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PBXIP1 mRNA	PMID:32699268
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313055	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PBXIP1 mRNA	PMID:36331819
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PBXIP1 mRNA	PMID:26079696
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313055	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PBXIP1 mRNA	PMID:30319688
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PBXIP1 mRNA	PMID:39241906
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of PBXIP1 mRNA	PMID:31614463
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313055	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PBXIP1 mRNA	PMID:39298647
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313055	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PBXIP1 mRNA	PMID:33711761
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PBXIP1 mRNA	PMID:38568856
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313054	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PBXIP1 mRNA	PMID:23649840
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313055	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PBXIP1 mRNA	PMID:33754040
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PBXIP1 mRNA	PMID:22061828
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313054	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PBXIP1 mRNA	PMID:28818685
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PBXIP1 protein	PMID:34915118
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of PBXIP1 mRNA	PMID:27462272
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313054	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PBXIP1 mRNA	PMID:23649840
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of PBXIP1 mRNA	PMID:21396975
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PBXIP1 mRNA	PMID:22129741
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313054	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PBXIP1 mRNA	PMID:23649840
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PBXIP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PBXIP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PBXIP1 mRNA	PMID:32699268
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of PBXIP1 mRNA	PMID:30779732
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313055	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PBXIP1 mRNA	PMID:17484886
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PBXIP1 mRNA	PMID:31150632
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of PBXIP1 protein	PMID:38460933
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in decreased expression of PBXIP1 protein	PMID:37834424
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313054	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PBXIP1 mRNA	PMID:27392435
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PBXIP1 mRNA	PMID:27392435
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PBXIP1 mRNA	PMID:30912803
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313054	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PBXIP1 mRNA	PMID:22298810
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PBXIP1 mRNA	PMID:21215274
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PBXIP1 mRNA	PMID:33956508
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PBXIP1 mRNA	PMID:34747641
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313054	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of PBXIP1 protein	PMID:39603559
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PBXIP1 protein	PMID:33212167
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1313054	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of PBXIP1 mRNA	PMID:23649840
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PBXIP1 mRNA	PMID:32763439
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313055	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of PBXIP1 mRNA	PMID:39631538
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1313054	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PBXIP1 protein	PMID:35688186
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PBXIP1 mRNA	PMID:29301061
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313054	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PBXIP1 promoter	PMID:27901495
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PBXIP1 mRNA	PMID:25895662
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PBXIP1 mRNA	PMID:24136188
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:31767	lead diacetate	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C008261	lead acetate affects the expression of PBXIP1 mRNA	PMID:21864555
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of PBXIP1 mRNA	PMID:23411599|PMID:34492290
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PBXIP1 mRNA	PMID:18648102
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PBXIP1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313054	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of PBXIP1 protein	PMID:34186270
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313054	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of PBXIP1 mRNA	PMID:19244175
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313054	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PBXIP1 protein	PMID:34186270
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313054	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PBXIP1 protein	PMID:34186270
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PBXIP1 mRNA	PMID:21266533
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PBXIP1 mRNA	PMID:22129741
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in decreased expression of PBXIP1 protein	PMID:34064677
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313054	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PBXIP1 mRNA	PMID:37042841
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PBXIP1 protein	PMID:26879310
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313054	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PBXIP1 mRNA	PMID:19376846
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PBXIP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PBXIP1 mRNA	PMID:32699268
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of PBXIP1 mRNA	PMID:23811191
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PBXIP1 mRNA	PMID:32588087
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PBXIP1 mRNA	PMID:28302478
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PBXIP1 mRNA	PMID:31533062
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313055	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PBXIP1 mRNA	PMID:36331819
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313055	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PBXIP1 mRNA	PMID:17292431
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PBXIP1 mRNA	PMID:23179753|PMID:26272509
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313054	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PBXIP1 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313055	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in increased expression of PBXIP1 mRNA	PMID:20546886
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBXIP1 mRNA	PMID:27188386
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of PBXIP1 mRNA	PMID:41580965
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PBXIP1 mRNA	PMID:20106945|PMID:25562108
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313055	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PBXIP1 mRNA	PMID:28973697
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313054	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of PBXIP1 mRNA	PMID:23649840
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of PBXIP1 mRNA	PMID:24136188
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PBXIP1 mRNA	PMID:38832940
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of PBXIP1 mRNA	PMID:24935251
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313055	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PBXIP1 mRNA	PMID:17562736
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of PBXIP1 protein	PMID:38460933
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PBXIP1 mRNA	PMID:29391264
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of PBXIP1 mRNA	PMID:38568856
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PBXIP1 mRNA; Nanotubes, Carbon results in decreased expression of PBXIP1 mRNA	PMID:25554681
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PBXIP1 mRNA	PMID:24136188
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313054	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PBXIP1 protein	PMID:23718831
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PBXIP1 protein	PMID:32959892
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PBXIP1 mRNA	PMID:25270620
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of PBXIP1 mRNA	PMID:28988120
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313055	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PBXIP1 mRNA	PMID:22776087
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:67895	corosolic acid	increases expression	ISO	RGD:1313054	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of PBXIP1 mRNA	PMID:37939859
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313055	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PBXIP1 mRNA	PMID:26307267
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313054	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PBXIP1 protein	PMID:34186270
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PBXIP1 mRNA	PMID:24136188
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1313054	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of PBXIP1 mRNA	PMID:36318118
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBXIP1 mRNA	PMID:27188386
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:80630	irinotecan	decreases response to substance	ISO	RGD:1313054	E	RGD:6480464	20181113	CTD	MESH:D000077146	PBXIP1 protein results in decreased susceptibility to Irinotecan	PMID:16734730
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1313054	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of PBXIP1 mRNA	PMID:26079696
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PBXIP1 mRNA	PMID:21278054
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313054	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBXIP1 mRNA	PMID:27188386
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PBXIP1 mRNA	PMID:19281266
1305180	Pbxip1	PBX homeobox interacting protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PBXIP1 mRNA	PMID:21346803
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A12 mRNA	PMID:18313992
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313056	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SLC25A12 mRNA	PMID:26272509
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313057	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC25A12 mRNA	PMID:33045310
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A12 mRNA]	PMID:31150632
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC25A12 mRNA	PMID:36331819
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SLC25A12 mRNA	PMID:22378314
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313057	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SLC25A12 mRNA	PMID:30319688
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in decreased expression of SLC25A12 mRNA	PMID:21632981
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SLC25A12 mRNA	PMID:30510588
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SLC25A12 mRNA	PMID:32145629
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313057	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC25A12 mRNA	PMID:39298647
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313056	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC25A12 mRNA	PMID:37042841
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of SLC25A12 mRNA	PMID:24349266
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of SLC25A12 mRNA	PMID:24349266
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SLC25A12 protein	PMID:31163220
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SLC25A12 mRNA	PMID:19850644
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SLC25A12 mRNA]	PMID:19850644
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SLC25A12 mRNA	PMID:22061828
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313056	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SLC25A12 mRNA	PMID:28818685
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A12 mRNA	PMID:36331819
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SLC25A12 mRNA	PMID:19549813
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of SLC25A12 mRNA	PMID:19376150
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC25A12 mRNA	PMID:31150632
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313057	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC25A12 mRNA	PMID:31919559
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A12 mRNA]	PMID:31150632
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A12 mRNA	PMID:22206623
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:D012643	Selenium results in decreased expression of SLC25A12 mRNA	PMID:19244175
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313056	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SLC25A12 mRNA	PMID:26272509
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:D002945	Cisplatin affects the reaction [Piroxicam results in decreased expression of SLC25A12 mRNA]	PMID:21858171
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC25A12 mRNA	PMID:21570461
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC25A12 mRNA	PMID:21215274
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC25A12 mRNA	PMID:33387578
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC25A12 mRNA	PMID:17942748
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SLC25A12 mRNA	PMID:33212167
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313056	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SLC25A12 mRNA	PMID:39709020
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SLC25A12 mRNA	PMID:28959563
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC25A12 mRNA	PMID:29803840
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC25A12 protein	PMID:29459688
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC25A12 mRNA; sodium arsenite results in decreased expression of SLC25A12 protein	PMID:38228842|PMID:38568856
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC25A12 protein	PMID:38266420
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313056	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC25A12 mRNA	PMID:34032870
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC25A12 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313057	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC25A12 intron	PMID:27901495
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLC25A12 mRNA	PMID:19150397
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313057	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC25A12 gene	PMID:35295148
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC25A12 mRNA	PMID:34492290
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC25A12 mRNA	PMID:19710929
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SLC25A12 mRNA	PMID:25181051
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC25A12 mRNA	PMID:30816183
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313056	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SLC25A12 protein	PMID:34186270|PMID:37567409
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SLC25A12 mRNA	PMID:19244175
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313056	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SLC25A12 mRNA	PMID:25979313
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313057	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SLC25A12 mRNA	PMID:39298647
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313056	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SLC25A12 intron	PMID:30157460
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313056	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC25A12 mRNA	PMID:37042841
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SLC25A12 mRNA	PMID:19320972
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:D012643	Selenium results in decreased expression of SLC25A12 mRNA	PMID:19244175
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SLC25A12 mRNA	PMID:28302478
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313057	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SLC25A12 protein	PMID:26178269
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A12 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC25A12 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC25A12 mRNA	PMID:36331819
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D014635	Valproic Acid affects the expression of SLC25A12 mRNA	PMID:17292431
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313056	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC25A12 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:29154799
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC25A12 mRNA	PMID:25562108
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC25A12 mRNA	PMID:19770486
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313057	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SLC25A12 mRNA	PMID:28973697
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of SLC25A12 mRNA	PMID:24349266
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:43602	obeticholic acid	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of SLC25A12 mRNA	PMID:27939613
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC25A12 mRNA	PMID:38832940
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313056	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SLC25A12 mRNA	PMID:24935251
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313056	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen affects the expression of SLC25A12 mRNA	PMID:25704631
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of SLC25A12 mRNA	PMID:17562736
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC25A12 mRNA	PMID:33387578
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SLC25A12 mRNA	PMID:29391264
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC25A12 mRNA	PMID:22079256
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313057	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC25A12 mRNA	PMID:35436446
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC25A12 mRNA	PMID:17942748
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313057	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLC25A12 mRNA; Nanotubes, Carbon results in increased expression of SLC25A12 mRNA	PMID:25620056
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SLC25A12 protein	PMID:32959892
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20130806	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A12 mRNA	PMID:18313992
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of SLC25A12 mRNA	PMID:24136188
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SLC25A12 mRNA	PMID:20111022
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313056	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SLC25A12 intron	PMID:30157460
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SLC25A12 mRNA	PMID:31758290
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313056	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SLC25A12 protein	PMID:34186270
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313057	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC25A12 mRNA	PMID:22206623
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A12 mRNA	PMID:22206623
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SLC25A12 mRNA	PMID:22079256
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC25A12 mRNA	PMID:22079256
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313057	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SLC25A12 mRNA	PMID:30294300
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of SLC25A12 protein	PMID:28903499
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:D010894	Piroxicam results in decreased expression of SLC25A12 mRNA	PMID:21858171
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20130806	CTD	MESH:D010894	Cisplatin affects the reaction [Piroxicam results in decreased expression of SLC25A12 mRNA]	PMID:21858171
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of SLC25A12 mRNA	PMID:26923065
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313056	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SLC25A12 mRNA	PMID:26272509
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313056	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1305181	Slc25a12	solute carrier family 25 member 12	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313056	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SLC25A12 mRNA	PMID:38568856
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313058	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of COL8A2 mRNA	PMID:26272509|PMID:27188386
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313058	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL8A2 mRNA	PMID:27188386
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313059	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COL8A2 mRNA	PMID:33045310
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COL8A2 gene	PMID:20938992
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313058	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of COL8A2 mRNA	PMID:15982314
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313058	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of COL8A2 mRNA	PMID:22378314
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313058	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of COL8A2 mRNA	PMID:30510588
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COL8A2 gene	PMID:20938992
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313058	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in increased expression of COL8A2 mRNA	PMID:28937961
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313058	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of COL8A2 mRNA	PMID:18070364
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of COL8A2 mRNA	PMID:22967744
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of COL8A2 mRNA	PMID:33387578
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313058	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of COL8A2 intron	PMID:30157460
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313058	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of COL8A2 intron	PMID:30157460
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313058	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of COL8A2 mRNA	PMID:41430723
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of COL8A2 mRNA	PMID:34911549
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313058	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of COL8A2 mRNA	PMID:19774075
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COL8A2 gene	PMID:20938992
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313058	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of COL8A2 mRNA	PMID:32525701
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COL8A2 mRNA	PMID:34747641
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313059	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of COL8A2 mRNA	PMID:35032568
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313058	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COL8A2 exon; Benzo(a)pyrene affects the methylation of COL8A2 intron	PMID:27901495|PMID:30157460
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313059	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COL8A2 3' UTR; Benzo(a)pyrene results in increased methylation of COL8A2 exon	PMID:27901495
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313058	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of COL8A2 mRNA	PMID:19128835|PMID:26705709
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of COL8A2 mRNA	PMID:24395379
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of COL8A2 mRNA	PMID:25729387
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313059	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of COL8A2 mRNA	PMID:29264374
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313059	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of COL8A2 promoter	PMID:35295148
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313059	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of COL8A2 gene	PMID:35295148
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313059	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of COL8A2 mRNA	PMID:20813756
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of COL8A2 mRNA	PMID:25181051|PMID:34947998|PMID:38750585|PMID:41034487
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of COL8A2 mRNA	PMID:30816183|PMID:41034487
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313059	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of COL8A2 mRNA	PMID:30951980|PMID:32156529|PMID:35598803
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313059	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of COL8A2 mRNA	PMID:30951980
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313058	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of COL8A2 exon; benzo(e)pyrene results in increased methylation of COL8A2 intron	PMID:30157460
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:34575	bisphenol F	affects expression	ISO	RGD:1313059	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F affects the expression of COL8A2 mRNA	PMID:30951980
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1313059	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of COL8A2 intron	PMID:28392331
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:34682	diazinon	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D003976	Diazinon results in increased expression of COL8A2 mRNA	PMID:29108742
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313058	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of COL8A2 mRNA	PMID:28628672
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of COL8A2 mRNA	PMID:32680482
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of COL8A2 mRNA	PMID:39241906
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313059	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of COL8A2 mRNA	PMID:40194260
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313058	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COL8A2 mRNA	PMID:25979313
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313058	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of COL8A2 gene	PMID:29154799
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313058	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of COL8A2 mRNA	PMID:28628672
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313058	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of COL8A2 mRNA	PMID:29523930
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313058	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of COL8A2 mRNA	PMID:32525701
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313058	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of COL8A2 mRNA	PMID:28628672
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313058	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of COL8A2 mRNA	PMID:19128835|PMID:26705709
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1313058	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of COL8A2 mRNA	PMID:21856257
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313059	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COL8A2 mRNA; Nanotubes, Carbon results in decreased expression of COL8A2 mRNA	PMID:25554681
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	ISO	RGD:1313058	E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of COL8A2 mRNA	PMID:15982314
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313059	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of COL8A2 mRNA	PMID:23608068
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1313058	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of COL8A2 mRNA	PMID:15982314
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313058	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of COL8A2 mRNA	PMID:15336504
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313058	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of COL8A2 exon; Methapyrilene results in increased methylation of COL8A2 intron	PMID:30157460
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313058	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL8A2 mRNA	PMID:27188386
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:80656	all-trans-4-oxoretinoic acid	decreases expression	ISO	RGD:1313058	E	RGD:6480464	20150120	CTD	MESH:C002202	4-oxoretinoic acid results in decreased expression of COL8A2 mRNA	PMID:15982314
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313059	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of COL8A2 mRNA	PMID:38648751
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1313058	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of COL8A2 mRNA	PMID:19095052
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313058	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of COL8A2 mRNA	PMID:32525701
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of COL8A2 mRNA	PMID:36843608
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of COL8A2 mRNA	PMID:39241906
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313058	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL8A2 mRNA	PMID:27188386
1305182	Col8a2	collagen type VIII alpha 2 chain	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313058	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of COL8A2 mRNA	PMID:29301935
1305183	Cep76	centrosomal protein 76	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313060	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CEP76 mRNA	PMID:38218311
1305183	Cep76	centrosomal protein 76	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313061	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CEP76 mRNA	PMID:26251327
1305183	Cep76	centrosomal protein 76	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313061	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of CEP76 promoter	PMID:26251327
1305183	Cep76	centrosomal protein 76	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313060	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CEP76 mRNA	PMID:21934132|PMID:33167477
1305183	Cep76	centrosomal protein 76	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313061	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CEP76 mRNA	PMID:22629407
1305183	Cep76	centrosomal protein 76	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313061	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CEP76 mRNA]	PMID:22629407
1305183	Cep76	centrosomal protein 76	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313061	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CEP76 mRNA	PMID:30319688
1305183	Cep76	centrosomal protein 76	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313061	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CEP76 mRNA	PMID:39241906
1305183	Cep76	centrosomal protein 76	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313061	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of CEP76 mRNA	PMID:29980752
1305183	Cep76	centrosomal protein 76	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313060	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CEP76 mRNA	PMID:37042841
1305183	Cep76	centrosomal protein 76	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313060	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CEP76 mRNA	PMID:23649840
1305183	Cep76	centrosomal protein 76	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313060	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of CEP76 mRNA	PMID:18070364
1305183	Cep76	centrosomal protein 76	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313060	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CEP76 protein	PMID:37730182
1305183	Cep76	centrosomal protein 76	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CEP76 mRNA	PMID:33387578
1305183	Cep76	centrosomal protein 76	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313060	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CEP76 mRNA	PMID:28818685
1305183	Cep76	centrosomal protein 76	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313060	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CEP76 intron	PMID:30157460
1305183	Cep76	centrosomal protein 76	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313061	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEP76 mRNA	PMID:37325564
1305183	Cep76	centrosomal protein 76	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313060	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CEP76 mRNA	PMID:23649840
1305183	Cep76	centrosomal protein 76	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313061	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of CEP76 mRNA	PMID:19376150
1305183	Cep76	centrosomal protein 76	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEP76 mRNA	PMID:22129741
1305183	Cep76	centrosomal protein 76	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313060	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CEP76 protein	PMID:20106945
1305183	Cep76	centrosomal protein 76	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEP76 mRNA	PMID:23630614|PMID:25378103
1305183	Cep76	centrosomal protein 76	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313060	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEP76 mRNA	PMID:21641981|PMID:22100608|PMID:27153756
1305183	Cep76	centrosomal protein 76	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313061	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEP76 mRNA	PMID:19770486
1305183	Cep76	centrosomal protein 76	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313060	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CEP76 intron	PMID:30157460
1305183	Cep76	centrosomal protein 76	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313060	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CEP76 mRNA	PMID:23649840
1305183	Cep76	centrosomal protein 76	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313060	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CEP76 mRNA	PMID:35430440
1305183	Cep76	centrosomal protein 76	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1313060	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of CEP76 mRNA	PMID:28534445
1305183	Cep76	centrosomal protein 76	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of CEP76 mRNA	PMID:31129395
1305183	Cep76	centrosomal protein 76	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CEP76 mRNA	PMID:31150632
1305183	Cep76	centrosomal protein 76	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313061	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of CEP76 mRNA	PMID:40618947
1305183	Cep76	centrosomal protein 76	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313060	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CEP76 mRNA	PMID:27392435
1305183	Cep76	centrosomal protein 76	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313060	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CEP76 mRNA	PMID:27392435
1305183	Cep76	centrosomal protein 76	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313060	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CEP76 mRNA	PMID:30851411
1305183	Cep76	centrosomal protein 76	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CEP76 mRNA	PMID:28959563
1305183	Cep76	centrosomal protein 76	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313060	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of CEP76 protein	PMID:35688186
1305183	Cep76	centrosomal protein 76	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313060	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEP76 mRNA	PMID:32234424
1305183	Cep76	centrosomal protein 76	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313060	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CEP76 mRNA	PMID:26238291
1305183	Cep76	centrosomal protein 76	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of CEP76 mRNA	PMID:25729387
1305183	Cep76	centrosomal protein 76	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CEP76 mRNA	PMID:25729387
1305183	Cep76	centrosomal protein 76	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313061	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CEP76 enhancer; titanium dioxide results in decreased methylation of CEP76 gene	PMID:35295148
1305183	Cep76	centrosomal protein 76	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CEP76 mRNA	PMID:23411599|PMID:34492290
1305183	Cep76	centrosomal protein 76	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313061	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CEP76 mRNA	PMID:19710929
1305183	Cep76	centrosomal protein 76	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CEP76 mRNA	PMID:25181051
1305183	Cep76	centrosomal protein 76	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CEP76 mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1305183	Cep76	centrosomal protein 76	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of CEP76 mRNA	PMID:31129395
1305183	Cep76	centrosomal protein 76	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313061	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CEP76 mRNA	PMID:39298647
1305183	Cep76	centrosomal protein 76	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313061	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CEP76 mRNA	PMID:38685157
1305183	Cep76	centrosomal protein 76	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEP76 mRNA	PMID:22129741
1305183	Cep76	centrosomal protein 76	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313060	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEP76 mRNA	PMID:37042841
1305183	Cep76	centrosomal protein 76	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313061	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEP76 mRNA	PMID:37325564
1305183	Cep76	centrosomal protein 76	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313060	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CEP76 mRNA	PMID:19376846
1305183	Cep76	centrosomal protein 76	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313060	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CEP76 mRNA	PMID:31533062
1305183	Cep76	centrosomal protein 76	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313060	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CEP76 mRNA	PMID:25979313
1305183	Cep76	centrosomal protein 76	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313060	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEP76 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1305183	Cep76	centrosomal protein 76	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313060	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CEP76 gene	PMID:29154799
1305183	Cep76	centrosomal protein 76	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313060	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CEP76 mRNA	PMID:38832940
1305183	Cep76	centrosomal protein 76	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313060	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CEP76 mRNA	PMID:28542535
1305183	Cep76	centrosomal protein 76	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CEP76 mRNA	PMID:33387578
1305183	Cep76	centrosomal protein 76	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313060	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CEP76 mRNA	PMID:22230336
1305183	Cep76	centrosomal protein 76	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CEP76 mRNA	PMID:29391264
1305183	Cep76	centrosomal protein 76	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313061	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CEP76 mRNA	PMID:35436446
1305183	Cep76	centrosomal protein 76	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313060	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of CEP76 mRNA	PMID:18175754
1305183	Cep76	centrosomal protein 76	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CEP76 mRNA	PMID:30307764
1305183	Cep76	centrosomal protein 76	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313061	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CEP76 mRNA	PMID:25554681
1305183	Cep76	centrosomal protein 76	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CEP76 mRNA	PMID:30047161
1305183	Cep76	centrosomal protein 76	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of CEP76 mRNA	PMID:25729387
1305183	Cep76	centrosomal protein 76	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CEP76 mRNA	PMID:25729387
1305183	Cep76	centrosomal protein 76	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313060	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CEP76 mRNA	PMID:28988120
1305183	Cep76	centrosomal protein 76	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313061	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CEP76 mRNA	PMID:22078008
1305183	Cep76	centrosomal protein 76	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313061	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CEP76 mRNA	PMID:22206623
1305183	Cep76	centrosomal protein 76	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313060	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CEP76 mRNA	PMID:37199045
1305183	Cep76	centrosomal protein 76	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313060	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CEP76 mRNA	PMID:30851411
1305183	Cep76	centrosomal protein 76	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313061	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CEP76 mRNA	PMID:31388691
1305183	Cep76	centrosomal protein 76	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CEP76 mRNA	PMID:23914054
1305183	Cep76	centrosomal protein 76	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CEP76 mRNA	PMID:24780913
1305183	Cep76	centrosomal protein 76	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CEP76 mRNA	PMID:30047161
1305184	Ifgga4l	interferon-gamma-inducible GTPase 4 like	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFGGA4L mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFGGA4L mRNA	PMID:33729688
1305184	Ifgga4l	interferon-gamma-inducible GTPase 4 like	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of IFGGA4L mRNA	PMID:33387578
1305184	Ifgga4l	interferon-gamma-inducible GTPase 4 like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of IFGGA4L mRNA	PMID:34492290
1305184	Ifgga4l	interferon-gamma-inducible GTPase 4 like	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin results in decreased expression of IFGGA4L mRNA	PMID:31324951
1305184	Ifgga4l	interferon-gamma-inducible GTPase 4 like	gene	CHEBI:8064	phenformin	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in increased expression of IFGGA4L mRNA	PMID:31324951
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313064	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of UBAP1 mRNA	PMID:38218311
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313065	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of UBAP1 mRNA	PMID:33045310
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBAP1 mRNA]	PMID:31150632
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBAP1 mRNA	PMID:19074003
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313064	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of UBAP1 mRNA	PMID:33167477
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313065	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of UBAP1 mRNA	PMID:36331819
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313065	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of UBAP1 mRNA	PMID:39241906
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313064	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of UBAP1 mRNA	PMID:38568856
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313064	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of UBAP1 mRNA	PMID:37042841
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1313065	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of UBAP1 mRNA	PMID:17945193
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313065	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of UBAP1 mRNA	PMID:23892564
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of UBAP1 mRNA	PMID:33387578
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313065	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of UBAP1 mRNA	PMID:28111341
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313064	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UBAP1 mRNA	PMID:19549813
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of UBAP1 protein	PMID:23301498
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of UBAP1 mRNA	PMID:41430723
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of UBAP1 mRNA	PMID:18593933
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBAP1 mRNA	PMID:31150632
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313065	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBAP1 mRNA	PMID:31919559
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBAP1 mRNA]	PMID:31150632
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313064	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of UBAP1 protein	PMID:35688186
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of UBAP1 gene	PMID:35440735
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313065	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBAP1 mRNA	PMID:21570461
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313065	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBAP1 mRNA	PMID:15328365
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of UBAP1 mRNA	PMID:29432896
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313064	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UBAP1 mRNA	PMID:38568856
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313065	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBAP1 mRNA	PMID:19770486
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of UBAP1 mRNA	PMID:18593933
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313065	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in increased expression of UBAP1 mRNA	PMID:25270620
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313065	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBAP1 gene	PMID:35295148
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of UBAP1 mRNA	PMID:25181051
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313064	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of UBAP1 gene	PMID:31601247
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of UBAP1 mRNA	PMID:30816183|PMID:32528016
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313064	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of UBAP1 gene	PMID:31601247
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBAP1 mRNA	PMID:28628672
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBAP1 mRNA	PMID:28628672
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of UBAP1 mRNA	PMID:18164116
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313064	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBAP1 mRNA	PMID:37042841
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313064	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBAP1 mRNA	PMID:38568856
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of UBAP1 promoter	PMID:22457795
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313065	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of UBAP1 mRNA	PMID:28111341
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313064	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBAP1 mRNA	PMID:19376846
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313065	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of UBAP1 mRNA	PMID:28962523
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313065	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of UBAP1 mRNA	PMID:18353800
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313064	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of UBAP1 mRNA	PMID:31533062
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313065	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of UBAP1 mRNA	PMID:36331819
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313064	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBAP1 mRNA	PMID:25979313
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313065	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of UBAP1 mRNA	PMID:17292431
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313064	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of UBAP1 mRNA	PMID:28001369
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313064	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of UBAP1 mRNA	PMID:25562108
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBAP1 mRNA	PMID:28628672
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313065	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBAP1 mRNA	PMID:17562736
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313065	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of UBAP1 mRNA	PMID:29279043
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of UBAP1 mRNA	PMID:29391264
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBAP1 mRNA	PMID:28628672
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313065	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of UBAP1 mRNA	PMID:35964746
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBAP1 mRNA	PMID:24136188|PMID:24793618
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of UBAP1 mRNA	PMID:20080153
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of UBAP1 mRNA	PMID:28801915
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313065	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of UBAP1 mRNA	PMID:23650126
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313065	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of UBAP1 mRNA	PMID:19751817
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:6443	levonorgestrel	multiple interactions	ISO	RGD:1313064	E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBAP1 mRNA	PMID:19074003
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:7438	N-methylformamide	affects expression	ISO	RGD:1313065	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide affects the expression of UBAP1 mRNA; methylformamide analog affects the expression of UBAP1 mRNA	PMID:17040096
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of UBAP1 mRNA	PMID:18164116
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1313064	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of UBAP1 mRNA	PMID:24921660
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UBAP1 mRNA	PMID:21346803
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313064	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of UBAP1 mRNA	PMID:38568856
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313064	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of UBAP1 mRNA	PMID:29301935
1305186	Ubap1	ubiquitin-associated protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of UBAP1 mRNA	PMID:21346803
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313066	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GPR31 mRNA	PMID:35811015
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1616350	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GPR31B mRNA	PMID:39241906
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313066	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GPR31 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of GPR31 mRNA	PMID:35811015
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR31 mRNA	PMID:32741896
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR31 mRNA	PMID:32741896
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of GPR31 mRNA	PMID:28522335
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1616350	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of GPR31B mRNA	PMID:28189721|PMID:28960355
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GPR31 mRNA	PMID:31881176
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313066	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR31 mRNA	PMID:23557933
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313066	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of GPR31 gene	PMID:28589171
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313066	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GPR31 promoter	PMID:27901495
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1616350	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the expression of GPR31B mRNA	PMID:35295148
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GPR31 mRNA	PMID:34492290
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GPR31 mRNA	PMID:25181051
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GPR31 gene	PMID:28505145
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313066	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GPR31 mRNA	PMID:25562108
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313066	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GPR31 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of GPR31 mRNA	PMID:35811015
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of GPR31 mRNA	PMID:35283115
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR31 mRNA	PMID:32741896
1305187	Gpr31	G protein-coupled receptor 31	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313066	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GPR31 gene]	PMID:28238834
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313067	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MGAT5B mRNA	PMID:38218311
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1618017	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MGAT5B mRNA	PMID:33045310
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1618017	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MGAT5B mRNA	PMID:20188158
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313067	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MGAT5B mRNA	PMID:26079696
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1618017	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MGAT5B mRNA	PMID:30319688
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1618017	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of MGAT5B mRNA	PMID:30319688
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313067	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MGAT5B mRNA	PMID:30165855
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MGAT5B mRNA	PMID:27523638
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MGAT5B mRNA	PMID:26577399
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MGAT5B mRNA	PMID:33387578
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1618017	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of MGAT5B intron	PMID:27776689
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313067	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT5B mRNA	PMID:27188386
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618017	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MGAT5B mRNA	PMID:21570461
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313067	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MGAT5B mRNA	PMID:32763439
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1618017	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of MGAT5B mRNA	PMID:39631538
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313067	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MGAT5B promoter	PMID:27901495
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313067	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MGAT5B 3' UTR	PMID:27901495
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313067	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MGAT5B exon	PMID:27901495
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313067	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MGAT5B promoter	PMID:23974009
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1618017	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of MGAT5B mRNA	PMID:29264374
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1618017	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MGAT5B gene	PMID:35295148
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313067	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of MGAT5B gene	PMID:31601247
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MGAT5B mRNA	PMID:25181051
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1618017	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MGAT5B mRNA	PMID:32156529
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of MGAT5B mRNA	PMID:41034487
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313067	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of MGAT5B mRNA	PMID:27685785
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MGAT5B gene	PMID:28505145
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1618017	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MGAT5B promoter	PMID:27312807
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1618017	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of MGAT5B intron	PMID:28392331
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313067	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of MGAT5B gene	PMID:22964155
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313067	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MGAT5B mRNA	PMID:40419075
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313067	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MGAT5B mRNA	PMID:23179753
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313067	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of MGAT5B promoter	PMID:27989131
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1618017	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of MGAT5B mRNA	PMID:24619417
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1313067	E	RGD:6480464	20190219	CTD	MESH:D004726	Endosulfan results in increased expression of MGAT5B mRNA	PMID:30090376
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MGAT5B mRNA	PMID:30307764
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1618017	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of MGAT5B mRNA	PMID:38701926
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of MGAT5B mRNA	PMID:28801915
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313067	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT5B mRNA	PMID:26378955
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MGAT5B gene	PMID:35440735
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:6980	monocrotaline	increases expression	ISO	RGD:1618017	E	RGD:6480464	20171114	CTD	MESH:D016686	Monocrotaline results in increased expression of MGAT5B mRNA	PMID:28818515
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313067	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT5B mRNA	PMID:27188386
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313067	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MGAT5B gene]	PMID:28238834
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MGAT5B mRNA	PMID:24780913
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313067	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT5B mRNA	PMID:27188386
1305188	Mgat5b	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of MGAT5B gene	PMID:31682807
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1604647	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PARP3 mRNA	PMID:38218311
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1550140	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PARP3 mRNA	PMID:37995155
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604647	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PARP3 mRNA	PMID:33167477
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PARP3 mRNA	PMID:36841081
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550140	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PARP3 mRNA	PMID:39241906
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1604647	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of PARP3 mRNA	PMID:22574217
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1550140	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of PARP3 mRNA	PMID:28973375
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1550140	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PARP3 mRNA	PMID:23892564
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PARP3 mRNA	PMID:26577399
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PARP3 mRNA	PMID:33387578
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PARP3 protein	PMID:34915118
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550140	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PARP3 mRNA	PMID:37236586
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550140	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PARP3 mRNA	PMID:34911549
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550140	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PARP3 mRNA	PMID:27339419|PMID:31919559
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550140	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PARP3 mRNA	PMID:22206623
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550140	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PARP3 mRNA	PMID:40504410
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PARP3 mRNA	PMID:38460933
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PARP3 mRNA	PMID:31881176
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1604647	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PARP3 mRNA	PMID:27392435|PMID:27594783
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:27899	cisplatin	increases response to substance	ISO	RGD:1604647	E	RGD:6480464	20250114	CTD	MESH:D002945	PARP3 protein mutant form results in increased susceptibility to Cisplatin	PMID:38830565
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PARP3 mRNA	PMID:27392435
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550140	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PARP3 mRNA	PMID:30912803
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1550140	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of PARP3 mRNA	PMID:18930951
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PARP3 mRNA	PMID:22298810
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550140	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PARP3 mRNA	PMID:21570461
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of PARP3 mRNA	PMID:30911355
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550140	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PARP3 mRNA	PMID:39631538
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:28748	doxorubicin	increases response to substance	ISO	RGD:1604647	E	RGD:6480464	20250114	CTD	MESH:D004317	PARP3 protein mutant form results in increased susceptibility to Doxorubicin	PMID:38830565
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1550140	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of PARP3 gene	PMID:39894169
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604647	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PARP3 mRNA	PMID:38568856
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550140	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PARP3 mRNA	PMID:40504410
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604647	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PARP3 5' UTR	PMID:27901495
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of PARP3 mRNA	PMID:30911355
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:30563	silicon dioxide	decreases methylation	ISO	RGD:1604647	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased methylation of PARP3 gene	PMID:34973136
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:31355	carboplatin	increases response to substance	ISO	RGD:1604647	E	RGD:6480464	20250114	CTD	MESH:D016190	PARP3 protein mutant form results in increased susceptibility to Carboplatin	PMID:38830565
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550140	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of PARP3 mRNA	PMID:27760801
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of PARP3 mRNA	PMID:34492290
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PARP3 mRNA	PMID:19710929
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PARP3 mRNA	PMID:34947998
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550140	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PARP3 mRNA	PMID:33221593
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604647	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of PARP3 mRNA	PMID:36232920
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PARP3 mRNA	PMID:25181051
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550140	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of PARP3 mRNA	PMID:30245210|PMID:30951980
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PARP3 mRNA	PMID:36041667
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PARP3 mRNA	PMID:28628672
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550140	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PARP3 gene	PMID:31683443
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550140	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PARP3 mRNA	PMID:30951980|PMID:38908815|PMID:39298647
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PARP3 mRNA	PMID:36041667
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550140	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PARP3 mRNA	PMID:30951980
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PARP3 mRNA	PMID:36041667
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PARP3 mRNA	PMID:28628672
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550140	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PARP3 mRNA	PMID:37236586
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550140	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PARP3 mRNA	PMID:40194260
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1604647	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PARP3 mRNA	PMID:31533062
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1604647	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PARP3 mRNA	PMID:40419075
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1550140	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of PARP3 mRNA	PMID:23125180
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604647	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PARP3 mRNA	PMID:29154799
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PARP3 mRNA	PMID:28628672
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550140	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PARP3 mRNA	PMID:28973697
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550140	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PARP3 mRNA	PMID:17562736
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PARP3 mRNA	PMID:38460933
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550140	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PARP3 mRNA	PMID:40504410
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PARP3 mRNA	PMID:28628672
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550140	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PARP3 mRNA	PMID:25620056
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550140	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PARP3 mRNA	PMID:25554681
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550140	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PARP3 mRNA	PMID:35964746
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PARP3 mRNA	PMID:24793618
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550140	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PARP3 mRNA	PMID:21641980
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:6887	methylphenidate	increases expression	ISO	RGD:1550140	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in increased expression of PARP3 mRNA	PMID:22470460
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550140	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PARP3 mRNA	PMID:22206623
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604647	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PARP3 gene]	PMID:28238834
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1550140	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of PARP3 mRNA	PMID:27029645
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550140	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PARP3 mRNA	PMID:39847705
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PARP3 mRNA	PMID:24780913
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PARP3 mRNA	PMID:21346803
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1604647	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PARP3 mRNA	PMID:38568856
1305189	Parp3	poly (ADP-ribose) polymerase family, member 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PARP3 mRNA	PMID:23034163
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20211116	CTD	MESH:D004237	Diuron results in decreased expression of SLC25A51 mRNA	PMID:21551480
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313070	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of SLC25A51 mRNA	PMID:35967413
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A51 mRNA]	PMID:31150632
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SLC25A51 mRNA]	PMID:19467301
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC25A51 mRNA	PMID:30529165
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313070	E	RGD:6480464	20220111	CTD	MESH:D001280	Atrazine results in decreased expression of SLC25A51 mRNA	PMID:22378314
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:16136	hydrogen sulfide	increases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D006862	Hydrogen Sulfide results in increased expression of SLC25A51 protein	PMID:29932956
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SLC25A51 mRNA	PMID:21179406
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of SLC25A51 mRNA	PMID:18951874
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SLC25A51 mRNA	PMID:39298647
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313070	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC25A51 mRNA	PMID:38568856
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SLC25A51 mRNA	PMID:23892564
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211116	CTD	MESH:D005839	Gentamicins results in decreased expression of SLC25A51 mRNA	PMID:22061828|PMID:33387578
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D019327	Copper Sulfate results in increased expression of SLC25A51 mRNA	PMID:19549813
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC25A51 mRNA	PMID:21641981
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SLC25A51 mRNA	PMID:18593933
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC25A51 mRNA	PMID:31150632
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A51 mRNA]	PMID:31150632
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D005492	Folic Acid results in decreased expression of SLC25A51 mRNA	PMID:21867686
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A51 mRNA	PMID:22206623
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313070	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC25A51 mRNA	PMID:39836092
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLC25A51 mRNA	PMID:28189721|PMID:28960355
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313070	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SLC25A51 mRNA	PMID:23557933
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC25A51 mRNA	PMID:33387578
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20220111	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC25A51 mRNA	PMID:25975270
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SLC25A51 mRNA	PMID:28001369
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC25A51 mRNA	PMID:29803840
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313070	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC25A51 mRNA	PMID:39836092
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC25A51 mRNA	PMID:26238291
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of SLC25A51 protein	PMID:37955338
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SLC25A51 mRNA	PMID:18593933
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SLC25A51 mRNA	PMID:19073995
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623784	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC25A51 gene; titanium dioxide results in decreased methylation of SLC25A51 promoter	PMID:35295148
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC25A51 mRNA	PMID:34492290
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:C006253	pirinixic acid results in increased expression of SLC25A51 mRNA	PMID:18445702
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C006780	bisphenol A results in increased expression of SLC25A51 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D002220	Carbamazepine affects the expression of SLC25A51 mRNA	PMID:25979313
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SLC25A51 mRNA	PMID:26682919
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1623784	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SLC25A51 mRNA	PMID:39298647
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SLC25A51 mRNA	PMID:28392331
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623784	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC25A51 mRNA	PMID:37019170
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of SLC25A51 mRNA	PMID:25270620
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20211116	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SLC25A51 promoter	PMID:22457795
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211116	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SLC25A51 mRNA	PMID:19162173
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SLC25A51 mRNA	PMID:28903501
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D002922	Ciguatoxins affects the expression of SLC25A51 mRNA	PMID:18353800
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D002994	Clofibrate results in decreased expression of SLC25A51 mRNA	PMID:17585979
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1313070	E	RGD:6480464	20220111	CTD	MESH:C100187	chloropicrin results in increased expression of SLC25A51 mRNA	PMID:26352163|PMID:28476498
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20211116	CTD	MESH:C016104	sodium bichromate results in increased expression of SLC25A51 mRNA	PMID:22561333
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SLC25A51 gene	PMID:29154799
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC25A51 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A51 mRNA	PMID:27188386
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313070	E	RGD:6480464	20220111	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC25A51 mRNA	PMID:25562108
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D013629	Tamoxifen affects the expression of SLC25A51 mRNA	PMID:20937368
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D017313	Fenretinide results in increased expression of SLC25A51 mRNA	PMID:28973697
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC25A51 mRNA	PMID:25704631
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SLC25A51 mRNA	PMID:29523930
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313070	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC25A51 mRNA	PMID:39836092
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC25A51 mRNA	PMID:30529165
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:D018038	Sodium Selenite results in increased expression of SLC25A51 mRNA	PMID:24383545
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C082360	fipronil results in increased expression of SLC25A51 mRNA	PMID:23962444
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20211116	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of SLC25A51 mRNA	PMID:19162173
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D005485	Flutamide results in decreased expression of SLC25A51 mRNA	PMID:24136188
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:63613	nevirapine	increases expression	ISO	RGD:1623784	E	RGD:6480464	20240903	CTD	MESH:D019829	Nevirapine results in increased expression of SLC25A51 mRNA	PMID:38636494
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C045463	Leflunomide results in decreased expression of SLC25A51 mRNA	PMID:24136188
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:C047246	Temozolomide results in decreased expression of SLC25A51 mRNA	PMID:31758290
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20220111	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC25A51 mRNA	PMID:22206623
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A51 mRNA	PMID:22206623
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313070	E	RGD:6480464	20220111	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SLC25A51 mRNA	PMID:22714537
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313070	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SLC25A51 mRNA	PMID:37199045
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A51 mRNA	PMID:27188386
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313070	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC25A51 gene]	PMID:28238834
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D010634	Phenobarbital results in decreased expression of SLC25A51 mRNA	PMID:19482888
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20211116	CTD	MESH:D010634	Phenobarbital results in increased expression of SLC25A51 mRNA	PMID:19162173
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SLC25A51 mRNA]	PMID:19482888
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:C009277	sodium arsenate results in decreased expression of SLC25A51 mRNA	PMID:30953684
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1623784	E	RGD:6480464	20211109	CTD	MESH:C045950	propiconazole results in increased expression of SLC25A51 mRNA	PMID:21278054
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313070	E	RGD:6480464	20211109	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A51 mRNA	PMID:27188386
1305190	Slc25a51	solute carrier family 25, member 51	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211116	CTD	MESH:C025643	vinclozolin results in increased methylation of SLC25A51 gene	PMID:31682807
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313072	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KIFAP3 mRNA	PMID:38218311
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313072	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of KIFAP3 mRNA	PMID:33167477
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313072	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of KIFAP3 mRNA	PMID:21934132
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1313073	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of KIFAP3 mRNA	PMID:20362636
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313072	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KIFAP3 mRNA	PMID:21632981
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1313072	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of KIFAP3 protein	PMID:35688186
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KIFAP3 mRNA	PMID:23829299
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313072	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KIFAP3 mRNA	PMID:37042841
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIFAP3 mRNA	PMID:37992649
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313073	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of KIFAP3 protein	PMID:20463053
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of KIFAP3 protein	PMID:20463053
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIFAP3 mRNA	PMID:37992649
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313072	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of KIFAP3 protein	PMID:37730182
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313072	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of KIFAP3 mRNA	PMID:16002434
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of KIFAP3 mRNA	PMID:22061828
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313072	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KIFAP3 mRNA	PMID:28818685
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KIFAP3 mRNA	PMID:39012411
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313072	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KIFAP3 gene	PMID:27153756
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313073	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of KIFAP3 mRNA	PMID:16377760
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20120412	CTD	MESH:D009151	Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of KIFAP3 mRNA]	PMID:16377760
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KIFAP3 mRNA	PMID:22206623
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313072	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KIFAP3 gene	PMID:25304211
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1313072	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of KIFAP3 mRNA	PMID:23300844
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313072	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of KIFAP3 mRNA	PMID:27392435
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313072	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of KIFAP3 mRNA	PMID:27392435
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313073	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KIFAP3 mRNA	PMID:21570461|PMID:24680724
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KIFAP3 mRNA	PMID:33387578
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIFAP3 mRNA	PMID:34747641
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313072	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KIFAP3 mRNA	PMID:28001369
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313072	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of KIFAP3 mRNA	PMID:39709020
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313072	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of KIFAP3 mRNA	PMID:29803840
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIFAP3 mRNA	PMID:37992649
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313073	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KIFAP3 mRNA	PMID:19770486
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313073	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of KIFAP3 protein	PMID:37955338
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1313072	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of KIFAP3 mRNA	PMID:30690063
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of KIFAP3 mRNA	PMID:30816183
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313072	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KIFAP3 gene	PMID:31601247
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KIFAP3 mRNA	PMID:25181051
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of KIFAP3 mRNA	PMID:23829299
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313073	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KIFAP3 mRNA	PMID:37019170
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313072	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KIFAP3 mRNA	PMID:37042841
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KIFAP3 mRNA	PMID:39012411
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of KIFAP3 mRNA	PMID:24386269
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313072	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KIFAP3 mRNA	PMID:31533062
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313072	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of KIFAP3 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313072	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA	PMID:27188386
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of KIFAP3 mRNA	PMID:21865292
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313072	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KIFAP3 mRNA	PMID:25562108
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIFAP3 mRNA	PMID:37992649
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313073	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of KIFAP3 mRNA	PMID:18502557
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313072	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of KIFAP3 mRNA	PMID:24935251|PMID:26272509
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313072	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA	PMID:27188386
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313073	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KIFAP3 mRNA	PMID:17562736
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KIFAP3 mRNA	PMID:33387578
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313072	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of KIFAP3 mRNA	PMID:21420995
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313072	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KIFAP3 gene	PMID:25304211
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313072	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KIFAP3 mRNA	PMID:22079256
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007213	Indomethacin results in decreased expression of KIFAP3 mRNA	PMID:25972201
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313072	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of KIFAP3 mRNA	PMID:23300844
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:51876	auramine O	increases expression	ISO	RGD:1313072	E	RGD:6480464	20191114	CTD	MESH:D001576	Benzophenoneidum results in increased expression of KIFAP3 protein	PMID:28722353
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313072	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of KIFAP3 mRNA	PMID:22714537
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:61057	tacrolimus hydrate	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D016559	Tacrolimus results in decreased expression of KIFAP3 mRNA	PMID:21865292
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:64198	dimercaprol	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20120412	CTD	MESH:D004112	Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of KIFAP3 mRNA]	PMID:16377760
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313073	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KIFAP3 mRNA	PMID:22206623
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KIFAP3 mRNA	PMID:22206623
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313072	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of KIFAP3 mRNA	PMID:22079256|PMID:22714537
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313072	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KIFAP3 mRNA	PMID:22079256
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of KIFAP3 mRNA	PMID:21346803
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313072	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA	PMID:27188386
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313073	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of KIFAP3 mRNA	PMID:23091169
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of KIFAP3 protein	PMID:28903499
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of KIFAP3 mRNA	PMID:36843608
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313072	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of KIFAP3 mRNA	PMID:26272509
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313072	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA	PMID:27188386
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313072	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA	PMID:27188386
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:9168	sirolimus	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D020123	Sirolimus results in increased expression of KIFAP3 mRNA	PMID:21865292
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of KIFAP3 mRNA	PMID:19281266
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KIFAP3 mRNA	PMID:21346803
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313072	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KIFAP3 mRNA	PMID:38568856
1305191	Kifap3	kinesin-associated protein 3	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of KIFAP3 gene	PMID:31079544
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313074	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SEMA7A mRNA	PMID:38218311
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SEMA7A mRNA]	PMID:31150632
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SEMA7A mRNA	PMID:20188158
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313074	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SEMA7A mRNA	PMID:33167477
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313074	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SEMA7A mRNA	PMID:26079696
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of SEMA7A mRNA	PMID:36841081
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SEMA7A mRNA	PMID:39241906
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SEMA7A mRNA]	PMID:39241906
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313074	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of SEMA7A mRNA	PMID:30510588
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313074	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SEMA7A mRNA	PMID:31614463
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SEMA7A mRNA	PMID:30165855
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of SEMA7A mRNA	PMID:18978301
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SEMA7A mRNA	PMID:33387578
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of SEMA7A mRNA	PMID:28937961
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SEMA7A mRNA	PMID:37992649
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SEMA7A mRNA	PMID:36706583
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SEMA7A mRNA	PMID:37992649
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SEMA7A mRNA	PMID:34319233
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SEMA7A mRNA	PMID:27523638
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SEMA7A mRNA	PMID:36139627
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SEMA7A mRNA	PMID:33387578
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313074	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SEMA7A mRNA	PMID:28818685
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:188855	Octicizer	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20260707	CTD	MESH:C018535	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in decreased expression of SEMA7A protein	PMID:42015365
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313074	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SEMA7A intron	PMID:30157460
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in increased expression of SEMA7A mRNA	PMID:28623178
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SEMA7A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SEMA7A mRNA	PMID:35430440|PMID:41430723
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SEMA7A mRNA	PMID:34911549
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SEMA7A mRNA	PMID:31150632
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SEMA7A mRNA]	PMID:31150632
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SEMA7A mRNA	PMID:31881176
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SEMA7A mRNA	PMID:27392435
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of SEMA7A mRNA	PMID:15691709
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313075	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEMA7A mRNA	PMID:24680724
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SEMA7A mRNA	PMID:33387578|PMID:34747641
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEMA7A mRNA	PMID:17942748
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313074	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SEMA7A mRNA	PMID:33212167
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SEMA7A mRNA	PMID:30851411
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SEMA7A mRNA	PMID:29803840
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SEMA7A mRNA	PMID:37992649
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SEMA7A mRNA	PMID:34032870|PMID:39719251
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313074	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEMA7A mRNA	PMID:38568856
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA	PMID:34876320
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA	PMID:34876320
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313074	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SEMA7A promoter	PMID:27901495
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SEMA7A mRNA	PMID:21569818
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SEMA7A mRNA	PMID:38458666
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313074	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SEMA7A mRNA	PMID:25895662
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SEMA7A mRNA	PMID:20382639
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SEMA7A mRNA	PMID:20458559|PMID:27829220
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:30660	thyroxine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D013974	Thyroxine results in increased expression of SEMA7A mRNA	PMID:29901742
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SEMA7A mRNA	PMID:30047161
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313075	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of SEMA7A mRNA	PMID:27760801
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SEMA7A mRNA	PMID:34492290
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313075	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SEMA7A mRNA	PMID:18648102
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of SEMA7A mRNA	PMID:38479592
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:33083	fluoranthene	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20170725	CTD	MESH:C007738	fluoranthene results in decreased expression of SEMA7A mRNA	PMID:28329830
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SEMA7A mRNA	PMID:19167457
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SEMA7A mRNA	PMID:25181051
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SEMA7A mRNA	PMID:29275510
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SEMA7A mRNA	PMID:30816183|PMID:34947998|PMID:38750585
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313075	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SEMA7A mRNA	PMID:25172293
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of SEMA7A mRNA	PMID:20713471
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of SEMA7A mRNA	PMID:20713471
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313075	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SEMA7A exon	PMID:33297965
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313075	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SEMA7A mRNA	PMID:30951980
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SEMA7A mRNA	PMID:26377693
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313075	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SEMA7A mRNA	PMID:30951980
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SEMA7A mRNA	PMID:20350560|PMID:37019170
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313074	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SEMA7A gene	PMID:22964155
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SEMA7A mRNA	PMID:28628672
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of SEMA7A mRNA	PMID:32680482
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of SEMA7A protein	PMID:39748354
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SEMA7A mRNA]	PMID:39241906
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313074	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEMA7A mRNA	PMID:37042841
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:35033	triphenyl phosphate	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20260707	CTD	MESH:C005445	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in decreased expression of SEMA7A protein	PMID:42015365
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SEMA7A mRNA	PMID:38458666
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20260707	CTD	MESH:C031324	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in decreased expression of SEMA7A protein	PMID:42015365
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20260707	CTD	MESH:C013320	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in decreased expression of SEMA7A protein	PMID:42015365
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of SEMA7A mRNA	PMID:35163327
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SEMA7A mRNA	PMID:35163327
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SEMA7A mRNA	PMID:35163327
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SEMA7A mRNA	PMID:30047161
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313075	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SEMA7A mRNA	PMID:40194260
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SEMA7A mRNA	PMID:31533062
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of SEMA7A mRNA	PMID:29038090
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of SEMA7A mRNA	PMID:23125180
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313074	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SEMA7A gene	PMID:29154799
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SEMA7A mRNA	PMID:30047161
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of SEMA7A mRNA	PMID:22733784
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SEMA7A mRNA	PMID:28628672
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SEMA7A mRNA	PMID:37077353
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313075	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SEMA7A mRNA	PMID:28973697
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SEMA7A mRNA	PMID:37992649
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313074	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of SEMA7A mRNA	PMID:21678067
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313074	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SEMA7A mRNA	PMID:38832940
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SEMA7A mRNA	PMID:33387578
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of SEMA7A mRNA	PMID:37077353
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of SEMA7A mRNA	PMID:31838189
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA	PMID:34876320
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313075	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SEMA7A mRNA	PMID:17942748
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEMA7A mRNA	PMID:17942748
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SEMA7A mRNA	PMID:28628672
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SEMA7A mRNA	PMID:20458559|PMID:27829220
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313075	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SEMA7A mRNA; Nanotubes, Carbon results in increased expression of SEMA7A mRNA	PMID:25554681
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SEMA7A mRNA	PMID:30047161
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of SEMA7A mRNA	PMID:22714537
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SEMA7A protein	PMID:23718831
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SEMA7A mRNA	PMID:38701926
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:5951	Iopanoic acid	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:D007480	Iopanoic Acid results in decreased expression of SEMA7A mRNA	PMID:41206128
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA7A mRNA	PMID:21641980
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of SEMA7A mRNA	PMID:28988120
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SEMA7A gene	PMID:35440735
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:6925	microcystin-LR	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C057862	cyanoginosin LR results in increased expression of SEMA7A protein	PMID:22430071
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313075	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SEMA7A mRNA	PMID:22206623
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SEMA7A mRNA	PMID:22714537
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313074	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SEMA7A mRNA	PMID:37199045
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313074	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SEMA7A mRNA	PMID:36139627
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:77131	sinapic acid	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20230404	CTD	MESH:C073734	sinapinic acid analog results in decreased expression of SEMA7A mRNA	PMID:36279966
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313074	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SEMA7A mRNA	PMID:30851411
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SEMA7A mRNA	PMID:32109520
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of SEMA7A protein	PMID:28903499
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:84070	sodium arsenate	affects methylation	ISO	RGD:1313075	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate affects the methylation of SEMA7A promoter	PMID:20667999
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313075	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SEMA7A mRNA	PMID:20667999
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA	PMID:34876320
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SEMA7A mRNA	PMID:24780913|PMID:25825206|PMID:30085217
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SEMA7A mRNA	PMID:30047161
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SEMA7A mRNA	PMID:36706583
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SEMA7A mRNA]	PMID:39241906
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313074	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SEMA7A mRNA	PMID:38568856
1305192	Sema7a	semaphorin 7A (John Milton Hagen blood group)	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SEMA7A mRNA	PMID:28973697
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313076	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of CYP2W1 protein	PMID:39638853
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313076	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CYP2W1 mRNA	PMID:38218311
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313076	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of CYP2W1 mRNA	PMID:16985168
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:15429	hydroxylamine	multiple interactions	ISO	RGD:1313076	E	RGD:6480464	20130312	CTD	MESH:D019811	[CYP2W1 protein results in increased oxidation of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole] which results in increased chemical synthesis of Hydroxylamine	PMID:22734839
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313076	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CYP2W1 mRNA	PMID:20044591
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313076	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CYP2W1 mRNA	PMID:30510588
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313076	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CYP2W1 mRNA	PMID:28818685
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313076	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CYP2W1 mRNA	PMID:19549813
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313076	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CYP2W1 promoter	PMID:22847954
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313076	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYP2W1 mRNA	PMID:16985168
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313076	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CYP2W1 mRNA	PMID:33212167
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313076	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CYP2W1 mRNA	PMID:39709020
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313076	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CYP2W1 promoter	PMID:27901495
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313076	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CYP2W1 mRNA	PMID:22316170|PMID:26238291
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313076	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CYP2W1 exon	PMID:27901495
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1614687	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CYP2W1 promoter	PMID:27901495
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1614687	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the expression of CYP2W1 mRNA	PMID:35295148
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313076	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CYP2W1 mRNA	PMID:30903817
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CYP2W1 mRNA	PMID:25181051
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1614687	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CYP2W1 gene	PMID:31683443
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313076	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CYP2W1 gene	PMID:31601247
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313076	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CYP2W1 protein	PMID:26879310
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313076	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CYP2W1 promoter	PMID:22847954
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313076	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CYP2W1 promoter	PMID:22847954
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313076	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CYP2W1 gene	PMID:29154799
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313076	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CYP2W1 mRNA	PMID:25562108
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313076	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of CYP2W1 mRNA	PMID:22230336
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1313076	E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of CYP2W1 promoter	PMID:29626692
1305193	Cyp2w1	cytochrome P450, family 2, subfamily w, polypeptide 1	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1313076	E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of CYP2W1 mRNA; beta-Naphthoflavone results in decreased expression of CYP2W1 protein	PMID:16985168|PMID:39638853
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313078	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPTA1 mRNA	PMID:33045310
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313078	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of SPTA1 mRNA	PMID:36189433
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPTA1 mRNA	PMID:36189433
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313077	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SPTA1 mRNA	PMID:26516004
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313078	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SPTA1 mRNA	PMID:22629407
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of SPTA1 mRNA	PMID:33729688
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20121113	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPTA1 mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SPTA1 mRNA]	PMID:22629407|PMID:30529165
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313077	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SPTA1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SPTA1 mRNA	PMID:35811015
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SPTA1 mRNA	PMID:32145629
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313078	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SPTA1 mRNA	PMID:39298647
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA	PMID:25510870
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of SPTA1 gene	PMID:27618143
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPTA1 mRNA	PMID:33387578
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313078	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SPTA1 mRNA	PMID:22401849
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPTA1 mRNA	PMID:36189433
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SPTA1 mRNA	PMID:26577399|PMID:27523638
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SPTA1 mRNA	PMID:22061828
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SPTA1 mRNA	PMID:22061828|PMID:33387578
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPTA1 mRNA	PMID:39012411
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA	PMID:25510870
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA	PMID:25510870
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SPTA1 mRNA	PMID:23630614
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SPTA1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SPTA1 mRNA	PMID:34911549
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313078	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SPTA1 mRNA	PMID:17484886
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SPTA1 mRNA	PMID:30723492
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D012643	[1-Methyl-4-phenylpyridinium co-treated with [Sodium Selenite results in increased abundance of Selenium]] results in increased expression of SPTA1 mRNA	PMID:37269647
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1313078	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of SPTA1 mRNA	PMID:28960355
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313078	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SPTA1 mRNA	PMID:40618947
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313078	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPTA1 mRNA	PMID:21570461
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPTA1 mRNA	PMID:32109520
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPTA1 mRNA	PMID:33387578
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313078	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SPTA1 protein	PMID:28918527
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20231031	CTD	MESH:D015084	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313077	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPTA1 mRNA	PMID:34032870|PMID:39719251
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313077	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of SPTA1 gene	PMID:25435355
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of SPTA1 mRNA	PMID:24395379
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of SPTA1 mRNA	PMID:25729387
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SPTA1 mRNA	PMID:25729387
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313078	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of SPTA1 mRNA	PMID:35295148
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SPTA1 mRNA	PMID:19710929
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SPTA1 mRNA	PMID:19167457
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313077	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SPTA1 protein	PMID:31675489
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SPTA1 mRNA	PMID:30816183|PMID:32145629
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313077	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SPTA1 protein	PMID:31675489
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA	PMID:25510870
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA	PMID:25510870
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313078	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SPTA1 mRNA	PMID:21266533
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1313077	E	RGD:6480464	20120412	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of SPTA1 mRNA	PMID:16314067
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPTA1 mRNA	PMID:36928142
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPTA1 mRNA	PMID:39012411
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SPTA1 mRNA	PMID:24386269
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D012643	[1-Methyl-4-phenylpyridinium co-treated with [Sodium Selenite results in increased abundance of Selenium]] results in increased expression of SPTA1 mRNA	PMID:37269647
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313078	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SPTA1 mRNA	PMID:40194260
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of SPTA1 mRNA	PMID:41580965
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313077	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SPTA1 mRNA	PMID:38832940
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of SPTA1 mRNA	PMID:33387578
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1313077	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of SPTA1 mRNA	PMID:35811015
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313077	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SPTA1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SPTA1 mRNA	PMID:35811015
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:48843	disodium selenite	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D018038	[1-Methyl-4-phenylpyridinium co-treated with [Sodium Selenite results in increased abundance of Selenium]] results in increased expression of SPTA1 mRNA	PMID:37269647
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:50819	ferric oxide	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C000499	ferric oxide analog results in increased expression of SPTA1 mRNA	PMID:38615722
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:51403	1,4-phenylenediamine	increases expression	ISO	RGD:1313077	E	RGD:6480464	20120412	CTD	MESH:C029728	4-phenylenediamine results in increased expression of SPTA1 mRNA	PMID:16314067
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313077	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of SPTA1 mRNA	PMID:16314067
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SPTA1 mRNA	PMID:25729387
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SPTA1 mRNA	PMID:25729387
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313078	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of SPTA1 mRNA	PMID:19812364
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:64090	tert-butyl hydroperoxide	multiple interactions	ISO	RGD:1313077	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]	PMID:15040847
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SPTA1 mRNA	PMID:37269647
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	[1-Methyl-4-phenylpyridinium co-treated with [Sodium Selenite results in increased abundance of Selenium]] results in increased expression of SPTA1 mRNA	PMID:37269647
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313078	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of SPTA1 mRNA	PMID:20003209
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1313078	E	RGD:6480464	20150127	CTD	MESH:C014476	diethyl maleate results in increased expression of SPTA1 mRNA	PMID:25270620
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:8093	phenylephrine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in decreased expression of SPTA1 mRNA	PMID:18158353
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of SPTA1 protein	PMID:28903499
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1313077	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SPTA1 protein	PMID:31675489
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of SPTA1 mRNA	PMID:24780913
1305194	Spta1	spectrin, alpha, erythrocytic 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of SPTA1 mRNA	PMID:25825206
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313079	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RBM11 mRNA	PMID:27188386
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313080	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RBM11 mRNA	PMID:30319688
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313080	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RBM11 mRNA	PMID:30319688
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RBM11 mRNA	PMID:33387578
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313080	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RBM11 mRNA	PMID:39922521
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313080	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RBM11 mRNA	PMID:39922521
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RBM11 mRNA	PMID:30779732
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RBM11 mRNA	PMID:33387578
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1313079	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of RBM11 mRNA	PMID:26272509
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313079	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBM11 mRNA	PMID:27188386
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313079	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBM11 promoter	PMID:27901495
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RBM11 mRNA	PMID:25729387
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313080	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBM11 gene	PMID:35295148
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of RBM11 mRNA	PMID:41034487
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313080	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RBM11 mRNA	PMID:37019170
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313079	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RBM11 mRNA	PMID:38382870
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313079	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of RBM11 mRNA	PMID:23179753|PMID:24935251|PMID:27188386
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313080	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RBM11 mRNA	PMID:39922521
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313079	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RBM11 mRNA	PMID:27188386
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313079	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RBM11 mRNA	PMID:28542535
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313079	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RBM11 mRNA	PMID:24935251
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RBM11 mRNA	PMID:33387578
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RBM11 mRNA	PMID:29391264
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1313079	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of RBM11 mRNA	PMID:38825487
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RBM11 mRNA	PMID:25729387
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313079	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RBM11 mRNA	PMID:22714537
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313079	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBM11 mRNA	PMID:27188386
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RBM11 mRNA	PMID:24780913
1305195	Rbm11	RNA binding motif protein 11	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313079	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBM11 mRNA	PMID:27188386
1305196	Jph2	junctophilin 2	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of JPH2 mRNA	PMID:21551480
1305196	Jph2	junctophilin 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313082	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of JPH2 mRNA	PMID:33045310
1305196	Jph2	junctophilin 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313082	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of JPH2 mRNA	PMID:37995155
1305196	Jph2	junctophilin 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of JPH2 mRNA	PMID:36841081
1305196	Jph2	junctophilin 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313081	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of JPH2 mRNA	PMID:22378314
1305196	Jph2	junctophilin 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of JPH2 mRNA	PMID:30510588
1305196	Jph2	junctophilin 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313082	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of JPH2 mRNA	PMID:33711761
1305196	Jph2	junctophilin 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of JPH2 mRNA	PMID:33387578
1305196	Jph2	junctophilin 2	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1313082	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of JPH2 mRNA	PMID:39984025
1305196	Jph2	junctophilin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of JPH2 mRNA	PMID:32234424
1305196	Jph2	junctophilin 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313082	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of JPH2 mRNA	PMID:34911549
1305196	Jph2	junctophilin 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313082	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of JPH2 mRNA	PMID:17484886
1305196	Jph2	junctophilin 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313081	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA	PMID:27188386
1305196	Jph2	junctophilin 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of JPH2 mRNA	PMID:27392435
1305196	Jph2	junctophilin 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313081	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of JPH2 mRNA	PMID:27392435
1305196	Jph2	junctophilin 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313082	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of JPH2 mRNA	PMID:32186404
1305196	Jph2	junctophilin 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of JPH2 mRNA	PMID:25583101
1305196	Jph2	junctophilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of JPH2 mRNA	PMID:32109520
1305196	Jph2	junctophilin 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313081	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of JPH2 mRNA	PMID:33212167
1305196	Jph2	junctophilin 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of JPH2 mRNA	PMID:28959563
1305196	Jph2	junctophilin 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of JPH2 mRNA	PMID:26033743
1305196	Jph2	junctophilin 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of JPH2 mRNA	PMID:29803840
1305196	Jph2	junctophilin 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of JPH2 mRNA	PMID:39631538
1305196	Jph2	junctophilin 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of JPH2 mRNA	PMID:19915844
1305196	Jph2	junctophilin 2	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Razoxane inhibits the reaction [Doxorubicin results in increased expression of JPH2 mRNA]	PMID:19915844
1305196	Jph2	junctophilin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of JPH2 mRNA	PMID:38568856
1305196	Jph2	junctophilin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of JPH2 mRNA	PMID:37682722
1305196	Jph2	junctophilin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313081	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of JPH2 3' UTR	PMID:27901495
1305196	Jph2	junctophilin 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of JPH2 mRNA	PMID:26033743
1305196	Jph2	junctophilin 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313081	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of JPH2 mRNA	PMID:28959546
1305196	Jph2	junctophilin 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313081	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of JPH2 mRNA	PMID:25895662
1305196	Jph2	junctophilin 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of JPH2 mRNA	PMID:19150397
1305196	Jph2	junctophilin 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313081	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of JPH2 mRNA	PMID:20458559
1305196	Jph2	junctophilin 2	gene	CHEBI:3139	bleomycin A2	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20260113	CTD	MESH:D001761	Bleomycin results in decreased expression of JPH2 mRNA	PMID:40645554
1305196	Jph2	junctophilin 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of JPH2 mRNA	PMID:23557971
1305196	Jph2	junctophilin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313082	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of JPH2 gene	PMID:35295148
1305196	Jph2	junctophilin 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of JPH2 mRNA	PMID:18648102
1305196	Jph2	junctophilin 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313081	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of JPH2 mRNA	PMID:38479592
1305196	Jph2	junctophilin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of JPH2 mRNA	PMID:41034487
1305196	Jph2	junctophilin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313082	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of JPH2 mRNA	PMID:30951980
1305196	Jph2	junctophilin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313082	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of JPH2 exon; bisphenol S affects the methylation of JPH2 gene	PMID:31683443|PMID:33297965
1305196	Jph2	junctophilin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313082	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of JPH2 mRNA	PMID:30951980
1305196	Jph2	junctophilin 2	gene	CHEBI:3441	carvedilol	increases expression	ISO	RGD:1313082	E	RGD:6480464	20120613	CTD	MESH:C043211	carvedilol results in increased expression of JPH2 protein	PMID:22375019
1305196	Jph2	junctophilin 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313081	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of JPH2 intron	PMID:30157460
1305196	Jph2	junctophilin 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313082	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of JPH2 mRNA	PMID:30951980
1305196	Jph2	junctophilin 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313082	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of JPH2 intron	PMID:28392331
1305196	Jph2	junctophilin 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313082	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of JPH2 mRNA	PMID:21266533
1305196	Jph2	junctophilin 2	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of JPH2 mRNA	PMID:35163327
1305196	Jph2	junctophilin 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of JPH2 mRNA	PMID:35163327
1305196	Jph2	junctophilin 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of JPH2 mRNA	PMID:38568856
1305196	Jph2	junctophilin 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313081	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of JPH2 mRNA	PMID:38382870
1305196	Jph2	junctophilin 2	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:1313082	E	RGD:6480464	20250204	CTD	MESH:C012125	diisononyl phthalate results in increased expression of JPH2 mRNA	PMID:33391822
1305196	Jph2	junctophilin 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of JPH2 mRNA	PMID:35163327
1305196	Jph2	junctophilin 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of JPH2 mRNA	PMID:40194260
1305196	Jph2	junctophilin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of JPH2 mRNA	PMID:40419075
1305196	Jph2	junctophilin 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of JPH2 mRNA	PMID:29038090
1305196	Jph2	junctophilin 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of JPH2 mRNA	PMID:22155349
1305196	Jph2	junctophilin 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313081	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of JPH2 mRNA	PMID:26272509
1305196	Jph2	junctophilin 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313081	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of JPH2 gene	PMID:29154799
1305196	Jph2	junctophilin 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313081	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA	PMID:27188386
1305196	Jph2	junctophilin 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of JPH2 mRNA	PMID:38832940
1305196	Jph2	junctophilin 2	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of JPH2 mRNA	PMID:33387578
1305196	Jph2	junctophilin 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of JPH2 mRNA	PMID:31838189
1305196	Jph2	junctophilin 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313082	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of JPH2 mRNA	PMID:30529165
1305196	Jph2	junctophilin 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of JPH2 mRNA	PMID:32234424
1305196	Jph2	junctophilin 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313081	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of JPH2 mRNA	PMID:20458559
1305196	Jph2	junctophilin 2	gene	CHEBI:50225	razoxane	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011929	Razoxane inhibits the reaction [Doxorubicin results in increased expression of JPH2 mRNA]	PMID:19915844
1305196	Jph2	junctophilin 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of JPH2 mRNA	PMID:40645554
1305196	Jph2	junctophilin 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of JPH2 mRNA	PMID:23608068
1305196	Jph2	junctophilin 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of JPH2 mRNA	PMID:36907384
1305196	Jph2	junctophilin 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313081	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of JPH2 intron	PMID:30157460
1305196	Jph2	junctophilin 2	gene	CHEBI:6904	metoprolol	increases expression	ISO	RGD:1313082	E	RGD:6480464	20120613	CTD	MESH:D008790	Metoprolol results in increased expression of JPH2 protein	PMID:22375019
1305196	Jph2	junctophilin 2	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1313081	E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of JPH2 mRNA	PMID:33244087
1305196	Jph2	junctophilin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313082	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of JPH2 mRNA	PMID:22206623
1305196	Jph2	junctophilin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313081	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA	PMID:27188386
1305196	Jph2	junctophilin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313081	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to JPH2 gene]	PMID:28238834
1305196	Jph2	junctophilin 2	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1313082	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of JPH2 mRNA	PMID:26655953
1305196	Jph2	junctophilin 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313082	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of JPH2 mRNA	PMID:38648751
1305196	Jph2	junctophilin 2	gene	CHEBI:82036	prothioconazole	increases expression	ISO	RGD:1313081	E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of JPH2 mRNA	PMID:35048155
1305196	Jph2	junctophilin 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313082	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of JPH2 mRNA	PMID:27935865
1305196	Jph2	junctophilin 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of JPH2 mRNA	PMID:21795629
1305196	Jph2	junctophilin 2	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1313081	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of JPH2 mRNA	PMID:31734321
1305196	Jph2	junctophilin 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313081	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA	PMID:27188386
1305196	Jph2	junctophilin 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313081	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of JPH2 mRNA	PMID:28959546
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:15367	all-trans-retinoic acid	affects binding	ISO	RGD:1313084	E	RGD:6480464	20120412	CTD	MESH:D014212	[Tretinoin binds to RARA protein] which binds to NRL promoter; [Tretinoin binds to RXRA protein] which binds to NRL promoter; [Tretinoin binds to RXRG protein] which binds to NRL promoter	PMID:16854989
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of NRL protein	PMID:16854989
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313083	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of NRL mRNA; Tretinoin results in increased expression of NRL protein	PMID:16854989
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313084	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of NRL mRNA	PMID:16854989
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313084	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NRL mRNA	PMID:34319233
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313083	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of NRL mRNA	PMID:28818685
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1313084	E	RGD:6480464	20231205	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of NRL mRNA	PMID:28050121
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313083	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of NRL mRNA	PMID:27392435
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:28077	rifampicin	increases expression	ISO	RGD:1313083	E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in increased expression of NRL mRNA	PMID:24552687
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313084	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NRL mRNA	PMID:24058054
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NRL mRNA	PMID:26033743
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313083	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of NRL gene	PMID:28589171
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313083	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NRL mRNA	PMID:38568856
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313083	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NRL 3' UTR	PMID:27901495
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313083	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NRL mRNA	PMID:22316170|PMID:32234424
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NRL mRNA	PMID:26033743
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1313084	E	RGD:6480464	20231205	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of NRL mRNA	PMID:28050121
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313084	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of NRL promoter	PMID:27334623
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NRL mRNA	PMID:25181051
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313083	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of NRL gene	PMID:31601247
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313083	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NRL mRNA	PMID:38568856
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313083	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NRL mRNA	PMID:31533062
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313084	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NRL mRNA	PMID:17963808
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313083	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NRL mRNA	PMID:38832940
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:49668	gefitinib	decreases expression	ISO	RGD:1313083	E	RGD:6480464	20120412	CTD	MESH:C419708	gefitinib results in decreased expression of NRL mRNA	PMID:16685379
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of NRL mRNA	PMID:30307764
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	ISO	RGD:1313083	E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of NRL mRNA; Alitretinoin results in increased expression of NRL protein	PMID:16854989
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:75261	arotinoid acid	increases expression	ISO	RGD:1313083	E	RGD:6480464	20130903	CTD	MESH:C038864	4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased expression of NRL mRNA; 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased expression of NRL protein	PMID:16854989
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313083	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NRL gene]	PMID:28238834
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313083	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of NRL mRNA	PMID:32234424
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NRL mRNA	PMID:24780913
1305197	Nrl	neural retina leucine zipper	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of NRL gene	PMID:31682807
1305198	Meis2	Meis homeobox 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MEIS2 mRNA	PMID:38218311
1305198	Meis2	Meis homeobox 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MEIS2 mRNA	PMID:33045310
1305198	Meis2	Meis homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of MEIS2 mRNA	PMID:20488242
1305198	Meis2	Meis homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313085	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in increased expression of MEIS2 mRNA	PMID:17034753|PMID:21934132
1305198	Meis2	Meis homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20260113	CTD	MESH:D014212	[Tretinoin co-treated with bisphenol A] results in increased expression of MEIS2 mRNA	PMID:40359302
1305198	Meis2	Meis homeobox 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MEIS2 gene	PMID:28931070
1305198	Meis2	Meis homeobox 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in decreased expression of MEIS2 mRNA	PMID:28986285
1305198	Meis2	Meis homeobox 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313085	E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in increased expression of MEIS2 mRNA	PMID:23378141
1305198	Meis2	Meis homeobox 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20180703	CTD	MESH:D000431	[Ethanol co-treated with Folic Acid] results in increased expression of MEIS2 mRNA	PMID:23378141
1305198	Meis2	Meis homeobox 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of MEIS2 mRNA	PMID:30319688
1305198	Meis2	Meis homeobox 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MEIS2 mRNA	PMID:21632981
1305198	Meis2	Meis homeobox 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313085	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MEIS2 mRNA	PMID:35811015
1305198	Meis2	Meis homeobox 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MEIS2 mRNA	PMID:35811015
1305198	Meis2	Meis homeobox 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313085	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of MEIS2 mRNA	PMID:22574217
1305198	Meis2	Meis homeobox 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of MEIS2 mRNA	PMID:25210133
1305198	Meis2	Meis homeobox 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313085	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MEIS2 mRNA	PMID:21179406
1305198	Meis2	Meis homeobox 2	gene	CHEBI:17336	all-trans-retinol	increases expression	ISO	RGD:1313085	E	RGD:6480464	20120412	CTD	MESH:D014801	Vitamin A results in increased expression of MEIS2 mRNA	PMID:17034753
1305198	Meis2	Meis homeobox 2	gene	CHEBI:17336	all-trans-retinol	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D014801	[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA]	PMID:16397886
1305198	Meis2	Meis homeobox 2	gene	CHEBI:17579	beta-carotene	increases expression	ISO	RGD:1313085	E	RGD:6480464	20120412	CTD	MESH:D019207	beta Carotene results in increased expression of MEIS2 mRNA	PMID:17034753
1305198	Meis2	Meis homeobox 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MEIS2 mRNA	PMID:26577399
1305198	Meis2	Meis homeobox 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MEIS2 mRNA	PMID:40850461
1305198	Meis2	Meis homeobox 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MEIS2 mRNA	PMID:19549813
1305198	Meis2	Meis homeobox 2	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1550144	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of MEIS2 mRNA	PMID:18579281
1305198	Meis2	Meis homeobox 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MEIS2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MEIS2 mRNA	PMID:27106289|PMID:34911549
1305198	Meis2	Meis homeobox 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20180703	CTD	MESH:D005492	[Ethanol co-treated with Folic Acid] results in increased expression of MEIS2 mRNA	PMID:23378141
1305198	Meis2	Meis homeobox 2	gene	CHEBI:27563	arsenic atom	increases response to substance	ISO	RGD:1313085	E	RGD:6480464	20120412	CTD	MESH:D001151	MEIS2 mRNA results in increased susceptibility to Arsenic	PMID:17976673
1305198	Meis2	Meis homeobox 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MEIS2 mRNA	PMID:39836092
1305198	Meis2	Meis homeobox 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313085	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MEIS2 mRNA	PMID:26272509
1305198	Meis2	Meis homeobox 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA	PMID:27188386
1305198	Meis2	Meis homeobox 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313085	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MEIS2 protein	PMID:35688186
1305198	Meis2	Meis homeobox 2	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of MEIS2 mRNA	PMID:38314887
1305198	Meis2	Meis homeobox 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of MEIS2 mRNA	PMID:19561079
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MEIS2 mRNA	PMID:25583101
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MEIS2 mRNA	PMID:34747641
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313085	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MEIS2 mRNA	PMID:22298810
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550144	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MEIS2 mRNA	PMID:24058054|PMID:24680724|PMID:26377647
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MEIS2 mRNA	PMID:32109520
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MEIS2 mRNA	PMID:19465110|PMID:21889950
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MEIS2 mRNA	PMID:25975270
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MEIS2 mRNA	PMID:28001369
1305198	Meis2	Meis homeobox 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MEIS2 mRNA	PMID:33212167
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of MEIS2 mRNA	PMID:30556269
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of MEIS2 mRNA	PMID:27862939
1305198	Meis2	Meis homeobox 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MEIS2 mRNA	PMID:29803840
1305198	Meis2	Meis homeobox 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MEIS2 mRNA	PMID:39719251
1305198	Meis2	Meis homeobox 2	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1550144	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of MEIS2 gene	PMID:39894169
1305198	Meis2	Meis homeobox 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MEIS2 mRNA	PMID:39836092
1305198	Meis2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of MEIS2 mRNA	PMID:22342234
1305198	Meis2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313085	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MEIS2 promoter	PMID:27901495
1305198	Meis2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MEIS2 mRNA	PMID:21839799
1305198	Meis2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MEIS2 mRNA	PMID:21715664|PMID:27195522
1305198	Meis2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313085	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MEIS2 exon	PMID:27901495
1305198	Meis2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MEIS2 mRNA	PMID:20127859
1305198	Meis2	Meis homeobox 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313085	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MEIS2 promoter	PMID:23974009
1305198	Meis2	Meis homeobox 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of MEIS2 mRNA	PMID:30556269
1305198	Meis2	Meis homeobox 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MEIS2 mRNA	PMID:25895662
1305198	Meis2	Meis homeobox 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MEIS2 mRNA	PMID:19150397|PMID:20382639
1305198	Meis2	Meis homeobox 2	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of MEIS2 mRNA	PMID:35984750
1305198	Meis2	Meis homeobox 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MEIS2 gene	PMID:31601247
1305198	Meis2	Meis homeobox 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MEIS2 mRNA	PMID:30047161
1305198	Meis2	Meis homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550144	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MEIS2 enhancer; titanium dioxide results in decreased methylation of MEIS2 gene	PMID:35295148
1305198	Meis2	Meis homeobox 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550144	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MEIS2 mRNA	PMID:23557971
1305198	Meis2	Meis homeobox 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MEIS2 mRNA	PMID:19710929
1305198	Meis2	Meis homeobox 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of MEIS2 mRNA	PMID:28329830
1305198	Meis2	Meis homeobox 2	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20180515	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of MEIS2 gene	PMID:28843141
1305198	Meis2	Meis homeobox 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1550144	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of MEIS2 promoter	PMID:27334623
1305198	Meis2	Meis homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MEIS2 mRNA	PMID:25181051
1305198	Meis2	Meis homeobox 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MEIS2 gene; [Tretinoin co-treated with bisphenol A] results in increased expression of MEIS2 mRNA	PMID:31601247|PMID:40359302
1305198	Meis2	Meis homeobox 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of MEIS2 mRNA	PMID:26682919
1305198	Meis2	Meis homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550144	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MEIS2 gene	PMID:31683443
1305198	Meis2	Meis homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1550144	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of MEIS2 exon; bisphenol S results in decreased methylation of MEIS2 promoter	PMID:33297965
1305198	Meis2	Meis homeobox 2	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1550144	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of MEIS2 mRNA	PMID:26377693
1305198	Meis2	Meis homeobox 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550144	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of MEIS2 intron	PMID:28392331
1305198	Meis2	Meis homeobox 2	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1550144	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of MEIS2 mRNA	PMID:31558096
1305198	Meis2	Meis homeobox 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MEIS2 mRNA	PMID:18668222
1305198	Meis2	Meis homeobox 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MEIS2 mRNA	PMID:40850461
1305198	Meis2	Meis homeobox 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313085	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MEIS2 mRNA	PMID:24449571
1305198	Meis2	Meis homeobox 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MEIS2 mRNA	PMID:40194260
1305198	Meis2	Meis homeobox 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MEIS2 mRNA	PMID:31533062
1305198	Meis2	Meis homeobox 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313085	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MEIS2 mRNA	PMID:25979313
1305198	Meis2	Meis homeobox 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313085	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MEIS2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1305198	Meis2	Meis homeobox 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA	PMID:27188386
1305198	Meis2	Meis homeobox 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MEIS2 mRNA	PMID:20106945
1305198	Meis2	Meis homeobox 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550144	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MEIS2 mRNA	PMID:28973697
1305198	Meis2	Meis homeobox 2	gene	CHEBI:44597	all-trans-4-oxoretinol	increases expression	ISO	RGD:1313085	E	RGD:6480464	20141111	CTD	MESH:C041819	4-oxoretinol results in increased expression of MEIS2 mRNA	PMID:17034753
1305198	Meis2	Meis homeobox 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313085	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MEIS2 mRNA	PMID:24935251|PMID:26272509
1305198	Meis2	Meis homeobox 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA	PMID:27188386
1305198	Meis2	Meis homeobox 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MEIS2 mRNA	PMID:21420995
1305198	Meis2	Meis homeobox 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MEIS2 mRNA	PMID:33387578
1305198	Meis2	Meis homeobox 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of MEIS2 mRNA	PMID:33725128
1305198	Meis2	Meis homeobox 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MEIS2 mRNA	PMID:35811015
1305198	Meis2	Meis homeobox 2	gene	CHEBI:47217	arsane	increases response to substance	ISO	RGD:1313085	E	RGD:6480464	20140805	CTD	MESH:D001151	MEIS2 mRNA results in increased susceptibility to Arsenic	PMID:17976673
1305198	Meis2	Meis homeobox 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MEIS2 mRNA	PMID:39836092
1305198	Meis2	Meis homeobox 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of MEIS2 mRNA	PMID:29391264
1305198	Meis2	Meis homeobox 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MEIS2 mRNA	PMID:22079256
1305198	Meis2	Meis homeobox 2	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D018038	Sodium Selenite results in decreased expression of MEIS2 mRNA	PMID:23274088
1305198	Meis2	Meis homeobox 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MEIS2 mRNA	PMID:17555576
1305198	Meis2	Meis homeobox 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of MEIS2 mRNA	PMID:17557909
1305198	Meis2	Meis homeobox 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MEIS2 mRNA; Nanotubes, Carbon results in decreased expression of MEIS2 mRNA	PMID:25554681
1305198	Meis2	Meis homeobox 2	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	ISO	RGD:1313085	E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of MEIS2 mRNA	PMID:17034753
1305198	Meis2	Meis homeobox 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MEIS2 mRNA	PMID:30047161
1305198	Meis2	Meis homeobox 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313085	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MEIS2 mRNA	PMID:22714537
1305198	Meis2	Meis homeobox 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MEIS2 mRNA	PMID:19042947
1305198	Meis2	Meis homeobox 2	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	increases expression	ISO	RGD:1313085	E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in increased expression of MEIS2 mRNA	PMID:17034753
1305198	Meis2	Meis homeobox 2	gene	CHEBI:63791	lenalidomide	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20161213	CTD	MESH:C467567	lenalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]	PMID:25043012
1305198	Meis2	Meis homeobox 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313085	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of MEIS2 mRNA	PMID:28988120
1305198	Meis2	Meis homeobox 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of MEIS2 mRNA	PMID:36851058
1305198	Meis2	Meis homeobox 2	gene	CHEBI:72690	pomalidomide	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20170110	CTD	MESH:C467566	pomalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]	PMID:25043012
1305198	Meis2	Meis homeobox 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550144	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MEIS2 mRNA	PMID:22206623
1305198	Meis2	Meis homeobox 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MEIS2 mRNA	PMID:22079256
1305198	Meis2	Meis homeobox 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MEIS2 mRNA	PMID:22079256
1305198	Meis2	Meis homeobox 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA	PMID:27188386
1305198	Meis2	Meis homeobox 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MEIS2 gene]	PMID:28238834
1305198	Meis2	Meis homeobox 2	gene	CHEBI:80656	all-trans-4-oxoretinoic acid	increases expression	ISO	RGD:1313085	E	RGD:6480464	20150120	CTD	MESH:C002202	4-oxoretinoic acid results in increased expression of MEIS2 mRNA	PMID:17034753
1305198	Meis2	Meis homeobox 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of MEIS2 mRNA	PMID:23091169
1305198	Meis2	Meis homeobox 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550144	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MEIS2 mRNA	PMID:31388691
1305198	Meis2	Meis homeobox 2	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of MEIS2 mRNA	PMID:31558096
1305198	Meis2	Meis homeobox 2	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313085	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of MEIS2 mRNA	PMID:21858171
1305198	Meis2	Meis homeobox 2	gene	CHEBI:82527	Ptaquiloside	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in decreased expression of MEIS2 mRNA	PMID:23274088
1305198	Meis2	Meis homeobox 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of MEIS2 mRNA	PMID:30953684
1305198	Meis2	Meis homeobox 2	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of MEIS2 mRNA	PMID:30047161
1305198	Meis2	Meis homeobox 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MEIS2 mRNA	PMID:30047161
1305198	Meis2	Meis homeobox 2	gene	CHEBI:85990	panobinostat	affects expression	ISO	RGD:1313085	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat affects the expression of MEIS2 mRNA	PMID:26733615
1305198	Meis2	Meis homeobox 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20161228	CTD	MESH:C496932	(+)-JQ1 compound promotes the reaction [panobinostat affects the expression of MEIS2 mRNA]; panobinostat promotes the reaction [(+)-JQ1 compound affects the expression of MEIS2 mRNA]	PMID:26733615
1305198	Meis2	Meis homeobox 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA	PMID:27188386
1305198	Meis2	Meis homeobox 2	gene	CHEBI:9513	thalidomide	multiple interactions	ISO	RGD:1313085	E	RGD:6480464	20151013	CTD	MESH:D013792	Thalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]	PMID:25043012
1305198	Meis2	Meis homeobox 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of MEIS2 mRNA	PMID:28973697
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MCTP1 mRNA	PMID:38218311
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1605937	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MCTP1 mRNA	PMID:38218311
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1605937	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in increased expression of MCTP1 mRNA	PMID:24172598
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605937	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of MCTP1 mRNA	PMID:21934132
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in decreased expression of MCTP1 mRNA	PMID:15894607
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1605937	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of MCTP1 mRNA	PMID:26079696
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1331997	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MCTP1 mRNA	PMID:30319688
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1331997	E	RGD:6480464	20130618	CTD	MESH:D000431	Ethanol results in decreased expression of MCTP1 mRNA	PMID:21955143
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of MCTP1 mRNA	PMID:23019147
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MCTP1 mRNA	PMID:25510870
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MCTP1 mRNA	PMID:33387578
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605937	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MCTP1 mRNA	PMID:37042841
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20250506	CTD	MESH:D002635	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MCTP1 mRNA	PMID:34589561
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:16767	3,4-dichloroaniline	increases expression	ISO	RGD:1605937	E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in increased expression of MCTP1 mRNA	PMID:24172598
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of MCTP1 mRNA	PMID:23649840
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1605937	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of MCTP1 mRNA	PMID:27664576
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1605937	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of MCTP1 mRNA	PMID:26079696
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCTP1 mRNA	PMID:37992649
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17303	morphine	increases expression	ISO	RGD:1331997	E	RGD:6480464	20130618	CTD	MESH:D009020	Morphine results in increased expression of MCTP1 mRNA	PMID:21955143
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of MCTP1 mRNA	PMID:33359661
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1605937	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of MCTP1 mRNA	PMID:31256213
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCTP1 mRNA	PMID:37992649
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20250506	CTD	MESH:D006000	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MCTP1 mRNA	PMID:34589561
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1331997	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of MCTP1 mRNA	PMID:21955143
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1605937	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MCTP1 mRNA	PMID:31163220
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1605937	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MCTP1 protein	PMID:37730182
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MCTP1 mRNA	PMID:36139627
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MCTP1 mRNA	PMID:33387578
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1605937	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MCTP1 mRNA	PMID:28818685
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1605937	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of MCTP1 intron	PMID:30157460
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1605937	E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of MCTP1 mRNA	PMID:20368581
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1331997	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of MCTP1 mRNA	PMID:21955143
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MCTP1 mRNA	PMID:25510870
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MCTP1 mRNA	PMID:25510870
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MCTP1 mRNA	PMID:23649840
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MCTP1 mRNA	PMID:32234424
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605937	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MCTP1 gene	PMID:27153756
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MCTP1 mRNA	PMID:23649840
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MCTP1 mRNA	PMID:35430440
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1331997	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MCTP1 mRNA	PMID:25629700
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20250506	CTD	MESH:D006002	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MCTP1 mRNA	PMID:34589561
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1605937	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MCTP1 mRNA	PMID:26272509
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA	PMID:27188386
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of MCTP1 gene	PMID:35440735
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1331997	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MCTP1 mRNA	PMID:28960355
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MCTP1 mRNA	PMID:27392435
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MCTP1 mRNA	PMID:27392435
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MCTP1 mRNA	PMID:33387578
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20160822	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MCTP1 mRNA	PMID:26159488
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MCTP1 mRNA	PMID:28001369
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MCTP1 mRNA	PMID:33212167
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1605937	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of MCTP1 mRNA	PMID:26272509
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA	PMID:27188386
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCTP1 mRNA	PMID:37992649
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1605937	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of MCTP1 protein	PMID:35688186
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20250506	CTD	MESH:D003840	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MCTP1 mRNA	PMID:34589561
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	ISO	RGD:1605937	E	RGD:6480464	20120412	CTD	MESH:C028473	MCTP1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1331997	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCTP1 mRNA	PMID:39515575
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605937	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MCTP1 mRNA	PMID:38568856
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605937	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MCTP1 intron; Benzo(a)pyrene affects the methylation of MCTP1 promoter	PMID:27901495|PMID:30157460
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCTP1 mRNA	PMID:20064835
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605937	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCTP1 mRNA	PMID:22316170
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MCTP1 mRNA]	PMID:32406909
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1605937	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of MCTP1 mRNA; Silicon Dioxide results in increased expression of MCTP1 mRNA	PMID:25351596|PMID:25895662
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of MCTP1 mRNA	PMID:15894607
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1605937	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of MCTP1 mRNA	PMID:37690743
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1331997	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MCTP1 promoter	PMID:35295148
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1331997	E	RGD:6480464	20130618	CTD	MESH:C006253	pirinixic acid results in increased expression of MCTP1 mRNA	PMID:20813756
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of MCTP1 mRNA	PMID:41034487
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MCTP1 mRNA	PMID:28628672
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1331997	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of MCTP1 mRNA	PMID:25172293
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1605937	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MCTP1 mRNA	PMID:25979313
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MCTP1 mRNA	PMID:25510870
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of MCTP1 mRNA	PMID:36804509
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MCTP1 mRNA	PMID:25510870
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1605937	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of MCTP1 gene	PMID:31601247
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1331997	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MCTP1 mRNA	PMID:32715474
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MCTP1 mRNA	PMID:28628672
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of MCTP1 mRNA	PMID:36117858
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] affects the methylation of MCTP1 gene	PMID:33148267
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1605937	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MCTP1 mRNA	PMID:38568856
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MCTP1 mRNA	PMID:24449571
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20250506	CTD	MESH:D005999	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MCTP1 mRNA	PMID:34589561
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1331997	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MCTP1 mRNA	PMID:40194260
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20200915	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MCTP1 mRNA	PMID:32588087
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1331997	E	RGD:6480464	20130618	CTD	MESH:D002737	Chloroprene results in increased expression of MCTP1 mRNA	PMID:23125180
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605937	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MCTP1 mRNA	PMID:25979313
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605937	E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of MCTP1 mRNA	PMID:23179753|PMID:25192806|PMID:28001369|PMID:29154799
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MCTP1 mRNA	PMID:28628672
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCTP1 mRNA	PMID:37992649
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605937	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MCTP1 mRNA	PMID:38832940
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1605937	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MCTP1 mRNA	PMID:27188386
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of MCTP1 mRNA	PMID:24935251
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1605937	E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of MCTP1 mRNA	PMID:24935251|PMID:27188386
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1605937	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MCTP1 mRNA	PMID:18687144|PMID:25351596
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:47381	diclofenac	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D004008	Diclofenac results in increased expression of MCTP1 mRNA	PMID:30723492
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1605937	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of MCTP1 mRNA	PMID:26833863|PMID:31838189
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of MCTP1 mRNA	PMID:32234424
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1605937	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of MCTP1 mRNA	PMID:26272509
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA	PMID:27188386
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MCTP1 mRNA	PMID:28628672
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of MCTP1 mRNA	PMID:15894607
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1331997	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MCTP1 mRNA; Nanotubes, Carbon results in increased expression of MCTP1 mRNA	PMID:25554681
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MCTP1 mRNA	PMID:35964746
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1331997	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of MCTP1 mRNA	PMID:36117858
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] affects the methylation of MCTP1 gene	PMID:33148267
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1605937	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MCTP1 mRNA	PMID:31758290
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1331997	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MCTP1 mRNA	PMID:22206623
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1605937	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MCTP1 mRNA	PMID:37199045
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MCTP1 mRNA	PMID:36139627
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA	PMID:27188386
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20250506	CTD	MESH:C005842	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MCTP1 mRNA	PMID:34589561
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1605937	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of MCTP1 mRNA	PMID:20368581
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1605937	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of MCTP1 mRNA	PMID:26079696
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1605937	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of MCTP1 mRNA	PMID:19429434
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1605937	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of MCTP1 mRNA	PMID:31734321
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605937	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA	PMID:27188386
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1605937	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MCTP1 mRNA	PMID:29301935
1305199	Mctp1	multiple C2 and transmembrane domain containing 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of MCTP1 gene	PMID:31682807
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1619527	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TTLL2 mRNA	PMID:37995155
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313087	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TTLL2 mRNA	PMID:28818685
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313087	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TTLL2 intron	PMID:30157460
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313087	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of TTLL2 mRNA	PMID:41028656
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313087	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TTLL2 mRNA	PMID:41028656
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1619527	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA	PMID:34876320
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1619527	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA	PMID:34876320
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313087	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TTLL2 exon; Benzo(a)pyrene affects the methylation of TTLL2 promoter	PMID:27901495
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313087	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TTLL2 3' UTR	PMID:27901495
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313087	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TTLL2 mRNA	PMID:41028656
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of TTLL2 mRNA	PMID:24395379
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1619527	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of TTLL2 mRNA	PMID:35295148
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TTLL2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313087	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TTLL2 gene	PMID:31601247
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of TTLL2 mRNA	PMID:18500788
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1619527	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TTLL2 mRNA	PMID:40194260
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313087	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TTLL2 gene	PMID:29154799
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1619527	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA	PMID:34876320
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313087	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TTLL2 gene]	PMID:28238834
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1619527	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA	PMID:34876320
1305200	Ttll2	tubulin tyrosine ligase like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TTLL2 mRNA	PMID:24780913
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313088	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of DR1 mRNA	PMID:24763279
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313088	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DR1 mRNA	PMID:20044591
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313089	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DR1 mRNA	PMID:39241906
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DR1 mRNA	PMID:33387578
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313088	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DR1 mRNA	PMID:21179406
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of DR1 mRNA	PMID:27683099
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313089	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DR1 mRNA	PMID:33754040
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313088	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DR1 mRNA	PMID:28818685
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of DR1 mRNA	PMID:17175027
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DR1 mRNA	PMID:37325564
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313088	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DR1 mRNA	PMID:19549813
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313088	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DR1 protein	PMID:23301498
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313089	E	RGD:6480464	20150303	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of DR1 mRNA	PMID:19376150
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313088	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DR1 mRNA	PMID:27153756
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313089	E	RGD:6480464	20150303	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DR1 mRNA	PMID:19770486
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313088	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DR1 mRNA	PMID:23649840
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313088	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DR1 mRNA	PMID:35430440
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313089	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DR1 mRNA	PMID:31919559
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313089	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DR1 mRNA	PMID:25629700
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DR1 mRNA	PMID:40504410
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DR1 mRNA	PMID:19244175
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313088	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DR1 protein	PMID:35688186
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313088	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DR1 mRNA	PMID:22298810
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DR1 mRNA	PMID:33387578
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DR1 mRNA	PMID:17101203
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313088	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DR1 mRNA	PMID:33212167
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313088	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DR1 mRNA	PMID:21457566
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DR1 mRNA	PMID:40504410
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313089	E	RGD:6480464	20150303	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DR1 mRNA	PMID:19770486
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of DR1 mRNA	PMID:32479839
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313089	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DR1 gene	PMID:35295148
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DR1 mRNA	PMID:34492290
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313089	E	RGD:6480464	20150303	CTD	MESH:C006253	pirinixic acid results in decreased expression of DR1 mRNA	PMID:23811191
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313089	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DR1 mRNA	PMID:28472532
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313089	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of DR1 promoter	PMID:27334623
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DR1 mRNA	PMID:29275510
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DR1 mRNA	PMID:19244175
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313089	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DR1 mRNA	PMID:37019170
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of DR1 mRNA]	PMID:19030233
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of DR1 mRNA	PMID:17175027
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1313089	E	RGD:6480464	20150303	CTD	MESH:D019256	Cadmium Chloride affects the expression of DR1 mRNA	PMID:18974090
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DR1 protein	PMID:24527689
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DR1 mRNA	PMID:37325564
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DR1 mRNA	PMID:19320972
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DR1 mRNA	PMID:19244175
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:3766	clozapine	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of DR1 protein	PMID:34122009
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313088	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DR1 mRNA	PMID:31533062
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313088	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DR1 gene	PMID:29154799
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313088	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DR1 mRNA	PMID:23179753
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313088	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DR1 mRNA	PMID:20106945|PMID:25562108
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of DR1 mRNA	PMID:36621641
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313089	E	RGD:6480464	20150303	CTD	MESH:D000082	Acetaminophen affects the expression of DR1 mRNA	PMID:17562736
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DR1 mRNA	PMID:40504410
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DR1 mRNA	PMID:17108234
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DR1 mRNA	PMID:35964746
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of DR1 mRNA	PMID:21983209
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:5613	haloperidol	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in decreased expression of DR1 protein	PMID:34122009
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1313088	E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of DR1 mRNA	PMID:17175027
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313088	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of DR1 mRNA	PMID:28988120
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313089	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DR1 mRNA	PMID:22206623
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313088	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DR1 protein	PMID:37664457
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of DR1 mRNA	PMID:24136188
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1313088	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of DR1 mRNA	PMID:19946333
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1313088	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of DR1 mRNA]	PMID:19946333
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of DR1 protein	PMID:28903499
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313088	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DR1 protein	PMID:37664457
1305201	Dr1	down-regulator of transcription 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DR1 mRNA	PMID:21346803
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1344204	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CCM2L mRNA	PMID:26272509|PMID:27188386
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA	PMID:27188386
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1344204	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CCM2L mRNA	PMID:26079696
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of CCM2L gene	PMID:35440735
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1344204	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CCM2L mRNA	PMID:35811015
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CCM2L mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CCM2L mRNA	PMID:35811015
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1344204	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of CCM2L mRNA	PMID:24758408|PMID:31614463
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in increased expression of CCM2L mRNA]	PMID:24758408
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CCM2L mRNA	PMID:33387578
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1344204	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CCM2L mRNA	PMID:26079696
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1344204	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of CCM2L mRNA	PMID:33647349
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1344204	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CCM2L mRNA	PMID:31163220
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CCM2L mRNA	PMID:36139627
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313090	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCM2L mRNA	PMID:40504410
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1344204	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CCM2L mRNA	PMID:26272509
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCM2L mRNA	PMID:27188386
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1344204	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CCM2L mRNA	PMID:25583101
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCM2L mRNA	PMID:33387578
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344204	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CCM2L mRNA	PMID:38568856
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313090	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCM2L mRNA	PMID:40504410
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1344204	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCM2L mRNA	PMID:32234424
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1344204	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCM2L 3' UTR; Benzo(a)pyrene results in increased methylation of CCM2L promoter	PMID:27901495
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313090	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCM2L mRNA	PMID:27858113
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313090	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CCM2L mRNA	PMID:35295148
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313090	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of CCM2L mRNA	PMID:23811191
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1313090	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of CCM2L mRNA	PMID:37894381
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CCM2L mRNA	PMID:30816183|PMID:34947998
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1344204	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CCM2L mRNA	PMID:25047013
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1344204	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CCM2L mRNA	PMID:25979313
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313090	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CCM2L gene	PMID:31683443
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313090	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of CCM2L mRNA	PMID:26377693
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313090	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCM2L mRNA	PMID:27858113
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313090	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CCM2L mRNA	PMID:38685157
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313090	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CCM2L mRNA	PMID:37019170
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313090	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of CCM2L mRNA	PMID:26377693
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1344204	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CCM2L mRNA	PMID:24449571
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1313090	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of CCM2L mRNA	PMID:28962523
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344204	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CCM2L mRNA	PMID:25979313
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344204	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CCM2L mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA	PMID:27188386
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1344204	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCM2L mRNA	PMID:38832940
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1344204	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CCM2L mRNA	PMID:26272509
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA	PMID:27188386
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1344204	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of CCM2L mRNA	PMID:26272509
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA	PMID:27188386
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CCM2L mRNA	PMID:33387578
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CCM2L mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CCM2L mRNA	PMID:35811015
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313090	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCM2L mRNA	PMID:40504410
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313090	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCM2L mRNA; Nanotubes, Carbon results in decreased expression of CCM2L mRNA	PMID:25620056
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313090	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CCM2L mRNA	PMID:25554681
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313090	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of CCM2L mRNA	PMID:26377693
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313090	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCM2L mRNA	PMID:27858113
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313090	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCM2L mRNA	PMID:27858113
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:6651	malathion	increases expression	ISO	RGD:1344204	E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of CCM2L mRNA	PMID:37047231
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CCM2L mRNA	PMID:36139627
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCM2L mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA	PMID:27188386
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313090	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of CCM2L mRNA	PMID:23091169
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1344204	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of CCM2L mRNA	PMID:26079696
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344204	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCM2L mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCM2L mRNA	PMID:27188386
1305202	Ccm2l	CCM2 like scaffold protein	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1344204	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of CCM2L mRNA	PMID:27188386
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of BAG1 mRNA	PMID:21551480
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BAG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BAG1 mRNA	PMID:32699268
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of BAG1 mRNA	PMID:24763279
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313092	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BAG1 mRNA	PMID:39241906
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of BAG1 mRNA	PMID:39298647
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of BAG1 gene	PMID:27618143
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of BAG1 protein	PMID:18093815
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of BAG1 mRNA	PMID:23649840|PMID:27664576
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of BAG1 mRNA	PMID:18037150
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of BAG1 mRNA	PMID:31256213
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of BAG1 protein alternative form	PMID:12479363
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of BAG1 mRNA	PMID:12634122
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313091	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of BAG1 mRNA	PMID:24376830
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313091	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BAG1 mRNA	PMID:19549813
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of BAG1 protein	PMID:23301498
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of BAG1 mRNA	PMID:26760959
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313091	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of BAG1 mRNA	PMID:23649840
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BAG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BAG1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of BAG1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of BAG1 mRNA	PMID:32699268|PMID:35430440
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of BAG1 mRNA	PMID:19774075
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of BAG1 mRNA	PMID:15226459
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of BAG1 mRNA	PMID:40512198
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313092	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BAG1 mRNA	PMID:40504410
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BAG1 mRNA	PMID:19244175
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313091	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of BAG1 mRNA	PMID:19561079
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1313092	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of BAG1 mRNA	PMID:15681117
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313092	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BAG1 mRNA	PMID:21570461
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BAG1 mRNA	PMID:33387578|PMID:34747641
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of BAG1 protein	PMID:39603559
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1313091	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of BAG1 mRNA	PMID:30851411
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of BAG1 mRNA	PMID:20971185
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of BAG1 mRNA	PMID:16439991
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D004317	[Doxorubicin co-treated with Cyclophosphamide] affects the expression of BAG1 mRNA	PMID:16322899
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of BAG1 mRNA	PMID:12760830|PMID:20886546|PMID:38568856
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of BAG1 mRNA	PMID:14691202|PMID:36209798
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313091	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of BAG1 mRNA	PMID:10910055|PMID:34032870
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of BAG1 mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BAG1 mRNA	PMID:12634122|PMID:40512198
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313092	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BAG1 mRNA	PMID:40504410
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313092	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BAG1 mRNA	PMID:20504355
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of BAG1 mRNA	PMID:18585952
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:C015001	XPA protein affects the reaction [arsenite results in increased expression of BAG1 mRNA]	PMID:18585952
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of BAG1 mRNA	PMID:20971185
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:30145	lithium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of BAG1 mRNA; Lithium results in increased expression of BAG1 protein	PMID:15872096
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:30146	lithium hydride	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of BAG1 mRNA; Lithium results in increased expression of BAG1 protein	PMID:15872096
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of BAG1 mRNA	PMID:15226459
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of BAG1 mRNA	PMID:25351596
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313091	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of BAG1 mRNA	PMID:20382639
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of BAG1 mRNA	PMID:17530438
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:C008261	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BAG1 mRNA	PMID:12634122
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313092	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BAG1 gene	PMID:35295148
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313092	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of BAG1 protein	PMID:10426811
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of BAG1 mRNA	PMID:38479592
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of BAG1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of BAG1 mRNA	PMID:33221593
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BAG1 mRNA	PMID:25181051
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of BAG1 gene	PMID:28505145
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:3392	carbendazim	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006698	carbendazim results in increased expression of BAG1 mRNA	PMID:22952946
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of BAG1 mRNA	PMID:22937105
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of BAG1 mRNA	PMID:22937105
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of BAG1 mRNA	PMID:17452286
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of BAG1 mRNA	PMID:22546817
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:34682	diazinon	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in decreased expression of BAG1 mRNA	PMID:17452286
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of BAG1 mRNA	PMID:17361019|PMID:21266533
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of BAG1 mRNA	PMID:22546817
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of BAG1 mRNA	PMID:34813904
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of BAG1 mRNA	PMID:22546817
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313091	E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of BAG1 mRNA	PMID:18836921
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313091	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BAG1 mRNA	PMID:37042841
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:35176	zinc sulfate	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of BAG1 mRNA	PMID:15226459
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BAG1 mRNA; Cadmium Chloride results in decreased expression of BAG1 protein	PMID:12160620
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BAG1 mRNA	PMID:15501611
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of BAG1 mRNA	PMID:33453195
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313091	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of BAG1 mRNA	PMID:38174414
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D019256	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BAG1 mRNA	PMID:12634122
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of BAG1 mRNA	PMID:17553155
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313091	E	RGD:6480464	20141223	CTD	MESH:C018021	cobaltous chloride results in increased expression of BAG1 mRNA	PMID:19320972|PMID:19376846|PMID:25281833
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20141223	CTD	MESH:C018021	cobaltous chloride promotes the reaction [Chromium Alloys results in increased expression of BAG1 mRNA]	PMID:25281833
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BAG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BAG1 mRNA	PMID:32699268
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BAG1 mRNA	PMID:19244175
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20130416	CTD	MESH:D013755	BAG1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of DUSP1 mRNA]; BAG1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MT2A mRNA]; BAG1 protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of RELA protein]; BAG1 protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of NFKB1 protein]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCL8 mRNA]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of FKBP5 mRNA]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 mRNA]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 mRNA]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein]	PMID:20858459
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:38319	usnic acid	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in decreased expression of BAG1 mRNA	PMID:32508146
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1313091	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of BAG1 mRNA	PMID:40434365
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20230606	CTD	MESH:D011722	Pyrethrins results in decreased expression of BAG1 mRNA	PMID:35321623
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313091	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BAG1 mRNA	PMID:25979313
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of BAG1 mRNA; Valproic Acid results in increased expression of BAG1 protein	PMID:15872096
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of BAG1 mRNA	PMID:17183730
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D003520	[Doxorubicin co-treated with Cyclophosphamide] affects the expression of BAG1 mRNA	PMID:16322899
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:41774	tamoxifen	affects response to substance	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D013629	BAG1 protein affects the susceptibility to Tamoxifen	PMID:19066611
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of BAG1 mRNA	PMID:17005392
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313092	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of BAG1 mRNA	PMID:21041162
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	affects localization	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide affects the localization of BAG1 protein	PMID:17110918
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of BAG1 mRNA	PMID:29309887
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of BAG1 mRNA	PMID:33387578
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1313091	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of BAG1 mRNA	PMID:19036117
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of BAG1 mRNA	PMID:40512198
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313092	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BAG1 mRNA	PMID:40504410
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:47344	alvocidib	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20170303	CTD	MESH:C077990	alvocidib results in decreased expression of BAG1 mRNA; alvocidib results in decreased expression of BAG1 protein; alvocidib results in decreased expression of BAG1 protein alternative form	PMID:10887097|PMID:15972445
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of BAG1 mRNA	PMID:31838189
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BAG1 mRNA	PMID:22079256
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313092	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of BAG1 mRNA	PMID:35436446
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:48242	dichromium trioxide	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:C023600	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BAG1 mRNA	PMID:12634122
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of BAG1 mRNA	PMID:38568856
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of BAG1 mRNA	PMID:17530438
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313091	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of BAG1 mRNA	PMID:15585362
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of BAG1 mRNA	PMID:17183730
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in decreased expression of BAG1 mRNA	PMID:21335049
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of BAG1 mRNA	PMID:29309887
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of BAG1 mRNA	PMID:30467583
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:6954	Mitotane	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D008939	Mitotane results in increased expression of BAG1 mRNA	PMID:23485034
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of BAG1 mRNA	PMID:22101062
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313091	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of BAG1 mRNA	PMID:22079256
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313091	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BAG1 mRNA	PMID:22079256
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:75701	sarin	decreases expression	ISO	RGD:1313091	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of BAG1 mRNA	PMID:19522546
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:75701	sarin	increases expression	ISO	RGD:1313091	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of BAG1 mRNA	PMID:19522546
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of BAG1 mRNA	PMID:15215175
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1313091	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of BAG1 mRNA	PMID:30851411
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of BAG1 mRNA	PMID:22538082
1305203	Bag1	BAG cochaperone 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313091	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of BAG1 mRNA	PMID:29301935
1305204	Rnf43	ring finger protein 43	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RNF43 mRNA	PMID:38218311
1305204	Rnf43	ring finger protein 43	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1342772	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RNF43 mRNA	PMID:26272509
1305204	Rnf43	ring finger protein 43	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA	PMID:27188386
1305204	Rnf43	ring finger protein 43	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF43 mRNA]	PMID:31150632
1305204	Rnf43	ring finger protein 43	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1342772	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of RNF43 mRNA	PMID:23830798
1305204	Rnf43	ring finger protein 43	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RNF43 mRNA	PMID:30529165
1305204	Rnf43	ring finger protein 43	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of RNF43 gene	PMID:35440735
1305204	Rnf43	ring finger protein 43	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1332400	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RNF43 mRNA	PMID:30319688
1305204	Rnf43	ring finger protein 43	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1332400	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of RNF43 mRNA	PMID:19167417|PMID:30319688
1305204	Rnf43	ring finger protein 43	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RNF43 mRNA	PMID:21632981
1305204	Rnf43	ring finger protein 43	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1342772	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of RNF43 protein	PMID:35688186
1305204	Rnf43	ring finger protein 43	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of RNF43 mRNA	PMID:20106945|PMID:31614463
1305204	Rnf43	ring finger protein 43	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of RNF43 mRNA	PMID:32145629
1305204	Rnf43	ring finger protein 43	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332400	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RNF43 mRNA	PMID:39298647
1305204	Rnf43	ring finger protein 43	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RNF43 mRNA	PMID:25510870
1305204	Rnf43	ring finger protein 43	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RNF43 mRNA	PMID:33387578
1305204	Rnf43	ring finger protein 43	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RNF43 mRNA	PMID:28973375
1305204	Rnf43	ring finger protein 43	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of RNF43 mRNA	PMID:22238285
1305204	Rnf43	ring finger protein 43	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1332400	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RNF43 mRNA	PMID:39922521
1305204	Rnf43	ring finger protein 43	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1332400	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RNF43 mRNA	PMID:39922521
1305204	Rnf43	ring finger protein 43	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of RNF43 mRNA	PMID:16002434
1305204	Rnf43	ring finger protein 43	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of RNF43 mRNA	PMID:22061828
1305204	Rnf43	ring finger protein 43	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RNF43 mRNA	PMID:33387578
1305204	Rnf43	ring finger protein 43	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RNF43 mRNA	PMID:28818685
1305204	Rnf43	ring finger protein 43	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1342772	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of RNF43 exon	PMID:30157460
1305204	Rnf43	ring finger protein 43	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RNF43 mRNA	PMID:36331819
1305204	Rnf43	ring finger protein 43	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RNF43 mRNA	PMID:37236586
1305204	Rnf43	ring finger protein 43	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RNF43 mRNA	PMID:25510870
1305204	Rnf43	ring finger protein 43	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RNF43 mRNA	PMID:25510870
1305204	Rnf43	ring finger protein 43	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RNF43 mRNA	PMID:19549813
1305204	Rnf43	ring finger protein 43	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1342772	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of RNF43 protein	PMID:20106945
1305204	Rnf43	ring finger protein 43	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RNF43 mRNA	PMID:22100608
1305204	Rnf43	ring finger protein 43	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1342772	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RNF43 exon	PMID:30157460
1305204	Rnf43	ring finger protein 43	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1342772	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RNF43 intron	PMID:30157460
1305204	Rnf43	ring finger protein 43	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RNF43 mRNA	PMID:30779732
1305204	Rnf43	ring finger protein 43	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RNF43 mRNA	PMID:31150632
1305204	Rnf43	ring finger protein 43	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RNF43 mRNA	PMID:31919559
1305204	Rnf43	ring finger protein 43	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF43 mRNA]	PMID:31150632
1305204	Rnf43	ring finger protein 43	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA	PMID:27188386
1305204	Rnf43	ring finger protein 43	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1342772	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RNF43 protein	PMID:35688186
1305204	Rnf43	ring finger protein 43	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of RNF43 mRNA	PMID:41028656
1305204	Rnf43	ring finger protein 43	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of RNF43 mRNA	PMID:32186404
1305204	Rnf43	ring finger protein 43	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332400	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF43 mRNA	PMID:21570461
1305204	Rnf43	ring finger protein 43	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF43 mRNA	PMID:32109520|PMID:34747641
1305204	Rnf43	ring finger protein 43	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20120515	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of RNF43 intron] which results in increased expression of RNF43 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RNF43 promoter]	PMID:19654925|PMID:33017471
1305204	Rnf43	ring finger protein 43	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of RNF43 mRNA	PMID:28374803
1305204	Rnf43	ring finger protein 43	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1342772	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNF43 mRNA	PMID:33212167
1305204	Rnf43	ring finger protein 43	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RNF43 mRNA	PMID:30556269
1305204	Rnf43	ring finger protein 43	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RNF43 mRNA	PMID:41028656
1305204	Rnf43	ring finger protein 43	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1342772	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of RNF43 mRNA	PMID:20044591
1305204	Rnf43	ring finger protein 43	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNF43 mRNA	PMID:34032870
1305204	Rnf43	ring finger protein 43	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1342772	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RNF43 intron	PMID:30157460
1305204	Rnf43	ring finger protein 43	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNF43 mRNA	PMID:32234424
1305204	Rnf43	ring finger protein 43	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1342772	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RNF43 5' UTR	PMID:27901495
1305204	Rnf43	ring finger protein 43	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RNF43 mRNA	PMID:30556269
1305204	Rnf43	ring finger protein 43	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RNF43 mRNA	PMID:41028656
1305204	Rnf43	ring finger protein 43	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of RNF43 mRNA	PMID:26014281
1305204	Rnf43	ring finger protein 43	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1342772	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of RNF43 mRNA	PMID:37690743
1305204	Rnf43	ring finger protein 43	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1342772	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of RNF43 mRNA	PMID:16510598
1305204	Rnf43	ring finger protein 43	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RNF43 mRNA	PMID:34492290
1305204	Rnf43	ring finger protein 43	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RNF43 mRNA	PMID:23411599
1305204	Rnf43	ring finger protein 43	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RNF43 mRNA	PMID:20813756
1305204	Rnf43	ring finger protein 43	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of RNF43 mRNA	PMID:19167457
1305204	Rnf43	ring finger protein 43	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1342772	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RNF43 mRNA	PMID:30903817
1305204	Rnf43	ring finger protein 43	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF43 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305204	Rnf43	ring finger protein 43	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332400	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RNF43 mRNA	PMID:30951980|PMID:32156529
1305204	Rnf43	ring finger protein 43	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RNF43 mRNA	PMID:25510870
1305204	Rnf43	ring finger protein 43	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RNF43 mRNA	PMID:25510870
1305204	Rnf43	ring finger protein 43	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1332400	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of RNF43 gene	PMID:31683443
1305204	Rnf43	ring finger protein 43	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF43 mRNA	PMID:40203079
1305204	Rnf43	ring finger protein 43	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1332400	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of RNF43 exon	PMID:33297965
1305204	Rnf43	ring finger protein 43	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332400	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RNF43 mRNA	PMID:30951980|PMID:39298647
1305204	Rnf43	ring finger protein 43	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1342772	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RNF43 exon	PMID:30157460
1305204	Rnf43	ring finger protein 43	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1342772	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RNF43 intron	PMID:30157460
1305204	Rnf43	ring finger protein 43	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1332400	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RNF43 mRNA	PMID:30951980
1305204	Rnf43	ring finger protein 43	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RNF43 mRNA	PMID:37236586
1305204	Rnf43	ring finger protein 43	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of RNF43 mRNA	PMID:28903501
1305204	Rnf43	ring finger protein 43	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RNF43 mRNA	PMID:32588087
1305204	Rnf43	ring finger protein 43	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RNF43 mRNA	PMID:31533062
1305204	Rnf43	ring finger protein 43	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332400	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RNF43 mRNA	PMID:36331819
1305204	Rnf43	ring finger protein 43	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of RNF43 mRNA	PMID:29038090
1305204	Rnf43	ring finger protein 43	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of RNF43 mRNA	PMID:23125180
1305204	Rnf43	ring finger protein 43	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1342772	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RNF43 mRNA	PMID:25979313
1305204	Rnf43	ring finger protein 43	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1342772	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RNF43 mRNA	PMID:23179753|PMID:23527032|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1305204	Rnf43	ring finger protein 43	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA	PMID:27188386
1305204	Rnf43	ring finger protein 43	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RNF43 mRNA	PMID:20106945|PMID:25562108
1305204	Rnf43	ring finger protein 43	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1332400	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RNF43 mRNA	PMID:20937368
1305204	Rnf43	ring finger protein 43	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332400	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RNF43 mRNA	PMID:28973697
1305204	Rnf43	ring finger protein 43	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1332400	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RNF43 mRNA	PMID:39922521
1305204	Rnf43	ring finger protein 43	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RNF43 mRNA	PMID:38832940
1305204	Rnf43	ring finger protein 43	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1342772	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of RNF43 mRNA	PMID:24935251|PMID:26272509
1305204	Rnf43	ring finger protein 43	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA	PMID:27188386
1305204	Rnf43	ring finger protein 43	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332400	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF43 mRNA	PMID:17562736
1305204	Rnf43	ring finger protein 43	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RNF43 mRNA	PMID:33387578
1305204	Rnf43	ring finger protein 43	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of RNF43 mRNA	PMID:29067470
1305204	Rnf43	ring finger protein 43	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RNF43 mRNA; Nanotubes, Carbon results in decreased expression of RNF43 mRNA	PMID:25554681|PMID:25620056
1305204	Rnf43	ring finger protein 43	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1332400	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of RNF43 mRNA	PMID:26377693
1305204	Rnf43	ring finger protein 43	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1342772	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of RNF43 mRNA	PMID:28988120
1305204	Rnf43	ring finger protein 43	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1342772	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RNF43 exon	PMID:30157460
1305204	Rnf43	ring finger protein 43	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1342772	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RNF43 intron	PMID:30157460
1305204	Rnf43	ring finger protein 43	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RNF43 gene	PMID:35440735
1305204	Rnf43	ring finger protein 43	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA	PMID:27188386
1305204	Rnf43	ring finger protein 43	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RNF43 gene]	PMID:28238834
1305204	Rnf43	ring finger protein 43	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1332400	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RNF43 mRNA	PMID:23091169
1305204	Rnf43	ring finger protein 43	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1332400	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of RNF43 mRNA	PMID:21278054
1305204	Rnf43	ring finger protein 43	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RNF43 mRNA	PMID:36843608
1305204	Rnf43	ring finger protein 43	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1342772	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of RNF43 mRNA	PMID:26272509
1305204	Rnf43	ring finger protein 43	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA	PMID:27188386
1305204	Rnf43	ring finger protein 43	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1342772	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA	PMID:27188386
1305204	Rnf43	ring finger protein 43	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of RNF43 mRNA	PMID:26014281
1305204	Rnf43	ring finger protein 43	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1342772	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of RNF43 mRNA	PMID:27188386
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of TMT1B protein	PMID:39638853
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D004237	Diuron results in increased expression of TMT1B mRNA	PMID:21551480
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of TMT1B mRNA	PMID:27188386
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TMT1B mRNA]	PMID:31150632
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of TMT1B mRNA	PMID:39506029
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000431	Ethanol results in decreased expression of TMT1B protein	PMID:19609968
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TMT1B mRNA	PMID:21632981
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1603260	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TMT1B mRNA	PMID:35811015
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of TMT1B mRNA	PMID:30510588
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D004958	Estradiol results in decreased expression of TMT1B mRNA	PMID:32145629
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603260	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TMT1B mRNA	PMID:31614463
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1603260	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of TMT1B mRNA	PMID:30165855
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:C024836	4-nitrophenol results in decreased expression of TMT1B mRNA	PMID:34673133
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in decreased expression of TMT1B mRNA	PMID:29221148
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TMT1B mRNA	PMID:31163220
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMT1B mRNA	PMID:19850644
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of TMT1B mRNA]	PMID:19850644
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D005839	Gentamicins results in decreased expression of TMT1B mRNA	PMID:33387578
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMT1B mRNA	PMID:36331819
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C500085	muraglitazar results in increased expression of TMT1B mRNA	PMID:21515302
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMT1B mRNA	PMID:37236586
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in increased expression of TMT1B protein]	PMID:32272095
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TMT1B mRNA	PMID:19770486
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMT1B mRNA	PMID:31150632
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TMT1B mRNA]	PMID:31150632
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMT1B mRNA	PMID:40504410
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMT1B mRNA	PMID:33854195
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603260	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TMT1B mRNA	PMID:27392435
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1603260	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TMT1B mRNA	PMID:27392435
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMT1B mRNA	PMID:22298810
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMT1B mRNA	PMID:21570461
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMT1B mRNA	PMID:33387578
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMT1B mRNA	PMID:21998131
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMT1B mRNA	PMID:18178546|PMID:18796159|PMID:32109520
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:2825	aristolochic acid A	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C000228	[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of TMT1B mRNA	PMID:23912714
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1603260	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of TMT1B mRNA	PMID:26272509
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1603260	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMT1B mRNA	PMID:27188386
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603260	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TMT1B mRNA	PMID:34032870
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMT1B mRNA	PMID:40504410
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMT1B mRNA	PMID:19770486|PMID:21715664
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603260	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMT1B exon	PMID:27901495
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TMT1B mRNA	PMID:25895662
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TMT1B mRNA	PMID:35984750
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C501413	tesaglitazar results in increased expression of TMT1B mRNA	PMID:21515302
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013853	Thioacetamide results in decreased expression of TMT1B mRNA	PMID:34492290
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:C006253	pirinixic acid results in increased expression of TMT1B mRNA	PMID:17426115|PMID:18301758
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TMT1B mRNA	PMID:19710929
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1603260	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TMT1B mRNA	PMID:19710929
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TMT1B mRNA	PMID:28472532
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A affects the expression of TMT1B mRNA	PMID:30903817
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of TMT1B mRNA	PMID:25181051
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:C006780	bisphenol A results in increased expression of TMT1B mRNA	PMID:30245210
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of TMT1B mRNA	PMID:25172293
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TMT1B mRNA	PMID:19692669
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332417	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TMT1B mRNA	PMID:39298647
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332417	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TMT1B mRNA	PMID:38685157
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMT1B mRNA	PMID:33854195
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D002995	Clofibric Acid affects the expression of TMT1B mRNA	PMID:17602206
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D016264	Dextran Sulfate results in increased expression of TMT1B protein	PMID:32272095
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in increased expression of TMT1B protein]	PMID:32272095
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMT1B mRNA	PMID:25993096
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of TMT1B promoter	PMID:22457795
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMT1B mRNA	PMID:37236586
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TMT1B mRNA	PMID:28903501
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of TMT1B mRNA	PMID:19162173
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMT1B mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TMT1B mRNA	PMID:36331819
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:C031763	1,3-butadiene results in decreased expression of TMT1B mRNA	PMID:29038090
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016104	sodium bichromate results in decreased expression of TMT1B mRNA	PMID:25993096
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D014635	Valproic Acid affects the expression of TMT1B mRNA	PMID:17292431
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603260	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of TMT1B mRNA	PMID:28001369
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TMT1B mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMT1B mRNA	PMID:33854195
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D013629	Tamoxifen results in decreased expression of TMT1B mRNA	PMID:17555576
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMT1B mRNA	PMID:33854195
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:D000082	Acetaminophen affects the expression of TMT1B mRNA	PMID:17562736
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMT1B mRNA	PMID:33387578
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1603260	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TMT1B mRNA	PMID:35811015
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332417	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMT1B mRNA	PMID:40504410
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D004726	Endosulfan results in decreased expression of TMT1B mRNA	PMID:29391264
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of TMT1B mRNA	PMID:19162173
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D005485	Flutamide results in decreased expression of TMT1B mRNA	PMID:24793618
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D005485	Flutamide results in increased expression of TMT1B mRNA	PMID:24136188
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMT1B mRNA	PMID:33854195
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of TMT1B mRNA	PMID:27188386
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TMT1B mRNA	PMID:18178546
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20180410	CTD	MESH:C045463	Leflunomide results in decreased expression of TMT1B mRNA	PMID:28988120
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C045463	Leflunomide results in increased expression of TMT1B mRNA	PMID:24136188
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:64163	diquat	affects expression	ISO	RGD:1332417	E	RGD:6480464	20260707	CTD	MESH:D004178	Diquat affects the expression of TMT1B mRNA	PMID:41009731
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:6437	levetiracetam	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000077287	Levetiracetam results in increased expression of TMT1B mRNA	PMID:20345932
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TMT1B mRNA	PMID:31758290
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of TMT1B mRNA	PMID:29522793
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:7599	Nivalenol	decreases expression	ISO	RGD:1603260	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in decreased expression of TMT1B protein	PMID:39638853
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603260	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMT1B mRNA	PMID:27188386
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1332417	E	RGD:6480464	20230704	CTD	MESH:C412815	GW 4064 results in increased expression of TMT1B mRNA	PMID:26655953
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:80630	irinotecan	affects expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000077146	Irinotecan affects the expression of TMT1B mRNA	PMID:20097248
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1332417	E	RGD:6480464	20250805	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TMT1B mRNA	PMID:38648751
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TMT1B mRNA	PMID:28712647
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1603260	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TMT1B mRNA	PMID:23146750
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603260	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMT1B mRNA	PMID:27188386
1305205	Tmt1b	thiol methyltransferase 1B	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C057693	Troglitazone results in increased expression of TMT1B mRNA	PMID:21515302
1305206	Ipo4	importin 4	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of IPO4 mRNA	PMID:38218311
1305206	Ipo4	importin 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IPO4 mRNA]	PMID:31150632
1305206	Ipo4	importin 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of IPO4 mRNA	PMID:23724009|PMID:33167477
1305206	Ipo4	importin 4	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of IPO4 mRNA	PMID:22378314
1305206	Ipo4	importin 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313096	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of IPO4 mRNA	PMID:30319688
1305206	Ipo4	importin 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313095	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of IPO4 mRNA	PMID:20044591
1305206	Ipo4	importin 4	gene	CHEBI:16240	hydrogen peroxide	decreases secretion	ISO	RGD:1313096	E	RGD:6480464	20121218	CTD	MESH:D006861	Hydrogen Peroxide results in decreased secretion of IPO4 mRNA	PMID:21179422
1305206	Ipo4	importin 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313096	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IPO4 mRNA	PMID:39241906
1305206	Ipo4	importin 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of IPO4 mRNA	PMID:32145629
1305206	Ipo4	importin 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313095	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of IPO4 mRNA	PMID:23019147|PMID:31614463
1305206	Ipo4	importin 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of IPO4 mRNA	PMID:26496021
1305206	Ipo4	importin 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313095	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IPO4 mRNA	PMID:37042841
1305206	Ipo4	importin 4	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of IPO4 protein	PMID:32044396
1305206	Ipo4	importin 4	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of IPO4 mRNA	PMID:23649840
1305206	Ipo4	importin 4	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of IPO4 mRNA	PMID:18037150
1305206	Ipo4	importin 4	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313095	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of IPO4 mRNA	PMID:33359661
1305206	Ipo4	importin 4	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313096	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of IPO4 mRNA	PMID:23892564
1305206	Ipo4	importin 4	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313095	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of IPO4 promoter	PMID:30157460
1305206	Ipo4	importin 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IPO4 mRNA	PMID:36331819
1305206	Ipo4	importin 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of IPO4 protein	PMID:34915118
1305206	Ipo4	importin 4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313095	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of IPO4 protein	PMID:23301498
1305206	Ipo4	importin 4	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of IPO4 mRNA	PMID:23649840
1305206	Ipo4	importin 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313095	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of IPO4 exon	PMID:30157460
1305206	Ipo4	importin 4	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of IPO4 mRNA	PMID:23649840
1305206	Ipo4	importin 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313095	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of IPO4 mRNA	PMID:35430440
1305206	Ipo4	importin 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IPO4 mRNA	PMID:34911549
1305206	Ipo4	importin 4	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of IPO4 mRNA	PMID:30779732
1305206	Ipo4	importin 4	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IPO4 mRNA	PMID:31150632
1305206	Ipo4	importin 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313096	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IPO4 mRNA	PMID:27339419|PMID:31919559
1305206	Ipo4	importin 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IPO4 mRNA]	PMID:31150632
1305206	Ipo4	importin 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IPO4 mRNA	PMID:22206623
1305206	Ipo4	importin 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IPO4 mRNA	PMID:40504410
1305206	Ipo4	importin 4	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of IPO4 mRNA	PMID:27594783
1305206	Ipo4	importin 4	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313095	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of IPO4 mRNA	PMID:23019147
1305206	Ipo4	importin 4	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313095	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IPO4 mRNA	PMID:24768652|PMID:25583101
1305206	Ipo4	importin 4	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D009532	MT1 affects the reaction [Nickel affects the expression of IPO4 mRNA]; MT2 affects the reaction [Nickel affects the expression of IPO4 mRNA]	PMID:16166738
1305206	Ipo4	importin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313096	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IPO4 mRNA	PMID:20702594|PMID:21570461
1305206	Ipo4	importin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IPO4 mRNA	PMID:17942748|PMID:18796159
1305206	Ipo4	importin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IPO4 mRNA	PMID:17942748
1305206	Ipo4	importin 4	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of IPO4 protein	PMID:39603559
1305206	Ipo4	importin 4	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of IPO4 mRNA	PMID:28374803
1305206	Ipo4	importin 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IPO4 mRNA	PMID:32763439
1305206	Ipo4	importin 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313095	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of IPO4 mRNA	PMID:29803840
1305206	Ipo4	importin 4	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313095	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of IPO4 gene	PMID:28589171
1305206	Ipo4	importin 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IPO4 mRNA	PMID:40504410
1305206	Ipo4	importin 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313095	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IPO4 exon	PMID:30157460
1305206	Ipo4	importin 4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313095	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of IPO4 mRNA	PMID:25895662
1305206	Ipo4	importin 4	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1313095	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of IPO4 gene	PMID:31601247
1305206	Ipo4	importin 4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313095	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IPO4 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of IPO4 gene	PMID:31601247
1305206	Ipo4	importin 4	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of IPO4 mRNA	PMID:24136188
1305206	Ipo4	importin 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20190910	CTD	MESH:C009495	titanium dioxide results in decreased expression of IPO4 protein	PMID:30910687
1305206	Ipo4	importin 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313096	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IPO4 gene; titanium dioxide results in decreased methylation of IPO4 promoter	PMID:35295148
1305206	Ipo4	importin 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of IPO4 mRNA	PMID:23411599|PMID:34492290
1305206	Ipo4	importin 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of IPO4 mRNA	PMID:18648102
1305206	Ipo4	importin 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313096	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of IPO4 mRNA	PMID:23811191
1305206	Ipo4	importin 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313095	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IPO4 mRNA	PMID:19710929
1305206	Ipo4	importin 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313095	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of IPO4 mRNA	PMID:30903817
1305206	Ipo4	importin 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of IPO4 mRNA	PMID:30816183|PMID:33296240|PMID:34947998
1305206	Ipo4	importin 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of IPO4 protein	PMID:37567409
1305206	Ipo4	importin 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313095	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of IPO4 gene	PMID:31601247
1305206	Ipo4	importin 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IPO4 mRNA	PMID:25181051
1305206	Ipo4	importin 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313095	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of IPO4 mRNA	PMID:17989879
1305206	Ipo4	importin 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of IPO4 mRNA	PMID:26496021
1305206	Ipo4	importin 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313095	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IPO4 gene	PMID:31601247
1305206	Ipo4	importin 4	gene	CHEBI:3423	carmustine	affects response to substance	ISO	RGD:1313095	E	RGD:6480464	20120412	CTD	MESH:D002330	IPO4 mRNA affects the susceptibility to Carmustine	PMID:16365179
1305206	Ipo4	importin 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313095	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of IPO4 protein	PMID:34186270
1305206	Ipo4	importin 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313096	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of IPO4 mRNA	PMID:39298647|PMID:40203079
1305206	Ipo4	importin 4	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313095	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of IPO4 promoter	PMID:30157460
1305206	Ipo4	importin 4	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313095	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of IPO4 gene	PMID:31601247
1305206	Ipo4	importin 4	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313095	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of IPO4 protein	PMID:34186270
1305206	Ipo4	importin 4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313096	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of IPO4 mRNA	PMID:28392331
1305206	Ipo4	importin 4	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of IPO4 mRNA	PMID:32680482
1305206	Ipo4	importin 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313095	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of IPO4 protein	PMID:26879310
1305206	Ipo4	importin 4	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of IPO4 gene	PMID:22079235
1305206	Ipo4	importin 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IPO4 mRNA	PMID:19320972|PMID:19376846
1305206	Ipo4	importin 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313095	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IPO4 mRNA	PMID:32588087
1305206	Ipo4	importin 4	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313095	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of IPO4 mRNA	PMID:28302478
1305206	Ipo4	importin 4	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313095	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of IPO4 mRNA	PMID:31533062
1305206	Ipo4	importin 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IPO4 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of IPO4 mRNA	PMID:36331819
1305206	Ipo4	importin 4	gene	CHEBI:39426	perfluorobutyric acid	increases expression	ISO	RGD:1313096	E	RGD:6480464	20220308	CTD	MESH:C033094	perfluorobutyric acid results in increased expression of IPO4 mRNA	PMID:34474067
1305206	Ipo4	importin 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313095	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IPO4 mRNA	PMID:25979313
1305206	Ipo4	importin 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of IPO4 mRNA	PMID:17292431
1305206	Ipo4	importin 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of IPO4 mRNA; Valproic Acid results in decreased expression of IPO4 protein	PMID:19101580|PMID:29501571
1305206	Ipo4	importin 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313095	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of IPO4 mRNA	PMID:23179753
1305206	Ipo4	importin 4	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313095	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IPO4 gene	PMID:29154799
1305206	Ipo4	importin 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of IPO4 mRNA	PMID:22147139
1305206	Ipo4	importin 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313095	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of IPO4 mRNA	PMID:20106945|PMID:25562108
1305206	Ipo4	importin 4	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of IPO4 mRNA	PMID:17555576
1305206	Ipo4	importin 4	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of IPO4 mRNA	PMID:24136188
1305206	Ipo4	importin 4	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of IPO4 protein	PMID:38832940
1305206	Ipo4	importin 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313095	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IPO4 mRNA	PMID:38832940
1305206	Ipo4	importin 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IPO4 mRNA	PMID:17562736
1305206	Ipo4	importin 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IPO4 mRNA	PMID:33387578
1305206	Ipo4	importin 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of IPO4 mRNA	PMID:21420995|PMID:22230336
1305206	Ipo4	importin 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of IPO4 mRNA	PMID:19420014
1305206	Ipo4	importin 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IPO4 mRNA	PMID:40504410
1305206	Ipo4	importin 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of IPO4 mRNA	PMID:17555576
1305206	Ipo4	importin 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of IPO4 mRNA	PMID:17942748
1305206	Ipo4	importin 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IPO4 mRNA	PMID:17942748
1305206	Ipo4	importin 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313096	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IPO4 mRNA; Nanotubes, Carbon results in increased expression of IPO4 mRNA	PMID:25554681
1305206	Ipo4	importin 4	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of IPO4 mRNA	PMID:24136188
1305206	Ipo4	importin 4	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of IPO4 mRNA	PMID:24793618
1305206	Ipo4	importin 4	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of IPO4 mRNA	PMID:24136188
1305206	Ipo4	importin 4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IPO4 protein	PMID:32959892
1305206	Ipo4	importin 4	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of IPO4 mRNA	PMID:24136188
1305206	Ipo4	importin 4	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313095	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of IPO4 mRNA	PMID:15336504
1305206	Ipo4	importin 4	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313095	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of IPO4 promoter	PMID:30157460
1305206	Ipo4	importin 4	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of IPO4 mRNA	PMID:28935588
1305206	Ipo4	importin 4	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313096	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of IPO4 mRNA	PMID:31052254
1305206	Ipo4	importin 4	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1313095	E	RGD:6480464	20130305	CTD	MESH:C047246	IPO4 mRNA affects the susceptibility to temozolomide	PMID:16365179
1305206	Ipo4	importin 4	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313095	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of IPO4 protein	PMID:34186270
1305206	Ipo4	importin 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IPO4 mRNA	PMID:22206623
1305206	Ipo4	importin 4	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313095	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of IPO4 protein	PMID:37664457
1305206	Ipo4	importin 4	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of IPO4 mRNA	PMID:24136188
1305206	Ipo4	importin 4	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313095	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of IPO4 protein	PMID:39638853
1305206	Ipo4	importin 4	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313095	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of IPO4 protein	PMID:39638853
1305206	Ipo4	importin 4	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of IPO4 mRNA	PMID:21346803
1305206	Ipo4	importin 4	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of IPO4 mRNA	PMID:30928695
1305206	Ipo4	importin 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313096	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of IPO4 mRNA	PMID:20702594
1305206	Ipo4	importin 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IPO4 protein	PMID:31675489
1305206	Ipo4	importin 4	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1313095	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of IPO4 protein	PMID:31675489
1305206	Ipo4	importin 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313096	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of IPO4 mRNA	PMID:39847705
1305206	Ipo4	importin 4	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of IPO4 mRNA	PMID:21278054
1305206	Ipo4	importin 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313095	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of IPO4 protein	PMID:37664457
1305206	Ipo4	importin 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of IPO4 mRNA	PMID:21346803
1305206	Ipo4	importin 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of IPO4 mRNA	PMID:21346803
1305206	Ipo4	importin 4	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of IPO4 mRNA	PMID:22570695
1305207	Krt88	keratin 88	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D005839	Gentamicins results in increased expression of KRT88 mRNA	PMID:33387578
1305207	Krt88	keratin 88	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KRT88 mRNA	PMID:33387578
1305207	Krt88	keratin 88	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313097	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of KRT88 mRNA	PMID:35295148
1305207	Krt88	keratin 88	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRT88 mRNA	PMID:33387578
1305207	Krt88	keratin 88	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313097	E	RGD:6480464	20221025	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of KRT88 mRNA	PMID:31388691
1305207	Krt88	keratin 88	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:C025643	vinclozolin results in decreased expression of KRT88 mRNA	PMID:23869203
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1605837	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ALS2CL mRNA	PMID:38218311
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1605837	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ALS2CL mRNA	PMID:38218311
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:110423	clodronic acid	affects expression	ISO	RGD:1605837	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid affects the expression of ALS2CL mRNA	PMID:25596134
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1553626	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ALS2CL mRNA	PMID:33045310
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1605837	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ALS2CL mRNA	PMID:25596134
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1553626	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ALS2CL mRNA	PMID:30319688
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553626	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ALS2CL mRNA	PMID:39241906
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553626	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ALS2CL mRNA	PMID:39298647
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605837	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ALS2CL mRNA	PMID:31614463
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1605837	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ALS2CL mRNA	PMID:21592394
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of ALS2CL mRNA	PMID:21592394
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1605837	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of ALS2CL mRNA	PMID:21592394|PMID:26485663
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of ALS2CL mRNA	PMID:21592394
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553626	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ALS2CL mRNA	PMID:37236586
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605837	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ALS2CL mRNA	PMID:19549813
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1553626	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ALS2CL mRNA	PMID:19770486
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553626	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALS2CL mRNA	PMID:40504410
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ALS2CL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALS2CL mRNA	PMID:40512198
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1605837	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ALS2CL mRNA	PMID:19244175
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1605837	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ALS2CL mRNA	PMID:38460933
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1605837	E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of ALS2CL mRNA	PMID:38460933
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ALS2CL mRNA	PMID:38460933
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1553626	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of ALS2CL mRNA	PMID:28189721|PMID:28960355
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27871	chloroacetaldehyde	affects expression	ISO	RGD:1605837	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde affects the expression of ALS2CL mRNA	PMID:25596134
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1605837	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin affects the expression of ALS2CL mRNA	PMID:25596134
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1605837	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ALS2CL mRNA	PMID:27392435
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ALS2CL mRNA	PMID:27392435
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1605837	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALS2CL mRNA	PMID:22903824
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1605837	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ALS2CL mRNA	PMID:30851411
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605837	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ALS2CL mRNA	PMID:29803840
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1553626	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ALS2CL mRNA	PMID:39631538
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605837	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ALS2CL mRNA	PMID:34032870
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1553626	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of ALS2CL mRNA	PMID:36209798
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605837	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ALS2CL mRNA	PMID:38568856|PMID:39719251
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553626	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALS2CL mRNA	PMID:40504410
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ALS2CL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALS2CL mRNA	PMID:40512198
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605837	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ALS2CL promoter	PMID:27901495
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605837	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ALS2CL 5' UTR	PMID:27901495
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1553626	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ALS2CL mRNA	PMID:39716349
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:31175	adefovir pivoxil	increases expression	ISO	RGD:1605837	E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of ALS2CL mRNA	PMID:25596134
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1605837	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of ALS2CL mRNA	PMID:37690743
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ALS2CL mRNA	PMID:32479839
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ALS2CL mRNA	PMID:25729387
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ALS2CL mRNA	PMID:25729387
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1553626	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ALS2CL promoter	PMID:35295148
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ALS2CL mRNA	PMID:34492290
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553626	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ALS2CL mRNA	PMID:18301758|PMID:18445702
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ALS2CL mRNA	PMID:19167457
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of ALS2CL mRNA	PMID:30816183
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ALS2CL mRNA	PMID:25181051|PMID:34947998|PMID:35192832
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553626	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ALS2CL mRNA	PMID:33221593
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1553626	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ALS2CL mRNA	PMID:39298647
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553626	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ALS2CL mRNA	PMID:30951980
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALS2CL mRNA	PMID:28628672
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1553626	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ALS2CL mRNA	PMID:38685157
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1553626	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ALS2CL intron	PMID:28392331
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALS2CL mRNA	PMID:28628672
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1605837	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ALS2CL mRNA	PMID:38568856
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553626	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ALS2CL mRNA	PMID:37236586
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1605837	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ALS2CL mRNA	PMID:36326898
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ALS2CL mRNA	PMID:24386269
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1605837	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ALS2CL mRNA	PMID:19244175
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:3696	cidofovir anhydrous	affects expression	ISO	RGD:1605837	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir affects the expression of ALS2CL mRNA	PMID:25596134
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1605837	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ALS2CL mRNA	PMID:40419075
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605837	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ALS2CL gene	PMID:29154799
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605837	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ALS2CL mRNA	PMID:25596134|PMID:27989131
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALS2CL mRNA	PMID:28628672
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1605837	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ALS2CL mRNA	PMID:38832940
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1605837	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ALS2CL mRNA	PMID:24714768|PMID:25596134
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ALS2CL mRNA	PMID:38460933
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553626	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALS2CL mRNA	PMID:40504410
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ALS2CL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALS2CL mRNA	PMID:40512198
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1605837	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALS2CL mRNA	PMID:28628672
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1553626	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ALS2CL mRNA	PMID:39716349
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553626	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ALS2CL mRNA; Nanotubes, Carbon results in decreased expression of ALS2CL mRNA	PMID:25554681
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553626	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ALS2CL mRNA	PMID:25620056
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ALS2CL mRNA	PMID:24136188
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:51348	tetraphene	affects expression	ISO	RGD:1553626	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene affects the expression of ALS2CL mRNA	PMID:26377693
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1553626	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of ALS2CL mRNA	PMID:26377693
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:5864	ifosfamide	affects expression	ISO	RGD:1605837	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide affects the expression of ALS2CL mRNA	PMID:25596134
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ALS2CL mRNA	PMID:25729387
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ALS2CL mRNA	PMID:25729387
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of ALS2CL mRNA	PMID:24136188
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of ALS2CL mRNA	PMID:24136188
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1553626	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ALS2CL mRNA	PMID:26307267
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ALS2CL mRNA	PMID:30467583
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1553626	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ALS2CL mRNA	PMID:22206623
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1605837	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ALS2CL mRNA	PMID:37199045
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of ALS2CL mRNA	PMID:23665939
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1605837	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ALS2CL mRNA	PMID:30851411
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ALS2CL mRNA	PMID:27291303
1305208	Als2cl	ALS2 C-terminal like	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605837	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ALS2CL mRNA	PMID:38568856
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LIPT2 mRNA	PMID:30071829
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313102	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LIPT2 mRNA	PMID:39241906
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LIPT2 mRNA	PMID:33387578
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:2947567	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of LIPT2 mRNA	PMID:26079696
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313102	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LIPT2 mRNA	PMID:34319233
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LIPT2 mRNA	PMID:33387578
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:2947567	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LIPT2 mRNA	PMID:28818685
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:2947567	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of LIPT2 mRNA	PMID:27392435
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:2947567	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of LIPT2 mRNA	PMID:27392435
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LIPT2 mRNA	PMID:33387578
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of LIPT2 mRNA	PMID:28959563
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:2947567	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of LIPT2 mRNA	PMID:32763439
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313102	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of LIPT2 mRNA	PMID:39631538
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:28854	2,4-D	decreases expression	ISO	RGD:2947567	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of LIPT2 mRNA	PMID:40294809
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:2947567	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of LIPT2 mRNA	PMID:29319823
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313102	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of LIPT2 mRNA	PMID:19073995|PMID:33720480
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:2947567	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of LIPT2 mRNA	PMID:35984750
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313102	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of LIPT2 mRNA	PMID:29264374
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:32588	potassium chloride	multiple interactions	ISO	RGD:2947567	E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of LIPT2 mRNA	PMID:29691375
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LIPT2 mRNA	PMID:25181051
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313102	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LIPT2 mRNA	PMID:32156529
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LIPT2 gene	PMID:28505145
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313102	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of LIPT2 mRNA	PMID:21266533
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:2947567	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LIPT2 mRNA	PMID:38568856
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LIPT2 mRNA	PMID:24386269
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313102	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of LIPT2 mRNA	PMID:35436446
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313102	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LIPT2 mRNA	PMID:22206623
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of LIPT2 mRNA	PMID:27291303
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of LIPT2 mRNA	PMID:23640034
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313102	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of LIPT2 mRNA	PMID:40826991
1305211	Lipt2	lipoyl(octanoyl) transferase 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of LIPT2 mRNA	PMID:19281266
1305212	Poli	DNA polymerase iota	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of POLI gene	PMID:20938992
1305212	Poli	DNA polymerase iota	gene	CHEBI:16235	guanine	decreases activity	ISO	RGD:1313103	E	RGD:6480464	20150825	CTD	MESH:D006147	Guanine metabolite results in decreased activity of POLI protein	PMID:26010525
1305212	Poli	DNA polymerase iota	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of POLI mRNA	PMID:39298647
1305212	Poli	DNA polymerase iota	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of POLI gene	PMID:27618143
1305212	Poli	DNA polymerase iota	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of POLI gene	PMID:20938992
1305212	Poli	DNA polymerase iota	gene	CHEBI:17256	2'-deoxyadenosine	multiple interactions	ISO	RGD:1313103	E	RGD:6480464	20150825	CTD	MESH:C058118	[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein; POLN protein inhibits the reaction [[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein]	PMID:26098310
1305212	Poli	DNA polymerase iota	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of POLI mRNA	PMID:33387578
1305212	Poli	DNA polymerase iota	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of POLI mRNA	PMID:28818685
1305212	Poli	DNA polymerase iota	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POLI mRNA	PMID:37236586
1305212	Poli	DNA polymerase iota	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POLI mRNA	PMID:19549813
1305212	Poli	DNA polymerase iota	gene	CHEBI:23704	diepoxybutane	multiple interactions	ISO	RGD:1313103	E	RGD:6480464	20150825	CTD	MESH:C007366	[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein; POLN protein inhibits the reaction [[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein]	PMID:26098310
1305212	Poli	DNA polymerase iota	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of POLI mRNA	PMID:30779732
1305212	Poli	DNA polymerase iota	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POLI mRNA	PMID:31150632
1305212	Poli	DNA polymerase iota	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of POLI gene	PMID:20938992
1305212	Poli	DNA polymerase iota	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of POLI mRNA	PMID:26272509
1305212	Poli	DNA polymerase iota	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313103	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	PMID:27188386
1305212	Poli	DNA polymerase iota	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313103	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of POLI protein	PMID:35688186
1305212	Poli	DNA polymerase iota	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of POLI mRNA	PMID:28189721|PMID:28960355
1305212	Poli	DNA polymerase iota	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of POLI mRNA	PMID:33775663
1305212	Poli	DNA polymerase iota	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313103	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of POLI mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of POLI mRNA	PMID:19167446|PMID:23557933
1305212	Poli	DNA polymerase iota	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of POLI mRNA	PMID:22228119
1305212	Poli	DNA polymerase iota	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLI mRNA	PMID:22298810
1305212	Poli	DNA polymerase iota	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313104	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLI mRNA	PMID:21570461
1305212	Poli	DNA polymerase iota	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLI mRNA	PMID:19770486
1305212	Poli	DNA polymerase iota	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLI mRNA	PMID:33387578
1305212	Poli	DNA polymerase iota	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to POLI promoter]	PMID:19654925
1305212	Poli	DNA polymerase iota	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of POLI mRNA	PMID:28001369
1305212	Poli	DNA polymerase iota	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313103	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of POLI mRNA	PMID:39709020
1305212	Poli	DNA polymerase iota	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of POLI mRNA	PMID:28959563
1305212	Poli	DNA polymerase iota	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313104	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of POLI mRNA	PMID:27862939
1305212	Poli	DNA polymerase iota	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of POLI mRNA	PMID:29803840
1305212	Poli	DNA polymerase iota	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLI mRNA	PMID:34032870
1305212	Poli	DNA polymerase iota	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313103	E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POLI mRNA	PMID:40419235
1305212	Poli	DNA polymerase iota	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of POLI mRNA	PMID:19073995|PMID:33720480
1305212	Poli	DNA polymerase iota	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313103	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of POLI mRNA	PMID:26238291
1305212	Poli	DNA polymerase iota	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313103	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of POLI mRNA	PMID:31745603
1305212	Poli	DNA polymerase iota	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of POLI mRNA	PMID:23411599
1305212	Poli	DNA polymerase iota	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of POLI mRNA	PMID:19710929
1305212	Poli	DNA polymerase iota	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of POLI mRNA	PMID:30816183|PMID:34947998
1305212	Poli	DNA polymerase iota	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of POLI mRNA	PMID:19244175
1305212	Poli	DNA polymerase iota	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of POLI mRNA	PMID:39298647
1305212	Poli	DNA polymerase iota	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of POLI mRNA	PMID:38685157
1305212	Poli	DNA polymerase iota	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1313104	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of POLI mRNA	PMID:36464114
1305212	Poli	DNA polymerase iota	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of POLI mRNA	PMID:17361019|PMID:21266533
1305212	Poli	DNA polymerase iota	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of POLI mRNA	PMID:34813904
1305212	Poli	DNA polymerase iota	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313103	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of POLI mRNA	PMID:37042841
1305212	Poli	DNA polymerase iota	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POLI mRNA	PMID:37236586
1305212	Poli	DNA polymerase iota	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of POLI mRNA	PMID:22079235
1305212	Poli	DNA polymerase iota	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313103	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of POLI mRNA	PMID:24449571
1305212	Poli	DNA polymerase iota	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of POLI mRNA	PMID:28302478
1305212	Poli	DNA polymerase iota	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313103	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of POLI mRNA	PMID:19167446
1305212	Poli	DNA polymerase iota	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of POLI mRNA	PMID:27153767
1305212	Poli	DNA polymerase iota	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of POLI mRNA	PMID:36331819
1305212	Poli	DNA polymerase iota	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313103	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of POLI mRNA	PMID:25979313
1305212	Poli	DNA polymerase iota	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of POLI mRNA	PMID:23179753
1305212	Poli	DNA polymerase iota	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1313104	E	RGD:6480464	20130416	CTD	MESH:C017160	cypermethrin results in increased expression of POLI mRNA	PMID:21142847
1305212	Poli	DNA polymerase iota	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of POLI mRNA	PMID:38832940
1305212	Poli	DNA polymerase iota	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313104	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of POLI mRNA	PMID:17562736
1305212	Poli	DNA polymerase iota	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of POLI mRNA	PMID:22077320
1305212	Poli	DNA polymerase iota	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313103	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of POLI mRNA	PMID:22079256
1305212	Poli	DNA polymerase iota	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of POLI mRNA	PMID:35436446
1305212	Poli	DNA polymerase iota	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1313104	E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in increased expression of POLI mRNA	PMID:17441966
1305212	Poli	DNA polymerase iota	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of POLI mRNA; Nanotubes, Carbon results in decreased expression of POLI mRNA	PMID:25554681
1305212	Poli	DNA polymerase iota	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1313104	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of POLI mRNA	PMID:22078008
1305212	Poli	DNA polymerase iota	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1313104	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of POLI mRNA	PMID:36464114
1305212	Poli	DNA polymerase iota	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313104	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of POLI mRNA	PMID:22206623
1305212	Poli	DNA polymerase iota	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of POLI mRNA	PMID:22079256
1305212	Poli	DNA polymerase iota	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313103	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of POLI mRNA	PMID:22079256
1305212	Poli	DNA polymerase iota	gene	CHEBI:75390	3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid	decreases activity	ISO	RGD:1313103	E	RGD:6480464	20161213	CTD	MESH:C060893	MK-886 results in decreased activity of POLI protein	PMID:23305233
1305212	Poli	DNA polymerase iota	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313103	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	PMID:27188386
1305212	Poli	DNA polymerase iota	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of POLI mRNA	PMID:30928695
1305212	Poli	DNA polymerase iota	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313104	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of POLI mRNA	PMID:21278054
1305212	Poli	DNA polymerase iota	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1313103	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of POLI mRNA	PMID:26272509
1305212	Poli	DNA polymerase iota	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313103	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	PMID:27188386
1305212	Poli	DNA polymerase iota	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313103	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	PMID:27188386
1305212	Poli	DNA polymerase iota	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of POLI mRNA	PMID:23034163
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550148	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of NT5DC1 mRNA	PMID:33045310
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NT5DC1 mRNA	PMID:33167477
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550148	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NT5DC1 mRNA	PMID:36331819
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1550148	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of NT5DC1 mRNA	PMID:23892564
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D009538	Nicotine results in increased expression of NT5DC1 mRNA	PMID:27782041
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D009538	Nicotine results in increased expression of NT5DC1 mRNA	PMID:27782041
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NT5DC1 mRNA	PMID:19549813
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313107	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NT5DC1 protein	PMID:23301498
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NT5DC1 mRNA	PMID:27153756
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313107	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NT5DC1 protein	PMID:38460933
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313107	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of NT5DC1 mRNA	PMID:27392435
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313107	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of NT5DC1 mRNA	PMID:27392435
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of NT5DC1 gene	PMID:28505145
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550148	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NT5DC1 mRNA	PMID:21570461
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550148	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NT5DC1 mRNA	PMID:33956508
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NT5DC1 mRNA	PMID:33387578
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NT5DC1 mRNA	PMID:28001369
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NT5DC1 mRNA	PMID:33212167
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313107	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NT5DC1 protein	PMID:33212167
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313107	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of NT5DC1 mRNA	PMID:39709020
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NT5DC1 mRNA	PMID:29803840
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NT5DC1 mRNA	PMID:38568856
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550148	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of NT5DC1 mRNA	PMID:36209798
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NT5DC1 mRNA	PMID:26238291|PMID:32234424
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1550148	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NT5DC1 intron	PMID:27901495
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1550148	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of NT5DC1 protein	PMID:37955338
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NT5DC1 mRNA	PMID:20018196|PMID:26238291
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NT5DC1 mRNA	PMID:25729387
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550148	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of NT5DC1 mRNA	PMID:29264374
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550148	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NT5DC1 gene	PMID:35295148
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550148	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NT5DC1 mRNA	PMID:18301758|PMID:23811191
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NT5DC1 mRNA	PMID:25181051
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of NT5DC1 protein	PMID:37567409
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313107	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of NT5DC1 protein	PMID:34186270
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NT5DC1 gene	PMID:28505145
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550148	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NT5DC1 mRNA	PMID:39298647
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313107	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of NT5DC1 protein	PMID:34186270
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550148	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of NT5DC1 mRNA	PMID:38685157
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313107	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of NT5DC1 protein	PMID:34186270
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1550148	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of NT5DC1 mRNA	PMID:28392331
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550148	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NT5DC1 mRNA	PMID:37019170
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1313107	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to NT5DC1 protein	PMID:32991956
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NT5DC1 mRNA	PMID:38568856
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1313107	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of NT5DC1 mRNA	PMID:19691856
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1313107	E	RGD:6480464	20250401	CTD	MESH:D015741	Metribolone results in increased expression of NT5C2L1 protein	PMID:17152098
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NT5DC1 mRNA	PMID:28302478
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NT5DC1 mRNA	PMID:31533062
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550148	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NT5DC1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NT5DC1 mRNA	PMID:36331819
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313107	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NT5DC1 mRNA	PMID:25979313
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of NT5DC1 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313107	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of NT5DC1 gene	PMID:29154799
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NT5DC1 mRNA	PMID:20106945|PMID:25562108
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NT5DC1 mRNA	PMID:38832940
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of NT5DC1 mRNA	PMID:24935251|PMID:26272509
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313107	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NT5DC1 mRNA	PMID:27188386
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NT5DC1 mRNA	PMID:33387578
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313107	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NT5DC1 protein	PMID:38460933
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of NT5DC1 mRNA	PMID:29391264
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313107	E	RGD:6480464	20250401	CTD	MESH:D018038	Sodium Selenite results in increased expression of NT5C2L1 mRNA	PMID:18175754
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of NT5DC1 mRNA	PMID:23962444
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of NT5DC1 mRNA	PMID:24793618
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313107	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NT5DC1 protein	PMID:32959892
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NT5DC1 mRNA	PMID:25729387
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of NT5DC1 mRNA	PMID:24136188
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of NT5DC1 mRNA	PMID:24136188
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of NT5DC1 mRNA	PMID:30467583
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550148	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NT5DC1 mRNA	PMID:22206623
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313107	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NT5DC1 protein	PMID:37664457
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313107	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NT5DC1 mRNA	PMID:27188386
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of NT5DC1 mRNA	PMID:20345932
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1550148	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of NT5DC1 mRNA	PMID:40826991
1305214	Nt5dc1	5'-nucleotidase domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313107	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NT5DC1 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NT5DC1 mRNA	PMID:27188386|PMID:37664457
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1606230	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of USB1 mRNA	PMID:38218311
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1606230	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of USB1 mRNA	PMID:35967413
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313109	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of USB1 mRNA	PMID:33045310
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606230	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of USB1 mRNA	PMID:31614463
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1606230	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of USB1 mRNA	PMID:26079696
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313109	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of USB1 mRNA	PMID:34319233
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1606230	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of USB1 protein	PMID:37730182
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313109	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of USB1 mRNA	PMID:37236586
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1606230	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of USB1 mRNA	PMID:35301059
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1606230	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of USB1 mRNA	PMID:21867686
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606230	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of USB1 mRNA	PMID:23557933
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606230	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of USB1 mRNA	PMID:27392435
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of USB1 mRNA	PMID:33387578
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1606230	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of USB1 mRNA	PMID:29955902
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606230	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of USB1 mRNA	PMID:38568856
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606230	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of USB1 mRNA	PMID:34032870
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1606230	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of USB1 mRNA	PMID:29453283
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1606230	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USB1 mRNA	PMID:26238291|PMID:32234424
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1606230	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of USB1 mRNA	PMID:26238291
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of USB1 mRNA	PMID:34492290
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of USB1 mRNA	PMID:34947998
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of USB1 mRNA	PMID:25181051
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313109	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of USB1 mRNA	PMID:37019170
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1606230	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of USB1 gene	PMID:22964155
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313109	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of USB1 mRNA	PMID:34813904
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606230	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of USB1 mRNA	PMID:37042841
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606230	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of USB1 mRNA	PMID:38382870
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313109	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of USB1 mRNA	PMID:37236586
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1606230	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of USB1 mRNA	PMID:35301059
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1606230	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of USB1 mRNA	PMID:19376846
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1606230	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of USB1 mRNA	PMID:24449571
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1606230	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of USB1 mRNA	PMID:28302478
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606230	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of USB1 mRNA	PMID:31533062
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606230	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of USB1 mRNA	PMID:25979313
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606230	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of USB1 mRNA	PMID:23179753|PMID:28001369
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606230	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of USB1 mRNA	PMID:20106945
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1606230	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of USB1 mRNA	PMID:28542535
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of USB1 mRNA	PMID:33387578
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313109	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of USB1 mRNA	PMID:35436446
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313109	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of USB1 mRNA	PMID:35964746
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1606230	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of USB1 mRNA	PMID:37199045
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313109	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of USB1 mRNA	PMID:38995820
1305215	Usb1	U6 snRNA biogenesis phosphodiesterase 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1606230	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of USB1 mRNA	PMID:38568856
1305216	Sirt6	sirtuin 6	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313110	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SIRT6 mRNA	PMID:38218311
1305216	Sirt6	sirtuin 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SIRT6 mRNA	PMID:37995155
1305216	Sirt6	sirtuin 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313111	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SIRT6 mRNA	PMID:30319688
1305216	Sirt6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	affects response to substance	EXP		E	RGD:6480464	20190312	CTD	MESH:D006861	SIRT6 protein affects the susceptibility to Hydrogen Peroxide	PMID:30660577
1305216	Sirt6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	decreases abundance	ISO	RGD:1313110	E	RGD:6480464	20230704	CTD	MESH:D006861	SIRT6 protein results in decreased abundance of Hydrogen Peroxide	PMID:36356655
1305216	Sirt6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of SIRT6 mRNA; Hydrogen Peroxide results in decreased expression of SIRT6 protein	PMID:30660577
1305216	Sirt6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313110	E	RGD:6480464	20230704	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of SIRT6 mRNA; Hydrogen Peroxide results in increased expression of SIRT6 protein	PMID:36356655
1305216	Sirt6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313111	E	RGD:6480464	20230704	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of SIRT6 mRNA; Hydrogen Peroxide results in increased expression of SIRT6 protein	PMID:36356655
1305216	Sirt6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D006861	BACH1 protein inhibits the reaction [SIRT6 protein inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]]; NFE2L2 protein promotes the reaction [SIRT6 protein inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]]; SIRT6 protein inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; SIRT6 protein inhibits the reaction [Hydrogen Peroxide results in increased expression of BACH1 protein]	PMID:30660577
1305216	Sirt6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20230704	CTD	MESH:D006861	SIRT6 protein affects the reaction [Hydrogen Peroxide affects the expression of NFE2L2 protein]	PMID:36356655
1305216	Sirt6	sirtuin 6	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313110	E	RGD:6480464	20240903	CTD	MESH:D011794	Quercetin results in increased expression of SIRT6 mRNA; Quercetin results in increased expression of SIRT6 protein	PMID:34219513
1305216	Sirt6	sirtuin 6	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313111	E	RGD:6480464	20150714	CTD	MESH:D011794	Quercetin results in increased expression of SIRT6 mRNA	PMID:25862958
1305216	Sirt6	sirtuin 6	gene	CHEBI:16509	1,4-benzoquinone	decreases expression	ISO	RGD:1313110	E	RGD:6480464	20250603	CTD	MESH:C004532	quinone results in decreased expression of SIRT6 mRNA	PMID:39357595
1305216	Sirt6	sirtuin 6	gene	CHEBI:16509	1,4-benzoquinone	multiple interactions	ISO	RGD:1313110	E	RGD:6480464	20250603	CTD	MESH:C004532	TUG1 inhibits the reaction [quinone results in decreased expression of SIRT6 mRNA]	PMID:39357595
1305216	Sirt6	sirtuin 6	gene	CHEBI:16814	dehydroepiandrosterone sulfate	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D019314	Dehydroepiandrosterone Sulfate results in increased expression of SIRT6 protein	PMID:25786523
1305216	Sirt6	sirtuin 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20190910	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT6 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT6 protein	PMID:31016965
1305216	Sirt6	sirtuin 6	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313110	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of SIRT6 mRNA	PMID:33359661
1305216	Sirt6	sirtuin 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SIRT6 mRNA	PMID:33908429
1305216	Sirt6	sirtuin 6	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313110	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SIRT6 protein	PMID:37730182
1305216	Sirt6	sirtuin 6	gene	CHEBI:197221	NORCANTHARIDIN	decreases expression	ISO	RGD:1313110	E	RGD:6480464	20231003	CTD	MESH:C069741	norcantharidin results in decreased expression of SIRT6 mRNA	PMID:34272796
1305216	Sirt6	sirtuin 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313110	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SIRT6 mRNA	PMID:19549813
1305216	Sirt6	sirtuin 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313110	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SIRT6 mRNA	PMID:35430440
1305216	Sirt6	sirtuin 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIRT6 mRNA	PMID:40504410
1305216	Sirt6	sirtuin 6	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313110	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SIRT6 protein	PMID:25533949
1305216	Sirt6	sirtuin 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313110	E	RGD:6480464	20160822	CTD	MESH:C059514	PARP1 protein affects the reaction [resveratrol results in increased expression of SIRT6 protein]; STF-118804 inhibits the reaction [resveratrol results in increased expression of SIRT6 protein]	PMID:25533949
1305216	Sirt6	sirtuin 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313110	E	RGD:6480464	20190910	CTD	MESH:D002945	[Cisplatin co-treated with hesperetin] results in increased expression of SIRT6 protein	PMID:31153982
1305216	Sirt6	sirtuin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313111	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SIRT6 mRNA	PMID:21570461
1305216	Sirt6	sirtuin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SIRT6 mRNA	PMID:33387578
1305216	Sirt6	sirtuin 6	gene	CHEBI:28230	hesperetin	increases expression	ISO	RGD:1313110	E	RGD:6480464	20190910	CTD	MESH:C013015	hesperetin results in increased expression of SIRT6 protein	PMID:31153982
1305216	Sirt6	sirtuin 6	gene	CHEBI:28230	hesperetin	multiple interactions	ISO	RGD:1313110	E	RGD:6480464	20190910	CTD	MESH:C013015	[Cisplatin co-treated with hesperetin] results in increased expression of SIRT6 protein	PMID:31153982
1305216	Sirt6	sirtuin 6	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313110	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SIRT6 mRNA	PMID:33212167
1305216	Sirt6	sirtuin 6	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313110	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SIRT6 mRNA	PMID:32763439
1305216	Sirt6	sirtuin 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313110	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SIRT6 mRNA	PMID:24690739
1305216	Sirt6	sirtuin 6	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D004317	Doxorubicin results in decreased expression of SIRT6 mRNA; Doxorubicin results in decreased expression of SIRT6 protein	PMID:34713381|PMID:38395252
1305216	Sirt6	sirtuin 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20220510	CTD	MESH:D004317	Doxorubicin results in decreased expression of SIRT6 mRNA; Doxorubicin results in decreased expression of SIRT6 protein	PMID:34713381|PMID:38395252
1305216	Sirt6	sirtuin 6	gene	CHEBI:28748	doxorubicin	increases response to substance	ISO	RGD:1313111	E	RGD:6480464	20220510	CTD	MESH:D004317	SIRT6 gene mutant form results in increased susceptibility to Doxorubicin	PMID:34713381
1305216	Sirt6	sirtuin 6	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D004317	Doxorubicin inhibits the reaction [SIRT6 protein binds to FAS promoter]; Doxorubicin inhibits the reaction [SIRT6 protein binds to FASLG promoter]; Doxorubicin promotes the reaction [SIRT6 protein binds to TP53 protein]; Doxorubicin results in decreased expression of and results in decreased activity of SIRT6 protein; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN2A mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL1B mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL6 mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TNF mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TP53 mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL1B protein]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL6 protein]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of TNF protein]]; SIRT6 protein inhibits the reaction [Doxorubicin promotes the reaction [TP53 protein binds to FAS promoter]]; SIRT6 protein inhibits the reaction [Doxorubicin promotes the reaction [TP53 protein binds to FASLG promoter]]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADL mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADM mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CAT mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CD36 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CPT1A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of GPX1 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of HMGB1 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of PRDX5 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of SOD2 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased acetylation of TP53 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased cleavage of CASP8 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN2A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FADD protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FAS mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FAS protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FASLG mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FASLG protein modified form]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FASLG protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL1B mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL6 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of PDK4 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of RIPK1 protein modified form]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of RIPK3 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TNF mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TP53 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL1B protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL6 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of TNF protein]	PMID:34713381|PMID:38395252
1305216	Sirt6	sirtuin 6	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20220510	CTD	MESH:D004317	Doxorubicin results in decreased expression of and results in decreased activity of SIRT6 protein; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of CAT mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of CAT protein]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of FAS mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of FASL mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of GPX1 mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of PRDX5 mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of SOD2 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADL mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADM mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CD36 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CPT1A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN2A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL1B mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL6 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of PDK4 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TNF mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TRP53 mRNA]; SIRT6 protein promotes the reaction [Doxorubicin results in decreased expression of RIPK1 protein]	PMID:34713381|PMID:38395252
1305216	Sirt6	sirtuin 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C017947	sodium arsenite results in decreased expression of SIRT6 protein	PMID:31874112
1305216	Sirt6	sirtuin 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313110	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SIRT6 mRNA	PMID:38568856|PMID:39719251
1305216	Sirt6	sirtuin 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIRT6 mRNA	PMID:40504410
1305216	Sirt6	sirtuin 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SIRT6 mRNA	PMID:22228805
1305216	Sirt6	sirtuin 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313110	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SIRT6 mRNA	PMID:24690739
1305216	Sirt6	sirtuin 6	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of SIRT6 mRNA	PMID:19167457
1305216	Sirt6	sirtuin 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SIRT6 mRNA	PMID:25181051|PMID:34947998
1305216	Sirt6	sirtuin 6	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SIRT6 mRNA	PMID:17316808
1305216	Sirt6	sirtuin 6	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SIRT6 mRNA	PMID:38685157
1305216	Sirt6	sirtuin 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313111	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SIRT6 mRNA	PMID:37019170
1305216	Sirt6	sirtuin 6	gene	CHEBI:34905	paraquat	decreases response to substance	ISO	RGD:1313110	E	RGD:6480464	20201215	CTD	MESH:D010269	SIRT6 protein results in decreased susceptibility to Paraquat	PMID:31216030
1305216	Sirt6	sirtuin 6	gene	CHEBI:34905	paraquat	decreases response to substance	ISO	RGD:1313111	E	RGD:6480464	20230704	CTD	MESH:D010269	SIRT6 protein results in decreased susceptibility to Paraquat	PMID:36356655
1305216	Sirt6	sirtuin 6	gene	CHEBI:34905	paraquat	decreases stability	ISO	RGD:1313111	E	RGD:6480464	20201215	CTD	MESH:D010269	Paraquat results in decreased stability of SIRT6 protein mutant form	PMID:31216030
1305216	Sirt6	sirtuin 6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313111	E	RGD:6480464	20230704	CTD	MESH:D010269	Paraquat results in increased expression of SIRT6 mRNA; Paraquat results in increased expression of SIRT6 protein	PMID:36356655
1305216	Sirt6	sirtuin 6	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313110	E	RGD:6480464	20201215	CTD	MESH:D010269	[SIRT6 protein results in decreased susceptibility to Paraquat] inhibits the reaction [NFE2L2 protein binds to HMOX1 enhancer]; NFE2L2 mRNA promotes the reaction [Paraquat promotes the reaction [SIRT6 protein binds to HMOX1 gene]]; Paraquat promotes the reaction [SIRT6 protein binds to HMOX1 gene]	PMID:31216030
1305216	Sirt6	sirtuin 6	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20201215	CTD	MESH:D010269	[SIRT6 protein mutant form results in decreased activity of SIRT6 protein] inhibits the reaction [Paraquat promotes the reaction [SMARCA4 protein binds to HMOX1 enhancer]]; [SIRT6 protein mutant form results in decreased activity of SIRT6 protein] inhibits the reaction [Paraquat results in increased expression of HMOX1 mRNA]; Paraquat promotes the reaction [SIRT6 protein binds to HMOX1 gene]; Paraquat promotes the reaction [SMARCC2 protein binds to SIRT6 protein]; SIRT6 promotes the reaction [Paraquat results in increased expression of GCLC mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of GCLM mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of GSS mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of HMOX1 mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of HSF1 mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of NQO1 mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of TXNRD1 mRNA]; SIRT6 protein affects the reaction [Paraquat results in increased cleavage of CASP3 protein]; SIRT6 protein promotes the reaction [Paraquat promotes the reaction [POLR2A protein modified form binds to HMOX1 gene]]; SIRT6 protein promotes the reaction [Paraquat promotes the reaction [SMARCA4 protein binds to HMOX1 enhancer]]; SIRT6 protein promotes the reaction [Paraquat promotes the reaction [SMARCC2 protein binds to HMOX1 enhancer]]	PMID:31216030|PMID:36356655
1305216	Sirt6	sirtuin 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313110	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SIRT6 mRNA	PMID:37042841
1305216	Sirt6	sirtuin 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313110	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SIRT6 mRNA	PMID:38174414
1305216	Sirt6	sirtuin 6	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313111	E	RGD:6480464	20190910	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SIRT6 mRNA	PMID:31016965
1305216	Sirt6	sirtuin 6	gene	CHEBI:37647	xanthone	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:C009689	xanthone inhibits the reaction [Isoproterenol results in decreased expression of SIRT6 mRNA]	PMID:36414029
1305216	Sirt6	sirtuin 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313111	E	RGD:6480464	20190910	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SIRT6 mRNA	PMID:31016965
1305216	Sirt6	sirtuin 6	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1313110	E	RGD:6480464	20220111	CTD	MESH:D003474	Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of SIRT6 mRNA]; Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of SIRT6 protein]; SIRT6 protein promotes the reaction [Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of ABCA1 mRNA]]; SIRT6 protein promotes the reaction [Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of ABCA1 protein]]; SIRT6 protein promotes the reaction [Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of CCL2 protein]]; SIRT6 protein promotes the reaction [Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of IL6 protein]]; SIRT6 protein promotes the reaction [Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of TNF protein]]	PMID:33952798
1305216	Sirt6	sirtuin 6	gene	CHEBI:42567	fisetin	affects expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C017875	fisetin affects the expression of SIRT6 protein	PMID:38278314
1305216	Sirt6	sirtuin 6	gene	CHEBI:42567	fisetin	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:C017875	fisetin inhibits the reaction [IL1B protein results in decreased expression of SIRT6 protein]	PMID:38278314
1305216	Sirt6	sirtuin 6	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1313110	E	RGD:6480464	20220405	CTD	MESH:D017239	Paclitaxel results in decreased expression of SIRT6 mRNA	PMID:34272796
1305216	Sirt6	sirtuin 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SIRT6 mRNA	PMID:33387578
1305216	Sirt6	sirtuin 6	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313110	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of SIRT6 mRNA	PMID:24690739
1305216	Sirt6	sirtuin 6	gene	CHEBI:46661	asbestos	affects expression	ISO	RGD:1313110	E	RGD:6480464	20120412	CTD	MESH:D001194	Asbestos affects the expression of SIRT6 mRNA	PMID:17297452
1305216	Sirt6	sirtuin 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIRT6 mRNA	PMID:40504410
1305216	Sirt6	sirtuin 6	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1313110	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of SIRT6 mRNA	PMID:22077320
1305216	Sirt6	sirtuin 6	gene	CHEBI:64317	isoprenaline	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007545	Isoproterenol results in decreased expression of SIRT6 mRNA	PMID:36414029
1305216	Sirt6	sirtuin 6	gene	CHEBI:64317	isoprenaline	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D007545	xanthone inhibits the reaction [Isoproterenol results in decreased expression of SIRT6 mRNA]	PMID:36414029
1305216	Sirt6	sirtuin 6	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SIRT6 protein affects the phosphorylation of EP300 protein]	PMID:27094368
1305216	Sirt6	sirtuin 6	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in decreased expression of SIRT6 mRNA	PMID:25452209
1305216	Sirt6	sirtuin 6	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [SIRT6 protein results in decreased expression of EP300 protein]	PMID:27094368
1305216	Sirt6	sirtuin 6	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313110	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SIRT6 protein	PMID:31285264
1305216	Sirt6	sirtuin 6	gene	CHEBI:79989	GW 6471	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C449302	GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN2A mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL1B mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL6 mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TNF mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TP53 mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL1B protein]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL6 protein]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of TNF protein]]	PMID:38395252
1305216	Sirt6	sirtuin 6	gene	CHEBI:8093	phenylephrine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D010656	[SIRT6 protein co-treated with EP300 protein] affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [SIRT6 protein co-treated with EP300 protein] affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; Phenylephrine results in decreased expression of and results in decreased activity of SIRT6 protein; SIRT6 protein affects the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of EP300 protein]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]	PMID:27094368
1305216	Sirt6	sirtuin 6	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of SIRT6 mRNA	PMID:40826991
1305216	Sirt6	sirtuin 6	gene	CHEBI:90369	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	decreases activity	ISO	RGD:1313110	E	RGD:6480464	20200211	CTD	MESH:C550547	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased activity of SIRT6 protein	PMID:26518726
1305216	Sirt6	sirtuin 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SIRT6 mRNA	PMID:21346803
1305216	Sirt6	sirtuin 6	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313110	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SIRT6 mRNA	PMID:38568856
1305217	Foxb1	forkhead box B1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313113	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXB1 gene	PMID:20938992
1305217	Foxb1	forkhead box B1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313112	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of FOXB1 mRNA	PMID:30510588
1305217	Foxb1	forkhead box B1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313113	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXB1 gene	PMID:20938992
1305217	Foxb1	forkhead box B1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313112	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FOXB1 mRNA	PMID:39836092
1305217	Foxb1	forkhead box B1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313113	E	RGD:6480464	20130806	CTD	MESH:D009151	Mustard Gas results in increased expression of FOXB1 mRNA	PMID:15674843|PMID:15674844
1305217	Foxb1	forkhead box B1	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1313112	E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in increased expression of FOXB1 mRNA	PMID:18356318
1305217	Foxb1	forkhead box B1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313113	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXB1 gene	PMID:20938992
1305217	Foxb1	forkhead box B1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313112	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXB1 mRNA	PMID:39836092
1305217	Foxb1	forkhead box B1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313113	E	RGD:6480464	20240604	CTD	MESH:C010974	Glyphosate results in decreased expression of FOXB1 mRNA	PMID:33713393
1305217	Foxb1	forkhead box B1	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313112	E	RGD:6480464	20130806	CTD	MESH:D010278	Parathion results in increased methylation of FOXB1 promoter	PMID:22847954
1305217	Foxb1	forkhead box B1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313112	E	RGD:6480464	20141223	CTD	MESH:D019833	Genistein results in decreased expression of FOXB1 mRNA	PMID:25136773
1305217	Foxb1	forkhead box B1	gene	CHEBI:28112	nickel atom	affects expression	ISO	RGD:1313112	E	RGD:6480464	20130806	CTD	MESH:D009532	Nickel affects the expression of FOXB1 mRNA	PMID:14575637
1305217	Foxb1	forkhead box B1	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1313112	E	RGD:6480464	20130806	CTD	MESH:D009532	trichostatin A inhibits the reaction [Nickel affects the expression of FOXB1 mRNA]	PMID:14575637
1305217	Foxb1	forkhead box B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313113	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FOXB1 mRNA	PMID:24058054
1305217	Foxb1	forkhead box B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313113	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to FOXB1 promoter]	PMID:19654925
1305217	Foxb1	forkhead box B1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313112	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of FOXB1 mRNA	PMID:34032870
1305217	Foxb1	forkhead box B1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313112	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXB1 mRNA	PMID:39836092
1305217	Foxb1	forkhead box B1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313112	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FOXB1 5' UTR; Benzo(a)pyrene results in increased methylation of FOXB1 promoter	PMID:27901495
1305217	Foxb1	forkhead box B1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313113	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene affects the reaction [AHR protein binds to FOXB1 promoter]	PMID:19654925
1305217	Foxb1	forkhead box B1	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313112	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of FOXB1 promoter	PMID:23974009
1305217	Foxb1	forkhead box B1	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1313112	E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in increased expression of FOXB1 mRNA	PMID:18356318
1305217	Foxb1	forkhead box B1	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313112	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FOXB1 mRNA	PMID:35984750
1305217	Foxb1	forkhead box B1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of FOXB1 mRNA	PMID:30047161
1305217	Foxb1	forkhead box B1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313113	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FOXB1 gene; titanium dioxide results in decreased methylation of FOXB1 promoter	PMID:35295148
1305217	Foxb1	forkhead box B1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C069837	fullerene C60 results in decreased expression of FOXB1 mRNA	PMID:19167457
1305217	Foxb1	forkhead box B1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FOXB1 mRNA	PMID:25181051
1305217	Foxb1	forkhead box B1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313113	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FOXB1 promoter	PMID:27334623
1305217	Foxb1	forkhead box B1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313112	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FOXB1 gene	PMID:31601247
1305217	Foxb1	forkhead box B1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of FOXB1 mRNA	PMID:41034487
1305217	Foxb1	forkhead box B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313112	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FOXB1 gene	PMID:31601247
1305217	Foxb1	forkhead box B1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313112	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FOXB1 mRNA	PMID:39836092
1305217	Foxb1	forkhead box B1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313113	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FOXB1 mRNA	PMID:40194260
1305217	Foxb1	forkhead box B1	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313112	E	RGD:6480464	20130806	CTD	MESH:D004397	Fonofos results in increased methylation of FOXB1 promoter	PMID:22847954
1305217	Foxb1	forkhead box B1	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313112	E	RGD:6480464	20130806	CTD	MESH:C012568	terbufos results in increased methylation of FOXB1 promoter	PMID:22847954
1305217	Foxb1	forkhead box B1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of FOXB1 mRNA	PMID:30047161
1305217	Foxb1	forkhead box B1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313112	E	RGD:6480464	20130806	CTD	MESH:C012589	trichostatin A inhibits the reaction [Nickel affects the expression of FOXB1 mRNA]	PMID:14575637
1305217	Foxb1	forkhead box B1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313113	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of FOXB1 mRNA	PMID:17562736
1305217	Foxb1	forkhead box B1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313112	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXB1 mRNA	PMID:39836092
1305217	Foxb1	forkhead box B1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of FOXB1 mRNA	PMID:30047161
1305217	Foxb1	forkhead box B1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313112	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FOXB1 mRNA	PMID:39836092
1305217	Foxb1	forkhead box B1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of FOXB1 mRNA	PMID:32109520
1305217	Foxb1	forkhead box B1	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1313113	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of FOXB1 mRNA	PMID:21195148
1305217	Foxb1	forkhead box B1	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1313113	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of FOXB1 mRNA	PMID:21195148
1305217	Foxb1	forkhead box B1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FOXB1 mRNA	PMID:30047161
1305217	Foxb1	forkhead box B1	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1313113	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of FOXB1 mRNA	PMID:21195148
1305217	Foxb1	forkhead box B1	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of FOXB1 mRNA	PMID:30047161
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MCM8 mRNA	PMID:38218311
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313115	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MCM8 mRNA	PMID:33045310
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MCM8 mRNA	PMID:33167477
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of MCM8 mRNA	PMID:26516004
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MCM8 mRNA	PMID:36331819
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313114	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MCM8 mRNA	PMID:21179406
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313115	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MCM8 mRNA	PMID:39241906
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313114	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MCM8 mRNA	PMID:21179406
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of MCM8 mRNA	PMID:38160208
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MCM8 mRNA	PMID:21592394
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM8 mRNA	PMID:21592394
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MCM8 mRNA	PMID:21592394
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM8 mRNA	PMID:21592394
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:1784	biphenyl-4-amine	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20200915	CTD	MESH:C006757	4-biphenylamine results in decreased expression of MCM8 protein	PMID:32433928
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:1784	biphenyl-4-amine	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20200915	CTD	MESH:C006757	Acetylcysteine inhibits the reaction [4-biphenylamine results in decreased expression of MCM8 protein]	PMID:32433928
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	ISO	RGD:1313114	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of MCM8 mRNA	PMID:17103032
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MCM8 mRNA	PMID:35301059
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MCM8 mRNA	PMID:28111341
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM8 mRNA	PMID:23630614
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313114	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM8 mRNA	PMID:22100608
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:2504	aflatoxin B1	increases mutagenesis	EXP		E	RGD:6480464	20240109	CTD	MESH:D016604	Aflatoxin B1 results in increased mutagenesis of MCM8 gene	PMID:36908029
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313114	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MCM8 mRNA	PMID:23649840
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MCM8 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MCM8 mRNA	PMID:35430440|PMID:41430723
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MCM8 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MCM8 mRNA	PMID:34911549
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313115	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MCM8 mRNA	PMID:31919559
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313114	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MCM8 gene	PMID:25304211
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313114	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MCM8 protein	PMID:35688186
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MCM8 mRNA	PMID:31881176
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of MCM8 mRNA	PMID:19167446
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313114	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MCM8 mRNA	PMID:28903495
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313114	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of MCM8 mRNA	PMID:27594783
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313114	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM8 mRNA	PMID:22574217
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313115	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM8 mRNA	PMID:21570461
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM8 mRNA	PMID:33387578
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313114	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of MCM8 protein	PMID:35688186
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MCM8 mRNA	PMID:29432896
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20200915	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [4-biphenylamine results in decreased expression of MCM8 protein]	PMID:32433928
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCM8 mRNA	PMID:22714537
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313114	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MCM8 mRNA	PMID:38568856
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM8 mRNA	PMID:16120219|PMID:20064835
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313114	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCM8 mRNA	PMID:32234424
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MCM8 mRNA	PMID:20018196
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313114	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MCM8 mRNA	PMID:26238291
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313114	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of MCM8 mRNA	PMID:38568856
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM8 mRNA	PMID:25729387
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MCM8 mRNA	PMID:34492290
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313115	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MCM8 mRNA	PMID:17950772|PMID:20813756|PMID:23811191
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of MCM8 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of MCM8 mRNA]	PMID:17950772|PMID:20813756
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MCM8 mRNA	PMID:38479592
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MCM8 mRNA	PMID:25181051
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313114	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MCM8 mRNA	PMID:30903817
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM8 mRNA	PMID:29275510|PMID:33670352
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MCM8 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313114	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of MCM8 gene	PMID:31601247
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313115	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MCM8 mRNA	PMID:37019170
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313114	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MCM8 mRNA	PMID:37042841
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of MCM8 mRNA	PMID:18500788
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MCM8 mRNA	PMID:38568856
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MCM8 mRNA	PMID:35301059
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MCM8 mRNA	PMID:28111341
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of MCM8 mRNA	PMID:25539665
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of MCM8 mRNA	PMID:24386269
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313115	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of MCM8 mRNA	PMID:23811191
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313115	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MCM8 mRNA	PMID:40194260
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MCM8 mRNA	PMID:31533062
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313114	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MCM8 mRNA	PMID:19167446
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM8 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MCM8 mRNA	PMID:19167446
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1313114	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of MCM8 mRNA	PMID:26352163
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:3930	cryptolepine	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of MCM8 mRNA	PMID:16120219
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MCM8 mRNA	PMID:36331819
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of MCM8 mRNA	PMID:22110744
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313114	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MCM8 gene	PMID:29154799
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1313114	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of MCM8 mRNA	PMID:25562108
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of MCM8 mRNA	PMID:20106945|PMID:21632981
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313114	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MCM8 mRNA	PMID:38832940
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MCM8 mRNA	PMID:33387578
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313114	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MCM8 mRNA	PMID:22230336
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MCM8 mRNA	PMID:29523930
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313114	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MCM8 gene	PMID:25304211
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20130416	CTD	MESH:D005047	Etoposide results in decreased expression of MCM8 mRNA	PMID:16120219
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313114	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of MCM8 mRNA	PMID:38568856
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of MCM8 mRNA	PMID:21148553
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of MCM8 mRNA	PMID:22714537
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313115	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MCM8 mRNA	PMID:19042947
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MCM8 mRNA	PMID:25729387
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM8 mRNA	PMID:25729387
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of MCM8 mRNA	PMID:19564919
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of MCM8 mRNA	PMID:19564919
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of MCM8 mRNA	PMID:36519830
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:73297	SCH 23390	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in decreased expression of MCM8 mRNA	PMID:19564919
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of MCM8 mRNA	PMID:19564919
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313115	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MCM8 mRNA	PMID:22206623
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313114	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of MCM8 mRNA	PMID:29522793
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1313114	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MCM8 mRNA	PMID:16120219
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MCM8 gene]	PMID:28238834
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313114	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM8 mRNA	PMID:19167446
1305218	Mcm8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313115	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of MCM8 mRNA	PMID:35537566
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313117	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CDK20 mRNA	PMID:20188158
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDK20 gene	PMID:20938992
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:16236	ethanol	affects response to substance	ISO	RGD:1313116	E	RGD:6480464	20120412	CTD	MESH:D000431	CDK20 gene SNP affects the susceptibility to Ethanol	PMID:18438686
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313117	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CDK20 mRNA	PMID:39241906
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDK20 gene	PMID:20938992
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313116	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CDK20 mRNA	PMID:21179406
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313117	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDK20 mRNA	PMID:34319233
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313117	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDK20 mRNA	PMID:19770486
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDK20 gene	PMID:20938992
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK20 mRNA	PMID:40504410
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313116	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CDK20 mRNA	PMID:23557933
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDK20 mRNA	PMID:22298810
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313117	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDK20 mRNA	PMID:21570461
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK20 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CDK20 mRNA	PMID:17942748|PMID:25975270
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of CDK20 mRNA	PMID:19013527
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313116	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDK20 mRNA	PMID:29803840
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313116	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDK20 mRNA	PMID:19615344|PMID:39719251
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313116	E	RGD:6480464	20161228	CTD	MESH:C017947	monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of CDK20 mRNA]	PMID:19615344
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK20 mRNA	PMID:40504410
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313116	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDK20 mRNA	PMID:20064835|PMID:22316170
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313117	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDK20 mRNA	PMID:22228805
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CDK20 mRNA	PMID:16507785
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CDK20 mRNA	PMID:23411599|PMID:34492290
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313116	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CDK20 mRNA	PMID:19710929
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CDK20 mRNA	PMID:25181051
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313117	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CDK20 mRNA	PMID:33221593
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313117	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CDK20 mRNA	PMID:39298647
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CDK20 mRNA	PMID:22546817
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313117	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CDK20 mRNA	PMID:21266533
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CDK20 mRNA	PMID:22546817
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313116	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CDK20 mRNA	PMID:40419075
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313116	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CDK20 mRNA	PMID:29154799
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:45285	pyrazinecarboxamide	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011718	Pyrazinamide results in decreased expression of CDK20 mRNA	PMID:22431067
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1313116	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of CDK20 mRNA	PMID:18058816
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDK20 mRNA	PMID:33387578
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK20 mRNA	PMID:40504410
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK20 mRNA	PMID:17942748
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1313116	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of CDK20 mRNA	PMID:25572481
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313117	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CDK20 mRNA	PMID:25620056
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313116	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CDK20 mRNA	PMID:16934159
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CDK20 mRNA	PMID:24136188
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313117	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CDK20 mRNA	PMID:22206623
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1313116	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of CDK20 mRNA	PMID:39904859
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of CDK20 mRNA	PMID:32109520
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313117	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CDK20 mRNA	PMID:31388691
1305219	Cdk20	cyclin-dependent kinase 20	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CDK20 mRNA	PMID:21346803
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PPM1L mRNA	PMID:39752319
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPM1L mRNA	PMID:20938992
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313118	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PPM1L mRNA	PMID:33167477
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313118	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PPM1L mRNA	PMID:22378314
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313119	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PPM1L mRNA	PMID:30319688
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PPM1L mRNA	PMID:39241906
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPM1L mRNA	PMID:20938992
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250506	CTD	MESH:D002635	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PPM1L mRNA	PMID:39752319
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313118	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PPM1L mRNA	PMID:33359661
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:17578	toluene	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D014050	Toluene affects the expression of PPM1L mRNA	PMID:21827849
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250506	CTD	MESH:D006000	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313118	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PPM1L mRNA	PMID:28818685
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPM1L mRNA	PMID:36331819
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA	PMID:39836092
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PPM1L mRNA	PMID:19770486
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313118	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PPM1L gene	PMID:27153756
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313118	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PPM1L intron	PMID:30157460
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPM1L mRNA	PMID:32553695
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PPM1L mRNA	PMID:17484886
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPM1L mRNA	PMID:20938992
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250506	CTD	MESH:D006002	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PPM1L mRNA	PMID:39836092
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PPM1L mRNA	PMID:31881176
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313118	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PPM1L mRNA	PMID:27392435
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PPM1L mRNA	PMID:27392435
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313118	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PPM1L mRNA	PMID:24768652|PMID:25583101
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPM1L mRNA	PMID:22298810|PMID:34747641
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313119	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPM1L mRNA	PMID:26377647
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPM1L mRNA	PMID:23238561|PMID:32109520|PMID:33387578
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPM1L mRNA	PMID:19770486|PMID:23238561|PMID:26290441|PMID:32553695
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPM1L mRNA	PMID:19933214
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of PPM1L mRNA	PMID:28374803
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313118	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PPM1L mRNA	PMID:28001369
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250506	CTD	MESH:D003840	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313118	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PPM1L mRNA	PMID:22714537|PMID:28336213
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1313118	E	RGD:6480464	20170613	CTD	MESH:C017947	sodium arsenite results in increased methylation of PPM1L gene	PMID:28336213
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20170613	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA; [sodium arsenite co-treated with sodium arsenite deficiency] results in increased methylation of PPM1L gene; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PPM1L mRNA; sodium arsenite deficiency inhibits the reaction [sodium arsenite results in increased expression of PPM1L mRNA]	PMID:28336213|PMID:39836092
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313118	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPM1L mRNA	PMID:32234424
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of PPM1L mRNA; Benzo(a)pyrene results in decreased expression of PPM1L mRNA	PMID:19770486|PMID:21715664|PMID:22228805|PMID:23735875|PMID:32553695
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313118	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PPM1L 3' UTR	PMID:27901495
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313119	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PPM1L intron	PMID:27901495
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PPM1L mRNA	PMID:27131904
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of PPM1L mRNA	PMID:25729387
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPM1L mRNA	PMID:25729387
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:3207	budesonide	increases expression	ISO	RGD:1313119	E	RGD:6480464	20250506	CTD	MESH:D019819	Budesonide results in increased expression of PPM1L protein	PMID:39714734
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313119	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PPM1L gene; titanium dioxide results in decreased methylation of PPM1L promoter	PMID:35295148
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PPM1L mRNA	PMID:18648102
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PPM1L mRNA	PMID:23811191
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PPM1L mRNA	PMID:25181051
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PPM1L mRNA	PMID:30816183|PMID:32528016
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of PPM1L mRNA	PMID:29097150|PMID:32145629
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313118	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of PPM1L mRNA	PMID:27685785|PMID:33670352
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313118	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PPM1L gene	PMID:31601247
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313119	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of PPM1L mRNA	PMID:39298647
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313119	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PPM1L exon	PMID:33297965
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313119	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of PPM1L mRNA	PMID:40203079
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of PPM1L mRNA	PMID:26377693
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313119	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PPM1L mRNA	PMID:38685157
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PPM1L mRNA	PMID:37019170
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PPM1L mRNA	PMID:21266533
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PPM1L mRNA	PMID:32680482
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313118	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPM1L mRNA	PMID:37042841
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA	PMID:39836092
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313118	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PPM1L mRNA	PMID:36326898
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PPM1L mRNA	PMID:24386269
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250506	CTD	MESH:D005999	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PPM1L mRNA	PMID:40194260
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313118	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PPM1L mRNA	PMID:32588087
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313118	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PPM1L mRNA	PMID:31533062
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313119	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PPM1L mRNA	PMID:39529242
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPM1L mRNA	PMID:36331819
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313118	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of PPM1L mRNA	PMID:28001369
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313118	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PPM1L mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313118	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PPM1L gene	PMID:29154799
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1L mRNA	PMID:27188386
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:4021	Cyclopamine	increases expression	ISO	RGD:1313119	E	RGD:6480464	20250506	CTD	MESH:C000541	cyclopamine results in increased expression of PPM1L protein	PMID:39714734
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313118	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of PPM1L mRNA	PMID:20106945
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PPM1L mRNA	PMID:33387578
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313118	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of PPM1L mRNA	PMID:29067470
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250506	CTD	MESH:D000082	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PPM1L mRNA	PMID:39836092
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:4744	Echimidine	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PPM1L mRNA	PMID:33884520
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PPM1L mRNA	PMID:35436446
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PPM1L mRNA	PMID:29097150
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PPM1L mRNA; Nanotubes, Carbon results in decreased expression of PPM1L mRNA	PMID:25554681
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313119	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PPM1L mRNA	PMID:25620056
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA	PMID:39836092
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPM1L mRNA	PMID:25729387
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:63924	riddelliine	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPM1L mRNA	PMID:33884520
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PPM1L mRNA	PMID:28801915
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PPM1L mRNA	PMID:30467583
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of PPM1L mRNA	PMID:33884520
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PPM1L mRNA	PMID:39752319
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:71418	triamcinolone acetonide	increases expression	ISO	RGD:1313119	E	RGD:6480464	20250506	CTD	MESH:D014222	Triamcinolone Acetonide results in increased expression of PPM1L protein	PMID:39714734
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313119	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PPM1L mRNA	PMID:22206623
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1L mRNA	PMID:27188386
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313118	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of PPM1L mRNA	PMID:30928695
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PPM1L gene]	PMID:28238834
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313119	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PPM1L mRNA	PMID:23091169
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of PPM1L mRNA	PMID:19482888
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of PPM1L mRNA]	PMID:19482888
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of PPM1L mRNA	PMID:31388691
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PPM1L mRNA	PMID:39752319
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313118	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1L mRNA	PMID:27188386
1305220	Ppm1l	protein phosphatase, Mg2+/Mn2+ dependent, 1L	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PPM1L mRNA	PMID:27131904
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of PGM3 mRNA	PMID:35967413
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313121	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PGM3 mRNA	PMID:33045310
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PGM3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PGM3 gene	PMID:20938992
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PGM3 mRNA	PMID:33167477
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1603410	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PGM3 mRNA	PMID:23724009
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PGM3 mRNA	PMID:36331819
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PGM3 mRNA	PMID:20044591
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1603410	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PGM3 mRNA	PMID:29581250
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313121	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PGM3 mRNA	PMID:27339419
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313121	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PGM3 mRNA	PMID:39298647
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of PGM3 mRNA	PMID:20106945
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PGM3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PGM3 gene	PMID:20938992
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of PGM3 mRNA	PMID:18037150
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1313121	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of PGM3 mRNA	PMID:17945193
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313121	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of PGM3 mRNA	PMID:28973375
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of PGM3 mRNA	PMID:21592394
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of PGM3 mRNA	PMID:21592394
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1603410	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PGM3 mRNA	PMID:31163220
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of PGM3 protein	PMID:34122009
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1603410	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PGM3 protein	PMID:37730182
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of PGM3 mRNA	PMID:21592394
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of PGM3 mRNA	PMID:21592394
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PGM3 mRNA	PMID:36331819
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PGM3 mRNA	PMID:29950665
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PGM3 protein	PMID:23301498
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PGM3 mRNA	PMID:22100608
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PGM3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PGM3 mRNA	PMID:34911549
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of PGM3 mRNA	PMID:31129395
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313121	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PGM3 mRNA	PMID:27339419|PMID:31919559
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PGM3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PGM3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PGM3 gene	PMID:20938992|PMID:22206623
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PGM3 mRNA	PMID:40504410
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PGM3 mRNA	PMID:19244175
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of PGM3 mRNA	PMID:19244175
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	increases expression	ISO	RGD:1603410	E	RGD:6480464	20180410	CTD	MESH:D000966	Antimony Potassium Tartrate results in increased expression of PGM3 mRNA	PMID:28713220
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1603410	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of PGM3 mRNA	PMID:33512557
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PGM3 mRNA	PMID:23557933
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1313121	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of PGM3 mRNA	PMID:34813904
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313121	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PGM3 mRNA	PMID:19465110
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PGM3 mRNA	PMID:33212167
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PGM3 mRNA	PMID:30851411
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PGM3 mRNA	PMID:28959563
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PGM3 mRNA	PMID:26033743
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of PGM3 mRNA	PMID:20971185
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313121	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PGM3 protein	PMID:28918527
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603410	E	RGD:6480464	20180410	CTD	MESH:C017947	sodium arsenite results in increased expression of PGM3 mRNA	PMID:28713220|PMID:38568856
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PGM3 mRNA	PMID:40504410
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1603410	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of PGM3 mRNA	PMID:22378314|PMID:38498338
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603410	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PGM3 5' UTR	PMID:27901495
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PGM3 mRNA	PMID:26033743
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of PGM3 mRNA	PMID:20971185
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of PGM3 protein	PMID:34122009
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PGM3 protein]	PMID:26598702
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of PGM3 mRNA	PMID:30047161
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313121	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the expression of PGM3 mRNA	PMID:35295148
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313121	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PGM3 gene	PMID:35295148
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PGM3 mRNA	PMID:29950665
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PGM3 mRNA	PMID:19710929
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313121	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PGM3 mRNA	PMID:28472532
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PGM3 mRNA	PMID:25181051
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1603410	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PGM3 mRNA	PMID:30903817
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PGM3 mRNA	PMID:34947998
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PGM3 mRNA; bisphenol A results in decreased expression of PGM3 protein	PMID:29275510|PMID:31675489
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1603410	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of PGM3 protein	PMID:37567409
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of PGM3 mRNA	PMID:31129395
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PGM3 protein	PMID:31675489
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of PGM3 mRNA	PMID:19244175
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313121	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PGM3 mRNA	PMID:39298647
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313121	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PGM3 mRNA	PMID:37019170
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PGM3 mRNA	PMID:29950665
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313121	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PGM3 mRNA	PMID:17361019
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313121	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PGM3 mRNA	PMID:24535843
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1603410	E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of PGM3 protein	PMID:34064677
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603410	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PGM3 mRNA	PMID:37042841
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PGM3 mRNA	PMID:35163327
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603410	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PGM3 mRNA	PMID:38174414|PMID:38568856
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313121	E	RGD:6480464	20230207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PGM3 protein	PMID:36214631
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PGM3 mRNA	PMID:35163327
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20140311	CTD	MESH:C023036	Dietary Fats, Unsaturated inhibits the reaction [perfluorooctanoic acid results in increased expression of PGM3 mRNA]	PMID:23626681
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PGM3 gene	PMID:22079235
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PGM3 mRNA	PMID:19244175
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of PGM3 mRNA	PMID:19244175
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PGM3 mRNA	PMID:28302478
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1603410	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PGM3 mRNA	PMID:31533062
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM3 mRNA	PMID:19167446
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1603410	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PGM3 mRNA	PMID:40419075
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PGM3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PGM3 mRNA	PMID:36331819
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313121	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PGM3 mRNA	PMID:17292431
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603410	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PGM3 mRNA	PMID:25979313
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PGM3 mRNA	PMID:23179753
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1603410	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PGM3 gene	PMID:29154799
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PGM3 mRNA	PMID:30047161
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603410	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PGM3 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1603410	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PGM3 mRNA	PMID:38832940
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1603410	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PGM3 mRNA	PMID:28542535
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313121	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PGM3 mRNA	PMID:17562736
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PGM3 mRNA	PMID:33387578
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603410	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of PGM3 mRNA	PMID:29067470
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PGM3 mRNA	PMID:40504410
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of PGM3 mRNA	PMID:31675489
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PGM3 mRNA	PMID:29391264
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313121	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PGM3 mRNA	PMID:35436446
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PGM3 protein]	PMID:26598702
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1603410	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of PGM3 mRNA	PMID:33512557
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313121	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PGM3 mRNA; Nanotubes, Carbon results in increased expression of PGM3 mRNA	PMID:25554681|PMID:25620056
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of PGM3 mRNA	PMID:30047161
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of PGM3 mRNA	PMID:24793618
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313121	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PGM3 mRNA	PMID:23608068
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PGM3 protein	PMID:32959892
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313121	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PGM3 mRNA	PMID:23650126
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1603410	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PGM3 mRNA	PMID:31758290
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1603410	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PGM3 protein	PMID:34186270
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313121	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PGM3 mRNA	PMID:22206623
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313121	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PGM3 mRNA	PMID:22206623
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PGM3 mRNA	PMID:30851411
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PGM3 gene]	PMID:28238834
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1603410	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of PGM3 mRNA	PMID:19159669
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of PGM3 mRNA	PMID:30047161
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1603410	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM3 mRNA	PMID:19167446
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313121	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PGM3 mRNA	PMID:30294300
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PGM3 protein	PMID:31675489
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1603410	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of PGM3 mRNA	PMID:19095052
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PGM3 protein	PMID:31675489
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1603410	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of PGM3 mRNA	PMID:33512557
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1603410	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of PGM3 protein	PMID:38348393
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of PGM3 mRNA	PMID:30047161
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1603410	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PGM3 mRNA	PMID:38568856
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1603410	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PGM3 mRNA	PMID:29301935
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1603410	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of PGM3 mRNA	PMID:22378314
1305221	Pgm3	phosphoglucomutase 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PGM3 mRNA	PMID:21346803
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1605071	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TMA16 mRNA	PMID:38218311
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TMA16 mRNA]	PMID:31150632
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1605071	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of TMA16 protein	PMID:36641056
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TMA16 mRNA	PMID:33167477
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313122	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMA16 mRNA	PMID:30529165
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313122	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TMA16 mRNA	PMID:39241906
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605071	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TMA16 mRNA	PMID:31614463
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1313122	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of TMA16 mRNA	PMID:34673133
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TMA16 mRNA	PMID:28818685
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313122	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMA16 mRNA	PMID:36331819
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1605071	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TMA16 protein	PMID:23301498
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of TMA16 mRNA	PMID:21396975
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1605071	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TMA16 protein	PMID:20106945
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TMA16 mRNA	PMID:21632981
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TMA16 mRNA	PMID:31150632
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TMA16 mRNA]	PMID:31150632
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1605071	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TMA16 protein	PMID:38460933
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313122	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of TMA16 mRNA	PMID:35897073
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605071	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TMA16 mRNA	PMID:23557933
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313122	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of TMA16 mRNA	PMID:32186404
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of TMA16 mRNA	PMID:23195993
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMA16 mRNA	PMID:20106945|PMID:21632981
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMA16 mRNA	PMID:33387578
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TMA16 mRNA; aristolochic acid I results in decreased expression of TMA16 protein	PMID:33212167
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMA16 mRNA	PMID:38568856
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMA16 mRNA	PMID:21632981
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605071	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMA16 promoter	PMID:27901495
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605071	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TMA16 mRNA]	PMID:32406909
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TMA16 mRNA	PMID:23411599|PMID:34492290
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TMA16 mRNA	PMID:25181051|PMID:34947998
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TMA16 mRNA	PMID:29275510
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMA16 gene	PMID:28505145
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of TMA16 mRNA	PMID:19244175
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313122	E	RGD:6480464	20200519	CTD	MESH:C543008	bisphenol S results in increased expression of TMA16 mRNA	PMID:31881267|PMID:39298647
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of TMA16 mRNA	PMID:32680482
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605071	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMA16 mRNA	PMID:37042841
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMA16 mRNA	PMID:38174414
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TMA16 mRNA	PMID:25539665
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313122	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TMA16 mRNA	PMID:28903501
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TMA16 mRNA	PMID:28302478
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605071	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TMA16 mRNA	PMID:31533062
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313122	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMA16 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TMA16 mRNA	PMID:36331819
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of TMA16 mRNA	PMID:25993096
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1605071	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TMA16 gene	PMID:29154799
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605071	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TMA16 mRNA	PMID:20106945|PMID:27989131
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1605071	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TMA16 protein	PMID:38460933
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TMA16 mRNA	PMID:29391264
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1605071	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of TMA16 mRNA	PMID:18175754
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313122	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TMA16 mRNA; Nanotubes, Carbon results in increased expression of TMA16 mRNA	PMID:25554681
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of TMA16 mRNA	PMID:24793618
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TMA16 mRNA	PMID:24136188
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1605071	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of TMA16 protein	PMID:32959892
1305222	Tma16	translation machinery associated 16 homolog	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1605071	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TMA16 mRNA	PMID:37199045
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552149	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC66A2 mRNA	PMID:33045310
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552149	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of SLC66A2 mRNA	PMID:37995155
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC66A2 gene	PMID:20938992
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313123	E	RGD:6480464	20241105	CTD	MESH:D014212	Tretinoin results in decreased expression of SLC66A2 mRNA	PMID:33167477
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313123	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SLC66A2 mRNA	PMID:26079696
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1313123	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of SLC66A2 mRNA	PMID:39506029
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in increased expression of SLC66A2 mRNA	PMID:32145629
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552149	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC66A2 mRNA	PMID:39298647
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC66A2 gene	PMID:20938992
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313123	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SLC66A2 protein	PMID:37730182
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313123	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SLC66A2 mRNA	PMID:28818685
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20241105	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC66A2 mRNA	PMID:36331819
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC66A2 mRNA	PMID:37236586
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLC66A2 mRNA	PMID:33354967
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313123	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLC66A2 mRNA	PMID:27153756
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D000638	Amiodarone affects the expression of SLC66A2 mRNA	PMID:19483382
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D000661	Amphetamine results in increased expression of SLC66A2 mRNA	PMID:30779732
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC66A2 gene	PMID:20938992
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313123	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SLC66A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC66A2 mRNA	PMID:40512198
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SLC66A2 mRNA	PMID:31881176
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D003042	Cocaine affects the expression of SLC66A2 mRNA	PMID:20187946
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC66A2 mRNA	PMID:22298810
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313123	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC66A2 mRNA	PMID:22298810
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC66A2 mRNA	PMID:18343893|PMID:21570461
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC66A2 mRNA	PMID:21215274
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC66A2 mRNA	PMID:34747641
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC66A2 mRNA	PMID:15328365|PMID:18796159|PMID:21889950|PMID:23994337|PMID:25975270
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of SLC66A2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC66A2 mRNA	PMID:16214954|PMID:25975270
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313123	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC66A2 mRNA	PMID:38568856
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313123	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC66A2 mRNA	PMID:39719251
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313123	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SLC66A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC66A2 mRNA	PMID:40512198
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313123	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC66A2 intron	PMID:30157460
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313123	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC66A2 mRNA	PMID:32234424
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC66A2 mRNA	PMID:22228805
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D001553	Benzbromarone affects the expression of SLC66A2 mRNA	PMID:19483382
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SLC66A2 mRNA	PMID:23221170
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D005897	Glafenine results in decreased expression of SLC66A2 mRNA	PMID:24136188
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552149	E	RGD:6480464	20241105	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC66A2 gene	PMID:35295148
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D013853	Thioacetamide affects the expression of SLC66A2 mRNA	PMID:19483382
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC66A2 mRNA	PMID:23411599
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C006253	pirinixic acid affects the expression of SLC66A2 mRNA	PMID:19483382
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:C006253	pirinixic acid results in decreased expression of SLC66A2 mRNA	PMID:18445702
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SLC66A2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552149	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SLC66A2 mRNA	PMID:33221593
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20200114	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC66A2 gene	PMID:28505145
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313123	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SLC66A2 mRNA	PMID:25979313
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SLC66A2 mRNA	PMID:23994337
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1552149	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SLC66A2 mRNA	PMID:39298647
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552149	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of SLC66A2 promoter	PMID:33297965
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552149	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC66A2 mRNA	PMID:37019170
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SLC66A2 mRNA	PMID:21266533
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SLC66A2 mRNA	PMID:21266533
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:34696	dieldrin	increases expression	ISO	RGD:1313123	E	RGD:6480464	20260707	CTD	MESH:D004026	Dieldrin results in increased expression of SLC66A2 mRNA	PMID:38723972
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313123	E	RGD:6480464	20241105	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC66A2 mRNA	PMID:37042841
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC66A2 mRNA	PMID:37236586
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D002922	Ciguatoxins affects the expression of SLC66A2 mRNA	PMID:18353800
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D002994	Clofibrate affects the expression of SLC66A2 mRNA	PMID:19483382
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D002994	Clofibrate results in decreased expression of SLC66A2 mRNA	PMID:17585979
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20241105	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC66A2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC66A2 mRNA	PMID:36331819
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC66A2 mRNA	PMID:19136453|PMID:20546886
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313123	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC66A2 gene	PMID:29154799
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313123	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC66A2 mRNA	PMID:20106945|PMID:25562108
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313123	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC66A2 mRNA	PMID:38832940
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D000082	Acetaminophen affects the expression of SLC66A2 mRNA	PMID:17562736
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313123	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SLC66A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC66A2 mRNA	PMID:40512198
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC66A2 mRNA	PMID:35436446
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D005001	Ethionine affects the expression of SLC66A2 mRNA	PMID:19483382
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D005485	Flutamide results in decreased expression of SLC66A2 mRNA	PMID:24136188
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SLC66A2 mRNA	PMID:23608068
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SLC66A2 gene	PMID:35440735
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C051752	nefazodone results in decreased expression of SLC66A2 mRNA	PMID:24136188
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of SLC66A2 mRNA	PMID:23994337
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D009853	Omeprazole affects the expression of SLC66A2 mRNA	PMID:19483382
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D009853	Omeprazole affects the expression of SLC66A2 mRNA	PMID:19483382
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of SLC66A2 mRNA	PMID:18343893
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:C045950	propiconazole results in decreased expression of SLC66A2 mRNA	PMID:21278054
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D011441	Propylthiouracil affects the expression of SLC66A2 mRNA	PMID:19483382
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SLC66A2 mRNA	PMID:24780913
1305223	Slc66a2	solute carrier family 66 member 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C025643	vinclozolin results in decreased expression of SLC66A2 mRNA	PMID:23034163
1305224	Sln	sarcolipin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313124	E	RGD:6480464	20190611	CTD	MESH:D014212	Tretinoin results in increased expression of SLN mRNA	PMID:30416051
1305224	Sln	sarcolipin	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of SLN mRNA	PMID:33729688
1305224	Sln	sarcolipin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313125	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLN mRNA	PMID:30529165
1305224	Sln	sarcolipin	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20130806	CTD	MESH:C029424	hydrazine results in decreased expression of SLN mRNA	PMID:15282401
1305224	Sln	sarcolipin	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313124	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SLN mRNA	PMID:26079696
1305224	Sln	sarcolipin	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313124	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of SLN mRNA	PMID:30510588
1305224	Sln	sarcolipin	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SLN mRNA	PMID:32145629
1305224	Sln	sarcolipin	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313124	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SLN mRNA	PMID:26079696
1305224	Sln	sarcolipin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313124	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SLN mRNA	PMID:31163220
1305224	Sln	sarcolipin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313124	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLN mRNA	PMID:35301059
1305224	Sln	sarcolipin	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C016517	indole-3-carbinol affects the expression of SLN mRNA	PMID:21396975
1305224	Sln	sarcolipin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313124	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLN gene	PMID:27153756
1305224	Sln	sarcolipin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313125	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLN mRNA	PMID:34911549
1305224	Sln	sarcolipin	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SLN mRNA	PMID:19111725
1305224	Sln	sarcolipin	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313124	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SLN mRNA	PMID:28903495
1305224	Sln	sarcolipin	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313124	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SLN mRNA	PMID:27392435
1305224	Sln	sarcolipin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLN mRNA	PMID:21215274|PMID:32109520
1305224	Sln	sarcolipin	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313124	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SLN mRNA	PMID:23179753
1305224	Sln	sarcolipin	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SLN mRNA	PMID:28959563
1305224	Sln	sarcolipin	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313124	E	RGD:6480464	20130806	CTD	MESH:D003561	Cytarabine results in decreased expression of SLN mRNA	PMID:21198554
1305224	Sln	sarcolipin	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of SLN mRNA	PMID:30556269
1305224	Sln	sarcolipin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313124	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLN mRNA	PMID:29301061
1305224	Sln	sarcolipin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313124	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLN promoter	PMID:27901495
1305224	Sln	sarcolipin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLN mRNA	PMID:22228805|PMID:22610609
1305224	Sln	sarcolipin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313124	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLN 5' UTR	PMID:27901495
1305224	Sln	sarcolipin	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of SLN mRNA	PMID:30556269
1305224	Sln	sarcolipin	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SLN mRNA	PMID:19111725
1305224	Sln	sarcolipin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313124	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SLN mRNA	PMID:25895662
1305224	Sln	sarcolipin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SLN mRNA	PMID:23557971
1305224	Sln	sarcolipin	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313125	E	RGD:6480464	20130806	CTD	MESH:C006253	pirinixic acid affects the expression of SLN mRNA	PMID:19136022
1305224	Sln	sarcolipin	gene	CHEBI:33128	C60 fullerene	affects expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C069837	fullerene C60 affects the expression of SLN mRNA	PMID:19167457
1305224	Sln	sarcolipin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLN mRNA	PMID:25181051|PMID:32145629
1305224	Sln	sarcolipin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313125	E	RGD:6480464	20140513	CTD	MESH:C006780	bisphenol A results in increased expression of SLN mRNA	PMID:24465770
1305224	Sln	sarcolipin	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313124	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of SLN gene	PMID:31601247
1305224	Sln	sarcolipin	gene	CHEBI:33418	graphite	increases expression	ISO	RGD:1313125	E	RGD:6480464	20180515	CTD	MESH:D006108	Graphite results in increased expression of SLN mRNA	PMID:27440207
1305224	Sln	sarcolipin	gene	CHEBI:3374	capsaicin	increases expression	ISO	RGD:1313125	E	RGD:6480464	20250603	CTD	MESH:D002211	Capsaicin results in increased expression of SLN mRNA; Capsaicin results in increased expression of SLN protein	PMID:39800145
1305224	Sln	sarcolipin	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of SLN mRNA	PMID:26377693
1305224	Sln	sarcolipin	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1313125	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of SLN mRNA	PMID:26377693
1305224	Sln	sarcolipin	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of SLN mRNA	PMID:35163327
1305224	Sln	sarcolipin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SLN mRNA	PMID:35163327
1305224	Sln	sarcolipin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313124	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLN mRNA	PMID:35301059
1305224	Sln	sarcolipin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SLN mRNA	PMID:35163327
1305224	Sln	sarcolipin	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of SLN mRNA	PMID:25539665
1305224	Sln	sarcolipin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313124	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SLN mRNA	PMID:26272509|PMID:28001369
1305224	Sln	sarcolipin	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313124	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLN mRNA	PMID:27188386
1305224	Sln	sarcolipin	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1313124	E	RGD:6480464	20130806	CTD	MESH:D013629	[Tamoxifen co-treated with ESR1 protein] results in decreased expression of SLN mRNA	PMID:19059307
1305224	Sln	sarcolipin	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313124	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SLN mRNA	PMID:38832940
1305224	Sln	sarcolipin	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313124	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SLN mRNA	PMID:24935251
1305224	Sln	sarcolipin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313125	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of SLN mRNA	PMID:17562736
1305224	Sln	sarcolipin	gene	CHEBI:4744	Echimidine	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C000615871	echimidine results in decreased expression of SLN mRNA	PMID:34185104
1305224	Sln	sarcolipin	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SLN mRNA	PMID:30307764
1305224	Sln	sarcolipin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SLN mRNA; Nanotubes, Carbon results in decreased expression of SLN mRNA	PMID:25554681|PMID:25620056
1305224	Sln	sarcolipin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313125	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLN mRNA; Nanotubes, Carbon results in increased expression of SLN mRNA	PMID:25554681|PMID:25620056
1305224	Sln	sarcolipin	gene	CHEBI:53227	poly(ethylene)	multiple interactions	ISO	RGD:1313125	E	RGD:6480464	20260602	CTD	MESH:D020959	[Polyethylene results in increased abundance of Microplastics] which results in decreased expression of SLN mRNA	PMID:40262053
1305224	Sln	sarcolipin	gene	CHEBI:5643	Heliotrine	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in decreased expression of SLN mRNA	PMID:34185104
1305224	Sln	sarcolipin	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	ISO	RGD:1313124	E	RGD:6480464	20130806	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of SLN mRNA	PMID:20843944
1305224	Sln	sarcolipin	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1313125	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLN mRNA	PMID:27935865
1305224	Sln	sarcolipin	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SLN mRNA	PMID:25566086
1305224	Sln	sarcolipin	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313124	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of SLN mRNA	PMID:29522793
1305224	Sln	sarcolipin	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of SLN mRNA	PMID:33484710
1305224	Sln	sarcolipin	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313124	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLN mRNA	PMID:27188386
1305224	Sln	sarcolipin	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313125	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of SLN mRNA	PMID:19136022
1305224	Sln	sarcolipin	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313125	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLN mRNA	PMID:27935865
1305224	Sln	sarcolipin	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of SLN mRNA	PMID:26377693
1305224	Sln	sarcolipin	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313124	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of SLN mRNA	PMID:26079696
1305224	Sln	sarcolipin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SLN mRNA	PMID:24780913
1305224	Sln	sarcolipin	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1313124	E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR1 protein] results in decreased expression of SLN mRNA	PMID:19059307
1305224	Sln	sarcolipin	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1313125	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate affects the expression of SLN mRNA	PMID:19162170
1305224	Sln	sarcolipin	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313124	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLN mRNA	PMID:27188386
1305224	Sln	sarcolipin	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313124	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SLN mRNA	PMID:38568856
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:132098	methoxyacetic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of CCDC174 mRNA	PMID:20864626
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313126	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CCDC174 mRNA	PMID:33045310
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCDC174 mRNA]	PMID:31150632
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1348248	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CCDC174 protein]	PMID:38195004
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1348248	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CCDC174 mRNA	PMID:33167477
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1348248	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CCDC174 mRNA	PMID:23649840
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CCDC174 mRNA	PMID:33387578
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1348248	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CCDC174 mRNA	PMID:28818685
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1348248	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of CCDC174 mRNA	PMID:39836092
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1348248	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CCDC174 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CCDC174 protein	PMID:38195004
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1348248	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CCDC174 mRNA	PMID:19549813
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1348248	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CCDC174 mRNA	PMID:23649840
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1348248	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CCDC174 intron	PMID:30157460
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1348248	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CCDC174 gene	PMID:27153756
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1348248	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CCDC174 mRNA	PMID:23649840
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCDC174 mRNA	PMID:31150632
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCDC174 mRNA]	PMID:31150632
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313126	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CCDC174 mRNA	PMID:22206623
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of CCDC174 mRNA	PMID:20864626
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1348248	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CCDC174 mRNA	PMID:27594783
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of CCDC174 mRNA	PMID:20187946
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCDC174 mRNA	PMID:33387578
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of CCDC174 mRNA	PMID:19013527
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CCDC174 mRNA	PMID:20864626
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1348248	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CCDC174 mRNA	PMID:29803840
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1348248	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CCDC174 mRNA	PMID:38568856
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CCDC174 mRNA	PMID:34947998
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313126	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CCDC174 mRNA	PMID:33221593
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CCDC174 mRNA	PMID:25181051
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313126	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CCDC174 mRNA	PMID:26063408
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313126	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of CCDC174 mRNA	PMID:34813904
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313126	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of CCDC174 mRNA	PMID:34813904
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1348248	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of CCDC174 mRNA	PMID:39836092
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1348248	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CCDC174 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CCDC174 protein	PMID:38195004
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1348248	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CCDC174 mRNA	PMID:31533062
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1348248	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CCDC174 mRNA	PMID:25979313
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1348248	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CCDC174 gene	PMID:29154799
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313126	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CCDC174 mRNA	PMID:28973697
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1348248	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of CCDC174 mRNA	PMID:39836092
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1348248	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CCDC174 mRNA	PMID:28988120
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1313126	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of CCDC174 mRNA	PMID:28444820
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313126	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CCDC174 mRNA	PMID:22206623
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of CCDC174 mRNA	PMID:32109520
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:88522	Monobutylphthalate	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of CCDC174 mRNA	PMID:20864626
1305225	Ccdc174	coiled-coil domain containing 174	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CCDC174 mRNA	PMID:19015723
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313127	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of KMT5C mRNA	PMID:33045310
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313127	E	RGD:6480464	20161115	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of KMT5C mRNA	PMID:26251327
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KMT5C mRNA	PMID:39241906
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1346503	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of KMT5C mRNA	PMID:22574217
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of KMT5C mRNA	PMID:35192832
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1346503	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of KMT5C mRNA	PMID:31614463
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1346503	E	RGD:6480464	20190709	CTD	MESH:D014520	Urethane results in increased expression of KMT5C mRNA	PMID:28818685
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313127	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KMT5C mRNA	PMID:37236586
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1346503	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of KMT5C mRNA	PMID:35430440
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313127	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KMT5C mRNA	PMID:22206623
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313127	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KMT5C mRNA	PMID:40504410
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of KMT5C mRNA	PMID:26302742
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313127	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of KMT5C mRNA	PMID:28960355
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1346503	E	RGD:6480464	20190709	CTD	MESH:D002945	Cisplatin results in increased expression of KMT5C mRNA	PMID:27594783
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313127	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KMT5C mRNA	PMID:21570461
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KMT5C mRNA	PMID:32277265
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20161115	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KMT5C mRNA	PMID:26290441
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1346503	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of KMT5C mRNA	PMID:33212167
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of KMT5C protein	PMID:30807115
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190709	CTD	MESH:D003300	Copper results in increased expression of KMT5C mRNA	PMID:30556269
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of KMT5C mRNA	PMID:36209798
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313127	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KMT5C mRNA	PMID:40504410
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KMT5C mRNA	PMID:20504355
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190709	CTD	MESH:D003300	Copper results in increased expression of KMT5C mRNA	PMID:30556269
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of KMT5C mRNA	PMID:34492290
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313127	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of KMT5C mRNA	PMID:18301758
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of KMT5C mRNA	PMID:19167457
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of KMT5C mRNA	PMID:30816183|PMID:32528016|PMID:35192832
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of KMT5C mRNA	PMID:32156529
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KMT5C mRNA	PMID:25181051
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20190709	CTD	MESH:C006780	bisphenol A results in increased methylation of KMT5C gene	PMID:28505145
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of KMT5C mRNA	PMID:39298647
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of KMT5C mRNA	PMID:38685157
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of KMT5C mRNA	PMID:34813904
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313127	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of KMT5C mRNA	PMID:34813904
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346503	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KMT5C mRNA	PMID:37042841
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313127	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KMT5C mRNA	PMID:37236586
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:C039281	furan results in decreased expression of KMT5C mRNA	PMID:24614236
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1346503	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of KMT5C mRNA	PMID:31533062
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313127	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of KMT5C mRNA	PMID:17292431
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1346503	E	RGD:6480464	20190709	CTD	MESH:D014635	Valproic Acid results in increased methylation of KMT5C gene	PMID:29154799
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of KMT5C mRNA	PMID:25123088
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313127	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KMT5C mRNA	PMID:28973697
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1346503	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of KMT5C mRNA	PMID:22230336
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KMT5C mRNA	PMID:33387578
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313127	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of KMT5C mRNA	PMID:17585979
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313127	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KMT5C mRNA	PMID:40504410
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1346503	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of KMT5C mRNA	PMID:31838189
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313127	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KMT5C mRNA; Nanotubes, Carbon results in decreased expression of KMT5C mRNA	PMID:25554681
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313127	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KMT5C mRNA	PMID:22206623
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313127	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KMT5C mRNA	PMID:22206623
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346503	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KMT5C gene]	PMID:28238834
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of KMT5C mRNA	PMID:36084822
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1346503	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of KMT5C mRNA	PMID:38568856
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of KMT5C mRNA	PMID:22570695|PMID:23869203
1305226	Kmt5c	lysine methyltransferase 5C	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of KMT5C mRNA	PMID:23034163
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SMC2 mRNA	PMID:33167477
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SMC2 mRNA	PMID:21632981
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SMC2 mRNA	PMID:39241906
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SMC2 mRNA	PMID:32145629
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313128	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of SMC2 mRNA	PMID:16474171|PMID:19167446|PMID:36581016
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA	PMID:25510870
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313128	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SMC2 mRNA	PMID:38568856
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SMC2 mRNA	PMID:33387578
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20120501	CTD	MESH:D001554	Benzene results in decreased expression of SMC2 mRNA	PMID:20018183
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313128	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of SMC2 mRNA	PMID:18070364
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of SMC2 mRNA	PMID:26079696
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMC2 mRNA	PMID:37992649
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of SMC2 mRNA	PMID:21592394
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of SMC2 mRNA	PMID:21592394
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMC2 mRNA	PMID:37992649
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of SMC2 mRNA	PMID:21592394
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of SMC2 mRNA	PMID:21592394
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SMC2 mRNA	PMID:22061828
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA	PMID:39836092
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SMC2 mRNA	PMID:37236586
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA	PMID:25510870
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA	PMID:25510870
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SMC2 protein	PMID:23301498
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313128	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SMC2 protein	PMID:20106945
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313128	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SMC2 mRNA	PMID:23649840
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of SMC2 mRNA	PMID:12763052
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SMC2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SMC2 mRNA	PMID:34911549
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313129	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SMC2 mRNA	PMID:27339419|PMID:31919559
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SMC2 mRNA	PMID:25629700
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMC2 mRNA	PMID:39836092
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SMC2 mRNA	PMID:31881176
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SMC2 mRNA	PMID:25905778
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of SMC2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of SMC2 mRNA	PMID:19167446|PMID:23557933
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SMC2 mRNA	PMID:27392435
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SMC2 mRNA	PMID:30912803
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313128	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of SMC2 mRNA	PMID:16474171
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313128	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SMC2 mRNA	PMID:25583101
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMC2 mRNA	PMID:34747641
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313129	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMC2 mRNA	PMID:21570461|PMID:26377647
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMC2 mRNA	PMID:32109520|PMID:33387578
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMC2 mRNA	PMID:21802500
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMC2 mRNA	PMID:17942748
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SMC2 mRNA	PMID:28374803
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMC2 mRNA	PMID:33212167
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313128	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SMC2 mRNA	PMID:39709020
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in increased expression of SMC2 mRNA	PMID:17205981
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SMC2 mRNA	PMID:15467011
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMC2 mRNA	PMID:29803840
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMC2 mRNA	PMID:37992649
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of SMC2 mRNA	PMID:22623647
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SMC2 mRNA	PMID:38568856
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313129	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of SMC2 mRNA	PMID:32068019
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMC2 mRNA	PMID:39836092
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMC2 mRNA	PMID:21802500
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313128	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SMC2 mRNA	PMID:32234424
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313128	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SMC2 promoter	PMID:27901495
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in increased expression of SMC2 mRNA	PMID:17205981
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SMC2 mRNA	PMID:15467011
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313129	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SMC2 mRNA	PMID:29341224
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SMC2 mRNA	PMID:20382639
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of SMC2 mRNA	PMID:25729387
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMC2 mRNA	PMID:25729387
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313129	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SMC2 gene	PMID:35295148
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SMC2 mRNA	PMID:34492290
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SMC2 mRNA	PMID:25380136
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SMC2 mRNA	PMID:18648102
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of SMC2 mRNA	PMID:19136022
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SMC2 mRNA	PMID:17426115
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of SMC2 mRNA	PMID:17950772|PMID:18301758|PMID:20813756
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of SMC2 mRNA]	PMID:17950772
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20170516	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of SMC2 mRNA	PMID:27793765
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SMC2 mRNA	PMID:25181051|PMID:26982218|PMID:30816183|PMID:32528016|PMID:34947998
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SMC2 mRNA	PMID:32145629
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313128	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of SMC2 mRNA	PMID:16474171
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313129	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SMC2 mRNA	PMID:26682919
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA	PMID:25510870
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA	PMID:25510870
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SMC2 mRNA	PMID:39298647|PMID:40203079
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313129	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SMC2 mRNA	PMID:26377693
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMC2 mRNA	PMID:37019170
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SMC2 mRNA	PMID:17854601
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of SMC2 mRNA]	PMID:17854601
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313128	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SMC2 mRNA	PMID:37042841
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SMC2 mRNA	PMID:30589522
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA	PMID:39836092
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SMC2 mRNA	PMID:25380136|PMID:30723492
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SMC2 mRNA	PMID:37236586
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SMC2 protein	PMID:26879310
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SMC2 mRNA	PMID:19376846
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SMC2 mRNA	PMID:25380136
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:3766	clozapine	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of SMC2 protein	PMID:34122009
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SMC2 mRNA	PMID:28302478
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SMC2 mRNA	PMID:31533062
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313128	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SMC2 mRNA	PMID:19167446
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of SMC2 mRNA	PMID:19167446
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SMC2 mRNA	PMID:39529242
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SMC2 mRNA	PMID:27153767|PMID:40419075
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313128	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SMC2 mRNA	PMID:25979313
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMC2 mRNA	PMID:23179753|PMID:27188386
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313128	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SMC2 gene	PMID:29154799
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313128	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of SMC2 mRNA	PMID:29154799
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMC2 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of SMC2 mRNA	PMID:21658437
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313129	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SMC2 mRNA	PMID:28973697
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMC2 mRNA	PMID:37992649
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMC2 mRNA	PMID:29067470
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SMC2 mRNA	PMID:33387578
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313128	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SMC2 mRNA	PMID:22230336
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMC2 mRNA	PMID:39836092
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMC2 mRNA	PMID:22079256
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SMC2 mRNA	PMID:17942748
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMC2 mRNA	PMID:17942748
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313129	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SMC2 mRNA; Nanotubes, Carbon results in increased expression of SMC2 mRNA	PMID:25554681
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SMC2 mRNA	PMID:19042947
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of SMC2 mRNA	PMID:17982090
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SMC2 mRNA	PMID:38701926
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SMC2 protein	PMID:32959892
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA	PMID:39836092
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMC2 mRNA	PMID:21641980
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SMC2 mRNA	PMID:25729387
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMC2 mRNA	PMID:25729387
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of SMC2 mRNA	PMID:19812364
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:6437	levetiracetam	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077287	Levetiracetam results in increased expression of SMC2 mRNA	PMID:20345932
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of SMC2 mRNA	PMID:35283115
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D008701	Methapyrilene results in increased expression of SMC2 mRNA	PMID:22584684
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SMC2 mRNA	PMID:22079256
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMC2 mRNA	PMID:22079256
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of SMC2 mRNA	PMID:29522793
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SMC2 mRNA	PMID:30928695
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313129	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SMC2 mRNA	PMID:19136022|PMID:23091169
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of SMC2 mRNA	PMID:20345932
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313128	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC2 mRNA	PMID:19167446
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313129	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SMC2 mRNA	PMID:38648751
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of SMC2 mRNA	PMID:32234424
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of SMC2 mRNA	PMID:21858171
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of SMC2 protein	PMID:38348393
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313129	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of SMC2 mRNA	PMID:30953684|PMID:39847705
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of SMC2 mRNA	PMID:32419051
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:9111	Senkirkine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of SMC2 mRNA	PMID:32419051
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1313128	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of SMC2 mRNA	PMID:17440010
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313128	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of SMC2 mRNA	PMID:19140230
1305227	Smc2	structural maintenance of chromosomes 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SMC2 mRNA	PMID:35537566
1305228	Phf2	PHD finger protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313130	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PHF2 mRNA	PMID:33167477
1305228	Phf2	PHD finger protein 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313130	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PHF2 mRNA	PMID:26079696
1305228	Phf2	PHD finger protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313131	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PHF2 mRNA	PMID:30319688
1305228	Phf2	PHD finger protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313131	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of PHF2 protein	PMID:31494107
1305228	Phf2	PHD finger protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313130	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHF2 mRNA	PMID:37042841
1305228	Phf2	PHD finger protein 2	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313130	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of PHF2 mRNA	PMID:26079696
1305228	Phf2	PHD finger protein 2	gene	CHEBI:17270	glycerol 2-phosphate	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20151215	CTD	MESH:C031463	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of PHF2 mRNA	PMID:26424790
1305228	Phf2	PHD finger protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313131	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PHF2 mRNA	PMID:34319233
1305228	Phf2	PHD finger protein 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313130	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PHF2 protein	PMID:37730182
1305228	Phf2	PHD finger protein 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PHF2 mRNA	PMID:22061828
1305228	Phf2	PHD finger protein 2	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313131	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of PHF2 intron	PMID:27776689
1305228	Phf2	PHD finger protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313130	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PHF2 mRNA	PMID:23649840
1305228	Phf2	PHD finger protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313131	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PHF2 mRNA	PMID:25629700
1305228	Phf2	PHD finger protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF2 mRNA	PMID:39836092
1305228	Phf2	PHD finger protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313130	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PHF2 protein	PMID:35688186
1305228	Phf2	PHD finger protein 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313131	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PHF2 mRNA	PMID:30912803
1305228	Phf2	PHD finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313131	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHF2 mRNA	PMID:21570461
1305228	Phf2	PHD finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PHF2 mRNA	PMID:33387578
1305228	Phf2	PHD finger protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313130	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PHF2 mRNA	PMID:33212167
1305228	Phf2	PHD finger protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313130	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHF2 mRNA	PMID:29803840
1305228	Phf2	PHD finger protein 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313130	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PHF2 protein	PMID:35688186
1305228	Phf2	PHD finger protein 2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20151215	CTD	MESH:D001205	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of PHF2 mRNA	PMID:26424790
1305228	Phf2	PHD finger protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313130	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PHF2 mRNA	PMID:39719251
1305228	Phf2	PHD finger protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF2 mRNA	PMID:39836092
1305228	Phf2	PHD finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313130	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PHF2 promoter	PMID:27901495
1305228	Phf2	PHD finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313131	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHF2 mRNA	PMID:22228805
1305228	Phf2	PHD finger protein 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PHF2 mRNA]	PMID:32406909
1305228	Phf2	PHD finger protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PHF2 mRNA	PMID:25729387
1305228	Phf2	PHD finger protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in decreased expression of PHF2 mRNA	PMID:27178563
1305228	Phf2	PHD finger protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF2 mRNA	PMID:25181051|PMID:41034487
1305228	Phf2	PHD finger protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313130	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PHF2 mRNA; bisphenol A results in increased expression of PHF2 protein	PMID:25047013|PMID:33376534
1305228	Phf2	PHD finger protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PHF2 mRNA	PMID:28628672
1305228	Phf2	PHD finger protein 2	gene	CHEBI:34093	1-Hydroxypyrene	increases expression	ISO	RGD:1313130	E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in increased expression of PHF2 mRNA	PMID:21854004
1305228	Phf2	PHD finger protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313131	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PHF2 mRNA	PMID:39298647
1305228	Phf2	PHD finger protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313131	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PHF2 exon	PMID:33297965
1305228	Phf2	PHD finger protein 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PHF2 mRNA	PMID:28628672
1305228	Phf2	PHD finger protein 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313131	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of PHF2 mRNA	PMID:34813904
1305228	Phf2	PHD finger protein 2	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of PHF2 gene	PMID:33148267
1305228	Phf2	PHD finger protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313130	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHF2 mRNA	PMID:37042841
1305228	Phf2	PHD finger protein 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313130	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PHF2 mRNA	PMID:24449571
1305228	Phf2	PHD finger protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313131	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PHF2 mRNA	PMID:36331819
1305228	Phf2	PHD finger protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313130	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHF2 mRNA	PMID:25979313
1305228	Phf2	PHD finger protein 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313130	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305228	Phf2	PHD finger protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF2 mRNA	PMID:27188386
1305228	Phf2	PHD finger protein 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20151215	CTD	MESH:D003907	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of PHF2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PHF2 mRNA	PMID:26424790|PMID:28628672
1305228	Phf2	PHD finger protein 2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313130	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PHF2 mRNA	PMID:28542535
1305228	Phf2	PHD finger protein 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHF2 mRNA	PMID:33387578
1305228	Phf2	PHD finger protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF2 mRNA	PMID:39836092
1305228	Phf2	PHD finger protein 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PHF2 mRNA	PMID:28628672
1305228	Phf2	PHD finger protein 2	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of PHF2 mRNA	PMID:21983209|PMID:24140754
1305228	Phf2	PHD finger protein 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PHF2 mRNA	PMID:25729387
1305228	Phf2	PHD finger protein 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313130	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PHF2 mRNA	PMID:15336504
1305228	Phf2	PHD finger protein 2	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PHF2 mRNA	PMID:30467583
1305228	Phf2	PHD finger protein 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PHF2 gene	PMID:35440735
1305228	Phf2	PHD finger protein 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of PHF2 gene	PMID:33148267
1305228	Phf2	PHD finger protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF2 mRNA	PMID:27188386
1305228	Phf2	PHD finger protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313130	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF2 mRNA	PMID:27188386
1305228	Phf2	PHD finger protein 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313131	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PHF2 mRNA	PMID:28973697
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FRMPD1 mRNA	PMID:37995155
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313133	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of FRMPD1 mRNA	PMID:40945087
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313133	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FRMPD1 mRNA	PMID:30319688
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313133	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FRMPD1 mRNA	PMID:30319688
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313132	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of FRMPD1 mRNA	PMID:30510588
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FRMPD1 mRNA	PMID:33387578
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in decreased expression of FRMPD1 mRNA	PMID:37084897
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FRMPD1 mRNA	PMID:34319233
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of FRMPD1 mRNA	PMID:27462272
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313132	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FRMPD1 exon	PMID:30157460
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313133	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FRMPD1 mRNA	PMID:27106289
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FRMPD1 mRNA	PMID:31150632
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313132	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FRMPD1 mRNA	PMID:32525701
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313132	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of FRMPD1 mRNA	PMID:38460933
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FRMPD1 mRNA	PMID:32109520
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FRMPD1 mRNA	PMID:33387578
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313132	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FRMPD1 mRNA	PMID:30851411
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313132	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FRMPD1 mRNA	PMID:29803840
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of FRMPD1 mRNA	PMID:37682722
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313132	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FRMPD1 mRNA	PMID:38568856
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313132	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FRMPD1 5' UTR	PMID:27901495
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313132	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FRMPD1 3' UTR	PMID:27901495
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313132	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FRMPD1 mRNA	PMID:35984750
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313132	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FRMPD1 gene	PMID:31601247
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of FRMPD1 mRNA	PMID:29264374
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313132	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of FRMPD1 gene	PMID:31601247
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of FRMPD1 mRNA	PMID:30951980
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313132	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FRMPD1 gene	PMID:31601247
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313133	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of FRMPD1 gene	PMID:31683443
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313132	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of FRMPD1 intron	PMID:30157460
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of FRMPD1 mRNA	PMID:28392331
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of FRMPD1 promoter	PMID:22457795
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of FRMPD1 mRNA	PMID:25539665
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313132	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FRMPD1 mRNA	PMID:31533062
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FRMPD1 mRNA	PMID:33387578
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313132	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of FRMPD1 mRNA	PMID:38460933
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313132	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FRMPD1 mRNA	PMID:32525701
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FRMPD1 mRNA; Nanotubes, Carbon results in decreased expression of FRMPD1 mRNA	PMID:25554681
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313132	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of FRMPD1 intron	PMID:30157460
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313133	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FRMPD1 mRNA	PMID:22206623
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313132	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of FRMPD1 mRNA	PMID:29522793
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313132	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FRMPD1 mRNA	PMID:30851411
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313132	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FRMPD1 mRNA	PMID:32525701
1305229	Frmpd1	FERM and PDZ domain containing 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of FRMPD1 mRNA	PMID:40826991
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313135	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of REEP1 mRNA	PMID:33045310
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:144400	dinophysistoxin 1	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in decreased expression of REEP1 mRNA	PMID:28939011
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of REEP1 mRNA	PMID:23830798
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313135	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of REEP1 mRNA	PMID:16604517
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313135	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of REEP1 mRNA	PMID:20880076
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313134	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of REEP1 mRNA	PMID:26079696
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313135	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of REEP1 mRNA	PMID:30319688
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of REEP1 mRNA	PMID:30510588
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of REEP1 mRNA	PMID:19619570
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313134	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of REEP1 mRNA	PMID:24758408
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of REEP1 mRNA; EGF protein inhibits the reaction [Estradiol results in increased expression of REEP1 mRNA]	PMID:19619570|PMID:24758408
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of REEP1 mRNA	PMID:33387578
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313135	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of REEP1 mRNA	PMID:39922521
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313135	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of REEP1 mRNA	PMID:39922521
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of REEP1 mRNA	PMID:34319233
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of REEP1 mRNA	PMID:36139627
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of REEP1 mRNA	PMID:33387578
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA	PMID:39836092
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313134	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of REEP1 mRNA	PMID:24376830
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of REEP1 mRNA	PMID:35301059
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313134	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of REEP1 protein	PMID:20106945
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of REEP1 mRNA	PMID:27153756
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313134	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of REEP1 exon	PMID:30157460
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1313134	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of REEP1 mRNA	PMID:15672453
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of REEP1 mRNA	PMID:25629700
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of REEP1 mRNA	PMID:22206623
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of REEP1 mRNA	PMID:39836092
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of REEP1 mRNA	PMID:31881176
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of REEP1 mRNA	PMID:24768652|PMID:25583101
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of REEP1 mRNA	PMID:34747641
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of REEP1 mRNA	PMID:19619570
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of REEP1 mRNA	PMID:33387578
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of REEP1 mRNA	PMID:19619570
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of REEP1 mRNA	PMID:28959563
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of REEP1 mRNA	PMID:29803840
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of REEP1 mRNA	PMID:39631538
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313134	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of REEP1 mRNA	PMID:20044591
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:29021	hexane	decreases methylation	EXP		E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of REEP1 promoter	PMID:23740543
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of REEP1 mRNA	PMID:29301061
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313134	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of REEP1 mRNA	PMID:39719251
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of REEP1 mRNA	PMID:39836092
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313134	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of REEP1 intron; Benzo(a)pyrene affects the methylation of REEP1 promoter	PMID:27901495|PMID:30157460
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313135	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of REEP1 mRNA	PMID:22610609
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA	PMID:27858113
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of REEP1 mRNA	PMID:19150397|PMID:20018196
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of REEP1 mRNA	PMID:30047161
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313135	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of REEP1 mRNA	PMID:23557971
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of REEP1 mRNA	PMID:29264374
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313135	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of REEP1 gene	PMID:35295148
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313135	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of REEP1 gene; titanium dioxide results in increased methylation of REEP1 promoter	PMID:35295148
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of REEP1 mRNA	PMID:34492290
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of REEP1 mRNA	PMID:25181051|PMID:34947998
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313134	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of REEP1 gene	PMID:31601247
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of REEP1 mRNA	PMID:19244175
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313135	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of REEP1 mRNA	PMID:26377693
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA	PMID:27858113
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313134	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of REEP1 intron	PMID:30157460
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of REEP1 mRNA	PMID:21266533
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of REEP1 mRNA	PMID:35163327
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of REEP1 mRNA	PMID:35163327
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA	PMID:39836092
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313135	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of REEP1 mRNA	PMID:26377693
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of REEP1 mRNA	PMID:33453195
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of REEP1 mRNA	PMID:35301059
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of REEP1 mRNA	PMID:35163327
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of REEP1 mRNA	PMID:25539665
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313134	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of REEP1 mRNA	PMID:24449571
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of REEP1 mRNA	PMID:40194260
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313134	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of REEP1 mRNA	PMID:31533062
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313134	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of REEP1 mRNA	PMID:25979313
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313134	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of REEP1 gene	PMID:29154799
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313134	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of REEP1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:28001369|PMID:29154799
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP1 mRNA	PMID:27188386
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of REEP1 mRNA	PMID:30047161
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of REEP1 mRNA	PMID:20106945|PMID:27989131
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of REEP1 mRNA	PMID:28973697
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313135	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of REEP1 mRNA	PMID:39922521
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313134	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of REEP1 mRNA	PMID:38832940
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313134	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of REEP1 mRNA	PMID:24935251
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313135	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of REEP1 mRNA	PMID:17562736
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of REEP1 mRNA	PMID:33387578
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313134	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of REEP1 mRNA	PMID:25704631
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of REEP1 mRNA	PMID:39836092
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313135	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of REEP1 mRNA	PMID:35436446
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of REEP1 mRNA	PMID:32234424
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1313134	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of REEP1 mRNA	PMID:38825487
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of REEP1 mRNA	PMID:30307764
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313135	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of REEP1 mRNA	PMID:25554681
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of REEP1 mRNA	PMID:30047161
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA	PMID:27858113
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA	PMID:27858113
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA	PMID:39836092
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:63618	pravastatin	affects expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of REEP1 mRNA	PMID:27225895
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1313135	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of REEP1 mRNA	PMID:27225895
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of REEP1 mRNA	PMID:36907384
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of REEP1 mRNA	PMID:20003209
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313134	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of REEP1 intron	PMID:30157460
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of REEP1 gene	PMID:35440735
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313135	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of REEP1 mRNA	PMID:22206623
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of REEP1 mRNA	PMID:22206623
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:75170	zaragozic acid A	affects expression	ISO	RGD:1313135	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 affects the expression of REEP1 mRNA	PMID:27225895
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of REEP1 mRNA	PMID:27225895
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313134	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of REEP1 mRNA	PMID:22714537
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1313135	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of REEP1 mRNA	PMID:27858113
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of REEP1 mRNA	PMID:36139627
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:77012	methylseleninic acid	increases expression	ISO	RGD:1313134	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of REEP1 mRNA	PMID:18548127
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP1 mRNA	PMID:27188386
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313135	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of REEP1 mRNA	PMID:19482888
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of REEP1 mRNA]	PMID:19482888
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of REEP1 mRNA	PMID:32109520
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313134	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of REEP1 mRNA	PMID:32234424
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313134	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of REEP1 mRNA	PMID:26079696
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of REEP1 mRNA	PMID:30047161
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of REEP1 mRNA	PMID:36843608
1305230	Reep1	receptor accessory protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313134	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP1 mRNA	PMID:27188386
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313136	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of USP42 mRNA	PMID:20655997
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313136	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of USP42 mRNA	PMID:21179406
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1623119	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of USP42 mRNA	PMID:23892564
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313136	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of USP42 protein	PMID:37730182
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313136	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of USP42 mRNA	PMID:28818685
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of USP42 mRNA	PMID:36331819
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313136	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of USP42 mRNA	PMID:19549813
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP42 mRNA	PMID:40504410
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313136	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of USP42 protein	PMID:35688186
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313136	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of USP42 mRNA	PMID:27594783
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1623119	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of USP42 mRNA	PMID:30912803
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of USP42 mRNA	PMID:34747641
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1623119	E	RGD:6480464	20150127	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of USP42 mRNA	PMID:25270620
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP42 mRNA	PMID:17942748
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313136	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of USP42 mRNA	PMID:33212167
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of USP42 mRNA	PMID:28959563
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313136	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of USP42 mRNA	PMID:29803840
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313136	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of USP42 protein	PMID:35688186
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of USP42 mRNA	PMID:21297353
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP42 mRNA	PMID:40504410
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313136	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of USP42 3' UTR	PMID:27901495
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313136	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of USP42 promoter	PMID:27901495
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313136	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to USP42 mRNA]	PMID:32406909
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1623119	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of USP42 mRNA	PMID:20542052
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623119	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USP42 promoter	PMID:35295148
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of USP42 mRNA	PMID:34492290
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1623119	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of USP42 mRNA	PMID:21318169
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of USP42 mRNA]	PMID:21318169
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of USP42 mRNA	PMID:25181051
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of USP42 mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:41034487
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313136	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA	PMID:28628672
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1623119	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of USP42 intron	PMID:28392331
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623119	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of USP42 mRNA	PMID:37019170
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313136	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA	PMID:28628672
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313136	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of USP42 mRNA	PMID:37042841
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of USP42 mRNA	PMID:36331819
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313136	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of USP42 mRNA	PMID:25979313
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313136	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of USP42 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313136	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of USP42 gene	PMID:29154799
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313136	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA	PMID:27188386
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of USP42 mRNA	PMID:38685447|PMID:41580965
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313136	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of USP42 mRNA	PMID:20106945|PMID:25562108
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313136	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA	PMID:28628672
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313136	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of USP42 mRNA	PMID:26272509
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313136	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA	PMID:27188386
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623119	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of USP42 mRNA	PMID:17562736
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313136	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of USP42 mRNA	PMID:21420995
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP42 mRNA	PMID:40504410
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP42 mRNA	PMID:17942748
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1313136	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of USP42 mRNA	PMID:23228038
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313136	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA	PMID:28628672
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of USP42 mRNA	PMID:41580965
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313136	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of USP42 mRNA	PMID:31758290
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1623119	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of USP42 mRNA	PMID:22206623
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of USP42 mRNA	PMID:33484710
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313136	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA	PMID:27188386
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of USP42 mRNA	PMID:36084822
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313136	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA	PMID:27188386
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of USP42 mRNA	PMID:21346803
1305231	Usp42	ubiquitin specific peptidase 42	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313136	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of USP42 mRNA	PMID:38568856
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313138	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SLC5A10 mRNA	PMID:33167477
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313139	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC5A10 mRNA	PMID:39241906
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC5A10 mRNA]	PMID:39241906
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC5A10 mRNA	PMID:33387578
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313138	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SLC5A10 mRNA	PMID:26079696
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA	PMID:37567420
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313138	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SLC5A10 mRNA	PMID:36314267
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA	PMID:37567420
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313138	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SLC5A10 gene	PMID:27153756
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313138	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SLC5A10 mRNA	PMID:18593933
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313138	E	RGD:6480464	20220510	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of SLC5A10 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC5A10 mRNA	PMID:23557933|PMID:41028656
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SLC5A10 mRNA	PMID:26033743
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313138	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SLC5A10 mRNA	PMID:41028656
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA	PMID:37567420
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313138	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC5A10 mRNA	PMID:34032870
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313138	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC5A10 mRNA	PMID:38568856
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313138	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC5A10 intron	PMID:30157460
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313139	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC5A10 intron	PMID:27901495
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SLC5A10 mRNA	PMID:26033743
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313138	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SLC5A10 mRNA	PMID:41028656
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313138	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SLC5A10 mRNA	PMID:18593933
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SLC5A10 mRNA	PMID:38458666
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313138	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SLC5A10 mRNA	PMID:25895662
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313138	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of SLC5A10 gene	PMID:31601247
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313139	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SLC5A10 mRNA	PMID:29264374
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC5A10 mRNA	PMID:25181051
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313138	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of SLC5A10 gene	PMID:31601247
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313138	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SLC5A10 intron	PMID:30157460
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC5A10 mRNA]	PMID:39241906
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SLC5A10 mRNA	PMID:38458666
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SLC5A10 mRNA	PMID:33453195
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313138	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC5A10 mRNA	PMID:38568856
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313139	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC5A10 mRNA	PMID:40194260
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313138	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC5A10 gene	PMID:29154799
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA	PMID:37567420
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313139	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC5A10 mRNA	PMID:17562736
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SLC5A10 mRNA	PMID:29391264
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1313138	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of SLC5A10 mRNA	PMID:40706910
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313139	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of SLC5A10 mRNA	PMID:36851058
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313138	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SLC5A10 intron	PMID:30157460
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313139	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC5A10 mRNA	PMID:22206623
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA	PMID:37567420
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of SLC5A10 mRNA	PMID:30449730
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313138	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC5A10 gene]	PMID:28238834
1305232	Slc5a10	solute carrier family 5 member 10	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC5A10 mRNA]	PMID:39241906
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HAVCR2 mRNA	PMID:20938992
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313140	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of HAVCR2 mRNA	PMID:33167477
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HAVCR2 mRNA	PMID:33729688
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HAVCR2 mRNA	PMID:36331819
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20130122	CTD	MESH:D002392	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of HAVCR2 mRNA	PMID:16806235
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313141	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of HAVCR2 mRNA	PMID:30319688
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313141	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of HAVCR2 mRNA	PMID:30319688
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of HAVCR2 mRNA	PMID:30517762
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313140	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HAVCR2 mRNA	PMID:35811015
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HAVCR2 mRNA	PMID:39241906
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313140	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HAVCR2 mRNA	PMID:35811015
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of HAVCR2 mRNA]	PMID:39241906
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20140805	CTD	MESH:C040048	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of HAVCR2 mRNA	PMID:16806235
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313140	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] promotes the reaction [NCOA2 protein binds to HAVCR2 promoter]; Estradiol promotes the reaction [ESR2 protein affects the expression of HAVCR2 mRNA]	PMID:20404318
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HAVCR2 mRNA	PMID:20938992
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313140	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HAVCR2 mRNA	PMID:37042841
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HAVCR2 mRNA	PMID:37992649
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20130122	CTD	MESH:C040048	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of HAVCR2 mRNA	PMID:16806235
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:17558	quercitrin	increases expression	ISO	RGD:1313140	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of HAVCR2 mRNA	PMID:25193878
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HAVCR2 mRNA	PMID:37992649
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313140	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of HAVCR2 mRNA	PMID:26485663
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HAVCR2 mRNA	PMID:36331819
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313140	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HAVCR2 intron	PMID:30157460
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of HAVCR2 mRNA	PMID:41580963
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of HAVCR2 mRNA	PMID:34911549
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of HAVCR2 mRNA	PMID:30779732
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of HAVCR2 mRNA	PMID:30517762
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HAVCR2 mRNA	PMID:20938992
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1313140	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of HAVCR2 gene	PMID:35377194
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20130122	CTD	MESH:C059514	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of HAVCR2 mRNA	PMID:16806235
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313140	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of HAVCR2 mRNA	PMID:23195993
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HAVCR2 mRNA	PMID:34747641
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HAVCR2 mRNA	PMID:32109520
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313140	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HAVCR2 mRNA	PMID:33212167
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of HAVCR2 mRNA	PMID:26033743
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HAVCR2 mRNA	PMID:37992649
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313141	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of HAVCR2 mRNA	PMID:37682722
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313140	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HAVCR2 mRNA	PMID:38568856
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313140	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HAVCR2 mRNA	PMID:20064835
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313140	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HAVCR2 promoter	PMID:27901495
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313141	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HAVCR2 mRNA	PMID:22228805
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of HAVCR2 mRNA]	PMID:22228805
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of HAVCR2 mRNA	PMID:26033743
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313140	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of HAVCR2 mRNA	PMID:23806026
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313140	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of HAVCR2 mRNA	PMID:25895662
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313140	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HAVCR2 mRNA	PMID:20458559
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313141	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of HAVCR2 mRNA	PMID:17656681
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313141	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HAVCR2 mRNA	PMID:29264374
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313141	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of HAVCR2 mRNA	PMID:23557971
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HAVCR2 mRNA	PMID:34492290
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	ISO	RGD:1313140	E	RGD:6480464	20250708	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of HAVCR2 gene	PMID:38723642
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of HAVCR2 mRNA	PMID:19167457
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of HAVCR2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313140	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of HAVCR2 mRNA	PMID:27685785
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HAVCR2 gene	PMID:28505145
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of HAVCR2 mRNA	PMID:32119087
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313140	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of HAVCR2 mRNA	PMID:22905168
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of HAVCR2 mRNA]	PMID:39241906
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313140	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HAVCR2 mRNA	PMID:37042841
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313140	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of HAVCR2 mRNA	PMID:29024780
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of HAVCR2 promoter	PMID:22457795
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313140	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of HAVCR2 mRNA	PMID:24449571
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HAVCR2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HAVCR2 mRNA	PMID:36331819
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HAVCR2 mRNA	PMID:37992649
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313140	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HAVCR2 mRNA	PMID:38832940
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313141	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HAVCR2 mRNA	PMID:17562736
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313140	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HAVCR2 mRNA	PMID:35811015
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313141	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of HAVCR2 mRNA	PMID:35436446
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313140	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of HAVCR2 mRNA	PMID:32234424
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313140	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HAVCR2 mRNA	PMID:20458559
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313141	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of HAVCR2 mRNA; Nanotubes, Carbon results in increased expression of HAVCR2 mRNA	PMID:25554681
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of HAVCR2 mRNA	PMID:24136188
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of HAVCR2 mRNA	PMID:38701926
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HAVCR2 mRNA	PMID:21641980
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313141	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of HAVCR2 mRNA	PMID:36851058
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of HAVCR2 mRNA	PMID:35283115
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	ISO	RGD:1313140	E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of HAVCR2 mRNA	PMID:20843944
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313141	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of HAVCR2 mRNA	PMID:22206623
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313140	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HAVCR2 gene]	PMID:28238834
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313141	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of HAVCR2 mRNA	PMID:38648751
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of HAVCR2 mRNA]	PMID:39241906
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of HAVCR2 mRNA	PMID:21346803
1305233	Havcr2	hepatitis A virus cellular receptor 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313140	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of HAVCR2 mRNA	PMID:22378314
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313142	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of YTHDF3 mRNA	PMID:33167477
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313143	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of YTHDF3 mRNA	PMID:30319688
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313142	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of YTHDF3 mRNA	PMID:37042841
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313142	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of YTHDF3 mRNA	PMID:23649840
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313143	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of YTHDF3 mRNA	PMID:36174712
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313142	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of YTHDF3 protein	PMID:37730182
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of YTHDF3 mRNA	PMID:22061828
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313142	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of YTHDF3 mRNA	PMID:28818685
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313142	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of YTHDF3 mRNA	PMID:24376830
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of YTHDF3 mRNA; [Cadmium co-treated with Dietary Fats] results in increased expression of YTHDF3 mRNA; [Cadmium co-treated with Dietary Fats] results in increased expression of YTHDF3 protein	PMID:36084736|PMID:37236586
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313142	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of YTHDF3 mRNA	PMID:19549813
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313142	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of YTHDF3 intron	PMID:30157460
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1313142	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of YTHDF3 mRNA	PMID:15672453
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313143	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of YTHDF3 mRNA	PMID:25629700
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of YTHDF3 mRNA	PMID:22206623
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1313142	E	RGD:6480464	20230307	CTD	MESH:D001151	Arsenic results in increased expression of YTHDF3	PMID:35363433
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of YTHDF3 mRNA	PMID:40504410
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313142	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of YTHDF3 protein	PMID:38460933
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313143	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of YTHDF3 protein	PMID:36173347
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313142	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of YTHDF3 mRNA	PMID:23557933
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of YTHDF3 mRNA	PMID:32109520
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313143	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of YTHDF3 mRNA	PMID:21570461
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of YTHDF3 mRNA	PMID:33387578
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313142	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of YTHDF3 mRNA	PMID:33212167
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1313142	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of YTHDF3 mRNA	PMID:23649840
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313142	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of YTHDF3 mRNA	PMID:32763439
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313142	E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite results in decreased expression of YTHDF3 mRNA	PMID:37061066
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313142	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of YTHDF3 mRNA	PMID:38568856
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313142	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of and results in increased activity of YTHDF3 protein	PMID:30528433
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of YTHDF3 mRNA	PMID:40504410
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313143	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of YTHDF3 mRNA	PMID:22228805
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313142	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of YTHDF3 mRNA	PMID:19150397|PMID:20018196
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:3090	bicalutamide	increases expression	ISO	RGD:1313142	E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of YTHDF3 mRNA	PMID:16631469
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313143	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of YTHDF3 gene; titanium dioxide results in decreased methylation of YTHDF3 promoter	PMID:35295148
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313143	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of YTHDF3 mRNA	PMID:18445702
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of YTHDF3 mRNA	PMID:25181051
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313142	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of YTHDF3 mRNA; bisphenol A results in decreased expression of YTHDF3 protein	PMID:37567409|PMID:38354435
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of YTHDF3 mRNA	PMID:30816183
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313143	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of YTHDF3 mRNA	PMID:39298647
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of YTHDF3 mRNA	PMID:33453195
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313142	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of YTHDF3 mRNA	PMID:38174414|PMID:38568856
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of YTHDF3 mRNA	PMID:37236586
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1313142	E	RGD:6480464	20210608	CTD	MESH:C056933	fumonisin B1 results in increased expression of YTHDF3 mRNA	PMID:33496827
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313142	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of YTHDF3 gene	PMID:29154799
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313142	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of YTHDF3 mRNA	PMID:27989131
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313142	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of YTHDF3 mRNA	PMID:23649840
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1313142	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of YTHDF3 mRNA	PMID:20977926
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313142	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of YTHDF3 protein	PMID:38460933
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1313142	E	RGD:6480464	20230307	CTD	MESH:D001151	Arsenic results in increased expression of YTHDF3	PMID:35363433
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of YTHDF3 mRNA	PMID:40504410
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1313142	E	RGD:6480464	20240702	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of YTHDF3 mRNA	PMID:38157273
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1313142	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of YTHDF3 mRNA	PMID:16984733
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1313142	E	RGD:6480464	20251007	CTD	MESH:C037123	cadmium sulfate results in increased expression of YTHDF3 mRNA	PMID:35794303
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of YTHDF3 mRNA	PMID:24136188
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of YTHDF3 mRNA	PMID:19162173
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313142	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of YTHDF3 protein	PMID:32959892
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:64310	crizotinib	decreases expression	ISO	RGD:1313142	E	RGD:6480464	20260303	CTD	MESH:C551994	Crizotinib results in decreased expression of YTHDF3 mRNA	PMID:41183147
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:64310	crizotinib	decreases expression	ISO	RGD:1313143	E	RGD:6480464	20260303	CTD	MESH:C551994	Crizotinib results in decreased expression of YTHDF3 mRNA	PMID:41183147
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of YTHDF3 gene	PMID:35440735
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313142	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of YTHDF3 protein	PMID:34186270
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313143	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of YTHDF3 mRNA	PMID:22206623
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of YTHDF3 mRNA	PMID:22206623
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313142	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of YTHDF3 protein	PMID:37664457
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313142	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to YTHDF3 gene]	PMID:28238834
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of YTHDF3 mRNA	PMID:32109520
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:81927	enilconazole	affects expression	ISO	RGD:1313143	E	RGD:6480464	20260804	CTD	MESH:C017435	enilconazole affects the expression of YTHDF3 mRNA	PMID:38232526
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313142	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of YTHDF3 protein	PMID:37664457
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:9130	sevoflurane	increases expression	ISO	RGD:1313143	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased expression of YTHDF3 protein	PMID:35249202
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of YTHDF3 mRNA	PMID:21346803
1305234	Ythdf3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of YTHDF3 mRNA	PMID:24136188
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313144	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DCPH1 mRNA	PMID:38218311
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:C084079	triptonide results in decreased expression of DCPH1 mRNA	PMID:33045310
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DCPH1 mRNA	PMID:30071829
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313144	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DCPH1 mRNA	PMID:33167477
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D000431	Ethanol results in increased expression of DCPH1 mRNA	PMID:30319688
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313144	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DCPH1 mRNA	PMID:20044591
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313144	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DCPH1 mRNA	PMID:21632981
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313144	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DCPH1 mRNA	PMID:37042841
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D005947	Glucose results in increased expression of DCPH1 mRNA	PMID:39922521
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D005947	Glucose results in increased expression of DCPH1 mRNA	PMID:39922521
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCPH1 mRNA	PMID:37236586
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313144	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DCPH1 mRNA	PMID:19549813
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313144	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DCPH1 mRNA	PMID:35430440
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313144	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCPH1 mRNA	PMID:39836092
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313144	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DCPH1 mRNA	PMID:23557933
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313144	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of DCPH1 mRNA	PMID:27594783
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313144	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of DCPH1 mRNA	PMID:23195993
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313144	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DCPH1 protein	PMID:33212167
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313144	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DCPH1 mRNA	PMID:32763439
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313144	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DCPH1 mRNA	PMID:29803840
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D004317	Doxorubicin results in increased expression of DCPH1 mRNA	PMID:39631538
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313144	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCPH1 mRNA	PMID:39836092
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:3048	benzatropine	increases expression	ISO	RGD:1313144	E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of DCPH1 protein	PMID:34122009
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002065	Buspirone results in decreased expression of DCPH1 mRNA	PMID:24136188
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in increased expression of DCPH1 mRNA	PMID:35295148
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in decreased expression of DCPH1 mRNA	PMID:34947998
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313144	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of DCPH1 protein	PMID:34186270
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCPH1 mRNA	PMID:37236586
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1313144	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of DCPH1 protein	PMID:34122009
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313144	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DCPH1 mRNA	PMID:28302478
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313144	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DCPH1 mRNA	PMID:27153767|PMID:40419075
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313144	E	RGD:6480464	20160607	CTD	MESH:D014635	Valproic Acid affects the expression of DCPH1 mRNA	PMID:25979313
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313144	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DCPH1 gene	PMID:29154799
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313144	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DCPH1 mRNA	PMID:19101580|PMID:23179753
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313144	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DCPH1 mRNA	PMID:20106945|PMID:25562108
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D005947	Glucose results in increased expression of DCPH1 mRNA	PMID:39922521
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313144	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCPH1 mRNA	PMID:39836092
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313144	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DCPH1 protein	PMID:32959892
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313144	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DCPH1 protein	PMID:34186270
1305235	Dcph1	damage control phosphatase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C080163	trovafloxacin results in decreased expression of DCPH1 mRNA	PMID:24136188
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1313147	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of PSMD13 protein	PMID:36252740
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313146	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PSMD13 mRNA	PMID:38218311
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313147	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PSMD13 mRNA	PMID:20188158
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of PSMD13 mRNA	PMID:15894607
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313147	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PSMD13 mRNA	PMID:39241906
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313147	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PSMD13 mRNA	PMID:39298647
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313146	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of PSMD13 mRNA	PMID:38685446
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PSMD13 protein	PMID:40089264
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PSMD13 mRNA	PMID:21318169
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313147	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PSMD13 mRNA	PMID:21318169
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PSMD13 mRNA	PMID:22061828
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMD13 mRNA	PMID:36331819
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1313146	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of PSMD13 mRNA	PMID:17103032
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313147	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of PSMD13 mRNA	PMID:27462272
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD13 mRNA	PMID:37236586|PMID:37325564
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313146	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PSMD13 mRNA	PMID:19549813
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PSMD13 protein	PMID:23301498
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313147	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of PSMD13 intron	PMID:27776689
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD13 protein	PMID:38598786
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313147	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PSMD13 mRNA	PMID:31919559
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PSMD13 mRNA	PMID:22206623
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1313146	E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in decreased expression of PSMD13 protein	PMID:25110733
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD13 mRNA	PMID:35809665
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PSMD13 mRNA	PMID:40504410
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1313146	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of PSMD13 mRNA	PMID:28903495
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20181016	CTD	MESH:D002945	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PSMD13 protein	PMID:29733421
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313147	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMD13 mRNA	PMID:21570461
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PSMD13 mRNA	PMID:19465110
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD13 mRNA	PMID:17942748
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PSMD13 mRNA	PMID:28959563
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313147	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PSMD13 protein	PMID:28918527
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313146	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PSMD13 mRNA	PMID:29803840
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313146	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PSMD13 gene	PMID:28589171
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313146	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PSMD13 mRNA	PMID:34032870
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313147	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PSMD13 mRNA	PMID:16014739
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PSMD13 mRNA	PMID:40504410
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to PSMD13 mRNA]	PMID:32406909
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:30145	lithium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of PSMD13 protein	PMID:18296634
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:30146	lithium hydride	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of PSMD13 protein	PMID:18296634
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PSMD13 mRNA	PMID:15894607
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20181016	CTD	MESH:D001761	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PSMD13 protein	PMID:29733421
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of PSMD13 mRNA	PMID:19162173|PMID:21318169
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313147	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PSMD13 mRNA	PMID:21318169|PMID:23811191
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of PSMD13 mRNA]	PMID:21318169
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of PSMD13 mRNA	PMID:22484513
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PSMD13 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PSMD13 gene	PMID:28505145
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313147	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PSMD13 promoter	PMID:27312807
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PSMD13 mRNA	PMID:36041667
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313147	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PSMD13 mRNA	PMID:39298647
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PSMD13 mRNA	PMID:36041667
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313147	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PSMD13 mRNA	PMID:38685157
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PSMD13 mRNA	PMID:36041667
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313146	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PSMD13 protein	PMID:34186270
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313147	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PSMD13 mRNA	PMID:37019170
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313147	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PSMD13 mRNA	PMID:17361019|PMID:21266533
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313147	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PSMD13 mRNA	PMID:34813904
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD13 protein	PMID:38598786
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313147	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of PSMD13 mRNA	PMID:34813904
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313146	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PSMD13 mRNA	PMID:37042841
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35456	cadmium dichloride	affects localization	ISO	RGD:1313146	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the localization of PSMD13 protein	PMID:18261755
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD13 mRNA	PMID:37236586|PMID:37325564
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of PSMD13 mRNA	PMID:19429403
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PSMD13 mRNA	PMID:19162173|PMID:21318169
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PSMD13 mRNA	PMID:19162173
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PSMD13 mRNA	PMID:24386269
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313146	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PSMD13 mRNA	PMID:19320972
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1313146	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of PSMD13 mRNA	PMID:40434365
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of PSMD13 mRNA	PMID:19429403
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313147	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PSMD13 mRNA	PMID:20936131
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20130416	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMD13 mRNA; PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of PSMD13 mRNA]	PMID:20936131|PMID:36331819
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313146	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PSMD13 gene	PMID:29154799
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMD13 mRNA	PMID:21318169
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313146	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMD13 mRNA	PMID:23179753|PMID:29154799
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313146	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PSMD13 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PSMD13 mRNA	PMID:24136188
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1313146	E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in decreased expression of PSMD13 protein	PMID:25110733
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD13 mRNA	PMID:35809665
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PSMD13 mRNA	PMID:40504410
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1313146	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of PSMD13 mRNA	PMID:36621641
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PSMD13 mRNA	PMID:17942748
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD13 mRNA	PMID:17942748
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20181016	CTD	MESH:D005047	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PSMD13 protein	PMID:29733421
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313146	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of PSMD13 mRNA	PMID:17211630
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PSMD13 mRNA	PMID:15894607
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PSMD13 mRNA	PMID:24136188
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PSMD13 mRNA	PMID:35964746
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PSMD13 mRNA	PMID:24136188
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1313146	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of PSMD13 mRNA	PMID:20977926
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313147	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PSMD13 mRNA	PMID:19042947
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313146	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PSMD13 protein	PMID:32959892
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PSMD13 mRNA	PMID:24136188
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:63952	arsenic trichloride	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD13 mRNA	PMID:35809665
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of PSMD13 mRNA	PMID:24136188
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:64317	isoprenaline	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD13 mRNA	PMID:30303030
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313147	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PSMD13 mRNA	PMID:22206623
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PSMD13 mRNA	PMID:22206623
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PSMD13 mRNA	PMID:24136188
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313146	E	RGD:6480464	20210406	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMD13 mRNA	PMID:31806706
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313146	E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PSMD13 mRNA; beta-Naphthoflavone results in increased expression of PSMD13 protein	PMID:19737606|PMID:39638853
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PSMD13 gene]	PMID:28238834
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PSMD13 mRNA	PMID:19162173
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313147	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PSMD13 mRNA	PMID:30294300
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1313147	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of PSMD13 protein	PMID:26903627
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313146	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PSMD13 mRNA	PMID:38568856
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313146	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD13 protein	PMID:38598786
1305236	Psmd13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PSMD13 mRNA	PMID:21346803
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313151	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TRIM32 mRNA	PMID:30319688
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313150	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIM32 mRNA	PMID:37042841
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:16708	adenine	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of TRIM32 mRNA	PMID:24211769
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TRIM32 mRNA	PMID:20655997
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313150	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TRIM32 mRNA	PMID:23649840
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313150	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TRIM32 mRNA	PMID:21179406
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313150	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TRIM32 protein	PMID:37730182
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:17967	urethane	affects expression	ISO	RGD:1313150	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane affects the expression of TRIM32 mRNA	PMID:28818685
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313151	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of TRIM32 mRNA	PMID:37748715
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TRIM32 mRNA	PMID:19549813
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TRIM32 mRNA	PMID:24211769
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313150	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TRIM32 mRNA	PMID:23649840
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313150	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TRIM32 gene	PMID:27153756
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRIM32 mRNA	PMID:19770486
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20140513	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TRIM32 mRNA	PMID:24211769
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313150	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TRIM32 mRNA	PMID:23649840
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TRIM32 mRNA	PMID:30779732
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TRIM32 mRNA	PMID:22206623
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20140513	CTD	MESH:D016685	Mitomycin results in decreased expression of TRIM32 mRNA	PMID:24211769
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313150	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRIM32 mRNA	PMID:40512198
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313150	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TRIM32 protein	PMID:35688186
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:27882	(S)-colchicine	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of TRIM32 mRNA	PMID:24211769
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin results in decreased expression of TRIM32 mRNA	PMID:24211769
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313150	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TRIM32 mRNA	PMID:27392435
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM32 mRNA	PMID:21570461
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRIM32 mRNA	PMID:33387578
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM32 mRNA	PMID:21215274
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM32 mRNA	PMID:17942748
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313151	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of TRIM32 mRNA	PMID:23186747
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TRIM32 mRNA	PMID:33212167
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TRIM32 mRNA	PMID:30851411
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRIM32 mRNA	PMID:38568856
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313150	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRIM32 mRNA	PMID:40512198
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313150	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of TRIM32 promoter	PMID:23974009
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313151	E	RGD:6480464	20250603	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TRIM32 mRNA; Silicon Dioxide results in decreased expression of TRIM32 protein	PMID:39742911
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20250603	CTD	MESH:D012822	MIR6236 promotes the reaction [Silicon Dioxide results in decreased expression of TRIM32 mRNA]; MIR6236 promotes the reaction [Silicon Dioxide results in decreased expression of TRIM32 protein]; TRIM32 protein inhibits the reaction [Silicon Dioxide results in increased cleavage of CASP3 protein]; TRIM32 protein inhibits the reaction [Silicon Dioxide results in increased cleavage of CASP9 protein]	PMID:39742911
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRIM32 gene; titanium dioxide results in decreased methylation of TRIM32 promoter	PMID:35295148
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TRIM32 mRNA	PMID:23411599|PMID:34492290
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TRIM32 mRNA	PMID:19162173
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRIM32 mRNA	PMID:25181051
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313151	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM32 mRNA	PMID:26063408
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TRIM32 mRNA	PMID:30816183|PMID:32528016
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313151	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TRIM32 mRNA	PMID:38685157
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313150	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRIM32 mRNA	PMID:28628672
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TRIM32 mRNA	PMID:17602206
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313150	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRIM32 mRNA	PMID:28628672
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TRIM32 mRNA	PMID:17602206
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of TRIM32 mRNA	PMID:36117858
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313150	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRIM32 mRNA	PMID:37042841
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRIM32 mRNA	PMID:38568856
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313150	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TRIM32 mRNA	PMID:24449571
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TRIM32 mRNA	PMID:32588087
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRIM32 mRNA	PMID:24383497|PMID:24935251
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313150	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRIM32 gene	PMID:29154799
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in increased expression of TRIM32 mRNA	PMID:27281708
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313150	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRIM32 mRNA	PMID:28628672
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:44423	hydroxyurea	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20140513	CTD	MESH:D006918	Hydroxyurea results in decreased expression of TRIM32 mRNA	PMID:24211769
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313150	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TRIM32 mRNA	PMID:22230336
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313150	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRIM32 mRNA	PMID:40512198
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313151	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TRIM32 mRNA	PMID:35436446
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TRIM32 mRNA	PMID:17942748
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM32 mRNA	PMID:17942748
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313150	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRIM32 mRNA	PMID:28628672
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of TRIM32 mRNA	PMID:23962444
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of TRIM32 mRNA	PMID:24793618
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TRIM32 mRNA	PMID:24136188
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of TRIM32 mRNA	PMID:36117858
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of TRIM32 mRNA	PMID:16780908
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TRIM32 protein	PMID:32959892
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TRIM32 mRNA	PMID:28988120
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TRIM32 mRNA	PMID:22206623
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TRIM32 mRNA	PMID:30851411
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital results in increased expression of TRIM32 mRNA	PMID:19270015
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TRIM32 mRNA	PMID:19281266
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRIM32 mRNA	PMID:21346803
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313150	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TRIM32 mRNA	PMID:38568856
1305238	Trim32	tripartite motif-containing 32	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TRIM32 mRNA	PMID:23034163
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1332515	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ZFP804A mRNA	PMID:37995155
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ZFP804A mRNA	PMID:33387578
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1349576	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZNF804A mRNA	PMID:23649840
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ZFP804A mRNA	PMID:26577399
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1349576	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ZNF804A mRNA	PMID:23649840
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1349576	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZNF804A gene	PMID:27153756
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1349576	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZNF804A intron	PMID:30157460
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1349576	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ZNF804A mRNA	PMID:23649840
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010126	Ozone results in decreased expression of ZFP804A mRNA	PMID:31397875
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1349576	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ZNF804A mRNA	PMID:41430723
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332515	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZFP804A mRNA	PMID:25629700
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332515	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP804A mRNA	PMID:21570461
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP804A mRNA	PMID:32109520
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1349576	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZNF804A mRNA	PMID:33212167
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1349576	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZNF804A mRNA	PMID:32763439
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349576	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF804A mRNA	PMID:22714537|PMID:38568856
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349576	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF804A promoter	PMID:27901495
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1332515	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZFP804A exon	PMID:27901495
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1332515	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ZFP804A mRNA	PMID:27131904
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1349576	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ZNF804A mRNA	PMID:25895662
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1349576	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF804A mRNA	PMID:20018196
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1349576	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ZNF804A mRNA	PMID:35984750
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332515	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP804A promoter	PMID:35295148
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1349576	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ZNF804A mRNA	PMID:30690063
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1349576	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ZNF804A mRNA	PMID:38479592
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1332515	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP804A mRNA	PMID:37019170
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349576	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNF804A mRNA	PMID:38568856
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349576	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF804A mRNA	PMID:25979313
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349576	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ZNF804A mRNA	PMID:23179753|PMID:26272509|PMID:27188386
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1349576	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF804A mRNA	PMID:27188386
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1349576	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF804A mRNA	PMID:20106945
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1349576	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ZNF804A mRNA	PMID:24935251
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFP804A mRNA	PMID:33387578
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1349576	E	RGD:6480464	20121009	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of ZNF804A mRNA	PMID:22079256
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1349576	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ZNF804A mRNA	PMID:22079256
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1349576	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of ZNF804A mRNA	PMID:31629900
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1349576	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF804A mRNA	PMID:26378955
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1349576	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ZNF804A mRNA	PMID:24810058
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ZFP804A gene	PMID:35440735
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1349576	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ZNF804A mRNA	PMID:22079256
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1349576	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ZNF804A mRNA	PMID:22714537
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1349576	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ZNF804A mRNA	PMID:22079256
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1349576	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF804A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF804A mRNA	PMID:27188386
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ZFP804A mRNA	PMID:32109520
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1349576	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF804A mRNA	PMID:27188386
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349576	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF804A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF804A mRNA	PMID:27188386
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1332515	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ZFP804A mRNA	PMID:27131904
1305239	Zfp804a	zinc finger protein 804A	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1349576	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF804A mRNA	PMID:38568856
1305240	Nomo1	nodal modulator 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1354081	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NOMO3 mRNA	PMID:38218311
1305240	Nomo1	nodal modulator 1	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:C049935	avobenzone results in increased expression of NOMO3 mRNA	PMID:31016361
1305240	Nomo1	nodal modulator 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D000431	Ethanol affects the expression of NOMO1 mRNA	PMID:30319688
1305240	Nomo1	nodal modulator 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of NOMO1 mRNA	PMID:30319688
1305240	Nomo1	nodal modulator 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553308	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NOMO1 mRNA	PMID:39241906
1305240	Nomo1	nodal modulator 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:D004958	Estradiol results in increased expression of NOMO3 mRNA	PMID:31614463
1305240	Nomo1	nodal modulator 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D004958	Estradiol results in increased expression of NOMO1 mRNA	PMID:39298647
1305240	Nomo1	nodal modulator 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1354081	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of NOMO3 mRNA	PMID:38568856
1305240	Nomo1	nodal modulator 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:D013739	Testosterone results in increased expression of NOMO3 mRNA	PMID:33359661
1305240	Nomo1	nodal modulator 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NOMO3 mRNA	PMID:28412506
1305240	Nomo1	nodal modulator 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NOMO1 mRNA	PMID:19770486
1305240	Nomo1	nodal modulator 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOMO1 mRNA	PMID:31919559
1305240	Nomo1	nodal modulator 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NOMO1 mRNA	PMID:22206623
1305240	Nomo1	nodal modulator 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:D012643	Selenium results in increased expression of NOMO3 mRNA	PMID:19244175
1305240	Nomo1	nodal modulator 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:D002110	Caffeine results in increased phosphorylation of NOMO3 protein	PMID:35688186
1305240	Nomo1	nodal modulator 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:D002945	Cisplatin results in decreased expression of NOMO3 mRNA	PMID:27594783
1305240	Nomo1	nodal modulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NOMO1 mRNA	PMID:21570461|PMID:26377647
1305240	Nomo1	nodal modulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NOMO1 mRNA	PMID:15328365|PMID:18796159|PMID:19933214|PMID:23994337
1305240	Nomo1	nodal modulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOMO1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NOMO1 mRNA	PMID:17942748|PMID:25975270
1305240	Nomo1	nodal modulator 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of NOMO1 protein	PMID:28918527
1305240	Nomo1	nodal modulator 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NOMO1 mRNA	PMID:34876320
1305240	Nomo1	nodal modulator 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NOMO1 mRNA	PMID:34876320
1305240	Nomo1	nodal modulator 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NOMO1 gene	PMID:35295148
1305240	Nomo1	nodal modulator 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:C074702	chromium hexavalent ion affects the expression of NOMO1 mRNA	PMID:28472532
1305240	Nomo1	nodal modulator 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:C006780	bisphenol A results in increased expression of NOMO3 protein	PMID:34186270
1305240	Nomo1	nodal modulator 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NOMO1 mRNA	PMID:23994337
1305240	Nomo1	nodal modulator 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:C543008	bisphenol S results in increased expression of NOMO3 protein	PMID:34186270
1305240	Nomo1	nodal modulator 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:C008745	bisphenol F results in increased expression of NOMO1 mRNA	PMID:38685157
1305240	Nomo1	nodal modulator 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1553308	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of NOMO1 mRNA	PMID:28392331
1305240	Nomo1	nodal modulator 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1553308	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NOMO1 intron	PMID:28392331
1305240	Nomo1	nodal modulator 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:D012643	Selenium results in increased expression of NOMO3 mRNA	PMID:19244175
1305240	Nomo1	nodal modulator 1	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:D003024	Clozapine results in increased expression of NOMO3 protein	PMID:34122009
1305240	Nomo1	nodal modulator 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D013629	Tamoxifen affects the expression of NOMO1 mRNA	PMID:17555576|PMID:20937368
1305240	Nomo1	nodal modulator 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D000082	Acetaminophen affects the expression of NOMO1 mRNA	PMID:17562736
1305240	Nomo1	nodal modulator 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NOMO1 mRNA	PMID:34876320
1305240	Nomo1	nodal modulator 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NOMO1 mRNA	PMID:17555576
1305240	Nomo1	nodal modulator 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NOMO1 mRNA	PMID:17942748
1305240	Nomo1	nodal modulator 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOMO1 mRNA	PMID:17942748
1305240	Nomo1	nodal modulator 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NOMO1 mRNA	PMID:35964746
1305240	Nomo1	nodal modulator 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1354081	E	RGD:6480464	20231031	CTD	MESH:D007559	Ivermectin results in decreased expression of NOMO3 protein	PMID:32959892
1305240	Nomo1	nodal modulator 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NOMO1 mRNA	PMID:22206623
1305240	Nomo1	nodal modulator 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of NOMO1 mRNA	PMID:23994337
1305240	Nomo1	nodal modulator 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:D010634	Phenobarbital affects the expression of NOMO1 mRNA	PMID:23091169
1305240	Nomo1	nodal modulator 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1553308	E	RGD:6480464	20250401	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NOMO1 mRNA	PMID:34876320
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313154	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SLC39A1 mRNA	PMID:38218311
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of SLC39A1 mRNA	PMID:21551480
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1557571	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC39A1 mRNA	PMID:26251327
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:144804	nickel subsulfide	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in increased expression of SLC39A1 mRNA	PMID:21086188
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313154	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SLC39A1 mRNA	PMID:33167477
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of SLC39A1 mRNA	PMID:17347304
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557571	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLC39A1 mRNA	PMID:39241906
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1557571	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC39A1 mRNA	PMID:39298647
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1557571	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SLC39A1 mRNA	PMID:34319233
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557571	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SLC39A1 mRNA	PMID:33754040
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20130212	CTD	MESH:D002117	Calcitriol results in decreased expression of SLC39A1 mRNA	PMID:20089671
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1557571	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SLC39A1 mRNA	PMID:27462272
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of SLC39A1 mRNA	PMID:24284285
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313154	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SLC39A1 protein	PMID:20106945
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313154	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC39A1 mRNA	PMID:22100608
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	affects expression	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of SLC39A1 mRNA	PMID:17085522
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	affects metabolic processing	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A1 protein affects the metabolism of Zinc	PMID:16652366
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of SLC39A1 mRNA	PMID:15226459
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	increases transport	ISO	RGD:1313154	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A1 protein results in increased transport of Zinc	PMID:18326752
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	increases uptake	ISO	RGD:1313154	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A1 protein results in increased uptake of Zinc	PMID:11301334|PMID:12888280
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	increases uptake	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:D015032	SLC39A1 protein results in increased uptake of Zinc	PMID:14525987|PMID:15322118|PMID:25089007
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313154	E	RGD:6480464	20120613	CTD	MESH:D015032	Zinc deficiency promotes the reaction [ochratoxin A results in decreased expression of SLC39A1 mRNA]	PMID:19720134
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:D015032	Cadmium Chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; cobaltous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; ferrous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; nickel chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1557571	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC39A1 mRNA	PMID:31919559
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1313154	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of SLC39A1 mRNA	PMID:19244175
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27584	aldosterone	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D000450	Aldosterone results in increased expression of SLC39A1 mRNA	PMID:19333130
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27584	aldosterone	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:D000450	Spironolactone inhibits the reaction [Aldosterone results in increased expression of SLC39A1 mRNA]	PMID:19333130
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27698	vanadium atom	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of SLC39A1 mRNA	PMID:19000753
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313154	E	RGD:6480464	20200331	CTD	MESH:D002945	[Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of SLC39A1 mRNA	PMID:30871063
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557571	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC39A1 mRNA	PMID:21570461
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC39A1 mRNA	PMID:16054898|PMID:34747641
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC39A1 mRNA	PMID:23152189
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313154	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC39A1 mRNA	PMID:33212167
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313154	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC39A1 mRNA	PMID:20106945|PMID:32234424
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313154	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC39A1 5' UTR	PMID:27901495
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	affects expression	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of SLC39A1 mRNA	PMID:17085522
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	affects metabolic processing	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A1 protein affects the metabolism of Zinc	PMID:16652366
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of SLC39A1 mRNA	PMID:15226459
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	increases transport	ISO	RGD:1313154	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A1 protein results in increased transport of Zinc	PMID:18326752
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	increases uptake	ISO	RGD:1313154	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A1 protein results in increased uptake of Zinc	PMID:11301334|PMID:12888280
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	increases uptake	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:D015032	SLC39A1 protein results in increased uptake of Zinc	PMID:14525987|PMID:15322118|PMID:25089007
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313154	E	RGD:6480464	20120613	CTD	MESH:D015032	Zinc deficiency promotes the reaction [ochratoxin A results in decreased expression of SLC39A1 mRNA]	PMID:19720134
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:D015032	Cadmium Chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; cobaltous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; ferrous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; nickel chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:30812	iron dichloride	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:C029451	ferrous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SLC39A1 mRNA	PMID:25729387
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557571	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC39A1 gene	PMID:35295148
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1557571	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of SLC39A1 mRNA	PMID:27760801
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SLC39A1 mRNA	PMID:18648102
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SLC39A1 mRNA	PMID:19167457
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SLC39A1 mRNA	PMID:25181051
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC39A1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC39A1 gene	PMID:28505145
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SLC39A1 mRNA	PMID:36041667
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313154	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SLC39A1 mRNA	PMID:19244175
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1313154	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of SLC39A1 mRNA	PMID:19244175
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SLC39A1 mRNA	PMID:36041667
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SLC39A1 mRNA	PMID:36041667
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1557571	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC39A1 mRNA	PMID:37019170
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:C022838	nickel chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:35170	vanadium(0)	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of SLC39A1 mRNA	PMID:19000753
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:35176	zinc sulfate	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of SLC39A1 mRNA; Zinc Sulfate results in decreased expression of SLC39A1 protein	PMID:15226459|PMID:25162517
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:35176	zinc sulfate	increases expression	ISO	RGD:1313154	E	RGD:6480464	20150127	CTD	MESH:D019287	Zinc Sulfate results in increased expression of SLC39A1 mRNA	PMID:25162517
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313154	E	RGD:6480464	20170516	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC39A1 mRNA	PMID:27647474
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:D019256	Cadmium Chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SLC39A1 mRNA	PMID:19376846
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:C018021	cobaltous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1313154	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of SLC39A1 mRNA	PMID:19244175
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SLC39A1 mRNA	PMID:38685447|PMID:41580965
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:41879	dexamethasone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone affects the expression of SLC39A1 mRNA	PMID:15102944
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC39A1 mRNA	PMID:17562736
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1313154	E	RGD:6480464	20120717	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of SLC39A1 mRNA	PMID:20471814
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1557571	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC39A1 mRNA	PMID:35436446
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:49976	zinc dichloride	multiple interactions	ISO	RGD:1313154	E	RGD:6480464	20120717	CTD	MESH:C016837	zinc chloride inhibits the reaction [Grape Seed Proanthocyanidins results in increased expression of SLC39A1 mRNA]	PMID:20471814
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557571	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLC39A1 mRNA; Nanotubes, Carbon results in increased expression of SLC39A1 mRNA	PMID:25554681|PMID:25620056
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of SLC39A1 mRNA	PMID:38685447|PMID:41580965
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SLC39A1 mRNA	PMID:35964746
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1557571	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SLC39A1 mRNA	PMID:38701926
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SLC39A1 mRNA	PMID:25729387
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:72544	flavonoids	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in decreased expression of SLC39A1 mRNA	PMID:18035473
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of SLC39A1 mRNA	PMID:19720134
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1313154	E	RGD:6480464	20120613	CTD	MESH:C025589	Zinc deficiency promotes the reaction [ochratoxin A results in decreased expression of SLC39A1 mRNA]	PMID:19720134
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1313154	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of SLC39A1 mRNA	PMID:34995734
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:80799	Bufotalin	increases expression	ISO	RGD:1313154	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of SLC39A1 mRNA	PMID:39904859
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1557571	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SLC39A1 mRNA	PMID:31388691
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	ISO	RGD:1313154	E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A1 mRNA	PMID:17622302
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SLC39A1 mRNA	PMID:19281266
1305241	Slc39a1	solute carrier family 39 member 1	gene	CHEBI:9241	spironolactone	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:D013148	Spironolactone inhibits the reaction [Aldosterone results in increased expression of SLC39A1 mRNA]	PMID:19333130
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313156	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZKSCAN7 mRNA	PMID:33045310
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	ISO	RGD:1313155	E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ZKSCAN7 mRNA	PMID:19074003
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313156	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ZKSCAN7 mRNA	PMID:36331819
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313156	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZKSCAN7 mRNA	PMID:39241906
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313155	E	RGD:6480464	20120522	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZKSCAN7 mRNA	PMID:20655997
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313156	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ZKSCAN7 mRNA	PMID:34319233
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313155	E	RGD:6480464	20120522	CTD	MESH:D002117	Calcitriol results in increased expression of ZKSCAN7 mRNA	PMID:16002434
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313155	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZKSCAN7 mRNA	PMID:28818685
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1313155	E	RGD:6480464	20120522	CTD	MESH:D001104	Arbutin results in decreased expression of ZKSCAN7 mRNA	PMID:17103032
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313155	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZKSCAN7 mRNA	PMID:19549813
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313155	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZKSCAN7 gene	PMID:27153756
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of ZKSCAN7 mRNA	PMID:31129395
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313155	E	RGD:6480464	20161115	CTD	MESH:D001151	Arsenic affects the methylation of ZKSCAN7 gene	PMID:25304211
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313155	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of ZKSCAN7 protein	PMID:35688186
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZKSCAN7 mRNA	PMID:33387578
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313156	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZKSCAN7 intron	PMID:27901495
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313155	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZKSCAN7 5' UTR; Benzo(a)pyrene results in increased methylation of ZKSCAN7 exon	PMID:27901495
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313155	E	RGD:6480464	20141111	CTD	MESH:C015001	arsenite results in increased methylation of ZKSCAN7 promoter	PMID:23974009
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:3048	benzatropine	decreases expression	ISO	RGD:1313155	E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in decreased expression of ZKSCAN7 protein	PMID:34122009
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313155	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ZKSCAN7 mRNA	PMID:25351596
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313156	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZKSCAN7 enhancer; titanium dioxide results in decreased methylation of ZKSCAN7 promoter	PMID:35295148
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZKSCAN7 mRNA	PMID:34492290
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:32588	potassium chloride	multiple interactions	ISO	RGD:1313155	E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZKSCAN7 mRNA	PMID:29691375
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C006780	bisphenol A results in decreased expression of ZKSCAN7 mRNA	PMID:25181051
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313156	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ZKSCAN7 mRNA	PMID:32156529
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313155	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZKSCAN7 gene	PMID:31601247
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of ZKSCAN7 mRNA	PMID:31129395
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313156	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ZKSCAN7 mRNA	PMID:39298647
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313155	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZKSCAN7 mRNA	PMID:37042841
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313156	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ZKSCAN7 mRNA	PMID:28903501
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313155	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ZKSCAN7 mRNA	PMID:31533062
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1313155	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of ZKSCAN7 mRNA	PMID:31626844
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313156	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ZKSCAN7 mRNA	PMID:36331819
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313155	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZKSCAN7 gene	PMID:29154799
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZKSCAN7 mRNA	PMID:33387578
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313155	E	RGD:6480464	20161115	CTD	MESH:D001151	Arsenic affects the methylation of ZKSCAN7 gene	PMID:25304211
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313156	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ZKSCAN7 mRNA	PMID:35436446
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:6443	levonorgestrel	multiple interactions	ISO	RGD:1313155	E	RGD:6480464	20120522	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ZKSCAN7 mRNA	PMID:19074003
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1313155	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of ZKSCAN7 protein	PMID:34122009
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313155	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ZKSCAN7 mRNA	PMID:37199045
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1313155	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of ZKSCAN7 mRNA	PMID:19946333
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1313155	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of ZKSCAN7 mRNA]	PMID:19946333
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313155	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZKSCAN7 gene]	PMID:28238834
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ZKSCAN7 mRNA	PMID:27291303
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ZKSCAN7 mRNA	PMID:23640034
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313155	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZKSCAN7 mRNA	PMID:29301935
1305242	Zkscan7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313156	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ZKSCAN7 mRNA	PMID:28973697
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1618142	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of RFWD3 mRNA	PMID:37995155
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RFWD3 mRNA	PMID:33167477
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of RFWD3 mRNA	PMID:26516004
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of RFWD3 mRNA	PMID:22378314
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1618142	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RFWD3 mRNA	PMID:30319688
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1349611	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RFWD3 mRNA	PMID:21632981
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1618142	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RFWD3 mRNA	PMID:39241906
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1618142	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RFWD3 mRNA	PMID:25510870
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1349611	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RFWD3 mRNA	PMID:38568856
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349611	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RFWD3 mRNA	PMID:37042841
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	ISO	RGD:1349611	E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of RFWD3 mRNA	PMID:38160208
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of RFWD3 mRNA	PMID:38685446
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RFWD3 mRNA	PMID:21592394
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1349611	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of RFWD3 mRNA	PMID:21592394
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1618142	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RFWD3 mRNA	PMID:23892564
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of RFWD3 mRNA	PMID:21592394
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1349611	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of RFWD3 mRNA	PMID:21592394
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618142	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RFWD3 mRNA	PMID:37236586
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1618142	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RFWD3 mRNA	PMID:25510870
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1618142	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RFWD3 mRNA	PMID:25510870
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1349611	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RFWD3 intron	PMID:30157460
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1349611	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RFWD3 mRNA	PMID:22100608
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1349611	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RFWD3 mRNA	PMID:23649840
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1349611	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RFWD3 mRNA	PMID:18593933
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1618142	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RFWD3 mRNA	PMID:31919559
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1618142	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RFWD3 mRNA	PMID:22206623
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1349611	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RFWD3 protein	PMID:35688186
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1349611	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RFWD3 mRNA	PMID:23557933
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1349611	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RFWD3 mRNA	PMID:28903495
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618142	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RFWD3 mRNA	PMID:21570461
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1618142	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RFWD3 mRNA	PMID:31961203
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1618142	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RFWD3 promoter]	PMID:19654925
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RFWD3 mRNA	PMID:30851411
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RFWD3 mRNA	PMID:29803840
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349611	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of RFWD3 mRNA	PMID:28595984|PMID:34032870
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1618142	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of RFWD3 mRNA	PMID:36209798
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1349611	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RFWD3 mRNA	PMID:32234424
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1618142	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RFWD3 mRNA	PMID:22228805
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1349611	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RFWD3 mRNA]	PMID:32406909
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1349611	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RFWD3 mRNA	PMID:18593933
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RFWD3 mRNA	PMID:20382639
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1349611	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of RFWD3 gene	PMID:31601247
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1349611	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of RFWD3 gene	PMID:31601247
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RFWD3 mRNA	PMID:25729387
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RFWD3 mRNA	PMID:23411599
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1618142	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RFWD3 mRNA	PMID:18648102
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RFWD3 mRNA	PMID:25181051
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RFWD3 mRNA	PMID:29275510
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1618142	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of RFWD3 mRNA	PMID:40036665
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1618142	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RFWD3 mRNA	PMID:25510870
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1618142	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RFWD3 mRNA	PMID:25510870
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1349611	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RFWD3 intron	PMID:30157460
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:34575	bisphenol F	decreases methylation	ISO	RGD:1349611	E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in decreased methylation of RFWD3 gene	PMID:31601247
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1618142	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RFWD3 mRNA	PMID:38685157
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1349611	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of RFWD3 gene	PMID:31601247
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1618142	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RFWD3 mRNA	PMID:37019170
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RFWD3 mRNA	PMID:38568856
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618142	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RFWD3 mRNA	PMID:37236586
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RFWD3 mRNA	PMID:24386269
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RFWD3 mRNA	PMID:24449571
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RFWD3 mRNA	PMID:31533062
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of RFWD3 mRNA	PMID:22110744
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RFWD3 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of RFWD3 mRNA	PMID:24449571
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1349611	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RFWD3 mRNA	PMID:38832940
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1349611	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RFWD3 mRNA	PMID:22230336
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1618142	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RFWD3 mRNA	PMID:19042947
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of RFWD3 mRNA	PMID:25729387
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RFWD3 mRNA	PMID:25729387
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1349611	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RFWD3 intron	PMID:30157460
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1618142	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RFWD3 mRNA	PMID:22206623
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1349611	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RFWD3 protein	PMID:31285264
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in decreased expression of RFWD3 mRNA	PMID:23358140
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1349611	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RFWD3 mRNA	PMID:30851411
1305243	Rfwd3	ring finger and WD repeat domain 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349611	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RFWD3 gene]	PMID:28238834
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313158	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PLEKHA3 mRNA	PMID:26272509
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313158	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313159	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PLEKHA3 mRNA	PMID:30319688
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313159	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PLEKHA3 mRNA	PMID:30319688
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313159	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PLEKHA3 mRNA	PMID:39241906
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313158	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PLEKHA3 mRNA	PMID:33359661
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313158	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PLEKHA3 protein	PMID:37730182
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PLEKHA3 mRNA	PMID:22061828|PMID:33387578
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313158	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PLEKHA3 mRNA	PMID:28818685
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLEKHA3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEKHA3 mRNA	PMID:28111341|PMID:37451636
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313158	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PLEKHA3 mRNA	PMID:19549813
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313158	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PLEKHA3 mRNA	PMID:23649840
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLEKHA3 mRNA	PMID:22206623
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313158	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHA3 mRNA	PMID:39836092
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313158	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PLEKHA3 protein	PMID:35688186
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313159	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLEKHA3 mRNA	PMID:21570461
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313159	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLEKHA3 mRNA	PMID:15034205
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLEKHA3 mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLEKHA3 mRNA]	PMID:15034205|PMID:17942748
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of PLEKHA3 mRNA	PMID:19013527
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313158	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PLEKHA3 mRNA; aristolochic acid I results in increased expression of PLEKHA3 protein	PMID:33212167
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1313158	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of PLEKHA3 mRNA	PMID:26272509
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313158	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313158	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PLEKHA3 mRNA	PMID:38568856
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313158	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHA3 mRNA	PMID:39836092
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313159	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLEKHA3 mRNA	PMID:15034205|PMID:22228805
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of PLEKHA3 mRNA]	PMID:15034205
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PLEKHA3 mRNA	PMID:27131904
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313159	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLEKHA3 gene	PMID:35295148
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PLEKHA3 mRNA	PMID:34492290
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLEKHA3 mRNA	PMID:25181051
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PLEKHA3 gene	PMID:28505145
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313159	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PLEKHA3 mRNA	PMID:39298647
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:34679	Di-n-octyl phthalate	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20240305	CTD	MESH:C010715	di-n-octyl phthalate results in decreased expression of PLEKHA3 mRNA	PMID:37810885
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PLEKHA3 mRNA	PMID:21266533
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PLEKHA3 mRNA	PMID:21266533
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:34709	Diisodecyl phthalate	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20240305	CTD	MESH:C042080	diisodecyl phthalate results in decreased expression of PLEKHA3 mRNA	PMID:37810885
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313158	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLEKHA3 mRNA	PMID:37042841
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PLEKHA3 mRNA	PMID:33453195
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLEKHA3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEKHA3 mRNA	PMID:28111341|PMID:37451636
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313158	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PLEKHA3 mRNA	PMID:28302478
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313158	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLEKHA3 mRNA	PMID:25979313
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313158	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLEKHA3 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLEKHA3 mRNA	PMID:21427059
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313158	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of PLEKHA3 mRNA	PMID:29154799
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313158	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of PLEKHA3 mRNA	PMID:38685447|PMID:41580965
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313158	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PLEKHA3 mRNA	PMID:25562108
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313158	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PLEKHA3 mRNA	PMID:24935251|PMID:26272509
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313158	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PLEKHA3 mRNA	PMID:33387578
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313158	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHA3 mRNA	PMID:39836092
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLEKHA3 mRNA	PMID:29391264
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PLEKHA3 mRNA	PMID:35436446
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313159	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PLEKHA3 mRNA	PMID:17942748
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLEKHA3 mRNA	PMID:17942748
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of PLEKHA3 mRNA	PMID:41580965
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PLEKHA3 mRNA	PMID:23650126
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313158	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PLEKHA3 mRNA	PMID:31758290
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PLEKHA3 mRNA	PMID:22206623
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLEKHA3 mRNA	PMID:22206623
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313158	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313158	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PLEKHA3 mRNA	PMID:27131904
1305244	Plekha3	pleckstrin homology domain containing A3	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313158	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PLEKHA3 mRNA	PMID:29301935
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ABHD17B mRNA]	PMID:31150632
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ABHD17B mRNA	PMID:26251327
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ABHD17B mRNA	PMID:39298647
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313162	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of ABHD17B mRNA	PMID:19167446
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ABHD17B mRNA	PMID:26496021
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313162	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ABHD17B mRNA	PMID:37042841
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313162	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ABHD17B mRNA	PMID:20655997
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313162	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ABHD17B protein	PMID:37730182
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313162	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ABHD17B mRNA	PMID:28818685
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABHD17B mRNA	PMID:37236586
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313162	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ABHD17B mRNA	PMID:19549813
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313162	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ABHD17B gene	PMID:27153756
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313163	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABHD17B mRNA	PMID:19770486
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ABHD17B mRNA	PMID:31150632
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ABHD17B mRNA]	PMID:31150632
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABHD17B mRNA	PMID:22206623
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313162	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABHD17B mRNA	PMID:40512198
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ABHD17B mRNA	PMID:40504410
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313162	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ABHD17B mRNA	PMID:26272509
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313162	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA	PMID:27188386
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ABHD17B mRNA	PMID:28189721|PMID:28960355
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313163	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABHD17B mRNA	PMID:21570461
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ABHD17B mRNA	PMID:33387578
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABHD17B mRNA	PMID:34747641
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313162	E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of ABHD17B mRNA	PMID:29704546
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313162	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD17B mRNA	PMID:30851411
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313162	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABHD17B mRNA	PMID:29803840
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313162	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABHD17B mRNA	PMID:40512198
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ABHD17B mRNA	PMID:40504410
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313163	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABHD17B mRNA	PMID:22228805
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313163	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABHD17B promoter alternative form	PMID:35295148
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313163	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ABHD17B gene	PMID:35295148
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ABHD17B mRNA	PMID:34492290
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ABHD17B mRNA	PMID:20813756|PMID:23811191
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ABHD17B mRNA	PMID:26063408
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD17B mRNA	PMID:33296240
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ABHD17B gene	PMID:28505145
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ABHD17B mRNA; [bisphenol A co-treated with Estradiol] results in increased expression of ABHD17B mRNA	PMID:26496021|PMID:36041667
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313163	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ABHD17B mRNA	PMID:39298647
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ABHD17B mRNA	PMID:36041667
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ABHD17B mRNA	PMID:36041667
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313163	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ABHD17B intron	PMID:28392331
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313163	E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of ABHD17B mRNA	PMID:21371552
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313162	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABHD17B mRNA	PMID:37042841
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ABHD17B mRNA	PMID:35163327
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABHD17B mRNA	PMID:37236586
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ABHD17B mRNA	PMID:35163327
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313163	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ABHD17B mRNA	PMID:22698814
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313163	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of ABHD17B mRNA	PMID:21139344
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313162	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ABHD17B mRNA	PMID:24449571
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313162	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ABHD17B mRNA	PMID:31533062
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313162	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABHD17B mRNA	PMID:25979313
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313162	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ABHD17B mRNA	PMID:23179753|PMID:26272509
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313162	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ABHD17B gene	PMID:29154799
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313162	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA	PMID:27188386
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313162	E	RGD:6480464	20161115	CTD	MESH:D016572	Cyclosporine results in decreased expression of ABHD17B mRNA	PMID:25562108
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313162	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ABHD17B mRNA	PMID:38832940
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313162	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ABHD17B mRNA	PMID:28542535
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313162	E	RGD:6480464	20150714	CTD	MESH:C012589	trichostatin A results in decreased expression of ABHD17B mRNA	PMID:24935251
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABHD17B mRNA	PMID:33387578
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313162	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ABHD17B mRNA	PMID:21420995
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313162	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABHD17B mRNA	PMID:40512198
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ABHD17B mRNA	PMID:40504410
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ABHD17B mRNA	PMID:29391264
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313162	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of ABHD17B mRNA	PMID:31629900
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ABHD17B mRNA	PMID:22206623
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABHD17B mRNA	PMID:22206623
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313162	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD17B mRNA	PMID:30851411
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313162	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA	PMID:27188386
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of ABHD17B mRNA	PMID:23091169
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ABHD17B mRNA	PMID:32109520
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313163	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of ABHD17B mRNA	PMID:40826991
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313162	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA	PMID:27188386
1305246	Abhd17b	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313162	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of ABHD17B mRNA	PMID:27188386
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PRDM9 mRNA	PMID:32145629
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of PRDM9 mRNA	PMID:26496021
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1623005	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRDM9 mRNA	PMID:25510870
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRDM9 mRNA	PMID:33387578
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1623005	E	RGD:6480464	20150825	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PRDM9 mRNA	PMID:25975992
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1623005	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRDM9 mRNA	PMID:25510870
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1623005	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRDM9 mRNA	PMID:25510870
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of PRDM9 mRNA	PMID:30779732
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PRDM9 mRNA	PMID:31150632
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1623005	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of PRDM9 mRNA	PMID:25629700
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623005	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRDM9 mRNA	PMID:40504410
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623005	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRDM9 mRNA	PMID:21570461
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRDM9 mRNA	PMID:33387578
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1623005	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRDM9 mRNA	PMID:36209798
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349245	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of PRDM9 mRNA	PMID:29301061|PMID:38568856
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623005	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRDM9 mRNA	PMID:40504410
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1349245	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRDM9 5' UTR; Benzo(a)pyrene affects the methylation of PRDM9 promoter	PMID:27901495
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1349245	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PRDM9 3' UTR	PMID:27901495
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623005	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PRDM9 promoter	PMID:35295148
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PRDM9 mRNA	PMID:34492290
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRDM9 mRNA	PMID:25181051|PMID:32145629
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1623005	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PRDM9 mRNA	PMID:32156529|PMID:33221593
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PRDM9 mRNA	PMID:30816183|PMID:32528016
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1349245	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PRDM9 gene	PMID:31601247
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of PRDM9 mRNA	PMID:26496021
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1623005	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRDM9 mRNA	PMID:25510870
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1623005	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRDM9 mRNA	PMID:25510870
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1623005	E	RGD:6480464	20180515	CTD	MESH:D008748	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of PRDM9 mRNA	PMID:25926378
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623005	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of PRDM9 mRNA	PMID:30951980
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1623005	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of PRDM9 mRNA	PMID:40203079
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1623005	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PRDM9 mRNA	PMID:38685157
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623005	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PRDM9 mRNA	PMID:37019170
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PRDM9 mRNA	PMID:32680482
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of PRDM9 mRNA	PMID:35163327
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PRDM9 mRNA	PMID:35163327
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of PRDM9 mRNA	PMID:30723492
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PRDM9 mRNA	PMID:35163327
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1623005	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PRDM9 mRNA	PMID:40194260
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PRDM9 mRNA	PMID:33387578
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623005	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRDM9 mRNA	PMID:40504410
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1623005	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PRDM9 mRNA	PMID:35436446
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1623005	E	RGD:6480464	20180515	CTD	MESH:D037742	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of PRDM9 mRNA	PMID:25926378
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349245	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PRDM9 gene]	PMID:28238834
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PRDM9 mRNA	PMID:24780913
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PRDM7 mRNA	PMID:21346803
1305247	Prdm9	PR/SET domain 9	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1623005	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PRDM9 mRNA	PMID:32835833
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SYNE2 mRNA	PMID:38218311
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of SYNE2 mRNA	PMID:35967413
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1615570	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SYNE2 mRNA	PMID:33045310
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:142921	3-phenylprop-2-enal	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in decreased expression of SYNE2 mRNA	PMID:24211530
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:15368	acrolein	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140812	CTD	MESH:D000171	Acrolein results in decreased expression of SYNE2 mRNA	PMID:24211530
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYNE2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of SYNE2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYNE2 mRNA	PMID:32699268|PMID:32845096
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SYNE2 mRNA	PMID:30529165
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SYNE2 mRNA	PMID:26079696
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of SYNE2 mRNA	PMID:30207508
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of SYNE2 protein	PMID:31494107
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1312719	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of SYNE2 protein	PMID:35688186
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SYNE2 mRNA	PMID:39241906
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SYNE2 mRNA	PMID:39298647
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA	PMID:25510870
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SYNE2 mRNA	PMID:38568856
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1312719	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of SYNE2 mRNA	PMID:27664576
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:C044887	beta-methylcholine affects the expression of SYNE2 mRNA	PMID:21179406
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SYNE2 gene	PMID:33872906
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SYNE2 mRNA	PMID:33754040
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1615570	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SYNE2 mRNA	PMID:34319233
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SYNE2 gene	PMID:33872906
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SYNE2 mRNA	PMID:26577399
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1312719	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SYNE2 protein	PMID:37730182
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1312719	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SYNE2 intron	PMID:30157460
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA	PMID:39836092
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of SYNE2 mRNA	PMID:27462272
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:2255	7beta-aminocephalosporanic acid	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140812	CTD	MESH:C030735	7-aminocephalosporanic acid results in decreased expression of SYNE2 mRNA	PMID:24211530
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA	PMID:25510870
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA	PMID:25510870
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SYNE2 mRNA	PMID:23649840
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1615570	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of SYNE2 intron	PMID:27776689
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1615570	E	RGD:6480464	20140729	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SYNE2 mRNA	PMID:19770486
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1312719	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SYNE2 intron	PMID:30157460
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SYNE2 mRNA	PMID:23649840
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYNE2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of SYNE2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYNE2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of SYNE2 mRNA	PMID:32699268|PMID:32845096
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SYNE2 mRNA	PMID:27106289
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SYNE2 mRNA	PMID:30723492
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SYNE2 mRNA	PMID:25629700
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SYNE2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SYNE2 mRNA	PMID:39836092|PMID:40512198
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1312719	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SYNE2 protein	PMID:35688186
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SYNE2 mRNA	PMID:28960355
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1312719	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of SYNE2 mRNA	PMID:28903495
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312719	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SYNE2 mRNA	PMID:27392435
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SYNE2 mRNA	PMID:27392435
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SYNE2 mRNA	PMID:33956508
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1615570	E	RGD:6480464	20140729	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SYNE2 mRNA	PMID:19933214
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SYNE2 mRNA	PMID:28374803
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of SYNE2 mRNA; Rotenone results in decreased expression of SYNE2 protein	PMID:33512557|PMID:39603559
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SYNE2 mRNA	PMID:28001369
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SYNE2 mRNA; aristolochic acid I results in decreased expression of SYNE2 protein	PMID:33212167
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SYNE2 mRNA	PMID:23649840
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SYNE2 mRNA	PMID:29803840
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SYNE2 mRNA	PMID:38568856
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1615570	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of SYNE2 mRNA	PMID:36209798
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SYNE2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SYNE2 mRNA	PMID:39836092|PMID:40512198
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1312719	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SYNE2 3' UTR; Benzo(a)pyrene affects the methylation of SYNE2 intron	PMID:27901495|PMID:30157460
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYNE2 mRNA	PMID:22316170|PMID:26238291
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20140729	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYNE2 mRNA	PMID:21715664
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312719	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SYNE2 promoter	PMID:27901495
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1615570	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SYNE2 exon; Benzo(a)pyrene results in decreased methylation of SYNE2 intron	PMID:27901495
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312719	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SYNE2 5' UTR; Benzo(a)pyrene results in increased methylation of SYNE2 exon	PMID:27901495
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA	PMID:27858113
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SYNE2 mRNA	PMID:19150397|PMID:26238291
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of SYNE2 mRNA	PMID:24395379
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of SYNE2 gene	PMID:31601247
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of SYNE2 mRNA	PMID:24136188
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32063	propylparaben	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20240702	CTD	MESH:C006068	propylparaben results in decreased expression of SYNE2 mRNA	PMID:38568856
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SYNE2 mRNA	PMID:30047161
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615570	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SYNE2 gene	PMID:35295148
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1615570	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of SYNE2 mRNA	PMID:29264374
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1615570	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SYNE2 gene	PMID:35295148
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20140729	CTD	MESH:C006253	pirinixic acid results in decreased expression of SYNE2 mRNA	PMID:18445702
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SYNE2 mRNA	PMID:25181051
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SYNE2 mRNA	PMID:30816183|PMID:34947998
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SYNE2 protein	PMID:33376534|PMID:37567409
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312719	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of SYNE2 gene	PMID:31601247
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of SYNE2 gene	PMID:31601247
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SYNE2 protein	PMID:31675489
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA	PMID:25510870
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA	PMID:25510870
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34292	1,3-benzothiazole-2-thiol	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140812	CTD	MESH:C005563	captax results in decreased expression of SYNE2 mRNA	PMID:24211530
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1615570	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SYNE2 gene	PMID:31683443
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SYNE2 mRNA	PMID:39298647
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312719	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of SYNE2 gene	PMID:31601247
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of SYNE2 mRNA	PMID:26377693
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA	PMID:27858113
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1312719	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SYNE2 intron	PMID:30157460
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1615570	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of SYNE2 protein	PMID:35362542
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SYNE2 protein]	PMID:35362542
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1312719	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SYNE2 mRNA	PMID:37042841
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA	PMID:39836092
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20140729	CTD	MESH:D002509	Cephaloridine results in decreased expression of SYNE2 mRNA	PMID:18500788
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SYNE2 mRNA	PMID:38568856
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1615570	E	RGD:6480464	20250603	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SYNE2 mRNA	PMID:39778857
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYNE2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYNE2 mRNA	PMID:32699268
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:37144	epichlorohydrin	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140812	CTD	MESH:D004811	Epichlorohydrin results in decreased expression of SYNE2 mRNA	PMID:24211530
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of SYNE2 mRNA	PMID:30047161
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SYNE2 mRNA	PMID:31533062
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:D003375	Coumestrol results in increased expression of SYNE2 mRNA	PMID:19167446
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140812	CTD	MESH:C100187	chloropicrin results in decreased expression of SYNE2 mRNA	PMID:24211530
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYNE2 mRNA	PMID:29427782
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYNE2 mRNA	PMID:23179753|PMID:28001369
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1615570	E	RGD:6480464	20140729	CTD	MESH:D013629	Tamoxifen affects the expression of SYNE2 mRNA	PMID:20937368
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1615570	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SYNE2 mRNA	PMID:28973697
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:D003703	Demecolcine results in decreased expression of SYNE2 mRNA	PMID:23649840
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SYNE2 mRNA	PMID:27188386
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SYNE2 mRNA	PMID:24935251
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNE2 mRNA	PMID:27188386
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNE2 mRNA	PMID:21420995
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SYNE2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SYNE2 mRNA	PMID:39836092|PMID:40512198
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of SYNE2 mRNA	PMID:22079256
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SYNE2 mRNA	PMID:22079256
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1615570	E	RGD:6480464	20140729	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SYNE2 mRNA	PMID:17555576
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SYNE2 protein]	PMID:35362542
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of SYNE2 mRNA	PMID:38568856
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SYNE2 mRNA; Nanotubes, Carbon results in decreased expression of SYNE2 mRNA	PMID:25554681
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SYNE2 mRNA	PMID:24136188
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SYNE2 mRNA	PMID:30047161
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of SYNE2 mRNA	PMID:24136188
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of SYNE2 mRNA	PMID:26377693
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA	PMID:27858113
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA	PMID:27858113
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:53578	hexamethylene diisocyanate	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140812	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in decreased expression of SYNE2 mRNA	PMID:24211530
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:59604	ammonium hexachloroplatinate	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140812	CTD	MESH:C018453	ammonium hexachloroplatinate results in decreased expression of SYNE2 mRNA	PMID:24211530
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SYNE2 protein	PMID:32959892
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA	PMID:39836092
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1615570	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SYNE2 protein	PMID:26558463
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1312719	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SYNE2 intron	PMID:30157460
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SYNE2 gene	PMID:35440735
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1615570	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SYNE2 mRNA	PMID:22206623
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SYNE2 protein	PMID:37664457
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of SYNE2 mRNA	PMID:24136188
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SYNE2 mRNA	PMID:22079256
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20140729	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SYNE2 mRNA	PMID:22079256
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of SYNE2 mRNA	PMID:27858113
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1312719	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SYNE2 mRNA	PMID:37199045
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of SYNE2 mRNA	PMID:34995734
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNE2 mRNA	PMID:27188386
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SYNE2 gene]	PMID:28238834
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1615570	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SYNE2 mRNA	PMID:38648751
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SYNE2 protein	PMID:31675489
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SYNE2 protein	PMID:31675489
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of SYNE2 mRNA	PMID:33512557
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SYNE2 mRNA	PMID:30047161
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SYNE2 mRNA	PMID:24780913
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1312719	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SYNE2 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNE2 mRNA	PMID:27188386|PMID:37664457
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:9422	tebufenpyrad	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SYNE2 mRNA	PMID:33512557
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20140812	CTD	MESH:D013893	Thiram results in decreased expression of SYNE2 mRNA	PMID:24211530
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1312719	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SYNE2 mRNA	PMID:29301935
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1312719	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SYNE2 mRNA	PMID:27188386
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SYNE2 mRNA	PMID:28973697
1305248	Syne2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SYNE2 mRNA	PMID:35537566
1305249	Snrpe-ps1	small nuclear ribonucleoprotein polypeptide E, pseudogene 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D005485	Flutamide results in increased expression of SNRPE-PS1 mRNA	PMID:24793618
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313170	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PDZRN3 mRNA	PMID:37995155
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PDZRN3 mRNA	PMID:26251327
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PDZRN3 gene	PMID:20938992
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313169	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PDZRN3 mRNA	PMID:21934132|PMID:23724009
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PDZRN3 mRNA	PMID:36331819
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PDZRN3 mRNA	PMID:36841081
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313169	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PDZRN3 mRNA	PMID:22378314
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313169	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PDZRN3 mRNA	PMID:20044591
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1313169	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PDZRN3 mRNA	PMID:29581250
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313170	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PDZRN3 mRNA	PMID:27339419
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PDZRN3 mRNA	PMID:32145629
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PDZRN3 gene	PMID:20938992
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313169	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PDZRN3 mRNA	PMID:33359661
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313169	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PDZRN3 protein	PMID:37730182
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313169	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of PDZRN3 mRNA	PMID:26485663
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313169	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PDZRN3 mRNA	PMID:28818685
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313169	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PDZRN3 mRNA	PMID:28818685
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PDZRN3 mRNA	PMID:36331819
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313169	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PDZRN3 intron	PMID:30157460
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313170	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of PDZRN3 mRNA	PMID:24535564
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PDZRN3 mRNA	PMID:31150632
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313170	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of PDZRN3 mRNA	PMID:25629700
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PDZRN3 gene	PMID:20938992
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PDZRN3 mRNA	PMID:31881176
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20231003	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased methylation of PDZRN3 intron	PMID:33445541
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of PDZRN3 mRNA	PMID:22023808
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313170	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PDZRN3 mRNA	PMID:20702594|PMID:21570461|PMID:26377647
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PDZRN3 mRNA	PMID:21215274|PMID:32109520
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PDZRN3 mRNA	PMID:18691609
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PDZRN3 mRNA	PMID:23238561
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313170	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PDZRN3 mRNA	PMID:18796159|PMID:23238561|PMID:26290441
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of PDZRN3 mRNA	PMID:16214954
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313169	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PDZRN3 mRNA	PMID:23179753|PMID:26272509|PMID:34089799
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1313169	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA	PMID:27188386
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PDZRN3 mRNA	PMID:28959563
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PDZRN3 mRNA	PMID:30556269
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313169	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PDZRN3 gene	PMID:28589171
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PDZRN3 mRNA	PMID:37682722
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PDZRN3 mRNA	PMID:19770486
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313170	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PDZRN3 mRNA	PMID:22228805
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313169	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PDZRN3 promoter	PMID:27901495
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313169	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of PDZRN3 promoter	PMID:23974009
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PDZRN3 mRNA	PMID:30556269
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PDZRN3 mRNA	PMID:27131904
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313169	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PDZRN3 gene	PMID:31601247
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PDZRN3 mRNA	PMID:24136188
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20231003	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased methylation of PDZRN3 intron	PMID:33445541
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PDZRN3 mRNA	PMID:30047161
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313170	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of PDZRN3 mRNA	PMID:29264374
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313170	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PDZRN3 promoter	PMID:35295148
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of PDZRN3 mRNA	PMID:23411599
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PDZRN3 mRNA	PMID:25380136
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313170	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PDZRN3 mRNA	PMID:18301758|PMID:18445702|PMID:23811191
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PDZRN3 mRNA	PMID:19710929
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PDZRN3 mRNA	PMID:25181051|PMID:32145629
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of PDZRN3 mRNA	PMID:39742910
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313169	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PDZRN3 gene	PMID:31601247
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313170	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of PDZRN3 promoter	PMID:27312807
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of PDZRN3 mRNA	PMID:41034487
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313169	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PDZRN3 mRNA	PMID:29275510
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313170	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of PDZRN3 mRNA	PMID:30951980|PMID:34585602
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PDZRN3 gene	PMID:28505145
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313169	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PDZRN3 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDZRN3 mRNA	PMID:28628672|PMID:31601247
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1313170	E	RGD:6480464	20120412	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of PDZRN3 mRNA	PMID:20702594
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313169	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PDZRN3 exon	PMID:30157460
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1313170	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of PDZRN3 intron	PMID:28392331
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PDZRN3 mRNA	PMID:37019170
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313169	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDZRN3 mRNA	PMID:28628672
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of PDZRN3 mRNA	PMID:24535843
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of PDZRN3 mRNA	PMID:30589522
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of PDZRN3 mRNA	PMID:25380136|PMID:30723492
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of PDZRN3 mRNA	PMID:25539665
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of PDZRN3 mRNA	PMID:25380136
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PDZRN3 mRNA	PMID:40194260
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:38845	profenofos	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C024273	profenofos results in increased expression of PDZRN3 mRNA	PMID:17569032
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1313170	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of PDZRN3 mRNA	PMID:34254344
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PDZRN3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PDZRN3 mRNA	PMID:36331819
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of PDZRN3 mRNA	PMID:23125180
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313169	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PDZRN3 mRNA	PMID:25979313
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313170	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of PDZRN3 mRNA	PMID:24535564
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PDZRN3 mRNA	PMID:30047161
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of PDZRN3 mRNA	PMID:22733784
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313169	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDZRN3 mRNA	PMID:28628672
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313169	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of PDZRN3 mRNA	PMID:24935251
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313169	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PDZRN3 mRNA	PMID:24935251|PMID:26272509
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313169	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA	PMID:27188386
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313169	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDZRN3 mRNA	PMID:28628672
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PDZRN3 mRNA	PMID:30047161
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PDZRN3 mRNA	PMID:24136188
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313170	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PDZRN3 mRNA	PMID:23608068
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:5613	haloperidol	decreases expression	ISO	RGD:1313169	E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in decreased expression of PDZRN3 protein	PMID:34122009
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1313169	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PDZRN3 mRNA	PMID:22079614
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:65408	andrographolide	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20121218	CTD	MESH:C030419	[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of PDZRN3 mRNA	PMID:19737545
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313169	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PDZRN3 exon	PMID:30157460
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PDZRN3 gene	PMID:35440735
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313169	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PDZRN3 mRNA	PMID:31758290
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PDZRN3 mRNA	PMID:27840820
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20140204	CTD	MESH:D019324	[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of PDZRN3 mRNA	PMID:19737545
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313169	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA	PMID:27188386
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313169	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PDZRN3 gene]	PMID:28238834
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:8064	phenformin	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in increased expression of PDZRN3 mRNA	PMID:31324951
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313170	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of PDZRN3 mRNA	PMID:20702594
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PDZRN3 mRNA	PMID:32109520
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313170	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of PDZRN3 mRNA	PMID:21795629
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PDZRN3 mRNA	PMID:24780913
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:9079	Securinine	decreases expression	ISO	RGD:1313169	E	RGD:6480464	20200915	CTD	MESH:C000785	securinine results in decreased expression of PDZRN3 mRNA	PMID:32662633
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of PDZRN3 protein	PMID:35357534
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313169	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA	PMID:27188386
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PDZRN3 mRNA	PMID:27131904
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PDZRN3 mRNA	PMID:19281266
1305250	Pdzrn3	PDZ domain containing RING finger 3	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of PDZRN3 gene	PMID:31682807
1305251	Rnf152	ring finger protein 152	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF152 mRNA]	PMID:31150632
1305251	Rnf152	ring finger protein 152	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1313171	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of RNF152 mRNA	PMID:34925699
1305251	Rnf152	ring finger protein 152	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RNF152 mRNA	PMID:20188158
1305251	Rnf152	ring finger protein 152	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of RNF152 mRNA	PMID:36189433
1305251	Rnf152	ring finger protein 152	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313171	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of RNF152 mRNA	PMID:23724009
1305251	Rnf152	ring finger protein 152	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550154	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RNF152 mRNA	PMID:36189433
1305251	Rnf152	ring finger protein 152	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313171	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RNF152 mRNA	PMID:26079696
1305251	Rnf152	ring finger protein 152	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of RNF152 mRNA	PMID:39506029
1305251	Rnf152	ring finger protein 152	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of RNF152 gene	PMID:30207508
1305251	Rnf152	ring finger protein 152	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313171	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RNF152 mRNA	PMID:35811015
1305251	Rnf152	ring finger protein 152	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of RNF152 mRNA	PMID:32145629
1305251	Rnf152	ring finger protein 152	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RNF152 mRNA	PMID:39298647
1305251	Rnf152	ring finger protein 152	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RNF152 mRNA	PMID:33387578
1305251	Rnf152	ring finger protein 152	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550154	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RNF152 mRNA	PMID:36189433
1305251	Rnf152	ring finger protein 152	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of RNF152 mRNA	PMID:26496021
1305251	Rnf152	ring finger protein 152	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313171	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RNF152 mRNA	PMID:31163220
1305251	Rnf152	ring finger protein 152	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550154	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RNF152 mRNA	PMID:28085963
1305251	Rnf152	ring finger protein 152	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RNF152 mRNA	PMID:33387578
1305251	Rnf152	ring finger protein 152	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RNF152 mRNA	PMID:28818685
1305251	Rnf152	ring finger protein 152	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550154	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RNF152 mRNA	PMID:36331819
1305251	Rnf152	ring finger protein 152	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1550154	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of RNF152 mRNA	PMID:18579281
1305251	Rnf152	ring finger protein 152	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313171	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RNF152 exon; Aflatoxin B1 results in decreased methylation of RNF152 gene; Aflatoxin B1 results in decreased methylation of RNF152 intron	PMID:27153756|PMID:30157460
1305251	Rnf152	ring finger protein 152	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RNF152 mRNA	PMID:31150632
1305251	Rnf152	ring finger protein 152	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RNF152 mRNA	PMID:27339419|PMID:31919559
1305251	Rnf152	ring finger protein 152	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF152 mRNA]	PMID:31150632
1305251	Rnf152	ring finger protein 152	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RNF152 mRNA	PMID:31881176
1305251	Rnf152	ring finger protein 152	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550154	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF152 mRNA	PMID:26377647|PMID:28922406
1305251	Rnf152	ring finger protein 152	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF152 mRNA	PMID:32109520|PMID:33387578
1305251	Rnf152	ring finger protein 152	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1313171	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of RNF152 mRNA	PMID:24834073
1305251	Rnf152	ring finger protein 152	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1313171	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RNF152 mRNA	PMID:30851411
1305251	Rnf152	ring finger protein 152	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF152 mRNA	PMID:29803840
1305251	Rnf152	ring finger protein 152	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNF152 mRNA	PMID:29301061|PMID:39719251
1305251	Rnf152	ring finger protein 152	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313171	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF152 mRNA	PMID:34032870
1305251	Rnf152	ring finger protein 152	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNF152 mRNA	PMID:32234424
1305251	Rnf152	ring finger protein 152	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNF152 mRNA	PMID:19770486
1305251	Rnf152	ring finger protein 152	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550154	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF152 mRNA	PMID:27195522
1305251	Rnf152	ring finger protein 152	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313171	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF152 exon; Benzo(a)pyrene results in increased methylation of RNF152 promoter	PMID:27901495
1305251	Rnf152	ring finger protein 152	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313171	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of RNF152 promoter	PMID:23974009
1305251	Rnf152	ring finger protein 152	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RNF152 mRNA	PMID:23221170
1305251	Rnf152	ring finger protein 152	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of RNF152 mRNA	PMID:37690743
1305251	Rnf152	ring finger protein 152	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550154	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF152 gene	PMID:35295148
1305251	Rnf152	ring finger protein 152	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RNF152 mRNA	PMID:34492290
1305251	Rnf152	ring finger protein 152	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550154	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RNF152 mRNA	PMID:28472532
1305251	Rnf152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of RNF152 mRNA	PMID:32145629
1305251	Rnf152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF152 mRNA	PMID:25181051|PMID:34947998
1305251	Rnf152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF152 mRNA	PMID:34585602
1305251	Rnf152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RNF152 mRNA	PMID:29097150|PMID:30816183|PMID:33296240
1305251	Rnf152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313171	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF152 gene	PMID:31601247
1305251	Rnf152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF152 mRNA; [bisphenol A co-treated with Testosterone] results in decreased expression of RNF152 mRNA	PMID:26496021|PMID:36041667
1305251	Rnf152	ring finger protein 152	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of RNF152 mRNA	PMID:26682919
1305251	Rnf152	ring finger protein 152	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF152 mRNA	PMID:30616060
1305251	Rnf152	ring finger protein 152	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF152 mRNA	PMID:30951980|PMID:39298647
1305251	Rnf152	ring finger protein 152	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF152 mRNA	PMID:36041667
1305251	Rnf152	ring finger protein 152	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of RNF152 mRNA	PMID:30951980
1305251	Rnf152	ring finger protein 152	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF152 mRNA	PMID:36041667
1305251	Rnf152	ring finger protein 152	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RNF152 mRNA	PMID:38382870
1305251	Rnf152	ring finger protein 152	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RNF152 promoter	PMID:22457795
1305251	Rnf152	ring finger protein 152	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of RNF152 mRNA	PMID:28903501
1305251	Rnf152	ring finger protein 152	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RNF152 mRNA	PMID:32588087
1305251	Rnf152	ring finger protein 152	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RNF152 mRNA	PMID:40194260
1305251	Rnf152	ring finger protein 152	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550154	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RNF152 mRNA	PMID:36331819
1305251	Rnf152	ring finger protein 152	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313171	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RNF152 gene	PMID:29154799
1305251	Rnf152	ring finger protein 152	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313171	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RNF152 mRNA	PMID:17183730
1305251	Rnf152	ring finger protein 152	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1313171	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of RNF152 promoter	PMID:27989131
1305251	Rnf152	ring finger protein 152	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550154	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RNF152 mRNA	PMID:28973697
1305251	Rnf152	ring finger protein 152	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RNF152 mRNA	PMID:38832940
1305251	Rnf152	ring finger protein 152	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550154	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF152 mRNA	PMID:17562736
1305251	Rnf152	ring finger protein 152	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF152 mRNA	PMID:33387578
1305251	Rnf152	ring finger protein 152	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313171	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RNF152 mRNA	PMID:35811015
1305251	Rnf152	ring finger protein 152	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550154	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RNF152 mRNA	PMID:35436446
1305251	Rnf152	ring finger protein 152	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RNF152 mRNA	PMID:29097150
1305251	Rnf152	ring finger protein 152	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of RNF152 mRNA	PMID:32234424
1305251	Rnf152	ring finger protein 152	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1313171	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of RNF152 mRNA	PMID:23228038
1305251	Rnf152	ring finger protein 152	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1550154	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of RNF152 mRNA	PMID:25620056
1305251	Rnf152	ring finger protein 152	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of RNF152 mRNA	PMID:25620056
1305251	Rnf152	ring finger protein 152	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313171	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of RNF152 mRNA	PMID:31629900
1305251	Rnf152	ring finger protein 152	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313171	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RNF152 mRNA	PMID:17183730
1305251	Rnf152	ring finger protein 152	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313171	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of RNF152 mRNA	PMID:24810058
1305251	Rnf152	ring finger protein 152	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RNF152 gene	PMID:35440735
1305251	Rnf152	ring finger protein 152	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RNF152 mRNA	PMID:22206623
1305251	Rnf152	ring finger protein 152	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1313171	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RNF152 mRNA	PMID:30851411
1305251	Rnf152	ring finger protein 152	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1550154	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of RNF152 mRNA	PMID:26655953
1305251	Rnf152	ring finger protein 152	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of RNF152 mRNA	PMID:23091169
1305251	Rnf152	ring finger protein 152	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RNF152 mRNA	PMID:32109520
1305251	Rnf152	ring finger protein 152	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:C010902	[Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of RNF152 mRNA	PMID:32207525
1305251	Rnf152	ring finger protein 152	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RNF152 mRNA	PMID:24780913
1305251	Rnf152	ring finger protein 152	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313171	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RNF152 mRNA	PMID:38568856
1305251	Rnf152	ring finger protein 152	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of RNF152 mRNA	PMID:32835833
1305252	Rnf135	ring finger protein 135	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:C084079	triptonide results in increased expression of RNF135 mRNA	PMID:33045310
1305252	Rnf135	ring finger protein 135	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF135 mRNA]	PMID:31150632
1305252	Rnf135	ring finger protein 135	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D014212	Tretinoin results in decreased expression of RNF135 mRNA	PMID:21934132
1305252	Rnf135	ring finger protein 135	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF135 mRNA	PMID:39241906
1305252	Rnf135	ring finger protein 135	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNF135 mRNA	PMID:27339419
1305252	Rnf135	ring finger protein 135	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313173	E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of RNF135 mRNA	PMID:22217510
1305252	Rnf135	ring finger protein 135	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D011374	Progesterone results in decreased expression of RNF135 mRNA	PMID:21770760
1305252	Rnf135	ring finger protein 135	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RNF135 mRNA	PMID:23892564
1305252	Rnf135	ring finger protein 135	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RNF135 mRNA	PMID:34319233
1305252	Rnf135	ring finger protein 135	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D002104	Cadmium results in increased expression of RNF135 mRNA	PMID:24376830
1305252	Rnf135	ring finger protein 135	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552157	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RNF135 mRNA	PMID:37236586
1305252	Rnf135	ring finger protein 135	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RNF135 mRNA	PMID:31150632
1305252	Rnf135	ring finger protein 135	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF135 mRNA]	PMID:31150632
1305252	Rnf135	ring finger protein 135	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RNF135 mRNA	PMID:26272509
1305252	Rnf135	ring finger protein 135	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF135 mRNA	PMID:27188386
1305252	Rnf135	ring finger protein 135	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313173	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RNF135 protein	PMID:35688186
1305252	Rnf135	ring finger protein 135	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D007854	Lead results in decreased expression of RNF135 mRNA	PMID:19921347
1305252	Rnf135	ring finger protein 135	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D002945	Cisplatin results in increased expression of RNF135 mRNA	PMID:27392435|PMID:27594783
1305252	Rnf135	ring finger protein 135	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RNF135 mRNA	PMID:27392435
1305252	Rnf135	ring finger protein 135	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:D010278	Parathion results in decreased expression of RNF135 mRNA	PMID:34813904
1305252	Rnf135	ring finger protein 135	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNF135 mRNA	PMID:33212167
1305252	Rnf135	ring finger protein 135	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF135 mRNA	PMID:29803840
1305252	Rnf135	ring finger protein 135	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313173	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNF135 mRNA	PMID:38568856
1305252	Rnf135	ring finger protein 135	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF135 mRNA	PMID:21715664|PMID:22228805
1305252	Rnf135	ring finger protein 135	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF135 promoter	PMID:27901495
1305252	Rnf135	ring finger protein 135	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF135 mRNA	PMID:22576693
1305252	Rnf135	ring finger protein 135	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RNF135 mRNA	PMID:25181051
1305252	Rnf135	ring finger protein 135	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:C006780	bisphenol A results in increased expression of RNF135 mRNA	PMID:33221593
1305252	Rnf135	ring finger protein 135	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF135 gene	PMID:28505145
1305252	Rnf135	ring finger protein 135	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF135 gene	PMID:22576693
1305252	Rnf135	ring finger protein 135	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF135 mRNA	PMID:40203079
1305252	Rnf135	ring finger protein 135	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552157	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RNF135 mRNA	PMID:39298647
1305252	Rnf135	ring finger protein 135	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RNF135 mRNA	PMID:21266533
1305252	Rnf135	ring finger protein 135	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:D005284	Fenthion results in decreased expression of RNF135 mRNA	PMID:34813904
1305252	Rnf135	ring finger protein 135	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313173	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNF135 mRNA	PMID:37042841
1305252	Rnf135	ring finger protein 135	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313173	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RNF135 mRNA	PMID:38568856
1305252	Rnf135	ring finger protein 135	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552157	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RNF135 mRNA	PMID:37236586
1305252	Rnf135	ring finger protein 135	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552157	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RNF135 mRNA	PMID:36331819
1305252	Rnf135	ring finger protein 135	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D014635	Valproic Acid affects the expression of RNF135 mRNA	PMID:25979313
1305252	Rnf135	ring finger protein 135	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF135 mRNA	PMID:27989131
1305252	Rnf135	ring finger protein 135	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RNF135 mRNA	PMID:25270620
1305252	Rnf135	ring finger protein 135	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:C012589	trichostatin A affects the expression of RNF135 mRNA	PMID:28542535
1305252	Rnf135	ring finger protein 135	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:D000082	Acetaminophen affects the expression of RNF135 mRNA	PMID:17562736
1305252	Rnf135	ring finger protein 135	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:C109476	epoxiconazole results in increased expression of RNF135 mRNA	PMID:35436446
1305252	Rnf135	ring finger protein 135	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552157	E	RGD:6480464	20220920	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RNF135 mRNA	PMID:25554681
1305252	Rnf135	ring finger protein 135	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF135 mRNA	PMID:27188386
1305252	Rnf135	ring finger protein 135	gene	CHEBI:88522	Monobutylphthalate	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of RNF135 mRNA	PMID:29162477
1305252	Rnf135	ring finger protein 135	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313173	E	RGD:6480464	20220920	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF135 mRNA	PMID:27188386
1305252	Rnf135	ring finger protein 135	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313173	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RNF135 mRNA	PMID:38568856
1305253	Otor	otoraplin	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1313174	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of OTOR mRNA	PMID:34925699
1305253	Otor	otoraplin	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313174	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of OTOR mRNA	PMID:23724009
1305253	Otor	otoraplin	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of OTOR mRNA	PMID:33387578
1305253	Otor	otoraplin	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313175	E	RGD:6480464	20241001	CTD	MESH:D005557	Formaldehyde results in increased expression of OTOR mRNA	PMID:33233951
1305253	Otor	otoraplin	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of OTOR mRNA	PMID:32553695
1305253	Otor	otoraplin	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of OTOR mRNA	PMID:40618947
1305253	Otor	otoraplin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20201006	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OTOR mRNA	PMID:32553695
1305253	Otor	otoraplin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OTOR mRNA	PMID:33387578
1305253	Otor	otoraplin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313174	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OTOR mRNA	PMID:20106945|PMID:21632981
1305253	Otor	otoraplin	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTOR mRNA	PMID:26033743
1305253	Otor	otoraplin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of OTOR mRNA	PMID:32553695
1305253	Otor	otoraplin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313174	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OTOR promoter	PMID:27901495
1305253	Otor	otoraplin	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTOR mRNA	PMID:26033743
1305253	Otor	otoraplin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313175	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of OTOR mRNA	PMID:35295148
1305253	Otor	otoraplin	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of OTOR mRNA	PMID:23411599|PMID:34492290
1305253	Otor	otoraplin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OTOR mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305253	Otor	otoraplin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of OTOR mRNA	PMID:41034487
1305253	Otor	otoraplin	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of OTOR mRNA	PMID:37019170
1305253	Otor	otoraplin	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of OTOR mRNA	PMID:21266533
1305253	Otor	otoraplin	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of OTOR mRNA	PMID:30047161
1305253	Otor	otoraplin	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313174	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of OTOR mRNA	PMID:37199045
1305253	Otor	otoraplin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of OTOR mRNA	PMID:30047161
1305253	Otor	otoraplin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of OTOR mRNA	PMID:24780913
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621437	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CEMIP mRNA	PMID:33045310
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313176	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CEMIP mRNA	PMID:26079696
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1313176	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of CEMIP mRNA	PMID:39506029
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313176	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of CEMIP mRNA	PMID:40865780
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of CEMIP mRNA	PMID:30207508
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1313176	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of CEMIP mRNA	PMID:21632981
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEMIP mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CEMIP mRNA	PMID:35811015
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313176	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CEMIP mRNA	PMID:30510588
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of CEMIP mRNA	PMID:24758408
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313176	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CEMIP mRNA	PMID:21795739|PMID:31614463
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in decreased expression of CEMIP mRNA]; Progesterone inhibits the reaction [Estradiol results in increased expression of CEMIP mRNA]	PMID:21795739|PMID:24758408
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA	PMID:25510870
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CEMIP mRNA	PMID:38568856
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CEMIP mRNA	PMID:33387578
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313176	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CEMIP mRNA	PMID:37042841
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	ISO	RGD:1313176	E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of CEMIP mRNA	PMID:39245080
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone inhibits the reaction [Estradiol results in increased expression of CEMIP mRNA]	PMID:21795739
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313176	E	RGD:6480464	20151215	CTD	MESH:C005556	propionaldehyde results in increased expression of CEMIP mRNA	PMID:25014914|PMID:26079696
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of CEMIP mRNA	PMID:33448797
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA]	PMID:33448797
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of CEMIP mRNA	PMID:22017230
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313176	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of CEMIP mRNA	PMID:31256213
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of CEMIP mRNA	PMID:33448797
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA]	PMID:33448797
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of CEMIP mRNA	PMID:16002434|PMID:26485663
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CEMIP mRNA	PMID:33387578
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:17935	octanal	increases expression	ISO	RGD:1313176	E	RGD:6480464	20151215	CTD	MESH:C031639	caprylic aldehyde results in increased expression of CEMIP mRNA	PMID:25014914
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CEMIP mRNA	PMID:28522335
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:188736	Archazolid B	increases expression	ISO	RGD:1313176	E	RGD:6480464	20220104	CTD	MESH:C519728	archazolid B results in increased expression of CEMIP mRNA	PMID:25218289
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1621437	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of CEMIP mRNA	PMID:39984025
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA	PMID:25510870
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA	PMID:25510870
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313176	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEMIP mRNA	PMID:32234424
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313176	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CEMIP gene	PMID:27153756
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEMIP mRNA	PMID:32525701
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20220510	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of CEMIP mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of CEMIP mRNA	PMID:23557933|PMID:41028656
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of CEMIP mRNA	PMID:19561079
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of CEMIP mRNA	PMID:40618947
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1621437	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of CEMIP mRNA	PMID:32186404
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313176	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CEMIP mRNA	PMID:25583101
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEMIP mRNA	PMID:32109520
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313176	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CEMIP mRNA	PMID:20106945|PMID:21632981|PMID:26238291|PMID:29704546
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313176	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CEMIP mRNA	PMID:33212167
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CEMIP mRNA	PMID:30851411
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of CEMIP mRNA	PMID:21198554
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CEMIP mRNA; [Disulfiram binds to Copper] which results in increased expression of CEMIP mRNA; [NSC 689534 binds to Copper] which results in decreased expression of CEMIP mRNA	PMID:20971185|PMID:24690739|PMID:41028656
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313176	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CEMIP mRNA	PMID:29803840
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CEMIP mRNA	PMID:25493608
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313176	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of CEMIP mRNA	PMID:34032870|PMID:38568856
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621437	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of CEMIP mRNA	PMID:39515575
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CEMIP mRNA	PMID:20064835|PMID:21632981
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313176	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CEMIP promoter	PMID:27901495
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313176	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEMIP mRNA	PMID:26238291
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313176	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CEMIP 3' UTR; Benzo(a)pyrene results in increased methylation of CEMIP 5' UTR	PMID:27901495
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CEMIP mRNA; [Disulfiram binds to Copper] which results in increased expression of CEMIP mRNA; [NSC 689534 binds to Copper] which results in decreased expression of CEMIP mRNA	PMID:20971185|PMID:24690739|PMID:41028656
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of CEMIP mRNA	PMID:26014281
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CEMIP mRNA	PMID:27131904
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313176	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CEMIP mRNA	PMID:25895662
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CEMIP mRNA	PMID:26238291
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CEMIP gene	PMID:31601247
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CEMIP mRNA	PMID:32479839
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1621437	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CEMIP mRNA	PMID:35295148
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:33083	fluoranthene	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20170725	CTD	MESH:C007738	fluoranthene results in decreased expression of CEMIP mRNA	PMID:28329830
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CEMIP mRNA	PMID:25181051|PMID:34947998|PMID:38750585
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CEMIP mRNA	PMID:26063408|PMID:37105096
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313176	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CEMIP gene	PMID:31601247
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CEMIP gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEMIP mRNA	PMID:28628672|PMID:31601247
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:34093	1-Hydroxypyrene	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20260203	CTD	MESH:C033146	[Metals, Heavy co-treated with 1-hydroxypyrene] results in decreased methylation of CEMIP gene	PMID:39164771
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1313176	E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CEMIP mRNA	PMID:23146750
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA	PMID:25510870
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA	PMID:25510870
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CEMIP mRNA	PMID:40203079
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621437	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CEMIP mRNA	PMID:30951980
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313176	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CEMIP intron	PMID:30157460
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:34787	heptanal	increases expression	ISO	RGD:1313176	E	RGD:6480464	20151215	CTD	MESH:C046204	heptanal results in increased expression of CEMIP mRNA	PMID:25014914
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEMIP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CEMIP mRNA	PMID:28628672
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313176	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEMIP mRNA	PMID:37042841
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313176	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CEMIP mRNA	PMID:29024780
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CEMIP mRNA	PMID:35163327
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CEMIP mRNA	PMID:30723492
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CEMIP mRNA	PMID:28511854
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CEMIP mRNA	PMID:35163327
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CEMIP mRNA	PMID:40194260
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313176	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CEMIP mRNA	PMID:28302478
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of CEMIP mRNA	PMID:39529242
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1313176	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of CEMIP mRNA	PMID:31626844
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEMIP mRNA	PMID:29427782
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CEMIP mRNA	PMID:25562108
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of CEMIP mRNA	PMID:25047013
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEMIP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CEMIP mRNA	PMID:28628672
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of CEMIP mRNA	PMID:33448797
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA]	PMID:33448797
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CEMIP mRNA	PMID:38832940
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of CEMIP mRNA	PMID:32479839
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313176	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CEMIP mRNA	PMID:22230336|PMID:29067470
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of CEMIP mRNA	PMID:24690739
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of CEMIP mRNA	PMID:35811015
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEMIP mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CEMIP mRNA	PMID:35811015
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CEMIP mRNA	PMID:29279043
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1313176	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of CEMIP mRNA	PMID:29523930
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEMIP mRNA	PMID:32525701
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CEMIP mRNA	PMID:29391264
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1621437	E	RGD:6480464	20200804	CTD	MESH:D002101	Cacodylic Acid results in increased expression of CEMIP mRNA	PMID:32052077
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CEMIP mRNA	PMID:32234424
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEMIP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CEMIP mRNA	PMID:28628672
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:507499	tricetin	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20240903	CTD	MESH:C469689	tricetin results in decreased expression of CEMIP mRNA	PMID:38654487
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA]	PMID:33448797
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313176	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of CEMIP mRNA	PMID:31629900
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1621437	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CEMIP mRNA	PMID:38701926
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313176	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CEMIP mRNA	PMID:28988120
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313176	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CEMIP intron	PMID:30157460
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1621437	E	RGD:6480464	20231031	CTD	MESH:C057862	cyanoginosin LR results in increased expression of CEMIP mRNA	PMID:37342990
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CEMIP mRNA	PMID:31758290
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1313176	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of CEMIP mRNA	PMID:29522793
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CEMIP mRNA	PMID:30851411
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CEMIP mRNA	PMID:32109520
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of CEMIP mRNA	PMID:19095052
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1313176	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CEMIP mRNA	PMID:23146750
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CEMIP mRNA	PMID:27935865
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1621437	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of CEMIP mRNA	PMID:27029645
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313176	E	RGD:6480464	20151215	CTD	MESH:C046012	pentanal results in increased expression of CEMIP mRNA	PMID:25014914|PMID:26079696
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313176	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEMIP mRNA	PMID:32525701
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CEMIP mRNA	PMID:24780913
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313176	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of CEMIP mRNA	PMID:26014281
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CEMIP mRNA	PMID:27131904
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:9355	sulfuretin	decreases activity	ISO	RGD:1621437	E	RGD:6480464	20241105	CTD	MESH:C054989	sulfuretin results in decreased activity of CEMIP protein	PMID:39454959
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313176	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CEMIP mRNA	PMID:38568856
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313176	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CEMIP mRNA	PMID:29301935
1305254	Cemip	cell migration inducing hyaluronidase 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of CEMIP gene	PMID:31682807
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of TBC1D30 mRNA	PMID:26272509
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA	PMID:27188386
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313177	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TBC1D30 mRNA	PMID:33045310
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313177	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBC1D30 mRNA	PMID:30529165
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313177	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TBC1D30 mRNA	PMID:36331819
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:2291766	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of TBC1D30 mRNA	PMID:29581250
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313177	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TBC1D30 mRNA	PMID:39298647
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:2291766	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TBC1D30 mRNA	PMID:31614463
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of TBC1D30 mRNA	PMID:30165855
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:2291766	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TBC1D30 mRNA	PMID:37042841
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of TBC1D30 gene	PMID:33872906
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TBC1D30 mRNA	PMID:31163220
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of TBC1D30 gene	PMID:33872906
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TBC1D30 mRNA	PMID:33387578
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TBC1D30 mRNA	PMID:28818685
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313177	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TBC1D30 mRNA	PMID:36331819
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313177	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TBC1D30 mRNA	PMID:37236586
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of TBC1D30 mRNA	PMID:21396975
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313177	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TBC1D30 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TBC1D30 mRNA	PMID:34911549
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TBC1D30 mRNA	PMID:30779732
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TBC1D30 mRNA	PMID:19244175
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of TBC1D30 mRNA	PMID:26272509
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA	PMID:27188386
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:2291766	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of TBC1D30 protein	PMID:35688186
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313177	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TBC1D30 mRNA	PMID:28189721|PMID:28960355
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBC1D30 mRNA	PMID:22298810
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBC1D30 mRNA	PMID:33387578
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TBC1D30 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TBC1D30 mRNA	PMID:33212167
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TBC1D30 mRNA	PMID:20971185
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TBC1D30 mRNA	PMID:20971185
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313177	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of TBC1D30 mRNA	PMID:23557971
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313177	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TBC1D30 gene	PMID:35295148
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TBC1D30 mRNA	PMID:23411599
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313177	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TBC1D30 mRNA	PMID:23811191
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TBC1D30 mRNA	PMID:25181051
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313177	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TBC1D30 mRNA	PMID:32156529
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TBC1D30 mRNA	PMID:30816183
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313177	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of TBC1D30 mRNA	PMID:25172293
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:2291766	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TBC1D30 mRNA	PMID:25979313
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313177	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of TBC1D30 mRNA	PMID:33297965|PMID:39298647|PMID:40203079
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313177	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TBC1D30 mRNA	PMID:26377693
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313177	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of TBC1D30 mRNA	PMID:30951980
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313177	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of TBC1D30 intron	PMID:28392331
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313177	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TBC1D30 3' UTR	PMID:28392331
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313177	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TBC1D30 mRNA	PMID:37019170
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:2291766	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TBC1D30 mRNA	PMID:37042841
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313177	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of TBC1D30 mRNA	PMID:26377693
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313177	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TBC1D30 mRNA	PMID:37236586
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TBC1D30 mRNA	PMID:19244175
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313177	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TBC1D30 mRNA	PMID:40194260
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:2291766	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TBC1D30 mRNA	PMID:31533062
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313177	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TBC1D30 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TBC1D30 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of TBC1D30 mRNA	PMID:36331819
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:2291766	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TBC1D30 mRNA	PMID:25979313
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TBC1D30 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:2291766	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of TBC1D30 mRNA	PMID:24935251
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA	PMID:27188386
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of TBC1D30 mRNA	PMID:26272509
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA	PMID:27188386
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TBC1D30 mRNA	PMID:24935251|PMID:26272509
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:2291766	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TBC1D30 mRNA	PMID:24935251
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA	PMID:27188386
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TBC1D30 mRNA	PMID:33387578
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in decreased expression of TBC1D30 mRNA	PMID:26833863
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TBC1D30 mRNA	PMID:29097150
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TBC1D30 mRNA	PMID:30307764
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313177	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TBC1D30 mRNA; Nanotubes, Carbon results in decreased expression of TBC1D30 mRNA	PMID:25554681|PMID:25620056
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313177	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TBC1D30 mRNA	PMID:38701926
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA	PMID:27188386
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:2291766	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of TBC1D30 mRNA	PMID:26272509
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA	PMID:27188386
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:2291766	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D30 mRNA	PMID:27188386
1305255	Tbc1d30	TBC1 domain family, member 30	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313177	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of TBC1D30 mRNA	PMID:28973697
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313179	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LRRN4 mRNA	PMID:33045310
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1313178	E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of LRRN4 mRNA	PMID:31600526
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313178	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of LRRN4 mRNA	PMID:21934132
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRRN4 mRNA	PMID:37992649
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313178	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of LRRN4 mRNA	PMID:33647349
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRRN4 mRNA	PMID:37992649
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313178	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LRRN4 mRNA	PMID:31163220
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LRRN4 mRNA	PMID:26577399
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LRRN4 mRNA	PMID:33387578
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313178	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LRRN4 mRNA	PMID:28818685
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313178	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LRRN4 mRNA	PMID:19549813
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of LRRN4 protein	PMID:33236894
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LRRN4 mRNA	PMID:22129741
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LRRN4 mRNA	PMID:28960355
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313179	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of LRRN4 mRNA	PMID:32186404
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313179	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRRN4 mRNA	PMID:21570461|PMID:26377647
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRRN4 mRNA	PMID:33387578
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313178	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRRN4 mRNA	PMID:20106945|PMID:21632981
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LRRN4 promoter]	PMID:19654925
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313178	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of LRRN4 mRNA	PMID:21198554
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313178	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LRRN4 mRNA	PMID:29803840
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRRN4 mRNA	PMID:37992649
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:28854	2,4-D	decreases expression	ISO	RGD:1313178	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of LRRN4 mRNA	PMID:40294809
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313179	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of LRRN4 mRNA	PMID:37682722
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313178	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRRN4 5' UTR	PMID:27901495
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313178	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRRN4 promoter	PMID:27901495
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313179	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRRN4 intron	PMID:27901495
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313178	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRRN4 mRNA	PMID:20106945|PMID:21632981|PMID:21871943
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to LRRN4 promoter]	PMID:19654925
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of LRRN4 mRNA	PMID:27131904
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of LRRN4 mRNA	PMID:35676786
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313179	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of LRRN4 mRNA	PMID:23557971
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313179	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRRN4 gene	PMID:35295148
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313178	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LRRN4 mRNA	PMID:19710929
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRN4 mRNA	PMID:25181051
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRN4 mRNA	PMID:26063408
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313179	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LRRN4 mRNA	PMID:32156529
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313178	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of LRRN4 gene	PMID:31601247
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313179	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LRRN4 mRNA	PMID:30951980
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1313179	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of LRRN4 mRNA	PMID:26377693
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313179	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of LRRN4 mRNA	PMID:38685157
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LRRN4 mRNA	PMID:22129741
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313178	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LRRN4 mRNA	PMID:31533062
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of LRRN4 mRNA	PMID:39529242
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313178	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LRRN4 mRNA	PMID:40419075
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:39481	chloroprene	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of LRRN4 mRNA	PMID:23125180
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313178	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LRRN4 mRNA	PMID:25979313
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313178	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of LRRN4 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313178	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LRRN4 gene	PMID:29154799
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313178	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA	PMID:27188386
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313178	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of LRRN4 mRNA	PMID:19159671
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of LRRN4 mRNA	PMID:28973697
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRRN4 mRNA	PMID:37992649
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313178	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LRRN4 mRNA	PMID:38832940
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313178	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of LRRN4 mRNA	PMID:24935251
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LRRN4 mRNA	PMID:33387578
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LRRN4 mRNA	PMID:29391264
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of LRRN4 mRNA	PMID:37567419
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1313178	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of LRRN4 mRNA	PMID:26272509
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of LRRN4 mRNA	PMID:35676786
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LRRN4 mRNA; Nanotubes, Carbon results in decreased expression of LRRN4 mRNA	PMID:25554681
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313179	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of LRRN4 mRNA	PMID:40234311
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of LRRN4 mRNA	PMID:26377693
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1313179	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of LRRN4 mRNA	PMID:26377693
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:53578	hexamethylene diisocyanate	increases methylation	ISO	RGD:1313178	E	RGD:6480464	20150414	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in increased methylation of LRRN4 gene	PMID:25445006
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:68508	diethyl maleate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in increased expression of LRRN4 mRNA	PMID:21161181
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of LRRN4 mRNA	PMID:23665939
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313178	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA	PMID:27188386
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313179	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LRRN4 mRNA	PMID:38648751
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of LRRN4 mRNA	PMID:26377693
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313178	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA	PMID:27188386
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313178	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA	PMID:27188386
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of LRRN4 mRNA	PMID:27131904
1305256	Lrrn4	leucine rich repeat neuronal 4	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in decreased expression of LRRN4 mRNA	PMID:22615374
1305257	Vom1r108	vomeronasal 1 receptor 108	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of VOM1R108 mRNA	PMID:25539665
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332196	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CWC25 mRNA	PMID:33045310
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CWC25 gene	PMID:28931070
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1603211	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CWC25 mRNA	PMID:22378314
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of CWC25 protein	PMID:32145629
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603211	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CWC25 mRNA	PMID:37042841
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1603211	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CWC25 protein	PMID:37730182
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CWC25 mRNA	PMID:33387578
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1603211	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CWC25 mRNA	PMID:19549813
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:25710	organophosphorus compound	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in decreased expression of CWC25 mRNA	PMID:39658253
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603211	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CWC25 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CWC25 mRNA	PMID:35430440|PMID:41430723
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1603211	E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in decreased expression of CWC25 protein	PMID:31195006
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603211	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CWC25 mRNA	PMID:23557933
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332196	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CWC25 mRNA	PMID:21570461
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1603211	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CWC25 mRNA	PMID:33212167
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CWC25 mRNA	PMID:28959563
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1603211	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CWC25 mRNA	PMID:24690739
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603211	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of CWC25 mRNA	PMID:39719251
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603211	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CWC25 mRNA	PMID:38568856
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1603211	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CWC25 mRNA	PMID:24690739
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1603211	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of CWC25 mRNA	PMID:26014281
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1332196	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CWC25 mRNA	PMID:35295148
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CWC25 mRNA	PMID:34492290
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of CWC25 protein	PMID:32145629
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CWC25 mRNA	PMID:25181051|PMID:30816183
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332196	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CWC25 mRNA	PMID:26063408
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1603211	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CWC25 mRNA	PMID:28628672
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332196	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CWC25 mRNA	PMID:37019170
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1603211	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CWC25 mRNA	PMID:28628672
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603211	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CWC25 mRNA	PMID:37042841
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332196	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CWC25 mRNA	PMID:36331819
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603211	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CWC25 mRNA	PMID:25562108
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1603211	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CWC25 mRNA	PMID:28628672
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1603211	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of CWC25 mRNA	PMID:24449571
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332196	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CWC25 mRNA	PMID:17562736
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603211	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CWC25 mRNA	PMID:22230336
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1603211	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of CWC25 mRNA	PMID:24690739
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1603211	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of CWC25 protein	PMID:31195006
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1603211	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CWC25 mRNA	PMID:28628672
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CWC25 mRNA	PMID:19564919
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:73297	SCH 23390	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in decreased expression of CWC25 mRNA	PMID:19564919
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1332196	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of CWC25 mRNA	PMID:22206623
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of CWC25 mRNA	PMID:36084822
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1603211	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of CWC25 mRNA	PMID:26014281
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CWC25 mRNA	PMID:19281266
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1603211	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CWC25 mRNA	PMID:38568856
1305258	Cwc25	CWC25 spliceosome associated protein	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CWC25 mRNA	PMID:20566332|PMID:23034163
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of AFG3L2 mRNA]	PMID:19467301
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313184	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of AFG3L2 mRNA	PMID:26251327
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313184	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of AFG3L2 promoter	PMID:26251327
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313183	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of AFG3L2 mRNA	PMID:33167477
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of AFG3L2 protein	PMID:39571964
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313183	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of AFG3L2 mRNA	PMID:22378314
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313184	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of AFG3L2 mRNA	PMID:30319688
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313184	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of AFG3L2 mRNA	PMID:39241906
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313183	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of AFG3L2 mRNA	PMID:21179406
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AFG3L2 mRNA	PMID:36331819
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:18388	apigenin	increases expression	ISO	RGD:1313184	E	RGD:6480464	20121113	CTD	MESH:D047310	Apigenin results in increased expression of AFG3L2 mRNA	PMID:22359648
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of AFG3L2 protein	PMID:34915118
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of AFG3L2 mRNA	PMID:22206623
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of AFG3L2 mRNA	PMID:23557933
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313184	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AFG3L2 mRNA	PMID:21570461
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313184	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AFG3L2 mRNA	PMID:15034205
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313184	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of AFG3L2 mRNA	PMID:26873546
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313183	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of AFG3L2 mRNA	PMID:29803840
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313183	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AFG3L2 mRNA	PMID:38568856
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20251007	CTD	MESH:C017947	[sodium arsenite co-treated with lead acetate] results in increased expression of AFG3L2 protein; [sodium arsenite co-treated with Tretinoin] results in increased expression of AFG3L2 protein	PMID:38072110|PMID:39571964
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313184	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AFG3L2 mRNA	PMID:15034205
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in increased expression of AFG3L2 protein	PMID:38072110
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313184	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AFG3L2 promoter	PMID:35295148
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of AFG3L2 mRNA	PMID:23411599
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313184	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of AFG3L2 mRNA	PMID:18301758
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AFG3L2 mRNA	PMID:30816183|PMID:32528016
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AFG3L2 mRNA	PMID:25181051
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313183	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of AFG3L2 protein	PMID:34186270|PMID:37567409
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AFG3L2 gene	PMID:28505145
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AFG3L2 mRNA	PMID:28628672
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313183	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of AFG3L2 protein	PMID:34186270
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFG3L2 mRNA	PMID:28628672
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313183	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of AFG3L2 protein	PMID:34186270
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AFG3L2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFG3L2 mRNA	PMID:28628672
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of AFG3L2 mRNA	PMID:36117858
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313183	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AFG3L2 mRNA	PMID:37042841
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of AFG3L2 mRNA	PMID:24386269
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AFG3L2 mRNA	PMID:36331819
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313183	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AFG3L2 mRNA	PMID:25979313
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313184	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of AFG3L2 mRNA	PMID:21427059
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of AFG3L2 mRNA	PMID:17183730
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AFG3L2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFG3L2 mRNA	PMID:28628672
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313183	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of AFG3L2 mRNA	PMID:24935251
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313183	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of AFG3L2 mRNA	PMID:25704631|PMID:26690555
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of AFG3L2 mRNA	PMID:29391264
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313184	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of AFG3L2 mRNA	PMID:35436446
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AFG3L2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFG3L2 mRNA	PMID:28628672
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of AFG3L2 mRNA	PMID:35964746
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of AFG3L2 mRNA	PMID:24136188
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of AFG3L2 mRNA	PMID:36117858
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of AFG3L2 mRNA	PMID:17183730
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313183	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AFG3L2 protein	PMID:32959892
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313184	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of AFG3L2 mRNA	PMID:23650126
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1313183	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of AFG3L2 mRNA	PMID:37939859
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313183	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AFG3L2 protein	PMID:34186270
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313184	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AFG3L2 mRNA	PMID:22206623
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of AFG3L2 mRNA	PMID:22206623
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AFG3L2 protein	PMID:37664457
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of AFG3L2 mRNA	PMID:24136188
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of AFG3L2 mRNA	PMID:21346803
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313184	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of AFG3L2 mRNA	PMID:31388691
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313183	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AFG3L2 protein	PMID:37664457
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313183	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AFG3L2 mRNA	PMID:38568856
1305259	Afg3l2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of AFG3L2 mRNA	PMID:21346803
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1346090	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TMED6 mRNA	PMID:20044591
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TMED6 mRNA	PMID:21632981
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1553422	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of TMED6 mRNA	PMID:33711761
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1346090	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TMED6 mRNA	PMID:23649840
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TMED6 mRNA	PMID:28818685
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TMED6 mRNA	PMID:19549813
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1346090	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TMED6 gene	PMID:27153756
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346090	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TMED6 mRNA	PMID:23557933
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of TMED6 mRNA	PMID:19921347
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TMED6 mRNA	PMID:27392435
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1553422	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of TMED6 mRNA	PMID:18930951
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1553422	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of TMED6 mRNA	PMID:32186404
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMED6 mRNA	PMID:26238291
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1346090	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TMED6 mRNA	PMID:33212167
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMED6 mRNA	PMID:29301061
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1553422	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMED6 mRNA	PMID:37682722
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553422	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMED6 mRNA	PMID:34876320
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1553422	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMED6 mRNA	PMID:34876320
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1346090	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of TMED6 mRNA	PMID:20106945
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMED6 mRNA	PMID:21632981|PMID:22316170|PMID:26238291
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553422	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TMED6 mRNA	PMID:17426115
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TMED6 mRNA	PMID:25181051
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1553422	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of TMED6 mRNA	PMID:26377693
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TMED6 mRNA	PMID:21266533
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1553422	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of TMED6 mRNA	PMID:24535843
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TMED6 mRNA	PMID:24449571
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TMED6 mRNA	PMID:28302478
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of TMED6 mRNA	PMID:22561333
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TMED6 mRNA	PMID:30047161
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TMED6 mRNA	PMID:20106945|PMID:25562108
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346090	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of TMED6 mRNA	PMID:27989131
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1346090	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TMED6 mRNA	PMID:38832940
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1553422	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMED6 mRNA	PMID:34876320
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TMED6 mRNA	PMID:30047161
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1553422	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TMED6 mRNA	PMID:19042947
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1346090	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TMED6 mRNA	PMID:28988120
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346090	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TMED6 gene]	PMID:28238834
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1553422	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in decreased expression of TMED6 mRNA	PMID:26655953
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1553422	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TMED6 mRNA	PMID:38648751
1305260	Tmed6	transmembrane p24 trafficking protein 6	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1553422	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMED6 mRNA	PMID:34876320
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20180116	CTD	MESH:C007262	[deoxynivalenol co-treated with Zearalenone] results in decreased expression of CYP4F3 mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of CYP4F3 mRNA	PMID:28865950|PMID:28935499
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20180116	CTD	MESH:D015025	Zearalenone results in decreased expression of CYP4F3 mRNA	PMID:28865950
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:10106	zearalenone	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20180116	CTD	MESH:D015025	[deoxynivalenol co-treated with Zearalenone] results in decreased expression of CYP4F3 mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of CYP4F3 mRNA	PMID:28865950|PMID:28935499
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1349362	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CYP4F3 mRNA	PMID:38218311
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1349362	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in increased expression of CYP4F3 mRNA	PMID:24172598
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313186	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CYP4F18 mRNA	PMID:33045310
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D014212	Tretinoin results in increased expression of CYP4F3 mRNA; Tretinoin results in increased expression of CYP4F3 protein	PMID:17218384|PMID:19029204|PMID:20036648|PMID:33167477
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CYP4F18 mRNA	PMID:33729688
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CYP4F3 mRNA	PMID:26079696
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:15843	arachidonic acid	increases hydroxylation	ISO	RGD:1349362	E	RGD:6480464	20200519	CTD	MESH:D016718	CYP4F3 protein alternative form results in increased hydroxylation of Arachidonic Acid	PMID:30259074
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:15843	arachidonic acid	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20200519	CTD	MESH:D016718	rubiarbonone C inhibits the reaction [CYP4F3 protein alternative form results in increased hydroxylation of Arachidonic Acid]	PMID:30259074
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:15882	phenol	increases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D019800	Phenol results in increased expression of CYP4F3 mRNA; Phenol results in increased expression of CYP4F3 protein	PMID:19029204|PMID:20036648
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of CYP4F3 mRNA	PMID:40865780
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CYP4F18 mRNA	PMID:30517762
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313186	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CYP4F18 mRNA	PMID:39241906
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CYP4F3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CYP4F3 mRNA	PMID:35811015
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D004958	Estradiol results in decreased expression of CYP4F3 mRNA	PMID:17982697
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D004958	[Parathion co-treated with Estradiol] results in increased expression of CYP4F3 mRNA	PMID:17982697
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CYP4F3 mRNA	PMID:38568856
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1349362	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CYP4F3 mRNA	PMID:37042841
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313186	E	RGD:6480464	20140211	CTD	MESH:D001554	Benzene metabolite results in increased expression of CYP4F18 mRNA	PMID:23940708
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D001554	Benzene results in increased expression of CYP4F3 mRNA; Benzene results in increased expression of CYP4F3 protein	PMID:20036648
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16767	3,4-dichloroaniline	increases expression	ISO	RGD:1349362	E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in increased expression of CYP4F3 mRNA	PMID:24172598
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of CYP4F3 mRNA	PMID:28937961
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1349362	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CYP4F3 mRNA	PMID:23649840
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CYP4F18 mRNA	PMID:37992649
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313186	E	RGD:6480464	20140211	CTD	MESH:C031927	hydroquinone results in increased expression of CYP4F18 mRNA; hydroquinone results in increased expression of CYP4F18 protein	PMID:23940708
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CYP4F18 mRNA	PMID:37992649
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1349362	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CYP4F3 mRNA	PMID:23825647
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20241001	CTD	MESH:D004051	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP4F18 protein	PMID:38995844
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CYP4F18 mRNA	PMID:33387578
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:17967	urethane	affects expression	ISO	RGD:1349362	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane affects the expression of CYP4F3 mRNA	PMID:28818685
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1349362	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CYP4F3 mRNA	PMID:23825647
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1349362	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of CYP4F3 mRNA	PMID:21120746
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP4F18 mRNA	PMID:37325564
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CYP4F3 mRNA	PMID:19549813
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1349362	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CYP4F3 mRNA	PMID:23649840
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1349362	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CYP4F3 mRNA	PMID:23649840
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CYP4F18 mRNA	PMID:34911549
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CYP4F3 mRNA	PMID:35430440
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CYP4F18 mRNA	PMID:30779732
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CYP4F18 mRNA	PMID:30517762
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CYP4F18 mRNA	PMID:22206623
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYP4F18 mRNA	PMID:40504410
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYP4F3 mRNA	PMID:40512198
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313186	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CYP4F18 mRNA	PMID:28960355
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1349362	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CYP4F3 mRNA	PMID:27392435
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CYP4F3 mRNA	PMID:27392435
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1313186	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of CYP4F18 mRNA	PMID:16917069
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D010278	Parathion results in increased expression of CYP4F3 mRNA	PMID:17982697
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:27928	parathion	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D010278	[Parathion co-treated with Estradiol] results in increased expression of CYP4F3 mRNA	PMID:17982697
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313186	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYP4F18 mRNA	PMID:26377647|PMID:28922406
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYP4F18 mRNA	PMID:33387578
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313186	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYP4F18 mRNA	PMID:28213091
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1349362	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of CYP4F3 mRNA	PMID:23649840
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CYP4F18 mRNA	PMID:37992649
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of CYP4F3 mRNA	PMID:29301061
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313186	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CYP4F18 mRNA	PMID:25065748|PMID:37682722
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1349362	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CYP4F3 mRNA	PMID:38568856|PMID:39719251
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYP4F18 mRNA	PMID:34876320|PMID:40504410
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYP4F3 mRNA	PMID:40512198
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA	PMID:34876320
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313186	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CYP4F18 mRNA	PMID:20127859
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CYP4F3 mRNA	PMID:32234424
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1349362	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CYP4F3 promoter	PMID:27901495
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313186	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYP4F18 mRNA	PMID:22228805
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CYP4F18 mRNA]	PMID:22228805
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CYP4F3 mRNA	PMID:25351596
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313186	E	RGD:6480464	20251007	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CYP4F18 mRNA	PMID:38758479
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1313186	E	RGD:6480464	20140408	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CYP4F18 mRNA	PMID:24472606
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CYP4F18 mRNA	PMID:30047161
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313186	E	RGD:6480464	20131008	CTD	MESH:C009495	titanium dioxide results in increased expression of CYP4F18 mRNA	PMID:23131501
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CYP4F18 mRNA	PMID:34492290
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313186	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of CYP4F18 mRNA	PMID:23811191
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313186	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CYP4F18 mRNA	PMID:28472532
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1349362	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CYP4F3 mRNA	PMID:30903817
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CYP4F11 mRNA; bisphenol A results in decreased expression of CYP4F3 mRNA	PMID:25181051
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:3387	carbamazepine	increases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D002220	Carbamazepine results in increased expression of CYP4F3 mRNA	PMID:17112801
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313186	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CYP4F18 mRNA	PMID:26682919
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:34185	19(S)-HETE	increases chemical synthesis	ISO	RGD:1349362	E	RGD:6480464	20200519	CTD	MESH:C055986	CYP4F3 protein alternative form results in increased chemical synthesis of 19-hydroxy-5,8,11,14-eicosatetraenoic acid	PMID:30259074
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of CYP4F18 mRNA	PMID:30316929
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:34306	20-HETE	increases abundance	ISO	RGD:1313186	E	RGD:6480464	20260616	CTD	MESH:C055987	CYP4F2 protein results in increased abundance of 20-hydroxy-5,8,11,14-eicosatetraenoic acid	PMID:27568038
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:34306	20-HETE	increases chemical synthesis	ISO	RGD:1349362	E	RGD:6480464	20200519	CTD	MESH:C055987	CYP4F3 protein alternative form results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid	PMID:30259074
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313186	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CYP4F18 mRNA	PMID:39298647
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313186	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CYP4F18 exon	PMID:28392331
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20241001	CTD	MESH:C027561	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP4F18 protein	PMID:38995844
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20241001	CTD	MESH:D003993	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP4F18 protein	PMID:38995844
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1349362	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CYP4F3 mRNA	PMID:37042841
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of CYP4F18 mRNA	PMID:35163327
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CYP4F3 mRNA	PMID:38382870
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CYP4F18 promoter	PMID:22457795
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1349362	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CYP4F3 mRNA	PMID:38174414
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP4F18 mRNA	PMID:37325564
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of CYP4F18 mRNA	PMID:35163327
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CYP4F3 mRNA	PMID:24449571
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313186	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of CYP4F18 mRNA	PMID:29038090
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313186	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of CYP4F18 mRNA	PMID:23125180
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313186	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of CYP4F18 mRNA	PMID:22155349
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of CYP4F3 mRNA	PMID:29501571
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CYP4F18 mRNA	PMID:30047161
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CYP4F18 mRNA	PMID:37992649
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:43602	obeticholic acid	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of CYP4F3 mRNA	PMID:27939613
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1349362	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of CYP4F3 mRNA	PMID:23649840
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D008727	Methotrexate results in increased expression of CYP4F3 mRNA	PMID:17400583
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CYP4F3 mRNA	PMID:38832940
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313186	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CYP4F18 mRNA	PMID:17562736
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D000082	Acetaminophen results in increased expression of CYP4F3 mRNA	PMID:22230336
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CYP4F3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CYP4F3 mRNA	PMID:35811015
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CYP4F3 mRNA	PMID:18687144|PMID:25351596
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYP4F18 mRNA	PMID:40504410
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYP4F3 mRNA	PMID:40512198
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1349362	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of CYP4F3 mRNA	PMID:26833863|PMID:31838189
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA	PMID:34876320
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313186	E	RGD:6480464	20251007	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CYP4F18 mRNA	PMID:38758479
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313186	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CYP4F18 mRNA; Nanotubes, Carbon results in increased expression of CYP4F18 mRNA	PMID:25554681|PMID:27106021
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CYP4F18 mRNA	PMID:30047161
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:5643	Heliotrine	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20150825	CTD	MESH:C010178	heliotrine results in decreased expression of CYP4F3 mRNA	PMID:26100227
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:5870	imidacloprid	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C082359	imidacloprid results in increased expression of CYP4F18 mRNA	PMID:37632782
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313186	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CYP4F18 mRNA	PMID:38701926
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D015474	Isotretinoin results in decreased expression of CYP4F3 mRNA	PMID:20436886
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:63998	19-HETE	increases chemical synthesis	ISO	RGD:1349362	E	RGD:6480464	20200519	CTD	MESH:C055986	CYP4F3 protein alternative form results in increased chemical synthesis of 19-hydroxy-5,8,11,14-eicosatetraenoic acid	PMID:30259074
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:69527	rubiarbonone C	decreases activity	ISO	RGD:1349362	E	RGD:6480464	20200519	CTD	MESH:C000654633	rubiarbonone C results in decreased activity of CYP4F3 protein alternative form	PMID:30259074
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:69527	rubiarbonone C	multiple interactions	ISO	RGD:1349362	E	RGD:6480464	20200519	CTD	MESH:C000654633	rubiarbonone C inhibits the reaction [CYP4F3 protein alternative form results in increased hydroxylation of Arachidonic Acid]	PMID:30259074
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CYP4F18 mRNA	PMID:27935865
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313186	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CYP4F18 mRNA	PMID:22206623
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CYP4F18 mRNA	PMID:22206623
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1349362	E	RGD:6480464	20171010	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CYP4F3 mRNA	PMID:28601433
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D010634	Phenobarbital affects the expression of CYP4F3 mRNA	PMID:19084549
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of CYP4F3 mRNA	PMID:39904859
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313186	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of CYP4F18 mRNA	PMID:39847705
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313186	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA	PMID:34876320
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CYP4F18 mRNA	PMID:24780913|PMID:30047161
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:87368	diethyl malate	increases expression	ISO	RGD:1349362	E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of CYP4F3 mRNA	PMID:38498338
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:9111	Senkirkine	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20150825	CTD	MESH:C009238	senkirkine results in decreased expression of CYP4F3 mRNA	PMID:26100227
1305261	Cyp4f18	cytochrome P450, family 4, subfamily f, polypeptide 18	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1349362	E	RGD:6480464	20131220	CTD	MESH:D019284	Thapsigargin results in decreased expression of CYP4F3 mRNA	PMID:19442820
1305262	Golga3	golgin A3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GOLGA3 mRNA]	PMID:31150632
1305262	Golga3	golgin A3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313187	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of GOLGA3 mRNA	PMID:23724009
1305262	Golga3	golgin A3	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of GOLGA3 mRNA	PMID:25056781
1305262	Golga3	golgin A3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313188	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of GOLGA3 mRNA	PMID:30319688
1305262	Golga3	golgin A3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313187	E	RGD:6480464	20170516	CTD	MESH:D011794	Quercetin results in decreased expression of GOLGA3 protein	PMID:14750173
1305262	Golga3	golgin A3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313187	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of GOLGA3 mRNA	PMID:38568856
1305262	Golga3	golgin A3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313187	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GOLGA3 mRNA	PMID:37042841
1305262	Golga3	golgin A3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of GOLGA3 mRNA	PMID:33848595
1305262	Golga3	golgin A3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of GOLGA3 mRNA]	PMID:33848595
1305262	Golga3	golgin A3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313187	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of GOLGA3 protein	PMID:37730182
1305262	Golga3	golgin A3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GOLGA3 mRNA	PMID:33387578
1305262	Golga3	golgin A3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GOLGA3 protein	PMID:34915118
1305262	Golga3	golgin A3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GOLGA3 mRNA	PMID:37236586
1305262	Golga3	golgin A3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313187	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GOLGA3 protein	PMID:23301498
1305262	Golga3	golgin A3	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of GOLGA3 mRNA	PMID:25056781
1305262	Golga3	golgin A3	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313187	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GOLGA3 mRNA	PMID:18593933
1305262	Golga3	golgin A3	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GOLGA3 mRNA	PMID:31150632
1305262	Golga3	golgin A3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GOLGA3 mRNA]	PMID:31150632
1305262	Golga3	golgin A3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GOLGA3 mRNA	PMID:25629700
1305262	Golga3	golgin A3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313187	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GOLGA3 gene	PMID:25304211
1305262	Golga3	golgin A3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GOLGA3 mRNA	PMID:40504410
1305262	Golga3	golgin A3	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313187	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of GOLGA3 mRNA	PMID:19244175
1305262	Golga3	golgin A3	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1313187	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA	PMID:19244175
1305262	Golga3	golgin A3	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313187	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of GOLGA3 protein	PMID:35688186
1305262	Golga3	golgin A3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313187	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of GOLGA3 mRNA	PMID:27594783
1305262	Golga3	golgin A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313188	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GOLGA3 mRNA	PMID:21570461
1305262	Golga3	golgin A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GOLGA3 mRNA	PMID:32109520
1305262	Golga3	golgin A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GOLGA3 mRNA	PMID:23994337
1305262	Golga3	golgin A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GOLGA3 mRNA	PMID:25975270
1305262	Golga3	golgin A3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20250401	CTD	MESH:D004317	Doxorubicin results in decreased expression of GOLGA3 protein	PMID:38244039
1305262	Golga3	golgin A3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313188	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of GOLGA3 mRNA	PMID:39631538
1305262	Golga3	golgin A3	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313187	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of GOLGA3 protein	PMID:35688186
1305262	Golga3	golgin A3	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313187	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of GOLGA3 mRNA	PMID:20044591
1305262	Golga3	golgin A3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313187	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GOLGA3 mRNA	PMID:38568856
1305262	Golga3	golgin A3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GOLGA3 mRNA	PMID:40504410
1305262	Golga3	golgin A3	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313187	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of GOLGA3 mRNA	PMID:22378314
1305262	Golga3	golgin A3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313187	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GOLGA3 promoter	PMID:27901495
1305262	Golga3	golgin A3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313187	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to GOLGA3 mRNA]	PMID:32406909
1305262	Golga3	golgin A3	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313187	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GOLGA3 mRNA	PMID:18593933
1305262	Golga3	golgin A3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313188	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of GOLGA3 mRNA	PMID:23221170
1305262	Golga3	golgin A3	gene	CHEBI:30778	gallic acid	increases expression	ISO	RGD:1313187	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of GOLGA3 mRNA	PMID:34408198
1305262	Golga3	golgin A3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313187	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GOLGA3 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of GOLGA3 gene	PMID:31601247
1305262	Golga3	golgin A3	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313187	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of GOLGA3 mRNA	PMID:31745603
1305262	Golga3	golgin A3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GOLGA3 mRNA	PMID:29264374
1305262	Golga3	golgin A3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313188	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GOLGA3 gene	PMID:35295148
1305262	Golga3	golgin A3	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of GOLGA3 mRNA	PMID:19167457
1305262	Golga3	golgin A3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GOLGA3 mRNA	PMID:34947998
1305262	Golga3	golgin A3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313187	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GOLGA3 gene	PMID:31601247
1305262	Golga3	golgin A3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GOLGA3 mRNA	PMID:25181051
1305262	Golga3	golgin A3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313187	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GOLGA3 gene	PMID:31601247
1305262	Golga3	golgin A3	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313187	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of GOLGA3 mRNA	PMID:19244175
1305262	Golga3	golgin A3	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1313187	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA	PMID:19244175
1305262	Golga3	golgin A3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GOLGA3 mRNA	PMID:23994337
1305262	Golga3	golgin A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GOLGA3 mRNA	PMID:39298647
1305262	Golga3	golgin A3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313187	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of GOLGA3 intron	PMID:30157460
1305262	Golga3	golgin A3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313188	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of GOLGA3 mRNA	PMID:38685157
1305262	Golga3	golgin A3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313187	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of GOLGA3 gene	PMID:31601247
1305262	Golga3	golgin A3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of GOLGA3 mRNA	PMID:37019170
1305262	Golga3	golgin A3	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313188	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of GOLGA3 protein	PMID:35362542
1305262	Golga3	golgin A3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GOLGA3 protein]	PMID:35362542
1305262	Golga3	golgin A3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313187	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GOLGA3 mRNA	PMID:37042841
1305262	Golga3	golgin A3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GOLGA3 mRNA	PMID:33453195
1305262	Golga3	golgin A3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GOLGA3 mRNA	PMID:37236586
1305262	Golga3	golgin A3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313187	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of GOLGA3 mRNA	PMID:23146750
1305262	Golga3	golgin A3	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313187	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of GOLGA3 mRNA	PMID:19244175
1305262	Golga3	golgin A3	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1313187	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA	PMID:19244175
1305262	Golga3	golgin A3	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1313187	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of GOLGA3 protein	PMID:34122009
1305262	Golga3	golgin A3	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313187	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of GOLGA3 mRNA	PMID:28302478
1305262	Golga3	golgin A3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313187	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GOLGA3 mRNA	PMID:25979313
1305262	Golga3	golgin A3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313188	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GOLGA3 mRNA	PMID:17292431
1305262	Golga3	golgin A3	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of GOLGA3 mRNA	PMID:29427782
1305262	Golga3	golgin A3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313187	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GOLGA3 mRNA	PMID:20106945|PMID:25562108
1305262	Golga3	golgin A3	gene	CHEBI:42223	emodin	increases expression	ISO	RGD:1313188	E	RGD:6480464	20180703	CTD	MESH:D004642	Emodin results in increased expression of GOLGA3 mRNA	PMID:21319176
1305262	Golga3	golgin A3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313187	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GOLGA3 mRNA	PMID:38832940
1305262	Golga3	golgin A3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313187	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of GOLGA3 mRNA	PMID:21420995
1305262	Golga3	golgin A3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313187	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GOLGA3 gene	PMID:25304211
1305262	Golga3	golgin A3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GOLGA3 mRNA	PMID:40504410
1305262	Golga3	golgin A3	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1313187	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of GOLGA3 mRNA	PMID:36621641
1305262	Golga3	golgin A3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GOLGA3 mRNA	PMID:35436446
1305262	Golga3	golgin A3	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GOLGA3 protein]	PMID:35362542
1305262	Golga3	golgin A3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313187	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GOLGA3 protein	PMID:32959892
1305262	Golga3	golgin A3	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313187	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of GOLGA3 intron	PMID:30157460
1305262	Golga3	golgin A3	gene	CHEBI:6925	microcystin-LR	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of GOLGA3 protein	PMID:22430071
1305262	Golga3	golgin A3	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313187	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GOLGA3 protein	PMID:34186270
1305262	Golga3	golgin A3	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313188	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of GOLGA3 mRNA	PMID:22206623
1305262	Golga3	golgin A3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313187	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of GOLGA3 mRNA	PMID:37199045
1305262	Golga3	golgin A3	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of GOLGA3 mRNA	PMID:23994337
1305262	Golga3	golgin A3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GOLGA3 mRNA	PMID:21346803
1305262	Golga3	golgin A3	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313187	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GOLGA3 mRNA	PMID:38568856
1305262	Golga3	golgin A3	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313187	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of GOLGA3 mRNA	PMID:22378314
1305262	Golga3	golgin A3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of GOLGA3 mRNA	PMID:21346803
1305262	Golga3	golgin A3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of GOLGA3 mRNA	PMID:28973697
1305262	Golga3	golgin A3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of GOLGA3 mRNA	PMID:23034163
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623831	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ASAP2 mRNA	PMID:33045310
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ASAP2 mRNA]	PMID:31150632
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313189	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ASAP2 mRNA	PMID:22378314
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313189	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ASAP2 mRNA	PMID:21632981
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:D004958	Estradiol affects the expression of ASAP2 mRNA	PMID:14699072
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:D004958	Estradiol results in increased expression of ASAP2 mRNA	PMID:20106945
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1623831	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ASAP2 mRNA	PMID:39298647
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313189	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in decreased expression of ASAP2 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of ASAP2 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of ASAP2 mRNA	PMID:20404318|PMID:20660070|PMID:30165855
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:D011374	Progesterone results in increased expression of ASAP2 mRNA	PMID:18037150
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313189	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of ASAP2 mRNA	PMID:20660070
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ASAP2 mRNA	PMID:26577399
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313189	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ASAP2 protein	PMID:37730182
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313189	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ASAP2 intron	PMID:30157460
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASAP2 mRNA	PMID:28111341|PMID:37236586|PMID:37325564
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313189	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ASAP2 mRNA	PMID:19549813
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ASAP2 mRNA	PMID:21396975
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313189	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ASAP2 intron	PMID:30157460
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of ASAP2 mRNA	PMID:41580963
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ASAP2 mRNA	PMID:34911549
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:D014501	Uranium affects the expression of ASAP2 mRNA	PMID:15672453
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ASAP2 mRNA	PMID:31150632
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ASAP2 mRNA]	PMID:31150632
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313189	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ASAP2 gene	PMID:25304211
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313189	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ASAP2 protein	PMID:35688186
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of ASAP2 gene	PMID:31011160
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:D002945	Cisplatin results in decreased expression of ASAP2 mRNA	PMID:19561079
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASAP2 mRNA	PMID:22298810
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623831	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASAP2 mRNA	PMID:21570461|PMID:26377647|PMID:28922406
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ASAP2 mRNA	PMID:20106945|PMID:21632981
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313189	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASAP2 mRNA	PMID:30851411
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of ASAP2 mRNA	PMID:30807115
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313189	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ASAP2 mRNA	PMID:32763439
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313189	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ASAP2 gene	PMID:28589171
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313189	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of ASAP2 protein	PMID:38228842
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313189	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ASAP2 mRNA	PMID:38568856
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313189	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of ASAP2 mRNA	PMID:21632981
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313189	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ASAP2 3' UTR	PMID:27901495
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ASAP2 mRNA	PMID:20064835|PMID:20106945
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20151110	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ASAP2 mRNA	PMID:19770486
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313189	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ASAP2 promoter	PMID:27901495
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313189	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASAP2 mRNA	PMID:21871943
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1623831	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASAP2 mRNA	PMID:22610609
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313189	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ASAP2 gene	PMID:25435355
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313189	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ASAP2 mRNA]	PMID:32406909
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASAP2 mRNA	PMID:19150397
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:3090	bicalutamide	increases expression	ISO	RGD:1313189	E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of ASAP2 mRNA	PMID:16631469
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313189	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ASAP2 gene	PMID:31601247
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313189	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of ASAP2 mRNA	PMID:38568856
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of ASAP2 mRNA	PMID:24136188
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ASAP2 promoter	PMID:35295148
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1623831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ASAP2 gene	PMID:35295148
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1623831	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ASAP2 mRNA	PMID:23811191
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20151110	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ASAP2 mRNA	PMID:19710929
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1313189	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of ASAP2 mRNA	PMID:30690063
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of ASAP2 mRNA	PMID:28329830
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A affects the expression of ASAP2 mRNA	PMID:34947998
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ASAP2 mRNA	PMID:25181051
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313189	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ASAP2 gene	PMID:31601247
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313189	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ASAP2 mRNA	PMID:25047013
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313189	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ASAP2 gene	PMID:31601247
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313189	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ASAP2 intron	PMID:30157460
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ASAP2 mRNA	PMID:32715474
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313189	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ASAP2 mRNA	PMID:37042841
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of ASAP2 mRNA	PMID:26377693
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASAP2 mRNA	PMID:28111341|PMID:37236586|PMID:37325564
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:C018021	cobaltous chloride results in increased expression of ASAP2 mRNA	PMID:19376846
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313189	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ASAP2 mRNA	PMID:31533062
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39163	acetamiprid	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C464485	acetamiprid results in increased expression of ASAP2 mRNA	PMID:27782041
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313189	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ASAP2 mRNA	PMID:40419075
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ASAP2 mRNA	PMID:36331819
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of ASAP2 mRNA	PMID:29427782
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313189	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ASAP2 mRNA	PMID:24935251|PMID:29154799
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313189	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ASAP2 gene	PMID:29154799
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:D016572	Cyclosporine results in increased expression of ASAP2 mRNA	PMID:20106945|PMID:25562108
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ASAP2 mRNA	PMID:24136188
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313189	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ASAP2 mRNA	PMID:38832940
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313189	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ASAP2 mRNA	PMID:24935251
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313189	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ASAP2 mRNA	PMID:29067470
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313189	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ASAP2 gene	PMID:25304211
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ASAP2 mRNA	PMID:22079256
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1623831	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ASAP2 mRNA	PMID:35436446
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313189	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of ASAP2 mRNA	PMID:38568856
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ASAP2 mRNA	PMID:25554681|PMID:25620056
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1623831	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ASAP2 mRNA	PMID:25620056
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ASAP2 mRNA	PMID:24793618
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313189	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ASAP2 intron	PMID:30157460
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313189	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ASAP2 protein	PMID:34186270
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ASAP2 mRNA	PMID:24136188
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313189	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ASAP2 mRNA	PMID:22079256|PMID:22714537
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ASAP2 mRNA	PMID:22079256
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313189	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASAP2 mRNA	PMID:30851411
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313189	E	RGD:6480464	20151110	CTD	MESH:D010634	Phenobarbital affects the expression of ASAP2 mRNA	PMID:19159669
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ASAP2 mRNA	PMID:21346803
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313189	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ASAP2 mRNA	PMID:38568856
1305263	Asap2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ASAP2 mRNA	PMID:28973697
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TTC27 mRNA]	PMID:31150632
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1332208	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TTC27 mRNA	PMID:20188158
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1332208	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TTC27 mRNA	PMID:30529165
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1604350	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TTC27 mRNA	PMID:20044591
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TTC27 mRNA	PMID:21632981
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1332208	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TTC27 mRNA	PMID:39241906
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1604350	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TTC27 mRNA	PMID:31614463
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of TTC27 mRNA	PMID:26496021
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1604350	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TTC27 mRNA	PMID:38568856
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1604350	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TTC27 mRNA	PMID:21179406
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of TTC27 mRNA	PMID:33359661
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TTC27 mRNA	PMID:33387578
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332208	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TTC27 mRNA	PMID:36331819
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1604350	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTC27 mRNA	PMID:35301059
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TTC27 mRNA	PMID:23649840
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:254496	7,12-dimethyltetraphene	affects expression	ISO	RGD:1332208	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene affects the expression of TTC27 mRNA	PMID:21785161
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TTC27 mRNA	PMID:31150632
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332208	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TTC27 mRNA	PMID:31919559
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TTC27 mRNA]	PMID:31150632
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332208	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TTC27 mRNA	PMID:25629700
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of TTC27 mRNA	PMID:27594783
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332208	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTC27 mRNA	PMID:21570461
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTC27 mRNA	PMID:21215274
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TTC27 mRNA	PMID:33387578
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TTC27 mRNA	PMID:33212167
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TTC27 mRNA	PMID:28959563
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1332208	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TTC27 protein	PMID:28918527
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TTC27 mRNA	PMID:29803840
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTC27 mRNA	PMID:38568856|PMID:39719251
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1332208	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TTC27 intron	PMID:27901495
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604350	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TTC27 intron	PMID:30157460
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332208	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTC27 mRNA	PMID:19770486|PMID:21715664
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTC27 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332208	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTC27 mRNA	PMID:22228805
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604350	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TTC27 promoter	PMID:27901495
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of TTC27 mRNA	PMID:25075043
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TTC27 mRNA	PMID:20382639
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of TTC27 mRNA	PMID:25729387
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TTC27 mRNA	PMID:25729387
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1332208	E	RGD:6480464	20120717	CTD	MESH:C009495	titanium dioxide results in decreased expression of TTC27 mRNA	PMID:19464567
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332208	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TTC27 mRNA	PMID:23811191
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1332208	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TTC27 mRNA	PMID:28472532
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TTC27 mRNA	PMID:25181051
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of TTC27 mRNA	PMID:26496021
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332208	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TTC27 mRNA	PMID:39298647
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1332208	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of TTC27 intron	PMID:28392331
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1332208	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TTC27 mRNA	PMID:37019170
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1332208	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TTC27 mRNA	PMID:34813904
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1332208	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TTC27 mRNA	PMID:34813904
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1332208	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of TTC27 mRNA	PMID:36117858
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604350	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TTC27 mRNA	PMID:37042841
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TTC27 mRNA	PMID:38174414
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1604350	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTC27 mRNA	PMID:35301059
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332208	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TTC27 mRNA	PMID:36331819
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1332208	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of TTC27 mRNA	PMID:22155349
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TTC27 mRNA	PMID:23179753
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1604350	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TTC27 mRNA	PMID:25562108
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in decreased expression of TTC27 mRNA	PMID:28542535
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TTC27 mRNA	PMID:33387578
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TTC27 mRNA	PMID:21420995|PMID:29067470
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1604350	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TTC27 mRNA	PMID:22079256
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1604350	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TTC27 mRNA	PMID:18175754
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TTC27 mRNA	PMID:29097150
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:50035	alpha-phellandrene	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of TTC27 mRNA	PMID:25075043
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332208	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TTC27 mRNA	PMID:25554681
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TTC27 mRNA	PMID:24136188
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of TTC27 mRNA	PMID:24793618
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TTC27 mRNA	PMID:24136188
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1332208	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of TTC27 mRNA	PMID:36117858
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1332208	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TTC27 mRNA	PMID:19042947
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of TTC27 mRNA	PMID:25729387
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TTC27 mRNA	PMID:25729387
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of TTC27 mRNA	PMID:24136188
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of TTC27 mRNA	PMID:39938710
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332208	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TTC27 mRNA	PMID:22206623
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1604350	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TTC27 mRNA	PMID:22079256
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1604350	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TTC27 mRNA	PMID:22079256
1305264	Ttc27	tetratricopeptide repeat domain 27	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1604350	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TTC27 mRNA	PMID:38568856
1305266	Phf10	PHD finger protein 10	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PHF10 mRNA	PMID:33045310
1305266	Phf10	PHD finger protein 10	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PHF10 mRNA	PMID:26251327
1305266	Phf10	PHD finger protein 10	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313193	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of PHF10 promoter	PMID:26251327
1305266	Phf10	PHD finger protein 10	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PHF10 mRNA	PMID:26079696
1305266	Phf10	PHD finger protein 10	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313192	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PHF10 mRNA	PMID:22378314
1305266	Phf10	PHD finger protein 10	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PHF10 mRNA	PMID:21632981
1305266	Phf10	PHD finger protein 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313192	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHF10 mRNA	PMID:37042841
1305266	Phf10	PHD finger protein 10	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PHF10 mRNA	PMID:23649840
1305266	Phf10	PHD finger protein 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PHF10 mRNA	PMID:33754040
1305266	Phf10	PHD finger protein 10	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313192	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PHF10 protein	PMID:37730182
1305266	Phf10	PHD finger protein 10	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313192	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PHF10 protein	PMID:23301498
1305266	Phf10	PHD finger protein 10	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313192	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PHF10 gene	PMID:27153756
1305266	Phf10	PHD finger protein 10	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313192	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PHF10 mRNA	PMID:23649840
1305266	Phf10	PHD finger protein 10	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313192	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PHF10 mRNA	PMID:35430440
1305266	Phf10	PHD finger protein 10	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1313192	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of PHF10 mRNA	PMID:15672453
1305266	Phf10	PHD finger protein 10	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313193	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PHF10 mRNA	PMID:31919559
1305266	Phf10	PHD finger protein 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313193	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHF10 mRNA	PMID:22206623
1305266	Phf10	PHD finger protein 10	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313192	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PHF10 protein	PMID:35688186
1305266	Phf10	PHD finger protein 10	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PHF10 mRNA	PMID:31881176
1305266	Phf10	PHD finger protein 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313192	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHF10 mRNA	PMID:21632981
1305266	Phf10	PHD finger protein 10	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PHF10 mRNA	PMID:33212167
1305266	Phf10	PHD finger protein 10	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PHF10 mRNA	PMID:30851411
1305266	Phf10	PHD finger protein 10	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313192	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PHF10 mRNA	PMID:20971185
1305266	Phf10	PHD finger protein 10	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1313192	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PHF10 protein	PMID:35688186
1305266	Phf10	PHD finger protein 10	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313192	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PHF10 mRNA	PMID:20044591
1305266	Phf10	PHD finger protein 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PHF10 protein	PMID:29044176
1305266	Phf10	PHD finger protein 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313192	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PHF10 promoter	PMID:27901495
1305266	Phf10	PHD finger protein 10	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313192	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PHF10 mRNA	PMID:20971185
1305266	Phf10	PHD finger protein 10	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313192	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PHF10 mRNA	PMID:25895662
1305266	Phf10	PHD finger protein 10	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313193	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in increased expression of PHF10 mRNA	PMID:25270620
1305266	Phf10	PHD finger protein 10	gene	CHEBI:31767	lead diacetate	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:C008261	lead acetate results in increased methylation of PHF10 gene	PMID:29571894
1305266	Phf10	PHD finger protein 10	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313192	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of PHF10 mRNA	PMID:31745603
1305266	Phf10	PHD finger protein 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313193	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHF10 gene; titanium dioxide results in decreased methylation of PHF10 promoter	PMID:35295148
1305266	Phf10	PHD finger protein 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PHF10 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305266	Phf10	PHD finger protein 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PHF10 mRNA	PMID:33221593
1305266	Phf10	PHD finger protein 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF10 mRNA	PMID:25181051
1305266	Phf10	PHD finger protein 10	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PHF10 gene	PMID:28505145
1305266	Phf10	PHD finger protein 10	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PHF10 mRNA	PMID:37019170
1305266	Phf10	PHD finger protein 10	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PHF10 mRNA	PMID:34813904
1305266	Phf10	PHD finger protein 10	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20190219	CTD	MESH:D010269	Paraquat results in decreased expression of PHF10 mRNA	PMID:28012437
1305266	Phf10	PHD finger protein 10	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313192	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHF10 mRNA	PMID:37042841
1305266	Phf10	PHD finger protein 10	gene	CHEBI:35546	perfluorodecanoic acid	increases expression	ISO	RGD:1313192	E	RGD:6480464	20240702	CTD	MESH:C036567	perfluorodecanoic acid results in increased expression of PHF10 mRNA	PMID:38568856
1305266	Phf10	PHD finger protein 10	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PHF10 mRNA	PMID:19376846
1305266	Phf10	PHD finger protein 10	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313192	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of PHF10 mRNA	PMID:19167446
1305266	Phf10	PHD finger protein 10	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313192	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHF10 mRNA	PMID:25979313
1305266	Phf10	PHD finger protein 10	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF10 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1305266	Phf10	PHD finger protein 10	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313192	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF10 mRNA	PMID:27188386
1305266	Phf10	PHD finger protein 10	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PHF10 mRNA	PMID:25562108
1305266	Phf10	PHD finger protein 10	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of PHF10 mRNA	PMID:22733784
1305266	Phf10	PHD finger protein 10	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of PHF10 mRNA	PMID:23649840
1305266	Phf10	PHD finger protein 10	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1313192	E	RGD:6480464	20120412	CTD	MESH:D008727	PHF10 protein affects the susceptibility to Methotrexate	PMID:16217747
1305266	Phf10	PHD finger protein 10	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PHF10 mRNA	PMID:38832940
1305266	Phf10	PHD finger protein 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313193	E	RGD:6480464	20120626	CTD	MESH:D000082	Acetaminophen affects the expression of PHF10 mRNA	PMID:17562736
1305266	Phf10	PHD finger protein 10	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of PHF10 mRNA	PMID:35537566
1305266	Phf10	PHD finger protein 10	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313193	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PHF10 mRNA	PMID:25620056
1305266	Phf10	PHD finger protein 10	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PHF10 mRNA	PMID:24793618
1305266	Phf10	PHD finger protein 10	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of PHF10 mRNA	PMID:28801915
1305266	Phf10	PHD finger protein 10	gene	CHEBI:6382	Lasiocarpine	multiple interactions	ISO	RGD:1313192	E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PHF10 mRNA	PMID:33884520
1305266	Phf10	PHD finger protein 10	gene	CHEBI:63924	riddelliine	multiple interactions	ISO	RGD:1313192	E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PHF10 mRNA	PMID:33884520
1305266	Phf10	PHD finger protein 10	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PHF10 mRNA	PMID:23650126
1305266	Phf10	PHD finger protein 10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PHF10 mRNA	PMID:28801915
1305266	Phf10	PHD finger protein 10	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of PHF10 mRNA	PMID:28444820
1305266	Phf10	PHD finger protein 10	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1313192	E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of PHF10 mRNA	PMID:33884520
1305266	Phf10	PHD finger protein 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313193	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHF10 mRNA	PMID:22206623
1305266	Phf10	PHD finger protein 10	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313192	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PHF10 mRNA	PMID:30851411
1305266	Phf10	PHD finger protein 10	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313192	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF10 mRNA	PMID:27188386
1305266	Phf10	PHD finger protein 10	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313192	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF10 mRNA	PMID:27188386
1305266	Phf10	PHD finger protein 10	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PHF10 mRNA	PMID:19281266
1305266	Phf10	PHD finger protein 10	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of PHF10 protein	PMID:35544339
1305266	Phf10	PHD finger protein 10	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PHF10 mRNA	PMID:35537566
1305266	Phf10	PHD finger protein 10	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of PHF10 gene	PMID:31682807
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313195	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ARHGAP32 mRNA	PMID:20188158
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313195	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ARHGAP32 mRNA	PMID:24205000
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1605412	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ARHGAP32 mRNA	PMID:26079696
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313195	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ARHGAP32 mRNA	PMID:30319688
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1605412	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ARHGAP32 mRNA	PMID:38568856
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ARHGAP32 mRNA	PMID:33387578
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313195	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARHGAP32 mRNA	PMID:34319233
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1605412	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ARHGAP32 protein	PMID:37730182
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARHGAP32 mRNA	PMID:33387578
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1605412	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ARHGAP32 mRNA	PMID:28818685
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605412	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGAP32 mRNA	PMID:35301059
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313195	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of ARHGAP32 mRNA	PMID:18579281
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:25710	organophosphorus compound	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in increased expression of ARHGAP32 mRNA	PMID:39658253
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313195	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ARHGAP32 mRNA	PMID:25629700
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1605412	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ARHGAP32 protein	PMID:35688186
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313195	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ARHGAP32 mRNA	PMID:28960355
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313195	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ARHGAP32 mRNA	PMID:40618947
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:27903	(2,4,5-trichlorophenoxy)acetic acid	increases expression	ISO	RGD:1313195	E	RGD:6480464	20130514	CTD	MESH:D015085	2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ARHGAP32 mRNA	PMID:18579281
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313195	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGAP32 mRNA	PMID:21570461
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313195	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ARHGAP32 mRNA	PMID:25975270
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605412	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ARHGAP32 mRNA	PMID:28001369
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605412	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARHGAP32 mRNA	PMID:33212167
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1605412	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ARHGAP32 mRNA	PMID:30851411
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1605412	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ARHGAP32 mRNA	PMID:20971185
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605412	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGAP32 mRNA	PMID:29803840
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1605412	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ARHGAP32 protein	PMID:35688186
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605412	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ARHGAP32 exon	PMID:27901495
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1605412	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ARHGAP32 gene	PMID:25435355
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313195	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ARHGAP32 mRNA]	PMID:22228805
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1605412	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ARHGAP32 mRNA	PMID:20971185
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605412	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ARHGAP32 gene	PMID:31601247
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ARHGAP32 mRNA	PMID:32479839
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ARHGAP32 mRNA	PMID:30047161
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ARHGAP32 mRNA	PMID:34492290
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313195	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ARHGAP32 mRNA	PMID:18648102
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1605412	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of ARHGAP32 gene	PMID:31601247
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP32 mRNA	PMID:30816183|PMID:32145629
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313195	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP32 mRNA	PMID:37894381
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP32 mRNA	PMID:25181051|PMID:33441873
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605412	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ARHGAP32 gene	PMID:31601247
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1605412	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARHGAP32 gene	PMID:31601247
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313195	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ARHGAP32 mRNA	PMID:28392331
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313195	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ARHGAP32 intron	PMID:28392331
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313195	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of ARHGAP32 mRNA	PMID:36117858
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605412	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGAP32 mRNA	PMID:37042841
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605412	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARHGAP32 mRNA	PMID:38568856
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1605412	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARHGAP32 mRNA	PMID:38174414
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605412	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGAP32 mRNA	PMID:35301059
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1605412	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ARHGAP32 mRNA	PMID:24449571
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313195	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ARHGAP32 mRNA	PMID:40194260
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1605412	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ARHGAP32 mRNA	PMID:28302478
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605412	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARHGAP32 mRNA	PMID:31533062
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313195	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ARHGAP32 mRNA	PMID:36331819
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313195	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGAP32 mRNA	PMID:17963808
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of ARHGAP32 mRNA	PMID:29427782
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605412	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGAP32 mRNA	PMID:29154799
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ARHGAP32 mRNA	PMID:30047161
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605412	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of ARHGAP32 mRNA	PMID:27989131
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGAP32 mRNA	PMID:33387578
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605412	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ARHGAP32 mRNA	PMID:29067470
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313195	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ARHGAP32 mRNA	PMID:35436446
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ARHGAP32 mRNA	PMID:30047161
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313195	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of ARHGAP32 mRNA	PMID:36117858
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1605412	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ARHGAP32 mRNA	PMID:28988120
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313195	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARHGAP32 mRNA	PMID:22206623
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ARHGAP32 mRNA	PMID:21346803
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1605412	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ARHGAP32 mRNA	PMID:30851411
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:78492	diallyl trisulfide	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C042577	diallyl trisulfide results in increased expression of ARHGAP32 mRNA	PMID:34014027
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605412	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARHGAP32 gene]	PMID:28238834
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1313195	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ARHGAP32 mRNA	PMID:31388691
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ARHGAP32 mRNA	PMID:21346803
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ARHGAP32 mRNA	PMID:19015723
1305267	Arhgap32	Rho GTPase activating protein 32	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of ARHGAP32 mRNA	PMID:20566332
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313197	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of AMOTL1 gene	PMID:20938992
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313196	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of AMOTL1 mRNA	PMID:23724009|PMID:33167477
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313197	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of AMOTL1 mRNA	PMID:30319688
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313196	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of AMOTL1 mRNA	PMID:22574217
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of AMOTL1 mRNA	PMID:32145629
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of AMOTL1 mRNA	PMID:26496021
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:165210	Mono-carboxy isooctyl phthalate	affects expression	ISO	RGD:1313196	E	RGD:6480464	20220906	CTD	MESH:C573544	mono(carboxy-isooctyl)phthalate affects the expression of AMOTL1 mRNA	PMID:34478338
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313197	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of AMOTL1 gene	PMID:20938992
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of AMOTL1 gene	PMID:30521419
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313196	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of AMOTL1 mRNA	PMID:23649840
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313196	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of AMOTL1 mRNA	PMID:26079696
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313196	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of AMOTL1 mRNA	PMID:31163220
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313196	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of AMOTL1 protein	PMID:37730182
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AMOTL1 mRNA	PMID:35301059
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313197	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of AMOTL1 mRNA	PMID:19376150
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:24828	indoles	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in decreased expression of AMOTL1 mRNA	PMID:20521778
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:24828	indoles	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in increased expression of AMOTL1 mRNA	PMID:20521778
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313196	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AMOTL1 promoter	PMID:30157460
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313196	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AMOTL1 mRNA	PMID:22100608
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313197	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of AMOTL1 mRNA	PMID:34911549
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313197	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of AMOTL1 gene	PMID:20938992
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313196	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of AMOTL1 mRNA	PMID:26272509
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMOTL1 mRNA	PMID:27188386
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of AMOTL1 gene	PMID:31011160
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313196	E	RGD:6480464	20150127	CTD	MESH:C059514	resveratrol results in increased expression of AMOTL1 mRNA	PMID:23750556
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313196	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of AMOTL1 mRNA	PMID:27392435|PMID:27594783
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AMOTL1 mRNA	PMID:27392435
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313196	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AMOTL1 mRNA	PMID:29803840
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313196	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of AMOTL1 mRNA	PMID:30031762
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313196	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of AMOTL1 protein	PMID:35688186
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313196	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of AMOTL1 mRNA	PMID:25879800
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to AMOTL1 mRNA]	PMID:32406909
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313197	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of AMOTL1 mRNA	PMID:27131904
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313197	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AMOTL1 gene; titanium dioxide results in decreased methylation of AMOTL1 promoter	PMID:35295148
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:32293	verteporfin	decreases response to substance	ISO	RGD:1313196	E	RGD:6480464	20220405	CTD	MESH:C098350	Verteporfin results in decreased susceptibility to AMOTL1 protein	PMID:34480788
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:32293	verteporfin	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20220405	CTD	MESH:C098350	Verteporfin inhibits the reaction [AMOTL1 protein results in increased activity of YAP1 protein]	PMID:34480788
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313197	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of AMOTL1 mRNA	PMID:20813756
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313196	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of AMOTL1 gene	PMID:31601247
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of AMOTL1 mRNA	PMID:32145629
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313197	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of AMOTL1 mRNA	PMID:26063408
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of AMOTL1 mRNA	PMID:26496021
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313196	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AMOTL1 mRNA	PMID:25979313
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313197	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of AMOTL1 exon	PMID:33297965
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313197	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of AMOTL1 mRNA	PMID:40203079
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313196	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of AMOTL1 gene	PMID:31601247
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313197	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of AMOTL1 mRNA	PMID:37019170
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313196	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AMOTL1 mRNA	PMID:37042841
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of AMOTL1 mRNA	PMID:35163327
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AMOTL1 mRNA	PMID:30917596
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313196	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AMOTL1 mRNA	PMID:25851441
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AMOTL1 mRNA	PMID:35301059
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313196	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AMOTL1 mRNA	PMID:19320972
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313196	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of AMOTL1 mRNA	PMID:24449571
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313196	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of AMOTL1 mRNA	PMID:24383497|PMID:24935251|PMID:28001369
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313196	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of AMOTL1 mRNA	PMID:38832940
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313196	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of AMOTL1 mRNA	PMID:21420995
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313196	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of AMOTL1 mRNA	PMID:31838189
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313196	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of AMOTL1 mRNA	PMID:32234424
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1313196	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of AMOTL1 mRNA	PMID:23228038
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313196	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of AMOTL1 mRNA	PMID:38568856
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:50729	mitoxantrone	affects response to substance	ISO	RGD:1313196	E	RGD:6480464	20120412	CTD	MESH:D008942	AMOTL1 mRNA affects the susceptibility to Mitoxantrone	PMID:16044152
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1313196	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of AMOTL1 mRNA	PMID:26705709
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of AMOTL1 gene	PMID:35440735
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMOTL1 mRNA	PMID:27188386
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1313196	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of AMOTL1 mRNA	PMID:30458266
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313197	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of AMOTL1 mRNA	PMID:27029645
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313196	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMOTL1 mRNA	PMID:27188386
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313197	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of AMOTL1 mRNA	PMID:27131904
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:9466	Testosterone propionate	increases expression	ISO	RGD:1313197	E	RGD:6480464	20141111	CTD	MESH:D043343	Testosterone Propionate results in increased expression of AMOTL1 mRNA	PMID:15601916
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313197	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of AMOTL1 mRNA	PMID:28973697
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313197	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of AMOTL1 mRNA	PMID:35537566
1305268	Amotl1	angiomotin-like 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of AMOTL1 mRNA	PMID:19015723
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of LIMCH1 mRNA	PMID:37995155
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LIMCH1 mRNA]	PMID:31150632
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313198	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LIMCH1 mRNA	PMID:20188158
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1604823	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of LIMCH1 mRNA	PMID:21934132|PMID:23724009
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of LIMCH1 protein	PMID:39571964
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LIMCH1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of LIMCH1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LIMCH1 mRNA	PMID:32699268|PMID:32845096
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1313198	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of LIMCH1 promoter	PMID:24205000
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313198	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of LIMCH1 mRNA	PMID:24205000
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1604823	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of LIMCH1 mRNA	PMID:26516004
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LIMCH1 mRNA	PMID:30529165
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1604823	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of LIMCH1 protein	PMID:28073184
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of LIMCH1 gene	PMID:28931070
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of LIMCH1 mRNA	PMID:36841081
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in decreased expression of LIMCH1 mRNA	PMID:28986285
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313198	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of LIMCH1 mRNA	PMID:30319688
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of LIMCH1 mRNA	PMID:30319688
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313198	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LIMCH1 mRNA	PMID:39241906
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of LIMCH1 mRNA]	PMID:39241906
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of LIMCH1 mRNA	PMID:19167446
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1604823	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of LIMCH1 mRNA	PMID:19619570|PMID:21185374
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LIMCH1 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of LIMCH1 mRNA; Raloxifene Hydrochloride promotes the reaction [Estradiol results in increased expression of LIMCH1 mRNA]	PMID:19619570|PMID:21185374|PMID:30165855
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313198	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of LIMCH1 mRNA	PMID:29980752|PMID:33711761
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of LIMCH1 mRNA	PMID:33387578
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LIMCH1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LIMCH1 mRNA	PMID:37992649
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1313198	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of LIMCH1 mRNA	PMID:28973375
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LIMCH1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LIMCH1 mRNA	PMID:37992649
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1604823	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LIMCH1 protein	PMID:37730182
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of LIMCH1 mRNA	PMID:16002434
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LIMCH1 mRNA	PMID:33387578
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LIMCH1 mRNA	PMID:39836092
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LIMCH1 mRNA	PMID:18579281
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of LIMCH1 mRNA	PMID:23487506
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604823	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LIMCH1 gene	PMID:27153756
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:2564	aldrin	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in decreased expression of LIMCH1 mRNA	PMID:18579281
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LIMCH1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of LIMCH1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LIMCH1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of LIMCH1 mRNA	PMID:32699268|PMID:32845096
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LIMCH1 mRNA	PMID:31150632
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LIMCH1 mRNA]	PMID:31150632
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D016685	LIMCH1 protein affects the susceptibility to Mitomycin	PMID:16217747
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604823	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LIMCH1 gene	PMID:25304211
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LIMCH1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] affects the expression of LIMCH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LIMCH1 mRNA	PMID:39836092|PMID:40512198
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of LIMCH1 mRNA	PMID:19244175
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of LIMCH1 mRNA	PMID:19244175
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1604823	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of LIMCH1 mRNA	PMID:26272509
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA	PMID:27188386
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of LIMCH1 gene	PMID:31011160
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LIMCH1 mRNA]	PMID:37992649
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LIMCH1 mRNA	PMID:28960355
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1604823	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of LIMCH1 mRNA	PMID:28903495
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D002945	LIMCH1 protein affects the susceptibility to Cisplatin	PMID:16217747
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of LIMCH1 mRNA	PMID:27392435
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:27903	(2,4,5-trichlorophenoxy)acetic acid	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20130514	CTD	MESH:D015085	2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of LIMCH1 mRNA	PMID:18579281
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LIMCH1 mRNA	PMID:33387578
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313198	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LIMCH1 mRNA	PMID:19465110
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LIMCH1 mRNA	PMID:19619570
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LIMCH1 mRNA	PMID:19619570
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1604823	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LIMCH1 mRNA	PMID:28001369
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LIMCH1 mRNA	PMID:33212167
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1604823	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of LIMCH1 mRNA	PMID:21198554
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of LIMCH1 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of LIMCH1 mRNA	PMID:20971185|PMID:24690739
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LIMCH1 mRNA	PMID:29803840
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LIMCH1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LIMCH1 mRNA	PMID:37992649
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1604823	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of LIMCH1 protein	PMID:35688186
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LIMCH1 mRNA]	PMID:37992649
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1604823	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of LIMCH1 gene	PMID:28589171
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of LIMCH1 mRNA	PMID:37682722
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of LIMCH1 mRNA	PMID:39719251
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604823	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of LIMCH1 protein	PMID:39571964
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LIMCH1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] affects the expression of LIMCH1 mRNA; [sodium arsenite co-treated with Tretinoin] results in decreased expression of LIMCH1 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LIMCH1 mRNA	PMID:39571964|PMID:39836092|PMID:40512198
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604823	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LIMCH1 promoter	PMID:27901495
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of LIMCH1 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of LIMCH1 mRNA	PMID:20971185|PMID:24690739
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of LIMCH1 mRNA; Silicon Dioxide results in decreased expression of LIMCH1 mRNA	PMID:25351596|PMID:25895662
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LIMCH1 mRNA	PMID:19150397
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of LIMCH1 gene	PMID:31601247
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of LIMCH1 mRNA	PMID:25729387
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] affects the expression of LIMCH1 mRNA	PMID:25729387
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313198	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LIMCH1 gene	PMID:35295148
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313198	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LIMCH1 promoter	PMID:35295148
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313198	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LIMCH1 mRNA	PMID:20813756
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of LIMCH1 mRNA	PMID:32145629
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LIMCH1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of LIMCH1 mRNA; bisphenol A results in decreased expression of LIMCH1 protein	PMID:27685785|PMID:33376534
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313198	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of LIMCH1 mRNA	PMID:30951980
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LIMCH1 gene	PMID:28505145
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1604823	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of LIMCH1 gene	PMID:31601247
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LIMCH1 mRNA	PMID:36041667
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of LIMCH1 gene	PMID:31601247
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of LIMCH1 mRNA	PMID:25172293
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of LIMCH1 mRNA	PMID:19244175
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of LIMCH1 mRNA	PMID:26682919
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313198	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LIMCH1 mRNA	PMID:30951980
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313198	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of LIMCH1 exon	PMID:33297965
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LIMCH1 mRNA	PMID:36041667
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313198	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LIMCH1 mRNA	PMID:30951980
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LIMCH1 mRNA	PMID:36041667
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313198	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LIMCH1 intron	PMID:28392331
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LIMCH1 mRNA	PMID:37019170
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313198	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LIMCH1 mRNA	PMID:21266533
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LIMCH1 mRNA	PMID:16997883
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of LIMCH1 mRNA	PMID:32680482
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of LIMCH1 mRNA]	PMID:39241906
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LIMCH1 mRNA	PMID:39836092
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313198	E	RGD:6480464	20190312	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of LIMCH1 mRNA	PMID:30711707
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1604823	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of LIMCH1 mRNA	PMID:22202117
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120717	CTD	MESH:C018021	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of LIMCH1 mRNA]	PMID:22202117
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1604823	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LIMCH1 mRNA	PMID:24449571
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LIMCH1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LIMCH1 mRNA	PMID:32699268
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of LIMCH1 mRNA	PMID:19244175
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of LIMCH1 mRNA	PMID:19244175
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313198	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LIMCH1 mRNA	PMID:40194260
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1604823	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of LIMCH1 mRNA	PMID:40419075
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of LIMCH1 mRNA	PMID:23125180
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604823	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LIMCH1 mRNA	PMID:25979313
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of LIMCH1 mRNA	PMID:23179753|PMID:24935251
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604823	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of LIMCH1 mRNA	PMID:26272509|PMID:28001369
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA	PMID:27188386
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of LIMCH1 mRNA	PMID:22147139|PMID:27989131
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LIMCH1 mRNA	PMID:16997883
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313198	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of LIMCH1 mRNA	PMID:28973697
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LIMCH1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LIMCH1 mRNA	PMID:37992649
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of LIMCH1 mRNA	PMID:24935251
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1604823	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of LIMCH1 mRNA	PMID:24935251
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LIMCH1 mRNA	PMID:33387578
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of LIMCH1 mRNA	PMID:21420995
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1604823	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of LIMCH1 mRNA	PMID:24714768
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of LIMCH1 mRNA	PMID:24690739
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of LIMCH1 mRNA	PMID:29279043
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of LIMCH1 mRNA	PMID:25351596
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604823	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LIMCH1 gene	PMID:25304211
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LIMCH1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] affects the expression of LIMCH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LIMCH1 mRNA	PMID:39836092|PMID:40512198
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LIMCH1 mRNA	PMID:29391264
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D005047	LIMCH1 protein affects the susceptibility to Etoposide	PMID:16217747
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA	PMID:27188386
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:49976	zinc dichloride	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120717	CTD	MESH:C016837	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of LIMCH1 mRNA]	PMID:22202117
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313198	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LIMCH1 mRNA; Nanotubes, Carbon results in decreased expression of LIMCH1 mRNA	PMID:25554681
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of LIMCH1 mRNA	PMID:20436886
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LIMCH1 protein	PMID:32959892
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of LIMCH1 mRNA	PMID:26272509
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIMCH1 mRNA	PMID:27188386
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LIMCH1 mRNA	PMID:39836092
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of LIMCH1 mRNA	PMID:25729387
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] affects the expression of LIMCH1 mRNA	PMID:25729387
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of LIMCH1 mRNA	PMID:15336504
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:64211	8-Br-cAMP	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20120412	CTD	MESH:D015124	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LIMCH1 mRNA	PMID:16997883
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LIMCH1 gene	PMID:35440735
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:69355	casticin	increases expression	ISO	RGD:1313198	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in increased expression of LIMCH1 mRNA	PMID:28444820
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1604823	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of LIMCH1 mRNA	PMID:31758290
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of LIMCH1 mRNA	PMID:32858204
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of LIMCH1 mRNA	PMID:30559759
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIMCH1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIMCH1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA	PMID:27188386
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of LIMCH1 protein	PMID:28903499
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1604823	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of LIMCH1 mRNA	PMID:26272509
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIMCH1 mRNA	PMID:27188386
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313198	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of LIMCH1 mRNA]	PMID:39241906
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride promotes the reaction [Estradiol results in increased expression of LIMCH1 mRNA]	PMID:21185374
1305269	Limch1	LIM and calponin homology domains 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604823	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIMCH1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIMCH1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA	PMID:27188386
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313199	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TOPORS mRNA	PMID:38218311
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313199	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TOPORS mRNA	PMID:33167477
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313199	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TOPORS protein	PMID:37730182
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TOPORS mRNA	PMID:33387578
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313199	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TOPORS mRNA	PMID:28818685
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313199	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TOPORS mRNA	PMID:39836092
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313199	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TOPORS mRNA	PMID:23649840
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313199	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TOPORS mRNA	PMID:23649840
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313199	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA	PMID:39836092
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOPORS mRNA	PMID:40504410
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313199	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TOPORS protein	PMID:35688186
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313199	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TOPORS mRNA	PMID:23557933
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313199	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of TOPORS mRNA	PMID:27594783
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313200	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TOPORS mRNA	PMID:21570461
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TOPORS mRNA	PMID:21215274|PMID:33387578
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TOPORS mRNA	PMID:19770486
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TOPORS mRNA	PMID:17942748
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313199	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of TOPORS mRNA	PMID:33512557
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313199	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TOPORS mRNA	PMID:32763439
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313199	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of TOPORS protein	PMID:35688186
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313200	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of TOPORS mRNA	PMID:36209798
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313199	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA	PMID:39836092
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOPORS mRNA	PMID:40504410
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:30563	silicon dioxide	increases methylation	ISO	RGD:1313199	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased methylation of TOPORS gene	PMID:34973136
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313200	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TOPORS gene	PMID:35295148
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TOPORS mRNA	PMID:34492290
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TOPORS mRNA	PMID:33221593|PMID:38074096
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of TOPORS mRNA	PMID:33296240|PMID:41034487
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TOPORS mRNA	PMID:39298647
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TOPORS mRNA	PMID:37019170
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313199	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TOPORS mRNA	PMID:37042841
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313199	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TOPORS mRNA	PMID:39836092
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313199	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TOPORS mRNA	PMID:38568856
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of TOPORS promoter	PMID:22457795
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313199	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TOPORS mRNA	PMID:28302478
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313199	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TOPORS mRNA	PMID:31533062
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313199	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TOPORS mRNA	PMID:23179753|PMID:27188386
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of TOPORS mRNA	PMID:20546886
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of TOPORS mRNA	PMID:19770486
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TOPORS mRNA	PMID:17555576
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TOPORS mRNA	PMID:17562736
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TOPORS mRNA	PMID:29279043
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313199	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA	PMID:39836092
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOPORS mRNA	PMID:40504410
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TOPORS mRNA	PMID:17555576
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TOPORS mRNA	PMID:17942748
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TOPORS mRNA	PMID:17942748
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1313200	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of TOPORS mRNA	PMID:21318169
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20120613	CTD	MESH:D011345	[PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of TOPORS mRNA	PMID:21318169
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313200	E	RGD:6480464	20180515	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TOPORS mRNA	PMID:25926378
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313199	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TOPORS mRNA	PMID:39836092
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TOPORS mRNA	PMID:22206623
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:7438	N-methylformamide	increases expression	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in increased expression of TOPORS mRNA; methylformamide results in increased expression of TOPORS mRNA	PMID:17040096
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313199	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TOPORS protein	PMID:31285264
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313199	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of TOPORS mRNA; Irinotecan results in decreased expression of TOPORS mRNA	PMID:15956246
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313200	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TOPORS mRNA	PMID:23091169
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:84070	sodium arsenate	affects methylation	ISO	RGD:1313200	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate affects the methylation of TOPORS promoter	PMID:20667999
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of TOPORS mRNA	PMID:20667999
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of TOPORS protein	PMID:35357534
1305270	Topors	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TOPORS mRNA	PMID:23869203
1305271	Cldn22	claudin 22	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1349320	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of CLDN22 mRNA	PMID:24763279
1305271	Cldn22	claudin 22	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313201	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of CLDN22 mRNA	PMID:19484750
1305271	Cldn22	claudin 22	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CLDN22 mRNA	PMID:33387578
1305271	Cldn22	claudin 22	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1349320	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CLDN22 mRNA	PMID:26079696
1305271	Cldn22	claudin 22	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313201	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CLDN22 mRNA	PMID:25629700
1305271	Cldn22	claudin 22	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1349320	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of CLDN22 mRNA	PMID:27392435
1305271	Cldn22	claudin 22	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1349320	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CLDN22 mRNA	PMID:27392435
1305271	Cldn22	claudin 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLDN22 mRNA	PMID:33387578
1305271	Cldn22	claudin 22	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313201	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of CLDN22 mRNA	PMID:23557971
1305271	Cldn22	claudin 22	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLDN22 mRNA	PMID:25181051
1305271	Cldn22	claudin 22	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313201	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CLDN22 mRNA	PMID:32156529
1305271	Cldn22	claudin 22	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CLDN22 mRNA	PMID:28300664
1305271	Cldn22	claudin 22	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CLDN22 mRNA	PMID:35163327
1305271	Cldn22	claudin 22	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CLDN22 promoter	PMID:22457795
1305271	Cldn22	claudin 22	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CLDN22 mRNA	PMID:35163327
1305271	Cldn22	claudin 22	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of CLDN22 mRNA	PMID:25539665
1305271	Cldn22	claudin 22	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313201	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CLDN22 mRNA	PMID:40194260
1305271	Cldn22	claudin 22	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1349320	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CLDN22 mRNA	PMID:31533062
1305271	Cldn22	claudin 22	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLDN22 mRNA	PMID:33387578
1305271	Cldn22	claudin 22	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313201	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CLDN22 mRNA	PMID:23608068
1305271	Cldn22	claudin 22	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1349320	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of CLDN22 mRNA	PMID:31629900
1305271	Cldn22	claudin 22	gene	CHEBI:6651	malathion	decreases expression	ISO	RGD:1349320	E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of CLDN22 mRNA	PMID:37047231
1305271	Cldn22	claudin 22	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349320	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CLDN22 gene]	PMID:28238834
1305271	Cldn22	claudin 22	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1349320	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of CLDN22 mRNA	PMID:26079696
1305271	Cldn22	claudin 22	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of CLDN22 mRNA	PMID:29162477
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of LIMS2 mRNA	PMID:21551480
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313205	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LIMS2 mRNA	PMID:20188158
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LIMS2 mRNA	PMID:36189433
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313204	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of LIMS2 mRNA	PMID:26079696
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of LIMS2 mRNA	PMID:25056781
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313204	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of LIMS2 mRNA	PMID:30510588
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of LIMS2 mRNA	PMID:32145629
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LIMS2 mRNA	PMID:39298647
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of LIMS2 mRNA	PMID:33711761
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LIMS2 mRNA	PMID:33387578
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313204	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LIMS2 mRNA	PMID:26079696
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313205	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LIMS2 mRNA	PMID:39922521
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LIMS2 mRNA	PMID:36189433
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1313205	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of LIMS2 mRNA	PMID:28973375
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313205	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LIMS2 mRNA	PMID:39922521
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313204	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LIMS2 intron	PMID:30157460
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of LIMS2 mRNA	PMID:33914522
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of LIMS2 mRNA	PMID:28522335
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313204	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LIMS2 mRNA	PMID:35301059
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313204	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LIMS2 mRNA	PMID:19549813
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313204	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LIMS2 mRNA	PMID:22100608
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313204	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LIMS2 intron	PMID:30157460
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of LIMS2 mRNA	PMID:25056781
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of LIMS2 mRNA	PMID:31626304
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LIMS2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of LIMS2 mRNA	PMID:34911549
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313205	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of LIMS2 mRNA	PMID:17484886
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LIMS2 mRNA	PMID:31150632
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of LIMS2 mRNA	PMID:22206623
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of LIMS2 mRNA	PMID:22023808
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313204	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of LIMS2 mRNA	PMID:27392435
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313204	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of LIMS2 mRNA	PMID:27392435
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of LIMS2 mRNA	PMID:20187946
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LIMS2 mRNA	PMID:22298810|PMID:34747641
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313205	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LIMS2 mRNA	PMID:21570461
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LIMS2 mRNA	PMID:21215274
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LIMS2 mRNA	PMID:33387578
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313205	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LIMS2 mRNA	PMID:18796159
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of LIMS2 mRNA	PMID:28374803
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LIMS2 mRNA	PMID:19770486
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313205	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LIMS2 mRNA	PMID:22228805
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313204	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LIMS2 promoter	PMID:27901495
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to LIMS2 promoter]	PMID:19654925
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313204	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LIMS2 mRNA	PMID:34973136
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313205	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LIMS2 mRNA	PMID:29203145
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313204	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of LIMS2 mRNA	PMID:20382639
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of LIMS2 mRNA	PMID:22641619
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of LIMS2 mRNA	PMID:30047161
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of LIMS2 mRNA	PMID:30012374
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of LIMS2 mRNA	PMID:19464567|PMID:23557971
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313204	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LIMS2 promoter	PMID:34973136
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313204	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased expression of LIMS2 mRNA	PMID:34973136
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of LIMS2 mRNA	PMID:23411599|PMID:34492290
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313205	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LIMS2 mRNA	PMID:18301758
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313204	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of LIMS2 mRNA	PMID:38479592
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313205	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of LIMS2 mRNA	PMID:33914522
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LIMS2 mRNA	PMID:25181051|PMID:30816183
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in increased expression of LIMS4 mRNA	PMID:25181051
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LIMS2 mRNA	PMID:39298647
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313205	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LIMS2 mRNA	PMID:30951980
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313204	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LIMS2 intron	PMID:30157460
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LIMS2 mRNA	PMID:38685157
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313205	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LIMS2 mRNA	PMID:30951980
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313205	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LIMS2 mRNA	PMID:37019170
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:34656	cumene	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20120412	CTD	MESH:C015763	cumene results in decreased expression of LIMS2 mRNA	PMID:18648096
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LIMS2 mRNA	PMID:35163327
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LIMS2 mRNA	PMID:33453195
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313204	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LIMS2 mRNA	PMID:35301059
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LIMS2 mRNA	PMID:35163327
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313204	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LIMS2 mRNA	PMID:19320972
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313204	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LIMS2 mRNA	PMID:24449571
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of LIMS2 mRNA	PMID:30047161
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313205	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LIMS2 mRNA	PMID:40194260
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313204	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LIMS2 mRNA	PMID:31533062
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313204	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LIMS2 mRNA	PMID:40419075
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1313205	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of LIMS2 mRNA	PMID:29038090
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313204	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LIMS2 mRNA	PMID:29154799
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of LIMS2 mRNA	PMID:30047161
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of LIMS2 mRNA	PMID:41580965
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313204	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of LIMS2 promoter	PMID:27989131
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313204	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of LIMS2 mRNA	PMID:25047013
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313205	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of LIMS2 mRNA	PMID:22733784
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313205	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of LIMS2 mRNA	PMID:28973697
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313205	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LIMS2 mRNA	PMID:39922521
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313204	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LIMS2 mRNA	PMID:38832940
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of LIMS2 mRNA	PMID:29279043
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of LIMS2 mRNA	PMID:30529165
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LIMS2 mRNA	PMID:29391264
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of LIMS2 mRNA	PMID:35436446
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LIMS2 mRNA; Nanotubes, Carbon results in decreased expression of LIMS2 mRNA	PMID:25554681
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of LIMS2 mRNA	PMID:30047161
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1313205	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in increased expression of LIMS2 mRNA	PMID:25086211
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LIMS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LIMS2 mRNA	PMID:21641980|PMID:26378955
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313205	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of LIMS2 mRNA	PMID:26307267
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of LIMS2 mRNA	PMID:30467583
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313204	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LIMS2 intron	PMID:30157460
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313205	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LIMS2 mRNA	PMID:22206623
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of LIMS2 mRNA	PMID:22206623
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of LIMS2 mRNA	PMID:24136188
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313204	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LIMS2 gene]	PMID:28238834
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313204	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of LIMS2 mRNA	PMID:26079696
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1313204	E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of LIMS2 mRNA	PMID:35688559
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LIMS2 mRNA	PMID:24780913|PMID:30047161
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313204	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of LIMS2 mRNA	PMID:29301935
1305273	Lims2	LIM zinc finger domain containing 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of LIMS2 mRNA	PMID:19015723
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of COA7 mRNA	PMID:33167477
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of COA7 mRNA	PMID:24236059|PMID:26516004
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313206	E	RGD:6480464	20200317	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COA7 mRNA	PMID:30529165
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of COA7 mRNA	PMID:22378314
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1606511	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of COA7 mRNA	PMID:20044591
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of COA7 mRNA	PMID:21632981
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313206	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of COA7 mRNA	PMID:39241906
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606511	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of COA7 mRNA	PMID:23019147|PMID:31614463
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1606511	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of COA7 mRNA	PMID:38568856
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606511	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COA7 mRNA	PMID:37042841
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:16708	adenine	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20140812	CTD	MESH:D000225	Adenine results in decreased expression of COA7 mRNA	PMID:24211769
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of COA7 mRNA	PMID:20655997
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of COA7 mRNA	PMID:33387578
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of COA7 mRNA	PMID:28818685
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313206	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of COA7 mRNA	PMID:37748715
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606511	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of COA7 mRNA	PMID:39836092
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COA7 mRNA	PMID:19549813
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1606511	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of COA7 protein	PMID:23301498
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20140812	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of COA7 mRNA	PMID:23649840|PMID:24211769
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20140812	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of COA7 mRNA	PMID:23649840|PMID:24211769
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20140812	CTD	MESH:D016685	Mitomycin results in decreased expression of COA7 mRNA	PMID:24211769
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606511	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of COA7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COA7 mRNA	PMID:39836092
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313206	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of COA7 mRNA	PMID:28960355
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606511	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of COA7 mRNA	PMID:23557933
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:27882	(S)-colchicine	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20140812	CTD	MESH:D003078	Colchicine results in decreased expression of COA7 mRNA	PMID:24211769
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1606511	E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in increased expression of COA7 protein	PMID:37834424
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20140812	CTD	MESH:D002945	Cisplatin results in decreased expression of COA7 mRNA	PMID:24211769
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COA7 mRNA	PMID:32109520|PMID:33387578
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606511	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of COA7 mRNA	PMID:33212167
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1606511	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of COA7 mRNA	PMID:39709020
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of COA7 mRNA	PMID:38568856
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606511	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of COA7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COA7 mRNA	PMID:39836092
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1606511	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of COA7 mRNA	PMID:25895662
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313206	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of COA7 mRNA	PMID:39716349
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313206	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of COA7 mRNA	PMID:27760801
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C006780	bisphenol A results in decreased expression of COA7 mRNA	PMID:25181051
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of COA7 mRNA	PMID:30816183|PMID:32528016
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606511	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of COA7 protein	PMID:33376534
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606511	E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in increased expression of COA7 protein]	PMID:33376534
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313206	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of COA7 mRNA	PMID:37019170
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of COA7 mRNA	PMID:21266533
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606511	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COA7 mRNA	PMID:37042841
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606511	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of COA7 mRNA	PMID:39836092
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of COA7 mRNA	PMID:38568856
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COA7 mRNA	PMID:31533062
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of COA7 mRNA	PMID:41580965
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:44423	hydroxyurea	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20140812	CTD	MESH:D006918	Hydroxyurea results in decreased expression of COA7 mRNA	PMID:24211769
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1606511	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of COA7 mRNA	PMID:28542535
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COA7 mRNA	PMID:33387578
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of COA7 mRNA	PMID:29067470
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606511	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of COA7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COA7 mRNA	PMID:39836092
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20140812	CTD	MESH:D005047	Etoposide results in decreased expression of COA7 mRNA	PMID:24211769
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:4917	eugenol	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in decreased expression of COA7 protein	PMID:39793947
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313206	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of COA7 mRNA	PMID:39716349
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313206	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of COA7 mRNA; Nanotubes, Carbon results in increased expression of COA7 mRNA	PMID:25554681
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D007649	Ketamine results in increased expression of COA7 mRNA	PMID:20080153
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606511	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of COA7 mRNA	PMID:39836092
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1313206	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of COA7 mRNA	PMID:22078008
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of COA7 mRNA	PMID:37939859
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1606511	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of COA7 mRNA	PMID:31758290
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1606511	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of COA7 protein	PMID:39638853
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of COA7 mRNA	PMID:19682730
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313206	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of COA7 mRNA	PMID:31388691
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313206	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of COA7 mRNA	PMID:39847705
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of COA7 mRNA	PMID:24780913
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1606511	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of COA7 mRNA	PMID:24921660
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1606511	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of COA7 mRNA	PMID:38568856
1305274	Coa7	cytochrome c oxidase assembly factor 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313206	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of COA7 mRNA	PMID:28973697
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313208	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ROR2 mRNA	PMID:33045310
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313208	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ROR2 mRNA	PMID:37995155
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ROR2 mRNA]	PMID:31150632
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313207	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ROR2 mRNA	PMID:33167477
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of ROR2 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of ROR2 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of ROR2 mRNA	PMID:30951980
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ROR2 mRNA	PMID:24763279
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313207	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ROR2 mRNA	PMID:26079696
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ROR2 gene	PMID:35440735
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ROR2 mRNA	PMID:30165855
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ROR2 mRNA	PMID:36139627
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ROR2 mRNA	PMID:21396975
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313207	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ROR2 exon	PMID:30157460
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313208	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ROR2 mRNA	PMID:34911549
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ROR2 mRNA	PMID:31150632
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ROR2 mRNA]	PMID:31150632
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ROR2 mRNA	PMID:23557933
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313208	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ROR2 mRNA	PMID:24680724
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313208	E	RGD:6480464	20141223	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ROR2 mRNA	PMID:24928892
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313207	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ROR2 mRNA	PMID:12377990
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313208	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ROR2 mRNA	PMID:17586704
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313207	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ROR2 mRNA	PMID:29803840
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313207	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ROR2 mRNA	PMID:34032870
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313207	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ROR2 intron	PMID:30157460
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313207	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ROR2 mRNA	PMID:32234424
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313207	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ROR2 promoter	PMID:27901495
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1313208	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of ROR2 gene	PMID:35295148
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:32497	thioacetamide	affects methylation	EXP		E	RGD:6480464	20141223	CTD	MESH:D013853	Thioacetamide affects the methylation of ROR2 promoter	PMID:25151969
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313207	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ROR2 mRNA	PMID:30690063
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ROR2 mRNA	PMID:25181051
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313207	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of ROR2 mRNA	PMID:15223131
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ROR2 mRNA	PMID:34947998
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ROR2 mRNA	PMID:30951980
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ROR2 gene	PMID:28505145
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of ROR2 mRNA	PMID:30951980
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ROR2 mRNA	PMID:30951980
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of ROR2 mRNA	PMID:30951980
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313207	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ROR2 intron	PMID:30157460
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ROR2 mRNA	PMID:30951980
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of ROR2 mRNA	PMID:30951980
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313208	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ROR2 intron	PMID:28392331
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313208	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of ROR2 protein	PMID:39748354
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ROR2 promoter	PMID:22457795
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313207	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ROR2 mRNA	PMID:25812627
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of ROR2 mRNA	PMID:27387713
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313207	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ROR2 mRNA	PMID:31533062
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313207	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ROR2 mRNA	PMID:25812627
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313207	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ROR2 mRNA	PMID:25979313
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313207	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ROR2 mRNA	PMID:28001369
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313207	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ROR2 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313208	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of ROR2 mRNA	PMID:24896083
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313207	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ROR2 gene	PMID:29154799
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA	PMID:27188386
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003907	Dexamethasone results in increased expression of ROR2 mRNA	PMID:38971901
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313207	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ROR2 mRNA	PMID:38832940
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313207	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ROR2 mRNA	PMID:24935251|PMID:26272509
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA	PMID:27188386
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of ROR2 mRNA	PMID:30723492
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313207	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ROR2 mRNA	PMID:29067470
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ROR2 mRNA	PMID:22079256
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	EXP		E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of ROR2 gene	PMID:37958445
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313208	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ROR2 mRNA; Nanotubes, Carbon results in increased expression of ROR2 mRNA	PMID:25554681
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313207	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ROR2 intron	PMID:30157460
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ROR2 gene	PMID:35440735
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313207	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ROR2 mRNA	PMID:22079256
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313207	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ROR2 mRNA	PMID:22714537
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ROR2 mRNA	PMID:22079256
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ROR2 mRNA	PMID:36139627
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA	PMID:27188386
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ROR2 gene]	PMID:28238834
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313208	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ROR2 mRNA	PMID:38648751
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313207	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ROR2 mRNA	PMID:26079696
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313208	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of ROR2 mRNA	PMID:30953684
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ROR2 mRNA	PMID:33150595
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ROR2 mRNA	PMID:24780913
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases methylation	EXP		E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in increased methylation of ROR2 promoter	PMID:33150595
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:8687	pyrvinium	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20250805	CTD	MESH:C024631	pyrvinium inhibits the reaction [ROR2 protein results in decreased expression of CDH1 protein]; pyrvinium inhibits the reaction [ROR2 protein results in increased expression of CDH2 protein]; pyrvinium inhibits the reaction [ROR2 protein results in increased expression of VIM protein]	PMID:39428718
1305275	Ror2	receptor tyrosine kinase-like orphan receptor 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313207	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA	PMID:27188386
1305276	Rell2	RELT-like 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313209	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RELL2 mRNA	PMID:38218311
1305276	Rell2	RELT-like 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313210	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RELL2 mRNA	PMID:20188158
1305276	Rell2	RELT-like 2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313209	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of RELL2 mRNA	PMID:30510588
1305276	Rell2	RELT-like 2	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RELL2 mRNA	PMID:23829299
1305276	Rell2	RELT-like 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA	PMID:25510870
1305276	Rell2	RELT-like 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RELL2 mRNA	PMID:33387578
1305276	Rell2	RELT-like 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313209	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RELL2 mRNA	PMID:37042841
1305276	Rell2	RELT-like 2	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313209	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of RELL2 mRNA	PMID:33647349
1305276	Rell2	RELT-like 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RELL2 mRNA	PMID:33387578
1305276	Rell2	RELT-like 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313209	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RELL2 mRNA	PMID:28818685
1305276	Rell2	RELT-like 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA	PMID:25510870
1305276	Rell2	RELT-like 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA	PMID:25510870
1305276	Rell2	RELT-like 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RELL2 mRNA	PMID:30779732
1305276	Rell2	RELT-like 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313210	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RELL2 mRNA	PMID:25629700
1305276	Rell2	RELT-like 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313209	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELL2 mRNA	PMID:40512198
1305276	Rell2	RELT-like 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313210	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of RELL2 mRNA	PMID:28960355
1305276	Rell2	RELT-like 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RELL2 mRNA	PMID:31881176
1305276	Rell2	RELT-like 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313209	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RELL2 mRNA	PMID:23557933
1305276	Rell2	RELT-like 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313209	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of RELL2 mRNA	PMID:27392435
1305276	Rell2	RELT-like 2	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of RELL2 mRNA	PMID:20187946
1305276	Rell2	RELT-like 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313210	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of RELL2 mRNA	PMID:32186404
1305276	Rell2	RELT-like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RELL2 mRNA	PMID:22298810
1305276	Rell2	RELT-like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RELL2 mRNA	PMID:32109520
1305276	Rell2	RELT-like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RELL2 mRNA	PMID:33387578
1305276	Rell2	RELT-like 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313209	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of RELL2 mRNA	PMID:32763439
1305276	Rell2	RELT-like 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of RELL2 mRNA]; MT2 affects the reaction [Copper results in increased expression of RELL2 mRNA]	PMID:16629173
1305276	Rell2	RELT-like 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313209	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RELL2 mRNA	PMID:38568856
1305276	Rell2	RELT-like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313209	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELL2 mRNA	PMID:40512198
1305276	Rell2	RELT-like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA	PMID:34876320
1305276	Rell2	RELT-like 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA	PMID:34876320
1305276	Rell2	RELT-like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RELL2 mRNA	PMID:21839799
1305276	Rell2	RELT-like 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313209	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RELL2 exon	PMID:27901495
1305276	Rell2	RELT-like 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to RELL2 promoter]	PMID:19654925
1305276	Rell2	RELT-like 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of RELL2 mRNA]; MT2 affects the reaction [Copper results in increased expression of RELL2 mRNA]	PMID:16629173
1305276	Rell2	RELT-like 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313210	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RELL2 gene	PMID:35295148
1305276	Rell2	RELT-like 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RELL2 mRNA	PMID:23411599|PMID:34492290
1305276	Rell2	RELT-like 2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of RELL2 mRNA	PMID:19167457
1305276	Rell2	RELT-like 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RELL2 mRNA	PMID:25181051
1305276	Rell2	RELT-like 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RELL2 mRNA	PMID:34947998
1305276	Rell2	RELT-like 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA	PMID:25510870
1305276	Rell2	RELT-like 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of RELL2 mRNA	PMID:23829299
1305276	Rell2	RELT-like 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA	PMID:25510870
1305276	Rell2	RELT-like 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313210	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RELL2 mRNA	PMID:28392331
1305276	Rell2	RELT-like 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RELL2 mRNA	PMID:21266533
1305276	Rell2	RELT-like 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313209	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RELL2 mRNA	PMID:29024780
1305276	Rell2	RELT-like 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313209	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RELL2 mRNA	PMID:38174414
1305276	Rell2	RELT-like 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of RELL2 mRNA	PMID:25539665
1305276	Rell2	RELT-like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313210	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RELL2 mRNA	PMID:40194260
1305276	Rell2	RELT-like 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313209	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RELL2 mRNA	PMID:31533062
1305276	Rell2	RELT-like 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313209	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of RELL2 mRNA	PMID:29154799
1305276	Rell2	RELT-like 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RELL2 mRNA	PMID:30047161
1305276	Rell2	RELT-like 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313209	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RELL2 mRNA	PMID:38832940
1305276	Rell2	RELT-like 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313209	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of RELL2 mRNA	PMID:29067470
1305276	Rell2	RELT-like 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313209	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELL2 mRNA	PMID:40512198
1305276	Rell2	RELT-like 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RELL2 mRNA	PMID:29391264
1305276	Rell2	RELT-like 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA	PMID:34876320
1305276	Rell2	RELT-like 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of RELL2 mRNA	PMID:34044035
1305276	Rell2	RELT-like 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RELL2 mRNA	PMID:30047161
1305276	Rell2	RELT-like 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313210	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RELL2 mRNA	PMID:38701926
1305276	Rell2	RELT-like 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RELL2 mRNA	PMID:28801915
1305276	Rell2	RELT-like 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA	PMID:34876320
1305276	Rell2	RELT-like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RELL2 mRNA	PMID:24780913
1305276	Rell2	RELT-like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RELL2 mRNA	PMID:30047161
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of ADAM33 mRNA	PMID:25152437
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:132606	mono(2-ethyl-5-oxohexyl) phthalate	multiple interactions	ISO	RGD:1313212	E	RGD:6480464	20190219	CTD	MESH:C080276	[[Endocrine Disruptors results in increased abundance of mono(2-ethyl-5-oxohexyl)phthalate] which results in increased methylation of ADAM33 intron] which results in increased expression of ADAM33 mRNA	PMID:30226539
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:132607	mono(2-ethyl-5-hydroxyhexyl) phthalate	multiple interactions	ISO	RGD:1313212	E	RGD:6480464	20190219	CTD	MESH:C479069	[[Endocrine Disruptors results in increased abundance of mono(2-ethyl-5-hydroxyhexyl) phthalate] which results in increased methylation of ADAM33 intron] which results in increased expression of ADAM33 mRNA	PMID:30226539
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:132611	mono(5-carboxy-2-ethylpentyl) phthalate	multiple interactions	ISO	RGD:1313212	E	RGD:6480464	20190219	CTD	MESH:C051450	[[Endocrine Disruptors results in increased abundance of 2-ethyl-5-carboxypentyl phthalate] which results in increased methylation of ADAM33 intron] which results in increased expression of ADAM33 mRNA	PMID:30226539
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1313212	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of ADAM33 mRNA	PMID:34925699
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:15365	acetylsalicylic acid	affects response to substance	ISO	RGD:1313212	E	RGD:6480464	20120501	CTD	MESH:D001241	ADAM33 SNP affects the susceptibility to Aspirin	PMID:17061022
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313213	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of ADAM33 mRNA	PMID:36189433
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADAM33 mRNA	PMID:36189433
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADAM33 mRNA	PMID:39241906
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313212	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ADAM33 mRNA	PMID:30510588
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313213	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ADAM33 mRNA	PMID:33711761
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313212	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ADAM33 mRNA	PMID:26079696
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADAM33 mRNA	PMID:36189433
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313212	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of ADAM33 mRNA	PMID:26485663
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADAM33 mRNA	PMID:34911549
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ADAM33 mRNA	PMID:25629700
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAM33 mRNA	PMID:40504410
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313213	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ADAM33 mRNA	PMID:28960355
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313212	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAM33 mRNA	PMID:23557933
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313212	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ADAM33 mRNA	PMID:24768652|PMID:25583101
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313213	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADAM33 mRNA	PMID:21570461
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADAM33 mRNA	PMID:33387578
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADAM33 mRNA	PMID:32109520
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1313212	E	RGD:6480464	20180828	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of ADAM33 mRNA]	PMID:29753051
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAM33 mRNA	PMID:37682722
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAM33 mRNA	PMID:40504410
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313212	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADAM33 promoter	PMID:27901495
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ADAM33 mRNA]	PMID:22228805
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:3015	benomyl	increases expression	ISO	RGD:1313212	E	RGD:6480464	20170516	CTD	MESH:D001542	Benomyl results in increased expression of ADAM33 protein	PMID:27784618
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:3015	benomyl	multiple interactions	ISO	RGD:1313212	E	RGD:6480464	20170516	CTD	MESH:D001542	ORMDL3 protein affects the reaction [Benomyl results in increased expression of ADAM33 protein]	PMID:27784618
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1313212	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ADAM33 mRNA	PMID:37690743
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ADAM33 mRNA	PMID:30047161
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ADAM33 mRNA	PMID:23557971
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313213	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ADAM33 gene	PMID:35295148
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313213	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of ADAM33 mRNA	PMID:30245210
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313213	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of ADAM33 exon; bisphenol S affects the methylation of ADAM33 promoter	PMID:33297965
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADAM33 mRNA	PMID:38685157
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ADAM33 mRNA	PMID:24893172
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ADAM33 mRNA	PMID:32680482
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313212	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ADAM33 mRNA	PMID:24449571
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ADAM33 mRNA	PMID:39529242
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADAM33 mRNA	PMID:29427782
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313212	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADAM33 gene	PMID:29154799
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ADAM33 mRNA	PMID:30047161
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADAM33 mRNA	PMID:33387578
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313212	E	RGD:6480464	20130312	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADAM33 mRNA	PMID:22230336
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313213	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ADAM33 mRNA	PMID:29279043
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAM33 mRNA	PMID:40504410
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313212	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ADAM33 mRNA	PMID:31838189
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ADAM33 mRNA	PMID:17557909
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	ISO	RGD:1313212	E	RGD:6480464	20211207	CTD	MESH:C014347	Decitabine results in decreased methylation of ADAM33 promoter	PMID:34534549
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ADAM33 mRNA	PMID:30047161
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1313213	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of ADAM33 mRNA	PMID:26377693
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313213	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ADAM33 mRNA	PMID:23608068
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313212	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ADAM33 mRNA	PMID:24810058
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:71193	liraglutide	decreases methylation	ISO	RGD:1313212	E	RGD:6480464	20211207	CTD	MESH:D000069450	Liraglutide results in decreased methylation of ADAM33 promoter	PMID:34534549
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:71193	liraglutide	decreases methylation	ISO	RGD:1313213	E	RGD:6480464	20211207	CTD	MESH:D000069450	Liraglutide results in decreased methylation of ADAM33 promoter	PMID:34534549
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:71193	liraglutide	increases expression	ISO	RGD:1313212	E	RGD:6480464	20211207	CTD	MESH:D000069450	Liraglutide results in increased expression of ADAM33 mRNA; Liraglutide results in increased expression of ADAM33 protein	PMID:34534549
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:71193	liraglutide	increases expression	ISO	RGD:1313213	E	RGD:6480464	20211207	CTD	MESH:D000069450	Liraglutide results in increased expression of ADAM33 mRNA; Liraglutide results in increased expression of ADAM33 protein	PMID:34534549
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313213	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ADAM33 mRNA	PMID:22206623
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of ADAM33 mRNA	PMID:32109520
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313213	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ADAM33 mRNA	PMID:38648751
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313213	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ADAM33 mRNA	PMID:21795629
1305278	Adam33	ADAM metallopeptidase domain 33	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313213	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of ADAM33 mRNA	PMID:35537566
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313214	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of CHERP protein	PMID:39638853
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313215	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CHERP mRNA	PMID:33045310
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CHERP mRNA]	PMID:31150632
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313215	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CHERP mRNA	PMID:24205000
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313215	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CHERP mRNA	PMID:30319688
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313214	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of CHERP mRNA	PMID:31614463
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313214	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CHERP protein	PMID:37730182
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CHERP protein]	PMID:32272095
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313214	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CHERP protein	PMID:23301498
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CHERP mRNA	PMID:31150632
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CHERP mRNA]	PMID:31150632
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHERP mRNA	PMID:22206623
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHERP mRNA	PMID:40504410
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313214	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CHERP protein	PMID:35688186
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313214	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of CHERP mRNA	PMID:27594783
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313215	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CHERP mRNA	PMID:30912803
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313214	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHERP mRNA	PMID:22574217
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313215	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHERP mRNA	PMID:21570461
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313215	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CHERP mRNA	PMID:19465110
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313214	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of CHERP mRNA	PMID:33512557
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313214	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CHERP mRNA	PMID:33212167
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of CHERP protein	PMID:23736079
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of CHERP mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CHERP mRNA	PMID:23783067
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHERP mRNA	PMID:40504410
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313215	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CHERP exon; Benzo(a)pyrene results in decreased methylation of CHERP intron	PMID:27901495
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CHERP mRNA	PMID:34492290
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313214	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CHERP gene	PMID:31601247
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CHERP mRNA	PMID:25181051
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CHERP mRNA	PMID:27914987
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313215	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CHERP gene	PMID:31683443
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHERP mRNA	PMID:17602206
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313215	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of CHERP protein	PMID:32272095
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CHERP protein]	PMID:32272095
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHERP mRNA	PMID:17602206
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313214	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHERP mRNA	PMID:37042841
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313214	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CHERP mRNA	PMID:38382870
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313214	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CHERP mRNA	PMID:19376846
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313214	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CHERP mRNA	PMID:28302478
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313214	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CHERP mRNA	PMID:25979313
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313214	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CHERP gene	PMID:29154799
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313214	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of CHERP mRNA	PMID:24449571
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313215	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CHERP mRNA	PMID:17562736
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313215	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CHERP mRNA	PMID:19446018
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHERP mRNA	PMID:40504410
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CHERP mRNA	PMID:35964746
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CHERP mRNA	PMID:24136188
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313214	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CHERP protein	PMID:32959892
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CHERP mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CHERP mRNA	PMID:23783067
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313215	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CHERP mRNA	PMID:26307267
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313214	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CHERP mRNA	PMID:31758290
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHERP mRNA	PMID:22206623
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1313214	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of CHERP protein	PMID:39638853
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1313215	E	RGD:6480464	20220607	CTD	MESH:C038405	nivalenol results in increased expression of CHERP mRNA	PMID:35016910
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CHERP mRNA	PMID:21346803
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313214	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CHERP mRNA	PMID:38568856
1305279	Cherp	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CHERP mRNA	PMID:21346803
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313216	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DAZAP1 mRNA	PMID:38218311
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313216	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DAZAP1 mRNA	PMID:38218311
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:15882	phenol	increases expression	ISO	RGD:1313216	E	RGD:6480464	20120412	CTD	MESH:D019800	Phenol results in increased expression of DAZAP1 mRNA	PMID:17547211
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313217	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DAZAP1 mRNA	PMID:39241906
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DAZAP1 mRNA	PMID:39298647
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of DAZAP1 mRNA	PMID:32145629
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313216	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of DAZAP1 mRNA	PMID:23649840
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in increased expression of DAZAP1 protein	PMID:34122009
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DAZAP1 mRNA	PMID:36331819
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DAZAP1 mRNA	PMID:37236586
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DAZAP1 protein	PMID:23301498
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313216	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DAZAP1 mRNA	PMID:23649840
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of DAZAP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of DAZAP1 protein	PMID:38598786
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DAZAP1 mRNA]	PMID:22206623
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313216	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DAZAP1 gene	PMID:25304211
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAZAP1 mRNA	PMID:40504410
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	increases expression	ISO	RGD:1313216	E	RGD:6480464	20120412	CTD	MESH:D000966	Antimony Potassium Tartrate results in increased expression of DAZAP1 mRNA	PMID:17547211
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DAZAP1 protein	PMID:38460933
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313216	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DAZAP1 protein	PMID:35688186
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313216	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DAZAP1 mRNA	PMID:28903495
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of DAZAP1 mRNA	PMID:20187946
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313217	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DAZAP1 mRNA	PMID:20702594|PMID:21570461
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DAZAP1 mRNA	PMID:33387578
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DAZAP1 mRNA	PMID:17942748
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313216	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DAZAP1 mRNA	PMID:23179753|PMID:26272509
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAZAP1 mRNA	PMID:27188386
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313216	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of DAZAP1 mRNA	PMID:39709020
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313216	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DAZAP1 mRNA	PMID:29803840
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313216	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DAZAP1 mRNA	PMID:38568856
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAZAP1 mRNA	PMID:40504410
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313216	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DAZAP1 promoter	PMID:27901495
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313217	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DAZAP1 mRNA	PMID:20504355|PMID:22228805
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313217	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of DAZAP1 protein	PMID:37955338
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:30304	antimony(0)	increases expression	ISO	RGD:1313216	E	RGD:6480464	20120412	CTD	MESH:D000965	Antimony results in increased expression of DAZAP1 mRNA	PMID:17547211
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in increased expression of DAZAP1 protein	PMID:34122009
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DAZAP1 mRNA	PMID:39716349
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313216	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DAZAP1 mRNA	PMID:20458559
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DAZAP1 gene	PMID:31601247
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:31739	josamycin	affects response to substance	ISO	RGD:1313216	E	RGD:6480464	20200609	CTD	MESH:D015570	DAZAP1 protein affects the susceptibility to Josamycin	PMID:31915244
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313216	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of DAZAP1 mRNA	PMID:38568856
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DAZAP1 mRNA	PMID:25729387
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313217	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of DAZAP1 mRNA	PMID:29264374
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313217	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DAZAP1 promoter alternative form	PMID:35295148
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313216	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DAZAP1 mRNA	PMID:29275510
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DAZAP1 mRNA	PMID:33221593
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DAZAP1 mRNA	PMID:25181051|PMID:32145629
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DAZAP1 gene	PMID:31601247
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:34093	1-Hydroxypyrene	decreases expression	ISO	RGD:1313216	E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in decreased expression of DAZAP1 mRNA	PMID:21854004
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313216	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of DAZAP1 gene	PMID:31601247
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D000487	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DAZAP1 mRNA	PMID:38685157
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313216	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of DAZAP1 protein	PMID:34186270
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313217	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DAZAP1 intron	PMID:28392331
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313217	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DAZAP1 mRNA	PMID:37019170
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of DAZAP1 protein	PMID:38598786
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DAZAP1 mRNA	PMID:33453195
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of DAZAP1 promoter	PMID:22457795
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DAZAP1 mRNA	PMID:37236586
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:39098	pyrethrins	affects expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins affects the expression of DAZAP1 mRNA	PMID:34896426
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DAZAP1 mRNA	PMID:36331819
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DAZAP1 mRNA	PMID:17963808
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of DAZAP1 mRNA	PMID:21427059
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of DAZAP1 mRNA	PMID:21427059
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313216	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DAZAP1 gene	PMID:29154799
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C037304	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C017160	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DAZAP1 mRNA	PMID:17555576
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of DAZAP1 mRNA	PMID:24136188
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DAZAP1 mRNA	PMID:17562736
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DAZAP1 protein	PMID:38460933
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313216	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DAZAP1 gene	PMID:25304211
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAZAP1 mRNA	PMID:40504410
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DAZAP1 mRNA	PMID:17555576
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DAZAP1 mRNA	PMID:17942748
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DAZAP1 mRNA	PMID:17942748
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DAZAP1 mRNA	PMID:39716349
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313216	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DAZAP1 mRNA	PMID:20458559
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C017690	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313216	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DAZAP1 protein	PMID:32959892
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DAZAP1 mRNA	PMID:25729387
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313217	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DAZAP1 mRNA	PMID:22206623
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DAZAP1 mRNA]	PMID:22206623
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DAZAP1 protein	PMID:37664457
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAZAP1 mRNA	PMID:27188386
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313217	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of DAZAP1 mRNA	PMID:20702594
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1313216	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of DAZAP1 mRNA	PMID:26079696
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313216	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DAZAP1 protein	PMID:38348393
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of DAZAP1 mRNA	PMID:40826991
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DAZAP1 protein; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAZAP1 mRNA	PMID:27188386|PMID:37664457
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DAZAP1 mRNA	PMID:19281266
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313216	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DAZAP1 mRNA	PMID:38568856
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313216	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of DAZAP1 protein	PMID:38598786
1305280	Dazap1	DAZ associated protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DAZAP1 mRNA	PMID:21346803
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313221	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CMC1 mRNA	PMID:36331819
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of CMC1 gene	PMID:30207508
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313221	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CMC1 mRNA	PMID:30319688
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1606956	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in decreased expression of CMC1 mRNA	PMID:23019147
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CMC1 gene	PMID:27618143
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of CMC1 mRNA	PMID:22967744
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CMC1 mRNA	PMID:33387578
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1606956	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CMC1 mRNA	PMID:28818685
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313221	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CMC1 mRNA	PMID:22206623
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313221	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CMC1 mRNA	PMID:40504410
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606956	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CMC1 mRNA	PMID:39836092
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313221	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of CMC1 mRNA	PMID:30912803
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313221	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CMC1 mRNA	PMID:21570461
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CMC1 mRNA	PMID:33387578
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1606956	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of CMC1 protein	PMID:39603559
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606956	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CMC1 mRNA	PMID:29803840
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1313221	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of CMC1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CMC1 mRNA	PMID:23783067
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1606956	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of CMC1 mRNA	PMID:29319823
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313221	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CMC1 mRNA	PMID:40504410
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606956	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CMC1 mRNA	PMID:39836092
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606956	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CMC1 promoter	PMID:27901495
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313221	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to CMC1 promoter]	PMID:19654925
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1606956	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CMC1 mRNA]	PMID:32406909
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313221	E	RGD:6480464	20130806	CTD	MESH:C008261	lead acetate results in decreased expression of CMC1 mRNA	PMID:21829687
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CMC1 mRNA	PMID:25729387
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CMC1 mRNA	PMID:34492290
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CMC1 mRNA	PMID:25181051
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CMC1 mRNA	PMID:30816183|PMID:34947998
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606956	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CMC1 mRNA; bisphenol A results in decreased expression of CMC1 protein	PMID:29275510|PMID:33376534
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CMC1 gene	PMID:28505145
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313221	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of CMC1 mRNA	PMID:40203079
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313221	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CMC1 intron	PMID:28392331
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313221	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CMC1 mRNA	PMID:28392331
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in increased expression of CMC1 mRNA	PMID:22982409
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313221	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CMC1 mRNA	PMID:36331819
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606956	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CMC1 mRNA	PMID:29154799
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606956	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CMC1 mRNA	PMID:25562108
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313221	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CMC1 mRNA	PMID:17562736
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CMC1 mRNA	PMID:33387578
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313221	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CMC1 mRNA	PMID:40504410
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606956	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CMC1 mRNA	PMID:39836092
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CMC1 mRNA	PMID:24136188
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of CMC1 mRNA	PMID:25729387
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CMC1 mRNA	PMID:25729387
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CMC1 mRNA	PMID:24136188
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313221	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CMC1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CMC1 mRNA	PMID:23783067
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313221	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CMC1 mRNA	PMID:22206623
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313221	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CMC1 mRNA	PMID:22206623
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CMC1 mRNA	PMID:24780913
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313221	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of CMC1 mRNA	PMID:40826991
1305283	Cmc1	C-x(9)-C motif containing 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of CMC1 mRNA	PMID:23869203
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ZNF512B mRNA	PMID:33167477
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZNF512B mRNA	PMID:26079696
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1621251	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ZFP512B mRNA	PMID:39298647
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ZNF512B gene	PMID:27618143
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1606523	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF512B protein	PMID:37730182
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP512B mRNA	PMID:33387578
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF512B mRNA	PMID:19549813
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1606523	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ZNF512B protein	PMID:23301498
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1606523	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZNF512B promoter	PMID:30157460
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1621251	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZNF512B mRNA	PMID:19770486
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZFP512B mRNA	PMID:30779732
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1606523	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF512B gene	PMID:25304211
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606523	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZNF512B mRNA	PMID:39836092
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1621251	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP512B mRNA	PMID:40504410
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1606523	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ZNF512B protein	PMID:35688186
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP512B mRNA	PMID:33387578
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZNF512B mRNA	PMID:28001369
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1606523	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF512B mRNA	PMID:33212167
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ZNF512B mRNA	PMID:32763439
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ZFP512B mRNA	PMID:30556269
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF512B mRNA	PMID:38568856
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606523	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF512B mRNA	PMID:39719251
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606523	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZNF512B mRNA	PMID:39836092
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1621251	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP512B mRNA	PMID:40504410
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZNF512B mRNA	PMID:32234424
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1606523	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZNF512B promoter	PMID:27901495
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ZFP512B mRNA	PMID:30556269
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1621251	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZNF512B gene; titanium dioxide results in increased methylation of ZNF512B promoter	PMID:35295148
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFP512B mRNA	PMID:34492290
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1606523	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ZNF512B mRNA	PMID:38479592
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF512B mRNA	PMID:25181051
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP512B mRNA	PMID:32145629|PMID:33296240
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1621251	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ZFP512B mRNA	PMID:39298647
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1621251	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ZNF512B mRNA	PMID:26377693
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1621251	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ZFP512B mRNA	PMID:34813904
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1621251	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ZFP512B mRNA	PMID:34813904
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of ZNF512B mRNA	PMID:17312168
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF512B mRNA	PMID:38174414
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ZFP512B mRNA	PMID:24386269
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1606523	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZNF512B mRNA	PMID:28302478
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606523	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF512B mRNA	PMID:25979313
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF512B mRNA	PMID:28001369|PMID:29154799
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606523	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZNF512B mRNA	PMID:23179753
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1606523	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZNF512B gene	PMID:29154799
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZNF512B mRNA	PMID:20106945|PMID:25562108
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ZNF512B mRNA	PMID:38832940
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZFP512B mRNA	PMID:33387578
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZNF512B mRNA	PMID:21420995|PMID:22230336|PMID:29067470
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1606523	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF512B gene	PMID:25304211
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606523	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZNF512B mRNA	PMID:39836092
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1621251	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP512B mRNA	PMID:40504410
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ZFP512B mRNA	PMID:29391264
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1606523	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ZNF512B mRNA	PMID:22079256
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1621251	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of ZNF512B mRNA	PMID:26377693
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ZNF512B mRNA	PMID:22079256
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1606523	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ZNF512B mRNA	PMID:22079256
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1606523	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of ZNF512B protein	PMID:39638853
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ZNF512B mRNA	PMID:23914054
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of ZNF512B mRNA	PMID:12756304
1305284	Zfp512b	zinc finger protein 512B	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1606523	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZNF512B mRNA	PMID:29301935
1305285	Postn	periostin	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of POSTN mRNA	PMID:25152437
1305285	Postn	periostin	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313223	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of POSTN mRNA	PMID:26272509
1305285	Postn	periostin	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1305285	Postn	periostin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of POSTN mRNA	PMID:20938992
1305285	Postn	periostin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313223	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of POSTN mRNA	PMID:21934132
1305285	Postn	periostin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of POSTN mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of POSTN mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of POSTN mRNA	PMID:30951980
1305285	Postn	periostin	gene	CHEBI:15379	dioxygen	decreases response to substance	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D010100	POSTN gene mutant form results in decreased susceptibility to Oxygen	PMID:22363622
1305285	Postn	periostin	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313223	E	RGD:6480464	20140211	CTD	MESH:D010100	Oxygen deficiency results in increased expression of POSTN protein	PMID:23728938
1305285	Postn	periostin	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen results in increased expression of POSTN mRNA; Oxygen results in increased expression of POSTN protein	PMID:22363622
1305285	Postn	periostin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20140211	CTD	MESH:D010100	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of POSTN protein]; POSTN protein affects the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; POSTN protein affects the reaction [Oxygen deficiency results in increased secretion of VEGFA protein]	PMID:23728938
1305285	Postn	periostin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D010100	[POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of ACTA2 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CCL4 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CXCL1 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CXCL2 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of ELN mRNA; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CCL4 mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CXCL1 mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CXCL2 mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of ELN mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of POSTN mRNA]	PMID:22363622
1305285	Postn	periostin	gene	CHEBI:156259	PD-166866	multiple interactions	EXP		E	RGD:6480464	20200908	CTD	MESH:C113399	PD 166866 inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA]	PMID:15121739
1305285	Postn	periostin	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of POSTN mRNA	PMID:36841081
1305285	Postn	periostin	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of POSTN mRNA	PMID:30517762
1305285	Postn	periostin	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in decreased expression of POSTN mRNA	PMID:17023530
1305285	Postn	periostin	gene	CHEBI:16359	cholic acid	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D019826	Cholic Acid results in decreased expression of POSTN mRNA	PMID:37813191
1305285	Postn	periostin	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313224	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POSTN mRNA	PMID:23585870
1305285	Postn	periostin	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313223	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of POSTN mRNA	PMID:30510588
1305285	Postn	periostin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of POSTN mRNA	PMID:21795739
1305285	Postn	periostin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313224	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in increased expression of POSTN protein; Estradiol results in increased expression of POSTN protein alternative form	PMID:26903627
1305285	Postn	periostin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of POSTN mRNA	PMID:32741896
1305285	Postn	periostin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of POSTN mRNA	PMID:20938992
1305285	Postn	periostin	gene	CHEBI:16865	gamma-aminobutyric acid	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005680	gamma-Aminobutyric Acid affects the expression of POSTN mRNA	PMID:24098073
1305285	Postn	periostin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of POSTN mRNA	PMID:37992649
1305285	Postn	periostin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of POSTN mRNA	PMID:36695872
1305285	Postn	periostin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of and results in increased methylation of POSTN mRNA	PMID:36314267
1305285	Postn	periostin	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of POSTN mRNA	PMID:32741896
1305285	Postn	periostin	gene	CHEBI:173719	Curcumol	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20210706	CTD	MESH:C022801	curcumol results in decreased expression of POSTN mRNA	PMID:32344006
1305285	Postn	periostin	gene	CHEBI:173719	Curcumol	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20210706	CTD	MESH:C022801	curcumol results in decreased expression of and results in decreased secretion of POSTN protein; POSTN protein affects the reaction [curcumol results in decreased expression of ICAM1 protein]; POSTN protein affects the reaction [curcumol results in decreased expression of VCAM1 protein]	PMID:32344006
1305285	Postn	periostin	gene	CHEBI:173719	Curcumol	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20210706	CTD	MESH:C022801	curcumol inhibits the reaction [Carbon Tetrachloride results in increased expression of POSTN protein]	PMID:32344006
1305285	Postn	periostin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of POSTN mRNA	PMID:37992649
1305285	Postn	periostin	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POSTN mRNA	PMID:36331819
1305285	Postn	periostin	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA	PMID:39836092
1305285	Postn	periostin	gene	CHEBI:194147	aristolochic acids	increases expression	EXP		E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in increased expression of POSTN mRNA	PMID:19717638
1305285	Postn	periostin	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in decreased expression of POSTN mRNA	PMID:15120970
1305285	Postn	periostin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20181016	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of POSTN mRNA	PMID:29741670
1305285	Postn	periostin	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of POSTN protein]	PMID:32272095
1305285	Postn	periostin	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313223	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of POSTN protein	PMID:20106945
1305285	Postn	periostin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313223	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of POSTN mRNA	PMID:22100608
1305285	Postn	periostin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of POSTN mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of POSTN mRNA	PMID:27106289|PMID:34911549
1305285	Postn	periostin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313224	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of POSTN mRNA; Carbon Tetrachloride results in increased expression of POSTN protein	PMID:27339419|PMID:29987408|PMID:31919559|PMID:32344006
1305285	Postn	periostin	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20200915	CTD	MESH:D002251	POSTN protein promotes the reaction [Carbon Tetrachloride results in increased expression of GPT protein]	PMID:32344006
1305285	Postn	periostin	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of POSTN mRNA; curcumol inhibits the reaction [Carbon Tetrachloride results in increased expression of POSTN protein]	PMID:30517762|PMID:32344006
1305285	Postn	periostin	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of POSTN mRNA	PMID:25629700
1305285	Postn	periostin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of POSTN mRNA	PMID:20938992
1305285	Postn	periostin	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20240702	CTD	MESH:D001151	Arsenic results in decreased expression of POSTN mRNA	PMID:38036231
1305285	Postn	periostin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POSTN mRNA	PMID:39836092
1305285	Postn	periostin	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of POSTN mRNA	PMID:19244175
1305285	Postn	periostin	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313223	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of POSTN mRNA	PMID:26272509
1305285	Postn	periostin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1305285	Postn	periostin	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of POSTN mRNA	PMID:38314887
1305285	Postn	periostin	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313224	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of POSTN protein	PMID:37208198
1305285	Postn	periostin	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1313223	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of POSTN mRNA	PMID:28903495
1305285	Postn	periostin	gene	CHEBI:27899	cisplatin	decreases response to substance	ISO	RGD:1313223	E	RGD:6480464	20151013	CTD	MESH:D002945	POSTN mRNA results in decreased susceptibility to Cisplatin	PMID:25199881
1305285	Postn	periostin	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of POSTN mRNA	PMID:12075121
1305285	Postn	periostin	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of POSTN mRNA	PMID:24768652|PMID:25583101
1305285	Postn	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POSTN mRNA	PMID:34747641
1305285	Postn	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313223	E	RGD:6480464	20230404	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POSTN mRNA	PMID:36370075
1305285	Postn	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POSTN mRNA	PMID:33387578
1305285	Postn	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POSTN mRNA	PMID:33956508
1305285	Postn	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POSTN mRNA	PMID:32109520
1305285	Postn	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313224	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POSTN mRNA	PMID:21889950
1305285	Postn	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of POSTN mRNA]	PMID:15667827
1305285	Postn	periostin	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of POSTN mRNA	PMID:28374803
1305285	Postn	periostin	gene	CHEBI:28445	vincristine	decreases response to substance	ISO	RGD:1313223	E	RGD:6480464	20161213	CTD	MESH:D014750	POSTN mRNA results in decreased susceptibility to Vincristine	PMID:25199881
1305285	Postn	periostin	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:1313224	E	RGD:6480464	20230606	CTD	MESH:D014752	Vinyl Chloride results in increased expression of POSTN protein	PMID:36892438
1305285	Postn	periostin	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of POSTN mRNA	PMID:28959563
1305285	Postn	periostin	gene	CHEBI:28659	phosphorus atom	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20120412	CTD	MESH:D010758	[Phosphorus co-treated with paricalcitol] results in decreased expression of POSTN mRNA	PMID:17715259
1305285	Postn	periostin	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of POSTN mRNA	PMID:21198554
1305285	Postn	periostin	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of POSTN mRNA	PMID:30556269
1305285	Postn	periostin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of POSTN mRNA	PMID:24690739
1305285	Postn	periostin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of POSTN mRNA	PMID:15467011
1305285	Postn	periostin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin results in decreased expression of POSTN mRNA	PMID:28940058
1305285	Postn	periostin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of POSTN mRNA	PMID:17888722|PMID:39631538
1305285	Postn	periostin	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1313223	E	RGD:6480464	20151013	CTD	MESH:D004317	POSTN mRNA results in decreased susceptibility to Doxorubicin	PMID:25199881
1305285	Postn	periostin	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of POSTN mRNA	PMID:19915844
1305285	Postn	periostin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313223	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of POSTN mRNA	PMID:29803840
1305285	Postn	periostin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313224	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of POSTN mRNA	PMID:36227756
1305285	Postn	periostin	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Razoxane inhibits the reaction [Doxorubicin results in increased expression of POSTN mRNA]	PMID:19915844
1305285	Postn	periostin	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D004317	DMD protein affects the reaction [Doxorubicin results in decreased expression of POSTN mRNA]	PMID:17888722
1305285	Postn	periostin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of POSTN mRNA	PMID:37992649
1305285	Postn	periostin	gene	CHEBI:28939	N-acetyl-L-cysteine	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20230801	CTD	MESH:D000111	Acetylcysteine results in decreased expression of POSTN mRNA	PMID:32947957
1305285	Postn	periostin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of POSTN mRNA	PMID:35954277
1305285	Postn	periostin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20190219	CTD	MESH:C017947	sodium arsenite results in decreased expression of POSTN mRNA	PMID:30130555|PMID:37682722
1305285	Postn	periostin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313223	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of POSTN mRNA	PMID:22714537|PMID:38568856
1305285	Postn	periostin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POSTN mRNA	PMID:39836092
1305285	Postn	periostin	gene	CHEBI:29852	methylarsonic acid	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:C020300	monomethylarsonic acid results in decreased expression of POSTN mRNA	PMID:37813191
1305285	Postn	periostin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of POSTN mRNA	PMID:20713471
1305285	Postn	periostin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313223	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POSTN mRNA	PMID:22316170|PMID:32234424
1305285	Postn	periostin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POSTN mRNA	PMID:21964900
1305285	Postn	periostin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313223	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POSTN exon; Benzo(a)pyrene results in increased methylation of POSTN promoter	PMID:27901495
1305285	Postn	periostin	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of POSTN mRNA	PMID:30556269
1305285	Postn	periostin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of POSTN mRNA	PMID:24690739
1305285	Postn	periostin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of POSTN mRNA	PMID:15467011
1305285	Postn	periostin	gene	CHEBI:30207	phosphorus(.)	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20120412	CTD	MESH:D010758	[Phosphorus co-treated with paricalcitol] results in decreased expression of POSTN mRNA	PMID:17715259
1305285	Postn	periostin	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of POSTN mRNA	PMID:27131904
1305285	Postn	periostin	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of POSTN mRNA	PMID:22431001
1305285	Postn	periostin	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of POSTN mRNA	PMID:26705709
1305285	Postn	periostin	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of POSTN gene	PMID:31601247
1305285	Postn	periostin	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313223	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of POSTN mRNA	PMID:38568856
1305285	Postn	periostin	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of POSTN mRNA	PMID:25729387
1305285	Postn	periostin	gene	CHEBI:32345	gamma-Oryzanol (TN)	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C013172	gamma-oryzanol affects the expression of POSTN mRNA	PMID:24098073
1305285	Postn	periostin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of POSTN mRNA	PMID:30723492
1305285	Postn	periostin	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of POSTN mRNA	PMID:19136022
1305285	Postn	periostin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313224	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of POSTN mRNA	PMID:23811191
1305285	Postn	periostin	gene	CHEBI:3312	calcium dichloride	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20150609	CTD	MESH:D002122	Calcium Chloride results in decreased expression of POSTN protein	PMID:25824407
1305285	Postn	periostin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of POSTN mRNA	PMID:12075121|PMID:25181051|PMID:30816183|PMID:34947998
1305285	Postn	periostin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of POSTN mRNA	PMID:36232920
1305285	Postn	periostin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of POSTN mRNA	PMID:29097150|PMID:32145629
1305285	Postn	periostin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313223	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of POSTN protein	PMID:34186270
1305285	Postn	periostin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of POSTN mRNA; bisphenol A results in increased expression of POSTN protein; bisphenol A results in increased expression of POSTN protein alternative form	PMID:26903627|PMID:30951980|PMID:38701888
1305285	Postn	periostin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of POSTN mRNA	PMID:30951980
1305285	Postn	periostin	gene	CHEBI:338412	(-)-anisomycin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000841	Anisomycin results in increased expression of POSTN mRNA	PMID:15121739
1305285	Postn	periostin	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313224	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of POSTN mRNA	PMID:26682919
1305285	Postn	periostin	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of POSTN mRNA	PMID:20713471
1305285	Postn	periostin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of POSTN mRNA	PMID:30951980
1305285	Postn	periostin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of POSTN mRNA	PMID:40203079
1305285	Postn	periostin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313224	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of POSTN mRNA	PMID:39298647
1305285	Postn	periostin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of POSTN gene	PMID:31601247
1305285	Postn	periostin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of POSTN mRNA	PMID:30951980
1305285	Postn	periostin	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313224	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of POSTN mRNA	PMID:26377693
1305285	Postn	periostin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313223	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of POSTN protein	PMID:34186270
1305285	Postn	periostin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of POSTN mRNA	PMID:30951980
1305285	Postn	periostin	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of POSTN mRNA	PMID:30951980
1305285	Postn	periostin	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313223	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of POSTN protein	PMID:34186270
1305285	Postn	periostin	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of POSTN protein	PMID:32272095
1305285	Postn	periostin	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of POSTN protein]	PMID:32272095
1305285	Postn	periostin	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of POSTN mRNA	PMID:21266533
1305285	Postn	periostin	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313223	E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of POSTN protein	PMID:34064677
1305285	Postn	periostin	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of POSTN mRNA	PMID:35163327
1305285	Postn	periostin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of POSTN mRNA	PMID:35163327
1305285	Postn	periostin	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA	PMID:39836092
1305285	Postn	periostin	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of POSTN mRNA	PMID:30723492
1305285	Postn	periostin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20181016	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of POSTN mRNA	PMID:29741670
1305285	Postn	periostin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of POSTN mRNA	PMID:35163327
1305285	Postn	periostin	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of POSTN mRNA	PMID:27387713
1305285	Postn	periostin	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of POSTN mRNA	PMID:24386269
1305285	Postn	periostin	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of POSTN mRNA	PMID:19244175
1305285	Postn	periostin	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in decreased expression of POSTN mRNA	PMID:37813191
1305285	Postn	periostin	gene	CHEBI:37918	fluorescein 5-isothiocyanate	affects binding	ISO	RGD:1313223	E	RGD:6480464	20180116	CTD	MESH:D016650	Fluorescein-5-isothiocyanate binds to POSTN protein	PMID:27129696
1305285	Postn	periostin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313224	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of POSTN mRNA	PMID:40194260
1305285	Postn	periostin	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of POSTN mRNA	PMID:31533062
1305285	Postn	periostin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of POSTN mRNA	PMID:27153767
1305285	Postn	periostin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POSTN mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of POSTN mRNA	PMID:36331819
1305285	Postn	periostin	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1313223	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in increased expression of POSTN mRNA	PMID:21594647
1305285	Postn	periostin	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313223	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of POSTN gene	PMID:29154799
1305285	Postn	periostin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313223	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of POSTN mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:29154799
1305285	Postn	periostin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313224	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of POSTN mRNA	PMID:24896083
1305285	Postn	periostin	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1305285	Postn	periostin	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of POSTN mRNA	PMID:15331540
1305285	Postn	periostin	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of POSTN mRNA	PMID:17555576
1305285	Postn	periostin	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of POSTN mRNA	PMID:25047013
1305285	Postn	periostin	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20250204	CTD	MESH:D003907	Dexamethasone inhibits the reaction [Particulate Matter results in increased expression of POSTN mRNA]	PMID:35335934
1305285	Postn	periostin	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20250204	CTD	MESH:D003907	Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Particulate Matter] results in increased expression of POSTN mRNA]	PMID:35335934
1305285	Postn	periostin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313224	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of POSTN mRNA	PMID:28973697
1305285	Postn	periostin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of POSTN mRNA	PMID:37992649
1305285	Postn	periostin	gene	CHEBI:44185	methotrexate	decreases response to substance	ISO	RGD:1313223	E	RGD:6480464	20151013	CTD	MESH:D008727	POSTN mRNA results in decreased susceptibility to Methotrexate	PMID:25199881
1305285	Postn	periostin	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of POSTN mRNA	PMID:38832940
1305285	Postn	periostin	gene	CHEBI:45863	paclitaxel	decreases response to substance	ISO	RGD:1313223	E	RGD:6480464	20161213	CTD	MESH:D017239	POSTN mRNA results in decreased susceptibility to Paclitaxel	PMID:25199881
1305285	Postn	periostin	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1313223	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of POSTN mRNA	PMID:19682730
1305285	Postn	periostin	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313223	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of POSTN mRNA	PMID:24935251|PMID:26272509
1305285	Postn	periostin	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1305285	Postn	periostin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of POSTN mRNA	PMID:21420995|PMID:29067470
1305285	Postn	periostin	gene	CHEBI:46345	5-fluorouracil	decreases response to substance	ISO	RGD:1313223	E	RGD:6480464	20120412	CTD	MESH:D005472	POSTN protein results in decreased susceptibility to Fluorouracil	PMID:15731169
1305285	Postn	periostin	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of POSTN mRNA	PMID:24690739
1305285	Postn	periostin	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20240702	CTD	MESH:D001151	Arsenic results in decreased expression of POSTN mRNA	PMID:38036231
1305285	Postn	periostin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POSTN mRNA	PMID:39836092
1305285	Postn	periostin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of POSTN mRNA	PMID:17555576
1305285	Postn	periostin	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of POSTN mRNA	PMID:12075121|PMID:17351261|PMID:17557909
1305285	Postn	periostin	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1313223	E	RGD:6480464	20181016	CTD	MESH:D005047	Etoposide results in increased expression of POSTN mRNA	PMID:29397400
1305285	Postn	periostin	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1305285	Postn	periostin	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of POSTN mRNA	PMID:26705709
1305285	Postn	periostin	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1313223	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of POSTN mRNA	PMID:38825487
1305285	Postn	periostin	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of POSTN mRNA	PMID:30307764
1305285	Postn	periostin	gene	CHEBI:50225	razoxane	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011929	Razoxane inhibits the reaction [Doxorubicin results in increased expression of POSTN mRNA]	PMID:19915844
1305285	Postn	periostin	gene	CHEBI:50693	milrinone	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D020105	Milrinone results in increased expression of POSTN mRNA	PMID:22936366
1305285	Postn	periostin	gene	CHEBI:52289	wortmannin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]; wortmannin inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA]	PMID:15121739
1305285	Postn	periostin	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313223	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of POSTN mRNA	PMID:22714537
1305285	Postn	periostin	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of POSTN mRNA	PMID:40645554
1305285	Postn	periostin	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of POSTN protein	PMID:32959892
1305285	Postn	periostin	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA	PMID:39836092
1305285	Postn	periostin	gene	CHEBI:63632	topotecan	decreases response to substance	ISO	RGD:1313223	E	RGD:6480464	20151013	CTD	MESH:D019772	POSTN mRNA results in decreased susceptibility to Topotecan	PMID:25199881
1305285	Postn	periostin	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of POSTN mRNA	PMID:25729387
1305285	Postn	periostin	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of POSTN mRNA	PMID:36851058
1305285	Postn	periostin	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313224	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of POSTN mRNA	PMID:20003209
1305285	Postn	periostin	gene	CHEBI:64317	isoprenaline	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADL mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADM mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADS mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADVL mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACSL1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of AKT1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5F1A mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5F1D mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5MC1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5PO mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP6AP2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of AZI2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of BAG4 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of BIRC2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CASP7 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CDC37 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CHUK mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of COPS3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CPT1A mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CPT2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CUL1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of DMAC2L mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ELP1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of GCLM mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of GLG1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of GPX1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of HADHA mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of JUN mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KCNQ1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KEAP1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KPNA3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KPNA6 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of LRPPRC mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of MAP2K4 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of MAP3K2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NCSTN mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFA10L1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFA11 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB8 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS4 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS8 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFV1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFV2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFE2L2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFKB1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFKBIA mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NKIRAS2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NOTCH1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NQO1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NSMAF mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PEBP1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PECR mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PRKACA mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMA7 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB8 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMC5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMC6 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD11 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD13 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of SLC25A20 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of SOD2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of STAT1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of STAT3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of TBK1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of TXNRD2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of UBA1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of USP2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of XDH mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of YWHAG mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ZFAND5 mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of ATP5ME mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of ATP5PD mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of BCL2 mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of DAP mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of TNF mRNA	PMID:30303030
1305285	Postn	periostin	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of POSTN mRNA	PMID:35283115
1305285	Postn	periostin	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TGFB1 protein results in increased expression of POSTN mRNA]	PMID:15121739|PMID:16325820
1305285	Postn	periostin	gene	CHEBI:6541	losartan	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20230801	CTD	MESH:D019808	Losartan results in decreased expression of POSTN mRNA	PMID:32947957
1305285	Postn	periostin	gene	CHEBI:6541	losartan	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120501	CTD	MESH:D019808	Losartan results in decreased expression of POSTN mRNA	PMID:21641384
1305285	Postn	periostin	gene	CHEBI:6541	losartan	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019808	Losartan inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]	PMID:15121739
1305285	Postn	periostin	gene	CHEBI:67895	corosolic acid	increases expression	ISO	RGD:1313223	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of POSTN mRNA	PMID:37939859
1305285	Postn	periostin	gene	CHEBI:6918	Mezerein	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:C011309	mezerein results in decreased expression of POSTN mRNA	PMID:37813191
1305285	Postn	periostin	gene	CHEBI:6980	monocrotaline	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D016686	Monocrotaline results in increased expression of POSTN protein	PMID:24947524
1305285	Postn	periostin	gene	CHEBI:72754	bisphenol AF	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in decreased expression of POSTN mRNA	PMID:39938710
1305285	Postn	periostin	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313223	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of POSTN protein	PMID:34186270
1305285	Postn	periostin	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of POSTN mRNA	PMID:22714537
1305285	Postn	periostin	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of POSTN mRNA	PMID:32741896
1305285	Postn	periostin	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of POSTN mRNA	PMID:19717638
1305285	Postn	periostin	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1305285	Postn	periostin	gene	CHEBI:79	(-)-Arctigenin	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20260303	CTD	MESH:C071942	arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in increased secretion of POSTN protein]; BIRC3 protein affects the reaction [KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in increased secretion of POSTN protein]]]; KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in increased secretion of POSTN protein]]; TNFSF12 protein affects the reaction [BIRC3 protein affects the reaction [KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in increased secretion of POSTN protein]]]]	PMID:40803538
1305285	Postn	periostin	gene	CHEBI:7931	paricalcitol	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20161213	CTD	MESH:C084656	[Phosphorus co-treated with paricalcitol] results in decreased expression of POSTN mRNA	PMID:17715259
1305285	Postn	periostin	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313224	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of POSTN mRNA	PMID:19136022|PMID:23091169
1305285	Postn	periostin	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of POSTN mRNA	PMID:19084549
1305285	Postn	periostin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313224	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of POSTN mRNA	PMID:38648751
1305285	Postn	periostin	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of POSTN mRNA	PMID:23914054
1305285	Postn	periostin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of POSTN mRNA	PMID:24780913
1305285	Postn	periostin	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1313223	E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of POSTN mRNA; Raloxifene Hydrochloride results in decreased expression of POSTN protein	PMID:32947957
1305285	Postn	periostin	gene	CHEBI:8887	rofecoxib	affects expression	ISO	RGD:1313223	E	RGD:6480464	20170303	CTD	MESH:C116926	rofecoxib affects the expression of POSTN mRNA	PMID:17070997
1305285	Postn	periostin	gene	CHEBI:90705	SB 203580	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]; SB 203580 inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA]	PMID:15121739|PMID:17485602
1305285	Postn	periostin	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313223	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1305285	Postn	periostin	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of POSTN mRNA	PMID:27131904
1305285	Postn	periostin	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA]	PMID:15121739
1305285	Postn	periostin	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313223	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of POSTN mRNA	PMID:38568856
1305285	Postn	periostin	gene	CHEBI:9927	valsartan	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C081489	Valsartan inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]	PMID:17485602
1305285	Postn	periostin	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of POSTN mRNA	PMID:19015723
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PLAG1 mRNA	PMID:30071829
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313226	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PLAG1 mRNA	PMID:20188158
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313225	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of PLAG1 mRNA	PMID:33167477
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313225	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PLAG1 mRNA	PMID:26079696
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PLAG1 mRNA	PMID:21632981
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of PLAG1 mRNA	PMID:26496021
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PLAG1 mRNA	PMID:20655997
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313225	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PLAG1 mRNA	PMID:26079696
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1313225	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLAG1 mRNA	PMID:36139627
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313225	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PLAG1 mRNA	PMID:28818685
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313225	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PLAG1 intron	PMID:30157460
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PLAG1 mRNA	PMID:30779732
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PLAG1 mRNA	PMID:26272509
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313225	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLAG1 mRNA	PMID:27188386
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313225	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PLAG1 mRNA	PMID:27392435
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PLAG1 mRNA	PMID:24768652|PMID:25583101
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLAG1 mRNA	PMID:33387578
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PLAG1 mRNA	PMID:28001369
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PLAG1 mRNA	PMID:33212167
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PLAG1 mRNA	PMID:29803840
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313225	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of PLAG1 mRNA	PMID:34032870
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313225	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PLAG1 mRNA	PMID:38568856
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313225	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLAG1 intron	PMID:30157460
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PLAG1 mRNA	PMID:21632981
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313225	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PLAG1 mRNA	PMID:25895662
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PLAG1 mRNA	PMID:30047161
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313226	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLAG1 gene	PMID:35295148
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313226	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of PLAG1 mRNA	PMID:18648102
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313225	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLAG1 mRNA	PMID:19710929
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PLAG1 mRNA	PMID:25181051
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313226	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of PLAG1 promoter	PMID:27334623
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313225	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PLAG1 mRNA	PMID:33670352
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313225	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PLAG1 gene	PMID:31601247
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of PLAG1 mRNA	PMID:26496021
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313225	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PLAG1 intron	PMID:30157460
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313225	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLAG1 mRNA	PMID:37042841
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:35456	cadmium dichloride	affects methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the methylation of PLAG1 promoter	PMID:22457795
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313225	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PLAG1 mRNA	PMID:31533062
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313225	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLAG1 mRNA	PMID:25979313
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PLAG1 mRNA	PMID:29427782
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLAG1 mRNA	PMID:29427782
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLAG1 mRNA	PMID:23179753|PMID:24935251|PMID:25192806|PMID:28001369
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313225	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PLAG1 gene	PMID:29154799
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313225	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of PLAG1 mRNA	PMID:19101580
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PLAG1 mRNA	PMID:30047161|PMID:41580965
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PLAG1 mRNA	PMID:25562108
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1313225	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of PLAG1 promoter	PMID:27989131
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313225	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of PLAG1 mRNA	PMID:16144937
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313225	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PLAG1 mRNA	PMID:38832940
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PLAG1 mRNA	PMID:33387578
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in decreased expression of PLAG1 mRNA	PMID:36653537
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PLAG1 mRNA	PMID:30047161|PMID:41580965
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313225	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of PLAG1 mRNA	PMID:28988120
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313225	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PLAG1 intron	PMID:30157460
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1313225	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of PLAG1 mRNA	PMID:29522793
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313225	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PLAG1 mRNA	PMID:37199045
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313225	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLAG1 mRNA	PMID:36139627
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313225	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLAG1 mRNA	PMID:27188386
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313225	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PLAG1 mRNA	PMID:26079696
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLAG1 mRNA	PMID:24780913|PMID:30047161
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313225	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLAG1 mRNA	PMID:27188386
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313225	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PLAG1 mRNA	PMID:29301935
1305286	Plag1	PLAG1 zinc finger	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of PLAG1 mRNA	PMID:23555832
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of ABRAXAS1 mRNA; Tretinoin results in decreased expression of FAM175A mRNA	PMID:21934132|PMID:33167477
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1604576	E	RGD:6480464	20150127	CTD	MESH:D014212	Tretinoin results in increased expression of ABRAXAS1 mRNA	PMID:23724009
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1604576	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ABRAXAS1 mRNA	PMID:21632981
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ABRAXAS1 mRNA	PMID:26577399
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1604576	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ABRAXAS1 protein	PMID:37730182
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332240	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ABRAXAS1 mRNA	PMID:36331819
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332240	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FAM175A mRNA	PMID:25629700
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ABRAXAS1 mRNA	PMID:26272509
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1604576	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABRAXAS1 mRNA	PMID:27188386
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1604576	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ABRAXAS1 protein	PMID:35688186
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332240	E	RGD:6480464	20150127	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABRAXAS1 mRNA	PMID:21570461
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1604576	E	RGD:6480464	20190702	CTD	MESH:D012402	Rotenone results in increased expression of ABRAXAS1 mRNA	PMID:29955902
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20180703	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ABRAXAS1 mRNA	PMID:28001369
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of ABRAXAS1 mRNA	PMID:22363485
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20181016	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABRAXAS1 mRNA	PMID:28595984|PMID:38568856
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604576	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM175A promoter	PMID:27901495
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332240	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM175A gene	PMID:35295148
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ABRAXAS1 mRNA	PMID:34492290
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1332240	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ABRAXAS1 mRNA	PMID:18648102
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332240	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ABRAXAS1 mRNA	PMID:32156529
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ABRAXAS1 mRNA	PMID:25181051
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604576	E	RGD:6480464	20181016	CTD	MESH:C006780	bisphenol A results in increased expression of ABRAXAS1 mRNA	PMID:29275510
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:C006780	bisphenol A results in increased methylation of ABRAXAS1 gene	PMID:28505145
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1604576	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ABRAXAS1 gene	PMID:31601247
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332240	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ABRAXAS1 mRNA	PMID:38685157
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604576	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABRAXAS1 mRNA	PMID:37042841
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1604576	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ABRAXAS1 mRNA	PMID:24449571
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20181016	CTD	MESH:C000944	dicrotophos results in decreased expression of ABRAXAS1 mRNA	PMID:28302478
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1604576	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ABRAXAS1 mRNA	PMID:31533062
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20150127	CTD	MESH:D003375	Coumestrol results in decreased expression of ABRAXAS1 mRNA	PMID:19167446
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332240	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ABRAXAS1 mRNA	PMID:36331819
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of ABRAXAS1 mRNA	PMID:23179753|PMID:24935251
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604576	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of ABRAXAS1 mRNA	PMID:23527032
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1604576	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ABRAXAS1 mRNA	PMID:20106945
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1604576	E	RGD:6480464	20170725	CTD	MESH:C012589	trichostatin A affects the expression of ABRAXAS1 mRNA	PMID:28542535
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ABRAXAS1 mRNA	PMID:24935251|PMID:26272509
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1604576	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABRAXAS1 mRNA	PMID:27188386
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABRAXAS1 mRNA	PMID:33387578
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ABRAXAS1 mRNA	PMID:22714537
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1604576	E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of ABRAXAS1 mRNA	PMID:33884520
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ABRAXAS1 mRNA	PMID:31758290
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332240	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FAM175A mRNA	PMID:22206623
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ABRAXAS1 mRNA	PMID:22714537
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1604576	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ABRAXAS1 protein	PMID:31285264
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in decreased expression of ABRAXAS1 mRNA	PMID:23358140
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604576	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABRAXAS1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABRAXAS1 mRNA	PMID:27188386
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1604576	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of ABRAXAS1 mRNA	PMID:39904859
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604576	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABRAXAS1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABRAXAS1 mRNA	PMID:27188386
1305287	Abraxas1	abraxas 1, BRCA1 A complex subunit	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ABRAXAS1 mRNA	PMID:19281266
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313228	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of HAUS4 mRNA	PMID:38218311
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313228	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of HAUS4 mRNA	PMID:25812627
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313229	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of HAUS4 mRNA	PMID:26251327
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313228	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of HAUS4 mRNA	PMID:22378314
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313229	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HAUS4 mRNA	PMID:39241906
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of HAUS4 mRNA	PMID:32145629
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of HAUS4 mRNA	PMID:23019147|PMID:31614463
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313229	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of HAUS4 mRNA	PMID:39298647
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of HAUS4 mRNA	PMID:22217510
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of HAUS4 mRNA	PMID:23649840
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of HAUS4 mRNA	PMID:21592394|PMID:33359661
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of HAUS4 mRNA	PMID:21592394
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of HAUS4 mRNA	PMID:21592394
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of HAUS4 mRNA	PMID:21592394
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HAUS4 mRNA	PMID:19549813
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of HAUS4 mRNA	PMID:19376150
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313229	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HAUS4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HAUS4 mRNA	PMID:34911549
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313229	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of HAUS4 mRNA	PMID:31919559
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313229	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HAUS4 mRNA	PMID:22206623
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313228	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HAUS4 mRNA	PMID:19244175
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of HAUS4 mRNA	PMID:26272509
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HAUS4 mRNA	PMID:27188386
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313228	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of HAUS4 protein	PMID:35688186
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HAUS4 mRNA	PMID:31881176
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1313228	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of HAUS4 gene	PMID:31636367
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HAUS4 mRNA	PMID:27392435
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313229	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of HAUS4 mRNA	PMID:30912803
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HAUS4 mRNA	PMID:34747641
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HAUS4 mRNA	PMID:33387578
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HAUS4 mRNA	PMID:28001369
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of HAUS4 mRNA	PMID:28959563
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HAUS4 mRNA	PMID:29803840
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HAUS4 mRNA	PMID:38568856
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313228	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of HAUS4 mRNA	PMID:29453283
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HAUS4 mRNA	PMID:20106945
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313228	E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HAUS4 protein	PMID:32717239
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of HAUS4 mRNA	PMID:23221170
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of HAUS4 mRNA	PMID:25729387
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HAUS4 mRNA	PMID:25729387
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HAUS4 mRNA	PMID:30047161
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of HAUS4 mRNA	PMID:24136188
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of HAUS4 mRNA	PMID:23411599|PMID:34492290
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of HAUS4 mRNA	PMID:18301758
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HAUS4 mRNA	PMID:19710929
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HAUS4 mRNA	PMID:19710929
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313228	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of HAUS4 mRNA	PMID:30903817
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HAUS4 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HAUS4 gene	PMID:28505145
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313228	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of HAUS4 gene	PMID:31601247
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HAUS4 mRNA	PMID:28628672
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313228	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of HAUS4 mRNA	PMID:19244175
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of HAUS4 mRNA	PMID:23196670
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313229	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of HAUS4 mRNA	PMID:39298647
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HAUS4 mRNA	PMID:21266533
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HAUS4 mRNA	PMID:21266533
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HAUS4 mRNA	PMID:28628672
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313228	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HAUS4 mRNA	PMID:37042841
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of HAUS4 mRNA	PMID:30723492
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HAUS4 mRNA	PMID:38382870
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of HAUS4 mRNA	PMID:25539665
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of HAUS4 mRNA	PMID:30047161
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313228	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HAUS4 mRNA	PMID:19244175
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:37825	p-toluidine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of HAUS4 mRNA	PMID:27638505
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313229	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HAUS4 mRNA	PMID:40194260
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of HAUS4 mRNA	PMID:28302478
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA	PMID:19167446
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of HAUS4 mRNA	PMID:39529242
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313228	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HAUS4 mRNA	PMID:25812627|PMID:40419075
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313228	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HAUS4 mRNA	PMID:25979313
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of HAUS4 mRNA	PMID:17963808
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of HAUS4 mRNA	PMID:23179753|PMID:25192806|PMID:28001369
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HAUS4 mRNA	PMID:30047161
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of HAUS4 mRNA	PMID:20106945|PMID:25562108
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313228	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of HAUS4 mRNA	PMID:27989131
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HAUS4 mRNA	PMID:28628672
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313229	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of HAUS4 mRNA	PMID:28973697
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of HAUS4 mRNA	PMID:24449571
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HAUS4 mRNA	PMID:38832940
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of HAUS4 mRNA	PMID:21420995
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HAUS4 mRNA	PMID:33387578
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HAUS4 mRNA	PMID:28628672
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of HAUS4 mRNA	PMID:25620056
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313229	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of HAUS4 mRNA	PMID:25554681
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of HAUS4 mRNA	PMID:30047161
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313229	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of HAUS4 mRNA	PMID:26377693
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:63598	levofloxacin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of HAUS4 mRNA	PMID:24136188
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of HAUS4 mRNA	PMID:25729387
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HAUS4 mRNA	PMID:25729387
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of HAUS4 mRNA	PMID:24136188
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313229	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HAUS4 mRNA	PMID:22206623
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of HAUS4 mRNA	PMID:22714537
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HAUS4 mRNA	PMID:27188386
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313229	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of HAUS4 mRNA	PMID:31388691
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA	PMID:19167446
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313229	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of HAUS4 mRNA	PMID:39847705
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of HAUS4 mRNA	PMID:21278054
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HAUS4 mRNA	PMID:25825206
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of HAUS4 mRNA	PMID:30047161
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313228	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HAUS4 mRNA	PMID:27188386
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313228	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of HAUS4 mRNA	PMID:38568856
1305288	Haus4	HAUS augmin-like complex, subunit 4	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of HAUS4 mRNA	PMID:35537566
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313230	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TUBAL3 mRNA	PMID:26079696
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1313230	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of TUBAL3 mRNA	PMID:39506029
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TUBAL3 gene	PMID:27618143
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313230	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TUBAL3 mRNA	PMID:26079696
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:17833	gentamycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein	PMID:30545405
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1313230	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TUBAL3 mRNA	PMID:18356318
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:1313230	E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in increased expression of TUBAL3 protein	PMID:31195006
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:28001	vancomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein	PMID:30545405
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:28971	ampicillin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein	PMID:30545405
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1619822	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TUBAL3 mRNA	PMID:37682722
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313230	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of TUBAL3 mRNA	PMID:29301061|PMID:39719251
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313230	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TUBAL3 promoter	PMID:27901495
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1313230	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TUBAL3 mRNA	PMID:18356318
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313230	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TUBAL3 mRNA	PMID:25895662
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TUBAL3 mRNA	PMID:25181051
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313230	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of TUBAL3 mRNA	PMID:31715268
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1619822	E	RGD:6480464	20220607	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TUBAL3 protein	PMID:34864091
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TUBAL3 mRNA	PMID:25539665|PMID:27387713
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1313230	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of TUBAL3 protein	PMID:34122009
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1619822	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TUBAL3 mRNA	PMID:40194260
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1619822	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TUBAL3 mRNA	PMID:17963808
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313230	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TUBAL3 mRNA	PMID:38832940
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1313230	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of TUBAL3 protein	PMID:31195006
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313230	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TUBAL3 protein	PMID:32959892
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:6909	metronidazole	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein	PMID:30545405
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:7507	neomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein	PMID:30545405
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313230	E	RGD:6480464	20190910	CTD	MESH:C025589	ochratoxin A results in decreased expression of TUBAL3 mRNA	PMID:30763683
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313230	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of TUBAL3 mRNA	PMID:26079696
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of TUBAL3 protein	PMID:32519852
1305289	Tubal3	tubulin, alpha-like 3	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of TUBAL3 gene	PMID:31682807
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313231	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RPP25 mRNA	PMID:26272509|PMID:27188386
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313231	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA	PMID:27188386
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313231	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of RPP25 mRNA	PMID:30510588
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313231	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RPP25 mRNA	PMID:31614463
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313232	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of RPP25 mRNA	PMID:19484750
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313231	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RPP25 mRNA	PMID:37042841
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RPP25 mRNA	PMID:37992649
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313232	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of RPP25 mRNA	PMID:22401849
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RPP25 mRNA	PMID:37992649
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313232	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RPP25 mRNA	PMID:33754040
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RPP25 mRNA	PMID:26577399
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313231	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RPP25 mRNA	PMID:22100608
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RPP25 mRNA	PMID:30779732
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313232	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RPP25 mRNA	PMID:17484886
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1313231	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of RPP25 mRNA	PMID:18414638
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313231	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RPP25 mRNA	PMID:26272509
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313231	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPP25 mRNA	PMID:27188386
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313232	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of RPP25 mRNA	PMID:32186404
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPP25 mRNA	PMID:22298810
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313232	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPP25 mRNA	PMID:21570461
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RPP25 mRNA	PMID:32109520|PMID:33387578
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313231	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RPP25 mRNA	PMID:23179753
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313231	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of RPP25 mRNA	PMID:21198554
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313231	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RPP25 mRNA	PMID:29803840
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313232	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RPP25 mRNA	PMID:37992649
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313231	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of RPP25 mRNA	PMID:34032870
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313231	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RPP25 gene	PMID:28589171
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313231	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of RPP25 mRNA	PMID:28595984
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313231	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RPP25 mRNA	PMID:32234424
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313231	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RPP25 3' UTR; Benzo(a)pyrene results in increased methylation of RPP25 exon; Benzo(a)pyrene results in increased methylation of RPP25 promoter	PMID:27901495
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313231	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of RPP25 mRNA	PMID:35984750
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313232	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RPP25 gene	PMID:35295148
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RPP25 mRNA	PMID:23411599|PMID:34492290
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RPP25 mRNA	PMID:25181051
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313232	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of RPP25 mRNA	PMID:30951980
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1313232	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of RPP25 mRNA	PMID:26377693
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313231	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of RPP25 gene	PMID:22964155
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RPP25 mRNA	PMID:21266533
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313232	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RPP25 mRNA	PMID:21266533
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RPP25 mRNA	PMID:35163327
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RPP25 mRNA	PMID:35163327
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of RPP25 gene	PMID:22079235
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313232	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RPP25 mRNA	PMID:39529242
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313231	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RPP25 mRNA	PMID:25979313
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313232	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of RPP25 mRNA	PMID:21427059
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313231	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RPP25 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313231	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA	PMID:27188386
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RPP25 mRNA	PMID:37992649
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1313231	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of RPP25 mRNA]	PMID:21233418
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313231	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RPP25 mRNA	PMID:38832940
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313231	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of RPP25 mRNA	PMID:26690555
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313231	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of RPP25 mRNA	PMID:29067470
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1313231	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of RPP25 mRNA	PMID:18414638
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1313232	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of RPP25 mRNA	PMID:31099283
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RPP25 mRNA	PMID:29391264
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313231	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPP25 mRNA	PMID:22079256
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of RPP25 mRNA	PMID:24793618
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313231	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of RPP25 mRNA	PMID:31629900
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:6076	itraconazole	increases expression	ISO	RGD:1313232	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of RPP25 mRNA	PMID:31099283
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313231	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RPP25 mRNA	PMID:31758290
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313232	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RPP25 mRNA	PMID:22206623
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313231	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RPP25 mRNA	PMID:22079256
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313231	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPP25 mRNA	PMID:22079256
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313231	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPP25 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA	PMID:27188386
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1313231	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of RPP25 mRNA	PMID:30458266
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RPP25 mRNA	PMID:24780913
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313231	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of RPP25 mRNA	PMID:26272509
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313231	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA	PMID:27188386
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313231	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPP25 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA	PMID:27188386
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RPP25 mRNA	PMID:19281266
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1313231	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of RPP25 mRNA	PMID:34581912
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:94366	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one	increases expression	ISO	RGD:1313232	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of RPP25 mRNA	PMID:31099283
1305290	Rpp25	ribonuclease P/MRP subunit p25	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of RPP25 mRNA	PMID:20566332
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASIP1 gene	PMID:20938992
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313233	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RASIP1 mRNA	PMID:26079696
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313233	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RASIP1 mRNA	PMID:22378314
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313233	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RASIP1 mRNA	PMID:29432896
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313233	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RASIP1 mRNA	PMID:20044591
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313233	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of RASIP1 mRNA	PMID:38568856
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RASIP1 mRNA	PMID:33387578
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASIP1 gene	PMID:20938992
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASIP1 mRNA	PMID:37992649
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASIP1 mRNA	PMID:37992649
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313233	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RASIP1 protein	PMID:37730182
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of RASIP1 mRNA	PMID:22061828|PMID:33387578
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RASIP1 mRNA	PMID:37236586
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RASIP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RASIP1 mRNA	PMID:34911549
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313233	E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RASIP1 mRNA	PMID:18356318
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASIP1 gene	PMID:20938992
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313233	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RASIP1 gene	PMID:25304211
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASIP1 mRNA	PMID:40504410
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASIP1 mRNA	PMID:22298810
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASIP1 mRNA	PMID:34747641
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RASIP1 mRNA	PMID:33387578
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASIP1 mRNA	PMID:37992649
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313233	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RASIP1 mRNA	PMID:29432896
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313233	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of RASIP1 mRNA	PMID:34032870
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313233	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RASIP1 mRNA	PMID:38568856
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASIP1 mRNA	PMID:40504410
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313233	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RASIP1 promoter	PMID:27901495
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313234	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RASIP1 mRNA	PMID:21964900|PMID:32417428
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313233	E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RASIP1 mRNA	PMID:18356318
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:31991	phenol red	multiple interactions	ISO	RGD:1313233	E	RGD:6480464	20200519	CTD	MESH:D010637	[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of RASIP1 protein	PMID:31629898
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RASIP1 mRNA	PMID:30047161
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313234	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RASIP1 gene	PMID:35295148
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RASIP1 mRNA	PMID:25181051
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RASIP1 mRNA	PMID:30816183
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313233	E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A analog results in increased expression of RASIP1 mRNA	PMID:32387340
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313234	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RASIP1 mRNA	PMID:30951980|PMID:32156529|PMID:33221593
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313233	E	RGD:6480464	20200519	CTD	MESH:C006780	[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of RASIP1 protein	PMID:31629898
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313234	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of RASIP1 gene	PMID:31683443
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313234	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of RASIP1 exon	PMID:33297965
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313234	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RASIP1 mRNA	PMID:30951980
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313234	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RASIP1 mRNA	PMID:38685157
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313234	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RASIP1 mRNA	PMID:30951980
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313234	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RASIP1 mRNA	PMID:37019170
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RASIP1 mRNA	PMID:21266533
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of RASIP1 mRNA	PMID:35163327
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20130806	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RASIP1 promoter	PMID:22457795
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RASIP1 mRNA	PMID:37236586
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of RASIP1 mRNA	PMID:35163327
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:3764	clotrimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of RASIP1 mRNA	PMID:30047161
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313234	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RASIP1 mRNA	PMID:40194260
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313233	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RASIP1 mRNA	PMID:31533062
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313234	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of RASIP1 mRNA	PMID:39529242
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RASIP1 mRNA	PMID:30047161
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313234	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RASIP1 mRNA	PMID:17555576
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313234	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RASIP1 mRNA	PMID:28973697
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASIP1 mRNA	PMID:37992649
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313233	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of RASIP1 mRNA	PMID:27188386
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313234	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RASIP1 mRNA	PMID:17562736
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1313233	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RASIP1 mRNA	PMID:29432896
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313233	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RASIP1 gene	PMID:25304211
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASIP1 mRNA	PMID:40504410
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RASIP1 mRNA	PMID:29391264
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313234	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RASIP1 mRNA	PMID:17555576
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1313233	E	RGD:6480464	20120412	CTD	MESH:D005047	RASIP1 protein affects the susceptibility to Etoposide	PMID:16217747
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RASIP1 mRNA	PMID:30047161
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313234	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of RASIP1 mRNA	PMID:19042947
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1313233	E	RGD:6480464	20130806	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RASIP1 mRNA	PMID:22079614
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313234	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RASIP1 mRNA	PMID:22206623
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313233	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RASIP1 gene]	PMID:28238834
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RASIP1 mRNA	PMID:30047161
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313234	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of RASIP1 mRNA	PMID:17569031
1305291	Rasip1	Ras interacting protein 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RASIP1 mRNA	PMID:19015723
1305292	Incenp	inner centromere protein	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of INCENP mRNA	PMID:39752319
1305292	Incenp	inner centromere protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552170	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of INCENP mRNA	PMID:26251327
1305292	Incenp	inner centromere protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of INCENP mRNA	PMID:20938992
1305292	Incenp	inner centromere protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of INCENP mRNA	PMID:33167477
1305292	Incenp	inner centromere protein	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313235	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of INCENP mRNA	PMID:22378314
1305292	Incenp	inner centromere protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313235	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of INCENP mRNA	PMID:20044591
1305292	Incenp	inner centromere protein	gene	CHEBI:16240	hydrogen peroxide	affects localization	ISO	RGD:1313235	E	RGD:6480464	20200211	CTD	MESH:D006861	Hydrogen Peroxide affects the localization of INCENP protein	PMID:28343997
1305292	Incenp	inner centromere protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of INCENP mRNA	PMID:39241906
1305292	Incenp	inner centromere protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA	PMID:25510870
1305292	Incenp	inner centromere protein	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of INCENP mRNA	PMID:33387578
1305292	Incenp	inner centromere protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of INCENP mRNA	PMID:20938992
1305292	Incenp	inner centromere protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313235	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of INCENP mRNA	PMID:37042841
1305292	Incenp	inner centromere protein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of INCENP mRNA	PMID:37992649
1305292	Incenp	inner centromere protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of INCENP mRNA	PMID:39752319
1305292	Incenp	inner centromere protein	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of INCENP mRNA	PMID:21592394
1305292	Incenp	inner centromere protein	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313235	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of INCENP mRNA	PMID:21592394
1305292	Incenp	inner centromere protein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of INCENP mRNA	PMID:37992649
1305292	Incenp	inner centromere protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552170	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of INCENP mRNA	PMID:34319233
1305292	Incenp	inner centromere protein	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313235	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of INCENP protein	PMID:37730182
1305292	Incenp	inner centromere protein	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of INCENP mRNA	PMID:21592394
1305292	Incenp	inner centromere protein	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313235	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of INCENP mRNA	PMID:21592394
1305292	Incenp	inner centromere protein	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of INCENP mRNA	PMID:22061828|PMID:33387578
1305292	Incenp	inner centromere protein	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313235	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of INCENP mRNA	PMID:28818685
1305292	Incenp	inner centromere protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA	PMID:25510870
1305292	Incenp	inner centromere protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA	PMID:25510870
1305292	Incenp	inner centromere protein	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of INCENP mRNA	PMID:19549813
1305292	Incenp	inner centromere protein	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of INCENP mRNA	PMID:25378103
1305292	Incenp	inner centromere protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313235	E	RGD:6480464	20250603	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of INCENP protein	PMID:39638853
1305292	Incenp	inner centromere protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313235	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of INCENP exon	PMID:30157460
1305292	Incenp	inner centromere protein	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1552170	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of INCENP mRNA	PMID:33026818
1305292	Incenp	inner centromere protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of INCENP mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of INCENP mRNA	PMID:34911549
1305292	Incenp	inner centromere protein	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of INCENP mRNA	PMID:17484886
1305292	Incenp	inner centromere protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of INCENP mRNA	PMID:31150632
1305292	Incenp	inner centromere protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552170	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of INCENP mRNA	PMID:31919559
1305292	Incenp	inner centromere protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of INCENP mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of INCENP mRNA]	PMID:20938992|PMID:22206623
1305292	Incenp	inner centromere protein	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in decreased expression of INCENP mRNA	PMID:25270620
1305292	Incenp	inner centromere protein	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313235	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of INCENP gene	PMID:25304211
1305292	Incenp	inner centromere protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INCENP mRNA	PMID:40504410
1305292	Incenp	inner centromere protein	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313235	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of INCENP protein	PMID:35688186
1305292	Incenp	inner centromere protein	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of INCENP mRNA	PMID:28960355
1305292	Incenp	inner centromere protein	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of INCENP mRNA	PMID:31881176
1305292	Incenp	inner centromere protein	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of INCENP protein	PMID:25505154
1305292	Incenp	inner centromere protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313235	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of INCENP mRNA	PMID:19167446
1305292	Incenp	inner centromere protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of INCENP mRNA	PMID:30912803
1305292	Incenp	inner centromere protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552170	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of INCENP mRNA	PMID:21570461
1305292	Incenp	inner centromere protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of INCENP mRNA	PMID:33387578|PMID:34747641
1305292	Incenp	inner centromere protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of INCENP mRNA	PMID:15667827
1305292	Incenp	inner centromere protein	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of INCENP mRNA	PMID:32763439
1305292	Incenp	inner centromere protein	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of INCENP mRNA	PMID:28959563
1305292	Incenp	inner centromere protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of INCENP mRNA	PMID:29803840
1305292	Incenp	inner centromere protein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of INCENP mRNA	PMID:37992649
1305292	Incenp	inner centromere protein	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1313235	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of INCENP protein	PMID:35688186
1305292	Incenp	inner centromere protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313235	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of INCENP mRNA	PMID:29301061|PMID:34032870
1305292	Incenp	inner centromere protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INCENP mRNA	PMID:40504410
1305292	Incenp	inner centromere protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of INCENP mRNA	PMID:17942131
1305292	Incenp	inner centromere protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552170	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of INCENP mRNA	PMID:19770486|PMID:20504355
1305292	Incenp	inner centromere protein	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of INCENP mRNA	PMID:18929588
1305292	Incenp	inner centromere protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313235	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to INCENP mRNA]	PMID:32406909
1305292	Incenp	inner centromere protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of INCENP mRNA	PMID:25895662
1305292	Incenp	inner centromere protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552170	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of INCENP mRNA	PMID:29341224
1305292	Incenp	inner centromere protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of INCENP mRNA	PMID:20382639
1305292	Incenp	inner centromere protein	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313235	E	RGD:6480464	20180828	CTD	MESH:C015358	methylparaben results in increased expression of INCENP mRNA	PMID:17121429
1305292	Incenp	inner centromere protein	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of INCENP mRNA	PMID:25729387
1305292	Incenp	inner centromere protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of INCENP mRNA	PMID:25729387
1305292	Incenp	inner centromere protein	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of INCENP mRNA	PMID:30047161
1305292	Incenp	inner centromere protein	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1552170	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of INCENP mRNA	PMID:17656681
1305292	Incenp	inner centromere protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552170	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of INCENP gene	PMID:35295148
1305292	Incenp	inner centromere protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552170	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of INCENP mRNA	PMID:23557971
1305292	Incenp	inner centromere protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of INCENP mRNA; Thioacetamide results in increased expression of INCENP protein	PMID:23411599
1305292	Incenp	inner centromere protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of INCENP mRNA	PMID:18648102
1305292	Incenp	inner centromere protein	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of INCENP mRNA	PMID:17426115
1305292	Incenp	inner centromere protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552170	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of INCENP mRNA	PMID:17950772|PMID:18301758|PMID:23811191
1305292	Incenp	inner centromere protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of INCENP mRNA]	PMID:17950772
1305292	Incenp	inner centromere protein	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of INCENP protein	PMID:23411599
1305292	Incenp	inner centromere protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313235	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of INCENP mRNA	PMID:38479592
1305292	Incenp	inner centromere protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of INCENP mRNA	PMID:25181051
1305292	Incenp	inner centromere protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of INCENP mRNA; bisphenol A results in decreased expression of INCENP protein	PMID:29275510|PMID:33376534
1305292	Incenp	inner centromere protein	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313235	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of INCENP gene	PMID:31601247
1305292	Incenp	inner centromere protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of INCENP mRNA	PMID:30816183
1305292	Incenp	inner centromere protein	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1552170	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of INCENP mRNA	PMID:26682919
1305292	Incenp	inner centromere protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA	PMID:25510870
1305292	Incenp	inner centromere protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA	PMID:25510870
1305292	Incenp	inner centromere protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of INCENP mRNA	PMID:39298647|PMID:40203079
1305292	Incenp	inner centromere protein	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552170	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of INCENP mRNA	PMID:26377693
1305292	Incenp	inner centromere protein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of INCENP mRNA	PMID:37019170
1305292	Incenp	inner centromere protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of INCENP mRNA	PMID:17361019|PMID:21266533
1305292	Incenp	inner centromere protein	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of INCENP mRNA	PMID:17854601
1305292	Incenp	inner centromere protein	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of INCENP mRNA]	PMID:17854601
1305292	Incenp	inner centromere protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313235	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of INCENP mRNA	PMID:37042841
1305292	Incenp	inner centromere protein	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of INCENP mRNA; 1-Naphthylisothiocyanate results in increased expression of INCENP protein	PMID:23411599|PMID:30723492
1305292	Incenp	inner centromere protein	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of INCENP mRNA	PMID:36326898
1305292	Incenp	inner centromere protein	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of INCENP mRNA	PMID:25539665
1305292	Incenp	inner centromere protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of INCENP mRNA	PMID:30047161
1305292	Incenp	inner centromere protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552170	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of INCENP mRNA	PMID:22698814
1305292	Incenp	inner centromere protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of INCENP mRNA	PMID:32588087
1305292	Incenp	inner centromere protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of INCENP mRNA	PMID:40194260
1305292	Incenp	inner centromere protein	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313235	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of INCENP mRNA	PMID:28302478
1305292	Incenp	inner centromere protein	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of INCENP mRNA	PMID:31533062
1305292	Incenp	inner centromere protein	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313235	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of INCENP mRNA	PMID:19167446
1305292	Incenp	inner centromere protein	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313235	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INCENP mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of INCENP mRNA	PMID:19167446
1305292	Incenp	inner centromere protein	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of INCENP mRNA	PMID:39529242
1305292	Incenp	inner centromere protein	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of INCENP mRNA	PMID:30047161
1305292	Incenp	inner centromere protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of INCENP mRNA	PMID:17942131
1305292	Incenp	inner centromere protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552170	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of INCENP mRNA	PMID:28973697
1305292	Incenp	inner centromere protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of INCENP mRNA	PMID:37992649
1305292	Incenp	inner centromere protein	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1313235	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of INCENP mRNA	PMID:16595896
1305292	Incenp	inner centromere protein	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313235	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of INCENP mRNA	PMID:38832940
1305292	Incenp	inner centromere protein	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in decreased expression of INCENP mRNA	PMID:19606018
1305292	Incenp	inner centromere protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of INCENP mRNA	PMID:17562736
1305292	Incenp	inner centromere protein	gene	CHEBI:46195	paracetamol	affects response to substance	EXP		E	RGD:6480464	20160119	CTD	MESH:D000082	INCENP mRNA affects the susceptibility to Acetaminophen	PMID:26512990
1305292	Incenp	inner centromere protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of INCENP mRNA	PMID:33387578
1305292	Incenp	inner centromere protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of INCENP mRNA	PMID:17942131
1305292	Incenp	inner centromere protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D000082	Acetaminophen results in increased expression of INCENP protein	PMID:23411599
1305292	Incenp	inner centromere protein	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313235	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of INCENP gene	PMID:25304211
1305292	Incenp	inner centromere protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INCENP mRNA	PMID:40504410
1305292	Incenp	inner centromere protein	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C005223	methyleugenol results in increased expression of INCENP protein	PMID:23411599
1305292	Incenp	inner centromere protein	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of INCENP mRNA	PMID:30307764
1305292	Incenp	inner centromere protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552170	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of INCENP mRNA; Nanotubes, Carbon results in increased expression of INCENP mRNA	PMID:25554681
1305292	Incenp	inner centromere protein	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of INCENP mRNA	PMID:22504374|PMID:30047161
1305292	Incenp	inner centromere protein	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1552170	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of INCENP mRNA	PMID:40234311
1305292	Incenp	inner centromere protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552170	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of INCENP mRNA	PMID:19042947
1305292	Incenp	inner centromere protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of INCENP mRNA	PMID:38701926
1305292	Incenp	inner centromere protein	gene	CHEBI:6015	isoflurane	decreases methylation	ISO	RGD:1552170	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in decreased methylation of INCENP mRNA	PMID:35249202
1305292	Incenp	inner centromere protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of INCENP protein	PMID:32959892
1305292	Incenp	inner centromere protein	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of INCENP mRNA	PMID:19606018
1305292	Incenp	inner centromere protein	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of INCENP mRNA	PMID:25729387
1305292	Incenp	inner centromere protein	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of INCENP mRNA	PMID:25729387
1305292	Incenp	inner centromere protein	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of INCENP mRNA	PMID:28988120
1305292	Incenp	inner centromere protein	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of INCENP mRNA	PMID:39752319
1305292	Incenp	inner centromere protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552170	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of INCENP mRNA	PMID:22206623
1305292	Incenp	inner centromere protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of INCENP mRNA]	PMID:22206623
1305292	Incenp	inner centromere protein	gene	CHEBI:749301	potassium perchlorate	increases expression	ISO	RGD:1313235	E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in increased expression of INCENP mRNA	PMID:29673971
1305292	Incenp	inner centromere protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313235	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of INCENP mRNA	PMID:37199045
1305292	Incenp	inner centromere protein	gene	CHEBI:754951	siponimod	increases expression	ISO	RGD:1552170	E	RGD:6480464	20260714	CTD	MESH:C578989	siponimod results in increased expression of INCENP mRNA	PMID:29556671
1305292	Incenp	inner centromere protein	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313235	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of INCENP protein	PMID:31285264
1305292	Incenp	inner centromere protein	gene	CHEBI:76604	MeIQx	increases expression	ISO	RGD:1313235	E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of INCENP mRNA	PMID:20816883
1305292	Incenp	inner centromere protein	gene	CHEBI:77092	fenbendazole	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005273	Fenbendazole results in increased expression of INCENP protein	PMID:23411599
1305292	Incenp	inner centromere protein	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of INCENP mRNA	PMID:34995734
1305292	Incenp	inner centromere protein	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1552170	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of INCENP mRNA	PMID:23091169
1305292	Incenp	inner centromere protein	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of INCENP mRNA	PMID:17942131|PMID:18958704
1305292	Incenp	inner centromere protein	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313235	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INCENP mRNA	PMID:19167446
1305292	Incenp	inner centromere protein	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1552170	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of INCENP mRNA	PMID:38648751
1305292	Incenp	inner centromere protein	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of INCENP mRNA	PMID:32234424
1305292	Incenp	inner centromere protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of INCENP mRNA	PMID:22504374|PMID:30047161
1305292	Incenp	inner centromere protein	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1313235	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of INCENP mRNA	PMID:22869556
1305292	Incenp	inner centromere protein	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of INCENP mRNA	PMID:40826991
1305292	Incenp	inner centromere protein	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of INCENP mRNA	PMID:39752319
1305292	Incenp	inner centromere protein	gene	CHEBI:88542	Butylparaben	increases expression	ISO	RGD:1313235	E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of INCENP mRNA	PMID:17121429
1305292	Incenp	inner centromere protein	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1552170	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of INCENP protein	PMID:24648495
1305292	Incenp	inner centromere protein	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of INCENP mRNA	PMID:35537566
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FKBP7 mRNA	PMID:38218311
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313236	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FKBP7 mRNA	PMID:27188386
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of FKBP7 protein	PMID:39571964
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FKBP7 mRNA	PMID:39241906
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FKBP7 mRNA	PMID:37992649
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FKBP7 mRNA	PMID:37992649
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FKBP7 mRNA	PMID:33387578
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of FKBP7 mRNA	PMID:28818685
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FKBP7 mRNA	PMID:39012411
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FKBP7 mRNA	PMID:19549813
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FKBP7 mRNA	PMID:19770486
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FKBP7 mRNA	PMID:17484886|PMID:31919559
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FKBP7 mRNA	PMID:25629700
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FKBP7 mRNA	PMID:28960355
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:27856	acetamide	affects expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide affects the expression of FKBP7 mRNA	PMID:31881176
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in decreased expression of FKBP7 protein	PMID:37834424
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of FKBP7 mRNA	PMID:27392435
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FKBP7 mRNA	PMID:34747641
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313237	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FKBP7 mRNA	PMID:21570461
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKBP7 mRNA	PMID:32109520
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKBP7 mRNA	PMID:17942748
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKBP7 mRNA	PMID:17942748
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of FKBP7 mRNA	PMID:30556269
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of FKBP7 mRNA	PMID:20971185
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FKBP7 mRNA	PMID:29803840
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FKBP7 mRNA	PMID:37992649
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FKBP7 mRNA	PMID:38568856|PMID:39719251
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313236	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of FKBP7 mRNA	PMID:22714537
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of FKBP7 protein	PMID:39571964
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313237	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FKBP7 mRNA	PMID:22228805
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of FKBP7 mRNA	PMID:30556269
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of FKBP7 mRNA	PMID:20971185
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313237	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FKBP7 mRNA	PMID:39716349
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of FKBP7 mRNA	PMID:25729387
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FKBP7 mRNA	PMID:19710929
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FKBP7 mRNA	PMID:30816183|PMID:34947998
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313237	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of FKBP7 mRNA	PMID:26063408|PMID:30951980
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FKBP7 gene	PMID:28505145
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FKBP7 mRNA	PMID:28628672
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313236	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of FKBP7 protein	PMID:34186270
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313237	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FKBP7 mRNA	PMID:30951980
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313236	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of FKBP7 protein	PMID:34186270
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313237	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FKBP7 mRNA	PMID:30951980
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP7 mRNA	PMID:28628672
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313236	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of FKBP7 protein	PMID:34186270
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FKBP7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP7 mRNA	PMID:28628672
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FKBP7 mRNA	PMID:39012411
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of FKBP7 protein	PMID:26879310
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of FKBP7 mRNA	PMID:27387713
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313237	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FKBP7 mRNA	PMID:40194260
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FKBP7 mRNA	PMID:31533062
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313236	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FKBP7 mRNA	PMID:25979313
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FKBP7 mRNA	PMID:17292431
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313236	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of FKBP7 mRNA	PMID:23179753|PMID:24935251|PMID:28001369|PMID:29154799
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FKBP7 mRNA	PMID:20106945|PMID:25562108
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FKBP7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP7 mRNA	PMID:28628672
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FKBP7 mRNA	PMID:37992649
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FKBP7 mRNA	PMID:38832940
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313236	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of FKBP7 mRNA	PMID:27188386
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313236	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FKBP7 mRNA	PMID:24935251
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FKBP7 mRNA	PMID:29279043
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:472805	ouabain	increases expression	ISO	RGD:1313236	E	RGD:6480464	20120412	CTD	MESH:D010042	Ouabain results in increased expression of FKBP7 mRNA	PMID:16412265
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of FKBP7 mRNA	PMID:22077320
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FKBP7 mRNA	PMID:29391264
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FKBP7 mRNA	PMID:35436446
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FKBP7 mRNA	PMID:17555576
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of FKBP7 mRNA	PMID:17557909
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FKBP7 mRNA	PMID:17942748
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKBP7 mRNA	PMID:17942748
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FKBP7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP7 mRNA	PMID:28628672
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313237	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FKBP7 mRNA	PMID:39716349
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of FKBP7 mRNA	PMID:24793618
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of FKBP7 mRNA	PMID:25729387
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313236	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of FKBP7 mRNA	PMID:28988120
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313236	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of FKBP7 protein	PMID:34186270
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313236	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FKBP7 gene]	PMID:28238834
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1313237	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of FKBP7 mRNA	PMID:18958704
1305293	Fkbp7	FKBP prolyl isomerase 7	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of FKBP7 mRNA	PMID:19281266
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313238	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of EIF4G2 protein	PMID:39638853
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313239	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EIF4G2 mRNA	PMID:33045310
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EIF4G2 mRNA	PMID:10336889
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EIF4G2 mRNA	PMID:20188158
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313238	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of EIF4G2 mRNA	PMID:18491231
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20120412	CTD	MESH:D014212	PDCD4 protein promotes the reaction [Tretinoin results in increased expression of EIF4G2 protein]; Tretinoin results in increased expression of and results in increased localization of EIF4G2 protein	PMID:17259349|PMID:18491231
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of EIF4G2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of EIF4G2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of EIF4G2 mRNA	PMID:32699268|PMID:32845096
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of EIF4G2 gene	PMID:28931070
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313238	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of EIF4G2 mRNA	PMID:22378314
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of EIF4G2 mRNA	PMID:30319688
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313238	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EIF4G2 mRNA	PMID:21179406
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313239	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of EIF4G2 mRNA	PMID:15598610
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313239	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EIF4G2 mRNA	PMID:39298647
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:166520	3,4-Methylenedioxyamphetamine	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:D015104	3,4-Methylenedioxyamphetamine results in increased expression of EIF4G2 mRNA	PMID:10336889
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of EIF4G2 mRNA	PMID:15878777
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20140408	CTD	MESH:D008550	Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EIF4G2 mRNA]	PMID:23963992
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313238	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of EIF4G2 mRNA	PMID:21179406
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of EIF4G2 protein	PMID:20463053
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313239	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of EIF4G2 mRNA	PMID:23892564
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of EIF4G2 mRNA	PMID:33754040
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313238	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EIF4G2 protein	PMID:37730182
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313238	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of EIF4G2 protein	PMID:18491231
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of EIF4G2 mRNA	PMID:22061828
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EIF4G2 mRNA	PMID:36331819
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EIF4G2 mRNA	PMID:28111341|PMID:37236586
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of EIF4G2 mRNA	PMID:26760959
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:254496	7,12-dimethyltetraphene	affects expression	ISO	RGD:1313239	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene affects the expression of EIF4G2 mRNA	PMID:21785161
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of EIF4G2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of EIF4G2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of EIF4G2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of EIF4G2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of EIF4G2 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of EIF4G2 protein	PMID:38598786
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EIF4G2 mRNA	PMID:22206623
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in decreased expression of EIF4G2 protein	PMID:18089832
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313238	E	RGD:6480464	20150414	CTD	MESH:D002945	Cisplatin results in increased expression of EIF4G2 mRNA	PMID:25450742
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIF4G2 mRNA	PMID:34747641
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313239	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIF4G2 mRNA	PMID:21570461|PMID:24680724
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EIF4G2 mRNA	PMID:19465110
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313238	E	RGD:6480464	20120412	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of EIF4G2 protein	PMID:18491231
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of EIF4G2 mRNA]; MT2 affects the reaction [Copper results in increased expression of EIF4G2 mRNA]	PMID:16629173
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EIF4G2 mRNA	PMID:29803840
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313238	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of EIF4G2 mRNA	PMID:20044591
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of and results in increased activity of EIF4G2 protein	PMID:30528433
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313239	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of EIF4G2 mRNA	PMID:22342234
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of EIF4G2 mRNA]; MT2 affects the reaction [Copper results in increased expression of EIF4G2 mRNA]	PMID:16629173
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:30621	diarsenic trioxide	increases cleavage	ISO	RGD:1313238	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased cleavage of EIF4G2 protein	PMID:18491231
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of EIF4G2 mRNA	PMID:20542052
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of EIF4G2 mRNA	PMID:30047161
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20190910	CTD	MESH:C009495	titanium dioxide results in decreased expression of EIF4G2 protein	PMID:30910687
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313239	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EIF4G2 gene	PMID:35295148
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EIF4G2 mRNA	PMID:34492290
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of EIF4G2 mRNA	PMID:18648102
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EIF4G2 mRNA	PMID:25181051
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313238	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of EIF4G2 mRNA	PMID:30903817
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF4G2 protein	PMID:31675489|PMID:37567409
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF4G2 mRNA	PMID:33221593
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of EIF4G2 mRNA	PMID:41034487
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of EIF4G2 mRNA	PMID:21932408
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EIF4G2 protein	PMID:31675489
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313239	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EIF4G2 mRNA	PMID:39298647
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313238	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of EIF4G2 protein	PMID:34186270
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313239	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of EIF4G2 mRNA	PMID:38685157
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G2 mRNA	PMID:28628672
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of EIF4G2 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of EIF4G2 protein	PMID:38598786
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G2 mRNA	PMID:28628672
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20140408	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of EIF4G2 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EIF4G2 mRNA]	PMID:23963992
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of EIF4G2 mRNA]	PMID:19030233
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313238	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EIF4G2 mRNA	PMID:37042841
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EIF4G2 mRNA	PMID:18974090
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EIF4G2 mRNA	PMID:28111341|PMID:37236586
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EIF4G2 mRNA	PMID:19320972
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of EIF4G2 mRNA	PMID:25908611
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of EIF4G2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of EIF4G2 mRNA	PMID:32699268
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1313238	E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of EIF4G2 protein	PMID:18491231
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20180703	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of EIF4G2 protein	PMID:24301089
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EIF4G2 mRNA	PMID:36331819
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313238	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EIF4G2 mRNA	PMID:25979313
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of EIF4G2 mRNA	PMID:19136453
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of EIF4G2 mRNA	PMID:30047161
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G2 mRNA	PMID:28628672
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of EIF4G2 mRNA	PMID:36621641
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:4469	(S)-amphetamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003913	Dextroamphetamine results in increased expression of EIF4G2 mRNA	PMID:10336889
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in decreased expression of EIF4G2 mRNA	PMID:19606018
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of EIF4G2 mRNA	PMID:31675489
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of EIF4G2 mRNA	PMID:22334560
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313238	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of EIF4G2 mRNA	PMID:18175754
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G2 mRNA	PMID:28628672
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:49900	arsenous acid	increases cleavage	ISO	RGD:1313238	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased cleavage of EIF4G2 protein	PMID:18491231
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of EIF4G2 mRNA	PMID:30047161
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of EIF4G2 mRNA	PMID:19162173
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EIF4G2 mRNA	PMID:35964746
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20140408	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of EIF4G2 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EIF4G2 mRNA]	PMID:23963992
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EIF4G2 protein	PMID:32959892
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of EIF4G2 mRNA	PMID:19606018
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:65329	LY294002	increases expression	ISO	RGD:1313238	E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of EIF4G2 protein	PMID:18491231
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in increased expression of EIF4G2 mRNA	PMID:10336889
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313238	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EIF4G2 protein	PMID:34186270
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EIF4G2 mRNA	PMID:22206623
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EIF4G2 mRNA	PMID:22206623
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1313238	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of EIF4G2 protein	PMID:39638853
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of EIF4G2 mRNA	PMID:12517777
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313238	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of EIF4G2 protein	PMID:39638853
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EIF4G2 gene]	PMID:28238834
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1313238	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of EIF4G2 mRNA	PMID:39904859
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of EIF4G2 mRNA	PMID:20056577
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of EIF4G2 mRNA	PMID:22334560
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in decreased expression of EIF4G2 mRNA	PMID:22334560
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of EIF4G2 mRNA	PMID:30047161
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:9168	sirolimus	increases expression	ISO	RGD:1313238	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in increased expression of EIF4G2 protein	PMID:18491231
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313238	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of EIF4G2 protein	PMID:38598786
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EIF4G2 mRNA	PMID:21346803
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of EIF4G2 mRNA	PMID:19015723
1305294	Eif4g2	eukaryotic translation initiation factor 4, gamma 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EIF4G2 mRNA	PMID:23034163
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of WFDC3 mRNA	PMID:25152437
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313240	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of WFDC3 mRNA	PMID:27188386
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1621504	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of WFDC3 mRNA	PMID:33045310
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621504	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of WFDC3 mRNA	PMID:33045310
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1621504	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of WFDC3 mRNA	PMID:37995155
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313240	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of WFDC3 mRNA	PMID:26516004
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of WFDC3 mRNA	PMID:36331819
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of WFDC3 gene	PMID:27618143
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of WFDC3 mRNA	PMID:37992649
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of WFDC3 mRNA	PMID:33848595
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of WFDC3 mRNA]	PMID:33848595
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of WFDC3 mRNA	PMID:37992649
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of WFDC3 mRNA	PMID:36331819
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of WFDC3 mRNA	PMID:21346803
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of WFDC3 mRNA	PMID:41580963
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313240	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of WFDC3 mRNA	PMID:35430440
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of WFDC3 mRNA	PMID:34911549
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1621504	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of WFDC3 mRNA	PMID:27339419|PMID:31919559
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313240	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of WFDC3 mRNA	PMID:32525701
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of WFDC3 mRNA	PMID:31881176
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of WFDC3 mRNA	PMID:32186404
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WFDC3 mRNA	PMID:21215274
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313240	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of WFDC3 mRNA	PMID:33212167
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of WFDC3 mRNA	PMID:28959563
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313240	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of WFDC3 mRNA	PMID:21198554
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of WFDC3 mRNA	PMID:37992649
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	ISO	RGD:1313240	E	RGD:6480464	20120412	CTD	MESH:C028473	WFDC3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of WFDC3 mRNA	PMID:37682722
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313240	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of WFDC3 mRNA	PMID:38568856
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313240	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WFDC3 5' UTR; Benzo(a)pyrene results in increased methylation of WFDC3 promoter	PMID:27901495
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of WFDC3 mRNA	PMID:30047161
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of WFDC3 mRNA	PMID:23557971
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of WFDC3 mRNA	PMID:34492290
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of WFDC3 mRNA	PMID:19710929
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of WFDC3 mRNA	PMID:25181051
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621504	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of WFDC3 mRNA	PMID:40203079
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of WFDC3 mRNA]	PMID:40203079
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1621504	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of WFDC3 mRNA	PMID:32715474
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of WFDC3 mRNA	PMID:35163327
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of WFDC3 mRNA	PMID:30723492
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of WFDC3 promoter	PMID:22457795
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of WFDC3 mRNA	PMID:35163327
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of WFDC3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of WFDC3 mRNA	PMID:36331819
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1621504	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of WFDC3 mRNA	PMID:23125180
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of WFDC3 mRNA	PMID:30047161
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of WFDC3 mRNA	PMID:37992649
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of WFDC3 mRNA	PMID:21346803
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313240	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of WFDC3 mRNA	PMID:32525701
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1621504	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of WFDC3 mRNA	PMID:27106021
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of WFDC3 mRNA	PMID:24136188
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of WFDC3 mRNA	PMID:30047161
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of WFDC3 mRNA	PMID:38701926
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of WFDC3 mRNA	PMID:22206623
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313240	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WFDC3 gene]	PMID:28238834
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313240	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of WFDC3 mRNA	PMID:32525701
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of WFDC3 mRNA	PMID:30047161
1305295	Wfdc3	WAP four-disulfide core domain 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of WFDC3 mRNA	PMID:21346803
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of R3HDML mRNA	PMID:33387578
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of R3HDML gene	PMID:27618143
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:2293981	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of R3HDML mRNA	PMID:33754040
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313241	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of R3HDML exon	PMID:30157460
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of R3HDML mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of R3HDML mRNA	PMID:34911549
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313241	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of R3HDML promoter	PMID:22847954
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20231031	CTD	MESH:D015084	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:2293981	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of R3HDML mRNA	PMID:37682722|PMID:39232337
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313241	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of R3HDML 5' UTR	PMID:27901495
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313241	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of R3HDML 3' UTR; Benzo(a)pyrene results in increased methylation of R3HDML promoter	PMID:27901495
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313241	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of R3HDML gene	PMID:25435355
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313241	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of R3HDML mRNA	PMID:25895662
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of R3HDML mRNA	PMID:34492290
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of R3HDML mRNA	PMID:25181051
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:2293981	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of R3HDML mRNA	PMID:40203079
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:34575	bisphenol F	affects expression	ISO	RGD:2293981	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F affects the expression of R3HDML mRNA	PMID:38685157
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of R3HDML mRNA	PMID:33453195
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313241	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of R3HDML promoter	PMID:22847954
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313241	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of R3HDML promoter	PMID:22847954
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313241	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of R3HDML gene	PMID:29154799
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313241	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of R3HDML mRNA	PMID:26690555
1305296	R3hdml	R3H domain containing-like	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1305297	Rlf	RLF zinc finger	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313242	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RLF mRNA	PMID:33167477
1305297	Rlf	RLF zinc finger	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313242	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RLF mRNA	PMID:24236059|PMID:25596134
1305297	Rlf	RLF zinc finger	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of RLF mRNA	PMID:30207508
1305297	Rlf	RLF zinc finger	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313242	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RLF mRNA	PMID:21632981
1305297	Rlf	RLF zinc finger	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1313242	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of RLF protein	PMID:35688186
1305297	Rlf	RLF zinc finger	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552172	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RLF mRNA	PMID:39241906
1305297	Rlf	RLF zinc finger	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313242	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RLF mRNA	PMID:37042841
1305297	Rlf	RLF zinc finger	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of RLF mRNA	PMID:20655997
1305297	Rlf	RLF zinc finger	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313242	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of RLF mRNA	PMID:16949557
1305297	Rlf	RLF zinc finger	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RLF mRNA	PMID:33387578
1305297	Rlf	RLF zinc finger	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RLF mRNA	PMID:39836092
1305297	Rlf	RLF zinc finger	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313242	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of RLF mRNA	PMID:16949557
1305297	Rlf	RLF zinc finger	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313242	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RLF mRNA	PMID:19549813
1305297	Rlf	RLF zinc finger	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313242	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RLF gene	PMID:27153756
1305297	Rlf	RLF zinc finger	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552172	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RLF mRNA	PMID:19770486
1305297	Rlf	RLF zinc finger	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RLF mRNA	PMID:41430723
1305297	Rlf	RLF zinc finger	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RLF mRNA	PMID:30779732
1305297	Rlf	RLF zinc finger	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552172	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RLF mRNA	PMID:31919559
1305297	Rlf	RLF zinc finger	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RLF mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RLF mRNA	PMID:32525701|PMID:39836092|PMID:40512198
1305297	Rlf	RLF zinc finger	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552172	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA	PMID:40504410
1305297	Rlf	RLF zinc finger	gene	CHEBI:27871	chloroacetaldehyde	affects expression	ISO	RGD:1313242	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde affects the expression of RLF mRNA	PMID:25596134
1305297	Rlf	RLF zinc finger	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of RLF mRNA	PMID:27392435
1305297	Rlf	RLF zinc finger	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313242	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of RLF mRNA	PMID:25596134
1305297	Rlf	RLF zinc finger	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RLF mRNA	PMID:27392435
1305297	Rlf	RLF zinc finger	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552172	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RLF mRNA	PMID:30912803
1305297	Rlf	RLF zinc finger	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313242	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of RLF mRNA	PMID:23195993
1305297	Rlf	RLF zinc finger	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RLF mRNA	PMID:21215274|PMID:34747641
1305297	Rlf	RLF zinc finger	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552172	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RLF mRNA	PMID:19770486
1305297	Rlf	RLF zinc finger	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RLF mRNA	PMID:33212167
1305297	Rlf	RLF zinc finger	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313242	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of RLF mRNA	PMID:39709020
1305297	Rlf	RLF zinc finger	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RLF mRNA	PMID:30851411
1305297	Rlf	RLF zinc finger	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RLF mRNA	PMID:29803840
1305297	Rlf	RLF zinc finger	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of RLF mRNA	PMID:39719251
1305297	Rlf	RLF zinc finger	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313242	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RLF mRNA	PMID:38568856
1305297	Rlf	RLF zinc finger	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RLF mRNA	PMID:39836092|PMID:40512198
1305297	Rlf	RLF zinc finger	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552172	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA	PMID:40504410
1305297	Rlf	RLF zinc finger	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313242	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RLF promoter	PMID:27901495
1305297	Rlf	RLF zinc finger	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RLF mRNA]	PMID:32406909
1305297	Rlf	RLF zinc finger	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313242	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RLF mRNA	PMID:25351596
1305297	Rlf	RLF zinc finger	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313242	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased methylation of RLF gene	PMID:34973136
1305297	Rlf	RLF zinc finger	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RLF mRNA	PMID:34492290
1305297	Rlf	RLF zinc finger	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of RLF mRNA	PMID:38479592
1305297	Rlf	RLF zinc finger	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313242	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of RLF gene	PMID:31601247
1305297	Rlf	RLF zinc finger	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1552172	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of RLF promoter	PMID:27334623
1305297	Rlf	RLF zinc finger	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RLF mRNA	PMID:25181051
1305297	Rlf	RLF zinc finger	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of RLF mRNA	PMID:30816183
1305297	Rlf	RLF zinc finger	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552172	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of RLF mRNA	PMID:35598803
1305297	Rlf	RLF zinc finger	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RLF mRNA	PMID:21241498
1305297	Rlf	RLF zinc finger	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552172	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RLF mRNA	PMID:37019170
1305297	Rlf	RLF zinc finger	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of RLF mRNA	PMID:22110744
1305297	Rlf	RLF zinc finger	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RLF mRNA	PMID:39836092
1305297	Rlf	RLF zinc finger	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RLF mRNA	PMID:33453195
1305297	Rlf	RLF zinc finger	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RLF mRNA	PMID:38568856
1305297	Rlf	RLF zinc finger	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552172	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of RLF mRNA	PMID:28903501
1305297	Rlf	RLF zinc finger	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RLF mRNA	PMID:24386269
1305297	Rlf	RLF zinc finger	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313242	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RLF mRNA	PMID:19320972|PMID:19376846
1305297	Rlf	RLF zinc finger	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of RLF mRNA	PMID:25596134
1305297	Rlf	RLF zinc finger	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313242	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RLF mRNA	PMID:31533062
1305297	Rlf	RLF zinc finger	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RLF mRNA	PMID:27153767|PMID:40419075
1305297	Rlf	RLF zinc finger	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RLF mRNA	PMID:23179753|PMID:27188386
1305297	Rlf	RLF zinc finger	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RLF mRNA	PMID:21658437
1305297	Rlf	RLF zinc finger	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552172	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RLF mRNA	PMID:17562736
1305297	Rlf	RLF zinc finger	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313242	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of RLF mRNA	PMID:21420995
1305297	Rlf	RLF zinc finger	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552172	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of RLF mRNA	PMID:29279043
1305297	Rlf	RLF zinc finger	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313242	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of RLF mRNA	PMID:18687144
1305297	Rlf	RLF zinc finger	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RLF mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RLF mRNA	PMID:32525701|PMID:39836092|PMID:40512198
1305297	Rlf	RLF zinc finger	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552172	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA	PMID:40504410
1305297	Rlf	RLF zinc finger	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1313242	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of RLF mRNA	PMID:22077320
1305297	Rlf	RLF zinc finger	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RLF mRNA	PMID:22079256
1305297	Rlf	RLF zinc finger	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of RLF mRNA	PMID:25596134
1305297	Rlf	RLF zinc finger	gene	CHEBI:5864	ifosfamide	increases expression	ISO	RGD:1313242	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of RLF mRNA	PMID:25596134
1305297	Rlf	RLF zinc finger	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RLF mRNA	PMID:39836092
1305297	Rlf	RLF zinc finger	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1552172	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RLF mRNA	PMID:23650126
1305297	Rlf	RLF zinc finger	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of RLF mRNA	PMID:25596134
1305297	Rlf	RLF zinc finger	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of RLF mRNA	PMID:19564919
1305297	Rlf	RLF zinc finger	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313242	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RLF mRNA	PMID:31758290
1305297	Rlf	RLF zinc finger	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313242	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RLF mRNA	PMID:22079256
1305297	Rlf	RLF zinc finger	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RLF mRNA	PMID:22079256
1305297	Rlf	RLF zinc finger	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313242	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of RLF protein	PMID:31285264
1305297	Rlf	RLF zinc finger	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313242	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RLF mRNA	PMID:30851411
1305297	Rlf	RLF zinc finger	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313242	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of RLF mRNA	PMID:19159669
1305297	Rlf	RLF zinc finger	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552172	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of RLF mRNA	PMID:30953684
1305297	Rlf	RLF zinc finger	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313242	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RLF mRNA	PMID:32525701
1305297	Rlf	RLF zinc finger	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1552172	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of RLF mRNA	PMID:21278054
1305297	Rlf	RLF zinc finger	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RLF mRNA	PMID:19281266
1305297	Rlf	RLF zinc finger	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313242	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RLF mRNA	PMID:38568856
1305297	Rlf	RLF zinc finger	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313242	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of RLF mRNA	PMID:29301935
1305297	Rlf	RLF zinc finger	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RLF mRNA	PMID:21346803
1305298	1700001K19Rikl	RIKEN cDNA 1700001K19 gene like	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of 1700001K19RIKL mRNA	PMID:33729688
1305298	1700001K19Rikl	RIKEN cDNA 1700001K19 gene like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of 1700001K19RIKL mRNA	PMID:36005737
1305298	1700001K19Rikl	RIKEN cDNA 1700001K19 gene like	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of 1700001K19RIKL mRNA	PMID:33387578
1305298	1700001K19Rikl	RIKEN cDNA 1700001K19 gene like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of 1700001K19RIKL mRNA	PMID:41034487
1305298	1700001K19Rikl	RIKEN cDNA 1700001K19 gene like	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of 1700001K19RIKL mRNA	PMID:36041667
1305298	1700001K19Rikl	RIKEN cDNA 1700001K19 gene like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of 1700001K19RIKL mRNA	PMID:36041667
1305298	1700001K19Rikl	RIKEN cDNA 1700001K19 gene like	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of 1700001K19RIKL mRNA	PMID:36041667
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313246	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ARID3A mRNA	PMID:37995155
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ARID3A; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARID3A gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARID3A mRNA	PMID:20938992
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ARID3A mRNA	PMID:33729688
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313246	E	RGD:6480464	20120522	CTD	MESH:C029424	hydrazine results in decreased expression of ARID3A mRNA	PMID:15282401
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313245	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ARID3A mRNA	PMID:22378314
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313245	E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ARID3A mRNA	PMID:23410634
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313246	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARID3A mRNA	PMID:39241906
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313246	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ARID3A mRNA	PMID:39298647
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ARID3A mRNA	PMID:30165855
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313245	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ARID3A mRNA	PMID:38568856
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ARID3A; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARID3A gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARID3A mRNA	PMID:20938992
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313245	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ARID3A mRNA	PMID:21179406
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ARID3A mRNA	PMID:26577399
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313245	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ARID3A protein	PMID:37730182
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARID3A mRNA	PMID:36331819
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARID3A mRNA	PMID:39836092
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313245	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ARID3A mRNA	PMID:19549813
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313245	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARID3A mRNA	PMID:22100608
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313245	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARID3A intron	PMID:30157460
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ARID3A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ARID3A mRNA	PMID:35430440|PMID:41430723
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1313245	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of ARID3A mRNA	PMID:22171008
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ARID3A; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARID3A gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARID3A mRNA	PMID:20938992
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313245	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ARID3A mRNA	PMID:26272509
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID3A mRNA	PMID:27188386
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313245	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of ARID3A protein	PMID:35688186
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1313246	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of ARID3A mRNA	PMID:28960355
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313246	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ARID3A mRNA	PMID:30912803
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313246	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARID3A mRNA	PMID:28922406|PMID:37172768
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARID3A mRNA	PMID:34747641
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313246	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARID3A mRNA	PMID:24058054
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313245	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ARID3A mRNA	PMID:23179753
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313245	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARID3A mRNA	PMID:33212167
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:28534	1,2-dibromoethane	increases expression	ISO	RGD:1313246	E	RGD:6480464	20120522	CTD	MESH:D015946	Ethylene Dibromide results in increased expression of ARID3A mRNA	PMID:15612046
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ARID3A mRNA	PMID:26033743
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313245	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARID3A mRNA	PMID:29803840
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313245	E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of ARID3A mRNA	PMID:20044591|PMID:23410634
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313245	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARID3A mRNA	PMID:29301061
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313245	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARID3A mRNA	PMID:38568856
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313245	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARID3A intron	PMID:30157460
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313246	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ARID3A intron	PMID:27901495
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313245	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARID3A mRNA	PMID:32234424
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313245	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ARID3A 3' UTR; Benzo(a)pyrene results in increased methylation of ARID3A 5' UTR; Benzo(a)pyrene results in increased methylation of ARID3A promoter	PMID:27901495
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ARID3A mRNA	PMID:26033743
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1313245	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of ARID3A mRNA	PMID:22171008
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1313246	E	RGD:6480464	20120522	CTD	MESH:C004312	glycidol results in increased expression of ARID3A mRNA	PMID:15612046
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ARID3A mRNA	PMID:30047161
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313246	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARID3A promoter	PMID:35295148
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313246	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of ARID3A mRNA	PMID:27760801
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:32588	potassium chloride	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of ARID3A mRNA	PMID:29691375
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:33098	2-nitrotoluene	increases expression	ISO	RGD:1313246	E	RGD:6480464	20120522	CTD	MESH:C029955	2-nitrotoluene results in increased expression of ARID3A mRNA	PMID:15612046
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313246	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ARID3A promoter	PMID:27334623
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARID3A mRNA	PMID:25181051
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313245	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARID3A protein	PMID:31675489|PMID:33376534
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313245	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARID3A gene	PMID:31601247
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313246	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ARID3A mRNA	PMID:39298647|PMID:40203079
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of ARID3A mRNA]	PMID:40203079
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313245	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ARID3A intron	PMID:30157460
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313245	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARID3A mRNA	PMID:37042841
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARID3A mRNA	PMID:39836092
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of ARID3A promoter	PMID:22457795
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ARID3A mRNA	PMID:30047161
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313245	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ARID3A mRNA	PMID:28302478
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313245	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARID3A mRNA	PMID:31533062
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARID3A mRNA	PMID:36331819
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313245	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARID3A mRNA	PMID:29154799
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313245	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ARID3A mRNA	PMID:23179753
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313245	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ARID3A gene	PMID:29154799
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ARID3A mRNA	PMID:30047161
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:42223	emodin	increases expression	ISO	RGD:1313246	E	RGD:6480464	20120522	CTD	MESH:D004642	Emodin results in increased expression of ARID3A mRNA	PMID:15612046
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313245	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARID3A mRNA	PMID:38832940
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313246	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of ARID3A mRNA	PMID:17562736
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARID3A mRNA	PMID:33387578
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313245	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ARID3A mRNA	PMID:22230336
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313245	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of ARID3A mRNA	PMID:31838189
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ARID3A mRNA	PMID:29391264
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:48981	quinolin-8-ol	increases expression	ISO	RGD:1313246	E	RGD:6480464	20120522	CTD	MESH:D015125	Oxyquinoline results in increased expression of ARID3A mRNA	PMID:15612046
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313246	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ARID3A mRNA	PMID:25554681|PMID:25620056
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of ARID3A mRNA	PMID:22504374
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:50845	doxycycline	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20240903	CTD	MESH:D004318	Doxycycline promotes the reaction [erastin results in increased expression of ARID3A mRNA]	PMID:38115220
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313246	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ARID3A mRNA	PMID:38701926
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of ARID3A mRNA	PMID:28801915
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARID3A mRNA	PMID:39836092
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	ISO	RGD:1313245	E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of ARID3A mRNA	PMID:23410634
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313245	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ARID3A intron	PMID:30157460
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313245	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ARID3A protein	PMID:31285264
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:76606	methyl carbamate	increases expression	ISO	RGD:1313246	E	RGD:6480464	20140107	CTD	MESH:C036868	methyl carbamate results in increased expression of ARID3A mRNA	PMID:15612046
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313245	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of ARID3A protein	PMID:39638853
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID3A mRNA	PMID:27188386
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1313245	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of ARID3A mRNA	PMID:32234424
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ARID3A mRNA	PMID:23914054
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARID3A mRNA	PMID:22504374
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID3A mRNA	PMID:27188386
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:94287	erastin	increases expression	ISO	RGD:1313245	E	RGD:6480464	20240903	CTD	MESH:C477224	erastin results in increased expression of ARID3A mRNA	PMID:38115220
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1313245	E	RGD:6480464	20240903	CTD	MESH:C477224	Doxycycline promotes the reaction [erastin results in increased expression of ARID3A mRNA]	PMID:38115220
1305299	Arid3a	AT-rich interaction domain 3A	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313245	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARID3A mRNA	PMID:38568856
1305300	Krt35	keratin 35	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KRT35 mRNA	PMID:33387578
1305300	Krt35	keratin 35	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1354440	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KRT35 mRNA	PMID:31163220
1305300	Krt35	keratin 35	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KRT35 mRNA	PMID:33387578
1305300	Krt35	keratin 35	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1621558	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of KRT35 mRNA	PMID:27776689
1305300	Krt35	keratin 35	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KRT35 mRNA	PMID:22129741
1305300	Krt35	keratin 35	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1354440	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KRT35 gene	PMID:27153756
1305300	Krt35	keratin 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KRT35 mRNA	PMID:33387578
1305300	Krt35	keratin 35	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1354440	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT35 promoter	PMID:27901495
1305300	Krt35	keratin 35	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT35 mRNA	PMID:25181051
1305300	Krt35	keratin 35	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1621558	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of KRT35 promoter	PMID:33297965
1305300	Krt35	keratin 35	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KRT35 mRNA	PMID:22129741
1305300	Krt35	keratin 35	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KRT35 mRNA	PMID:35163327
1305300	Krt35	keratin 35	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT35 mRNA	PMID:35163327
1305300	Krt35	keratin 35	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT35 mRNA	PMID:35163327
1305300	Krt35	keratin 35	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1354440	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KRT35 gene	PMID:29154799
1305300	Krt35	keratin 35	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRT35 mRNA	PMID:33387578
1305300	Krt35	keratin 35	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1354440	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of KRT35 mRNA	PMID:18175754
1305300	Krt35	keratin 35	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1354440	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT35 gene]	PMID:28238834
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ABCE1 mRNA]	PMID:31150632
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ABCE1 mRNA	PMID:16140955|PMID:23724009|PMID:33167477
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20120412	CTD	MESH:D014212	Thiophenes analog promotes the reaction [Tretinoin results in decreased expression of ABCE1 mRNA]	PMID:16140955
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABCE1 mRNA	PMID:32699268
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1313249	E	RGD:6480464	20150310	CTD	MESH:D019308	Palmitic Acid results in increased expression of ABCE1 protein	PMID:24651439
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ABCE1 mRNA	PMID:22378314
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313250	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ABCE1 mRNA	PMID:39241906
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ABCE1 mRNA]	PMID:39241906
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ABCE1 protein	PMID:32145629
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313249	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of ABCE1 mRNA	PMID:24758408|PMID:31614463
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313250	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ABCE1 mRNA	PMID:39298647
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein promotes the reaction [Estradiol results in increased expression of ABCE1 mRNA]	PMID:24758408
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313249	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ABCE1 mRNA	PMID:38568856
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ABCE1 mRNA	PMID:33387578
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313249	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ABCE1 mRNA	PMID:21179406
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:17323	trans-pinosylvin	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20140805	CTD	MESH:C049032	pinosylvin results in decreased expression of ABCE1 mRNA	PMID:23333577
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ABCE1 mRNA	PMID:22061828|PMID:33387578
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ABCE1 mRNA	PMID:28818685
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ABCE1 mRNA	PMID:37236586
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1313250	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of ABCE1 mRNA	PMID:15664270
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ABCE1 protein	PMID:23301498
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ABCE1 mRNA	PMID:23649840
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ABCE1 mRNA	PMID:23649840
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABCE1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ABCE1 mRNA	PMID:32699268
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ABCE1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ABCE1 protein	PMID:38598786
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:26961	thiophenes	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20170103	CTD	MESH:D013876	Thiophenes analog promotes the reaction [Tretinoin results in decreased expression of ABCE1 mRNA]	PMID:16140955
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ABCE1 mRNA	PMID:17484886
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ABCE1 mRNA	PMID:31150632
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313250	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ABCE1 mRNA	PMID:27339419|PMID:31919559
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ABCE1 mRNA]	PMID:31150632
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ABCE1 mRNA	PMID:22206623
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ABCE1 mRNA	PMID:27392435
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313249	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCE1 mRNA	PMID:22298810
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313250	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCE1 mRNA	PMID:21570461
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313250	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABCE1 mRNA	PMID:15034205
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABCE1 mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ABCE1 mRNA]	PMID:15034205|PMID:17942748
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ABCE1 mRNA	PMID:33212167
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of ABCE1 mRNA	PMID:39709020
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABCE1 mRNA	PMID:29803840
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABCE1 mRNA	PMID:38568856
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of ABCE1 mRNA	PMID:17127020
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313250	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCE1 mRNA	PMID:15034205|PMID:22228805
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of ABCE1 mRNA]	PMID:15034205
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313249	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ABCE1 mRNA	PMID:25895662
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of ABCE1 mRNA	PMID:11578147
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of ABCE1 mRNA	PMID:31745603
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ABCE1 mRNA	PMID:30047161
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ABCE1 mRNA	PMID:34492290
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313250	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ABCE1 mRNA	PMID:28472532
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ABCE1 mRNA	PMID:19167457
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCE1 protein	PMID:31675489|PMID:37567409
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313250	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCE1 mRNA	PMID:33221593
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ABCE1 mRNA	PMID:25181051
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1313249	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of ABCE1 mRNA	PMID:19041380
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313250	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ABCE1 mRNA	PMID:39298647
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313249	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ABCE1 protein	PMID:34186270
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:34575	bisphenol F	increases methylation	ISO	RGD:1313249	E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in increased methylation of ABCE1 gene	PMID:31601247
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313249	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ABCE1 protein	PMID:34186270
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313250	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ABCE1 mRNA	PMID:37019170
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ABCE1 protein	PMID:38598786
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ABCE1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ABCE1 promoter	PMID:25374375
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ABCE1 mRNA	PMID:32680482
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ABCE1 mRNA]	PMID:39241906
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313249	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABCE1 mRNA	PMID:37042841
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ABCE1 mRNA	PMID:38174414|PMID:38568856
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ABCE1 mRNA	PMID:37236586
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313250	E	RGD:6480464	20240206	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ABCE1 protein	PMID:37422089
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ABCE1 mRNA	PMID:24449571
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:36011	pinosylvin	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20140311	CTD	MESH:C049032	pinosylvin results in decreased expression of ABCE1 mRNA	PMID:23333577
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABCE1 mRNA	PMID:32699268
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1313249	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of ABCE1 protein	PMID:34122009
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313249	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABCE1 mRNA	PMID:32588087
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ABCE1 mRNA	PMID:28302478
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313249	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ABCE1 mRNA	PMID:31533062
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313249	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ABCE1 mRNA	PMID:19167446
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ABCE1 mRNA	PMID:17292431
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ABCE1 mRNA	PMID:23179753|PMID:27188386
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ABCE1 mRNA	PMID:30047161
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313250	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of ABCE1 mRNA	PMID:19770486
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ABCE1 mRNA	PMID:24136188
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ABCE1 mRNA	PMID:17562736
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCE1 mRNA	PMID:33387578
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCE1 mRNA	PMID:21420995|PMID:25704631
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABCE1 mRNA	PMID:22079256
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABCE1 mRNA	PMID:17942748
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313250	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ABCE1 mRNA	PMID:25554681
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ABCE1 mRNA	PMID:24136188
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ABCE1 mRNA	PMID:30047161
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ABCE1 mRNA	PMID:35964746
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ABCE1 mRNA	PMID:24136188
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ABCE1 protein	PMID:32959892
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ABCE1 mRNA	PMID:26378955
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABCE1 mRNA	PMID:26378955
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313250	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ABCE1 mRNA	PMID:23650126
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ABCE1 mRNA	PMID:30467583
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ABCE1 mRNA	PMID:22206623
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ABCE1 protein	PMID:37664457
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ABCE1 mRNA	PMID:24136188
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ABCE1 mRNA	PMID:22079256
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABCE1 mRNA	PMID:22079256
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20260714	CTD	MESH:D000077143	[Docetaxel results in decreased susceptibility to Docetaxel] which results in decreased expression of ABCE1 mRNA	PMID:19944135
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313249	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of ABCE1 mRNA; beta-Naphthoflavone results in increased expression of ABCE1 protein	PMID:32858204|PMID:39638853
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ABCE1 mRNA	PMID:21346803
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of ABCE1 mRNA	PMID:30047161
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:8069	phenobarbital	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ABCE1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ABCE1 promoter	PMID:25374375
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313250	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ABCE1 mRNA	PMID:30294300
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ABCE1 protein	PMID:31675489
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of ABCE1 protein	PMID:38348393
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ABCE1 mRNA	PMID:30047161
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of ABCE1 mRNA	PMID:21278054
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ABCE1 mRNA	PMID:30047161
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ABCE1 mRNA]	PMID:39241906
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ABCE1 protein	PMID:37664457
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ABCE1 mRNA	PMID:21346803
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313249	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ABCE1 mRNA	PMID:38568856
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313249	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ABCE1 protein	PMID:38598786
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ABCE1 mRNA	PMID:21346803
1305301	Abce1	ATP binding cassette subfamily E member 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of ABCE1 mRNA	PMID:23555832
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313251	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CDKN2AIP mRNA	PMID:33045310
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313251	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CDKN2AIP mRNA	PMID:26251327
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313251	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CDKN2AIP mRNA	PMID:39241906
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604354	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDKN2AIP mRNA	PMID:37042841
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1604354	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CDKN2AIP mRNA	PMID:23649840
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1604354	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of CDKN2AIP mRNA	PMID:18070364
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1604354	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CDKN2AIP protein	PMID:37730182
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CDKN2AIP mRNA	PMID:33387578
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313251	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CDKN2AIP mRNA	PMID:36331819
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313251	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDKN2AIP mRNA	PMID:37236586
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1604354	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDKN2AIP mRNA	PMID:35301059
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1604354	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CDKN2AIP mRNA	PMID:19549813
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1604354	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CDKN2AIP mRNA	PMID:23649840
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1604354	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CDKN2AIP gene	PMID:27153756
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313251	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDKN2AIP mRNA	PMID:19770486
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604354	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CDKN2AIP mRNA	PMID:23649840
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604354	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CDKN2AIP mRNA	PMID:35430440
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313251	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CDKN2AIP mRNA	PMID:31919559
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1604354	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CDKN2AIP protein	PMID:35688186
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1604354	E	RGD:6480464	20120412	CTD	MESH:D002945	CDKN2AIP protein affects the susceptibility to Cisplatin	PMID:16217747
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of CDKN2AIP mRNA	PMID:27392435
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1604354	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CDKN2AIP mRNA	PMID:27594783
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1604354	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin promotes the reaction [jinfukang results in decreased expression of CDKN2AIP mRNA]; jinfukang promotes the reaction [Cisplatin results in decreased expression of CDKN2AIP mRNA]	PMID:27392435
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of CDKN2AIP protein	PMID:35544339
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604354	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CDKN2AIP mRNA	PMID:33212167
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1604354	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CDKN2AIP mRNA	PMID:39709020
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1604354	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CDKN2AIP mRNA	PMID:30851411
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1604354	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CDKN2AIP mRNA	PMID:32763439
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604354	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CDKN2AIP mRNA	PMID:24690739
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CDKN2AIP mRNA	PMID:25523186
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDKN2AIP protein	PMID:38228842|PMID:39571964
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604354	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CDKN2AIP mRNA	PMID:38568856
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313251	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of CDKN2AIP protein	PMID:37955338
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CDKN2AIP mRNA	PMID:25523186
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604354	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CDKN2AIP mRNA	PMID:24690739
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313251	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CDKN2AIP mRNA	PMID:27131904
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313251	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CDKN2AIP mRNA	PMID:29264374
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313251	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDKN2AIP gene	PMID:35295148
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CDKN2AIP mRNA	PMID:34492290
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313251	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of CDKN2AIP mRNA	PMID:18648102
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDKN2AIP mRNA	PMID:25181051
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CDKN2AIP mRNA	PMID:30816183|PMID:32145629
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604354	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDKN2AIP mRNA	PMID:37042841
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1604354	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CDKN2AIP mRNA	PMID:38174414
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313251	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDKN2AIP mRNA	PMID:37236586
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1604354	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDKN2AIP mRNA	PMID:35301059
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of CDKN2AIP mRNA	PMID:30047161
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CDKN2AIP mRNA	PMID:28302478
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1604354	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CDKN2AIP mRNA	PMID:31533062
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of CDKN2AIP mRNA	PMID:19167446
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CDKN2AIP mRNA	PMID:40419075
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313251	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CDKN2AIP mRNA	PMID:36331819
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604354	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDKN2AIP mRNA	PMID:25979313
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDKN2AIP mRNA	PMID:23179753|PMID:27188386
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CDKN2AIP mRNA	PMID:30047161
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1604354	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CDKN2AIP mRNA	PMID:20106945
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CDKN2AIP mRNA	PMID:33387578
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604354	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CDKN2AIP mRNA	PMID:21420995
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1604354	E	RGD:6480464	20120412	CTD	MESH:D005472	CDKN2AIP protein affects the susceptibility to Fluorouracil	PMID:16217747
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of CDKN2AIP mRNA	PMID:24714768
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1604354	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of CDKN2AIP mRNA	PMID:24690739
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313251	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CDKN2AIP mRNA	PMID:29279043
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1604354	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CDKN2AIP mRNA	PMID:18687144
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1604354	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of CDKN2AIP mRNA	PMID:22077320
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of CDKN2AIP mRNA	PMID:31838189
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1604354	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CDKN2AIP mRNA	PMID:22079256
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CDKN2AIP protein	PMID:32959892
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CDKN2AIP mRNA	PMID:24136188
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313251	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CDKN2AIP mRNA	PMID:23650126
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1604354	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CDKN2AIP mRNA	PMID:28988120
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:69120	withaferin A	decreases expression	ISO	RGD:1604354	E	RGD:6480464	20180116	CTD	MESH:C009684	withaferin A results in decreased expression of CDKN2AIP protein	PMID:22973447
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313251	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CDKN2AIP mRNA	PMID:22206623
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1604354	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CDKN2AIP mRNA	PMID:22079256
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1604354	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CDKN2AIP mRNA	PMID:22079256
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1604354	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CDKN2AIP mRNA	PMID:37199045
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1604354	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of CDKN2AIP protein	PMID:39638853
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1604354	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CDKN2AIP mRNA	PMID:30851411
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of CDKN2AIP protein	PMID:28903499
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CDKN2AIP mRNA	PMID:30047161
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313251	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CDKN2AIP mRNA	PMID:27131904
1305302	Cdkn2aip	CDKN2A interacting protein	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1604354	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CDKN2AIP mRNA	PMID:38568856
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313252	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of IRAK4 mRNA	PMID:27188386
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1313252	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of IRAK4 protein	PMID:36641056
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313252	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of IRAK4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of IRAK4 mRNA	PMID:32699268
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313252	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of IRAK4 mRNA	PMID:26079696
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313252	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of IRAK4 mRNA; Ethanol results in increased expression of IRAK4 protein	PMID:28964808
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313253	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of IRAK4 protein	PMID:28964808
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313252	E	RGD:6480464	20180515	CTD	MESH:D000431	[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 mRNA; [Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 protein; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 mRNA]; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 protein]; acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]; PRKAA1 protein promotes the reaction [acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]]	PMID:28964808
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20180515	CTD	MESH:D000431	acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]	PMID:28964808
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	increases degradation	ISO	RGD:1313253	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased degradation of IRAK4 protein	PMID:22849695
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313252	E	RGD:6480464	20180515	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IRAK4 protein	PMID:28964808
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	increases phosphorylation	ISO	RGD:1313253	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased phosphorylation of IRAK4 protein	PMID:25294874
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Titanium] results in decreased expression of IRAK4 mRNA	PMID:21308757
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313252	E	RGD:6480464	20180515	CTD	MESH:D008070	[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 mRNA; [Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 protein; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 mRNA]; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 protein]	PMID:28964808
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20161228	CTD	MESH:D008070	ginsenoside Re inhibits the reaction [Lipopolysaccharides results in increased degradation of IRAK4 protein]; iberin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRAK4 protein]	PMID:22849695|PMID:25294874
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313253	E	RGD:6480464	20211109	CTD	MESH:D014241	Trichloroethylene results in increased expression of IRAK4 protein	PMID:33007382
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20211109	CTD	MESH:D014241	sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of IRAK4 protein]	PMID:33007382
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313252	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of IRAK4 protein	PMID:17701593
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313252	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of IRAK4 mRNA	PMID:33359661
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IRAK4 mRNA	PMID:33387578
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20241203	CTD	MESH:D001397	[Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of IRAK4 protein	PMID:34273909
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:233299	(-)-acanthoic acid	multiple interactions	ISO	RGD:1313252	E	RGD:6480464	20250408	CTD	MESH:C099958	acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 mRNA]; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 protein]; acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]; PRKAA1 protein promotes the reaction [acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]]	PMID:28964808
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:233299	(-)-acanthoic acid	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20250408	CTD	MESH:C099958	acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]	PMID:28964808
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313252	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of IRAK4 gene	PMID:27153756
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313252	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of IRAK4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of IRAK4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of IRAK4 mRNA	PMID:32699268
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:26710	sodium chloride	increases phosphorylation	ISO	RGD:1313252	E	RGD:6480464	20260113	CTD	MESH:D012965	Sodium Chloride results in increased phosphorylation of IRAK4 protein	PMID:40447172
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313252	E	RGD:6480464	20260113	CTD	MESH:D012965	IRAK4 protein affects the reaction [Sodium Chloride results in decreased expression of ARG1 protein]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in decreased expression of ARG1 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of ACTA2 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of HAVCR1 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of IL1B mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of IL6 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of LCN2 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of TGFB1 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of TNF mRNA]]; IRAK4 protein promotes the reaction [Sodium Chloride results in decreased expression of IL10 mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of ACTA2 protein]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of HAVCR1 mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL1B mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL6 mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of LCN2 mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of TNF mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]; liquiritigenin inhibits the reaction [IRAK4 protein affects the reaction [Sodium Chloride results in decreased expression of ARG1 protein]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in decreased expression of IL10 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of ACTA2 protein]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL1B mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL6 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of LCN2 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of TNF mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]]	PMID:40447172
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313252	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IRAK4 gene	PMID:25304211
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of IRAK4 gene	PMID:31011160
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313252	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of IRAK4 mRNA	PMID:27392435
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313253	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of IRAK4 mRNA	PMID:30912803
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IRAK4 mRNA	PMID:22298810
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313253	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IRAK4 mRNA	PMID:24680724
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313252	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IRAK4 mRNA	PMID:29803840
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:28777	liquiritigenin	affects binding	ISO	RGD:1313252	E	RGD:6480464	20260113	CTD	MESH:C083152	liquiritigenin binds to IRAK4 protein	PMID:40447172
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:28777	liquiritigenin	multiple interactions	ISO	RGD:1313252	E	RGD:6480464	20260113	CTD	MESH:C083152	IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in decreased expression of ARG1 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of ACTA2 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of HAVCR1 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of IL1B mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of IL6 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of LCN2 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of TGFB1 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of TNF mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein affects the reaction [Sodium Chloride results in decreased expression of ARG1 protein]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in decreased expression of IL10 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of ACTA2 protein]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL1B mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL6 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of LCN2 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of TNF mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]]	PMID:40447172
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:28777	liquiritigenin	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20260113	CTD	MESH:C083152	liquiritigenin inhibits the reaction [Sodium Chloride, Dietary results in increased phosphorylation of IRAK4 protein]	PMID:40447172
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313253	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of IRAK4 mRNA	PMID:39515575
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313252	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IRAK4 5' UTR	PMID:27901495
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313252	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of IRAK4 mRNA; Silicon Dioxide results in decreased expression of IRAK4 mRNA	PMID:25351596|PMID:25895662
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313253	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IRAK4 gene	PMID:35295148
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of IRAK4 mRNA	PMID:34492290
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313253	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of IRAK4 mRNA	PMID:28472532
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IRAK4 mRNA	PMID:25181051|PMID:34947998
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313253	E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in increased expression of IRAK4 protein modified form	PMID:33706241
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:33341	titanium atom	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D014025	[Lipopolysaccharides co-treated with Titanium] results in decreased expression of IRAK4 mRNA	PMID:21308757
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20220308	CTD	MESH:D016264	[Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of IRAK4 protein	PMID:34273909
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313253	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of IRAK4 mRNA	PMID:21266533
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1313252	E	RGD:6480464	20120613	CTD	MESH:C022838	nickel chloride results in increased expression of IRAK4 protein	PMID:21473897
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313253	E	RGD:6480464	20171010	CTD	MESH:D010269	Paraquat results in increased expression of IRAK4 protein modified form	PMID:28363843
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20171010	CTD	MESH:D010269	Phosphorothioate Oligonucleotides inhibits the reaction [Paraquat results in increased expression of IRAK4 protein modified form]	PMID:28363843
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of IRAK4 mRNA	PMID:33453195
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313252	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of IRAK4 mRNA	PMID:36326898
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C018021	cobaltous chloride results in increased expression of IRAK4 mRNA; cobaltous chloride results in increased expression of IRAK4 protein	PMID:21925238
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313252	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IRAK4 mRNA	PMID:24449571
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:36706	resiquimod	increases phosphorylation	ISO	RGD:1313252	E	RGD:6480464	20180515	CTD	MESH:C402365	resiquimod results in increased phosphorylation of IRAK4 protein	PMID:28924041
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:36706	resiquimod	multiple interactions	ISO	RGD:1313252	E	RGD:6480464	20180515	CTD	MESH:C402365	[Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod promotes the reaction [IRF5 protein binds to CXCL10 promoter]]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod promotes the reaction [IRF5 protein binds to TNF promoter]]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased expression of IL6 protein]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased expression of TNF protein]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased phosphorylation of IKBKB protein]	PMID:28924041
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313252	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of IRAK4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of IRAK4 mRNA	PMID:32699268
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:37699	protein kinase inhibitor	decreases activity	ISO	RGD:1313252	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors results in decreased activity of IRAK4 protein	PMID:28003376
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:37699	protein kinase inhibitor	decreases activity	ISO	RGD:1313253	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors results in decreased activity of IRAK4 protein	PMID:28003376
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1313252	E	RGD:6480464	20180515	CTD	MESH:D047428	[Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod promotes the reaction [IRF5 protein binds to CXCL10 promoter]]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod promotes the reaction [IRF5 protein binds to TNF promoter]]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased expression of IL6 protein]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased expression of TNF protein]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased phosphorylation of IKBKB protein]; Protein Kinase Inhibitors results in decreased phosphorylation of and results in decreased activity of IRAK4 protein	PMID:28924041
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313252	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of IRAK4 gene	PMID:29154799
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313252	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of IRAK4 mRNA	PMID:25562108|PMID:27989131
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313252	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of IRAK4 mRNA	PMID:17400583
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1313253	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of IRAK4 mRNA	PMID:29279043
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313252	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IRAK4 gene	PMID:25304211
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1313253	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of IRAK4 mRNA	PMID:26934552
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20211109	CTD	MESH:C016766	sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of IRAK4 protein]	PMID:33007382
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313252	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of IRAK4 mRNA	PMID:18175754
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:50692	mifepristone	decreases expression	ISO	RGD:1313252	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of IRAK4 protein	PMID:17701593
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:50924	sorafenib	increases expression	ISO	RGD:1313253	E	RGD:6480464	20260203	CTD	MESH:C471405	Sorafenib results in increased expression of IRAK4 mRNA	PMID:40518001
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:51081	nitrates	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in increased expression of IRAK4 mRNA	PMID:30022042
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:5199	Fusaric acid	decreases expression	ISO	RGD:1313252	E	RGD:6480464	20190312	CTD	MESH:D005669	Fusaric Acid results in decreased expression of IRAK4 protein	PMID:30582969
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313253	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IRAK4 mRNA	PMID:38701926
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:61668	oroxylin A	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:C080669	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [endotoxin, Escherichia coli results in increased expression of IRAK4 protein]	PMID:32464219
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:6541	losartan	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20260113	CTD	MESH:D019808	Losartan inhibits the reaction [Sodium Chloride, Dietary results in increased phosphorylation of IRAK4 protein]	PMID:40447172
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:69355	casticin	increases expression	ISO	RGD:1313252	E	RGD:6480464	20170516	CTD	MESH:C054133	casticin results in increased expression of IRAK4 mRNA	PMID:27862857
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:77148	ginsenoside Re	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20140408	CTD	MESH:C049864	ginsenoside Re inhibits the reaction [Lipopolysaccharides results in increased degradation of IRAK4 protein]	PMID:22849695
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:89494	iberin	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20151103	CTD	MESH:C082585	iberin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRAK4 protein]	PMID:25294874
1305303	Irak4	interleukin-1 receptor-associated kinase 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of IRAK4 mRNA	PMID:21346803
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:D015025	Zearalenone results in increased expression of ETNK2 mRNA	PMID:19371625
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313255	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ETNK2 mRNA	PMID:33045310
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ETNK2 mRNA]	PMID:31150632
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313254	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ETNK2 mRNA	PMID:26079696
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313254	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ETNK2 mRNA	PMID:22378314
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in decreased expression of ETNK2 mRNA	PMID:20106945
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ETNK2 mRNA	PMID:39298647
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313254	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ETNK2 mRNA	PMID:26079696
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ETNK2 mRNA	PMID:34319233
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313255	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ETNK2 mRNA	PMID:33754040
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:D002117	Calcitriol results in increased expression of ETNK2 mRNA	PMID:16002434
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ETNK2 mRNA	PMID:33387578
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ETNK2 mRNA	PMID:36331819
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ETNK2 mRNA	PMID:37236586
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ETNK2 protein	PMID:20106945
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ETNK2 mRNA	PMID:27153756
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ETNK2 mRNA	PMID:19770486
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313254	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ETNK2 exon	PMID:30157460
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ETNK2 mRNA	PMID:30690589|PMID:31150632
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ETNK2 mRNA	PMID:27339419|PMID:31919559
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:27385	tetrachloromethane	increases methylation	EXP		E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in increased methylation of ETNK2 promoter	PMID:30690589
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ETNK2 mRNA]	PMID:31150632
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ETNK2 mRNA	PMID:28189721|PMID:28960355
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:C059514	resveratrol results in increased expression of ETNK2 mRNA	PMID:19371625
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313254	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ETNK2 mRNA	PMID:28903495
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1313255	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of ETNK2 mRNA	PMID:34813904
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:D019833	Genistein results in increased expression of ETNK2 mRNA	PMID:19371625
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of ETNK2 gene	PMID:28505145
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313255	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ETNK2 mRNA	PMID:24680724
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ETNK2 mRNA	PMID:32109520|PMID:33387578
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ETNK2 mRNA	PMID:20106945
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ETNK2 mRNA	PMID:28213091
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ETNK2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ETNK2 gene]	PMID:25975270|PMID:28213091
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313255	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of ETNK2 mRNA	PMID:30807115
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ETNK2 mRNA	PMID:29803840
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:C028473	ETNK2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313255	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ETNK2 gene	PMID:39894169
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA	PMID:34876320
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA	PMID:34876320
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313254	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ETNK2 exon	PMID:30157460
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ETNK2 mRNA	PMID:20106945|PMID:32234424
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313254	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ETNK2 3' UTR; Benzo(a)pyrene results in decreased methylation of ETNK2 exon; Benzo(a)pyrene results in decreased methylation of ETNK2 promoter	PMID:27901495
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ETNK2 mRNA	PMID:22316170
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of ETNK2 mRNA	PMID:38458666
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313254	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ETNK2 mRNA	PMID:34973136
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:30772	butyric acid	increases expression	ISO	RGD:1313254	E	RGD:6480464	20220607	CTD	MESH:D020148	Butyric Acid results in increased expression of ETNK2 mRNA	PMID:34581912
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:32063	propylparaben	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:C006068	propylparaben results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of ETNK2 mRNA	PMID:24136188
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of ETNK2 mRNA	PMID:23411599
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ETNK2 mRNA	PMID:20813756|PMID:23811191
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ETNK2 mRNA	PMID:25181051
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313254	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ETNK2 mRNA	PMID:30903817
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313255	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A affects the expression of ETNK2 mRNA	PMID:39742910
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ETNK2 mRNA	PMID:34947998
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ETNK2 mRNA	PMID:32145629
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:C006780	bisphenol A results in increased expression of ETNK2 mRNA	PMID:19371625
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ETNK2 gene	PMID:28505145
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of ETNK2 gene	PMID:28505145
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20241001	CTD	MESH:C006780	[Dietary Fats co-treated with bisphenol A] results in decreased expression of ETNK2 mRNA	PMID:36632902
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1313254	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of ETNK2 mRNA	PMID:19371625
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313255	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ETNK2 mRNA	PMID:39298647
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313255	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ETNK2 gene	PMID:31683443
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:C543008	bisphenol S results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of ETNK2 mRNA	PMID:33297965
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313254	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ETNK2 gene	PMID:31601247
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:C008745	bisphenol F results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20241001	CTD	MESH:C008745	[Dietary Fats co-treated with bisphenol F] results in decreased expression of ETNK2 mRNA	PMID:36632902
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ETNK2 mRNA	PMID:37019170
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313255	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ETNK2 mRNA	PMID:32715474
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of ETNK2 mRNA	PMID:38458666
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ETNK2 mRNA	PMID:37236586
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313255	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ETNK2 mRNA	PMID:28903501
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ETNK2 mRNA	PMID:24386269
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313254	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ETNK2 mRNA	PMID:24449571
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313255	E	RGD:6480464	20130806	CTD	MESH:D002922	Ciguatoxins affects the expression of ETNK2 mRNA	PMID:18353800
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of ETNK2 mRNA	PMID:23811191
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1313255	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of ETNK2 mRNA	PMID:34254344
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ETNK2 mRNA	PMID:31533062
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ETNK2 mRNA	PMID:36331819
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313254	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of ETNK2 mRNA	PMID:28001369|PMID:29154799
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in decreased expression of ETNK2 mRNA	PMID:20106945
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313255	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of ETNK2 mRNA	PMID:25123088
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ETNK2 mRNA	PMID:36653537
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ETNK2 mRNA; Okadaic Acid results in decreased expression of ETNK2 protein	PMID:38832940
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313255	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of ETNK2 mRNA	PMID:17562736
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ETNK2 mRNA	PMID:29067470
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ETNK2 mRNA	PMID:31838189
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ETNK2 mRNA	PMID:35436446
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA	PMID:34876320
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ETNK2 mRNA	PMID:32234424
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of ETNK2 mRNA	PMID:25572481
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ETNK2 mRNA	PMID:25620056
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of ETNK2 mRNA	PMID:34044035
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313255	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ETNK2 mRNA	PMID:23608068
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313255	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of ETNK2 mRNA	PMID:23091169
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ETNK2 mRNA	PMID:32109520
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313255	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ETNK2 mRNA	PMID:38648751
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313254	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ETNK2 mRNA	PMID:26079696
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA	PMID:34876320
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ETNK2 mRNA	PMID:19281266
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ETNK2 mRNA	PMID:38568856
1305304	Etnk2	ethanolamine kinase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313254	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of ETNK2 mRNA	PMID:25572481
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313256	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of UBE2Q1 mRNA	PMID:25812627
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552177	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2Q1 gene	PMID:20938992
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313256	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of UBE2Q1 mRNA	PMID:33167477
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313256	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of UBE2Q1 mRNA	PMID:22378314
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552177	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2Q1 gene	PMID:20938992
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313256	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of UBE2Q1 mRNA	PMID:19162166
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552177	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of UBE2Q1 mRNA	PMID:23892564
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552177	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of UBE2Q1 mRNA	PMID:33754040
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552177	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2Q1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2Q1 gene	PMID:20938992|PMID:22206623
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313256	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2Q1 mRNA	PMID:39836092
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552177	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of UBE2Q1 mRNA	PMID:28960355
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552177	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2Q1 mRNA	PMID:21570461
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1552177	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of UBE2Q1 mRNA	PMID:23186747
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313256	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of UBE2Q1 mRNA	PMID:33212167
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313256	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of UBE2Q1 mRNA	PMID:29803840
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313256	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2Q1 mRNA	PMID:39836092
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313256	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of UBE2Q1 mRNA	PMID:29453283
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552177	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBE2Q1 mRNA	PMID:22228805
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552177	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of UBE2Q1 promoter alternative form	PMID:35295148
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2Q1 mRNA	PMID:34947998
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313256	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2Q1 mRNA	PMID:22576693
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552177	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2Q1 mRNA	PMID:26063408
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313256	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of UBE2Q1 gene	PMID:22576693
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552177	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of UBE2Q1 mRNA	PMID:37019170
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313256	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of UBE2Q1 gene	PMID:22964155
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552177	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of UBE2Q1 mRNA	PMID:34813904
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313256	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBE2Q1 mRNA	PMID:37042841
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1552177	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE2Q1 mRNA	PMID:20061341
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313256	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of UBE2Q1 mRNA	PMID:25812627
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313256	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of UBE2Q1 mRNA	PMID:25812627
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313256	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of UBE2Q1 mRNA	PMID:25812627
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313256	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of UBE2Q1 mRNA	PMID:23179753
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313256	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of UBE2Q1 mRNA	PMID:28542535
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552177	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBE2Q1 mRNA	PMID:17562736
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of UBE2Q1 mRNA	PMID:33387578
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313256	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2Q1 mRNA	PMID:39836092
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552177	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of UBE2Q1 mRNA	PMID:17555576
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552177	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of UBE2Q1 mRNA	PMID:35964746
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313256	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UBE2Q1 protein	PMID:32959892
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1552177	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of UBE2Q1 mRNA	PMID:22206623
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552177	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2Q1 mRNA	PMID:22206623
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of UBE2Q1 mRNA	PMID:22124623
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1552177	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of UBE2Q1 mRNA	PMID:22538082
1305305	Ube2q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:9944	venlafaxine hydrochloride	decreases expression	ISO	RGD:1313256	E	RGD:6480464	20170303	CTD	MESH:D000069470	Venlafaxine Hydrochloride results in decreased expression of UBE2Q1 mRNA	PMID:16341940
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313259	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EPB42 mRNA	PMID:33045310
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:D010100	Oxygen deficiency results in increased expression of EPB42 mRNA	PMID:22629407
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of EPB42 mRNA]	PMID:22629407
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313258	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of EPB42 mRNA	PMID:30510588
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of EPB42 mRNA	PMID:32145629
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313259	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EPB42 mRNA	PMID:39298647
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPB42 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA	PMID:37567420|PMID:37992649
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPB42 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA	PMID:37567420|PMID:37992649
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EPB42 mRNA	PMID:33387578
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1313259	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of EPB42 mRNA	PMID:29279043
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of EPB42 protein	PMID:33236894
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313258	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EPB42 gene	PMID:27153756
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313259	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of EPB42 mRNA	PMID:40618947
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:D019833	Genistein results in decreased expression of EPB42 mRNA	PMID:21048042
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPB42 mRNA	PMID:33387578
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313259	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPB42 mRNA	PMID:28213091
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of EPB42 mRNA	PMID:28959563
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPB42 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA	PMID:37567420|PMID:37992649
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313259	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EPB42 exon; Benzo(a)pyrene results in decreased methylation of EPB42 intron	PMID:27901495
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313258	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EPB42 promoter	PMID:27901495
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of EPB42 mRNA	PMID:25729387
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of EPB42 mRNA; [Topotecan co-treated with oxaliplatin] results in decreased expression of EPB42 mRNA	PMID:25729387
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EPB42 mRNA	PMID:34492290
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of EPB42 mRNA	PMID:18648102
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EPB42 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EPB42 mRNA	PMID:32145629|PMID:34947998
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EPB42 mRNA	PMID:36041667
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20200915	CTD	MESH:C014024	[NR1I2 protein affects the susceptibility to 2,4,5,2',4',5'-hexachlorobiphenyl] which affects the expression of EPB42 mRNA	PMID:32352317
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EPB42 mRNA	PMID:36041667
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EPB42 mRNA	PMID:36041667
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313259	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EPB42 mRNA	PMID:37019170
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EPB42 mRNA	PMID:21266533
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:D014635	Valproic Acid affects the expression of EPB42 mRNA	PMID:17292431
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of EPB42 mRNA	PMID:41580965
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPB42 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA	PMID:37567420|PMID:37992649
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EPB42 mRNA	PMID:33387578
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of EPB42 mRNA	PMID:25729387
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of EPB42 mRNA; [Topotecan co-treated with oxaliplatin] results in decreased expression of EPB42 mRNA	PMID:25729387
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:C017096	n-butoxyethanol results in increased expression of EPB42 mRNA	PMID:19812364
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases degradation	ISO	RGD:1313258	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased degradation of EPB42 protein	PMID:15040847
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA	PMID:37567420
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of EPB42 mRNA	PMID:33484710
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313258	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPB42 gene]	PMID:28238834
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EPB42 mRNA	PMID:24780913
1305306	Epb42	erythrocyte membrane protein band 4.2	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1313258	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of EPB42 mRNA	PMID:34581912
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313265	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NETO2 mRNA	PMID:33045310
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of NETO2 mRNA	PMID:23724009|PMID:33167477
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NETO2 mRNA	PMID:24236059
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NETO2 mRNA	PMID:22378314
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313264	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of NETO2 mRNA	PMID:21632981
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313265	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NETO2 mRNA	PMID:39241906
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313264	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of NETO2 mRNA	PMID:31614463
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313265	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NETO2 mRNA	PMID:37992649
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313265	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NETO2 mRNA	PMID:37992649
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NETO2 mRNA	PMID:33387578
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA	PMID:39836092
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NETO2 mRNA	PMID:22129741
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313264	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NETO2 gene	PMID:27153756
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313264	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NETO2 mRNA	PMID:27153756
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313264	E	RGD:6480464	20120412	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NETO2 mRNA	PMID:21527772
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313264	E	RGD:6480464	20120412	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of NETO2 mRNA	PMID:21527772
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NETO2 mRNA	PMID:39836092
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1313264	E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of NETO2 mRNA	PMID:21527772
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313265	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of NETO2 mRNA	PMID:28189721|PMID:28960355
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1313264	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of NETO2 mRNA	PMID:15009677
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313264	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NETO2 mRNA	PMID:25583101
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NETO2 mRNA	PMID:33387578
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NETO2 mRNA	PMID:19933214
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313265	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NETO2 mRNA	PMID:19465110
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NETO2 mRNA	PMID:30851411
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of NETO2 mRNA	PMID:27862939
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NETO2 mRNA	PMID:29803840
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313265	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NETO2 mRNA	PMID:37992649
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NETO2 mRNA	PMID:38568856
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of NETO2 mRNA	PMID:36209798
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NETO2 mRNA	PMID:39836092
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NETO2 mRNA	PMID:22378314
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313264	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NETO2 promoter	PMID:27901495
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313264	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NETO2 mRNA	PMID:26238291
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1313265	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of NETO2 mRNA	PMID:27131904
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of NETO2 mRNA	PMID:38458666
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NETO2 mRNA	PMID:19150397|PMID:20382639
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313264	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NETO2 mRNA	PMID:26238291
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of NETO2 mRNA	PMID:25258189
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of NETO2 mRNA	PMID:25729387
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313265	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NETO2 promoter	PMID:35295148
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NETO2 mRNA	PMID:34492290
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313265	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of NETO2 mRNA	PMID:20813756
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NETO2 mRNA	PMID:25181051
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of NETO2 mRNA	PMID:32156529
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of NETO2 mRNA	PMID:29097150
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313264	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of NETO2 mRNA	PMID:25047013|PMID:31715268
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NETO2 mRNA	PMID:28628672
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313264	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of NETO2 mRNA	PMID:25979313
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of NETO2 mRNA	PMID:28392331
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NETO2 mRNA	PMID:28628672
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313264	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NETO2 mRNA	PMID:21527772
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NETO2 mRNA	PMID:22129741
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of NETO2 mRNA	PMID:32680482
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of NETO2 mRNA	PMID:38458666
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA	PMID:39836092
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NETO2 mRNA	PMID:25993096
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NETO2 mRNA	PMID:38568856
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of NETO2 promoter	PMID:22457795
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NETO2 mRNA	PMID:19320972
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NETO2 mRNA	PMID:24449571
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313265	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of NETO2 mRNA	PMID:28962523
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of NETO2 mRNA	PMID:40194260
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NETO2 mRNA	PMID:31533062
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313264	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NETO2 mRNA	PMID:19167446
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NETO2 mRNA	PMID:40419075
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313264	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NETO2 mRNA	PMID:25979313
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of NETO2 mRNA	PMID:23179753|PMID:23527032|PMID:27188386|PMID:28001369
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313264	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NETO2 gene	PMID:29154799
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1313264	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of NETO2 mRNA	PMID:21527772
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NETO2 mRNA	PMID:25562108
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NETO2 mRNA	PMID:28628672
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313265	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NETO2 mRNA	PMID:37992649
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NETO2 mRNA	PMID:33387578
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313264	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NETO2 mRNA	PMID:22230336
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313264	E	RGD:6480464	20120412	CTD	MESH:D005472	NETO2 protein affects the susceptibility to Fluorouracil	PMID:16217747
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NETO2 mRNA	PMID:39836092
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NETO2 mRNA	PMID:28628672
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of NETO2 mRNA	PMID:25258189
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of NETO2 mRNA	PMID:20977926
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of NETO2 mRNA	PMID:26272509|PMID:27188386
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NETO2 mRNA	PMID:27188386
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA	PMID:39836092
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NETO2 mRNA	PMID:25729387
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:6887	methylphenidate	increases expression	ISO	RGD:1313265	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in increased expression of NETO2 mRNA	PMID:22470460
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of NETO2 mRNA	PMID:31758290
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313265	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NETO2 mRNA	PMID:22206623
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NETO2 mRNA	PMID:22714537
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of NETO2 mRNA	PMID:29522793
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313264	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NETO2 mRNA	PMID:37199045
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:7719	ochratoxin A	increases acetylation	ISO	RGD:1313264	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in increased acetylation of NETO2 promoter	PMID:29098329
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NETO2 mRNA	PMID:30851411
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NETO2 mRNA	PMID:27188386
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NETO2 gene]	PMID:28238834
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of NETO2 mRNA	PMID:36843608
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313264	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NETO2 mRNA	PMID:27188386
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1313265	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of NETO2 mRNA	PMID:27131904
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313264	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NETO2 mRNA	PMID:22378314
1305310	Neto2	neuropilin and tolloid like 2	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313265	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of NETO2 mRNA	PMID:32835833
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1349054	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DRC11 mRNA	PMID:27188386
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DRC11 mRNA	PMID:27188386
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1349054	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of DRC11 mRNA	PMID:21934132
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DRC11 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of DRC11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DRC11 mRNA	PMID:32699268|PMID:32845096
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1349054	E	RGD:6480464	20230801	CTD	MESH:D013739	Testosterone results in decreased expression of DRC11 mRNA	PMID:21592394
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20230801	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of DRC11 mRNA	PMID:21592394
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DRC11 mRNA	PMID:34319233
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D003471	Cuprizone results in increased expression of DRC11 mRNA	PMID:26577399
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1349054	E	RGD:6480464	20230801	CTD	MESH:D002117	Calcitriol results in increased expression of DRC11 mRNA	PMID:21592394
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20230801	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of DRC11 mRNA	PMID:21592394
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1349054	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of DRC11 intron	PMID:30157460
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DRC11 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of DRC11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DRC11 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of DRC11 mRNA	PMID:32699268|PMID:32845096
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:28077	rifampicin	decreases expression	ISO	RGD:1349054	E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in decreased expression of DRC11 mRNA	PMID:24552687
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of DRC11 intron] which results in decreased expression of DRC11 mRNA	PMID:33017471
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1349054	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DRC11 mRNA	PMID:23179753|PMID:28001369
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:D004317	Doxorubicin results in increased expression of DRC11 mRNA	PMID:28608983
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1349054	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DRC11 mRNA	PMID:22714537
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1349054	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DRC11 3' UTR	PMID:27901495
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DRC11 intron	PMID:27901495
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in decreased expression of DRC11 mRNA	PMID:23557971
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:C006253	pirinixic acid results in increased expression of DRC11 mRNA	PMID:20813756
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of DRC11 mRNA	PMID:20813756
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in decreased expression of DRC11 mRNA	PMID:25181051|PMID:41034487
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1349054	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of DRC11 mRNA	PMID:27685785
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in increased expression of DRC11 mRNA	PMID:30951980
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1349054	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S affects the methylation of DRC11 gene	PMID:31601247
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:C543008	bisphenol S results in increased expression of DRC11 mRNA	PMID:30951980
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1349054	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of DRC11 intron	PMID:30157460
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1349054	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of DRC11 promoter	PMID:30157460
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:C008745	bisphenol F results in increased expression of DRC11 mRNA	PMID:30951980
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DRC11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DRC11 mRNA	PMID:32699268
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1349054	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DRC11 mRNA	PMID:31533062
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1349054	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DRC11 mRNA	PMID:25979313
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1349054	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of DRC11 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1349054	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DRC11 gene	PMID:29154799
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DRC11 mRNA	PMID:27188386
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:D017313	Fenretinide results in increased expression of DRC11 mRNA	PMID:28973697
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1349054	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of DRC11 mRNA	PMID:24935251
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1349054	E	RGD:6480464	20230801	CTD	MESH:D018021	Lithium Chloride results in increased expression of DRC11 mRNA	PMID:23527032
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C017690	fenvalerate results in increased expression of DRC11 mRNA	PMID:30307764
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DRC11 mRNA; Nanotubes, Carbon results in decreased expression of DRC11 mRNA	PMID:25554681
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1553411	E	RGD:6480464	20260707	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of DRC11 mRNA	PMID:23608068
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1349054	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DRC11 mRNA	PMID:24810058
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1349054	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of DRC11 intron	PMID:30157460
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1349054	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of DRC11 promoter	PMID:30157460
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DRC11 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DRC11 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DRC11 mRNA	PMID:27188386
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20230801	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DRC11 gene]	PMID:28238834
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1349054	E	RGD:6480464	20161228	CTD	MESH:C496932	Panobinostat results in increased expression of DRC11 mRNA	PMID:26272509
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DRC11 mRNA	PMID:27188386
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1349054	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DRC11 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DRC11 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DRC11 mRNA	PMID:27188386
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20260707	CTD	MESH:C025643	vinclozolin results in decreased methylation of DRC11 gene	PMID:31079544
1305311	Drc11	dynein regulatory complex subunit 11	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20260707	CTD	MESH:C025643	vinclozolin results in increased methylation of DRC11 gene	PMID:31079544
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313269	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CNOT7 mRNA	PMID:20188158
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313269	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CNOT7 gene	PMID:20938992
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20130611	CTD	MESH:D004958	Estradiol results in decreased expression of CNOT7 mRNA	PMID:21453500
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313268	E	RGD:6480464	20130611	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of CNOT7 mRNA	PMID:21453500
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313269	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CNOT7 gene	PMID:20938992
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CNOT7 mRNA	PMID:23649840
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313268	E	RGD:6480464	20130611	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of CNOT7 mRNA	PMID:21453500
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313268	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CNOT7 mRNA	PMID:21179406
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CNOT7 mRNA	PMID:22061828
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNOT7 mRNA	PMID:39012411
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CNOT7 mRNA	PMID:23649840
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313269	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CNOT7 mRNA	PMID:19770486
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CNOT7 mRNA	PMID:23649840
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313268	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of CNOT7 mRNA	PMID:19774075
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313269	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CNOT7 gene	PMID:20938992
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313268	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNOT7 mRNA	PMID:39836092
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CNOT7 mRNA	PMID:26302742
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CNOT7 mRNA	PMID:25905778
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313268	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of CNOT7 mRNA	PMID:24768652
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313269	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNOT7 mRNA	PMID:21570461|PMID:24680724
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CNOT7 mRNA	PMID:33387578
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313268	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of CNOT7 mRNA	PMID:18191903
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CNOT7 mRNA	PMID:28001369
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CNOT7 mRNA	PMID:33212167
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CNOT7 mRNA	PMID:25523186
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313268	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNOT7 mRNA	PMID:39836092
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CNOT7 mRNA	PMID:25523186
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CNOT7 mRNA	PMID:19150397
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:30778	gallic acid	increases expression	ISO	RGD:1313268	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of CNOT7 mRNA	PMID:34408198
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313268	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CNOT7 gene	PMID:31601247
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313269	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CNOT7 gene; titanium dioxide results in decreased methylation of CNOT7 promoter alternative form	PMID:35295148
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CNOT7 mRNA	PMID:25181051
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CNOT7 mRNA	PMID:30816183|PMID:34947998|PMID:41034487
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313269	E	RGD:6480464	20150127	CTD	MESH:C006780	bisphenol A results in increased expression of CNOT7 mRNA	PMID:25270620
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313268	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CNOT7 gene	PMID:31601247
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313269	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CNOT7 mRNA	PMID:39298647
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313269	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CNOT7 mRNA	PMID:38685157
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1313269	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of CNOT7 mRNA	PMID:25270620
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313269	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CNOT7 mRNA	PMID:34813904
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313268	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNOT7 mRNA	PMID:37042841
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNOT7 mRNA	PMID:39012411
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CNOT7 gene	PMID:22079235
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CNOT7 mRNA	PMID:28302478
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313268	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CNOT7 mRNA	PMID:31533062
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313268	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CNOT7 mRNA	PMID:25979313
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CNOT7 mRNA	PMID:23179753
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313269	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CNOT7 mRNA	PMID:18502557
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313268	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CNOT7 mRNA	PMID:27188386
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313268	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CNOT7 mRNA	PMID:24935251
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CNOT7 mRNA	PMID:21420995
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313269	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CNOT7 mRNA	PMID:29279043
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313268	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNOT7 mRNA	PMID:39836092
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313268	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CNOT7 protein	PMID:32959892
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313268	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CNOT7 mRNA	PMID:26378955
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313269	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CNOT7 mRNA	PMID:25270620
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313269	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CNOT7 protein	PMID:36851058
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313269	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CNOT7 mRNA	PMID:22206623
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313268	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CNOT7 gene]	PMID:28238834
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of CNOT7 mRNA	PMID:20345932
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1313269	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in increased expression of CNOT7 protein	PMID:26903627
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313268	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of CNOT7 mRNA	PMID:27188386
1305313	Cnot7	CCR4-NOT transcription complex, subunit 7	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CNOT7 mRNA	PMID:23034163
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:132098	methoxyacetic acid	affects expression	ISO	RGD:1550714	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid affects the expression of ZFP518A mRNA	PMID:20421339
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZNF518A mRNA	PMID:19074003
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:136004	linsidomine	increases oxidation	EXP		E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of ZFP518A protein	PMID:28086193
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1550714	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin affects the expression of ZFP518A mRNA	PMID:20421339
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ZNF518A mRNA	PMID:21632981
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of ZNF518A mRNA	PMID:33647349
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550714	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ZFP518A mRNA	PMID:33754040
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550714	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ZFP518A mRNA	PMID:34319233
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1348764	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ZNF518A protein	PMID:37730182
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1348764	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZNF518A mRNA	PMID:19549813
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550714	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZFP518A mRNA	PMID:40504410
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ZNF518A mRNA	PMID:26272509
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF518A mRNA	PMID:27188386
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1348764	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZNF518A protein	PMID:35688186
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ZNF518A mRNA	PMID:27392435
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP518A mRNA	PMID:32109520
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550714	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of ZFP518A intron] which results in increased expression of ZFP518A mRNA	PMID:33017471
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZNF518A mRNA	PMID:28001369
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZNF518A mRNA	PMID:33212167
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550714	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZFP518A mRNA	PMID:40504410
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348764	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF518A 3' UTR	PMID:27901495
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1348764	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZNF518A promoter	PMID:27901495
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ZNF518A mRNA	PMID:34973136
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1348764	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ZNF518A mRNA	PMID:25895662
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:30563	silicon dioxide	increases methylation	ISO	RGD:1348764	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased methylation of ZNF518A gene	PMID:34973136
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1550714	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZFP518A mRNA	PMID:35676786
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZNF518A mRNA	PMID:34973136
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550714	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP518A gene	PMID:35295148
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ZFP518A mRNA; Thioacetamide results in increased expression of ZNF518A mRNA	PMID:23411599|PMID:34492290
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of ZNF518A mRNA	PMID:30690063
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF518A mRNA	PMID:25181051
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550714	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP518A mRNA	PMID:33221593
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550714	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZFP518A mRNA	PMID:39298647
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1348764	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ZNF518A gene	PMID:31601247
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550714	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ZFP518A mRNA	PMID:38685157
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF518A mRNA	PMID:28628672
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550714	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP518A mRNA	PMID:37019170
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF518A mRNA	PMID:28628672
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348764	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF518A mRNA	PMID:37042841
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF518A mRNA	PMID:38382870
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1550714	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZFP518A mRNA	PMID:24982889
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ZFP518A gene	PMID:22079235
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZNF518A mRNA	PMID:28302478
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ZNF518A mRNA	PMID:31533062
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ZNF518A mRNA	PMID:23125180
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550714	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ZFP518A mRNA	PMID:20421339
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF518A mRNA	PMID:23179753|PMID:25192806|PMID:27188386
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of ZFP518A mRNA	PMID:38685447|PMID:41580965
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF518A mRNA	PMID:28628672
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of ZNF518A mRNA	PMID:18769122|PMID:27188386
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZFP518A mRNA	PMID:33387578
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZNF518A mRNA	PMID:29067470
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1550714	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of ZFP518A mRNA	PMID:20421339
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550714	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZFP518A mRNA	PMID:40504410
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ZFP518A mRNA	PMID:29391264
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20171010	CTD	MESH:D004726	Endosulfan results in decreased expression of ZNF518A mRNA	PMID:28108160|PMID:40706910
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ZNF518A mRNA	PMID:22079256
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF518A mRNA	PMID:28628672
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1550714	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZFP518A mRNA	PMID:35676786
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of ZFP518A mRNA	PMID:41580965
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1348764	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of ZNF518A mRNA	PMID:26705709
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ZNF518A mRNA	PMID:22714537
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1550714	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ZFP518A mRNA	PMID:23608068
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF518A mRNA	PMID:26378955
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:6443	levonorgestrel	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZNF518A mRNA	PMID:19074003
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550714	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP518A mRNA	PMID:22206623
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ZNF518A mRNA	PMID:22079256|PMID:22714537
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ZNF518A mRNA	PMID:22079256
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1348764	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ZNF518A protein	PMID:31285264
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:7719	ochratoxin A	decreases acetylation	ISO	RGD:1348764	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of ZNF518A promoter	PMID:29098329
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of ZNF518A mRNA	PMID:29098329
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of ZNF518A promoter] which results in decreased expression of ZNF518A mRNA	PMID:29098329
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF518A mRNA	PMID:27188386
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ZNF518A mRNA	PMID:30928695
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550714	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ZFP518A mRNA	PMID:23091169
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:80799	Bufotalin	increases expression	ISO	RGD:1348764	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of ZNF518A mRNA	PMID:39904859
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1550714	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of ZFP518A mRNA	PMID:40826991
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1550714	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate affects the expression of ZFP518A mRNA	PMID:20421339
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1348764	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF518A mRNA	PMID:27188386
1305314	Zfp518a	zinc finger protein 518A	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1348764	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZNF518A mRNA	PMID:29301935
1305315	Rnf115	ring finger protein 115	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313272	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RNF115 mRNA	PMID:33045310
1305315	Rnf115	ring finger protein 115	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1313271	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin affects the expression of RNF115 mRNA	PMID:15498508
1305315	Rnf115	ring finger protein 115	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313271	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of RNF115 mRNA	PMID:22378314
1305315	Rnf115	ring finger protein 115	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313271	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of RNF115 mRNA	PMID:22574217
1305315	Rnf115	ring finger protein 115	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313271	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RNF115 mRNA	PMID:37042841
1305315	Rnf115	ring finger protein 115	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313271	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RNF115 mRNA	PMID:33359661
1305315	Rnf115	ring finger protein 115	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313272	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RNF115 mRNA	PMID:23892564
1305315	Rnf115	ring finger protein 115	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RNF115 mRNA	PMID:33387578
1305315	Rnf115	ring finger protein 115	gene	CHEBI:18112	2-aminophenol	affects response to substance	ISO	RGD:1313271	E	RGD:6480464	20150609	CTD	MESH:C027667	RNF115 gene SNP affects the susceptibility to 2-aminophenol	PMID:25622337
1305315	Rnf115	ring finger protein 115	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313272	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RNF115 mRNA	PMID:37325564
1305315	Rnf115	ring finger protein 115	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313271	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RNF115 mRNA	PMID:19549813
1305315	Rnf115	ring finger protein 115	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313272	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of RNF115 mRNA	PMID:19376150
1305315	Rnf115	ring finger protein 115	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313271	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RNF115 mRNA	PMID:27153756
1305315	Rnf115	ring finger protein 115	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313271	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RNF115 mRNA	PMID:23649840
1305315	Rnf115	ring finger protein 115	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of RNF115 mRNA	PMID:31129395
1305315	Rnf115	ring finger protein 115	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313272	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF115 mRNA	PMID:22206623
1305315	Rnf115	ring finger protein 115	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RNF115 mRNA	PMID:31881176
1305315	Rnf115	ring finger protein 115	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313272	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF115 mRNA	PMID:21570461
1305315	Rnf115	ring finger protein 115	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313271	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNF115 mRNA	PMID:33212167
1305315	Rnf115	ring finger protein 115	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313272	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RNF115 mRNA	PMID:27862939
1305315	Rnf115	ring finger protein 115	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313271	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF115 mRNA	PMID:29803840
1305315	Rnf115	ring finger protein 115	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313271	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RNF115 mRNA	PMID:29432896
1305315	Rnf115	ring finger protein 115	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313271	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF115 mRNA	PMID:38568856|PMID:39719251
1305315	Rnf115	ring finger protein 115	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313271	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RNF115 mRNA	PMID:19150397
1305315	Rnf115	ring finger protein 115	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313272	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in increased expression of RNF115 mRNA	PMID:25270620
1305315	Rnf115	ring finger protein 115	gene	CHEBI:32181	tamibarotene	affects expression	ISO	RGD:1313271	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of RNF115 mRNA	PMID:15498508
1305315	Rnf115	ring finger protein 115	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1313271	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of RNF115 mRNA	PMID:30690063
1305315	Rnf115	ring finger protein 115	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RNF115 mRNA	PMID:25181051
1305315	Rnf115	ring finger protein 115	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of RNF115 mRNA	PMID:31129395
1305315	Rnf115	ring finger protein 115	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313271	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF115 mRNA	PMID:28628672
1305315	Rnf115	ring finger protein 115	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313272	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RNF115 mRNA	PMID:37019170
1305315	Rnf115	ring finger protein 115	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313271	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF115 mRNA	PMID:28628672
1305315	Rnf115	ring finger protein 115	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313272	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RNF115 mRNA	PMID:37325564
1305315	Rnf115	ring finger protein 115	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313271	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of RNF115 mRNA	PMID:19376846
1305315	Rnf115	ring finger protein 115	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313271	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RNF115 mRNA	PMID:31533062
1305315	Rnf115	ring finger protein 115	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313271	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RNF115 mRNA	PMID:25979313
1305315	Rnf115	ring finger protein 115	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313271	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RNF115 mRNA	PMID:23179753
1305315	Rnf115	ring finger protein 115	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313271	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF115 mRNA	PMID:25562108
1305315	Rnf115	ring finger protein 115	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313271	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF115 mRNA	PMID:28628672
1305315	Rnf115	ring finger protein 115	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313271	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RNF115 mRNA	PMID:36621641
1305315	Rnf115	ring finger protein 115	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1313271	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of RNF115 mRNA	PMID:36621641
1305315	Rnf115	ring finger protein 115	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313271	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RNF115 mRNA	PMID:22079256
1305315	Rnf115	ring finger protein 115	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313271	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF115 mRNA	PMID:28628672
1305315	Rnf115	ring finger protein 115	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RNF115 mRNA	PMID:24136188
1305315	Rnf115	ring finger protein 115	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313272	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RNF115 mRNA	PMID:23650126
1305315	Rnf115	ring finger protein 115	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313271	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RNF115 mRNA	PMID:31758290
1305315	Rnf115	ring finger protein 115	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313272	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF115 mRNA	PMID:22206623
1305315	Rnf115	ring finger protein 115	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RNF115 mRNA	PMID:24136188
1305315	Rnf115	ring finger protein 115	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313271	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RNF115 mRNA	PMID:22079256|PMID:22714537
1305315	Rnf115	ring finger protein 115	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313271	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RNF115 mRNA	PMID:22079256
1305315	Rnf115	ring finger protein 115	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1313271	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of RNF115 mRNA	PMID:19946333
1305315	Rnf115	ring finger protein 115	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of RNF115 mRNA	PMID:20345932
1305315	Rnf115	ring finger protein 115	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313272	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of RNF115 mRNA	PMID:31388691
1305315	Rnf115	ring finger protein 115	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313272	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of RNF115 mRNA	PMID:21278054
1305316	Btd	biotinidase	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of BTD mRNA	PMID:38218311
1305316	Btd	biotinidase	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313274	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of BTD mRNA	PMID:37995155
1305316	Btd	biotinidase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BTD mRNA]	PMID:31150632
1305316	Btd	biotinidase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313274	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of BTD mRNA	PMID:20188158
1305316	Btd	biotinidase	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of BTD mRNA	PMID:26079696
1305316	Btd	biotinidase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of BTD mRNA	PMID:39241906
1305316	Btd	biotinidase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313274	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of BTD mRNA	PMID:39298647
1305316	Btd	biotinidase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313273	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BTD mRNA	PMID:37042841
1305316	Btd	biotinidase	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of BTD mRNA	PMID:19693291
1305316	Btd	biotinidase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of BTD mRNA	PMID:19693291
1305316	Btd	biotinidase	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of BTD mRNA	PMID:33387578
1305316	Btd	biotinidase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313274	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BTD mRNA	PMID:36331819
1305316	Btd	biotinidase	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of BTD mRNA	PMID:21515302
1305316	Btd	biotinidase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of BTD mRNA	PMID:19549813
1305316	Btd	biotinidase	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313273	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of BTD protein	PMID:20106945
1305316	Btd	biotinidase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of BTD mRNA	PMID:19770486
1305316	Btd	biotinidase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of BTD mRNA	PMID:35430440
1305316	Btd	biotinidase	gene	CHEBI:27385	tetrachloromethane	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased activity of BTD protein	PMID:12867299
1305316	Btd	biotinidase	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of BTD mRNA	PMID:31150632
1305316	Btd	biotinidase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BTD mRNA]	PMID:31150632
1305316	Btd	biotinidase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313274	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BTD mRNA	PMID:22206623
1305316	Btd	biotinidase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BTD mRNA	PMID:39836092
1305316	Btd	biotinidase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313274	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of BTD mRNA	PMID:28189721|PMID:28960355
1305316	Btd	biotinidase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313273	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of BTD mRNA	PMID:27392435
1305316	Btd	biotinidase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of BTD mRNA	PMID:27392435
1305316	Btd	biotinidase	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of BTD mRNA	PMID:24768652|PMID:25583101
1305316	Btd	biotinidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313274	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BTD mRNA	PMID:21570461
1305316	Btd	biotinidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BTD mRNA	PMID:34747641
1305316	Btd	biotinidase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of BTD mRNA	PMID:32763439
1305316	Btd	biotinidase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BTD mRNA	PMID:29803840
1305316	Btd	biotinidase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of BTD mRNA	PMID:38568856
1305316	Btd	biotinidase	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1313274	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased methylation of BTD gene	PMID:24118411
1305316	Btd	biotinidase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BTD mRNA	PMID:39836092
1305316	Btd	biotinidase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BTD mRNA	PMID:32234424
1305316	Btd	biotinidase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313273	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BTD 3' UTR	PMID:27901495
1305316	Btd	biotinidase	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of BTD mRNA	PMID:30047161
1305316	Btd	biotinidase	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of BTD mRNA	PMID:21515302
1305316	Btd	biotinidase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313274	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BTD promoter alternative form	PMID:35295148
1305316	Btd	biotinidase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of BTD mRNA	PMID:23411599|PMID:34492290
1305316	Btd	biotinidase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313274	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of BTD mRNA	PMID:28472532
1305316	Btd	biotinidase	gene	CHEBI:33007	chromium(6+)	affects localization	ISO	RGD:1313273	E	RGD:6480464	20150310	CTD	MESH:C074702	chromium hexavalent ion affects the localization of BTD protein	PMID:24858232
1305316	Btd	biotinidase	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20120918	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of BTD mRNA; chromium hexavalent ion results in decreased expression of BTD protein	PMID:21641978
1305316	Btd	biotinidase	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20120918	CTD	MESH:C074702	trichostatin A inhibits the reaction [chromium hexavalent ion results in decreased expression of BTD protein]	PMID:21641978
1305316	Btd	biotinidase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of BTD mRNA	PMID:25181051
1305316	Btd	biotinidase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of BTD mRNA	PMID:30816183|PMID:32528016
1305316	Btd	biotinidase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:36041667
1305316	Btd	biotinidase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BTD mRNA	PMID:28628672
1305316	Btd	biotinidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313274	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of BTD mRNA	PMID:39298647
1305316	Btd	biotinidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:36041667
1305316	Btd	biotinidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:28628672
1305316	Btd	biotinidase	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:36041667
1305316	Btd	biotinidase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313274	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of BTD intron	PMID:28392331
1305316	Btd	biotinidase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of BTD mRNA	PMID:37019170
1305316	Btd	biotinidase	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313274	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of BTD mRNA	PMID:34813904
1305316	Btd	biotinidase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BTD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:28628672
1305316	Btd	biotinidase	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of BTD mRNA	PMID:22110744
1305316	Btd	biotinidase	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313274	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of BTD protein	PMID:39748354
1305316	Btd	biotinidase	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of BTD gene	PMID:22079235
1305316	Btd	biotinidase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of BTD mRNA	PMID:24386269
1305316	Btd	biotinidase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of BTD mRNA	PMID:17585979
1305316	Btd	biotinidase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313273	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of BTD mRNA	PMID:40419075
1305316	Btd	biotinidase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313274	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BTD mRNA	PMID:36331819
1305316	Btd	biotinidase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313273	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BTD mRNA	PMID:25979313
1305316	Btd	biotinidase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of BTD mRNA	PMID:23179753
1305316	Btd	biotinidase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of BTD mRNA	PMID:30047161
1305316	Btd	biotinidase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of BTD mRNA	PMID:20106945|PMID:25562108
1305316	Btd	biotinidase	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313273	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of BTD promoter	PMID:27989131
1305316	Btd	biotinidase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BTD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:28628672
1305316	Btd	biotinidase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of BTD mRNA	PMID:28973697
1305316	Btd	biotinidase	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313273	E	RGD:6480464	20120918	CTD	MESH:C012589	trichostatin A results in increased expression of BTD protein	PMID:21641978
1305316	Btd	biotinidase	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20120918	CTD	MESH:C012589	trichostatin A inhibits the reaction [chromium hexavalent ion results in decreased expression of BTD protein]	PMID:21641978
1305316	Btd	biotinidase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of BTD mRNA	PMID:29067470
1305316	Btd	biotinidase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of BTD mRNA	PMID:33387578
1305316	Btd	biotinidase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BTD mRNA	PMID:39836092
1305316	Btd	biotinidase	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313273	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BTD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:28628672
1305316	Btd	biotinidase	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of BTD mRNA	PMID:30047161
1305316	Btd	biotinidase	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of BTD mRNA	PMID:19162173
1305316	Btd	biotinidase	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of BTD mRNA	PMID:24793618
1305316	Btd	biotinidase	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of BTD mRNA	PMID:20436886
1305316	Btd	biotinidase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of BTD mRNA	PMID:15336504
1305316	Btd	biotinidase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of BTD mRNA	PMID:28801915
1305316	Btd	biotinidase	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313273	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of BTD mRNA	PMID:27918106
1305316	Btd	biotinidase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of BTD mRNA	PMID:22206623
1305316	Btd	biotinidase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313274	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BTD mRNA	PMID:22206623
1305316	Btd	biotinidase	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of BTD mRNA	PMID:30047161
1305316	Btd	biotinidase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases methylation	EXP		E	RGD:6480464	20260407	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased methylation of BTD gene	PMID:40889571
1305316	Btd	biotinidase	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of BTD mRNA	PMID:23914054
1305316	Btd	biotinidase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of BTD mRNA	PMID:30047161
1305316	Btd	biotinidase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of BTD mRNA	PMID:21346803
1305316	Btd	biotinidase	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1313273	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of BTD mRNA	PMID:17440010
1305316	Btd	biotinidase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313273	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of BTD mRNA	PMID:38568856
1305316	Btd	biotinidase	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of BTD mRNA	PMID:30047161
1305317	Cntrl	centriolin	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of CNTRL mRNA	PMID:35967413
1305317	Cntrl	centriolin	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CNTRL mRNA	PMID:27188386
1305317	Cntrl	centriolin	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CNTRL mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CNTRL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CNTRL mRNA	PMID:32699268|PMID:32845096
1305317	Cntrl	centriolin	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20160210	CTD	MESH:C018475	butyraldehyde results in decreased expression of CNTRL mRNA	PMID:26079696
1305317	Cntrl	centriolin	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CNTRL gene	PMID:28931070
1305317	Cntrl	centriolin	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20140715	CTD	MESH:D011794	Quercetin results in decreased expression of CNTRL mRNA	PMID:21632981
1305317	Cntrl	centriolin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CNTRL mRNA	PMID:39241906
1305317	Cntrl	centriolin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CNTRL mRNA	PMID:39298647
1305317	Cntrl	centriolin	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA	PMID:25510870
1305317	Cntrl	centriolin	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313275	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CNTRL mRNA	PMID:38568856
1305317	Cntrl	centriolin	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CNTRL mRNA	PMID:33387578
1305317	Cntrl	centriolin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313275	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CNTRL mRNA	PMID:37042841
1305317	Cntrl	centriolin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CNTRL mRNA	PMID:22401849
1305317	Cntrl	centriolin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557555	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CNTRL mRNA	PMID:34319233
1305317	Cntrl	centriolin	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CNTRL mRNA	PMID:26577399
1305317	Cntrl	centriolin	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CNTRL mRNA	PMID:36331819
1305317	Cntrl	centriolin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CNTRL mRNA	PMID:35301059
1305317	Cntrl	centriolin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNTRL mRNA	PMID:37236586
1305317	Cntrl	centriolin	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA	PMID:25510870
1305317	Cntrl	centriolin	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA	PMID:25510870
1305317	Cntrl	centriolin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313275	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CNTRL mRNA	PMID:23649840
1305317	Cntrl	centriolin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CNTRL mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CNTRL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CNTRL mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of CNTRL mRNA	PMID:32699268|PMID:32845096
1305317	Cntrl	centriolin	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CNTRL mRNA	PMID:26272509
1305317	Cntrl	centriolin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA	PMID:27188386
1305317	Cntrl	centriolin	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CNTRL mRNA	PMID:23557933
1305317	Cntrl	centriolin	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313275	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CNTRL mRNA	PMID:28903495
1305317	Cntrl	centriolin	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CNTRL mRNA	PMID:27392435
1305317	Cntrl	centriolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNTRL mRNA	PMID:34747641
1305317	Cntrl	centriolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CNTRL mRNA	PMID:33387578
1305317	Cntrl	centriolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CNTRL mRNA	PMID:19933214
1305317	Cntrl	centriolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CNTRL mRNA	PMID:25975270
1305317	Cntrl	centriolin	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1313275	E	RGD:6480464	20140715	CTD	MESH:D003561	Cytarabine results in increased expression of CNTRL mRNA	PMID:21198554
1305317	Cntrl	centriolin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:D004317	Doxorubicin results in increased expression of CNTRL mRNA	PMID:25896364
1305317	Cntrl	centriolin	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CNTRL mRNA	PMID:27131904
1305317	Cntrl	centriolin	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CNTRL mRNA	PMID:30047161
1305317	Cntrl	centriolin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1557555	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of CNTRL mRNA	PMID:29264374
1305317	Cntrl	centriolin	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CNTRL mRNA	PMID:34492290
1305317	Cntrl	centriolin	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:C006253	pirinixic acid results in decreased expression of CNTRL mRNA	PMID:23811191
1305317	Cntrl	centriolin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:C006253	pirinixic acid results in increased expression of CNTRL mRNA	PMID:18301758
1305317	Cntrl	centriolin	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of CNTRL mRNA	PMID:30816183
1305317	Cntrl	centriolin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased expression of CNTRL mRNA	PMID:29097150
1305317	Cntrl	centriolin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CNTRL protein	PMID:33376534
1305317	Cntrl	centriolin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CNTRL mRNA	PMID:32156529|PMID:33221593
1305317	Cntrl	centriolin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of CNTRL mRNA	PMID:32145629|PMID:32528016
1305317	Cntrl	centriolin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1557555	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CNTRL mRNA	PMID:26063408
1305317	Cntrl	centriolin	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA	PMID:25510870
1305317	Cntrl	centriolin	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA	PMID:25510870
1305317	Cntrl	centriolin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CNTRL mRNA	PMID:40203079
1305317	Cntrl	centriolin	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of CNTRL mRNA	PMID:26377693
1305317	Cntrl	centriolin	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1557555	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CNTRL mRNA	PMID:28392331
1305317	Cntrl	centriolin	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CNTRL mRNA	PMID:37019170
1305317	Cntrl	centriolin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CNTRL mRNA	PMID:17361019
1305317	Cntrl	centriolin	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313275	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNTRL mRNA	PMID:37042841
1305317	Cntrl	centriolin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CNTRL mRNA	PMID:35301059
1305317	Cntrl	centriolin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNTRL mRNA	PMID:37236586
1305317	Cntrl	centriolin	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CNTRL mRNA	PMID:24386269
1305317	Cntrl	centriolin	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of CNTRL mRNA	PMID:25908611
1305317	Cntrl	centriolin	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D002922	Ciguatoxins affects the expression of CNTRL mRNA	PMID:18353800
1305317	Cntrl	centriolin	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CNTRL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CNTRL mRNA	PMID:32699268
1305317	Cntrl	centriolin	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D002994	Clofibrate results in increased expression of CNTRL mRNA	PMID:17585979|PMID:23811191
1305317	Cntrl	centriolin	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CNTRL mRNA	PMID:31533062
1305317	Cntrl	centriolin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CNTRL mRNA	PMID:27153767
1305317	Cntrl	centriolin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CNTRL mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CNTRL mRNA	PMID:36331819
1305317	Cntrl	centriolin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313275	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CNTRL mRNA	PMID:25979313
1305317	Cntrl	centriolin	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CNTRL mRNA	PMID:23179753|PMID:24935251|PMID:27188386|PMID:28001369
1305317	Cntrl	centriolin	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CNTRL mRNA	PMID:30047161
1305317	Cntrl	centriolin	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313275	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CNTRL mRNA	PMID:25562108
1305317	Cntrl	centriolin	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CNTRL mRNA	PMID:26272509
1305317	Cntrl	centriolin	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA	PMID:27188386
1305317	Cntrl	centriolin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D000082	Acetaminophen affects the expression of CNTRL mRNA	PMID:17562736
1305317	Cntrl	centriolin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CNTRL mRNA	PMID:33387578
1305317	Cntrl	centriolin	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CNTRL mRNA	PMID:29391264
1305317	Cntrl	centriolin	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1313275	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of CNTRL protein	PMID:31195006
1305317	Cntrl	centriolin	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of CNTRL mRNA	PMID:29097150
1305317	Cntrl	centriolin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of CNTRL mRNA	PMID:19363521
1305317	Cntrl	centriolin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20191114	CTD	MESH:C014347	TP53 protein affects the reaction [Decitabine results in decreased expression of CNTRL mRNA]	PMID:19363521
1305317	Cntrl	centriolin	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1557555	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of CNTRL mRNA	PMID:25620056
1305317	Cntrl	centriolin	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CNTRL mRNA	PMID:30047161
1305317	Cntrl	centriolin	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CNTRL mRNA	PMID:35964746
1305317	Cntrl	centriolin	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:C030935	benz(a)anthracene results in increased expression of CNTRL mRNA	PMID:26377693
1305317	Cntrl	centriolin	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CNTRL mRNA	PMID:23608068
1305317	Cntrl	centriolin	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CNTRL mRNA	PMID:22206623
1305317	Cntrl	centriolin	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA	PMID:27188386
1305317	Cntrl	centriolin	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CNTRL gene]	PMID:28238834
1305317	Cntrl	centriolin	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1313275	E	RGD:6480464	20160210	CTD	MESH:C046012	pentanal results in decreased expression of CNTRL mRNA	PMID:26079696
1305317	Cntrl	centriolin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CNTRL mRNA	PMID:30047161
1305317	Cntrl	centriolin	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of CNTRL protein	PMID:35357534
1305317	Cntrl	centriolin	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313275	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA	PMID:27188386
1305317	Cntrl	centriolin	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CNTRL mRNA	PMID:27131904
1305317	Cntrl	centriolin	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313275	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CNTRL mRNA	PMID:38568856
1305317	Cntrl	centriolin	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CNTRL mRNA	PMID:35537566
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of TTLL12 mRNA	PMID:23724009|PMID:33167477
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313277	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TTLL12 mRNA	PMID:30319688
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:16348	3-nitropropanoic acid	decreases expression	ISO	RGD:1313277	E	RGD:6480464	20250603	CTD	MESH:C015392	3-nitropropionic acid results in decreased expression of TTLL12 mRNA	PMID:39832703
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313277	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TTLL12 mRNA	PMID:39241906
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1604381	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of TTLL12 mRNA	PMID:23019147
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604381	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TTLL12 mRNA	PMID:37042841
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TTLL12 mRNA	PMID:23649840
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of TTLL12 mRNA	PMID:18037150
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313277	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TTLL12 mRNA	PMID:34319233
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TTLL12 mRNA	PMID:28818685
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313277	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TTLL12 mRNA	PMID:36331819
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TTLL12 mRNA	PMID:39836092
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313277	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of TTLL12 mRNA	PMID:27462272
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TTLL12 protein	PMID:23301498
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TTLL12 mRNA	PMID:23649840
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TTLL12 mRNA	PMID:23649840
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of TTLL12 mRNA	PMID:28623178
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313277	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TTLL12 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TTLL12 mRNA	PMID:34911549
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of TTLL12 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of TTLL12 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of TTLL12 protein	PMID:38598786
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313277	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TTLL12 mRNA	PMID:22206623
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604381	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TTLL12 gene	PMID:25304211
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TTLL12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTLL12 mRNA	PMID:39836092
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313277	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of TTLL12 protein	PMID:37208198
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of TTLL12 mRNA	PMID:19921347
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1604381	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of TTLL12 mRNA	PMID:23019147
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1604381	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTLL12 mRNA	PMID:22298810
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1313277	E	RGD:6480464	20120613	CTD	MESH:D012402	Rotenone affects the expression of TTLL12 mRNA	PMID:21893155
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of TTLL12 protein	PMID:39603559
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1313277	E	RGD:6480464	20120613	CTD	MESH:D012402	TRP53 affects the reaction [Rotenone affects the expression of TTLL12 mRNA]	PMID:21893155
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604381	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TTLL12 protein	PMID:33212167
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TTLL12 mRNA	PMID:20971185
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TTLL12 mRNA	PMID:29432896
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTLL12 mRNA	PMID:38568856
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604381	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TTLL12 mRNA	PMID:34032870|PMID:39719251
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20220405	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TTLL12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTLL12 mRNA; sodium arsenite promotes the reaction [TTLL12 protein binds to CAPRIN1 protein]	PMID:33939924|PMID:39836092
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of TTLL12 mRNA	PMID:22378314
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313277	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTLL12 mRNA	PMID:22228805
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313277	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to TTLL12 promoter]	PMID:19654925
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TTLL12 mRNA	PMID:20971185
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1604381	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TTLL12 mRNA	PMID:25895662
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TTLL12 mRNA	PMID:24136188
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TTLL12 mRNA	PMID:34492290
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of TTLL12 mRNA	PMID:38479592
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TTLL12 mRNA	PMID:25181051
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of TTLL12 protein	PMID:37567409
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313277	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of TTLL12 mRNA	PMID:21932408|PMID:32156529
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604381	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of TTLL12 protein	PMID:34186270
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of TTLL12 protein	PMID:31675489
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1604381	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of TTLL12 protein	PMID:34186270
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313277	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of TTLL12 mRNA	PMID:28392331
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1604381	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TTLL12 gene	PMID:22964155
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TTLL12 mRNA	PMID:21266533
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313277	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TTLL12 mRNA	PMID:34813904
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of TTLL12 protein	PMID:38598786
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313277	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TTLL12 mRNA	PMID:34813904
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TTLL12 mRNA	PMID:35163327
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TTLL12 mRNA	PMID:39836092
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TTLL12 mRNA	PMID:38568856
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1604381	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TTLL12 protein	PMID:24527689
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TTLL12 mRNA	PMID:35163327
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TTLL12 mRNA	PMID:19320972|PMID:19376846
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1604381	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TTLL12 mRNA	PMID:24449571
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313277	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TTLL12 mRNA	PMID:40194260
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1604381	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TTLL12 mRNA	PMID:28302478
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313277	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TTLL12 mRNA	PMID:36331819
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313277	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TTLL12 mRNA	PMID:17292431
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604381	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TTLL12 mRNA	PMID:25979313
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604381	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TTLL12 mRNA	PMID:23179753
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604381	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TTLL12 gene	PMID:29154799
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1604381	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TTLL12 mRNA	PMID:38832940
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313277	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TTLL12 mRNA	PMID:17562736
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of TTLL12 mRNA	PMID:22230336
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313277	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of TTLL12 mRNA	PMID:29246445
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313277	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of TTLL12 mRNA]	PMID:29246445
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604381	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TTLL12 gene	PMID:25304211
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TTLL12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTLL12 mRNA	PMID:39836092
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313277	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TTLL12 mRNA	PMID:25620056
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313277	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TTLL12 mRNA; Nanotubes, Carbon results in increased expression of TTLL12 mRNA	PMID:25554681
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313277	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TTLL12 mRNA	PMID:19042947
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TTLL12 protein	PMID:32959892
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TTLL12 mRNA	PMID:39836092
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313277	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of TTLL12 mRNA	PMID:19812364
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of TTLL12 mRNA	PMID:19564919
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1604381	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TTLL12 mRNA	PMID:31758290
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313277	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TTLL12 mRNA	PMID:22206623
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TTLL12 protein	PMID:37664457
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1604381	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of TTLL12 protein	PMID:39638853
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of TTLL12 mRNA	PMID:21346803
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in decreased expression of TTLL12 protein	PMID:35881160
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313277	E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in increased expression of TTLL12 protein	PMID:35881160
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TTLL12 protein	PMID:31675489
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of TTLL12 protein	PMID:31675489
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TTLL12 protein	PMID:37664457
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TTLL12 mRNA	PMID:21346803
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TTLL12 mRNA	PMID:38568856
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1604381	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TTLL12 mRNA	PMID:29301935
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1604381	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of TTLL12 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of TTLL12 protein	PMID:38598786
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TTLL12 mRNA	PMID:23034163
1305319	Ttll12	tubulin tyrosine ligase like 12	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of TTLL12 mRNA	PMID:23034163
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RCL1 mRNA	PMID:23724009|PMID:33167477
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of RCL1 mRNA	PMID:33729688
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of RCL1 mRNA	PMID:22378314
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313278	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RCL1 mRNA	PMID:20044591
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313279	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RCL1 mRNA	PMID:39241906
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RCL1 mRNA	PMID:39298647
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313278	E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in increased expression of RCL1 mRNA	PMID:26865669|PMID:28711546|PMID:31614463
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:17263	estrone	increases expression	ISO	RGD:1313278	E	RGD:6480464	20160705	CTD	MESH:D004970	Estrone results in increased expression of RCL1 mRNA	PMID:26865669
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1313279	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of RCL1 mRNA	PMID:28973375
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RCL1 mRNA	PMID:33387578
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RCL1 mRNA	PMID:22061828
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313278	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RCL1 intron	PMID:30157460
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RCL1 mRNA	PMID:36331819
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA	PMID:39836092
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of RCL1 protein	PMID:34915118
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RCL1 mRNA	PMID:37236586
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313278	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RCL1 mRNA	PMID:19549813
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313279	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RCL1 mRNA	PMID:19770486
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313278	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RCL1 intron	PMID:30157460
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of RCL1 protein	PMID:39638853
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313279	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RCL1 mRNA	PMID:31919559
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RCL1 mRNA	PMID:25629700
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of RCL1 gene	PMID:39164771|PMID:39836092
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RCL1 mRNA	PMID:31881176
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313278	E	RGD:6480464	20160705	CTD	MESH:D019833	Genistein results in increased expression of RCL1 mRNA	PMID:26865669
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313279	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RCL1 mRNA	PMID:21570461
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RCL1 mRNA	PMID:11489354|PMID:20106945|PMID:21632981
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RCL1 mRNA	PMID:33387578
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RCL1 mRNA	PMID:17942748
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RCL1 mRNA	PMID:29803840
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of RCL1 mRNA	PMID:29301061|PMID:38568856
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA	PMID:39836092
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313279	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RCL1 exon; Benzo(a)pyrene results in decreased methylation of RCL1 intron	PMID:27901495
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313278	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RCL1 mRNA	PMID:17879257
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313278	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RCL1 promoter	PMID:27901495
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of RCL1 mRNA	PMID:25075043
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313278	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of RCL1 mRNA	PMID:25258189
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:31638	fulvestrant	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant results in decreased expression of RCL1 mRNA	PMID:26865669
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RCL1 gene	PMID:31601247
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of RCL1 mRNA	PMID:24136188
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:31669	hexestrol	increases expression	ISO	RGD:1313278	E	RGD:6480464	20160705	CTD	MESH:D006589	Hexestrol results in increased expression of RCL1 mRNA	PMID:26865669
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of RCL1 mRNA	PMID:24136188
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RCL1 mRNA	PMID:19710929
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313279	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RCL1 mRNA	PMID:28472532
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RCL1 mRNA	PMID:25181051
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313278	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RCL1 mRNA	PMID:30903817
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of RCL1 protein	PMID:37567409
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313278	E	RGD:6480464	20171010	CTD	MESH:C006780	bisphenol A results in increased expression of RCL1 mRNA	PMID:28711546
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RCL1 gene	PMID:31601247
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313278	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of RCL1 protein	PMID:31945527
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RCL1 mRNA	PMID:39298647
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313278	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RCL1 intron	PMID:30157460
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RCL1 mRNA	PMID:37019170
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of RCL1 mRNA	PMID:19638242
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of RCL1 mRNA	PMID:32680482
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of RCL1 gene	PMID:33148267
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313278	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RCL1 mRNA	PMID:37042841
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA	PMID:39836092
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RCL1 mRNA	PMID:38174414
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RCL1 mRNA	PMID:37236586
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RCL1 mRNA	PMID:24449571
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313279	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of RCL1 mRNA	PMID:18353800
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of RCL1 mRNA	PMID:17585979
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of RCL1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RCL1 mRNA]	PMID:17585979
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:3752	clomiphene	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20160705	CTD	MESH:D002996	Clomiphene results in decreased expression of RCL1 mRNA	PMID:26865669
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RCL1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RCL1 mRNA	PMID:36331819
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313279	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of RCL1 mRNA	PMID:22155349
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313278	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RCL1 mRNA	PMID:25979313
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313278	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RCL1 gene	PMID:29154799
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313278	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RCL1 mRNA	PMID:23179753
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RCL1 mRNA	PMID:17183730
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313278	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RCL1 mRNA	PMID:25562108
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313278	E	RGD:6480464	20160705	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RCL1 mRNA	PMID:26865669
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of RCL1 mRNA]	PMID:21233418
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313279	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RCL1 mRNA	PMID:17562736
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of RCL1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RCL1 mRNA]	PMID:17585979
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of RCL1 gene	PMID:39164771|PMID:39836092
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RCL1 mRNA	PMID:22079256
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RCL1 mRNA	PMID:17942748
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313278	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of RCL1 mRNA	PMID:25258189
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:50035	alpha-phellandrene	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of RCL1 mRNA	PMID:25075043
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313279	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RCL1 mRNA	PMID:25554681
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RCL1 mRNA	PMID:35964746
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313279	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RCL1 mRNA	PMID:19042947
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RCL1 mRNA	PMID:17183730
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RCL1 protein	PMID:32959892
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA	PMID:39836092
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313279	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RCL1 protein	PMID:26558463
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:6784	mestranol	increases expression	ISO	RGD:1313278	E	RGD:6480464	20160705	CTD	MESH:D008656	Mestranol results in increased expression of RCL1 mRNA	PMID:26865669
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of RCL1 mRNA	PMID:30467583
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313278	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RCL1 intron	PMID:30157460
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of RCL1 gene	PMID:33148267
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313278	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RCL1 mRNA	PMID:31758290
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313279	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RCL1 mRNA	PMID:22206623
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313278	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RCL1 mRNA	PMID:22079256
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RCL1 mRNA	PMID:22079256
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313278	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RCL1 mRNA	PMID:37199045
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1313278	E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of RCL1 protein	PMID:39638853
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313278	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of RCL1 mRNA	PMID:19159669
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of RCL1 mRNA	PMID:21278054
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1313278	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of RCL1 mRNA	PMID:26865669
1305320	Rcl1	RNA terminal phosphate cyclase-like 1	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of RCL1 protein	PMID:35357534
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of MARS1 mRNA	PMID:15784690
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313281	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MARS1 mRNA	PMID:33045310
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MARS1 mRNA]	PMID:31150632
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MARS1 gene	PMID:20938992
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D001280	Atrazine results in decreased expression of MARS1 mRNA	PMID:22378314
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D000431	Ethanol affects the splicing of MARS1 mRNA	PMID:30319688
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313281	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MARS1 mRNA	PMID:39241906
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313281	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MARS1 mRNA	PMID:39298647
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MARS1 gene	PMID:20938992
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D011374	Progesterone results in increased expression of MARS1 mRNA	PMID:18037150
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of MARS1 mRNA	PMID:22321834
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313281	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of MARS1 mRNA	PMID:33848595
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:175901	gemcitabine	increases expression	ISO	RGD:1313280	E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased expression of MARS1 mRNA	PMID:17039268
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313280	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MARS1 protein	PMID:37730182
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313280	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of MARS1 promoter	PMID:30157460
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of MARS1 protein	PMID:34915118
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D019327	Copper Sulfate results in increased expression of MARS1 mRNA	PMID:19549813
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MARS1 mRNA	PMID:23649840
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of MARS1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of MARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of MARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of MARS1 protein	PMID:38598786
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MARS1 mRNA	PMID:31150632
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MARS1 mRNA]	PMID:31150632
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MARS1 gene	PMID:20938992
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MARS1 mRNA	PMID:40504410
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MARS1 mRNA	PMID:23557933
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MARS1 mRNA]	PMID:21858171
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D009532	Nickel results in increased expression of MARS1 mRNA	PMID:25583101
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MARS1 mRNA	PMID:21570461
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MARS1 mRNA	PMID:20106945|PMID:21632981
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MARS1 mRNA	PMID:21354282
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of MARS1 mRNA	PMID:16214954
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313280	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MARS1 mRNA	PMID:28001369
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARS1 mRNA	PMID:27188386
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of MARS1 mRNA	PMID:23649840
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of MARS1 protein	PMID:23736079
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MARS1 mRNA	PMID:29803840
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MARS1 mRNA	PMID:29432896
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313280	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MARS1 mRNA	PMID:38568856
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MARS1 mRNA	PMID:40504410
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D014415	Tunicamycin results in increased expression of MARS1 mRNA	PMID:22378314|PMID:29453283
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MARS1 mRNA	PMID:22228805
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MARS1 mRNA	PMID:21569818|PMID:22228805
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313280	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of MARS1 mRNA	PMID:26014281
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of MARS1 mRNA	PMID:11578147
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:C009495	titanium dioxide affects the expression of MARS1 mRNA	PMID:23557971
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:C009495	titanium dioxide results in increased expression of MARS1 mRNA	PMID:27760801
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MARS1 mRNA	PMID:28472532
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313280	E	RGD:6480464	20200114	CTD	MESH:C006780	bisphenol A affects the expression of MARS1 mRNA	PMID:30903817
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MARS1 mRNA	PMID:30816183|PMID:32528016
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of MARS1 protein	PMID:37567409
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MARS1 mRNA	PMID:25181051
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313280	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MARS1 mRNA; bisphenol A results in increased expression of MARS1 protein	PMID:33670352|PMID:34186270
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D002220	Carbamazepine affects the expression of MARS1 mRNA	PMID:25979313
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:C032668	1-nitropyrene results in increased expression of MARS1 mRNA	PMID:19041380
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313281	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MARS1 mRNA	PMID:39298647
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313280	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of MARS1 protein	PMID:34186270
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313280	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MARS1 protein	PMID:34186270
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313281	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MARS1 mRNA	PMID:37019170
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of MARS1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of MARS1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of MARS1 protein	PMID:38598786
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:C022838	nickel chloride results in increased expression of MARS1 mRNA	PMID:17312168
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MARS1 mRNA	PMID:20551477
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MARS1 mRNA	PMID:24449571
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:C100187	chloropicrin results in decreased expression of MARS1 mRNA	PMID:26352163
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313280	E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MARS1 mRNA	PMID:36864359
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D014635	Valproic Acid results in increased expression of MARS1 mRNA	PMID:23179753
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D016572	Cyclosporine results in increased expression of MARS1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313280	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MARS1 mRNA	PMID:38832940
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20161213	CTD	MESH:C111237	Vorinostat results in decreased expression of MARS1 mRNA	PMID:27188386
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313280	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of MARS1 mRNA	PMID:29067470
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of MARS1 mRNA]	PMID:15016801
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1313280	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of MARS1 mRNA	PMID:33725128
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313280	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MARS1 mRNA	PMID:29523930
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MARS1 mRNA	PMID:40504410
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:48707	(-)-citrinin	increases expression	ISO	RGD:1313280	E	RGD:6480464	20250603	CTD	MESH:D002953	Citrinin results in increased expression of MARS1 protein	PMID:39638853
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MARS1 mRNA; Nanotubes, Carbon results in increased expression of MARS1 mRNA	PMID:25554681
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MARS1 mRNA	PMID:35964746
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MARS1 mRNA	PMID:19042947
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MARS1 protein	PMID:32959892
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of MARS1 mRNA	PMID:15784690
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of MARS1 mRNA	PMID:30467583
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313280	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MARS1 protein	PMID:34186270
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MARS1 protein	PMID:37664457
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313280	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of MARS1 protein	PMID:39638853
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of MARS1 mRNA	PMID:30559759
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARS1 mRNA	PMID:27188386
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:C010327	salinomycin results in decreased expression of MARS1 mRNA	PMID:19682730
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MARS1 protein	PMID:31675489
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1313280	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of MARS1 mRNA	PMID:19095052
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MARS1 mRNA	PMID:23640034
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MARS1 mRNA	PMID:23914054
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D010894	Piroxicam results in decreased expression of MARS1 mRNA	PMID:21858171
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MARS1 mRNA]	PMID:21858171
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MARS1 protein; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARS1 mRNA	PMID:27188386|PMID:37664457
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313280	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of MARS1 mRNA	PMID:26014281
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313280	E	RGD:6480464	20160712	CTD	MESH:D019284	Thapsigargin results in increased expression of MARS1 mRNA	PMID:22378314
1305321	Mars1	methionyl-tRNA synthetase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313280	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of MARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of MARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of MARS1 protein	PMID:38598786
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of MAP4K4 mRNA	PMID:35967413
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of MAP4K4 mRNA	PMID:37995155
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP4K4 mRNA]	PMID:31150632
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K4 mRNA	PMID:20938992
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20120522	CTD	MESH:D001241	Aspirin results in decreased expression of MAP4K4 mRNA	PMID:15928584
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MAP4K4 mRNA	PMID:33167477
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MAP4K4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MAP4K4 mRNA	PMID:32699268
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAP4K4 mRNA	PMID:36331819
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20190611	CTD	MESH:D019308	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MAP4K4 mRNA	PMID:30547786
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20190611	CTD	MESH:D019301	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MAP4K4 mRNA	PMID:30547786
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313283	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MAP4K4 mRNA	PMID:30319688
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313283	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MAP4K4 mRNA	PMID:30319688
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20190507	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of MAP4K4 mRNA; Ethanol affects the expression of and affects the splicing of MAP4K4 mRNA	PMID:30319688|PMID:30517762
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MAP4K4 mRNA	PMID:21632981
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MAP4K4 mRNA	PMID:39241906
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MAP4K4 mRNA]	PMID:39241906
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20130806	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MAP4K4 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of MAP4K4 mRNA	PMID:20660070|PMID:20823114
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K4 mRNA	PMID:20938992
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313282	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAP4K4 mRNA	PMID:37042841
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20120522	CTD	MESH:D005557	Formaldehyde results in decreased expression of MAP4K4 mRNA	PMID:20655997
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313282	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MAP4K4 mRNA	PMID:23649840
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20130806	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of MAP4K4 mRNA	PMID:20660070
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20250805	CTD	MESH:C016599	MAP4K4 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the localization of RELB protein]; MAP4K4 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CRH mRNA]; MAP4K4 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 mRNA]	PMID:26751383
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MAP4K4 mRNA	PMID:33754040
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313282	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MAP4K4 protein	PMID:37730182
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP4K4 mRNA	PMID:36331819
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MAP4K4 mRNA	PMID:19549813
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313282	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MAP4K4 mRNA	PMID:23649840
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of MAP4K4 protein	PMID:33236894
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of MAP4K4 mRNA	PMID:21396975
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313283	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MAP4K4 mRNA	PMID:19770486
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313282	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MAP4K4 exon	PMID:30157460
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313282	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MAP4K4 mRNA	PMID:23649840
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MAP4K4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MAP4K4 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of MAP4K4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MAP4K4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of MAP4K4 mRNA	PMID:32699268|PMID:35430440|PMID:41430723
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MAP4K4 mRNA	PMID:30779732
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:26820	sulfates	affects methylation	ISO	RGD:1313282	E	RGD:6480464	20170303	CTD	MESH:D013431	Sulfates affects the methylation of MAP4K4 promoter	PMID:25395096
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:26820	sulfates	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20170303	CTD	MESH:D013431	[Soot co-treated with Sulfates] affects the methylation of MAP4K4 promoter	PMID:25395096
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20170516	CTD	MESH:C011559	tributyltin results in decreased expression of MAP4K4 mRNA	PMID:27678064
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAP4K4 mRNA	PMID:31150632
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313283	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAP4K4 mRNA	PMID:31919559
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP4K4 mRNA]	PMID:31150632
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of MAP4K4 mRNA	PMID:30517762
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K4 mRNA	PMID:20938992
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of MAP4K4 gene	PMID:39164771
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27698	vanadium atom	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of MAP4K4 mRNA	PMID:19000753
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313282	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MAP4K4 protein	PMID:35688186
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MAP4K4 mRNA	PMID:31881176
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MAP4K4 mRNA	PMID:23557933
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1313282	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of MAP4K4 mRNA	PMID:28903495
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of MAP4K4 mRNA	PMID:19561079
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MAP4K4 mRNA	PMID:30912803
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313282	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MAP4K4 mRNA	PMID:25583101
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP4K4 mRNA	PMID:34747641
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313283	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP4K4 mRNA	PMID:21570461
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAP4K4 mRNA	PMID:33387578
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAP4K4 mRNA	PMID:20106945|PMID:21632981
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20120522	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of MAP4K4 mRNA	PMID:19465110
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313282	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MAP4K4 mRNA	PMID:23179753|PMID:28001369
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1313282	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of MAP4K4 mRNA	PMID:23649840
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MAP4K4 mRNA	PMID:30911355
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313282	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MAP4K4 mRNA	PMID:29803840
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313282	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of MAP4K4 protein	PMID:35688186
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313282	E	RGD:6480464	20120522	CTD	MESH:D024483	Vitamin K 3 affects the expression of MAP4K4 mRNA	PMID:20044591
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MAP4K4 mRNA	PMID:18812580
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313282	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MAP4K4 mRNA	PMID:24431212|PMID:38568856
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313282	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAP4K4 promoter	PMID:27901495
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAP4K4 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313282	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAP4K4 mRNA	PMID:32234424
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313283	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAP4K4 mRNA	PMID:19770486|PMID:22228805|PMID:22610609
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA	PMID:27858113
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MAP4K4 mRNA]	PMID:32406909
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MAP4K4 mRNA	PMID:30911355
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313283	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MAP4K4 mRNA	PMID:23221170
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAP4K4 mRNA	PMID:19150397
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of MAP4K4 mRNA	PMID:34408198
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of MAP4K4 gene	PMID:31601247
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313282	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of MAP4K4 mRNA	PMID:38568856
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313283	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of MAP4K4 mRNA	PMID:21829687
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of MAP4K4 mRNA	PMID:25729387
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of MAP4K4 mRNA	PMID:25729387
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313283	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MAP4K4 promoter	PMID:35295148
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MAP4K4 mRNA	PMID:23411599|PMID:34492290
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313283	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MAP4K4 mRNA	PMID:18301758|PMID:21318169|PMID:23811191
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of MAP4K4 mRNA]	PMID:21318169
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:32888	gamma-hexachlorocyclohexane	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D001556	Hexachlorocyclohexane results in decreased expression of MAP4K4 mRNA	PMID:17785943
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313282	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MAP4K4 mRNA	PMID:30903817
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313282	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of MAP4K4 gene	PMID:31601247
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP4K4 mRNA	PMID:32145629
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP4K4 protein	PMID:33376534
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP4K4 mRNA	PMID:38074096
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MAP4K4 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313282	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of MAP4K4 protein	PMID:34186270
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MAP4K4 gene	PMID:28505145
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MAP4K4 mRNA	PMID:36041667
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of MAP4K4 gene	PMID:31601247
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313282	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of MAP4K4 mRNA	PMID:24752500
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313283	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MAP4K4 mRNA	PMID:26682919
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313282	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MAP4K4 protein	PMID:34186270
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313283	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of MAP4K4 mRNA	PMID:33297965|PMID:39298647|PMID:40203079
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MAP4K4 mRNA	PMID:36041667
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313283	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MAP4K4 mRNA	PMID:26377693
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA	PMID:27858113
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MAP4K4 mRNA	PMID:36041667
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313283	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of MAP4K4 intron	PMID:28392331
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of MAP4K4 mRNA	PMID:31558096
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MAP4K4 mRNA	PMID:34813904
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313283	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MAP4K4 mRNA	PMID:24535843
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MAP4K4 mRNA]	PMID:39241906
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313282	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MAP4K4 mRNA	PMID:37042841
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35170	vanadium(0)	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of MAP4K4 mRNA	PMID:19000753
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313283	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MAP4K4 mRNA	PMID:26377693
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313282	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAP4K4 mRNA	PMID:38568856
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35458	cerium trichloride	increases expression	ISO	RGD:1313283	E	RGD:6480464	20121113	CTD	MESH:C026690	cerous chloride results in increased expression of MAP4K4 mRNA; cerous chloride results in increased expression of MAP4K4 protein	PMID:21656643
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of MAP4K4 gene	PMID:22079235
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313282	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MAP4K4 mRNA	PMID:24449571
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of MAP4K4 mRNA	PMID:25908611
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MAP4K4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MAP4K4 mRNA	PMID:32699268
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of MAP4K4 mRNA	PMID:19167446
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA	PMID:19167446
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP4K4 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAP4K4 mRNA	PMID:36331819
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39481	chloroprene	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of MAP4K4 mRNA	PMID:23125180
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313282	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAP4K4 mRNA	PMID:25979313
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of MAP4K4 mRNA	PMID:29427782
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MAP4K4 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313282	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MAP4K4 gene	PMID:29154799
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313282	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MAP4K4 mRNA	PMID:26272509
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of MAP4K4 mRNA	PMID:38685447|PMID:41580965
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MAP4K4 mRNA	PMID:25562108|PMID:27989131
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313283	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MAP4K4 mRNA	PMID:28973697
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313282	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of MAP4K4 mRNA	PMID:23649840
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313282	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of MAP4K4 mRNA	PMID:21678067
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313282	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MAP4K4 mRNA	PMID:38832940
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MAP4K4 mRNA	PMID:27188386
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313282	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MAP4K4 mRNA	PMID:24935251|PMID:26272509
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4K4 mRNA	PMID:27188386
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313283	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of MAP4K4 mRNA	PMID:17562736
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of MAP4K4 gene	PMID:39164771
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1313282	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of MAP4K4 mRNA	PMID:24752500
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313283	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MAP4K4 mRNA	PMID:35436446
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313282	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of MAP4K4 mRNA	PMID:38568856
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1313282	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of MAP4K4 mRNA	PMID:26272509
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20120522	CTD	MESH:D007213	Indomethacin results in decreased expression of MAP4K4 mRNA	PMID:16984733
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MAP4K4 mRNA	PMID:20823114
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MAP4K4 mRNA	PMID:30307764
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313283	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MAP4K4 mRNA	PMID:25554681
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:51081	nitrates	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in increased expression of MAP4K4 mRNA	PMID:30022042
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA	PMID:27858113
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA	PMID:27858113
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1313282	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of MAP4K4 mRNA	PMID:20977926
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of MAP4K4 mRNA	PMID:23608068
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MAP4K4 mRNA	PMID:25729387
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of MAP4K4 mRNA	PMID:25729387
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MAP4K4 mRNA	PMID:24810058
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MAP4K4 mRNA	PMID:20823114
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cannabidiol co-treated with moringin] results in decreased expression of MAP4K4 mRNA	PMID:30096889
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313282	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MAP4K4 protein	PMID:34186270
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MAP4K4 mRNA	PMID:22242189
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313283	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MAP4K4 mRNA	PMID:22206623
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of MAP4K4 mRNA	PMID:30559759
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of MAP4K4 mRNA	PMID:23665939
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4K4 mRNA	PMID:27188386
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA	PMID:19167446
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of MAP4K4 mRNA	PMID:39847705
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313283	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of MAP4K4 mRNA	PMID:30953684
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MAP4K4 mRNA	PMID:24780913
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MAP4K4 mRNA]	PMID:39241906
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4K4 mRNA	PMID:27188386
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9123	sertraline	decreases expression	ISO	RGD:1313282	E	RGD:6480464	20140909	CTD	MESH:D020280	Sertraline results in decreased expression of MAP4K4 mRNA	PMID:24865413
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9123	sertraline	multiple interactions	ISO	RGD:1313282	E	RGD:6480464	20140909	CTD	MESH:D020280	MAP4K4 mutant form inhibits the reaction [Sertraline results in increased cleavage of CASP4 protein]; MAP4K4 mutant form inhibits the reaction [Sertraline results in increased expression of DDIT3 protein]; MAP4K4 mutant form inhibits the reaction [Sertraline results in increased phosphorylation of EIF2AK3 protein]	PMID:24865413
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MAP4K4 mRNA	PMID:19281266
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313282	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MAP4K4 mRNA	PMID:38568856
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313283	E	RGD:6480464	20120522	CTD	MESH:C057693	troglitazone results in increased expression of MAP4K4 mRNA	PMID:17569031
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of MAP4K4 mRNA	PMID:19015723
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MAP4K4 mRNA	PMID:23034163
1305322	Map4k4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MAP4K4 mRNA	PMID:20566332
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313284	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PLA2G3 mRNA	PMID:26272509
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313284	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G3 mRNA	PMID:27188386
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PLA2G3 mRNA	PMID:36841081
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313284	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of PLA2G3 mRNA	PMID:23019147
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:16482	naphthalene	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C031721	naphthalene analog results in decreased expression of PLA2G3 mRNA	PMID:24976557
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552182	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PLA2G3 mRNA	PMID:34319233
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PLA2G3 mRNA	PMID:27523638
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PLA2G3 mRNA	PMID:33387578
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313284	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PLA2G3 mRNA	PMID:28818685
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D002104	[cadmium sulfate results in increased abundance of Cadmium] which results in increased expression of PLA2G3 protein	PMID:30090467
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313284	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PLA2G3 mRNA	PMID:19549813
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313284	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PLA2G3 mRNA	PMID:21641981
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313284	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of PLA2G3 mRNA	PMID:25102026
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010126	Ozone results in increased expression of PLA2G3 mRNA	PMID:31397875
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313284	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PLA2G3 mRNA	PMID:21867686
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1552182	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of PLA2G3 mRNA	PMID:35897073
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552182	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PLA2G3 mRNA	PMID:28960355
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313284	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PLA2G3 mRNA	PMID:24768652|PMID:25583101
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1313284	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PLA2G3 mRNA	PMID:30851411
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313284	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PLA2G3 protein	PMID:35688186
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313284	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLA2G3 promoter	PMID:27901495
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552182	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLA2G3 mRNA	PMID:27195522
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552182	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to PLA2G3 promoter]	PMID:19654925
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:30966	glycidol	affects expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol affects the expression of PLA2G3 mRNA	PMID:24915197
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of PLA2G3 mRNA	PMID:24395379
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313284	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLA2G3 gene	PMID:31601247
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552182	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PLA2G3 mRNA	PMID:29264374|PMID:35295148
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PLA2G3 mRNA	PMID:34947998
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552182	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PLA2G3 mRNA	PMID:32156529
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313284	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PLA2G3 gene	PMID:31601247
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313284	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLA2G3 gene	PMID:31601247
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313284	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PLA2G3 mRNA	PMID:25979313
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	ISO	RGD:1313284	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in decreased expression of PLA2G3 mRNA	PMID:19371625
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552182	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PLA2G3 gene	PMID:31683443
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:34757	fenitrothion	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D005278	Fenitrothion results in decreased expression of PLA2G3 protein	PMID:29292090
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PLA2G3 promoter	PMID:22457795
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of PLA2G3 mRNA	PMID:25539665
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552182	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PLA2G3 mRNA	PMID:40194260
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:38683	4-nitro-m-cresol	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C008636	4-nitro-3-cresol results in decreased expression of PLA2G3 protein	PMID:29292090
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313284	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PLA2G3 mRNA	PMID:31533062
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313284	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLA2G3 mRNA	PMID:25979313
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313284	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLA2G3 mRNA	PMID:23179753
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313284	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PLA2G3 mRNA	PMID:27188386
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLA2G3 mRNA	PMID:33387578
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of PLA2G3 mRNA	PMID:37077353
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLA2G3 mRNA	PMID:29391264
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:50292	cadmium sulfate	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:C037123	[cadmium sulfate results in increased abundance of Cadmium] which results in increased expression of PLA2G3 protein	PMID:30090467
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1552182	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PLA2G3 mRNA	PMID:23608068
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1552182	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of PLA2G3 mRNA	PMID:38701926
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313284	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PLA2G3 mRNA	PMID:24810058
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313284	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PLA2G3 mRNA	PMID:31758290
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552182	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PLA2G3 mRNA	PMID:22206623
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1313284	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PLA2G3 mRNA	PMID:30851411
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313284	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G3 mRNA	PMID:27188386
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLA2G3 mRNA	PMID:25825206
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313284	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G3 mRNA	PMID:27188386
1305323	Pla2g3	phospholipase A2, group III	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1552182	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PLA2G3 mRNA	PMID:32835833
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313286	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SPRY4 mRNA	PMID:38218311
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313287	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPRY4 mRNA	PMID:33045310
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1313286	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of SPRY4 mRNA	PMID:34925699
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SPRY4 mRNA]	PMID:19467301
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313286	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SPRY4 mRNA	PMID:33167477
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SPRY4 mRNA	PMID:36189433
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SPRY4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SPRY4 mRNA	PMID:32699268
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SPRY4 mRNA	PMID:33729688
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPRY4 mRNA	PMID:30529165
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of SPRY4 mRNA	PMID:36841081
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20180703	CTD	MESH:D000431	[Ethanol co-treated with Folic Acid] results in decreased expression of SPRY4 mRNA	PMID:23378141
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313286	E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SPRY4 mRNA	PMID:23410634
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313286	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SPRY4 mRNA	PMID:30510588
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SPRY4 mRNA	PMID:39298647
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SPRY4 mRNA	PMID:32145629
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313286	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of SPRY4 mRNA	PMID:23019147|PMID:30165855|PMID:31614463
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of SPRY4 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of SPRY4 mRNA	PMID:20660070|PMID:30165855
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SPRY4 mRNA	PMID:23829299
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313286	E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of SPRY4 mRNA	PMID:28937961
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	ISO	RGD:1313286	E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of SPRY4 mRNA	PMID:39245080
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313286	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of SPRY4 mRNA	PMID:18037150
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of SPRY4 mRNA	PMID:20660070
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313286	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SPRY4 mRNA	PMID:36314267
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SPRY4 mRNA	PMID:16809437
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313286	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SPRY4 mRNA	PMID:36695872
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SPRY4 mRNA	PMID:36189433
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313286	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SPRY4 mRNA	PMID:33647349
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313286	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of SPRY4 mRNA	PMID:31256213
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SPRY4 mRNA	PMID:19850644
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313286	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SPRY4 mRNA	PMID:31163220
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SPRY4 mRNA]	PMID:19850644
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SPRY4 mRNA	PMID:27523638
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313286	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SPRY4 protein	PMID:37730182
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SPRY4 mRNA	PMID:22061828
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SPRY4 mRNA	PMID:33387578
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313286	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SPRY4 mRNA	PMID:28818685
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:193591	Didecyldimethylammonium	increases expression	ISO	RGD:1313286	E	RGD:6480464	20250805	CTD	MESH:C027118	didecyldimethylammonium results in increased expression of SPRY4 mRNA	PMID:39710153
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313287	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SPRY4 mRNA	PMID:27462272
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPRY4 mRNA	PMID:39012411
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPRY4 mRNA	PMID:37236586
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313286	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SPRY4 mRNA	PMID:19549813
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SPRY4 mRNA	PMID:33354967
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313286	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SPRY4 mRNA	PMID:22100608
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of SPRY4 mRNA	PMID:15674844
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SPRY4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SPRY4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of SPRY4 mRNA	PMID:32699268
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SPRY4 mRNA	PMID:34911549
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SPRY4 mRNA	PMID:18593933
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPRY4 mRNA	PMID:25629700
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20180703	CTD	MESH:D005492	[Ethanol co-treated with Folic Acid] results in decreased expression of SPRY4 mRNA	PMID:23378141
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313286	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SPRY4 mRNA	PMID:26272509
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA	PMID:27188386
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313286	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SPRY4 protein	PMID:35688186
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SPRY4 mRNA	PMID:27392435
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D003042	Cocaine results in increased expression of SPRY4 mRNA	PMID:27899881
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313287	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPRY4 mRNA	PMID:21570461
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPRY4 mRNA	PMID:33387578
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313286	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPRY4 mRNA	PMID:20106945|PMID:21632981
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPRY4 mRNA	PMID:26232522
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313286	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of SPRY4 mRNA	PMID:29955902
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313286	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SPRY4 mRNA	PMID:28001369
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313286	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SPRY4 mRNA	PMID:33212167
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SPRY4 mRNA	PMID:28959563
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313286	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SPRY4 mRNA	PMID:30031762
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313286	E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of SPRY4 mRNA	PMID:23410634
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1313286	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of SPRY4 mRNA	PMID:22623647
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313286	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SPRY4 mRNA	PMID:38568856
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA	PMID:34876320
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA	PMID:34876320
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313286	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPRY4 mRNA	PMID:21632981|PMID:21714911|PMID:26238291|PMID:32234424|PMID:35870112
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313286	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPRY4 5' UTR	PMID:27901495
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313286	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of SPRY4 promoter	PMID:23974009
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SPRY4 mRNA	PMID:18593933
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313286	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SPRY4 mRNA	PMID:26014281
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313287	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SPRY4 mRNA	PMID:27131904
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313286	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SPRY4 mRNA	PMID:22300531|PMID:25351596
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313286	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SPRY4 mRNA	PMID:20382639
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313286	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SPRY4 mRNA	PMID:26238291
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of SPRY4 mRNA	PMID:24915197
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313286	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of SPRY4 mRNA	PMID:38568856
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SPRY4 mRNA	PMID:30047161
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SPRY4 mRNA	PMID:34492290
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of SPRY4 mRNA	PMID:23811191
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of SPRY4 mRNA	PMID:28329830
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SPRY4 mRNA	PMID:19167457
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SPRY4 mRNA	PMID:25181051|PMID:32145629
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313286	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SPRY4 mRNA	PMID:29275510
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of SPRY4 mRNA	PMID:25594700
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313287	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SPRY4 mRNA	PMID:30951980|PMID:32156529
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313287	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SPRY4 mRNA	PMID:25172293
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313287	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SPRY4 mRNA	PMID:39298647
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313287	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SPRY4 gene	PMID:31683443
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of SPRY4 mRNA	PMID:33297965
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313287	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SPRY4 mRNA	PMID:30951980|PMID:40203079
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SPRY4 mRNA	PMID:28628672
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313287	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SPRY4 mRNA	PMID:30951980|PMID:38685157
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPRY4 mRNA	PMID:28628672
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313287	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SPRY4 mRNA	PMID:37019170
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SPRY4 mRNA	PMID:31050326
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SPRY4 mRNA	PMID:21266533
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313287	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SPRY4 mRNA	PMID:17361019|PMID:21266533
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPRY4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SPRY4 mRNA	PMID:28628672
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPRY4 mRNA	PMID:39012411
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPRY4 mRNA	PMID:37236586
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313286	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SPRY4 protein	PMID:26879310
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SPRY4 mRNA	PMID:30047161
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of SPRY4 mRNA	PMID:28962523
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SPRY4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SPRY4 mRNA	PMID:32699268
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313286	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SPRY4 mRNA	PMID:28302478
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313286	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SPRY4 mRNA	PMID:40419075
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SPRY4 mRNA	PMID:36331819
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of SPRY4 mRNA	PMID:23125180
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313286	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPRY4 mRNA	PMID:25979313
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of SPRY4 mRNA	PMID:29427782
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SPRY4 mRNA	PMID:21427059
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313286	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SPRY4 mRNA	PMID:28001369
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SPRY4 mRNA	PMID:30047161
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313286	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SPRY4 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPRY4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SPRY4 mRNA	PMID:28628672
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313287	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SPRY4 mRNA	PMID:28973697
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SPRY4 mRNA	PMID:18502557
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313286	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SPRY4 mRNA	PMID:38832940
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313286	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of SPRY4 mRNA	PMID:21420995|PMID:29067470
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1313286	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of SPRY4 mRNA	PMID:33725128
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1313286	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of SPRY4 mRNA	PMID:25757056
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313286	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SPRY4 mRNA	PMID:18687144|PMID:25351596
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of SPRY4 mRNA	PMID:26934552
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313286	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of SPRY4 mRNA	PMID:31838189
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1313286	E	RGD:6480464	20230404	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of SPRY4 mRNA	PMID:35701726
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SPRY4 mRNA	PMID:22079256
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA	PMID:34876320
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313286	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SPRY4 mRNA	PMID:38568856
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA	PMID:27188386
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPRY4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SPRY4 mRNA	PMID:28628672
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313286	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SPRY4 mRNA	PMID:25102311
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313287	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SPRY4 mRNA; Nanotubes, Carbon results in increased expression of SPRY4 mRNA	PMID:25554681
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SPRY4 mRNA	PMID:30047161
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313287	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of SPRY4 mRNA	PMID:40234311
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:507499	tricetin	increases expression	ISO	RGD:1313286	E	RGD:6480464	20240903	CTD	MESH:C469689	tricetin results in increased expression of SPRY4 mRNA	PMID:38654487
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313286	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of SPRY4 mRNA	PMID:31629900
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313287	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SPRY4 mRNA	PMID:38701926
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313286	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SPRY4 protein	PMID:32959892
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of SPRY4 mRNA	PMID:28801915
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313286	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SPRY4 mRNA	PMID:28988120
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	ISO	RGD:1313286	E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of SPRY4 mRNA	PMID:23410634
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SPRY4 mRNA	PMID:28801915
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of SPRY4 mRNA	PMID:27840820
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313286	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of SPRY4 mRNA	PMID:22079256
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SPRY4 mRNA	PMID:22079256
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C007350	nitrofen results in decreased expression of SPRY4 mRNA	PMID:23982388|PMID:26720608|PMID:33484710
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA	PMID:27188386
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1313286	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of SPRY4 mRNA	PMID:32234424
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA	PMID:34876320
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SPRY4 mRNA	PMID:21278054
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of SPRY4 mRNA	PMID:24780913
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SPRY4 mRNA	PMID:30047161
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313286	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA	PMID:27188386
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313286	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SPRY4 mRNA	PMID:26014281
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313287	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SPRY4 mRNA	PMID:27131904
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313286	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SPRY4 mRNA	PMID:38568856
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313287	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of SPRY4 mRNA	PMID:17569031
1305324	Spry4	sprouty RTK signaling antagonist 4	gene	CHEBI:9907	ursodeoxycholic acid	affects expression	ISO	RGD:1313286	E	RGD:6480464	20120613	CTD	MESH:D014580	Ursodeoxycholic Acid affects the expression of SPRY4 mRNA	PMID:18422935
1305325	Plxna2	plexin A2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313289	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PLXNA2 mRNA	PMID:33045310
1305325	Plxna2	plexin A2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PLXNA2 mRNA	PMID:26251327
1305325	Plxna2	plexin A2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313288	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PLXNA2 mRNA	PMID:21934132|PMID:23724009
1305325	Plxna2	plexin A2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313289	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PLXNA2 mRNA	PMID:30319688
1305325	Plxna2	plexin A2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313289	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PLXNA2 mRNA	PMID:30319688
1305325	Plxna2	plexin A2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of PLXNA2 mRNA	PMID:32145629
1305325	Plxna2	plexin A2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313289	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PLXNA2 mRNA	PMID:39298647
1305325	Plxna2	plexin A2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PLXNA2 mRNA	PMID:30165855
1305325	Plxna2	plexin A2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA	PMID:25510870
1305325	Plxna2	plexin A2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313288	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PLXNA2 mRNA	PMID:38568856
1305325	Plxna2	plexin A2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313288	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PLXNA2 mRNA	PMID:37042841
1305325	Plxna2	plexin A2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313288	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PLXNA2 mRNA	PMID:36695872
1305325	Plxna2	plexin A2	gene	CHEBI:17627	ferroheme b	increases expression	ISO	RGD:1313289	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in increased expression of PLXNA2 mRNA	PMID:19191707
1305325	Plxna2	plexin A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PLXNA2 mRNA	PMID:19850644
1305325	Plxna2	plexin A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of PLXNA2 mRNA]	PMID:19850644
1305325	Plxna2	plexin A2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313288	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PLXNA2 protein	PMID:37730182
1305325	Plxna2	plexin A2	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PLXNA2 mRNA	PMID:36139627
1305325	Plxna2	plexin A2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313288	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of PLXNA2 mRNA	PMID:16002434
1305325	Plxna2	plexin A2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313288	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PLXNA2 mRNA	PMID:28818685
1305325	Plxna2	plexin A2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313288	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PLXNA2 intron	PMID:30157460
1305325	Plxna2	plexin A2	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1313289	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of PLXNA2 mRNA	PMID:33914522
1305325	Plxna2	plexin A2	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of PLXNA2 mRNA	PMID:27462272
1305325	Plxna2	plexin A2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA	PMID:25510870
1305325	Plxna2	plexin A2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA	PMID:25510870
1305325	Plxna2	plexin A2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313288	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PLXNA2 mRNA	PMID:19549813
1305325	Plxna2	plexin A2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313288	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PLXNA2 gene	PMID:27153756
1305325	Plxna2	plexin A2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313288	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PLXNA2 intron	PMID:30157460
1305325	Plxna2	plexin A2	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PLXNA2 mRNA	PMID:32553695
1305325	Plxna2	plexin A2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D010126	pyrazolanthrone inhibits the reaction [Ozone results in increased expression of PLXNA2 mRNA]	PMID:17460151
1305325	Plxna2	plexin A2	gene	CHEBI:26355	heme b	increases expression	ISO	RGD:1313289	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in increased expression of PLXNA2 mRNA	PMID:19191707
1305325	Plxna2	plexin A2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PLXNA2 mRNA	PMID:31150632
1305325	Plxna2	plexin A2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PLXNA2 mRNA	PMID:31919559
1305325	Plxna2	plexin A2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313289	E	RGD:6480464	20181016	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PLXNA2 mRNA	PMID:29987408
1305325	Plxna2	plexin A2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PLXNA2 mRNA	PMID:25629700
1305325	Plxna2	plexin A2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313288	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PLXNA2 gene	PMID:25304211
1305325	Plxna2	plexin A2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313288	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PLXNA2 mRNA	PMID:26272509
1305325	Plxna2	plexin A2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1305325	Plxna2	plexin A2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313289	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PLXNA2 mRNA	PMID:28960355
1305325	Plxna2	plexin A2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PLXNA2 mRNA	PMID:31881176
1305325	Plxna2	plexin A2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of PLXNA2 mRNA]	PMID:31298478
1305325	Plxna2	plexin A2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PLXNA2 mRNA	PMID:27392435
1305325	Plxna2	plexin A2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PLXNA2 mRNA	PMID:27392435
1305325	Plxna2	plexin A2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313289	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of PLXNA2 mRNA	PMID:32186404
1305325	Plxna2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLXNA2 mRNA	PMID:22298810
1305325	Plxna2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313289	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLXNA2 mRNA	PMID:21570461
1305325	Plxna2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLXNA2 mRNA	PMID:23238561|PMID:32109520|PMID:33387578
1305325	Plxna2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLXNA2 mRNA	PMID:20106945
1305325	Plxna2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLXNA2 mRNA	PMID:18796159|PMID:19465110|PMID:23238561|PMID:32553695
1305325	Plxna2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLXNA2 mRNA	PMID:34747641
1305325	Plxna2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of PLXNA2 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA]	PMID:16054899|PMID:16214954
1305325	Plxna2	plexin A2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of PLXNA2 mRNA	PMID:28374803
1305325	Plxna2	plexin A2	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1313288	E	RGD:6480464	20150414	CTD	MESH:D004317	Doxorubicin affects the expression of PLXNA2 mRNA	PMID:25529476
1305325	Plxna2	plexin A2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313288	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PLXNA2 mRNA	PMID:29803840
1305325	Plxna2	plexin A2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PLXNA2 mRNA	PMID:22714537
1305325	Plxna2	plexin A2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PLXNA2 mRNA	PMID:37682722
1305325	Plxna2	plexin A2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313288	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PLXNA2 mRNA	PMID:38568856|PMID:39719251
1305325	Plxna2	plexin A2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313288	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLXNA2 intron	PMID:30157460
1305325	Plxna2	plexin A2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PLXNA2 mRNA	PMID:20106945|PMID:22316170|PMID:26238291
1305325	Plxna2	plexin A2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of PLXNA2 mRNA	PMID:32553695
1305325	Plxna2	plexin A2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313288	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PLXNA2 5' UTR	PMID:27901495
1305325	Plxna2	plexin A2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313289	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLXNA2 mRNA	PMID:21569818|PMID:21964900|PMID:22610609|PMID:23735875
1305325	Plxna2	plexin A2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313289	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in increased expression of PLXNA2 mRNA	PMID:33053406
1305325	Plxna2	plexin A2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313289	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of PLXNA2 mRNA	PMID:27131904
1305325	Plxna2	plexin A2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PLXNA2 mRNA	PMID:25895662
1305325	Plxna2	plexin A2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PLXNA2 mRNA	PMID:19150397|PMID:26238291
1305325	Plxna2	plexin A2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLXNA2 gene	PMID:31601247
1305325	Plxna2	plexin A2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of PLXNA2 mRNA	PMID:24136188
1305325	Plxna2	plexin A2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313288	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of PLXNA2 mRNA	PMID:38568856
1305325	Plxna2	plexin A2	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of PLXNA2 mRNA	PMID:32479839
1305325	Plxna2	plexin A2	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313288	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of PLXNA2 mRNA	PMID:38568856
1305325	Plxna2	plexin A2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20190219	CTD	MESH:C030110	Oxaliplatin results in decreased expression of PLXNA2 protein	PMID:30031110
1305325	Plxna2	plexin A2	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of PLXNA2 mRNA	PMID:24136188
1305325	Plxna2	plexin A2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313289	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLXNA2 gene	PMID:35295148
1305325	Plxna2	plexin A2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313289	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of PLXNA2 mRNA	PMID:27760801|PMID:31298478
1305325	Plxna2	plexin A2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20200211	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of PLXNA2 mRNA]	PMID:31298478
1305325	Plxna2	plexin A2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PLXNA2 mRNA	PMID:34492290
1305325	Plxna2	plexin A2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PLXNA2 mRNA	PMID:19167457
1305325	Plxna2	plexin A2	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313289	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of PLXNA2 mRNA	PMID:33914522
1305325	Plxna2	plexin A2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of PLXNA2 mRNA	PMID:32145629
1305325	Plxna2	plexin A2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PLXNA2 mRNA	PMID:25181051|PMID:30816183
1305325	Plxna2	plexin A2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313288	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PLXNA2 gene	PMID:31601247
1305325	Plxna2	plexin A2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313288	E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A analog results in increased expression of PLXNA2 mRNA; bisphenol A results in increased expression of PLXNA2 mRNA	PMID:32387340|PMID:38568856
1305325	Plxna2	plexin A2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313289	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of PLXNA2 mRNA	PMID:30245210|PMID:35479511
1305325	Plxna2	plexin A2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLXNA2 gene	PMID:31601247
1305325	Plxna2	plexin A2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313288	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PLXNA2 mRNA	PMID:25979313
1305325	Plxna2	plexin A2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA	PMID:25510870
1305325	Plxna2	plexin A2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA	PMID:25510870
1305325	Plxna2	plexin A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PLXNA2 mRNA	PMID:39298647
1305325	Plxna2	plexin A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313289	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PLXNA2 mRNA	PMID:30951980|PMID:33297965|PMID:40203079
1305325	Plxna2	plexin A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313288	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of PLXNA2 gene	PMID:31601247
1305325	Plxna2	plexin A2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313289	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PLXNA2 mRNA	PMID:26377693
1305325	Plxna2	plexin A2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313288	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PLXNA2 intron	PMID:30157460
1305325	Plxna2	plexin A2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313289	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PLXNA2 mRNA	PMID:30951980|PMID:38685157
1305325	Plxna2	plexin A2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PLXNA2 mRNA	PMID:28392331
1305325	Plxna2	plexin A2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313289	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLXNA2 mRNA	PMID:37019170
1305325	Plxna2	plexin A2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA]	PMID:16054899
1305325	Plxna2	plexin A2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PLXNA2 mRNA	PMID:32680482
1305325	Plxna2	plexin A2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313288	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLXNA2 mRNA	PMID:37042841
1305325	Plxna2	plexin A2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of PLXNA2 mRNA	PMID:30589522
1305325	Plxna2	plexin A2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313288	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of PLXNA2 mRNA	PMID:29024780
1305325	Plxna2	plexin A2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PLXNA2 mRNA	PMID:38174414
1305325	Plxna2	plexin A2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313288	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PLXNA2 mRNA	PMID:38382870
1305325	Plxna2	plexin A2	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of PLXNA2 mRNA	PMID:26194646
1305325	Plxna2	plexin A2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PLXNA2 mRNA	PMID:28903501
1305325	Plxna2	plexin A2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PLXNA2 mRNA	PMID:19320972
1305325	Plxna2	plexin A2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313289	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PLXNA2 mRNA	PMID:18353800
1305325	Plxna2	plexin A2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PLXNA2 mRNA	PMID:38568856
1305325	Plxna2	plexin A2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20240702	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PLXNA2 mRNA	PMID:38568856
1305325	Plxna2	plexin A2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313288	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PLXNA2 mRNA	PMID:40419075
1305325	Plxna2	plexin A2	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1313289	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of PLXNA2 mRNA	PMID:29038090
1305325	Plxna2	plexin A2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313289	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of PLXNA2 mRNA	PMID:23125180
1305325	Plxna2	plexin A2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313288	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLXNA2 mRNA	PMID:25979313
1305325	Plxna2	plexin A2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PLXNA2 mRNA	PMID:29427782
1305325	Plxna2	plexin A2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLXNA2 mRNA	PMID:29427782
1305325	Plxna2	plexin A2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313288	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PLXNA2 gene	PMID:29154799
1305325	Plxna2	plexin A2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313288	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PLXNA2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509
1305325	Plxna2	plexin A2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1305325	Plxna2	plexin A2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of PLXNA2 mRNA	PMID:27989131
1305325	Plxna2	plexin A2	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313288	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of PLXNA2 promoter	PMID:27989131
1305325	Plxna2	plexin A2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313288	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PLXNA2 mRNA	PMID:20106945|PMID:25562108
1305325	Plxna2	plexin A2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA]	PMID:16054899
1305325	Plxna2	plexin A2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313289	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PLXNA2 mRNA	PMID:28973697
1305325	Plxna2	plexin A2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PLXNA2 mRNA	PMID:18502557
1305325	Plxna2	plexin A2	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of PLXNA2 mRNA	PMID:24136188
1305325	Plxna2	plexin A2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313288	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PLXNA2 mRNA	PMID:38832940
1305325	Plxna2	plexin A2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313288	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PLXNA2 mRNA	PMID:24935251|PMID:26272509
1305325	Plxna2	plexin A2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1305325	Plxna2	plexin A2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PLXNA2 mRNA	PMID:17562736
1305325	Plxna2	plexin A2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLXNA2 mRNA	PMID:32479839
1305325	Plxna2	plexin A2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PLXNA2 mRNA	PMID:33387578
1305325	Plxna2	plexin A2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313288	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of PLXNA2 mRNA	PMID:29067470
1305325	Plxna2	plexin A2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313288	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PLXNA2 gene	PMID:25304211
1305325	Plxna2	plexin A2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLXNA2 mRNA	PMID:29391264
1305325	Plxna2	plexin A2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLXNA2 mRNA	PMID:22079256
1305325	Plxna2	plexin A2	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1313289	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of PLXNA2 mRNA	PMID:35436446
1305325	Plxna2	plexin A2	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313288	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of PLXNA2 mRNA	PMID:38568856
1305325	Plxna2	plexin A2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313289	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PLXNA2 mRNA	PMID:25554681
1305325	Plxna2	plexin A2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PLXNA2 mRNA	PMID:25620056
1305325	Plxna2	plexin A2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313289	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PLXNA2 mRNA	PMID:25554681
1305325	Plxna2	plexin A2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of PLXNA2 mRNA	PMID:26377693
1305325	Plxna2	plexin A2	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1313288	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of PLXNA2 mRNA	PMID:26705709
1305325	Plxna2	plexin A2	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of PLXNA2 mRNA	PMID:22714537
1305325	Plxna2	plexin A2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313289	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PLXNA2 mRNA	PMID:23608068
1305325	Plxna2	plexin A2	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PLXNA2 mRNA	PMID:20080153
1305325	Plxna2	plexin A2	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of PLXNA2 mRNA	PMID:24136188
1305325	Plxna2	plexin A2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313288	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PLXNA2 mRNA	PMID:15336504
1305325	Plxna2	plexin A2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PLXNA2 mRNA	PMID:24810058
1305325	Plxna2	plexin A2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313288	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PLXNA2 intron	PMID:30157460
1305325	Plxna2	plexin A2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PLXNA2 mRNA	PMID:22206623
1305325	Plxna2	plexin A2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PLXNA2 mRNA	PMID:24136188
1305325	Plxna2	plexin A2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313288	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PLXNA2 mRNA	PMID:22079256
1305325	Plxna2	plexin A2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLXNA2 mRNA	PMID:22079256
1305325	Plxna2	plexin A2	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PLXNA2 mRNA	PMID:36139627
1305325	Plxna2	plexin A2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of PLXNA2 mRNA	PMID:21346803
1305325	Plxna2	plexin A2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1305325	Plxna2	plexin A2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PLXNA2 gene]	PMID:28238834
1305325	Plxna2	plexin A2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of PLXNA2 mRNA	PMID:19270015|PMID:23091169
1305325	Plxna2	plexin A2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PLXNA2 mRNA	PMID:32109520
1305325	Plxna2	plexin A2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313289	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PLXNA2 mRNA	PMID:24680724
1305325	Plxna2	plexin A2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PLXNA2 mRNA	PMID:21394737
1305325	Plxna2	plexin A2	gene	CHEBI:82299	3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone	affects response to substance	ISO	RGD:1313288	E	RGD:6480464	20150609	CTD	MESH:C054121	PLXNA2 gene SNP affects the susceptibility to 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone	PMID:25622337
1305325	Plxna2	plexin A2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313289	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PLXNA2 mRNA	PMID:39847705
1305325	Plxna2	plexin A2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PLXNA2 mRNA	PMID:21278054
1305325	Plxna2	plexin A2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLXNA2 mRNA	PMID:24780913
1305325	Plxna2	plexin A2	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313288	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PLXNA2 mRNA	PMID:26272509
1305325	Plxna2	plexin A2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1305325	Plxna2	plexin A2	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Ozone results in increased expression of PLXNA2 mRNA]	PMID:17460151
1305325	Plxna2	plexin A2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313288	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1305325	Plxna2	plexin A2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313289	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of PLXNA2 mRNA	PMID:27131904
1305325	Plxna2	plexin A2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PLXNA2 mRNA	PMID:21346803
1305325	Plxna2	plexin A2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313288	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PLXNA2 mRNA	PMID:38568856
1305325	Plxna2	plexin A2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PLXNA2 mRNA	PMID:28973697
1305325	Plxna2	plexin A2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C025643	vinclozolin results in decreased expression of PLXNA2 mRNA	PMID:30207508
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MCUB mRNA	PMID:26272509
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20170613	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA	PMID:27188386
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCUB mRNA	PMID:20938992
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of MCUB mRNA	PMID:21934132|PMID:23724009
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1332347	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MCUB mRNA	PMID:30529165
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MCUB mRNA	PMID:21632981
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MCUB mRNA	PMID:35811015
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D004958	Estradiol results in increased expression of MCUB mRNA	PMID:19484750
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1332347	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of MCUB mRNA	PMID:33711761
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1602886	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MCUB mRNA	PMID:38568856
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MCUB mRNA	PMID:33387578
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCUB mRNA	PMID:20938992
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602886	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MCUB mRNA	PMID:37042841
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D011374	Progesterone results in decreased expression of MCUB mRNA	PMID:22238285
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332347	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCUB mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MCUB mRNA	PMID:37567420|PMID:37992649
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332347	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCUB mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MCUB mRNA	PMID:37567420|PMID:37992649
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MCUB mRNA	PMID:33387578
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MCUB mRNA	PMID:35301059
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MCUB mRNA	PMID:19549813
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MCUB mRNA	PMID:30779732
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCUB mRNA	PMID:20938992
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of MCUB mRNA	PMID:40512198
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MCUB mRNA	PMID:26272509
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20170613	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA	PMID:27188386
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1602886	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of MCUB mRNA	PMID:27594783
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1602886	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MCUB mRNA	PMID:24768652|PMID:25583101
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCUB mRNA	PMID:22298810
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1602886	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCUB mRNA	PMID:22574217
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MCUB mRNA	PMID:19770486
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCUB mRNA	PMID:33387578
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20170613	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MCUB mRNA	PMID:28001369
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1332347	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of MCUB mRNA	PMID:39631538
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332347	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCUB mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MCUB mRNA	PMID:37567420|PMID:37992649
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1602886	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of MCUB mRNA	PMID:34032870
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1332347	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCUB mRNA	PMID:37682722
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCUB mRNA	PMID:38568856
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of MCUB mRNA	PMID:40512198
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCUB mRNA	PMID:19770486
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCUB mRNA	PMID:20064835
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCUB mRNA	PMID:22228805
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MCUB mRNA	PMID:23221170
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of MCUB mRNA	PMID:32479839
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of MCUB mRNA	PMID:31745603
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:32234	titanium dioxide	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide affects the expression of MCUB mRNA	PMID:30012374
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332347	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MCUB gene	PMID:35295148
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MCUB mRNA	PMID:34492290
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MCUB mRNA	PMID:30723492
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MCUB mRNA	PMID:29275510
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MCUB mRNA	PMID:25181051
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332347	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MCUB mRNA	PMID:32156529
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1602886	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MCUB mRNA	PMID:25979313
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1332347	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MCUB gene	PMID:31683443
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1332347	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of MCUB mRNA	PMID:28392331
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MCUB mRNA	PMID:30723492
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MCUB mRNA	PMID:35301059
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MCUB mRNA	PMID:24449571
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MCUB mRNA	PMID:31533062
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1602886	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MCUB mRNA	PMID:19167446
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCUB mRNA	PMID:19167446
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:39481	chloroprene	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of MCUB mRNA	PMID:23125180
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602886	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MCUB mRNA	PMID:25979313
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602886	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MCUB mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D016572	Cyclosporine results in decreased expression of MCUB mRNA	PMID:19770486
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MCUB mRNA	PMID:25562108
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1602886	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MCUB mRNA	PMID:20106945
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1602886	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of MCUB promoter	PMID:27989131
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:41791	calyculin A	increases expression	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:C059041	calyculin A results in increased expression of MCUB mRNA	PMID:25270620
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1332347	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MCUB mRNA	PMID:28973697
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332347	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCUB mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MCUB mRNA	PMID:37567420|PMID:37992649
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1602886	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MCUB mRNA	PMID:38832940
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1602886	E	RGD:6480464	20170613	CTD	MESH:C111237	vorinostat results in increased expression of MCUB mRNA	PMID:27188386
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MCUB mRNA	PMID:24935251|PMID:26272509
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20170613	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA	PMID:27188386
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MCUB mRNA	PMID:35811015
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of MCUB mRNA	PMID:40512198
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of MCUB mRNA	PMID:29391264
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332347	E	RGD:6480464	20170613	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MCUB mRNA; Nanotubes, Carbon results in increased expression of MCUB mRNA	PMID:25554681
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332347	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MCUB mRNA	PMID:22206623
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1332347	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MCUB mRNA	PMID:37567420
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20170613	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA	PMID:27188386
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MCUB mRNA	PMID:32109520
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCUB mRNA	PMID:19167446
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1332347	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MCUB mRNA	PMID:38648751
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MCUB mRNA	PMID:27291303
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MCUB mRNA	PMID:23640034
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of MCUB mRNA	PMID:26272509
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20170613	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA	PMID:27188386
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602886	E	RGD:6480464	20170613	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCUB mRNA	PMID:27188386
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MCUB mRNA	PMID:38568856
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1602886	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MCUB mRNA	PMID:29301935
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1602886	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of MCUB mRNA	PMID:22378314
1305326	Mcub	mitochondrial calcium uniporter dominant negative subunit beta	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of MCUB gene	PMID:31079544
1305327	Nol12	nucleolar protein 12	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313291	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NOL12 mRNA	PMID:33045310
1305327	Nol12	nucleolar protein 12	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313291	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOL12 mRNA	PMID:30529165
1305327	Nol12	nucleolar protein 12	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1601850	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NOL12 mRNA	PMID:22378314
1305327	Nol12	nucleolar protein 12	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1601850	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of NOL12 protein	PMID:35688186
1305327	Nol12	nucleolar protein 12	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313291	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NOL12 mRNA	PMID:39241906
1305327	Nol12	nucleolar protein 12	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313291	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of NOL12 mRNA	PMID:28973375
1305327	Nol12	nucleolar protein 12	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1601850	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NOL12 protein	PMID:37730182
1305327	Nol12	nucleolar protein 12	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NOL12 mRNA	PMID:33387578
1305327	Nol12	nucleolar protein 12	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313291	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NOL12 mRNA	PMID:36331819
1305327	Nol12	nucleolar protein 12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1601850	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of NOL12 mRNA	PMID:35430440
1305327	Nol12	nucleolar protein 12	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOL12 mRNA	PMID:31150632
1305327	Nol12	nucleolar protein 12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313291	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NOL12 mRNA	PMID:22206623
1305327	Nol12	nucleolar protein 12	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1601850	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of NOL12 protein	PMID:35688186
1305327	Nol12	nucleolar protein 12	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313291	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of NOL12 protein	PMID:25505154
1305327	Nol12	nucleolar protein 12	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of NOL12 mRNA	PMID:20187946
1305327	Nol12	nucleolar protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NOL12 mRNA	PMID:22298810
1305327	Nol12	nucleolar protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313291	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NOL12 mRNA	PMID:21570461
1305327	Nol12	nucleolar protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NOL12 mRNA	PMID:34747641
1305327	Nol12	nucleolar protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NOL12 mRNA	PMID:33387578
1305327	Nol12	nucleolar protein 12	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1601850	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of NOL12 mRNA	PMID:23649840
1305327	Nol12	nucleolar protein 12	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1601850	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of NOL12 mRNA	PMID:24690739
1305327	Nol12	nucleolar protein 12	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1601850	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NOL12 mRNA	PMID:29803840
1305327	Nol12	nucleolar protein 12	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1601850	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NOL12 mRNA	PMID:38568856
1305327	Nol12	nucleolar protein 12	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1601850	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NOL12 promoter	PMID:27901495
1305327	Nol12	nucleolar protein 12	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1601850	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of NOL12 mRNA	PMID:24690739
1305327	Nol12	nucleolar protein 12	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of NOL12 mRNA	PMID:24136188
1305327	Nol12	nucleolar protein 12	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313291	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NOL12 gene	PMID:35295148
1305327	Nol12	nucleolar protein 12	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NOL12 mRNA	PMID:23411599|PMID:34492290
1305327	Nol12	nucleolar protein 12	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NOL12 mRNA	PMID:25181051
1305327	Nol12	nucleolar protein 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1601850	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NOL12 mRNA	PMID:29275510
1305327	Nol12	nucleolar protein 12	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1601850	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of NOL12 mRNA	PMID:25979313
1305327	Nol12	nucleolar protein 12	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313291	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of NOL12 mRNA	PMID:38685157
1305327	Nol12	nucleolar protein 12	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of NOL12 mRNA	PMID:32680482
1305327	Nol12	nucleolar protein 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1601850	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NOL12 mRNA	PMID:37042841
1305327	Nol12	nucleolar protein 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313291	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NOL12 mRNA	PMID:36331819
1305327	Nol12	nucleolar protein 12	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1601850	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of NOL12 mRNA	PMID:29154799
1305327	Nol12	nucleolar protein 12	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1601850	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NOL12 mRNA	PMID:23179753
1305327	Nol12	nucleolar protein 12	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1601850	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of NOL12 mRNA	PMID:22147139
1305327	Nol12	nucleolar protein 12	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1601850	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of NOL12 mRNA	PMID:28542535
1305327	Nol12	nucleolar protein 12	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313291	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NOL12 mRNA	PMID:17562736
1305327	Nol12	nucleolar protein 12	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NOL12 mRNA	PMID:33387578
1305327	Nol12	nucleolar protein 12	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1601850	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of NOL12 mRNA	PMID:24690739
1305327	Nol12	nucleolar protein 12	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NOL12 mRNA	PMID:29391264
1305327	Nol12	nucleolar protein 12	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313291	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of NOL12 mRNA	PMID:35436446
1305327	Nol12	nucleolar protein 12	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313291	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NOL12 mRNA; Nanotubes, Carbon results in increased expression of NOL12 mRNA	PMID:25554681
1305327	Nol12	nucleolar protein 12	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NOL12 mRNA	PMID:24136188
1305327	Nol12	nucleolar protein 12	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313291	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NOL12 mRNA	PMID:22206623
1305327	Nol12	nucleolar protein 12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313291	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NOL12 mRNA	PMID:22206623
1305327	Nol12	nucleolar protein 12	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313291	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NOL12 mRNA	PMID:30294300
1305327	Nol12	nucleolar protein 12	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313291	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of NOL12 mRNA	PMID:40826991
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313296	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ALOX12B mRNA	PMID:37995155
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:15843	arachidonic acid	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20191112	CTD	MESH:D016718	[TP53 protein results in increased expression of ALOX12B mRNA] which results in increased metabolism of Arachidonic Acid	PMID:30258081
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313296	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ALOX12B mRNA	PMID:30319688
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313295	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of ALOX12B mRNA	PMID:27664576
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313296	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ALOX12B mRNA	PMID:39922521
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313295	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ALOX12B mRNA	PMID:31256213
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313296	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ALOX12B mRNA	PMID:39922521
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX12B mRNA	PMID:29950665
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313295	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ALOX12B mRNA	PMID:23649840
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313295	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ALOX12B mRNA	PMID:22100608
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313295	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ALOX12B gene	PMID:27153756
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313295	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ALOX12B mRNA	PMID:23649840
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ALOX12B mRNA	PMID:22206623
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ALOX12B mRNA	PMID:32525701
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1313295	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ALOX12B mRNA	PMID:38460933
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ALOX12B mRNA	PMID:38460933
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ALOX12B mRNA	PMID:27392435
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ALOX12B mRNA	PMID:32109520
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ALOX12B mRNA	PMID:15251184
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313295	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALOX12B mRNA	PMID:21296121|PMID:23152189
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313296	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALOX12B mRNA	PMID:17035482
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20120412	CTD	MESH:D013749	[decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ALOX12B mRNA	PMID:15251184
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313295	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ALOX12B mRNA	PMID:30851411
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313295	E	RGD:6480464	20191112	CTD	MESH:D004317	Doxorubicin results in increased expression of ALOX12B mRNA	PMID:30258081
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20191112	CTD	MESH:D004317	TP53 gene mutant form inhibits the reaction [Doxorubicin results in increased expression of ALOX12B mRNA]; TP53 protein promotes the reaction [Doxorubicin results in increased expression of ALOX12B mRNA]	PMID:30258081
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313295	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ALOX12B gene	PMID:28589171
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ALOX12B mRNA	PMID:37682722
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313295	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ALOX12B intron	PMID:30157460
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ALOX12B mRNA	PMID:22228805
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313295	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ALOX12B 3' UTR; Benzo(a)pyrene results in decreased methylation of ALOX12B exon	PMID:27901495
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313295	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ALOX12B mRNA	PMID:32234424
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313295	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ALOX12B promoter	PMID:27901495
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ALOX12B mRNA	PMID:29264374
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX12B mRNA	PMID:29950665
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313296	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ALOX12B mRNA	PMID:20813756
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALOX12B mRNA	PMID:28628672
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ALOX12B mRNA	PMID:26377693
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX12B mRNA	PMID:29950665
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALOX12B mRNA	PMID:28628672
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313296	E	RGD:6480464	20190219	CTD	MESH:D010269	Paraquat results in increased expression of ALOX12B mRNA	PMID:28012437
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ALOX12B mRNA	PMID:17585979
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313295	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ALOX12B gene	PMID:29154799
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALOX12B mRNA	PMID:28628672
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313296	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ALOX12B mRNA	PMID:39922521
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313295	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ALOX12B mRNA	PMID:38832940
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313296	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ALOX12B mRNA	PMID:17562736
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ALOX12B mRNA	PMID:38460933
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ALOX12B mRNA	PMID:32525701
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1313295	E	RGD:6480464	20171010	CTD	MESH:D004726	Endosulfan results in increased expression of ALOX12B mRNA	PMID:28108160|PMID:40706910
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALOX12B mRNA	PMID:28628672
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of ALOX12B mRNA	PMID:15251184
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ALOX12B mRNA	PMID:15251184
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ALOX12B mRNA	PMID:23608068
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:5855	ibuprofen	affects expression	ISO	RGD:1313295	E	RGD:6480464	20120412	CTD	MESH:D007052	Ibuprofen affects the expression of ALOX12B mRNA	PMID:17070997
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ALOX12B mRNA	PMID:22206623
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:7553	niclosamide	decreases response to substance	ISO	RGD:1313295	E	RGD:6480464	20191114	CTD	MESH:D009534	ALOX12B protein results in decreased susceptibility to Niclosamide	PMID:30258081
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1313295	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in increased expression of ALOX12B mRNA	PMID:30258081
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1313296	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in increased expression of ALOX12B mRNA	PMID:30258081
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:7553	niclosamide	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20191114	CTD	MESH:D009534	TP53 gene mutant form inhibits the reaction [Niclosamide results in increased expression of ALOX12B mRNA]; TP53 protein mutant form inhibits the reaction [Niclosamide results in increased expression of ALOX12B mRNA]	PMID:30258081
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313295	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ALOX12B mRNA	PMID:30851411
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ALOX12B gene]	PMID:28238834
1305330	Alox12b	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313295	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ALOX12B mRNA	PMID:32525701
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of TPST2 mRNA	PMID:35967413
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TPST2 mRNA	PMID:39752319
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TPST2 mRNA	PMID:21632981
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TPST2 mRNA	PMID:39241906
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of TPST2 gene	PMID:21212295
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313297	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TPST2 mRNA	PMID:37042841
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313297	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TPST2 mRNA	PMID:21179406
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TPST2 mRNA	PMID:22401849
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TPST2 mRNA	PMID:39752319
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of TPST2 mRNA	PMID:33359661
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313298	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TPST2 mRNA	PMID:33754040
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313297	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TPST2 mRNA	PMID:28818685
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TPST2 mRNA	PMID:27153756
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TPST2 mRNA	PMID:34911549
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313297	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TPST2 mRNA	PMID:18593933
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TPST2 mRNA	PMID:22206623
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TPST2 mRNA	PMID:40504410
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313298	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TPST2 mRNA	PMID:21570461
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TPST2 mRNA	PMID:17949056
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TPST2 mRNA	PMID:33387578|PMID:34747641
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TPST2 mRNA	PMID:19933214
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases methylation	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased methylation of TPST2 gene	PMID:21212295
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TPST2 mRNA; [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of TPST2 gene	PMID:17942748|PMID:21212295
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TPST2 mRNA	PMID:23179753
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313297	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TPST2 mRNA	PMID:33212167
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TPST2 protein	PMID:28918527
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TPST2 mRNA	PMID:40504410
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313297	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TPST2 5' UTR	PMID:27901495
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TPST2 mRNA	PMID:32234424
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313298	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TPST2 exon; Benzo(a)pyrene results in decreased methylation of TPST2 intron	PMID:27901495
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313297	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TPST2 mRNA	PMID:18593933
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of TPST2 mRNA	PMID:24136188
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TPST2 mRNA	PMID:30047161
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TPST2 mRNA	PMID:29264374
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313298	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TPST2 gene	PMID:35295148
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TPST2 mRNA	PMID:19162173
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TPST2 mRNA	PMID:19167457
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TPST2 mRNA	PMID:25181051
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313298	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TPST2 promoter	PMID:27312807
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313298	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of TPST2 mRNA	PMID:39298647
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313298	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TPST2 gene	PMID:31683443
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of TPST2 mRNA	PMID:21241498
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313298	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TPST2 mRNA	PMID:37019170
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TPST2 mRNA	PMID:17917374
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313297	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TPST2 mRNA	PMID:37042841
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of TPST2 mRNA	PMID:30589522
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TPST2 mRNA	PMID:40194260
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313297	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TPST2 mRNA	PMID:23179753|PMID:23527032
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TPST2 mRNA	PMID:30047161
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TPST2 mRNA	PMID:25562108
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313297	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TPST2 mRNA	PMID:14699072
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:43572	kojic acid	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:C011890	[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TPST2 mRNA	PMID:17917374
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of TPST2 mRNA	PMID:24136188
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TPST2 mRNA	PMID:26272509
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313297	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPST2 mRNA	PMID:27188386
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TPST2 mRNA	PMID:17562736
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TPST2 mRNA	PMID:33387578
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313297	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TPST2 mRNA	PMID:29067470
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313297	E	RGD:6480464	20120412	CTD	MESH:D005472	TPST2 protein affects the susceptibility to Fluorouracil	PMID:16217747
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TPST2 mRNA	PMID:24714768
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TPST2 mRNA	PMID:40504410
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TPST2 mRNA	PMID:29391264
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313297	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TPST2 mRNA	PMID:22079256
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TPST2 mRNA	PMID:17942748
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TPST2 mRNA	PMID:30047161
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of TPST2 mRNA	PMID:19162173
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TPST2 mRNA	PMID:35964746
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of TPST2 mRNA	PMID:24136188
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313297	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TPST2 mRNA	PMID:15336504
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TPST2 gene	PMID:35440735
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TPST2 mRNA	PMID:39752319
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TPST2 mRNA	PMID:31758290
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TPST2 mRNA	PMID:22206623
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TPST2 mRNA	PMID:22206623
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313297	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TPST2 mRNA	PMID:22079256
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313297	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TPST2 mRNA	PMID:22079256
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313297	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPST2 mRNA	PMID:27188386
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TPST2 mRNA	PMID:19162173
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TPST2 mRNA	PMID:30047161
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TPST2 mRNA	PMID:39752319
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313297	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPST2 mRNA	PMID:27188386
1305331	Tpst2	tyrosylprotein sulfotransferase 2	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of TPST2 gene	PMID:31079544
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313299	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of MDM2 mRNA	PMID:31863870
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D015215	Zidovudine results in increased expression of MDM2 protein	PMID:16797627
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:113532	thymoquinone	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in decreased expression of MDM2 protein	PMID:31433961|PMID:34627931
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:119486	efavirenz	increases expression	ISO	RGD:1313299	E	RGD:6480464	20260303	CTD	MESH:C098320	efavirenz results in increased expression of MDM2 mRNA	PMID:40582629
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:1224	2-nitrofluorene	increases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C019499	2-nitrofluorene results in increased expression of MDM2 mRNA	PMID:14600272|PMID:15890375|PMID:22484513|PMID:23052194
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313300	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MDM2 mRNA	PMID:33045310
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MDM2 mRNA]	PMID:31150632
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1313299	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of MDM2 mRNA	PMID:31016361
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:136609	theaflavin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20180206	CTD	MESH:C056068	[theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]	PMID:23717041
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	ISO	RGD:1313299	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of MDM2 mRNA	PMID:19000754
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MDM2 gene	PMID:20938992
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120501	CTD	MESH:D001241	Aspirin results in decreased expression of MDM2 mRNA	PMID:20457246
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120814	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MDM2 mRNA; Oxygen deficiency results in increased expression of MDM2 protein	PMID:19502547|PMID:19578757|PMID:19714248|PMID:25596134
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D010100	[Cisplatin co-treated with eprenetapopt co-treated with Oxygen deficiency] results in increased expression of MDM2 mRNA; [Oxygen deficiency co-treated with eprenetapopt] results in increased expression of MDM2 mRNA; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]]; Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 protein]	PMID:19578757|PMID:29690507
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MDM2 mRNA	PMID:30529165
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:15600	(+)-catechin	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20170207	CTD	MESH:D002392	Catechin results in decreased expression of MDM2 mRNA	PMID:23706674
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:15738	staurosporine	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D019311	Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]]	PMID:15542774
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:15864	luteolin	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D047311	Luteolin results in increased expression of MDM2 mRNA	PMID:31201582
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:15864	luteolin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D047311	Luteolin promotes the reaction [Hydrogen Peroxide results in increased expression of MDM2 mRNA]	PMID:27525270
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MDM2 gene	PMID:28931070|PMID:35440735
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16096	palmatine	affects binding	ISO	RGD:1313299	E	RGD:6480464	20230606	CTD	MESH:C005413	palmatine binds to MDM2 protein	PMID:35997646
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16130	DDT	increases expression	ISO	RGD:1313300	E	RGD:6480464	20140211	CTD	MESH:D003634	DDT results in increased expression of MDM2 mRNA; DDT results in increased expression of MDM2 protein	PMID:23684557
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16130	DDT	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20140211	CTD	MESH:D003634	Androstanols inhibits the reaction [DDT results in increased expression of MDM2 mRNA]	PMID:23684557
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20130416	CTD	MESH:D000431	Ethanol results in decreased expression of MDM2 mRNA	PMID:22535522
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20151013	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of MDM2 protein	PMID:25005833
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of MDM2 mRNA	PMID:14689451|PMID:27525270
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20180703	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of MDM2 mRNA	PMID:21751221
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D006861	[Quercetin co-treated with Hydrogen Peroxide] results in increased expression of MDM2 mRNA; Hydrogen Peroxide results in increased expression of and affects the localization of MDM2 protein; Luteolin promotes the reaction [Hydrogen Peroxide results in increased expression of MDM2 mRNA]	PMID:14689451|PMID:27525270
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D006861	EUK-134 inhibits the reaction [Hydrogen Peroxide results in decreased expression of MDM2 protein]; Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein]; Hydrogen Peroxide promotes the reaction [TP53 protein binds to MDM2 promoter]; Hydrogen Peroxide promotes the reaction [TP53 protein results in increased expression of MDM2]	PMID:21552291|PMID:25005833
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide promotes the reaction [TRP53 protein results in increased expression of MDM2]	PMID:21552291
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20170207	CTD	MESH:D011794	Quercetin results in decreased expression of MDM2 protein	PMID:21933852
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D011794	Quercetin results in increased expression of MDM2 mRNA	PMID:31201582
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170110	CTD	MESH:D011794	Quercetin results in increased expression of MDM2 mRNA	PMID:21632981|PMID:23727915|PMID:24849437
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D011794	[Quercetin co-treated with Hydrogen Peroxide] results in increased expression of MDM2 mRNA	PMID:27525270
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of and results in decreased expression of MDM2 protein	PMID:17973296
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20230502	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MDM2 mRNA	PMID:35953652
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313300	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MDM2 mRNA	PMID:10975854|PMID:23107598
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20161228	CTD	MESH:D008070	Indirubin E804 inhibits the reaction [Lipopolysaccharides results in increased expression of MDM2 mRNA]	PMID:23107598
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16469	17beta-estradiol	decreases phosphorylation	ISO	RGD:1313300	E	RGD:6480464	20120717	CTD	MESH:D004958	Estradiol results in decreased phosphorylation of MDM2 protein	PMID:22314386
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MDM2 mRNA alternative form; Estradiol results in increased expression of MDM2 protein	PMID:12168835
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20140211	CTD	MESH:D004958	Estradiol results in increased expression of MDM2 mRNA; Estradiol results in increased expression of MDM2 protein	PMID:23684557
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20130514	CTD	MESH:D004958	[Estradiol co-treated with Parathion] results in increased expression of MDM2 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of MDM2 mRNA	PMID:17622325|PMID:30165855
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:165199	Paraoxon-methyl	increases expression	ISO	RGD:1313299	E	RGD:6480464	20201208	CTD	MESH:C008480	methylparaoxon results in increased expression of MDM2 mRNA	PMID:18418871
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:165219	PCB138	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16602	trichloroethene	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene affects the expression of MDM2 mRNA	PMID:21135412
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MDM2 mRNA	PMID:33387578
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16602	trichloroethene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014241	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of MDM2 mRNA	PMID:17905399
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MDM2 gene	PMID:20938992
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120918	CTD	MESH:D001554	Benzene results in increased expression of MDM2 mRNA	PMID:11896287|PMID:15342939|PMID:15935812
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16716	benzene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of MDM2 mRNA	PMID:17905399
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120814	CTD	MESH:D001554	MDM2 gene polymorphism affects the reaction [CDKN2A gene polymorphism affects the susceptibility to Benzene]	PMID:19596022
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D001554	TRP53 protein affects the reaction [Benzene results in increased expression of MDM2 mRNA]	PMID:11896287
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of MDM2 mRNA; Formaldehyde results in increased expression of MDM2 protein	PMID:18045764
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MDM2 mRNA; Formaldehyde results in increased expression of MDM2 protein	PMID:18045764|PMID:23649840
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313299	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of MDM2 mRNA	PMID:26079696
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17154	nicotinamide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D009536	Niacinamide results in increased expression of MDM2 mRNA	PMID:16998810
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20150127	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MDM2 protein	PMID:24706461
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313300	E	RGD:6480464	20250311	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of MDM2 mRNA	PMID:20463053|PMID:33162236
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MDM2 mRNA	PMID:20403060
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17356	2-acetamidofluorene	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of MDM2 mRNA; 2-Acetylaminofluorene results in increased expression of MDM2 protein	PMID:19167416|PMID:22213190|PMID:22584684
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of MDM2 mRNA	PMID:21607683
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17356	2-acetamidofluorene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015073	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of MDM2 protein	PMID:11003613
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:174442	Carbadox	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D002218	Carbadox results in increased expression of MDM2 mRNA	PMID:26558467
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17580	linalool	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120717	CTD	MESH:C018584	linalool results in increased expression of MDM2 mRNA	PMID:19922762
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:175901	gemcitabine	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in decreased expression of MDM2 mRNA	PMID:20103597
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:175901	gemcitabine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased expression of MDM2 mRNA	PMID:17039268
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313299	E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in increased expression of MDM2 mRNA	PMID:29221148
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MDM2 mRNA	PMID:23892564
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20190312	CTD	MESH:D009538	[[Nicotine results in decreased expression of RPS27A protein] which results in increased phosphorylation of MDM2 protein] which results in increased ubiquitination of TP53 protein; [Nicotine results in decreased expression of RPS27A protein] which results in increased phosphorylation of MDM2 protein	PMID:30272249
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:177387	brequinar	increases expression	ISO	RGD:1313299	E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in increased expression of MDM2 mRNA	PMID:39900124
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased phosphorylation of MDM2 protein	PMID:31163220
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313299	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MDM2 mRNA	PMID:31163220
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MDM2 protein	PMID:37730182
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MDM2 mRNA	PMID:22061828|PMID:33387578
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:1784	biphenyl-4-amine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20210406	CTD	MESH:C006757	4-biphenylamine results in increased expression of MDM2 mRNA	PMID:32905825
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:1784	biphenyl-4-amine	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20210406	CTD	MESH:C006757	TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of MDM2 mRNA]	PMID:32905825
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17846	(S)-naringenin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20230207	CTD	MESH:C005273	naringenin metabolite results in increased expression of MDM2 mRNA	PMID:36235125
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17846	(S)-naringenin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin co-treated with bisphenol A] results in increased expression of MDM2 mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of MDM2 mRNA	PMID:36235125
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:17967	urethane	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D014520	[Urethane co-treated with Freund's Adjuvant] results in increased expression of MDM2 mRNA	PMID:12400877
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:180692	EUK-134	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20211109	CTD	MESH:C433928	EUK-134 inhibits the reaction [Hydrogen Peroxide results in decreased expression of MDM2 protein]; EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of MDM2 protein]	PMID:25005833
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:18088	formononetin	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C007768	formononetin results in increased expression of MDM2 protein	PMID:28414026
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:181416	Leucomalachite green	increases phosphorylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C015320	leucomalachite green results in increased phosphorylation of MDM2 protein	PMID:26558467
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008345	Manganese results in decreased expression of MDM2 protein	PMID:25791630
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D008345	[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein]	PMID:25791630
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:184401	3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20220104	CTD	MESH:C045421	3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of MDM2 mRNA	PMID:23810796
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20190312	CTD	MESH:D009538	[[Nicotine results in decreased expression of RPS27A protein] which results in increased phosphorylation of MDM2 protein] which results in increased ubiquitination of TP53 protein; [Nicotine results in decreased expression of RPS27A protein] which results in increased phosphorylation of MDM2 protein	PMID:30272249
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:188855	Octicizer	increases expression	ISO	RGD:1313299	E	RGD:6480464	20220104	CTD	MESH:C018535	2-ethylhexyldiphenylphosphate results in increased expression of MDM2 mRNA	PMID:30981936
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:195250	corn oil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D003314	Corn Oil results in decreased expression of MDM2 mRNA	PMID:22760963
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:196991	4-hydroperoxycyclophosphamide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:C011272	perfosfamide results in increased expression of MDM2	PMID:18034189
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:201674	icaritin	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20240806	CTD	MESH:C499403	icaritin results in decreased expression of MDM2 protein	PMID:38431053
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of MDM2 mRNA	PMID:20823114
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of MDM2 mRNA	PMID:12634122
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120814	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of MDM2 protein	PMID:12135628
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120814	CTD	MESH:D008769	Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in increased expression of MDM2 protein]	PMID:12135628
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:229764	selinexor	increases expression	ISO	RGD:1313299	E	RGD:6480464	20240409	CTD	MESH:C585161	selinexor results in increased expression of MDM2 protein	PMID:37899423
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:229764	selinexor	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20240409	CTD	MESH:C585161	[INCB057643 co-treated with selinexor] results in increased expression of MDM2 protein	PMID:37899423
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D002104	Cadmium results in decreased expression of MDM2 mRNA	PMID:21467746
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D002104	Cadmium results in increased expression of MDM2 mRNA	PMID:22666406
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20251202	CTD	MESH:D002104	[sulforaphane co-treated with Cadmium] results in increased expression of MDM2 mRNA	PMID:31035011
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	EXP		E	RGD:6480464	20240409	CTD	MESH:C121565	pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of MDM2 mRNA]	PMID:17487067
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20240409	CTD	MESH:C121565	pifithrin inhibits the reaction [Doxorubicin results in increased expression of MDM2 mRNA]; pifithrin inhibits the reaction [Vehicle Emissions results in decreased expression of MDM2 protein]	PMID:14766674|PMID:18940243
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:231415	DENSPM	increases expression	ISO	RGD:1313299	E	RGD:6480464	20240604	CTD	MESH:C059685	N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein	PMID:15546879
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:231415	DENSPM	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20240604	CTD	MESH:C059685	Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]]; TP53 protein promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]	PMID:15546879
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:232486	5-ethynyl-2'-deoxyuridine	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20260804	CTD	MESH:C031086	5-ethynyl-2'-deoxyuridine results in decreased expression of MDM2 protein	PMID:42178126
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:232796	cadmium acetate	increases expression	ISO	RGD:1313299	E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in increased expression of MDM2 protein	PMID:15450950
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20250408	CTD	MESH:C081766	2,4,4'-trichlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709|PMID:20840854
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20250408	CTD	MESH:C081766	2,4,4'-trichlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]	PMID:20840854
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20250408	CTD	MESH:C009828	2,4,5,2',5'-pentachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709|PMID:20840854
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20250408	CTD	MESH:C009828	2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; MDM2 mutant form inhibits the reaction [2,4,5,2',5'-pentachlorobiphenyl results in decreased phosphorylation of FOXO3 protein]	PMID:20840854
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:23704	diepoxybutane	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20121009	CTD	MESH:C007366	diepoxybutane inhibits the reaction [TP53 protein binds to MDM2 protein]	PMID:20024960
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MDM2 mRNA	PMID:23649840
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased expression of MDM2 mRNA	PMID:15954086
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased expression of MDM2 mRNA	PMID:19100860
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MDM2 protein	PMID:20106945
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313299	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MDM2 gene	PMID:27153756
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MDM2 mRNA	PMID:14600272|PMID:15890375|PMID:22484513|PMID:23052194|PMID:23630614|PMID:25378103|PMID:33354967
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313299	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MDM2 mRNA	PMID:21632981|PMID:21641981|PMID:27153756|PMID:29445054|PMID:31555880|PMID:32234424
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MDM2 mRNA	PMID:19770486
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313299	E	RGD:6480464	20141223	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MDM2 mRNA; Methyl Methanesulfonate results in increased expression of MDM2 protein	PMID:23649840|PMID:25078064
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of MDM2 mRNA	PMID:15651846
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20210608	CTD	MESH:D009151	Mustard Gas results in increased expression of MDM2 mRNA	PMID:33491125
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120501	CTD	MESH:D009151	Mustard Gas results in increased expression of MDM2 mRNA	PMID:15674843|PMID:18955075
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20140610	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of MDM2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA	PMID:23717041|PMID:32553695
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20140610	CTD	MESH:D015127	[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]	PMID:23717041
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2636	amifostine	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D004999	Amifostine results in decreased expression of MDM2 mRNA	PMID:14555708
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20180313	CTD	MESH:D017382	[[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in increased expression of MDM2 protein	PMID:27634759
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MDM2 mRNA	PMID:30779732
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2687	amsacrine	decreases response to substance	ISO	RGD:1313299	E	RGD:6480464	20161213	CTD	MESH:D000677	MDM2 promoter SNP results in decreased susceptibility to Amsacrine	PMID:17575151
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27363	zinc atom	affects expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of MDM2 protein	PMID:16636310
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27363	zinc atom	increases ubiquitination	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in increased ubiquitination of MDM2 protein	PMID:16965791
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc binds to and results in increased folding of MDM2 protein; Zinc promotes the reaction [MDM2 protein binds to MDM2 protein]; Zinc promotes the reaction [MDM2 protein binds to MDM4 protein]	PMID:16965791
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MDM2 mRNA	PMID:31150632
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313300	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MDM2 mRNA	PMID:31919559
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MDM2 mRNA]	PMID:31150632
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27470	folic acid	affects expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the expression of MDM2 mRNA	PMID:16361273
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MDM2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MDM2 gene	PMID:20938992|PMID:22206623
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1313299	E	RGD:6480464	20121009	CTD	MESH:D016685	Mitomycin results in increased expression of MDM2 protein	PMID:18096571
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1313300	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of MDM2 mRNA	PMID:25270620
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27504	mitomycin C	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120717	CTD	MESH:D016685	[Mitomycin results in increased stability of TP53 protein] which results in increased expression of MDM2 mRNA	PMID:20536192
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313299	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MDM2 gene	PMID:25304211
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27563	arsenic atom	affects response to substance	ISO	RGD:1313299	E	RGD:6480464	20120918	CTD	MESH:D001151	MDM2 SNP affects the susceptibility to Arsenic	PMID:21982800
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1313299	E	RGD:6480464	20240402	CTD	MESH:D001151	Arsenic results in increased expression of MDM2 protein	PMID:35821281
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20240402	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MDM2 mRNA; USP7 protein affects the reaction [Arsenic results in increased expression of MDM2 protein]	PMID:35821281|PMID:39836092
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1313299	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of MDM2 mRNA	PMID:33512557
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27638	cobalt atom	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140114	CTD	MESH:D003035	Cobalt results in increased expression of MDM2 mRNA	PMID:24068677
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27638	cobalt atom	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20140114	CTD	MESH:D003035	TP53 protein affects the reaction [Cobalt results in increased expression of MDM2 mRNA]	PMID:24068677
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D002166	Camptothecin results in increased expression of MDM2 protein	PMID:17555331
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1313299	E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of MDM2 mRNA	PMID:38460933
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of MDM2 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of MDM2 protein	PMID:38460933
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313299	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MDM2 mRNA	PMID:26272509
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA	PMID:27188386
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MDM2 protein	PMID:35688186
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MDM2 mRNA	PMID:31295307
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MDM2 mRNA	PMID:31881176
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27871	chloroacetaldehyde	increases expression	ISO	RGD:1313299	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of MDM2 mRNA	PMID:25596134
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol affects the expression of MDM2 protein	PMID:16369916
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120613	CTD	MESH:C059514	resveratrol results in decreased expression of MDM2 mRNA; resveratrol results in decreased expression of MDM2 protein	PMID:16998810|PMID:19846903|PMID:20878097|PMID:25667456
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313299	E	RGD:6480464	20150714	CTD	MESH:C059514	resveratrol results in increased expression of MDM2 mRNA	PMID:15280659|PMID:15767336|PMID:25888808
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of MDM2 mRNA; resveratrol results in increased expression of MDM2 protein	PMID:11245472|PMID:16081268|PMID:16369916
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MDM2 mRNA; Capsaicin promotes the reaction [Resveratrol results in decreased expression of MDM2 protein]; EGF protein inhibits the reaction [Resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]; Resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]; Resveratrol promotes the reaction [Capsaicin results in decreased expression of MDM2 protein]; Staurosporine inhibits the reaction [EGF protein inhibits the reaction [Resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]]; TP53 affects the reaction [Resveratrol results in decreased expression of MDM2 protein]	PMID:15542774|PMID:19846903|PMID:23557933
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20121218	CTD	MESH:C059514	[resveratrol results in increased phosphorylation of TRP53 protein] inhibits the reaction [TRP53 protein binds to MDM2 protein]	PMID:11245472
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D002945	Cisplatin results in decreased expression of MDM2 mRNA; Cisplatin results in decreased expression of MDM2 protein	PMID:35842499
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D002945	Cisplatin results in increased expression of MDM2 mRNA	PMID:24880025
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of MDM2 mRNA; Cisplatin results in increased expression of MDM2 protein	PMID:16797627|PMID:24280081|PMID:25450742|PMID:25596134|PMID:32856486|PMID:33545341|PMID:38498338
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of MDM2 mRNA; Cisplatin results in increased expression of MDM2 protein	PMID:21151649|PMID:24280081|PMID:25270620|PMID:32856486|PMID:35842499
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D002945	Cisplatin promotes the reaction [NFE2L2 protein results in increased expression of MDM2 mRNA]; NFE2L2 protein inhibits the reaction [Cisplatin results in decreased expression of MDM2 mRNA]; NFE2L2 protein inhibits the reaction [Cisplatin results in decreased expression of MDM2 protein]	PMID:35842499
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with eprenetapopt co-treated with Oxygen deficiency] results in increased expression of MDM2 mRNA; [Cisplatin co-treated with eprenetapopt] results in increased expression of MDM2 mRNA; [TP53 protein binds to MDM2 protein] which results in decreased susceptibility to Cisplatin; Cisplatin promotes the reaction [TP53 protein binds to MDM2 promoter]; Cisplatin promotes the reaction [TP53 protein results in increased expression of MDM2]; Cisplatin results in increased activity of and results in increased expression of MDM2 protein; MDM2 protein promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein]; MDM2 protein promotes the reaction [Cisplatin results in increased expression of HES1 protein]; MDM2 protein promotes the reaction [Cisplatin results in increased expression of MDM2 protein]; NOTCH1 protein affects the reaction [MDM2 protein promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein]]; NOTCH1 protein affects the reaction [MDM2 protein promotes the reaction [Cisplatin results in increased expression of HES1 protein]]; nutlin 3 promotes the reaction [Cisplatin results in increased activity of and results in increased expression of MDM2 protein]; TP53 affects the reaction [Cisplatin results in increased activity of and results in increased expression of MDM2 protein]; TP53 affects the reaction [nutlin 3 promotes the reaction [Cisplatin results in increased activity of and results in increased expression of MDM2 protein]]	PMID:21509038|PMID:21552291|PMID:21624110|PMID:29690507|PMID:32856486
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin promotes the reaction [TRP53 protein results in increased expression of MDM2]; NFE2L2 protein affects the reaction [Cisplatin results in increased expression of MDM2 mRNA]; NFE2L2 protein affects the reaction [Cisplatin results in increased expression of MDM2 protein]; nutlin 3 inhibits the reaction [Cisplatin results in increased expression of MDM2 protein]	PMID:21552291|PMID:32856486|PMID:35842499
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:27928	parathion	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20130514	CTD	MESH:D010278	[Estradiol co-treated with Parathion] results in increased expression of MDM2 mRNA	PMID:17622325
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28077	rifampicin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D012293	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of MDM2 mRNA	PMID:21224054
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of MDM2 mRNA	PMID:21048042
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140114	CTD	MESH:D009532	Nickel results in increased expression of MDM2 mRNA	PMID:24068677
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20140114	CTD	MESH:D009532	TP53 protein affects the reaction [Nickel results in increased expression of MDM2 mRNA]	PMID:24068677
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313300	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MDM2 mRNA	PMID:21570461
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MDM2 mRNA	PMID:16039398
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases degradation	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased degradation of MDM2 protein	PMID:15459018
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA	PMID:33387578
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA	PMID:19578757
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA	PMID:12167310|PMID:21041162|PMID:26290441
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased phosphorylation of MDM2 protein	PMID:15459018
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased phosphorylation of MDM2 protein	PMID:19751709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin inhibits the reaction [Etoposide results in increased expression of MDM2 protein]; Tetrachlorodibenzodioxin results in increased expression of and results in increased phosphorylation of and results in increased activity of MDM2 protein	PMID:15459018
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D013749	alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 protein]; Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein modified form]; Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein]	PMID:19578757|PMID:22044530
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MDM2 mRNA	PMID:17942748
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313299	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of MDM2 mRNA	PMID:33512557
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20140610	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MDM2 mRNA	PMID:23202902
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MDM2 mRNA	PMID:28001369
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28277	brassinolide	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120501	CTD	MESH:C023623	brassinolide results in decreased expression of MDM2 protein	PMID:20833159
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1313299	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of MDM2 mRNA	PMID:26272509
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA	PMID:27188386
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of MDM2 mRNA	PMID:16001973
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of MDM2 mRNA	PMID:23649840
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28509	chloroethene	affects response to substance	ISO	RGD:1313299	E	RGD:6480464	20140513	CTD	MESH:D014752	MDM2 polymorphism affects the susceptibility to Vinyl Chloride	PMID:24464562
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1313300	E	RGD:6480464	20130910	CTD	MESH:D003300	Copper results in increased expression of MDM2 mRNA	PMID:16629173
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MDM2 mRNA	PMID:30911355
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1313299	E	RGD:6480464	20150414	CTD	MESH:D004317	Doxorubicin affects the expression of MDM2 mRNA	PMID:25529476|PMID:29803840
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1313300	E	RGD:6480464	20180828	CTD	MESH:D004317	Doxorubicin affects the expression of MDM2 mRNA	PMID:29653124
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1313299	E	RGD:6480464	20160119	CTD	MESH:D004317	MDM2 protein results in decreased susceptibility to Doxorubicin	PMID:26317544
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D004317	Doxorubicin results in increased expression of MDM2 mRNA	PMID:12187937|PMID:27255381|PMID:34713381
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20160119	CTD	MESH:D004317	Doxorubicin results in increased expression of MDM2 mRNA; Doxorubicin results in increased expression of MDM2 protein	PMID:14665630|PMID:17653088|PMID:17959036|PMID:19074854|PMID:19560264|PMID:26317544
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120501	CTD	MESH:D004317	Doxorubicin results in increased expression of MDM2 mRNA	PMID:14766674|PMID:16949053|PMID:34713381
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased phosphorylation of MDM2 protein	PMID:17935137
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin inhibits the reaction [TP53 protein binds to MDM2 protein]; Doxorubicin results in increased activity of and results in increased expression of MDM2 protein; IFNA1 protein promotes the reaction [Doxorubicin results in increased expression of MDM2 protein]; MDM2 protein inhibits the reaction [HIPK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein]]; MDM2 protein promotes the reaction [cobaltous chloride inhibits the reaction [HIPK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein]]]; nutlin 3 promotes the reaction [Doxorubicin results in increased activity of and results in increased expression of MDM2 protein]; SETD7 mutant form promotes the reaction [Doxorubicin results in increased expression of MDM2 mRNA]; SETD7 mutant form promotes the reaction [Doxorubicin results in increased expression of MDM2 protein]; TP53 affects the reaction [Doxorubicin results in increased activity of and results in increased expression of MDM2 protein]; TP53 affects the reaction [nutlin 3 promotes the reaction [Doxorubicin results in increased activity of and results in increased expression of MDM2 protein]]; wortmannin promotes the reaction [Doxorubicin results in increased phosphorylation of MDM2 protein]	PMID:17935137|PMID:17959036|PMID:19351845|PMID:19714248|PMID:21624110|PMID:26317544
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004317	pifithrin inhibits the reaction [Doxorubicin results in increased expression of MDM2 mRNA]	PMID:14766674
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MDM2 mRNA	PMID:23783067
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28794	coumarin	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20201006	CTD	MESH:C030123	coumarin analog results in decreased expression of MDM2 mRNA	PMID:32578917
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28830	chlorambucil	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D002699	Chlorambucil results in increased expression of MDM2 mRNA	PMID:17476690
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28863	flavanones	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:D044950	Flavanones results in increased phosphorylation of MDM2 protein	PMID:21616090
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20151013	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of MDM2 protein	PMID:25005833
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:28869	menadione	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20151013	CTD	MESH:D024483	EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of MDM2 protein]	PMID:25005833
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D001205	Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of MDM2 protein]	PMID:21262251
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of MDM2 mRNA	PMID:36057382
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313299	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of MDM2 mRNA	PMID:29319823
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MDM2 protein	PMID:16166651
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313299	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MDM2 mRNA; sodium arsenite results in increased expression of MDM2 protein; sodium arsenite results in increased expression of MDM2 protein alternative form	PMID:11813266|PMID:12016162|PMID:19010883|PMID:20375080|PMID:28785074|PMID:29301061|PMID:29319823|PMID:32844245|PMID:39900124
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313300	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MDM2 mRNA	PMID:11353140|PMID:20477944|PMID:39232337
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20161228	CTD	MESH:C017947	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased expression of MDM2 protein]; [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MDM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MDM2 mRNA; MAPK1 protein promotes the reaction [sodium arsenite results in increased expression of MDM2 protein]; TP53 protein mutant form inhibits the reaction [sodium arsenite results in increased expression of MDM2 mRNA]; TP53 protein promotes the reaction [sodium arsenite results in increased expression of MDM2 protein]	PMID:20375080|PMID:23192986|PMID:28785074|PMID:39836092
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20250805	CTD	MESH:C017947	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in increased expression of MDM2 mRNA]	PMID:39232337
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20250902	CTD	MESH:D014415	Tunicamycin results in increased expression of MDM2 mRNA	PMID:39900124
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29852	methylarsonic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C020300	monomethylarsonic acid results in increased expression of MDM2 mRNA	PMID:17481689
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20150414	CTD	MESH:C020300	[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MDM2 mRNA	PMID:23192986
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MDM2 protein	PMID:21467743
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20190312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MDM2 mRNA	PMID:30562542
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313299	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MDM2 mRNA; Benzo(a)pyrene results in increased expression of MDM2 protein; Benzo(a)pyrene results in increased expression of MDM2 protein modified form	PMID:10837373|PMID:18418871|PMID:20106945|PMID:21632981|PMID:21871943|PMID:22044530|PMID:22316170|PMID:22889811|PMID:25690898|PMID:26238291|PMID:27694624|PMID:28461126|PMID:30562542|PMID:31555880|PMID:32234424|PMID:40280401
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of MDM2 mRNA; Benzo(a)pyrene results in increased expression of MDM2 mRNA	PMID:18656336|PMID:19146932|PMID:19770486|PMID:21569818|PMID:22228805|PMID:22610609|PMID:23735875|PMID:32553695|PMID:9006915
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20150609	CTD	MESH:D001564	Benzo(a)pyrene results in increased phosphorylation of MDM2 protein	PMID:20840854|PMID:25744307
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D001564	2,4,4'-trichlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; 2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; 2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; 3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of MDM2 mRNA; Benzo(a)pyrene promotes the reaction [TP53 protein binds to MDM2 protein]; Benzo(a)pyrene results in increased expression of and results in increased phosphorylation of MDM2 protein; Cadmium Chloride affects the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; MAPK3 mutant form inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; MDM2 mutant form promotes the reaction [Benzo(a)pyrene results in increased expression of TP53 protein]; Simvastatin promotes the reaction [Benzo(a)pyrene promotes the reaction [TP53 protein binds to MDM2 protein]]; TP53 affects the reaction [Benzo(a)pyrene results in increased expression of MDM2 mRNA]; U 0126 inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]	PMID:10837373|PMID:15625077|PMID:17690111|PMID:18096571|PMID:20840854|PMID:25744307|PMID:40280401
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:27858113
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313299	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite results in increased expression of MDM2 mRNA; arsenite results in increased expression of MDM2 protein; arsenite results in increased expression of MDM2 protein modified form	PMID:30177839|PMID:34425169
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20121009	CTD	MESH:C015001	[[[arsenite results in increased activity of PRKDC protein] which results in increased phosphorylation of and results in increased activity of MAPK9 protein] promotes the reaction [MAPK9 protein binds to TP53 protein]] inhibits the reaction [MDM2 results in increased degradation of and results in decreased stability of TP53 protein]; arsenite inhibits the reaction [G3BP1 protein binds to MDM2 mRNA]; arsenite promotes the reaction [IKBKB protein binds to MDM2 protein]; DAPK1 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein modified form]; DAPK1 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein]; ETS1 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein modified form]; ETS1 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein]; IKBKB protein promotes the reaction [arsenite results in increased expression of MDM2 protein modified form]; IKBKB protein promotes the reaction [arsenite results in increased expression of MDM2 protein]; TP53 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein modified form]; TP53 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein]	PMID:22366412|PMID:30177839|PMID:32406909
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of MDM2 mRNA	PMID:36057382
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1313300	E	RGD:6480464	20130910	CTD	MESH:D003300	Copper results in increased expression of MDM2 mRNA	PMID:16629173
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MDM2 mRNA	PMID:30911355
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30185	zinc(0)	affects expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of MDM2 protein	PMID:16636310
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30185	zinc(0)	increases ubiquitination	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in increased ubiquitination of MDM2 protein	PMID:16965791
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc binds to and results in increased folding of MDM2 protein; Zinc promotes the reaction [MDM2 protein binds to MDM2 protein]; Zinc promotes the reaction [MDM2 protein binds to MDM4 protein]	PMID:16965791
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of MDM2 mRNA	PMID:26014281
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30512	silver atom	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20170516	CTD	MESH:D012834	[Silver co-treated with Povidone] affects the expression of MDM2 protein; [Silver co-treated with Povidone] results in decreased expression of MDM2 mRNA	PMID:27387714
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MDM2 mRNA	PMID:19073995
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313299	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MDM2 mRNA	PMID:20382639|PMID:26238291|PMID:28593498
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313300	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MDM2 mRNA	PMID:39826883
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MDM2 mRNA; Arsenic Trioxide results in decreased expression of MDM2 protein	PMID:21145380|PMID:38070468
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MDM2 mRNA	PMID:20458559
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MDM2 mRNA	PMID:17487067
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MDM2 mRNA	PMID:20862710|PMID:25574600|PMID:26705709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased expression of MDM2 mRNA]; pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of MDM2 mRNA]	PMID:17487067|PMID:38070468
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:30682	ruthenium atom	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D012428	Ruthenium results in decreased expression of MDM2 protein	PMID:17210701
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:31175	adefovir pivoxil	increases expression	ISO	RGD:1313299	E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of MDM2 mRNA	PMID:25596134
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:31206	ammonium chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of MDM2 mRNA; Ammonium Chloride results in increased expression of MDM2 protein	PMID:12420312|PMID:16483693
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:31781	lopinavir	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20260303	CTD	MESH:D061466	Lopinavir results in decreased expression of MDM2 mRNA	PMID:40582629
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of MDM2 mRNA	PMID:23202902
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of MDM2 mRNA	PMID:25729387
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of MDM2 mRNA	PMID:25729387
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:32076	zinc pyrithione	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C010423	pyrithione zinc results in increased expression of MDM2 mRNA	PMID:21424779
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313300	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MDM2 gene	PMID:35295148
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20121113	CTD	MESH:C009495	titanium dioxide results in increased expression of MDM2 mRNA	PMID:21067279
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D013853	Thioacetamide results in increased expression of MDM2 mRNA	PMID:18619722|PMID:22659510|PMID:23411599|PMID:25242409|PMID:26011634|PMID:34492290
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:32497	thioacetamide	increases phosphorylation	EXP		E	RGD:6480464	20160210	CTD	MESH:D013853	Thioacetamide results in increased phosphorylation of MDM2 protein	PMID:26558467
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MDM2 mRNA	PMID:18648102
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MDM2 mRNA	PMID:15890375|PMID:19162173
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	MDM2 protein affects the reaction [pirinixic acid results in increased activity of PPARA protein]; MDM2 protein promotes the reaction [[pirinixic acid results in increased activity of PPARA protein] which results in increased expression of ACOX1 mRNA]; MDM2 protein promotes the reaction [[pirinixic acid results in increased activity of PPARA protein] which results in increased expression of ANGPTL4 mRNA]; MDM2 protein promotes the reaction [[pirinixic acid results in increased activity of PPARA protein] which results in increased expression of CYP4A1 mRNA]; MDM2 protein promotes the reaction [[pirinixic acid results in increased activity of PPARA protein] which results in increased expression of EHHADH mRNA]; MDM2 protein promotes the reaction [[pirinixic acid results in increased activity of PPARA protein] which results in increased expression of FABP1 mRNA]; MDM2 protein promotes the reaction [pirinixic acid results in increased expression of PPARA protein]; pirinixic acid promotes the reaction [[PPARA protein binds to MDM2 protein] which binds to ACOX1 promoter]; pirinixic acid promotes the reaction [[PPARA protein binds to MDM2 protein] which binds to DBI promoter]; pirinixic acid promotes the reaction [MDM2 protein binds to PPARA protein]	PMID:19103650
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of MDM2 mRNA	PMID:15890375|PMID:22484513
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MDM2 mRNA	PMID:14600272|PMID:15890375|PMID:22484513|PMID:23052194
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20121113	CTD	MESH:C007738	[Benzo(a)pyrene co-treated with fluoranthene] affects the expression of MDM2 mRNA	PMID:17690111
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MDM2 mRNA	PMID:25181051
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313299	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MDM2 mRNA	PMID:30903817
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MDM2 mRNA	PMID:26982218
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MDM2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313299	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A analog results in increased expression of MDM2 mRNA; bisphenol A results in increased expression of MDM2 mRNA	PMID:29275510|PMID:32387340
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MDM2 mRNA	PMID:26063408
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased phosphorylation of MDM2 protein	PMID:24831732
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20150825	CTD	MESH:C006780	[naringenin co-treated with bisphenol A] results in increased expression of MDM2 mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of MDM2 mRNA; Curcumin inhibits the reaction [bisphenol A results in increased phosphorylation of MDM2 protein]	PMID:24831732|PMID:36235125
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3374	capsaicin	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in decreased expression of MDM2 protein	PMID:19846903
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3374	capsaicin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D002211	Capsaicin results in increased expression of MDM2 mRNA	PMID:19502594
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3374	capsaicin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin promotes the reaction [resveratrol results in decreased expression of MDM2 protein]; resveratrol promotes the reaction [Capsaicin results in decreased expression of MDM2 protein]; TP53 affects the reaction [Capsaicin results in decreased expression of MDM2 protein]	PMID:19846903
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313299	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MDM2 mRNA	PMID:25979313
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	affects expression	ISO	RGD:1313300	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT affects the expression of MDM2 mRNA	PMID:18925944
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of MDM2 mRNA; 1-nitropyrene results in increased expression of MDM2 protein; 1-nitropyrene results in increased expression of MDM2 protein modified form	PMID:10837373|PMID:22044530
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34107	1-nitropyrene	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20140415	CTD	MESH:C032668	nutlin 3 results in increased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein modified form]; nutlin 3 results in increased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein]; Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein modified form]; Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein]; TP53 affects the reaction [1-nitropyrene results in increased expression of MDM2 mRNA]	PMID:10837373|PMID:22044530
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34199	2,2',3,3',6,6'-hexachlorobiphenyl	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:C010498	2,3,6,2',3',6'-hexachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20120918	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709|PMID:20840854
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120918	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]	PMID:20840854
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34204	2,2',4,4'-tetrachlorobiphenyl	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:C035976	2,4,2',4'-tetrachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34205	2,2',4,5-tetrachlorobiphenyl	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C042128	2,4,4',5-tetrachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20120918	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709|PMID:20840854
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120918	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; MDM2 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased phosphorylation of FOXO3 protein]	PMID:20840854
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MDM2 mRNA	PMID:39298647
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313300	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of MDM2 promoter	PMID:33297965
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MDM2 mRNA	PMID:26377693
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20260407	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:40280401
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:27858113
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313300	E	RGD:6480464	20230207	CTD	MESH:C008745	bisphenol F results in increased expression of MDM2 mRNA	PMID:35387338
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MDM2 mRNA	PMID:37019170
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313299	E	RGD:6480464	20191112	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MDM2 mRNA	PMID:30981936
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of MDM2 mRNA	PMID:22546817
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of MDM2 mRNA	PMID:22546817
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1313300	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of MDM2 gene	PMID:38995845
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MDM2 mRNA; Diethylnitrosamine results in increased expression of MDM2 protein	PMID:14555611|PMID:15459018|PMID:25242409
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MDM2 mRNA; Diethylnitrosamine results in increased expression of MDM2 protein	PMID:17854601|PMID:18506893|PMID:19100860|PMID:21607683
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of MDM2 protein; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MDM2 mRNA	PMID:11003613|PMID:18544905
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MDM2 mRNA]	PMID:17854601
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of MDM2 mRNA	PMID:22546817
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140211	CTD	MESH:C022838	nickel chloride results in increased expression of MDM2 mRNA	PMID:23566959|PMID:28552779
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20140211	CTD	MESH:C022838	TP53 protein affects the reaction [nickel chloride results in increased expression of MDM2 mRNA]	PMID:23566959
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MDM2 mRNA	PMID:32680482
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120501	CTD	MESH:D010269	Paraquat results in increased expression of MDM2 mRNA	PMID:20883675|PMID:34097952
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D010269	GPX1 protein affects the reaction [Paraquat affects the expression of MDM2 mRNA]	PMID:12654481
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313299	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MDM2 mRNA	PMID:37042841
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of MDM2 mRNA	PMID:30589522
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008345	Manganese results in decreased expression of MDM2 protein	PMID:25791630
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D008345	[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein]	PMID:25791630
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MDM2 mRNA	PMID:26377693
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of MDM2 mRNA	PMID:22110744
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MDM2 mRNA	PMID:31077537
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MDM2 mRNA	PMID:38568856
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	decreases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased phosphorylation of MDM2 protein	PMID:28651161
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MDM2 mRNA	PMID:23405080
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120918	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MDM2 mRNA	PMID:11958953|PMID:20061341|PMID:22314386
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20150609	CTD	MESH:D019256	Cadmium Chloride results in increased phosphorylation of MDM2 protein	PMID:25744307
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	increases phosphorylation	ISO	RGD:1313300	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased phosphorylation of MDM2 protein	PMID:20525538|PMID:22314386
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of MDM2 mRNA	PMID:31077537
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20150609	CTD	MESH:D019256	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MDM2 protein]; Cadmium Chloride affects the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; Cadmium Chloride affects the reaction [Etoposide results in increased phosphorylation of MDM2 protein]; Cadmium Chloride affects the reaction [Fluorouracil results in increased phosphorylation of MDM2 protein]; GJA1 promotes the reaction [Cadmium Chloride results in decreased phosphorylation of MDM2 protein]	PMID:25744307|PMID:28651161
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in increased expression of MDM2 protein]; MT1 affects the reaction [Cadmium Chloride results in increased expression of MDM2 mRNA]; MT2 affects the reaction [Cadmium Chloride results in increased expression of MDM2 mRNA]	PMID:11958953|PMID:12135628
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35509	androstane	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170131	CTD	MESH:D000732	Androstanols inhibits the reaction [DDT results in increased expression of MDM2 mRNA]	PMID:23684557
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MDM2 mRNA	PMID:19162173
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of MDM2 mRNA	PMID:22079235
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MDM2 mRNA	PMID:19162173
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of MDM2 mRNA	PMID:24386269
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of MDM2 protein	PMID:19714248
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120814	CTD	MESH:C018021	MDM2 protein promotes the reaction [cobaltous chloride inhibits the reaction [HIPK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein]]]	PMID:19714248
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of MDM2 mRNA	PMID:14600272|PMID:15890375
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35812	oxfendazole	decreases phosphorylation	EXP		E	RGD:6480464	20160210	CTD	MESH:C011030	oxfendazole results in decreased phosphorylation of MDM2 protein	PMID:26558467
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:35812	oxfendazole	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C011030	oxfendazole results in increased expression of MDM2 mRNA	PMID:26558467
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3647	chlorpromazine	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in increased expression of MDM2 mRNA	PMID:25596134
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:36791	escitalopram	increases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D000089983	Escitalopram results in increased expression of MDM2 mRNA	PMID:28467792
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3696	cidofovir anhydrous	affects expression	ISO	RGD:1313299	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir affects the expression of MDM2 mRNA	PMID:25596134
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3723	citalopram	increases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in increased expression of MDM2 mRNA	PMID:28467792
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of MDM2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MDM2 mRNA]	PMID:17585979
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:38211	potassium bromate	increases expression	ISO	RGD:1313299	E	RGD:6480464	20190611	CTD	MESH:C019536	potassium bromate results in increased expression of MDM2 mRNA	PMID:30559759
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:38221	fumonisin B1	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 mRNA]; fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 protein]	PMID:18206046
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:38746	parathion-methyl	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D008743	Methyl Parathion results in increased expression of MDM2 mRNA	PMID:18418871
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313299	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MDM2 mRNA	PMID:31533062
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313300	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of MDM2 mRNA	PMID:39529242
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:39171	nitenpyram	increases expression	ISO	RGD:1313299	E	RGD:6480464	20221004	CTD	MESH:C464843	nitenpyram results in increased expression of MDM2 mRNA	PMID:35568224
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3930	cryptolepine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in increased expression of MDM2 mRNA; cryptolepine results in increased expression of MDM2 protein	PMID:16120219
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313299	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MDM2 mRNA	PMID:40419075
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of MDM2 mRNA	PMID:23125180
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate affects the expression of MDM2 mRNA	PMID:11960910|PMID:22110744
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of MDM2 mRNA	PMID:25993096
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D003474	[Curcumin results in decreased expression of MDM2 protein] which results in decreased expression of CDKN1A mRNA; Curcumin results in decreased expression of MDM2 mRNA; Curcumin results in decreased expression of MDM2 protein	PMID:17332326
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20151110	CTD	MESH:D003474	Curcumin analog results in increased expression of MDM2 mRNA	PMID:26409325
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20150825	CTD	MESH:D003474	Curcumin inhibits the reaction [bisphenol A results in increased phosphorylation of MDM2 protein]	PMID:24831732
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313299	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MDM2 mRNA	PMID:25979313
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of MDM2 mRNA	PMID:28001369
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MDM2 mRNA	PMID:23179753
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of MDM2 mRNA	PMID:38685447|PMID:41580965
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313299	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MDM2 mRNA	PMID:20106945|PMID:25562108|PMID:25596134
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20201103	CTD	MESH:C087670	azoxystrobin results in increased expression of MDM2 protein	PMID:32339800
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MDM2 mRNA	PMID:17555576
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20220809	CTD	MESH:D013629	Tamoxifen results in decreased expression of MDM2 mRNA	PMID:34821461
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:41922	diethylstilbestrol	affects mutagenesis	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol affects the mutagenesis of MDM2 gene	PMID:7916985
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of MDM2 mRNA	PMID:21041162
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MDM2 mRNA	PMID:15890375
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MDM2 mRNA	PMID:15545218
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:41948	eflornithine	decreases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D000518	Eflornithine results in decreased expression of MDM2 mRNA	PMID:11502571
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in decreased expression of MDM2 mRNA	PMID:16570282
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313300	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MDM2 mRNA	PMID:28973697
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4356	desferrioxamine B	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003676	Deferoxamine results in increased expression of MDM2 protein	PMID:19950214
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of MDM2 mRNA	PMID:33512557
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:43572	kojic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MDM2 mRNA	PMID:18544905
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of MDM2 mRNA	PMID:23649840
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of MDM2 mRNA	PMID:18502557
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased expression of MDM2 mRNA; Methotrexate results in increased expression of MDM2 protein	PMID:17637740|PMID:21678067|PMID:24449571
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased activity of and results in increased expression of MDM2 protein; nutlin 3 promotes the reaction [Methotrexate results in increased activity of and results in increased expression of MDM2 protein]; TP53 affects the reaction [Methotrexate results in increased activity of and results in increased expression of MDM2 protein]; TP53 affects the reaction [nutlin 3 promotes the reaction [Methotrexate results in increased activity of and results in increased expression of MDM2 protein]]	PMID:21624110
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:44423	hydroxyurea	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea affects the expression of MDM2 protein	PMID:16356682
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of MDM2 mRNA	PMID:18647660
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of MDM2 mRNA	PMID:16356682
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MDM2 mRNA	PMID:24136188
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:44658	okadaic acid	decreases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased phosphorylation of MDM2 protein	PMID:38832940
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:C028009	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of MDM2 mRNA	PMID:31077537
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:44975	1,10-phenanthroline	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120501	CTD	MESH:C025205	1,10-phenanthroline results in increased expression of MDM2 mRNA	PMID:19502547
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MDM2 mRNA	PMID:27188386
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:45863	paclitaxel	decreases response to substance	ISO	RGD:1313299	E	RGD:6480464	20161213	CTD	MESH:D017239	MDM2 protein results in decreased susceptibility to Paclitaxel	PMID:13130078
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313299	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MDM2 mRNA	PMID:28542535
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MDM2 mRNA	PMID:17562736
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MDM2 mRNA	PMID:21807079
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MDM2 mRNA	PMID:21420995
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of MDM2 mRNA	PMID:17202762|PMID:33387578
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313299	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MDM2 mRNA	PMID:22230336
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160315	CTD	MESH:D000082	Acetaminophen results in increased expression of MDM2 mRNA	PMID:26056430
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased phosphorylation of MDM2 protein	PMID:16330492
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen promotes the reaction [MDM2 protein binds to TP53 protein]	PMID:16330492
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of MDM2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MDM2 mRNA]	PMID:17585979
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1313299	E	RGD:6480464	20121009	CTD	MESH:D005472	Fluorouracil results in increased expression of MDM2 mRNA; Fluorouracil results in increased expression of MDM2 protein; Fluorouracil results in increased expression of MDM2 protein modified form	PMID:14665630|PMID:15546879|PMID:16557594|PMID:17982676|PMID:18096571|PMID:19098008|PMID:22525470|PMID:28785074|PMID:30177839
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of MDM2 mRNA	PMID:16949053
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46345	5-fluorouracil	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20150609	CTD	MESH:D005472	Fluorouracil results in increased phosphorylation of MDM2 protein	PMID:25744307
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D005472	Cadmium Chloride affects the reaction [Fluorouracil results in increased phosphorylation of MDM2 protein]; Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 protein]	PMID:15546879|PMID:17982676|PMID:25744307
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:465284	ganciclovir	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D015774	Ganciclovir results in increased expression of MDM2 protein	PMID:15592511
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20230502	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of MDM2 mRNA	PMID:36576512
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MDM2 mRNA	PMID:29279043
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46677	amphibole asbestos	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:D017636	Asbestos, Amphibole results in decreased expression of MDM2 protein	PMID:20855422
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46742	Nutlin-3	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20220809	CTD	MESH:C482205	nutlin 3 results in decreased expression of MDM2 protein	PMID:35213076
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46742	Nutlin-3	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C482205	nutlin 3 results in increased expression of MDM2 mRNA; nutlin 3 results in increased expression of MDM2 protein; nutlin 3 results in increased expression of MDM2 protein modified form	PMID:16014563|PMID:16439685|PMID:19098008|PMID:21109480|PMID:22044530|PMID:38460933
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46742	Nutlin-3	increases expression	ISO	RGD:1313300	E	RGD:6480464	20170303	CTD	MESH:C482205	nutlin 3 results in increased expression of MDM2 mRNA	PMID:16949053
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of MDM2 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of MDM2 protein; [nutlin 3 inhibits the reaction [TP53 protein binds to MDM2 protein]] which results in increased activity of TP53 protein; nutlin 3 inhibits the reaction [TP53 protein binds to MDM2 protein]; nutlin 3 inhibits the reaction [TP73 binds to MDM2]; nutlin 3 promotes the reaction [Cisplatin results in increased activity of and results in increased expression of MDM2 protein]; nutlin 3 promotes the reaction [Doxorubicin results in increased activity of and results in increased expression of MDM2 protein]; nutlin 3 promotes the reaction [Methotrexate results in increased activity of and results in increased expression of MDM2 protein]; nutlin 3 results in increased activity of and results in increased expression of MDM2 protein; nutlin 3 results in increased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein modified form]; nutlin 3 results in increased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein]; PVT1 protein inhibits the reaction [nutlin 3 results in decreased expression of MDM2 protein]; TP53 affects the reaction [nutlin 3 promotes the reaction [Cisplatin results in increased activity of and results in increased expression of MDM2 protein]]; TP53 affects the reaction [nutlin 3 promotes the reaction [Doxorubicin results in increased activity of and results in increased expression of MDM2 protein]]; TP53 affects the reaction [nutlin 3 promotes the reaction [Methotrexate results in increased activity of and results in increased expression of MDM2 protein]]; TP53 affects the reaction [nutlin 3 results in increased activity of and results in increased expression of MDM2 protein]; TP53 protein affects the reaction [nutlin 3 results in increased expression of MDM2 protein]; TP53 protein promotes the reaction [nutlin 3 results in increased expression of MDM2 mRNA]; TP53 protein promotes the reaction [nutlin 3 results in increased expression of MDM2 protein]	PMID:16439685|PMID:20422343|PMID:21109480|PMID:21509038|PMID:21624110|PMID:22044530|PMID:22260869|PMID:35213076|PMID:38460933
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20241105	CTD	MESH:C482205	nutlin 3 inhibits the reaction [Cisplatin results in increased expression of MDM2 protein]	PMID:32856486
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:46979	N-acetylsphingosine	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C064769	N-acetylsphingosine results in decreased expression of MDM2 mRNA; N-acetylsphingosine results in decreased expression of MDM2 protein	PMID:18206046
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313299	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MDM2 gene	PMID:25304211
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:47217	arsane	affects response to substance	ISO	RGD:1313299	E	RGD:6480464	20140805	CTD	MESH:D001151	MDM2 SNP affects the susceptibility to Arsenic	PMID:21982800
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1313299	E	RGD:6480464	20240402	CTD	MESH:D001151	Arsenic results in increased expression of MDM2 protein	PMID:35821281
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20240402	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MDM2 mRNA; USP7 protein affects the reaction [Arsenic results in increased expression of MDM2 protein]	PMID:35821281|PMID:39836092
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:472805	ouabain	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20200609	CTD	MESH:D010042	Ouabain results in decreased expression of and results in decreased phosphorylation of MDM2 protein	PMID:31436044
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:47344	alvocidib	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C077990	alvocidib results in decreased expression of MDM2 mRNA; alvocidib results in decreased expression of MDM2 protein	PMID:12589031
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:47381	diclofenac	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004008	Diclofenac results in decreased expression of MDM2 mRNA	PMID:17202759
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:47426	furosemide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005665	Furosemide affects the expression of MDM2 mRNA	PMID:17497460
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4776	ellipticine	decreases response to substance	ISO	RGD:1313299	E	RGD:6480464	20140415	CTD	MESH:C034192	MDM2 promoter SNP results in decreased susceptibility to ellipticine	PMID:17575151
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20251202	CTD	MESH:C016766	[sulforaphane co-treated with Cadmium] results in increased expression of MDM2 mRNA	PMID:31035011
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of MDM2 mRNA	PMID:29391264
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20140610	CTD	MESH:C045651	[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]	PMID:23717041
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4811	epoxiconazole	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C109476	epoxiconazole results in increased expression of MDM2 mRNA	PMID:29038839
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4811	epoxiconazole	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C109476	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MDM2 mRNA	PMID:29038839
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:48765	dimethylarsinic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in increased expression of MDM2 mRNA	PMID:17481689
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20150414	CTD	MESH:D002101	[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MDM2 mRNA	PMID:23192986
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of MDM2 mRNA	PMID:24383545
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MDM2 mRNA	PMID:17555576
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MDM2 mRNA alternative form; Ethinyl Estradiol results in increased expression of MDM2 protein	PMID:12168835
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MDM2 mRNA	PMID:17942748
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MDM2 mRNA	PMID:17942748
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20160210	CTD	MESH:D005047	Etoposide results in decreased expression of MDM2 protein	PMID:26259609
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	decreases response to substance	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D005047	MDM2 promoter SNP results in decreased susceptibility to Etoposide	PMID:17575151
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of MDM2 protein	PMID:15459018
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20141223	CTD	MESH:D005047	Etoposide results in increased expression of MDM2 mRNA; Etoposide results in increased expression of MDM2 protein; Etoposide results in increased expression of MDM2 protein modified form	PMID:16120219|PMID:18096571|PMID:25078064|PMID:30177839|PMID:31542801
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20150609	CTD	MESH:D005047	Etoposide results in increased phosphorylation of MDM2 protein	PMID:17935137|PMID:25744307
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Tetrachlorodibenzodioxin inhibits the reaction [Etoposide results in increased expression of MDM2 protein]	PMID:15459018
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D005047	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Etoposide promotes the reaction [MDM2 protein binds to TOP2A protein]]; Cadmium Chloride affects the reaction [Etoposide results in increased phosphorylation of MDM2 protein]; Etoposide promotes the reaction [MDM2 protein binds to TOP2A protein]; IKBKB protein promotes the reaction [Etoposide results in increased expression of MDM2 protein modified form]; IKBKB protein promotes the reaction [Etoposide results in increased expression of MDM2 protein]; Wortmannin promotes the reaction [Etoposide results in increased phosphorylation of MDM2 protein]	PMID:17575151|PMID:17935137|PMID:25744307|PMID:30177839
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C005223	methyleugenol results in increased expression of MDM2 mRNA	PMID:26011634
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of MDM2 mRNA	PMID:26272509
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA	PMID:27188386
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:49747	methylmercury(1+)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C030957	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of MDM2 mRNA	PMID:17905399
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MDM2 mRNA; Arsenic Trioxide results in decreased expression of MDM2 protein	PMID:21145380|PMID:38070468
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MDM2 mRNA	PMID:20458559
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MDM2 mRNA	PMID:17487067
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313299	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MDM2 mRNA	PMID:20862710|PMID:25574600|PMID:26705709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased expression of MDM2 mRNA]; pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of MDM2 mRNA]	PMID:17487067|PMID:38070468
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of MDM2 mRNA	PMID:25596134
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D008770	Methylnitrosourea results in increased expression of MDM2 mRNA	PMID:28688903
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313299	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MDM2 mRNA	PMID:17145863
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:50161	motexafin gadolinium	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of MDM2 mRNA	PMID:16357179
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of MDM2 mRNA]	PMID:16357179
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:50182	3,3'-diindolylmethane	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20160210	CTD	MESH:C016392	3,3'-diindolylmethane analog results in decreased expression of MDM2 mRNA	PMID:26593444
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of MDM2 mRNA	PMID:23962444
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of MDM2 mRNA	PMID:41580965
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313299	E	RGD:6480464	20180703	CTD	MESH:D000069059	Atorvastatin results in increased expression of MDM2 protein	PMID:29630879
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:50692	mifepristone	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of MDM2 mRNA	PMID:12605714
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:50729	mitoxantrone	decreases response to substance	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D008942	MDM2 promoter SNP results in decreased susceptibility to Mitoxantrone	PMID:17575151
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:50924	sorafenib	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C471405	sorafenib results in increased expression of MDM2 mRNA	PMID:26409325
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:5100	flucytosine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D005437	Flucytosine results in increased expression of MDM2 protein	PMID:15592511
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MDM2 mRNA	PMID:24136188
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20260407	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:40280401
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:27858113
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20260407	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:40280401
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:27858113
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin promotes the reaction [Doxorubicin results in increased phosphorylation of MDM2 protein]; wortmannin promotes the reaction [Etoposide results in increased phosphorylation of MDM2 protein]	PMID:17935137
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:52492	mancozeb	increases expression	ISO	RGD:1313299	E	RGD:6480464	20171114	CTD	MESH:C013099	mancozeb results in increased expression of MDM2 mRNA	PMID:27235710
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:52492	mancozeb	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20171114	CTD	MESH:C013099	lupeol inhibits the reaction [mancozeb results in increased expression of MDM2 mRNA]	PMID:27235710
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:52646	leptomycin B	increases expression	ISO	RGD:1313299	E	RGD:6480464	20121113	CTD	MESH:C038753	leptomycin B results in increased expression of MDM2 mRNA	PMID:20803015
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:52717	bortezomib	affects expression	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib affects the expression of MDM2 protein	PMID:12393500
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:52717	bortezomib	increases cleavage	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased cleavage of MDM2 protein	PMID:12393500
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:52717	bortezomib	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:D000069286	[CASP8 protein results in increased activity of CASP3 protein] affects the reaction [Bortezomib results in increased cleavage of MDM2 protein]; Bortezomib promotes the reaction [TP53 protein binds to MDM2 protein]	PMID:12393500
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of MDM2 mRNA	PMID:26705709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:53248	poly(vinylpyrrolidone)	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20170516	CTD	MESH:D011205	[Silver co-treated with Povidone] affects the expression of MDM2 protein; [Silver co-treated with Povidone] results in decreased expression of MDM2 mRNA	PMID:27387714
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of MDM2 protein	PMID:21262251
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:53444	potassium dichromate	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D011192	Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of MDM2 protein]	PMID:21262251
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:5864	ifosfamide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of MDM2 mRNA	PMID:25596134
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6015	isoflurane	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007530	Isoflurane results in decreased expression of MDM2 mRNA	PMID:16978161
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:61014	PD123319	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:C073402	PD 123319 inhibits the reaction [AGT protein results in increased expression of MDM2 mRNA]; PD 123319 inhibits the reaction [AGT protein results in increased expression of MDM2 protein]	PMID:18206046
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:62984	zinc acetate	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of MDM2 mRNA	PMID:16357179
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:62984	zinc acetate	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:D019345	motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of MDM2 mRNA]	PMID:16357179
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of MDM2 mRNA	PMID:28801915
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:63618	pravastatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017035	Pravastatin results in increased expression of MDM2 protein	PMID:15625077
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:63618	pravastatin	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D017035	Pravastatin results in increased phosphorylation of MDM2 protein	PMID:15625077
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:63618	pravastatin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D017035	[Pravastatin results in increased phosphorylation of MDM2 protein] which results in increased degradation of TP53 protein; Sirolimus inhibits the reaction [Pravastatin results in increased phosphorylation of MDM2 protein]; U 0126 inhibits the reaction [Pravastatin results in increased phosphorylation of MDM2 protein]	PMID:15625077
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MDM2 mRNA	PMID:26378955
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MDM2 mRNA	PMID:25729387
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of MDM2 mRNA	PMID:25729387
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20200211	CTD	MESH:D019772	[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with Topotecan] results in decreased expression of MDM2 protein	PMID:23376119
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of MDM2 mRNA	PMID:24136188
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6382	Lasiocarpine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in increased expression of MDM2 mRNA	PMID:40054833
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of MDM2 mRNA	PMID:28988120
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170110	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of MDM2 mRNA	PMID:27509014
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:64153	tanespimycin	increases degradation	ISO	RGD:1313299	E	RGD:6480464	20170228	CTD	MESH:C112765	tanespimycin results in increased degradation of MDM2 protein	PMID:17157164
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20200714	CTD	MESH:D002193	Cantharidin results in decreased expression of MDM2 mRNA	PMID:31945315
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MDM2 mRNA	PMID:23783067
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:65329	LY294002	increases expression	ISO	RGD:1313299	E	RGD:6480464	20200519	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of MDM2 protein	PMID:16412023
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:65345	PX-866	decreases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20230801	CTD	MESH:C496788	PX-866 results in decreased phosphorylation of MDM2 protein	PMID:27017931
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:65345	PX-866	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20230801	CTD	MESH:C496788	[Raloxifene Hydrochloride co-treated with PX-866] results in decreased phosphorylation of MDM2 protein	PMID:27017931
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6570	lupeol	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20171114	CTD	MESH:C010480	lupeol inhibits the reaction [mancozeb results in increased expression of MDM2 mRNA]	PMID:27235710
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of MDM2 mRNA	PMID:25596134
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D008701	Methapyrilene results in decreased expression of MDM2 mRNA	PMID:22584684
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D008701	Methapyrilene results in increased expression of MDM2 mRNA	PMID:15890375|PMID:18619722|PMID:25242409|PMID:26558467|PMID:30467583
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6820	methapyrilene	increases phosphorylation	EXP		E	RGD:6480464	20160210	CTD	MESH:D008701	Methapyrilene results in increased phosphorylation of MDM2 protein	PMID:26558467
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6856	methyl caffeate	affects binding	ISO	RGD:1313299	E	RGD:6480464	20151110	CTD	MESH:C042405	methyl caffeate binds to MDM2 protein	PMID:26415618
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6925	microcystin-LR	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of MDM2 protein	PMID:31157505
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20171010	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of MDM2 mRNA; cyanoginosin LR results in decreased expression of MDM2 protein	PMID:28414124
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313299	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MDM2 mRNA	PMID:27932991|PMID:30713602
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol results in increased expression of MDM2 mRNA	PMID:30742662
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20201215	CTD	MESH:D002185	[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of MDM2 mRNA	PMID:30742662
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D016686	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of MDM2 mRNA	PMID:21224054
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:70436	platycodin D	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20190910	CTD	MESH:C108953	platycodin D results in decreased expression of MDM2 protein	PMID:25431082|PMID:27432230
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:70436	platycodin D	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20190910	CTD	MESH:C108953	MDM2 protein inhibits the reaction [platycodin D results in increased expression of FOXO3 protein]	PMID:25431082
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:72754	bisphenol AF	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20250114	CTD	MESH:C583074	[bisphenol AF co-treated with cylindrospermopsin] results in increased expression of MDM2 mRNA	PMID:32244372
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:73726	GW 501516	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C425931	MDM2 protein inhibits the reaction [GW 501516 results in increased activity of PPARB protein]	PMID:19103650
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MDM2 mRNA	PMID:22206623
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:749301	potassium perchlorate	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of MDM2 mRNA	PMID:29673971
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MDM2 mRNA	PMID:24136188
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313300	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MDM2 mRNA	PMID:20061341
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Etoposide promotes the reaction [MDM2 protein binds to TOP2A protein]]	PMID:17575151
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:75458	carbonyl cyanide p-trifluoromethoxyphenylhydrazone	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20131008	CTD	MESH:D002259	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of MDM2 mRNA	PMID:16039398
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20260714	CTD	MESH:C533410	[Cisplatin co-treated with eprenetapopt co-treated with Oxygen deficiency] results in increased expression of MDM2 mRNA; [Cisplatin co-treated with eprenetapopt] results in increased expression of MDM2 mRNA; [Oxygen deficiency co-treated with eprenetapopt] results in increased expression of MDM2 mRNA	PMID:29690507
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:755540	docetaxel	increases expression	ISO	RGD:1313299	E	RGD:6480464	20260714	CTD	MESH:D000077143	Docetaxel results in increased expression of MDM2 protein	PMID:16080190|PMID:16797627
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313299	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MDM2 protein	PMID:31285264
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:757885	8-chloroadenosine	increases expression	ISO	RGD:1313300	E	RGD:6480464	20260714	CTD	MESH:C075440	8-chloroadenosine results in increased expression of MDM2 mRNA	PMID:31778309
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1313299	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MDM2 protein	PMID:15635149
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of MDM2 mRNA; N-nitrosomorpholine results in increased expression of MDM2 protein	PMID:14587038|PMID:19716841
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:76995	alpha-naphthoflavone	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20140204	CTD	MESH:C011512	alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA]	PMID:19578757
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:77013	beta-naphthoflavone	increases phosphorylation	EXP		E	RGD:6480464	20160210	CTD	MESH:D019324	beta-Naphthoflavone results in increased phosphorylation of MDM2 protein	PMID:26558467
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:77092	fenbendazole	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005273	Fenbendazole results in increased expression of MDM2 mRNA	PMID:23411599
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20190910	CTD	MESH:C025589	ochratoxin A results in decreased expression of MDM2 mRNA	PMID:30763683
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of MDM2 mRNA	PMID:23358140
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:77397	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile	increases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in increased expression of MDM2 mRNA	PMID:28467792
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20141014	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of MDM2 protein	PMID:24415872
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:78492	diallyl trisulfide	increases degradation	ISO	RGD:1313299	E	RGD:6480464	20170725	CTD	MESH:C042577	diallyl trisulfide results in increased degradation of MDM2 protein	PMID:23754639
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA	PMID:27188386
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of MDM2 mRNA	PMID:30928695
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:80043	Nodularin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20190312	CTD	MESH:C063998	nodularin results in increased expression of MDM2 mRNA	PMID:30562542
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1313299	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in increased expression of MDM2 mRNA; Irinotecan results in increased expression of MDM2 mRNA	PMID:15956246
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D010634	Phenobarbital results in increased expression of MDM2 mRNA	PMID:25145657
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313300	E	RGD:6480464	20141223	CTD	MESH:D010634	Phenobarbital results in increased expression of MDM2 mRNA	PMID:19482888|PMID:20816995|PMID:25145657
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8069	phenobarbital	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased phosphorylation of MDM2 protein	PMID:19751709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MDM2 mRNA]; NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of MDM2 mRNA]	PMID:19482888
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:80774	tauroursodeoxycholic acid	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C031655	ursodoxicoltaurine results in increased expression of MDM2 mRNA	PMID:15885361
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8107	phenytoin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D010672	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of MDM2 mRNA	PMID:21224054
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of MDM2 mRNA	PMID:22538082
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:81395	10-Hydroxycamptothecin	affects response to substance	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C028098	MDM2 protein affects the susceptibility to 10-hydroxycamptothecin	PMID:13130078
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:81525	2,3,3',4,4',5,5'-Heptachlorobiphenyl	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C034559	2,2',3,3',4,4',5-heptachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8163	phosphoramide mustard	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C030090	phosphoramide mustard results in increased expression of MDM2 mRNA	PMID:26708502
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:81758	cyproconazole	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C093628	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MDM2 mRNA	PMID:29038839
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:82285	ortho-Aminoazotoluene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20141111	CTD	MESH:D009762	o-Aminoazotoluene results in increased expression of MDM2 mRNA	PMID:15346788
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	increases expression	ISO	RGD:1313299	E	RGD:6480464	20200609	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in increased expression of MDM2 mRNA	PMID:32251684
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:82551	N-Vinyl-2-pyrrolidone	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C042670	[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which affects the expression of MDM2 mRNA	PMID:22037397
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of MDM2 mRNA	PMID:33512557
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313300	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of MDM2 mRNA	PMID:11353140|PMID:39847705
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8434	prochloraz	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C045362	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA	PMID:29038839
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8450	procymidone	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C035988	procymidone results in decreased expression of MDM2 mRNA	PMID:15686871
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8461	promethazine	increases phosphorylation	EXP		E	RGD:6480464	20160210	CTD	MESH:D011398	Promethazine results in increased phosphorylation of MDM2 protein	PMID:26558467
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:85078	dapagliflozin	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C529054	dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased expression of MDM2 mRNA]	PMID:38070468
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:86193	DAPT	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170228	CTD	MESH:C419410	N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein	PMID:25005833
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:86193	DAPT	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20170228	CTD	MESH:C419410	Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein]	PMID:25005833
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20230801	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with PX-866] results in decreased phosphorylation of MDM2 protein	PMID:27017931
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of MDM2 mRNA	PMID:21607682
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:88046	cylindrospermopsin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20220308	CTD	MESH:C089595	[bisphenol AF co-treated with cylindrospermopsin] results in increased expression of MDM2 mRNA	PMID:32244372
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	ISO	RGD:1313299	E	RGD:6480464	20210504	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of MDM2 mRNA	PMID:33645215
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA	PMID:27188386
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:91215	1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170221	CTD	MESH:C095284	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased expression of MDM2 protein	PMID:16288207
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of MDM2 mRNA	PMID:26014281
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9141	silver(0)	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20170516	CTD	MESH:D012834	[Silver co-treated with Povidone] affects the expression of MDM2 protein; [Silver co-treated with Povidone] results in decreased expression of MDM2 mRNA	PMID:27387714
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9150	simvastatin	increases phosphorylation	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin results in increased phosphorylation of MDM2 protein	PMID:15625077
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9150	simvastatin	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin promotes the reaction [Benzo(a)pyrene promotes the reaction [TP53 protein binds to MDM2 protein]]	PMID:15625077
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9168	sirolimus	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased expression of MDM2 protein	PMID:19560264
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D020123	EIF4E protein inhibits the reaction [Sirolimus results in decreased expression of MDM2 protein]; Sirolimus inhibits the reaction [Pravastatin results in increased phosphorylation of MDM2 protein]; Sirolimus promotes the reaction [TP73 protein binds to MDM2 promoter]	PMID:15625077|PMID:19560264|PMID:21245298
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MDM2 mRNA	PMID:21346803
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in increased expression of MDM2 mRNA	PMID:26141394
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1313299	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in increased expression of MDM2 mRNA	PMID:31863870
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9410	taurodeoxycholic acid	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20250805	CTD	MESH:D013657	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in increased expression of MDM2 mRNA]	PMID:39232337
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1313299	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MDM2 mRNA	PMID:33512557
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:94995	2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one	increases expression	ISO	RGD:1313299	E	RGD:6480464	20170303	CTD	MESH:C451219	2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one results in increased expression of MDM2	PMID:21647879
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313299	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MDM2 mRNA	PMID:29301935
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MDM2 mRNA	PMID:21346803
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1313299	E	RGD:6480464	20231205	CTD	MESH:C001899	triptolide results in decreased expression of MDM2 protein	PMID:36990132
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313300	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of MDM2 mRNA	PMID:32835833
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313300	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of MDM2 mRNA	PMID:35537566
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MDM2 mRNA	PMID:18930950
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9907	ursodeoxycholic acid	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014580	Ursodeoxycholic Acid results in increased expression of MDM2 mRNA	PMID:15885361
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9907	ursodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014580	[Ursodeoxycholic Acid promotes the reaction [TP53 protein binds to MDM2 protein]] which results in increased degradation of TP53 protein; MDM2 mutant form inhibits the reaction [Ursodeoxycholic Acid affects the localization of TP53 protein]; NR3C1 mutant form inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [TGFB1 protein results in decreased expression of MDM2 protein]]; NR3C2 mutant form inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [TGFB1 protein results in decreased expression of MDM2 protein]]; Ursodeoxycholic Acid inhibits the reaction [TGFB1 protein results in decreased expression of MDM2 protein]; Ursodeoxycholic Acid promotes the reaction [TP53 protein binds to MDM2 protein]	PMID:14514686|PMID:15222754|PMID:17881359
1305332	Mdm2	MDM2 proto-oncogene	gene	CHEBI:9907	ursodeoxycholic acid	multiple interactions	ISO	RGD:1313299	E	RGD:6480464	20120412	CTD	MESH:D014580	MDM2 mutant form inhibits the reaction [Ursodeoxycholic Acid results in increased ubiquitination of TP53 protein]	PMID:20807506
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621378	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GSC2 mRNA	PMID:33045310
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1621378	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of GSC2 mRNA	PMID:33711761
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313301	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of GSC2 mRNA	PMID:24376830
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1621378	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of GSC2 mRNA	PMID:28960355
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313301	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of GSC2 mRNA	PMID:23557933
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621378	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GSC2 mRNA	PMID:24058054
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1621378	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of GSC2 mRNA	PMID:27862939
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313301	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GSC2 promoter	PMID:27901495
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621378	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GSC2 gene; titanium dioxide results in decreased methylation of GSC2 promoter	PMID:35295148
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1621378	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of GSC2 promoter	PMID:27334623
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GSC2 mRNA	PMID:25181051
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GSC2 gene	PMID:28505145
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1621378	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of GSC2 gene	PMID:31683443
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621378	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of GSC2 mRNA	PMID:30951980
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313301	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GSC2 gene	PMID:29154799
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621378	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GSC2 mRNA	PMID:17562736
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1313301	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of GSC2 promoter	PMID:29626692
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1313301	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of GSC2 promoter	PMID:29626692
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1621378	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of GSC2 mRNA	PMID:35436446
1305333	Gsc2	goosecoid homeobox 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1621378	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GSC2 mRNA	PMID:22206623
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313303	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CCDC89 mRNA	PMID:33045310
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313303	E	RGD:6480464	20141021	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of CCDC89 mRNA	PMID:24205000
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1602421	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CCDC89 mRNA	PMID:26516004
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CCDC89 mRNA	PMID:33387578
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of CCDC89 mRNA	PMID:26496021
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313303	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCDC89 mRNA	PMID:34319233
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1602421	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CCDC89 mRNA	PMID:36139627
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of CCDC89 mRNA	PMID:28522335
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1602421	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CCDC89 mRNA	PMID:22100608
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313303	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CCDC89 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CCDC89 mRNA	PMID:34911549
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1602421	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CCDC89 gene	PMID:25304211
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313303	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCDC89 mRNA	PMID:26377647
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1602421	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of CCDC89 mRNA	PMID:29955902
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1602421	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CCDC89 mRNA	PMID:33212167
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of CCDC89 mRNA	PMID:28959563
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602421	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCDC89 promoter	PMID:27901495
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1602421	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of CCDC89 mRNA	PMID:35984750
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CCDC89 mRNA	PMID:25181051
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CCDC89 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of CCDC89 mRNA	PMID:26496021
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313303	E	RGD:6480464	20141021	CTD	MESH:D002737	Chloroprene results in increased expression of CCDC89 mRNA	PMID:23125180
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1602421	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCDC89 mRNA	PMID:38832940
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1602421	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CCDC89 gene	PMID:25304211
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313303	E	RGD:6480464	20141021	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CCDC89 mRNA	PMID:23608068
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1602421	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CCDC89 mRNA	PMID:31758290
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1602421	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CCDC89 mRNA	PMID:36139627
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602421	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCDC89 gene]	PMID:28238834
1305335	Ccdc89	coiled-coil domain containing 89	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CCDC89 mRNA	PMID:24780913
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313304	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CIZ1 mRNA	PMID:38218311
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CIZ1 mRNA	PMID:33045310
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313304	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CIZ1 mRNA	PMID:33167477
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CIZ1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CIZ1 mRNA	PMID:32699268
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313305	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CIZ1 mRNA	PMID:30319688
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CIZ1 mRNA	PMID:39241906
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CIZ1 mRNA	PMID:33387578
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313304	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CIZ1 protein	PMID:37730182
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CIZ1 mRNA	PMID:35301059
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CIZ1 protein	PMID:23301498
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313304	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CIZ1 intron	PMID:30157460
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313304	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CIZ1 gene	PMID:27153756
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CIZ1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CIZ1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of CIZ1 mRNA	PMID:32699268
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313305	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CIZ1 mRNA	PMID:40504410
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313304	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CIZ1 mRNA	PMID:19244175
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313304	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of CIZ1 mRNA	PMID:27594783
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in increased expression of CIZ1 mRNA]	PMID:21858171
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:28077	rifampicin	decreases expression	ISO	RGD:1313304	E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in decreased expression of CIZ1 mRNA	PMID:24552687
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313305	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CIZ1 mRNA	PMID:21570461
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CIZ1 mRNA	PMID:33387578
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313304	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CIZ1 protein	PMID:33212167
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313304	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CIZ1 mRNA	PMID:29803840
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313304	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of CIZ1 protein	PMID:35688186
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313304	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CIZ1 mRNA	PMID:39719251
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313305	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CIZ1 mRNA	PMID:40504410
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313304	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CIZ1 5' UTR; Benzo(a)pyrene affects the methylation of CIZ1 promoter	PMID:27901495
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313305	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CIZ1 mRNA	PMID:22228805
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CIZ1 mRNA	PMID:30047161
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313305	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CIZ1 gene	PMID:35295148
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CIZ1 mRNA	PMID:33221593
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CIZ1 mRNA	PMID:25181051
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313304	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CIZ1 mRNA	PMID:33670352
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CIZ1 gene	PMID:28505145
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313305	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CIZ1 gene	PMID:31683443
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CIZ1 mRNA	PMID:39298647
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313304	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CIZ1 gene	PMID:31601247
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CIZ1 mRNA	PMID:38685157
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIZ1 mRNA	PMID:28628672
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CIZ1 mRNA	PMID:37019170
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIZ1 mRNA	PMID:28628672
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CIZ1 mRNA	PMID:22546817
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CIZ1 mRNA	PMID:35163327
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CIZ1 mRNA	PMID:35301059
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CIZ1 mRNA	PMID:35163327
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313304	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CIZ1 mRNA	PMID:19376846
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CIZ1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CIZ1 mRNA	PMID:32699268
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313304	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CIZ1 mRNA	PMID:19244175
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of CIZ1 mRNA	PMID:23811191
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313304	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CIZ1 mRNA	PMID:28302478
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313304	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CIZ1 mRNA	PMID:31533062
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313304	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CIZ1 mRNA	PMID:29154799
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CIZ1 mRNA	PMID:30047161
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313304	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CIZ1 mRNA	PMID:20106945|PMID:25562108
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIZ1 mRNA	PMID:28628672
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1313304	E	RGD:6480464	20120412	CTD	MESH:D008727	CIZ1 protein affects the susceptibility to Methotrexate	PMID:16217747
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313304	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of CIZ1 mRNA	PMID:29067470
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CIZ1 mRNA	PMID:29279043
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313305	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CIZ1 mRNA	PMID:40504410
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CIZ1 mRNA	PMID:22079256
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313305	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CIZ1 mRNA	PMID:17942748
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIZ1 mRNA	PMID:28628672
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CIZ1 mRNA	PMID:30047161
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CIZ1 mRNA	PMID:22206623
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313304	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CIZ1 mRNA	PMID:22079256
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CIZ1 mRNA	PMID:22079256
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313304	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CIZ1 protein	PMID:31285264
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CIZ1 mRNA	PMID:27291303
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:8249	piroxicam	increases expression	ISO	RGD:1313304	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of CIZ1 mRNA	PMID:21858171
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1313304	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in increased expression of CIZ1 mRNA]	PMID:21858171
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CIZ1 mRNA	PMID:21278054
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CIZ1 mRNA	PMID:30047161
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of CIZ1 mRNA	PMID:40826991
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CIZ1 mRNA	PMID:21346803
1305336	Ciz1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CIZ1 mRNA	PMID:28973697
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313306	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TRIML1 mRNA	PMID:36189433
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:16899	D-mannitol	increases expression	ISO	RGD:1313306	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in increased expression of TRIML1 mRNA	PMID:25270620
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313306	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TRIML1 mRNA	PMID:36189433
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313306	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TRIML1 mRNA	PMID:36189433
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1605231	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TRIML1 mRNA	PMID:22100608
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313306	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of TRIML1 mRNA	PMID:28960355
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313306	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of TRIML1 mRNA	PMID:32186404
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605231	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRIML1 promoter	PMID:27901495
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1605231	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of TRIML1 promoter	PMID:23974009
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605231	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TRIML1 gene	PMID:31601247
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIML1 mRNA	PMID:25181051|PMID:27178563
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605231	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TRIML1 gene	PMID:31601247
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:3374	capsaicin	increases expression	ISO	RGD:1605231	E	RGD:6480464	20230404	CTD	MESH:D002211	Capsaicin results in increased expression of TRIML1 mRNA	PMID:36044967
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313306	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TRIML1 mRNA	PMID:40194260
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605231	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRIML1 gene	PMID:29154799
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:4027	cyclophosphamide	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of TRIML1 mRNA	PMID:27281708
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in increased expression of TRIML1 mRNA	PMID:30723492
1305337	Triml1	tripartite motif family-like 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605231	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TRIML1 mRNA	PMID:29067470
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313307	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HIC2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of HIC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HIC2 mRNA	PMID:32699268|PMID:32845096
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313307	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of HIC2 mRNA	PMID:22378314
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of HIC2 mRNA	PMID:32145629
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313307	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of HIC2 mRNA	PMID:20655997
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HIC2 mRNA	PMID:37992649
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313307	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of HIC2 mRNA	PMID:33647349
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HIC2 mRNA	PMID:37992649
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313307	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of HIC2 protein	PMID:37730182
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313307	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HIC2 mRNA	PMID:35301059
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313307	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HIC2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of HIC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HIC2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of HIC2 mRNA	PMID:32699268|PMID:32845096
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HIC2 mRNA	PMID:22206623
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313307	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HIC2 gene	PMID:25304211
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313307	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of HIC2 protein	PMID:35688186
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313307	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HIC2 mRNA	PMID:27392435
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313307	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HIC2 mRNA	PMID:27392435
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313308	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HIC2 mRNA	PMID:21570461
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HIC2 mRNA	PMID:17942748
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HIC2 mRNA	PMID:17942748
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313307	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of HIC2 mRNA	PMID:23179753
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313307	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HIC2 mRNA	PMID:33212167
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of HIC2 mRNA	PMID:28959563
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313307	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HIC2 mRNA	PMID:29803840
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HIC2 mRNA	PMID:37992649
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313307	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of HIC2 mRNA	PMID:34032870
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313307	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HIC2 3' UTR	PMID:30157460
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313307	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HIC2 5' UTR	PMID:27901495
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of HIC2 mRNA	PMID:30047161
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313308	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HIC2 mRNA	PMID:29264374
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313308	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HIC2 promoter	PMID:35295148
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313308	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HIC2 promoter	PMID:35295148
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313308	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of HIC2 mRNA	PMID:18301758|PMID:23811191
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313307	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HIC2 mRNA	PMID:19710929
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of HIC2 mRNA	PMID:25181051
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of HIC2 mRNA; bisphenol A results in decreased expression of HIC2 protein	PMID:24552547|PMID:30816183|PMID:32528016
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313308	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HIC2 mRNA	PMID:39298647
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313308	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of HIC2 exon	PMID:33297965
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313307	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HIC2 mRNA	PMID:35301059
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of HIC2 mRNA	PMID:30047161
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313307	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of HIC2 mRNA	PMID:24449571
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313308	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of HIC2 mRNA	PMID:28962523
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313308	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of HIC2 mRNA	PMID:18353800
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313307	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HIC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HIC2 mRNA	PMID:32699268
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313307	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of HIC2 mRNA	PMID:28302478
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313307	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of HIC2 mRNA	PMID:31533062
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313307	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HIC2 mRNA	PMID:25979313
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of HIC2 mRNA	PMID:17292431
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of HIC2 mRNA	PMID:30047161
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of HIC2 mRNA	PMID:17555576
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HIC2 mRNA	PMID:37992649
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313307	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HIC2 mRNA	PMID:38832940
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313307	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of HIC2 mRNA	PMID:27188386
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313307	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of HIC2 mRNA	PMID:21420995|PMID:29067470
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313307	E	RGD:6480464	20120412	CTD	MESH:D005472	HIC2 protein affects the susceptibility to Fluorouracil	PMID:16217747
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313307	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HIC2 gene	PMID:25304211
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313307	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of HIC2 mRNA	PMID:31838189
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of HIC2 mRNA	PMID:17555576
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of HIC2 mRNA	PMID:17942748
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HIC2 mRNA	PMID:17942748
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	ISO	RGD:1313308	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of HIC2 gene	PMID:27923600
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of HIC2 mRNA	PMID:30047161
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313308	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HIC2 mRNA	PMID:22206623
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HIC2 mRNA	PMID:22206623
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313307	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HIC2 gene]	PMID:28238834
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HIC2 mRNA	PMID:30047161
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of HIC2 mRNA	PMID:24780913
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	ISO	RGD:1313307	E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of HIC2 mRNA	PMID:12756304
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313308	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of HIC2 protein	PMID:35357534
1305338	Hic2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of HIC2 mRNA	PMID:20566332
1305339	Dap3	death associated protein 3	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313309	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DAP3 mRNA	PMID:38218311
1305339	Dap3	death associated protein 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313310	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DAP3 mRNA	PMID:33045310
1305339	Dap3	death associated protein 3	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DAP3 mRNA	PMID:19074003
1305339	Dap3	death associated protein 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DAP3 mRNA	PMID:20938992
1305339	Dap3	death associated protein 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313309	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DAP3 mRNA	PMID:33167477
1305339	Dap3	death associated protein 3	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of DAP3 mRNA	PMID:24763279
1305339	Dap3	death associated protein 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313310	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DAP3 mRNA	PMID:39241906
1305339	Dap3	death associated protein 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313310	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DAP3 mRNA	PMID:39298647
1305339	Dap3	death associated protein 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DAP3 mRNA	PMID:20938992
1305339	Dap3	death associated protein 3	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20140408	CTD	MESH:D008550	Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of DAP3 mRNA]	PMID:23963992
1305339	Dap3	death associated protein 3	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of DAP3 mRNA	PMID:17251523
1305339	Dap3	death associated protein 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313310	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of DAP3 protein	PMID:20463053
1305339	Dap3	death associated protein 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of DAP3 protein	PMID:20463053
1305339	Dap3	death associated protein 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DAP3 mRNA	PMID:36331819
1305339	Dap3	death associated protein 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DAP3 protein	PMID:34915118
1305339	Dap3	death associated protein 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313309	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DAP3 gene	PMID:27153756
1305339	Dap3	death associated protein 3	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1313309	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of DAP3 mRNA	PMID:26760959
1305339	Dap3	death associated protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DAP3 mRNA	PMID:35430440
1305339	Dap3	death associated protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DAP3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DAP3 mRNA	PMID:20938992|PMID:22206623
1305339	Dap3	death associated protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:39836092
1305339	Dap3	death associated protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:40504410
1305339	Dap3	death associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313310	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DAP3 mRNA	PMID:21570461
1305339	Dap3	death associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DAP3 mRNA	PMID:33387578
1305339	Dap3	death associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DAP3 mRNA	PMID:17942748
1305339	Dap3	death associated protein 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313309	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DAP3 mRNA	PMID:33212167
1305339	Dap3	death associated protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313310	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DAP3 mRNA	PMID:16014739
1305339	Dap3	death associated protein 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313309	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DAP3 mRNA	PMID:38568856
1305339	Dap3	death associated protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:39836092
1305339	Dap3	death associated protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:40504410
1305339	Dap3	death associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313309	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DAP3 5' UTR	PMID:27901495
1305339	Dap3	death associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313310	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DAP3 mRNA	PMID:22228805
1305339	Dap3	death associated protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313310	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DAP3 promoter	PMID:35295148
1305339	Dap3	death associated protein 3	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	ISO	RGD:1313309	E	RGD:6480464	20140114	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of DAP3 mRNA	PMID:23777605
1305339	Dap3	death associated protein 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313309	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DAP3 mRNA	PMID:30903817
1305339	Dap3	death associated protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313309	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of DAP3 protein	PMID:37567409
1305339	Dap3	death associated protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313310	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DAP3 mRNA; bisphenol A results in increased expression of DAP3 protein	PMID:26903627|PMID:33221593
1305339	Dap3	death associated protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313310	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DAP3 mRNA	PMID:39298647
1305339	Dap3	death associated protein 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313309	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of DAP3 protein	PMID:34186270
1305339	Dap3	death associated protein 3	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313309	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of DAP3 protein	PMID:34186270
1305339	Dap3	death associated protein 3	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of DAP3 mRNA	PMID:22546817
1305339	Dap3	death associated protein 3	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1313309	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to DAP3 protein	PMID:32991956
1305339	Dap3	death associated protein 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313310	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of DAP3 mRNA	PMID:34813904
1305339	Dap3	death associated protein 3	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of DAP3 mRNA	PMID:22546817
1305339	Dap3	death associated protein 3	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20140408	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of DAP3 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of DAP3 mRNA]	PMID:23963992
1305339	Dap3	death associated protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313309	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DAP3 mRNA	PMID:37042841
1305339	Dap3	death associated protein 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313309	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DAP3 protein	PMID:24527689
1305339	Dap3	death associated protein 3	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313309	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of DAP3 mRNA	PMID:19320972|PMID:19376846
1305339	Dap3	death associated protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DAP3 mRNA	PMID:36331819
1305339	Dap3	death associated protein 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of DAP3 mRNA	PMID:21427059
1305339	Dap3	death associated protein 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313309	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DAP3 mRNA	PMID:20106945|PMID:25562108
1305339	Dap3	death associated protein 3	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C017160	cypermethrin results in increased expression of DAP3 mRNA	PMID:22528246
1305339	Dap3	death associated protein 3	gene	CHEBI:41423	celecoxib	affects expression	ISO	RGD:1313310	E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib affects the expression of DAP3 mRNA	PMID:20562220
1305339	Dap3	death associated protein 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313309	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of DAP3 mRNA	PMID:25704631
1305339	Dap3	death associated protein 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:39836092
1305339	Dap3	death associated protein 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:40504410
1305339	Dap3	death associated protein 3	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313309	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of DAP3 mRNA	PMID:18175754
1305339	Dap3	death associated protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DAP3 mRNA	PMID:17942748
1305339	Dap3	death associated protein 3	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313310	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of DAP3 mRNA	PMID:40234311
1305339	Dap3	death associated protein 3	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20140408	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of DAP3 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of DAP3 mRNA]	PMID:23963992
1305339	Dap3	death associated protein 3	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1313309	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of DAP3 mRNA	PMID:17659339
1305339	Dap3	death associated protein 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313309	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DAP3 protein	PMID:32959892
1305339	Dap3	death associated protein 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of DAP3 mRNA	PMID:14729362
1305339	Dap3	death associated protein 3	gene	CHEBI:6443	levonorgestrel	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DAP3 mRNA	PMID:19074003
1305339	Dap3	death associated protein 3	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1313309	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of DAP3 mRNA	PMID:37939859
1305339	Dap3	death associated protein 3	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of DAP3 mRNA	PMID:17654400
1305339	Dap3	death associated protein 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313309	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DAP3 mRNA	PMID:31758290
1305339	Dap3	death associated protein 3	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313309	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DAP3 protein	PMID:34186270
1305339	Dap3	death associated protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DAP3 mRNA	PMID:22206623
1305339	Dap3	death associated protein 3	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DAP3 protein	PMID:37664457
1305339	Dap3	death associated protein 3	gene	CHEBI:7602	nobiletin	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of DAP3 protein]	PMID:38348393
1305339	Dap3	death associated protein 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DAP3 gene]	PMID:28238834
1305339	Dap3	death associated protein 3	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1313309	E	RGD:6480464	20120412	CTD	MESH:D010672	Phenytoin results in increased expression of DAP3 mRNA	PMID:14741686
1305339	Dap3	death associated protein 3	gene	CHEBI:8207	(+)-pilocarpine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in increased expression of DAP3 mRNA	PMID:17971868
1305339	Dap3	death associated protein 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313309	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DAP3 protein	PMID:38348393
1305339	Dap3	death associated protein 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of DAP3 protein]	PMID:38348393
1305339	Dap3	death associated protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313309	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DAP3 protein	PMID:37664457
1305339	Dap3	death associated protein 3	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313309	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DAP3 mRNA	PMID:38568856
1305339	Dap3	death associated protein 3	gene	CHEBI:9907	ursodeoxycholic acid	affects expression	ISO	RGD:1313309	E	RGD:6480464	20120613	CTD	MESH:D014580	Ursodeoxycholic Acid affects the expression of DAP3 mRNA	PMID:18422935
1305339	Dap3	death associated protein 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of DAP3 mRNA	PMID:23034163
1305340	Cep55	centrosomal protein 55	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CEP55 mRNA	PMID:20938992
1305340	Cep55	centrosomal protein 55	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of CEP55 mRNA	PMID:23724009|PMID:33167477
1305340	Cep55	centrosomal protein 55	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CEP55 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CEP55 mRNA	PMID:33729688
1305340	Cep55	centrosomal protein 55	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20120918	CTD	MESH:D000431	Ethanol results in decreased expression of CEP55 protein	PMID:20621659
1305340	Cep55	centrosomal protein 55	gene	CHEBI:16243	quercetin	affects phosphorylation	ISO	RGD:1313311	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin affects the phosphorylation of CEP55 protein	PMID:35688186
1305340	Cep55	centrosomal protein 55	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313311	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of CEP55 mRNA	PMID:21632981
1305340	Cep55	centrosomal protein 55	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of CEP55 mRNA	PMID:35877022
1305340	Cep55	centrosomal protein 55	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313311	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of CEP55 mRNA	PMID:19167446
1305340	Cep55	centrosomal protein 55	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA	PMID:25510870
1305340	Cep55	centrosomal protein 55	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CEP55 mRNA	PMID:33387578
1305340	Cep55	centrosomal protein 55	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CEP55 gene	PMID:27618143
1305340	Cep55	centrosomal protein 55	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CEP55 mRNA	PMID:20938992
1305340	Cep55	centrosomal protein 55	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20250506	CTD	MESH:D002635	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of CEP55 mRNA	PMID:21795739
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313311	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of CEP55 mRNA	PMID:18070364
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313311	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CEP55 mRNA	PMID:21179406
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA	PMID:37992649
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of CEP55 mRNA	PMID:21592394
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of CEP55 mRNA	PMID:21592394
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA	PMID:37992649
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20250506	CTD	MESH:D006000	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313311	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CEP55 mRNA	PMID:31163220
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1623932	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CEP55 mRNA	PMID:34319233
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CEP55 promoter	PMID:23359474
1305340	Cep55	centrosomal protein 55	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CEP55 mRNA	PMID:26577399
1305340	Cep55	centrosomal protein 55	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313311	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CEP55 protein	PMID:37730182
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of CEP55 mRNA	PMID:21592394
1305340	Cep55	centrosomal protein 55	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of CEP55 mRNA	PMID:21592394
1305340	Cep55	centrosomal protein 55	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CEP55 mRNA	PMID:38301995
1305340	Cep55	centrosomal protein 55	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of CEP55 mRNA	PMID:21120746
1305340	Cep55	centrosomal protein 55	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA	PMID:25510870
1305340	Cep55	centrosomal protein 55	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA	PMID:25510870
1305340	Cep55	centrosomal protein 55	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CEP55 mRNA	PMID:19549813
1305340	Cep55	centrosomal protein 55	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CEP55 protein	PMID:23301498
1305340	Cep55	centrosomal protein 55	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313311	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CEP55 protein	PMID:20106945
1305340	Cep55	centrosomal protein 55	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CEP55 mRNA	PMID:19770486
1305340	Cep55	centrosomal protein 55	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEP55 mRNA	PMID:23630614|PMID:25378103
1305340	Cep55	centrosomal protein 55	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of CEP55 mRNA	PMID:25102026
1305340	Cep55	centrosomal protein 55	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1623932	E	RGD:6480464	20150609	CTD	MESH:D010126	Ozone results in increased expression of CEP55 mRNA	PMID:25658374
1305340	Cep55	centrosomal protein 55	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEP55 mRNA	PMID:41430723
1305340	Cep55	centrosomal protein 55	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CEP55 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEP55 mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of CEP55 mRNA; TTPA protein affects the reaction [Ozone results in increased expression of CEP55 mRNA]	PMID:19555225|PMID:24381131|PMID:25658374|PMID:27106289|PMID:34911549
1305340	Cep55	centrosomal protein 55	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of CEP55 mRNA	PMID:17484886
1305340	Cep55	centrosomal protein 55	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1623932	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CEP55 mRNA	PMID:31919559
1305340	Cep55	centrosomal protein 55	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1623932	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CEP55 mRNA	PMID:25629700
1305340	Cep55	centrosomal protein 55	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CEP55 mRNA	PMID:20938992
1305340	Cep55	centrosomal protein 55	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20250506	CTD	MESH:D006002	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1305340	Cep55	centrosomal protein 55	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CEP55 mRNA	PMID:40504410
1305340	Cep55	centrosomal protein 55	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1313311	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of CEP55 mRNA	PMID:33512557
1305340	Cep55	centrosomal protein 55	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]	PMID:37992649
1305340	Cep55	centrosomal protein 55	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CEP55 mRNA	PMID:31881176
1305340	Cep55	centrosomal protein 55	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of CEP55 mRNA	PMID:19167446
1305340	Cep55	centrosomal protein 55	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313311	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CEP55 mRNA	PMID:25583101
1305340	Cep55	centrosomal protein 55	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313311	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CEP55 mRNA	PMID:22298810
1305340	Cep55	centrosomal protein 55	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEP55 mRNA	PMID:33387578|PMID:34747641
1305340	Cep55	centrosomal protein 55	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEP55 mRNA	PMID:21802500
1305340	Cep55	centrosomal protein 55	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313311	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of CEP55 mRNA	PMID:33512557
1305340	Cep55	centrosomal protein 55	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CEP55 protein	PMID:33212167
1305340	Cep55	centrosomal protein 55	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CEP55 mRNA	PMID:32763439
1305340	Cep55	centrosomal protein 55	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CEP55 mRNA	PMID:30031762
1305340	Cep55	centrosomal protein 55	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA	PMID:37992649
1305340	Cep55	centrosomal protein 55	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20250506	CTD	MESH:D003840	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1305340	Cep55	centrosomal protein 55	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]	PMID:37992649
1305340	Cep55	centrosomal protein 55	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of CEP55 mRNA	PMID:22623647
1305340	Cep55	centrosomal protein 55	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CEP55 mRNA	PMID:17998272
1305340	Cep55	centrosomal protein 55	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313311	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CEP55 mRNA	PMID:29301061|PMID:39719251
1305340	Cep55	centrosomal protein 55	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1623932	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of CEP55 mRNA	PMID:39515575
1305340	Cep55	centrosomal protein 55	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CEP55 mRNA	PMID:40504410
1305340	Cep55	centrosomal protein 55	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of CEP55 mRNA	PMID:22378314|PMID:29453283
1305340	Cep55	centrosomal protein 55	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CEP55 mRNA	PMID:20064835|PMID:21802500
1305340	Cep55	centrosomal protein 55	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CEP55 mRNA	PMID:19770486
1305340	Cep55	centrosomal protein 55	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313311	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEP55 mRNA	PMID:32234424
1305340	Cep55	centrosomal protein 55	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEP55 mRNA	PMID:20713471|PMID:32417428
1305340	Cep55	centrosomal protein 55	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of CEP55 mRNA	PMID:18929588
1305340	Cep55	centrosomal protein 55	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1623932	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CEP55 mRNA	PMID:29341224
1305340	Cep55	centrosomal protein 55	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CEP55 mRNA	PMID:20382639
1305340	Cep55	centrosomal protein 55	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313311	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CEP55 mRNA	PMID:20458559
1305340	Cep55	centrosomal protein 55	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CEP55 mRNA	PMID:30047161
1305340	Cep55	centrosomal protein 55	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623932	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CEP55 gene; titanium dioxide results in decreased methylation of CEP55 promoter	PMID:35295148
1305340	Cep55	centrosomal protein 55	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of CEP55 mRNA	PMID:30012374
1305340	Cep55	centrosomal protein 55	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1623932	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CEP55 mRNA	PMID:23557971
1305340	Cep55	centrosomal protein 55	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1623932	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CEP55 promoter	PMID:35295148
1305340	Cep55	centrosomal protein 55	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CEP55 mRNA	PMID:22659510|PMID:23411599|PMID:34492290
1305340	Cep55	centrosomal protein 55	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CEP55 mRNA	PMID:18301758
1305340	Cep55	centrosomal protein 55	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CEP55 mRNA	PMID:19710929
1305340	Cep55	centrosomal protein 55	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CEP55 mRNA	PMID:38479592
1305340	Cep55	centrosomal protein 55	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CEP55 mRNA	PMID:25181051
1305340	Cep55	centrosomal protein 55	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CEP55 mRNA	PMID:29275510
1305340	Cep55	centrosomal protein 55	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of CEP55 mRNA	PMID:32145629
1305340	Cep55	centrosomal protein 55	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1623932	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of CEP55 mRNA	PMID:40036665
1305340	Cep55	centrosomal protein 55	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CEP55 promoter	PMID:23359474
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1623932	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CEP55 mRNA	PMID:26682919
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA	PMID:25510870
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA	PMID:25510870
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of CEP55 mRNA	PMID:20713471
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CEP55 mRNA	PMID:39298647|PMID:40203079
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313311	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CEP55 gene	PMID:31601247
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CEP55 mRNA	PMID:20350560
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313311	E	RGD:6480464	20230704	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CEP55 mRNA	PMID:36828243
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CEP55 promoter	PMID:23359474
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20230704	CTD	MESH:D003993	N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of CEP55 mRNA]	PMID:36828243
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CEP55 mRNA	PMID:24535843
1305340	Cep55	centrosomal protein 55	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of CEP55 gene	PMID:33148267
1305340	Cep55	centrosomal protein 55	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CEP55 mRNA	PMID:30723492
1305340	Cep55	centrosomal protein 55	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313311	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CEP55 mRNA	PMID:26472689
1305340	Cep55	centrosomal protein 55	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CEP55 mRNA	PMID:25539665
1305340	Cep55	centrosomal protein 55	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CEP55 mRNA	PMID:30047161
1305340	Cep55	centrosomal protein 55	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CEP55 mRNA	PMID:19320972
1305340	Cep55	centrosomal protein 55	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20250506	CTD	MESH:D005999	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1305340	Cep55	centrosomal protein 55	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1623932	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of CEP55 mRNA	PMID:28962523
1305340	Cep55	centrosomal protein 55	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CEP55 mRNA	PMID:40194260
1305340	Cep55	centrosomal protein 55	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1623932	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CEP55 mRNA	PMID:40194260
1305340	Cep55	centrosomal protein 55	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CEP55 mRNA	PMID:28302478
1305340	Cep55	centrosomal protein 55	gene	CHEBI:38725	mevinphos	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D008799	Mevinphos results in increased expression of CEP55 mRNA; Mevinphos results in increased expression of CEP55 protein	PMID:25449601
1305340	Cep55	centrosomal protein 55	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CEP55 mRNA	PMID:31533062
1305340	Cep55	centrosomal protein 55	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313311	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CEP55 mRNA	PMID:19167446
1305340	Cep55	centrosomal protein 55	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CEP55 mRNA	PMID:19167446
1305340	Cep55	centrosomal protein 55	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of CEP55 mRNA	PMID:39529242
1305340	Cep55	centrosomal protein 55	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CEP55 mRNA	PMID:40419075
1305340	Cep55	centrosomal protein 55	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313311	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CEP55 mRNA	PMID:25979313
1305340	Cep55	centrosomal protein 55	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CEP55 mRNA	PMID:30047161
1305340	Cep55	centrosomal protein 55	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA	PMID:37992649
1305340	Cep55	centrosomal protein 55	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1313311	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of CEP55 mRNA	PMID:33512557
1305340	Cep55	centrosomal protein 55	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313311	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CEP55 mRNA	PMID:38832940
1305340	Cep55	centrosomal protein 55	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313311	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CEP55 mRNA	PMID:27188386
1305340	Cep55	centrosomal protein 55	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313311	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CEP55 mRNA	PMID:28542535
1305340	Cep55	centrosomal protein 55	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313311	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CEP55 mRNA	PMID:22230336
1305340	Cep55	centrosomal protein 55	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of CEP55 mRNA	PMID:17039268
1305340	Cep55	centrosomal protein 55	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of CEP55 mRNA	PMID:24714768
1305340	Cep55	centrosomal protein 55	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CEP55 mRNA	PMID:40504410
1305340	Cep55	centrosomal protein 55	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313311	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of CEP55 mRNA	PMID:31838189
1305340	Cep55	centrosomal protein 55	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CEP55 mRNA	PMID:29391264
1305340	Cep55	centrosomal protein 55	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313311	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CEP55 mRNA	PMID:20458559
1305340	Cep55	centrosomal protein 55	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1623932	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CEP55 mRNA; Nanotubes, Carbon results in increased expression of CEP55 mRNA	PMID:25554681|PMID:25620056
1305340	Cep55	centrosomal protein 55	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CEP55 mRNA	PMID:30047161
1305340	Cep55	centrosomal protein 55	gene	CHEBI:50883	boron nitride	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20190409	CTD	MESH:C017282	boron nitride results in decreased expression of CEP55 mRNA	PMID:30644070
1305340	Cep55	centrosomal protein 55	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of CEP55 mRNA	PMID:21148553
1305340	Cep55	centrosomal protein 55	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1623932	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CEP55 mRNA	PMID:19042947
1305340	Cep55	centrosomal protein 55	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CEP55 mRNA	PMID:38701926
1305340	Cep55	centrosomal protein 55	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of CEP55 mRNA	PMID:19812364
1305340	Cep55	centrosomal protein 55	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CEP55 mRNA	PMID:37269647
1305340	Cep55	centrosomal protein 55	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CEP55 mRNA	PMID:24810058
1305340	Cep55	centrosomal protein 55	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of CEP55 mRNA	PMID:35283115
1305340	Cep55	centrosomal protein 55	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in decreased expression of CEP55 mRNA	PMID:25290377
1305340	Cep55	centrosomal protein 55	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of CEP55 gene	PMID:33148267
1305340	Cep55	centrosomal protein 55	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of CEP55 mRNA	PMID:29522793
1305340	Cep55	centrosomal protein 55	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313311	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CEP55 mRNA	PMID:37199045
1305340	Cep55	centrosomal protein 55	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of CEP55 mRNA	PMID:28960945
1305340	Cep55	centrosomal protein 55	gene	CHEBI:76604	MeIQx	increases expression	ISO	RGD:1313311	E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CEP55 mRNA	PMID:20816883
1305340	Cep55	centrosomal protein 55	gene	CHEBI:7719	ochratoxin A	decreases acetylation	ISO	RGD:1313311	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of CEP55 promoter	PMID:29098329
1305340	Cep55	centrosomal protein 55	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of CEP55 mRNA	PMID:29098329
1305340	Cep55	centrosomal protein 55	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C025589	ochratoxin A results in increased expression of CEP55 mRNA	PMID:38301995
1305340	Cep55	centrosomal protein 55	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of CEP55 promoter] which results in decreased expression of CEP55 mRNA	PMID:29098329
1305340	Cep55	centrosomal protein 55	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of CEP55 mRNA	PMID:34995734
1305340	Cep55	centrosomal protein 55	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of CEP55 mRNA	PMID:30928695
1305340	Cep55	centrosomal protein 55	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1623932	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CEP55 mRNA	PMID:23091169
1305340	Cep55	centrosomal protein 55	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CEP55 mRNA	PMID:24535843
1305340	Cep55	centrosomal protein 55	gene	CHEBI:81555	Enterolactone	increases expression	ISO	RGD:1313311	E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP55 mRNA	PMID:19167446
1305340	Cep55	centrosomal protein 55	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA	PMID:19167446
1305340	Cep55	centrosomal protein 55	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1623932	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CEP55 mRNA	PMID:38648751
1305340	Cep55	centrosomal protein 55	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1313311	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of CEP55 mRNA	PMID:33512557
1305340	Cep55	centrosomal protein 55	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of CEP55 mRNA	PMID:32234424
1305340	Cep55	centrosomal protein 55	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of CEP55 mRNA	PMID:21858171
1305340	Cep55	centrosomal protein 55	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	ISO	RGD:1313311	E	RGD:6480464	20250506	CTD	MESH:C005842	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1305340	Cep55	centrosomal protein 55	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1313311	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of CEP55 mRNA	PMID:33512557
1305340	Cep55	centrosomal protein 55	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of CEP55 mRNA	PMID:24780913
1305340	Cep55	centrosomal protein 55	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CEP55 mRNA	PMID:30047161
1305340	Cep55	centrosomal protein 55	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1313311	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of CEP55 mRNA	PMID:22869556
1305340	Cep55	centrosomal protein 55	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CEP55 mRNA	PMID:35537566
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313312	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of LEMD2 mRNA	PMID:38568856
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LEMD2 mRNA	PMID:33387578
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313312	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Clozapine] results in increased expression of LEMD2 protein	PMID:34122009
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313312	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LEMD2 protein	PMID:37730182
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313312	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LEMD2 mRNA	PMID:28818685
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552183	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LEMD2 mRNA	PMID:19770486
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313312	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LEMD2 gene	PMID:27153756
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1552183	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of LEMD2 mRNA	PMID:25629700
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552183	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LEMD2 mRNA	PMID:40504410
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313312	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of LEMD2 protein	PMID:35688186
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552183	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LEMD2 mRNA	PMID:21570461
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LEMD2 mRNA	PMID:33387578
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313312	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of LEMD2 mRNA	PMID:24690739
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313312	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LEMD2 mRNA	PMID:29803840
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313312	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of LEMD2 protein	PMID:35688186
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313312	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LEMD2 mRNA	PMID:38568856
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552183	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LEMD2 mRNA	PMID:40504410
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LEMD2 mRNA	PMID:21839799
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313312	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LEMD2 5' UTR	PMID:27901495
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552183	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LEMD2 mRNA	PMID:22228805
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313312	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LEMD2 3' UTR; Benzo(a)pyrene results in increased methylation of LEMD2 promoter	PMID:27901495
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313312	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of LEMD2 mRNA	PMID:24690739
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552183	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LEMD2 promoter	PMID:35295148
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C069837	fullerene C60 results in increased expression of LEMD2 mRNA	PMID:19167457
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LEMD2 mRNA	PMID:25181051
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313312	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LEMD2 gene	PMID:31601247
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313312	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of LEMD2 protein	PMID:34186270
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552183	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of LEMD2 exon	PMID:33297965
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313312	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of LEMD2 protein	PMID:34186270
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313312	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LEMD2 mRNA	PMID:28628672
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313312	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of LEMD2 protein	PMID:34186270
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552183	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LEMD2 intron	PMID:28392331
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552183	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LEMD2 mRNA	PMID:37019170
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552183	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of LEMD2 mRNA	PMID:34813904
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313312	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LEMD2 mRNA	PMID:28628672
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552183	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of LEMD2 mRNA	PMID:34813904
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313312	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LEMD2 mRNA	PMID:37042841
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1552183	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of LEMD2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LEMD2 mRNA]	PMID:17585979
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:3766	clozapine	multiple interactions	ISO	RGD:1313312	E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in increased expression of LEMD2 protein	PMID:34122009
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313312	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LEMD2 mRNA	PMID:31533062
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313312	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LEMD2 gene	PMID:29154799
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313312	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of LEMD2 mRNA	PMID:20106945
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313312	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LEMD2 mRNA	PMID:28628672
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LEMD2 mRNA	PMID:33387578
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1552183	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of LEMD2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LEMD2 mRNA]	PMID:17585979
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313312	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of LEMD2 mRNA	PMID:24690739
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552183	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LEMD2 mRNA	PMID:40504410
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313312	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LEMD2 mRNA	PMID:28628672
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:50729	mitoxantrone	affects response to substance	ISO	RGD:1313312	E	RGD:6480464	20120412	CTD	MESH:D008942	LEMD2 mRNA affects the susceptibility to Mitoxantrone	PMID:16044152
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of LEMD2 mRNA	PMID:19162173
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of LEMD2 mRNA	PMID:24793618
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313312	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of LEMD2 protein	PMID:23718831
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313312	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LEMD2 protein	PMID:32959892
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of LEMD2 mRNA	PMID:28801915
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313312	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LEMD2 protein	PMID:34186270
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552183	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LEMD2 mRNA	PMID:22206623
1305341	Lemd2	LEM domain nuclear envelope protein 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313312	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LEMD2 mRNA	PMID:38568856
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313314	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ARHGAP9 mRNA	PMID:26272509
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313314	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP9 mRNA	PMID:27188386
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313315	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ARHGAP9 mRNA	PMID:33045310
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313315	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ARHGAP9 mRNA	PMID:26251327
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:15354	choline	affects expression	ISO	RGD:1313314	E	RGD:6480464	20120412	CTD	MESH:D002794	Choline affects the expression of ARHGAP9 mRNA	PMID:17616785
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGAP9 mRNA	PMID:20938992
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGAP9 mRNA	PMID:20488242
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313314	E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGAP9 mRNA	PMID:15894607|PMID:33167477
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313314	E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of ARHGAP9 mRNA	PMID:15894607
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGAP9 mRNA	PMID:36189433
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARHGAP9 mRNA	PMID:39241906
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP9 mRNA	PMID:32741896
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGAP9 mRNA	PMID:20938992
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313314	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARHGAP9 mRNA	PMID:37042841
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP9 mRNA	PMID:37992649
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGAP9 mRNA	PMID:36189433
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP9 mRNA	PMID:32741896
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP9 mRNA	PMID:37992649
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ARHGAP9 mRNA	PMID:22061828
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1313315	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of ARHGAP9 mRNA	PMID:39984025
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGAP9 mRNA	PMID:39012411
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313314	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ARHGAP9 mRNA	PMID:19549813
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313314	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARHGAP9 intron	PMID:30157460
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313314	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ARHGAP9 mRNA	PMID:35430440
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313314	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ARHGAP9 mRNA	PMID:19774075
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ARHGAP9 mRNA	PMID:31150632
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGAP9 mRNA	PMID:20938992
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of ARHGAP9 mRNA	PMID:38314887
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ARHGAP9 mRNA	PMID:31881176
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ARHGAP9 mRNA	PMID:25905778
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of ARHGAP9 mRNA	PMID:25905778
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1313314	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ARHGAP9 mRNA	PMID:23300844
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of ARHGAP9 mRNA	PMID:17898221
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313314	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ARHGAP9 mRNA	PMID:25583101
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGAP9 mRNA	PMID:34747641
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313314	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ARHGAP9 mRNA	PMID:32763439
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP9 mRNA	PMID:37992649
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313314	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGAP9 mRNA	PMID:34032870
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313314	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGAP9 mRNA	PMID:38568856
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313314	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ARHGAP9 gene	PMID:25435355
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313315	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ARHGAP9 mRNA	PMID:27131904
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313315	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ARHGAP9 mRNA	PMID:29341224
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313314	E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ARHGAP9 mRNA	PMID:15894607
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313314	E	RGD:6480464	20180828	CTD	MESH:C015358	methylparaben results in increased expression of ARHGAP9 mRNA	PMID:17121429
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313315	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARHGAP9 gene	PMID:35295148
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ARHGAP9 mRNA	PMID:34492290
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313315	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ARHGAP9 mRNA	PMID:18301758
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP9 mRNA	PMID:25181051|PMID:32145629
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313315	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARHGAP9 promoter	PMID:27312807
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313315	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP9 mRNA	PMID:32156529|PMID:38701888
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313315	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ARHGAP9 gene	PMID:31683443
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ARHGAP9 mRNA	PMID:38685157
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of ARHGAP9 mRNA	PMID:31558096
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313314	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGAP9 mRNA	PMID:37042841
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ARHGAP9 mRNA	PMID:35163327
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ARHGAP9 mRNA	PMID:25380136
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313314	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARHGAP9 mRNA	PMID:38382870
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGAP9 mRNA	PMID:39012411
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313314	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ARHGAP9 mRNA	PMID:24449571
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313314	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARHGAP9 mRNA	PMID:31533062
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ARHGAP9 mRNA	PMID:39529242
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of ARHGAP9 mRNA	PMID:23125180
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of ARHGAP9 mRNA	PMID:31558096
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP9 mRNA	PMID:37992649
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1313314	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of ARHGAP9 mRNA	PMID:33512557
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313314	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARHGAP9 mRNA	PMID:38832940
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313315	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ARHGAP9 mRNA	PMID:29279043
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313314	E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ARHGAP9 mRNA	PMID:15894607
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1313314	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of ARHGAP9 mRNA	PMID:38825487
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1313314	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of ARHGAP9 mRNA	PMID:33512557
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313314	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ARHGAP9 mRNA	PMID:23300844
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ARHGAP9 mRNA	PMID:38701926
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of ARHGAP9 mRNA	PMID:36907384
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:6809	methamphetamine	increases methylation	ISO	RGD:1313315	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased methylation of ARHGAP9 promoter	PMID:26307267
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1313314	E	RGD:6480464	20210608	CTD	MESH:C014476	diethyl maleate results in increased expression of ARHGAP9 mRNA	PMID:33545341
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313315	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARHGAP9 mRNA	PMID:22206623
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP9 mRNA	PMID:32741896
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313314	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP9 mRNA	PMID:27188386
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313314	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARHGAP9 gene]	PMID:28238834
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1313314	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of ARHGAP9 mRNA	PMID:33512557
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of ARHGAP9 mRNA	PMID:31558096
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in increased expression of ARHGAP9 mRNA	PMID:26923065
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARHGAP9 mRNA	PMID:24780913
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:88542	Butylparaben	increases expression	ISO	RGD:1313314	E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of ARHGAP9 mRNA	PMID:17121429
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313314	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP9 mRNA	PMID:27188386
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313315	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ARHGAP9 mRNA	PMID:27131904
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of ARHGAP9 mRNA	PMID:25905778
1305342	Arhgap9	Rho GTPase activating protein 9	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1313314	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of ARHGAP9 mRNA	PMID:33512557
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of EMILIN2 mRNA	PMID:25152437
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313316	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of EMILIN2 mRNA	PMID:27188386
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313317	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of EMILIN2 mRNA	PMID:37995155
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of EMILIN2 mRNA	PMID:20188158
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EMILIN2 mRNA	PMID:20938992
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313316	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of EMILIN2 mRNA	PMID:26079696
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:16130	DDT	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased expression of EMILIN2 mRNA	PMID:30207508
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313317	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of EMILIN2 mRNA	PMID:19484750
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EMILIN2 mRNA	PMID:20938992
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMILIN2 mRNA	PMID:37992649
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMILIN2 mRNA	PMID:37992649
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of EMILIN2 mRNA	PMID:22061828
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EMILIN2 mRNA	PMID:33387578
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EMILIN2 mRNA	PMID:36331819
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313316	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of EMILIN2 mRNA	PMID:19549813
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA	PMID:22129741
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313316	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of EMILIN2 mRNA	PMID:22100608
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313316	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EMILIN2 intron	PMID:30157460
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313316	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of EMILIN2 mRNA	PMID:41430723
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of EMILIN2 mRNA	PMID:30779732
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313317	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EMILIN2 mRNA	PMID:31919559
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EMILIN2 mRNA	PMID:25629700
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EMILIN2 mRNA	PMID:20938992
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313316	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EMILIN2 gene	PMID:25304211
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313316	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of EMILIN2 mRNA	PMID:26272509
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313316	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EMILIN2 mRNA	PMID:27188386
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313317	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of EMILIN2 mRNA	PMID:35897073
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313316	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of EMILIN2 mRNA	PMID:23557933
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1313316	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of EMILIN2 gene	PMID:31636367
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313316	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of EMILIN2 mRNA	PMID:27594783
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313317	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of EMILIN2 mRNA	PMID:21151649
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313316	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of EMILIN2 mRNA	PMID:24768652|PMID:25583101
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313317	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EMILIN2 mRNA	PMID:21570461
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313317	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of EMILIN2 mRNA	PMID:32937126
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313316	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of EMILIN2 mRNA	PMID:28001369
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of EMILIN2 mRNA	PMID:39631538
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313316	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of EMILIN2 mRNA	PMID:29803840
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMILIN2 mRNA	PMID:37992649
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA	PMID:22129741
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of EMILIN2 mRNA	PMID:37682722|PMID:39515575
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313316	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EMILIN2 mRNA	PMID:38568856
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313316	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EMILIN2 promoter	PMID:27901495
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EMILIN2 mRNA	PMID:21569818|PMID:22228805
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313316	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EMILIN2 exon	PMID:27901495
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313316	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of EMILIN2 promoter	PMID:23974009
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313317	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of EMILIN2 mRNA	PMID:23221170
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313317	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of EMILIN2 gene	PMID:35295148
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EMILIN2 mRNA	PMID:34492290
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313317	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of EMILIN2 mRNA	PMID:26063408|PMID:32156529
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313317	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of EMILIN2 mRNA	PMID:26682919
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313317	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of EMILIN2 exon	PMID:33297965
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313317	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of EMILIN2 mRNA	PMID:30951980
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1313316	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of EMILIN2 intron	PMID:30157460
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313317	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of EMILIN2 intron	PMID:28392331
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA	PMID:22129741
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EMILIN2 mRNA	PMID:35163327
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of EMILIN2 mRNA	PMID:24982889
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313317	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EMILIN2 mRNA	PMID:24982889
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EMILIN2 mRNA	PMID:35163327
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of EMILIN2 mRNA	PMID:22698814
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313316	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of EMILIN2 mRNA	PMID:24449571
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313316	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EMILIN2 mRNA	PMID:31533062
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EMILIN2 mRNA	PMID:36331819
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of EMILIN2 mRNA	PMID:23125180
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313316	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EMILIN2 mRNA	PMID:23179753
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313317	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of EMILIN2 mRNA	PMID:24896083
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313316	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of EMILIN2 gene	PMID:29154799
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313316	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of EMILIN2 mRNA	PMID:25047013
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of EMILIN2 mRNA	PMID:28973697
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMILIN2 mRNA	PMID:37992649
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313316	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EMILIN2 mRNA	PMID:38832940
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EMILIN2 mRNA	PMID:33387578
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313316	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EMILIN2 gene	PMID:25304211
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313317	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of EMILIN2 mRNA	PMID:25554681
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313317	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of EMILIN2 mRNA	PMID:25554681
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313317	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of EMILIN2 mRNA	PMID:40234311
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313317	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of EMILIN2 mRNA	PMID:19042947
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:5643	Heliotrine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in increased expression of EMILIN2 mRNA	PMID:34185104
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313317	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of EMILIN2 mRNA	PMID:38701926
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1313316	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of EMILIN2 intron	PMID:30157460
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313316	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of EMILIN2 mRNA	PMID:31758290
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313317	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EMILIN2 mRNA	PMID:22206623
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1313317	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of EMILIN2 mRNA	PMID:27858113
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313316	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EMILIN2 mRNA	PMID:27188386
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313317	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of EMILIN2 mRNA	PMID:38648751
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313316	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of EMILIN2 mRNA	PMID:26079696
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of EMILIN2 mRNA	PMID:39847705
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313317	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of EMILIN2 mRNA	PMID:30953684
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C009237	senecionine results in increased expression of EMILIN2 mRNA	PMID:34185104
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313316	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EMILIN2 mRNA	PMID:27188386
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:9111	Senkirkine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C009238	senkirkine results in increased expression of EMILIN2 mRNA	PMID:34185104
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313316	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of EMILIN2 mRNA	PMID:29301935
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313316	E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in increased expression of EMILIN2 mRNA	PMID:29453283
1305343	Emilin2	elastin microfibril interfacer 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313317	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of EMILIN2 mRNA	PMID:28973697
1305344	Iglon5	IgLON family member 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313318	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of IGLON5 mRNA	PMID:33045310
1305344	Iglon5	IgLON family member 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:2302828	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of IGLON5 mRNA	PMID:21934132
1305344	Iglon5	IgLON family member 5	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313318	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of IGLON5 mRNA	PMID:36189433
1305344	Iglon5	IgLON family member 5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:2302828	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of IGLON5 mRNA	PMID:35811015
1305344	Iglon5	IgLON family member 5	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:2302828	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of IGLON5 mRNA	PMID:30510588
1305344	Iglon5	IgLON family member 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of IGLON5 mRNA	PMID:26496021
1305344	Iglon5	IgLON family member 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313318	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGLON5 mRNA	PMID:37992649
1305344	Iglon5	IgLON family member 5	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313318	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of IGLON5 mRNA	PMID:36189433
1305344	Iglon5	IgLON family member 5	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of IGLON5 mRNA	PMID:26496021
1305344	Iglon5	IgLON family member 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313318	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGLON5 mRNA	PMID:37992649
1305344	Iglon5	IgLON family member 5	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IGLON5 mRNA	PMID:33387578
1305344	Iglon5	IgLON family member 5	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1313318	E	RGD:6480464	20141223	CTD	MESH:D014284	Triiodothyronine results in increased expression of IGLON5 mRNA	PMID:25172293
1305344	Iglon5	IgLON family member 5	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1313318	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of IGLON5 mRNA	PMID:39984025
1305344	Iglon5	IgLON family member 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:2302828	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of IGLON5 mRNA	PMID:41430723
1305344	Iglon5	IgLON family member 5	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:2302828	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of IGLON5 mRNA	PMID:26272509
1305344	Iglon5	IgLON family member 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:2302828	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGLON5 mRNA	PMID:27188386
1305344	Iglon5	IgLON family member 5	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313318	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of IGLON5 mRNA	PMID:35489704
1305344	Iglon5	IgLON family member 5	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313318	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of IGLON5 mRNA	PMID:28960355
1305344	Iglon5	IgLON family member 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313318	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IGLON5 mRNA	PMID:24680724
1305344	Iglon5	IgLON family member 5	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:2302828	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of IGLON5 mRNA	PMID:28001369
1305344	Iglon5	IgLON family member 5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:2302828	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of IGLON5 mRNA	PMID:33212167
1305344	Iglon5	IgLON family member 5	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:2302828	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IGLON5 mRNA	PMID:32763439
1305344	Iglon5	IgLON family member 5	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of IGLON5 mRNA	PMID:26033743
1305344	Iglon5	IgLON family member 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313318	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGLON5 mRNA	PMID:37992649
1305344	Iglon5	IgLON family member 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313318	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of IGLON5 mRNA	PMID:37682722
1305344	Iglon5	IgLON family member 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:2302828	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of IGLON5 3' UTR	PMID:27901495
1305344	Iglon5	IgLON family member 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:2302828	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IGLON5 promoter	PMID:27901495
1305344	Iglon5	IgLON family member 5	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of IGLON5 mRNA	PMID:26033743
1305344	Iglon5	IgLON family member 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313318	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IGLON5 enhancer	PMID:35295148
1305344	Iglon5	IgLON family member 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IGLON5 mRNA	PMID:25181051|PMID:30816183
1305344	Iglon5	IgLON family member 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of IGLON5 mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of IGLON5 mRNA	PMID:26496021
1305344	Iglon5	IgLON family member 5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IGLON5 mRNA	PMID:32119087
1305344	Iglon5	IgLON family member 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:2302828	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of IGLON5 gene	PMID:31601247
1305344	Iglon5	IgLON family member 5	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of IGLON5 mRNA	PMID:35163327
1305344	Iglon5	IgLON family member 5	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of IGLON5 mRNA	PMID:35163327
1305344	Iglon5	IgLON family member 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:2302828	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IGLON5 mRNA	PMID:25979313
1305344	Iglon5	IgLON family member 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:2302828	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of IGLON5 mRNA	PMID:19101580
1305344	Iglon5	IgLON family member 5	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of IGLON5 mRNA	PMID:30047161
1305344	Iglon5	IgLON family member 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313318	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGLON5 mRNA	PMID:37992649
1305344	Iglon5	IgLON family member 5	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:2302828	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of IGLON5 mRNA	PMID:27188386
1305344	Iglon5	IgLON family member 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IGLON5 mRNA	PMID:33387578
1305344	Iglon5	IgLON family member 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:2302828	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of IGLON5 mRNA	PMID:35811015
1305344	Iglon5	IgLON family member 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:2302828	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of IGLON5 mRNA	PMID:35811015
1305344	Iglon5	IgLON family member 5	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:2302828	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of IGLON5 mRNA	PMID:38825487
1305344	Iglon5	IgLON family member 5	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of IGLON5 mRNA	PMID:30047161
1305344	Iglon5	IgLON family member 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:2302828	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGLON5 mRNA	PMID:27188386
1305344	Iglon5	IgLON family member 5	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of IGLON5 mRNA	PMID:32109520
1305344	Iglon5	IgLON family member 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of IGLON5 mRNA	PMID:30047161
1305344	Iglon5	IgLON family member 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:2302828	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGLON5 mRNA	PMID:27188386
1305344	Iglon5	IgLON family member 5	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:2302828	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of IGLON5 mRNA	PMID:27188386
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1551635	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PARS2 mRNA	PMID:20188158
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1551635	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PARS2 mRNA	PMID:30319688
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1551635	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of PARS2 mRNA	PMID:19167417
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PARS2 mRNA	PMID:33387578
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PARS2 mRNA	PMID:20655997
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:17627	ferroheme b	decreases expression	ISO	RGD:1551635	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in decreased expression of PARS2 mRNA	PMID:19191707
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1551635	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PARS2 mRNA	PMID:23892564
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PARS2 mRNA	PMID:33387578
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PARS2 mRNA	PMID:28818685
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1551635	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of PARS2 mRNA	PMID:39984025
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551635	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PARS2 mRNA	PMID:19770486
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:26355	heme b	decreases expression	ISO	RGD:1551635	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in decreased expression of PARS2 mRNA	PMID:19191707
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PARS2 mRNA	PMID:30779732
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551635	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PARS2 mRNA	PMID:25629700
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603670	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PARS2 mRNA	PMID:39836092
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of PARS2 mRNA	PMID:19921347
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603670	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PARS2 mRNA	PMID:27392435
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551635	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PARS2 mRNA	PMID:21570461
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PARS2 mRNA	PMID:33387578
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551635	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PARS2 promoter]	PMID:19654925
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PARS2 mRNA	PMID:30851411
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PARS2 mRNA	PMID:29803840
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551635	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PARS2 mRNA	PMID:37682722
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PARS2 mRNA	PMID:38568856
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603670	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PARS2 mRNA	PMID:39836092
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PARS2 protein	PMID:33278487
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551635	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to PARS2 promoter]	PMID:19654925
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PARS2 mRNA	PMID:35984750
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551635	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PARS2 gene	PMID:35295148
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PARS2 mRNA	PMID:34492290
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:32588	potassium chloride	multiple interactions	ISO	RGD:1603670	E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of PARS2 mRNA	PMID:29691375
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1551635	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of PARS2 mRNA	PMID:28329830
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PARS2 mRNA	PMID:25181051
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1551635	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PARS2 promoter	PMID:27312807
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551635	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PARS2 mRNA	PMID:39298647
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1551635	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PARS2 mRNA	PMID:17361019|PMID:21266533
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1603670	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of PARS2 mRNA	PMID:29024780
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PARS2 mRNA	PMID:38568856
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1603670	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PARS2 mRNA	PMID:28302478
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1603670	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PARS2 mRNA	PMID:40419075
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551635	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PARS2 mRNA	PMID:17963808
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PARS2 mRNA	PMID:33387578
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603670	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of PARS2 mRNA	PMID:25704631
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603670	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PARS2 mRNA	PMID:39836092
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551635	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PARS2 mRNA	PMID:22206623
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1603670	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PARS2 mRNA	PMID:37199045
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of PARS2 mRNA	PMID:21346803
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PARS2 mRNA	PMID:30851411
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603670	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PARS2 gene]	PMID:28238834
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of PARS2 protein	PMID:28903499
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PARS2 mRNA	PMID:21346803
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1603670	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PARS2 mRNA	PMID:38568856
1305345	Pars2	prolyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PARS2 mRNA	PMID:21346803
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of FARP1 mRNA	PMID:21551480
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of FARP1 mRNA	PMID:26272509
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA	PMID:27188386
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of FARP1 mRNA	PMID:33045310
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FARP1 mRNA	PMID:36331819
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FARP1 mRNA	PMID:26079696
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of FARP1 gene	PMID:28931070|PMID:35440735
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313321	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FARP1 mRNA	PMID:30319688
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FARP1 mRNA	PMID:21632981
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1313320	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of FARP1 protein	PMID:35688186
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of FARP1 mRNA	PMID:20068009
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313321	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FARP1 mRNA	PMID:39298647
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol inhibits the reaction [afimoxifene results in increased expression of FARP1 mRNA]	PMID:16849584
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313320	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FARP1 mRNA	PMID:37042841
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313320	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FARP1 protein	PMID:37730182
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1313320	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of FARP1 intron	PMID:30157460
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FARP1 mRNA	PMID:36331819
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of FARP1 protein	PMID:34915118
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FARP1 mRNA	PMID:37236586
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FARP1 mRNA	PMID:19549813
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FARP1 mRNA	PMID:19770486
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313320	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FARP1 gene	PMID:27153756
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313320	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FARP1 intron	PMID:30157460
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313320	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FARP1 mRNA	PMID:23649840
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in decreased expression of FARP1 mRNA	PMID:35737395
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FARP1 mRNA	PMID:25629700
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FARP1 mRNA	PMID:22206623
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20240702	CTD	MESH:D001151	Arsenic results in decreased expression of FARP1 mRNA	PMID:38150313
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FARP1 mRNA	PMID:40504410
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313320	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of FARP1 mRNA	PMID:19244175
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313320	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of FARP1 protein	PMID:35688186
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of FARP1 gene	PMID:31011160
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313320	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of FARP1 promoter	PMID:22847954
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313320	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in increased expression of FARP1 mRNA	PMID:20884965
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of FARP1 mRNA	PMID:25583101
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FARP1 mRNA	PMID:26290441
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FARP1 mRNA	PMID:28001369
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FARP1 mRNA	PMID:33212167
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of FARP1 mRNA	PMID:30556269
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of FARP1 mRNA	PMID:20971185
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FARP1 mRNA	PMID:15467011
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FARP1 mRNA	PMID:29803840
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313320	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of FARP1 protein	PMID:35688186
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313320	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FARP1 mRNA	PMID:20044591
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313320	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of FARP1 gene	PMID:28589171
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of FARP1 mRNA	PMID:34032870
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313320	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FARP1 mRNA	PMID:38568856
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FARP1 mRNA	PMID:40504410
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313320	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FARP1 3' UTR; Benzo(a)pyrene affects the methylation of FARP1 5' UTR	PMID:27901495
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FARP1 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FARP1 mRNA	PMID:19770486
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313320	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FARP1 promoter	PMID:27901495
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313320	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of FARP1 gene	PMID:25435355
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA	PMID:27858113
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to FARP1 mRNA]	PMID:32406909
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of FARP1 mRNA	PMID:30556269
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of FARP1 mRNA	PMID:20971185
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FARP1 mRNA	PMID:15467011
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313321	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of FARP1 mRNA	PMID:23221170
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1313320	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of FARP1 gene	PMID:31601247
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20120412	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FARP1 gene; Fulvestrant inhibits the reaction [afimoxifene results in increased expression of FARP1 mRNA]	PMID:16849584|PMID:31601247
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313321	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FARP1 gene	PMID:35295148
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FARP1 mRNA	PMID:34492290
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313321	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of FARP1 mRNA	PMID:18648102
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of FARP1 mRNA	PMID:19167457
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FARP1 mRNA	PMID:25181051
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313320	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of FARP1 mRNA	PMID:30903817
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FARP1 promoter	PMID:27415467
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313321	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FARP1 promoter	PMID:27334623
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of FARP1 mRNA	PMID:22576693
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FARP1 mRNA	PMID:26063408
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313321	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of FARP1 mRNA	PMID:30951980
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FARP1 gene	PMID:28505145
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313320	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of FARP1 gene	PMID:22576693
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FARP1 gene	PMID:31601247
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313320	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S affects the methylation of FARP1 gene	PMID:31601247
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313321	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FARP1 mRNA	PMID:30951980|PMID:39298647
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA	PMID:27858113
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313320	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of FARP1 intron	PMID:30157460
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of FARP1 mRNA	PMID:26377693
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein	PMID:34896426
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313321	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FARP1 mRNA	PMID:30951980
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313321	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of FARP1 intron	PMID:28392331
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313321	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FARP1 mRNA	PMID:37019170
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of FARP1 gene	PMID:33148267
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313320	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FARP1 mRNA	PMID:37042841
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FARP1 mRNA	PMID:26472689
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313320	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FARP1 mRNA	PMID:38382870
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FARP1 mRNA	PMID:37236586
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313321	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of FARP1 mRNA	PMID:28903501
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FARP1 mRNA	PMID:19320972
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313320	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of FARP1 mRNA	PMID:19244175
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313320	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of FARP1 mRNA	PMID:28302478
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313320	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of FARP1 promoter	PMID:22847954
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313320	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of FARP1 promoter	PMID:22847954
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of FARP1 protein	PMID:34896426
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FARP1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FARP1 mRNA	PMID:36331819
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313320	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FARP1 mRNA	PMID:23179753|PMID:25979313
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of FARP1 mRNA	PMID:29427782
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FARP1 mRNA	PMID:24383497|PMID:26272509
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313320	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FARP1 gene	PMID:29154799
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA	PMID:27188386
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FARP1 mRNA	PMID:25562108|PMID:27989131
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein	PMID:34896426
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein	PMID:34896426
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of FARP1 mRNA	PMID:28973697
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313321	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FARP1 mRNA	PMID:28973697
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1313320	E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in increased expression of FARP1 mRNA	PMID:16849584
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20200211	CTD	MESH:C016601	ESR2 protein inhibits the reaction [afimoxifene results in increased expression of FARP1 mRNA]; Estradiol inhibits the reaction [afimoxifene results in increased expression of FARP1 mRNA]; Fulvestrant inhibits the reaction [afimoxifene results in increased expression of FARP1 mRNA]	PMID:16849584
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of FARP1 mRNA	PMID:24935251
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313321	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FARP1 mRNA	PMID:17562736
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FARP1 mRNA	PMID:33387578
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FARP1 mRNA	PMID:21420995
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313320	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of FARP1 mRNA	PMID:29067470
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1313320	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of FARP1 promoter	PMID:29626692
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1313320	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of FARP1 promoter	PMID:29626692
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1313320	E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of FARP1 promoter	PMID:29626692
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46680	serpentine asbestos	increases methylation	ISO	RGD:1313320	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of FARP1 3' UTR	PMID:29523930
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20240702	CTD	MESH:D001151	Arsenic results in decreased expression of FARP1 mRNA	PMID:38150313
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FARP1 mRNA	PMID:40504410
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of FARP1 mRNA	PMID:31838189
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313321	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of FARP1 mRNA	PMID:35436446
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of FARP1 mRNA	PMID:18175754
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein	PMID:34896426
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FARP1 mRNA	PMID:25554681
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313321	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of FARP1 mRNA	PMID:25554681
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in increased expression of FARP1 mRNA	PMID:38685447
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of FARP1 mRNA	PMID:26377693
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA	PMID:27858113
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA	PMID:27858113
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313320	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of FARP1 mRNA	PMID:16780908
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of FARP1 mRNA	PMID:19042947
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:53578	hexamethylene diisocyanate	increases methylation	ISO	RGD:1313320	E	RGD:6480464	20150414	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in increased methylation of FARP1 gene	PMID:25445006
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FARP1 protein	PMID:32959892
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of FARP1 mRNA	PMID:15336504
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313321	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in increased expression of FARP1 mRNA	PMID:21335049
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313320	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of FARP1 intron	PMID:30157460
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FARP1 gene	PMID:35440735
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of FARP1 gene	PMID:33148267
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FARP1 mRNA	PMID:22206623
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of FARP1 protein	PMID:37664457
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA	PMID:27188386
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FARP1 gene]	PMID:28238834
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of FARP1 mRNA	PMID:19482888
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of FARP1 mRNA]	PMID:19482888
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313321	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of FARP1 mRNA	PMID:30294300
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of FARP1 mRNA	PMID:38995820
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of FARP1 protein	PMID:28903499
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313320	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of FARP1 protein	PMID:38348393
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FARP1 mRNA	PMID:24780913
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313320	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of FARP1 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA	PMID:27188386|PMID:37664457
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of FARP1 mRNA	PMID:19281266
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of FARP1 mRNA	PMID:19015723
1305346	Farp1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FARP1 mRNA	PMID:23034163
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1603568	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in increased expression of C1ORF210 mRNA	PMID:24172598
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of C5H1ORF210 mRNA]	PMID:31150632
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of C5H1ORF210 mRNA	PMID:17347304
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1603568	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of C1ORF210 mRNA	PMID:23019147|PMID:31614463
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of C5H1ORF210 mRNA	PMID:26496021
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1603568	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of C1ORF210 mRNA	PMID:30165855
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:16767	3,4-dichloroaniline	increases expression	ISO	RGD:1603568	E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in increased expression of C1ORF210 mRNA	PMID:24172598
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1603568	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of C1ORF210 mRNA	PMID:31163220
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of C5H1ORF210 mRNA	PMID:26577399
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of C5H1ORF210 mRNA	PMID:27523638
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of C5H1ORF210 mRNA	PMID:33387578
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1603568	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of C1ORF210 promoter	PMID:30157460
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1603568	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of C1ORF210 mRNA	PMID:21641981
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of C5H1ORF210 mRNA	PMID:31150632
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of C5H1ORF210 mRNA]	PMID:31150632
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1603568	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of C1ORF210 gene	PMID:25304211
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1603568	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of C1ORF210 mRNA	PMID:26272509
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1603568	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1ORF210 mRNA	PMID:27188386
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of C5H1ORF210 mRNA	PMID:31881176
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1603568	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of C1ORF210 mRNA	PMID:24768652
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of C5H1ORF210 mRNA	PMID:22298810
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of C5H1ORF210 mRNA	PMID:21215274
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1603568	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of C1ORF210 mRNA	PMID:30851411
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603568	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of C1ORF210 promoter	PMID:27901495|PMID:30157460
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1603568	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of C1ORF210 5' UTR; Benzo(a)pyrene results in decreased methylation of C1ORF210 exon	PMID:27901495
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603568	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C1ORF210 3' UTR	PMID:27901495
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1603568	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of C1ORF210 gene	PMID:31601247
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of C5H1ORF210 mRNA	PMID:34492290
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of C5H1ORF210 mRNA	PMID:25380136
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of C1ORF210 mRNA	PMID:25181051
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of C5H1ORF210 mRNA	PMID:30816183|PMID:32528016
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of C5H1ORF210 mRNA	PMID:26496021
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1603568	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of C1ORF210 gene	PMID:31601247
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:351346	phenethyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in increased expression of C5H1ORF210 mRNA	PMID:17616710
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of C5H1ORF210 mRNA	PMID:25380136
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603568	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of C1ORF210 mRNA	PMID:38174414
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of C5H1ORF210 gene	PMID:22079235
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of C5H1ORF210 mRNA	PMID:24386269
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of C5H1ORF210 mRNA	PMID:25380136
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332060	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of C1ORF210 mRNA	PMID:28973697
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1603568	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of C1ORF210 mRNA	PMID:38832940
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603568	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of C1ORF210 mRNA	PMID:22230336
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1603568	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of C1ORF210 gene	PMID:25304211
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of C5H1ORF210 mRNA	PMID:29391264
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1603568	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of C1ORF210 mRNA	PMID:26272509
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1603568	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1ORF210 mRNA	PMID:27188386
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of C5H1ORF210 mRNA	PMID:24136188
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of C5H1ORF210 mRNA	PMID:19564919
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of C5H1ORF210 mRNA	PMID:19564919
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of C5H1ORF210 mRNA	PMID:19564919
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of C5H1ORF210 mRNA	PMID:24136188
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1603568	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of C1ORF210 mRNA	PMID:30851411
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603568	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1ORF210 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1ORF210 mRNA	PMID:27188386
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of C5H1ORF210 mRNA	PMID:27291303
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	ISO	RGD:1603568	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of C1ORF210 mRNA	PMID:24834073
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of C5H1ORF210 mRNA	PMID:24780913|PMID:25825206
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603568	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1ORF210 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1ORF210 mRNA	PMID:27188386
1305347	C5h1orf210	similar to human chromosome 1 open reading frame 210	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1332060	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of C1ORF210 mRNA	PMID:28973697
1305348	Cep152	centrosomal protein 152	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1604825	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CEP152 mRNA	PMID:38218311
1305348	Cep152	centrosomal protein 152	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313323	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CEP152 mRNA	PMID:37995155
1305348	Cep152	centrosomal protein 152	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313323	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CEP152 mRNA	PMID:26251327
1305348	Cep152	centrosomal protein 152	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CEP152 mRNA	PMID:33167477
1305348	Cep152	centrosomal protein 152	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CEP152 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CEP152 mRNA	PMID:32699268
1305348	Cep152	centrosomal protein 152	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CEP152 mRNA	PMID:26079696
1305348	Cep152	centrosomal protein 152	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of CEP152 gene	PMID:35440735
1305348	Cep152	centrosomal protein 152	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1604825	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of CEP152 mRNA	PMID:21632981
1305348	Cep152	centrosomal protein 152	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1604825	E	RGD:6480464	20170516	CTD	MESH:D011794	Quercetin results in increased expression of CEP152 protein	PMID:14750173
1305348	Cep152	centrosomal protein 152	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313323	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CEP152 mRNA	PMID:39241906
1305348	Cep152	centrosomal protein 152	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313323	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CEP152 mRNA	PMID:39298647
1305348	Cep152	centrosomal protein 152	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1604825	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of CEP152 mRNA	PMID:19167446
1305348	Cep152	centrosomal protein 152	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1604825	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CEP152 mRNA	PMID:38568856
1305348	Cep152	centrosomal protein 152	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604825	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CEP152 mRNA	PMID:37042841
1305348	Cep152	centrosomal protein 152	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313323	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CEP152 mRNA	PMID:37992649
1305348	Cep152	centrosomal protein 152	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of CEP152 mRNA	PMID:21592394
1305348	Cep152	centrosomal protein 152	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of CEP152 mRNA	PMID:26496021
1305348	Cep152	centrosomal protein 152	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of CEP152 mRNA	PMID:21592394
1305348	Cep152	centrosomal protein 152	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313323	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CEP152 mRNA	PMID:37992649
1305348	Cep152	centrosomal protein 152	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313323	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CEP152 mRNA	PMID:34319233
1305348	Cep152	centrosomal protein 152	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1604825	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CEP152 protein	PMID:37730182
1305348	Cep152	centrosomal protein 152	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of CEP152 mRNA	PMID:21592394
1305348	Cep152	centrosomal protein 152	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of CEP152 mRNA	PMID:21592394
1305348	Cep152	centrosomal protein 152	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of CEP152 mRNA	PMID:39836092
1305348	Cep152	centrosomal protein 152	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CEP152 mRNA	PMID:28522335
1305348	Cep152	centrosomal protein 152	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1604825	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CEP152 mRNA	PMID:23649840
1305348	Cep152	centrosomal protein 152	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1604825	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CEP152 gene	PMID:27153756
1305348	Cep152	centrosomal protein 152	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604825	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CEP152 mRNA	PMID:23649840
1305348	Cep152	centrosomal protein 152	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313323	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CEP152 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEP152 mRNA	PMID:34911549
1305348	Cep152	centrosomal protein 152	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CEP152 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CEP152 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CEP152 mRNA	PMID:32699268
1305348	Cep152	centrosomal protein 152	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CEP152 mRNA	PMID:30779732
1305348	Cep152	centrosomal protein 152	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1604825	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in increased expression of CEP152 mRNA	PMID:19167446
1305348	Cep152	centrosomal protein 152	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of CEP152 mRNA	PMID:19167446
1305348	Cep152	centrosomal protein 152	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of CEP152 mRNA	PMID:19921347
1305348	Cep152	centrosomal protein 152	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1313323	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of CEP152 mRNA	PMID:34813904
1305348	Cep152	centrosomal protein 152	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEP152 mRNA	PMID:21724226
1305348	Cep152	centrosomal protein 152	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of CEP152 mRNA	PMID:19013527
1305348	Cep152	centrosomal protein 152	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1604825	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CEP152 mRNA	PMID:30851411
1305348	Cep152	centrosomal protein 152	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CEP152 mRNA	PMID:32763439
1305348	Cep152	centrosomal protein 152	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313323	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CEP152 mRNA	PMID:37992649
1305348	Cep152	centrosomal protein 152	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1604825	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of CEP152 protein	PMID:35688186
1305348	Cep152	centrosomal protein 152	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of CEP152 mRNA	PMID:22623647
1305348	Cep152	centrosomal protein 152	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604825	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CEP152 promoter	PMID:27901495
1305348	Cep152	centrosomal protein 152	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CEP152 mRNA]	PMID:32406909
1305348	Cep152	centrosomal protein 152	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313323	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CEP152 gene; titanium dioxide results in decreased methylation of CEP152 promoter	PMID:35295148
1305348	Cep152	centrosomal protein 152	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313323	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CEP152 mRNA	PMID:19710929
1305348	Cep152	centrosomal protein 152	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313323	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CEP152 mRNA	PMID:32156529
1305348	Cep152	centrosomal protein 152	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CEP152 mRNA	PMID:29275510
1305348	Cep152	centrosomal protein 152	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CEP152 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305348	Cep152	centrosomal protein 152	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313323	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CEP152 mRNA	PMID:33221593
1305348	Cep152	centrosomal protein 152	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of CEP152 mRNA	PMID:26496021
1305348	Cep152	centrosomal protein 152	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313323	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CEP152 mRNA	PMID:39298647
1305348	Cep152	centrosomal protein 152	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313323	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CEP152 mRNA	PMID:34813904
1305348	Cep152	centrosomal protein 152	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604825	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEP152 mRNA	PMID:37042841
1305348	Cep152	centrosomal protein 152	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of CEP152 mRNA	PMID:39836092
1305348	Cep152	centrosomal protein 152	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of CEP152 mRNA	PMID:26194646
1305348	Cep152	centrosomal protein 152	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of CEP152 mRNA	PMID:24386269
1305348	Cep152	centrosomal protein 152	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CEP152 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CEP152 mRNA	PMID:32699268
1305348	Cep152	centrosomal protein 152	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CEP152 mRNA	PMID:32588087
1305348	Cep152	centrosomal protein 152	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CEP152 mRNA	PMID:28302478
1305348	Cep152	centrosomal protein 152	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CEP152 mRNA	PMID:31533062
1305348	Cep152	centrosomal protein 152	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1604825	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CEP152 mRNA	PMID:19167446
1305348	Cep152	centrosomal protein 152	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of CEP152 mRNA	PMID:19167446
1305348	Cep152	centrosomal protein 152	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CEP152 mRNA	PMID:40419075
1305348	Cep152	centrosomal protein 152	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEP152 mRNA	PMID:23179753
1305348	Cep152	centrosomal protein 152	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1604825	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CEP152 mRNA	PMID:25562108
1305348	Cep152	centrosomal protein 152	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313323	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CEP152 mRNA	PMID:37992649
1305348	Cep152	centrosomal protein 152	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604825	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CEP152 mRNA	PMID:22230336
1305348	Cep152	centrosomal protein 152	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of CEP152 mRNA	PMID:39836092
1305348	Cep152	centrosomal protein 152	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CEP152 mRNA	PMID:30467583
1305348	Cep152	centrosomal protein 152	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1604825	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CEP152 mRNA	PMID:31758290
1305348	Cep152	centrosomal protein 152	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of CEP152 mRNA	PMID:29522793
1305348	Cep152	centrosomal protein 152	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1604825	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CEP152 mRNA	PMID:30851411
1305348	Cep152	centrosomal protein 152	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604825	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CEP152 gene]	PMID:28238834
1305348	Cep152	centrosomal protein 152	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313323	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CEP152 mRNA	PMID:30294300
1305348	Cep152	centrosomal protein 152	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1604825	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of CEP152 mRNA	PMID:32234424
1305348	Cep152	centrosomal protein 152	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313323	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of CEP152 mRNA	PMID:39847705
1305348	Cep152	centrosomal protein 152	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1604825	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CEP152 mRNA	PMID:38568856
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1345982	E	RGD:6480464	20230411	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PCDHB9 mRNA	PMID:21179406
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDHB21 mRNA; Trichloroethylene results in decreased expression of PCDHB9 mRNA	PMID:33387578
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20230411	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of PCDHB9 gene	PMID:27618143
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D005839	Gentamicins results in decreased expression of PCDHB21 mRNA	PMID:33387578
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDHB21 mRNA	PMID:33387578
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PCDHB9 mRNA	PMID:28959563
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20230411	CTD	MESH:D003300	Copper deficiency results in increased expression of PCDHB9 mRNA	PMID:26033743
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1345982	E	RGD:6480464	20230411	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDHB9 promoter	PMID:27901495
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1345982	E	RGD:6480464	20230411	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PCDHB9 exon	PMID:27901495
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20230411	CTD	MESH:D003300	Copper deficiency results in increased expression of PCDHB9 mRNA	PMID:26033743
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1345982	E	RGD:6480464	20230411	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PCDHB9 mRNA	PMID:25895662
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PCDHB21 mRNA	PMID:30047161
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230411	CTD	MESH:C006780	bisphenol A affects the expression of PCDHB9 mRNA	PMID:25181051
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20230411	CTD	MESH:C039281	furan results in increased expression of PCDHB9 mRNA	PMID:27387713
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1345982	E	RGD:6480464	20230411	CTD	MESH:C473478	Sunitinib results in decreased expression of PCDHB9 mRNA	PMID:31533062
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1345982	E	RGD:6480464	20230411	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PCDHB9 gene	PMID:29154799
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D000640	Amitrole results in decreased expression of PCDHB21 mRNA	PMID:30047161
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCDHB21 mRNA	PMID:33387578
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20230411	CTD	MESH:C017690	fenvalerate results in increased expression of PCDHB9 mRNA	PMID:30307764
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D008713	Methimazole results in decreased expression of PCDHB21 mRNA	PMID:30047161
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C025589	ochratoxin A results in increased expression of PCDHB21 mRNA	PMID:18417182
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1345982	E	RGD:6480464	20230411	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDHB9 gene]	PMID:28238834
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C045950	propiconazole results in decreased expression of PCDHB21 mRNA	PMID:30047161
1305349	Pcdhb21	protocadherin beta 21	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PCDHB21 mRNA	PMID:30047161
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1602668	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KIAA2013 protein]	PMID:38195004
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1602668	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA2013 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA2013 mRNA	PMID:32699268
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1602668	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of KIAA2013 mRNA	PMID:39506029
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602668	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KIAA2013 mRNA	PMID:37042841
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1602668	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KIAA2013 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KIAA2013 protein	PMID:38195004
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602668	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KIAA2013 mRNA	PMID:19549813
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602668	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA2013 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA2013 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of KIAA2013 mRNA	PMID:32699268
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KIAA2013 mRNA	PMID:33387578
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIAA2013 mRNA	PMID:32109520
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1602668	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of KIAA2013 mRNA	PMID:33212167
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1602668	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of KIAA2013 mRNA	PMID:30903817
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KIAA2013 mRNA	PMID:25181051|PMID:34947998
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KIAA2013 mRNA	PMID:21266533
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602668	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KIAA2013 mRNA	PMID:37042841
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KIAA2013 mRNA	PMID:21297351
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1602668	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KIAA2013 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KIAA2013 protein	PMID:38195004
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1602668	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of KIAA2013 protein	PMID:26879310
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1602668	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA2013 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA2013 mRNA	PMID:32699268
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602668	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of KIAA2013 mRNA	PMID:22230336
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D000082	Acetaminophen results in increased expression of KIAA2013 mRNA	PMID:33387578
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1602668	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of KIAA2013 mRNA	PMID:29523930
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1602668	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of KIAA2013 mRNA	PMID:31758290
1305350	2510039O18Rikl	RIKEN cDNA 2510039O18 gene like	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602668	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of KIAA2013 mRNA	PMID:38568856
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1604184	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DRC12 mRNA	PMID:27188386
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1604184	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of DRC12 mRNA	PMID:26079696
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1604184	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of DRC12 mRNA	PMID:31614463
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of DRC12 mRNA	PMID:26496021
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DRC12 mRNA	PMID:33387578
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604184	E	RGD:6480464	20260707	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DRC12 mRNA	PMID:37042841
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1604184	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of DRC12 mRNA	PMID:26079696
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D003471	Cuprizone results in increased expression of DRC12 mRNA	PMID:26577399|PMID:27523638
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D005839	Gentamicins results in decreased expression of DRC12 mRNA	PMID:33387578
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1604184	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DRC12 mRNA	PMID:28818685
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of DRC12 mRNA	PMID:38314887
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1604184	E	RGD:6480464	20260505	CTD	MESH:C010974	Glyphosate results in increased expression of DRC12 mRNA	PMID:40294809
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DRC12 mRNA	PMID:32109520
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D020106	Acrylamide results in decreased expression of OR1S2 mRNA	PMID:28959563
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:28854	2,4-D	increases expression	ISO	RGD:1604184	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in increased expression of DRC12 mRNA	PMID:40294809
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313326	E	RGD:6480464	20260707	CTD	MESH:C017947	sodium arsenite results in decreased expression of DRC12 mRNA	PMID:37682722
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604184	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DRC12 promoter	PMID:27901495
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1604184	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DRC12 mRNA	PMID:25895662
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C004312	glycidol results in decreased expression of DRC12 mRNA	PMID:24395379
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C501413	tesaglitazar results in increased expression of DRC12 mRNA	PMID:21515302
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313326	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in decreased expression of DRC12 mRNA	PMID:23557971
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313326	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in increased expression of DRC12 mRNA	PMID:29264374
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in decreased expression of DRC12 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313326	E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in increased expression of DRC12 mRNA	PMID:32156529
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DRC12 mRNA; [bisphenol A co-treated with Estradiol] results in increased expression of DRC12 mRNA	PMID:26496021|PMID:36041667
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313326	E	RGD:6480464	20260707	CTD	MESH:C543008	bisphenol S results in increased expression of DRC12 mRNA	PMID:30951980
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DRC12 mRNA	PMID:36041667
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313326	E	RGD:6480464	20260707	CTD	MESH:C008745	bisphenol F results in increased expression of DRC12 mRNA	PMID:30951980
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DRC12 mRNA	PMID:36041667
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604184	E	RGD:6480464	20260707	CTD	MESH:C005445	triphenyl phosphate affects the expression of DRC12 mRNA	PMID:37042841
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1604184	E	RGD:6480464	20260707	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DRC12 mRNA	PMID:38382870
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1604184	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DRC12 mRNA	PMID:40419075
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000640	Amitrole results in increased expression of DRC12 mRNA	PMID:38685447
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313326	E	RGD:6480464	20260707	CTD	MESH:D017313	Fenretinide results in increased expression of DRC12 mRNA	PMID:28973697
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313326	E	RGD:6480464	20260707	CTD	MESH:C016766	sulforaphane results in increased expression of DRC12 mRNA	PMID:30529165
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C017690	fenvalerate results in increased expression of DRC12 mRNA	PMID:30307764
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313326	E	RGD:6480464	20260707	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DRC12 mRNA; Nanotubes, Carbon results in decreased expression of DRC12 mRNA	PMID:25554681
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D008713	Methimazole results in increased expression of DRC12 mRNA	PMID:38685447
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313326	E	RGD:6480464	20260707	CTD	MESH:D011192	Potassium Dichromate results in increased expression of DRC12 mRNA	PMID:23608068
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1604184	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DRC12 mRNA	PMID:37199045
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of DRC12 mRNA	PMID:32109520
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1604184	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of DRC12 mRNA	PMID:26079696
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D011441	Propylthiouracil affects the expression of DRC12 mRNA	PMID:24780913
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DRC12 mRNA	PMID:25825206
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C028577	monobutyl phthalate results in increased expression of DRC12 mRNA	PMID:29162477
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C057693	Troglitazone results in increased expression of DRC12 mRNA	PMID:21515302
1305351	Drc12	dynein regulatory complex subunit 12 homolog	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20260707	CTD	MESH:C025643	vinclozolin results in increased methylation of DRC12 gene	PMID:31079544
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1604346	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of LYAR protein	PMID:39638853
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1604346	E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in increased expression of LYAR mRNA	PMID:36828454
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of LYAR mRNA	PMID:35967413
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313327	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of LYAR mRNA	PMID:33045310
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LYAR mRNA]	PMID:31150632
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of LYAR mRNA	PMID:23724009|PMID:33167477
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of LYAR mRNA	PMID:32845096
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of LYAR mRNA	PMID:26516004
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313327	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LYAR mRNA	PMID:30529165
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in decreased expression of LYAR mRNA	PMID:23378141
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1604346	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LYAR mRNA	PMID:20044591
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313327	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LYAR mRNA	PMID:39241906
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of LYAR mRNA	PMID:32145629
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1604346	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of LYAR mRNA	PMID:23019147|PMID:31614463|PMID:36828454
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of LYAR mRNA	PMID:33387578
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of LYAR mRNA	PMID:23649840
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1604346	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of LYAR mRNA	PMID:21179406
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of LYAR mRNA	PMID:21592394
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of LYAR mRNA	PMID:21592394
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313327	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of LYAR mRNA	PMID:23892564
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1604346	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LYAR protein	PMID:37730182
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of LYAR mRNA	PMID:21592394
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of LYAR mRNA	PMID:21592394
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA	PMID:39836092
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313327	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LYAR mRNA	PMID:37236586
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LYAR mRNA	PMID:35301059
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LYAR protein	PMID:23301498
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of LYAR mRNA	PMID:23649840
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1604346	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LYAR mRNA	PMID:22100608|PMID:27153756
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604346	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LYAR gene	PMID:27153756
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LYAR mRNA	PMID:23649840
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of LYAR mRNA	PMID:25102026
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of LYAR mRNA	PMID:32845096
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LYAR mRNA	PMID:31150632
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313327	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LYAR mRNA	PMID:27339419|PMID:31919559
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LYAR mRNA]	PMID:31150632
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313327	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LYAR mRNA	PMID:25629700
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313327	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LYAR mRNA	PMID:40504410
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LYAR mRNA	PMID:39836092
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313327	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of LYAR protein	PMID:25505154
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1604346	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LYAR mRNA	PMID:24768652|PMID:25583101
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313327	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LYAR mRNA	PMID:21570461
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LYAR mRNA	PMID:20106945|PMID:21632981
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LYAR mRNA	PMID:34747641
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313327	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LYAR mRNA	PMID:17942748|PMID:19465110
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313327	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LYAR mRNA	PMID:17942748
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of LYAR mRNA	PMID:33512557
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1604346	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LYAR mRNA	PMID:28001369
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of LYAR mRNA	PMID:28959563
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28694	copper atom	affects binding	ISO	RGD:1604346	E	RGD:6480464	20120814	CTD	MESH:D003300	LYAR protein binds to Copper	PMID:15359738
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of LYAR mRNA	PMID:20971185
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313327	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of LYAR mRNA	PMID:39631538
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1604346	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of LYAR protein	PMID:35688186
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1604346	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of LYAR mRNA	PMID:20044591
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LYAR mRNA	PMID:38568856
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313327	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LYAR mRNA	PMID:40504410
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LYAR mRNA	PMID:39836092
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LYAR mRNA	PMID:22316170
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313327	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LYAR mRNA	PMID:22228805
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1604346	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LYAR mRNA	PMID:32234424
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313327	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of LYAR protein	PMID:37955338
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:30052	copper(0)	affects binding	ISO	RGD:1604346	E	RGD:6480464	20120814	CTD	MESH:D003300	LYAR protein binds to Copper	PMID:15359738
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of LYAR mRNA	PMID:20971185
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1604346	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of LYAR mRNA	PMID:25895662
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1604346	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of LYAR mRNA	PMID:20018196
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of LYAR mRNA	PMID:30047161
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LYAR mRNA	PMID:34492290
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313327	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of LYAR mRNA	PMID:18648102
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313327	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LYAR mRNA	PMID:18301758
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313327	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LYAR mRNA	PMID:28472532
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of LYAR mRNA	PMID:19167457
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313327	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LYAR mRNA	PMID:33221593
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LYAR mRNA	PMID:29275510
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LYAR mRNA	PMID:25181051|PMID:34947998
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604346	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of LYAR mRNA	PMID:36232920|PMID:36828454
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1604346	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of LYAR gene	PMID:31601247
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LYAR mRNA	PMID:23196670
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313327	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LYAR mRNA	PMID:39298647
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1604346	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S results in increased expression of LYAR protein	PMID:31945527
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313327	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LYAR mRNA	PMID:38685157
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313327	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LYAR mRNA	PMID:37019170
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of LYAR mRNA	PMID:32680482
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA	PMID:39836092
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LYAR mRNA	PMID:38174414
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313327	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LYAR mRNA	PMID:37236586
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LYAR mRNA	PMID:35301059
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LYAR mRNA	PMID:24449571
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1604346	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LYAR mRNA	PMID:31533062
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1604346	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of LYAR mRNA	PMID:19167446
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313327	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of LYAR mRNA	PMID:39529242
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of LYAR mRNA	PMID:22110744
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604346	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LYAR mRNA	PMID:25979313
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604346	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of LYAR mRNA	PMID:29154799
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of LYAR mRNA	PMID:41580965
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of LYAR mRNA	PMID:30047161
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1604346	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of LYAR mRNA	PMID:20106945|PMID:27989131
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of LYAR mRNA	PMID:33512557
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1604346	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LYAR mRNA	PMID:38832940
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of LYAR mRNA	PMID:22230336
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313327	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LYAR mRNA	PMID:40504410
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LYAR mRNA	PMID:39836092
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313327	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LYAR mRNA	PMID:17942748
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313327	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LYAR mRNA	PMID:17942748
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1604346	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of LYAR mRNA	PMID:38568856
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of LYAR mRNA	PMID:30047161
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313327	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LYAR mRNA	PMID:35964746
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of LYAR mRNA	PMID:24136188
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313327	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of LYAR mRNA	PMID:19042947
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LYAR protein	PMID:32959892
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LYAR mRNA	PMID:39836092
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313327	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of LYAR mRNA	PMID:23650126
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313327	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LYAR mRNA	PMID:22206623
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of LYAR protein	PMID:37664457
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1604346	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of LYAR mRNA	PMID:28960945
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1604346	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of LYAR protein	PMID:31285264
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1604346	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of LYAR mRNA	PMID:19159669
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of LYAR mRNA	PMID:30047161
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604346	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of LYAR protein	PMID:37664457
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LYAR mRNA	PMID:21346803
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1604346	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of LYAR mRNA	PMID:29301935
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of LYAR protein	PMID:35544339
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LYAR mRNA	PMID:21346803
1305352	Lyar	Ly1 antibody reactive	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of LYAR mRNA	PMID:23034163
1305353	Matn2	matrilin 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of MATN2 mRNA	PMID:25152437
1305353	Matn2	matrilin 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313328	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MATN2 mRNA	PMID:26272509
1305353	Matn2	matrilin 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA	PMID:27188386
1305353	Matn2	matrilin 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313329	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MATN2 mRNA	PMID:37995155
1305353	Matn2	matrilin 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313329	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MATN2 mRNA	PMID:20188158
1305353	Matn2	matrilin 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MATN2 mRNA	PMID:20938992
1305353	Matn2	matrilin 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of MATN2 mRNA	PMID:16249480
1305353	Matn2	matrilin 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of MATN2 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of MATN2 mRNA	PMID:30951980
1305353	Matn2	matrilin 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MATN2 mRNA	PMID:26079696
1305353	Matn2	matrilin 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of MATN2 gene	PMID:35440735
1305353	Matn2	matrilin 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313329	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MATN2 mRNA	PMID:30319688
1305353	Matn2	matrilin 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313329	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in increased expression of MATN2 mRNA	PMID:29018328
1305353	Matn2	matrilin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of MATN2 mRNA	PMID:19619570
1305353	Matn2	matrilin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of MATN2 mRNA	PMID:14664709
1305353	Matn2	matrilin 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of MATN2 mRNA	PMID:26496021
1305353	Matn2	matrilin 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of MATN2 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MATN2 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of MATN2 mRNA	PMID:19619570|PMID:20660070|PMID:30165855
1305353	Matn2	matrilin 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MATN2 mRNA	PMID:33387578
1305353	Matn2	matrilin 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MATN2 mRNA	PMID:20938992
1305353	Matn2	matrilin 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313328	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of MATN2 mRNA	PMID:21795739
1305353	Matn2	matrilin 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of MATN2 mRNA	PMID:20660070
1305353	Matn2	matrilin 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MATN2 mRNA	PMID:37992649
1305353	Matn2	matrilin 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MATN2 mRNA	PMID:36314267
1305353	Matn2	matrilin 2	gene	CHEBI:17356	2-acetamidofluorene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of MATN2 mRNA; 2-Acetylaminofluorene results in increased expression of MATN2 protein	PMID:17513098
1305353	Matn2	matrilin 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MATN2 mRNA	PMID:37992649
1305353	Matn2	matrilin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313329	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MATN2 mRNA	PMID:33754040
1305353	Matn2	matrilin 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MATN2 mRNA	PMID:26577399
1305353	Matn2	matrilin 2	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MATN2 mRNA	PMID:36139627
1305353	Matn2	matrilin 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MATN2 mRNA	PMID:33387578
1305353	Matn2	matrilin 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA	PMID:39836092
1305353	Matn2	matrilin 2	gene	CHEBI:193591	Didecyldimethylammonium	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in decreased expression of MATN2 mRNA	PMID:32763356
1305353	Matn2	matrilin 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased expression of MATN2 mRNA	PMID:28860664
1305353	Matn2	matrilin 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MATN2 protein	PMID:20106945
1305353	Matn2	matrilin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MATN2 mRNA	PMID:32234424
1305353	Matn2	matrilin 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313328	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MATN2 intron	PMID:30157460
1305353	Matn2	matrilin 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313329	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MATN2 mRNA	PMID:27339419|PMID:31919559
1305353	Matn2	matrilin 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MATN2 mRNA	PMID:20938992
1305353	Matn2	matrilin 2	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D016685	MATN2 protein affects the susceptibility to Mitomycin	PMID:16217747
1305353	Matn2	matrilin 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313328	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MATN2 gene	PMID:25304211
1305353	Matn2	matrilin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN2 mRNA	PMID:39836092
1305353	Matn2	matrilin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MATN2 mRNA	PMID:40504410
1305353	Matn2	matrilin 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA	PMID:27188386
1305353	Matn2	matrilin 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313328	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MATN2 mRNA	PMID:28903495
1305353	Matn2	matrilin 2	gene	CHEBI:27899	cisplatin	decreases response to substance	ISO	RGD:1313328	E	RGD:6480464	20151013	CTD	MESH:D002945	MATN2 mRNA results in decreased susceptibility to Cisplatin	PMID:25199881
1305353	Matn2	matrilin 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20151013	CTD	MESH:D002945	[Cisplatin co-treated with Paclitaxel] results in decreased expression of MATN2 mRNA	PMID:20705681
1305353	Matn2	matrilin 2	gene	CHEBI:28077	rifampicin	increases expression	ISO	RGD:1313328	E	RGD:6480464	20180220	CTD	MESH:D012293	Rifampin results in increased expression of MATN2 mRNA	PMID:27177772
1305353	Matn2	matrilin 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MATN2 mRNA	PMID:25583101
1305353	Matn2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MATN2 mRNA	PMID:22298810
1305353	Matn2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313328	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MATN2 mRNA	PMID:22298810
1305353	Matn2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313329	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MATN2 mRNA	PMID:26377647
1305353	Matn2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MATN2 mRNA	PMID:33387578
1305353	Matn2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MATN2 mRNA	PMID:19619570|PMID:20106945
1305353	Matn2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MATN2 mRNA	PMID:11007951
1305353	Matn2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MATN2 mRNA	PMID:17942748
1305353	Matn2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MATN2 mRNA	PMID:19619570
1305353	Matn2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MATN2 mRNA	PMID:17942748
1305353	Matn2	matrilin 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MATN2 protein	PMID:39603559
1305353	Matn2	matrilin 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MATN2 mRNA	PMID:28001369
1305353	Matn2	matrilin 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MATN2 mRNA; aristolochic acid I results in decreased expression of MATN2 protein	PMID:33212167
1305353	Matn2	matrilin 2	gene	CHEBI:28445	vincristine	decreases response to substance	ISO	RGD:1313328	E	RGD:6480464	20161213	CTD	MESH:D014750	MATN2 mRNA results in decreased susceptibility to Vincristine	PMID:25199881
1305353	Matn2	matrilin 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MATN2 mRNA	PMID:28959563
1305353	Matn2	matrilin 2	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of MATN2 mRNA	PMID:21198554
1305353	Matn2	matrilin 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MATN2 mRNA; [NSC 689534 binds to Copper] which results in increased expression of MATN2 mRNA	PMID:20971185|PMID:31162603
1305353	Matn2	matrilin 2	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1313328	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of MATN2 mRNA	PMID:29803840
1305353	Matn2	matrilin 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of MATN2 mRNA	PMID:15033991|PMID:28608983|PMID:39631538
1305353	Matn2	matrilin 2	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1313328	E	RGD:6480464	20151013	CTD	MESH:D004317	MATN2 mRNA results in decreased susceptibility to Doxorubicin	PMID:25199881
1305353	Matn2	matrilin 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MATN2 mRNA	PMID:37992649
1305353	Matn2	matrilin 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313329	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite affects the methylation of MATN2 gene	PMID:39894169
1305353	Matn2	matrilin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of MATN2 mRNA	PMID:29301061
1305353	Matn2	matrilin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MATN2 mRNA	PMID:37682722
1305353	Matn2	matrilin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN2 mRNA	PMID:39836092
1305353	Matn2	matrilin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MATN2 mRNA	PMID:40504410
1305353	Matn2	matrilin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313328	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MATN2 polyA tail; Benzo(a)pyrene affects the methylation of MATN2 promoter	PMID:27901495|PMID:30157460
1305353	Matn2	matrilin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MATN2 mRNA	PMID:20106945|PMID:21871943|PMID:22316170|PMID:32234424
1305353	Matn2	matrilin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MATN2 mRNA	PMID:20713471|PMID:22610609
1305353	Matn2	matrilin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MATN2 mRNA	PMID:21839799
1305353	Matn2	matrilin 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MATN2 mRNA; [NSC 689534 binds to Copper] which results in increased expression of MATN2 mRNA	PMID:20971185|PMID:31162603
1305353	Matn2	matrilin 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MATN2 mRNA	PMID:25895662
1305353	Matn2	matrilin 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313328	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of MATN2 mRNA	PMID:23806026
1305353	Matn2	matrilin 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1313328	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of MATN2 mRNA	PMID:20382639
1305353	Matn2	matrilin 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MATN2 mRNA	PMID:26705709
1305353	Matn2	matrilin 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MATN2 mRNA	PMID:23557971
1305353	Matn2	matrilin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313329	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MATN2 gene	PMID:35295148
1305353	Matn2	matrilin 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313329	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MATN2 promoter	PMID:35295148
1305353	Matn2	matrilin 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313329	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MATN2 mRNA	PMID:28472532
1305353	Matn2	matrilin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MATN2 mRNA	PMID:25181051
1305353	Matn2	matrilin 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of MATN2 mRNA	PMID:41034487
1305353	Matn2	matrilin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313328	E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in increased expression of MATN2 mRNA	PMID:27177772
1305353	Matn2	matrilin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313329	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MATN2 mRNA	PMID:33221593
1305353	Matn2	matrilin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of MATN2 mRNA	PMID:26496021
1305353	Matn2	matrilin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA	PMID:28628672
1305353	Matn2	matrilin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of MATN2 mRNA	PMID:30951980
1305353	Matn2	matrilin 2	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of MATN2 mRNA	PMID:20713471
1305353	Matn2	matrilin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313328	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MATN2 gene	PMID:31601247
1305353	Matn2	matrilin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of MATN2 mRNA	PMID:30951980
1305353	Matn2	matrilin 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313328	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MATN2 intron	PMID:30157460
1305353	Matn2	matrilin 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA	PMID:28628672
1305353	Matn2	matrilin 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of MATN2 mRNA	PMID:36117858
1305353	Matn2	matrilin 2	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of MATN2 mRNA	PMID:26678675
1305353	Matn2	matrilin 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA	PMID:39836092
1305353	Matn2	matrilin 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313329	E	RGD:6480464	20190312	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MATN2 mRNA	PMID:30711707
1305353	Matn2	matrilin 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313328	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MATN2 mRNA	PMID:24449571
1305353	Matn2	matrilin 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MATN2 mRNA	PMID:31533062
1305353	Matn2	matrilin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MATN2 mRNA	PMID:40419075
1305353	Matn2	matrilin 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313328	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MATN2 mRNA	PMID:25979313
1305353	Matn2	matrilin 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of MATN2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:29154799
1305353	Matn2	matrilin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MATN2 mRNA	PMID:20106945|PMID:27989131
1305353	Matn2	matrilin 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MATN2 mRNA	PMID:17555576
1305353	Matn2	matrilin 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA	PMID:28628672
1305353	Matn2	matrilin 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MATN2 mRNA	PMID:28973697
1305353	Matn2	matrilin 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MATN2 mRNA	PMID:37992649
1305353	Matn2	matrilin 2	gene	CHEBI:44185	methotrexate	decreases response to substance	ISO	RGD:1313328	E	RGD:6480464	20151013	CTD	MESH:D008727	MATN2 mRNA results in decreased susceptibility to Methotrexate	PMID:25199881
1305353	Matn2	matrilin 2	gene	CHEBI:45863	paclitaxel	decreases response to substance	ISO	RGD:1313328	E	RGD:6480464	20161213	CTD	MESH:D017239	MATN2 mRNA results in decreased susceptibility to Paclitaxel	PMID:25199881
1305353	Matn2	matrilin 2	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20161213	CTD	MESH:D017239	[Cisplatin co-treated with Paclitaxel] results in decreased expression of MATN2 mRNA	PMID:20705681
1305353	Matn2	matrilin 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of MATN2 mRNA	PMID:24935251
1305353	Matn2	matrilin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MATN2 mRNA	PMID:17562736
1305353	Matn2	matrilin 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of MATN2 mRNA	PMID:26690555
1305353	Matn2	matrilin 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MATN2 mRNA	PMID:33387578
1305353	Matn2	matrilin 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MATN2 mRNA	PMID:29523930
1305353	Matn2	matrilin 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MATN2 mRNA	PMID:29279043
1305353	Matn2	matrilin 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313328	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MATN2 gene	PMID:25304211
1305353	Matn2	matrilin 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN2 mRNA	PMID:39836092
1305353	Matn2	matrilin 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MATN2 mRNA	PMID:40504410
1305353	Matn2	matrilin 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MATN2 mRNA	PMID:29391264
1305353	Matn2	matrilin 2	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of MATN2 mRNA	PMID:37567419
1305353	Matn2	matrilin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MATN2 mRNA	PMID:17555576
1305353	Matn2	matrilin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of MATN2 mRNA	PMID:17557909
1305353	Matn2	matrilin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MATN2 mRNA	PMID:17942748
1305353	Matn2	matrilin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MATN2 mRNA	PMID:17942748
1305353	Matn2	matrilin 2	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D005047	MATN2 protein affects the susceptibility to Etoposide	PMID:16217747
1305353	Matn2	matrilin 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of MATN2 mRNA	PMID:32234424
1305353	Matn2	matrilin 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA	PMID:28628672
1305353	Matn2	matrilin 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MATN2 mRNA	PMID:26705709
1305353	Matn2	matrilin 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313329	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MATN2 mRNA	PMID:25554681
1305353	Matn2	matrilin 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of MATN2 mRNA	PMID:36117858
1305353	Matn2	matrilin 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MATN2 mRNA	PMID:19042947
1305353	Matn2	matrilin 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA	PMID:39836092
1305353	Matn2	matrilin 2	gene	CHEBI:63632	topotecan	decreases response to substance	ISO	RGD:1313328	E	RGD:6480464	20151013	CTD	MESH:D019772	MATN2 mRNA results in decreased susceptibility to Topotecan	PMID:25199881
1305353	Matn2	matrilin 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MATN2 mRNA	PMID:15336504
1305353	Matn2	matrilin 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of MATN2 mRNA	PMID:36851058
1305353	Matn2	matrilin 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313328	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MATN2 intron	PMID:30157460
1305353	Matn2	matrilin 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MATN2 mRNA	PMID:31758290
1305353	Matn2	matrilin 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313328	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MATN2 mRNA	PMID:22714537
1305353	Matn2	matrilin 2	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MATN2 mRNA	PMID:36139627
1305353	Matn2	matrilin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA	PMID:27188386
1305353	Matn2	matrilin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MATN2 gene]	PMID:28238834
1305353	Matn2	matrilin 2	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1313328	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of MATN2 mRNA	PMID:18927307
1305353	Matn2	matrilin 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MATN2 mRNA	PMID:27291303
1305353	Matn2	matrilin 2	gene	CHEBI:8922	Rutecarpine	decreases expression	ISO	RGD:1313328	E	RGD:6480464	20250114	CTD	MESH:C028632	rutecarpine results in decreased expression of MATN2 mRNA	PMID:34955744
1305353	Matn2	matrilin 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313328	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA	PMID:27188386
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313331	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of LSM7 mRNA	PMID:33045310
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313330	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of LSM7 mRNA	PMID:22378314
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313331	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LSM7 mRNA	PMID:39241906
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313330	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LSM7 mRNA	PMID:37042841
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:166595	Yessotoxin	decreases expression	ISO	RGD:1313330	E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of LSM7 mRNA	PMID:30679557
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20130115	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of LSM7 mRNA]	PMID:20032058
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of LSM7 mRNA	PMID:22967744
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313331	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LSM7 mRNA	PMID:33754040
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LSM7 mRNA	PMID:36331819
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LSM7 mRNA	PMID:37236586
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	ISO	RGD:1313330	E	RGD:6480464	20130115	CTD	MESH:D014747	LSM7 protein affects the susceptibility to Vinblastine	PMID:16217747
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LSM7 mRNA	PMID:33387578
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM7 mRNA	PMID:22206623
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1313330	E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in increased expression of LSM7 protein	PMID:37834424
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LSM7 mRNA	PMID:32109520|PMID:33387578
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LSM7 mRNA	PMID:34747641
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313330	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LSM7 mRNA	PMID:30851411
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1313330	E	RGD:6480464	20130115	CTD	MESH:D004317	LSM7 protein affects the susceptibility to Doxorubicin	PMID:16217747
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313330	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LSM7 mRNA	PMID:29803840
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313330	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LSM7 mRNA	PMID:38568856
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313330	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of LSM7 mRNA	PMID:28595984|PMID:34032870
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313331	E	RGD:6480464	20150922	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LSM7 mRNA	PMID:20504355
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1313331	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of LSM7 gene	PMID:35295148
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313331	E	RGD:6480464	20150922	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of LSM7 mRNA	PMID:18648102
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313331	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LSM7 mRNA	PMID:28472532
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313330	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of LSM7 mRNA	PMID:30903817
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LSM7 mRNA	PMID:25181051
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313330	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of LSM7 mRNA	PMID:19244175
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313331	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of LSM7 promoter	PMID:33297965
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313331	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of LSM7 exon	PMID:33297965
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313331	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LSM7 mRNA	PMID:38685157
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20130115	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LSM7 mRNA	PMID:17602206
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313330	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of LSM7 gene	PMID:22964155
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313331	E	RGD:6480464	20150922	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of LSM7 mRNA	PMID:17361019|PMID:21266533
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20130115	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LSM7 mRNA	PMID:17602206
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LSM7 mRNA	PMID:37236586
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313330	E	RGD:6480464	20130115	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LSM7 mRNA	PMID:19320972|PMID:19376846
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313330	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of LSM7 mRNA	PMID:19167446
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LSM7 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of LSM7 mRNA	PMID:36331819
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313330	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LSM7 gene	PMID:29154799
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D003907	Dexamethasone results in decreased expression of LSM7 mRNA	PMID:20032058
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20130115	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of LSM7 mRNA]	PMID:20032058
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313331	E	RGD:6480464	20150922	CTD	MESH:D000082	Acetaminophen affects the expression of LSM7 mRNA	PMID:17562736
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LSM7 mRNA	PMID:33387578
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of LSM7 mRNA	PMID:24136188
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of LSM7 mRNA	PMID:24136188
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM7 mRNA	PMID:22206623
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313330	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of LSM7 protein	PMID:37664457
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313330	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LSM7 mRNA	PMID:30851411
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313330	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LSM7 gene]	PMID:28238834
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:80630	irinotecan	increases response to substance	ISO	RGD:1313330	E	RGD:6480464	20181113	CTD	MESH:D000077146	LSM7 protein results in increased susceptibility to Irinotecan	PMID:16734730
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313331	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of LSM7 mRNA	PMID:31388691
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313331	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of LSM7 mRNA	PMID:30294300
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of LSM7 protein	PMID:28903499
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313330	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of LSM7 protein	PMID:37664457
1305354	Lsm7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of LSM7 mRNA	PMID:23034163|PMID:23555832
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313333	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of COL4A4 mRNA	PMID:36189433
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of COL4A4 mRNA	PMID:36189433
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A4 mRNA	PMID:30529165
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313332	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of COL4A4 mRNA	PMID:26079696
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313332	E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in increased expression of COL4A4 mRNA	PMID:34681664
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313332	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of COL4A4 mRNA	PMID:38568856
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of COL4A4 gene	PMID:27618143
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	Glucose results in increased expression of COL4A4 mRNA	PMID:33631230
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]	PMID:33631230
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of COL4A4 mRNA	PMID:36189433
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	Glucose results in increased expression of COL4A4 mRNA	PMID:33631230
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]	PMID:33631230
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COL4A4 mRNA	PMID:23630614
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313332	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of COL4A4 mRNA	PMID:23557933
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313332	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of COL4A4 mRNA	PMID:25583101
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of COL4A4 mRNA	PMID:31734292
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313333	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL4A4 mRNA	PMID:26377647
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COL4A4 mRNA	PMID:32109520|PMID:33387578|PMID:34747641
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COL4A4 mRNA	PMID:33956508
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313332	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COL4A4 mRNA	PMID:12377990
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313333	E	RGD:6480464	20170110	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COL4A4 mRNA	PMID:27562557
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313332	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of COL4A4 mRNA	PMID:30911355
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313332	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL4A4 mRNA	PMID:29803840
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20130326	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL4A4 mRNA	PMID:15033991|PMID:39631538
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313332	E	RGD:6480464	20230704	CTD	MESH:D004317	Doxorubicin results in increased expression of COL4A4 mRNA	PMID:37062353
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313332	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL4A4 mRNA	PMID:34032870
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL4A4 mRNA	PMID:36209798
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA	PMID:27858113
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313332	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of COL4A4 mRNA	PMID:30911355
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1313333	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of COL4A4 mRNA	PMID:36087614
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of COL4A4 mRNA	PMID:11578147
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of COL4A4 mRNA	PMID:16507785
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of COL4A4 mRNA	PMID:30012374
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313333	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of COL4A4 mRNA	PMID:23557971
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of COL4A4 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313332	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of COL4A4 gene	PMID:31601247
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COL4A4 mRNA	PMID:25181051
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of COL4A4 mRNA	PMID:26682919
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313333	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of COL4A4 gene	PMID:31683443
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of COL4A4 mRNA	PMID:26377693
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA	PMID:27858113
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313333	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COL4A4 mRNA	PMID:37019170
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313333	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of COL4A4 mRNA	PMID:24535843
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of COL4A4 mRNA	PMID:32680482
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313332	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COL4A4 mRNA	PMID:37042841
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of COL4A4 mRNA	PMID:35163327
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of COL4A4 mRNA	PMID:18500788
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313332	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COL4A4 mRNA	PMID:38382870
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of COL4A4 mRNA	PMID:35163327
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of COL4A4 mRNA	PMID:29427782
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313332	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of COL4A4 mRNA	PMID:24935251
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of COL4A4 mRNA	PMID:28973697
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313333	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of COL4A4 mRNA	PMID:28973697
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	Glucose results in increased expression of COL4A4 mRNA	PMID:33631230
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]	PMID:33631230
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313332	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased expression of COL4A4 protein	PMID:8667468
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313332	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of COL4A4 mRNA	PMID:38832940
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313332	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of COL4A4 mRNA	PMID:26272509
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1313332	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL4A4 mRNA	PMID:27188386
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313332	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of COL4A4 mRNA	PMID:24935251
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COL4A4 mRNA	PMID:33387578
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313332	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of COL4A4 mRNA	PMID:22230336
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of COL4A4 mRNA	PMID:29391264
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:4948	Evodiamine	decreases expression	ISO	RGD:1313332	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in decreased expression of COL4A4 mRNA	PMID:38878560
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COL4A4 mRNA; Nanotubes, Carbon results in decreased expression of COL4A4 mRNA	PMID:25554681
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of COL4A4 mRNA	PMID:26377693
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA	PMID:27858113
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of COL4A4 mRNA	PMID:26377693
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA	PMID:27858113
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:53001	nickel sulfate	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of COL4A4 mRNA	PMID:31734292
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1313332	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of COL4A4 mRNA	PMID:22079614
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313332	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL4A4 mRNA	PMID:27188386
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313332	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COL4A4 gene]	PMID:28238834
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313332	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of COL4A4 mRNA	PMID:18927307
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313332	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of COL4A4 mRNA	PMID:19084549
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of COL4A4 mRNA	PMID:24780913
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313332	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL4A4 mRNA	PMID:27188386
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D013311	Streptozocin results in increased expression of COL4A4 mRNA	PMID:33631230
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D013311	3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Streptozocin results in increased expression of COL4A4 mRNA]; Valsartan inhibits the reaction [Streptozocin results in increased expression of COL4A4 mRNA]	PMID:33631230
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:9927	valsartan	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:C081489	Valsartan inhibits the reaction [Streptozocin results in increased expression of COL4A4 mRNA]	PMID:33631230
1305355	Col4a4	collagen type IV alpha 4 chain	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of COL4A4 mRNA	PMID:23034163
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1604479	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SREK1IP1 mRNA	PMID:38218311
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SREK1IP1 mRNA	PMID:26272509
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA	PMID:27188386
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20131220	CTD	MESH:D014212	Tretinoin results in decreased expression of SREK1IP1 mRNA	PMID:21934132
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SREK1IP1 mRNA	PMID:26079696
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313334	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of SREK1IP1 mRNA	PMID:30319688
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313334	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SREK1IP1 mRNA	PMID:39241906
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1604479	E	RGD:6480464	20131220	CTD	MESH:D004958	Estradiol affects the expression of SREK1IP1 mRNA	PMID:22574217
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SREK1IP1 mRNA	PMID:33387578
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SREK1IP1 mRNA	PMID:23649840
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:16856	glutathione	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D005978	Glutathione deficiency results in decreased expression of SREK1IP1 mRNA	PMID:20621112
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1604479	E	RGD:6480464	20131220	CTD	MESH:D002117	Calcitriol results in increased expression of SREK1IP1 mRNA	PMID:16002434
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SREK1IP1 mRNA	PMID:33387578
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SREK1IP1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SREK1IP1 mRNA	PMID:39836092
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1604479	E	RGD:6480464	20131220	CTD	MESH:D019327	Copper Sulfate results in increased expression of SREK1IP1 mRNA	PMID:19549813
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1604479	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SREK1IP1 gene	PMID:27153756
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604479	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SREK1IP1 mRNA	PMID:23649840
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313334	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SREK1IP1 mRNA	PMID:34911549
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1604479	E	RGD:6480464	20131220	CTD	MESH:D000638	Amiodarone results in increased expression of SREK1IP1 mRNA	PMID:19774075
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313334	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SREK1IP1 mRNA	PMID:22206623
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SREK1IP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SREK1IP1 mRNA	PMID:39836092
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SREK1IP1 mRNA	PMID:26272509
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA	PMID:27188386
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1604479	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SREK1IP1 protein	PMID:35688186
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313334	E	RGD:6480464	20131220	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SREK1IP1 mRNA	PMID:21570461
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SREK1IP1 mRNA	PMID:33387578
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313334	E	RGD:6480464	20131220	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SREK1IP1 promoter]	PMID:19654925
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SREK1IP1 mRNA	PMID:25523186
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of SREK1IP1 mRNA	PMID:22714537
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604479	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SREK1IP1 mRNA	PMID:38568856
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SREK1IP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SREK1IP1 mRNA	PMID:39836092
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313334	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SREK1IP1 exon; Benzo(a)pyrene results in increased methylation of SREK1IP1 intron	PMID:27901495
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SREK1IP1 mRNA	PMID:25523186
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313334	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SREK1IP1 promoter alternative form	PMID:35295148
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313334	E	RGD:6480464	20131220	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SREK1IP1 mRNA	PMID:19710929
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313334	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of SREK1IP1 mRNA	PMID:30245210|PMID:33221593
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313334	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SREK1IP1 promoter	PMID:27312807
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SREK1IP1 mRNA	PMID:25181051
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313334	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SREK1IP1 promoter	PMID:27312807
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313334	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SREK1IP1 mRNA	PMID:39298647
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313334	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SREK1IP1 intron	PMID:28392331
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604479	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SREK1IP1 mRNA	PMID:37042841
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SREK1IP1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SREK1IP1 mRNA	PMID:39836092
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313334	E	RGD:6480464	20131220	CTD	MESH:C018021	cobaltous chloride results in increased expression of SREK1IP1 mRNA	PMID:21139344
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SREK1IP1 mRNA	PMID:28302478
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313334	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SREK1IP1 mRNA	PMID:36331819
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604479	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SREK1IP1 mRNA	PMID:25979313
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SREK1IP1 mRNA	PMID:23179753|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA	PMID:27188386
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SREK1IP1 mRNA	PMID:27281708
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SREK1IP1 mRNA	PMID:25562108
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313334	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in increased expression of SREK1IP1 mRNA	PMID:25270620
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SREK1IP1 mRNA	PMID:26272509
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA	PMID:27188386
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313334	E	RGD:6480464	20131220	CTD	MESH:D000082	Acetaminophen affects the expression of SREK1IP1 mRNA	PMID:17562736
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SREK1IP1 mRNA	PMID:33387578
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SREK1IP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SREK1IP1 mRNA	PMID:39836092
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1604479	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of SREK1IP1 mRNA	PMID:40706910
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313334	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SREK1IP1 mRNA	PMID:35436446
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1604479	E	RGD:6480464	20131220	CTD	MESH:D018038	Sodium Selenite results in increased expression of SREK1IP1 mRNA	PMID:18175754
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SREK1IP1 mRNA	PMID:24136188
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SREK1IP1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SREK1IP1 mRNA	PMID:39836092
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of SREK1IP1 mRNA	PMID:30467583
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313334	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SREK1IP1 mRNA	PMID:22206623
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313334	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SREK1IP1 mRNA	PMID:22206623
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA	PMID:27188386
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604479	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA	PMID:27188386
1305356	Srek1ip1	SREK1-interacting protein 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1604479	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SREK1IP1 mRNA	PMID:38568856
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1603630	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of UNC45A mRNA	PMID:38218311
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313335	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of UNC45A mRNA	PMID:33045310
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313335	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of UNC45A mRNA	PMID:36331819
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313335	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of UNC45A mRNA	PMID:39298647
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603630	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of UNC45A mRNA	PMID:37042841
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1603630	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of UNC45A mRNA	PMID:26079696
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1603630	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of UNC45A protein	PMID:37730182
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of UNC45A mRNA	PMID:22061828
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313335	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UNC45A mRNA	PMID:28111341
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of UNC45A protein	PMID:33236894
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1603630	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of UNC45A protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UNC45A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of UNC45A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of UNC45A protein	PMID:38598786
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313335	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of UNC45A mRNA	PMID:25629700
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313335	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UNC45A mRNA	PMID:40504410
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1603630	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of UNC45A protein	PMID:38460933
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1603630	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of UNC45A protein	PMID:35688186
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UNC45A mRNA	PMID:33854195
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313335	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of UNC45A mRNA	PMID:30912803
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313335	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UNC45A mRNA	PMID:21570461
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313335	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UNC45A mRNA	PMID:19465110
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UNC45A mRNA	PMID:33387578
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1603630	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UNC45A mRNA	PMID:11489354
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1603630	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of UNC45A mRNA	PMID:33212167
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313335	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of UNC45A protein	PMID:28918527
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603630	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of UNC45A protein	PMID:38228842
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313335	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UNC45A mRNA	PMID:40504410
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603630	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of UNC45A 5' UTR	PMID:27901495
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603630	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of UNC45A promoter	PMID:27901495
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313335	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of UNC45A protein	PMID:37955338
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313335	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UNC45A gene	PMID:35295148
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of UNC45A mRNA	PMID:23411599
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of UNC45A mRNA	PMID:30816183|PMID:33296240
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603630	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of UNC45A protein	PMID:37567409
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UNC45A mRNA	PMID:25181051
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1603630	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of UNC45A protein	PMID:34186270
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1603630	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of UNC45A protein	PMID:31675489
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313335	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UNC45A mRNA	PMID:39298647
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1603630	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of UNC45A protein	PMID:34186270
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313335	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of UNC45A mRNA	PMID:38685157
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1603630	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of UNC45A protein	PMID:34186270
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313335	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of UNC45A mRNA	PMID:28392331
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UNC45A mRNA	PMID:33854195
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1603630	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of UNC45A gene	PMID:22964155
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313335	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of UNC45A mRNA	PMID:34813904
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1603630	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of UNC45A protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of UNC45A protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UNC45A protein	PMID:38598786
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313335	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UNC45A mRNA	PMID:28111341
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1603630	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of UNC45A mRNA	PMID:19320972
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1603630	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of UNC45A mRNA	PMID:31533062
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313335	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of UNC45A mRNA	PMID:36331819
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603630	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of UNC45A mRNA	PMID:29154799
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603630	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of UNC45A gene	PMID:29154799
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603630	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of UNC45A mRNA	PMID:17183730
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UNC45A mRNA	PMID:33854195
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1603630	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of UNC45A mRNA	PMID:33512557
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UNC45A mRNA	PMID:33854195
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313335	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UNC45A mRNA	PMID:17562736
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1603630	E	RGD:6480464	20150825	CTD	MESH:D000082	UNC45A gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603630	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of UNC45A mRNA	PMID:22230336
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1603630	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of UNC45A protein	PMID:38460933
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313335	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UNC45A mRNA	PMID:40504410
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1313335	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of UNC45A mRNA	PMID:26377693
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1603630	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of UNC45A mRNA	PMID:17183730
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UNC45A mRNA	PMID:33854195
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603630	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UNC45A protein	PMID:32959892
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1603630	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of UNC45A protein	PMID:37664457
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603630	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of UNC45A protein	PMID:37664457
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of UNC45A mRNA	PMID:19281266
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UNC45A mRNA	PMID:21346803
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of UNC45A protein	PMID:35544339
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1603630	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of UNC45A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of UNC45A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of UNC45A protein	PMID:38598786
1305357	Unc45a	unc-45 myosin chaperone A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of UNC45A mRNA	PMID:23034163
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313336	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of B4GALT2 mRNA	PMID:38218311
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of B4GALT2 mRNA	PMID:27188386
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313337	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of B4GALT2 mRNA	PMID:33045310
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B4GALT2 mRNA	PMID:20938992
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of B4GALT2 mRNA	PMID:33167477
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B4GALT2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B4GALT2 mRNA	PMID:32699268
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313337	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of B4GALT2 mRNA	PMID:30319688
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B4GALT2 mRNA	PMID:35811015
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313336	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of B4GALT2 mRNA	PMID:31614463
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313337	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of B4GALT2 mRNA	PMID:39298647
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313336	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of B4GALT2 mRNA	PMID:38568856
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B4GALT2 mRNA	PMID:20938992
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313337	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of B4GALT2 mRNA	PMID:17251523
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of B4GALT2 mRNA	PMID:18037150
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B4GALT2 mRNA	PMID:37992649
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of B4GALT2 mRNA	PMID:22967744
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B4GALT2 mRNA	PMID:37992649
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of B4GALT2 mRNA	PMID:17997037
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of B4GALT2 promoter	PMID:23359474
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of B4GALT2 mRNA	PMID:28818685
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313336	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of B4GALT2 intron	PMID:30157460
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of B4GALT2 mRNA	PMID:17997037
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:232796	cadmium acetate	increases expression	ISO	RGD:1313336	E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in increased expression of B4GALT2 mRNA	PMID:18155341
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of B4GALT2 mRNA	PMID:19549813
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313336	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of B4GALT2 gene	PMID:27153756
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B4GALT2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B4GALT2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of B4GALT2 mRNA	PMID:32699268
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B4GALT2 mRNA	PMID:20938992
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of B4GALT2 mRNA	PMID:39836092
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B4GALT2 mRNA	PMID:40504410
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of B4GALT2 gene	PMID:31011160
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of B4GALT2 mRNA	PMID:23557933
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of B4GALT2 mRNA	PMID:33212167
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of B4GALT2 mRNA	PMID:20971185
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of B4GALT2 mRNA	PMID:29803840
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B4GALT2 mRNA	PMID:37992649
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of B4GALT2 mRNA	PMID:35314868
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of B4GALT2 mRNA	PMID:38568856
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of B4GALT2 mRNA	PMID:37682722
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313336	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of B4GALT2 mRNA	PMID:39719251
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of B4GALT2 mRNA	PMID:39836092
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B4GALT2 mRNA	PMID:40504410
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313336	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of B4GALT2 5' UTR	PMID:27901495
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313336	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of B4GALT2 exon; Benzo(a)pyrene results in increased methylation of B4GALT2 promoter	PMID:27901495
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of B4GALT2 mRNA	PMID:20971185
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in decreased expression of B4GALT2 mRNA	PMID:17997037
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313337	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of B4GALT2 gene	PMID:35295148
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of B4GALT2 mRNA	PMID:23411599|PMID:34492290
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of B4GALT2 mRNA	PMID:19167457
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of B4GALT2 mRNA	PMID:25181051
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of B4GALT2 mRNA	PMID:26063408
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313337	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of B4GALT2 promoter	PMID:27312807
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of B4GALT2 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of B4GALT2 promoter	PMID:23359474|PMID:36041667
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313337	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of B4GALT2 gene	PMID:31683443
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of B4GALT2 mRNA	PMID:36041667
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313336	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of B4GALT2 intron	PMID:30157460
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of B4GALT2 mRNA	PMID:36041667
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of B4GALT2 promoter	PMID:23359474
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of B4GALT2 mRNA	PMID:38174414|PMID:38568856
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of B4GALT2 mRNA	PMID:33453195
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of B4GALT2 mRNA	PMID:19320972|PMID:19376846
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313336	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of B4GALT2 mRNA	PMID:24449571
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B4GALT2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B4GALT2 mRNA	PMID:32699268
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313336	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of B4GALT2 mRNA	PMID:27153767|PMID:40419075
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313336	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of B4GALT2 mRNA	PMID:25979313
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of B4GALT2 mRNA	PMID:23179753|PMID:28001369
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313336	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of B4GALT2 gene	PMID:29154799
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of B4GALT2 mRNA	PMID:38685447
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20210608	CTD	MESH:D016572	Cyclosporine results in decreased expression of B4GALT2 mRNA	PMID:33631201
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of B4GALT2 mRNA	PMID:28973697
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B4GALT2 mRNA	PMID:37992649
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313336	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of B4GALT2 mRNA	PMID:29067470
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B4GALT2 mRNA	PMID:35811015
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of B4GALT2 mRNA	PMID:39836092
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B4GALT2 mRNA	PMID:40504410
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of B4GALT2 mRNA	PMID:29391264
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313337	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of B4GALT2 mRNA; Nanotubes, Carbon results in increased expression of B4GALT2 mRNA	PMID:25554681
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313336	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of B4GALT2 intron	PMID:30157460
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313337	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of B4GALT2 mRNA	PMID:22206623
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313336	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to B4GALT2 gene]	PMID:28238834
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of B4GALT2 mRNA	PMID:23914054
1305358	B4galt2	beta-1,4-galactosyltransferase 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313336	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of B4GALT2 mRNA	PMID:38568856
1305359	Klk1c8	kallikrein 1-related peptidase C8	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D004237	Diuron results in increased expression of KLK1B21 mRNA	PMID:25152437
1305359	Klk1c8	kallikrein 1-related peptidase C8	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of KLK1B21 mRNA	PMID:15885261
1305359	Klk1c8	kallikrein 1-related peptidase C8	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of KLK1C8 mRNA	PMID:28959563
1305359	Klk1c8	kallikrein 1-related peptidase C8	gene	CHEBI:3015	benomyl	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D001542	Benomyl results in decreased expression of KLK1B21 mRNA	PMID:15885261
1305359	Klk1c8	kallikrein 1-related peptidase C8	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KLK1C8 gene	PMID:28505145
1305359	Klk1c8	kallikrein 1-related peptidase C8	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D005485	Flutamide results in decreased expression of KLK1B21 mRNA	PMID:15885261
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313339	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAP1 mRNA	PMID:27188386
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313340	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ACAP1 mRNA	PMID:33045310
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313339	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ACAP1 mRNA	PMID:35811015
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313339	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACAP1 mRNA	PMID:35811015
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA	PMID:32741896
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313339	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ACAP1 mRNA	PMID:38568856
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313339	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACAP1 mRNA	PMID:37042841
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313340	E	RGD:6480464	20130806	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ACAP1 mRNA	PMID:22401849
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA	PMID:32741896
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ACAP1 mRNA	PMID:22061828|PMID:33387578
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D024502	[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased expression of ACAP1 mRNA]	PMID:39325335
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACAP1 mRNA	PMID:37236586
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313339	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in increased expression of ACAP1 mRNA	PMID:19549813
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of ACAP1 mRNA	PMID:28623178
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ACAP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ACAP1 mRNA	PMID:34911549
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACAP1 mRNA	PMID:17484886
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313339	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:32525701
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:40504410
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ACAP1 mRNA	PMID:31881176
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313339	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ACAP1 mRNA	PMID:27392435
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313339	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ACAP1 mRNA	PMID:25583101
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACAP1 mRNA	PMID:34747641
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACAP1 mRNA	PMID:33387578
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1313339	E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in increased expression of ACAP1 mRNA	PMID:19194470
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D001205	[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased expression of ACAP1 mRNA]	PMID:39325335
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACAP1 mRNA	PMID:37682722
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of ACAP1 mRNA	PMID:39325335
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased expression of ACAP1 mRNA]	PMID:39325335
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:34876320|PMID:40504410
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA	PMID:34876320
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313339	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ACAP1 promoter	PMID:27901495
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313340	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ACAP1 mRNA	PMID:29341224
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ACAP1 mRNA	PMID:34492290
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313339	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of ACAP1 mRNA	PMID:36232920
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACAP1 mRNA	PMID:25181051|PMID:34947998
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313339	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ACAP1 gene	PMID:31601247
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313340	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of ACAP1 mRNA	PMID:25172293
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ACAP1 mRNA	PMID:40203079
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313340	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ACAP1 exon	PMID:33297965
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ACAP1 mRNA	PMID:38685157
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313340	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ACAP1 mRNA	PMID:32715474
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313339	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACAP1 mRNA	PMID:37042841
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ACAP1 mRNA	PMID:35163327
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of ACAP1 mRNA	PMID:30723492
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACAP1 mRNA	PMID:37236586
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:35842	antirheumatic drug	affects expression	ISO	RGD:1313339	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents affects the expression of ACAP1 mRNA	PMID:24449571
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313340	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACAP1 mRNA	PMID:40194260
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313339	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ACAP1 mRNA	PMID:31533062
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of ACAP1 mRNA	PMID:29038090
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20130806	CTD	MESH:D002737	Chloroprene results in decreased expression of ACAP1 mRNA	PMID:23125180
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313340	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACAP1 mRNA	PMID:17562736
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313339	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACAP1 mRNA	PMID:35811015
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313339	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:32525701
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:40504410
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA	PMID:34876320
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	ISO	RGD:1313339	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of ACAP1 mRNA	PMID:38825487
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ACAP1 mRNA	PMID:23608068
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313340	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ACAP1 mRNA	PMID:38701926
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of ACAP1 mRNA	PMID:28801915
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20130806	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACAP1 mRNA	PMID:21641980
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313340	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ACAP1 mRNA	PMID:22206623
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA	PMID:32741896
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313339	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAP1 mRNA	PMID:27188386
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ACAP1 mRNA	PMID:39847705
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313339	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:32525701
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA	PMID:34876320
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ACAP1 mRNA	PMID:24780913
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313339	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAP1 mRNA	PMID:27188386
1305360	Acap1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ACAP1 mRNA	PMID:35537566
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551437	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of WFIKKN2 mRNA	PMID:33045310
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1551437	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of WFIKKN2 mRNA	PMID:20188158|PMID:26251327
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1551437	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of WFIKKN2 promoter	PMID:26251327
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1346693	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of WFIKKN2 mRNA	PMID:26079696
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of WFIKKN2 mRNA	PMID:30207508
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551437	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of WFIKKN2 mRNA	PMID:37567420
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:17627	ferroheme b	decreases expression	ISO	RGD:1551437	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in decreased expression of WFIKKN2 mRNA	PMID:19191707
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551437	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of WFIKKN2 mRNA	PMID:37567420
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WFIKKN2 mRNA	PMID:33354967
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1346693	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WFIKKN2 mRNA	PMID:21641981
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1346693	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of WFIKKN2 gene	PMID:27153756
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:26355	heme b	decreases expression	ISO	RGD:1551437	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in decreased expression of WFIKKN2 mRNA	PMID:19191707
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of WFIKKN2 mRNA	PMID:38314887
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1551437	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of WFIKKN2 mRNA	PMID:37567420
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1551437	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of WFIKKN2 mRNA	PMID:40618947
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1551437	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of WFIKKN2 mRNA	PMID:32186404
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551437	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WFIKKN2 mRNA	PMID:21570461|PMID:26377647
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WFIKKN2 mRNA	PMID:33387578
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551437	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WFIKKN2 mRNA	PMID:33956508
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WFIKKN2 mRNA	PMID:34747641
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1551437	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of WFIKKN2 mRNA	PMID:35032568
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551437	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of WFIKKN2 mRNA	PMID:37567420
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346693	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of WFIKKN2 promoter	PMID:27901495
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1346693	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WFIKKN2 mRNA	PMID:21871943
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346693	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WFIKKN2 exon	PMID:27901495
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1551437	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of WFIKKN2 mRNA	PMID:29341224
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1346693	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of WFIKKN2 gene	PMID:31601247
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of WFIKKN2 mRNA	PMID:25181051|PMID:34947998
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551437	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of WFIKKN2 mRNA	PMID:32156529
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346693	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of WFIKKN2 gene	PMID:31601247
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1346693	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of WFIKKN2 mRNA	PMID:25812627
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:38102	triazines	multiple interactions	ISO	RGD:1551437	E	RGD:6480464	20180313	CTD	MESH:D014227	Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of WFIKKN2 mRNA]	PMID:27469509
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1346693	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of WFIKKN2 mRNA	PMID:25812627
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1551437	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of WFIKKN2 mRNA	PMID:40194260
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1551437	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of WFIKKN2 mRNA	PMID:39529242
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551437	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of WFIKKN2 mRNA	PMID:17963808
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of WFIKKN2 mRNA	PMID:35594946
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in increased expression of WFIKKN2 mRNA	PMID:29427782
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1346693	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of WFIKKN2 gene	PMID:29154799
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551437	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of WFIKKN2 mRNA	PMID:37567420
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1346693	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of WFIKKN2 mRNA	PMID:24449571
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of WFIKKN2 mRNA	PMID:29391264
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1346693	E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of WFIKKN2 mRNA	PMID:26615145
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1551437	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of WFIKKN2 mRNA	PMID:23608068
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1551437	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of WFIKKN2 mRNA	PMID:37567420
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346693	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WFIKKN2 gene]	PMID:28238834
1305361	Wfikkn2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1551437	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of WFIKKN2 mRNA	PMID:38648751
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313342	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of FAM114A2 mRNA	PMID:22378314
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313343	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FAM114A2 mRNA	PMID:39241906
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313342	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FAM114A2 protein	PMID:37730182
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313342	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FAM114A2 mRNA	PMID:19549813
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A2 mRNA	PMID:22129741
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313342	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FAM114A2 gene	PMID:27153756
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313343	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAM114A2 mRNA	PMID:22206623
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313342	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of FAM114A2 protein	PMID:38460933
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313342	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of FAM114A2 protein	PMID:35688186
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313342	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of FAM114A2 mRNA	PMID:28903495
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313342	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FAM114A2 mRNA	PMID:28001369
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313342	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FAM114A2 mRNA	PMID:33212167
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313342	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of FAM114A2 mRNA	PMID:39709020
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313342	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FAM114A2 mRNA	PMID:29803840
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A2 mRNA	PMID:22129741
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313342	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of FAM114A2 mRNA; sodium arsenite results in decreased expression of FAM114A2 protein	PMID:25879800|PMID:30528433
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313342	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM114A2 3' UTR	PMID:27901495
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313343	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM114A2 gene	PMID:35295148
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313343	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of FAM114A2 mRNA	PMID:29264374
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FAM114A2 mRNA	PMID:25181051
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM114A2 mRNA	PMID:30816183
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313342	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM114A2 protein	PMID:33376534
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313342	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of FAM114A2 protein	PMID:34186270
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313342	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of FAM114A2 protein	PMID:34186270
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313342	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM114A2 mRNA	PMID:28628672
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313342	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of FAM114A2 protein	PMID:34186270
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313342	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM114A2 mRNA	PMID:28628672
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A2 mRNA	PMID:22129741
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313342	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FAM114A2 mRNA	PMID:37042841
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313342	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FAM114A2 mRNA	PMID:31533062
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313342	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FAM114A2 mRNA	PMID:25979313
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313342	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FAM114A2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313342	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM114A2 mRNA	PMID:28628672
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313342	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in increased expression of FAM114A2 mRNA	PMID:22230336
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313342	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of FAM114A2 protein	PMID:38460933
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313343	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FAM114A2 mRNA	PMID:35436446
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313342	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM114A2 mRNA	PMID:28628672
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313342	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FAM114A2 protein	PMID:23718831
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313342	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FAM114A2 protein	PMID:32959892
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FAM114A2 gene	PMID:35440735
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313343	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FAM114A2 mRNA	PMID:22206623
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313343	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAM114A2 mRNA	PMID:22206623
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313342	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of FAM114A2 protein	PMID:38348393
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313342	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FAM114A2 mRNA	PMID:38568856
1305362	Fam114a2	family with sequence similarity 114, member A2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313342	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of FAM114A2 mRNA	PMID:29301935
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313345	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAPKAP1 mRNA	PMID:36331819
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313344	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MAPKAP1 mRNA	PMID:26079696
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MAPKAP1 gene	PMID:28931070
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313344	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MAPKAP1 mRNA	PMID:22378314
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1313344	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of MAPKAP1 mRNA	PMID:18951874
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313344	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAPKAP1 mRNA	PMID:37042841
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313344	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MAPKAP1 mRNA	PMID:23649840
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313345	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MAPKAP1 mRNA	PMID:34319233
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313344	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MAPKAP1 protein	PMID:37730182
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of MAPKAP1 mRNA	PMID:22061828
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1313344	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of MAPKAP1 intron	PMID:30157460
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313344	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MAPKAP1 mRNA	PMID:23649840
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1313344	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of MAPKAP1 intron	PMID:30157460
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313344	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MAPKAP1 gene	PMID:27153756
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313344	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MAPKAP1 mRNA	PMID:23649840
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313345	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MAPKAP1 mRNA	PMID:25629700
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313344	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MAPKAP1 protein	PMID:35688186
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313344	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MAPKAP1 mRNA	PMID:23557933
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313344	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of MAPKAP1 mRNA	PMID:19561079|PMID:27594783
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313345	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of MAPKAP1 mRNA	PMID:21151649
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313345	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAPKAP1 mRNA	PMID:21570461
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313344	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAPKAP1 intron	PMID:30157460
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313344	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAPKAP1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313345	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAPKAP1 mRNA	PMID:22228805
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313345	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MAPKAP1 intron	PMID:27901495
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313345	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MAPKAP1 mRNA]	PMID:22228805
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313345	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MAPKAP1 mRNA	PMID:39716349
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAPKAP1 mRNA	PMID:25729387
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MAPKAP1 mRNA	PMID:34492290
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MAPKAP1 mRNA	PMID:25181051|PMID:30816183
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313345	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MAPKAP1 mRNA	PMID:33221593
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MAPKAP1 gene	PMID:28505145
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313344	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MAPKAP1 mRNA	PMID:28628672
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313344	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MAPKAP1 mRNA	PMID:25979313
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1313344	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to MAPKAP1 promoter]	PMID:20348232
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313344	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MAPKAP1 gene	PMID:31601247
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313344	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MAPKAP1 intron	PMID:30157460
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313344	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MAPKAP1 mRNA	PMID:28628672
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313344	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MAPKAP1 mRNA	PMID:19320972
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313345	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAPKAP1 mRNA	PMID:36331819
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313344	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MAPKAP1 gene	PMID:29154799
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313344	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MAPKAP1 mRNA	PMID:23179753|PMID:25192806|PMID:26272509|PMID:28001369
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313345	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of MAPKAP1 mRNA	PMID:21427059
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313344	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAPKAP1 mRNA	PMID:27188386
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313344	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MAPKAP1 mRNA	PMID:28628672
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313344	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MAPKAP1 mRNA	PMID:36621641
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313345	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAPKAP1 mRNA	PMID:17562736
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313344	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAPKAP1 mRNA	PMID:21420995
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1313344	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of MAPKAP1 mRNA	PMID:16557594
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313344	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MAPKAP1 mRNA	PMID:28628672
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313345	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MAPKAP1 mRNA	PMID:39716349
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MAPKAP1 mRNA	PMID:24136188
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MAPKAP1 mRNA	PMID:24136188
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1313344	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of MAPKAP1 mRNA	PMID:20977926
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAPKAP1 mRNA	PMID:25729387
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313345	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MAPKAP1 mRNA	PMID:23650126
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313344	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MAPKAP1 mRNA	PMID:28988120
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313344	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MAPKAP1 intron	PMID:30157460
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MAPKAP1 gene	PMID:35440735
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313344	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MAPKAP1 mRNA	PMID:27714895|PMID:27918106
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313344	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cannabidiol co-treated with moringin] results in increased expression of MAPKAP1 mRNA	PMID:30096889
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313344	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MAPKAP1 mRNA	PMID:31758290
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313345	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of MAPKAP1 mRNA	PMID:22206623
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313344	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAPKAP1 mRNA	PMID:27188386
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313345	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of MAPKAP1 mRNA	PMID:30953684
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313344	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAPKAP1 mRNA	PMID:27188386
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MAPKAP1 mRNA	PMID:21346803
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313344	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MAPKAP1 mRNA	PMID:38568856
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313345	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of MAPKAP1 protein	PMID:24648495
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MAPKAP1 mRNA	PMID:23869203
1305363	Mapkap1	MAPK associated protein 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of MAPKAP1 gene	PMID:31682807
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1618151	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CROCC mRNA	PMID:33045310
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1618151	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CROCC mRNA	PMID:30319688
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313346	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CROCC mRNA	PMID:37042841
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1618151	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CROCC mRNA	PMID:34319233
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CROCC mRNA	PMID:26577399
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313346	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618151	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CROCC mRNA	PMID:37236586
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of CROCC protein	PMID:33236894
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313346	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CROCC exon	PMID:30157460
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CROCC mRNA	PMID:30779732
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313346	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of CROCC mRNA	PMID:18356318
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313346	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CROCC mRNA	PMID:21867686
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313346	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CROCC gene	PMID:25304211
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313346	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313346	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CROCC mRNA	PMID:27392435
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of CROCC gene	PMID:28505145
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618151	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CROCC mRNA	PMID:21570461
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CROCC mRNA	PMID:33387578
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313346	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313346	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CROCC promoter	PMID:27901495
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1618151	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CROCC mRNA	PMID:22228805
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313346	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CROCC gene	PMID:25435355
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313346	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of CROCC mRNA	PMID:18356318
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of CROCC mRNA	PMID:16507785
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1618151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CROCC promoter	PMID:35295148
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1618151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CROCC gene; titanium dioxide results in increased methylation of CROCC promoter	PMID:35295148
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CROCC mRNA	PMID:34492290
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1618151	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CROCC mRNA	PMID:19710929
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1618151	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of CROCC promoter	PMID:27312807
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313346	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CROCC gene	PMID:31601247
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of CROCC gene	PMID:28505145
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CROCC mRNA	PMID:32119087
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1618151	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CROCC gene	PMID:31683443
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1618151	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CROCC mRNA	PMID:21266533
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1313346	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to CROCC protein	PMID:32991956
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CROCC gene	PMID:33148267
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313346	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CROCC mRNA	PMID:33453195
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313346	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CROCC mRNA	PMID:38568856
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618151	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CROCC mRNA	PMID:37236586
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313346	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CROCC mRNA	PMID:24449571
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313346	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CROCC mRNA	PMID:31533062
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1618151	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CROCC mRNA	PMID:17963808
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313346	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CROCC gene	PMID:29154799
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1618151	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CROCC mRNA	PMID:28973697
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CROCC mRNA	PMID:33387578
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313346	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CROCC gene	PMID:25304211
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313346	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1313346	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of CROCC mRNA	PMID:19194470
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1618151	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CROCC mRNA; Nanotubes, Carbon results in decreased expression of CROCC mRNA	PMID:25554681
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of CROCC mRNA	PMID:22504374
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313346	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CROCC gene	PMID:35440735
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CROCC gene	PMID:33148267
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1618151	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CROCC mRNA	PMID:22206623
1305364	Crocc	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of CROCC mRNA	PMID:22504374
1305365	Tesl	testis derived transcript-like	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of TESL gene	PMID:27618143
1305365	Tesl	testis derived transcript-like	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of TESL mRNA	PMID:28374803
1305365	Tesl	testis derived transcript-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TESL mRNA	PMID:25181051
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:144441	triacsin C	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20190903	CTD	MESH:C034613	triacsin C results in decreased expression of HS2ST1 mRNA	PMID:16704987
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of HS2ST1 mRNA	PMID:33167477
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313349	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HS2ST1 mRNA	PMID:30529165
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1313349	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of HS2ST1 mRNA	PMID:15282401
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:15843	arachidonic acid	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20161213	CTD	MESH:D016718	Arachidonic Acid results in decreased expression of HS2ST1 mRNA	PMID:16704987
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of HS2ST1 mRNA	PMID:21632981
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313349	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HS2ST1 mRNA	PMID:25549359
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of HS2ST1 mRNA	PMID:23649840
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HS2ST1 mRNA	PMID:26516888
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HS2ST1 mRNA	PMID:19549813
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313348	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HS2ST1 gene	PMID:27153756
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of HS2ST1 mRNA	PMID:27392435
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313348	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the reaction [Piroxicam results in decreased expression of HS2ST1 mRNA]	PMID:21858171
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313348	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HS2ST1 mRNA	PMID:22574217
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313349	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HS2ST1 mRNA	PMID:21570461
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HS2ST1 mRNA	PMID:33387578
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HS2ST1 mRNA	PMID:26232522|PMID:34747641
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313348	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of HS2ST1 mRNA	PMID:33512557
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313349	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of HS2ST1 mRNA	PMID:32937126
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HS2ST1 mRNA	PMID:28001369
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HS2ST1 mRNA	PMID:33212167
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of HS2ST1 mRNA	PMID:23649840
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HS2ST1 mRNA	PMID:29803840
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313349	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of HS2ST1 mRNA	PMID:19073829
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HS2ST1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313349	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HS2ST1 intron	PMID:27901495
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HS2ST1 mRNA	PMID:26238291
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HS2ST1 mRNA	PMID:25729387
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313349	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HS2ST1 gene	PMID:35295148
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HS2ST1 mRNA	PMID:34492290
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HS2ST1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313348	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of HS2ST1 mRNA	PMID:25979313
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313349	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of HS2ST1 mRNA	PMID:38685157
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313348	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HS2ST1 mRNA	PMID:37042841
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:35176	zinc sulfate	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20130122	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of HS2ST1 mRNA	PMID:12756304
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HS2ST1 mRNA	PMID:31533062
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of HS2ST1 mRNA	PMID:40419075
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313349	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of HS2ST1 mRNA	PMID:31558096
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313348	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HS2ST1 mRNA	PMID:25979313
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313348	E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of HS2ST1 mRNA	PMID:23179753|PMID:25192806|PMID:29154799
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313348	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of HS2ST1 mRNA	PMID:25562108
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of HS2ST1 mRNA	PMID:23649840
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313348	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HS2ST1 mRNA	PMID:38832940
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of HS2ST1 mRNA	PMID:29391264
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of HS2ST1 mRNA	PMID:24793618
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HS2ST1 mRNA	PMID:25729387
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313349	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of HS2ST1 mRNA	PMID:20003209
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313348	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HS2ST1 gene]	PMID:28238834
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of HS2ST1 mRNA	PMID:19682730
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313349	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of HS2ST1 mRNA	PMID:31388691
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313349	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of HS2ST1 mRNA	PMID:31558096
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of HS2ST1 mRNA	PMID:21858171
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1313348	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin affects the reaction [Piroxicam results in decreased expression of HS2ST1 mRNA]	PMID:21858171
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313348	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of HS2ST1 protein	PMID:38348393
1305366	Hs2st1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of HS2ST1 mRNA	PMID:19015723
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313350	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GTPBP3 mRNA	PMID:38218311
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313351	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of GTPBP3 mRNA	PMID:33045310
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20130618	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of GTPBP3; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GTPBP3 gene	PMID:20938992
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313350	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GTPBP3 mRNA	PMID:26079696
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313350	E	RGD:6480464	20130618	CTD	MESH:D004958	Estradiol affects the expression of GTPBP3 mRNA	PMID:22574217
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GTPBP3 mRNA	PMID:33387578
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20130618	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of GTPBP3; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GTPBP3 gene	PMID:20938992
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313350	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GTPBP3 mRNA	PMID:37042841
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313350	E	RGD:6480464	20130618	CTD	MESH:C044887	beta-methylcholine affects the expression of GTPBP3 mRNA	PMID:21179406
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313350	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GTPBP3 mRNA	PMID:28818685
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GTPBP3 mRNA	PMID:36331819
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of GTPBP3 protein	PMID:34915118
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313351	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of GTPBP3 mRNA	PMID:24067728
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313350	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GTPBP3 mRNA	PMID:35301059
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313350	E	RGD:6480464	20130618	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GTPBP3 mRNA	PMID:19549813
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20130618	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of GTPBP3; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GTPBP3 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of GTPBP3 mRNA]	PMID:20938992|PMID:22206623
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1313350	E	RGD:6480464	20130618	CTD	MESH:D001151	Arsenic affects the expression of GTPBP3 mRNA	PMID:18414638
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1313350	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of GTPBP3 gene	PMID:31636367
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313351	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GTPBP3 mRNA	PMID:21570461
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GTPBP3 mRNA	PMID:33387578
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313350	E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of GTPBP3 mRNA	PMID:29704546
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313350	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of GTPBP3 mRNA	PMID:23649840
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313350	E	RGD:6480464	20130618	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GTPBP3 mRNA	PMID:20971185
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313351	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of GTPBP3 mRNA	PMID:27862939
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313350	E	RGD:6480464	20130618	CTD	MESH:D024483	Vitamin K 3 affects the expression of GTPBP3 mRNA	PMID:20044591
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313350	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GTPBP3 mRNA	PMID:38568856
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313351	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of GTPBP3 mRNA	PMID:20883709
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313350	E	RGD:6480464	20130618	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GTPBP3 mRNA	PMID:20971185
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313350	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of GTPBP3 mRNA	PMID:25895662
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313351	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GTPBP3 gene	PMID:35295148
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GTPBP3 mRNA	PMID:34492290
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GTPBP3 mRNA	PMID:25181051
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313351	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of GTPBP3 exon	PMID:33297965
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GTPBP3 mRNA	PMID:21266533
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313350	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GTPBP3 mRNA	PMID:38174414
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313351	E	RGD:6480464	20130618	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GTPBP3 mRNA	PMID:20883709
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313350	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GTPBP3 mRNA	PMID:35301059
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313350	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GTPBP3 protein	PMID:26879310
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313350	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of GTPBP3 mRNA	PMID:28302478
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313350	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GTPBP3 mRNA	PMID:31533062
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GTPBP3 mRNA	PMID:36331819
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313350	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of GTPBP3 mRNA	PMID:23179753
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313350	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GTPBP3 gene	PMID:29154799
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1313350	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of GTPBP3 mRNA	PMID:23649840
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GTPBP3 mRNA	PMID:33387578
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1313350	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of GTPBP3 mRNA	PMID:18414638
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313350	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of GTPBP3 protein	PMID:23718831
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313351	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GTPBP3 mRNA	PMID:22206623
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of GTPBP3 mRNA]	PMID:22206623
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313350	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of GTPBP3 mRNA	PMID:37199045
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of GTPBP3 mRNA	PMID:32109520
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313350	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GTPBP3 mRNA	PMID:38568856
1305367	Gtpbp3	GTP binding protein 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313350	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GTPBP3 mRNA	PMID:29301935
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313353	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KLHL40 mRNA	PMID:33045310
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313353	E	RGD:6480464	20161115	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of KLHL40 mRNA	PMID:26251327
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of KLHL40 mRNA	PMID:36841081
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313353	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of KLHL40 mRNA	PMID:30319688
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D000431	Ethanol results in decreased expression of KLHL40 mRNA	PMID:31078653
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KLHL40 mRNA	PMID:33387578
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of KLHL40 mRNA	PMID:22061828
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of KLHL40 mRNA	PMID:33387578
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313352	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of KLHL40 polyA tail	PMID:30157460
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D015122	Mercaptopurine results in increased expression of KLHL40 mRNA	PMID:23358152
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313352	E	RGD:6480464	20141111	CTD	MESH:D010278	Parathion results in increased methylation of KLHL40 promoter	PMID:22847954
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313353	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of KLHL40 mRNA	PMID:32186404
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KLHL40 mRNA	PMID:32109520|PMID:33387578
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D004317	Doxorubicin results in increased expression of KLHL40 mRNA	PMID:20211217
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313352	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KLHL40 exon	PMID:27901495
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313353	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KLHL40 gene	PMID:35295148
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313353	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KLHL40 gene	PMID:35295148
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of KLHL40 mRNA	PMID:25181051
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313353	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of KLHL40 gene	PMID:31683443
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:34611	carbofuran	increases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D002235	Carbofuran results in increased expression of KLHL40 mRNA	PMID:20211217
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of KLHL40 mRNA	PMID:21266533
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KLHL40 mRNA	PMID:35163327
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KLHL40 mRNA	PMID:35163327
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KLHL40 mRNA	PMID:35163327
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1313353	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of KLHL40 mRNA	PMID:28962523
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313353	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KLHL40 mRNA	PMID:40194260
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313352	E	RGD:6480464	20141111	CTD	MESH:D004397	Fonofos results in increased methylation of KLHL40 promoter	PMID:22847954
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313352	E	RGD:6480464	20141111	CTD	MESH:C012568	terbufos results in increased methylation of KLHL40 promoter	PMID:22847954
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313352	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLHL40 mRNA	PMID:25979313
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of KLHL40 mRNA	PMID:41580965
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313352	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KLHL40 mRNA	PMID:38832940
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KLHL40 mRNA	PMID:33387578
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KLHL40 mRNA	PMID:29391264
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D015122	Mercaptopurine results in increased expression of KLHL40 mRNA	PMID:23358152
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313353	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of KLHL40 mRNA	PMID:19751817
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:64317	isoprenaline	increases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D007545	Isoproterenol results in increased expression of KLHL40 mRNA	PMID:20211217
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313353	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KLHL40 mRNA	PMID:27935865
1305368	Klhl40	kelch-like family member 40	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of KLHL40 mRNA	PMID:23358152
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1313354	E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of NKX3-1 mRNA	PMID:31600526
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of NKX3-1 mRNA; Tretinoin results in increased expression of NKX3-1 protein	PMID:16817226
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313354	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NKX3-1 mRNA	PMID:26079696
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of NKX3-1 mRNA	PMID:11238180
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313354	E	RGD:6480464	20170110	CTD	MESH:D011794	Quercetin results in increased expression of NKX3-1 protein	PMID:25380086
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20170110	CTD	MESH:D011794	[Quercetin co-treated with arctigenin] results in increased expression of NKX3-1 protein	PMID:25380086
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in decreased expression of NKX3-1 mRNA	PMID:12711008
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of NKX3-1 mRNA	PMID:17131305|PMID:29581250
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D013196	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dihydrotestosterone results in increased expression of NKX3-1 mRNA]	PMID:17131305
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313354	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NKX3-1 mRNA	PMID:35811015
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NKX3-1 mRNA]	PMID:35811015
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of NKX3-1 mRNA	PMID:30510588
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of NKX3-1 mRNA	PMID:17131305|PMID:31614463
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D004958	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of NKX3-1 mRNA]; [Estradiol co-treated with TGFB1 protein] results in increased expression of NKX3-1 mRNA; AR protein affects the reaction [Estradiol results in increased expression of NKX3-1 mRNA]; ESR2 protein affects the reaction [Estradiol results in increased expression of NKX3-1 mRNA]; Fulvestrant inhibits the reaction [Estradiol results in increased expression of NKX3-1 mRNA]	PMID:17131305|PMID:30165855
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313355	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of NKX3-1 mRNA	PMID:33711761
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of NKX3-1 mRNA	PMID:38685446
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313355	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of NKX3-1 mRNA	PMID:33848595
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313355	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of NKX3-1 mRNA]	PMID:33848595
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313354	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of NKX3-1 mRNA	PMID:33647349
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313354	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NKX3-1 mRNA	PMID:28818685
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313354	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NKX3-1 mRNA	PMID:22100608
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NKX3-1 mRNA	PMID:18593933
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	increases expression	ISO	RGD:1313354	E	RGD:6480464	20181016	CTD	MESH:D000966	Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA; Antimony Potassium Tartrate results in increased expression of NKX3-1 protein	PMID:29462692
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20181016	CTD	MESH:D000966	bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA]	PMID:29462692
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol results in decreased expression of NKX3-1 mRNA	PMID:18586690|PMID:22700762|PMID:25297617
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313354	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of NKX3-1 mRNA	PMID:19561079
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20120501	CTD	MESH:D019833	Genistein results in decreased expression of NKX3-1 mRNA	PMID:15378649|PMID:16865672
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313355	E	RGD:6480464	20120515	CTD	MESH:D019833	Genistein results in increased expression of NKX3-1 mRNA	PMID:21810550
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1313355	E	RGD:6480464	20120515	CTD	MESH:D019833	fulvestrant inhibits the reaction [Genistein results in decreased expression of NKX3-1 mRNA]	PMID:21810550
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313355	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NKX3-1 mRNA	PMID:24058054
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:28197	daidzein	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:C004742	daidzein results in decreased expression of NKX3-1 mRNA	PMID:16865672
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313354	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NKX3-1 mRNA	PMID:28001369
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313354	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NKX3-1 mRNA	PMID:33212167
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of NKX3-1 mRNA	PMID:28959563
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of NKX3-1 mRNA	PMID:30911355
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313355	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of NKX3-1 mRNA	PMID:27862939
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NKX3-1 mRNA	PMID:29803840
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of NKX3-1 mRNA	PMID:39719251
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313355	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of NKX3-1 mRNA	PMID:36209798
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313354	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NKX3-1 mRNA	PMID:38568856
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313354	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NKX3-1 promoter	PMID:27901495
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of NKX3-1 mRNA	PMID:30911355
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NKX3-1 mRNA	PMID:18593933
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of NKX3-1 mRNA	PMID:25351596
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313354	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NKX3-1 mRNA	PMID:19150397
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of NKX3-1 mRNA	PMID:35984750
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:3090	bicalutamide	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in decreased expression of NKX3-1 mRNA	PMID:15638997|PMID:28500234
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:3090	bicalutamide	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20161213	CTD	MESH:C053541	[Niclosamide co-treated with bicalutamide] results in decreased expression of NKX3-1 mRNA; bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA]; bicalutamide inhibits the reaction [Cadmium Chloride results in increased expression of NKX3-1 mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]	PMID:11751618|PMID:28500234|PMID:29462692
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant inhibits the reaction [Estradiol results in increased expression of NKX3-1 mRNA]	PMID:17131305
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313355	E	RGD:6480464	20120515	CTD	MESH:C070081	fulvestrant inhibits the reaction [Genistein results in decreased expression of NKX3-1 mRNA]	PMID:21810550
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313355	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NKX3-1 gene	PMID:35295148
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313355	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NKX3-1 promoter	PMID:35295148
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of NKX3-1 mRNA	PMID:19167457
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NKX3-1 mRNA	PMID:25181051
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313355	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of NKX3-1 promoter	PMID:27334623
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313354	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in increased expression of NKX3-1 mRNA	PMID:23146750
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313355	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of NKX3-1 mRNA	PMID:30951980
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:34240	2,4-Dihydroxybenzophenone	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20211012	CTD	MESH:C121479	2,4-dihydroxybenzophenone analog results in decreased expression of NKX3-1 mRNA	PMID:33684284
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313355	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of NKX3-1 mRNA	PMID:30951980
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313355	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of NKX3-1 mRNA	PMID:30951980
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:34741	equol	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20141111	CTD	MESH:D060754	Equol results in decreased expression of NKX3-1 mRNA	PMID:16865672
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:34849	mibolerone	increases expression	ISO	RGD:1313354	E	RGD:6480464	20161213	CTD	MESH:C100075	mibolerone results in increased expression of NKX3-1 mRNA	PMID:10537180
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:34849	mibolerone	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20161213	CTD	MESH:C100075	Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA]; Piroxicam inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA]	PMID:10537180
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313354	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NKX3-1 mRNA	PMID:37042841
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313354	E	RGD:6480464	20201006	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NKX3-1 mRNA	PMID:11751618|PMID:38568856
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20201006	CTD	MESH:D019256	bicalutamide inhibits the reaction [Cadmium Chloride results in increased expression of NKX3-1 mRNA]	PMID:11751618
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NKX3-1 mRNA	PMID:24449571
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313355	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of NKX3-1 mRNA	PMID:17585979
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in decreased expression of NKX3-1 mRNA	PMID:12711008
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of NKX3-1 mRNA; Metribolone results in increased expression of NKX3-1 protein	PMID:11751618|PMID:17010675|PMID:17131305|PMID:17202838|PMID:17303007|PMID:19318562|PMID:21440447
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D015741	bicalutamide inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]; Dapsone analog inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]; Metribolone promotes the reaction [AR protein binds to NKX3-1 enhancer]; Metribolone promotes the reaction [AR protein binds to NKX3-1 promoter]; Metribolone promotes the reaction [KDM3A protein binds to NKX3-1 enhancer]; Metribolone promotes the reaction [UXT protein binds to NKX3-1 promoter]; TP53 protein inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]; UXT protein affects the reaction [Metribolone results in increased expression of NKX3-1 mRNA]	PMID:11751618|PMID:16603237|PMID:17202838|PMID:19318562|PMID:21440447
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:38757	isoflavones	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones results in decreased expression of NKX3-1 mRNA	PMID:17374662
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:39397	tetramethrin	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:C009424	tetramethrin results in decreased expression of NKX3-1 mRNA	PMID:12711008
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of NKX3-1 mRNA; Curcumin results in decreased expression of NKX3-1 protein	PMID:17303007|PMID:18719366
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313354	E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of NKX3-1 mRNA	PMID:23179753|PMID:24935251|PMID:25192806
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313355	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of NKX3-1 mRNA	PMID:21427059
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313354	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of NKX3-1 mRNA	PMID:36621641
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:42638	flufenamic acid	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20120613	CTD	MESH:D005439	Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA]	PMID:10537180
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:4325	dapsone	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D003622	Dapsone analog inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]	PMID:21440447
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313354	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NKX3-1 mRNA	PMID:38832940
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313354	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of NKX3-1 mRNA	PMID:21420995|PMID:29067470
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NKX3-1 mRNA]	PMID:35811015
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1313354	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of NKX3-1 mRNA	PMID:24160326
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of NKX3-1 mRNA	PMID:25351596
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313354	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of NKX3-1 mRNA	PMID:18687144|PMID:25757056
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:46680	serpentine asbestos	affects expression	ISO	RGD:1313354	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine affects the expression of NKX3-1 mRNA	PMID:24160326
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of NKX3-1 mRNA	PMID:16984733
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1313354	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of NKX3-1 mRNA	PMID:18174752
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	ISO	RGD:1313354	E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of NKX3-1 mRNA; Alitretinoin results in increased expression of NKX3-1 protein	PMID:16763719
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D005485	Flutamide results in decreased expression of NKX3-1 protein	PMID:17303007
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:5132	flutamide	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D005485	[Flutamide binds to and results in decreased activity of AR protein] which results in decreased expression of NKX3-1 protein	PMID:17303007
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313354	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of NKX3-1 mRNA	PMID:31629900
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:63959	celastrol	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in decreased expression of NKX3-1 mRNA	PMID:17010675
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313354	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of NKX3-1 mRNA	PMID:15336504
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:65954	gedunin	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in decreased expression of NKX3-1 mRNA	PMID:17010675
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:68534	enzalutamide	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20210608	CTD	MESH:C540278	enzalutamide results in decreased expression of NKX3-1 mRNA	PMID:29581250|PMID:32184358
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:68534	enzalutamide	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20210608	CTD	MESH:C540278	enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of NKX3-1 mRNA]; NVP-BHG712 promotes the reaction [enzalutamide results in decreased expression of NKX3-1 mRNA]	PMID:32184358
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1313355	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NKX3-1 mRNA	PMID:27935865
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:73158	sirtinol	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20170303	CTD	MESH:C439060	sirtinol results in decreased expression of NKX3-1 mRNA	PMID:22495798
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313354	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NKX3-1 mRNA	PMID:37199045
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of NKX3-1 mRNA	PMID:28500234
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:7553	niclosamide	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20191114	CTD	MESH:D009534	[Niclosamide co-treated with bicalutamide] results in decreased expression of NKX3-1 mRNA	PMID:28500234
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:77012	methylseleninic acid	affects expression	ISO	RGD:1313354	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid affects the expression of NKX3-1 mRNA	PMID:14617803
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:79	(-)-Arctigenin	increases expression	ISO	RGD:1313354	E	RGD:6480464	20170110	CTD	MESH:C071942	arctigenin results in increased expression of NKX3-1 protein	PMID:25380086
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:79	(-)-Arctigenin	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20170110	CTD	MESH:C071942	[Quercetin co-treated with arctigenin] results in increased expression of NKX3-1 protein	PMID:25380086
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:81760	difenoconazole	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20141111	CTD	MESH:C115058	difenoconazole results in decreased expression of NKX3-1 mRNA	PMID:12711008
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:81918	fentin acetate	decreases expression	ISO	RGD:1313354	E	RGD:6480464	20141104	CTD	MESH:C011978	phentin acetate results in decreased expression of NKX3-1 mRNA	PMID:12711008
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313355	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NKX3-1 mRNA	PMID:27935865
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1313354	E	RGD:6480464	20120613	CTD	MESH:D010894	Piroxicam inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA]	PMID:10537180
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:93751	PF-3758309	increases expression	ISO	RGD:1313354	E	RGD:6480464	20240806	CTD	MESH:C550923	PF 3758309 results in increased expression of NKX3-1 mRNA	PMID:29048629
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313354	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NKX3-1 mRNA	PMID:38568856
1305369	Nkx3-1	NK3 homeobox 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of NKX3-1 mRNA	PMID:18220299
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313356	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of IFT22 mRNA	PMID:38218311
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313357	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of IFT22 mRNA	PMID:33045310
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313356	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of IFT22 mRNA	PMID:23019147
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313356	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of IFT22 mRNA	PMID:23649840
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313357	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IFT22 mRNA	PMID:33754040
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IFT22 mRNA	PMID:33387578
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313357	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IFT22 mRNA	PMID:37236586
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313356	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of IFT22 mRNA	PMID:19549813
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313356	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of IFT22 mRNA	PMID:23649840
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313356	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of IFT22 mRNA	PMID:23649840
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313357	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IFT22 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of IFT22 mRNA	PMID:34911549
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313357	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of IFT22 mRNA	PMID:25629700
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313356	E	RGD:6480464	20161025	CTD	MESH:D001151	Arsenic affects the methylation of IFT22 gene	PMID:25304211
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of IFT22 gene	PMID:31011160
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313357	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of IFT22 protein	PMID:25505154
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313357	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of IFT22 mRNA	PMID:30912803
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IFT22 mRNA	PMID:22298810
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313357	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IFT22 mRNA	PMID:21570461
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IFT22 mRNA	PMID:33387578
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313356	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of IFT22 mRNA	PMID:29955902
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of IFT22 mRNA	PMID:28959563
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313356	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of IFT22 mRNA	PMID:20044591
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313356	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to IFT22 mRNA]	PMID:32406909
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of IFT22 mRNA	PMID:23411599
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313357	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of IFT22 mRNA	PMID:18648102
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313356	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of IFT22 mRNA	PMID:38479592
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of IFT22 gene	PMID:28505145
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313356	E	RGD:6480464	20161025	CTD	MESH:D002220	Carbamazepine affects the expression of IFT22 mRNA	PMID:25979313
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313357	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of IFT22 mRNA	PMID:37019170
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313356	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IFT22 mRNA	PMID:38568856
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313357	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IFT22 mRNA	PMID:37236586
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313356	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of IFT22 mRNA	PMID:24449571
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313356	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid affects the expression of IFT22 mRNA	PMID:25979313
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313356	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of IFT22 mRNA	PMID:19101580|PMID:23179753|PMID:28001369|PMID:29154799
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313356	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of IFT22 mRNA	PMID:17183730
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313356	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of IFT22 mRNA	PMID:20106945
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313357	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of IFT22 mRNA	PMID:28973697
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313357	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IFT22 mRNA	PMID:28973697
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313356	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of IFT22 mRNA	PMID:23649840
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313356	E	RGD:6480464	20161025	CTD	MESH:D001151	Arsenic affects the methylation of IFT22 gene	PMID:25304211
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D005485	Flutamide results in decreased expression of IFT22 mRNA	PMID:24793618
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313356	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of IFT22 mRNA	PMID:17183730
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313357	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IFT22 mRNA	PMID:22206623
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313357	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of IFT22 mRNA	PMID:30953684
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313356	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IFT22 mRNA	PMID:38568856
1305370	Ift22	intraflagellar transport 22	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C025643	vinclozolin results in decreased expression of IFT22 mRNA	PMID:23034163
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:10119	ziprasidone	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:C092292	ziprasidone results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:145994	remdesivir	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20221101	CTD	MESH:C000606551	remdesivir results in decreased expression of SOX17 mRNA	PMID:35605700
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:15366	acetic acid	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20120717	CTD	MESH:D019342	Acetic Acid results in decreased expression of SOX17 protein	PMID:21296659
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1313358	E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of SOX17 mRNA	PMID:31600526
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D014212	Tretinoin results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of SOX17 mRNA	PMID:16236135
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313358	E	RGD:6480464	20200519	CTD	MESH:D014212	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA]	PMID:31711903
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313358	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SOX17 mRNA	PMID:26079696
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:15920	columbamine	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20130416	CTD	MESH:C055786	columbamine results in decreased expression of SOX17 mRNA	PMID:23124089
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313359	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SOX17 mRNA	PMID:10975854
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SOX17 mRNA	PMID:30510588
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of SOX17 mRNA	PMID:25210133
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in decreased expression of SOX17 mRNA]	PMID:25210133
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:C031721	naphthalene results in increased expression of SOX17 protein	PMID:16239640
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20170516	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SOX17 mRNA	PMID:28013219
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of SOX17 gene	PMID:27618143
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SOX17 mRNA	PMID:33387578
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SOX17 mRNA	PMID:37992649
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SOX17 mRNA	PMID:28973375
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:17336	all-trans-retinol	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:D014801	[Vitamin A co-treated with INHBA protein] results in increased expression of SOX17 mRNA	PMID:17244017
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313358	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SOX17 mRNA	PMID:33647349
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of SOX17 mRNA	PMID:22967744
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SOX17 mRNA	PMID:37992649
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313359	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SOX17 mRNA	PMID:34319233
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of SOX17 mRNA	PMID:25031359
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:177802	Cuprizon	affects expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of SOX17 mRNA	PMID:27523638
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SOX17 mRNA	PMID:26577399
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SOX17 mRNA	PMID:33387578
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:18300	maleic acid	increases expression	ISO	RGD:1313358	E	RGD:6480464	20180220	CTD	MESH:C030272	maleic acid results in increased expression of SOX17 mRNA	PMID:28392987
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SOX17 mRNA	PMID:22100608
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313358	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SOX17 gene	PMID:27153756
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SOX17 mRNA	PMID:33354967
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SOX17 mRNA	PMID:34911549
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SOX17 mRNA	PMID:25629700
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SOX17 mRNA	PMID:40504410
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:27656	camptothecin	increases methylation	ISO	RGD:1313358	E	RGD:6480464	20190409	CTD	MESH:D002166	Camptothecin results in increased methylation of SOX17 gene	PMID:30720231
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:27666	actinomycin D	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D003609	Dactinomycin results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313358	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX17 mRNA	PMID:27188386
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313359	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SOX17 mRNA	PMID:28960355
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SOX17 mRNA	PMID:31881176
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SOX17 mRNA	PMID:25905778
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of SOX17 mRNA	PMID:19371625
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20231031	CTD	MESH:D007854	Lead results in decreased expression of SOX17 mRNA	PMID:37467947
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of SOX17 mRNA; Genistein results in decreased expression of SOX17 protein	PMID:32186404
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D019833	[Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of SOX17 mRNA	PMID:25031359
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313359	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SOX17 mRNA	PMID:26377647
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SOX17 mRNA	PMID:34747641
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SOX17 mRNA	PMID:33387578
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313359	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SOX17 mRNA	PMID:19770486|PMID:24058054
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SOX17 mRNA	PMID:25975270
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20121009	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of SOX17 mRNA	PMID:22105179
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28748	doxorubicin	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D004317	Doxorubicin results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313359	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SOX17 mRNA	PMID:39631538
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SOX17 mRNA	PMID:37992649
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1313358	E	RGD:329853329|PMID:32078435	20230614	RGD	MESH:D000111	N-acetyl-cysteine inhibits the reaction [angiotensin II decreases expression of SOX17 protein in retinal endothelial cells]	
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of SOX17 mRNA; Cholecalciferol results in increased expression of SOX17 protein	PMID:17170073
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SOX17 mRNA	PMID:40504410
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SOX17 mRNA	PMID:21839799
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SOX17 mRNA	PMID:19770486|PMID:22228805|PMID:32417428
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313358	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SOX17 3' UTR; Benzo(a)pyrene results in increased methylation of SOX17 promoter	PMID:27901495
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA	PMID:27858113
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313358	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of SOX17 promoter	PMID:23974009
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SOX17 mRNA	PMID:25895662
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SOX17 mRNA	PMID:25729387
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313359	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SOX17 gene; titanium dioxide results in decreased methylation of SOX17 promoter	PMID:35295148
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313359	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SOX17 mRNA	PMID:23557971
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313359	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SOX17 gene	PMID:35295148
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SOX17 mRNA	PMID:34492290
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of SOX17 mRNA	PMID:18648102
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of SOX17 mRNA	PMID:19167457
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SOX17 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313358	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of SOX17 mRNA	PMID:27271280
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313359	E	RGD:6480464	20140311	CTD	MESH:C006780	bisphenol A results in increased expression of SOX17 mRNA	PMID:24090592|PMID:30951980
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SOX17 gene	PMID:28505145
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313358	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SOX17 mRNA	PMID:25979313
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SOX17 mRNA	PMID:26682919
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20140715	CTD	MESH:D008748	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOX17 mRNA	PMID:23519560
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313359	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SOX17 mRNA	PMID:30951980
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313359	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SOX17 mRNA	PMID:26377693
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA	PMID:27858113
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1313359	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of SOX17 mRNA	PMID:26377693
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SOX17 mRNA	PMID:38685157
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313359	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SOX17 mRNA	PMID:30951980
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313359	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SOX17 mRNA	PMID:34289071|PMID:37019170
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34719	dinoseb	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20141111	CTD	MESH:C018527	dinoseb results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of SOX17 mRNA	PMID:21527772
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of SOX17 mRNA	PMID:12595580
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SOX17 mRNA	PMID:38382870
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20140715	CTD	MESH:D013755	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOX17 mRNA	PMID:23519560
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313359	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SOX17 mRNA	PMID:40194260
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:38940	sunitinib	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20170303	CTD	MESH:C473478	sunitinib results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20150414	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SOX17 mRNA	PMID:25510869
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of SOX17 mRNA	PMID:29038090
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of SOX17 mRNA	PMID:23125180
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313358	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SOX17 mRNA	PMID:25979313
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in decreased expression of SOX17 mRNA	PMID:37505509
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:39867	valproic acid	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D014635	Valproic Acid results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:41922	diethylstilbestrol	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D004054	Diethylstilbestrol results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313358	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SOX17 mRNA	PMID:19371625
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313359	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SOX17 mRNA	PMID:28973697
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SOX17 mRNA	PMID:37992649
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SOX17 mRNA	PMID:17562736
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of SOX17 mRNA	PMID:22230336
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313358	E	RGD:6480464	20180703	CTD	MESH:D005472	Fluorouracil results in decreased expression of SOX17 mRNA	PMID:24737281
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20120717	CTD	MESH:D005472	Fluorouracil results in decreased expression of SOX17 protein	PMID:21296659
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:46345	5-fluorouracil	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D005472	Fluorouracil results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1313358	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of SOX17 mRNA	PMID:24714768
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SOX17 mRNA	PMID:40504410
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:472552	5-bromo-2'-deoxyuridine	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20191114	CTD	MESH:D001973	Bromodeoxyuridine results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SOX17 mRNA	PMID:29391264
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:48432	angiotensin II	decreases expression	ISO	RGD:1313358	E	RGD:329853329|PMID:32078435	20230614	RGD	MESH:D000804	Angiotensin II decreases expression of SOX17 protein in retinal endothelial cells	
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:48432	angiotensin II	increases expression	ISO	RGD:1313358	E	RGD:329853320|PMID:36200131	20230614	RGD	MESH:D000804	Angiotensin II increases expression of SOX17 mRNA and protein in retinal microvascular endothelial cells	
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:49668	gefitinib	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:C419708	gefitinib results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:49960	vandetanib	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20170110	CTD	MESH:C452423	vandetanib results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	ISO	RGD:1313358	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of SOX17 promoter	PMID:18413743
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1313358	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of SOX17 mRNA; Decitabine results in increased expression of SOX17 protein	PMID:18413743
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SOX17 mRNA	PMID:30307764
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313359	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SOX17 mRNA; Nanotubes, Carbon results in increased expression of SOX17 mRNA	PMID:25554681
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D015735	Mifepristone results in decreased expression of SOX17 mRNA	PMID:25972201
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:50924	sorafenib	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20170303	CTD	MESH:C471405	sorafenib results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:51137	mianserin	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D008803	Mianserin results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313359	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of SOX17 mRNA	PMID:26377693
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA	PMID:27858113
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA	PMID:27858113
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of SOX17 mRNA	PMID:19042947
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:6067	isotretinoin	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D015474	Isotretinoin results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SOX17 mRNA	PMID:25729387
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of SOX17 mRNA	PMID:34858468
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:64163	diquat	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D004178	Diquat results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:64195	ritanserin	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D016713	Ritanserin results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:64206	bromochloroacetic acid	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20120717	CTD	MESH:C099813	bromochloroacetic acid results in decreased expression of SOX17 protein	PMID:21296659
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of SOX17 mRNA	PMID:20003209
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of SOX17 mRNA	PMID:19564919
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of SOX17 mRNA	PMID:19564919
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:6980	monocrotaline	decreases expression	EXP		E	RGD:329853317|PMID:36913491	20230614	RGD	MESH:D016686	Monocrotaline decreases expression of Sox17 protein in the lung	
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of SOX17 mRNA	PMID:19564919
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313359	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SOX17 mRNA	PMID:22206623
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:74514	6-aminonicotinamide	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D015120	6-Aminonicotinamide results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:78510	dorsomorphin	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20161228	CTD	MESH:C516138	dorsomorphin results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313358	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX17 mRNA	PMID:27188386
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313358	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SOX17 gene]	PMID:28238834
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313359	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SOX17 mRNA	PMID:23091169
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:81766	hexaconazole	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:81796	Chlorophacinone	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20141111	CTD	MESH:C004662	chlorophacinone results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:81843	fluazinam	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20141104	CTD	MESH:C075780	fluazinam results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:81913	diniconazole	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20170303	CTD	MESH:C049346	diniconazole results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:81922	flusilazole	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of SOX17 mRNA	PMID:26377693
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SOX17 mRNA	PMID:24780913
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:91091	CHIR 99021	increases expression	ISO	RGD:1313358	E	RGD:6480464	20200519	CTD	MESH:C473711	Chir 99021 results in increased expression of SOX17 mRNA	PMID:31711903
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:91091	CHIR 99021	multiple interactions	ISO	RGD:1313358	E	RGD:6480464	20200519	CTD	MESH:C473711	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA]	PMID:31711903
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:91108	SB 431542	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20161228	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313358	E	RGD:6480464	20161228	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA]; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX17 mRNA	PMID:27188386|PMID:31711903
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:9513	thalidomide	decreases localization	ISO	RGD:1313358	E	RGD:6480464	20140211	CTD	MESH:D013792	Thalidomide results in decreased localization of SOX17 protein	PMID:24154490
1305371	Sox17	SRY-box transcription factor 17	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SOX17 mRNA	PMID:19015723
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313362	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of EIF6 mRNA; deoxynivalenol results in increased expression of EIF6 protein	PMID:39638853|PMID:40320232
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of EIF6 mRNA	PMID:21551480
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	increases expression	ISO	RGD:1313362	E	RGD:6480464	20170228	CTD	MESH:C014026	hexamethylene bisacetamide results in increased expression of EIF6 protein	PMID:17569113
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein]	PMID:38195004
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	ISO	RGD:1313362	E	RGD:6480464	20260303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of EIF6 mRNA	PMID:40320232
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF6 mRNA	PMID:30529165
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313363	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of EIF6 mRNA	PMID:40945087
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EIF6 mRNA	PMID:29432896
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313362	E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of EIF6 mRNA	PMID:39709020
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313363	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EIF6 mRNA	PMID:39241906
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of EIF6 mRNA	PMID:15598610
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313363	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EIF6 mRNA	PMID:39298647
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313362	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EIF6 mRNA	PMID:37042841
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313363	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of EIF6 protein	PMID:20463053
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in increased expression of EIF6 protein	PMID:20463053
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313363	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EIF6 mRNA	PMID:34319233
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313362	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of EIF6 protein	PMID:37730182
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EIF6 mRNA	PMID:33387578
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of EIF6 protein	PMID:34915118
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313363	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of EIF6 mRNA	PMID:27462272
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein	PMID:38195004
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EIF6 protein	PMID:23301498
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of EIF6 mRNA	PMID:35430440
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EIF6 protein	PMID:38598786
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EIF6 mRNA	PMID:31150632
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313363	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EIF6 mRNA	PMID:27339419|PMID:31919559
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIF6 mRNA	PMID:40504410
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313362	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of EIF6 mRNA	PMID:19244175
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA	PMID:19244175
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1313362	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of EIF6 mRNA	PMID:33512557
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EIF6 protein	PMID:38460933
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313362	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of EIF6 protein	PMID:35688186
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313363	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of EIF6 protein	PMID:25505154
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of EIF6 mRNA	PMID:18930951
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313363	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIF6 mRNA	PMID:21570461
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313363	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EIF6 mRNA	PMID:15328365|PMID:17942748|PMID:18796159
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of EIF6 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF6 mRNA	PMID:16214954|PMID:17942748
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of EIF6 protein	PMID:35544339
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313362	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of EIF6 mRNA; aristolochic acid I results in increased expression of EIF6 protein	PMID:33212167
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313362	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EIF6 mRNA	PMID:30851411
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:28694	copper atom	affects binding	ISO	RGD:1313362	E	RGD:6480464	20130806	CTD	MESH:D003300	EIF6 protein binds to Copper	PMID:14534351
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20130806	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of EIF6 mRNA	PMID:15467011
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EIF6 mRNA	PMID:29432896
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIF6 mRNA	PMID:40504410
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313362	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EIF6 promoter	PMID:27901495
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313363	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EIF6 mRNA	PMID:23735875
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to EIF6 protein]	PMID:32406909
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:30052	copper(0)	affects binding	ISO	RGD:1313362	E	RGD:6480464	20130806	CTD	MESH:D003300	EIF6 protein binds to Copper	PMID:14534351
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20130806	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of EIF6 mRNA	PMID:15467011
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:3048	benzatropine	decreases expression	ISO	RGD:1313362	E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in decreased expression of EIF6 protein	PMID:34122009
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313362	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of EIF6 mRNA	PMID:25895662
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313362	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of EIF6 protein	PMID:20416286
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of EIF6 mRNA	PMID:24136188
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313363	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EIF6 gene	PMID:35295148
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EIF6 mRNA	PMID:34492290
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C069837	fullerene C60 results in decreased expression of EIF6 mRNA	PMID:19167457
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313362	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of EIF6 mRNA	PMID:30903817
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313362	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF6 protein	PMID:34186270
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313363	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of EIF6 promoter	PMID:27312807
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EIF6 mRNA	PMID:25181051
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313363	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of EIF6 promoter	PMID:27312807
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF6 mRNA	PMID:28628672
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313362	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of EIF6 mRNA	PMID:19244175
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA	PMID:19244175
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313363	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of EIF6 mRNA	PMID:26682919
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1313362	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of EIF6 mRNA	PMID:15980968
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313362	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of EIF6 protein	PMID:34186270
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313363	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EIF6 mRNA	PMID:39298647
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313362	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of EIF6 protein	PMID:34186270
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313363	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of EIF6 mRNA	PMID:38685157
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF6 mRNA	PMID:28628672
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313362	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of EIF6 protein	PMID:34186270
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313363	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EIF6 mRNA	PMID:37019170
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313363	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EIF6 mRNA	PMID:17361019
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EIF6 mRNA	PMID:21266533
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF6 protein	PMID:38598786
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF6 mRNA	PMID:28628672
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of EIF6 mRNA	PMID:32680482
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313362	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EIF6 mRNA	PMID:37042841
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EIF6 mRNA	PMID:33453195
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein	PMID:38195004
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313362	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of EIF6 mRNA	PMID:19244175
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA	PMID:19244175
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313363	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of EIF6 mRNA	PMID:17585979
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:3766	clozapine	decreases expression	ISO	RGD:1313362	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of EIF6 protein	PMID:34122009
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in increased expression of EIF6 mRNA	PMID:16221962
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313362	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EIF6 mRNA	PMID:32588087
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1313362	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of EIF6 mRNA	PMID:26352163
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of EIF6 mRNA	PMID:25993096
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of EIF6 mRNA	PMID:17292431
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313362	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of EIF6 mRNA	PMID:19101580
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313362	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EIF6 mRNA	PMID:23179753
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313362	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of EIF6 gene	PMID:29154799
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of EIF6 mRNA	PMID:17555576
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF6 mRNA	PMID:28628672
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EIF6 mRNA	PMID:17562736
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EIF6 protein	PMID:38460933
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIF6 mRNA	PMID:40504410
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313363	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EIF6 mRNA	PMID:35436446
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of EIF6 mRNA	PMID:17555576
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EIF6 mRNA	PMID:17942748
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF6 mRNA	PMID:17942748
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF6 mRNA	PMID:28628672
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313363	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EIF6 mRNA; Nanotubes, Carbon results in increased expression of EIF6 mRNA	PMID:25554681|PMID:25620056
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of EIF6 mRNA	PMID:34044035
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of EIF6 mRNA	PMID:15375163
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EIF6 mRNA	PMID:35964746
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EIF6 mRNA	PMID:24136188
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313362	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EIF6 protein	PMID:32959892
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313363	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of EIF6 mRNA	PMID:19751817
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313363	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of EIF6 protein	PMID:26558463
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313363	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of EIF6 mRNA	PMID:36851058
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313362	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EIF6 protein	PMID:34186270
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313363	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of EIF6 mRNA	PMID:22206623
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of EIF6 mRNA	PMID:24136188
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313362	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of EIF6 protein	PMID:31285264
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1313362	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of EIF6 mRNA; nivalenol results in increased expression of EIF6 protein	PMID:39638853|PMID:40320232
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313362	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of EIF6 protein	PMID:39638853
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313362	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EIF6 mRNA	PMID:30851411
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313363	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of EIF6 mRNA	PMID:30294300
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313362	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of EIF6 protein	PMID:38348393
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EIF6 mRNA	PMID:21346803
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:9381	T-2 toxin	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of EIF6 protein	PMID:26141394
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313362	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EIF6 mRNA	PMID:38568856
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313362	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EIF6 protein	PMID:38598786
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EIF6 mRNA	PMID:21346803
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of EIF6 mRNA	PMID:18930950
1305373	Eif6	eukaryotic translation initiation factor 6	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EIF6 mRNA	PMID:23034163
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GNT8 mRNA	PMID:20938992
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313364	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of B3GNT8 mRNA	PMID:33167477
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313364	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of B3GNT8 mRNA	PMID:22378314
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313364	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of B3GNT8 mRNA	PMID:35811015
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of B3GNT8 mRNA	PMID:26582142|PMID:39241906
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313364	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GNT8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GNT8 mRNA	PMID:35811015
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313364	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of B3GNT8 mRNA	PMID:30165855
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GNT8 mRNA	PMID:20938992
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of B3GNT8 mRNA	PMID:33387578
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of B3GNT8 mRNA	PMID:39984025
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of B3GNT8 mRNA	PMID:29950665
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GNT8 mRNA	PMID:20938992
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313364	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of B3GNT8 mRNA	PMID:23557933
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313364	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of B3GNT8 mRNA	PMID:38568856
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313364	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of B3GNT8 5' UTR	PMID:27901495
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622061	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of B3GNT8 promoter	PMID:35295148
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of B3GNT8 mRNA	PMID:29950665
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of B3GNT8 mRNA	PMID:25181051|PMID:34947998
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of B3GNT8 mRNA	PMID:30245210
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of B3GNT8 mRNA	PMID:41034487
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1622061	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of B3GNT8 mRNA	PMID:32156529
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1622061	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of B3GNT8 gene	PMID:31683443
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1622061	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of B3GNT8 exon	PMID:33297965
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of B3GNT8 mRNA	PMID:29950665
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of B3GNT8 mRNA	PMID:21266533
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313364	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of B3GNT8 mRNA	PMID:37042841
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313364	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of B3GNT8 mRNA	PMID:24449571
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of B3GNT8 mRNA	PMID:36331819
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313364	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of B3GNT8 mRNA	PMID:26272509|PMID:28001369
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313364	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of B3GNT8 gene	PMID:29154799
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313364	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GNT8 mRNA	PMID:27188386
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of B3GNT8 mRNA	PMID:28973697
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20230801	CTD	MESH:C016601	afimoxifene results in decreased expression of B3GNT8 mRNA	PMID:26879975
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622061	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of B3GNT8 mRNA	PMID:17562736
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313364	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GNT8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GNT8 mRNA	PMID:35811015
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of B3GNT8 mRNA	PMID:29391264
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1622061	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of B3GNT8 mRNA	PMID:38701926
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313364	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GNT8 mRNA	PMID:27188386
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of B3GNT8 mRNA	PMID:39847705
1305374	B3gnt8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313364	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GNT8 mRNA	PMID:27188386
1305375	Galk1	galactokinase 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of GALK1 protein	PMID:39638853
1305375	Galk1	galactokinase 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313365	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GALK1 mRNA	PMID:27188386
1305375	Galk1	galactokinase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GALK1 mRNA	PMID:33167477
1305375	Galk1	galactokinase 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:10617	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of GALK1 mRNA	PMID:20880076
1305375	Galk1	galactokinase 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GALK1 mRNA	PMID:36331819
1305375	Galk1	galactokinase 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313365	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GALK1 mRNA	PMID:26079696
1305375	Galk1	galactokinase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GALK1 mRNA	PMID:39241906
1305375	Galk1	galactokinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:10617	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of GALK1 mRNA	PMID:39298647
1305375	Galk1	galactokinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of GALK1 mRNA	PMID:30165855
1305375	Galk1	galactokinase 1	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of GALK1 protein	PMID:20109541
1305375	Galk1	galactokinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313365	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GALK1 mRNA	PMID:37042841
1305375	Galk1	galactokinase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALK1 mRNA	PMID:37992649
1305375	Galk1	galactokinase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALK1 mRNA	PMID:37992649
1305375	Galk1	galactokinase 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GALK1 mRNA	PMID:28818685
1305375	Galk1	galactokinase 1	gene	CHEBI:17973	alpha-D-galactose 1-phosphate	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20120501	CTD	MESH:C029973	[Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein] which results in decreased abundance of galactose-1-phosphate; [GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate	PMID:20696150
1305375	Galk1	galactokinase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GALK1 mRNA	PMID:36331819
1305375	Galk1	galactokinase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GALK1 protein	PMID:34915118
1305375	Galk1	galactokinase 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:10617	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of GALK1 mRNA	PMID:27462272
1305375	Galk1	galactokinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GALK1 mRNA	PMID:37236586
1305375	Galk1	galactokinase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GALK1 mRNA	PMID:19549813
1305375	Galk1	galactokinase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein] which results in decreased abundance of galactose-1-phosphate; Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein	PMID:20696150
1305375	Galk1	galactokinase 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of GALK1 mRNA	PMID:19376150
1305375	Galk1	galactokinase 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313365	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of GALK1 protein	PMID:20106945
1305375	Galk1	galactokinase 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313365	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of GALK1 mRNA	PMID:25102026
1305375	Galk1	galactokinase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of GALK1 protein	PMID:38598786
1305375	Galk1	galactokinase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:10617	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GALK1 mRNA	PMID:31919559
1305375	Galk1	galactokinase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GALK1 mRNA	PMID:22206623
1305375	Galk1	galactokinase 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313365	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GALK1 gene	PMID:25304211
1305375	Galk1	galactokinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GALK1 mRNA	PMID:40504410
1305375	Galk1	galactokinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GALK1 mRNA	PMID:39836092
1305375	Galk1	galactokinase 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of GALK1 protein	PMID:38460933
1305375	Galk1	galactokinase 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of GALK1 mRNA	PMID:31881176
1305375	Galk1	galactokinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of GALK1 mRNA	PMID:27392435
1305375	Galk1	galactokinase 1	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of GALK1 mRNA	PMID:20187946
1305375	Galk1	galactokinase 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:10617	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of GALK1 mRNA	PMID:30912803
1305375	Galk1	galactokinase 1	gene	CHEBI:28061	alpha-D-galactose	increases metabolic processing	ISO	RGD:1313365	E	RGD:6480464	20140805	CTD	MESH:D005690	GALK1 protein results in increased metabolism of Galactose	PMID:20696150
1305375	Galk1	galactokinase 1	gene	CHEBI:28061	alpha-D-galactose	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20140805	CTD	MESH:D005690	[GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate	PMID:20696150
1305375	Galk1	galactokinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10617	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GALK1 mRNA	PMID:21570461
1305375	Galk1	galactokinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GALK1 mRNA	PMID:21215274|PMID:32109520
1305375	Galk1	galactokinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:10617	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GALK1 mRNA	PMID:26290441
1305375	Galk1	galactokinase 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of GALK1 protein	PMID:39603559
1305375	Galk1	galactokinase 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of GALK1 mRNA	PMID:28374803
1305375	Galk1	galactokinase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GALK1 mRNA	PMID:33212167
1305375	Galk1	galactokinase 1	gene	CHEBI:28260	galactose	increases metabolic processing	ISO	RGD:1313365	E	RGD:6480464	20120501	CTD	MESH:D005690	GALK1 protein results in increased metabolism of Galactose	PMID:20696150
1305375	Galk1	galactokinase 1	gene	CHEBI:28260	galactose	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20120501	CTD	MESH:D005690	[GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate	PMID:20696150
1305375	Galk1	galactokinase 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of GALK1 mRNA	PMID:32763439
1305375	Galk1	galactokinase 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of GALK1 mRNA	PMID:28959563
1305375	Galk1	galactokinase 1	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:10617	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper results in decreased expression of GALK1 protein	PMID:23882024
1305375	Galk1	galactokinase 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GALK1 mRNA	PMID:20971185
1305375	Galk1	galactokinase 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:10617	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of GALK1 protein	PMID:28918527
1305375	Galk1	galactokinase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313365	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of GALK1 mRNA	PMID:29803840
1305375	Galk1	galactokinase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALK1 mRNA	PMID:37992649
1305375	Galk1	galactokinase 1	gene	CHEBI:28940	calciol	decreases expression	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in decreased expression of GALK1 mRNA	PMID:16508948
1305375	Galk1	galactokinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GALK1 mRNA	PMID:38568856
1305375	Galk1	galactokinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GALK1 mRNA	PMID:40504410
1305375	Galk1	galactokinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GALK1 mRNA	PMID:39836092
1305375	Galk1	galactokinase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313365	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GALK1 promoter	PMID:30157460
1305375	Galk1	galactokinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GALK1 mRNA	PMID:20106945|PMID:32234424
1305375	Galk1	galactokinase 1	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:10617	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper results in decreased expression of GALK1 protein	PMID:23882024
1305375	Galk1	galactokinase 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GALK1 mRNA	PMID:20971185
1305375	Galk1	galactokinase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313365	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of GALK1 protein	PMID:19364129
1305375	Galk1	galactokinase 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GALK1 protein]	PMID:26598702
1305375	Galk1	galactokinase 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of GALK1 mRNA	PMID:30047161
1305375	Galk1	galactokinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:10617	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GALK1 gene	PMID:35295148
1305375	Galk1	galactokinase 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GALK1 mRNA	PMID:34492290
1305375	Galk1	galactokinase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:10617	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of GALK1 mRNA	PMID:17426115|PMID:18301758|PMID:20059764|PMID:23811191
1305375	Galk1	galactokinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GALK1 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of GALK1 mRNA]	PMID:19710929|PMID:20059764
1305375	Galk1	galactokinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GALK1 mRNA	PMID:19710929
1305375	Galk1	galactokinase 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of GALK1 mRNA	PMID:38479592
1305375	Galk1	galactokinase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313365	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of GALK1 mRNA	PMID:30903817
1305375	Galk1	galactokinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of GALK1 mRNA	PMID:33296240
1305375	Galk1	galactokinase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313365	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GALK1 gene	PMID:31601247
1305375	Galk1	galactokinase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GALK1 mRNA	PMID:25181051
1305375	Galk1	galactokinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:10617	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GALK1 mRNA	PMID:32156529|PMID:33221593
1305375	Galk1	galactokinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313365	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of GALK1 protein	PMID:37567409
1305375	Galk1	galactokinase 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GALK1 mRNA	PMID:17316808
1305375	Galk1	galactokinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:10617	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GALK1 mRNA	PMID:39298647
1305375	Galk1	galactokinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313365	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of GALK1 gene	PMID:31601247
1305375	Galk1	galactokinase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:10617	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GALK1 mRNA	PMID:37019170
1305375	Galk1	galactokinase 1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:10617	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of GALK1 protein	PMID:35362542
1305375	Galk1	galactokinase 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GALK1 protein]	PMID:35362542
1305375	Galk1	galactokinase 1	gene	CHEBI:34682	diazinon	decreases methylation	ISO	RGD:1313365	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of GALK1 gene	PMID:22964155
1305375	Galk1	galactokinase 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of GALK1 protein	PMID:38598786
1305375	Galk1	galactokinase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of GALK1 mRNA	PMID:16054899
1305375	Galk1	galactokinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313365	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GALK1 mRNA	PMID:37042841
1305375	Galk1	galactokinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313365	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GALK1 protein	PMID:24527689
1305375	Galk1	galactokinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GALK1 mRNA	PMID:37236586
1305375	Galk1	galactokinase 1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of GALK1 mRNA	PMID:19429403
1305375	Galk1	galactokinase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GALK1 mRNA	PMID:19320972
1305375	Galk1	galactokinase 1	gene	CHEBI:37480	D-galactopyranose 1-phosphate	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20120501	CTD	MESH:C029973	[Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein] which results in decreased abundance of galactose-1-phosphate; [GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate	PMID:20696150
1305375	Galk1	galactokinase 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of GALK1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GALK1 mRNA]	PMID:17585979
1305375	Galk1	galactokinase 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GALK1 mRNA	PMID:28302478
1305375	Galk1	galactokinase 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of GALK1 mRNA	PMID:39529242
1305375	Galk1	galactokinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of GALK1 mRNA	PMID:19429403
1305375	Galk1	galactokinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GALK1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GALK1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of GALK1 mRNA	PMID:36331819
1305375	Galk1	galactokinase 1	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of GALK1 mRNA	PMID:22110744
1305375	Galk1	galactokinase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of GALK1 mRNA	PMID:29154799
1305375	Galk1	galactokinase 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of GALK1 mRNA	PMID:41580965
1305375	Galk1	galactokinase 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of GALK1 mRNA	PMID:30047161
1305375	Galk1	galactokinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of GALK1 mRNA	PMID:20106945|PMID:25562108
1305375	Galk1	galactokinase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of GALK1 mRNA	PMID:16054899
1305375	Galk1	galactokinase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:10617	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of GALK1 mRNA	PMID:28973697
1305375	Galk1	galactokinase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALK1 mRNA	PMID:37992649
1305375	Galk1	galactokinase 1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of GALK1 mRNA	PMID:24136188
1305375	Galk1	galactokinase 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GALK1 mRNA	PMID:38832940
1305375	Galk1	galactokinase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GALK1 mRNA	PMID:33387578
1305375	Galk1	galactokinase 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of GALK1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GALK1 mRNA]	PMID:17585979
1305375	Galk1	galactokinase 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of GALK1 protein	PMID:38460933
1305375	Galk1	galactokinase 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313365	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GALK1 gene	PMID:25304211
1305375	Galk1	galactokinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GALK1 mRNA	PMID:40504410
1305375	Galk1	galactokinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GALK1 mRNA	PMID:39836092
1305375	Galk1	galactokinase 1	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:10617	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide analog results in decreased expression of GALK1 protein	PMID:23882024
1305375	Galk1	galactokinase 1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GALK1 protein]	PMID:35362542
1305375	Galk1	galactokinase 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313365	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of GALK1 protein	PMID:19364129
1305375	Galk1	galactokinase 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GALK1 protein]	PMID:26598702
1305375	Galk1	galactokinase 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C017690	fenvalerate results in increased expression of GALK1 protein	PMID:33656234
1305375	Galk1	galactokinase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:10617	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GALK1 mRNA	PMID:25620056
1305375	Galk1	galactokinase 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of GALK1 mRNA	PMID:24136188
1305375	Galk1	galactokinase 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of GALK1 mRNA	PMID:30047161
1305375	Galk1	galactokinase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GALK1 mRNA	PMID:35964746
1305375	Galk1	galactokinase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:10617	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of GALK1 mRNA	PMID:19042947
1305375	Galk1	galactokinase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GALK1 protein	PMID:32959892
1305375	Galk1	galactokinase 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:10617	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of GALK1 mRNA	PMID:23650126
1305375	Galk1	galactokinase 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of GALK1 mRNA	PMID:24136188
1305375	Galk1	galactokinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313365	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GALK1 mRNA	PMID:24810058
1305375	Galk1	galactokinase 1	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:10617	E	RGD:6480464	20200331	CTD	MESH:D012970	Sodium Glutamate results in increased expression of GALK1 mRNA	PMID:20111022
1305375	Galk1	galactokinase 1	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GALK1 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GALK1 mRNA	PMID:19001666|PMID:20111022
1305375	Galk1	galactokinase 1	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of GALK1 mRNA	PMID:19564919
1305375	Galk1	galactokinase 1	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:10617	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of GALK1 mRNA	PMID:27462272
1305375	Galk1	galactokinase 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313365	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GALK1 protein	PMID:34186270
1305375	Galk1	galactokinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GALK1 mRNA	PMID:22206623
1305375	Galk1	galactokinase 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of GALK1 mRNA	PMID:24136188
1305375	Galk1	galactokinase 1	gene	CHEBI:7599	Nivalenol	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in decreased expression of GALK1 protein	PMID:39638853
1305375	Galk1	galactokinase 1	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of GALK1 protein	PMID:19716841
1305375	Galk1	galactokinase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313365	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of GALK1 mRNA	PMID:19159669
1305375	Galk1	galactokinase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GALK1 mRNA	PMID:21394737
1305375	Galk1	galactokinase 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of GALK1 mRNA	PMID:21278054
1305375	Galk1	galactokinase 1	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of GALK1 mRNA	PMID:30047161
1305375	Galk1	galactokinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of GALK1 mRNA	PMID:30047161
1305375	Galk1	galactokinase 1	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of GALK1 mRNA	PMID:24136188
1305375	Galk1	galactokinase 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313365	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GALK1 mRNA	PMID:38568856
1305375	Galk1	galactokinase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313365	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of GALK1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of GALK1 protein	PMID:38598786
1305375	Galk1	galactokinase 1	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:10617	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of GALK1 mRNA	PMID:32835833
1305376	Srp68	signal recognition particle 68	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SRP68 mRNA]	PMID:31150632
1305376	Srp68	signal recognition particle 68	gene	CHEBI:135741	testosterone undecanoate	increases expression	ISO	RGD:1313366	E	RGD:6480464	20170307	CTD	MESH:C010792	testosterone undecanoate results in increased expression of SRP68 mRNA	PMID:19074003
1305376	Srp68	signal recognition particle 68	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550190	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SRP68 mRNA	PMID:20188158
1305376	Srp68	signal recognition particle 68	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550190	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SRP68 mRNA	PMID:30319688
1305376	Srp68	signal recognition particle 68	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550190	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SRP68 mRNA	PMID:39298647
1305376	Srp68	signal recognition particle 68	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	ISO	RGD:1313366	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of SRP68 protein	PMID:20109541
1305376	Srp68	signal recognition particle 68	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313366	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SRP68 mRNA	PMID:37042841
1305376	Srp68	signal recognition particle 68	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313366	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SRP68 protein	PMID:37730182
1305376	Srp68	signal recognition particle 68	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SRP68 mRNA	PMID:22061828|PMID:33387578
1305376	Srp68	signal recognition particle 68	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313366	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SRP68 mRNA	PMID:19549813
1305376	Srp68	signal recognition particle 68	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313366	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SRP68 protein	PMID:23301498
1305376	Srp68	signal recognition particle 68	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of SRP68 protein	PMID:33236894
1305376	Srp68	signal recognition particle 68	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313366	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SRP68 mRNA	PMID:23649840
1305376	Srp68	signal recognition particle 68	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313366	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SRP68 mRNA	PMID:35430440
1305376	Srp68	signal recognition particle 68	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313366	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SRP68 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SRP68 protein	PMID:38598786
1305376	Srp68	signal recognition particle 68	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SRP68 mRNA	PMID:31150632
1305376	Srp68	signal recognition particle 68	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550190	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SRP68 mRNA	PMID:31919559
1305376	Srp68	signal recognition particle 68	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SRP68 mRNA]	PMID:31150632
1305376	Srp68	signal recognition particle 68	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1313366	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of SRP68 mRNA	PMID:16835338
1305376	Srp68	signal recognition particle 68	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313366	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SRP68 protein	PMID:35688186
1305376	Srp68	signal recognition particle 68	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of SRP68 gene	PMID:35440735
1305376	Srp68	signal recognition particle 68	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1550190	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SRP68 protein	PMID:25505154
1305376	Srp68	signal recognition particle 68	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313366	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SRP68 mRNA	PMID:23557933
1305376	Srp68	signal recognition particle 68	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550190	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SRP68 mRNA	PMID:30912803
1305376	Srp68	signal recognition particle 68	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550190	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SRP68 mRNA	PMID:21570461
1305376	Srp68	signal recognition particle 68	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SRP68 mRNA	PMID:32109520
1305376	Srp68	signal recognition particle 68	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550190	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRP68 mRNA	PMID:17942748
1305376	Srp68	signal recognition particle 68	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313366	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of SRP68 protein	PMID:39603559
1305376	Srp68	signal recognition particle 68	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313366	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SRP68 mRNA	PMID:33212167
1305376	Srp68	signal recognition particle 68	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313366	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of SRP68 protein	PMID:30528433
1305376	Srp68	signal recognition particle 68	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313366	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SRP68 mRNA	PMID:38568856
1305376	Srp68	signal recognition particle 68	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313366	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SRP68 mRNA	PMID:22378314
1305376	Srp68	signal recognition particle 68	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313366	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SRP68 promoter	PMID:27901495
1305376	Srp68	signal recognition particle 68	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SRP68 mRNA	PMID:24136188
1305376	Srp68	signal recognition particle 68	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of SRP68 mRNA	PMID:32479839
1305376	Srp68	signal recognition particle 68	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550190	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SRP68 gene	PMID:35295148
1305376	Srp68	signal recognition particle 68	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SRP68 mRNA	PMID:19167457
1305376	Srp68	signal recognition particle 68	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SRP68 gene	PMID:28505145
1305376	Srp68	signal recognition particle 68	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SRP68 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305376	Srp68	signal recognition particle 68	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313366	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SRP68 protein	PMID:34186270
1305376	Srp68	signal recognition particle 68	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SRP68 gene	PMID:28505145
1305376	Srp68	signal recognition particle 68	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550190	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SRP68 mRNA	PMID:39298647
1305376	Srp68	signal recognition particle 68	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1550190	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of SRP68 mRNA	PMID:26377693
1305376	Srp68	signal recognition particle 68	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313366	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SRP68 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SRP68 protein	PMID:38598786
1305376	Srp68	signal recognition particle 68	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313366	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SRP68 mRNA	PMID:37042841
1305376	Srp68	signal recognition particle 68	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SRP68 gene	PMID:22079235
1305376	Srp68	signal recognition particle 68	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550190	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SRP68 mRNA	PMID:17585979
1305376	Srp68	signal recognition particle 68	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313366	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SRP68 mRNA	PMID:25979313
1305376	Srp68	signal recognition particle 68	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550190	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SRP68 mRNA	PMID:17292431
1305376	Srp68	signal recognition particle 68	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313366	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SRP68 gene	PMID:29154799
1305376	Srp68	signal recognition particle 68	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313366	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SRP68 mRNA	PMID:20106945|PMID:25562108
1305376	Srp68	signal recognition particle 68	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550190	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SRP68 mRNA	PMID:17562736
1305376	Srp68	signal recognition particle 68	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313366	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SRP68 mRNA	PMID:29523930
1305376	Srp68	signal recognition particle 68	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1313366	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of SRP68 mRNA	PMID:16835338
1305376	Srp68	signal recognition particle 68	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SRP68 mRNA	PMID:29391264
1305376	Srp68	signal recognition particle 68	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550190	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRP68 mRNA	PMID:17942748
1305376	Srp68	signal recognition particle 68	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of SRP68 mRNA	PMID:34044035
1305376	Srp68	signal recognition particle 68	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550190	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SRP68 mRNA	PMID:35964746
1305376	Srp68	signal recognition particle 68	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SRP68 mRNA	PMID:24136188
1305376	Srp68	signal recognition particle 68	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313366	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SRP68 protein	PMID:32959892
1305376	Srp68	signal recognition particle 68	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313366	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SRP68 protein	PMID:34186270
1305376	Srp68	signal recognition particle 68	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550190	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SRP68 mRNA	PMID:22206623
1305376	Srp68	signal recognition particle 68	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313366	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SRP68 gene]	PMID:28238834
1305376	Srp68	signal recognition particle 68	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1550190	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SRP68 mRNA	PMID:30294300
1305376	Srp68	signal recognition particle 68	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313366	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SRP68 protein	PMID:31675489
1305376	Srp68	signal recognition particle 68	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of SRP68 protein	PMID:28903499
1305376	Srp68	signal recognition particle 68	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1550190	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SRP68 mRNA	PMID:21278054
1305376	Srp68	signal recognition particle 68	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1313366	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of SRP68 mRNA	PMID:24921660
1305376	Srp68	signal recognition particle 68	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313366	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SRP68 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SRP68 protein	PMID:38598786
1305376	Srp68	signal recognition particle 68	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SRP68 mRNA	PMID:21346803
1305377	Best2	bestrophin 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313368	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of BEST2 mRNA	PMID:26272509
1305377	Best2	bestrophin 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313368	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEST2 mRNA	PMID:27188386
1305377	Best2	bestrophin 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313369	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of BEST2 mRNA	PMID:33045310
1305377	Best2	bestrophin 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313369	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of BEST2 mRNA	PMID:30319688
1305377	Best2	bestrophin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313368	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of BEST2 mRNA	PMID:31614463
1305377	Best2	bestrophin 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313368	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of BEST2 mRNA	PMID:38568856
1305377	Best2	bestrophin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BEST2 promoter	PMID:23359474
1305377	Best2	bestrophin 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of BEST2 mRNA	PMID:33387578
1305377	Best2	bestrophin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313369	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BEST2 mRNA	PMID:21570461
1305377	Best2	bestrophin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313368	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BEST2 mRNA	PMID:21296121
1305377	Best2	bestrophin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313369	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BEST2 mRNA	PMID:21354282
1305377	Best2	bestrophin 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313368	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of BEST2 mRNA	PMID:33212167
1305377	Best2	bestrophin 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313368	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BEST2 mRNA	PMID:38568856
1305377	Best2	bestrophin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313368	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BEST2 exon	PMID:27901495
1305377	Best2	bestrophin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313369	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BEST2 gene	PMID:35295148
1305377	Best2	bestrophin 2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of BEST2 mRNA	PMID:19167457
1305377	Best2	bestrophin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of BEST2 mRNA	PMID:41034487
1305377	Best2	bestrophin 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BEST2 mRNA	PMID:25181051|PMID:41034487
1305377	Best2	bestrophin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BEST2 promoter	PMID:23359474
1305377	Best2	bestrophin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313369	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of BEST2 exon	PMID:33297965
1305377	Best2	bestrophin 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313368	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BEST2 mRNA	PMID:28628672
1305377	Best2	bestrophin 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BEST2 promoter	PMID:23359474
1305377	Best2	bestrophin 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313368	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BEST2 mRNA	PMID:28628672
1305377	Best2	bestrophin 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of BEST2 mRNA	PMID:30047161
1305377	Best2	bestrophin 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313368	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BEST2 mRNA	PMID:28628672
1305377	Best2	bestrophin 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313368	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of BEST2 mRNA	PMID:38832940
1305377	Best2	bestrophin 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313368	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BEST2 mRNA	PMID:28628672
1305377	Best2	bestrophin 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of BEST2 mRNA	PMID:30047161
1305377	Best2	bestrophin 2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of BEST2 mRNA	PMID:35283115
1305377	Best2	bestrophin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313369	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of BEST2 mRNA	PMID:22206623
1305377	Best2	bestrophin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313368	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEST2 mRNA	PMID:27188386
1305377	Best2	bestrophin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313368	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BEST2 gene]	PMID:28238834
1305377	Best2	bestrophin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of BEST2 mRNA	PMID:30047161
1305377	Best2	bestrophin 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313368	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEST2 mRNA	PMID:27188386
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313371	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MTMR6 gene	PMID:20938992
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of MTMR6 mRNA	PMID:15498508
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313370	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MTMR6 mRNA	PMID:33167477
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313371	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MTMR6 mRNA	PMID:24205000
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313371	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of MTMR6 mRNA	PMID:30319688
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1313370	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of MTMR6 protein	PMID:35688186
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313371	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MTMR6 gene	PMID:20938992
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313370	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MTMR6 mRNA	PMID:37042841
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313370	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MTMR6 mRNA	PMID:21179406
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313371	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of MTMR6 mRNA	PMID:19376150
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313371	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MTMR6 mRNA	PMID:19770486
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313371	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTMR6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MTMR6 gene	PMID:20938992|PMID:22206623
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313370	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MTMR6 protein	PMID:35688186
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313370	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MTMR6 mRNA	PMID:23557933
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313370	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MTMR6 mRNA	PMID:27392435
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313370	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MTMR6 mRNA	PMID:22574217
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MTMR6 mRNA	PMID:33387578
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313370	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MTMR6 mRNA	PMID:22903824
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MTMR6 protein	PMID:39603559
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MTMR6 mRNA	PMID:28001369
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MTMR6 mRNA	PMID:30851411
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MTMR6 mRNA	PMID:25523186
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313370	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MTMR6 mRNA	PMID:38568856
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313371	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MTMR6 intron	PMID:27901495
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313370	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MTMR6 promoter	PMID:27901495
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313371	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MTMR6 exon	PMID:27901495
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313370	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MTMR6 mRNA]	PMID:32406909
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MTMR6 mRNA	PMID:25523186
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MTMR6 mRNA	PMID:19150397
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of MTMR6 mRNA	PMID:15498508
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313371	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MTMR6 gene	PMID:35295148
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313371	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MTMR6 mRNA	PMID:18648102
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313371	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MTMR6 mRNA	PMID:17426115
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MTMR6 mRNA	PMID:25181051
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MTMR6 mRNA	PMID:29275510
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MTMR6 gene	PMID:28505145
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313371	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MTMR6 mRNA	PMID:38685157
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313371	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MTMR6 mRNA	PMID:17681415
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MTMR6 mRNA	PMID:24449571
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MTMR6 mRNA	PMID:28302478
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313370	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MTMR6 mRNA	PMID:25979313
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313370	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MTMR6 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369|PMID:29154799
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313370	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTMR6 mRNA	PMID:27188386
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313370	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MTMR6 mRNA	PMID:25562108
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313370	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MTMR6 mRNA	PMID:27188386
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1313370	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of MTMR6 mRNA	PMID:19151715
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1313370	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of MTMR6 mRNA	PMID:20977926
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MTMR6 protein	PMID:32959892
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of MTMR6 mRNA	PMID:28801915
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313371	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MTMR6 mRNA	PMID:23650126
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313370	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of MTMR6 mRNA	PMID:28988120
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313371	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MTMR6 mRNA	PMID:22206623
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313371	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTMR6 mRNA	PMID:22206623
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MTMR6 mRNA	PMID:22714537
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313370	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MTMR6 mRNA	PMID:30851411
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313370	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTMR6 mRNA	PMID:27188386
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313370	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTMR6 mRNA	PMID:27188386
1305378	Mtmr6	myotubularin related protein 6	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313371	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of MTMR6 protein	PMID:24648495
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313372	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CLCN6 mRNA	PMID:38218311
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein]	PMID:38195004
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313372	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CLCN6 mRNA	PMID:23724009|PMID:33167477
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313373	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CLCN6 mRNA	PMID:30319688
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313373	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CLCN6 mRNA	PMID:30319688
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313372	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CLCN6 mRNA	PMID:38568856
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CLCN6 mRNA	PMID:33387578
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313372	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CLCN6 mRNA	PMID:21179406
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CLCN6 mRNA	PMID:33387578
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA	PMID:39836092
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein	PMID:38195004
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313373	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CLCN6 mRNA	PMID:19770486
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313372	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CLCN6 gene	PMID:27153756
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313373	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CLCN6 mRNA	PMID:34911549
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313372	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of CLCN6 mRNA	PMID:19774075
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CLCN6 mRNA	PMID:31150632
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CLCN6 mRNA	PMID:39836092
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CLCN6 mRNA	PMID:31881176
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313373	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of CLCN6 mRNA	PMID:32186404
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLCN6 mRNA	PMID:22298810
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313373	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLCN6 mRNA	PMID:21570461
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLCN6 mRNA	PMID:33387578
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CLCN6 mRNA	PMID:28959563
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313372	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CLCN6 mRNA	PMID:29803840
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CLCN6 mRNA	PMID:29432896
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313372	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of CLCN6 mRNA	PMID:29319823
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CLCN6 mRNA	PMID:39836092
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313372	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLCN6 mRNA	PMID:26238291
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313372	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CLCN6 promoter	PMID:27901495
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CLCN6 gene	PMID:31601247
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313373	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CLCN6 mRNA	PMID:29264374
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313373	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of CLCN6 mRNA	PMID:18648102
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313372	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CLCN6 gene	PMID:31601247
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of CLCN6 mRNA	PMID:32145629
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313373	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CLCN6 mRNA	PMID:32156529
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CLCN6 mRNA	PMID:25181051
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313373	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of CLCN6 mRNA	PMID:38074096
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CLCN6 gene	PMID:31601247
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313373	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CLCN6 mRNA	PMID:26682919
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313373	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CLCN6 gene	PMID:31683443
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313373	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CLCN6 mRNA	PMID:40203079
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313372	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of CLCN6 gene	PMID:31601247
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313373	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CLCN6 mRNA	PMID:37019170
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313372	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CLCN6 gene	PMID:22964155
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CLCN6 mRNA	PMID:21266533
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313372	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CLCN6 mRNA	PMID:37042841
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA	PMID:39836092
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CLCN6 mRNA	PMID:30723492
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313372	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLCN6 mRNA	PMID:26472689
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CLCN6 mRNA	PMID:33453195
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein	PMID:38195004
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of CLCN6 mRNA	PMID:26194646
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313372	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CLCN6 mRNA	PMID:28302478
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313372	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CLCN6 mRNA	PMID:31533062
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1313372	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of CLCN6 mRNA	PMID:17198877
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313372	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CLCN6 mRNA	PMID:25562108
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLCN6 mRNA	PMID:33387578
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CLCN6 mRNA	PMID:29432896
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CLCN6 mRNA	PMID:39836092
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1313372	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of CLCN6 mRNA	PMID:22077320
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1313373	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of CLCN6 mRNA	PMID:35436446
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313372	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of CLCN6 mRNA	PMID:18175754
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313372	E	RGD:6480464	20220705	CTD	MESH:C029892	cupric chloride results in decreased expression of CLCN6 mRNA	PMID:34921933
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313372	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of CLCN6 mRNA	PMID:17211630
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CLCN6 mRNA	PMID:24793618
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313372	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA	PMID:39836092
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:63618	pravastatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of CLCN6 mRNA	PMID:27225895
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1313373	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of CLCN6 mRNA	PMID:27225895
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313373	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CLCN6 mRNA	PMID:26307267
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313373	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CLCN6 mRNA	PMID:22206623
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:75170	zaragozic acid A	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CLCN6 mRNA	PMID:27225895
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1313373	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CLCN6 mRNA	PMID:27225895
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:8107	phenytoin	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in decreased expression of CLCN6 mRNA	PMID:20345932
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CLCN6 mRNA	PMID:27291303
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1313372	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of CLCN6 mRNA	PMID:16497877
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CLCN6 mRNA	PMID:21346803
1305379	Clcn6	Cl-/H+ antiporter 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CLCN6 mRNA	PMID:21346803
1305381	Relt	RELT, TNF receptor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313377	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RELT mRNA	PMID:33045310
1305381	Relt	RELT, TNF receptor	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RELT gene	PMID:20938992
1305381	Relt	RELT, TNF receptor	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313376	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RELT mRNA	PMID:33167477
1305381	Relt	RELT, TNF receptor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RELT mRNA	PMID:39241906
1305381	Relt	RELT, TNF receptor	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313376	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of RELT mRNA	PMID:23019147|PMID:31614463
1305381	Relt	RELT, TNF receptor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RELT mRNA	PMID:32741896
1305381	Relt	RELT, TNF receptor	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RELT mRNA	PMID:33387578
1305381	Relt	RELT, TNF receptor	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RELT gene	PMID:20938992
1305381	Relt	RELT, TNF receptor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313376	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RELT mRNA	PMID:37042841
1305381	Relt	RELT, TNF receptor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RELT mRNA	PMID:37992649
1305381	Relt	RELT, TNF receptor	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RELT mRNA	PMID:32741896
1305381	Relt	RELT, TNF receptor	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313376	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of RELT mRNA	PMID:33647349
1305381	Relt	RELT, TNF receptor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RELT mRNA	PMID:37992649
1305381	Relt	RELT, TNF receptor	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RELT mRNA	PMID:27523638
1305381	Relt	RELT, TNF receptor	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313376	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RELT protein	PMID:37730182
1305381	Relt	RELT, TNF receptor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RELT mRNA	PMID:33387578
1305381	Relt	RELT, TNF receptor	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313376	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RELT mRNA	PMID:28818685
1305381	Relt	RELT, TNF receptor	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313376	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RELT intron	PMID:30157460
1305381	Relt	RELT, TNF receptor	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313376	E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of RELT mRNA	PMID:22562489
1305381	Relt	RELT, TNF receptor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RELT mRNA	PMID:37325564
1305381	Relt	RELT, TNF receptor	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313376	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RELT mRNA	PMID:19549813
1305381	Relt	RELT, TNF receptor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313376	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RELT mRNA	PMID:22100608
1305381	Relt	RELT, TNF receptor	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313376	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RELT intron	PMID:30157460
1305381	Relt	RELT, TNF receptor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313376	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RELT mRNA	PMID:35430440
1305381	Relt	RELT, TNF receptor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RELT gene	PMID:20938992
1305381	Relt	RELT, TNF receptor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313376	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELT mRNA	PMID:39836092
1305381	Relt	RELT, TNF receptor	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RELT mRNA	PMID:31881176
1305381	Relt	RELT, TNF receptor	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313376	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RELT mRNA	PMID:24768652|PMID:25583101
1305381	Relt	RELT, TNF receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313377	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RELT mRNA	PMID:21570461
1305381	Relt	RELT, TNF receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RELT mRNA	PMID:33387578
1305381	Relt	RELT, TNF receptor	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313376	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RELT mRNA	PMID:28001369
1305381	Relt	RELT, TNF receptor	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313376	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RELT mRNA	PMID:33212167
1305381	Relt	RELT, TNF receptor	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RELT mRNA	PMID:28959563
1305381	Relt	RELT, TNF receptor	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313376	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RELT mRNA	PMID:29803840
1305381	Relt	RELT, TNF receptor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RELT mRNA	PMID:37992649
1305381	Relt	RELT, TNF receptor	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313376	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of RELT mRNA	PMID:34032870
1305381	Relt	RELT, TNF receptor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313376	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RELT mRNA	PMID:38568856
1305381	Relt	RELT, TNF receptor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313376	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELT mRNA	PMID:39836092
1305381	Relt	RELT, TNF receptor	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313376	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RELT 5' UTR	PMID:27901495
1305381	Relt	RELT, TNF receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313376	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RELT mRNA	PMID:26238291|PMID:32234424
1305381	Relt	RELT, TNF receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313377	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RELT mRNA	PMID:22228805
1305381	Relt	RELT, TNF receptor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to RELT promoter]	PMID:19654925
1305381	Relt	RELT, TNF receptor	gene	CHEBI:3000	beauvericin	decreases expression	ISO	RGD:1313376	E	RGD:6480464	20180515	CTD	MESH:C004456	beauvericin results in decreased expression of RELT mRNA	PMID:29203277
1305381	Relt	RELT, TNF receptor	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313377	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RELT mRNA	PMID:27131904
1305381	Relt	RELT, TNF receptor	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RELT mRNA	PMID:34492290
1305381	Relt	RELT, TNF receptor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RELT mRNA	PMID:25181051
1305381	Relt	RELT, TNF receptor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313376	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RELT mRNA	PMID:29275510
1305381	Relt	RELT, TNF receptor	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313377	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RELT promoter	PMID:27312807
1305381	Relt	RELT, TNF receptor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RELT mRNA	PMID:34947998
1305381	Relt	RELT, TNF receptor	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313376	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RELT mRNA	PMID:37042841
1305381	Relt	RELT, TNF receptor	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of RELT mRNA	PMID:35163327
1305381	Relt	RELT, TNF receptor	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RELT mRNA	PMID:35163327
1305381	Relt	RELT, TNF receptor	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313376	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RELT mRNA	PMID:38568856
1305381	Relt	RELT, TNF receptor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RELT mRNA	PMID:37325564
1305381	Relt	RELT, TNF receptor	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of RELT mRNA	PMID:35163327
1305381	Relt	RELT, TNF receptor	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RELT mRNA	PMID:35163327
1305381	Relt	RELT, TNF receptor	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313376	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RELT mRNA	PMID:24449571
1305381	Relt	RELT, TNF receptor	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313376	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RELT mRNA	PMID:31533062
1305381	Relt	RELT, TNF receptor	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313376	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RELT mRNA	PMID:25562108
1305381	Relt	RELT, TNF receptor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RELT mRNA	PMID:37992649
1305381	Relt	RELT, TNF receptor	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313377	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of RELT mRNA	PMID:18502557
1305381	Relt	RELT, TNF receptor	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313376	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RELT mRNA	PMID:38832940
1305381	Relt	RELT, TNF receptor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RELT mRNA	PMID:33387578
1305381	Relt	RELT, TNF receptor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313376	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of RELT mRNA	PMID:29067470
1305381	Relt	RELT, TNF receptor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313376	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELT mRNA	PMID:39836092
1305381	Relt	RELT, TNF receptor	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313376	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of RELT mRNA	PMID:18175754
1305381	Relt	RELT, TNF receptor	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RELT mRNA	PMID:38701926
1305381	Relt	RELT, TNF receptor	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RELT gene	PMID:35440735
1305381	Relt	RELT, TNF receptor	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1313376	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of RELT mRNA	PMID:28960945
1305381	Relt	RELT, TNF receptor	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RELT mRNA	PMID:32741896
1305381	Relt	RELT, TNF receptor	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313377	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of RELT mRNA	PMID:39847705
1305381	Relt	RELT, TNF receptor	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RELT mRNA	PMID:24780913
1305381	Relt	RELT, TNF receptor	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313377	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RELT mRNA	PMID:27131904
1305381	Relt	RELT, TNF receptor	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RELT mRNA	PMID:19281266
1305381	Relt	RELT, TNF receptor	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313376	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RELT mRNA	PMID:38568856
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313378	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of UBE2C mRNA	PMID:31863870
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of UBE2C mRNA	PMID:38218311
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313379	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of UBE2C mRNA	PMID:33045310
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2C mRNA	PMID:39752319
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of UBE2C mRNA	PMID:20938992
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of UBE2C mRNA	PMID:21934132
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20161025	CTD	MESH:D010100	Oxygen results in decreased expression of UBE2C mRNA	PMID:27103661
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of UBE2C mRNA	PMID:17547211
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of UBE2C mRNA	PMID:12414654
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of UBE2C mRNA	PMID:35877022
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in increased expression of UBE2C mRNA]	PMID:19442820
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of UBE2C mRNA	PMID:16474171
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of UBE2C mRNA	PMID:20826375|PMID:27623287
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBE2C mRNA	PMID:32741896
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA	PMID:25510870
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313378	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of UBE2C mRNA	PMID:38568856
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of UBE2C mRNA	PMID:33387578
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of UBE2C mRNA	PMID:25549359
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of UBE2C mRNA	PMID:20938992
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:16827	corticosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003345	Corticosterone results in decreased expression of UBE2C mRNA	PMID:15755911
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313378	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of UBE2C mRNA	PMID:21179406
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of UBE2C mRNA	PMID:26079696
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UBE2C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420|PMID:37992649
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2C mRNA	PMID:39752319
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of UBE2C mRNA	PMID:21592394
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBE2C mRNA	PMID:32741896
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of UBE2C mRNA	PMID:21592394
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17356	2-acetamidofluorene	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of UBE2C mRNA	PMID:22584684
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of UBE2C mRNA	PMID:17317680
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17356	2-acetamidofluorene	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D015073	TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of UBE2C mRNA]	PMID:17317680
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in increased expression of UBE2C mRNA]	PMID:19442820
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of UBE2C mRNA	PMID:27683099
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:174627	2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20210706	CTD	MESH:C088115	anacardic acid inhibits the reaction [[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein]	PMID:27129209
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:175901	gemcitabine	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in decreased expression of UBE2C mRNA	PMID:17039268
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UBE2C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420|PMID:37992649
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of UBE2C mRNA	PMID:16949557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313378	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of UBE2C mRNA	PMID:23825647
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20161213	CTD	MESH:D009538	Tubocurarine inhibits the reaction [Nicotine results in decreased expression of UBE2C mRNA]	PMID:16949557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UBE2C mRNA	PMID:33789034
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of UBE2C mRNA	PMID:26577399
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of UBE2C mRNA	PMID:21592394
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of UBE2C mRNA	PMID:21592394
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of UBE2C mRNA	PMID:22061828
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:17924	D-glucitol	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20240305	CTD	MESH:D013012	Sorbitol results in decreased expression of UBE2C mRNA	PMID:35678645
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UBE2C mRNA	PMID:36331819
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of UBE2C mRNA	PMID:38301995
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of UBE2C mRNA	PMID:16949557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313378	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of UBE2C mRNA	PMID:23825647
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20161213	CTD	MESH:D009538	Tubocurarine inhibits the reaction [Nicotine results in decreased expression of UBE2C mRNA]	PMID:16949557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:2038	5-azacytidine	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D001374	[Azacitidine co-treated with Thalidomide] affects the expression of UBE2C mRNA	PMID:18720364
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of UBE2C mRNA	PMID:21120746
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA	PMID:25510870
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA	PMID:25510870
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of UBE2C mRNA	PMID:19549813
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UBE2C mRNA	PMID:22129741
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of UBE2C mRNA	PMID:23630614|PMID:25378103
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of UBE2C mRNA	PMID:17547211
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of UBE2C mRNA	PMID:25102026
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of UBE2C mRNA	PMID:32553695
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of UBE2C mRNA	PMID:19555225
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of UBE2C mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of UBE2C mRNA	PMID:27106289|PMID:34911549
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:2687	amsacrine	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20161213	CTD	MESH:D000677	Amsacrine results in decreased expression of UBE2C mRNA	PMID:17374387
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1313378	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of UBE2C mRNA	PMID:22171008
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of UBE2C mRNA	PMID:17484886
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of UBE2C mRNA	PMID:31150632
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313379	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE2C mRNA	PMID:27339419|PMID:29987408
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UBE2C mRNA	PMID:25629700
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of UBE2C mRNA	PMID:24657277
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of UBE2C mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of UBE2C mRNA]	PMID:20938992|PMID:22206623
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2C mRNA	PMID:39836092
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D000966	Antimony Potassium Tartrate results in increased expression of UBE2C mRNA	PMID:17547211
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1313378	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of UBE2C mRNA	PMID:33512557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of UBE2C mRNA	PMID:28189721|PMID:28960355
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of UBE2C mRNA	PMID:31881176
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of UBE2C mRNA	PMID:22023808
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of UBE2C mRNA	PMID:27392435|PMID:27594783
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of UBE2C mRNA	PMID:40618947
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of UBE2C mRNA	PMID:21151649
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28073	chromium atom	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D002857	Chromium results in increased expression of UBE2C mRNA	PMID:17547211
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein affects the expression of UBE2C mRNA alternative form	PMID:18847459
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of UBE2C mRNA	PMID:16474171
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2C mRNA	PMID:34747641
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313378	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2C mRNA	PMID:22298810
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313379	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2C mRNA	PMID:21570461
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE2C mRNA	PMID:32109520|PMID:33387578
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE2C mRNA	PMID:21802500
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE2C mRNA	PMID:15034205
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2C mRNA	PMID:21215274
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313378	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2C mRNA	PMID:20106945|PMID:21496263
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313379	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2C mRNA	PMID:21496263|PMID:26290441
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2C mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of UBE2C mRNA]	PMID:15034205|PMID:17942748
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of UBE2C mRNA	PMID:28374803
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313378	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of UBE2C mRNA	PMID:33512557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of UBE2C mRNA	PMID:20061341
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1313378	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of UBE2C mRNA	PMID:24834073
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of UBE2C mRNA	PMID:23649840
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in decreased expression of UBE2C mRNA	PMID:17374387
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of UBE2C mRNA	PMID:30556269
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of UBE2C mRNA	PMID:20971185
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20170516	CTD	MESH:D004317	Doxorubicin results in decreased expression of UBE2C mRNA; Doxorubicin results in decreased expression of UBE2C protein	PMID:27129209|PMID:29803840|PMID:38447685
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of UBE2C mRNA	PMID:39631538
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20170516	CTD	MESH:D004317	[Doxorubicin results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein; TP53 protein inhibits the reaction [Doxorubicin results in decreased expression of UBE2C protein]	PMID:27129209
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UBE2C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420|PMID:37992649
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of UBE2C mRNA	PMID:12414654
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of UBE2C mRNA	PMID:22623647
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBE2C mRNA	PMID:38568856
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBE2C mRNA	PMID:17998272
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2C mRNA; TP53 protein affects the reaction [sodium arsenite results in increased expression of UBE2C mRNA]	PMID:16966095|PMID:39836092
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of UBE2C mRNA	PMID:22378314
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE2C mRNA	PMID:20064835|PMID:21802500
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE2C mRNA	PMID:15034205
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBE2C mRNA	PMID:32417428|PMID:35678645
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of UBE2C mRNA]	PMID:15034205
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of UBE2C mRNA	PMID:18929588
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to UBE2C mRNA]	PMID:32406909
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of UBE2C mRNA]	PMID:18929588
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of UBE2C mRNA	PMID:30556269
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of UBE2C mRNA	PMID:20971185
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:30145	lithium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of UBE2C mRNA	PMID:21711903
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:30146	lithium hydride	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of UBE2C mRNA	PMID:21711903
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1313378	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of UBE2C mRNA	PMID:22171008
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:30304	antimony(0)	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D000965	Antimony results in increased expression of UBE2C mRNA	PMID:17547211
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313379	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of UBE2C mRNA	PMID:29341224
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of UBE2C mRNA	PMID:20382639|PMID:26238291
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313378	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UBE2C mRNA	PMID:17547211
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:3090	bicalutamide	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20190219	CTD	MESH:C053541	[Niclosamide co-treated with bicalutamide] results in decreased expression of UBE2C mRNA	PMID:28500234
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of UBE2C mRNA	PMID:25729387
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of UBE2C mRNA	PMID:30047161
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of UBE2C mRNA	PMID:24136188
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313379	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBE2C promoter	PMID:35295148
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of UBE2C mRNA	PMID:30012374
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313379	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of UBE2C mRNA	PMID:23557971
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313379	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of UBE2C promoter	PMID:35295148
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UBE2C mRNA	PMID:34492290
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313379	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of UBE2C mRNA	PMID:18301758|PMID:21318169|PMID:23811191
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of UBE2C mRNA]	PMID:21318169
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of UBE2C mRNA	PMID:19191707
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of UBE2C mRNA	PMID:38479592
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of UBE2C mRNA	PMID:19490990|PMID:30903817
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2C mRNA	PMID:25181051
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2C mRNA; bisphenol A results in decreased expression of UBE2C protein	PMID:29275510|PMID:37567409
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2C mRNA	PMID:16474171
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2C mRNA	PMID:20826375
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of UBE2C mRNA	PMID:20826375
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of UBE2C mRNA	PMID:26682919
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA	PMID:25510870
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA	PMID:25510870
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of UBE2C mRNA	PMID:20713471
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of UBE2C mRNA	PMID:20713471
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of UBE2C mRNA	PMID:39298647
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313378	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of UBE2C mRNA	PMID:27685785
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of UBE2C mRNA	PMID:26377693
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of UBE2C mRNA	PMID:22546817
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20180116	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UBE2C mRNA	PMID:28973377
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of UBE2C mRNA	PMID:22546817
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UBE2C mRNA	PMID:22129741
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of UBE2C mRNA	PMID:24535843
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:C022838	nickel chloride results in increased expression of UBE2C mRNA	PMID:17547211
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313378	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBE2C mRNA	PMID:37042841
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of UBE2C mRNA	PMID:26377693
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of UBE2C mRNA	PMID:18500788
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of UBE2C mRNA	PMID:30723492
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UBE2C mRNA	PMID:25993096
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UBE2C mRNA	PMID:20061341
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313378	E	RGD:6480464	20160210	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE2C protein	PMID:26220685
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:1313379	E	RGD:6480464	20250204	CTD	MESH:C012125	diisononyl phthalate results in increased expression of UBE2C mRNA	PMID:33391822
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of UBE2C mRNA	PMID:36326898
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313379	E	RGD:6480464	20240305	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of UBE2C mRNA	PMID:35678645
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of UBE2C mRNA	PMID:25539665
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of UBE2C mRNA	PMID:30047161
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313379	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of UBE2C mRNA	PMID:22698814
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of UBE2C mRNA	PMID:24386269
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of UBE2C mRNA	PMID:19320972
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of UBE2C mRNA	PMID:40194260
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1313378	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of UBE2C mRNA	PMID:33512557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of UBE2C mRNA	PMID:31533062
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of UBE2C mRNA	PMID:39529242
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UBE2C mRNA	PMID:36331819
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of UBE2C mRNA	PMID:23125180
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of UBE2C mRNA	PMID:31558096
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20130611	CTD	MESH:D003474	Curcumin results in decreased expression of UBE2C mRNA; Curcumin results in decreased expression of UBE2C protein	PMID:22258452|PMID:38348716
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of UBE2C mRNA	PMID:41580965
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of UBE2C mRNA	PMID:30047161
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of UBE2C mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1313378	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of UBE2C mRNA	PMID:33512557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of UBE2C mRNA	PMID:17555576
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of UBE2C mRNA	PMID:21658437
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in decreased expression of UBE2C mRNA	PMID:16671099
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of UBE2C mRNA	PMID:28973697
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in increased expression of UBE2C mRNA	PMID:16570282
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313379	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of UBE2C mRNA	PMID:28973697
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UBE2C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420|PMID:37992649
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1313378	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of UBE2C mRNA	PMID:33512557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of UBE2C mRNA	PMID:23649840
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D008727	Methotrexate results in decreased expression of UBE2C mRNA	PMID:24136188
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in decreased expression of UBE2C mRNA	PMID:17374387
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of UBE2C mRNA	PMID:24657277
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:44423	hydroxyurea	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in decreased expression of UBE2C mRNA	PMID:17374387
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of UBE2C mRNA	PMID:24136188
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of UBE2C mRNA	PMID:33387578
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313378	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of UBE2C mRNA	PMID:22230336
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of UBE2C mRNA; Fluorouracil results in decreased expression of UBE2C protein	PMID:16557594|PMID:17039268|PMID:17374387|PMID:27129209
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20170516	CTD	MESH:D005472	[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein; anacardic acid inhibits the reaction [[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein]; CDKN1A protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; CDKN1A protein affects the reaction [Fluorouracil results in decreased expression of UBE2C protein]; Fluorouracil inhibits the reaction [NFYA protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [EP300 protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [TP53 protein mutant form binds to UBE2C promoter]; TP53 protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C protein]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]]	PMID:27129209
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of UBE2C mRNA	PMID:24714768
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2C mRNA	PMID:39836092
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in decreased expression of UBE2C mRNA	PMID:18175754|PMID:24383545
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of UBE2C mRNA	PMID:17555576
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UBE2C mRNA	PMID:17942748
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2C mRNA	PMID:17942748
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in decreased expression of UBE2C mRNA; Etoposide results in decreased expression of UBE2C protein	PMID:17374387|PMID:27129209
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20170516	CTD	MESH:D005047	[Etoposide results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein; CDKN1A protein affects the reaction [Etoposide results in decreased expression of UBE2C protein]; TP53 protein affects the reaction [Etoposide results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Etoposide results in decreased expression of UBE2C protein]	PMID:27129209
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313378	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UBE2C mRNA	PMID:17547211
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1313379	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of UBE2C mRNA	PMID:25270620
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1313378	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of UBE2C mRNA	PMID:33512557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313379	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UBE2C mRNA; Nanotubes, Carbon results in increased expression of UBE2C mRNA	PMID:25554681
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of UBE2C mRNA	PMID:30047161
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of UBE2C mRNA	PMID:24140754
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of UBE2C mRNA	PMID:19042947
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D011192	Potassium Dichromate results in increased expression of UBE2C mRNA	PMID:17547211
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313379	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of UBE2C mRNA	PMID:38701926
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UBE2C protein	PMID:32959892
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of UBE2C mRNA	PMID:25729387
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of UBE2C mRNA	PMID:25729387
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of UBE2C mRNA	PMID:24136188
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of UBE2C mRNA	PMID:23650126
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of UBE2C mRNA	PMID:24136188
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of UBE2C mRNA	PMID:28988120
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of UBE2C mRNA	PMID:12414654
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of UBE2C mRNA	PMID:37269647
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of UBE2C mRNA	PMID:24810058
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of UBE2C mRNA	PMID:17547211
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of UBE2C mRNA	PMID:35283115
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of UBE2C mRNA	PMID:37939859
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D008694	Methamphetamine results in decreased expression of UBE2C mRNA	PMID:28341135
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D008701	Methapyrilene results in increased expression of UBE2C mRNA	PMID:22484513|PMID:22584684
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:68534	enzalutamide	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20210608	CTD	MESH:C540278	[enzalutamide co-treated with NVP-BHG712] results in decreased expression of UBE2C mRNA	PMID:32184358
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2C mRNA	PMID:39752319
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313379	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of UBE2C mRNA	PMID:22206623
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of UBE2C mRNA]	PMID:22206623
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of UBE2C protein	PMID:37664457
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:749016	gossypol acetic acid	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of UBE2C protein	PMID:29938581
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of UBE2C mRNA	PMID:20061341
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of UBE2C mRNA	PMID:27225895
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of UBE2C mRNA	PMID:27225895
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of UBE2C mRNA	PMID:29522793
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1313379	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of UBE2C mRNA	PMID:27858113
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of UBE2C mRNA	PMID:28500234
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:7553	niclosamide	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20191114	CTD	MESH:D009534	[Niclosamide co-treated with bicalutamide] results in decreased expression of UBE2C mRNA	PMID:28500234
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of UBE2C mRNA	PMID:29877212
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBE2C mRNA	PMID:32741896
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of UBE2C mRNA	PMID:32858204
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of UBE2C mRNA	PMID:23358140|PMID:38301995
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of UBE2C mRNA	PMID:34995734
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in decreased expression of UBE2C mRNA	PMID:20097248
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of UBE2C mRNA; Irinotecan results in decreased expression of UBE2C mRNA	PMID:15956246
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of UBE2C mRNA	PMID:31324951
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313379	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of UBE2C mRNA	PMID:19363144|PMID:19482888|PMID:20403969|PMID:23091169
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of UBE2C mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of UBE2C mRNA]	PMID:19482888|PMID:24535843
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313379	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of UBE2C mRNA	PMID:38648751
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1313378	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of UBE2C mRNA	PMID:33512557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	ISO	RGD:1313378	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of UBE2C mRNA	PMID:24834073
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1313378	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of UBE2C mRNA	PMID:33512557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313379	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of UBE2C mRNA	PMID:39847705
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of UBE2C mRNA	PMID:21278054
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of UBE2C mRNA	PMID:24780913|PMID:30047161
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of UBE2C mRNA	PMID:22869556
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2C mRNA	PMID:39752319
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of UBE2C protein	PMID:37664457
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of UBE2C mRNA	PMID:19281266
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1313378	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of UBE2C mRNA	PMID:33512557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:9513	thalidomide	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20120412	CTD	MESH:D013792	[Azacitidine co-treated with Thalidomide] affects the expression of UBE2C mRNA	PMID:18720364
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313378	E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in increased expression of UBE2C mRNA	PMID:19442820
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20121113	CTD	MESH:D019284	caffeic acid promotes the reaction [Thapsigargin results in increased expression of UBE2C mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in increased expression of UBE2C mRNA]	PMID:19442820
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of UBE2C mRNA	PMID:19140230
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:9763	trovafloxacin	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of UBE2C mRNA	PMID:24136188
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:9774	tubocurarine	decreases expression	ISO	RGD:1313378	E	RGD:6480464	20120515	CTD	MESH:D014403	Tubocurarine results in decreased expression of UBE2C mRNA	PMID:16949557
1305382	Ube2c	ubiquitin-conjugating enzyme E2C	gene	CHEBI:9774	tubocurarine	multiple interactions	ISO	RGD:1313378	E	RGD:6480464	20120515	CTD	MESH:D014403	Tubocurarine inhibits the reaction [Nicotine results in decreased expression of UBE2C mRNA]	PMID:16949557
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ARHGDIB mRNA	PMID:38218311
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of ARHGDIB mRNA	PMID:21551480
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ARHGDIB mRNA	PMID:35967413
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313380	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ARHGDIB mRNA	PMID:27188386
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313380	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGDIB mRNA	PMID:17218384|PMID:23830798|PMID:33167477
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ARHGDIB mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ARHGDIB mRNA	PMID:32699268
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:15555	prostaglandin D2	increases cleavage	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:D015230	Prostaglandin D2 results in increased cleavage of ARHGDIB protein	PMID:15843042
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of ARHGDIB mRNA	PMID:15282401
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313380	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ARHGDIB mRNA	PMID:26079696
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16240	hydrogen peroxide	increases cleavage	EXP		E	RGD:6480464	20161213	CTD	MESH:D006861	Hydrogen Peroxide results in increased cleavage of ARHGDIB protein	PMID:16647178
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D006861	Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of ARHGDIB protein]	PMID:16647178
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16243	quercetin	increases cleavage	ISO	RGD:1313380	E	RGD:6480464	20170110	CTD	MESH:D011794	Quercetin results in increased cleavage of ARHGDIB protein	PMID:12874837
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313380	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ARHGDIB mRNA	PMID:21632981
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of ARHGDIB protein]	PMID:16647178
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:D011794	[Quercetin co-treated with Ascorbic Acid] results in increased expression of ARHGDIB mRNA	PMID:17639512
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313381	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ARHGDIB mRNA	PMID:27339419|PMID:39241906
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313380	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ARHGDIB mRNA	PMID:30510588
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313380	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol affects the expression of ARHGDIB mRNA	PMID:25321415
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGDIB mRNA	PMID:39298647
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of ARHGDIB mRNA	PMID:29980752
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ARHGDIB mRNA	PMID:23649840
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313380	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ARHGDIB mRNA	PMID:26079696
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ARHGDIB mRNA	PMID:33448797
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGDIB mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA]	PMID:33448797|PMID:37992649
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ARHGDIB mRNA	PMID:33448797
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGDIB mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA]	PMID:33448797|PMID:37992649
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313380	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ARHGDIB mRNA	PMID:31163220
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ARHGDIB mRNA	PMID:22061828
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:18152	myricetin	increases cleavage	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:C040015	myricetin results in increased cleavage of ARHGDIB protein	PMID:15748703
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA	PMID:39836092
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ARHGDIB protein	PMID:34915118
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20200609	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGDIB mRNA	PMID:31738976
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGDIB mRNA	PMID:29950665
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARHGDIB protein	PMID:21527772
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ARHGDIB mRNA	PMID:23649840
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ARHGDIB mRNA	PMID:21527772
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARHGDIB mRNA	PMID:21527772
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ARHGDIB mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ARHGDIB mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ARHGDIB mRNA	PMID:32699268
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARHGDIB mRNA	PMID:34911549
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313381	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARHGDIB mRNA	PMID:27339419|PMID:31919559
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:27485	prostaglandin J2	increases cleavage	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:C037112	9-deoxy-delta-9-prostaglandin D2 results in increased cleavage of ARHGDIB protein	PMID:15843042
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313380	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ARHGDIB gene	PMID:25304211
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARHGDIB mRNA	PMID:39836092
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of ARHGDIB mRNA	PMID:21527772
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313380	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ARHGDIB mRNA	PMID:26272509
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA	PMID:27188386
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ARHGDIB mRNA	PMID:31881176
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ARHGDIB mRNA	PMID:27594783
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ARHGDIB mRNA	PMID:27392435
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of ARHGDIB mRNA	PMID:18930951
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28009	N-acetyl-beta-D-glucosamine	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of ARHGDIB mRNA	PMID:18047607
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of ARHGDIB gene	PMID:28505145
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313380	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ARHGDIB mRNA	PMID:25583101
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGDIB mRNA	PMID:34747641
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313381	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGDIB mRNA	PMID:21570461
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313381	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARHGDIB mRNA	PMID:31961203
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313380	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ARHGDIB mRNA	PMID:28001369
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of ARHGDIB mRNA	PMID:21198554
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of ARHGDIB mRNA	PMID:30556269
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper results in decreased expression of ARHGDIB protein	PMID:23882024
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313381	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ARHGDIB protein	PMID:28918527
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGDIB mRNA	PMID:29803840
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGDIB mRNA	PMID:39631538
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGDIB mRNA	PMID:37992649
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29073	L-ascorbic acid	increases expression	ISO	RGD:1313381	E	RGD:6480464	20120501	CTD	MESH:D001205	Ascorbic Acid results in increased expression of ARHGDIB protein	PMID:22139585
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:D001205	[Quercetin co-treated with Ascorbic Acid] results in increased expression of ARHGDIB mRNA	PMID:17639512
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGDIB mRNA	PMID:12634122|PMID:12727804|PMID:38568856|PMID:39719251
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARHGDIB mRNA; sodium arsenite results in decreased expression of and affects the splicing of ARHGDIB mRNA	PMID:25879800|PMID:39836092
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA	PMID:34876320
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA	PMID:34876320
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313380	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARHGDIB 5' UTR; Benzo(a)pyrene affects the methylation of ARHGDIB promoter	PMID:27901495
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARHGDIB mRNA	PMID:21569818
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313381	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARHGDIB mRNA	PMID:22228805
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313380	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ARHGDIB 3' UTR	PMID:27901495
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ARHGDIB mRNA]	PMID:22228805
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ARHGDIB mRNA]	PMID:32406909
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of ARHGDIB mRNA	PMID:30556269
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper results in decreased expression of ARHGDIB protein	PMID:23882024
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313381	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ARHGDIB mRNA	PMID:27131904
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313381	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ARHGDIB mRNA	PMID:29341224
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313380	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ARHGDIB mRNA	PMID:20458559
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of ARHGDIB mRNA	PMID:24136188
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313381	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ARHGDIB mRNA	PMID:23557971
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGDIB mRNA	PMID:29950665
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ARHGDIB mRNA	PMID:34492290
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ARHGDIB mRNA	PMID:25380136
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ARHGDIB mRNA	PMID:17426115
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARHGDIB mRNA	PMID:25181051
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGDIB mRNA	PMID:29275510
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGDIB mRNA; bisphenol A results in decreased expression of ARHGDIB protein	PMID:33221593|PMID:35999755
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313381	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARHGDIB promoter	PMID:27312807
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGDIB mRNA	PMID:34947998
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313381	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGDIB mRNA	PMID:30951980|PMID:32156529
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of ARHGDIB gene	PMID:28505145
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ARHGDIB mRNA	PMID:39298647
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313381	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ARHGDIB mRNA	PMID:30951980
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313380	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ARHGDIB intron	PMID:30157460
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313381	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ARHGDIB mRNA	PMID:30951980
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313381	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ARHGDIB mRNA	PMID:28392331
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of ARHGDIB protein	PMID:35999755
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313381	E	RGD:6480464	20140211	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ARHGDIB mRNA	PMID:23894361
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGDIB mRNA	PMID:29950665
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARHGDIB mRNA	PMID:21266533
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313381	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ARHGDIB mRNA	PMID:34813904
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313381	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ARHGDIB mRNA	PMID:34813904
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313380	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGDIB mRNA	PMID:37042841
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ARHGDIB mRNA	PMID:35163327
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of ARHGDIB mRNA	PMID:26678675
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA	PMID:39836092
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARHGDIB mRNA	PMID:33453195
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313380	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARHGDIB mRNA	PMID:38382870|PMID:38568856
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20200609	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGDIB mRNA	PMID:31738976
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARHGDIB mRNA	PMID:19320972
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of ARHGDIB mRNA	PMID:25380136
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ARHGDIB mRNA	PMID:24449571
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ARHGDIB mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ARHGDIB mRNA	PMID:32699268
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:37187	lead nitrate	increases expression	ISO	RGD:1313381	E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate results in increased expression of ARHGDIB protein	PMID:20435106
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ARHGDIB mRNA	PMID:31533062
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of ARHGDIB mRNA	PMID:29038090
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of ARHGDIB mRNA	PMID:23125180
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARHGDIB mRNA]	PMID:18200517
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARHGDIB mRNA	PMID:29154799
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313380	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGDIB mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313381	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGDIB mRNA	PMID:24896083
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA	PMID:27188386
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ARHGDIB mRNA	PMID:41580965
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of ARHGDIB mRNA	PMID:21527772
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ARHGDIB mRNA	PMID:15171707
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ARHGDIB mRNA	PMID:33448797
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGDIB mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA]	PMID:33448797|PMID:37992649
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of ARHGDIB mRNA	PMID:17400583
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ARHGDIB mRNA	PMID:24136188
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313380	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARHGDIB mRNA	PMID:38832940
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:4488	diallyl disulfide	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide results in decreased expression of ARHGDIB mRNA; diallyl disulfide results in decreased expression of ARHGDIB protein	PMID:36793247
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:4488	diallyl disulfide	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20230801	CTD	MESH:C028009	ARHGDIB protein affects the reaction [diallyl disulfide results in decreased expression of CD33 protein]; ARHGDIB protein affects the reaction [diallyl disulfide results in increased expression of ITGAM protein]; ARHGDIB protein inhibits the reaction [diallyl disulfide results in decreased expression of LIMK1 protein]; ARHGDIB protein inhibits the reaction [diallyl disulfide results in decreased expression of PAK1 protein]; ARHGDIB protein inhibits the reaction [diallyl disulfide results in decreased expression of RAC1 protein]	PMID:36793247
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of ARHGDIB protein	PMID:20543569
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARHGDIB mRNA	PMID:17562736
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGDIB mRNA	PMID:33387578
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGDIB mRNA	PMID:21420995
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1313380	E	RGD:6480464	20211109	CTD	MESH:D005472	Fluorouracil affects the expression of ARHGDIB mRNA	PMID:34151400
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313380	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ARHGDIB gene	PMID:25304211
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARHGDIB mRNA	PMID:39836092
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide analog results in decreased expression of ARHGDIB protein	PMID:23882024
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ARHGDIB mRNA	PMID:31838189
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA	PMID:34876320
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARHGDIB mRNA	PMID:17557909
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of ARHGDIB mRNA	PMID:21527772
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA	PMID:27188386
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313380	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ARHGDIB mRNA	PMID:20458559
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1313380	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of ARHGDIB mRNA	PMID:38825487
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313381	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of ARHGDIB protein; Nanotubes, Carbon analog affects the expression of ARHGDIB mRNA	PMID:21135415|PMID:25554681
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:506227	N-acetyl-D-glucosamine	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of ARHGDIB mRNA	PMID:18047607
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ARHGDIB mRNA	PMID:30047161
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ARHGDIB mRNA	PMID:35964746
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ARHGDIB mRNA	PMID:24136188
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA]	PMID:33448797
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of ARHGDIB mRNA	PMID:18200517
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARHGDIB mRNA]	PMID:18200517
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313380	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ARHGDIB protein	PMID:23718831
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313381	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ARHGDIB mRNA	PMID:38701926
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1313380	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of ARHGDIB mRNA	PMID:20436886
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA	PMID:39836092
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313380	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ARHGDIB mRNA	PMID:28988120
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313381	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ARHGDIB mRNA	PMID:22776087
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:64317	isoprenaline	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D007545	Isoproterenol results in increased expression of ARHGDIB mRNA	PMID:30303030
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313380	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ARHGDIB intron	PMID:30157460
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313380	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ARHGDIB mRNA	PMID:31758290
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313380	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ARHGDIB mRNA	PMID:25912373
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313381	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARHGDIB mRNA	PMID:22206623
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ARHGDIB mRNA	PMID:22714537
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1313380	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ARHGDIB mRNA	PMID:36318118
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA	PMID:27188386
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:7852	oxycodone	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in decreased expression of ARHGDIB mRNA	PMID:23439660
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of ARHGDIB mRNA	PMID:19084549
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of ARHGDIB mRNA	PMID:19482888
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ARHGDIB mRNA]	PMID:19482888
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of ARHGDIB mRNA	PMID:26705709
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of ARHGDIB mRNA	PMID:12727804
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA	PMID:34876320
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARHGDIB mRNA	PMID:30047161
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1313380	E	RGD:6480464	20120918	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of ARHGDIB mRNA	PMID:20713136
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:90633	perfluorododecanoic acid	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in increased expression of ARHGDIB protein	PMID:19854247
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313380	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA	PMID:27188386
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313381	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ARHGDIB mRNA	PMID:27131904
1305383	Arhgdib	Rho GDP dissociation inhibitor beta	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ARHGDIB mRNA	PMID:19015723
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CPT1C mRNA	PMID:21551480
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:131843	meldonium	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20201103	CTD	MESH:C050147	3-(2,2,2-trimethylhydrazine)propionate results in decreased expression of CPT1C mRNA	PMID:32389661
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CPT1C mRNA	PMID:20188158
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313383	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CPT1C mRNA	PMID:26251327
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313383	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of CPT1C promoter	PMID:26251327
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313382	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CPT1C mRNA	PMID:21934132
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPT1C mRNA	PMID:30529165
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313382	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CPT1C mRNA	PMID:22378314
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20220705	CTD	MESH:D000431	Ethanol results in decreased expression of CPT1C mRNA	PMID:34995708
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CPT1C mRNA; withaferin A inhibits the reaction [Ethanol results in decreased expression of CPT1C mRNA]	PMID:30517762|PMID:34995708
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D011794	Quercetin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein]	PMID:33733575
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CPT1C mRNA	PMID:23829299
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CPT1C mRNA	PMID:33387578
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313382	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CPT1C mRNA	PMID:26079696
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of CPT1C mRNA	PMID:31606821
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CPT1C mRNA	PMID:33387578
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein; MIR21 promotes the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein]; Quercetin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein]	PMID:33733575
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313382	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CPT1C intron	PMID:30157460
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313383	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CPT1C mRNA	PMID:19770486
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CPT1C mRNA	PMID:30517762
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313383	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CPT1C mRNA	PMID:28960355
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313382	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CPT1C mRNA	PMID:23557933
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313383	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in increased expression of CPT1C mRNA	PMID:25270620
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313383	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CPT1C mRNA	PMID:21570461
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CPT1C mRNA	PMID:33387578
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPT1C mRNA	PMID:17942748
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313382	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CPT1C mRNA	PMID:33212167
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313383	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in increased expression of CPT1C mRNA	PMID:26873546
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20160607	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of CPT1C mRNA	PMID:26873546
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1C mRNA	PMID:23783067
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313382	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CPT1C mRNA	PMID:22714537
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of CPT1C mRNA	PMID:38359550
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20251007	CTD	MESH:C017947	Ketoglutaric Acids inhibits the reaction [sodium arsenite results in decreased expression of CPT1C mRNA]	PMID:38359550
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313382	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of CPT1C mRNA	PMID:22378314
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CPT1C mRNA	PMID:22228805
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313382	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CPT1C 5' UTR	PMID:27901495
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313383	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of CPT1C mRNA; Benzo(a)pyrene results in increased expression of CPT1C mRNA	PMID:19770486|PMID:22610609|PMID:32553695
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313382	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CPT1C promoter	PMID:27901495
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA	PMID:27858113
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CPT1C mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CPT1C mRNA	PMID:37105096
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CPT1C mRNA	PMID:25181051
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313382	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of CPT1C mRNA	PMID:29275510
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CPT1C gene	PMID:28505145
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CPT1C mRNA	PMID:36041667
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20250311	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CPT1C protein	PMID:39197524
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20250311	CTD	MESH:C023035	[Palm Oil co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in decreased expression of CPT1C protein	PMID:39197524
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313383	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CPT1C gene	PMID:31683443
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CPT1C mRNA	PMID:36041667
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA	PMID:27858113
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313382	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CPT1C exon	PMID:30157460
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CPT1C mRNA	PMID:38685157
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CPT1C mRNA	PMID:36041667
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein; MIR21 promotes the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein]; Quercetin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein]	PMID:33733575
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313383	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CPT1C mRNA	PMID:40194260
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313383	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CPT1C mRNA	PMID:17963808
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313382	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CPT1C gene	PMID:29154799
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313383	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CPT1C mRNA	PMID:28973697
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313382	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CPT1C mRNA	PMID:28542535
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313382	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CPT1C mRNA	PMID:24935251|PMID:26272509
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313382	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPT1C mRNA	PMID:27188386
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CPT1C mRNA	PMID:33387578
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313383	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CPT1C mRNA	PMID:17555576
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPT1C mRNA	PMID:17942748
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1313383	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of CPT1C mRNA	PMID:25270620
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:50223	(+)-dexrazoxane	increases expression	ISO	RGD:1313383	E	RGD:6480464	20170303	CTD	MESH:D064730	Dexrazoxane results in increased expression of CPT1C mRNA	PMID:26873546
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20170303	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of CPT1C mRNA	PMID:26873546
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313383	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of CPT1C mRNA	PMID:40234311
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA	PMID:27858113
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA	PMID:27858113
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:52717	bortezomib	increases response to substance	ISO	RGD:1313382	E	RGD:6480464	20170303	CTD	MESH:D000069286	CPT1C gene SNP results in increased susceptibility to Bortezomib	PMID:20864405
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313382	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of CPT1C mRNA	PMID:22714537
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1C mRNA	PMID:23783067
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313382	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CPT1C exon	PMID:30157460
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:68656	raspberry ketone	increases expression	ISO	RGD:1313383	E	RGD:6480464	20230404	CTD	MESH:C035522	raspberry ketone results in increased expression of CPT1C mRNA	PMID:36460224
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:69120	withaferin A	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20220705	CTD	MESH:C009684	withaferin A inhibits the reaction [Ethanol results in decreased expression of CPT1C mRNA]	PMID:34995708
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313382	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CPT1C mRNA	PMID:31758290
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313383	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CPT1C mRNA	PMID:22206623
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313382	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPT1C mRNA	PMID:27188386
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313382	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CPT1C gene]	PMID:28238834
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1313382	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of CPT1C mRNA	PMID:39904859
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CPT1C mRNA	PMID:23640034
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CPT1C mRNA	PMID:37926403
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of CPT1C mRNA	PMID:40826991
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:88249	PD 0325901	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:C506614	mirdametinib inhibits the reaction [polyphyllin I inhibits the reaction [Dietary Fats results in decreased expression of CPT1C protein]]	PMID:36120828
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313382	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPT1C mRNA	PMID:27188386
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CPT1C mRNA	PMID:19281266
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of CPT1C mRNA	PMID:31606821
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313382	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of CPT1C mRNA	PMID:22378314
1305384	Cpt1c	carnitine palmitoyltransferase 1c	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C032910	triadimefon results in decreased expression of CPT1C mRNA; triadimefon results in decreased expression of CPT1C protein	PMID:36179991
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of HROB mRNA	PMID:33167477
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1622992	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HROB mRNA	PMID:39241906
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HROB mRNA	PMID:32741896
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of HROB mRNA	PMID:33387578
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of HROB mRNA	PMID:21592394
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HROB mRNA	PMID:32741896
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1602101	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of HROB mRNA	PMID:21592394
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1602101	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of HROB protein	PMID:37730182
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of HROB mRNA	PMID:21592394
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1602101	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of HROB mRNA	PMID:21592394
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HROB mRNA	PMID:33387578
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HROB mRNA	PMID:19549813
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1602101	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HROB mRNA	PMID:22100608
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1602101	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of HROB mRNA	PMID:23649840
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1622992	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HROB mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HROB mRNA	PMID:34911549
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of HROB mRNA	PMID:31129395
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602101	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HROB mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HROB mRNA	PMID:32525701|PMID:40512198
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1602101	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HROB mRNA	PMID:27392435
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1602101	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HROB mRNA	PMID:27392435
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HROB mRNA	PMID:33387578
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1602101	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HROB mRNA	PMID:33212167
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of HROB mRNA	PMID:32763439
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HROB mRNA	PMID:29803840
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HROB mRNA	PMID:38568856
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602101	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HROB mRNA	PMID:40512198
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602101	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HROB promoter	PMID:27901495
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1602101	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HROB mRNA	PMID:32234424
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1622992	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of HROB mRNA	PMID:29341224
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HROB mRNA	PMID:25181051
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of HROB mRNA	PMID:27685785|PMID:29275510
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of HROB mRNA	PMID:32145629
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602101	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of HROB mRNA	PMID:36232920
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of HROB mRNA	PMID:31129395
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1622992	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of HROB mRNA	PMID:28392331
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HROB mRNA	PMID:33453195
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HROB mRNA	PMID:31533062
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1622992	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of HROB mRNA	PMID:39529242
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1602101	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HROB mRNA	PMID:38832940
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of HROB mRNA	PMID:29067470
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HROB mRNA	PMID:33387578
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1602101	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of HROB mRNA	PMID:22230336
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602101	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HROB mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HROB mRNA	PMID:32525701|PMID:40512198
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1622992	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of HROB mRNA	PMID:38701926
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of HROB mRNA	PMID:37269647
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1602101	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of HROB mRNA	PMID:24810058
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1622992	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of HROB mRNA	PMID:36851058
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1602101	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of HROB mRNA	PMID:27918106
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1602101	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of HROB mRNA	PMID:22714537
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1602101	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of HROB protein	PMID:31285264
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HROB mRNA	PMID:32741896
1305385	Hrob	homologous recombination factor with OB-fold	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1602101	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HROB mRNA	PMID:32525701
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550269	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of FNBP1L mRNA	PMID:33045310
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FNBP1L mRNA	PMID:33167477
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FNBP1L mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FNBP1L mRNA	PMID:32699268
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1550269	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of FNBP1L mRNA	PMID:40945087
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1346897	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FNBP1L mRNA	PMID:20044591
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1346897	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of FNBP1L protein	PMID:35688186
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1346897	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in increased expression of FNBP1L mRNA	PMID:21632981
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1346897	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of FNBP1L mRNA	PMID:29581250
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550269	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FNBP1L mRNA	PMID:39298647
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550269	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FNBP1L mRNA	PMID:25510870
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1346897	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of FNBP1L mRNA	PMID:23649840
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of FNBP1L mRNA	PMID:33359661
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550269	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FNBP1L mRNA	PMID:33754040
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1346897	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FNBP1L protein	PMID:37730182
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1346897	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of FNBP1L mRNA	PMID:16002434
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1346897	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FNBP1L mRNA	PMID:28818685
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FNBP1L mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of FNBP1L mRNA	PMID:39836092
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550269	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FNBP1L mRNA	PMID:25510870
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550269	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FNBP1L mRNA	PMID:25510870
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1346897	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in increased expression of FNBP1L mRNA	PMID:19549813
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346897	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FNBP1L gene	PMID:27153756
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550269	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FNBP1L mRNA	PMID:19770486
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1346897	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FNBP1L mRNA	PMID:23649840
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1346897	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of FNBP1L mRNA	PMID:25102026
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FNBP1L mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FNBP1L mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of FNBP1L mRNA	PMID:32699268
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550269	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FNBP1L mRNA	PMID:27339419|PMID:31919559
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FNBP1L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FNBP1L mRNA	PMID:39836092
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1346897	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of FNBP1L protein	PMID:35688186
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1346897	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of FNBP1L mRNA	PMID:28903495
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1550269	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of FNBP1L mRNA	PMID:40618947
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of FNBP1L mRNA	PMID:25583101
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550269	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FNBP1L mRNA	PMID:21570461
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FNBP1L mRNA	PMID:33387578|PMID:34747641
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FNBP1L mRNA	PMID:32109520
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1346897	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FNBP1L mRNA	PMID:21632981
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550269	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FNBP1L mRNA	PMID:17942748
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FNBP1L mRNA	PMID:33212167
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1346897	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of FNBP1L mRNA	PMID:30851411
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of FNBP1L mRNA	PMID:28959563
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of FNBP1L mRNA	PMID:30556269
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1346897	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of FNBP1L protein	PMID:35688186
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of FNBP1L mRNA	PMID:28595984|PMID:34032870|PMID:39719251
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550269	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of FNBP1L mRNA	PMID:37682722
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FNBP1L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FNBP1L mRNA	PMID:39836092
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FNBP1L mRNA	PMID:20064835
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1346897	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FNBP1L promoter	PMID:27901495
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346897	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FNBP1L 3' UTR	PMID:27901495
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to FNBP1L mRNA]	PMID:32406909
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of FNBP1L mRNA	PMID:30556269
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FNBP1L mRNA	PMID:19150397
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of FNBP1L mRNA	PMID:15761015
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FNBP1L gene	PMID:31601247
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550269	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FNBP1L gene	PMID:35295148
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550269	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of FNBP1L mRNA	PMID:23557971
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550269	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FNBP1L gene	PMID:35295148
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of FNBP1L mRNA	PMID:23411599|PMID:34492290
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FNBP1L mRNA	PMID:19710929
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FNBP1L mRNA	PMID:25181051
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of FNBP1L mRNA	PMID:30816183
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FNBP1L gene	PMID:31601247
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1346897	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of FNBP1L mRNA	PMID:25979313
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550269	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FNBP1L mRNA	PMID:25510870
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550269	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FNBP1L mRNA	PMID:25510870
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1550269	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of FNBP1L mRNA	PMID:39298647
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550269	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of FNBP1L mRNA	PMID:38685157
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1346897	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of FNBP1L mRNA	PMID:22905168
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550269	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of FNBP1L mRNA	PMID:21266533
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346897	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FNBP1L mRNA	PMID:37042841
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FNBP1L mRNA	PMID:35163327
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FNBP1L mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of FNBP1L mRNA	PMID:39836092
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FNBP1L mRNA	PMID:38568856
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1550269	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FNBP1L mRNA	PMID:24982889
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FNBP1L mRNA	PMID:35163327
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of FNBP1L gene	PMID:22079235
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1346897	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FNBP1L mRNA	PMID:24449571
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1550269	E	RGD:6480464	20130806	CTD	MESH:D002922	Ciguatoxins affects the expression of FNBP1L mRNA	PMID:18353800
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FNBP1L mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FNBP1L mRNA	PMID:32699268
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1346897	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FNBP1L mRNA	PMID:31533062
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20130806	CTD	MESH:D003375	Coumestrol results in decreased expression of FNBP1L mRNA	PMID:19167446
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20130806	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1L mRNA	PMID:19167446
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of FNBP1L mRNA	PMID:40419075
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550269	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FNBP1L mRNA	PMID:17963808
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of FNBP1L mRNA	PMID:29427782
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of FNBP1L mRNA	PMID:23179753
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of FNBP1L mRNA	PMID:30047161
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of FNBP1L mRNA	PMID:27989131
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346897	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FNBP1L mRNA	PMID:25562108
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550269	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of FNBP1L mRNA	PMID:17555576
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550269	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FNBP1L mRNA	PMID:28973697
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550269	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FNBP1L mRNA	PMID:29279043
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FNBP1L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FNBP1L mRNA	PMID:39836092
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20130806	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FNBP1L mRNA	PMID:22079256
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of FNBP1L mRNA	PMID:18175754
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550269	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FNBP1L mRNA	PMID:17555576
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550269	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FNBP1L mRNA	PMID:17942748
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550269	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FNBP1L mRNA	PMID:17942748
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of FNBP1L mRNA	PMID:15761015
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550269	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FNBP1L mRNA	PMID:25554681
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of FNBP1L mRNA	PMID:30047161
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FNBP1L protein	PMID:32959892
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FNBP1L mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of FNBP1L mRNA	PMID:39836092
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1346897	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of FNBP1L mRNA	PMID:28988120
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1346897	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of FNBP1L mRNA	PMID:31758290
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1346897	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FNBP1L mRNA	PMID:22079256
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FNBP1L mRNA	PMID:22079256
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1346897	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of FNBP1L mRNA	PMID:20816883
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1346897	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of FNBP1L mRNA	PMID:30851411
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FNBP1L gene]	PMID:28238834
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1346897	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1L mRNA	PMID:19167446
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1550269	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of FNBP1L mRNA	PMID:39847705
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FNBP1L mRNA	PMID:30047161
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FNBP1L mRNA	PMID:24780913
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of FNBP1L protein	PMID:35544339
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of FNBP1L mRNA	PMID:30047161
1305386	Fnbp1l	formin binding protein 1-like	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1550269	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of FNBP1L mRNA	PMID:35537566
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1551494	E	RGD:6480464	20171010	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of HSDL2 mRNA	PMID:28558994
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HSDL2 mRNA]	PMID:31150632
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1350650	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of HSDL2 mRNA	PMID:21934132
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:15521	lauroyl-CoA	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20150414	CTD	MESH:C050466	[lauroyl-coenzyme A co-treated with NADP] binds to HSDL2 protein	PMID:25526675
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20190611	CTD	MESH:D019308	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of HSDL2 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of HSDL2 mRNA	PMID:30547786
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20190611	CTD	MESH:D019301	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of HSDL2 mRNA; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of HSDL2 mRNA	PMID:30547786
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1551494	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of HSDL2 mRNA	PMID:30319688
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of HSDL2 mRNA	PMID:32145629
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551494	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of HSDL2 mRNA	PMID:39298647
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20150414	CTD	MESH:D004958	[Estradiol co-treated with NADP] binds to HSDL2 protein	PMID:25526675
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1551494	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in increased expression of HSDL2 mRNA	PMID:28973375
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350650	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HSDL2 mRNA	PMID:37042841
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:166802	22-Hydroxycholesterol	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20201208	CTD	MESH:C003585	[22-hydroxycholesterol co-treated with NADP] binds to HSDL2 protein	PMID:25526675
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1350650	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of HSDL2 mRNA	PMID:23649840
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551494	E	RGD:6480464	20200915	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of HSDL2 mRNA	PMID:32522588
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of HSDL2 mRNA	PMID:33359661
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1551494	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of HSDL2 mRNA	PMID:23892564
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551494	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HSDL2 mRNA	PMID:19850644
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20120412	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSDL2 mRNA; PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of HSDL2 mRNA]	PMID:19850644|PMID:39150890
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:18009	NADP(+)	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20150414	CTD	MESH:D009249	[22-hydroxycholesterol co-treated with NADP] binds to HSDL2 protein; [decanoyl-coenzyme A co-treated with NADP] binds to HSDL2 protein; [Estradiol co-treated with NADP] binds to HSDL2 protein; [lauroyl-coenzyme A co-treated with NADP] binds to HSDL2 protein; NADP binds to and results in increased activity of HSDL2 protein	PMID:25526675
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HSDL2 mRNA	PMID:36331819
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of HSDL2 mRNA	PMID:39836092
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of HSDL2 mRNA	PMID:21515302
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1350650	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of HSDL2 mRNA	PMID:24376830
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSDL2 mRNA	PMID:37236586
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HSDL2 mRNA	PMID:19549813
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1350650	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of HSDL2 mRNA	PMID:23649840
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of HSDL2 mRNA	PMID:22129741
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551494	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HSDL2 mRNA	PMID:19770486
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1350650	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of HSDL2 mRNA	PMID:23649840
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of HSDL2 mRNA	PMID:19483382
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HSDL2 mRNA	PMID:31150632
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HSDL2 mRNA]	PMID:31150632
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HSDL2 mRNA	PMID:22206623
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HSDL2 mRNA	PMID:31881176
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of HSDL2 mRNA	PMID:23557933
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of HSDL2 mRNA	PMID:22023808
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1350650	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HSDL2 mRNA	PMID:27392435|PMID:27594783
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HSDL2 mRNA	PMID:27392435
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1350650	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HSDL2 mRNA	PMID:22298810
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HSDL2 mRNA	PMID:21215274|PMID:34747641
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551494	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HSDL2 mRNA	PMID:19770486
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSDL2 mRNA	PMID:33387578
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1350650	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSDL2 mRNA	PMID:20106945|PMID:21632981
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551494	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSDL2 mRNA	PMID:19465110
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of HSDL2 mRNA	PMID:28374803
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1350650	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HSDL2 protein	PMID:33212167
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:28493	decanoyl-CoA	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20150414	CTD	MESH:C045561	[decanoyl-coenzyme A co-treated with NADP] binds to HSDL2 protein	PMID:25526675
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1350650	E	RGD:6480464	20120412	CTD	MESH:D004317	HSDL2 protein affects the susceptibility to Doxorubicin	PMID:16217747
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551494	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of HSDL2 mRNA	PMID:26873546
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of HSDL2 mRNA	PMID:22623647
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551494	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HSDL2 mRNA	PMID:19770486
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of HSDL2 mRNA	PMID:19483382
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of HSDL2 mRNA	PMID:24136188
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of HSDL2 mRNA	PMID:21515302
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of HSDL2 mRNA	PMID:24136188
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551494	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HSDL2 gene; titanium dioxide results in decreased methylation of HSDL2 promoter	PMID:35295148
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of HSDL2 mRNA	PMID:19483382
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HSDL2 mRNA	PMID:34492290
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of HSDL2 mRNA	PMID:19483382
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C006253	pirinixic acid results in increased expression of HSDL2 mRNA	PMID:32741897
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551494	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of HSDL2 mRNA	PMID:17426115|PMID:18301758|PMID:18445702|PMID:23811191
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of HSDL2 mRNA	PMID:30903817
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1350650	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of HSDL2 mRNA	PMID:30903817
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HSDL2 mRNA	PMID:25181051|PMID:34947998
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of HSDL2 protein	PMID:34186270
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551494	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of HSDL2 mRNA	PMID:33221593
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1350650	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of HSDL2 protein	PMID:37567409
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34283	oxybenzone	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in decreased expression of HSDL2 mRNA	PMID:30316929
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1350650	E	RGD:6480464	20120501	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of HSDL2 mRNA	PMID:19692669
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551494	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HSDL2 mRNA	PMID:39298647
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1350650	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of HSDL2 protein	PMID:34186270
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1350650	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of HSDL2 protein	PMID:34186270
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1551494	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of HSDL2 mRNA	PMID:38685157
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1350650	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of HSDL2 protein	PMID:34186270
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSDL2 mRNA	PMID:39150890
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSDL2 mRNA	PMID:39150890
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSDL2 mRNA	PMID:39150890
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of HSDL2 mRNA	PMID:22129741
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1551494	E	RGD:6480464	20190507	CTD	MESH:D026023	Permethrin results in increased expression of HSDL2 mRNA	PMID:30629241
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350650	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HSDL2 mRNA	PMID:37042841
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of HSDL2 mRNA	PMID:39836092
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HSDL2 mRNA	PMID:38568856
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSDL2 mRNA	PMID:37236586
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSDL2 mRNA	PMID:39150890
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of HSDL2 mRNA; perfluorooctanoic acid results in increased expression of HSDL2 protein	PMID:28511854|PMID:34958885
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1551494	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of HSDL2 mRNA	PMID:28558994|PMID:30711707
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of HSDL2 mRNA	PMID:24386269
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1551494	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of HSDL2 mRNA	PMID:28962523
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of HSDL2 mRNA	PMID:19483382
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:3750	clofibrate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate results in increased expression of HSDL2 mRNA; Clofibrate results in increased expression of HSDL2 protein	PMID:16470657|PMID:32741897
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1551494	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of HSDL2 mRNA	PMID:17585979|PMID:23811191|PMID:30629241
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of HSDL2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HSDL2 mRNA]	PMID:17585979
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1551494	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HSDL2 mRNA	PMID:28558994
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of HSDL2 mRNA	PMID:28302478
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1551494	E	RGD:6480464	20171010	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HSDL2 mRNA	PMID:28558994
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20171010	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HSDL2 mRNA; PPARA protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of HSDL2 mRNA]	PMID:28558994|PMID:36331819
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350650	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HSDL2 mRNA	PMID:25979313
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1551494	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of HSDL2 mRNA	PMID:17292431
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in decreased expression of HSDL2 mRNA	PMID:23527032
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1551494	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of HSDL2 mRNA	PMID:21427059
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1350650	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of HSDL2 mRNA	PMID:23179753|PMID:24935251|PMID:27188386|PMID:29154799
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1551494	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of HSDL2 mRNA	PMID:21427059
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of HSDL2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1551494	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of HSDL2 mRNA	PMID:19770486
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1551494	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of HSDL2 mRNA	PMID:28973697
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:44409	NADP zwitterion	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20150414	CTD	MESH:D009249	[22-hydroxycholesterol co-treated with NADP] binds to HSDL2 protein; [decanoyl-coenzyme A co-treated with NADP] binds to HSDL2 protein; [Estradiol co-treated with NADP] binds to HSDL2 protein; [lauroyl-coenzyme A co-treated with NADP] binds to HSDL2 protein; NADP binds to and results in increased activity of HSDL2 protein	PMID:25526675
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of HSDL2 mRNA	PMID:24136188
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1350650	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of HSDL2 mRNA	PMID:28542535
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1350650	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of HSDL2 mRNA	PMID:24935251
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1350650	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen affects the expression of HSDL2 mRNA	PMID:25704631
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HSDL2 mRNA	PMID:33387578
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of HSDL2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HSDL2 mRNA]	PMID:17585979
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of HSDL2 mRNA	PMID:22079256
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of HSDL2 mRNA	PMID:19483382
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D011345	Fenofibrate results in increased expression of HSDL2 mRNA	PMID:32741897
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of HSDL2 mRNA	PMID:19194470
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of HSDL2 mRNA	PMID:24136188
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of HSDL2 mRNA	PMID:35964746
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HSDL2 protein	PMID:32959892
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:61057	tacrolimus hydrate	decreases expression	ISO	RGD:1551494	E	RGD:6480464	20150127	CTD	MESH:D016559	Tacrolimus results in decreased expression of HSDL2 mRNA	PMID:25270620
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of HSDL2 mRNA	PMID:39836092
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1551494	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of HSDL2 mRNA	PMID:27225895
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:63618	pravastatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of HSDL2 mRNA	PMID:27225895
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:63630	tolcapone	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in increased expression of HSDL2 mRNA	PMID:24136188
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of HSDL2 mRNA	PMID:24136188
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of HSDL2 mRNA	PMID:24136188
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1350650	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of HSDL2 protein	PMID:34186270
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:73726	GW 501516	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20170303	CTD	MESH:C425931	[GW 501516 binds to PPARD protein] which results in increased expression of HSDL2 mRNA	PMID:16197558
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551494	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HSDL2 mRNA	PMID:22206623
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HSDL2 mRNA	PMID:22206623
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of HSDL2 mRNA	PMID:24136188
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:75170	zaragozic acid A	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of HSDL2 mRNA	PMID:27225895
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1551494	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of HSDL2 mRNA	PMID:27225895
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1350650	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of HSDL2 mRNA	PMID:22079256
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1350650	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of HSDL2 mRNA	PMID:22079256
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of HSDL2 mRNA	PMID:19483382
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of HSDL2 mRNA	PMID:19483382
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1551494	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSDL2 mRNA	PMID:39150890
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of HSDL2 mRNA	PMID:23640034
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of HSDL2 mRNA	PMID:19483382
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of HSDL2 mRNA; troglitazone results in increased expression of HSDL2 protein	PMID:21315101|PMID:21515302
1305387	Hsdl2	hydroxysteroid dehydrogenase like 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of HSDL2 mRNA	PMID:19015723
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1604837	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of JOSD1 mRNA	PMID:38218311
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D004237	Diuron results in increased expression of JOSD1 mRNA	PMID:21551480
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604837	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of JOSD1 mRNA	PMID:33167477
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1604837	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of JOSD1 mRNA	PMID:24763279
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313390	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of JOSD1 mRNA	PMID:39241906
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313390	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of JOSD1 mRNA	PMID:39298647
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604837	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of JOSD1 mRNA	PMID:37042841
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1604837	E	RGD:6480464	20130618	CTD	MESH:D001554	Benzene results in increased expression of JOSD1 mRNA	PMID:19162166
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1313390	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of JOSD1 mRNA	PMID:28973375
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313390	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of JOSD1 mRNA	PMID:34319233
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1604837	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of JOSD1 protein	PMID:37730182
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of JOSD1 mRNA	PMID:39012411
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604837	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of JOSD1 mRNA	PMID:23649840
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1604837	E	RGD:6480464	20130618	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of JOSD1 mRNA	PMID:18593933
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313390	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of JOSD1 mRNA	PMID:22206623
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604837	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of JOSD1 gene	PMID:25304211
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1604837	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of JOSD1 protein	PMID:35688186
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1604837	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of JOSD1 mRNA	PMID:27594783
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1604837	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of JOSD1 mRNA	PMID:23195993
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313390	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of JOSD1 mRNA	PMID:18343893|PMID:21570461
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of JOSD1 mRNA	PMID:33387578
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313390	E	RGD:6480464	20150825	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of JOSD1 mRNA	PMID:15328365|PMID:21889950|PMID:23994337|PMID:25975270
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313390	E	RGD:6480464	20130806	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of JOSD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of JOSD1 mRNA	PMID:16214954|PMID:25975270
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604837	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of JOSD1 mRNA	PMID:33212167
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1604837	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of JOSD1 mRNA	PMID:32763439
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604837	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of JOSD1 mRNA	PMID:38568856
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604837	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of JOSD1 promoter	PMID:27901495
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1604837	E	RGD:6480464	20130618	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of JOSD1 mRNA	PMID:18593933
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313390	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of JOSD1 gene	PMID:35295148
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313390	E	RGD:6480464	20130806	CTD	MESH:C006253	pirinixic acid results in increased expression of JOSD1 mRNA	PMID:18301758
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1604837	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of JOSD1 mRNA	PMID:30903817
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of JOSD1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1313390	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JOSD1 mRNA	PMID:23994337
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313390	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of JOSD1 mRNA	PMID:39298647
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313390	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of JOSD1 mRNA	PMID:21266533
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of JOSD1 mRNA	PMID:39012411
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1604837	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of JOSD1 mRNA	PMID:31533062
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604837	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of JOSD1 mRNA	PMID:25979313
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604837	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of JOSD1 mRNA	PMID:29154799
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1604837	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of JOSD1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604837	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of JOSD1 mRNA	PMID:29067470
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1604837	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of JOSD1 mRNA	PMID:20977926
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604837	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of JOSD1 gene	PMID:25304211
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of JOSD1 mRNA	PMID:24136188
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of JOSD1 mRNA	PMID:24136188
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313390	E	RGD:6480464	20130806	CTD	MESH:C017096	n-butoxyethanol results in increased expression of JOSD1 mRNA	PMID:19812364
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of JOSD1 mRNA	PMID:24136188
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313390	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of JOSD1 mRNA	PMID:22206623
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of JOSD1 mRNA	PMID:24136188
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313390	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of JOSD1 mRNA	PMID:23994337
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604837	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to JOSD1 gene]	PMID:28238834
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313390	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of JOSD1 mRNA	PMID:18343893
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20130618	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of JOSD1 mRNA	PMID:21346803
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of JOSD1 mRNA	PMID:24136188
1305388	Josd1	Josephin domain containing 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1604837	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of JOSD1 mRNA	PMID:38568856
1305390	Plk4	polo-like kinase 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313393	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PLK4 mRNA	PMID:33045310
1305390	Plk4	polo-like kinase 4	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLK4 mRNA	PMID:39752319
1305390	Plk4	polo-like kinase 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of PLK4 mRNA	PMID:15498508|PMID:33167477
1305390	Plk4	polo-like kinase 4	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of PLK4 mRNA	PMID:26516004
1305390	Plk4	polo-like kinase 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PLK4 mRNA	PMID:39241906
1305390	Plk4	polo-like kinase 4	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in increased expression of PLK4 mRNA]	PMID:19442820
1305390	Plk4	polo-like kinase 4	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of PLK4 mRNA	PMID:15598610
1305390	Plk4	polo-like kinase 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313392	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of PLK4 mRNA	PMID:16474171|PMID:19167446
1305390	Plk4	polo-like kinase 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313393	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of PLK4 mRNA	PMID:25210133
1305390	Plk4	polo-like kinase 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of PLK4 mRNA]	PMID:25210133
1305390	Plk4	polo-like kinase 4	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313392	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PLK4 mRNA	PMID:38568856
1305390	Plk4	polo-like kinase 4	gene	CHEBI:16827	corticosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003345	Corticosterone results in decreased expression of PLK4 mRNA	PMID:15755911
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of PLK4 mRNA	PMID:17251523
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313392	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PLK4 mRNA	PMID:21179406
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of PLK4 mRNA	PMID:26079696
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:37992649
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLK4 mRNA	PMID:39752319
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PLK4 mRNA	PMID:21592394
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of PLK4 mRNA]	PMID:20032058
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of PLK4 mRNA	PMID:21592394
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in increased expression of PLK4 mRNA]	PMID:19442820
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:37992649
1305390	Plk4	polo-like kinase 4	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PLK4 mRNA	PMID:26577399|PMID:27523638
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of PLK4 mRNA	PMID:21592394
1305390	Plk4	polo-like kinase 4	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of PLK4 mRNA	PMID:21592394
1305390	Plk4	polo-like kinase 4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1305390	Plk4	polo-like kinase 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLK4 mRNA	PMID:28111341
1305390	Plk4	polo-like kinase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLK4 mRNA	PMID:23630614
1305390	Plk4	polo-like kinase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313392	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLK4 mRNA	PMID:22100608
1305390	Plk4	polo-like kinase 4	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of PLK4 mRNA	PMID:25102026
1305390	Plk4	polo-like kinase 4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120501	CTD	MESH:D010126	Ozone results in increased expression of PLK4 mRNA	PMID:12763052|PMID:19555225
1305390	Plk4	polo-like kinase 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PLK4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PLK4 mRNA	PMID:34911549
1305390	Plk4	polo-like kinase 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313393	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PLK4 mRNA	PMID:31919559
1305390	Plk4	polo-like kinase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1305390	Plk4	polo-like kinase 4	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PLK4 mRNA	PMID:31881176
1305390	Plk4	polo-like kinase 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of PLK4 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of PLK4 mRNA	PMID:19167446|PMID:23557933
1305390	Plk4	polo-like kinase 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin promotes the reaction [Piroxicam results in decreased expression of PLK4 mRNA]	PMID:21858171
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313392	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of PLK4 mRNA	PMID:16474171
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313393	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLK4 mRNA	PMID:21570461
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLK4 mRNA	PMID:33387578|PMID:34747641
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLK4 mRNA	PMID:17942748
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of PLK4 mRNA	PMID:28374803
1305390	Plk4	polo-like kinase 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PLK4 mRNA	PMID:33212167
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PLK4 mRNA	PMID:32763439
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PLK4 mRNA	PMID:26033743
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:26033743
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PLK4 mRNA	PMID:30031762
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:37992649
1305390	Plk4	polo-like kinase 4	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PLK4 mRNA	PMID:29432896
1305390	Plk4	polo-like kinase 4	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313392	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite affects the expression of PLK4 mRNA	PMID:29301061
1305390	Plk4	polo-like kinase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PLK4 mRNA	PMID:38568856
1305390	Plk4	polo-like kinase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1305390	Plk4	polo-like kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313392	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLK4 mRNA	PMID:32234424
1305390	Plk4	polo-like kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLK4 mRNA	PMID:20713471|PMID:32417428
1305390	Plk4	polo-like kinase 4	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PLK4 mRNA	PMID:26033743
1305390	Plk4	polo-like kinase 4	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:26033743
1305390	Plk4	polo-like kinase 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PLK4 mRNA	PMID:23806026
1305390	Plk4	polo-like kinase 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PLK4 mRNA	PMID:20382639
1305390	Plk4	polo-like kinase 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PLK4 mRNA	PMID:26705709
1305390	Plk4	polo-like kinase 4	gene	CHEBI:30966	glycidol	affects expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol affects the expression of PLK4 mRNA	PMID:24395379
1305390	Plk4	polo-like kinase 4	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of PLK4 mRNA	PMID:21829687
1305390	Plk4	polo-like kinase 4	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of PLK4 mRNA	PMID:22641619
1305390	Plk4	polo-like kinase 4	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of PLK4 mRNA	PMID:25729387
1305390	Plk4	polo-like kinase 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLK4 mRNA	PMID:25729387
1305390	Plk4	polo-like kinase 4	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of PLK4 mRNA	PMID:15498508
1305390	Plk4	polo-like kinase 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313393	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLK4 gene	PMID:35295148
1305390	Plk4	polo-like kinase 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013853	Thioacetamide results in increased expression of PLK4 mRNA	PMID:22659510|PMID:34492290
1305390	Plk4	polo-like kinase 4	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PLK4 mRNA	PMID:12832660
1305390	Plk4	polo-like kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of PLK4 mRNA	PMID:26982218|PMID:30816183|PMID:32528016
1305390	Plk4	polo-like kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PLK4 mRNA	PMID:29275510
1305390	Plk4	polo-like kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLK4 mRNA	PMID:25181051|PMID:32145629
1305390	Plk4	polo-like kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313392	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of PLK4 mRNA	PMID:16474171
1305390	Plk4	polo-like kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313393	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PLK4 mRNA	PMID:26063408
1305390	Plk4	polo-like kinase 4	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313393	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of PLK4 mRNA	PMID:26682919
1305390	Plk4	polo-like kinase 4	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of PLK4 mRNA	PMID:20713471
1305390	Plk4	polo-like kinase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PLK4 mRNA	PMID:40203079
1305390	Plk4	polo-like kinase 4	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PLK4 mRNA	PMID:37019170
1305390	Plk4	polo-like kinase 4	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of PLK4 mRNA	PMID:22546817
1305390	Plk4	polo-like kinase 4	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of PLK4 mRNA	PMID:22546817
1305390	Plk4	polo-like kinase 4	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PLK4 mRNA	PMID:17854601
1305390	Plk4	polo-like kinase 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of PLK4 mRNA]	PMID:17854601
1305390	Plk4	polo-like kinase 4	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of PLK4 mRNA	PMID:22546817
1305390	Plk4	polo-like kinase 4	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20190219	CTD	MESH:D010269	[ATG7 protein affects the susceptibility to Paraquat] which affects the expression of PLK4 mRNA	PMID:28012437
1305390	Plk4	polo-like kinase 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313392	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLK4 mRNA	PMID:37042841
1305390	Plk4	polo-like kinase 4	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of PLK4 mRNA	PMID:26678675
1305390	Plk4	polo-like kinase 4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1305390	Plk4	polo-like kinase 4	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PLK4 mRNA	PMID:30723492
1305390	Plk4	polo-like kinase 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PLK4 mRNA	PMID:38174414
1305390	Plk4	polo-like kinase 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313392	E	RGD:6480464	20241105	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PLK4 protein	PMID:38185225
1305390	Plk4	polo-like kinase 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20241105	CTD	MESH:D019256	Cadmium Chloride promotes the reaction [[CCDC85C protein binds to PLK4 protein] which results in increased localization of CCDC85C protein]; Cadmium Chloride promotes the reaction [[CCDC85C protein binds to PLK4 protein] which results in increased localization of PLK4 protein]; Cadmium Chloride promotes the reaction [CCDC85C protein binds to PLK4 protein]; Cadmium Chloride results in increased expression of and results in increased localization of PLK4 protein; CCDC85C protein promotes the reaction [Cadmium Chloride results in increased expression of PLK4 protein]; CCDC85C protein promotes the reaction [Cadmium Chloride results in increased localization of PLK4 protein]; GCLM protein promotes the reaction [Cadmium Chloride results in increased expression of PLK4 protein]; PLK4 protein promotes the reaction [Cadmium Chloride results in increased localization of PLK4 protein]	PMID:38185225
1305390	Plk4	polo-like kinase 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLK4 mRNA	PMID:28111341
1305390	Plk4	polo-like kinase 4	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PLK4 mRNA	PMID:36326898
1305390	Plk4	polo-like kinase 4	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of PLK4 mRNA	PMID:25539665
1305390	Plk4	polo-like kinase 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PLK4 mRNA	PMID:24449571
1305390	Plk4	polo-like kinase 4	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PLK4 mRNA	PMID:40194260
1305390	Plk4	polo-like kinase 4	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PLK4 mRNA	PMID:28302478
1305390	Plk4	polo-like kinase 4	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PLK4 mRNA	PMID:31533062
1305390	Plk4	polo-like kinase 4	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313392	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of PLK4 mRNA	PMID:19167446
1305390	Plk4	polo-like kinase 4	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of PLK4 mRNA	PMID:19167446
1305390	Plk4	polo-like kinase 4	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PLK4 mRNA	PMID:39529242
1305390	Plk4	polo-like kinase 4	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of PLK4 mRNA	PMID:22110744
1305390	Plk4	polo-like kinase 4	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1313392	E	RGD:6480464	20151110	CTD	MESH:D003474	Curcumin analog results in increased expression of PLK4 mRNA	PMID:26409325
1305390	Plk4	polo-like kinase 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313392	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLK4 mRNA	PMID:25979313
1305390	Plk4	polo-like kinase 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLK4 mRNA	PMID:23179753|PMID:27188386
1305390	Plk4	polo-like kinase 4	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of PLK4 mRNA	PMID:41580965
1305390	Plk4	polo-like kinase 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of PLK4 mRNA	PMID:20106945|PMID:21632981|PMID:22147139
1305390	Plk4	polo-like kinase 4	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in decreased expression of PLK4 mRNA	PMID:20032058
1305390	Plk4	polo-like kinase 4	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of PLK4 mRNA]	PMID:20032058
1305390	Plk4	polo-like kinase 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PLK4 mRNA	PMID:28973697
1305390	Plk4	polo-like kinase 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313393	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PLK4 mRNA	PMID:28973697
1305390	Plk4	polo-like kinase 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:37992649
1305390	Plk4	polo-like kinase 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PLK4 mRNA	PMID:18502557
1305390	Plk4	polo-like kinase 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313392	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PLK4 mRNA	PMID:38832940
1305390	Plk4	polo-like kinase 4	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313392	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PLK4 mRNA	PMID:27188386
1305390	Plk4	polo-like kinase 4	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of PLK4 mRNA	PMID:15000894
1305390	Plk4	polo-like kinase 4	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313392	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PLK4 mRNA	PMID:28542535
1305390	Plk4	polo-like kinase 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLK4 mRNA	PMID:33387578
1305390	Plk4	polo-like kinase 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLK4 mRNA	PMID:26690555
1305390	Plk4	polo-like kinase 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313392	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PLK4 mRNA	PMID:22230336
1305390	Plk4	polo-like kinase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1305390	Plk4	polo-like kinase 4	gene	CHEBI:4744	Echimidine	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PLK4 mRNA	PMID:33884520
1305390	Plk4	polo-like kinase 4	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of PLK4 mRNA	PMID:40706910
1305390	Plk4	polo-like kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PLK4 mRNA	PMID:17351261
1305390	Plk4	polo-like kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PLK4 mRNA	PMID:17942748
1305390	Plk4	polo-like kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLK4 mRNA	PMID:17942748
1305390	Plk4	polo-like kinase 4	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PLK4 mRNA	PMID:26705709
1305390	Plk4	polo-like kinase 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313393	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PLK4 mRNA; Nanotubes, Carbon results in increased expression of PLK4 mRNA	PMID:25554681
1305390	Plk4	polo-like kinase 4	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of PLK4 mRNA	PMID:41580965
1305390	Plk4	polo-like kinase 4	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of PLK4 mRNA	PMID:21148553
1305390	Plk4	polo-like kinase 4	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PLK4 mRNA	PMID:19042947
1305390	Plk4	polo-like kinase 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1305390	Plk4	polo-like kinase 4	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLK4 mRNA	PMID:21641980
1305390	Plk4	polo-like kinase 4	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PLK4 mRNA	PMID:25729387
1305390	Plk4	polo-like kinase 4	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLK4 mRNA	PMID:25729387
1305390	Plk4	polo-like kinase 4	gene	CHEBI:6382	Lasiocarpine	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PLK4 mRNA	PMID:33884520
1305390	Plk4	polo-like kinase 4	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of PLK4 mRNA	PMID:19812364
1305390	Plk4	polo-like kinase 4	gene	CHEBI:63924	riddelliine	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PLK4 mRNA	PMID:33884520
1305390	Plk4	polo-like kinase 4	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PLK4 mRNA	PMID:23650126
1305390	Plk4	polo-like kinase 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PLK4 mRNA	PMID:37269647
1305390	Plk4	polo-like kinase 4	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of PLK4 mRNA	PMID:33884520
1305390	Plk4	polo-like kinase 4	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLK4 mRNA	PMID:39752319
1305390	Plk4	polo-like kinase 4	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of PLK4 mRNA	PMID:29522793
1305390	Plk4	polo-like kinase 4	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313392	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PLK4 mRNA	PMID:37199045
1305390	Plk4	polo-like kinase 4	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of PLK4 mRNA	PMID:28960945
1305390	Plk4	polo-like kinase 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313393	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PLK4 mRNA	PMID:23091169
1305390	Plk4	polo-like kinase 4	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK4 mRNA	PMID:19167446
1305390	Plk4	polo-like kinase 4	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of PLK4 mRNA	PMID:21858171
1305390	Plk4	polo-like kinase 4	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin promotes the reaction [Piroxicam results in decreased expression of PLK4 mRNA]	PMID:21858171
1305390	Plk4	polo-like kinase 4	gene	CHEBI:82615	diminazene diaceturate	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20240604	CTD	MESH:C003915	diminazene aceturate results in decreased expression of PLK4 mRNA	PMID:37681557
1305390	Plk4	polo-like kinase 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLK4 mRNA	PMID:24780913
1305390	Plk4	polo-like kinase 4	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLK4 mRNA	PMID:39752319
1305390	Plk4	polo-like kinase 4	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of PLK4 mRNA	PMID:32419051
1305390	Plk4	polo-like kinase 4	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313392	E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in increased expression of PLK4 mRNA	PMID:19442820
1305390	Plk4	polo-like kinase 4	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1313392	E	RGD:6480464	20121113	CTD	MESH:D019284	4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in increased expression of PLK4 mRNA]; caffeic acid promotes the reaction [Thapsigargin results in increased expression of PLK4 mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in increased expression of PLK4 mRNA]	PMID:19442820
1305390	Plk4	polo-like kinase 4	gene	CHEBI:9607	Tiron	increases expression	ISO	RGD:1313392	E	RGD:6480464	20200211	CTD	MESH:D014013	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt results in increased expression of PLK4 protein	PMID:22785532
1305390	Plk4	polo-like kinase 4	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313392	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of PLK4 mRNA	PMID:19140230
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313395	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NAP1L4 mRNA	PMID:33045310
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1313394	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of NAP1L4 protein	PMID:35688186
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313395	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NAP1L4 mRNA	PMID:39241906
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313394	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of NAP1L4 mRNA	PMID:23019147
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NAP1L4 mRNA	PMID:33387578
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313395	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NAP1L4 mRNA	PMID:34319233
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313394	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NAP1L4 protein	PMID:37730182
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NAP1L4 mRNA	PMID:22061828
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NAP1L4 mRNA	PMID:39836092
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313394	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NAP1L4 3' UTR	PMID:30157460
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313394	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NAP1L4 mRNA	PMID:23649840
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	ISO	RGD:1313394	E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of NAP1L4 protein	PMID:19845377
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313395	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of NAP1L4 mRNA	PMID:12763052
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NAP1L4 mRNA	PMID:34911549
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of NAP1L4 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of NAP1L4 protein	PMID:38598786
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of NAP1L4 mRNA	PMID:30779732
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NAP1L4 mRNA	PMID:25629700
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAP1L4 mRNA	PMID:22206623
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313394	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NAP1L4 gene	PMID:25304211
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NAP1L4 mRNA	PMID:40504410
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NAP1L4 protein	PMID:38460933
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NAP1L4 mRNA	PMID:23557933
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313394	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of NAP1L4 mRNA	PMID:27392435
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313394	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of NAP1L4 mRNA	PMID:16705744
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313394	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NAP1L4 mRNA	PMID:22574217
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313395	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NAP1L4 mRNA	PMID:21570461
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1313394	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of NAP1L4 protein	PMID:29385562
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313394	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NAP1L4 mRNA	PMID:38568856
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313395	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of NAP1L4 protein	PMID:29044176
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NAP1L4 mRNA	PMID:40504410
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313394	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NAP1L4 5' UTR; Benzo(a)pyrene results in decreased methylation of NAP1L4 promoter	PMID:27901495
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313394	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NAP1L4 mRNA	PMID:19150397
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1313394	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of NAP1L4 mRNA	PMID:34408198
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NAP1L4 gene	PMID:31601247
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313395	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NAP1L4 gene	PMID:35295148
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of NAP1L4 mRNA	PMID:18648102
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NAP1L4 mRNA	PMID:19710929
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NAP1L4 mRNA	PMID:34947998
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313394	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NAP1L4 mRNA; bisphenol A results in decreased expression of NAP1L4 protein	PMID:29275510|PMID:31675489
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NAP1L4 mRNA	PMID:25181051|PMID:41034487
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313394	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of NAP1L4 protein	PMID:37567409
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313395	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of NAP1L4 mRNA	PMID:26063408
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NAP1L4 gene	PMID:31601247
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313394	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of NAP1L4 mRNA	PMID:25979313
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313395	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NAP1L4 mRNA	PMID:39298647
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NAP1L4 mRNA	PMID:28628672
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313394	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NAP1L4 3' UTR	PMID:30157460
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAP1L4 mRNA	PMID:28628672
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAP1L4 mRNA	PMID:17361019
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of NAP1L4 mRNA	PMID:34813904
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of NAP1L4 protein	PMID:38598786
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAP1L4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NAP1L4 mRNA	PMID:28628672
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of NAP1L4 mRNA	PMID:34813904
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NAP1L4 mRNA	PMID:39836092
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313394	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NAP1L4 mRNA	PMID:26472689
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1313394	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of NAP1L4 protein	PMID:34122009
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313394	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NAP1L4 mRNA	PMID:19167446
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313395	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NAP1L4 mRNA	PMID:17292431
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAP1L4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NAP1L4 mRNA	PMID:28628672
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313395	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NAP1L4 mRNA	PMID:17562736
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NAP1L4 protein	PMID:38460933
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313394	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NAP1L4 gene	PMID:25304211
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NAP1L4 mRNA	PMID:40504410
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:47286	CU-O LINKAGE	increases phosphorylation	ISO	RGD:1313394	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased phosphorylation of NAP1L4 protein	PMID:25470785
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of NAP1L4 mRNA	PMID:35436446
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313395	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NAP1L4 mRNA	PMID:17942748
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAP1L4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NAP1L4 mRNA	PMID:28628672
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NAP1L4 mRNA	PMID:24136188
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of NAP1L4 mRNA	PMID:26377693
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313394	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NAP1L4 protein	PMID:32959892
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NAP1L4 mRNA	PMID:39836092
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NAP1L4 protein	PMID:26558463
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313394	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of NAP1L4 3' UTR	PMID:30157460
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313395	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of NAP1L4 mRNA	PMID:22206623
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAP1L4 mRNA	PMID:22206623
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NAP1L4 protein	PMID:37664457
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313394	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of NAP1L4 protein	PMID:39638853
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313395	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of NAP1L4 mRNA	PMID:31388691
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NAP1L4 protein	PMID:37664457
1305391	Nap1l4	nucleosome assembly protein 1-like 4	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313394	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of NAP1L4 protein	PMID:38598786
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313398	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TIGD3 mRNA	PMID:38218311
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550196	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TIGD3 mRNA	PMID:30319688
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313398	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TIGD3 mRNA	PMID:20044591
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550196	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TIGD3 mRNA	PMID:39241906
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in increased expression of TIGD3 mRNA]	PMID:20032058
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313398	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of TIGD3 mRNA	PMID:33647349
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TIGD3 mRNA	PMID:34319233
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313398	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TIGD3 mRNA	PMID:19549813
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313398	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TIGD3 mRNA	PMID:21641981
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313398	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TIGD3 mRNA	PMID:27392435
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TIGD3 mRNA	PMID:33387578
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TIGD3 mRNA	PMID:19933214
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313398	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of TIGD3 mRNA	PMID:29955902
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313398	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TIGD3 mRNA	PMID:32763439
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of TIGD3 mRNA	PMID:36209798
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313398	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TIGD3 mRNA	PMID:23806026
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313398	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TIGD3 mRNA	PMID:35984750
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of TIGD3 mRNA	PMID:24915197
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TIGD3 mRNA	PMID:29264374
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550196	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TIGD3 gene	PMID:35295148
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550196	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TIGD3 promoter	PMID:35295148
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TIGD3 mRNA	PMID:34492290
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TIGD3 mRNA	PMID:19167457
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TIGD3 mRNA	PMID:25181051|PMID:30816183
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of TIGD3 mRNA	PMID:30951980
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313398	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TIGD3 mRNA	PMID:37042841
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TIGD3 mRNA	PMID:39529242
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of TIGD3 mRNA	PMID:40633821
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of TIGD3 mRNA	PMID:20032058
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in increased expression of TIGD3 mRNA]	PMID:20032058
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313398	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TIGD3 mRNA	PMID:38832940
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313398	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of TIGD3 mRNA	PMID:24935251
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TIGD3 mRNA	PMID:33387578
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313398	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TIGD3 mRNA	PMID:28988120
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1313398	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of TIGD3 mRNA	PMID:36318118
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313398	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TIGD3 gene]	PMID:28238834
1305393	Tigd3	tigger transposable element derived 3	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of TIGD3 mRNA	PMID:29162477
1305394	Acy3	aminoacylase 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACY3 mRNA]	PMID:31150632
1305394	Acy3	aminoacylase 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1352202	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ACY3 mRNA	PMID:22378314
1305394	Acy3	aminoacylase 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ACY3 mRNA	PMID:39298647
1305394	Acy3	aminoacylase 3	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1352202	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ACY3 mRNA	PMID:36139627
1305394	Acy3	aminoacylase 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ACY3 mRNA	PMID:33387578
1305394	Acy3	aminoacylase 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1352202	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ACY3 mRNA	PMID:28818685
1305394	Acy3	aminoacylase 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of ACY3 protein	PMID:26597043
1305394	Acy3	aminoacylase 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1352202	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACY3 mRNA	PMID:35301059
1305394	Acy3	aminoacylase 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553036	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACY3 mRNA	PMID:37236586
1305394	Acy3	aminoacylase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACY3 mRNA	PMID:31150632
1305394	Acy3	aminoacylase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACY3 mRNA	PMID:31919559
1305394	Acy3	aminoacylase 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACY3 mRNA]	PMID:31150632
1305394	Acy3	aminoacylase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553036	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACY3 mRNA	PMID:22206623
1305394	Acy3	aminoacylase 3	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1352202	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ACY3 mRNA	PMID:38460933
1305394	Acy3	aminoacylase 3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ACY3 mRNA	PMID:31881176
1305394	Acy3	aminoacylase 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1352202	E	RGD:6480464	20220510	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of ACY3 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACY3 mRNA	PMID:23557933|PMID:41028656
1305394	Acy3	aminoacylase 3	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of ACY3 mRNA	PMID:20187946
1305394	Acy3	aminoacylase 3	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1553036	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of ACY3 mRNA	PMID:18930951
1305394	Acy3	aminoacylase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553036	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACY3 mRNA	PMID:21570461
1305394	Acy3	aminoacylase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACY3 mRNA	PMID:18796159|PMID:21215274
1305394	Acy3	aminoacylase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACY3 mRNA	PMID:21354282
1305394	Acy3	aminoacylase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACY3 mRNA	PMID:32109520
1305394	Acy3	aminoacylase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553036	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACY3 mRNA	PMID:17942748
1305394	Acy3	aminoacylase 3	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ACY3 mRNA	PMID:28374803
1305394	Acy3	aminoacylase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1352202	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ACY3 mRNA	PMID:41028656
1305394	Acy3	aminoacylase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1352202	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ACY3 5' UTR	PMID:27901495
1305394	Acy3	aminoacylase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1352202	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACY3 mRNA	PMID:32234424
1305394	Acy3	aminoacylase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1352202	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ACY3 3' UTR	PMID:27901495
1305394	Acy3	aminoacylase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553036	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACY3 mRNA	PMID:22228805
1305394	Acy3	aminoacylase 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1352202	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ACY3 promoter	PMID:27901495
1305394	Acy3	aminoacylase 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1553036	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to ACY3 promoter]	PMID:19654925
1305394	Acy3	aminoacylase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1352202	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ACY3 mRNA	PMID:41028656
1305394	Acy3	aminoacylase 3	gene	CHEBI:3016	Benoxacor	increases expression	ISO	RGD:1553036	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in increased expression of ACY3 mRNA	PMID:34850242
1305394	Acy3	aminoacylase 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1553036	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ACY3 mRNA	PMID:27131904
1305394	Acy3	aminoacylase 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1352202	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ACY3 mRNA	PMID:25895662
1305394	Acy3	aminoacylase 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ACY3 mRNA	PMID:23221170
1305394	Acy3	aminoacylase 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of ACY3 mRNA	PMID:23411599|PMID:34492290
1305394	Acy3	aminoacylase 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ACY3 mRNA	PMID:18445702|PMID:23811191
1305394	Acy3	aminoacylase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1352202	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ACY3 mRNA	PMID:19710929
1305394	Acy3	aminoacylase 3	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1553036	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of ACY3 mRNA	PMID:28329830
1305394	Acy3	aminoacylase 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ACY3 mRNA	PMID:25181051|PMID:30816183
1305394	Acy3	aminoacylase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ACY3 mRNA	PMID:32145629|PMID:34947998
1305394	Acy3	aminoacylase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ACY3 mRNA	PMID:33221593
1305394	Acy3	aminoacylase 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1352202	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ACY3 gene	PMID:31601247
1305394	Acy3	aminoacylase 3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ACY3 mRNA	PMID:26682919
1305394	Acy3	aminoacylase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1553036	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ACY3 gene	PMID:31683443
1305394	Acy3	aminoacylase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ACY3 mRNA	PMID:39298647
1305394	Acy3	aminoacylase 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553036	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ACY3 mRNA	PMID:30951980
1305394	Acy3	aminoacylase 3	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of ACY3 mRNA	PMID:17602206
1305394	Acy3	aminoacylase 3	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1553036	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ACY3 mRNA	PMID:34813904
1305394	Acy3	aminoacylase 3	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1553036	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ACY3 mRNA	PMID:34813904
1305394	Acy3	aminoacylase 3	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of ACY3 mRNA	PMID:19638242
1305394	Acy3	aminoacylase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACY3 mRNA	PMID:30589522
1305394	Acy3	aminoacylase 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ACY3 promoter	PMID:22457795
1305394	Acy3	aminoacylase 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1352202	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACY3 mRNA	PMID:35301059
1305394	Acy3	aminoacylase 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553036	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACY3 mRNA	PMID:37236586
1305394	Acy3	aminoacylase 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ACY3 mRNA	PMID:28903501
1305394	Acy3	aminoacylase 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ACY3 mRNA	PMID:24386269
1305394	Acy3	aminoacylase 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1553036	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACY3 mRNA	PMID:40194260
1305394	Acy3	aminoacylase 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1352202	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ACY3 mRNA	PMID:29154799
1305394	Acy3	aminoacylase 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1352202	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ACY3 gene	PMID:29154799
1305394	Acy3	aminoacylase 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1352202	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACY3 mRNA	PMID:20106945
1305394	Acy3	aminoacylase 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1352202	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ACY3 mRNA	PMID:38832940
1305394	Acy3	aminoacylase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553036	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACY3 mRNA	PMID:17562736
1305394	Acy3	aminoacylase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACY3 mRNA	PMID:33387578
1305394	Acy3	aminoacylase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1352202	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACY3 mRNA	PMID:26690555|PMID:29067470
1305394	Acy3	aminoacylase 3	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1352202	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ACY3 mRNA	PMID:38460933
1305394	Acy3	aminoacylase 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ACY3 mRNA	PMID:29391264
1305394	Acy3	aminoacylase 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ACY3 mRNA	PMID:35436446
1305394	Acy3	aminoacylase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ACY3 mRNA	PMID:17942748
1305394	Acy3	aminoacylase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553036	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACY3 mRNA	PMID:17942748
1305394	Acy3	aminoacylase 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ACY3 mRNA	PMID:25620056
1305394	Acy3	aminoacylase 3	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ACY3 mRNA	PMID:24136188
1305394	Acy3	aminoacylase 3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of ACY3 mRNA	PMID:19042947
1305394	Acy3	aminoacylase 3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1553036	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACY3 mRNA	PMID:26378955
1305394	Acy3	aminoacylase 3	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1553036	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of ACY3 mRNA	PMID:23650126
1305394	Acy3	aminoacylase 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1553036	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of ACY3 mRNA	PMID:15003993
1305394	Acy3	aminoacylase 3	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ACY3 mRNA	PMID:30467583
1305394	Acy3	aminoacylase 3	gene	CHEBI:68508	diethyl maleate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased expression of ACY3 mRNA	PMID:21161181
1305394	Acy3	aminoacylase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553036	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACY3 mRNA	PMID:22206623
1305394	Acy3	aminoacylase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553036	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACY3 mRNA	PMID:22206623
1305394	Acy3	aminoacylase 3	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1352202	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ACY3 mRNA	PMID:36139627
1305394	Acy3	aminoacylase 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of ACY3 mRNA	PMID:32109520
1305394	Acy3	aminoacylase 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1553036	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ACY3 mRNA	PMID:31388691
1305394	Acy3	aminoacylase 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1553036	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ACY3 mRNA	PMID:27131904
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313400	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of JMJD6 mRNA	PMID:38218311
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313401	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of JMJD6 mRNA	PMID:33045310
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of JMJD6 mRNA]	PMID:31150632
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of JMJD6 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of JMJD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of JMJD6 mRNA	PMID:32699268|PMID:32845096
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313401	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of JMJD6 mRNA	PMID:20880076
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JMJD6 mRNA	PMID:30529165
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1313400	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of JMJD6 protein	PMID:28073184
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1313400	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of JMJD6 mRNA	PMID:29581250
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313401	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of JMJD6 mRNA	PMID:39241906
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313401	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of JMJD6 mRNA	PMID:15598610
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313400	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of JMJD6 mRNA	PMID:37042841
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313400	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of JMJD6 mRNA	PMID:20655997|PMID:23649840
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313400	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of JMJD6 mRNA	PMID:38685446
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313400	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of JMJD6 mRNA	PMID:33647349
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of JMJD6 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of JMJD6 mRNA]	PMID:20230807
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of JMJD6 mRNA	PMID:33387578
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1313401	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of JMJD6 mRNA	PMID:20230807
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20120501	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of JMJD6 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of JMJD6 mRNA]	PMID:20230807
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of JMJD6 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of JMJD6 mRNA]	PMID:20230807
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20120717	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of JMJD6 mRNA	PMID:19840844
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313400	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of JMJD6 mRNA	PMID:21120746
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of JMJD6 protein	PMID:23301498
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313401	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of JMJD6 mRNA	PMID:19770486
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313400	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of JMJD6 mRNA	PMID:23649840
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of JMJD6 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of JMJD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of JMJD6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of JMJD6 mRNA	PMID:32699268|PMID:32845096
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of JMJD6 mRNA	PMID:18593933
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of JMJD6 mRNA	PMID:31150632
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313401	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of JMJD6 mRNA	PMID:31919559
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of JMJD6 mRNA]	PMID:31150632
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of JMJD6 mRNA]	PMID:22206623
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1313400	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of JMJD6 mRNA	PMID:18414638
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313400	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of JMJD6 gene	PMID:25304211
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA	PMID:32525701|PMID:39836092
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1313400	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of JMJD6 mRNA	PMID:33512557
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of JMJD6 mRNA	PMID:21151649
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313401	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of JMJD6 mRNA	PMID:30912803
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313401	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of JMJD6 mRNA	PMID:21570461|PMID:24680724
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of JMJD6 mRNA	PMID:32109520
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313400	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of JMJD6 mRNA	PMID:28001369
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313400	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of JMJD6 mRNA	PMID:33212167
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28358	rac-lactic acid	affects expression	ISO	RGD:1313400	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of JMJD6 mRNA	PMID:30851411
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28428	beta-hexachlorocyclohexane	increases expression	ISO	RGD:1313401	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in increased expression of JMJD6 mRNA	PMID:25270620
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of JMJD6 mRNA	PMID:28959563
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313400	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of JMJD6 mRNA	PMID:32763439
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313400	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of JMJD6 mRNA	PMID:29803840
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313400	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in decreased expression of JMJD6 protein	PMID:39571964
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313400	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of JMJD6 mRNA	PMID:34032870|PMID:36586010|PMID:38568856
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA	PMID:39836092
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of JMJD6 mRNA	PMID:18593933
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313400	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of JMJD6 mRNA	PMID:25351596
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313400	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of JMJD6 mRNA	PMID:19150397
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:31206	ammonium chloride	increases expression	EXP		E	RGD:6480464	20230117	CTD	MESH:D000643	Ammonium Chloride results in increased expression of JMJD6 protein	PMID:16483693
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of JMJD6 mRNA	PMID:24136188
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of JMJD6 mRNA	PMID:21829687
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of JMJD6 mRNA	PMID:21515302
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313401	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of JMJD6 gene; titanium dioxide results in decreased methylation of JMJD6 promoter alternative form	PMID:35295148
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of JMJD6 mRNA	PMID:23411599|PMID:34492290
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of JMJD6 mRNA	PMID:19710929
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:32588	potassium chloride	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of JMJD6 mRNA	PMID:29691375
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of JMJD6 mRNA	PMID:25181051
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of JMJD6 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of JMJD6 gene	PMID:28505145
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JMJD6 mRNA	PMID:23196670
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313401	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of JMJD6 exon	PMID:33297965
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313401	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of JMJD6 mRNA	PMID:39298647
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313401	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of JMJD6 mRNA	PMID:37019170
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of JMJD6 mRNA	PMID:22546817
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of JMJD6 mRNA	PMID:21266533
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of JMJD6 mRNA	PMID:22546817
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1313401	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of JMJD6 mRNA	PMID:25270620
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20151215	CTD	MESH:D015056	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 protein; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of CEBPA protein]; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	PMID:26117538
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of JMJD6 mRNA	PMID:22546817
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of JMJD6 mRNA	PMID:22110744
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313400	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of JMJD6 mRNA	PMID:37042841
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313400	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of JMJD6 mRNA	PMID:38568856
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20120717	CTD	MESH:D019256	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of JMJD6 mRNA	PMID:19840844
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of JMJD6 mRNA	PMID:24386269
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313400	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of JMJD6 mRNA	PMID:19320972|PMID:19376846
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of JMJD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of JMJD6 mRNA	PMID:32699268
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of JMJD6 mRNA	PMID:17585979
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1313400	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of JMJD6 mRNA	PMID:33512557
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of JMJD6 mRNA	PMID:25993096
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313400	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of JMJD6 mRNA	PMID:25979313
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313401	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of JMJD6 mRNA	PMID:17292431|PMID:17963808
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of JMJD6 mRNA	PMID:19136453
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313400	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of JMJD6 mRNA	PMID:23179753|PMID:29154799
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of JMJD6 mRNA	PMID:30047161|PMID:41580965
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313400	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of JMJD6 mRNA	PMID:20106945|PMID:25562108
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:41607	crotonaldehyde	increases expression	ISO	RGD:1313400	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased expression of JMJD6 mRNA	PMID:20471460
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20151215	CTD	MESH:D003907	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 protein; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of CEBPA protein]; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	PMID:26117538
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1313400	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of JMJD6 mRNA	PMID:33512557
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313400	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of JMJD6 mRNA	PMID:38832940
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of JMJD6 mRNA	PMID:29279043
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313400	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of JMJD6 mRNA	PMID:25351596
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1313400	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of JMJD6 mRNA	PMID:18414638
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313400	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of JMJD6 gene	PMID:25304211
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA	PMID:32525701|PMID:39836092
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1313400	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of JMJD6 mRNA	PMID:33512557
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313401	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of JMJD6 mRNA; Nanotubes, Carbon results in increased expression of JMJD6 mRNA	PMID:25554681
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of JMJD6 mRNA	PMID:30047161
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of JMJD6 mRNA	PMID:40234311
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of JMJD6 mRNA	PMID:24136188
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313401	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of JMJD6 mRNA	PMID:16166746
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313400	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of JMJD6 protein	PMID:32959892
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313400	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of JMJD6 mRNA	PMID:28988120
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases methylation	ISO	RGD:1313400	E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased methylation of JMJD6 gene	PMID:29432895
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313400	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of JMJD6 mRNA	PMID:15336504
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:6809	methamphetamine	decreases methylation	ISO	RGD:1313401	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased methylation of JMJD6 promoter	PMID:26307267
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313401	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of JMJD6 mRNA	PMID:26307267
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313401	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of JMJD6 mRNA	PMID:22206623
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of JMJD6 mRNA]	PMID:22206623
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313400	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of JMJD6 mRNA	PMID:37199045
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1313400	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of JMJD6 mRNA	PMID:19946333
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of JMJD6 mRNA]	PMID:19946333
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313400	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of JMJD6 protein	PMID:31285264
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313400	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of JMJD6 protein	PMID:39638853
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of JMJD6 mRNA	PMID:22124623
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313400	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of JMJD6 mRNA	PMID:22124623
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of JMJD6 mRNA	PMID:21346803
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	ISO	RGD:1313400	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of JMJD6 mRNA	PMID:30851411
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to JMJD6 gene]	PMID:28238834
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1313401	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of JMJD6 mRNA	PMID:21195148
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1313400	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of JMJD6 mRNA	PMID:33512557
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1313401	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of JMJD6 mRNA	PMID:21195148
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of JMJD6 mRNA	PMID:31558096
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:8249	piroxicam	increases expression	ISO	RGD:1313400	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of JMJD6 mRNA	PMID:21858171
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313400	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA	PMID:32525701
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of JMJD6 mRNA	PMID:30047161
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of JMJD6 mRNA	PMID:40826991
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:87368	diethyl malate	increases expression	ISO	RGD:1313400	E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of JMJD6 mRNA	PMID:38498338
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1313401	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of JMJD6 protein	PMID:35357534
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of JMJD6 mRNA	PMID:21346803
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1313400	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of JMJD6 mRNA	PMID:33512557
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313400	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of JMJD6 mRNA	PMID:38568856
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313400	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of JMJD6 mRNA	PMID:29301935
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1313401	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of JMJD6 mRNA	PMID:21195148
1305395	Jmjd6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:9753	troglitazone	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20151215	CTD	MESH:C057693	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 protein; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of CEBPA protein]; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	PMID:26117538
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313405	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RBSN mRNA	PMID:33045310
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313405	E	RGD:6480464	20150310	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RBSN mRNA	PMID:20188158
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313404	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RBSN mRNA	PMID:37042841
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of RBSN mRNA	PMID:28973375
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313404	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RBSN protein	PMID:37730182
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RBSN mRNA	PMID:31150632
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313405	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RBSN mRNA	PMID:22206623
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313404	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RBSN protein	PMID:35688186
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313404	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RBSN mRNA	PMID:23557933
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313404	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of RBSN mRNA	PMID:27594783
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RBSN mRNA	PMID:30912803
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of RBSN mRNA	PMID:32186404
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313405	E	RGD:6480464	20150310	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBSN mRNA	PMID:21570461
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RBSN mRNA	PMID:33387578
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313405	E	RGD:6480464	20160822	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RBSN mRNA	PMID:25975270
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313404	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of RBSN protein	PMID:35688186
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313404	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RBSN mRNA	PMID:38568856
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313405	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of RBSN protein	PMID:29044176
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313404	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBSN 5' UTR; Benzo(a)pyrene results in increased methylation of RBSN promoter	PMID:27901495
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313405	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of RBSN protein	PMID:37955338
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20150310	CTD	MESH:C008261	lead acetate results in decreased expression of RBSN mRNA	PMID:21829687
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313405	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBSN gene	PMID:35295148
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20150310	CTD	MESH:C006253	pirinixic acid results in decreased expression of RBSN mRNA	PMID:20813756
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C006780	bisphenol A results in increased expression of RBSN mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313405	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RBSN mRNA	PMID:26063408
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1313404	E	RGD:6480464	20150310	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to RBSN promoter]	PMID:20348232
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313405	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RBSN mRNA	PMID:38685157
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of RBSN mRNA	PMID:21241498
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RBSN mRNA	PMID:37019170
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D002509	Cephaloridine results in decreased expression of RBSN mRNA	PMID:18500788
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313404	E	RGD:6480464	20150310	CTD	MESH:C018021	cobaltous chloride results in increased expression of RBSN mRNA	PMID:19320972
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D002737	Chloroprene results in increased expression of RBSN mRNA	PMID:23125180
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313404	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RBSN gene	PMID:29154799
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313404	E	RGD:6480464	20150310	CTD	MESH:D016572	Cyclosporine results in increased expression of RBSN mRNA	PMID:20106945
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of RBSN mRNA	PMID:29279043
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RBSN mRNA	PMID:22206623
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313405	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RBSN mRNA	PMID:22206623
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of RBSN protein	PMID:28903499
1305397	Rbsn	rabenosyn, RAB effector	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RBSN mRNA	PMID:21346803
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313407	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TAF13 mRNA	PMID:33045310
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1313406	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of TAF13 mRNA	PMID:31016361
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313406	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol affects the expression of TAF13 mRNA	PMID:22574217
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313406	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TAF13 mRNA	PMID:31614463
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TAF13 mRNA	PMID:33387578
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313406	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TAF13 mRNA	PMID:37042841
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313407	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TAF13 mRNA	PMID:19850644
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313407	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TAF13 mRNA	PMID:33754040
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313407	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of TAF13 mRNA]	PMID:19850644
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of TAF13 mRNA	PMID:22061828
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313406	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TAF13 mRNA	PMID:28818685
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313406	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TAF13 promoter	PMID:30157460
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA	PMID:39836092
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313406	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in increased expression of TAF13 mRNA	PMID:19549813
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of TAF13 mRNA	PMID:41580963
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1313406	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of TAF13 mRNA	PMID:28534445
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF13 mRNA	PMID:39836092
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313406	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TAF13 mRNA	PMID:26272509
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAF13 mRNA	PMID:27188386
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313407	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAF13 mRNA	PMID:21570461|PMID:24680724
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TAF13 mRNA	PMID:32109520|PMID:33387578
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313406	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TAF13 mRNA	PMID:28001369
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313406	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TAF13 mRNA	PMID:39709020
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20130806	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of TAF13 mRNA; [NSC 689534 binds to Copper] which results in increased expression of TAF13 mRNA	PMID:20971185|PMID:24690739
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313406	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TAF13 mRNA	PMID:38568856
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF13 mRNA	PMID:39836092
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313406	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TAF13 promoter	PMID:27901495
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313406	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF13 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313407	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF13 mRNA	PMID:22228805
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20130806	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of TAF13 mRNA; [NSC 689534 binds to Copper] which results in increased expression of TAF13 mRNA	PMID:20971185|PMID:24690739
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TAF13 mRNA	PMID:25729387
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TAF13 mRNA	PMID:30047161
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313407	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TAF13 mRNA	PMID:29264374
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313407	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TAF13 mRNA	PMID:18648102
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TAF13 mRNA	PMID:19710929
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of TAF13 mRNA	PMID:38479592
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313406	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TAF13 mRNA	PMID:30903817
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313407	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TAF13 promoter	PMID:27334623
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313406	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF13 mRNA	PMID:29275510
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TAF13 mRNA	PMID:25181051
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TAF13 gene	PMID:28505145
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TAF13 mRNA	PMID:28628672
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF13 mRNA	PMID:28628672
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TAF13 mRNA	PMID:28628672
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313407	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TAF13 mRNA	PMID:28392331
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313407	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TAF13 mRNA	PMID:17361019|PMID:21266533
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF13 mRNA	PMID:28628672
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313406	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TAF13 mRNA	PMID:37042841
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA	PMID:39836092
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of TAF13 gene	PMID:22079235
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313406	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of TAF13 mRNA	PMID:28001369
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of TAF13 mRNA	PMID:38685447|PMID:41580965
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TAF13 mRNA	PMID:30047161
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313406	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TAF13 mRNA	PMID:20106945|PMID:25562108
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF13 mRNA	PMID:28628672
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TAF13 mRNA	PMID:24136188
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313406	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TAF13 mRNA	PMID:38832940
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TAF13 mRNA	PMID:33387578
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of TAF13 mRNA	PMID:24690739
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF13 mRNA	PMID:39836092
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1313406	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of TAF13 mRNA	PMID:22077320
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF13 mRNA	PMID:28628672
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TAF13 mRNA	PMID:24136188
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of TAF13 mRNA	PMID:41580965
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TAF13 mRNA	PMID:30047161
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TAF13 mRNA	PMID:24136188
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA	PMID:39836092
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TAF13 mRNA	PMID:25729387
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313407	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TAF13 mRNA	PMID:22206623
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAF13 mRNA	PMID:27188386
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313406	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of TAF13 mRNA	PMID:30928695
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TAF13 gene]	PMID:28238834
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313406	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of TAF13 mRNA	PMID:19159669
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313407	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TAF13 mRNA	PMID:30294300
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313407	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TAF13 mRNA	PMID:39847705
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of TAF13 mRNA	PMID:30047161
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TAF13 mRNA	PMID:30047161
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313406	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAF13 mRNA	PMID:27188386
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313406	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TAF13 mRNA	PMID:38568856
1305398	Taf13	TATA-box binding protein associated factor 13	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TAF13 mRNA	PMID:23034163
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313409	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased expression of IFNAR1 mRNA	PMID:17090620
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313409	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of IFNAR1 mRNA	PMID:33045310
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313408	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of IFNAR1 mRNA	PMID:33167477
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of IFNAR1 mRNA	PMID:36841081
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of IFNAR1 mRNA	PMID:21632981
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20161228	CTD	MESH:D008070	IFNAR1 protein affects the reaction [Lipopolysaccharides results in increased activity of STAT3 protein]	PMID:21586572
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313409	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of IFNAR1 mRNA	PMID:39298647
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:16830	methylamine	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20120412	CTD	MESH:C027451	methylamine inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of IFNAR1 protein]	PMID:18722370
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of IFNAR1 mRNA	PMID:18247414
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of IFNAR1 mRNA	PMID:22061828
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of IFNAR1 mRNA	PMID:22061828
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of IFNAR1 mRNA	PMID:18247414
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IFNAR1 mRNA	PMID:37325564
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313408	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of IFNAR1 mRNA	PMID:41430723
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:2618	amantadine	affects expression	ISO	RGD:1313408	E	RGD:6480464	20120412	CTD	MESH:D000547	Amantadine affects the expression of IFNAR1 mRNA	PMID:16756086
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of IFNAR1 mRNA	PMID:18316168
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of IFNAR1 mRNA	PMID:31295307
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:27878	2-naphthylamine	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20120412	CTD	MESH:D015081	2-Naphthylamine results in decreased expression of IFNAR1 mRNA	PMID:18247414
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of IFNAR1 mRNA	PMID:22228119
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of IFNAR1 mRNA	PMID:23195993
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IFNAR1 mRNA	PMID:33387578|PMID:34747641
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of IFNAR1 mRNA	PMID:28001369
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313408	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of IFNAR1 mRNA	PMID:30911355
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IFNAR1 mRNA	PMID:29803840
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313408	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of IFNAR1 mRNA	PMID:38568856
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IFNAR1 mRNA	PMID:18247414
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313408	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of IFNAR1 mRNA	PMID:30911355
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of IFNAR1 mRNA	PMID:18316168
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313409	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IFNAR1 gene	PMID:35295148
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IFNAR1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313408	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IFNAR1 mRNA	PMID:37042841
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IFNAR1 mRNA	PMID:37325564
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IFNAR1 mRNA	PMID:24449571
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313409	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of IFNAR1 mRNA	PMID:17585979
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1313408	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin promotes the reaction [IFNA1 protein results in increased expression of IFNAR1 protein]; Curcumin promotes the reaction [IFNB1 protein results in increased expression of IFNAR1 protein]	PMID:17979888
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313408	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of IFNAR1 mRNA	PMID:23179753
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313409	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of IFNAR1 mRNA	PMID:21427059
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of IFNAR1 mRNA	PMID:25562108
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313409	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IFNAR1 mRNA	PMID:28973697
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313409	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IFNAR1 mRNA	PMID:17562736
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313408	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of IFNAR1 mRNA	PMID:21420995
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1313408	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of IFNAR1 mRNA; Fluorouracil results in increased expression of IFNAR1 protein	PMID:17088986
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313409	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IFNAR1 mRNA	PMID:25554681
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:5062	finasteride	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in decreased expression of IFNAR1 mRNA	PMID:24136188
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of IFNAR1 mRNA	PMID:24136188
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313409	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IFNAR1 mRNA	PMID:38701926
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:6482	linuron	increases expression	ISO	RGD:1313409	E	RGD:6480464	20210112	CTD	MESH:D008044	Linuron results in increased expression of IFNAR1 mRNA	PMID:30661753
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:6482	linuron	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20210112	CTD	MESH:D008044	SIGMAR1 gene promotes the reaction [Linuron results in increased expression of IFNAR1 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IFNAR1 mRNA]	PMID:30661753
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of IFNAR1 mRNA	PMID:30467583
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:69478	cannabidiol	affects expression	ISO	RGD:1313408	E	RGD:6480464	20250708	CTD	MESH:D002185	Cannabidiol affects the expression of IFNAR1 mRNA	PMID:39894194
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313409	E	RGD:6480464	20250708	CTD	MESH:D002185	Cannabidiol results in increased expression of IFNAR1 mRNA	PMID:39894194
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:75934	vadimezan	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20260804	CTD	MESH:C066668	IFNAR1 protein affects the reaction [vadimezan results in increased expression of ACOD1 protein]	PMID:36862550
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313409	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of IFNAR1 mRNA	PMID:21795629
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of IFNAR1 mRNA	PMID:24136188
1305399	Ifnar1	interferon alpha and beta receptor subunit 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of IFNAR1 mRNA	PMID:20566332
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:137392	chlormequat chloride	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of NIPA1 protein	PMID:34958886
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NIPA1 mRNA	PMID:20938992
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606742	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NIPA1 mRNA	PMID:33167477
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1550198	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of NIPA1 mRNA	PMID:22629407
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20121113	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NIPA1 mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of NIPA1 mRNA]	PMID:22629407|PMID:30529165
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1606742	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NIPA1 mRNA	PMID:22378314
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550198	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of NIPA1 mRNA	PMID:30319688
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of NIPA1 mRNA	PMID:27157538
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1606742	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of NIPA1 mRNA	PMID:38568856
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NIPA1 mRNA	PMID:20938992
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1606742	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of NIPA1 mRNA	PMID:21179406
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NIPA1 mRNA	PMID:37992649
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NIPA1 mRNA	PMID:37992649
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NIPA1 mRNA	PMID:33387578
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1606742	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NIPA1 mRNA	PMID:28818685
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1606742	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of NIPA1 intron	PMID:30157460
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NIPA1 mRNA	PMID:36331819
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606742	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of NIPA1 mRNA	PMID:39836092
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1606742	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NIPA1 intron	PMID:30157460
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1606742	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NIPA1 mRNA	PMID:18593933
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550198	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NIPA1 mRNA	PMID:27339419|PMID:31919559
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NIPA1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NIPA1 mRNA	PMID:20938992|PMID:22206623
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550198	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NIPA1 mRNA	PMID:21570461
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D012402	Rotenone results in decreased expression of NIPA1 mRNA	PMID:27157538
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of NIPA1 mRNA	PMID:28959563
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550198	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of NIPA1 mRNA	PMID:39631538
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606742	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NIPA1 mRNA	PMID:29803840
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NIPA1 mRNA	PMID:37992649
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550198	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of NIPA1 mRNA	PMID:37682722
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606742	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NIPA1 mRNA	PMID:38568856
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1606742	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NIPA1 mRNA	PMID:18593933
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550198	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NIPA1 gene	PMID:35295148
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550198	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NIPA1 mRNA	PMID:18301758|PMID:23811191
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NIPA1 mRNA	PMID:25181051
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NIPA1 mRNA	PMID:34947998
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606742	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of NIPA1 mRNA	PMID:22576693
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of NIPA1 mRNA	PMID:29097150
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1606742	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of NIPA1 gene	PMID:22576693
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550198	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NIPA1 mRNA	PMID:37019170
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of NIPA1 gene	PMID:33148267
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606742	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NIPA1 mRNA	PMID:37042841
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606742	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of NIPA1 mRNA	PMID:39836092
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NIPA1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NIPA1 mRNA	PMID:36331819
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606742	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NIPA1 mRNA	PMID:25979313
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606742	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of NIPA1 mRNA	PMID:27989131
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550198	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NIPA1 mRNA	PMID:28973697
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NIPA1 mRNA	PMID:37992649
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1606742	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NIPA1 mRNA	PMID:38832940
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1606742	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of NIPA1 mRNA	PMID:24935251|PMID:26272509
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1606742	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIPA1 mRNA	PMID:27188386
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NIPA1 mRNA	PMID:29097150
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1550198	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of NIPA1 mRNA	PMID:23608068
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606742	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of NIPA1 mRNA	PMID:39836092
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1606742	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of NIPA1 mRNA	PMID:28988120
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NIPA1 mRNA	PMID:27157538
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of NIPA1 gene	PMID:33148267
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1606742	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of NIPA1 mRNA	PMID:31758290
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550198	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NIPA1 mRNA	PMID:22206623
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NIPA1 mRNA	PMID:22206623
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:749301	potassium perchlorate	increases expression	ISO	RGD:1606742	E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in increased expression of NIPA1 mRNA	PMID:29673971
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:75458	carbonyl cyanide p-trifluoromethoxyphenylhydrazone	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D002259	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of NIPA1 mRNA	PMID:27157538
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1606742	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of NIPA1 mRNA	PMID:34995734
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606742	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIPA1 mRNA	PMID:27188386
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550198	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of NIPA1 mRNA	PMID:23091169
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1550198	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of NIPA1 mRNA	PMID:19482888
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1550198	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NIPA1 mRNA]	PMID:19482888
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550198	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of NIPA1 mRNA	PMID:39847705
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1606742	E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of NIPA1 mRNA	PMID:35688559
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1550198	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of NIPA1 mRNA	PMID:40826991
1305401	Nipa1	NIPA magnesium transporter 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606742	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIPA1 mRNA	PMID:27188386
1305402	Commd8	COMM domain containing 8	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313414	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COMMD8 mRNA	PMID:33045310
1305402	Commd8	COMM domain containing 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313414	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COMMD8 gene	PMID:20938992
1305402	Commd8	COMM domain containing 8	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313413	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of COMMD8 mRNA	PMID:20044591
1305402	Commd8	COMM domain containing 8	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of COMMD8 mRNA	PMID:21632981
1305402	Commd8	COMM domain containing 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313414	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of COMMD8 mRNA	PMID:39241906
1305402	Commd8	COMM domain containing 8	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313413	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of COMMD8 mRNA	PMID:22574217
1305402	Commd8	COMM domain containing 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313414	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COMMD8 gene	PMID:20938992
1305402	Commd8	COMM domain containing 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313413	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COMMD8 mRNA	PMID:37042841
1305402	Commd8	COMM domain containing 8	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of COMMD8 mRNA	PMID:26496021
1305402	Commd8	COMM domain containing 8	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COMMD8 mRNA	PMID:19549813
1305402	Commd8	COMM domain containing 8	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313413	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of COMMD8 protein	PMID:20106945
1305402	Commd8	COMM domain containing 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313414	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COMMD8 gene	PMID:20938992
1305402	Commd8	COMM domain containing 8	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313414	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of COMMD8 protein	PMID:25505154
1305402	Commd8	COMM domain containing 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313414	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COMMD8 mRNA	PMID:21570461
1305402	Commd8	COMM domain containing 8	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of COMMD8 mRNA	PMID:33212167
1305402	Commd8	COMM domain containing 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COMMD8 mRNA	PMID:30851411
1305402	Commd8	COMM domain containing 8	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of COMMD8 mRNA	PMID:28959563
1305402	Commd8	COMM domain containing 8	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of COMMD8 mRNA	PMID:25523186
1305402	Commd8	COMM domain containing 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of COMMD8 mRNA	PMID:39719251
1305402	Commd8	COMM domain containing 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313414	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of COMMD8 mRNA	PMID:37682722
1305402	Commd8	COMM domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313414	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COMMD8 mRNA	PMID:15034205
1305402	Commd8	COMM domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313414	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of COMMD8 mRNA	PMID:22228805
1305402	Commd8	COMM domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313414	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of COMMD8 mRNA]	PMID:15034205
1305402	Commd8	COMM domain containing 8	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of COMMD8 mRNA	PMID:25523186
1305402	Commd8	COMM domain containing 8	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of COMMD8 mRNA	PMID:30047161
1305402	Commd8	COMM domain containing 8	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313414	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of COMMD8 mRNA	PMID:23811191
1305402	Commd8	COMM domain containing 8	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of COMMD8 mRNA	PMID:25181051
1305402	Commd8	COMM domain containing 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313414	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of COMMD8 mRNA	PMID:26063408
1305402	Commd8	COMM domain containing 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of COMMD8 mRNA	PMID:30816183|PMID:32528016
1305402	Commd8	COMM domain containing 8	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of COMMD8 gene	PMID:28505145
1305402	Commd8	COMM domain containing 8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of COMMD8 mRNA	PMID:26496021
1305402	Commd8	COMM domain containing 8	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of COMMD8 mRNA	PMID:28302478
1305402	Commd8	COMM domain containing 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of COMMD8 mRNA	PMID:27153767
1305402	Commd8	COMM domain containing 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313413	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COMMD8 mRNA	PMID:25979313
1305402	Commd8	COMM domain containing 8	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313413	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of COMMD8 gene	PMID:29154799
1305402	Commd8	COMM domain containing 8	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313413	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of COMMD8 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1305402	Commd8	COMM domain containing 8	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of COMMD8 mRNA	PMID:30047161
1305402	Commd8	COMM domain containing 8	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313413	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of COMMD8 mRNA	PMID:36621641
1305402	Commd8	COMM domain containing 8	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313413	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of COMMD8 mRNA	PMID:27188386
1305402	Commd8	COMM domain containing 8	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313413	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of COMMD8 mRNA	PMID:18175754
1305402	Commd8	COMM domain containing 8	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in decreased expression of COMMD8 mRNA	PMID:17211630
1305402	Commd8	COMM domain containing 8	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of COMMD8 mRNA	PMID:24136188
1305402	Commd8	COMM domain containing 8	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of COMMD8 mRNA	PMID:24136188
1305402	Commd8	COMM domain containing 8	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COMMD8 protein	PMID:32959892
1305402	Commd8	COMM domain containing 8	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313414	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of COMMD8 mRNA	PMID:22206623
1305402	Commd8	COMM domain containing 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313413	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COMMD8 mRNA	PMID:30851411
1305402	Commd8	COMM domain containing 8	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313413	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COMMD8 gene]	PMID:28238834
1305402	Commd8	COMM domain containing 8	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of COMMD8 mRNA	PMID:30047161
1305402	Commd8	COMM domain containing 8	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313414	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of COMMD8 mRNA	PMID:40826991
1305402	Commd8	COMM domain containing 8	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of COMMD8 mRNA	PMID:30047161
1305402	Commd8	COMM domain containing 8	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in decreased expression of COMMD8 mRNA	PMID:22615374
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ANKRD34C mRNA	PMID:27523638
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313415	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ANKRD34C mRNA	PMID:28960355
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:2291762	E	RGD:6480464	20220510	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of ANKRD34C mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of ANKRD34C mRNA	PMID:23557933|PMID:41028656
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:2291762	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ANKRD34C mRNA	PMID:41028656
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:2291762	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ANKRD34C mRNA	PMID:29803840
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:2291762	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ANKRD34C 5' UTR	PMID:27901495
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:2291762	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ANKRD34C promoter	PMID:27901495
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:2291762	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ANKRD34C exon	PMID:27901495
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:2291762	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ANKRD34C mRNA	PMID:41028656
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKRD34C mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ANKRD34C mRNA	PMID:32109520
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ANKRD34C mRNA	PMID:24780913
1305403	Ankrd34c	ankyrin repeat domain 34C	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:2291762	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ANKRD34C mRNA	PMID:38568856
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LECT2 mRNA]	PMID:31150632
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of LECT2 mRNA]	PMID:19467301
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LECT2 mRNA	PMID:20938992
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LECT2 mRNA	PMID:39298647
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of LECT2 mRNA	PMID:32145629
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LECT2 mRNA	PMID:20938992
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of LECT2 mRNA	PMID:28973375
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of LECT2 mRNA	PMID:26496021
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313416	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LECT2 mRNA	PMID:31163220
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313416	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LECT2 mRNA	PMID:27153756
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313417	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of LECT2 mRNA	PMID:31919559
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LECT2 mRNA	PMID:31150632
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LECT2 mRNA]	PMID:31150632
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LECT2 mRNA	PMID:20938992
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LECT2 mRNA	PMID:28189721|PMID:28960355
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LECT2 mRNA	PMID:22298810
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313416	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LECT2 mRNA	PMID:22298810
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313417	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LECT2 mRNA	PMID:26377647
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LECT2 mRNA	PMID:21215274
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313416	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LECT2 mRNA	PMID:29955902
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of LECT2 mRNA	PMID:39631538
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of LECT2 mRNA	PMID:37682722
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313417	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LECT2 3' UTR; Benzo(a)pyrene results in increased methylation of LECT2 exon	PMID:27901495
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of LECT2 mRNA	PMID:23411599|PMID:34492290
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of LECT2 mRNA	PMID:28943392
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of LECT2 mRNA	PMID:20059764|PMID:23811191
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313416	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LECT2 mRNA	PMID:19710929
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of LECT2 mRNA]	PMID:20059764
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313417	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LECT2 mRNA	PMID:28472532
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LECT2 mRNA	PMID:25181051
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LECT2 gene	PMID:28505145
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of LECT2 mRNA	PMID:26496021
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LECT2 mRNA	PMID:39298647|PMID:40203079
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of LECT2 mRNA	PMID:24535843
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of LECT2 mRNA	PMID:28943392
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LECT2 mRNA	PMID:24535843
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of LECT2 mRNA	PMID:30589522
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LECT2 mRNA	PMID:35163327
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of LECT2 mRNA	PMID:18500788
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LECT2 mRNA	PMID:35163327
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LECT2 mRNA	PMID:24386269
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of LECT2 mRNA	PMID:29038090
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313416	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LECT2 mRNA	PMID:29154799
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313416	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of LECT2 mRNA	PMID:27989131
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of LECT2 mRNA	PMID:28973697
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of LECT2 mRNA	PMID:24136188
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313417	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LECT2 mRNA	PMID:17562736
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313416	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of LECT2 mRNA	PMID:26690555
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313417	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of LECT2 mRNA	PMID:29246445
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of LECT2 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of LECT2 mRNA]	PMID:29246445|PMID:34546377
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LECT2 mRNA	PMID:17108234
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of LECT2 mRNA	PMID:23962444
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of LECT2 mRNA	PMID:24136188
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of LECT2 mRNA	PMID:24136188
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of LECT2 mRNA	PMID:33484710
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313417	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of LECT2 mRNA	PMID:19270015|PMID:19482888
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LECT2 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LECT2 mRNA]	PMID:19482888|PMID:24535843
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313417	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LECT2 mRNA	PMID:38648751
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313417	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of LECT2 mRNA	PMID:21278054
1305404	Lect2	leukocyte cell-derived chemotaxin 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LECT2 mRNA	PMID:21346803
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313418	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ZCWPW1 mRNA	PMID:38218311
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D001280	Atrazine results in decreased expression of ZCWPW1 mRNA	PMID:22378314
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1617950	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZCWPW1 mRNA	PMID:39241906
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1617950	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ZCWPW1 mRNA	PMID:39298647
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ZCWPW1 mRNA	PMID:33387578
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313418	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZCWPW1 mRNA	PMID:37042841
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20180918	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of ZCWPW1 mRNA	PMID:21346803
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZCWPW1 mRNA	PMID:19549813
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D012643	Selenium results in increased expression of ZCWPW1 mRNA	PMID:19244175
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of ZCWPW1 mRNA	PMID:19244175
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1617950	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ZCWPW1 mRNA	PMID:30912803
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20180918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZCWPW1 mRNA	PMID:22298810
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1617950	E	RGD:6480464	20180911	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZCWPW1 mRNA	PMID:21570461
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313418	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ZCWPW1 mRNA	PMID:29955902
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313418	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZCWPW1 mRNA	PMID:33212167
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313418	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZCWPW1 mRNA	PMID:34032870
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313418	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of ZCWPW1 mRNA	PMID:29453283
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZCWPW1 mRNA	PMID:26238291
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617950	E	RGD:6480464	20180911	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZCWPW1 mRNA	PMID:22228805
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313418	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZCWPW1 5' UTR	PMID:27901495
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1617950	E	RGD:6480464	20180911	CTD	MESH:D012834	Silver results in increased expression of ZCWPW1 mRNA	PMID:27131904
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ZCWPW1 mRNA	PMID:25351596
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZCWPW1 mRNA	PMID:26238291
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617950	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZCWPW1 gene	PMID:35295148
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1617950	E	RGD:6480464	20180911	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZCWPW1 promoter	PMID:27312807
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180918	CTD	MESH:C006780	bisphenol A results in increased expression of ZCWPW1 mRNA	PMID:25181051|PMID:36779543
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1617950	E	RGD:6480464	20180911	CTD	MESH:C006780	bisphenol A results in increased expression of ZCWPW1 mRNA	PMID:20739668
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D024502	Vitamin E results in increased expression of ZCWPW1 mRNA	PMID:19244175
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of ZCWPW1 mRNA	PMID:19244175
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1617950	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ZCWPW1 intron	PMID:28392331
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313418	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZCWPW1 mRNA	PMID:37042841
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313418	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZCWPW1 mRNA	PMID:38382870
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D012643	Selenium results in increased expression of ZCWPW1 mRNA	PMID:19244175
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of ZCWPW1 mRNA	PMID:19244175
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1617950	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ZCWPW1 mRNA	PMID:40194260
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313418	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZCWPW1 mRNA	PMID:31533062
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313418	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ZCWPW1 mRNA	PMID:40419075
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D014635	Valproic Acid affects the expression of ZCWPW1 mRNA	PMID:25979313
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZCWPW1 gene	PMID:29154799
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZCWPW1 mRNA	PMID:33387578
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1617950	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ZCWPW1 mRNA	PMID:38648751
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1617950	E	RGD:6480464	20180911	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZCWPW1 mRNA	PMID:27935865
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180918	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZCWPW1 mRNA	PMID:24780913
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1617950	E	RGD:6480464	20180911	CTD	MESH:D012834	Silver results in increased expression of ZCWPW1 mRNA	PMID:27131904
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313418	E	RGD:6480464	20180911	CTD	MESH:D019284	Thapsigargin results in increased expression of ZCWPW1 mRNA	PMID:22378314|PMID:29453283
1305405	Zcwpw1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1617950	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ZCWPW1 mRNA	PMID:35537566
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313419	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of SMARCD1 protein	PMID:39638853
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313419	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SMARCD1 mRNA	PMID:38218311
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313420	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SMARCD1 mRNA	PMID:37995155
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313419	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SMARCD1 mRNA	PMID:33167477
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313419	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SMARCD1 mRNA	PMID:26079696
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313420	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SMARCD1 mRNA	PMID:30319688
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313420	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SMARCD1 mRNA	PMID:39298647
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA	PMID:25510870
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313419	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SMARCD1 mRNA	PMID:21179406
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313420	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SMARCD1 protein	PMID:20463053
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313420	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SMARCD1 mRNA	PMID:28973375
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA	PMID:25510870
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA	PMID:25510870
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SMARCD1 gene] which results in increased expression of SMARCD1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCD1 mRNA	PMID:40504410
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:27698	vanadium atom	decreases expression	ISO	RGD:1313419	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of SMARCD1 mRNA	PMID:19000753
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313419	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SMARCD1 mRNA	PMID:28903495
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313420	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMARCD1 mRNA	PMID:21570461|PMID:24680724
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313419	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMARCD1 mRNA	PMID:11489354
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCD1 mRNA	PMID:17942748
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313419	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMARCD1 mRNA	PMID:33212167
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313419	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMARCD1 mRNA	PMID:29803840
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SMARCD1 gene] which results in increased expression of SMARCD1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCD1 mRNA	PMID:40504410
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313420	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SMARCD1 promoter	PMID:35295148
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SMARCD1 mRNA	PMID:23411599
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313420	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SMARCD1 mRNA	PMID:18648102
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SMARCD1 mRNA	PMID:25181051
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of SMARCD1 mRNA	PMID:38750585
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SMARCD1 gene	PMID:28505145
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA	PMID:25510870
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA	PMID:25510870
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:3423	carmustine	increases expression	ISO	RGD:1313419	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of SMARCD1 mRNA	PMID:15980968
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313420	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SMARCD1 exon	PMID:33297965
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313420	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of SMARCD1 mRNA	PMID:33297965
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313420	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SMARCD1 mRNA	PMID:38685157
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313419	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCD1 mRNA	PMID:28628672
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMARCD1 mRNA	PMID:18668222
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313419	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCD1 mRNA	PMID:28628672
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:35170	vanadium(0)	decreases expression	ISO	RGD:1313419	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of SMARCD1 mRNA	PMID:19000753
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313419	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SMARCD1 mRNA	PMID:38382870
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313419	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SMARCD1 mRNA	PMID:19320972
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313420	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of SMARCD1 mRNA	PMID:17585979
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313419	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCD1 mRNA	PMID:23179753
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313419	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCD1 mRNA	PMID:28628672
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SMARCD1 gene] which results in increased expression of SMARCD1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCD1 mRNA	PMID:40504410
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCD1 mRNA	PMID:17942748
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313419	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCD1 mRNA	PMID:28628672
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313420	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of SMARCD1 mRNA	PMID:40234311
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313419	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SMARCD1 protein	PMID:31285264
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of SMARCD1 mRNA	PMID:26923065
1305406	Smarcd1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313420	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SMARCD1 mRNA	PMID:21278054
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313422	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KY mRNA	PMID:36189433
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KY mRNA	PMID:33729688
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:15746	spermine	increases expression	ISO	RGD:1313422	E	RGD:6480464	20120412	CTD	MESH:D013096	Spermine results in increased expression of KY mRNA	PMID:18673383
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313422	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of KY mRNA	PMID:30319688
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of KY mRNA	PMID:19484750
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KY mRNA	PMID:33387578
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313421	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KY mRNA	PMID:37042841
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313422	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KY mRNA	PMID:36189433
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of KY mRNA	PMID:20403060
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313421	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KY gene	PMID:27153756
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in decreased expression of KY mRNA	PMID:33026818
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of KY mRNA	PMID:31150632
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of KY mRNA	PMID:31881176
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of KY mRNA	PMID:17898221
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of KY mRNA	PMID:32186404
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313421	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of KY mRNA	PMID:24768652
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KY mRNA	PMID:32109520
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of KY mRNA	PMID:28959563
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313421	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KY mRNA	PMID:29803840
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of KY mRNA	PMID:39631538
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313421	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KY promoter	PMID:27901495
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313422	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KY mRNA	PMID:27195522
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313421	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KY 3' UTR; Benzo(a)pyrene results in increased methylation of KY 5' UTR	PMID:27901495
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1313421	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of KY gene	PMID:31601247
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313422	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of KY mRNA	PMID:20542052
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of KY mRNA	PMID:30047161
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of KY mRNA	PMID:19167457
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KY mRNA	PMID:25181051
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313422	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of KY exon	PMID:33297965
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313421	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of KY gene	PMID:31601247
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313422	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of KY intron	PMID:28392331
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of KY mRNA	PMID:21266533
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313421	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KY mRNA	PMID:37042841
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KY mRNA	PMID:35163327
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KY mRNA	PMID:35163327
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313421	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KY mRNA	PMID:38568856
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KY mRNA	PMID:35163327
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313421	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of KY mRNA	PMID:24449571
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:39175	thiacloprid	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C417209	thiacloprid results in decreased expression of KY mRNA	PMID:33426623
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:39175	thiacloprid	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:C417209	[thiacloprid co-treated with clothianidin] results in decreased expression of KY mRNA; [thiacloprid co-treated with enilconazole] results in decreased expression of KY mRNA	PMID:33426623
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:39178	clothianidin	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C480342	clothianidin results in decreased expression of KY mRNA	PMID:33426623
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:39178	clothianidin	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:C480342	[enilconazole co-treated with clothianidin] results in decreased expression of KY mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of KY mRNA	PMID:33426623
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of KY mRNA	PMID:30047161
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313421	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of KY mRNA	PMID:26690555
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of KY mRNA	PMID:38701926
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of KY mRNA	PMID:20003209
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1313422	E	RGD:6480464	20160315	CTD	MESH:C072553	[MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of KY mRNA	PMID:25566086
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:753160	lard	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in decreased expression of KY mRNA	PMID:26115784
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313422	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of KY mRNA	PMID:31388691
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:81927	enilconazole	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C017435	enilconazole results in decreased expression of KY mRNA	PMID:33426623
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:81927	enilconazole	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:C017435	[enilconazole co-treated with clothianidin] results in decreased expression of KY mRNA; [thiacloprid co-treated with enilconazole] results in decreased expression of KY mRNA	PMID:33426623
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313422	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KY mRNA	PMID:27935865
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KY mRNA	PMID:24780913|PMID:25825206|PMID:30047161
1305407	Ky	kyphoscoliosis peptidase	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of KY mRNA	PMID:23869203
1305408	Foxk2	forkhead box K2	gene	CHEBI:137392	chlormequat chloride	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of FOXK2 protein	PMID:34958886
1305408	Foxk2	forkhead box K2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1614344	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of FOXK2 mRNA	PMID:26251327
1305408	Foxk2	forkhead box K2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313423	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FOXK2 mRNA	PMID:33167477
1305408	Foxk2	forkhead box K2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614344	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FOXK2 mRNA	PMID:39241906
1305408	Foxk2	forkhead box K2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313423	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol affects the expression of FOXK2 mRNA	PMID:22574217
1305408	Foxk2	forkhead box K2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313423	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in increased expression of FOXK2 mRNA	PMID:23019147|PMID:31614463
1305408	Foxk2	forkhead box K2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1313423	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of FOXK2 gene	PMID:30521419
1305408	Foxk2	forkhead box K2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1614344	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of FOXK2 mRNA	PMID:23892564
1305408	Foxk2	forkhead box K2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313423	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FOXK2 protein	PMID:37730182
1305408	Foxk2	forkhead box K2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FOXK2 mRNA	PMID:22061828
1305408	Foxk2	forkhead box K2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313423	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FOXK2 mRNA	PMID:28818685
1305408	Foxk2	forkhead box K2	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1614344	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of FOXK2 mRNA	PMID:37748715
1305408	Foxk2	forkhead box K2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614344	E	RGD:6480464	20260113	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FOXK2 mRNA	PMID:37451636
1305408	Foxk2	forkhead box K2	gene	CHEBI:25187	p-menthan-3-ol	increases expression	ISO	RGD:1313423	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of FOXK2 mRNA	PMID:26760959
1305408	Foxk2	forkhead box K2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614344	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of FOXK2 mRNA]	PMID:22206623
1305408	Foxk2	forkhead box K2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313423	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FOXK2 gene	PMID:25304211
1305408	Foxk2	forkhead box K2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313423	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of FOXK2 protein	PMID:35688186
1305408	Foxk2	forkhead box K2	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1313423	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of FOXK2 gene	PMID:31636367
1305408	Foxk2	forkhead box K2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1614344	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FOXK2 mRNA	PMID:24058054
1305408	Foxk2	forkhead box K2	gene	CHEBI:28177	theophylline	increases expression	ISO	RGD:1313423	E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of FOXK2 mRNA	PMID:16083514
1305408	Foxk2	forkhead box K2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313423	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of FOXK2 mRNA	PMID:39709020
1305408	Foxk2	forkhead box K2	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313423	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of FOXK2 mRNA	PMID:23649840
1305408	Foxk2	forkhead box K2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of FOXK2 mRNA	PMID:28959563
1305408	Foxk2	forkhead box K2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1614344	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of FOXK2 mRNA	PMID:27862939
1305408	Foxk2	forkhead box K2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313423	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FOXK2 mRNA	PMID:29803840
1305408	Foxk2	forkhead box K2	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313423	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of FOXK2 protein	PMID:35688186
1305408	Foxk2	forkhead box K2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of FOXK2 mRNA	PMID:21297353
1305408	Foxk2	forkhead box K2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313423	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FOXK2 mRNA	PMID:19150397
1305408	Foxk2	forkhead box K2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of FOXK2 mRNA	PMID:30047161
1305408	Foxk2	forkhead box K2	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1614344	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of FOXK2 mRNA	PMID:17656681
1305408	Foxk2	forkhead box K2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614344	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FOXK2 promoter	PMID:35295148
1305408	Foxk2	forkhead box K2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FOXK2 mRNA	PMID:34492290
1305408	Foxk2	forkhead box K2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FOXK2 mRNA	PMID:25181051
1305408	Foxk2	forkhead box K2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313423	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of FOXK2 mRNA	PMID:30903817
1305408	Foxk2	forkhead box K2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1614344	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FOXK2 promoter	PMID:27334623
1305408	Foxk2	forkhead box K2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FOXK2 mRNA	PMID:30816183|PMID:32528016
1305408	Foxk2	forkhead box K2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313423	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FOXK2 gene	PMID:31601247
1305408	Foxk2	forkhead box K2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1614344	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of FOXK2 promoter	PMID:27312807
1305408	Foxk2	forkhead box K2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313423	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of FOXK2 mRNA	PMID:33670352
1305408	Foxk2	forkhead box K2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FOXK2 gene	PMID:28505145
1305408	Foxk2	forkhead box K2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313423	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of FOXK2 mRNA	PMID:25979313
1305408	Foxk2	forkhead box K2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1614344	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FOXK2 mRNA	PMID:39298647
1305408	Foxk2	forkhead box K2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313423	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FOXK2 mRNA	PMID:37042841
1305408	Foxk2	forkhead box K2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of FOXK2 mRNA	PMID:30589522
1305408	Foxk2	forkhead box K2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614344	E	RGD:6480464	20260113	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FOXK2 mRNA	PMID:37451636
1305408	Foxk2	forkhead box K2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of FOXK2 mRNA	PMID:19162173
1305408	Foxk2	forkhead box K2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1614344	E	RGD:6480464	20130806	CTD	MESH:D002922	Ciguatoxins affects the expression of FOXK2 mRNA	PMID:18353800
1305408	Foxk2	forkhead box K2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313423	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of FOXK2 mRNA	PMID:28302478
1305408	Foxk2	forkhead box K2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313423	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FOXK2 mRNA	PMID:31533062
1305408	Foxk2	forkhead box K2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313423	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of FOXK2 mRNA	PMID:29154799
1305408	Foxk2	forkhead box K2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313423	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FOXK2 gene	PMID:29154799
1305408	Foxk2	forkhead box K2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of FOXK2 mRNA	PMID:30047161
1305408	Foxk2	forkhead box K2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313423	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FOXK2 mRNA	PMID:20106945|PMID:25562108
1305408	Foxk2	forkhead box K2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1614344	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of FOXK2 mRNA	PMID:19770486
1305408	Foxk2	forkhead box K2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1313423	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of FOXK2 mRNA	PMID:23649840
1305408	Foxk2	forkhead box K2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313423	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of FOXK2 mRNA	PMID:24449571
1305408	Foxk2	forkhead box K2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614344	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FOXK2 mRNA	PMID:17562736
1305408	Foxk2	forkhead box K2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313423	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in decreased expression of FOXK2 mRNA	PMID:22230336
1305408	Foxk2	forkhead box K2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FOXK2 mRNA	PMID:33387578
1305408	Foxk2	forkhead box K2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313423	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of FOXK2 mRNA	PMID:29067470
1305408	Foxk2	forkhead box K2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1614344	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FOXK2 mRNA	PMID:29279043
1305408	Foxk2	forkhead box K2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313423	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FOXK2 gene	PMID:25304211
1305408	Foxk2	forkhead box K2	gene	CHEBI:50594	carbon nanotube	decreases methylation	ISO	RGD:1313423	E	RGD:6480464	20191008	CTD	MESH:D037742	Nanotubes, Carbon results in decreased methylation of FOXK2 gene	PMID:29426343
1305408	Foxk2	forkhead box K2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of FOXK2 mRNA	PMID:30047161
1305408	Foxk2	forkhead box K2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of FOXK2 mRNA	PMID:19162173
1305408	Foxk2	forkhead box K2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1614344	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FOXK2 mRNA	PMID:35964746
1305408	Foxk2	forkhead box K2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1614344	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of FOXK2 mRNA	PMID:19042947
1305408	Foxk2	forkhead box K2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1614344	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FOXK2 mRNA	PMID:22206623
1305408	Foxk2	forkhead box K2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614344	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of FOXK2 mRNA]	PMID:22206623
1305408	Foxk2	forkhead box K2	gene	CHEBI:756894	tak-243	affects sumoylation	ISO	RGD:1313423	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of FOXK2 protein	PMID:31285264
1305408	Foxk2	forkhead box K2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313423	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of FOXK2 mRNA	PMID:19159669
1305408	Foxk2	forkhead box K2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1614344	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of FOXK2 mRNA	PMID:23091169
1305408	Foxk2	forkhead box K2	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of FOXK2 mRNA	PMID:30047161
1305408	Foxk2	forkhead box K2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FOXK2 mRNA	PMID:27291303
1305408	Foxk2	forkhead box K2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of FOXK2 mRNA	PMID:30047161
1305408	Foxk2	forkhead box K2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FOXK2 mRNA	PMID:21346803
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550206	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of TTC17 mRNA	PMID:33045310
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TTC17 mRNA	PMID:36331819
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313426	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TTC17 mRNA	PMID:21632981
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TTC17 mRNA	PMID:39298647
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of TTC17 mRNA	PMID:38568856
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TTC17 mRNA	PMID:33387578
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313426	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TTC17 mRNA	PMID:37042841
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TTC17 mRNA	PMID:23649840
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TTC17 mRNA	PMID:38685446
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TTC17 mRNA	PMID:22061828
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TTC17 mRNA	PMID:36331819
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of TTC17 mRNA	PMID:27462272
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TTC17 mRNA	PMID:37236586
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313426	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TTC17 mRNA	PMID:19549813
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313426	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TTC17 mRNA	PMID:23649840
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313426	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TTC17 mRNA	PMID:23649840
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550206	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TTC17 mRNA	PMID:31919559
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTC17 mRNA	PMID:40504410
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TTC17 mRNA	PMID:19244175
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of TTC17 gene	PMID:31011160
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TTC17 mRNA	PMID:28960355
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TTC17 mRNA	PMID:30912803
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTC17 mRNA	PMID:22298810
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550206	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTC17 mRNA	PMID:21570461
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TTC17 mRNA	PMID:18796159|PMID:32109520
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TTC17 mRNA	PMID:33212167
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TTC17 mRNA	PMID:20971185
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TTC17 mRNA	PMID:29803840
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTC17 mRNA	PMID:28595984|PMID:34032870
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313426	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TTC17 mRNA	PMID:38568856
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550206	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of TTC17 mRNA	PMID:36209798
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTC17 mRNA	PMID:40504410
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313426	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of TTC17 mRNA	PMID:29453283
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313426	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TTC17 promoter	PMID:27901495
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313426	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTC17 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TTC17 mRNA	PMID:20971185
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TTC17 mRNA	PMID:25351596
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313426	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of TTC17 mRNA	PMID:31745603
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TTC17 mRNA	PMID:34492290
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TTC17 mRNA	PMID:33221593
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313426	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TTC17 gene	PMID:31601247
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TTC17 mRNA	PMID:28628672
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of TTC17 mRNA	PMID:19244175
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TTC17 mRNA	PMID:39298647
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTC17 mRNA	PMID:28628672
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1550206	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of TTC17 mRNA	PMID:31558096
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TTC17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTC17 mRNA	PMID:28628672
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313426	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TTC17 mRNA	PMID:37042841
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TTC17 mRNA	PMID:37236586
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of TTC17 mRNA	PMID:25539665
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TTC17 mRNA	PMID:19244175
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313426	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TTC17 mRNA	PMID:31533062
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TTC17 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TTC17 mRNA	PMID:36331819
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1550206	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of TTC17 mRNA	PMID:31558096
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TTC17 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTC17 mRNA	PMID:27188386
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1313426	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of TTC17 mRNA	PMID:25562108
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313426	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of TTC17 promoter	PMID:27989131
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550206	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TTC17 mRNA	PMID:17555576
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TTC17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTC17 mRNA	PMID:28628672
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313426	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TTC17 mRNA	PMID:24935251
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313426	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TTC17 mRNA	PMID:21420995
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC17 mRNA	PMID:33387578
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313426	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC17 mRNA	PMID:22230336
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTC17 mRNA	PMID:40504410
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550206	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TTC17 mRNA	PMID:17555576
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TTC17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTC17 mRNA	PMID:28628672
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of TTC17 mRNA	PMID:24136188
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of TTC17 mRNA	PMID:30467583
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313426	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TTC17 mRNA	PMID:31758290
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550206	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TTC17 mRNA	PMID:22206623
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTC17 mRNA	PMID:27188386
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TTC17 gene]	PMID:28238834
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1550206	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of TTC17 mRNA	PMID:31558096
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313426	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTC17 mRNA	PMID:27188386
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TTC17 mRNA	PMID:19281266
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1550206	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of TTC17 protein	PMID:24648495
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TTC17 mRNA	PMID:21346803
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TTC17 mRNA	PMID:23034163
1305410	Ttc17	tetratricopeptide repeat domain 17	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of TTC17 mRNA	PMID:23034163
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313429	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CDC34 mRNA	PMID:33045310
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDC34 gene	PMID:20938992
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15368	acrolein	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20140812	CTD	MESH:D000171	Acrolein results in decreased expression of CDC34 protein	PMID:24812010
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CDC34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CDC34 mRNA	PMID:32699268
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313429	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CDC34 mRNA	PMID:24205000
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDC34 mRNA	PMID:30529165
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CDC34 mRNA	PMID:36331819
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of CDC34 mRNA	PMID:39506029
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313429	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of CDC34 mRNA	PMID:40945087
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of CDC34 mRNA	PMID:15353170
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313429	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CDC34 mRNA	PMID:39241906
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D004958	Estradiol affects the expression of CDC34 mRNA	PMID:15598610
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:16602	trichloroethene	affects expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D014241	Trichloroethylene affects the expression of CDC34 mRNA	PMID:21135412
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDC34 gene	PMID:20938992
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313428	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CDC34 mRNA	PMID:21179406
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313428	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of CDC34 mRNA	PMID:33647349
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313429	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of CDC34 mRNA	PMID:23892564
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDC34 mRNA	PMID:21318169
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313429	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDC34 mRNA	PMID:33754040
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of CDC34 mRNA	PMID:22061828
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313428	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CDC34 mRNA	PMID:28818685
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDC34 mRNA	PMID:36331819
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CDC34 mRNA	PMID:37236586
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313428	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CDC34 intron	PMID:30157460
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CDC34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CDC34 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of CDC34 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CDC34 mRNA	PMID:32699268|PMID:35430440
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CDC34 mRNA	PMID:34911549
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CDC34 mRNA	PMID:31150632
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313429	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CDC34 mRNA	PMID:25629700
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CDC34 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDC34 gene	PMID:20938992|PMID:22206623
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC34 mRNA	PMID:34747641
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC34 mRNA	PMID:21570461
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC34 mRNA	PMID:21354282
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313428	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CDC34 mRNA	PMID:28001369
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313428	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CDC34 mRNA	PMID:33212167
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CDC34 mRNA	PMID:30851411
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CDC34 mRNA	PMID:28959563
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDC34 protein	PMID:30528433
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313428	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CDC34 mRNA	PMID:38568856
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDC34 mRNA	PMID:16120219|PMID:20106945
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDC34 mRNA	PMID:22228805
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CDC34 mRNA	PMID:20458559
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313428	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CDC34 mRNA	PMID:17530438
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C032036	bromobenzene results in increased expression of CDC34 mRNA	PMID:15056800
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313429	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CDC34 promoter	PMID:35295148
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CDC34 mRNA	PMID:18648102
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313429	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CDC34 mRNA	PMID:18301758|PMID:23811191
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CDC34 gene	PMID:23968726
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of CDC34 mRNA	PMID:33296240
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313428	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CDC34 gene	PMID:31601247
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CDC34 mRNA	PMID:25181051|PMID:32145629
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313429	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CDC34 mRNA	PMID:32156529
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:36041667
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDC34 mRNA	PMID:28628672
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313429	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CDC34 mRNA	PMID:39298647
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:36041667
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:28628672
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:36041667
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDC34 mRNA	PMID:28628672
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CDC34 mRNA	PMID:22546817
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CDC34 mRNA	PMID:22546817
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313429	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of CDC34 mRNA	PMID:34813904
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:28628672
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CDC34 gene	PMID:23968726
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313428	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC34 mRNA	PMID:37042841
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CDC34 promoter	PMID:22457795
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CDC34 mRNA	PMID:37236586
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CDC34 mRNA	PMID:19162173|PMID:21318169
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CDC34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CDC34 mRNA	PMID:32699268
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D002994	Clofibrate results in increased expression of CDC34 mRNA	PMID:17585979
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of CDC34 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CDC34 mRNA]	PMID:17585979
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313429	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CDC34 mRNA	PMID:40194260
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313428	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CDC34 mRNA	PMID:31533062
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:3930	cryptolepine	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of CDC34 mRNA	PMID:16120219
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDC34 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CDC34 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CDC34 mRNA	PMID:36331819
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:C016104	sodium bichromate results in increased expression of CDC34 mRNA	PMID:22155349
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of CDC34 mRNA	PMID:21318169
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313428	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CDC34 mRNA	PMID:29154799
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313428	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CDC34 gene	PMID:29154799
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313428	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CDC34 promoter	PMID:27989131
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D013629	Tamoxifen results in increased expression of CDC34 mRNA	PMID:17555576
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:28628672
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1313428	E	RGD:6480464	20120412	CTD	MESH:D008727	CDC34 protein affects the susceptibility to Methotrexate	PMID:16217747
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313428	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CDC34 mRNA	PMID:38832940
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of CDC34 mRNA	PMID:29309887
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of CDC34 mRNA	PMID:21346803
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of CDC34 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CDC34 mRNA]	PMID:17585979
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313428	E	RGD:6480464	20120412	CTD	MESH:D005472	CDC34 protein affects the susceptibility to Fluorouracil	PMID:16217747
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313429	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of CDC34 mRNA	PMID:22334560
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:48707	(-)-citrinin	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20190219	CTD	MESH:D002953	Citrinin results in decreased expression of CDC34 mRNA	PMID:30428381
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:48707	(-)-citrinin	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20190219	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC34 mRNA	PMID:30428381
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:49553	copper(II) chloride	affects expression	ISO	RGD:1313428	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride affects the expression of CDC34 mRNA	PMID:17211630
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:28628672
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CDC34 mRNA	PMID:20458559
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313428	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CDC34 mRNA	PMID:17530438
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313429	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CDC34 mRNA	PMID:25620056
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CDC34 mRNA	PMID:24136188
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1313428	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of CDC34 mRNA	PMID:20977926
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313428	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of CDC34 mRNA	PMID:18651567
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CDC34 mRNA	PMID:19042947
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CDC34 protein	PMID:32959892
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CDC34 mRNA	PMID:18178546
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313429	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CDC34 mRNA	PMID:23650126
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20130611	CTD	MESH:D015655	U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CDC34 mRNA]	PMID:12710931
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313429	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CDC34 mRNA	PMID:36851058
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of CDC34 mRNA	PMID:29309887
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008701	Methapyrilene results in increased expression of CDC34 mRNA	PMID:16393664
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313429	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CDC34 mRNA	PMID:22206623
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CDC34 mRNA	PMID:22206623
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313428	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CDC34 mRNA	PMID:37199045
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1313428	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CDC34 mRNA	PMID:16120219
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of CDC34 mRNA	PMID:30428381
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1313428	E	RGD:6480464	20190219	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC34 mRNA	PMID:30428381
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313428	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CDC34 mRNA	PMID:30851411
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313428	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CDC34 mRNA	PMID:19159669
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital results in increased expression of CDC34 mRNA	PMID:19270015
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1313429	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of CDC34 mRNA	PMID:22334560
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:C045950	propiconazole results in increased expression of CDC34 mRNA	PMID:22334560
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CDC34 mRNA	PMID:21346803
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313428	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CDC34 mRNA	PMID:38568856
1305411	Cdc34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313429	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of CDC34 mRNA	PMID:35537566
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1332310	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of REXO5 mRNA	PMID:33045310
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:136004	linsidomine	increases oxidation	EXP		E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of REXO5 protein	PMID:28086193
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1601954	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of REXO5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of REXO5 mRNA	PMID:32699268
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1601954	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of REXO5 mRNA	PMID:29581250
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1332310	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of REXO5 mRNA	PMID:39298647
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1601954	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of REXO5 mRNA	PMID:28818685
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of REXO5 mRNA	PMID:25378103|PMID:33354967
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1601954	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of REXO5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of REXO5 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of REXO5 mRNA	PMID:32699268
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of REXO5 mRNA	PMID:31881176
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1332310	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of REXO5 mRNA	PMID:32186404
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of REXO5 gene	PMID:28505145
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of REXO5 mRNA	PMID:32109520
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of REXO5 mRNA	PMID:28959563
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1332310	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of REXO5 mRNA	PMID:39631538
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601954	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of REXO5 mRNA	PMID:29301061
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of REXO5 mRNA	PMID:38458666
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D013853	Thioacetamide results in increased expression of REXO5 mRNA	PMID:23411599
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of REXO5 mRNA	PMID:30816183|PMID:32528016
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332310	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of REXO5 mRNA	PMID:32156529
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of REXO5 mRNA	PMID:34947998
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332310	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of REXO5 mRNA	PMID:33221593
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of REXO5 gene	PMID:28505145
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1332310	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of REXO5 mRNA	PMID:39298647
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of REXO5 protein	PMID:34896426
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332310	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of REXO5 mRNA	PMID:38685157
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1332310	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of REXO5 intron	PMID:28392331
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1332310	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of REXO5 mRNA	PMID:37019170
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of REXO5 mRNA	PMID:38458666
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of REXO5 mRNA	PMID:35163327
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of REXO5 mRNA	PMID:30723492
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1601954	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of REXO5 mRNA	PMID:38568856
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of REXO5 mRNA	PMID:35163327
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C039281	furan results in increased expression of REXO5 mRNA	PMID:25539665
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1601954	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of REXO5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of REXO5 mRNA	PMID:32699268
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1601954	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of REXO5 mRNA	PMID:31533062
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of REXO5 protein	PMID:34896426
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of REXO5 protein	PMID:34896426
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of REXO5 protein	PMID:34896426
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1332310	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of REXO5 mRNA	PMID:28973697
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332310	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of REXO5 mRNA	PMID:28973697
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of REXO5 mRNA	PMID:33387578
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of REXO5 protein	PMID:34896426
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1601954	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of REXO5 mRNA	PMID:28988120
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of REXO5 mRNA	PMID:28801915
1305412	Rexo5	RNA exonuclease 5	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1601954	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of REXO5 mRNA	PMID:32234424
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1604530	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of MROH2B mRNA	PMID:34925699
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MROH2B gene	PMID:28931070
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313431	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of MROH2B mRNA	PMID:22401849
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313431	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MROH2B mRNA	PMID:34319233
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1604530	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MROH2B gene	PMID:27153756
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MROH2B mRNA	PMID:28959563
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313431	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of MROH2B protein	PMID:28918527
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604530	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MROH2B exon; Benzo(a)pyrene results in increased methylation of MROH2B promoter	PMID:27901495
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1604530	E	RGD:6480464	20161115	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of MROH2B gene	PMID:25435355
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313431	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of MROH2B exon	PMID:28392331
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:37187	lead nitrate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate results in decreased expression of MROH2B mRNA	PMID:21628963
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313431	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MROH2B mRNA	PMID:40194260
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1604530	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MROH2B gene	PMID:29154799
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1604530	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MROH2B mRNA	PMID:38832940
1305413	Mroh2b	maestro heat-like repeat family member 2B	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313431	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of MROH2B mRNA	PMID:23608068
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of UCHL5 mRNA	PMID:21934132|PMID:33167477
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol results in decreased expression of UCHL5 protein	PMID:19609968
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313432	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of UCHL5 mRNA	PMID:18951874
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313433	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of UCHL5 mRNA	PMID:39241906
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16583	butane-2,3-dione	increases expression	ISO	RGD:1313432	E	RGD:6480464	20211109	CTD	MESH:D003931	Diacetyl results in increased expression of UCHL5 protein	PMID:34031698
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313432	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of UCHL5 mRNA	PMID:38568856
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of UCHL5 mRNA	PMID:23649840
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313432	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of UCHL5 mRNA	PMID:21179406
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of UCHL5 mRNA	PMID:28818685
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UCHL5 mRNA	PMID:37236586
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of UCHL5 mRNA	PMID:23649840
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313432	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UCHL5 gene	PMID:27153756
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of UCHL5 mRNA	PMID:23649840
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of UCHL5 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of UCHL5 mRNA	PMID:34911549
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313433	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UCHL5 mRNA	PMID:31919559
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UCHL5 mRNA	PMID:21867686
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UCHL5 mRNA	PMID:22206623
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UCHL5 mRNA	PMID:39836092
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin results in increased phosphorylation of TP63 protein alternative form] promotes the reaction [ADRM1 protein binds to UCHL5 protein binds to TP63 protein alternative form]; Cisplatin promotes the reaction [ADRM1 protein binds to UCHL5 protein binds to STK11 protein alternative form]; Cisplatin promotes the reaction [NOS2 protein binds to ADRM1 protein binds to UCHL5 protein]; TP63 protein promotes the reaction [Cisplatin promotes the reaction [NOS2 protein binds to ADRM1 protein binds to UCHL5 protein]]	PMID:20959455|PMID:21191146
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019833	Genistein results in increased expression of UCHL5 protein	PMID:24552547
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313433	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UCHL5 mRNA	PMID:21570461
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UCHL5 mRNA	PMID:33387578
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313432	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of UCHL5 mRNA	PMID:23179753|PMID:26272509
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA	PMID:27188386
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of UCHL5 mRNA	PMID:33212167
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313433	E	RGD:6480464	20231205	CTD	MESH:C000228	aristolochic acid I results in increased expression of UCHL5 mRNA; aristolochic acid I results in increased expression of UCHL5 protein	PMID:26108275
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of UCHL5 mRNA	PMID:38568856
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UCHL5 mRNA	PMID:39836092
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UCHL5 mRNA	PMID:21839799
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313433	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UCHL5 mRNA	PMID:22228805
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313432	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of UCHL5 mRNA	PMID:25895662
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313432	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UCHL5 mRNA	PMID:20458559
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of UCHL5 mRNA	PMID:25729387
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313433	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UCHL5 gene	PMID:35295148
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UCHL5 mRNA	PMID:34492290
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313433	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of UCHL5 mRNA	PMID:18648102
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of UCHL5 mRNA	PMID:33670352
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313432	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of UCHL5 gene	PMID:31601247
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UCHL5 mRNA	PMID:25181051
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313432	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of UCHL5 protein	PMID:34186270
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of UCHL5 protein	PMID:33376534
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of UCHL5 mRNA	PMID:23196670
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313432	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of UCHL5 protein	PMID:31945527
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313432	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of UCHL5 gene	PMID:31601247
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313432	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of UCHL5 protein	PMID:34186270
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1313433	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of UCHL5 mRNA	PMID:36464114
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313432	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of UCHL5 gene	PMID:22964155
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313433	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UCHL5 mRNA	PMID:17361019|PMID:21266533
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1313432	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to UCHL5 protein	PMID:32991956
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313433	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased expression of UCHL5 mRNA	PMID:21371552
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20130514	CTD	MESH:D010269	[Paraquat co-treated with Maneb] results in increased expression of UCHL5 mRNA	PMID:18386188
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313432	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UCHL5 mRNA	PMID:37042841
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UCHL5 mRNA	PMID:33453195
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UCHL5 mRNA	PMID:37236586
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of UCHL5 mRNA	PMID:28302478
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313432	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of UCHL5 mRNA	PMID:19167446
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCHL5 mRNA	PMID:19167446
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of UCHL5 mRNA	PMID:22110744
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313432	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UCHL5 mRNA	PMID:25979313
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313432	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of UCHL5 gene	PMID:29154799
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313432	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of UCHL5 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA	PMID:27188386
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313432	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of UCHL5 mRNA	PMID:20106945|PMID:27989131
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of UCHL5 protein]	PMID:30980806
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of UCHL5 mRNA	PMID:24136188
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of UCHL5 mRNA	PMID:18754875
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313432	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of UCHL5 mRNA	PMID:24935251
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UCHL5 mRNA	PMID:39836092
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313432	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of UCHL5 mRNA	PMID:18175754
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313432	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UCHL5 mRNA	PMID:20458559
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313433	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of UCHL5 mRNA	PMID:25554681
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of UCHL5 mRNA	PMID:24136188
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UCHL5 mRNA	PMID:24136188
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20130514	CTD	MESH:D008344	[Paraquat co-treated with Maneb] results in increased expression of UCHL5 mRNA	PMID:18386188
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313433	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of UCHL5 mRNA	PMID:19042947
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UCHL5 protein	PMID:32959892
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of UCHL5 mRNA	PMID:25729387
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313433	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of UCHL5 mRNA	PMID:23650126
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1313433	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of UCHL5 mRNA	PMID:36464114
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313432	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of UCHL5 protein	PMID:34186270
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313433	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UCHL5 mRNA	PMID:22206623
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UCHL5 mRNA	PMID:22206623
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of UCHL5 mRNA	PMID:24136188
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA	PMID:27188386
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of UCHL5 mRNA; Irinotecan results in decreased expression of UCHL5 mRNA	PMID:15956246
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1313433	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of UCHL5 mRNA	PMID:22538082
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCHL5 mRNA	PMID:19167446
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of UCHL5 mRNA	PMID:21858171
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313432	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA	PMID:27188386
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013311	Streptozocin results in increased expression of UCHL5 protein	PMID:30980806
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D013311	4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of UCHL5 protein]	PMID:30980806
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313432	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of UCHL5 mRNA	PMID:38568856
1305414	Uchl5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of UCHL5 mRNA	PMID:21346803
1305415	Micall1	MICAL-like 1	gene	CHEBI:10022	deoxynivalenol	decreases phosphorylation	ISO	RGD:1602200	E	RGD:6480464	20211109	CTD	MESH:C007262	deoxynivalenol results in decreased phosphorylation of MICALL1 protein	PMID:33890134
1305415	Micall1	MICAL-like 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1602200	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MICALL1 mRNA	PMID:38218311
1305415	Micall1	MICAL-like 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313434	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of MICALL1 mRNA	PMID:37995155
1305415	Micall1	MICAL-like 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MICALL1 mRNA]	PMID:31150632
1305415	Micall1	MICAL-like 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313434	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MICALL1 mRNA	PMID:20938992
1305415	Micall1	MICAL-like 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313434	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MICALL1 mRNA	PMID:30319688
1305415	Micall1	MICAL-like 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313434	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MICALL1 mRNA	PMID:30319688
1305415	Micall1	MICAL-like 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1602200	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of MICALL1 mRNA	PMID:21632981
1305415	Micall1	MICAL-like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1602200	E	RGD:6480464	20120522	CTD	MESH:D004958	Estradiol results in increased expression of MICALL1 mRNA	PMID:20106945
1305415	Micall1	MICAL-like 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1602200	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of MICALL1 mRNA	PMID:38568856
1305415	Micall1	MICAL-like 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313434	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MICALL1 mRNA	PMID:20938992
1305415	Micall1	MICAL-like 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1602200	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MICALL1 mRNA	PMID:23649840
1305415	Micall1	MICAL-like 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MICALL1 mRNA	PMID:26577399|PMID:27523638
1305415	Micall1	MICAL-like 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1602200	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MICALL1 protein	PMID:37730182
1305415	Micall1	MICAL-like 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MICALL1 mRNA	PMID:33387578
1305415	Micall1	MICAL-like 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MICALL1 protein	PMID:23301498
1305415	Micall1	MICAL-like 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1602200	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MICALL1 mRNA	PMID:23649840
1305415	Micall1	MICAL-like 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1602200	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MICALL1 protein	PMID:20106945
1305415	Micall1	MICAL-like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313434	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MICALL1 mRNA	PMID:19770486
1305415	Micall1	MICAL-like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1602200	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MICALL1 mRNA	PMID:21632981|PMID:22100608
1305415	Micall1	MICAL-like 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1602200	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MICALL1 mRNA	PMID:23649840
1305415	Micall1	MICAL-like 1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MICALL1 mRNA	PMID:30779732
1305415	Micall1	MICAL-like 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MICALL1 mRNA	PMID:31150632
1305415	Micall1	MICAL-like 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MICALL1 mRNA]	PMID:31150632
1305415	Micall1	MICAL-like 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313434	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MICALL1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MICALL1 mRNA	PMID:20938992|PMID:22206623
1305415	Micall1	MICAL-like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MICALL1 mRNA	PMID:39836092
1305415	Micall1	MICAL-like 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of MICALL1 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of MICALL1 protein	PMID:38460933
1305415	Micall1	MICAL-like 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1602200	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MICALL1 mRNA	PMID:26272509
1305415	Micall1	MICAL-like 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA	PMID:27188386
1305415	Micall1	MICAL-like 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1602200	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MICALL1 protein	PMID:35688186
1305415	Micall1	MICAL-like 1	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313434	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of MICALL1 mRNA	PMID:35897073
1305415	Micall1	MICAL-like 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MICALL1 mRNA	PMID:23557933
1305415	Micall1	MICAL-like 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1602200	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of MICALL1 mRNA	PMID:27392435
1305415	Micall1	MICAL-like 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MICALL1 mRNA	PMID:27392435
1305415	Micall1	MICAL-like 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1602200	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MICALL1 mRNA	PMID:23179753|PMID:26272509
1305415	Micall1	MICAL-like 1	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA	PMID:27188386
1305415	Micall1	MICAL-like 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313434	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of MICALL1 mRNA	PMID:30807115
1305415	Micall1	MICAL-like 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602200	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MICALL1 mRNA	PMID:29803840
1305415	Micall1	MICAL-like 1	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1602200	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of MICALL1 protein	PMID:35688186
1305415	Micall1	MICAL-like 1	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313434	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of MICALL1 gene	PMID:39894169
1305415	Micall1	MICAL-like 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602200	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MICALL1 mRNA	PMID:38568856|PMID:39719251
1305415	Micall1	MICAL-like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MICALL1 mRNA	PMID:39836092
1305415	Micall1	MICAL-like 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1602200	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MICALL1 mRNA	PMID:20106945|PMID:21632981|PMID:32234424
1305415	Micall1	MICAL-like 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MICALL1 mRNA]	PMID:32406909
1305415	Micall1	MICAL-like 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MICALL1 gene	PMID:31601247
1305415	Micall1	MICAL-like 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313434	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MICALL1 mRNA	PMID:23557971
1305415	Micall1	MICAL-like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313434	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MICALL1 gene	PMID:35295148
1305415	Micall1	MICAL-like 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MICALL1 mRNA	PMID:34492290
1305415	Micall1	MICAL-like 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MICALL1 mRNA	PMID:38479592
1305415	Micall1	MICAL-like 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MICALL1 mRNA	PMID:25181051
1305415	Micall1	MICAL-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of MICALL1 mRNA	PMID:32145629
1305415	Micall1	MICAL-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1602200	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of MICALL1 protein	PMID:31675489
1305415	Micall1	MICAL-like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313434	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MICALL1 mRNA	PMID:26063408
1305415	Micall1	MICAL-like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MICALL1 gene	PMID:31601247
1305415	Micall1	MICAL-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313434	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MICALL1 gene	PMID:31683443
1305415	Micall1	MICAL-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313434	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MICALL1 mRNA	PMID:39298647
1305415	Micall1	MICAL-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313434	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of MICALL1 exon	PMID:33297965
1305415	Micall1	MICAL-like 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1602200	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MICALL1 mRNA	PMID:19320972
1305415	Micall1	MICAL-like 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1602200	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MICALL1 mRNA	PMID:32588087
1305415	Micall1	MICAL-like 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1602200	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MICALL1 mRNA	PMID:28302478
1305415	Micall1	MICAL-like 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602200	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MICALL1 mRNA	PMID:31533062
1305415	Micall1	MICAL-like 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1602200	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of MICALL1 mRNA	PMID:19167446
1305415	Micall1	MICAL-like 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313434	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of MICALL1 mRNA	PMID:39529242
1305415	Micall1	MICAL-like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602200	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MICALL1 mRNA	PMID:25979313
1305415	Micall1	MICAL-like 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313434	E	RGD:6480464	20120522	CTD	MESH:D014635	Valproic Acid results in increased expression of MICALL1 mRNA	PMID:21427059
1305415	Micall1	MICAL-like 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602200	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MICALL1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:29154799
1305415	Micall1	MICAL-like 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA	PMID:27188386
1305415	Micall1	MICAL-like 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1602200	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MICALL1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305415	Micall1	MICAL-like 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313434	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MICALL1 mRNA	PMID:28973697
1305415	Micall1	MICAL-like 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1602200	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MICALL1 mRNA	PMID:38832940
1305415	Micall1	MICAL-like 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1602200	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MICALL1 mRNA	PMID:24935251|PMID:26272509
1305415	Micall1	MICAL-like 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA	PMID:27188386
1305415	Micall1	MICAL-like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313434	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of MICALL1 mRNA	PMID:17562736
1305415	Micall1	MICAL-like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MICALL1 mRNA	PMID:33387578
1305415	Micall1	MICAL-like 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1602200	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MICALL1 mRNA	PMID:22230336
1305415	Micall1	MICAL-like 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313434	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MICALL1 mRNA	PMID:29279043
1305415	Micall1	MICAL-like 1	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1313434	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of MICALL1 mRNA	PMID:29279043
1305415	Micall1	MICAL-like 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of MICALL1 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of MICALL1 protein	PMID:38460933
1305415	Micall1	MICAL-like 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MICALL1 mRNA	PMID:39836092
1305415	Micall1	MICAL-like 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1602200	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of MICALL1 mRNA	PMID:31675489
1305415	Micall1	MICAL-like 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313434	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MICALL1 mRNA	PMID:35436446
1305415	Micall1	MICAL-like 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313434	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MICALL1 mRNA; Nanotubes, Carbon results in increased expression of MICALL1 mRNA	PMID:25554681
1305415	Micall1	MICAL-like 1	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1313434	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of MICALL1 mRNA	PMID:26377693
1305415	Micall1	MICAL-like 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1602200	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MICALL1 protein	PMID:32959892
1305415	Micall1	MICAL-like 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313434	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of MICALL1 mRNA	PMID:26307267
1305415	Micall1	MICAL-like 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1602200	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MICALL1 mRNA	PMID:31758290
1305415	Micall1	MICAL-like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313434	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MICALL1 mRNA	PMID:22206623
1305415	Micall1	MICAL-like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA	PMID:27188386
1305415	Micall1	MICAL-like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MICALL1 gene]	PMID:28238834
1305415	Micall1	MICAL-like 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1602200	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MICALL1 mRNA	PMID:19159669
1305415	Micall1	MICAL-like 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1602200	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MICALL1 protein	PMID:31675489
1305415	Micall1	MICAL-like 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1602200	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MICALL1 protein	PMID:31675489
1305415	Micall1	MICAL-like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MICALL1 mRNA	PMID:24780913
1305415	Micall1	MICAL-like 1	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1602200	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of MICALL1 mRNA	PMID:26272509
1305415	Micall1	MICAL-like 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA	PMID:27188386
1305415	Micall1	MICAL-like 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313434	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of MICALL1 mRNA	PMID:40826991
1305415	Micall1	MICAL-like 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602200	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MICALL1 mRNA	PMID:27188386
1305415	Micall1	MICAL-like 1	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313434	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of MICALL1 mRNA	PMID:35537566
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of ATPAF1 mRNA	PMID:19371625
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:132098	methoxyacetic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of ATPAF1 mRNA	PMID:20864626
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313436	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATPAF1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of ATPAF1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATPAF1 mRNA	PMID:32699268|PMID:32845096
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313436	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ATPAF1 mRNA	PMID:24763279
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ATPAF1 mRNA	PMID:22378314
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313436	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATPAF1 mRNA	PMID:37042841
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ATPAF1 mRNA	PMID:23649840
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313436	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ATPAF1 mRNA	PMID:21179406
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1619843	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ATPAF1 mRNA	PMID:23892564
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ATPAF1 mRNA	PMID:33387578
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ATPAF1 mRNA	PMID:28818685
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313436	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATPAF1 mRNA	PMID:35301059
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313436	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ATPAF1 protein	PMID:23301498
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ATPAF1 mRNA	PMID:21396975
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313436	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATPAF1 gene	PMID:27153756
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313436	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATPAF1 mRNA	PMID:23649840
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313436	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATPAF1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of ATPAF1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATPAF1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ATPAF1 mRNA	PMID:32699268|PMID:32845096
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ATPAF1 mRNA	PMID:21867686
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313436	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATPAF1 gene	PMID:25304211
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of ATPAF1 mRNA	PMID:20864626
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1619843	E	RGD:6480464	20120412	CTD	MESH:D003042	[Cocaine co-treated with FOS protein mutant form] results in decreased expression of ATPAF1 mRNA	PMID:18355967
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATPAF1 mRNA	PMID:21632981
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1619843	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATPAF1 mRNA	PMID:20399798
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ATPAF1 mRNA	PMID:20864626
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ATPAF1 mRNA	PMID:28001369
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ATPAF1 mRNA	PMID:33212167
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATPAF1 mRNA	PMID:29803840
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1619843	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATPAF1 mRNA	PMID:39631538
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313436	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ATPAF1 mRNA	PMID:29432896
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313436	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of ATPAF1 mRNA	PMID:29319823
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1619843	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of ATPAF1 mRNA	PMID:33053406
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1619843	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ATPAF1 mRNA	PMID:18648102
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATPAF1 mRNA	PMID:25181051
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313436	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ATPAF1 mRNA	PMID:30903817
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ATPAF1 mRNA	PMID:33670352
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1619843	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ATPAF1 mRNA	PMID:38685157
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1619843	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ATPAF1 mRNA	PMID:21266533
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313436	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATPAF1 mRNA	PMID:35301059
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313436	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATPAF1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATPAF1 mRNA	PMID:32699268
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ATPAF1 mRNA	PMID:28302478
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ATPAF1 mRNA	PMID:31533062
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313436	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATPAF1 mRNA	PMID:25979313
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313436	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ATPAF1 mRNA	PMID:23179753|PMID:37505509
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATPAF1 mRNA	PMID:20106945|PMID:25562108
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313436	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATPAF1 gene	PMID:25304211
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ATPAF1 mRNA	PMID:29391264
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ATPAF1 mRNA	PMID:24136188
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1619843	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ATPAF1 mRNA	PMID:22206623
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:7602	nobiletin	multiple interactions	ISO	RGD:1313436	E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of ATPAF1 protein]	PMID:38348393
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313436	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in increased expression of ATPAF1 mRNA	PMID:30559759
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:8107	phenytoin	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in decreased expression of ATPAF1 mRNA	PMID:20345932
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of ATPAF1 mRNA	PMID:19095052
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of ATPAF1 protein	PMID:38348393
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313436	E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of ATPAF1 protein]	PMID:38348393
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1619843	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of ATPAF1 mRNA	PMID:21278054
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:88522	Monobutylphthalate	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of ATPAF1 mRNA	PMID:20864626
1305417	Atpaf1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313436	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ATPAF1 mRNA	PMID:38568856
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313439	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RARS2 mRNA	PMID:38218311
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of RARS2 protein	PMID:36641056
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313440	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RARS2 mRNA	PMID:36331819
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313440	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RARS2 mRNA	PMID:30319688
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20191008	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RARS2 mRNA	PMID:31059760
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313440	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RARS2 mRNA	PMID:39241906
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313439	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of RARS2 mRNA	PMID:31059760
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313439	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RARS2 mRNA	PMID:38568856
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313439	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RARS2 mRNA	PMID:37042841
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313440	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of RARS2 mRNA	PMID:17251523
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313440	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RARS2 mRNA	PMID:37236586
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313439	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RARS2 gene	PMID:27153756
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313439	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RARS2 mRNA	PMID:23557933
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313440	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RARS2 mRNA	PMID:21570461
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RARS2 mRNA	PMID:33387578
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RARS2 mRNA	PMID:33212167
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RARS2 mRNA	PMID:30851411
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of RARS2 mRNA	PMID:39719251
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313439	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RARS2 mRNA	PMID:38568856
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313440	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RARS2 mRNA	PMID:22228805
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313440	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of RARS2 protein	PMID:37955338
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RARS2 mRNA	PMID:20018196
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RARS2 mRNA	PMID:25729387
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RARS2 mRNA	PMID:34492290
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33146	vanadyl sulfate	increases expression	ISO	RGD:1313439	E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in increased expression of RARS2 mRNA	PMID:16330358
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RARS2 mRNA	PMID:30816183|PMID:32528016
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RARS2 mRNA	PMID:25181051
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313439	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RARS2 mRNA	PMID:25047013
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313440	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of RARS2 mRNA	PMID:26682919
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313440	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RARS2 mRNA	PMID:39298647
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313440	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RARS2 mRNA	PMID:17361019|PMID:21266533
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313439	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RARS2 mRNA	PMID:37042841
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313440	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RARS2 mRNA	PMID:37236586
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313439	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RARS2 mRNA	PMID:24449571
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RARS2 mRNA	PMID:28302478
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RARS2 mRNA	PMID:31533062
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313440	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RARS2 mRNA	PMID:36331819
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313439	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RARS2 mRNA	PMID:25979313
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RARS2 mRNA	PMID:23179753
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313439	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RARS2 gene	PMID:29154799
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RARS2 mRNA	PMID:33387578
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of RARS2 mRNA	PMID:25704631|PMID:31059760
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313439	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of RARS2 mRNA	PMID:31059760
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RARS2 mRNA	PMID:24136188
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RARS2 mRNA	PMID:25729387
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313440	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RARS2 mRNA	PMID:23650126
1305419	Rars2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313439	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RARS2 mRNA	PMID:30851411
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313441	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TRMO mRNA	PMID:38218311
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313441	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TRMO mRNA	PMID:22378314
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TRMO mRNA	PMID:33387578
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313441	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRMO mRNA	PMID:37042841
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TRMO mRNA	PMID:33387578
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313441	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TRMO mRNA	PMID:19549813
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C016517	indole-3-carbinol affects the expression of TRMO mRNA	PMID:21396975
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313441	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TRMO mRNA	PMID:23649840
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313441	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRMO mRNA	PMID:39836092
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313441	E	RGD:6480464	20160315	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TRMO mRNA	PMID:26272509
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313441	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMO mRNA	PMID:27188386
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313442	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of TRMO mRNA	PMID:40618947
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRMO mRNA	PMID:33387578
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313441	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TRMO mRNA	PMID:30851411
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313441	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRMO mRNA	PMID:29803840
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313441	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TRMO mRNA	PMID:38568856
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313441	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRMO mRNA	PMID:39836092
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313441	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TRMO mRNA	PMID:35984750
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of TRMO mRNA	PMID:25729387
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TRMO mRNA	PMID:25729387
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313442	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TRMO mRNA	PMID:29264374
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRMO mRNA	PMID:25181051
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TRMO mRNA	PMID:34947998
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313441	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TRMO mRNA	PMID:25979313
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313442	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TRMO mRNA	PMID:38685157
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313442	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of TRMO mRNA	PMID:28392331
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313441	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRMO mRNA	PMID:37042841
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313441	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TRMO mRNA	PMID:38174414|PMID:38568856
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313441	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TRMO mRNA	PMID:28302478
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313441	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRMO mRNA	PMID:23179753
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313441	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TRMO mRNA	PMID:20106945
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TRMO mRNA	PMID:33387578
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313441	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRMO mRNA	PMID:39836092
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of TRMO mRNA	PMID:25729387
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TRMO mRNA	PMID:25729387
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313441	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TRMO mRNA	PMID:30851411
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313441	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMO mRNA	PMID:27188386
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1313441	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of TRMO mRNA	PMID:24921660
1305420	Trmo	tRNA methyltransferase O	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313441	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMO mRNA	PMID:27188386
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1353596	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RUBCN mRNA	PMID:38218311
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1353596	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of RUBCN mRNA	PMID:26272509
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1353596	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RUBCN mRNA	PMID:27188386
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of RUBCN gene	PMID:35440735
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313444	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RUBCN mRNA	PMID:30319688
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313444	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RUBCN mRNA	PMID:30319688
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313444	E	RGD:6480464	20181113	CTD	MESH:D004958	[Polyphenols co-treated with Estradiol] results in decreased expression of RUBCN mRNA	PMID:30077407
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1353596	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RUBCN protein	PMID:37730182
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1353596	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RUBCN mRNA	PMID:28818685
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313444	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RUBCN mRNA	PMID:37236586
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1353596	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUBCN mRNA	PMID:35301059
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1353596	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RUBCN mRNA; [Ozone results in increased abundance of Soot metabolite] which results in decreased expression of RUBCN mRNA	PMID:28410501|PMID:35430440
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313444	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RUBCN mRNA	PMID:40504410
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1353596	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RUBCN mRNA	PMID:29803840
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353596	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RUBCN mRNA	PMID:38568856
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313444	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RUBCN mRNA	PMID:40504410
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1353596	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RUBCN 5' UTR	PMID:27901495
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1353596	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RUBCN mRNA	PMID:25351596
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RUBCN mRNA	PMID:25181051|PMID:30816183
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313444	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RUBCN mRNA	PMID:33221593
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1353596	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RUBCN mRNA	PMID:25979313
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of RUBCN mRNA	PMID:32119087
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313444	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RUBCN mRNA	PMID:39298647
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313444	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RUBCN mRNA	PMID:37019170
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313444	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RUBCN mRNA	PMID:37236586
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1353596	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUBCN mRNA	PMID:35301059
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1353596	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of RUBCN mRNA	PMID:28302478
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1353596	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RUBCN mRNA	PMID:31533062
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353596	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RUBCN mRNA	PMID:25979313
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353596	E	RGD:6480464	20161115	CTD	MESH:D014635	Valproic Acid results in increased expression of RUBCN mRNA	PMID:23179753|PMID:27188386
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1353596	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RUBCN mRNA	PMID:20106945|PMID:25562108
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1353596	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of RUBCN mRNA	PMID:29067470
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313444	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RUBCN mRNA	PMID:40504410
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1353596	E	RGD:6480464	20161115	CTD	MESH:C082360	fipronil results in decreased expression of RUBCN mRNA	PMID:27091632
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:5063	fipronil	multiple interactions	ISO	RGD:1353596	E	RGD:6480464	20161115	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of RUBCN mRNA	PMID:27091632
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313444	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RUBCN mRNA	PMID:35964746
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1353596	E	RGD:6480464	20120522	CTD	MESH:C029938	nickel sulfate results in increased expression of RUBCN mRNA	PMID:16780908
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RUBCN gene	PMID:35440735
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1353596	E	RGD:6480464	20161115	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of RUBCN mRNA	PMID:27091632
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1353596	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of RUBCN mRNA	PMID:19946333
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1353596	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RUBCN mRNA	PMID:27188386
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313444	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RUBCN mRNA	PMID:40826991
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353596	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RUBCN mRNA	PMID:27188386
1305422	Rubcn	rubicon autophagy regulator	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1353596	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RUBCN mRNA	PMID:38568856
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1603895	E	RGD:6480464	20191008	CTD	MESH:C000628730	graphene oxide results in increased expression of EFCAB3 mRNA	PMID:29348435
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1603895	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of EFCAB3 mRNA	PMID:35811015
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1603895	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of EFCAB3 mRNA	PMID:31614463
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313445	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of EFCAB3 mRNA	PMID:23892564
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	decreases expression	ISO	RGD:1603895	E	RGD:6480464	20140408	CTD	MESH:D014284	Triiodothyronine results in decreased expression of EFCAB3 mRNA	PMID:23397585
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1603895	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of EFCAB3 mRNA	PMID:23649840
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFCAB3 mRNA	PMID:22129741
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1603895	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EFCAB3 gene	PMID:27153756
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1603895	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EFCAB3 intron	PMID:30157460
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1603895	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of EFCAB3 mRNA	PMID:23649840
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313445	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EFCAB3 mRNA	PMID:25629700
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313445	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of EFCAB3 mRNA	PMID:28960355
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D003042	Cocaine affects the expression of EFCAB3 mRNA	PMID:20187946
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D003042	Cocaine results in decreased expression of EFCAB3 mRNA	PMID:17898221
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1603895	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of EFCAB3 mRNA	PMID:25583101
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EFCAB3 mRNA	PMID:32109520
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFCAB3 mRNA	PMID:22129741
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603895	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EFCAB3 exon	PMID:27901495
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313445	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of EFCAB3 mRNA	PMID:23557971
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EFCAB3 mRNA	PMID:25181051
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313445	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of EFCAB3 mRNA	PMID:32156529
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EFCAB3 mRNA	PMID:34947998
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFCAB3 mRNA	PMID:22129741
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of EFCAB3 gene	PMID:33148267
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1603895	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of EFCAB3 mRNA	PMID:28542535
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of EFCAB3 mRNA	PMID:30723492
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1603895	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of EFCAB3 mRNA	PMID:35811015
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1603895	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of EFCAB3 mRNA	PMID:35811015
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of EFCAB3 gene	PMID:33148267
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603895	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EFCAB3 gene]	PMID:28238834
1305423	Efcab3	EF-hand calcium binding domain 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of EFCAB3 mRNA	PMID:32109520
1305424	Tspan11	tetraspanin 11	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552634	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TSPAN11 mRNA	PMID:30319688
1305424	Tspan11	tetraspanin 11	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1604416	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TSPAN11 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TSPAN11 mRNA	PMID:35811015
1305424	Tspan11	tetraspanin 11	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1604416	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of TSPAN11 mRNA	PMID:20660070
1305424	Tspan11	tetraspanin 11	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1604416	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of TSPAN11 mRNA	PMID:20660070
1305424	Tspan11	tetraspanin 11	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1604416	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TSPAN11 intron	PMID:30157460
1305424	Tspan11	tetraspanin 11	gene	CHEBI:2208	purine-6-thiol	decreases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D015122	Mercaptopurine results in decreased expression of TSPAN11 mRNA	PMID:23358152
1305424	Tspan11	tetraspanin 11	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604416	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TSPAN11 intron	PMID:30157460
1305424	Tspan11	tetraspanin 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552634	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TSPAN11 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TSPAN11 mRNA	PMID:34911549
1305424	Tspan11	tetraspanin 11	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1552634	E	RGD:6480464	20130618	CTD	MESH:D001151	Arsenic results in decreased expression of TSPAN11 mRNA	PMID:19654921
1305424	Tspan11	tetraspanin 11	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1604416	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TSPAN11 mRNA	PMID:24768652|PMID:25583101
1305424	Tspan11	tetraspanin 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552634	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TSPAN11 promoter]	PMID:19654925
1305424	Tspan11	tetraspanin 11	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TSPAN11 mRNA	PMID:28959563
1305424	Tspan11	tetraspanin 11	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TSPAN11 mRNA	PMID:26033743
1305424	Tspan11	tetraspanin 11	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of TSPAN11 mRNA	PMID:26033743
1305424	Tspan11	tetraspanin 11	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1604416	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TSPAN11 mRNA	PMID:29803840|PMID:30031762
1305424	Tspan11	tetraspanin 11	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604416	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of TSPAN11 mRNA	PMID:37939567
1305424	Tspan11	tetraspanin 11	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604416	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TSPAN11 intron	PMID:30157460
1305424	Tspan11	tetraspanin 11	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604416	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TSPAN11 promoter	PMID:27901495
1305424	Tspan11	tetraspanin 11	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TSPAN11 mRNA	PMID:26033743
1305424	Tspan11	tetraspanin 11	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of TSPAN11 mRNA	PMID:26033743
1305424	Tspan11	tetraspanin 11	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1604416	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TSPAN11 mRNA	PMID:25895662
1305424	Tspan11	tetraspanin 11	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TSPAN11 mRNA	PMID:30012374
1305424	Tspan11	tetraspanin 11	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552634	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of TSPAN11 mRNA	PMID:27760801
1305424	Tspan11	tetraspanin 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TSPAN11 mRNA	PMID:25181051
1305424	Tspan11	tetraspanin 11	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604416	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TSPAN11 gene	PMID:31601247
1305424	Tspan11	tetraspanin 11	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN11 mRNA	PMID:34947998|PMID:41034487
1305424	Tspan11	tetraspanin 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552634	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN11 mRNA	PMID:30951980
1305424	Tspan11	tetraspanin 11	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1604416	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TSPAN11 mRNA	PMID:25979313
1305424	Tspan11	tetraspanin 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552634	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TSPAN11 mRNA	PMID:30951980
1305424	Tspan11	tetraspanin 11	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552634	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TSPAN11 mRNA	PMID:30951980
1305424	Tspan11	tetraspanin 11	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552634	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TSPAN11 intron	PMID:28392331
1305424	Tspan11	tetraspanin 11	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552634	E	RGD:6480464	20130618	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TSPAN11 mRNA	PMID:21266533
1305424	Tspan11	tetraspanin 11	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of TSPAN11 mRNA	PMID:32680482
1305424	Tspan11	tetraspanin 11	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1604416	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of TSPAN11 mRNA	PMID:36326898
1305424	Tspan11	tetraspanin 11	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TSPAN11 mRNA	PMID:27387713
1305424	Tspan11	tetraspanin 11	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1552634	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TSPAN11 mRNA	PMID:40194260
1305424	Tspan11	tetraspanin 11	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1604416	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TSPAN11 mRNA	PMID:31533062
1305424	Tspan11	tetraspanin 11	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1552634	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of TSPAN11 mRNA	PMID:29038090
1305424	Tspan11	tetraspanin 11	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1552634	E	RGD:6480464	20130618	CTD	MESH:D002737	Chloroprene results in increased expression of TSPAN11 mRNA	PMID:23125180
1305424	Tspan11	tetraspanin 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604416	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TSPAN11 mRNA	PMID:25979313
1305424	Tspan11	tetraspanin 11	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604416	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TSPAN11 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305424	Tspan11	tetraspanin 11	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604416	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN11 mRNA	PMID:27188386
1305424	Tspan11	tetraspanin 11	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TSPAN11 mRNA	PMID:30047161
1305424	Tspan11	tetraspanin 11	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1604416	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of TSPAN11 mRNA	PMID:25047013
1305424	Tspan11	tetraspanin 11	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1604416	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of TSPAN11 mRNA	PMID:24935251
1305424	Tspan11	tetraspanin 11	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1604416	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of TSPAN11 mRNA	PMID:26690555
1305424	Tspan11	tetraspanin 11	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1604416	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TSPAN11 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TSPAN11 mRNA	PMID:35811015
1305424	Tspan11	tetraspanin 11	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1552634	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of TSPAN11 mRNA	PMID:19654921
1305424	Tspan11	tetraspanin 11	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552634	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TSPAN11 mRNA; Nanotubes, Carbon results in increased expression of TSPAN11 mRNA	PMID:25554681
1305424	Tspan11	tetraspanin 11	gene	CHEBI:50667	mercaptopurine	decreases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D015122	Mercaptopurine results in decreased expression of TSPAN11 mRNA	PMID:23358152
1305424	Tspan11	tetraspanin 11	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TSPAN11 mRNA	PMID:30047161
1305424	Tspan11	tetraspanin 11	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552634	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TSPAN11 mRNA	PMID:23650126
1305424	Tspan11	tetraspanin 11	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604416	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN11 mRNA	PMID:27188386
1305424	Tspan11	tetraspanin 11	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604416	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TSPAN11 gene]	PMID:28238834
1305424	Tspan11	tetraspanin 11	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TSPAN11 mRNA	PMID:30047161
1305424	Tspan11	tetraspanin 11	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604416	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN11 mRNA	PMID:27188386
1305424	Tspan11	tetraspanin 11	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of TSPAN11 mRNA	PMID:23358152
1305424	Tspan11	tetraspanin 11	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of TSPAN11 gene	PMID:31079544
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300LE mRNA	PMID:32741896
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300LE mRNA	PMID:32741896
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CD300LE mRNA	PMID:30779732
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CD300LE mRNA	PMID:31881176
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of CD300LE mRNA	PMID:30556269
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of CD300LE mRNA	PMID:30556269
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CD300LE mRNA	PMID:30047161
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CD300LE mRNA	PMID:34492290
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CD300LE mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of CD300LE mRNA	PMID:41034487
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CD300LE gene	PMID:28505145
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of CD300LE mRNA	PMID:35163327
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CD300LE mRNA	PMID:35163327
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CD300LE mRNA	PMID:27387713
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CD300LE mRNA	PMID:29391264
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CD300LE mRNA	PMID:30047161
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300LE mRNA	PMID:32741896
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of CD300LE mRNA	PMID:30047161
1305426	Cd300le	Cd300 molecule-like family member E	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CD300LE mRNA	PMID:30047161
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313452	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KDM5A mRNA	PMID:38218311
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313453	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KDM5A mRNA	PMID:33045310
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313452	E	RGD:6480464	20141014	CTD	MESH:D014212	Tretinoin results in increased expression of KDM5A mRNA	PMID:22906706|PMID:33167477
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of KDM5A mRNA	PMID:22378314
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20220510	CTD	MESH:D000431	Ethanol results in decreased expression of KDM5A protein	PMID:35149083
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313452	E	RGD:6480464	20120522	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of KDM5A mRNA	PMID:20044591
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:16243	quercetin	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin affects the expression of KDM5A mRNA	PMID:18178720
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KDM5A mRNA	PMID:39241906
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of KDM5A gene	PMID:21212295
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313452	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KDM5A mRNA	PMID:37042841
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313452	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KDM5A protein	PMID:37730182
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of KDM5A mRNA	PMID:22061828|PMID:33387578
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313452	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KDM5A mRNA	PMID:28818685
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KDM5A mRNA	PMID:35301059
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of KDM5A mRNA	PMID:37236586
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:232469	Crenigacestat	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20241203	CTD	MESH:C000654634	crenigacestat inhibits the reaction [Aconitine results in increased expression of KDM5A protein]	PMID:32234357
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313452	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KDM5A mRNA	PMID:19549813
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1313452	E	RGD:6480464	20201006	CTD	MESH:D000157	Aconitine results in increased expression of KDM5A protein	PMID:32234357
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:2430	aconitine	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20201006	CTD	MESH:D000157	Aconitine promotes the reaction [NOTCH1 protein modified form binds to KDM5A protein]; crenigacestat inhibits the reaction [Aconitine results in increased expression of KDM5A protein]	PMID:32234357
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313452	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KDM5A gene	PMID:27153756
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313453	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KDM5A mRNA	PMID:19770486
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of KDM5A mRNA	PMID:26760959
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313452	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KDM5A mRNA	PMID:23649840
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of KDM5A mRNA	PMID:41430723
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of KDM5A gene	PMID:35440735
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of KDM5A mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of KDM5A mRNA	PMID:19167446|PMID:23557933
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of KDM5A mRNA	PMID:30912803
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KDM5A mRNA	PMID:33387578|PMID:34747641
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KDM5A mRNA	PMID:31961203
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20120522	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of KDM5A gene	PMID:21212295
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of KDM5A mRNA	PMID:33512557
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KDM5A mRNA	PMID:28001369
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of KDM5A mRNA	PMID:28959563
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of KDM5A mRNA	PMID:38578163
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313452	E	RGD:6480464	20200211	CTD	MESH:C017947	sodium arsenite results in increased expression of KDM5A mRNA; sodium arsenite results in increased expression of KDM5A protein	PMID:29148585|PMID:38568856
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KDM5A mRNA	PMID:19150397
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313452	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of KDM5A mRNA	PMID:26238291
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1313452	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of KDM5A gene	PMID:31601247
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313453	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KDM5A gene; titanium dioxide results in decreased methylation of KDM5A promoter alternative form	PMID:35295148
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313453	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of KDM5A mRNA	PMID:29264374
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of KDM5A mRNA	PMID:28329830
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313453	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of KDM5A promoter	PMID:27334623
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KDM5A mRNA	PMID:25181051|PMID:30816183
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313452	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of KDM5A intron	PMID:30157460
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KDM5A mRNA	PMID:37019170
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:34778	glycitein	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1313452	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of KDM5A mRNA	PMID:37047231
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313452	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KDM5A mRNA	PMID:37042841
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KDM5A mRNA	PMID:35301059
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of KDM5A mRNA	PMID:37236586
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of KDM5A mRNA	PMID:24386269
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313452	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of KDM5A mRNA	PMID:19376846
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313452	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KDM5A mRNA	PMID:31533062
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of KDM5A mRNA	PMID:19167446
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of KDM5A mRNA	PMID:19167446
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of KDM5A mRNA	PMID:23125180
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of KDM5A mRNA	PMID:29427782
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of KDM5A mRNA	PMID:29427782
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of KDM5A mRNA	PMID:23179753|PMID:27188386
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of KDM5A mRNA	PMID:25562108
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313452	E	RGD:6480464	20120522	CTD	MESH:D013629	Tamoxifen results in increased expression of KDM5A mRNA	PMID:15590111
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313453	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KDM5A mRNA	PMID:28973697
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313453	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of KDM5A mRNA	PMID:17562736
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KDM5A mRNA	PMID:33387578
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20120522	CTD	MESH:D005472	Fluorouracil results in decreased expression of KDM5A mRNA	PMID:16557594
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20120522	CTD	MESH:D018038	Sodium Selenite results in decreased expression of KDM5A mRNA	PMID:16705456
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313452	E	RGD:6480464	20120522	CTD	MESH:D018038	Sodium Selenite results in increased expression of KDM5A mRNA	PMID:18175754
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of KDM5A mRNA	PMID:24793618
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313452	E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in increased expression of KDM5A mRNA	PMID:11678601
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] affects the expression of KDM5A mRNA	PMID:26378955
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313452	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of KDM5A mRNA	PMID:28988120
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313452	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of KDM5A intron	PMID:30157460
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KDM5A mRNA	PMID:22206623
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313452	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of KDM5A mRNA	PMID:37199045
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KDM5A gene]	PMID:28238834
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:80373	glycitin	multiple interactions	ISO	RGD:1313452	E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313453	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of KDM5A mRNA	PMID:23091169
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of KDM5A mRNA	PMID:23091169
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:81555	Enterolactone	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM5A mRNA	PMID:19167446
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1313452	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of KDM5A mRNA	PMID:33512557
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1313452	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of KDM5A mRNA	PMID:17440010
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313452	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KDM5A mRNA	PMID:38568856
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:95077	GSK-J4	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of KDM5A mRNA]; GSK-J4 inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of KDM5A protein]	PMID:36537648
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of KDM5A mRNA	PMID:28973697
1305429	Kdm5a	lysine demethylase 5A	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of KDM5A mRNA	PMID:18042343
1305430	Cdh18	cadherin 18	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313454	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CDH18 mRNA	PMID:26272509
1305430	Cdh18	cadherin 18	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313454	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1305430	Cdh18	cadherin 18	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1615561	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CDH18 mRNA	PMID:37995155
1305430	Cdh18	cadherin 18	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of CDH18 gene	PMID:35440735
1305430	Cdh18	cadherin 18	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1615561	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CDH18 mRNA	PMID:30319688
1305430	Cdh18	cadherin 18	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313454	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in increased expression of CDH18 mRNA	PMID:17555868
1305430	Cdh18	cadherin 18	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA	PMID:25510870
1305430	Cdh18	cadherin 18	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CDH18 mRNA	PMID:33387578
1305430	Cdh18	cadherin 18	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDH18 mRNA	PMID:37992649
1305430	Cdh18	cadherin 18	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDH18 mRNA	PMID:37992649
1305430	Cdh18	cadherin 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313454	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CDH18 mRNA	PMID:31163220
1305430	Cdh18	cadherin 18	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA	PMID:25510870
1305430	Cdh18	cadherin 18	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA	PMID:25510870
1305430	Cdh18	cadherin 18	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313454	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CDH18 gene	PMID:27153756
1305430	Cdh18	cadherin 18	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313454	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CDH18 intron	PMID:30157460
1305430	Cdh18	cadherin 18	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1615561	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CDH18 mRNA	PMID:25629700
1305430	Cdh18	cadherin 18	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313454	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of CDH18 mRNA	PMID:26272509
1305430	Cdh18	cadherin 18	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313454	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1305430	Cdh18	cadherin 18	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313454	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CDH18 mRNA	PMID:28903495
1305430	Cdh18	cadherin 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615561	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDH18 mRNA	PMID:26377647
1305430	Cdh18	cadherin 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDH18 mRNA	PMID:33387578
1305430	Cdh18	cadherin 18	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313454	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of CDH18 mRNA	PMID:29955902
1305430	Cdh18	cadherin 18	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313454	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CDH18 mRNA	PMID:28001369
1305430	Cdh18	cadherin 18	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDH18 mRNA	PMID:37992649
1305430	Cdh18	cadherin 18	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313454	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CDH18 5' UTR; Benzo(a)pyrene affects the methylation of CDH18 promoter	PMID:27901495
1305430	Cdh18	cadherin 18	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313454	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDH18 3' UTR; Benzo(a)pyrene results in increased methylation of CDH18 exon	PMID:27901495
1305430	Cdh18	cadherin 18	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313454	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CDH18 mRNA	PMID:23806026
1305430	Cdh18	cadherin 18	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D000643	Ammonium Chloride affects the expression of CDH18 mRNA	PMID:16483693
1305430	Cdh18	cadherin 18	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313454	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDH18 gene	PMID:31601247
1305430	Cdh18	cadherin 18	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313454	E	RGD:6480464	20130806	CTD	MESH:C006780	bisphenol A affects the expression of CDH18 mRNA	PMID:20170705
1305430	Cdh18	cadherin 18	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313454	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CDH18 gene	PMID:31601247
1305430	Cdh18	cadherin 18	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CDH18 mRNA	PMID:34947998
1305430	Cdh18	cadherin 18	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDH18 mRNA	PMID:36041667
1305430	Cdh18	cadherin 18	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313454	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDH18 gene	PMID:31601247
1305430	Cdh18	cadherin 18	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA	PMID:25510870
1305430	Cdh18	cadherin 18	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA	PMID:25510870
1305430	Cdh18	cadherin 18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDH18 mRNA	PMID:36041667
1305430	Cdh18	cadherin 18	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313454	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CDH18 intron	PMID:30157460
1305430	Cdh18	cadherin 18	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDH18 mRNA	PMID:36041667
1305430	Cdh18	cadherin 18	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1615561	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CDH18 intron	PMID:28392331
1305430	Cdh18	cadherin 18	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313454	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CDH18 mRNA	PMID:38568856
1305430	Cdh18	cadherin 18	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313454	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CDH18 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1305430	Cdh18	cadherin 18	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313454	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1305430	Cdh18	cadherin 18	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313454	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in increased expression of CDH18 mRNA	PMID:20106945
1305430	Cdh18	cadherin 18	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDH18 mRNA	PMID:37992649
1305430	Cdh18	cadherin 18	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313454	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CDH18 mRNA	PMID:26272509
1305430	Cdh18	cadherin 18	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1313454	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1305430	Cdh18	cadherin 18	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313454	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CDH18 mRNA	PMID:24935251
1305430	Cdh18	cadherin 18	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CDH18 mRNA	PMID:33387578
1305430	Cdh18	cadherin 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1313454	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of CDH18 mRNA	PMID:33725128
1305430	Cdh18	cadherin 18	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313454	E	RGD:6480464	20130806	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CDH18 mRNA	PMID:20170705
1305430	Cdh18	cadherin 18	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1313454	E	RGD:6480464	20130806	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of CDH18 mRNA	PMID:18936297
1305430	Cdh18	cadherin 18	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1313454	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of CDH18 mRNA	PMID:26272509
1305430	Cdh18	cadherin 18	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313454	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CDH18 mRNA	PMID:24810058
1305430	Cdh18	cadherin 18	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313454	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CDH18 intron	PMID:30157460
1305430	Cdh18	cadherin 18	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CDH18 gene	PMID:35440735
1305430	Cdh18	cadherin 18	gene	CHEBI:72544	flavonoids	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D005419	Flavonoids results in decreased expression of CDH18 mRNA	PMID:18035473
1305430	Cdh18	cadherin 18	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313454	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1305430	Cdh18	cadherin 18	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1615561	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of CDH18 mRNA	PMID:31388691
1305430	Cdh18	cadherin 18	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313454	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of CDH18 mRNA	PMID:26272509
1305430	Cdh18	cadherin 18	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313454	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1305430	Cdh18	cadherin 18	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313454	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313457	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of UBL3 mRNA	PMID:33045310
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313456	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of UBL3 mRNA	PMID:33167477
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of UBL3 mRNA	PMID:21632981
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of UBL3 mRNA	PMID:39241906
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of UBL3 mRNA	PMID:15289156
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of UBL3 mRNA	PMID:38568856
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313456	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UBL3 mRNA	PMID:31163220
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of UBL3 mRNA	PMID:22061828
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313456	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of UBL3 mRNA	PMID:28818685
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBL3 mRNA	PMID:35301059
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313456	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UBL3 mRNA	PMID:19549813
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of UBL3 mRNA	PMID:22100608
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313456	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UBL3 gene	PMID:27153756
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of UBL3 mRNA	PMID:19770486
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of UBL3 mRNA	PMID:30779732
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313457	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBL3 mRNA	PMID:22206623
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1313456	E	RGD:6480464	20120412	CTD	MESH:D016685	UBL3 protein affects the susceptibility to Mitomycin	PMID:16217747
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBL3 mRNA	PMID:39836092
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of UBL3 mRNA	PMID:19244175
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313456	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of UBL3 mRNA	PMID:28903495
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of UBL3 mRNA	PMID:27392435
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of UBL3 mRNA	PMID:27392435
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of UBL3 mRNA	PMID:15289156
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313457	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBL3 mRNA	PMID:21570461
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBL3 mRNA	PMID:21215274|PMID:32109520
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBL3 mRNA	PMID:34747641
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBL3 mRNA	PMID:17942748|PMID:19933214
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBL3 mRNA	PMID:17942748
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313456	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of UBL3 mRNA	PMID:39709020
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBL3 mRNA	PMID:30851411
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1313456	E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in increased expression of UBL3 mRNA	PMID:19194470
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313456	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UBL3 mRNA	PMID:38568856
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBL3 mRNA	PMID:39836092
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBL3 mRNA	PMID:22228805
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313456	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of UBL3 mRNA	PMID:26014281
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of UBL3 mRNA	PMID:35676786
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313457	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBL3 promoter	PMID:35295148
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of UBL3 mRNA	PMID:25181051
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of UBL3 mRNA	PMID:34947998
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313456	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of UBL3 gene	PMID:31601247
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313457	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of UBL3 promoter	PMID:27312807
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of UBL3 mRNA	PMID:33296240
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of UBL3 mRNA	PMID:36041667
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of UBL3 mRNA	PMID:19244175
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313457	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of UBL3 mRNA	PMID:40203079
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of UBL3 mRNA	PMID:36041667
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of UBL3 mRNA	PMID:26377693
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of UBL3 mRNA	PMID:36041667
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UBL3 mRNA	PMID:17602206
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UBL3 mRNA	PMID:17602206
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313457	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of UBL3 mRNA	PMID:26377693
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313456	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBL3 mRNA	PMID:38174414
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBL3 mRNA	PMID:35301059
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313456	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBL3 mRNA	PMID:19376846
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313456	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of UBL3 mRNA	PMID:24449571
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of UBL3 mRNA	PMID:19244175
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of UBL3 mRNA	PMID:28302478
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of UBL3 mRNA	PMID:27153767|PMID:40419075
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313456	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBL3 mRNA	PMID:25979313
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313456	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of UBL3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:29154799
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA	PMID:27188386
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of UBL3 mRNA	PMID:38685447
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313456	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of UBL3 mRNA	PMID:25562108
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of UBL3 mRNA	PMID:17555576
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of UBL3 mRNA	PMID:15289156
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1313456	E	RGD:6480464	20260505	CTD	MESH:D017239	Paclitaxel results in increased expression of UBL3 mRNA	PMID:40481235
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313456	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of UBL3 mRNA	PMID:24935251|PMID:26272509
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA	PMID:27188386
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of UBL3 mRNA	PMID:29279043
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBL3 mRNA	PMID:39836092
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of UBL3 mRNA	PMID:17555576
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UBL3 mRNA	PMID:17942748
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBL3 mRNA	PMID:17942748
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1313456	E	RGD:6480464	20120412	CTD	MESH:D005047	UBL3 protein affects the susceptibility to Etoposide	PMID:16217747
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of UBL3 mRNA	PMID:35676786
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:50729	mitoxantrone	affects response to substance	ISO	RGD:1313456	E	RGD:6480464	20120412	CTD	MESH:D008942	UBL3 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBL3 mRNA	PMID:24136188
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of UBL3 mRNA	PMID:22714537
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of UBL3 mRNA	PMID:23650126
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of UBL3 mRNA	PMID:31758290
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UBL3 mRNA	PMID:22206623
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313457	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBL3 mRNA	PMID:22206623
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of UBL3 mRNA	PMID:24136188
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313456	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBL3 mRNA	PMID:30851411
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA	PMID:27188386
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to UBL3 gene]	PMID:28238834
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of UBL3 mRNA	PMID:19363144
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of UBL3 mRNA	PMID:32109520
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of UBL3 protein	PMID:35357534
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313456	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA	PMID:27188386
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313456	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of UBL3 mRNA	PMID:26014281
1305431	Ubl3	ubiquitin-like 3	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313456	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of UBL3 mRNA	PMID:38568856
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:149681	methcathinone	increases expression	ISO	RGD:1348004	E	RGD:6480464	20200602	CTD	MESH:C047806	monomethylpropion results in increased expression of SIGLEC6 mRNA	PMID:22303338
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SIGLEC5 mRNA	PMID:33729688
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1348004	E	RGD:6480464	20170411	CTD	MESH:C018475	butyraldehyde results in decreased expression of SIGLEC6 mRNA	PMID:26079696
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20250401	CTD	MESH:D001280	Atrazine affects the methylation of SIGLEC5 gene	PMID:35440735
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D004958	Estradiol results in decreased expression of SIGLEC5 mRNA	PMID:32145629
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SIGLEC5 mRNA	PMID:32741896
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D014241	Trichloroethylene results in increased expression of SIGLEC5 mRNA	PMID:33387578
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SIGLEC5 mRNA	PMID:32741896
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1348004	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SIGLEC6 mRNA	PMID:31163220
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003471	Cuprizone results in increased expression of SIGLEC5 mRNA	PMID:27523638
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1348004	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SIGLEC6 mRNA	PMID:41430723
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1348004	E	RGD:6480464	20170411	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SIGLEC6 mRNA	PMID:16979875
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SIGLEC5 mRNA	PMID:31150632
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1348004	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SIGLEC6 mRNA	PMID:21867686
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C030686	acetamide results in increased expression of SIGLEC5 mRNA	PMID:31881176
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1348004	E	RGD:6480464	20170411	CTD	MESH:D009532	Nickel results in increased expression of SIGLEC6 mRNA	PMID:24768652|PMID:25583101
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SIGLEC5 mRNA	PMID:23238561
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SIGLEC5 mRNA	PMID:32109520
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SIGLEC5 mRNA	PMID:34747641
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348004	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SIGLEC6 3' UTR	PMID:27901495
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1348004	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SIGLEC6 promoter	PMID:27901495
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1348004	E	RGD:6480464	20170411	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SIGLEC6 mRNA	PMID:16979875
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1348004	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of SIGLEC6 mRNA	PMID:28959546
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1348004	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SIGLEC6 mRNA	PMID:15761015
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1348004	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of SIGLEC6 mRNA	PMID:37690743
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1348004	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SIGLEC6 gene	PMID:31601247
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C008261	lead acetate results in increased expression of SIGLEC5 mRNA	PMID:22641619
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C032036	bromobenzene results in increased expression of SIGLEC5 mRNA	PMID:32479839
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in increased expression of SIGLEC5 mRNA	PMID:25729387
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1348004	E	RGD:6480464	20170411	CTD	MESH:C009495	titanium dioxide results in increased expression of SIGLEC6 mRNA	PMID:19695317
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013853	Thioacetamide affects the expression of SIGLEC5 mRNA	PMID:34492290
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SIGLEC5 mRNA	PMID:25380136
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of SIGLEC5 mRNA	PMID:32145629
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SIGLEC5 mRNA	PMID:41034487
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D002509	Cephaloridine results in increased expression of SIGLEC5 mRNA	PMID:18500788
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SIGLEC5 mRNA	PMID:25380136
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SIGLEC5 mRNA	PMID:25993096
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1348004	E	RGD:6480464	20170411	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SIGLEC6 mRNA	PMID:16979875
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1348004	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SIGLEC6 gene	PMID:29154799
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1348004	E	RGD:6480464	20170411	CTD	MESH:C016766	sulforaphane results in decreased expression of SIGLEC6 mRNA	PMID:26833863
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1348004	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SIGLEC6 mRNA	PMID:15761015
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in increased expression of SIGLEC5 mRNA	PMID:25729387
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C007350	nitrofen results in increased expression of SIGLEC5 mRNA	PMID:33484710
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SIGLEC5 mRNA	PMID:32741896
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1348004	E	RGD:6480464	20170411	CTD	MESH:C046012	pentanal results in decreased expression of SIGLEC6 mRNA	PMID:26079696
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1348004	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of SIGLEC6 mRNA	PMID:28959546
1305432	Siglecf	sialic acid binding Ig-like lectin F	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C025643	vinclozolin results in increased expression of SIGLEC5 mRNA	PMID:23034163
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D004237	Diuron results in increased expression of GRAMD1C mRNA	PMID:25152437
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1606791	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GRAMD1C mRNA	PMID:27188386
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313460	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GRAMD1C mRNA	PMID:33045310
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313460	E	RGD:6480464	20150602	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GRAMD1C mRNA	PMID:20188158
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1606791	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of GRAMD1C mRNA	PMID:21934132|PMID:23724009
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1606791	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GRAMD1C mRNA	PMID:26079696
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of GRAMD1C mRNA	PMID:31614463
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313460	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of GRAMD1C mRNA	PMID:39298647
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of GRAMD1C mRNA	PMID:30165855
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606791	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GRAMD1C mRNA	PMID:37042841
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1606791	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of GRAMD1C mRNA	PMID:26079696
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GRAMD1C mRNA	PMID:39836092
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GRAMD1C mRNA	PMID:39012411
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313460	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GRAMD1C mRNA	PMID:37325564
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313460	E	RGD:6480464	20150602	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GRAMD1C mRNA	PMID:19770486
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GRAMD1C mRNA	PMID:22100608|PMID:27153756
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313460	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GRAMD1C mRNA	PMID:40504410
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GRAMD1C mRNA	PMID:39836092
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of GRAMD1C mRNA	PMID:26272509
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA	PMID:27188386
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of GRAMD1C gene	PMID:31011160
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of GRAMD1C mRNA	PMID:31881176
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606791	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of GRAMD1C mRNA	PMID:27392435
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of GRAMD1C mRNA	PMID:24768652|PMID:25583101
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313460	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GRAMD1C mRNA	PMID:26377647
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313460	E	RGD:6480464	20150602	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of GRAMD1C mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GRAMD1C mRNA	PMID:16214954|PMID:25975270
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of GRAMD1C mRNA	PMID:28374803
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GRAMD1C mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GRAMD1C mRNA	PMID:30851411
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of GRAMD1C mRNA	PMID:26272509
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA	PMID:27188386
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:1313460	E	RGD:6480464	20150602	CTD	MESH:D014752	Vinyl Chloride results in increased expression of GRAMD1C mRNA	PMID:18579281
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606791	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of GRAMD1C mRNA	PMID:22714537|PMID:38568856
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313460	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GRAMD1C mRNA	PMID:40504410
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GRAMD1C mRNA	PMID:39836092
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GRAMD1C mRNA	PMID:32234424
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D013853	Thioacetamide results in decreased expression of GRAMD1C mRNA	PMID:23411599
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313460	E	RGD:6480464	20150602	CTD	MESH:C006253	pirinixic acid results in decreased expression of GRAMD1C mRNA	PMID:23811191
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313460	E	RGD:6480464	20150602	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GRAMD1C mRNA	PMID:19710929
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in decreased expression of GRAMD1C mRNA	PMID:25181051
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of GRAMD1C mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313460	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GRAMD1C mRNA	PMID:34585602
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GRAMD1C gene	PMID:28505145
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313460	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of GRAMD1C mRNA	PMID:39298647
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313460	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of GRAMD1C mRNA	PMID:26377693
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313460	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of GRAMD1C mRNA	PMID:38685157
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313460	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of GRAMD1C intron	PMID:28392331
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1313460	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of GRAMD1C gene	PMID:38995845
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606791	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GRAMD1C mRNA	PMID:37042841
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of GRAMD1C mRNA	PMID:35163327
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GRAMD1C mRNA	PMID:39836092
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606791	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GRAMD1C mRNA	PMID:38568856
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GRAMD1C mRNA	PMID:39012411
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313460	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GRAMD1C mRNA	PMID:37325564
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of GRAMD1C mRNA	PMID:35163327
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313460	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of GRAMD1C mRNA	PMID:40194260
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:39178	clothianidin	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in decreased expression of GRAMD1C mRNA	PMID:31626844
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GRAMD1C mRNA	PMID:27153767
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606791	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GRAMD1C mRNA	PMID:25979313
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of GRAMD1C mRNA	PMID:23179753|PMID:24935251
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1606791	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GRAMD1C gene	PMID:29154799
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606791	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of GRAMD1C mRNA	PMID:23179753|PMID:24935251|PMID:27188386|PMID:28001369
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of GRAMD1C mRNA	PMID:30047161
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of GRAMD1C mRNA	PMID:20106945|PMID:27989131
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313460	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of GRAMD1C mRNA	PMID:28973697
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GRAMD1C mRNA	PMID:38832940
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1606791	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of GRAMD1C mRNA	PMID:27188386
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1606791	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of GRAMD1C mRNA	PMID:28542535
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of GRAMD1C mRNA	PMID:24935251
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1606791	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of GRAMD1C mRNA	PMID:24935251
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen results in decreased expression of GRAMD1C mRNA	PMID:21420995|PMID:29067470
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GRAMD1C mRNA	PMID:33387578
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1606791	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of GRAMD1C mRNA	PMID:21148743
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313460	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GRAMD1C mRNA	PMID:40504410
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GRAMD1C mRNA	PMID:39836092
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of GRAMD1C mRNA	PMID:26272509
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA	PMID:27188386
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313460	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GRAMD1C mRNA; Nanotubes, Carbon results in decreased expression of GRAMD1C mRNA	PMID:25554681|PMID:25620056
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of GRAMD1C mRNA	PMID:30047161
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D005485	Flutamide results in increased expression of GRAMD1C mRNA	PMID:24793618
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313460	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of GRAMD1C mRNA	PMID:26377693
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1606791	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of GRAMD1C mRNA	PMID:22714537
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313460	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of GRAMD1C mRNA	PMID:38701926
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1606791	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of GRAMD1C protein	PMID:32959892
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GRAMD1C mRNA	PMID:39836092
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313460	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GRAMD1C mRNA	PMID:22206623
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of GRAMD1C mRNA	PMID:27840820
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1606791	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GRAMD1C mRNA	PMID:30851411
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA	PMID:27188386
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of GRAMD1C mRNA	PMID:32109520
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1606791	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of GRAMD1C mRNA	PMID:26079696
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of GRAMD1C mRNA	PMID:30047161
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GRAMD1C mRNA	PMID:30047161
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D011441	Propylthiouracil results in increased expression of GRAMD1C mRNA	PMID:24780913|PMID:25825206
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606791	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA	PMID:27188386
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GRAMD1C mRNA	PMID:21346803
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1606791	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of GRAMD1C mRNA	PMID:29301935
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of GRAMD1C mRNA	PMID:30047161
1305433	Gramd1c	GRAM domain containing 1C	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of GRAMD1C gene	PMID:31682807
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in decreased expression of PKMYT1 mRNA	PMID:20370541
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552537	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PKMYT1 mRNA	PMID:26251327
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PKMYT1 mRNA	PMID:33167477
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of PKMYT1 mRNA	PMID:26516004
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1603703	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PKMYT1 mRNA	PMID:21632981
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552537	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PKMYT1 mRNA	PMID:39241906
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of PKMYT1 mRNA	PMID:30510588
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PKMYT1 mRNA	PMID:32145629
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1603703	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PKMYT1 mRNA	PMID:38568856
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PKMYT1 mRNA	PMID:33387578
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603703	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PKMYT1 mRNA	PMID:37042841
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PKMYT1 mRNA	PMID:21592394
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of PKMYT1 mRNA	PMID:21592394
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of PKMYT1 mRNA	PMID:27683099
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552537	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PKMYT1 mRNA	PMID:34319233
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D004051	[Genistein co-treated with Diethylhexyl Phthalate] results in decreased expression of PKMYT1 mRNA	PMID:36674726
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1603703	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PKMYT1 protein	PMID:37730182
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of PKMYT1 mRNA	PMID:21592394
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of PKMYT1 mRNA	PMID:21592394
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PKMYT1 mRNA	PMID:33387578
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552537	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PKMYT1 mRNA	PMID:36331819
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:18388	apigenin	decreases expression	ISO	RGD:1552537	E	RGD:6480464	20121113	CTD	MESH:D047310	Apigenin results in decreased expression of PKMYT1 mRNA	PMID:22359648
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1603703	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of PKMYT1 mRNA	PMID:24376830
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552537	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PKMYT1 mRNA	PMID:37325564
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1603703	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of PKMYT1 mRNA	PMID:19549813
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1552537	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of PKMYT1 mRNA	PMID:19376150
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PKMYT1 mRNA	PMID:25378103
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1603703	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PKMYT1 mRNA	PMID:22100608
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552537	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PKMYT1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PKMYT1 mRNA	PMID:34911549
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552537	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PKMYT1 mRNA	PMID:40504410
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:27698	vanadium atom	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20260203	CTD	MESH:D014639	[Metals, Heavy results in increased abundance of Vanadium] which results in increased methylation of PKMYT1 gene	PMID:39164771
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1603703	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PKMYT1 protein	PMID:35688186
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552537	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PKMYT1 mRNA	PMID:28960355
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PKMYT1 mRNA	PMID:31881176
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PKMYT1 mRNA	PMID:23557933
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603703	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of PKMYT1 mRNA	PMID:27594783
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PKMYT1 mRNA	PMID:27392435
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D019833	[Genistein co-treated with Diethylhexyl Phthalate] results in decreased expression of PKMYT1 mRNA	PMID:36674726
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PKMYT1 mRNA	PMID:22298810
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552537	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PKMYT1 mRNA	PMID:21570461
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PKMYT1 mRNA	PMID:32109520
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PKMYT1 mRNA	PMID:33387578
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1603703	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PKMYT1 mRNA	PMID:33212167
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PKMYT1 mRNA	PMID:32763439
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PKMYT1 mRNA	PMID:28959563
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of PKMYT1 mRNA	PMID:30911355
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PKMYT1 mRNA	PMID:38568856
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603703	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of PKMYT1 mRNA	PMID:29301061|PMID:34032870
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552537	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PKMYT1 mRNA	PMID:40504410
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PKMYT1 mRNA	PMID:22378314
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603703	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PKMYT1 promoter	PMID:27901495
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PKMYT1 mRNA	PMID:20064835
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1603703	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PKMYT1 mRNA	PMID:32234424|PMID:33411230
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of PKMYT1 mRNA	PMID:30911355
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1603703	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PKMYT1 mRNA	PMID:19150397
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PKMYT1 mRNA	PMID:20458559
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1603703	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PKMYT1 mRNA	PMID:20862710
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of PKMYT1 mRNA	PMID:24915197
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1603703	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of PKMYT1 mRNA	PMID:38568856
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1603703	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of PKMYT1 mRNA	PMID:38568856
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552537	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PKMYT1 gene	PMID:35295148
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PKMYT1 mRNA	PMID:34492290
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1552537	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of PKMYT1 mRNA	PMID:19136022
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552537	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PKMYT1 mRNA	PMID:23811191
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of PKMYT1 mRNA	PMID:38479592
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PKMYT1 mRNA	PMID:25181051
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PKMYT1 mRNA	PMID:29275510
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PKMYT1 mRNA	PMID:34947998
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PKMYT1 gene	PMID:28505145
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552537	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PKMYT1 mRNA	PMID:39298647|PMID:40203079
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552537	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PKMYT1 mRNA	PMID:37019170
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1552537	E	RGD:6480464	20190219	CTD	MESH:D010269	Paraquat results in decreased expression of PKMYT1 mRNA	PMID:28012437
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:35170	vanadium(0)	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20260203	CTD	MESH:D014639	[Metals, Heavy results in increased abundance of Vanadium] which results in increased methylation of PKMYT1 gene	PMID:39164771
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of PKMYT1 mRNA	PMID:18500788
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PKMYT1 mRNA	PMID:30723492
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552537	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PKMYT1 mRNA	PMID:37325564
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PKMYT1 mRNA	PMID:36326898
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of PKMYT1 mRNA	PMID:25539665
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PKMYT1 gene	PMID:22079235
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552537	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PKMYT1 mRNA	PMID:22698814
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PKMYT1 mRNA	PMID:24386269
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1552537	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of PKMYT1 mRNA	PMID:38531469
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1552537	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PKMYT1 mRNA	PMID:40194260
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552537	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PKMYT1 mRNA	PMID:40194260
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PKMYT1 mRNA	PMID:31533062
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1603703	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of PKMYT1 mRNA	PMID:19167446
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKMYT1 mRNA	PMID:19167446
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552537	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PKMYT1 mRNA	PMID:39529242
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552537	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PKMYT1 mRNA	PMID:36331819
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603703	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PKMYT1 gene	PMID:29154799
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20230502	CTD	MESH:C017160	cypermethrin results in decreased expression of PKMYT1 protein	PMID:36063984
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552537	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PKMYT1 mRNA	PMID:28973697
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1603703	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PKMYT1 mRNA	PMID:38832940
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552537	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PKMYT1 mRNA	PMID:17562736
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PKMYT1 mRNA	PMID:33387578
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603703	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PKMYT1 mRNA	PMID:22230336
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552537	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PKMYT1 mRNA	PMID:40504410
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:4744	Echimidine	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which affects the expression of PKMYT1 mRNA	PMID:33884520
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:47458	saracatinib	decreases activity	ISO	RGD:1603703	E	RGD:6480464	20210803	CTD	MESH:C515233	saracatinib results in decreased activity of PKMYT1 protein	PMID:29941193
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PKMYT1 mRNA	PMID:29391264
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1603703	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of PKMYT1 mRNA	PMID:38568856
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PKMYT1 mRNA	PMID:20458559
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1603703	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PKMYT1 mRNA	PMID:20862710
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552537	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PKMYT1 mRNA	PMID:19042947
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1552537	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in increased expression of PKMYT1 mRNA	PMID:21404309
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1552537	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of PKMYT1 mRNA	PMID:21404309
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1552537	E	RGD:6480464	20180828	CTD	MESH:D016559	Tacrolimus results in increased expression of PKMYT1 mRNA	PMID:29362864
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:63924	riddelliine	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PKMYT1 mRNA	PMID:33884520
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of PKMYT1 mRNA	PMID:36519830
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of PKMYT1 mRNA	PMID:33884520
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:748225	pd-0166285	decreases activity	ISO	RGD:1603703	E	RGD:6480464	20260714	CTD	MESH:C440869	PD 0166285 results in decreased activity of PKMYT1 protein	PMID:29941193
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of PKMYT1 mRNA	PMID:28960945
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1552537	E	RGD:6480464	20150414	CTD	MESH:C025589	ochratoxin A results in increased expression of PKMYT1 mRNA	PMID:25636497
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1552537	E	RGD:6480464	20150414	CTD	MESH:C025589	TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of PKMYT1 mRNA]	PMID:25636497
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552537	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of PKMYT1 mRNA	PMID:19136022
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:80799	Bufotalin	increases expression	ISO	RGD:1603703	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of PKMYT1 mRNA	PMID:39904859
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1603703	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKMYT1 mRNA	PMID:19167446
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552537	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PKMYT1 mRNA	PMID:39847705
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PKMYT1 mRNA	PMID:24780913
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:88046	cylindrospermopsin	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20190910	CTD	MESH:C089595	cylindrospermopsin results in decreased expression of PKMYT1 mRNA	PMID:30905859
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in decreased expression of PKMYT1 mRNA	PMID:17428261
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of PKMYT1 mRNA	PMID:22378314
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PKMYT1 mRNA	PMID:21346803
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1603703	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of PKMYT1 mRNA	PMID:19140230
1305434	Pkmyt1	protein kinase, membrane associated tyrosine/threonine 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552537	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PKMYT1 mRNA	PMID:35537566
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550211	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CDK19 mRNA	PMID:33045310
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1343762	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of CDK19 mRNA	PMID:31016361
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550211	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CDK19 mRNA	PMID:20188158
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1343762	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of CDK19 mRNA	PMID:11906190
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550211	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDK19 mRNA	PMID:30529165
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CDK19 mRNA	PMID:26079696
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550211	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CDK19 mRNA	PMID:30319688
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550211	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CDK19 mRNA	PMID:39241906
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of CDK19 mRNA	PMID:31614463
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CDK19 mRNA	PMID:38568856
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1343762	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDK19 mRNA	PMID:37042841
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1343762	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of CDK19 mRNA	PMID:18037150
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1550211	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone deficiency results in increased expression of CDK19 mRNA; Testosterone results in increased expression of CDK19 mRNA	PMID:20403060|PMID:33848595
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CDK19 mRNA	PMID:22061828
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CDK19 mRNA	PMID:19549813
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CDK19 mRNA	PMID:23649840
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1343762	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CDK19 mRNA	PMID:23649840
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of CDK19 mRNA	PMID:35737395
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1343762	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CDK19 mRNA	PMID:41430723
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CDK19 mRNA	PMID:31150632
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550211	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CDK19 mRNA	PMID:22206623
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1343762	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CDK19 gene	PMID:25304211
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550211	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK19 mRNA	PMID:40504410
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CDK19 mRNA	PMID:26272509
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1343762	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA	PMID:27188386
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CDK19 mRNA	PMID:25583101
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1343762	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDK19 mRNA	PMID:22298810
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDK19 mRNA	PMID:33387578|PMID:34747641
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550211	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDK19 mRNA	PMID:20819909
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550211	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CDK19 gene]	PMID:20819909
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CDK19 mRNA	PMID:30851411
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CDK19 mRNA	PMID:23649840
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1343762	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of CDK19 mRNA	PMID:20971185
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDK19 mRNA	PMID:29803840
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDK19 mRNA	PMID:34032870
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1343762	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CDK19 mRNA	PMID:38568856
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550211	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK19 mRNA	PMID:40504410
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDK19 mRNA	PMID:20106945
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1343762	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of CDK19 mRNA	PMID:20971185
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CDK19 mRNA	PMID:25351596
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550211	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDK19 promoter	PMID:35295148
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550211	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CDK19 mRNA	PMID:23557971
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550211	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CDK19 gene	PMID:35295148
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CDK19 mRNA	PMID:34492290
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550211	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of CDK19 mRNA	PMID:23811191
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550211	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CDK19 mRNA	PMID:19710929
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CDK19 mRNA	PMID:25181051|PMID:30816183|PMID:33296240|PMID:34947998|PMID:38750585
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550211	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CDK19 mRNA	PMID:39298647
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550211	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CDK19 intron	PMID:28392331
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1550211	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of CDK19 mRNA	PMID:31558096
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343762	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDK19 mRNA	PMID:37042841
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1343762	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CDK19 mRNA	PMID:19320972
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CDK19 mRNA	PMID:24449571
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CDK19 mRNA	PMID:31533062
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDK19 mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:28001369
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1343762	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA	PMID:27188386
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CDK19 mRNA	PMID:25562108
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1343762	E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in increased expression of CDK19 mRNA	PMID:16849584
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CDK19 mRNA	PMID:26272509
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1343762	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in increased expression of CDK19 mRNA	PMID:28542535
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1343762	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA	PMID:27188386
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDK19 mRNA	PMID:22230336
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1343762	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CDK19 gene	PMID:25304211
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550211	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK19 mRNA	PMID:40504410
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1343762	E	RGD:6480464	20230404	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of CDK19 mRNA	PMID:35701726
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of CDK19 mRNA	PMID:26272509
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1343762	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA	PMID:27188386
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:50161	motexafin gadolinium	increases expression	ISO	RGD:1343762	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of CDK19 mRNA	PMID:16357179
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:62984	zinc acetate	increases expression	ISO	RGD:1343762	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of CDK19 mRNA	PMID:16357179
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CDK19 gene	PMID:35440735
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20250708	CTD	MESH:D002185	Cannabidiol results in decreased expression of CDK19 mRNA	PMID:39894194
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CDK19 mRNA	PMID:31758290
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550211	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CDK19 mRNA	PMID:22206623
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1343762	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of CDK19 mRNA	PMID:28960945
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CDK19 mRNA	PMID:30851411
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1343762	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA	PMID:27188386
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1550211	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of CDK19 mRNA	PMID:31558096
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1343762	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of CDK19 mRNA	PMID:33512557
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1550211	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of CDK19 mRNA	PMID:39847705
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1343762	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA	PMID:27188386
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1343762	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA	PMID:27188386
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CDK19 mRNA	PMID:21346803
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CDK19 mRNA	PMID:21346803
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550211	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CDK19 mRNA	PMID:28973697
1305435	Cdk19	cyclin-dependent kinase 19	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CDK19 mRNA	PMID:19015723
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of RPP14 mRNA	PMID:37995155
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1313464	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of RPP14 protein	PMID:36641056
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313465	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RPP14 mRNA	PMID:30319688
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313464	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RPP14 mRNA	PMID:37042841
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:17579	beta-carotene	multiple interactions	ISO	RGD:1313465	E	RGD:6480464	20140909	CTD	MESH:D019207	[BCO1 protein affects the susceptibility to beta Carotene] which affects the expression of RPP14 mRNA	PMID:24657404
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313464	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPP14 mRNA	PMID:35301059
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313464	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RPP14 mRNA	PMID:19549813
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313464	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPP14 protein	PMID:23301498
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313464	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RPP14 mRNA	PMID:35430440
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RPP14 mRNA	PMID:33387578
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313464	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPP14 mRNA	PMID:39836092
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RPP14 mRNA	PMID:28960355
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313464	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RPP14 mRNA	PMID:23557933
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RPP14 mRNA	PMID:21354282
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313465	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPP14 mRNA	PMID:17942748
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313464	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RPP14 protein	PMID:39603559
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313464	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RPP14 mRNA	PMID:33212167
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313464	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPP14 mRNA	PMID:39836092
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313464	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RPP14 promoter	PMID:27901495
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	ISO	RGD:1313464	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of RPP14 mRNA	PMID:25075043
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RPP14 mRNA	PMID:23411599
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RPP14 mRNA	PMID:25181051
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RPP14 mRNA	PMID:36041667
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RPP14 mRNA	PMID:36041667
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RPP14 mRNA	PMID:36041667
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RPP14 mRNA	PMID:21266533
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313464	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RPP14 mRNA	PMID:38568856
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313464	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPP14 mRNA	PMID:35301059
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313464	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RPP14 mRNA	PMID:28302478
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313464	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RPP14 mRNA	PMID:25979313
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313464	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RPP14 mRNA	PMID:25562108
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RPP14 mRNA	PMID:33387578
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313464	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPP14 mRNA	PMID:39836092
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of RPP14 mRNA	PMID:35436446
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313465	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RPP14 mRNA	PMID:17942748
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313465	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPP14 mRNA	PMID:17942748
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:50035	alpha-phellandrene	decreases expression	ISO	RGD:1313464	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of RPP14 mRNA	PMID:25075043
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1313465	E	RGD:6480464	20190219	CTD	MESH:D007559	Ivermectin results in increased expression of RPP14 mRNA	PMID:28942281
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313464	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RPP14 mRNA	PMID:37199045
1305436	Rpp14	ribonuclease P/MRP subunit p14	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of RPP14 mRNA	PMID:30953684
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313467	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TEX14 mRNA	PMID:33045310
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000242	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of TEX14 mRNA]	PMID:19414516
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313466	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TEX14 protein	PMID:37730182
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TEX14 mRNA	PMID:33387578
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313466	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TEX14 mRNA	PMID:28818685
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313466	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TEX14 intron	PMID:30157460
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313467	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TEX14 mRNA	PMID:27106289
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313466	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TEX14 mRNA	PMID:21867686
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313466	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TEX14 gene	PMID:25304211
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313466	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TEX14 mRNA	PMID:33212167
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313466	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TEX14 mRNA	PMID:32763439
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313467	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TEX14 protein	PMID:28918527
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313466	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TEX14 5' UTR; Benzo(a)pyrene affects the methylation of TEX14 intron; Benzo(a)pyrene affects the methylation of TEX14 promoter	PMID:27901495|PMID:30157460
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313466	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TEX14 3' UTR	PMID:27901495
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313466	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TEX14 mRNA	PMID:23806026
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313466	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TEX14 mRNA	PMID:19710929
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TEX14 mRNA	PMID:25181051
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313467	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TEX14 mRNA	PMID:30951980
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of TEX14 mRNA]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of TEX14 mRNA]	PMID:19414516
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein	PMID:34896426
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313467	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TEX14 mRNA	PMID:28392331
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313466	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TEX14 mRNA	PMID:38382870
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313467	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TEX14 mRNA	PMID:40194260
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of TEX14 protein	PMID:34896426
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313466	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX14 mRNA	PMID:27188386
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of TEX14 mRNA	PMID:21865292
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein	PMID:34896426
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein	PMID:34896426
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313466	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TEX14 mRNA	PMID:38832940
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313466	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TEX14 mRNA	PMID:28542535
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313466	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TEX14 gene	PMID:25304211
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein	PMID:34896426
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313467	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of TEX14 mRNA	PMID:23608068
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313466	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of TEX14 mRNA	PMID:31629900
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TEX14 gene	PMID:35440735
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:756028	mivebresib	increases expression	ISO	RGD:1313466	E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of TEX14 mRNA	PMID:35486664
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313466	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX14 mRNA	PMID:27188386
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313466	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TEX14 gene]	PMID:28238834
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313467	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TEX14 mRNA	PMID:31388691
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:83784	galaxolide	decreases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C033119	galaxolide results in decreased expression of TEX14 mRNA	PMID:37797914
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1313466	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of TEX14 mRNA	PMID:31734321
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313466	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX14 mRNA	PMID:27188386
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:9367	swainsonine	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D017026	Swainsonine results in increased expression of TEX14 mRNA	PMID:40381828
1305437	Tex14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313467	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of TEX14 mRNA	PMID:32835833
1305438	Cdh20	cadherin 20	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDH20 mRNA	PMID:33729688
1305438	Cdh20	cadherin 20	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313469	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CDH20 mRNA	PMID:30319688
1305438	Cdh20	cadherin 20	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313468	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of CDH20 mRNA	PMID:30510588
1305438	Cdh20	cadherin 20	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313468	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CDH20 mRNA	PMID:31163220
1305438	Cdh20	cadherin 20	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313468	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CDH20 exon; Aflatoxin B1 results in decreased methylation of CDH20 gene; Aflatoxin B1 results in decreased methylation of CDH20 intron	PMID:27153756|PMID:30157460
1305438	Cdh20	cadherin 20	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313468	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CDH20 mRNA	PMID:33212167
1305438	Cdh20	cadherin 20	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CDH20 mRNA	PMID:26033743
1305438	Cdh20	cadherin 20	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313468	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDH20 exon; Benzo(a)pyrene results in increased methylation of CDH20 promoter	PMID:27901495
1305438	Cdh20	cadherin 20	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CDH20 mRNA	PMID:26033743
1305438	Cdh20	cadherin 20	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313468	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of CDH20 mRNA	PMID:35984750
1305438	Cdh20	cadherin 20	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1313468	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of CDH20 mRNA	PMID:37690743
1305438	Cdh20	cadherin 20	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313468	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of CDH20 gene	PMID:31601247
1305438	Cdh20	cadherin 20	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313469	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of CDH20 mRNA	PMID:35295148
1305438	Cdh20	cadherin 20	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313469	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDH20 gene	PMID:35295148
1305438	Cdh20	cadherin 20	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDH20 mRNA	PMID:25181051|PMID:34947998
1305438	Cdh20	cadherin 20	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313468	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CDH20 gene	PMID:31601247
1305438	Cdh20	cadherin 20	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313468	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of CDH20 gene	PMID:31601247
1305438	Cdh20	cadherin 20	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313468	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CDH20 intron	PMID:30157460
1305438	Cdh20	cadherin 20	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313469	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of CDH20 mRNA	PMID:30951980
1305438	Cdh20	cadherin 20	gene	CHEBI:35004	Tetrachlorobisphenol A	decreases expression	ISO	RGD:1313468	E	RGD:6480464	20191210	CTD	MESH:C041181	tetrachlorodian results in decreased expression of CDH20 mRNA	PMID:31326446
1305438	Cdh20	cadherin 20	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CDH20 promoter	PMID:22457795
1305438	Cdh20	cadherin 20	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313468	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDH20 mRNA	PMID:26690555
1305438	Cdh20	cadherin 20	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1313468	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of CDH20 mRNA	PMID:25757056
1305438	Cdh20	cadherin 20	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313469	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CDH20 mRNA	PMID:35436446
1305438	Cdh20	cadherin 20	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313468	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CDH20 intron	PMID:30157460
1305439	Best3	bestrophin 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313470	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of BEST3 mRNA	PMID:22378314
1305439	Best3	bestrophin 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313470	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of BEST3 gene	PMID:27153756
1305439	Best3	bestrophin 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313470	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of BEST3 mRNA	PMID:27392435
1305439	Best3	bestrophin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BEST3 mRNA	PMID:33387578
1305439	Best3	bestrophin 3	gene	CHEBI:28741	sodium fluoride	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of BEST3 mRNA	PMID:27257137
1305439	Best3	bestrophin 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550212	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of BEST3 mRNA	PMID:36209798
1305439	Best3	bestrophin 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313470	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BEST3 intron; Benzo(a)pyrene affects the methylation of BEST3 promoter	PMID:27901495|PMID:30157460
1305439	Best3	bestrophin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313470	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of BEST3 3' UTR	PMID:27901495
1305439	Best3	bestrophin 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313470	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BEST3 mRNA	PMID:22316170
1305439	Best3	bestrophin 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313470	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of BEST3 mRNA	PMID:25895662
1305439	Best3	bestrophin 3	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of BEST3 mRNA	PMID:22641619
1305439	Best3	bestrophin 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of BEST3 mRNA	PMID:34492290
1305439	Best3	bestrophin 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BEST3 mRNA	PMID:25181051|PMID:34973380
1305439	Best3	bestrophin 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550212	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of BEST3 gene	PMID:31683443
1305439	Best3	bestrophin 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313470	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of BEST3 mRNA	PMID:38568856
1305439	Best3	bestrophin 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313470	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of BEST3 mRNA	PMID:36326898
1305439	Best3	bestrophin 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550212	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of BEST3 mRNA	PMID:40194260
1305439	Best3	bestrophin 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313470	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of BEST3 mRNA	PMID:31533062
1305439	Best3	bestrophin 3	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1550212	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of BEST3 mRNA	PMID:29038090
1305439	Best3	bestrophin 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313470	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of BEST3 mRNA	PMID:38832940
1305439	Best3	bestrophin 3	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313470	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of BEST3 mRNA	PMID:29522793
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313471	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of UBOX5 mRNA	PMID:26251327
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:15343	acetaldehyde	increases expression	ISO	RGD:1605087	E	RGD:6480464	20130312	CTD	MESH:D000079	Acetaldehyde results in increased expression of UBOX5 mRNA	PMID:23416264
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313471	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBOX5 gene	PMID:20938992
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313471	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of UBOX5 mRNA	PMID:16604517
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313471	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBOX5 gene	PMID:20938992
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605087	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of UBOX5 mRNA	PMID:37042841
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1605087	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of UBOX5 mRNA	PMID:28818685
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605087	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of UBOX5 mRNA	PMID:35430440
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313471	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBOX5 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBOX5 gene	PMID:20938992|PMID:22206623
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313471	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UBOX5 mRNA	PMID:40504410
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1313471	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of UBOX5 mRNA	PMID:28960355
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313471	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBOX5 mRNA	PMID:21570461
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313471	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBOX5 mRNA	PMID:19933214
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1605087	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of UBOX5 mRNA	PMID:33212167
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of UBOX5 mRNA	PMID:28959563
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605087	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UBOX5 mRNA	PMID:38568856
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313471	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UBOX5 mRNA	PMID:40504410
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605087	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of UBOX5 promoter	PMID:27901495
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313471	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBOX5 mRNA	PMID:22228805
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UBOX5 mRNA	PMID:25181051|PMID:30816183
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313471	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of UBOX5 mRNA	PMID:39298647
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313471	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in increased expression of UBOX5 mRNA	PMID:20350560
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605087	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBOX5 mRNA	PMID:37042841
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1605087	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of UBOX5 mRNA	PMID:29024780
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBOX5 mRNA	PMID:33453195
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1313471	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of UBOX5 mRNA	PMID:24183702
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1605087	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBOX5 mRNA	PMID:19320972
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1605087	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of UBOX5 mRNA	PMID:28302478
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605087	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of UBOX5 mRNA	PMID:31533062
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313471	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of UBOX5 mRNA	PMID:20546886
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605087	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in decreased expression of UBOX5 mRNA	PMID:17183730
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605087	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of UBOX5 mRNA	PMID:25562108
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1605087	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of UBOX5 mRNA	PMID:38832940
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605087	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of UBOX5 mRNA	PMID:26690555
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313471	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UBOX5 mRNA	PMID:40504410
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1605087	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in decreased expression of UBOX5 mRNA	PMID:17183730
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1605087	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of UBOX5 mRNA	PMID:28988120
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313471	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBOX5 mRNA	PMID:22206623
1305440	Ubox5	U-box domain containing 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605087	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to UBOX5 gene]	PMID:28238834
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602680	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CPSF7 mRNA	PMID:33167477
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1332109	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CPSF7 mRNA	PMID:36331819
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1332109	E	RGD:6480464	20160705	CTD	MESH:D001280	Atrazine results in decreased expression of CPSF7 mRNA	PMID:26518232
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1602680	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CPSF7 mRNA	PMID:22378314
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1332109	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CPSF7 mRNA	PMID:30319688
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1332109	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of CPSF7 protein	PMID:31494107
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of CPSF7 mRNA	PMID:35192832
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1602680	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CPSF7 protein	PMID:37730182
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CPSF7 mRNA	PMID:33387578
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332109	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CPSF7 mRNA	PMID:36331819
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1602680	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPSF7 mRNA	PMID:35301059
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1332109	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CPSF7 mRNA	PMID:19770486
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602680	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CPSF7 gene	PMID:27153756
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332109	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF7 mRNA	PMID:40504410
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602680	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF7 mRNA	PMID:40512198
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1602680	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CPSF7 protein	PMID:35688186
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of CPSF7 mRNA	PMID:26302742
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1602680	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CPSF7 mRNA	PMID:23557933
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CPSF7 mRNA	PMID:33387578
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of CPSF7 mRNA	PMID:30556269
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1602680	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CPSF7 protein	PMID:35688186
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:29678	sodium arsenite	increases activity	ISO	RGD:1602680	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in increased activity of CPSF7 protein	PMID:30528433
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332109	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF7 mRNA	PMID:40504410
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602680	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF7 mRNA	PMID:40512198
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of CPSF7 mRNA	PMID:30556269
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:30778	gallic acid	increases expression	ISO	RGD:1602680	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of CPSF7 mRNA	PMID:34408198
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332109	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CPSF7 gene	PMID:35295148
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332109	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CPSF7 gene	PMID:35295148
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF7 mRNA	PMID:31129395|PMID:35192832
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1602680	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF7 protein	PMID:34186270
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CPSF7 mRNA	PMID:25181051
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332109	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CPSF7 mRNA	PMID:33221593
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CPSF7 gene	PMID:28505145
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1602680	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CPSF7 mRNA	PMID:25979313
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332109	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CPSF7 mRNA	PMID:38685157
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602680	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CPSF7 mRNA	PMID:37042841
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602680	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CPSF7 mRNA	PMID:38568856
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1602680	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPSF7 mRNA	PMID:35301059
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1602680	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CPSF7 mRNA	PMID:28302478
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332109	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CPSF7 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CPSF7 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CPSF7 mRNA	PMID:36331819
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of CPSF7 mRNA	PMID:22110744
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602680	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CPSF7 mRNA	PMID:25979313
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1332109	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of CPSF7 mRNA	PMID:21427059
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602680	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of CPSF7 mRNA	PMID:28001369|PMID:29154799
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332109	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF7 mRNA	PMID:40504410
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602680	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF7 mRNA	PMID:40512198
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1332109	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CPSF7 mRNA	PMID:35436446
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332109	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CPSF7 mRNA	PMID:35964746
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1602680	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CPSF7 protein	PMID:32959892
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1332109	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of CPSF7 protein	PMID:36851058
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1332109	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of CPSF7 protein	PMID:35926579
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332109	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CPSF7 mRNA	PMID:22206623
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1602680	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CPSF7 protein	PMID:37664457
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of CPSF7 protein	PMID:28903499
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:81922	flusilazole	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C061365	flusilazole results in decreased expression of CPSF7 mRNA	PMID:28263823
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of CPSF7 mRNA	PMID:36084822
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1602680	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of CPSF7 protein	PMID:38348393
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602680	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CPSF7 protein	PMID:37664457
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of CPSF7 protein	PMID:35544339
1305441	Cpsf7	cleavage and polyadenylation specific factor 7	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CPSF7 mRNA	PMID:23034163
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1602315	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TM2D1 mRNA	PMID:38218311
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552206	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TM2D1 gene	PMID:20938992
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1602315	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of TM2D1 mRNA	PMID:16823088
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552206	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TM2D1 gene	PMID:20938992
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552206	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TM2D1 mRNA	PMID:33754040
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1552206	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of TM2D1 mRNA	PMID:33914522
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552206	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TM2D1 mRNA	PMID:37236586
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1602315	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of TM2D1 mRNA	PMID:16823088
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552206	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TM2D1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TM2D1 gene	PMID:20938992|PMID:22206623
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1602315	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TM2D1 gene	PMID:25304211
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1602315	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TM2D1 mRNA	PMID:19244175
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1602315	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of TM2D1 mRNA	PMID:23300844
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552206	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TM2D1 mRNA	PMID:17942748
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1602315	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TM2D1 mRNA	PMID:23179753
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1602315	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TM2D1 mRNA	PMID:30851411
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1602315	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of TM2D1 mRNA	PMID:23649840
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602315	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of TM2D1 mRNA	PMID:39719251
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TM2D1 mRNA	PMID:30047161
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552206	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TM2D1 mRNA	PMID:29264374
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1552206	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of TM2D1 mRNA	PMID:33914522
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TM2D1 mRNA	PMID:25181051|PMID:41034487
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552206	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TM2D1 mRNA	PMID:26512966
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TM2D1 mRNA	PMID:34947998|PMID:41034487
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552206	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of TM2D1 mRNA	PMID:38074096
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602315	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TM2D1 mRNA	PMID:28628672
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1602315	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TM2D1 gene	PMID:31601247
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552206	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TM2D1 mRNA	PMID:39298647|PMID:40203079
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552206	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TM2D1 mRNA	PMID:38685157
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552206	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TM2D1 mRNA	PMID:37019170
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TM2D1 mRNA	PMID:17602206
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1602315	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TM2D1 mRNA	PMID:28628672
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TM2D1 mRNA	PMID:17602206
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552206	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TM2D1 mRNA	PMID:37236586
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1602315	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TM2D1 mRNA	PMID:19244175
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1552206	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of TM2D1 mRNA	PMID:17585979
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1602315	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TM2D1 mRNA	PMID:28302478
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602315	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TM2D1 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TM2D1 mRNA	PMID:30047161
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1602315	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TM2D1 mRNA	PMID:28628672
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1602315	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TM2D1 mRNA	PMID:36621641
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TM2D1 mRNA	PMID:24136188
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1602315	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TM2D1 gene	PMID:25304211
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552206	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TM2D1 mRNA	PMID:35436446
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552206	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TM2D1 mRNA	PMID:17942748
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1602315	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TM2D1 mRNA	PMID:28628672
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1602315	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TM2D1 mRNA	PMID:23300844
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TM2D1 mRNA	PMID:24136188
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TM2D1 mRNA	PMID:30047161
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TM2D1 mRNA	PMID:24136188
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of TM2D1 mRNA	PMID:24136188
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1602315	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TM2D1 mRNA	PMID:16934159
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of TM2D1 mRNA	PMID:24136188
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552206	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TM2D1 mRNA	PMID:22206623
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552206	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TM2D1 mRNA	PMID:22206623
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TM2D1 mRNA	PMID:24136188
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:75701	sarin	increases expression	ISO	RGD:1602315	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of TM2D1 mRNA	PMID:19522546
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1602315	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TM2D1 mRNA	PMID:30851411
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1552206	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TM2D1 mRNA	PMID:31388691
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TM2D1 mRNA	PMID:27291303
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TM2D1 mRNA	PMID:23640034
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1552206	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of TM2D1 mRNA	PMID:21795629
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TM2D1 mRNA	PMID:30047161
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of TM2D1 mRNA	PMID:24136188
1305442	Tm2d1	TM2 domain containing 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TM2D1 mRNA	PMID:21346803
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:131762	dodecyldimethylamine N-oxide	increases expression	ISO	RGD:1606522	E	RGD:6480464	20260407	CTD	MESH:C014518	dodecyldimethylamine oxide results in increased expression of GRAMD1B mRNA	PMID:40571133
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of GRAMD1B mRNA	PMID:30071829
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRAMD1B mRNA	PMID:20938992
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1606522	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of GRAMD1B mRNA	PMID:33167477
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GRAMD1B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GRAMD1B mRNA	PMID:32699268
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1606522	E	RGD:6480464	20160712	CTD	MESH:C018475	butyraldehyde results in increased expression of GRAMD1B mRNA	PMID:26079696
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of GRAMD1B gene	PMID:35440735
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313474	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of GRAMD1B mRNA	PMID:30319688
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606522	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of GRAMD1B mRNA	PMID:31614463
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of GRAMD1B mRNA	PMID:30165855
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of GRAMD1B mRNA	PMID:38568856
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRAMD1B mRNA	PMID:20938992
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606522	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GRAMD1B mRNA	PMID:37042841
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GRAMD1B mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GRAMD1B mRNA	PMID:37992649
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GRAMD1B mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GRAMD1B mRNA	PMID:37992649
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1606522	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of GRAMD1B mRNA	PMID:23825647
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of GRAMD1B mRNA	PMID:31163220
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GRAMD1B mRNA	PMID:39150890
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GRAMD1B mRNA	PMID:36139627
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1606522	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of GRAMD1B intron	PMID:30157460
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1313474	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of GRAMD1B mRNA	PMID:33914522
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1606522	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of GRAMD1B mRNA	PMID:23825647
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:193591	Didecyldimethylammonium	increases expression	ISO	RGD:1606522	E	RGD:6480464	20250805	CTD	MESH:C027118	didecyldimethylammonium results in increased expression of GRAMD1B mRNA	PMID:39710153
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20160712	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of GRAMD1B mRNA	PMID:23649840
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:25710	organophosphorus compound	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in increased expression of GRAMD1B mRNA	PMID:39658253
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GRAMD1B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GRAMD1B mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of GRAMD1B mRNA	PMID:32699268
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GRAMD1B mRNA	PMID:21867686
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRAMD1B mRNA	PMID:20938992
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GRAMD1B mRNA]	PMID:37992649
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1313474	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of GRAMD1B mRNA	PMID:28960355
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313474	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of GRAMD1B mRNA	PMID:28189721
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GRAMD1B mRNA	PMID:31881176
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1606522	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of GRAMD1B mRNA	PMID:28903495
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313474	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GRAMD1B mRNA	PMID:21570461
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GRAMD1B mRNA	PMID:34747641
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313474	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GRAMD1B mRNA	PMID:19933214
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GRAMD1B mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GRAMD1B mRNA	PMID:37992649
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1606522	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of GRAMD1B protein	PMID:35688186
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GRAMD1B mRNA]	PMID:37992649
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of GRAMD1B mRNA	PMID:29301061
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606522	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GRAMD1B intron	PMID:30157460
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to GRAMD1B mRNA]	PMID:32406909
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of GRAMD1B mRNA	PMID:38458666
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of GRAMD1B gene	PMID:31601247
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313474	E	RGD:6480464	20230307	CTD	MESH:C008261	lead acetate results in decreased expression of GRAMD1B mRNA	PMID:36183778
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20160712	CTD	MESH:D008627	Mercuric Chloride results in increased expression of GRAMD1B mRNA	PMID:16507785
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313474	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GRAMD1B gene; titanium dioxide results in decreased methylation of GRAMD1B promoter	PMID:35295148
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313474	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of GRAMD1B mRNA	PMID:23557971
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313474	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of GRAMD1B mRNA	PMID:20813756|PMID:23811191
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313474	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of GRAMD1B mRNA	PMID:28472532
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of GRAMD1B mRNA	PMID:28329830
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313474	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of GRAMD1B mRNA	PMID:33914522
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313474	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of GRAMD1B mRNA	PMID:32156529
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of GRAMD1B mRNA	PMID:29275510
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160712	CTD	MESH:C006780	bisphenol A results in increased expression of GRAMD1B mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313474	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of GRAMD1B mRNA	PMID:26063408|PMID:34585602
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GRAMD1B gene	PMID:28505145
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of GRAMD1B gene	PMID:31601247
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1606522	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of GRAMD1B intron	PMID:30157460
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GRAMD1B mRNA	PMID:39150890
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20160712	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GRAMD1B mRNA	PMID:21266533
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GRAMD1B mRNA	PMID:39150890
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GRAMD1B mRNA	PMID:39150890
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GRAMD1B mRNA	PMID:24535843
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of GRAMD1B mRNA	PMID:38458666
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GRAMD1B mRNA	PMID:39150890
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of GRAMD1B mRNA	PMID:35163327
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GRAMD1B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GRAMD1B mRNA	PMID:32699268
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313474	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of GRAMD1B mRNA	PMID:40194260
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GRAMD1B mRNA	PMID:31533062
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of GRAMD1B mRNA	PMID:29427782
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of GRAMD1B mRNA	PMID:30047161
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313474	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of GRAMD1B mRNA	PMID:28973697
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GRAMD1B mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GRAMD1B mRNA	PMID:37992649
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1606522	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GRAMD1B mRNA	PMID:38832940
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20160712	CTD	MESH:C012589	trichostatin A results in decreased expression of GRAMD1B mRNA	PMID:24935251
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313474	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GRAMD1B mRNA	PMID:17562736
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of GRAMD1B mRNA	PMID:29067470
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20160712	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GRAMD1B mRNA	PMID:22079256
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20160712	CTD	MESH:D018038	Sodium Selenite results in decreased expression of GRAMD1B mRNA	PMID:18175754
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313474	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GRAMD1B mRNA; Nanotubes, Carbon results in decreased expression of GRAMD1B mRNA	PMID:25554681
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of GRAMD1B mRNA	PMID:30047161
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GRAMD1B protein	PMID:32959892
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GRAMD1B mRNA	PMID:21641980
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1606522	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of GRAMD1B intron	PMID:30157460
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GRAMD1B gene	PMID:35440735
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20160712	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of GRAMD1B mRNA	PMID:22079256
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20160712	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GRAMD1B mRNA	PMID:22079256
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:756028	mivebresib	decreases expression	ISO	RGD:1606522	E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of GRAMD1B mRNA	PMID:35486664
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GRAMD1B mRNA	PMID:36139627
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GRAMD1B mRNA	PMID:39150890
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606522	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GRAMD1B gene]	PMID:28238834
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of GRAMD1B mRNA	PMID:30047161
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313474	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GRAMD1B mRNA	PMID:24535843
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of GRAMD1B mRNA	PMID:30047161
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of GRAMD1B mRNA	PMID:30047161
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of GRAMD1B mRNA	PMID:30047161
1305443	Gramd1b	GRAM domain containing 1B	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313474	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of GRAMD1B mRNA	PMID:28973697
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313476	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PRRG2 mRNA	PMID:33045310
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PRRG2 mRNA	PMID:36331819
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313476	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PRRG2 mRNA	PMID:39241906
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313476	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of PRRG2 mRNA	PMID:29980752
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313475	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PRRG2 mRNA	PMID:38568856
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRRG2 mRNA	PMID:33387578
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313475	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRRG2 mRNA	PMID:29093498
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PRRG2 mRNA	PMID:31150632
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRRG2 mRNA	PMID:22206623
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1313475	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of PRRG2 mRNA	PMID:36861143
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313475	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PRRG2 mRNA	PMID:23557933
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313475	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PRRG2 mRNA	PMID:27392435
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313476	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRRG2 mRNA	PMID:21570461
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRRG2 mRNA	PMID:32109520|PMID:33387578
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313475	E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of PRRG2 mRNA	PMID:29704546
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRRG2 mRNA	PMID:17942748
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313475	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRRG2 promoter	PMID:27901495
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313475	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PRRG2 5' UTR	PMID:27901495
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313476	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of PRRG2 mRNA	PMID:22609695
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313476	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PRRG2 gene	PMID:35295148
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313476	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PRRG2 mRNA	PMID:23811191
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PRRG2 mRNA	PMID:34947998
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PRRG2 gene	PMID:28505145
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313476	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PRRG2 mRNA	PMID:37019170
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313476	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PRRG2 mRNA	PMID:21266533
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313476	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of PRRG2 mRNA	PMID:34813904
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313476	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of PRRG2 mRNA	PMID:34813904
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRRG2 mRNA	PMID:33453195
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313475	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRRG2 mRNA	PMID:38174414
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313475	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRRG2 mRNA	PMID:29093498
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313476	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of PRRG2 mRNA	PMID:17585979
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313476	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PRRG2 mRNA	PMID:40194260
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PRRG2 mRNA	PMID:36331819
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313475	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PRRG2 gene	PMID:29154799
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of PRRG2 mRNA	PMID:21346803
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRRG2 mRNA	PMID:33387578
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1313475	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of PRRG2 mRNA	PMID:36861143
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PRRG2 mRNA	PMID:29391264
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRRG2 mRNA	PMID:17942748
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1313476	E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in increased expression of PRRG2 mRNA	PMID:19274763
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313476	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of PRRG2 mRNA	PMID:23650126
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313476	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PRRG2 mRNA	PMID:14729362
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRRG2 mRNA	PMID:22206623
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313475	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PRRG2 gene]	PMID:28238834
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PRRG2 mRNA	PMID:21346803
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313475	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PRRG2 mRNA	PMID:38568856
1305444	Prrg2	proline rich and Gla domain 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PRRG2 mRNA	PMID:21346803
1305445	Ltf	lactotransferrin	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313478	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of LTF mRNA	PMID:37995155
1305445	Ltf	lactotransferrin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20120412	CTD	MESH:D014212	LTF protein inhibits the reaction [Tretinoin results in increased activity of CASP3 protein]	PMID:16168621
1305445	Ltf	lactotransferrin	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313477	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of LTF mRNA	PMID:22378314
1305445	Ltf	lactotransferrin	gene	CHEBI:16130	DDT	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D003634	DDT results in increased expression of LTF mRNA	PMID:9607801
1305445	Ltf	lactotransferrin	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1313478	E	RGD:6480464	20231031	CTD	MESH:D008628	Mercury results in increased expression of LTF protein	PMID:37137463
1305445	Ltf	lactotransferrin	gene	CHEBI:16412	lipopolysaccharide	increases secretion	ISO	RGD:1313477	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased secretion of LTF protein	PMID:11302825
1305445	Ltf	lactotransferrin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20161228	CTD	MESH:D008070	Thalidomide inhibits the reaction [Lipopolysaccharides results in increased secretion of LTF protein]	PMID:11302825
1305445	Ltf	lactotransferrin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20161228	CTD	MESH:D008070	[LTF protein co-treated with Phosphatidylcholines co-treated with Phytosterols] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:16141546
1305445	Ltf	lactotransferrin	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of LTF mRNA	PMID:15598610|PMID:39298647
1305445	Ltf	lactotransferrin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20210907	CTD	MESH:D004958	Estradiol results in decreased expression of LTF mRNA	PMID:31646340
1305445	Ltf	lactotransferrin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of LTF mRNA; Estradiol results in increased expression of LTF protein	PMID:10433208|PMID:11006360|PMID:11390168|PMID:15289156|PMID:16684588|PMID:17640991|PMID:19484750|PMID:19654927|PMID:24052564|PMID:25575267|PMID:32186404|PMID:9607801
1305445	Ltf	lactotransferrin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20130122	CTD	MESH:D004958	[Estradiol co-treated with ESR1 protein] results in increased expression of LTF mRNA; [Estradiol co-treated with ESR2 protein] results in increased expression of LTF mRNA; Fulvestrant inhibits the reaction [Estradiol results in decreased expression of LTF mRNA]	PMID:21783566|PMID:31646340
1305445	Ltf	lactotransferrin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004958	AHR protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of LTF mRNA]]; ESR1 protein affects the reaction [Estradiol results in increased expression of LTF mRNA]; fulvestrant inhibits the reaction [Estradiol results in increased expression of LTF mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of LTF mRNA]	PMID:10433208|PMID:11006360|PMID:17640991|PMID:19654927|PMID:24052564|PMID:9607801
1305445	Ltf	lactotransferrin	gene	CHEBI:16480	nitric oxide	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide deficiency results in decreased activity of LTF protein	PMID:14563657
1305445	Ltf	lactotransferrin	gene	CHEBI:16480	nitric oxide	increases chemical synthesis	EXP		E	RGD:6480464	20120412	CTD	MESH:D009569	LTF protein results in increased chemical synthesis of Nitric Oxide	PMID:14563657
1305445	Ltf	lactotransferrin	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120501	CTD	MESH:D007631	Chlordecone results in increased expression of LTF mRNA	PMID:33711761|PMID:9371753|PMID:9607801
1305445	Ltf	lactotransferrin	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D007631	fulvestrant inhibits the reaction [Chlordecone results in increased expression of LTF mRNA]	PMID:9607801
1305445	Ltf	lactotransferrin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313477	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LTF mRNA	PMID:37042841
1305445	Ltf	lactotransferrin	gene	CHEBI:16684	atropine	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20130723	CTD	MESH:D001285	Atropine inhibits the reaction [methylcholine results in increased secretion of LTF protein]	PMID:11112886
1305445	Ltf	lactotransferrin	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of LTF mRNA	PMID:17251523
1305445	Ltf	lactotransferrin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTF mRNA	PMID:37992649
1305445	Ltf	lactotransferrin	gene	CHEBI:17276	phloretin	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D010693	Phloretin results in increased expression of LTF protein	PMID:24487097
1305445	Ltf	lactotransferrin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTF mRNA	PMID:37992649
1305445	Ltf	lactotransferrin	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of LTF mRNA	PMID:23825647
1305445	Ltf	lactotransferrin	gene	CHEBI:17741	N,N-dimethylformamide	increases expression	ISO	RGD:1313477	E	RGD:6480464	20120412	CTD	MESH:D004126	Dimethylformamide results in increased expression of LTF mRNA	PMID:18063697
1305445	Ltf	lactotransferrin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LTF mRNA	PMID:29945229
1305445	Ltf	lactotransferrin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in increased expression of LTF mRNA	PMID:31606821
1305445	Ltf	lactotransferrin	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313477	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of LTF mRNA	PMID:26485663
1305445	Ltf	lactotransferrin	gene	CHEBI:18152	myricetin	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C040015	myricetin results in increased expression of LTF protein	PMID:24487097
1305445	Ltf	lactotransferrin	gene	CHEBI:18388	apigenin	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D047310	Apigenin results in increased expression of LTF protein	PMID:24487097
1305445	Ltf	lactotransferrin	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of LTF mRNA	PMID:23825647
1305445	Ltf	lactotransferrin	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20210907	CTD	MESH:D002104	Cadmium results in decreased expression of LTF mRNA	PMID:31646340
1305445	Ltf	lactotransferrin	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LTF mRNA	PMID:39012411
1305445	Ltf	lactotransferrin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20210907	CTD	MESH:D002104	Fulvestrant inhibits the reaction [Cadmium results in decreased expression of LTF mRNA]	PMID:31646340
1305445	Ltf	lactotransferrin	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LTF protein	PMID:23301498
1305445	Ltf	lactotransferrin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313477	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LTF intron	PMID:30157460
1305445	Ltf	lactotransferrin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LTF mRNA	PMID:19770486
1305445	Ltf	lactotransferrin	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1313478	E	RGD:6480464	20231031	CTD	MESH:D008628	Mercury results in increased expression of LTF protein	PMID:37137463
1305445	Ltf	lactotransferrin	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of LTF mRNA	PMID:15674844
1305445	Ltf	lactotransferrin	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of LTF mRNA	PMID:12763052|PMID:33026818
1305445	Ltf	lactotransferrin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LTF mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LTF mRNA	PMID:34911549
1305445	Ltf	lactotransferrin	gene	CHEBI:26125	phytosterols	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20170303	CTD	MESH:D010840	[LTF protein co-treated with Phosphatidylcholines co-treated with Phytosterols] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:16141546
1305445	Ltf	lactotransferrin	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	LTF protein inhibits the reaction [Dexamethasone results in increased abundance of Reactive Oxygen Species]	PMID:24587916
1305445	Ltf	lactotransferrin	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313478	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of LTF mRNA	PMID:31939706
1305445	Ltf	lactotransferrin	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120515	CTD	MESH:C040641	genistin results in increased expression of LTF mRNA	PMID:20049207
1305445	Ltf	lactotransferrin	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic results in decreased expression of LTF protein	PMID:19167470
1305445	Ltf	lactotransferrin	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of LTF mRNA	PMID:19654921
1305445	Ltf	lactotransferrin	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20120613	CTD	MESH:D002945	Cisplatin results in decreased expression of LTF mRNA	PMID:11099651
1305445	Ltf	lactotransferrin	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313477	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of LTF promoter	PMID:22847954
1305445	Ltf	lactotransferrin	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of LTF mRNA	PMID:30912803
1305445	Ltf	lactotransferrin	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D019833	Genistein results in increased expression of LTF mRNA; Genistein results in increased expression of LTF protein	PMID:24487097|PMID:29217487
1305445	Ltf	lactotransferrin	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313478	E	RGD:6480464	20140513	CTD	MESH:D019833	Genistein results in increased expression of LTF mRNA	PMID:15289156|PMID:22553218
1305445	Ltf	lactotransferrin	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20130122	CTD	MESH:D019833	[Genistein co-treated with ESR1 protein] results in increased expression of LTF mRNA; [Genistein co-treated with ESR2 protein] results in increased expression of LTF mRNA	PMID:21783566
1305445	Ltf	lactotransferrin	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313477	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LTF mRNA	PMID:25583101
1305445	Ltf	lactotransferrin	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in increased expression of LTF mRNA	PMID:12540486
1305445	Ltf	lactotransferrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313478	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LTF mRNA	PMID:26377647|PMID:28922406
1305445	Ltf	lactotransferrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LTF mRNA	PMID:15034205|PMID:28213091
1305445	Ltf	lactotransferrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313478	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LTF mRNA	PMID:37172768
1305445	Ltf	lactotransferrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LTF mRNA; AHR protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of LTF mRNA]]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of LTF mRNA]	PMID:11006360|PMID:17942748|PMID:24052564
1305445	Ltf	lactotransferrin	gene	CHEBI:28177	theophylline	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20120412	CTD	MESH:D013806	Theophylline results in decreased expression of LTF protein	PMID:12016098
1305445	Ltf	lactotransferrin	gene	CHEBI:28640	lipoteichoic acid	increases secretion	ISO	RGD:1313477	E	RGD:6480464	20170303	CTD	MESH:C009900	lipoteichoic acid results in increased secretion of LTF protein	PMID:11302825
1305445	Ltf	lactotransferrin	gene	CHEBI:28640	lipoteichoic acid	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20170303	CTD	MESH:C009900	Thalidomide inhibits the reaction [lipoteichoic acid results in increased secretion of LTF protein]	PMID:11302825
1305445	Ltf	lactotransferrin	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313478	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of LTF protein	PMID:28918527
1305445	Ltf	lactotransferrin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313478	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of LTF mRNA	PMID:36227756
1305445	Ltf	lactotransferrin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTF mRNA	PMID:37992649
1305445	Ltf	lactotransferrin	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D001379	Azathioprine results in decreased expression of LTF mRNA	PMID:21621594
1305445	Ltf	lactotransferrin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LTF mRNA	PMID:38568856
1305445	Ltf	lactotransferrin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of LTF mRNA	PMID:36209798|PMID:37682722|PMID:39515575
1305445	Ltf	lactotransferrin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20161228	CTD	MESH:C017947	[Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of LTF mRNA	PMID:16452187
1305445	Ltf	lactotransferrin	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313478	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of LTF mRNA	PMID:22342234
1305445	Ltf	lactotransferrin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313477	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LTF promoter	PMID:27901495
1305445	Ltf	lactotransferrin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LTF mRNA	PMID:15034205|PMID:22228805
1305445	Ltf	lactotransferrin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LTF mRNA	PMID:19770486
1305445	Ltf	lactotransferrin	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20210907	CTD	MESH:C015001	arsenite results in decreased expression of LTF mRNA	PMID:31646340
1305445	Ltf	lactotransferrin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20210907	CTD	MESH:C015001	Fulvestrant inhibits the reaction [arsenite results in decreased expression of LTF mRNA]	PMID:31646340
1305445	Ltf	lactotransferrin	gene	CHEBI:3001	beclomethasone	decreases secretion	ISO	RGD:1313477	E	RGD:6480464	20130723	CTD	MESH:D001507	Beclomethasone results in decreased secretion of LTF protein	PMID:11112886
1305445	Ltf	lactotransferrin	gene	CHEBI:3001	beclomethasone	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20130723	CTD	MESH:D001507	Beclomethasone inhibits the reaction [methylcholine results in increased secretion of LTF protein]	PMID:11112886
1305445	Ltf	lactotransferrin	gene	CHEBI:30187	aluminium oxide	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20150609	CTD	MESH:D000537	[Nanotubes, Carbon co-treated with Aluminum Oxide] results in increased secretion of LTF protein	PMID:25598225
1305445	Ltf	lactotransferrin	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313478	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LTF mRNA	PMID:27131904
1305445	Ltf	lactotransferrin	gene	CHEBI:31638	fulvestrant	increases expression	ISO	RGD:1313477	E	RGD:6480464	20210907	CTD	MESH:C070081	Fulvestrant results in increased expression of LTF mRNA	PMID:31646340
1305445	Ltf	lactotransferrin	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20210907	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of LTF gene; Fulvestrant inhibits the reaction [arsenite results in decreased expression of LTF mRNA]; Fulvestrant inhibits the reaction [Cadmium results in decreased expression of LTF mRNA]; Fulvestrant inhibits the reaction [Estradiol results in decreased expression of LTF mRNA]	PMID:31601247|PMID:31646340
1305445	Ltf	lactotransferrin	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20130514	CTD	MESH:C070081	Fulvestrant inhibits the reaction [1,7-diphenyl-5-heptene-3-one results in increased expression of LTF mRNA]; Fulvestrant inhibits the reaction [Chlordecone results in increased expression of LTF mRNA]; Fulvestrant inhibits the reaction [Estradiol results in increased expression of LTF mRNA]; Fulvestrant inhibits the reaction [o,p'-DDT results in increased expression of LTF mRNA]	PMID:10433208|PMID:17640991|PMID:19654927|PMID:9607801
1305445	Ltf	lactotransferrin	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of LTF mRNA	PMID:38568856
1305445	Ltf	lactotransferrin	gene	CHEBI:3207	budesonide	decreases secretion	ISO	RGD:1313477	E	RGD:6480464	20130723	CTD	MESH:D019819	Budesonide results in decreased secretion of LTF protein	PMID:11112886
1305445	Ltf	lactotransferrin	gene	CHEBI:3207	budesonide	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20130723	CTD	MESH:D019819	Budesonide inhibits the reaction [methylcholine results in increased secretion of LTF protein]	PMID:11112886
1305445	Ltf	lactotransferrin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of LTF mRNA	PMID:23557971|PMID:29264374
1305445	Ltf	lactotransferrin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313478	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of LTF mRNA	PMID:27760801|PMID:35295148
1305445	Ltf	lactotransferrin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LTF mRNA	PMID:25181051
1305445	Ltf	lactotransferrin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313477	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LTF gene	PMID:31601247
1305445	Ltf	lactotransferrin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313478	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LTF mRNA	PMID:32156529
1305445	Ltf	lactotransferrin	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LTF gene	PMID:28505145
1305445	Ltf	lactotransferrin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20130122	CTD	MESH:C006780	[bisphenol A co-treated with ESR1 protein] results in increased expression of LTF mRNA; [bisphenol A co-treated with ESR2 protein] results in increased expression of LTF mRNA; [bisphenol A co-treated with Fulvestrant] results in decreased methylation of LTF gene	PMID:21783566|PMID:31601247
1305445	Ltf	lactotransferrin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20230207	CTD	MESH:C006780	[Dextran Sulfate co-treated with bisphenol A] results in increased expression of LTF protein	PMID:35999755
1305445	Ltf	lactotransferrin	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313477	E	RGD:6480464	20150414	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of LTF mRNA; tetrabromobisphenol A results in increased expression of LTF protein	PMID:25461914|PMID:31675489
1305445	Ltf	lactotransferrin	gene	CHEBI:3374	capsaicin	increases expression	ISO	RGD:1313477	E	RGD:6480464	20120412	CTD	MESH:D002211	Capsaicin results in increased expression of LTF protein	PMID:9537786
1305445	Ltf	lactotransferrin	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of LTF mRNA; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of LTF protein	PMID:11390168|PMID:11908639
1305445	Ltf	lactotransferrin	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1313478	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of LTF mRNA; o,p'-DDT results in increased expression of LTF protein	PMID:11390168|PMID:9607801
1305445	Ltf	lactotransferrin	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20141111	CTD	MESH:C016340	fulvestrant inhibits the reaction [o,p'-DDT results in increased expression of LTF mRNA]	PMID:9607801
1305445	Ltf	lactotransferrin	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of LTF mRNA	PMID:36804509
1305445	Ltf	lactotransferrin	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LTF mRNA	PMID:32119087
1305445	Ltf	lactotransferrin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LTF mRNA	PMID:39298647
1305445	Ltf	lactotransferrin	gene	CHEBI:34432	4-octylphenol	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20140204	CTD	MESH:C080417	[4-octylphenol co-treated with ESR1 protein] results in increased expression of LTF mRNA; [4-octylphenol co-treated with ESR2 protein] results in increased expression of LTF mRNA	PMID:21783566
1305445	Ltf	lactotransferrin	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20130122	CTD	MESH:C041594	[4-nonylphenol co-treated with ESR1 protein] results in increased expression of LTF mRNA; [4-nonylphenol co-treated with ESR2 protein] results in increased expression of LTF mRNA	PMID:21783566
1305445	Ltf	lactotransferrin	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LTF mRNA	PMID:34289071
1305445	Ltf	lactotransferrin	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of LTF protein	PMID:35999755
1305445	Ltf	lactotransferrin	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20230207	CTD	MESH:D016264	[Dextran Sulfate co-treated with bisphenol A] results in increased expression of LTF protein	PMID:35999755
1305445	Ltf	lactotransferrin	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313477	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of LTF gene	PMID:22964155
1305445	Ltf	lactotransferrin	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of LTF protein	PMID:39748354
1305445	Ltf	lactotransferrin	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313477	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LTF mRNA	PMID:37042841
1305445	Ltf	lactotransferrin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LTF mRNA	PMID:39012411
1305445	Ltf	lactotransferrin	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of LTF mRNA	PMID:17132714
1305445	Ltf	lactotransferrin	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313478	E	RGD:6480464	20240206	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of LTF protein	PMID:37422089
1305445	Ltf	lactotransferrin	gene	CHEBI:35852	transplatin	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20120613	CTD	MESH:C034697	transplatin results in decreased expression of LTF mRNA	PMID:11099651
1305445	Ltf	lactotransferrin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313478	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LTF mRNA	PMID:40194260
1305445	Ltf	lactotransferrin	gene	CHEBI:38626	pyridaben	increases expression	ISO	RGD:1313478	E	RGD:6480464	20121113	CTD	MESH:C428725	pyridaben results in increased expression of LTF mRNA	PMID:22563483
1305445	Ltf	lactotransferrin	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313477	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of LTF promoter	PMID:22847954
1305445	Ltf	lactotransferrin	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313477	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of LTF promoter	PMID:22847954
1305445	Ltf	lactotransferrin	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of LTF mRNA	PMID:21621594
1305445	Ltf	lactotransferrin	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of LTF mRNA	PMID:21621594
1305445	Ltf	lactotransferrin	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of LTF mRNA	PMID:17555576
1305445	Ltf	lactotransferrin	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of LTF protein	PMID:11390168
1305445	Ltf	lactotransferrin	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D013629	[Ethinyl Estradiol co-treated with Tamoxifen] results in increased expression of LTF protein	PMID:24487097
1305445	Ltf	lactotransferrin	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D003907	LTF protein inhibits the reaction [Dexamethasone results in increased abundance of Reactive Oxygen Species]	PMID:24587916
1305445	Ltf	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	affects methylation	ISO	RGD:1313478	E	RGD:6480464	20140513	CTD	MESH:D004054	Diethylstilbestrol affects the methylation of LTF promoter	PMID:24316720
1305445	Ltf	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of LTF protein	PMID:15082075
1305445	Ltf	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	decreases methylation	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased methylation of LTF promoter	PMID:9331098
1305445	Ltf	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of LTF; Diethylstilbestrol results in increased expression of LTF mRNA; Diethylstilbestrol results in increased expression of LTF protein	PMID:11390168|PMID:15082075|PMID:15289156|PMID:15591538|PMID:16452187|PMID:16690809|PMID:17394237|PMID:22275727|PMID:25575267
1305445	Ltf	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20130122	CTD	MESH:D004054	[Diethylstilbestrol co-treated with ESR1 protein] results in increased expression of LTF mRNA; [Diethylstilbestrol co-treated with ESR2 protein] results in increased expression of LTF mRNA	PMID:21783566
1305445	Ltf	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004054	[Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of LTF mRNA; ESR1 mutant form inhibits the reaction [Diethylstilbestrol affects the methylation of LTF promoter]; ESR1 protein affects the reaction [Diethylstilbestrol results in increased expression of LTF]	PMID:16452187|PMID:22275727|PMID:24316720
1305445	Ltf	lactotransferrin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTF mRNA	PMID:37992649
1305445	Ltf	lactotransferrin	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D008727	Methotrexate results in decreased expression of LTF mRNA	PMID:21621594
1305445	Ltf	lactotransferrin	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in increased expression of LTF protein	PMID:11390168
1305445	Ltf	lactotransferrin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LTF mRNA	PMID:17562736
1305445	Ltf	lactotransferrin	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1313477	E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid results in increased expression of LTF protein	PMID:28871336
1305445	Ltf	lactotransferrin	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1313478	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of LTF mRNA	PMID:29279043
1305445	Ltf	lactotransferrin	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic results in decreased expression of LTF protein	PMID:19167470
1305445	Ltf	lactotransferrin	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1313478	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of LTF mRNA	PMID:19654921
1305445	Ltf	lactotransferrin	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313478	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of LTF mRNA	PMID:30529165
1305445	Ltf	lactotransferrin	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313478	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of LTF mRNA	PMID:35436446
1305445	Ltf	lactotransferrin	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313477	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of LTF mRNA	PMID:18175754
1305445	Ltf	lactotransferrin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of LTF mRNA	PMID:17555576
1305445	Ltf	lactotransferrin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LTF protein	PMID:24487097
1305445	Ltf	lactotransferrin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LTF mRNA	PMID:17942748|PMID:30675821
1305445	Ltf	lactotransferrin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D004997	[Ethinyl Estradiol co-treated with Tamoxifen] results in increased expression of LTF protein	PMID:24487097
1305445	Ltf	lactotransferrin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LTF mRNA	PMID:17942748
1305445	Ltf	lactotransferrin	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of LTF mRNA	PMID:38568856
1305445	Ltf	lactotransferrin	gene	CHEBI:4998	fenarimol	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C033789	fenarimol results in decreased expression of LTF mRNA	PMID:16324804
1305445	Ltf	lactotransferrin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313478	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LTF mRNA; Nanotubes, Carbon results in increased expression of LTF mRNA	PMID:25554681|PMID:27106021
1305445	Ltf	lactotransferrin	gene	CHEBI:50594	carbon nanotube	increases secretion	ISO	RGD:1313478	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased secretion of LTF protein	PMID:25598225
1305445	Ltf	lactotransferrin	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20161228	CTD	MESH:D037742	[Nanotubes, Carbon co-treated with Aluminum Oxide] results in increased secretion of LTF protein	PMID:25598225
1305445	Ltf	lactotransferrin	gene	CHEBI:51214	diamminedichloroplatinum	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20120613	CTD	MESH:C034697	transplatin results in decreased expression of LTF mRNA	PMID:11099651
1305445	Ltf	lactotransferrin	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LTF mRNA	PMID:38701926
1305445	Ltf	lactotransferrin	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D016559	Tacrolimus results in increased expression of LTF mRNA	PMID:21621594
1305445	Ltf	lactotransferrin	gene	CHEBI:62845	4-hydroxy-17beta-estradiol	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:C014036	4-hydroxyestradiol results in increased expression of LTF mRNA	PMID:9371753|PMID:9607801
1305445	Ltf	lactotransferrin	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of LTF mRNA	PMID:23650126
1305445	Ltf	lactotransferrin	gene	CHEBI:64482	phosphatidylcholine	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20170228	CTD	MESH:D010713	[LTF protein co-treated with Phosphatidylcholines co-treated with Phytosterols] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:16141546
1305445	Ltf	lactotransferrin	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of LTF protein	PMID:35926579
1305445	Ltf	lactotransferrin	gene	CHEBI:67895	corosolic acid	increases expression	ISO	RGD:1313477	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of LTF mRNA	PMID:37939859
1305445	Ltf	lactotransferrin	gene	CHEBI:6842	methoxychlor	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor metabolite results in increased expression of LTF mRNA; Methoxychlor metabolite results in increased expression of LTF protein; Methoxychlor results in increased expression of LTF mRNA; Methoxychlor results in increased expression of LTF protein	PMID:10433208|PMID:11390168|PMID:11908639
1305445	Ltf	lactotransferrin	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313478	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LTF mRNA	PMID:30675821
1305445	Ltf	lactotransferrin	gene	CHEBI:7459	naloxone	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D009270	Naloxone results in decreased activity of LTF protein	PMID:14563657
1305445	Ltf	lactotransferrin	gene	CHEBI:7590	nitrofen	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20260804	CTD	MESH:C007350	[nitrofen co-treated with 4-phenylbenzoic acid] results in increased expression of LTF mRNA	PMID:39181781
1305445	Ltf	lactotransferrin	gene	CHEBI:76604	MeIQx	multiple interactions	EXP		E	RGD:6480464	20140107	CTD	MESH:C036990	LTF protein inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]; LTF protein inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 protein]	PMID:12079509
1305445	Ltf	lactotransferrin	gene	CHEBI:78734	tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20140805	CTD	MESH:D001285	Atropine inhibits the reaction [methylcholine results in increased secretion of LTF protein]	PMID:11112886
1305445	Ltf	lactotransferrin	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1313478	E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in increased expression of LTF protein	PMID:11390168
1305445	Ltf	lactotransferrin	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313477	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of LTF mRNA; Irinotecan results in decreased expression of LTF mRNA	PMID:15956246
1305445	Ltf	lactotransferrin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313478	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LTF mRNA	PMID:38648751
1305445	Ltf	lactotransferrin	gene	CHEBI:8378	prednisolone	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D011239	Prednisolone results in decreased expression of LTF mRNA	PMID:21621594
1305445	Ltf	lactotransferrin	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of LTF mRNA	PMID:21621594
1305445	Ltf	lactotransferrin	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1313478	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of LTF protein	PMID:35357534
1305445	Ltf	lactotransferrin	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313478	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LTF mRNA	PMID:27131904
1305445	Ltf	lactotransferrin	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in increased expression of LTF mRNA	PMID:31606821
1305445	Ltf	lactotransferrin	gene	CHEBI:9513	thalidomide	multiple interactions	ISO	RGD:1313477	E	RGD:6480464	20120412	CTD	MESH:D013792	Thalidomide inhibits the reaction [Lipopolysaccharides results in increased secretion of LTF protein]; Thalidomide inhibits the reaction [lipoteichoic acid results in increased secretion of LTF protein]	PMID:11302825
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TRRAP mRNA	PMID:33045310
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:144804	nickel subsulfide	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in decreased expression of TRRAP mRNA	PMID:12760830
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of TRRAP mRNA	PMID:15498508|PMID:33167477
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20130806	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in decreased expression of TRRAP protein	PMID:15894607
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRRAP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TRRAP mRNA	PMID:32699268
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of TRRAP mRNA	PMID:29018328
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of TRRAP mRNA	PMID:30319688
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313479	E	RGD:6480464	20130806	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TRRAP mRNA	PMID:21179406
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313479	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in increased expression of TRRAP mRNA	PMID:21632981
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TRRAP mRNA	PMID:39241906
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20140610	CTD	MESH:D004958	Estradiol promotes the reaction [ESR1 protein binds to TRRAP protein mutant form]; Estradiol promotes the reaction [ESR1 protein binds to TRRAP protein]	PMID:23665804|PMID:32088792
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313479	E	RGD:6480464	20130806	CTD	MESH:C044887	beta-methylcholine affects the expression of TRRAP mRNA	PMID:21179406
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550217	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TRRAP mRNA	PMID:34319233
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313479	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TRRAP protein	PMID:37730182
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of TRRAP mRNA	PMID:39836092
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of TRRAP mRNA	PMID:27462272
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRRAP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TRRAP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRRAP mRNA	PMID:32699268
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TRRAP mRNA	PMID:30779732
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313479	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRRAP gene	PMID:25304211
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRRAP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:39836092|PMID:40512198
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:40504410
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313479	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TRRAP mRNA	PMID:19244175
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313479	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TRRAP protein	PMID:35688186
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20130806	CTD	MESH:D002945	Cisplatin results in decreased expression of TRRAP mRNA	PMID:19561079|PMID:27594783
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TRRAP mRNA	PMID:30912803
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313479	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of TRRAP protein	PMID:39603559
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313479	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TRRAP mRNA	PMID:39709020
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TRRAP mRNA	PMID:28959563
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20250204	CTD	MESH:D004317	[VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of TRRAP protein	PMID:38367682
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313479	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of TRRAP protein	PMID:35688186
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313479	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of TRRAP mRNA	PMID:20044591
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRRAP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:39836092|PMID:40512198
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:40504410
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRRAP mRNA	PMID:20106945|PMID:21632981
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRRAP mRNA	PMID:20504355
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313479	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRRAP 5' UTR; Benzo(a)pyrene results in decreased methylation of TRRAP promoter	PMID:27901495
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TRRAP mRNA]	PMID:32406909
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TRRAP mRNA	PMID:19150397|PMID:20018196
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of TRRAP protein	PMID:15894607
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1313479	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of TRRAP gene	PMID:31601247
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of TRRAP mRNA	PMID:15498508
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550217	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRRAP promoter alternative form	PMID:35295148
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550217	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TRRAP gene	PMID:35295148
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:32509	pirinixic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TRRAP mRNA	PMID:16940010
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRRAP mRNA	PMID:25181051|PMID:30816183
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TRRAP mRNA	PMID:26982218
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRRAP protein	PMID:33376534
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313479	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TRRAP gene	PMID:31601247
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550217	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TRRAP mRNA	PMID:33221593
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A binds to and affects the folding of AR protein] affects the reaction [AR protein modified form binds to TRRAP protein modified form]; [ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of TRRAP protein]; bisphenol A inhibits the reaction [ESR1 protein binds to TRRAP protein]	PMID:28751236|PMID:29389661|PMID:33376534
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TRRAP mRNA	PMID:39298647
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313479	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TRRAP gene	PMID:31601247
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550217	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TRRAP mRNA	PMID:40203079
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TRRAP mRNA	PMID:37019170
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313479	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TRRAP gene	PMID:22964155
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313479	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRRAP mRNA	PMID:37042841
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of TRRAP mRNA	PMID:39836092
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRRAP mRNA	PMID:38568856
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313479	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TRRAP mRNA	PMID:38382870
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRRAP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TRRAP mRNA	PMID:32699268
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313479	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TRRAP mRNA	PMID:19244175
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of TRRAP mRNA	PMID:23811191
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20180116	CTD	MESH:D015741	[Metribolone binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to TRRAP protein modified form]	PMID:28751236
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313479	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TRRAP mRNA	PMID:28302478
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313479	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TRRAP mRNA	PMID:31533062
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20120412	CTD	MESH:C016104	sodium bichromate results in decreased expression of TRRAP mRNA	PMID:12760830
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRRAP mRNA	PMID:29427782
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313479	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRRAP gene	PMID:29154799
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20140610	CTD	MESH:D013629	Tamoxifen inhibits the reaction [ESR1 protein binds to TRRAP protein]	PMID:23665804
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRRAP mRNA	PMID:21420995
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:46680	serpentine asbestos	increases methylation	ISO	RGD:1313479	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of TRRAP gene	PMID:29523930
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313479	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRRAP gene	PMID:25304211
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRRAP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:39836092|PMID:40512198
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:40504410
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20240702	CTD	MESH:D004008	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of TRRAP mRNA	PMID:37844793
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20240702	CTD	MESH:D004997	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of TRRAP mRNA	PMID:37844793
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of TRRAP protein	PMID:15894607
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of TRRAP mRNA	PMID:20977926
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of TRRAP protein	PMID:23718831
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20240702	CTD	MESH:D007052	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of TRRAP mRNA	PMID:37844793
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TRRAP protein	PMID:32959892
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of TRRAP mRNA	PMID:39836092
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TRRAP mRNA	PMID:15336504
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1313479	E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in increased expression of TRRAP mRNA	PMID:29518473
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:72754	bisphenol AF	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20250114	CTD	MESH:C583074	[bisphenol AF binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to TRRAP protein modified form]; bisphenol AF inhibits the reaction [ESR1 protein binds to TRRAP protein]	PMID:28751236|PMID:29389661
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550217	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TRRAP mRNA	PMID:22206623
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313479	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of TRRAP protein	PMID:31285264
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313479	E	RGD:6480464	20130806	CTD	MESH:C025589	ochratoxin A results in decreased expression of TRRAP mRNA	PMID:19287073
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313479	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRRAP gene]	PMID:28238834
1305446	Trrap	transformation/transcription domain-associated protein	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of TRRAP mRNA	PMID:23034163
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of SPTLC2 mRNA	PMID:31863870
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1354205	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SPTLC2 mRNA	PMID:26272509
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPTLC2 mRNA	PMID:27188386
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SPTLC2 mRNA]	PMID:31150632
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1614415	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SPTLC2 mRNA	PMID:26251327
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPTLC2 mRNA	PMID:20938992
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1354205	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SPTLC2 mRNA	PMID:33167477
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SPTLC2 mRNA	PMID:26079696
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1614415	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SPTLC2 mRNA	PMID:30319688
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:16325	lithocholic acid	increases expression	ISO	RGD:1614415	E	RGD:6480464	20131210	CTD	MESH:D008095	Lithocholic Acid results in increased expression of SPTLC2 mRNA	PMID:21480330
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614415	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SPTLC2 mRNA	PMID:39241906
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of SPTLC2 mRNA	PMID:15289156
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPTLC2 mRNA	PMID:20938992
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPTLC2 mRNA	PMID:37992649
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SPTLC2 mRNA	PMID:33359661
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of SPTLC2 mRNA	PMID:17317680
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:17579	beta-carotene	affects expression	ISO	RGD:1354205	E	RGD:6480464	20120412	CTD	MESH:D019207	beta Carotene affects the expression of SPTLC2 mRNA	PMID:17034753
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPTLC2 mRNA	PMID:37992649
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1614415	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SPTLC2 mRNA	PMID:23892564
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1354205	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SPTLC2 mRNA	PMID:16002434
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SPTLC2 mRNA	PMID:22061828|PMID:33387578
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1354205	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SPTLC2 mRNA	PMID:28818685
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPTLC2 mRNA	PMID:36331819
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1354205	E	RGD:6480464	20140408	CTD	MESH:D014284	Triiodothyronine results in increased expression of SPTLC2 mRNA	PMID:23397585
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of SPTLC2 protein	PMID:34915118
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20260707	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPTLC2 mRNA	PMID:37776818
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1614415	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SPTLC2 mRNA	PMID:19770486
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SPTLC2 mRNA	PMID:35430440
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SPTLC2 mRNA	PMID:30779732
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SPTLC2 mRNA	PMID:18593933
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SPTLC2 mRNA	PMID:31150632
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1614415	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SPTLC2 mRNA	PMID:27339419|PMID:31919559
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SPTLC2 mRNA]	PMID:31150632
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPTLC2 mRNA	PMID:20938992
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SPTLC2 mRNA	PMID:31881176
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SPTLC2 mRNA	PMID:23557933
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1354205	E	RGD:6480464	20120412	CTD	MESH:D002945	SPTLC2 protein affects the susceptibility to Cisplatin	PMID:16217747
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of SPTLC2 mRNA	PMID:18930951
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of SPTLC2 mRNA	PMID:15289156
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1354205	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SPTLC2 mRNA	PMID:24768652|PMID:25583101
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614415	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPTLC2 mRNA	PMID:21570461
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1354205	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPTLC2 mRNA	PMID:23152189
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1614415	E	RGD:6480464	20170613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPTLC2 mRNA	PMID:28238261
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20211012	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to ARNT protein] which binds to SPTLC2 promoter]	PMID:34097992
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SPTLC2 mRNA	PMID:33212167
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPTLC2 mRNA	PMID:30851411
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1614415	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of SPTLC2 protein	PMID:28918527
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPTLC2 mRNA	PMID:37992649
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1354205	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SPTLC2 mRNA	PMID:39719251
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1614415	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of SPTLC2 protein	PMID:37955338
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SPTLC2 mRNA]	PMID:32406909
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:30045	divanadium pentaoxide	affects expression	ISO	RGD:1614415	E	RGD:6480464	20160607	CTD	MESH:C066075	vanadium pentoxide affects the expression of SPTLC2 mRNA	PMID:26210822
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SPTLC2 mRNA	PMID:18593933
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SPTLC2 mRNA	PMID:19150397|PMID:20382639
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1354205	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SPTLC2 mRNA	PMID:20458559
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614415	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPTLC2 enhancer	PMID:35295148
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614415	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SPTLC2 enhancer; titanium dioxide results in increased methylation of SPTLC2 gene	PMID:35295148
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SPTLC2 mRNA	PMID:23411599|PMID:34492290
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SPTLC2 mRNA	PMID:18648102
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SPTLC2 mRNA	PMID:17426115|PMID:18301758
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1354205	E	RGD:6480464	20220111	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SPTLC2 mRNA	PMID:34627992
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to SPTLC2 promoter]	PMID:20348232
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1354205	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SPTLC2 intron	PMID:30157460
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1614415	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SPTLC2 intron	PMID:28392331
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SPTLC2 mRNA	PMID:21266533
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1614415	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SPTLC2 mRNA	PMID:34813904
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1614415	E	RGD:6480464	20230905	CTD	MESH:D010269	Paraquat results in increased expression of SPTLC2 mRNA	PMID:36108500
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20260707	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPTLC2 mRNA	PMID:37776818
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SPTLC2 protein	PMID:26879310
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1354205	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SPTLC2 mRNA	PMID:19376846
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPTLC2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SPTLC2 mRNA	PMID:36331819
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1354205	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SPTLC2 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SPTLC2 mRNA	PMID:21427059
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1614415	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SPTLC2 mRNA	PMID:19770486
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1354205	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SPTLC2 mRNA	PMID:20106945|PMID:25562108
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SPTLC2 mRNA	PMID:15289156
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPTLC2 mRNA	PMID:37992649
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SPTLC2 mRNA	PMID:18502557
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SPTLC2 mRNA	PMID:17562736
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1354205	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of SPTLC2 mRNA	PMID:21420995
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SPTLC2 mRNA	PMID:22079256
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:48347	triclocarban	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C009540	triclocarban results in increased expression of SPTLC2 mRNA	PMID:31576746
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1354205	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SPTLC2 mRNA	PMID:20458559
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SPTLC2 mRNA	PMID:24136188
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	affects expression	ISO	RGD:1354205	E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal affects the expression of SPTLC2 mRNA	PMID:17034753
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SPTLC2 protein	PMID:32959892
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1614415	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SPTLC2 mRNA	PMID:23650126
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1354205	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of SPTLC2 mRNA	PMID:15336504
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1614415	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of SPTLC2 mRNA	PMID:20003209
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1354205	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SPTLC2 intron	PMID:30157460
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SPTLC2 gene	PMID:35440735
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614415	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SPTLC2 mRNA	PMID:22206623
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SPTLC2 mRNA	PMID:22079256
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SPTLC2 mRNA	PMID:22079256
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1354205	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SPTLC2 mRNA	PMID:37199045
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:7599	Nivalenol	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in decreased expression of SPTLC2 protein	PMID:39638853
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPTLC2 mRNA	PMID:30851411
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPTLC2 mRNA	PMID:27188386
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20180220	CTD	MESH:C412815	GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SPTLC2 mRNA]	PMID:28223344
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:8062	phenethyl caffeate	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20180220	CTD	MESH:C055494	[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SPTLC2 mRNA; GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SPTLC2 mRNA]; NR1H4 protein affects the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SPTLC2 mRNA]	PMID:28223344
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of SPTLC2 mRNA	PMID:19482888
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SPTLC2 mRNA]	PMID:19482888
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1614415	E	RGD:6480464	20211012	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of SPTLC2 mRNA	PMID:34097992
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	multiple interactions	ISO	RGD:1614415	E	RGD:6480464	20211012	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran promotes the reaction [AHR protein binds to SPTLC2 promoter]; AHR gene mutant form inhibits the reaction [2,3,7,8-tetrachlorodibenzofuran results in increased expression of SPTLC2 mRNA]	PMID:34097992
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of SPTLC2 mRNA	PMID:21858171
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:83537	1-benzylpiperazine	increases expression	EXP		E	RGD:6480464	20170221	CTD	MESH:C006737	N-benzylpiperazine results in increased expression of SPTLC2 mRNA	PMID:26821219
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1354205	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SPTLC2 mRNA	PMID:26079696
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1354205	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPTLC2 mRNA	PMID:27188386
1305447	Sptlc2	serine palmitoyltransferase, long chain base subunit 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1354205	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SPTLC2 mRNA	PMID:38568856
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313483	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TRIM11 mRNA	PMID:26251327
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TRIM11 gene	PMID:20938992
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313482	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TRIM11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TRIM11 mRNA	PMID:32699268
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313483	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TRIM11 mRNA	PMID:30319688
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313482	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in increased expression of TRIM11 mRNA	PMID:21632981
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TRIM11 mRNA	PMID:39241906
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TRIM11 gene	PMID:20938992
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313482	E	RGD:6480464	20130806	CTD	MESH:D001554	Benzene results in increased expression of TRIM11 mRNA	PMID:19162166
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313483	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TRIM11 mRNA	PMID:34319233
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TRIM11 mRNA	PMID:33387578
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313482	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TRIM11 mRNA	PMID:28818685
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313482	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TRIM11 3' UTR	PMID:30157460
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313482	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in increased expression of TRIM11 mRNA	PMID:19549813
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313483	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of TRIM11 gene	PMID:27776689
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313483	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRIM11 mRNA	PMID:19770486
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313482	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TRIM11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TRIM11 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of TRIM11 mRNA	PMID:32699268
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313482	E	RGD:6480464	20130806	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TRIM11 mRNA	PMID:18593933
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TRIM11 gene	PMID:20938992
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM11 mRNA	PMID:40504410
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1313482	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of TRIM11 mRNA	PMID:19921347
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313483	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM11 mRNA	PMID:21570461
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM11 mRNA	PMID:32109520
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM11 mRNA	PMID:17942748
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM11 mRNA	PMID:17942748
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313482	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TRIM11 mRNA	PMID:28001369
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313482	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TRIM11 mRNA	PMID:33212167
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313483	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of TRIM11 gene	PMID:39894169
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313482	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TRIM11 mRNA	PMID:38568856|PMID:39719251
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM11 mRNA	PMID:40504410
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313482	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of TRIM11 mRNA	PMID:22378314
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313482	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRIM11 3' UTR	PMID:30157460
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313483	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRIM11 mRNA	PMID:19770486|PMID:22228805|PMID:22610609
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313482	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRIM11 3' UTR	PMID:27901495
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313482	E	RGD:6480464	20130806	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TRIM11 mRNA	PMID:18593933
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313482	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of TRIM11 mRNA	PMID:38568856
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TRIM11 mRNA	PMID:29264374
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313483	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRIM11 gene; titanium dioxide results in decreased methylation of TRIM11 promoter	PMID:35295148
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TRIM11 mRNA	PMID:18648102
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of TRIM11 mRNA	PMID:21318169|PMID:23811191
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20130806	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of TRIM11 mRNA]	PMID:21318169
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C069837	fullerene C60 results in increased expression of TRIM11 mRNA	PMID:19167457
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TRIM11 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TRIM11 mRNA	PMID:36041667
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313483	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TRIM11 gene	PMID:31683443
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313482	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TRIM11 gene	PMID:31601247
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TRIM11 mRNA	PMID:36041667
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313483	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TRIM11 mRNA	PMID:26377693
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TRIM11 mRNA	PMID:38685157
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TRIM11 mRNA	PMID:36041667
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313482	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRIM11 mRNA	PMID:37042841
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313482	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRIM11 mRNA	PMID:38568856
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313483	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TRIM11 mRNA	PMID:28903501
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313482	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TRIM11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TRIM11 mRNA	PMID:32699268
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of TRIM11 mRNA	PMID:23811191
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313482	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TRIM11 mRNA	PMID:31533062
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313483	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of TRIM11 mRNA	PMID:39529242
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313482	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRIM11 gene	PMID:29154799
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313482	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TRIM11 mRNA	PMID:25562108
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TRIM11 mRNA	PMID:17555576
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM11 mRNA	PMID:40504410
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TRIM11 mRNA	PMID:17555576
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TRIM11 mRNA	PMID:17942748
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM11 mRNA	PMID:17942748
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TRIM11 mRNA; Nanotubes, Carbon results in decreased expression of TRIM11 mRNA	PMID:25554681
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313483	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of TRIM11 mRNA	PMID:26377693
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of TRIM11 mRNA	PMID:19812364
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313483	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TRIM11 mRNA	PMID:22206623
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	affects expression	ISO	RGD:1313483	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the expression of TRIM11 mRNA	PMID:31388691
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRIM11 mRNA	PMID:21346803
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313482	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TRIM11 mRNA	PMID:38568856
1305448	Trim11	tripartite motif-containing 11	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313483	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TRIM11 mRNA	PMID:35537566
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313486	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of BHLHE22 mRNA	PMID:27188386
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313487	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BHLHE22 mRNA	PMID:30529165
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313486	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of BHLHE22 mRNA	PMID:24763279
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of BHLHE22 mRNA	PMID:33387578
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313486	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of BHLHE22 promoter; [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of BHLHE22 gene	PMID:33872906
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313486	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of BHLHE22 mRNA	PMID:31163220
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313486	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of BHLHE22 promoter; [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of BHLHE22 gene	PMID:33872906
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of BHLHE22 mRNA	PMID:26577399
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of BHLHE22 mRNA	PMID:27523638
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313486	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of BHLHE22 mRNA	PMID:23649840
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313486	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of BHLHE22 gene	PMID:27153756
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313486	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of BHLHE22 mRNA	PMID:23649840
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313486	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of BHLHE22 mRNA	PMID:41430723
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of BHLHE22 mRNA	PMID:30779732
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313487	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BHLHE22 mRNA	PMID:17484886
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313487	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of BHLHE22 mRNA	PMID:28960355
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of BHLHE22 mRNA	PMID:17898221
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313486	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of BHLHE22 mRNA	PMID:24768652
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313487	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BHLHE22 promoter]	PMID:19654925
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1313486	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of BHLHE22 mRNA	PMID:21198554
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313486	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of BHLHE22 gene	PMID:28589171
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313487	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of BHLHE22 mRNA	PMID:37682722
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313486	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BHLHE22 promoter	PMID:27901495
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313486	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BHLHE22 exon	PMID:27901495
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313486	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of BHLHE22 promoter	PMID:23974009
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313487	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of BHLHE22 mRNA	PMID:27131904
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of BHLHE22 mRNA	PMID:24915197
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of BHLHE22 mRNA	PMID:30047161
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313487	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BHLHE22 gene	PMID:35295148
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313487	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of BHLHE22 mRNA	PMID:20813756
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BHLHE22 mRNA	PMID:25181051|PMID:34947998
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of BHLHE22 mRNA	PMID:33296240
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313487	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of BHLHE22 mRNA	PMID:32365465
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313486	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of BHLHE22 gene	PMID:31601247
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of BHLHE22 gene	PMID:27387713
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of BHLHE22 mRNA	PMID:27387713
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of BHLHE22 mRNA	PMID:30047161
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313486	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BHLHE22 mRNA	PMID:25979313
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313486	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of BHLHE22 mRNA	PMID:28001369
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313486	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of BHLHE22 gene	PMID:29154799
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of BHLHE22 mRNA	PMID:30047161
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313487	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of BHLHE22 mRNA	PMID:19446018
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313487	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of BHLHE22 mRNA	PMID:29279043
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of BHLHE22 mRNA	PMID:30047161
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313487	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of BHLHE22 mRNA	PMID:23608068
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of BHLHE22 mRNA	PMID:20080153
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in increased expression of BHLHE22 mRNA	PMID:32741896
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313486	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BHLHE22 gene]	PMID:28238834
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of BHLHE22 mRNA	PMID:30047161
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of BHLHE22 mRNA	PMID:24780913
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313487	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of BHLHE22 mRNA	PMID:27131904
1305451	Bhlhe22	basic helix-loop-helix family, member e22	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of BHLHE22 mRNA	PMID:19281266
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:10033	warfarin	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in decreased expression of CCT8 mRNA	PMID:20493250
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313489	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of CCT8 mRNA	PMID:33045310
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313489	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CCT8 mRNA	PMID:37995155
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCT8 mRNA]	PMID:31150632
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:133296	microcystin RR	increases expression	ISO	RGD:1313488	E	RGD:6480464	20161004	CTD	MESH:C063855	microcystin RR results in increased expression of CCT8 protein	PMID:19111056
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCT8 mRNA	PMID:30529165
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313489	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CCT8 mRNA	PMID:30319688
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313489	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CCT8 mRNA	PMID:39241906
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of CCT8 mRNA	PMID:35877022
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT8 mRNA]	PMID:39241906
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313489	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CCT8 mRNA	PMID:15598610
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313488	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CCT8 mRNA	PMID:38568856
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:17296	aniline	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C023650	aniline results in increased nitrosation of and results in increased expression of CCT8 protein	PMID:21708182
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CCT8 mRNA	PMID:33754040
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of CCT8 protein; [Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT8 protein; [Cuprizone co-treated with Haloperidol] results in decreased expression of CCT8 protein	PMID:34122009
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313488	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CCT8 protein	PMID:37730182
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	ISO	RGD:1313488	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of CCT8 mRNA	PMID:17103032
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCT8 mRNA	PMID:35301059
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CCT8 protein	PMID:23301498
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313489	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of CCT8 mRNA	PMID:27776689
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CCT8 mRNA	PMID:35430440
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CCT8 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CCT8 protein	PMID:38598786
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCT8 mRNA	PMID:31150632
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313489	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCT8 mRNA	PMID:31919559
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCT8 mRNA]	PMID:31150632
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCT8 mRNA	PMID:22206623
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1313488	E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in decreased expression of CCT8 protein	PMID:31195006
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CCT8 protein	PMID:37208198
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CCT8 mRNA	PMID:23557933
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20181016	CTD	MESH:D002945	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of CCT8 protein	PMID:29733421
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313488	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCT8 mRNA	PMID:22574217
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313489	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCT8 mRNA	PMID:21570461|PMID:24680724
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313488	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCT8 mRNA	PMID:15056799
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCT8 mRNA	PMID:19770486
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCT8 mRNA	PMID:17942748
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313488	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CCT8 mRNA	PMID:32763439
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313488	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CCT8 mRNA	PMID:29803840
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313488	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCT8 mRNA; sodium arsenite results in decreased expression of CCT8 protein	PMID:20050688|PMID:30528433|PMID:39719251
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313489	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCT8 mRNA	PMID:22228805
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CCT8 mRNA]; arsenite promotes the reaction [G3BP1 protein binds to CCT8 protein]	PMID:32406909
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of CCT8 protein	PMID:34122009
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313488	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CCT8 mRNA	PMID:20458559
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCT8 protein]	PMID:26598702
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20181016	CTD	MESH:D001761	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of CCT8 protein	PMID:29733421
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CCT8 mRNA	PMID:25729387
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CCT8 mRNA	PMID:30047161
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313489	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCT8 gene	PMID:35295148
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CCT8 mRNA	PMID:34492290
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313489	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CCT8 mRNA	PMID:28472532
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313488	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of CCT8 protein	PMID:34186270
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CCT8 mRNA	PMID:25181051|PMID:41034487
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313488	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CCT8 protein	PMID:34186270
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313489	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CCT8 mRNA	PMID:39298647
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313488	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CCT8 protein	PMID:34186270
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313488	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CCT8 protein	PMID:34186270
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313489	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CCT8 intron	PMID:28392331
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CCT8 protein	PMID:38598786
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT8 mRNA]	PMID:39241906
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CCT8 mRNA	PMID:33453195
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CCT8 promoter	PMID:22457795
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCT8 mRNA	PMID:35301059
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313488	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CCT8 mRNA	PMID:24449571
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313488	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CCT8 mRNA	PMID:28302478
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1313488	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of CCT8 mRNA	PMID:26352163
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of CCT8 mRNA	PMID:25993096
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CCT8 mRNA	PMID:30047161
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:40303	lovastatin	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in decreased expression of CCT8 mRNA	PMID:20493250
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of CCT8 mRNA	PMID:21041162
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of CCT8 mRNA	PMID:21041162
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CCT8 mRNA	PMID:24136188
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1313488	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of CCT8 protein	PMID:25470785
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCT8 mRNA	PMID:30529165
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1313488	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of CCT8 protein	PMID:31195006
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313489	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CCT8 mRNA	PMID:35436446
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313489	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CCT8 mRNA	PMID:17942748
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCT8 mRNA	PMID:17942748
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20181016	CTD	MESH:D005047	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of CCT8 protein	PMID:29733421
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313488	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CCT8 mRNA	PMID:20458559
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCT8 protein]	PMID:26598702
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C017690	fenvalerate results in increased expression of CCT8 protein	PMID:33656234
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313489	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CCT8 mRNA; Nanotubes, Carbon results in increased expression of CCT8 mRNA	PMID:25554681
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CCT8 mRNA	PMID:24136188
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CCT8 mRNA	PMID:30047161
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CCT8 mRNA	PMID:40234311
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CCT8 mRNA	PMID:35964746
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CCT8 mRNA	PMID:24136188
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:5613	haloperidol	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in decreased expression of CCT8 protein	PMID:34122009
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313488	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CCT8 protein	PMID:32959892
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CCT8 mRNA	PMID:25729387
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CCT8 mRNA	PMID:24136188
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CCT8 mRNA	PMID:23650126
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:64153	tanespimycin	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20200804	CTD	MESH:C112765	[tanespimycin co-treated with VER 155008] results in decreased expression of CCT8 protein	PMID:31370342
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313489	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of CCT8 mRNA	PMID:27462272
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT8 protein	PMID:34122009
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313488	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CCT8 protein	PMID:34186270
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCT8 mRNA	PMID:22206623
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CCT8 mRNA	PMID:24136188
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313488	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CCT8 protein	PMID:31285264
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CCT8 mRNA	PMID:15215175
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of CCT8 protein	PMID:19716841
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313488	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CCT8 protein	PMID:39638853
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:7719	ochratoxin A	affects expression	ISO	RGD:1313488	E	RGD:6480464	20160607	CTD	MESH:C025589	ochratoxin A affects the expression of CCT8 protein	PMID:26861962
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCT8 gene]	PMID:28238834
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of CCT8 mRNA	PMID:30047161
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of CCT8 protein	PMID:19954255
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of CCT8 protein	PMID:19954255
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313489	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CCT8 mRNA	PMID:30294300
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of CCT8 protein	PMID:28903499
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313488	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of CCT8 protein	PMID:38348393
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CCT8 mRNA	PMID:30047161
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT8 mRNA]	PMID:39241906
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CCT8 mRNA	PMID:19281266
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CCT8 mRNA	PMID:21346803
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313488	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CCT8 protein	PMID:38598786
1305452	Cct8	chaperonin containing TCP1 subunit 8	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CCT8 mRNA	PMID:23034163
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1332255	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of MTFR1L mRNA	PMID:37995155
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1332255	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MTFR1L mRNA	PMID:30319688
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332255	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MTFR1L mRNA	PMID:39298647
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606533	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MTFR1L mRNA	PMID:37042841
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1606533	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MTFR1L protein	PMID:37730182
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606533	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MTFR1L mRNA	PMID:39836092
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332255	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTFR1L mRNA	PMID:37236586
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1606533	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MTFR1L protein	PMID:23301498
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MTFR1L mRNA	PMID:31150632
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332255	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTFR1L mRNA	PMID:22206623
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606533	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MTFR1L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MTFR1L mRNA	PMID:39836092
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1606533	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MTFR1L protein	PMID:35688186
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MTFR1L mRNA	PMID:31881176
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606533	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MTFR1L mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of MTFR1L mRNA	PMID:23557933
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1332255	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MTFR1L mRNA	PMID:19770486
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606533	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MTFR1L mRNA	PMID:33212167
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of MTFR1L mRNA	PMID:28959563
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606533	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MTFR1L mRNA	PMID:29803840
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606533	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MTFR1L mRNA	PMID:38568856
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606533	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MTFR1L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MTFR1L mRNA	PMID:39836092
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606533	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MTFR1L 5' UTR	PMID:27901495
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1606533	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MTFR1L protein]	PMID:26598702
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1332255	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of MTFR1L mRNA	PMID:21829687
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332255	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MTFR1L promoter	PMID:35295148
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332255	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MTFR1L promoter	PMID:35295148
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MTFR1L mRNA	PMID:34492290
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606533	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of MTFR1L protein	PMID:34186270
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in increased expression of MTFR1L mRNA	PMID:25181051|PMID:30816183
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MTFR1L mRNA	PMID:36041667
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332255	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MTFR1L mRNA	PMID:39298647|PMID:40203079
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1606533	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MTFR1L protein	PMID:34186270
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MTFR1L mRNA	PMID:36041667
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MTFR1L mRNA	PMID:36041667
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1606533	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MTFR1L protein	PMID:34186270
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1332255	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of MTFR1L mRNA	PMID:28392331
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1332255	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MTFR1L mRNA	PMID:34813904
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606533	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MTFR1L mRNA	PMID:39836092
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332255	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTFR1L mRNA	PMID:37236586
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606533	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MTFR1L mRNA	PMID:20106945
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1606533	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MTFR1L mRNA	PMID:38832940
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606533	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MTFR1L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MTFR1L mRNA	PMID:39836092
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1606533	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MTFR1L protein]	PMID:26598702
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332255	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MTFR1L mRNA	PMID:25554681
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606533	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MTFR1L mRNA	PMID:39836092
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1606533	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MTFR1L protein	PMID:34186270
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1332255	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of MTFR1L mRNA	PMID:22206623
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332255	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTFR1L mRNA	PMID:22206623
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MTFR1L mRNA	PMID:19281266
1305453	Mtfr1l	mitochondrial fission regulator 1-like	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1606533	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MTFR1L mRNA	PMID:38568856
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PSMG1 mRNA	PMID:33167477
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313491	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PSMG1 mRNA	PMID:20044591
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PSMG1 mRNA	PMID:21632981
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313492	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PSMG1 mRNA	PMID:39241906
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of PSMG1 mRNA	PMID:32145629
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PSMG1 gene	PMID:27618143
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PSMG1 mRNA	PMID:20655997
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of PSMG1 mRNA	PMID:17997037
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PSMG1 mRNA	PMID:22061828
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PSMG1 mRNA	PMID:28818685
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMG1 mRNA	PMID:36331819
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20260203	CTD	MESH:D008345	Manganese results in decreased expression of PSMG1 protein	PMID:37834424
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of PSMG1 mRNA	PMID:17997037
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PSMG1 mRNA	PMID:19549813
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313491	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PSMG1 protein	PMID:23301498
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313491	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PSMG1 gene	PMID:27153756
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PSMG1 mRNA	PMID:34911549
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1313491	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of PSMG1 mRNA	PMID:15672453
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PSMG1 mRNA	PMID:31150632
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PSMG1 mRNA	PMID:31919559
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMG1 mRNA	PMID:22206623
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313491	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PSMG1 protein	PMID:35688186
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313492	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of PSMG1 mRNA	PMID:30912803
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313492	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMG1 mRNA	PMID:21570461
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PSMG1 mRNA	PMID:32109520
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313492	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PSMG1 mRNA	PMID:18796159
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of PSMG1 mRNA	PMID:33512557
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313491	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PSMG1 mRNA	PMID:20044591
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PSMG1 mRNA	PMID:38568856
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of PSMG1 protein	PMID:37955338
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313492	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PSMG1 promoter	PMID:35295148
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PSMG1 mRNA	PMID:34492290
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313492	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of PSMG1 mRNA	PMID:18648102
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PSMG1 mRNA	PMID:18445702
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313492	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PSMG1 mRNA	PMID:28472532
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMG1 mRNA	PMID:34947998
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMG1 mRNA	PMID:29275510
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PSMG1 mRNA	PMID:25181051|PMID:32145629
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PSMG1 gene	PMID:28505145
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313492	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PSMG1 mRNA	PMID:39298647
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PSMG1 mRNA	PMID:21266533
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20260203	CTD	MESH:D008345	Manganese results in decreased expression of PSMG1 protein	PMID:37834424
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PSMG1 gene	PMID:22079235
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PSMG1 mRNA	PMID:19320972|PMID:19376846
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMG1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PSMG1 mRNA	PMID:36331819
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313492	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of PSMG1 mRNA	PMID:31558096
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313491	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PSMG1 mRNA	PMID:25979313
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313491	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMG1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313491	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PSMG1 mRNA	PMID:27188386
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of PSMG1 mRNA	PMID:41580965
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313491	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of PSMG1 mRNA	PMID:20106945
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313491	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PSMG1 mRNA	PMID:38832940
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313491	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PSMG1 mRNA	PMID:24935251
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313492	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PSMG1 mRNA	PMID:17562736
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PSMG1 mRNA	PMID:21420995
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313492	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PSMG1 mRNA; Nanotubes, Carbon results in increased expression of PSMG1 mRNA	PMID:25554681
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PSMG1 mRNA	PMID:24136188
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PSMG1 mRNA	PMID:35964746
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PSMG1 mRNA	PMID:24793618
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PSMG1 mRNA	PMID:24136188
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:6030	isoniazide	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of PSMG1 protein	PMID:40015660
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PSMG1 protein	PMID:32959892
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313491	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PSMG1 protein	PMID:34186270
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMG1 mRNA	PMID:22206623
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313491	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of PSMG1 protein	PMID:31285264
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313491	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PSMG1 mRNA	PMID:27188386
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313491	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PSMG1 gene]	PMID:28238834
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313492	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PSMG1 mRNA	PMID:30294300
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1313492	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of PSMG1 mRNA	PMID:31558096
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313491	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PSMG1 mRNA	PMID:27188386
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PSMG1 mRNA	PMID:19281266
1305454	Psmg1	proteasome assembly chaperone 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313491	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PSMG1 mRNA	PMID:38568856
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313493	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TRAPPC14 mRNA	PMID:39241906
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313493	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TRAPPC14 mRNA	PMID:39298647
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of TRAPPC14 mRNA	PMID:26496021
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1605367	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of TRAPPC14 mRNA	PMID:33359661
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1605367	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of TRAPPC14 mRNA	PMID:33647349
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1605367	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TRAPPC14 protein	PMID:37730182
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TRAPPC14 mRNA	PMID:33387578
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313493	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAPPC14 mRNA	PMID:40504410
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1605367	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TRAPPC14 mRNA	PMID:19244175
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1605367	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TRAPPC14 protein	PMID:35688186
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRAPPC14 mRNA	PMID:34747641
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRAPPC14 mRNA	PMID:33387578
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D020106	Acrylamide results in increased expression of TRAPPC14 mRNA	PMID:28959563
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605367	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRAPPC14 mRNA	PMID:29803840
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605367	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of TRAPPC14 mRNA	PMID:38568856
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313493	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAPPC14 mRNA	PMID:40504410
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRAPPC14 mRNA	PMID:34947998
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C006780	bisphenol A results in increased expression of TRAPPC14 mRNA	PMID:25181051
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TRAPPC14 mRNA; [bisphenol A co-treated with Estradiol] results in increased expression of TRAPPC14 mRNA	PMID:26496021|PMID:36041667
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TRAPPC14 mRNA	PMID:36041667
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313493	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TRAPPC14 mRNA	PMID:38685157
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TRAPPC14 mRNA	PMID:36041667
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313493	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TRAPPC14 mRNA	PMID:37019170
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313493	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TRAPPC14 mRNA	PMID:34813904
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313493	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TRAPPC14 mRNA	PMID:34813904
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20210209	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of TRAPPC14 promoter	PMID:22457795
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1605367	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TRAPPC14 mRNA	PMID:19244175
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605367	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRAPPC14 gene	PMID:29154799
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605367	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TRAPPC14 mRNA	PMID:25562108
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605367	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TRAPPC14 mRNA	PMID:38832940
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313493	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAPPC14 mRNA	PMID:40504410
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D004726	Endosulfan results in increased expression of TRAPPC14 mRNA	PMID:29391264
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313493	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of TRAPPC14 mRNA	PMID:40234311
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313493	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of TRAPPC14 mRNA	PMID:40826991
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C025643	vinclozolin results in decreased expression of TRAPPC14 mRNA	PMID:23034163
1305455	Trappc14	trafficking protein particle complex subunit 14	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C025643	vinclozolin results in increased expression of TRAPPC14 mRNA	PMID:23869203
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20211109	CTD	MESH:C007262	deoxynivalenol results in decreased expression of TFCP2L1 protein	PMID:33890134
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313494	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TFCP2L1 mRNA	PMID:26272509
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313494	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA	PMID:27188386
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552211	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TFCP2L1 mRNA	PMID:33045310
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TFCP2L1 mRNA]	PMID:31150632
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1313494	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of TFCP2L1 protein	PMID:36641056
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:15366	acetic acid	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20120717	CTD	MESH:D019342	Acetic Acid results in decreased expression of TFCP2L1 protein	PMID:21296659
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TFCP2L1 mRNA	PMID:36189433
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313494	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TFCP2L1 mRNA	PMID:26079696
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552211	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TFCP2L1 mRNA	PMID:30319688
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313494	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of TFCP2L1 mRNA	PMID:28986285
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552211	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TFCP2L1 mRNA	PMID:30319688
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of TFCP2L1 mRNA	PMID:15598610
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313494	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TFCP2L1 mRNA	PMID:31614463
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of TFCP2L1 mRNA	PMID:26496021
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1552211	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of TFCP2L1 mRNA	PMID:33711761
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313494	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TFCP2L1 mRNA	PMID:38568856
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of TFCP2L1 mRNA	PMID:17251523
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of TFCP2L1 mRNA	PMID:21540246
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313494	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TFCP2L1 mRNA	PMID:26079696
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TFCP2L1 mRNA	PMID:36189433
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of TFCP2L1 mRNA	PMID:20403060
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TFCP2L1 mRNA	PMID:34319233
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313494	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of TFCP2L1 mRNA	PMID:26485663
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TFCP2L1 mRNA	PMID:28818685
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TFCP2L1 mRNA	PMID:36331819
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:2208	purine-6-thiol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of TFCP2L1 mRNA	PMID:23358152
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TFCP2L1 mRNA	PMID:19549813
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20170303	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of TFCP2L1 mRNA	PMID:23876855
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1552211	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of TFCP2L1 intron	PMID:27776689
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TFCP2L1 mRNA	PMID:25378103
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TFCP2L1 mRNA	PMID:34911549
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TFCP2L1 mRNA	PMID:31150632
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TFCP2L1 mRNA]	PMID:31150632
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313494	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of TFCP2L1 mRNA	PMID:41028656
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552211	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of TFCP2L1 mRNA	PMID:40618947
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TFCP2L1 mRNA	PMID:24768652|PMID:25583101
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TFCP2L1 mRNA	PMID:33387578
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TFCP2L1 mRNA	PMID:26290441
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TFCP2L1 mRNA	PMID:32109520
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of TFCP2L1 intron] which results in decreased expression of TFCP2L1 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of TFCP2L1 mRNA	PMID:17942748|PMID:33017471
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1552211	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of TFCP2L1 mRNA	PMID:32937126
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313494	E	RGD:6480464	20141014	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TFCP2L1 mRNA	PMID:23903816
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313494	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TFCP2L1 mRNA	PMID:33212167
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TFCP2L1 mRNA	PMID:30851411
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TFCP2L1 mRNA	PMID:28959563
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313494	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TFCP2L1 mRNA	PMID:41028656
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552211	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of TFCP2L1 mRNA	PMID:39631538
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TFCP2L1 mRNA	PMID:38568856
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TFCP2L1 mRNA	PMID:37682722
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313494	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TFCP2L1 mRNA	PMID:34032870
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313494	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TFCP2L1 intron	PMID:30157460
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313494	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TFCP2L1 3' UTR	PMID:27901495
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA	PMID:27858113
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313494	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TFCP2L1 mRNA	PMID:41028656
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TFCP2L1 mRNA; Silicon Dioxide results in decreased expression of TFCP2L1 mRNA	PMID:25351596|PMID:25895662
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of TFCP2L1 mRNA	PMID:38568856
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of TFCP2L1 mRNA	PMID:22641619
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552211	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TFCP2L1 mRNA	PMID:23557971|PMID:35295148
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552211	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TFCP2L1 gene	PMID:35295148
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TFCP2L1 mRNA	PMID:23411599|PMID:34492290
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TFCP2L1 mRNA	PMID:25181051
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1552211	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TFCP2L1 promoter	PMID:27334623
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313494	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TFCP2L1 gene	PMID:31601247
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552211	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of TFCP2L1 mRNA	PMID:32156529|PMID:35598803
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of TFCP2L1 mRNA	PMID:26496021
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TFCP2L1 mRNA	PMID:40203079
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of TFCP2L1 mRNA	PMID:26377693
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA	PMID:27858113
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552211	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TFCP2L1 mRNA	PMID:38685157
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TFCP2L1 mRNA	PMID:34813904
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TFCP2L1 mRNA	PMID:35163327
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of TFCP2L1 mRNA	PMID:26377693
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TFCP2L1 mRNA	PMID:38382870|PMID:38568856
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TFCP2L1 mRNA	PMID:35163327
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TFCP2L1 mRNA	PMID:25539665
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of TFCP2L1 mRNA	PMID:24386269
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TFCP2L1 mRNA	PMID:24449571
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1552211	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of TFCP2L1 mRNA	PMID:18353800
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552211	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TFCP2L1 mRNA	PMID:40194260
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TFCP2L1 mRNA	PMID:39529242
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TFCP2L1 mRNA	PMID:36331819
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313494	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TFCP2L1 mRNA	PMID:25979313
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313494	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TFCP2L1 mRNA	PMID:26272509|PMID:28001369
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313494	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA	PMID:27188386
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of TFCP2L1 mRNA	PMID:41580965
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TFCP2L1 mRNA	PMID:17555576
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of TFCP2L1 mRNA	PMID:25123088
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TFCP2L1 mRNA	PMID:17394237
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552211	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TFCP2L1 mRNA	PMID:28973697
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1552211	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in increased expression of TFCP2L1 mRNA	PMID:25270620
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313494	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TFCP2L1 mRNA	PMID:24935251
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TFCP2L1 mRNA	PMID:17562736
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TFCP2L1 mRNA	PMID:33387578
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1552211	E	RGD:6480464	20120717	CTD	MESH:D005472	Fluorouracil results in increased expression of TFCP2L1 protein	PMID:21296659
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TFCP2L1 mRNA	PMID:24714768
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TFCP2L1 mRNA	PMID:29391264
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TFCP2L1 mRNA	PMID:17555576
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TFCP2L1 mRNA	PMID:17942748
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of TFCP2L1 mRNA	PMID:17942748
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of TFCP2L1 mRNA	PMID:38568856
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TFCP2L1 mRNA; Nanotubes, Carbon results in decreased expression of TFCP2L1 mRNA	PMID:25554681
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:50667	mercaptopurine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of TFCP2L1 mRNA	PMID:23358152
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of TFCP2L1 mRNA	PMID:26377693
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA	PMID:27858113
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA	PMID:27858113
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552211	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TFCP2L1 mRNA	PMID:25270620
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TFCP2L1 mRNA	PMID:22206623
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:76290	PhIP	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of TFCP2L1 mRNA	PMID:15215175
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TFCP2L1 mRNA	PMID:30851411
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313494	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA	PMID:27188386
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313494	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TFCP2L1 gene]	PMID:28238834
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552211	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TFCP2L1 mRNA	PMID:23091169
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of TFCP2L1 mRNA	PMID:30047161
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TFCP2L1 mRNA	PMID:19270015|PMID:19482888
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of TFCP2L1 mRNA]	PMID:19482888
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552211	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TFCP2L1 mRNA	PMID:30294300
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TFCP2L1 mRNA	PMID:30047161
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313494	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of TFCP2L1 mRNA	PMID:26272509
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313494	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA	PMID:27188386
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313494	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA	PMID:27188386
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of TFCP2L1 mRNA	PMID:23358152
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313494	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TFCP2L1 mRNA	PMID:38568856
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of TFCP2L1 mRNA	PMID:23034163
1305456	Tfcp2l1	transcription factor CP2-like 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TFCP2L1 mRNA	PMID:20566332
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1605589	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of IKBIP mRNA	PMID:27188386
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IKBIP protein]	PMID:38195004
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1605589	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of IKBIP mRNA	PMID:31016361
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1615109	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of IKBIP mRNA	PMID:26251327
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1615109	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of IKBIP promoter	PMID:26251327
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1615109	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IKBIP mRNA	PMID:36331819
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of IKBIP mRNA	PMID:22378314
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20120613	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of IKBIP protein	PMID:18951874
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1605589	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of IKBIP mRNA	PMID:21632981
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of IKBIP mRNA	PMID:23019147
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1615109	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of IKBIP mRNA	PMID:39298647
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of IKBIP mRNA	PMID:30165855
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1605589	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of IKBIP mRNA	PMID:23649840
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1615109	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IKBIP mRNA	PMID:37992649
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of IKBIP mRNA	PMID:38685446
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of IKBIP protein	PMID:40089264
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1615109	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IKBIP mRNA	PMID:37992649
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IKBIP protein	PMID:31163220
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1615109	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IKBIP mRNA	PMID:34319233
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1605589	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IKBIP mRNA	PMID:31163220
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Haloperidol] results in increased expression of IKBIP protein	PMID:34122009
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IKBIP mRNA	PMID:33387578
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of IKBIP mRNA	PMID:28818685
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20221101	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IKBIP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IKBIP mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IKBIP protein	PMID:35301059|PMID:38195004
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of IKBIP mRNA	PMID:19549813
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1605589	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of IKBIP mRNA	PMID:23649840
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1605589	E	RGD:6480464	20120613	CTD	MESH:D016604	Aflatoxin B1 affects the expression of IKBIP protein	PMID:20106945
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1605589	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IKBIP mRNA	PMID:21632981
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605589	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of IKBIP mRNA	PMID:23649840
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1615109	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IKBIP mRNA	PMID:27339419|PMID:31919559
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1615109	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IKBIP mRNA	PMID:22206623
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IKBIP mRNA	PMID:39836092
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1605589	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of IKBIP mRNA	PMID:33512557
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1605589	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of IKBIP mRNA	PMID:26272509
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IKBIP mRNA	PMID:27188386
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1615109	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of IKBIP mRNA	PMID:28960355
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in increased expression of IKBIP mRNA	PMID:41028656
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1615109	E	RGD:6480464	20120613	CTD	MESH:D002945	Cisplatin results in increased expression of IKBIP mRNA	PMID:21151649
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1605589	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IKBIP mRNA	PMID:25583101
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IKBIP mRNA	PMID:33387578
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IKBIP mRNA	PMID:21215274
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1615109	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IKBIP mRNA	PMID:15034205
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1615109	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IKBIP mRNA]	PMID:15034205
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20120613	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of IKBIP protein	PMID:18951874
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1605589	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of IKBIP mRNA	PMID:33512557
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of IKBIP mRNA; aristolochic acid I results in decreased expression of IKBIP protein	PMID:33212167
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of IKBIP mRNA	PMID:41028656
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1605589	E	RGD:6480464	20240806	CTD	MESH:D004317	Doxorubicin results in increased expression of IKBIP mRNA	PMID:38447685
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1615109	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IKBIP mRNA	PMID:37992649
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of IKBIP mRNA	PMID:29432896
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of IKBIP mRNA	PMID:39719251
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IKBIP mRNA	PMID:39836092
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605589	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IKBIP mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291|PMID:32234424
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1615109	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IKBIP mRNA	PMID:15034205|PMID:19770486
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1615109	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of IKBIP mRNA]	PMID:15034205
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of IKBIP mRNA	PMID:41028656
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1615109	E	RGD:6480464	20120522	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of IKBIP mRNA	PMID:19073995
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IKBIP mRNA	PMID:19150397
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of IKBIP mRNA	PMID:35984750
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1615109	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of IKBIP mRNA	PMID:36087614
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of IKBIP mRNA	PMID:31745603
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of IKBIP mRNA	PMID:25729387
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1615109	E	RGD:6480464	20120717	CTD	MESH:C009495	titanium dioxide results in decreased expression of IKBIP mRNA	PMID:19464567
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615109	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IKBIP gene	PMID:35295148
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1615109	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IKBIP gene	PMID:35295148
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1615109	E	RGD:6480464	20120522	CTD	MESH:C006253	pirinixic acid results in decreased expression of IKBIP mRNA	PMID:20813756
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of IKBIP mRNA	PMID:25181051
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of IKBIP mRNA	PMID:34947998
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of IKBIP mRNA; bisphenol A results in decreased expression of IKBIP protein	PMID:29275510|PMID:34186270
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1615109	E	RGD:6480464	20131210	CTD	MESH:C006780	bisphenol A results in increased expression of IKBIP mRNA	PMID:23798566
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1615109	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of IKBIP mRNA	PMID:26682919
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1605589	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of IKBIP protein	PMID:34186270
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1605589	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of IKBIP gene	PMID:22964155
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605589	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IKBIP mRNA	PMID:37042841
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IKBIP mRNA	PMID:38174414
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20221101	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IKBIP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IKBIP mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IKBIP protein	PMID:35301059|PMID:38195004
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of IKBIP protein	PMID:26879310
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1605589	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of IKBIP mRNA	PMID:33512557
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of IKBIP mRNA	PMID:28302478
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605589	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of IKBIP mRNA	PMID:31533062
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of IKBIP mRNA	PMID:27153767
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1615109	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IKBIP mRNA	PMID:36331819
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605589	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid affects the expression of IKBIP mRNA	PMID:23179753
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605589	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of IKBIP mRNA	PMID:25192806|PMID:27188386
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1615109	E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of IKBIP mRNA	PMID:19136453|PMID:21427059
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of IKBIP mRNA	PMID:25562108
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1615109	E	RGD:6480464	20120522	CTD	MESH:D016572	Cyclosporine results in decreased expression of IKBIP mRNA	PMID:19770486
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605589	E	RGD:6480464	20120613	CTD	MESH:D016572	Cyclosporine results in increased expression of IKBIP mRNA	PMID:20106945
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1615109	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of IKBIP mRNA	PMID:28973697
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1615109	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IKBIP mRNA	PMID:37992649
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1605589	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of IKBIP mRNA	PMID:33512557
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1605589	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of IKBIP mRNA	PMID:27188386
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605589	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of IKBIP mRNA	PMID:22230336
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1605589	E	RGD:6480464	20120613	CTD	MESH:D005472	Fluorouracil results in increased expression of IKBIP mRNA	PMID:17982676
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20120613	CTD	MESH:D005472	TP53 protein promotes the reaction [Fluorouracil results in increased expression of IKBIP mRNA]	PMID:17982676
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IKBIP mRNA	PMID:39836092
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of IKBIP mRNA	PMID:29391264
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1615109	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of IKBIP mRNA	PMID:35436446
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:48318	fragrance	increases expression	ISO	RGD:1605589	E	RGD:6480464	20170228	CTD	MESH:D010476	Perfume results in increased expression of IKBIP mRNA	PMID:24768652
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of IKBIP mRNA	PMID:30307764
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1615109	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IKBIP mRNA; Nanotubes, Carbon results in increased expression of IKBIP mRNA	PMID:25554681
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:5613	haloperidol	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in increased expression of IKBIP protein	PMID:34122009
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605589	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IKBIP protein	PMID:32959892
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of IKBIP mRNA	PMID:20080153
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of IKBIP mRNA	PMID:25729387
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of IKBIP mRNA	PMID:25729387
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1605589	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of IKBIP mRNA	PMID:31758290
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1605589	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of IKBIP protein	PMID:34186270
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1615109	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IKBIP mRNA	PMID:22206623
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IKBIP mRNA	PMID:27188386
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1605589	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of IKBIP mRNA	PMID:33512557
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605589	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IKBIP mRNA	PMID:27188386
1305457	Ikbip	IKBKB interacting protein	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1605589	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of IKBIP mRNA	PMID:33512557
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADAMTSL2 mRNA	PMID:20938992
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1343515	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ADAMTSL2 mRNA	PMID:23724009
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAMTSL2 mRNA	PMID:36331819
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ADAMTSL2 gene	PMID:35440735
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1343515	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ADAMTSL2 mRNA	PMID:35811015
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of ADAMTSL2 mRNA	PMID:32145629
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550215	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ADAMTSL2 mRNA	PMID:39298647
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ADAMTSL2 mRNA	PMID:33387578
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADAMTSL2 mRNA	PMID:20938992
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1343515	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ADAMTSL2 mRNA	PMID:21179406
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1550215	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ADAMTSL2 mRNA	PMID:39922521
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL2 mRNA	PMID:37992649
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1343515	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ADAMTSL2 mRNA	PMID:26717081
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:17578	toluene	increases methylation	ISO	RGD:1343515	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ADAMTSL2 gene	PMID:26717081
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1550215	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ADAMTSL2 mRNA	PMID:39922521
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL2 mRNA	PMID:37992649
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ADAMTSL2 mRNA	PMID:26577399
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1343515	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ADAMTSL2 intron	PMID:30157460
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1343515	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ADAMTSL2 promoter	PMID:30157460
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ADAMTSL2 mRNA	PMID:33354967
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADAMTSL2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ADAMTSL2 mRNA	PMID:34911549
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ADAMTSL2 mRNA	PMID:31150632
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADAMTSL2 mRNA	PMID:20938992
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1343515	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADAMTSL2 gene	PMID:25304211
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAMTSL2 mRNA	PMID:40504410
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1550215	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of ADAMTSL2 mRNA	PMID:40618947
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1343515	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADAMTSL2 mRNA	PMID:29803840
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL2 mRNA	PMID:37992649
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343515	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAMTSL2 mRNA	PMID:29301061
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550215	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAMTSL2 mRNA	PMID:37682722
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAMTSL2 mRNA	PMID:40504410
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343515	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADAMTSL2 5' UTR; Benzo(a)pyrene affects the methylation of ADAMTSL2 intron; Benzo(a)pyrene affects the methylation of ADAMTSL2 promoter	PMID:27901495|PMID:30157460
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550215	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADAMTSL2 mRNA	PMID:22228805
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550215	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADAMTSL2 mRNA	PMID:22610609
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1343515	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ADAMTSL2 mRNA	PMID:37690743
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ADAMTSL2 mRNA	PMID:30047161
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of ADAMTSL2 mRNA	PMID:30012374
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ADAMTSL2 mRNA	PMID:34492290
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ADAMTSL2 mRNA	PMID:19167457
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of ADAMTSL2 mRNA	PMID:30816183
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTSL2 mRNA	PMID:25181051|PMID:32145629|PMID:32528016
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550215	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTSL2 mRNA	PMID:32156529
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550215	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ADAMTSL2 mRNA	PMID:30951980|PMID:33221593|PMID:37894381
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1343515	E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of ADAMTSL2 mRNA	PMID:23146750
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1343515	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ADAMTSL2 mRNA	PMID:23146750
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550215	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ADAMTSL2 mRNA	PMID:30951980|PMID:40203079
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1550215	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ADAMTSL2 exon	PMID:33297965
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550215	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ADAMTSL2 mRNA	PMID:26377693
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550215	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ADAMTSL2 mRNA	PMID:30951980
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550215	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ADAMTSL2 intron	PMID:28392331
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1550215	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of ADAMTSL2 mRNA	PMID:26377693
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1343515	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ADAMTSL2 mRNA	PMID:23146750
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of ADAMTSL2 mRNA	PMID:26194646
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1550215	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ADAMTSL2 mRNA	PMID:28903501
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550215	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADAMTSL2 mRNA	PMID:40194260
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1343515	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ADAMTSL2 mRNA	PMID:31533062
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAMTSL2 mRNA	PMID:36331819
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1550215	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of ADAMTSL2 mRNA	PMID:29038090
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1343515	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADAMTSL2 gene	PMID:29154799
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ADAMTSL2 mRNA	PMID:30047161
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1550215	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ADAMTSL2 mRNA	PMID:39922521
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL2 mRNA	PMID:37992649
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:43602	obeticholic acid	decreases expression	ISO	RGD:1343515	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of ADAMTSL2 mRNA	PMID:27939613
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1343515	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ADAMTSL2 mRNA	PMID:35811015
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1343515	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADAMTSL2 gene	PMID:25304211
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550215	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAMTSL2 mRNA	PMID:40504410
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ADAMTSL2 mRNA	PMID:29391264
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550215	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADAMTSL2 mRNA	PMID:25620056
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of ADAMTSL2 mRNA	PMID:31881178
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ADAMTSL2 mRNA	PMID:30047161
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1550215	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ADAMTSL2 mRNA	PMID:23608068
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ADAMTSL2 mRNA	PMID:37269647
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1550215	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ADAMTSL2 mRNA	PMID:20003209
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1343515	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ADAMTSL2 gene]	PMID:28238834
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550215	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of ADAMTSL2 mRNA	PMID:19270015
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550215	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ADAMTSL2 mRNA	PMID:38648751
1305459	Adamtsl2	ADAMTS-like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ADAMTSL2 mRNA	PMID:30047161
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313498	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of PPM1D mRNA	PMID:31863870
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of PPM1D mRNA	PMID:25596134
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313499	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PPM1D mRNA	PMID:33045310
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PPM1D mRNA	PMID:37995155
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:136185	VX nerve agent	increases expression	ISO	RGD:1313498	E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of PPM1D mRNA	PMID:38555327
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPM1D gene	PMID:20938992
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313498	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PPM1D mRNA	PMID:23724009
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of PPM1D mRNA	PMID:25596134
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPM1D mRNA	PMID:36331819
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313498	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PPM1D mRNA	PMID:26079696
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:15882	phenol	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D019800	Phenol results in increased expression of PPM1D mRNA	PMID:17547211
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of PPM1D mRNA	PMID:12414654
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313498	E	RGD:6480464	20141223	CTD	MESH:D011794	Quercetin results in increased expression of PPM1D mRNA; Quercetin results in increased expression of PPM1D protein	PMID:21632981|PMID:25078064
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1313498	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PPM1D mRNA	PMID:29581250
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of PPM1D mRNA	PMID:16514628
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16480	nitric oxide	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide results in increased expression of PPM1D mRNA	PMID:15126337
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313499	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PPM1D mRNA	PMID:33711761
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PPM1D mRNA	PMID:38568856
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PPM1D gene	PMID:27618143
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPM1D gene	PMID:20938992
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16708	adenine	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of PPM1D mRNA	PMID:24211769
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of PPM1D mRNA	PMID:34673133
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PPM1D mRNA	PMID:20655997
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313498	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PPM1D mRNA	PMID:23649840
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313498	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PPM1D mRNA	PMID:21179406
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PPM1D mRNA	PMID:33359661
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313498	E	RGD:6480464	20130312	CTD	MESH:C031927	hydroquinone results in increased expression of PPM1D mRNA	PMID:23416264
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313498	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PPM1D protein	PMID:37730182
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PPM1D mRNA	PMID:33387578
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:17846	(S)-naringenin	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of PPM1D mRNA	PMID:36235125
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008345	Manganese results in decreased expression of PPM1D protein	PMID:25791630
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D008345	[Manganese co-treated with NGF protein] results in decreased expression of PPM1D protein; PPM1D mutant form promotes the reaction [[Manganese co-treated with NGF protein] results in increased cleavage of PARP1 protein]; PPM1D mutant form promotes the reaction [[Manganese co-treated with NGF protein] results in increased phosphorylation of TP53 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased cleavage of PARP1 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in increased expression of BAX protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in increased phosphorylation of TP53 protein]	PMID:25791630
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:211249	Ampullosporin	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C109004	[ampullosporin co-treated with Ketamine] results in increased expression of PPM1D mRNA	PMID:16635253
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313498	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PPM1D mRNA	PMID:23649840
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PPM1D protein	PMID:20106945
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313498	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPM1D mRNA	PMID:21632981|PMID:21641981|PMID:22100608|PMID:27153756
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313499	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPM1D mRNA	PMID:19770486
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20121009	CTD	MESH:D016604	TP53 protein affects the reaction [Aflatoxin B1 results in increased expression of PPM1D mRNA]	PMID:22100608
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313498	E	RGD:6480464	20141223	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PPM1D mRNA; Methyl Methanesulfonate results in increased expression of PPM1D protein	PMID:22100608|PMID:23649840|PMID:25078064
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313499	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PPM1D mRNA	PMID:32553695
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PPM1D mRNA	PMID:41430723
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PPM1D mRNA	PMID:18593933
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPM1D gene	PMID:20938992
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313498	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPM1D gene	PMID:25304211
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1313498	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of PPM1D mRNA	PMID:33512557
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1313498	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of PPM1D mRNA	PMID:38460933
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PPM1D mRNA	PMID:38460933
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313498	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PPM1D mRNA	PMID:26272509
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA	PMID:27188386
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313498	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PPM1D protein	PMID:35688186
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PPM1D mRNA	PMID:28960355
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27871	chloroacetaldehyde	affects expression	ISO	RGD:1313498	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde affects the expression of PPM1D mRNA	PMID:25596134
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of PPM1D mRNA	PMID:33775663
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PPM1D mRNA	PMID:23557933
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27882	(S)-colchicine	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of PPM1D mRNA	PMID:24211769
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313498	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of PPM1D mRNA	PMID:21532991|PMID:23300844|PMID:24280081|PMID:33545341
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313499	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of PPM1D mRNA	PMID:24280081|PMID:25270620
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313499	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPM1D mRNA	PMID:21570461
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPM1D mRNA	PMID:33387578
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of PPM1D mRNA	PMID:33512557
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313498	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of PPM1D mRNA	PMID:39709020
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1313498	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of PPM1D mRNA	PMID:26272509
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA	PMID:27188386
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of PPM1D mRNA	PMID:30911355
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313498	E	RGD:6480464	20230704	CTD	MESH:D004317	Doxorubicin results in increased expression of PPM1D mRNA	PMID:36634904
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20230704	CTD	MESH:D004317	[TP53 protein affects the susceptibility to Doxorubicin] which affects the expression of PPM1D mRNA	PMID:36634904
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1313498	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PPM1D protein	PMID:35688186
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:28869	menadione	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 results in increased expression of PPM1D mRNA	PMID:12414654
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPM1D mRNA	PMID:39900124
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313498	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PPM1D mRNA	PMID:38568856
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1313499	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased methylation of PPM1D gene	PMID:39894169
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20250902	CTD	MESH:D014415	Tunicamycin results in decreased expression of PPM1D mRNA	PMID:39900124
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313498	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of PPM1D mRNA	PMID:21873647
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313498	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PPM1D mRNA; Benzo(a)pyrene results in increased expression of PPM1D protein	PMID:20106945|PMID:21632981|PMID:22316170|PMID:22409540|PMID:32234424|PMID:40280401
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313499	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of PPM1D mRNA; Benzo(a)pyrene results in increased expression of PPM1D mRNA	PMID:19770486|PMID:32553695
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20260407	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPM1D mRNA	PMID:40280401
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PPM1D mRNA]	PMID:22228805
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of PPM1D mRNA	PMID:30911355
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PPM1D mRNA	PMID:18593933
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313498	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PPM1D mRNA	PMID:20382639|PMID:26238291|PMID:28593498
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:30621	diarsenic trioxide	affects activity	ISO	RGD:1313498	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide affects the activity of PPM1D	PMID:18482988
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PPM1D protein	PMID:21175813
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313499	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PPM1D mRNA	PMID:29095437
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20191114	CTD	MESH:C006632	MIR29A protein affects the reaction [Arsenic Trioxide results in decreased expression of PPM1D protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of CHEK2 protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]	PMID:18482988|PMID:21175813
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20191114	CTD	MESH:C006632	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PPM1D mRNA]	PMID:29095437
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:31175	adefovir pivoxil	increases expression	ISO	RGD:1313498	E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of PPM1D mRNA	PMID:25596134
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:31638	fulvestrant	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of PPM1D mRNA	PMID:16514628
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPM1D mRNA	PMID:25729387
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313499	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PPM1D gene; titanium dioxide results in decreased methylation of PPM1D promoter	PMID:35295148
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PPM1D mRNA	PMID:34492290
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of PPM1D mRNA	PMID:38479592
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of PPM1D mRNA	PMID:41034487
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of PPM1D mRNA	PMID:36982678
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PPM1D mRNA	PMID:25181051|PMID:30816183|PMID:33296240|PMID:34947998
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [naringenin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of PPM1D mRNA	PMID:28628672|PMID:36235125
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313498	E	RGD:6480464	20121009	CTD	MESH:D008748	Methylcholanthrene results in increased expression of PPM1D mRNA	PMID:22100608
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20260407	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPM1D mRNA	PMID:40280401
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPM1D mRNA	PMID:28628672
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of PPM1D mRNA	PMID:31558096
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of PPM1D mRNA	PMID:22546817
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPM1D mRNA	PMID:28628672
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313498	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPM1D mRNA	PMID:37042841
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313498	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of PPM1D mRNA	PMID:29024780
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008345	Manganese results in decreased expression of PPM1D protein	PMID:25791630
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D008345	[Manganese co-treated with NGF protein] results in decreased expression of PPM1D protein; PPM1D mutant form promotes the reaction [[Manganese co-treated with NGF protein] results in increased cleavage of PARP1 protein]; PPM1D mutant form promotes the reaction [[Manganese co-treated with NGF protein] results in increased phosphorylation of TP53 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased cleavage of PARP1 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in increased expression of BAX protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in increased phosphorylation of TP53 protein]	PMID:25791630
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PPM1D mRNA	PMID:38568856
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313498	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PPM1D mRNA	PMID:25596134
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of PPM1D mRNA	PMID:22079235
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PPM1D mRNA	PMID:19376846
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313498	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PPM1D mRNA	PMID:24449571
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120918	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of PPM1D mRNA; dibenzo(a,l)pyrene results in increased expression of PPM1D protein	PMID:22409540
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:38211	potassium bromate	increases expression	ISO	RGD:1313498	E	RGD:6480464	20190611	CTD	MESH:C019536	potassium bromate results in increased expression of PPM1D mRNA	PMID:30559759
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1313498	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of PPM1D mRNA	PMID:40434365
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313498	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PPM1D mRNA	PMID:31533062
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPM1D mRNA	PMID:36331819
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313498	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PPM1D mRNA	PMID:23179753|PMID:29154799
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPM1D mRNA	PMID:28628672
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:42223	emodin	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D004642	Emodin results in increased expression of PPM1D mRNA	PMID:16045814
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313498	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of PPM1D mRNA	PMID:23649840
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1313498	E	RGD:6480464	20140513	CTD	MESH:D006918	Hydroxyurea results in increased expression of PPM1D mRNA	PMID:24211769
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of PPM1D mRNA	PMID:16514628
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313498	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PPM1D mRNA	PMID:38832940
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313499	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPM1D mRNA	PMID:17562736
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PPM1D mRNA	PMID:33387578
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313498	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PPM1D mRNA	PMID:21420995|PMID:22230336
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of PPM1D mRNA; Fluorouracil results in increased expression of PPM1D protein	PMID:14665630|PMID:17982676
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in increased expression of PPM1D mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of PPM1D mRNA]	PMID:15016801|PMID:17982676
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PPM1D mRNA	PMID:18687144
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PPM1D mRNA	PMID:38460933
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313498	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPM1D gene	PMID:25304211
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PPM1D mRNA	PMID:35436446
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of PPM1D mRNA	PMID:18175754
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1313498	E	RGD:6480464	20141223	CTD	MESH:D005047	Etoposide results in increased expression of PPM1D protein	PMID:25078064
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1313498	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PPM1D mRNA	PMID:26272509
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA	PMID:27188386
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPM1D mRNA	PMID:28628672
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:49900	arsenous acid	affects activity	ISO	RGD:1313498	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide affects the activity of PPM1D	PMID:18482988
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PPM1D protein	PMID:21175813
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313499	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PPM1D mRNA	PMID:29095437
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20191114	CTD	MESH:C032793	MIR29A protein affects the reaction [Arsenic Trioxide results in decreased expression of PPM1D protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of CHEK2 protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]	PMID:18482988|PMID:21175813
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20191114	CTD	MESH:C032793	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PPM1D mRNA]	PMID:29095437
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of PPM1D mRNA	PMID:25596134
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1313498	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of PPM1D mRNA	PMID:23300844
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:50292	cadmium sulfate	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in decreased expression of PPM1D mRNA	PMID:21783983
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PPM1D mRNA	PMID:35964746
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20260407	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPM1D mRNA	PMID:40280401
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20260407	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPM1D mRNA	PMID:40280401
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20120918	CTD	MESH:C009687	wortmannin inhibits the reaction [Soil Pollutants results in increased expression of PPM1D protein]	PMID:22409540
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:5864	ifosfamide	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of PPM1D mRNA	PMID:25596134
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:6121	ketamine	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D007649	[ampullosporin co-treated with Ketamine] results in increased expression of PPM1D mRNA	PMID:16635253
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPM1D mRNA	PMID:25729387
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313498	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PPM1D mRNA	PMID:12414654
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PPM1D mRNA]	PMID:29095437
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PPM1D mRNA	PMID:19564919
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PPM1D mRNA	PMID:22206623
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of PPM1D mRNA	PMID:23358140
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313498	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in increased expression of PPM1D mRNA	PMID:30559759
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA	PMID:27188386
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1313498	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of PPM1D mRNA	PMID:18927307
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1313498	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of PPM1D mRNA	PMID:32234424
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of PPM1D mRNA	PMID:23640034
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313498	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PPM1D mRNA	PMID:26079696
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1313498	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of PPM1D mRNA	PMID:16514628
1305460	Ppm1d	protein phosphatase, Mg2+/Mn2+ dependent, 1D	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313498	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA	PMID:27188386
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TRP53BP2 mRNA	PMID:26251327
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRP53BP2 mRNA	PMID:30529165
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TRP53BP2 mRNA	PMID:36331819
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1313500	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of TP53BP2 protein	PMID:28073184
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of TP53BP2 gene	PMID:30207508
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313501	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TRP53BP2 mRNA	PMID:30319688
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313501	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TRP53BP2 mRNA	PMID:30319688
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of TP53BP2 protein	PMID:31494107
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313500	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of TP53BP2 mRNA	PMID:15309432
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TRP53BP2 mRNA	PMID:39298647
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313500	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of TP53BP2 mRNA	PMID:20106945
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TP53BP2 mRNA	PMID:33387578
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313500	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TP53BP2 mRNA	PMID:37042841
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313500	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TP53BP2 mRNA	PMID:21179406
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313500	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TP53BP2 protein	PMID:37730182
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:17846	(S)-naringenin	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP53BP2 mRNA	PMID:36235125
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313500	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TP53BP2 mRNA	PMID:28818685
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TP53BP2 mRNA	PMID:35301059
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313500	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TP53BP2 intron	PMID:30157460
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:25187	p-menthan-3-ol	increases expression	ISO	RGD:1313500	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TP53BP2 mRNA	PMID:26760959
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313500	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TP53BP2 mRNA	PMID:23649840
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of TRP53BP2 mRNA	PMID:18955075
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TP53BP2 mRNA	PMID:30779732
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313501	E	RGD:6480464	20200609	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRP53BP2 protein	PMID:31513885
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:27385	tetrachloromethane	increases response to substance	ISO	RGD:1313501	E	RGD:6480464	20200609	CTD	MESH:D002251	TRP53BP2 protein results in increased susceptibility to Carbon Tetrachloride	PMID:31513885
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20200609	CTD	MESH:D002251	[TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of ATG5 protein; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of ATG7 protein; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of BECN1 protein; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of IL1B mRNA; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of IL6 mRNA; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of SQSTM1 protein; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of TNF mRNA; TRP53BP2 protein affects the reaction [Carbon Tetrachloride results in increased expression of GPT protein]; TRP53BP2 protein affects the reaction [Carbon Tetrachloride results in increased expression of SQSTM1 protein]	PMID:31513885
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313500	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of TP53BP2 protein	PMID:35688186
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of TP53BP2 mRNA	PMID:25905778
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313500	E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in decreased expression of TP53BP2 protein	PMID:18089832
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TP53BP2 mRNA	PMID:23557933
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313500	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TP53BP2 mRNA	PMID:28903495
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in decreased expression of TP53BP2 mRNA	PMID:12540486
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313501	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRP53BP2 mRNA	PMID:21570461
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TP53BP2 mRNA	PMID:33387578
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313500	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TP53BP2 mRNA	PMID:33212167
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313500	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of TP53BP2 protein	PMID:35688186
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313500	E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of TP53BP2 mRNA	PMID:39900124
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313500	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TP53BP2 mRNA	PMID:38568856
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313500	E	RGD:6480464	20250902	CTD	MESH:D014415	Tunicamycin results in decreased expression of TP53BP2 mRNA	PMID:39900124
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313500	E	RGD:6480464	20210608	CTD	MESH:D014415	Tunicamycin results in increased expression of TP53BP2 mRNA	PMID:33545341
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313500	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TP53BP2 mRNA	PMID:26238291
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313500	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TP53BP2 promoter	PMID:27901495
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TP53BP2 mRNA]	PMID:32406909
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313500	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TP53BP2 mRNA	PMID:25351596
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313500	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TP53BP2 mRNA	PMID:19150397
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of TRP53BP2 mRNA	PMID:27760801
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313501	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRP53BP2 gene	PMID:35295148
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313501	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TRP53BP2 mRNA	PMID:18301758
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of TRP53BP2 mRNA	PMID:28329830
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TP53BP2 mRNA	PMID:25181051
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313500	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TP53BP2 mRNA	PMID:36235125
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRP53BP2 mRNA	PMID:33221593
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TP53BP2 mRNA	PMID:30816183
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313500	E	RGD:6480464	20240305	CTD	MESH:C006780	bisphenol A results in increased expression of TP53BP2 mRNA	PMID:33312107
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313501	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TRP53BP2 mRNA	PMID:32156529
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20230207	CTD	MESH:C006780	[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP53BP2 mRNA	PMID:36235125
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of TP53BP2 mRNA	PMID:22937105
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of TP53BP2 mRNA	PMID:22937105
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of TRP53BP2 mRNA	PMID:26682919
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TRP53BP2 mRNA	PMID:39298647
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313500	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TP53BP2 gene	PMID:31601247
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313500	E	RGD:6480464	20240305	CTD	MESH:C543008	bisphenol S results in increased expression of TP53BP2 mRNA	PMID:33312107
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TP53BP2 mRNA	PMID:28628672
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313500	E	RGD:6480464	20240305	CTD	MESH:C008745	bisphenol F results in increased expression of TP53BP2 mRNA	PMID:33312107
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of TP53BP2 mRNA	PMID:22546817
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TP53BP2 mRNA	PMID:28628672
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313500	E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of TP53BP2 mRNA	PMID:18836921|PMID:19526292
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313500	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TP53BP2 mRNA	PMID:12160620
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TP53BP2 mRNA	PMID:35301059
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313501	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of TRP53BP2 mRNA	PMID:18353800
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:38635	3-methyladenine	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20200609	CTD	MESH:C025946	TRP53BP2 protein affects the reaction [3-methyladenine results in increased expression of GPT protein]; TRP53BP2 protein affects the reaction [3-methyladenine results in increased expression of IL1B mRNA]; TRP53BP2 protein affects the reaction [3-methyladenine results in increased expression of IL6 mRNA]	PMID:31513885
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TRP53BP2 mRNA	PMID:36331819
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313500	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TP53BP2 mRNA	PMID:25979313
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313500	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TP53BP2 mRNA	PMID:20106945|PMID:25562108
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313501	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TRP53BP2 mRNA	PMID:17555576
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TP53BP2 mRNA	PMID:28628672
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1313500	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of TP53BP2 mRNA	PMID:16595896
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313500	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TP53BP2 mRNA	PMID:38832940
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TP53BP2 mRNA	PMID:33387578
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313500	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of TP53BP2 mRNA	PMID:21420995
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313501	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TRP53BP2 mRNA	PMID:17555576
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TP53BP2 mRNA	PMID:28628672
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TRP53BP2 mRNA; Nanotubes, Carbon results in decreased expression of TRP53BP2 mRNA	PMID:25554681
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:6954	Mitotane	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D008939	Mitotane results in increased expression of TP53BP2 mRNA	PMID:23485034
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313501	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TRP53BP2 mRNA	PMID:22206623
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313500	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TP53BP2 gene]	PMID:28238834
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313500	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of TP53BP2 mRNA	PMID:19159669
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of TRP53BP2 mRNA	PMID:20345932
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRP53BP2 mRNA	PMID:21346803
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313500	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TP53BP2 mRNA	PMID:38568856
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313501	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of TRP53BP2 protein	PMID:24648495
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TRP53BP2 mRNA	PMID:21346803
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TP53BP2 mRNA	PMID:23034163
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of TP53BP2 gene	PMID:31079544
1305461	Tp53bp2	tumor protein p53 binding protein, 2	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of TP53BP2 gene	PMID:31079544
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313503	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of GPT2 mRNA	PMID:37995155
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPT2 mRNA]	PMID:31150632
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of GPT2 mRNA]	PMID:19467301
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GPT2 mRNA	PMID:33167477
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GPT2 mRNA	PMID:36189433
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of GPT2 mRNA	PMID:22378314
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313503	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of GPT2 mRNA	PMID:30319688
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPT2 mRNA	PMID:29432896
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313502	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of GPT2 mRNA	PMID:20044591
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313502	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of GPT2 mRNA	PMID:18951874
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of GPT2 mRNA	PMID:21632981
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GPT2 mRNA	PMID:35811015
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313503	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of GPT2 mRNA	PMID:39298647
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of GPT2 mRNA	PMID:20068009
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of GPT2 mRNA	PMID:19484750
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of GPT2 mRNA	PMID:38568856
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of GPT2 gene	PMID:27618143
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of GPT2 protein	PMID:32044396
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GPT2 mRNA	PMID:36189433
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of GPT2 mRNA	PMID:34319233
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of GPT2 mRNA	PMID:26577399
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313502	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of GPT2 mRNA	PMID:26485663
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of GPT2 mRNA	PMID:37748715
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313502	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of GPT2 intron	PMID:30157460
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPT2 mRNA	PMID:35301059
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1313502	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of GPT2 mRNA	PMID:19549813
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1313502	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of GPT2 intron	PMID:30157460
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313502	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GPT2 gene	PMID:27153756
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D016604	[sulforaphane co-treated with Aflatoxin B1] affects the expression of GPT2 mRNA	PMID:25450479
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313503	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of GPT2 mRNA	PMID:24489787
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27086	tributylstannane	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in decreased expression of GPT2 mRNA	PMID:31129395
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GPT2 mRNA	PMID:31150632
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27385	tetrachloromethane	increases activity	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased activity of GPT2 protein	PMID:19085960
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GPT2 mRNA; Carbon Tetrachloride results in increased expression of GPT2 protein	PMID:19085960|PMID:27339419|PMID:31919559
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPT2 mRNA]	PMID:31150632
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GPT2 mRNA	PMID:25629700
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GPT2 mRNA	PMID:22206623
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27638	cobalt atom	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20130514	CTD	MESH:D003035	[tungsten carbide co-treated with Cobalt] results in increased expression of GPT2 mRNA	PMID:23052192
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of GPT2 mRNA	PMID:31881176
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313502	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of GPT2 mRNA	PMID:27594783
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:27902	tetracycline	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20150127	CTD	MESH:D013752	Tetracycline results in decreased expression of GPT2 mRNA	PMID:24489787
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPT2 mRNA	PMID:22298810
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA	PMID:21215274|PMID:32109520
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA	PMID:20106945|PMID:21632981
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA	PMID:19770486
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GPT2 mRNA	PMID:25975270
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313502	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of GPT2 mRNA	PMID:28001369
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GPT2 mRNA	PMID:33212167
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of GPT2 mRNA	PMID:28959563
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313502	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of GPT2 mRNA	PMID:32763439
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20150512	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of GPT2 mRNA; [Disulfiram binds to Copper] which results in increased expression of GPT2 mRNA	PMID:24690739|PMID:30911355
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GPT2 mRNA	PMID:29803840
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313502	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of GPT2 mRNA	PMID:20044591
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPT2 mRNA	PMID:29432896
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GPT2 mRNA	PMID:37682722
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313502	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GPT2 mRNA	PMID:38568856
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313502	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of GPT2 mRNA	PMID:22378314|PMID:29453283
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313502	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GPT2 intron	PMID:30157460
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GPT2 mRNA	PMID:21839799
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20140909	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of GPT2 mRNA; Benzo(a)pyrene results in decreased expression of GPT2 mRNA; Benzo(a)pyrene results in decreased expression of GPT2 protein	PMID:20064835|PMID:20106945|PMID:21632981|PMID:24356939|PMID:26238291|PMID:32234424|PMID:32717239
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GPT2 mRNA	PMID:19770486
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313502	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GPT2 3' UTR; Benzo(a)pyrene results in decreased methylation of GPT2 promoter	PMID:27901495
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:29866	arsenite(3-)	affects expression	ISO	RGD:1313502	E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of GPT2 mRNA	PMID:22959463
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to GPT2 mRNA]	PMID:32406909
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20150512	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of GPT2 mRNA; [Disulfiram binds to Copper] which results in increased expression of GPT2 mRNA	PMID:24690739|PMID:30911355
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GPT2 mRNA	PMID:39826883
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313502	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of GPT2 mRNA	PMID:24356939
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of GPT2 mRNA	PMID:24136188
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of GPT2 mRNA	PMID:23557971
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313503	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GPT2 gene	PMID:35295148
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of GPT2 mRNA	PMID:18648102
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of GPT2 mRNA	PMID:23811191
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of GPT2 mRNA	PMID:18445702
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPT2 mRNA	PMID:19710929
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	ISO	RGD:1313502	E	RGD:6480464	20140909	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of GPT2 mRNA	PMID:24356939
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of GPT2 mRNA	PMID:30903817
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GPT2 mRNA	PMID:25181051
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313502	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of GPT2 mRNA	PMID:25979313
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1313502	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of GPT2 mRNA	PMID:19041380
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313503	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of GPT2 gene	PMID:31683443
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of GPT2 mRNA	PMID:33297965
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313503	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GPT2 mRNA	PMID:39298647
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313502	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of GPT2 gene	PMID:31601247
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1313502	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of GPT2 intron	PMID:30157460
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of GPT2 mRNA	PMID:35093514
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:34682	diazinon	increases expression	ISO	RGD:1313502	E	RGD:6480464	20140909	CTD	MESH:D003976	Diazinon results in increased expression of GPT2 mRNA	PMID:24356939
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313502	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of GPT2 gene	PMID:22964155
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GPT2 mRNA	PMID:33453195
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313502	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GPT2 mRNA	PMID:38174414
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPT2 mRNA	PMID:35301059
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313502	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GPT2 protein	PMID:26879310
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313503	E	RGD:6480464	20161025	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of GPT2 mRNA	PMID:27413110
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313502	E	RGD:6480464	20140909	CTD	MESH:C018021	cobaltous chloride results in increased expression of GPT2 mRNA	PMID:24356939
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313503	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of GPT2 mRNA	PMID:18353800
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of GPT2 mRNA	PMID:23811191
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of GPT2 mRNA	PMID:40194260
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313502	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GPT2 mRNA	PMID:32588087
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313502	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GPT2 mRNA	PMID:31533062
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1313502	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of GPT2 mRNA	PMID:26352163
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313502	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of GPT2 mRNA	PMID:40419075
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313503	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of GPT2 mRNA	PMID:23125180
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GPT2 mRNA	PMID:17292431
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313502	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GPT2 gene	PMID:29154799
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313502	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of GPT2 mRNA	PMID:29154799
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of GPT2 mRNA	PMID:38685447|PMID:41580965
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20140909	CTD	MESH:D003520	Cyclophosphamide metabolite results in decreased expression of GPT2 mRNA	PMID:24356939
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20140715	CTD	MESH:D016572	Cyclosporine results in decreased expression of GPT2 mRNA	PMID:19770486|PMID:23308384
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313502	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of GPT2 mRNA	PMID:20106945|PMID:27989131
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313503	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of GPT2 mRNA	PMID:25224403
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of GPT2 mRNA	PMID:28973697
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of GPT2 mRNA	PMID:18502557
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of GPT2 mRNA	PMID:24136188
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GPT2 mRNA	PMID:38832940
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GPT2 mRNA	PMID:17562736
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:46195	paracetamol	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased activity of GPT2 protein	PMID:19085960
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of GPT2 protein	PMID:19085960
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of GPT2 mRNA	PMID:24690739
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1313502	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of GPT2 mRNA	PMID:33725128
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GPT2 mRNA	PMID:35811015
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of GPT2 mRNA	PMID:35537566
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:47807	sulforaphane	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:C016766	[sulforaphane co-treated with Aflatoxin B1] affects the expression of GPT2 mRNA	PMID:25450479
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GPT2 mRNA	PMID:35436446
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of GPT2 mRNA	PMID:36868495
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313502	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of GPT2 mRNA	PMID:24356939
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:50161	motexafin gadolinium	increases expression	ISO	RGD:1313502	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of GPT2 mRNA	PMID:16357179
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313503	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GPT2 mRNA; Nanotubes, Carbon results in increased expression of GPT2 mRNA	PMID:25620056
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of GPT2 mRNA	PMID:41580965
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of GPT2 mRNA	PMID:38701926
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:62984	zinc acetate	increases expression	ISO	RGD:1313502	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of GPT2 mRNA	PMID:16357179
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of GPT2 mRNA	PMID:24136188
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GPT2 mRNA	PMID:28801915
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313502	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GPT2 mRNA	PMID:24810058
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313503	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GPT2 mRNA	PMID:22776087
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of GPT2 protein	PMID:36851058
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:64307	2,4-diaminobutyric acid	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20210608	CTD	MESH:C005959	[beta-N-methylamino-L-alanine co-treated with 2,4-diaminobutyric acid] results in increased expression of GPT2 mRNA	PMID:28634653
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:67895	corosolic acid	increases expression	ISO	RGD:1313502	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of GPT2 mRNA	PMID:37939859
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1313502	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of GPT2 intron	PMID:30157460
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313503	E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol results in increased expression of GPT2 mRNA	PMID:21542829
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313502	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of GPT2 mRNA	PMID:31758290
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313502	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GPT2 protein	PMID:34186270
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GPT2 mRNA	PMID:22206623
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GPT2 mRNA	PMID:22206623
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:7507	neomycin	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20190507	CTD	MESH:D009355	Neomycin results in decreased expression of GPT2 mRNA	PMID:30626089
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313502	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of GPT2 mRNA	PMID:22714537
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20140909	CTD	MESH:C025589	ochratoxin A metabolite results in decreased expression of GPT2 mRNA	PMID:24356939
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:7852	oxycodone	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in increased expression of GPT2 mRNA	PMID:23439660
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GPT2 gene]	PMID:28238834
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of GPT2 mRNA	PMID:19270015
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of GPT2 mRNA	PMID:32109520
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313503	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of GPT2 mRNA	PMID:38648751
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1313502	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of GPT2 mRNA	PMID:26705709
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:82036	prothioconazole	increases expression	ISO	RGD:1313502	E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of GPT2 mRNA	PMID:35048155
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:82283	Tungsten carbide	multiple interactions	ISO	RGD:1313502	E	RGD:6480464	20170303	CTD	MESH:C002802	[tungsten carbide co-treated with Cobalt] results in increased expression of GPT2 mRNA	PMID:23052192
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313503	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of GPT2 mRNA	PMID:39847705
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of GPT2 mRNA	PMID:21278054
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GPT2 mRNA	PMID:21346803
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313502	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GPT2 mRNA	PMID:38568856
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313502	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GPT2 mRNA	PMID:29301935
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313502	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of GPT2 mRNA	PMID:22378314|PMID:29453283
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of GPT2 mRNA	PMID:35537566
1305462	Gpt2	glutamic--pyruvic transaminase 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of GPT2 mRNA	PMID:19015723
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313504	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MAP4K1 mRNA	PMID:27188386
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K1 mRNA	PMID:20938992|PMID:33549593
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of MAP4K1 mRNA	PMID:15282401
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of MAP4K1 mRNA	PMID:15309432
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313504	E	RGD:6480464	20140408	CTD	MESH:D004958	[Estradiol co-treated with IGF1R mutant form] results in increased expression of MAP4K1 mRNA	PMID:23094148
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K1 mRNA	PMID:20938992|PMID:33549593
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313504	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAP4K1 mRNA	PMID:37042841
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:17439	cyanocob(III)alamin	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20210608	CTD	MESH:D014805	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA	PMID:33549593
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MAP4K1 mRNA	PMID:21318169
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313505	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MAP4K1 mRNA	PMID:21318169
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:17750	glycine betaine	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20210608	CTD	MESH:D001622	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA	PMID:33549593
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1313504	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MAP4K1 mRNA	PMID:36139627
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MAP4K1 mRNA	PMID:33387578
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MAP4K1 mRNA	PMID:22061828
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313504	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of MAP4K1 intron	PMID:30157460
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of MAP4K1 mRNA	PMID:39984025
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of MAP4K1 mRNA	PMID:19376150
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313504	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MAP4K1 gene; Aflatoxin B1 results in increased methylation of MAP4K1 intron	PMID:28458013|PMID:30157460
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MAP4K1 mRNA	PMID:23649840
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:26820	sulfates	affects methylation	ISO	RGD:1313504	E	RGD:6480464	20170303	CTD	MESH:D013431	Sulfates affects the methylation of MAP4K1 promoter	PMID:25395096
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:26820	sulfates	multiple interactions	ISO	RGD:1313504	E	RGD:6480464	20170303	CTD	MESH:D013431	[Soot co-treated with Sulfates] affects the methylation of MAP4K1 promoter	PMID:25395096
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA	PMID:33549593
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MAP4K1 mRNA	PMID:31150632
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K1 mRNA	PMID:20938992|PMID:33549593
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP4K1 mRNA	PMID:40504410
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MAP4K1 mRNA	PMID:26272509
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313504	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP4K1 mRNA	PMID:27188386
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MAP4K1 mRNA	PMID:31881176
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MAP4K1 mRNA	PMID:19921347
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1313504	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of MAP4K1 mRNA	PMID:23300844
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313504	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MAP4K1 mRNA	PMID:27392435
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:28017	starch	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D013213	Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of MAP4K1 mRNA]	PMID:27363782
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313504	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MAP4K1 mRNA	PMID:25583101
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP4K1 mRNA	PMID:34747641
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP4K1 mRNA	PMID:17942748
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MAP4K1 mRNA	PMID:28001369
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of MAP4K1 mRNA	PMID:26033743
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP4K1 mRNA	PMID:34876320|PMID:40504410
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA	PMID:34876320
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313504	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAP4K1 intron; Benzo(a)pyrene affects the methylation of MAP4K1 promoter	PMID:27901495|PMID:30157460
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAP4K1 mRNA	PMID:21569818|PMID:22610609
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313505	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAP4K1 mRNA	PMID:32417428
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313504	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MAP4K1 exon	PMID:27901495
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of MAP4K1 mRNA	PMID:26033743
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA	PMID:33549593
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313505	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of MAP4K1 mRNA	PMID:27131904
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1313504	E	RGD:6480464	20120412	CTD	MESH:C061133	tamibarotene results in increased expression of MAP4K1 mRNA	PMID:17229644
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of MAP4K1 mRNA	PMID:27760801
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313505	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MAP4K1 mRNA	PMID:23557971
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MAP4K1 mRNA	PMID:34492290
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313505	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MAP4K1 mRNA	PMID:20059764|PMID:23811191
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAP4K1 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of MAP4K1 mRNA]	PMID:19710929|PMID:20059764
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP4K1 mRNA	PMID:25181051
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313504	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MAP4K1 mRNA	PMID:25979313
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313505	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MAP4K1 gene	PMID:31683443
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313505	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of MAP4K1 mRNA	PMID:28392331
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of MAP4K1 mRNA	PMID:30589522
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of MAP4K1 mRNA	PMID:35163327
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313505	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAP4K1 mRNA	PMID:24982889
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MAP4K1 mRNA	PMID:25812627
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MAP4K1 mRNA	PMID:24449571
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MAP4K1 mRNA	PMID:25812627
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313505	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MAP4K1 mRNA	PMID:40194260
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313504	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MAP4K1 mRNA	PMID:31533062
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MAP4K1 mRNA	PMID:25812627
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of MAP4K1 mRNA	PMID:29038090
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313504	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAP4K1 mRNA	PMID:25979313
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313504	E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in increased expression of MAP4K1 mRNA	PMID:37505509
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313504	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MAP4K1 gene	PMID:29154799
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of MAP4K1 mRNA	PMID:21041162
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of MAP4K1 mRNA	PMID:14648872
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAP4K1 mRNA	PMID:33387578
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1313504	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of MAP4K1 mRNA	PMID:17331233
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP4K1 mRNA	PMID:40504410
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MAP4K1 mRNA	PMID:35436446
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of MAP4K1 mRNA	PMID:17720352
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA	PMID:34876320
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MAP4K1 mRNA	PMID:17942748
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP4K1 mRNA	PMID:17942748
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313504	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MAP4K1 mRNA	PMID:23300844
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313505	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of MAP4K1 mRNA	PMID:25554681
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MAP4K1 mRNA	PMID:25554681
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MAP4K1 mRNA	PMID:35964746
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313505	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MAP4K1 mRNA	PMID:38701926
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of MAP4K1 mRNA	PMID:19812364
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in decreased expression of MAP4K1 mRNA	PMID:16982809
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of MAP4K1 mRNA	PMID:28954212
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of MAP4K1 mRNA	PMID:35283115
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313505	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MAP4K1 mRNA	PMID:22206623
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313504	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MAP4K1 mRNA	PMID:37199045
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313504	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MAP4K1 mRNA	PMID:36139627
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313504	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP4K1 mRNA	PMID:27188386
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313504	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MAP4K1 gene]	PMID:28238834
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of MAP4K1 mRNA	PMID:39847705
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA	PMID:34876320
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of MAP4K1 mRNA	PMID:40826991
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313504	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP4K1 mRNA	PMID:27188386
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313505	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of MAP4K1 mRNA	PMID:27131904
1305463	Map4k1	mitogen activated protein kinase kinase kinase kinase 1	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1313504	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MAP4K1 mRNA	PMID:27188386
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D004237	Diuron results in increased expression of PRMT2IP mRNA	PMID:25152437
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PRMT2IP mRNA]	PMID:31150632
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D014212	Tretinoin results in increased expression of PRMT2IP mRNA	PMID:20488242
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313506	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PRMT2IP mRNA	PMID:39241906
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1604333	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of PRMT2IP mRNA	PMID:31614463
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRMT2IP mRNA	PMID:33387578
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604333	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PRMT2IP mRNA	PMID:37042841
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PRMT2IP mRNA	PMID:23649840
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1604333	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PRMT2IP protein	PMID:37730182
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1604333	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PRMT2IP mRNA	PMID:28818685
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1604333	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PRMT2IP intron	PMID:30157460
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PRMT2IP mRNA	PMID:19549813
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PRMT2IP mRNA	PMID:23649840
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604333	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PRMT2IP gene; Aflatoxin B1 results in increased methylation of PRMT2IP intron	PMID:27153756|PMID:30157460
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PRMT2IP mRNA	PMID:23649840
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PRMT2IP mRNA	PMID:18593933
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PRMT2IP mRNA	PMID:31150632
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PRMT2IP mRNA]	PMID:31150632
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604333	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRMT2IP gene	PMID:25304211
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1604333	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PRMT2IP protein	PMID:35688186
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of PRMT2IP mRNA	PMID:27594783
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PRMT2IP mRNA	PMID:27392435
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRMT2IP mRNA	PMID:21215274
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of PRMT2IP mRNA	PMID:29955902
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1604333	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PRMT2IP mRNA	PMID:30851411
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of PRMT2IP mRNA	PMID:23649840
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PRMT2IP mRNA	PMID:20971185
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PRMT2IP mRNA	PMID:29803840
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1604333	E	RGD:6480464	20120522	CTD	MESH:D024483	Vitamin K 3 affects the expression of PRMT2IP mRNA	PMID:20044591
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604333	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PRMT2IP mRNA	PMID:39719251
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604333	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRMT2IP intron	PMID:30157460
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604333	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PRMT2IP promoter	PMID:27901495
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1604333	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PRMT2IP mRNA	PMID:32234424
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PRMT2IP mRNA	PMID:20971185
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PRMT2IP mRNA	PMID:18593933
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1604333	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PRMT2IP mRNA	PMID:25351596
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PRMT2IP mRNA	PMID:35984750
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C004312	glycidol results in increased expression of PRMT2IP mRNA	PMID:24915197
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C032036	bromobenzene results in increased expression of PRMT2IP mRNA	PMID:32479839
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013853	Thioacetamide results in increased expression of PRMT2IP mRNA	PMID:23411599|PMID:34492290
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:32888	gamma-hexachlorocyclohexane	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20140909	CTD	MESH:D001556	Hexachlorocyclohexane results in decreased expression of PRMT2IP mRNA	PMID:24356939
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PRMT2IP mRNA	PMID:25181051
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in decreased expression of PRMT2IP mRNA	PMID:30816183|PMID:32528016
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604333	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PRMT2IP gene	PMID:31601247
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604333	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of PRMT2IP mRNA	PMID:36232920
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PRMT2IP mRNA	PMID:28628672
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1604333	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PRMT2IP intron	PMID:30157460
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRMT2IP mRNA	PMID:28628672
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRMT2IP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PRMT2IP mRNA	PMID:28628672
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604333	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PRMT2IP mRNA	PMID:37042841
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PRMT2IP mRNA	PMID:38568856
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1604333	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRMT2IP mRNA	PMID:38382870
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1604333	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PRMT2IP mRNA	PMID:28302478
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1604333	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PRMT2IP mRNA	PMID:40419075
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604333	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PRMT2IP gene	PMID:29154799
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRMT2IP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PRMT2IP mRNA	PMID:28628672
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of PRMT2IP mRNA	PMID:23649840
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1604333	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PRMT2IP mRNA	PMID:38832940
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000082	Acetaminophen results in increased expression of PRMT2IP mRNA	PMID:33387578
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604333	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of PRMT2IP mRNA	PMID:21420995|PMID:29067470
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604333	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRMT2IP gene	PMID:25304211
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PRMT2IP mRNA	PMID:22079256
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRMT2IP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PRMT2IP mRNA	PMID:28628672
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D005485	Flutamide results in increased expression of PRMT2IP mRNA	PMID:24136188
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313506	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PRMT2IP mRNA	PMID:38701926
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C406224	valdecoxib results in increased expression of PRMT2IP mRNA	PMID:24136188
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1604333	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PRMT2IP intron	PMID:30157460
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1604333	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PRMT2IP mRNA	PMID:22079256
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1604333	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PRMT2IP mRNA	PMID:22079256
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1604333	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of PRMT2IP protein	PMID:31285264
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1604333	E	RGD:6480464	20140909	CTD	MESH:C025589	ochratoxin A metabolite results in decreased expression of PRMT2IP mRNA; ochratoxin A results in decreased expression of PRMT2IP mRNA	PMID:24356939
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D009966	Orphenadrine affects the expression of PRMT2IP mRNA	PMID:23665939
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1604333	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PRMT2IP mRNA	PMID:30851411
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1604333	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PRMT2IP mRNA	PMID:38568856
1305464	Prmt2ip	PRMT2 interacting protein	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C025643	vinclozolin results in decreased expression of PRMT2IP mRNA	PMID:23034163
1305465	Fbxo10	F-box protein 10	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313508	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FBXO10 mRNA	PMID:30319688
1305465	Fbxo10	F-box protein 10	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313507	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of FBXO10 mRNA	PMID:21632981
1305465	Fbxo10	F-box protein 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of FBXO10 mRNA	PMID:32145629
1305465	Fbxo10	F-box protein 10	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of FBXO10 mRNA	PMID:20068009
1305465	Fbxo10	F-box protein 10	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313507	E	RGD:6480464	20190611	CTD	MESH:D004958	Estradiol results in increased expression of FBXO10 mRNA	PMID:30165855|PMID:31614463
1305465	Fbxo10	F-box protein 10	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313507	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of FBXO10 mRNA	PMID:39613055
1305465	Fbxo10	F-box protein 10	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313508	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXO10 mRNA	PMID:37992649
1305465	Fbxo10	F-box protein 10	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313507	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of FBXO10 mRNA	PMID:39613055
1305465	Fbxo10	F-box protein 10	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313508	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXO10 mRNA	PMID:37992649
1305465	Fbxo10	F-box protein 10	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of FBXO10 mRNA	PMID:26577399
1305465	Fbxo10	F-box protein 10	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313507	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of FBXO10 protein	PMID:37730182
1305465	Fbxo10	F-box protein 10	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FBXO10 mRNA	PMID:22061828
1305465	Fbxo10	F-box protein 10	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313507	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1305465	Fbxo10	F-box protein 10	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313508	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of FBXO10 mRNA	PMID:31626304
1305465	Fbxo10	F-box protein 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313507	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1305465	Fbxo10	F-box protein 10	gene	CHEBI:28009	N-acetyl-beta-D-glucosamine	increases expression	ISO	RGD:1313507	E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in increased expression of FBXO10 mRNA	PMID:18047607
1305465	Fbxo10	F-box protein 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO10 mRNA	PMID:22298810
1305465	Fbxo10	F-box protein 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXO10 mRNA	PMID:33387578
1305465	Fbxo10	F-box protein 10	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313507	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FBXO10 mRNA	PMID:33212167
1305465	Fbxo10	F-box protein 10	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313507	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO10 mRNA	PMID:30851411
1305465	Fbxo10	F-box protein 10	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313507	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FBXO10 mRNA	PMID:29803840
1305465	Fbxo10	F-box protein 10	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313508	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXO10 mRNA	PMID:37992649
1305465	Fbxo10	F-box protein 10	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313507	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXO10 mRNA	PMID:38568856
1305465	Fbxo10	F-box protein 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313507	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1305465	Fbxo10	F-box protein 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313507	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXO10 5' UTR	PMID:27901495
1305465	Fbxo10	F-box protein 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313507	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FBXO10 promoter	PMID:27901495
1305465	Fbxo10	F-box protein 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313508	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FBXO10 exon; Benzo(a)pyrene results in decreased methylation of FBXO10 intron	PMID:27901495
1305465	Fbxo10	F-box protein 10	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FBXO10 mRNA	PMID:34492290
1305465	Fbxo10	F-box protein 10	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313508	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of FBXO10 mRNA	PMID:18301758
1305465	Fbxo10	F-box protein 10	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of FBXO10 mRNA	PMID:30816183
1305465	Fbxo10	F-box protein 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO10 mRNA	PMID:32145629
1305465	Fbxo10	F-box protein 10	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313507	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FBXO10 gene	PMID:31601247
1305465	Fbxo10	F-box protein 10	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXO10 mRNA	PMID:36041667
1305465	Fbxo10	F-box protein 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXO10 mRNA	PMID:36041667
1305465	Fbxo10	F-box protein 10	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXO10 mRNA	PMID:36041667
1305465	Fbxo10	F-box protein 10	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of FBXO10 mRNA	PMID:32680482
1305465	Fbxo10	F-box protein 10	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313507	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1305465	Fbxo10	F-box protein 10	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313507	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of FBXO10 mRNA	PMID:39613055
1305465	Fbxo10	F-box protein 10	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313508	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXO10 mRNA	PMID:37992649
1305465	Fbxo10	F-box protein 10	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXO10 mRNA	PMID:33387578
1305465	Fbxo10	F-box protein 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313507	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1305465	Fbxo10	F-box protein 10	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FBXO10 mRNA	PMID:29391264
1305465	Fbxo10	F-box protein 10	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of FBXO10 mRNA	PMID:30307764
1305465	Fbxo10	F-box protein 10	gene	CHEBI:506227	N-acetyl-D-glucosamine	increases expression	ISO	RGD:1313507	E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in increased expression of FBXO10 mRNA	PMID:18047607
1305465	Fbxo10	F-box protein 10	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313507	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1305465	Fbxo10	F-box protein 10	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FBXO10 gene	PMID:35440735
1305465	Fbxo10	F-box protein 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of FBXO10 mRNA	PMID:27840820
1305465	Fbxo10	F-box protein 10	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1313508	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of FBXO10 mRNA	PMID:25566086
1305465	Fbxo10	F-box protein 10	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1313508	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of FBXO10 mRNA]	PMID:25566086
1305465	Fbxo10	F-box protein 10	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313507	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO10 mRNA	PMID:30851411
1305465	Fbxo10	F-box protein 10	gene	CHEBI:78492	diallyl trisulfide	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C042577	diallyl trisulfide results in increased expression of FBXO10 mRNA	PMID:34014027
1305465	Fbxo10	F-box protein 10	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FBXO10 mRNA	PMID:24780913
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332507	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LONP2 mRNA	PMID:39241906
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332507	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of LONP2 mRNA	PMID:39298647
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605609	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LONP2 mRNA	PMID:37042841
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LONP2 protein	PMID:17929048
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of LONP2 mRNA	PMID:21515302
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605609	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LONP2 gene	PMID:27153756
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of LONP2 mRNA	PMID:23649840
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D000452	Aldrin results in increased expression of LONP2 mRNA	PMID:18579281
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:27214	uranium atom	increases expression	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:D014501	Uranium results in increased expression of LONP2 mRNA	PMID:15672453
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1332507	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LONP2 mRNA	PMID:31919559
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:D001151	Arsenic affects the methylation of LONP2 gene	PMID:25304211
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605609	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LONP2 mRNA	PMID:27188386
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1605609	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of LONP2 protein	PMID:35688186
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of LONP2 mRNA	PMID:31881176
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605609	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LONP2 mRNA	PMID:23557933
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1605609	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of LONP2 gene	PMID:31636367
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1605609	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of LONP2 mRNA	PMID:27392435
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LONP2 mRNA	PMID:21570461
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LONP2 mRNA	PMID:21215274
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of LONP2 mRNA	PMID:16214954
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1605609	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of LONP2 protein	PMID:39603559
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605609	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LONP2 mRNA	PMID:33212167
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1605609	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of LONP2 mRNA	PMID:32763439
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1332507	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of LONP2 protein	PMID:28918527
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605609	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LONP2 promoter	PMID:27901495
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LONP2 mRNA	PMID:20127859
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LONP2 mRNA	PMID:22228805
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of LONP2 mRNA]	PMID:22228805
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LONP2 mRNA	PMID:19150397|PMID:20018196
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605609	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of LONP2 gene	PMID:31601247
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of LONP2 mRNA	PMID:24136188
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of LONP2 mRNA	PMID:21515302
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of LONP2 mRNA	PMID:34492290
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:C006253	pirinixic acid results in increased expression of LONP2 mRNA	PMID:17426115|PMID:20813756|PMID:23811191
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LONP2 mRNA	PMID:19710929
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1605609	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of LONP2 gene	PMID:31601247
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of LONP2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C006780	bisphenol A results in increased expression of LONP2 mRNA	PMID:25181051
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LONP2 gene	PMID:28505145
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605609	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of LONP2 gene	PMID:31601247
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:D002220	Carbamazepine affects the expression of LONP2 mRNA	PMID:25979313
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332507	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LONP2 mRNA	PMID:39298647
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1605609	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of LONP2 gene	PMID:31601247
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1605609	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LONP2 polyA tail	PMID:30157460
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1332507	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of LONP2 mRNA	PMID:38685157
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1332507	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LONP2 intron	PMID:28392331
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1332507	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of LONP2 mRNA	PMID:34813904
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1332507	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of LONP2 mRNA	PMID:34813904
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605609	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LONP2 mRNA	PMID:37042841
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D002994	Clofibrate results in increased expression of LONP2 mRNA	PMID:17585979|PMID:23811191
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of LONP2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LONP2 mRNA]	PMID:17585979
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1605609	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of LONP2 mRNA	PMID:40419075
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D014635	Valproic Acid affects the expression of LONP2 mRNA	PMID:17963808
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:D014635	Valproic Acid affects the expression of LONP2 mRNA	PMID:25979313
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:D014635	Valproic Acid results in increased expression of LONP2 mRNA	PMID:23179753|PMID:24935251
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D016572	Cyclosporine results in decreased expression of LONP2 mRNA	PMID:19770486
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:D016572	Cyclosporine results in decreased expression of LONP2 mRNA	PMID:20106945
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:C012589	trichostatin A results in increased expression of LONP2 mRNA	PMID:24935251
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D000082	Acetaminophen affects the expression of LONP2 mRNA	PMID:17562736
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:D000082	Acetaminophen results in decreased expression of LONP2 mRNA	PMID:21420995|PMID:29067470
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of LONP2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LONP2 mRNA]	PMID:17585979
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1605609	E	RGD:6480464	20151215	CTD	MESH:D001151	Arsenic affects the methylation of LONP2 gene	PMID:25304211
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of LONP2 mRNA	PMID:17108234
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332507	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LONP2 mRNA	PMID:35964746
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605609	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LONP2 protein	PMID:32959892
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of LONP2 mRNA	PMID:30467583
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1605609	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LONP2 polyA tail	PMID:30157460
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LONP2 gene	PMID:35440735
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1605609	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of LONP2 mRNA	PMID:31758290
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1332507	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of LONP2 mRNA	PMID:22206623
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605609	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LONP2 mRNA	PMID:27188386
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:D010634	Phenobarbital affects the expression of LONP2 mRNA	PMID:23091169
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of LONP2 mRNA	PMID:31826744
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1605609	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of LONP2 protein	PMID:38348393
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1332507	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of LONP2 mRNA	PMID:21795629
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1332507	E	RGD:6480464	20151215	CTD	MESH:C045950	propiconazole results in decreased expression of LONP2 mRNA	PMID:21278054
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605609	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LONP2 mRNA	PMID:27188386
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of LONP2 protein	PMID:35544339
1305466	Lonp2	lon peptidase 2, peroxisomal	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C057693	troglitazone results in increased expression of LONP2 mRNA	PMID:21515302
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313510	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PRPF8 mRNA	PMID:38218311
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PRPF8 mRNA	PMID:33045310
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of PRPF8 mRNA]	PMID:19467301
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PRPF8 mRNA	PMID:26251327
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRPF8 gene	PMID:20938992
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313510	E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of PRPF8 mRNA	PMID:15894607
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of PRPF8 mRNA	PMID:15894607
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313511	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PRPF8 mRNA	PMID:30319688
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PRPF8 mRNA	PMID:39298647
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PRPF8 mRNA	PMID:33387578
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRPF8 gene	PMID:20938992
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313510	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PRPF8 mRNA	PMID:37042841
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313510	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of PRPF8 mRNA	PMID:19162166
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313510	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PRPF8 mRNA	PMID:21179406
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PRPF8 mRNA	PMID:33754040
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313511	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PRPF8 mRNA	PMID:34319233
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20241001	CTD	MESH:D004051	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of PRPF8 protein	PMID:38995844
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PRPF8 mRNA	PMID:22061828
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRPF8 gene	PMID:20938992
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313510	E	RGD:6480464	20210504	CTD	MESH:D001151	Arsenic affects the methylation of PRPF8 gene	PMID:32603190
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313510	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PRPF8 mRNA	PMID:19244175
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of PRPF8 mRNA	PMID:26302742
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of PRPF8 protein	PMID:25505154
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313510	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of PRPF8 mRNA	PMID:27594783
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PRPF8 mRNA	PMID:30912803
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313510	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of PRPF8 mRNA	PMID:16705744
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313511	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRPF8 mRNA	PMID:21570461
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PRPF8 mRNA	PMID:33387578
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313511	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRPF8 mRNA	PMID:19770486
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRPF8 mRNA	PMID:17942748
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313510	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRPF8 mRNA	PMID:38568856
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313511	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of PRPF8 mRNA	PMID:36209798
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313511	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of PRPF8 mRNA	PMID:22342234
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313511	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PRPF8 mRNA	PMID:22228805
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PRPF8 mRNA]	PMID:32406909
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PRPF8 mRNA	PMID:15894607
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313511	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PRPF8 promoter	PMID:35295148
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of PRPF8 gene	PMID:23968726
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313510	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of PRPF8 protein	PMID:31675489
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PRPF8 mRNA	PMID:25181051|PMID:41034487
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313510	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PRPF8 mRNA; bisphenol A results in increased expression of PRPF8 protein	PMID:33670352|PMID:34186270
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313511	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of PRPF8 mRNA	PMID:40036665
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF8 mRNA	PMID:36041667
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of PRPF8 mRNA	PMID:24096037
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1313511	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of PRPF8 mRNA	PMID:24096037
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PRPF8 mRNA	PMID:39298647
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF8 mRNA	PMID:36041667
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF8 mRNA	PMID:36041667
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRPF8 mRNA	PMID:28628672
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313510	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PRPF8 protein	PMID:34186270
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PRPF8 mRNA	PMID:28392331
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20241001	CTD	MESH:C027561	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of PRPF8 protein	PMID:38995844
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PRPF8 mRNA	PMID:37019170
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34687	dibutyl phthalate	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D003993	Dibutyl Phthalate affects the expression of PRPF8 mRNA	PMID:30934153
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20241001	CTD	MESH:D003993	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of PRPF8 protein	PMID:38995844
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRPF8 mRNA	PMID:28628672
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of PRPF8 gene	PMID:23968726
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313510	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PRPF8 mRNA	PMID:37042841
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313510	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRPF8 mRNA	PMID:38382870
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313510	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PRPF8 mRNA	PMID:19244175
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:38221	fumonisin B1	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in decreased expression of PRPF8 mRNA	PMID:16221962
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313510	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PRPF8 mRNA	PMID:28302478
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PRPF8 mRNA	PMID:36331819
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313511	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PRPF8 mRNA	PMID:17555576
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRPF8 mRNA	PMID:28628672
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRPF8 mRNA	PMID:33387578
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313510	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PRPF8 mRNA	PMID:29523930
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313510	E	RGD:6480464	20210504	CTD	MESH:D001151	Arsenic affects the methylation of PRPF8 gene	PMID:32603190
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313510	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of PRPF8 mRNA	PMID:18175754
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313511	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PRPF8 mRNA	PMID:17555576
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PRPF8 mRNA	PMID:17108234|PMID:24096037
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313511	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PRPF8 mRNA	PMID:17942748|PMID:24096037
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRPF8 mRNA	PMID:17942748
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRPF8 mRNA	PMID:28628672
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PRPF8 mRNA	PMID:15894607
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PRPF8 mRNA	PMID:35964746
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313511	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PRPF8 mRNA	PMID:19042947
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313510	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PRPF8 protein	PMID:32959892
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313510	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:63630	tolcapone	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to PRPF8 protein	PMID:19783845
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313511	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PRPF8 protein	PMID:26558463
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PRPF8 mRNA	PMID:30467583
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313511	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of PRPF8 mRNA	PMID:27462272
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313510	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PRPF8 mRNA	PMID:31758290
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313510	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PRPF8 protein	PMID:34186270
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313511	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PRPF8 mRNA	PMID:22206623
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1313510	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of PRPF8 mRNA	PMID:36318118
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313510	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PRPF8 protein	PMID:31285264
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313511	E	RGD:6480464	20200519	CTD	MESH:D010634	Phenobarbital results in increased expression of PRPF8 mRNA	PMID:31836555
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313510	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PRPF8 protein	PMID:31675489
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:9130	sevoflurane	increases expression	ISO	RGD:1313511	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased expression of PRPF8 protein	PMID:35249202
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313510	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PRPF8 mRNA	PMID:38568856
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313511	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of PRPF8 protein	PMID:24648495
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of PRPF8 mRNA	PMID:23555832
1305467	Prpf8	pre-mRNA processing factor 8	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PRPF8 mRNA	PMID:23034163
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313512	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ALG8 mRNA	PMID:38218311
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313513	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ALG8 mRNA	PMID:33045310
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ALG8 mRNA	PMID:33167477
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of ALG8 mRNA	PMID:30951980
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313513	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ALG8 mRNA	PMID:39241906
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313512	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ALG8 mRNA	PMID:37042841
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313512	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ALG8 mRNA	PMID:21179406
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ALG8 mRNA	PMID:33359661
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ALG8 mRNA	PMID:33387578
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ALG8 mRNA	PMID:28818685
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ALG8 mRNA	PMID:36331819
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ALG8 mRNA	PMID:19549813
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313512	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ALG8 mRNA	PMID:35430440
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ALG8 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ALG8 mRNA	PMID:34911549
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of ALG8 mRNA	PMID:31129395
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313513	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ALG8 mRNA	PMID:31919559
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313512	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ALG8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ALG8 mRNA	PMID:40512198
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG8 mRNA	PMID:40504410
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313513	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of ALG8 mRNA	PMID:28189721|PMID:28960355
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313513	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ALG8 protein	PMID:25505154
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of ALG8 mRNA	PMID:19921347
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of ALG8 gene	PMID:28505145
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313513	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ALG8 mRNA	PMID:21570461
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALG8 mRNA	PMID:33387578
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ALG8 mRNA	PMID:25975270
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313512	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of ALG8 mRNA	PMID:33512557
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ALG8 mRNA	PMID:29803840
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ALG8 mRNA	PMID:38568856|PMID:39719251
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313512	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ALG8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ALG8 mRNA	PMID:40512198
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG8 mRNA	PMID:40504410
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ALG8 mRNA	PMID:30047161
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313513	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ALG8 mRNA	PMID:32156529
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ALG8 mRNA	PMID:25181051
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of ALG8 gene; [bisphenol A co-treated with tributyltin] results in increased expression of ALG8 mRNA	PMID:28505145|PMID:31129395
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of ALG8 mRNA	PMID:30951980
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ALG8 mRNA	PMID:21266533
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313512	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ALG8 mRNA	PMID:37042841
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ALG8 mRNA	PMID:19376846
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313513	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ALG8 mRNA	PMID:40194260
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1313512	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of ALG8 mRNA	PMID:33512557
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ALG8 mRNA	PMID:28302478
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313512	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ALG8 mRNA	PMID:19167446
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313512	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA	PMID:19167446
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ALG8 mRNA	PMID:36331819
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313512	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ALG8 mRNA	PMID:25979313
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313513	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ALG8 mRNA	PMID:17292431
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ALG8 mRNA	PMID:30047161
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ALG8 mRNA	PMID:20106945|PMID:25562108
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:45863	paclitaxel	affects response to substance	ISO	RGD:1313512	E	RGD:6480464	20161213	CTD	MESH:D017239	ALG8 protein affects the susceptibility to Paclitaxel	PMID:16217747
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ALG8 mRNA	PMID:26690555|PMID:29067470
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ALG8 mRNA	PMID:33387578
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313512	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ALG8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ALG8 mRNA	PMID:40512198
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG8 mRNA	PMID:40504410
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313512	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ALG8 mRNA	PMID:22079256
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313513	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ALG8 mRNA; Nanotubes, Carbon results in increased expression of ALG8 mRNA	PMID:25554681
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ALG8 mRNA	PMID:24793618
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ALG8 protein	PMID:32959892
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313513	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ALG8 mRNA	PMID:22206623
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ALG8 mRNA	PMID:22079256
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313512	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ALG8 mRNA	PMID:22079256
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of ALG8 mRNA	PMID:18548127
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313512	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ALG8 mRNA	PMID:19159669
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313513	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ALG8 mRNA	PMID:23091169
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313512	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA	PMID:19167446
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313513	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ALG8 mRNA	PMID:30294300
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1313512	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of ALG8 mRNA	PMID:33512557
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ALG8 mRNA	PMID:30047161
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ALG8 mRNA	PMID:30047161
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ALG8 mRNA	PMID:38568856
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313512	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ALG8 mRNA	PMID:29301935
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ALG8 mRNA	PMID:21346803
1305468	Alg8	ALG8, alpha-1,3-glucosyltransferase	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ALG8 mRNA	PMID:23034163
1305469	Prr14l	proline rich 14-like	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PRR14L mRNA	PMID:38218311
1305469	Prr14l	proline rich 14-like	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1604500	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PRR14L mRNA	PMID:22378314
1305469	Prr14l	proline rich 14-like	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PRR14L mRNA	PMID:32145629
1305469	Prr14l	proline rich 14-like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1604500	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PRR14L mRNA	PMID:23019147
1305469	Prr14l	proline rich 14-like	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PRR14L mRNA	PMID:20655997
1305469	Prr14l	proline rich 14-like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1616579	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PRR14L mRNA	PMID:34319233
1305469	Prr14l	proline rich 14-like	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1604500	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PRR14L protein	PMID:37730182
1305469	Prr14l	proline rich 14-like	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PRR14L mRNA	PMID:33387578
1305469	Prr14l	proline rich 14-like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1616579	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRR14L mRNA	PMID:36331819
1305469	Prr14l	proline rich 14-like	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604500	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PRR14L gene	PMID:27153756
1305469	Prr14l	proline rich 14-like	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PRR14L mRNA	PMID:30779732
1305469	Prr14l	proline rich 14-like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616579	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRR14L mRNA	PMID:22206623
1305469	Prr14l	proline rich 14-like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604500	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRR14L mRNA	PMID:39836092
1305469	Prr14l	proline rich 14-like	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PRR14L mRNA	PMID:26272509
1305469	Prr14l	proline rich 14-like	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1604500	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA	PMID:27188386
1305469	Prr14l	proline rich 14-like	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1604500	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PRR14L protein	PMID:35688186
1305469	Prr14l	proline rich 14-like	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of PRR14L mRNA	PMID:27594783
1305469	Prr14l	proline rich 14-like	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1616579	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PRR14L mRNA	PMID:30912803
1305469	Prr14l	proline rich 14-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PRR14L mRNA	PMID:33387578
1305469	Prr14l	proline rich 14-like	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PRR14L mRNA	PMID:33212167
1305469	Prr14l	proline rich 14-like	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604500	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PRR14L protein	PMID:33212167
1305469	Prr14l	proline rich 14-like	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PRR14L mRNA	PMID:30851411
1305469	Prr14l	proline rich 14-like	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PRR14L mRNA	PMID:29803840
1305469	Prr14l	proline rich 14-like	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1604500	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PRR14L protein	PMID:35688186
1305469	Prr14l	proline rich 14-like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604500	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRR14L mRNA	PMID:39836092
1305469	Prr14l	proline rich 14-like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PRR14L mRNA	PMID:34492290
1305469	Prr14l	proline rich 14-like	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of PRR14L mRNA	PMID:30816183|PMID:32145629
1305469	Prr14l	proline rich 14-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRR14L mRNA	PMID:25181051
1305469	Prr14l	proline rich 14-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1616579	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of PRR14L mRNA	PMID:39298647
1305469	Prr14l	proline rich 14-like	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1616579	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PRR14L mRNA	PMID:28392331
1305469	Prr14l	proline rich 14-like	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1616579	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PRR14L mRNA	PMID:37019170
1305469	Prr14l	proline rich 14-like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604500	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PRR14L mRNA	PMID:37042841
1305469	Prr14l	proline rich 14-like	gene	CHEBI:35842	antirheumatic drug	affects expression	ISO	RGD:1604500	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents affects the expression of PRR14L mRNA	PMID:24449571
1305469	Prr14l	proline rich 14-like	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1604500	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PRR14L mRNA	PMID:28302478
1305469	Prr14l	proline rich 14-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616579	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRR14L mRNA	PMID:36331819
1305469	Prr14l	proline rich 14-like	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PRR14L mRNA	PMID:29427782
1305469	Prr14l	proline rich 14-like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PRR14L mRNA	PMID:24935251|PMID:26272509
1305469	Prr14l	proline rich 14-like	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604500	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA	PMID:27188386
1305469	Prr14l	proline rich 14-like	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PRR14L mRNA	PMID:30047161
1305469	Prr14l	proline rich 14-like	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1604500	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of PRR14L mRNA	PMID:24449571
1305469	Prr14l	proline rich 14-like	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PRR14L mRNA	PMID:27188386
1305469	Prr14l	proline rich 14-like	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PRR14L mRNA	PMID:26272509
1305469	Prr14l	proline rich 14-like	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1604500	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA	PMID:27188386
1305469	Prr14l	proline rich 14-like	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1616579	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PRR14L mRNA	PMID:29279043
1305469	Prr14l	proline rich 14-like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604500	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRR14L mRNA	PMID:39836092
1305469	Prr14l	proline rich 14-like	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1616579	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PRR14L mRNA	PMID:35436446
1305469	Prr14l	proline rich 14-like	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PRR14L mRNA	PMID:30047161
1305469	Prr14l	proline rich 14-like	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PRR14L mRNA	PMID:24136188
1305469	Prr14l	proline rich 14-like	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1604500	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of PRR14L mRNA	PMID:26705709
1305469	Prr14l	proline rich 14-like	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D008694	Methamphetamine results in increased expression of PRR14L mRNA	PMID:28341135
1305469	Prr14l	proline rich 14-like	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1616579	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRR14L mRNA	PMID:22206623
1305469	Prr14l	proline rich 14-like	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PRR14L mRNA	PMID:30851411
1305469	Prr14l	proline rich 14-like	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604500	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA	PMID:27188386
1305469	Prr14l	proline rich 14-like	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604500	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR14L mRNA	PMID:27188386
1305469	Prr14l	proline rich 14-like	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1604500	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of PRR14L mRNA	PMID:27188386
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313515	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RNF19B mRNA	PMID:38218311
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1615038	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RNF19B mRNA	PMID:33045310
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313515	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RNF19B mRNA	PMID:33167477
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of RNF19B mRNA	PMID:24763279
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313515	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RNF19B mRNA	PMID:26079696
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313515	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RNF19B mRNA	PMID:22378314
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1615038	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RNF19B mRNA	PMID:30319688
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313515	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in increased expression of RNF19B mRNA	PMID:21632981
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF19B mRNA	PMID:39241906
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313515	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNF19B mRNA	PMID:35811015
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNF19B mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RNF19B mRNA	PMID:35811015
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RNF19B mRNA	PMID:39298647
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313515	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of RNF19B mRNA	PMID:20106945
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313515	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RNF19B mRNA	PMID:37042841
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:16708	adenine	decreases expression	ISO	RGD:1313515	E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of RNF19B mRNA	PMID:24211769
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313515	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RNF19B mRNA	PMID:23649840
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313515	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of RNF19B mRNA	PMID:33647349
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RNF19B mRNA	PMID:27523638
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RNF19B mRNA	PMID:33387578
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313515	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RNF19B mRNA	PMID:28818685
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA	PMID:39836092
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313515	E	RGD:6480464	20130806	CTD	MESH:D002104	Cadmium results in increased expression of RNF19B mRNA	PMID:16439709
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313515	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in increased expression of RNF19B mRNA	PMID:19549813
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313515	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RNF19B mRNA	PMID:23649840
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313515	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RNF19B mRNA	PMID:27153756
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313515	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RNF19B mRNA	PMID:23649840
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RNF19B mRNA	PMID:41430723
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1615038	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RNF19B mRNA	PMID:17484886
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1615038	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RNF19B mRNA	PMID:31919559
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF19B mRNA	PMID:39836092
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RNF19B mRNA	PMID:40504410
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of RNF19B mRNA	PMID:38460933
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RNF19B mRNA	PMID:28960355
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RNF19B mRNA	PMID:31881176
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27882	(S)-colchicine	decreases expression	ISO	RGD:1313515	E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of RNF19B mRNA	PMID:24211769
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313515	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RNF19B mRNA	PMID:28903495
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313515	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin results in decreased expression of RNF19B mRNA	PMID:24211769
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313515	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RNF19B mRNA	PMID:27392435|PMID:27594783
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313515	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RNF19B mRNA	PMID:23195993|PMID:25583101
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313515	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF19B mRNA	PMID:22574217
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF19B mRNA	PMID:34747641
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313515	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNF19B mRNA	PMID:33212167
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313515	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of RNF19B mRNA	PMID:39709020
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1313515	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RNF19B mRNA	PMID:30851411
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1313515	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of RNF19B mRNA	PMID:23649840
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1313515	E	RGD:6480464	20120412	CTD	MESH:D004317	RNF19B protein affects the susceptibility to Doxorubicin	PMID:16217747
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RNF19B mRNA	PMID:29432896
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313515	E	RGD:6480464	20151013	CTD	MESH:D001379	Azathioprine results in decreased expression of RNF19B mRNA	PMID:19192274
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313515	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF19B mRNA	PMID:38568856|PMID:39719251
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF19B mRNA	PMID:39836092
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RNF19B mRNA	PMID:40504410
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313515	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF19B mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313515	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF19B promoter	PMID:27901495
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RNF19B mRNA]	PMID:32406909
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1313515	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of RNF19B mRNA	PMID:25075043
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313515	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RNF19B mRNA	PMID:25895662
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615038	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF19B gene; titanium dioxide results in decreased methylation of RNF19B promoter	PMID:35295148
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of RNF19B mRNA	PMID:17426115|PMID:18445702|PMID:21318169|PMID:23811191
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20130806	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of RNF19B mRNA]	PMID:21318169
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20130806	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of RNF19B mRNA	PMID:19191707
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1615038	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RNF19B mRNA	PMID:28472532
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of RNF19B mRNA	PMID:38479592
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of RNF19B mRNA	PMID:28329830
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF19B mRNA	PMID:25181051
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF19B gene	PMID:28505145
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF19B mRNA	PMID:36041667
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF19B mRNA	PMID:39298647
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313515	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RNF19B gene	PMID:31601247
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF19B mRNA	PMID:36041667
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1615038	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RNF19B mRNA	PMID:38685157
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF19B mRNA	PMID:36041667
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RNF19B mRNA	PMID:21266533
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of RNF19B mRNA	PMID:32680482
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313515	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNF19B mRNA	PMID:37042841
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA	PMID:39836092
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313515	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RNF19B mRNA	PMID:38568856
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313515	E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in increased expression of RNF19B mRNA	PMID:19376846
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1615038	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RNF19B mRNA	PMID:40194260
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313515	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RNF19B mRNA	PMID:31533062
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1615038	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of RNF19B mRNA	PMID:39529242
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313515	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RNF19B mRNA	PMID:25979313
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313515	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RNF19B gene	PMID:29154799
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313515	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF19B mRNA	PMID:20106945|PMID:25562108
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of RNF19B mRNA	PMID:28973697
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313515	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of RNF19B mRNA	PMID:23649840
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313515	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in decreased expression of RNF19B mRNA	PMID:19192274
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313515	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RNF19B mRNA	PMID:38832940
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313515	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RNF19B mRNA	PMID:28542535
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1615038	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF19B mRNA	PMID:17562736
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF19B mRNA	PMID:33387578
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313515	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF19B mRNA	PMID:21420995|PMID:22230336|PMID:29067470
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNF19B mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RNF19B mRNA	PMID:35811015
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1313515	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of RNF19B mRNA	PMID:24160326
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:46680	serpentine asbestos	affects expression	ISO	RGD:1313515	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine affects the expression of RNF19B mRNA	PMID:24160326
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of RNF19B mRNA	PMID:38460933
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF19B mRNA	PMID:39836092
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RNF19B mRNA	PMID:40504410
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313515	E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac results in decreased expression of RNF19B mRNA	PMID:19192274
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of RNF19B mRNA	PMID:35436446
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1313515	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of RNF19B mRNA	PMID:25075043
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:50161	motexafin gadolinium	increases expression	ISO	RGD:1313515	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of RNF19B mRNA	PMID:15867382
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of RNF19B mRNA	PMID:25620056
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1615038	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RNF19B mRNA; Nanotubes, Carbon results in increased expression of RNF19B mRNA	PMID:25554681
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RNF19B mRNA	PMID:35964746
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313515	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of RNF19B mRNA	PMID:31629900
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:5516	sodium aurothiomalate	decreases expression	ISO	RGD:1313515	E	RGD:6480464	20151013	CTD	MESH:D006052	Gold Sodium Thiomalate results in decreased expression of RNF19B mRNA	PMID:19192274
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1615038	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RNF19B mRNA	PMID:38701926
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA	PMID:39836092
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20130806	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RNF19B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF19B mRNA	PMID:21641980|PMID:26378955
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:6888	6alpha-methylprednisolone	decreases expression	ISO	RGD:1313515	E	RGD:6480464	20151013	CTD	MESH:D008775	Methylprednisolone results in decreased expression of RNF19B mRNA	PMID:19192274
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1615038	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of RNF19B mRNA	PMID:22206623
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1313515	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RNF19B mRNA	PMID:30851411
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313515	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RNF19B gene]	PMID:28238834
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313515	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of RNF19B mRNA	PMID:19159669
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1615038	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of RNF19B mRNA	PMID:23091169
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1615038	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of RNF19B mRNA	PMID:19270015
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313515	E	RGD:6480464	20151013	CTD	MESH:D010894	Piroxicam results in decreased expression of RNF19B mRNA	PMID:19192274
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:8378	prednisolone	decreases expression	ISO	RGD:1313515	E	RGD:6480464	20151013	CTD	MESH:D011239	Prednisolone results in decreased expression of RNF19B mRNA	PMID:19192274
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RNF19B mRNA	PMID:24780913
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RNF19B mRNA	PMID:40826991
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313515	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RNF19B mRNA	PMID:38568856
1305470	Rnf19b	ring finger protein 19B	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313515	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of RNF19B mRNA	PMID:29301935
1305471	Atf6	activating transcription factor 6	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313517	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of ATF6 mRNA	PMID:20682335|PMID:22846391
1305471	Atf6	activating transcription factor 6	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313518	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of ATF6 protein	PMID:19336499
1305471	Atf6	activating transcription factor 6	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20141111	CTD	MESH:C007262	ATF6 protein affects the reaction [deoxynivalenol results in increased expression of IL6 mRNA]	PMID:19336499
1305471	Atf6	activating transcription factor 6	gene	CHEBI:113532	thymoquinone	increases expression	ISO	RGD:1313517	E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in increased expression of ATF6 mRNA; thymoquinone results in increased expression of ATF6 protein	PMID:29981725
1305471	Atf6	activating transcription factor 6	gene	CHEBI:131923	salubrinal	increases expression	ISO	RGD:1313518	E	RGD:6480464	20170303	CTD	MESH:C496827	salubrinal results in increased expression of ATF6 mRNA	PMID:23958496
1305471	Atf6	activating transcription factor 6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 mRNA]	PMID:31150632
1305471	Atf6	activating transcription factor 6	gene	CHEBI:134990	agomelatine	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:C084711	agomelatine inhibits the reaction [Dietary Fats results in increased expression of ATF6 protein]	PMID:34081941
1305471	Atf6	activating transcription factor 6	gene	CHEBI:135285	vildagliptin	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:C502012	Vildagliptin inhibits the reaction [Dietary Fats results in increased expression of ATF6 protein]	PMID:34081941
1305471	Atf6	activating transcription factor 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ATF6 mRNA	PMID:20188158
1305471	Atf6	activating transcription factor 6	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	ISO	RGD:1313517	E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of ATF6 mRNA	PMID:20682335
1305471	Atf6	activating transcription factor 6	gene	CHEBI:146195	3-acetyldeoxynivalenol	increases expression	ISO	RGD:1313517	E	RGD:6480464	20200303	CTD	MESH:C043247	3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA	PMID:20682335
1305471	Atf6	activating transcription factor 6	gene	CHEBI:146195	3-acetyldeoxynivalenol	increases expression	ISO	RGD:1313518	E	RGD:6480464	20221206	CTD	MESH:C043247	3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA	PMID:35413383
1305471	Atf6	activating transcription factor 6	gene	CHEBI:146195	3-acetyldeoxynivalenol	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20221206	CTD	MESH:C043247	4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA]	PMID:35413383
1305471	Atf6	activating transcription factor 6	gene	CHEBI:146245	SR 144528	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20200407	CTD	MESH:C110630	[Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of ATF6 mRNA]	PMID:31054322
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of ATF6 mRNA; Tretinoin results in increased expression of ATF6 protein	PMID:19960509|PMID:21934132
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313518	E	RGD:6480464	20121009	CTD	MESH:D014212	Tretinoin results in increased expression of ATF6 mRNA; Tretinoin results in increased expression of ATF6 protein	PMID:22498432
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313518	E	RGD:6480464	20150310	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ATF6 protein; Oxygen results in increased expression of ATF6 protein	PMID:24680926|PMID:32996202
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20210406	CTD	MESH:D010100	1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Oxygen results in increased expression of ATF6 protein]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Oxygen results in increased expression of ATF6 protein]]	PMID:32996202
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ATF6 mRNA	PMID:24763279
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230404	CTD	MESH:D019308	Palmitic Acid results in increased expression of ATF6 mRNA	PMID:36030031
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20201006	CTD	MESH:D019308	3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of ATF6 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ATF6 mRNA	PMID:32369900
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230404	CTD	MESH:D019308	[4-phenylbutyric acid co-treated with Palmitic Acid] results in decreased expression of ATF6 protein; [Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein]	PMID:36030031|PMID:39701215
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15864	luteolin	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20201103	CTD	MESH:D047311	Luteolin inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein modified form]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein modified form]	PMID:32407927
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15866	2-deoxy-D-glucose	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20250603	CTD	MESH:D003847	Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]	PMID:39798073
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15930	atrazine	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20231205	CTD	MESH:D001280	Atrazine results in increased cleavage of ATF6 protein	PMID:25259610
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20231205	CTD	MESH:D001280	Melatonin inhibits the reaction [Atrazine results in increased cleavage of ATF6 protein]	PMID:25259610
1305471	Atf6	activating transcription factor 6	gene	CHEBI:15948	lycopene	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:C015329	Lycopene inhibits the reaction [Oxaliplatin results in increased expression of ATF6 mRNA]	PMID:32544411
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16015	L-glutamic acid	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D018698	Glutamic Acid results in increased expression of ATF6 protein	PMID:35028790
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16015	L-glutamic acid	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:D018698	shikonin inhibits the reaction [Glutamic Acid results in increased expression of ATF6 protein]	PMID:35028790
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16112	chlorogenic acid	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D002726	Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]	PMID:34801538
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20201006	CTD	MESH:D019301	3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of ATF6 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ATF6 mRNA	PMID:32369900
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20220208	CTD	MESH:D019301	Oleic Acid inhibits the reaction [[Palmitates co-treated with bisphenol A] results in increased expression of ATF6 mRNA]	PMID:32976987
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16236	ethanol	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20180313	CTD	MESH:D000431	Ethanol results in increased cleavage of ATF6 protein	PMID:28119953
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D000431	Ethanol results in increased expression of ATF6 protein	PMID:24146112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140513	CTD	MESH:D000431	Ethanol results in increased expression of ATF6 protein	PMID:24146112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D000431	dioscin inhibits the reaction [Ethanol results in increased expression of ATF6 protein]	PMID:24146112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20140513	CTD	MESH:D000431	dioscin inhibits the reaction [Ethanol results in increased expression of ATF6 protein]	PMID:24146112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in increased expression of ATF6 protein	PMID:30152185
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D011794	Quercetin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; Quercetin inhibits the reaction [Cadmium results in increased expression of ATF6 protein]; Quercetin inhibits the reaction [cypermethrin results in increased expression of ATF6 mRNA]; Quercetin inhibits the reaction [Vincristine results in increased expression of ATF6 mRNA]	PMID:33038355|PMID:35714484|PMID:35876585
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16412	lipopolysaccharide	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased cleavage of ATF6 protein	PMID:19675143
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313517	E	RGD:6480464	20170613	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATF6 protein	PMID:28245985|PMID:30918470
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATF6 mRNA	PMID:39241906
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20170613	CTD	MESH:D008070	4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATF6 protein]; ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased expression of ATF6 protein]	PMID:28245985|PMID:30918470
1305471	Atf6	activating transcription factor 6	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in decreased expression of ATF6 mRNA	PMID:34681664
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ATF6 mRNA	PMID:26496021
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16494	lipoic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20140211	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of ATF6 mRNA]	PMID:23892647
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16598	DDE	increases activity	ISO	RGD:1313517	E	RGD:6480464	20170207	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased activity of ATF6 protein	PMID:27589886
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ATF6 mRNA	PMID:33387578|PMID:36396003
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ATF6 gene	PMID:27618143
1305471	Atf6	activating transcription factor 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313517	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATF6 mRNA	PMID:37042841
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16738	2,4-dichlorophenol	increases expression	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:C004762	2,4-dichlorophenol results in increased expression of ATF6 mRNA; 2,4-dichlorophenol results in increased expression of ATF6 protein	PMID:25160872
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20200804	CTD	MESH:D002635	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16796	melatonin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008550	Melatonin inhibits the reaction [Methamphetamine results in increased expression of ATF6 protein]; Melatonin inhibits the reaction [sodium arsenite results in increased activity of ATF6 protein]	PMID:18715270|PMID:28070110
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20231205	CTD	MESH:D008550	Melatonin inhibits the reaction [Atrazine results in increased cleavage of ATF6 protein]; Melatonin inhibits the reaction [bisphenol A results in increased expression of ATF6 protein]	PMID:25259610|PMID:38538260
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16856	glutathione	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:D005978	SOD1 gene mutant form inhibits the reaction [Glutathione results in increased expression of ATF6 protein modified form]	PMID:27349771
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16990	bilirubin IXalpha	increases expression	ISO	RGD:1313517	E	RGD:6480464	20170516	CTD	MESH:D001663	Bilirubin results in increased expression of ATF6 mRNA	PMID:27578021
1305471	Atf6	activating transcription factor 6	gene	CHEBI:16990	bilirubin IXalpha	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:D001663	4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of ATF6 mRNA]	PMID:27578021
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17115	L-serine	increases expression	ISO	RGD:1313517	E	RGD:6480464	20210608	CTD	MESH:D012694	Serine results in increased expression of ATF6 mRNA	PMID:29098664
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313517	E	RGD:6480464	20191008	CTD	MESH:D005947	Glucose deficiency results in increased expression of ATF6 protein; Glucose results in increased expression of ATF6 mRNA; Glucose results in increased expression of ATF6 protein	PMID:31022492|PMID:39798073
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D005947	Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; Glucose results in increased expression of and affects the localization of ATF6 protein; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]	PMID:34801538
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20191008	CTD	MESH:D005947	4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF6 protein]; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]	PMID:31022492|PMID:39798073
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20260303	CTD	MESH:D005947	3-(indol-3-yl)propionic acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; [Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein]	PMID:39701215|PMID:40628365
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of ATF6 mRNA	PMID:17945193
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313518	E	RGD:6480464	20240305	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein	PMID:37692514
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20240305	CTD	MESH:C016599	4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]	PMID:37692514
1305471	Atf6	activating transcription factor 6	gene	CHEBI:173086	ferrostatin-1	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]	PMID:37075931
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of ATF6 mRNA	PMID:17178593
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:20165829
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1313517	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:19383982|PMID:20165829|PMID:33812996
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 protein	PMID:30602124
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20260203	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829|PMID:33812996
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20260203	CTD	MESH:D005944	ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]	PMID:30602124
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17447	geraniol	increases expression	ISO	RGD:1313517	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of ATF6 mRNA	PMID:27683099
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17447	geraniol	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20190702	CTD	MESH:C007836	geraniol inhibits the reaction [Rotenone results in increased expression of ATF6 protein]	PMID:30141137
1305471	Atf6	activating transcription factor 6	gene	CHEBI:174748	C.I. Natural Red 20	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:C016101	shikonin inhibits the reaction [Glutamic Acid results in increased expression of ATF6 protein]	PMID:35028790
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17515	L-gamma-glutamyl-L-cysteine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20260407	CTD	MESH:C017341	gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein]	PMID:39701215
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17573	glycyrrhetinate	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C119129	18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of ATF6 mRNA]	PMID:35699857
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20240109	CTD	MESH:C031927	hydroquinone results in decreased expression of ATF6 mRNA; hydroquinone results in decreased expression of ATF6 protein	PMID:37148176
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313517	E	RGD:6480464	20231205	CTD	MESH:C031927	hydroquinone results in increased expression of ATF6 protein	PMID:36646296
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17594	hydroquinone	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20231205	CTD	MESH:C031927	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; [Sirolimus co-treated with hydroquinone] results in decreased expression of ATF6 protein; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; ATF6 protein affects the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; ATF6 protein affects the reaction [hydroquinone results in increased expression of BAX protein]; ATF6 protein affects the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]	PMID:36646296|PMID:37148176
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313517	E	RGD:6480464	20191008	CTD	MESH:D005947	Glucose deficiency results in increased expression of ATF6 protein; Glucose results in increased expression of ATF6 mRNA; Glucose results in increased expression of ATF6 protein	PMID:31022492|PMID:39798073
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D005947	Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; Glucose results in increased expression of and affects the localization of ATF6 protein; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]	PMID:34801538
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20191008	CTD	MESH:D005947	4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF6 protein]; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]	PMID:31022492|PMID:39798073
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20260303	CTD	MESH:D005947	3-(indol-3-yl)propionic acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; [Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein]	PMID:39701215|PMID:40628365
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20200804	CTD	MESH:D006000	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]	PMID:18477628
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ATF6 protein	PMID:37692514
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ATF6 mRNA	PMID:34319233
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATF6 mRNA	PMID:21673306|PMID:25280772
1305471	Atf6	activating transcription factor 6	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313517	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ATF6 protein	PMID:37730182
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ATF6 mRNA	PMID:16002434
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20230307	CTD	MESH:D002117	[salinomycin co-treated with Calcitriol] results in increased expression of ATF6 mRNA	PMID:35914560
1305471	Atf6	activating transcription factor 6	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATF6 mRNA	PMID:33387578
1305471	Atf6	activating transcription factor 6	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of ATF6 mRNA	PMID:37748715
1305471	Atf6	activating transcription factor 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATF6 mRNA	PMID:36331819
1305471	Atf6	activating transcription factor 6	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of ATF6 mRNA	PMID:17175027
1305471	Atf6	activating transcription factor 6	gene	CHEBI:18388	apigenin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:D047310	Apigenin inhibits the reaction [Brefeldin A results in increased cleavage of ATF6 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased cleavage of ATF6 protein]	PMID:20493918
1305471	Atf6	activating transcription factor 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of and affects the cleavage of ATF6 protein	PMID:33651226
1305471	Atf6	activating transcription factor 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20210706	CTD	MESH:D000517	[4-phenylbutyric acid co-treated with alpha-Chlorohydrin] results in decreased expression of ATF6 protein	PMID:33651226
1305471	Atf6	activating transcription factor 6	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]	PMID:18477628
1305471	Atf6	activating transcription factor 6	gene	CHEBI:193416	Pendulone	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20221018	CTD	MESH:C569898	pendulone results in increased cleavage of ATF6 protein	PMID:35288263
1305471	Atf6	activating transcription factor 6	gene	CHEBI:201674	icaritin	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20260303	CTD	MESH:C499403	icaritin inhibits the reaction [Thapsigargin results in increased expression of ATF6 mRNA]	PMID:36372277
1305471	Atf6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of ATF6 mRNA	PMID:17178593
1305471	Atf6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:20165829
1305471	Atf6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1313517	E	RGD:6480464	20120515	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:19383982|PMID:20165829|PMID:33812996
1305471	Atf6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 protein	PMID:30602124
1305471	Atf6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1305471	Atf6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829|PMID:33812996
1305471	Atf6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]	PMID:30602124
1305471	Atf6	activating transcription factor 6	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in increased expression of ATF6 mRNA; Cadmium results in increased expression of ATF6 protein	PMID:35714484|PMID:37453011|PMID:37886005|PMID:38238535
1305471	Atf6	activating transcription factor 6	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313517	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of ATF6 mRNA	PMID:28860664
1305471	Atf6	activating transcription factor 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein; chrysin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; Gallic Acid inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]; morin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; Quercetin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; Quercetin inhibits the reaction [Cadmium results in increased expression of ATF6 protein]	PMID:35714484|PMID:37453011|PMID:37886005|PMID:38001299|PMID:38238535
1305471	Atf6	activating transcription factor 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230905	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATF6 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein	PMID:37236586|PMID:37261864
1305471	Atf6	activating transcription factor 6	gene	CHEBI:232991	Perhexiline maleate	increases expression	ISO	RGD:1313517	E	RGD:6480464	20250107	CTD	MESH:C023470	perhexiline maleate results in increased expression of ATF6 mRNA	PMID:33309543
1305471	Atf6	activating transcription factor 6	gene	CHEBI:232991	Perhexiline maleate	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20250107	CTD	MESH:C023470	[perhexiline maleate results in increased abundance of Perhexiline] which results in increased expression of ATF6 mRNA; CYP2D6 protein inhibits the reaction [[perhexiline maleate results in increased abundance of Perhexiline] which results in increased expression of ATF6 mRNA]	PMID:36083301
1305471	Atf6	activating transcription factor 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ATF6 mRNA	PMID:33354967
1305471	Atf6	activating transcription factor 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ATF6 mRNA	PMID:19770486
1305471	Atf6	activating transcription factor 6	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20170303	CTD	MESH:D017382	[arsenic trioxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased cleavage of ATF6 protein	PMID:23892647
1305471	Atf6	activating transcription factor 6	gene	CHEBI:2663	amiodarone	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20171114	CTD	MESH:D000638	Amiodarone results in increased expression of and affects the localization of ATF6 protein	PMID:28962527
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27086	tributylstannane	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20140211	CTD	MESH:C011559	tributyltin results in increased cleavage of ATF6 protein	PMID:23743301
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATF6 mRNA; Carbon Tetrachloride results in increased expression of ATF6 protein	PMID:31150632|PMID:33779329
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313518	E	RGD:6480464	20150714	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATF6 mRNA	PMID:25827057|PMID:31919559
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 protein]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 mRNA]	PMID:31150632|PMID:33779329
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20150714	CTD	MESH:D002251	1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 mRNA]	PMID:25827057
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20200804	CTD	MESH:D006002	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to ATF6 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of and results in increased cleavage of ATF6 protein; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein; AKR1C3 protein promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein]; NFE2L2 protein affects the reaction [[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA]	PMID:35625704|PMID:40571110
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27616	psoralen	increases expression	ISO	RGD:1313517	E	RGD:6480464	20230606	CTD	MESH:D005363	Ficusin results in increased expression of ATF6 mRNA; Ficusin results in increased expression of ATF6 protein	PMID:31364909
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27616	psoralen	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20230606	CTD	MESH:D005363	4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 protein]	PMID:31364909
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ATF6 mRNA	PMID:31881176
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27869	chloroacetic acid	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20150414	CTD	MESH:C006972	chloroacetic acid results in increased cleavage of ATF6 protein	PMID:25451595
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27869	chloroacetic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20150414	CTD	MESH:C006972	Acetylcysteine inhibits the reaction [chloroacetic acid results in increased cleavage of ATF6 protein]	PMID:25451595
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313517	E	RGD:6480464	20141223	CTD	MESH:C059514	resveratrol results in increased expression of ATF6 protein	PMID:24264887
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:C059514	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]	PMID:31433112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20141111	CTD	MESH:C059514	resveratrol inhibits the reaction [arsenic trioxide results in increased expression of ATF6 protein]	PMID:25107562
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]	PMID:31298478
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20240604	CTD	MESH:D002945	Cisplatin results in increased expression of ATF6 protein	PMID:38688426
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20240604	CTD	MESH:D002945	ATP2A2 protein inhibits the reaction [Cisplatin results in increased expression of ATF6 protein]	PMID:38688426
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D003042	Cocaine affects the expression of ATF6 mRNA	PMID:23644055
1305471	Atf6	activating transcription factor 6	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ATF6 mRNA	PMID:30912803
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28077	rifampicin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20210706	CTD	MESH:D012293	Rifampin results in increased expression of ATF6 mRNA	PMID:32535746
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in increased expression of ATF6 mRNA	PMID:31734292
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313518	E	RGD:6480464	20230404	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATF6 mRNA	PMID:36222588
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATF6 mRNA	PMID:34747641
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases cleavage	EXP		E	RGD:6480464	20150310	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased cleavage of ATF6 protein	PMID:24932542
1305471	Atf6	activating transcription factor 6	gene	CHEBI:2814	arecoline	increases expression	ISO	RGD:1313518	E	RGD:6480464	20250506	CTD	MESH:D001115	Arecoline results in increased expression of ATF6 mRNA; Arecoline results in increased expression of ATF6 protein	PMID:38450909
1305471	Atf6	activating transcription factor 6	gene	CHEBI:2814	arecoline	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20250506	CTD	MESH:D001115	4-phenylbutyric acid inhibits the reaction [Arecoline results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [Arecoline results in increased expression of ATF6 protein]	PMID:38450909
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D012402	Rotenone results in increased expression of ATF6 protein	PMID:36538285|PMID:37105514
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313517	E	RGD:6480464	20190702	CTD	MESH:D012402	Rotenone results in increased expression of ATF6 protein	PMID:30141137
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313518	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of ATF6 mRNA	PMID:32189544
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D012402	repaglinide inhibits the reaction [Rotenone results in increased expression of ATF6 protein]; Roflumilast inhibits the reaction [Rotenone results in increased expression of ATF6 protein]	PMID:36538285|PMID:37105514
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20190702	CTD	MESH:D012402	geraniol inhibits the reaction [Rotenone results in increased expression of ATF6 protein]	PMID:30141137
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20210907	CTD	MESH:D012402	Metformin inhibits the reaction [Rotenone results in increased expression of ATF6 mRNA]	PMID:32189544
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28216	methylmercury chloride	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20191210	CTD	MESH:C004925	methylmercuric chloride results in increased cleavage of ATF6 protein	PMID:31330229
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20191210	CTD	MESH:C004925	Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein]	PMID:31330229
1305471	Atf6	activating transcription factor 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ATF6 mRNA	PMID:33212167
1305471	Atf6	activating transcription factor 6	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313518	E	RGD:6480464	20260407	CTD	MESH:C000228	aristolochic acid I results in increased expression of ATF6 protein	PMID:40480416
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28299	quercetin 3-O-beta-D-glucofuranoside	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C016527	isoquercitrin results in increased expression of ATF6 mRNA	PMID:30365939
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28299	quercetin 3-O-beta-D-glucofuranoside	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C016527	isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]	PMID:38001299
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ATF6 mRNA	PMID:30851411
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of ATF6 mRNA	PMID:17178593
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:20165829
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1313517	E	RGD:6480464	20120515	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:19383982|PMID:20165829|PMID:33812996
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 protein	PMID:30602124
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829|PMID:33812996
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]	PMID:30602124
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D014750	Vincristine results in increased expression of ATF6 mRNA	PMID:33038355
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28445	vincristine	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D014750	Quercetin inhibits the reaction [Vincristine results in increased expression of ATF6 mRNA]	PMID:33038355
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28527	rutin	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D012431	Rutin inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; Rutin inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]	PMID:30973085
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ATF6 mRNA	PMID:28959563
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28741	sodium fluoride	affects expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D012969	Sodium Fluoride affects the expression of ATF6 mRNA	PMID:25132241
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28741	sodium fluoride	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ATF6 mRNA	PMID:35413380
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140311	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ATF6 mRNA; Sodium Fluoride results in increased expression of ATF6 protein	PMID:21626649|PMID:38823497
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28741	sodium fluoride	multiple interactions	EXP		E	RGD:6480464	20221206	CTD	MESH:D012969	Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of ATF6 mRNA]	PMID:35413380
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATF6 mRNA	PMID:29803840
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D004317	Doxorubicin results in increased expression of ATF6 protein	PMID:35152301
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D004317	sacubitril and valsartan sodium hydrate drug combination inhibits the reaction [Doxorubicin results in increased expression of ATF6 protein]	PMID:35152301
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28757	fructose	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D005632	[dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; [Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein; [Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein; Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; Metformin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]	PMID:34801538|PMID:34939712
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28775	hesperidin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D006569	Hesperidin results in decreased expression of ATF6 mRNA	PMID:36966900
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28775	hesperidin	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D006569	Hesperidin inhibits the reaction [abamectin results in increased expression of ATF6 mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of ATF6 mRNA]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of ATF6 mRNA]	PMID:34748272|PMID:35413380|PMID:36966900
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28819	naringin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20250506	CTD	MESH:C005274	naringin results in increased expression of ATF6 protein	PMID:39056589
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28819	naringin	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C005274	naringin inhibits the reaction [Oxaliplatin results in increased expression of ATF6 mRNA]	PMID:38037725
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20200804	CTD	MESH:D003840	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28869	menadione	increases expression	ISO	RGD:1313517	E	RGD:6480464	20120501	CTD	MESH:D024483	Vitamin K 3 results in increased expression of ATF6 protein	PMID:19819344
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28869	menadione	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20120501	CTD	MESH:D024483	Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of ATF6 protein]; S 3483 promotes the reaction [Vitamin K 3 results in increased expression of ATF6 protein]	PMID:19819344
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of ATF6 protein]	PMID:18077580|PMID:21198628|PMID:24291486
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; Acetylcysteine results in increased metabolism of and results in increased activity of ATF6 protein	PMID:19722195|PMID:34520753|PMID:37148176
1305471	Atf6	activating transcription factor 6	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20121218	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Arecoline results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased cleavage of ATF6 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ATF6 protein]	PMID:21911445|PMID:25451595|PMID:31330229|PMID:37692514|PMID:38450909
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29287	gold atom	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20170516	CTD	MESH:D006046	Gold analog results in increased cleavage of ATF6 protein	PMID:26551149
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	affects localization	ISO	RGD:1313518	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of ATF6 protein	PMID:21911445
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATF6 mRNA	PMID:28595984|PMID:34032870
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	increases activity	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased activity of ATF6 protein	PMID:18715270
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ATF6 mRNA	PMID:38897041
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313517	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ATF6 mRNA	PMID:38568856
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313518	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ATF6 protein	PMID:21911445
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	Melatonin inhibits the reaction [sodium arsenite results in increased activity of ATF6 protein]; zingerone inhibits the reaction [sodium arsenite results in increased expression of ATF6 mRNA]	PMID:18715270|PMID:38897041
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein; AKR1C3 protein promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein]	PMID:40571110
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20161228	CTD	MESH:C017947	Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ATF6 protein]	PMID:21911445
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	decreases cleavage	ISO	RGD:1313517	E	RGD:6480464	20130416	CTD	MESH:D014415	Tunicamycin results in decreased cleavage of ATF6 protein	PMID:22959463
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20170516	CTD	MESH:D014415	Tunicamycin results in increased cleavage of ATF6 protein	PMID:26551149
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20160412	CTD	MESH:D014415	Tunicamycin results in increased cleavage of ATF6 protein	PMID:24648495
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of ATF6 protein	PMID:18477628|PMID:28399139|PMID:32740777
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of ATF6 mRNA; Tunicamycin results in increased expression of ATF6 protein; Tunicamycin results in increased expression of ATF6 protein modified form	PMID:22378314|PMID:29723631|PMID:30592132|PMID:32407927|PMID:39900124
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313518	E	RGD:401842386|PMID:27813192	20231018	RGD	MESH:D014415	tunicamycin increases expression of Atf6 mRNA in liver	
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20130416	CTD	MESH:D014415	Tunicamycin results in increased expression of ATF6 mRNA; Tunicamycin results in increased expression of ATF6 protein	PMID:22001960|PMID:22959925|PMID:25160872|PMID:29894845|PMID:36030031
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014415	ibutilide inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; Nicotine inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]	PMID:18477628|PMID:28399139
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20201103	CTD	MESH:D014415	Luteolin inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein modified form]	PMID:32407927
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	multiple interactions	ISO	RGD:1313518	E	RGD:401842386|PMID:27813192	20231018	RGD	MESH:D014415	naltrexone inhibits the reaction [tunicamycin increases expression of Atf6 mRNA in liver]	
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20160412	CTD	MESH:D014415	1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of ATF6 mRNA]; 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]	PMID:22959925|PMID:24648495|PMID:29894845
1305471	Atf6	activating transcription factor 6	gene	CHEBI:2979	baicalein	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:C006680	baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 protein]	PMID:33779329
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313517	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATF6 3' UTR	PMID:27901495
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATF6 mRNA	PMID:19770486
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313517	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ATF6 promoter	PMID:27901495
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATF6 protein	PMID:36736873
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29866	arsenite(3-)	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite results in increased cleavage of ATF6 protein	PMID:22959463
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29866	arsenite(3-)	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C015001	arsenite results in increased expression of ATF6 protein	PMID:18077580
1305471	Atf6	activating transcription factor 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:C015001	Acetylcysteine inhibits the reaction [arsenite results in increased expression of ATF6 protein]	PMID:18077580
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30050	gold(0)	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20170516	CTD	MESH:D006046	Gold analog results in increased cleavage of ATF6 protein	PMID:26551149
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20140211	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of ATF6 mRNA]	PMID:23892647
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ATF6 protein	PMID:31028789
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ATF6 protein	PMID:37075931
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30563	silicon dioxide	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D012822	Poly G inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]	PMID:31028789
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:D012822	ferrostatin-1 inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]; KN 93 inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]; N-butyloxycarbonyl-methionyl-aspartyl-glycyl-cysteinyl-glutamyl-leucine inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]	PMID:37075931
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATF6 mRNA	PMID:20018196
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ATF6 protein	PMID:23883479
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313517	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATF6 mRNA; Arsenic Trioxide results in increased expression of ATF6 protein	PMID:17963750|PMID:19176121|PMID:25107562|PMID:25258189
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATF6 mRNA	PMID:23892647|PMID:34091186
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	increases phosphorylation	ISO	RGD:1313517	E	RGD:6480464	20220111	CTD	MESH:C006632	Arsenic Trioxide results in increased phosphorylation of ATF6 protein	PMID:34560123
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide promotes the reaction [nilotinib results in decreased expression of ATF6 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in increased expression of ATF6 protein]	PMID:23883479|PMID:25107562
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20191114	CTD	MESH:C006632	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; [Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of ATF6 mRNA; [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased cleavage of ATF6 protein; Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of ATF6 mRNA]	PMID:23892647|PMID:34091186
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30778	gallic acid	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D005707	Gallic Acid inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]	PMID:37886005
1305471	Atf6	activating transcription factor 6	gene	CHEBI:30853	glycyrrhetinic acid	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C119129	18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of ATF6 mRNA]	PMID:35699857
1305471	Atf6	activating transcription factor 6	gene	CHEBI:31243	atazanavir sulfate	increases expression	ISO	RGD:1313517	E	RGD:6480464	20200804	CTD	MESH:D000069446	Atazanavir Sulfate results in increased expression of ATF6 mRNA	PMID:32152650
1305471	Atf6	activating transcription factor 6	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20200804	CTD	MESH:D000069446	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1305471	Atf6	activating transcription factor 6	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATF6 gene	PMID:31601247
1305471	Atf6	activating transcription factor 6	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of ATF6 mRNA	PMID:11578147|PMID:38530053
1305471	Atf6	activating transcription factor 6	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313518	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of ATF6 mRNA	PMID:21829687
1305471	Atf6	activating transcription factor 6	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C008261	sinapinic acid inhibits the reaction [lead acetate results in increased expression of ATF6 mRNA]	PMID:38530053
1305471	Atf6	activating transcription factor 6	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:D008627	Mercuric Chloride results in increased expression of ATF6 mRNA	PMID:39096083
1305471	Atf6	activating transcription factor 6	gene	CHEBI:31823	mercury dichloride	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D008627	syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of ATF6 mRNA]	PMID:39096083
1305471	Atf6	activating transcription factor 6	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C030110	Oxaliplatin results in increased expression of ATF6 mRNA	PMID:32544411|PMID:38037725
1305471	Atf6	activating transcription factor 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:C030110	Lycopene inhibits the reaction [Oxaliplatin results in increased expression of ATF6 mRNA]; naringin inhibits the reaction [Oxaliplatin results in increased expression of ATF6 mRNA]	PMID:32544411|PMID:38037725
1305471	Atf6	activating transcription factor 6	gene	CHEBI:32234	titanium dioxide	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20200211	CTD	MESH:C009495	titanium dioxide results in increased cleavage of ATF6 protein	PMID:31298478
1305471	Atf6	activating transcription factor 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313517	E	RGD:6480464	20250401	CTD	MESH:C009495	titanium dioxide results in increased expression of ATF6 mRNA	PMID:39461655
1305471	Atf6	activating transcription factor 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20200609	CTD	MESH:C009495	titanium dioxide results in increased expression of ATF6 mRNA	PMID:31769605
1305471	Atf6	activating transcription factor 6	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20200211	CTD	MESH:C009495	4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]; Resveratrol inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]; titanium dioxide results in increased expression of and results in increased cleavage of ATF6 protein	PMID:31298478|PMID:31769605
1305471	Atf6	activating transcription factor 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased expression of ATF6 protein modified form	PMID:27349771
1305471	Atf6	activating transcription factor 6	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form	PMID:24291486
1305471	Atf6	activating transcription factor 6	gene	CHEBI:32585	4-hydroxynon-2-enal	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:C027576	Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form]	PMID:24291486
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C074702	[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATF6 protein	PMID:30974164
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33118	boric acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20171010	CTD	MESH:C032688	boric acid results in increased cleavage of and affects the localization of ATF6 protein	PMID:27587023
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33128	C60 fullerene	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 affects the expression of ATF6 mRNA	PMID:19167457
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATF6 mRNA	PMID:25181051
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313518	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ATF6 promoter	PMID:27334623
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of ATF6 mRNA	PMID:22576693
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ATF6 protein	PMID:35999755
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313517	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATF6 gene	PMID:31601247
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ATF6 mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:35699857|PMID:41034487
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313517	E	RGD:6480464	20241001	CTD	MESH:C006780	bisphenol A results in increased expression of ATF6 mRNA	PMID:38134982
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313518	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ATF6 mRNA; bisphenol A results in increased expression of ATF6 protein	PMID:32575098|PMID:35569583|PMID:38538260
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313517	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of ATF6 gene	PMID:22576693
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of ATF6 mRNA]; [bisphenol A co-treated with Estradiol] results in decreased expression of ATF6 mRNA	PMID:26496021|PMID:35699857
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATF6 gene	PMID:31601247
1305471	Atf6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20220208	CTD	MESH:C006780	[Palmitates co-treated with bisphenol A] results in increased expression of ATF6 mRNA; Melatonin inhibits the reaction [bisphenol A results in increased expression of ATF6 protein]; Oleic Acid inhibits the reaction [[Palmitates co-treated with bisphenol A] results in increased expression of ATF6 mRNA]	PMID:32976987|PMID:38538260
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1313518	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of ATF6 mRNA	PMID:37080397
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ATF6 mRNA	PMID:39298647
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313518	E	RGD:6480464	20241105	CTD	MESH:C543008	bisphenol S results in increased expression of ATF6 mRNA	PMID:35569583
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34421	4-Hydroxybenzophenone	increases expression	ISO	RGD:1313518	E	RGD:6480464	20221101	CTD	MESH:C024292	4-hydroxybenzophenone results in increased expression of ATF6 protein	PMID:35476924
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34421	4-Hydroxybenzophenone	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20221101	CTD	MESH:C024292	CXCL1 protein promotes the reaction [4-hydroxybenzophenone results in increased expression of ATF6 protein]	PMID:35476924
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313517	E	RGD:6480464	20241001	CTD	MESH:C008745	bisphenol F results in increased expression of ATF6 mRNA	PMID:38134982
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313518	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ATF6 mRNA	PMID:38685157
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATF6 mRNA	PMID:28628672
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ATF6 mRNA	PMID:37019170
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34631	chlorpyrifos	decreases methylation	EXP		E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in decreased methylation of ATF6 gene	PMID:32905263
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ATF6 protein	PMID:26804720
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ATF6 protein	PMID:26804720
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D003993	4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]	PMID:26804720
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:D003993	4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]	PMID:26804720
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATF6 mRNA	PMID:28628672
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34905	paraquat	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20180515	CTD	MESH:D010269	Paraquat results in increased cleavage of ATF6 protein	PMID:28986289
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010269	Paraquat results in increased expression of ATF6 protein	PMID:22245251
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313517	E	RGD:6480464	20180515	CTD	MESH:D010269	Paraquat results in increased expression of ATF6 mRNA; Paraquat results in increased expression of ATF6 protein modified form	PMID:28986289|PMID:34097952
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D010269	Minocycline inhibits the reaction [Paraquat results in increased expression of ATF6 protein]	PMID:22245251
1305471	Atf6	activating transcription factor 6	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20210202	CTD	MESH:D000077285	[Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of ATF6 mRNA]	PMID:31054322
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313517	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATF6 mRNA	PMID:37042841
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ATF6 mRNA	PMID:30589522
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of ATF6 mRNA	PMID:17175027
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATF6 mRNA; Cadmium Chloride results in increased expression of ATF6 protein	PMID:30973085|PMID:31433112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313517	E	RGD:6480464	20190702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATF6 mRNA; Cadmium Chloride results in increased expression of ATF6 protein	PMID:30796460
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313518	E	RGD:6480464	20150414	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATF6 mRNA; Cadmium Chloride results in increased expression of ATF6 protein	PMID:25409916|PMID:38242296|PMID:39038763
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D019256	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; Rutin inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; Rutin inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]	PMID:30973085|PMID:31433112|PMID:38001299
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20190702	CTD	MESH:D019256	4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]	PMID:30796460
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230905	CTD	MESH:D019256	4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATF6 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein	PMID:37236586|PMID:37261864|PMID:38242296
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313517	E	RGD:6480464	20230704	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ATF6 mRNA	PMID:36251517
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35553	perhexiline	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20230502	CTD	MESH:D010480	[perhexiline maleate results in increased abundance of Perhexiline] which results in increased expression of ATF6 mRNA; CYP2D6 protein inhibits the reaction [[perhexiline maleate results in increased abundance of Perhexiline] which results in increased expression of ATF6 mRNA]	PMID:36083301
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ATF6 gene	PMID:22079235
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATF6 mRNA	PMID:24386269
1305471	Atf6	activating transcription factor 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ATF6 mRNA	PMID:24449571
1305471	Atf6	activating transcription factor 6	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20200804	CTD	MESH:D005999	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1305471	Atf6	activating transcription factor 6	gene	CHEBI:3682	chrysazin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20120717	CTD	MESH:C004315	danthron results in increased expression of ATF6 protein	PMID:21126053
1305471	Atf6	activating transcription factor 6	gene	CHEBI:37288	gadolinium trichloride	affects expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C038958	gadolinium chloride affects the expression of ATF6 mRNA	PMID:21198628
1305471	Atf6	activating transcription factor 6	gene	CHEBI:37288	gadolinium trichloride	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C038958	gadolinium chloride results in increased expression of ATF6 protein	PMID:21198628
1305471	Atf6	activating transcription factor 6	gene	CHEBI:37288	gadolinium trichloride	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:C038958	Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of ATF6 protein]	PMID:21198628
1305471	Atf6	activating transcription factor 6	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ATF6 mRNA	PMID:28302478
1305471	Atf6	activating transcription factor 6	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313518	E	RGD:6480464	20250603	CTD	MESH:C473478	Sunitinib results in increased expression of ATF6 mRNA	PMID:39613054
1305471	Atf6	activating transcription factor 6	gene	CHEBI:39214	abamectin	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C048324	abamectin results in increased expression of ATF6 mRNA	PMID:34748272
1305471	Atf6	activating transcription factor 6	gene	CHEBI:39214	abamectin	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C048324	Hesperidin inhibits the reaction [abamectin results in increased expression of ATF6 mRNA]	PMID:34748272
1305471	Atf6	activating transcription factor 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ATF6 mRNA	PMID:37955688
1305471	Atf6	activating transcription factor 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313517	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ATF6 mRNA	PMID:40419075
1305471	Atf6	activating transcription factor 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATF6 mRNA	PMID:36331819
1305471	Atf6	activating transcription factor 6	gene	CHEBI:39426	perfluorobutyric acid	increases expression	ISO	RGD:1313517	E	RGD:6480464	20230704	CTD	MESH:C033094	perfluorobutyric acid results in increased expression of ATF6 mRNA	PMID:36251517
1305471	Atf6	activating transcription factor 6	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of ATF6 mRNA	PMID:22561333
1305471	Atf6	activating transcription factor 6	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20180828	CTD	MESH:D003474	Curcumin results in increased expression of ATF6 mRNA	PMID:29723631
1305471	Atf6	activating transcription factor 6	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140311	CTD	MESH:D003474	Curcumin results in increased expression of ATF6 protein	PMID:21793155
1305471	Atf6	activating transcription factor 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313517	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATF6 mRNA	PMID:25979313
1305471	Atf6	activating transcription factor 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATF6 mRNA	PMID:23179753
1305471	Atf6	activating transcription factor 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313517	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ATF6 mRNA	PMID:29154799
1305471	Atf6	activating transcription factor 6	gene	CHEBI:40279	allopurinol	increases expression	ISO	RGD:1313517	E	RGD:6480464	20210706	CTD	MESH:D000493	Allopurinol results in increased expression of ATF6 mRNA	PMID:32535746
1305471	Atf6	activating transcription factor 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313517	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ATF6 mRNA	PMID:20106945|PMID:24973091|PMID:25562108|PMID:27989131|PMID:32152650
1305471	Atf6	activating transcription factor 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140114	CTD	MESH:D016572	Cyclosporine results in increased expression of ATF6 mRNA	PMID:23958496
1305471	Atf6	activating transcription factor 6	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; ATF6 protein affects the reaction [Cyclosporine results in increased expression of XBP1 protein alternative form]	PMID:32152650|PMID:35033536
1305471	Atf6	activating transcription factor 6	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C017160	cypermethrin results in increased expression of ATF6 mRNA	PMID:35876585
1305471	Atf6	activating transcription factor 6	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:C017160	Quercetin inhibits the reaction [cypermethrin results in increased expression of ATF6 mRNA]	PMID:35876585
1305471	Atf6	activating transcription factor 6	gene	CHEBI:41500	4-phenylbutyric acid	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20190702	CTD	MESH:C075773	4-phenylbutyric acid results in decreased expression of ATF6 protein	PMID:30796460
1305471	Atf6	activating transcription factor 6	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased cleavage of ATF6 protein]	PMID:20165829|PMID:26804720|PMID:30980806|PMID:38001299
1305471	Atf6	activating transcription factor 6	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20120501	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; [4-phenylbutyric acid co-treated with alpha-Chlorohydrin] results in decreased expression of ATF6 protein	PMID:20165829|PMID:27638906|PMID:28245985|PMID:30796460|PMID:31364909|PMID:33651226|PMID:34520753|PMID:36646296|PMID:37148176
1305471	Atf6	activating transcription factor 6	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Arecoline results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]; [4-phenylbutyric acid co-treated with Palmitic Acid] results in decreased expression of ATF6 protein	PMID:26804720|PMID:27578021|PMID:31298478|PMID:35413383|PMID:36030031|PMID:37692514|PMID:38242296|PMID:38450909
1305471	Atf6	activating transcription factor 6	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATF6 mRNA	PMID:28628672
1305471	Atf6	activating transcription factor 6	gene	CHEBI:42567	fisetin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20180116	CTD	MESH:C017875	fisetin results in increased expression of ATF6 protein	PMID:28181380
1305471	Atf6	activating transcription factor 6	gene	CHEBI:42567	fisetin	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20180116	CTD	MESH:C017875	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6 protein]	PMID:28181380
1305471	Atf6	activating transcription factor 6	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313517	E	RGD:6480464	20191008	CTD	MESH:D005947	Glucose deficiency results in increased expression of ATF6 protein; Glucose results in increased expression of ATF6 mRNA; Glucose results in increased expression of ATF6 protein	PMID:31022492|PMID:39798073
1305471	Atf6	activating transcription factor 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D005947	Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; Glucose results in increased expression of and affects the localization of ATF6 protein; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]	PMID:34801538
1305471	Atf6	activating transcription factor 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20191008	CTD	MESH:D005947	4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF6 protein]; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]	PMID:31022492|PMID:39798073
1305471	Atf6	activating transcription factor 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20260303	CTD	MESH:D005947	3-(indol-3-yl)propionic acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; [Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein]	PMID:39701215|PMID:40628365
1305471	Atf6	activating transcription factor 6	gene	CHEBI:44241	metyrapone	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20120501	CTD	MESH:D008797	Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of ATF6 protein]	PMID:19819344
1305471	Atf6	activating transcription factor 6	gene	CHEBI:44975	1,10-phenanthroline	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:C025205	[1,10-phenanthroline results in decreased activity of MBTPS2 protein] which affects the localization of ATF6 protein; [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which results in decreased cleavage of ATF6 protein	PMID:21355074
1305471	Atf6	activating transcription factor 6	gene	CHEBI:45285	pyrazinecarboxamide	increases expression	ISO	RGD:1313517	E	RGD:6480464	20170613	CTD	MESH:D011718	Pyrazinamide results in increased expression of ATF6 mRNA	PMID:28063906
1305471	Atf6	activating transcription factor 6	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D017239	Paclitaxel results in increased expression of ATF6 mRNA	PMID:36966900
1305471	Atf6	activating transcription factor 6	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D017239	Hesperidin inhibits the reaction [Paclitaxel results in increased expression of ATF6 mRNA]	PMID:36966900
1305471	Atf6	activating transcription factor 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATF6 mRNA	PMID:17562736
1305471	Atf6	activating transcription factor 6	gene	CHEBI:46195	paracetamol	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20191210	CTD	MESH:D000082	Acetaminophen results in increased cleavage of ATF6 protein	PMID:31524377
1305471	Atf6	activating transcription factor 6	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ATF6 mRNA	PMID:33387578
1305471	Atf6	activating transcription factor 6	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased cleavage of and results in increased activity of ATF6 protein; Guanabenz inhibits the reaction [Acetaminophen results in increased cleavage of ATF6 protein]	PMID:19931551|PMID:31524377
1305471	Atf6	activating transcription factor 6	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1313517	E	RGD:6480464	20211109	CTD	MESH:D005472	Fluorouracil affects the expression of ATF6 mRNA	PMID:34151400
1305471	Atf6	activating transcription factor 6	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of ATF6 mRNA	PMID:17331233
1305471	Atf6	activating transcription factor 6	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1313517	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of ATF6 protein	PMID:25324550
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to ATF6 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of and results in increased cleavage of ATF6 protein; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein; AKR1C3 protein promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein]; NFE2L2 protein affects the reaction [[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA]	PMID:35625704|PMID:40571110
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47381	diclofenac	increases expression	EXP		E	RGD:6480464	20260602	CTD	MESH:D004008	Diclofenac results in increased expression of ATF6 mRNA	PMID:40534331
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47381	diclofenac	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D004008	chrysin inhibits the reaction [Diclofenac results in increased expression of ATF6 mRNA]	PMID:40534331
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47657	roflumilast	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:C424423	Roflumilast inhibits the reaction [Rotenone results in increased expression of ATF6 protein]	PMID:37105514
1305471	Atf6	activating transcription factor 6	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in decreased expression of ATF6 mRNA	PMID:31464424
1305471	Atf6	activating transcription factor 6	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ATF6 mRNA	PMID:29391264
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of ATF6 mRNA	PMID:17178593
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:20165829
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1313517	E	RGD:6480464	20120515	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:19383982|PMID:20165829|PMID:33812996
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 protein	PMID:30602124
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829|PMID:33812996
1305471	Atf6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]	PMID:30602124
1305471	Atf6	activating transcription factor 6	gene	CHEBI:48080	brefeldin A	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:D020126	Apigenin inhibits the reaction [Brefeldin A results in increased cleavage of ATF6 protein]	PMID:20493918
1305471	Atf6	activating transcription factor 6	gene	CHEBI:4811	epoxiconazole	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C109476	[cyproconazole co-treated with epoxiconazole] results in increased expression of ATF6 mRNA	PMID:29038839
1305471	Atf6	activating transcription factor 6	gene	CHEBI:48347	triclocarban	increases expression	ISO	RGD:1313517	E	RGD:6480464	20190409	CTD	MESH:C009540	triclocarban results in increased expression of ATF6 mRNA; triclocarban results in increased expression of ATF6 protein	PMID:30592132
1305471	Atf6	activating transcription factor 6	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313517	E	RGD:6480464	20211207	CTD	MESH:D018038	Sodium Selenite results in increased expression of ATF6 protein	PMID:34520753
1305471	Atf6	activating transcription factor 6	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20211207	CTD	MESH:D018038	4-phenylbutyric acid inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]	PMID:34520753
1305471	Atf6	activating transcription factor 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ATF6 mRNA	PMID:29097150
1305471	Atf6	activating transcription factor 6	gene	CHEBI:49662	indometacin	increases activity	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased activity of ATF6 protein	PMID:17341418
1305471	Atf6	activating transcription factor 6	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20210706	CTD	MESH:D007213	Indomethacin results in increased expression of ATF6 mRNA	PMID:32535746
1305471	Atf6	activating transcription factor 6	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATF6 mRNA	PMID:28628672
1305471	Atf6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ATF6 protein	PMID:23883479
1305471	Atf6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313517	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATF6 mRNA; Arsenic Trioxide results in increased expression of ATF6 protein	PMID:17963750|PMID:19176121|PMID:25107562|PMID:25258189
1305471	Atf6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313518	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATF6 mRNA	PMID:23892647|PMID:34091186
1305471	Atf6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	increases phosphorylation	ISO	RGD:1313517	E	RGD:6480464	20220111	CTD	MESH:C032793	Arsenic Trioxide results in increased phosphorylation of ATF6 protein	PMID:34560123
1305471	Atf6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide promotes the reaction [nilotinib results in decreased expression of ATF6 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in increased expression of ATF6 protein]	PMID:23883479|PMID:25107562
1305471	Atf6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20191114	CTD	MESH:C032793	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; [Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of ATF6 mRNA; [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased cleavage of ATF6 protein; Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of ATF6 mRNA]	PMID:23892647|PMID:34091186
1305471	Atf6	activating transcription factor 6	gene	CHEBI:5001	fenofibrate	multiple interactions	EXP		E	RGD:6480464	20240305	CTD	MESH:D011345	Fenofibrate inhibits the reaction [Dietary Fats results in increased expression of ATF6 mRNA]; Fenofibrate inhibits the reaction [Dietary Fats results in increased expression of ATF6 protein]	PMID:38216941
1305471	Atf6	activating transcription factor 6	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of ATF6 mRNA	PMID:34044035
1305471	Atf6	activating transcription factor 6	gene	CHEBI:50686	atorvastatin calcium	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:D000069059	[dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]	PMID:34939712
1305471	Atf6	activating transcription factor 6	gene	CHEBI:50694	minocycline	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D008911	Minocycline inhibits the reaction [Paraquat results in increased expression of ATF6 protein]	PMID:22245251
1305471	Atf6	activating transcription factor 6	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20130416	CTD	MESH:C049325	1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of ATF6 mRNA]	PMID:22959925
1305471	Atf6	activating transcription factor 6	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20241105	CTD	MESH:D005485	Flutamide results in increased expression of ATF6 mRNA; Flutamide results in increased expression of ATF6 protein	PMID:32662666
1305471	Atf6	activating transcription factor 6	gene	CHEBI:52172	nilotinib	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20170228	CTD	MESH:C498826	nilotinib results in decreased expression of ATF6 protein	PMID:23883479
1305471	Atf6	activating transcription factor 6	gene	CHEBI:52172	nilotinib	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20170228	CTD	MESH:C498826	Arsenic Trioxide promotes the reaction [nilotinib results in decreased expression of ATF6 protein]	PMID:23883479
1305471	Atf6	activating transcription factor 6	gene	CHEBI:53001	nickel sulfate	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in increased expression of ATF6 mRNA	PMID:31734292
1305471	Atf6	activating transcription factor 6	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ATF6 mRNA	PMID:19042947
1305471	Atf6	activating transcription factor 6	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313518	E	RGD:6480464	20150414	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ATF6 mRNA	PMID:25409916
1305471	Atf6	activating transcription factor 6	gene	CHEBI:53444	potassium dichromate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D011192	[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATF6 protein	PMID:30974164
1305471	Atf6	activating transcription factor 6	gene	CHEBI:5553	Guanabenz	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20191210	CTD	MESH:D006143	Guanabenz inhibits the reaction [Acetaminophen results in increased cleavage of ATF6 protein]	PMID:31524377
1305471	Atf6	activating transcription factor 6	gene	CHEBI:5856	Ibutilide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C067192	ibutilide inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]	PMID:28399139
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20190219	CTD	MESH:D007559	Ivermectin results in increased expression of ATF6 mRNA	PMID:28942281
1305471	Atf6	activating transcription factor 6	gene	CHEBI:60799	esketamine	increases expression	ISO	RGD:1313517	E	RGD:6480464	20240702	CTD	MESH:C000629870	Esketamine results in increased expression of ATF6 mRNA	PMID:38219984
1305471	Atf6	activating transcription factor 6	gene	CHEBI:60888	BAPTA	increases expression	ISO	RGD:1313517	E	RGD:6480464	20180116	CTD	MESH:C025603	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of ATF6 protein	PMID:28181380
1305471	Atf6	activating transcription factor 6	gene	CHEBI:60888	BAPTA	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20180116	CTD	MESH:C025603	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6 protein]	PMID:28181380
1305471	Atf6	activating transcription factor 6	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140114	CTD	MESH:D016559	Tacrolimus results in increased expression of ATF6 mRNA	PMID:23958496
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20221206	CTD	MESH:D007649	Ketamine results in increased expression of ATF6 mRNA	PMID:35728656
1305471	Atf6	activating transcription factor 6	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of ATF6 mRNA	PMID:17175027
1305471	Atf6	activating transcription factor 6	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C025340	manganese chloride results in increased expression of ATF6 protein	PMID:25732873
1305471	Atf6	activating transcription factor 6	gene	CHEBI:63621	saquinavir	increases expression	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:D019258	Saquinavir results in increased expression of ATF6 protein	PMID:19147209
1305471	Atf6	activating transcription factor 6	gene	CHEBI:63952	arsenic trichloride	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to ATF6 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of and results in increased cleavage of ATF6 protein; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA; NFE2L2 protein affects the reaction [[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA]	PMID:35625704
1305471	Atf6	activating transcription factor 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ATF6 mRNA	PMID:28801915
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6413	letrozole	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C067431	Letrozole results in increased expression of ATF6 mRNA	PMID:33491863
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6413	letrozole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C067431	ADM protein inhibits the reaction [Letrozole results in increased expression of ATF6 mRNA]	PMID:33491863
1305471	Atf6	activating transcription factor 6	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313518	E	RGD:6480464	20210907	CTD	MESH:D004178	Diquat results in increased expression of ATF6 mRNA	PMID:32536062
1305471	Atf6	activating transcription factor 6	gene	CHEBI:64213	cantharidin	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20170613	CTD	MESH:D002193	Cantharidin results in increased cleavage of ATF6 protein	PMID:27113412
1305471	Atf6	activating transcription factor 6	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]	PMID:31433112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20150127	CTD	MESH:C085911	[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with HRAS protein] results in decreased expression of ATF6 protein	PMID:24898257
1305471	Atf6	activating transcription factor 6	gene	CHEBI:65347	carfilzomib	increases expression	ISO	RGD:1313517	E	RGD:6480464	20250506	CTD	MESH:C524865	carfilzomib results in increased expression of ATF6 protein	PMID:39645617
1305471	Atf6	activating transcription factor 6	gene	CHEBI:65737	demethoxycurcumin	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20160210	CTD	MESH:C050229	demethoxycurcumin analog inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein]	PMID:26264395
1305471	Atf6	activating transcription factor 6	gene	CHEBI:67486	quercetin 3-O-beta-D-galactopyranoside	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20250401	CTD	MESH:C021304	hyperoside inhibits the reaction [Particulate Matter results in increased cleavage of ATF6 protein]	PMID:38848825
1305471	Atf6	activating transcription factor 6	gene	CHEBI:67987	ginsenoside Rg1	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20200519	CTD	MESH:C035054	ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased expression of ATF6 protein]	PMID:30918470
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D008687	Metformin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]	PMID:34801538
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20210907	CTD	MESH:D008687	Metformin inhibits the reaction [Rotenone results in increased expression of ATF6 mRNA]	PMID:32189544
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	affects localization	ISO	RGD:1313517	E	RGD:6480464	20180220	CTD	MESH:D008694	Methamphetamine affects the localization of ATF6 protein	PMID:27323860
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20180220	CTD	MESH:D008694	Methamphetamine results in increased cleavage of ATF6 protein	PMID:27323860
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:D008694	Methamphetamine results in increased cleavage of ATF6 protein	PMID:27323860
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ATF6 mRNA; Methamphetamine results in increased expression of ATF6 protein	PMID:19564919|PMID:28070110|PMID:34214594
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313517	E	RGD:6480464	20250506	CTD	MESH:D008694	Methamphetamine results in increased expression of ATF6 protein	PMID:38901802
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20170725	CTD	MESH:D008694	Melatonin inhibits the reaction [Methamphetamine results in increased expression of ATF6 protein]	PMID:28070110
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20180220	CTD	MESH:D008694	ATF6 protein affects the reaction [Methamphetamine results in increased cleavage of CASP3 protein]; ATF6 protein affects the reaction [Methamphetamine results in increased cleavage of CASP9 protein]; ATF6 protein affects the reaction [Methamphetamine results in increased expression of DDIT3 mRNA]; ATF6 protein affects the reaction [Methamphetamine results in increased expression of DDIT3 protein]; ATF6 protein affects the reaction [Methamphetamine results in increased expression of XBP1 mRNA]; ATF6 protein affects the reaction [Methamphetamine results in increased expression of XBP1 protein]; Methamphetamine results in decreased expression of and results in increased cleavage of ATF6 protein; Naltrexone inhibits the reaction [Methamphetamine results in increased cleavage of ATF6 protein]; norbinaltorphimine inhibits the reaction [Methamphetamine results in increased cleavage of ATF6 protein]; STIM1 protein affects the reaction [Methamphetamine results in increased expression of ATF6 protein]	PMID:27323860|PMID:38901802
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ATF6 mRNA	PMID:30467583
1305471	Atf6	activating transcription factor 6	gene	CHEBI:68329	syringic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C001945	syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of ATF6 mRNA]	PMID:39096083
1305471	Atf6	activating transcription factor 6	gene	CHEBI:68352	quercetin 3-O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C016527	isoquercitrin results in increased expression of ATF6 mRNA	PMID:30365939
1305471	Atf6	activating transcription factor 6	gene	CHEBI:68352	quercetin 3-O-beta-D-glucopyranoside	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C016527	isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]	PMID:38001299
1305471	Atf6	activating transcription factor 6	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ATF6 gene	PMID:35440735
1305471	Atf6	activating transcription factor 6	gene	CHEBI:68657	zingerone	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:C013738	zingerone inhibits the reaction [sodium arsenite results in increased expression of ATF6 mRNA]	PMID:38897041
1305471	Atf6	activating transcription factor 6	gene	CHEBI:69074	linderalactone	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20250708	CTD	MESH:C477965	linderalactone inhibits the reaction [Streptozocin results in increased expression of ATF6 protein]	PMID:37757635
1305471	Atf6	activating transcription factor 6	gene	CHEBI:69355	casticin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20170516	CTD	MESH:C054133	casticin results in increased expression of ATF6 protein	PMID:27862857
1305471	Atf6	activating transcription factor 6	gene	CHEBI:72959	N-hexadecanoylsphingosine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C097760	N-palmitoylsphingosine results in increased expression of ATF6 mRNA	PMID:28223344
1305471	Atf6	activating transcription factor 6	gene	CHEBI:72959	N-hexadecanoylsphingosine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C097760	[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ATF6 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ATF6 mRNA]	PMID:28223344
1305471	Atf6	activating transcription factor 6	gene	CHEBI:73278	poly(guanylic acid)	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D011068	Poly G inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]	PMID:31028789
1305471	Atf6	activating transcription factor 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ATF6 mRNA	PMID:22206623
1305471	Atf6	activating transcription factor 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of ATF6 mRNA	PMID:27840820
1305471	Atf6	activating transcription factor 6	gene	CHEBI:74023	dioscin	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:C019357	dioscin inhibits the reaction [Ethanol results in increased expression of ATF6 protein]	PMID:24146112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:74023	dioscin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20140513	CTD	MESH:C019357	dioscin inhibits the reaction [Ethanol results in increased expression of ATF6 protein]	PMID:24146112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7465	naltrexone	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20180220	CTD	MESH:D009271	Naltrexone inhibits the reaction [Methamphetamine results in increased cleavage of ATF6 protein]	PMID:27323860
1305471	Atf6	activating transcription factor 6	gene	CHEBI:74856	antimony trichloride	increases expression	ISO	RGD:1313518	E	RGD:6480464	20231003	CTD	MESH:C054672	antimony trichloride results in increased expression of ATF6 mRNA	PMID:34091186
1305471	Atf6	activating transcription factor 6	gene	CHEBI:74856	antimony trichloride	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20231003	CTD	MESH:C054672	[Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of ATF6 mRNA	PMID:34091186
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1313517	E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in increased expression of ATF6 mRNA	PMID:32152650
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7494	nefazodone	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7496	nelfinavir	affects localization	ISO	RGD:1313517	E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir affects the localization of ATF6 protein	PMID:21355074
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7496	nelfinavir	decreases cleavage	ISO	RGD:1313517	E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir results in decreased cleavage of ATF6 protein	PMID:21355074
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7496	nelfinavir	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir results in decreased expression of ATF6 protein alternative form	PMID:21355074
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7496	nelfinavir	increases stability	ISO	RGD:1313517	E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir results in increased stability of ATF6 protein	PMID:21355074
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7496	nelfinavir	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir inhibits the reaction [MBTPS2 protein results in increased cleavage of and results in increased activity of ATF6 protein]	PMID:21355074
1305471	Atf6	activating transcription factor 6	gene	CHEBI:75092	morin	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C008548	morin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]	PMID:38238535
1305471	Atf6	activating transcription factor 6	gene	CHEBI:75095	chrysin	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:C043561	chrysin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; chrysin inhibits the reaction [Diclofenac results in increased expression of ATF6 mRNA]	PMID:37453011|PMID:40534331
1305471	Atf6	activating transcription factor 6	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313517	E	RGD:6480464	20220510	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF6 protein	PMID:27638906
1305471	Atf6	activating transcription factor 6	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20220510	CTD	MESH:C072553	4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF6 protein]; ATF6 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ACE2 protein]; ATF6 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of CTSD protein]	PMID:27638906
1305471	Atf6	activating transcription factor 6	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313517	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ATF6 protein	PMID:31285264
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1313517	E	RGD:6480464	20141111	CTD	MESH:C038405	nivalenol results in increased expression of ATF6 mRNA	PMID:20682335
1305471	Atf6	activating transcription factor 6	gene	CHEBI:77012	methylseleninic acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased cleavage of and results in increased activity of ATF6 protein	PMID:16205645
1305471	Atf6	activating transcription factor 6	gene	CHEBI:77131	sinapic acid	decreases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:C073734	sinapinic acid results in decreased expression of ATF6 mRNA	PMID:38530053
1305471	Atf6	activating transcription factor 6	gene	CHEBI:77131	sinapic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C073734	sinapinic acid inhibits the reaction [lead acetate results in increased expression of ATF6 mRNA]	PMID:38530053
1305471	Atf6	activating transcription factor 6	gene	CHEBI:77148	ginsenoside Re	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20250603	CTD	MESH:C049864	Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]	PMID:39798073
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313517	E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in increased expression of ATF6 mRNA; ochratoxin A results in increased expression of ATF6 protein	PMID:30559759|PMID:36058351
1305471	Atf6	activating transcription factor 6	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ATF6 mRNA	PMID:21346803
1305471	Atf6	activating transcription factor 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313517	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ATF6 mRNA	PMID:30851411
1305471	Atf6	activating transcription factor 6	gene	CHEBI:78420	icariin	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:C056599	icariin results in decreased expression of ATF6 protein	PMID:34018553
1305471	Atf6	activating transcription factor 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:C516138	dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]	PMID:31433112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:78708	Nonidet P-40	increases expression	ISO	RGD:1313517	E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in increased expression of ATF6 mRNA	PMID:26552463
1305471	Atf6	activating transcription factor 6	gene	CHEBI:7959	D-penicillamine	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20120412	CTD	MESH:D010396	Penicillamine results in increased metabolism of and results in increased activity of ATF6 protein	PMID:19722195
1305471	Atf6	activating transcription factor 6	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C412815	GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of ATF6 mRNA]	PMID:28223344
1305471	Atf6	activating transcription factor 6	gene	CHEBI:80025	Salinomycin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20230307	CTD	MESH:C010327	salinomycin results in increased expression of ATF6 mRNA	PMID:35914560
1305471	Atf6	activating transcription factor 6	gene	CHEBI:80025	Salinomycin	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20230307	CTD	MESH:C010327	[salinomycin co-treated with Calcitriol] results in increased expression of ATF6 mRNA	PMID:35914560
1305471	Atf6	activating transcription factor 6	gene	CHEBI:8062	phenethyl caffeate	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C055494	[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of ATF6 mRNA; GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of ATF6 mRNA]	PMID:28223344
1305471	Atf6	activating transcription factor 6	gene	CHEBI:80774	tauroursodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C031655	ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1305471	Atf6	activating transcription factor 6	gene	CHEBI:80774	tauroursodeoxycholic acid	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20141111	CTD	MESH:C031655	ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1305471	Atf6	activating transcription factor 6	gene	CHEBI:80774	tauroursodeoxycholic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C031655	ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ATF6 mRNA]	PMID:28223344
1305471	Atf6	activating transcription factor 6	gene	CHEBI:80885	Pachymic acid	increases expression	ISO	RGD:1313517	E	RGD:6480464	20230307	CTD	MESH:C102487	pachymic acid results in increased expression of ATF6 mRNA; pachymic acid results in increased expression of ATF6 protein	PMID:35524978
1305471	Atf6	activating transcription factor 6	gene	CHEBI:81068	Shikonin	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:C016101	shikonin inhibits the reaction [Glutamic Acid results in increased expression of ATF6 protein]	PMID:35028790
1305471	Atf6	activating transcription factor 6	gene	CHEBI:81529	Norbinaltorphimine	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20180220	CTD	MESH:C051844	norbinaltorphimine inhibits the reaction [Methamphetamine results in increased cleavage of ATF6 protein]	PMID:27323860
1305471	Atf6	activating transcription factor 6	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of ATF6 mRNA	PMID:22434021
1305471	Atf6	activating transcription factor 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ATF6 mRNA	PMID:27291303
1305471	Atf6	activating transcription factor 6	gene	CHEBI:81758	cyproconazole	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C093628	[cyproconazole co-treated with epoxiconazole] results in increased expression of ATF6 mRNA	PMID:29038839
1305471	Atf6	activating transcription factor 6	gene	CHEBI:82416	Chloroacetonitrile	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230801	CTD	MESH:C069277	chloroacetonitrile results in increased expression of ATF6 protein	PMID:36940772
1305471	Atf6	activating transcription factor 6	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ATF6 mRNA	PMID:23640034
1305471	Atf6	activating transcription factor 6	gene	CHEBI:82445	Dibromoacetonitrile	increases expression	ISO	RGD:1313518	E	RGD:6480464	20240806	CTD	MESH:C051715	dibromoacetonitrile results in increased expression of ATF6 protein	PMID:38065397
1305471	Atf6	activating transcription factor 6	gene	CHEBI:82577	Fusarenone X	increases expression	ISO	RGD:1313517	E	RGD:6480464	20141111	CTD	MESH:C002469	fusarenon-X results in increased expression of ATF6 mRNA	PMID:20682335
1305471	Atf6	activating transcription factor 6	gene	CHEBI:8450	procymidone	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:C035988	procymidone results in increased expression of ATF6 mRNA; procymidone results in increased expression of ATF6 protein	PMID:35913088
1305471	Atf6	activating transcription factor 6	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of ATF6 mRNA	PMID:21278054
1305471	Atf6	activating transcription factor 6	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil affects the expression of ATF6 mRNA	PMID:36038036
1305471	Atf6	activating transcription factor 6	gene	CHEBI:85078	dapagliflozin	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:C529054	[dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]	PMID:34939712
1305471	Atf6	activating transcription factor 6	gene	CHEBI:8653	pyocyanine	increases activity	EXP		E	RGD:6480464	20170516	CTD	MESH:D011710	Pyocyanine results in increased activity of ATF6 protein	PMID:27613716
1305471	Atf6	activating transcription factor 6	gene	CHEBI:8805	Repaglinide	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:C072379	repaglinide inhibits the reaction [Rotenone results in increased expression of ATF6 protein]	PMID:36538285
1305471	Atf6	activating transcription factor 6	gene	CHEBI:88542	Butylparaben	increases expression	ISO	RGD:1313517	E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of ATF6 protein	PMID:29319206
1305471	Atf6	activating transcription factor 6	gene	CHEBI:8863	Riluzole	increases expression	ISO	RGD:1313517	E	RGD:6480464	20200331	CTD	MESH:D019782	Riluzole results in increased expression of ATF6 protein	PMID:30280407
1305471	Atf6	activating transcription factor 6	gene	CHEBI:90369	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:C550547	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]	PMID:31433112
1305471	Atf6	activating transcription factor 6	gene	CHEBI:91460	KN-93	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:C072105	KN 93 results in increased expression of ATF6 protein	PMID:37075931
1305471	Atf6	activating transcription factor 6	gene	CHEBI:91460	KN-93	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:C072105	KN 93 inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]	PMID:37075931
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9150	simvastatin	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of ATF6 mRNA; Simvastatin results in increased expression of ATF6 protein	PMID:18807172
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20240109	CTD	MESH:D020123	[Sirolimus co-treated with hydroquinone] results in decreased expression of ATF6 protein	PMID:37148176
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9288	streptozocin	increases cleavage	EXP		E	RGD:6480464	20190910	CTD	MESH:D013311	Streptozocin results in increased cleavage of ATF6 protein	PMID:30980806
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1313518	E	RGD:156430337|PMID:36044268	20230228	RGD	MESH:D013311	streptozocin increases expression of Atf6 protein in heart	
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20250708	CTD	MESH:D013311	Streptozocin results in increased expression of ATF6 protein	PMID:37757635
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D013311	4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased cleavage of ATF6 protein]; [Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein; Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; Metformin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]	PMID:30980806|PMID:34801538
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20211109	CTD	MESH:D013311	[Dietary Fats co-treated with Streptozocin] results in increased expression of ATF6 mRNA; linderalactone inhibits the reaction [Streptozocin results in increased expression of ATF6 protein]; NUS1 protein inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of ATF6 mRNA]	PMID:33812996|PMID:37757635
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1313517	E	RGD:6480464	20210706	CTD	MESH:D013467	Sulindac results in increased expression of ATF6 mRNA	PMID:32535746
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases activity	ISO	RGD:1313517	E	RGD:6480464	20130611	CTD	MESH:D019284	Thapsigargin results in increased activity of ATF6 protein	PMID:23383089
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases cleavage	EXP		E	RGD:6480464	20150714	CTD	MESH:D019284	Thapsigargin results in increased cleavage of ATF6 protein	PMID:24638036
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases cleavage	ISO	RGD:1313517	E	RGD:6480464	20230404	CTD	MESH:D019284	Thapsigargin results in increased cleavage of ATF6 protein	PMID:23741617
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:D019284	Thapsigargin results in increased cleavage of ATF6 protein	PMID:20493918
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019284	Thapsigargin results in increased expression of ATF6 protein	PMID:18477628
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313517	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of ATF6 mRNA; Thapsigargin results in increased expression of ATF6 protein; Thapsigargin results in increased expression of ATF6 protein modified form	PMID:17963750|PMID:22378314|PMID:23576437|PMID:26264395|PMID:30796460|PMID:32407927
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140211	CTD	MESH:D019284	Thapsigargin results in increased expression of ATF6 mRNA; Thapsigargin results in increased expression of ATF6 protein	PMID:23576437|PMID:28223344
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1313517	E	RGD:6480464	20140211	CTD	MESH:D019284	1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein]; ATF6 promotes the reaction [Thapsigargin results in increased expression of DDIT3 protein]; ATF6 promotes the reaction [Thapsigargin results in increased expression of HSPA5 protein]; demethoxycurcumin analog inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein]; icaritin inhibits the reaction [Thapsigargin results in increased expression of ATF6 mRNA]; Luteolin inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein modified form]; Thapsigargin results in increased cleavage of and affects the localization of ATF6 protein	PMID:23576437|PMID:26264395|PMID:27358234|PMID:27587023|PMID:32407927|PMID:36372277
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:D019284	1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased cleavage of ATF6 protein]	PMID:20493918|PMID:23576437
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9607	Tiron	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20141111	CTD	MESH:D014013	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [arsenic trioxide results in increased expression of and results in increased cleavage of ATF6 protein]	PMID:23892647
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20170613	CTD	MESH:C001899	triptolide results in decreased expression of ATF6 protein	PMID:26990902
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230502	CTD	MESH:C001899	triptolide results in increased expression of ATF6 mRNA	PMID:36520315
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9747	Triptolide	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230502	CTD	MESH:C001899	STING1 protein affects the reaction [triptolide results in increased expression of ATF6 mRNA]; STING1 protein affects the reaction [triptolide results in increased expression of ATF6 protein]	PMID:36520315
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ATF6 mRNA	PMID:28973697
1305471	Atf6	activating transcription factor 6	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313517	E	RGD:6480464	20210706	CTD	MESH:C057693	Troglitazone results in increased expression of ATF6 mRNA	PMID:32535746
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313520	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SPAG7 mRNA	PMID:38218311
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313521	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SPAG7 mRNA	PMID:33045310
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	ISO	RGD:1313520	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of SPAG7 protein	PMID:28073184
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313521	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of SPAG7 mRNA	PMID:40945087
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313520	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of SPAG7 protein	PMID:34122009
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313520	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SPAG7 protein	PMID:37730182
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SPAG7 mRNA	PMID:33387578
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313520	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SPAG7 mRNA	PMID:28818685
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313521	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of SPAG7 mRNA	PMID:37748715
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313520	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SPAG7 mRNA	PMID:39836092
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313520	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SPAG7 mRNA	PMID:19549813
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313520	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SPAG7 protein	PMID:23301498
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313521	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SPAG7 mRNA	PMID:22206623
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313520	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SPAG7 protein	PMID:35688186
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313520	E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in decreased expression of SPAG7 protein	PMID:37834424
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313521	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPAG7 mRNA	PMID:21570461
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPAG7 mRNA	PMID:21215274
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of SPAG7 mRNA	PMID:19013527
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313520	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of SPAG7 mRNA	PMID:33512557
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313520	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SPAG7 mRNA	PMID:39709020
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313520	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPAG7 mRNA	PMID:30851411
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313520	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SPAG7 mRNA	PMID:29803840
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313521	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPAG7 mRNA	PMID:22228805
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SPAG7 mRNA	PMID:34492290
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313520	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SPAG7 mRNA	PMID:25047013
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313521	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SPAG7 mRNA	PMID:33221593
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SPAG7 mRNA	PMID:25181051
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313520	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SPAG7 protein	PMID:37567409
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313520	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SPAG7 mRNA	PMID:19244175
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313520	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SPAG7 gene	PMID:22964155
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313520	E	RGD:6480464	20220607	CTD	MESH:D010269	Paraquat results in increased expression of SPAG7 mRNA	PMID:35182771
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313520	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SPAG7 mRNA	PMID:39836092
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313520	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPAG7 mRNA	PMID:25979313
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313520	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SPAG7 mRNA	PMID:23179753|PMID:29154799
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313520	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of SPAG7 mRNA	PMID:25047013
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313521	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SPAG7 mRNA; Nanotubes, Carbon results in decreased expression of SPAG7 mRNA	PMID:25554681
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313521	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SPAG7 mRNA	PMID:35964746
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1313520	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of SPAG7 protein	PMID:32959892
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313520	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SPAG7 mRNA	PMID:39836092
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313520	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of SPAG7 protein	PMID:34122009
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313521	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SPAG7 mRNA	PMID:22206623
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313521	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SPAG7 mRNA	PMID:22206623
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313520	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPAG7 mRNA	PMID:30851411
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313520	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPAG7 gene]	PMID:28238834
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313521	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of SPAG7 mRNA	PMID:40826991
1305473	Spag7	sperm associated antigen 7	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SPAG7 mRNA	PMID:19281266
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of L3MBTL3 gene	PMID:35440735
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1313522	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of L3MBTL3 mRNA	PMID:29581250
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of L3MBTL3 mRNA	PMID:39241906
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of L3MBTL3 mRNA	PMID:35811015
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of L3MBTL3 mRNA	PMID:20068009
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of L3MBTL3 mRNA	PMID:33387578
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of L3MBTL3 gene	PMID:27618143
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313522	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of L3MBTL3 protein	PMID:37730182
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of L3MBTL3 mRNA	PMID:16002434
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of L3MBTL3 mRNA	PMID:22061828
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of L3MBTL3 mRNA	PMID:28818685
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of L3MBTL3 mRNA	PMID:36331819
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:234430	gardiquimod	increases expression	ISO	RGD:1313522	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of L3MBTL3 mRNA	PMID:28003376
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of L3MBTL3 mRNA]	PMID:28003376
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of L3MBTL3 mRNA	PMID:23649840
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of L3MBTL3 mRNA	PMID:41430723
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of L3MBTL3 mRNA	PMID:30779732
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of L3MBTL3 mRNA	PMID:30912803
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313523	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of L3MBTL3 mRNA	PMID:21570461
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of L3MBTL3 mRNA	PMID:33387578
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of L3MBTL3 mRNA	PMID:28959563
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of L3MBTL3 mRNA	PMID:25879800
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA	PMID:34876320
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA	PMID:34876320
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313522	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of L3MBTL3 5' UTR; Benzo(a)pyrene affects the methylation of L3MBTL3 promoter	PMID:27901495
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313523	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of L3MBTL3 intron	PMID:27901495
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of L3MBTL3 mRNA	PMID:25729387
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of L3MBTL3 mRNA	PMID:30047161
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313523	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of L3MBTL3 promoter	PMID:35295148
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of L3MBTL3 mRNA	PMID:34492290
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of L3MBTL3 mRNA	PMID:30816183
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of L3MBTL3 mRNA	PMID:31715268
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of L3MBTL3 mRNA	PMID:33221593
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of L3MBTL3 mRNA	PMID:41034487
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313522	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of L3MBTL3 mRNA	PMID:29275510
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313523	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of L3MBTL3 mRNA	PMID:35479511
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA	PMID:28628672
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:34237	2,4-diaminotoluene	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in decreased expression of L3MBTL3 mRNA	PMID:20713471
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA	PMID:28628672
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313522	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of L3MBTL3 mRNA	PMID:37042841
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of L3MBTL3 mRNA	PMID:38174414
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of L3MBTL3 promoter	PMID:22457795
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of L3MBTL3 mRNA	PMID:24386269
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of L3MBTL3 mRNA	PMID:19320972
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of L3MBTL3 mRNA]	PMID:28003376
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:37825	p-toluidine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of L3MBTL3 mRNA	PMID:27638505
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of L3MBTL3 mRNA	PMID:40194260
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of L3MBTL3 mRNA	PMID:36331819
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313522	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of L3MBTL3 mRNA	PMID:25979313
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of L3MBTL3 mRNA	PMID:23179753
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313522	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of L3MBTL3 mRNA	PMID:24935251|PMID:29154799
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313522	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of L3MBTL3 gene	PMID:29154799
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of L3MBTL3 mRNA	PMID:30047161
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA	PMID:28628672
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of L3MBTL3 mRNA	PMID:28973697
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of L3MBTL3 mRNA	PMID:38832940
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313522	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of L3MBTL3 mRNA	PMID:24935251
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313523	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of L3MBTL3 mRNA	PMID:17562736
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of L3MBTL3 mRNA	PMID:33387578
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of L3MBTL3 mRNA	PMID:29067470
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of L3MBTL3 mRNA	PMID:24714768
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of L3MBTL3 mRNA	PMID:35811015
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of L3MBTL3 mRNA	PMID:22079256
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA	PMID:34876320
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA	PMID:28628672
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of L3MBTL3 mRNA	PMID:30047161
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of L3MBTL3 mRNA	PMID:35964746
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of L3MBTL3 mRNA	PMID:24793618
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of L3MBTL3 mRNA	PMID:25729387
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of L3MBTL3 mRNA	PMID:22079614
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313522	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of L3MBTL3 mRNA	PMID:22079256
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313522	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of L3MBTL3 mRNA	PMID:22079256
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313523	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of L3MBTL3 mRNA	PMID:23091169
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of L3MBTL3 mRNA	PMID:39847705
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA	PMID:34876320
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of L3MBTL3 mRNA	PMID:30047161
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of L3MBTL3 mRNA	PMID:21346803
1305474	L3mbtl3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of L3MBTL3 mRNA	PMID:23555832
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of THOC7 mRNA	PMID:38218311
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1602206	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of THOC7 mRNA	PMID:38218311
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of THOC7 mRNA	PMID:35967413
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of THOC7 mRNA	PMID:25812627
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of THOC7 mRNA	PMID:22378314
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of THOC7 mRNA	PMID:29432896
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of THOC7 mRNA	PMID:33387578
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:17579	beta-carotene	multiple interactions	ISO	RGD:1313524	E	RGD:6480464	20140909	CTD	MESH:D019207	[BCO1 protein affects the susceptibility to beta Carotene] which affects the expression of THOC7 mRNA	PMID:24657404
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of THOC7 mRNA	PMID:28818685
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313524	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of THOC7 mRNA	PMID:37236586
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of THOC7 mRNA	PMID:19549813
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313524	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of THOC7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of THOC7 mRNA	PMID:34911549
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of THOC7 mRNA	PMID:33387578
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313524	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of THOC7 mRNA	PMID:40504410
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of THOC7 mRNA	PMID:39836092
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of THOC7 mRNA	PMID:28001369
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of THOC7 mRNA	PMID:33212167
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of THOC7 mRNA	PMID:38568856
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313524	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of THOC7 mRNA	PMID:40504410
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of THOC7 mRNA	PMID:39836092
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602206	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of THOC7 promoter	PMID:27901495
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to THOC7 mRNA]	PMID:32406909
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of THOC7 mRNA	PMID:25729387
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313524	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of THOC7 gene; titanium dioxide results in decreased methylation of THOC7 promoter	PMID:35295148
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313524	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of THOC7 promoter	PMID:35295148
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313524	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of THOC7 mRNA	PMID:23811191
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of THOC7 mRNA	PMID:34947998
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of THOC7 mRNA	PMID:29275510
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of THOC7 protein	PMID:33376534
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313524	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of THOC7 mRNA	PMID:39298647
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of THOC7 mRNA	PMID:28628672
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of THOC7 mRNA	PMID:28628672
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313524	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of THOC7 mRNA	PMID:34813904
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313524	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of THOC7 mRNA	PMID:37236586
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1602206	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of THOC7 mRNA	PMID:25812627
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1602206	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of THOC7 mRNA	PMID:25812627
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of THOC7 mRNA	PMID:28628672
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of THOC7 mRNA	PMID:21420995
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313524	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of THOC7 mRNA	PMID:40504410
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of THOC7 mRNA	PMID:39836092
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313524	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of THOC7 mRNA	PMID:35436446
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of THOC7 mRNA	PMID:28628672
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of THOC7 mRNA	PMID:24136188
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of THOC7 mRNA	PMID:21983209
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313524	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of THOC7 mRNA	PMID:23608068
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of THOC7 mRNA	PMID:25729387
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313524	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of THOC7 mRNA	PMID:22206623
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1602206	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of THOC7 protein	PMID:31285264
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of THOC7 mRNA	PMID:30928695
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602206	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to THOC7 gene]	PMID:28238834
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1602206	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of THOC7 mRNA	PMID:39904859
1305475	Thoc7	THO complex subunit 7	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of THOC7 mRNA	PMID:23555832
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313525	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of MKI67 mRNA; deoxynivalenol results in increased expression of MKI67 protein	PMID:31863870|PMID:39638853
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C007262	deoxynivalenol results in increased expression of MKI67 protein	PMID:32416088
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:10022	deoxynivalenol	increases phosphorylation	ISO	RGD:1313526	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased phosphorylation of MKI67 protein	PMID:23352502|PMID:23811945
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C007262	Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of MKI67 protein]	PMID:32416088
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:10043	wogonin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20200915	CTD	MESH:C085514	wogonin results in decreased expression of MKI67 protein	PMID:32671444
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1313525	E	RGD:6480464	20180116	CTD	MESH:D015025	Zearalenone results in increased expression of MKI67 mRNA	PMID:28965971
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:10335	2,2':5',2''-terthiophene	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20230905	CTD	MESH:C019101	alpha-terthienyl results in decreased expression of MKI67 mRNA	PMID:35691152
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:113532	thymoquinone	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in decreased expression of MKI67 protein	PMID:31298468
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:131518	N,N-bis(2-hydroxypropyl)nitrosamine	multiple interactions	EXP		E	RGD:6480464	20160405	CTD	MESH:C012457	[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein; [Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein; Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Indomethacin inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]; nimesulide inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]	PMID:19497425|PMID:22387750
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MKI67 protein	PMID:21041383
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MKI67 mRNA	PMID:33045310
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:132446	perfluorobutanesulfonic acid	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20260203	CTD	MESH:C539348	[perfluorobutanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in increased expression of MKI67 protein	PMID:40334771
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:132448	perfluorohexanesulfonic acid	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20240806	CTD	MESH:C471071	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in increased expression of MKI67 protein	PMID:38603627
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20230704	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:35861251
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:31884101|PMID:39752319
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:133246	tetramethylpyrazine	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20250114	CTD	MESH:C017953	[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of MKI67 protein	PMID:39486648
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:134609	nitrosobis(2-oxopropyl)amine	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C013622	nitrosobis(2-oxopropyl)amine results in increased expression of MKI67 protein	PMID:29877212
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:134689	rucaparib	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20200211	CTD	MESH:C531549	[Irinotecan co-treated with rucaparib] results in decreased expression of MKI67 protein	PMID:30612311
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:134716	brexpiprazole	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240109	CTD	MESH:C000591922	brexpiprazole results in decreased expression of MKI67 protein	PMID:37347510
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:135632	camostat	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C034532	camostat results in increased expression of MKI67 protein	PMID:25104499
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:135632	camostat	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C034532	mirdametinib inhibits the reaction [camostat results in increased expression of MKI67 protein]	PMID:25104499
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:138236	oridonin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20200519	CTD	MESH:C011959	oridonin analog results in decreased expression of MKI67 protein	PMID:31594861
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:145994	remdesivir	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20220809	CTD	MESH:C000606551	remdesivir results in decreased expression of MKI67 protein	PMID:35417658
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA	PMID:20938992|PMID:33549593
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:D001241	Aspirin results in increased expression of MKI67 protein	PMID:38563870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	EXP		E	RGD:6480464	20180410	CTD	MESH:D001241	Aspirin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Aspirin inhibits the reaction [Tartrazine results in increased expression of MKI67 mRNA]	PMID:29031619|PMID:31032366
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MKI67 mRNA; Tretinoin results in decreased expression of MKI67 protein	PMID:16249480|PMID:16461808|PMID:33167477
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of MKI67 protein]	PMID:21964460
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MKI67 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MKI67 mRNA	PMID:32699268
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313526	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MKI67 mRNA	PMID:22629407|PMID:24205000
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MKI67 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MKI67 mRNA	PMID:33729688
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MKI67 mRNA]	PMID:22629407
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15571	hydrazine	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C029424	hydrazine results in increased expression of MKI67 protein	PMID:37527026
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MKI67 mRNA	PMID:26079696
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	ISO	RGD:1313525	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of MKI67 protein	PMID:28073184
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15864	luteolin	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20260407	CTD	MESH:D047311	[CB-5083 co-treated with Luteolin] results in decreased expression of MKI67 protein	PMID:40194745
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20211109	CTD	MESH:D001280	Atrazine results in decreased expression of MKI67 mRNA	PMID:34146662
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D001280	[Atrazine co-treated with Arsenates] results in increased expression of MKI67 mRNA	PMID:18585445
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:15948	lycopene	multiple interactions	EXP		E	RGD:6480464	20210504	CTD	MESH:C015329	Lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of MKI67 protein]	PMID:33592256
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16037	2-nitropropane	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C016617	2-nitropropane results in increased expression of MKI67 protein	PMID:37527026
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16113	cholesterol	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20221101	CTD	MESH:D002784	[[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with Silver Compounds] results in decreased expression of MKI67 protein; [[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with Silver Compounds] results in increased expression of MKI67 mRNA; [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the expression of MKI67 mRNA; [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [Silver Compounds affects the expression of MKI67 mRNA]; [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [Silver Compounds results in decreased expression of MKI67 protein]; [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] results in increased expression of MKI67 protein; [EGF protein co-treated with [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]]] inhibits the reaction [[EGF protein co-treated with Silver Compounds] results in decreased expression of MKI67 protein]	PMID:35385781
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D000431	Ethanol results in decreased expression of MKI67 protein	PMID:17067360|PMID:26188107|PMID:29548890|PMID:31226463
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20190910	CTD	MESH:D000431	Ethanol results in decreased expression of MKI67 protein	PMID:31226463
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D000431	Ethanol results in increased expression of MKI67 protein	PMID:29769550
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20190910	CTD	MESH:D000431	IGF1 protein inhibits the reaction [Ethanol results in decreased expression of MKI67 protein]	PMID:31226463
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:D000431	Ethanol promotes the reaction [4-Nitroquinoline-1-oxide results in increased expression of MKI67 protein]	PMID:37406968
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16243	quercetin	affects phosphorylation	ISO	RGD:1313525	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin affects the phosphorylation of MKI67 protein	PMID:35688186
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of MKI67 protein	PMID:15067354
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D011794	[Cisplatin co-treated with Quercetin] results in decreased expression of MKI67 protein; [Quercetin co-treated with Ascorbic Acid] results in increased expression of MKI67 mRNA	PMID:16082193|PMID:17639512
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin promotes the reaction [Tamoxifen results in decreased expression of MKI67 protein]	PMID:15067354
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16335	adenosine	affects expression	ISO	RGD:1313525	E	RGD:6480464	20231205	CTD	MESH:D000241	Adenosine affects the expression of MKI67 mRNA	PMID:34070360
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16335	adenosine	increases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D000241	Adenosine results in increased expression of MKI67 protein	PMID:19638569
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16348	3-nitropropanoic acid	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C015392	3-nitropropionic acid results in decreased expression of MKI67 protein	PMID:21827787
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MKI67 mRNA	PMID:39241906
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of MKI67 mRNA	PMID:30510588
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:164200	triclosan	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250708	CTD	MESH:D014260	Triclosan inhibits the reaction [beta-Naphthoflavone results in increased expression of MKI67 mRNA]; Triclosan promotes the reaction [alpha-naphthoflavone results in increased expression of MKI67 mRNA]	PMID:39653182
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MKI67 mRNA	PMID:32145629
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MKI67 mRNA	PMID:39298647
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004958	Estradiol results in increased expression of MKI67 mRNA; Estradiol results in increased expression of MKI67 protein	PMID:16607101|PMID:20381596|PMID:23288143|PMID:26372666|PMID:26945725|PMID:31119341
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313525	E	RGD:6480464	20161025	CTD	MESH:D004958	Estradiol results in increased expression of MKI67 mRNA	PMID:18310284|PMID:19167446|PMID:27260121|PMID:28965971
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:D004958	Estradiol deficiency results in increased expression of MKI67 protein; Estradiol results in increased expression of MKI67 protein	PMID:15845746|PMID:19654927|PMID:21484412
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MKI67 mRNA; [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MKI67 protein; Isoflavones inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 protein]; Plant Preparations inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]]	PMID:16891317|PMID:20381596|PMID:23288143|PMID:26372666|PMID:26945725|PMID:32741896
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161025	CTD	MESH:D004958	[Arsenic co-treated with Estradiol] results in increased expression of MKI67 mRNA; Fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]	PMID:27260121|PMID:33047385
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:D004958	fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 protein]; Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]]; Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]; SOD2 protein affects the reaction [Estradiol deficiency results in increased expression of MKI67 protein]	PMID:15845746|PMID:19654927|PMID:21484412
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:165199	Paraoxon-methyl	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20201208	CTD	MESH:C008480	methylparaoxon results in decreased expression of MKI67 protein	PMID:18418871
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA	PMID:25510870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313525	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MKI67 mRNA	PMID:38568856
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MKI67 mRNA	PMID:33387578
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased expression of MKI67 mRNA	PMID:25549359|PMID:27618143
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA	PMID:20938992|PMID:33549593
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20121113	CTD	MESH:D001554	Benzene results in decreased expression of MKI67 mRNA	PMID:21843810
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260203	CTD	MESH:D001554	Benzene results in decreased expression of MKI67 protein	PMID:40885242
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:167830	isorhapontigenin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240430	CTD	MESH:C432307	isorhapontigenin results in decreased expression of MKI67 protein	PMID:37619952
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16796	melatonin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20121113	CTD	MESH:D008550	Melatonin results in decreased expression of MKI67 mRNA; Melatonin results in decreased expression of MKI67 protein	PMID:21062352
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16796	melatonin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008550	Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]; Melatonin inhibits the reaction [Cyclophosphamide results in decreased expression of MKI67 protein]	PMID:19028472|PMID:36154502
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16907	4-nitroquinoline N-oxide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:D015112	4-Nitroquinoline-1-oxide results in increased expression of MKI67 protein	PMID:37406968
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:16907	4-nitroquinoline N-oxide	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:D015112	Ethanol promotes the reaction [4-Nitroquinoline-1-oxide results in increased expression of MKI67 protein]	PMID:37406968
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of MKI67 mRNA; Progesterone affects the expression of MKI67 protein	PMID:17251523|PMID:22238285
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of MKI67 mRNA	PMID:16966611
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of MKI67 mRNA	PMID:16888808
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Estrogens co-treated with Progesterone] results in increased expression of MKI67 protein	PMID:16800253
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20200609	CTD	MESH:D011374	Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]; Lead inhibits the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]	PMID:32004626
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D011374	Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]]; Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]	PMID:15845746
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of MKI67 mRNA	PMID:26079696
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17234	glucose	affects expression	ISO	RGD:1313525	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose affects the expression of MKI67 protein	PMID:39613055
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of MKI67 mRNA	PMID:39613055
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of MKI67 protein	PMID:40638403
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20151013	CTD	MESH:D005947	[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]	PMID:25192544
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA; alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]; imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]	PMID:37567420|PMID:37992649|PMID:40638403
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17241	1H-pyrazole	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:C031280	pyrazole results in decreased expression of MKI67 protein	PMID:33737021
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313525	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of MKI67 protein	PMID:36314267
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20230704	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:35861251
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:31884101|PMID:39752319
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17276	phloretin	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:D010693	[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]	PMID:34896434
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17296	aniline	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C023650	aniline results in increased expression of MKI67 protein	PMID:21070798
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17315	D-glucosamine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of MKI67 mRNA	PMID:17109745
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MKI67 mRNA	PMID:21592394
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MKI67 mRNA	PMID:32741896
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MKI67 mRNA	PMID:21592394
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17356	2-acetamidofluorene	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of MKI67 protein	PMID:15565650|PMID:23665045|PMID:26338220
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of MKI67 mRNA	PMID:17317680
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17356	2-acetamidofluorene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015073	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein]; Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]	PMID:15565650|PMID:17393424|PMID:23665045
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17439	cyanocob(III)alamin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:D014805	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA	PMID:33549593
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:174442	Carbadox	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D002218	Carbadox results in decreased expression of MKI67 protein	PMID:26558467
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of MKI67 mRNA	PMID:27683099
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20190611	CTD	MESH:C007836	geraniol results in decreased expression of MKI67 protein	PMID:26154255
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17509	5'-S-methyl-5'-thioadenosine	decreases expression	ISO	RGD:1313526	E	RGD:153297773|PMID:21209952	20220726	RGD	MESH:C008500	5'-S-methyl-5'-thioadenosine decreases expression of Ki-67 protein in Mdr2-/- mouse liver	
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:175111	Berberrubine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240402	CTD	MESH:C115958	berberrubine inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein]	PMID:37871880
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17574	biochanin A	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240702	CTD	MESH:C004541	biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of MKI67 protein]	PMID:38648921
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17579	beta-carotene	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D019207	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:175901	gemcitabine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240109	CTD	MESH:C056507	Gemcitabine results in decreased expression of MKI67 protein	PMID:38000456
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:175901	gemcitabine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230207	CTD	MESH:C056507	[Curcumin co-treated with Gemcitabine] results in decreased expression of MKI67 protein	PMID:17440100
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17634	D-glucose	affects expression	ISO	RGD:1313525	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose affects the expression of MKI67 protein	PMID:39613055
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of MKI67 mRNA	PMID:39613055
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of MKI67 protein	PMID:40638403
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20151013	CTD	MESH:D005947	[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]	PMID:25192544
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA; alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]; imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]	PMID:37567420|PMID:37992649|PMID:40638403
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D009538	Nicotine results in decreased expression of MKI67 protein	PMID:30959089
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D009538	Nicotine results in increased expression of MKI67 protein	PMID:31678612
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D009538	[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein; Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]; methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]	PMID:29501575
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230801	CTD	MESH:D009538	[Nicotine co-treated with Quartz] results in increased expression of MKI67 protein	PMID:36868510
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1313526	E	RGD:6480464	20230801	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of MKI67 mRNA	PMID:37059381
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MKI67 protein	PMID:37258237
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MKI67 mRNA; Diethylhexyl Phthalate results in decreased expression of MKI67 protein	PMID:33754040|PMID:34492810|PMID:35716406|PMID:36209858
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313526	E	RGD:6480464	20140513	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MKI67 mRNA; Diethylhexyl Phthalate results in increased expression of MKI67 protein	PMID:24496636|PMID:34319233|PMID:37406783
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17750	glycine betaine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:D001622	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA	PMID:33549593
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:177631	Ulipristal	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C094854	ulipristal results in decreased expression of MKI67 protein	PMID:38458359
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MKI67 mRNA	PMID:26577399
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313525	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MKI67 protein	PMID:37730182
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MKI67 mRNA; Calcitriol results in decreased expression of MKI67 protein	PMID:21592394|PMID:8950452
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MKI67 mRNA	PMID:21592394
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17948	(+)-taxifolin	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:C003377	Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]; taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]; taxifolin promotes the reaction [Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]	PMID:35465754
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17967	urethane	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D014520	Urethane affects the expression of MKI67 protein	PMID:15790490
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17967	urethane	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D014520	CYP2E1 gene mutant form inhibits the reaction [Urethane affects the expression of MKI67 protein]	PMID:15790490
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:17992	sucrose	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240109	CTD	MESH:D013395	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of MKI67 mRNA]; [Sucrose co-treated with Dietary Fats] results in increased expression of MKI67 mRNA	PMID:37516258
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18135	catechol	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C034221	catechol results in decreased expression of MKI67 protein	PMID:23535288
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18135	catechol	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C034221	catechol results in increased expression of MKI67 protein	PMID:23535288
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:181416	Leucomalachite green	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C015320	leucomalachite green results in decreased expression of MKI67 protein	PMID:26558467
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D024502	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1313526	E	RGD:6480464	20180116	CTD	MESH:D014284	Triiodothyronine results in increased expression of MKI67 mRNA	PMID:28315333
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20180116	CTD	MESH:D014284	U 0126 inhibits the reaction [Triiodothyronine results in increased expression of MKI67 mRNA]	PMID:28315333
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MKI67 mRNA	PMID:39836092
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of MKI67 mRNA	PMID:17103032
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:183735	Nitrosoheptamethyleneimine	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C002148	N-nitrosoheptamethyleneimine results in increased expression of MKI67 protein	PMID:37527026
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D009538	Nicotine results in decreased expression of MKI67 protein	PMID:30959089
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D009538	Nicotine results in increased expression of MKI67 protein	PMID:31678612
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D009538	[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein; Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]; methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]	PMID:29501575
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230801	CTD	MESH:D009538	[Nicotine co-treated with Quartz] results in increased expression of MKI67 protein	PMID:36868510
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:188855	Octicizer	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20221004	CTD	MESH:C018535	2-ethylhexyldiphenylphosphate results in decreased expression of MKI67 protein	PMID:35503735
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:188855	Octicizer	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20221004	CTD	MESH:C018535	2-ethylhexyldiphenylphosphate results in decreased expression of MKI67 protein	PMID:35503735
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:18917	1,3-dichloropropan-2-ol	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C033489	1,3-dichloro-2-propanol results in increased expression of MKI67 protein	PMID:34269859
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:189471	pseudolaric acid B	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240109	CTD	MESH:C058391	pseudolaric acid B results in decreased expression of MKI67 protein	PMID:37244295
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:199329	Inotodiol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20250114	CTD	MESH:C517091	inotodiol results in decreased expression of MKI67 mRNA	PMID:21359924
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2038	5-azacytidine	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D001374	[Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA	PMID:18720364
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of MKI67 mRNA	PMID:27462272
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:205919	clobetasol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260602	CTD	MESH:D002990	[Clobetasol co-treated with calcipotriene] inhibits the reaction [Imiquimod results in increased expression of MKI67 protein]	PMID:40568777
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of MKI67 mRNA	PMID:17109745
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of MKI67 protein	PMID:38563870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:22542	androstane-3,17-dione	increases expression	ISO	RGD:1313525	E	RGD:6480464	20250204	CTD	MESH:C006576	androstane-3,17-dione results in increased expression of MKI67 protein	PMID:38122923
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:22542	androstane-3,17-dione	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20250204	CTD	MESH:C006576	apalutamide inhibits the reaction [androstane-3,17-dione results in increased expression of MKI67 protein]	PMID:38122923
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:22718	benzoates	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in decreased expression of MKI67 protein	PMID:29472718
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of MKI67 mRNA	PMID:21120746
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:D002104	Cadmium results in increased expression of MKI67 protein	PMID:38563870|PMID:39892737
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 protein; Grape Seed Extract inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 protein]	PMID:26935153
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20181016	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of MKI67 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 mRNA	PMID:29741670|PMID:36671501
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:23115	chlorohydrocarbon	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210406	CTD	MESH:D006843	[Hydrocarbons, Fluorinated co-treated with Hydrocarbons, Brominated co-treated with Hydrocarbons, Chlorinated] results in increased expression of MKI67 protein	PMID:33333158
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:231344	talazoparib	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20251007	CTD	MESH:C586365	[talazoparib co-treated with darinaparsin] results in decreased expression of MKI67 protein	PMID:36253561
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:232159	silmitasertib	increases expression	ISO	RGD:1313525	E	RGD:6480464	20241119	CTD	MESH:C555142	silmitasertib results in increased expression of MKI67 protein	PMID:25798061
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:232521	CB-5083	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20260407	CTD	MESH:C000606272	[CB-5083 co-treated with Luteolin] results in decreased expression of MKI67 protein	PMID:40194745
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:232612	Azoxymethane	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:D001397	Azoxymethane results in increased expression of MKI67 protein	PMID:38563870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:232612	Azoxymethane	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:D001397	[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]	PMID:19028472
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241203	CTD	MESH:D001397	[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein; berberrubine inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein]; sinpeinine A inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]	PMID:34273909|PMID:37871880|PMID:39551424
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA	PMID:25510870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA	PMID:25510870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:233362	Abemaciclib	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20250408	CTD	MESH:C000590451	abemaciclib results in decreased expression of MKI67 protein	PMID:28620137
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:233362	Abemaciclib	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20250408	CTD	MESH:C000590451	RB1 protein affects the reaction [abemaciclib results in decreased expression of MKI67 protein]	PMID:28620137
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1313525	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of MKI67 mRNA	PMID:19549813
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:234265	SHP099	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20250610	CTD	MESH:C000609471	SHP099 results in decreased expression of MKI67 protein	PMID:32417439
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:234265	SHP099	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20250610	CTD	MESH:C000609471	SHP099 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in decreased expression of MKI67 protein]	PMID:32417439
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:23480	cyclohexanols	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D003511	[Diethylnitrosamine co-treated with Cyclohexanols] results in increased expression of MKI67 protein	PMID:17393424
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MKI67 protein	PMID:23301498
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:25036	lignan	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20170124	CTD	MESH:D017705	Lignans results in decreased expression of MKI67 protein	PMID:15897583
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MKI67 protein	PMID:20106945
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MKI67 mRNA	PMID:21641981
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MKI67 mRNA	PMID:19770486
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MKI67 mRNA	PMID:25378103
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313525	E	RGD:6480464	20250603	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MKI67 protein	PMID:39638853
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313525	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MKI67 mRNA	PMID:23649840
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein	PMID:34896434|PMID:39214269
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015127	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]; [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MKI67 protein; [Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]]; Plant Preparations inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]]	PMID:16891317|PMID:26945725|PMID:34896434|PMID:39214269
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of MKI67 mRNA	PMID:24336422
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313526	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of MKI67 protein	PMID:33026818
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MKI67 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MKI67 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MKI67 mRNA	PMID:32699268
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MKI67 mRNA; [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MKI67 protein; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MKI67 mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of MKI67 mRNA; TTPA protein affects the reaction [Ozone results in increased expression of MKI67 mRNA]	PMID:19555225|PMID:25658374|PMID:27106289|PMID:34911549
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2676	amoxicillin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20231205	CTD	MESH:D000658	Amoxicillin results in decreased expression of MKI67 mRNA; Amoxicillin results in decreased expression of MKI67 protein	PMID:36529298
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2704	anastrozole	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20161213	CTD	MESH:C090450	anastrozole results in decreased expression of MKI67 protein	PMID:15767642|PMID:16002280
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2704	anastrozole	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161213	CTD	MESH:C090450	[Tamoxifen co-treated with anastrozole] results in decreased expression of MKI67 protein	PMID:15767642
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27086	tributylstannane	decreases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:C011559	tributyltin results in decreased expression of MKI67 protein	PMID:32783468
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:C011559	Fatty Acids, Omega-3 inhibits the reaction [tributyltin results in decreased expression of MKI67 protein]	PMID:32783468
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D015032	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA	PMID:33549593
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MKI67 mRNA	PMID:17484886
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MKI67 mRNA	PMID:31150632
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MKI67 protein	PMID:16325526
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MKI67 mRNA; Carbon Tetrachloride results in increased expression of MKI67 protein	PMID:27339419|PMID:29987408|PMID:31816328|PMID:36526012|PMID:38992766
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20181016	CTD	MESH:D002251	[calcipotriene co-treated with Carbon Tetrachloride] results in increased expression of MKI67 mRNA; ATM protein inhibits the reaction [Carbon Tetrachloride results in increased expression of MKI67 protein]; GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of MKI67 protein]; PANX1 protein affects the reaction [Carbon Tetrachloride results in increased expression of MKI67 mRNA]; Verteporfin inhibits the reaction [[calcipotriene co-treated with Carbon Tetrachloride] results in increased expression of MKI67 mRNA]; Verteporfin inhibits the reaction [Carbon Tetrachloride results in increased expression of MKI67 mRNA]	PMID:29987408|PMID:31816328|PMID:36526012|PMID:38992766
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27470	folic acid	affects expression	ISO	RGD:1313525	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid affects the expression of MKI67 protein	PMID:21349824
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA	PMID:20938992|PMID:33549593
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210907	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [Arsenic co-treated with Estradiol] results in increased expression of MKI67 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of MKI67 protein; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of MKI67 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKI67 mRNA	PMID:33047385|PMID:35809665|PMID:39836092
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MKI67 mRNA	PMID:40504410
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1313525	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of MKI67 mRNA	PMID:33512557
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27698	vanadium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014639	Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]	PMID:15565650
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313525	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MKI67 protein	PMID:35688186
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002110	Caffeine results in decreased expression of MKI67 protein	PMID:30528684
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27732	caffeine	multiple interactions	EXP		E	RGD:6480464	20160119	CTD	MESH:D002110	Caffeine inhibits the reaction [aluminum chloride results in decreased expression of MKI67 protein]	PMID:26339337
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of MKI67 protein	PMID:27486271
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA	PMID:37567420|PMID:37992649
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MKI67 mRNA	PMID:28189721|PMID:28960355
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27812	Se-methyl-L-selenocysteine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:C002979	selenomethylselenocysteine results in decreased expression of MKI67 protein	PMID:18855134
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27812	Se-methyl-L-selenocysteine	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:C002979	[selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein	PMID:18855134
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MKI67 mRNA; acetamide results in increased expression of MKI67 protein	PMID:31881176
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20121218	CTD	MESH:C059514	Resveratrol results in decreased expression of MKI67; Resveratrol results in decreased expression of MKI67 mRNA; Resveratrol results in decreased expression of MKI67 protein	PMID:15767336|PMID:17992120|PMID:21209944|PMID:21291235|PMID:24604232
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of MKI67 protein	PMID:25505154
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313525	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MKI67 mRNA	PMID:15149879
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313526	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MKI67 protein	PMID:22086758
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C059514	Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in decreased expression of MKI67 protein]]	PMID:33978298|PMID:35236239
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20130122	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of MKI67 protein; [Coumestrol co-treated with Resveratrol] results in increased expression of MKI67 mRNA; Resveratrol results in decreased expression of and affects the localization of MKI67 protein; SIRT1 protein affects the reaction [Resveratrol results in decreased expression of MKI67 protein]	PMID:19167446|PMID:26959057|PMID:41028656
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313525	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MKI67 mRNA	PMID:28903495
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20200609	CTD	MESH:D007854	Lead results in decreased expression of MKI67 protein	PMID:32004626
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:D007854	Lead results in increased expression of MKI67 protein	PMID:38563870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27889	lead(0)	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein]	PMID:33978298
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20200609	CTD	MESH:D007854	Lead inhibits the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]	PMID:32004626
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of MKI67 mRNA; Cisplatin results in decreased expression of MKI67 protein	PMID:27594783|PMID:39461470
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of MKI67 mRNA	PMID:40618947
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of MKI67 protein	PMID:20702592
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of MKI67 protein	PMID:22006019
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161213	CTD	MESH:D002945	[Cisplatin co-treated with Quercetin] results in decreased expression of MKI67 protein; Cisplatin promotes the reaction [selenocystine results in decreased expression of MKI67 protein]; selenocystine promotes the reaction [Cisplatin results in decreased expression of MKI67 protein]	PMID:16082193|PMID:39461470
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of MKI67 protein	PMID:34813904
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MKI67 mRNA	PMID:30912803
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:27999	tolbutamide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014044	Tolbutamide results in decreased expression of MKI67 protein	PMID:16718685
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28077	rifampicin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D012293	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein	PMID:21224054
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:D019833	Genistein results in decreased expression of MKI67 mRNA	PMID:31593742
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D019833	Genistein results in increased expression of MKI67 mRNA	PMID:20381596
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D019833	Isoflavones inhibits the reaction [Genistein results in increased expression of MKI67 mRNA]	PMID:20381596
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313525	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MKI67 mRNA	PMID:25583101
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MKI67 mRNA	PMID:34747641
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313526	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MKI67 mRNA	PMID:18691609|PMID:26377647
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MKI67 mRNA	PMID:32109520|PMID:33387578
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MKI67 protein	PMID:32283119|PMID:39880321
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MKI67 mRNA	PMID:21846477
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in increased expression of MKI67 protein]	PMID:21846477
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28172	harmaline	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230404	CTD	MESH:D006246	Harmaline results in decreased expression of MKI67 protein	PMID:35963316
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1313525	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone affects the expression of MKI67 mRNA	PMID:33512557
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of MKI67 mRNA	PMID:28374803
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313525	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MKI67 mRNA	PMID:23179753|PMID:26272509
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MKI67 mRNA	PMID:27188386
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of MKI67 mRNA	PMID:17109745
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28445	vincristine	increases response to substance	ISO	RGD:1313525	E	RGD:6480464	20161213	CTD	MESH:D014750	MKI67 gene SNP results in increased susceptibility to Vincristine	PMID:20864405
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28509	chloroethene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240604	CTD	MESH:D014752	[Vinyl Chloride co-treated with Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of MKI67 protein	PMID:37061008
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28553	selenocystine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20241203	CTD	MESH:C009226	selenocystine results in decreased expression of MKI67 protein	PMID:39461470
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28553	selenocystine	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20241203	CTD	MESH:C009226	Cisplatin promotes the reaction [selenocystine results in decreased expression of MKI67 protein]; selenocystine promotes the reaction [Cisplatin results in decreased expression of MKI67 protein]	PMID:39461470
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120717	CTD	MESH:D020106	Acrylamide results in decreased expression of MKI67 mRNA; Acrylamide results in decreased expression of MKI67 protein	PMID:20734998|PMID:32763439
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MKI67 mRNA	PMID:28959563
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20200609	CTD	MESH:D003300	Copper results in decreased expression of MKI67 protein	PMID:32004626
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20150512	CTD	MESH:D003300	Copper deficiency results in decreased expression of MKI67 protein	PMID:24013775
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of MKI67 mRNA	PMID:30556269
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1313525	E	RGD:6480464	20240402	CTD	MESH:D003300	Copper results in increased expression of MKI67 protein	PMID:35809665
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]	PMID:19497425
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of MKI67 protein; [Copper co-treated with Resveratrol] results in decreased expression of MKI67 protein; [NSC 689534 binds to Copper] which results in decreased expression of MKI67 mRNA; Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]	PMID:20971185|PMID:32004626|PMID:35809665|PMID:41028656
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of MKI67 mRNA	PMID:15205334|PMID:29803840|PMID:30031762
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004317	Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]]	PMID:39214269
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D004317	[zoledronic acid co-treated with Doxorubicin] results in decreased expression of MKI67 protein; Doxorubicin promotes the reaction [palbociclib results in decreased expression of MKI67 protein]	PMID:18695136|PMID:22751436
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:D004317	Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]]	PMID:30482226
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA	PMID:37567420|PMID:37992649
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1313525	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of MKI67 protein	PMID:35688186
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240109	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of MKI67 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein	PMID:37516258|PMID:37992649
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20191210	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [1,12-benzoperylene results in increased expression of MKI67 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of MKI67 protein]	PMID:31518672|PMID:32745510
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:28946	theobromine	multiple interactions	EXP		E	RGD:127229954|PMID:33360052	20210607	RGD	MESH:D013805	[Theobromine co-treated with Theanine] inhibits the reaction [1,2-dimethylhydrazine increases expression Mki67 protein in the colon]	
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1313525	E	RGD:6480464	20231205	CTD	MESH:C058120	cordycepin results in increased expression of MKI67 mRNA	PMID:34070360
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29014	cordycepin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230704	CTD	MESH:C058120	cordycepin inhibits the reaction [FGF9 protein results in increased expression of MKI67 protein]	PMID:33172093
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29019	nonanoic acid	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:C008776	pelargonic acid affects the expression of MKI67 mRNA	PMID:22302311
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29073	L-ascorbic acid	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240702	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of MKI67 protein	PMID:38160894
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D001205	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D001205	[Quercetin co-treated with Ascorbic Acid] results in increased expression of MKI67 mRNA; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of MKI67 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]	PMID:17639512|PMID:38160894
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of MKI67 mRNA	PMID:36057382
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which results in increased expression of MKI67 mRNA	PMID:28433809
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of MKI67 mRNA	PMID:22623647
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:2955	azithromycin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240109	CTD	MESH:D017963	Azithromycin results in decreased expression of MKI67 mRNA	PMID:37995777|PMID:39890031
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313525	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of MKI67 mRNA	PMID:34032870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MKI67 protein	PMID:21964460
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MKI67 mRNA	PMID:38072110|PMID:38568856
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of MKI67 protein	PMID:38977090
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313525	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of MKI67 mRNA	PMID:29301061|PMID:39719251
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of MKI67 protein	PMID:37668303
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of MKI67 protein]; sodium arsenite promotes the reaction [Methylnitrosourea results in increased expression of MKI67 protein]; Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of MKI67 protein]	PMID:21964460|PMID:38977090
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKI67 mRNA	PMID:39836092
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MKI67 mRNA	PMID:40504410
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MKI67 mRNA	PMID:22378314
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MKI67 mRNA	PMID:17942131|PMID:19770486|PMID:21569818
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MKI67 mRNA	PMID:20713471|PMID:32417428
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20170516	CTD	MESH:D001564	[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA	PMID:27858113|PMID:38237855
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:C015001	arsenite results in increased expression of MKI67 protein	PMID:38563870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MKI67 mRNA]	PMID:32406909
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of MKI67 mRNA	PMID:36057382
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which results in increased expression of MKI67 mRNA	PMID:28433809
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20200609	CTD	MESH:D003300	Copper results in decreased expression of MKI67 protein	PMID:32004626
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20150512	CTD	MESH:D003300	Copper deficiency results in decreased expression of MKI67 protein	PMID:24013775
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of MKI67 mRNA	PMID:30556269
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1313525	E	RGD:6480464	20240402	CTD	MESH:D003300	Copper results in increased expression of MKI67 protein	PMID:35809665
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]	PMID:19497425
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of MKI67 protein; [Copper co-treated with Resveratrol] results in decreased expression of MKI67 protein; [NSC 689534 binds to Copper] which results in decreased expression of MKI67 mRNA; Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]	PMID:20971185|PMID:32004626|PMID:35809665|PMID:41028656
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30145	lithium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of MKI67 mRNA	PMID:21711903
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30146	lithium hydride	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of MKI67 mRNA	PMID:21711903
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D015032	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA	PMID:33549593
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MKI67 mRNA	PMID:27131904
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30537	triphenylstannane	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C030665	triphenyltin results in decreased expression of MKI67 mRNA; triphenyltin results in decreased expression of MKI67 protein	PMID:35489455
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20220510	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MKI67 protein	PMID:35288261
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MKI67 mRNA	PMID:29341224
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MKI67 mRNA	PMID:20382639
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MKI67 mRNA; Arsenic Trioxide results in decreased expression of MKI67 protein	PMID:27318970|PMID:30091188|PMID:38160894
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MKI67 protein	PMID:31421153
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20191114	CTD	MESH:C006632	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of MKI67 mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of MKI67 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]	PMID:27318970|PMID:38160894
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200114	CTD	MESH:C006632	FOXO3 protein affects the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]	PMID:31421153
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30682	ruthenium atom	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:D012428	[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]	PMID:34896434
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:30772	butyric acid	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241105	CTD	MESH:D020148	Butyric Acid promotes the reaction [erastin results in decreased expression of MKI67 protein]	PMID:37341073
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3086	betulin	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20190910	CTD	MESH:C002503	[Gefitinib co-treated with betulin] results in decreased expression of MKI67 protein	PMID:27447558
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3090	bicalutamide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in decreased expression of MKI67 mRNA	PMID:15638997
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:310312	isoliquiritigenin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20170516	CTD	MESH:C040920	isoliquiritigenin results in decreased expression of MKI67 mRNA; isoliquiritigenin results in decreased expression of MKI67 protein	PMID:27702603
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:31355	carboplatin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230606	CTD	MESH:D016190	Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Carboplatin promotes the reaction [Pulsatilla saponin A inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]]; Pulsatilla saponin A promotes the reaction [Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]]	PMID:33190582
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3139	bleomycin A2	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260113	CTD	MESH:D001761	Bleomycin results in decreased expression of MKI67 mRNA	PMID:40645554
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161025	CTD	MESH:C070081	fulvestrant inhibits the reaction [bisphenol A results in decreased expression of MKI67 mRNA]; fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; fulvestrant inhibits the reaction [nonylphenol results in increased expression of MKI67 mRNA]	PMID:27260121|PMID:28701262
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:C070081	fulvestrant inhibits the reaction [1,7-diphenyl-5-heptene-3-one results in increased expression of MKI67 protein]; fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 protein]	PMID:19654927
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:31695	indigo carmine	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:D007203	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein	PMID:24941295
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein]	PMID:33978298
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:31832	methyl salicylate	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:C033069	methyl salicylate affects the expression of MKI67 mRNA	PMID:22302311
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313525	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of MKI67 mRNA; methylparaben results in increased expression of MKI67 protein	PMID:31745603|PMID:35174924
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MKI67 mRNA	PMID:25729387
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MKI67 mRNA	PMID:25729387
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MKI67 protein	PMID:22387750|PMID:23535288
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32161	sulfadimethoxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013412	[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein; Indomethacin inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]; Indomethacin inhibits the reaction [Sulfadimethoxine results in increased expression of MKI67 protein]; nimesulide inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]	PMID:22387750
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of MKI67 mRNA	PMID:30012374
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313525	E	RGD:6480464	20200714	CTD	MESH:C009495	titanium dioxide results in increased expression of MKI67 mRNA	PMID:32224134
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MKI67 mRNA; titanium dioxide results in increased expression of MKI67 protein	PMID:23557971|PMID:29128614
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20150512	CTD	MESH:C009495	[Vitallium analog binds to titanium dioxide] which results in decreased expression of MKI67 mRNA	PMID:23825117
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32293	verteporfin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230307	CTD	MESH:C098350	Verteporfin inhibits the reaction [[calcipotriene co-treated with Carbon Tetrachloride] results in increased expression of MKI67 mRNA]; Verteporfin inhibits the reaction [Carbon Tetrachloride results in increased expression of MKI67 mRNA]; Verteporfin inhibits the reaction [perfluorooctanoic acid results in increased expression of MKI67 protein]	PMID:36152675|PMID:38992766
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32297	Vinpocetine	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:C013983	vinpocetine inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]	PMID:32840391
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D013853	Thioacetamide results in increased expression of MKI67 mRNA; Thioacetamide results in increased expression of MKI67 protein	PMID:23411599|PMID:26011634|PMID:26558467|PMID:32840391|PMID:34492290|PMID:37258237|PMID:39716576
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D013853	montelukast inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]; Trimetazidine inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]; vinpocetine inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]	PMID:32840391|PMID:39716576
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MKI67 mRNA	PMID:25380136
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of MKI67 mRNA	PMID:22484513|PMID:32741897
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313526	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MKI67 mRNA	PMID:17950772|PMID:23811191
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of MKI67 mRNA]	PMID:17950772
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of MKI67 mRNA	PMID:19191707
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	ISO	RGD:1313525	E	RGD:6480464	20121113	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MKI67 protein	PMID:21776270
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of MKI67 protein	PMID:38563870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MKI67 mRNA	PMID:38479592
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313525	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MKI67 mRNA	PMID:30903817
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MKI67 mRNA	PMID:23146694|PMID:25181051|PMID:30816183
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased expression of MKI67 mRNA	PMID:28701262|PMID:29275510
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in decreased expression of MKI67 protein	PMID:35278557
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MKI67 mRNA; bisphenol A results in increased expression of MKI67 protein	PMID:26877094|PMID:32145629|PMID:35465754
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313526	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased expression of MKI67 mRNA; bisphenol A results in increased expression of MKI67 protein	PMID:22875908
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:C006780	Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]; Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]; taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]; taxifolin promotes the reaction [Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]	PMID:35465754
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20180116	CTD	MESH:C006780	fulvestrant inhibits the reaction [bisphenol A results in decreased expression of MKI67 mRNA]	PMID:28701262
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241105	CTD	MESH:C006780	[ERBB2 protein results in increased susceptibility to bisphenol A] which results in increased expression of MKI67 protein	PMID:38892447
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3374	capsaicin	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D002211	Capsaicin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]	PMID:29155087
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313525	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MKI67 mRNA	PMID:25979313
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MKI67 mRNA	PMID:26682919
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA	PMID:25510870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA	PMID:25510870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of MKI67 mRNA	PMID:20713471
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D008748	Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 protein]	PMID:26372666
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3437	carteolol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240206	CTD	MESH:D002354	Carteolol results in decreased expression of MKI67 protein	PMID:37120125
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313526	E	RGD:6480464	20180828	CTD	MESH:C543008	bisphenol S affects the expression of MKI67 protein	PMID:29526645
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MKI67 mRNA	PMID:39298647|PMID:40203079
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313525	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S results in increased expression of MKI67 protein	PMID:31945527|PMID:38657712
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34421	4-Hydroxybenzophenone	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20221101	CTD	MESH:C024292	4-hydroxybenzophenone results in decreased expression of MKI67 protein	PMID:35476924
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34421	4-Hydroxybenzophenone	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20221101	CTD	MESH:C024292	CXCL1 protein promotes the reaction [4-hydroxybenzophenone results in decreased expression of MKI67 protein]	PMID:35476924
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34533	Amaranth	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:D000548	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein	PMID:24941295
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313525	E	RGD:6480464	20121113	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MKI67 protein	PMID:21776270
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MKI67 mRNA	PMID:26377693
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20170516	CTD	MESH:C006703	[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA	PMID:27858113|PMID:38237855
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20220607	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of MKI67 protein	PMID:35182551
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1313525	E	RGD:6480464	20191210	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of MKI67 protein	PMID:31518672
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34568	Benzo[ghi]perylene	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20191210	CTD	MESH:C006718	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [1,12-benzoperylene results in decreased expression of MKI67 protein]; Acetylcysteine inhibits the reaction [1,12-benzoperylene results in increased expression of MKI67 protein]	PMID:31518672|PMID:35182551
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230404	CTD	MESH:C008745	bisphenol F results in decreased expression of MKI67 protein	PMID:35278557
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240702	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of MKI67 protein	PMID:38648921
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34674	dextran sulfate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016264	[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]	PMID:19028472
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20220308	CTD	MESH:D016264	[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein; berberrubine inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein]; biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of MKI67 protein]; sinpeinine A inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]	PMID:34273909|PMID:37871880|PMID:38648921|PMID:39551424
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of MKI67 mRNA	PMID:22546817
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MKI67 mRNA	PMID:21266533|PMID:31050326
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MKI67 protein	PMID:16916955
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of MKI67 mRNA	PMID:22546817
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1313525	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to MKI67 protein	PMID:32991956
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene affects the expression of MKI67 mRNA	PMID:22302311
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34750	Ethylenethiourea	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D005031	Ethylenethiourea results in increased expression of MKI67 protein	PMID:37527026
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MKI67 protein	PMID:34813904
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MKI67 mRNA; Diethylnitrosamine results in increased expression of MKI67 protein	PMID:24012840|PMID:37527026|PMID:40882885
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313525	E	RGD:6480464	20121113	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MKI67 protein	PMID:21776270
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MKI67 mRNA; Diethylnitrosamine results in increased expression of MKI67 protein	PMID:17854601|PMID:17942915
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein; [Diethylnitrosamine co-treated with Cyclohexanols] results in increased expression of MKI67 protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 protein; [Mirtazapine co-treated with Diethylnitrosamine] results in increased expression of MKI67 mRNA; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein]; Mirtazapine inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 mRNA]; Mirtazapine inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 protein]; Proliferating Cell Nuclear Antigen inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 protein]	PMID:17393424|PMID:17651763|PMID:23665045|PMID:24012840|PMID:40882885
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 protein]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 mRNA]	PMID:17854601|PMID:17942915|PMID:24535843
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D010269	Paraquat results in decreased expression of MKI67 protein	PMID:35236239
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230905	CTD	MESH:D010269	Paraquat results in decreased expression of MKI67 protein	PMID:34811946
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D010269	MIR136 promotes the reaction [Paraquat results in decreased expression of MKI67 protein]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in decreased expression of MKI67 protein]]	PMID:35236239
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of MKI67 mRNA; ST2825 inhibits the reaction [Paraquat results in decreased expression of MKI67 protein]	PMID:34811946|PMID:36117858
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313525	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MKI67 mRNA	PMID:37042841
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of MKI67 mRNA	PMID:30589522
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of MKI67 mRNA	PMID:17616710
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:351346	phenethyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C058305	phenethyl isothiocyanate results in increased expression of MKI67 protein	PMID:23535288
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MKI67 mRNA	PMID:39836092
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35170	vanadium(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014639	Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]	PMID:15565650
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MKI67 mRNA	PMID:26377693
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of MKI67 mRNA	PMID:18500788
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35455	1-naphthyl isothiocyanate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D015058	1-Naphthylisothiocyanate affects the expression of MKI67 protein	PMID:26011634
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MKI67 mRNA; 1-Naphthylisothiocyanate results in increased expression of MKI67 protein	PMID:23411599|PMID:30723492
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MKI67 mRNA; Cadmium Chloride results in decreased expression of MKI67 protein	PMID:25993096|PMID:30506660
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MKI67 mRNA	PMID:38568856
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MKI67 mRNA	PMID:24982889
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MKI67 protein	PMID:22081424|PMID:22457795
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313525	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MKI67 mRNA	PMID:26472689|PMID:38382870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 protein; Decitabine inhibits the reaction [Cadmium Chloride results in increased expression of MKI67 protein]; Grape Seed Extract inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 protein]	PMID:22457795|PMID:26935153
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20181016	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of MKI67 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 mRNA	PMID:29741670|PMID:36671501
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:1313526	E	RGD:6480464	20220111	CTD	MESH:C012125	diisononyl phthalate results in increased expression of MKI67 protein	PMID:34453847
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MKI67 mRNA	PMID:36326898
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313525	E	RGD:6480464	20260203	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MKI67 protein	PMID:40334771
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313526	E	RGD:6480464	20230307	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MKI67 mRNA; perfluorooctanoic acid results in increased expression of MKI67 protein	PMID:36152675
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20240806	CTD	MESH:C023036	[perfluorobutanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in increased expression of MKI67 protein; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in increased expression of MKI67 protein	PMID:38603627|PMID:40334771
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230307	CTD	MESH:C023036	Verteporfin inhibits the reaction [perfluorooctanoic acid results in increased expression of MKI67 protein]	PMID:36152675
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C039281	furan results in increased expression of MKI67 mRNA; furan results in increased expression of MKI67 protein	PMID:20562052|PMID:22507866|PMID:25539665
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of MKI67 mRNA	PMID:28903501
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313526	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MKI67 mRNA	PMID:22698814
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20140311	CTD	MESH:D011285	[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Pregnenolone Carbonitrile] results in increased expression of MKI67 mRNA	PMID:23626729
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MKI67 mRNA	PMID:19320972|PMID:19376846
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20151013	CTD	MESH:C018021	[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]	PMID:25192544
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of MKI67 mRNA	PMID:25380136
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35812	oxfendazole	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C011030	oxfendazole results in decreased expression of MKI67 protein	PMID:26558467
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MKI67 mRNA	PMID:24449571
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20121113	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of MKI67 mRNA	PMID:16269432
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20200331	CTD	MESH:D002738	[Chloroquine co-treated with flavokawain B] results in decreased expression of MKI67 protein	PMID:30025493
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:D002738	[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]]	PMID:30482226
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3647	chlorpromazine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D002746	Chlorpromazine analog results in decreased expression of MKI67 mRNA	PMID:15924885
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:36704	imiquimod	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260602	CTD	MESH:C056493	Imiquimod results in increased expression of MKI67 protein	PMID:40568777
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:36704	imiquimod	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260602	CTD	MESH:C056493	[Clobetasol co-treated with calcipotriene] inhibits the reaction [Imiquimod results in increased expression of MKI67 protein]; pyrimidin-2-one beta-ribofuranoside inhibits the reaction [Imiquimod results in increased expression of MKI67 protein]	PMID:40568777
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MKI67 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MKI67 mRNA	PMID:32699268
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3750	clofibrate	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D002994	Clofibrate results in increased expression of MKI67 mRNA	PMID:32741897
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1313526	E	RGD:6480464	20130312	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of MKI67 protein	PMID:22981962
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MKI67 mRNA	PMID:32588087
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MKI67 mRNA	PMID:40194260
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:38561	fluvastatin	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:C065180	Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]; Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]; taxifolin promotes the reaction [Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]	PMID:35465754
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313525	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MKI67 mRNA	PMID:28302478
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:38746	parathion-methyl	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D008743	Methyl Parathion results in decreased expression of MKI67 protein	PMID:18418871
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:38757	isoflavones	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones results in decreased expression of MKI67 mRNA	PMID:23288143
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:38757	isoflavones	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones results in increased expression of MKI67 mRNA	PMID:23288143
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:38757	isoflavones	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; Isoflavones inhibits the reaction [Genistein results in increased expression of MKI67 mRNA]	PMID:20381596|PMID:23288143
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MKI67 mRNA	PMID:31533062
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20231205	CTD	MESH:C473478	Sunitinib results in decreased expression of MKI67 protein	PMID:36797997
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313525	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MKI67 mRNA	PMID:19167446
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MKI67 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA]	PMID:18310284|PMID:19167446
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20201103	CTD	MESH:C464485	acetamiprid results in decreased expression of MKI67 mRNA	PMID:30103633|PMID:39529242
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:39175	thiacloprid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:C417209	thiacloprid results in decreased expression of MKI67 mRNA; thiacloprid results in decreased expression of MKI67 protein	PMID:37468076
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MKI67 mRNA	PMID:40419075
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313525	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MKI67 protein	PMID:40334771
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20240806	CTD	MESH:C076994	[perfluorobutanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in increased expression of MKI67 protein; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in increased expression of MKI67 protein	PMID:38603627|PMID:40334771
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of MKI67 mRNA	PMID:22561333
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120501	CTD	MESH:D003474	Curcumin results in decreased expression of MKI67 protein	PMID:18226269|PMID:19372569|PMID:38348716
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003474	Curcumin inhibits the reaction [Lamotrigine results in decreased expression of MKI67 protein]	PMID:38050455
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D003474	[Curcumin co-treated with Gemcitabine] results in decreased expression of MKI67 protein	PMID:17440100
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313525	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MKI67 mRNA	PMID:25979313
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of MKI67 mRNA	PMID:28001369
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4021	Cyclopamine	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20141111	CTD	MESH:C000541	cyclopamine results in decreased expression of MKI67 protein	PMID:22923130
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4027	cyclophosphamide	decreases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of MKI67 protein	PMID:39209270
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of MKI67 protein	PMID:33737021|PMID:39952379
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003520	Cyclophosphamide results in increased expression of MKI67 protein	PMID:36154502
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4027	cyclophosphamide	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003520	coenzyme Q10 inhibits the reaction [Cyclophosphamide results in decreased expression of MKI67 protein]; Melatonin inhibits the reaction [Cyclophosphamide results in decreased expression of MKI67 protein]	PMID:36154502|PMID:39209270
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of MKI67 mRNA	PMID:24971338
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MKI67 mRNA	PMID:19159671|PMID:20106945|PMID:21632981|PMID:25562108|PMID:27318970
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of MKI67 mRNA	PMID:17942131|PMID:19770486
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20230502	CTD	MESH:C017160	cypermethrin results in decreased expression of MKI67 protein	PMID:36063984
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230704	CTD	MESH:C017160	cypermethrin results in decreased expression of MKI67 mRNA; cypermethrin results in decreased expression of MKI67 protein	PMID:37011868
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:40618	aminoguanidine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120814	CTD	MESH:C004479	pimagedine results in decreased expression of MKI67 mRNA	PMID:19266598
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41423	celecoxib	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib results in decreased expression of MKI67	PMID:20697803
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41423	celecoxib	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20170303	CTD	MESH:C105934	[FEC protocol co-treated with Celecoxib] results in decreased expression of MKI67 protein	PMID:16507397
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41423	celecoxib	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C105934	Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of MKI67 protein]	PMID:32416088
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120717	CTD	MESH:D013629	Tamoxifen results in decreased expression of MKI67 protein	PMID:15767642|PMID:16002280|PMID:18855134|PMID:20332317
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of MKI67 protein	PMID:15067354
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of MKI67 protein	PMID:17219426
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of MKI67 protein	PMID:12627041
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D013629	[selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein; [Tamoxifen co-treated with anastrozole] results in decreased expression of MKI67 protein	PMID:15767642|PMID:18855134
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D013629	Quercetin promotes the reaction [Tamoxifen results in decreased expression of MKI67 protein]	PMID:15067354
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41879	dexamethasone	affects expression	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:D003907	Dexamethasone affects the expression of MKI67 mRNA	PMID:40262731
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D003907	Dexamethasone results in decreased expression of MKI67 protein	PMID:29111458
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120918	CTD	MESH:D003907	Dexamethasone results in decreased expression of MKI67 protein	PMID:22048647
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:D003907	Dexamethasone results in increased expression of MKI67 protein	PMID:40262731
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MKI67 protein	PMID:16468032
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MKI67 mRNA	PMID:28973697
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:42758	aldehydo-D-glucose	affects expression	ISO	RGD:1313525	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose affects the expression of MKI67 protein	PMID:39613055
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of MKI67 mRNA	PMID:39613055
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of MKI67 protein	PMID:40638403
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20151013	CTD	MESH:D005947	[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]	PMID:25192544
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA; alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]; imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]	PMID:37567420|PMID:37992649|PMID:40638403
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20141111	CTD	MESH:C107676	deguelin results in decreased expression of MKI67 protein	PMID:22623043
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:43931	methyllycaconitine	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:C054634	methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]	PMID:29501575
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of MKI67 mRNA	PMID:24657277
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:44445	nimesulide	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C012655	nimesulide inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]	PMID:22387750
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313525	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MKI67 mRNA; Okadaic Acid results in increased expression of MKI67 protein	PMID:38832940
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4489	Diallyl sulfide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240109	CTD	MESH:C038491	allyl sulfide results in decreased expression of MKI67 protein	PMID:37209385
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:44915	propofol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20230502	CTD	MESH:D015742	Propofol results in decreased expression of MKI67 protein	PMID:36207479
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4512	Dictamnine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20230905	CTD	MESH:C026398	dictamnine results in decreased expression of MKI67 protein	PMID:34861243
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MKI67 mRNA	PMID:27188386
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313525	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MKI67 mRNA	PMID:28542535
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20140408	CTD	MESH:C012589	trichostatin A results in decreased expression of MKI67 mRNA	PMID:23770000
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen affects the expression of MKI67 protein	PMID:26011634
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313526	E	RGD:6480464	20260407	CTD	MESH:D000082	Acetaminophen affects the expression of MKI67 mRNA	PMID:40505803
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MKI67 mRNA	PMID:33387578
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of MKI67 mRNA	PMID:29067470
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of MKI67 mRNA	PMID:17942131
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of MKI67 protein	PMID:17431590
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313525	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MKI67 mRNA	PMID:22230336
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313526	E	RGD:6480464	20240903	CTD	MESH:D000082	Acetaminophen results in increased expression of MKI67 mRNA	PMID:38657942
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46245	coenzyme Q10	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C024989	coenzyme Q10 inhibits the reaction [Cyclophosphamide results in decreased expression of MKI67 protein]	PMID:39209270
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4631	diosmin	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D004145	Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein]	PMID:23665045
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005472	Fluorouracil affects the expression of MKI67 protein	PMID:36203040
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D005472	MKI67 mRNA affects the susceptibility to Fluorouracil; MKI67 protein affects the susceptibility to Fluorouracil	PMID:15548681|PMID:18286688
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of MKI67; Fluorouracil results in decreased expression of MKI67 mRNA	PMID:11300326|PMID:15205334|PMID:16709241|PMID:21594360
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005472	Fluorouracil results in decreased expression of MKI67 protein	PMID:36203040
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46557	zoledronic acid	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with Doxorubicin] results in decreased expression of MKI67 protein	PMID:18695136
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MKI67 mRNA	PMID:29279043
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of MKI67 mRNA	PMID:29279043
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1313526	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of MKI67 protein	PMID:17200189
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46680	serpentine asbestos	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20170303	CTD	MESH:D017632	[MPO protein affects the susceptibility to Asbestos, Serpentine] which affects the expression of MKI67 protein; PRKDC protein affects the reaction [Asbestos, Serpentine results in increased expression of MKI67 protein]	PMID:16266986|PMID:17200189
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46727	quartz	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230801	CTD	MESH:D011791	[Nicotine co-treated with Quartz] results in increased expression of MKI67 protein	PMID:36868510
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:46938	zebularine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260602	CTD	MESH:C009131	pyrimidin-2-one beta-ribofuranoside inhibits the reaction [Imiquimod results in increased expression of MKI67 protein]	PMID:40568777
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210907	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [Arsenic co-treated with Estradiol] results in increased expression of MKI67 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of MKI67 protein; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of MKI67 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKI67 mRNA	PMID:33047385|PMID:35809665|PMID:39836092
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MKI67 mRNA	PMID:40504410
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4744	Echimidine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C000615871	echimidine results in increased expression of MKI67 mRNA	PMID:32419051
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160412	CTD	MESH:D007654	Ketoconazole results in increased expression of MKI67 mRNA	PMID:25808816
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:47575	ABT-737	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20210504	CTD	MESH:C501332	ABT-737 results in decreased expression of MKI67 protein	PMID:19773376
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:47575	ABT-737	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210504	CTD	MESH:C501332	[ABT-737 co-treated with Sirolimus] results in decreased expression of MKI67 protein	PMID:19773376
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4778	embelin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20141014	CTD	MESH:C010945	embelin results in decreased expression of MKI67 protein	PMID:24694877
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MKI67 mRNA	PMID:29391264
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004726	Endosulfan results in increased expression of MKI67 protein	PMID:28935589
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of MKI67 mRNA	PMID:17109745
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313526	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of MKI67 protein	PMID:22334560
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:48607	lithium chloride	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]]	PMID:15845746
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:48765	dimethylarsinic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in increased expression of MKI67 mRNA	PMID:37567419
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in decreased expression of MKI67 mRNA	PMID:24383545
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:48843	disodium selenite	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D018038	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MKI67 mRNA	PMID:17351261
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C005223	methyleugenol results in increased expression of MKI67 protein	PMID:23411599|PMID:26011634
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4948	Evodiamine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in decreased expression of MKI67 protein	PMID:37611839
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20250114	CTD	MESH:C049639	[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of MKI67 protein	PMID:39486648
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4953	exemestane	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:C056516	exemestane results in decreased expression of MKI67 protein	PMID:16002280
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D007213	Indomethacin inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]; Indomethacin inhibits the reaction [Sulfadimethoxine results in increased expression of MKI67 protein]	PMID:22387750
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:49668	gefitinib	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20190910	CTD	MESH:C419708	[Gefitinib co-treated with betulin] results in decreased expression of MKI67 protein	PMID:27447558
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MKI67 mRNA; Arsenic Trioxide results in decreased expression of MKI67 protein	PMID:27318970|PMID:30091188|PMID:38160894
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MKI67 protein	PMID:31421153
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20191114	CTD	MESH:C032793	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of MKI67 mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of MKI67 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]	PMID:27318970|PMID:38160894
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200114	CTD	MESH:C032793	FOXO3 protein affects the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]	PMID:31421153
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:4994	Febrifugine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240702	CTD	MESH:C001207	febrifugine results in decreased expression of MKI67 protein	PMID:38431229
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D011345	Fenofibrate results in increased expression of MKI67 mRNA; Fenofibrate results in increased expression of MKI67 protein	PMID:17264098|PMID:32741897
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1313526	E	RGD:6480464	20241203	CTD	MESH:D011345	Fenofibrate results in increased expression of MKI67 protein	PMID:39442682
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50095	bucladesine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003994	Bucladesine results in decreased expression of MKI67 protein	PMID:16718685
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D008770	Methylnitrosourea results in increased expression of MKI67 protein	PMID:38977090
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1313526	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of MKI67 mRNA	PMID:25270620
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50102	N-methyl-N-nitrosourea	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D008770	Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of MKI67 protein]; sodium arsenite promotes the reaction [Methylnitrosourea results in increased expression of MKI67 protein]	PMID:38977090
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1313525	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of MKI67 mRNA	PMID:33512557
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Cadmium Chloride results in increased expression of MKI67 protein]	PMID:22457795
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50207	sophoraflavanone B	decreases expression	EXP		E	RGD:6480464	20170103	CTD	MESH:C119737	8-prenylnaringenin results in decreased expression of MKI67 mRNA	PMID:26372666
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313526	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of MKI67 mRNA; Nanotubes, Carbon analog affects the expression of MKI67 mRNA	PMID:25554681
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MKI67 mRNA	PMID:40234311
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50692	mifepristone	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of MKI67 protein	PMID:18579510
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50730	montelukast	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:C093875	montelukast inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]	PMID:39716576
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:50749	calcipotriol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250114	CTD	MESH:C055085	[calcipotriene co-treated with Carbon Tetrachloride] results in increased expression of MKI67 mRNA; [Clobetasol co-treated with calcipotriene] inhibits the reaction [Imiquimod results in increased expression of MKI67 protein]; Verteporfin inhibits the reaction [[calcipotriene co-treated with Carbon Tetrachloride] results in increased expression of MKI67 mRNA]	PMID:38992766|PMID:40568777
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of MKI67 mRNA	PMID:21148553
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:5118	fluoxetine	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260303	CTD	MESH:D005473	Fluoxetine results in decreased expression of MKI67 mRNA; Fluoxetine results in decreased expression of MKI67 protein	PMID:39826770
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:51311	bromoethene	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C003763	vinyl bromide results in increased expression of MKI67 protein	PMID:37527026
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D005485	Flutamide results in increased expression of MKI67 protein	PMID:26485406
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20170516	CTD	MESH:C030935	[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA	PMID:27858113|PMID:38237855
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20170516	CTD	MESH:C031180	[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA	PMID:27858113|PMID:38237855
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:5169	fraxetin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240430	CTD	MESH:C105671	fraxetin results in decreased expression of MKI67 protein	PMID:37867445
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:517248	bufalin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240604	CTD	MESH:C022777	bufalin results in decreased expression of MKI67 protein	PMID:36924737
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:51876	auramine O	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D001576	Benzophenoneidum results in increased expression of MKI67 protein	PMID:37527026
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of MKI67 mRNA	PMID:36117858
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of MKI67 protein	PMID:19372569
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:52717	bortezomib	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:D000069286	[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]]	PMID:30482226
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313525	E	RGD:6480464	20121113	CTD	MESH:C029938	nickel sulfate results in increased expression of MKI67 protein	PMID:21776270
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:53050	trimellitic anhydride	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:C015559	trimellitic anhydride affects the expression of MKI67 mRNA	PMID:22302311
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MKI67 mRNA	PMID:40645554
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MKI67 mRNA	PMID:19042947
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of MKI67 mRNA	PMID:17982090
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:55365	alpha-hexylcinnamaldehyde	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:C080043	hexyl cinnamic aldehyde affects the expression of MKI67 mRNA	PMID:22302311
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:5643	Heliotrine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C010178	heliotrine results in increased expression of MKI67 mRNA	PMID:32419051
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:5700	Hexamethonium	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D018738	Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]	PMID:29501575
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MKI67 mRNA	PMID:38701926
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6039	isopimaric acid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230704	CTD	MESH:C115138	isopimaric acid results in decreased expression of MKI67 protein	PMID:36754215
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MKI67 protein	PMID:32959892
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:61000	erythrosin B	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:D004923	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein	PMID:24941295
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D007649	Ketamine results in increased expression of MKI67 protein	PMID:19919587
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:61278	scutellarin	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20151013	CTD	MESH:C484876	scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]	PMID:25192544
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MKI67 mRNA	PMID:39836092
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63053	purmorphamine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241203	CTD	MESH:C470893	purmorphamine inhibits the reaction [nonylphenol results in decreased expression of MKI67 protein]	PMID:39111523
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63607	linezolid	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C098010	Linezolid results in decreased expression of MKI67 mRNA	PMID:21296123
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MKI67 mRNA	PMID:21641980
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MKI67 mRNA	PMID:25729387
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MKI67 mRNA	PMID:25729387
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63637	vemurafenib	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20230404	CTD	MESH:C551177	[Vemurafenib co-treated with 3,5-bis((4-nitrophenyl)methylidene)-1-prop-2-enoylpiperidin-4-one] results in decreased expression of MKI67 protein	PMID:35648318
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6367	lamotrigine	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C047781	Lamotrigine results in decreased expression of MKI67 protein	PMID:38050455
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6367	lamotrigine	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C047781	Curcumin inhibits the reaction [Lamotrigine results in decreased expression of MKI67 protein]	PMID:38050455
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6382	Lasiocarpine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260505	CTD	MESH:C005136	lasiocarpine results in decreased expression of MKI67 mRNA	PMID:40956406
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6382	Lasiocarpine	increases expression	ISO	RGD:1313525	E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in increased expression of MKI67 mRNA	PMID:40054833
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6382	Lasiocarpine	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20260505	CTD	MESH:C005136	[CYP3A4 protein co-treated with lasiocarpine] results in decreased expression of MKI67 mRNA	PMID:40956406
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63918	artesunate	multiple interactions	EXP		E	RGD:6480464	20180410	CTD	MESH:C039726	artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]	PMID:29031619
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of MKI67 protein	PMID:33592256
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63933	Aroclor 1254	multiple interactions	EXP		E	RGD:6480464	20210504	CTD	MESH:D020111	Lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of MKI67 protein]	PMID:33592256
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63948	trimethyltin	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160412	CTD	MESH:C046488	trimethyltin results in increased expression of MKI67 mRNA	PMID:24002884
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:63952	arsenic trichloride	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of MKI67 protein; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of MKI67 protein	PMID:35809665
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MKI67 mRNA	PMID:28988120
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of MKI67 protein	PMID:26558463
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6413	letrozole	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20161213	CTD	MESH:C067431	letrozole results in decreased expression of MKI67 protein	PMID:16002280
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of MKI67 mRNA	PMID:36851058
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:64227	ciglitazone	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MKI67 mRNA	PMID:16197558
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6443	levonorgestrel	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D016912	Levonorgestrel results in decreased expression of MKI67 protein	PMID:16019350
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20200331	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ANGPT2 protein results in increased expression of MKI67 protein]	PMID:31838054
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6570	lupeol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20130416	CTD	MESH:C010480	lupeol results in decreased expression of MKI67 mRNA	PMID:20732907
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:65899	flavokawain B	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20200331	CTD	MESH:C452039	[ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of MKI67 protein; [Chloroquine co-treated with flavokawain B] results in decreased expression of MKI67 protein	PMID:30025493
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:66331	xanthohumol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20220510	CTD	MESH:C104536	xanthohumol results in decreased expression of MKI67 protein	PMID:35259468
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:66790	Pulsatilla saponin D	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20250603	CTD	MESH:C000601508	Pulsatilla saponin D results in decreased expression of MKI67 protein	PMID:39954838
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:67991	(20S)-ginsenoside Rg3	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210406	CTD	MESH:C097367	[ginsenoside Rg3 co-treated with osimertinib] results in decreased expression of MKI67 protein	PMID:31916386
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D008694	Methamphetamine results in decreased expression of MKI67 mRNA	PMID:28619521
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in decreased expression of MKI67 mRNA	PMID:25290377
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D008701	Methapyrilene results in increased expression of MKI67 protein	PMID:26558467
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:68233	(Z)-3-butylidenephthalide	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C026105	butylidenephthalide results in decreased expression of MKI67 protein	PMID:16987298
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:68233	(Z)-3-butylidenephthalide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20130903	CTD	MESH:C026105	butylidenephthalide results in decreased expression of MKI67 protein	PMID:16987298
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:68508	diethyl maleate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in increased expression of MKI67 mRNA	PMID:21161181
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:68534	enzalutamide	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210608	CTD	MESH:C540278	enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of MKI67 protein]	PMID:32184358
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:68641	(-)-cotinine	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D003367	Cotinine results in increased expression of MKI67 protein	PMID:31678612
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:68657	zingerone	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:C013738	zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]	PMID:30720227
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of MKI67 mRNA	PMID:27462272
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:69236	falcarindiol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260602	CTD	MESH:C034379	falcarindiol results in decreased expression of MKI67 protein	PMID:40901755
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1313526	E	RGD:6480464	20170613	CTD	MESH:C057862	cyanoginosin LR results in increased expression of MKI67 protein	PMID:28189720|PMID:36115647|PMID:36288207
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200804	CTD	MESH:D002185	Cannabidiol results in decreased expression of MKI67 protein	PMID:24910342
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6950	mirtazapine	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C035133	[Mirtazapine co-treated with Diethylnitrosamine] results in increased expression of MKI67 mRNA; Mirtazapine inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 mRNA]; Mirtazapine inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 protein]	PMID:40882885
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D016686	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein	PMID:21224054
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:69832	osthole	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20200331	CTD	MESH:C046627	osthol results in decreased expression of MKI67 protein	PMID:31870840
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:70851	phthalaldehyde	affects expression	ISO	RGD:1313526	E	RGD:6480464	20121218	CTD	MESH:D009764	o-Phthalaldehyde affects the expression of MKI67 mRNA	PMID:22302311
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20230704	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:35861251
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:31884101|PMID:39752319
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:71019	omacetaxine mepesuccinate	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20200714	CTD	MESH:C001652	Homoharringtonine results in decreased expression of MKI67 protein	PMID:31726078
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:71418	triamcinolone acetonide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20130115	CTD	MESH:D014222	Triamcinolone Acetonide results in decreased expression of MKI67 protein	PMID:16029572
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:72821	1-methyltryptophan	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20230404	CTD	MESH:C525396	1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]	PMID:35687267
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:73458	NS-398	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20171114	CTD	MESH:C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of MKI67 mRNA	PMID:27318970
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MKI67 protein	PMID:29031619|PMID:29155087|PMID:30720227
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MKI67 mRNA; 1,2-Dimethylhydrazine results in increased expression of MKI67 protein	PMID:22206623|PMID:33190582|PMID:38563870
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180410	CTD	MESH:D019813	Artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Aspirin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Capsaicin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]	PMID:29031619|PMID:29155087|PMID:30720227
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230606	CTD	MESH:D019813	Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Carboplatin promotes the reaction [Pulsatilla saponin A inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]]; Pulsatilla saponin A inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Pulsatilla saponin A promotes the reaction [Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]]	PMID:33190582
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:74571	iodoacetic acid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:D019807	Iodoacetic Acid results in decreased expression of MKI67 mRNA	PMID:31693920
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:747353	darolutamide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260224	CTD	MESH:C000607739	darolutamide results in decreased expression of MKI67 protein	PMID:39309439
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:747353	darolutamide	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20260224	CTD	MESH:C000607739	darolutamide promotes the reaction [RSL3 compound results in decreased expression of MKI67 protein]; RSL3 compound promotes the reaction [darolutamide results in decreased expression of MKI67 protein]	PMID:39309439
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone results in decreased expression of MKI67 mRNA	PMID:27318970
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of MKI67 mRNA]	PMID:27318970
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:748911	alanosine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:C000082	alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]	PMID:40638403
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of MKI67 mRNA	PMID:29522793
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA	PMID:37567420
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of MKI67 mRNA	PMID:27858113
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:75393	Y-27632	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20210504	CTD	MESH:C108830	Y 27632 results in decreased expression of MKI67 protein	PMID:32417439
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:75393	Y-27632	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210504	CTD	MESH:C108830	Y 27632 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in decreased expression of MKI67 protein]	PMID:32417439
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313525	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MKI67 mRNA	PMID:37199045
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:754951	siponimod	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C578989	siponimod results in increased expression of MKI67 mRNA	PMID:29556671
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:754951	siponimod	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:C578989	siponimod results in increased expression of MKI67 mRNA	PMID:29556671
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:755199	apalutamide	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20260714	CTD	MESH:C572045	apalutamide inhibits the reaction [androstane-3,17-dione results in increased expression of MKI67 protein]	PMID:38122923
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of MKI67 mRNA; Niclosamide results in decreased expression of MKI67 protein	PMID:28284560|PMID:35115509
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:755540	docetaxel	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:D000077143	Docetaxel results in decreased expression of MKI67 protein	PMID:38546343
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20260714	CTD	MESH:D000077143	[Docetaxel co-treated with fatostatin] results in decreased expression of MKI67 protein; Docetaxel promotes the reaction [[TP53 protein mutant form results in increased susceptibility to fatostatin] which results in decreased expression of MKI67 protein]	PMID:26512780
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:D000077143	METTL14 protein inhibits the reaction [Docetaxel results in decreased expression of MKI67 protein]	PMID:38546343
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:755599	epacadostat	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20260714	CTD	MESH:C000613752	epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]	PMID:35687267
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:755912	aluminum chloride	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in decreased expression of MKI67 protein	PMID:26339337
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:755912	aluminum chloride	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077410	Caffeine inhibits the reaction [Aluminum Chloride results in decreased expression of MKI67 protein]	PMID:26339337
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:756940	abbv-744	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260714	CTD	MESH:C000706695	ABBV-744 results in decreased expression of MKI67 protein	PMID:37769529
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:C575881	alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]; imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]	PMID:40638403
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:757488	omega-3 fatty acids	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 inhibits the reaction [tributyltin results in decreased expression of MKI67 protein]	PMID:32783468
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C007350	nitrofen results in decreased expression of MKI67 protein	PMID:31843527
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:759101	me-344	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260714	CTD	MESH:C000597890	ME-344 results in decreased expression of MKI67 protein	PMID:31597662
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1313525	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of MKI67 protein	PMID:39638853
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:C560077	[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of MKI67 protein	PMID:37116855
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:76016	vortioxetine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260113	CTD	MESH:C557874	Vortioxetine results in decreased expression of MKI67 protein	PMID:40972861
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:76290	PhIP	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of MKI67 protein	PMID:23535288
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MKI67 protein	PMID:29877212
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:76359	butylated hydroxyanisole	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002083	Butylated Hydroxyanisole results in decreased expression of MKI67 protein	PMID:23535288
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:76359	butylated hydroxyanisole	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002083	Butylated Hydroxyanisole results in increased expression of MKI67 protein	PMID:23535288
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:76604	MeIQx	increases expression	ISO	RGD:1313525	E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of MKI67 mRNA	PMID:20816883
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:76989	phytoestrogen	increases expression	ISO	RGD:1313525	E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of MKI67 mRNA	PMID:18310284
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:76995	alpha-naphthoflavone	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250708	CTD	MESH:C011512	alpha-naphthoflavone results in increased expression of MKI67 mRNA	PMID:39653182
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:76995	alpha-naphthoflavone	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250708	CTD	MESH:C011512	Triclosan promotes the reaction [alpha-naphthoflavone results in increased expression of MKI67 mRNA]	PMID:39653182
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MKI67 mRNA	PMID:32741896
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of MKI67 mRNA	PMID:12517777
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250708	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of MKI67 mRNA	PMID:39653182
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250708	CTD	MESH:D019324	Triclosan inhibits the reaction [beta-Naphthoflavone results in increased expression of MKI67 mRNA]	PMID:39653182
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:77092	fenbendazole	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005273	Fenbendazole results in increased expression of MKI67 protein	PMID:23411599
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in decreased expression of MKI67 mRNA	PMID:21703336
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in decreased expression of MKI67 protein	PMID:39638853
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C025589	SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of MKI67 mRNA]	PMID:21703336
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:7735	olanzapine	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C076029	Olanzapine results in increased expression of MKI67 protein	PMID:38437955
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of MKI67 mRNA	PMID:34995734
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MKI67 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MKI67 mRNA	PMID:27188386
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:79516	Nonylphenol	decreases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C025256	nonylphenol results in decreased expression of MKI67 protein	PMID:39111523
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:79516	Nonylphenol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20241203	CTD	MESH:C025256	nonylphenol results in decreased expression of MKI67 protein	PMID:39111523
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1313525	E	RGD:6480464	20161025	CTD	MESH:C025256	nonylphenol results in increased expression of MKI67 mRNA	PMID:27260121
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:79516	Nonylphenol	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161025	CTD	MESH:C025256	fulvestrant inhibits the reaction [nonylphenol results in increased expression of MKI67 mRNA]	PMID:27260121
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:79516	Nonylphenol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241203	CTD	MESH:C025256	purmorphamine inhibits the reaction [nonylphenol results in decreased expression of MKI67 protein]	PMID:39111523
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:80495	benzidine	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C029876	benzidine results in increased expression of MKI67 protein	PMID:37527026
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:80630	irinotecan	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20200211	CTD	MESH:D000077146	[Irinotecan co-treated with rucaparib] results in decreased expression of MKI67 protein	PMID:30612311
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of MKI67 mRNA	PMID:31324951
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D010634	Phenobarbital results in increased expression of MKI67 mRNA	PMID:25145657
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313526	E	RGD:6480464	20141223	CTD	MESH:D010634	Phenobarbital results in increased expression of MKI67 mRNA; Phenobarbital results in increased expression of MKI67 protein	PMID:19363144|PMID:19482888|PMID:20403969|PMID:23091169|PMID:24690595|PMID:25145657|PMID:33549593|PMID:34813904
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8069	phenobarbital	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 protein	PMID:17651763
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MKI67 mRNA]	PMID:19482888|PMID:24535843|PMID:33549593
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:80887	Phellopterin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240430	CTD	MESH:C104601	phellopterin results in decreased expression of MKI67 protein	PMID:37708916
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8107	phenytoin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D010672	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein	PMID:21224054
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:81336	pectolinarigenin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240206	CTD	MESH:C528671	pectolinarigenin results in decreased expression of MKI67 protein	PMID:37393350
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of MKI67 mRNA	PMID:17942131|PMID:18958704
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA	PMID:19167446
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313526	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MKI67 mRNA	PMID:38648751
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20191112	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MKI67 mRNA	PMID:31173147
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20190702	CTD	MESH:C511295	[2,2',4,4'-tetrabromodiphenyl ether co-treated with hexabrominated diphenyl ether 153 co-treated with pentabrominated diphenyl ether 100] results in increased expression of MKI67 protein	PMID:30796839
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1313526	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of MKI67 protein	PMID:22334560
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:81760	difenoconazole	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C115058	difenoconazole results in increased expression of MKI67 protein	PMID:34519103
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:81760	difenoconazole	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C115058	ginger extract inhibits the reaction [difenoconazole results in increased expression of MKI67 protein]	PMID:34519103
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82119	Dimefox	increases expression	ISO	RGD:1313525	E	RGD:6480464	20141111	CTD	MESH:C012920	dimefox results in increased expression of MKI67 protein	PMID:18418871
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82307	para-Cresidine	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C013453	cresidine results in increased expression of MKI67 protein	PMID:26338220
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	increases expression	ISO	RGD:1313525	E	RGD:6480464	20230404	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in increased expression of MKI67 mRNA; indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein	PMID:35687267
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20230404	CTD	MESH:C041508	1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]	PMID:35687267
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82357	N-Nitrosodiethanolamine	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C014129	N-nitrosodiethanolamine results in increased expression of MKI67 protein	PMID:37527026
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82360	N-Nitrosomethylethylamine	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C017510	methylethylnitrosamine results in increased expression of MKI67 protein	PMID:37527026
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of MKI67 mRNA	PMID:32234424
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82411	Brilliant Blue	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:C006796	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein	PMID:24941295
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20180515	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MKI67 protein	PMID:26206603
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of MKI67 mRNA	PMID:21858171
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82527	Ptaquiloside	increases expression	ISO	RGD:1313526	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in increased expression of MKI67 mRNA	PMID:22143989
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:C005842	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein	PMID:24941295
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82615	diminazene diaceturate	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240604	CTD	MESH:C003915	diminazene aceturate results in decreased expression of MKI67 mRNA	PMID:37681557
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:82619	icariside II	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20150127	CTD	MESH:C060988	baohuoside I results in decreased expression of MKI67 protein	PMID:25119583
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:83766	olaparib	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20231205	CTD	MESH:C531550	olaparib results in decreased expression of MKI67 protein	PMID:29567272
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:83766	olaparib	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20231205	CTD	MESH:C531550	INCB054329 promotes the reaction [olaparib results in decreased expression of MKI67 protein]; olaparib promotes the reaction [INCB054329 results in decreased expression of MKI67 protein]	PMID:29567272
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8382	prednisone	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240604	CTD	MESH:D011241	Prednisone results in decreased expression of MKI67 mRNA	PMID:38439560
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:84050	trabectedin	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C099150	trabectedin results in increased expression of MKI67 protein	PMID:12154027
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of MKI67 protein	PMID:38348393
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8461	promethazine	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D011398	Promethazine affects the expression of MKI67 protein	PMID:26011634
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8461	promethazine	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D011398	Promethazine results in increased expression of MKI67 protein	PMID:26558467
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of MKI67 mRNA; propiconazole results in increased expression of MKI67 protein	PMID:21278054|PMID:22334560
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8499	propranolol	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20200331	CTD	MESH:D011433	Propranolol results in decreased expression of MKI67 protein	PMID:31838054
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8499	propranolol	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20200331	CTD	MESH:D011433	ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of MKI67 protein]	PMID:31838054
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein; Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]	PMID:19497425
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of MKI67 protein	PMID:15542782|PMID:22170262|PMID:22383795|PMID:22751436|PMID:23708653|PMID:26318986|PMID:28620137
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:85993	palbociclib	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20170303	CTD	MESH:C500026	Doxorubicin promotes the reaction [palbociclib results in decreased expression of MKI67 protein]; RB1 protein affects the reaction [palbociclib results in decreased expression of MKI67 protein]	PMID:22751436|PMID:28620137
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:86290	6-bromoindirubin-3'-oxime	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:C483321	[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of MKI67 protein	PMID:37116855
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of MKI67 protein	PMID:11535548
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:88249	PD 0325901	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C506614	[mirdametinib affects the susceptibility to KRAS protein] affects the reaction [NVP-BKM120 results in decreased expression of MKI67 protein]; mirdametinib inhibits the reaction [camostat results in increased expression of MKI67 protein]	PMID:24576621|PMID:25104499
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20230704	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:35861251
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:39752319
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:8890	(S)-ropivacaine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20231205	CTD	MESH:C037663	Ropivacaine results in decreased expression of MKI67 protein	PMID:36193553
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9068	Se-methylselenocysteine	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:C002979	selenomethylselenocysteine results in decreased expression of MKI67 protein	PMID:18855134
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9068	Se-methylselenocysteine	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:C002979	[selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein	PMID:18855134
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:90943	osimertinib	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20210406	CTD	MESH:C000603933	[ginsenoside Rg3 co-treated with osimertinib] results in decreased expression of MKI67 protein	PMID:31916386
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of MKI67 mRNA	PMID:32419051
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MKI67 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MKI67 mRNA	PMID:27188386
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9111	Senkirkine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of MKI67 mRNA	PMID:32419051
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:91275	N-butyl-N-(4-hydroxybutyl)nitrosamine	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D002085	[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein; Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]; methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]	PMID:29501575
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9130	sevoflurane	increases expression	ISO	RGD:1313525	E	RGD:6480464	20230502	CTD	MESH:C009250	Sevoflurane results in increased expression of MKI67 protein	PMID:36207479
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MKI67 mRNA	PMID:27131904
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:91450	sapanisertib	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240702	CTD	MESH:C572449	sapanisertib results in decreased expression of MKI67 protein	PMID:26536665
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:91450	sapanisertib	increases cleavage	ISO	RGD:1313525	E	RGD:6480464	20240702	CTD	MESH:C572449	sapanisertib results in increased cleavage of MKI67 protein	PMID:26536665
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9150	simvastatin	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019821	Simvastatin results in decreased expression of MKI67 protein	PMID:26577051
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9159	sinensetin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20250708	CTD	MESH:C059295	sinensetin results in decreased expression of MKI67 protein	PMID:39434434
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9159	sinensetin	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20250708	CTD	MESH:C059295	AKT activator SC79 inhibits the reaction [sinensetin results in decreased expression of MKI67 protein]	PMID:39434434
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9168	sirolimus	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D020123	Sirolimus affects the expression of MKI67 mRNA	PMID:24971338
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9168	sirolimus	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased expression of MKI67 protein	PMID:19773376
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D020123	[ABT-737 co-treated with Sirolimus] results in decreased expression of MKI67 protein	PMID:19773376
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9316	sufentanil	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20260707	CTD	MESH:D017409	Sufentanil results in decreased expression of MKI67 protein	PMID:38952040
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9316	sufentanil	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20260707	CTD	MESH:D017409	tilianin promotes the reaction [Sufentanil results in decreased expression of MKI67 protein]	PMID:38952040
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9405	tartrazine	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:D013645	Tartrazine results in increased expression of MKI67 mRNA	PMID:31032366
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9405	tartrazine	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D013645	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein; Aspirin inhibits the reaction [Tartrazine results in increased expression of MKI67 mRNA]	PMID:24941295|PMID:31032366
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1313525	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MKI67 mRNA	PMID:33512557
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:94287	erastin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20220809	CTD	MESH:C477224	erastin results in decreased expression of MKI67 protein	PMID:35234341
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:94287	erastin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20241105	CTD	MESH:C477224	erastin results in decreased expression of MKI67 protein	PMID:37341073
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20220809	CTD	MESH:C477224	BGN mRNA alternative form inhibits the reaction [erastin results in decreased expression of MKI67 protein]	PMID:35234341
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241105	CTD	MESH:C477224	Butyric Acid promotes the reaction [erastin results in decreased expression of MKI67 protein]	PMID:37341073
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:94789	1-[(2,3,4-trimethoxyphenyl)methyl]piperazine	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:D014292	Trimetazidine inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]	PMID:39716576
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20211207	CTD	MESH:D013792	Thalidomide results in decreased expression of MKI67 protein	PMID:34520751
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9513	thalidomide	multiple interactions	ISO	RGD:1313525	E	RGD:6480464	20120412	CTD	MESH:D013792	[Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA	PMID:18720364
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of MKI67 mRNA	PMID:22378314
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9607	Tiron	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D014013	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]]	PMID:39214269
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20151013	CTD	MESH:C001899	triptolide results in decreased expression of MKI67 protein	PMID:24842335
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of MKI67 mRNA	PMID:19140230
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313525	E	RGD:6480464	20120515	CTD	MESH:C057693	troglitazone results in increased expression of MKI67 protein	PMID:10097144
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of MKI67 mRNA	PMID:35537566
1305476	Mki67	marker of proliferation Ki-67	gene	CHEBI:9928	Valtratum	decreases expression	ISO	RGD:1313525	E	RGD:6480464	20240806	CTD	MESH:C030127	valtrate results in decreased expression of MKI67 protein	PMID:36048842
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of TREM3 mRNA	PMID:33729688
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D004958	Estradiol results in increased expression of TREM3 mRNA	PMID:32145629
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TREM3 mRNA	PMID:32741896
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TREM3 mRNA	PMID:32741896
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D000661	Amphetamine results in increased expression of TREM3 mRNA	PMID:30779732
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TREM3 mRNA	PMID:30723492
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C030686	acetamide results in increased expression of TREM3 mRNA	PMID:31881176
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003300	Copper deficiency results in increased expression of TREM3 mRNA	PMID:26033743
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003300	Copper deficiency results in increased expression of TREM3 mRNA	PMID:26033743
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D013853	Thioacetamide results in increased expression of TREM3 mRNA	PMID:34492290
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of TREM3 mRNA	PMID:25181051
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in increased methylation of TREM3 gene	PMID:28505145
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TREM3 mRNA	PMID:35163327
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TREM3 mRNA	PMID:35163327
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C039281	furan results in increased expression of TREM3 mRNA	PMID:27387713
1305477	Trem3	triggering receptor expressed on myeloid cells 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TREM3 mRNA	PMID:32741896
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ELP6 mRNA	PMID:38218311
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ELP6 mRNA	PMID:35967413
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of ELP6 protein	PMID:36641056
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ELP6 mRNA	PMID:29432896
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1606547	E	RGD:6480464	20121218	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ELP6 mRNA	PMID:21179406
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1606547	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ELP6 mRNA	PMID:18951874
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ELP6 protein	PMID:18951874
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313528	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ELP6 mRNA	PMID:39241906
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606547	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ELP6 mRNA	PMID:37042841
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1606547	E	RGD:6480464	20121218	CTD	MESH:C044887	beta-methylcholine affects the expression of ELP6 mRNA	PMID:21179406
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ELP6 mRNA	PMID:33387578
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ELP6 mRNA	PMID:21396975
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ELP6 mRNA	PMID:39836092
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1606547	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ELP6 mRNA	PMID:28903495
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1606547	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ELP6 mRNA	PMID:27594783
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1606547	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of ELP6 mRNA	PMID:24768652
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ELP6 protein	PMID:18951874
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ELP6 mRNA	PMID:32763439
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ELP6 mRNA	PMID:20971185
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:29073	L-ascorbic acid	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20160705	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of ELP6 mRNA	PMID:25555879
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20160705	CTD	MESH:D001205	[arsenic trioxide co-treated with Ascorbic Acid] results in decreased expression of ELP6 mRNA	PMID:25555879
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ELP6 mRNA	PMID:39836092
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606547	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ELP6 promoter	PMID:27901495
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1606547	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ELP6 gene	PMID:25435355
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ELP6 mRNA	PMID:20971185
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ELP6 mRNA	PMID:25555879
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of ELP6 mRNA	PMID:25555879
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ELP6 gene	PMID:31601247
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:31767	lead diacetate	affects expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C008261	lead acetate affects the expression of ELP6 protein	PMID:36539177
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313528	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ELP6 mRNA	PMID:18301758
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313528	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ELP6 mRNA	PMID:19710929
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ELP6 mRNA	PMID:38479592
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ELP6 mRNA	PMID:25181051
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ELP6 mRNA	PMID:34947998
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ELP6 gene	PMID:28505145
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ELP6 gene	PMID:31601247
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313528	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ELP6 mRNA	PMID:38685157
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313528	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of ELP6 protein	PMID:39748354
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ELP6 mRNA	PMID:31533062
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1606547	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ELP6 mRNA	PMID:19167446
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELP6 mRNA	PMID:19167446
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313528	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ELP6 mRNA	PMID:39529242
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ELP6 mRNA	PMID:29154799
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606547	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ELP6 mRNA	PMID:26272509
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELP6 mRNA	PMID:27188386
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313528	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ELP6 mRNA	PMID:28973697
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1606547	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ELP6 mRNA	PMID:28542535
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ELP6 mRNA	PMID:33387578
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1606547	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ELP6 mRNA	PMID:22230336
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ELP6 mRNA	PMID:29432896
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ELP6 mRNA	PMID:39836092
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ELP6 mRNA	PMID:25555879
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of ELP6 mRNA	PMID:25555879
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ELP6 mRNA	PMID:24136188
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ELP6 mRNA	PMID:28988120
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1606547	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ELP6 mRNA	PMID:31758290
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ELP6 mRNA	PMID:21346803
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELP6 mRNA	PMID:27188386
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELP6 mRNA	PMID:19167446
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of ELP6 mRNA	PMID:19095052
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ELP6 mRNA	PMID:23640034
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:88542	Butylparaben	increases expression	ISO	RGD:1606547	E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of ELP6 mRNA	PMID:17121429
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606547	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELP6 mRNA	PMID:27188386
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ELP6 mRNA	PMID:21346803
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1606547	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ELP6 mRNA	PMID:29301935
1305478	Elp6	elongator acetyltransferase complex subunit 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ELP6 mRNA	PMID:21346803
1305480	Snx7	sorting nexin 7	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SNX7 mRNA]	PMID:31150632
1305480	Snx7	sorting nexin 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX7 mRNA	PMID:36331819
1305480	Snx7	sorting nexin 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313531	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SNX7 mRNA	PMID:30319688
1305480	Snx7	sorting nexin 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313530	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SNX7 mRNA	PMID:20044591
1305480	Snx7	sorting nexin 7	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SNX7 mRNA	PMID:21632981
1305480	Snx7	sorting nexin 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313531	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SNX7 mRNA	PMID:39241906
1305480	Snx7	sorting nexin 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313531	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SNX7 mRNA	PMID:39298647
1305480	Snx7	sorting nexin 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of SNX7 mRNA	PMID:26496021
1305480	Snx7	sorting nexin 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SNX7 mRNA	PMID:34319233
1305480	Snx7	sorting nexin 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNX7 mRNA	PMID:19850644
1305480	Snx7	sorting nexin 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of SNX7 mRNA]	PMID:19850644
1305480	Snx7	sorting nexin 7	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SNX7 mRNA	PMID:26577399
1305480	Snx7	sorting nexin 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SNX7 mRNA	PMID:19549813
1305480	Snx7	sorting nexin 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:D019327	Copper Sulfate results in increased expression of SNX7 mRNA	PMID:18579281
1305480	Snx7	sorting nexin 7	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:D000452	Aldrin results in increased expression of SNX7 mRNA	PMID:18579281
1305480	Snx7	sorting nexin 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SNX7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SNX7 mRNA	PMID:34911549
1305480	Snx7	sorting nexin 7	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNX7 mRNA	PMID:31150632
1305480	Snx7	sorting nexin 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313531	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNX7 mRNA	PMID:31919559
1305480	Snx7	sorting nexin 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SNX7 mRNA]	PMID:31150632
1305480	Snx7	sorting nexin 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX7 mRNA	PMID:22206623
1305480	Snx7	sorting nexin 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNX7 mRNA	PMID:40504410
1305480	Snx7	sorting nexin 7	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of SNX7 mRNA	PMID:33512557
1305480	Snx7	sorting nexin 7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SNX7 mRNA	PMID:28960355
1305480	Snx7	sorting nexin 7	gene	CHEBI:27903	(2,4,5-trichlorophenoxy)acetic acid	increases expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:D015085	2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SNX7 mRNA	PMID:18579281
1305480	Snx7	sorting nexin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX7 mRNA	PMID:21570461
1305480	Snx7	sorting nexin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNX7 mRNA	PMID:19465110
1305480	Snx7	sorting nexin 7	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of SNX7 protein	PMID:39603559
1305480	Snx7	sorting nexin 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNX7 mRNA	PMID:30851411
1305480	Snx7	sorting nexin 7	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of SNX7 mRNA	PMID:27862939
1305480	Snx7	sorting nexin 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNX7 mRNA	PMID:29803840
1305480	Snx7	sorting nexin 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX7 mRNA	PMID:38568856|PMID:39719251
1305480	Snx7	sorting nexin 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNX7 mRNA	PMID:40504410
1305480	Snx7	sorting nexin 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313530	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SNX7 promoter	PMID:27901495
1305480	Snx7	sorting nexin 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNX7 mRNA	PMID:22228805
1305480	Snx7	sorting nexin 7	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313530	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SNX7 mRNA]	PMID:32406909
1305480	Snx7	sorting nexin 7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SNX7 mRNA	PMID:29264374
1305480	Snx7	sorting nexin 7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:C009495	titanium dioxide results in increased expression of SNX7 mRNA	PMID:23557971|PMID:27760801
1305480	Snx7	sorting nexin 7	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SNX7 mRNA	PMID:34492290
1305480	Snx7	sorting nexin 7	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of SNX7 mRNA	PMID:28329830
1305480	Snx7	sorting nexin 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNX7 mRNA	PMID:25181051
1305480	Snx7	sorting nexin 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of SNX7 mRNA	PMID:26496021
1305480	Snx7	sorting nexin 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313531	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SNX7 mRNA	PMID:30951980|PMID:39298647
1305480	Snx7	sorting nexin 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313531	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SNX7 mRNA	PMID:30951980|PMID:38685157
1305480	Snx7	sorting nexin 7	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1313531	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of SNX7 mRNA	PMID:31558096
1305480	Snx7	sorting nexin 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313531	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SNX7 mRNA	PMID:37019170
1305480	Snx7	sorting nexin 7	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313531	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of SNX7 protein	PMID:39748354
1305480	Snx7	sorting nexin 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SNX7 mRNA	PMID:38568856
1305480	Snx7	sorting nexin 7	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of SNX7 mRNA	PMID:27387713
1305480	Snx7	sorting nexin 7	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SNX7 mRNA	PMID:24386269
1305480	Snx7	sorting nexin 7	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SNX7 mRNA	PMID:28302478
1305480	Snx7	sorting nexin 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SNX7 mRNA	PMID:40419075
1305480	Snx7	sorting nexin 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX7 mRNA	PMID:36331819
1305480	Snx7	sorting nexin 7	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313531	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of SNX7 mRNA	PMID:31558096
1305480	Snx7	sorting nexin 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313531	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of SNX7 mRNA	PMID:24896083
1305480	Snx7	sorting nexin 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SNX7 mRNA	PMID:28973697
1305480	Snx7	sorting nexin 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:D000082	Acetaminophen affects the expression of SNX7 mRNA	PMID:17562736
1305480	Snx7	sorting nexin 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNX7 mRNA	PMID:33387578
1305480	Snx7	sorting nexin 7	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1313531	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of SNX7 mRNA	PMID:29279043
1305480	Snx7	sorting nexin 7	gene	CHEBI:46680	serpentine asbestos	increases methylation	ISO	RGD:1313530	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of SNX7 5' UTR	PMID:29523930
1305480	Snx7	sorting nexin 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNX7 mRNA	PMID:40504410
1305480	Snx7	sorting nexin 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313531	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SNX7 mRNA; Nanotubes, Carbon results in increased expression of SNX7 mRNA	PMID:25554681|PMID:25620056
1305480	Snx7	sorting nexin 7	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SNX7 mRNA	PMID:24136188
1305480	Snx7	sorting nexin 7	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SNX7 mRNA	PMID:23650126
1305480	Snx7	sorting nexin 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNX7 mRNA	PMID:22206623
1305480	Snx7	sorting nexin 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX7 mRNA	PMID:22206623
1305480	Snx7	sorting nexin 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313530	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNX7 mRNA	PMID:30851411
1305480	Snx7	sorting nexin 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313530	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SNX7 gene]	PMID:28238834
1305480	Snx7	sorting nexin 7	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1313531	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of SNX7 mRNA	PMID:31558096
1305480	Snx7	sorting nexin 7	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313531	E	RGD:6480464	20150303	CTD	MESH:C045950	propiconazole results in increased expression of SNX7 mRNA	PMID:21278054
1305480	Snx7	sorting nexin 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SNX7 mRNA	PMID:36843608
1305480	Snx7	sorting nexin 7	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1313531	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in increased expression of SNX7 protein	PMID:26903627
1305480	Snx7	sorting nexin 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SNX7 mRNA	PMID:21346803
1305480	Snx7	sorting nexin 7	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SNX7 mRNA	PMID:21346803
1305480	Snx7	sorting nexin 7	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of SNX7 gene	PMID:31079544
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313532	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of SFR1 mRNA	PMID:21934132
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313532	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SFR1 mRNA	PMID:26079696
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1313532	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of SFR1 mRNA	PMID:18951874
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313533	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SFR1 mRNA	PMID:39241906
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313532	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of SFR1 mRNA	PMID:23019147
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313533	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SFR1 mRNA	PMID:39298647
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SFR1 mRNA	PMID:33387578
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313532	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SFR1 mRNA	PMID:37042841
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313533	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SFR1 mRNA	PMID:33754040
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SFR1 mRNA	PMID:33387578
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313532	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SFR1 mRNA	PMID:28818685
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313533	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SFR1 mRNA	PMID:37236586
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313532	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SFR1 mRNA	PMID:19549813
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313533	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SFR1 mRNA	PMID:31919559
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313532	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of SFR1 mRNA	PMID:19167446
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313532	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SFR1 mRNA	PMID:27594783
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313533	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SFR1 mRNA	PMID:24680724
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFR1 mRNA	PMID:33387578|PMID:34747641
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313533	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SFR1 mRNA	PMID:23994337
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313532	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of SFR1 mRNA	PMID:29955902
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313532	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SFR1 mRNA	PMID:28001369
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313532	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SFR1 mRNA	PMID:32234424
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313532	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SFR1 mRNA	PMID:20382639
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SFR1 mRNA	PMID:25181051|PMID:34947998
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313533	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SFR1 mRNA	PMID:33221593
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SFR1 mRNA	PMID:41034487
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313533	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of SFR1 mRNA	PMID:25594700
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1313533	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SFR1 mRNA	PMID:23994337
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313532	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of SFR1 gene	PMID:31601247
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313532	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of SFR1 mRNA	PMID:27685785
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313533	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SFR1 mRNA	PMID:39298647
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313532	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SFR1 mRNA	PMID:38174414
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313533	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SFR1 mRNA	PMID:37236586
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313532	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SFR1 mRNA	PMID:24449571
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313532	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SFR1 mRNA	PMID:19167446
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313532	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of SFR1 mRNA	PMID:19167446
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313532	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SFR1 mRNA	PMID:40419075
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SFR1 mRNA	PMID:40128328
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313532	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SFR1 mRNA	PMID:25979313
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313533	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SFR1 mRNA	PMID:17292431
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313532	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SFR1 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of SFR1 mRNA	PMID:41580965
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1313532	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine affects the expression of SFR1 mRNA	PMID:20106945
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313532	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SFR1 mRNA	PMID:25562108|PMID:27989131
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313533	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of SFR1 mRNA	PMID:22733784
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313532	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SFR1 mRNA	PMID:27188386
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SFR1 mRNA	PMID:33387578
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1313533	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of SFR1 mRNA	PMID:26377693
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313533	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of SFR1 mRNA	PMID:27462272
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313533	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SFR1 mRNA	PMID:22206623
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313532	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SFR1 mRNA	PMID:37199045
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313533	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of SFR1 mRNA	PMID:23994337
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of SFR1 mRNA	PMID:32109520
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313533	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of SFR1 mRNA	PMID:40826991
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of SFR1 protein	PMID:35544339
1305481	Sfr1	SWI5-dependent homologous recombination repair protein 1	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313532	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of SFR1 mRNA	PMID:27188386
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313535	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of LRRN2 mRNA	PMID:37995155
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LRRN2 gene	PMID:20938992
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313534	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of LRRN2 mRNA	PMID:30510588
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313534	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LRRN2 mRNA	PMID:31614463
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of LRRN2 mRNA	PMID:33387578
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LRRN2 gene	PMID:20938992
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313534	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRRN2 mRNA	PMID:37042841
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA	PMID:37567420
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA	PMID:37567420
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LRRN2 gene	PMID:20938992
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313534	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRRN2 gene	PMID:25304211
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313535	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of LRRN2 mRNA	PMID:32186404
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313534	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LRRN2 mRNA	PMID:33212167
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313534	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of LRRN2 mRNA	PMID:21198554
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA	PMID:37567420
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313535	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of LRRN2 mRNA	PMID:37682722
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313534	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRRN2 3' UTR; Benzo(a)pyrene affects the methylation of LRRN2 5' UTR	PMID:27901495
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313534	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRRN2 mRNA	PMID:32234424
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313534	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRRN2 promoter	PMID:27901495
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313534	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of LRRN2 mRNA	PMID:35984750
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313535	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRRN2 promoter	PMID:35295148
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313535	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LRRN2 gene	PMID:35295148
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313534	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LRRN2 mRNA	PMID:19710929
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRN2 mRNA	PMID:25181051
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313534	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRN2 mRNA	PMID:27685785
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LRRN2 mRNA	PMID:30816183|PMID:34947998|PMID:38750585
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313535	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of LRRN2 gene	PMID:31683443
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313535	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of LRRN2 exon	PMID:33297965
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313535	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LRRN2 intron	PMID:28392331
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313535	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRRN2 mRNA	PMID:37019170
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of LRRN2 mRNA	PMID:36117858
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313534	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRRN2 mRNA	PMID:29154799
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313534	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LRRN2 gene	PMID:29154799
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313534	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of LRRN2 mRNA	PMID:27989131
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA	PMID:37567420
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313534	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LRRN2 mRNA	PMID:38832940
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313534	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of LRRN2 mRNA	PMID:22230336
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313534	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRRN2 gene	PMID:25304211
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of LRRN2 mRNA	PMID:36117858
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LRRN2 gene	PMID:35440735
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313535	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LRRN2 mRNA	PMID:22206623
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA	PMID:37567420
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313534	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LRRN2 gene]	PMID:28238834
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of LRRN2 mRNA	PMID:27291303
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of LRRN2 mRNA	PMID:19281266
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313534	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of LRRN2 mRNA	PMID:29301935
1305482	Lrrn2	leucine rich repeat neuronal 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of LRRN2 mRNA	PMID:23034163
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313536	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PMS2 mRNA	PMID:38218311
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260811	CTD	MESH:C084079	triptonide results in increased expression of RSPH10B mRNA	PMID:33045310
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313536	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PMS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PMS2 mRNA	PMID:32699268
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313536	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of PMS2 mRNA	PMID:11566570
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313536	E	RGD:6480464	20140513	CTD	MESH:D004958	Estradiol results in decreased expression of PMS2 mRNA	PMID:22082530
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:16480	nitric oxide	increases expression	ISO	RGD:1313537	E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide deficiency results in increased expression of PMS2 mRNA	PMID:15878706
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313536	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PMS2 mRNA	PMID:37042841
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260811	CTD	MESH:D005947	Glucose results in increased expression of RSPH10B mRNA	PMID:39922521
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313537	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in increased expression of PMS2 protein	PMID:20463053
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260811	CTD	MESH:D005947	Glucose results in increased expression of RSPH10B mRNA	PMID:39922521
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PMS2 mRNA	PMID:33387578
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:196991	4-hydroperoxycyclophosphamide	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C011272	perfosfamide results in decreased expression of PMS2 mRNA	PMID:11754170
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313536	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMS2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMS2 protein	PMID:31390735
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313536	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PMS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PMS2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PMS2 mRNA	PMID:32699268
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313537	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PMS2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PMS2 mRNA	PMID:34911549
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313536	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PMS2 mRNA	PMID:11566570
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313537	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PMS2 mRNA	PMID:28960355
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313536	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PMS2 mRNA	PMID:23557933
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27899	cisplatin	affects localization	ISO	RGD:1313536	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the localization of PMS2 protein	PMID:21064154
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313536	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PMS2 mRNA	PMID:27392435
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313536	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PMS2 mRNA	PMID:27392435
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313537	E	RGD:6480464	20130423	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PMS2 mRNA	PMID:21570461
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313537	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PMS2 mRNA	PMID:25975270
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313536	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PMS2 mRNA	PMID:33212167
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313536	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PMS2 mRNA	PMID:38568856
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313537	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PMS2 mRNA	PMID:11353140
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313536	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PMS2 mRNA	PMID:28461126
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313537	E	RGD:6480464	20130423	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PMS2 mRNA	PMID:22228805
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313536	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PMS2 mRNA	PMID:22521957
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PMS2 mRNA	PMID:30047161
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313537	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PMS2 gene	PMID:35295148
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:33007	chromium(6+)	increases response to substance	ISO	RGD:1313537	E	RGD:6480464	20130723	CTD	MESH:C074702	PMS2 protein results in increased susceptibility to chromium hexavalent ion	PMID:15831465
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PMS2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1313537	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of PMS2 mRNA	PMID:36464114
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313537	E	RGD:6480464	20130423	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PMS2 mRNA	PMID:17361019|PMID:21266533
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35019	tributyl phosphate	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260303	CTD	MESH:C009524	tributyl phosphate results in increased expression of PMS2 mRNA	PMID:40389058
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35019	tributyl phosphate	multiple interactions	ISO	RGD:1313537	E	RGD:6480464	20260303	CTD	MESH:C009524	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [tributyl phosphate results in increased expression of PMS2 mRNA]; U 0126 inhibits the reaction [tributyl phosphate results in increased expression of PMS2 mRNA]	PMID:40389058
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313536	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PMS2 mRNA	PMID:37042841
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260303	CTD	MESH:C031324	tris(chloroethyl)phosphate results in increased expression of PMS2 mRNA	PMID:40389058
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313537	E	RGD:6480464	20130423	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PMS2 mRNA	PMID:11958953
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313536	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMS2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMS2 protein	PMID:31390735
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313537	E	RGD:6480464	20130423	CTD	MESH:D019256	MT1 affects the reaction [Cadmium Chloride results in increased expression of PMS2 mRNA]; MT2 affects the reaction [Cadmium Chloride results in increased expression of PMS2 mRNA]	PMID:11958953
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20130402	CTD	MESH:C039281	furan results in increased expression of PMS2 mRNA	PMID:22079235
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PMS2 mRNA	PMID:30047161
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:36704	imiquimod	decreases expression	ISO	RGD:1313537	E	RGD:6480464	20120412	CTD	MESH:C056493	imiquimod results in decreased expression of PMS2 mRNA	PMID:21878529
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313536	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PMS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PMS2 mRNA	PMID:32699268
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313536	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PMS2 mRNA	PMID:32588087
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313537	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PMS2 mRNA	PMID:39529242
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:4027	cyclophosphamide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of PMS2 mRNA	PMID:11056294
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260811	CTD	MESH:D005947	Glucose results in increased expression of RSPH10B mRNA	PMID:39922521
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313537	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PMS2 mRNA	PMID:17562736
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C005223	methyleugenol results in decreased expression of PMS2 mRNA	PMID:21659616
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313536	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PMS2 mRNA	PMID:22521957
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:50102	N-methyl-N-nitrosourea	affects response to substance	ISO	RGD:1313537	E	RGD:6480464	20120412	CTD	MESH:D008770	PMS2 protein affects the susceptibility to Methylnitrosourea	PMID:12967659
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases response to substance	ISO	RGD:1313536	E	RGD:6480464	20120412	CTD	MESH:D008770	PMS2 protein results in increased susceptibility to Methylnitrosourea	PMID:16426742
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:50102	N-methyl-N-nitrosourea	multiple interactions	ISO	RGD:1313536	E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein]	PMID:16204460
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1313536	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of PMS2 mRNA	PMID:22082530
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PMS2 mRNA	PMID:30047161
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313537	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of PMS2 mRNA	PMID:38701926
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:68234	myristicin	decreases expression	ISO	RGD:1313536	E	RGD:6480464	20141111	CTD	MESH:C005246	myristicin results in decreased expression of PMS2 mRNA	PMID:24792648
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1313537	E	RGD:6480464	20130423	CTD	MESH:C047246	PMS2 protein affects the susceptibility to temozolomide	PMID:12967659
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:72564	temozolomide	multiple interactions	ISO	RGD:1313536	E	RGD:6480464	20130402	CTD	MESH:C047246	[temozolomide co-treated with O(6)-benzylguanine] affects the expression of PMS2 protein	PMID:20980775
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1313537	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of PMS2 mRNA	PMID:36464114
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:748866	6-o-benzylguanine	multiple interactions	ISO	RGD:1313536	E	RGD:6480464	20260714	CTD	MESH:C064976	[Temozolomide co-treated with O(6)-benzylguanine] affects the expression of PMS2 protein	PMID:20980775
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:77012	methylseleninic acid	increases expression	ISO	RGD:1313536	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of PMS2 mRNA	PMID:12517777
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PMS2 mRNA	PMID:30047161
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1313536	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of PMS2 mRNA	PMID:16202921
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1313536	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of PMS2 mRNA	PMID:24921660
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313536	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PMS2 mRNA	PMID:38568856
1305483	Pms2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PMS2 mRNA	PMID:21346803
1305484	Dpep3	dipeptidase 3	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313538	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DPEP3 mRNA	PMID:26272509
1305484	Dpep3	dipeptidase 3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313538	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPEP3 mRNA	PMID:27188386
1305484	Dpep3	dipeptidase 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313538	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of DPEP3 mRNA	PMID:20404318
1305484	Dpep3	dipeptidase 3	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DPEP3 mRNA	PMID:33387578
1305484	Dpep3	dipeptidase 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313538	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DPEP3 mRNA	PMID:37042841
1305484	Dpep3	dipeptidase 3	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313538	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of DPEP3 mRNA	PMID:26079696
1305484	Dpep3	dipeptidase 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DPEP3 mRNA	PMID:33387578
1305484	Dpep3	dipeptidase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313538	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DPEP3 mRNA	PMID:35430440
1305484	Dpep3	dipeptidase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313538	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DPEP3 promoter	PMID:27901495
1305484	Dpep3	dipeptidase 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313539	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of DPEP3 mRNA	PMID:29264374
1305484	Dpep3	dipeptidase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313539	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DPEP3 gene	PMID:35295148
1305484	Dpep3	dipeptidase 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313539	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of DPEP3 mRNA	PMID:35295148
1305484	Dpep3	dipeptidase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DPEP3 mRNA	PMID:25181051
1305484	Dpep3	dipeptidase 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313539	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of DPEP3 promoter	PMID:27312807
1305484	Dpep3	dipeptidase 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DPEP3 mRNA	PMID:30816183|PMID:32528016
1305484	Dpep3	dipeptidase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313538	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DPEP3 mRNA	PMID:37042841
1305484	Dpep3	dipeptidase 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313539	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of DPEP3 mRNA	PMID:40194260
1305484	Dpep3	dipeptidase 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313538	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DPEP3 gene	PMID:29154799
1305484	Dpep3	dipeptidase 3	gene	CHEBI:4453	desogestrel	multiple interactions	ISO	RGD:1313538	E	RGD:6480464	20120412	CTD	MESH:D017135	[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DPEP3 mRNA	PMID:18160741
1305484	Dpep3	dipeptidase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DPEP3 mRNA	PMID:33387578
1305484	Dpep3	dipeptidase 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313539	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of DPEP3 mRNA	PMID:38701926
1305484	Dpep3	dipeptidase 3	gene	CHEBI:59224	cetrorelix	multiple interactions	ISO	RGD:1313538	E	RGD:6480464	20120412	CTD	MESH:C062876	[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DPEP3 mRNA; [cetrorelix co-treated with testosterone enanthate] results in decreased expression of DPEP3 mRNA	PMID:18160741
1305484	Dpep3	dipeptidase 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313538	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPEP3 mRNA	PMID:27188386
1305484	Dpep3	dipeptidase 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313539	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of DPEP3 mRNA	PMID:31388691
1305484	Dpep3	dipeptidase 3	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of DPEP3 mRNA	PMID:29162477
1305484	Dpep3	dipeptidase 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313538	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPEP3 mRNA	PMID:27188386
1305484	Dpep3	dipeptidase 3	gene	CHEBI:9464	testosterone enanthate	multiple interactions	ISO	RGD:1313538	E	RGD:6480464	20161213	CTD	MESH:C004648	[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DPEP3 mRNA; [cetrorelix co-treated with testosterone enanthate] results in decreased expression of DPEP3 mRNA	PMID:18160741
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1603675	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TSLIG3A mRNA	PMID:38218311
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of FAM98A mRNA	PMID:25152437
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FAM98A mRNA]	PMID:31150632
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TSLIG3A mRNA	PMID:33167477
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TSLIG3A mRNA	PMID:21632981
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313541	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FAM98A mRNA	PMID:39241906
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of FAM98A mRNA	PMID:32145629
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313541	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FAM98A mRNA	PMID:39298647
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603675	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TSLIG3A mRNA	PMID:31614463
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603675	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TSLIG3A mRNA	PMID:37042841
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1603675	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of TSLIG3A mRNA	PMID:19162166
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1603675	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TSLIG3A mRNA	PMID:21179406
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313541	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of FAM98A mRNA	PMID:20463053
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313541	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of FAM98A mRNA	PMID:33848595
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TSLIG3A protein	PMID:31163220
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1603675	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of TSLIG3A protein	PMID:37730182
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FAM98A mRNA	PMID:22061828
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313541	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of FAM98A mRNA	PMID:37748715
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TSLIG3A mRNA	PMID:39836092
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of FAM98A protein	PMID:34915118
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TSLIG3A protein	PMID:23301498
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TSLIG3A mRNA	PMID:23649840
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313541	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of FAM98A mRNA	PMID:27776689
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TSLIG3A mRNA	PMID:23649840
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of FAM98A mRNA	PMID:31129395
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FAM98A mRNA	PMID:31150632
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313541	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FAM98A mRNA	PMID:27339419|PMID:31919559
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FAM98A mRNA]	PMID:31150632
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313541	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAM98A mRNA	PMID:22206623
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313541	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM98A mRNA	PMID:40504410
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TSLIG3A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSLIG3A mRNA	PMID:39836092
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TSLIG3A protein	PMID:38460933
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TSLIG3A mRNA	PMID:23557933
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of TSLIG3A mRNA	PMID:27594783
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of FAM98A protein	PMID:35544339
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TSLIG3A mRNA	PMID:30851411
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313541	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FAM98A mRNA	PMID:15467011
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TSLIG3A mRNA	PMID:29803840
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313541	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM98A mRNA	PMID:40504410
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20220405	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TSLIG3A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSLIG3A mRNA; sodium arsenite results in decreased expression of and results in increased activity of TSLIG3A protein	PMID:30528433|PMID:39836092
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313541	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FAM98A mRNA	PMID:15467011
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TSLIG3A mRNA	PMID:19150397
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of FAM98A mRNA	PMID:24136188
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313541	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM98A gene	PMID:35295148
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FAM98A mRNA	PMID:34492290
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313541	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of FAM98A mRNA	PMID:23811191
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM98A mRNA	PMID:25181051|PMID:34947998
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of TSLIG3A protein	PMID:31675489|PMID:37567409
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of FAM98A mRNA	PMID:31129395
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313541	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FAM98A mRNA	PMID:39298647
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1603675	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TSLIG3A protein	PMID:34186270
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603675	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TSLIG3A mRNA	PMID:37042841
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TSLIG3A mRNA	PMID:39836092
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1603675	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TSLIG3A mRNA	PMID:24449571
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TSLIG3A mRNA	PMID:31533062
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of TSLIG3A mRNA	PMID:26352163
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603675	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TSLIG3A mRNA	PMID:25979313
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603675	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TSLIG3A mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSLIG3A mRNA	PMID:27188386
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603675	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TSLIG3A mRNA	PMID:20106945
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1603675	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TSLIG3A mRNA	PMID:38832940
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1603675	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TSLIG3A mRNA	PMID:24935251
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TSLIG3A mRNA	PMID:29432896
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313541	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FAM98A mRNA	PMID:29279043
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TSLIG3A protein	PMID:38460933
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313541	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM98A mRNA	PMID:40504410
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TSLIG3A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSLIG3A mRNA	PMID:39836092
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of TSLIG3A mRNA	PMID:31675489
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313541	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FAM98A mRNA	PMID:35436446
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313541	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FAM98A mRNA; Nanotubes, Carbon results in increased expression of FAM98A mRNA	PMID:25554681|PMID:25620056
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of FAM98A mRNA	PMID:24136188
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TSLIG3A protein	PMID:32959892
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of FAM98A mRNA	PMID:20080153
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TSLIG3A mRNA	PMID:39836092
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FAM98A gene	PMID:35440735
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1603675	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TSLIG3A protein	PMID:34186270
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313541	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAM98A mRNA	PMID:22206623
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TSLIG3A mRNA	PMID:30851411
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSLIG3A mRNA	PMID:27188386
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TSLIG3A protein	PMID:31675489
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1603675	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of TSLIG3A protein	PMID:38348393
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313541	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of FAM98A mRNA	PMID:21278054
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313541	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of FAM98A mRNA	PMID:40826991
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603675	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSLIG3A mRNA	PMID:27188386
1305486	Fam98a	family with sequence similarity 98, member A	gene	CHEBI:9763	trovafloxacin	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of FAM98A mRNA	PMID:24136188
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of ACSS2 protein	PMID:39638853
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ACSS2 mRNA	PMID:38218311
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron results in decreased expression of ACSS2 mRNA	PMID:21551480|PMID:24172598
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:131762	dodecyldimethylamine N-oxide	increases expression	ISO	RGD:1313544	E	RGD:6480464	20260407	CTD	MESH:C014518	dodecyldimethylamine oxide results in increased expression of ACSS2 mRNA	PMID:40571133
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1618386	E	RGD:6480464	20160822	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ACSS2 mRNA	PMID:21705711|PMID:37995155
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of ACSS2 protein	PMID:36641056
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1313544	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of ACSS2 mRNA	PMID:31016361
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ACSS2 mRNA	PMID:20188158
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313544	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ACSS2 mRNA	PMID:33167477
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACSS2 mRNA	PMID:36189433
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ACSS2 mRNA	PMID:32699268
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:15379	dioxygen	affects expression	ISO	RGD:1313544	E	RGD:6480464	20190910	CTD	MESH:D010100	Oxygen deficiency affects the expression of ACSS2 protein	PMID:26087400
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313544	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ACSS2 mRNA	PMID:24236059
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSS2 mRNA	PMID:30529165
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACSS2 mRNA	PMID:36331819
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of ACSS2 mRNA	PMID:36841081
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16130	DDT	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D003634	DDT results in increased expression of ACSS2 mRNA	PMID:29477483
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSS2 mRNA	PMID:29432896
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ACSS2 mRNA	PMID:30517762
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ACSS2 mRNA	PMID:27339419
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ACSS2 mRNA	PMID:32145629
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of ACSS2 mRNA	PMID:19484750|PMID:39298647
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1618386	E	RGD:6480464	20171010	CTD	MESH:D004958	Estradiol results in increased expression of ACSS2 mRNA	PMID:28476547
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ACSS2 mRNA	PMID:26496021
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20171010	CTD	MESH:D004958	bisphenol A inhibits the reaction [Estradiol results in increased expression of ACSS2 mRNA]	PMID:28476547
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ACSS2 mRNA	PMID:38568856
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ACSS2 mRNA	PMID:33387578
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313544	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACSS2 mRNA	PMID:37042841
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:166595	Yessotoxin	increases expression	ISO	RGD:1313544	E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in increased expression of ACSS2 mRNA	PMID:30679557
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:16767	3,4-dichloroaniline	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in decreased expression of ACSS2 mRNA	PMID:24172598
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:168262	Ganoderic acid A	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20210504	CTD	MESH:C515005	[Dietary Fats co-treated with ganoderic acid A] affects the expression of ACSS2 mRNA	PMID:29852127
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313544	E	RGD:6480464	20230207	CTD	MESH:D005947	Glucose results in increased expression of ACSS2 mRNA	PMID:36156098|PMID:39613055
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACSS2 mRNA	PMID:36189433
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1618386	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of ACSS2 mRNA	PMID:17178593
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17336	all-trans-retinol	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D014801	Vitamin A deficiency results in decreased expression of ACSS2 mRNA	PMID:12163651
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ACSS2 mRNA	PMID:16579987
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313544	E	RGD:6480464	20230207	CTD	MESH:D005947	Glucose results in increased expression of ACSS2 mRNA	PMID:36156098|PMID:39613055
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ACSS2 protein	PMID:31163220
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ACSS2 mRNA	PMID:19850644
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D004051	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACSS2 mRNA; PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACSS2 mRNA]	PMID:19850644|PMID:28433925
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313544	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ACSS2 protein	PMID:37730182
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ACSS2 mRNA	PMID:22061828|PMID:33387578
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ACSS2 mRNA	PMID:28818685
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1618386	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of ACSS2 mRNA	PMID:27462272
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ACSS2 mRNA	PMID:17178593
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS2 mRNA	PMID:29950665
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ACSS2 mRNA	PMID:19549813
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of ACSS2 mRNA	PMID:23487506
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313544	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ACSS2 protein	PMID:20106945
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ACSS2 mRNA	PMID:21641981|PMID:22100608|PMID:27153756
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313544	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ACSS2 gene	PMID:27153756
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1618386	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of ACSS2 mRNA	PMID:18579281
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1618386	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of ACSS2 mRNA	PMID:33026818
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ACSS2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of ACSS2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA	PMID:32699268|PMID:35430440
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D000638	Amiodarone results in increased expression of ACSS2 mRNA	PMID:32084307|PMID:40216313
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1618386	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of ACSS2 mRNA	PMID:24535564
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACSS2 mRNA	PMID:31150632
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACSS2 mRNA	PMID:27339419|PMID:31919559
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ACSS2 mRNA	PMID:30517762
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSS2 mRNA	PMID:22206623
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS2 mRNA	PMID:32045263
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313544	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ACSS2 protein	PMID:35688186
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ACSS2 mRNA	PMID:28189721|PMID:28960355
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ACSS2 mRNA	PMID:31881176
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313544	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ACSS2 mRNA	PMID:27594783
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ACSS2 mRNA; [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of ACSS2 mRNA	PMID:27392435|PMID:30871063
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:27902	tetracycline	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20150127	CTD	MESH:D013752	Tetracycline results in decreased expression of ACSS2 mRNA	PMID:24489787
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of ACSS2 mRNA	PMID:18930951
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ACSS2 mRNA	PMID:24768652|PMID:25583101
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618386	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACSS2 mRNA	PMID:21570461|PMID:26377647
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACSS2 mRNA	PMID:21215274|PMID:21724226
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACSS2 mRNA	PMID:20106945
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACSS2 mRNA	PMID:19770486
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACSS2 mRNA	PMID:33387578
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20180116	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACSS2 mRNA	PMID:28433925
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28201	rotenone	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of ACSS2 mRNA	PMID:28374803
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313544	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ACSS2 mRNA	PMID:29955902
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1618386	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of ACSS2 mRNA	PMID:32937126
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313544	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ACSS2 mRNA	PMID:33212167
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ACSS2 mRNA	PMID:17178593
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:1618386	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in increased expression of ACSS2 mRNA	PMID:18579281
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ACSS2 mRNA	PMID:32763439
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ACSS2 mRNA	PMID:24690739
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ACSS2 mRNA	PMID:29803840
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313544	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ACSS2 protein	PMID:35688186
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313544	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ACSS2 mRNA	PMID:34032870|PMID:39719251
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1618386	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ACSS2 mRNA	PMID:37682722
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20220208	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS2 mRNA	PMID:32045263
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACSS2 mRNA	PMID:22178795|PMID:26238291|PMID:32234424
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACSS2 mRNA	PMID:22228805
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1618386	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACSS2 mRNA	PMID:19770486|PMID:21964900
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313544	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ACSS2 promoter	PMID:27901495
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ACSS2 mRNA	PMID:24690739
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1313544	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of ACSS2 mRNA	PMID:25075043
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of ACSS2 mRNA	PMID:38458666
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313544	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ACSS2 mRNA	PMID:25895662
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ACSS2 mRNA	PMID:27829220
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ACSS2 mRNA	PMID:24136188
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of ACSS2 mRNA	PMID:32479839
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313544	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of ACSS2 mRNA	PMID:31745603
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:32138	sodium acetate trihydrate	increases expression	ISO	RGD:1313544	E	RGD:6480464	20230207	CTD	MESH:D019346	Sodium Acetate results in increased expression of ACSS2 mRNA	PMID:36156098
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACSS2 mRNA	PMID:23557971
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1618386	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACSS2 promoter alternative form	PMID:35295148
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS2 mRNA	PMID:29950665
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ACSS2 mRNA	PMID:34492290
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ACSS2 mRNA	PMID:18648102
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ACSS2 mRNA	PMID:18445702
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ACSS2 mRNA	PMID:32145629
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313544	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ACSS2 mRNA	PMID:30903817
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313544	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ACSS2 gene	PMID:31601247
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACSS2 mRNA	PMID:25181051
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313544	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ACSS2 protein	PMID:34186270
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1618386	E	RGD:6480464	20171010	CTD	MESH:C006780	bisphenol A results in increased expression of ACSS2 mRNA	PMID:28476547
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of ACSS2 mRNA	PMID:26496021
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20171010	CTD	MESH:C006780	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACSS2 mRNA; bisphenol A inhibits the reaction [Estradiol results in increased expression of ACSS2 mRNA]	PMID:28433925|PMID:28476547
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20180116	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACSS2 mRNA	PMID:28433925
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of ACSS2 mRNA	PMID:30316929
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1618386	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ACSS2 mRNA	PMID:39298647
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ACSS2 mRNA	PMID:40203079
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313544	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ACSS2 protein	PMID:34186270
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313544	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ACSS2 protein	PMID:34186270
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1618386	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ACSS2 protein	PMID:35362542
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS2 mRNA; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ACSS2 protein]	PMID:29950665|PMID:35362542
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ACSS2 mRNA	PMID:21266533
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ACSS2 mRNA	PMID:21266533
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSS2 mRNA	PMID:28628672
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACSS2 mRNA	PMID:30589522
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313544	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACSS2 mRNA	PMID:37042841
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of ACSS2 mRNA	PMID:38458666
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ACSS2 mRNA	PMID:35163327
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ACSS2 mRNA	PMID:30723492
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20200915	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ACSS2 mRNA	PMID:32588087
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1618386	E	RGD:6480464	20190507	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ACSS2 mRNA	PMID:30657992
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ACSS2 mRNA	PMID:35163327
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ACSS2 mRNA	PMID:28903501
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ACSS2 mRNA	PMID:32699268
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ACSS2 mRNA	PMID:32588087
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1618386	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACSS2 mRNA	PMID:40194260
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313544	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ACSS2 mRNA	PMID:31533062
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20200915	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ACSS2 mRNA	PMID:32588087|PMID:36864359|PMID:40419075
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACSS2 mRNA	PMID:36331819
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1618386	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ACSS2 mRNA	PMID:23125180
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of ACSS2 mRNA	PMID:25993096
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313544	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ACSS2 mRNA	PMID:25979313
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ACSS2 mRNA	PMID:17292431
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ACSS2 mRNA	PMID:29154799
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313544	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ACSS2 gene	PMID:29154799
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1618386	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of ACSS2 mRNA	PMID:21427059|PMID:24535564
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of ACSS2 mRNA	PMID:38685447
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:40303	lovastatin	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20181016	CTD	MESH:D008148	[Dietary Fats co-treated with Lovastatin] affects the expression of ACSS2 mRNA	PMID:29852127
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACSS2 mRNA	PMID:21865292
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20140408	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACSS2 mRNA	PMID:20106945|PMID:23830897
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20140408	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACSS2 mRNA	PMID:23830897
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313544	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of ACSS2 mRNA	PMID:27989131
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ACSS2 mRNA	PMID:20937368
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313544	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of ACSS2 mRNA	PMID:25047013
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSS2 mRNA	PMID:28628672
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313544	E	RGD:6480464	20230207	CTD	MESH:D005947	Glucose results in increased expression of ACSS2 mRNA	PMID:36156098|PMID:39613055
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313544	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of ACSS2 mRNA	PMID:17400583
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:44658	okadaic acid	affects expression	ISO	RGD:1313544	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid affects the expression of ACSS2 protein	PMID:38832940
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:45409	ritonavir	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019438	Ritonavir affects the expression of ACSS2 mRNA	PMID:17719200
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACSS2 mRNA	PMID:17562736
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACSS2 mRNA	PMID:29067470
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ACSS2 mRNA	PMID:33387578
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1313544	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ACSS2 mRNA	PMID:24714768
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of ACSS2 mRNA	PMID:24690739
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSS2 mRNA	PMID:29432896
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS2 mRNA	PMID:32045263
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:47612	bezafibrate	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001629	Bezafibrate affects the expression of ACSS2 mRNA	PMID:17719200
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of ACSS2 mRNA	PMID:29391264
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ACSS2 mRNA	PMID:17178593
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1313544	E	RGD:6480464	20201006	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of ACSS2 mRNA	PMID:32512070
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ACSS2 mRNA	PMID:35436446
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ACSS2 mRNA	PMID:32234424
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ACSS2 protein]	PMID:35362542
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20220705	CTD	MESH:C029892	cupric chloride results in decreased expression of ACSS2 mRNA	PMID:34921933|PMID:38568856
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of ACSS2 mRNA	PMID:36868495
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSS2 mRNA	PMID:28628672
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ACSS2 mRNA	PMID:27829220
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of ACSS2 mRNA	PMID:25572481
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1313544	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of ACSS2 mRNA	PMID:25075043
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ACSS2 mRNA; Nanotubes, Carbon results in decreased expression of ACSS2 mRNA	PMID:25554681|PMID:25620056
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1618386	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in increased expression of ACSS2 mRNA	PMID:25086211
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:5118	fluoxetine	increases expression	ISO	RGD:1313544	E	RGD:6480464	20240206	CTD	MESH:D005473	Fluoxetine results in increased expression of ACSS2 mRNA	PMID:37386098
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313544	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ACSS2 mRNA	PMID:22714537
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313544	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ACSS2 protein	PMID:23718831
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACSS2 protein	PMID:32959892
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of ACSS2 mRNA	PMID:28801915
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:63630	tolcapone	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in increased expression of ACSS2 mRNA	PMID:24136188
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ACSS2 mRNA	PMID:28801915
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:65585	carnosic acid	increases expression	ISO	RGD:1618386	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in increased expression of ACSS2 protein	PMID:35926579
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1618386	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of ACSS2 mRNA	PMID:27462272
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ACSS2 mRNA	PMID:31758290
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313544	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ACSS2 protein	PMID:34186270
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACSS2 mRNA	PMID:22206623
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSS2 mRNA	PMID:22206623
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ACSS2 mRNA	PMID:24136188
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1313544	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of ACSS2 mRNA	PMID:28960945
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of ACSS2 mRNA	PMID:19717638
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313544	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of ACSS2 protein	PMID:39638853
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313544	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ACSS2 gene]	PMID:28238834
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACSS2 protein	PMID:31675489
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ACSS2 mRNA	PMID:24780913
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ACSS2 mRNA	PMID:21346803
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ACSS2 mRNA	PMID:38568856
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ACSS2 mRNA	PMID:21346803
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of ACSS2 mRNA	PMID:32835833
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313544	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of ACSS2 mRNA	PMID:25572481
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ACSS2 mRNA	PMID:35537566
1305489	Acss2	acyl-CoA synthetase short-chain family member 2	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of ACSS2 gene	PMID:31079544
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:10043	wogonin	multiple interactions	ISO	RGD:1313547	E	RGD:6480464	20240305	CTD	MESH:C085514	wogonin inhibits the reaction [Ovalbumin results in increased expression of RUNX1T1 mRNA]	PMID:37004399
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1350261	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RUNX1T1 mRNA	PMID:26272509
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA	PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of RUNX1T1 mRNA	PMID:33045310
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RUNX1T1 mRNA	PMID:30071829
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313547	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RUNX1T1 mRNA	PMID:20938992
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of RUNX1T1 mRNA	PMID:16604517
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RUNX1T1 mRNA	PMID:39241906
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1350261	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RUNX1T1 mRNA	PMID:35811015
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RUNX1T1 mRNA	PMID:35811015
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of RUNX1T1 mRNA	PMID:25210133
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of RUNX1T1 mRNA	PMID:30165855
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of RUNX1T1 mRNA	PMID:23829299
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313547	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RUNX1T1 mRNA	PMID:20938992
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of RUNX1T1 mRNA	PMID:18247414
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1350261	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RUNX1T1 mRNA	PMID:31163220
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313547	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RUNX1T1 protein	PMID:16467308
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313547	E	RGD:6480464	20120412	CTD	MESH:D002117	[Calcitriol results in increased expression of RUNX1T1 protein] which results in decreased activity of CEBPB protein	PMID:16467308
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RUNX1T1 mRNA	PMID:33387578
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of RUNX1T1 mRNA	PMID:18247414
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUNX1T1 mRNA	PMID:35301059
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1350261	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RUNX1T1 gene	PMID:27153756
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1350261	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of RUNX1T1 mRNA	PMID:18356318
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313547	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RUNX1T1 mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RUNX1T1 mRNA]	PMID:20938992|PMID:22206623
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of RUNX1T1 mRNA	PMID:19244175
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1350261	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RUNX1T1 mRNA	PMID:26272509
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA	PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of RUNX1T1 gene	PMID:31011160
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:27878	2-naphthylamine	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20120412	CTD	MESH:D015081	2-Naphthylamine results in decreased expression of RUNX1T1 mRNA	PMID:18247414
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RUNX1T1 mRNA	PMID:23557933
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1350261	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of RUNX1T1 mRNA	PMID:28903495
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of RUNX1T1 mRNA	PMID:17898221
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of RUNX1T1 mRNA	PMID:24768652|PMID:25583101
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RUNX1T1 mRNA	PMID:24058054
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RUNX1T1 mRNA	PMID:33387578
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1350261	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RUNX1T1 mRNA	PMID:21296121
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1350261	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RUNX1T1 mRNA	PMID:23179753|PMID:28001369
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of RUNX1T1 mRNA	PMID:30807115
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RUNX1T1 mRNA	PMID:29803840
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of RUNX1T1 mRNA	PMID:22363485
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1313547	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of RUNX1T1 mRNA	PMID:17170073
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of RUNX1T1 mRNA	PMID:37682722
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of RUNX1T1 mRNA	PMID:22378314
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RUNX1T1 mRNA	PMID:18247414
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313547	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RUNX1T1 mRNA	PMID:22228805
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350261	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RUNX1T1 promoter	PMID:27901495
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1350261	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of RUNX1T1 mRNA	PMID:18356318
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of RUNX1T1 gene	PMID:31601247
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RUNX1T1 mRNA	PMID:30047161
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of RUNX1T1 mRNA	PMID:27760801|PMID:29264374
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of RUNX1T1 mRNA	PMID:23411599
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313547	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RUNX1T1 mRNA	PMID:19710929
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of RUNX1T1 mRNA	PMID:38479592
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313547	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of RUNX1T1 promoter	PMID:27334623
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1350261	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RUNX1T1 gene	PMID:31601247
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RUNX1T1 mRNA	PMID:25181051
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1350261	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of RUNX1T1 mRNA	PMID:20678512
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of RUNX1T1 mRNA	PMID:25172293
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RUNX1T1 mRNA	PMID:19244175
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of RUNX1T1 mRNA	PMID:19244175
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl affects the expression of RUNX1T1 mRNA	PMID:23829299
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of RUNX1T1 gene	PMID:31601247
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of RUNX1T1 mRNA	PMID:18500788
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RUNX1T1 promoter	PMID:22457795
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUNX1T1 mRNA	PMID:35301059
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of RUNX1T1 mRNA	PMID:27387713
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of RUNX1T1 mRNA	PMID:19244175
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of RUNX1T1 mRNA	PMID:29038090
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of RUNX1T1 mRNA	PMID:23125180
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313547	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RUNX1T1 mRNA	PMID:17292431
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1350261	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RUNX1T1 mRNA	PMID:25979313
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RUNX1T1 mRNA	PMID:23179753|PMID:23527032|PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1350261	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RUNX1T1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA	PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RUNX1T1 mRNA	PMID:30047161
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1350261	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of RUNX1T1 promoter	PMID:27989131
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:41607	crotonaldehyde	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of RUNX1T1 mRNA	PMID:20471460
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1350261	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of RUNX1T1 mRNA	PMID:16202921
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313547	E	RGD:6480464	20240305	CTD	MESH:D003907	Dexamethasone inhibits the reaction [Ovalbumin results in increased expression of RUNX1T1 mRNA]	PMID:37004399
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RUNX1T1 mRNA	PMID:38832940
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of RUNX1T1 mRNA	PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1350261	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RUNX1T1 mRNA	PMID:26272509
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA	PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1350261	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of RUNX1T1 mRNA	PMID:24935251|PMID:26272509
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA	PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RUNX1T1 mRNA	PMID:33387578
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RUNX1T1 mRNA	PMID:35811015
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313547	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RUNX1T1 mRNA	PMID:17942748
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1350261	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of RUNX1T1 mRNA	PMID:26272509
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of RUNX1T1 mRNA	PMID:30307764
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RUNX1T1 mRNA; Nanotubes, Carbon results in decreased expression of RUNX1T1 mRNA	PMID:25554681
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RUNX1T1 mRNA	PMID:30047161
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1350261	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of RUNX1T1 mRNA	PMID:26272509
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA	PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RUNX1T1 mRNA	PMID:16934159
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of RUNX1T1 mRNA	PMID:24810058
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:64153	tanespimycin	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20220111	CTD	MESH:C112765	tanespimycin results in decreased expression of RUNX1T1 protein mutant form	PMID:33609515
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1350261	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RUNX1T1 mRNA	PMID:22079614
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1313547	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RUNX1T1 mRNA	PMID:27935865
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313547	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RUNX1T1 mRNA	PMID:22206623
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313547	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RUNX1T1 mRNA]	PMID:22206623
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of RUNX1T1 mRNA	PMID:33484710
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA	PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RUNX1T1 gene]	PMID:28238834
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1313547	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of RUNX1T1 mRNA	PMID:26655953
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:8093	phenylephrine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in decreased expression of RUNX1T1 mRNA	PMID:18158353
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313547	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of RUNX1T1 mRNA	PMID:31388691
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313547	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RUNX1T1 mRNA	PMID:27935865
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RUNX1T1 mRNA	PMID:30047161
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RUNX1T1 mRNA	PMID:24780913|PMID:36843608
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1350261	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of RUNX1T1 mRNA	PMID:26272509
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA	PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:87368	diethyl malate	affects expression	ISO	RGD:1313547	E	RGD:6480464	20170303	CTD	MESH:C058705	diethyl malate affects the expression of RUNX1T1 mRNA	PMID:24814887
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1350261	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX1T1 mRNA	PMID:27188386
1305490	Runx1t1	RUNX1 partner transcriptional co-repressor 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RUNX1T1 mRNA	PMID:19015723
1305491	Rnf2	ring finger protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313549	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RNF2 mRNA	PMID:30319688
1305491	Rnf2	ring finger protein 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313549	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RNF2 mRNA	PMID:30319688
1305491	Rnf2	ring finger protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20260602	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF2 mRNA; Lipopolysaccharides results in decreased expression of RNF2 protein	PMID:39241906|PMID:40465481
1305491	Rnf2	ring finger protein 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20260602	CTD	MESH:D008070	naringenin inhibits the reaction [Lipopolysaccharides results in decreased expression of RNF2 protein]	PMID:40465481
1305491	Rnf2	ring finger protein 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RNF2 mRNA	PMID:26577399
1305491	Rnf2	ring finger protein 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313548	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RNF2 protein	PMID:37730182
1305491	Rnf2	ring finger protein 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313548	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RNF2 mRNA	PMID:16002434
1305491	Rnf2	ring finger protein 2	gene	CHEBI:17846	(S)-naringenin	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20260602	CTD	MESH:C005273	naringenin inhibits the reaction [Lipopolysaccharides results in decreased expression of RNF2 protein]	PMID:40465481
1305491	Rnf2	ring finger protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNF2 mRNA	PMID:37236586
1305491	Rnf2	ring finger protein 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313548	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RNF2 protein	PMID:23301498
1305491	Rnf2	ring finger protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313549	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RNF2 mRNA	PMID:19770486
1305491	Rnf2	ring finger protein 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313549	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in increased expression of RNF2 mRNA	PMID:15674843|PMID:26392148
1305491	Rnf2	ring finger protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313548	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RNF2 protein	PMID:35688186
1305491	Rnf2	ring finger protein 2	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1313549	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of RNF2 protein	PMID:22006019
1305491	Rnf2	ring finger protein 2	gene	CHEBI:27928	parathion	decreases methylation	ISO	RGD:1313548	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of RNF2 promoter	PMID:22847954
1305491	Rnf2	ring finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313549	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF2 mRNA	PMID:24680724
1305491	Rnf2	ring finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF2 mRNA	PMID:19770486
1305491	Rnf2	ring finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313549	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RNF2 mRNA	PMID:15034205
1305491	Rnf2	ring finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RNF2 mRNA]	PMID:15034205
1305491	Rnf2	ring finger protein 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of RNF2 protein	PMID:35544339
1305491	Rnf2	ring finger protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313548	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RNF2 mRNA	PMID:33212167
1305491	Rnf2	ring finger protein 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313548	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RNF2 mRNA	PMID:30851411
1305491	Rnf2	ring finger protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313548	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF2 mRNA	PMID:29803840
1305491	Rnf2	ring finger protein 2	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313548	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RNF2 mRNA	PMID:25523186
1305491	Rnf2	ring finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNF2 mRNA	PMID:15034205
1305491	Rnf2	ring finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313548	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RNF2 promoter	PMID:27901495
1305491	Rnf2	ring finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases response to substance	ISO	RGD:1313548	E	RGD:6480464	20140211	CTD	MESH:D001564	RNF2 protein results in decreased susceptibility to Benzo(a)pyrene	PMID:23712474
1305491	Rnf2	ring finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of RNF2 mRNA]	PMID:15034205
1305491	Rnf2	ring finger protein 2	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313548	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RNF2 mRNA	PMID:25523186
1305491	Rnf2	ring finger protein 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RNF2 mRNA	PMID:27131904
1305491	Rnf2	ring finger protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313549	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF2 promoter	PMID:35295148
1305491	Rnf2	ring finger protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313549	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RNF2 gene	PMID:35295148
1305491	Rnf2	ring finger protein 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RNF2 mRNA	PMID:34492290
1305491	Rnf2	ring finger protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RNF2 mRNA	PMID:30723492
1305491	Rnf2	ring finger protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RNF2 mRNA	PMID:20059764
1305491	Rnf2	ring finger protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of RNF2 mRNA]	PMID:20059764
1305491	Rnf2	ring finger protein 2	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	ISO	RGD:1313548	E	RGD:6480464	20180515	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of RNF2 5' UTR	PMID:28843141
1305491	Rnf2	ring finger protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RNF2 mRNA	PMID:25181051
1305491	Rnf2	ring finger protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313548	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RNF2 gene	PMID:31601247
1305491	Rnf2	ring finger protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of RNF2 mRNA	PMID:30816183
1305491	Rnf2	ring finger protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF2 gene	PMID:28505145
1305491	Rnf2	ring finger protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313549	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RNF2 mRNA	PMID:39298647
1305491	Rnf2	ring finger protein 2	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein	PMID:34896426
1305491	Rnf2	ring finger protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313549	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RNF2 mRNA	PMID:28392331
1305491	Rnf2	ring finger protein 2	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of RNF2 mRNA]	PMID:19030233
1305491	Rnf2	ring finger protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNF2 mRNA	PMID:37236586
1305491	Rnf2	ring finger protein 2	gene	CHEBI:37825	p-toluidine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of RNF2 mRNA	PMID:27638505
1305491	Rnf2	ring finger protein 2	gene	CHEBI:38689	fonofos	decreases methylation	ISO	RGD:1313548	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of RNF2 promoter	PMID:22847954
1305491	Rnf2	ring finger protein 2	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of RNF2 protein	PMID:34896426
1305491	Rnf2	ring finger protein 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313548	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RNF2 gene	PMID:29154799
1305491	Rnf2	ring finger protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of RNF2 mRNA	PMID:19770486
1305491	Rnf2	ring finger protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313548	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF2 mRNA	PMID:20106945
1305491	Rnf2	ring finger protein 2	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein	PMID:34896426
1305491	Rnf2	ring finger protein 2	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein	PMID:34896426
1305491	Rnf2	ring finger protein 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313548	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RNF2 mRNA	PMID:36621641
1305491	Rnf2	ring finger protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313549	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF2 mRNA	PMID:17562736
1305491	Rnf2	ring finger protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313548	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF2 protein	PMID:22230336
1305491	Rnf2	ring finger protein 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313549	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RNF2 mRNA	PMID:35436446
1305491	Rnf2	ring finger protein 2	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein	PMID:34896426
1305491	Rnf2	ring finger protein 2	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1313548	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of RNF2 mRNA	PMID:20977926
1305491	Rnf2	ring finger protein 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313548	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RNF2 protein	PMID:32959892
1305491	Rnf2	ring finger protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RNF2 mRNA	PMID:22206623
1305491	Rnf2	ring finger protein 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313548	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RNF2 protein	PMID:37664457
1305491	Rnf2	ring finger protein 2	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of RNF2 mRNA	PMID:23358140
1305491	Rnf2	ring finger protein 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313548	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RNF2 mRNA	PMID:30851411
1305491	Rnf2	ring finger protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313548	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RNF2 gene]	PMID:28238834
1305491	Rnf2	ring finger protein 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313548	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of RNF2 mRNA	PMID:19159669
1305491	Rnf2	ring finger protein 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313549	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of RNF2 mRNA	PMID:31388691
1305491	Rnf2	ring finger protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RNF2 mRNA	PMID:24780913
1305491	Rnf2	ring finger protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313548	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RNF2 protein	PMID:37664457
1305491	Rnf2	ring finger protein 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RNF2 mRNA	PMID:27131904
1305491	Rnf2	ring finger protein 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RNF2 mRNA	PMID:21346803
1305491	Rnf2	ring finger protein 2	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of RNF2 mRNA	PMID:28946194
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1607008	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of GPBP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of GPBP1 mRNA	PMID:32699268
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313550	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of GPBP1 mRNA	PMID:22629407
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313550	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of GPBP1 mRNA]	PMID:22629407
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of GPBP1 mRNA	PMID:23829299
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1607008	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of GPBP1 mRNA	PMID:20655997
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1607008	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of GPBP1 mRNA	PMID:33359661
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1607008	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of GPBP1 protein	PMID:37730182
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of GPBP1 mRNA	PMID:22061828
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GPBP1 mRNA	PMID:33387578
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1607008	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of GPBP1 mRNA	PMID:28818685
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1607008	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of GPBP1 intron	PMID:30157460
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313550	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of GPBP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPBP1 mRNA	PMID:28111341|PMID:37325564
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1607008	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of GPBP1 mRNA	PMID:19549813
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313550	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of GPBP1 mRNA	PMID:19376150
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1607008	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GPBP1 gene	PMID:27153756
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1607008	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of GPBP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of GPBP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of GPBP1 mRNA	PMID:32699268
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1607008	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GPBP1 mRNA	PMID:18593933
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313550	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of GPBP1 mRNA]	PMID:22206623
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313550	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GPBP1 mRNA	PMID:40504410
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1607008	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of GPBP1 protein	PMID:35688186
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313550	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPBP1 mRNA	PMID:21570461
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313550	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GPBP1 mRNA	PMID:24058054
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1607008	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GPBP1 mRNA	PMID:28001369
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1607008	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GPBP1 mRNA	PMID:33212167
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1607008	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of GPBP1 mRNA	PMID:32763439
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1607008	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GPBP1 mRNA	PMID:29803840
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313550	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of GPBP1 mRNA	PMID:20829426
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1607008	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of GPBP1 mRNA	PMID:39719251
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1607008	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GPBP1 mRNA	PMID:38568856
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313550	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GPBP1 mRNA	PMID:40504410
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1607008	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GPBP1 intron	PMID:30157460
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1607008	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GPBP1 mRNA	PMID:18593933
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1607008	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of GPBP1 mRNA	PMID:26014281
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1607008	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GPBP1 mRNA	PMID:19150397
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313550	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GPBP1 gene	PMID:35295148
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313550	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of GPBP1 gene	PMID:35295148
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of GPBP1 mRNA	PMID:23411599
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of GPBP1 mRNA	PMID:30723492
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313550	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of GPBP1 mRNA	PMID:18648102
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of GPBP1 mRNA	PMID:19167457
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GPBP1 mRNA	PMID:25181051
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313550	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of GPBP1 promoter	PMID:27312807
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of GPBP1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313550	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of GPBP1 mRNA	PMID:40036665
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1607008	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of GPBP1 gene	PMID:31601247
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313550	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of GPBP1 mRNA	PMID:34813904
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313550	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of GPBP1 mRNA	PMID:34813904
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313550	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of GPBP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPBP1 mRNA	PMID:28111341|PMID:37325564
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of GPBP1 mRNA	PMID:30047161
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1607008	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of GPBP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of GPBP1 mRNA	PMID:32699268
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1607008	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GPBP1 mRNA	PMID:28302478
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1607008	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GPBP1 mRNA	PMID:31533062
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1607008	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of GPBP1 mRNA	PMID:23179753
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of GPBP1 mRNA	PMID:30047161
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1607008	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of GPBP1 mRNA	PMID:24449571
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1607008	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of GPBP1 mRNA	PMID:21420995
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313550	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GPBP1 mRNA	PMID:40504410
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1607008	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of GPBP1 mRNA	PMID:18175754
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of GPBP1 mRNA	PMID:30047161
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1313550	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of GPBP1 mRNA	PMID:20829426
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313550	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPBP1 mRNA	PMID:21641980
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1313550	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of GPBP1 mRNA	PMID:20829426
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313550	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GPBP1 mRNA	PMID:22206623
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313550	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of GPBP1 mRNA]	PMID:22206623
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1607008	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of GPBP1 mRNA	PMID:30928695
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1313550	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 promotes the reaction [NR1H4 protein binds to GPBP1 gene]	PMID:20091679
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313550	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of GPBP1 mRNA	PMID:23091169
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313550	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of GPBP1 mRNA	PMID:19270015
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313550	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of GPBP1 mRNA	PMID:21795629
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of GPBP1 mRNA	PMID:26923065
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GPBP1 mRNA	PMID:30047161
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313550	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of GPBP1 mRNA	PMID:40826991
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1607008	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of GPBP1 mRNA	PMID:26014281
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of GPBP1 mRNA	PMID:19015723
1305492	Gpbp1	GC-rich promoter binding protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of GPBP1 mRNA	PMID:20566332
1305493	Sema6a	semaphorin 6A	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313551	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SEMA6A mRNA	PMID:26272509
1305493	Sema6a	semaphorin 6A	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA	PMID:27188386
1305493	Sema6a	semaphorin 6A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1617604	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SEMA6A mRNA	PMID:33045310
1305493	Sema6a	semaphorin 6A	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SEMA6A mRNA	PMID:37995155
1305493	Sema6a	semaphorin 6A	gene	CHEBI:135937	enzacamene	increases expression	ISO	RGD:1313551	E	RGD:6480464	20190409	CTD	MESH:C038939	enzacamene results in increased expression of SEMA6A mRNA	PMID:30597193
1305493	Sema6a	semaphorin 6A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SEMA6A gene	PMID:20938992
1305493	Sema6a	semaphorin 6A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SEMA6A mRNA	PMID:23724009
1305493	Sema6a	semaphorin 6A	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313551	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of SEMA6A mRNA	PMID:22378314
1305493	Sema6a	semaphorin 6A	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1617604	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of SEMA6A mRNA	PMID:30319688
1305493	Sema6a	semaphorin 6A	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1617604	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SEMA6A mRNA	PMID:30319688
1305493	Sema6a	semaphorin 6A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SEMA6A mRNA	PMID:35811015
1305493	Sema6a	semaphorin 6A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313551	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of SEMA6A mRNA	PMID:21185374
1305493	Sema6a	semaphorin 6A	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA	PMID:25510870
1305493	Sema6a	semaphorin 6A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SEMA6A gene	PMID:20938992
1305493	Sema6a	semaphorin 6A	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313551	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SEMA6A mRNA	PMID:21179406
1305493	Sema6a	semaphorin 6A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20250902	CTD	MESH:D005947	[imeglimin co-treated with Glucose] results in increased expression of SEMA6A mRNA	PMID:34588186
1305493	Sema6a	semaphorin 6A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20250902	CTD	MESH:D005947	[imeglimin co-treated with Glucose] results in increased expression of SEMA6A mRNA	PMID:34588186
1305493	Sema6a	semaphorin 6A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313551	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SEMA6A protein	PMID:31163220
1305493	Sema6a	semaphorin 6A	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of SEMA6A mRNA	PMID:37748715
1305493	Sema6a	semaphorin 6A	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SEMA6A mRNA	PMID:28522335
1305493	Sema6a	semaphorin 6A	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA	PMID:25510870
1305493	Sema6a	semaphorin 6A	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA	PMID:25510870
1305493	Sema6a	semaphorin 6A	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SEMA6A mRNA	PMID:22100608
1305493	Sema6a	semaphorin 6A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SEMA6A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SEMA6A mRNA	PMID:27106289|PMID:34911549
1305493	Sema6a	semaphorin 6A	gene	CHEBI:2666	amitriptyline	increases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D000639	Amitriptyline results in increased expression of SEMA6A mRNA	PMID:22341215
1305493	Sema6a	semaphorin 6A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SEMA6A gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of SEMA6A mRNA]	PMID:20938992|PMID:22206623
1305493	Sema6a	semaphorin 6A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEMA6A mRNA	PMID:40504410
1305493	Sema6a	semaphorin 6A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA	PMID:27188386
1305493	Sema6a	semaphorin 6A	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313551	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SEMA6A protein	PMID:35688186
1305493	Sema6a	semaphorin 6A	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1313551	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of SEMA6A mRNA	PMID:28903495
1305493	Sema6a	semaphorin 6A	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of SEMA6A mRNA	PMID:19921347
1305493	Sema6a	semaphorin 6A	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313551	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of SEMA6A promoter	PMID:22847954
1305493	Sema6a	semaphorin 6A	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of SEMA6A mRNA	PMID:18000554
1305493	Sema6a	semaphorin 6A	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of SEMA6A mRNA	PMID:15691709
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEMA6A mRNA	PMID:22298810
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SEMA6A mRNA	PMID:33387578|PMID:34747641
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SEMA6A mRNA	PMID:19933214
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SEMA6A mRNA	PMID:32109520
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313551	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SEMA6A mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA	PMID:27188386
1305493	Sema6a	semaphorin 6A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SEMA6A mRNA	PMID:33212167
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1313551	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of SEMA6A mRNA	PMID:26272509
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SEMA6A mRNA	PMID:32763439
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SEMA6A mRNA	PMID:29803840
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313551	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SEMA6A protein	PMID:35688186
1305493	Sema6a	semaphorin 6A	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313551	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SEMA6A mRNA	PMID:20044591
1305493	Sema6a	semaphorin 6A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of and affects the splicing of SEMA6A mRNA	PMID:25879800
1305493	Sema6a	semaphorin 6A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEMA6A mRNA	PMID:40504410
1305493	Sema6a	semaphorin 6A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313551	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SEMA6A 5' UTR	PMID:27901495
1305493	Sema6a	semaphorin 6A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SEMA6A mRNA	PMID:20106945
1305493	Sema6a	semaphorin 6A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SEMA6A mRNA	PMID:21569818
1305493	Sema6a	semaphorin 6A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313551	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SEMA6A exon	PMID:27901495
1305493	Sema6a	semaphorin 6A	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313551	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of SEMA6A promoter	PMID:23974009
1305493	Sema6a	semaphorin 6A	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of SEMA6A mRNA	PMID:26551752|PMID:28959546
1305493	Sema6a	semaphorin 6A	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SEMA6A mRNA	PMID:38458666
1305493	Sema6a	semaphorin 6A	gene	CHEBI:30563	silicon dioxide	decreases methylation	ISO	RGD:1313551	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased methylation of SEMA6A gene	PMID:34973136
1305493	Sema6a	semaphorin 6A	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313551	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SEMA6A mRNA	PMID:34973136
1305493	Sema6a	semaphorin 6A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SEMA6A gene	PMID:31601247
1305493	Sema6a	semaphorin 6A	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of SEMA6A mRNA	PMID:22613225
1305493	Sema6a	semaphorin 6A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617604	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SEMA6A gene	PMID:35295148
1305493	Sema6a	semaphorin 6A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SEMA6A mRNA	PMID:18648102
1305493	Sema6a	semaphorin 6A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of SEMA6A mRNA	PMID:30816183
1305493	Sema6a	semaphorin 6A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of SEMA6A mRNA	PMID:31129395
1305493	Sema6a	semaphorin 6A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of SEMA6A mRNA	PMID:23146750
1305493	Sema6a	semaphorin 6A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1617604	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SEMA6A mRNA	PMID:34585602|PMID:35479511
1305493	Sema6a	semaphorin 6A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SEMA6A gene	PMID:31601247
1305493	Sema6a	semaphorin 6A	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of SEMA6A mRNA	PMID:23146750
1305493	Sema6a	semaphorin 6A	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA	PMID:25510870
1305493	Sema6a	semaphorin 6A	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA	PMID:25510870
1305493	Sema6a	semaphorin 6A	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of SEMA6A mRNA	PMID:23146750
1305493	Sema6a	semaphorin 6A	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of SEMA6A mRNA	PMID:26377693
1305493	Sema6a	semaphorin 6A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SEMA6A mRNA	PMID:38685157
1305493	Sema6a	semaphorin 6A	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1617604	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SEMA6A mRNA	PMID:37019170
1305493	Sema6a	semaphorin 6A	gene	CHEBI:34682	diazinon	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D003976	Diazinon results in increased expression of SEMA6A mRNA	PMID:29108742
1305493	Sema6a	semaphorin 6A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313551	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEMA6A mRNA	PMID:37042841
1305493	Sema6a	semaphorin 6A	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SEMA6A mRNA	PMID:38458666
1305493	Sema6a	semaphorin 6A	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SEMA6A mRNA	PMID:23146750
1305493	Sema6a	semaphorin 6A	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SEMA6A mRNA	PMID:24386269
1305493	Sema6a	semaphorin 6A	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SEMA6A mRNA	PMID:24386269
1305493	Sema6a	semaphorin 6A	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313551	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SEMA6A mRNA	PMID:28302478
1305493	Sema6a	semaphorin 6A	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313551	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of SEMA6A promoter	PMID:22847954
1305493	Sema6a	semaphorin 6A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313551	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SEMA6A mRNA	PMID:31533062
1305493	Sema6a	semaphorin 6A	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313551	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of SEMA6A promoter	PMID:22847954
1305493	Sema6a	semaphorin 6A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313551	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SEMA6A mRNA	PMID:25979313
1305493	Sema6a	semaphorin 6A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1617604	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SEMA6A mRNA	PMID:17292431
1305493	Sema6a	semaphorin 6A	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SEMA6A mRNA	PMID:29427782
1305493	Sema6a	semaphorin 6A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SEMA6A mRNA	PMID:23179753
1305493	Sema6a	semaphorin 6A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313551	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SEMA6A mRNA	PMID:19101580
1305493	Sema6a	semaphorin 6A	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SEMA6A mRNA	PMID:38685447|PMID:41580965
1305493	Sema6a	semaphorin 6A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SEMA6A mRNA	PMID:28973697
1305493	Sema6a	semaphorin 6A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20250902	CTD	MESH:D005947	[imeglimin co-treated with Glucose] results in increased expression of SEMA6A mRNA	PMID:34588186
1305493	Sema6a	semaphorin 6A	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SEMA6A mRNA	PMID:27188386
1305493	Sema6a	semaphorin 6A	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313551	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SEMA6A mRNA	PMID:24935251
1305493	Sema6a	semaphorin 6A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313551	E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of SEMA6A mRNA	PMID:25458485
1305493	Sema6a	semaphorin 6A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1617604	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SEMA6A mRNA	PMID:17562736
1305493	Sema6a	semaphorin 6A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SEMA6A mRNA	PMID:33387578
1305493	Sema6a	semaphorin 6A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313551	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SEMA6A mRNA	PMID:22230336
1305493	Sema6a	semaphorin 6A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of SEMA6A mRNA	PMID:35811015
1305493	Sema6a	semaphorin 6A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SEMA6A mRNA	PMID:35811015
1305493	Sema6a	semaphorin 6A	gene	CHEBI:46680	serpentine asbestos	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of SEMA6A mRNA	PMID:21148743
1305493	Sema6a	semaphorin 6A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEMA6A mRNA	PMID:40504410
1305493	Sema6a	semaphorin 6A	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SEMA6A mRNA	PMID:29391264
1305493	Sema6a	semaphorin 6A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SEMA6A mRNA	PMID:29097150
1305493	Sema6a	semaphorin 6A	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1313551	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SEMA6A mRNA	PMID:26272509
1305493	Sema6a	semaphorin 6A	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of SEMA6A mRNA	PMID:38825487
1305493	Sema6a	semaphorin 6A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SEMA6A mRNA; Nanotubes, Carbon results in decreased expression of SEMA6A mRNA	PMID:25554681
1305493	Sema6a	semaphorin 6A	gene	CHEBI:5870	imidacloprid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C082359	imidacloprid results in increased expression of SEMA6A mRNA	PMID:40750069
1305493	Sema6a	semaphorin 6A	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of SEMA6A mRNA	PMID:28801915
1305493	Sema6a	semaphorin 6A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SEMA6A mRNA	PMID:22206623
1305493	Sema6a	semaphorin 6A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of SEMA6A mRNA]	PMID:22206623
1305493	Sema6a	semaphorin 6A	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of SEMA6A mRNA	PMID:29522793
1305493	Sema6a	semaphorin 6A	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20260714	CTD	MESH:C575881	[imeglimin co-treated with Glucose] results in increased expression of SEMA6A mRNA	PMID:34588186
1305493	Sema6a	semaphorin 6A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA	PMID:27188386
1305493	Sema6a	semaphorin 6A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SEMA6A gene]	PMID:28238834
1305493	Sema6a	semaphorin 6A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SEMA6A mRNA	PMID:23146750
1305493	Sema6a	semaphorin 6A	gene	CHEBI:81794	thifluzamide	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of SEMA6A mRNA	PMID:33512557
1305493	Sema6a	semaphorin 6A	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of SEMA6A mRNA	PMID:36084822
1305493	Sema6a	semaphorin 6A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313551	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA	PMID:27188386
1305493	Sema6a	semaphorin 6A	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of SEMA6A mRNA	PMID:26551752|PMID:28959546
1305493	Sema6a	semaphorin 6A	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1313551	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SEMA6A mRNA	PMID:27188386
1305493	Sema6a	semaphorin 6A	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SEMA6A mRNA	PMID:19015723
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552220	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GTF2H3 mRNA	PMID:33045310
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of GTF2H3 mRNA	PMID:17045167|PMID:33167477
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313552	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GTF2H3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GTF2H3 mRNA	PMID:32699268
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GTF2H3 mRNA	PMID:36331819
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GTF2H3 mRNA	PMID:39241906
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of GTF2H3 mRNA	PMID:19167446
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313552	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of GTF2H3 mRNA	PMID:38568856
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313552	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GTF2H3 mRNA	PMID:37042841
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of GTF2H3 mRNA	PMID:33359661
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of GTF2H3 mRNA	PMID:33387578
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GTF2H3 mRNA	PMID:28818685
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GTF2H3 protein	PMID:34915118
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GTF2H3 mRNA	PMID:37236586
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313552	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GTF2H3 gene	PMID:27153756
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313552	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GTF2H3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GTF2H3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of GTF2H3 mRNA	PMID:32699268
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GTF2H3 mRNA	PMID:25629700
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF2H3 mRNA	PMID:22206623
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313552	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GTF2H3 mRNA	PMID:39836092
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of GTF2H3 mRNA	PMID:31295307
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552220	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GTF2H3 mRNA	PMID:21570461
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GTF2H3 mRNA	PMID:15056799
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GTF2H3 mRNA	PMID:33387578
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313552	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GTF2H3 mRNA	PMID:39836092
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552220	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GTF2H3 mRNA	PMID:22228805
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to GTF2H3 promoter]	PMID:19654925
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GTF2H3 mRNA	PMID:20018196
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552220	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of GTF2H3 mRNA	PMID:28472532
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GTF2H3 mRNA	PMID:25181051
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1552220	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of GTF2H3 promoter	PMID:27334623
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of GTF2H3 protein	PMID:31675489
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of GTF2H3 protein	PMID:31675489
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of GTF2H3 mRNA	PMID:17602206
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GTF2H3 mRNA	PMID:21266533
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GTF2H3 mRNA	PMID:17361019|PMID:21266533
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of GTF2H3 mRNA	PMID:34813904
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of GTF2H3 mRNA	PMID:34813904
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313552	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GTF2H3 mRNA	PMID:37042841
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GTF2H3 mRNA	PMID:33453195
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GTF2H3 mRNA	PMID:38568856
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GTF2H3 mRNA	PMID:37236586
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:36704	imiquimod	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20120412	CTD	MESH:C056493	imiquimod results in decreased expression of GTF2H3 mRNA	PMID:21878529
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313552	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GTF2H3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GTF2H3 mRNA	PMID:32699268
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GTF2H3 mRNA	PMID:28302478
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GTF2H3 mRNA	PMID:36331819
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313552	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GTF2H3 gene	PMID:29154799
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of GTF2H3 mRNA	PMID:38685447|PMID:41580965
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313552	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of GTF2H3 mRNA	PMID:26690555
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313552	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GTF2H3 mRNA	PMID:39836092
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of GTF2H3 mRNA	PMID:31675489
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GTF2H3 mRNA	PMID:35436446
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552220	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of GTF2H3 mRNA	PMID:25620056
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of GTF2H3 mRNA	PMID:41580965
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552220	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of GTF2H3 mRNA	PMID:19042947
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GTF2H3 protein	PMID:32959892
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of GTF2H3 mRNA	PMID:20080153
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF2H3 mRNA	PMID:22206623
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313552	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of GTF2H3 mRNA	PMID:37199045
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552220	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of GTF2H3 mRNA	PMID:30294300
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of GTF2H3 protein	PMID:31675489
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of GTF2H3 mRNA	PMID:19281266
1305494	Gtf2h3	general transcription factor IIH subunit 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313552	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GTF2H3 mRNA	PMID:29301935
1305495	Plxnb2	plexin B2	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of PLXNB2 protein	PMID:39638853
1305495	Plxnb2	plexin B2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PLXNB2 mRNA	PMID:38218311
1305495	Plxnb2	plexin B2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PLXNB2 mRNA	PMID:25812627
1305495	Plxnb2	plexin B2	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein]	PMID:38195004
1305495	Plxnb2	plexin B2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313555	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PLXNB2 mRNA	PMID:20188158
1305495	Plxnb2	plexin B2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PLXNB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PLXNB2 mRNA	PMID:32699268
1305495	Plxnb2	plexin B2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313555	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PLXNB2 mRNA	PMID:24205000
1305495	Plxnb2	plexin B2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLXNB2 mRNA	PMID:36331819
1305495	Plxnb2	plexin B2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313555	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PLXNB2 mRNA	PMID:30319688
1305495	Plxnb2	plexin B2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313554	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PLXNB2 mRNA	PMID:21632981
1305495	Plxnb2	plexin B2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313554	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of PLXNB2 mRNA	PMID:30510588
1305495	Plxnb2	plexin B2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313554	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of PLXNB2 mRNA	PMID:22574217
1305495	Plxnb2	plexin B2	gene	CHEBI:16708	adenine	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of PLXNB2 mRNA	PMID:24211769
1305495	Plxnb2	plexin B2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313554	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PLXNB2 mRNA	PMID:23649840
1305495	Plxnb2	plexin B2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313554	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PLXNB2 mRNA	PMID:21179406
1305495	Plxnb2	plexin B2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PLXNB2 mRNA	PMID:26577399
1305495	Plxnb2	plexin B2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313554	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PLXNB2 intron	PMID:30157460
1305495	Plxnb2	plexin B2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA	PMID:39836092
1305495	Plxnb2	plexin B2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein	PMID:38195004
1305495	Plxnb2	plexin B2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLXNB2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLXNB2 mRNA	PMID:37236586|PMID:37325564
1305495	Plxnb2	plexin B2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313554	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PLXNB2 mRNA	PMID:23649840
1305495	Plxnb2	plexin B2	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313555	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of PLXNB2 intron; Ethylnitrosourea results in increased mutagenesis of PLXNB2 mRNA	PMID:27776689
1305495	Plxnb2	plexin B2	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of PLXNB2 mRNA	PMID:19376150
1305495	Plxnb2	plexin B2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313554	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PLXNB2 protein	PMID:20106945
1305495	Plxnb2	plexin B2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313554	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLXNB2 mRNA	PMID:21632981
1305495	Plxnb2	plexin B2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313554	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PLXNB2 mRNA	PMID:23649840
1305495	Plxnb2	plexin B2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PLXNB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PLXNB2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PLXNB2 mRNA	PMID:32699268
1305495	Plxnb2	plexin B2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PLXNB2 mRNA	PMID:34911549
1305495	Plxnb2	plexin B2	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of PLXNB2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PLXNB2 protein	PMID:38598786
1305495	Plxnb2	plexin B2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PLXNB2 mRNA	PMID:31150632
1305495	Plxnb2	plexin B2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PLXNB2 mRNA	PMID:22206623
1305495	Plxnb2	plexin B2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313554	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PLXNB2 gene	PMID:25304211
1305495	Plxnb2	plexin B2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLXNB2 mRNA	PMID:39836092
1305495	Plxnb2	plexin B2	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313554	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PLXNB2 mRNA	PMID:19244175
1305495	Plxnb2	plexin B2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313555	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of PLXNB2 protein	PMID:25505154
1305495	Plxnb2	plexin B2	gene	CHEBI:27882	(S)-colchicine	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of PLXNB2 mRNA	PMID:24211769
1305495	Plxnb2	plexin B2	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1313554	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of PLXNB2 mRNA	PMID:28903495
1305495	Plxnb2	plexin B2	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of PLXNB2 mRNA	PMID:19921347
1305495	Plxnb2	plexin B2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in increased expression of PLXNB2 mRNA	PMID:21858171
1305495	Plxnb2	plexin B2	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of PLXNB2 mRNA	PMID:20187946
1305495	Plxnb2	plexin B2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PLXNB2 mRNA	PMID:30912803
1305495	Plxnb2	plexin B2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of PLXNB2 mRNA	PMID:23195993
1305495	Plxnb2	plexin B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLXNB2 mRNA	PMID:34747641
1305495	Plxnb2	plexin B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLXNB2 mRNA	PMID:15652763|PMID:33956508
1305495	Plxnb2	plexin B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313555	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLXNB2 mRNA	PMID:17035482
1305495	Plxnb2	plexin B2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313554	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PLXNB2 mRNA	PMID:33212167
1305495	Plxnb2	plexin B2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PLXNB2 mRNA	PMID:32763439
1305495	Plxnb2	plexin B2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of PLXNB2 mRNA	PMID:24690739
1305495	Plxnb2	plexin B2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313554	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PLXNB2 mRNA	PMID:29803840
1305495	Plxnb2	plexin B2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313554	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PLXNB2 mRNA	PMID:39719251
1305495	Plxnb2	plexin B2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313555	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of PLXNB2 mRNA	PMID:36209798
1305495	Plxnb2	plexin B2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLXNB2 mRNA	PMID:39836092
1305495	Plxnb2	plexin B2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313554	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLXNB2 5' UTR	PMID:27901495
1305495	Plxnb2	plexin B2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313555	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PLXNB2 5' UTR; Benzo(a)pyrene results in decreased methylation of PLXNB2 exon; Benzo(a)pyrene results in decreased methylation of PLXNB2 intron	PMID:27901495
1305495	Plxnb2	plexin B2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313554	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLXNB2 mRNA	PMID:21632981
1305495	Plxnb2	plexin B2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of PLXNB2 mRNA	PMID:33053406
1305495	Plxnb2	plexin B2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of PLXNB2 mRNA	PMID:24690739
1305495	Plxnb2	plexin B2	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1313554	E	RGD:6480464	20191114	CTD	MESH:C006632	PLXNB2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305495	Plxnb2	plexin B2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313555	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLXNB2 gene; titanium dioxide results in decreased methylation of PLXNB2 promoter	PMID:35295148
1305495	Plxnb2	plexin B2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313555	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of PLXNB2 mRNA	PMID:23557971
1305495	Plxnb2	plexin B2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313555	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PLXNB2 gene	PMID:35295148
1305495	Plxnb2	plexin B2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PLXNB2 mRNA	PMID:34492290
1305495	Plxnb2	plexin B2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PLXNB2 mRNA	PMID:18445702
1305495	Plxnb2	plexin B2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of PLXNB2 mRNA	PMID:19167457
1305495	Plxnb2	plexin B2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313554	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PLXNB2 mRNA	PMID:30903817
1305495	Plxnb2	plexin B2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313554	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of PLXNB2 gene	PMID:31601247
1305495	Plxnb2	plexin B2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLXNB2 mRNA	PMID:25181051|PMID:32145629
1305495	Plxnb2	plexin B2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313554	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of PLXNB2 protein	PMID:34186270
1305495	Plxnb2	plexin B2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313555	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PLXNB2 mRNA	PMID:26063408|PMID:33221593
1305495	Plxnb2	plexin B2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PLXNB2 gene	PMID:28505145
1305495	Plxnb2	plexin B2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313554	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PLXNB2 promoter	PMID:27271280
1305495	Plxnb2	plexin B2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313554	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PLXNB2 mRNA	PMID:25979313
1305495	Plxnb2	plexin B2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313554	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of PLXNB2 protein	PMID:31945527
1305495	Plxnb2	plexin B2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PLXNB2 mRNA	PMID:39298647
1305495	Plxnb2	plexin B2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313555	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of PLXNB2 exon	PMID:33297965
1305495	Plxnb2	plexin B2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313554	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PLXNB2 intron	PMID:30157460
1305495	Plxnb2	plexin B2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313554	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PLXNB2 protein	PMID:34186270
1305495	Plxnb2	plexin B2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313554	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PLXNB2 protein	PMID:34186270
1305495	Plxnb2	plexin B2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PLXNB2 mRNA	PMID:34813904
1305495	Plxnb2	plexin B2	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of PLXNB2 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of PLXNB2 protein	PMID:38598786
1305495	Plxnb2	plexin B2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA	PMID:39836092
1305495	Plxnb2	plexin B2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein	PMID:38195004
1305495	Plxnb2	plexin B2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLXNB2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLXNB2 mRNA	PMID:37236586|PMID:37325564
1305495	Plxnb2	plexin B2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PLXNB2 mRNA	PMID:25812627
1305495	Plxnb2	plexin B2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PLXNB2 mRNA	PMID:24449571
1305495	Plxnb2	plexin B2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PLXNB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PLXNB2 mRNA	PMID:32699268
1305495	Plxnb2	plexin B2	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313554	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PLXNB2 mRNA	PMID:19244175
1305495	Plxnb2	plexin B2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PLXNB2 mRNA	PMID:25812627
1305495	Plxnb2	plexin B2	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PLXNB2 mRNA	PMID:19167446
1305495	Plxnb2	plexin B2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PLXNB2 mRNA	PMID:25812627
1305495	Plxnb2	plexin B2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLXNB2 mRNA	PMID:36331819
1305495	Plxnb2	plexin B2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLXNB2 mRNA	PMID:29154799
1305495	Plxnb2	plexin B2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313554	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PLXNB2 mRNA	PMID:23179753
1305495	Plxnb2	plexin B2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313555	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PLXNB2 mRNA	PMID:28973697
1305495	Plxnb2	plexin B2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLXNB2 mRNA	PMID:21420995|PMID:26690555
1305495	Plxnb2	plexin B2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313554	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PLXNB2 mRNA	PMID:22230336
1305495	Plxnb2	plexin B2	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of PLXNB2 mRNA	PMID:24690739
1305495	Plxnb2	plexin B2	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLXNB2 mRNA	PMID:29432896
1305495	Plxnb2	plexin B2	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1313555	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of PLXNB2 mRNA	PMID:16251409
1305495	Plxnb2	plexin B2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313554	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PLXNB2 gene	PMID:25304211
1305495	Plxnb2	plexin B2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLXNB2 mRNA	PMID:39836092
1305495	Plxnb2	plexin B2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLXNB2 mRNA	PMID:29391264
1305495	Plxnb2	plexin B2	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1313554	E	RGD:6480464	20191114	CTD	MESH:C032793	PLXNB2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305495	Plxnb2	plexin B2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of PLXNB2 mRNA	PMID:25620056
1305495	Plxnb2	plexin B2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PLXNB2 protein	PMID:32959892
1305495	Plxnb2	plexin B2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA	PMID:39836092
1305495	Plxnb2	plexin B2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PLXNB2 mRNA	PMID:15336504
1305495	Plxnb2	plexin B2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313554	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PLXNB2 intron	PMID:30157460
1305495	Plxnb2	plexin B2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of PLXNB2 mRNA	PMID:22101062
1305495	Plxnb2	plexin B2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PLXNB2 mRNA	PMID:22206623
1305495	Plxnb2	plexin B2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PLXNB2 mRNA	PMID:24136188
1305495	Plxnb2	plexin B2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of PLXNB2 protein	PMID:39638853
1305495	Plxnb2	plexin B2	gene	CHEBI:8107	phenytoin	decreases expression	ISO	RGD:1313554	E	RGD:6480464	20120412	CTD	MESH:D010672	Phenytoin results in decreased expression of PLXNB2 mRNA	PMID:14741686
1305495	Plxnb2	plexin B2	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of PLXNB2 mRNA	PMID:21858171
1305495	Plxnb2	plexin B2	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313555	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of PLXNB2 mRNA	PMID:27029645
1305495	Plxnb2	plexin B2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313555	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PLXNB2 mRNA	PMID:39847705
1305495	Plxnb2	plexin B2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLXNB2 mRNA	PMID:24780913
1305495	Plxnb2	plexin B2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PLXNB2 mRNA	PMID:19281266
1305495	Plxnb2	plexin B2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313554	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of PLXNB2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PLXNB2 protein	PMID:38598786
1305495	Plxnb2	plexin B2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of PLXNB2 mRNA	PMID:23034163
1305496	Msc	musculin	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313557	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MSC mRNA	PMID:33045310
1305496	Msc	musculin	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313557	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MSC mRNA	PMID:37995155
1305496	Msc	musculin	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MSC mRNA]	PMID:31150632
1305496	Msc	musculin	gene	CHEBI:149681	methcathinone	increases expression	ISO	RGD:1313556	E	RGD:6480464	20200602	CTD	MESH:C047806	monomethylpropion results in increased expression of MSC mRNA	PMID:22303338
1305496	Msc	musculin	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MSC mRNA	PMID:16604517
1305496	Msc	musculin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MSC mRNA	PMID:36189433
1305496	Msc	musculin	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MSC mRNA	PMID:26079696
1305496	Msc	musculin	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313556	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MSC mRNA	PMID:35811015
1305496	Msc	musculin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313556	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MSC mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MSC mRNA	PMID:35811015
1305496	Msc	musculin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of MSC mRNA	PMID:25210133
1305496	Msc	musculin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MSC mRNA	PMID:32741896
1305496	Msc	musculin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313556	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MSC mRNA	PMID:30165855
1305496	Msc	musculin	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MSC mRNA	PMID:33387578
1305496	Msc	musculin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313556	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MSC mRNA	PMID:37042841
1305496	Msc	musculin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MSC mRNA	PMID:37992649
1305496	Msc	musculin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313556	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of MSC promoter	PMID:33872906
1305496	Msc	musculin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in increased expression of MSC mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MSC mRNA	PMID:20463053|PMID:36189433
1305496	Msc	musculin	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MSC mRNA	PMID:32741896
1305496	Msc	musculin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MSC mRNA	PMID:37992649
1305496	Msc	musculin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313556	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of MSC promoter	PMID:33872906
1305496	Msc	musculin	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MSC mRNA	PMID:33387578
1305496	Msc	musculin	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MSC mRNA	PMID:39012411
1305496	Msc	musculin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MSC mRNA	PMID:37236586
1305496	Msc	musculin	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1313557	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of MSC mRNA	PMID:15664270
1305496	Msc	musculin	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MSC mRNA	PMID:23649840
1305496	Msc	musculin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313556	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MSC gene	PMID:27153756
1305496	Msc	musculin	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MSC mRNA	PMID:23649840
1305496	Msc	musculin	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313557	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MSC mRNA	PMID:17484886
1305496	Msc	musculin	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MSC mRNA	PMID:31150632
1305496	Msc	musculin	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MSC mRNA]	PMID:31150632
1305496	Msc	musculin	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MSC mRNA	PMID:27392435
1305496	Msc	musculin	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of MSC mRNA	PMID:32186404
1305496	Msc	musculin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MSC mRNA	PMID:17942748
1305496	Msc	musculin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MSC mRNA	PMID:29803840
1305496	Msc	musculin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MSC mRNA	PMID:37992649
1305496	Msc	musculin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MSC mRNA	PMID:37682722
1305496	Msc	musculin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313556	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MSC mRNA	PMID:22714537
1305496	Msc	musculin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MSC mRNA	PMID:22316170
1305496	Msc	musculin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313556	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MSC exon; Benzo(a)pyrene results in decreased methylation of MSC promoter	PMID:27901495
1305496	Msc	musculin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313556	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MSC mRNA	PMID:20064835
1305496	Msc	musculin	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313556	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MSC promoter	PMID:23974009
1305496	Msc	musculin	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313557	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MSC mRNA	PMID:29341224
1305496	Msc	musculin	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MSC mRNA	PMID:15761015
1305496	Msc	musculin	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of MSC mRNA	PMID:35984750
1305496	Msc	musculin	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of MSC mRNA	PMID:24395379
1305496	Msc	musculin	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1313556	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of MSC gene	PMID:31601247
1305496	Msc	musculin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313557	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of MSC mRNA	PMID:35295148
1305496	Msc	musculin	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MSC mRNA	PMID:34492290
1305496	Msc	musculin	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313556	E	RGD:6480464	20220607	CTD	MESH:C006780	bisphenol A affects the methylation of MSC gene	PMID:33391824
1305496	Msc	musculin	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313557	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of MSC promoter	PMID:27334623
1305496	Msc	musculin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20150127	CTD	MESH:C006780	bisphenol A results in decreased expression of MSC mRNA	PMID:25270620
1305496	Msc	musculin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313556	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MSC gene	PMID:31601247
1305496	Msc	musculin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MSC mRNA	PMID:25181051
1305496	Msc	musculin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313556	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of MSC mRNA	PMID:29275510
1305496	Msc	musculin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313557	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of MSC mRNA	PMID:30951980
1305496	Msc	musculin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313556	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MSC gene	PMID:31601247
1305496	Msc	musculin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313557	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of MSC mRNA	PMID:30951980
1305496	Msc	musculin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313557	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of MSC mRNA	PMID:30951980
1305496	Msc	musculin	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MSC mRNA	PMID:32680482
1305496	Msc	musculin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MSC mRNA	PMID:39012411
1305496	Msc	musculin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MSC mRNA	PMID:37236586
1305496	Msc	musculin	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MSC mRNA	PMID:35163327
1305496	Msc	musculin	gene	CHEBI:3647	chlorpromazine	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in decreased expression of MSC mRNA	PMID:25596134
1305496	Msc	musculin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313556	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MSC mRNA	PMID:32588087
1305496	Msc	musculin	gene	CHEBI:40279	allopurinol	increases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:D000493	Allopurinol results in increased expression of MSC mRNA	PMID:37876353
1305496	Msc	musculin	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313556	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MSC mRNA	PMID:20106945
1305496	Msc	musculin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313557	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MSC mRNA	PMID:28973697
1305496	Msc	musculin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MSC mRNA	PMID:37992649
1305496	Msc	musculin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MSC mRNA	PMID:33387578
1305496	Msc	musculin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313556	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of MSC mRNA	PMID:29067470
1305496	Msc	musculin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313556	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MSC mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MSC mRNA	PMID:35811015
1305496	Msc	musculin	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1313556	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of MSC mRNA	PMID:25757056
1305496	Msc	musculin	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313556	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of MSC mRNA	PMID:26833863
1305496	Msc	musculin	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MSC mRNA	PMID:29391264
1305496	Msc	musculin	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313556	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of MSC mRNA	PMID:24383545
1305496	Msc	musculin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313557	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MSC mRNA	PMID:17942748
1305496	Msc	musculin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MSC mRNA	PMID:17942748
1305496	Msc	musculin	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20150127	CTD	MESH:D005047	Etoposide results in decreased expression of MSC mRNA	PMID:25270620
1305496	Msc	musculin	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MSC mRNA	PMID:15761015
1305496	Msc	musculin	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of MSC mRNA	PMID:25596134
1305496	Msc	musculin	gene	CHEBI:50102	N-methyl-N-nitrosourea	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in decreased expression of MSC mRNA	PMID:25270620
1305496	Msc	musculin	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313557	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MSC mRNA	PMID:40234311
1305496	Msc	musculin	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313556	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MSC mRNA	PMID:22714537
1305496	Msc	musculin	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of MSC mRNA	PMID:25596134
1305496	Msc	musculin	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MSC mRNA	PMID:22714537
1305496	Msc	musculin	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MSC mRNA	PMID:32741896
1305496	Msc	musculin	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313556	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MSC gene]	PMID:28238834
1305496	Msc	musculin	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313556	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MSC mRNA	PMID:19159669
1305496	Msc	musculin	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1313556	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MSC mRNA	PMID:23146750
1305496	Msc	musculin	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1313556	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of MSC mRNA	PMID:26079696
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313561	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COTL1 mRNA	PMID:33045310
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1313560	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of COTL1 protein	PMID:36641056
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COTL1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COTL1 gene	PMID:20938992
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313560	E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of COTL1 mRNA	PMID:15894607|PMID:33167477
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of COTL1 mRNA	PMID:16604517
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of COTL1 mRNA	PMID:15894607
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of COTL1 mRNA	PMID:15282401
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313560	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of COTL1 mRNA	PMID:26079696
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of COTL1 mRNA	PMID:21632981
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of COTL1 mRNA	PMID:39241906
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of COTL1 mRNA	PMID:32145629
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of COTL1 mRNA	PMID:39298647
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313560	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of COTL1 mRNA	PMID:31614463
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313561	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of COTL1 mRNA	PMID:33711761
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of COTL1 mRNA	PMID:33387578
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COTL1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COTL1 gene	PMID:20938992
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of COTL1 mRNA	PMID:18037150
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313560	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of COTL1 mRNA	PMID:26079696
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COTL1 mRNA	PMID:37992649
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COTL1 mRNA	PMID:37992649
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313561	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of COTL1 mRNA	PMID:23892564
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:17750	glycine betaine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in decreased expression of COTL1 mRNA	PMID:26391144
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of COTL1 mRNA	PMID:22061828
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313560	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of COTL1 mRNA	PMID:28818685
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313560	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of COTL1 intron	PMID:30157460
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COTL1 mRNA	PMID:36331819
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313561	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of COTL1 mRNA	PMID:27462272
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20210706	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COTL1 protein	PMID:33040242
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of COTL1 mRNA	PMID:23649840
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of COTL1 mRNA	PMID:19770486
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COTL1 mRNA	PMID:22484513
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313560	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COTL1 mRNA	PMID:22100608|PMID:27153756
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of COTL1 mRNA	PMID:23649840
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of COTL1 protein	PMID:33146391
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of COTL1 mRNA	PMID:34911549
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of COTL1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of COTL1 protein	PMID:38598786
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313561	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of COTL1 mRNA	PMID:17484886|PMID:27339419|PMID:31919559
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COTL1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COTL1 gene	PMID:20938992
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COTL1 mRNA	PMID:40504410
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313560	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of COTL1 mRNA	PMID:26272509
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA	PMID:27188386
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of COTL1 gene	PMID:31011160
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of COTL1 mRNA	PMID:31881176
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of COTL1 mRNA	PMID:25905778
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of COTL1 mRNA	PMID:25905778
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of COTL1 mRNA	PMID:22023808
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of COTL1 mRNA	PMID:27392435
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of COTL1 mRNA	PMID:27392435
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of COTL1 protein	PMID:20884965
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of COTL1 protein]	PMID:20884965
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313560	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of COTL1 mRNA	PMID:25583101
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COTL1 mRNA	PMID:34747641
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313561	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COTL1 mRNA	PMID:16611356|PMID:21570461|PMID:24680724
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COTL1 mRNA	PMID:20106945|PMID:21632981
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COTL1 mRNA	PMID:19933214
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COTL1 mRNA	PMID:21215274
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of COTL1 protein	PMID:35544339
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313560	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of COTL1 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA	PMID:27188386
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313560	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of COTL1 mRNA	PMID:33212167
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of COTL1 protein	PMID:28918527
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1313560	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of COTL1 protein	PMID:29385562
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COTL1 mRNA	PMID:29803840
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of COTL1 mRNA	PMID:19277126
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COTL1 mRNA	PMID:37992649
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of COTL1 mRNA	PMID:38568856
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313560	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of COTL1 mRNA	PMID:39719251
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COTL1 mRNA	PMID:34876320|PMID:40504410
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA	PMID:34876320
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313560	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COTL1 3' UTR	PMID:27901495
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COTL1 mRNA	PMID:20106945|PMID:21632981
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120814	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COTL1 mRNA	PMID:19770486|PMID:20713471|PMID:21569818
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to COTL1 protein]	PMID:32406909
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:3000	beauvericin	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20180515	CTD	MESH:C004456	beauvericin results in decreased expression of COTL1 mRNA	PMID:29203277
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:30563	silicon dioxide	affects secretion	ISO	RGD:1313560	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the secretion of COTL1 protein	PMID:25895662
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of COTL1 mRNA	PMID:22431001
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313560	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of COTL1 mRNA	PMID:25895662
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313561	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of COTL1 mRNA	PMID:29341224
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313560	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of COTL1 mRNA	PMID:20382639
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of COTL1 mRNA	PMID:15894607
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of COTL1 mRNA	PMID:24136188
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313561	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of COTL1 mRNA	PMID:23557971
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of COTL1 mRNA	PMID:34492290
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of COTL1 mRNA	PMID:28943392
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of COTL1 mRNA	PMID:25380136
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313561	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of COTL1 mRNA	PMID:18301758|PMID:23811191
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of COTL1 mRNA	PMID:19710929
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313561	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of COTL1 mRNA	PMID:28472532
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of COTL1 mRNA	PMID:25181051
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of COTL1 mRNA	PMID:32145629
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of COTL1 protein	PMID:34186270|PMID:37664457
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of COTL1 protein	PMID:35999755
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of COTL1 protein	PMID:32145629
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313560	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of COTL1 protein	PMID:37567409
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313561	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of COTL1 mRNA	PMID:32156529|PMID:34585602|PMID:38701888
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COTL1 mRNA	PMID:28628672
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313560	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of COTL1 mRNA	PMID:25979313
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of COTL1 mRNA	PMID:20713471
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of COTL1 mRNA	PMID:39298647
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313560	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of COTL1 protein	PMID:34186270
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313561	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of COTL1 intron	PMID:28392331
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313561	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COTL1 mRNA	PMID:37019170
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of COTL1 protein	PMID:35999755
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313561	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of COTL1 mRNA	PMID:34813904
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of COTL1 protein	PMID:38598786
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COTL1 mRNA	PMID:28628672
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313561	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of COTL1 mRNA	PMID:34813904
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of COTL1 mRNA	PMID:28943392
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313560	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COTL1 mRNA	PMID:37042841
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of COTL1 mRNA	PMID:30589522
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313560	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of COTL1 mRNA	PMID:29024780
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of COTL1 mRNA	PMID:25380136
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of COTL1 mRNA	PMID:33453195
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COTL1 mRNA	PMID:25993096
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313560	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COTL1 protein	PMID:24527689
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20210706	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COTL1 protein	PMID:33040242
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of COTL1 mRNA	PMID:19320972
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of COTL1 mRNA	PMID:25380136
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of COTL1 mRNA	PMID:24449571
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COTL1 mRNA	PMID:31533062
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COTL1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of COTL1 mRNA	PMID:36331819
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313560	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COTL1 mRNA	PMID:25979313
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313560	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of COTL1 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of COTL1 mRNA	PMID:21427059
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of COTL1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of COTL1 mRNA	PMID:22733784
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COTL1 mRNA	PMID:28628672
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313561	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of COTL1 mRNA	PMID:28973697
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COTL1 mRNA	PMID:37992649
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313560	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of COTL1 mRNA	PMID:38832940
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313560	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of COTL1 mRNA	PMID:28542535
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313560	E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of COTL1 mRNA	PMID:25458485
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of COTL1 mRNA	PMID:17562736
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of COTL1 mRNA	PMID:33387578
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of COTL1 mRNA	PMID:29432896
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313560	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of COTL1 mRNA	PMID:18687144
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COTL1 mRNA	PMID:40504410
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1313561	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of COTL1 mRNA	PMID:26934552
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of COTL1 mRNA	PMID:29391264
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of COTL1 mRNA	PMID:22079256
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA	PMID:34876320
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:4917	eugenol	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in decreased expression of COTL1 protein	PMID:39793947
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COTL1 mRNA	PMID:28628672
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of COTL1 mRNA	PMID:15894607
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate affects the reaction [MTF1 affects the expression of COTL1 mRNA]	PMID:16221973
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COTL1 mRNA	PMID:25620056
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313561	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of COTL1 mRNA; Nanotubes, Carbon results in increased expression of COTL1 mRNA	PMID:25554681
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313561	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of COTL1 mRNA	PMID:40234311
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of COTL1 mRNA	PMID:38701926
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313560	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COTL1 protein	PMID:32959892
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:63613	nevirapine	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D019829	Nevirapine results in decreased expression of COTL1 mRNA	PMID:23947594
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313561	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of COTL1 mRNA	PMID:36851058
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of COTL1 mRNA	PMID:22078008
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313560	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of COTL1 mRNA	PMID:31758290
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313560	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of COTL1 protein	PMID:34186270
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of COTL1 mRNA	PMID:22206623
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of COTL1 protein	PMID:37664457
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313560	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of COTL1 mRNA	PMID:22079256
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of COTL1 mRNA	PMID:22079256
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C025589	ochratoxin A results in decreased expression of COTL1 protein	PMID:31369848
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA	PMID:27188386
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:7852	oxycodone	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in decreased expression of COTL1 mRNA	PMID:23439660
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313560	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of COTL1 mRNA	PMID:26079696
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA	PMID:34876320
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of COTL1 mRNA	PMID:24780913
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of COTL1 protein; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA	PMID:27188386|PMID:37664457
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of COTL1 mRNA	PMID:25905778
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of COTL1 protein	PMID:24648495
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313560	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of COTL1 protein	PMID:38598786
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of COTL1 mRNA	PMID:19015723
1305498	Cotl1	coactosin-like F-actin binding protein 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of COTL1 mRNA	PMID:22570695|PMID:23869203
1305499	Calml3	calmodulin-like 3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313562	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CALML3 mRNA	PMID:38218311
1305499	Calml3	calmodulin-like 3	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CALML3 mRNA	PMID:21551480
1305499	Calml3	calmodulin-like 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313563	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CALML3 mRNA	PMID:19484750
1305499	Calml3	calmodulin-like 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313562	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CALML3 mRNA	PMID:30165855
1305499	Calml3	calmodulin-like 3	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CALML3 mRNA	PMID:33387578
1305499	Calml3	calmodulin-like 3	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313563	E	RGD:6480464	20220308	CTD	MESH:D001554	Benzene results in increased expression of CALML3 mRNA	PMID:34624356
1305499	Calml3	calmodulin-like 3	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1313562	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of CALML3 mRNA	PMID:31256213
1305499	Calml3	calmodulin-like 3	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313562	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CALML3 mRNA	PMID:26485663
1305499	Calml3	calmodulin-like 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CALML3 mRNA	PMID:33387578
1305499	Calml3	calmodulin-like 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313562	E	RGD:6480464	20181016	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CALML3 mRNA	PMID:29741670
1305499	Calml3	calmodulin-like 3	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313563	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of CALML3 mRNA	PMID:31626304
1305499	Calml3	calmodulin-like 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313563	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CALML3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CALML3 mRNA	PMID:34911549
1305499	Calml3	calmodulin-like 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CALML3 mRNA	PMID:30779732
1305499	Calml3	calmodulin-like 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313562	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CALML3 mRNA	PMID:32525701
1305499	Calml3	calmodulin-like 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313563	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CALML3 mRNA	PMID:28960355
1305499	Calml3	calmodulin-like 3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CALML3 mRNA	PMID:31881176
1305499	Calml3	calmodulin-like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CALML3 mRNA	PMID:33387578
1305499	Calml3	calmodulin-like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313563	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CALML3 mRNA	PMID:17942748
1305499	Calml3	calmodulin-like 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313563	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CALML3 protein	PMID:28918527
1305499	Calml3	calmodulin-like 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313563	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CALML3 mRNA	PMID:37682722
1305499	Calml3	calmodulin-like 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313562	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CALML3 3' UTR	PMID:27901495
1305499	Calml3	calmodulin-like 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313562	E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CALML3 mRNA	PMID:40419235
1305499	Calml3	calmodulin-like 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313562	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CALML3 exon; Benzo(a)pyrene results in increased methylation of CALML3 promoter	PMID:27901495
1305499	Calml3	calmodulin-like 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313562	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CALML3 promoter	PMID:23974009
1305499	Calml3	calmodulin-like 3	gene	CHEBI:3139	bleomycin A2	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001761	Bleomycin results in decreased expression of CALML3 protein	PMID:25933445
1305499	Calml3	calmodulin-like 3	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of CALML3 mRNA	PMID:11578147
1305499	Calml3	calmodulin-like 3	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CALML3 mRNA	PMID:32479839
1305499	Calml3	calmodulin-like 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313563	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CALML3 mRNA	PMID:23557971
1305499	Calml3	calmodulin-like 3	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of CALML3 mRNA	PMID:19167457
1305499	Calml3	calmodulin-like 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CALML3 mRNA	PMID:25181051
1305499	Calml3	calmodulin-like 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of CALML3 mRNA	PMID:36779543
1305499	Calml3	calmodulin-like 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313563	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CALML3 mRNA	PMID:32156529
1305499	Calml3	calmodulin-like 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313562	E	RGD:6480464	20181016	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CALML3 mRNA	PMID:29741670
1305499	Calml3	calmodulin-like 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313563	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CALML3 mRNA	PMID:40194260
1305499	Calml3	calmodulin-like 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313562	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CALML3 gene	PMID:29154799
1305499	Calml3	calmodulin-like 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CALML3 mRNA	PMID:33387578
1305499	Calml3	calmodulin-like 3	gene	CHEBI:46195	paracetamol	increases secretion	ISO	RGD:1313563	E	RGD:6480464	20180703	CTD	MESH:D000082	Acetaminophen results in increased secretion of CALML3 protein	PMID:24038040
1305499	Calml3	calmodulin-like 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313562	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CALML3 mRNA	PMID:32525701
1305499	Calml3	calmodulin-like 3	gene	CHEBI:47381	diclofenac	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D004008	Diclofenac results in increased expression of CALML3 mRNA	PMID:30723492
1305499	Calml3	calmodulin-like 3	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313563	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of CALML3 mRNA	PMID:30529165
1305499	Calml3	calmodulin-like 3	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313563	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of CALML3 mRNA; Nanotubes, Carbon analog affects the expression of CALML3 mRNA	PMID:25554681
1305499	Calml3	calmodulin-like 3	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of CALML3 mRNA	PMID:21983209
1305499	Calml3	calmodulin-like 3	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1313562	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CALML3 mRNA	PMID:20436886
1305499	Calml3	calmodulin-like 3	gene	CHEBI:753160	lard	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in decreased expression of CALML3 mRNA	PMID:26115784
1305499	Calml3	calmodulin-like 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313562	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CALML3 mRNA	PMID:37199045
1305499	Calml3	calmodulin-like 3	gene	CHEBI:78420	icariin	affects expression	ISO	RGD:1313563	E	RGD:6480464	20260303	CTD	MESH:C056599	icariin affects the expression of CALML3 mRNA	PMID:31296789
1305499	Calml3	calmodulin-like 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CALML3 mRNA	PMID:27291303
1305499	Calml3	calmodulin-like 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313562	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CALML3 mRNA	PMID:32525701
1305499	Calml3	calmodulin-like 3	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of CALML3 mRNA	PMID:29162477
1305499	Calml3	calmodulin-like 3	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1313562	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of CALML3 mRNA	PMID:17428261
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313564	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FAM204A mRNA	PMID:37042841
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313565	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FAM204A mRNA	PMID:33754040
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FAM204A mRNA	PMID:33387578
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313564	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FAM204A mRNA	PMID:39836092
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313565	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FAM204A mRNA	PMID:19770486
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313564	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FAM204A mRNA	PMID:23649840
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313564	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of FAM204A mRNA	PMID:18356318
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313564	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM204A mRNA	PMID:39836092
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313565	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FAM204A mRNA	PMID:40504410
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313564	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of FAM204A mRNA	PMID:26272509
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313564	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM204A mRNA	PMID:27188386
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA	PMID:33854195
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FAM204A mRNA	PMID:31881176
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM204A mRNA	PMID:34747641
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of FAM204A mRNA	PMID:19013527
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313564	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM204A mRNA	PMID:39836092
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313565	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FAM204A mRNA	PMID:40504410
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313564	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FAM204A mRNA	PMID:22316170
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313564	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of FAM204A mRNA	PMID:18356318
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313565	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM204A gene	PMID:35295148
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM204A mRNA	PMID:34947998
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313565	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM204A mRNA	PMID:33221593
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313565	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of FAM204A mRNA	PMID:26063408|PMID:29161229|PMID:40036665
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313564	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of FAM204A mRNA	PMID:25979313
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313565	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FAM204A mRNA	PMID:39298647
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA	PMID:33854195
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313564	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FAM204A mRNA	PMID:39836092
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313564	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FAM204A mRNA	PMID:38382870
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313564	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FAM204A mRNA	PMID:24449571
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313564	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FAM204A mRNA	PMID:32588087
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313564	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FAM204A mRNA	PMID:28302478
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313564	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FAM204A mRNA	PMID:25979313
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313564	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of FAM204A mRNA	PMID:23179753
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313564	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of FAM204A mRNA	PMID:20106945
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA	PMID:33854195
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313565	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FAM204A mRNA	PMID:28973697
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1313564	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of FAM204A mRNA]	PMID:21233418
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA	PMID:33854195
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313565	E	RGD:6480464	20140610	CTD	MESH:D000082	Acetaminophen affects the expression of FAM204A mRNA	PMID:17562736
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313565	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FAM204A mRNA	PMID:29279043
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313564	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM204A mRNA	PMID:39836092
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313565	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FAM204A mRNA	PMID:40504410
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA	PMID:33854195
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313564	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FAM204A mRNA	PMID:39836092
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313565	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FAM204A mRNA	PMID:22206623
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313564	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM204A mRNA	PMID:27188386
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of FAM204A mRNA	PMID:29162477
1305500	Fam204a	family with sequence similarity 204, member A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313564	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM204A mRNA	PMID:27188386
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:10033	warfarin	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in decreased expression of TUFM mRNA	PMID:20493250
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552222	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TUFM mRNA	PMID:33045310
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552222	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TUFM mRNA	PMID:20188158
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of TUFM mRNA	PMID:16604517
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20190611	CTD	MESH:D019308	[Palmitic Acid co-treated with Oleic Acid] affects the expression of TUFM mRNA	PMID:30547786
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20190611	CTD	MESH:D019301	[Palmitic Acid co-treated with Oleic Acid] affects the expression of TUFM mRNA	PMID:30547786
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552222	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TUFM mRNA	PMID:30319688
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313566	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of TUFM protein	PMID:19207037
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313566	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of TUFM protein	PMID:17292933
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552222	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TUFM mRNA	PMID:39241906
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of TUFM mRNA	PMID:31059760
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TUFM mRNA	PMID:39298647
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of TUFM protein	PMID:32145629
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313566	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TUFM mRNA	PMID:37042841
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	ISO	RGD:1313566	E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of TUFM protein	PMID:32044396
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of TUFM mRNA; Gentamicins results in decreased expression of TUFM protein	PMID:22061828|PMID:33387578
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TUFM mRNA	PMID:22061828
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:18243	dopamine	increases expression	ISO	RGD:1313566	E	RGD:6480464	20150714	CTD	MESH:D004298	Dopamine results in increased expression of TUFM protein	PMID:24675778
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TUFM mRNA	PMID:36331819
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TUFM protein	PMID:34915118
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TUFM protein	PMID:23301498
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of TUFM protein	PMID:33146391
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of TUFM protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of TUFM protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of TUFM protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of TUFM protein	PMID:38598786
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:27363	zinc atom	affects binding	ISO	RGD:1313566	E	RGD:6480464	20120918	CTD	MESH:D015032	TUFM protein binds to Zinc	PMID:14534351
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUFM mRNA	PMID:40504410
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TUFM protein	PMID:38460933
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1552222	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of TUFM protein	PMID:36173347
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:27827	paraoxon	increases expression	ISO	RGD:1313566	E	RGD:6480464	20120717	CTD	MESH:D010261	Paraoxon results in increased expression of TUFM protein	PMID:20931991
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1552222	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of TUFM protein	PMID:25505154
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TUFM mRNA	PMID:23557933
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552222	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TUFM mRNA	PMID:21570461
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TUFM mRNA	PMID:19770486
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TUFM mRNA	PMID:17942748
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313566	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of TUFM protein	PMID:39603559
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of TUFM protein	PMID:35544339
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TUFM mRNA	PMID:27862939
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of TUFM mRNA	PMID:19915844
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313566	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TUFM mRNA	PMID:29803840
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of TUFM protein	PMID:16144979
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of TUFM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TUFM mRNA	PMID:23783067
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TUFM mRNA	PMID:29432896
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20150310	CTD	MESH:D006046	Gold analog results in decreased expression of and results in increased phosphorylation of TUFM protein	PMID:24780912
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313566	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TUFM mRNA	PMID:38568856
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUFM mRNA	PMID:40504410
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313566	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TUFM protein	PMID:17292933
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20150310	CTD	MESH:D006046	Gold analog results in decreased expression of and results in increased phosphorylation of TUFM protein	PMID:24780912
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:30185	zinc(0)	affects binding	ISO	RGD:1313566	E	RGD:6480464	20120918	CTD	MESH:D015032	TUFM protein binds to Zinc	PMID:14534351
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of TUFM mRNA	PMID:24136188
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552222	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TUFM gene; titanium dioxide results in decreased methylation of TUFM promoter	PMID:35295148
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552222	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TUFM mRNA	PMID:15375163|PMID:18301758|PMID:23811191
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313566	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of TUFM protein	PMID:34186270
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TUFM mRNA; bisphenol A results in increased expression of TUFM protein	PMID:25181051|PMID:32145629
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313566	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of TUFM protein	PMID:37567409
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TUFM gene	PMID:28505145
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:3423	carmustine	affects response to substance	ISO	RGD:1313566	E	RGD:6480464	20120412	CTD	MESH:D002330	TUFM mRNA affects the susceptibility to Carmustine	PMID:16365179
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552222	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TUFM gene	PMID:31683443
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313566	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of TUFM protein	PMID:34186270
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313566	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TUFM protein	PMID:34186270
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552222	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TUFM mRNA	PMID:38685157
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313566	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TUFM protein	PMID:34186270
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TUFM mRNA	PMID:17602206
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:34709	Diisodecyl phthalate	increases expression	ISO	RGD:1552222	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in increased expression of TUFM mRNA	PMID:25270620
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of TUFM protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of TUFM protein	PMID:38598786
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TUFM mRNA	PMID:17602206
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TUFM protein	PMID:21699967
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:3750	clofibrate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate results in increased expression of TUFM protein	PMID:16470657
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313566	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TUFM mRNA	PMID:31533062
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TUFM mRNA	PMID:36331819
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313566	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TUFM mRNA	PMID:25979313
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TUFM mRNA	PMID:17292431
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313566	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TUFM mRNA	PMID:23179753
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:40303	lovastatin	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in decreased expression of TUFM mRNA	PMID:20493250
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313566	E	RGD:6480464	20120814	CTD	MESH:D016572	Cyclosporine results in decreased expression of TUFM mRNA	PMID:20106945|PMID:21163907
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of TUFM mRNA	PMID:19770486
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TUFM mRNA	PMID:17562736
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313566	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in increased expression of TUFM mRNA	PMID:31059760
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of TUFM mRNA	PMID:31059760
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TUFM protein	PMID:38460933
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUFM mRNA	PMID:40504410
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TUFM mRNA	PMID:22079256
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313566	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TUFM mRNA	PMID:18175754
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TUFM mRNA	PMID:17942748
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TUFM mRNA	PMID:17942748
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20181016	CTD	MESH:D005047	Etoposide results in decreased expression of TUFM protein	PMID:29733421
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TUFM mRNA	PMID:30307764
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TUFM mRNA	PMID:25620056
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552222	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TUFM mRNA; Nanotubes, Carbon results in increased expression of TUFM mRNA	PMID:25554681
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TUFM mRNA	PMID:35964746
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TUFM mRNA	PMID:24136188
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313566	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TUFM protein	PMID:32959892
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:63918	artesunate	decreases response to substance	ISO	RGD:1313566	E	RGD:6480464	20170228	CTD	MESH:C039726	TUFM mRNA results in decreased susceptibility to artesunate	PMID:20144594
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313566	E	RGD:6480464	20150714	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TUFM protein	PMID:24675778
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TUFM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of TUFM mRNA	PMID:23783067
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in decreased expression of TUFM protein	PMID:19826936
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:68233	(Z)-3-butylidenephthalide	increases expression	ISO	RGD:1313566	E	RGD:6480464	20140311	CTD	MESH:C026105	butylidenephthalide results in increased expression of TUFM protein	PMID:23770345
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:6925	microcystin-LR	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C057862	cyanoginosin LR results in increased expression of TUFM protein	PMID:22430071
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1313566	E	RGD:6480464	20130305	CTD	MESH:C047246	TUFM mRNA affects the susceptibility to temozolomide	PMID:16365179
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313566	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TUFM protein	PMID:34186270
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313566	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of TUFM mRNA	PMID:22079256
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TUFM mRNA	PMID:22079256
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:79516	Nonylphenol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in increased expression of TUFM protein	PMID:19260726
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of TUFM protein	PMID:19954255
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552222	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TUFM mRNA	PMID:30294300
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of TUFM protein	PMID:28903499
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:8493	Propiverine	affects binding	EXP		E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine binds to TUFM protein	PMID:29273565
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of TUFM mRNA	PMID:40826991
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TUFM mRNA	PMID:19281266
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:9381	T-2 toxin	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of TUFM protein	PMID:26141394
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313566	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TUFM mRNA	PMID:38568856
1305501	Tufm	Tu translation elongation factor, mitochondrial	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313566	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of TUFM protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of TUFM protein	PMID:38598786
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621868	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of XRRA1 mRNA	PMID:33045310
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of XRRA1 mRNA	PMID:33387578
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313568	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of XRRA1 mRNA	PMID:37042841
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of XRRA1 mRNA	PMID:26577399
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313568	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of XRRA1 mRNA	PMID:28818685
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313568	E	RGD:6480464	20220405	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the splicing of XRRA1 mRNA	PMID:35072517
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XRRA1 mRNA	PMID:33387578
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313568	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of XRRA1 mRNA	PMID:39709020
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of XRRA1 mRNA	PMID:28959563
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313568	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of XRRA1 mRNA	PMID:29803840
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313568	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of XRRA1 mRNA	PMID:34032870
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621868	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of XRRA1 mRNA	PMID:37682722
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313568	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the splicing of XRRA1 mRNA	PMID:35072517
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313568	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of XRRA1 5' UTR	PMID:27901495
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of XRRA1 mRNA	PMID:30047161
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621868	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of XRRA1 gene	PMID:35295148
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1621868	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of XRRA1 promoter alternative form	PMID:35295148
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of XRRA1 mRNA	PMID:25181051
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1621868	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of XRRA1 gene	PMID:31683443
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313568	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of XRRA1 mRNA	PMID:31533062
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313568	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of XRRA1 mRNA	PMID:40419075
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of XRRA1 mRNA	PMID:30047161
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313568	E	RGD:6480464	20120522	CTD	MESH:D016572	Cyclosporine results in increased expression of XRRA1 mRNA	PMID:20106945
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313568	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of XRRA1 mRNA	PMID:24449571
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313568	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of XRRA1 mRNA	PMID:28542535
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313568	E	RGD:6480464	20220405	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the splicing of XRRA1 mRNA	PMID:35072517
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of XRRA1 mRNA	PMID:30047161
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1621868	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of XRRA1 mRNA	PMID:23608068
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313568	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to XRRA1 gene]	PMID:28238834
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1313568	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of XRRA1 mRNA	PMID:26079696
1305502	Xrra1	X-ray radiation resistance associated 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of XRRA1 mRNA	PMID:24780913
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313569	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of UBE2V1 mRNA	PMID:33045310
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313569	E	RGD:6480464	20130618	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of UBE2V1 mRNA	PMID:20188158
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of UBE2V1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of UBE2V1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of UBE2V1 mRNA	PMID:32699268|PMID:32845096
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313569	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of UBE2V1 mRNA	PMID:30319688
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313569	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of UBE2V1 mRNA	PMID:33711761
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1346082	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of UBE2V1 mRNA	PMID:37042841
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1346082	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of UBE2V1 protein	PMID:37730182
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1346082	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of UBE2V1 intron	PMID:30157460
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of UBE2V1 mRNA	PMID:35301059
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1346082	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UBE2V1 mRNA	PMID:19549813
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of UBE2V1 protein	PMID:23301498
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346082	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UBE2V1 gene	PMID:27153756
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313569	E	RGD:6480464	20130618	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of UBE2V1 mRNA	PMID:19770486
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of UBE2V1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of UBE2V1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of UBE2V1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of UBE2V1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of UBE2V1 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1346082	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UBE2V1 gene	PMID:25304211
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1346082	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of UBE2V1 mRNA	PMID:19244175
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of UBE2V1 mRNA	PMID:19244175
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313569	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of UBE2V1 protein	PMID:25505154
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1346082	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of UBE2V1 mRNA	PMID:28903495
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313569	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of UBE2V1 mRNA	PMID:23186747
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1346082	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of UBE2V1 mRNA	PMID:34089799
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346082	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBE2V1 mRNA	PMID:38568856
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346082	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of UBE2V1 promoter	PMID:27901495
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313569	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBE2V1 gene	PMID:35295148
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313569	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of UBE2V1 enhancer; titanium dioxide results in increased methylation of UBE2V1 promoter	PMID:35295148
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of UBE2V1 mRNA	PMID:25181051
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2V1 mRNA	PMID:30816183|PMID:32528016
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of UBE2V1 gene	PMID:28505145
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1346082	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of UBE2V1 mRNA	PMID:19244175
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of UBE2V1 mRNA	PMID:19244175
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313569	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UBE2V1 mRNA	PMID:39298647
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UBE2V1 mRNA	PMID:28628672
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313569	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of UBE2V1 mRNA	PMID:38685157
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313569	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of UBE2V1 mRNA	PMID:34813904
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UBE2V1 mRNA	PMID:28628672
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313569	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of UBE2V1 mRNA	PMID:34813904
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313569	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of UBE2V1 mRNA	PMID:36117858
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of UBE2V1 mRNA	PMID:35301059
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313569	E	RGD:6480464	20130618	CTD	MESH:D002922	Ciguatoxins affects the expression of UBE2V1 mRNA	PMID:18353800
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of UBE2V1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of UBE2V1 mRNA	PMID:32699268
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1346082	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of UBE2V1 mRNA	PMID:19244175
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of UBE2V1 mRNA	PMID:19244175
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1346082	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of UBE2V1 mRNA	PMID:28302478
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313569	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of UBE2V1 mRNA	PMID:17292431
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1346082	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of UBE2V1 gene	PMID:29154799
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UBE2V1 mRNA	PMID:28628672
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313569	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of UBE2V1 mRNA	PMID:17562736
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1346082	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UBE2V1 gene	PMID:25304211
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UBE2V1 mRNA	PMID:28628672
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313569	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UBE2V1 mRNA	PMID:25554681
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBE2V1 mRNA	PMID:24136188
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313569	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of UBE2V1 mRNA	PMID:36117858
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1346082	E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in increased expression of UBE2V1 mRNA	PMID:11678601
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1346082	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of UBE2V1 mRNA	PMID:16934159
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313569	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of UBE2V1 mRNA	PMID:22206623
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346082	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to UBE2V1 gene]	PMID:28238834
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of UBE2V1 mRNA	PMID:23914054
1305503	Ube2v1	ubiquitin conjugating enzyme E2 V1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1346082	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of UBE2V1 mRNA	PMID:29301935
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ADCK5 mRNA	PMID:33045310
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of ADCK5 mRNA	PMID:25056781
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313570	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ADCK5 mRNA	PMID:20044591
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADCK5 mRNA	PMID:39241906
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313571	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ADCK5 mRNA	PMID:39298647
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313570	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADCK5 mRNA	PMID:37042841
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313571	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of ADCK5 mRNA	PMID:33848595
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of ADCK5 mRNA	PMID:25056781
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADCK5 mRNA	PMID:31919559
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313571	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ADCK5 mRNA	PMID:25629700
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313570	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADCK5 gene	PMID:25304211
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ADCK5 mRNA	PMID:28960355
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313570	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ADCK5 mRNA	PMID:27392435
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313571	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADCK5 mRNA	PMID:21570461
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADCK5 mRNA	PMID:21215274
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADCK5 mRNA	PMID:28922406
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADCK5 mRNA	PMID:33387578
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313570	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ADCK5 mRNA	PMID:32763439
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313571	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ADCK5 protein	PMID:28918527
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADCK5 mRNA	PMID:33145626
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313571	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of ADCK5 mRNA	PMID:39095385
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of ADCK5 protein	PMID:37955338
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313570	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ADCK5 mRNA	PMID:35984750
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ADCK5 mRNA	PMID:24136188
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313571	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADCK5 gene	PMID:35295148
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADCK5 mRNA	PMID:34492290
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313571	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ADCK5 mRNA	PMID:18301758|PMID:23811191
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313571	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ADCK5 mRNA	PMID:28472532
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1313571	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of ADCK5 mRNA	PMID:37894381
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADCK5 mRNA	PMID:25181051
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313571	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ADCK5 gene	PMID:31683443
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313571	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ADCK5 mRNA	PMID:39298647
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADCK5 mRNA	PMID:38685157
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ADCK5 mRNA	PMID:21266533
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ADCK5 mRNA	PMID:30047161
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ADCK5 mRNA	PMID:28903501
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313571	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADCK5 mRNA	PMID:40194260
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313571	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ADCK5 mRNA	PMID:17292431
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ADCK5 mRNA	PMID:30047161
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313571	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ADCK5 mRNA	PMID:28973697
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ADCK5 mRNA	PMID:24136188
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313571	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADCK5 mRNA	PMID:17562736
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313570	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADCK5 gene	PMID:25304211
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ADCK5 mRNA	PMID:29391264
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ADCK5 mRNA	PMID:35436446
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ADCK5 mRNA	PMID:25620056
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ADCK5 mRNA	PMID:30047161
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of ADCK5 mRNA	PMID:19564919
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADCK5 mRNA	PMID:22206623
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ADCK5 mRNA	PMID:24136188
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of ADCK5 mRNA	PMID:19270015
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of ADCK5 mRNA	PMID:21278054
1305504	Adck5	aarF domain containing kinase 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADCK5 mRNA	PMID:30047161
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of UBTD2 mRNA	PMID:25152437
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBTD2 mRNA]	PMID:31150632
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1601834	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of UBTD2 mRNA	PMID:33167477
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1601834	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of UBTD2 mRNA	PMID:22574217
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1601834	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of UBTD2 mRNA	PMID:37042841
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1601834	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of UBTD2 mRNA	PMID:20655997
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1601834	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of UBTD2 gene	PMID:33872906
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1601834	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of UBTD2 gene	PMID:33872906
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1601834	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UBTD2 mRNA	PMID:39836092
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1601834	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of UBTD2 mRNA	PMID:19549813
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of UBTD2 mRNA	PMID:33387578
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBTD2 mRNA	PMID:31150632
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313574	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBTD2 mRNA	PMID:31919559
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBTD2 mRNA]	PMID:31150632
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1601834	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UBTD2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UBTD2 mRNA	PMID:39836092
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313574	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of UBTD2 mRNA	PMID:28960355
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1601834	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of UBTD2 mRNA	PMID:28903495
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313574	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBTD2 mRNA	PMID:21570461
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBTD2 mRNA	PMID:33387578
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1601834	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of UBTD2 mRNA	PMID:33212167
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:28358	rac-lactic acid	affects expression	ISO	RGD:1601834	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of UBTD2 mRNA	PMID:30851411
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1601834	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBTD2 mRNA	PMID:34032870
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1601834	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UBTD2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UBTD2 mRNA	PMID:39836092
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313574	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBTD2 mRNA	PMID:19770486
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1601834	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of UBTD2 mRNA	PMID:19150397|PMID:20018196
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313574	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of UBTD2 mRNA	PMID:23557971
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313574	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBTD2 gene; titanium dioxide results in decreased methylation of UBTD2 promoter	PMID:35295148
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313574	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of UBTD2 gene	PMID:35295148
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UBTD2 mRNA	PMID:34492290
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313574	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of UBTD2 mRNA	PMID:23811191
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of UBTD2 mRNA	PMID:25181051
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313574	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of UBTD2 mRNA	PMID:33221593
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of UBTD2 mRNA	PMID:38750585
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313574	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of UBTD2 mRNA	PMID:37019170
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313574	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of UBTD2 mRNA	PMID:24535843
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1601834	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UBTD2 mRNA	PMID:39836092
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UBTD2 mRNA	PMID:33453195
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1601834	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UBTD2 mRNA	PMID:38568856
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1601834	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBTD2 mRNA	PMID:25979313
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1601834	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of UBTD2 gene	PMID:29154799
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1601834	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of UBTD2 mRNA	PMID:25562108
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1601834	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of UBTD2 mRNA	PMID:21420995
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1601834	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of UBTD2 mRNA	PMID:24160326
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:46680	serpentine asbestos	affects expression	ISO	RGD:1601834	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine affects the expression of UBTD2 mRNA	PMID:24160326
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1601834	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UBTD2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UBTD2 mRNA	PMID:39836092
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of UBTD2 mRNA	PMID:29391264
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1601834	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of UBTD2 mRNA	PMID:39836092
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1601834	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of UBTD2 mRNA	PMID:28988120
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313574	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UBTD2 mRNA	PMID:22206623
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	ISO	RGD:1601834	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of UBTD2 mRNA	PMID:30851411
1305506	Ubtd2	ubiquitin domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of UBTD2 mRNA	PMID:24780913
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1332457	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DHRS13 mRNA	PMID:33045310
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603266	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DHRS13 mRNA	PMID:33167477
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1603266	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DHRS13 mRNA	PMID:22378314
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1332457	E	RGD:6480464	20130806	CTD	MESH:D000431	Ethanol results in increased expression of DHRS13 mRNA	PMID:19167417
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1603266	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in increased expression of DHRS13 mRNA	PMID:21632981
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1603266	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of DHRS13 mRNA	PMID:31614463
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1603266	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of DHRS13 mRNA	PMID:30165855
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DHRS13 mRNA	PMID:33387578
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1603266	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DHRS13 mRNA	PMID:28818685
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:18009	NADP(+)	multiple interactions	ISO	RGD:1603266	E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of DHRS13 protein	PMID:25526675
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1603266	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DHRS13 mRNA	PMID:19549813
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1603266	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DHRS13 mRNA	PMID:21641981
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DHRS13 mRNA	PMID:33387578
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1603266	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DHRS13 mRNA	PMID:28903495
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603266	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of DHRS13 mRNA	PMID:27392435
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1603266	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of DHRS13 mRNA	PMID:27392435
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332457	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DHRS13 mRNA	PMID:21570461
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1603266	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of DHRS13 mRNA	PMID:29955902
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1603266	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DHRS13 mRNA	PMID:33212167
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603266	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DHRS13 mRNA	PMID:38568856
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1603266	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of DHRS13 mRNA	PMID:29453283
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1603266	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DHRS13 mRNA	PMID:21632981|PMID:32234424
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DHRS13 mRNA	PMID:25729387
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332457	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DHRS13 promoter	PMID:35295148
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332457	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DHRS13 mRNA	PMID:23811191
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1603266	E	RGD:6480464	20130806	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DHRS13 mRNA	PMID:19710929
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332457	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of DHRS13 mRNA	PMID:38074096
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1603266	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of DHRS13 protein	PMID:33181973
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1603266	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in decreased expression of DHRS13 mRNA	PMID:27685785
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1332457	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DHRS13 mRNA	PMID:21266533
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603266	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DHRS13 mRNA	PMID:37042841
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1603266	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DHRS13 mRNA	PMID:38568856
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603266	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DHRS13 mRNA	PMID:25979313
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1603266	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DHRS13 gene	PMID:29154799
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603266	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of DHRS13 mRNA	PMID:29154799
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1603266	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DHRS13 mRNA	PMID:25562108
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603266	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in increased expression of DHRS13 mRNA	PMID:20106945
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:44409	NADP zwitterion	multiple interactions	ISO	RGD:1603266	E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of DHRS13 protein	PMID:25526675
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332457	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen affects the expression of DHRS13 mRNA	PMID:17562736
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DHRS13 mRNA	PMID:33387578
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1332457	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of DHRS13 mRNA	PMID:35436446
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332457	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DHRS13 mRNA	PMID:25620056
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of DHRS13 mRNA	PMID:24136188
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1332457	E	RGD:6480464	20130806	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DHRS13 mRNA	PMID:19042947
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DHRS13 mRNA	PMID:25729387
1305508	Dhrs13	dehydrogenase/reductase 13	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1603266	E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in increased expression of DHRS13 mRNA	PMID:29453283
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SENP7 mRNA	PMID:26272509
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP7 mRNA	PMID:27188386
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550234	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SENP7 mRNA	PMID:33045310
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SENP7 mRNA]	PMID:31150632
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SENP7 mRNA	PMID:21632981
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313579	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of SENP7 mRNA	PMID:22574217
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SENP7 mRNA	PMID:32145629
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313579	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SENP7 mRNA	PMID:37042841
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313579	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SENP7 protein	PMID:37730182
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SENP7 mRNA	PMID:22061828
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA	PMID:39836092
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SENP7 mRNA	PMID:22100608
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313579	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SENP7 mRNA	PMID:23649840
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SENP7 mRNA	PMID:22171008
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SENP7 mRNA	PMID:31150632
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SENP7 mRNA]	PMID:31150632
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SENP7 mRNA	PMID:21867686
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of SENP7 mRNA	PMID:38723480
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:39836092
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550234	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:40504410
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SENP7 mRNA	PMID:25905778
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SENP7 mRNA	PMID:23557933
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SENP7 mRNA	PMID:27392435
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SENP7 mRNA	PMID:27392435
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550234	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SENP7 mRNA	PMID:21570461
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SENP7 mRNA	PMID:21215274
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550234	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SENP7 mRNA	PMID:21354282
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SENP7 mRNA	PMID:28001369
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SENP7 mRNA	PMID:33212167
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SENP7 mRNA	PMID:32763439
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SENP7 mRNA	PMID:29803840
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of SENP7 mRNA	PMID:28595984|PMID:34032870
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313579	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SENP7 mRNA	PMID:38568856
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:39836092
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550234	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:40504410
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313579	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of SENP7 mRNA	PMID:21714911
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313579	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SENP7 promoter	PMID:27901495
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SENP7 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SENP7 mRNA	PMID:21839799
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SENP7 mRNA	PMID:22171008
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SENP7 mRNA	PMID:34973136
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP7 mRNA	PMID:25729387
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SENP7 mRNA	PMID:30047161
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550234	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SENP7 gene	PMID:35295148
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SENP7 mRNA	PMID:34492290
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550234	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SENP7 mRNA	PMID:19710929
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20170516	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of SENP7 mRNA	PMID:27793765
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SENP7 mRNA	PMID:25181051
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of SENP7 mRNA	PMID:33296240|PMID:41034487
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SENP7 gene	PMID:28505145
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SENP7 mRNA	PMID:39298647
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SENP7 mRNA	PMID:20350560
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA	PMID:39836092
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1313579	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of SENP7 mRNA	PMID:19691856
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of SENP7 mRNA	PMID:30047161
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SENP7 mRNA	PMID:28302478
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313579	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SENP7 mRNA	PMID:31533062
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SENP7 mRNA	PMID:27153767|PMID:40419075
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of SENP7 mRNA	PMID:22110744
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SENP7 mRNA	PMID:23179753|PMID:27188386
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SENP7 mRNA	PMID:30047161
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550234	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SENP7 mRNA	PMID:17562736
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SENP7 mRNA	PMID:33387578
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SENP7 mRNA	PMID:29067470
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SENP7 mRNA	PMID:29279043
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of SENP7 mRNA	PMID:38723480
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:39836092
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550234	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:40504410
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SENP7 mRNA	PMID:22079256
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SENP7 mRNA	PMID:30047161
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of SENP7 mRNA	PMID:20080153
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA	PMID:39836092
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550234	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SENP7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SENP7 mRNA	PMID:21641980|PMID:26378955
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SENP7 mRNA	PMID:25729387
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP7 mRNA	PMID:25729387
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of SENP7 protein	PMID:36851058
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SENP7 mRNA	PMID:22206623
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SENP7 mRNA	PMID:22079256
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SENP7 mRNA	PMID:22079256
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP7 mRNA	PMID:27188386
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SENP7 mRNA	PMID:30928695
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550234	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SENP7 mRNA	PMID:23091169
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of SENP7 mRNA	PMID:20345932
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1313579	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SENP7 mRNA	PMID:26079696
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SENP7 mRNA	PMID:30047161
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313579	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP7 mRNA	PMID:27188386
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1550234	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of SENP7 protein	PMID:24648495
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313579	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of SENP7 mRNA	PMID:27188386
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SENP7 mRNA	PMID:28973697
1305510	Senp7	SUMO specific peptidase 7	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of SENP7 mRNA	PMID:23034163
1305511	Ppl	periplakin	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of PPL mRNA	PMID:21551480
1305511	Ppl	periplakin	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313581	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PPL mRNA	PMID:26272509
1305511	Ppl	periplakin	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1305511	Ppl	periplakin	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PPL mRNA	PMID:20188158
1305511	Ppl	periplakin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PPL mRNA	PMID:20938992
1305511	Ppl	periplakin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of PPL mRNA	PMID:30951980
1305511	Ppl	periplakin	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPL mRNA	PMID:32699268
1305511	Ppl	periplakin	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313581	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PPL mRNA	PMID:24403227|PMID:26516004
1305511	Ppl	periplakin	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PPL mRNA	PMID:33729688
1305511	Ppl	periplakin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20151013	CTD	MESH:D010100	1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of PPL mRNA]	PMID:24403227
1305511	Ppl	periplakin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPL mRNA	PMID:30529165
1305511	Ppl	periplakin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PPL mRNA	PMID:35811015
1305511	Ppl	periplakin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PPL mRNA	PMID:39298647
1305511	Ppl	periplakin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PPL mRNA	PMID:30165855
1305511	Ppl	periplakin	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PPL mRNA	PMID:38568856
1305511	Ppl	periplakin	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PPL mRNA	PMID:33387578
1305511	Ppl	periplakin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PPL mRNA	PMID:20938992
1305511	Ppl	periplakin	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313581	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PPL mRNA	PMID:23649840|PMID:28937961
1305511	Ppl	periplakin	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313581	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of PPL mRNA	PMID:18070364
1305511	Ppl	periplakin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPL mRNA	PMID:37992649
1305511	Ppl	periplakin	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PPL mRNA	PMID:33359661
1305511	Ppl	periplakin	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of PPL mRNA	PMID:19693291
1305511	Ppl	periplakin	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313581	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of PPL mRNA	PMID:21592394
1305511	Ppl	periplakin	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of PPL mRNA	PMID:21592394
1305511	Ppl	periplakin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPL mRNA	PMID:37992649
1305511	Ppl	periplakin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PPL mRNA	PMID:33754040
1305511	Ppl	periplakin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PPL mRNA	PMID:19850644
1305511	Ppl	periplakin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of PPL mRNA]	PMID:19850644
1305511	Ppl	periplakin	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PPL mRNA	PMID:27523638
1305511	Ppl	periplakin	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313581	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of PPL mRNA	PMID:21592394|PMID:26485663
1305511	Ppl	periplakin	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of PPL mRNA	PMID:21592394
1305511	Ppl	periplakin	gene	CHEBI:181932	3-Nitrobenzanthrone	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in decreased expression of PPL mRNA	PMID:34036453
1305511	Ppl	periplakin	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased expression of PPL mRNA	PMID:28860664
1305511	Ppl	periplakin	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of PPL mRNA	PMID:23487506
1305511	Ppl	periplakin	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313581	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PPL mRNA	PMID:23649840
1305511	Ppl	periplakin	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPL mRNA	PMID:25378103
1305511	Ppl	periplakin	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313581	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PPL intron; Aflatoxin B1 results in increased methylation of PPL polyA tail	PMID:30157460
1305511	Ppl	periplakin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313581	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PPL mRNA	PMID:23649840
1305511	Ppl	periplakin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPL mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PPL mRNA	PMID:32699268
1305511	Ppl	periplakin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PPL mRNA	PMID:34911549
1305511	Ppl	periplakin	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of PPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of PPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of PPL protein	PMID:38598786
1305511	Ppl	periplakin	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of PPL mRNA	PMID:28534445
1305511	Ppl	periplakin	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PPL mRNA	PMID:31150632
1305511	Ppl	periplakin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313582	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PPL mRNA	PMID:27339419
1305511	Ppl	periplakin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PPL mRNA	PMID:20938992
1305511	Ppl	periplakin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPL mRNA	PMID:40504410
1305511	Ppl	periplakin	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20191105	CTD	MESH:D000968	Antimycin A results in decreased expression of PPL mRNA	PMID:19304788
1305511	Ppl	periplakin	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313581	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PPL mRNA	PMID:26272509
1305511	Ppl	periplakin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1305511	Ppl	periplakin	gene	CHEBI:27779	griseofulvin	affects expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D006118	Griseofulvin affects the expression of PPL mRNA	PMID:12735108
1305511	Ppl	periplakin	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PPL mRNA	PMID:31881176
1305511	Ppl	periplakin	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of PPL mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of PPL mRNA	PMID:19167446|PMID:23557933
1305511	Ppl	periplakin	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PPL mRNA	PMID:27392435
1305511	Ppl	periplakin	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of PPL mRNA	PMID:22023808
1305511	Ppl	periplakin	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313582	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of PPL mRNA	PMID:40618947
1305511	Ppl	periplakin	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of PPL protein	PMID:20884965
1305511	Ppl	periplakin	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of PPL protein]	PMID:20884965
1305511	Ppl	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313581	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPL mRNA	PMID:22298810
1305511	Ppl	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313582	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPL mRNA	PMID:21570461
1305511	Ppl	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPL mRNA	PMID:20106945
1305511	Ppl	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPL mRNA	PMID:19933214
1305511	Ppl	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPL mRNA	PMID:33387578
1305511	Ppl	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313581	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPL mRNA	PMID:23152189
1305511	Ppl	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPL mRNA	PMID:17035482|PMID:28922406
1305511	Ppl	periplakin	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of PPL mRNA	PMID:19304788
1305511	Ppl	periplakin	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PPL mRNA	PMID:30851411
1305511	Ppl	periplakin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20200804	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPL mRNA	PMID:31768571
1305511	Ppl	periplakin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPL mRNA	PMID:37992649
1305511	Ppl	periplakin	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PPL mRNA	PMID:29432896
1305511	Ppl	periplakin	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1313582	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of PPL mRNA	PMID:32042022
1305511	Ppl	periplakin	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1313581	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of PPL mRNA	PMID:22623647
1305511	Ppl	periplakin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPL mRNA	PMID:38568856
1305511	Ppl	periplakin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPL mRNA	PMID:37682722
1305511	Ppl	periplakin	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313581	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased methylation of PPL gene	PMID:24570342
1305511	Ppl	periplakin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313581	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PPL mRNA	PMID:24570342|PMID:39719251
1305511	Ppl	periplakin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPL mRNA	PMID:40504410
1305511	Ppl	periplakin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313581	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPL intron	PMID:30157460
1305511	Ppl	periplakin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPL mRNA	PMID:20106945
1305511	Ppl	periplakin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313581	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PPL 3' UTR; Benzo(a)pyrene results in decreased methylation of PPL promoter	PMID:27901495
1305511	Ppl	periplakin	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to PPL promoter]	PMID:19654925
1305511	Ppl	periplakin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PPL mRNA]	PMID:32406909
1305511	Ppl	periplakin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PPL mRNA	PMID:25895662
1305511	Ppl	periplakin	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PPL gene	PMID:31601247
1305511	Ppl	periplakin	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of PPL mRNA	PMID:38568856
1305511	Ppl	periplakin	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of PPL mRNA	PMID:30012374
1305511	Ppl	periplakin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of PPL mRNA	PMID:23557971
1305511	Ppl	periplakin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313582	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PPL gene	PMID:35295148
1305511	Ppl	periplakin	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PPL mRNA	PMID:23411599|PMID:34492290
1305511	Ppl	periplakin	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PPL mRNA	PMID:19710929
1305511	Ppl	periplakin	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PPL mRNA	PMID:19167457
1305511	Ppl	periplakin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PPL mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1305511	Ppl	periplakin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of PPL protein	PMID:31675489
1305511	Ppl	periplakin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313581	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PPL gene	PMID:31601247
1305511	Ppl	periplakin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PPL mRNA	PMID:35192832|PMID:36779543
1305511	Ppl	periplakin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313581	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of PPL protein	PMID:37567409
1305511	Ppl	periplakin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313582	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of PPL mRNA	PMID:25594700|PMID:32156529
1305511	Ppl	periplakin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PPL gene	PMID:31601247
1305511	Ppl	periplakin	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313581	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of PPL protein	PMID:31675489
1305511	Ppl	periplakin	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PPL mRNA	PMID:19244175
1305511	Ppl	periplakin	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313581	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PPL mRNA	PMID:25979313
1305511	Ppl	periplakin	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20120501	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPL mRNA	PMID:19692669
1305511	Ppl	periplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313581	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of PPL protein	PMID:31945527
1305511	Ppl	periplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313582	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PPL mRNA	PMID:30951980
1305511	Ppl	periplakin	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1313582	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of PPL mRNA	PMID:26377693
1305511	Ppl	periplakin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313581	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PPL protein	PMID:34186270
1305511	Ppl	periplakin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313582	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PPL mRNA	PMID:30951980
1305511	Ppl	periplakin	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of PPL mRNA	PMID:30951980
1305511	Ppl	periplakin	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313581	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PPL protein	PMID:34186270
1305511	Ppl	periplakin	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1313581	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to PPL protein	PMID:32991956
1305511	Ppl	periplakin	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of PPL protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of PPL protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of PPL protein	PMID:38598786
1305511	Ppl	periplakin	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313582	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PPL mRNA	PMID:24535843
1305511	Ppl	periplakin	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313581	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPL mRNA	PMID:37042841
1305511	Ppl	periplakin	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of PPL mRNA	PMID:30589522
1305511	Ppl	periplakin	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313582	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PPL mRNA	PMID:26377693
1305511	Ppl	periplakin	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PPL mRNA	PMID:30723492
1305511	Ppl	periplakin	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313581	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PPL mRNA	PMID:38382870
1305511	Ppl	periplakin	gene	CHEBI:35546	perfluorodecanoic acid	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20240702	CTD	MESH:C036567	perfluorodecanoic acid results in decreased expression of PPL mRNA	PMID:38568856
1305511	Ppl	periplakin	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of PPL gene	PMID:27387713
1305511	Ppl	periplakin	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of PPL mRNA	PMID:25539665|PMID:27387713
1305511	Ppl	periplakin	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1313582	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of PPL mRNA	PMID:24183702
1305511	Ppl	periplakin	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PPL mRNA	PMID:28903501
1305511	Ppl	periplakin	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313581	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PPL mRNA	PMID:24449571
1305511	Ppl	periplakin	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPL mRNA	PMID:32699268
1305511	Ppl	periplakin	gene	CHEBI:37825	p-toluidine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of PPL mRNA	PMID:27638505
1305511	Ppl	periplakin	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PPL mRNA	PMID:19167446
1305511	Ppl	periplakin	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of PPL mRNA	PMID:19167446
1305511	Ppl	periplakin	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313582	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PPL mRNA	PMID:39529242
1305511	Ppl	periplakin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PPL mRNA	PMID:40419075
1305511	Ppl	periplakin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PPL mRNA	PMID:17292431
1305511	Ppl	periplakin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313581	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PPL mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1305511	Ppl	periplakin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of PPL mRNA	PMID:21427059
1305511	Ppl	periplakin	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1305511	Ppl	periplakin	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1313581	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine affects the expression of PPL mRNA	PMID:20106945
1305511	Ppl	periplakin	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of PPL mRNA	PMID:21865292
1305511	Ppl	periplakin	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313581	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PPL mRNA	PMID:21632981|PMID:25562108
1305511	Ppl	periplakin	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of PPL mRNA	PMID:25123088
1305511	Ppl	periplakin	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313582	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of PPL mRNA	PMID:22733784
1305511	Ppl	periplakin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PPL mRNA	PMID:28973697
1305511	Ppl	periplakin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPL mRNA	PMID:37992649
1305511	Ppl	periplakin	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PPL mRNA	PMID:38832940
1305511	Ppl	periplakin	gene	CHEBI:44658	okadaic acid	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of and results in increased phosphorylation of PPL protein	PMID:38832940
1305511	Ppl	periplakin	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313581	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PPL mRNA	PMID:24935251
1305511	Ppl	periplakin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPL mRNA	PMID:17562736
1305511	Ppl	periplakin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPL mRNA	PMID:33387578
1305511	Ppl	periplakin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPL mRNA	PMID:21420995
1305511	Ppl	periplakin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313581	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of PPL mRNA	PMID:25704631
1305511	Ppl	periplakin	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of PPL mRNA	PMID:24714768
1305511	Ppl	periplakin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of PPL mRNA	PMID:35811015
1305511	Ppl	periplakin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PPL mRNA	PMID:35811015
1305511	Ppl	periplakin	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20120717	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PPL mRNA	PMID:20831825
1305511	Ppl	periplakin	gene	CHEBI:46677	amphibole asbestos	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20170303	CTD	MESH:D017636	Asbestos, Amphibole results in decreased expression of PPL mRNA	PMID:20831825
1305511	Ppl	periplakin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPL mRNA	PMID:40504410
1305511	Ppl	periplakin	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of PPL mRNA	PMID:31675489
1305511	Ppl	periplakin	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PPL mRNA	PMID:29391264
1305511	Ppl	periplakin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PPL mRNA	PMID:17557909
1305511	Ppl	periplakin	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of PPL mRNA	PMID:38568856
1305511	Ppl	periplakin	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1313581	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PPL mRNA	PMID:26272509
1305511	Ppl	periplakin	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1305511	Ppl	periplakin	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313582	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PPL mRNA	PMID:25554681
1305511	Ppl	periplakin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313582	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PPL mRNA	PMID:25554681
1305511	Ppl	periplakin	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of PPL mRNA	PMID:22504374
1305511	Ppl	periplakin	gene	CHEBI:507499	tricetin	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20240903	CTD	MESH:C469689	tricetin results in decreased expression of PPL mRNA	PMID:38654487
1305511	Ppl	periplakin	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of PPL mRNA	PMID:19042947
1305511	Ppl	periplakin	gene	CHEBI:61057	tacrolimus hydrate	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D016559	Tacrolimus results in increased expression of PPL mRNA	PMID:21865292
1305511	Ppl	periplakin	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PPL mRNA	PMID:15336504
1305511	Ppl	periplakin	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PPL mRNA	PMID:15003993
1305511	Ppl	periplakin	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313581	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PPL mRNA	PMID:24810058
1305511	Ppl	periplakin	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	ISO	RGD:1313581	E	RGD:6480464	20240206	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of PPL protein	PMID:37788135
1305511	Ppl	periplakin	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PPL gene	PMID:35440735
1305511	Ppl	periplakin	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313581	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PPL protein	PMID:34186270
1305511	Ppl	periplakin	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313582	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PPL mRNA	PMID:20061341
1305511	Ppl	periplakin	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313581	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PPL mRNA	PMID:37199045
1305511	Ppl	periplakin	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PPL mRNA	PMID:30851411
1305511	Ppl	periplakin	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1305511	Ppl	periplakin	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PPL mRNA	PMID:19482888
1305511	Ppl	periplakin	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PPL mRNA]	PMID:19482888
1305511	Ppl	periplakin	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA	PMID:19167446
1305511	Ppl	periplakin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313582	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PPL mRNA	PMID:38648751
1305511	Ppl	periplakin	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PPL protein	PMID:31675489
1305511	Ppl	periplakin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PPL mRNA	PMID:24780913
1305511	Ppl	periplakin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of PPL mRNA	PMID:22504374
1305511	Ppl	periplakin	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313581	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PPL mRNA	PMID:26272509
1305511	Ppl	periplakin	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1305511	Ppl	periplakin	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1305511	Ppl	periplakin	gene	CHEBI:9168	sirolimus	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D020123	Sirolimus results in increased expression of PPL mRNA	PMID:21865292
1305511	Ppl	periplakin	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PPL mRNA	PMID:19281266
1305511	Ppl	periplakin	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PPL mRNA	PMID:21346803
1305511	Ppl	periplakin	gene	CHEBI:92181	lasalocid	increases expression	ISO	RGD:1313581	E	RGD:6480464	20240206	CTD	MESH:D007832	Lasalocid results in increased expression of PPL protein	PMID:37788135
1305511	Ppl	periplakin	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313581	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PPL mRNA	PMID:38568856
1305511	Ppl	periplakin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313581	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of PPL protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of PPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of PPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of PPL protein	PMID:38598786
1305511	Ppl	periplakin	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of PPL protein	PMID:32519852
1305511	Ppl	periplakin	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313582	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of PPL mRNA	PMID:28973697
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of FAM3D gene	PMID:28931070|PMID:35440735
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D004958	Estradiol results in increased expression of FAM3D mRNA	PMID:15289156|PMID:26879975
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of FAM3D mRNA	PMID:33711761
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313584	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FAM3D mRNA	PMID:34319233
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FAM3D mRNA	PMID:33387578
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1313583	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of FAM3D mRNA	PMID:17103032
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of FAM3D mRNA	PMID:21396975
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313584	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FAM3D mRNA	PMID:34911549
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D005492	Folic Acid results in increased expression of FAM3D mRNA	PMID:25629700
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of FAM3D mRNA]	PMID:22206623
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313583	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM3D mRNA	PMID:23557933
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313583	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of FAM3D promoter	PMID:22847954
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D019833	Genistein results in increased expression of FAM3D mRNA	PMID:15289156
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM3D mRNA	PMID:17942748
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FAM3D mRNA	PMID:17942748
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:28436	delphinidin	decreases expression	ISO	RGD:1313584	E	RGD:6480464	20240604	CTD	MESH:C017185	delphinidin results in decreased expression of FAM3D mRNA; delphinidin results in decreased expression of FAM3D protein	PMID:38291899
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of FAM3D mRNA	PMID:30556269
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313584	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of FAM3D mRNA	PMID:36209798
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:C017947	sodium arsenite results in increased expression of FAM3D mRNA	PMID:17350061
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313583	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM3D intron	PMID:30157460
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313583	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM3D 5' UTR	PMID:27901495
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of FAM3D mRNA	PMID:30556269
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313584	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the expression of FAM3D mRNA	PMID:35295148
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:C009495	titanium dioxide results in decreased expression of FAM3D mRNA	PMID:23557971
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:C006253	pirinixic acid results in decreased expression of FAM3D mRNA	PMID:17426115
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM3D mRNA	PMID:25181051
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of FAM3D mRNA	PMID:41034487
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313584	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of FAM3D mRNA	PMID:32156529
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313583	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of FAM3D intron	PMID:30157460
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:C008745	bisphenol F results in increased expression of FAM3D mRNA	PMID:30951980
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of FAM3D mRNA	PMID:35163327
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of FAM3D mRNA	PMID:27387713
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313583	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of FAM3D promoter	PMID:22847954
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313583	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of FAM3D promoter	PMID:22847954
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313583	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FAM3D gene	PMID:29154799
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D013629	Tamoxifen affects the expression of FAM3D mRNA	PMID:17555576
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of FAM3D mRNA	PMID:15289156
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FAM3D mRNA	PMID:33387578
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FAM3D mRNA	PMID:17555576
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FAM3D mRNA	PMID:17557909
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FAM3D mRNA	PMID:17942748
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FAM3D mRNA	PMID:17942748
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313584	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of FAM3D mRNA	PMID:38701926
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313583	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of FAM3D intron	PMID:30157460
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FAM3D gene	PMID:35440735
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FAM3D mRNA	PMID:22206623
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of FAM3D mRNA]	PMID:22206623
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313583	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FAM3D gene]	PMID:28238834
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D010634	Phenobarbital affects the expression of FAM3D mRNA	PMID:23091169
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FAM3D mRNA	PMID:27291303
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of FAM3D mRNA	PMID:36084822
1305512	Fam3d	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of FAM3D mRNA	PMID:23640034
1305513	Rnf31	ring finger protein 31	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1348836	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RNF31 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RNF31 mRNA	PMID:32699268
1305513	Rnf31	ring finger protein 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313585	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNF31 mRNA	PMID:39241906
1305513	Rnf31	ring finger protein 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1348836	E	RGD:6480464	20211207	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNF31 protein	PMID:34416243
1305513	Rnf31	ring finger protein 31	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20211207	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Galactose] results in increased expression of RNF31 protein; [Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RNF31 mRNA]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of GPT protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of IL6 protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNF protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNFAIP3 protein]	PMID:34416243|PMID:39241906
1305513	Rnf31	ring finger protein 31	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1348836	E	RGD:6480464	20211207	CTD	MESH:D008070	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [RNF31 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNFAIP3 protein]]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [RNF31 protein inhibits the reaction [TNFAIP3 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [RNF31 protein inhibits the reaction [TNFAIP3 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]]; RNF31 protein affects the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; RNF31 protein affects the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; RNF31 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNFAIP3 protein]; RNF31 protein inhibits the reaction [TNFAIP3 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; RNF31 protein inhibits the reaction [TNFAIP3 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; RNF31 protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; RNF31 protein promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; TNFAIP3 protein affects the reaction [RNF31 protein affects the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; TNFAIP3 protein affects the reaction [RNF31 protein affects the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]	PMID:34416243
1305513	Rnf31	ring finger protein 31	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313585	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RNF31 mRNA	PMID:39298647
1305513	Rnf31	ring finger protein 31	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1348836	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of RNF31 mRNA	PMID:15929907
1305513	Rnf31	ring finger protein 31	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1348836	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RNF31 mRNA	PMID:21179406
1305513	Rnf31	ring finger protein 31	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1348836	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of RNF31 mRNA	PMID:33647349
1305513	Rnf31	ring finger protein 31	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313585	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RNF31 mRNA	PMID:23892564
1305513	Rnf31	ring finger protein 31	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1348836	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RNF31 protein	PMID:37730182
1305513	Rnf31	ring finger protein 31	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1313585	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of RNF31 mRNA	PMID:39984025
1305513	Rnf31	ring finger protein 31	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1348836	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RNF31 mRNA	PMID:19549813
1305513	Rnf31	ring finger protein 31	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313585	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RNF31 mRNA	PMID:19770486
1305513	Rnf31	ring finger protein 31	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1348836	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RNF31 gene	PMID:27153756
1305513	Rnf31	ring finger protein 31	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1348836	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RNF31 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RNF31 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of RNF31 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RNF31 mRNA	PMID:32699268|PMID:35430440
1305513	Rnf31	ring finger protein 31	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF31 mRNA	PMID:22206623
1305513	Rnf31	ring finger protein 31	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF31 mRNA	PMID:40504410
1305513	Rnf31	ring finger protein 31	gene	CHEBI:27656	camptothecin	decreases response to substance	ISO	RGD:1348836	E	RGD:6480464	20160315	CTD	MESH:D002166	RNF31 mRNA results in decreased susceptibility to Camptothecin	PMID:25269479
1305513	Rnf31	ring finger protein 31	gene	CHEBI:28061	alpha-D-galactose	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20211207	CTD	MESH:D005690	[Lipopolysaccharides co-treated with Galactose] results in increased expression of RNF31 protein; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of GPT protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of IL6 protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNF protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNFAIP3 protein]	PMID:34416243
1305513	Rnf31	ring finger protein 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313585	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF31 mRNA	PMID:21570461
1305513	Rnf31	ring finger protein 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF31 mRNA	PMID:21215274
1305513	Rnf31	ring finger protein 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RNF31 mRNA	PMID:26232522|PMID:33387578
1305513	Rnf31	ring finger protein 31	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1348836	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RNF31 protein	PMID:39603559
1305513	Rnf31	ring finger protein 31	gene	CHEBI:28260	galactose	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20211207	CTD	MESH:D005690	[Lipopolysaccharides co-treated with Galactose] results in increased expression of RNF31 protein; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of GPT protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of IL6 protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNF protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNFAIP3 protein]	PMID:34416243
1305513	Rnf31	ring finger protein 31	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1348836	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of RNF31 mRNA	PMID:32763439
1305513	Rnf31	ring finger protein 31	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313585	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of RNF31 protein	PMID:28918527
1305513	Rnf31	ring finger protein 31	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1348836	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF31 mRNA	PMID:29803840
1305513	Rnf31	ring finger protein 31	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF31 mRNA	PMID:40504410
1305513	Rnf31	ring finger protein 31	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313585	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF31 mRNA	PMID:22228805
1305513	Rnf31	ring finger protein 31	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RNF31 mRNA	PMID:30047161
1305513	Rnf31	ring finger protein 31	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313585	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF31 gene; titanium dioxide results in decreased methylation of RNF31 promoter alternative form	PMID:35295148
1305513	Rnf31	ring finger protein 31	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313585	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RNF31 mRNA	PMID:28472532
1305513	Rnf31	ring finger protein 31	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313585	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF31 mRNA	PMID:38074096
1305513	Rnf31	ring finger protein 31	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RNF31 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305513	Rnf31	ring finger protein 31	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313585	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of RNF31 gene	PMID:31683443
1305513	Rnf31	ring finger protein 31	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313585	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF31 mRNA	PMID:39298647
1305513	Rnf31	ring finger protein 31	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1348836	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF31 mRNA	PMID:28628672
1305513	Rnf31	ring finger protein 31	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313585	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RNF31 mRNA	PMID:37019170
1305513	Rnf31	ring finger protein 31	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1348836	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF31 mRNA	PMID:28628672
1305513	Rnf31	ring finger protein 31	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RNF31 mRNA]	PMID:39241906
1305513	Rnf31	ring finger protein 31	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348836	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNF31 mRNA	PMID:37042841
1305513	Rnf31	ring finger protein 31	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1348836	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RNF31 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RNF31 mRNA	PMID:32699268
1305513	Rnf31	ring finger protein 31	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1348836	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RNF31 gene	PMID:29154799
1305513	Rnf31	ring finger protein 31	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RNF31 mRNA	PMID:30047161
1305513	Rnf31	ring finger protein 31	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1348836	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF31 mRNA	PMID:28628672
1305513	Rnf31	ring finger protein 31	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1348836	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RNF31 mRNA	PMID:28542535
1305513	Rnf31	ring finger protein 31	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF31 mRNA	PMID:40504410
1305513	Rnf31	ring finger protein 31	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1348836	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF31 mRNA	PMID:28628672
1305513	Rnf31	ring finger protein 31	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of RNF31 mRNA	PMID:30307764
1305513	Rnf31	ring finger protein 31	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313585	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RNF31 mRNA	PMID:25554681
1305513	Rnf31	ring finger protein 31	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RNF31 mRNA	PMID:30047161
1305513	Rnf31	ring finger protein 31	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RNF31 mRNA	PMID:35964746
1305513	Rnf31	ring finger protein 31	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1348836	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RNF31 protein	PMID:32959892
1305513	Rnf31	ring finger protein 31	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of RNF31 mRNA	PMID:20080153
1305513	Rnf31	ring finger protein 31	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of RNF31 mRNA	PMID:19564919
1305513	Rnf31	ring finger protein 31	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF31 mRNA	PMID:22206623
1305513	Rnf31	ring finger protein 31	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1348836	E	RGD:6480464	20211207	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [RNF31 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNFAIP3 protein]]	PMID:34416243
1305513	Rnf31	ring finger protein 31	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348836	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RNF31 gene]	PMID:28238834
1305513	Rnf31	ring finger protein 31	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RNF31 mRNA	PMID:30047161
1305513	Rnf31	ring finger protein 31	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313585	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RNF31 mRNA]	PMID:39241906
1305513	Rnf31	ring finger protein 31	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RNF31 mRNA	PMID:21346803
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332387	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PATL1 gene	PMID:20938992
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1606423	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of PATL1 mRNA	PMID:33167477
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1606423	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of PATL1 mRNA	PMID:40865780
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332387	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PATL1 gene	PMID:20938992
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606423	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PATL1 mRNA	PMID:37042841
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1606423	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PATL1 mRNA	PMID:21179406
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1606423	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PATL1 protein	PMID:37730182
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PATL1 mRNA	PMID:33387578
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332387	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PATL1 mRNA	PMID:37236586
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PATL1 mRNA	PMID:35301059
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PATL1 protein	PMID:23301498
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1332387	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PATL1 mRNA	PMID:19770486
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332387	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PATL1 mRNA	PMID:31919559
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1332387	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PATL1 mRNA	PMID:25629700
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332387	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PATL1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PATL1 gene	PMID:20938992|PMID:22206623
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1606423	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of PATL1 promoter	PMID:21291286
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332387	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PATL1 mRNA	PMID:40504410
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1606423	E	RGD:6480464	20260804	CTD	MESH:C010974	Glyphosate results in decreased expression of PATL1 mRNA	PMID:40865780
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PATL1 mRNA	PMID:23557933
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1606423	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PATL1 mRNA	PMID:24768652|PMID:25583101
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332387	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PATL1 mRNA	PMID:21570461
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1606423	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of PATL1 protein	PMID:39603559
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606423	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PATL1 mRNA	PMID:33212167
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1606423	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PATL1 mRNA	PMID:30851411
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1606423	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of PATL1 mRNA	PMID:23649840
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606423	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PATL1 mRNA	PMID:29803840
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332387	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PATL1 mRNA	PMID:40504410
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606423	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PATL1 promoter	PMID:27901495
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PATL1 mRNA	PMID:34492290
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PATL1 mRNA	PMID:19710929
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PATL1 mRNA	PMID:30816183|PMID:32528016|PMID:41034487
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606423	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PATL1 mRNA	PMID:29275510
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PATL1 mRNA	PMID:36041667
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1606423	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PATL1 mRNA	PMID:25979313
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PATL1 mRNA	PMID:36041667
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PATL1 mRNA	PMID:28628672
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PATL1 mRNA	PMID:36041667
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332387	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PATL1 mRNA	PMID:37019170
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1332387	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PATL1 mRNA	PMID:34813904
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PATL1 mRNA	PMID:28628672
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1332387	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PATL1 mRNA	PMID:34813904
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606423	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PATL1 mRNA	PMID:37042841
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332387	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PATL1 mRNA	PMID:37236586
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PATL1 mRNA	PMID:35301059
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1606423	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PATL1 mRNA	PMID:28302478
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1606423	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PATL1 mRNA	PMID:31533062
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606423	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PATL1 mRNA	PMID:25979313
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PATL1 mRNA	PMID:27188386
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606423	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PATL1 mRNA	PMID:25562108
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1332387	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PATL1 mRNA	PMID:17555576
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PATL1 mRNA	PMID:28628672
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1606423	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of PATL1 mRNA	PMID:23649840
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332387	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PATL1 mRNA	PMID:17562736
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PATL1 mRNA	PMID:33387578
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606423	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PATL1 mRNA	PMID:21420995
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1332387	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PATL1 mRNA	PMID:29279043
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1606423	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of PATL1 promoter	PMID:21291286
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332387	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PATL1 mRNA	PMID:40504410
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1332387	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PATL1 mRNA	PMID:17555576
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1606423	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of PATL1 mRNA	PMID:23228038
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PATL1 mRNA	PMID:28628672
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PATL1 mRNA	PMID:30307764
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1606423	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PATL1 protein	PMID:32959892
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1606423	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PATL1 mRNA	PMID:31758290
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1332387	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PATL1 mRNA	PMID:22206623
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332387	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PATL1 mRNA	PMID:22206623
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1606423	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PATL1 mRNA	PMID:30851411
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PATL1 mRNA	PMID:27188386
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PATL1 mRNA	PMID:27291303
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1332387	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of PATL1 mRNA	PMID:38995820
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1332387	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of PATL1 mRNA	PMID:21278054
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606423	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PATL1 mRNA	PMID:27188386
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1606423	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PATL1 mRNA	PMID:29301935
1305514	Patl1	PAT1 homolog 1, processing body mRNA decay factor	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1332387	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PATL1 mRNA	PMID:28973697
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RGS17 mRNA	PMID:30071829
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS17 mRNA	PMID:20938992
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in decreased expression of RGS17 mRNA	PMID:20488242
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313587	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of RGS17 mRNA	PMID:21934132
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of RGS17 mRNA	PMID:36841081
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313587	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of RGS17 mRNA	PMID:30165855
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RGS17 mRNA	PMID:33387578
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS17 mRNA	PMID:20938992
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313587	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RGS17 mRNA	PMID:37042841
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:17303	morphine	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20130122	CTD	MESH:D009020	Morphine promotes the reaction [GNAI2 protein binds to RGS17 protein]; Morphine promotes the reaction [GNAZ protein binds to RGS17 protein]	PMID:18652891
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313587	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RGS17 mRNA	PMID:21592394
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313587	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of RGS17 mRNA	PMID:21592394
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313587	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of RGS17 mRNA	PMID:31256213
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313587	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RGS17 mRNA	PMID:21592394
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313587	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of RGS17 mRNA	PMID:21592394
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1313587	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of RGS17 intron	PMID:30157460
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20130122	CTD	MESH:D015032	RGS17 protein affects the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]; Zinc promotes the reaction [OPRM1 protein binds to RGS17 protein]	PMID:18652891
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS17 mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RGS17 mRNA]	PMID:20938992|PMID:22206623
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313587	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RGS17 gene	PMID:25304211
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313587	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RGS17 mRNA	PMID:26272509
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313587	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGS17 mRNA	PMID:27188386
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RGS17 mRNA	PMID:28960355
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313587	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RGS17 mRNA	PMID:23557933
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313587	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of RGS17 mRNA	PMID:21044322|PMID:27392435
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27899	cisplatin	increases response to substance	ISO	RGD:1313587	E	RGD:6480464	20120412	CTD	MESH:D002945	RGS17 protein results in increased susceptibility to Cisplatin	PMID:21044322
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313587	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RGS17 mRNA	PMID:27392435
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313587	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of RGS17 promoter	PMID:22847954
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of RGS17 mRNA	PMID:32186404
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RGS17 mRNA	PMID:19933214
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313587	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RGS17 mRNA	PMID:33212167
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:28445	vincristine	increases response to substance	ISO	RGD:1313587	E	RGD:6480464	20161213	CTD	MESH:D014750	RGS17 protein results in increased susceptibility to Vincristine	PMID:21044322
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RGS17 mRNA	PMID:28959563
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313588	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of RGS17 mRNA	PMID:39631538
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of RGS17 mRNA	PMID:36209798
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313587	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RGS17 intron	PMID:30157460
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313588	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RGS17 mRNA	PMID:22228805
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313587	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RGS17 5' UTR; Benzo(a)pyrene results in increased methylation of RGS17 promoter	PMID:27901495
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20130122	CTD	MESH:D015032	RGS17 protein affects the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]; Zinc promotes the reaction [OPRM1 protein binds to RGS17 protein]	PMID:18652891
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313587	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RGS17 mRNA	PMID:25351596
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1313587	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of RGS17 gene	PMID:31601247
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313588	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RGS17 gene	PMID:35295148
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RGS17 mRNA	PMID:18648102
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:33128	C60 fullerene	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 affects the expression of RGS17 mRNA	PMID:19167457
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RGS17 mRNA	PMID:25181051
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RGS17 mRNA	PMID:32156529
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RGS17 mRNA	PMID:29097150
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313588	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of RGS17 mRNA	PMID:35598803
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RGS17 gene	PMID:28505145
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313588	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RGS17 mRNA	PMID:30951980
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313588	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RGS17 mRNA	PMID:30951980
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:34682	diazinon	decreases methylation	ISO	RGD:1313587	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of RGS17 gene	PMID:22964155
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313587	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RGS17 mRNA	PMID:37042841
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313587	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RGS17 mRNA	PMID:26472689
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RGS17 protein	PMID:34958885
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313587	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of RGS17 promoter	PMID:22847954
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313587	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of RGS17 promoter	PMID:22847954
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313587	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RGS17 mRNA	PMID:25979313
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313587	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of RGS17 mRNA	PMID:24935251
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313587	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RGS17 gene	PMID:29154799
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313588	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of RGS17 mRNA	PMID:22733784
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313587	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of RGS17 mRNA	PMID:24935251
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313587	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RGS17 mRNA	PMID:24935251
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RGS17 mRNA	PMID:33387578
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1313587	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RGS17 mRNA	PMID:29432896
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313587	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RGS17 gene	PMID:25304211
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RGS17 mRNA	PMID:29097150
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of RGS17 mRNA	PMID:19042947
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:6809	methamphetamine	affects response to substance	ISO	RGD:1313587	E	RGD:6480464	20120412	CTD	MESH:D008694	RGS17 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313587	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RGS17 mRNA	PMID:31758290
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RGS17 mRNA	PMID:22206623
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of RGS17 mRNA	PMID:27840820
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RGS17 mRNA]	PMID:22206623
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313587	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RGS17 mRNA	PMID:37199045
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:755540	docetaxel	increases response to substance	ISO	RGD:1313587	E	RGD:6480464	20260714	CTD	MESH:D000077143	RGS17 protein results in increased susceptibility to Docetaxel	PMID:21044322
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:77702	S-nitroso-N-acetyl-D-penicillamine	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20140415	CTD	MESH:D026423	S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RGS17 protein]	PMID:18652891
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313587	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGS17 mRNA	PMID:27188386
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1313587	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of RGS17 mRNA	PMID:26705709
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RGS17 mRNA	PMID:27291303
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RGS17 mRNA	PMID:24780913
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313587	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGS17 mRNA	PMID:27188386
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313587	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RGS17 mRNA	PMID:29301935
1305515	Rgs17	regulator of G-protein signaling 17	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RGS17 mRNA	PMID:19015723
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1313589	E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in increased expression of CABLES1 mRNA	PMID:19371625|PMID:36828454
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313590	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CABLES1 mRNA	PMID:20188158
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of CABLES1 mRNA	PMID:23724009|PMID:33167477
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CABLES1 mRNA	PMID:36189433
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CABLES1 mRNA	PMID:36841081
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313590	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CABLES1 mRNA	PMID:30319688
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313589	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CABLES1 mRNA	PMID:20044591
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CABLES1 mRNA	PMID:21632981
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1313589	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of CABLES1 protein	PMID:35688186
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CABLES1 mRNA	PMID:39241906
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313589	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of CABLES1 mRNA	PMID:23019147|PMID:36828454
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313590	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CABLES1 mRNA	PMID:39298647
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313589	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CABLES1 mRNA	PMID:30165855
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313590	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of CABLES1 mRNA	PMID:25549359
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CABLES1 mRNA	PMID:36189433
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CABLES1 promoter	PMID:23359474
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313589	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CABLES1 protein	PMID:37730182
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313589	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CABLES1 intron	PMID:30157460
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CABLES1 mRNA	PMID:39012411
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CABLES1 mRNA	PMID:37325564
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CABLES1 mRNA	PMID:19549813
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CABLES1 mRNA	PMID:23649840
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CABLES1 mRNA	PMID:21396975
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CABLES1 mRNA	PMID:23649840
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CABLES1 mRNA	PMID:34911549
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CABLES1 mRNA	PMID:22206623
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313589	E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of CABLES1 gene	PMID:39164771
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313589	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CABLES1 protein	PMID:35688186
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1313589	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of CABLES1 mRNA	PMID:23300844
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of CABLES1 mRNA	PMID:27392435
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313589	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of CABLES1 mRNA	PMID:19371625|PMID:23019147
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CABLES1 mRNA	PMID:24768652|PMID:25583101
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CABLES1 mRNA	PMID:32109520
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CABLES1 mRNA	PMID:21215274|PMID:33387578
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313589	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CABLES1 mRNA	PMID:28001369
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313589	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CABLES1 mRNA	PMID:33212167
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313589	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CABLES1 mRNA	PMID:20971185
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313589	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CABLES1 protein	PMID:35688186
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313589	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of CABLES1 mRNA	PMID:20044591
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of CABLES1 mRNA	PMID:22363485
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CABLES1 mRNA	PMID:38568856
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of CABLES1 mRNA	PMID:36209798
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313589	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CABLES1 intron; Benzo(a)pyrene affects the methylation of CABLES1 promoter	PMID:27901495|PMID:30157460
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CABLES1 mRNA	PMID:21839799
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CABLES1 mRNA	PMID:32234424
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313589	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CABLES1 3' UTR	PMID:27901495
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313589	E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CABLES1 mRNA	PMID:30453624
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313589	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CABLES1 exon	PMID:27901495
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of CABLES1 mRNA	PMID:18929588
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of CABLES1 mRNA]	PMID:18929588
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313589	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CABLES1 mRNA	PMID:20971185
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313589	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CABLES1 mRNA	PMID:25895662
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CABLES1 mRNA	PMID:19150397
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of CABLES1 mRNA	PMID:22641619
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CABLES1 mRNA	PMID:30047161
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313590	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CABLES1 gene; titanium dioxide results in decreased methylation of CABLES1 promoter	PMID:35295148
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of CABLES1 mRNA	PMID:34492290
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313590	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CABLES1 mRNA	PMID:20813756|PMID:23811191
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313590	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CABLES1 mRNA	PMID:28472532
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of CABLES1 mRNA	PMID:19167457
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CABLES1 mRNA	PMID:25181051
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CABLES1 mRNA	PMID:30816183|PMID:34947998
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313589	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of CABLES1 mRNA	PMID:19371625|PMID:29275510|PMID:36828454
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313589	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CABLES1 gene	PMID:31601247
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CABLES1 promoter	PMID:23359474
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313589	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CABLES1 mRNA	PMID:28628672
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1313589	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of CABLES1 mRNA	PMID:19371625
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313590	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of CABLES1 mRNA	PMID:26377693
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CABLES1 mRNA	PMID:28392331
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313590	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CABLES1 mRNA	PMID:37019170
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CABLES1 mRNA	PMID:21266533
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CABLES1 promoter	PMID:23359474
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CABLES1 mRNA	PMID:22546817
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313589	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CABLES1 mRNA	PMID:28628672
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of CABLES1 mRNA	PMID:21527772
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CABLES1 gene	PMID:33148267
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313590	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CABLES1 mRNA	PMID:18974090
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CABLES1 promoter	PMID:22457795
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CABLES1 mRNA	PMID:39012411
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CABLES1 mRNA	PMID:37325564
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CABLES1 mRNA	PMID:36326898
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CABLES1 mRNA	PMID:19320972
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313590	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CABLES1 mRNA	PMID:40194260
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313589	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CABLES1 mRNA	PMID:31533062
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313590	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CABLES1 mRNA	PMID:17292431
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CABLES1 mRNA	PMID:30047161
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313589	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CABLES1 mRNA	PMID:28628672
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313589	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CABLES1 mRNA	PMID:19371625
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CABLES1 mRNA	PMID:28973697
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313590	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CABLES1 mRNA	PMID:17562736
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313589	E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of CABLES1 gene	PMID:39164771
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CABLES1 mRNA	PMID:29391264
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313589	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CABLES1 mRNA	PMID:28628672
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313589	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of CABLES1 mRNA	PMID:23300844
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects methylation	ISO	RGD:1313589	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the methylation of CABLES1 promoter	PMID:17982127
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CABLES1 mRNA; Nanotubes, Carbon results in decreased expression of CABLES1 mRNA	PMID:25554681
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CABLES1 mRNA	PMID:30047161
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313589	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of CABLES1 mRNA	PMID:22714537
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of CABLES1 mRNA	PMID:19042947
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of CABLES1 mRNA	PMID:27188386
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of CABLES1 mRNA	PMID:28801915
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313589	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CABLES1 mRNA	PMID:28988120
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CABLES1 mRNA	PMID:28801915
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1313589	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CABLES1 mRNA	PMID:22079614
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1313589	E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in increased expression of CABLES1 mRNA	PMID:29518473
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CABLES1 gene	PMID:33148267
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313589	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CABLES1 mRNA	PMID:31758290
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CABLES1 mRNA	PMID:22206623
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CABLES1 mRNA	PMID:22206623
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313589	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CABLES1 gene]	PMID:28238834
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313589	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CABLES1 mRNA	PMID:19159669
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:83537	1-benzylpiperazine	increases expression	EXP		E	RGD:6480464	20170221	CTD	MESH:C006737	N-benzylpiperazine results in increased expression of CABLES1 mRNA	PMID:26821219
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1313590	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of CABLES1 mRNA	PMID:39847705
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CABLES1 mRNA	PMID:24780913|PMID:30047161
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of CABLES1 mRNA	PMID:25825206
1305516	Cables1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CABLES1 mRNA	PMID:28973697
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313595	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of AAK1 mRNA	PMID:26272509
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of AAK1 mRNA	PMID:40945087
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1618841	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of AAK1 mRNA	PMID:30319688
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of AAK1 protein	PMID:31494107
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of AAK1 mRNA	PMID:39241906
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313595	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of AAK1 mRNA	PMID:23649840
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313595	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of AAK1 protein	PMID:37730182
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313595	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of AAK1 mRNA	PMID:28818685
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313595	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of AAK1 intron	PMID:30157460
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of AAK1 mRNA	PMID:39836092
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AAK1 mRNA	PMID:35301059
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of AAK1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AAK1 mRNA	PMID:28111341|PMID:37236586
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313595	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in increased expression of AAK1 mRNA	PMID:19549813
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AAK1 protein	PMID:23301498
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313595	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of AAK1 mRNA	PMID:23649840
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of AAK1 protein	PMID:33236894
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313595	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AAK1 gene	PMID:27153756
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1618841	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AAK1 mRNA	PMID:19770486
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313595	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of AAK1 intron	PMID:30157460
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313595	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of AAK1 mRNA	PMID:23649840
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	ISO	RGD:1313595	E	RGD:6480464	20130806	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of AAK1 protein	PMID:19845377
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20211109	CTD	MESH:D017382	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of AAK1 mRNA	PMID:33656867
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of AAK1 mRNA	PMID:21867686
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AAK1 mRNA	PMID:32525701
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AAK1 mRNA	PMID:40504410
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313595	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of AAK1 mRNA	PMID:26272509
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313595	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of AAK1 protein	PMID:35688186
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of AAK1 mRNA	PMID:28711546
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1618841	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of AAK1 mRNA	PMID:21151649
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of AAK1 mRNA	PMID:30912803
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618841	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AAK1 mRNA	PMID:21570461
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AAK1 mRNA	PMID:33387578
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AAK1 mRNA	PMID:32109520
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313595	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of AAK1 protein	PMID:39603559
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313595	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of AAK1 protein	PMID:35688186
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1618841	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of AAK1 gene	PMID:39894169
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313595	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of AAK1 mRNA	PMID:38568856
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AAK1 mRNA	PMID:40504410
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1618841	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of AAK1 intron	PMID:27901495
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of AAK1 protein	PMID:37955338
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of AAK1 gene	PMID:31601247
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of AAK1 mRNA	PMID:25729387
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of AAK1 mRNA	PMID:25181051
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313595	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of AAK1 mRNA	PMID:30903817
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AAK1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of AAK1 protein	PMID:31675489
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313595	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of AAK1 gene	PMID:31601247
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AAK1 gene	PMID:28505145
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of AAK1 gene	PMID:31601247
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of AAK1 protein	PMID:31675489
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313595	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AAK1 mRNA	PMID:25979313
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1618841	E	RGD:6480464	20250805	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of AAK1 protein; 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of AAK1 protein alternative form	PMID:26903627
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1618841	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of AAK1 intron	PMID:28392331
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of AAK1 mRNA	PMID:36117858
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313595	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AAK1 mRNA	PMID:37042841
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of AAK1 mRNA	PMID:39836092
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AAK1 mRNA	PMID:33453195
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313595	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AAK1 mRNA	PMID:38382870
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AAK1 mRNA	PMID:35301059
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of AAK1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AAK1 mRNA	PMID:28111341|PMID:37236586
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313595	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of AAK1 mRNA; perfluorooctanoic acid results in increased expression of AAK1 protein	PMID:26879310|PMID:36326898
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of AAK1 mRNA	PMID:24449571
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of AAK1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of AAK1 mRNA]	PMID:17585979
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313595	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of AAK1 mRNA	PMID:28302478
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313595	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of AAK1 mRNA	PMID:31533062
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313595	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of AAK1 mRNA	PMID:40419075
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D002737	Chloroprene results in increased expression of AAK1 mRNA	PMID:23125180
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313595	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AAK1 mRNA	PMID:25979313
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313595	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of AAK1 mRNA	PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313595	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AAK1 mRNA	PMID:25562108
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313595	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of AAK1 mRNA	PMID:38832940
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of AAK1 mRNA	PMID:27188386
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313595	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of AAK1 mRNA	PMID:24935251|PMID:26272509
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20211109	CTD	MESH:C013503	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of AAK1 mRNA	PMID:33656867
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1618841	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of AAK1 mRNA	PMID:17562736
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in decreased expression of AAK1 mRNA	PMID:21420995
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313595	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of AAK1 mRNA	PMID:29067470
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of AAK1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of AAK1 mRNA]	PMID:17585979
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AAK1 mRNA	PMID:32525701
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AAK1 mRNA	PMID:40504410
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of AAK1 mRNA	PMID:31675489
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of AAK1 mRNA	PMID:35436446
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of AAK1 mRNA	PMID:30307764
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of AAK1 mRNA	PMID:34044035
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:5118	fluoxetine	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D005473	Fluoxetine results in decreased expression of AAK1 mRNA	PMID:17033635
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of AAK1 mRNA	PMID:36117858
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AAK1 protein	PMID:32959892
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of AAK1 mRNA	PMID:39836092
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of AAK1 mRNA	PMID:25729387
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of AAK1 mRNA	PMID:36907384
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of AAK1 mRNA	PMID:22206623
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AAK1 gene]	PMID:28238834
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of AAK1 mRNA	PMID:32109520
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:81543	Tributyltin oxide	decreases phosphorylation	ISO	RGD:1618841	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased phosphorylation of AAK1 protein	PMID:22174045
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of AAK1 protein	PMID:31675489
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of AAK1 protein	PMID:28903499
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1313595	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of AAK1 protein	PMID:31675489
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AAK1 mRNA	PMID:32525701
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AAK1 mRNA	PMID:24780913
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313595	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313595	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of AAK1 mRNA	PMID:38568856
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:95341	baricitinib	decreases activity	ISO	RGD:1313595	E	RGD:6480464	20220104	CTD	MESH:C000596027	baricitinib results in decreased activity of AAK1 protein	PMID:32113509
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of AAK1 mRNA	PMID:19015723
1305520	Aak1	AP2 associated kinase 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of AAK1 mRNA	PMID:23034163
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313596	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GNPDA2 mRNA	PMID:33167477
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313597	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GNPDA2 mRNA	PMID:39241906
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GNPDA2 mRNA	PMID:33387578
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313596	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of GNPDA2 mRNA	PMID:33359661
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313596	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of GNPDA2 mRNA	PMID:28818685
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313596	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313596	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in increased expression of GNPDA2 mRNA	PMID:23369406
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313597	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GNPDA2 mRNA	PMID:19770486
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313596	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GNPDA2 intron	PMID:30157460
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313596	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GNPDA2 mRNA	PMID:23649840
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313596	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GNPDA2 gene	PMID:25304211
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313596	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA	PMID:33854195
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GNPDA2 mRNA	PMID:31881176
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313597	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of GNPDA2 mRNA	PMID:30912803
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GNPDA2 mRNA	PMID:34747641
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GNPDA2 mRNA	PMID:32109520|PMID:33387578
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313597	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GNPDA2 mRNA	PMID:17942748
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313597	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of GNPDA2 protein	PMID:28918527
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313596	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313596	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GNPDA2 intron	PMID:30157460
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313597	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GNPDA2 mRNA	PMID:22228805
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313596	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GNPDA2 promoter	PMID:27901495
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313597	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GNPDA2 gene; titanium dioxide results in decreased methylation of GNPDA2 promoter	PMID:35295148
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of GNPDA2 mRNA	PMID:34492290
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313597	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of GNPDA2 mRNA	PMID:18648102
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of GNPDA2 mRNA	PMID:30816183|PMID:34947998
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GNPDA2 mRNA	PMID:25181051|PMID:41034487
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313596	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of GNPDA2 protein	PMID:34186270
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313597	E	RGD:6480464	20131210	CTD	MESH:C006780	bisphenol A results in increased expression of GNPDA2 mRNA	PMID:23798566
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313596	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of GNPDA2 gene	PMID:31601247
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313596	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of GNPDA2 protein	PMID:34186270
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313597	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of GNPDA2 mRNA	PMID:28392331
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA	PMID:33854195
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313596	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GNPDA2 mRNA	PMID:37042841
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313596	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313596	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GNPDA2 protein	PMID:24527689
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313596	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of GNPDA2 mRNA	PMID:24449571
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1313596	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of GNPDA2 mRNA	PMID:19691856
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313596	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GNPDA2 mRNA	PMID:28302478
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313596	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GNPDA2 gene	PMID:29154799
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313596	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GNPDA2 mRNA	PMID:20106945|PMID:25562108
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA	PMID:33854195
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA	PMID:33854195
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GNPDA2 mRNA	PMID:33387578
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313596	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of GNPDA2 mRNA	PMID:29067470
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313597	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of GNPDA2 mRNA	PMID:29279043
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313596	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GNPDA2 gene	PMID:25304211
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313596	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GNPDA2 mRNA	PMID:29391264
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313597	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of GNPDA2 mRNA	PMID:35436446
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313597	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of GNPDA2 mRNA	PMID:17942748
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313597	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GNPDA2 mRNA	PMID:17942748
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA	PMID:33854195
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313596	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GNPDA2 protein	PMID:32959892
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313596	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313596	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of GNPDA2 mRNA	PMID:28988120
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313597	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GNPDA2 mRNA	PMID:22206623
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313596	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of GNPDA2 mRNA	PMID:22714537
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313597	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GNPDA2 mRNA	PMID:23091169
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of GNPDA2 mRNA	PMID:20345932
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of GNPDA2 mRNA	PMID:32109520
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313596	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of GNPDA2 protein	PMID:38348393
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313597	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of GNPDA2 mRNA	PMID:30953684
1305521	Gnpda2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GNPDA2 mRNA	PMID:21346803
1305522	B9d1	B9 domain containing 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of B9D1 mRNA	PMID:38218311
1305522	B9d1	B9 domain containing 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1602004	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of B9D1 mRNA	PMID:38218311
1305522	B9d1	B9 domain containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B9D1 mRNA	PMID:20938992
1305522	B9d1	B9 domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of B9D1 mRNA	PMID:33167477
1305522	B9d1	B9 domain containing 1	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1313598	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of B9D1 mRNA	PMID:18978301
1305522	B9d1	B9 domain containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B9D1 mRNA	PMID:20938992
1305522	B9d1	B9 domain containing 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B9D1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B9D1 mRNA	PMID:37992649
1305522	B9d1	B9 domain containing 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B9D1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B9D1 mRNA	PMID:37992649
1305522	B9d1	B9 domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313598	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of B9D1 mRNA	PMID:34319233
1305522	B9d1	B9 domain containing 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of B9D1 mRNA	PMID:33387578
1305522	B9d1	B9 domain containing 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of B9D1 mRNA	PMID:28818685
1305522	B9d1	B9 domain containing 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1602004	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of B9D1 polyA tail	PMID:30157460
1305522	B9d1	B9 domain containing 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of B9D1 mRNA	PMID:39836092
1305522	B9d1	B9 domain containing 1	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1313598	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of B9D1 mRNA	PMID:39984025
1305522	B9d1	B9 domain containing 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of B9D1 mRNA	PMID:19549813
1305522	B9d1	B9 domain containing 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of B9D1 mRNA	PMID:21396975
1305522	B9d1	B9 domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602004	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of B9D1 polyA tail	PMID:30157460
1305522	B9d1	B9 domain containing 1	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of B9D1 mRNA	PMID:41580963
1305522	B9d1	B9 domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of B9D1 mRNA	PMID:34911549
1305522	B9d1	B9 domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of B9D1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B9D1 mRNA	PMID:20938992|PMID:22206623
1305522	B9d1	B9 domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of B9D1 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of B9D1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of B9D1 mRNA	PMID:32525701|PMID:39836092
1305522	B9d1	B9 domain containing 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of B9D1 mRNA	PMID:26272509
1305522	B9d1	B9 domain containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA	PMID:27188386
1305522	B9d1	B9 domain containing 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B9D1 mRNA]	PMID:37992649
1305522	B9d1	B9 domain containing 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in decreased expression of B9D1 mRNA	PMID:37386098
1305522	B9d1	B9 domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313598	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of B9D1 mRNA	PMID:21570461
1305522	B9d1	B9 domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of B9D1 mRNA	PMID:17942748
1305522	B9d1	B9 domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of B9D1 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1305522	B9d1	B9 domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of B9D1 mRNA	PMID:33212167
1305522	B9d1	B9 domain containing 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of B9D1 mRNA	PMID:26272509
1305522	B9d1	B9 domain containing 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA	PMID:27188386
1305522	B9d1	B9 domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of B9D1 mRNA	PMID:29803840
1305522	B9d1	B9 domain containing 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B9D1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B9D1 mRNA	PMID:37992649
1305522	B9d1	B9 domain containing 1	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B9D1 mRNA]	PMID:37992649
1305522	B9d1	B9 domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of B9D1 mRNA	PMID:38568856
1305522	B9d1	B9 domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of B9D1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of B9D1 mRNA	PMID:39836092
1305522	B9d1	B9 domain containing 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1602004	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of B9D1 mRNA	PMID:29453283
1305522	B9d1	B9 domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602004	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of B9D1 polyA tail	PMID:30157460
1305522	B9d1	B9 domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of B9D1 mRNA	PMID:20106945
1305522	B9d1	B9 domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313598	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of B9D1 mRNA	PMID:23557971
1305522	B9d1	B9 domain containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of B9D1 mRNA	PMID:34492290
1305522	B9d1	B9 domain containing 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313598	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of B9D1 mRNA	PMID:18648102
1305522	B9d1	B9 domain containing 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of B9D1 mRNA	PMID:25380136
1305522	B9d1	B9 domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of B9D1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305522	B9d1	B9 domain containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1602004	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of B9D1 gene	PMID:31601247
1305522	B9d1	B9 domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in increased expression of B9D1 mRNA	PMID:34973380
1305522	B9d1	B9 domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of B9D1 gene	PMID:28505145
1305522	B9d1	B9 domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of B9D1 mRNA	PMID:36041667
1305522	B9d1	B9 domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of B9D1 mRNA	PMID:36041667
1305522	B9d1	B9 domain containing 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of B9D1 mRNA	PMID:36041667
1305522	B9d1	B9 domain containing 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313598	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of B9D1 mRNA	PMID:37019170
1305522	B9d1	B9 domain containing 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1602004	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of B9D1 mRNA	PMID:29024780
1305522	B9d1	B9 domain containing 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of B9D1 mRNA	PMID:39836092
1305522	B9d1	B9 domain containing 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of B9D1 mRNA	PMID:25380136
1305522	B9d1	B9 domain containing 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of B9D1 mRNA	PMID:19376846
1305522	B9d1	B9 domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1602004	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of B9D1 mRNA	PMID:40419075
1305522	B9d1	B9 domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of B9D1 mRNA	PMID:36331819
1305522	B9d1	B9 domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602004	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of B9D1 mRNA	PMID:25979313
1305522	B9d1	B9 domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602004	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of B9D1 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1305522	B9d1	B9 domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in decreased expression of B9D1 mRNA	PMID:17183730
1305522	B9d1	B9 domain containing 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of B9D1 mRNA	PMID:25562108
1305522	B9d1	B9 domain containing 1	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1602004	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of B9D1 promoter	PMID:27989131
1305522	B9d1	B9 domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1602004	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of B9D1 mRNA	PMID:20106945|PMID:27989131
1305522	B9d1	B9 domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313598	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of B9D1 mRNA	PMID:28973697
1305522	B9d1	B9 domain containing 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B9D1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B9D1 mRNA	PMID:37992649
1305522	B9d1	B9 domain containing 1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1602004	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of B9D1 mRNA	PMID:27188386
1305522	B9d1	B9 domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313598	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of B9D1 mRNA	PMID:17562736
1305522	B9d1	B9 domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of B9D1 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of B9D1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of B9D1 mRNA	PMID:32525701|PMID:39836092
1305522	B9d1	B9 domain containing 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313598	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of B9D1 mRNA	PMID:17942748
1305522	B9d1	B9 domain containing 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of B9D1 mRNA	PMID:17942748
1305522	B9d1	B9 domain containing 1	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of B9D1 mRNA	PMID:26272509
1305522	B9d1	B9 domain containing 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA	PMID:27188386
1305522	B9d1	B9 domain containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313598	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of B9D1 mRNA	PMID:25554681
1305522	B9d1	B9 domain containing 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in decreased expression of B9D1 mRNA	PMID:17183730
1305522	B9d1	B9 domain containing 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of B9D1 mRNA	PMID:39836092
1305522	B9d1	B9 domain containing 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313598	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of B9D1 mRNA	PMID:23650126
1305522	B9d1	B9 domain containing 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of B9D1 mRNA	PMID:28988120
1305522	B9d1	B9 domain containing 1	gene	CHEBI:6651	malathion	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of B9D1 mRNA	PMID:37047231
1305522	B9d1	B9 domain containing 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of B9D1 mRNA	PMID:39938710
1305522	B9d1	B9 domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313598	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of B9D1 mRNA	PMID:22206623
1305522	B9d1	B9 domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA	PMID:27188386
1305522	B9d1	B9 domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to B9D1 gene]	PMID:28238834
1305522	B9d1	B9 domain containing 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of B9D1 mRNA	PMID:32525701
1305522	B9d1	B9 domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602004	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA	PMID:27188386
1305522	B9d1	B9 domain containing 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1602004	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of B9D1 mRNA	PMID:38568856
1305522	B9d1	B9 domain containing 1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313598	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of B9D1 mRNA	PMID:28973697
1305522	B9d1	B9 domain containing 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of B9D1 mRNA	PMID:23555832
1305522	B9d1	B9 domain containing 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of B9D1 gene	PMID:31682807
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of FBXL14 mRNA	PMID:26272509
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FBXL14 mRNA	PMID:33167477
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313599	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of FBXL14 mRNA	PMID:40865780
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313600	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FBXL14 mRNA	PMID:39241906
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313599	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FBXL14 mRNA	PMID:37042841
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313600	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXL14 mRNA	PMID:37236586
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FBXL14 mRNA	PMID:22100608
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313599	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FBXL14 intron	PMID:30157460
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXL14 mRNA	PMID:18593933
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313600	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FBXL14 mRNA	PMID:31919559
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of FBXL14 mRNA	PMID:26272509
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313599	E	RGD:6480464	20260804	CTD	MESH:C010974	Glyphosate results in increased expression of FBXL14 mRNA	PMID:40865780
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of FBXL14 mRNA	PMID:27392435
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313600	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXL14 mRNA	PMID:21570461
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313599	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of FBXL14 mRNA	PMID:29955902
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FBXL14 mRNA	PMID:28001369
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of FBXL14 mRNA	PMID:26272509
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313599	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of FBXL14 mRNA	PMID:32763439
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313599	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FBXL14 promoter	PMID:27901495
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313599	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBXL14 3' UTR; Benzo(a)pyrene results in increased methylation of FBXL14 exon	PMID:27901495
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXL14 mRNA	PMID:18593933
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of FBXL14 mRNA; Silicon Dioxide results in decreased expression of FBXL14 mRNA	PMID:25351596|PMID:25895662
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FBXL14 mRNA	PMID:35984750
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of FBXL14 mRNA	PMID:16483693
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313600	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXL14 gene; titanium dioxide results in decreased methylation of FBXL14 promoter	PMID:35295148
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXL14 mRNA	PMID:25181051
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313600	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of FBXL14 mRNA	PMID:32156529
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL14 mRNA	PMID:28628672
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313599	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of FBXL14 gene	PMID:22964155
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL14 mRNA	PMID:28628672
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313599	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FBXL14 mRNA	PMID:37042841
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXL14 mRNA	PMID:38568856
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313599	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FBXL14 mRNA	PMID:38174414
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313600	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXL14 mRNA	PMID:37236586
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313599	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXL14 mRNA	PMID:31533062
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXL14 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313599	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FBXL14 gene	PMID:29154799
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313599	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXL14 mRNA	PMID:28001369
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL14 mRNA	PMID:28628672
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313599	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FBXL14 mRNA	PMID:24935251|PMID:26272509
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313600	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBXL14 mRNA	PMID:17562736
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313600	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of FBXL14 mRNA	PMID:29279043
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in decreased expression of FBXL14 mRNA	PMID:36653537
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL14 mRNA	PMID:28628672
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313600	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FBXL14 mRNA	PMID:35964746
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313599	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of FBXL14 mRNA	PMID:31629900
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FBXL14 gene	PMID:35440735
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313599	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of FBXL14 mRNA	PMID:37199045
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FBXL14 gene]	PMID:28238834
1305523	Fbxl14	F-box and leucine-rich repeat protein 14	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313599	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NT5DC2 mRNA	PMID:20938992
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NT5DC2 mRNA	PMID:33167477
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of NT5DC2 mRNA	PMID:36841081
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1601740	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of NT5DC2 mRNA	PMID:22378314
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313601	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of NT5DC2 mRNA	PMID:30319688
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313601	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NT5DC2 mRNA	PMID:39241906
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of NT5DC2 mRNA	PMID:32145629
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in increased expression of NT5DC2 mRNA	PMID:19484750
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D004958	Estradiol results in increased expression of NT5DC2 mRNA	PMID:20106945
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of NT5DC2 mRNA	PMID:30165855
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1601740	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NT5DC2 mRNA	PMID:38568856
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313601	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of NT5DC2 mRNA	PMID:25549359
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NT5DC2 mRNA	PMID:20938992
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of NT5DC2 mRNA	PMID:23649840
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NT5DC2 mRNA	PMID:37567420
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of NT5DC2 promoter	PMID:33872906
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of NT5DC2 mRNA	PMID:22967744
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NT5DC2 mRNA	PMID:37567420
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NT5DC2 mRNA	PMID:19850644
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of NT5DC2 mRNA]	PMID:19850644
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of NT5DC2 promoter	PMID:33872906
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of NT5DC2 mRNA	PMID:26577399
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313601	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of NT5DC2 mRNA	PMID:27462272
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NT5DC2 mRNA	PMID:35301059
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NT5DC2 mRNA	PMID:19549813
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NT5DC2 protein	PMID:23301498
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NT5DC2 mRNA	PMID:19770486
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NT5DC2 mRNA	PMID:25378103
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313601	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of NT5DC2 mRNA	PMID:33026818
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D015032	Zinc deficiency results in increased expression of NT5DC2 mRNA	PMID:22171008
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of NT5DC2 mRNA	PMID:17484886
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313601	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NT5DC2 mRNA	PMID:27339419|PMID:31919559
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NT5DC2 mRNA	PMID:20938992
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NT5DC2 mRNA	PMID:39836092
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D012643	Selenium results in increased expression of NT5DC2 mRNA	PMID:19244175
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of NT5DC2 mRNA	PMID:19244175
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of NT5DC2 mRNA	PMID:26272509
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NT5DC2 mRNA	PMID:27188386
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NT5DC2 mRNA	PMID:34747641
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NT5DC2 mRNA	PMID:15034205|PMID:19770486
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NT5DC2 mRNA	PMID:33387578
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NT5DC2 mRNA	PMID:20106945
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1601740	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NT5DC2 mRNA	PMID:26272509
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NT5DC2 mRNA	PMID:27188386
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NT5DC2 mRNA	PMID:15467011
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NT5DC2 mRNA	PMID:20971185
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NT5DC2 mRNA	PMID:29803840
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NT5DC2 mRNA	PMID:37567420
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1601740	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of NT5DC2 gene	PMID:28589171
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NT5DC2 mRNA	PMID:38568856
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601740	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of NT5DC2 mRNA	PMID:28595984|PMID:34032870
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NT5DC2 mRNA	PMID:39836092
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1601740	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of NT5DC2 mRNA	PMID:22378314
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NT5DC2 mRNA	PMID:15034205|PMID:19770486
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1601740	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NT5DC2 promoter	PMID:27901495
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NT5DC2 mRNA	PMID:27858113
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NT5DC2 mRNA	PMID:15467011
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NT5DC2 mRNA	PMID:20971185
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D015032	Zinc deficiency results in increased expression of NT5DC2 mRNA	PMID:22171008
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of NT5DC2 mRNA	PMID:35984750
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1601740	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of NT5DC2 mRNA	PMID:38568856
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NT5DC2 mRNA	PMID:25729387
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313601	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NT5DC2 gene	PMID:35295148
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NT5DC2 mRNA	PMID:23411599
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313601	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NT5DC2 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NT5DC2 mRNA	PMID:19710929
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NT5DC2 mRNA	PMID:25181051
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1601740	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NT5DC2 mRNA	PMID:30903817
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NT5DC2 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1601740	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of NT5DC2 mRNA	PMID:19244175
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of NT5DC2 mRNA	PMID:19244175
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NT5DC2 mRNA	PMID:27858113
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1601740	E	RGD:6480464	20240702	CTD	MESH:C008745	bisphenol F results in increased expression of NT5DC2 mRNA	PMID:38568856
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313601	E	RGD:6480464	20250311	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of NT5DC2 mRNA	PMID:28392331|PMID:32308655
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20130618	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NT5DC2 mRNA	PMID:17602206
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NT5DC2 mRNA	PMID:21266533
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34696	dieldrin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin results in increased expression of NT5DC2 mRNA	PMID:23153324
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313601	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of NT5DC2 mRNA	PMID:34813904
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34785	heptachlor	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D006533	Heptachlor results in increased expression of NT5DC2 mRNA	PMID:23153324
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34852	mirex	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D008917	Mirex results in increased expression of NT5DC2 mRNA	PMID:23153324
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20130618	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NT5DC2 mRNA	PMID:17602206
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20220607	CTD	MESH:D010269	Paraquat results in decreased expression of NT5DC2 mRNA	PMID:35182771
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20130618	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of NT5DC2 promoter	PMID:22457795
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NT5DC2 mRNA	PMID:35301059
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of NT5DC2 mRNA	PMID:25539665|PMID:26194646
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NT5DC2 mRNA	PMID:19320972
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NT5DC2 mRNA	PMID:24449571
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D012643	Selenium results in increased expression of NT5DC2 mRNA	PMID:19244175
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of NT5DC2 mRNA	PMID:19244175
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of NT5DC2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NT5DC2 mRNA]	PMID:17585979
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NT5DC2 mRNA	PMID:31533062
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1601740	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NT5DC2 mRNA	PMID:40419075
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of NT5DC2 mRNA	PMID:17685462
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1601740	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NT5DC2 mRNA	PMID:23179753
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1601740	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NT5DC2 gene	PMID:29154799
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NT5DC2 mRNA	PMID:25562108
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D013629	Tamoxifen affects the expression of NT5DC2 mRNA	PMID:20937368
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313601	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NT5DC2 mRNA	PMID:28973697
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313601	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NT5DC2 mRNA	PMID:28973697
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NT5DC2 mRNA	PMID:37567420
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NT5DC2 mRNA	PMID:38832940
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D014303	Trinitrotoluene affects the expression of NT5DC2 mRNA	PMID:21346803
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NT5DC2 mRNA	PMID:33387578
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1601740	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen results in increased expression of NT5DC2 mRNA	PMID:22230336
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of NT5DC2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NT5DC2 mRNA]	PMID:17585979
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313601	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of NT5DC2 mRNA	PMID:19446018
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NT5DC2 mRNA	PMID:39836092
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NT5DC2 mRNA	PMID:29391264
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of NT5DC2 mRNA	PMID:17557909
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of NT5DC2 mRNA	PMID:17555576
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313601	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NT5DC2 mRNA; Nanotubes, Carbon results in increased expression of NT5DC2 mRNA	PMID:25554681
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of NT5DC2 mRNA	PMID:23962444|PMID:34044035
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NT5DC2 mRNA	PMID:27858113
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NT5DC2 mRNA	PMID:27858113
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NT5DC2 mRNA	PMID:19042947
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NT5DC2 mRNA	PMID:25729387
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NT5DC2 mRNA	PMID:25729387
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of NT5DC2 mRNA	PMID:28988120
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of NT5DC2 mRNA	PMID:35283115
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of NT5DC2 mRNA	PMID:33244087
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of NT5DC2 mRNA	PMID:31758290
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NT5DC2 mRNA	PMID:22714537
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of NT5DC2 mRNA	PMID:37567420
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of NT5DC2 mRNA	PMID:21346803
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NT5DC2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NT5DC2 mRNA	PMID:27188386
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NT5DC2 gene]	PMID:28238834
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of NT5DC2 mRNA	PMID:23091169
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital results in increased expression of NT5DC2 mRNA	PMID:19482888
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313601	E	RGD:6480464	20130806	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NT5DC2 mRNA]	PMID:19482888
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of NT5DC2 mRNA	PMID:19095052
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases methylation	EXP		E	RGD:6480464	20260407	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased methylation of NT5DC2 gene	PMID:40889571
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313601	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of NT5DC2 mRNA	PMID:39847705
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NT5DC2 mRNA	PMID:25825206
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NT5DC2 mRNA	PMID:24780913
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1601740	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NT5DC2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NT5DC2 mRNA	PMID:27188386
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20130618	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NT5DC2 mRNA	PMID:21346803
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NT5DC2 mRNA	PMID:38568856
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1601740	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of NT5DC2 mRNA	PMID:27188386
1305524	Nt5dc2	5'-nucleotidase domain containing 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313601	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of NT5DC2 mRNA	PMID:35537566
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1617562	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MLLT11 mRNA	PMID:33045310
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MLLT11 mRNA	PMID:33167477
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605692	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of MLLT11 mRNA	PMID:16012519|PMID:23724009
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MLLT11 mRNA	PMID:33729688
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1617562	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MLLT11 mRNA	PMID:30319688
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605692	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MLLT11 mRNA	PMID:19619570
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MLLT11 mRNA	PMID:19619570
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605692	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MLLT11 mRNA	PMID:37042841
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1605692	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of MLLT11 mRNA	PMID:21540246
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1617562	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MLLT11 mRNA	PMID:33162236
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA	PMID:31199487
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MLLT11 mRNA	PMID:33387578
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1617562	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MLLT11 mRNA	PMID:36331819
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MLLT11 mRNA	PMID:39836092
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of MLLT11 mRNA	PMID:24376830
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617562	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MLLT11 mRNA	PMID:37236586
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605692	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MLLT11 mRNA	PMID:19549813
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1617562	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MLLT11 mRNA	PMID:19770486
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605692	E	RGD:6480464	20120412	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MLLT11 mRNA	PMID:21527772
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of MLLT11 mRNA	PMID:22171008
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MLLT11 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MLLT11 mRNA	PMID:39836092
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of MLLT11 mRNA	PMID:33512557
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:27666	actinomycin D	increases expression	ISO	RGD:1605692	E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of MLLT11 mRNA	PMID:21527772
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1605692	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MLLT11 mRNA	PMID:26272509
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLLT11 mRNA	PMID:27188386
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MLLT11 mRNA	PMID:22298810
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1617562	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MLLT11 mRNA	PMID:21570461
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MLLT11 mRNA	PMID:33387578
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1605692	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MLLT11 mRNA	PMID:19619570
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MLLT11 mRNA	PMID:19619570
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1605692	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of MLLT11 mRNA	PMID:33512557
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1605692	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MLLT11 mRNA	PMID:28001369
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1605692	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MLLT11 mRNA	PMID:33212167
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of MLLT11 mRNA	PMID:20971185
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1617562	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of MLLT11 mRNA	PMID:27862939
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MLLT11 mRNA	PMID:29803840
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605692	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MLLT11 mRNA	PMID:24516582|PMID:25493608|PMID:34032870|PMID:38568856
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MLLT11 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MLLT11 mRNA	PMID:39836092
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MLLT11 mRNA	PMID:22378314|PMID:29453283
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605692	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MLLT11 mRNA	PMID:15808406|PMID:20106945|PMID:21632981
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617562	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MLLT11 mRNA	PMID:19770486|PMID:21569818|PMID:22228805
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605692	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MLLT11 3' UTR; Benzo(a)pyrene results in increased methylation of MLLT11 5' UTR	PMID:27901495
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:29866	arsenite(3-)	affects expression	ISO	RGD:1605692	E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of MLLT11 mRNA	PMID:22959463
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of MLLT11 mRNA	PMID:20971185
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of MLLT11 mRNA	PMID:22171008
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1605692	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of MLLT11 mRNA	PMID:26014281
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1605692	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MLLT11 mRNA	PMID:25258189
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1605692	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of MLLT11 mRNA	PMID:35984750
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1605692	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of MLLT11 mRNA	PMID:38568856
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MLLT11 mRNA	PMID:34492290
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1617562	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MLLT11 mRNA	PMID:20813756|PMID:23811191
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MLLT11 mRNA	PMID:19710929
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1617562	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MLLT11 mRNA	PMID:19710929
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of MLLT11 mRNA	PMID:30816183
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1617562	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MLLT11 mRNA	PMID:32156529
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MLLT11 mRNA	PMID:25181051|PMID:34947998
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1605692	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MLLT11 protein	PMID:32981897
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1617562	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of MLLT11 mRNA	PMID:25172293
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1617562	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MLLT11 mRNA	PMID:39298647
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA	PMID:31199487
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MLLT11 mRNA	PMID:21266533
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA	PMID:31199487
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:34698	diethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA	PMID:31199487
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MLLT11 mRNA	PMID:32680482
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MLLT11 mRNA	PMID:39836092
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of MLLT11 mRNA	PMID:22110744
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1605692	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MLLT11 mRNA	PMID:38174414|PMID:38568856
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617562	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MLLT11 mRNA	PMID:37236586
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA	PMID:31199487
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1605692	E	RGD:6480464	20220208	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MLLT11 mRNA	PMID:33772556
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of MLLT11 mRNA	PMID:24386269
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1605692	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of MLLT11 mRNA	PMID:19320972|PMID:19376846
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1605692	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MLLT11 mRNA	PMID:24449571
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:38604	pyrimidifen	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of MLLT11 mRNA	PMID:33512557
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MLLT11 mRNA	PMID:31533062
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1605692	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of MLLT11 mRNA	PMID:26352163
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1605692	E	RGD:6480464	20220208	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MLLT11 mRNA	PMID:33772556
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617562	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MLLT11 mRNA	PMID:36331819
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605692	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MLLT11 mRNA	PMID:25979313
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1617562	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of MLLT11 mRNA	PMID:15799026
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of MLLT11 mRNA	PMID:41580965
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:4027	cyclophosphamide	decreases response to substance	ISO	RGD:1605692	E	RGD:6480464	20211207	CTD	MESH:D003520	MLLT11 protein results in decreased susceptibility to Cyclophosphamide	PMID:31587870
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1605692	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine affects the expression of MLLT11 mRNA	PMID:27989131
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605692	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MLLT11 mRNA	PMID:20106945|PMID:25562108
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of MLLT11 mRNA	PMID:33512557
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1617562	E	RGD:6480464	20180220	CTD	MESH:D003907	Dexamethasone results in decreased expression of MLLT11 mRNA	PMID:27645313
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of MLLT11 mRNA	PMID:33512557
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:43602	obeticholic acid	increases expression	ISO	RGD:1605692	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in increased expression of MLLT11 mRNA	PMID:27939613
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20140610	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MLLT11 mRNA	PMID:23561263
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605692	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MLLT11 mRNA	PMID:38832940
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of MLLT11 mRNA	PMID:33387578
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1617562	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MLLT11 mRNA	PMID:17562736
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1605692	E	RGD:6480464	20120412	CTD	MESH:D005472	MLLT11 protein affects the susceptibility to Fluorouracil	PMID:16217747
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of MLLT11 mRNA	PMID:24714768
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MLLT11 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MLLT11 mRNA	PMID:39836092
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:48607	lithium chloride	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in decreased expression of MLLT11 mRNA	PMID:23527032
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1605692	E	RGD:6480464	20120412	CTD	MESH:D005047	MLLT11 protein affects the susceptibility to Etoposide	PMID:16217747
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1605692	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of MLLT11 mRNA	PMID:17211630
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1605692	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MLLT11 mRNA	PMID:25258189
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:5011	fenpyroximate	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of MLLT11 mRNA	PMID:33512557
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1617562	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MLLT11 mRNA; Nanotubes, Carbon results in increased expression of MLLT11 mRNA	PMID:25554681
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:50859	bexarotene	increases expression	ISO	RGD:1605692	E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in increased expression of MLLT11 mRNA	PMID:17178900
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1605692	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of MLLT11 mRNA	PMID:20977926
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of MLLT11 mRNA	PMID:22714537
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MLLT11 mRNA	PMID:39836092
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol inhibits the reaction [MLLT11 protein results in decreased expression of ICAM1 protein]	PMID:31587870
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1605692	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MLLT11 mRNA	PMID:31758290
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1617562	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MLLT11 mRNA	PMID:25566086
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MLLT11 mRNA	PMID:22714537
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of MLLT11 mRNA	PMID:29522793
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of MLLT11 mRNA	PMID:33484710
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLLT11 mRNA	PMID:27188386
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA	PMID:31199487
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:8093	phenylephrine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased expression of MLLT11 mRNA	PMID:18158353
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MLLT11 mRNA	PMID:27291303
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:81836	thallium sulfate	increases expression	ISO	RGD:1605692	E	RGD:6480464	20260303	CTD	MESH:C013707	thallium sulfate results in increased expression of MLLT11 mRNA	PMID:40101890
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of MLLT11 mRNA	PMID:21858171
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of MLLT11 mRNA	PMID:33512557
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1605692	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of MLLT11 mRNA	PMID:12727804
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1617562	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of MLLT11 mRNA	PMID:21278054
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MLLT11 mRNA	PMID:24780913
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605692	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLLT11 mRNA	PMID:27188386
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1605692	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of MLLT11 mRNA	PMID:26014281
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:9422	tebufenpyrad	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of MLLT11 mRNA	PMID:33512557
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605692	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MLLT11 mRNA	PMID:38568856
1305525	Mllt11	MLLT11, transcription factor 7 cofactor	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1605692	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MLLT11 mRNA	PMID:29301935
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1615875	E	RGD:6480464	20231205	CTD	MESH:C084079	triptonide results in decreased expression of ARB2A mRNA	PMID:33045310
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ARB2A mRNA]	PMID:31150632
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1615875	E	RGD:6480464	20231205	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ARB2A mRNA	PMID:20188158
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ARB2A mRNA	PMID:26079696
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ARB2A mRNA	PMID:22378314
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:16261	chitosan	increases expression	ISO	RGD:1605018	E	RGD:6480464	20230704	CTD	MESH:D048271	Chitosan results in increased expression of ARB2A mRNA	PMID:36706893
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:16261	chitosan	multiple interactions	ISO	RGD:1605018	E	RGD:6480464	20230704	CTD	MESH:D048271	ARB2A protein affects the reaction [Chitosan results in decreased expression of CPE protein]; ARB2A protein affects the reaction [Chitosan results in decreased expression of MMP9 protein]; ARB2A protein affects the reaction [Chitosan results in decreased phosphorylation of MAPK1 protein]; ARB2A protein affects the reaction [Chitosan results in decreased phosphorylation of MAPK3 protein]	PMID:36706893
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ARB2A mRNA	PMID:23649840
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1605018	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ARB2A protein	PMID:37730182
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1605018	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ARB2A mRNA	PMID:28818685
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1615875	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARB2A mRNA	PMID:37236586
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605018	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ARB2A mRNA	PMID:19549813
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ARB2A mRNA	PMID:21641981
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1615875	E	RGD:6480464	20231205	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ARB2A mRNA	PMID:19770486
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605018	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ARB2A gene	PMID:27153756
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of ARB2A mRNA	PMID:25102026
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ARB2A mRNA	PMID:31150632
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ARB2A mRNA]	PMID:31150632
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of ARB2A gene	PMID:35440735
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARB2A mRNA	PMID:32109520
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1615875	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARB2A mRNA	PMID:31961203
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARB2A mRNA	PMID:33212167
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARB2A mRNA	PMID:29803840
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1615875	E	RGD:6480464	20231205	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ARB2A gene	PMID:32068019
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARB2A mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1615875	E	RGD:6480464	20231205	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARB2A mRNA	PMID:19770486|PMID:21715664
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605018	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ARB2A promoter	PMID:27901495
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ARB2A mRNA	PMID:25895662
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARB2A mRNA	PMID:26238291
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of ARB2A mRNA	PMID:27188386
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in decreased expression of ARB2A mRNA	PMID:25729387
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D013853	Thioacetamide results in decreased expression of ARB2A mRNA	PMID:34492290
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1615875	E	RGD:6480464	20231205	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARB2A mRNA	PMID:19710929
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A affects the expression of ARB2A mRNA	PMID:25181051
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of ARB2A mRNA	PMID:30816183|PMID:32528016
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1615875	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ARB2A mRNA	PMID:37894381
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of ARB2A mRNA	PMID:33296240
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1615875	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARB2A mRNA	PMID:37236586
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1605018	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ARB2A mRNA	PMID:24449571
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605018	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARB2A mRNA	PMID:25979313
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARB2A mRNA	PMID:23179753|PMID:24935251
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARB2A mRNA	PMID:25562108
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ARB2A mRNA	PMID:38832940
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20161213	CTD	MESH:C111237	Vorinostat results in decreased expression of ARB2A mRNA	PMID:27188386
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ARB2A mRNA	PMID:26272509
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1605018	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARB2A mRNA	PMID:27188386
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605018	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ARB2A mRNA	PMID:26690555
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ARB2A mRNA	PMID:32234424
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1605018	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of ARB2A mRNA	PMID:26705709
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in decreased expression of ARB2A mRNA	PMID:25729387
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20231205	CTD	MESH:D008731	Methoxychlor affects the methylation of ARB2A gene	PMID:35440735
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ARB2A mRNA	PMID:31758290
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1615875	E	RGD:6480464	20231205	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ARB2A mRNA	PMID:22206623
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ARB2A mRNA	PMID:22714537
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605018	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARB2A mRNA	PMID:27188386
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ARB2A mRNA	PMID:30928695
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1615875	E	RGD:6480464	20231205	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ARB2A mRNA	PMID:31388691
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605018	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARB2A mRNA	PMID:27188386
1305526	Arb2a	ARB2 cotranscriptional regulator A	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1605018	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ARB2A mRNA	PMID:27188386
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of ANKRD35 mRNA	PMID:27188386
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552869	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ANKRD35 mRNA	PMID:33045310
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1352290	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ANKRD35 mRNA	PMID:26079696
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ANKRD35 mRNA	PMID:35811015
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1352290	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ANKRD35 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ANKRD35 mRNA	PMID:35811015
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ANKRD35 mRNA	PMID:31614463
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1352290	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of ANKRD35 mRNA	PMID:20660070
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of ANKRD35 mRNA	PMID:21540246
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1352290	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of ANKRD35 mRNA	PMID:20660070
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of ANKRD35 mRNA	PMID:26496021
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ANKRD35 mRNA	PMID:33387578
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1552869	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of ANKRD35 intron	PMID:27776689
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ANKRD35 mRNA	PMID:27153756
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1352290	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ANKRD35 gene	PMID:27153756
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ANKRD35 mRNA	PMID:26272509
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1352290	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD35 mRNA	PMID:27188386
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ANKRD35 mRNA	PMID:24768652|PMID:25583101
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANKRD35 mRNA	PMID:33387578
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of ANKRD35 mRNA	PMID:29955902
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1352290	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ANKRD35 mRNA	PMID:33212167
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ANKRD35 mRNA	PMID:28959563
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552869	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of ANKRD35 mRNA	PMID:39515575
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1352290	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ANKRD35 mRNA	PMID:19710929
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKRD35 mRNA	PMID:25181051|PMID:41034487
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of ANKRD35 mRNA	PMID:26496021
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1352290	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ANKRD35 mRNA	PMID:25979313
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552869	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ANKRD35 mRNA	PMID:21266533
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1352290	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to ANKRD35 protein	PMID:32991956
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1552869	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of ANKRD35 mRNA	PMID:28962523
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1352290	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ANKRD35 mRNA	PMID:25979313
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ANKRD35 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1352290	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ANKRD35 mRNA	PMID:28542535
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ANKRD35 mRNA	PMID:24935251
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ANKRD35 mRNA	PMID:33387578
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1352290	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ANKRD35 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ANKRD35 mRNA	PMID:35811015
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1352290	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD35 mRNA	PMID:27188386
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1352290	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ANKRD35 gene]	PMID:28238834
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1552869	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ANKRD35 mRNA	PMID:31388691
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ANKRD35 mRNA	PMID:24780913
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1352290	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD35 mRNA	PMID:27188386
1305527	Ankrd35	ankyrin repeat domain 35	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1352290	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ANKRD35 mRNA	PMID:27188386
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313605	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of FBXL12 mRNA	PMID:38218311
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550238	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FBXL12 mRNA	PMID:33045310
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FBXL12 mRNA	PMID:37995155
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXL12 mRNA]	PMID:31150632
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1550238	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of FBXL12 promoter	PMID:26251327
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550238	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBXL12 mRNA	PMID:26251327
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXL12 mRNA	PMID:39241906
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of FBXL12 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA]	PMID:20230807
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FBXL12 mRNA	PMID:33387578
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA	PMID:20230807
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of FBXL12 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of FBXL12 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA]	PMID:20230807
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of FBXL12 mRNA	PMID:37748715
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of FBXL12 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA]	PMID:20230807
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550238	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FBXL12 mRNA	PMID:19770486
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313605	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FBXL12 mRNA	PMID:23649840
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FBXL12 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FBXL12 mRNA	PMID:34911549
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313605	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXL12 mRNA	PMID:18593933
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FBXL12 mRNA	PMID:31150632
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550238	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FBXL12 mRNA	PMID:31919559
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXL12 mRNA]	PMID:31150632
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of FBXL12 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA]	PMID:20230807
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20120412	CTD	MESH:D009532	MT1 affects the reaction [Nickel affects the expression of FBXL12 mRNA]; MT2 affects the reaction [Nickel affects the expression of FBXL12 mRNA]	PMID:16166738
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550238	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXL12 mRNA	PMID:21570461
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXL12 mRNA	PMID:33387578
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550238	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXL12 mRNA	PMID:26290441
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313605	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of FBXL12 mRNA	PMID:33512557
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313605	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FBXL12 mRNA	PMID:33212167
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:28358	rac-lactic acid	affects expression	ISO	RGD:1313605	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of FBXL12 mRNA	PMID:30851411
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313605	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXL12 mRNA	PMID:38568856
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550238	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FBXL12 mRNA	PMID:22228805
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of FBXL12 mRNA]	PMID:22228805
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313605	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXL12 mRNA	PMID:18593933
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FBXL12 mRNA	PMID:34492290
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FBXL12 mRNA	PMID:25181051
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of FBXL12 mRNA	PMID:38685157
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313605	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FBXL12 mRNA	PMID:37042841
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313605	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXL12 mRNA	PMID:31533062
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313605	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FBXL12 mRNA	PMID:25562108
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550238	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of FBXL12 mRNA	PMID:17555576
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:46661	asbestos	affects expression	ISO	RGD:1313605	E	RGD:6480464	20120412	CTD	MESH:D001194	Asbestos affects the expression of FBXL12 mRNA	PMID:17297452
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of FBXL12 mRNA	PMID:30529165
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of FBXL12 mRNA	PMID:29391264
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313605	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FBXL12 mRNA	PMID:22079256
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313605	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of FBXL12 mRNA	PMID:18175754
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550238	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FBXL12 mRNA	PMID:17555576
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of FBXL12 mRNA	PMID:17942748
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FBXL12 mRNA; Nanotubes, Carbon results in decreased expression of FBXL12 mRNA	PMID:25554681
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1550238	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of FBXL12 mRNA	PMID:26377693
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of FBXL12 mRNA	PMID:19812364
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of FBXL12 mRNA	PMID:20061341
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313605	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of FBXL12 mRNA	PMID:22079256
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313605	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FBXL12 mRNA	PMID:22079256
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	ISO	RGD:1313605	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of FBXL12 mRNA	PMID:30851411
1305528	Fbxl12	F-box and leucine-rich repeat protein 12	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1550238	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of FBXL12 mRNA	PMID:35537566
1305529	Pcnx3	pecanex 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313607	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PCNX3 mRNA	PMID:33045310
1305529	Pcnx3	pecanex 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313607	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PCNX3 mRNA	PMID:30319688
1305529	Pcnx3	pecanex 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313607	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PCNX3 mRNA	PMID:30319688
1305529	Pcnx3	pecanex 3	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1602160	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PCNX3 mRNA	PMID:21632981
1305529	Pcnx3	pecanex 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313607	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of PCNX3 gene	PMID:21212295
1305529	Pcnx3	pecanex 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313607	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PCNX3 mRNA	PMID:39298647
1305529	Pcnx3	pecanex 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1602160	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of PCNX3 mRNA	PMID:36314267
1305529	Pcnx3	pecanex 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313607	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PCNX3 mRNA	PMID:34319233
1305529	Pcnx3	pecanex 3	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PCNX3 mRNA	PMID:26577399
1305529	Pcnx3	pecanex 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1602160	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PCNX3 protein	PMID:37730182
1305529	Pcnx3	pecanex 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PCNX3 mRNA	PMID:33387578
1305529	Pcnx3	pecanex 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1602160	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PCNX3 intron	PMID:30157460
1305529	Pcnx3	pecanex 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602160	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PCNX3 intron	PMID:30157460
1305529	Pcnx3	pecanex 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313607	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PCNX3 mRNA	PMID:34911549
1305529	Pcnx3	pecanex 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602160	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PCNX3 mRNA	PMID:35430440
1305529	Pcnx3	pecanex 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313607	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PCNX3 mRNA	PMID:22206623
1305529	Pcnx3	pecanex 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602160	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCNX3 mRNA	PMID:39836092
1305529	Pcnx3	pecanex 3	gene	CHEBI:27585	selenomethionine	affects expression	ISO	RGD:1602160	E	RGD:6480464	20120412	CTD	MESH:D012645	Selenomethionine affects the expression of PCNX3 mRNA	PMID:17222674
1305529	Pcnx3	pecanex 3	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1602160	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PCNX3 protein	PMID:35688186
1305529	Pcnx3	pecanex 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313607	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PCNX3 mRNA	PMID:30912803
1305529	Pcnx3	pecanex 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313607	E	RGD:6480464	20160412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PCNX3 mRNA	PMID:21570461
1305529	Pcnx3	pecanex 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCNX3 mRNA	PMID:33387578
1305529	Pcnx3	pecanex 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313607	E	RGD:6480464	20160412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PCNX3 mRNA; [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of PCNX3 gene	PMID:17942748|PMID:21212295
1305529	Pcnx3	pecanex 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1602160	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PCNX3 mRNA	PMID:32763439
1305529	Pcnx3	pecanex 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602160	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCNX3 mRNA	PMID:29803840
1305529	Pcnx3	pecanex 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602160	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PCNX3 mRNA; sodium arsenite results in increased expression of PCNX3 protein	PMID:30528433|PMID:34032870|PMID:39719251
1305529	Pcnx3	pecanex 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602160	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCNX3 mRNA	PMID:39836092
1305529	Pcnx3	pecanex 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602160	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCNX3 intron	PMID:30157460
1305529	Pcnx3	pecanex 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313607	E	RGD:6480464	20160412	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to PCNX3 promoter]	PMID:19654925
1305529	Pcnx3	pecanex 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313607	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PCNX3 gene	PMID:35295148
1305529	Pcnx3	pecanex 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PCNX3 mRNA	PMID:30816183
1305529	Pcnx3	pecanex 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PCNX3 mRNA	PMID:25181051
1305529	Pcnx3	pecanex 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313607	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PCNX3 mRNA	PMID:33221593
1305529	Pcnx3	pecanex 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313607	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PCNX3 mRNA	PMID:39298647
1305529	Pcnx3	pecanex 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313607	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PCNX3 mRNA	PMID:37019170
1305529	Pcnx3	pecanex 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602160	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PCNX3 mRNA	PMID:37042841
1305529	Pcnx3	pecanex 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313607	E	RGD:6480464	20160412	CTD	MESH:D002994	Clofibrate results in decreased expression of PCNX3 mRNA	PMID:23811191
1305529	Pcnx3	pecanex 3	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1602160	E	RGD:6480464	20181016	CTD	MESH:C000944	dicrotophos results in increased expression of PCNX3 mRNA	PMID:28302478
1305529	Pcnx3	pecanex 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602160	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PCNX3 mRNA	PMID:31533062
1305529	Pcnx3	pecanex 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602160	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of PCNX3 gene	PMID:29154799
1305529	Pcnx3	pecanex 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602160	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCNX3 mRNA	PMID:25562108
1305529	Pcnx3	pecanex 3	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1602160	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of PCNX3 mRNA	PMID:16595896
1305529	Pcnx3	pecanex 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1602160	E	RGD:6480464	20181016	CTD	MESH:D000082	Acetaminophen results in increased expression of PCNX3 mRNA	PMID:26690555
1305529	Pcnx3	pecanex 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602160	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCNX3 mRNA	PMID:39836092
1305529	Pcnx3	pecanex 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313607	E	RGD:6480464	20160412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PCNX3 mRNA	PMID:17942748
1305529	Pcnx3	pecanex 3	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313607	E	RGD:6480464	20160412	CTD	MESH:D008694	Methamphetamine results in increased expression of PCNX3 mRNA	PMID:26307267
1305529	Pcnx3	pecanex 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313607	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PCNX3 mRNA	PMID:22206623
1305529	Pcnx3	pecanex 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602160	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCNX3 gene]	PMID:28238834
1305529	Pcnx3	pecanex 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PCNX3 mRNA	PMID:21346803
1305529	Pcnx3	pecanex 3	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PCNX3 mRNA	PMID:23034163
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased expression of CCL25 mRNA	PMID:22968694
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1313609	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in increased expression of CCL25 mRNA	PMID:33227293
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313609	E	RGD:6480464	20171114	CTD	MESH:D000431	Ethanol results in increased expression of CCL25 protein	PMID:28843478
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:16240	hydrogen peroxide	increases secretion	ISO	RGD:1313608	E	RGD:6480464	20210608	CTD	MESH:D006861	Hydrogen Peroxide results in increased secretion of CCL25 protein	PMID:33491125
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313608	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CCL25 mRNA	PMID:30510588
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of CCL25 mRNA	PMID:26496021
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CCL25 mRNA	PMID:33387578
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:168396	mycophenolic acid	increases expression	ISO	RGD:1313609	E	RGD:6480464	20120501	CTD	MESH:D009173	Mycophenolic Acid results in increased expression of CCL25 mRNA	PMID:19818335
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313608	E	RGD:6480464	20250708	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCL25 mRNA	PMID:35818422
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313608	E	RGD:6480464	20250708	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Asian ginseng] results in increased expression of CCL25 mRNA	PMID:35818422
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:18227	sterigmatocystin	increases expression	ISO	RGD:1313609	E	RGD:6480464	20120501	CTD	MESH:D013241	Sterigmatocystin results in increased expression of CCL25 mRNA	PMID:19818335
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCL25 mRNA	PMID:36331819
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:200715	Brevianamide A	increases expression	ISO	RGD:1313609	E	RGD:6480464	20231219	CTD	MESH:C006794	brevianamide A results in increased expression of CCL25 mRNA	PMID:19818335
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:211551	TMC-120A	increases expression	ISO	RGD:1313609	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in increased expression of CCL25 mRNA	PMID:19818335
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL25 mRNA	PMID:29950665
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases secretion	ISO	RGD:1313608	E	RGD:6480464	20210608	CTD	MESH:D009151	Mustard Gas results in increased secretion of CCL25 protein	PMID:33491125
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:25442	mycotoxin	increases expression	ISO	RGD:1313609	E	RGD:6480464	20170228	CTD	MESH:D009183	Mycotoxins results in increased expression of CCL25 mRNA	PMID:19818335
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20200310	CTD	MESH:D010126	Ozone results in decreased expression of CCL25 mRNA	PMID:26342085
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313609	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of CCL25 mRNA	PMID:31939706
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D015032	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20181016	CTD	MESH:D002251	[PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of CCL25 protein	PMID:29987408
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CCL25 mRNA	PMID:25629700
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:27638	cobalt atom	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D003035	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1313609	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of CCL25 mRNA	PMID:28960355
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D009532	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313609	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCL25 mRNA	PMID:21570461
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313608	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCL25 mRNA	PMID:21296121
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313609	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCL25 mRNA	PMID:21041162
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313609	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of CCL25 mRNA	PMID:39095385
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313608	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CCL25 promoter	PMID:27901495
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CCL25 mRNA	PMID:22228805
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D015032	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CCL25 mRNA	PMID:30047161
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL25 mRNA	PMID:29950665
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313609	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CCL25 mRNA	PMID:18648102
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313609	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CCL25 mRNA	PMID:20813756
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCL25 mRNA	PMID:19710929
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CCL25 mRNA	PMID:25181051
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CCL25 mRNA	PMID:32156529
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CCL25 gene	PMID:28505145
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of CCL25 mRNA	PMID:26496021
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313608	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CCL25 intron	PMID:30157460
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313609	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CCL25 intron	PMID:28392331
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313609	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CCL25 mRNA	PMID:37019170
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL25 mRNA	PMID:29950665
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D015056	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CCL25 promoter	PMID:22457795
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20200331	CTD	MESH:D002738	Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL25 protein]	PMID:22341560
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313609	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CCL25 mRNA	PMID:40194260
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCL25 mRNA	PMID:36331819
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CCL25 mRNA	PMID:30047161
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of CCL25 mRNA	PMID:21041162
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:41607	crotonaldehyde	increases expression	ISO	RGD:1313608	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased expression of CCL25 mRNA	PMID:20471460
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of CCL25 mRNA	PMID:21041162
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D003907	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of CCL25 mRNA	PMID:21041162
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313608	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of CCL25 mRNA	PMID:17400583
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313609	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCL25 mRNA	PMID:25270620
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCL25 mRNA; Nanotubes, Carbon results in decreased expression of CCL25 mRNA	PMID:25554681|PMID:25620056
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CCL25 mRNA	PMID:30047161
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:52007	monodansylcadaverine	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20200331	CTD	MESH:C008542	monodansylcadaverine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL25 protein]	PMID:22341560
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CCL25 mRNA	PMID:38701926
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313608	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CCL25 intron	PMID:30157460
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:68792	asperentin	increases expression	ISO	RGD:1313609	E	RGD:6480464	20131008	CTD	MESH:C000488	cladosporin results in increased expression of CCL25 mRNA	PMID:19818335
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:68794	neoechinulin A	increases expression	ISO	RGD:1313609	E	RGD:6480464	20170228	CTD	MESH:C490266	neoechinulin A results in increased expression of CCL25 mRNA	PMID:19818335
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313609	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CCL25 mRNA	PMID:22206623
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:753435	ginseng, asian	multiple interactions	ISO	RGD:1313608	E	RGD:6480464	20260714	CTD	MESH:C000713447	[Diethylhexyl Phthalate co-treated with Asian ginseng] results in increased expression of CCL25 mRNA	PMID:35818422
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CCL25 mRNA	PMID:23640034
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CCL25 mRNA	PMID:30047161
1305530	Ccl25	C-C motif chemokine ligand 25	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of CCL25 gene	PMID:31079544
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313610	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of HSPA12A mRNA	PMID:26272509
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA	PMID:27188386
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of HSPA12A mRNA	PMID:26251327
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HSPA12A gene	PMID:20938992
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of HSPA12A mRNA	PMID:23724009
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20210810	CTD	MESH:D019308	[Palmitic Acid co-treated with Arsenic] affects the expression of HSPA12A mRNA	PMID:33736254
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of HSPA12A gene	PMID:28931070
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313611	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of HSPA12A mRNA	PMID:30319688
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313610	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of HSPA12A mRNA	PMID:21632981
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HSPA12A mRNA	PMID:39241906
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313610	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of HSPA12A mRNA	PMID:31614463
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of HSPA12A mRNA	PMID:30165855
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of HSPA12A gene	PMID:27618143
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HSPA12A gene	PMID:20938992
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D005947	Glucose results in decreased expression of HSPA12A protein	PMID:22413817
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D005947	KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA12A protein]	PMID:22413817
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D005947	Glucose results in decreased expression of HSPA12A protein	PMID:22413817
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D005947	KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA12A protein]	PMID:22413817
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313610	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of HSPA12A protein	PMID:37730182
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313610	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of HSPA12A intron	PMID:30157460
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA12A mRNA	PMID:35301059
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313610	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HSPA12A intron	PMID:30157460
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of HSPA12A mRNA	PMID:34911549
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HSPA12A mRNA	PMID:25629700
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HSPA12A gene	PMID:20938992
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1313610	E	RGD:6480464	20210810	CTD	MESH:D001151	Arsenic affects the expression of HSPA12A mRNA	PMID:33736254
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313610	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HSPA12A gene	PMID:25304211
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20210810	CTD	MESH:D001151	[Palmitic Acid co-treated with Arsenic] affects the expression of HSPA12A mRNA	PMID:33736254
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSPA12A mRNA	PMID:40504410
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of HSPA12A gene	PMID:35440735
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of HSPA12A mRNA	PMID:23557933
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1313610	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of HSPA12A mRNA	PMID:23300844
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313610	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HSPA12A mRNA	PMID:27392435
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HSPA12A mRNA	PMID:27392435
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1313611	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein affects the expression of HSPA12A mRNA	PMID:32186404
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSPA12A mRNA	PMID:26232522
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313610	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSPA12A mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of HSPA12A mRNA	PMID:29955902
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1313610	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of HSPA12A mRNA	PMID:26272509
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA	PMID:27188386
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HSPA12A mRNA	PMID:29803840
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of HSPA12A mRNA	PMID:39631538
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20120918	CTD	MESH:D004317	[[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of HSPA12A mRNA	PMID:21040762
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313610	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of HSPA12A gene	PMID:28589171
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of HSPA12A mRNA	PMID:37682722
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSPA12A mRNA	PMID:40504410
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313610	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HSPA12A intron	PMID:30157460
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313610	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HSPA12A mRNA	PMID:20106945|PMID:21632981|PMID:26238291|PMID:32234424
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to HSPA12A mRNA]	PMID:32406909
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313610	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of HSPA12A mRNA	PMID:25351596
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HSPA12A mRNA	PMID:20382639
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HSPA12A gene	PMID:31601247
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of HSPA12A mRNA	PMID:16507785
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:32130	silver(1+) nitrate	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in decreased expression of HSPA12A mRNA	PMID:22831968
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:3215	bupivacaine	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20220607	CTD	MESH:D002045	Bupivacaine results in decreased expression of HSPA12A protein	PMID:34793778
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:3215	bupivacaine	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20220607	CTD	MESH:D002045	HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of BCL2 protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of DNM1L protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of MFN1 protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of PINK1 protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of PPARGC1A protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of PRKN protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of SLC2A1 protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of SLC2A4 protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of TOMM20 protein]	PMID:34793778
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313611	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HSPA12A promoter	PMID:35295148
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of HSPA12A mRNA	PMID:18648102
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of HSPA12A mRNA	PMID:20813756
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313610	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of HSPA12A gene	PMID:31601247
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HSPA12A mRNA	PMID:25181051|PMID:30816183
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HSPA12A gene	PMID:31601247
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34093	1-Hydroxypyrene	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20260203	CTD	MESH:C033146	[Metals, Heavy co-treated with 1-hydroxypyrene] results in decreased methylation of HSPA12A gene	PMID:39164771
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313611	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of HSPA12A mRNA	PMID:40203079
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSPA12A mRNA	PMID:28628672
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of HSPA12A mRNA]	PMID:40203079
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313610	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of HSPA12A intron	PMID:30157460
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSPA12A mRNA	PMID:28628672
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HSPA12A mRNA	PMID:37019170
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HSPA12A mRNA	PMID:21266533
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34698	diethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSPA12A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSPA12A mRNA	PMID:28628672
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of HSPA12A mRNA	PMID:32680482
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of HSPA12A mRNA	PMID:35163327
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HSPA12A mRNA	PMID:33453195
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HSPA12A mRNA	PMID:38382870
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA12A mRNA	PMID:35301059
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of HSPA12A mRNA	PMID:35163327
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313610	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HSPA12A mRNA	PMID:25979313
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313610	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of HSPA12A mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA	PMID:27188386
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of HSPA12A mRNA	PMID:25562108
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSPA12A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSPA12A mRNA	PMID:28628672
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of HSPA12A mRNA	PMID:28973697
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D005947	Glucose results in decreased expression of HSPA12A protein	PMID:22413817
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D005947	KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA12A protein]	PMID:22413817
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313610	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HSPA12A mRNA	PMID:38832940
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313610	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of HSPA12A mRNA	PMID:24935251
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HSPA12A mRNA	PMID:33387578
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313610	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of HSPA12A mRNA	PMID:29067470
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of HSPA12A mRNA	PMID:24714768
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of HSPA12A mRNA	PMID:29279043
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1313610	E	RGD:6480464	20210810	CTD	MESH:D001151	Arsenic affects the expression of HSPA12A mRNA	PMID:33736254
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313610	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HSPA12A gene	PMID:25304211
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20210810	CTD	MESH:D001151	[Palmitic Acid co-treated with Arsenic] affects the expression of HSPA12A mRNA	PMID:33736254
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSPA12A mRNA	PMID:40504410
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:48607	lithium chloride	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in decreased expression of HSPA12A mRNA	PMID:23527032
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSPA12A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSPA12A mRNA	PMID:28628672
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313610	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of HSPA12A mRNA	PMID:23300844
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313610	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of HSPA12A mRNA	PMID:22714537
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of HSPA12A mRNA	PMID:23608068
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HSPA12A protein	PMID:32959892
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313610	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of HSPA12A mRNA	PMID:28988120
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313610	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of HSPA12A intron	PMID:30157460
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of HSPA12A gene	PMID:35440735
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313610	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of HSPA12A protein	PMID:34186270
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HSPA12A mRNA	PMID:22206623
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313610	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of HSPA12A mRNA	PMID:22714537
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of HSPA12A mRNA	PMID:32858204
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313610	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of HSPA12A protein	PMID:39638853
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1313610	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of HSPA12A mRNA	PMID:34995734
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA	PMID:27188386
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HSPA12A mRNA	PMID:24780913
1305531	Hspa12a	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313610	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA	PMID:27188386
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313612	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of RBBP5 mRNA	PMID:19438726
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313613	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of RBBP5 mRNA	PMID:33045310
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RBBP5 mRNA]	PMID:31150632
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313613	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RBBP5 mRNA	PMID:26251327
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313613	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RBBP5 mRNA	PMID:20188158
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313612	E	RGD:6480464	20220510	CTD	MESH:D000431	Ethanol results in increased expression of RBBP5 protein	PMID:35149083
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313612	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RBBP5 mRNA	PMID:37042841
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:17303	morphine	decreases expression	ISO	RGD:1313613	E	RGD:6480464	20220111	CTD	MESH:D009020	Morphine results in decreased expression of RBBP5 mRNA	PMID:33891991
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RBBP5 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA]	PMID:20230807
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313612	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RBBP5 protein	PMID:37730182
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1313613	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA	PMID:20230807
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of RBBP5 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RBBP5 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA]	PMID:20230807
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313612	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RBBP5 mRNA	PMID:28818685
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBBP5 mRNA	PMID:36331819
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RBBP5 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA]	PMID:20230807
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1313612	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of RBBP5 mRNA	PMID:12634122
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313612	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RBBP5 mRNA	PMID:19549813
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313612	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RBBP5 gene	PMID:27153756
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1313612	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of RBBP5 mRNA	PMID:26760959
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1313612	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of RBBP5 mRNA; Amphotericin B results in decreased expression of RBBP5 mRNA	PMID:28534445
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RBBP5 mRNA	PMID:31150632
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RBBP5 mRNA]	PMID:31150632
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313612	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RBBP5 protein	PMID:35688186
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of RBBP5 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA]	PMID:20230807
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313612	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RBBP5 mRNA	PMID:23557933
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313613	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBBP5 mRNA	PMID:21570461
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313612	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RBBP5 mRNA	PMID:29803840
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313612	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of RBBP5 protein	PMID:35688186
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313612	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of RBBP5 protein	PMID:38228842
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313612	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RBBP5 mRNA	PMID:38568856
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313612	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RBBP5 mRNA	PMID:20064835
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313612	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBBP5 3' UTR	PMID:27901495
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313613	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RBBP5 mRNA	PMID:18648102
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313613	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in decreased expression of RBBP5 mRNA	PMID:25270620
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RBBP5 mRNA	PMID:25181051
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313613	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RBBP5 promoter	PMID:27312807
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RBBP5 mRNA	PMID:34947998
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313612	E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of RBBP5 protein	PMID:33376534
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:34631	chlorpyrifos	affects expression	ISO	RGD:1313613	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos affects the expression of RBBP5 mRNA	PMID:37019170
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313612	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RBBP5 mRNA	PMID:37042841
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313612	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RBBP5 mRNA	PMID:31533062
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBBP5 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RBBP5 mRNA	PMID:36331819
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313612	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of RBBP5 mRNA	PMID:29154799
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:41791	calyculin A	decreases expression	ISO	RGD:1313613	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in decreased expression of RBBP5 mRNA	PMID:25270620
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:41977	daunorubicin	affects expression	ISO	RGD:1313612	E	RGD:6480464	20120412	CTD	MESH:D003630	Daunorubicin affects the expression of RBBP5 mRNA	PMID:12656675
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313612	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RBBP5 mRNA	PMID:38832940
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313612	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RBBP5 mRNA	PMID:28542535
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313612	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RBBP5 mRNA	PMID:22230336
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RBBP5 mRNA	PMID:24136188
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313612	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RBBP5 protein	PMID:32959892
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1313612	E	RGD:6480464	20130611	CTD	MESH:D015655	U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of RBBP5 mRNA]	PMID:12710931
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313613	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RBBP5 mRNA	PMID:22206623
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313612	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RBBP5 protein	PMID:37664457
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313612	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RBBP5 gene]	PMID:28238834
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313612	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of RBBP5 mRNA; Irinotecan results in decreased expression of RBBP5 mRNA	PMID:15956246
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1313612	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in increased expression of RBBP5 mRNA; Irinotecan results in increased expression of RBBP5 mRNA	PMID:15956246
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313612	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RBBP5 protein	PMID:37664457
1305532	Rbbp5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1313612	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of RBBP5 mRNA	PMID:17440010
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313615	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TBCE mRNA	PMID:37995155
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313614	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TBCE mRNA	PMID:33167477
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313614	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TBCE mRNA	PMID:22378314
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313614	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TBCE mRNA	PMID:20044591
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313615	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TBCE mRNA	PMID:39298647
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1313615	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to TBCE gene]	PMID:31084621
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TBCE mRNA	PMID:22061828
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313614	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313614	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TBCE protein	PMID:23301498
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313615	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TBCE mRNA	PMID:19770486
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313614	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TBCE intron	PMID:30157460
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313614	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBCE mRNA	PMID:33387578
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1313615	E	RGD:6480464	20120613	CTD	MESH:D012402	Rotenone affects the expression of TBCE mRNA	PMID:21893155
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1313615	E	RGD:6480464	20120613	CTD	MESH:D012402	TRP53 affects the reaction [Rotenone affects the expression of TBCE mRNA]	PMID:21893155
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313614	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TBCE mRNA	PMID:33212167
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313615	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of TBCE mRNA	PMID:25896364|PMID:39631538
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313615	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TBCE mRNA	PMID:20883709
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313614	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313615	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TBCE mRNA	PMID:19770486
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313615	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of TBCE protein	PMID:37955338
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313614	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TBCE mRNA]	PMID:32406909
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313615	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TBCE gene	PMID:35295148
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TBCE mRNA	PMID:18648102
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TBCE mRNA	PMID:19167457
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TBCE mRNA	PMID:25181051
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313614	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TBCE protein	PMID:33376534
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TBCE mRNA	PMID:36041667
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313615	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TBCE mRNA	PMID:39298647
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TBCE mRNA	PMID:36041667
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TBCE mRNA	PMID:38685157
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313614	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TBCE protein	PMID:34186270
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TBCE mRNA	PMID:36041667
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313614	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TBCE protein	PMID:34186270
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TBCE mRNA	PMID:37019170
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313614	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1313615	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride affects the expression of TBCE mRNA	PMID:20883709
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TBCE mRNA	PMID:19162173
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313614	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of TBCE mRNA	PMID:19376846
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313615	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TBCE mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TBCE mRNA]	PMID:17585979
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313614	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TBCE mRNA	PMID:23179753|PMID:29154799
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313614	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TBCE mRNA	PMID:25562108
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313615	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TBCE mRNA	PMID:28973697
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TBCE mRNA	PMID:24136188
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313615	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TBCE mRNA	PMID:17562736
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in decreased expression of TBCE mRNA	PMID:17585979
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313615	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TBCE mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TBCE mRNA]	PMID:17585979
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313614	E	RGD:6480464	20120412	CTD	MESH:D005472	TBCE protein affects the susceptibility to Fluorouracil	PMID:16217747
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TBCE mRNA	PMID:29279043
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313614	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TBCE mRNA	PMID:29097150
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TBCE mRNA	PMID:24136188
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TBCE mRNA	PMID:24136188
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313614	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TBCE protein	PMID:32959892
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313614	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TBCE mRNA	PMID:23650126
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TBCE gene	PMID:35440735
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313614	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TBCE protein	PMID:34186270
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:748572	acyline	increases expression	ISO	RGD:1313614	E	RGD:6480464	20260714	CTD	MESH:C109238	acyline results in increased expression of TBCE mRNA	PMID:17510436
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TBCE mRNA	PMID:24136188
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TBCE mRNA	PMID:19162173
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1313614	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of TBCE mRNA	PMID:39904859
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313615	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TBCE mRNA	PMID:30294300
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313614	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of TBCE protein	PMID:38348393
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TBCE mRNA	PMID:21346803
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TBCE mRNA	PMID:21346803
1305533	Tbce	tubulin folding cofactor E	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TBCE mRNA	PMID:22570695
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1617233	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DOP1A mRNA	PMID:33045310
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313616	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DOP1A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DOP1A mRNA	PMID:32699268
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313616	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of DOP1A mRNA	PMID:24763279
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313616	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of DOP1A mRNA	PMID:26079696
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313616	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DOP1A mRNA	PMID:20044591
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313616	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DOP1A mRNA	PMID:21632981
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1617233	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DOP1A mRNA	PMID:39298647
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313616	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DOP1A mRNA	PMID:37042841
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313616	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of DOP1A mRNA	PMID:19162166
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313616	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DOP1A mRNA	PMID:23649840
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313616	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DOP1A protein	PMID:37730182
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313616	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DOP1A mRNA	PMID:28818685
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1617233	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DOP1A mRNA	PMID:36331819
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313616	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DOP1A mRNA	PMID:35301059
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617233	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DOP1A mRNA	PMID:37236586
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313616	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of DOP1A mRNA	PMID:23649840
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313616	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DOP1A mRNA	PMID:23649840
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313616	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DOP1A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DOP1A mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of DOP1A mRNA	PMID:32699268
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313616	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DOP1A protein	PMID:35688186
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1617233	E	RGD:6480464	20210209	CTD	MESH:C024565	ethylene dichloride affects the expression of DOP1A mRNA	PMID:28960355
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313616	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DOP1A mRNA	PMID:23557933
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DOP1A mRNA	PMID:34747641
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313616	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DOP1A mRNA	PMID:28001369
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313616	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DOP1A mRNA	PMID:33212167
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313616	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DOP1A mRNA	PMID:29803840
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313616	E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DOP1A exon	PMID:30157460
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617233	E	RGD:6480464	20181113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DOP1A mRNA	PMID:21569818
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313616	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DOP1A gene	PMID:31601247
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1617233	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of DOP1A mRNA	PMID:35295148
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617233	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DOP1A gene	PMID:35295148
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of DOP1A mRNA	PMID:30816183
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313616	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DOP1A gene	PMID:31601247
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1617233	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of DOP1A mRNA	PMID:35598803
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313616	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DOP1A gene	PMID:31601247
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313616	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DOP1A mRNA	PMID:37042841
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DOP1A mRNA	PMID:33453195
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313616	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DOP1A mRNA	PMID:35301059
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617233	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DOP1A mRNA	PMID:37236586
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1617233	E	RGD:6480464	20181113	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DOP1A mRNA	PMID:28903501
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313616	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DOP1A mRNA	PMID:24449571
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313616	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DOP1A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DOP1A mRNA	PMID:32699268
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617233	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DOP1A mRNA	PMID:36331819
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313616	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of DOP1A mRNA	PMID:24383497|PMID:28001369
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313616	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DOP1A mRNA	PMID:20106945
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1617233	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DOP1A mRNA	PMID:29279043
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1617233	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of DOP1A mRNA	PMID:35436446
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of DOP1A mRNA	PMID:30307764
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DOP1A gene	PMID:35440735
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:80799	Bufotalin	increases expression	ISO	RGD:1313616	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of DOP1A mRNA	PMID:39904859
1305534	Dop1a	DOP1 leucine zipper like protein A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1617233	E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DOP1A mRNA	PMID:30294300
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313619	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ARL6 mRNA	PMID:33045310
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313619	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ARL6 mRNA	PMID:30319688
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313619	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ARL6 mRNA	PMID:30319688
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313618	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ARL6 mRNA	PMID:21632981
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313618	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of ARL6 mRNA	PMID:22574217
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ARL6 mRNA	PMID:33387578
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313618	E	RGD:6480464	20201006	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARL6 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARL6 mRNA; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CTNNB1 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LEF1 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUNX2 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TCF7 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT3A protein]	PMID:32522577|PMID:35301059
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ARL6 mRNA	PMID:21396975
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313619	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARL6 mRNA	PMID:19770486
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313619	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ARL6 mRNA	PMID:34911549
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313619	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARL6 mRNA	PMID:27339419|PMID:31919559
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313619	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ARL6 protein	PMID:25505154
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313619	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARL6 mRNA	PMID:21570461
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313618	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARL6 mRNA	PMID:33212167
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ARL6 mRNA	PMID:28959563
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313619	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARL6 promoter	PMID:35295148
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ARL6 mRNA	PMID:23411599|PMID:34492290
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313618	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of ARL6 mRNA	PMID:27685785
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313618	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARL6 mRNA	PMID:37042841
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARL6 mRNA	PMID:30917596
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARL6 mRNA	PMID:33453195
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313618	E	RGD:6480464	20201006	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARL6 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARL6 mRNA; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CTNNB1 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LEF1 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUNX2 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TCF7 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT3A protein]	PMID:32522577|PMID:35301059
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ARL6 mRNA	PMID:25539665
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313618	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARL6 mRNA	PMID:31533062
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1313618	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of ARL6 mRNA	PMID:31626844
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313619	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ARL6 mRNA	PMID:17963808
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313618	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ARL6 mRNA	PMID:24935251|PMID:29154799
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313618	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ARL6 mRNA	PMID:20106945
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313619	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of ARL6 mRNA	PMID:19770486
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313619	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ARL6 mRNA	PMID:28973697
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313618	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ARL6 mRNA	PMID:24935251
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARL6 mRNA	PMID:33387578
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313618	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARL6 mRNA	PMID:26690555
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ARL6 mRNA	PMID:29391264
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313619	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ARL6 mRNA	PMID:35436446
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313618	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ARL6 protein	PMID:23718831
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of ARL6 mRNA	PMID:20080153
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313618	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARL6 gene]	PMID:28238834
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313619	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ARL6 mRNA	PMID:23091169
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARL6 mRNA	PMID:24780913
1305535	Arl6	ARF like GTPase 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ARL6 mRNA	PMID:21346803
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HECTD2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HECTD2 gene	PMID:20938992
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313620	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of HECTD2 mRNA	PMID:21934132
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313620	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HECTD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HECTD2 mRNA	PMID:32699268
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313620	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in decreased expression of HECTD2 mRNA	PMID:21632981
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313621	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of HECTD2 mRNA	PMID:39298647
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313620	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of HECTD2 mRNA	PMID:30165855
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HECTD2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HECTD2 gene	PMID:20938992
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HECTD2 mRNA	PMID:37992649
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HECTD2 mRNA	PMID:37992649
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313620	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of HECTD2 mRNA	PMID:28818685
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HECTD2 mRNA	PMID:39012411
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313620	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HECTD2 mRNA	PMID:35301059
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HECTD2 mRNA	PMID:37236586
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313620	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in increased expression of HECTD2 mRNA	PMID:19549813
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313620	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HECTD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HECTD2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of HECTD2 mRNA	PMID:32699268
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27086	tributylstannane	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in increased expression of HECTD2 mRNA	PMID:31129395
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HECTD2 mRNA	PMID:31150632
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313621	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HECTD2 mRNA	PMID:31919559
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HECTD2 mRNA	PMID:25629700
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HECTD2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HECTD2 gene	PMID:20938992
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HECTD2 mRNA	PMID:40504410
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of HECTD2 mRNA	PMID:28189721|PMID:28960355
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HECTD2 mRNA	PMID:22298810
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313621	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HECTD2 mRNA	PMID:21570461
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HECTD2 mRNA	PMID:19933214|PMID:24680724
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313621	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HECTD2 mRNA	PMID:17949056|PMID:19770486
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of HECTD2 mRNA	PMID:16214954
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of HECTD2 mRNA	PMID:27862939
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313620	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HECTD2 mRNA	PMID:29803840
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HECTD2 mRNA	PMID:37992649
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313620	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HECTD2 mRNA	PMID:38568856
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HECTD2 mRNA	PMID:40504410
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313621	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HECTD2 mRNA	PMID:32417428
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:3016	Benoxacor	increases expression	ISO	RGD:1313621	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in increased expression of HECTD2 mRNA	PMID:34850242
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HECTD2 mRNA	PMID:29264374
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313621	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HECTD2 gene; titanium dioxide results in decreased methylation of HECTD2 promoter	PMID:35295148
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of HECTD2 mRNA	PMID:34947998
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of HECTD2 mRNA	PMID:33296240
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of HECTD2 mRNA	PMID:38685157
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313620	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HECTD2 mRNA	PMID:37042841
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HECTD2 mRNA	PMID:39012411
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313620	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HECTD2 mRNA	PMID:35301059
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HECTD2 mRNA	PMID:37236586
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of HECTD2 gene	PMID:22079235
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of HECTD2 mRNA	PMID:28903501
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313620	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of HECTD2 mRNA	PMID:24449571
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313621	E	RGD:6480464	20130806	CTD	MESH:D002922	Ciguatoxins affects the expression of HECTD2 mRNA	PMID:18353800
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313620	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HECTD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HECTD2 mRNA	PMID:32699268
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1313620	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of HECTD2 mRNA	PMID:33512557
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313620	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of HECTD2 mRNA	PMID:31533062
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1313620	E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin results in increased expression of HECTD2 mRNA	PMID:29044138
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313620	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of HECTD2 mRNA	PMID:27153767
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313620	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HECTD2 mRNA	PMID:25979313
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313620	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of HECTD2 mRNA	PMID:23179753|PMID:27188386
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313620	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HECTD2 gene	PMID:29154799
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313621	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of HECTD2 mRNA	PMID:19770486
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HECTD2 mRNA	PMID:37992649
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313621	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HECTD2 mRNA	PMID:17562736
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HECTD2 mRNA	PMID:40504410
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1313620	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of HECTD2 mRNA	PMID:40706910
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of HECTD2 mRNA	PMID:22334560
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:48981	quinolin-8-ol	decreases expression	ISO	RGD:1313620	E	RGD:6480464	20130806	CTD	MESH:D015125	Oxyquinoline results in decreased expression of HECTD2 mRNA	PMID:21632981
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of HECTD2 mRNA	PMID:25554681
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1313620	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of HECTD2 mRNA	PMID:20977926
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313621	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of HECTD2 mRNA	PMID:19042947
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1313621	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of HECTD2 mRNA	PMID:23608068
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HECTD2 mRNA	PMID:22206623
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313620	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of HECTD2 mRNA	PMID:18927307
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital results in decreased expression of HECTD2 mRNA	PMID:23091169
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of HECTD2 mRNA	PMID:22334560
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20131210	CTD	MESH:C045950	propiconazole results in decreased expression of HECTD2 mRNA	PMID:21278054|PMID:22334560|PMID:23970803
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of HECTD2 mRNA	PMID:19281266
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313620	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of HECTD2 mRNA	PMID:38568856
1305536	Hectd2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313620	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of HECTD2 mRNA	PMID:27188386
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANKK1 mRNA	PMID:32741896
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313623	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ANKK1 mRNA	PMID:37042841
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANKK1 mRNA	PMID:32741896
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313623	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ANKK1 mRNA	PMID:19549813
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313623	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANKK1 exon	PMID:30157460
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620554	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ANKK1 mRNA	PMID:27106289
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1313623	E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased methylation of ANKK1 gene	PMID:24525453
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ANKK1 mRNA	PMID:28959563
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ANKK1 mRNA	PMID:26033743
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313623	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ANKK1 mRNA	PMID:25879800
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313623	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ANKK1 promoter	PMID:27901495
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620554	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANKK1 mRNA	PMID:23735875
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313623	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ANKK1 exon	PMID:27901495
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ANKK1 mRNA	PMID:26033743
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313623	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ANKK1 mRNA	PMID:23806026
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of ANKK1 mRNA	PMID:30012374
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKK1 mRNA	PMID:25181051
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313623	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ANKK1 mRNA	PMID:38382870
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620554	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ANKK1 mRNA	PMID:40194260
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313623	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in decreased expression of ANKK1 mRNA	PMID:23527032
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313623	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ANKK1 mRNA	PMID:38832940
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313623	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ANKK1 mRNA	PMID:26690555
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1313623	E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased methylation of ANKK1 gene	PMID:24525453
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1620554	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ANKK1 mRNA	PMID:23608068
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1620554	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ANKK1 mRNA	PMID:38701926
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANKK1 mRNA	PMID:32741896
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313623	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of ANKK1 mRNA	PMID:32234424
1305538	Ankk1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ANKK1 mRNA	PMID:24780913
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CFAP91 mRNA	PMID:26272509
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313624	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CFAP91 mRNA	PMID:33045310
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1346781	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MAATS1 mRNA	PMID:35811015
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1346781	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MAATS1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MAATS1 mRNA	PMID:35811015
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MAATS1 mRNA	PMID:33387578
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of MAATS1 mRNA	PMID:33359661
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CFAP91 mRNA	PMID:31163220
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313624	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MAATS1 mRNA	PMID:34319233
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CFAP91 mRNA	PMID:26272509
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1346781	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA	PMID:27188386
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CFAP91 mRNA	PMID:24768652|PMID:25583101
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CFAP91 mRNA	PMID:28001369
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of CFAP91 mRNA	PMID:26272509
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1346781	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA	PMID:27188386
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313624	E	RGD:6480464	20201215	CTD	MESH:D004317	Doxorubicin results in increased expression of CFAP91 mRNA	PMID:26873546
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313624	E	RGD:6480464	20201215	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CFAP91 intron	PMID:27901495
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1346781	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CFAP91 promoter	PMID:27901495
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1346781	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CFAP91 5' UTR	PMID:27901495
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1346781	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CFAP91 gene	PMID:25435355
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1346781	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CFAP91 mRNA	PMID:23806026
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313624	E	RGD:6480464	20201215	CTD	MESH:C009495	titanium dioxide affects the expression of CFAP91 mRNA	PMID:23557971
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313624	E	RGD:6480464	20201215	CTD	MESH:C009495	titanium dioxide results in decreased expression of CFAP91 mRNA	PMID:29264374
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CFAP91 mRNA	PMID:25181051
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313624	E	RGD:6480464	20201215	CTD	MESH:C006780	bisphenol A results in increased expression of CFAP91 mRNA	PMID:30951980
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CFAP91 mRNA	PMID:36041667
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313624	E	RGD:6480464	20201215	CTD	MESH:C543008	bisphenol S results in increased expression of CFAP91 mRNA	PMID:30951980
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CFAP91 mRNA	PMID:36041667
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313624	E	RGD:6480464	20201215	CTD	MESH:C008745	bisphenol F results in increased expression of CFAP91 mRNA	PMID:30951980
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CFAP91 mRNA	PMID:36041667
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313624	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CFAP91 mRNA; Chlorpyrifos results in decreased expression of MAATS1 mRNA	PMID:32715474|PMID:37019170
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1346781	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to MAATS1 protein	PMID:32991956
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CFAP91 mRNA	PMID:30723492
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MAATS1 mRNA	PMID:38382870
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346781	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CFAP91 mRNA	PMID:25979313
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CFAP91 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346781	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of CFAP91 mRNA	PMID:19101580
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1346781	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA	PMID:27188386
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CFAP91 mRNA	PMID:26272509
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1346781	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA	PMID:27188386
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAATS1 mRNA	PMID:33387578
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1346781	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MAATS1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MAATS1 mRNA	PMID:35811015
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of CFAP91 mRNA	PMID:26272509
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1346781	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA	PMID:27188386
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313624	E	RGD:6480464	20201215	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CFAP91 mRNA; Nanotubes, Carbon results in decreased expression of CFAP91 mRNA	PMID:25554681
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313624	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CFAP91 mRNA	PMID:38701926
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:6651	malathion	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of CFAP91 mRNA	PMID:37047231
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1346781	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CFAP91 mRNA	PMID:37199045
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346781	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA	PMID:27188386
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1346781	E	RGD:6480464	20161228	CTD	MESH:C496932	Panobinostat results in decreased expression of CFAP91 mRNA	PMID:26272509
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1346781	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA	PMID:27188386
1305539	Cfap91	cilia and flagella associated protein 91	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346781	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA	PMID:27188386
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313628	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of FBL protein	PMID:39638853
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313628	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of FBL mRNA	PMID:38218311
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBL mRNA]	PMID:31150632
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313629	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBL mRNA	PMID:20188158
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313628	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FBL mRNA	PMID:33167477
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313629	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FBL mRNA	PMID:39241906
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313629	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of FBL mRNA	PMID:15598610
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FBL mRNA	PMID:23829299
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313628	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of FBL mRNA	PMID:38568856
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	ISO	RGD:1313628	E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of FBL protein	PMID:39245080
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:17574	biochanin A	increases expression	ISO	RGD:1313628	E	RGD:6480464	20120412	CTD	MESH:C004541	biochanin A results in increased expression of FBL mRNA	PMID:12111696
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313628	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FBL protein	PMID:37730182
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FBL mRNA	PMID:22061828
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D024502	alpha-Tocopherol deficiency results in decreased expression of FBL protein	PMID:15247049
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FBL mRNA	PMID:36331819
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of FBL protein	PMID:34915118
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:193591	Didecyldimethylammonium	decreases expression	ISO	RGD:1313628	E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in decreased expression of FBL protein	PMID:32763356
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313629	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of FBL mRNA	PMID:27462272
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBL mRNA	PMID:35301059
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:231511	Potassium hexachloropalladate(IV)	affects localization	ISO	RGD:1313628	E	RGD:6480464	20240702	CTD	MESH:C532828	potassium hexachloropalladate(IV) analog affects the localization of FBL protein	PMID:10942594
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FBL protein	PMID:23301498
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of FBL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of FBL protein	PMID:38598786
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FBL mRNA	PMID:31150632
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBL mRNA]	PMID:31150632
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBL mRNA	PMID:22206623
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27504	mitomycin C	affects localization	ISO	RGD:1313628	E	RGD:6480464	20120814	CTD	MESH:D016685	Mitomycin analog affects the localization of FBL protein	PMID:10942594
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of FBL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBL mRNA	PMID:39836092|PMID:40512198
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20120412	CTD	MESH:D003513	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of FBL mRNA	PMID:19684285
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27666	actinomycin D	affects localization	ISO	RGD:1313628	E	RGD:6480464	20120814	CTD	MESH:D003609	Dactinomycin analog affects the localization of FBL protein	PMID:10942594
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27899	cisplatin	affects localization	ISO	RGD:1313628	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin analog affects the localization of FBL protein	PMID:10942594
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of FBL mRNA	PMID:21151649
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBL mRNA	PMID:33387578
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313628	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBL mRNA	PMID:19684285
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of FBL mRNA	PMID:19684285
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of FBL protein	PMID:35544339
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313628	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of FBL mRNA; Rotenone results in increased expression of FBL protein	PMID:33512557|PMID:39603559
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of FBL protein	PMID:28918527
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313628	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FBL mRNA	PMID:29803840
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313628	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBL mRNA	PMID:36989763|PMID:38568856
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of FBL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBL mRNA	PMID:39836092|PMID:40512198
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313628	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBL 3' UTR	PMID:27901495
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313628	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBL promoter	PMID:27901495
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to FBL mRNA]	PMID:32406909
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313628	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FBL mRNA	PMID:20382639
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of FBL mRNA	PMID:24136188
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31767	lead diacetate	affects localization	ISO	RGD:1313628	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate affects the localization of FBL protein	PMID:10942594
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31823	mercury dichloride	affects localization	ISO	RGD:1313628	E	RGD:6480464	20120814	CTD	MESH:D008627	Mercuric Chloride affects the localization of FBL protein	PMID:10942594
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31823	mercury dichloride	affects localization	ISO	RGD:1313629	E	RGD:6480464	20120918	CTD	MESH:D008627	Mercuric Chloride affects the localization of FBL protein	PMID:10942594|PMID:12388758
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31823	mercury dichloride	decreases activity	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D008627	Mercuric Chloride results in decreased activity of FBL protein	PMID:19077085
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31823	mercury dichloride	increases cleavage	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D008627	Mercuric Chloride results in increased cleavage of FBL protein	PMID:10925315
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31823	mercury dichloride	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D008627	CD28 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IFNG protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IL4 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IL6 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]	PMID:19077085
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:32130	silver(1+) nitrate	decreases activity	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D012835	Silver Nitrate results in decreased activity of FBL protein	PMID:19077085
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:32130	silver(1+) nitrate	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D012835	CD28 protein affects the reaction [Silver Nitrate results in decreased activity of FBL protein]; IFNG protein affects the reaction [Silver Nitrate results in decreased activity of FBL protein]; IL4 protein affects the reaction [Silver Nitrate results in decreased activity of FBL protein]; IL6 protein affects the reaction [Silver Nitrate results in decreased activity of FBL protein]	PMID:19077085
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of FBL mRNA	PMID:30047161
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FBL mRNA	PMID:34492290
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313629	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of FBL mRNA	PMID:28472532
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of FBL mRNA	PMID:38479592
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313628	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of FBL mRNA; bisphenol A results in decreased expression of FBL protein	PMID:29275510|PMID:31675489|PMID:34186270
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FBL mRNA	PMID:25181051
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBL mRNA	PMID:36041667
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313628	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of FBL protein	PMID:31675489
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313629	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FBL mRNA	PMID:39298647
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBL mRNA	PMID:36041667
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313628	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of FBL protein	PMID:34186270
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBL mRNA	PMID:36041667
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313629	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FBL mRNA	PMID:37019170
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FBL mRNA	PMID:17361019
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of FBL protein	PMID:38598786
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of FBL mRNA	PMID:32680482
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313628	E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of FBL protein	PMID:34064677
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:35456	cadmium dichloride	affects localization	ISO	RGD:1313628	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride affects the localization of FBL protein	PMID:10942594
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBL mRNA	PMID:35301059
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313628	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of FBL protein	PMID:26879310
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of FBL mRNA	PMID:17585979
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1313628	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of FBL mRNA	PMID:33512557
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FBL mRNA	PMID:36331819
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of FBL mRNA	PMID:25993096
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313629	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FBL mRNA	PMID:17292431
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313628	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FBL gene	PMID:29154799
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of FBL mRNA	PMID:41580965
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313628	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of FBL mRNA	PMID:20106945|PMID:27989131
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of FBL mRNA	PMID:24136188
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313629	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBL mRNA	PMID:17562736
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of FBL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBL mRNA	PMID:39836092|PMID:40512198
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313628	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of FBL mRNA	PMID:31675489
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313628	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of FBL mRNA	PMID:18175754
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:4911	etoposide	affects localization	ISO	RGD:1313628	E	RGD:6480464	20120814	CTD	MESH:D005047	Etoposide analog affects the localization of FBL protein	PMID:10942594
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:49852	5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole	affects localization	ISO	RGD:1313628	E	RGD:6480464	20250107	CTD	MESH:D004004	Dichlororibofuranosylbenzimidazole analog affects the localization of FBL protein	PMID:10942594
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1313628	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of FBL mRNA	PMID:33512557
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313629	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FBL mRNA; Nanotubes, Carbon results in increased expression of FBL mRNA	PMID:25554681
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of FBL mRNA	PMID:30047161
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FBL mRNA	PMID:35964746
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of FBL mRNA	PMID:24136188
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313628	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of FBL protein	PMID:31629900
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:5516	sodium aurothiomalate	affects localization	ISO	RGD:1313628	E	RGD:6480464	20120814	CTD	MESH:D006052	Gold Sodium Thiomalate affects the localization of FBL protein	PMID:10942594
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:5516	sodium aurothiomalate	decreases activity	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D006052	Gold Sodium Thiomalate results in decreased activity of FBL protein	PMID:19077085
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:5516	sodium aurothiomalate	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D006052	CD28 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IFNG protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IL4 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IL6 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]	PMID:19077085
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313628	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FBL protein	PMID:32959892
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of FBL mRNA	PMID:20080153
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of FBL mRNA	PMID:24136188
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313629	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of FBL protein	PMID:26558463
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313629	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of FBL mRNA	PMID:27462272
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313628	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of FBL protein	PMID:34186270
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBL mRNA	PMID:22206623
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of FBL protein	PMID:37664457
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of FBL mRNA	PMID:24136188
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313628	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of FBL protein	PMID:31285264
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313629	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of FBL mRNA	PMID:30294300
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1313628	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of FBL protein	PMID:31675489
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of FBL mRNA	PMID:31558096
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1313628	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of FBL protein	PMID:31675489
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1313628	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of FBL mRNA	PMID:33512557
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of FBL mRNA	PMID:30047161
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of FBL protein	PMID:20553848
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of FBL protein	PMID:37664457
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of FBL mRNA	PMID:19281266
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1313628	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of FBL mRNA	PMID:33512557
1305542	Fbl	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313628	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of FBL protein	PMID:38598786
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CDK14 mRNA	PMID:33045310
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CDK14 mRNA	PMID:30071829
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313633	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CDK14 mRNA	PMID:20188158
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK14 mRNA	PMID:20938992
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CDK14 mRNA	PMID:21934132
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313632	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CDK14 mRNA	PMID:33167477
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDK14 mRNA	PMID:30529165
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CDK14 gene	PMID:28931070
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CDK14 mRNA	PMID:30319688
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313632	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CDK14 mRNA	PMID:30165855
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CDK14 mRNA	PMID:38568856
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK14 mRNA	PMID:20938992
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313632	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDK14 mRNA	PMID:37042841
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313633	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in increased expression of CDK14 mRNA	PMID:37084897
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1313633	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of CDK14 mRNA	PMID:34673133
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CDK14 mRNA	PMID:23649840
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDK14 mRNA	PMID:37992649
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDK14 mRNA	PMID:37992649
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CDK14 mRNA	PMID:33754040
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CDK14 mRNA	PMID:33387578
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:181932	3-Nitrobenzanthrone	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in decreased expression of CDK14 mRNA	PMID:34036453
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313632	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CDK14 protein	PMID:20106945
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CDK14 mRNA	PMID:22100608
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313632	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CDK14 gene	PMID:27153756
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of CDK14 mRNA	PMID:15651846
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1313633	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of CDK14 mRNA	PMID:18579281
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313632	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CDK14 mRNA	PMID:35430440
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of CDK14 mRNA	PMID:17484886
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK14 mRNA	PMID:20938992
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1313633	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of CDK14 mRNA	PMID:28960355
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of CDK14 mRNA	PMID:22023808
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313632	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CDK14 mRNA	PMID:27392435
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313633	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDK14 mRNA	PMID:24680724
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDK14 mRNA	PMID:32109520|PMID:33387578
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK14 mRNA	PMID:17942748
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CDK14 mRNA	PMID:33212167
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CDK14 mRNA	PMID:28959563
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDK14 mRNA	PMID:37992649
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313632	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CDK14 protein	PMID:35688186
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDK14 mRNA	PMID:34032870
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313632	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CDK14 3' UTR; Benzo(a)pyrene affects the methylation of CDK14 intron; Benzo(a)pyrene affects the methylation of CDK14 promoter	PMID:27901495|PMID:30157460
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDK14 mRNA	PMID:20064835|PMID:20106945|PMID:22316170
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDK14 mRNA	PMID:15894712|PMID:21569818
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313632	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDK14 exon	PMID:27901495
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:D001564	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of CDK14 mRNA	PMID:15894712
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of CDK14 mRNA	PMID:15894712
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313632	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CDK14 mRNA]	PMID:32406909
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:C015001	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of CDK14 mRNA	PMID:15894712
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of CDK14 mRNA	PMID:27188386
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1313632	E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CDK14 mRNA	PMID:27188386
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of CDK14 mRNA	PMID:25729387
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313633	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDK14 gene	PMID:35295148
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313633	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CDK14 mRNA	PMID:35295148
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of CDK14 mRNA	PMID:19167457
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313632	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CDK14 gene	PMID:31601247
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDK14 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of CDK14 mRNA	PMID:32145629
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313633	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of CDK14 mRNA	PMID:35598803
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313633	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CDK14 gene	PMID:31683443
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313632	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDK14 mRNA	PMID:28628672
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1313632	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of CDK14 intron	PMID:30157460
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313633	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CDK14 mRNA	PMID:37019170
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313632	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDK14 mRNA	PMID:28628672
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of CDK14 gene	PMID:33148267
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CDK14 mRNA	PMID:30589522
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CDK14 mRNA	PMID:33453195
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CDK14 mRNA	PMID:24449571
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CDK14 mRNA	PMID:40194260
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CDK14 mRNA	PMID:40419075
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of CDK14 mRNA	PMID:22110744
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313632	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDK14 mRNA	PMID:25979313
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDK14 mRNA	PMID:26272509
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313632	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CDK14 gene	PMID:29154799
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of CDK14 mRNA	PMID:38685447
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of CDK14 mRNA	PMID:22147139|PMID:27989131
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313632	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CDK14 promoter	PMID:27989131
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313632	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDK14 mRNA	PMID:28628672
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CDK14 mRNA	PMID:28973697
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDK14 mRNA	PMID:37992649
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of CDK14 mRNA	PMID:27188386
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CDK14 mRNA	PMID:26272509
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDK14 mRNA	PMID:21420995
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CDK14 mRNA	PMID:29279043
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CDK14 mRNA	PMID:29391264
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313633	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CDK14 mRNA	PMID:35436446
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CDK14 mRNA	PMID:17942748
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK14 mRNA	PMID:17942748
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CDK14 mRNA	PMID:32234424
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1313632	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of CDK14 mRNA	PMID:23228038
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313632	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDK14 mRNA	PMID:28628672
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CDK14 mRNA	PMID:25554681
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in decreased expression of CDK14 mRNA	PMID:22504374
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of CDK14 mRNA	PMID:21983209
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of CDK14 mRNA	PMID:26377693
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1313632	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of CDK14 mRNA	PMID:26705709
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of CDK14 mRNA	PMID:22714537
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of CDK14 mRNA	PMID:20080153
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of CDK14 mRNA	PMID:25729387
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1313632	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of CDK14 intron	PMID:30157460
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CDK14 gene	PMID:35440735
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of CDK14 gene	PMID:33148267
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CDK14 mRNA	PMID:31758290
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:73295	WIN 55212-2	increases expression	ISO	RGD:1313633	E	RGD:6480464	20170303	CTD	MESH:C070417	(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in increased expression of CDK14 mRNA	PMID:12237329
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CDK14 mRNA	PMID:22714537
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1313633	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of CDK14 mRNA	PMID:37699712
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:7719	ochratoxin A	decreases acetylation	ISO	RGD:1313632	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of CDK14 promoter	PMID:29098329
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313632	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of CDK14 mRNA	PMID:29098329
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1313632	E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of CDK14 promoter] which results in decreased expression of CDK14 mRNA	PMID:29098329
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313632	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CDK14 gene]	PMID:28238834
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CDK14 mRNA	PMID:32109520
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313633	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CDK14 mRNA	PMID:38648751
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CDK14 mRNA	PMID:23914054
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CDK14 mRNA	PMID:22504374
1305544	Cdk14	cyclin-dependent kinase 14	gene	CHEBI:9546	thimerosal	affects expression	ISO	RGD:1313632	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal affects the expression of CDK14 mRNA	PMID:27188386
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313635	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of METAP1 mRNA	PMID:20188158
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313634	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of METAP1 mRNA	PMID:33167477
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313634	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of METAP1 mRNA	PMID:29432896
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313635	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of METAP1 mRNA	PMID:39241906
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313635	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of METAP1 mRNA	PMID:27462272
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313634	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of METAP1 mRNA	PMID:23649840
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313635	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of METAP1 mRNA]	PMID:22206623
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313634	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of METAP1 mRNA	PMID:22574217
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313635	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of METAP1 mRNA	PMID:21570461
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313634	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of METAP1 protein	PMID:39603559
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313634	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of METAP1 mRNA	PMID:33212167
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313634	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of METAP1 protein	PMID:33212167
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1313634	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of METAP1 mRNA	PMID:39709020
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313634	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of METAP1 mRNA	PMID:29803840
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313634	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of METAP1 mRNA	PMID:20044591
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313634	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of METAP1 mRNA; sodium arsenite results in decreased expression of METAP1 protein	PMID:30528433|PMID:38568856
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313634	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite inhibits the reaction [METAP1 protein binds to Ribonucleotides]	PMID:30528433
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313634	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of METAP1 promoter	PMID:27901495
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313635	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of METAP1 protein	PMID:37955338
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1313635	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of METAP1 protein	PMID:40770094
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1313635	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of METAP1 protein	PMID:40770094
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313634	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to METAP1 protein]	PMID:26598702
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of METAP1 mRNA	PMID:30047161
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313635	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of METAP1 promoter	PMID:35295148
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313635	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of METAP1 mRNA	PMID:18648102
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313635	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of METAP1 mRNA	PMID:23811191
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313635	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of METAP1 mRNA	PMID:33221593
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of METAP1 mRNA	PMID:25181051|PMID:34947998
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313634	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of METAP1 protein	PMID:34186270
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313635	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of METAP1 mRNA	PMID:39298647
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313634	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of METAP1 mRNA	PMID:37042841
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313634	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of METAP1 mRNA	PMID:38568856
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of METAP1 gene	PMID:22079235
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of METAP1 mRNA	PMID:30047161
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313634	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of METAP1 mRNA	PMID:19320972
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313634	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of METAP1 mRNA	PMID:25979313
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313634	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of METAP1 gene	PMID:29154799
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of METAP1 mRNA	PMID:30047161
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1313634	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of METAP1 promoter	PMID:27989131
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313635	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of METAP1 mRNA	PMID:17562736
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:48635	fumagillin	decreases activity	ISO	RGD:1313634	E	RGD:6480464	20120814	CTD	MESH:C026211	fumagillin results in decreased activity of METAP1 protein	PMID:14534293
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:48635	fumagillin	multiple interactions	ISO	RGD:1313634	E	RGD:6480464	20120814	CTD	MESH:C026211	[fumagillin results in decreased activity of [METAP1 protein co-treated with METAP2 protein]] which results in decreased metabolism of YWHAG protein	PMID:14534293
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313634	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to METAP1 protein]	PMID:26598702
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of METAP1 mRNA	PMID:30307764
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313635	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of METAP1 mRNA; Nanotubes, Carbon results in increased expression of METAP1 mRNA	PMID:25554681
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of METAP1 mRNA	PMID:23962444
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of METAP1 mRNA	PMID:30047161
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of METAP1 mRNA	PMID:24136188
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313634	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of METAP1 protein	PMID:34186270
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313635	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of METAP1 mRNA	PMID:22206623
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313635	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of METAP1 mRNA]	PMID:22206623
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313634	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of METAP1 protein	PMID:37664457
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313634	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to METAP1 gene]	PMID:28238834
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of METAP1 mRNA	PMID:30047161
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313634	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of METAP1 protein	PMID:37664457
1305545	Metap1	methionyl aminopeptidase 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of METAP1 mRNA	PMID:19015723
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:15368	acrolein	decreases expression	ISO	RGD:1313636	E	RGD:6480464	20160412	CTD	MESH:D000171	Acrolein results in decreased expression of ANAPC2 mRNA	PMID:26719373
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313637	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ANAPC2 mRNA	PMID:30319688
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ANAPC2 mRNA	PMID:39241906
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313637	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ANAPC2 mRNA	PMID:39298647
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313636	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ANAPC2 protein	PMID:37730182
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ANAPC2 mRNA	PMID:22061828
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1313636	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of ANAPC2 intron	PMID:30157460
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313636	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANAPC2 intron	PMID:30157460
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ANAPC2 mRNA	PMID:22206623
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANAPC2 mRNA	PMID:40504410
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313636	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ANAPC2 mRNA	PMID:19244175
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313636	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ANAPC2 protein	PMID:35688186
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313636	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of ANAPC2 mRNA	PMID:19921347
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313637	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANAPC2 mRNA	PMID:21570461
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313636	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ANAPC2 mRNA	PMID:33212167
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313636	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ANAPC2 mRNA	PMID:30911355
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ANAPC2 mRNA	PMID:27862939
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313636	E	RGD:6480464	20120814	CTD	MESH:D004317	Doxorubicin promotes the reaction [CCAR1 protein binds to ANAPC2 protein]	PMID:21903591
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313636	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ANAPC2 protein	PMID:35688186
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANAPC2 mRNA	PMID:16014739
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313636	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ANAPC2 mRNA	PMID:39719251
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANAPC2 mRNA	PMID:40504410
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313636	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ANAPC2 mRNA	PMID:30911355
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:3016	Benoxacor	increases expression	ISO	RGD:1313637	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in increased expression of ANAPC2 mRNA	PMID:34850242
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1313636	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ANAPC2 gene	PMID:31601247
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313636	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ANAPC2 gene	PMID:31601247
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313637	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ANAPC2 gene	PMID:35295148
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ANAPC2 mRNA	PMID:18648102
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313636	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A affects the expression of ANAPC2 mRNA	PMID:35628146
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ANAPC2 mRNA	PMID:25181051|PMID:30816183
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313637	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ANAPC2 gene	PMID:31683443
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313637	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ANAPC2 mRNA	PMID:39298647
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313636	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ANAPC2 intron	PMID:30157460
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313636	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ANAPC2 gene	PMID:31601247
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ANAPC2 mRNA	PMID:34813904
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ANAPC2 mRNA	PMID:34813904
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:34892	nocodazole	multiple interactions	ISO	RGD:1313636	E	RGD:6480464	20120814	CTD	MESH:D015739	Nocodazole promotes the reaction [CCAR1 protein binds to ANAPC2 protein]	PMID:21903591
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313636	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANAPC2 mRNA	PMID:37042841
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313636	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ANAPC2 mRNA	PMID:19376846
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313636	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ANAPC2 mRNA	PMID:19244175
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313636	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ANAPC2 mRNA	PMID:31533062
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313636	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ANAPC2 gene	PMID:29154799
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ANAPC2 mRNA	PMID:33387578
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANAPC2 mRNA	PMID:40504410
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:4744	Echimidine	multiple interactions	ISO	RGD:1313636	E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of ANAPC2 mRNA	PMID:33884520
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ANAPC2 mRNA	PMID:24136188
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ANAPC2 mRNA	PMID:35964746
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313636	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ANAPC2 protein	PMID:32959892
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:6382	Lasiocarpine	multiple interactions	ISO	RGD:1313636	E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ANAPC2 mRNA	PMID:33884520
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313636	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ANAPC2 intron	PMID:30157460
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1313636	E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of ANAPC2 mRNA	PMID:33884520
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313637	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ANAPC2 mRNA	PMID:22206623
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ANAPC2 mRNA	PMID:22206623
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of ANAPC2 mRNA	PMID:22538082
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1313637	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of ANAPC2 protein	PMID:35357534
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ANAPC2 mRNA	PMID:21346803
1305546	Anapc2	anaphase promoting complex subunit 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ANAPC2 mRNA	PMID:21346803
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606257	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of INTS2 mRNA	PMID:33167477
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1606257	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of INTS2 mRNA	PMID:20044591|PMID:21179406
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313638	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of INTS2 mRNA	PMID:39241906
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1313638	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of INTS2 mRNA	PMID:18978301
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606257	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of INTS2 mRNA	PMID:37042841
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1606257	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of INTS2 mRNA	PMID:21179406
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606257	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of INTS2 mRNA	PMID:39836092
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313638	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of INTS2 mRNA	PMID:37236586
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606257	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of INTS2 mRNA	PMID:19549813
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1606257	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of INTS2 protein	PMID:20106945
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313638	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of INTS2 mRNA	PMID:19770486
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1606257	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of INTS2 gene; Aflatoxin B1 results in increased methylation of INTS2 intron	PMID:27153756|PMID:30157460
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1606257	E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in increased expression of INTS2 mRNA	PMID:28652203
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313638	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of INTS2 mRNA	PMID:34911549
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606257	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of INTS2 mRNA	PMID:41430723
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of INTS2 mRNA	PMID:30779732
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of INTS2 mRNA	PMID:31150632
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313638	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of INTS2 mRNA	PMID:27339419|PMID:31919559
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313638	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of INTS2 protein	PMID:25505154
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606257	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of INTS2 mRNA	PMID:23557933
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1606257	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of INTS2 mRNA	PMID:27594783
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313638	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of INTS2 mRNA	PMID:19465110
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313638	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of INTS2 mRNA	PMID:32937126
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1606257	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of INTS2 mRNA	PMID:30851411
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of INTS2 mRNA	PMID:28959563
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1606257	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of INTS2 mRNA	PMID:32763439
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313638	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of INTS2 mRNA	PMID:39631538
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606257	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of INTS2 mRNA	PMID:29803840
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1606257	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of INTS2 mRNA	PMID:19150397
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of INTS2 mRNA	PMID:30047161
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313638	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of INTS2 gene	PMID:35295148
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of INTS2 mRNA	PMID:23411599
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of INTS2 mRNA	PMID:25181051
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313638	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of INTS2 mRNA	PMID:37894381
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of INTS2 mRNA	PMID:27571134
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606257	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of INTS2 mRNA	PMID:29275510
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1606257	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of INTS2 mRNA	PMID:25979313
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313638	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of INTS2 mRNA	PMID:39298647
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313638	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of INTS2 mRNA	PMID:28392331
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606257	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of INTS2 mRNA	PMID:37042841
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606257	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of INTS2 mRNA	PMID:39836092
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313638	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of INTS2 mRNA	PMID:37236586
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of INTS2 mRNA	PMID:25539665
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313638	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of INTS2 mRNA	PMID:17292431
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313638	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of INTS2 mRNA	PMID:21427059
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606257	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of INTS2 mRNA	PMID:23179753
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of INTS2 mRNA	PMID:30047161
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606257	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of INTS2 mRNA	PMID:20106945|PMID:25562108
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313638	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of INTS2 mRNA	PMID:17562736
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of INTS2 mRNA	PMID:30047161
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1606257	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of INTS2 mRNA	PMID:22714537
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of INTS2 mRNA	PMID:28801915
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606257	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of INTS2 mRNA	PMID:39836092
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of INTS2 mRNA	PMID:28801915
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1606257	E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in increased expression of INTS2 mRNA	PMID:29518473
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313638	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of INTS2 mRNA	PMID:22206623
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1606257	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of INTS2 mRNA	PMID:30851411
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606257	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to INTS2 gene]	PMID:28238834
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:80025	Salinomycin	decreases expression	ISO	RGD:1606257	E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of INTS2 mRNA	PMID:19682730
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of INTS2 mRNA	PMID:30047161
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313638	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of INTS2 mRNA	PMID:32835833
1305547	Ints2	integrator complex subunit 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of INTS2 mRNA	PMID:23034163
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552231	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of STAC2 mRNA	PMID:37995155
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1313639	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of STAC2 mRNA	PMID:34925699
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552231	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of STAC2 mRNA	PMID:20188158
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STAC2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAC2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of STAC2 gene	PMID:20938992
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1552231	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of STAC2 mRNA	PMID:36189433
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STAC2 mRNA	PMID:36189433
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313639	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of STAC2 mRNA	PMID:26079696
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552231	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of STAC2 mRNA	PMID:30319688
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552231	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of STAC2 mRNA	PMID:30319688
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313639	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of STAC2 mRNA	PMID:35811015
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STAC2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAC2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of STAC2 gene	PMID:20938992
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313639	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of STAC2 mRNA	PMID:26079696
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA	PMID:37567420
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STAC2 mRNA	PMID:36189433
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA	PMID:37567420
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of STAC2 mRNA	PMID:33387578
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313639	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of STAC2 mRNA	PMID:24376830
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313639	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of STAC2 mRNA	PMID:19549813
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of STAC2 mRNA	PMID:22100608|PMID:32234424
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:2666	amitriptyline	increases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D000639	Amitriptyline results in increased expression of STAC2 mRNA	PMID:22341215
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of STAC2 mRNA	PMID:30723492
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STAC2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAC2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of STAC2 gene	PMID:20938992
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552231	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of STAC2 mRNA	PMID:28189721|PMID:28960355
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313639	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of STAC2 promoter	PMID:22847954
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of STAC2 mRNA	PMID:25583101
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STAC2 mRNA	PMID:33387578
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313639	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of STAC2 mRNA	PMID:29955902
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA	PMID:37567420
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313639	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of STAC2 mRNA	PMID:22378314
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313639	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STAC2 promoter	PMID:27901495
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of STAC2 mRNA	PMID:25895662
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552231	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of STAC2 mRNA	PMID:29203145|PMID:38811393
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of STAC2 mRNA	PMID:37690743
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of STAC2 mRNA	PMID:38568856
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552231	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STAC2 gene	PMID:35295148
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552231	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of STAC2 gene	PMID:35295148
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of STAC2 mRNA	PMID:19167457
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of STAC2 mRNA	PMID:34947998
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of STAC2 mRNA	PMID:25181051
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552231	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of STAC2 mRNA	PMID:32156529
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of STAC2 mRNA	PMID:32680482
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of STAC2 mRNA	PMID:30723492
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of STAC2 mRNA	PMID:35163327
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1552231	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of STAC2 mRNA	PMID:28962523
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313639	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of STAC2 promoter	PMID:22847954
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313639	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of STAC2 promoter	PMID:22847954
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1313639	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of STAC2 mRNA	PMID:31626844
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of STAC2 mRNA	PMID:40419075
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552231	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of STAC2 mRNA	PMID:21427059
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA	PMID:37567420
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of STAC2 mRNA	PMID:38832940
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of STAC2 mRNA	PMID:29067470
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STAC2 mRNA	PMID:33387578
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313639	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of STAC2 mRNA	PMID:35811015
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of STAC2 mRNA	PMID:31838189
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of STAC2 mRNA	PMID:38568856
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552231	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of STAC2 mRNA; Nanotubes, Carbon results in increased expression of STAC2 mRNA	PMID:25554681
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of STAC2 mRNA	PMID:35964746
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552231	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of STAC2 mRNA	PMID:38701926
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STAC2 mRNA	PMID:26378955
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313639	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of STAC2 mRNA	PMID:24810058
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA	PMID:37567420
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1313639	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of STAC2 mRNA	PMID:36318118
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of STAC2 mRNA	PMID:19084549
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313639	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of STAC2 mRNA	PMID:26079696
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1552231	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of STAC2 mRNA	PMID:39847705
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of STAC2 mRNA	PMID:24780913
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of STAC2 mRNA	PMID:19281266
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313639	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of STAC2 mRNA	PMID:38568856
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of STAC2 mRNA	PMID:19015723
1305548	Stac2	SH3 and cysteine rich domain 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of STAC2 mRNA	PMID:22615374
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of MS4A7 mRNA	PMID:25152437
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of MS4A7 mRNA	PMID:21551480
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552232	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MS4A7 mRNA	PMID:37995155
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A7 mRNA	PMID:20938992
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of MS4A7 mRNA	PMID:24205000
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MS4A7 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MS4A7 mRNA	PMID:33729688
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552232	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of MS4A7 mRNA	PMID:19484750
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A7 mRNA	PMID:32741896
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MS4A7 mRNA	PMID:33387578
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A7 mRNA	PMID:20938992
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313641	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of MS4A7 mRNA	PMID:26079696
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA	PMID:37992649
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1552232	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of MS4A7 mRNA	PMID:33848595
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A7 mRNA	PMID:32741896
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of MS4A7 mRNA]	PMID:33848595
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA	PMID:37992649
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313641	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of MS4A7 mRNA	PMID:26485663
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D007501	Iron deficiency results in increased expression of MS4A7 mRNA	PMID:16629162
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:194147	aristolochic acids	increases expression	EXP		E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in increased expression of MS4A7 mRNA	PMID:21834575
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313641	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MS4A7 mRNA	PMID:23649840
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313641	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MS4A7 gene	PMID:27153756
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313641	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MS4A7 mRNA	PMID:23649840
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MS4A7 mRNA	PMID:34911549
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552232	E	RGD:6480464	20181016	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MS4A7 mRNA	PMID:29987408|PMID:31919559
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A7 mRNA	PMID:20938992
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MS4A7 mRNA	PMID:40504410
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]	PMID:37992649
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MS4A7 mRNA	PMID:28960355
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MS4A7 mRNA	PMID:31881176
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313641	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of MS4A7 mRNA	PMID:23195993
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313641	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MS4A7 mRNA	PMID:24768652|PMID:25583101
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MS4A7 mRNA	PMID:34747641
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552232	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MS4A7 mRNA	PMID:21570461|PMID:26377647
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MS4A7 mRNA	PMID:26232522|PMID:32109520
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of MS4A7 mRNA	PMID:39631538
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA	PMID:37992649
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]	PMID:37992649
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MS4A7 mRNA	PMID:40504410
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313641	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MS4A7 mRNA	PMID:20064835
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552232	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MS4A7 mRNA	PMID:22228805|PMID:23735875
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313641	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MS4A7 promoter	PMID:27901495
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MS4A7 mRNA]	PMID:22228805
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552232	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MS4A7 mRNA	PMID:29341224|PMID:38811393
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of MS4A7 mRNA	PMID:25729387
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of MS4A7 mRNA	PMID:25729387
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of MS4A7 mRNA	PMID:29264374
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of MS4A7 mRNA	PMID:30012374
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552232	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MS4A7 mRNA	PMID:19464567|PMID:21259345|PMID:23557971|PMID:27760801
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552232	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MS4A7 mRNA	PMID:23811191
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MS4A7 mRNA	PMID:25181051
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of MS4A7 mRNA	PMID:25594700
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MS4A7 mRNA	PMID:28300664
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1552232	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MS4A7 mRNA	PMID:26682919
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MS4A7 mRNA	PMID:32119087
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1313641	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to MS4A7 promoter]	PMID:20348232
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552232	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MS4A7 mRNA	PMID:26377693
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:34709	Diisodecyl phthalate	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in decreased expression of MS4A7 mRNA	PMID:25270620
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1313641	E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of MS4A7 mRNA	PMID:17374397
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of MS4A7 mRNA	PMID:27387713
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313641	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MS4A7 mRNA	PMID:24449571
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MS4A7 mRNA	PMID:28973697
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA	PMID:37992649
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313641	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of MS4A7 mRNA	PMID:23649840
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552232	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MS4A7 mRNA	PMID:17562736
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MS4A7 mRNA	PMID:33387578
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MS4A7 mRNA	PMID:40504410
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:4917	eugenol	increases expression	ISO	RGD:1313641	E	RGD:6480464	20120515	CTD	MESH:D005054	Eugenol results in increased expression of MS4A7 mRNA	PMID:17374397
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of MS4A7 mRNA	PMID:30307764
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552232	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MS4A7 mRNA; Nanotubes, Carbon results in increased expression of MS4A7 mRNA	PMID:25554681
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313641	E	RGD:6480464	20120515	CTD	MESH:C029938	nickel sulfate results in increased expression of MS4A7 mRNA	PMID:16780908|PMID:17374397
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MS4A7 mRNA	PMID:38701926
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:63613	nevirapine	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D019829	Nevirapine results in decreased expression of MS4A7 mRNA	PMID:23947594
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MS4A7 mRNA	PMID:25729387
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of MS4A7 mRNA	PMID:25729387
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552232	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of MS4A7 mRNA	PMID:23650126
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1313641	E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of MS4A7 mRNA	PMID:29518473
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A7 mRNA	PMID:32741896
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313641	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MS4A7 gene]	PMID:28238834
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1552232	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MS4A7 mRNA	PMID:38648751
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:8228	pioglitazone	increases expression	ISO	RGD:1313641	E	RGD:6480464	20181113	CTD	MESH:C060836	Pioglitazone results in increased expression of MS4A7 mRNA	PMID:30031879
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of MS4A7 mRNA	PMID:16629162
1305549	Ms4a7	membrane spanning 4-domains A7	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552232	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MS4A7 mRNA	PMID:39847705
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS15 mRNA	PMID:20938992
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of EPS15 mRNA	PMID:26079696
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of EPS15 mRNA	PMID:21632981
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313642	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EPS15 mRNA	PMID:21370964
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313642	E	RGD:6480464	20161228	CTD	MESH:D008070	coenzyme Q10 inhibits the reaction [Lipopolysaccharides results in increased expression of EPS15 mRNA]	PMID:21370964
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313643	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EPS15 mRNA	PMID:39298647
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS15 mRNA	PMID:20938992
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313642	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of EPS15 mRNA	PMID:23649840
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:17574	biochanin A	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20120412	CTD	MESH:C004541	biochanin A results in decreased expression of EPS15 mRNA	PMID:12111696
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of EPS15 mRNA	PMID:27523638
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313642	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EPS15 protein	PMID:37730182
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of EPS15 mRNA	PMID:22061828|PMID:33387578
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of EPS15 protein	PMID:34915118
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313642	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of EPS15 mRNA	PMID:19549813
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313642	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EPS15 protein	PMID:23301498
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313642	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EPS15 gene	PMID:27153756
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1313642	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of EPS15 mRNA	PMID:15672453
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313643	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EPS15 mRNA	PMID:27339419
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EPS15 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS15 mRNA	PMID:20938992|PMID:22206623
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EPS15 mRNA	PMID:40504410
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313642	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of EPS15 protein	PMID:35688186
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313642	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of EPS15 mRNA	PMID:12002526
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313643	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of EPS15 mRNA	PMID:30912803
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313643	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EPS15 mRNA	PMID:21570461|PMID:24680724
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPS15 mRNA	PMID:33387578|PMID:34747641
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPS15 mRNA	PMID:12377990
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPS15 mRNA	PMID:32109520
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28177	theophylline	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in decreased expression of EPS15 mRNA	PMID:18951874
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EPS15 mRNA	PMID:33212167
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313642	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of EPS15 mRNA	PMID:32763439
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313643	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of EPS15 mRNA	PMID:32068019
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EPS15 mRNA	PMID:40504410
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313642	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EPS15 promoter	PMID:27901495
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313643	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EPS15 mRNA	PMID:22228805
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:29866	arsenite(3-)	decreases methylation	ISO	RGD:1313642	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of EPS15 promoter	PMID:23974009
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313643	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EPS15 gene; titanium dioxide results in decreased methylation of EPS15 promoter	PMID:35295148
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313643	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in increased expression of EPS15 mRNA	PMID:25270620
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of EPS15 mRNA	PMID:12419474
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of EPS15 mRNA	PMID:30816183
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of EPS15 protein	PMID:31675489|PMID:34186270
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313642	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EPS15 gene	PMID:31601247
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313643	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of EPS15 promoter	PMID:27312807
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of EPS15 mRNA	PMID:29097150|PMID:32145629
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313643	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EPS15 mRNA	PMID:33221593
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EPS15 protein	PMID:31675489
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313642	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of EPS15 mRNA	PMID:25979313
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1313642	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to EPS15 promoter]	PMID:20348232
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313643	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EPS15 mRNA	PMID:39298647
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313643	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EPS15 mRNA	PMID:37019170
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313643	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EPS15 mRNA	PMID:21266533
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EPS15 mRNA	PMID:18164116
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of EPS15 mRNA]	PMID:19030233
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313642	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EPS15 mRNA	PMID:37042841
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of EPS15 mRNA	PMID:30589522
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313642	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EPS15 mRNA	PMID:25979313
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313642	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of EPS15 mRNA	PMID:29154799
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313642	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of EPS15 mRNA	PMID:25562108
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1313642	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of EPS15 mRNA	PMID:33512557
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313643	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EPS15 mRNA	PMID:17562736
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EPS15 mRNA	PMID:33387578
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:46245	coenzyme Q10	multiple interactions	ISO	RGD:1313642	E	RGD:6480464	20161213	CTD	MESH:C024989	coenzyme Q10 inhibits the reaction [Lipopolysaccharides results in increased expression of EPS15 mRNA]	PMID:21370964
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EPS15 mRNA	PMID:40504410
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:4775	ellagic acid	increases expression	ISO	RGD:1313642	E	RGD:6480464	20120412	CTD	MESH:D004610	Ellagic Acid results in increased expression of EPS15 mRNA	PMID:12002526
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EPS15 mRNA	PMID:29097150
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:49668	gefitinib	increases expression	ISO	RGD:1313642	E	RGD:6480464	20120412	CTD	MESH:C419708	gefitinib results in increased expression of EPS15 mRNA	PMID:16685379
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EPS15 mRNA	PMID:24136188
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EPS15 protein	PMID:32959892
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EPS15 mRNA	PMID:26378955
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of EPS15 mRNA	PMID:30467583
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of EPS15 gene	PMID:35440735
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313642	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EPS15 protein	PMID:34186270
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313643	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EPS15 mRNA	PMID:22206623
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EPS15 mRNA	PMID:22206623
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EPS15 mRNA	PMID:18164116
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313642	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPS15 gene]	PMID:28238834
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313643	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of EPS15 mRNA	PMID:23091169
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313643	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of EPS15 mRNA	PMID:31388691
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of EPS15 protein	PMID:31675489
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1313642	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of EPS15 mRNA	PMID:33512557
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of EPS15 protein	PMID:28903499
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1313642	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of EPS15 protein	PMID:31675489
1305550	Eps15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EPS15 mRNA	PMID:24780913
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in decreased expression of RASSF2 mRNA	PMID:36828454
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313645	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of RASSF2 mRNA	PMID:37995155
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313645	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RASSF2 mRNA	PMID:20188158
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASSF2 gene	PMID:20938992
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RASSF2 mRNA	PMID:23724009
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of RASSF2 mRNA	PMID:16788091
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313644	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of RASSF2 mRNA	PMID:23830798|PMID:33167477
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313645	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RASSF2 mRNA	PMID:30319688
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RASSF2 mRNA	PMID:39241906
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of RASSF2 mRNA	PMID:31614463|PMID:36828454
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RASSF2 mRNA	PMID:33387578
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASSF2 gene	PMID:20938992
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313644	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of RASSF2 mRNA	PMID:19162166
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313644	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of RASSF2 mRNA	PMID:26079696
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASSF2 mRNA	PMID:37992649
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of RASSF2 mRNA	PMID:33647349
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASSF2 mRNA	PMID:37992649
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RASSF2 mRNA	PMID:34319233
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313644	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RASSF2 protein	PMID:37730182
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RASSF2 mRNA	PMID:33387578
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RASSF2 mRNA	PMID:28818685
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1313644	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of RASSF2 intron	PMID:30157460
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313644	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RASSF2 mRNA	PMID:19549813
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313644	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RASSF2 intron	PMID:30157460
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313644	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RASSF2 mRNA	PMID:22100608
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313644	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RASSF2 mRNA	PMID:26035830|PMID:41430723
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RASSF2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASSF2 gene	PMID:20938992|PMID:22206623
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASSF2 mRNA	PMID:40504410
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RASSF2 mRNA	PMID:28960355
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RASSF2 mRNA	PMID:31881176
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313644	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RASSF2 mRNA	PMID:23557933
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RASSF2 mRNA	PMID:30912803
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of RASSF2 mRNA	PMID:12075121
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313644	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RASSF2 mRNA	PMID:25583101
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313645	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASSF2 mRNA	PMID:26377647
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASSF2 mRNA	PMID:32109520|PMID:33387578
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RASSF2 mRNA	PMID:34747641
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RASSF2 promoter]	PMID:19654925
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RASSF2 mRNA	PMID:33212167
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1313644	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of RASSF2 mRNA	PMID:21198554
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASSF2 mRNA	PMID:37992649
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of RASSF2 mRNA	PMID:39515575
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313644	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RASSF2 mRNA	PMID:38568856
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASSF2 mRNA	PMID:40504410
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313644	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RASSF2 3' UTR; Benzo(a)pyrene affects the methylation of RASSF2 5' UTR	PMID:27901495
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313644	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RASSF2 mRNA; Benzo(a)pyrene results in increased expression of RASSF2 mRNA alternative form	PMID:25690898|PMID:32234424
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313644	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RASSF2 promoter	PMID:27901495
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313644	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of RASSF2 gene	PMID:25435355
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of RASSF2 mRNA	PMID:18929588
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313644	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RASSF2 mRNA]	PMID:32406909
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RASSF2 mRNA	PMID:19073995
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RASSF2 mRNA	PMID:30047161
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RASSF2 mRNA	PMID:34492290
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RASSF2 mRNA	PMID:17950772
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20120412	CTD	MESH:C006253	NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of RASSF2 mRNA]	PMID:17950772
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of RASSF2 mRNA	PMID:19191707
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RASSF2 mRNA	PMID:25181051
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of RASSF2 mRNA	PMID:36828454
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of RASSF2 mRNA	PMID:26063408
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313644	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RASSF2 gene	PMID:31601247
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of RASSF2 mRNA	PMID:12075121
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of RASSF2 mRNA	PMID:36804509
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RASSF2 mRNA	PMID:40203079
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313644	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RASSF2 intron	PMID:30157460
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313645	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RASSF2 intron	PMID:28392331
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313644	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RASSF2 mRNA	PMID:37042841
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	decreases methylation	ISO	RGD:1313645	E	RGD:6480464	20200714	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in decreased methylation of RASSF2 gene	PMID:32135139
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20200714	CTD	MESH:D013755	corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased methylation of RASSF2 gene]	PMID:32135139
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RASSF2 mRNA	PMID:31533062
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RASSF2 mRNA	PMID:40419075
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1313644	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in increased expression of RASSF2 mRNA	PMID:17198877
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of RASSF2 mRNA	PMID:28001369
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313644	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of RASSF2 mRNA	PMID:19101580|PMID:24935251|PMID:29154799
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313644	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RASSF2 gene	PMID:29154799
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RASSF2 mRNA	PMID:30047161
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of RASSF2 mRNA	PMID:27989131
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASSF2 mRNA	PMID:37992649
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313644	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RASSF2 mRNA	PMID:38832940
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of RASSF2 mRNA	PMID:26272509
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313644	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RASSF2 mRNA	PMID:24935251
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313644	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF2 mRNA	PMID:27188386
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313645	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RASSF2 mRNA	PMID:17562736
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RASSF2 mRNA	PMID:33387578
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASSF2 mRNA	PMID:40504410
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of RASSF2 mRNA	PMID:31838189
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RASSF2 mRNA	PMID:29391264
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RASSF2 mRNA	PMID:12075121
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1313644	E	RGD:6480464	20180703	CTD	MESH:D007213	Indomethacin results in increased expression of RASSF2 mRNA	PMID:24737281
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of RASSF2 mRNA	PMID:38825487
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313644	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of RASSF2 mRNA	PMID:17013896
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RASSF2 mRNA	PMID:30047161
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RASSF2 mRNA	PMID:35964746
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RASSF2 mRNA	PMID:38701926
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1313644	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of RASSF2 mRNA	PMID:20436886
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of RASSF2 mRNA	PMID:20080153
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASSF2 mRNA	PMID:21641980
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313644	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of RASSF2 mRNA	PMID:28988120
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:67895	corosolic acid	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20200714	CTD	MESH:C113861	corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased methylation of RASSF2 gene]	PMID:32135139
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313644	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RASSF2 intron	PMID:30157460
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313644	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RASSF2 mRNA	PMID:31758290
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313645	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of RASSF2 mRNA	PMID:22206623
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RASSF2 mRNA	PMID:22206623
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313644	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF2 mRNA	PMID:27188386
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313644	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RASSF2 gene]	PMID:28238834
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313644	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of RASSF2 mRNA	PMID:26079696
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RASSF2 mRNA	PMID:24780913|PMID:30047161
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313644	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF2 mRNA	PMID:27188386
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313644	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RASSF2 mRNA	PMID:29301935
1305551	Rassf2	Ras association domain family member 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of RASSF2 mRNA	PMID:17569031
1305552	Med8	mediator complex subunit 8	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313646	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MED8 mRNA	PMID:38218311
1305552	Med8	mediator complex subunit 8	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20211221	CTD	MESH:C084079	triptonide results in decreased expression of MED8 mRNA	PMID:33045310
1305552	Med8	mediator complex subunit 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614251	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MED8 mRNA	PMID:39241906
1305552	Med8	mediator complex subunit 8	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1614251	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MED8 mRNA	PMID:39298647
1305552	Med8	mediator complex subunit 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313646	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MED8 mRNA	PMID:37042841
1305552	Med8	mediator complex subunit 8	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313646	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MED8 mRNA	PMID:39836092
1305552	Med8	mediator complex subunit 8	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MED8 mRNA	PMID:23649840
1305552	Med8	mediator complex subunit 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MED8 mRNA	PMID:33387578
1305552	Med8	mediator complex subunit 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313646	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MED8 mRNA	PMID:39836092
1305552	Med8	mediator complex subunit 8	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313646	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MED8 mRNA	PMID:23557933
1305552	Med8	mediator complex subunit 8	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of MED8 mRNA	PMID:34813904
1305552	Med8	mediator complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614251	E	RGD:6480464	20211221	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MED8 mRNA	PMID:21570461|PMID:24680724
1305552	Med8	mediator complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MED8 mRNA	PMID:21215274|PMID:33387578
1305552	Med8	mediator complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MED8 mRNA	PMID:29704546
1305552	Med8	mediator complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20211221	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of MED8 mRNA]	PMID:21215274
1305552	Med8	mediator complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of MED8 mRNA	PMID:29704546
1305552	Med8	mediator complex subunit 8	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D020106	Acrylamide results in decreased expression of MED8 mRNA	PMID:32763439
1305552	Med8	mediator complex subunit 8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D004317	Doxorubicin results in decreased expression of MED8 mRNA	PMID:29803840
1305552	Med8	mediator complex subunit 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313646	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MED8 mRNA	PMID:38568856
1305552	Med8	mediator complex subunit 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313646	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MED8 mRNA	PMID:39836092
1305552	Med8	mediator complex subunit 8	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D014415	Tunicamycin results in increased expression of MED8 mRNA	PMID:22378314
1305552	Med8	mediator complex subunit 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614251	E	RGD:6480464	20211221	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MED8 mRNA	PMID:22228805
1305552	Med8	mediator complex subunit 8	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of MED8 mRNA	PMID:25895662
1305552	Med8	mediator complex subunit 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MED8 mRNA	PMID:20382639
1305552	Med8	mediator complex subunit 8	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20211221	CTD	MESH:C009495	titanium dioxide results in decreased expression of MED8 mRNA	PMID:29264374
1305552	Med8	mediator complex subunit 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614251	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MED8 gene	PMID:35295148
1305552	Med8	mediator complex subunit 8	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:C006780	bisphenol A affects the expression of MED8 mRNA	PMID:20170705
1305552	Med8	mediator complex subunit 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MED8 mRNA	PMID:33221593
1305552	Med8	mediator complex subunit 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:C006780	bisphenol A results in increased expression of MED8 mRNA	PMID:25181051
1305552	Med8	mediator complex subunit 8	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20211221	CTD	MESH:C006780	bisphenol A results in increased methylation of MED8 gene	PMID:28505145
1305552	Med8	mediator complex subunit 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1614251	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MED8 mRNA	PMID:39298647
1305552	Med8	mediator complex subunit 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20211221	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MED8 mRNA	PMID:17361019
1305552	Med8	mediator complex subunit 8	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MED8 mRNA	PMID:34813904
1305552	Med8	mediator complex subunit 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313646	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MED8 mRNA	PMID:37042841
1305552	Med8	mediator complex subunit 8	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313646	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MED8 mRNA	PMID:39836092
1305552	Med8	mediator complex subunit 8	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313646	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MED8 mRNA	PMID:38174414|PMID:38568856
1305552	Med8	mediator complex subunit 8	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:C000944	dicrotophos results in decreased expression of MED8 mRNA	PMID:28302478
1305552	Med8	mediator complex subunit 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313646	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MED8 mRNA	PMID:40419075
1305552	Med8	mediator complex subunit 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D014635	Valproic Acid affects the expression of MED8 mRNA	PMID:25979313
1305552	Med8	mediator complex subunit 8	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D014635	Valproic Acid results in increased expression of MED8 mRNA	PMID:23179753
1305552	Med8	mediator complex subunit 8	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of MED8 mRNA	PMID:17183730
1305552	Med8	mediator complex subunit 8	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D016572	Cyclosporine results in increased expression of MED8 mRNA	PMID:20106945|PMID:27989131
1305552	Med8	mediator complex subunit 8	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D000082	Acetaminophen results in decreased expression of MED8 mRNA	PMID:33387578
1305552	Med8	mediator complex subunit 8	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20211221	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MED8 mRNA	PMID:29279043
1305552	Med8	mediator complex subunit 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313646	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MED8 mRNA	PMID:39836092
1305552	Med8	mediator complex subunit 8	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D004726	Endosulfan results in increased expression of MED8 mRNA	PMID:29391264
1305552	Med8	mediator complex subunit 8	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MED8 mRNA	PMID:20170705
1305552	Med8	mediator complex subunit 8	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D005485	Flutamide results in increased expression of MED8 mRNA	PMID:24136188
1305552	Med8	mediator complex subunit 8	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of MED8 mRNA	PMID:17183730
1305552	Med8	mediator complex subunit 8	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:D015474	Isotretinoin results in decreased expression of MED8 mRNA	PMID:20436886
1305552	Med8	mediator complex subunit 8	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313646	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MED8 mRNA	PMID:39836092
1305552	Med8	mediator complex subunit 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1614251	E	RGD:6480464	20211221	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MED8 mRNA	PMID:22206623
1305552	Med8	mediator complex subunit 8	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313646	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MED8 protein	PMID:31285264
1305552	Med8	mediator complex subunit 8	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1313646	E	RGD:6480464	20211221	CTD	MESH:C004648	testosterone enanthate affects the expression of MED8 mRNA	PMID:17440010
1305552	Med8	mediator complex subunit 8	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313646	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MED8 mRNA	PMID:38568856
1305553	Telo2	telomere maintenance 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1331890	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TELO2 mRNA	PMID:33045310
1305553	Telo2	telomere maintenance 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TELO2 mRNA	PMID:25812627
1305553	Telo2	telomere maintenance 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1331890	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of TELO2 mRNA	PMID:30319688
1305553	Telo2	telomere maintenance 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1331890	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TELO2 mRNA	PMID:39241906
1305553	Telo2	telomere maintenance 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of TELO2 mRNA	PMID:16705744
1305553	Telo2	telomere maintenance 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1331890	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TELO2 mRNA	PMID:39298647
1305553	Telo2	telomere maintenance 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1605097	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TELO2 mRNA	PMID:38568856
1305553	Telo2	telomere maintenance 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605097	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TELO2 mRNA	PMID:37042841
1305553	Telo2	telomere maintenance 2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1605097	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of TELO2 gene	PMID:30521419
1305553	Telo2	telomere maintenance 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1605097	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of TELO2 protein	PMID:37730182
1305553	Telo2	telomere maintenance 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1331890	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TELO2 mRNA	PMID:36331819
1305553	Telo2	telomere maintenance 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of TELO2 mRNA	PMID:23369406
1305553	Telo2	telomere maintenance 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1605097	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of TELO2 mRNA	PMID:24376830
1305553	Telo2	telomere maintenance 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1331890	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TELO2 mRNA	PMID:37236586
1305553	Telo2	telomere maintenance 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TELO2 mRNA	PMID:30779732
1305553	Telo2	telomere maintenance 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1605097	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TELO2 gene	PMID:25304211
1305553	Telo2	telomere maintenance 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1605097	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TELO2 protein	PMID:35688186
1305553	Telo2	telomere maintenance 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1331890	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TELO2 mRNA	PMID:28960355
1305553	Telo2	telomere maintenance 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TELO2 mRNA	PMID:27392435
1305553	Telo2	telomere maintenance 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of TELO2 mRNA	PMID:16705744
1305553	Telo2	telomere maintenance 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TELO2 mRNA	PMID:21215274|PMID:32109520
1305553	Telo2	telomere maintenance 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TELO2 mRNA	PMID:33387578
1305553	Telo2	telomere maintenance 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of TELO2 protein	PMID:39603559
1305553	Telo2	telomere maintenance 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TELO2 mRNA	PMID:32763439
1305553	Telo2	telomere maintenance 2	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1605097	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of TELO2 protein	PMID:35688186
1305553	Telo2	telomere maintenance 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of TELO2 protein	PMID:38228842
1305553	Telo2	telomere maintenance 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605097	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TELO2 mRNA	PMID:34032870|PMID:38568856
1305553	Telo2	telomere maintenance 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605097	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TELO2 promoter	PMID:27901495
1305553	Telo2	telomere maintenance 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1331890	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of TELO2 mRNA	PMID:22609695
1305553	Telo2	telomere maintenance 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1605097	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of TELO2 mRNA	PMID:38568856
1305553	Telo2	telomere maintenance 2	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1605097	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of TELO2 mRNA	PMID:38568856
1305553	Telo2	telomere maintenance 2	gene	CHEBI:32063	propylparaben	increases expression	ISO	RGD:1605097	E	RGD:6480464	20240702	CTD	MESH:C006068	propylparaben results in increased expression of TELO2 mRNA	PMID:38568856
1305553	Telo2	telomere maintenance 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1331890	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TELO2 gene	PMID:35295148
1305553	Telo2	telomere maintenance 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1331890	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TELO2 mRNA	PMID:28472532
1305553	Telo2	telomere maintenance 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of TELO2 mRNA	PMID:19167457
1305553	Telo2	telomere maintenance 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TELO2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305553	Telo2	telomere maintenance 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1605097	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of TELO2 gene	PMID:31601247
1305553	Telo2	telomere maintenance 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1331890	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of TELO2 exon	PMID:33297965
1305553	Telo2	telomere maintenance 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1331890	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TELO2 mRNA	PMID:39298647
1305553	Telo2	telomere maintenance 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1605097	E	RGD:6480464	20240702	CTD	MESH:C008745	bisphenol F results in increased expression of TELO2 mRNA	PMID:38568856
1305553	Telo2	telomere maintenance 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1331890	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TELO2 mRNA	PMID:37236586
1305553	Telo2	telomere maintenance 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TELO2 mRNA	PMID:25812627
1305553	Telo2	telomere maintenance 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TELO2 mRNA	PMID:25812627
1305553	Telo2	telomere maintenance 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TELO2 mRNA	PMID:31533062
1305553	Telo2	telomere maintenance 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TELO2 mRNA	PMID:25812627
1305553	Telo2	telomere maintenance 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331890	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TELO2 mRNA	PMID:36331819
1305553	Telo2	telomere maintenance 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605097	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TELO2 mRNA	PMID:25979313
1305553	Telo2	telomere maintenance 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1605097	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TELO2 gene	PMID:29154799
1305553	Telo2	telomere maintenance 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1605097	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TELO2 gene	PMID:25304211
1305553	Telo2	telomere maintenance 2	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1605097	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of TELO2 mRNA	PMID:38568856
1305553	Telo2	telomere maintenance 2	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of TELO2 mRNA	PMID:21983209
1305553	Telo2	telomere maintenance 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TELO2 protein	PMID:32959892
1305553	Telo2	telomere maintenance 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1331890	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TELO2 mRNA	PMID:23650126
1305553	Telo2	telomere maintenance 2	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1605097	E	RGD:6480464	20201006	CTD	MESH:D008687	Metformin results in increased expression of TELO2 mRNA	PMID:32589349
1305553	Telo2	telomere maintenance 2	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1605097	E	RGD:6480464	20201006	CTD	MESH:D008687	[Metformin co-treated with Pioglitazone] results in increased expression of TELO2 mRNA	PMID:32589349
1305553	Telo2	telomere maintenance 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1331890	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TELO2 mRNA	PMID:22206623
1305553	Telo2	telomere maintenance 2	gene	CHEBI:749301	potassium perchlorate	decreases expression	ISO	RGD:1605097	E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of TELO2 mRNA	PMID:29673971
1305553	Telo2	telomere maintenance 2	gene	CHEBI:8228	pioglitazone	increases expression	ISO	RGD:1605097	E	RGD:6480464	20201006	CTD	MESH:C060836	Pioglitazone results in increased expression of TELO2 mRNA	PMID:32589349
1305553	Telo2	telomere maintenance 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1605097	E	RGD:6480464	20201006	CTD	MESH:C060836	[Metformin co-treated with Pioglitazone] results in increased expression of TELO2 mRNA	PMID:32589349
1305553	Telo2	telomere maintenance 2	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TELO2 mRNA	PMID:19281266
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1343721	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FBXL21P mRNA	PMID:26272509|PMID:27188386
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1343721	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXL21P mRNA	PMID:27188386
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FBXL21 mRNA]	PMID:31150632
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1623006	E	RGD:6480464	20141021	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FBXL21 gene	PMID:20938992
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1343721	E	RGD:6480464	20141021	CTD	MESH:D011794	Quercetin results in decreased expression of FBXL21P mRNA	PMID:21632981
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1623006	E	RGD:6480464	20141021	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FBXL21 gene	PMID:20938992
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1343721	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FBXL21 mRNA	PMID:31163220
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FBXL21 mRNA	PMID:33387578
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1343721	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of FBXL21P mRNA	PMID:28818685
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FBXL21 mRNA	PMID:33354967
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1623006	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FBXL21 mRNA	PMID:27106289
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FBXL21 mRNA	PMID:31150632
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FBXL21 mRNA]	PMID:31150632
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623006	E	RGD:6480464	20141021	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FBXL21 gene	PMID:20938992
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1623006	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of FBXL21 mRNA	PMID:28960355
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1343721	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of FBXL21P mRNA	PMID:27392435
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1343721	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of FBXL21P mRNA	PMID:27392435
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1343721	E	RGD:6480464	20141021	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXL21P mRNA	PMID:20106945|PMID:21632981
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1343721	E	RGD:6480464	20141021	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of FBXL21P mRNA	PMID:24834073
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1623006	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXL21 mRNA	PMID:37682722
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1343721	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXL21 5' UTR; Benzo(a)pyrene affects the methylation of FBXL21 promoter	PMID:27901495
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1343721	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBXL21 exon	PMID:27901495
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1623006	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBXL21 5' UTR; Benzo(a)pyrene results in increased methylation of FBXL21 exon; Benzo(a)pyrene results in increased methylation of FBXL21 intron	PMID:27901495
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1343721	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of FBXL21P gene	PMID:31601247
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1623006	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of FBXL21 mRNA	PMID:35295148
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623006	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXL21 promoter	PMID:35295148
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1343721	E	RGD:6480464	20141021	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FBXL21P mRNA	PMID:19710929
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXL21 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1623006	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of FBXL21 intron	PMID:28392331
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1623006	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of FBXL21 mRNA	PMID:28962523
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343721	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXL21P mRNA	PMID:25979313
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1343721	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXL21P mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1343721	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXL21P mRNA	PMID:27188386
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1343721	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FBXL21P mRNA	PMID:25562108|PMID:27989131
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1343721	E	RGD:6480464	20141021	CTD	MESH:C012589	trichostatin A results in increased expression of FBXL21P mRNA	PMID:24935251
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXL21 mRNA	PMID:33387578
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1343721	E	RGD:6480464	20141021	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXL21P mRNA	PMID:22230336
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1623006	E	RGD:6480464	20141021	CTD	MESH:D011192	Potassium Dichromate affects the expression of FBXL21 mRNA	PMID:23608068
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of FBXL21 mRNA	PMID:35283115
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1343721	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXL21P mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXL21P mRNA	PMID:27188386
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1343721	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FBXL21 gene]	PMID:28238834
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1343721	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of FBXL21 mRNA	PMID:26705709
1305555	Fbxl21	F-box and leucine-rich repeat protein 21	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1343721	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXL21P mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXL21P mRNA	PMID:27188386
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313651	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NELFA mRNA	PMID:38218311
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313651	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NELFA mRNA	PMID:38218311
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NELFA gene	PMID:20938992
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NELFA mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NELFA mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NELFA mRNA	PMID:32699268|PMID:32845096
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313652	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of NELFA mRNA	PMID:30319688
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NELFA gene	PMID:20938992
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313651	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NELFA mRNA	PMID:37042841
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313651	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NELFA protein	PMID:37730182
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NELFA mRNA	PMID:22061828
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313651	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of NELFA intron	PMID:30157460
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313652	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of NELFA mRNA	PMID:24067728
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313651	E	RGD:6480464	20141111	CTD	MESH:D002104	Cadmium results in increased expression of NELFA mRNA	PMID:24376830
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NELFA protein	PMID:23301498
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313651	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NELFA intron	PMID:30157460
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NELFA mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NELFA mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NELFA mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of NELFA mRNA	PMID:32699268|PMID:32845096
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NELFA gene	PMID:20938992
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313651	E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of NELFA gene	PMID:25304211
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313651	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NELFA mRNA	PMID:19244175
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of NELFA mRNA	PMID:19244175
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313651	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of NELFA protein	PMID:35688186
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of NELFA mRNA	PMID:23557933
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313652	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NELFA mRNA	PMID:21570461
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NELFA mRNA	PMID:33387578
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NELFA mRNA	PMID:17942748
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of NELFA mRNA	PMID:19013527
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313651	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of NELFA protein	PMID:35688186
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313651	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NELFA intron	PMID:30157460
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313651	E	RGD:6480464	20240702	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NELFA promoter	PMID:27901495
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NELFA gene	PMID:31601247
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313652	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of NELFA mRNA	PMID:21829687
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313652	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of NELFA mRNA	PMID:29264374
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313652	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NELFA gene; titanium dioxide results in decreased methylation of NELFA promoter	PMID:35295148
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313651	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NELFA protein	PMID:33376534
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in increased expression of NELFA mRNA	PMID:25181051
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NELFA gene; [ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of NELFA protein]; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NELFA mRNA	PMID:28628672|PMID:31601247|PMID:33376534
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of NELFA mRNA	PMID:19244175
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313652	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NELFA mRNA	PMID:39298647
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313651	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of NELFA intron	PMID:30157460
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313652	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NELFA mRNA	PMID:37019170
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NELFA mRNA	PMID:21266533
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NELFA mRNA	PMID:28628672
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313651	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of NELFA mRNA	PMID:24449571
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NELFA mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NELFA mRNA	PMID:32699268
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313651	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NELFA mRNA	PMID:19244175
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of NELFA mRNA	PMID:19244175
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313651	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NELFA mRNA	PMID:31533062
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313651	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NELFA mRNA	PMID:25979313
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313651	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NELFA gene	PMID:29154799
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313651	E	RGD:6480464	20160210	CTD	MESH:D016572	Cyclosporine results in increased expression of NELFA mRNA	PMID:25562108
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313651	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of NELFA mRNA	PMID:16144937
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NELFA mRNA	PMID:28628672
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313652	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of NELFA mRNA	PMID:18502557
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313651	E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of NELFA gene	PMID:25304211
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:47344	alvocidib	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20170303	CTD	MESH:C077990	alvocidib inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to IFIT1 promoter]]; alvocidib inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to ISG15 promoter]]; alvocidib inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to MX1 promoter]]	PMID:23589332
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313651	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of NELFA mRNA	PMID:18175754
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313652	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NELFA mRNA	PMID:17942748
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NELFA mRNA	PMID:17942748
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313651	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NELFA mRNA	PMID:28628672
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:49852	5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20250107	CTD	MESH:D004004	Dichlororibofuranosylbenzimidazole inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to IFIT1 promoter]]; Dichlororibofuranosylbenzimidazole inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to ISG15 promoter]]; Dichlororibofuranosylbenzimidazole inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to MX1 promoter]]	PMID:23589332
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313651	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NELFA protein	PMID:32959892
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313651	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of NELFA intron	PMID:30157460
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313652	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of NELFA mRNA	PMID:19270015
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:8107	phenytoin	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in decreased expression of NELFA mRNA	PMID:20345932
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:81543	Tributyltin oxide	increases phosphorylation	ISO	RGD:1313652	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased phosphorylation of NELFA protein	PMID:22174045
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NELFA mRNA	PMID:19281266
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NELFA mRNA	PMID:21346803
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313651	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of NELFA mRNA	PMID:29301935
1305556	Nelfa	negative elongation factor complex member A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NELFA mRNA	PMID:21346803
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313654	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TMEM59L mRNA	PMID:33045310
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313654	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TMEM59L mRNA	PMID:20188158
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM59L mRNA	PMID:20488242
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313654	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM59L mRNA	PMID:36189433
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313654	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM59L mRNA	PMID:36189433
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313653	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of TMEM59L mRNA	PMID:22378314
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313654	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TMEM59L mRNA	PMID:30319688
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM59L mRNA	PMID:33387578
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313654	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM59L mRNA	PMID:36189433
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1313653	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of TMEM59L mRNA	PMID:17103032
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313654	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM59L mRNA	PMID:37325564
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313653	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TMEM59L mRNA	PMID:21867686
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313653	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM59L gene	PMID:25304211
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313653	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TMEM59L mRNA	PMID:28903495
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313653	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of TMEM59L promoter	PMID:22847954
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313654	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM59L mRNA	PMID:21570461
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313654	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TMEM59L promoter]	PMID:19654925
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313653	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM59L mRNA	PMID:32763439
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313653	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMEM59L promoter	PMID:27901495
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313653	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMEM59L mRNA	PMID:20106945
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313653	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TMEM59L mRNA	PMID:22316170
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1313653	E	RGD:6480464	20191114	CTD	MESH:C006632	TMEM59L protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TMEM59L mRNA	PMID:30047161
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313654	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM59L promoter alternative form	PMID:35295148
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313654	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TMEM59L mRNA	PMID:23557971
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TMEM59L mRNA	PMID:25181051
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM59L mRNA	PMID:34947998
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313654	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TMEM59L mRNA	PMID:37019170
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of TMEM59L mRNA	PMID:32680482
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313653	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of TMEM59L mRNA	PMID:29024780
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TMEM59L mRNA	PMID:30723492
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313653	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMEM59L mRNA	PMID:38382870
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313654	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM59L mRNA	PMID:37325564
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TMEM59L mRNA	PMID:30047161
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313653	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of TMEM59L promoter	PMID:22847954
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313653	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TMEM59L mRNA	PMID:31533062
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313653	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of TMEM59L promoter	PMID:22847954
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313653	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM59L mRNA	PMID:28001369
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TMEM59L mRNA	PMID:30047161
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1313653	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of TMEM59L mRNA	PMID:16595896
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313653	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TMEM59L mRNA	PMID:28542535
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313654	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMEM59L mRNA	PMID:17562736
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313653	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM59L mRNA	PMID:22230336
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313653	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM59L gene	PMID:25304211
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1313653	E	RGD:6480464	20191114	CTD	MESH:C032793	TMEM59L protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TMEM59L mRNA	PMID:30307764
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TMEM59L mRNA	PMID:30047161
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of TMEM59L mRNA	PMID:28801915
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TMEM59L mRNA	PMID:28801915
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TMEM59L mRNA	PMID:30047161
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:88522	Monobutylphthalate	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of TMEM59L mRNA	PMID:29162477
1305557	Tmem59l	transmembrane protein 59-like	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313653	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TMEM59L mRNA	PMID:38568856
1305558	Ttk	Ttk protein kinase	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313655	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of TTK mRNA	PMID:31863870
1305558	Ttk	Ttk protein kinase	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TTK mRNA	PMID:38218311
1305558	Ttk	Ttk protein kinase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313656	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TTK mRNA	PMID:33045310
1305558	Ttk	Ttk protein kinase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene	PMID:20938992
1305558	Ttk	Ttk protein kinase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TTK mRNA	PMID:33167477
1305558	Ttk	Ttk protein kinase	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TTK mRNA	PMID:21632981
1305558	Ttk	Ttk protein kinase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313656	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TTK mRNA	PMID:39241906
1305558	Ttk	Ttk protein kinase	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of TTK mRNA	PMID:32145629
1305558	Ttk	Ttk protein kinase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313655	E	RGD:6480464	20130212	CTD	MESH:D004958	Estradiol results in increased expression of TTK mRNA	PMID:18310284|PMID:19167446|PMID:20106945
1305558	Ttk	Ttk protein kinase	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA	PMID:25510870
1305558	Ttk	Ttk protein kinase	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313655	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TTK mRNA	PMID:38568856
1305558	Ttk	Ttk protein kinase	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TTK mRNA	PMID:33387578
1305558	Ttk	Ttk protein kinase	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TTK gene	PMID:27618143
1305558	Ttk	Ttk protein kinase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene	PMID:20938992
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313655	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TTK mRNA	PMID:21179406
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of TTK mRNA	PMID:26079696
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA	PMID:37567420|PMID:37992649
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of TTK mRNA	PMID:21592394|PMID:33359661
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of TTK mRNA	PMID:26496021
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of TTK mRNA	PMID:21592394
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of TTK mRNA	PMID:27683099
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA	PMID:37567420|PMID:37992649
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20140408	CTD	MESH:D014527	Uric Acid results in decreased expression of TTK mRNA	PMID:23619996
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20140408	CTD	MESH:D014527	NLRP3 gene mutant form inhibits the reaction [Uric Acid results in decreased expression of TTK mRNA]	PMID:23619996
1305558	Ttk	Ttk protein kinase	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TTK mRNA	PMID:26577399
1305558	Ttk	Ttk protein kinase	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313655	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of TTK protein	PMID:37730182
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of TTK mRNA	PMID:21592394
1305558	Ttk	Ttk protein kinase	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of TTK mRNA	PMID:21592394
1305558	Ttk	Ttk protein kinase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TTK mRNA	PMID:36331819
1305558	Ttk	Ttk protein kinase	gene	CHEBI:2038	5-azacytidine	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D001374	[Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA	PMID:18720364
1305558	Ttk	Ttk protein kinase	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA	PMID:25510870
1305558	Ttk	Ttk protein kinase	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA	PMID:25510870
1305558	Ttk	Ttk protein kinase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TTK mRNA	PMID:19549813
1305558	Ttk	Ttk protein kinase	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TTK protein	PMID:20106945
1305558	Ttk	Ttk protein kinase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TTK mRNA	PMID:23630614|PMID:25378103
1305558	Ttk	Ttk protein kinase	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of TTK mRNA	PMID:25102026
1305558	Ttk	Ttk protein kinase	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of TTK mRNA	PMID:18955075
1305558	Ttk	Ttk protein kinase	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of TTK mRNA	PMID:15674844
1305558	Ttk	Ttk protein kinase	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313656	E	RGD:6480464	20150609	CTD	MESH:D010126	Ozone results in increased expression of TTK mRNA	PMID:25658374
1305558	Ttk	Ttk protein kinase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TTK mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TTK mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of TTK mRNA	PMID:25658374|PMID:27106289|PMID:34911549
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D014747	TTK protein affects the susceptibility to Vinblastine	PMID:16217747
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TTK mRNA	PMID:17484886
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313656	E	RGD:6480464	20181016	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TTK mRNA	PMID:29987408|PMID:31919559
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene	PMID:20938992
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]	PMID:37992649
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TTK mRNA	PMID:31881176
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of TTK mRNA	PMID:15767336
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313655	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in increased expression of TTK mRNA	PMID:19167446
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of TTK mRNA	PMID:19167446
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of TTK mRNA	PMID:22023808
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of TTK mRNA	PMID:21151649
1305558	Ttk	Ttk protein kinase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA]	PMID:21858171
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein affects the expression of TTK mRNA	PMID:18847459
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313655	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TTK mRNA	PMID:25583101
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313655	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTK mRNA	PMID:22298810|PMID:22574217
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313656	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTK mRNA	PMID:26377647
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTK mRNA	PMID:32109520
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TTK mRNA	PMID:34747641
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TTK mRNA	PMID:28374803
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313655	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of TTK mRNA	PMID:33512557
1305558	Ttk	Ttk protein kinase	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TTK mRNA	PMID:33212167
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TTK mRNA	PMID:32763439
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TTK mRNA	PMID:28959563
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D004317	TTK protein affects the susceptibility to Doxorubicin	PMID:16217747
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20231031	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA	PMID:37567420|PMID:37992649
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313655	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of TTK protein	PMID:35688186
1305558	Ttk	Ttk protein kinase	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]	PMID:37992649
1305558	Ttk	Ttk protein kinase	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of TTK mRNA	PMID:22623647
1305558	Ttk	Ttk protein kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTK mRNA	PMID:38568856
1305558	Ttk	Ttk protein kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTK mRNA	PMID:17998272
1305558	Ttk	Ttk protein kinase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313655	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of TTK mRNA	PMID:29301061
1305558	Ttk	Ttk protein kinase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313656	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of TTK mRNA	PMID:39515575
1305558	Ttk	Ttk protein kinase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313655	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TTK promoter	PMID:27901495
1305558	Ttk	Ttk protein kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTK mRNA	PMID:16120219|PMID:20064835|PMID:21632981
1305558	Ttk	Ttk protein kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTK mRNA	PMID:19770486
1305558	Ttk	Ttk protein kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313656	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TTK intron	PMID:27901495
1305558	Ttk	Ttk protein kinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313655	E	RGD:6480464	20210706	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTK mRNA	PMID:33411230
1305558	Ttk	Ttk protein kinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313656	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTK mRNA	PMID:32417428
1305558	Ttk	Ttk protein kinase	gene	CHEBI:30145	lithium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of TTK mRNA	PMID:21711903
1305558	Ttk	Ttk protein kinase	gene	CHEBI:30146	lithium hydride	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of TTK mRNA	PMID:21711903
1305558	Ttk	Ttk protein kinase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313656	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TTK mRNA	PMID:29341224
1305558	Ttk	Ttk protein kinase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TTK mRNA	PMID:20018196|PMID:20382639
1305558	Ttk	Ttk protein kinase	gene	CHEBI:31638	fulvestrant	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of TTK mRNA	PMID:19016759
1305558	Ttk	Ttk protein kinase	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:C070081	[fulvestrant co-treated with Sirolimus] results in decreased expression of TTK mRNA	PMID:19016759
1305558	Ttk	Ttk protein kinase	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of TTK mRNA	PMID:25729387
1305558	Ttk	Ttk protein kinase	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TTK mRNA	PMID:25729387
1305558	Ttk	Ttk protein kinase	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313656	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of TTK mRNA	PMID:17656681
1305558	Ttk	Ttk protein kinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313656	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TTK gene; titanium dioxide results in decreased methylation of TTK promoter	PMID:35295148
1305558	Ttk	Ttk protein kinase	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TTK mRNA	PMID:30012374
1305558	Ttk	Ttk protein kinase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of TTK mRNA	PMID:32145629
1305558	Ttk	Ttk protein kinase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TTK mRNA	PMID:25181051
1305558	Ttk	Ttk protein kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TTK mRNA	PMID:29275510
1305558	Ttk	Ttk protein kinase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313655	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TTK gene	PMID:31601247
1305558	Ttk	Ttk protein kinase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of TTK mRNA	PMID:26496021
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313656	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TTK mRNA	PMID:26682919
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA	PMID:25510870
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA	PMID:25510870
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of TTK mRNA	PMID:20713471
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TTK mRNA	PMID:40203079
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313656	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of TTK mRNA	PMID:33297965
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of TTK mRNA	PMID:22546817
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TTK mRNA	PMID:17361019|PMID:21266533
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of TTK mRNA	PMID:22546817
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of TTK mRNA	PMID:17854601
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of TTK mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of TTK mRNA]	PMID:17854601|PMID:24535843
1305558	Ttk	Ttk protein kinase	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of TTK mRNA	PMID:22546817
1305558	Ttk	Ttk protein kinase	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of TTK mRNA	PMID:30589522
1305558	Ttk	Ttk protein kinase	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of TTK mRNA	PMID:18500788
1305558	Ttk	Ttk protein kinase	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TTK mRNA	PMID:30723492
1305558	Ttk	Ttk protein kinase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TTK mRNA	PMID:25993096
1305558	Ttk	Ttk protein kinase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TTK mRNA	PMID:36326898
1305558	Ttk	Ttk protein kinase	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TTK mRNA	PMID:25539665
1305558	Ttk	Ttk protein kinase	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313656	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of TTK mRNA	PMID:28962523
1305558	Ttk	Ttk protein kinase	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA]	PMID:17585979
1305558	Ttk	Ttk protein kinase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TTK mRNA	PMID:32588087
1305558	Ttk	Ttk protein kinase	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1313655	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of TTK mRNA	PMID:33512557
1305558	Ttk	Ttk protein kinase	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TTK mRNA	PMID:28302478
1305558	Ttk	Ttk protein kinase	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TTK mRNA	PMID:31533062
1305558	Ttk	Ttk protein kinase	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313655	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of TTK mRNA	PMID:19167446
1305558	Ttk	Ttk protein kinase	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of TTK mRNA	PMID:19167446
1305558	Ttk	Ttk protein kinase	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TTK mRNA	PMID:39529242
1305558	Ttk	Ttk protein kinase	gene	CHEBI:3930	cryptolepine	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of TTK mRNA	PMID:16120219
1305558	Ttk	Ttk protein kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TTK mRNA	PMID:36331819
1305558	Ttk	Ttk protein kinase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TTK mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1305558	Ttk	Ttk protein kinase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of TTK mRNA	PMID:20106945|PMID:21632981
1305558	Ttk	Ttk protein kinase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA	PMID:37567420|PMID:37992649
1305558	Ttk	Ttk protein kinase	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1313655	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of TTK mRNA	PMID:33512557
1305558	Ttk	Ttk protein kinase	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of TTK mRNA	PMID:16595896
1305558	Ttk	Ttk protein kinase	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313655	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TTK mRNA	PMID:38832940
1305558	Ttk	Ttk protein kinase	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TTK mRNA	PMID:26272509
1305558	Ttk	Ttk protein kinase	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTK mRNA	PMID:27188386
1305558	Ttk	Ttk protein kinase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TTK mRNA	PMID:33387578
1305558	Ttk	Ttk protein kinase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of TTK mRNA	PMID:26690555|PMID:29067470
1305558	Ttk	Ttk protein kinase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313655	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TTK mRNA	PMID:22230336
1305558	Ttk	Ttk protein kinase	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA]	PMID:17585979
1305558	Ttk	Ttk protein kinase	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TTK mRNA	PMID:24714768
1305558	Ttk	Ttk protein kinase	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313655	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of TTK mRNA	PMID:31838189
1305558	Ttk	Ttk protein kinase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of TTK mRNA	PMID:40706910
1305558	Ttk	Ttk protein kinase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TTK mRNA	PMID:22079256
1305558	Ttk	Ttk protein kinase	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20130416	CTD	MESH:D005047	Etoposide results in decreased expression of TTK mRNA	PMID:16120219
1305558	Ttk	Ttk protein kinase	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1313656	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of TTK mRNA	PMID:25270620
1305558	Ttk	Ttk protein kinase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TTK mRNA	PMID:15585362
1305558	Ttk	Ttk protein kinase	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of TTK mRNA	PMID:21148553
1305558	Ttk	Ttk protein kinase	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313656	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TTK mRNA	PMID:19042947
1305558	Ttk	Ttk protein kinase	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313656	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TTK mRNA	PMID:38701926
1305558	Ttk	Ttk protein kinase	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of TTK mRNA	PMID:25729387
1305558	Ttk	Ttk protein kinase	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TTK mRNA	PMID:25729387
1305558	Ttk	Ttk protein kinase	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313656	E	RGD:6480464	20260113	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TTK mRNA	PMID:40930398
1305558	Ttk	Ttk protein kinase	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TTK mRNA	PMID:28988120
1305558	Ttk	Ttk protein kinase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TTK mRNA	PMID:37269647
1305558	Ttk	Ttk protein kinase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TTK mRNA	PMID:24810058
1305558	Ttk	Ttk protein kinase	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of TTK mRNA	PMID:35283115
1305558	Ttk	Ttk protein kinase	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of TTK mRNA	PMID:19564919
1305558	Ttk	Ttk protein kinase	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of TTK mRNA	PMID:19564919
1305558	Ttk	Ttk protein kinase	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TTK gene	PMID:35440735
1305558	Ttk	Ttk protein kinase	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of TTK mRNA	PMID:36519830
1305558	Ttk	Ttk protein kinase	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313655	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TTK mRNA	PMID:31758290
1305558	Ttk	Ttk protein kinase	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of TTK mRNA	PMID:19564919
1305558	Ttk	Ttk protein kinase	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TTK mRNA	PMID:22079256
1305558	Ttk	Ttk protein kinase	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TTK mRNA	PMID:22079256
1305558	Ttk	Ttk protein kinase	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of TTK mRNA	PMID:29522793
1305558	Ttk	Ttk protein kinase	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA	PMID:37567420
1305558	Ttk	Ttk protein kinase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313655	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TTK mRNA	PMID:37199045
1305558	Ttk	Ttk protein kinase	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1313655	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of TTK mRNA	PMID:16120219
1305558	Ttk	Ttk protein kinase	gene	CHEBI:76989	phytoestrogen	increases expression	ISO	RGD:1313655	E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of TTK mRNA	PMID:18310284
1305558	Ttk	Ttk protein kinase	gene	CHEBI:77012	methylseleninic acid	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of TTK mRNA	PMID:18548127
1305558	Ttk	Ttk protein kinase	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of TTK mRNA	PMID:34995734
1305558	Ttk	Ttk protein kinase	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTK mRNA	PMID:27188386
1305558	Ttk	Ttk protein kinase	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of TTK mRNA	PMID:30928695
1305558	Ttk	Ttk protein kinase	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1313655	E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in increased expression of TTK mRNA	PMID:31437187
1305558	Ttk	Ttk protein kinase	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of TTK mRNA; Irinotecan results in decreased expression of TTK mRNA	PMID:15956246
1305558	Ttk	Ttk protein kinase	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of TTK mRNA	PMID:31324951
1305558	Ttk	Ttk protein kinase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313656	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of TTK mRNA	PMID:23091169
1305558	Ttk	Ttk protein kinase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of TTK mRNA	PMID:24535843
1305558	Ttk	Ttk protein kinase	gene	CHEBI:81555	Enterolactone	increases expression	ISO	RGD:1313655	E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TTK mRNA	PMID:19167446
1305558	Ttk	Ttk protein kinase	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA	PMID:19167446
1305558	Ttk	Ttk protein kinase	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1313655	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of TTK mRNA	PMID:33512557
1305558	Ttk	Ttk protein kinase	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of TTK mRNA	PMID:32234424
1305558	Ttk	Ttk protein kinase	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of TTK mRNA	PMID:21858171
1305558	Ttk	Ttk protein kinase	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA]	PMID:21858171
1305558	Ttk	Ttk protein kinase	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1313655	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of TTK mRNA	PMID:33512557
1305558	Ttk	Ttk protein kinase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TTK mRNA	PMID:24780913
1305558	Ttk	Ttk protein kinase	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of TTK mRNA	PMID:22869556
1305558	Ttk	Ttk protein kinase	gene	CHEBI:88046	cylindrospermopsin	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20190910	CTD	MESH:C089595	cylindrospermopsin results in decreased expression of TTK mRNA	PMID:30905859
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of TTK mRNA	PMID:32419051
1305558	Ttk	Ttk protein kinase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTK mRNA	PMID:27188386
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9111	Senkirkine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of TTK mRNA	PMID:32419051
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D020123	[fulvestrant co-treated with Sirolimus] results in decreased expression of TTK mRNA	PMID:19016759
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in decreased expression of TTK mRNA	PMID:34581912
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TTK mRNA	PMID:38568856
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9513	thalidomide	multiple interactions	ISO	RGD:1313655	E	RGD:6480464	20120412	CTD	MESH:D013792	[Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA	PMID:18720364
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313655	E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in increased expression of TTK mRNA	PMID:19442820
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C001899	triptolide results in increased expression of TTK mRNA	PMID:23639586
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313655	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of TTK mRNA	PMID:19140230
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TTK mRNA	PMID:35537566
1305558	Ttk	Ttk protein kinase	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of TTK gene	PMID:31079544
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313657	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ADGRG5 mRNA	PMID:33167477
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313657	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ADGRG5 mRNA	PMID:18951874
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRG5 mRNA; [Testosterone co-treated with Estradiol] results in decreased expression of ADGRG5 mRNA	PMID:32741896
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ADGRG5 mRNA	PMID:33387578
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313657	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADGRG5 mRNA	PMID:37042841
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1550253	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ADGRG5 mRNA	PMID:39922521
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRG5 mRNA; [Testosterone co-treated with Estradiol] results in decreased expression of ADGRG5 mRNA	PMID:32741896
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1550253	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ADGRG5 mRNA	PMID:39922521
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ADGRG5 mRNA	PMID:27523638
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ADGRG5 mRNA	PMID:33354967
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313657	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ADGRG5 intron	PMID:30157460
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ADGRG5 mRNA	PMID:30779732
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ADGRG5 mRNA	PMID:31881176
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADGRG5 mRNA	PMID:32109520
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313657	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ADGRG5 mRNA	PMID:28001369
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1550253	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ADGRG5 mRNA	PMID:19465457
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ADGRG5 mRNA	PMID:28959563
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:28854	2,4-D	decreases expression	ISO	RGD:1313657	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of ADGRG5 mRNA	PMID:40294809
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313657	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADGRG5 promoter	PMID:27901495
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313657	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADGRG5 3' UTR; Benzo(a)pyrene results in increased methylation of ADGRG5 exon	PMID:27901495
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313657	E	RGD:6480464	20161115	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ADGRG5 gene	PMID:25435355
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550253	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ADGRG5 mRNA	PMID:29341224
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ADGRG5 mRNA	PMID:32479839
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADGRG5 mRNA	PMID:34492290
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRG5 mRNA	PMID:25181051
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550253	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRG5 mRNA	PMID:26063408
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1550253	E	RGD:6480464	20180515	CTD	MESH:D008748	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of ADGRG5 mRNA; [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of ADGRG5 mRNA	PMID:25926378
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313657	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADGRG5 mRNA	PMID:37042841
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1550253	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of ADGRG5 mRNA	PMID:29038090
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313657	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ADGRG5 mRNA	PMID:25979313
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313657	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of ADGRG5 mRNA	PMID:23527032
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1550253	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ADGRG5 mRNA	PMID:39922521
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550253	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ADGRG5 mRNA	PMID:25554681
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1550253	E	RGD:6480464	20180515	CTD	MESH:D037742	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of ADGRG5 mRNA; [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of ADGRG5 mRNA	PMID:25926378
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550253	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ADGRG5 mRNA	PMID:38701926
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550253	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADGRG5 mRNA	PMID:22206623
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRG5 mRNA	PMID:32741896
1305559	Adgrg5	adhesion G protein-coupled receptor G5	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313657	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ADGRG5 mRNA	PMID:29301935
1305561	Satb1	SATB homeobox 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SATB1 mRNA	PMID:26272509
1305561	Satb1	SATB homeobox 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313660	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SATB1 mRNA	PMID:27188386
1305561	Satb1	SATB homeobox 1	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1313660	E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of SATB1 mRNA	PMID:31600526
1305561	Satb1	SATB homeobox 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313660	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SATB1 mRNA	PMID:26079696
1305561	Satb1	SATB homeobox 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SATB1 mRNA	PMID:22378314
1305561	Satb1	SATB homeobox 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313661	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SATB1 mRNA	PMID:30319688
1305561	Satb1	SATB homeobox 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of SATB1 mRNA	PMID:19484750|PMID:25210133
1305561	Satb1	SATB homeobox 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SATB1 mRNA	PMID:26496021
1305561	Satb1	SATB homeobox 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313660	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SATB1 mRNA	PMID:37042841
1305561	Satb1	SATB homeobox 1	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of SATB1 mRNA	PMID:15120971
1305561	Satb1	SATB homeobox 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SATB1 mRNA	PMID:33359661
1305561	Satb1	SATB homeobox 1	gene	CHEBI:17447	geraniol	increases expression	ISO	RGD:1313660	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of SATB1 mRNA	PMID:27683099
1305561	Satb1	SATB homeobox 1	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of SATB1 mRNA	PMID:31256213
1305561	Satb1	SATB homeobox 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SATB1 mRNA	PMID:36005737
1305561	Satb1	SATB homeobox 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SATB1 mRNA	PMID:34319233
1305561	Satb1	SATB homeobox 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313660	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SATB1 protein	PMID:37730182
1305561	Satb1	SATB homeobox 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SATB1 mRNA	PMID:22061828
1305561	Satb1	SATB homeobox 1	gene	CHEBI:2208	purine-6-thiol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of SATB1 mRNA	PMID:23358152
1305561	Satb1	SATB homeobox 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313660	E	RGD:6480464	20191008	CTD	MESH:D002104	Cadmium results in increased expression of SATB1 mRNA	PMID:31082426
1305561	Satb1	SATB homeobox 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313660	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SATB1 mRNA	PMID:35301059
1305561	Satb1	SATB homeobox 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SATB1 mRNA	PMID:27153756
1305561	Satb1	SATB homeobox 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313660	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SATB1 gene	PMID:27153756
1305561	Satb1	SATB homeobox 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SATB1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SATB1 mRNA	PMID:34911549
1305561	Satb1	SATB homeobox 1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SATB1 mRNA	PMID:30779732
1305561	Satb1	SATB homeobox 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SATB1 mRNA	PMID:31150632
1305561	Satb1	SATB homeobox 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SATB1 mRNA	PMID:22206623
1305561	Satb1	SATB homeobox 1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SATB1 mRNA	PMID:19244175
1305561	Satb1	SATB homeobox 1	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of SATB1 mRNA	PMID:33512557
1305561	Satb1	SATB homeobox 1	gene	CHEBI:27690	acetazolamide	increases expression	ISO	RGD:1313661	E	RGD:6480464	20120717	CTD	MESH:D000086	Acetazolamide results in increased expression of SATB1 mRNA	PMID:19274763
1305561	Satb1	SATB homeobox 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SATB1 mRNA	PMID:31881176
1305561	Satb1	SATB homeobox 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313660	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SATB1 mRNA	PMID:28903495
1305561	Satb1	SATB homeobox 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of SATB1 mRNA	PMID:27594783
1305561	Satb1	SATB homeobox 1	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of SATB1 mRNA	PMID:18355967
1305561	Satb1	SATB homeobox 1	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D003042	FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of SATB1 mRNA]	PMID:18355967
1305561	Satb1	SATB homeobox 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SATB1 mRNA	PMID:30912803
1305561	Satb1	SATB homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313660	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SATB1 mRNA	PMID:22574217
1305561	Satb1	SATB homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313661	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SATB1 mRNA	PMID:24058054
1305561	Satb1	SATB homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SATB1 mRNA	PMID:32109520
1305561	Satb1	SATB homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SATB1 mRNA	PMID:17942748
1305561	Satb1	SATB homeobox 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of SATB1 mRNA	PMID:33512557
1305561	Satb1	SATB homeobox 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SATB1 mRNA	PMID:28001369
1305561	Satb1	SATB homeobox 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313660	E	RGD:6480464	20120717	CTD	MESH:D003300	[Thiosemicarbazones binds to Copper] which results in increased expression of SATB1 protein	PMID:20931265
1305561	Satb1	SATB homeobox 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SATB1 mRNA	PMID:29803840
1305561	Satb1	SATB homeobox 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313660	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of SATB1 gene	PMID:28589171
1305561	Satb1	SATB homeobox 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SATB1 mRNA; sodium arsenite results in decreased expression of SATB1 protein	PMID:34032870|PMID:39571964
1305561	Satb1	SATB homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313660	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SATB1 5' UTR; Benzo(a)pyrene affects the methylation of SATB1 promoter	PMID:27901495
1305561	Satb1	SATB homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SATB1 mRNA	PMID:30453624
1305561	Satb1	SATB homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SATB1 mRNA	PMID:21569818
1305561	Satb1	SATB homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313660	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SATB1 mRNA	PMID:22316170
1305561	Satb1	SATB homeobox 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313660	E	RGD:6480464	20120717	CTD	MESH:D003300	[Thiosemicarbazones binds to Copper] which results in increased expression of SATB1 protein	PMID:20931265
1305561	Satb1	SATB homeobox 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313660	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SATB1 mRNA	PMID:20382639
1305561	Satb1	SATB homeobox 1	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1313660	E	RGD:6480464	20191114	CTD	MESH:C006632	SATB1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:25317073
1305561	Satb1	SATB homeobox 1	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1313660	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of SATB1 gene	PMID:31601247
1305561	Satb1	SATB homeobox 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SATB1 mRNA	PMID:25729387
1305561	Satb1	SATB homeobox 1	gene	CHEBI:32095	retinyl acetate	increases expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:C009166	retinol acetate results in increased expression of SATB1 mRNA	PMID:16772331
1305561	Satb1	SATB homeobox 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SATB1 mRNA	PMID:30047161
1305561	Satb1	SATB homeobox 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313661	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SATB1 mRNA	PMID:23557971
1305561	Satb1	SATB homeobox 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313661	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SATB1 promoter	PMID:35295148
1305561	Satb1	SATB homeobox 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of SATB1 mRNA	PMID:18648102
1305561	Satb1	SATB homeobox 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of SATB1 mRNA	PMID:12419474
1305561	Satb1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SATB1 mRNA	PMID:25181051
1305561	Satb1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313661	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SATB1 promoter	PMID:27334623
1305561	Satb1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SATB1 mRNA	PMID:41034487
1305561	Satb1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313660	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SATB1 mRNA	PMID:29275510
1305561	Satb1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313661	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SATB1 mRNA	PMID:26063408
1305561	Satb1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SATB1 mRNA	PMID:26496021
1305561	Satb1	SATB homeobox 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SATB1 mRNA	PMID:19244175
1305561	Satb1	SATB homeobox 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313661	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SATB1 gene	PMID:31683443
1305561	Satb1	SATB homeobox 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SATB1 mRNA	PMID:37019170
1305561	Satb1	SATB homeobox 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313660	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SATB1 mRNA	PMID:37042841
1305561	Satb1	SATB homeobox 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of SATB1 mRNA	PMID:35163327
1305561	Satb1	SATB homeobox 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313660	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SATB1 mRNA	PMID:35301059
1305561	Satb1	SATB homeobox 1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SATB1 mRNA	PMID:19244175
1305561	Satb1	SATB homeobox 1	gene	CHEBI:38604	pyrimidifen	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of SATB1 mRNA	PMID:33512557
1305561	Satb1	SATB homeobox 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SATB1 mRNA	PMID:31533062
1305561	Satb1	SATB homeobox 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SATB1 mRNA	PMID:40419075
1305561	Satb1	SATB homeobox 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SATB1 mRNA	PMID:22237054
1305561	Satb1	SATB homeobox 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of SATB1 mRNA	PMID:29038090
1305561	Satb1	SATB homeobox 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of SATB1 mRNA	PMID:23125180
1305561	Satb1	SATB homeobox 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313660	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SATB1 mRNA	PMID:25979313
1305561	Satb1	SATB homeobox 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SATB1 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1305561	Satb1	SATB homeobox 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SATB1 mRNA	PMID:30047161
1305561	Satb1	SATB homeobox 1	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of SATB1 mRNA	PMID:21041162
1305561	Satb1	SATB homeobox 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SATB1 mRNA	PMID:20106945
1305561	Satb1	SATB homeobox 1	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of SATB1 mRNA	PMID:33512557
1305561	Satb1	SATB homeobox 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SATB1 mRNA	PMID:17555576
1305561	Satb1	SATB homeobox 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of SATB1 mRNA	PMID:21041162
1305561	Satb1	SATB homeobox 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of SATB1 mRNA	PMID:21041162
1305561	Satb1	SATB homeobox 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313661	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SATB1 mRNA	PMID:28973697
1305561	Satb1	SATB homeobox 1	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of SATB1 mRNA	PMID:33512557
1305561	Satb1	SATB homeobox 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SATB1 mRNA	PMID:38832940
1305561	Satb1	SATB homeobox 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SATB1 mRNA	PMID:21420995
1305561	Satb1	SATB homeobox 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313660	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of SATB1 mRNA	PMID:26690555
1305561	Satb1	SATB homeobox 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SATB1 mRNA	PMID:29279043
1305561	Satb1	SATB homeobox 1	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1313660	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of SATB1 mRNA	PMID:21148743
1305561	Satb1	SATB homeobox 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of SATB1 mRNA	PMID:31838189
1305561	Satb1	SATB homeobox 1	gene	CHEBI:47807	sulforaphane	increases methylation	ISO	RGD:1313660	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased methylation of SATB1 gene	PMID:31838189
1305561	Satb1	SATB homeobox 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313660	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SATB1 mRNA	PMID:18175754
1305561	Satb1	SATB homeobox 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SATB1 mRNA	PMID:17555576
1305561	Satb1	SATB homeobox 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SATB1 mRNA	PMID:17942748
1305561	Satb1	SATB homeobox 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SATB1 mRNA	PMID:17942748
1305561	Satb1	SATB homeobox 1	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1313660	E	RGD:6480464	20191114	CTD	MESH:C032793	SATB1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:25317073
1305561	Satb1	SATB homeobox 1	gene	CHEBI:5011	fenpyroximate	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of SATB1 mRNA	PMID:33512557
1305561	Satb1	SATB homeobox 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313660	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SATB1 mRNA	PMID:17145863
1305561	Satb1	SATB homeobox 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SATB1 mRNA	PMID:23634900
1305561	Satb1	SATB homeobox 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SATB1 mRNA; Nanotubes, Carbon results in decreased expression of SATB1 mRNA	PMID:25554681
1305561	Satb1	SATB homeobox 1	gene	CHEBI:50667	mercaptopurine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of SATB1 mRNA	PMID:23358152
1305561	Satb1	SATB homeobox 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SATB1 mRNA	PMID:30047161
1305561	Satb1	SATB homeobox 1	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313660	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of SATB1 mRNA	PMID:16780908
1305561	Satb1	SATB homeobox 1	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1313660	E	RGD:6480464	20120412	CTD	MESH:D019772	SATB1 protein affects the susceptibility to Topotecan	PMID:16217747
1305561	Satb1	SATB homeobox 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SATB1 mRNA	PMID:25729387
1305561	Satb1	SATB homeobox 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SATB1 mRNA	PMID:25729387
1305561	Satb1	SATB homeobox 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SATB1 mRNA	PMID:15336504
1305561	Satb1	SATB homeobox 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of SATB1 mRNA	PMID:36907384
1305561	Satb1	SATB homeobox 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313661	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SATB1 mRNA	PMID:22206623
1305561	Satb1	SATB homeobox 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SATB1 mRNA	PMID:22206623
1305561	Satb1	SATB homeobox 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313660	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of SATB1 mRNA	PMID:22714537
1305561	Satb1	SATB homeobox 1	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1313660	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SATB1 mRNA	PMID:36318118
1305561	Satb1	SATB homeobox 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313660	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SATB1 mRNA	PMID:27188386
1305561	Satb1	SATB homeobox 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313660	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SATB1 gene]	PMID:28238834
1305561	Satb1	SATB homeobox 1	gene	CHEBI:81794	thifluzamide	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of SATB1 mRNA	PMID:33512557
1305561	Satb1	SATB homeobox 1	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1313660	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of SATB1 mRNA	PMID:33512557
1305561	Satb1	SATB homeobox 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SATB1 mRNA	PMID:39847705
1305561	Satb1	SATB homeobox 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SATB1 mRNA	PMID:30047161
1305561	Satb1	SATB homeobox 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313660	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SATB1 mRNA	PMID:27188386
1305561	Satb1	SATB homeobox 1	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of SATB1 mRNA	PMID:23358152
1305561	Satb1	SATB homeobox 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of SATB1 gene	PMID:31682807
1305562	Xpot	exportin for tRNA	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of XPOT mRNA]	PMID:31150632
1305562	Xpot	exportin for tRNA	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of XPOT mRNA	PMID:15498508|PMID:18614847|PMID:33167477
1305562	Xpot	exportin for tRNA	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1313663	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of XPOT mRNA	PMID:15282401
1305562	Xpot	exportin for tRNA	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in decreased expression of XPOT mRNA	PMID:21632981
1305562	Xpot	exportin for tRNA	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313662	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of XPOT mRNA	PMID:20106945|PMID:31614463
1305562	Xpot	exportin for tRNA	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313663	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of XPOT mRNA	PMID:39298647
1305562	Xpot	exportin for tRNA	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of XPOT mRNA	PMID:33387578
1305562	Xpot	exportin for tRNA	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313663	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of XPOT mRNA	PMID:17251523
1305562	Xpot	exportin for tRNA	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313663	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of XPOT mRNA	PMID:34319233
1305562	Xpot	exportin for tRNA	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20120501	CTD	MESH:D002117	Calcitriol results in decreased expression of XPOT mRNA	PMID:16847355|PMID:18614847
1305562	Xpot	exportin for tRNA	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of XPOT mRNA	PMID:22061828
1305562	Xpot	exportin for tRNA	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313662	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of XPOT protein	PMID:23301498
1305562	Xpot	exportin for tRNA	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313662	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of XPOT protein	PMID:20106945
1305562	Xpot	exportin for tRNA	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of XPOT mRNA	PMID:21632981
1305562	Xpot	exportin for tRNA	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of XPOT mRNA	PMID:31150632
1305562	Xpot	exportin for tRNA	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313663	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of XPOT mRNA	PMID:27339419|PMID:31919559
1305562	Xpot	exportin for tRNA	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of XPOT mRNA]	PMID:31150632
1305562	Xpot	exportin for tRNA	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313662	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of XPOT protein	PMID:38460933
1305562	Xpot	exportin for tRNA	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of XPOT mRNA	PMID:31881176
1305562	Xpot	exportin for tRNA	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of XPOT gene	PMID:28505145
1305562	Xpot	exportin for tRNA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of XPOT mRNA	PMID:20106945|PMID:21632981
1305562	Xpot	exportin for tRNA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313663	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XPOT mRNA	PMID:19465110
1305562	Xpot	exportin for tRNA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313663	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of XPOT mRNA	PMID:16214954
1305562	Xpot	exportin for tRNA	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313662	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of XPOT mRNA	PMID:28001369
1305562	Xpot	exportin for tRNA	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of XPOT mRNA	PMID:33212167
1305562	Xpot	exportin for tRNA	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313662	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of XPOT mRNA	PMID:32763439
1305562	Xpot	exportin for tRNA	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of XPOT mRNA	PMID:28595984|PMID:34032870
1305562	Xpot	exportin for tRNA	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313662	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of XPOT mRNA; sodium arsenite results in increased expression of XPOT protein	PMID:38228842|PMID:38568856|PMID:39719251
1305562	Xpot	exportin for tRNA	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313662	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of XPOT mRNA; Tunicamycin results in increased expression of XPOT protein	PMID:22378314|PMID:29453283
1305562	Xpot	exportin for tRNA	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of XPOT mRNA	PMID:20106945|PMID:21632981
1305562	Xpot	exportin for tRNA	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313662	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XPOT mRNA	PMID:17879257
1305562	Xpot	exportin for tRNA	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313662	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of XPOT 5' UTR	PMID:27901495
1305562	Xpot	exportin for tRNA	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313662	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to XPOT mRNA]	PMID:32406909
1305562	Xpot	exportin for tRNA	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313662	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of XPOT mRNA	PMID:25895662
1305562	Xpot	exportin for tRNA	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of XPOT protein	PMID:25419056
1305562	Xpot	exportin for tRNA	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C008261	lead acetate results in increased expression of XPOT mRNA	PMID:11578147
1305562	Xpot	exportin for tRNA	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313662	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of XPOT mRNA	PMID:31745603
1305562	Xpot	exportin for tRNA	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of XPOT mRNA	PMID:30047161
1305562	Xpot	exportin for tRNA	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of XPOT mRNA	PMID:15498508
1305562	Xpot	exportin for tRNA	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of XPOT mRNA	PMID:29264374
1305562	Xpot	exportin for tRNA	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313663	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of XPOT gene	PMID:35295148
1305562	Xpot	exportin for tRNA	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of XPOT mRNA	PMID:34492290
1305562	Xpot	exportin for tRNA	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313662	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of XPOT mRNA	PMID:30903817
1305562	Xpot	exportin for tRNA	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of XPOT protein	PMID:32981897|PMID:37567409
1305562	Xpot	exportin for tRNA	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313663	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of XPOT promoter	PMID:27312807
1305562	Xpot	exportin for tRNA	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of XPOT mRNA	PMID:25181051
1305562	Xpot	exportin for tRNA	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313662	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of XPOT mRNA	PMID:29275510|PMID:33670352
1305562	Xpot	exportin for tRNA	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313662	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of XPOT mRNA	PMID:25979313
1305562	Xpot	exportin for tRNA	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1313662	E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of XPOT mRNA	PMID:19041380
1305562	Xpot	exportin for tRNA	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313663	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of XPOT mRNA	PMID:39298647
1305562	Xpot	exportin for tRNA	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313662	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of XPOT protein	PMID:34186270
1305562	Xpot	exportin for tRNA	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313662	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of XPOT mRNA	PMID:28628672
1305562	Xpot	exportin for tRNA	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313662	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of XPOT protein	PMID:34186270
1305562	Xpot	exportin for tRNA	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of XPOT mRNA	PMID:28392331
1305562	Xpot	exportin for tRNA	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of XPOT mRNA	PMID:37019170
1305562	Xpot	exportin for tRNA	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of XPOT mRNA	PMID:34813904
1305562	Xpot	exportin for tRNA	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313662	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of XPOT mRNA	PMID:28628672
1305562	Xpot	exportin for tRNA	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of XPOT mRNA	PMID:34813904
1305562	Xpot	exportin for tRNA	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313662	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of XPOT mRNA	PMID:37042841
1305562	Xpot	exportin for tRNA	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of XPOT mRNA	PMID:38568856
1305562	Xpot	exportin for tRNA	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of XPOT mRNA	PMID:24386269
1305562	Xpot	exportin for tRNA	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313662	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of XPOT mRNA	PMID:24449571
1305562	Xpot	exportin for tRNA	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313663	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of XPOT mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of XPOT mRNA]	PMID:17585979
1305562	Xpot	exportin for tRNA	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313662	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of XPOT mRNA	PMID:32588087
1305562	Xpot	exportin for tRNA	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313662	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of XPOT mRNA	PMID:31533062
1305562	Xpot	exportin for tRNA	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313662	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of XPOT mRNA	PMID:40419075
1305562	Xpot	exportin for tRNA	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313662	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of XPOT mRNA	PMID:29154799
1305562	Xpot	exportin for tRNA	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of XPOT mRNA	PMID:30047161
1305562	Xpot	exportin for tRNA	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313662	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of XPOT mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1305562	Xpot	exportin for tRNA	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313662	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of XPOT mRNA	PMID:28628672
1305562	Xpot	exportin for tRNA	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of XPOT mRNA	PMID:24136188
1305562	Xpot	exportin for tRNA	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313662	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of XPOT mRNA	PMID:38832940
1305562	Xpot	exportin for tRNA	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in decreased expression of XPOT mRNA	PMID:22230336
1305562	Xpot	exportin for tRNA	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313662	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of XPOT mRNA	PMID:29067470
1305562	Xpot	exportin for tRNA	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313663	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of XPOT mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of XPOT mRNA]	PMID:17585979
1305562	Xpot	exportin for tRNA	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313662	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of XPOT protein	PMID:38460933
1305562	Xpot	exportin for tRNA	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of XPOT mRNA	PMID:36621641
1305562	Xpot	exportin for tRNA	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313662	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of XPOT mRNA	PMID:31838189
1305562	Xpot	exportin for tRNA	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of XPOT mRNA	PMID:29391264
1305562	Xpot	exportin for tRNA	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313662	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of XPOT mRNA	PMID:28628672
1305562	Xpot	exportin for tRNA	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of XPOT protein	PMID:25419056
1305562	Xpot	exportin for tRNA	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of XPOT mRNA	PMID:30047161
1305562	Xpot	exportin for tRNA	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of XPOT mRNA	PMID:24136188
1305562	Xpot	exportin for tRNA	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of XPOT protein	PMID:32959892
1305562	Xpot	exportin for tRNA	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of XPOT mRNA	PMID:24136188
1305562	Xpot	exportin for tRNA	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of XPOT mRNA	PMID:28801915|PMID:37269647
1305562	Xpot	exportin for tRNA	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313662	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of XPOT mRNA	PMID:24810058
1305562	Xpot	exportin for tRNA	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313663	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of XPOT protein	PMID:26558463
1305562	Xpot	exportin for tRNA	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of XPOT mRNA	PMID:30467583
1305562	Xpot	exportin for tRNA	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313662	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of XPOT protein	PMID:34186270
1305562	Xpot	exportin for tRNA	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of XPOT mRNA	PMID:24136188
1305562	Xpot	exportin for tRNA	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1313662	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of XPOT mRNA	PMID:19946333
1305562	Xpot	exportin for tRNA	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1313662	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of XPOT mRNA]	PMID:19946333
1305562	Xpot	exportin for tRNA	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313662	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of XPOT protein	PMID:39638853
1305562	Xpot	exportin for tRNA	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313662	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of XPOT protein	PMID:39638853
1305562	Xpot	exportin for tRNA	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313662	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of XPOT mRNA	PMID:19159669
1305562	Xpot	exportin for tRNA	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1313662	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of XPOT mRNA	PMID:26705709
1305562	Xpot	exportin for tRNA	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of XPOT protein	PMID:31675489
1305562	Xpot	exportin for tRNA	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313662	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of XPOT mRNA	PMID:21858171
1305562	Xpot	exportin for tRNA	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313662	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in increased expression of XPOT protein	PMID:38348393
1305562	Xpot	exportin for tRNA	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of XPOT mRNA	PMID:30047161
1305562	Xpot	exportin for tRNA	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of XPOT mRNA	PMID:21346803
1305562	Xpot	exportin for tRNA	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313662	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of XPOT mRNA	PMID:22378314
1305562	Xpot	exportin for tRNA	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of XPOT mRNA	PMID:35537566
1305562	Xpot	exportin for tRNA	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of XPOT mRNA	PMID:23555832
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CPA2 mRNA	PMID:36841081
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of CPA2 mRNA	PMID:17347304
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA	PMID:25510870
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1614164	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of CPA2 mRNA	PMID:29980752
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CPA2 mRNA	PMID:33387578
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of CPA2 mRNA	PMID:31606821
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313664	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CPA2 exon	PMID:30157460
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPA2 mRNA	PMID:37236586
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA	PMID:25510870
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA	PMID:25510870
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313664	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CPA2 gene	PMID:27153756
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313664	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CPA2 exon	PMID:30157460
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CPA2 mRNA	PMID:31150632
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614164	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CPA2 mRNA	PMID:26377647
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CPA2 mRNA	PMID:20959002
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CPA2 mRNA	PMID:33387578
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1614164	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of CPA2 mRNA	PMID:37682722
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313664	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of CPA2 promoter	PMID:18448484
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CPA2 mRNA	PMID:30085273
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CPA2 mRNA	PMID:16483693
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1614164	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of CPA2 mRNA	PMID:20542052|PMID:22609695
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1614164	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CPA2 mRNA	PMID:17426115
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of CPA2 mRNA	PMID:19167457
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CPA2 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CPA2 mRNA	PMID:35192832
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA	PMID:25510870
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA	PMID:25510870
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CPA2 mRNA	PMID:20959002|PMID:23196670
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313664	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CPA2 exon	PMID:30157460
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1614164	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CPA2 intron	PMID:28392331
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CPA2 mRNA	PMID:21266533
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CPA2 mRNA	PMID:35163327
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPA2 mRNA	PMID:37236586
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CPA2 mRNA	PMID:35163327
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CPA2 mRNA	PMID:24386269
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614164	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CPA2 mRNA	PMID:40194260
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of CPA2 mRNA	PMID:22561333
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of CPA2 mRNA	PMID:22561333
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CPA2 mRNA	PMID:33387578
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1614164	E	RGD:6480464	20161213	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CPA2 mRNA	PMID:23917077
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614164	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CPA2 mRNA	PMID:25620056
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614164	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CPA2 mRNA	PMID:25620056
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:63933	Aroclor 1254	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CPA2 mRNA	PMID:18178546
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313664	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CPA2 exon	PMID:30157460
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1614164	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CPA2 mRNA	PMID:22206623
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CPA2 mRNA	PMID:21346803
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1614164	E	RGD:6480464	20250401	CTD	MESH:D013311	Streptozocin results in increased expression of CPA2 mRNA	PMID:31606821
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of CPA2 mRNA	PMID:31606821
1305563	Cpa2	carboxypeptidase A2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CPA2 mRNA	PMID:21346803
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313665	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KLHL7 mRNA	PMID:38218311
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313665	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of KLHL7 mRNA	PMID:27188386
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313666	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of KLHL7 mRNA	PMID:37995155
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:137392	chlormequat chloride	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of KLHL7 protein	PMID:34958886
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313665	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of KLHL7 mRNA	PMID:21934132
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313665	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of KLHL7 mRNA	PMID:21179406
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313665	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of KLHL7 mRNA	PMID:18951874
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313665	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of KLHL7 protein	PMID:18951874
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313665	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of KLHL7 protein	PMID:19207037
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313666	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KLHL7 mRNA	PMID:39241906
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313665	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KLHL7 mRNA	PMID:37042841
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313665	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of KLHL7 mRNA	PMID:21179406
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of KLHL7 mRNA	PMID:22061828
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLHL7 mRNA	PMID:39012411
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLHL7 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLHL7 mRNA	PMID:37236586|PMID:37325564
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313665	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KLHL7 mRNA	PMID:19549813
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313665	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of KLHL7 mRNA	PMID:23649840
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313665	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KLHL7 mRNA	PMID:23649840
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313666	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KLHL7 mRNA	PMID:31919559
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313666	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KLHL7 mRNA	PMID:25629700
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KLHL7 mRNA	PMID:40504410
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of KLHL7 mRNA	PMID:25905778
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313665	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KLHL7 mRNA	PMID:23557933
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1313665	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of KLHL7 mRNA	PMID:23300844
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313665	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of KLHL7 mRNA	PMID:27392435|PMID:27594783
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1313665	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of KLHL7 protein	PMID:18951874
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313665	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KLHL7 mRNA	PMID:28001369
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313665	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KLHL7 mRNA	PMID:29803840
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313666	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of KLHL7 mRNA	PMID:25896364|PMID:39631538
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KLHL7 mRNA	PMID:40504410
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KLHL7 mRNA	PMID:21839799
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313666	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLHL7 mRNA	PMID:22228805
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of KLHL7 mRNA	PMID:24136188
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313666	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KLHL7 gene	PMID:35295148
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313666	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of KLHL7 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of KLHL7 mRNA	PMID:19167457
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KLHL7 gene	PMID:28505145
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313666	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of KLHL7 mRNA	PMID:28392331
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313666	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KLHL7 mRNA	PMID:37019170
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313665	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KLHL7 mRNA	PMID:37042841
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KLHL7 mRNA	PMID:33453195
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLHL7 mRNA	PMID:39012411
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLHL7 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLHL7 mRNA	PMID:37236586|PMID:37325564
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of KLHL7 mRNA	PMID:24386269
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313665	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of KLHL7 mRNA	PMID:19376846
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1313665	E	RGD:6480464	20120717	CTD	MESH:C018021	[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of KLHL7 mRNA	PMID:18654764
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313665	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of KLHL7 mRNA	PMID:24449571
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of KLHL7 mRNA	PMID:36331819
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313665	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLHL7 mRNA	PMID:25979313
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313665	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of KLHL7 mRNA	PMID:23179753|PMID:27188386
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313665	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KLHL7 gene	PMID:29154799
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313665	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of KLHL7 promoter	PMID:27989131
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313665	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KLHL7 mRNA	PMID:25562108
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313665	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KLHL7 mRNA	PMID:38832940
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313665	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of KLHL7 mRNA	PMID:26272509
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313665	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL7 mRNA	PMID:27188386
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KLHL7 mRNA	PMID:33387578
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313665	E	RGD:6480464	20120412	CTD	MESH:D005472	KLHL7 protein affects the susceptibility to Fluorouracil	PMID:16217747
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KLHL7 mRNA	PMID:40504410
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313665	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of KLHL7 mRNA	PMID:18175754
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313665	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of KLHL7 mRNA	PMID:23300844
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1313665	E	RGD:6480464	20120717	CTD	MESH:C037123	[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of KLHL7 mRNA	PMID:18654764
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of KLHL7 mRNA	PMID:20080153
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313666	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of KLHL7 mRNA	PMID:23650126
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313666	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of KLHL7 mRNA	PMID:20003209
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of KLHL7 mRNA	PMID:30467583
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313666	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KLHL7 mRNA	PMID:22206623
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313665	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL7 mRNA	PMID:27188386
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313666	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of KLHL7 mRNA	PMID:23091169
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of KLHL7 mRNA	PMID:20345932
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1313666	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of KLHL7 mRNA	PMID:31388691
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of KLHL7 mRNA	PMID:24780913
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:88212	lead(II) chloride	multiple interactions	ISO	RGD:1313665	E	RGD:6480464	20151103	CTD	MESH:C029891	[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of KLHL7 mRNA	PMID:18654764
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313665	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL7 mRNA	PMID:27188386
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KLHL7 mRNA	PMID:21346803
1305564	Klhl7	kelch-like family member 7	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of KLHL7 mRNA	PMID:20566332
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313667	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SUPV3L1 mRNA	PMID:33167477
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SUPV3L1 gene	PMID:28931070
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313667	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SUPV3L1 mRNA	PMID:22378314
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of SUPV3L1 protein	PMID:23178681
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313668	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SUPV3L1 mRNA	PMID:23892564
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313667	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SUPV3L1 protein	PMID:37730182
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SUPV3L1 mRNA	PMID:33387578
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313668	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUPV3L1 mRNA	PMID:36331819
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313667	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SUPV3L1 mRNA	PMID:19549813
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313668	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SUPV3L1 mRNA	PMID:25629700
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of SUPV3L1 gene	PMID:31011160
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1313668	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of SUPV3L1 protein	PMID:22006019
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313668	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SUPV3L1 mRNA	PMID:21570461
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SUPV3L1 mRNA	PMID:21215274
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313667	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of SUPV3L1 mRNA	PMID:33512557
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SUPV3L1 mRNA	PMID:28959563
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of SUPV3L1 mRNA	PMID:19915844
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313667	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SUPV3L1 mRNA	PMID:29803840
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	ISO	RGD:1313667	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of SUPV3L1 mRNA	PMID:25075043
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313667	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SUPV3L1 mRNA	PMID:25895662
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SUPV3L1 mRNA	PMID:19162173
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SUPV3L1 mRNA	PMID:30816183|PMID:32528016
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313667	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of SUPV3L1 mRNA	PMID:20678512
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SUPV3L1 mRNA	PMID:25181051
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313667	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SUPV3L1 protein	PMID:34186270
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313667	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA	PMID:28628672
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313667	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SUPV3L1 protein	PMID:34186270
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313667	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SUPV3L1 protein	PMID:34186270
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313668	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SUPV3L1 promoter	PMID:28392331
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313668	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SUPV3L1 mRNA	PMID:34813904
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313667	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA	PMID:28628672
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313668	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SUPV3L1 mRNA	PMID:34813904
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SUPV3L1 mRNA	PMID:24386269
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313667	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SUPV3L1 mRNA	PMID:32588087
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313668	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUPV3L1 mRNA	PMID:36331819
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313667	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SUPV3L1 mRNA	PMID:25979313
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313667	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SUPV3L1 mRNA	PMID:20106945|PMID:25562108
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313667	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA	PMID:28628672
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1313667	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SUPV3L1 mRNA	PMID:33512557
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313667	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of SUPV3L1 mRNA	PMID:25704631
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313667	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of SUPV3L1 mRNA	PMID:17039268
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313667	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA	PMID:28628672
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:50035	alpha-phellandrene	decreases expression	ISO	RGD:1313667	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of SUPV3L1 mRNA	PMID:25075043
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313668	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SUPV3L1 mRNA; Nanotubes, Carbon results in increased expression of SUPV3L1 mRNA	PMID:25554681
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SUPV3L1 mRNA	PMID:24136188
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SUPV3L1 mRNA	PMID:24136188
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313667	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SUPV3L1 protein	PMID:32959892
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313667	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SUPV3L1 mRNA	PMID:19159669
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1313667	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of SUPV3L1 mRNA	PMID:33512557
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SUPV3L1 mRNA	PMID:21346803
1305565	Supv3l1	Suv3 like RNA helicase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SUPV3L1 mRNA	PMID:21346803
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313669	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of UPP1 mRNA	PMID:38218311
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of UPP1 mRNA	PMID:35967413
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313669	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of UPP1 mRNA	PMID:23724009|PMID:23830798|PMID:33167477
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20140408	CTD	MESH:D010100	Oxygen inhibits the reaction [darinaparsin results in increased expression of UPP1 mRNA]	PMID:22535156
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313669	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of UPP1 mRNA	PMID:26079696
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313669	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of UPP1 mRNA	PMID:28986285
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of UPP1 mRNA	PMID:20044591
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16335	adenosine	increases metabolic processing	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D000241	UPP1 protein results in increased metabolism of Adenosine	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of UPP1 mRNA	PMID:39298647
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of UPP1 mRNA	PMID:20106945|PMID:31614463
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of UPP1 mRNA	PMID:20660070
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313670	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of UPP1 mRNA	PMID:33711761
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of UPP1 mRNA	PMID:33387578
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16704	uridine	affects abundance	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D014529	UPP1 protein affects the abundance of Uridine	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16704	uridine	increases metabolic processing	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D014529	UPP1 protein results in increased metabolism of Uridine	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16704	uridine	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D014529	[UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil; [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16750	guanosine	increases metabolic processing	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D006151	UPP1 protein results in increased metabolism of Guanosine	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20250506	CTD	MESH:D002635	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D005557	Formaldehyde results in increased expression of UPP1 protein	PMID:40907675
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313669	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of UPP1 mRNA	PMID:27664576
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:16898	pyrimidine	increases metabolic processing	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:C030986	UPP1 protein results in increased metabolism of pyrimidine	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of UPP1 mRNA	PMID:20660070
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UPP1 mRNA	PMID:37992649
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313669	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of UPP1 mRNA	PMID:33647349
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:17562	cytidine	increases metabolic processing	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D003562	UPP1 protein results in increased metabolism of Cytidine	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313669	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of UPP1 mRNA	PMID:31256213
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UPP1 mRNA	PMID:37992649
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20250506	CTD	MESH:D006000	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313669	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of UPP1 mRNA	PMID:23825647
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313669	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UPP1 mRNA	PMID:31163220
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of UPP1 mRNA	PMID:26577399
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313669	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of UPP1 mRNA	PMID:28818685
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of UPP1 protein	PMID:34915118
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313669	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of UPP1 mRNA	PMID:23825647
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in increased expression of UPP1 mRNA	PMID:21172416
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UPP1 mRNA	PMID:19549813
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of UPP1 protein	PMID:33236894
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of UPP1 protein	PMID:20106945
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313669	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of UPP1 mRNA	PMID:27153756
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of UPP1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UPP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of UPP1 protein	PMID:38598786
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of UPP1 mRNA	PMID:30779732
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313670	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of UPP1 mRNA	PMID:31939706
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20250506	CTD	MESH:D006002	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313669	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UPP1 gene	PMID:25304211
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of UPP1 mRNA	PMID:40512198
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of UPP1 mRNA	PMID:31881176
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of UPP1 mRNA	PMID:25905778
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of UPP1 mRNA	PMID:23557933
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of UPP1 mRNA	PMID:27392435
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of UPP1 mRNA	PMID:27392435
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313669	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of UPP1 mRNA	PMID:24768652|PMID:25583101
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UPP1 mRNA	PMID:34747641
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313670	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UPP1 mRNA	PMID:21570461|PMID:26377647
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UPP1 mRNA	PMID:20106945|PMID:21632981
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA	PMID:33387578
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA	PMID:16704738
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313670	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA	PMID:26290441
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA	PMID:17942748
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of UPP1 mRNA	PMID:31378766
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313669	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of UPP1 mRNA	PMID:28001369
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313669	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of UPP1 mRNA	PMID:33212167
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UPP1 mRNA	PMID:30851411
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of UPP1 mRNA	PMID:20971185
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of UPP1 mRNA	PMID:18510171
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313669	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of UPP1 mRNA	PMID:29803840
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UPP1 mRNA	PMID:37992649
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20250506	CTD	MESH:D003840	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of UPP1 mRNA	PMID:20044591
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of UPP1 mRNA	PMID:25270620
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:28940	calciol	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in decreased expression of UPP1 mRNA	PMID:16508948
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1313669	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of UPP1 mRNA	PMID:22623647
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313669	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UPP1 mRNA	PMID:38568856|PMID:39719251
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of UPP1 mRNA	PMID:40512198
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313669	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of UPP1 mRNA	PMID:29453283
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313669	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UPP1 5' UTR	PMID:27901495
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313669	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UPP1 mRNA	PMID:21632981|PMID:26238291
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313670	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UPP1 mRNA	PMID:22228805|PMID:23735875|PMID:32417428
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of UPP1 mRNA	PMID:20971185
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313669	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of UPP1 mRNA	PMID:25895662
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313670	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of UPP1 mRNA	PMID:23221170
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313669	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UPP1 mRNA	PMID:27829220
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:3090	bicalutamide	increases expression	ISO	RGD:1313669	E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of UPP1 mRNA	PMID:15638997
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:31521	doxifluridine	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20130806	CTD	MESH:C025034	5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine]; [TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine; [TNF protein results in increased expression of UPP1 mRNA] which results in increased susceptibility to doxifluridine	PMID:16397116
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of UPP1 mRNA	PMID:16507785
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313669	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of UPP1 mRNA	PMID:31745603
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of UPP1 mRNA	PMID:25729387
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of UPP1 mRNA	PMID:30047161
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UPP1 mRNA	PMID:34492290
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of UPP1 mRNA	PMID:18648102
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of UPP1 mRNA	PMID:17426115
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313670	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of UPP1 mRNA	PMID:18301758|PMID:20813756
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of UPP1 mRNA	PMID:20170705|PMID:30903817
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of UPP1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of UPP1 mRNA	PMID:20678512
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UPP1 mRNA	PMID:25181051|PMID:32145629
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA	PMID:28628672
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313670	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of UPP1 mRNA	PMID:25172293
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313669	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of UPP1 mRNA	PMID:25979313
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1313670	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of UPP1 mRNA	PMID:20713471
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of UPP1 mRNA	PMID:20713471
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of UPP1 mRNA	PMID:40203079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313670	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of UPP1 mRNA	PMID:30951980
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313670	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of UPP1 mRNA	PMID:30951980
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of UPP1 protein	PMID:35362542
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of UPP1 protein]	PMID:35362542
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UPP1 mRNA	PMID:21266533
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of UPP1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UPP1 protein	PMID:38598786
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA	PMID:28628672
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of UPP1 mRNA	PMID:32680482
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313669	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UPP1 mRNA	PMID:37042841
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	increases expression	ISO	RGD:1313669	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate results in increased expression of UPP1 mRNA	PMID:29024780
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of UPP1 mRNA	PMID:35163327
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of UPP1 mRNA	PMID:18500788
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313669	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UPP1 mRNA	PMID:38568856
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of UPP1 mRNA	PMID:35163327
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313669	E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in increased expression of UPP1 mRNA	PMID:19320972|PMID:19376846|PMID:22941251
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of UPP1 mRNA	PMID:24449571
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20250506	CTD	MESH:D005999	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313669	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of UPP1 mRNA	PMID:32588087
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313670	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of UPP1 mRNA	PMID:40194260
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1313669	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of UPP1 mRNA	PMID:40434365
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1313669	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of UPP1 mRNA	PMID:26352163
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313669	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of UPP1 mRNA	PMID:40419075
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of UPP1 mRNA	PMID:23125180
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of UPP1 mRNA	PMID:19136453
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313669	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of UPP1 mRNA	PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of UPP1 mRNA	PMID:30047161|PMID:41580965
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313669	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of UPP1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:41037	5-benzyl-1-(2-hydroxyethoxymethyl)uracil	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20161213	CTD	MESH:C034753	5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine]	PMID:16397116
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:41607	crotonaldehyde	increases expression	ISO	RGD:1313669	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased expression of UPP1 mRNA	PMID:20471460
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:41791	calyculin A	increases expression	ISO	RGD:1313670	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in increased expression of UPP1 mRNA	PMID:25270620
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA	PMID:28628672
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313670	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of UPP1 mRNA	PMID:28973697
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UPP1 mRNA	PMID:37992649
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:43602	obeticholic acid	increases expression	ISO	RGD:1313669	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in increased expression of UPP1 mRNA	PMID:27939613
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313669	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of UPP1 mRNA	PMID:17379860
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313669	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of UPP1 mRNA	PMID:38832940
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:4488	diallyl disulfide	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide inhibits the reaction [tobacco tar analog results in increased expression of UPP1 mRNA]	PMID:36758788
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of UPP1 mRNA	PMID:26272509
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPP1 mRNA	PMID:27188386
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of UPP1 mRNA	PMID:33387578
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313669	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of UPP1 mRNA	PMID:29067470
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20250506	CTD	MESH:D000082	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D005472	UPP1 affects the susceptibility to Fluorouracil	PMID:15067352
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D005472	UPP1 protein affects the susceptibility to Fluorouracil	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of UPP1 mRNA; Fluorouracil results in increased expression of UPP1 protein	PMID:15109396|PMID:15331170|PMID:24737281
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D005472	[UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of UPP1 mRNA	PMID:24714768
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1313669	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of UPP1 mRNA	PMID:25757056
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313669	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UPP1 gene	PMID:25304211
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of UPP1 mRNA	PMID:40512198
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313669	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of UPP1 mRNA	PMID:31838189
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1313669	E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of UPP1 mRNA	PMID:26615145
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313669	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of UPP1 mRNA	PMID:24383545
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UPP1 mRNA	PMID:17557909
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UPP1 mRNA	PMID:17942748
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA	PMID:17942748
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of UPP1 protein]	PMID:35362542
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313669	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of UPP1 mRNA	PMID:38568856
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of UPP1 mRNA	PMID:36868495
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of UPP1 mRNA	PMID:16984733
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA	PMID:28628672
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313669	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UPP1 mRNA	PMID:27829220
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:50102	N-methyl-N-nitrosourea	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in decreased expression of UPP1 mRNA	PMID:25270620
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea results in increased expression of UPP1 mRNA	PMID:17412507
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of UPP1 mRNA	PMID:25620056
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313670	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UPP1 mRNA; Nanotubes, Carbon results in increased expression of UPP1 mRNA	PMID:25554681
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of UPP1 mRNA	PMID:30047161
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:52717	bortezomib	decreases activity	ISO	RGD:1313670	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased activity of UPP1 protein	PMID:16397116
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:52717	bortezomib	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib inhibits the reaction [TNF protein results in increased activity of UPP1 protein]; Bortezomib inhibits the reaction [TNF protein results in increased expression of UPP1 mRNA]	PMID:16397116
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of UPP1 mRNA	PMID:18651567
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C015559	trimellitic anhydride results in increased expression of UPP1 mRNA	PMID:21893156
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D010081	Oxazolone results in increased expression of UPP1 mRNA	PMID:21893156
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313670	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of UPP1 mRNA	PMID:38701926
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UPP1 protein	PMID:32959892
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of UPP1 mRNA	PMID:28801915
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of UPP1 mRNA	PMID:21641980
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of UPP1 mRNA	PMID:25729387
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of UPP1 mRNA	PMID:25729387
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of UPP1 mRNA	PMID:15336504
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of UPP1 mRNA	PMID:28801915
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D004178	Diquat results in increased expression of UPP1 mRNA	PMID:21172416
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of UPP1 mRNA	PMID:19564919
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of UPP1 mRNA	PMID:19564919
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313669	E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in increased expression of UPP1 mRNA	PMID:33244087
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of UPP1 mRNA	PMID:19564919
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:75408	sulindac sulfide	increases expression	ISO	RGD:1313669	E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in increased expression of UPP1 mRNA	PMID:16184548
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:78160	bleomycin A5	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in decreased expression of UPP1 mRNA	PMID:21040473
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313669	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UPP1 mRNA	PMID:30851411
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPP1 mRNA	PMID:27188386
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:7983	pentobarbital	affects response to substance	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D010424	UPP1 protein affects the susceptibility to Pentobarbital	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:7983	pentobarbital	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D010424	[UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital	PMID:15772079
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313669	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of UPP1 mRNA	PMID:19159669
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in increased expression of UPP1 mRNA	PMID:19084549
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1313669	E	RGD:6480464	20191112	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of UPP1 mRNA	PMID:31173147
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of UPP1 mRNA	PMID:39847705
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313669	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of UPP1 mRNA	PMID:12727804
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of UPP1 mRNA	PMID:24780913
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of UPP1 mRNA	PMID:30047161
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1313669	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of UPP1 mRNA	PMID:24921660
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1313670	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate affects the expression of UPP1 mRNA	PMID:19162170
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPP1 mRNA	PMID:27188386
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UPP1 mRNA	PMID:21346803
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313669	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of UPP1 mRNA	PMID:38568856
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of UPP1 mRNA	PMID:26217789
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313669	E	RGD:6480464	20120412	CTD	MESH:D013849	Thimerosal results in increased expression of UPP1 mRNA	PMID:16870260
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313669	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of UPP1 protein	PMID:38598786
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of UPP1 protein	PMID:32519852
1305566	Upp1	uridine phosphorylase 1	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of UPP1 mRNA	PMID:18930950
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide analog results in decreased expression of LRFN3 mRNA	PMID:33227293
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313672	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of LRFN3 mRNA	PMID:24205000
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LRFN3 mRNA	PMID:36331819
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313672	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of LRFN3 mRNA	PMID:30319688
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313672	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of LRFN3 mRNA	PMID:39298647
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313671	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of LRFN3 mRNA	PMID:38568856
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LRFN3 mRNA	PMID:33387578
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313672	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of LRFN3 mRNA	PMID:25549359
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313671	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRFN3 mRNA	PMID:37042841
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313672	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LRFN3 mRNA	PMID:32235866
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LRFN3 mRNA	PMID:33387578
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LRFN3 mRNA	PMID:36331819
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRFN3 mRNA	PMID:37236586
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313671	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LRFN3 mRNA	PMID:19549813
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313671	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LRFN3 gene	PMID:27153756
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in decreased expression of LRFN3 mRNA	PMID:31939706
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRFN3 mRNA	PMID:22206623
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27698	vanadium atom	multiple interactions	ISO	RGD:1313671	E	RGD:6480464	20260203	CTD	MESH:D014639	[Metals, Heavy results in increased abundance of Vanadium] which results in increased methylation of LRFN3 gene	PMID:39164771
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of LRFN3 gene	PMID:31011160
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313672	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of LRFN3 mRNA	PMID:28960355
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313671	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LRFN3 mRNA	PMID:23557933
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313672	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRFN3 mRNA	PMID:28922406
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRFN3 mRNA	PMID:33387578
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313671	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LRFN3 mRNA	PMID:28001369
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313671	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of LRFN3 mRNA	PMID:32763439
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313671	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of LRFN3 mRNA	PMID:20044591
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:29021	hexane	decreases methylation	EXP		E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of LRFN3 promoter	PMID:23740543
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRFN3 mRNA	PMID:27195522
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313672	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRFN3 mRNA	PMID:22228805
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to LRFN3 promoter]	PMID:19654925
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313671	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LRFN3 mRNA	PMID:34973136
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313672	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRFN3 gene	PMID:35295148
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313672	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LRFN3 gene	PMID:35295148
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of LRFN3 mRNA	PMID:34492290
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313672	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of LRFN3 mRNA	PMID:17950772
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313672	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of LRFN3 mRNA	PMID:18301758|PMID:23811191
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LRFN3 mRNA	PMID:19710929
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LRFN3 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313672	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LRFN3 mRNA	PMID:32156529
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LRFN3 mRNA	PMID:32119087
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313672	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRFN3 mRNA	PMID:37019170
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of LRFN3 mRNA	PMID:34813904
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35170	vanadium(0)	multiple interactions	ISO	RGD:1313671	E	RGD:6480464	20260203	CTD	MESH:D014639	[Metals, Heavy results in increased abundance of Vanadium] which results in increased methylation of LRFN3 gene	PMID:39164771
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of LRFN3 mRNA	PMID:26377693
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313671	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LRFN3 mRNA	PMID:38568856
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313671	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LRFN3 mRNA	PMID:38382870
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRFN3 mRNA	PMID:37236586
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of LRFN3 mRNA	PMID:25539665|PMID:26194646|PMID:27387713
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased methylation of LRFN3 gene	PMID:27387713
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313671	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LRFN3 mRNA	PMID:19376846
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313671	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LRFN3 mRNA	PMID:24449571
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313672	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of LRFN3 mRNA	PMID:28962523
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313672	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of LRFN3 mRNA	PMID:23811191
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRFN3 mRNA	PMID:40194260
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313671	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of LRFN3 mRNA	PMID:28302478
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313671	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LRFN3 mRNA	PMID:31533062
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LRFN3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LRFN3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of LRFN3 mRNA	PMID:36331819
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313672	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LRFN3 mRNA	PMID:17963808
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313671	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LRFN3 gene	PMID:29154799
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313671	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of LRFN3 mRNA	PMID:20106945
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of LRFN3 mRNA	PMID:19770486
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313672	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of LRFN3 mRNA	PMID:18502557
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LRFN3 mRNA	PMID:33387578
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of LRFN3 mRNA	PMID:29391264
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313671	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of LRFN3 mRNA	PMID:18175754
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313672	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of LRFN3 mRNA	PMID:25620056
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of LRFN3 mRNA	PMID:19042947
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313671	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of LRFN3 mRNA	PMID:31758290
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRFN3 mRNA	PMID:22206623
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of LRFN3 mRNA	PMID:21346803
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313671	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LRFN3 gene]	PMID:28238834
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LRFN3 mRNA	PMID:21346803
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313671	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of LRFN3 mRNA	PMID:29301935
1305567	Lrfn3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of LRFN3 mRNA	PMID:20566332
1305568	Pax2	paired box 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313673	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PAX2 mRNA	PMID:26272509
1305568	Pax2	paired box 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313673	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA	PMID:27188386
1305568	Pax2	paired box 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313674	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PAX2 mRNA	PMID:33045310
1305568	Pax2	paired box 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PAX2 mRNA	PMID:37995155
1305568	Pax2	paired box 2	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide analog results in decreased expression of PAX2 mRNA	PMID:33227293
1305568	Pax2	paired box 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PAX2 mRNA	PMID:20188158
1305568	Pax2	paired box 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313674	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PAX2 gene	PMID:20938992
1305568	Pax2	paired box 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313674	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of PAX2 mRNA	PMID:36189433
1305568	Pax2	paired box 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313674	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PAX2 mRNA	PMID:36189433
1305568	Pax2	paired box 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of PAX2 gene	PMID:28931070|PMID:35440735
1305568	Pax2	paired box 2	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in decreased expression of PAX2 mRNA	PMID:29548890|PMID:31039417
1305568	Pax2	paired box 2	gene	CHEBI:16412	lipopolysaccharide	increases response to substance	ISO	RGD:1313674	E	RGD:6480464	20161228	CTD	MESH:D008070	PAX2 protein results in increased susceptibility to Lipopolysaccharides	PMID:21131441
1305568	Pax2	paired box 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PAX2 mRNA	PMID:25549359
1305568	Pax2	paired box 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313674	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PAX2 gene	PMID:20938992
1305568	Pax2	paired box 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313674	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PAX2 mRNA	PMID:36189433
1305568	Pax2	paired box 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313674	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PAX2 mRNA	PMID:36189433
1305568	Pax2	paired box 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313673	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PAX2 mRNA	PMID:33359661
1305568	Pax2	paired box 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PAX2 mRNA	PMID:22677342
1305568	Pax2	paired box 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313673	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PAX2 intron	PMID:30157460
1305568	Pax2	paired box 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313673	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of PAX2 mRNA	PMID:21120746
1305568	Pax2	paired box 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313673	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of PAX2 mRNA	PMID:24376830
1305568	Pax2	paired box 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313674	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of PAX2 mRNA	PMID:25629700
1305568	Pax2	paired box 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313674	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PAX2 gene	PMID:20938992
1305568	Pax2	paired box 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PAX2 mRNA	PMID:28189721|PMID:28960355
1305568	Pax2	paired box 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313673	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PAX2 mRNA	PMID:28903495
1305568	Pax2	paired box 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313674	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PAX2 mRNA	PMID:21570461|PMID:24058054
1305568	Pax2	paired box 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PAX2 mRNA	PMID:32109520
1305568	Pax2	paired box 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313673	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PAX2 mRNA	PMID:21296121
1305568	Pax2	paired box 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313673	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PAX2 mRNA	PMID:33212167
1305568	Pax2	paired box 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313674	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PAX2 mRNA	PMID:27862939
1305568	Pax2	paired box 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313673	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in increased expression of PAX2 mRNA	PMID:35954277
1305568	Pax2	paired box 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313673	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PAX2 3' UTR; Benzo(a)pyrene affects the methylation of PAX2 intron; Benzo(a)pyrene affects the methylation of PAX2 promoter	PMID:27901495|PMID:30157460
1305568	Pax2	paired box 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PAX2 mRNA	PMID:21803694
1305568	Pax2	paired box 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313673	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PAX2 gene	PMID:31601247
1305568	Pax2	paired box 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of PAX2 mRNA	PMID:35295148
1305568	Pax2	paired box 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313674	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PAX2 gene; titanium dioxide results in decreased methylation of PAX2 promoter	PMID:35295148
1305568	Pax2	paired box 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313674	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of PAX2 mRNA	PMID:29264374
1305568	Pax2	paired box 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313674	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PAX2 promoter	PMID:35295148
1305568	Pax2	paired box 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PAX2 mRNA	PMID:23411599
1305568	Pax2	paired box 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of PAX2 mRNA	PMID:19167457
1305568	Pax2	paired box 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313673	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of PAX2 gene	PMID:31601247
1305568	Pax2	paired box 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313674	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of PAX2 promoter	PMID:27334623
1305568	Pax2	paired box 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PAX2 mRNA	PMID:25181051
1305568	Pax2	paired box 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of PAX2 mRNA	PMID:30951980
1305568	Pax2	paired box 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313674	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PAX2 mRNA	PMID:32156529
1305568	Pax2	paired box 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313673	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PAX2 gene	PMID:31601247
1305568	Pax2	paired box 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313674	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PAX2 gene	PMID:31683443
1305568	Pax2	paired box 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of PAX2 mRNA	PMID:30951980
1305568	Pax2	paired box 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of PAX2 mRNA	PMID:26377693
1305568	Pax2	paired box 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313673	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PAX2 intron	PMID:30157460
1305568	Pax2	paired box 2	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of PAX2 mRNA	PMID:26377693
1305568	Pax2	paired box 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of PAX2 mRNA	PMID:30951980
1305568	Pax2	paired box 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313674	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PAX2 mRNA	PMID:37019170
1305568	Pax2	paired box 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PAX2 mRNA	PMID:28415704
1305568	Pax2	paired box 2	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1313674	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of PAX2 gene	PMID:38995845
1305568	Pax2	paired box 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PAX2 mRNA	PMID:40194260
1305568	Pax2	paired box 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313673	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PAX2 mRNA	PMID:25979313
1305568	Pax2	paired box 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313673	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PAX2 gene	PMID:29154799
1305568	Pax2	paired box 2	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of PAX2 mRNA	PMID:25123088
1305568	Pax2	paired box 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313673	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PAX2 mRNA	PMID:24935251
1305568	Pax2	paired box 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PAX2 mRNA	PMID:33387578
1305568	Pax2	paired box 2	gene	CHEBI:46680	serpentine asbestos	increases methylation	ISO	RGD:1313673	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of PAX2 gene	PMID:29523930
1305568	Pax2	paired box 2	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	EXP		E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of PAX2 gene	PMID:37958445
1305568	Pax2	paired box 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313674	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PAX2 mRNA	PMID:25620056
1305568	Pax2	paired box 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PAX2 mRNA	PMID:25620056
1305568	Pax2	paired box 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313673	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PAX2 intron	PMID:30157460
1305568	Pax2	paired box 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PAX2 gene	PMID:35440735
1305568	Pax2	paired box 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313674	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PAX2 mRNA	PMID:25566086
1305568	Pax2	paired box 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313673	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA	PMID:27188386
1305568	Pax2	paired box 2	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313673	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PAX2 mRNA	PMID:26272509
1305568	Pax2	paired box 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313673	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA	PMID:27188386
1305568	Pax2	paired box 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313673	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA	PMID:27188386
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313675	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ARL5B mRNA	PMID:26272509
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL5B mRNA	PMID:27188386
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313676	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ARL5B mRNA	PMID:33045310
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ARL5B mRNA	PMID:26251327
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	ISO	RGD:1313675	E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of ARL5B mRNA	PMID:23792671
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:15343	acetaldehyde	increases expression	ISO	RGD:1313675	E	RGD:6480464	20130806	CTD	MESH:D000079	Acetaldehyde results in increased expression of ARL5B mRNA	PMID:23416264
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ARL5B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ARL5B mRNA	PMID:32699268
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ARL5B mRNA	PMID:36331819
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313675	E	RGD:6480464	20250401	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ARL8 mRNA	PMID:20044591
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313675	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ARL5B mRNA	PMID:35811015
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARL5B mRNA	PMID:35811015
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of ARL5B mRNA	PMID:32145629
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ARL5B mRNA	PMID:39298647
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313675	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARL5B mRNA	PMID:37042841
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313676	E	RGD:6480464	20130806	CTD	MESH:D005947	Glucose results in increased expression of ARL5B mRNA	PMID:17178593
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ARL5B mRNA	PMID:37992649
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313676	E	RGD:6480464	20130806	CTD	MESH:D005947	Glucose results in increased expression of ARL5B mRNA	PMID:17178593
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ARL5B mRNA	PMID:37992649
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313675	E	RGD:6480464	20250401	CTD	MESH:D002117	Calcitriol results in increased expression of ARL8 mRNA	PMID:16002434
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARL5B mRNA	PMID:33387578
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARL5B mRNA	PMID:36331819
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARL5B mRNA	PMID:39836092
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1313676	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of ARL5B mRNA	PMID:33914522
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARL5B mRNA	PMID:39012411
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313675	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in increased expression of ARL5B mRNA	PMID:19549813
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313676	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARL5B mRNA	PMID:19770486
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313675	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ARL5B mRNA	PMID:23649840
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ARL5B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ARL5B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ARL5B mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ARL5B mRNA	PMID:32699268|PMID:41430723
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARL5B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ARL5B mRNA	PMID:34911549
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20130806	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ARL5B mRNA	PMID:18593933
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313676	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARL5B mRNA	PMID:31919559
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARL5B mRNA	PMID:40504410
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ARL5B mRNA	PMID:27392435
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ARL5B mRNA	PMID:27392435
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313676	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ARL5B mRNA	PMID:30912803
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313675	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ARL5B mRNA	PMID:23195993|PMID:24768652|PMID:25583101
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313676	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARL5B mRNA	PMID:21570461
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARL5B mRNA	PMID:33387578
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARL5B promoter]	PMID:19654925
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ARL5B mRNA	PMID:28001369
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313675	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ARL5B mRNA	PMID:28001369
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARL5B mRNA	PMID:33212167
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1313675	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of ARL5B mRNA	PMID:23649840
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20130806	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ARL5B mRNA	PMID:20971185
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARL5B mRNA	PMID:29803840
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ARL5B mRNA	PMID:37992649
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ARL5B mRNA	PMID:25523186
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARL5B mRNA	PMID:39719251
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313675	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARL5B mRNA	PMID:38568856
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARL5B mRNA	PMID:40504410
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313675	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARL5B mRNA	PMID:20106945
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ARL5B mRNA	PMID:25523186
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20130806	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ARL5B mRNA	PMID:20971185
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20130806	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ARL5B mRNA	PMID:18593933
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ARL5B mRNA	PMID:27131904
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313675	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ARL5B mRNA	PMID:23806026
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARL5B mRNA	PMID:26238291
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313675	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ARL5B mRNA	PMID:22521957
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of ARL5B mRNA	PMID:16507785
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313676	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARL5B promoter alternative form	PMID:35295148
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ARL5B mRNA	PMID:23411599|PMID:34492290
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20130806	CTD	MESH:C006253	pirinixic acid results in decreased expression of ARL5B mRNA	PMID:20813756
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20130806	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARL5B mRNA	PMID:19710929
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20130806	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARL5B mRNA	PMID:19710929
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of ARL5B mRNA	PMID:28329830
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313676	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of ARL5B mRNA	PMID:33914522
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ARL5B mRNA	PMID:32145629
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:33418	graphite	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of ARL5B mRNA	PMID:29933104
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ARL5B mRNA	PMID:39298647
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ARL5B mRNA	PMID:21241498
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313676	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARL5B mRNA	PMID:21266533
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARL5B mRNA	PMID:39836092
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313675	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARL5B mRNA	PMID:38174414|PMID:38568856
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARL5B mRNA	PMID:39012411
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ARL5B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ARL5B mRNA	PMID:32699268
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ARL5B mRNA	PMID:27153767
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARL5B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ARL5B mRNA	PMID:36331819
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARL5B mRNA	PMID:23179753|PMID:27188386
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313675	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ARL5B mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313676	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of ARL5B mRNA	PMID:17178593
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ARL5B mRNA	PMID:37992649
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313675	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ARL5B mRNA	PMID:23649840
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313675	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ARL5B mRNA	PMID:28542535
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ARL5B mRNA	PMID:33387578
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313675	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ARL5B mRNA	PMID:26690555
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20130806	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARL5B mRNA]	PMID:18700144
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1313675	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ARL5B mRNA	PMID:20977926
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARL5B mRNA	PMID:35811015
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313675	E	RGD:6480464	20130806	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ARL5B mRNA	PMID:18687144
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARL5B mRNA	PMID:40504410
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ARL5B mRNA	PMID:29391264
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARL5B mRNA	PMID:29097150
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1313675	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of ARL5B mRNA	PMID:23228038
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313675	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ARL5B mRNA	PMID:22521957
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARL5B mRNA; Nanotubes, Carbon results in decreased expression of ARL5B mRNA	PMID:25554681|PMID:25620056
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313676	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ARL5B mRNA	PMID:23608068
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARL5B mRNA	PMID:39836092
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313675	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ARL5B mRNA	PMID:28988120
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ARL5B mRNA	PMID:28801915
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ARL5B mRNA	PMID:19564919
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of ARL5B mRNA	PMID:19564919
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:73297	SCH 23390	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in increased expression of ARL5B mRNA	PMID:19564919
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of ARL5B mRNA	PMID:19564919
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ARL5B mRNA	PMID:22206623
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL5B mRNA	PMID:27188386
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313675	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ARL5B mRNA	PMID:30928695
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARL5B gene]	PMID:28238834
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313675	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of ARL5B mRNA	PMID:19159669
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital results in decreased expression of ARL5B mRNA	PMID:23091169
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1313675	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of ARL5B mRNA	PMID:19095052
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of ARL5B mRNA	PMID:38995820
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313676	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ARL5B mRNA	PMID:39847705
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313675	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL5B mRNA	PMID:27188386
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ARL5B mRNA	PMID:27131904
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313675	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARL5B mRNA	PMID:38568856
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313675	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ARL5B mRNA	PMID:29301935
1305569	Arl5b	ARF like GTPase 5B	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ARL5B mRNA	PMID:23869203
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ZMPSTE24 mRNA	PMID:24236059
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZMPSTE24 mRNA	PMID:22378314
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313678	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ZMPSTE24 mRNA	PMID:30319688
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313677	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ZMPSTE24 mRNA	PMID:20044591
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ZMPSTE24 mRNA	PMID:21632981
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313678	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZMPSTE24 mRNA	PMID:39241906
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZMPSTE24 mRNA	PMID:33387578
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZMPSTE24 mRNA	PMID:36331819
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313677	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZMPSTE24 mRNA	PMID:35301059
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZMPSTE24 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZMPSTE24 mRNA	PMID:37236586|PMID:37325564
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZMPSTE24 mRNA	PMID:19549813
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313677	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZMPSTE24 gene	PMID:27153756
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313677	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ZMPSTE24 mRNA	PMID:35430440
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZMPSTE24 mRNA	PMID:22206623
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313677	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZMPSTE24 mRNA	PMID:39836092
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ZMPSTE24 mRNA	PMID:31881176
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20141111	CTD	MESH:C059514	Resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased acetylation of FOXO3 protein]; Resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of CAT protein]; Resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of GADD45A protein]; SIRT1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of CAT protein]]; SIRT1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of GADD45A protein]]	PMID:23217256
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313677	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ZMPSTE24 mRNA	PMID:28903495
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313678	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZMPSTE24 mRNA	PMID:20702594|PMID:21570461
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313678	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZMPSTE24 mRNA	PMID:31961203
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZMPSTE24 mRNA	PMID:17942748
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313677	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of ZMPSTE24 protein	PMID:39603559
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313677	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZMPSTE24 mRNA	PMID:32763439
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313678	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ZMPSTE24 protein	PMID:28918527
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ZMPSTE24 mRNA	PMID:25523186
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZMPSTE24 mRNA	PMID:39719251
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313677	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZMPSTE24 mRNA	PMID:39836092
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313678	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZMPSTE24 mRNA	PMID:22228805
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ZMPSTE24 mRNA	PMID:25523186
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313677	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZMPSTE24 mRNA	PMID:20458559
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:31781	lopinavir	decreases activity	ISO	RGD:1313677	E	RGD:6480464	20170303	CTD	MESH:D061466	Lopinavir results in decreased activity of ZMPSTE24 protein	PMID:18230615
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ZMPSTE24 mRNA	PMID:19136022
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313678	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZMPSTE24 mRNA	PMID:17426115|PMID:17950772
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of ZMPSTE24 mRNA]	PMID:17950772
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZMPSTE24 mRNA	PMID:25181051
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZMPSTE24 mRNA	PMID:34947998
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313677	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ZMPSTE24 protein	PMID:34186270
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313678	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZMPSTE24 promoter	PMID:27312807
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313678	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZMPSTE24 mRNA	PMID:39298647
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313677	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ZMPSTE24 protein	PMID:34186270
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313678	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ZMPSTE24 protein	PMID:35362542
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ZMPSTE24 protein]	PMID:35362542
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313677	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZMPSTE24 mRNA	PMID:35301059
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZMPSTE24 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZMPSTE24 mRNA	PMID:37236586|PMID:37325564
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZMPSTE24 mRNA	PMID:28302478
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZMPSTE24 mRNA	PMID:36331819
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313677	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZMPSTE24 mRNA	PMID:25979313
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313677	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZMPSTE24 mRNA	PMID:23179753
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313677	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ZMPSTE24 mRNA	PMID:17183730
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZMPSTE24 mRNA	PMID:25562108
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313677	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ZMPSTE24 mRNA	PMID:38832940
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:45409	ritonavir	decreases activity	ISO	RGD:1313677	E	RGD:6480464	20170303	CTD	MESH:D019438	Ritonavir results in decreased activity of ZMPSTE24 protein	PMID:18230615
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZMPSTE24 mRNA	PMID:17562736
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313677	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZMPSTE24 mRNA	PMID:39836092
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZMPSTE24 mRNA	PMID:17942748
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ZMPSTE24 protein]	PMID:35362542
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313677	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZMPSTE24 mRNA	PMID:20458559
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313677	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ZMPSTE24 mRNA	PMID:17183730
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ZMPSTE24 protein	PMID:32959892
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313678	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZMPSTE24 mRNA	PMID:22206623
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZMPSTE24 mRNA	PMID:22206623
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313677	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZMPSTE24 gene]	PMID:28238834
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of ZMPSTE24 mRNA	PMID:19136022
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313678	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of ZMPSTE24 mRNA	PMID:20702594
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of ZMPSTE24 mRNA	PMID:21858171
1305570	Zmpste24	zinc metallopeptidase STE24	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313677	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ZMPSTE24 mRNA	PMID:38568856
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313680	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CNNM4 mRNA	PMID:33045310
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313679	E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in increased expression of CNNM4 mRNA	PMID:30152185
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313680	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CNNM4 mRNA	PMID:39241906
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CNNM4 mRNA	PMID:39298647
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313679	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CNNM4 mRNA	PMID:38568856
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CNNM4 mRNA	PMID:33387578
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313679	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of CNNM4 mRNA	PMID:33647349
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313680	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CNNM4 mRNA	PMID:34319233
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313679	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CNNM4 protein	PMID:37730182
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CNNM4 mRNA	PMID:33387578
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313679	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CNNM4 mRNA	PMID:28818685
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313680	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CNNM4 mRNA	PMID:36331819
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313679	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CNNM4 mRNA	PMID:39836092
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CNNM4 protein	PMID:34915118
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:22984	calcium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the expression of CNNM4 mRNA	PMID:15913539
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313679	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CNNM4 mRNA	PMID:19549813
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313679	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CNNM4 gene	PMID:27153756
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313679	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNNM4 mRNA	PMID:39836092
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313680	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNNM4 mRNA	PMID:26377647
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313679	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CNNM4 mRNA	PMID:33212167
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313679	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CNNM4 mRNA	PMID:30851411
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CNNM4 mRNA	PMID:28959563
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313679	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CNNM4 mRNA	PMID:29803840
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29320	calcium(0)	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the expression of CNNM4 mRNA	PMID:15913539
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313679	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CNNM4 mRNA	PMID:38568856
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313679	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNNM4 mRNA	PMID:39836092
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CNNM4 mRNA	PMID:19770486
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313679	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CNNM4 mRNA	PMID:20106945|PMID:21632981
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313679	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CNNM4 exon; Benzo(a)pyrene results in increased methylation of CNNM4 promoter	PMID:27901495
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1313679	E	RGD:6480464	20191114	CTD	MESH:C006632	CNNM4 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313679	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CNNM4 protein]	PMID:26598702
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313680	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CNNM4 gene	PMID:35295148
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CNNM4 mRNA	PMID:34492290
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CNNM4 mRNA	PMID:18648102
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313680	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CNNM4 mRNA	PMID:18301758
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313680	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of CNNM4 mRNA	PMID:28329830
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CNNM4 mRNA	PMID:34947998
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CNNM4 mRNA	PMID:25181051
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313680	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CNNM4 mRNA	PMID:25172293
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CNNM4 mRNA	PMID:39298647
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313680	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CNNM4 intron	PMID:28392331
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313679	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNNM4 mRNA	PMID:37042841
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313679	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CNNM4 mRNA	PMID:39836092
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313679	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CNNM4 protein	PMID:26879310
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CNNM4 mRNA	PMID:40194260
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313679	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CNNM4 mRNA	PMID:28302478
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313680	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CNNM4 mRNA	PMID:36331819
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:39867	valproic acid	affects methylation	ISO	RGD:1313679	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid affects the methylation of CNNM4 gene	PMID:29501571
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313679	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of CNNM4 mRNA; Valproic Acid results in increased expression of CNNM4 protein	PMID:24935251|PMID:29154799|PMID:29501571
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313679	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CNNM4 gene	PMID:29154799
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313679	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CNNM4 mRNA	PMID:25562108|PMID:27989131
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313680	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CNNM4 mRNA	PMID:18502557
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313679	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CNNM4 mRNA	PMID:38832940
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313680	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CNNM4 mRNA	PMID:17562736
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CNNM4 mRNA	PMID:33387578
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313679	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CNNM4 mRNA	PMID:21420995|PMID:22230336|PMID:29067470
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313679	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNNM4 mRNA	PMID:39836092
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CNNM4 mRNA	PMID:29391264
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CNNM4 mRNA	PMID:35436446
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1313679	E	RGD:6480464	20191114	CTD	MESH:C032793	CNNM4 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313679	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CNNM4 protein]	PMID:26598702
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313680	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CNNM4 mRNA	PMID:25554681
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313679	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CNNM4 mRNA	PMID:39836092
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313680	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CNNM4 mRNA	PMID:36851058
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CNNM4 mRNA	PMID:22206623
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313679	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CNNM4 mRNA	PMID:30851411
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313679	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CNNM4 mRNA	PMID:19159669
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1313679	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of CNNM4 mRNA	PMID:11906190
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313679	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CNNM4 mRNA	PMID:38568856
1305571	Cnnm4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CNNM4 mRNA	PMID:23034163
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SDE2 mRNA]	PMID:31150632
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313681	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SDE2 mRNA	PMID:30529165
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1603354	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SDE2 mRNA	PMID:26079696
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313681	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SDE2 mRNA	PMID:30319688
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313681	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SDE2 mRNA	PMID:39241906
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SDE2 mRNA	PMID:23829299
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603354	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SDE2 mRNA	PMID:37042841
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1603354	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SDE2 protein	PMID:37730182
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SDE2 mRNA	PMID:33387578
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SDE2 mRNA	PMID:39012411
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1603354	E	RGD:6480464	20121113	CTD	MESH:D019327	Copper Sulfate results in increased expression of SDE2 mRNA	PMID:19549813
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:23808	dimethylarsinous acid	increases expression	ISO	RGD:1603354	E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in increased expression of SDE2 mRNA	PMID:23487506
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1603354	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SDE2 protein	PMID:23301498
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1603354	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SDE2 mRNA	PMID:27153756
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1603354	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SDE2 mRNA	PMID:23649840
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SDE2 mRNA	PMID:31150632
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SDE2 mRNA]	PMID:31150632
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1603354	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of SDE2 mRNA	PMID:18414638
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1603354	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SDE2 mRNA	PMID:39836092
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1603354	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SDE2 mRNA	PMID:27392435
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1603354	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of SDE2 mRNA	PMID:23195993
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SDE2 mRNA	PMID:34747641
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1603354	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SDE2 mRNA	PMID:33212167
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1603354	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SDE2 mRNA	PMID:30851411
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1603354	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SDE2 mRNA	PMID:32763439
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1603354	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of SDE2 mRNA	PMID:29803840
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603354	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SDE2 mRNA	PMID:38568856
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1603354	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SDE2 mRNA	PMID:39836092
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1603354	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SDE2 mRNA	PMID:20064835
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1603354	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SDE2 mRNA	PMID:26014281
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1603354	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SDE2 mRNA	PMID:25895662
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SDE2 mRNA	PMID:34492290
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1603354	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of SDE2 mRNA	PMID:38479592
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313681	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of SDE2 mRNA	PMID:28329830
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SDE2 mRNA	PMID:25181051
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603354	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SDE2 protein	PMID:33376534
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SDE2 mRNA	PMID:30816183|PMID:32528016
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1603354	E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of SDE2 protein]	PMID:33376534
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1603354	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of SDE2 gene	PMID:31601247
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313681	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SDE2 mRNA	PMID:37019170
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603354	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SDE2 mRNA	PMID:37042841
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SDE2 mRNA	PMID:19010381
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SDE2 mRNA	PMID:39012411
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SDE2 mRNA	PMID:30047161
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1603354	E	RGD:6480464	20121113	CTD	MESH:C018021	cobaltous chloride results in increased expression of SDE2 mRNA	PMID:19320972
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1603354	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SDE2 mRNA	PMID:31533062
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603354	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SDE2 mRNA	PMID:25979313
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SDE2 mRNA	PMID:38685447|PMID:41580965
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603354	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SDE2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SDE2 mRNA	PMID:33387578
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603354	E	RGD:6480464	20121113	CTD	MESH:D000082	Acetaminophen results in increased expression of SDE2 mRNA	PMID:21420995
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1603354	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of SDE2 mRNA	PMID:18414638
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1603354	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SDE2 mRNA	PMID:39836092
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313681	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SDE2 mRNA	PMID:30529165
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of SDE2 mRNA	PMID:41580965
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1603354	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SDE2 mRNA	PMID:28988120
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:749016	gossypol acetic acid	decreases expression	ISO	RGD:1603354	E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of SDE2 protein	PMID:29938581
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1603354	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SDE2 mRNA	PMID:30851411
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:79369	elesclomol	increases expression	ISO	RGD:1603354	E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of SDE2 mRNA	PMID:18723479
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SDE2 mRNA	PMID:30047161
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1603354	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SDE2 mRNA	PMID:26014281
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1603354	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SDE2 mRNA	PMID:38568856
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313681	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SDE2 mRNA	PMID:28973697
1305572	Sde2	spliceosome associated SDE2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SDE2 mRNA	PMID:23034163
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313682	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RPL38 mRNA	PMID:38218311
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of RPL38 mRNA	PMID:35967413
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313683	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RPL38 mRNA	PMID:33045310
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of RPL38 gene	PMID:35440735
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313683	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RPL38 mRNA	PMID:30319688
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313683	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RPL38 mRNA	PMID:39241906
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D004958	Estradiol results in decreased expression of RPL38 mRNA	PMID:23019147
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RPL38 mRNA	PMID:33754040
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL38 protein	PMID:23301498
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RPL38 mRNA	PMID:30779732
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RPL38 mRNA	PMID:18356318
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL38 mRNA	PMID:39836092
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D012643	Selenium results in decreased expression of RPL38 mRNA	PMID:19244175
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313683	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of RPL38 mRNA	PMID:30912803
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D019833	Genistein results in decreased expression of RPL38 protein	PMID:20884965
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of RPL38 protein]	PMID:20884965
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313683	E	RGD:6480464	20160223	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPL38 mRNA	PMID:17949056|PMID:21570461
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313683	E	RGD:6480464	20160223	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of RPL38 mRNA	PMID:17942748
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313682	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RPL38 mRNA	PMID:34089799
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RPL38 protein	PMID:33212167
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of RPL38 mRNA	PMID:24690739
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL38 mRNA; sodium arsenite results in decreased expression of and results in increased activity of RPL38 protein	PMID:30528433|PMID:39836092
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RPL38 protein	PMID:33278487
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:C015001	arsenite results in increased methylation of RPL38 promoter	PMID:23974009
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RPL38 mRNA]	PMID:32406909
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of RPL38 mRNA	PMID:24690739
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RPL38 mRNA	PMID:18356318
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RPL38 mRNA	PMID:20018196
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RPL38 mRNA	PMID:19150397
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20160223	CTD	MESH:D000643	Ammonium Chloride affects the expression of RPL38 mRNA	PMID:16483693
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of RPL38 mRNA	PMID:38568856
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313683	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RPL38 gene; titanium dioxide results in decreased methylation of RPL38 promoter	PMID:35295148
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20160223	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RPL38 mRNA	PMID:18648102
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313682	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RPL38 mRNA	PMID:30903817
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL38 mRNA	PMID:32145629
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL38 mRNA	PMID:38568856
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL38 mRNA	PMID:35598803
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160223	CTD	MESH:C006780	bisphenol A results in increased expression of RPL38 mRNA	PMID:25181051
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RPL38 mRNA	PMID:19244175
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RPL38 mRNA	PMID:40203079
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313682	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of RPL38 protein	PMID:34186270
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313683	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RPL38 mRNA	PMID:39298647
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RPL38 mRNA	PMID:38685157
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313682	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RPL38 protein	PMID:34186270
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of RPL38 mRNA	PMID:21241498
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313683	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RPL38 mRNA	PMID:37019170
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313683	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of RPL38 mRNA	PMID:34813904
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313683	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of RPL38 mRNA	PMID:34813904
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of RPL38 gene	PMID:33148267
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313682	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RPL38 mRNA	PMID:37042841
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313682	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RPL38 mRNA	PMID:38568856
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D012643	Selenium results in decreased expression of RPL38 mRNA	PMID:19244175
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RPL38 mRNA	PMID:38568856
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313682	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RPL38 mRNA	PMID:31533062
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:C100187	chloropicrin affects the expression of RPL38 mRNA	PMID:26352163
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313683	E	RGD:6480464	20160223	CTD	MESH:D013629	Tamoxifen affects the expression of RPL38 mRNA	PMID:17555576
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313683	E	RGD:6480464	20160223	CTD	MESH:D000082	Acetaminophen affects the expression of RPL38 mRNA	PMID:17562736
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of RPL38 mRNA	PMID:24690739
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL38 mRNA	PMID:39836092
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313683	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RPL38 mRNA	PMID:35436446
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313683	E	RGD:6480464	20160223	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RPL38 mRNA	PMID:17555576
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20160223	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of RPL38 mRNA	PMID:17942748
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313683	E	RGD:6480464	20160223	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of RPL38 mRNA	PMID:17942748
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RPL38 mRNA	PMID:30047161
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313682	E	RGD:6480464	20160223	CTD	MESH:D011192	Potassium Dichromate results in increased expression of RPL38 mRNA	PMID:11678601
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313682	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPL38 protein	PMID:32959892
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20160223	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of RPL38 protein	PMID:26558463
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of RPL38 gene	PMID:33148267
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313682	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RPL38 protein	PMID:34186270
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL38 protein	PMID:37664457
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313682	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RPL38 protein	PMID:31285264
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313683	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPL38 mRNA	PMID:30294300
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RPL38 mRNA	PMID:30047161
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RPL38 mRNA	PMID:40826991
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1313683	E	RGD:6480464	20180703	CTD	MESH:C089595	cylindrospermopsin results in increased expression of RPL38 mRNA	PMID:20936652
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313682	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL38 protein	PMID:37664457
1305573	Rpl38	ribosomal protein L38	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of RPL38 mRNA	PMID:30047161
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1351863	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of POLR3A mRNA	PMID:38218311
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of POLR3A mRNA]	PMID:31150632
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of POLR3A mRNA	PMID:32145629
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1351863	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of POLR3A mRNA	PMID:31614463
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1351863	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of POLR3A mRNA	PMID:21179406
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313684	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of POLR3A mRNA	PMID:19770486
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1351863	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of POLR3A exon; Aflatoxin B1 results in increased methylation of POLR3A intron	PMID:30157460
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of POLR3A mRNA	PMID:31150632
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of POLR3A mRNA]	PMID:31150632
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313684	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of POLR3A mRNA	PMID:25629700
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313684	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of POLR3A mRNA	PMID:30912803
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLR3A mRNA	PMID:22298810
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313684	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLR3A mRNA	PMID:21570461
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1351863	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of POLR3A mRNA	PMID:33212167
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1351863	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POLR3A mRNA	PMID:30851411
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1351863	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of POLR3A exon	PMID:30157460
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313684	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POLR3A mRNA	PMID:22228805
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1351863	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POLR3A promoter	PMID:27901495
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1351863	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to POLR3A mRNA]	PMID:32406909
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of POLR3A mRNA	PMID:25181051
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1351863	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of POLR3A gene	PMID:31601247
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1351863	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of POLR3A mRNA	PMID:24752500
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313684	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of POLR3A mRNA	PMID:37019170
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of POLR3A mRNA	PMID:17602206
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of POLR3A mRNA	PMID:17602206
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351863	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of POLR3A mRNA	PMID:37042841
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of POLR3A mRNA	PMID:19162173
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1351863	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of POLR3A mRNA	PMID:40419075
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1351863	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of POLR3A mRNA	PMID:38832940
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1351863	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of POLR3A mRNA	PMID:24752500
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1351863	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of POLR3A mRNA	PMID:31675489
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313684	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of POLR3A mRNA	PMID:35436446
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313684	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of POLR3A mRNA	PMID:40234311
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of POLR3A mRNA	PMID:19162173
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of POLR3A mRNA	PMID:24136188
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1351863	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POLR3A mRNA	PMID:30851411
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1351863	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to POLR3A gene]	PMID:28238834
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1351863	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of POLR3A protein	PMID:31675489
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313684	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of POLR3A protein	PMID:24648495
1305574	Polr3a	RNA polymerase III subunit A	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313684	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of POLR3A mRNA	PMID:28973697
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313686	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of OSGEPL1 mRNA	PMID:33045310
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313686	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of OSGEPL1 mRNA	PMID:37995155
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of OSGEPL1 mRNA]	PMID:31150632
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of OSGEPL1 mRNA	PMID:33167477
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of OSGEPL1 mRNA	PMID:21632981
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of OSGEPL1 mRNA	PMID:35811015
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313685	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of OSGEPL1 mRNA	PMID:35811015
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of OSGEPL1 mRNA	PMID:19484750
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313686	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of OSGEPL1 mRNA	PMID:39298647
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of OSGEPL1 mRNA	PMID:33387578
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313685	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of OSGEPL1 mRNA	PMID:37042841
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of OSGEPL1 mRNA	PMID:33387578
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of OSGEPL1 mRNA	PMID:28818685
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of OSGEPL1 mRNA	PMID:37748715
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of OSGEPL1 mRNA	PMID:21396975
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313685	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of OSGEPL1 mRNA	PMID:35430440
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of OSGEPL1 mRNA	PMID:31150632
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of OSGEPL1 mRNA	PMID:31919559
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of OSGEPL1 mRNA]	PMID:31150632
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313686	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of OSGEPL1 mRNA	PMID:22206623
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313685	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of OSGEPL1 gene	PMID:25304211
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313686	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of OSGEPL1 mRNA	PMID:40504410
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of OSGEPL1 mRNA	PMID:27594783
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313685	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of OSGEPL1 mRNA	PMID:27392435
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313685	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of OSGEPL1 mRNA	PMID:27392435
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313686	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of OSGEPL1 mRNA	PMID:21570461
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of OSGEPL1 mRNA	PMID:33212167
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:2896	astemizole	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016589	Astemizole results in increased expression of OSGEPL1 mRNA	PMID:20221588
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:29191	hydroxyl	multiple interactions	ISO	RGD:1313685	E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in decreased expression of OSGEPL1 mRNA	PMID:33656867
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of OSGEPL1 mRNA	PMID:38568856
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313686	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of OSGEPL1 mRNA	PMID:40504410
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313685	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of OSGEPL1 promoter	PMID:27901495
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313685	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to OSGEPL1 mRNA]	PMID:32406909
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313685	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of OSGEPL1 mRNA	PMID:20458559
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of OSGEPL1 mRNA	PMID:23411599
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of OSGEPL1 mRNA	PMID:25181051
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of OSGEPL1 mRNA	PMID:34947998
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of OSGEPL1 protein	PMID:33376534
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of OSGEPL1 mRNA	PMID:33221593
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of OSGEPL1 mRNA	PMID:30816183|PMID:32528016
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313686	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of OSGEPL1 mRNA	PMID:39298647
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313686	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of OSGEPL1 mRNA	PMID:38685157
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of OSGEPL1 mRNA	PMID:21266533
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313685	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of OSGEPL1 mRNA	PMID:37042841
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of OSGEPL1 mRNA	PMID:25539665
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of OSGEPL1 mRNA	PMID:28302478
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of OSGEPL1 mRNA	PMID:31533062
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313685	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of OSGEPL1 mRNA	PMID:25979313
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313685	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of OSGEPL1 gene	PMID:29154799
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313685	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of OSGEPL1 mRNA	PMID:29154799
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of OSGEPL1 mRNA	PMID:20106945|PMID:25562108
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of OSGEPL1 mRNA	PMID:19770486
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of OSGEPL1 mRNA	PMID:38832940
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	ISO	RGD:1313685	E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in decreased expression of OSGEPL1 mRNA	PMID:33656867
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of OSGEPL1 mRNA	PMID:29067470
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of OSGEPL1 mRNA	PMID:33387578
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of OSGEPL1 mRNA	PMID:20977926
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313685	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of OSGEPL1 mRNA	PMID:35811015
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313685	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of OSGEPL1 gene	PMID:25304211
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313686	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of OSGEPL1 mRNA	PMID:40504410
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313685	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of OSGEPL1 mRNA	PMID:22079256
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313685	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of OSGEPL1 mRNA	PMID:20458559
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of OSGEPL1 mRNA	PMID:28988120
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of OSGEPL1 mRNA	PMID:22206623
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313686	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of OSGEPL1 mRNA	PMID:22206623
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of OSGEPL1 mRNA	PMID:22079256
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313685	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of OSGEPL1 mRNA	PMID:22079256
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313685	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of OSGEPL1 mRNA	PMID:37199045
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313686	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of OSGEPL1 mRNA	PMID:39847705
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of OSGEPL1 mRNA	PMID:21346803
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313685	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of OSGEPL1 mRNA	PMID:38568856
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of OSGEPL1 mRNA	PMID:21346803
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of OSGEPL1 mRNA	PMID:19015723
1305575	Osgepl1	O-sialoglycoprotein endopeptidase-like 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of OSGEPL1 mRNA	PMID:23034163
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of SETD2 mRNA	PMID:35967413
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SETD2 mRNA	PMID:33045310
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of SETD2 mRNA	PMID:40945087
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:16118	berberine	increases expression	ISO	RGD:1602894	E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in increased expression of SETD2 mRNA	PMID:27311644
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of SETD2 mRNA	PMID:30207508
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1621311	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SETD2 mRNA	PMID:30319688
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of SETD2 mRNA	PMID:29018328
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of SETD2 mRNA	PMID:18951874
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of SETD2 protein	PMID:19207037
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SETD2 mRNA	PMID:39241906
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SETD2 mRNA	PMID:32145629
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1602894	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SETD2 mRNA	PMID:32030086
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602894	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SETD2 mRNA	PMID:37042841
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of SETD2 mRNA	PMID:20655997
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SETD2 mRNA	PMID:33754040
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1602894	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SETD2 protein	PMID:37730182
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of SETD2 mRNA	PMID:27462272
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:21891	N(6)-methyladenosine	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:C010223	METTL3 inhibits the reaction [N-methyladenosine results in decreased expression of SETD2 mRNA alternative form]	PMID:36260529
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:21891	N(6)-methyladenosine	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20230704	CTD	MESH:C010223	[FTO results in decreased abundance of N-methyladenosine] which results in decreased methylation of SETD2 mRNA alternative form; [METTL3 results in increased abundance of N-methyladenosine] which results in increased methylation of SETD2 mRNA alternative form	PMID:36260529
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of SETD2 mRNA	PMID:23369406
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1621311	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SETD2 mRNA	PMID:37236586
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1621311	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SETD2 mRNA	PMID:19770486
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SETD2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SETD2 mRNA	PMID:35430440|PMID:41430723
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1621311	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SETD2 mRNA	PMID:22206623
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1602894	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SETD2 protein	PMID:35688186
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of SETD2 gene	PMID:35440735
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SETD2 mRNA	PMID:30912803
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019833	Genistein results in increased expression of SETD2 protein	PMID:24552547
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621311	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SETD2 mRNA	PMID:21570461
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SETD2 mRNA	PMID:34747641
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:28177	theophylline	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in decreased expression of SETD2 mRNA	PMID:18951874
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1602894	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SETD2 mRNA	PMID:26272509
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SETD2 mRNA	PMID:33212167
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SETD2 mRNA	PMID:29803840
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1602894	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SETD2 protein	PMID:35688186
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased expression of SETD2 mRNA	PMID:32844245
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602894	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SETD2 intron	PMID:30157460
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SETD2 mRNA]	PMID:32406909
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1602894	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of SETD2 mRNA	PMID:20382639
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SETD2 mRNA	PMID:19150397
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SETD2 mRNA	PMID:25729387
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621311	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SETD2 promoter	PMID:35295148
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SETD2 mRNA	PMID:34492290
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SETD2 mRNA	PMID:33221593
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SETD2 mRNA	PMID:30816183
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602894	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of SETD2 mRNA	PMID:32030086
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SETD2 gene	PMID:28505145
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SETD2 mRNA	PMID:19244175
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1621311	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SETD2 mRNA	PMID:39298647
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SETD2 mRNA	PMID:28628672
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SETD2 mRNA	PMID:28392331
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SETD2 mRNA	PMID:37019170
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SETD2 mRNA	PMID:28628672
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602894	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SETD2 mRNA	PMID:37042841
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1621311	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SETD2 mRNA	PMID:37236586
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20230704	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SETD2 mRNA alternative form	PMID:36260529
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1602894	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SETD2 mRNA	PMID:24449571
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of SETD2 mRNA	PMID:28001369
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SETD2 mRNA	PMID:28628672
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:4356	desferrioxamine B	affects expression	ISO	RGD:1602894	E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine affects the expression of SETD2 mRNA	PMID:23483119
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:4356	desferrioxamine B	increases expression	ISO	RGD:1602894	E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine results in increased expression of SETD2 mRNA	PMID:23483119
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SETD2 mRNA	PMID:27188386
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SETD2 mRNA	PMID:26272509
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SETD2 mRNA	PMID:27188386
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621311	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SETD2 mRNA	PMID:17562736
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:46666	crocidolite asbestos	affects response to substance	ISO	RGD:1602894	E	RGD:6480464	20240109	CTD	MESH:D017638	SETD2 protein affects the susceptibility to Asbestos, Crocidolite	PMID:37147272
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SETD2 mRNA	PMID:29279043
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:46666	crocidolite asbestos	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20240109	CTD	MESH:D017638	SETD2 protein affects the reaction [Asbestos, Crocidolite results in decreased expression of CADM1 mRNA]; SETD2 protein affects the reaction [Asbestos, Crocidolite results in decreased expression of THBS2 mRNA]; SETD2 protein affects the reaction [Asbestos, Crocidolite results in increased expression of CLDN11 mRNA]	PMID:37147272
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:47286	CU-O LINKAGE	decreases phosphorylation	ISO	RGD:1602894	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased phosphorylation of SETD2 protein	PMID:25470785
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1621311	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SETD2 mRNA	PMID:17555576
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SETD2 mRNA	PMID:28628672
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SETD2 mRNA; Nanotubes, Carbon results in decreased expression of SETD2 mRNA	PMID:25554681
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1602894	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SETD2 mRNA	PMID:26705709
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SETD2 mRNA	PMID:25729387
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SETD2 mRNA	PMID:25729387
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SETD2 mRNA	PMID:15336504
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of SETD2 mRNA	PMID:27462272
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1621311	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SETD2 mRNA	PMID:22206623
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1621311	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SETD2 mRNA	PMID:22206623
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:7549	N(gamma)-nitro-L-arginine methyl ester	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D019331	NG-Nitroarginine Methyl Ester results in decreased expression of SETD2 mRNA alternative form	PMID:36260529
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1602894	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SETD2 protein	PMID:31285264
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SETD2 mRNA	PMID:27188386
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SETD2 gene]	PMID:28238834
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602894	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SETD2 mRNA	PMID:27188386
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1602894	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SETD2 mRNA	PMID:38568856
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1602894	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SETD2 mRNA	PMID:29301935
1305576	Setd2	SET domain containing 2, histone lysine methyltransferase	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1602894	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SETD2 mRNA	PMID:27188386
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MCM2 mRNA	PMID:38218311
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20170228	CTD	MESH:C014026	hexamethylene bisacetamide results in decreased expression of MCM2 mRNA	PMID:26941288
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313690	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MCM2 mRNA	PMID:37995155
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCM2 mRNA	PMID:20938992
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MCM2 mRNA	PMID:16249480
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of MCM2 protein	PMID:39571964
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MCM2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MCM2 mRNA	PMID:32699268
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of MCM2 mRNA	PMID:26516004
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MCM2 mRNA	PMID:36331819
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16118	berberine	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20131008	CTD	MESH:D001599	Berberine inhibits the reaction [Dexamethasone results in increased expression of MCM2 mRNA]	PMID:20462044
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of MCM2 mRNA	PMID:17547211
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of MCM2 mRNA	PMID:23727915
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1313689	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of MCM2 protein	PMID:35688186
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MCM2 mRNA	PMID:39241906
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of MCM2 mRNA	PMID:15598610
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	affects phosphorylation	ISO	RGD:1313689	E	RGD:6480464	20160607	CTD	MESH:D004958	Estradiol affects the phosphorylation of MCM2 protein	PMID:27026707
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of MCM2 mRNA	PMID:32145629
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313689	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of MCM2 mRNA	PMID:16474171|PMID:17268063|PMID:19167446|PMID:24758408
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313690	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of MCM2 mRNA	PMID:25210133
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in increased expression of MCM2 mRNA]	PMID:24758408
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20160315	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] affects the localization of MCM2 protein; [Progesterone co-treated with Estradiol] results in decreased expression of MCM2 protein; ESR1 protein promotes the reaction [Estradiol results in increased expression of MCM2 mRNA]	PMID:16966611|PMID:25210133
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA	PMID:25510870
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313689	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MCM2 mRNA	PMID:38568856
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16602	trichloroethene	decreases phosphorylation	ISO	RGD:1313689	E	RGD:6480464	20231205	CTD	MESH:D014241	Trichloroethylene results in decreased phosphorylation of MCM2 protein	PMID:26018768
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCM2 mRNA	PMID:20938992
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of MCM2 mRNA	PMID:16966611
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] affects the localization of MCM2 protein; [Progesterone co-treated with Estradiol] results in decreased expression of MCM2 protein	PMID:16966611
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313689	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MCM2 mRNA	PMID:21179406
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of MCM2 mRNA	PMID:26079696
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of MCM2 mRNA	PMID:38160208
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM2 mRNA	PMID:37992649
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17296	aniline	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C023650	aniline results in increased expression of MCM2 protein	PMID:21070798
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MCM2 mRNA	PMID:21592394
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM2 mRNA	PMID:21592394
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of MCM2 mRNA	PMID:27683099
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM2 mRNA	PMID:37992649
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313690	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MCM2 mRNA	PMID:23892564
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313689	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MCM2 protein	PMID:31163220
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MCM2 mRNA	PMID:26577399
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313689	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MCM2 protein	PMID:37730182
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MCM2 mRNA	PMID:21592394
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM2 mRNA	PMID:21592394
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MCM2 mRNA	PMID:33387578
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MCM2 mRNA	PMID:22061828
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MCM2 mRNA	PMID:28818685
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in decreased expression of MCM2 mRNA	PMID:12634122
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120717	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MCM2 mRNA	PMID:19840844
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:22633	arsenite ion	multiple interactions	EXP		E	RGD:6480464	20170117	CTD	MESH:D018053	[AS3MT protein results in increased susceptibility to Arsenites] which affects the expression of MCM2 mRNA	PMID:19411561
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in increased expression of MCM2 mRNA	PMID:17547211
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA	PMID:25510870
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA	PMID:25510870
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MCM2 mRNA	PMID:19549813
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MCM2 protein	PMID:20106945
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313689	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM2 mRNA	PMID:22100608
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of MCM2 mRNA	PMID:17547211
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of MCM2 mRNA	PMID:25102026
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MCM2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MCM2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MCM2 mRNA	PMID:32699268
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MCM2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MCM2 mRNA	PMID:34911549
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MCM2 mRNA	PMID:30779732
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1313689	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of MCM2 mRNA	PMID:22171008
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313690	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MCM2 mRNA	PMID:27339419|PMID:31919559
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MCM2 mRNA	PMID:25629700
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCM2 mRNA	PMID:20938992
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MCM2 mRNA	PMID:40504410
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D000966	Antimony Potassium Tartrate results in increased expression of MCM2 mRNA	PMID:17547211
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MCM2 mRNA	PMID:26272509
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM2 mRNA	PMID:27188386
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313689	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MCM2 protein	PMID:35688186
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MCM2 mRNA	PMID:31295307
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MCM2 mRNA	PMID:31881176
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of MCM2 mRNA	PMID:19167446
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MCM2 mRNA	PMID:19921347
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MCM2 mRNA	PMID:27392435
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of MCM2 mRNA	PMID:21151649|PMID:40618947
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of MCM2 mRNA	PMID:16061661|PMID:27594783
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1313689	E	RGD:6480464	20130514	CTD	MESH:D010278	Parathion results in increased expression of MCM2 mRNA	PMID:17390078
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:27928	parathion	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D010278	[Parathion co-treated with Estrogens] results in increased expression of MCM2 mRNA	PMID:18204794
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28073	chromium atom	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D002857	Chromium results in increased expression of MCM2 mRNA	PMID:17547211
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of MCM2 mRNA	PMID:16474171
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313689	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MCM2 mRNA	PMID:25583101
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313689	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM2 mRNA	PMID:22574217
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313690	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM2 mRNA	PMID:21570461
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MCM2 mRNA	PMID:16611356
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM2 mRNA	PMID:34747641
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313689	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM2 mRNA	PMID:20106945|PMID:21496263
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313690	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM2 mRNA	PMID:15667827|PMID:21496263
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20160822	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of MCM2 mRNA	PMID:26159488
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MCM2 mRNA	PMID:17942748
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MCM2 protein	PMID:39603559
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MCM2 mRNA	PMID:28959563
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of MCM2 mRNA	PMID:22465980|PMID:30556269
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MCM2 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MCM2 mRNA	PMID:20971185|PMID:30911355
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MCM2 mRNA	PMID:29803840
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM2 mRNA	PMID:37992649
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1313689	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of MCM2 protein	PMID:35688186
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:28794	coumarin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of MCM2 mRNA	PMID:18480146
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of MCM2 mRNA	PMID:22623647
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCM2 mRNA	PMID:12760830|PMID:38568856
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313689	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of MCM2 mRNA	PMID:28595984|PMID:29301061|PMID:34032870|PMID:39719251
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20240430	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of MCM2 protein; MCM2 protein inhibits the reaction [sodium arsenite inhibits the reaction [H3-3A protein binds to MT1F promoter]]; MCM2 protein inhibits the reaction [sodium arsenite inhibits the reaction [H3-3A protein binds to NR4A1 promoter]]; sodium arsenite inhibits the reaction [H3-3A protein binds to MCM2 protein]	PMID:37734572|PMID:39571964
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MCM2 mRNA	PMID:40504410
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MCM2 mRNA	PMID:22378314
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313689	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MCM2 intron	PMID:30157460
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM2 mRNA	PMID:16120219|PMID:21632981
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM2 mRNA	PMID:19770486
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313690	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MCM2 exon; Benzo(a)pyrene results in decreased methylation of MCM2 intron	PMID:27901495
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCM2 mRNA	PMID:20106945|PMID:32234424
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to MCM2 promoter]	PMID:19654925
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of MCM2 mRNA	PMID:22465980|PMID:30556269
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MCM2 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MCM2 mRNA	PMID:20971185|PMID:30911355
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1313689	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of MCM2 mRNA	PMID:22171008
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:30304	antimony(0)	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D000965	Antimony results in increased expression of MCM2 mRNA	PMID:17547211
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MCM2 mRNA	PMID:20382639
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313689	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MCM2 mRNA; Arsenic Trioxide results in increased expression of MCM2 protein	PMID:17530438|PMID:17547211|PMID:25419056
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MCM2 protein]	PMID:26598702
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:3090	bicalutamide	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in decreased expression of MCM2 mRNA	PMID:15638997
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MCM2 gene	PMID:31601247
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of MCM2 mRNA	PMID:21829687
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MCM2 mRNA	PMID:25729387
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM2 mRNA	PMID:25729387
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313690	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MCM2 gene	PMID:35295148
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313690	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MCM2 mRNA	PMID:23557971
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313690	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MCM2 gene	PMID:35295148
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:32293	verteporfin	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20181113	CTD	MESH:C098350	Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of MCM2 mRNA]	PMID:29893953
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of MCM2 mRNA	PMID:34492290
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MCM2 mRNA	PMID:30723492
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313690	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MCM2 mRNA	PMID:17950772|PMID:18301758|PMID:20813756|PMID:23626729|PMID:23811191
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of MCM2 mRNA; [pirinixic acid co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM2 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of MCM2 mRNA]	PMID:17950772|PMID:20813756|PMID:23626729
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313690	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MCM2 mRNA	PMID:28472532
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MCM2 mRNA	PMID:38479592
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of MCM2 mRNA	PMID:19167457
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MCM2 mRNA	PMID:25181051|PMID:32145629
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313689	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MCM2 mRNA	PMID:30903817
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313690	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of MCM2 promoter	PMID:27334623
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM2 mRNA	PMID:34947998
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM2 mRNA; bisphenol A results in decreased expression of MCM2 protein	PMID:29275510|PMID:37567409
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120501	CTD	MESH:C006780	bisphenol A results in increased expression of MCM2 mRNA; bisphenol A results in increased expression of MCM2 protein	PMID:16474171|PMID:17268063|PMID:33516137
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MCM2 gene	PMID:28505145
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MCM2 gene	PMID:31601247
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MCM2 protein	PMID:31675489
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313690	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MCM2 mRNA	PMID:26682919
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA	PMID:25510870
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA	PMID:25510870
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MCM2 mRNA	PMID:40203079
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313689	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MCM2 gene	PMID:31601247
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313690	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MCM2 mRNA	PMID:26377693
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MCM2 mRNA	PMID:28628672
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20250311	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MCM2 mRNA	PMID:28392331|PMID:32308655
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313689	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MCM2 protein	PMID:32171938
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MCM2 mRNA	PMID:21266533
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MCM2 mRNA	PMID:17361019|PMID:21266533
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1313689	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to MCM2 protein	PMID:32991956
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1313690	E	RGD:6480464	20180703	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of MCM2 mRNA	PMID:21404309
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MCM2 mRNA	PMID:28628672
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MCM2 mRNA	PMID:19041683
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313690	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MCM2 mRNA	PMID:17854601|PMID:24535843
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MCM2 mRNA]	PMID:17854601
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of MCM2 mRNA	PMID:17312168
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34905	paraquat	affects expression	ISO	RGD:1313690	E	RGD:6480464	20160119	CTD	MESH:D010269	Paraquat affects the expression of MCM2 mRNA	PMID:26345256
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20220111	CTD	MESH:D010269	[Paraquat co-treated with Antigens, Dermatophagoides] results in decreased expression of MCM2 mRNA	PMID:34097952
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313689	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MCM2 mRNA	PMID:37042841
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of MCM2 mRNA	PMID:30589522
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of MCM2 mRNA	PMID:26678675
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313690	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MCM2 mRNA	PMID:26377693
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of MCM2 mRNA	PMID:18500788
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MCM2 mRNA	PMID:30723492
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MCM2 mRNA	PMID:17547211
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120717	CTD	MESH:D019256	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MCM2 mRNA	PMID:19840844
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MCM2 mRNA	PMID:35163327
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of MCM2 mRNA	PMID:20562052|PMID:22079235|PMID:25539665
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20140311	CTD	MESH:D011285	[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM2 mRNA; [Phenobarbital co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM2 mRNA; [pirinixic acid co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM2 mRNA	PMID:23626729
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MCM2 mRNA	PMID:19320972
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MCM2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MCM2 mRNA	PMID:32699268
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MCM2 mRNA	PMID:40194260
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MCM2 mRNA	PMID:31533062
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313689	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MCM2 mRNA	PMID:19167446
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MCM2 mRNA	PMID:19167446
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MCM2 mRNA	PMID:39529242
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:3930	cryptolepine	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of MCM2 mRNA	PMID:16120219
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MCM2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MCM2 mRNA	PMID:36331819
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of MCM2 mRNA	PMID:22110744
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of MCM2 mRNA	PMID:25993096
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of MCM2 mRNA	PMID:18299980
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MCM2 mRNA	PMID:17963808
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MCM2 mRNA	PMID:30047161
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1313689	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of MCM2 mRNA	PMID:25562108
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of MCM2 mRNA	PMID:20106945|PMID:21632981
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MCM2 mRNA	PMID:17555576
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313690	E	RGD:6480464	20131008	CTD	MESH:D003907	Dexamethasone results in increased expression of MCM2 mRNA	PMID:20462044
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MCM2 mRNA	PMID:28628672
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20131008	CTD	MESH:D003907	Berberine inhibits the reaction [Dexamethasone results in increased expression of MCM2 mRNA]	PMID:20462044
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313690	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MCM2 mRNA	PMID:28973697
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM2 mRNA	PMID:37992649
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313689	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MCM2 mRNA	PMID:38832940
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20140408	CTD	MESH:C012589	trichostatin A results in decreased expression of MCM2 mRNA; trichostatin A results in decreased expression of MCM2 protein	PMID:23770000
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20140408	CTD	MESH:C012589	pyrazolanthrone inhibits the reaction [trichostatin A results in decreased expression of MCM2 protein]	PMID:23770000
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MCM2 mRNA	PMID:17562736
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D005472	MCM2 protein affects the susceptibility to Fluorouracil	PMID:15548681
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of MCM2 protein	PMID:17562444|PMID:28871336
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:46557	zoledronic acid	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with docetaxel] results in decreased expression of MCM2 protein	PMID:17562444
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:4659	disulfiram	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D004221	Disulfiram results in decreased expression of MCM2 mRNA	PMID:19789329
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D004221	cupric chloride promotes the reaction [Disulfiram results in decreased expression of MCM2 mRNA]	PMID:19789329
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MCM2 mRNA	PMID:40504410
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:47286	CU-O LINKAGE	decreases phosphorylation	ISO	RGD:1313689	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased phosphorylation of MCM2 protein	PMID:25470785
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:4791	endosulfan	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of MCM2 mRNA	PMID:26159488
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:48607	lithium chloride	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in decreased expression of MCM2 mRNA	PMID:17440966
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:48707	(-)-citrinin	increases expression	ISO	RGD:1313689	E	RGD:6480464	20250603	CTD	MESH:D002953	Citrinin results in increased expression of MCM2 protein	PMID:39638853
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MCM2 mRNA	PMID:17555576
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MCM2 mRNA	PMID:17942748
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MCM2 mRNA	PMID:17942748
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20130416	CTD	MESH:D005047	Etoposide results in decreased expression of MCM2 mRNA	PMID:16120219
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:49553	copper(II) chloride	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:C029892	cupric chloride promotes the reaction [Disulfiram results in decreased expression of MCM2 mRNA]	PMID:19789329
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MCM2 mRNA	PMID:28628672
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313689	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MCM2 mRNA; Arsenic Trioxide results in increased expression of MCM2 protein	PMID:17530438|PMID:17547211|PMID:25419056
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MCM2 protein]	PMID:26598702
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate affects the reaction [MTF1 affects the expression of MCM2 mRNA]	PMID:16221973
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313690	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MCM2 mRNA; Nanotubes, Carbon results in increased expression of MCM2 mRNA	PMID:25554681
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MCM2 mRNA	PMID:30047161
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313690	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MCM2 mRNA	PMID:40234311
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313690	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MCM2 mRNA	PMID:19042947
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1313690	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in increased expression of MCM2 mRNA	PMID:21404309
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D011192	Potassium Dichromate results in increased expression of MCM2 mRNA	PMID:17547211
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1313690	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of MCM2 mRNA	PMID:21404309
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MCM2 mRNA	PMID:38701926
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MCM2 protein	PMID:32959892
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MCM2 mRNA	PMID:25729387
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM2 mRNA	PMID:25729387
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:6382	Lasiocarpine	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20260505	CTD	MESH:C005136	lasiocarpine results in decreased expression of MCM2 mRNA	PMID:40956406
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:6382	Lasiocarpine	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20260505	CTD	MESH:C005136	[CYP3A4 protein co-treated with lasiocarpine] results in decreased expression of MCM2 mRNA	PMID:40956406
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MCM2 mRNA	PMID:15336504
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of MCM2 mRNA	PMID:17547211
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of MCM2 mRNA	PMID:35283115
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:6651	malathion	increases expression	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D008294	Malathion results in increased expression of MCM2 mRNA	PMID:18204794
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:6651	malathion	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20120412	CTD	MESH:D008294	[Malathion co-treated with Estrogens] results in increased expression of MCM2 mRNA	PMID:18204794
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1313690	E	RGD:6480464	20230404	CTD	MESH:C057862	cyanoginosin LR results in increased expression of MCM2 protein	PMID:36115647
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:6925	microcystin-LR	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20230404	CTD	MESH:C057862	cyanoginosin LR results in increased expression of and results in increased phosphorylation of MCM2 protein	PMID:36115647
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:6925	microcystin-LR	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20230404	CTD	MESH:C057862	cyanoginosin LR results in increased expression of and results in increased phosphorylation of MCM2 protein	PMID:36115647
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of MCM2 mRNA; Cannabidiol results in decreased expression of MCM2 protein	PMID:33244087|PMID:34122009|PMID:36519830
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of MCM2 mRNA	PMID:22101062
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313690	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MCM2 mRNA	PMID:22206623
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:749016	gossypol acetic acid	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of MCM2 protein	PMID:29938581
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1313690	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of MCM2 mRNA	PMID:27858113
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:75408	sulindac sulfide	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in decreased expression of MCM2 mRNA	PMID:16184548
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of MCM2 mRNA; Niclosamide results in decreased expression of MCM2 protein	PMID:28284560|PMID:29031202
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20260714	CTD	MESH:D000077143	[Zoledronic Acid co-treated with Docetaxel] results in decreased expression of MCM2 protein	PMID:17562444
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313689	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of MCM2 protein	PMID:31285264
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1313689	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MCM2 mRNA	PMID:16120219
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:77012	methylseleninic acid	affects expression	ISO	RGD:1313689	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid affects the expression of MCM2 mRNA	PMID:14617803
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313689	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of MCM2 protein	PMID:39638853
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:78160	bleomycin A5	increases expression	ISO	RGD:1313689	E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in increased expression of MCM2 mRNA	PMID:21040473
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM2 mRNA	PMID:27188386
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1313689	E	RGD:6480464	20220208	CTD	MESH:C025256	nonylphenol results in increased expression of MCM2 mRNA; nonylphenol results in increased expression of MCM2 protein	PMID:33516137
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:79995	GW 3965	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20200915	CTD	MESH:C473027	GW 3965 results in decreased expression of MCM2 mRNA	PMID:31437187
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1313689	E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in increased expression of MCM2 mRNA	PMID:31437187
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313689	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MCM2 mRNA	PMID:19159669
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313690	E	RGD:6480464	20140311	CTD	MESH:D010634	Phenobarbital results in increased expression of MCM2 mRNA	PMID:19482888|PMID:23091169|PMID:23626729
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D010634	[Phenobarbital co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM2 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MCM2 mRNA]	PMID:19482888|PMID:23626729
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of MCM2 mRNA	PMID:18958704
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM2 mRNA	PMID:19167446
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313690	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of MCM2 mRNA	PMID:30294300
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MCM2 protein	PMID:31675489
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1313689	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MCM2 protein	PMID:31675489
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313690	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of MCM2 mRNA	PMID:27029645
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313690	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of MCM2 mRNA	PMID:30953684
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MCM2 mRNA	PMID:24780913|PMID:30047161
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [trichostatin A results in decreased expression of MCM2 protein]	PMID:23770000
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313689	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM2 mRNA	PMID:27188386
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus inhibits the reaction [IL2 protein results in increased expression of MCM2 mRNA]	PMID:11355896
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MCM2 mRNA	PMID:19281266
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MCM2 mRNA	PMID:21346803
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MCM2 mRNA	PMID:38568856
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MCM2 mRNA	PMID:29301935
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of MCM2 mRNA	PMID:22378314
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313689	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of MCM2 mRNA	PMID:19140230
1305577	Mcm2	minichromosome maintenance complex component 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MCM2 mRNA	PMID:23034163
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1601855	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CDCP1 mRNA	PMID:38218311
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1601855	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in increased expression of CDCP1 mRNA	PMID:24172598
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1601855	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CDCP1 mRNA	PMID:26272509
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDCP1 mRNA	PMID:27188386
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550104	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CDCP1 mRNA	PMID:33045310
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1601855	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of CDCP1 mRNA	PMID:21934132
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550104	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of CDCP1 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of CDCP1 mRNA	PMID:30951980
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550104	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDCP1 mRNA	PMID:30529165
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1601855	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CDCP1 mRNA	PMID:26079696
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of CDCP1 mRNA	PMID:18951874
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CDCP1 mRNA	PMID:35811015
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CDCP1 mRNA	PMID:35811015
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1601855	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CDCP1 mRNA	PMID:30510588
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550104	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CDCP1 mRNA	PMID:15289156|PMID:39298647
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1601855	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of CDCP1 mRNA	PMID:23019147
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CDCP1 mRNA	PMID:38568856
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CDCP1 mRNA	PMID:33387578
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1601855	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of CDCP1 mRNA	PMID:19162166
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:16767	3,4-dichloroaniline	increases expression	ISO	RGD:1601855	E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in increased expression of CDCP1 mRNA	PMID:24172598
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1601855	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CDCP1 mRNA	PMID:26079696
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1601855	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDCP1 mRNA	PMID:31163220
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CDCP1 mRNA	PMID:36139627
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1601855	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CDCP1 mRNA	PMID:26485663
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CDCP1 mRNA	PMID:33387578
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDCP1 mRNA	PMID:39836092
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDCP1 mRNA	PMID:23630614
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1601855	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDCP1 mRNA	PMID:22100608
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1601855	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CDCP1 intron	PMID:30157460
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CDCP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CDCP1 protein	PMID:38598786
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550104	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CDCP1 mRNA	PMID:31919559
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CDCP1 mRNA	PMID:21867686
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1601855	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of CDCP1 mRNA	PMID:18414638
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDCP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDCP1 mRNA	PMID:39836092
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CDCP1 mRNA	PMID:31881176
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1550104	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of CDCP1 mRNA	PMID:15289156
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1601855	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CDCP1 mRNA	PMID:25583101
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550104	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDCP1 mRNA	PMID:26377647
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDCP1 mRNA	PMID:33387578
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1601855	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CDCP1 mRNA; aristolochic acid I results in increased expression of CDCP1 protein	PMID:33212167
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CDCP1 mRNA	PMID:28959563
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDCP1 mRNA	PMID:29803840
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1601855	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CDCP1 mRNA	PMID:30031762
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CDCP1 mRNA	PMID:29432896
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550104	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDCP1 mRNA	PMID:37682722
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601855	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CDCP1 mRNA	PMID:29301061
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDCP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDCP1 mRNA	PMID:39836092
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1601855	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CDCP1 intron; Benzo(a)pyrene affects the methylation of CDCP1 promoter	PMID:27901495|PMID:30157460
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550104	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDCP1 mRNA	PMID:32417428
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1601855	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDCP1 mRNA	PMID:22316170|PMID:32234424
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CDCP1 mRNA	PMID:23806026
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1601855	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CDCP1 mRNA	PMID:25895662
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CDCP1 mRNA	PMID:20382639
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550104	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CDCP1 mRNA	PMID:23557971
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550104	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CDCP1 mRNA	PMID:23811191
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDCP1 mRNA	PMID:25181051
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1601855	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CDCP1 gene	PMID:31601247
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550104	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CDCP1 mRNA	PMID:32156529
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1601855	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of CDCP1 mRNA	PMID:18204070
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1601855	E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CDCP1 mRNA	PMID:23146750
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550104	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CDCP1 mRNA	PMID:30951980
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1550104	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of CDCP1 mRNA	PMID:30951980
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550104	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CDCP1 mRNA	PMID:30951980|PMID:38685157
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1550104	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of CDCP1 mRNA	PMID:30951980
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1601855	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CDCP1 gene	PMID:22964155
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CDCP1 protein	PMID:38598786
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of CDCP1 mRNA	PMID:32680482
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDCP1 mRNA	PMID:39836092
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CDCP1 mRNA	PMID:26472689
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CDCP1 mRNA	PMID:27387713
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CDCP1 mRNA	PMID:24449571
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1550104	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of CDCP1 mRNA	PMID:34254344
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1601855	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CDCP1 mRNA	PMID:40419075
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1601855	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of CDCP1 mRNA	PMID:23179753|PMID:23527032|PMID:24383497|PMID:28001369
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1550104	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of CDCP1 mRNA	PMID:25123088
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1550104	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CDCP1 mRNA	PMID:15289156
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550104	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CDCP1 mRNA	PMID:28973697
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1601855	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CDCP1 mRNA	PMID:38832940
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1601855	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of CDCP1 mRNA	PMID:29067470
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CDCP1 mRNA	PMID:35811015
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1601855	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CDCP1 mRNA	PMID:18687144
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1601855	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of CDCP1 mRNA	PMID:29523930
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1601855	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of CDCP1 mRNA	PMID:18414638
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDCP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDCP1 mRNA	PMID:39836092
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1550104	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CDCP1 mRNA	PMID:35436446
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1550104	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CDCP1 mRNA	PMID:23608068
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CDCP1 protein	PMID:32959892
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDCP1 mRNA	PMID:39836092
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1601855	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CDCP1 mRNA	PMID:15336504
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1601855	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CDCP1 mRNA	PMID:22714537
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1601855	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of CDCP1 mRNA	PMID:29522793
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1601855	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CDCP1 mRNA	PMID:37199045
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CDCP1 mRNA	PMID:36139627
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDCP1 mRNA	PMID:27188386
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1601855	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of CDCP1 mRNA	PMID:26079696
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550104	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of CDCP1 mRNA	PMID:30953684
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDCP1 mRNA	PMID:27188386
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1601855	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CDCP1 protein	PMID:38598786
1305578	Cdcp1	CUB domain containing protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CDCP1 mRNA	PMID:23034163
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1604631	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SWAP70 mRNA	PMID:27188386
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313692	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SWAP70 mRNA	PMID:33045310
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313692	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of SWAP70 mRNA	PMID:37995155
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604631	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of SWAP70 mRNA	PMID:21934132
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SWAP70 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SWAP70 mRNA	PMID:32699268
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313692	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of SWAP70 mRNA	PMID:30319688
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313692	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SWAP70 mRNA	PMID:30319688
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313692	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SWAP70 mRNA	PMID:39241906
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313692	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SWAP70 mRNA	PMID:39298647
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:16563	tetrahydropalmatine	increases expression	ISO	RGD:1604631	E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in increased expression of SWAP70 protein	PMID:20109541
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313692	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of SWAP70 mRNA	PMID:33848595
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313692	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of SWAP70 mRNA]	PMID:33848595
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313692	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SWAP70 mRNA	PMID:34319233
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1604631	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SWAP70 protein	PMID:37730182
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SWAP70 mRNA	PMID:33387578
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:22718	benzoates	increases expression	ISO	RGD:1604631	E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in increased expression of SWAP70 mRNA	PMID:29472718
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1604631	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SWAP70 mRNA	PMID:19549813
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313692	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SWAP70 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SWAP70 mRNA	PMID:27106289|PMID:34911549
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SWAP70 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SWAP70 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SWAP70 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SWAP70 mRNA	PMID:32699268|PMID:41430723
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SWAP70 mRNA	PMID:30779732
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SWAP70 mRNA	PMID:32525701
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1604631	E	RGD:6480464	20120412	CTD	MESH:D002945	SWAP70 protein affects the susceptibility to Cisplatin	PMID:16217747
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1604631	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SWAP70 mRNA	PMID:27594783
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313692	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SWAP70 mRNA	PMID:30912803
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SWAP70 mRNA	PMID:34747641
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313692	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SWAP70 mRNA	PMID:21570461
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1604631	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SWAP70 mRNA	PMID:23179753|PMID:27188386
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1604631	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SWAP70 mRNA	PMID:29803840|PMID:40854400
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604631	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SWAP70 mRNA	PMID:38568856
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604631	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SWAP70 intron	PMID:30157460
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313692	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SWAP70 intron	PMID:27901495
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313692	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SWAP70 mRNA	PMID:22228805
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604631	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SWAP70 promoter	PMID:27901495
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604631	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SWAP70 mRNA	PMID:19150397
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1604631	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SWAP70 mRNA	PMID:26238291
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1604631	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SWAP70 protein	PMID:25419056
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1604631	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of SWAP70 gene	PMID:31601247
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of SWAP70 gene	PMID:31601247
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313692	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of SWAP70 mRNA	PMID:27760801
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313692	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SWAP70 promoter	PMID:35295148
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313692	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SWAP70 gene	PMID:35295148
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SWAP70 mRNA	PMID:34947998
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SWAP70 mRNA	PMID:25181051
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of SWAP70 gene	PMID:31601247
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1604631	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SWAP70 mRNA	PMID:19244175
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313692	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SWAP70 mRNA	PMID:39298647
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1604631	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of SWAP70 gene	PMID:31601247
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313692	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SWAP70 mRNA	PMID:30951980
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1604631	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SWAP70 protein	PMID:34186270
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313692	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SWAP70 intron	PMID:28392331
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604631	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SWAP70 mRNA	PMID:37042841
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1604631	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SWAP70 mRNA	PMID:19320972
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1604631	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SWAP70 mRNA	PMID:19376846
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1604631	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SWAP70 mRNA	PMID:24449571
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SWAP70 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SWAP70 mRNA	PMID:32699268
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1604631	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of SWAP70 mRNA	PMID:19167446
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SWAP70 mRNA	PMID:19167446
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1604631	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SWAP70 mRNA	PMID:40419075
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604631	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SWAP70 mRNA	PMID:23179753|PMID:23527032|PMID:26272509
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SWAP70 mRNA	PMID:27188386
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604631	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of SWAP70 mRNA	PMID:27989131
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313692	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SWAP70 mRNA	PMID:28973697
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1604631	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of SWAP70 mRNA	PMID:16595896
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1604631	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of SWAP70 mRNA	PMID:28542535
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SWAP70 mRNA	PMID:33387578
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604631	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SWAP70 mRNA	PMID:22230336
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1604631	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of SWAP70 mRNA	PMID:16510598
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SWAP70 mRNA	PMID:32525701
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1604631	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SWAP70 protein	PMID:25419056
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1604631	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of SWAP70 mRNA	PMID:19194470
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313692	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SWAP70 mRNA; Nanotubes, Carbon results in decreased expression of SWAP70 mRNA	PMID:25554681
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313692	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SWAP70 mRNA	PMID:35964746
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SWAP70 mRNA	PMID:24793618
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604631	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SWAP70 protein	PMID:32959892
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1313692	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of SWAP70 mRNA	PMID:19812364
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1604631	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SWAP70 protein	PMID:34186270
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SWAP70 mRNA	PMID:27188386
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1604631	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SWAP70 mRNA	PMID:19159669
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313692	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SWAP70 mRNA	PMID:31388691
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SWAP70 mRNA	PMID:19167446
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313692	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of SWAP70 mRNA	PMID:27029645
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SWAP70 mRNA	PMID:32525701
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SWAP70 mRNA	PMID:24780913
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604631	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SWAP70 mRNA	PMID:27188386
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1604631	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SWAP70 mRNA	PMID:38568856
1305579	Swap70	switching B-cell complex subunit SWAP70	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1604631	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SWAP70 mRNA	PMID:29301935
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1619186	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of DIRAS2 mRNA	PMID:36189433
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DIRAS2 mRNA	PMID:36189433
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of DIRAS2 gene	PMID:35440735
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313693	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of DIRAS2 mRNA	PMID:22378314
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1619186	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of DIRAS2 mRNA	PMID:30319688
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1619186	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DIRAS2 mRNA	PMID:30319688
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313693	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DIRAS2 mRNA	PMID:35811015
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA	PMID:25510870
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DIRAS2 mRNA	PMID:33387578
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1619186	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of DIRAS2 mRNA	PMID:36189433
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DIRAS2 mRNA	PMID:36189433
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1619186	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DIRAS2 mRNA	PMID:34319233
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DIRAS2 mRNA	PMID:37325564
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA	PMID:25510870
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA	PMID:25510870
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313693	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DIRAS2 intron	PMID:30157460
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DIRAS2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DIRAS2 mRNA	PMID:34911549
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1313693	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in increased expression of DIRAS2 mRNA	PMID:36861143
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313693	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DIRAS2 mRNA	PMID:27188386
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313693	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of DIRAS2 mRNA	PMID:23557933
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313693	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of DIRAS2 promoter	PMID:22847954
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DIRAS2 mRNA	PMID:32109520
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DIRAS2 mRNA	PMID:33387578
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1619186	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of DIRAS2 mRNA	PMID:37682722
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA	PMID:34876320
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA	PMID:34876320
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313693	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DIRAS2 5' UTR	PMID:27901495
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313693	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DIRAS2 mRNA	PMID:22316170
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313693	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DIRAS2 promoter	PMID:27901495
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to DIRAS2 promoter]	PMID:19654925
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313693	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DIRAS2 gene	PMID:31601247
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1619186	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DIRAS2 gene	PMID:35295148
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313693	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DIRAS2 mRNA	PMID:19710929
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DIRAS2 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313693	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DIRAS2 gene	PMID:31601247
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA	PMID:25510870
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA	PMID:25510870
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1619186	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of DIRAS2 mRNA	PMID:30951980
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1619186	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DIRAS2 mRNA	PMID:37019170
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1619186	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DIRAS2 mRNA	PMID:21266533
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DIRAS2 mRNA	PMID:37325564
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1619186	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DIRAS2 mRNA	PMID:40194260
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313693	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of DIRAS2 promoter	PMID:22847954
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313693	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of DIRAS2 promoter	PMID:22847954
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313693	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DIRAS2 gene	PMID:29154799
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313693	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of DIRAS2 mRNA	PMID:24383497|PMID:26272509|PMID:28001369
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313693	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DIRAS2 mRNA	PMID:20106945
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1619186	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of DIRAS2 mRNA	PMID:22733784
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313693	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DIRAS2 mRNA	PMID:35811015
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1313693	E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in increased expression of DIRAS2 mRNA	PMID:36861143
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA	PMID:34876320
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1619186	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DIRAS2 mRNA; Nanotubes, Carbon results in decreased expression of DIRAS2 mRNA	PMID:25554681
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1619186	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of DIRAS2 mRNA	PMID:26377693
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313693	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DIRAS2 mRNA	PMID:27188386
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313693	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DIRAS2 gene]	PMID:28238834
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1313693	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of DIRAS2 mRNA	PMID:26705709
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA	PMID:34876320
1305580	Diras2	DIRAS family GTPase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313693	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DIRAS2 mRNA	PMID:27188386
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313695	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of ITGB2 mRNA	PMID:22968694
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ITGB2 mRNA	PMID:35967413
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ITGB2 mRNA	PMID:33045310
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:132853	acteoside	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20191114	CTD	MESH:C058956	acteoside inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; acteoside inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]	PMID:16393473
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1313695	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide analog results in increased expression of ITGB2 mRNA; graphene oxide results in increased expression of ITGB2 mRNA	PMID:33227293
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:134926	drometrizole	affects expression	ISO	RGD:1313694	E	RGD:6480464	20250805	CTD	MESH:C033674	benazol P affects the expression of ITGB2 mRNA	PMID:36586167
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:142487	(20S)-ginsenoside Rh1	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20191114	CTD	MESH:C425564	ginsenoside Rh1 inhibits the reaction [TNF protein results in increased expression of [ITGAL protein binds to ITGB2 protein]]	PMID:21875580
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB2 mRNA	PMID:20938992
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of [ITGA2B protein binds to ITGB2 protein]	PMID:15140583
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of ITGB2 mRNA; Tretinoin results in increased expression of ITGB2 protein	PMID:15498508|PMID:16322068|PMID:16581781|PMID:18055984|PMID:33167477
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D014212	[GABPA protein binds to EP300 protein] promotes the reaction [Tretinoin results in increased expression of ITGB2 mRNA]; CSF3 protein promotes the reaction [Tretinoin results in increased expression of ITGB2 protein]; EP300 protein promotes the reaction [Tretinoin results in increased expression of ITGB2 mRNA]	PMID:16581781|PMID:18055984
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15368	acrolein	increases expression	ISO	RGD:1313695	E	RGD:6480464	20121113	CTD	MESH:D000171	Acrolein results in increased expression of ITGB2 mRNA	PMID:18515264
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ITGB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ITGB2 mRNA	PMID:32699268
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ITGB2 mRNA	PMID:33729688
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D002392	Catechin inhibits the reaction [S100B protein results in increased expression of ITGB2 mRNA]	PMID:17103373
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15647	leukotriene B4	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007975	Leukotriene B4 results in increased expression of ITGB2 protein	PMID:14716214
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15647	leukotriene B4	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20161025	CTD	MESH:D007975	Leukotriene B4 results in increased expression of [ITGAM protein binds to ITGB2 protein]; LY 255283 analog inhibits the reaction [Leukotriene B4 results in increased expression of [ITGAM protein binds to ITGB2 protein]]; LY 255283 inhibits the reaction [Leukotriene B4 results in increased expression of [ITGAM protein binds to ITGB2 protein]]; LY 293111 inhibits the reaction [Leukotriene B4 results in increased expression of [ITGAM protein binds to ITGB2 protein]]	PMID:7473568
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15738	staurosporine	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20130212	CTD	MESH:D019311	Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]	PMID:16393473
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ITGB2 mRNA	PMID:26079696
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ITGB2 gene	PMID:35440735
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16112	chlorogenic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D002726	Chlorogenic Acid results in decreased expression of ITGB2 protein	PMID:21414398
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16112	chlorogenic acid	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D002726	Chlorogenic Acid inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of ITGB2 protein]	PMID:21414398
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313695	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ITGB2 mRNA	PMID:30319688
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ITGB2 mRNA	PMID:30517762
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin inhibits the reaction [S100B protein results in increased expression of ITGB2 mRNA]	PMID:17103373
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ITGB2 protein	PMID:17655881
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313695	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ITGB2 mRNA	PMID:10975854|PMID:27339419|PMID:39241906
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	ginsenoside Rb1 inhibits the reaction [Lipopolysaccharides results in increased expression of ITGB2 protein]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of ITGB2 protein]	PMID:17655881
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20161228	CTD	MESH:D008070	ITGB2 protein affects the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:12538815
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ITGB2 mRNA	PMID:39298647
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGB2 mRNA	PMID:32741896
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ITGB2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ITGB2 mRNA	PMID:20226447|PMID:30165855
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16480	nitric oxide	increases abundance	EXP		E	RGD:6480464	20120412	CTD	MESH:D009569	ITGB2 protein results in increased abundance of Nitric Oxide	PMID:8600936
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16480	nitric oxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D009569	[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide; [ITGB2 protein results in increased susceptibility to Ozone] which results in increased abundance of Nitric Oxide; CSF2 protein promotes the reaction [ITGB2 protein results in increased abundance of Nitric Oxide]; Ozone promotes the reaction [[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide]	PMID:8600936
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16480	nitric oxide	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide promotes the reaction [ITGB2 protein results in increased activity of RAP1A protein]; Nitric Oxide promotes the reaction [ITGB2 protein results in increased activity of RAP2A protein]	PMID:16963453
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ITGB2 mRNA	PMID:33387578
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ITGB2 gene	PMID:27618143
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB2 mRNA	PMID:20938992
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in decreased expression of ITGB2 mRNA	PMID:16188091|PMID:20036648
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16761	ADP	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20260407	CTD	MESH:D000244	Cadmium promotes the reaction [Adenosine Diphosphate results in increased activity of [ITGB2 protein binds to ITGA3 protein]]	PMID:26023812
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ITGB2 mRNA	PMID:23649840
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of ITGB2 mRNA	PMID:17251523
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313694	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of ITGB2 mRNA	PMID:21540246
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20130723	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in increased expression of ITGB2 mRNA	PMID:20226447
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB2 mRNA	PMID:37992649
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGB2 mRNA	PMID:32741896
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20130611	CTD	MESH:C031927	hydroquinone results in decreased expression of ITGB2 mRNA	PMID:19148301
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:C031927	hydroquinone results in decreased expression of ITGB2 protein	PMID:17464197
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313695	E	RGD:6480464	20120613	CTD	MESH:C031927	hydroquinone results in increased expression of ITGB2 protein	PMID:21664406
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB2 mRNA	PMID:37992649
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ITGB2 mRNA	PMID:27523638
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ITGB2 mRNA	PMID:22061828
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ITGB2 mRNA	PMID:36331819
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of ITGB2 mRNA	PMID:20368581
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:183083	indirubin	increases expression	ISO	RGD:1313694	E	RGD:6480464	20211207	CTD	MESH:C027185	indirubin results in increased expression of ITGB2 protein	PMID:16115123
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of ITGB2 mRNA	PMID:28522335
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:2038	5-azacytidine	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in decreased expression of ITGB2 mRNA	PMID:19194470
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:211551	TMC-120A	increases expression	ISO	RGD:1313695	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in increased expression of ITGB2 mRNA	PMID:19818335
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20260407	CTD	MESH:D002104	Cadmium promotes the reaction [Adenosine Diphosphate results in increased activity of [ITGB2 protein binds to ITGA3 protein]]	PMID:26023812
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGB2 mRNA	PMID:29950665
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ITGB2 protein]	PMID:32272095
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ITGB2 mRNA	PMID:22100608
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ITGB2 mRNA	PMID:23649840
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of ITGB2 mRNA	PMID:18955075
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:25442	mycotoxin	increases expression	ISO	RGD:1313695	E	RGD:6480464	20170228	CTD	MESH:D009183	Mycotoxins results in increased expression of ITGB2 mRNA	PMID:19818335
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:25812	ozone	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D010126	ITGB2 protein results in increased susceptibility to Ozone	PMID:8600936
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010126	[ITGB2 protein results in increased susceptibility to Ozone] which results in increased abundance of Nitric Oxide; Ozone promotes the reaction [[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide]	PMID:8600936
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ITGB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ITGB2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ITGB2 mRNA	PMID:32699268
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ITGB2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ITGB2 mRNA	PMID:34911549
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27086	tributylstannane	affects localization	ISO	RGD:1313694	E	RGD:6480464	20240109	CTD	MESH:C011559	tributyltin affects the localization of ITGB2 protein	PMID:20883105
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313694	E	RGD:6480464	20160119	CTD	MESH:C011559	tributyltin results in increased expression of ITGB2 mRNA	PMID:26314263
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20240109	CTD	MESH:C011559	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tributyltin affects the localization of ITGB2 protein]	PMID:20883105
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27300	vitamin D	increases expression	ISO	RGD:1313694	E	RGD:6480464	20170303	CTD	MESH:D014807	Vitamin D results in increased expression of ITGB2 mRNA	PMID:20368581
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of ITGB2 mRNA	PMID:19071009
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313695	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ITGB2 mRNA	PMID:15056808|PMID:27339419|PMID:31919559
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ITGB2 mRNA	PMID:30517762
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB2 mRNA	PMID:20938992
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGB2 mRNA	PMID:40504410
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27779	griseofulvin	affects expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D006118	Griseofulvin affects the expression of ITGB2 mRNA	PMID:12735108
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ITGB2 mRNA	PMID:31881176
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313694	E	RGD:6480464	20150714	CTD	MESH:C059514	resveratrol results in increased expression of ITGB2 mRNA	PMID:25888808
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of ITGB2 mRNA	PMID:25905778
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol analog inhibits the reaction [formylmethionyl-leucyl-phenylalanine methyl ester results in increased expression of ITGB2 protein]	PMID:9605577
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ITGB2 mRNA	PMID:22023808
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313694	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ITGB2 mRNA	PMID:25583101
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ITGB2 mRNA	PMID:34747641
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ITGB2 mRNA	PMID:16962184
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:28177	theophylline	increases expression	ISO	RGD:1313694	E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of ITGB2 mRNA	PMID:16083514
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313694	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ITGB2 mRNA; aristolochic acid I results in increased expression of ITGB2 protein	PMID:33212167
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:28262	dimethyl sulfoxide	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D004121	Dimethyl Sulfoxide promotes the reaction [alitretinoin results in increased expression of ITGB2 protein]	PMID:15964820
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ITGB2 mRNA	PMID:39631538
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB2 mRNA	PMID:37992649
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ITGB2 mRNA	PMID:14691202|PMID:37682722
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313694	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ITGB2 mRNA	PMID:29301061|PMID:34032870|PMID:36989763|PMID:38568856
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGB2 mRNA	PMID:40504410
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313694	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ITGB2 5' UTR; Benzo(a)pyrene affects the methylation of ITGB2 intron	PMID:27901495|PMID:30157460
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313694	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ITGB2 promoter	PMID:27901495
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313694	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of ITGB2 mRNA; Benzo(a)pyrene results in increased expression of ITGB2 mRNA	PMID:22316170|PMID:26314263
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313695	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ITGB2 mRNA	PMID:22228805
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of ITGB2 mRNA	PMID:19071009
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:30537	triphenylstannane	increases expression	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:C030665	triphenyltin results in increased expression of ITGB2 mRNA; triphenyltin results in increased expression of ITGB2 protein	PMID:12788061
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ITGB2 mRNA	PMID:25895662
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313695	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ITGB2 mRNA	PMID:29341224
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313694	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ITGB2 mRNA	PMID:20458559
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1313695	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in increased expression of ITGB2 mRNA	PMID:30825431
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of ITGB2 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of ITGB2 mRNA]	PMID:30825431
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ITGB2 gene	PMID:31601247
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:31739	josamycin	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20130806	CTD	MESH:D015570	Josamycin results in decreased expression of ITGB2 protein	PMID:8096833
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:31739	josamycin	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20130806	CTD	MESH:D015570	Ribomunyl inhibits the reaction [Josamycin results in decreased expression of ITGB2 protein]	PMID:8096833
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:32023	plaunotol	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:C047686	plaunotol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]	PMID:10215738
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20180313	CTD	MESH:C061133	tamibarotene results in decreased expression of ITGB2 mRNA	PMID:27737899
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1313694	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of ITGB2 mRNA	PMID:15498508
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:32181	tamibarotene	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20180313	CTD	MESH:C061133	CSF3 protein inhibits the reaction [tamibarotene results in decreased expression of ITGB2 mRNA]; tamibarotene inhibits the reaction [CSF3 protein results in increased expression of ITGB2 mRNA]	PMID:27737899
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of ITGB2 mRNA	PMID:24136188
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGB2 mRNA	PMID:29950665
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ITGB2 mRNA	PMID:34492290
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ITGB2 mRNA	PMID:25380136
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ITGB2 mRNA	PMID:17426115
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ITGB2 mRNA	PMID:19710929
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:3305	Calcimycin	increases expression	ISO	RGD:1313694	E	RGD:6480464	20141111	CTD	MESH:D000001	Calcimycin results in increased expression of ITGB2 protein	PMID:8094364
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:33098	2-nitrotoluene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029955	2-nitrotoluene results in increased expression of ITGB2 mRNA	PMID:16460773
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ITGB2 mRNA	PMID:25181051
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of ITGB2 mRNA	PMID:25594700
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in increased expression of ITGB2 mRNA	PMID:34973380
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ITGB2 mRNA; bisphenol A results in increased expression of ITGB2 protein	PMID:14555285
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313695	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ITGB2 mRNA	PMID:32156529|PMID:38701888
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ITGB2 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ITGB2 mRNA	PMID:28628672|PMID:31601247
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20200310	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ITGB2 protein	PMID:21623697
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313695	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of ITGB2 mRNA	PMID:26682919
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ITGB2 mRNA	PMID:39298647|PMID:40203079
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313695	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ITGB2 mRNA	PMID:30951980
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of ITGB2 mRNA	PMID:30951980|PMID:38685157
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313695	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ITGB2 mRNA	PMID:32715474
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313695	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ITGB2 protein	PMID:32272095
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGB2 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ITGB2 protein]	PMID:29950665|PMID:32272095
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313694	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of ITGB2 gene	PMID:22964155
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ITGB2 mRNA	PMID:28628672
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313694	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ITGB2 mRNA	PMID:37042841
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of ITGB2 mRNA	PMID:30589522
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ITGB2 mRNA	PMID:35163327
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ITGB2 mRNA	PMID:25380136
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases response to substance	ISO	RGD:1313695	E	RGD:6480464	20120918	CTD	MESH:D015058	ITGB2 protein results in increased susceptibility to 1-Naphthylisothiocyanate	PMID:16614373|PMID:21070799
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20160822	CTD	MESH:D015058	[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ITGB2 mRNA	PMID:27344345
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ITGB2 promoter	PMID:22457795
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313694	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ITGB2 mRNA	PMID:38568856
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20240903	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ITGB2 protein	PMID:38758093
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ITGB2 mRNA	PMID:35163327
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:3558	cerivastatin	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20170228	CTD	MESH:C086276	cerivastatin inhibits the reaction [TNF results in increased expression of ITGB2]	PMID:12615677
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313694	E	RGD:6480464	20160119	CTD	MESH:C018021	cobaltous chloride results in increased expression of ITGB2 mRNA	PMID:26314263
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of ITGB2 mRNA	PMID:25380136
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ITGB2 mRNA	PMID:24449571
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ITGB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ITGB2 mRNA	PMID:32699268
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	affects localization	ISO	RGD:1313694	E	RGD:6480464	20240109	CTD	MESH:D013755	Tetradecanoylphorbol Acetate affects the localization of ITGB2 protein	PMID:20883105
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1313694	E	RGD:6480464	20130212	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein	PMID:16393473
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20130212	CTD	MESH:D013755	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of ITGB2 protein]; acteoside inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]; crenatoside inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]; Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]	PMID:16393473|PMID:20883105
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313695	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ITGB2 mRNA	PMID:40194260
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1313694	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of ITGB2 mRNA	PMID:40434365
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:38757	isoflavones	affects expression	ISO	RGD:1313694	E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones affects the expression of ITGB2 mRNA	PMID:16365062
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ITGB2 mRNA	PMID:36331819
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313694	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of ITGB2 mRNA	PMID:23527032
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313694	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ITGB2 gene	PMID:29154799
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ITGB2 mRNA	PMID:25562108
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:41072	3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20141111	CTD	MESH:C070515	bisindolylmaleimide I inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]	PMID:16963453
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ITGB2 mRNA	PMID:28628672
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB2 mRNA	PMID:37992649
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313694	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of ITGB2 mRNA	PMID:21678067
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ITGB2 mRNA	PMID:38832940
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ITGB2 mRNA	PMID:17562736
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of ITGB2	PMID:15485462
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1313694	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ITGB2 mRNA	PMID:24714768
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:46661	asbestos	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20120918	CTD	MESH:D001194	Asbestos results in decreased expression of ITGB2 mRNA	PMID:22398240
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313694	E	RGD:6480464	20161213	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ITGB2 mRNA	PMID:23634900
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGB2 mRNA	PMID:40504410
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1313695	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of ITGB2 mRNA	PMID:26934552
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313694	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of ITGB2 mRNA	PMID:26833863
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of ITGB2 mRNA	PMID:31464424
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ITGB2 mRNA	PMID:35436446
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20160822	CTD	MESH:D004997	[Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of ITGB2 mRNA	PMID:27344345
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:49662	indometacin	affects response to substance	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D007213	ITGB2 protein affects the susceptibility to Indomethacin	PMID:10486359
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of ITGB2 mRNA	PMID:36868495
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ITGB2 mRNA	PMID:28628672
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of [ITGAM protein binds to ITGB2 protein]	PMID:10761979
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:49747	methylmercury(1+)	increases expression	ISO	RGD:1313694	E	RGD:6480464	20160119	CTD	MESH:C030957	methylmercury II results in increased expression of ITGB2 mRNA	PMID:26314263
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313694	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ITGB2 mRNA	PMID:20458559
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313695	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of ITGB2 mRNA	PMID:23845593
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313695	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ITGB2 mRNA; Nanotubes, Carbon results in increased expression of ITGB2 mRNA	PMID:25554681
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:50648	9-cis-retinoic acid	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20191114	CTD	MESH:C103303	Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of ITGB2 protein]	PMID:15964820
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313695	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of ITGB2 mRNA	PMID:40234311
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:50686	atorvastatin calcium	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20170303	CTD	MESH:D000069059	Atorvastatin inhibits the reaction [TNF results in increased expression of ITGB2]	PMID:12615677
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ITGB2 mRNA	PMID:24136188
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:5158	Formylmethionyl-leucyl-phenylalanine methyl ester	increases expression	ISO	RGD:1313694	E	RGD:6480464	20141111	CTD	MESH:C042932	formylmethionyl-leucyl-phenylalanine methyl ester results in increased expression of ITGB2 protein	PMID:9605577
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:5158	Formylmethionyl-leucyl-phenylalanine methyl ester	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20141111	CTD	MESH:C042932	resveratrol analog inhibits the reaction [formylmethionyl-leucyl-phenylalanine methyl ester results in increased expression of ITGB2 protein]	PMID:9605577
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]	PMID:16963453
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:53490	N-formyl-L-methionyl-L-leucyl-L-phenylalanine	increases expression	ISO	RGD:1313694	E	RGD:6480464	20130212	CTD	MESH:D009240	N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein	PMID:10215738|PMID:16393473
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:53490	N-formyl-L-methionyl-L-leucyl-L-phenylalanine	increases expression	ISO	RGD:1313695	E	RGD:6480464	20120613	CTD	MESH:D009240	N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein	PMID:21664406
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:53490	N-formyl-L-methionyl-L-leucyl-L-phenylalanine	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20130212	CTD	MESH:D009240	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; acteoside inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; crenatoside inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; plaunotol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]	PMID:10215738|PMID:16393473
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:5643	Heliotrine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in increased expression of ITGB2 mRNA	PMID:34185104
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313695	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ITGB2 mRNA	PMID:38701926
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of ITGB2 mRNA	PMID:20436886
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:64206	bromochloroacetic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C099813	bromochloroacetic acid results in increased expression of ITGB2 mRNA	PMID:16460773
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:6456	lidocaine	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D008012	Lidocaine inhibits the reaction [TNF protein results in increased expression of [ITGAM protein binds to ITGB2 protein]]	PMID:9336308
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]	PMID:16963453
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of ITGB2 protein	PMID:35926579
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:67989	ginsenoside Rb1	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C442759	ginsenoside Rb1 inhibits the reaction [Lipopolysaccharides results in increased expression of ITGB2 protein]	PMID:17655881
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ITGB2 gene	PMID:35440735
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:68794	neoechinulin A	increases expression	ISO	RGD:1313695	E	RGD:6480464	20170228	CTD	MESH:C490266	neoechinulin A results in increased expression of ITGB2 mRNA	PMID:19818335
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:6925	microcystin-LR	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C057862	cyanoginosin LR results in increased expression of ITGB2 mRNA; cyanoginosin LR results in increased expression of ITGB2 protein	PMID:19360947
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of ITGB2 mRNA]	PMID:30825431
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313695	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ITGB2 mRNA	PMID:22206623
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:748998	lenabasum	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260714	CTD	MESH:C471849	lenabasum inhibits the reaction [Bleomycin results in increased expression of ITGB2 mRNA]	PMID:30825431
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGB2 mRNA	PMID:32741896
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:77146	ginsenoside C-K	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20170117	CTD	MESH:C112772	ginsenoside compound K inhibits the reaction [TNF protein results in increased expression of [ITGAL protein binds to ITGB2 protein]]	PMID:21875580
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:77149	notoginsenoside R1	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20151110	CTD	MESH:C072936	notoginsenoside R1 results in decreased expression of ITGB2 protein	PMID:18176958
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:77149	notoginsenoside R1	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:C072936	notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of ITGB2 protein]	PMID:17655881
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313694	E	RGD:6480464	20160119	CTD	MESH:C025589	ochratoxin A metabolite results in increased expression of ITGB2 mRNA; ochratoxin A results in increased expression of ITGB2 mRNA	PMID:26314263
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:7852	oxycodone	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in decreased expression of ITGB2 mRNA	PMID:23439660
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:79	(-)-Arctigenin	decreases secretion	ISO	RGD:1313694	E	RGD:6480464	20230404	CTD	MESH:C071942	arctigenin results in decreased secretion of ITGB2 protein	PMID:29740324
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:7986	Pentoxifylline	affects expression	ISO	RGD:1313694	E	RGD:6480464	20141111	CTD	MESH:D010431	Pentoxifylline affects the expression of ITGB2	PMID:1976392
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1313694	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of ITGB2 mRNA	PMID:26314263
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:81555	Enterolactone	decreases secretion	ISO	RGD:1313694	E	RGD:6480464	20230404	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased secretion of ITGB2 protein	PMID:29740324
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313695	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ITGB2 mRNA	PMID:38648751
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ITGB2 mRNA	PMID:27291303
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of ITGB2 mRNA	PMID:38995820
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ITGB2 mRNA	PMID:23640034
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1313694	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of ITGB2 mRNA	PMID:20368581
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ITGB2 mRNA	PMID:26079696
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:8427	probucol	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20130903	CTD	MESH:D011341	Probucol promotes the reaction [APOE gene mutant form results in increased expression of ITGB2 mRNA]	PMID:19394937
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:8890	(S)-ropivacaine	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20191114	CTD	MESH:C037663	Ropivacaine inhibits the reaction [TNF protein results in increased expression of [ITGAM protein binds to ITGB2 protein]]	PMID:9336308
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:90721	N-[3-(aminomethyl)benzyl]acetamidine	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20170303	CTD	MESH:C104820	N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [ITGB2 protein results in increased activity of RAP2A protein]	PMID:16963453
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:9111	Senkirkine	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C009238	senkirkine results in increased expression of ITGB2 mRNA	PMID:34185104
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:91462	SU6656	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20170110	CTD	MESH:C416927	SU 6656 inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]	PMID:16963453
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:9150	simvastatin	affects binding	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin binds to [ITGAL protein binds to ITGB2 protein]	PMID:15041742
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in decreased expression of ITGB2 mRNA	PMID:12615677
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:9150	simvastatin	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin inhibits the reaction [TNF results in increased expression of ITGB2]	PMID:12615677
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:9150	simvastatin	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin results in decreased expression of [ITGAM protein binds to ITGB2 protein]	PMID:21330348
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ITGB2 mRNA	PMID:19281266
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013311	Streptozocin results in increased expression of ITGB2 protein	PMID:16129698
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of ITGB2 mRNA; KLK1 protein inhibits the reaction [Streptozocin results in increased expression of ITGB2 protein]	PMID:16129698|PMID:25905778
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:9334	sulfasalazine	multiple interactions	ISO	RGD:1313694	E	RGD:6480464	20120412	CTD	MESH:D012460	Sulfasalazine inhibits the reaction [TNF protein results in increased expression of ITGB2 protein]	PMID:8094364
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313694	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ITGB2 mRNA	PMID:29301935
1305581	Itgb2	integrin subunit beta 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ITGB2 mRNA	PMID:19015723
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in increased expression of DHRS3 mRNA	PMID:19371625
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of DHRS3 mRNA	PMID:21551480
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313699	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DHRS3 mRNA	PMID:26272509
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA	PMID:27188386
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DHRS3 mRNA	PMID:33045310
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DHRS3 mRNA]	PMID:31150632
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of DHRS3 mRNA	PMID:26251327
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases abundance	ISO	RGD:1313700	E	RGD:6480464	20140610	CTD	MESH:D014212	DHRS3 gene mutant form results in increased abundance of Tretinoin	PMID:24005908
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014212	Tretinoin results in increased expression of DHRS3 mRNA	PMID:20488242|PMID:22262565|PMID:22664269
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313699	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of DHRS3 mRNA	PMID:15498508|PMID:16054129|PMID:16249480|PMID:17431108|PMID:21934132|PMID:23724009|PMID:23830798
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313700	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of DHRS3 mRNA	PMID:36189433
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20140610	CTD	MESH:D014212	[DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of ALDH1A1 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of ALDH1A2 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of ALDH1A3 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of HOXA13 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of HOXD13 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of RDH10 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of CYP26A1 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of HOXA1 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of RARB mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DHRS3 mRNA	PMID:24005908|PMID:36189433
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313699	E	RGD:6480464	20151013	CTD	MESH:D010100	Oxygen deficiency results in increased expression of DHRS3 mRNA	PMID:24403227
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20151013	CTD	MESH:D010100	1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of DHRS3 mRNA]	PMID:24403227
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DHRS3 mRNA	PMID:30529165
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DHRS3 mRNA	PMID:26079696
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of DHRS3 mRNA	PMID:36841081
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313700	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of DHRS3 mRNA	PMID:40945087
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DHRS3 mRNA	PMID:20044591
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DHRS3 mRNA	PMID:39241906
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DHRS3 mRNA	PMID:35811015
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:16422	androst-4-ene-3,17-dione	increases metabolic processing	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:D000735	DHRS3 protein results in increased metabolism of Androstenedione	PMID:25451588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DHRS3 mRNA	PMID:39298647
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313699	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of DHRS3 mRNA	PMID:19619570|PMID:23019147
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of DHRS3 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DHRS3 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]	PMID:19619570|PMID:20660070|PMID:23275455|PMID:30165855
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DHRS3 mRNA	PMID:19448997
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DHRS3 mRNA	PMID:33387578
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313699	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DHRS3 mRNA	PMID:37042841
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313699	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of DHRS3 mRNA	PMID:21540246
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20121009	CTD	MESH:D011374	7-propyl spirolactone inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; [Estradiol co-treated with Progesterone] results in decreased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein; Aldosterone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; Mifepristone promotes the reaction [Progesterone affects the expression of DHRS3 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]	PMID:20660070|PMID:22414680|PMID:23275455
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of DHRS3 mRNA	PMID:36695872
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DHRS3 mRNA	PMID:36189433
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17263	estrone	increases metabolic processing	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:D004970	DHRS3 protein results in increased metabolism of Estrone	PMID:25451588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1313700	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of DHRS3 mRNA	PMID:28973375
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17336	all-trans-retinol	decreases abundance	ISO	RGD:1313700	E	RGD:6480464	20140610	CTD	MESH:D014801	DHRS3 gene mutant form results in decreased abundance of Vitamin A	PMID:24005908
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of DHRS3 mRNA	PMID:21592394
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of DHRS3 mRNA	PMID:21592394
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17378	D-glyceraldehyde	increases metabolic processing	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:D005985	DHRS3 protein results in increased metabolism of Glyceraldehyde	PMID:25451588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of DHRS3 mRNA	PMID:23892564
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313699	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of DHRS3 mRNA	PMID:23825647
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DHRS3 promoter	PMID:23359474
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of DHRS3 mRNA	PMID:16002434
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of DHRS3 mRNA	PMID:21592394
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of DHRS3 mRNA	PMID:21592394
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of DHRS3 mRNA	PMID:22061828
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DHRS3 mRNA	PMID:28818685
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:18009	NADP(+)	increases activity	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:D009249	NADP results in increased activity of DHRS3 protein	PMID:25451588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:18009	NADP(+)	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of DHRS3 protein	PMID:25526675
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313699	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of DHRS3 mRNA	PMID:23825647
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of DHRS3 mRNA	PMID:21515302
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:22718	benzoates	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in decreased expression of DHRS3 mRNA	PMID:29472718
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased expression of DHRS3 mRNA	PMID:28860664
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DHRS3 mRNA	PMID:37236586
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DHRS3 protein	PMID:20106945
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DHRS3 mRNA	PMID:27153756
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DHRS3 mRNA	PMID:19770486
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313699	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DHRS3 intron	PMID:30157460
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of DHRS3 mRNA	PMID:25102026
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DHRS3 mRNA	PMID:31150632
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DHRS3 mRNA	PMID:27339419|PMID:31919559
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DHRS3 mRNA	PMID:17484886
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DHRS3 mRNA]	PMID:31150632
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of DHRS3 mRNA	PMID:18414638
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHRS3 mRNA	PMID:40504410
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:27584	aldosterone	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20130910	CTD	MESH:D000450	Aldosterone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]	PMID:23275455
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313699	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of DHRS3 mRNA	PMID:26272509
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA	PMID:27188386
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of DHRS3 mRNA	PMID:19371625
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of DHRS3 mRNA	PMID:18930951
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28052	acetohexamide	increases metabolic processing	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:D000092	DHRS3 protein results in increased metabolism of Acetohexamide	PMID:25451588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313699	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of DHRS3 mRNA	PMID:19371625|PMID:23019147|PMID:26865667
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20141223	CTD	MESH:D019833	[Dexamethasone co-treated with Genistein] results in increased expression of DHRS3 mRNA	PMID:25136773
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DHRS3 mRNA	PMID:22298810
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DHRS3 mRNA	PMID:18343893
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DHRS3 mRNA	PMID:21215274|PMID:21724226
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DHRS3 mRNA	PMID:19770486
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHRS3 mRNA	PMID:33387578|PMID:34747641
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHRS3 mRNA	PMID:19619570|PMID:20106945
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHRS3 mRNA	PMID:15328365|PMID:15800033|PMID:16611356
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DHRS3 mRNA	PMID:19619570
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DHRS3 mRNA	PMID:34089799
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313699	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DHRS3 mRNA	PMID:33212167
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DHRS3 mRNA	PMID:30851411
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313699	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DHRS3 mRNA	PMID:32763439
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DHRS3 mRNA	PMID:30556269
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of DHRS3 mRNA	PMID:24690739
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DHRS3 mRNA	PMID:15467011
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28735	4-nitroacetophenone	increases metabolic processing	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:C001972	DHRS3 protein results in increased metabolism of 4-nitroacetophenone	PMID:25451588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313699	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of DHRS3 mRNA	PMID:30031762
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DHRS3 mRNA	PMID:12727804|PMID:38568856
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313699	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of DHRS3 mRNA	PMID:39719251
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHRS3 mRNA	PMID:40504410
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313699	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of DHRS3 mRNA	PMID:22378314
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DHRS3 mRNA	PMID:32234424
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DHRS3 mRNA	PMID:15894712|PMID:19770486
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313699	E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DHRS3 mRNA; Benzo(a)pyrene results in increased expression of DHRS3 protein	PMID:32717239|PMID:38036013
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D001564	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of DHRS3 mRNA	PMID:15894712
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of DHRS3 mRNA	PMID:15894712
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of DHRS3 mRNA	PMID:18929588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:C015001	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of DHRS3 mRNA; TRP53 protein affects the reaction [arsenite results in increased expression of DHRS3 mRNA]	PMID:15894712|PMID:18929588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DHRS3 mRNA	PMID:30556269
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of DHRS3 mRNA	PMID:24690739
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DHRS3 mRNA	PMID:15467011
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of DHRS3 mRNA	PMID:27131904
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DHRS3 mRNA	PMID:25895662
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313699	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of DHRS3 mRNA	PMID:19150397
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of DHRS3 mRNA	PMID:35984750
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DHRS3 gene	PMID:31601247
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of DHRS3 mRNA	PMID:24136188
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of DHRS3 mRNA	PMID:22641619
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313699	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of DHRS3 mRNA	PMID:38568856
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:32181	tamibarotene	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of DHRS3 mRNA	PMID:15498508
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of DHRS3 mRNA	PMID:23557971
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313700	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DHRS3 promoter	PMID:35295148
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of DHRS3 mRNA	PMID:34492290
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of DHRS3 mRNA	PMID:18648102
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DHRS3 mRNA	PMID:18445702
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of DHRS3 mRNA	PMID:17426115|PMID:18301758
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases metabolic processing	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:C016583	DHRS3 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone	PMID:25451588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of DHRS3 mRNA	PMID:22576693
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DHRS3 mRNA	PMID:25181051|PMID:34947998
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313699	E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A results in increased expression of DHRS3 mRNA	PMID:19371625|PMID:23019147|PMID:29275510|PMID:29718440|PMID:34831106
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313700	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of DHRS3 mRNA	PMID:30951980|PMID:35341816|PMID:37105096
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313699	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of DHRS3 gene	PMID:22576693
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DHRS3 promoter	PMID:23359474
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DHRS3 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DHRS3 mRNA	PMID:28628672|PMID:31601247
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DHRS3 mRNA	PMID:25172293
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1313699	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of DHRS3 mRNA	PMID:19371625
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of DHRS3 mRNA	PMID:26682919
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of DHRS3 mRNA	PMID:36804509
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:3423	carmustine	affects response to substance	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D002330	DHRS3 mRNA affects the susceptibility to Carmustine	PMID:16365179
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DHRS3 mRNA	PMID:39298647
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313699	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of DHRS3 mRNA	PMID:34831106
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313700	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DHRS3 mRNA	PMID:30951980|PMID:40203079
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313699	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of DHRS3 mRNA	PMID:34831106
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313700	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of DHRS3 mRNA	PMID:30951980
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313699	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of DHRS3 protein	PMID:34186270
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of DHRS3 mRNA	PMID:17602206
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DHRS3 mRNA	PMID:21266533
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DHRS3 promoter	PMID:23359474
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DHRS3 mRNA	PMID:28628672
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of DHRS3 mRNA	PMID:21527772
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of DHRS3 mRNA	PMID:25380136
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313699	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DHRS3 mRNA	PMID:26472689
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DHRS3 mRNA	PMID:37236586
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313700	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DHRS3 mRNA	PMID:40194260
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313699	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DHRS3 mRNA	PMID:31533062
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313699	E	RGD:6480464	20240702	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of DHRS3 mRNA	PMID:38568856
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313699	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DHRS3 mRNA	PMID:25979313
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DHRS3 mRNA	PMID:17292431|PMID:17963808
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of DHRS3 mRNA	PMID:29154799
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313699	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DHRS3 gene	PMID:29154799
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313699	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of DHRS3 mRNA	PMID:24935251
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of DHRS3 mRNA	PMID:20106945
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313699	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DHRS3 mRNA	PMID:25562108|PMID:27989131
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DHRS3 mRNA	PMID:17555576
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20141223	CTD	MESH:D003907	[Dexamethasone co-treated with Genistein] results in increased expression of DHRS3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DHRS3 mRNA	PMID:25136773|PMID:28628672
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of DHRS3 mRNA	PMID:19371625
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in increased expression of DHRS3 mRNA	PMID:15958647
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:44409	NADP zwitterion	increases activity	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:D009249	NADP results in increased activity of DHRS3 protein	PMID:25451588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:44409	NADP zwitterion	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of DHRS3 protein	PMID:25526675
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of DHRS3 mRNA	PMID:38832940
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DHRS3 mRNA	PMID:17562736
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of DHRS3 mRNA	PMID:21420995|PMID:29067470
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in decreased expression of DHRS3 mRNA	PMID:29246445
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DHRS3 mRNA	PMID:33387578
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form promotes the reaction [Acetaminophen results in decreased expression of DHRS3 mRNA]	PMID:29246445
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of DHRS3 mRNA	PMID:24714768
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of DHRS3 mRNA	PMID:24690739
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of DHRS3 mRNA	PMID:33725128
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DHRS3 mRNA	PMID:35811015
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1313699	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of DHRS3 mRNA	PMID:18414638
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHRS3 mRNA	PMID:40504410
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of DHRS3 mRNA	PMID:35537566
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of DHRS3 mRNA	PMID:37077353
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of DHRS3 mRNA	PMID:29391264
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DHRS3 mRNA	PMID:17555576
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DHRS3 mRNA	PMID:17108234
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DHRS3 mRNA	PMID:18936297
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of DHRS3 mRNA	PMID:38568856
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DHRS3 mRNA	PMID:28628672
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:4998	fenarimol	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C033789	fenarimol results in increased expression of DHRS3 mRNA	PMID:28970091
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DHRS3 mRNA; Nanotubes, Carbon results in decreased expression of DHRS3 mRNA	PMID:25554681|PMID:25620056
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:50692	mifepristone	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20121009	CTD	MESH:D015735	Mifepristone promotes the reaction [Progesterone affects the expression of DHRS3 mRNA]	PMID:22414680
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:50859	bexarotene	increases expression	ISO	RGD:1313699	E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in increased expression of DHRS3 mRNA	PMID:17178900
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of DHRS3 mRNA	PMID:24793618
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:51507	benzil	increases metabolic processing	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:C006697	DHRS3 protein results in increased metabolism of benzil	PMID:25451588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:5445	glyceraldehyde	increases metabolic processing	ISO	RGD:1313699	E	RGD:6480464	20150414	CTD	MESH:D005985	DHRS3 protein results in increased metabolism of Glyceraldehyde	PMID:25451588
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of DHRS3 mRNA	PMID:18769122
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of DHRS3 mRNA	PMID:28801915
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DHRS3 mRNA	PMID:28801915
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	ISO	RGD:1313699	E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in increased expression of DHRS3 mRNA	PMID:16982809
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:64211	8-Br-cAMP	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20130910	CTD	MESH:D015124	7-propyl spirolactone inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein; Aldosterone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]	PMID:23275455
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in decreased expression of DHRS3 mRNA	PMID:21335049
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:67895	corosolic acid	increases expression	ISO	RGD:1313699	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of DHRS3 mRNA	PMID:37939859
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313700	E	RGD:6480464	20181016	CTD	MESH:D008825	Miconazole results in increased expression of DHRS3 mRNA	PMID:29337257
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1313699	E	RGD:6480464	20130305	CTD	MESH:C047246	DHRS3 mRNA affects the susceptibility to temozolomide	PMID:16365179
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313699	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DHRS3 mRNA	PMID:31758290
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:72754	bisphenol AF	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of DHRS3 mRNA	PMID:25912373
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1313699	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of DHRS3 mRNA	PMID:28960945
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1313699	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of DHRS3 mRNA	PMID:36318118
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of DHRS3 mRNA	PMID:26720608
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DHRS3 mRNA	PMID:30851411
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of DHRS3 mRNA	PMID:34995734
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA	PMID:27188386
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313700	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of DHRS3 mRNA	PMID:18343893
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:81758	cyproconazole	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of DHRS3 mRNA	PMID:22664269
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:81922	flusilazole	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C061365	flusilazole results in increased expression of DHRS3 mRNA	PMID:22664269|PMID:27094377|PMID:28263823
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:81922	flusilazole	increases expression	ISO	RGD:1313700	E	RGD:6480464	20181016	CTD	MESH:C061365	flusilazole results in increased expression of DHRS3 mRNA	PMID:29337257
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of DHRS3 mRNA	PMID:12727804
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DHRS3 mRNA	PMID:36843608
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313699	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of DHRS3 mRNA	PMID:26272509
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA	PMID:27188386
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:87368	diethyl malate	affects expression	ISO	RGD:1313700	E	RGD:6480464	20170303	CTD	MESH:C058705	diethyl malate affects the expression of DHRS3 mRNA	PMID:24814887
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of DHRS3 mRNA	PMID:35278568
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313699	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA	PMID:27188386
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of DHRS3 mRNA	PMID:27131904
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313699	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DHRS3 mRNA	PMID:38568856
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313699	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of DHRS3 mRNA	PMID:22378314
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in increased expression of DHRS3 mRNA	PMID:22664269|PMID:28263823
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of DHRS3 mRNA	PMID:21515302
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of DHRS3 mRNA	PMID:12732648
1305584	Dhrs3	dehydrogenase/reductase 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DHRS3 mRNA	PMID:35537566
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of COL6A2 mRNA	PMID:31863870
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313701	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of COL6A2 mRNA	PMID:38218311
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of COL6A2 mRNA	PMID:25152437
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of COL6A2 mRNA	PMID:21551480
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313702	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COL6A2 mRNA	PMID:33045310
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of COL6A2 mRNA	PMID:30951980
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL6A2 mRNA	PMID:36331819
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313701	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of COL6A2 mRNA	PMID:22378314
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:16130	DDT	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased expression of COL6A2 mRNA	PMID:30207508
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313702	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of COL6A2 mRNA	PMID:30319688
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313702	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of COL6A2 mRNA	PMID:16977382
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20161228	CTD	MESH:D008070	Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of COL6A2 mRNA]	PMID:16977382
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of COL6A2 mRNA	PMID:32145629
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313702	E	RGD:6480464	20130416	CTD	MESH:D004958	Estradiol results in increased expression of COL6A2 mRNA	PMID:23144751
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL6A2 mRNA	PMID:32741896
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A2 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of COL6A2 mRNA	PMID:20823114|PMID:30165855
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D004958	[bisphenol A results in increased susceptibility to Estradiol] which results in decreased expression of COL6A2 mRNA; Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of COL6A2 mRNA]	PMID:16977382|PMID:27312807
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313701	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of COL6A2 mRNA	PMID:26079696
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:17234	glucose	affects secretion	ISO	RGD:1313701	E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency affects the secretion of COL6A2 protein	PMID:24802182
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL6A2 mRNA	PMID:37992649
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL6A2 mRNA	PMID:32741896
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313701	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of COL6A2 mRNA	PMID:33647349
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:17634	D-glucose	affects secretion	ISO	RGD:1313701	E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency affects the secretion of COL6A2 protein	PMID:24802182
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL6A2 mRNA	PMID:37992649
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313702	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of COL6A2 mRNA	PMID:33754040
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313701	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of COL6A2 mRNA	PMID:28818685
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313701	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of COL6A2 intron	PMID:30157460
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL6A2 mRNA	PMID:36331819
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20181016	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL6A2 mRNA	PMID:29741670
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL6A2 protein]	PMID:32272095
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313701	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of COL6A2 polyA tail	PMID:30157460
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of COL6A2 mRNA	PMID:18356318
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of COL6A2 mRNA]	PMID:22206623
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene	PMID:40504410
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313701	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of COL6A2 mRNA	PMID:19244175
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of COL6A2 mRNA	PMID:28960355
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of COL6A2 mRNA	PMID:31881176
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:27881	resveratrol	affects secretion	ISO	RGD:1313701	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol affects the secretion of COL6A2 protein	PMID:24802182
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of COL6A2 mRNA	PMID:23625948
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313702	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of COL6A2 mRNA	PMID:32186404
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL6A2 mRNA	PMID:34747641
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313702	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL6A2 mRNA	PMID:26377647
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COL6A2 mRNA	PMID:33387578
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL6A2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to COL6A2 promoter]	PMID:17942748|PMID:19654925
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of COL6A2 mRNA	PMID:28959563
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of COL6A2 mRNA	PMID:21198554
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of COL6A2 mRNA	PMID:30556269
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of COL6A2 mRNA	PMID:30911355
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of COL6A2 protein	PMID:28918527
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28741	sodium fluoride	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D012969	Sodium Fluoride results in increased expression of COL6A2 protein	PMID:29653260
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL6A2 mRNA	PMID:29803840
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL6A2 mRNA	PMID:39631538
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20120918	CTD	MESH:D004317	[[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of COL6A2 mRNA	PMID:21040762
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL6A2 mRNA	PMID:37992649
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313701	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of COL6A2 gene	PMID:28589171
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL6A2 mRNA	PMID:18812580
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313702	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of COL6A2 gene	PMID:39894169
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313701	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COL6A2 mRNA	PMID:38568856
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA	PMID:12634122
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene	PMID:40504410
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313701	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COL6A2 intron; Benzo(a)pyrene affects the methylation of COL6A2 promoter	PMID:27901495|PMID:30157460
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313701	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of COL6A2 3' UTR	PMID:27901495
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313701	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COL6A2 5' UTR	PMID:27901495
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of COL6A2 mRNA	PMID:18929588
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of COL6A2 mRNA]	PMID:18929588
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of COL6A2 mRNA	PMID:30556269
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of COL6A2 mRNA	PMID:30911355
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of COL6A2 mRNA	PMID:18356318
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1313701	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of COL6A2 gene	PMID:31601247
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20120412	CTD	MESH:C008261	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA	PMID:12634122
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of COL6A2 mRNA	PMID:25729387
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of COL6A2 mRNA	PMID:25729387
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of COL6A2 mRNA	PMID:35295148
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313702	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of COL6A2 gene; titanium dioxide results in decreased methylation of COL6A2 promoter	PMID:35295148
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of COL6A2 mRNA	PMID:34492290
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of COL6A2 mRNA	PMID:25380136
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of COL6A2 mRNA	PMID:17426115
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of COL6A2 mRNA	PMID:20813756
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of COL6A2 mRNA	PMID:25181051
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of COL6A2 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998|PMID:38750585
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of COL6A2 protein	PMID:34186270
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313702	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of COL6A2 mRNA	PMID:30951980|PMID:32156529|PMID:32370801
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of COL6A2 gene	PMID:28505145
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A results in increased susceptibility to Estradiol] which results in decreased expression of COL6A2 mRNA	PMID:27312807
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313701	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of COL6A2 mRNA	PMID:19244175
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of COL6A2 mRNA	PMID:40203079
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313702	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of COL6A2 mRNA	PMID:30951980
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313701	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of COL6A2 protein	PMID:34186270
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313702	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of COL6A2 mRNA	PMID:30951980
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of COL6A2 mRNA	PMID:30951980
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313701	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of COL6A2 protein	PMID:34186270
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of COL6A2 mRNA	PMID:31558096
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of COL6A2 mRNA; Dextran Sulfate results in decreased expression of COL6A2 protein	PMID:32272095|PMID:35093514
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313702	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of COL6A2 protein	PMID:35362542
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL6A2 protein]; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of COL6A2 protein]	PMID:32272095|PMID:35362542
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL6A2 mRNA	PMID:18164116
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313701	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of COL6A2 mRNA	PMID:29024780
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of COL6A2 mRNA	PMID:25380136
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313701	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COL6A2 mRNA	PMID:38568856
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20120412	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL6A2 mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA	PMID:12634122|PMID:29741670
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of COL6A2 mRNA	PMID:27387713
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313701	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of COL6A2 mRNA	PMID:19244175
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:3764	clotrimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of COL6A2 mRNA	PMID:30047161
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1313701	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of COL6A2 mRNA	PMID:40434365
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COL6A2 mRNA	PMID:31533062
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1313701	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of COL6A2 mRNA	PMID:31626844
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL6A2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL6A2 mRNA	PMID:36331819
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:39501	2,2,2-tetramine	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D014266	Trientine inhibits the reaction [Streptozocin results in increased expression of COL6A2 protein]	PMID:19634143
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of COL6A2 mRNA	PMID:17963808
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313701	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of COL6A2 mRNA	PMID:19101580|PMID:26272509
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313701	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of COL6A2 gene	PMID:29154799
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A2 mRNA	PMID:27188386
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of COL6A2 mRNA	PMID:30047161|PMID:41580965
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of COL6A2 mRNA	PMID:40633821
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of COL6A2 mRNA	PMID:25047013
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of COL6A2 mRNA	PMID:28973697
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:42758	aldehydo-D-glucose	affects secretion	ISO	RGD:1313701	E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency affects the secretion of COL6A2 protein	PMID:24802182
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL6A2 mRNA	PMID:37992649
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of COL6A2 mRNA	PMID:38832940
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1313701	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of COL6A2 mRNA	PMID:19682730
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of COL6A2 mRNA	PMID:17562736
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene	PMID:40504410
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of COL6A2 mRNA	PMID:29391264
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:48242	dichromium trioxide	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20120412	CTD	MESH:C023600	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA	PMID:12634122
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313701	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of COL6A2 mRNA	PMID:18175754
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20130514	CTD	MESH:D018038	[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of COL6A2 mRNA	PMID:23274088
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of COL6A2 mRNA	PMID:17942748
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL6A2 mRNA	PMID:17942748
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in increased expression of COL6A2 protein	PMID:39793947
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of COL6A2 protein]	PMID:35362542
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A2 mRNA	PMID:20823114
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313702	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of COL6A2 mRNA; Nanotubes, Carbon results in increased expression of COL6A2 mRNA	PMID:25554681
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of COL6A2 mRNA	PMID:30047161
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:52774	pentane-2,3-dione	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in increased expression of COL6A2 mRNA	PMID:25710175
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1313701	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of COL6A2 mRNA	PMID:20436886
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1313701	E	RGD:6480464	20120412	CTD	MESH:D019772	COL6A2 protein affects the susceptibility to Topotecan	PMID:16217747
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of COL6A2 mRNA	PMID:25729387
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of COL6A2 mRNA	PMID:25729387
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313702	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of COL6A2 mRNA	PMID:23650126
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313701	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of COL6A2 mRNA	PMID:15336504
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of COL6A2 mRNA	PMID:36907384
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:64648	enniatin	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20230502	CTD	MESH:C100264	enniatins results in decreased expression of COL6A2 mRNA	PMID:36016515
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A2 mRNA	PMID:20823114
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in decreased expression of COL6A2 mRNA	PMID:36914120
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313701	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of COL6A2 mRNA	PMID:31758290
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313701	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of COL6A2 protein	PMID:34186270
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313702	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of COL6A2 mRNA	PMID:22206623
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of COL6A2 mRNA]	PMID:22206623
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1313701	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of COL6A2 mRNA	PMID:36318118
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL6A2 mRNA	PMID:32741896
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL6A2 mRNA	PMID:18164116
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A2 mRNA	PMID:27188386
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COL6A2 gene]	PMID:28238834
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1313701	E	RGD:6480464	20120412	CTD	MESH:D010672	Phenytoin results in increased expression of COL6A2 mRNA	PMID:8224229
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313702	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of COL6A2 mRNA	PMID:38648751
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of COL6A2 mRNA	PMID:27291303
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of COL6A2 mRNA	PMID:38995820
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of COL6A2 mRNA	PMID:31558096
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of COL6A2 mRNA	PMID:23640034
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:82527	Ptaquiloside	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in decreased expression of COL6A2 mRNA	PMID:23274088
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:82527	Ptaquiloside	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20141111	CTD	MESH:C043680	[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of COL6A2 mRNA	PMID:23274088
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313701	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A2 mRNA	PMID:27188386
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1313702	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of COL6A2 mRNA	PMID:16274305
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of COL6A2 mRNA	PMID:19281266
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D013311	Streptozocin results in increased expression of COL6A2 protein	PMID:19634143
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D013311	Trientine inhibits the reaction [Streptozocin results in increased expression of COL6A2 protein]	PMID:19634143
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of COL6A2 mRNA	PMID:18499699
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1313701	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of COL6A2 mRNA	PMID:17440010
1305585	Col6a2	collagen type VI alpha 2 chain	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313701	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of COL6A2 mRNA	PMID:38568856
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:110423	clodronic acid	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of TMEM45B mRNA	PMID:25596134
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1550758	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TMEM45B mRNA	PMID:37995155
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TMEM45B mRNA	PMID:26251327
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMEM45B mRNA	PMID:20938992
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of TMEM45B mRNA	PMID:23724009
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1348060	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TMEM45B mRNA	PMID:25596134
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM45B mRNA	PMID:36331819
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1348060	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of TMEM45B mRNA	PMID:24763279
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of TMEM45B mRNA	PMID:19167446|PMID:23019147|PMID:24758408
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TMEM45B mRNA	PMID:39298647
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1348060	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of TMEM45B mRNA	PMID:21185374
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[Testosterone co-treated with Estradiol] results in increased expression of TMEM45B mRNA	PMID:32741896
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1348060	E	RGD:6480464	20160412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of TMEM45B mRNA; EGF protein inhibits the reaction [Estradiol results in decreased expression of TMEM45B mRNA]	PMID:24758408|PMID:30165855
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:165219	PCB138	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of TMEM45B mRNA	PMID:23829299
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of TMEM45B mRNA	PMID:33711761
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TMEM45B mRNA	PMID:33387578
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMEM45B mRNA	PMID:20938992
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1348060	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TMEM45B mRNA	PMID:37042841
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of TMEM45B mRNA	PMID:22238285
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM45B mRNA	PMID:37992649
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of TMEM45B mRNA	PMID:28973375
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] results in increased expression of TMEM45B mRNA	PMID:32741896
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1348060	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of TMEM45B mRNA	PMID:31256213
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM45B mRNA	PMID:37992649
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TMEM45B mRNA	PMID:31163220
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TMEM45B mRNA	PMID:28818685
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:18248	iron atom	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D007501	Iron deficiency results in decreased expression of TMEM45B mRNA	PMID:16629162
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1348060	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of TMEM45B mRNA	PMID:19549813
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TMEM45B mRNA	PMID:27153756
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TMEM45B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TMEM45B mRNA	PMID:34911549
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1550758	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of TMEM45B mRNA	PMID:31939706
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM45B mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMEM45B mRNA	PMID:20938992|PMID:22206623
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1348060	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of TMEM45B protein	PMID:35688186
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TMEM45B mRNA	PMID:28960355
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of TMEM45B mRNA	PMID:25596134
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of TMEM45B mRNA	PMID:25596134
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1348060	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of TMEM45B promoter	PMID:22847954
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of TMEM45B mRNA	PMID:20884965
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1348060	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TMEM45B mRNA	PMID:25583101
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM45B mRNA	PMID:34747641
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1348060	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM45B mRNA	PMID:22903824
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1348060	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TMEM45B mRNA	PMID:33212167
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM45B mRNA	PMID:30851411
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM45B mRNA	PMID:37992649
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1348060	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of TMEM45B mRNA	PMID:20044591
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1348060	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TMEM45B mRNA	PMID:39719251
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1348060	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMEM45B 5' UTR; Benzo(a)pyrene affects the methylation of TMEM45B intron	PMID:27901495|PMID:30157460
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1348060	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TMEM45B mRNA	PMID:20064835|PMID:22316170
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1348060	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM45B promoter	PMID:27901495
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1550758	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM45B intron	PMID:27901495
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TMEM45B mRNA	PMID:25895662
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TMEM45B mRNA	PMID:22431001
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1348060	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TMEM45B mRNA	PMID:23806026
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of TMEM45B mRNA	PMID:23557971|PMID:35295148
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TMEM45B mRNA	PMID:30012374
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1348060	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TMEM45B mRNA	PMID:30903817
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM45B mRNA	PMID:25181051|PMID:41034487
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM45B mRNA	PMID:34947998
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1348060	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM45B mRNA	PMID:32028606
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:33418	graphite	increases expression	ISO	RGD:1550758	E	RGD:6480464	20180515	CTD	MESH:D006108	Graphite results in increased expression of TMEM45B mRNA	PMID:27440207
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of TMEM45B mRNA	PMID:26682919
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of TMEM45B mRNA	PMID:23829299
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene results in decreased expression of TMEM45B mRNA	PMID:19925653
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1348060	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to TMEM45B promoter]	PMID:20348232
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1348060	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of TMEM45B intron	PMID:30157460
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550758	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of TMEM45B mRNA	PMID:24535843
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1348060	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMEM45B mRNA	PMID:37042841
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMEM45B mRNA	PMID:25596134
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1348060	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMEM45B mRNA	PMID:38174414
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TMEM45B mRNA	PMID:27387713
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of TMEM45B mRNA	PMID:25596134
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TMEM45B mRNA	PMID:28302478
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1348060	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of TMEM45B promoter	PMID:22847954
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1348060	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of TMEM45B promoter	PMID:22847954
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of TMEM45B mRNA	PMID:19167446
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1348060	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM45B mRNA	PMID:19167446
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM45B mRNA	PMID:36331819
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM45B mRNA	PMID:29154799
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1348060	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TMEM45B gene	PMID:29154799
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TMEM45B mRNA	PMID:30047161
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TMEM45B mRNA	PMID:28973697
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM45B mRNA	PMID:37992649
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:4488	diallyl disulfide	multiple interactions	ISO	RGD:1348060	E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide inhibits the reaction [tobacco tar analog results in increased expression of TMEM45B mRNA]	PMID:36758788
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:46727	quartz	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D011791	Quartz results in increased expression of TMEM45B mRNA	PMID:32976597
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:46727	quartz	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D011791	Tobacco Smoke Pollution promotes the reaction [Quartz results in increased expression of TMEM45B mRNA]	PMID:32976597
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1550758	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of TMEM45B mRNA	PMID:30529165
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TMEM45B mRNA	PMID:30047161
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1348060	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of TMEM45B intron	PMID:30157460
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:69355	casticin	increases expression	ISO	RGD:1348060	E	RGD:6480464	20170516	CTD	MESH:C054133	casticin results in increased expression of TMEM45B mRNA	PMID:27862857
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMEM45B mRNA	PMID:22206623
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550758	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM45B mRNA	PMID:22206623
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM45B mRNA	PMID:30851411
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348060	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TMEM45B gene]	PMID:28238834
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1348060	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM45B mRNA	PMID:19167446
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550758	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TMEM45B mRNA	PMID:38648751
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1550758	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of TMEM45B mRNA	PMID:26377693
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:82664	iron(0)	decreases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in decreased expression of TMEM45B mRNA	PMID:16629162
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TMEM45B mRNA	PMID:30047161
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1348060	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of TMEM45B mRNA	PMID:31734321
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of TMEM45B mRNA	PMID:30047161
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1550758	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of TMEM45B mRNA	PMID:28973697
1305586	Tmem45b	transmembrane protein 45b	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of TMEM45B gene	PMID:31682807
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313704	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of FAM241B mRNA	PMID:38218311
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313705	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FAM241B mRNA	PMID:33045310
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of FAM241B mRNA	PMID:36331819
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313704	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of FAM241B mRNA	PMID:26079696
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313705	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FAM241B mRNA	PMID:30319688
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM241B mRNA	PMID:37992649
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM241B mRNA	PMID:37992649
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FAM241B mRNA	PMID:33387578
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313704	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FAM241B mRNA	PMID:28818685
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAM241B mRNA	PMID:36331819
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20200609	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FAM241B mRNA	PMID:31738976
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313704	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of FAM241B mRNA	PMID:19549813
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313704	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FAM241B gene	PMID:27153756
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313704	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FAM241B exon	PMID:30157460
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FAM241B mRNA	PMID:31150632
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313705	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of FAM241B mRNA	PMID:35897073
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FAM241B mRNA	PMID:31881176
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM241B mRNA	PMID:23557933
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FAM241B mRNA	PMID:34747641
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM241B mRNA	PMID:32109520|PMID:34747641
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313704	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of FAM241B mRNA	PMID:28001369
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313704	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FAM241B mRNA	PMID:33212167
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of FAM241B mRNA	PMID:28959563
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM241B mRNA	PMID:37992649
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313704	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FAM241B mRNA	PMID:20044591
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313704	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FAM241B mRNA	PMID:38568856
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313704	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of FAM241B mRNA	PMID:29453283
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313704	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM241B promoter	PMID:27901495
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313704	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM241B mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FAM241B mRNA	PMID:24136188
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FAM241B mRNA	PMID:34492290
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FAM241B mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313705	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM241B mRNA	PMID:35598803
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of FAM241B mRNA	PMID:41034487
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313705	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of FAM241B mRNA	PMID:32156529
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313705	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of FAM241B exon	PMID:33297965
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:34778	glycitein	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of FAM241B mRNA	PMID:36117858
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313704	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of FAM241B mRNA	PMID:29024780
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313704	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FAM241B mRNA	PMID:38174414|PMID:38568856
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20200609	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FAM241B mRNA	PMID:31738976
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313704	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FAM241B mRNA	PMID:24449571
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313704	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FAM241B mRNA	PMID:31533062
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAM241B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of FAM241B mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of FAM241B mRNA	PMID:36331819
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313704	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FAM241B mRNA	PMID:25979313
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313704	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FAM241B gene	PMID:29154799
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of FAM241B mRNA	PMID:17183730
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of FAM241B mRNA	PMID:41580965
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313704	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FAM241B mRNA	PMID:25562108
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313705	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FAM241B mRNA	PMID:28973697
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM241B mRNA	PMID:37992649
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313704	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FAM241B mRNA	PMID:38832940
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1313704	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of FAM241B mRNA	PMID:22077320
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of FAM241B mRNA	PMID:29391264
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of FAM241B mRNA	PMID:24136188
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of FAM241B mRNA	PMID:36117858
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1313704	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of FAM241B mRNA	PMID:20977926
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of FAM241B mRNA	PMID:17183730
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1313704	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of FAM241B protein	PMID:32959892
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313704	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of FAM241B mRNA	PMID:31758290
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:80373	glycitin	multiple interactions	ISO	RGD:1313704	E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of FAM241B mRNA	PMID:32109520
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of FAM241B mRNA	PMID:24136188
1305587	Fam241b	family with sequence similarity 241 member B	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FAM241B mRNA	PMID:23034163
1305588	Rag2	recombination activating 2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313706	E	RGD:6480464	20241001	CTD	MESH:C007262	deoxynivalenol results in increased expression of RAG2 mRNA	PMID:38549690
1305588	Rag2	recombination activating 2	gene	CHEBI:132446	perfluorobutanesulfonic acid	decreases expression	ISO	RGD:1313706	E	RGD:6480464	20241001	CTD	MESH:C539348	perfluorobutanesulfonic acid results in decreased expression of RAG2 mRNA	PMID:38549690
1305588	Rag2	recombination activating 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313706	E	RGD:6480464	20230502	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of RAG2 mRNA	PMID:36326898|PMID:38549690
1305588	Rag2	recombination activating 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313707	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAG2 mRNA	PMID:12057914
1305588	Rag2	recombination activating 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313706	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RAG2 gene	PMID:27153756
1305588	Rag2	recombination activating 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313707	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of RAG2 mRNA	PMID:40618947
1305588	Rag2	recombination activating 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313707	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAG2 mRNA	PMID:26377647
1305588	Rag2	recombination activating 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of RAG2 mRNA	PMID:26033743
1305588	Rag2	recombination activating 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of RAG2 mRNA	PMID:26033743
1305588	Rag2	recombination activating 2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RAG2 mRNA	PMID:16483693
1305588	Rag2	recombination activating 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313707	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of RAG2 mRNA	PMID:20542052
1305588	Rag2	recombination activating 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313707	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAG2 promoter	PMID:27312807
1305588	Rag2	recombination activating 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313706	E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in increased expression of RAG2 mRNA	PMID:30616060
1305588	Rag2	recombination activating 2	gene	CHEBI:34591	bromodichloromethane	multiple interactions	ISO	RGD:1313707	E	RGD:6480464	20140812	CTD	MESH:C025191	[PRF1 protein co-treated with RAG2 protein] affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of CASP3 protein modified form]; [PRF1 protein co-treated with RAG2 protein] affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL2 mRNA]; [PRF1 protein co-treated with RAG2 protein] affects the susceptibility to [bromodichloromethane co-treated with Dietary Fats]	PMID:24211274
1305588	Rag2	recombination activating 2	gene	CHEBI:35546	perfluorodecanoic acid	decreases expression	ISO	RGD:1313706	E	RGD:6480464	20241001	CTD	MESH:C036567	perfluorodecanoic acid results in decreased expression of RAG2 mRNA	PMID:38549690
1305588	Rag2	recombination activating 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313706	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RAG2 mRNA	PMID:36326898|PMID:38549690
1305588	Rag2	recombination activating 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313706	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RAG2 mRNA	PMID:24449571
1305588	Rag2	recombination activating 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313706	E	RGD:6480464	20230502	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RAG2 mRNA	PMID:36326898|PMID:38549690
1305588	Rag2	recombination activating 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313706	E	RGD:6480464	20230502	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RAG2 mRNA	PMID:36326898|PMID:38549690
1305588	Rag2	recombination activating 2	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1313707	E	RGD:6480464	20130416	CTD	MESH:C017160	cypermethrin results in increased expression of RAG2 mRNA	PMID:21142847
1305588	Rag2	recombination activating 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RAG2 mRNA	PMID:33387578
1305588	Rag2	recombination activating 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1313707	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of RAG2 mRNA	PMID:19812364
1305588	Rag2	recombination activating 2	gene	CHEBI:83492	perfluorohexanoic acid	decreases expression	ISO	RGD:1313706	E	RGD:6480464	20241001	CTD	MESH:C479228	perfluorohexanoic acid results in decreased expression of RAG2 mRNA	PMID:38549690
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313708	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FGD5 mRNA	PMID:26272509|PMID:27188386
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313709	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FGD5 mRNA	PMID:33045310
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313709	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FGD5 mRNA	PMID:26251327
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313708	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FGD5 mRNA	PMID:35811015
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FGD5 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of FGD5 mRNA	PMID:35811015
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of FGD5 mRNA	PMID:20404318
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313709	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FGD5 mRNA	PMID:37992649
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of FGD5 mRNA	PMID:22967744
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313709	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FGD5 mRNA	PMID:37992649
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313708	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of FGD5 exon	PMID:30157460
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313708	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FGD5 mRNA	PMID:32234424
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313708	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FGD5 exon	PMID:30157460
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313709	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FGD5 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FGD5 mRNA	PMID:27106289|PMID:34911549
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313708	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of FGD5 mRNA	PMID:19774075
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313709	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of FGD5 protein	PMID:37208198
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FGD5 mRNA	PMID:23557933
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1313708	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of FGD5 mRNA	PMID:23300844
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of FGD5 mRNA	PMID:17898221
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313708	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of FGD5 mRNA	PMID:25583101
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313709	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FGD5 mRNA	PMID:21570461
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FGD5 mRNA	PMID:32109520
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FGD5 mRNA	PMID:34747641
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313709	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FGD5 mRNA	PMID:23994337
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313709	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FGD5 mRNA	PMID:37992649
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313708	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FGD5 intron; Benzo(a)pyrene affects the methylation of FGD5 promoter	PMID:27901495|PMID:30157460
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313708	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FGD5 mRNA	PMID:32234424
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313709	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FGD5 mRNA	PMID:27195522
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313709	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FGD5 mRNA	PMID:22228805|PMID:32417428
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313708	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of FGD5 gene	PMID:25435355
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1313708	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of FGD5 mRNA	PMID:37690743
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313709	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of FGD5 mRNA	PMID:23557971
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313709	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FGD5 promoter	PMID:35295148
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313709	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of FGD5 mRNA	PMID:18648102
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FGD5 mRNA	PMID:25181051
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FGD5 mRNA	PMID:30816183|PMID:32145629
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313709	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FGD5 mRNA	PMID:26063408
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313709	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of FGD5 mRNA	PMID:30951980
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313709	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of FGD5 mRNA	PMID:26682919
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1313709	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FGD5 mRNA	PMID:23994337
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313708	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FGD5 gene	PMID:31601247
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313709	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of FGD5 exon	PMID:33297965
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313709	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FGD5 mRNA	PMID:30951980|PMID:33297965
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313709	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of FGD5 mRNA	PMID:26377693
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313708	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of FGD5 exon; benzo(e)pyrene results in increased methylation of FGD5 intron	PMID:30157460
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313709	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FGD5 mRNA	PMID:30951980
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313709	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FGD5 mRNA	PMID:37019170
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313708	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FGD5 mRNA	PMID:19320972
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313709	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FGD5 mRNA	PMID:40194260
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313708	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FGD5 mRNA	PMID:25979313
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313708	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of FGD5 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313708	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FGD5 gene	PMID:29154799
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313708	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of FGD5 mRNA	PMID:27989131
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313709	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FGD5 mRNA	PMID:28973697
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313709	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FGD5 mRNA	PMID:37992649
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313708	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FGD5 mRNA	PMID:38832940
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313708	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of FGD5 mRNA	PMID:24935251|PMID:26272509
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1313708	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of FGD5 mRNA	PMID:35811015
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FGD5 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of FGD5 mRNA	PMID:35811015
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313708	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of FGD5 mRNA	PMID:32234424
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313708	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of FGD5 mRNA	PMID:23300844
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313709	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of FGD5 protein	PMID:36851058
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313708	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of FGD5 exon; Methapyrilene results in increased methylation of FGD5 intron	PMID:30157460
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FGD5 gene	PMID:35440735
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313709	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FGD5 mRNA	PMID:22206623
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313709	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of FGD5 mRNA	PMID:23994337
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of FGD5 mRNA	PMID:23665939
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FGD5 gene]	PMID:28238834
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313708	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of FGD5 mRNA	PMID:32234424
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313708	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of FGD5 mRNA	PMID:26272509
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313708	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FGD5 mRNA	PMID:19281266
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313709	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FGD5 mRNA	PMID:28973697
1305589	Fgd5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of FGD5 mRNA	PMID:19015723
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313710	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SAR1B mRNA	PMID:38218311
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of SAR1B mRNA	PMID:21551480
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313710	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SAR1B mRNA	PMID:21934132
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SAR1B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SAR1B mRNA	PMID:32699268
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SAR1B mRNA	PMID:36331819
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313711	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of SAR1B mRNA	PMID:40945087
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313711	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SAR1B mRNA	PMID:30319688
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SAR1B mRNA	PMID:29432896
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313711	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SAR1B mRNA	PMID:39241906
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SAR1B mRNA	PMID:39298647
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SAR1B mRNA	PMID:19448997
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313711	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in increased expression of SAR1B mRNA	PMID:28973375
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313710	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SAR1B mRNA	PMID:37042841
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313710	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SAR1B mRNA	PMID:21179406
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SAR1B mRNA	PMID:33848595
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313711	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SAR1B mRNA	PMID:17997037
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SAR1B mRNA	PMID:36331819
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313711	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SAR1B mRNA	PMID:17997037
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313711	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SAR1B mRNA	PMID:27462272
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SAR1B mRNA	PMID:35301059
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SAR1B mRNA	PMID:37325564
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313710	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SAR1B mRNA	PMID:23649840
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SAR1B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SAR1B mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SAR1B mRNA	PMID:32699268
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SAR1B mRNA	PMID:22206623
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20121113	CTD	MESH:D012643	Selenium results in decreased expression of SAR1B mRNA	PMID:19244175
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313710	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SAR1B mRNA	PMID:26272509
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SAR1B mRNA	PMID:31881176
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SAR1B mRNA	PMID:23557933
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1313710	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of SAR1B gene	PMID:31636367
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313711	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SAR1B mRNA	PMID:21570461
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SAR1B mRNA	PMID:34747641
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of SAR1B protein	PMID:39603559
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SAR1B mRNA	PMID:28001369
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SAR1B mRNA	PMID:30851411
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SAR1B mRNA	PMID:24690739
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SAR1B mRNA	PMID:25523186
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of SAR1B protein	PMID:38266420
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313710	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SAR1B mRNA	PMID:38568856
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313710	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SAR1B mRNA	PMID:22378314
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SAR1B mRNA	PMID:32234424
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SAR1B mRNA	PMID:25523186
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SAR1B mRNA	PMID:24690739
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of SAR1B mRNA	PMID:24136188
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SAR1B mRNA	PMID:34492290
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313711	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of SAR1B mRNA	PMID:17426115|PMID:18301758
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SAR1B mRNA	PMID:19710929
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SAR1B mRNA	PMID:30903817
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SAR1B mRNA	PMID:25181051
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SAR1B mRNA	PMID:39298647
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313710	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SAR1B protein	PMID:34186270
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAR1B mRNA	PMID:28628672
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SAR1B mRNA	PMID:17602206
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAR1B mRNA	PMID:28628672
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313711	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of SAR1B mRNA	PMID:34813904
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SAR1B mRNA	PMID:17602206
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SAR1B mRNA	PMID:35163327
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SAR1B mRNA	PMID:38568856
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SAR1B mRNA	PMID:35301059
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SAR1B mRNA	PMID:37325564
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1313711	E	RGD:6480464	20121113	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of SAR1B mRNA	PMID:18281256
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SAR1B mRNA	PMID:35163327
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SAR1B mRNA	PMID:24386269
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SAR1B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SAR1B mRNA	PMID:32699268
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20121113	CTD	MESH:D012643	Selenium results in decreased expression of SAR1B mRNA	PMID:19244175
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SAR1B mRNA	PMID:17585979
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SAR1B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SAR1B mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SAR1B mRNA	PMID:36331819
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313710	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SAR1B mRNA	PMID:25979313
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313710	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SAR1B mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:29154799
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313710	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of SAR1B gene	PMID:29501571
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SAR1B mRNA	PMID:19770486
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313710	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of SAR1B mRNA	PMID:27989131
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAR1B mRNA	PMID:28628672
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of SAR1B mRNA	PMID:24136188
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313710	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SAR1B mRNA	PMID:27188386
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313710	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SAR1B mRNA	PMID:24935251|PMID:26272509
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of SAR1B mRNA	PMID:24690739
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:46666	crocidolite asbestos	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite inhibits the reaction [SPARC gene mutant form results in increased expression of SAR1B mRNA]	PMID:19446018
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313711	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of SAR1B mRNA	PMID:22334560
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1313710	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SAR1B mRNA	PMID:26272509
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAR1B mRNA	PMID:28628672
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of SAR1B mRNA	PMID:40234311
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1313710	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SAR1B mRNA	PMID:26705709
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20121113	CTD	MESH:D015474	Isotretinoin results in decreased expression of SAR1B mRNA	PMID:20436886
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SAR1B protein	PMID:32959892
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of SAR1B mRNA	PMID:24136188
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313710	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of SAR1B mRNA	PMID:15336504
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SAR1B gene	PMID:35440735
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313710	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SAR1B protein	PMID:34186270
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SAR1B mRNA	PMID:22206623
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SAR1B mRNA	PMID:22206623
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of SAR1B mRNA	PMID:24136188
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313710	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SAR1B mRNA	PMID:30851411
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SAR1B mRNA	PMID:31826744
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1313711	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of SAR1B mRNA	PMID:22334560
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313711	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of SAR1B mRNA	PMID:21278054|PMID:22334560
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313711	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of SAR1B mRNA	PMID:40826991
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of SAR1B protein	PMID:26903627
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313710	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of SAR1B protein	PMID:24648495
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of SAR1B protein	PMID:35544339
1305590	Sar1b	secretion associated, Ras related GTPase 1B	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313710	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of SAR1B mRNA	PMID:27188386
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1622023	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of CCDC15 mRNA	PMID:33045310
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CCDC15 mRNA	PMID:21632981
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1605034	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of CCDC15 mRNA	PMID:29581250
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CCDC15 mRNA	PMID:33387578
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1605034	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CCDC15 mRNA	PMID:23649840
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1605034	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CCDC15 mRNA	PMID:21179406
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CCDC15 mRNA	PMID:26079696
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of CCDC15 mRNA	PMID:21592394
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1605034	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of CCDC15 mRNA	PMID:21592394
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of CCDC15 mRNA	PMID:21592394
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1605034	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of CCDC15 mRNA	PMID:21592394
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CCDC15 mRNA	PMID:33387578
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CCDC15 mRNA	PMID:28818685
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1622023	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCDC15 mRNA	PMID:37236586
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CCDC15 mRNA	PMID:19549813
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1605034	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CCDC15 mRNA	PMID:23649840
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605034	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CCDC15 gene	PMID:27153756
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605034	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CCDC15 mRNA	PMID:23649840
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CCDC15 mRNA	PMID:30779732
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605034	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC15 mRNA	PMID:23557933
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1605034	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CCDC15 mRNA	PMID:27594783
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCDC15 mRNA	PMID:20106945|PMID:21632981
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCDC15 mRNA	PMID:33387578
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CCDC15 mRNA	PMID:28001369
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CCDC15 mRNA	PMID:30851411
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1605034	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of CCDC15 mRNA	PMID:21198554
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of CCDC15 mRNA	PMID:22623647
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605034	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCDC15 mRNA	PMID:32234424
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622023	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCDC15 gene	PMID:35295148
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1622023	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CCDC15 promoter	PMID:35295148
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CCDC15 mRNA	PMID:25181051
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CCDC15 mRNA	PMID:29275510
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1622023	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CCDC15 mRNA	PMID:26063408
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1622023	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of CCDC15 mRNA	PMID:30951980|PMID:40203079
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1622023	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of CCDC15 mRNA	PMID:30951980
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1622023	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CCDC15 mRNA	PMID:37019170
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605034	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCDC15 mRNA	PMID:37042841
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1622023	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCDC15 mRNA	PMID:37236586
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605034	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CCDC15 mRNA	PMID:25979313
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in decreased expression of CCDC15 mRNA	PMID:23527032
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605034	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of CCDC15 mRNA	PMID:23179753|PMID:24935251
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CCDC15 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605034	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCDC15 mRNA	PMID:38832940
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1605034	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CCDC15 mRNA	PMID:27188386
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1605034	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CCDC15 mRNA	PMID:24935251
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CCDC15 mRNA	PMID:33387578
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1622023	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CCDC15 mRNA	PMID:35436446
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of CCDC15 mRNA	PMID:28801915
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CCDC15 mRNA	PMID:28988120
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CCDC15 mRNA	PMID:28801915
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CCDC15 mRNA	PMID:22714537
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of CCDC15 mRNA	PMID:29522793
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1605034	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CCDC15 mRNA	PMID:30851411
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605034	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCDC15 gene]	PMID:28238834
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1622023	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of CCDC15 mRNA	PMID:32835833
1305591	Ccdc15	coiled-coil domain containing 15	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1622023	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CCDC15 mRNA	PMID:35537566
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313714	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PAGR1A mRNA	PMID:37995155
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:132844	glycidyl methacrylate	increases expression	ISO	RGD:1606780	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of PAGR1 protein	PMID:36641056
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20130806	CTD	MESH:D014212	Tretinoin results in decreased expression of PAGR1 mRNA	PMID:21934132
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PAGR1 mRNA	PMID:29432896
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313714	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PAGR1A mRNA	PMID:39298647
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606780	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PAGR1 mRNA	PMID:37042841
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1606780	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PAGR1 mRNA	PMID:23649840
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313714	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of PAGR1A mRNA	PMID:39922521
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313714	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of PAGR1A mRNA	PMID:39922521
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313714	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PAGR1A mRNA	PMID:23892564
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313714	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PAGR1A mRNA	PMID:34319233
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1606780	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PAGR1 protein	PMID:37730182
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PAGR1 mRNA	PMID:33387578
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PAGR1 mRNA	PMID:28818685
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PAGR1 mRNA	PMID:19549813
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PAGR1 mRNA	PMID:23649840
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PAGR1 mRNA	PMID:23649840
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of PAGR1 mRNA	PMID:25102026
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313714	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PAGR1A mRNA	PMID:34911549
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PAGR1 mRNA	PMID:35430440
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313714	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PAGR1A mRNA	PMID:31919559
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313714	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PAGR1A mRNA	PMID:22206623
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PAGR1 mRNA	PMID:23557933
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20130806	CTD	MESH:D007854	Lead results in decreased expression of PAGR1 mRNA	PMID:19921347
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PAGR1 mRNA	PMID:33387578
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PAGR1 mRNA	PMID:32109520
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PAGR1 mRNA	PMID:28001369
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313714	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of PAGR1A mRNA	PMID:35032568
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PAGR1 mRNA	PMID:32763439
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20130806	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PAGR1 mRNA	PMID:20971185
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1606780	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PAGR1 protein	PMID:35688186
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PAGR1 mRNA	PMID:29432896
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PAGR1 mRNA	PMID:38568856
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606780	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PAGR1 promoter	PMID:27901495
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20130806	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PAGR1 mRNA	PMID:20971185
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PAGR1 mRNA	PMID:19150397
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PAGR1 mRNA	PMID:34492290
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PAGR1 mRNA	PMID:30816183|PMID:32528016
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PAGR1 mRNA	PMID:29275510
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313714	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of PAGR1A mRNA	PMID:38074096
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1606780	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PAGR1 mRNA	PMID:25979313
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313714	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PAGR1A mRNA	PMID:34289071
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PAGR1 mRNA	PMID:19320972
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1606780	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PAGR1 mRNA	PMID:31533062
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1606780	E	RGD:6480464	20130806	CTD	MESH:D003375	Coumestrol results in increased expression of PAGR1 mRNA	PMID:19167446
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PAGR1 mRNA	PMID:23179753|PMID:26272509
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAGR1 mRNA	PMID:27188386
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PAGR1 mRNA	PMID:25562108
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313714	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of PAGR1A mRNA	PMID:39922521
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1606780	E	RGD:6480464	20130806	CTD	MESH:C011890	kojic acid results in increased expression of PAGR1 mRNA	PMID:16595896
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1606780	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PAGR1 mRNA	PMID:38832940
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PAGR1 mRNA	PMID:22083351
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1606780	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PAGR1 mRNA	PMID:28542535
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20130806	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PAGR1 mRNA	PMID:22079256
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313714	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PAGR1A mRNA	PMID:22206623
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PAGR1 mRNA	PMID:22079256
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PAGR1 mRNA	PMID:22079256
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAGR1 mRNA	PMID:27188386
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of PAGR1 mRNA	PMID:36084822
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PAGR1 mRNA	PMID:24780913
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606780	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAGR1 mRNA	PMID:27188386
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PAGR1 mRNA	PMID:38568856
1305592	Pagr1	Paxip1-associated glutamate-rich protein 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1606780	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PAGR1 mRNA	PMID:29301935
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EVX2 mRNA	PMID:33387578
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1348415	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EVX2 gene	PMID:27153756
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313716	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EVX2 mRNA	PMID:25629700
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1348415	E	RGD:6480464	20160712	CTD	MESH:D001151	Arsenic affects the methylation of EVX2 gene	PMID:25304211
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313716	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EVX2 mRNA	PMID:24058054
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1348415	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EVX2 promoter	PMID:27901495
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313716	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EVX2 gene	PMID:35295148
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313716	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of EVX2 promoter	PMID:27334623
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EVX2 mRNA	PMID:25181051
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313716	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of EVX2 mRNA	PMID:17706920|PMID:30951980
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1348415	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of EVX2 mRNA	PMID:33670352
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of EVX2 mRNA	PMID:41034487
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313716	E	RGD:6480464	20120412	CTD	MESH:C006780	LHB protein affects the reaction [bisphenol A results in decreased expression of EVX2 mRNA]	PMID:17706920
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313716	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of EVX2 mRNA	PMID:30951980
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313716	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of EVX2 mRNA	PMID:30951980
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1348415	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of EVX2 promoter	PMID:29626692
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1348415	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of EVX2 promoter	PMID:29626692
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1348415	E	RGD:6480464	20160712	CTD	MESH:D001151	Arsenic affects the methylation of EVX2 gene	PMID:25304211
1305594	Evx2	even-skipped homeobox 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313716	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EVX2 mRNA	PMID:22206623
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313717	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ADGRE5 mRNA	PMID:27188386
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1313717	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of ADGRE5 mRNA	PMID:31016361
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313718	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ADGRE5 mRNA	PMID:20188158
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ADGRE5 mRNA	PMID:23724009
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313717	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ADGRE5 mRNA	PMID:33167477
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of ADGRE5 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of ADGRE5 mRNA	PMID:30951980
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:15368	acrolein	increases expression	ISO	RGD:1313718	E	RGD:6480464	20121113	CTD	MESH:D000171	Acrolein results in increased expression of ADGRE5 mRNA	PMID:18515264
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:15414	S-adenosyl-L-methionine	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D012436	S-Adenosylmethionine results in decreased expression of ADGRE5 mRNA	PMID:18098314
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313717	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ADGRE5 mRNA	PMID:20044591
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20130212	CTD	MESH:D011794	Quercetin results in decreased expression of ADGRE5 mRNA	PMID:21738342
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313718	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ADGRE5 mRNA	PMID:25890327
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ADGRE5 mRNA	PMID:39298647
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313717	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of ADGRE5 mRNA	PMID:23019147
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ADGRE5 mRNA	PMID:30165855
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313717	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ADGRE5 mRNA	PMID:21179406
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRE5 mRNA	PMID:37992649
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of ADGRE5 mRNA	PMID:22967744
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRE5 mRNA	PMID:37992649
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:17650	cortisol	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20121113	CTD	MESH:D006854	Hydrocortisone results in decreased expression of ADGRE5 mRNA	PMID:21267416
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ADGRE5 mRNA	PMID:26577399
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313717	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ADGRE5 mRNA	PMID:16002434
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ADGRE5 mRNA	PMID:33387578
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ADGRE5 mRNA	PMID:22061828
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRE5 mRNA	PMID:35301059
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRE5 mRNA	PMID:37236586
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRE5 mRNA	PMID:29950665
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313717	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ADGRE5 mRNA	PMID:19549813
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313717	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ADGRE5 protein	PMID:20106945
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of ADGRE5 mRNA	PMID:28623178
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADGRE5 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ADGRE5 mRNA	PMID:34911549
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ADGRE5 mRNA	PMID:30779732
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313718	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ADGRE5 mRNA	PMID:27339419
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:40504410
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ADGRE5 mRNA	PMID:31881176
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in decreased expression of ADGRE5 mRNA	PMID:21738342
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ADGRE5 mRNA	PMID:25905778
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of ADGRE5 mRNA	PMID:18930951
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20130212	CTD	MESH:D019833	Genistein results in decreased expression of ADGRE5 mRNA	PMID:21738342
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in decreased expression of ADGRE5 mRNA	PMID:12540486
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313717	E	RGD:6480464	20151215	CTD	MESH:D009532	Nickel results in increased expression of ADGRE5 mRNA	PMID:24768652|PMID:25583101
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313718	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADGRE5 mRNA	PMID:21570461|PMID:24680724
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ADGRE5 mRNA	PMID:28959563
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20151215	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ADGRE5 mRNA	PMID:24690739
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADGRE5 mRNA	PMID:15467011
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRE5 mRNA	PMID:37992649
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADGRE5 mRNA	PMID:38568856
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313718	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of ADGRE5 mRNA	PMID:36209798
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:40504410
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313717	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADGRE5 promoter	PMID:27901495
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADGRE5 mRNA	PMID:20064835|PMID:30453624
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313717	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADGRE5 mRNA	PMID:32234424
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313718	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADGRE5 mRNA	PMID:22228805
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313717	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADGRE5 3' UTR	PMID:27901495
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20151215	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ADGRE5 mRNA	PMID:24690739
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADGRE5 mRNA	PMID:15467011
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ADGRE5 mRNA	PMID:21602193
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ADGRE5 mRNA	PMID:19128835
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313718	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ADGRE5 mRNA	PMID:39716349
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRE5 mRNA	PMID:29950665
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADGRE5 mRNA	PMID:34492290
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ADGRE5 mRNA	PMID:18648102
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ADGRE5 mRNA	PMID:19710929
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ADGRE5 mRNA	PMID:19167457
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRE5 mRNA	PMID:33296240|PMID:41034487
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRE5 mRNA	PMID:29275510
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRE5 mRNA	PMID:25181051
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRE5 mRNA	PMID:30951980
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of ADGRE5 mRNA	PMID:30951980
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:33418	graphite	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of ADGRE5 mRNA	PMID:29933104
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ADGRE5 mRNA	PMID:39298647
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ADGRE5 mRNA	PMID:30951980
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ADGRE5 mRNA	PMID:30951980
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of ADGRE5 mRNA	PMID:30951980
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313718	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ADGRE5 mRNA	PMID:28392331
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313718	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ADGRE5 mRNA	PMID:37019170
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRE5 mRNA	PMID:29950665
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1313718	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of ADGRE5 mRNA	PMID:25270620
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313717	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADGRE5 mRNA	PMID:37042841
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ADGRE5 mRNA	PMID:35163327
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADGRE5 mRNA	PMID:35163327
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRE5 mRNA	PMID:35301059
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRE5 mRNA	PMID:37236586
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADGRE5 mRNA	PMID:35163327
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ADGRE5 mRNA	PMID:24449571
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313717	E	RGD:6480464	20151215	CTD	MESH:D014635	Valproic Acid affects the expression of ADGRE5 mRNA	PMID:25979313
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADGRE5 mRNA	PMID:29154799
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ADGRE5 mRNA	PMID:41580965
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRE5 mRNA	PMID:37992649
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313717	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ADGRE5 mRNA	PMID:23649840
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ADGRE5 mRNA	PMID:18502557
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313717	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ADGRE5 mRNA; Okadaic Acid results in increased expression of ADGRE5 protein	PMID:38832940
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADGRE5 mRNA	PMID:17562736
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20151215	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of ADGRE5 mRNA	PMID:24690739
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ADGRE5 mRNA	PMID:29279043
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:40504410
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313717	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of ADGRE5 mRNA	PMID:31838189
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1313717	E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in increased expression of ADGRE5 mRNA	PMID:23527032
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADGRE5 mRNA	PMID:12072388
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ADGRE5 mRNA	PMID:19128835
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313718	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ADGRE5 mRNA	PMID:39716349
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADGRE5 mRNA; Nanotubes, Carbon results in decreased expression of ADGRE5 mRNA	PMID:25554681
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313718	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of ADGRE5 mRNA	PMID:40234311
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1313717	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of ADGRE5 mRNA	PMID:20436886
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313717	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ADGRE5 mRNA	PMID:23650126
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:67040	S-adenosyl-L-methioninate	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20140805	CTD	MESH:D012436	S-Adenosylmethionine results in decreased expression of ADGRE5 mRNA	PMID:18098314
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313717	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ADGRE5 protein	PMID:31285264
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of ADGRE5 mRNA	PMID:32858204
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ADGRE5 mRNA	PMID:19482888
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ADGRE5 mRNA]	PMID:19482888
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313718	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of ADGRE5 mRNA	PMID:27029645
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1313717	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of ADGRE5 mRNA	PMID:31734321
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ADGRE5 mRNA	PMID:21346803
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313717	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of ADGRE5 protein	PMID:15785241
1305595	Adgre5	adhesion G protein-coupled receptor E5	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C025643	vinclozolin results in increased expression of ADGRE5 mRNA	PMID:22570695|PMID:23034163
1305596	Gykl1	glycerol kinase-like 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C030686	acetamide results in decreased expression of GYKL1 mRNA	PMID:31881176
1305596	Gykl1	glycerol kinase-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in decreased expression of GYKL1 mRNA	PMID:25181051
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SAMD4B mRNA]	PMID:31150632
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:144804	nickel subsulfide	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in increased expression of SAMD4B mRNA	PMID:21086188
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313720	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SAMD4B mRNA	PMID:30319688
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1605980	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of SAMD4B protein	PMID:35688186
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SAMD4B mRNA	PMID:33387578
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605980	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SAMD4B mRNA	PMID:37042841
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313720	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SAMD4B mRNA	PMID:39150890
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1605980	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SAMD4B protein	PMID:37730182
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SAMD4B mRNA	PMID:33387578
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313720	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of SAMD4B mRNA	PMID:27462272
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1605980	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SAMD4B protein	PMID:23301498
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605980	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SAMD4B intron	PMID:30157460
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605980	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SAMD4B mRNA	PMID:35430440
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SAMD4B mRNA	PMID:31150632
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SAMD4B mRNA]	PMID:31150632
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1605980	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SAMD4B protein	PMID:35688186
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313720	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SAMD4B mRNA	PMID:30912803
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SAMD4B mRNA	PMID:34747641
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313720	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SAMD4B mRNA	PMID:21570461
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1605980	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SAMD4B mRNA	PMID:22574217
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1605980	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SAMD4B mRNA	PMID:29803840
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1605980	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of SAMD4B protein	PMID:35688186
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605980	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SAMD4B mRNA	PMID:38568856
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313720	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SAMD4B mRNA	PMID:39716349
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SAMD4B mRNA	PMID:30047161
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313720	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SAMD4B promoter alternative form	PMID:35295148
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313720	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SAMD4B promoter alternative form	PMID:35295148
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SAMD4B mRNA	PMID:23411599|PMID:34492290
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SAMD4B mRNA	PMID:19167457
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SAMD4B mRNA	PMID:25181051|PMID:30816183
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313720	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SAMD4B mRNA	PMID:39298647
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313720	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SAMD4B mRNA	PMID:39150890
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313720	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SAMD4B mRNA	PMID:37019170
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313720	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SAMD4B mRNA	PMID:39150890
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313720	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SAMD4B mRNA	PMID:39150890
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313720	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of SAMD4B mRNA	PMID:34813904
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313720	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of SAMD4B mRNA	PMID:34813904
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605980	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SAMD4B mRNA	PMID:37042841
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313720	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SAMD4B mRNA	PMID:39150890
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1605980	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SAMD4B mRNA	PMID:19320972
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313720	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SAMD4B mRNA	PMID:17585979
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1605980	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SAMD4B mRNA	PMID:28302478
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SAMD4B mRNA	PMID:38685447|PMID:41580965
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SAMD4B mRNA	PMID:30047161
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605980	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SAMD4B mRNA	PMID:21420995
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605980	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of SAMD4B mRNA	PMID:26690555|PMID:29067470
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313720	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SAMD4B mRNA	PMID:39716349
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of SAMD4B mRNA	PMID:38685447|PMID:41580965
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in increased expression of SAMD4B mRNA	PMID:20566332
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1605980	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SAMD4B protein	PMID:23718831
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1313720	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of SAMD4B mRNA	PMID:22078008
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313720	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SAMD4B mRNA	PMID:22206623
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313720	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SAMD4B mRNA	PMID:39150890
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SAMD4B mRNA	PMID:23640034
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SAMD4B mRNA	PMID:30047161
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SAMD4B mRNA	PMID:19281266
1305597	Samd4b	sterile alpha motif domain containing 4B	gene	CHEBI:9907	ursodeoxycholic acid	affects expression	ISO	RGD:1605980	E	RGD:6480464	20120613	CTD	MESH:D014580	Ursodeoxycholic Acid affects the expression of SAMD4B mRNA	PMID:18422935
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313721	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GBA2 mRNA	PMID:38218311
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313722	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of GBA2 mRNA]	PMID:19467301
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313721	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GBA2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GBA2 mRNA	PMID:32699268
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GBA2 mRNA	PMID:39298647
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of GBA2 gene	PMID:27618143
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313721	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of GBA2 mRNA	PMID:21179406
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313721	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of GBA2 mRNA	PMID:28818685
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313722	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GBA2 mRNA	PMID:36331819
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313722	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GBA2 mRNA	PMID:37236586
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313721	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GBA2 gene	PMID:27153756
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313721	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GBA2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GBA2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of GBA2 mRNA	PMID:32699268
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GBA2 mRNA	PMID:31919559
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of GBA2 mRNA	PMID:16917069
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313721	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of GBA2 mRNA	PMID:23195993
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313722	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GBA2 mRNA	PMID:21570461
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GBA2 mRNA	PMID:21215274|PMID:33387578
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313721	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GBA2 mRNA	PMID:19684285
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GBA2 mRNA	PMID:19684285
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313721	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GBA2 mRNA	PMID:30851411
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313721	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of GBA2 mRNA	PMID:32763439
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1313722	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in increased expression of GBA2 protein	PMID:40770094
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1313722	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in increased expression of GBA2 protein	PMID:40770094
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313722	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GBA2 promoter	PMID:35295148
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of GBA2 mRNA	PMID:18648102
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of GBA2 mRNA	PMID:23811191
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GBA2 mRNA	PMID:25181051
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GBA2 mRNA	PMID:36041667
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GBA2 mRNA	PMID:39298647
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GBA2 mRNA	PMID:36041667
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GBA2 mRNA	PMID:36041667
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313721	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GBA2 mRNA	PMID:28628672
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313721	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of GBA2 gene	PMID:22964155
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313721	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GBA2 mRNA	PMID:28628672
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GBA2 mRNA	PMID:18164116
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313721	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GBA2 mRNA	PMID:37042841
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313722	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GBA2 mRNA	PMID:37236586
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313721	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GBA2 mRNA	PMID:19320972
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313721	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GBA2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GBA2 mRNA	PMID:32699268
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of GBA2 mRNA	PMID:23811191
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313722	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GBA2 mRNA	PMID:36331819
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GBA2 mRNA	PMID:17292431
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313721	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GBA2 mRNA	PMID:28628672
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GBA2 mRNA	PMID:17562736
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313721	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GBA2 mRNA	PMID:28628672
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GBA2 mRNA; Nanotubes, Carbon results in decreased expression of GBA2 mRNA	PMID:25620056
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of GBA2 protein	PMID:36851058
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:68508	diethyl maleate	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20150127	CTD	MESH:C014476	diethyl maleate results in decreased expression of GBA2 mRNA	PMID:25270620
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GBA2 mRNA	PMID:18164116
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313721	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GBA2 mRNA	PMID:30851411
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313721	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GBA2 gene]	PMID:28238834
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of GBA2 mRNA	PMID:19270015
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GBA2 mRNA	PMID:21346803
1305598	Gba2	glucosylceramidase beta 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of GBA2 mRNA	PMID:23034163
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1343980	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of U2AF1L4 mRNA	PMID:38218311
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313724	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of U2AF1L4 mRNA	PMID:33045310
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313724	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of U2AF1L4 mRNA	PMID:20188158
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1343980	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of U2AF1L4 mRNA	PMID:22378314
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1343980	E	RGD:6480464	20171010	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of U2AF1L4 mRNA	PMID:28412506
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313724	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of U2AF1L4 mRNA	PMID:27776689
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1343980	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of U2AF1L4 mRNA	PMID:23649840
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313724	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of U2AF1L4 mRNA	PMID:22206623
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313724	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of U2AF1L4 mRNA	PMID:21570461
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1343980	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of U2AF1L4 mRNA	PMID:22574217
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of U2AF1L4 mRNA	PMID:32109520
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of U2AF1L4 mRNA	PMID:33387578
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1343980	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of U2AF1L4 mRNA	PMID:24834073
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1343980	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of U2AF1L4 mRNA	PMID:29803840
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1343980	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of U2AF1L4 mRNA	PMID:22378314|PMID:29453283
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of U2AF1L4 mRNA	PMID:22484513
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313724	E	RGD:6480464	20150127	CTD	MESH:C006780	bisphenol A results in decreased expression of U2AF1L4 mRNA	PMID:25270620
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of U2AF1L4 mRNA	PMID:25181051
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313724	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of U2AF1L4 mRNA	PMID:38074096
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1343980	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in decreased expression of U2AF1L4 mRNA	PMID:27685785
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313724	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of U2AF1L4 exon	PMID:33297965
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1343980	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of U2AF1L4 mRNA	PMID:28628672
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1343980	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of U2AF1L4 gene	PMID:22964155
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1343980	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of U2AF1L4 mRNA	PMID:28628672
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1343980	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of U2AF1L4 mRNA	PMID:37042841
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313724	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of U2AF1L4 mRNA	PMID:17585979
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1343980	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of U2AF1L4 mRNA	PMID:31533062
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1343980	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of U2AF1L4 mRNA	PMID:40419075
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343980	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of U2AF1L4 mRNA	PMID:25979313
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1343980	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of U2AF1L4 mRNA	PMID:25562108
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1343980	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of U2AF1L4 mRNA	PMID:28628672
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of U2AF1L4 mRNA	PMID:33387578
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1343980	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of U2AF1L4 mRNA	PMID:28628672
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313724	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of U2AF1L4 mRNA	PMID:25620056
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of U2AF1L4 mRNA	PMID:24793618
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313724	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of U2AF1L4 mRNA	PMID:22206623
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1343980	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to U2AF1L4 gene]	PMID:28238834
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1343980	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of U2AF1L4 mRNA	PMID:19095052
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of U2AF1L4 mRNA	PMID:21346803
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1343980	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of U2AF1L4 mRNA	PMID:38568856
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1343980	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of U2AF1L4 mRNA	PMID:29301935
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1343980	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of U2AF1L4 mRNA	PMID:22378314
1305600	U2af1l4	U2 small nuclear RNA auxiliary factor 1-like 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of U2AF1L4 mRNA	PMID:21346803
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550260	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RSPH14 mRNA	PMID:30529165
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313725	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RSPH14 mRNA	PMID:26079696
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of RSPH14 gene	PMID:35440735
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RSPH14 mRNA	PMID:33387578
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RSPH14 mRNA	PMID:26577399
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313725	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RSPH14 gene	PMID:27153756
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RSPH14 mRNA	PMID:32109520
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RSPH14 mRNA	PMID:28959563
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550260	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of RSPH14 protein	PMID:28918527
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313725	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RSPH14 gene	PMID:28589171
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1550260	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RSPH14 intron	PMID:27901495
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313725	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RSPH14 promoter	PMID:27901495
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313725	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RSPH14 mRNA	PMID:25895662
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550260	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RSPH14 mRNA	PMID:23557971
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RSPH14 mRNA	PMID:25181051|PMID:41034487
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RSPH14 gene	PMID:28505145
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313725	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RSPH14 intron	PMID:30157460
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313725	E	RGD:6480464	20120522	CTD	MESH:D018038	Sodium Selenite results in decreased expression of RSPH14 mRNA	PMID:18175754
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550260	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RSPH14 mRNA; Nanotubes, Carbon results in decreased expression of RSPH14 mRNA	PMID:25554681
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313725	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RSPH14 intron	PMID:30157460
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RSPH14 mRNA	PMID:27291303
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RSPH14 mRNA	PMID:24780913
1305601	Rsph14	radial spoke head 14 homolog	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of RSPH14 gene	PMID:31682807
1305602	Ephb3	Eph receptor B3	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in decreased expression of EPHB3 mRNA	PMID:36828454
1305602	Ephb3	Eph receptor B3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of EPHB3 mRNA	PMID:38218311
1305602	Ephb3	Eph receptor B3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of EPHB3 mRNA	PMID:33045310
1305602	Ephb3	Eph receptor B3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313728	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EPHB3 mRNA	PMID:20188158
1305602	Ephb3	Eph receptor B3	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	ISO	RGD:1313727	E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of EPHB3 mRNA	PMID:23792671
1305602	Ephb3	Eph receptor B3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313727	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of EPHB3 mRNA	PMID:23724009
1305602	Ephb3	Eph receptor B3	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313727	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of EPHB3 mRNA	PMID:26079696
1305602	Ephb3	Eph receptor B3	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of EPHB3 gene	PMID:35440735
1305602	Ephb3	Eph receptor B3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313727	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of EPHB3 mRNA	PMID:22378314
1305602	Ephb3	Eph receptor B3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313728	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of EPHB3 mRNA	PMID:30319688
1305602	Ephb3	Eph receptor B3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EPHB3 mRNA	PMID:35811015
1305602	Ephb3	Eph receptor B3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313727	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EPHB3 mRNA	PMID:35811015
1305602	Ephb3	Eph receptor B3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20240206	CTD	MESH:D004958	Estradiol results in decreased expression of EPHB3 mRNA	PMID:36828454
1305602	Ephb3	Eph receptor B3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of EPHB3 mRNA	PMID:38568856
1305602	Ephb3	Eph receptor B3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EPHB3 mRNA	PMID:15363585
1305602	Ephb3	Eph receptor B3	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313727	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of EPHB3 mRNA	PMID:26079696
1305602	Ephb3	Eph receptor B3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB3 mRNA	PMID:37992649
1305602	Ephb3	Eph receptor B3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB3 mRNA	PMID:37992649
1305602	Ephb3	Eph receptor B3	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of EPHB3 mRNA	PMID:18247414
1305602	Ephb3	Eph receptor B3	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313727	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of EPHB3 protein	PMID:34122009
1305602	Ephb3	Eph receptor B3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EPHB3 mRNA	PMID:33387578
1305602	Ephb3	Eph receptor B3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313727	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of EPHB3 mRNA	PMID:28818685
1305602	Ephb3	Eph receptor B3	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of EPHB3 mRNA	PMID:18247414
1305602	Ephb3	Eph receptor B3	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in decreased expression of EPHB3 mRNA	PMID:12634122
1305602	Ephb3	Eph receptor B3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EPHB3 mRNA	PMID:37325564
1305602	Ephb3	Eph receptor B3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EPHB3 mRNA	PMID:23630614
1305602	Ephb3	Eph receptor B3	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313728	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of EPHB3 mRNA	PMID:25629700
1305602	Ephb3	Eph receptor B3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EPHB3 mRNA	PMID:22206623
1305602	Ephb3	Eph receptor B3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313727	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EPHB3 gene	PMID:25304211
1305602	Ephb3	Eph receptor B3	gene	CHEBI:27878	2-naphthylamine	increases expression	ISO	RGD:1313727	E	RGD:6480464	20120412	CTD	MESH:D015081	2-Naphthylamine results in increased expression of EPHB3 mRNA	PMID:18247414
1305602	Ephb3	Eph receptor B3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313727	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of EPHB3 mRNA	PMID:27392435
1305602	Ephb3	Eph receptor B3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313727	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of EPHB3 mRNA	PMID:27392435
1305602	Ephb3	Eph receptor B3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of EPHB3 mRNA	PMID:23625948
1305602	Ephb3	Eph receptor B3	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of EPHB3 mRNA	PMID:15691709
1305602	Ephb3	Eph receptor B3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPHB3 mRNA	PMID:32109520
1305602	Ephb3	Eph receptor B3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPHB3 mRNA	PMID:19933214
1305602	Ephb3	Eph receptor B3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EPHB3 mRNA	PMID:29803840
1305602	Ephb3	Eph receptor B3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of EPHB3 mRNA	PMID:39631538
1305602	Ephb3	Eph receptor B3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB3 mRNA	PMID:37992649
1305602	Ephb3	Eph receptor B3	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313727	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of EPHB3 gene	PMID:28589171
1305602	Ephb3	Eph receptor B3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EPHB3 mRNA	PMID:18247414
1305602	Ephb3	Eph receptor B3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313727	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EPHB3 promoter	PMID:27901495
1305602	Ephb3	Eph receptor B3	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1313727	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of EPHB3 protein	PMID:34122009
1305602	Ephb3	Eph receptor B3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of EPHB3 mRNA	PMID:25895662
1305602	Ephb3	Eph receptor B3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313727	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of EPHB3 gene	PMID:31601247
1305602	Ephb3	Eph receptor B3	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of EPHB3 mRNA	PMID:11578147
1305602	Ephb3	Eph receptor B3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313728	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EPHB3 promoter	PMID:35295148
1305602	Ephb3	Eph receptor B3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313728	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of EPHB3 gene	PMID:35295148
1305602	Ephb3	Eph receptor B3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EPHB3 mRNA	PMID:34492290
1305602	Ephb3	Eph receptor B3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313728	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of EPHB3 mRNA	PMID:28472532
1305602	Ephb3	Eph receptor B3	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of EPHB3 mRNA	PMID:19167457
1305602	Ephb3	Eph receptor B3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EPHB3 mRNA	PMID:25181051|PMID:33296240|PMID:34947998
1305602	Ephb3	Eph receptor B3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of EPHB3 mRNA	PMID:27685785|PMID:36828454
1305602	Ephb3	Eph receptor B3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of EPHB3 mRNA	PMID:41034487
1305602	Ephb3	Eph receptor B3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313728	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of EPHB3 mRNA	PMID:32156529
1305602	Ephb3	Eph receptor B3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313727	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of EPHB3 gene	PMID:31601247
1305602	Ephb3	Eph receptor B3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EPHB3 mRNA	PMID:25172293
1305602	Ephb3	Eph receptor B3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313728	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of EPHB3 gene	PMID:31683443
1305602	Ephb3	Eph receptor B3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313728	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of EPHB3 promoter	PMID:33297965
1305602	Ephb3	Eph receptor B3	gene	CHEBI:34687	dibutyl phthalate	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D003993	Dibutyl Phthalate affects the expression of EPHB3 mRNA	PMID:30934153
1305602	Ephb3	Eph receptor B3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EPHB3 mRNA	PMID:35163327
1305602	Ephb3	Eph receptor B3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of EPHB3 mRNA	PMID:30723492
1305602	Ephb3	Eph receptor B3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of EPHB3 mRNA	PMID:38568856
1305602	Ephb3	Eph receptor B3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313727	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EPHB3 mRNA	PMID:38174414
1305602	Ephb3	Eph receptor B3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EPHB3 mRNA	PMID:37325564
1305602	Ephb3	Eph receptor B3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EPHB3 mRNA	PMID:35163327
1305602	Ephb3	Eph receptor B3	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of EPHB3 gene	PMID:27387713
1305602	Ephb3	Eph receptor B3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of EPHB3 mRNA	PMID:27387713
1305602	Ephb3	Eph receptor B3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313727	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EPHB3 mRNA	PMID:24449571
1305602	Ephb3	Eph receptor B3	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1313727	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of EPHB3 protein	PMID:34122009
1305602	Ephb3	Eph receptor B3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of EPHB3 mRNA	PMID:40194260
1305602	Ephb3	Eph receptor B3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313727	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EPHB3 mRNA	PMID:31533062
1305602	Ephb3	Eph receptor B3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313728	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of EPHB3 mRNA	PMID:17292431
1305602	Ephb3	Eph receptor B3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313727	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of EPHB3 mRNA	PMID:24383497|PMID:26272509
1305602	Ephb3	Eph receptor B3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313727	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHB3 mRNA	PMID:27188386
1305602	Ephb3	Eph receptor B3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB3 mRNA	PMID:37992649
1305602	Ephb3	Eph receptor B3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313727	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EPHB3 mRNA	PMID:38832940
1305602	Ephb3	Eph receptor B3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313728	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EPHB3 mRNA	PMID:17562736
1305602	Ephb3	Eph receptor B3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EPHB3 mRNA	PMID:33387578
1305602	Ephb3	Eph receptor B3	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of EPHB3 mRNA	PMID:24714768
1305602	Ephb3	Eph receptor B3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313727	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EPHB3 mRNA	PMID:35811015
1305602	Ephb3	Eph receptor B3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313727	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EPHB3 gene	PMID:25304211
1305602	Ephb3	Eph receptor B3	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313727	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of EPHB3 mRNA	PMID:38568856
1305602	Ephb3	Eph receptor B3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EPHB3 mRNA; Nanotubes, Carbon results in decreased expression of EPHB3 mRNA	PMID:25554681
1305602	Ephb3	Eph receptor B3	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1313728	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of EPHB3 mRNA	PMID:17982090
1305602	Ephb3	Eph receptor B3	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313728	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of EPHB3 mRNA	PMID:23608068
1305602	Ephb3	Eph receptor B3	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313727	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of EPHB3 mRNA	PMID:31629900
1305602	Ephb3	Eph receptor B3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of EPHB3 gene	PMID:35440735
1305602	Ephb3	Eph receptor B3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EPHB3 mRNA	PMID:22206623
1305602	Ephb3	Eph receptor B3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313727	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHB3 mRNA	PMID:27188386
1305602	Ephb3	Eph receptor B3	gene	CHEBI:78543	ponatinib	decreases activity	ISO	RGD:1313727	E	RGD:6480464	20170303	CTD	MESH:C545373	ponatinib results in decreased activity of EPHB3 protein	PMID:19878872
1305602	Ephb3	Eph receptor B3	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1313728	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of EPHB3 mRNA	PMID:18958704
1305602	Ephb3	Eph receptor B3	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of EPHB3 mRNA	PMID:24780913
1305602	Ephb3	Eph receptor B3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of EPHB3 mRNA	PMID:24780913
1305602	Ephb3	Eph receptor B3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313727	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHB3 mRNA	PMID:27188386
1305602	Ephb3	Eph receptor B3	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of EPHB3 mRNA	PMID:19281266
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of PFDN1 mRNA	PMID:21551480
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313729	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of PFDN1 mRNA	PMID:35967413
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PFDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PFDN1 mRNA	PMID:32699268
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313730	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PFDN1 mRNA	PMID:40945087
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1313730	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of PFDN1 mRNA	PMID:20362636
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313730	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PFDN1 mRNA	PMID:30319688
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313730	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PFDN1 mRNA	PMID:39241906
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of PFDN1 mRNA	PMID:26496021
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of PFDN1 mRNA	PMID:22967744
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PFDN1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA]	PMID:20230807
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313730	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PFDN1 mRNA	PMID:33754040
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PFDN1 mRNA	PMID:22061828
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1313730	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA	PMID:20230807
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PFDN1 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PFDN1 mRNA; Caffeine promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA]	PMID:20230807
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PFDN1 mRNA	PMID:36331819
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PFDN1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA]	PMID:20230807
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PFDN1 mRNA	PMID:37236586|PMID:37325564
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313729	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PFDN1 gene	PMID:27153756
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313729	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PFDN1 intron	PMID:30157460
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PFDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PFDN1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PFDN1 mRNA	PMID:32699268
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PFDN1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PFDN1 mRNA	PMID:34911549
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313730	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PFDN1 mRNA	PMID:31919559
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PFDN1 mRNA	PMID:40504410
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PFDN1 mRNA; Caffeine promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA]	PMID:20230807
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313730	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of PFDN1 mRNA	PMID:30912803
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PFDN1 mRNA	PMID:34747641
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313730	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PFDN1 mRNA	PMID:21570461
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PFDN1 mRNA	PMID:33387578
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PFDN1 mRNA	PMID:17942748
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313729	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PFDN1 mRNA	PMID:33212167
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PFDN1 mRNA	PMID:40504410
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313730	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PFDN1 mRNA	PMID:18648102
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of PFDN1 mRNA	PMID:33296240
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PFDN1 mRNA	PMID:25181051
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313729	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of PFDN1 protein	PMID:37567409
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PFDN1 gene	PMID:28505145
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of PFDN1 mRNA	PMID:26496021
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313730	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PFDN1 mRNA	PMID:17361019
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313730	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PFDN1 mRNA	PMID:34813904
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of PFDN1 gene	PMID:33148267
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PFDN1 protein	PMID:21699967
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313729	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PFDN1 mRNA	PMID:38568856
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PFDN1 mRNA	PMID:37236586|PMID:37325564
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PFDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PFDN1 mRNA	PMID:32699268
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313729	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PFDN1 mRNA	PMID:31533062
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PFDN1 mRNA	PMID:36331819
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1313729	E	RGD:6480464	20150825	CTD	MESH:D000082	PFDN1 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313730	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PFDN1 mRNA	PMID:29279043
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PFDN1 mRNA	PMID:40504410
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313730	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PFDN1 mRNA	PMID:35436446
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313730	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PFDN1 mRNA	PMID:17942748
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PFDN1 mRNA	PMID:17942748
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PFDN1 mRNA	PMID:24136188
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PFDN1 mRNA	PMID:24136188
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313729	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PFDN1 protein	PMID:32959892
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of PFDN1 mRNA	PMID:24136188
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313730	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of PFDN1 mRNA	PMID:27462272
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of PFDN1 gene	PMID:33148267
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313730	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PFDN1 mRNA	PMID:22206623
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PFDN1 protein	PMID:37664457
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PFDN1 gene]	PMID:28238834
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313730	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PFDN1 mRNA	PMID:30294300
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of PFDN1 protein	PMID:28903499
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313730	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PFDN1 mRNA	PMID:40826991
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1313729	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of PFDN1 mRNA	PMID:24921660
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313729	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PFDN1 protein	PMID:37664457
1305603	Pfdn1	prefoldin subunit 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of PFDN1 gene	PMID:31682807
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1605139	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CCDC30 mRNA	PMID:18951874
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1605139	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of CCDC30 protein	PMID:18951874
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313731	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CCDC30 mRNA	PMID:39298647
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CCDC30 mRNA	PMID:33387578
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605139	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of CCDC30 mRNA	PMID:27905399
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1605139	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CCDC30 mRNA	PMID:26079696
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CCDC30 mRNA	PMID:33387578
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1605139	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CCDC30 intron	PMID:30157460
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605139	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CCDC30 intron	PMID:30157460
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313731	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CCDC30 mRNA	PMID:34911549
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313731	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CCDC30 mRNA	PMID:28960355
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCDC30 mRNA	PMID:22298810
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCDC30 mRNA	PMID:33387578
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313731	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCDC30 mRNA	PMID:19770486
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313731	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CCDC30 mRNA	PMID:16214954
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1605139	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of CCDC30 protein	PMID:18951874
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1605139	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of CCDC30 mRNA	PMID:34032870
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313731	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCDC30 mRNA	PMID:36209798
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605139	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CCDC30 mRNA	PMID:38568856
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605139	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CCDC30 mRNA	PMID:21871943|PMID:22316170|PMID:32234424
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605139	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CCDC30 5' UTR	PMID:27901495
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605139	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCDC30 3' UTR; Benzo(a)pyrene results in increased methylation of CCDC30 promoter	PMID:27901495
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1605139	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CCDC30 mRNA	PMID:25895662
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605139	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CCDC30 gene; [bisphenol S co-treated with Fulvestrant] results in increased methylation of CCDC30 gene	PMID:31601247
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313731	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CCDC30 mRNA	PMID:23557971
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313731	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCDC30 gene; titanium dioxide results in decreased methylation of CCDC30 promoter	PMID:35295148
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313731	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CCDC30 mRNA	PMID:23557971|PMID:29264374
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313731	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CCDC30 gene	PMID:35295148
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CCDC30 mRNA	PMID:23411599
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CCDC30 mRNA	PMID:25181051|PMID:30816183
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of CCDC30 mRNA	PMID:41034487
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605139	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CCDC30 gene	PMID:31601247
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313731	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CCDC30 mRNA	PMID:39298647
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1605139	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of CCDC30 gene	PMID:31601247
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1313731	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of CCDC30 mRNA	PMID:26377693
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1605139	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CCDC30 intron	PMID:30157460
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605139	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CCDC30 mRNA	PMID:38382870
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313731	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of CCDC30 mRNA	PMID:23125180
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605139	E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in increased expression of CCDC30 mRNA	PMID:37505509
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CCDC30 mRNA	PMID:30047161
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313731	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CCDC30 mRNA	PMID:28973697
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1605139	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CCDC30 mRNA	PMID:38832940
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of CCDC30 mRNA	PMID:29097150
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CCDC30 mRNA	PMID:30307764
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313731	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCDC30 mRNA; Nanotubes, Carbon results in decreased expression of CCDC30 mRNA	PMID:25554681
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CCDC30 mRNA	PMID:30047161
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313731	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of CCDC30 mRNA	PMID:26377693
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1313731	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of CCDC30 mRNA	PMID:23608068
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313731	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CCDC30 mRNA	PMID:38701926
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1313731	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of CCDC30 mRNA	PMID:22078008
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1605139	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CCDC30 intron	PMID:30157460
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313731	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CCDC30 mRNA	PMID:22206623
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313731	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CCDC30 mRNA	PMID:23091169
1305604	Ccdc30	coiled-coil domain containing 30	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CCDC30 mRNA	PMID:30047161
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313732	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of NOP14 protein	PMID:39638853
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOP14 mRNA]	PMID:31150632
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313732	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NOP14 mRNA	PMID:33167477
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313732	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP14 mRNA	PMID:32699268
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP14 mRNA	PMID:30529165
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313733	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NOP14 mRNA	PMID:39241906
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP14 mRNA]	PMID:39241906
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313732	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of NOP14 mRNA	PMID:31614463
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313733	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NOP14 mRNA	PMID:39298647
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313732	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NOP14 mRNA	PMID:38568856
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313733	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NOP14 mRNA	PMID:33754040
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313732	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Haloperidol] results in increased expression of NOP14 protein	PMID:34122009
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313732	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NOP14 protein	PMID:37730182
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NOP14 mRNA	PMID:33387578
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313732	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of NOP14 intron	PMID:30157460
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NOP14 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOP14 mRNA	PMID:37236586|PMID:37325564
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313732	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NOP14 gene	PMID:27153756
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1313732	E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of NOP14 protein	PMID:39638853
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313732	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP14 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of NOP14 mRNA	PMID:32699268
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOP14 mRNA	PMID:31150632
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313733	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOP14 mRNA	PMID:31919559
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOP14 mRNA]	PMID:31150632
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP14 mRNA	PMID:40504410
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313732	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NOP14 mRNA	PMID:23557933
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313733	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NOP14 mRNA	PMID:21570461
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NOP14 mRNA	PMID:33387578
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313732	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NOP14 mRNA	PMID:33212167
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NOP14 mRNA	PMID:15467011
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313732	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NOP14 mRNA	PMID:29803840
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313732	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NOP14 mRNA	PMID:38568856
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP14 mRNA	PMID:40504410
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313733	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NOP14 mRNA	PMID:22228805
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313732	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of NOP14 gene	PMID:25435355
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NOP14 mRNA	PMID:15467011
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NOP14 mRNA	PMID:23411599|PMID:34492290
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313733	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NOP14 mRNA	PMID:33221593
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NOP14 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313733	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NOP14 mRNA	PMID:39298647
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313733	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NOP14 intron	PMID:28392331
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313733	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of NOP14 mRNA	PMID:34813904
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NOP14 mRNA	PMID:19041683
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of NOP14 mRNA	PMID:32680482
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP14 mRNA]	PMID:39241906
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313732	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NOP14 mRNA	PMID:37042841
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NOP14 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOP14 mRNA	PMID:37236586|PMID:37325564
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313732	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP14 mRNA	PMID:32699268
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313732	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of NOP14 mRNA	PMID:28302478
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313732	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NOP14 mRNA	PMID:31533062
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313732	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NOP14 mRNA	PMID:25979313
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313733	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NOP14 mRNA	PMID:17292431
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313732	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NOP14 mRNA	PMID:23179753
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313733	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NOP14 mRNA	PMID:17562736
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP14 mRNA	PMID:40504410
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313733	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NOP14 mRNA; Nanotubes, Carbon results in increased expression of NOP14 mRNA	PMID:25554681
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NOP14 mRNA	PMID:35964746
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313733	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NOP14 mRNA	PMID:19042947
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:5613	haloperidol	multiple interactions	ISO	RGD:1313732	E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in increased expression of NOP14 protein	PMID:34122009
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313732	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NOP14 protein	PMID:32959892
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313733	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NOP14 mRNA	PMID:22206623
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313732	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NOP14 mRNA	PMID:37199045
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1313732	E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of NOP14 protein	PMID:39638853
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313733	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NOP14 mRNA	PMID:30294300
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP14 mRNA]	PMID:39241906
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1313732	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of NOP14 mRNA	PMID:34581912
1305605	Nop14	NOP14 nucleolar protein	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313732	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NOP14 mRNA	PMID:38568856
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313734	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of OTUD4 mRNA	PMID:33045310
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of OTUD4 mRNA	PMID:26079696
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313734	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of OTUD4 mRNA	PMID:39241906
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of OTUD4 mRNA	PMID:32145629
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313734	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of OTUD4 mRNA	PMID:39298647
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1603307	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of OTUD4 mRNA	PMID:31614463
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313734	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OTUD4 mRNA	PMID:25510870
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313734	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of OTUD4 mRNA	PMID:33754040
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1603307	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of OTUD4 protein	PMID:37730182
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313734	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OTUD4 mRNA	PMID:37236586
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313734	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OTUD4 mRNA	PMID:25510870
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313734	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OTUD4 mRNA	PMID:25510870
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1603307	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of OTUD4 mRNA	PMID:19549813
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1603307	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of OTUD4 protein	PMID:23301498
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of OTUD4 protein	PMID:33236894
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313734	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of OTUD4 mRNA	PMID:19376150
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1603307	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of OTUD4 gene	PMID:27153756
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of OTUD4 mRNA	PMID:31150632
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of OTUD4 mRNA	PMID:21867686
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313734	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of OTUD4 mRNA]	PMID:22206623
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1603307	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of OTUD4 protein	PMID:35688186
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of OTUD4 mRNA	PMID:31881176
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1603307	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of OTUD4 mRNA	PMID:23557933
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OTUD4 mRNA	PMID:33387578
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of OTUD4 mRNA	PMID:33212167
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313734	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of OTUD4 exon; Benzo(a)pyrene results in decreased methylation of OTUD4 intron	PMID:27901495
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of OTUD4 mRNA	PMID:19150397
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313734	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of OTUD4 gene; titanium dioxide results in decreased methylation of OTUD4 promoter	PMID:35295148
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of OTUD4 mRNA	PMID:23411599|PMID:34492290
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313734	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of OTUD4 mRNA	PMID:28472532
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of OTUD4 mRNA	PMID:32145629
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313734	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of OTUD4 mRNA	PMID:26063408
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of OTUD4 mRNA	PMID:25181051|PMID:30816183|PMID:38750585
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313734	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OTUD4 mRNA	PMID:25510870
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313734	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OTUD4 mRNA	PMID:25510870
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1603307	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of OTUD4 gene	PMID:31601247
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313734	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of OTUD4 mRNA	PMID:39298647
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603307	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of OTUD4 mRNA	PMID:37042841
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of OTUD4 mRNA	PMID:38568856
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313734	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OTUD4 mRNA	PMID:37236586
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:35572	phorone	affects expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C018637	phorone affects the expression of OTUD4 mRNA	PMID:18198479
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of OTUD4 mRNA	PMID:24386269
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of OTUD4 mRNA	PMID:25993096
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of OTUD4 mRNA	PMID:27188386
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of OTUD4 mRNA	PMID:26272509
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1603307	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTUD4 mRNA	PMID:27188386
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313734	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of OTUD4 mRNA	PMID:17562736
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of OTUD4 mRNA	PMID:22230336
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of OTUD4 mRNA	PMID:22077320
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of OTUD4 mRNA	PMID:29097150
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1603307	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of OTUD4 mRNA	PMID:23228038
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1603307	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of OTUD4 mRNA	PMID:26705709
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1313734	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of OTUD4 mRNA	PMID:17982090
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313734	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of OTUD4 mRNA	PMID:23608068
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313734	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of OTUD4 mRNA	PMID:26378955
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313734	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of OTUD4 mRNA	PMID:19751817
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313734	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of OTUD4 mRNA	PMID:22206623
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313734	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of OTUD4 mRNA]	PMID:22206623
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603307	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTUD4 mRNA	PMID:27188386
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603307	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to OTUD4 gene]	PMID:28238834
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of OTUD4 mRNA	PMID:26079696
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313734	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of OTUD4 mRNA	PMID:21795629
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603307	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTUD4 mRNA	PMID:27188386
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of OTUD4 mRNA	PMID:21346803
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1603307	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of OTUD4 mRNA	PMID:27188386
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of OTUD4 mRNA	PMID:21346803
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313734	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of OTUD4 mRNA	PMID:28973697
1305606	Otud4	OTU deubiquitinase 4	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of OTUD4 mRNA	PMID:18042343
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313735	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ADAMTSL5 mRNA	PMID:38218311
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of ADAMTSL5 mRNA	PMID:25152437
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313736	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ADAMTSL5 mRNA	PMID:37995155
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADAMTSL5 gene	PMID:20938992
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313736	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ADAMTSL5 mRNA	PMID:30319688
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADAMTSL5 mRNA	PMID:39241906
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313735	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ADAMTSL5 mRNA	PMID:31614463
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313735	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol promotes the reaction [ESR2 protein affects the expression of ADAMTSL5 mRNA]	PMID:20404318
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADAMTSL5 gene	PMID:20938992
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313735	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADAMTSL5 mRNA	PMID:37042841
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL5 mRNA	PMID:37992649
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313735	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ADAMTSL5 mRNA	PMID:33359661
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL5 mRNA	PMID:37992649
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313736	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ADAMTSL5 mRNA	PMID:34319233
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ADAMTSL5 mRNA	PMID:33387578
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313735	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of ADAMTSL5 mRNA	PMID:33914522
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADAMTSL5 mRNA	PMID:28111341
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADAMTSL5 mRNA	PMID:34911549
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADAMTSL5 mRNA	PMID:33387578
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADAMTSL5 gene	PMID:20938992
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313735	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADAMTSL5 gene	PMID:25304211
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313735	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of ADAMTSL5 mRNA	PMID:38314887
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ADAMTSL5 mRNA	PMID:31881176
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313736	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADAMTSL5 mRNA	PMID:21570461
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADAMTSL5 mRNA	PMID:32109520
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of ADAMTSL5 mRNA	PMID:28959563
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313735	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADAMTSL5 mRNA	PMID:29803840
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL5 mRNA	PMID:37992649
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAMTSL5 mRNA	PMID:37682722
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313735	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ADAMTSL5 mRNA	PMID:38568856
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313735	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313735	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADAMTSL5 5' UTR	PMID:27901495
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ADAMTSL5 mRNA]	PMID:22228805
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313736	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ADAMTSL5 mRNA	PMID:29203145
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ADAMTSL5 mRNA	PMID:35295148
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313736	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADAMTSL5 gene; titanium dioxide results in decreased methylation of ADAMTSL5 promoter alternative form	PMID:35295148
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313736	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of ADAMTSL5 mRNA	PMID:27760801|PMID:29264374
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313736	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of ADAMTSL5 mRNA	PMID:33914522
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTSL5 mRNA	PMID:34947998
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313735	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTSL5 mRNA	PMID:23146750
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ADAMTSL5 mRNA	PMID:25181051
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313736	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ADAMTSL5 mRNA	PMID:26063408|PMID:32156529
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1313735	E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of ADAMTSL5 mRNA	PMID:23146750
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313735	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ADAMTSL5 mRNA	PMID:23146750
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313736	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ADAMTSL5 gene	PMID:31683443
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313736	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ADAMTSL5 mRNA	PMID:40203079
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADAMTSL5 mRNA	PMID:38685157
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ADAMTSL5 mRNA	PMID:32680482
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADAMTSL5 mRNA	PMID:35163327
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313735	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADAMTSL5 mRNA	PMID:28111341
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313735	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ADAMTSL5 mRNA	PMID:23146750
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADAMTSL5 mRNA	PMID:35163327
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of ADAMTSL5 mRNA	PMID:30047161
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313736	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADAMTSL5 mRNA	PMID:40194260
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313735	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ADAMTSL5 mRNA	PMID:31533062
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ADAMTSL5 mRNA	PMID:30047161
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ADAMTSL5 mRNA	PMID:28973697
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL5 mRNA	PMID:37992649
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313735	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADAMTSL5 gene	PMID:25304211
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313735	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of ADAMTSL5 mRNA	PMID:29391264
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313736	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADAMTSL5 mRNA	PMID:17942748
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ADAMTSL5 mRNA	PMID:25554681
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ADAMTSL5 mRNA	PMID:30047161
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313735	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of ADAMTSL5 mRNA	PMID:36907384
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313736	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ADAMTSL5 mRNA	PMID:26307267
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADAMTSL5 mRNA	PMID:22206623
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313735	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ADAMTSL5 gene]	PMID:28238834
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313735	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ADAMTSL5 mRNA	PMID:23146750
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313736	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ADAMTSL5 mRNA	PMID:39847705
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADAMTSL5 mRNA	PMID:30047161
1305607	Adamtsl5	ADAMTS-like 5	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313735	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ADAMTSL5 mRNA	PMID:38568856
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313738	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ADGRB1 mRNA	PMID:37995155
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313738	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ADGRB1 mRNA	PMID:20188158
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADGRB1 gene	PMID:20938992
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313737	E	RGD:6480464	20161115	CTD	MESH:C018475	butyraldehyde results in increased expression of ADGRB1 mRNA	PMID:26079696
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313738	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ADGRB1 mRNA	PMID:30319688
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313738	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ADGRB1 mRNA	PMID:30319688
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313737	E	RGD:6480464	20240206	CTD	MESH:D011794	Quercetin metabolite results in increased expression of ADGRB1 mRNA; Quercetin results in increased expression of ADGRB1 mRNA	PMID:36982678
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313737	E	RGD:6480464	20240206	CTD	MESH:D011794	[bisphenol A co-treated with Quercetin metabolite] results in increased expression of ADGRB1 mRNA	PMID:36982678
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313737	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ADGRB1 mRNA	PMID:35811015
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313737	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ADGRB1 mRNA	PMID:30510588
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADGRB1 gene	PMID:20938992
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1313738	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of ADGRB1 mRNA	PMID:34673133
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313737	E	RGD:6480464	20161115	CTD	MESH:C005556	propionaldehyde results in increased expression of ADGRB1 mRNA	PMID:26079696
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA	PMID:37567420
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:17558	quercitrin	decreases expression	ISO	RGD:1313737	E	RGD:6480464	20170110	CTD	MESH:C012526	quercitrin results in decreased expression of ADGRB1 mRNA	PMID:25193878
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA	PMID:37567420
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ADGRB1 mRNA	PMID:22061828
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:17846	(S)-naringenin	increases expression	ISO	RGD:1313737	E	RGD:6480464	20230207	CTD	MESH:C005273	naringenin metabolite results in increased expression of ADGRB1 mRNA	PMID:36235125
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:17846	(S)-naringenin	multiple interactions	ISO	RGD:1313737	E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin co-treated with bisphenol A] results in increased expression of ADGRB1 mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of ADGRB1 mRNA	PMID:36235125
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313737	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADGRB1 mRNA	PMID:39836092
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADGRB1 mRNA	PMID:29950665
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ADGRB1 mRNA	PMID:21396975
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADGRB1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADGRB1 gene	PMID:20938992|PMID:22206623
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313737	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADGRB1 gene	PMID:25304211
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313737	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ADGRB1 mRNA	PMID:19244175
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313737	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ADGRB1 mRNA	PMID:28903495
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313737	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ADGRB1 mRNA	PMID:33212167
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313737	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ADGRB1 mRNA	PMID:32763439
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA	PMID:37567420
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313737	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ADGRB1 mRNA	PMID:38568856
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313738	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ADGRB1 mRNA	PMID:37682722
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313737	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADGRB1 5' UTR; Benzo(a)pyrene affects the methylation of ADGRB1 intron	PMID:27901495|PMID:30157460
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313737	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADGRB1 3' UTR; Benzo(a)pyrene results in decreased methylation of ADGRB1 promoter	PMID:27901495
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313737	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADGRB1 exon	PMID:27901495
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1313737	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ADGRB1 mRNA	PMID:37690743
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313738	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADGRB1 gene; titanium dioxide results in decreased methylation of ADGRB1 promoter	PMID:35295148
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313738	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ADGRB1 gene	PMID:35295148
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADGRB1 mRNA	PMID:29950665
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRB1 mRNA	PMID:30816183
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313738	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRB1 mRNA	PMID:32156529
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313737	E	RGD:6480464	20230207	CTD	MESH:C006780	[bisphenol A co-treated with Quercetin metabolite] results in increased expression of ADGRB1 mRNA; [naringenin co-treated with bisphenol A] results in increased expression of ADGRB1 mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of ADGRB1 mRNA	PMID:36235125|PMID:36982678
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313737	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of ADGRB1 mRNA	PMID:19244175
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313738	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ADGRB1 gene	PMID:31683443
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313738	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ADGRB1 exon	PMID:33297965
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313737	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ADGRB1 intron	PMID:30157460
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADGRB1 mRNA	PMID:29950665
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313738	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ADGRB1 mRNA	PMID:21266533
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20130416	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of ADGRB1 mRNA	PMID:23017109
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313737	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADGRB1 mRNA	PMID:39836092
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313737	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ADGRB1 mRNA	PMID:19244175
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313738	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ADGRB1 mRNA	PMID:40194260
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313738	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ADGRB1 mRNA	PMID:17292431
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313737	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADGRB1 gene	PMID:29154799
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA	PMID:37567420
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313737	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ADGRB1 mRNA	PMID:35811015
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313737	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADGRB1 gene	PMID:25304211
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1313737	E	RGD:6480464	20161228	CTD	MESH:D037742	[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of ADGRB1 protein	PMID:23026733
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20130416	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of ADGRB1 mRNA	PMID:23017109
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313737	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADGRB1 mRNA	PMID:39836092
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313737	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ADGRB1 intron	PMID:30157460
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313738	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADGRB1 mRNA	PMID:22206623
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADGRB1 mRNA	PMID:22206623
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:749466	calfactant	multiple interactions	ISO	RGD:1313737	E	RGD:6480464	20260721	CTD	MESH:C117342	[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of ADGRB1 protein	PMID:23026733
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA	PMID:37567420
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ADGRB1 mRNA	PMID:27291303
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ADGRB1 mRNA	PMID:23640034
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313737	E	RGD:6480464	20161115	CTD	MESH:C046012	pentanal results in increased expression of ADGRB1 mRNA	PMID:26079696
1305608	Adgrb1	adhesion G protein-coupled receptor B1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADGRB1 mRNA	PMID:24780913
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313740	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SHCBP1L mRNA	PMID:33045310
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313740	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SHCBP1L mRNA	PMID:37995155
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313739	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SHCBP1L mRNA	PMID:31614463
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA	PMID:37567420
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA	PMID:37567420
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:2208	purine-6-thiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of SHCBP1L mRNA	PMID:23358152
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SHCBP1L mRNA	PMID:37236586
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA	PMID:37567420
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313740	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SHCBP1L mRNA	PMID:37682722
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313739	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SHCBP1L promoter	PMID:27901495
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SHCBP1L mRNA	PMID:25181051|PMID:41034487
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313740	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SHCBP1L exon	PMID:33297965
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SHCBP1L mRNA	PMID:37236586
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of SHCBP1L mRNA	PMID:35594946
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA	PMID:37567420
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313739	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of SHCBP1L mRNA	PMID:24449571
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:50667	mercaptopurine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of SHCBP1L mRNA	PMID:23358152
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA	PMID:37567420
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of SHCBP1L mRNA	PMID:23358152
1305609	Shcbp1l	SHC binding and spindle associated 1 like	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313740	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SHCBP1L mRNA	PMID:35537566
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of SH3TC1 mRNA	PMID:21551480
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SH3TC1 mRNA	PMID:33045310
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SH3TC1 mRNA	PMID:25596134
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SH3TC1 mRNA	PMID:35811015
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SH3TC1 mRNA	PMID:39241906
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313741	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SH3TC1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SH3TC1 mRNA	PMID:35811015
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313741	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of SH3TC1 mRNA	PMID:27664576
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of SH3TC1 mRNA	PMID:26079696
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3TC1 mRNA	PMID:37992649
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313741	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SH3TC1 mRNA	PMID:21592394
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313741	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SH3TC1 mRNA	PMID:21592394
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313741	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of SH3TC1 mRNA	PMID:31256213
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3TC1 mRNA	PMID:37992649
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313741	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SH3TC1 mRNA	PMID:16002434|PMID:21592394
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313741	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SH3TC1 mRNA	PMID:21592394
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SH3TC1 mRNA	PMID:33387578
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313741	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SH3TC1 mRNA	PMID:28818685
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of SH3TC1 mRNA	PMID:37748715
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SH3TC1 mRNA	PMID:37325564
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313741	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SH3TC1 mRNA	PMID:19549813
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313741	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SH3TC1 mRNA	PMID:18593933
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SH3TC1 mRNA	PMID:31881176
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of SH3TC1 mRNA	PMID:25596134
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313741	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SH3TC1 mRNA	PMID:27594783
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313741	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SH3TC1 mRNA	PMID:24768652|PMID:25583101
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313742	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SH3TC1 mRNA	PMID:21570461
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SH3TC1 mRNA	PMID:31961203
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3TC1 mRNA	PMID:37992649
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313741	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SH3TC1 mRNA	PMID:29432896
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313741	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SH3TC1 mRNA	PMID:34032870|PMID:38568856
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313741	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SH3TC1 5' UTR; Benzo(a)pyrene affects the methylation of SH3TC1 intron	PMID:27901495|PMID:30157460
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SH3TC1 mRNA	PMID:21569818
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313741	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SH3TC1 exon; Benzo(a)pyrene results in decreased methylation of SH3TC1 promoter	PMID:27901495
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313741	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SH3TC1 mRNA	PMID:18593933
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:31175	adefovir pivoxil	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in decreased expression of SH3TC1 mRNA	PMID:25596134
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313742	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SH3TC1 mRNA	PMID:23557971
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SH3TC1 mRNA	PMID:34492290
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313742	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SH3TC1 mRNA	PMID:23811191
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SH3TC1 mRNA	PMID:25181051
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313741	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SH3TC1 mRNA	PMID:30903817
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3TC1 mRNA	PMID:34947998
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313741	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SH3TC1 gene	PMID:31601247
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313742	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SH3TC1 mRNA	PMID:33221593
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313742	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SH3TC1 exon	PMID:33297965
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313742	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SH3TC1 mRNA	PMID:30951980
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313741	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SH3TC1 intron	PMID:30157460
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313742	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SH3TC1 mRNA	PMID:37019170
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SH3TC1 mRNA	PMID:25596134
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of SH3TC1 promoter	PMID:22457795
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SH3TC1 mRNA	PMID:37325564
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SH3TC1 mRNA	PMID:24386269
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SH3TC1 mRNA	PMID:24449571
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of SH3TC1 mRNA	PMID:25596134
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SH3TC1 mRNA	PMID:31533062
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1313741	E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin results in increased expression of SH3TC1 mRNA	PMID:29044138
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313741	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SH3TC1 mRNA	PMID:28001369
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313741	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SH3TC1 gene	PMID:29154799
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SH3TC1 mRNA	PMID:25596134
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313741	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SH3TC1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3TC1 mRNA	PMID:37992649
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313741	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SH3TC1 mRNA	PMID:38832940
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313742	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SH3TC1 mRNA	PMID:17562736
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SH3TC1 mRNA	PMID:33387578
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313741	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SH3TC1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SH3TC1 mRNA	PMID:35811015
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313741	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SH3TC1 mRNA	PMID:38568856
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1313741	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of SH3TC1 mRNA	PMID:25596134
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SH3TC1 mRNA	PMID:25554681
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:5855	ibuprofen	increases expression	ISO	RGD:1313741	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of SH3TC1 mRNA	PMID:25596134
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:5864	ifosfamide	decreases expression	ISO	RGD:1313741	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of SH3TC1 mRNA	PMID:25596134
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313741	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SH3TC1 mRNA	PMID:28988120
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313741	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SH3TC1 intron	PMID:30157460
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SH3TC1 mRNA	PMID:22206623
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:80799	Bufotalin	increases expression	ISO	RGD:1313741	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of SH3TC1 mRNA	PMID:39904859
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:82036	prothioconazole	increases expression	ISO	RGD:1313741	E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of SH3TC1 mRNA	PMID:35048155
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SH3TC1 mRNA	PMID:24780913
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SH3TC1 mRNA	PMID:21346803
1305610	Sh3tc1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313741	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SH3TC1 mRNA	PMID:38568856
1305611	Smarce1-ps10	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1, pseudogene 10	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SMARCE1-PS10 mRNA	PMID:25181051
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20190507	CTD	MESH:D014212	Tretinoin results in decreased expression of DUS2 protein	PMID:30093655
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1603040	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DUS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DUS2 mRNA	PMID:32699268
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20151013	CTD	MESH:D001280	Atrazine results in decreased expression of DUS2 mRNA	PMID:22378314
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1553224	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DUS2 mRNA	PMID:39241906
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DUS2 mRNA	PMID:33387578
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DUS2 mRNA	PMID:33387578
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DUS2 mRNA	PMID:28818685
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553224	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DUS2 mRNA	PMID:36331819
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1603040	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DUS2 mRNA	PMID:35301059
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DUS2 mRNA	PMID:19549813
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of DUS2 mRNA	PMID:23649840
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1603040	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DUS2 gene	PMID:28458013
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DUS2 mRNA	PMID:23649840
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603040	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DUS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DUS2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DUS2 mRNA	PMID:32699268
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553224	E	RGD:6480464	20140114	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DUS2 mRNA	PMID:21570461
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DUS2 mRNA	PMID:33387578
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553224	E	RGD:6480464	20140114	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to DUS2 promoter]	PMID:19654925
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DUS2 mRNA	PMID:30851411
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of DUS2 mRNA	PMID:32763439
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DUS2 mRNA	PMID:29803840
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1603040	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of DUS2 mRNA	PMID:34032870
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DUS2 mRNA	PMID:38568856
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603040	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DUS2 5' UTR	PMID:27901495
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DUS2 protein	PMID:30093655
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1603040	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DUS2 gene	PMID:31601247
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553224	E	RGD:6480464	20151013	CTD	MESH:C006253	pirinixic acid results in increased expression of DUS2 mRNA	PMID:23811191
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DUS2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C006780	bisphenol A results in increased expression of DUS2 mRNA	PMID:25181051
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553224	E	RGD:6480464	20161115	CTD	MESH:C006780	bisphenol A results in increased expression of DUS2 mRNA	PMID:26063408
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DUS2 mRNA	PMID:36041667
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1603040	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DUS2 gene	PMID:31601247
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1553224	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of DUS2 mRNA	PMID:39298647
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DUS2 mRNA	PMID:36041667
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DUS2 mRNA	PMID:36041667
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603040	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DUS2 mRNA	PMID:37042841
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DUS2 mRNA	PMID:31077537
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of DUS2 mRNA	PMID:31077537
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1603040	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DUS2 mRNA	PMID:35301059
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1553224	E	RGD:6480464	20140114	CTD	MESH:D002922	Ciguatoxins affects the expression of DUS2 mRNA	PMID:18353800
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1603040	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DUS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DUS2 mRNA	PMID:32699268
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553224	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DUS2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of DUS2 mRNA	PMID:36331819
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1553224	E	RGD:6480464	20140114	CTD	MESH:D014635	Valproic Acid affects the expression of DUS2 mRNA	PMID:17963808
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1553224	E	RGD:6480464	20140114	CTD	MESH:D013629	Tamoxifen affects the expression of DUS2 mRNA	PMID:17555576
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:4488	diallyl disulfide	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C028009	diallyl disulfide results in decreased expression of DUS2 mRNA	PMID:31077537
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:C028009	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of DUS2 mRNA	PMID:31077537
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1603040	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DUS2 mRNA	PMID:22079256
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1553224	E	RGD:6480464	20140114	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DUS2 mRNA	PMID:17555576
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DUS2 protein	PMID:30093655
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553224	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DUS2 mRNA	PMID:25554681
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of DUS2 mRNA	PMID:24136188
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DUS2 mRNA	PMID:22079256
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1603040	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DUS2 mRNA	PMID:22079256
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1603040	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of DUS2 protein	PMID:31285264
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DUS2 mRNA	PMID:30851411
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603040	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DUS2 gene]	PMID:28238834
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DUS2 mRNA	PMID:21346803
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1603040	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DUS2 mRNA	PMID:38568856
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DUS2 mRNA	PMID:21346803
1305612	Dus2	dihydrouridine synthase 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1553224	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of DUS2 mRNA	PMID:28973697
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313746	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SPNS1 mRNA	PMID:33045310
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313746	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of SPNS1 mRNA	PMID:37995155
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:137392	chlormequat chloride	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of SPNS1 protein	PMID:34958886
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313746	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of SPNS1 mRNA	PMID:30951980
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1602314	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of SPNS1 protein	PMID:35688186
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313746	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SPNS1 mRNA	PMID:39241906
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1602314	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SPNS1 mRNA	PMID:23649840
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313746	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SPNS1 mRNA	PMID:34319233
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1602314	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SPNS1 protein	PMID:37730182
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SPNS1 mRNA	PMID:33387578
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SPNS1 mRNA	PMID:39836092
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602314	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SPNS1 exon; Aflatoxin B1 results in increased methylation of SPNS1 intron	PMID:30157460
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1602314	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SPNS1 mRNA	PMID:23649840
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313746	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPNS1 mRNA	PMID:40504410
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SPNS1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPNS1 mRNA	PMID:39836092
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313746	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPNS1 mRNA	PMID:21570461
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPNS1 mRNA	PMID:21215274
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPNS1 mRNA	PMID:32109520|PMID:33387578|PMID:34747641
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SPNS1 mRNA	PMID:28374803
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of SPNS1 mRNA	PMID:30556269
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1602314	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of SPNS1 protein	PMID:35688186
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313746	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPNS1 mRNA	PMID:40504410
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SPNS1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPNS1 mRNA	PMID:39836092
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602314	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPNS1 intron	PMID:30157460
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313746	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPNS1 mRNA	PMID:22228805
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602314	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPNS1 promoter	PMID:27901495
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of SPNS1 mRNA	PMID:30556269
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of SPNS1 mRNA	PMID:24136188
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313746	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPNS1 gene	PMID:35295148
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of SPNS1 mRNA	PMID:31129395
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313746	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SPNS1 promoter	PMID:27312807
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SPNS1 mRNA	PMID:25181051
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313746	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SPNS1 mRNA	PMID:33221593
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602314	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SPNS1 mRNA	PMID:29275510
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SPNS1 gene	PMID:28505145
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SPNS1 mRNA	PMID:28628672
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1602314	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SPNS1 mRNA	PMID:25979313
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1602314	E	RGD:6480464	20220111	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SPNS1 mRNA	PMID:34627992
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313746	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SPNS1 gene	PMID:31683443
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313746	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SPNS1 mRNA	PMID:39298647
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313746	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of SPNS1 mRNA	PMID:30951980
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPNS1 mRNA	PMID:28628672
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313746	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SPNS1 mRNA	PMID:34813904
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SPNS1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPNS1 mRNA	PMID:28628672
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313746	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SPNS1 mRNA	PMID:34813904
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SPNS1 mRNA	PMID:39836092
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPNS1 mRNA	PMID:21297351
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313746	E	RGD:6480464	20130618	CTD	MESH:D002994	Clofibrate results in decreased expression of SPNS1 mRNA	PMID:17585979
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602314	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SPNS1 mRNA	PMID:31533062
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1602314	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SPNS1 mRNA	PMID:40419075
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313746	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of SPNS1 mRNA	PMID:17292431
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602314	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPNS1 mRNA	PMID:25979313
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602314	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SPNS1 mRNA	PMID:23179753|PMID:29154799
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602314	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SPNS1 gene	PMID:29154799
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SPNS1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPNS1 mRNA	PMID:28628672
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313746	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of SPNS1 mRNA	PMID:17562736
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313746	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPNS1 mRNA	PMID:40504410
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SPNS1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPNS1 mRNA	PMID:39836092
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SPNS1 mRNA	PMID:29391264
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SPNS1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPNS1 mRNA	PMID:28628672
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of SPNS1 mRNA	PMID:24136188
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1602314	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SPNS1 protein	PMID:32959892
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1602314	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SPNS1 mRNA	PMID:39836092
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1602314	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SPNS1 mRNA	PMID:31758290
1305613	Spns1	SPNS lysolipid transporter 1, lysophospholipid	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313746	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of SPNS1 mRNA	PMID:30953684
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614069	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of IGF2BP2 mRNA	PMID:33045310
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1614069	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of IGF2BP2 mRNA	PMID:26251327
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1614069	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of IGF2BP2 promoter	PMID:26251327
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of IGF2BP2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IGF2BP2 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGF2BP2 mRNA	PMID:20938992
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of IGF2BP2 mRNA	PMID:33167477
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IGF2BP2 mRNA	PMID:30529165
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of IGF2BP2 gene	PMID:35440735
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of IGF2BP2 mRNA	PMID:30517762
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1614069	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of IGF2BP2 mRNA	PMID:39241906
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of IGF2BP2 mRNA	PMID:32145629
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1606569	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of IGF2BP2 mRNA	PMID:23019147
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of IGF2BP2 mRNA	PMID:26496021
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of IGF2BP2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IGF2BP2 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGF2BP2 mRNA	PMID:20938992
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20241203	CTD	MESH:D001554	Benzene results in decreased expression of IGF2BP2 mRNA; Benzene results in decreased expression of IGF2BP2 protein	PMID:38367942
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGF2BP2 mRNA	PMID:37992649
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of IGF2BP2 mRNA	PMID:38685446
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGF2BP2 mRNA	PMID:37992649
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1614069	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of IGF2BP2 mRNA	PMID:17997037
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IGF2BP2 mRNA	PMID:26577399
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of IGF2BP2 mRNA	PMID:33387578
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1614069	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of IGF2BP2 mRNA	PMID:17997037
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:195250	corn oil	affects expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D003314	Corn Oil affects the expression of IGF2BP2 mRNA	PMID:22760963
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:195250	corn oil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D003314	Corn Oil results in increased expression of IGF2BP2 mRNA	PMID:22760963
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1606569	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of IGF2BP2 mRNA	PMID:19549813
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1614069	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IGF2BP2 mRNA	PMID:19770486
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of IGF2BP2 protein	PMID:38598786
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of IGF2BP2 mRNA	PMID:30517762
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614069	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of IGF2BP2 mRNA	PMID:25629700
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of IGF2BP2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IGF2BP2 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGF2BP2 mRNA	PMID:20938992
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IGF2BP2 mRNA	PMID:32525701
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1606569	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of IGF2BP2 protein	PMID:35688186
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1614069	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of IGF2BP2 protein	PMID:25505154
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27889	lead(0)	affects methylation	ISO	RGD:1606569	E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of IGF2BP2 gene	PMID:31636367
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1606569	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of IGF2BP2 mRNA	PMID:28903495
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1606569	E	RGD:6480464	20260602	CTD	MESH:D002945	IGF2BP2 protein affects the susceptibility to Cisplatin	PMID:40801328
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of IGF2BP2 mRNA	PMID:19561079
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20260602	CTD	MESH:D002945	SEZ6L2 protein affects the reaction [IGF2BP2 protein affects the susceptibility to Cisplatin]	PMID:40801328
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of IGF2BP2 protein	PMID:39603559
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of IGF2BP2 mRNA	PMID:33212167
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of IGF2BP2 mRNA	PMID:26033743
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1614069	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of IGF2BP2 mRNA	PMID:39631538
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGF2BP2 mRNA	PMID:37992649
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of IGF2BP2 protein	PMID:39771098
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1614069	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of IGF2BP2 mRNA; sodium arsenite results in decreased expression of IGF2BP2 protein	PMID:37682722|PMID:39771098
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:29678	sodium arsenite	increases localization	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased localization of IGF2BP2 protein	PMID:38714084
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[IGF2BP2 protein promotes the reaction [sodium arsenite results in increased methylation of TGFB1 mRNA]] which results in increased expression of TGFB1 protein; IGF2BP2 promotes the reaction [sodium arsenite results in increased expression of ACTA2 protein]; IGF2BP2 promotes the reaction [sodium arsenite results in increased expression of COL1A2 protein]; IGF2BP2 promotes the reaction [sodium arsenite results in increased phosphorylation of SMAD2 protein]; IGF2BP2 promotes the reaction [sodium arsenite results in increased phosphorylation of SMAD3 protein]; IGF2BP2 protein promotes the reaction [sodium arsenite results in increased methylation of TGFB1 mRNA]; IGF2BP2 protein promotes the reaction [sodium arsenite results in increased stability of TGFB1 mRNA]; sodium arsenite promotes the reaction [IGF2BP2 protein binds to TGFB1 mRNA]	PMID:38714084
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20240206	CTD	MESH:C017947	HIPK3 mRNA alternative form promotes the reaction [sodium arsenite results in decreased expression of IGF2BP2 protein]; sodium arsenite inhibits the reaction [CCN1 mRNA binds to IGF2BP2 protein]	PMID:37682722|PMID:39771098
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IGF2BP2 mRNA	PMID:21839799
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IGF2BP2 protein	PMID:32717239
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1614069	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IGF2BP2 mRNA	PMID:19770486
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606569	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of IGF2BP2 promoter	PMID:27901495
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of IGF2BP2 mRNA	PMID:26033743
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1614069	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IGF2BP2 mRNA	PMID:19073995|PMID:29203145
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IGF2BP2 mRNA	PMID:19150397
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of IGF2BP2 mRNA	PMID:22521957
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20220906	CTD	MESH:C006632	IGF2BP2 protein promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP1 protein modified form]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL18 protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL1B protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased stability of NLRP3 mRNA]	PMID:35226250
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1606569	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of IGF2BP2 gene	PMID:31601247
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of IGF2BP2 gene	PMID:31601247
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of IGF2BP2 mRNA	PMID:30047161
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614069	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IGF2BP2 gene	PMID:35295148
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614069	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IGF2BP2 gene	PMID:35295148
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1614069	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of IGF2BP2 mRNA	PMID:23811191
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IGF2BP2 mRNA	PMID:19710929
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IGF2BP2 mRNA	PMID:19710929
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of IGF2BP2 mRNA	PMID:25181051
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of IGF2BP2 mRNA	PMID:32145629
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of IGF2BP2 protein	PMID:31675489
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1606569	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of IGF2BP2 gene	PMID:31601247
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1606569	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of IGF2BP2 protein	PMID:37567409
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of IGF2BP2 mRNA	PMID:26496021
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of IGF2BP2 gene	PMID:31601247
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of IGF2BP2 protein	PMID:31675489
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of IGF2BP2 mRNA	PMID:19244175
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1614069	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of IGF2BP2 mRNA	PMID:26682919
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1606569	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of IGF2BP2 protein	PMID:34186270
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1614069	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of IGF2BP2 intron	PMID:28392331
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of IGF2BP2 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of IGF2BP2 protein	PMID:38598786
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of IGF2BP2 mRNA	PMID:32680482
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606569	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IGF2BP2 mRNA	PMID:37042841
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606569	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of IGF2BP2 mRNA; Cadmium Chloride results in increased expression of IGF2BP2 protein	PMID:24527689|PMID:38568856
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of IGF2BP2 mRNA	PMID:27387713
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of IGF2BP2 mRNA	PMID:30047161
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IGF2BP2 mRNA	PMID:19320972
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:3764	clotrimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of IGF2BP2 mRNA	PMID:30047161
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1606569	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of IGF2BP2 mRNA	PMID:26352163
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1614069	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of IGF2BP2 mRNA	PMID:23125180
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1614069	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of IGF2BP2 mRNA	PMID:31558096
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606569	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of IGF2BP2 mRNA	PMID:19101580
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1606569	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IGF2BP2 gene	PMID:29154799
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of IGF2BP2 mRNA	PMID:17183730
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of IGF2BP2 mRNA	PMID:41580965
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1614069	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of IGF2BP2 mRNA	PMID:28973697
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGF2BP2 mRNA	PMID:37992649
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1606569	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of IGF2BP2 mRNA	PMID:24449571
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614069	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IGF2BP2 mRNA	PMID:17562736
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1606569	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of IGF2BP2 mRNA	PMID:21148743
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IGF2BP2 mRNA	PMID:32525701
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of IGF2BP2 mRNA	PMID:31675489
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1614069	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of IGF2BP2 mRNA	PMID:35436446
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of IGF2BP2 mRNA	PMID:18175754
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of IGF2BP2 mRNA	PMID:22521957
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20220906	CTD	MESH:C032793	IGF2BP2 protein promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP1 protein modified form]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL18 protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL1B protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased stability of NLRP3 mRNA]	PMID:35226250
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614069	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IGF2BP2 mRNA; Nanotubes, Carbon results in increased expression of IGF2BP2 mRNA	PMID:25554681
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:52774	pentane-2,3-dione	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in increased expression of IGF2BP2 mRNA	PMID:25710175
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of IGF2BP2 mRNA	PMID:17183730
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IGF2BP2 protein	PMID:32959892
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1614069	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGF2BP2 mRNA	PMID:21641980
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1614069	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of IGF2BP2 mRNA	PMID:36851058
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1606569	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGF2BP2 mRNA	PMID:22079614
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1614069	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of IGF2BP2 mRNA	PMID:20003209
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1606569	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of IGF2BP2 protein	PMID:34186270
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614069	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of IGF2BP2 mRNA	PMID:22206623
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of IGF2BP2 protein	PMID:37664457
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of IGF2BP2 mRNA	PMID:30047161
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IGF2BP2 protein	PMID:31675489
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1614069	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of IGF2BP2 mRNA	PMID:31558096
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of IGF2BP2 protein	PMID:31675489
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1606569	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of IGF2BP2 protein	PMID:38348393
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IGF2BP2 mRNA	PMID:32525701
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:91108	SB 431542	increases expression	ISO	RGD:1606569	E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of IGF2BP2 protein	PMID:25670856
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of IGF2BP2 protein	PMID:37664457
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in increased expression of IGF2BP2 mRNA	PMID:26141394
1305614	Igf2bp2	insulin-like growth factor 2 mRNA binding protein 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1606569	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of IGF2BP2 protein	PMID:38598786
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313748	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ARMC9 mRNA	PMID:33045310
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ARMC9 mRNA	PMID:33167477
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1604597	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ARMC9 mRNA	PMID:23724009
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ARMC9 mRNA	PMID:30165855
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of ARMC9 mRNA	PMID:21795739
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ARMC9 mRNA	PMID:26577399
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1604597	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ARMC9 protein	PMID:37730182
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1604597	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of ARMC9 intron	PMID:30157460
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313748	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARMC9 mRNA	PMID:36331819
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMC9 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ARMC9 mRNA	PMID:39836092
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ARMC9 protein	PMID:34915118
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313748	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARMC9 mRNA	PMID:37236586
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ARMC9 mRNA	PMID:19549813
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ARMC9 mRNA	PMID:22100608
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1604597	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ARMC9 intron	PMID:30157460
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313748	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ARMC9 mRNA	PMID:34911549
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1604597	E	RGD:6480464	20120522	CTD	MESH:D000638	Amiodarone results in increased expression of ARMC9 mRNA	PMID:19774075
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:27214	uranium atom	increases expression	ISO	RGD:1604597	E	RGD:6480464	20120522	CTD	MESH:D014501	Uranium results in increased expression of ARMC9 mRNA	PMID:15672453
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ARMC9 mRNA	PMID:31150632
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313748	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ARMC9 mRNA	PMID:25629700
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMC9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARMC9 mRNA	PMID:39836092
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of ARMC9 gene	PMID:31011160
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313748	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ARMC9 mRNA	PMID:28960355
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ARMC9 mRNA	PMID:31881176
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313748	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of ARMC9 mRNA	PMID:32186404
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313748	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARMC9 mRNA	PMID:21570461
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1604597	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARMC9 mRNA	PMID:22574217
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARMC9 mRNA	PMID:21215274|PMID:34747641
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1604597	E	RGD:6480464	20120522	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARMC9 mRNA	PMID:20106945
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20160822	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of ARMC9 mRNA	PMID:26159488
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ARMC9 mRNA	PMID:20971185
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1604597	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ARMC9 mRNA	PMID:30031762
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMC9 mRNA; [sodium arsenite co-treated with lead acetate] results in decreased expression of ARMC9 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARMC9 mRNA	PMID:38072110|PMID:39836092
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604597	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARMC9 intron	PMID:30157460
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARMC9 mRNA	PMID:22316170|PMID:26238291
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1604597	E	RGD:6480464	20120522	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARMC9 mRNA	PMID:20064835
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ARMC9 mRNA	PMID:20971185
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARMC9 mRNA	PMID:26238291
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ARMC9 mRNA	PMID:15761015
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ARMC9 mRNA	PMID:24136188
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in decreased expression of ARMC9 protein	PMID:38072110
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ARMC9 mRNA	PMID:34492290
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313748	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ARMC9 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20120522	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARMC9 mRNA	PMID:19710929
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARMC9 mRNA	PMID:25181051
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604597	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARMC9 gene	PMID:31601247
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ARMC9 mRNA	PMID:34947998
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313748	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ARMC9 mRNA	PMID:26063408
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604597	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ARMC9 mRNA	PMID:29275510
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ARMC9 gene	PMID:28505145
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARMC9 mRNA	PMID:36041667
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313748	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ARMC9 gene	PMID:31683443
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARMC9 mRNA	PMID:36041667
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARMC9 mRNA	PMID:36041667
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313748	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ARMC9 mRNA	PMID:28392331
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313748	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ARMC9 intron	PMID:28392331
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313748	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ARMC9 mRNA	PMID:32715474|PMID:37019170
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ARMC9 mRNA	PMID:28628672
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ARMC9 mRNA	PMID:30589522
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMC9 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ARMC9 mRNA	PMID:39836092
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1313748	E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride affects the expression of ARMC9 mRNA	PMID:29408670
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313748	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARMC9 mRNA	PMID:37236586
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313748	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARMC9 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ARMC9 mRNA	PMID:36331819
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1604597	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ARMC9 gene	PMID:29154799
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARMC9 mRNA	PMID:25562108
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ARMC9 mRNA	PMID:28628672
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1604597	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ARMC9 mRNA	PMID:28542535
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMC9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARMC9 mRNA	PMID:39836092
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:4791	endosulfan	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of ARMC9 mRNA	PMID:26159488
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARMC9 mRNA	PMID:22079256
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ARMC9 mRNA	PMID:28628672
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ARMC9 mRNA	PMID:15761015
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARMC9 protein	PMID:32959892
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMC9 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ARMC9 mRNA	PMID:39836092
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of ARMC9 mRNA	PMID:24136188
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1313748	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of ARMC9 mRNA	PMID:22470460
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1313748	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of ARMC9 mRNA	PMID:28444820
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313748	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARMC9 mRNA	PMID:22206623
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1604597	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ARMC9 mRNA	PMID:22079256
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1604597	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARMC9 mRNA	PMID:22079256
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1604597	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of ARMC9 mRNA	PMID:29522793
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1604597	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ARMC9 protein	PMID:31285264
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313748	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ARMC9 mRNA	PMID:23091169
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313748	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ARMC9 mRNA	PMID:39847705
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313748	E	RGD:6480464	20120522	CTD	MESH:C045950	propiconazole results in increased expression of ARMC9 mRNA	PMID:21278054
1305615	Armc9	armadillo repeat containing 9	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of ARMC9 protein	PMID:32519852
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:C118739	entinostat results in increased expression of SPAG6 mRNA	PMID:27188386
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620435	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPAG6 mRNA	PMID:33045310
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:D001241	Aspirin results in increased expression of SPAG6 mRNA	PMID:11906190
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of SPAG6 gene	PMID:35440735
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1620435	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SPAG6 mRNA	PMID:30319688
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPAG6 mRNA	PMID:33387578
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SPAG6 mRNA	PMID:31163220
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1620435	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SPAG6 mRNA	PMID:34319233
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D003471	Cuprizone results in increased expression of SPAG6 mRNA	PMID:26577399
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313749	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPAG6 mRNA	PMID:35301059
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SPAG6 gene	PMID:27153756
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D000661	Amphetamine results in increased expression of SPAG6 mRNA	PMID:30779732
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1620435	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPAG6 mRNA	PMID:25629700
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:27496	simazine	decreases expression	ISO	RGD:1620435	E	RGD:6480464	20151222	CTD	MESH:D012839	Simazine results in decreased expression of SPAG6 mRNA	PMID:22984576
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SPAG6 mRNA	PMID:26272509
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA	PMID:27188386
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of SPAG6 mRNA	PMID:38314887
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPAG6 mRNA	PMID:33387578
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SPAG6 mRNA	PMID:28001369
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1620435	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SPAG6 protein	PMID:28918527
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SPAG6 mRNA	PMID:22316170
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPAG6 mRNA	PMID:17879257
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:C004312	glycidol results in decreased expression of SPAG6 mRNA	PMID:24915197
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313749	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPAG6 gene	PMID:31601247
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1620435	E	RGD:6480464	20151222	CTD	MESH:C009495	titanium dioxide results in decreased expression of SPAG6 mRNA	PMID:23557971
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620435	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPAG6 gene	PMID:35295148
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1620435	E	RGD:6480464	20151222	CTD	MESH:C006253	pirinixic acid results in increased expression of SPAG6 mRNA	PMID:20813756
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20211221	CTD	MESH:C006780	bisphenol A affects the expression of SPAG6 mRNA	PMID:25181051
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620435	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SPAG6 mRNA	PMID:30951980
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313749	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPAG6 gene	PMID:31601247
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1620435	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SPAG6 exon	PMID:33297965
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1620435	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of SPAG6 intron	PMID:28392331
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313749	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPAG6 mRNA	PMID:35301059
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SPAG6 mRNA	PMID:30047161
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1620435	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of SPAG6 mRNA	PMID:39529242
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1620435	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of SPAG6 mRNA	PMID:29038090
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:D014635	Valproic Acid affects the expression of SPAG6 mRNA	PMID:25979313
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SPAG6 gene	PMID:29154799
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:D014635	Valproic Acid results in increased expression of SPAG6 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:27188386|PMID:28001369
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SPAG6 mRNA	PMID:30047161
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1620435	E	RGD:6480464	20151222	CTD	MESH:D013629	Tamoxifen affects the expression of SPAG6 mRNA	PMID:17555576
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:C111237	Vorinostat results in increased expression of SPAG6 mRNA	PMID:27188386
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1620435	E	RGD:6480464	20151222	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SPAG6 mRNA	PMID:17555576
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:C042720	mercuric bromide results in decreased expression of SPAG6 mRNA	PMID:26272509
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA	PMID:27188386
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620435	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SPAG6 mRNA; Nanotubes, Carbon results in decreased expression of SPAG6 mRNA	PMID:25554681
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA	PMID:27188386
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:84491	poly(I:C)	decreases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D011070	Poly I-C results in decreased expression of SPAG6 mRNA	PMID:26923065
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of SPAG6 mRNA	PMID:30047161
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPAG6 mRNA	PMID:25825206|PMID:30047161
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313749	E	RGD:6480464	20211214	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA	PMID:27188386
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of SPAG6 mRNA	PMID:30047161
1305616	Spag6	sperm associated antigen 6	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20211221	CTD	MESH:C025643	vinclozolin results in increased expression of SPAG6 mRNA	PMID:22615374
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of MARCHF5 mRNA]	PMID:19467301
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:D014212	Tretinoin results in decreased expression of MARCHF5 mRNA	PMID:16604517
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MARCHF5 mRNA	PMID:22629407
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MARCHF5 mRNA]	PMID:22629407
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1346314	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MARCHF5 mRNA	PMID:22378314
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557961	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MARCHF5 mRNA	PMID:39241906
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MARCHF5 mRNA	PMID:25510870
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1346314	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of MARCHF5 mRNA	PMID:38568856
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MARCHF5 mRNA	PMID:21318169
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MARCHF5 mRNA	PMID:28111341
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MARCHF5 mRNA	PMID:25510870
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MARCHF5 mRNA	PMID:25510870
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1346314	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MARCHF5 mRNA	PMID:19549813
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1346314	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MARCHF5 mRNA	PMID:23649840
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MARCHF5 mRNA	PMID:22206623
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:C059514	Resveratrol results in increased expression of MARCHF5 protein	PMID:25505154
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346314	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MARCHF5 mRNA	PMID:23557933
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MARCHF5 mRNA	PMID:17942748
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1346314	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MARCHF5 mRNA	PMID:30851411
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346314	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MARCHF5 mRNA	PMID:38568856
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1346314	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MARCHF5 mRNA]	PMID:32406909
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1557961	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MARCHF5 mRNA	PMID:39826883
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1346314	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of MARCHF5 mRNA	PMID:31745603
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C030110	Oxaliplatin results in decreased expression of MARCHF5 mRNA	PMID:25729387
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20200114	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in decreased expression of MARCHF5 mRNA	PMID:25729387
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557961	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MARCHF5 enhancer	PMID:35295148
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:C006253	pirinixic acid results in increased expression of MARCHF5 mRNA	PMID:23811191
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1346314	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MARCHF5 mRNA	PMID:29275510
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C006780	bisphenol A results in increased expression of MARCHF5 mRNA	PMID:25181051|PMID:34947998
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20200114	CTD	MESH:C006780	bisphenol A results in increased methylation of MARCHF5 gene	PMID:28505145
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1346314	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MARCHF5 mRNA	PMID:25979313
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MARCHF5 mRNA	PMID:25510870
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MARCHF5 mRNA	PMID:25510870
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1346314	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of MARCHF5 protein	PMID:34186270
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1346314	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MARCHF5 mRNA	PMID:28628672
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1557961	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MARCHF5 mRNA	PMID:37019170
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MARCHF5 mRNA	PMID:21266533
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1557961	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MARCHF5 mRNA	PMID:34813904
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1346314	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MARCHF5 mRNA	PMID:28628672
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346314	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MARCHF5 mRNA	PMID:37042841
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MARCHF5 mRNA	PMID:28111341
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1346314	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of MARCHF5 mRNA	PMID:19376846
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346314	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MARCHF5 mRNA	PMID:25979313
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1346314	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of MARCHF5 mRNA	PMID:28001369
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346314	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MARCHF5 mRNA	PMID:25562108
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1346314	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MARCHF5 mRNA	PMID:28628672
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C012655	nimesulide results in increased expression of MARCHF5 mRNA	PMID:24136188
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1346314	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of MARCHF5 mRNA	PMID:29067470
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1557961	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MARCHF5 mRNA	PMID:29279043
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MARCHF5 mRNA	PMID:17942748
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MARCHF5 mRNA	PMID:17942748
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1346314	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MARCHF5 mRNA	PMID:28628672
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557961	E	RGD:6480464	20200114	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MARCHF5 mRNA; Nanotubes, Carbon results in increased expression of MARCHF5 mRNA	PMID:25554681|PMID:25620056
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1557961	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of MARCHF5 mRNA	PMID:40234311
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D005485	Flutamide results in increased expression of MARCHF5 mRNA	PMID:24136188
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1346314	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MARCHF5 protein	PMID:32959892
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20200114	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in decreased expression of MARCHF5 mRNA	PMID:25729387
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C406224	valdecoxib results in increased expression of MARCHF5 mRNA	PMID:24136188
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C045463	Leflunomide results in increased expression of MARCHF5 mRNA	PMID:24136188
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1557961	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MARCHF5 mRNA	PMID:22206623
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1557961	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MARCHF5 mRNA	PMID:22206623
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C051752	nefazodone results in increased expression of MARCHF5 mRNA	PMID:24136188
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1346314	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MARCHF5 mRNA	PMID:30851411
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D012999	Soman results in increased expression of MARCHF5 mRNA	PMID:19281266
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MARCHF5 mRNA	PMID:21346803
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1346314	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MARCHF5 mRNA	PMID:38568856
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1346314	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MARCHF5 mRNA	PMID:29301935
1305617	Marchf5	membrane associated ring-CH-type finger 5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MARCHF5 mRNA	PMID:21346803
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1313754	E	RGD:6480464	20120412	CTD	MESH:D015215	Zidovudine results in increased expression of NDUFAB1 mRNA	PMID:16894629
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAB1 mRNA	PMID:18313992
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NDUFAB1 mRNA	PMID:22629407
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of NDUFAB1 mRNA]	PMID:22629407
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NDUFAB1 mRNA	PMID:22378314
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16136	hydrogen sulfide	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20181113	CTD	MESH:D006862	Hydrogen Sulfide results in decreased expression of NDUFAB1 protein	PMID:29932956
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20141007	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of NDUFAB1 mRNA	PMID:17347304
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313755	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDUFAB1 mRNA	PMID:39241906
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFAB1 mRNA	PMID:31059760
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NDUFAB1 mRNA]	PMID:39241906
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NDUFAB1 mRNA	PMID:39298647
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313754	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NDUFAB1 mRNA	PMID:37042841
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:17303	morphine	affects expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D009020	Morphine affects the expression of NDUFAB1 mRNA	PMID:20144693
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:17578	toluene	affects expression	EXP		E	RGD:6480464	20141007	CTD	MESH:D014050	Toluene affects the expression of NDUFAB1 mRNA	PMID:21827849
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NDUFAB1 mRNA	PMID:35550907
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NDUFAB1 mRNA	PMID:22061828
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:17833	gentamycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein	PMID:30545405
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NDUFAB1 mRNA	PMID:36331819
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA	PMID:39836092
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NDUFAB1 mRNA	PMID:19549813
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of NDUFAB1 protein	PMID:33236894
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NDUFAB1 mRNA	PMID:19770486
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NDUFAB1 mRNA	PMID:31919559
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NDUFAB1 mRNA	PMID:22206623
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of NDUFAB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NDUFAB1 mRNA	PMID:39836092|PMID:40512198
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313755	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NDUFAB1 mRNA	PMID:30912803
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28001	vancomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein	PMID:30545405
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NDUFAB1 mRNA	PMID:21570461
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFAB1 mRNA	PMID:27913140|PMID:32109520
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFAB1 mRNA	PMID:20106945|PMID:21632981
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFAB1 mRNA	PMID:33387578
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D012402	Rotenone results in decreased expression of NDUFAB1 mRNA	PMID:17702527
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D012402	Rotenone results in increased expression of NDUFAB1 mRNA	PMID:17702527
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDUFAB1 mRNA	PMID:30851411
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of NDUFAB1 mRNA	PMID:27862939
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of NDUFAB1 mRNA	PMID:26873546
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313754	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NDUFAB1 mRNA	PMID:29803840
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28971	ampicillin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein	PMID:30545405
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313754	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of NDUFAB1 mRNA	PMID:34032870
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of NDUFAB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NDUFAB1 mRNA	PMID:39836092|PMID:40512198
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NDUFAB1 mRNA	PMID:22378314
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313754	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NDUFAB1 mRNA	PMID:17879257
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NDUFAB1 mRNA	PMID:19770486|PMID:22228805
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of NDUFAB1 mRNA	PMID:33053406
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to NDUFAB1 mRNA]	PMID:32406909
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of NDUFAB1 mRNA	PMID:19073995
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of NDUFAB1 mRNA	PMID:19422848
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313754	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NDUFAB1 mRNA	PMID:22521957|PMID:29633893
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:C008261	lead acetate results in decreased expression of NDUFAB1 mRNA	PMID:21829687
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of NDUFAB1 mRNA	PMID:30047161
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20141007	CTD	MESH:C006253	pirinixic acid results in increased expression of NDUFAB1 mRNA	PMID:19162173
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:C006253	pirinixic acid results in increased expression of NDUFAB1 mRNA	PMID:11798191|PMID:15375163|PMID:18301758|PMID:20813756|PMID:23811191
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NDUFAB1 mRNA	PMID:25181051
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313754	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NDUFAB1 mRNA	PMID:30903817
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFAB1 mRNA; bisphenol A results in decreased expression of NDUFAB1 protein	PMID:29275510|PMID:37664457
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFAB1 mRNA; bisphenol A results in decreased expression of NDUFAB1 protein	PMID:37992956
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFAB1 mRNA	PMID:34947998
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313754	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFAB1 protein	PMID:37567409
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NDUFAB1 mRNA	PMID:36041667
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of NDUFAB1 mRNA	PMID:30316929
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313754	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of NDUFAB1 gene	PMID:31601247
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313755	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NDUFAB1 mRNA	PMID:39298647
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NDUFAB1 mRNA	PMID:36041667
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NDUFAB1 mRNA	PMID:36041667
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313755	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NDUFAB1 mRNA	PMID:37019170
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NDUFAB1 mRNA	PMID:17361019|PMID:21266533
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NDUFAB1 mRNA]	PMID:39241906
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA	PMID:39836092
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of NDUFAB1 protein	PMID:26879310
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D002994	Clofibrate results in decreased expression of NDUFAB1 mRNA	PMID:17585979
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of NDUFAB1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NDUFAB1 mRNA]	PMID:17585979
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1313754	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of NDUFAB1 mRNA	PMID:26352163
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NDUFAB1 mRNA	PMID:20936131
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NDUFAB1 mRNA; PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of NDUFAB1 mRNA]	PMID:20936131|PMID:36331819
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:39501	2,2,2-tetramine	multiple interactions	EXP		E	RGD:6480464	20141007	CTD	MESH:D014266	Trientine inhibits the reaction [Streptozocin results in increased expression of NDUFAB1 protein]	PMID:19634143
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313754	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NDUFAB1 mRNA	PMID:25979313
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of NDUFAB1 mRNA	PMID:30047161
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NDUFAB1 mRNA	PMID:30047161
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313754	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of NDUFAB1 mRNA	PMID:27989131
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	affects expression	ISO	RGD:1313754	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide affects the expression of NDUFAB1 mRNA	PMID:16570282
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NDUFAB1 mRNA	PMID:28973697
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of NDUFAB1 mRNA	PMID:24136188
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D000082	Acetaminophen affects the expression of NDUFAB1 mRNA	PMID:17562736
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of NDUFAB1 mRNA	PMID:31059760
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFAB1 mRNA	PMID:31059760
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of NDUFAB1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NDUFAB1 mRNA]	PMID:17585979
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1313754	E	RGD:6480464	20211109	CTD	MESH:D005472	Fluorouracil affects the expression of NDUFAB1 mRNA	PMID:34151400
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of NDUFAB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NDUFAB1 mRNA	PMID:39836092|PMID:40512198
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313755	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of NDUFAB1 mRNA	PMID:30529165
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313754	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of NDUFAB1 mRNA	PMID:18175754
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20141007	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NDUFAB1 mRNA	PMID:17108234
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:4917	eugenol	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in decreased expression of NDUFAB1 protein	PMID:39793947
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of NDUFAB1 mRNA	PMID:19422848
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313754	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NDUFAB1 mRNA	PMID:22521957|PMID:29633893
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D011345	Fenofibrate results in increased expression of NDUFAB1 mRNA	PMID:11798191
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of NDUFAB1 mRNA	PMID:25620056
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313755	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NDUFAB1 mRNA; Nanotubes, Carbon results in increased expression of NDUFAB1 mRNA	PMID:25554681
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of NDUFAB1 mRNA	PMID:24136188
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of NDUFAB1 mRNA	PMID:30047161
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NDUFAB1 mRNA	PMID:30047161
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	EXP		E	RGD:6480464	20141007	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of NDUFAB1 mRNA	PMID:19162173
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D005485	Flutamide analog results in decreased expression of NDUFAB1 mRNA; Flutamide results in decreased expression of NDUFAB1 mRNA	PMID:17702527
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NDUFAB1 mRNA	PMID:24136188
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D005485	Flutamide analog results in increased expression of NDUFAB1 mRNA; Flutamide results in increased expression of NDUFAB1 mRNA	PMID:17702527
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NDUFAB1 mRNA	PMID:19042947
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:6030	isoniazide	affects expression	ISO	RGD:1313755	E	RGD:6480464	20141014	CTD	MESH:D007538	Isoniazid affects the expression of NDUFAB1 mRNA	PMID:24848797
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:6030	isoniazide	increases expression	ISO	RGD:1313754	E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of NDUFAB1 protein	PMID:40015660
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NDUFAB1 protein	PMID:32959892
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA	PMID:39836092
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAB1 mRNA	PMID:18313992
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDUFAB1 mRNA	PMID:21641980
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of NDUFAB1 mRNA	PMID:37939859
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:6909	metronidazole	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein	PMID:30545405
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313754	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NDUFAB1 protein	PMID:34186270
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NDUFAB1 mRNA	PMID:22206623
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NDUFAB1 protein	PMID:37664457
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of NDUFAB1 mRNA	PMID:24136188
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:7507	neomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein	PMID:30545405
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDUFAB1 mRNA	PMID:30851411
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NDUFAB1 gene]	PMID:28238834
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1313755	E	RGD:6480464	20141007	CTD	MESH:D010695	Phlorhizin results in increased expression of NDUFAB1 mRNA	PMID:22538082
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313755	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NDUFAB1 mRNA	PMID:30294300
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of NDUFAB1 mRNA	PMID:21795629
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NDUFAB1 mRNA	PMID:30047161
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NDUFAB1 mRNA	PMID:30047161
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NDUFAB1 mRNA]	PMID:39241906
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313754	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NDUFAB1 protein	PMID:37664457
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20141007	CTD	MESH:D013311	Streptozocin results in increased expression of NDUFAB1 protein	PMID:19634143
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20141007	CTD	MESH:D013311	Trientine inhibits the reaction [Streptozocin results in increased expression of NDUFAB1 protein]	PMID:19634143
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313754	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NDUFAB1 mRNA	PMID:22378314
1305619	Ndufab1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of NDUFAB1 mRNA	PMID:30047161
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313759	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of USP20 mRNA	PMID:33045310
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of USP20 mRNA	PMID:26251327
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313759	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of USP20 mRNA	PMID:20188158
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313758	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of USP20 mRNA	PMID:23724009
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of USP20 mRNA	PMID:30319688
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of USP20 mRNA	PMID:39241906
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of USP20 mRNA	PMID:33387578
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313758	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of USP20 mRNA	PMID:37042841
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313759	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of USP20 mRNA	PMID:21318169
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of USP20 mRNA	PMID:33387578
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313758	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of USP20 mRNA	PMID:28818685
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of USP20 mRNA	PMID:36331819
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of USP20 mRNA	PMID:33914522
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20150127	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of USP20 mRNA	PMID:25270620
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of USP20 mRNA	PMID:22206623
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313758	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of USP20 gene	PMID:25304211
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP20 mRNA	PMID:40504410
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313758	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of USP20 mRNA	PMID:16705744
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313759	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USP20 mRNA	PMID:21570461
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of USP20 mRNA	PMID:33387578
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313758	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of USP20 mRNA	PMID:33212167
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313758	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of USP20 mRNA	PMID:30851411
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1313758	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of USP20 protein	PMID:35688186
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313758	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of USP20 mRNA	PMID:38568856
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP20 mRNA	PMID:40504410
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313758	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of USP20 intron	PMID:30157460
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313759	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USP20 mRNA	PMID:22228805
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313758	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of USP20 mRNA	PMID:25895662
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313759	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USP20 gene	PMID:35295148
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313759	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of USP20 mRNA	PMID:18301758|PMID:21318169|PMID:23811191
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of USP20 mRNA]	PMID:21318169
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of USP20 mRNA	PMID:33914522
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of USP20 mRNA	PMID:25181051
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313758	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of USP20 intron	PMID:30157460
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of USP20 mRNA	PMID:34813904
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of USP20 mRNA	PMID:34813904
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313758	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of USP20 mRNA	PMID:38568856
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313758	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of USP20 mRNA	PMID:40419075
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of USP20 mRNA	PMID:36331819
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of USP20 mRNA	PMID:33387578
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313758	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of USP20 gene	PMID:25304211
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP20 mRNA	PMID:40504410
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of USP20 mRNA	PMID:25554681
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of USP20 mRNA	PMID:24136188
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313758	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of USP20 mRNA	PMID:28988120
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313759	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of USP20 mRNA	PMID:26307267
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313758	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of USP20 intron	PMID:30157460
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of USP20 mRNA	PMID:22206623
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313758	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of USP20 mRNA	PMID:22714537
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313758	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of USP20 mRNA	PMID:30851411
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313758	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to USP20 gene]	PMID:28238834
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313759	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of USP20 mRNA	PMID:19482888
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of USP20 mRNA]	PMID:19482888
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of USP20 mRNA	PMID:33269387
1305621	Usp20	ubiquitin specific peptidase 20	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of USP20 mRNA	PMID:21346803
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1348370	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of BOD1 mRNA	PMID:38218311
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BOD1 mRNA]	PMID:31150632
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1348370	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of BOD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of BOD1 mRNA	PMID:32699268
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1332058	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of BOD1 mRNA	PMID:40945087
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1332058	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of BOD1 mRNA	PMID:30319688
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of BOD1 gene	PMID:27618143
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1332058	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of BOD1 mRNA	PMID:33754040
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of BOD1 mRNA	PMID:33387578
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1348370	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of BOD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of BOD1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of BOD1 mRNA	PMID:32699268
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BOD1 mRNA	PMID:31150632
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BOD1 mRNA]	PMID:31150632
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332058	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BOD1 mRNA	PMID:22206623
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332058	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BOD1 mRNA	PMID:40504410
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1348370	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of BOD1 mRNA	PMID:32763439
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332058	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BOD1 mRNA	PMID:40504410
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1348370	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of BOD1 promoter	PMID:27901495
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332058	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BOD1 mRNA	PMID:19770486
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1348370	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of BOD1 mRNA	PMID:25075043
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332058	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BOD1 promoter	PMID:35295148
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of BOD1 mRNA	PMID:34492290
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BOD1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of BOD1 gene	PMID:28505145
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332058	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of BOD1 mRNA	PMID:37019170
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1348370	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BOD1 mRNA	PMID:38568856
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of BOD1 promoter	PMID:22457795
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1348370	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of BOD1 mRNA	PMID:24449571
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1348370	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of BOD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of BOD1 mRNA	PMID:32699268
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1348370	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of BOD1 mRNA	PMID:32588087
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1348370	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of BOD1 mRNA	PMID:31533062
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1348370	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of BOD1 mRNA	PMID:26352163
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1348370	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BOD1 mRNA	PMID:25979313
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1348370	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of BOD1 mRNA	PMID:23179753
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1348370	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of BOD1 mRNA	PMID:20106945
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1348370	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of BOD1 mRNA]	PMID:21233418
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1348370	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of BOD1 mRNA	PMID:38832940
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332058	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BOD1 mRNA	PMID:40504410
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of BOD1 mRNA	PMID:29391264
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1348370	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of BOD1 mRNA	PMID:25075043
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1332058	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BOD1 mRNA	PMID:22206623
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1348370	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BOD1 gene]	PMID:28238834
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1332058	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of BOD1 mRNA	PMID:31388691
1305622	Bod1	biorientation of chromosomes in cell division 1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1332058	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of BOD1 mRNA	PMID:26217789
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of MRPS34 mRNA	PMID:37995155
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPS34 mRNA	PMID:33167477
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in decreased expression of MRPS34 protein	PMID:40631627
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313761	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS34 mRNA	PMID:31059760
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313762	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MRPS34 mRNA	PMID:39298647
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313761	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPS34 mRNA	PMID:37042841
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of MRPS34 mRNA	PMID:23649840
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of MRPS34 protein	PMID:40631627
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of MRPS34 mRNA	PMID:28973375
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of MRPS34 protein	PMID:40631627
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MRPS34 mRNA	PMID:22061828
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS34 mRNA	PMID:36331819
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPS34 mRNA	PMID:28111341
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRPS34 mRNA	PMID:19549813
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MRPS34 mRNA	PMID:23649840
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MRPS34 mRNA	PMID:23649840
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS34 mRNA	PMID:22206623
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS34 mRNA	PMID:40504410
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313762	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MRPS34 mRNA	PMID:30912803
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313762	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPS34 mRNA	PMID:21570461
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPS34 mRNA	PMID:32109520
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313762	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPS34 mRNA	PMID:18796159
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313761	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MRPS34 mRNA	PMID:29803840
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPS34 mRNA	PMID:38568856
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313761	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of MRPS34 mRNA	PMID:34032870|PMID:39719251
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313761	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [MRPS34 protein binds to CAPRIN1 protein]	PMID:33939924
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS34 mRNA	PMID:40504410
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPS34 mRNA	PMID:27195522
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of MRPS34 mRNA	PMID:24136188
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MRPS34 mRNA	PMID:30047161
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPS34 mRNA	PMID:33221593
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPS34 mRNA	PMID:25181051|PMID:30816183|PMID:32145629
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MRPS34 gene	PMID:28505145
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313762	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPS34 mRNA	PMID:39298647
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313762	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MRPS34 mRNA	PMID:37019170
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MRPS34 mRNA	PMID:17602206
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313761	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of MRPS34 gene	PMID:22964155
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPS34 mRNA	PMID:17361019|PMID:21266533
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MRPS34 mRNA	PMID:34813904
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of MRPS34 mRNA	PMID:34813904
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MRPS34 mRNA	PMID:17602206
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MRPS34 mRNA	PMID:32680482
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of MRPS34 promoter	PMID:22457795
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPS34 mRNA	PMID:28111341
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of MRPS34 gene	PMID:22079235
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of MRPS34 mRNA	PMID:17585979
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS34 mRNA	PMID:36331819
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313761	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPS34 mRNA	PMID:25979313
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPS34 mRNA	PMID:29501571
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313761	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MRPS34 mRNA	PMID:23179753
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313761	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MRPS34 gene	PMID:29154799
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MRPS34 mRNA	PMID:30047161
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MRPS34 mRNA	PMID:25562108
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of MRPS34 protein	PMID:40631627
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MRPS34 mRNA	PMID:24136188
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPS34 mRNA	PMID:22230336|PMID:25704631|PMID:31059760
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPS34 mRNA	PMID:33387578
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313761	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS34 mRNA	PMID:31059760
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS34 mRNA	PMID:40504410
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313761	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MRPS34 mRNA	PMID:18175754
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of MRPS34 mRNA	PMID:23962444
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MRPS34 mRNA	PMID:30047161
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPS34 mRNA	PMID:24136188
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MRPS34 protein	PMID:32959892
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of MRPS34 mRNA	PMID:24136188
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of MRPS34 mRNA	PMID:37939859
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPS34 mRNA	PMID:22206623
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS34 mRNA	PMID:22206623
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MRPS34 mRNA	PMID:24136188
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313761	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MRPS34 protein	PMID:31285264
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased expression of MRPS34 mRNA	PMID:37162024
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:7719	ochratoxin A	increases methylation	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased methylation of MRPS34 gene	PMID:37162024
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1313762	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of MRPS34 mRNA	PMID:31558096
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MRPS34 mRNA	PMID:30047161
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of MRPS34 mRNA	PMID:40826991
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRPS34 mRNA	PMID:21346803
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313761	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MRPS34 mRNA	PMID:38568856
1305623	Mrps34	mitochondrial ribosomal protein S34	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MRPS34 mRNA	PMID:21346803
1305624	Palmd	palmdelphin	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of PALMD protein	PMID:36641056
1305624	Palmd	palmdelphin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PALMD mRNA	PMID:30529165
1305624	Palmd	palmdelphin	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PALMD mRNA	PMID:21632981
1305624	Palmd	palmdelphin	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313764	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PALMD mRNA	PMID:39241906
1305624	Palmd	palmdelphin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of PALMD mRNA]	PMID:39241906
1305624	Palmd	palmdelphin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of PALMD mRNA	PMID:31614463
1305624	Palmd	palmdelphin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PALMD mRNA	PMID:39298647
1305624	Palmd	palmdelphin	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of PALMD mRNA	PMID:32145629
1305624	Palmd	palmdelphin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of PALMD mRNA	PMID:20660070
1305624	Palmd	palmdelphin	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20250506	CTD	MESH:D002635	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PALMD mRNA	PMID:34589561
1305624	Palmd	palmdelphin	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of PALMD mRNA	PMID:20660070
1305624	Palmd	palmdelphin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313763	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PALMD mRNA	PMID:22017230
1305624	Palmd	palmdelphin	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of PALMD mRNA	PMID:33647349
1305624	Palmd	palmdelphin	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of PALMD mRNA	PMID:31256213
1305624	Palmd	palmdelphin	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20250506	CTD	MESH:D006000	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PALMD mRNA	PMID:34589561
1305624	Palmd	palmdelphin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PALMD mRNA	PMID:31163220
1305624	Palmd	palmdelphin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PALMD mRNA	PMID:32235866|PMID:34319233
1305624	Palmd	palmdelphin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1305624	Palmd	palmdelphin	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PALMD mRNA	PMID:28818685
1305624	Palmd	palmdelphin	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PALMD mRNA	PMID:36331819
1305624	Palmd	palmdelphin	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313763	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of PALMD mRNA	PMID:24376830
1305624	Palmd	palmdelphin	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PALMD mRNA	PMID:19549813
1305624	Palmd	palmdelphin	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PALMD mRNA	PMID:22100608|PMID:27153756
1305624	Palmd	palmdelphin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313763	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PALMD gene	PMID:27153756
1305624	Palmd	palmdelphin	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of PALMD mRNA	PMID:30779732
1305624	Palmd	palmdelphin	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PALMD mRNA	PMID:25629700
1305624	Palmd	palmdelphin	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20250506	CTD	MESH:D006002	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PALMD mRNA	PMID:34589561
1305624	Palmd	palmdelphin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PALMD mRNA	PMID:32525701
1305624	Palmd	palmdelphin	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1313763	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of PALMD mRNA	PMID:38460933
1305624	Palmd	palmdelphin	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PALMD mRNA	PMID:38460933
1305624	Palmd	palmdelphin	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313763	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PALMD protein	PMID:35688186
1305624	Palmd	palmdelphin	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313763	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PALMD mRNA	PMID:27392435
1305624	Palmd	palmdelphin	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1313763	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of PALMD mRNA	PMID:26865667
1305624	Palmd	palmdelphin	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PALMD mRNA	PMID:24768652|PMID:25583101
1305624	Palmd	palmdelphin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313764	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PALMD mRNA	PMID:21570461
1305624	Palmd	palmdelphin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PALMD mRNA	PMID:21215274|PMID:21724226
1305624	Palmd	palmdelphin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PALMD mRNA	PMID:19770486|PMID:21889950
1305624	Palmd	palmdelphin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PALMD mRNA	PMID:26232522
1305624	Palmd	palmdelphin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PALMD mRNA	PMID:25975270
1305624	Palmd	palmdelphin	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of PALMD mRNA	PMID:39709020
1305624	Palmd	palmdelphin	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PALMD mRNA	PMID:30851411
1305624	Palmd	palmdelphin	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PALMD mRNA	PMID:32763439
1305624	Palmd	palmdelphin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PALMD mRNA	PMID:20971185
1305624	Palmd	palmdelphin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PALMD mRNA	PMID:29803840
1305624	Palmd	palmdelphin	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313763	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PALMD protein	PMID:35688186
1305624	Palmd	palmdelphin	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20250506	CTD	MESH:D003840	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PALMD mRNA	PMID:34589561
1305624	Palmd	palmdelphin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PALMD mRNA	PMID:23876855|PMID:39719251
1305624	Palmd	palmdelphin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PALMD mRNA	PMID:22178795
1305624	Palmd	palmdelphin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PALMD mRNA	PMID:19770486
1305624	Palmd	palmdelphin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313764	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PALMD mRNA	PMID:21569818|PMID:22610609
1305624	Palmd	palmdelphin	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PALMD mRNA	PMID:27858113
1305624	Palmd	palmdelphin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PALMD mRNA	PMID:20971185
1305624	Palmd	palmdelphin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PALMD mRNA; Silicon Dioxide results in decreased expression of PALMD mRNA	PMID:25351596|PMID:25895662
1305624	Palmd	palmdelphin	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PALMD mRNA	PMID:35984750
1305624	Palmd	palmdelphin	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of PALMD mRNA	PMID:24915197
1305624	Palmd	palmdelphin	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PALMD mRNA	PMID:24136188
1305624	Palmd	palmdelphin	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of PALMD mRNA	PMID:25729387
1305624	Palmd	palmdelphin	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of PALMD mRNA	PMID:24136188
1305624	Palmd	palmdelphin	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313764	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of PALMD mRNA	PMID:17656681
1305624	Palmd	palmdelphin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PALMD mRNA	PMID:25380136
1305624	Palmd	palmdelphin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PALMD mRNA	PMID:18648102
1305624	Palmd	palmdelphin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313764	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PALMD mRNA	PMID:18301758|PMID:23811191
1305624	Palmd	palmdelphin	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PALMD mRNA	PMID:19710929
1305624	Palmd	palmdelphin	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313763	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PALMD mRNA; bisphenol A affects the expression of PALMD protein	PMID:30903817|PMID:34186270
1305624	Palmd	palmdelphin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PALMD mRNA	PMID:25181051
1305624	Palmd	palmdelphin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PALMD mRNA	PMID:33221593
1305624	Palmd	palmdelphin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of PALMD mRNA	PMID:32145629
1305624	Palmd	palmdelphin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313764	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PALMD mRNA	PMID:32156529
1305624	Palmd	palmdelphin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PALMD mRNA	PMID:39298647
1305624	Palmd	palmdelphin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313763	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PALMD protein	PMID:34186270
1305624	Palmd	palmdelphin	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313764	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PALMD mRNA	PMID:26377693
1305624	Palmd	palmdelphin	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PALMD mRNA	PMID:27858113
1305624	Palmd	palmdelphin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313763	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PALMD protein	PMID:34186270
1305624	Palmd	palmdelphin	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313763	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PALMD protein	PMID:34186270
1305624	Palmd	palmdelphin	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of PALMD mRNA	PMID:21241498
1305624	Palmd	palmdelphin	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1305624	Palmd	palmdelphin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PALMD mRNA	PMID:21266533
1305624	Palmd	palmdelphin	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1305624	Palmd	palmdelphin	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1305624	Palmd	palmdelphin	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PALMD mRNA	PMID:28628672
1305624	Palmd	palmdelphin	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PALMD mRNA	PMID:12771043|PMID:17942915
1305624	Palmd	palmdelphin	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PALMD mRNA]	PMID:17942915
1305624	Palmd	palmdelphin	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of PALMD mRNA]	PMID:39241906
1305624	Palmd	palmdelphin	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of PALMD mRNA	PMID:30589522
1305624	Palmd	palmdelphin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PALMD mRNA	PMID:35163327
1305624	Palmd	palmdelphin	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313764	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PALMD mRNA	PMID:26377693
1305624	Palmd	palmdelphin	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1305624	Palmd	palmdelphin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PALMD mRNA	PMID:35163327
1305624	Palmd	palmdelphin	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PALMD mRNA	PMID:24386269
1305624	Palmd	palmdelphin	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PALMD mRNA	PMID:19320972
1305624	Palmd	palmdelphin	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of PALMD mRNA	PMID:25380136
1305624	Palmd	palmdelphin	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20250506	CTD	MESH:D005999	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PALMD mRNA	PMID:34589561
1305624	Palmd	palmdelphin	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313764	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of PALMD mRNA	PMID:28962523
1305624	Palmd	palmdelphin	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313764	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PALMD mRNA	PMID:18353800
1305624	Palmd	palmdelphin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313764	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PALMD mRNA	PMID:40194260
1305624	Palmd	palmdelphin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PALMD mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PALMD mRNA	PMID:36331819
1305624	Palmd	palmdelphin	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PALMD mRNA	PMID:29154799
1305624	Palmd	palmdelphin	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313763	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PALMD gene	PMID:29154799
1305624	Palmd	palmdelphin	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in increased expression of PALMD mRNA	PMID:38685447|PMID:41580965
1305624	Palmd	palmdelphin	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PALMD mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305624	Palmd	palmdelphin	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of PALMD mRNA	PMID:19770486
1305624	Palmd	palmdelphin	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PALMD mRNA	PMID:28628672
1305624	Palmd	palmdelphin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PALMD mRNA	PMID:28973697
1305624	Palmd	palmdelphin	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of PALMD mRNA	PMID:24136188
1305624	Palmd	palmdelphin	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PALMD mRNA	PMID:38832940
1305624	Palmd	palmdelphin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PALMD mRNA	PMID:17562736
1305624	Palmd	palmdelphin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PALMD mRNA	PMID:21420995
1305624	Palmd	palmdelphin	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PALMD mRNA	PMID:38460933
1305624	Palmd	palmdelphin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PALMD mRNA	PMID:32525701
1305624	Palmd	palmdelphin	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of PALMD mRNA	PMID:31838189
1305624	Palmd	palmdelphin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313763	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PALMD mRNA	PMID:26865667
1305624	Palmd	palmdelphin	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of PALMD mRNA	PMID:18936297
1305624	Palmd	palmdelphin	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PALMD mRNA	PMID:28628672
1305624	Palmd	palmdelphin	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PALMD mRNA	PMID:30307764
1305624	Palmd	palmdelphin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PALMD mRNA; Nanotubes, Carbon results in decreased expression of PALMD mRNA	PMID:25554681|PMID:25620056
1305624	Palmd	palmdelphin	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of PALMD mRNA	PMID:22504374
1305624	Palmd	palmdelphin	gene	CHEBI:50867	ciprofibrate	increases expression	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:C019304	ciprofibrate results in increased expression of PALMD mRNA	PMID:12771043
1305624	Palmd	palmdelphin	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PALMD mRNA	PMID:24136188
1305624	Palmd	palmdelphin	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313764	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of PALMD mRNA	PMID:26377693
1305624	Palmd	palmdelphin	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PALMD mRNA	PMID:27858113
1305624	Palmd	palmdelphin	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PALMD mRNA	PMID:27858113
1305624	Palmd	palmdelphin	gene	CHEBI:63598	levofloxacin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of PALMD mRNA	PMID:24136188
1305624	Palmd	palmdelphin	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of PALMD mRNA	PMID:25729387
1305624	Palmd	palmdelphin	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PALMD mRNA	PMID:23650126
1305624	Palmd	palmdelphin	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1313763	E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PALMD mRNA	PMID:20147733
1305624	Palmd	palmdelphin	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PALMD mRNA	PMID:36907384
1305624	Palmd	palmdelphin	gene	CHEBI:6651	malathion	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of PALMD mRNA	PMID:37047231
1305624	Palmd	palmdelphin	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PALMD mRNA	PMID:31758290
1305624	Palmd	palmdelphin	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313763	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PALMD protein	PMID:34186270
1305624	Palmd	palmdelphin	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PALMD mRNA	PMID:24136188
1305624	Palmd	palmdelphin	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313763	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PALMD protein	PMID:31285264
1305624	Palmd	palmdelphin	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PALMD mRNA	PMID:30851411
1305624	Palmd	palmdelphin	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1305624	Palmd	palmdelphin	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PALMD gene]	PMID:28238834
1305624	Palmd	palmdelphin	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313763	E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in decreased expression of PALMD protein	PMID:35881160
1305624	Palmd	palmdelphin	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in decreased expression of PALMD protein	PMID:35881160
1305624	Palmd	palmdelphin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313764	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PALMD mRNA	PMID:38648751
1305624	Palmd	palmdelphin	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313763	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PALMD mRNA	PMID:32525701
1305624	Palmd	palmdelphin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PALMD mRNA	PMID:22504374|PMID:24780913
1305624	Palmd	palmdelphin	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of PALMD mRNA]	PMID:39241906
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TMEM123 mRNA	PMID:33045310
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TMEM123 gene	PMID:20938992
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605596	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM123 mRNA	PMID:33167477
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20140311	CTD	MESH:D010100	[Oxygen deficiency co-treated with Glucose deficiency] affects the expression of TMEM123 mRNA	PMID:23637816
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM123 mRNA	PMID:36331819
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1605596	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TMEM123 mRNA	PMID:20044591
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313765	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TMEM123 mRNA	PMID:39241906
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313765	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TMEM123 mRNA	PMID:39298647
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of TMEM123 mRNA	PMID:33711761
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TMEM123 gene	PMID:20938992
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20140311	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] affects the expression of TMEM123 mRNA	PMID:23637816
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20140311	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] affects the expression of TMEM123 mRNA	PMID:23637816
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of TMEM123 mRNA	PMID:23892564
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TMEM123 mRNA	PMID:34319233
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313765	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMEM123 mRNA	PMID:33754040
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TMEM123 mRNA	PMID:26577399
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMEM123 mRNA	PMID:36331819
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM123 mRNA	PMID:28111341
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1605596	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TMEM123 protein	PMID:23301498
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:24527	herbicide	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in decreased expression of TMEM123 mRNA	PMID:28711546
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TMEM123 mRNA	PMID:23649840
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of TMEM123 mRNA	PMID:19483382
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM123 mRNA	PMID:31150632
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM123 mRNA	PMID:31919559
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TMEM123 mRNA	PMID:25629700
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TMEM123 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TMEM123 gene	PMID:20938992|PMID:22206623
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM123 mRNA	PMID:40504410
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TMEM123 mRNA	PMID:28960355
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TMEM123 mRNA	PMID:27392435
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM123 mRNA	PMID:33387578|PMID:34747641
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM123 mRNA	PMID:33956508
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1605596	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM123 mRNA	PMID:20106945|PMID:21632981|PMID:23152189|PMID:26238291
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TMEM123 mRNA	PMID:33212167
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMEM123 mRNA	PMID:38568856
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1313765	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased methylation of TMEM123 gene	PMID:32068019
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM123 mRNA	PMID:40504410
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMEM123 mRNA	PMID:19770486
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605596	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TMEM123 mRNA	PMID:20064835
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of TMEM123 mRNA	PMID:19483382
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TMEM123 mRNA	PMID:19073995
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of TMEM123 mRNA	PMID:24395379
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605596	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TMEM123 gene	PMID:31601247
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TMEM123 mRNA	PMID:30047161
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313765	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TMEM123 promoter	PMID:35295148
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of TMEM123 mRNA	PMID:19483382
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TMEM123 mRNA	PMID:34492290
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of TMEM123 mRNA	PMID:19483382
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TMEM123 mRNA	PMID:25181051
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1605596	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TMEM123 mRNA	PMID:30903817
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM123 mRNA	PMID:34947998
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM123 mRNA	PMID:33221593
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605596	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TMEM123 gene	PMID:31601247
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of TMEM123 mRNA	PMID:27914987
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313765	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TMEM123 mRNA	PMID:26682919
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313765	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TMEM123 mRNA	PMID:39298647
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313765	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TMEM123 mRNA	PMID:38685157
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of TMEM123 mRNA	PMID:21241498
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313765	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TMEM123 mRNA	PMID:28392331
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313765	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TMEM123 mRNA	PMID:37019170
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313765	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TMEM123 mRNA	PMID:21266533
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313765	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of TMEM123 protein	PMID:39748354
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMEM123 mRNA	PMID:38568856
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM123 mRNA	PMID:28111341
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TMEM123 mRNA	PMID:27387713
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TMEM123 mRNA	PMID:19320972
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TMEM123 mRNA	PMID:24449571
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of TMEM123 mRNA	PMID:19483382
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TMEM123 mRNA	PMID:28302478
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1605596	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TMEM123 mRNA	PMID:31533062
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of TMEM123 mRNA	PMID:26352163
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TMEM123 mRNA	PMID:27153767|PMID:40419075
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMEM123 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM123 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TMEM123 mRNA	PMID:36331819
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TMEM123 mRNA	PMID:30047161
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605596	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TMEM123 mRNA	PMID:20106945
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20140311	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] affects the expression of TMEM123 mRNA	PMID:23637816
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM123 mRNA	PMID:33387578
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM123 mRNA	PMID:40504410
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TMEM123 mRNA	PMID:29391264
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of TMEM123 mRNA	PMID:19483382
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TMEM123 mRNA	PMID:30047161
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TMEM123 mRNA	PMID:35964746
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TMEM123 mRNA	PMID:23650126
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of TMEM123 mRNA	PMID:19564919
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of TMEM123 mRNA	PMID:19564919
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of TMEM123 mRNA	PMID:19564919
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313765	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TMEM123 mRNA	PMID:22206623
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313765	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TMEM123 mRNA	PMID:22206623
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of TMEM123 mRNA	PMID:19483382
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of TMEM123 mRNA	PMID:19483382
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1605596	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TMEM123 gene]	PMID:28238834
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of TMEM123 mRNA	PMID:18927307
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313765	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TMEM123 mRNA	PMID:23091169
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of TMEM123 mRNA	PMID:19483382
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TMEM123 mRNA	PMID:30047161
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in decreased expression of TMEM123 mRNA	PMID:26141394
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1605596	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TMEM123 mRNA	PMID:38568856
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1605596	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of TMEM123 mRNA	PMID:29301935
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313765	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TMEM123 mRNA	PMID:35537566
1305625	Tmem123	transmembrane protein 123	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of TMEM123 mRNA	PMID:19015723
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313766	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TAF11 mRNA	PMID:20044591
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313766	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TAF11 mRNA	PMID:20655997
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313766	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TAF11 mRNA	PMID:19549813
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TAF11 mRNA	PMID:22206623
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF11 mRNA	PMID:40504410
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313766	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TAF11 mRNA	PMID:23557933
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313767	E	RGD:6480464	20140805	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAF11 mRNA	PMID:21570461
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313766	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TAF11 mRNA	PMID:30851411
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313766	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TAF11 mRNA	PMID:32763439
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF11 mRNA	PMID:40504410
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313767	E	RGD:6480464	20140805	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF11 mRNA	PMID:22228805
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:3016	Benoxacor	increases expression	ISO	RGD:1313767	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in increased expression of TAF11 mRNA	PMID:34850242
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313767	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TAF11 mRNA	PMID:29264374
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20140805	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TAF11 mRNA	PMID:19710929
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313766	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF11 mRNA	PMID:29275510
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313767	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF11 mRNA	PMID:29161229
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TAF11 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313766	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF11 mRNA	PMID:28628672
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313767	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TAF11 mRNA	PMID:37019170
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313766	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF11 mRNA	PMID:28628672
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1313766	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of TAF11 mRNA	PMID:17312168
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313767	E	RGD:6480464	20140805	CTD	MESH:D014635	Valproic Acid affects the expression of TAF11 mRNA	PMID:17292431
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313766	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TAF11 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313766	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TAF11 mRNA	PMID:25562108
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313766	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF11 mRNA	PMID:28628672
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313766	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TAF11 mRNA	PMID:21420995
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF11 mRNA	PMID:40504410
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313766	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF11 mRNA	PMID:28628672
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313767	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TAF11 mRNA	PMID:22206623
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TAF11 mRNA	PMID:22206623
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313766	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TAF11 mRNA	PMID:30851411
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313766	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TAF11 gene]	PMID:28238834
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:9130	sevoflurane	decreases methylation	ISO	RGD:1313767	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased methylation of TAF11 mRNA	PMID:35249202
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TAF11 mRNA	PMID:19281266
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TAF11 mRNA	PMID:19281266
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TAF11 mRNA	PMID:21346803
1305626	Taf11	TATA-box binding protein associated factor 11	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TAF11 mRNA	PMID:23034163
1305627	Rd3l	RD3 like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RD3L mRNA	PMID:29945229
1305627	Rd3l	RD3 like	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RD3L mRNA	PMID:26577399
1305627	Rd3l	RD3 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RD3L mRNA	PMID:32109520
1305627	Rd3l	RD3 like	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:5683670	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of RD3L gene	PMID:31601247
1305627	Rd3l	RD3 like	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RD3L mRNA	PMID:25181051
1305627	Rd3l	RD3 like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of RD3L mRNA	PMID:30816183|PMID:32528016|PMID:36779543
1305627	Rd3l	RD3 like	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RD3L gene	PMID:28505145
1305627	Rd3l	RD3 like	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of RD3L mRNA	PMID:30307764
1305627	Rd3l	RD3 like	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin results in decreased expression of RD3L mRNA	PMID:31324951
1305627	Rd3l	RD3 like	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of RD3L mRNA	PMID:33484710
1305627	Rd3l	RD3 like	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RD3L mRNA	PMID:32109520
1305627	Rd3l	RD3 like	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RD3L mRNA	PMID:27291303
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CRYBG3 mRNA	PMID:27188386
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CRYBG3 mRNA]	PMID:31150632
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:2301266	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CRYBG3 mRNA	PMID:23724009
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CRYBG3 mRNA	PMID:26079696
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313769	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of CRYBG3 mRNA	PMID:40945087
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313769	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of CRYBG3 mRNA	PMID:39298647
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313769	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CRYBG3 mRNA	PMID:25510870
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:2301266	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CRYBG3 mRNA	PMID:37042841
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313769	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of CRYBG3 mRNA	PMID:22238285
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313769	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CRYBG3 mRNA	PMID:37992649
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313769	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CRYBG3 mRNA	PMID:37992649
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:2301266	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CRYBG3 protein	PMID:37730182
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:2301266	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CRYBG3 mRNA	PMID:16002434
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:2301266	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CRYBG3 mRNA	PMID:28818685
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:2301266	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CRYBG3 mRNA	PMID:35301059
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313769	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CRYBG3 mRNA	PMID:25510870
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313769	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CRYBG3 mRNA	PMID:25510870
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CRYBG3 mRNA	PMID:19549813
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CRYBG3 mRNA	PMID:23649840
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CRYBG3 mRNA	PMID:30779732
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CRYBG3 mRNA	PMID:31150632
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CRYBG3 mRNA]	PMID:31150632
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CRYBG3 mRNA	PMID:21867686
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:2301266	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CRYBG3 protein	PMID:35688186
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:2301266	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CRYBG3 mRNA	PMID:23557933
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CRYBG3 mRNA	PMID:22298810
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313769	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CRYBG3 mRNA	PMID:21570461
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CRYBG3 mRNA	PMID:33387578
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CRYBG3 mRNA	PMID:32109520
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313769	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CRYBG3 mRNA	PMID:25975270
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CRYBG3 mRNA	PMID:33212167
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CRYBG3 mRNA	PMID:30851411
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CRYBG3 mRNA	PMID:28959563
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313769	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CRYBG3 mRNA	PMID:27862939
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313769	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CRYBG3 protein	PMID:28918527
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313769	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CRYBG3 mRNA	PMID:37992649
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:2301266	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of CRYBG3 protein	PMID:35688186
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313769	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CRYBG3 intron	PMID:27901495
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313769	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CRYBG3 mRNA	PMID:22228805
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313769	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CRYBG3 exon	PMID:27901495
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313769	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CRYBG3 mRNA	PMID:29264374
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CRYBG3 mRNA	PMID:23411599|PMID:34492290
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CRYBG3 mRNA	PMID:25181051
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313769	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CRYBG3 mRNA	PMID:25510870
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313769	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CRYBG3 mRNA	PMID:25510870
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313769	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CRYBG3 gene	PMID:31683443
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313769	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CRYBG3 mRNA	PMID:39298647
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313769	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CRYBG3 mRNA	PMID:37019170
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:2301266	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CRYBG3 mRNA	PMID:37042841
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CRYBG3 mRNA	PMID:30589522
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:2301266	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CRYBG3 mRNA	PMID:29024780
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CRYBG3 mRNA	PMID:33453195
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:2301266	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CRYBG3 mRNA	PMID:35301059
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of CRYBG3 mRNA	PMID:26194646
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CRYBG3 mRNA	PMID:27153767
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:2301266	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CRYBG3 mRNA	PMID:25979313
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CRYBG3 mRNA	PMID:23179753|PMID:27188386
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313769	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of CRYBG3 mRNA	PMID:24896083
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313769	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CRYBG3 mRNA	PMID:37992649
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:2301266	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CRYBG3 mRNA	PMID:38832940
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CRYBG3 mRNA	PMID:33387578
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:2301266	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of CRYBG3 mRNA	PMID:26690555
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313769	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CRYBG3 mRNA	PMID:35436446
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313769	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CRYBG3 mRNA	PMID:25554681
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313769	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CRYBG3 mRNA	PMID:25620056
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of CRYBG3 mRNA	PMID:22714537
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:2301266	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CRYBG3 mRNA	PMID:30851411
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313769	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CRYBG3 mRNA	PMID:23091169
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CRYBG3 mRNA	PMID:32109520
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313769	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CRYBG3 mRNA	PMID:31388691
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313769	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of CRYBG3 mRNA	PMID:21795629
1305628	Crybg3	crystallin beta-gamma domain containing 3	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313769	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of CRYBG3 protein	PMID:24648495
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CTDSP1 mRNA	PMID:33045310
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CTDSP1 mRNA]	PMID:31150632
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein]	PMID:38195004
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTDSP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CTDSP1 mRNA	PMID:32699268
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CTDSP1 mRNA	PMID:30529165
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CTDSP1 mRNA	PMID:26079696
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313771	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CTDSP1 mRNA	PMID:30319688
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313770	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CTDSP1 mRNA	PMID:37042841
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CTDSP1 mRNA	PMID:26079696
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CTDSP1 mRNA	PMID:34319233
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CTDSP1 mRNA	PMID:26577399
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CTDSP1 mRNA	PMID:33387578
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CTDSP1 mRNA	PMID:22061828
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CTDSP1 mRNA	PMID:36331819
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA	PMID:39836092
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein	PMID:38195004
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CTDSP1 mRNA	PMID:19549813
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CTDSP1 mRNA	PMID:23649840
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of CTDSP1 mRNA	PMID:19376150
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CTDSP1 mRNA	PMID:27153756
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CTDSP1 mRNA	PMID:23649840
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of CTDSP1 mRNA	PMID:28652203
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTDSP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CTDSP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CTDSP1 mRNA	PMID:32699268
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CTDSP1 mRNA	PMID:31150632
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CTDSP1 mRNA	PMID:31919559
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CTDSP1 mRNA]	PMID:31150632
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTDSP1 mRNA	PMID:22206623
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CTDSP1 mRNA	PMID:39836092|PMID:40512198
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CTDSP1 mRNA	PMID:26272509
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA	PMID:27188386
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in decreased expression of CTDSP1 mRNA	PMID:37386098
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:27899	cisplatin	decreases response to substance	ISO	RGD:1313770	E	RGD:6480464	20120412	CTD	MESH:D002945	CTDSP1 protein results in decreased susceptibility to Cisplatin	PMID:16734730
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313771	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CTDSP1 mRNA	PMID:21570461
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CTDSP1 mRNA	PMID:21215274
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CTDSP1 mRNA	PMID:28001369
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CTDSP1 mRNA	PMID:33212167
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of CTDSP1 mRNA	PMID:26272509
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA	PMID:27188386
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CTDSP1 mRNA	PMID:28959563
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CTDSP1 mRNA	PMID:32763439
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CTDSP1 mRNA	PMID:21281968|PMID:38568856
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313770	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CTDSP1 mRNA	PMID:39719251
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CTDSP1 mRNA	PMID:39836092|PMID:40512198
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313770	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CTDSP1 promoter	PMID:27901495
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of CTDSP1 protein	PMID:37955338
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of CTDSP1 mRNA	PMID:26014281
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CTDSP1 mRNA	PMID:26705709
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of CTDSP1 mRNA	PMID:35984750
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CTDSP1 mRNA	PMID:34492290
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CTDSP1 mRNA	PMID:25181051
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CTDSP1 mRNA	PMID:34947998
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313771	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CTDSP1 mRNA	PMID:32156529|PMID:33221593
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313771	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CTDSP1 gene	PMID:31683443
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CTDSP1 mRNA	PMID:39298647
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313771	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CTDSP1 mRNA	PMID:37019170
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of CTDSP1 mRNA	PMID:17602206
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313770	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CTDSP1 gene	PMID:22964155
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313771	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of CTDSP1 mRNA	PMID:34813904
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1313771	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of CTDSP1 mRNA	PMID:34813904
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313770	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CTDSP1 mRNA	PMID:37042841
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA	PMID:39836092
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CTDSP1 mRNA	PMID:38174414
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CTDSP1 promoter	PMID:22457795
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein	PMID:38195004
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CTDSP1 mRNA	PMID:19376846
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTDSP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CTDSP1 mRNA	PMID:32699268
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313770	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CTDSP1 mRNA	PMID:31533062
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CTDSP1 mRNA	PMID:36331819
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CTDSP1 mRNA	PMID:29154799
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313770	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CTDSP1 gene	PMID:29154799
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CTDSP1 mRNA	PMID:25562108
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of CTDSP1 mRNA]	PMID:21233418
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CTDSP1 mRNA	PMID:38832940
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of CTDSP1 mRNA	PMID:22083351
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313770	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CTDSP1 mRNA	PMID:28542535
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313771	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CTDSP1 mRNA	PMID:17562736
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTDSP1 mRNA	PMID:33387578
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTDSP1 mRNA	PMID:21420995
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CTDSP1 mRNA	PMID:39836092|PMID:40512198
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CTDSP1 mRNA	PMID:30529165
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313771	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CTDSP1 mRNA	PMID:35436446
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of CTDSP1 mRNA	PMID:26272509
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA	PMID:27188386
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CTDSP1 mRNA	PMID:26705709
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CTDSP1 mRNA	PMID:35964746
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CTDSP1 mRNA	PMID:24136188
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA	PMID:39836092
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTDSP1 mRNA	PMID:22206623
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA	PMID:27188386
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CTDSP1 mRNA	PMID:19162173
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of CTDSP1 mRNA	PMID:39904859
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313770	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA	PMID:27188386
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of CTDSP1 mRNA	PMID:26014281
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313770	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CTDSP1 mRNA	PMID:38568856
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CTDSP1 mRNA	PMID:28973697
1305629	Ctdsp1	CTD small phosphatase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CTDSP1 mRNA	PMID:35537566
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313772	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ELOVL4 mRNA	PMID:26079696
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313772	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ELOVL4 mRNA	PMID:30510588
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313773	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of ELOVL4 mRNA	PMID:19484750
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ELOVL4 mRNA	PMID:33387578
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313772	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ELOVL4 mRNA	PMID:26079696
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313772	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ELOVL4 mRNA	PMID:31256213
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313772	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ELOVL4 mRNA	PMID:28818685
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1313772	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of ELOVL4 mRNA	PMID:19549813
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ELOVL4 mRNA	PMID:25629700
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313772	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ELOVL4 mRNA	PMID:32525701
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313773	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELOVL4 mRNA	PMID:40504410
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313773	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of ELOVL4 mRNA	PMID:23625948
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELOVL4 mRNA	PMID:33387578
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313772	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELOVL4 mRNA	PMID:23152189
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313772	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELOVL4 mRNA	PMID:35954277
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELOVL4 mRNA	PMID:36209798
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313772	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ELOVL4 mRNA	PMID:22714537|PMID:38568856
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313773	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELOVL4 mRNA	PMID:40504410
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313772	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ELOVL4 promoter	PMID:27901495
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ELOVL4 mRNA	PMID:27131904
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313772	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ELOVL4 mRNA; Silicon Dioxide results in increased expression of ELOVL4 mRNA	PMID:23806026|PMID:25351596|PMID:25895662
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313773	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ELOVL4 gene	PMID:35295148
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313773	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ELOVL4 gene	PMID:35295148
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ELOVL4 mRNA	PMID:25181051|PMID:41034487
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ELOVL4 mRNA	PMID:32156529|PMID:34585602
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313772	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ELOVL4 gene	PMID:31601247
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ELOVL4 mRNA	PMID:34947998
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ELOVL4 mRNA	PMID:26377693
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313773	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ELOVL4 mRNA	PMID:37019170
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1313772	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of ELOVL4 mRNA	PMID:37047231
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ELOVL4 mRNA	PMID:35163327
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313772	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ELOVL4 mRNA	PMID:38382870
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313772	E	RGD:6480464	20240109	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ELOVL4 mRNA	PMID:37738295
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ELOVL4 mRNA	PMID:35163327
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ELOVL4 mRNA	PMID:40194260
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313772	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ELOVL4 mRNA	PMID:31533062
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313772	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ELOVL4 mRNA	PMID:25979313
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313772	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ELOVL4 mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313772	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ELOVL4 mRNA	PMID:24935251|PMID:26272509
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313772	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ELOVL4 mRNA	PMID:27188386
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ELOVL4 mRNA	PMID:33387578
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313772	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ELOVL4 mRNA	PMID:32525701
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313773	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELOVL4 mRNA	PMID:40504410
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ELOVL4 mRNA	PMID:30307764
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313772	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of ELOVL4 mRNA	PMID:31629900
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1313772	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of ELOVL4 mRNA	PMID:20436886
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313772	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ELOVL4 mRNA	PMID:31758290
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313772	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ELOVL4 mRNA	PMID:22714537
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313772	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ELOVL4 mRNA	PMID:27188386
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313772	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ELOVL4 gene]	PMID:28238834
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:81980	triticonazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in increased expression of ELOVL4 mRNA	PMID:36084822
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:8228	pioglitazone	increases expression	ISO	RGD:1313772	E	RGD:6480464	20181113	CTD	MESH:C060836	Pioglitazone results in increased expression of ELOVL4 mRNA	PMID:30031879
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313772	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ELOVL4 mRNA	PMID:26079696
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313772	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ELOVL4 mRNA	PMID:32525701
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313772	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ELOVL4 mRNA	PMID:27188386
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ELOVL4 mRNA	PMID:27131904
1305630	Elovl4	ELOVL fatty acid elongase 4	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313772	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ELOVL4 mRNA	PMID:38568856
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1604553	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of COX19 mRNA	PMID:31016361
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of COX19 mRNA	PMID:30071829
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1604553	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of COX19 mRNA	PMID:26079696
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1604553	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of COX19 mRNA	PMID:21632981
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313774	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of COX19 mRNA	PMID:39241906
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313774	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of COX19 mRNA	PMID:39298647
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1604553	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of COX19 mRNA	PMID:21179406
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313774	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of COX19 mRNA	PMID:35550907
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1604553	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of COX19 mRNA	PMID:28818685
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313774	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COX19 mRNA	PMID:36331819
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313774	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of COX19 mRNA	PMID:27462272
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1604553	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of COX19 mRNA	PMID:23649840
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1604553	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of COX19 mRNA	PMID:23649840
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313774	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COX19 mRNA	PMID:22206623
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313774	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COX19 mRNA	PMID:40504410
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604553	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of COX19 mRNA	PMID:23557933
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:27902	tetracycline	decreases expression	ISO	RGD:1313774	E	RGD:6480464	20150127	CTD	MESH:D013752	Tetracycline results in decreased expression of COX19 mRNA	PMID:24489787
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313774	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COX19 mRNA	PMID:21570461
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COX19 mRNA	PMID:33387578
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COX19 mRNA	PMID:32109520
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313774	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COX19 mRNA	PMID:18796159|PMID:25975270|PMID:26290441
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313774	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of COX19 mRNA	PMID:16214954
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1604553	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of COX19 mRNA	PMID:29955902
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1604553	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of COX19 mRNA	PMID:28001369
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604553	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of COX19 mRNA	PMID:20971185
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1604553	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COX19 mRNA	PMID:29432896
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313774	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of COX19 mRNA	PMID:20883709
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604553	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COX19 mRNA	PMID:38568856|PMID:39719251
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313774	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COX19 mRNA	PMID:40504410
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1604553	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of COX19 mRNA	PMID:29453283
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604553	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of COX19 promoter	PMID:27901495
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313774	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COX19 promoter	PMID:27901495
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604553	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COX19 3' UTR	PMID:27901495
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604553	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of COX19 mRNA	PMID:20971185
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1604553	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of COX19 mRNA	PMID:19150397
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313774	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of COX19 promoter alternative form	PMID:35295148
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313774	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of COX19 mRNA	PMID:23811191
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COX19 mRNA	PMID:25181051|PMID:30816183
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313774	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of COX19 mRNA	PMID:39298647
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313774	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of COX19 mRNA	PMID:38685157
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313774	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of COX19 intron	PMID:28392331
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604553	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COX19 mRNA	PMID:37042841
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313774	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of COX19 mRNA	PMID:20883709
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1604553	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COX19 mRNA	PMID:38568856
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1604553	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of COX19 mRNA	PMID:32588087
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313774	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COX19 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of COX19 mRNA	PMID:36331819
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604553	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of COX19 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1604553	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COX19 mRNA	PMID:27188386
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of COX19 mRNA	PMID:24136188
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1604553	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of COX19 mRNA	PMID:27188386
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of COX19 mRNA	PMID:33387578
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313774	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COX19 mRNA	PMID:40504410
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313774	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of COX19 mRNA	PMID:25554681
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of COX19 mRNA	PMID:24136188
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of COX19 mRNA	PMID:24136188
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of COX19 mRNA	PMID:24136188
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313774	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of COX19 mRNA	PMID:22206623
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313774	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COX19 mRNA	PMID:22206623
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of COX19 mRNA	PMID:24136188
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1604553	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of COX19 protein	PMID:39638853
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604553	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COX19 mRNA	PMID:27188386
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1604553	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of COX19 mRNA	PMID:31734321
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604553	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COX19 mRNA	PMID:27188386
1305631	Cox19	cytochrome c oxidase assembly factor COX19	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1604553	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in increased expression of COX19 mRNA	PMID:31863870
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of ASH2L mRNA	PMID:21551480
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313776	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ASH2L mRNA	PMID:33045310
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASH2L gene	PMID:20938992
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ASH2L mRNA	PMID:36331819
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313775	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of ASH2L mRNA; Ethanol results in increased expression of ASH2L protein	PMID:28986285|PMID:35149083
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ASH2L gene	PMID:27618143
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASH2L gene	PMID:20938992
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313775	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ASH2L mRNA	PMID:37042841
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313775	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ASH2L protein	PMID:37730182
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ASH2L mRNA	PMID:22061828
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ASH2L mRNA	PMID:19549813
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313775	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ASH2L protein	PMID:23301498
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313775	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ASH2L mRNA	PMID:23649840
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ASH2L mRNA	PMID:21867686
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASH2L gene	PMID:20938992
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313775	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASH2L mRNA	PMID:39836092
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313775	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ASH2L mRNA	PMID:27594783
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of ASH2L gene	PMID:28505145
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313776	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASH2L mRNA	PMID:21570461
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASH2L mRNA	PMID:33387578
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASH2L mRNA	PMID:17942748
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ASH2L protein	PMID:39603559
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ASH2L mRNA	PMID:28001369
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ASH2L mRNA	PMID:29803840
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:29323	methylazoxymethanol	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:C030667	methylazoxymethanol results in decreased expression of ASH2L protein	PMID:23932495
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ASH2L mRNA	PMID:38568856
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313775	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASH2L mRNA	PMID:39836092
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313775	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ASH2L intron	PMID:30157460
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313776	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ASH2L mRNA	PMID:23557971
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ASH2L mRNA	PMID:23411599
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313776	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ASH2L promoter	PMID:27334623
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ASH2L mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ASH2L protein	PMID:31675489
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ASH2L mRNA	PMID:25181051
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ASH2L gene	PMID:28505145
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of ASH2L gene	PMID:28505145
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ASH2L protein	PMID:31675489
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313775	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of ASH2L mRNA	PMID:24752500
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313776	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ASH2L mRNA	PMID:39298647
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313776	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ASH2L mRNA	PMID:37019170
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ASH2L promoter	PMID:22457795
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:38518	benzophenanthridine	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20170117	CTD	MESH:D053119	Benzophenanthridines analog results in decreased expression of ASH2L mRNA	PMID:23117580
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313776	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ASH2L protein	PMID:26178269
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ASH2L mRNA	PMID:36331819
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313775	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ASH2L mRNA	PMID:25979313
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ASH2L mRNA	PMID:25562108
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:4356	desferrioxamine B	affects expression	ISO	RGD:1313775	E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine affects the expression of ASH2L mRNA	PMID:23483119
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:4356	desferrioxamine B	increases expression	ISO	RGD:1313775	E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine results in increased expression of ASH2L mRNA	PMID:23483119
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313776	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ASH2L mRNA	PMID:17562736
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ASH2L mRNA	PMID:33387578
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313775	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASH2L mRNA	PMID:39836092
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1313775	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of ASH2L mRNA	PMID:24752500
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of ASH2L mRNA	PMID:31675489
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313775	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ASH2L mRNA	PMID:22079256
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASH2L mRNA	PMID:17942748
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ASH2L mRNA	PMID:24136188
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ASH2L mRNA	PMID:24136188
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313776	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ASH2L mRNA	PMID:19042947
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ASH2L mRNA	PMID:30467583
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313776	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ASH2L mRNA	PMID:22206623
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ASH2L mRNA	PMID:22079256
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313775	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ASH2L mRNA	PMID:22079256
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ASH2L mRNA	PMID:21346803
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ASH2L protein	PMID:31675489
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1313775	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ASH2L protein	PMID:31675489
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ASH2L mRNA	PMID:21346803
1305632	Ash2l	ASH2 like histone lysine methyltransferase complex subunit	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ASH2L mRNA	PMID:21346803
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313777	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of RRP1B protein	PMID:39638853
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of RRP1B mRNA	PMID:25152437
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313777	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RRP1B mRNA	PMID:23724009|PMID:33167477
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	ISO	RGD:1313777	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of RRP1B protein	PMID:28073184
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of RRP1B mRNA	PMID:19484750
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313777	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of RRP1B mRNA	PMID:23019147|PMID:31614463
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313778	E	RGD:6480464	20150609	CTD	MESH:D004958	Estradiol results in increased expression of RRP1B mRNA	PMID:25575267
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313777	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RRP1B mRNA	PMID:38568856
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313777	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RRP1B mRNA	PMID:37042841
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313778	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RRP1B mRNA	PMID:23892564
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RRP1B mRNA	PMID:26577399
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313777	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RRP1B protein	PMID:37730182
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RRP1B mRNA	PMID:33387578
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313778	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RRP1B mRNA	PMID:28111341
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313777	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RRP1B mRNA	PMID:19549813
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313777	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RRP1B protein	PMID:23301498
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313777	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RRP1B gene	PMID:27153756
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313778	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RRP1B mRNA	PMID:19770486
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313777	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RRP1B mRNA	PMID:23649840
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313778	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RRP1B mRNA	PMID:34911549
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RRP1B mRNA	PMID:30779732
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RRP1B mRNA	PMID:25629700
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1313777	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of RRP1B mRNA	PMID:33512557
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313777	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RRP1B protein	PMID:35688186
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RRP1B protein	PMID:25505154
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313777	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RRP1B mRNA	PMID:23557933
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:27974	estriol	increases expression	ISO	RGD:1313778	E	RGD:6480464	20150609	CTD	MESH:D004964	Estriol results in increased expression of RRP1B mRNA	PMID:25575267
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313778	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RRP1B mRNA	PMID:21570461
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RRP1B mRNA	PMID:21889950
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313778	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RRP1B mRNA	PMID:16611356|PMID:23994337
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313777	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of RRP1B mRNA	PMID:33512557
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RRP1B mRNA	PMID:28959563
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313777	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RRP1B mRNA	PMID:29803840
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1313777	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of RRP1B protein	PMID:35688186
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:29014	cordycepin	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in decreased expression of RRP1B mRNA	PMID:32042022
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313777	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RRP1B mRNA	PMID:38568856
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313777	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of RRP1B mRNA	PMID:34032870
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313777	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [RRP1B protein binds to CAPRIN1 protein]	PMID:33939924
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313777	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RRP1B mRNA	PMID:22316170|PMID:26238291
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313777	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RRP1B promoter	PMID:27901495
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313777	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RRP1B mRNA	PMID:19150397
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RRP1B mRNA	PMID:30047161
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313778	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RRP1B gene	PMID:35295148
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RRP1B mRNA	PMID:23411599|PMID:34492290
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of RRP1B mRNA	PMID:23811191
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313778	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RRP1B mRNA	PMID:19710929
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313778	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RRP1B mRNA	PMID:28472532
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RRP1B mRNA	PMID:25181051|PMID:30816183
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RRP1B mRNA	PMID:34947998
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313777	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of RRP1B mRNA	PMID:25912373
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313778	E	RGD:6480464	20150609	CTD	MESH:C006780	bisphenol A results in increased expression of RRP1B mRNA	PMID:25575267
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	increases expression	ISO	RGD:1313778	E	RGD:6480464	20150609	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of RRP1B mRNA	PMID:25575267
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1313778	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RRP1B mRNA	PMID:23994337
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313777	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RRP1B intron	PMID:30157460
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RRP1B mRNA	PMID:38685157
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313778	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of RRP1B enhancer	PMID:28392331
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313778	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RRP1B mRNA	PMID:37019170
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313778	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of RRP1B mRNA	PMID:34813904
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313778	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of RRP1B mRNA	PMID:34813904
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of RRP1B mRNA	PMID:30589522
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313778	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RRP1B mRNA	PMID:28111341
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313778	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of RRP1B mRNA	PMID:28903501
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313777	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RRP1B mRNA	PMID:19320972
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313777	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of RRP1B mRNA	PMID:28302478
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of RRP1B mRNA	PMID:19136453
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313777	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RRP1B gene	PMID:29154799
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313777	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RRP1B mRNA	PMID:23179753
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RRP1B mRNA	PMID:30047161
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313778	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RRP1B mRNA	PMID:17555576
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313778	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of RRP1B mRNA	PMID:22733784
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313778	E	RGD:6480464	20150609	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RRP1B mRNA	PMID:25575267
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1313777	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of RRP1B mRNA	PMID:33512557
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313778	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RRP1B mRNA	PMID:17562736
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1313778	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of RRP1B mRNA	PMID:35436446
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313778	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RRP1B mRNA	PMID:17555576
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RRP1B mRNA	PMID:30047161
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of RRP1B mRNA	PMID:24793618
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RRP1B mRNA	PMID:24136188
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313778	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RRP1B mRNA	PMID:19042947
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313777	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RRP1B protein	PMID:32959892
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of RRP1B mRNA	PMID:20080153
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313777	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RRP1B intron	PMID:30157460
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008701	Methapyrilene results in increased expression of RRP1B mRNA	PMID:22484513
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313778	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of RRP1B mRNA	PMID:22206623
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313777	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RRP1B protein	PMID:37664457
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313778	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of RRP1B mRNA	PMID:23994337
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of RRP1B mRNA	PMID:23914054
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RRP1B mRNA	PMID:30047161
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313777	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RRP1B protein	PMID:37664457
1305633	Rrp1b	ribosomal RNA processing 1B	gene	CHEBI:9422	tebufenpyrad	increases expression	ISO	RGD:1313777	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of RRP1B mRNA	PMID:33512557
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313779	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of DDX27 protein	PMID:39638853
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX27 mRNA]	PMID:31150632
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX27 mRNA	PMID:30529165
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313779	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DDX27 mRNA	PMID:22378314
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313780	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of DDX27 mRNA	PMID:30319688
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313780	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DDX27 mRNA	PMID:30319688
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313780	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DDX27 mRNA	PMID:39241906
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DDX27 mRNA]	PMID:39241906
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313779	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DDX27 mRNA	PMID:19698761
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313779	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of DDX27 mRNA	PMID:20823114
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313779	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DDX27 mRNA	PMID:37042841
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1313779	E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of DDX27 protein	PMID:39638853
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DDX27 mRNA	PMID:27106289
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX27 mRNA	PMID:31150632
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313780	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX27 mRNA	PMID:27339419|PMID:31919559
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX27 mRNA]	PMID:31150632
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313779	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DDX27 gene	PMID:25304211
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX27 mRNA	PMID:40504410
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DDX27 protein	PMID:25505154
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313779	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DDX27 mRNA	PMID:23557933
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of DDX27 mRNA	PMID:30912803
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313780	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDX27 mRNA	PMID:21570461
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of DDX27 mRNA	PMID:19013527
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313779	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DDX27 mRNA	PMID:29803840
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313780	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of DDX27 mRNA	PMID:39631538
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of DDX27 protein	PMID:29044176
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX27 mRNA	PMID:40504410
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313779	E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DDX27 protein	PMID:33278487
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DDX27 mRNA	PMID:23411599|PMID:34492290
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313780	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DDX27 mRNA	PMID:28472532
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DDX27 mRNA	PMID:25181051
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313779	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DDX27 mRNA	PMID:30903817
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313779	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX27 protein	PMID:37567409
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX27 mRNA	PMID:33221593
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DDX27 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313780	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DDX27 mRNA	PMID:39298647
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DDX27 mRNA	PMID:37019170
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DDX27 mRNA	PMID:21266533
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of DDX27 mRNA	PMID:32680482
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DDX27 mRNA]	PMID:39241906
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in decreased expression of DDX27 mRNA]	PMID:19030233
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313780	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DDX27 mRNA	PMID:28903501
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of DDX27 mRNA	PMID:36331819
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of DDX27 mRNA	PMID:25993096
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313779	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of DDX27 mRNA	PMID:17183730
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313779	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DDX27 mRNA	PMID:20106945|PMID:25562108
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313780	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of DDX27 mRNA	PMID:18502557
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1313779	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of DDX27 mRNA	PMID:19698761
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313780	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DDX27 mRNA	PMID:17562736
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313779	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DDX27 gene	PMID:25304211
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX27 mRNA	PMID:40504410
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DDX27 mRNA	PMID:29097150
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313780	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DDX27 mRNA	PMID:17942748
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1313779	E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of DDX27 mRNA	PMID:20823114
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DDX27 mRNA	PMID:35964746
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DDX27 mRNA	PMID:24136188
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:5613	haloperidol	increases expression	ISO	RGD:1313779	E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in increased expression of DDX27 protein	PMID:34122009
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313779	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of DDX27 mRNA	PMID:17183730
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313779	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DDX27 protein	PMID:32959892
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DDX27 mRNA	PMID:23650126
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1313779	E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of DDX27 mRNA	PMID:20823114
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of DDX27 mRNA	PMID:28444820
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313779	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DDX27 protein	PMID:37664457
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1313779	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of DDX27 protein	PMID:39638853
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1313779	E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of DDX27 protein	PMID:39638853
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DDX27 mRNA]	PMID:39241906
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of DDX27 mRNA	PMID:40826991
1305634	Ddx27	DEAD-box helicase 27	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313779	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DDX27 protein	PMID:37664457
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313782	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of IL1F10 mRNA	PMID:22968694
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313781	E	RGD:6480464	20161228	CTD	MESH:D008070	Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of IL1F10 mRNA]	PMID:20507366
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:164200	triclosan	multiple interactions	ISO	RGD:1313781	E	RGD:6480464	20120412	CTD	MESH:D014260	Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of IL1F10 mRNA]	PMID:20507366
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of IL1F10 mRNA	PMID:33387578
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313781	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of IL1F10 gene	PMID:33872906
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313781	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of IL1F10 mRNA	PMID:31256213
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313781	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of IL1F10 gene	PMID:33872906
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:193350	ferulic acid	multiple interactions	ISO	RGD:1313782	E	RGD:6480464	20241119	CTD	MESH:C004999	ferulic acid inhibits the reaction [Imiquimod results in decreased expression of IL1F10 mRNA]	PMID:31054998
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313781	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of IL1F10 gene	PMID:27153756
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1313781	E	RGD:6480464	20140610	CTD	MESH:D001151	Arsenic affects the expression of IL1F10 protein	PMID:24675094
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313781	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of IL1F10 mRNA	PMID:30851411
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D004317	Doxorubicin results in increased expression of IL1F10 mRNA	PMID:27181935
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D004317	Doxorubicin inhibits the reaction [Fungal Polysaccharides results in increased expression of IL1F10 mRNA]; Fungal Polysaccharides inhibits the reaction [Doxorubicin results in increased expression of IL1F10 mRNA]	PMID:27181935
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313781	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of IL1F10 5' UTR	PMID:27901495
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313781	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IL1F10 promoter	PMID:27901495
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1313782	E	RGD:6480464	20190219	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of IL1F10 mRNA	PMID:30171875
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313781	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of IL1F10 mRNA	PMID:25895662
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313781	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IL1F10 protein]	PMID:26598702
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313781	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IL1F10 gene	PMID:31601247
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313782	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of IL1F10 mRNA	PMID:29264374
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313782	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of IL1F10 mRNA	PMID:35295148
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313782	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of IL1F10 mRNA	PMID:18648102
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IL1F10 mRNA	PMID:25181051
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313782	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of IL1F10 mRNA	PMID:32156529
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313781	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IL1F10 gene	PMID:31601247
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of IL1F10 promoter	PMID:22457795
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:36704	imiquimod	decreases expression	ISO	RGD:1313782	E	RGD:6480464	20190910	CTD	MESH:C056493	Imiquimod results in decreased expression of IL1F10 mRNA	PMID:31054998
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:36704	imiquimod	multiple interactions	ISO	RGD:1313782	E	RGD:6480464	20190910	CTD	MESH:C056493	ferulic acid inhibits the reaction [Imiquimod results in decreased expression of IL1F10 mRNA]	PMID:31054998
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1313781	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of IL1F10 protein	PMID:24675094
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313781	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IL1F10 protein]	PMID:26598702
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1313781	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of IL1F10 protein	PMID:32959892
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313781	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of IL1F10 mRNA	PMID:30851411
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313781	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IL1F10 gene]	PMID:28238834
1305635	Il1f10	interleukin 1 family member 10	gene	CHEBI:81980	triticonazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in increased expression of IL1F10 mRNA	PMID:36084822
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313783	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ZNF410 mRNA	PMID:38218311
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552255	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ZFP410 mRNA	PMID:20188158
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZNF410 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZNF410 mRNA	PMID:32699268
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313783	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF410 mRNA	PMID:37042841
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313783	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ZNF410 mRNA	PMID:21179406
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:17447	geraniol	increases expression	ISO	RGD:1313783	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of ZNF410 mRNA	PMID:27683099
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313783	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF410 protein	PMID:37730182
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313783	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZNF410 mRNA	PMID:28818685
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP410 mRNA	PMID:36331819
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNF410 mRNA	PMID:35301059
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313783	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNF410 mRNA	PMID:23649840
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZNF410 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZNF410 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ZNF410 mRNA	PMID:32699268
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZNF410 mRNA	PMID:18593933
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552255	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZFP410 mRNA	PMID:31919559
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552255	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZFP410 mRNA	PMID:25629700
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZFP410 mRNA	PMID:22206623
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF410 mRNA	PMID:23557933
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313783	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ZNF410 mRNA	PMID:27594783
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552255	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP410 mRNA	PMID:21570461
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP410 mRNA	PMID:33387578
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZFP410 mRNA	PMID:17942748
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313783	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of ZNF410 mRNA	PMID:39709020
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313783	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZNF410 mRNA	PMID:32763439
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313783	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF410 mRNA	PMID:28595984
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313783	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF410 mRNA	PMID:39719251
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552255	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFP410 mRNA	PMID:22228805
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZNF410 mRNA	PMID:18593933
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313783	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF410 mRNA	PMID:19150397
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1552255	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZFP410 mRNA	PMID:35676786
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552255	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP410 gene	PMID:35295148
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZFP410 mRNA	PMID:34492290
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP410 mRNA; bisphenol A results in increased expression of ZNF410 mRNA	PMID:25181051|PMID:34947998
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552255	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP410 mRNA	PMID:33221593
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZFP410 gene	PMID:28505145
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313783	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ZNF410 mRNA	PMID:25979313
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552255	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ZFP410 mRNA	PMID:38685157
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA	PMID:28628672
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552255	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZFP410 mRNA	PMID:21266533
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA	PMID:28628672
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZFP410 mRNA	PMID:33453195
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNF410 mRNA	PMID:35301059
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZNF410 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZNF410 mRNA	PMID:32699268
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313783	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZNF410 mRNA	PMID:31533062
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP410 mRNA	PMID:36331819
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313783	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF410 mRNA	PMID:20106945|PMID:25562108
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA	PMID:28628672
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313783	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of ZNF410 mRNA	PMID:24449571
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552255	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ZFP410 mRNA	PMID:35436446
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ZFP410 mRNA; Ethinyl Estradiol results in decreased expression of ZNF410 mRNA	PMID:15953391|PMID:17108234
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZFP410 mRNA	PMID:17942748
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313783	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA	PMID:28628672
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1552255	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZFP410 mRNA	PMID:35676786
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1552255	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of ZFP410 mRNA	PMID:40234311
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552255	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP410 mRNA	PMID:22206623
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZFP410 mRNA	PMID:22206623
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313783	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF410 protein	PMID:31285264
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313783	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ZNF410 mRNA	PMID:19159669
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1552255	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of ZFP410 mRNA	PMID:21195148
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1552255	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of ZFP410 mRNA	PMID:21195148
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZFP410 mRNA	PMID:24780913
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1552255	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of ZFP410 mRNA	PMID:21195148
1305636	Zfp410	zinc finger protein 410	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of ZFP410 gene	PMID:31079544
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313785	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of STN1 mRNA	PMID:23724009
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of STN1 mRNA	PMID:26079696
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313785	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of STN1 mRNA	PMID:22378314
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313785	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of STN1 mRNA	PMID:21632981
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313785	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of STN1 mRNA	PMID:22574217
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313785	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of STN1 mRNA	PMID:21179406
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STN1 mRNA	PMID:36139627
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of STN1 mRNA	PMID:33387578
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of STN1 protein	PMID:34915118
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313785	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STN1 gene	PMID:27153756
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313785	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of STN1 mRNA	PMID:23649840
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550272	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of STN1 mRNA	PMID:34911549
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of STN1 mRNA	PMID:30779732
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of STN1 mRNA	PMID:31150632
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20161213	CTD	MESH:D001151	Arsenic results in decreased expression of STN1 mRNA	PMID:25460668
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550272	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of STN1 mRNA	PMID:28960355
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of STN1 mRNA	PMID:23557933
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of STN1 mRNA	PMID:19921347
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313785	E	RGD:6480464	20171114	CTD	MESH:D002945	Cisplatin results in increased expression of STN1 mRNA	PMID:27392435
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20171114	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of STN1 mRNA	PMID:27392435
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550272	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STN1 mRNA	PMID:21570461
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20171114	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of STN1 mRNA	PMID:28001369
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313785	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of STN1 mRNA	PMID:33212167
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of STN1 mRNA	PMID:32763439
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STN1 mRNA	PMID:29803840
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of STN1 mRNA	PMID:38568856
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313785	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STN1 promoter	PMID:27901495
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550272	E	RGD:6480464	20170516	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of STN1 mRNA]	PMID:22228805
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of STN1 mRNA	PMID:34492290
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of STN1 mRNA	PMID:19710929
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C006780	bisphenol A affects the expression of STN1 mRNA	PMID:25181051
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1550272	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of STN1 promoter	PMID:27334623
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of STN1 mRNA	PMID:30816183|PMID:34947998
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550272	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of STN1 mRNA	PMID:39298647
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313785	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of STN1 gene	PMID:31601247
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STN1 mRNA	PMID:28628672
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550272	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of STN1 mRNA	PMID:37019170
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550272	E	RGD:6480464	20170516	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of STN1 mRNA	PMID:21266533
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STN1 mRNA	PMID:28628672
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STN1 mRNA	PMID:38568856
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of STN1 mRNA	PMID:19320972|PMID:19376846
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:37825	p-toluidine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C029370	4-toluidine results in increased expression of STN1 mRNA	PMID:27638505
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313785	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STN1 mRNA	PMID:25979313
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of STN1 mRNA	PMID:26272509
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313785	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of STN1 gene	PMID:29154799
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STN1 mRNA	PMID:27188386
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313785	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of STN1 mRNA	PMID:25562108
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STN1 mRNA	PMID:28628672
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of STN1 mRNA	PMID:24935251
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20161213	CTD	MESH:D001151	Arsenic results in decreased expression of STN1 mRNA	PMID:25460668
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of STN1 mRNA	PMID:29391264
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STN1 mRNA	PMID:28628672
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of STN1 mRNA	PMID:30307764
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313785	E	RGD:6480464	20171114	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of STN1 mRNA	PMID:24810058
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of STN1 mRNA	PMID:31758290
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550272	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of STN1 mRNA	PMID:22206623
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of STN1 mRNA	PMID:22714537
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STN1 mRNA	PMID:36139627
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STN1 mRNA	PMID:27188386
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to STN1 gene]	PMID:28238834
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of STN1 mRNA	PMID:39904859
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of STN1 mRNA	PMID:23914054
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1550272	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of STN1 mRNA	PMID:40826991
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313785	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STN1 mRNA	PMID:27188386
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of STN1 mRNA	PMID:38568856
1305637	Stn1	STN1 subunit of CST complex	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313785	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of STN1 mRNA	PMID:29301935
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1553816	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TMEM50A mRNA	PMID:37995155
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1606813	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM50A mRNA	PMID:23724009
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1606813	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TMEM50A mRNA	PMID:22378314
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1553816	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TMEM50A mRNA	PMID:30319688
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553816	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TMEM50A mRNA	PMID:39241906
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553816	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TMEM50A mRNA	PMID:39298647
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553816	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMEM50A mRNA	PMID:33754040
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1606813	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TMEM50A mRNA	PMID:28818685
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553816	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMEM50A mRNA	PMID:36331819
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553816	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM50A mRNA	PMID:22206623
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1606813	E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of TMEM50A mRNA	PMID:37386098
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553816	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM50A mRNA	PMID:21570461
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM50A mRNA	PMID:34747641
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1606813	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TMEM50A mRNA	PMID:28001369
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1606813	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM50A mRNA	PMID:30851411
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606813	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM50A mRNA	PMID:29803840
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1553816	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of TMEM50A mRNA	PMID:39631538
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1606813	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TMEM50A gene	PMID:28589171
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606813	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TMEM50A mRNA	PMID:38568856
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1553816	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of TMEM50A mRNA	PMID:34850242
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:31429	colforsin daropate hydrochloride	increases expression	ISO	RGD:1606813	E	RGD:6480464	20141111	CTD	MESH:D005576	Colforsin results in increased expression of TMEM50A mRNA	PMID:16751804
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1606813	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of TMEM50A mRNA	PMID:31745603
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TMEM50A mRNA	PMID:30047161
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553816	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of TMEM50A mRNA	PMID:23811191
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM50A mRNA	PMID:34947998
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM50A mRNA	PMID:25181051
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553816	E	RGD:6480464	20131210	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM50A mRNA	PMID:23798566
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMEM50A gene	PMID:28505145
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553816	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TMEM50A mRNA	PMID:39298647
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1553816	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TMEM50A mRNA	PMID:40203079
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1606813	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM50A mRNA	PMID:28628672
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1606813	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM50A mRNA	PMID:28628672
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606813	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMEM50A mRNA	PMID:37042841
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1553816	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TMEM50A mRNA	PMID:28903501
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1606813	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TMEM50A mRNA	PMID:24449571
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1606813	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of TMEM50A mRNA	PMID:16751804
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553816	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMEM50A mRNA	PMID:36331819
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1553816	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM50A mRNA	PMID:17292431
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606813	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM50A mRNA	PMID:23179753
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TMEM50A mRNA	PMID:30047161
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1606813	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM50A mRNA	PMID:28628672
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TMEM50A mRNA	PMID:24136188
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1606813	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM50A mRNA	PMID:22230336
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553816	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TMEM50A mRNA	PMID:35436446
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1606813	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM50A mRNA	PMID:28628672
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553816	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TMEM50A mRNA	PMID:25554681|PMID:25620056
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1553816	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TMEM50A mRNA	PMID:35964746
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1606813	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TMEM50A mRNA	PMID:31758290
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553816	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMEM50A mRNA	PMID:22206623
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553816	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM50A mRNA	PMID:22206623
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1606813	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM50A mRNA	PMID:30851411
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606813	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TMEM50A gene]	PMID:28238834
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1553816	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of TMEM50A mRNA	PMID:21278054
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of TMEM50A mRNA	PMID:30047161
1305638	Tmem50a	transmembrane protein 50A	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TMEM50A mRNA	PMID:30047161
1305640	Wdr55	WD repeat domain 55	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WDR55 mRNA	PMID:34747641
1305640	Wdr55	WD repeat domain 55	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of WDR55 mRNA	PMID:25181051
1305640	Wdr55	WD repeat domain 55	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of WDR55 mRNA	PMID:33387578
1305640	Wdr55	WD repeat domain 55	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of WDR55 mRNA	PMID:29097150
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552256	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ADPRHL1 mRNA	PMID:33045310
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313790	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ADPRHL1 mRNA	PMID:30510588
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313790	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ADPRHL1 mRNA	PMID:31614463
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ADPRHL1 mRNA	PMID:33387578
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1313790	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ADPRHL1 mRNA	PMID:26717081
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:17578	toluene	increases methylation	ISO	RGD:1313790	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ADPRHL1 gene	PMID:26717081
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313790	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ADPRHL1 gene	PMID:27153756
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313790	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ADPRHL1 mRNA	PMID:35430440
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552256	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ADPRHL1 mRNA]	PMID:22206623
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313790	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ADPRHL1 mRNA	PMID:27392435
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552256	E	RGD:6480464	20151215	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ADPRHL1 mRNA	PMID:17942748
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313790	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ADPRHL1 mRNA	PMID:33212167
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313790	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ADPRHL1 mRNA	PMID:32763439
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313790	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADPRHL1 mRNA	PMID:29803840
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313790	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADPRHL1 promoter	PMID:27901495
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552256	E	RGD:6480464	20151215	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADPRHL1 mRNA	PMID:22228805
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313790	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ADPRHL1 mRNA]	PMID:32406909
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552256	E	RGD:6480464	20151215	CTD	MESH:C009495	titanium dioxide results in decreased expression of ADPRHL1 mRNA	PMID:23557971
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552256	E	RGD:6480464	20151215	CTD	MESH:C006253	pirinixic acid results in increased expression of ADPRHL1 mRNA	PMID:20813756|PMID:23811191
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552256	E	RGD:6480464	20151215	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of ADPRHL1 mRNA	PMID:20813756
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313790	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ADPRHL1 mRNA	PMID:38479592
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADPRHL1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of ADPRHL1 mRNA	PMID:41034487
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313790	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ADPRHL1 protein	PMID:37567409
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ADPRHL1 gene	PMID:28505145
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:34283	oxybenzone	affects expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone affects the expression of ADPRHL1 mRNA	PMID:30316929
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313790	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ADPRHL1 gene	PMID:31601247
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552256	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ADPRHL1 exon	PMID:28392331
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ADPRHL1 mRNA	PMID:32680482
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313790	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADPRHL1 mRNA	PMID:37042841
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADPRHL1 mRNA	PMID:35163327
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ADPRHL1 promoter	PMID:22457795
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADPRHL1 mRNA	PMID:35163327
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313790	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ADPRHL1 mRNA	PMID:31533062
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313790	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADPRHL1 gene	PMID:29154799
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552256	E	RGD:6480464	20151215	CTD	MESH:D013629	Tamoxifen affects the expression of ADPRHL1 mRNA	PMID:17555576
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313790	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ADPRHL1 mRNA	PMID:38832940
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552256	E	RGD:6480464	20151215	CTD	MESH:D000082	Acetaminophen affects the expression of ADPRHL1 mRNA	PMID:17562736
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:4798	entacapone	affects binding	EXP		E	RGD:6480464	20170303	CTD	MESH:C071192	entacapone binds to ADPRHL1 protein	PMID:19783845
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552256	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ADPRHL1 mRNA	PMID:35436446
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552256	E	RGD:6480464	20151215	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ADPRHL1 mRNA	PMID:17555576
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552256	E	RGD:6480464	20151215	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ADPRHL1 mRNA	PMID:17942748
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:63630	tolcapone	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to ADPRHL1 protein	PMID:19783845
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313790	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ADPRHL1 mRNA	PMID:31758290
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552256	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADPRHL1 mRNA	PMID:22206623
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552256	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ADPRHL1 mRNA]	PMID:22206623
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ADPRHL1 mRNA	PMID:21346803
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:8093	phenylephrine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased expression of ADPRHL1 mRNA	PMID:18158353
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADPRHL1 mRNA	PMID:24780913
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:9466	Testosterone propionate	decreases expression	ISO	RGD:1552256	E	RGD:6480464	20151215	CTD	MESH:D043343	Testosterone Propionate results in decreased expression of ADPRHL1 mRNA	PMID:15601916
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313790	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ADPRHL1 mRNA	PMID:38568856
1305641	Adprhl1	ADP-ribosylhydrolase like 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ADPRHL1 mRNA	PMID:21346803
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ORMDL2 mRNA	PMID:35967413
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313792	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ORMDL2 mRNA	PMID:33045310
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313792	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ORMDL2 mRNA	PMID:37995155
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313791	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ORMDL2 mRNA	PMID:33167477
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313791	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ORMDL2 mRNA	PMID:21632981
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313792	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ORMDL2 mRNA	PMID:39241906
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313792	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ORMDL2 mRNA	PMID:39298647
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313791	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ORMDL2 mRNA	PMID:37042841
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ORMDL2 mRNA	PMID:28818685
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313792	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ORMDL2 mRNA	PMID:36331819
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1313792	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of ORMDL2 mRNA	PMID:29279043
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313791	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of ORMDL2 mRNA	PMID:24376830
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1313791	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of ORMDL2 mRNA	PMID:19549813
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313791	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ORMDL2 protein	PMID:20106945
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313791	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ORMDL2 mRNA	PMID:21632981
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313791	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ORMDL2 mRNA	PMID:35430440
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313792	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ORMDL2 mRNA	PMID:25629700
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313792	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ORMDL2 mRNA	PMID:22206623
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313791	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ORMDL2 mRNA	PMID:39836092
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313791	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ORMDL2 mRNA	PMID:26272509
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313791	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ORMDL2 mRNA	PMID:27188386
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313792	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ORMDL2 protein	PMID:25505154
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313791	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ORMDL2 mRNA	PMID:27392435
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ORMDL2 mRNA	PMID:23195993
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313791	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ORMDL2 mRNA	PMID:20106945|PMID:21632981
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313791	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of ORMDL2 mRNA	PMID:33512557
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ORMDL2 mRNA	PMID:33212167
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ORMDL2 mRNA	PMID:30851411
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ORMDL2 mRNA	PMID:28959563
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ORMDL2 mRNA	PMID:29803840
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313791	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ORMDL2 mRNA	PMID:20044591
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313791	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ORMDL2 mRNA	PMID:38568856
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313791	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ORMDL2 mRNA	PMID:39836092
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313791	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ORMDL2 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313792	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ORMDL2 mRNA	PMID:21715664
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ORMDL2 mRNA	PMID:34492290
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313792	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ORMDL2 mRNA	PMID:18445702
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313792	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of ORMDL2 mRNA	PMID:28329830
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ORMDL2 protein	PMID:33376534
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ORMDL2 mRNA	PMID:25181051
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313792	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ORMDL2 mRNA	PMID:33221593
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ORMDL2 gene	PMID:28505145
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ORMDL2 mRNA	PMID:36041667
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ORMDL2 mRNA	PMID:36041667
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ORMDL2 mRNA	PMID:36041667
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ORMDL2 mRNA	PMID:17602206
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ORMDL2 mRNA	PMID:17602206
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ORMDL2 promoter	PMID:22457795
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ORMDL2 mRNA	PMID:19162173
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ORMDL2 mRNA	PMID:19376846
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ORMDL2 mRNA	PMID:24449571
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313792	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ORMDL2 mRNA	PMID:40194260
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313792	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ORMDL2 mRNA	PMID:36331819
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of ORMDL2 mRNA	PMID:17685462
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313791	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ORMDL2 mRNA	PMID:25979313
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313791	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ORMDL2 gene	PMID:29154799
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313791	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ORMDL2 mRNA	PMID:23179753|PMID:27188386
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313791	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ORMDL2 mRNA	PMID:25562108
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313791	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ORMDL2 mRNA	PMID:38832940
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313791	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ORMDL2 mRNA	PMID:27188386
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313791	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ORMDL2 mRNA	PMID:28542535
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313792	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ORMDL2 mRNA	PMID:17562736
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313791	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ORMDL2 mRNA	PMID:39836092
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313791	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ORMDL2 mRNA	PMID:22079256
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313791	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ORMDL2 mRNA	PMID:18175754
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313792	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ORMDL2 mRNA; Nanotubes, Carbon results in decreased expression of ORMDL2 mRNA	PMID:25620056
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of ORMDL2 mRNA	PMID:20436886
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1313791	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of ORMDL2 protein	PMID:32959892
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313792	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ORMDL2 mRNA	PMID:22206623
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ORMDL2 mRNA	PMID:22079256
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313791	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ORMDL2 mRNA	PMID:22079256
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of ORMDL2 mRNA	PMID:19287073
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ORMDL2 mRNA	PMID:30851411
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313791	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ORMDL2 mRNA	PMID:27188386
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1313791	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of ORMDL2 mRNA	PMID:33512557
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313791	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ORMDL2 mRNA	PMID:27188386
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313791	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ORMDL2 mRNA	PMID:29301935
1305642	Ormdl2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ORMDL2 mRNA	PMID:21346803
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313793	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CTNND1 mRNA	PMID:38218311
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552257	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of CTNND1 mRNA	PMID:33045310
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552257	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CTNND1 mRNA	PMID:20188158
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1552257	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of CTNND1 mRNA	PMID:16236135
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of CTNND1 protein	PMID:39571964
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CTNND1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CTNND1 mRNA	PMID:32699268
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CTNND1 mRNA	PMID:26079696
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	ISO	RGD:1313793	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of CTNND1 protein	PMID:28073184
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313793	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CTNND1 protein	PMID:21179406
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313793	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CTNND1 protein	PMID:18603805
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1313793	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of CTNND1 protein	PMID:35688186
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CTNND1 protein	PMID:20172018
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CTNND1 mRNA	PMID:39241906
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20161228	CTD	MESH:D008070	CTNND1 protein affects the reaction [Lipopolysaccharides affects the localization of RELA protein]; CTNND1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]; CTNND1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein]	PMID:20172018
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of CTNND1 protein	PMID:32145629
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552257	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CTNND1 mRNA	PMID:14648872
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA	PMID:25510870
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CTNND1 mRNA	PMID:33387578
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16796	melatonin	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20241105	CTD	MESH:D008550	Melatonin results in decreased expression of CTNND1 protein	PMID:37755321
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20241105	CTD	MESH:D008550	MIR532 promotes the reaction [Melatonin results in decreased expression of CTNND1 protein]	PMID:37755321
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313793	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CTNND1 mRNA	PMID:23649840
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:17287	N-phosphocreatine	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D010725	Phosphocreatine promotes the reaction [Doxorubicin results in decreased expression of CTNND1 mRNA]	PMID:37597758
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in increased expression of CTNND1 protein	PMID:34122009
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313793	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CTNND1 protein	PMID:37730182
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:17847	p-cresol	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:C032538	4-cresol affects the localization of and results in decreased phosphorylation of CTNND1 protein; 4-cresol inhibits the reaction [CTNND1 protein binds to CDH2 protein]; Go 6976 inhibits the reaction [4-cresol affects the localization of and results in decreased phosphorylation of CTNND1 protein]; Go 6976 inhibits the reaction [4-cresol inhibits the reaction [CTNND1 protein binds to CDH2 protein]]; PRKCA mutant form inhibits the reaction [4-cresol affects the localization of and results in decreased phosphorylation of CTNND1 protein]	PMID:23466501
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA	PMID:25510870
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA	PMID:25510870
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313793	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CTNND1 mRNA	PMID:19549813
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CTNND1 protein	PMID:23301498
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313793	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CTNND1 mRNA	PMID:23649840
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313793	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CTNND1 mRNA	PMID:23649840
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	ISO	RGD:1313793	E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of CTNND1 protein	PMID:19845377
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CTNND1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CTNND1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of CTNND1 mRNA	PMID:32699268
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CTNND1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of CTNND1 protein	PMID:38598786
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CTNND1 mRNA	PMID:22206623
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTNND1 mRNA	PMID:39836092
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313793	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CTNND1 protein	PMID:35688186
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1552257	E	RGD:6480464	20141111	CTD	MESH:C059514	resveratrol results in increased expression of CTNND1 protein	PMID:24330398
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of CTNND1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CTNND1 mRNA	PMID:19167446|PMID:23557933
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1313793	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of CTNND1 mRNA	PMID:28903495
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CTNND1 mRNA	PMID:33387578|PMID:34747641
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CTNND1 protein	PMID:28918527
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20230404	CTD	MESH:D012969	DKK1 protein inhibits the reaction [Sodium Fluoride results in increased expression of CTNND1 protein]	PMID:36063856
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D004317	Doxorubicin results in decreased expression of CTNND1 mRNA	PMID:37597758
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D004317	Phosphocreatine promotes the reaction [Doxorubicin results in decreased expression of CTNND1 mRNA]	PMID:37597758
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1313793	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of CTNND1 protein	PMID:35688186
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313793	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of CTNND1 mRNA	PMID:20044591
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CTNND1 mRNA	PMID:24431212
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of CTNND1 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTNND1 mRNA	PMID:39571964|PMID:39836092
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313793	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CTNND1 5' UTR; Benzo(a)pyrene affects the methylation of CTNND1 promoter	PMID:27901495
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CTNND1 mRNA	PMID:19770486
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1552257	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CTNND1 exon; Benzo(a)pyrene results in increased methylation of CTNND1 intron	PMID:27901495
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1552257	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CTNND1 mRNA	PMID:27131904
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1313793	E	RGD:6480464	20191114	CTD	MESH:C006632	CTNND1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1552257	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CTNND1 mRNA	PMID:35676786
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of CTNND1 mRNA	PMID:34408198
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:31206	ammonium chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of CTNND1 protein	PMID:16483693
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1313793	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of CTNND1 gene	PMID:31601247
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:31991	phenol red	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20200519	CTD	MESH:D010637	[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of CTNND1 protein	PMID:31629898
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CTNND1 mRNA	PMID:30047161
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313793	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CTNND1 mRNA	PMID:30903817
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CTNND1 mRNA	PMID:30816183|PMID:34947998
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CTNND1 mRNA; bisphenol A results in increased expression of CTNND1 protein	PMID:25181051|PMID:32145629
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313793	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of CTNND1 protein	PMID:34186270|PMID:37567409
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20200519	CTD	MESH:C006780	[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of CTNND1 protein	PMID:31629898
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CTNND1 protein	PMID:31675489
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA	PMID:25510870
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA	PMID:25510870
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CTNND1 mRNA	PMID:23146750
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CTNND1 mRNA	PMID:39298647
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313793	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CTNND1 protein	PMID:34186270
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552257	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CTNND1 mRNA	PMID:38685157
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313793	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CTNND1 protein	PMID:34186270
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CTNND1 mRNA	PMID:28392331
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1552257	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CTNND1 intron	PMID:28392331
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1552257	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of CTNND1 mRNA	PMID:31558096
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552257	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CTNND1 mRNA	PMID:37019170
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552257	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CTNND1 mRNA	PMID:17361019|PMID:21266533
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNND1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CTNND1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of CTNND1 protein	PMID:38598786
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20150714	CTD	MESH:D010269	Paraquat results in decreased expression of CTNND1 mRNA alternative form	PMID:24912632
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20150714	CTD	MESH:D010269	mangiferin inhibits the reaction [Paraquat results in decreased expression of and affects the localization of CTNND1 protein]; mangiferin inhibits the reaction [Paraquat results in decreased expression of CTNND1 mRNA alternative form]; Paraquat results in decreased expression of and affects the localization of CTNND1 protein	PMID:24912632
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CTNND1 mRNA	PMID:38568856
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313793	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CTNND1 mRNA	PMID:25882684|PMID:26472689
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1552257	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of CTNND1 mRNA	PMID:19429403
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CTNND1 mRNA	PMID:23146750
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CTNND1 mRNA	PMID:19320972
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CTNND1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CTNND1 mRNA	PMID:32699268
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:38604	pyrimidifen	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of CTNND1 mRNA	PMID:33512557
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CTNND1 mRNA	PMID:31533062
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of CTNND1 mRNA	PMID:19167446
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of CTNND1 mRNA	PMID:19167446
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1552257	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of CTNND1 mRNA	PMID:19429403
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1552257	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of CTNND1 mRNA	PMID:31558096
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313793	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CTNND1 mRNA	PMID:25979313
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CTNND1 mRNA	PMID:23179753
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of CTNND1 mRNA	PMID:17183730
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CTNND1 mRNA	PMID:20106945
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1552257	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CTNND1 mRNA	PMID:14648872
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of CTNND1 mRNA	PMID:33512557
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of CTNND1 mRNA	PMID:24449571
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313793	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of CTNND1 mRNA	PMID:21678067
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:44658	okadaic acid	increases phosphorylation	ISO	RGD:1313793	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased phosphorylation of CTNND1 protein	PMID:38832940
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTNND1 mRNA	PMID:33387578
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTNND1 mRNA	PMID:21420995
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CTNND1 mRNA	PMID:29279043
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTNND1 mRNA	PMID:39836092
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CTNND1 mRNA	PMID:31675489
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313793	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of CTNND1 mRNA	PMID:26833863
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CTNND1 mRNA	PMID:29391264
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1313793	E	RGD:6480464	20191114	CTD	MESH:C032793	CTNND1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1552257	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CTNND1 mRNA	PMID:35676786
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:5011	fenpyroximate	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of CTNND1 mRNA	PMID:33512557
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1552257	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of CTNND1 mRNA	PMID:27915011
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CTNND1 mRNA; Nanotubes, Carbon results in decreased expression of CTNND1 mRNA	PMID:25554681
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CTNND1 mRNA	PMID:30047161
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:51913	Goe 6976	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:C081021	Go 6976 inhibits the reaction [4-cresol affects the localization of and results in decreased phosphorylation of CTNND1 protein]; Go 6976 inhibits the reaction [4-cresol inhibits the reaction [CTNND1 protein binds to CDH2 protein]]	PMID:23466501
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of CTNND1 mRNA	PMID:17183730
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:5870	imidacloprid	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C082359	imidacloprid results in increased expression of CTNND1 mRNA	PMID:27792329
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of CTNND1 mRNA	PMID:28801915
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1552257	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CTNND1 protein	PMID:26558463
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:6682	mangiferin	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20150714	CTD	MESH:C013592	mangiferin inhibits the reaction [Paraquat results in decreased expression of and affects the localization of CTNND1 protein]; mangiferin inhibits the reaction [Paraquat results in decreased expression of CTNND1 mRNA alternative form]	PMID:24912632
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in increased expression of CTNND1 protein	PMID:34122009
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313793	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CTNND1 protein	PMID:34186270
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552257	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CTNND1 mRNA	PMID:22206623
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CTNND1 mRNA	PMID:22206623
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:7719	ochratoxin A	decreases acetylation	ISO	RGD:1313793	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of CTNND1 promoter	PMID:29098329
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of CTNND1 mRNA	PMID:29098329
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of CTNND1 promoter] which results in decreased expression of CTNND1 mRNA	PMID:29098329
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CTNND1 mRNA	PMID:23146750
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:81794	thifluzamide	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of CTNND1 mRNA	PMID:33512557
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of CTNND1 protein	PMID:28903499
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1552257	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of CTNND1 mRNA	PMID:31558096
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of CTNND1 mRNA	PMID:33512557
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of CTNND1 protein	PMID:38348393
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CTNND1 mRNA	PMID:30047161
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CTNND1 mRNA	PMID:24780913
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1552257	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in increased expression of CTNND1 protein	PMID:35278568
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20240430	CTD	MESH:C028577	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [monobutyl phthalate results in increased expression of CTNND1 protein]	PMID:35278568
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:91108	SB 431542	increases expression	ISO	RGD:1313793	E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of CTNND1 protein	PMID:25670856
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1552257	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CTNND1 mRNA	PMID:27131904
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:9422	tebufenpyrad	decreases expression	ISO	RGD:1313793	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of CTNND1 mRNA	PMID:33512557
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313793	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CTNND1 mRNA	PMID:29301935
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313793	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNND1 protein	PMID:38598786
1305643	Ctnnd1	catenin delta 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CTNND1 mRNA	PMID:28973697
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1346022	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of UBE2E2 mRNA	PMID:38218311
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1346022	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of UBE2E2 mRNA	PMID:27188386
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2E2 gene	PMID:20938992
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of UBE2E2 gene	PMID:35440735
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1346022	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of UBE2E2 mRNA	PMID:22378314
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1346022	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of UBE2E2 mRNA	PMID:21179406
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1346022	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of UBE2E2 mRNA	PMID:21632981
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1346022	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of UBE2E2 mRNA	PMID:21185374
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313795	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of UBE2E2 mRNA	PMID:39298647
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of UBE2E2 mRNA	PMID:33387578
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2E2 gene	PMID:20938992
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313795	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of UBE2E2 mRNA	PMID:34319233
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of UBE2E2 mRNA	PMID:22061828|PMID:33387578
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UBE2E2 mRNA	PMID:36331819
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBE2E2 mRNA	PMID:37236586
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313795	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of UBE2E2 mRNA	PMID:19770486
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1346022	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UBE2E2 gene	PMID:27153756
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of UBE2E2 mRNA	PMID:27106289
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2E2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2E2 gene	PMID:20938992|PMID:22206623
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1346022	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UBE2E2 gene	PMID:25304211
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1346022	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of UBE2E2 promoter	PMID:21291286
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1346022	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2E2 mRNA	PMID:39836092
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of UBE2E2 gene	PMID:35440735
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313795	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of UBE2E2 mRNA	PMID:24280081
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1346022	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of UBE2E2 mRNA	PMID:19561079|PMID:24280081
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313795	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2E2 mRNA	PMID:21570461
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE2E2 mRNA	PMID:21215274|PMID:32109520
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313795	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2E2 mRNA	PMID:18172886|PMID:18796159|PMID:26290441
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of UBE2E2 mRNA]	PMID:21215274
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of UBE2E2 mRNA	PMID:16214954
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313795	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of UBE2E2 mRNA	PMID:23186747
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1346022	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of UBE2E2 mRNA	PMID:23179753
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1346022	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of UBE2E2 mRNA	PMID:33212167
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346022	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of UBE2E2 mRNA	PMID:29803840
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	ISO	RGD:1346022	E	RGD:6480464	20120412	CTD	MESH:C028473	UBE2E2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1346022	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of UBE2E2 gene	PMID:28589171
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313795	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of UBE2E2 gene	PMID:39894169
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1346022	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2E2 mRNA	PMID:39836092
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313795	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE2E2 mRNA	PMID:19770486|PMID:21715664
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1346022	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE2E2 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:21871943
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBE2E2 mRNA	PMID:21839799
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1346022	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to UBE2E2 mRNA]	PMID:32406909
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of UBE2E2 mRNA	PMID:25729387
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of UBE2E2 mRNA	PMID:30047161
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313795	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBE2E2 promoter	PMID:35295148
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in decreased expression of UBE2E2 mRNA	PMID:27914986|PMID:34492290
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:32497	thioacetamide	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased methylation of UBE2E2 promoter	PMID:27914986
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of UBE2E2 protein	PMID:27914986
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313795	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of UBE2E2 mRNA	PMID:18301758|PMID:21318169|PMID:23811191
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of UBE2E2 mRNA]	PMID:21318169
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D010882	[Diethylnitrosamine co-treated with Piperonyl Butoxide] results in decreased expression of UBE2E2 protein	PMID:27914986
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of UBE2E2 mRNA	PMID:25181051
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313795	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2E2 mRNA	PMID:33221593
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313795	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2E2 mRNA	PMID:32156529
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:33418	graphite	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of UBE2E2 mRNA	PMID:29933104
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313795	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UBE2E2 mRNA	PMID:39298647
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313795	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of UBE2E2 intron	PMID:28392331
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of UBE2E2 protein; [Diethylnitrosamine co-treated with Fenbendazole] results in decreased expression of UBE2E2 protein; [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of UBE2E2 protein; [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in decreased expression of UBE2E2 protein; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of UBE2E2 protein	PMID:27914986
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBE2E2 mRNA	PMID:37236586
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313795	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of UBE2E2 mRNA	PMID:18353800
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1346022	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of UBE2E2 mRNA	PMID:31533062
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UBE2E2 mRNA	PMID:36331819
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346022	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBE2E2 mRNA	PMID:25979313
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346022	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of UBE2E2 mRNA	PMID:23179753|PMID:27188386
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of UBE2E2 mRNA	PMID:30047161
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313795	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of UBE2E2 mRNA	PMID:19770486
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1346022	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of UBE2E2 promoter	PMID:27989131
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1346022	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of UBE2E2 mRNA	PMID:20106945
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1346022	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of UBE2E2 mRNA	PMID:26272509
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1346022	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2E2 mRNA	PMID:27188386
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313795	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBE2E2 mRNA	PMID:17562736
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of UBE2E2 mRNA	PMID:33387578
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1346022	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UBE2E2 gene	PMID:25304211
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1346022	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of UBE2E2 promoter	PMID:21291286
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1346022	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2E2 mRNA	PMID:39836092
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:49976	zinc dichloride	increases expression	ISO	RGD:1346022	E	RGD:6480464	20130122	CTD	MESH:C016837	zinc chloride results in increased expression of UBE2E2 mRNA	PMID:18947441
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of UBE2E2 mRNA	PMID:23962444
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of UBE2E2 mRNA	PMID:30047161
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBE2E2 mRNA	PMID:24136188
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1346022	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of UBE2E2 mRNA	PMID:22714537
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of UBE2E2 mRNA	PMID:25729387
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1346022	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of UBE2E2 mRNA	PMID:28025562
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313795	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UBE2E2 mRNA	PMID:22206623
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2E2 mRNA	PMID:22206623
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of UBE2E2 protein	PMID:27914986
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:77092	fenbendazole	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D005273	[Diethylnitrosamine co-treated with Fenbendazole] results in decreased expression of UBE2E2 protein	PMID:27914986
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346022	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2E2 mRNA	PMID:27188386
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313795	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of UBE2E2 mRNA	PMID:19482888
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:8069	phenobarbital	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of UBE2E2 protein	PMID:27914986
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313795	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of UBE2E2 mRNA]	PMID:19482888
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of UBE2E2 mRNA	PMID:32109520
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313795	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of UBE2E2 mRNA	PMID:31388691
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313795	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of UBE2E2 mRNA	PMID:39847705
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313795	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of UBE2E2 mRNA	PMID:40826991
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1346022	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of UBE2E2 mRNA	PMID:31734321
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346022	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2E2 mRNA	PMID:27188386
1305644	Ube2e2	ubiquitin-conjugating enzyme E2E 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UBE2E2 mRNA	PMID:21346803
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D004237	Diuron results in decreased expression of ECRG4 mRNA	PMID:25152437
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D004237	Diuron results in increased expression of ECRG4 mRNA	PMID:21551480
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1603606	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ECRG4 mRNA	PMID:26272509
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1603606	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECRG4 mRNA	PMID:27188386
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of ECRG4 mRNA	PMID:36841081
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:16827	corticosterone	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D003345	Corticosterone results in decreased expression of ECRG4 mRNA	PMID:15755911
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ECRG4 mRNA	PMID:26577399
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of ECRG4 mRNA	PMID:19480007
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313796	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ECRG4 mRNA	PMID:32186404
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1603606	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ECRG4 mRNA	PMID:24768652|PMID:25583101
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ECRG4 mRNA	PMID:34747641
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313796	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ECRG4 mRNA	PMID:33956508
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1603606	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ECRG4 mRNA	PMID:29955902
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1603606	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ECRG4 mRNA	PMID:34089799
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313796	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of ECRG4 mRNA	PMID:35032568
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313796	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ECRG4 mRNA	PMID:37682722
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1603606	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ECRG4 promoter	PMID:27901495
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:30563	silicon dioxide	affects expression	ISO	RGD:1603606	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog affects the expression of ECRG4 mRNA	PMID:23806026
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313796	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ECRG4 mRNA	PMID:35676786
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:30621	diarsenic trioxide	decreases methylation	ISO	RGD:1603606	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased methylation of ECRG4 promoter	PMID:22325214
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1603606	E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide results in decreased methylation of ECRG4 promoter] which results in increased expression of ECRG4 mRNA	PMID:22325214
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1603606	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of ECRG4 gene	PMID:31601247
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ECRG4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of ECRG4 mRNA	PMID:36779543
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313796	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ECRG4 mRNA	PMID:30951980|PMID:32156529
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of ECRG4 mRNA	PMID:28300664
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313796	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ECRG4 mRNA	PMID:30951980
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1603606	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of ECRG4 gene	PMID:31601247
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313796	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ECRG4 mRNA	PMID:30951980
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ECRG4 mRNA	PMID:21266533|PMID:24893172
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ECRG4 mRNA	PMID:35163327
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ECRG4 mRNA	PMID:35163327
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603606	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ECRG4 mRNA	PMID:25979313
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603606	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ECRG4 mRNA	PMID:23179753
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D014635	Valproic Acid results in increased expression of ECRG4 mRNA	PMID:29427782
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603606	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ECRG4 mRNA	PMID:24935251|PMID:26272509|PMID:29154799
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603606	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECRG4 mRNA	PMID:27188386
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1603606	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of ECRG4 mRNA	PMID:27989131
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313796	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ECRG4 mRNA	PMID:28973697
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313796	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ECRG4 mRNA	PMID:28973697
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603606	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ECRG4 mRNA	PMID:26690555
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D004726	Endosulfan results in decreased expression of ECRG4 mRNA	PMID:29391264
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ECRG4 mRNA	PMID:17557909
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313796	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ECRG4 mRNA	PMID:35676786
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:49900	arsenous acid	decreases methylation	ISO	RGD:1603606	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased methylation of ECRG4 promoter	PMID:22325214
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1603606	E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide results in decreased methylation of ECRG4 promoter] which results in increased expression of ECRG4 mRNA	PMID:22325214
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C025340	manganese chloride results in decreased expression of ECRG4 mRNA	PMID:28801915
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ECRG4 mRNA	PMID:28801915
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603606	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECRG4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECRG4 mRNA	PMID:27188386
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313796	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ECRG4 mRNA	PMID:38648751
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1603606	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of C2ORF40 mRNA	PMID:26705709
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ECRG4 mRNA	PMID:23914054
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603606	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECRG4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECRG4 mRNA	PMID:27188386
1305645	Ecrg4	ECRG4 augurin precursor	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1603606	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ECRG4 mRNA	PMID:27188386
1305646	Chit1	chitinase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313798	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CHIT1 mRNA	PMID:33045310
1305646	Chit1	chitinase 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CHIT1 gene	PMID:28931070|PMID:35440735
1305646	Chit1	chitinase 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313797	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CHIT1 mRNA	PMID:22378314
1305646	Chit1	chitinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313798	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CHIT1 mRNA	PMID:19484750
1305646	Chit1	chitinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313797	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CHIT1 mRNA	PMID:37042841
1305646	Chit1	chitinase 1	gene	CHEBI:17029	chitin	affects binding	ISO	RGD:1313798	E	RGD:6480464	20130611	CTD	MESH:D002686	CHIT1 protein binds to Chitin	PMID:16005164
1305646	Chit1	chitinase 1	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313797	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CHIT1 mRNA	PMID:26079696
1305646	Chit1	chitinase 1	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1313797	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of CHIT1 mRNA	PMID:20823114
1305646	Chit1	chitinase 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313798	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of CHIT1 mRNA	PMID:19376150
1305646	Chit1	chitinase 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313797	E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of CHIT1 mRNA	PMID:23033980
1305646	Chit1	chitinase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313798	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of CHIT1 mRNA	PMID:40618947
1305646	Chit1	chitinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CHIT1 mRNA	PMID:34747641
1305646	Chit1	chitinase 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CHIT1 mRNA	PMID:28959563
1305646	Chit1	chitinase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313797	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHIT1 promoter	PMID:27901495
1305646	Chit1	chitinase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313797	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CHIT1 mRNA	PMID:19128835
1305646	Chit1	chitinase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313797	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CHIT1 gene	PMID:31601247
1305646	Chit1	chitinase 1	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of CHIT1 mRNA	PMID:25729387
1305646	Chit1	chitinase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313798	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CHIT1 mRNA	PMID:23557971|PMID:35295148
1305646	Chit1	chitinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313797	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CHIT1 mRNA	PMID:19710929
1305646	Chit1	chitinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CHIT1 mRNA	PMID:25181051|PMID:34947998
1305646	Chit1	chitinase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313797	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CHIT1 gene	PMID:31601247
1305646	Chit1	chitinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313797	E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in decreased expression of CHIT1 mRNA	PMID:30616060
1305646	Chit1	chitinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313797	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHIT1 mRNA	PMID:37042841
1305646	Chit1	chitinase 1	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CHIT1 gene	PMID:22079235
1305646	Chit1	chitinase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313798	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CHIT1 mRNA	PMID:40194260
1305646	Chit1	chitinase 1	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1313798	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of CHIT1 mRNA	PMID:29038090
1305646	Chit1	chitinase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313797	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CHIT1 mRNA	PMID:23179753|PMID:26272509
1305646	Chit1	chitinase 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313797	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHIT1 mRNA	PMID:27188386
1305646	Chit1	chitinase 1	gene	CHEBI:40808	ALLOSAMIDIN	decreases activity	ISO	RGD:1313798	E	RGD:6480464	20141111	CTD	MESH:C054851	allosamidin results in decreased activity of CHIT1 protein	PMID:16005164
1305646	Chit1	chitinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313798	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CHIT1 mRNA	PMID:17562736
1305646	Chit1	chitinase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313797	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of CHIT1 mRNA	PMID:26690555
1305646	Chit1	chitinase 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313797	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CHIT1 mRNA	PMID:19128835
1305646	Chit1	chitinase 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313798	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CHIT1 mRNA	PMID:21641980
1305646	Chit1	chitinase 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of CHIT1 mRNA	PMID:25729387
1305646	Chit1	chitinase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313797	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHIT1 mRNA	PMID:27188386
1305646	Chit1	chitinase 1	gene	CHEBI:8228	pioglitazone	decreases expression	ISO	RGD:1313797	E	RGD:6480464	20181113	CTD	MESH:C060836	Pioglitazone results in decreased expression of CHIT1 mRNA	PMID:30031879
1305646	Chit1	chitinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CHIT1 mRNA	PMID:24780913
1305646	Chit1	chitinase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313797	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHIT1 mRNA	PMID:27188386
1305646	Chit1	chitinase 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313797	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CHIT1 mRNA	PMID:38568856
1305646	Chit1	chitinase 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of CHIT1 gene	PMID:31079544
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1605041	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TMEM62 mRNA	PMID:38218311
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TMEM62 mRNA]	PMID:31150632
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM62 mRNA	PMID:20488242
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605041	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM62 mRNA	PMID:33167477
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552205	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM62 mRNA	PMID:36331819
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1605041	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TMEM62 mRNA	PMID:22378314
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552205	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TMEM62 mRNA	PMID:39298647
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM62 mRNA	PMID:33387578
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552205	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TMEM62 mRNA	PMID:22401849
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552205	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of TMEM62 mRNA	PMID:23892564
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552205	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMEM62 mRNA	PMID:36331819
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605041	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TMEM62 gene; Aflatoxin B1 results in increased methylation of TMEM62 intron	PMID:27153756|PMID:30157460
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TMEM62 mRNA	PMID:31150632
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552205	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TMEM62 mRNA	PMID:31919559
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TMEM62 mRNA]	PMID:31150632
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM62 mRNA	PMID:39836092
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552205	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of TMEM62 mRNA	PMID:28189721|PMID:28960355
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TMEM62 mRNA	PMID:23557933
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552205	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM62 mRNA	PMID:26377647
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM62 mRNA	PMID:21215274|PMID:33387578
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552205	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM62 mRNA	PMID:26290441
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1605041	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM62 mRNA	PMID:32763439
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1605041	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of TMEM62 mRNA	PMID:21198554
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM62 mRNA	PMID:39836092
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552205	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TMEM62 mRNA	PMID:32417428
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1605041	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of TMEM62 gene	PMID:31601247
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TMEM62 gene	PMID:31601247
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552205	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM62 promoter alternative form	PMID:35295148
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TMEM62 mRNA	PMID:34492290
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552205	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TMEM62 mRNA	PMID:18301758
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of TMEM62 mRNA	PMID:30816183
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605041	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM62 mRNA	PMID:29275510
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM62 mRNA	PMID:25181051
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TMEM62 gene	PMID:31601247
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552205	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TMEM62 mRNA	PMID:39298647
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552205	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TMEM62 mRNA	PMID:37019170
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552205	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TMEM62 mRNA	PMID:34813904
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMEM62 mRNA	PMID:33453195
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1552205	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of TMEM62 mRNA	PMID:24183702
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1552205	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of TMEM62 mRNA	PMID:28962523
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552205	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMEM62 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM62 mRNA	PMID:36331819
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM62 mRNA	PMID:27188386
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552205	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TMEM62 mRNA	PMID:17555576
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TMEM62 mRNA	PMID:24136188
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605041	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TMEM62 mRNA	PMID:38832940
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552205	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMEM62 mRNA	PMID:17562736
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMEM62 mRNA	PMID:33387578
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605041	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM62 mRNA	PMID:22230336
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552205	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TMEM62 mRNA	PMID:29279043
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM62 mRNA	PMID:39836092
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TMEM62 mRNA	PMID:29391264
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TMEM62 mRNA	PMID:22079256
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552205	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TMEM62 mRNA	PMID:17555576
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552205	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TMEM62 mRNA	PMID:25620056
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of TMEM62 mRNA	PMID:23962444
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TMEM62 mRNA	PMID:24136188
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of TMEM62 mRNA	PMID:24136188
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1605041	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TMEM62 mRNA	PMID:31758290
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552205	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMEM62 mRNA	PMID:22206623
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TMEM62 mRNA	PMID:24136188
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1605041	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TMEM62 mRNA	PMID:22079256
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TMEM62 mRNA	PMID:22079256
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM62 mRNA	PMID:27188386
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1552205	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of TMEM62 mRNA	PMID:21278054
1305647	Tmem62	transmembrane protein 62	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605041	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM62 mRNA	PMID:27188386
1305648	Fbxo7	F-box protein 7	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313801	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of FBXO7 mRNA	PMID:22629407
1305648	Fbxo7	F-box protein 7	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313801	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of FBXO7 mRNA]	PMID:22629407
1305648	Fbxo7	F-box protein 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313800	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FBXO7 mRNA	PMID:37042841
1305648	Fbxo7	F-box protein 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FBXO7 mRNA	PMID:33387578
1305648	Fbxo7	F-box protein 7	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1313801	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of FBXO7 mRNA	PMID:18930951
1305648	Fbxo7	F-box protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313801	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO7 mRNA	PMID:21570461
1305648	Fbxo7	F-box protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313801	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXO7 mRNA	PMID:19465110|PMID:21354282
1305648	Fbxo7	F-box protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXO7 mRNA	PMID:33387578
1305648	Fbxo7	F-box protein 7	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of FBXO7 protein	PMID:39603559
1305648	Fbxo7	F-box protein 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FBXO7 mRNA	PMID:28001369
1305648	Fbxo7	F-box protein 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313801	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FBXO7 mRNA	PMID:21715664|PMID:22228805
1305648	Fbxo7	F-box protein 7	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313800	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of FBXO7 gene	PMID:31601247
1305648	Fbxo7	F-box protein 7	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FBXO7 mRNA	PMID:24136188
1305648	Fbxo7	F-box protein 7	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1313800	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of FBXO7 mRNA	PMID:31745603
1305648	Fbxo7	F-box protein 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313801	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXO7 gene	PMID:35295148
1305648	Fbxo7	F-box protein 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313801	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FBXO7 promoter alternative form	PMID:35295148
1305648	Fbxo7	F-box protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO7 mRNA	PMID:41034487
1305648	Fbxo7	F-box protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO7 protein	PMID:31675489
1305648	Fbxo7	F-box protein 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FBXO7 mRNA	PMID:25181051
1305648	Fbxo7	F-box protein 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of FBXO7 mRNA	PMID:36041667
1305648	Fbxo7	F-box protein 7	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of FBXO7 protein	PMID:31675489
1305648	Fbxo7	F-box protein 7	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313801	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of FBXO7 mRNA	PMID:26682919
1305648	Fbxo7	F-box protein 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of FBXO7 mRNA	PMID:36041667
1305648	Fbxo7	F-box protein 7	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of FBXO7 mRNA	PMID:36041667
1305648	Fbxo7	F-box protein 7	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313800	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of FBXO7 gene	PMID:31601247
1305648	Fbxo7	F-box protein 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313801	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FBXO7 mRNA	PMID:37019170
1305648	Fbxo7	F-box protein 7	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of FBXO7 gene	PMID:22079235
1305648	Fbxo7	F-box protein 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313800	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO7 mRNA	PMID:25979313
1305648	Fbxo7	F-box protein 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313801	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO7 mRNA	PMID:17292431
1305648	Fbxo7	F-box protein 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXO7 mRNA	PMID:23179753|PMID:28001369
1305648	Fbxo7	F-box protein 7	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of FBXO7 mRNA	PMID:41580965
1305648	Fbxo7	F-box protein 7	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of FBXO7 mRNA	PMID:33512557
1305648	Fbxo7	F-box protein 7	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of FBXO7 mRNA	PMID:27188386
1305648	Fbxo7	F-box protein 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313801	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBXO7 mRNA	PMID:17562736
1305648	Fbxo7	F-box protein 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FBXO7 mRNA	PMID:21420995
1305648	Fbxo7	F-box protein 7	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of FBXO7 mRNA	PMID:31675489
1305648	Fbxo7	F-box protein 7	gene	CHEBI:5011	fenpyroximate	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of FBXO7 mRNA	PMID:33512557
1305648	Fbxo7	F-box protein 7	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313801	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of FBXO7 mRNA	PMID:19042947
1305648	Fbxo7	F-box protein 7	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FBXO7 protein	PMID:32959892
1305648	Fbxo7	F-box protein 7	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313800	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of FBXO7 mRNA; 1-Methyl-4-phenylpyridinium results in increased expression of FBXO7 protein	PMID:41640382
1305648	Fbxo7	F-box protein 7	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of FBXO7 mRNA	PMID:24136188
1305648	Fbxo7	F-box protein 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313800	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FBXO7 gene]	PMID:28238834
1305648	Fbxo7	F-box protein 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FBXO7 protein	PMID:31675489
1305648	Fbxo7	F-box protein 7	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of FBXO7 protein	PMID:31675489
1305648	Fbxo7	F-box protein 7	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of FBXO7 mRNA	PMID:33512557
1305648	Fbxo7	F-box protein 7	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313800	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of FBXO7 mRNA	PMID:29301935
1305648	Fbxo7	F-box protein 7	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1313800	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of FBXO7 mRNA	PMID:27188386
1305648	Fbxo7	F-box protein 7	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of FBXO7 protein	PMID:32519852
1305649	Xkr8	XK related 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of XKR8 mRNA]	PMID:31150632
1305649	Xkr8	XK related 8	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313802	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of XKR8 mRNA	PMID:36331819
1305649	Xkr8	XK related 8	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313802	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of XKR8 mRNA	PMID:30319688
1305649	Xkr8	XK related 8	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of XKR8 mRNA	PMID:33387578
1305649	Xkr8	XK related 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1602706	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of XKR8 mRNA	PMID:37042841
1305649	Xkr8	XK related 8	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of XKR8 mRNA	PMID:33387578
1305649	Xkr8	XK related 8	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1602706	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of XKR8 mRNA	PMID:28818685
1305649	Xkr8	XK related 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of XKR8 mRNA	PMID:31150632
1305649	Xkr8	XK related 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of XKR8 mRNA]	PMID:31150632
1305649	Xkr8	XK related 8	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313802	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of XKR8 mRNA	PMID:25629700
1305649	Xkr8	XK related 8	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1602706	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of XKR8 mRNA	PMID:27392435
1305649	Xkr8	XK related 8	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1602706	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of XKR8 mRNA	PMID:27392435
1305649	Xkr8	XK related 8	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of XKR8 mRNA	PMID:20187946
1305649	Xkr8	XK related 8	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313802	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of XKR8 mRNA	PMID:32186404
1305649	Xkr8	XK related 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313802	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of XKR8 mRNA	PMID:21570461
1305649	Xkr8	XK related 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of XKR8 mRNA	PMID:33387578
1305649	Xkr8	XK related 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313802	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of XKR8 mRNA	PMID:34876320
1305649	Xkr8	XK related 8	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313802	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of XKR8 mRNA	PMID:34876320
1305649	Xkr8	XK related 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602706	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of XKR8 exon	PMID:27901495
1305649	Xkr8	XK related 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313802	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XKR8 mRNA	PMID:22228805
1305649	Xkr8	XK related 8	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313802	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of XKR8 mRNA	PMID:29264374
1305649	Xkr8	XK related 8	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of XKR8 mRNA	PMID:23411599|PMID:34492290
1305649	Xkr8	XK related 8	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of XKR8 mRNA	PMID:25181051
1305649	Xkr8	XK related 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of XKR8 mRNA	PMID:30816183
1305649	Xkr8	XK related 8	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313802	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of XKR8 promoter	PMID:27312807
1305649	Xkr8	XK related 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of XKR8 mRNA	PMID:41034487
1305649	Xkr8	XK related 8	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1602706	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of XKR8 mRNA	PMID:19244175
1305649	Xkr8	XK related 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1602706	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in decreased expression of XKR8 mRNA	PMID:34979203
1305649	Xkr8	XK related 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313802	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of XKR8 promoter	PMID:33297965
1305649	Xkr8	XK related 8	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313802	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of XKR8 mRNA	PMID:38685157
1305649	Xkr8	XK related 8	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1602706	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of XKR8 gene	PMID:22964155
1305649	Xkr8	XK related 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313802	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of XKR8 mRNA	PMID:21266533
1305649	Xkr8	XK related 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602706	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of XKR8 mRNA	PMID:37042841
1305649	Xkr8	XK related 8	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of XKR8 gene	PMID:22079235
1305649	Xkr8	XK related 8	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313802	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of XKR8 mRNA	PMID:40194260
1305649	Xkr8	XK related 8	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1602706	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of XKR8 mRNA	PMID:31533062
1305649	Xkr8	XK related 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313802	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of XKR8 mRNA	PMID:36331819
1305649	Xkr8	XK related 8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313802	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of XKR8 mRNA	PMID:28973697
1305649	Xkr8	XK related 8	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1602706	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of XKR8 mRNA	PMID:38832940
1305649	Xkr8	XK related 8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313802	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of XKR8 mRNA	PMID:17562736
1305649	Xkr8	XK related 8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of XKR8 mRNA	PMID:33387578
1305649	Xkr8	XK related 8	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313802	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of XKR8 mRNA	PMID:34876320
1305649	Xkr8	XK related 8	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1602706	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of XKR8 mRNA	PMID:18175754
1305649	Xkr8	XK related 8	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313802	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of XKR8 mRNA	PMID:25554681
1305649	Xkr8	XK related 8	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of XKR8 mRNA	PMID:24136188
1305649	Xkr8	XK related 8	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1602706	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of XKR8 mRNA	PMID:31758290
1305649	Xkr8	XK related 8	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313802	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of XKR8 mRNA	PMID:22206623
1305649	Xkr8	XK related 8	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602706	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to XKR8 gene]	PMID:28238834
1305649	Xkr8	XK related 8	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313802	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of XKR8 mRNA	PMID:34876320
1305649	Xkr8	XK related 8	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of XKR8 mRNA	PMID:24780913
1305649	Xkr8	XK related 8	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of XKR8 mRNA	PMID:22570695
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313804	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MGAT4A mRNA	PMID:33045310
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313803	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of MGAT4A mRNA	PMID:23724009|PMID:33167477
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313804	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of MGAT4A mRNA	PMID:40945087
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MGAT4A mRNA	PMID:39241906
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313803	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of MGAT4A mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MGAT4A mRNA	PMID:26667767|PMID:35811015
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of MGAT4A mRNA	PMID:21185374
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313803	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MGAT4A mRNA	PMID:30165855
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313803	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of MGAT4A mRNA	PMID:26079696
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGAT4A mRNA	PMID:37992649
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGAT4A mRNA	PMID:37992649
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313803	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MGAT4A protein	PMID:37730182
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MGAT4A mRNA	PMID:28111341|PMID:37236586
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MGAT4A mRNA	PMID:22100608
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313803	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MGAT4A intron	PMID:30157460
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313803	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MGAT4A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MGAT4A mRNA	PMID:35430440|PMID:41430723
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313803	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of MGAT4A mRNA	PMID:19774075
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MGAT4A mRNA	PMID:30779732
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313804	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of MGAT4A mRNA	PMID:31939706
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene] which results in increased expression of MGAT4A mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MGAT4A mRNA	PMID:40504410
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MGAT4A mRNA	PMID:26272509
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313803	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA	PMID:27188386
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313804	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of MGAT4A mRNA	PMID:28960355
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313803	E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with resveratrol] results in decreased expression of MGAT4A mRNA	PMID:26667767
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313803	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MGAT4A mRNA	PMID:28903495
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313803	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MGAT4A mRNA	PMID:24768652|PMID:25583101
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MGAT4A mRNA	PMID:22298810
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313804	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MGAT4A mRNA	PMID:26377647
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MGAT4A mRNA	PMID:34747641
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313804	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MGAT4A mRNA	PMID:26290441
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MGAT4A mRNA	PMID:28001369
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of MGAT4A mRNA	PMID:23649840
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MGAT4A mRNA	PMID:29803840
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGAT4A mRNA	PMID:37992649
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of MGAT4A mRNA	PMID:35314868
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of MGAT4A mRNA	PMID:34032870
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313803	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MGAT4A mRNA	PMID:17879257
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313804	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of MGAT4A mRNA	PMID:37682722
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene] which results in increased expression of MGAT4A mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MGAT4A mRNA	PMID:40504410
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313803	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MGAT4A promoter	PMID:27901495
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MGAT4A mRNA	PMID:34492290
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MGAT4A mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MGAT4A gene	PMID:28505145
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313803	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MGAT4A mRNA	PMID:25979313
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313803	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MGAT4A intron	PMID:30157460
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313804	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of MGAT4A intron	PMID:28392331
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313804	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MGAT4A mRNA	PMID:20524982
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of MGAT4A mRNA	PMID:32680482
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313803	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MGAT4A mRNA	PMID:37042841
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MGAT4A mRNA	PMID:33453195
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MGAT4A mRNA	PMID:28111341|PMID:37236586
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of MGAT4A mRNA	PMID:27387713
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MGAT4A mRNA	PMID:19320972
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313803	E	RGD:6480464	20120412	CTD	MESH:C018021	cobaltous chloride results in increased expression of MGAT4A mRNA	PMID:20105288
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MGAT4A mRNA	PMID:24449571
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MGAT4A mRNA	PMID:28302478
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MGAT4A mRNA	PMID:31533062
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313803	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MGAT4A mRNA	PMID:25979313
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313803	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of MGAT4A mRNA	PMID:24935251
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313803	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MGAT4A gene	PMID:29154799
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MGAT4A mRNA	PMID:25562108
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1313803	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of MGAT4A promoter	PMID:27989131
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313804	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MGAT4A mRNA	PMID:28973697
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGAT4A mRNA	PMID:37992649
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313803	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MGAT4A mRNA	PMID:24935251|PMID:26272509
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313803	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of MGAT4A mRNA	PMID:24935251
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313803	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA	PMID:27188386
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MGAT4A mRNA	PMID:33387578
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313803	E	RGD:6480464	20160210	CTD	MESH:D000082	Acetaminophen results in increased expression of MGAT4A mRNA	PMID:26497421
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313803	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MGAT4A mRNA	PMID:35811015
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313804	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MGAT4A mRNA	PMID:29279043
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene] which results in increased expression of MGAT4A mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MGAT4A mRNA	PMID:40504410
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313804	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MGAT4A mRNA	PMID:35436446
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MGAT4A mRNA	PMID:29097150
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313804	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MGAT4A mRNA; Nanotubes, Carbon results in increased expression of MGAT4A mRNA	PMID:25554681
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of MGAT4A mRNA	PMID:24793618
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MGAT4A mRNA	PMID:38701926
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313803	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MGAT4A mRNA	PMID:26378955
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT4A mRNA	PMID:26378955
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313803	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MGAT4A intron	PMID:30157460
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MGAT4A gene	PMID:35440735
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313804	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MGAT4A mRNA	PMID:22206623
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313803	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MGAT4A mRNA	PMID:22714537
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313803	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA	PMID:27188386
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313804	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MGAT4A mRNA	PMID:31388691
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313803	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA	PMID:27188386
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313803	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MGAT4A mRNA	PMID:29301935
1305650	Mgat4a	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MGAT4A mRNA	PMID:23034163
1305651	Ccnq	cyclin Q	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1604257	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CCNQ mRNA	PMID:38218311
1305651	Ccnq	cyclin Q	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1604257	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CCNQ mRNA	PMID:38218311
1305651	Ccnq	cyclin Q	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313805	E	RGD:6480464	20181016	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CCNQ mRNA	PMID:26251327
1305651	Ccnq	cyclin Q	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1604257	E	RGD:6480464	20250603	CTD	MESH:D014212	Tretinoin results in decreased expression of CCNQ mRNA	PMID:33167477
1305651	Ccnq	cyclin Q	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1604257	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CCNQ mRNA	PMID:22378314
1305651	Ccnq	cyclin Q	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313805	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CCNQ mRNA	PMID:30319688
1305651	Ccnq	cyclin Q	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1604257	E	RGD:6480464	20130618	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CCNQ mRNA	PMID:21179406
1305651	Ccnq	cyclin Q	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313805	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCNQ mRNA	PMID:39241906
1305651	Ccnq	cyclin Q	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604257	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CCNQ mRNA	PMID:37042841
1305651	Ccnq	cyclin Q	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1604257	E	RGD:6480464	20130618	CTD	MESH:C044887	beta-methylcholine affects the expression of CCNQ mRNA	PMID:21179406
1305651	Ccnq	cyclin Q	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CCNQ mRNA	PMID:33387578
1305651	Ccnq	cyclin Q	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604257	E	RGD:6480464	20130618	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CCNQ mRNA	PMID:19549813
1305651	Ccnq	cyclin Q	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C016517	indole-3-carbinol affects the expression of CCNQ mRNA	PMID:21396975
1305651	Ccnq	cyclin Q	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604257	E	RGD:6480464	20250603	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CCNQ intron	PMID:30157460
1305651	Ccnq	cyclin Q	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313805	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNQ mRNA	PMID:22206623
1305651	Ccnq	cyclin Q	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCNQ mRNA	PMID:33387578
1305651	Ccnq	cyclin Q	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCNQ mRNA	PMID:32109520
1305651	Ccnq	cyclin Q	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20180403	CTD	MESH:D012402	Rotenone results in decreased expression of CCNQ mRNA	PMID:19013527
1305651	Ccnq	cyclin Q	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1604257	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CCNQ mRNA	PMID:29803840
1305651	Ccnq	cyclin Q	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1604257	E	RGD:6480464	20130618	CTD	MESH:D024483	Vitamin K 3 affects the expression of CCNQ mRNA	PMID:20044591
1305651	Ccnq	cyclin Q	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604257	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCNQ mRNA	PMID:38568856
1305651	Ccnq	cyclin Q	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604257	E	RGD:6480464	20250603	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CCNQ promoter	PMID:27901495
1305651	Ccnq	cyclin Q	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604257	E	RGD:6480464	20250603	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCNQ 5' UTR	PMID:27901495
1305651	Ccnq	cyclin Q	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313805	E	RGD:6480464	20181016	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CCNQ mRNA	PMID:19073995|PMID:33720480
1305651	Ccnq	cyclin Q	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313805	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCNQ gene	PMID:35295148
1305651	Ccnq	cyclin Q	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CCNQ mRNA	PMID:34492290
1305651	Ccnq	cyclin Q	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1604257	E	RGD:6480464	20130618	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCNQ mRNA	PMID:19710929
1305651	Ccnq	cyclin Q	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1604257	E	RGD:6480464	20250603	CTD	MESH:C006780	bisphenol A results in decreased expression of CCNQ mRNA	PMID:29275510
1305651	Ccnq	cyclin Q	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CCNQ mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305651	Ccnq	cyclin Q	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313805	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CCNQ mRNA	PMID:39298647
1305651	Ccnq	cyclin Q	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313805	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CCNQ mRNA	PMID:37019170
1305651	Ccnq	cyclin Q	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1604257	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CCNQ mRNA	PMID:31533062
1305651	Ccnq	cyclin Q	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1604257	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCNQ mRNA	PMID:38832940
1305651	Ccnq	cyclin Q	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CCNQ mRNA	PMID:29391264
1305651	Ccnq	cyclin Q	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D018120	Finasteride results in increased expression of CCNQ mRNA	PMID:24136188
1305651	Ccnq	cyclin Q	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C082360	fipronil results in increased expression of CCNQ mRNA	PMID:23962444
1305651	Ccnq	cyclin Q	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313805	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CCNQ mRNA	PMID:35964746
1305651	Ccnq	cyclin Q	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CCNQ mRNA	PMID:30467583
1305651	Ccnq	cyclin Q	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1604257	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CCNQ mRNA	PMID:31758290
1305651	Ccnq	cyclin Q	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313805	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNQ mRNA	PMID:22206623
1305651	Ccnq	cyclin Q	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313805	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of CCNQ mRNA	PMID:39847705
1305651	Ccnq	cyclin Q	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012999	Soman results in decreased expression of CCNQ mRNA	PMID:19281266
1305651	Ccnq	cyclin Q	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D013467	Sulindac results in decreased expression of CCNQ mRNA	PMID:24136188
1305651	Ccnq	cyclin Q	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313805	E	RGD:6480464	20181016	CTD	MESH:D019284	Thapsigargin results in decreased expression of CCNQ protein	PMID:24648495
1305652	Mkx	mohawk homeobox	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1313806	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of MKX mRNA	PMID:34925699
1305652	Mkx	mohawk homeobox	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MKX gene	PMID:20938992
1305652	Mkx	mohawk homeobox	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313806	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of MKX mRNA	PMID:23019147
1305652	Mkx	mohawk homeobox	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of MKX mRNA	PMID:26496021
1305652	Mkx	mohawk homeobox	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313806	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MKX mRNA	PMID:30165855
1305652	Mkx	mohawk homeobox	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MKX gene	PMID:20938992
1305652	Mkx	mohawk homeobox	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MKX mRNA	PMID:26577399
1305652	Mkx	mohawk homeobox	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MKX mRNA	PMID:33387578
1305652	Mkx	mohawk homeobox	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313806	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA	PMID:39836092
1305652	Mkx	mohawk homeobox	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313806	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MKX gene	PMID:27153756
1305652	Mkx	mohawk homeobox	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MKX mRNA	PMID:33387578
1305652	Mkx	mohawk homeobox	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MKX gene	PMID:20938992
1305652	Mkx	mohawk homeobox	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313806	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKX mRNA	PMID:39836092
1305652	Mkx	mohawk homeobox	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313807	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of MKX mRNA	PMID:32186404
1305652	Mkx	mohawk homeobox	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313806	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MKX mRNA	PMID:25583101
1305652	Mkx	mohawk homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313807	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MKX mRNA	PMID:21570461|PMID:24058054|PMID:28922406
1305652	Mkx	mohawk homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313807	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MKX mRNA	PMID:19933214
1305652	Mkx	mohawk homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MKX mRNA	PMID:32109520
1305652	Mkx	mohawk homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MKX promoter]	PMID:19654925
1305652	Mkx	mohawk homeobox	gene	CHEBI:28842	octadecanoic acid	increases expression	ISO	RGD:1313806	E	RGD:6480464	20210706	CTD	MESH:C031183	stearic acid results in increased expression of MKX mRNA	PMID:32347412
1305652	Mkx	mohawk homeobox	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313807	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of MKX mRNA	PMID:36209798|PMID:37682722
1305652	Mkx	mohawk homeobox	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313806	E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKX mRNA; sodium arsenite results in decreased expression of and affects the splicing of MKX mRNA	PMID:25879800|PMID:39836092
1305652	Mkx	mohawk homeobox	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA	PMID:34876320
1305652	Mkx	mohawk homeobox	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA	PMID:34876320
1305652	Mkx	mohawk homeobox	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313806	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MKX intron	PMID:30157460
1305652	Mkx	mohawk homeobox	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313806	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MKX 5' UTR; Benzo(a)pyrene results in increased methylation of MKX promoter	PMID:27901495
1305652	Mkx	mohawk homeobox	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313806	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MKX promoter	PMID:23974009
1305652	Mkx	mohawk homeobox	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313807	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MKX mRNA	PMID:27131904
1305652	Mkx	mohawk homeobox	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313807	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MKX gene	PMID:35295148
1305652	Mkx	mohawk homeobox	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313806	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MKX mRNA	PMID:30690063
1305652	Mkx	mohawk homeobox	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313806	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of MKX mRNA	PMID:27685785
1305652	Mkx	mohawk homeobox	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MKX mRNA	PMID:30816183
1305652	Mkx	mohawk homeobox	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of MKX mRNA	PMID:26496021
1305652	Mkx	mohawk homeobox	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313807	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MKX mRNA	PMID:39298647
1305652	Mkx	mohawk homeobox	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313806	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S affects the methylation of MKX gene	PMID:31601247
1305652	Mkx	mohawk homeobox	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313807	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of MKX mRNA	PMID:30951980
1305652	Mkx	mohawk homeobox	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of MKX gene	PMID:33148267
1305652	Mkx	mohawk homeobox	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313806	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA	PMID:39836092
1305652	Mkx	mohawk homeobox	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MKX mRNA	PMID:33453195
1305652	Mkx	mohawk homeobox	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313806	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MKX mRNA	PMID:32588087
1305652	Mkx	mohawk homeobox	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313806	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MKX gene	PMID:29154799
1305652	Mkx	mohawk homeobox	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313806	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of MKX mRNA	PMID:24935251
1305652	Mkx	mohawk homeobox	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313806	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MKX mRNA	PMID:20106945|PMID:27989131
1305652	Mkx	mohawk homeobox	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313806	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MKX mRNA	PMID:38832940
1305652	Mkx	mohawk homeobox	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313806	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of MKX mRNA	PMID:24935251
1305652	Mkx	mohawk homeobox	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MKX mRNA	PMID:33387578
1305652	Mkx	mohawk homeobox	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313806	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of MKX mRNA	PMID:16510598
1305652	Mkx	mohawk homeobox	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313806	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKX mRNA	PMID:39836092
1305652	Mkx	mohawk homeobox	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313806	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MKX mRNA	PMID:22079256
1305652	Mkx	mohawk homeobox	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA	PMID:34876320
1305652	Mkx	mohawk homeobox	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313806	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MKX mRNA	PMID:22714537
1305652	Mkx	mohawk homeobox	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313806	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA	PMID:39836092
1305652	Mkx	mohawk homeobox	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of MKX gene	PMID:33148267
1305652	Mkx	mohawk homeobox	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313807	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MKX mRNA	PMID:22206623
1305652	Mkx	mohawk homeobox	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313806	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MKX mRNA	PMID:22079256
1305652	Mkx	mohawk homeobox	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313806	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MKX mRNA	PMID:22714537
1305652	Mkx	mohawk homeobox	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313806	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MKX mRNA	PMID:22079256
1305652	Mkx	mohawk homeobox	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313806	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MKX protein	PMID:31285264
1305652	Mkx	mohawk homeobox	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313806	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of MKX mRNA	PMID:18927307
1305652	Mkx	mohawk homeobox	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA	PMID:34876320
1305652	Mkx	mohawk homeobox	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313807	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MKX mRNA	PMID:27131904
1305652	Mkx	mohawk homeobox	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313806	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MKX mRNA	PMID:29301935
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313808	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PEAR1 mRNA	PMID:37995155
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1642918	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of PEAR1 mRNA	PMID:21934132
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of PEAR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of PEAR1 mRNA	PMID:32699268
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1642918	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PEAR1 mRNA	PMID:21632981
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313808	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PEAR1 mRNA	PMID:39241906
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313808	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PEAR1 mRNA]	PMID:39241906
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1642918	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of PEAR1 mRNA	PMID:31614463
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1642918	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PEAR1 mRNA	PMID:37042841
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1642918	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PEAR1 mRNA	PMID:26079696
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1642918	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PEAR1 mRNA	PMID:31163220
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PEAR1 mRNA	PMID:26577399
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PEAR1 mRNA	PMID:33387578
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1642918	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PEAR1 intron	PMID:30157460
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1642918	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PEAR1 mRNA	PMID:21641981
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313808	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PEAR1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PEAR1 mRNA	PMID:34911549
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of PEAR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of PEAR1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of PEAR1 mRNA	PMID:32699268
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313808	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PEAR1 mRNA	PMID:40504410
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1642918	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PEAR1 mRNA	PMID:26272509
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEAR1 mRNA	PMID:27188386
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PEAR1 mRNA	PMID:31881176
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313808	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PEAR1 mRNA	PMID:30912803
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1642918	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PEAR1 mRNA	PMID:24768652|PMID:25583101
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PEAR1 mRNA	PMID:33387578
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PEAR1 mRNA	PMID:34747641
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1642918	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of PEAR1 mRNA	PMID:29955902
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1642918	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PEAR1 mRNA	PMID:33212167
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1642918	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PEAR1 mRNA	PMID:29803840
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1642918	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of PEAR1 mRNA	PMID:34032870
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1642918	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PEAR1 mRNA	PMID:38568856|PMID:39719251
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313808	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PEAR1 mRNA	PMID:40504410
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1642918	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PEAR1 intron	PMID:30157460
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313808	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PEAR1 mRNA	PMID:22228805
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1642918	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PEAR1 mRNA	PMID:32234424
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1642918	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PEAR1 5' UTR	PMID:27901495
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1642918	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of PEAR1 gene	PMID:25435355
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PEAR1 mRNA]	PMID:32406909
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313808	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of PEAR1 mRNA	PMID:27131904
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1642918	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PEAR1 mRNA	PMID:25895662
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313808	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PEAR1 promoter	PMID:35295148
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of PEAR1 mRNA	PMID:30816183
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PEAR1 mRNA	PMID:25181051|PMID:34947998
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313808	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of PEAR1 mRNA	PMID:30951980|PMID:33221593
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PEAR1 gene	PMID:28505145
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313808	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PEAR1 gene	PMID:31683443
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313808	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PEAR1 mRNA	PMID:40203079
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313808	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PEAR1 exon	PMID:33297965
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313808	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PEAR1 mRNA	PMID:30951980|PMID:40203079
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313808	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PEAR1 mRNA	PMID:26377693
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313808	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PEAR1 mRNA	PMID:38685157
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313808	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PEAR1 mRNA	PMID:30951980
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313808	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PEAR1 mRNA	PMID:37019170
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PEAR1 mRNA	PMID:21266533
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PEAR1 mRNA	PMID:28628672
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313808	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of PEAR1 mRNA	PMID:36117858
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313808	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PEAR1 mRNA]	PMID:39241906
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1642918	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PEAR1 mRNA	PMID:37042841
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1642918	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of PEAR1 mRNA	PMID:29024780
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1642918	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PEAR1 mRNA	PMID:26472689
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313808	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PEAR1 mRNA	PMID:28903501
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1642918	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PEAR1 mRNA	PMID:24449571
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of PEAR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of PEAR1 mRNA	PMID:32699268
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1642918	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PEAR1 mRNA	PMID:40419075
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1642918	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PEAR1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1642918	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PEAR1 gene	PMID:29154799
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEAR1 mRNA	PMID:27188386
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1642918	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of PEAR1 promoter	PMID:27989131
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1642918	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PEAR1 mRNA	PMID:25562108
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PEAR1 mRNA	PMID:28628672
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1642918	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PEAR1 mRNA	PMID:38832940
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1642918	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PEAR1 mRNA	PMID:24935251
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PEAR1 mRNA	PMID:33387578
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313808	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PEAR1 mRNA	PMID:40504410
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313808	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PEAR1 mRNA	PMID:35436446
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PEAR1 mRNA	PMID:28628672
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313808	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of PEAR1 mRNA	PMID:40234311
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313808	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of PEAR1 mRNA	PMID:36117858
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:6887	methylphenidate	increases expression	ISO	RGD:1313808	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in increased expression of PEAR1 mRNA	PMID:22470460
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1642918	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PEAR1 mRNA	PMID:22714537
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1642918	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PEAR1 mRNA	PMID:37199045
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:7719	ochratoxin A	increases acetylation	ISO	RGD:1642918	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in increased acetylation of PEAR1 promoter	PMID:29098329
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEAR1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEAR1 mRNA	PMID:27188386
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313808	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PEAR1 mRNA]	PMID:39241906
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1642918	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEAR1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEAR1 mRNA	PMID:27188386
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313808	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of PEAR1 mRNA	PMID:27131904
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1642918	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PEAR1 mRNA	PMID:38568856
1305653	Pear1	platelet endothelial aggregation receptor 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of PEAR1 gene	PMID:31682807
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1603378	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DCTN5 mRNA	PMID:38218311
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1332187	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DCTN5 mRNA	PMID:30319688
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332187	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DCTN5 mRNA	PMID:39241906
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1332187	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of DCTN5 mRNA	PMID:18978301
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1603378	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DCTN5 mRNA	PMID:23649840
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DCTN5 mRNA	PMID:33387578
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of DCTN5 mRNA	PMID:22061828
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1603378	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DCTN5 mRNA	PMID:19549813
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1603378	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of DCTN5 mRNA	PMID:23649840
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of DCTN5 protein	PMID:33236894
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1603378	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DCTN5 mRNA	PMID:22100608
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1603378	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DCTN5 mRNA	PMID:23649840
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603378	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DCTN5 mRNA	PMID:35430440
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1332187	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of DCTN5 mRNA	PMID:25629700
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332187	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of DCTN5 mRNA	PMID:40504410
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1332187	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of DCTN5 protein	PMID:25505154
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603378	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of DCTN5 mRNA	PMID:27392435
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1603378	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DCTN5 mRNA	PMID:24768652|PMID:25583101
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332187	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DCTN5 mRNA	PMID:21570461
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DCTN5 mRNA	PMID:33387578
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DCTN5 mRNA	PMID:34747641
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1332187	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to DCTN5 promoter]	PMID:19654925
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1603378	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DCTN5 mRNA	PMID:33212167
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603378	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DCTN5 mRNA	PMID:29803840
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603378	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DCTN5 mRNA	PMID:38568856
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332187	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of DCTN5 mRNA	PMID:40504410
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1332187	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DCTN5 mRNA	PMID:22228805
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1603378	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to DCTN5 protein]	PMID:32406909
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of DCTN5 mRNA	PMID:30047161
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332187	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DCTN5 gene	PMID:35295148
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332187	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DCTN5 mRNA	PMID:20813756|PMID:23811191
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1603378	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DCTN5 mRNA	PMID:19710929
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of DCTN5 mRNA	PMID:26982218
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DCTN5 mRNA	PMID:25181051
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603378	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DCTN5 mRNA	PMID:37042841
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1332187	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of DCTN5 mRNA	PMID:18353800
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603378	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DCTN5 mRNA	PMID:25979313
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603378	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of DCTN5 mRNA	PMID:23179753|PMID:26272509
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603378	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCTN5 mRNA	PMID:27188386
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of DCTN5 mRNA	PMID:30047161
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603378	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DCTN5 mRNA	PMID:20106945|PMID:25562108
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1603378	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DCTN5 mRNA	PMID:29432896
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332187	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of DCTN5 mRNA	PMID:40504410
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1603378	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of DCTN5 mRNA	PMID:23228038
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of DCTN5 mRNA	PMID:24136188
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332187	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DCTN5 mRNA	PMID:35964746
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DCTN5 mRNA	PMID:24136188
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:6015	isoflurane	decreases expression	ISO	RGD:1332187	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in decreased expression of DCTN5 protein	PMID:35249202
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases methylation	ISO	RGD:1603378	E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased methylation of DCTN5 gene	PMID:29432895
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1332187	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in increased expression of DCTN5 mRNA	PMID:21335049
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332187	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DCTN5 mRNA	PMID:22206623
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603378	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCTN5 mRNA	PMID:27188386
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of DCTN5 mRNA	PMID:30047161
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603378	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCTN5 mRNA	PMID:27188386
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of DCTN5 mRNA	PMID:19281266
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DCTN5 mRNA	PMID:21346803
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of DCTN5 mRNA	PMID:24136188
1305654	Dctn5	dynactin subunit 5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DCTN5 mRNA	PMID:21346803
1305655	Actl7b	actin-like 7b	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313811	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ACTL7B mRNA	PMID:33045310
1305655	Actl7b	actin-like 7b	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ACTL7B mRNA	PMID:33387578
1305655	Actl7b	actin-like 7b	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ACTL7B gene	PMID:27618143
1305655	Actl7b	actin-like 7b	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313810	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACTL7B mRNA	PMID:35301059
1305655	Actl7b	actin-like 7b	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313811	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ACTL7B mRNA	PMID:27106289
1305655	Actl7b	actin-like 7b	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ACTL7B mRNA	PMID:31881176
1305655	Actl7b	actin-like 7b	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313811	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACTL7B mRNA	PMID:21570461
1305655	Actl7b	actin-like 7b	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACTL7B mRNA	PMID:33387578
1305655	Actl7b	actin-like 7b	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313811	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACTL7B mRNA	PMID:31961203
1305655	Actl7b	actin-like 7b	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313810	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ACTL7B mRNA	PMID:33212167
1305655	Actl7b	actin-like 7b	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313810	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ACTL7B promoter	PMID:27901495
1305655	Actl7b	actin-like 7b	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of ACTL7B mRNA	PMID:32479839
1305655	Actl7b	actin-like 7b	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313811	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACTL7B mRNA	PMID:35295148
1305655	Actl7b	actin-like 7b	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313811	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACTL7B mRNA	PMID:19710929
1305655	Actl7b	actin-like 7b	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ACTL7B mRNA	PMID:19167457
1305655	Actl7b	actin-like 7b	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ACTL7B mRNA	PMID:25181051
1305655	Actl7b	actin-like 7b	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313810	E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of ACTL7B mRNA	PMID:23146750
1305655	Actl7b	actin-like 7b	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1313810	E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of ACTL7B mRNA	PMID:23146750
1305655	Actl7b	actin-like 7b	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313810	E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ACTL7B mRNA	PMID:23146750
1305655	Actl7b	actin-like 7b	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1313810	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of ACTL7B mRNA	PMID:37047231
1305655	Actl7b	actin-like 7b	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313810	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACTL7B mRNA	PMID:35301059
1305655	Actl7b	actin-like 7b	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313810	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ACTL7B mRNA	PMID:23146750
1305655	Actl7b	actin-like 7b	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of ACTL7B mRNA	PMID:25539665
1305655	Actl7b	actin-like 7b	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313811	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACTL7B mRNA	PMID:40194260
1305655	Actl7b	actin-like 7b	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313810	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ACTL7B mRNA	PMID:25979313
1305655	Actl7b	actin-like 7b	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313810	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ACTL7B gene	PMID:29154799
1305655	Actl7b	actin-like 7b	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313811	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ACTL7B mRNA	PMID:28973697
1305655	Actl7b	actin-like 7b	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313810	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACTL7B mRNA	PMID:23146750
1305655	Actl7b	actin-like 7b	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ACTL7B mRNA	PMID:23914054
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313812	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of IGFBPL1 mRNA	PMID:26272509
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313812	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA	PMID:27188386
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313812	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of IGFBPL1 mRNA	PMID:21934132
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313812	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of IGFBPL1 mRNA	PMID:24763279
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313812	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IGFBPL1 mRNA	PMID:26079696
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313812	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of IGFBPL1 mRNA	PMID:28986285
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313812	E	RGD:6480464	20171010	CTD	MESH:D004958	Estradiol results in decreased expression of IGFBPL1 mRNA	PMID:28591870|PMID:28711546
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA	PMID:25510870
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of IGFBPL1 gene	PMID:27618143
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IGFBPL1 mRNA	PMID:26577399
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA	PMID:25510870
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA	PMID:25510870
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313812	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of IGFBPL1 mRNA	PMID:23557933
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313812	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of IGFBPL1 mRNA	PMID:28903495
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of IGFBPL1 mRNA	PMID:28959563
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313812	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of IGFBPL1 mRNA	PMID:25879800
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313812	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IGFBPL1 3' UTR; Benzo(a)pyrene results in increased methylation of IGFBPL1 5' UTR	PMID:27901495
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:31767	lead diacetate	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C008261	lead acetate affects the expression of IGFBPL1 mRNA	PMID:21864555
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IGFBPL1 mRNA	PMID:25181051
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313813	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of IGFBPL1 mRNA	PMID:32156529|PMID:32365465
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of IGFBPL1 mRNA	PMID:30816183|PMID:34947998
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA	PMID:25510870
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA	PMID:25510870
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1313812	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to IGFBPL1 promoter]	PMID:20348232
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313813	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of IGFBPL1 gene	PMID:31683443
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313813	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of IGFBPL1 mRNA	PMID:30951980
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313813	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of IGFBPL1 exon	PMID:33297965
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313813	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of IGFBPL1 mRNA	PMID:30951980
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313813	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of IGFBPL1 exon; butylbenzyl phthalate results in increased methylation of IGFBPL1 intron	PMID:28392331
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of IGFBPL1 mRNA	PMID:22110744
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of IGFBPL1 mRNA	PMID:32680482
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of IGFBPL1 promoter	PMID:22457795
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IGFBPL1 mRNA	PMID:24386269
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBPL1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBPL1 mRNA]	PMID:17585979
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313812	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of IGFBPL1 mRNA	PMID:31533062
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of IGFBPL1 mRNA	PMID:22110744
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313812	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of IGFBPL1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313812	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA	PMID:27188386
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313813	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of IGFBPL1 mRNA	PMID:25123088
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313812	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IGFBPL1 mRNA	PMID:38832940
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313812	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of IGFBPL1 mRNA	PMID:24935251
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313813	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IGFBPL1 mRNA	PMID:17562736
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBPL1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBPL1 mRNA]	PMID:17585979
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of IGFBPL1 mRNA	PMID:30307764
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of IGFBPL1 mRNA	PMID:20080153
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313813	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of IGFBPL1 mRNA	PMID:22206623
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313812	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA	PMID:27188386
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313812	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IGFBPL1 gene]	PMID:28238834
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of IGFBPL1 mRNA	PMID:21394737
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:81922	flusilazole	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C061365	flusilazole results in decreased expression of IGFBPL1 mRNA	PMID:28263823
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313813	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of IGFBPL1 mRNA	PMID:27029645
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of IGFBPL1 mRNA	PMID:24780913
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313812	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA	PMID:27188386
1305656	Igfbpl1	insulin-like growth factor binding protein-like 1	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in increased expression of IGFBPL1 mRNA	PMID:26141394
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313815	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PPP2R5E mRNA	PMID:33045310
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of PPP2R5E mRNA]	PMID:19467301
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP2R5E mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPP2R5E gene	PMID:20938992
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP2R5E mRNA	PMID:36331819
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:15891	taurine	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20120412	CTD	MESH:D013654	Taurine results in decreased expression of PPP2R5E mRNA	PMID:16579726
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PPP2R5E mRNA	PMID:22378314
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PPP2R5E mRNA	PMID:39298647
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PPP2R5E gene	PMID:27618143
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP2R5E mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPP2R5E gene	PMID:20938992
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PPP2R5E mRNA	PMID:23649840
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:17578	toluene	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D014050	Toluene affects the expression of PPP2R5E mRNA	PMID:21827849
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:17642	pentachlorophenol	affects expression	ISO	RGD:1313815	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol affects the expression of PPP2R5E mRNA	PMID:23892564
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313814	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PPP2R5E protein	PMID:37730182
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313814	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PPP2R5E intron	PMID:30157460
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP2R5E mRNA	PMID:36331819
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	decreases response to substance	ISO	RGD:1313814	E	RGD:6480464	20150609	CTD	MESH:D008769	PPP2R5E protein results in decreased susceptibility to Methylnitronitrosoguanidine	PMID:25772433
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPP2R5E mRNA	PMID:37236586
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313814	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PPP2R5E mRNA	PMID:19549813
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of PPP2R5E mRNA	PMID:23487506
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PPP2R5E mRNA	PMID:35430440
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP2R5E mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPP2R5E gene	PMID:20938992
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:27504	mitomycin C	decreases response to substance	ISO	RGD:1313814	E	RGD:6480464	20150609	CTD	MESH:D016685	PPP2R5E protein results in decreased susceptibility to Mitomycin	PMID:25772433
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP2R5E mRNA	PMID:40512198
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PPP2R5E mRNA	PMID:19244175
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:27656	camptothecin	decreases response to substance	ISO	RGD:1313814	E	RGD:6480464	20150609	CTD	MESH:D002166	PPP2R5E protein results in decreased susceptibility to Camptothecin	PMID:25772433
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:27656	camptothecin	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20150609	CTD	MESH:D002166	Camptothecin affects the localization of [PPP2R5E protein binds to PPP2CA protein]; PPP2R5E protein inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form]	PMID:25772433
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PPP2R5E mRNA	PMID:26272509
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA	PMID:27188386
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313814	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PPP2R5E protein	PMID:35688186
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313815	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPP2R5E mRNA	PMID:21570461|PMID:24680724
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPP2R5E mRNA	PMID:21215274
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPP2R5E mRNA	PMID:23994337
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP2R5E mRNA	PMID:17942748
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PPP2R5E mRNA	PMID:33212167
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPP2R5E mRNA	PMID:29803840
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313814	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PPP2R5E protein	PMID:35688186
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in decreased expression of PPP2R5E mRNA	PMID:19695318
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313814	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PPP2R5E mRNA	PMID:38568856
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP2R5E mRNA	PMID:40512198
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of PPP2R5E mRNA	PMID:17127020
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313814	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPP2R5E intron	PMID:30157460
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPP2R5E mRNA	PMID:19770486
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313815	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PPP2R5E mRNA	PMID:22228805
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to PPP2R5E mRNA]	PMID:32406909
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in decreased expression of PPP2R5E mRNA	PMID:19695318
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PPP2R5E mRNA	PMID:19150397|PMID:20018196
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PPP2R5E mRNA	PMID:39716349
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PPP2R5E mRNA	PMID:24136188
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPP2R5E mRNA	PMID:25729387
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313815	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PPP2R5E gene; titanium dioxide results in decreased methylation of PPP2R5E promoter	PMID:35295148
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313815	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PPP2R5E promoter	PMID:35295148
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PPP2R5E mRNA	PMID:23811191
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PPP2R5E mRNA	PMID:25181051
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of PPP2R5E protein	PMID:31675489
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313814	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PPP2R5E gene	PMID:31601247
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PPP2R5E gene	PMID:28505145
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PPP2R5E protein	PMID:31675489
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPP2R5E mRNA	PMID:23994337
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313815	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PPP2R5E mRNA	PMID:39298647
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313814	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PPP2R5E intron	PMID:30157460
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PPP2R5E mRNA	PMID:34813904
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PPP2R5E mRNA	PMID:34813904
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313814	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPP2R5E mRNA	PMID:37042841
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPP2R5E mRNA	PMID:37236586
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313814	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PPP2R5E mRNA	PMID:24449571
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313815	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PPP2R5E mRNA	PMID:18353800
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PPP2R5E mRNA	PMID:19244175
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PPP2R5E mRNA	PMID:19167446
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PPP2R5E mRNA	PMID:40419075
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP2R5E mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP2R5E mRNA	PMID:36331819
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PPP2R5E mRNA	PMID:17292431
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PPP2R5E mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA	PMID:27188386
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of PPP2R5E mRNA	PMID:19770486
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PPP2R5E mRNA	PMID:17555576
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPP2R5E mRNA	PMID:21420995
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP2R5E mRNA	PMID:40512198
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:4744	Echimidine	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of PPP2R5E mRNA	PMID:33884520
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313814	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of PPP2R5E mRNA	PMID:18175754
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PPP2R5E mRNA	PMID:17555576
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of PPP2R5E mRNA	PMID:17942748
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PPP2R5E mRNA	PMID:17942748
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP2R5E mRNA	PMID:17942748
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PPP2R5E mRNA	PMID:39716349
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313815	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PPP2R5E mRNA	PMID:25620056
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PPP2R5E protein	PMID:32959892
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PPP2R5E mRNA	PMID:25729387
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPP2R5E mRNA	PMID:25729387
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of PPP2R5E mRNA	PMID:24136188
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PPP2R5E mRNA	PMID:30467583
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313814	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PPP2R5E intron	PMID:30157460
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PPP2R5E gene	PMID:35440735
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in increased expression of PPP2R5E mRNA	PMID:33884520
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PPP2R5E mRNA	PMID:22206623
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PPP2R5E mRNA	PMID:24136188
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313815	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PPP2R5E mRNA	PMID:23994337
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA	PMID:27188386
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of PPP2R5E mRNA	PMID:23091169
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313814	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PPP2R5E protein	PMID:31675489
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PPP2R5E mRNA	PMID:27291303
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of PPP2R5E mRNA	PMID:23640034
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313814	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA	PMID:27188386
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PPP2R5E mRNA	PMID:21346803
1305657	Ppp2r5e	protein phosphatase 2 regulatory subunit B', epsilon	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PPP2R5E mRNA	PMID:19015723
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TAF1C mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TAF1C gene	PMID:20938992
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313816	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TAF1C mRNA	PMID:22378314
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of TAF1C mRNA	PMID:32145629
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TAF1C mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TAF1C gene	PMID:20938992
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313817	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TAF1C mRNA	PMID:34319233
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313816	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TAF1C protein	PMID:37730182
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TAF1C mRNA	PMID:33387578
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313816	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA	PMID:39836092
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TAF1C mRNA	PMID:23630614
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313817	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TAF1C mRNA	PMID:19770486
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TAF1C mRNA	PMID:31150632
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313817	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TAF1C mRNA	PMID:25629700
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TAF1C mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TAF1C gene	PMID:20938992
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313816	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TAF1C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:39836092|PMID:40512198
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:40504410
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313816	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TAF1C protein	PMID:35688186
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313816	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of TAF1C mRNA	PMID:27594783
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1313817	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of TAF1C protein	PMID:22006019
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313817	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAF1C mRNA	PMID:21570461
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TAF1C mRNA	PMID:33387578
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TAF1C mRNA	PMID:17942748
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313816	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TAF1C mRNA	PMID:33212167
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313816	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TAF1C mRNA	PMID:29803840
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313816	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of TAF1C protein	PMID:35688186
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313816	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TAF1C mRNA	PMID:39719251
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313816	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TAF1C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:39836092|PMID:40512198
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:40504410
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313816	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TAF1C 5' UTR	PMID:27901495
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TAF1C mRNA	PMID:21839799
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313816	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF1C mRNA	PMID:17879257
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313817	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF1C mRNA	PMID:19770486
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313817	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TAF1C mRNA	PMID:27131904
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313817	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TAF1C gene	PMID:35295148
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TAF1C mRNA	PMID:23411599|PMID:34492290
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313817	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of TAF1C mRNA	PMID:18648102
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF1C mRNA	PMID:32145629|PMID:33296240
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313816	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF1C mRNA	PMID:25047013
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TAF1C mRNA	PMID:25181051|PMID:34947998
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313817	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TAF1C mRNA	PMID:33221593
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1313816	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of TAF1C mRNA	PMID:36804509
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313817	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TAF1C mRNA	PMID:38685157
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313817	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TAF1C mRNA	PMID:37019170
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313816	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA	PMID:39836092
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TAF1C mRNA	PMID:33453195
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313816	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TAF1C mRNA	PMID:31533062
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313816	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TAF1C gene	PMID:29154799
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TAF1C mRNA	PMID:33387578
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313816	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TAF1C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:39836092|PMID:40512198
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:40504410
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:4775	ellagic acid	decreases expression	ISO	RGD:1313816	E	RGD:6480464	20120412	CTD	MESH:D004610	Ellagic Acid results in decreased expression of TAF1C mRNA	PMID:12002526
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TAF1C mRNA	PMID:29391264
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TAF1C mRNA	PMID:17942748
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313816	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TAF1C protein	PMID:32959892
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313816	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA	PMID:39836092
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:6809	methamphetamine	affects methylation	ISO	RGD:1313817	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine affects the methylation of TAF1C promoter	PMID:26307267
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313817	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of TAF1C mRNA	PMID:26307267
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313817	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TAF1C mRNA	PMID:22206623
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313817	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TAF1C mRNA	PMID:30294300
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313817	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TAF1C mRNA	PMID:27131904
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TAF1C mRNA	PMID:21346803
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313817	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of TAF1C mRNA	PMID:32835833
1305658	Taf1c	TATA-box binding protein associated factor, RNA polymerase 1 subunit C	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313817	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TAF1C mRNA	PMID:35537566
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1343078	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of FBXL3 mRNA	PMID:27188386
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of FBXL3 mRNA	PMID:33045310
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1343078	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of FBXL3 mRNA	PMID:15928584
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552263	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FBXL3 mRNA	PMID:30319688
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXL3 mRNA	PMID:39241906
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1343078	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FBXL3 mRNA	PMID:31614463
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of FBXL3 mRNA	PMID:29980752
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552263	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of FBXL3 mRNA	PMID:20463053
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of FBXL3 mRNA; Gentamicins results in decreased expression of FBXL3A mRNA	PMID:22061828
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1343078	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FBXL3 mRNA	PMID:28818685
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1552263	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of FBXL3 mRNA	PMID:19376150
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:27214	uranium atom	affects expression	ISO	RGD:1343078	E	RGD:6480464	20250401	CTD	MESH:D014501	Uranium affects the expression of FBXL3A mRNA	PMID:15672453
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FBXL3 mRNA	PMID:17484886
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FBXL3 mRNA	PMID:25629700
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552263	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBXL3 mRNA	PMID:22206623
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1343078	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FBXL3 mRNA	PMID:23557933
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of FBXL3 mRNA	PMID:17898221
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1552263	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of FBXL3 mRNA	PMID:30912803
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXL3 mRNA	PMID:15034205
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552263	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FBXL3 mRNA]	PMID:15034205
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1343078	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FBXL3 mRNA	PMID:33212167
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552263	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of FBXL3 mRNA	PMID:25896364|PMID:39631538
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343078	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBXL3 mRNA	PMID:34032870
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FBXL3 mRNA	PMID:15034205
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552263	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of FBXL3 mRNA]	PMID:15034205
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1343078	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FBXL3 mRNA	PMID:20018196
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in decreased expression of FBXL3 mRNA	PMID:22609695
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552263	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXL3 promoter	PMID:35295148
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552263	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of FBXL3 mRNA	PMID:17426115
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of FBXL3 mRNA	PMID:33296240
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXL3 mRNA	PMID:36041667
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1343078	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL3 mRNA	PMID:28628672
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FBXL3 mRNA	PMID:39298647
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXL3 mRNA	PMID:36041667
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXL3 mRNA	PMID:36041667
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of FBXL3 mRNA	PMID:37019170
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of FBXL3 mRNA	PMID:21266533
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552263	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of FBXL3 mRNA	PMID:21266533
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1343078	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL3 mRNA	PMID:28628672
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1343078	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXL3 mRNA	PMID:38568856
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1343078	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FBXL3 mRNA	PMID:28302478
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1343078	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXL3 mRNA	PMID:31533062
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1343078	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of FBXL3 mRNA	PMID:40419075
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1343078	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXL3 mRNA	PMID:23179753|PMID:24383497|PMID:29154799
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of FBXL3 mRNA	PMID:38685447|PMID:41580965
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552263	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of FBXL3 mRNA	PMID:17555576
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1343078	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL3 mRNA	PMID:28628672
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1343078	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FBXL3 mRNA	PMID:24935251
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FBXL3 mRNA	PMID:29279043
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552263	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of FBXL3 mRNA	PMID:35436446
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552263	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FBXL3 mRNA	PMID:17555576
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1343078	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL3 mRNA	PMID:28628672
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of FBXL3 mRNA	PMID:41580965
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FBXL3 mRNA	PMID:22206623
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552263	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBXL3 mRNA	PMID:22206623
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552263	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of FBXL3 mRNA	PMID:23091169
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of FBXL3 mRNA	PMID:20345932
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1552263	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of FBXL3 mRNA	PMID:21795629
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FBXL3 mRNA	PMID:36843608
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of FBXL3 mRNA	PMID:19281266
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FBXL3 mRNA	PMID:21346803
1305660	Fbxl3	F-box and leucine-rich repeat protein 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FBXL3 mRNA	PMID:21346803
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313823	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBXW5 mRNA	PMID:20188158
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313823	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FBXW5 mRNA	PMID:30319688
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXW5 mRNA	PMID:39241906
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313823	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FBXW5 mRNA	PMID:39298647
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of FBXW5 mRNA	PMID:20823114
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FBXW5 mRNA	PMID:33387578
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313822	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FBXW5 mRNA	PMID:37042841
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313822	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of FBXW5 mRNA	PMID:18045764
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of FBXW5 mRNA	PMID:17997037
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313822	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FBXW5 protein	PMID:37730182
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:18248	iron atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D007501	[Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of FBXW5 mRNA	PMID:24619124
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA	PMID:39836092
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of FBXW5 mRNA	PMID:17997037
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of FBXW5 mRNA	PMID:19376150
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313822	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FBXW5 mRNA	PMID:23649840
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of FBXW5 mRNA	PMID:35430440
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of FBXW5 mRNA	PMID:22206623
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXW5 mRNA	PMID:39836092
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXW5 mRNA	PMID:40504410
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:27638	cobalt atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003035	[Tungsten co-treated with Nickel co-treated with Cobalt] results in decreased expression of FBXW5 mRNA	PMID:24619124
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:27998	tungsten	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D014414	[Tungsten co-treated with Nickel co-treated with Cobalt] results in decreased expression of FBXW5 mRNA; [Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of FBXW5 mRNA	PMID:24619124
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D009532	[Tungsten co-treated with Nickel co-treated with Cobalt] results in decreased expression of FBXW5 mRNA; [Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of FBXW5 mRNA	PMID:24619124
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXW5 mRNA	PMID:33387578
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBXW5 mRNA	PMID:17942748
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313823	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of FBXW5 mRNA	PMID:30807115
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313822	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBXW5 mRNA	PMID:38568856
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313822	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXW5 mRNA	PMID:39719251
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXW5 mRNA	PMID:39836092
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXW5 mRNA	PMID:40504410
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of FBXW5 mRNA	PMID:35676786
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in decreased expression of FBXW5 mRNA	PMID:17997037
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FBXW5 mRNA	PMID:34492290
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of FBXW5 mRNA	PMID:18301758
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of FBXW5 mRNA	PMID:19167457
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FBXW5 mRNA	PMID:25181051
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXW5 mRNA	PMID:36041667
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXW5 mRNA	PMID:28628672
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313823	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FBXW5 mRNA	PMID:39298647
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXW5 mRNA	PMID:36041667
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXW5 mRNA	PMID:36041667
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBXW5 mRNA	PMID:28628672
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313823	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FBXW5 mRNA	PMID:37019170
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313822	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of FBXW5 gene	PMID:22964155
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FBXW5 mRNA	PMID:21266533
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of FBXW5 mRNA	PMID:34813904
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXW5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBXW5 mRNA	PMID:28628672
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of FBXW5 mRNA	PMID:34813904
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA	PMID:39836092
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FBXW5 mRNA	PMID:24619124
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313822	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXW5 mRNA	PMID:31533062
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXW5 mRNA	PMID:21318169
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313822	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FBXW5 gene	PMID:29154799
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXW5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBXW5 mRNA	PMID:28628672
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXW5 mRNA	PMID:33387578
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FBXW5 mRNA	PMID:29432896
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXW5 mRNA	PMID:39836092
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXW5 mRNA	PMID:40504410
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FBXW5 mRNA	PMID:35436446
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FBXW5 mRNA	PMID:17942748
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBXW5 mRNA	PMID:17942748
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXW5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBXW5 mRNA	PMID:28628672
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of FBXW5 mRNA	PMID:35676786
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of FBXW5 mRNA	PMID:20823114
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of FBXW5 mRNA	PMID:23962444
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FBXW5 mRNA	PMID:35964746
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA	PMID:39836092
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:63940	sodium tungstate	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C025399	sodium tungstate(VI) results in decreased expression of FBXW5 mRNA	PMID:24619124
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1313822	E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of FBXW5 mRNA	PMID:20823114
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313823	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FBXW5 mRNA	PMID:22206623
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of FBXW5 mRNA	PMID:22206623
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1313822	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of FBXW5 mRNA	PMID:20185912
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313823	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of FBXW5 mRNA	PMID:30294300
1305661	Fbxw5	F-box and WD repeat domain containing 5	gene	CHEBI:82664	iron(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D007501	[Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of FBXW5 mRNA	PMID:24619124
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313824	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ZNF143 mRNA	PMID:33167477
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313824	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ZNF143 mRNA	PMID:26079696
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1313824	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of ZNF143 mRNA	PMID:39506029
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313824	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZNF143 mRNA	PMID:22378314
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313825	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP143 mRNA	PMID:39241906
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ZFP143 mRNA	PMID:33387578
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313824	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZNF143 mRNA	PMID:28818685
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313824	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ZNF143 intron	PMID:30157460
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313824	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZNF143 mRNA	PMID:19549813
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313825	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZFP143 mRNA	PMID:19770486
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313824	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZNF143 gene	PMID:27153756
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ZNF143 mRNA	PMID:41430723
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20170303	CTD	MESH:D017382	[IGF1 protein results in increased abundance of Reactive Oxygen Species] which results in increased expression of ZNF143 protein; monodansylcadaverine inhibits the reaction [[IGF1 protein results in increased abundance of Reactive Oxygen Species] which results in increased expression of ZNF143 protein]	PMID:20733350
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313824	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF143 gene	PMID:25304211
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF143 mRNA	PMID:23557933
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ZNF143 mRNA	PMID:27392435
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313824	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZNF143 mRNA	PMID:22298810
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313825	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP143 mRNA	PMID:21570461
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313825	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP143 mRNA	PMID:25975270
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ZFP143 mRNA	PMID:28374803
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313824	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZNF143 mRNA	PMID:32763439
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of ZNF143 mRNA	PMID:24690739
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313824	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF143 mRNA	PMID:29803840
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313824	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF143 mRNA	PMID:38568856
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313824	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF143 3' UTR; Benzo(a)pyrene affects the methylation of ZNF143 intron	PMID:27901495|PMID:30157460
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313825	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFP143 mRNA	PMID:22228805
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of ZNF143 mRNA	PMID:24690739
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313824	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ZNF143 mRNA; Silicon Dioxide results in increased expression of ZNF143 mRNA	PMID:23806026|PMID:25351596
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313825	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP143 gene; titanium dioxide results in decreased methylation of ZFP143 promoter	PMID:35295148
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZFP143 mRNA	PMID:34492290
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ZNF143 mRNA	PMID:38479592
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF143 mRNA	PMID:34947998
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313824	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF143 mRNA	PMID:29275510
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313825	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP143 mRNA	PMID:33221593
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZNF143 mRNA	PMID:25181051
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZFP143 gene	PMID:28505145
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313824	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ZNF143 intron	PMID:30157460
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313824	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF143 mRNA	PMID:37042841
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313824	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNF143 mRNA	PMID:38174414|PMID:38568856
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ZFP143 mRNA	PMID:30047161
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313824	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZNF143 mRNA	PMID:28302478
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313824	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ZNF143 mRNA	PMID:40419075
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313824	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF143 mRNA	PMID:23179753
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZFP143 mRNA	PMID:30047161
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313824	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF143 mRNA	PMID:20106945|PMID:25562108
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313825	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZFP143 mRNA	PMID:17562736
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZFP143 mRNA	PMID:33387578
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313824	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ZNF143 mRNA	PMID:29067470
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of ZNF143 mRNA	PMID:24690739
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313825	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ZFP143 mRNA	PMID:19446018
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313824	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF143 gene	PMID:25304211
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1313824	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of ZNF143 mRNA	PMID:22077320
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313825	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ZFP143 mRNA	PMID:35436446
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZFP143 mRNA	PMID:30047161
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313825	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ZFP143 mRNA	PMID:35964746
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:52007	monodansylcadaverine	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20120412	CTD	MESH:C008542	monodansylcadaverine inhibits the reaction [[IGF1 protein results in increased abundance of Reactive Oxygen Species] which results in increased expression of ZNF143 protein]	PMID:20733350
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin inhibits the reaction [IGF1 protein results in increased expression of ZNF143 protein]	PMID:20733350
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313824	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ZNF143 intron	PMID:30157460
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313825	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP143 mRNA	PMID:22206623
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:77986	dibenziodolium	multiple interactions	ISO	RGD:1313824	E	RGD:6480464	20140415	CTD	MESH:C007517	diphenyleneiodonium inhibits the reaction [IGF1 protein results in increased expression of ZNF143 protein]	PMID:20733350
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ZFP143 mRNA	PMID:32109520
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZFP143 mRNA	PMID:30047161
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313824	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF143 mRNA	PMID:38568856
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313825	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of ZFP143 mRNA	PMID:32835833
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313825	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ZNF143 mRNA	PMID:28973697
1305662	Zfp143	zinc finger protein 143	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of ZFP143 gene	PMID:31682807
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RAB40B mRNA]	PMID:31150632
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RAB40B mRNA	PMID:26079696
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313827	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RAB40B mRNA	PMID:30319688
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RAB40B mRNA	PMID:21632981
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313827	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of RAB40B mRNA	PMID:19484750
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of RAB40B mRNA	PMID:33448797
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of RAB40B mRNA]	PMID:33448797
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of RAB40B mRNA	PMID:33448797
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of RAB40B mRNA]	PMID:33448797
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RAB40B mRNA	PMID:33387578
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313826	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of RAB40B mRNA	PMID:24376830
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RAB40B mRNA	PMID:19549813
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313826	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RAB40B intron	PMID:30157460
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RAB40B mRNA	PMID:30723492|PMID:31150632
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RAB40B mRNA]	PMID:31150632
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RAB40B mRNA	PMID:40512198
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313826	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RAB40B protein	PMID:35688186
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RAB40B mRNA	PMID:31881176
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1313826	E	RGD:6480464	20120412	CTD	MESH:D002945	RAB40B protein affects the susceptibility to Cisplatin	PMID:16217747
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of RAB40B mRNA	PMID:24768652
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAB40B mRNA	PMID:32109520
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RAB40B mRNA	PMID:28001369
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of RAB40B mRNA	PMID:26272509
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB40B mRNA	PMID:27188386
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RAB40B mRNA	PMID:29803840
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAB40B mRNA	PMID:38568856
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RAB40B mRNA	PMID:40512198
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313826	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RAB40B intron	PMID:30157460
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RAB40B mRNA	PMID:26238291
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RAB40B mRNA	PMID:21839799
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RAB40B mRNA	PMID:25895662
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RAB40B mRNA	PMID:29341224
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:31348	capecitabine	increases response to substance	ISO	RGD:1313826	E	RGD:6480464	20170228	CTD	MESH:C110904	RAB40B protein results in increased susceptibility to Capecitabine	PMID:16734730
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:31521	doxifluridine	increases response to substance	ISO	RGD:1313826	E	RGD:6480464	20130806	CTD	MESH:C025034	RAB40B protein results in increased susceptibility to doxifluridine	PMID:16734730
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RAB40B mRNA	PMID:30047161
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of RAB40B mRNA	PMID:29264374
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313827	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RAB40B gene	PMID:35295148
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RAB40B mRNA	PMID:34492290
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RAB40B mRNA	PMID:25380136
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RAB40B mRNA	PMID:34947998
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313826	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in decreased methylation of RAB40B intron	PMID:29721103
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAB40B mRNA	PMID:25181051|PMID:41034487
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313827	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in increased expression of RAB40B mRNA	PMID:29161229|PMID:32156529
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAB40B gene	PMID:28505145
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RAB40B mRNA	PMID:28628672
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of RAB40B mRNA	PMID:26682919
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313826	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RAB40B intron	PMID:30157460
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RAB40B mRNA	PMID:28628672
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of RAB40B mRNA	PMID:22110744
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of RAB40B mRNA	PMID:36117858
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of RAB40B mRNA	PMID:30589522
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RAB40B mRNA	PMID:35163327
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of RAB40B mRNA	PMID:25380136
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RAB40B mRNA	PMID:35163327
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RAB40B mRNA	PMID:24386269
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313826	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RAB40B mRNA	PMID:19376846
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of RAB40B mRNA	PMID:25380136
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313826	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RAB40B mRNA	PMID:24449571
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RAB40B mRNA	PMID:28302478
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of RAB40B mRNA	PMID:19167446
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB40B mRNA	PMID:19167446
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313826	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAB40B mRNA	PMID:25979313
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of RAB40B mRNA	PMID:29154799
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313826	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RAB40B mRNA	PMID:22083351|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313826	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RAB40B gene	PMID:29154799
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB40B mRNA	PMID:27188386
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RAB40B mRNA	PMID:30047161
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RAB40B mRNA	PMID:25562108
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1313827	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in increased expression of RAB40B mRNA	PMID:40633821
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RAB40B mRNA	PMID:28628672
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of RAB40B mRNA	PMID:33448797
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of RAB40B mRNA]	PMID:33448797
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RAB40B mRNA	PMID:38832940
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313826	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RAB40B mRNA	PMID:22083351
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313826	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RAB40B mRNA	PMID:24935251
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RAB40B mRNA	PMID:33387578
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RAB40B mRNA	PMID:40512198
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RAB40B mRNA	PMID:28628672
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RAB40B mRNA	PMID:30047161
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of RAB40B mRNA]	PMID:33448797
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of RAB40B mRNA	PMID:36117858
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of RAB40B mRNA	PMID:38701926
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of RAB40B mRNA	PMID:24136188
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313826	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RAB40B mRNA	PMID:28988120
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313826	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RAB40B intron	PMID:30157460
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313826	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RAB40B mRNA	PMID:31758290
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB40B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB40B mRNA	PMID:27188386
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1313827	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of RAB40B mRNA	PMID:25270620
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB40B mRNA	PMID:19167446
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313827	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of RAB40B mRNA	PMID:38648751
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of RAB40B mRNA	PMID:23640034
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RAB40B mRNA	PMID:30047161
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313826	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB40B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB40B mRNA	PMID:27188386
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RAB40B mRNA	PMID:19281266
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RAB40B mRNA	PMID:21346803
1305663	Rab40b	Rab40b, member RAS oncogene family	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of RAB40B mRNA	PMID:22615374
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1332239	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ARHGAP44 mRNA	PMID:33045310
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ARHGAP44 gene	PMID:35440735
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1332239	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARHGAP44 mRNA	PMID:30319688
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ARHGAP44 mRNA	PMID:21632981
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1332239	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ARHGAP44 mRNA	PMID:39298647
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP44 mRNA	PMID:37992649
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP44 mRNA	PMID:37992649
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1604841	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ARHGAP44 intron	PMID:30157460
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGAP44 mRNA	PMID:37236586
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ARHGAP44 mRNA	PMID:19549813
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ARHGAP44 mRNA	PMID:22100608
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604841	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARHGAP44 intron	PMID:30157460
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP44 mRNA	PMID:40504410
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D003042	Cocaine results in decreased expression of ARHGAP44 protein	PMID:25100957
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ARHGAP44 mRNA	PMID:25583101
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20120522	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGAP44 mRNA	PMID:20106945
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARHGAP44 mRNA	PMID:33212167
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of ARHGAP44 mRNA	PMID:21198554
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGAP44 mRNA	PMID:29803840
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP44 mRNA	PMID:37992649
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1332239	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite affects the methylation of ARHGAP44 gene	PMID:39894169
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP44 mRNA	PMID:40504410
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604841	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARHGAP44 3' UTR; Benzo(a)pyrene affects the methylation of ARHGAP44 promoter	PMID:27901495
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARHGAP44 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604841	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ARHGAP44 exon	PMID:27901495
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARHGAP44 mRNA	PMID:26238291
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332239	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARHGAP44 gene	PMID:35295148
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332239	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ARHGAP44 mRNA	PMID:23811191
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of ARHGAP44 mRNA	PMID:30816183|PMID:34947998
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP44 mRNA	PMID:41034487
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1332239	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP44 mRNA	PMID:26063408
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604841	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARHGAP44 gene	PMID:31601247
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332239	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP44 mRNA	PMID:32156529
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1604841	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to ARHGAP44 promoter]	PMID:20348232
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332239	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ARHGAP44 mRNA	PMID:39298647
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1604841	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ARHGAP44 intron	PMID:30157460
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332239	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ARHGAP44 mRNA	PMID:37019170
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of ARHGAP44 mRNA	PMID:36117858
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGAP44 mRNA	PMID:35163327
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGAP44 mRNA	PMID:37236586
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1604841	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ARHGAP44 mRNA	PMID:25812627
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGAP44 mRNA	PMID:35163327
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1332239	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ARHGAP44 mRNA	PMID:40194260
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1604841	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ARHGAP44 mRNA	PMID:25812627|PMID:27153767
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARHGAP44 mRNA	PMID:24383497
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARHGAP44 mRNA	PMID:25562108|PMID:27989131
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1332239	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ARHGAP44 mRNA	PMID:28973697
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332239	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ARHGAP44 mRNA	PMID:28973697
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP44 mRNA	PMID:37992649
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP44 mRNA	PMID:40504410
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ARHGAP44 mRNA	PMID:29391264
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:48981	quinolin-8-ol	decreases expression	ISO	RGD:1604841	E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of ARHGAP44 mRNA	PMID:21632981
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1332239	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARHGAP44 mRNA	PMID:25554681
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of ARHGAP44 mRNA	PMID:21983209
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1332239	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of ARHGAP44 mRNA	PMID:36117858
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1604841	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ARHGAP44 mRNA	PMID:22714537
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1332239	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ARHGAP44 mRNA	PMID:23608068
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20160210	CTD	MESH:D008701	Methapyrilene results in increased methylation of ARHGAP44 gene	PMID:26431795
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1604841	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ARHGAP44 intron	PMID:30157460
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332239	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARHGAP44 mRNA	PMID:22206623
1305664	Arhgap44	Rho GTPase activating protein 44	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of ARHGAP44 mRNA	PMID:26923065
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1343640	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SCYL2 mRNA	PMID:23724009
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550516	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SCYL2 mRNA	PMID:39298647
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SCYL2 mRNA	PMID:33359661
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550516	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SCYL2 mRNA	PMID:34319233
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1343640	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SCYL2 protein	PMID:37730182
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SCYL2 mRNA	PMID:22061828|PMID:33387578
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1343640	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SCYL2 mRNA	PMID:28818685
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1343640	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCYL2 mRNA	PMID:39836092
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1343640	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SCYL2 mRNA	PMID:19549813
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1343640	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SCYL2 mRNA	PMID:23649840
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1343640	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SCYL2 gene	PMID:27153756
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1343640	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SCYL2 mRNA	PMID:23649840
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SCYL2 mRNA	PMID:21867686
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1343640	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCYL2 mRNA	PMID:39836092
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1343640	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SCYL2 mRNA	PMID:27392435
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550516	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SCYL2 mRNA	PMID:19770486
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SCYL2 mRNA	PMID:28001369
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1343640	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SCYL2 mRNA	PMID:32763439
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1343640	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SCYL2 mRNA	PMID:20971185
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550516	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of SCYL2 protein	PMID:28918527
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of SCYL2 mRNA	PMID:39719251
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1343640	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SCYL2 mRNA; sodium arsenite results in increased expression of SCYL2 protein	PMID:38228842|PMID:38568856
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1343640	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCYL2 mRNA	PMID:39836092
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1343640	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SCYL2 mRNA	PMID:20971185
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550516	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SCYL2 gene	PMID:35295148
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550516	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SCYL2 mRNA	PMID:18301758|PMID:23811191
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550516	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SCYL2 mRNA	PMID:33221593
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SCYL2 mRNA	PMID:25181051|PMID:30816183
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550516	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SCYL2 mRNA	PMID:39298647
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1343640	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCYL2 mRNA	PMID:39836092
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1550516	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of SCYL2 mRNA	PMID:28962523
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1550516	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of SCYL2 mRNA	PMID:23811191
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SCYL2 mRNA	PMID:28302478
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SCYL2 mRNA	PMID:27153767
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1343640	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SCYL2 mRNA	PMID:25979313
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1343640	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SCYL2 gene	PMID:29154799
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550516	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SCYL2 mRNA	PMID:19770486
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1343640	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SCYL2 mRNA	PMID:25562108
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SCYL2 mRNA	PMID:27188386
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SCYL2 mRNA	PMID:24935251|PMID:26272509
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550516	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SCYL2 mRNA	PMID:29279043
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1343640	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCYL2 mRNA	PMID:39836092
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of SCYL2 mRNA	PMID:40706910
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550516	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SCYL2 mRNA	PMID:25620056
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1343640	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SCYL2 mRNA	PMID:26705709
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SCYL2 protein	PMID:32959892
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1343640	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCYL2 mRNA	PMID:39836092
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1343640	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SCYL2 mRNA	PMID:31758290
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550516	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SCYL2 mRNA	PMID:22206623
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1343640	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SCYL2 mRNA	PMID:29301935
1305665	Scyl2	SCY1 like pseudokinase 2	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1343640	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SCYL2 mRNA	PMID:27188386
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313830	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of UNC45B mRNA	PMID:30510588
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004958	Estradiol results in decreased expression of UNC45B mRNA	PMID:26945725
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA	PMID:25510870
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of UNC45B mRNA	PMID:33387578
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D009538	Nicotine results in decreased expression of UNC45B mRNA	PMID:27782041
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313831	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UNC45B mRNA	PMID:32235866
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313830	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of UNC45B protein	PMID:34122009
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313830	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of UNC45B intron	PMID:30157460
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D009538	Nicotine results in decreased expression of UNC45B mRNA	PMID:27782041
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA	PMID:25510870
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA	PMID:25510870
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UNC45B mRNA	PMID:22129741
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313830	E	RGD:6480464	20150609	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of UNC45B mRNA	PMID:21641981
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of UNC45B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of UNC45B mRNA	PMID:34911549
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UNC45B mRNA	PMID:32109520
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UNC45B mRNA	PMID:19933214
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313830	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of UNC45B mRNA	PMID:29803840
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313830	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of UNC45B promoter	PMID:27901495
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UNC45B mRNA	PMID:22228805
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313830	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of UNC45B 5' UTR	PMID:27901495
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:C015001	arsenite results in decreased expression of UNC45B mRNA	PMID:18929588
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1313830	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of UNC45B protein	PMID:34122009
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UNC45B gene	PMID:35295148
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:C069837	fullerene C60 results in increased expression of UNC45B mRNA	PMID:19167457
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of UNC45B mRNA	PMID:41034487
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313830	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of UNC45B protein	PMID:37567409
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313831	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of UNC45B mRNA	PMID:32156529
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313831	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of UNC45B mRNA	PMID:26682919
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA	PMID:25510870
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA	PMID:25510870
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313831	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of UNC45B gene	PMID:31683443
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313831	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of UNC45B mRNA	PMID:39298647
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313831	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of UNC45B mRNA	PMID:30951980
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313831	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of UNC45B mRNA	PMID:30951980
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UNC45B mRNA	PMID:22129741
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313830	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UNC45B mRNA	PMID:37042841
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of UNC45B mRNA	PMID:35163327
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of UNC45B mRNA	PMID:35163327
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of UNC45B mRNA	PMID:35163327
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20150609	CTD	MESH:C039281	furan results in increased methylation of UNC45B gene	PMID:22079235
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1313830	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of UNC45B protein	PMID:34122009
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:39163	acetamiprid	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C464485	acetamiprid results in decreased expression of UNC45B mRNA	PMID:27782041
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313830	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of UNC45B promoter	PMID:27989131
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:D000082	Acetaminophen affects the expression of UNC45B mRNA	PMID:17562736
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313830	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of UNC45B mRNA	PMID:26690555
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1313830	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of UNC45B 3' UTR; Asbestos, Serpentine results in decreased methylation of UNC45B 5' UTR	PMID:29523930
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of UNC45B mRNA	PMID:15576828
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of UNC45B mRNA	PMID:19042947
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:5870	imidacloprid	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C082359	imidacloprid results in decreased expression of UNC45B mRNA	PMID:27782041
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313831	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of UNC45B mRNA	PMID:36907384
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313830	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of UNC45B mRNA	PMID:29522793
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313830	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to UNC45B gene]	PMID:28238834
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of UNC45B mRNA	PMID:32109520
1305666	Unc45b	unc-45 myosin chaperone B	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of UNC45B mRNA	PMID:27935865
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313833	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of VSX1 mRNA	PMID:33045310
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313832	E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of VSX1 protein	PMID:18951874
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313832	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in increased expression of VSX1 mRNA	PMID:27905399
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of VSX1 mRNA	PMID:33387578
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313832	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VSX1 mRNA	PMID:19549813
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of VSX1 mRNA	PMID:23630614
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of VSX1 mRNA	PMID:31129395
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313832	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VSX1 mRNA	PMID:27188386
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313832	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of VSX1 mRNA	PMID:23557933
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313832	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of VSX1 mRNA	PMID:27392435
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313833	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VSX1 mRNA	PMID:24058054
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:28177	theophylline	multiple interactions	ISO	RGD:1313832	E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of VSX1 protein	PMID:18951874
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313832	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of VSX1 3' UTR; Benzo(a)pyrene affects the methylation of VSX1 promoter	PMID:27901495
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313832	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of VSX1 exon	PMID:27901495
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313832	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of VSX1 promoter	PMID:23974009
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in decreased expression of VSX1 mRNA	PMID:33150645
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:30966	glycidol	increases methylation	EXP		E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in increased methylation of VSX1 promoter	PMID:33150595
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313833	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VSX1 gene	PMID:35295148
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313833	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of VSX1 promoter	PMID:27334623
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of VSX1 mRNA	PMID:25181051
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of VSX1 gene	PMID:28505145
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313833	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of VSX1 promoter	PMID:27312807
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of VSX1 mRNA	PMID:31129395
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313832	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of VSX1 mRNA	PMID:28298639
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:35004	Tetrachlorobisphenol A	increases expression	ISO	RGD:1313832	E	RGD:6480464	20191210	CTD	MESH:C041181	tetrachlorodian results in increased expression of VSX1 mRNA	PMID:31326446
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of VSX1 mRNA	PMID:35163327
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:D014635	Valproic Acid results in decreased expression of VSX1 mRNA	PMID:33150595
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20231003	CTD	MESH:D014635	Valproic Acid results in increased methylation of VSX1 promoter	PMID:33150595
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313832	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of VSX1 mRNA	PMID:22230336
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1313832	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of VSX1 promoter	PMID:29626692
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1313832	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of VSX1 promoter	PMID:29626692
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of VSX1 mRNA	PMID:29391264
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313832	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VSX1 mRNA	PMID:27188386
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in decreased expression of VSX1 mRNA	PMID:33150595
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases methylation	EXP		E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in increased methylation of VSX1 promoter	PMID:33150595
1305667	Vsx1	visual system homeobox 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313832	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VSX1 mRNA	PMID:27188386
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:10607	n-propyl gallate	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D011435	Propyl Gallate affects the expression of PAIP1 mRNA	PMID:18539377
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313834	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PAIP1 mRNA	PMID:23724009
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PAIP1 mRNA	PMID:22378314
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313835	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PAIP1 mRNA	PMID:40945087
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of PAIP1 mRNA	PMID:12419474
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PAIP1 mRNA	PMID:20849824
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313835	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PAIP1 mRNA	PMID:37236586
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PAIP1 mRNA	PMID:19549813
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PAIP1 protein	PMID:23301498
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of PAIP1 protein	PMID:33236894
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20130416	CTD	MESH:D000666	Amphotericin B results in decreased expression of PAIP1 mRNA	PMID:20849824
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313834	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PAIP1 protein	PMID:35688186
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20130416	CTD	MESH:D002945	Cisplatin results in decreased expression of PAIP1 mRNA	PMID:20849824
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313835	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PAIP1 mRNA	PMID:21570461
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PAIP1 mRNA	PMID:28001369
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PAIP1 mRNA	PMID:33212167
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of PAIP1 mRNA	PMID:23649840
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PAIP1 mRNA	PMID:28959563
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PAIP1 mRNA	PMID:20971185
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PAIP1 mRNA	PMID:29803840
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313835	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of PAIP1 mRNA	PMID:22342234
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313834	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PAIP1 promoter	PMID:27901495
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PAIP1 mRNA	PMID:20971185
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PAIP1 mRNA	PMID:25351596
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PAIP1 mRNA	PMID:19150397
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PAIP1 mRNA	PMID:30047161
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313835	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PAIP1 mRNA	PMID:18648102
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313835	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PAIP1 mRNA	PMID:18445702
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of PAIP1 mRNA	PMID:12419474
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PAIP1 mRNA	PMID:19167457
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PAIP1 mRNA	PMID:25181051
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PAIP1 mRNA	PMID:29275510|PMID:33670352
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313835	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PAIP1 mRNA	PMID:26063408
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP1 mRNA	PMID:28628672
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313835	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PAIP1 mRNA	PMID:39298647
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313835	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PAIP1 mRNA	PMID:21266533
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP1 mRNA	PMID:28628672
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PAIP1 mRNA	PMID:33453195
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313835	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PAIP1 mRNA	PMID:37236586
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313834	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PAIP1 mRNA	PMID:19376846
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PAIP1 mRNA	PMID:28302478
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PAIP1 mRNA	PMID:19167446
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PAIP1 mRNA	PMID:23179753|PMID:27188386
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of PAIP1 mRNA	PMID:38685447|PMID:41580965
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20130416	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of PAIP1 mRNA	PMID:20849824
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP1 mRNA	PMID:28628672
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313835	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PAIP1 mRNA	PMID:28973697
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of PAIP1 mRNA	PMID:33512557
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of PAIP1 mRNA	PMID:23649840
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PAIP1 mRNA	PMID:24935251|PMID:26272509
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAIP1 mRNA	PMID:27188386
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20160210	CTD	MESH:D000082	Acetaminophen results in decreased expression of PAIP1 mRNA	PMID:21420995|PMID:26497421
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of PAIP1 mRNA]	PMID:15016801
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313835	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PAIP1 mRNA	PMID:35436446
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP1 mRNA	PMID:28628672
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:49976	zinc dichloride	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20130122	CTD	MESH:C016837	zinc chloride results in decreased expression of PAIP1 mRNA	PMID:18947441
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of PAIP1 mRNA	PMID:38685447|PMID:41580965
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of PAIP1 mRNA	PMID:19162173
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313834	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PAIP1 protein	PMID:32959892
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D008694	Methamphetamine results in increased expression of PAIP1 mRNA	PMID:28341135
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PAIP1 mRNA	PMID:30467583
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1313835	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of PAIP1 mRNA	PMID:28444820
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313835	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PAIP1 mRNA	PMID:22206623
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PAIP1 protein	PMID:37664457
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAIP1 mRNA	PMID:27188386
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313835	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PAIP1 mRNA	PMID:31388691
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313835	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PAIP1 mRNA	PMID:30294300
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PAIP1 mRNA	PMID:30047161
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313834	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PAIP1 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAIP1 mRNA	PMID:27188386|PMID:37664457
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313834	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PAIP1 mRNA	PMID:29301935
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313835	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of PAIP1 protein	PMID:24648495
1305668	Paip1	poly(A) binding protein interacting protein 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PAIP1 mRNA	PMID:19015723
1305670	Lmo4	LIM domain only 4	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D004237	Diuron results in decreased expression of STIMATE mRNA	PMID:21551480
1305670	Lmo4	LIM domain only 4	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of LMO4 mRNA	PMID:21551480
1305670	Lmo4	LIM domain only 4	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of LMO4 mRNA	PMID:26272509
1305670	Lmo4	LIM domain only 4	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA	PMID:27188386
1305670	Lmo4	LIM domain only 4	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313838	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of LMO4 mRNA	PMID:33045310
1305670	Lmo4	LIM domain only 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of LMO4 mRNA	PMID:23724009
1305670	Lmo4	LIM domain only 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313838	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of LMO4 mRNA	PMID:30319688
1305670	Lmo4	LIM domain only 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of LMO4 mRNA	PMID:29432896
1305670	Lmo4	LIM domain only 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313838	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of LMO4 mRNA	PMID:39298647
1305670	Lmo4	LIM domain only 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LMO4 mRNA	PMID:33387578
1305670	Lmo4	LIM domain only 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313837	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LMO4 mRNA	PMID:37042841
1305670	Lmo4	LIM domain only 4	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250506	CTD	MESH:D002635	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1305670	Lmo4	LIM domain only 4	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313837	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of LMO4 mRNA	PMID:18037150
1305670	Lmo4	LIM domain only 4	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20260811	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of STIMATE mRNA	PMID:26496021
1305670	Lmo4	LIM domain only 4	gene	CHEBI:17687	glycocholic acid	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250506	CTD	MESH:D006000	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1305670	Lmo4	LIM domain only 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LMO4 mRNA	PMID:19850644
1305670	Lmo4	LIM domain only 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of LMO4 mRNA]	PMID:19850644
1305670	Lmo4	LIM domain only 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D005839	Gentamicins results in decreased expression of STIMATE mRNA	PMID:33387578
1305670	Lmo4	LIM domain only 4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of LMO4 mRNA	PMID:22061828
1305670	Lmo4	LIM domain only 4	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313837	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LMO4 mRNA	PMID:28818685
1305670	Lmo4	LIM domain only 4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA	PMID:39836092
1305670	Lmo4	LIM domain only 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LMO4 mRNA	PMID:37236586
1305670	Lmo4	LIM domain only 4	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313837	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LMO4 mRNA	PMID:19549813
1305670	Lmo4	LIM domain only 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313837	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LMO4 gene	PMID:27153756
1305670	Lmo4	LIM domain only 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of LMO4 mRNA	PMID:27106289
1305670	Lmo4	LIM domain only 4	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1313838	E	RGD:6480464	20200519	CTD	MESH:D015032	Zinc deficiency results in increased expression of LMO4 mRNA	PMID:31505237
1305670	Lmo4	LIM domain only 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LMO4 mRNA	PMID:22206623
1305670	Lmo4	LIM domain only 4	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250506	CTD	MESH:D006002	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1305670	Lmo4	LIM domain only 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:39836092
1305670	Lmo4	LIM domain only 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:40504410
1305670	Lmo4	LIM domain only 4	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of LMO4 mRNA	PMID:26272509
1305670	Lmo4	LIM domain only 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA	PMID:27188386
1305670	Lmo4	LIM domain only 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LMO4 mRNA	PMID:28960355
1305670	Lmo4	LIM domain only 4	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of LMO4 mRNA	PMID:24768652
1305670	Lmo4	LIM domain only 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313838	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LMO4 mRNA	PMID:21570461
1305670	Lmo4	LIM domain only 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LMO4 mRNA	PMID:20106945|PMID:21632981
1305670	Lmo4	LIM domain only 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LMO4 mRNA	PMID:33387578|PMID:34747641
1305670	Lmo4	LIM domain only 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LMO4 mRNA	PMID:17942748
1305670	Lmo4	LIM domain only 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LMO4 mRNA	PMID:28001369
1305670	Lmo4	LIM domain only 4	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313837	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LMO4 mRNA	PMID:28001369
1305670	Lmo4	LIM domain only 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of LMO4 mRNA	PMID:16243910
1305670	Lmo4	LIM domain only 4	gene	CHEBI:28834	deoxycholic acid	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250506	CTD	MESH:D003840	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1305670	Lmo4	LIM domain only 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313837	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LMO4 mRNA	PMID:38568856
1305670	Lmo4	LIM domain only 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:39836092
1305670	Lmo4	LIM domain only 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:40504410
1305670	Lmo4	LIM domain only 4	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313837	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of LMO4 mRNA	PMID:22378314
1305670	Lmo4	LIM domain only 4	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313838	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of LMO4 mRNA	PMID:22342234
1305670	Lmo4	LIM domain only 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313837	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LMO4 promoter	PMID:27901495
1305670	Lmo4	LIM domain only 4	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313837	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of LMO4 promoter	PMID:23974009
1305670	Lmo4	LIM domain only 4	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1313838	E	RGD:6480464	20200519	CTD	MESH:D015032	Zinc deficiency results in increased expression of LMO4 mRNA	PMID:31505237
1305670	Lmo4	LIM domain only 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LMO4 mRNA	PMID:20382639
1305670	Lmo4	LIM domain only 4	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D005897	Glafenine results in increased expression of STIMATE mRNA	PMID:24136188
1305670	Lmo4	LIM domain only 4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313837	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of LMO4 mRNA	PMID:38568856
1305670	Lmo4	LIM domain only 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of LMO4 mRNA	PMID:25729387
1305670	Lmo4	LIM domain only 4	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of STIMATE mRNA	PMID:30047161
1305670	Lmo4	LIM domain only 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313838	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LMO4 gene	PMID:35295148
1305670	Lmo4	LIM domain only 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313838	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LMO4 promoter	PMID:35295148
1305670	Lmo4	LIM domain only 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LMO4 mRNA	PMID:34492290
1305670	Lmo4	LIM domain only 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LMO4 mRNA	PMID:18445702
1305670	Lmo4	LIM domain only 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LMO4 mRNA	PMID:19710929
1305670	Lmo4	LIM domain only 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LMO4 mRNA	PMID:19710929
1305670	Lmo4	LIM domain only 4	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of LMO4 mRNA	PMID:38479592
1305670	Lmo4	LIM domain only 4	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of LMO4 mRNA	PMID:28329830
1305670	Lmo4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LMO4 mRNA; bisphenol A affects the expression of STIMATE mRNA	PMID:25181051
1305670	Lmo4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313838	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of LMO4 promoter	PMID:27334623
1305670	Lmo4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of LMO4 mRNA	PMID:32145629
1305670	Lmo4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LMO4 mRNA	PMID:29275510
1305670	Lmo4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in increased expression of STIMATE mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305670	Lmo4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in increased methylation of STIMATE gene	PMID:28505145
1305670	Lmo4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20260811	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of STIMATE mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of STIMATE mRNA	PMID:26496021|PMID:36041667
1305670	Lmo4	LIM domain only 4	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313837	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LMO4 mRNA	PMID:25979313
1305670	Lmo4	LIM domain only 4	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of LMO4 mRNA	PMID:26682919
1305670	Lmo4	LIM domain only 4	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LMO4 mRNA	PMID:23196670
1305670	Lmo4	LIM domain only 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20260811	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of STIMATE mRNA	PMID:36041667
1305670	Lmo4	LIM domain only 4	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20260811	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of STIMATE mRNA	PMID:36041667
1305670	Lmo4	LIM domain only 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LMO4 mRNA	PMID:21266533
1305670	Lmo4	LIM domain only 4	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313838	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of LMO4 mRNA	PMID:34813904
1305670	Lmo4	LIM domain only 4	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313838	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of LMO4 mRNA	PMID:34813904
1305670	Lmo4	LIM domain only 4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA	PMID:39836092
1305670	Lmo4	LIM domain only 4	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20260811	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of STIMATE promoter	PMID:22457795
1305670	Lmo4	LIM domain only 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LMO4 mRNA	PMID:37236586
1305670	Lmo4	LIM domain only 4	gene	CHEBI:35572	phorone	affects expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C018637	phorone affects the expression of LMO4 mRNA	PMID:18198479
1305670	Lmo4	LIM domain only 4	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of STIMATE mRNA	PMID:30047161
1305670	Lmo4	LIM domain only 4	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250506	CTD	MESH:D005999	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1305670	Lmo4	LIM domain only 4	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313838	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of LMO4 mRNA	PMID:18353800
1305670	Lmo4	LIM domain only 4	gene	CHEBI:39285	chloropicrin	affects expression	ISO	RGD:1313837	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of LMO4 mRNA	PMID:26352163
1305670	Lmo4	LIM domain only 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313837	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of LMO4 mRNA	PMID:40419075
1305670	Lmo4	LIM domain only 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313837	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LMO4 mRNA	PMID:25979313
1305670	Lmo4	LIM domain only 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313838	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid affects the expression of LMO4 mRNA	PMID:17292431|PMID:17963808
1305670	Lmo4	LIM domain only 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of LMO4 mRNA	PMID:28001369
1305670	Lmo4	LIM domain only 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of LMO4 mRNA	PMID:19136453
1305670	Lmo4	LIM domain only 4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313837	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LMO4 gene	PMID:29154799
1305670	Lmo4	LIM domain only 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313837	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of LMO4 mRNA	PMID:26272509
1305670	Lmo4	LIM domain only 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA	PMID:27188386
1305670	Lmo4	LIM domain only 4	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D000640	Amitrole results in increased expression of STIMATE mRNA	PMID:30047161
1305670	Lmo4	LIM domain only 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313837	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of LMO4 mRNA	PMID:20106945|PMID:22147139
1305670	Lmo4	LIM domain only 4	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of LMO4 mRNA	PMID:15171707
1305670	Lmo4	LIM domain only 4	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313837	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of LMO4 mRNA	PMID:24449571
1305670	Lmo4	LIM domain only 4	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of LMO4 mRNA	PMID:24935251
1305670	Lmo4	LIM domain only 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313837	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of LMO4 mRNA	PMID:24935251|PMID:26272509
1305670	Lmo4	LIM domain only 4	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA	PMID:27188386
1305670	Lmo4	LIM domain only 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LMO4 mRNA	PMID:17562736
1305670	Lmo4	LIM domain only 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LMO4 mRNA; Acetaminophen results in increased expression of STIMATE mRNA	PMID:33387578
1305670	Lmo4	LIM domain only 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313837	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of LMO4 mRNA	PMID:21420995|PMID:29067470
1305670	Lmo4	LIM domain only 4	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250506	CTD	MESH:D000082	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1305670	Lmo4	LIM domain only 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:39836092
1305670	Lmo4	LIM domain only 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:40504410
1305670	Lmo4	LIM domain only 4	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of LMO4 mRNA	PMID:35537566
1305670	Lmo4	LIM domain only 4	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313837	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of LMO4 mRNA	PMID:31838189
1305670	Lmo4	LIM domain only 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LMO4 mRNA	PMID:17942748
1305670	Lmo4	LIM domain only 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313838	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LMO4 mRNA; Nanotubes, Carbon results in increased expression of LMO4 mRNA	PMID:25554681|PMID:25620056
1305670	Lmo4	LIM domain only 4	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of LMO4 mRNA	PMID:41580965
1305670	Lmo4	LIM domain only 4	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D008713	Methimazole results in increased expression of STIMATE mRNA	PMID:30047161
1305670	Lmo4	LIM domain only 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313837	E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in increased expression of LMO4 mRNA	PMID:11678601
1305670	Lmo4	LIM domain only 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA	PMID:39836092
1305670	Lmo4	LIM domain only 4	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of LMO4 mRNA	PMID:25729387
1305670	Lmo4	LIM domain only 4	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313837	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LMO4 mRNA	PMID:28988120
1305670	Lmo4	LIM domain only 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of LMO4 mRNA	PMID:28801915
1305670	Lmo4	LIM domain only 4	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of LMO4 mRNA	PMID:30467583
1305670	Lmo4	LIM domain only 4	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20260811	CTD	MESH:D008731	Methoxychlor affects the methylation of STIMATE gene	PMID:35440735
1305670	Lmo4	LIM domain only 4	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20190910	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of LMO4 mRNA]	PMID:29891994
1305670	Lmo4	LIM domain only 4	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313837	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of LMO4 mRNA	PMID:31758290
1305670	Lmo4	LIM domain only 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LMO4 mRNA	PMID:22206623
1305670	Lmo4	LIM domain only 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LMO4 mRNA	PMID:22206623
1305670	Lmo4	LIM domain only 4	gene	CHEBI:76290	PhIP	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of LMO4 mRNA	PMID:15215175
1305670	Lmo4	LIM domain only 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA	PMID:27188386
1305670	Lmo4	LIM domain only 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LMO4 gene]	PMID:28238834
1305670	Lmo4	LIM domain only 4	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20120613	CTD	MESH:D010634	Phenobarbital results in decreased expression of LMO4 mRNA	PMID:19363144|PMID:19482888
1305670	Lmo4	LIM domain only 4	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of LMO4 mRNA]	PMID:19482888
1305670	Lmo4	LIM domain only 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of LMO4 mRNA; Propylthiouracil results in increased expression of STIMATE mRNA	PMID:24780913|PMID:30047161
1305670	Lmo4	LIM domain only 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313837	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA	PMID:27188386
1305670	Lmo4	LIM domain only 4	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313837	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LMO4 mRNA	PMID:38568856
1305670	Lmo4	LIM domain only 4	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313837	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of LMO4 mRNA	PMID:22378314
1305670	Lmo4	LIM domain only 4	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1313837	E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon results in increased expression of LMO4 mRNA	PMID:26705709
1305670	Lmo4	LIM domain only 4	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of LMO4 mRNA	PMID:35537566
1305670	Lmo4	LIM domain only 4	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:C025643	vinclozolin results in increased expression of STIMATE mRNA	PMID:22570695
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313839	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DIP2B mRNA	PMID:37995155
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DIP2B mRNA	PMID:26079696
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	ISO	RGD:1605978	E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of DIP2B protein	PMID:28073184
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of DIP2B gene	PMID:35440735
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313839	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DIP2B mRNA	PMID:30319688
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313839	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DIP2B mRNA	PMID:39241906
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313839	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in increased expression of DIP2B protein	PMID:26903627
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313839	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIP2B mRNA	PMID:25510870
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605978	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DIP2B mRNA	PMID:37042841
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1605978	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DIP2B mRNA	PMID:21179406
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1605978	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DIP2B protein	PMID:37730182
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1605978	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of DIP2B intron	PMID:30157460
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313839	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIP2B mRNA	PMID:25510870
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313839	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIP2B mRNA	PMID:25510870
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605978	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DIP2B mRNA	PMID:35430440
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of DIP2B mRNA	PMID:30779732
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313839	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DIP2B mRNA	PMID:25629700
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313839	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of DIP2B mRNA	PMID:40504410
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1605978	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DIP2B protein	PMID:35688186
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605978	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DIP2B mRNA	PMID:23557933
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313839	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of DIP2B mRNA	PMID:30912803
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313839	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DIP2B mRNA	PMID:21570461
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DIP2B mRNA	PMID:20106945|PMID:21632981
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DIP2B mRNA	PMID:33212167
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1605978	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of DIP2B mRNA	PMID:39709020
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1605978	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DIP2B mRNA	PMID:32763439
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1605978	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of DIP2B protein	PMID:35688186
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605978	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DIP2B mRNA	PMID:38568856
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313839	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of DIP2B mRNA	PMID:40504410
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DIP2B mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605978	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to DIP2B mRNA]	PMID:32406909
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DIP2B mRNA	PMID:19150397
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313839	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DIP2B mRNA	PMID:35676786
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605978	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DIP2B gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of DIP2B gene	PMID:31601247
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313839	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DIP2B gene	PMID:35295148
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313839	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of DIP2B mRNA	PMID:20813756
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DIP2B protein	PMID:31675489
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DIP2B mRNA	PMID:30816183|PMID:34947998
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1605978	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of DIP2B mRNA	PMID:29275510
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605978	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DIP2B gene	PMID:31601247
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DIP2B protein	PMID:31675489
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313839	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIP2B mRNA	PMID:25510870
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313839	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIP2B mRNA	PMID:25510870
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1605978	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of DIP2B gene	PMID:31601247
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1605978	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of DIP2B gene	PMID:31601247
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313839	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DIP2B mRNA	PMID:32715474|PMID:37019170
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313839	E	RGD:6480464	20121113	CTD	MESH:D010269	Paraquat results in increased expression of DIP2B mRNA	PMID:22563483
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313839	E	RGD:6480464	20121113	CTD	MESH:D010269	[Paraquat co-treated with Maneb] affects the expression of DIP2B mRNA	PMID:22563483
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of DIP2B gene	PMID:33148267
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DIP2B protein	PMID:26879310
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:38626	pyridaben	increases expression	ISO	RGD:1313839	E	RGD:6480464	20121113	CTD	MESH:C428725	pyridaben results in increased expression of DIP2B mRNA	PMID:22563483
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1605978	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of DIP2B mRNA	PMID:28302478
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1605978	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DIP2B gene	PMID:29154799
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605978	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DIP2B mRNA	PMID:38832940
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313839	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of DIP2B mRNA	PMID:40504410
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1605978	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DIP2B mRNA	PMID:22079256
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313839	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DIP2B mRNA	PMID:35676786
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313839	E	RGD:6480464	20121113	CTD	MESH:D008344	[Paraquat co-treated with Maneb] affects the expression of DIP2B mRNA	PMID:22563483
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313839	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DIP2B mRNA	PMID:19042947
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DIP2B protein	PMID:32959892
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DIP2B gene	PMID:35440735
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of DIP2B gene	PMID:33148267
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DIP2B mRNA	PMID:22079256
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1605978	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DIP2B mRNA	PMID:22079256
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DIP2B protein	PMID:31675489
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1605978	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of DIP2B protein	PMID:31675489
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1605978	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DIP2B protein	PMID:38348393
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DIP2B mRNA	PMID:19281266
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605978	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DIP2B mRNA	PMID:38568856
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DIP2B mRNA	PMID:19015723
1305671	Dip2b	Dip2 acetate--CoA ligase B	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of DIP2B gene	PMID:31079544
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313840	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SPOCK3 mRNA	PMID:21934132
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313841	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SPOCK3 mRNA	PMID:24205000
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313841	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SPOCK3 mRNA	PMID:30319688
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313840	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of SPOCK3 mRNA	PMID:19429434
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA	PMID:25510870
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313841	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SPOCK3 mRNA	PMID:33711761
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPOCK3 mRNA	PMID:33387578
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SPOCK3 promoter	PMID:23359474
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:181932	3-Nitrobenzanthrone	decreases expression	ISO	RGD:1313840	E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in decreased expression of SPOCK3 mRNA	PMID:34036453
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA	PMID:25510870
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA	PMID:25510870
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313840	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SPOCK3 mRNA	PMID:19549813
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:2422	acetohydrazide	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20120412	CTD	MESH:C014949	acetylhydrazine results in decreased expression of SPOCK3 mRNA	PMID:15282401
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313840	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SPOCK3 mRNA	PMID:22100608|PMID:32234424|PMID:35690182
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPOCK3 mRNA	PMID:25629700
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313840	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of SPOCK3 mRNA	PMID:21867686
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313840	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SPOCK3 mRNA	PMID:26272509
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313840	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA	PMID:27188386
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SPOCK3 mRNA	PMID:28960355
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313841	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPOCK3 mRNA	PMID:21570461|PMID:24680724
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPOCK3 mRNA	PMID:32109520
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313840	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPOCK3 mRNA	PMID:21296121
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313840	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SPOCK3 mRNA	PMID:33212167
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313840	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of SPOCK3 gene	PMID:28589171
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313840	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SPOCK3 mRNA	PMID:32234424|PMID:35690182
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313840	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPOCK3 promoter	PMID:27901495
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to SPOCK3 promoter]	PMID:19654925
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1313840	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of SPOCK3 mRNA	PMID:37690743
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:31638	fulvestrant	decreases methylation	ISO	RGD:1313840	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of SPOCK3 gene	PMID:31601247
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SPOCK3 mRNA	PMID:29264374
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPOCK3 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SPOCK3 promoter	PMID:23359474
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA	PMID:25510870
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA	PMID:25510870
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313841	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SPOCK3 intron	PMID:28392331
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SPOCK3 promoter	PMID:23359474
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SPOCK3 mRNA	PMID:32680482
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SPOCK3 promoter	PMID:22457795
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313840	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SPOCK3 mRNA	PMID:24449571
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313840	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPOCK3 mRNA	PMID:25979313
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of SPOCK3 mRNA	PMID:24896083
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313840	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SPOCK3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313840	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA	PMID:27188386
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313840	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SPOCK3 mRNA	PMID:38832940
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313840	E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of SPOCK3 mRNA	PMID:24935251|PMID:27188386
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SPOCK3 mRNA	PMID:33387578
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313840	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of SPOCK3 mRNA	PMID:32234424|PMID:35690182
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:6382	Lasiocarpine	decreases expression	ISO	RGD:1313840	E	RGD:6480464	20200714	CTD	MESH:C005136	lasiocarpine results in decreased expression of SPOCK3 mRNA	PMID:32234424|PMID:35690182
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313840	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SPOCK3 mRNA	PMID:24810058
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313840	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA	PMID:27188386
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313840	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPOCK3 gene]	PMID:28238834
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SPOCK3 mRNA	PMID:32109520
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313841	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SPOCK3 mRNA	PMID:38648751
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313840	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of SPOCK3 mRNA	PMID:32234424|PMID:35690182
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:83258	fenamidone	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in decreased expression of SPOCK3 mRNA	PMID:27029645
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313841	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SPOCK3 mRNA	PMID:21795629
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPOCK3 mRNA	PMID:24780913
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1313840	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of SPOCK3 mRNA	PMID:19429434
1305672	Spock3	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313840	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA	PMID:27188386
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313843	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ADGRG3 mRNA	PMID:33167477
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20190409	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADGRG3 mRNA	PMID:30529165
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA	PMID:25510870
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313843	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADGRG3 mRNA	PMID:37042841
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1550278	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of ADGRG3 mRNA	PMID:15120971|PMID:15122651
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRG3 mRNA	PMID:37992649
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1313843	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of ADGRG3 mRNA	PMID:33647349
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRG3 mRNA	PMID:37992649
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313843	E	RGD:6480464	20190409	CTD	MESH:D014520	Urethane results in decreased expression of ADGRG3 mRNA	PMID:28818685
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ADGRG3 mRNA	PMID:36331819
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA	PMID:25510870
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA	PMID:25510870
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313843	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ADGRG3 mRNA	PMID:41430723
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADGRG3 mRNA	PMID:22206623
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550278	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADGRG3 mRNA	PMID:26377647
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADGRG3 mRNA	PMID:32109520
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550278	E	RGD:6480464	20160822	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADGRG3 mRNA	PMID:21889950|PMID:25975270|PMID:26290441|PMID:28922406
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of ADGRG3 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADGRG3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ADGRG3 mRNA	PMID:16214954|PMID:17942748|PMID:25975270
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550278	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ADGRG3 mRNA	PMID:39631538
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRG3 mRNA	PMID:37992649
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313843	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADGRG3 promoter	PMID:27901495
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313843	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADGRG3 3' UTR	PMID:27901495
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550278	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADGRG3 mRNA	PMID:32417428
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1313843	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ADGRG3 mRNA	PMID:37690743
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of ADGRG3 mRNA	PMID:32479839
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADGRG3 mRNA	PMID:34492290
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1550278	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ADGRG3 mRNA	PMID:18648102
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRG3 mRNA	PMID:25181051
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550278	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRG3 mRNA	PMID:32156529|PMID:33221593
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA	PMID:25510870
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA	PMID:25510870
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313843	E	RGD:6480464	20210504	CTD	MESH:C543008	bisphenol S results in decreased expression of ADGRG3 mRNA	PMID:33476716
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550278	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ADGRG3 mRNA	PMID:39298647
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550278	E	RGD:6480464	20160822	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ADGRG3 mRNA	PMID:26377693
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1550278	E	RGD:6480464	20160822	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of ADGRG3 mRNA	PMID:26377693
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550278	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADGRG3 mRNA	PMID:38685157
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313843	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADGRG3 mRNA	PMID:37042841
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313843	E	RGD:6480464	20190409	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of ADGRG3 mRNA	PMID:29024780
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADGRG3 mRNA	PMID:35163327
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313843	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ADGRG3 mRNA	PMID:25812627
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADGRG3 mRNA	PMID:35163327
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313843	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ADGRG3 mRNA	PMID:25812627
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550278	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADGRG3 mRNA	PMID:40194260
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313843	E	RGD:6480464	20190409	CTD	MESH:C000944	dicrotophos results in increased expression of ADGRG3 mRNA	PMID:28302478
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313843	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ADGRG3 mRNA	PMID:25812627
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ADGRG3 mRNA	PMID:36331819
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313843	E	RGD:6480464	20160822	CTD	MESH:D016572	Cyclosporine results in increased expression of ADGRG3 mRNA	PMID:25562108
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550278	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ADGRG3 mRNA	PMID:20937368
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550278	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ADGRG3 mRNA	PMID:28973697
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRG3 mRNA	PMID:37992649
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313843	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ADGRG3 mRNA	PMID:38832940
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313843	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADGRG3 mRNA	PMID:22230336
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313843	E	RGD:6480464	20160822	CTD	MESH:C016766	sulforaphane results in increased expression of ADGRG3 mRNA	PMID:26833863
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADGRG3 mRNA	PMID:17942748
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313843	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of ADGRG3 mRNA	PMID:38568856
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550278	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADGRG3 mRNA	PMID:25620056
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550278	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ADGRG3 mRNA; Nanotubes, Carbon results in increased expression of ADGRG3 mRNA	PMID:25554681
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313843	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ADGRG3 mRNA	PMID:28988120
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ADGRG3 mRNA	PMID:27935865
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550278	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADGRG3 mRNA	PMID:22206623
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550278	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ADGRG3 mRNA	PMID:22206623
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADGRG3 mRNA	PMID:22206623
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313843	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ADGRG3 gene]	PMID:28238834
1305674	Adgrg3	adhesion G protein-coupled receptor G3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313843	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ADGRG3 mRNA	PMID:29301935
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313844	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MPP7 gene	PMID:20938992
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313844	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MPP7 mRNA	PMID:30319688
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1344792	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MPP7 mRNA	PMID:20044591
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MPP7 mRNA	PMID:21632981
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1344792	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MPP7 mRNA	PMID:30165855
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313844	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MPP7 gene	PMID:20938992
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1344792	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MPP7 mRNA	PMID:37042841
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1344792	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of MPP7 mRNA	PMID:26485663
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MPP7 mRNA	PMID:33387578
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MPP7 mRNA	PMID:28818685
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:228849	Alisol C 23-acetate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C457234	[alisol A co-treated with alisol A 24-acetate co-treated with alisol B co-treated with alisol B 23-acetate co-treated with alisol C 23-acetate co-treated with alisol F co-treated with alisol F 24-acetate] results in increased expression of MPP7 mRNA	PMID:33035272
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313844	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MPP7 mRNA	PMID:37236586
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MPP7 mRNA	PMID:19549813
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1344792	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MPP7 protein	PMID:20106945
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MPP7 mRNA	PMID:21632981|PMID:21641981
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313844	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of MPP7 mRNA	PMID:34911549
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MPP7 mRNA	PMID:21867686
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313844	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MPP7 gene	PMID:20938992
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1344792	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MPP7 gene	PMID:25304211
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1344792	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MPP7 mRNA	PMID:39836092
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1344792	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MPP7 mRNA	PMID:23557933
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MPP7 mRNA	PMID:22298810
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MPP7 mRNA	PMID:21724226|PMID:34747641
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313844	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MPP7 mRNA	PMID:19933214|PMID:33956508
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MPP7 mRNA	PMID:33387578
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of MPP7 mRNA	PMID:19013527|PMID:28374803
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MPP7 mRNA	PMID:23179753|PMID:28001369
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MPP7 mRNA	PMID:33212167
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20161025	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of MPP7 mRNA	PMID:27188386
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1344792	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of MPP7 mRNA	PMID:20971185
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1344792	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of MPP7 mRNA	PMID:29803840
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C017947	sodium arsenite results in decreased expression of MPP7 protein	PMID:31874112
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313844	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MPP7 mRNA	PMID:37682722
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313844	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of MPP7 mRNA	PMID:39095385
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1344792	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MPP7 mRNA	PMID:38568856
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1344792	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MPP7 mRNA	PMID:39836092
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MPP7 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313844	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MPP7 mRNA	PMID:27195522
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1344792	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MPP7 5' UTR	PMID:27901495
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased expression of MPP7 mRNA	PMID:23974009
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1344792	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of MPP7 mRNA	PMID:20971185
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MPP7 mRNA	PMID:19150397
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MPP7 mRNA	PMID:23411599
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313844	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MPP7 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MPP7 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of MPP7 protein	PMID:31675489
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MPP7 mRNA	PMID:34947998
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of MPP7 mRNA	PMID:32119087
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313844	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MPP7 mRNA	PMID:39298647
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313844	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MPP7 mRNA	PMID:37019170
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313844	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MPP7 mRNA	PMID:37236586
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MPP7 protein	PMID:26879310
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1344792	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of MPP7 mRNA	PMID:19691856
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313844	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MPP7 mRNA	PMID:40194260
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1344792	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of MPP7 mRNA	PMID:40434365
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MPP7 mRNA	PMID:27153767|PMID:40419075
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313844	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MPP7 mRNA	PMID:17963808
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344792	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of MPP7 mRNA	PMID:23179753|PMID:24935251|PMID:27188386|PMID:29154799
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MPP7 mRNA	PMID:25562108
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313844	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MPP7 mRNA	PMID:28973697
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1344792	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MPP7 mRNA	PMID:27188386
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MPP7 mRNA	PMID:33387578
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of MPP7 mRNA	PMID:16510598
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1344792	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MPP7 gene	PMID:25304211
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1344792	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MPP7 mRNA	PMID:39836092
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of MPP7 mRNA	PMID:31675489
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of MPP7 mRNA	PMID:31838189
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MPP7 mRNA	PMID:29391264
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MPP7 mRNA	PMID:30307764
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1313844	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate affects the reaction [MTF1 affects the expression of MPP7 mRNA]	PMID:16221973
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1344792	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of MPP7 mRNA	PMID:28988120
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313844	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of MPP7 mRNA	PMID:20003209
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313844	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MPP7 mRNA	PMID:22206623
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1344792	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MPP7 mRNA	PMID:22714537
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1344792	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MPP7 gene]	PMID:28238834
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1344792	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of MPP7 mRNA	PMID:18927307
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313844	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MPP7 mRNA	PMID:23091169
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:81103	Alisol A	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C000050	[alisol A co-treated with alisol A 24-acetate co-treated with alisol B co-treated with alisol B 23-acetate co-treated with alisol C 23-acetate co-treated with alisol F co-treated with alisol F 24-acetate] results in increased expression of MPP7 mRNA	PMID:33035272
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:81104	Alisol B	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C457232	[alisol A co-treated with alisol A 24-acetate co-treated with alisol B co-treated with alisol B 23-acetate co-treated with alisol C 23-acetate co-treated with alisol F co-treated with alisol F 24-acetate] results in increased expression of MPP7 mRNA	PMID:33035272
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1344792	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MPP7 protein	PMID:31675489
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MPP7 mRNA	PMID:23640034
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1344792	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MPP7 protein	PMID:31675489
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313844	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of MPP7 mRNA	PMID:21278054
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MPP7 mRNA	PMID:24780913
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313844	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of MPP7 mRNA	PMID:40826991
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1344792	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MPP7 mRNA	PMID:29301935
1305675	Mpp7	MAGUK p55 scaffold protein 7	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313844	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of MPP7 mRNA	PMID:32835833
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1604272	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TMEM126A mRNA	PMID:24763279
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1604272	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TMEM126A mRNA	PMID:21632981
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313846	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TMEM126A mRNA	PMID:39241906
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1604272	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TMEM126A mRNA	PMID:28818685
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of TMEM126A protein	PMID:33236894
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1604272	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TMEM126A mRNA	PMID:27153756
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313846	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM126A mRNA	PMID:22206623
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604272	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TMEM126A mRNA	PMID:23557933
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313846	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM126A mRNA	PMID:21570461
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM126A mRNA	PMID:21215274
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1604272	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of TMEM126A protein	PMID:39603559
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of TMEM126A mRNA	PMID:19013527
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1604272	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of TMEM126A mRNA	PMID:33512557
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1604272	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TMEM126A mRNA	PMID:33212167
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1604272	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM126A mRNA	PMID:30851411
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1604272	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TMEM126A mRNA	PMID:32763439
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313846	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMEM126A protein	PMID:29044176
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1604272	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMEM126A protein	PMID:38228842
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604272	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMEM126A promoter	PMID:27901495
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604272	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TMEM126A mRNA	PMID:20382639
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1604272	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TMEM126A gene	PMID:31601247
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM126A mRNA	PMID:25181051
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1604272	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TMEM126A gene	PMID:31601247
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1604272	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TMEM126A mRNA	PMID:25979313
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313846	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TMEM126A mRNA	PMID:39298647
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TMEM126A mRNA	PMID:17602206
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TMEM126A mRNA	PMID:17602206
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1604272	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TMEM126A mRNA	PMID:28302478
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604272	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM126A mRNA	PMID:25979313
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1604272	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TMEM126A mRNA	PMID:25562108
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1604272	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of TMEM126A mRNA	PMID:33512557
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TMEM126A mRNA	PMID:24136188
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1604272	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TMEM126A mRNA	PMID:18175754
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313846	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TMEM126A mRNA; Nanotubes, Carbon results in increased expression of TMEM126A mRNA	PMID:25554681
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TMEM126A mRNA	PMID:24136188
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TMEM126A mRNA	PMID:24136188
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of TMEM126A mRNA	PMID:24136188
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313846	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMEM126A mRNA	PMID:22206623
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313846	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM126A mRNA	PMID:22206623
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TMEM126A mRNA	PMID:24136188
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1604272	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM126A mRNA	PMID:30851411
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604272	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TMEM126A gene]	PMID:28238834
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1604272	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of TMEM126A mRNA	PMID:33512557
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:90724	AM-251	increases expression	ISO	RGD:1604272	E	RGD:6480464	20170303	CTD	MESH:C103505	AM 251 results in increased expression of TMEM126A mRNA	PMID:16500647
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1604272	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TMEM126A mRNA	PMID:38568856
1305677	Tmem126a	transmembrane protein 126A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TMEM126A mRNA	PMID:23869203
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313847	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CADM2 mRNA	PMID:21934132
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313848	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CADM2 mRNA	PMID:24205000
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of CADM2 mRNA	PMID:25056781
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313848	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CADM2 mRNA	PMID:30319688
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of CADM2 mRNA	PMID:29980752
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CADM2 mRNA	PMID:33387578
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313847	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CADM2 mRNA	PMID:26079696
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313847	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CADM2 intron	PMID:30157460
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313847	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CADM2 protein	PMID:20106945
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313847	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CADM2 gene	PMID:27153756
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313847	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CADM2 intron	PMID:30157460
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of CADM2 mRNA	PMID:25056781
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313848	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CADM2 mRNA	PMID:27106289
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CADM2 mRNA	PMID:25629700
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313847	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of CADM2 mRNA	PMID:26272509
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313847	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313847	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CADM2 mRNA	PMID:28903495
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313847	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CADM2 mRNA	PMID:24768652|PMID:25583101
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CADM2 mRNA	PMID:32109520
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313847	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CADM2 mRNA	PMID:28001369
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313847	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CADM2 mRNA	PMID:23179753
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:28741	sodium fluoride	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CADM2 mRNA	PMID:27257137
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313847	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CADM2 mRNA	PMID:25879800
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313847	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CADM2 5' UTR; Benzo(a)pyrene results in increased methylation of CADM2 exon; Benzo(a)pyrene results in increased methylation of CADM2 promoter	PMID:27901495
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CADM2 mRNA	PMID:29341224
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313847	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CADM2 gene	PMID:31601247
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313848	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CADM2 gene	PMID:35295148
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CADM2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CADM2 mRNA	PMID:32156529|PMID:39742910
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of CADM2 mRNA	PMID:29097150
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313847	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CADM2 gene	PMID:31601247
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313847	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CADM2 gene	PMID:31601247
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313847	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CADM2 intron	PMID:30157460
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313847	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CADM2 mRNA	PMID:25979313
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of CADM2 mRNA	PMID:29427782
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313847	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CADM2 mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313847	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313847	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CADM2 mRNA	PMID:20106945
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CADM2 mRNA	PMID:28973697
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313847	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CADM2 mRNA	PMID:38832940
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313847	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CADM2 mRNA	PMID:27188386
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1313847	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313847	E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of CADM2 mRNA	PMID:27188386
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CADM2 mRNA	PMID:33387578
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CADM2 mRNA	PMID:29097150
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313847	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CADM2 mRNA	PMID:32234424
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1313847	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of CADM2 mRNA	PMID:26272509
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313847	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1313847	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CADM2 mRNA	PMID:22079614
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313847	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CADM2 intron	PMID:30157460
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of CADM2 mRNA	PMID:27840820
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313847	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CADM2 mRNA	PMID:32109520
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313848	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CADM2 mRNA	PMID:27935865
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CADM2 mRNA	PMID:24780913
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313847	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313847	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CADM2 mRNA	PMID:38568856
1305678	Cadm2	cell adhesion molecule 2	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313847	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of CADM2 mRNA	PMID:27188386
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313850	E	RGD:6480464	20171010	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ADTRP mRNA	PMID:28558994
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADTRP mRNA]	PMID:31150632
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1313849	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of ADTRP mRNA	PMID:34925699
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:136638	9-hydroxyoctadecanoic acid	affects chemical synthesis	ISO	RGD:1313850	E	RGD:6480464	20200609	CTD	MESH:C070375	ADTRP protein affects the chemical synthesis of 9-hydroxystearic acid	PMID:32152231
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313849	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ADTRP mRNA	PMID:26079696
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ADTRP gene	PMID:28931070
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADTRP mRNA	PMID:39241906
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313849	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ADTRP mRNA	PMID:35811015
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313850	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ADTRP mRNA	PMID:39298647
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313850	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ADTRP mRNA	PMID:33711761
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ADTRP mRNA	PMID:33387578
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313849	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADTRP mRNA	PMID:37042841
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313849	E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of ADTRP mRNA	PMID:27664576
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313849	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ADTRP mRNA	PMID:26079696
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313849	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ADTRP mRNA	PMID:31256213
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313849	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of ADTRP mRNA	PMID:23825647
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ADTRP mRNA	PMID:28085963
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ADTRP mRNA	PMID:27523638
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:17833	gentamycin	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins affects the expression of ADTRP mRNA	PMID:33387578
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313849	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of ADTRP mRNA	PMID:23825647
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of ADTRP mRNA	PMID:21515302
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of ADTRP mRNA	PMID:19483382
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADTRP mRNA	PMID:31150632
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADTRP mRNA	PMID:31919559
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADTRP mRNA]	PMID:31150632
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ADTRP mRNA	PMID:31881176
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of ADTRP gene	PMID:28505145
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADTRP mRNA	PMID:21215274
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADTRP mRNA	PMID:33387578
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313849	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ADTRP mRNA	PMID:20971185
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313850	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ADTRP mRNA	PMID:27862939
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313850	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ADTRP gene	PMID:39894169
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313849	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ADTRP mRNA	PMID:38568856|PMID:39719251
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313849	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADTRP mRNA	PMID:22316170
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313849	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADTRP 3' UTR	PMID:27901495
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313849	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ADTRP mRNA	PMID:20971185
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of ADTRP mRNA	PMID:19483382
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313849	E	RGD:6480464	20160210	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ADTRP mRNA	PMID:23806026
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313849	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ADTRP gene	PMID:31601247
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ADTRP mRNA	PMID:24136188
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313850	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of ADTRP mRNA	PMID:22609695
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of ADTRP mRNA	PMID:16507785
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of ADTRP mRNA	PMID:21515302
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of ADTRP mRNA	PMID:19483382
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ADTRP mRNA	PMID:34492290
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ADTRP mRNA	PMID:28943392
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ADTRP mRNA	PMID:19483382
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C006780	bisphenol A affects the expression of ADTRP mRNA	PMID:25181051
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ADTRP mRNA	PMID:30816183|PMID:32528016
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of ADTRP mRNA	PMID:41034487
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313850	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ADTRP mRNA	PMID:32156529|PMID:37894381
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313849	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ADTRP gene	PMID:31601247
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of ADTRP mRNA	PMID:30744511
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ADTRP mRNA	PMID:39298647
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ADTRP mRNA	PMID:26377693
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADTRP mRNA	PMID:38685157
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313850	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ADTRP intron	PMID:28392331
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ADTRP mRNA	PMID:24893172
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ADTRP mRNA	PMID:28943392
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313849	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ADTRP mRNA	PMID:38174414|PMID:38568856
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ADTRP mRNA	PMID:28511854
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313850	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ADTRP mRNA	PMID:28558994
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ADTRP gene	PMID:22079235
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ADTRP mRNA	PMID:24386269
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313849	E	RGD:6480464	20160210	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ADTRP mRNA	PMID:19320972
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of ADTRP mRNA	PMID:19483382
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313850	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of ADTRP mRNA	PMID:23811191
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:37825	p-toluidine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of ADTRP mRNA	PMID:27638505
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313850	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADTRP mRNA	PMID:28558994
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313850	E	RGD:6480464	20171010	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ADTRP mRNA	PMID:28558994
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313850	E	RGD:6480464	20171010	CTD	MESH:C076994	PPARA protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of ADTRP mRNA]	PMID:28558994
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313849	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADTRP mRNA	PMID:29154799
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313849	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ADTRP gene	PMID:29154799
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313849	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ADTRP mRNA	PMID:23179753
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313849	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of ADTRP mRNA	PMID:27989131
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313850	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ADTRP mRNA	PMID:28973697
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313849	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ADTRP mRNA	PMID:38832940
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:4488	diallyl disulfide	multiple interactions	ISO	RGD:1313849	E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide inhibits the reaction [tobacco tar analog results in increased expression of ADTRP mRNA]	PMID:36758788
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ADTRP mRNA	PMID:33387578
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313849	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ADTRP mRNA	PMID:35811015
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ADTRP mRNA	PMID:29391264
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of ADTRP mRNA	PMID:19483382
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADTRP mRNA	PMID:25620056
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ADTRP mRNA	PMID:24136188|PMID:24793618
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313850	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ADTRP mRNA	PMID:38701926
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1313849	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of ADTRP mRNA	PMID:20436886
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of ADTRP mRNA	PMID:33484710
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of ADTRP mRNA	PMID:19483382
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of ADTRP mRNA	PMID:19483382
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1313850	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of ADTRP mRNA	PMID:26655953
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:81517	3,4,5,3',4',5'-Hexachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C027309	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of ADTRP mRNA	PMID:30744511
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313850	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ADTRP mRNA	PMID:38648751
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1313849	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of ADTRP mRNA	PMID:26705709
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of ADTRP mRNA	PMID:19483382
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADTRP mRNA	PMID:24780913
1305679	Adtrp	androgen-dependent TFPI-regulating protein	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of ADTRP mRNA	PMID:21515302
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313851	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of BICRAL mRNA	PMID:26079696
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313851	E	RGD:6480464	20141111	CTD	MESH:D001280	Atrazine results in decreased expression of BICRAL mRNA	PMID:22378314
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of BICRAL mRNA	PMID:39241906
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of GLTSCR1L mRNA	PMID:32145629
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313851	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BICRAL mRNA	PMID:37042841
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of BICRAL mRNA	PMID:23892564
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313851	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of BICRAL protein	PMID:37730182
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of BICRAL mRNA	PMID:33387578
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313851	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of BICRAL intron	PMID:30157460
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1313851	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of BICRAL promoter	PMID:21291286
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BICRAL mRNA	PMID:39836092
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313851	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of BICRAL mRNA	PMID:26272509
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA	PMID:27188386
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313851	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of BICRAL protein	PMID:35688186
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313852	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of GLTSCR1L mRNA	PMID:28960355
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of BICRAL mRNA	PMID:31881176
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of BICRAL mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of BICRAL mRNA	PMID:23557933
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313851	E	RGD:6480464	20181016	CTD	MESH:D002945	Cisplatin results in decreased expression of BICRAL mRNA	PMID:27594783
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of GLTSCR1L mRNA	PMID:30912803
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BICRAL mRNA	PMID:33387578
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313851	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of BICRAL mRNA	PMID:33212167
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BICRAL mRNA	PMID:39836092
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313851	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BICRAL intron	PMID:30157460
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313851	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BICRAL mRNA	PMID:21632981|PMID:26238291
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313851	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of BICRAL gene	PMID:25435355
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to BICRAL mRNA]	PMID:32406909
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313851	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of BICRAL mRNA	PMID:25351596
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313851	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of BICRAL mRNA	PMID:35984750
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of BICRAL mRNA	PMID:24395379
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BICRAL gene	PMID:31601247
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of BICRAL mRNA	PMID:34492290
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BICRAL mRNA; bisphenol A results in decreased expression of GLTSCR1L mRNA	PMID:25181051|PMID:32145629
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313852	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of BICRAL mRNA	PMID:26063408
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BICRAL gene	PMID:31601247
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313851	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of BICRAL mRNA	PMID:25979313
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of BICRAL mRNA	PMID:39298647
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313851	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of BICRAL intron	PMID:30157460
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20181016	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BICRAL mRNA	PMID:28628672
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of BICRAL mRNA	PMID:34813904
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20181016	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BICRAL mRNA	PMID:28628672
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313852	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of BICRAL mRNA	PMID:36117858
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313851	E	RGD:6480464	20181016	CTD	MESH:C000944	dicrotophos results in increased expression of BICRAL mRNA	PMID:28302478
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313851	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of BICRAL mRNA	PMID:31533062
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313851	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of BICRAL mRNA	PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA	PMID:27188386
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of BICRAL mRNA	PMID:38685447|PMID:41580965
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20181016	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BICRAL mRNA	PMID:28628672
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of BICRAL mRNA	PMID:33387578
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313851	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of BICRAL mRNA	PMID:22230336
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1313851	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of BICRAL promoter	PMID:21291286
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BICRAL mRNA	PMID:39836092
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20181016	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BICRAL mRNA	PMID:28628672
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of BICRAL mRNA; Nanotubes, Carbon results in decreased expression of BICRAL mRNA	PMID:25554681
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313852	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of BICRAL mRNA	PMID:36117858
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313851	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of BICRAL mRNA	PMID:28988120
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313851	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of BICRAL intron	PMID:30157460
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA	PMID:27188386
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313852	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of BICRAL mRNA	PMID:23091169
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313852	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of BICRAL mRNA	PMID:39847705
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313851	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA	PMID:27188386
1305680	Bicral	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of BICRAL mRNA	PMID:28973697
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of SYNCRIP protein	PMID:36252740
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1557624	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SYNCRIP mRNA	PMID:33045310
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein]	PMID:38195004
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SYNCRIP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SYNCRIP gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SYNCRIP mRNA	PMID:20938992
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SYNCRIP mRNA	PMID:23724009
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SYNCRIP mRNA	PMID:36331819
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:15738	staurosporine	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:D019311	Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein]	PMID:19331829
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SYNCRIP mRNA	PMID:22378314
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1557624	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SYNCRIP mRNA	PMID:30319688
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in decreased expression of SYNCRIP mRNA	PMID:28986285
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SYNCRIP mRNA	PMID:20044591
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557624	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SYNCRIP mRNA	PMID:39241906
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SYNCRIP mRNA]	PMID:39241906
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1557624	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of SYNCRIP mRNA	PMID:15598610
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1557624	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SYNCRIP mRNA	PMID:39298647
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16526	carbon dioxide	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20220906	CTD	MESH:D002245	[[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Carbon Dioxide] which affects the expression of SYNCRIP mRNA	PMID:29980036
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313857	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SYNCRIP mRNA	PMID:38568856
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SYNCRIP mRNA	PMID:33387578
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SYNCRIP gene	PMID:27618143
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SYNCRIP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SYNCRIP gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SYNCRIP mRNA	PMID:20938992
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of SYNCRIP protein	PMID:32044396
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SYNCRIP mRNA	PMID:23649840
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313857	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SYNCRIP mRNA	PMID:21179406
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:175901	gemcitabine	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in decreased expression of SYNCRIP mRNA	PMID:17039268
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SYNCRIP mRNA	PMID:33754040
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SYNCRIP mRNA	PMID:22061828
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20210706	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SYNCRIP protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein	PMID:33040242|PMID:38195004
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SYNCRIP mRNA	PMID:37236586
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313857	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SYNCRIP mRNA	PMID:19549813
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SYNCRIP protein	PMID:23301498
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SYNCRIP mRNA	PMID:23649840
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SYNCRIP mRNA	PMID:23649840
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SYNCRIP protein	PMID:38598786
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1557624	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SYNCRIP mRNA	PMID:27339419|PMID:31919559
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SYNCRIP mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SYNCRIP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SYNCRIP gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SYNCRIP mRNA	PMID:20938992|PMID:22206623
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SYNCRIP mRNA	PMID:19244175
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SYNCRIP mRNA	PMID:26272509
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA	PMID:27188386
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313857	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SYNCRIP protein	PMID:35688186
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1557624	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of SYNCRIP mRNA	PMID:28960355
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1313857	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SYNCRIP mRNA	PMID:23300844
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1557624	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of SYNCRIP mRNA	PMID:34813904
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313857	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SYNCRIP mRNA	PMID:24768652|PMID:25583101
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557624	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SYNCRIP mRNA	PMID:21570461
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SYNCRIP mRNA	PMID:33387578
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SYNCRIP mRNA	PMID:19465110
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of SYNCRIP mRNA	PMID:19013527
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313857	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SYNCRIP mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA	PMID:27188386
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SYNCRIP mRNA	PMID:33212167
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA	PMID:27188386
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SYNCRIP mRNA	PMID:23649840
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SYNCRIP protein	PMID:21146535
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SYNCRIP mRNA	PMID:20971185
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313857	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SYNCRIP mRNA	PMID:29803840
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SYNCRIP mRNA	PMID:38568856
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of SYNCRIP mRNA	PMID:22378314
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYNCRIP mRNA	PMID:20106945|PMID:21632981
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYNCRIP mRNA	PMID:19770486
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:29866	arsenite(3-)	affects localization	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite affects the localization of SYNCRIP protein	PMID:19331829
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SYNCRIP protein	PMID:21146535
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SYNCRIP mRNA	PMID:20971185
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:3048	benzatropine	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in decreased expression of SYNCRIP protein	PMID:34122009
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SYNCRIP mRNA	PMID:19150397|PMID:20018196|PMID:26238291
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313857	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SYNCRIP mRNA	PMID:20458559
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of SYNCRIP mRNA	PMID:31745603
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SYNCRIP mRNA	PMID:25729387
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SYNCRIP mRNA	PMID:23557971
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557624	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SYNCRIP gene	PMID:35295148
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1557624	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SYNCRIP promoter	PMID:35295148
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SYNCRIP mRNA	PMID:18445702
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1557624	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SYNCRIP mRNA	PMID:28472532
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SYNCRIP protein	PMID:33376534|PMID:34186270|PMID:37567409
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SYNCRIP mRNA	PMID:33221593
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313857	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased methylation of SYNCRIP gene	PMID:22576693
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SYNCRIP mRNA	PMID:25181051|PMID:30816183
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313857	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased expression of SYNCRIP mRNA	PMID:22576693
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of SYNCRIP mRNA	PMID:21932408
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SYNCRIP mRNA	PMID:19244175
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313857	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SYNCRIP protein	PMID:34186270
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557624	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SYNCRIP mRNA	PMID:39298647
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313857	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SYNCRIP protein	PMID:34186270
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313857	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SYNCRIP protein	PMID:34186270
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SYNCRIP mRNA]	PMID:39241906
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313857	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SYNCRIP mRNA	PMID:37042841
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SYNCRIP mRNA	PMID:38568856
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20210706	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SYNCRIP protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein	PMID:33040242|PMID:38195004
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SYNCRIP mRNA	PMID:37236586
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SYNCRIP mRNA	PMID:24386269
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SYNCRIP mRNA	PMID:19320972|PMID:19376846
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:35842	antirheumatic drug	affects expression	ISO	RGD:1313857	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents affects the expression of SYNCRIP mRNA	PMID:24449571
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SYNCRIP mRNA	PMID:19244175
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	affects localization	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein	PMID:19331829
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:D013755	Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein]	PMID:19331829
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:3766	clozapine	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of SYNCRIP protein	PMID:34122009
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313857	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SYNCRIP mRNA	PMID:19167446
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of SYNCRIP mRNA	PMID:26352163
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SYNCRIP mRNA	PMID:36331819
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313857	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid affects the expression of SYNCRIP mRNA	PMID:23179753|PMID:25979313|PMID:26272509
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1557624	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SYNCRIP mRNA	PMID:17292431
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYNCRIP mRNA	PMID:24935251|PMID:25192806|PMID:27188386|PMID:28001369|PMID:29154799
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20120717	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYNCRIP mRNA	PMID:19136453|PMID:21427059
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of SYNCRIP mRNA	PMID:27188386
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of SYNCRIP mRNA	PMID:41580965
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of SYNCRIP mRNA	PMID:22147139
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of SYNCRIP mRNA	PMID:16595896
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of SYNCRIP mRNA	PMID:23649840
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SYNCRIP mRNA	PMID:22083351|PMID:27188386
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313857	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A affects the expression of SYNCRIP mRNA	PMID:26272509
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SYNCRIP mRNA	PMID:24935251
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313857	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SYNCRIP mRNA	PMID:24935251
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA	PMID:27188386
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557624	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SYNCRIP mRNA	PMID:17562736
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNCRIP mRNA	PMID:33387578
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNCRIP mRNA	PMID:21420995
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of SYNCRIP mRNA	PMID:17039268
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SYNCRIP mRNA	PMID:29279043
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313857	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SYNCRIP mRNA	PMID:20458559
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313857	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SYNCRIP mRNA	PMID:23300844
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557624	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SYNCRIP mRNA; Nanotubes, Carbon results in increased expression of SYNCRIP mRNA	PMID:25554681|PMID:25620056
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SYNCRIP mRNA	PMID:24136188
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SYNCRIP mRNA	PMID:19042947
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SYNCRIP protein	PMID:32959892
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SYNCRIP mRNA	PMID:21641980
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SYNCRIP mRNA	PMID:25729387
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SYNCRIP mRNA	PMID:25729387
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SYNCRIP mRNA	PMID:23650126
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SYNCRIP mRNA	PMID:24810058
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of SYNCRIP mRNA	PMID:28444820
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SYNCRIP mRNA	PMID:22206623
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SYNCRIP mRNA	PMID:22206623
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of SYNCRIP mRNA	PMID:24136188
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	ISO	RGD:1313857	E	RGD:6480464	20220405	CTD	MESH:C045338	SYNCRIP protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313857	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SYNCRIP protein	PMID:31285264
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of SYNCRIP mRNA	PMID:27188386
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SYNCRIP mRNA	PMID:30928695
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SYNCRIP gene]	PMID:28238834
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1557624	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SYNCRIP mRNA	PMID:30294300
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:8249	piroxicam	increases expression	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of SYNCRIP mRNA	PMID:21858171
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1557624	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of SYNCRIP mRNA	PMID:30953684
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA	PMID:27188386
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SYNCRIP mRNA]	PMID:39241906
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1557624	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of SYNCRIP mRNA	PMID:40826991
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of SYNCRIP mRNA	PMID:27188386
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SYNCRIP mRNA	PMID:21346803
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1313857	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of SYNCRIP mRNA	PMID:17440010
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:9516	thapsigargin	affects localization	ISO	RGD:1313857	E	RGD:6480464	20120412	CTD	MESH:D019284	Thapsigargin affects the localization of SYNCRIP protein	PMID:19331829
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of SYNCRIP protein	PMID:35544339
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1313857	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SYNCRIP mRNA	PMID:27188386
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313857	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SYNCRIP protein	PMID:38598786
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SYNCRIP mRNA	PMID:21346803
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SYNCRIP mRNA	PMID:28973697
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SYNCRIP mRNA	PMID:18930950
1305683	Syncrip	synaptotagmin binding, cytoplasmic RNA interacting protein	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of SYNCRIP mRNA	PMID:22570695
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PCMTD2 mRNA	PMID:38218311
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PCMTD2 mRNA	PMID:33045310
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PCMTD2 mRNA]	PMID:31150632
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PCMTD2 mRNA	PMID:33167477
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313859	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCMTD2 mRNA	PMID:30529165
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PCMTD2 mRNA	PMID:26079696
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313859	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PCMTD2 mRNA	PMID:30319688
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20130806	CTD	MESH:D000431	Ethanol results in decreased expression of PCMTD2 mRNA	PMID:19167417
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313858	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of PCMTD2 mRNA	PMID:18951874
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PCMTD2 mRNA	PMID:39241906
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PCMTD2 mRNA	PMID:32145629
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of PCMTD2 mRNA	PMID:31614463
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PCMTD2 mRNA	PMID:39298647
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313858	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PCMTD2 mRNA	PMID:37042841
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PCMTD2 mRNA	PMID:33387578
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PCMTD2 mRNA	PMID:22061828
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313859	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PCMTD2 mRNA	PMID:36331819
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313858	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA	PMID:39836092
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	ISO	RGD:1313858	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of PCMTD2 mRNA	PMID:17103032
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of PCMTD2 mRNA	PMID:41580963
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of PCMTD2 mRNA	PMID:31129395
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PCMTD2 mRNA	PMID:31150632
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PCMTD2 mRNA	PMID:27339419|PMID:31919559
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PCMTD2 mRNA]	PMID:31150632
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PCMTD2 mRNA	PMID:25629700
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313858	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCMTD2 mRNA	PMID:39836092
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PCMTD2 mRNA	PMID:31881176
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313858	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PCMTD2 mRNA	PMID:23557933
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313858	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PCMTD2 mRNA	PMID:27392435
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313858	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PCMTD2 mRNA	PMID:27392435
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313858	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PCMTD2 mRNA	PMID:22574217
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCMTD2 mRNA	PMID:33387578
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PCMTD2 mRNA	PMID:30851411
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PCMTD2 mRNA	PMID:28959563
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313859	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of PCMTD2 mRNA	PMID:39631538
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of PCMTD2 mRNA	PMID:28595984|PMID:38568856
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313858	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCMTD2 mRNA	PMID:39836092
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313859	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PCMTD2 mRNA	PMID:22228805
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PCMTD2 mRNA; Silicon Dioxide results in decreased expression of PCMTD2 mRNA	PMID:23806026|PMID:25351596
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PCMTD2 mRNA	PMID:24136188
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313859	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PCMTD2 gene	PMID:35295148
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PCMTD2 mRNA	PMID:30723492
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:32509	pirinixic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PCMTD2 mRNA	PMID:19162173
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PCMTD2 mRNA	PMID:18445702
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of PCMTD2 mRNA	PMID:32145629
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PCMTD2 mRNA	PMID:25181051|PMID:33296240
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313858	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PCMTD2 mRNA	PMID:29275510
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of PCMTD2 mRNA	PMID:31129395
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PCMTD2 mRNA	PMID:39298647
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313858	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA	PMID:39836092
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PCMTD2 mRNA	PMID:19162173
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20130806	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PCMTD2 mRNA	PMID:19320972
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313858	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PCMTD2 mRNA	PMID:31533062
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313859	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PCMTD2 mRNA	PMID:36331819
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313858	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCMTD2 mRNA	PMID:25979313
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313859	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PCMTD2 mRNA	PMID:17292431
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCMTD2 mRNA	PMID:23179753
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313858	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PCMTD2 gene	PMID:29154799
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of PCMTD2 mRNA	PMID:41580965
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCMTD2 mRNA	PMID:20106945|PMID:25562108
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PCMTD2 mRNA	PMID:38832940
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PCMTD2 mRNA	PMID:27188386
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313859	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PCMTD2 mRNA	PMID:17562736
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313858	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCMTD2 mRNA	PMID:39836092
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PCMTD2 mRNA; Nanotubes, Carbon results in decreased expression of PCMTD2 mRNA	PMID:25554681|PMID:25620056
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of PCMTD2 mRNA	PMID:19162173
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PCMTD2 mRNA	PMID:24136188
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313858	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA	PMID:39836092
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PCMTD2 mRNA	PMID:15336504
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313859	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of PCMTD2 mRNA	PMID:20003209
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PCMTD2 mRNA	PMID:22206623
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1313858	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of PCMTD2 mRNA	PMID:28960945
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PCMTD2 mRNA	PMID:30851411
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313858	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCMTD2 gene]	PMID:28238834
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313859	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of PCMTD2 mRNA	PMID:23091169
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PCMTD2 mRNA	PMID:31826744
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313859	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PCMTD2 mRNA	PMID:39847705
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PCMTD2 mRNA	PMID:21278054
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313858	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PCMTD2 mRNA	PMID:38568856
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PCMTD2 mRNA	PMID:28973697
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PCMTD2 mRNA	PMID:19015723
1305684	Pcmtd2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PCMTD2 mRNA	PMID:23034163
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NAA25 mRNA]	PMID:31150632
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313860	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NAA25 mRNA	PMID:39241906
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313860	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NAA25 mRNA]	PMID:39241906
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313860	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NAA25 mRNA	PMID:39298647
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605042	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of NAA25 mRNA	PMID:31614463
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1605042	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NAA25 mRNA	PMID:38568856
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605042	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NAA25 mRNA	PMID:37042841
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605042	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of NAA25 mRNA	PMID:20655997
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NAA25 mRNA	PMID:33387578
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313860	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NAA25 mRNA	PMID:37236586
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605042	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of NAA25 mRNA	PMID:19549813
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1605042	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NAA25 protein	PMID:23301498
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605042	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NAA25 polyA tail	PMID:30157460
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of NAA25 mRNA	PMID:30779732
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NAA25 mRNA	PMID:31150632
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313860	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NAA25 mRNA	PMID:31919559
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NAA25 mRNA]	PMID:31150632
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605042	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NAA25 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NAA25 mRNA	PMID:40512198
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1605042	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NAA25 mRNA	PMID:25583101
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1605042	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NAA25 mRNA	PMID:21632981
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1605042	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of NAA25 protein	PMID:39603559
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1605042	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of NAA25 mRNA	PMID:23649840
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605042	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of NAA25 mRNA; sodium arsenite results in decreased expression of NAA25 protein	PMID:30528433|PMID:38568856
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605042	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NAA25 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NAA25 mRNA	PMID:40512198
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313860	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NAA25 mRNA	PMID:21569818
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605042	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to NAA25 mRNA]	PMID:32406909
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605042	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NAA25 mRNA	PMID:19150397
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313860	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NAA25 promoter	PMID:35295148
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313860	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of NAA25 mRNA	PMID:27760801
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NAA25 mRNA	PMID:25181051
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NAA25 mRNA	PMID:30816183|PMID:32528016
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313860	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NAA25 mRNA	PMID:39298647
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313860	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NAA25 mRNA	PMID:37019170
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of NAA25 mRNA	PMID:32680482
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313860	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of NAA25 mRNA	PMID:36117858
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313860	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NAA25 mRNA]	PMID:39241906
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605042	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NAA25 mRNA	PMID:37042841
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NAA25 mRNA	PMID:33453195
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of NAA25 promoter	PMID:22457795
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313860	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NAA25 mRNA	PMID:37236586
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313860	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NAA25 mRNA	PMID:28903501
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605042	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of NAA25 mRNA	PMID:19101580|PMID:23179753|PMID:27188386
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605042	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of NAA25 mRNA	PMID:29154799
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605042	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of NAA25 mRNA	PMID:20106945|PMID:27989131
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313860	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NAA25 mRNA	PMID:28973697
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1605042	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of NAA25 mRNA	PMID:16595896
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1605042	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of NAA25 mRNA	PMID:26272509
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NAA25 mRNA	PMID:33387578
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605042	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of NAA25 mRNA	PMID:21420995
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605042	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NAA25 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NAA25 mRNA	PMID:40512198
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NAA25 mRNA	PMID:29391264
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313860	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of NAA25 mRNA	PMID:35436446
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of NAA25 mRNA	PMID:30307764
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313860	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NAA25 mRNA; Nanotubes, Carbon results in increased expression of NAA25 mRNA	PMID:25554681
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313860	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of NAA25 mRNA	PMID:36117858
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1605042	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NAA25 protein	PMID:32959892
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1605042	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of NAA25 protein	PMID:39638853
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NAA25 mRNA	PMID:27291303
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313860	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of NAA25 mRNA	PMID:21278054
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NAA25 mRNA	PMID:24780913
1305685	Naa25	N(alpha)-acetyltransferase 25, NatB auxiliary subunit	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313860	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NAA25 mRNA]	PMID:39241906
1305687	Rnasek	ribonuclease K	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313862	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RNASEK mRNA	PMID:33045310
1305687	Rnasek	ribonuclease K	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNASEK mRNA]	PMID:31150632
1305687	Rnasek	ribonuclease K	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313862	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RNASEK mRNA	PMID:30319688
1305687	Rnasek	ribonuclease K	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of RNASEK mRNA	PMID:32145629
1305687	Rnasek	ribonuclease K	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RNASEK mRNA	PMID:33387578
1305687	Rnasek	ribonuclease K	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604138	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RNASEK mRNA	PMID:37042841
1305687	Rnasek	ribonuclease K	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313862	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of RNASEK mRNA	PMID:37992649
1305687	Rnasek	ribonuclease K	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313862	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of RNASEK mRNA	PMID:37992649
1305687	Rnasek	ribonuclease K	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RNASEK promoter	PMID:23359474
1305687	Rnasek	ribonuclease K	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RNASEK mRNA	PMID:33387578
1305687	Rnasek	ribonuclease K	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604138	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RNASEK mRNA	PMID:35430440
1305687	Rnasek	ribonuclease K	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RNASEK mRNA	PMID:30779732
1305687	Rnasek	ribonuclease K	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RNASEK mRNA	PMID:31150632
1305687	Rnasek	ribonuclease K	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNASEK mRNA]	PMID:31150632
1305687	Rnasek	ribonuclease K	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313862	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNASEK mRNA	PMID:22206623
1305687	Rnasek	ribonuclease K	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313862	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RNASEK mRNA	PMID:40504410
1305687	Rnasek	ribonuclease K	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of RNASEK mRNA	PMID:28374803
1305687	Rnasek	ribonuclease K	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1604138	E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RNASEK mRNA	PMID:34089799
1305687	Rnasek	ribonuclease K	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604138	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNASEK mRNA	PMID:33212167
1305687	Rnasek	ribonuclease K	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1604138	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RNASEK mRNA	PMID:29803840
1305687	Rnasek	ribonuclease K	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313862	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of RNASEK mRNA	PMID:37992649
1305687	Rnasek	ribonuclease K	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604138	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNASEK mRNA	PMID:38568856
1305687	Rnasek	ribonuclease K	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313862	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RNASEK mRNA	PMID:40504410
1305687	Rnasek	ribonuclease K	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313862	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNASEK mRNA	PMID:22228805
1305687	Rnasek	ribonuclease K	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of RNASEK mRNA	PMID:24395379
1305687	Rnasek	ribonuclease K	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313862	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNASEK gene	PMID:35295148
1305687	Rnasek	ribonuclease K	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RNASEK mRNA	PMID:25181051
1305687	Rnasek	ribonuclease K	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313862	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RNASEK mRNA	PMID:33221593
1305687	Rnasek	ribonuclease K	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604138	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RNASEK mRNA	PMID:25047013
1305687	Rnasek	ribonuclease K	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RNASEK promoter	PMID:23359474
1305687	Rnasek	ribonuclease K	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313862	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of RNASEK mRNA	PMID:40203079
1305687	Rnasek	ribonuclease K	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313862	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RNASEK mRNA	PMID:38685157
1305687	Rnasek	ribonuclease K	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RNASEK mRNA	PMID:21266533
1305687	Rnasek	ribonuclease K	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RNASEK promoter	PMID:23359474
1305687	Rnasek	ribonuclease K	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of RNASEK mRNA	PMID:22110744
1305687	Rnasek	ribonuclease K	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604138	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNASEK mRNA	PMID:37042841
1305687	Rnasek	ribonuclease K	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of RNASEK promoter	PMID:22457795
1305687	Rnasek	ribonuclease K	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604138	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RNASEK mRNA	PMID:25979313
1305687	Rnasek	ribonuclease K	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604138	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of RNASEK mRNA	PMID:23179753|PMID:27188386
1305687	Rnasek	ribonuclease K	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604138	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RNASEK gene	PMID:29154799
1305687	Rnasek	ribonuclease K	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of RNASEK mRNA	PMID:41580965
1305687	Rnasek	ribonuclease K	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313862	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of RNASEK mRNA	PMID:37992649
1305687	Rnasek	ribonuclease K	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RNASEK mRNA	PMID:33387578
1305687	Rnasek	ribonuclease K	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313862	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RNASEK mRNA	PMID:40504410
1305687	Rnasek	ribonuclease K	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313862	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNASEK mRNA	PMID:22206623
1305687	Rnasek	ribonuclease K	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RNASEK mRNA	PMID:32109520
1305687	Rnasek	ribonuclease K	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of RNASEK mRNA	PMID:23034163
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313863	E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of RHPN1 mRNA	PMID:35877022
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313863	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of RHPN1 mRNA	PMID:30165855
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313863	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of RHPN1 mRNA	PMID:38568856
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RHPN1 mRNA	PMID:33387578
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313863	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of RHPN1 mRNA	PMID:26079696
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313864	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RHPN1 mRNA	PMID:39922521
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313864	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RHPN1 mRNA	PMID:39922521
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313864	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RHPN1 mRNA	PMID:34319233
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RHPN1 mRNA	PMID:33387578
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RHPN1 mRNA	PMID:33354967
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RHPN1 mRNA	PMID:31881176
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313863	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RHPN1 mRNA	PMID:27392435
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313864	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of RHPN1 mRNA	PMID:23625948
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RHPN1 mRNA	PMID:33387578
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313863	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of RHPN1 mRNA	PMID:29955902
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313863	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of RHPN1 mRNA	PMID:32763439
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313863	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RHPN1 mRNA	PMID:38568856
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313864	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to RHPN1 promoter]	PMID:19654925
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313864	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RHPN1 gene	PMID:35295148
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313864	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RHPN1 mRNA	PMID:18648102
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313864	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of RHPN1 mRNA	PMID:25172293
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RHPN1 mRNA	PMID:32119087
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313864	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of RHPN1 exon	PMID:33297965
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313864	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RHPN1 mRNA	PMID:32715474
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313864	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RHPN1 mRNA	PMID:21266533
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313863	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RHPN1 mRNA	PMID:37042841
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RHPN1 mRNA	PMID:35163327
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RHPN1 mRNA	PMID:35163327
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RHPN1 mRNA	PMID:24386269
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313863	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RHPN1 mRNA	PMID:24449571
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313864	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RHPN1 mRNA	PMID:40194260
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313863	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RHPN1 mRNA	PMID:31533062
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313863	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RHPN1 mRNA	PMID:25979313
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313863	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RHPN1 gene	PMID:29154799
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313863	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of RHPN1 promoter	PMID:27989131
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313864	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RHPN1 mRNA	PMID:39922521
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313863	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RHPN1 mRNA	PMID:38832940
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RHPN1 mRNA	PMID:33387578
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313863	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of RHPN1 mRNA	PMID:31838189
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1313863	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of RHPN1 mRNA	PMID:32234424
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313864	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of RHPN1 mRNA	PMID:38701926
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313863	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RHPN1 mRNA	PMID:24810058
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:80799	Bufotalin	decreases expression	ISO	RGD:1313863	E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of RHPN1 mRNA	PMID:39904859
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RHPN1 mRNA	PMID:24780913|PMID:36843608
1305688	Rhpn1	rhophilin, Rho GTPase binding protein 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313863	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RHPN1 mRNA	PMID:38568856
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C084079	triptonide results in increased expression of TMEM254 mRNA	PMID:33045310
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol A co-treated with Tretinoin] results in increased expression of TMEM254 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol F co-treated with Tretinoin] results in increased expression of TMEM254 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol S co-treated with Tretinoin] results in increased expression of TMEM254 mRNA	PMID:30951980
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313865	E	RGD:6480464	20150714	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TMEM254 mRNA	PMID:24763279
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TMEM254 mRNA	PMID:26079696
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of TMEM254 mRNA	PMID:32145629
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313866	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of TMEM254 mRNA	PMID:39298647
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313865	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TMEM254 mRNA	PMID:37042841
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMEM254 mRNA	PMID:19850644
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of TMEM254 mRNA]	PMID:19850644
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TMEM254 mRNA	PMID:28818685
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TMEM254 mRNA	PMID:19549813
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TMEM254 mRNA	PMID:19770486
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of TMEM254 mRNA	PMID:23195993|PMID:24768652
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM254 mRNA	PMID:21215274|PMID:33387578
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of TMEM254 mRNA	PMID:16214954
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TMEM254 mRNA	PMID:28001369
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM254 mRNA	PMID:30851411
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM254 mRNA	PMID:39631538
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313865	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of TMEM254 mRNA	PMID:29453283
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313865	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMEM254 promoter	PMID:27901495
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313865	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM254 3' UTR	PMID:27901495
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TMEM254 mRNA	PMID:39716349
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C008261	lead acetate results in decreased expression of TMEM254 mRNA	PMID:25270620
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313866	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM254 gene; titanium dioxide results in decreased methylation of TMEM254 promoter	PMID:35295148
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C006253	pirinixic acid results in increased expression of TMEM254 mRNA	PMID:18301758|PMID:23811191
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:33083	fluoranthene	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C007738	fluoranthene results in decreased expression of TMEM254 mRNA	PMID:28329830
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM254 mRNA	PMID:28329830
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A affects the expression of TMEM254 mRNA	PMID:25181051|PMID:32145629
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM254 mRNA	PMID:30816183|PMID:32528016
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM254 mRNA	PMID:30951980|PMID:35598803
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM254 mRNA	PMID:30951980|PMID:33221593
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C006780	[bisphenol A co-treated with LIF protein] results in increased expression of TMEM254 mRNA; [bisphenol A co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol A co-treated with Tretinoin] results in increased expression of TMEM254 mRNA	PMID:30951980
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TMEM254 mRNA	PMID:23196670
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C543008	bisphenol S affects the expression of TMEM254 mRNA	PMID:30951980
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TMEM254 mRNA	PMID:39298647
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C543008	[bisphenol S co-treated with LIF protein] affects the expression of TMEM254 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol S co-treated with Tretinoin] results in increased expression of TMEM254 mRNA	PMID:30951980
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C008745	bisphenol F results in decreased expression of TMEM254 mRNA	PMID:30951980
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C008745	bisphenol F results in increased expression of TMEM254 mRNA	PMID:30951980
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313865	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA	PMID:28628672
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C008745	[bisphenol F co-treated with LIF protein] results in decreased expression of TMEM254 mRNA; [bisphenol F co-treated with LIF protein] results in increased expression of TMEM254 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol F co-treated with Tretinoin] results in increased expression of TMEM254 mRNA	PMID:30951980
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:34786	Heptachlor epoxide	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D006534	Heptachlor Epoxide results in decreased expression of TMEM254 mRNA	PMID:25270620
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313865	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA	PMID:28628672
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of TMEM254 promoter	PMID:22457795
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313865	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TMEM254 mRNA	PMID:31533062
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313865	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TMEM254 mRNA	PMID:40419075
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313865	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM254 mRNA	PMID:25979313
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM254 mRNA	PMID:17292431|PMID:17963808
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM254 mRNA	PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM254 mRNA	PMID:21427059
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313865	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM254 mRNA	PMID:19101580
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313865	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM254 mRNA	PMID:27188386
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TMEM254 mRNA	PMID:20106945|PMID:25562108
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313865	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA	PMID:28628672
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D017313	Fenretinide results in decreased expression of TMEM254 mRNA	PMID:28973697
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D000082	Acetaminophen affects the expression of TMEM254 mRNA	PMID:17562736
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMEM254 mRNA	PMID:33387578
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMEM254 mRNA	PMID:29246445
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form promotes the reaction [Acetaminophen results in decreased expression of TMEM254 mRNA]	PMID:29246445
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:4791	endosulfan	affects expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of TMEM254 mRNA	PMID:29391264
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313865	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA	PMID:28628672
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TMEM254 mRNA	PMID:39716349
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of TMEM254 mRNA	PMID:20977926
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of TMEM254 mRNA	PMID:20436886
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TMEM254 mRNA	PMID:25270620
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TMEM254 mRNA	PMID:37269647
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TMEM254 mRNA	PMID:31758290
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM254 mRNA	PMID:30851411
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313865	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM254 mRNA	PMID:27188386
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of TMEM254 mRNA	PMID:25270620
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TMEM254 mRNA	PMID:23914054
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1313865	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of TMEM254 mRNA	PMID:26079696
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313865	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM254 mRNA	PMID:27188386
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TMEM254 mRNA	PMID:23034163
1305689	Tmem254	transmembrane protein 254	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C025643	vinclozolin results in increased expression of TMEM254 mRNA	PMID:22570695
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1603945	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SARNP mRNA	PMID:38218311
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1603945	E	RGD:6480464	20160210	CTD	MESH:D014212	Tretinoin affects the expression of SARNP protein	PMID:17098229
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1603945	E	RGD:6480464	20160210	CTD	MESH:D014212	[Tretinoin co-treated with Tamoxifen] affects the expression of SARNP protein	PMID:17098229
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313869	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of SARNP mRNA	PMID:40945087
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of SARNP mRNA	PMID:30207508
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1603945	E	RGD:6480464	20160210	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SARNP mRNA	PMID:20044591
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1603945	E	RGD:6480464	20160210	CTD	MESH:D001554	Benzene results in increased expression of SARNP mRNA	PMID:15929907
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1603945	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SARNP protein	PMID:37730182
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SARNP mRNA	PMID:33387578
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin analog results in decreased expression of SARNP protein	PMID:26597043
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1313869	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SARNP protein]	PMID:32272095
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1603945	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SARNP gene	PMID:27153756
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313869	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of SARNP protein	PMID:39910959
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1603945	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of SARNP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SARNP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SARNP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SARNP protein	PMID:38598786
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1603945	E	RGD:6480464	20260505	CTD	MESH:C010974	Glyphosate results in increased expression of SARNP mRNA	PMID:40294809
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313869	E	RGD:6480464	20220913	CTD	MESH:C059514	Resveratrol results in decreased expression of SARNP protein	PMID:25505154
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1603945	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SARNP mRNA	PMID:28903495
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603945	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SARNP mRNA	PMID:27594783
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1603945	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SARNP mRNA	PMID:27392435
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313869	E	RGD:6480464	20220913	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SARNP mRNA	PMID:16962184
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1603945	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of SARNP protein	PMID:39603559
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1603945	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SARNP mRNA	PMID:28001369
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1603945	E	RGD:6480464	20140610	CTD	MESH:D004317	SARNP protein results in decreased susceptibility to Doxorubicin	PMID:24675091
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:28854	2,4-D	increases expression	ISO	RGD:1603945	E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in increased expression of SARNP mRNA	PMID:40294809
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1603945	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SARNP mRNA	PMID:25523186
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SARNP mRNA	PMID:21839799
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1603945	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SARNP mRNA	PMID:25523186
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1313869	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of SARNP protein	PMID:40770094
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1313869	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of SARNP protein	PMID:40770094
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1603945	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SARNP protein	PMID:20416286
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of SARNP mRNA	PMID:24136188
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313869	E	RGD:6480464	20220913	CTD	MESH:C009495	titanium dioxide results in decreased expression of SARNP mRNA	PMID:29264374
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313869	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SARNP gene	PMID:35295148
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313869	E	RGD:6480464	20220913	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SARNP mRNA	PMID:28472532
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313869	E	RGD:6480464	20220913	CTD	MESH:C006780	bisphenol A results in decreased expression of SARNP mRNA	PMID:33221593
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1603945	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SARNP mRNA	PMID:29275510
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SARNP mRNA	PMID:25181051
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313869	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SARNP mRNA	PMID:39298647
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313869	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SARNP mRNA	PMID:38685157
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313869	E	RGD:6480464	20220913	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of SARNP protein	PMID:32272095
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313869	E	RGD:6480464	20220913	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SARNP protein]	PMID:32272095
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1603945	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of SARNP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SARNP protein	PMID:38598786
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313869	E	RGD:6480464	20230207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SARNP protein	PMID:36214631
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1603945	E	RGD:6480464	20160210	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SARNP mRNA	PMID:19320972
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1603945	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SARNP mRNA	PMID:28302478
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1603945	E	RGD:6480464	20160210	CTD	MESH:C100187	chloropicrin results in increased expression of SARNP mRNA	PMID:26352163
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603945	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SARNP mRNA	PMID:23179753
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1603945	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SARNP gene	PMID:29154799
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1603945	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SARNP mRNA	PMID:25562108
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:41500	4-phenylbutyric acid	decreases expression	ISO	RGD:1603945	E	RGD:6480464	20160210	CTD	MESH:C075773	4-phenylbutyric acid results in decreased expression of SARNP mRNA	PMID:14583596
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1603945	E	RGD:6480464	20160210	CTD	MESH:D013629	Tamoxifen affects the expression of SARNP protein	PMID:17098229
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1603945	E	RGD:6480464	20160210	CTD	MESH:D013629	[Tretinoin co-treated with Tamoxifen] affects the expression of SARNP protein	PMID:17098229
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SARNP mRNA	PMID:33387578
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:46666	crocidolite asbestos	affects methylation	ISO	RGD:1603945	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite affects the methylation of SARNP gene	PMID:29523930
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313869	E	RGD:6480464	20220913	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SARNP mRNA	PMID:19446018|PMID:29279043
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SARNP mRNA	PMID:24136188
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313869	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SARNP mRNA	PMID:35964746
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:517248	bufalin	increases expression	ISO	RGD:1603945	E	RGD:6480464	20151110	CTD	MESH:C022777	bufalin results in increased expression of SARNP protein	PMID:23091618
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603945	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SARNP protein	PMID:32959892
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:6773	Mesaconitine	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in decreased expression of SARNP protein	PMID:37182599
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313869	E	RGD:6480464	20220913	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SARNP mRNA	PMID:22206623
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1603945	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SARNP protein	PMID:31285264
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1603945	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of SARNP mRNA	PMID:19095052
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1603945	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of SARNP protein	PMID:38348393
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of SARNP mRNA	PMID:36843608
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313869	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of SARNP protein	PMID:35357534
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of SARNP protein	PMID:35544339
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1603945	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SARNP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SARNP protein	PMID:38598786
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:9763	trovafloxacin	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of SARNP mRNA	PMID:24136188
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of SARNP mRNA	PMID:22570695
1305692	Sarnp	SAP domain containing ribonucleoprotein	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of SARNP mRNA	PMID:23555832
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313871	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ABHD8 mRNA	PMID:20188158
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ABHD8 mRNA	PMID:36331819
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313871	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ABHD8 mRNA	PMID:30319688
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ABHD8 mRNA	PMID:32145629
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313870	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ABHD8 mRNA	PMID:37042841
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313870	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ABHD8 mRNA	PMID:21179406
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313870	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ABHD8 mRNA	PMID:26079696
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1313870	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ABHD8 mRNA	PMID:26717081
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:17578	toluene	increases methylation	ISO	RGD:1313870	E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ABHD8 gene	PMID:26717081
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313871	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ABHD8 mRNA	PMID:34319233
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ABHD8 mRNA	PMID:33387578
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313870	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ABHD8 mRNA	PMID:28818685
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of ABHD8 mRNA	PMID:28522335
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABHD8 mRNA	PMID:22129741
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313870	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of ABHD8 mRNA	PMID:25102026
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ABHD8 mRNA	PMID:34911549
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ABHD8 mRNA	PMID:31881176
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313870	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ABHD8 mRNA	PMID:28903495
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313871	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABHD8 mRNA	PMID:21570461
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313870	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ABHD8 mRNA	PMID:33212167
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313870	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD8 mRNA	PMID:30851411
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ABHD8 mRNA	PMID:28959563
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABHD8 mRNA	PMID:39631538
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313870	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABHD8 mRNA	PMID:34032870
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313870	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ABHD8 mRNA	PMID:38568856
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313870	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ABHD8 promoter	PMID:27901495
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ABHD8 mRNA	PMID:27195522
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313870	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ABHD8 5' UTR	PMID:27901495
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to ABHD8 promoter]	PMID:19654925
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ABHD8 mRNA	PMID:23221170
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313871	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABHD8 gene	PMID:35295148
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of ABHD8 mRNA	PMID:34492290
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ABHD8 mRNA	PMID:23811191
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313870	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ABHD8 mRNA	PMID:19710929
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ABHD8 mRNA	PMID:19167457
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ABHD8 mRNA	PMID:32145629
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313870	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ABHD8 gene	PMID:31601247
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD8 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313871	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD8 mRNA	PMID:32156529|PMID:33221593
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313871	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ABHD8 mRNA	PMID:37019170
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ABHD8 mRNA	PMID:21266533
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ABHD8 mRNA	PMID:21266533
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313871	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ABHD8 mRNA	PMID:34813904
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313871	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ABHD8 mRNA	PMID:34813904
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABHD8 mRNA	PMID:22129741
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of ABHD8 mRNA	PMID:36117858
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313870	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABHD8 mRNA	PMID:37042841
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313870	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ABHD8 mRNA	PMID:38568856
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ABHD8 mRNA	PMID:17585979
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ABHD8 mRNA	PMID:36331819
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313870	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ABHD8 gene	PMID:29154799
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313871	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ABHD8 mRNA	PMID:28973697
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1313870	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of ABHD8 mRNA	PMID:38825487
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ABHD8 mRNA	PMID:30307764
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ABHD8 mRNA	PMID:35964746
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of ABHD8 mRNA	PMID:36117858
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313871	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ABHD8 mRNA	PMID:22206623
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313870	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD8 mRNA	PMID:30851411
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:8772	raloxifene	affects response to substance	ISO	RGD:1313870	E	RGD:6480464	20230801	CTD	MESH:D020849	ABHD8 affects the susceptibility to Raloxifene Hydrochloride	PMID:32934756
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313870	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ABHD8 mRNA	PMID:29301935
1305693	Abhd8	abhydrolase domain containing 8	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ABHD8 mRNA	PMID:19015723
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313872	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of MRPL54 mRNA	PMID:35967413
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:137392	chlormequat chloride	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of MRPL54 protein	PMID:34958886
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL54 mRNA	PMID:30529165
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL54 mRNA	PMID:36331819
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313873	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL54 mRNA	PMID:39241906
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313872	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL54 mRNA	PMID:31059760
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313872	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MRPL54 mRNA	PMID:21179406
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313873	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of MRPL54 mRNA	PMID:17456735
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313872	E	RGD:6480464	20171010	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MRPL54 mRNA	PMID:28412506
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MRPL54 mRNA	PMID:35550907
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MRPL54 mRNA	PMID:19850644|PMID:33754040
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of MRPL54 mRNA]	PMID:19850644
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MRPL54 mRNA	PMID:33387578
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL54 mRNA	PMID:36331819
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313873	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of MRPL54 mRNA	PMID:17456735
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313872	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MRPL54 mRNA	PMID:23649840
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313872	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MRPL54 gene	PMID:27153756
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRPL54 mRNA	PMID:19770486
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of MRPL54 mRNA	PMID:12763052
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MRPL54 mRNA	PMID:34911549
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL54 mRNA	PMID:22206623
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL54 mRNA	PMID:40504410
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:27585	selenomethionine	affects expression	ISO	RGD:1313872	E	RGD:6480464	20120412	CTD	MESH:D012645	Selenomethionine affects the expression of MRPL54 mRNA	PMID:17222674
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313873	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MRPL54 mRNA	PMID:30912803
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313873	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL54 mRNA	PMID:21570461
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL54 mRNA	PMID:32109520
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL54 mRNA	PMID:33387578
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313872	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of MRPL54 protein	PMID:39603559
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313872	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPL54 mRNA	PMID:30851411
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL54 mRNA	PMID:36209798
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL54 mRNA	PMID:40504410
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313872	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPL54 mRNA	PMID:20106945
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MRPL54 mRNA	PMID:22228805
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of MRPL54 mRNA	PMID:24136188
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MRPL54 mRNA	PMID:30047161
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MRPL54 mRNA	PMID:18648102
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313873	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPL54 mRNA	PMID:18301758|PMID:23811191
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313872	E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL54 mRNA	PMID:38568856
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL54 mRNA	PMID:33221593|PMID:35598803
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL54 mRNA	PMID:25181051|PMID:32145629
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313873	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL54 mRNA	PMID:32156529
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313872	E	RGD:6480464	20240702	CTD	MESH:C543008	bisphenol S results in decreased expression of MRPL54 mRNA	PMID:38568856
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313873	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL54 mRNA	PMID:39298647
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MRPL54 mRNA	PMID:38685157
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313873	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MRPL54 mRNA	PMID:37019170
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313873	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MRPL54 mRNA	PMID:34813904
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313873	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of MRPL54 mRNA	PMID:34813904
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313872	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MRPL54 mRNA	PMID:37042841
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of MRPL54 mRNA	PMID:17585979
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MRPL54 mRNA	PMID:39529242
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313872	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MRPL54 mRNA	PMID:27153767
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL54 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL54 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MRPL54 mRNA	PMID:36331819
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313872	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPL54 mRNA	PMID:29154799
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313872	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MRPL54 gene	PMID:29154799
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MRPL54 mRNA	PMID:30047161
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1313872	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of MRPL54 promoter	PMID:27989131
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313872	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MRPL54 mRNA	PMID:25562108
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313872	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL54 mRNA	PMID:25704631|PMID:31059760
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313872	E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL54 mRNA	PMID:31059760
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL54 mRNA	PMID:40504410
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20240702	CTD	MESH:D004008	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL54 mRNA	PMID:37844793
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313873	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of MRPL54 mRNA	PMID:22334560
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of MRPL54 mRNA	PMID:29097150
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MRPL54 mRNA	PMID:17942748
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20240702	CTD	MESH:D004997	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL54 mRNA	PMID:37844793
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313873	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MRPL54 mRNA	PMID:25554681
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPL54 mRNA	PMID:24136188
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MRPL54 mRNA	PMID:30047161
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPL54 mRNA	PMID:24136188
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20240702	CTD	MESH:D007052	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL54 mRNA	PMID:37844793
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313872	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MRPL54 mRNA	PMID:27714895
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL54 mRNA	PMID:22206623
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased expression of MRPL54 mRNA	PMID:37162024
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:7719	ochratoxin A	increases methylation	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased methylation of MRPL54 gene	PMID:37162024
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313872	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPL54 mRNA	PMID:30851411
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1313873	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of MRPL54 mRNA	PMID:22334560
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of MRPL54 mRNA	PMID:22334560
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MRPL54 mRNA	PMID:30047161
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of MRPL54 mRNA	PMID:40826991
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of MRPL54 mRNA	PMID:24136188
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:9466	Testosterone propionate	increases expression	ISO	RGD:1313873	E	RGD:6480464	20141111	CTD	MESH:D043343	Testosterone Propionate results in increased expression of MRPL54 mRNA	PMID:15601916
1305694	Mrpl54	mitochondrial ribosomal protein L54	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MRPL54 mRNA	PMID:23034163|PMID:23555832
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313874	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LSM14A mRNA	PMID:38218311
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313875	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of LSM14A mRNA	PMID:33045310
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of LSM14A mRNA	PMID:15498508
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313875	E	RGD:6480464	20181113	CTD	MESH:D004958	Estradiol affects the expression of LSM14A mRNA	PMID:30077407
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313875	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LSM14A mRNA	PMID:39298647
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20181113	CTD	MESH:D004958	[Polyphenols co-treated with Estradiol] results in increased expression of LSM14A mRNA	PMID:30077407
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313874	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LSM14A protein	PMID:37730182
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LSM14A mRNA	PMID:33387578
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313874	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LSM14A intron	PMID:30157460
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LSM14A mRNA	PMID:37236586
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313874	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LSM14A protein	PMID:23301498
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313874	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LSM14A intron	PMID:30157460
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LSM14A mRNA	PMID:23649840
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM14A mRNA	PMID:22206623
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM14A mRNA	PMID:40504410
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313874	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of LSM14A protein	PMID:35688186
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313874	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LSM14A mRNA	PMID:23557933
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of LSM14A mRNA	PMID:19921347
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313875	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LSM14A mRNA	PMID:21570461
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LSM14A mRNA	PMID:34747641
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LSM14A mRNA	PMID:33212167
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of LSM14A mRNA	PMID:28959563
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LSM14A mRNA	PMID:29803840
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313874	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of LSM14A protein	PMID:35688186
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313874	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of LSM14A mRNA	PMID:20044591
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM14A mRNA	PMID:40504410
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313874	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LSM14A intron	PMID:30157460
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313874	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LSM14A mRNA]	PMID:32406909
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LSM14A mRNA	PMID:19150397
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of LSM14A mRNA	PMID:15498508
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LSM14A mRNA	PMID:34492290
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LSM14A mRNA	PMID:34947998
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of LSM14A protein	PMID:37567409
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LSM14A mRNA	PMID:25181051|PMID:30816183
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313874	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LSM14A mRNA	PMID:25979313
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313874	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LSM14A mRNA	PMID:28628672
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313874	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LSM14A intron	PMID:30157460
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:34575	bisphenol F	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:C008745	bisphenol F results in decreased expression of LSM14A protein	PMID:40188933
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313874	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LSM14A mRNA	PMID:28628672
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313874	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LSM14A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LSM14A mRNA	PMID:28628672
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LSM14A mRNA	PMID:37236586
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LSM14A mRNA	PMID:19320972
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313874	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LSM14A mRNA	PMID:24449571
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313874	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LSM14A mRNA	PMID:31533062
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313874	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LSM14A mRNA	PMID:25979313
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of LSM14A mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LSM14A mRNA	PMID:25562108
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313874	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LSM14A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LSM14A mRNA	PMID:28628672
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of LSM14A mRNA	PMID:21420995
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM14A mRNA	PMID:40504410
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313874	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LSM14A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LSM14A mRNA	PMID:28628672
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313874	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LSM14A protein	PMID:32959892
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313875	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of LSM14A mRNA	PMID:23650126
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313875	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of LSM14A mRNA	PMID:20003209
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313874	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LSM14A intron	PMID:30157460
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313874	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LSM14A protein	PMID:34186270
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM14A mRNA	PMID:22206623
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313874	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LSM14A gene]	PMID:28238834
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LSM14A mRNA	PMID:21346803
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313874	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of LSM14A mRNA	PMID:29301935
1305695	Lsm14a	LSM14A mRNA processing body assembly factor	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LSM14A mRNA	PMID:21346803
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313878	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of HEPACAM2 mRNA	PMID:33045310
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313878	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HEPACAM2 mRNA	PMID:30529165
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313878	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HEPACAM2 mRNA	PMID:39241906
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1602173	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HEPACAM2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of HEPACAM2 mRNA	PMID:35811015
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602173	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HEPACAM2 gene	PMID:27153756
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313878	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in decreased expression of HEPACAM2 mRNA	PMID:33026818
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313878	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of HEPACAM2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of HEPACAM2 mRNA	PMID:34911549
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:27928	parathion	decreases methylation	ISO	RGD:1602173	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of HEPACAM2 promoter	PMID:22847954
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HEPACAM2 mRNA	PMID:32109520
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of HEPACAM2 mRNA	PMID:26033743
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602173	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HEPACAM2 mRNA	PMID:38568856
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602173	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HEPACAM2 promoter	PMID:27901495
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602173	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HEPACAM2 3' UTR; Benzo(a)pyrene results in increased methylation of HEPACAM2 exon	PMID:27901495
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of HEPACAM2 mRNA	PMID:26033743
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of HEPACAM2 mRNA	PMID:34779285
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1602173	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of HEPACAM2 gene	PMID:31601247
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313878	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of HEPACAM2 mRNA	PMID:22609695
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C009495	titanium dioxide results in increased expression of HEPACAM2 mRNA	PMID:28181387
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313878	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of HEPACAM2 mRNA	PMID:35295148
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HEPACAM2 mRNA	PMID:25181051
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1602173	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of HEPACAM2 gene	PMID:31601247
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313878	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of HEPACAM2 mRNA	PMID:32156529
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HEPACAM2 gene	PMID:28505145
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602173	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of HEPACAM2 gene	PMID:31601247
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313878	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of HEPACAM2 mRNA	PMID:26682919
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:34575	bisphenol F	decreases methylation	ISO	RGD:1602173	E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in decreased methylation of HEPACAM2 gene	PMID:31601247
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:34698	diethyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of HEPACAM2 mRNA	PMID:32341500
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of HEPACAM2 mRNA	PMID:18500788
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1602173	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of HEPACAM2 mRNA	PMID:25812627
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of HEPACAM2 mRNA	PMID:27387713
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1602173	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of HEPACAM2 mRNA	PMID:24449571
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313878	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HEPACAM2 mRNA	PMID:40194260
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:38689	fonofos	decreases methylation	ISO	RGD:1602173	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of HEPACAM2 promoter	PMID:22847954
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:38960	terbufos	decreases methylation	ISO	RGD:1602173	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of HEPACAM2 promoter	PMID:22847954
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1602173	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HEPACAM2 mRNA	PMID:25812627
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313878	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of HEPACAM2 mRNA	PMID:29038090
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1602173	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HEPACAM2 gene	PMID:29154799
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1602173	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of HEPACAM2 mRNA	PMID:35811015
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1602173	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HEPACAM2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of HEPACAM2 mRNA	PMID:35811015
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313878	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of HEPACAM2 mRNA	PMID:30529165
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313878	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HEPACAM2 mRNA; Nanotubes, Carbon results in decreased expression of HEPACAM2 mRNA	PMID:25554681
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313878	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of HEPACAM2 mRNA	PMID:19042947
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313878	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HEPACAM2 mRNA	PMID:22206623
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1602173	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of HEPACAM2 mRNA	PMID:30928695
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of HEPACAM2 mRNA	PMID:32109520
1305697	Hepacam2	HEPACAM family member 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313878	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of HEPACAM2 mRNA	PMID:38648751
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TAF1A mRNA]	PMID:31150632
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313879	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of TAF1A mRNA	PMID:21934132
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313879	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TAF1A mRNA	PMID:21632981
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313879	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of TAF1A mRNA	PMID:22574217
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313879	E	RGD:6480464	20130416	CTD	MESH:D014241	Trichloroethylene results in increased expression of TAF1A protein	PMID:22771849
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313879	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TAF1A mRNA	PMID:23649840
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313879	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TAF1A mRNA	PMID:21179406
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313879	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of TAF1A protein	PMID:34122009
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313879	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TAF1A protein	PMID:37730182
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313879	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TAF1A mRNA	PMID:28818685
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TAF1A mRNA	PMID:37236586
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313879	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TAF1A mRNA	PMID:19549813
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313879	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TAF1A protein	PMID:20106945
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313879	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TAF1A mRNA	PMID:22100608|PMID:27153756
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313880	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TAF1A mRNA	PMID:19770486
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27086	tributylstannane	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in increased expression of TAF1A mRNA	PMID:31129395
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of TAF1A mRNA	PMID:31129395
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TAF1A mRNA	PMID:31150632
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313880	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TAF1A mRNA	PMID:31919559
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TAF1A mRNA]	PMID:31150632
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313879	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:39836092
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:40504410
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313879	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TAF1A mRNA	PMID:27392435
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313879	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TAF1A mRNA	PMID:25583101
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313879	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TAF1A mRNA	PMID:20106945|PMID:21632981
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:28177	theophylline	increases expression	ISO	RGD:1313879	E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of TAF1A mRNA	PMID:18951874
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TAF1A mRNA	PMID:28959563
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313879	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:39836092
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:40504410
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313879	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TAF1A mRNA	PMID:22316170
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313879	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF1A mRNA	PMID:17879257|PMID:20106945
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313879	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TAF1A mRNA]	PMID:32406909
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313879	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TAF1A mRNA	PMID:20018196|PMID:20382639
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF1A mRNA	PMID:28329830
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF1A mRNA	PMID:25181051
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TAF1A mRNA	PMID:31129395
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of TAF1A mRNA	PMID:31129395
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313880	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TAF1A mRNA	PMID:38685157
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313879	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TAF1A mRNA	PMID:37042841
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313879	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TAF1A mRNA	PMID:38568856
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TAF1A mRNA	PMID:37236586
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313879	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TAF1A mRNA	PMID:25979313
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313879	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TAF1A mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313879	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of TAF1A mRNA	PMID:29154799
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313879	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TAF1A mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313879	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TAF1A mRNA	PMID:38832940
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313880	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TAF1A mRNA	PMID:17562736
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313879	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:39836092
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:40504410
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313880	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TAF1A mRNA	PMID:35436446
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TAF1A mRNA	PMID:22078008
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TAF1A gene	PMID:35440735
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313879	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of TAF1A protein	PMID:34122009
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313880	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TAF1A mRNA	PMID:22206623
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313880	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TAF1A mRNA	PMID:25566086
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313879	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TAF1A mRNA	PMID:37199045
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313879	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TAF1A gene]	PMID:28238834
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:94287	erastin	decreases expression	ISO	RGD:1313879	E	RGD:6480464	20220809	CTD	MESH:C477224	erastin results in decreased expression of TAF1A mRNA alternative form	PMID:35234341
1305698	Taf1a	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313880	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TAF1A mRNA	PMID:35537566
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313882	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of P3H3 mRNA	PMID:33045310
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of P3H3 mRNA	PMID:20938992
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313882	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of P3H3 mRNA	PMID:30319688
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of P3H3 mRNA	PMID:39241906
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H3 mRNA]	PMID:39241906
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313882	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of P3H3 mRNA	PMID:19484750
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of P3H3 mRNA	PMID:30165855
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of P3H3 gene	PMID:27618143
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of P3H3 mRNA	PMID:20938992
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H3 mRNA	PMID:37992649
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H3 mRNA	PMID:37992649
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of P3H3 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA]	PMID:20230807
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of P3H3 mRNA	PMID:33387578
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1313882	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA	PMID:20230807
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of P3H3 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of P3H3 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA]	PMID:20230807
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of P3H3 mRNA	PMID:39836092
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of P3H3 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA]	PMID:20230807
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P3H3 mRNA	PMID:29950665
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313881	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of P3H3 mRNA	PMID:19549813
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of P3H3 mRNA	PMID:19376150
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313881	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of P3H3 intron	PMID:30157460
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of P3H3 mRNA	PMID:35430440
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of P3H3 mRNA	PMID:30779732
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of P3H3 mRNA	PMID:20938992
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of P3H3 mRNA	PMID:39836092
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of P3H3 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA]	PMID:20230807
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of P3H3 mRNA	PMID:27392435
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of P3H3 mRNA	PMID:17341692
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of P3H3 mRNA	PMID:34747641
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to P3H3 promoter]	PMID:19654925
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313881	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of P3H3 mRNA	PMID:33212167
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20160412	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of P3H3 mRNA	PMID:24690739
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313881	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of P3H3 mRNA	PMID:29803840
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H3 mRNA	PMID:37992649
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313881	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of P3H3 mRNA	PMID:38568856
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of P3H3 mRNA	PMID:39836092
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313881	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of P3H3 intron	PMID:30157460
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313881	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of P3H3 exon; Benzo(a)pyrene results in increased methylation of P3H3 promoter	PMID:27901495
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20160412	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of P3H3 mRNA	PMID:24690739
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of P3H3 mRNA	PMID:25729387
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313882	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of P3H3 gene	PMID:35295148
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P3H3 mRNA	PMID:29950665
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of P3H3 mRNA	PMID:19167457
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of P3H3 mRNA	PMID:25181051
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of P3H3 mRNA	PMID:41034487
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313881	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of P3H3 protein	PMID:34186270
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313882	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of P3H3 promoter	PMID:27312807
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313882	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of P3H3 mRNA	PMID:30951980|PMID:33221593
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:3423	carmustine	affects response to substance	ISO	RGD:1313881	E	RGD:6480464	20120412	CTD	MESH:D002330	P3H3 mRNA affects the susceptibility to Carmustine	PMID:16365179
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313882	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of P3H3 gene	PMID:31683443
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313882	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of P3H3 mRNA	PMID:30951980
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313882	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of P3H3 promoter	PMID:33297965
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313881	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of P3H3 intron	PMID:30157460
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313882	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of P3H3 mRNA	PMID:30951980
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313881	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of P3H3 protein	PMID:34186270
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of P3H3 mRNA	PMID:31558096
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P3H3 mRNA	PMID:29950665
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H3 mRNA]	PMID:39241906
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of P3H3 mRNA	PMID:39836092
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313881	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of P3H3 protein	PMID:26879310
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of P3H3 mRNA	PMID:27387713
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313881	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of P3H3 mRNA	PMID:19320972
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313882	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of P3H3 mRNA	PMID:40194260
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313881	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of P3H3 mRNA	PMID:31533062
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313881	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of P3H3 mRNA	PMID:40419075
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313881	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of P3H3 mRNA	PMID:23179753|PMID:28001369
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313881	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of P3H3 gene	PMID:29154799
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H3 mRNA	PMID:37992649
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313882	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of P3H3 mRNA	PMID:17562736
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20160412	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of P3H3 mRNA	PMID:24690739
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of P3H3 mRNA	PMID:39836092
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of P3H3 mRNA	PMID:29391264
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of P3H3 mRNA	PMID:17557909
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of P3H3 mRNA	PMID:22504374
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313881	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of P3H3 protein	PMID:32959892
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313881	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of P3H3 mRNA	PMID:39836092
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of P3H3 mRNA	PMID:25729387
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of P3H3 protein	PMID:36851058
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313881	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of P3H3 intron	PMID:30157460
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1313881	E	RGD:6480464	20130305	CTD	MESH:C047246	P3H3 mRNA affects the susceptibility to temozolomide	PMID:16365179
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313882	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of P3H3 mRNA	PMID:22206623
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313881	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of P3H3 mRNA	PMID:37199045
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of P3H3 mRNA	PMID:31558096
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of P3H3 mRNA	PMID:22504374
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H3 mRNA]	PMID:39241906
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of P3H3 mRNA	PMID:40826991
1305699	P3h3	prolyl 3-hydroxylase 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of P3H3 mRNA	PMID:35537566
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CATSPER3 mRNA	PMID:36331819
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313883	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of CATSPER3 mRNA	PMID:21632981
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CATSPER3 mRNA	PMID:37992649
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CATSPER3 mRNA	PMID:37992649
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 protein	PMID:38798119
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313884	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CATSPER3 mRNA	PMID:28960355
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CATSPER3 mRNA	PMID:37992649
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313883	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CATSPER3 mRNA	PMID:38568856
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 protein	PMID:38798119
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313884	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CATSPER3 mRNA	PMID:20813756
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CATSPER3 mRNA	PMID:25181051
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313884	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in decreased expression of CATSPER3 mRNA; bisphenol A results in decreased expression of CATSPER3 protein	PMID:34953956
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313884	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of CATSPER3 mRNA	PMID:38922122
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20250114	CTD	MESH:C006780	TET1 protein inhibits the reaction [bisphenol A results in decreased expression of CATSPER3 protein]	PMID:34953956
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313884	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CATSPER3 mRNA	PMID:40194260
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313883	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CATSPER3 mRNA	PMID:31533062
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CATSPER3 mRNA	PMID:36331819
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CATSPER3 mRNA	PMID:37992649
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 protein	PMID:38798119
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1313883	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CATSPER3 mRNA	PMID:32234424
1305700	Catsper3	cation channel, sperm associated 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313883	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CATSPER3 gene]	PMID:28238834
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TBX5 gene	PMID:35440735
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of TBX5 mRNA	PMID:17676605
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313887	E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of TBX5 mRNA	PMID:27905399
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313887	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TBX5 mRNA	PMID:31163220
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TBX5 mRNA	PMID:34319233
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313888	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of and results in increased expression of TBX5 mRNA	PMID:34120004
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of TBX5 mRNA	PMID:33914522
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313887	E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of TBX5 mRNA	PMID:29993192
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313888	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of TBX5 mRNA	PMID:18579281
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313887	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TBX5 gene	PMID:27153756
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313887	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TBX5 intron	PMID:30157460
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313888	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TBX5 mRNA	PMID:34911549
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313887	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of TBX5 mRNA	PMID:23557933
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313887	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of TBX5 promoter	PMID:22847954
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313888	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBX5 mRNA	PMID:24058054
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313888	E	RGD:6480464	20151110	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBX5 mRNA	PMID:26139165
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TBX5 mRNA	PMID:27862939
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313887	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TBX5 mRNA	PMID:29803840
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313887	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TBX5 gene	PMID:28589171
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313887	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TBX5 5' UTR; Benzo(a)pyrene affects the methylation of TBX5 exon; Benzo(a)pyrene affects the methylation of TBX5 promoter	PMID:27901495
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TBX5 mRNA	PMID:22228805
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313887	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of TBX5 promoter	PMID:23974009
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313888	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TBX5 mRNA	PMID:27131904
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313887	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TBX5 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of TBX5 gene	PMID:31601247
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313888	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TBX5 gene	PMID:35295148
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313888	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of TBX5 mRNA	PMID:33914522
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313888	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TBX5 promoter	PMID:27334623
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TBX5 mRNA	PMID:25181051
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313887	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TBX5 gene	PMID:31601247
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of TBX5 mRNA	PMID:36779543
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313887	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of TBX5 mRNA	PMID:29275510
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313888	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TBX5 mRNA	PMID:30951980
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313887	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TBX5 gene	PMID:31601247
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:33418	graphite	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of TBX5 mRNA	PMID:29933104
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313887	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TBX5 gene	PMID:31601247
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313888	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TBX5 mRNA	PMID:30951980
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein	PMID:34896426
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313888	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TBX5 mRNA	PMID:30951980
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313887	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of TBX5 gene	PMID:31601247
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313888	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TBX5 mRNA	PMID:37019170
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TBX5 mRNA	PMID:21266533
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313887	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of TBX5 promoter	PMID:22847954
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313887	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TBX5 mRNA	PMID:31533062
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313887	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of TBX5 promoter	PMID:22847954
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of TBX5 protein	PMID:34896426
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313888	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of TBX5 mRNA	PMID:20219112
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein	PMID:34896426
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein	PMID:34896426
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313887	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TBX5 mRNA	PMID:38832940
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1313887	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of TBX5 mRNA	PMID:17331233
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TBX5 mRNA	PMID:29279043
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein	PMID:34896426
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C007350	nitrofen results in decreased expression of TBX5 mRNA; nitrofen results in decreased expression of TBX5 protein	PMID:27833996
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313887	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TBX5 gene]	PMID:28238834
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313888	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TBX5 mRNA	PMID:27131904
1305702	Tbx5	T-box transcription factor 5	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of TBX5 gene	PMID:31682807
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1347417	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of TMEM38B mRNA	PMID:35967413
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1347417	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM38B mRNA	PMID:33167477
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1347417	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of TMEM38B mRNA	PMID:26516004
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550568	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM38B mRNA	PMID:36331819
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1347417	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of TMEM38B mRNA	PMID:22378314
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of TMEM38B mRNA	PMID:32145629
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1347417	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of TMEM38B mRNA	PMID:22574217
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1347417	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of TMEM38B mRNA	PMID:16474171|PMID:19167446
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:17642	pentachlorophenol	affects expression	ISO	RGD:1550568	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol affects the expression of TMEM38B mRNA	PMID:23892564
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550568	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMEM38B mRNA	PMID:34319233
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1347417	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TMEM38B mRNA	PMID:28818685
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TMEM38B mRNA	PMID:39836092
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550568	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TMEM38B mRNA	PMID:37236586
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1347417	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TMEM38B mRNA	PMID:19549813
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1550568	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of TMEM38B mRNA	PMID:25629700
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TMEM38B mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of TMEM38B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM38B mRNA	PMID:32525701|PMID:39836092
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TMEM38B mRNA	PMID:31881176
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of TMEM38B mRNA	PMID:19167446
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1347417	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of TMEM38B mRNA	PMID:16474171
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550568	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM38B mRNA	PMID:21570461|PMID:24680724
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM38B mRNA	PMID:21215274|PMID:34747641
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550568	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM38B mRNA	PMID:19770486
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550568	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM38B mRNA	PMID:19933214
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1347417	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TMEM38B mRNA	PMID:28001369
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1347417	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM38B mRNA	PMID:30851411
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM38B mRNA	PMID:28959563
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1347417	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM38B mRNA	PMID:29803840
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550568	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of TMEM38B mRNA	PMID:39631538
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1347417	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TMEM38B mRNA	PMID:38568856
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TMEM38B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM38B mRNA	PMID:39836092
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550568	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMEM38B mRNA	PMID:19770486
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550568	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TMEM38B mRNA	PMID:22228805
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1550568	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of TMEM38B protein	PMID:37955338
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TMEM38B mRNA]	PMID:32406909
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1347417	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TMEM38B mRNA	PMID:20382639
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of TMEM38B mRNA	PMID:24136188
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550568	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TMEM38B mRNA	PMID:29264374
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550568	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of TMEM38B mRNA	PMID:35295148
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of TMEM38B mRNA	PMID:32145629
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1347417	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM38B protein	PMID:33376534
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM38B mRNA	PMID:25181051
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1347417	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM38B mRNA	PMID:16474171|PMID:27685785|PMID:29275510
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of TMEM38B protein]	PMID:33376534
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1347417	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of TMEM38B mRNA	PMID:36804509
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550568	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TMEM38B mRNA	PMID:40203079
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1550568	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of TMEM38B intron	PMID:28392331
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1347417	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TMEM38B gene	PMID:22964155
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1347417	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMEM38B mRNA	PMID:37042841
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TMEM38B mRNA	PMID:39836092
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1347417	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMEM38B mRNA	PMID:26472689
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550568	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TMEM38B mRNA	PMID:37236586
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550568	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TMEM38B mRNA	PMID:40194260
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1347417	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TMEM38B mRNA	PMID:28302478
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1347417	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TMEM38B mRNA	PMID:31533062
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1347417	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of TMEM38B mRNA	PMID:19167446
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM38B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of TMEM38B mRNA	PMID:19167446
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550568	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM38B mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TMEM38B mRNA	PMID:36331819
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1347417	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM38B mRNA	PMID:25979313
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1347417	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM38B mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM38B mRNA	PMID:27188386
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of TMEM38B mRNA	PMID:38685447|PMID:41580965
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550568	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of TMEM38B mRNA	PMID:19770486
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1347417	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of TMEM38B mRNA	PMID:27989131
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1550568	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of TMEM38B mRNA	PMID:22733784
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TMEM38B mRNA	PMID:24136188
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1347417	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TMEM38B mRNA	PMID:24935251
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1347417	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM38B mRNA	PMID:21420995
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TMEM38B mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of TMEM38B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM38B mRNA	PMID:32525701|PMID:39836092
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550568	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TMEM38B mRNA	PMID:25620056
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of TMEM38B mRNA	PMID:38685447|PMID:41580965
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1550568	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of TMEM38B mRNA	PMID:40234311
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of TMEM38B mRNA	PMID:21983209
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TMEM38B mRNA	PMID:39836092
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:63598	levofloxacin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in increased expression of TMEM38B mRNA	PMID:24136188
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550568	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM38B mRNA	PMID:21641980
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550568	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TMEM38B mRNA	PMID:23650126
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of TMEM38B mRNA	PMID:24136188
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1550568	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of TMEM38B mRNA	PMID:20003209
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of TMEM38B mRNA	PMID:30467583
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TMEM38B gene	PMID:35440735
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550568	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TMEM38B mRNA	PMID:22206623
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TMEM38B mRNA	PMID:24136188
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1347417	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of TMEM38B mRNA	PMID:22714537
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1347417	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM38B mRNA	PMID:30851411
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM38B mRNA	PMID:27188386
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM38B mRNA	PMID:19167446
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1550568	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of TMEM38B mRNA	PMID:39847705
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of TMEM38B mRNA	PMID:32525701
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347417	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM38B mRNA	PMID:27188386
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1347417	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of TMEM38B mRNA	PMID:29301935
1305703	Tmem38b	transmembrane protein 38B	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TMEM38B mRNA	PMID:23034163
1305704	Larp4-ps1	La ribonucleoprotein 4, pseudogene 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LARP4-PS1 mRNA	PMID:31150632
1305704	Larp4-ps1	La ribonucleoprotein 4, pseudogene 1	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of LARP4-PS1 mRNA	PMID:23125180
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1313892	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of OTX2 mRNA	PMID:34925699
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:15343	acetaldehyde	affects expression	ISO	RGD:1313893	E	RGD:6480464	20150623	CTD	MESH:D000079	Acetaldehyde affects the expression of OTX2 mRNA	PMID:22634333
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20150623	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OTX2 gene	PMID:20938992
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1313892	E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of OTX2 mRNA	PMID:31600526
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1313893	E	RGD:6480464	20150623	CTD	MESH:D014212	Tretinoin affects the expression of OTX2 mRNA	PMID:16211290
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D014212	Tretinoin results in decreased expression of OTX2 mRNA	PMID:20488242
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of OTX2 mRNA	PMID:21934132|PMID:34742744|PMID:40359302
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20150623	CTD	MESH:D014212	Tretinoin results in decreased expression of OTX2 mRNA	PMID:16788091|PMID:21427059|PMID:36189433
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20260113	CTD	MESH:D014212	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; 4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [Tretinoin results in decreased expression of OTX2 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [Tretinoin results in decreased expression of OTX2 mRNA]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline promotes the reaction [Tretinoin results in decreased expression of OTX2 mRNA]; [bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA; Fulvestrant promotes the reaction [Tretinoin results in decreased expression of OTX2 mRNA]; LE 135 affects the reaction [Tretinoin results in decreased expression of OTX2 mRNA]; LE 135 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; LY2955303 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; LY2955303 inhibits the reaction [Tretinoin results in decreased expression of OTX2 mRNA]	PMID:40359302
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OTX2 mRNA	PMID:36189433
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20240604	CTD	MESH:D000431	Ethanol results in decreased expression of OTX2 mRNA	PMID:25566775
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20240604	CTD	MESH:D000431	[Folic Acid co-treated with Ethanol] results in decreased expression of OTX2 mRNA	PMID:25566775
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of OTX2 mRNA	PMID:30510588
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:16494	lipoic acid	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]	PMID:31068541
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of OTX2 mRNA	PMID:33387578
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20150623	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OTX2 gene	PMID:20938992
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:167162	L-ascorbic acid 2-phosphate	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20220208	CTD	MESH:C011669	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA	PMID:34480604
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:167657	CHIR-98014	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20210406	CTD	MESH:C473710	Chir 98014 results in decreased expression of OTX2 mRNA	PMID:22723015
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of OTX2 mRNA	PMID:36189433
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OTX2 mRNA	PMID:36189433
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of OTX2 mRNA	PMID:26577399
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313892	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of OTX2 gene; Aflatoxin B1 results in decreased methylation of OTX2 promoter	PMID:27153756|PMID:30157460
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:27086	tributylstannane	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C011559	tributyltin results in increased expression of OTX2 mRNA	PMID:21683754
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of OTX2 mRNA	PMID:25629700
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20240604	CTD	MESH:D005492	[Folic Acid co-treated with Ethanol] results in decreased expression of OTX2 mRNA	PMID:25566775
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20150623	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OTX2 gene	PMID:20938992
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of OTX2 mRNA	PMID:26272509
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA	PMID:27188386
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313893	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of OTX2 mRNA	PMID:28960355
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of OTX2 mRNA	PMID:23557933
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20231205	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of OTX2 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of OTX2 mRNA	PMID:28050121|PMID:39150886
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OTX2 mRNA	PMID:24058054|PMID:33956508
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20210608	CTD	MESH:D012402	Rotenone affects the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of OTX2 mRNA	PMID:28001369
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:28299	quercetin 3-O-beta-D-glucofuranoside	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C016527	isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]	PMID:31068541
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of OTX2 mRNA	PMID:35032568
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTX2 mRNA	PMID:26033743
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of OTX2 mRNA	PMID:26033743
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20220208	CTD	MESH:D001205	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA	PMID:34480604
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313892	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of OTX2 gene	PMID:28589171
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313892	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of OTX2 5' UTR; Benzo(a)pyrene affects the methylation of OTX2 promoter	PMID:27901495
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of OTX2 mRNA	PMID:21839799
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313893	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of OTX2 mRNA	PMID:27195522
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1313892	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of OTX2 promoter	PMID:23974009
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTX2 mRNA	PMID:26033743
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of OTX2 mRNA	PMID:26033743
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]	PMID:31068541
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of OTX2 mRNA	PMID:26551752
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of OTX2 mRNA	PMID:24395379
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D000643	Ammonium Chloride affects the expression of OTX2 mRNA	PMID:16483693
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:31638	fulvestrant	increases expression	ISO	RGD:1313892	E	RGD:6480464	20260113	CTD	MESH:C070081	Fulvestrant results in increased expression of OTX2 mRNA	PMID:40359302
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20260113	CTD	MESH:C070081	Fulvestrant promotes the reaction [Tretinoin results in decreased expression of OTX2 mRNA]	PMID:40359302
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:31746	kainic acid	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D007608	Kainic Acid results in decreased expression of OTX2 mRNA	PMID:19700661
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:31767	lead diacetate	affects expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C008261	lead acetate affects the expression of OTX2 mRNA	PMID:21864555
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C008261	lead acetate results in decreased expression of OTX2 mRNA	PMID:22641619
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20231205	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of OTX2 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of OTX2 mRNA	PMID:28050121|PMID:39150886
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of OTX2 mRNA	PMID:30047161
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313893	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of OTX2 gene; titanium dioxide results in decreased methylation of OTX2 promoter alternative form	PMID:35295148
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:32888	gamma-hexachlorocyclohexane	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20210608	CTD	MESH:D001556	Hexachlorocyclohexane inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in decreased expression of OTX2 mRNA	PMID:33476716
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in increased expression of OTX2 mRNA	PMID:25181051
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313892	E	RGD:6480464	20260113	CTD	MESH:C006780	bisphenol A results in increased expression of OTX2 mRNA	PMID:40359302
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20260113	CTD	MESH:C006780	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; [bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA; LE 135 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; LY2955303 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]	PMID:40359302
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313892	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of OTX2 mRNA	PMID:25979313
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:3390	carbaryl	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20210608	CTD	MESH:D012721	Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20210504	CTD	MESH:C008745	bisphenol F results in decreased expression of OTX2 mRNA	PMID:33476716
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:34608	captan	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20210608	CTD	MESH:D002215	Captan promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:34682	diazinon	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D003976	Diazinon results in decreased expression of OTX2 mRNA	PMID:29108742
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:34696	dieldrin	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20210608	CTD	MESH:D004026	Dieldrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1313893	E	RGD:6480464	20150623	CTD	MESH:D019256	Cadmium Chloride affects the expression of OTX2 mRNA	PMID:18974090
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313892	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of OTX2 mRNA	PMID:25979313
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of OTX2 mRNA	PMID:22723015|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:34742744
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20150623	CTD	MESH:D014635	Valproic Acid results in decreased expression of OTX2 mRNA	PMID:19136453|PMID:20546886|PMID:21427059|PMID:24896083
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; Valproic Acid inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:27188386|PMID:32949729
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of OTX2 mRNA	PMID:30047161
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of OTX2 mRNA	PMID:22723015|PMID:24935251|PMID:26272509
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA	PMID:27188386
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20190312	CTD	MESH:D005472	Fluorouracil results in decreased expression of OTX2 mRNA	PMID:30518710
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20200714	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of OTX2 mRNA	PMID:31978390
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of OTX2 mRNA	PMID:30047161
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:5118	fluoxetine	affects expression	ISO	RGD:1313893	E	RGD:6480464	20181113	CTD	MESH:D005473	Fluoxetine affects the expression of OTX2 mRNA	PMID:29893963
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:5693	hexachlorophene	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20210608	CTD	MESH:D006582	Hexachlorophene inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:62878	XAV939	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20220208	CTD	MESH:C544261	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA	PMID:34480604
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases response to substance	ISO	RGD:1313893	E	RGD:6480464	20150623	CTD	MESH:D015655	OTX2 protein results in decreased susceptibility to 1-Methyl-4-phenylpyridinium	PMID:20573704
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:68352	quercetin 3-O-beta-D-glucopyranoside	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C016527	isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]	PMID:31068541
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20260324	CTD	MESH:C554430	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA; Captan promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; decamethrin affects the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Dieldrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Diethylhexyl Phthalate promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Hexachlorocyclohexane inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Hexachlorophene inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Rotenone affects the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Valproic Acid inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA	PMID:27188386
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1313893	E	RGD:6480464	20150623	CTD	MESH:C061365	flusilazole affects the expression of OTX2 mRNA	PMID:22634333
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of OTX2 mRNA	PMID:30047161
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D011441	Propylthiouracil results in increased expression of OTX2 mRNA	PMID:31068541
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D011441	isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]; Thioctic Acid inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]	PMID:31068541
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA	PMID:27188386
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:91091	CHIR 99021	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20220208	CTD	MESH:C473711	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA	PMID:34480604
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313892	E	RGD:6480464	20161228	CTD	MESH:C459179	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; Captan promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; decamethrin affects the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Dieldrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Diethylhexyl Phthalate promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Hexachlorocyclohexane inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Hexachlorophene inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Rotenone affects the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Valproic Acid inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:27188386|PMID:32949729
1305705	Otx2	orthodenticle homeobox 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313892	E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of OTX2 mRNA	PMID:26551752
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313895	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of H1F1 mRNA	PMID:33045310
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313894	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of H1-1 mRNA	PMID:26516004
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:164200	triclosan	increases methylation	ISO	RGD:1313894	E	RGD:6480464	20220607	CTD	MESH:D014260	Triclosan results in increased methylation of H1-1 gene	PMID:34523531
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313894	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of H1-1 mRNA	PMID:38568856
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313895	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in decreased expression of H1F1 mRNA	PMID:28973375
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1313895	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of H1F1 mRNA	PMID:33754040
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of H1F1 mRNA	PMID:33387578
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	ISO	RGD:1313894	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of H1-1 mRNA	PMID:17103032
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313894	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of H1-1 mRNA	PMID:35301059
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313895	E	RGD:6480464	20181016	CTD	MESH:D002251	[PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of H1F1 mRNA	PMID:29987408
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:27563	arsenic atom	decreases methylation	ISO	RGD:1313894	E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of H1-1 promoter	PMID:31135185
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of H1F1 mRNA	PMID:31881176
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313894	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in increased expression of H1-1 mRNA	PMID:41028656
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313894	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of H1-1 mRNA	PMID:41028656
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313894	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of H1-1 mRNA	PMID:38568856
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313894	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of H1-1 mRNA	PMID:25266719
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313895	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of H1F1 mRNA	PMID:37682722
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313894	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of H1-1 5' UTR; Benzo(a)pyrene results in decreased methylation of H1-1 exon; Benzo(a)pyrene results in decreased methylation of H1-1 promoter	PMID:27901495
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313895	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of H1F1 mRNA	PMID:20504355
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313894	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of H1-1 mRNA	PMID:41028656
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313894	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of H1-1 mRNA	PMID:34973136
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313895	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of H1F1 promoter alternative form	PMID:35295148
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of H1F1 mRNA	PMID:30012374
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313895	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of H1F1 mRNA	PMID:23557971
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of H1F1 mRNA	PMID:25181051
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313894	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of H1-1 mRNA; bisphenol A results in decreased expression of H1-1 protein	PMID:29275510|PMID:33376534
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	ISO	RGD:1313895	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of H1F1 mRNA	PMID:26377693
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313895	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of H1F1 protein	PMID:35362542
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313895	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of H1F1 protein]	PMID:35362542
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D002509	Cephaloridine results in increased expression of H1F1 mRNA	PMID:18500788
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313894	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of H1-1 mRNA	PMID:35301059
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:C039281	furan results in increased methylation of H1F1 gene	PMID:22079235
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313894	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of H1-1 mRNA	PMID:19320972
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313895	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of H1F1 mRNA	PMID:28962523
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313895	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of H1F1 mRNA	PMID:39529242
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313895	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of H1F1 mRNA	PMID:24896083
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:43572	kojic acid	increases expression	ISO	RGD:1313894	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of H1-1 mRNA	PMID:16595896
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313894	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of H1-1 mRNA	PMID:26690555
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of H1F1 mRNA	PMID:33387578
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:47217	arsane	decreases methylation	ISO	RGD:1313894	E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of H1-1 promoter	PMID:31135185
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D004726	Endosulfan results in increased expression of H1F1 mRNA	PMID:29391264
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313894	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of H1-1 mRNA	PMID:22079256
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313895	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of H1F1 protein]	PMID:35362542
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313895	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of H1F1 mRNA; Nanotubes, Carbon results in increased expression of H1F1 mRNA	PMID:25554681
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1313895	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of H1F1 mRNA	PMID:26377693
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313895	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of H1F1 mRNA	PMID:19042947
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:53620	methylisothiazolinone	decreases expression	ISO	RGD:1313894	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of H1-1 mRNA	PMID:31629900
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313895	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of H1F1 mRNA	PMID:38701926
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C025340	manganese chloride results in decreased expression of H1F1 mRNA	PMID:28801915
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of H1F1 mRNA	PMID:28801915
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:72676	versicolorin A	increases expression	ISO	RGD:1313894	E	RGD:6480464	20210209	CTD	MESH:C029826	versicolorin A results in increased expression of H1-1 mRNA	PMID:32106047
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313895	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of H1F1 mRNA	PMID:22206623
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313894	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of H1-1 mRNA	PMID:22079256
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313894	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of H1-1 mRNA	PMID:22079256
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313894	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to H1-1 gene]	PMID:28238834
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313895	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of H1F1 mRNA	PMID:38648751
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D011441	Propylthiouracil affects the expression of H1F1 mRNA	PMID:24780913
1305706	H1f1	H1.1 linker histone, cluster member	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of H1F1 protein	PMID:35544339
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of CAPRIN1 mRNA	PMID:25152437
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CAPRIN1 mRNA	PMID:21551480
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CAPRIN1 mRNA	PMID:33045310
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein]	PMID:38195004
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of CAPRIN1 mRNA	PMID:15498508
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of CAPRIN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA	PMID:32699268|PMID:32845096
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CAPRIN1 mRNA	PMID:36331819
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CAPRIN1 mRNA	PMID:26079696
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313896	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CAPRIN1 mRNA	PMID:22378314
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313897	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CAPRIN1 mRNA	PMID:30319688
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313896	E	RGD:6480464	20160607	CTD	MESH:D000431	Ethanol results in increased expression of CAPRIN1 mRNA	PMID:27010169
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313897	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CAPRIN1 mRNA	PMID:39241906
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313896	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of CAPRIN1 mRNA	PMID:22574217
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313897	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CAPRIN1 mRNA	PMID:39298647
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CAPRIN1 mRNA	PMID:23829299
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CAPRIN1 mRNA	PMID:19448997
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313896	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CAPRIN1 mRNA	PMID:21179406
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CAPRIN1 mRNA	PMID:33754040
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of CAPRIN1 protein	PMID:34122009
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:17924	D-glucitol	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20220405	CTD	MESH:D013012	Sorbitol promotes the reaction [SNRNP200 protein binds to CAPRIN1 protein]	PMID:33939924
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CAPRIN1 mRNA	PMID:36331819
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein	PMID:38195004
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CAPRIN1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CAPRIN1 mRNA	PMID:28111341|PMID:37236586
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CAPRIN1 protein	PMID:23301498
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313896	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CAPRIN1 gene	PMID:28458013
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CAPRIN1 mRNA	PMID:15674844
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of CAPRIN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of CAPRIN1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CAPRIN1 mRNA	PMID:34911549
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of CAPRIN1 mRNA	PMID:19483382
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CAPRIN1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CAPRIN1 protein	PMID:38598786
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAPRIN1 mRNA	PMID:22206623
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313896	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CAPRIN1 protein	PMID:35688186
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CAPRIN1 protein	PMID:25505154
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CAPRIN1 mRNA	PMID:23557933
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of CAPRIN1 mRNA	PMID:34813904
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in increased expression of CAPRIN1 mRNA	PMID:18922574
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313897	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CAPRIN1 mRNA	PMID:21570461
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CAPRIN1 mRNA	PMID:19465110
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:28177	theophylline	increases expression	ISO	RGD:1313896	E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of CAPRIN1 mRNA	PMID:18951874
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of CAPRIN1 protein	PMID:35544339
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CAPRIN1 mRNA	PMID:28001369
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CAPRIN1 mRNA	PMID:33212167
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CAPRIN1 mRNA	PMID:29803840
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:29678	sodium arsenite	affects localization	ISO	RGD:1313896	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of CAPRIN1 protein	PMID:19073175|PMID:33939924
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of CAPRIN1 mRNA; sodium arsenite results in decreased expression of CAPRIN1 protein	PMID:30528433|PMID:38568856
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20161228	CTD	MESH:C017947	Emetine inhibits the reaction [sodium arsenite affects the localization of CAPRIN1 protein]; sodium arsenite promotes the reaction [ABCC1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ACTG1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ADAMTS12 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [AFMID protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [AHNAK2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [AHSA1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ANKRD17 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ANXA6 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [AP3D1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ARF1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ARFGAP2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ARPC5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ASF1B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ATRX protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [BIN3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [BOLA2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [BUD23 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [C11ORF68 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [C17ORF100 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CAMSAP2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CAVIN1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CCDC71 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CCNL2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CCT7 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CDC16 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CDC27 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CDIPT protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CDK5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CENPE protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CEP131 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CHCHD3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CHD1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CHTOP protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CKM protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CLINT1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CMPK1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CNOT4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [COG5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CPA4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CSNK2A2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CTPS1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DDX46 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DHCR24 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DMD protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DNAJB4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DOCK9 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DTYMK protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DYNC1LI1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DYNLL2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ECH1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EIF2A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EIF2D protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EIF4A2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ELMO2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ELOB protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ELOVL1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EMC1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ERP29 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EXOC6B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EXOSC5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FGF3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FKBP2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FMNL1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FMR1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FNDC3A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FRY protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GALNT2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GART protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GCC2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GNE protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GOSR1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GPR107 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GPR156 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GSPT1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GSTM2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [H2AC18 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [H3C15 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HADH protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HAUS5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HBA1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HCK protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HLA-C protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HMGB1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HNF1A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HNRNPA3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HSD17B11 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HUWE1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [IGDCC3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [IQCN protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ISYNA1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ITGB4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [KIF5A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [KLF3-AS1 mRNA binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [KNDC1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [KRT8 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [LARS2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [LATS1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [LMAN2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [LMF2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MAP1S protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MAP7D3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MED4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MRPL11 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MRPL44 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MRPL46 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MRPS34 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MSI2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MTAP protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MTHFD2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MTREX protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MVB12A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MYH2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MYH7 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MZT2B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NCBP2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NDUFS3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NFATC4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NHEJ1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NHSL2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NIFK protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NNMT protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NUP85 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NUP98 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ORMDL3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PABPC4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PAFAH1B3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PBK protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PCDH11X protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PCYT1B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PDIA3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PDXDC1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PFN2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PIGS protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PIK3R4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PLEC protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [POLR2E protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PPIE protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PPP2CB protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PRKAR2A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PRKCA protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PRRG1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PSMB7 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PSMC2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PSMC6 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PSME1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PTGES3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PTP4A1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PTPN23 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PUM1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PYGB protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RANGAP1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RBM10 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RELCH protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RNF40 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ROCK1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RPL36A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RPS21 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RRBP1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RRP1B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RTCB protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SART3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SCGN protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SCO2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SEC24C protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SEH1L protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SGTA protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SHLD3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SLC25A10 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SLC25A13 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SLC35F6 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SNAP29 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SNX1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SNX12 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SRFBP1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [STT3B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SULT1A3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TBC1D15 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TBC1D5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TGM2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TIMM29 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TIMMDC1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TIPRL protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TJP1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TMEM11 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TRAM1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TRIM47 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TRIM56 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TTI1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TTLL12 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TTN protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TYMS protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [UBAP2L protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [UBE2M protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [UBR2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [UNC13B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [UNC13D protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [VPS53 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [WASF2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [WDR6 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [WWP1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [XPC protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [YARS1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [YBX1 protein binds to CAPRIN1 protein]	PMID:19073175|PMID:33939924
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CAPRIN1 mRNA	PMID:19770486|PMID:22228805
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CAPRIN1 protein]	PMID:32406909
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:3023	benzbromarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of CAPRIN1 mRNA	PMID:19483382
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of CAPRIN1 protein	PMID:34122009
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CAPRIN1 mRNA	PMID:19150397
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of CAPRIN1 mRNA	PMID:24136188
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CAPRIN1 mRNA	PMID:25729387
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of CAPRIN1 mRNA	PMID:15498508
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CAPRIN1 mRNA	PMID:29264374
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313897	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CAPRIN1 gene	PMID:35295148
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of CAPRIN1 mRNA	PMID:19483382
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CAPRIN1 mRNA	PMID:23411599|PMID:34492290
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:32509	pirinixic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of CAPRIN1 mRNA	PMID:19483382
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CAPRIN1 mRNA	PMID:18445702
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of CAPRIN1 mRNA	PMID:22484513
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CAPRIN1 mRNA	PMID:18301758
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313896	E	RGD:6480464	20160607	CTD	MESH:C006780	bisphenol A affects the expression of CAPRIN1 mRNA	PMID:27010169
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPRIN1 mRNA	PMID:30816183|PMID:34947998
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPRIN1 protein	PMID:37567409
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CAPRIN1 mRNA	PMID:25181051
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313896	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of CAPRIN1 protein	PMID:34186270
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of CAPRIN1 mRNA	PMID:19925653
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313897	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CAPRIN1 mRNA	PMID:39298647
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313896	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CAPRIN1 protein	PMID:34186270
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313897	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CAPRIN1 mRNA	PMID:38685157
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313896	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CAPRIN1 protein	PMID:34186270
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CAPRIN1 protein	PMID:38598786
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313896	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CAPRIN1 mRNA	PMID:37042841
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of CAPRIN1 mRNA	PMID:26377693
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CAPRIN1 mRNA	PMID:38568856
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein	PMID:38195004
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CAPRIN1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CAPRIN1 mRNA	PMID:28111341|PMID:37236586
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CAPRIN1 protein	PMID:26879310
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CAPRIN1 mRNA	PMID:19320972
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313897	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CAPRIN1 mRNA	PMID:18353800
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA	PMID:32699268
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:3750	clofibrate	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of CAPRIN1 mRNA	PMID:19483382
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CAPRIN1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CAPRIN1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CAPRIN1 mRNA	PMID:36331819
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313896	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CAPRIN1 mRNA	PMID:25979313
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CAPRIN1 mRNA	PMID:17963808
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CAPRIN1 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAPRIN1 mRNA	PMID:27188386
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CAPRIN1 mRNA	PMID:17555576
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of CAPRIN1 mRNA	PMID:36621641
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of CAPRIN1 mRNA	PMID:27188386
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of CAPRIN1 mRNA	PMID:18058816
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313896	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CAPRIN1 mRNA	PMID:28542535
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CAPRIN1 mRNA	PMID:17562736
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CAPRIN1 mRNA	PMID:21420995
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1313896	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of CAPRIN1 mRNA	PMID:20977926
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of CAPRIN1 mRNA	PMID:21061450
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:4781	emetine	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20120412	CTD	MESH:D004640	Emetine inhibits the reaction [sodium arsenite affects the localization of CAPRIN1 protein]	PMID:19073175
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313897	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CAPRIN1 mRNA	PMID:35436446
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313896	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of CAPRIN1 mRNA	PMID:18175754
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:4886	L-ethionine	affects expression	EXP		E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of CAPRIN1 mRNA	PMID:19483382
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CAPRIN1 mRNA	PMID:17555576
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CAPRIN1 mRNA	PMID:30307764
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CAPRIN1 mRNA	PMID:24136188
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CAPRIN1 mRNA	PMID:35964746
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CAPRIN1 mRNA	PMID:24136188
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CAPRIN1 mRNA	PMID:19042947
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313897	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CAPRIN1 mRNA	PMID:23608068
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CAPRIN1 protein	PMID:32959892
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of CAPRIN1 mRNA	PMID:27188386
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CAPRIN1 mRNA	PMID:25729387
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CAPRIN1 mRNA	PMID:30467583
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	increases expression	ISO	RGD:1313896	E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in increased expression of CAPRIN1 mRNA	PMID:22101062
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313896	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CAPRIN1 mRNA	PMID:31758290
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313896	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CAPRIN1 protein	PMID:34186270
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CAPRIN1 mRNA	PMID:22206623
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAPRIN1 mRNA	PMID:22206623
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CAPRIN1 protein	PMID:37664457
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CAPRIN1 mRNA	PMID:24136188
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1313896	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of CAPRIN1 protein	PMID:39638853
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CAPRIN1 mRNA	PMID:15215175
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of CAPRIN1 mRNA	PMID:19483382
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:7772	omeprazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of CAPRIN1 mRNA	PMID:19483382
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAPRIN1 mRNA	PMID:27188386
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 promotes the reaction [NR1H4 protein binds to CAPRIN1 gene]	PMID:20091679
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313897	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CAPRIN1 mRNA	PMID:31388691
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of CAPRIN1 protein	PMID:19954255
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1313896	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of CAPRIN1 mRNA	PMID:26079696
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of CAPRIN1 mRNA	PMID:19483382
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CAPRIN1 protein; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAPRIN1 mRNA	PMID:27188386|PMID:37664457
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CAPRIN1 mRNA	PMID:21346803
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313896	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CAPRIN1 protein	PMID:38598786
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CAPRIN1 mRNA	PMID:21346803
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CAPRIN1 mRNA	PMID:18930950
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CAPRIN1 mRNA	PMID:19015723
1305707	Caprin1	cell cycle associated protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CAPRIN1 mRNA	PMID:20566332
1305711	Foxn3	forkhead box N3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FOXN3 mRNA	PMID:38218311
1305711	Foxn3	forkhead box N3	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of FOXN3 mRNA	PMID:21551480
1305711	Foxn3	forkhead box N3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of FOXN3 mRNA	PMID:33045310
1305711	Foxn3	forkhead box N3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FOXN3 mRNA]	PMID:31150632
1305711	Foxn3	forkhead box N3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CHES1 mRNA	PMID:20938992
1305711	Foxn3	forkhead box N3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313904	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of FOXN3 mRNA	PMID:23724009
1305711	Foxn3	forkhead box N3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313904	E	RGD:6480464	20151013	CTD	MESH:D010100	Oxygen deficiency results in increased expression of FOXN3 mRNA	PMID:24403227
1305711	Foxn3	forkhead box N3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313904	E	RGD:6480464	20151013	CTD	MESH:D010100	1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of FOXN3 mRNA]	PMID:24403227
1305711	Foxn3	forkhead box N3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313904	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of FOXN3 mRNA	PMID:22378314
1305711	Foxn3	forkhead box N3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313905	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FOXN3 mRNA	PMID:30319688
1305711	Foxn3	forkhead box N3	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313904	E	RGD:6480464	20250401	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CHES1 mRNA	PMID:20044591
1305711	Foxn3	forkhead box N3	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313904	E	RGD:6480464	20250401	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CHES1 mRNA	PMID:18951874
1305711	Foxn3	forkhead box N3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FOXN3 mRNA	PMID:21632981
1305711	Foxn3	forkhead box N3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FOXN3 mRNA	PMID:39241906
1305711	Foxn3	forkhead box N3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of FOXN3 mRNA	PMID:32145629
1305711	Foxn3	forkhead box N3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FOXN3 mRNA	PMID:31614463
1305711	Foxn3	forkhead box N3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CHES1 mRNA	PMID:20938992
1305711	Foxn3	forkhead box N3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313904	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FOXN3 mRNA	PMID:37042841
1305711	Foxn3	forkhead box N3	gene	CHEBI:16716	benzene	affects expression	ISO	RGD:1313904	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene affects the expression of FOXN3 mRNA	PMID:16188086
1305711	Foxn3	forkhead box N3	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of FOXN3 mRNA	PMID:27523638
1305711	Foxn3	forkhead box N3	gene	CHEBI:17833	gentamycin	affects expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins affects the expression of FOXN3 mRNA	PMID:33387578
1305711	Foxn3	forkhead box N3	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1313904	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of FOXN3 intron	PMID:30157460
1305711	Foxn3	forkhead box N3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313904	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXN3 mRNA	PMID:35301059
1305711	Foxn3	forkhead box N3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313905	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXN3 mRNA	PMID:37325564
1305711	Foxn3	forkhead box N3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FOXN3 mRNA	PMID:19549813
1305711	Foxn3	forkhead box N3	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1313904	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of FOXN3 intron	PMID:30157460
1305711	Foxn3	forkhead box N3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313904	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FOXN3 gene	PMID:27153756
1305711	Foxn3	forkhead box N3	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313905	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOXN3 mRNA	PMID:21785161
1305711	Foxn3	forkhead box N3	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of FOXN3 mRNA	PMID:30779732
1305711	Foxn3	forkhead box N3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FOXN3 mRNA	PMID:31150632
1305711	Foxn3	forkhead box N3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FOXN3 mRNA	PMID:31919559
1305711	Foxn3	forkhead box N3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FOXN3 mRNA]	PMID:31150632
1305711	Foxn3	forkhead box N3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CHES1 mRNA	PMID:20938992
1305711	Foxn3	forkhead box N3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313904	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FOXN3 gene	PMID:25304211
1305711	Foxn3	forkhead box N3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313904	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXN3 mRNA	PMID:39836092
1305711	Foxn3	forkhead box N3	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313905	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of FOXN3 mRNA	PMID:35897073
1305711	Foxn3	forkhead box N3	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FOXN3 mRNA	PMID:31881176
1305711	Foxn3	forkhead box N3	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of FOXN3 mRNA	PMID:12569576
1305711	Foxn3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FOXN3 mRNA	PMID:32109520
1305711	Foxn3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313905	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FOXN3 mRNA	PMID:24058054
1305711	Foxn3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FOXN3 mRNA	PMID:21215274|PMID:33387578
1305711	Foxn3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FOXN3 mRNA	PMID:20106945|PMID:21632981
1305711	Foxn3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHES1 mRNA	PMID:19770486
1305711	Foxn3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FOXN3 mRNA	PMID:34747641
1305711	Foxn3	forkhead box N3	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of FOXN3 mRNA	PMID:28374803
1305711	Foxn3	forkhead box N3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FOXN3 mRNA	PMID:33212167
1305711	Foxn3	forkhead box N3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FOXN3 mRNA	PMID:29803840
1305711	Foxn3	forkhead box N3	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313904	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of FOXN3 protein	PMID:35688186
1305711	Foxn3	forkhead box N3	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313904	E	RGD:6480464	20250401	CTD	MESH:D024483	Vitamin K 3 affects the expression of CHES1 mRNA	PMID:20044591
1305711	Foxn3	forkhead box N3	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313904	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of FOXN3 gene	PMID:28589171
1305711	Foxn3	forkhead box N3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313904	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXN3 mRNA	PMID:39836092
1305711	Foxn3	forkhead box N3	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313904	E	RGD:6480464	20250401	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of CHES1 mRNA	PMID:22316170
1305711	Foxn3	forkhead box N3	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313905	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of FOXN3 mRNA	PMID:22342234
1305711	Foxn3	forkhead box N3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313904	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FOXN3 5' UTR; Benzo(a)pyrene affects the methylation of FOXN3 intron; Benzo(a)pyrene affects the methylation of FOXN3 promoter	PMID:27901495|PMID:30157460
1305711	Foxn3	forkhead box N3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FOXN3 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:26238291
1305711	Foxn3	forkhead box N3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of FOXN3 mRNA	PMID:27131904
1305711	Foxn3	forkhead box N3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of FOXN3 mRNA	PMID:25351596
1305711	Foxn3	forkhead box N3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of FOXN3 mRNA	PMID:23221170
1305711	Foxn3	forkhead box N3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FOXN3 mRNA	PMID:19150397|PMID:20018196
1305711	Foxn3	forkhead box N3	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FOXN3 mRNA	PMID:24136188
1305711	Foxn3	forkhead box N3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of FOXN3 mRNA	PMID:25729387
1305711	Foxn3	forkhead box N3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of FOXN3 mRNA	PMID:30047161
1305711	Foxn3	forkhead box N3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313905	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FOXN3 gene	PMID:35295148
1305711	Foxn3	forkhead box N3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FOXN3 mRNA	PMID:25181051|PMID:32145629
1305711	Foxn3	forkhead box N3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of FOXN3 mRNA	PMID:36232920
1305711	Foxn3	forkhead box N3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of FOXN3 mRNA	PMID:37894381|PMID:38074096
1305711	Foxn3	forkhead box N3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313904	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FOXN3 gene	PMID:31601247
1305711	Foxn3	forkhead box N3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313905	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of FOXN3 promoter	PMID:27312807
1305711	Foxn3	forkhead box N3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of FOXN3 mRNA	PMID:30816183
1305711	Foxn3	forkhead box N3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313904	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of FOXN3 mRNA	PMID:20678512|PMID:36232920
1305711	Foxn3	forkhead box N3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FOXN3 gene	PMID:28505145
1305711	Foxn3	forkhead box N3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of FOXN3 mRNA	PMID:26682919
1305711	Foxn3	forkhead box N3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FOXN3 mRNA	PMID:32119087
1305711	Foxn3	forkhead box N3	gene	CHEBI:34342	3-methylcholanthrene	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D008748	Methylcholanthrene results in increased expression of FOXN3 mRNA	PMID:29094188
1305711	Foxn3	forkhead box N3	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D008748	alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of FOXN3 mRNA]	PMID:29094188
1305711	Foxn3	forkhead box N3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FOXN3 mRNA	PMID:39298647
1305711	Foxn3	forkhead box N3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313905	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of FOXN3 mRNA	PMID:40203079
1305711	Foxn3	forkhead box N3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313904	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of FOXN3 intron	PMID:30157460
1305711	Foxn3	forkhead box N3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313905	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of FOXN3 mRNA	PMID:38685157
1305711	Foxn3	forkhead box N3	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1313905	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of FOXN3 intron	PMID:28392331
1305711	Foxn3	forkhead box N3	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of FOXN3 mRNA	PMID:18668222
1305711	Foxn3	forkhead box N3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313905	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FOXN3 mRNA	PMID:37019170
1305711	Foxn3	forkhead box N3	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHES1 mRNA	PMID:17602206
1305711	Foxn3	forkhead box N3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FOXN3 mRNA	PMID:21266533
1305711	Foxn3	forkhead box N3	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of FOXN3 mRNA	PMID:22546817
1305711	Foxn3	forkhead box N3	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313905	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of FOXN3 mRNA	PMID:34813904
1305711	Foxn3	forkhead box N3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHES1 mRNA	PMID:17602206
1305711	Foxn3	forkhead box N3	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of FOXN3 gene	PMID:33148267
1305711	Foxn3	forkhead box N3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313904	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FOXN3 mRNA	PMID:37042841
1305711	Foxn3	forkhead box N3	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of FOXN3 mRNA	PMID:30589522
1305711	Foxn3	forkhead box N3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of FOXN3 mRNA	PMID:30723492
1305711	Foxn3	forkhead box N3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313904	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXN3 mRNA	PMID:35301059
1305711	Foxn3	forkhead box N3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313905	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXN3 mRNA	PMID:37325564
1305711	Foxn3	forkhead box N3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313904	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FOXN3 mRNA	PMID:24449571
1305711	Foxn3	forkhead box N3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313904	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FOXN3 mRNA	PMID:31533062
1305711	Foxn3	forkhead box N3	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20250401	CTD	MESH:D003375	Coumestrol results in decreased expression of CHES1 mRNA	PMID:19167446
1305711	Foxn3	forkhead box N3	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313904	E	RGD:6480464	20250401	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHES1 mRNA	PMID:19167446
1305711	Foxn3	forkhead box N3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of FOXN3 mRNA	PMID:23179753
1305711	Foxn3	forkhead box N3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313904	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FOXN3 gene	PMID:29154799
1305711	Foxn3	forkhead box N3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of FOXN3 mRNA	PMID:30047161
1305711	Foxn3	forkhead box N3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FOXN3 mRNA	PMID:25562108
1305711	Foxn3	forkhead box N3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D013629	Tamoxifen affects the expression of CHES1 mRNA	PMID:17555576
1305711	Foxn3	forkhead box N3	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313904	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of FOXN3 mRNA	PMID:15849065
1305711	Foxn3	forkhead box N3	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1313904	E	RGD:6480464	20120412	CTD	MESH:D008727	FOXN3 protein affects the susceptibility to Methotrexate	PMID:16217747
1305711	Foxn3	forkhead box N3	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of FOXN3 mRNA	PMID:24136188
1305711	Foxn3	forkhead box N3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313905	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FOXN3 mRNA	PMID:17562736
1305711	Foxn3	forkhead box N3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FOXN3 mRNA	PMID:33387578
1305711	Foxn3	forkhead box N3	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313904	E	RGD:6480464	20120412	CTD	MESH:D005472	FOXN3 protein affects the susceptibility to Fluorouracil	PMID:15352031
1305711	Foxn3	forkhead box N3	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of FOXN3 protein	PMID:15352031
1305711	Foxn3	forkhead box N3	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1313904	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of FOXN3 promoter	PMID:29626692
1305711	Foxn3	forkhead box N3	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1313904	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of FOXN3 promoter	PMID:29626692
1305711	Foxn3	forkhead box N3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313904	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FOXN3 gene	PMID:25304211
1305711	Foxn3	forkhead box N3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313904	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXN3 mRNA	PMID:39836092
1305711	Foxn3	forkhead box N3	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1313904	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of FOXN3 mRNA	PMID:22077320
1305711	Foxn3	forkhead box N3	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313904	E	RGD:6480464	20250401	CTD	MESH:D018038	Sodium Selenite results in increased expression of CHES1 mRNA	PMID:18175754
1305711	Foxn3	forkhead box N3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CHES1 mRNA	PMID:17555576
1305711	Foxn3	forkhead box N3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FOXN3 mRNA; Nanotubes, Carbon results in decreased expression of FOXN3 mRNA	PMID:25554681
1305711	Foxn3	forkhead box N3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of FOXN3 mRNA	PMID:30047161
1305711	Foxn3	forkhead box N3	gene	CHEBI:50692	mifepristone	increases expression	ISO	RGD:1313904	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of FOXN3 mRNA	PMID:17584828
1305711	Foxn3	forkhead box N3	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of FOXN3 mRNA	PMID:24136188
1305711	Foxn3	forkhead box N3	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313904	E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FOXN3 mRNA	PMID:11678601
1305711	Foxn3	forkhead box N3	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1313905	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of FOXN3 mRNA	PMID:20829426
1305711	Foxn3	forkhead box N3	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of FOXN3 mRNA	PMID:25729387
1305711	Foxn3	forkhead box N3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of FOXN3 mRNA	PMID:25729387
1305711	Foxn3	forkhead box N3	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313904	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of FOXN3 mRNA	PMID:16934159
1305711	Foxn3	forkhead box N3	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313904	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of FOXN3 mRNA	PMID:28988120
1305711	Foxn3	forkhead box N3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313904	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of FOXN3 intron	PMID:30157460
1305711	Foxn3	forkhead box N3	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1313905	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of FOXN3 mRNA	PMID:20829426
1305711	Foxn3	forkhead box N3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of FOXN3 gene	PMID:33148267
1305711	Foxn3	forkhead box N3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313904	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of FOXN3 mRNA	PMID:31758290
1305711	Foxn3	forkhead box N3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FOXN3 mRNA	PMID:22206623
1305711	Foxn3	forkhead box N3	gene	CHEBI:749301	potassium perchlorate	decreases expression	ISO	RGD:1313904	E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of FOXN3 mRNA	PMID:29673971
1305711	Foxn3	forkhead box N3	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of FOXN3 mRNA	PMID:24136188
1305711	Foxn3	forkhead box N3	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of FOXN3 mRNA	PMID:26720608
1305711	Foxn3	forkhead box N3	gene	CHEBI:76995	alpha-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C011512	alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of FOXN3 mRNA]	PMID:29094188
1305711	Foxn3	forkhead box N3	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CHES1 mRNA	PMID:21346803
1305711	Foxn3	forkhead box N3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313904	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FOXN3 gene]	PMID:28238834
1305711	Foxn3	forkhead box N3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313905	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of FOXN3 mRNA	PMID:23091169
1305711	Foxn3	forkhead box N3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of FOXN3 mRNA	PMID:32109520
1305711	Foxn3	forkhead box N3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of FOXN3 mRNA	PMID:31388691
1305711	Foxn3	forkhead box N3	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313904	E	RGD:6480464	20250401	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHES1 mRNA	PMID:19167446
1305711	Foxn3	forkhead box N3	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CHES1 mRNA; propiconazole results in decreased expression of FOXN3 mRNA	PMID:21278054
1305711	Foxn3	forkhead box N3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FOXN3 mRNA	PMID:24780913|PMID:30047161
1305711	Foxn3	forkhead box N3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of FOXN3 mRNA	PMID:27131904
1305711	Foxn3	forkhead box N3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CHES1 mRNA	PMID:21346803
1305711	Foxn3	forkhead box N3	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313904	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of FOXN3 mRNA	PMID:29301935
1305711	Foxn3	forkhead box N3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FOXN3 mRNA	PMID:28973697
1305711	Foxn3	forkhead box N3	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of FOXN3 gene	PMID:31682807
1305711	Foxn3	forkhead box N3	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of FOXN3 mRNA	PMID:23034163
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313907	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ETF1 gene	PMID:20938992
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313907	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETF1 mRNA; [sulforaphane affects the susceptibility to Oxygen] which affects the expression of ETF1 mRNA	PMID:30529165
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313907	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ETF1 mRNA	PMID:39241906
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313907	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of ETF1 mRNA	PMID:15598610
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313906	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ETF1 mRNA	PMID:31614463
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313907	E	RGD:6480464	20150609	CTD	MESH:D004958	Estradiol results in increased expression of ETF1 mRNA	PMID:25575267|PMID:39298647
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313907	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of ETF1 mRNA	PMID:19448997
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313907	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ETF1 gene	PMID:20938992
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313906	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ETF1 mRNA	PMID:37042841
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313906	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of ETF1 mRNA	PMID:19162166
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ETF1 mRNA	PMID:33754040
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ETF1 mRNA	PMID:22061828|PMID:33387578
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA	PMID:39836092
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313906	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ETF1 mRNA	PMID:19549813
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313906	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ETF1 mRNA	PMID:23649840
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ETF1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ETF1 mRNA	PMID:35430440|PMID:41430723
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ETF1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ETF1 protein	PMID:38598786
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ETF1 mRNA	PMID:18593933
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313907	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ETF1 mRNA	PMID:27339419|PMID:31919559
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ETF1 mRNA	PMID:25629700
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313907	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ETF1 gene	PMID:20938992
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ETF1 mRNA	PMID:39836092
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ETF1 protein	PMID:38460933
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of ETF1 protein	PMID:37208198
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of ETF1 mRNA	PMID:20187946
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:27974	estriol	increases expression	ISO	RGD:1313907	E	RGD:6480464	20150609	CTD	MESH:D004964	Estriol results in increased expression of ETF1 mRNA	PMID:25575267
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313907	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ETF1 mRNA	PMID:21570461
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ETF1 mRNA	PMID:19770486
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313906	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ETF1 mRNA	PMID:32763439
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	ISO	RGD:1313907	E	RGD:6480464	20120814	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of ETF1 mRNA	PMID:15707499
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313906	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ETF1 mRNA	PMID:39719251
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ETF1 mRNA	PMID:39836092
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313907	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ETF1 mRNA	PMID:19770486
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of ETF1 mRNA	PMID:34850242
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ETF1 mRNA	PMID:18593933
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313906	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ETF1 mRNA	PMID:26238291
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:31206	ammonium chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of ETF1 mRNA	PMID:12420312
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313907	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of ETF1 mRNA	PMID:22609695
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ETF1 mRNA	PMID:30047161
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313907	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ETF1 gene; titanium dioxide results in decreased methylation of ETF1 promoter	PMID:35295148
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ETF1 mRNA	PMID:34492290
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313907	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ETF1 mRNA	PMID:28472532
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313906	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ETF1 mRNA	PMID:30903817
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313906	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ETF1 protein	PMID:37567409
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ETF1 mRNA	PMID:26063408
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ETF1 mRNA	PMID:25181051
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313907	E	RGD:6480464	20150609	CTD	MESH:C006780	bisphenol A results in increased expression of ETF1 mRNA	PMID:25575267
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	increases expression	ISO	RGD:1313907	E	RGD:6480464	20150609	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of ETF1 mRNA	PMID:25575267
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313907	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ETF1 gene	PMID:31683443
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313907	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ETF1 mRNA	PMID:39298647
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313906	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ETF1 protein	PMID:34186270
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313907	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ETF1 mRNA	PMID:38685157
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313906	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ETF1 protein	PMID:34186270
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ETF1 mRNA	PMID:21266533
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of ETF1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ETF1 protein	PMID:38598786
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313907	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ETF1 mRNA	PMID:34813904
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ETF1 mRNA	PMID:32680482
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313906	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ETF1 mRNA	PMID:37042841
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1313906	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of ETF1 mRNA	PMID:29024780
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA	PMID:39836092
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ETF1 mRNA	PMID:30047161
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:1313907	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate affects the expression of ETF1 mRNA	PMID:17585979
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313906	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ETF1 mRNA	PMID:28302478
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313906	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ETF1 mRNA	PMID:31533062
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in increased expression of ETF1 mRNA	PMID:12325037
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313906	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ETF1 mRNA	PMID:25979313
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313907	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ETF1 mRNA	PMID:17292431
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313906	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ETF1 mRNA	PMID:23179753|PMID:29154799
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ETF1 mRNA	PMID:30047161
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313906	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ETF1 mRNA	PMID:20106945
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313907	E	RGD:6480464	20150609	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ETF1 mRNA	PMID:25575267
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1313906	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of ETF1 mRNA	PMID:33512557
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313907	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ETF1 mRNA	PMID:17562736
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of ETF1 mRNA]	PMID:15016801
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ETF1 protein	PMID:38460933
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of ETF1 mRNA	PMID:21061450
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ETF1 mRNA	PMID:39836092
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313907	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ETF1 mRNA	PMID:30529165
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313907	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ETF1 mRNA; Nanotubes, Carbon results in increased expression of ETF1 mRNA	PMID:25554681|PMID:25620056
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ETF1 mRNA	PMID:30047161
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ETF1 mRNA	PMID:24136188
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313907	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ETF1 mRNA	PMID:19042947
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313906	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ETF1 protein	PMID:32959892
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA	PMID:39836092
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ETF1 mRNA	PMID:23650126
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313906	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of ETF1 mRNA	PMID:15336504
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313907	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ETF1 mRNA	PMID:20003209
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313906	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ETF1 protein	PMID:34186270
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ETF1 protein	PMID:37664457
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ETF1 mRNA	PMID:24136188
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313906	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of ETF1 protein	PMID:39638853
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313906	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of ETF1 protein	PMID:39638853
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313907	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ETF1 mRNA	PMID:30294300
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ETF1 mRNA	PMID:30047161
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ETF1 protein	PMID:37664457
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ETF1 mRNA	PMID:19281266
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of ETF1 protein	PMID:35544339
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313906	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of ETF1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ETF1 protein	PMID:38598786
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ETF1 mRNA	PMID:21346803
1305712	Etf1	eukaryotic translation termination factor 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ETF1 mRNA	PMID:19015723
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1604247	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of C15ORF40 mRNA	PMID:38218311
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1604247	E	RGD:6480464	20171212	CTD	MESH:D019327	Copper Sulfate results in decreased expression of C15ORF40 mRNA	PMID:19549813
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1604247	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of C15ORF40 mRNA	PMID:35430440
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1604247	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of C15ORF40 mRNA	PMID:21867686
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604247	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of C15ORF40 promoter	PMID:27901495
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20171212	CTD	MESH:C006780	bisphenol A affects the expression of C15ORF40 mRNA	PMID:25181051
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of C1H15ORF40 mRNA	PMID:30816183|PMID:32528016
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of C1H15ORF40 gene	PMID:28505145
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of C1H15ORF40 mRNA	PMID:36041667
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of C1H15ORF40 mRNA	PMID:36041667
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of C1H15ORF40 mRNA	PMID:36041667
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of C1H15ORF40 mRNA	PMID:21266533
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604247	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of C15ORF40 mRNA	PMID:37042841
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of C1H15ORF40 mRNA	PMID:25993096
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604247	E	RGD:6480464	20171212	CTD	MESH:D014635	Valproic Acid affects the expression of C15ORF40 mRNA	PMID:25979313
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604247	E	RGD:6480464	20171212	CTD	MESH:D014635	Valproic Acid results in increased expression of C15ORF40 mRNA	PMID:23179753
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of C1H15ORF40 mRNA	PMID:38685447|PMID:41580965
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604247	E	RGD:6480464	20171212	CTD	MESH:D016572	Cyclosporine results in decreased expression of C15ORF40 mRNA	PMID:25562108
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of C1H15ORF40 mRNA	PMID:34044035
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of C1H15ORF40 mRNA	PMID:38685447|PMID:41580965
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of C1H15ORF40 mRNA	PMID:21983209
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of C1H15ORF40 mRNA	PMID:23914054
1305713	C1h15orf40	similar to human chromosome 15 open reading frame 40	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of C1H15ORF40 mRNA	PMID:20566332
1305714	Tspan14	tetraspanin 14	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553869	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TSPAN14 gene	PMID:20938992
1305714	Tspan14	tetraspanin 14	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1342494	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of TSPAN14 mRNA	PMID:23830798|PMID:33167477
1305714	Tspan14	tetraspanin 14	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of TSPAN14 gene	PMID:30207508
1305714	Tspan14	tetraspanin 14	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TSPAN14 mRNA	PMID:35811015
1305714	Tspan14	tetraspanin 14	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1342494	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TSPAN14 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TSPAN14 mRNA	PMID:35811015
1305714	Tspan14	tetraspanin 14	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553869	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TSPAN14 gene	PMID:20938992
1305714	Tspan14	tetraspanin 14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1342494	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TSPAN14 mRNA	PMID:37042841
1305714	Tspan14	tetraspanin 14	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1342494	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TSPAN14 mRNA	PMID:26079696
1305714	Tspan14	tetraspanin 14	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1342494	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of TSPAN14 mRNA	PMID:22017230
1305714	Tspan14	tetraspanin 14	gene	CHEBI:17558	quercitrin	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of TSPAN14 mRNA	PMID:25193878
1305714	Tspan14	tetraspanin 14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1553869	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TSPAN14 mRNA	PMID:34319233
1305714	Tspan14	tetraspanin 14	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TSPAN14 mRNA	PMID:33387578
1305714	Tspan14	tetraspanin 14	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1342494	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TSPAN14 intron; aflatoxin B2 results in decreased methylation of TSPAN14 polyA tail	PMID:30157460
1305714	Tspan14	tetraspanin 14	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1342494	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TSPAN14 protein	PMID:23301498
1305714	Tspan14	tetraspanin 14	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1342494	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TSPAN14 mRNA	PMID:23649840
1305714	Tspan14	tetraspanin 14	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1342494	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TSPAN14 polyA tail	PMID:30157460
1305714	Tspan14	tetraspanin 14	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TSPAN14 mRNA	PMID:21867686
1305714	Tspan14	tetraspanin 14	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553869	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TSPAN14 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TSPAN14 gene	PMID:20938992|PMID:22206623
1305714	Tspan14	tetraspanin 14	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1342494	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TSPAN14 gene	PMID:25304211
1305714	Tspan14	tetraspanin 14	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1342494	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TSPAN14 mRNA	PMID:19244175
1305714	Tspan14	tetraspanin 14	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1342494	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of TSPAN14 mRNA	PMID:19244175
1305714	Tspan14	tetraspanin 14	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1342494	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TSPAN14 protein	PMID:35688186
1305714	Tspan14	tetraspanin 14	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of TSPAN14 gene	PMID:35440735
1305714	Tspan14	tetraspanin 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553869	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TSPAN14 mRNA	PMID:21570461
1305714	Tspan14	tetraspanin 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TSPAN14 mRNA	PMID:33387578
1305714	Tspan14	tetraspanin 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553869	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TSPAN14 mRNA	PMID:17942748
1305714	Tspan14	tetraspanin 14	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TSPAN14 mRNA	PMID:28374803
1305714	Tspan14	tetraspanin 14	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TSPAN14 mRNA	PMID:29803840
1305714	Tspan14	tetraspanin 14	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TSPAN14 mRNA	PMID:38568856
1305714	Tspan14	tetraspanin 14	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1342494	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TSPAN14 5' UTR	PMID:27901495
1305714	Tspan14	tetraspanin 14	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1553869	E	RGD:6480464	20120717	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TSPAN14 mRNA	PMID:19770486|PMID:21569818
1305714	Tspan14	tetraspanin 14	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1342494	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TSPAN14 promoter	PMID:27901495
1305714	Tspan14	tetraspanin 14	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TSPAN14 mRNA	PMID:29633893
1305714	Tspan14	tetraspanin 14	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TSPAN14 mRNA	PMID:24136188
1305714	Tspan14	tetraspanin 14	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1553869	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of TSPAN14 promoter	PMID:35295148
1305714	Tspan14	tetraspanin 14	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553869	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TSPAN14 gene	PMID:35295148
1305714	Tspan14	tetraspanin 14	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TSPAN14 mRNA	PMID:34492290
1305714	Tspan14	tetraspanin 14	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1553869	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TSPAN14 mRNA	PMID:17426115
1305714	Tspan14	tetraspanin 14	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1342494	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TSPAN14 mRNA	PMID:30903817
1305714	Tspan14	tetraspanin 14	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TSPAN14 gene	PMID:28505145
1305714	Tspan14	tetraspanin 14	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1342494	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of TSPAN14 mRNA	PMID:19244175
1305714	Tspan14	tetraspanin 14	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1342494	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of TSPAN14 mRNA	PMID:19244175
1305714	Tspan14	tetraspanin 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553869	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TSPAN14 mRNA	PMID:39298647
1305714	Tspan14	tetraspanin 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1553869	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of TSPAN14 exon	PMID:33297965
1305714	Tspan14	tetraspanin 14	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1342494	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TSPAN14 mRNA	PMID:38382870
1305714	Tspan14	tetraspanin 14	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1342494	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TSPAN14 mRNA	PMID:19244175
1305714	Tspan14	tetraspanin 14	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1342494	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of TSPAN14 mRNA	PMID:19244175
1305714	Tspan14	tetraspanin 14	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1342494	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TSPAN14 mRNA	PMID:28302478
1305714	Tspan14	tetraspanin 14	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553869	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of TSPAN14 mRNA	PMID:36331819
1305714	Tspan14	tetraspanin 14	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1342494	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TSPAN14 mRNA	PMID:25979313
1305714	Tspan14	tetraspanin 14	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1553869	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TSPAN14 mRNA	PMID:17292431
1305714	Tspan14	tetraspanin 14	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of TSPAN14 mRNA	PMID:29154799
1305714	Tspan14	tetraspanin 14	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1342494	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TSPAN14 gene	PMID:29154799
1305714	Tspan14	tetraspanin 14	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TSPAN14 mRNA	PMID:25562108|PMID:27989131
1305714	Tspan14	tetraspanin 14	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1342494	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of TSPAN14 mRNA	PMID:25047013
1305714	Tspan14	tetraspanin 14	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1342494	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TSPAN14 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TSPAN14 mRNA	PMID:35811015
1305714	Tspan14	tetraspanin 14	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1342494	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TSPAN14 gene	PMID:25304211
1305714	Tspan14	tetraspanin 14	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1342494	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of TSPAN14 mRNA	PMID:26833863
1305714	Tspan14	tetraspanin 14	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553869	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TSPAN14 mRNA	PMID:35436446
1305714	Tspan14	tetraspanin 14	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1553869	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TSPAN14 mRNA	PMID:17942748
1305714	Tspan14	tetraspanin 14	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553869	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TSPAN14 mRNA	PMID:17942748
1305714	Tspan14	tetraspanin 14	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TSPAN14 mRNA	PMID:29633893
1305714	Tspan14	tetraspanin 14	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1553869	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TSPAN14 mRNA	PMID:35964746
1305714	Tspan14	tetraspanin 14	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TSPAN14 protein	PMID:32959892
1305714	Tspan14	tetraspanin 14	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of TSPAN14 mRNA	PMID:20080153
1305714	Tspan14	tetraspanin 14	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1553869	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TSPAN14 mRNA	PMID:21641980
1305714	Tspan14	tetraspanin 14	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1342494	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TSPAN14 mRNA	PMID:15336504
1305714	Tspan14	tetraspanin 14	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TSPAN14 gene	PMID:35440735
1305714	Tspan14	tetraspanin 14	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1553869	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TSPAN14 mRNA	PMID:22206623
1305714	Tspan14	tetraspanin 14	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1342494	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TSPAN14 gene]	PMID:28238834
1305714	Tspan14	tetraspanin 14	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1342494	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TSPAN14 mRNA	PMID:38568856
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ZSWIM1 mRNA	PMID:37995155
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313910	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZSWIM1 mRNA	PMID:26079696
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of ZSWIM1 mRNA	PMID:19484750
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313911	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ZSWIM1 mRNA	PMID:39298647
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313910	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZSWIM1 mRNA	PMID:37042841
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ZSWIM1 mRNA	PMID:33387578
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313910	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZSWIM1 mRNA	PMID:28818685
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313910	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZSWIM1 mRNA	PMID:35301059
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZSWIM1 mRNA	PMID:25629700
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313911	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZSWIM1 mRNA	PMID:21570461
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZSWIM1 mRNA	PMID:33387578
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313911	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZSWIM1 mRNA	PMID:25975270
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313910	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZSWIM1 mRNA	PMID:33212167
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313910	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZSWIM1 mRNA	PMID:29803840
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313910	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZSWIM1 3' UTR	PMID:27901495
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313911	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZSWIM1 mRNA	PMID:22228805
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZSWIM1 mRNA	PMID:29264374
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZSWIM1 mRNA	PMID:34492290
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313911	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZSWIM1 promoter	PMID:27312807
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZSWIM1 mRNA	PMID:21266533
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ZSWIM1 mRNA	PMID:34813904
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313910	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZSWIM1 mRNA	PMID:35301059
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313910	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ZSWIM1 mRNA	PMID:24449571
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313910	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZSWIM1 mRNA	PMID:28302478
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZSWIM1 mRNA	PMID:33387578
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313910	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ZSWIM1 mRNA	PMID:22230336
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1313910	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ZSWIM1 mRNA	PMID:29432896
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ZSWIM1 mRNA	PMID:40826991
1305715	Zswim1	zinc finger, SWIM-type containing 1	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ZSWIM1 mRNA	PMID:19281266
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1313912	E	RGD:6480464	20200804	CTD	MESH:D015025	Zearalenone results in increased expression of HAT1 mRNA	PMID:32119988
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of HAT1 mRNA	PMID:16054129|PMID:33167477
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16118	berberine	increases expression	ISO	RGD:1313912	E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in increased expression of HAT1 mRNA	PMID:27311644
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313913	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of HAT1 mRNA	PMID:30319688
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20180220	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of HAT1 mRNA	PMID:27655674
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16243	quercetin	increases activity	ISO	RGD:1313912	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased activity of HAT1 protein	PMID:21165570
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20161213	CTD	MESH:D011794	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased activity of HAT1 protein]; pyrazolanthrone inhibits the reaction [Quercetin results in increased activity of HAT1 protein]	PMID:21165570
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313913	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HAT1 mRNA	PMID:39241906
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of HAT1 mRNA	PMID:32145629
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313912	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of HAT1 mRNA	PMID:22952798
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol inhibits the reaction [sodium arsenite results in increased expression of HAT1 mRNA]; sodium arsenite inhibits the reaction [Estradiol results in increased expression of HAT1 mRNA]	PMID:22952798
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313912	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of HAT1 mRNA	PMID:38568856
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:16643	L-methionine	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20221206	CTD	MESH:D008715	Methionine results in decreased expression of HAT1 mRNA	PMID:35314295
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313912	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of HAT1 mRNA	PMID:21179406
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of HAT1 mRNA	PMID:38685446
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of HAT1 protein; [Cuprizone co-treated with Cannabidiol] results in decreased expression of HAT1 protein; [Cuprizone co-treated with Clozapine] results in decreased expression of HAT1 protein	PMID:34122009
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313912	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of HAT1 protein	PMID:37730182
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HAT1 mRNA	PMID:36331819
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HAT1 mRNA	PMID:37236586
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HAT1 protein	PMID:23301498
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HAT1 mRNA	PMID:33354967
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313913	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in increased expression of HAT1 mRNA	PMID:26392148
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HAT1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HAT1 mRNA	PMID:34911549
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27086	tributylstannane	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C011559	tributyltin results in increased activity of HAT1 protein	PMID:15603928
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313913	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HAT1 mRNA	PMID:27339419|PMID:31919559
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HAT1 mRNA	PMID:25629700
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1313912	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of HAT1 promoter	PMID:21291286
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HAT1 mRNA	PMID:40512198
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27618	chalcone	decreases activity	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D002599	Chalcone analog results in decreased activity of HAT1 protein	PMID:22155221
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313912	E	RGD:6480464	20260407	CTD	MESH:C010974	Glyphosate results in increased expression of HAT1 mRNA	PMID:40578477
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of HAT1 mRNA	PMID:27392435|PMID:35279909
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20220705	CTD	MESH:D002945	Cisplatin results in decreased expression of HAT1 mRNA; Cisplatin results in decreased expression of HAT1 protein	PMID:35279909
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313912	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of HAT1 mRNA	PMID:27594783
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20220705	CTD	MESH:D002945	MIR486 mRNA affects the reaction [Cisplatin results in decreased expression of HAT1 protein]	PMID:35279909
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313913	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of HAT1 mRNA	PMID:30912803
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313913	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HAT1 mRNA	PMID:21570461
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HAT1 mRNA	PMID:34747641
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HAT1 mRNA	PMID:17942748
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of HAT1 protein	PMID:35544339
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313912	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of HAT1 mRNA	PMID:33512557
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HAT1 mRNA	PMID:33212167
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313912	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of HAT1 mRNA	PMID:32763439
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:28812	(aminomethyl)phosphonic acid	increases expression	ISO	RGD:1313912	E	RGD:6480464	20260407	CTD	MESH:C036423	1-aminomethylphosphonic acid results in increased expression of HAT1 mRNA	PMID:40578477
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of HAT1 mRNA	PMID:25523186
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of HAT1 mRNA	PMID:39719251
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313912	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HAT1 mRNA; sodium arsenite results in increased expression of HAT1 protein	PMID:22952798|PMID:28595984|PMID:34032870|PMID:38146662|PMID:38228842|PMID:38568856
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313913	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HAT1 mRNA	PMID:19822182
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HAT1 mRNA; epigallocatechin gallate inhibits the reaction [sodium arsenite results in increased expression of HAT1 mRNA]; Estradiol inhibits the reaction [sodium arsenite results in increased expression of HAT1 mRNA]; sodium arsenite inhibits the reaction [Estradiol results in increased expression of HAT1 mRNA]	PMID:22952798|PMID:38146662|PMID:40512198
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of HAT1 mRNA]	PMID:22228805
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to HAT1 mRNA]	PMID:32406909
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of HAT1 mRNA	PMID:25523186
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of HAT1 protein	PMID:34122009
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313912	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HAT1 protein	PMID:25419056
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:31206	ammonium chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of HAT1 protein	PMID:16483693
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of HAT1 mRNA	PMID:25729387
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HAT1 mRNA	PMID:25729387
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HAT1 mRNA	PMID:30047161
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of HAT1 mRNA	PMID:24136188
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313913	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HAT1 gene	PMID:35295148
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HAT1 mRNA	PMID:34492290
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313913	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of HAT1 mRNA	PMID:17950772|PMID:18301758|PMID:23811191
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of HAT1 mRNA]	PMID:17950772
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of HAT1 mRNA	PMID:32145629
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313912	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of HAT1 mRNA	PMID:30903817
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of HAT1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of HAT1 mRNA; bisphenol A results in decreased expression of HAT1 protein	PMID:29275510|PMID:31675489|PMID:37567409
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313912	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of HAT1 gene	PMID:31601247
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HAT1 mRNA	PMID:25181051
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313912	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of HAT1 mRNA	PMID:28765096
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313913	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of HAT1 mRNA	PMID:26063408
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of HAT1 protein	PMID:31675489
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313912	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of HAT1 mRNA	PMID:24752500
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1313913	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of HAT1 mRNA	PMID:37080397
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of HAT1 mRNA	PMID:28628672
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA	PMID:28628672
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of HAT1 mRNA	PMID:21241498
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1313913	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of HAT1 mRNA	PMID:31558096
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HAT1 mRNA	PMID:37019170
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HAT1 mRNA	PMID:17361019
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of HAT1 mRNA	PMID:34813904
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of HAT1 mRNA	PMID:28628672
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of HAT1 mRNA	PMID:17854601
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of HAT1 mRNA]	PMID:17854601
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313912	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HAT1 mRNA	PMID:37042841
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:35036	fentin chloride	increases activity	EXP		E	RGD:6480464	20141104	CTD	MESH:C012594	triphenyltin chloride results in increased activity of HAT1 protein	PMID:15603928
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HAT1 mRNA	PMID:37236586
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of HAT1 mRNA	PMID:19376846
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:3766	clozapine	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in decreased expression of HAT1 protein	PMID:34122009
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of HAT1 mRNA	PMID:28302478
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313912	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of HAT1 mRNA	PMID:19167446
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of HAT1 mRNA	PMID:39529242
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of HAT1 mRNA	PMID:27153767
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313913	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HAT1 protein	PMID:26178269
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HAT1 mRNA	PMID:36331819
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313912	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HAT1 mRNA	PMID:25979313
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313912	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of HAT1 mRNA	PMID:23179753|PMID:29154799
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of HAT1 mRNA	PMID:41580965
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HAT1 mRNA	PMID:30047161
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1313912	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of HAT1 mRNA	PMID:25562108
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of HAT1 mRNA	PMID:17555576
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of HAT1 mRNA	PMID:28628672
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313913	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of HAT1 mRNA	PMID:28973697
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313912	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of HAT1 mRNA	PMID:27188386
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HAT1 mRNA	PMID:17562736
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313912	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of HAT1 mRNA	PMID:22230336
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1313912	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of HAT1 promoter	PMID:21291286
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HAT1 mRNA	PMID:40512198
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1313912	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of HAT1 mRNA	PMID:24752500
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of HAT1 mRNA	PMID:31675489
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20251007	CTD	MESH:C045651	epigallocatechin gallate inhibits the reaction [sodium arsenite results in increased expression of HAT1 mRNA]	PMID:38146662
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313913	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of HAT1 mRNA	PMID:35436446
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:48965	trans-chalcone	decreases activity	ISO	RGD:1313913	E	RGD:6480464	20140805	CTD	MESH:D002599	Chalcone analog results in decreased activity of HAT1 protein	PMID:22155221
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of HAT1 mRNA	PMID:17555576
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of HAT1 mRNA	PMID:17942748
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HAT1 mRNA	PMID:17942748
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of HAT1 mRNA	PMID:28628672
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313912	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HAT1 protein	PMID:25419056
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313913	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of HAT1 mRNA; Nanotubes, Carbon results in increased expression of HAT1 mRNA	PMID:25554681
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of HAT1 mRNA	PMID:24136188
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of HAT1 mRNA	PMID:23962444
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of HAT1 mRNA	PMID:30047161
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of HAT1 mRNA	PMID:24136188
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313913	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of HAT1 mRNA	PMID:19042947
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HAT1 protein	PMID:32959892
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C025340	manganese chloride results in decreased expression of HAT1 protein	PMID:29155171
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20180703	CTD	MESH:C025340	manganese chloride results in decreased expression of HAT1 protein	PMID:29155171
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HAT1 mRNA	PMID:25729387
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of HAT1 mRNA	PMID:23650126
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of HAT1 protein	PMID:34122009
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:749016	gossypol acetic acid	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of HAT1 protein	PMID:29938581
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:753820	batroxobin	increases expression	ISO	RGD:1313912	E	RGD:6480464	20260714	CTD	MESH:D012103	Batroxobin analog results in increased expression of HAT1 mRNA	PMID:31271808
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313912	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of HAT1 protein	PMID:39638853
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of HAT1 mRNA	PMID:30928695
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HAT1 gene]	PMID:28238834
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313912	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of HAT1 mRNA	PMID:19159669
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313913	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of HAT1 mRNA	PMID:23091169
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HAT1 protein	PMID:31675489
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1313912	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of HAT1 protein	PMID:31675489
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of HAT1 mRNA	PMID:21858171
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1313912	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of HAT1 mRNA	PMID:33512557
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of HAT1 mRNA	PMID:30047161
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1313912	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Quercetin results in increased activity of HAT1 protein]	PMID:21165570
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313912	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of HAT1 mRNA	PMID:27188386
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of HAT1 mRNA	PMID:21346803
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of HAT1 mRNA	PMID:30047161
1305716	Hat1	histone acetyltransferase 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313912	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of HAT1 mRNA	PMID:19140230
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:10022	deoxynivalenol	affects phosphorylation	ISO	RGD:1332434	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol affects the phosphorylation of PLEKHO2 protein	PMID:23811945
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1332434	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PLEKHO2 mRNA	PMID:33045310
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1601963	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of PLEKHO2 mRNA	PMID:33167477
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1601963	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PLEKHO2 mRNA	PMID:26079696
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1332434	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PLEKHO2 mRNA	PMID:30319688
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1332434	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PLEKHO2 mRNA	PMID:30319688
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PLEKHO2 mRNA	PMID:32145629
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PLEKHO2 mRNA	PMID:33387578
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1601963	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of PLEKHO2 mRNA	PMID:19162166
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1601963	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PLEKHO2 mRNA	PMID:23649840
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLEKHO2 mRNA	PMID:37992649
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1601963	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of PLEKHO2 mRNA	PMID:33647349
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLEKHO2 mRNA	PMID:37992649
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1332434	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of PLEKHO2 mRNA	PMID:23892564
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PLEKHO2 mRNA	PMID:26577399
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1601963	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PLEKHO2 protein	PMID:37730182
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1601963	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of PLEKHO2 mRNA	PMID:16002434
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PLEKHO2 mRNA	PMID:33387578
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1601963	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PLEKHO2 mRNA	PMID:28818685
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLEKHO2 mRNA	PMID:36331819
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEKHO2 mRNA	PMID:37236586
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1601963	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEKHO2 mRNA	PMID:35301059
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1601963	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PLEKHO2 mRNA	PMID:19549813
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1601963	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PLEKHO2 mRNA	PMID:23649840
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1601963	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PLEKHO2 mRNA	PMID:23649840
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1601963	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PLEKHO2 mRNA	PMID:35430440
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHO2 mRNA	PMID:40504410
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1601963	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PLEKHO2 protein	PMID:35688186
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1601963	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of PLEKHO2 mRNA	PMID:27594783
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1332434	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PLEKHO2 mRNA	PMID:30912803
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1601963	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PLEKHO2 mRNA	PMID:24768652|PMID:25583101
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332434	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLEKHO2 mRNA	PMID:21570461
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1601963	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PLEKHO2 mRNA	PMID:33212167
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLEKHO2 mRNA	PMID:37992649
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1601963	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PLEKHO2 mRNA	PMID:20044591
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1601963	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PLEKHO2 gene	PMID:28589171
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601963	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PLEKHO2 mRNA	PMID:38568856
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHO2 mRNA	PMID:40504410
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1601963	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLEKHO2 mRNA	PMID:32234424
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1601963	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PLEKHO2 promoter	PMID:27901495
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1601963	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PLEKHO2 mRNA; Silicon Dioxide results in increased expression of PLEKHO2 mRNA	PMID:25351596|PMID:25895662
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332434	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PLEKHO2 promoter alternative form	PMID:35295148
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PLEKHO2 mRNA	PMID:34492290
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1332434	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PLEKHO2 mRNA	PMID:17426115
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of PLEKHO2 mRNA	PMID:19167457
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PLEKHO2 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1601963	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of PLEKHO2 protein	PMID:31675489
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332434	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PLEKHO2 mRNA	PMID:26063408|PMID:32156529
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1601963	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of PLEKHO2 mRNA	PMID:19244175
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1332434	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PLEKHO2 mRNA	PMID:30951980
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1601963	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PLEKHO2 protein	PMID:34186270
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1332434	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PLEKHO2 mRNA	PMID:30951980|PMID:38685157
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1601963	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PLEKHO2 protein	PMID:34186270
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1601963	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PLEKHO2 protein	PMID:34186270
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1332434	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PLEKHO2 intron	PMID:28392331
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1332434	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of PLEKHO2 protein	PMID:35362542
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PLEKHO2 protein]	PMID:35362542
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1332434	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of PLEKHO2 mRNA	PMID:34813904
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1601963	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLEKHO2 mRNA	PMID:37042841
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEKHO2 mRNA	PMID:37236586
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1601963	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEKHO2 mRNA	PMID:35301059
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1601963	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PLEKHO2 mRNA	PMID:19320972
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1601963	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PLEKHO2 mRNA	PMID:24449571
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1601963	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PLEKHO2 mRNA	PMID:28302478
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1601963	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PLEKHO2 mRNA	PMID:31533062
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1601963	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PLEKHO2 mRNA	PMID:40419075
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLEKHO2 mRNA	PMID:36331819
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1332434	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of PLEKHO2 mRNA	PMID:21427059
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1601963	E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in increased expression of PLEKHO2 mRNA	PMID:22083351
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1601963	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of PLEKHO2 mRNA	PMID:25047013
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLEKHO2 mRNA	PMID:37992649
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1601963	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PLEKHO2 mRNA	PMID:38832940
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1332434	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PLEKHO2 mRNA	PMID:17562736
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PLEKHO2 mRNA	PMID:33387578
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHO2 mRNA	PMID:40504410
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLEKHO2 mRNA	PMID:29391264
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PLEKHO2 protein]	PMID:35362542
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1332434	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PLEKHO2 mRNA; Nanotubes, Carbon results in increased expression of PLEKHO2 mRNA	PMID:25554681
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1332434	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of PLEKHO2 mRNA	PMID:40234311
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332434	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PLEKHO2 mRNA	PMID:35964746
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1332434	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PLEKHO2 mRNA	PMID:38701926
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1601963	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of PLEKHO2 mRNA	PMID:28988120
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332434	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PLEKHO2 mRNA	PMID:22206623
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1332434	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PLEKHO2 mRNA	PMID:31388691
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1601963	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PLEKHO2 protein	PMID:31675489
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1332434	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of PLEKHO2 mRNA	PMID:27029645
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1332434	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of PLEKHO2 mRNA	PMID:21795629
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLEKHO2 mRNA	PMID:24780913
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1332434	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PLEKHO2 mRNA	PMID:40826991
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1601963	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PLEKHO2 mRNA	PMID:38568856
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1332434	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of PLEKHO2 protein	PMID:24648495
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PLEKHO2 mRNA	PMID:23034163
1305718	Plekho2	pleckstrin homology domain containing O2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of PLEKHO2 mRNA	PMID:22615374
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1602409	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ASPNAT mRNA	PMID:38218311
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313916	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NAT8L mRNA	PMID:33045310
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313916	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NAT8L mRNA	PMID:20188158
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NAT8L gene	PMID:20938992
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602409	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ASPNAT mRNA	PMID:23724009
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ASPNAT mRNA	PMID:24763279
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1602409	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ASPNAT mRNA	PMID:26079696
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1602409	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ASPNAT mRNA	PMID:22378314
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313916	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of NAT8L mRNA	PMID:30319688
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ASPNAT mRNA	PMID:35811015
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1602409	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of ASPNAT mRNA	PMID:23019147|PMID:31614463
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NAT8L mRNA	PMID:33387578
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NAT8L gene	PMID:20938992
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of ASPNAT gene	PMID:30521419
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1602409	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ASPNAT mRNA	PMID:26079696
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313916	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NAT8L mRNA	PMID:39922521
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAT8L mRNA	PMID:37992649
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313916	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NAT8L mRNA	PMID:39922521
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAT8L mRNA	PMID:37992649
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of and results in increased expression of NAT8L mRNA	PMID:34120004
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of NAT8L mRNA	PMID:26577399
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1602409	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ASPNAT mRNA	PMID:28818685
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NAT8L mRNA	PMID:36331819
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASPNAT mRNA	PMID:39836092
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602409	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ASPNAT 3' UTR; Aflatoxin B1 results in decreased methylation of ASPNAT intron	PMID:30157460
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313916	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of NAT8L mRNA	PMID:31626304
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NAT8L mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NAT8L mRNA	PMID:34911549
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of NAT8L mRNA	PMID:30779732
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NAT8L gene	PMID:20938992
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASPNAT mRNA	PMID:39836092
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1602409	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ASPNAT mRNA	PMID:26272509
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPNAT mRNA	PMID:27188386
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1602409	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ASPNAT mRNA	PMID:27392435|PMID:27594783
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313916	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of NAT8L mRNA	PMID:32186404
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1602409	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of ASPNAT mRNA	PMID:23019147
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1602409	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ASPNAT mRNA	PMID:21632981
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NAT8L promoter]	PMID:19654925
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1313916	E	RGD:6480464	20130910	CTD	MESH:D003300	Copper results in increased expression of NAT8L mRNA	PMID:16629173
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAT8L mRNA	PMID:37992649
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313916	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of NAT8L mRNA	PMID:37682722
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASPNAT mRNA	PMID:39836092
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1602409	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASPNAT mRNA	PMID:32234424
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602409	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ASPNAT 3' UTR; Benzo(a)pyrene results in increased methylation of ASPNAT promoter	PMID:27901495
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to NAT8L promoter]	PMID:19654925
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1313916	E	RGD:6480464	20130910	CTD	MESH:D003300	Copper results in increased expression of NAT8L mRNA	PMID:16629173
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313916	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of NAT8L mRNA	PMID:27131904
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1602409	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ASPNAT mRNA	PMID:25895662
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1602409	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ASPNAT mRNA	PMID:37690743
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of NAT8L mRNA	PMID:30047161
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313916	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NAT8L gene	PMID:35295148
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313916	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NAT8L gene	PMID:35295148
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313916	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of NAT8L mRNA	PMID:20813756
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of NAT8L mRNA	PMID:20813756
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NAT8L mRNA	PMID:25181051
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NAT8L mRNA	PMID:34947998
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602409	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of ASPNAT mRNA	PMID:31715268
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313916	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of NAT8L mRNA	PMID:25172293
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:34698	diethyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of NAT8L mRNA	PMID:32341500
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASPNAT mRNA	PMID:39836092
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of NAT8L mRNA	PMID:30047161
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NAT8L mRNA	PMID:36331819
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602409	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ASPNAT mRNA	PMID:25979313
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602409	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ASPNAT mRNA	PMID:23179753|PMID:26272509
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602409	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ASPNAT gene	PMID:29154799
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPNAT mRNA	PMID:27188386
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313916	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NAT8L mRNA	PMID:28973697
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313916	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NAT8L mRNA	PMID:39922521
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313916	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAT8L mRNA	PMID:37992649
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1602409	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ASPNAT mRNA	PMID:38832940
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1602409	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ASPNAT mRNA	PMID:26272509
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPNAT mRNA	PMID:27188386
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NAT8L mRNA	PMID:33387578
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ASPNAT mRNA	PMID:35811015
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASPNAT mRNA	PMID:39836092
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1602409	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ASPNAT mRNA	PMID:18936297
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:5000	fenfluramine	increases expression	ISO	RGD:1602409	E	RGD:6480464	20231205	CTD	MESH:D005277	Fenfluramine results in increased expression of ASPNAT mRNA	PMID:22140631
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of NAT8L mRNA	PMID:30047161
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of NAT8L mRNA	PMID:28801915
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASPNAT mRNA	PMID:39836092
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of NAT8L mRNA	PMID:27840820
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1602409	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ASPNAT mRNA	PMID:22714537
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPNAT mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPNAT mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPNAT mRNA	PMID:27188386
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1602409	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ASPNAT mRNA	PMID:26079696
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NAT8L mRNA	PMID:24780913|PMID:30047161
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602409	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPNAT mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPNAT mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPNAT mRNA	PMID:27188386
1305719	Nat8l	N-acetyltransferase 8-like	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313916	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of NAT8L mRNA	PMID:27131904
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of L3HYPDH mRNA]	PMID:31150632
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313918	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of L3HYPDH mRNA	PMID:33167477
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of L3HYPDH mRNA	PMID:36331819
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of L3HYPDH mRNA	PMID:17347304
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313919	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of L3HYPDH mRNA	PMID:39241906
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313918	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of L3HYPDH mRNA	PMID:31614463
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313918	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of L3HYPDH mRNA	PMID:38568856
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313918	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of L3HYPDH mRNA	PMID:16002434
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313918	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of L3HYPDH mRNA	PMID:28818685
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of L3HYPDH mRNA	PMID:36331819
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of L3HYPDH mRNA	PMID:28522335
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of L3HYPDH mRNA	PMID:37236586
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313918	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of L3HYPDH gene	PMID:27153756
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313918	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of L3HYPDH mRNA	PMID:27153756
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of L3HYPDH mRNA	PMID:31150632
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313919	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of L3HYPDH mRNA	PMID:27339419|PMID:31919559
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of L3HYPDH mRNA]	PMID:31150632
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of L3HYPDH mRNA	PMID:40504410
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313918	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of L3HYPDH mRNA	PMID:25583101
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of L3HYPDH mRNA	PMID:22298810
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of L3HYPDH mRNA	PMID:21215274|PMID:32109520
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of L3HYPDH mRNA	PMID:33387578
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313919	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of L3HYPDH protein	PMID:28918527
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313918	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of L3HYPDH mRNA	PMID:38568856
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313919	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of L3HYPDH protein	PMID:29044176
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of L3HYPDH mRNA	PMID:40504410
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313918	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of L3HYPDH mRNA	PMID:26238291
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313918	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of L3HYPDH mRNA	PMID:35984750
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of L3HYPDH mRNA	PMID:16507785
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of L3HYPDH mRNA	PMID:30047161
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of L3HYPDH mRNA	PMID:23411599|PMID:34492290
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of L3HYPDH mRNA	PMID:25380136
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20200609	CTD	MESH:C074702	[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of L3HYPDH mRNA; SHH protein affects the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of L3HYPDH mRNA]	PMID:31756458
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of L3HYPDH mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313918	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of L3HYPDH protein	PMID:34186270
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C014024	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of L3HYPDH mRNA	PMID:16984957
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of L3HYPDH mRNA	PMID:16984957
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313918	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of L3HYPDH protein	PMID:34186270
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of L3HYPDH mRNA	PMID:21266533
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313918	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of L3HYPDH mRNA	PMID:37042841
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of L3HYPDH mRNA	PMID:30589522
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of L3HYPDH mRNA	PMID:25380136|PMID:30723492
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of L3HYPDH mRNA	PMID:25993096
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of L3HYPDH mRNA	PMID:37236586
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of L3HYPDH mRNA	PMID:25380136
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313918	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of L3HYPDH mRNA	PMID:31533062
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313918	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of L3HYPDH mRNA	PMID:40419075
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of L3HYPDH mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of L3HYPDH mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of L3HYPDH mRNA	PMID:36331819
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313918	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of L3HYPDH mRNA	PMID:25979313
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of L3HYPDH mRNA	PMID:30047161
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313918	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of L3HYPDH mRNA	PMID:25562108
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313918	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of L3HYPDH mRNA	PMID:21420995
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of L3HYPDH mRNA	PMID:33387578
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of L3HYPDH mRNA	PMID:40504410
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313918	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of L3HYPDH mRNA	PMID:31838189
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of L3HYPDH mRNA	PMID:29391264
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of L3HYPDH mRNA	PMID:36868495
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of L3HYPDH mRNA	PMID:30047161
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20200609	CTD	MESH:D011192	[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of L3HYPDH mRNA; SHH protein affects the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of L3HYPDH mRNA]	PMID:31756458
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of L3HYPDH mRNA	PMID:24136188
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of L3HYPDH mRNA	PMID:24136188
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313918	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of L3HYPDH protein	PMID:34186270
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313918	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of L3HYPDH mRNA	PMID:22714537
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313918	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of L3HYPDH mRNA	PMID:38568856
1305721	L3hypdh	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313919	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of L3HYPDH mRNA	PMID:35537566
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313924	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FBXL4 mRNA	PMID:33045310
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FBXL4 mRNA	PMID:25812627
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313924	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of FBXL4 mRNA]	PMID:19467301
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FBXL4 mRNA	PMID:33167477
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FBXL4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FBXL4 mRNA	PMID:32699268
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313924	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FBXL4 mRNA	PMID:30319688
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313923	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FBXL4 mRNA	PMID:20044591
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313924	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXL4 mRNA	PMID:39241906
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FBXL4 mRNA	PMID:33387578
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of FBXL4 mRNA	PMID:23649840
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FBXL4 mRNA	PMID:33387578
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313923	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of FBXL4 intron	PMID:30157460
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1313923	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of FBXL4 exon	PMID:30157460
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA	PMID:39836092
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FBXL4 mRNA	PMID:19549813
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of FBXL4 mRNA	PMID:23649840
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313923	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FBXL4 intron	PMID:30157460
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of FBXL4 mRNA	PMID:23649840
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FBXL4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FBXL4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of FBXL4 mRNA	PMID:32699268
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of FBXL4 mRNA	PMID:31129395
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313924	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FBXL4 mRNA	PMID:25629700
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL4 mRNA	PMID:39836092
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313924	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FBXL4 mRNA	PMID:28960355
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in decreased expression of FBXL4 mRNA	PMID:37386098
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313924	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXL4 mRNA	PMID:21570461
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FBXL4 mRNA	PMID:33212167
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313923	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of FBXL4 mRNA	PMID:39709020
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of FBXL4 mRNA	PMID:23649840
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBXL4 mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL4 mRNA	PMID:39836092
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313923	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXL4 promoter	PMID:27901495
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313924	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FBXL4 mRNA	PMID:22228805
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313923	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBXL4 5' UTR	PMID:27901495
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1313923	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of FBXL4 gene	PMID:25435355
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313923	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of FBXL4 mRNA	PMID:23806026
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313923	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FBXL4 mRNA	PMID:20458559
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of FBXL4 mRNA	PMID:30047161
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313924	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXL4 gene	PMID:35295148
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FBXL4 mRNA	PMID:34492290
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FBXL4 mRNA	PMID:19710929
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FBXL4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:41034487
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of FBXL4 mRNA	PMID:31129395
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313924	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of FBXL4 mRNA	PMID:26377693
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313924	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of FBXL4 mRNA	PMID:28392331
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313923	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FBXL4 mRNA	PMID:37042841
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA	PMID:39836092
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXL4 mRNA	PMID:38568856
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313923	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of FBXL4 mRNA	PMID:25812627
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FBXL4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FBXL4 mRNA	PMID:32699268
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313924	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FBXL4 mRNA	PMID:40194260
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FBXL4 mRNA	PMID:28302478
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313923	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXL4 mRNA	PMID:31533062
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313923	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of FBXL4 mRNA	PMID:25812627|PMID:40419075
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313923	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXL4 mRNA	PMID:24935251
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of FBXL4 mRNA	PMID:30047161
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of FBXL4 mRNA	PMID:23649840
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FBXL4 mRNA	PMID:38832940
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313923	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FBXL4 mRNA	PMID:24935251
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313924	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBXL4 mRNA	PMID:17562736
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXL4 mRNA	PMID:33387578
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL4 mRNA	PMID:39836092
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of FBXL4 mRNA	PMID:22077320
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FBXL4 mRNA	PMID:22079256
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1313923	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of FBXL4 mRNA	PMID:23228038
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313923	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FBXL4 mRNA	PMID:20458559
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of FBXL4 mRNA	PMID:24136188
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of FBXL4 mRNA	PMID:23962444
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of FBXL4 mRNA	PMID:30047161
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of FBXL4 mRNA	PMID:28801915
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA	PMID:39836092
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of FBXL4 mRNA	PMID:28801915
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of FBXL4 mRNA	PMID:19564919
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313924	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FBXL4 mRNA	PMID:22206623
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313923	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FBXL4 mRNA	PMID:22079256
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FBXL4 mRNA	PMID:22079256
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:755208	eprenetapopt	affects expression	ISO	RGD:1313923	E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of FBXL4 mRNA	PMID:19946333
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:755208	eprenetapopt	multiple interactions	ISO	RGD:1313923	E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of FBXL4 mRNA]	PMID:19946333
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FBXL4 mRNA	PMID:27291303
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FBXL4 mRNA	PMID:30047161
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FBXL4 mRNA	PMID:19281266
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of FBXL4 mRNA	PMID:24136188
1305724	Fbxl4	F-box and leucine-rich repeat protein 4	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of FBXL4 protein	PMID:32519852
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313926	E	RGD:6480464	20140729	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of VSTM2L mRNA	PMID:20188158
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VSTM2L mRNA	PMID:36189433
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313925	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of VSTM2L mRNA	PMID:35811015
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of VSTM2L mRNA	PMID:30510588
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313925	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of VSTM2L mRNA	PMID:31614463
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VSTM2L mRNA	PMID:32741896
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313925	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of VSTM2L mRNA	PMID:30165855
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA	PMID:25510870
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of VSTM2L mRNA	PMID:38568856
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of VSTM2L mRNA	PMID:33387578
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1313925	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of VSTM2L gene	PMID:30521419
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VSTM2L mRNA	PMID:36189433
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313925	E	RGD:6480464	20140729	CTD	MESH:D013739	Testosterone results in increased expression of VSTM2L mRNA	PMID:21592394
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VSTM2L mRNA	PMID:32741896
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313925	E	RGD:6480464	20140729	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of VSTM2L mRNA	PMID:21592394
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of VSTM2L mRNA	PMID:31163220
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313925	E	RGD:6480464	20140729	CTD	MESH:D002117	Calcitriol results in increased expression of VSTM2L mRNA	PMID:21592394
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313925	E	RGD:6480464	20140729	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of VSTM2L mRNA	PMID:21592394
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of VSTM2L mRNA	PMID:33387578
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313925	E	RGD:6480464	20191008	CTD	MESH:D002104	Cadmium results in increased expression of VSTM2L mRNA	PMID:31082426
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA	PMID:25510870
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA	PMID:25510870
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313925	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of VSTM2L mRNA	PMID:32234424
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313925	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of VSTM2L mRNA	PMID:28903495
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VSTM2L mRNA	PMID:32109520
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of VSTM2L mRNA	PMID:28001369
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VSTM2L mRNA	PMID:29803840
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313925	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of VSTM2L mRNA	PMID:29803840
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of VSTM2L mRNA	PMID:35954277
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of VSTM2L mRNA	PMID:22378314
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313925	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of VSTM2L promoter	PMID:27901495
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313925	E	RGD:6480464	20140729	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of VSTM2L mRNA	PMID:20064835|PMID:32234424
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of VSTM2L mRNA	PMID:25895662
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313925	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of VSTM2L mRNA	PMID:38568856
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313926	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VSTM2L gene	PMID:35295148
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313926	E	RGD:6480464	20140729	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of VSTM2L mRNA	PMID:18648102
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313925	E	RGD:6480464	20140729	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of VSTM2L mRNA	PMID:19710929
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313926	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of VSTM2L mRNA	PMID:28472532
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of VSTM2L mRNA	PMID:25181051
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313925	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of VSTM2L gene	PMID:31601247
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313926	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of VSTM2L mRNA	PMID:34585602
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA	PMID:25510870
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA	PMID:25510870
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313926	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of VSTM2L exon; bisphenol S affects the methylation of VSTM2L gene	PMID:31683443|PMID:33297965
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313926	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of VSTM2L intron	PMID:28392331
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313926	E	RGD:6480464	20140729	CTD	MESH:D002922	Ciguatoxins affects the expression of VSTM2L mRNA	PMID:18353800
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of VSTM2L mRNA	PMID:31533062
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313925	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of VSTM2L mRNA	PMID:25979313
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of VSTM2L mRNA	PMID:29154799
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313925	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of VSTM2L mRNA	PMID:23179753|PMID:27188386
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313925	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of VSTM2L gene	PMID:29154799
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20140729	CTD	MESH:D016572	Cyclosporine results in decreased expression of VSTM2L mRNA	PMID:20106945
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313925	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of VSTM2L mRNA	PMID:38832940
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of VSTM2L mRNA	PMID:33387578
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313925	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of VSTM2L mRNA	PMID:35811015
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313925	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of VSTM2L mRNA	PMID:38568856
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313926	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VSTM2L mRNA	PMID:22206623
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VSTM2L mRNA	PMID:32741896
1305725	Vstm2l	V-set and transmembrane domain containing 2 like	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313925	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of VSTM2L mRNA	PMID:26079696
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1313927	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of TUBGCP3 mRNA	PMID:31016361
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313928	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUBGCP3 gene	PMID:20938992
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313928	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TUBGCP3 mRNA	PMID:30319688
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in decreased expression of TUBGCP3 mRNA	PMID:21632981
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313928	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUBGCP3 gene	PMID:20938992
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of TUBGCP3 gene	PMID:33872906
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of TUBGCP3 gene	PMID:33872906
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TUBGCP3 mRNA	PMID:28818685
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313927	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TUBGCP3 polyA tail	PMID:30157460
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:23808	dimethylarsinous acid	increases expression	ISO	RGD:1313927	E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in increased expression of TUBGCP3 mRNA	PMID:23487506
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313927	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TUBGCP3 polyA tail	PMID:30157460
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:27086	tributylstannane	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in decreased expression of TUBGCP3 mRNA	PMID:31129395
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TUBGCP3 mRNA	PMID:25629700
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313928	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUBGCP3 gene	PMID:20938992
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313927	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TUBGCP3 gene	PMID:25304211
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TUBGCP3 mRNA]	PMID:11007951
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of TUBGCP3 mRNA	PMID:26272509
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA	PMID:27188386
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TUBGCP3 mRNA	PMID:23557933
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1313927	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of TUBGCP3 mRNA	PMID:19921347
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:28009	N-acetyl-beta-D-glucosamine	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of TUBGCP3 mRNA	PMID:18047607
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313927	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TUBGCP3 mRNA	PMID:22574217
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TUBGCP3 mRNA	PMID:11007951
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313928	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TUBGCP3 mRNA	PMID:19465110
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20120412	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TUBGCP3 mRNA]	PMID:11007951
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1313928	E	RGD:6480464	20130806	CTD	MESH:D012402	Rotenone affects the expression of TUBGCP3 mRNA	PMID:21893155
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1313928	E	RGD:6480464	20130806	CTD	MESH:D012402	TRP53 affects the reaction [Rotenone affects the expression of TUBGCP3 mRNA]	PMID:21893155
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TUBGCP3 mRNA	PMID:28001369
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TUBGCP3 mRNA	PMID:33212167
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TUBGCP3 mRNA	PMID:38568856
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313927	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TUBGCP3 polyA tail	PMID:30157460
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TUBGCP3 mRNA	PMID:20064835
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TUBGCP3 mRNA]	PMID:32406909
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TUBGCP3 mRNA	PMID:19150397|PMID:20382639
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TUBGCP3 mRNA	PMID:25729387
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313928	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TUBGCP3 promoter	PMID:35295148
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313928	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of TUBGCP3 mRNA	PMID:29264374
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TUBGCP3 mRNA	PMID:33221593
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TUBGCP3 mRNA	PMID:25181051|PMID:30816183
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of TUBGCP3 protein	PMID:33376534
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of TUBGCP3 mRNA	PMID:33297965
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313927	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of TUBGCP3 polyA tail	PMID:30157460
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TUBGCP3 mRNA	PMID:38685157
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TUBGCP3 mRNA	PMID:37019170
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313927	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TUBGCP3 mRNA	PMID:37042841
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TUBGCP3 mRNA	PMID:38568856
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of TUBGCP3 gene	PMID:22079235
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313927	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TUBGCP3 mRNA	PMID:31533062
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:39178	clothianidin	increases expression	ISO	RGD:1313927	E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of TUBGCP3 mRNA	PMID:31626844
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TUBGCP3 mRNA	PMID:26272509
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA	PMID:27188386
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313927	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of TUBGCP3 mRNA	PMID:27989131
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313928	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of TUBGCP3 mRNA	PMID:19770486
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313927	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TUBGCP3 mRNA	PMID:28542535
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in decreased expression of TUBGCP3 mRNA	PMID:21420995
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313927	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TUBGCP3 gene	PMID:25304211
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of TUBGCP3 mRNA	PMID:16984733
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:506227	N-acetyl-D-glucosamine	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of TUBGCP3 mRNA	PMID:18047607
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D005485	Flutamide results in increased expression of TUBGCP3 mRNA	PMID:20566332
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313928	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of TUBGCP3 mRNA	PMID:26377693
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TUBGCP3 protein	PMID:32959892
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1313927	E	RGD:6480464	20120412	CTD	MESH:D019772	TUBGCP3 protein affects the susceptibility to Topotecan	PMID:16217747
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TUBGCP3 mRNA	PMID:25729387
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313927	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TUBGCP3 mRNA	PMID:15336504
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313927	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of TUBGCP3 polyA tail	PMID:30157460
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TUBGCP3 gene	PMID:35440735
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TUBGCP3 mRNA	PMID:22206623
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313927	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TUBGCP3 mRNA	PMID:37199045
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313927	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TUBGCP3 protein	PMID:31285264
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA	PMID:27188386
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TUBGCP3 gene]	PMID:28238834
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313927	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA	PMID:27188386
1305726	Tubgcp3	tubulin gamma complex component 3	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1313927	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of TUBGCP3 mRNA	PMID:27188386
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1605076	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of NOP16 protein	PMID:39638853
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1605076	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of NOP16 mRNA	PMID:26272509
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOP16 mRNA	PMID:27188386
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOP16 mRNA]	PMID:31150632
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of NOP16 mRNA	PMID:16054129|PMID:23724009
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NOP16 mRNA	PMID:26516004
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313929	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP16 mRNA	PMID:30529165
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NOP16 mRNA	PMID:22378314
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313929	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of NOP16 mRNA	PMID:30319688
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1605076	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of NOP16 mRNA	PMID:20044591
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313929	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NOP16 mRNA	PMID:39241906
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1605076	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NOP16 mRNA	PMID:35811015
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313929	E	RGD:6480464	20161228	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP16 mRNA]; [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of NOP16 gene	PMID:21212295|PMID:39241906
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NOP16 mRNA	PMID:35811015
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1605076	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of NOP16 mRNA	PMID:31614463
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1605076	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NOP16 mRNA	PMID:38568856
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605076	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NOP16 mRNA	PMID:37042841
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of NOP16 mRNA	PMID:23649840
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1605076	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of NOP16 mRNA	PMID:22017230
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313929	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NOP16 mRNA	PMID:36331819
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP16 mRNA	PMID:39836092
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOP16 mRNA	PMID:35301059
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NOP16 protein	PMID:23301498
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of NOP16 mRNA	PMID:23649840
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:24556	1,3,5-trinitro-1,3,5-triazinane	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C009160	cyclonite results in decreased expression of NOP16 mRNA	PMID:25559034
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1605076	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NOP16 mRNA	PMID:27153756
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605076	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NOP16 gene	PMID:27153756
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of NOP16 protein	PMID:39638853
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of NOP16 mRNA	PMID:23649840
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOP16 mRNA	PMID:31150632
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOP16 mRNA]	PMID:31150632
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313929	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NOP16 mRNA	PMID:25629700
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313929	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NOP16 mRNA]	PMID:22206623
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP16 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP16 mRNA	PMID:39836092
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313929	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of NOP16 protein	PMID:25505154
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of NOP16 mRNA	PMID:27594783
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1605076	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NOP16 mRNA	PMID:25583101
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1605076	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NOP16 mRNA	PMID:22903824
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313929	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of NOP16 gene	PMID:21212295
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of NOP16 mRNA	PMID:39709020
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1605076	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of NOP16 mRNA	PMID:20044591
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NOP16 mRNA	PMID:38568856
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605076	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of NOP16 mRNA	PMID:34032870
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP16 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP16 mRNA	PMID:39836092
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1605076	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NOP16 mRNA	PMID:20106945
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605076	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NOP16 promoter	PMID:27901495
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1605076	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NOP16 mRNA	PMID:19150397
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of NOP16 mRNA	PMID:24136188
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313929	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of NOP16 mRNA	PMID:27760801
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NOP16 mRNA	PMID:34492290
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313929	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NOP16 mRNA	PMID:23811191
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313929	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NOP16 mRNA	PMID:19710929
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313929	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of NOP16 mRNA	PMID:28472532
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1605076	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NOP16 mRNA	PMID:30903817
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NOP16 mRNA; bisphenol A results in decreased expression of NOP16 protein	PMID:29275510|PMID:37567409
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NOP16 mRNA	PMID:25181051
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of NOP16 protein]	PMID:33376534
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1605076	E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of NOP16 protein	PMID:31945527
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313929	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of NOP16 mRNA	PMID:34813904
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313929	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP16 mRNA]	PMID:39241906
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP16 mRNA	PMID:39836092
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NOP16 mRNA	PMID:38568856
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOP16 mRNA	PMID:35301059
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of NOP16 gene	PMID:22079235
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313929	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NOP16 mRNA	PMID:28903501
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NOP16 mRNA	PMID:19320972|PMID:19376846
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1605076	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NOP16 mRNA	PMID:32588087
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313929	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NOP16 mRNA	PMID:36331819
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of NOP16 mRNA	PMID:25993096
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605076	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NOP16 mRNA	PMID:25979313
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605076	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of NOP16 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOP16 mRNA	PMID:27188386
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605076	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of NOP16 mRNA	PMID:20106945
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in decreased expression of NOP16 mRNA	PMID:12782123
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1605076	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of NOP16 mRNA	PMID:28542535
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1605076	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of NOP16 mRNA	PMID:24935251|PMID:26272509
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOP16 mRNA	PMID:27188386
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1605076	E	RGD:6480464	20150825	CTD	MESH:D000082	NOP16 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of NOP16 mRNA	PMID:21420995
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NOP16 mRNA	PMID:35811015
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP16 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP16 mRNA	PMID:39836092
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313929	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NOP16 mRNA; Nanotubes, Carbon results in increased expression of NOP16 mRNA	PMID:25554681
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313929	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of NOP16 mRNA	PMID:40234311
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NOP16 mRNA	PMID:24136188
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1605076	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of NOP16 mRNA	PMID:31629900
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of NOP16 mRNA	PMID:20436886
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP16 mRNA	PMID:39836092
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1605076	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NOP16 mRNA	PMID:31758290
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313929	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NOP16 mRNA	PMID:22206623
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313929	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NOP16 mRNA]	PMID:22206623
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NOP16 protein	PMID:37664457
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of NOP16 mRNA	PMID:24136188
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:754906	afuresertib	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of NOP16 mRNA	PMID:28960945
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1605076	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of NOP16 protein	PMID:31285264
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1605076	E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of NOP16 protein	PMID:39638853
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of NOP16 protein	PMID:39638853
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOP16 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOP16 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOP16 mRNA	PMID:27188386
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:8069	phenobarbital	decreases methylation	ISO	RGD:1313929	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased methylation of NOP16 gene	PMID:19233941
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313929	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NOP16 mRNA	PMID:30294300
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of NOP16 protein	PMID:38348393
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313929	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP16 mRNA]	PMID:39241906
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313929	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of NOP16 protein	PMID:35357534
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605076	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NOP16 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOP16 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOP16 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOP16 mRNA	PMID:27188386|PMID:37664457
1305727	Nop16	NOP16 nucleolar protein	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1605076	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NOP16 mRNA	PMID:38568856
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:10022	deoxynivalenol	affects phosphorylation	ISO	RGD:1313931	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol affects the phosphorylation of MKNK2 protein	PMID:23811945
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of MKNK2 mRNA	PMID:31863870
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313930	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MKNK2 mRNA	PMID:38218311
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313931	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MKNK2 mRNA	PMID:33045310
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MKNK2 mRNA]	PMID:31150632
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MKNK2 mRNA	PMID:20188158
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313930	E	RGD:6480464	20120814	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MKNK2 mRNA	PMID:20042640
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MKNK2 mRNA	PMID:30529165
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of MKNK2 gene	PMID:35440735
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313930	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MKNK2 mRNA	PMID:22378314
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of MKNK2 mRNA	PMID:15513904
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MKNK2 mRNA	PMID:21632981
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313930	E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in increased expression of MKNK2 mRNA	PMID:30152185
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MKNK2 mRNA	PMID:39241906
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of MKNK2 mRNA	PMID:31614463
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MKNK2 mRNA	PMID:39298647
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313930	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of MKNK2 mRNA	PMID:23019147
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MKNK2 mRNA	PMID:15289156
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MKNK2 mRNA	PMID:30165855
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of MKNK2 mRNA	PMID:33711761
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MKNK2 gene	PMID:30521419
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313930	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of MKNK2 mRNA	PMID:18037150
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1313930	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MKNK2 protein	PMID:37730182
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313930	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MKNK2 mRNA	PMID:28818685
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MKNK2 mRNA	PMID:36331819
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MKNK2 mRNA	PMID:39836092
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MKNK2 mRNA	PMID:37236586
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313930	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MKNK2 mRNA	PMID:19549813
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MKNK2 mRNA	PMID:35430440
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MKNK2 mRNA	PMID:31150632
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313931	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MKNK2 mRNA	PMID:31919559
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MKNK2 mRNA]	PMID:31150632
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:32525701|PMID:39836092
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:40504410
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1313930	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of MKNK2 mRNA	PMID:38460933
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313930	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of MKNK2 mRNA	PMID:31295307
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MKNK2 mRNA	PMID:28189721|PMID:28960355
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MKNK2 mRNA	PMID:23557933
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1313930	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of MKNK2 mRNA	PMID:23300844
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of MKNK2 mRNA	PMID:21993003
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Oxytocin inhibits the reaction [Cisplatin results in increased expression of MKNK2 mRNA]	PMID:21993003
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1313931	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of MKNK2 mRNA	PMID:34813904
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313930	E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in increased expression of MKNK2 mRNA	PMID:22228119
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of MKNK2 mRNA	PMID:15289156
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313931	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MKNK2 mRNA	PMID:21570461
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MKNK2 mRNA	PMID:21215274
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of MKNK2 mRNA	PMID:28374803
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MKNK2 mRNA	PMID:30851411
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1313930	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of MKNK2 mRNA	PMID:23649840
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MKNK2 mRNA	PMID:30911355
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313931	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of MKNK2 mRNA	PMID:39631538
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313930	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of MKNK2 mRNA	PMID:29319823|PMID:34032870
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of MKNK2 mRNA	PMID:28595984
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313930	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MKNK2 mRNA	PMID:38568856|PMID:39719251
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:39836092
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:40504410
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to MKNK2 promoter]	PMID:19654925
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MKNK2 mRNA	PMID:30911355
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1313930	E	RGD:6480464	20191114	CTD	MESH:C006632	MKNK2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:18299328
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein; MAPK14 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein]; MKNK2 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]	PMID:18299328
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in decreased expression of MKNK2 mRNA	PMID:25270620
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of MKNK2 mRNA	PMID:32479839
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313931	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MKNK2 promoter	PMID:35295148
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MKNK2 mRNA	PMID:34492290
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MKNK2 mRNA	PMID:25181051
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of MKNK2 mRNA	PMID:32145629
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MKNK2 mRNA	PMID:34947998
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313930	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MKNK2 mRNA	PMID:25047013|PMID:29275510
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313931	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MKNK2 mRNA	PMID:32156529
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313930	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of MKNK2 mRNA	PMID:24752500
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313931	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MKNK2 mRNA	PMID:39298647
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of MKNK2 mRNA	PMID:33297965
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313930	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MKNK2 3' UTR	PMID:30157460
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313931	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MKNK2 mRNA	PMID:37019170
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MKNK2 mRNA	PMID:18164116
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of MKNK2 mRNA	PMID:30589522
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313930	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MKNK2 mRNA	PMID:37042841
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MKNK2 mRNA	PMID:39836092
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313931	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MKNK2 mRNA	PMID:26377693
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MKNK2 mRNA	PMID:30723492
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of MKNK2 promoter	PMID:22457795
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MKNK2 mRNA	PMID:37236586
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of MKNK2 mRNA	PMID:26194646
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313930	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of MKNK2 mRNA	PMID:19376846
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313931	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of MKNK2 mRNA	PMID:18353800
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of MKNK2 mRNA	PMID:17585979
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:37825	p-toluidine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of MKNK2 mRNA	PMID:27638505
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313930	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MKNK2 mRNA	PMID:32588087
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313930	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MKNK2 mRNA	PMID:31533062
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of MKNK2 mRNA	PMID:19167446
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA	PMID:19167446
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313930	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MKNK2 mRNA	PMID:40419075
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MKNK2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MKNK2 mRNA	PMID:36331819
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313930	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MKNK2 mRNA	PMID:25979313
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313930	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MKNK2 gene	PMID:29154799
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of MKNK2 mRNA	PMID:38685447|PMID:41580965
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313930	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MKNK2 mRNA	PMID:25562108|PMID:27989131
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313930	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of MKNK2 mRNA	PMID:25047013
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313931	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of MKNK2 mRNA	PMID:22733784
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MKNK2 mRNA	PMID:15289156
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1313930	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of MKNK2 mRNA	PMID:23649840
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313930	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MKNK2 mRNA	PMID:38832940
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MKNK2 mRNA	PMID:27188386
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313930	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MKNK2 mRNA	PMID:28542535
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MKNK2 mRNA	PMID:15606129|PMID:17562736
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MKNK2 mRNA	PMID:33387578
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313930	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of MKNK2 mRNA	PMID:21420995|PMID:29067470
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1313930	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of MKNK2 promoter	PMID:29626692
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1313930	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of MKNK2 promoter	PMID:29626692
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1313930	E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of MKNK2 promoter	PMID:29626692
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:32525701|PMID:39836092
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:40504410
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1313930	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of MKNK2 mRNA	PMID:24752500
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MKNK2 mRNA	PMID:35436446
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313930	E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of MKNK2 mRNA	PMID:24383545
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MKNK2 mRNA	PMID:17942748
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1313930	E	RGD:6480464	20191114	CTD	MESH:C032793	MKNK2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:18299328
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein; MAPK14 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein]; MKNK2 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]	PMID:18299328
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1313930	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MKNK2 mRNA	PMID:23300844
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MKNK2 mRNA; Nanotubes, Carbon results in decreased expression of MKNK2 mRNA	PMID:25554681|PMID:25620056
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of MKNK2 mRNA	PMID:41580965
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MKNK2 mRNA	PMID:39836092
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1313930	E	RGD:6480464	20120412	CTD	MESH:D019772	MKNK2 protein affects the susceptibility to Topotecan	PMID:16217747
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of MKNK2 mRNA	PMID:24136188
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MKNK2 mRNA	PMID:15336504
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of MKNK2 mRNA	PMID:15003993
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313931	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of MKNK2 mRNA	PMID:36851058
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of MKNK2 mRNA	PMID:20003209
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313930	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MKNK2 3' UTR	PMID:30157460
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:68508	diethyl maleate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased expression of MKNK2 mRNA	PMID:21161181
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:72754	bisphenol AF	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of MKNK2 mRNA	PMID:25912373
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of MKNK2 mRNA	PMID:24136188
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1313930	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of MKNK2 mRNA	PMID:36318118
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MKNK2 mRNA	PMID:15215175
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MKNK2 mRNA	PMID:18164116
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of MKNK2 mRNA	PMID:23665939
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MKNK2 mRNA	PMID:30851411
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:7872	oxytocin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010121	Oxytocin inhibits the reaction [Cisplatin results in increased expression of MKNK2 mRNA]	PMID:21993003
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of MKNK2 mRNA	PMID:31324951
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of MKNK2 mRNA	PMID:19270015|PMID:19482888
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MKNK2 mRNA]	PMID:19482888
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA	PMID:19167446
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313930	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:32525701
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:9288	streptozocin	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	Streptozocin results in increased expression of MKNK2 mRNA	PMID:25905778
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1313930	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of MKNK2 mRNA	PMID:31863870
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313930	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MKNK2 mRNA	PMID:38568856
1305728	Mknk2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MKNK2 mRNA	PMID:23034163
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of LRP8 mRNA	PMID:33045310
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRP8 mRNA]	PMID:31150632
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LRP8 mRNA	PMID:20188158
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:149906	Tanshinone I	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone results in decreased expression of LRP8 mRNA	PMID:15849732
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of LRP8 mRNA	PMID:21934132|PMID:33167477
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of LRP8 mRNA	PMID:26516004
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LRP8 mRNA	PMID:33729688
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313933	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of LRP8 mRNA	PMID:30319688
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313933	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of LRP8 mRNA	PMID:30319688
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313932	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of LRP8 mRNA	PMID:23019147|PMID:31614463
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of LRP8 mRNA	PMID:20660070
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LRP8 mRNA	PMID:33387578
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313932	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRP8 mRNA	PMID:37042841
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of LRP8 mRNA	PMID:23649840
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of LRP8 mRNA	PMID:20660070
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313933	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LRP8 mRNA	PMID:39922521
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313933	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRP8 mRNA	PMID:37992649
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313933	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LRP8 mRNA	PMID:39922521
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313933	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRP8 mRNA	PMID:37992649
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LRP8 mRNA	PMID:33387578
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LRP8 mRNA	PMID:28818685
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA	PMID:39836092
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP8 mRNA	PMID:35301059
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313932	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LRP8 mRNA	PMID:19549813
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of LRP8 mRNA	PMID:23649840
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313933	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of LRP8 mRNA	PMID:27776689
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313932	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of LRP8 protein	PMID:20106945
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LRP8 mRNA	PMID:21632981|PMID:21641981
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313932	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LRP8 mRNA	PMID:22100608
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LRP8 mRNA	PMID:23649840
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of LRP8 mRNA	PMID:25102026
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313933	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LRP8 mRNA	PMID:34911549
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of LRP8 mRNA	PMID:17484886
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LRP8 mRNA	PMID:31150632
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRP8 mRNA]	PMID:31150632
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LRP8 mRNA	PMID:25629700
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313932	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRP8 gene	PMID:25304211
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA	PMID:32525701|PMID:39836092
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27568	selenium atom	affects abundance	ISO	RGD:1313933	E	RGD:6480464	20120918	CTD	MESH:D012643	LRP8 protein affects the abundance of Selenium	PMID:17314095|PMID:17553992
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27568	selenium atom	affects response to substance	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D012643	LRP8 protein affects the susceptibility to Selenium	PMID:18172410
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27568	selenium atom	increases uptake	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D012643	LRP8 protein results in increased uptake of Selenium	PMID:19007311
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA	PMID:27188386
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of LRP8 mRNA	PMID:19167446
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313933	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of LRP8 mRNA	PMID:40618947
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of LRP8 mRNA	PMID:27392435
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313932	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of LRP8 mRNA	PMID:23019147
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313932	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LRP8 mRNA	PMID:24768652|PMID:25583101
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313932	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRP8 mRNA	PMID:22298810
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRP8 mRNA	PMID:20106945
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRP8 mRNA	PMID:33387578
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRP8 mRNA	PMID:19770486
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313932	E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LRP8 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP8 mRNA	PMID:27188386
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LRP8 mRNA	PMID:33212167
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LRP8 mRNA	PMID:30851411
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28445	vincristine	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of LRP8 mRNA	PMID:23649840
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of LRP8 mRNA	PMID:32763439
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of LRP8 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of LRP8 mRNA	PMID:20971185|PMID:24690739
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LRP8 mRNA	PMID:29803840
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313933	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of LRP8 mRNA	PMID:36227756
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313933	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRP8 mRNA	PMID:37992649
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1313932	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of LRP8 mRNA	PMID:34032870
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LRP8 mRNA	PMID:38568856
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313932	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of LRP8 mRNA	PMID:25493608
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA	PMID:39836092
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of LRP8 mRNA	PMID:22378314|PMID:29453283
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313932	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of LRP8 mRNA	PMID:22316170
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313932	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRP8 promoter	PMID:27901495
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRP8 mRNA	PMID:20106945|PMID:21632981
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313932	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRP8 mRNA	PMID:26238291|PMID:32234424
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRP8 mRNA	PMID:19770486
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of LRP8 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of LRP8 mRNA	PMID:20971185|PMID:24690739
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LRP8 mRNA	PMID:19150397|PMID:20018196
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313932	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of LRP8 mRNA	PMID:38568856
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of LRP8 mRNA	PMID:16507785
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of LRP8 mRNA	PMID:31745603
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313933	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRP8 gene	PMID:35295148
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LRP8 mRNA	PMID:34492290
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:C006253	pirinixic acid results in increased expression of LRP8 mRNA	PMID:20813756
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of LRP8 mRNA	PMID:30816183|PMID:34947998
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRP8 mRNA	PMID:25181051
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313932	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LRP8 gene	PMID:31601247
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313933	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of LRP8 promoter	PMID:27312807
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313932	E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in increased expression of LRP8 mRNA	PMID:38568856
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRP8 mRNA	PMID:28628672
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313933	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of LRP8 gene	PMID:31683443
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1313932	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LRP8 intron	PMID:30157460
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of LRP8 mRNA	PMID:28392331
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313933	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LRP8 intron	PMID:28392331
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313933	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRP8 mRNA	PMID:37019170
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:34693	Dicyclohexyl phthalate	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:C036042	dicyclohexyl phthalate results in decreased expression of LRP8 mRNA	PMID:40690386
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1313933	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of LRP8 gene	PMID:38995845
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:34709	Diisodecyl phthalate	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in decreased expression of LRP8 mRNA	PMID:25270620
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRP8 mRNA	PMID:28628672
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of LRP8 mRNA	PMID:32680482
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313932	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRP8 mRNA	PMID:37042841
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA	PMID:39836092
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LRP8 mRNA	PMID:33453195
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP8 mRNA	PMID:35301059
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LRP8 mRNA	PMID:19376846
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313932	E	RGD:6480464	20120412	CTD	MESH:C018021	cobaltous chloride results in increased expression of LRP8 mRNA	PMID:20105288
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LRP8 mRNA	PMID:24449571
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:36904	elemental selenium	affects abundance	ISO	RGD:1313933	E	RGD:6480464	20120918	CTD	MESH:D012643	LRP8 protein affects the abundance of Selenium	PMID:17314095|PMID:17553992
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:36904	elemental selenium	affects response to substance	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D012643	LRP8 protein affects the susceptibility to Selenium	PMID:18172410
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:36904	elemental selenium	increases uptake	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D012643	LRP8 protein results in increased uptake of Selenium	PMID:19007311
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRP8 mRNA	PMID:40194260
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313932	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of LRP8 mRNA	PMID:28302478
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313932	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of LRP8 mRNA	PMID:19167446
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of LRP8 mRNA	PMID:19167446
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313932	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LRP8 mRNA	PMID:25979313
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRP8 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA	PMID:27188386
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313932	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LRP8 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:41607	crotonaldehyde	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of LRP8 mRNA	PMID:20471460
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRP8 mRNA	PMID:28628672
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313933	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LRP8 mRNA	PMID:39922521
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313933	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRP8 mRNA	PMID:37992649
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313932	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LRP8 mRNA	PMID:38832940
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of LRP8 mRNA	PMID:27188386
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313932	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of LRP8 mRNA	PMID:28542535
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in decreased expression of LRP8 mRNA	PMID:27188386
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LRP8 mRNA	PMID:33387578
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313932	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of LRP8 mRNA	PMID:29067470
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of LRP8 mRNA	PMID:16101138
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of LRP8 mRNA	PMID:24690739
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313932	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRP8 gene	PMID:25304211
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA	PMID:32525701|PMID:39836092
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1313933	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in increased expression of LRP8 mRNA	PMID:35537566
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313932	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of LRP8 mRNA	PMID:31838189
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LRP8 mRNA	PMID:29391264
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1313932	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of LRP8 mRNA	PMID:32234424
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313932	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of LRP8 mRNA	PMID:38568856
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRP8 mRNA	PMID:28628672
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313933	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of LRP8 mRNA	PMID:25554681
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of LRP8 mRNA	PMID:23962444
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of LRP8 mRNA	PMID:23608068
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313933	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LRP8 mRNA	PMID:38701926
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120918	CTD	MESH:C025340	manganese chloride results in increased expression of LRP8 mRNA	PMID:22407947
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA	PMID:39836092
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:C017096	n-butoxyethanol results in increased expression of LRP8 mRNA	PMID:19812364
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313932	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LRP8 mRNA	PMID:28988120
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1313932	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LRP8 intron	PMID:30157460
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LRP8 gene	PMID:35440735
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313932	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of LRP8 mRNA	PMID:37199045
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:75701	sarin	increases expression	ISO	RGD:1313932	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of LRP8 mRNA	PMID:19522546
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LRP8 mRNA	PMID:30851411
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP8 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA	PMID:27188386
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313933	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LRP8 mRNA	PMID:38648751
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1313933	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of LRP8 mRNA	PMID:21195148
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1313933	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of LRP8 mRNA	PMID:21195148
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:82284	2-Amino-9H-pyrido[2,3-b]indole	increases expression	ISO	RGD:1313932	E	RGD:6480464	20260113	CTD	MESH:C017822	2-amino-9H-pyrido(2,3-b)indole results in increased expression of LRP8 mRNA	PMID:40713012
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA	PMID:32525701
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA	PMID:27188386
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313932	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP8 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA	PMID:27188386
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313932	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of LRP8 mRNA	PMID:22378314
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1313933	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of LRP8 mRNA	PMID:21195148
1305729	Lrp8	LDL receptor related protein 8	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of LRP8 mRNA	PMID:35537566
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1614792	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ATXN7L1 mRNA	PMID:33045310
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1614792	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ATXN7L1 mRNA	PMID:37995155
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ATXN7L1 mRNA]	PMID:31150632
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1614792	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ATXN7L1 mRNA	PMID:26251327
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1614792	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of ATXN7L1 promoter	PMID:26251327
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ATXN7L1 mRNA	PMID:26079696
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:16548	chlordecone	affects response to substance	ISO	RGD:1345348	E	RGD:6480464	20150609	CTD	MESH:D007631	ATXN7L1 gene SNP affects the susceptibility to Chlordecone	PMID:25622337
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1345348	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATXN7L1 mRNA	PMID:37042841
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ATXN7L1 mRNA	PMID:33359661
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATXN7L1 mRNA	PMID:33387578
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ATXN7L1 mRNA	PMID:28818685
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATXN7L1 mRNA	PMID:35301059
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1345348	E	RGD:6480464	20130806	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ATXN7L1 protein	PMID:20106945
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1345348	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATXN7L1 gene	PMID:27153756
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1345348	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ATXN7L1 intron	PMID:30157460
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ATXN7L1 mRNA	PMID:31150632
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ATXN7L1 mRNA]	PMID:31150632
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614792	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ATXN7L1 mRNA	PMID:25629700
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1614792	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATXN7L1 mRNA	PMID:40504410
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ATXN7L1 mRNA	PMID:27594783
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ATXN7L1 mRNA	PMID:27392435
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1345348	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATXN7L1 mRNA	PMID:22574217
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATXN7L1 mRNA	PMID:29803840
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1345348	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ATXN7L1 mRNA	PMID:38568856
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1614792	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATXN7L1 mRNA	PMID:40504410
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1345348	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATXN7L1 intron	PMID:30157460
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATXN7L1 mRNA	PMID:20064835|PMID:20106945|PMID:32234424
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1614792	E	RGD:6480464	20151215	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATXN7L1 mRNA	PMID:19770486
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1345348	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATXN7L1 promoter	PMID:27901495
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1345348	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ATXN7L1 mRNA	PMID:25895662
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATXN7L1 gene	PMID:31601247
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of ATXN7L1 mRNA	PMID:23411599|PMID:34492290
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of ATXN7L1 mRNA	PMID:30816183
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATXN7L1 mRNA	PMID:25181051
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1345348	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATXN7L1 gene	PMID:31601247
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1345348	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ATXN7L1 mRNA	PMID:29275510|PMID:36232920
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATXN7L1 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATXN7L1 mRNA	PMID:28628672|PMID:31601247
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614792	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ATXN7L1 mRNA	PMID:40203079
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1614792	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ATXN7L1 exon	PMID:33297965
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1614792	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ATXN7L1 intron	PMID:28392331
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ATXN7L1 mRNA	PMID:21266533
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATXN7L1 mRNA	PMID:28628672
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1345348	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATXN7L1 mRNA	PMID:37042841
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of ATXN7L1 mRNA	PMID:30723492
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATXN7L1 mRNA	PMID:38568856
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATXN7L1 mRNA	PMID:35301059
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1614792	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ATXN7L1 mRNA	PMID:28903501
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ATXN7L1 mRNA	PMID:24449571
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATXN7L1 mRNA	PMID:23179753|PMID:24935251
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1345348	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ATXN7L1 gene	PMID:29154799
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20130806	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ATXN7L1 mRNA	PMID:17183730
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20130806	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATXN7L1 mRNA	PMID:20106945
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1345348	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of ATXN7L1 promoter	PMID:27989131
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATXN7L1 mRNA	PMID:28628672
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1614792	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ATXN7L1 mRNA	PMID:28973697
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ATXN7L1 mRNA	PMID:38832940
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATXN7L1 mRNA	PMID:27188386
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ATXN7L1 mRNA	PMID:24935251
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATXN7L1 mRNA	PMID:33387578
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATXN7L1 mRNA	PMID:29067470
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1345348	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in increased expression of ATXN7L1 mRNA	PMID:22230336
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1614792	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ATXN7L1 mRNA	PMID:40504410
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1345348	E	RGD:6480464	20130806	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of ATXN7L1 mRNA	PMID:22079256
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20130806	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATXN7L1 mRNA	PMID:22079256
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1614792	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ATXN7L1 mRNA	PMID:35436446
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATXN7L1 mRNA	PMID:28628672
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614792	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATXN7L1 mRNA; Nanotubes, Carbon results in decreased expression of ATXN7L1 mRNA	PMID:25554681
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of ATXN7L1 mRNA	PMID:34044035
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1345348	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ATXN7L1 mRNA	PMID:22714537
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20130806	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ATXN7L1 mRNA	PMID:17183730
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1614792	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ATXN7L1 mRNA	PMID:26307267
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ATXN7L1 gene	PMID:35440735
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ATXN7L1 mRNA	PMID:22079256
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATXN7L1 mRNA	PMID:22079256
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATXN7L1 mRNA	PMID:27188386
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATXN7L1 gene]	PMID:28238834
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1345348	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of ATXN7L1 mRNA	PMID:30458266
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1614792	E	RGD:6480464	20130806	CTD	MESH:C045950	propiconazole results in increased expression of ATXN7L1 mRNA	PMID:21278054
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATXN7L1 mRNA	PMID:24780913
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1345348	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATXN7L1 mRNA	PMID:27188386
1305730	Atxn7l1	ataxin 7-like 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ATXN7L1 mRNA	PMID:23034163
1305731	Phf12	PHD finger protein 12	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313936	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of PHF12 mRNA	PMID:33045310
1305731	Phf12	PHD finger protein 12	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1313935	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PHF12 mRNA	PMID:26079696
1305731	Phf12	PHD finger protein 12	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313936	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PHF12 mRNA	PMID:30319688
1305731	Phf12	PHD finger protein 12	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313936	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PHF12 mRNA	PMID:30319688
1305731	Phf12	PHD finger protein 12	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313935	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PHF12 mRNA	PMID:23019147
1305731	Phf12	PHD finger protein 12	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313935	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHF12 mRNA	PMID:37042841
1305731	Phf12	PHD finger protein 12	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313935	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PHF12 mRNA	PMID:20655997
1305731	Phf12	PHD finger protein 12	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313935	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PHF12 protein	PMID:37730182
1305731	Phf12	PHD finger protein 12	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PHF12 mRNA	PMID:33387578
1305731	Phf12	PHD finger protein 12	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PHF12 mRNA	PMID:36331819
1305731	Phf12	PHD finger protein 12	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313935	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PHF12 mRNA	PMID:35301059
1305731	Phf12	PHD finger protein 12	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313936	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PHF12 mRNA	PMID:19770486
1305731	Phf12	PHD finger protein 12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313935	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PHF12 mRNA	PMID:35430440
1305731	Phf12	PHD finger protein 12	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PHF12 mRNA	PMID:25629700
1305731	Phf12	PHD finger protein 12	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313935	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PHF12 mRNA	PMID:40512198
1305731	Phf12	PHD finger protein 12	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PHF12 mRNA	PMID:40504410
1305731	Phf12	PHD finger protein 12	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PHF12 mRNA	PMID:30912803
1305731	Phf12	PHD finger protein 12	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of PHF12 mRNA	PMID:31734292
1305731	Phf12	PHD finger protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313936	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHF12 mRNA	PMID:21570461
1305731	Phf12	PHD finger protein 12	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313935	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHF12 mRNA	PMID:29803840
1305731	Phf12	PHD finger protein 12	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1313935	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PHF12 protein	PMID:35688186
1305731	Phf12	PHD finger protein 12	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313935	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PHF12 mRNA	PMID:38568856
1305731	Phf12	PHD finger protein 12	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313936	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of PHF12 gene	PMID:39894169
1305731	Phf12	PHD finger protein 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313935	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PHF12 mRNA	PMID:40512198
1305731	Phf12	PHD finger protein 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PHF12 mRNA	PMID:40504410
1305731	Phf12	PHD finger protein 12	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313935	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PHF12 intron	PMID:30157460
1305731	Phf12	PHD finger protein 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313936	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHF12 mRNA	PMID:22228805
1305731	Phf12	PHD finger protein 12	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313935	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PHF12 mRNA	PMID:20382639
1305731	Phf12	PHD finger protein 12	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313935	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PHF12 mRNA	PMID:21461292
1305731	Phf12	PHD finger protein 12	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1313935	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of PHF12 gene	PMID:31601247
1305731	Phf12	PHD finger protein 12	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PHF12 mRNA	PMID:25729387
1305731	Phf12	PHD finger protein 12	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313936	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHF12 gene	PMID:35295148
1305731	Phf12	PHD finger protein 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PHF12 mRNA	PMID:33221593
1305731	Phf12	PHD finger protein 12	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF12 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305731	Phf12	PHD finger protein 12	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PHF12 mRNA	PMID:38685157
1305731	Phf12	PHD finger protein 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313935	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHF12 mRNA	PMID:37042841
1305731	Phf12	PHD finger protein 12	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313935	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PHF12 mRNA	PMID:35301059
1305731	Phf12	PHD finger protein 12	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313936	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of PHF12 mRNA	PMID:17585979
1305731	Phf12	PHD finger protein 12	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313935	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PHF12 mRNA	PMID:28302478
1305731	Phf12	PHD finger protein 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PHF12 mRNA	PMID:36331819
1305731	Phf12	PHD finger protein 12	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313935	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF12 mRNA	PMID:28001369
1305731	Phf12	PHD finger protein 12	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313935	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PHF12 gene	PMID:29154799
1305731	Phf12	PHD finger protein 12	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PHF12 mRNA	PMID:30047161
1305731	Phf12	PHD finger protein 12	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313936	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PHF12 mRNA	PMID:18502557
1305731	Phf12	PHD finger protein 12	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHF12 mRNA	PMID:17585979
1305731	Phf12	PHD finger protein 12	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313935	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PHF12 mRNA	PMID:40512198
1305731	Phf12	PHD finger protein 12	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PHF12 mRNA	PMID:40504410
1305731	Phf12	PHD finger protein 12	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313935	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PHF12 mRNA	PMID:21461292
1305731	Phf12	PHD finger protein 12	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PHF12 mRNA	PMID:30047161
1305731	Phf12	PHD finger protein 12	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PHF12 mRNA	PMID:35964746
1305731	Phf12	PHD finger protein 12	gene	CHEBI:53001	nickel sulfate	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of PHF12 mRNA	PMID:31734292
1305731	Phf12	PHD finger protein 12	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PHF12 mRNA	PMID:25729387
1305731	Phf12	PHD finger protein 12	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313936	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PHF12 mRNA	PMID:31388691
1305731	Phf12	PHD finger protein 12	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of PHF12 mRNA	PMID:39847705
1305731	Phf12	PHD finger protein 12	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PHF12 mRNA	PMID:30047161
1305731	Phf12	PHD finger protein 12	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PHF12 mRNA	PMID:19281266
1305731	Phf12	PHD finger protein 12	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PHF12 mRNA	PMID:21346803
1305731	Phf12	PHD finger protein 12	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PHF12 mRNA	PMID:21346803
1305731	Phf12	PHD finger protein 12	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PHF12 mRNA	PMID:28973697
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1605713	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of GCC2 mRNA	PMID:38218311
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605713	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of GCC2 mRNA	PMID:23724009
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1605713	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GCC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of GCC2 mRNA	PMID:32699268
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of GCC2 mRNA	PMID:30207508
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1623954	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of GCC2 mRNA	PMID:30319688
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of GCC2 mRNA	PMID:26496021
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of GCC2 mRNA	PMID:33387578
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605713	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GCC2 mRNA	PMID:37042841
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1605713	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of GCC2 mRNA	PMID:23649840
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1623954	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of GCC2 mRNA	PMID:33754040
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1605713	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of GCC2 protein	PMID:37730182
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of GCC2 mRNA	PMID:33387578
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1623954	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GCC2 mRNA	PMID:37236586
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605713	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of GCC2 mRNA	PMID:19549813
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1605713	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of GCC2 mRNA	PMID:23649840
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1623954	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GCC2 mRNA	PMID:19770486
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1605713	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GCC2 mRNA	PMID:23649840
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605713	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GCC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of GCC2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of GCC2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of GCC2 mRNA	PMID:32699268|PMID:41430723
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of GCC2 mRNA	PMID:31129395
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1623954	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GCC2 mRNA	PMID:31919559
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1623954	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GCC2 mRNA	PMID:25629700
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1605713	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of GCC2 mRNA	PMID:26272509
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1605713	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCC2 mRNA	PMID:27188386
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623954	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GCC2 mRNA	PMID:21570461
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GCC2 mRNA	PMID:33387578
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GCC2 mRNA	PMID:32109520
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:29191	hydroxyl	multiple interactions	ISO	RGD:1605713	E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA] which results in increased expression of GCC2 mRNA	PMID:33656867
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1605713	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of GCC2 mRNA	PMID:28595984|PMID:34032870
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605713	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GCC2 mRNA	PMID:38568856
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605713	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [GCC2 protein binds to CAPRIN1 protein]	PMID:33939924
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605713	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GCC2 3' UTR	PMID:27901495
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1605713	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of GCC2 mRNA	PMID:25895662
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605713	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GCC2 mRNA	PMID:19150397
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1605713	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of GCC2 mRNA	PMID:22521957
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of GCC2 mRNA	PMID:25729387
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GCC2 mRNA	PMID:34492290
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GCC2 mRNA	PMID:25181051
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of GCC2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1623954	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GCC2 mRNA	PMID:33221593
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of GCC2 mRNA	PMID:33296240
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of GCC2 mRNA; [bisphenol A co-treated with tributyltin] results in increased expression of GCC2 mRNA	PMID:26496021|PMID:31129395
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1623954	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of GCC2 mRNA	PMID:26377693
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1623954	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of GCC2 mRNA	PMID:38685157
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623954	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of GCC2 mRNA	PMID:37019170
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605713	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GCC2 mRNA	PMID:37042841
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1623954	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GCC2 mRNA	PMID:24982889
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1623954	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GCC2 mRNA	PMID:37236586
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1623954	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of GCC2 mRNA	PMID:22698814
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1605713	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of GCC2 mRNA	PMID:19376846
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1605713	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GCC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of GCC2 mRNA	PMID:32699268
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:3763	clorgyline	increases expression	ISO	RGD:1605713	E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of GCC2 mRNA	PMID:19691856
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:3766	clozapine	decreases expression	ISO	RGD:1605713	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of GCC2 protein	PMID:34122009
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1605713	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GCC2 mRNA	PMID:28302478
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1605713	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GCC2 mRNA	PMID:27153767
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of GCC2 mRNA	PMID:23125180
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605713	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GCC2 mRNA	PMID:25979313
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1623954	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GCC2 mRNA	PMID:17963808
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of GCC2 mRNA	PMID:29427782
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605713	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of GCC2 mRNA	PMID:23179753
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of GCC2 mRNA	PMID:41580965
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1623954	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of GCC2 mRNA	PMID:19770486
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605713	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GCC2 mRNA	PMID:25562108
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:4610	dimethylselenide	multiple interactions	ISO	RGD:1605713	E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA] which results in increased expression of GCC2 mRNA	PMID:33656867
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623954	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GCC2 mRNA	PMID:17562736
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GCC2 mRNA	PMID:33387578
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1605713	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of GCC2 mRNA	PMID:21420995
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1605713	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of GCC2 mRNA	PMID:21148743
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1605713	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of GCC2 mRNA	PMID:40706910
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1605713	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of GCC2 mRNA	PMID:22521957
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of GCC2 mRNA	PMID:24136188
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1623954	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of GCC2 mRNA	PMID:26377693
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1623954	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of GCC2 mRNA	PMID:23608068
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of GCC2 mRNA	PMID:25729387
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1623954	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GCC2 mRNA	PMID:22206623
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605713	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCC2 mRNA	PMID:27188386
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:81980	triticonazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in increased expression of GCC2 mRNA	PMID:36084822
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1623954	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of GCC2 mRNA	PMID:39847705
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:8493	Propiverine	affects binding	EXP		E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine binds to GCC2 protein	PMID:29273565
1305732	Gcc2	GRIP and coiled-coil domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605713	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCC2 mRNA	PMID:27188386
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BMERB1 mRNA]	PMID:31150632
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1345550	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of BMERB1 mRNA	PMID:26079696
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313939	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of BMERB1 mRNA	PMID:30319688
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1345550	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of BMERB1 mRNA	PMID:21632981
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of BMERB1 mRNA	PMID:19167446
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1345550	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of BMERB1 mRNA	PMID:19619570
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of BMERB1 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of BMERB1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of BMERB1 mRNA	PMID:17404688|PMID:19619570|PMID:30165855
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of BMERB1 mRNA	PMID:17404688
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313939	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BMERB1 mRNA	PMID:37992649
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313939	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BMERB1 mRNA	PMID:37992649
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20191112	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of BMERB1 mRNA	PMID:31163220
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1345550	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of BMERB1 mRNA	PMID:16002434
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BMERB1 mRNA	PMID:39836092
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1345550	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BMERB1 mRNA	PMID:19549813
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of BMERB1 mRNA	PMID:22100608|PMID:32234424
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1345550	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of BMERB1 gene	PMID:27153756
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of BMERB1 mRNA	PMID:31150632
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BMERB1 mRNA]	PMID:31150632
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BMERB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BMERB1 mRNA	PMID:39836092
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of BMERB1 mRNA	PMID:19167446
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1345550	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of BMERB1 promoter	PMID:22847954
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313939	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of BMERB1 mRNA	PMID:32186404
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BMERB1 mRNA	PMID:22298810
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BMERB1 mRNA	PMID:32109520
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BMERB1 mRNA	PMID:19619570
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of BMERB1 mRNA	PMID:19619570
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BMERB1 mRNA	PMID:29803840
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313939	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BMERB1 mRNA	PMID:37992649
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313939	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of BMERB1 mRNA	PMID:37682722
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of BMERB1 mRNA	PMID:21457566|PMID:34032870
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BMERB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BMERB1 mRNA	PMID:39836092
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1345550	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BMERB1 promoter	PMID:27901495
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BMERB1 mRNA	PMID:22316170
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1345550	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of BMERB1 mRNA	PMID:25895662
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1345550	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of BMERB1 gene	PMID:31601247
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BMERB1 gene	PMID:31601247
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of BMERB1 mRNA	PMID:34492290
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C006780	bisphenol A results in decreased expression of BMERB1 mRNA	PMID:25181051
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BMERB1 gene	PMID:31601247
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1345550	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of BMERB1 mRNA	PMID:29024780
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BMERB1 mRNA	PMID:39836092
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C039281	furan results in decreased expression of BMERB1 mRNA	PMID:26194646
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313939	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of BMERB1 mRNA	PMID:40194260
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1345550	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of BMERB1 promoter	PMID:22847954
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of BMERB1 mRNA	PMID:31533062
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1345550	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of BMERB1 promoter	PMID:22847954
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of BMERB1 mRNA	PMID:19167446
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMERB1 mRNA; [Coumestrol co-treated with Resveratrol] results in decreased expression of BMERB1 mRNA	PMID:19167446
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1345550	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of BMERB1 mRNA	PMID:40419075
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1345550	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BMERB1 mRNA	PMID:25979313
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1345550	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of BMERB1 mRNA	PMID:29154799
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1345550	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of BMERB1 mRNA	PMID:25562108
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313939	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BMERB1 mRNA	PMID:37992649
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of BMERB1 mRNA	PMID:24935251|PMID:26272509
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BMERB1 mRNA	PMID:27188386
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BMERB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BMERB1 mRNA	PMID:39836092
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of BMERB1 mRNA	PMID:32234424
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1345550	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of BMERB1 mRNA	PMID:20436886
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BMERB1 mRNA	PMID:39836092
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of BMERB1 mRNA	PMID:15336504
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1345550	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of BMERB1 mRNA	PMID:31758290
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in increased expression of BMERB1 mRNA	PMID:32741896
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BMERB1 mRNA	PMID:27188386
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of BMERB1 mRNA	PMID:32109520
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMERB1 mRNA	PMID:19167446
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1345550	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of BMERB1 mRNA	PMID:26705709
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D011441	Propylthiouracil results in increased expression of BMERB1 mRNA	PMID:24780913|PMID:36843608
1305733	Bmerb1	bMERB domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1345550	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BMERB1 mRNA	PMID:27188386
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ILF2 mRNA	PMID:33167477
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313941	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ILF2 mRNA	PMID:30319688
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313941	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ILF2 mRNA	PMID:39241906
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313940	E	RGD:6480464	20120522	CTD	MESH:D004958	Estradiol results in increased expression of ILF2 mRNA	PMID:16474171
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ILF2 gene	PMID:27618143
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of ILF2 mRNA	PMID:27683099
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313941	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ILF2 mRNA	PMID:34319233
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of ILF2 protein	PMID:34122009
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313940	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ILF2 protein	PMID:37730182
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ILF2 mRNA	PMID:39836092
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:183083	indirubin	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20211207	CTD	MESH:C027185	indirubin results in decreased expression of ILF2 mRNA	PMID:15056799
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313941	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of ILF2 mRNA	PMID:27462272
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ILF2 protein	PMID:23301498
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313941	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ILF2 mRNA	PMID:19770486
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313940	E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of ILF2 mRNA	PMID:23033980
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of ILF2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of ILF2 protein	PMID:38598786
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ILF2 mRNA]	PMID:22206623
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:39836092
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:40504410
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313941	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ILF2 mRNA	PMID:28960355
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:27827	paraoxon	increases expression	ISO	RGD:1313940	E	RGD:6480464	20120717	CTD	MESH:D010261	Paraoxon results in increased expression of ILF2 protein	PMID:20931991
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313941	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of ILF2 protein	PMID:25505154
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313940	E	RGD:6480464	20120522	CTD	MESH:D019833	Genistein results in increased expression of ILF2 mRNA	PMID:16474171
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313941	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ILF2 mRNA	PMID:21570461
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20120522	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ILF2 mRNA	PMID:17942748
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ILF2 mRNA	PMID:30851411
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ILF2 mRNA	PMID:28959563
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313940	E	RGD:6480464	20120522	CTD	MESH:D024483	Vitamin K 3 affects the expression of ILF2 mRNA	PMID:20044591
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313940	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ILF2 gene	PMID:28589171
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ILF2 mRNA	PMID:38568856
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:39836092
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:40504410
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA	PMID:27858113
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ILF2 mRNA]	PMID:32406909
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1313941	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of ILF2 gene	PMID:35295148
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ILF2 mRNA	PMID:25181051
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ILF2 mRNA; bisphenol A results in decreased expression of ILF2 protein	PMID:29275510|PMID:37567409
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313940	E	RGD:6480464	20120522	CTD	MESH:C006780	bisphenol A results in increased expression of ILF2 mRNA; bisphenol A results in increased expression of ILF2 protein	PMID:16474171|PMID:34186270
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ILF2 mRNA	PMID:36041667
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ILF2 mRNA	PMID:36041667
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA	PMID:27858113
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ILF2 mRNA	PMID:36041667
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of ILF2 protein	PMID:38598786
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ILF2 mRNA	PMID:39836092
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ILF2 mRNA	PMID:19320972|PMID:19376846
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20120522	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ILF2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ILF2 mRNA]	PMID:17585979
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313940	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ILF2 mRNA	PMID:19167446
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILF2 mRNA	PMID:19167446
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313941	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ILF2 mRNA	PMID:39529242
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1313940	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of ILF2 mRNA	PMID:26352163
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313940	E	RGD:6480464	20120522	CTD	MESH:D016572	Cyclosporine results in increased expression of ILF2 mRNA	PMID:20106945
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1313940	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of ILF2 mRNA	PMID:33512557
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313940	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ILF2 mRNA	PMID:38832940
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20120522	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ILF2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ILF2 mRNA]	PMID:17585979
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:39836092
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:40504410
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of ILF2 protein	PMID:31195006
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313941	E	RGD:6480464	20120522	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ILF2 mRNA	PMID:17942748
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20120522	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ILF2 mRNA	PMID:17942748
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA	PMID:27858113
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA	PMID:27858113
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313941	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ILF2 mRNA	PMID:23608068
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ILF2 protein	PMID:32959892
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ILF2 mRNA	PMID:39836092
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of ILF2 protein	PMID:34122009
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313940	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ILF2 protein	PMID:34186270
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313941	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ILF2 mRNA	PMID:22206623
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ILF2 mRNA]	PMID:22206623
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313940	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ILF2 protein	PMID:31285264
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:75701	sarin	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of ILF2 mRNA	PMID:19522546
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:75701	sarin	increases expression	ISO	RGD:1313940	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of ILF2 mRNA	PMID:19522546
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ILF2 mRNA	PMID:21346803
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313940	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ILF2 mRNA	PMID:30851411
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ILF2 gene]	PMID:28238834
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILF2 mRNA	PMID:19167446
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120522	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ILF2 mRNA	PMID:21346803
1305734	Ilf2	interleukin enhancer binding factor 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313940	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of ILF2 protein	PMID:38598786
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GRHL1 mRNA]	PMID:31150632
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRHL1 mRNA	PMID:20938992
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313942	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of GRHL1 mRNA	PMID:21934132
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313942	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of GRHL1 mRNA	PMID:26516004
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GRHL1 mRNA	PMID:36331819
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313942	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GRHL1 mRNA	PMID:26079696
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1618199	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of GRHL1 mRNA	PMID:30319688
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1618199	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GRHL1 mRNA	PMID:39241906
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313942	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of GRHL1 mRNA	PMID:30510588
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of GRHL1 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of GRHL1 mRNA	PMID:20660070|PMID:30165855
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRHL1 mRNA	PMID:20938992
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of GRHL1 mRNA	PMID:20660070
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313942	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of GRHL1 mRNA	PMID:26079696
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313942	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of GRHL1 mRNA	PMID:31256213
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313942	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of GRHL1 mRNA	PMID:16002434|PMID:26485663
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313942	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of GRHL1 mRNA	PMID:28818685
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313942	E	RGD:6480464	20190910	CTD	MESH:D002104	Cadmium results in increased expression of GRHL1 mRNA	PMID:30125854
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313942	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GRHL1 mRNA	PMID:23649840
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of GRHL1 mRNA	PMID:35430440
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GRHL1 mRNA	PMID:18593933
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GRHL1 mRNA	PMID:31150632
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1618199	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GRHL1 mRNA	PMID:31919559
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GRHL1 mRNA]	PMID:31150632
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRHL1 mRNA	PMID:20938992
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of GRHL1 mRNA	PMID:40504410
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20210907	CTD	MESH:D000966	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of GRHL1 mRNA	PMID:32076005
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313942	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of GRHL1 protein	PMID:35688186
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1618199	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of GRHL1 mRNA	PMID:28960355
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313942	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of GRHL1 mRNA	PMID:27392435
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GRHL1 mRNA	PMID:32109520
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618199	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GRHL1 mRNA	PMID:24058054|PMID:26377647
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313942	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GRHL1 mRNA	PMID:23152189
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313942	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GRHL1 mRNA	PMID:28001369
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313942	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of GRHL1 mRNA	PMID:39709020
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313942	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of GRHL1 mRNA	PMID:32763439
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GRHL1 mRNA	PMID:20971185
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1618199	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of GRHL1 mRNA	PMID:27862939
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313942	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GRHL1 mRNA	PMID:38568856
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20210907	CTD	MESH:C017947	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of GRHL1 mRNA	PMID:32076005
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of GRHL1 mRNA	PMID:40504410
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313942	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GRHL1 promoter	PMID:27901495
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20210907	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of GRHL1 mRNA; arsenite inhibits the reaction [G3BP1 protein binds to GRHL1 mRNA]	PMID:32076005|PMID:32406909
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GRHL1 mRNA	PMID:20971185
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GRHL1 mRNA	PMID:18593933
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:30297	antimonite	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20210907	CTD	MESH:C061374	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of GRHL1 mRNA	PMID:32076005
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313942	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of GRHL1 mRNA	PMID:26014281
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of GRHL1 mRNA	PMID:30047161
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1618199	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GRHL1 mRNA	PMID:29264374
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1618199	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GRHL1 promoter	PMID:35295148
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313942	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased methylation of GRHL1 promoter	PMID:34973136
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of GRHL1 mRNA	PMID:23411599
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1618199	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of GRHL1 mRNA	PMID:18301758|PMID:23811191
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GRHL1 mRNA	PMID:19710929
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313942	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of GRHL1 mRNA	PMID:27685785
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313942	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of GRHL1 gene	PMID:31601247
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1618199	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of GRHL1 mRNA	PMID:26377693
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1618199	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of GRHL1 mRNA	PMID:30951980
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1618199	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of GRHL1 intron	PMID:28392331
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1618199	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of GRHL1 mRNA	PMID:24535843
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313942	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GRHL1 mRNA	PMID:37042841
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of GRHL1 mRNA	PMID:22110744
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GRHL1 mRNA	PMID:31077537
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313942	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GRHL1 mRNA	PMID:38174414|PMID:38568856
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of GRHL1 mRNA	PMID:31077537
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1618199	E	RGD:6480464	20190312	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GRHL1 mRNA	PMID:30711707
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1618199	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of GRHL1 mRNA	PMID:24183702
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313942	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of GRHL1 mRNA	PMID:24449571
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1618199	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of GRHL1 mRNA	PMID:18353800
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1618199	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of GRHL1 mRNA	PMID:23811191
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313942	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GRHL1 mRNA	PMID:32588087
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1313942	E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of GRHL1 mRNA	PMID:36864359
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313942	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GRHL1 mRNA	PMID:40419075
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GRHL1 mRNA	PMID:36331819
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1618199	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of GRHL1 mRNA	PMID:29038090
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1618199	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of GRHL1 mRNA	PMID:23125180
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313942	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GRHL1 mRNA	PMID:25979313
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1618199	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GRHL1 mRNA	PMID:17963808
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313942	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of GRHL1 mRNA	PMID:19101580|PMID:24383497|PMID:24935251|PMID:25192806|PMID:27188386
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313942	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of GRHL1 gene	PMID:29501571
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of GRHL1 mRNA	PMID:30047161
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313942	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of GRHL1 mRNA	PMID:25562108
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313942	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of GRHL1 mRNA	PMID:20106945
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1618199	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of GRHL1 mRNA	PMID:28973697
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313942	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GRHL1 mRNA	PMID:38832940
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:C028009	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of GRHL1 mRNA	PMID:31077537
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1313942	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of GRHL1 mRNA	PMID:28542535
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313942	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of GRHL1 mRNA	PMID:24935251
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1618199	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GRHL1 mRNA	PMID:17562736
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313942	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of GRHL1 mRNA	PMID:21420995|PMID:29067470
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of GRHL1 mRNA	PMID:40504410
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313942	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of GRHL1 mRNA	PMID:18175754
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA	PMID:27188386
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of GRHL1 mRNA	PMID:30307764
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1618199	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GRHL1 mRNA; Nanotubes, Carbon results in decreased expression of GRHL1 mRNA	PMID:25554681
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1618199	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GRHL1 mRNA; Nanotubes, Carbon results in increased expression of GRHL1 mRNA	PMID:25620056
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of GRHL1 mRNA	PMID:30047161
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313942	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of GRHL1 mRNA	PMID:31629900
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA	PMID:27188386
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GRHL1 gene]	PMID:28238834
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1618199	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GRHL1 mRNA	PMID:23091169
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of GRHL1 mRNA	PMID:32109520
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1618199	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of GRHL1 mRNA	PMID:31388691
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313942	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of GRHL1 mRNA	PMID:26079696
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of GRHL1 mRNA	PMID:30047161
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA	PMID:27188386
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1313942	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of GRHL1 mRNA	PMID:19429434
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1313942	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of GRHL1 mRNA	PMID:31734321
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313942	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA	PMID:27188386
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313942	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of GRHL1 mRNA	PMID:26014281
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313942	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GRHL1 mRNA	PMID:38568856
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1618199	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of GRHL1 mRNA	PMID:32835833
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1618199	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of GRHL1 mRNA	PMID:35537566
1305735	Grhl1	grainyhead-like transcription factor 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of GRHL1 mRNA	PMID:19015723
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ADAM23 mRNA	PMID:30071829
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313950	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ADAM23 mRNA	PMID:20188158
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	ISO	RGD:1313949	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of ADAM23 mRNA	PMID:19524605
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313949	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ADAM23 mRNA	PMID:21934132|PMID:23724009
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of ADAM23 mRNA	PMID:16604517
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313950	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAM23 mRNA	PMID:36331819
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313949	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ADAM23 mRNA	PMID:22378314
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of ADAM23 mRNA	PMID:29018328
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1313949	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ADAM23 mRNA	PMID:30510588
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ADAM23 mRNA	PMID:32145629
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313949	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ADAM23 mRNA	PMID:30165855
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313950	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ADAM23 mRNA	PMID:33711761
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ADAM23 gene	PMID:27618143
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ADAM23 mRNA	PMID:22401849
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313949	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ADAM23 mRNA	PMID:31163220
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ADAM23 mRNA	PMID:28522335
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of ADAM23 mRNA	PMID:39984025
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313949	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ADAM23 gene; Aflatoxin B1 results in decreased methylation of ADAM23 intron	PMID:27153756|PMID:30157460
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ADAM23 mRNA	PMID:17484886
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of ADAM23 gene	PMID:35440735
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ADAM23 mRNA	PMID:28960355
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ADAM23 mRNA	PMID:31881176
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:27889	lead(0)	increases methylation	ISO	RGD:1313950	E	RGD:6480464	20250311	CTD	MESH:D007854	Lead results in increased methylation of ADAM23 gene	PMID:38833407
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313949	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ADAM23 mRNA	PMID:27392435
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313949	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ADAM23 mRNA	PMID:27392435
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1313949	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of ADAM23 promoter	PMID:22847954
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313950	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADAM23 mRNA	PMID:26377647
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADAM23 mRNA	PMID:19933214
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADAM23 mRNA	PMID:32109520
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ADAM23 mRNA	PMID:28959563
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313949	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAM23 mRNA	PMID:34032870
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of ADAM23 mRNA	PMID:17127020
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313949	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADAM23 mRNA	PMID:22316170
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADAM23 mRNA	PMID:20713471|PMID:32417428
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313949	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADAM23 promoter	PMID:27901495
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313950	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADAM23 gene	PMID:35295148
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADAM23 mRNA	PMID:34492290
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of ADAM23 mRNA	PMID:18648102
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ADAM23 mRNA	PMID:18648102
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ADAM23 mRNA	PMID:25181051|PMID:32145629
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAM23 mRNA	PMID:30816183
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAM23 mRNA	PMID:32156529
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of ADAM23 mRNA	PMID:29097150
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313950	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of ADAM23 mRNA	PMID:38701888
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313949	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ADAM23 gene	PMID:31601247
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ADAM23 mRNA	PMID:40203079
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1313949	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ADAM23 intron	PMID:30157460
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ADAM23 protein	PMID:34058248
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313950	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ADAM23 mRNA	PMID:37019170
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313950	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ADAM23 mRNA	PMID:24535843
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ADAM23 gene	PMID:22079235
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313949	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ADAM23 mRNA	PMID:19320972
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1313949	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of ADAM23 promoter	PMID:22847954
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1313949	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of ADAM23 promoter	PMID:22847954
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313950	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ADAM23 mRNA	PMID:39529242
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313950	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAM23 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ADAM23 mRNA	PMID:36331819
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313949	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADAM23 mRNA	PMID:24383497
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ADAM23 mRNA	PMID:28973697
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADAM23 mRNA	PMID:17562736
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ADAM23 mRNA	PMID:33387578
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ADAM23 mRNA	PMID:35436446
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADAM23 mRNA	PMID:29097150
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ADAM23 mRNA	PMID:30307764
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313950	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ADAM23 mRNA; Nanotubes, Carbon results in increased expression of ADAM23 mRNA	PMID:25620056
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1313949	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ADAM23 intron	PMID:30157460
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ADAM23 gene	PMID:35440735
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313949	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ADAM23 mRNA	PMID:31758290
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ADAM23 mRNA	PMID:27567155
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313950	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ADAM23 mRNA	PMID:22206623
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1313949	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ADAM23 mRNA	PMID:30928695
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313950	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ADAM23 mRNA	PMID:23091169
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313950	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ADAM23 mRNA	PMID:24535843
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313950	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ADAM23 mRNA	PMID:31388691
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313950	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADAM23 mRNA	PMID:27935865
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313949	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in increased expression of ADAM23 mRNA	PMID:25572481
1305739	Adam23	ADAM metallopeptidase domain 23	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of ADAM23 gene	PMID:31682807
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313951	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CYBRD1 mRNA	PMID:27188386
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313952	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CYBRD1 mRNA	PMID:33045310
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1313952	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of CYBRD1 promoter	PMID:24205000
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313952	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CYBRD1 mRNA	PMID:24205000
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYBRD1 mRNA	PMID:30529165
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of CYBRD1 gene	PMID:35440735
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313951	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CYBRD1 mRNA	PMID:22378314
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313952	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CYBRD1 mRNA	PMID:30319688
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313952	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CYBRD1 mRNA	PMID:30319688
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CYBRD1 mRNA	PMID:29432896
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CYBRD1 mRNA	PMID:27523638
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CYBRD1 mRNA	PMID:26577399
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CYBRD1 mRNA	PMID:33387578
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313951	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CYBRD1 intron	PMID:30157460
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:18248	iron atom	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20120501	CTD	MESH:D007501	Iron results in decreased expression of CYBRD1 protein	PMID:18815723
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D007501	Iron deficiency results in increased expression of CYBRD1 mRNA	PMID:16629162|PMID:19821111|PMID:21540277|PMID:23814049
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1313951	E	RGD:6480464	20120501	CTD	MESH:D007501	Iron results in increased expression of CYBRD1 protein	PMID:18815723
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1313952	E	RGD:6480464	20150609	CTD	MESH:D007501	Iron deficiency results in increased expression of CYBRD1 mRNA	PMID:23776592
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20260113	CTD	MESH:D002104	Cadmium results in decreased expression of CYBRD1 mRNA	PMID:37505606
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:D002104	Cadmium results in increased expression of CYBRD1 mRNA	PMID:39025289
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20200915	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYBRD1 mRNA	PMID:32645461
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20200915	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYBRD1 mRNA	PMID:32645461
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313951	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CYBRD1 intron	PMID:30157460
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CYBRD1 mRNA	PMID:34911549
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313951	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of CYBRD1 mRNA	PMID:26272509
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA	PMID:27188386
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313951	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CYBRD1 mRNA	PMID:27594783
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CYBRD1 mRNA	PMID:27392435
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313952	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of CYBRD1 mRNA	PMID:32186404
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CYBRD1 mRNA	PMID:23195993|PMID:24768652|PMID:25583101
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313951	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYBRD1 mRNA	PMID:22298810
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYBRD1 mRNA	PMID:33387578
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYBRD1 mRNA	PMID:17101203
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYBRD1 mRNA	PMID:28213091
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper deficiency results in increased expression of CYBRD1 mRNA	PMID:19821111
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1313952	E	RGD:6480464	20151110	CTD	MESH:D003300	Copper deficiency results in increased expression of CYBRD1 mRNA; Copper deficiency results in increased expression of CYBRD1 protein	PMID:23555700
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20151110	CTD	MESH:D003300	EPAS1 gene mutant form inhibits the reaction [Copper deficiency results in increased expression of CYBRD1 mRNA]	PMID:23555700
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1313951	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of CYBRD1 mRNA	PMID:29803840
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CYBRD1 mRNA	PMID:29432896
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:29073	L-ascorbic acid	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20120501	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of CYBRD1 protein	PMID:18815723
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:29073	L-ascorbic acid	increases expression	ISO	RGD:1313951	E	RGD:6480464	20120501	CTD	MESH:D001205	Ascorbic Acid results in increased expression of CYBRD1 protein	PMID:18815723
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CYBRD1 mRNA	PMID:34032870|PMID:38568856|PMID:39719251
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of CYBRD1 mRNA	PMID:39232337
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:C017947	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in decreased expression of CYBRD1 mRNA]	PMID:39232337
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper deficiency results in increased expression of CYBRD1 mRNA	PMID:19821111
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1313952	E	RGD:6480464	20151110	CTD	MESH:D003300	Copper deficiency results in increased expression of CYBRD1 mRNA; Copper deficiency results in increased expression of CYBRD1 protein	PMID:23555700
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20151110	CTD	MESH:D003300	EPAS1 gene mutant form inhibits the reaction [Copper deficiency results in increased expression of CYBRD1 mRNA]	PMID:23555700
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CYBRD1 mRNA	PMID:39716349
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313951	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CYBRD1 mRNA	PMID:15761015
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:31856	mithramycin	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D008926	Plicamycin results in decreased expression of CYBRD1 mRNA	PMID:23814049
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:31856	mithramycin	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D008926	Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of CYBRD1 mRNA]	PMID:23814049
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of CYBRD1 mRNA	PMID:27760801
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313952	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CYBRD1 gene	PMID:35295148
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of CYBRD1 mRNA	PMID:24418189
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20140812	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of CYBRD1 mRNA	PMID:24418189
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CYBRD1 mRNA	PMID:34947998
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313951	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CYBRD1 gene	PMID:31601247
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CYBRD1 mRNA	PMID:25181051
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313951	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of CYBRD1 mRNA; bisphenol A results in increased expression of CYBRD1 protein	PMID:29275510|PMID:34186270
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313952	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CYBRD1 mRNA	PMID:32156529
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313952	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CYBRD1 mRNA	PMID:26682919
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of CYBRD1 mRNA	PMID:30316929
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CYBRD1 mRNA	PMID:23196670
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313952	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CYBRD1 exon	PMID:33297965
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313951	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CYBRD1 protein	PMID:34186270
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313951	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CYBRD1 protein	PMID:34186270
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CYBRD1 3' UTR	PMID:28392331
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313952	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CYBRD1 mRNA	PMID:21266533
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:34778	glycitein	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CYBRD1 mRNA	PMID:32680482
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313951	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CYBRD1 mRNA	PMID:37042841
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20200915	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYBRD1 mRNA	PMID:32645461
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20200915	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYBRD1 mRNA	PMID:32645461
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in increased expression of CYBRD1 mRNA	PMID:23814049
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:C018021	Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of CYBRD1 mRNA]	PMID:23814049
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313952	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CYBRD1 mRNA	PMID:40194260
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313951	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CYBRD1 mRNA	PMID:31533062
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313952	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of CYBRD1 mRNA	PMID:39529242
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of CYBRD1 mRNA	PMID:22561333
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313952	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of CYBRD1 mRNA	PMID:22155349
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313951	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CYBRD1 mRNA	PMID:25979313
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of CYBRD1 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313951	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CYBRD1 mRNA	PMID:23179753|PMID:26272509|PMID:27188386
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313952	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of CYBRD1 mRNA	PMID:24896083
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA	PMID:27188386
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CYBRD1 mRNA	PMID:38832940
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of CYBRD1 mRNA	PMID:24935251
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CYBRD1 mRNA	PMID:33387578
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of CYBRD1 mRNA	PMID:37567419
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of CYBRD1 mRNA	PMID:38568856
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CYBRD1 mRNA	PMID:39716349
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313951	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CYBRD1 mRNA	PMID:15761015
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CYBRD1 mRNA; Nanotubes, Carbon results in decreased expression of CYBRD1 mRNA	PMID:25554681
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313952	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of CYBRD1 mRNA	PMID:40234311
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CYBRD1 mRNA	PMID:31758290
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313951	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CYBRD1 protein	PMID:34186270
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CYBRD1 mRNA	PMID:22206623
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:78492	diallyl trisulfide	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C042577	diallyl trisulfide results in increased expression of CYBRD1 mRNA	PMID:34014027
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA	PMID:27188386
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CYBRD1 gene]	PMID:28238834
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:80373	glycitin	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:82664	iron(0)	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron results in decreased expression of CYBRD1 protein	PMID:18815723
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D007501	Iron deficiency results in increased expression of CYBRD1 mRNA	PMID:16629162|PMID:19821111|PMID:21540277|PMID:23814049
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1313951	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron results in increased expression of CYBRD1 protein	PMID:18815723
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1313952	E	RGD:6480464	20150609	CTD	MESH:D007501	Iron deficiency results in increased expression of CYBRD1 mRNA	PMID:23776592
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CYBRD1 mRNA	PMID:24780913
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313951	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA	PMID:27188386
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:9410	taurodeoxycholic acid	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:D013657	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in decreased expression of CYBRD1 mRNA]	PMID:39232337
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313951	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CYBRD1 mRNA	PMID:38568856
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CYBRD1 mRNA	PMID:19015723
1305740	Cybrd1	cytochrome b reductase 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CYBRD1 mRNA	PMID:23034163
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of YEATS4 mRNA	PMID:21934132|PMID:33167477
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551159	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of YEATS4 mRNA	PMID:39298647
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1551159	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of YEATS4 mRNA	PMID:33754040
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551159	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of YEATS4 mRNA	PMID:36331819
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1353043	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of YEATS4 protein	PMID:23301498
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of YEATS4 mRNA	PMID:27392435
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1353043	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of YEATS4 mRNA	PMID:22574217
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551159	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of YEATS4 mRNA	PMID:21570461
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of YEATS4 mRNA	PMID:21215274
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1551159	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of YEATS4 mRNA	PMID:19465110
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of YEATS4 protein	PMID:39603559
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of YEATS4 mRNA	PMID:33212167
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of YEATS4 mRNA	PMID:30851411
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of YEATS4 mRNA	PMID:28959563
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1353043	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of YEATS4 mRNA	PMID:20044591
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of YEATS4 mRNA	PMID:38568856
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551159	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of YEATS4 mRNA	PMID:22228805
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1353043	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of YEATS4 promoter	PMID:27901495
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1353043	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to YEATS4 mRNA]	PMID:32406909
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of YEATS4 mRNA	PMID:25351596
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of YEATS4 mRNA	PMID:20382639
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551159	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of YEATS4 gene	PMID:35295148
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of YEATS4 mRNA	PMID:25181051
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1551159	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of YEATS4 promoter	PMID:27334623
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of YEATS4 mRNA	PMID:29275510
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of YEATS4 mRNA	PMID:36041667
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551159	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of YEATS4 mRNA	PMID:39298647
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of YEATS4 mRNA	PMID:36041667
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of YEATS4 mRNA	PMID:36041667
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of YEATS4 mRNA	PMID:17602206
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of YEATS4 mRNA	PMID:17602206
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of YEATS4 mRNA	PMID:30589522
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:3750	clofibrate	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002994	Clofibrate results in increased expression of YEATS4 mRNA	PMID:12851107
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of YEATS4 mRNA	PMID:31533062
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551159	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of YEATS4 mRNA	PMID:36331819
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of YEATS4 mRNA	PMID:23179753|PMID:27188386
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1353043	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of YEATS4 mRNA	PMID:28542535
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of YEATS4 mRNA	PMID:26272509
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1353043	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of YEATS4 mRNA	PMID:27188386
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1353043	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of YEATS4 mRNA	PMID:36621641
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1353043	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of YEATS4 mRNA	PMID:22079256
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of YEATS4 mRNA	PMID:24136188
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551159	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of YEATS4 mRNA	PMID:35964746
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of YEATS4 mRNA	PMID:24793618
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1353043	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of YEATS4 mRNA	PMID:31629900
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:63630	tolcapone	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of YEATS4 mRNA	PMID:24136188
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551159	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of YEATS4 mRNA	PMID:22206623
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of YEATS4 mRNA	PMID:22079256
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1353043	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of YEATS4 mRNA	PMID:22079256
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1353043	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of YEATS4 protein	PMID:31285264
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1353043	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of YEATS4 mRNA	PMID:30851411
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1353043	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of YEATS4 mRNA	PMID:27188386
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1353043	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to YEATS4 gene]	PMID:28238834
1305741	Yeats4	YEATS domain containing 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353043	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of YEATS4 mRNA	PMID:27188386
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TIA1 mRNA	PMID:38218311
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of TIA1 mRNA	PMID:21551480
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TIA1 mRNA	PMID:33045310
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of TIA1 mRNA	PMID:16166294
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TIA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TIA1 mRNA	PMID:32699268
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TIA1 mRNA	PMID:29432896
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313955	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TIA1 mRNA	PMID:21179406
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TIA1 mRNA	PMID:21632981
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TIA1 mRNA	PMID:39241906
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of TIA1 mRNA	PMID:31614463
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313956	E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in increased expression of TIA1 mRNA	PMID:22467019
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA	PMID:25510870
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313955	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TIA1 mRNA	PMID:38568856
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:16610	spermidine	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D013095	Spermidine inhibits the reaction [Pentanoic Acids affects the localization of TIA1 protein]	PMID:22555848
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313955	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TIA1 mRNA	PMID:37042841
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TIA1 mRNA	PMID:23649840
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313955	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TIA1 mRNA	PMID:21179406
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:17148	putrescine	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D011700	[ODC1 protein results in increased abundance of Putrescine] which affects the localization of TIA1 protein; Pentanoic Acids inhibits the reaction [[ODC1 protein results in increased abundance of Putrescine] which affects the localization of TIA1 protein]; Putrescine inhibits the reaction [Pentanoic Acids affects the localization of TIA1 protein]	PMID:22555848
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313956	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TIA1 mRNA	PMID:33754040|PMID:34319233
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TIA1 mRNA	PMID:33387578
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TIA1 mRNA	PMID:28818685
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:18170	selenic acid	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20200609	CTD	MESH:D064586	Selenic Acid promotes the reaction [TUBA4A protein binds to TIA1 protein]	PMID:31585128
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA	PMID:39836092
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of TIA1 mRNA	PMID:27462272
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIA1 mRNA	PMID:35301059
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIA1 mRNA	PMID:37236586
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA	PMID:25510870
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA	PMID:25510870
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:23643	depsipeptide	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20170110	CTD	MESH:D047630	[decitabine co-treated with Depsipeptides] results in decreased expression of TIA1 mRNA	PMID:17064661
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313955	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TIA1 gene	PMID:27153756
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313956	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TIA1 mRNA	PMID:19770486
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TIA1 mRNA	PMID:23649840
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313955	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TIA1 mRNA	PMID:23649840
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TIA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TIA1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TIA1 mRNA	PMID:32699268
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:27363	zinc atom	affects binding	ISO	RGD:1313956	E	RGD:6480464	20220510	CTD	MESH:D015032	Zinc binds to TIA1 protein	PMID:29298433
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TIA1 mRNA	PMID:25629700
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TIA1 mRNA	PMID:39836092
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TIA1 mRNA	PMID:19244175
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of TIA1 mRNA	PMID:19244175
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:27585	selenomethionine	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20200609	CTD	MESH:D012645	Selenomethionine promotes the reaction [TUBA4A protein binds to TIA1 protein]	PMID:31585128
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [sodium arsenite affects the localization of TIA1 protein]; TIA1 mutant form inhibits the reaction [Pentanoic Acids results in decreased susceptibility to [TNF protein co-treated with Cycloheximide]]; TIA1 mutant form inhibits the reaction [sodium arsenite results in decreased susceptibility to [TNF protein co-treated with Cycloheximide]]	PMID:19171178|PMID:22555848
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:27690	acetazolamide	increases expression	ISO	RGD:1313956	E	RGD:6480464	20120717	CTD	MESH:D000086	Acetazolamide results in increased expression of TIA1 mRNA	PMID:19274763
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:27889	lead(0)	affects splicing	ISO	RGD:1313955	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of TIA1 mRNA	PMID:28903495
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of TIA1 mRNA	PMID:15256057
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313956	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TIA1 mRNA	PMID:21570461
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TIA1 mRNA	PMID:33387578
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313955	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of TIA1 protein	PMID:39603559
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TIA1 mRNA	PMID:28001369
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TIA1 mRNA	PMID:33212167
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TIA1 mRNA	PMID:30556269
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TIA1 mRNA	PMID:20971185
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of TIA1 mRNA	PMID:16404146|PMID:29803840
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of TIA1 mRNA	PMID:25523186
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	affects localization	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of TIA1 protein	PMID:19171178
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	affects localization	ISO	RGD:1313955	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of TIA1 protein	PMID:16951406
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of TIA1 mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313956	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of TIA1 gene	PMID:39894169
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	Cycloheximide inhibits the reaction [sodium arsenite affects the localization of TIA1 protein]; sodium arsenite promotes the reaction [TIA1 protein binds to ELAV1 protein binds to DYNLL2 protein]; TIA1 mutant form inhibits the reaction [sodium arsenite results in decreased susceptibility to [TNF protein co-treated with Cycloheximide]]	PMID:19171178|PMID:22555848
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TIA1 mRNA; EIF2A protein mutant form inhibits the reaction [sodium arsenite affects the localization of TIA1 protein]; sodium arsenite promotes the reaction [AGO2 protein binds to TIA1 protein]	PMID:16951406|PMID:30404558|PMID:39836092
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite promotes the reaction [ELAVL1 protein binds to TIA1 protein]; sodium arsenite promotes the reaction [TARDBP protein binds to TIA1 protein]; sodium arsenite promotes the reaction [TIA1 protein binds to and affects the localization of GRIA2 mRNA]; sodium arsenite promotes the reaction [TIA1 protein binds to and affects the localization of YBX1 protein]	PMID:19765185|PMID:24231679
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TIA1 mRNA	PMID:26238291
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313956	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TIA1 mRNA	PMID:19770486
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TIA1 protein]	PMID:32406909
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of TIA1 mRNA	PMID:25523186
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TIA1 mRNA	PMID:30556269
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TIA1 mRNA	PMID:20971185
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:30185	zinc(0)	affects binding	ISO	RGD:1313956	E	RGD:6480464	20220510	CTD	MESH:D015032	Zinc binds to TIA1 protein	PMID:29298433
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TIA1 mRNA	PMID:19073995
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TIA1 mRNA	PMID:20018196|PMID:26238291
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TIA1 mRNA	PMID:30047161
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313955	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TIA1 mRNA	PMID:30903817
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TIA1 mRNA; bisphenol A results in decreased expression of TIA1 protein	PMID:29275510|PMID:33376534
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TIA1 mRNA	PMID:32156529
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TIA1 mRNA	PMID:25181051|PMID:27571134
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of TIA1 mRNA	PMID:19244175
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of TIA1 mRNA	PMID:19244175
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA	PMID:25510870
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA	PMID:25510870
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TIA1 mRNA	PMID:40203079
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TIA1 mRNA	PMID:28628672
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TIA1 mRNA	PMID:38685157
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TIA1 mRNA	PMID:17361019|PMID:21266533
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TIA1 mRNA	PMID:28628672
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34887	nickel dichloride	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of TIA1 mRNA	PMID:22546817
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of TIA1 mRNA	PMID:17312168
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34905	paraquat	affects splicing	ISO	RGD:1313956	E	RGD:6480464	20171114	CTD	MESH:D010269	Paraquat affects the splicing of TIA1 exon	PMID:27111068
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20171114	CTD	MESH:D010269	Paraquat results in decreased expression of TIA1 protein	PMID:27111068
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313955	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TIA1 mRNA	PMID:37042841
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA	PMID:39836092
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313955	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TIA1 mRNA	PMID:38174414
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIA1 mRNA	PMID:35301059
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIA1 mRNA	PMID:37236586
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TIA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TIA1 mRNA	PMID:32699268
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TIA1 mRNA	PMID:19244175
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of TIA1 mRNA	PMID:19244175
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TIA1 mRNA	PMID:28302478
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TIA1 mRNA	PMID:31533062
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313955	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TIA1 mRNA	PMID:25979313
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TIA1 mRNA	PMID:29427782
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TIA1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of TIA1 mRNA	PMID:21427059
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA	PMID:27188386
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TIA1 mRNA	PMID:30047161
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TIA1 mRNA	PMID:25562108|PMID:27989131
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TIA1 mRNA	PMID:28628672
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313956	E	RGD:6480464	20121009	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TIA1 mRNA	PMID:22467019
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:45863	paclitaxel	affects response to substance	ISO	RGD:1313955	E	RGD:6480464	20161213	CTD	MESH:D017239	TIA1 protein affects the susceptibility to Paclitaxel	PMID:16217747
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TIA1 mRNA	PMID:26272509
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA	PMID:27188386
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313956	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TIA1 mRNA	PMID:17562736
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TIA1 mRNA	PMID:33387578
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TIA1 mRNA	PMID:21420995
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TIA1 mRNA	PMID:39836092
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:4781	emetine	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20120412	CTD	MESH:D004640	Emetine affects the reaction [TARDBP protein binds to TIA1 protein]	PMID:19765185
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TIA1 mRNA	PMID:22079256
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TIA1 mRNA	PMID:35436446
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20200609	CTD	MESH:D018038	Sodium Selenite promotes the reaction [TUBA4A protein binds to TIA1 protein]	PMID:31585128
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TIA1 mRNA	PMID:28628672
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with Depsipeptides] results in decreased expression of TIA1 mRNA	PMID:17064661
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TIA1 mRNA	PMID:30307764
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TIA1 mRNA	PMID:30047161
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:50729	mitoxantrone	affects response to substance	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D008942	TIA1 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:53620	methylisothiazolinone	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of TIA1 mRNA	PMID:31629900
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TIA1 protein	PMID:32959892
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of TIA1 mRNA	PMID:20080153
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA	PMID:39836092
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D019772	TIA1 protein affects the susceptibility to Topotecan	PMID:16217747
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of TIA1 mRNA	PMID:19812364
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TIA1 mRNA	PMID:16934159
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TIA1 mRNA	PMID:23650126
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TIA1 mRNA	PMID:15336504
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of TIA1 mRNA	PMID:27462272
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313955	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TIA1 mRNA	PMID:31758290
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313956	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TIA1 mRNA	PMID:22206623
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of TIA1 protein	PMID:37664457
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	ISO	RGD:1313955	E	RGD:6480464	20220405	CTD	MESH:C045338	TIA1 protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TIA1 mRNA	PMID:22079256
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TIA1 mRNA	PMID:22079256
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA	PMID:27188386
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313956	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TIA1 mRNA	PMID:23091169
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of TIA1 mRNA	PMID:32109520
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of TIA1 protein	PMID:38348393
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313956	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of TIA1 mRNA	PMID:21795629
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TIA1 mRNA	PMID:30047161
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313956	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of TIA1 mRNA	PMID:40826991
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313955	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of TIA1 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA	PMID:27188386|PMID:37664457
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TIA1 mRNA	PMID:19281266
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:94646	N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20170307	CTD	MESH:C034161	flupirtine results in decreased expression of TIA1 protein	PMID:9804146
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313955	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TIA1 mRNA	PMID:38568856
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of TIA1 mRNA	PMID:19015723
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TIA1 mRNA	PMID:22570695
1305742	Tia1	TIA1 cytotoxic granule-associated RNA binding protein	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TIA1 mRNA	PMID:20566332
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313959	E	RGD:6480464	20260804	CTD	MESH:C084079	triptonide results in increased expression of DRC5 mRNA	PMID:33045310
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:132448	perfluorohexanesulfonic acid	multiple interactions	ISO	RGD:1604203	E	RGD:6480464	20240806	CTD	MESH:C471071	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in decreased expression of DRC5 mRNA	PMID:38603627
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D011794	Quercetin results in decreased expression of DRC5 mRNA	PMID:17103110
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DRC5 mRNA	PMID:33387578
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DRC5 mRNA	PMID:31199487
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313959	E	RGD:6480464	20260804	CTD	MESH:D005492	Folic Acid results in decreased expression of DRC5 mRNA	PMID:25629700
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313959	E	RGD:6480464	20260804	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DRC5 mRNA	PMID:39401686
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604203	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DRC5 mRNA	PMID:33212167
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1604203	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DRC5 mRNA	PMID:32763439
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D003300	Copper deficiency results in increased expression of DRC5 mRNA	PMID:26033743
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of DRC5 mRNA	PMID:26033743
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604203	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DRC5 5' UTR	PMID:27901495
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604203	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DRC5 promoter	PMID:27901495
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D003300	Copper deficiency results in increased expression of DRC5 mRNA	PMID:26033743
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of DRC5 mRNA	PMID:26033743
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1604203	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of DRC5 mRNA	PMID:37690743
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313959	E	RGD:6480464	20260804	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DRC5 gene	PMID:35295148
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313959	E	RGD:6480464	20260804	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DRC5 mRNA	PMID:18648102
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C006780	bisphenol A results in decreased expression of DRC5 mRNA	PMID:25181051
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C006780	bisphenol A results in increased expression of DRC5 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DRC5 mRNA	PMID:31199487
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DRC5 mRNA	PMID:31199487
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:34698	diethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DRC5 mRNA	PMID:31199487
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20260804	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of DRC5 promoter	PMID:22457795
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DRC5 mRNA	PMID:31199487
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1604203	E	RGD:6480464	20240806	CTD	MESH:C023036	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in decreased expression of DRC5 mRNA	PMID:38603627
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313959	E	RGD:6480464	20260804	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of DRC5 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DRC5 mRNA]	PMID:17585979
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313959	E	RGD:6480464	20260804	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DRC5 mRNA	PMID:40194260
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1604203	E	RGD:6480464	20240806	CTD	MESH:C076994	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in decreased expression of DRC5 mRNA	PMID:38603627
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313959	E	RGD:6480464	20260804	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of DRC5 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DRC5 mRNA]	PMID:17585979
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313959	E	RGD:6480464	20260804	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of DRC5 mRNA	PMID:25554681
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DRC5 mRNA	PMID:31199487
1305744	Drc5	dynein regulatory complex subunit 5	gene	CHEBI:8093	phenylephrine	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D010656	Phenylephrine results in decreased expression of DRC5 mRNA	PMID:18158353
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1313960	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of STAC mRNA	PMID:26079696
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of STAC gene	PMID:28931070
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of STAC mRNA	PMID:33387578
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313960	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of STAC mRNA	PMID:21179406
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of STAC mRNA	PMID:26496021
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1313961	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of STAC mRNA	PMID:36706583
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313960	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of STAC mRNA	PMID:23825647
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313961	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of STAC mRNA	PMID:27405655
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313960	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of STAC mRNA	PMID:26485663
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1313960	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of STAC intron	PMID:30157460
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313960	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of STAC mRNA	PMID:23825647
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:232796	cadmium acetate	increases expression	ISO	RGD:1313960	E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in increased expression of STAC mRNA	PMID:18155341
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313960	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STAC gene; Aflatoxin B1 results in decreased methylation of STAC intron	PMID:27153756|PMID:30157460
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313961	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of STAC mRNA	PMID:25629700
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313960	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of STAC mRNA	PMID:40512198
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313960	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of STAC mRNA	PMID:41028656
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313960	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of STAC mRNA	PMID:27392435
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313960	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of STAC mRNA	PMID:27392435
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of STAC mRNA	PMID:26033743
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of STAC mRNA	PMID:26033743
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313960	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of STAC mRNA	PMID:41028656
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1313960	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of STAC mRNA	PMID:22363485
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313960	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of STAC mRNA	PMID:29301061|PMID:39719251
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313960	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of STAC mRNA	PMID:40512198
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313960	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STAC intron	PMID:30157460
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313960	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STAC mRNA	PMID:32234424
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313961	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STAC mRNA	PMID:22228805
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313960	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STAC exon; Benzo(a)pyrene results in increased methylation of STAC promoter	PMID:27901495
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313961	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to STAC promoter]	PMID:19654925
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of STAC mRNA	PMID:26033743
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of STAC mRNA	PMID:26033743
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313960	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of STAC mRNA	PMID:41028656
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313961	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of STAC mRNA	PMID:27131904
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313960	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of STAC mRNA	PMID:38568856
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of STAC mRNA	PMID:30047161
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of STAC mRNA	PMID:30816183
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STAC mRNA	PMID:25181051
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313960	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of STAC gene	PMID:31601247
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of STAC mRNA	PMID:26496021
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313960	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of STAC mRNA	PMID:25979313
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313961	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of STAC mRNA	PMID:18353800
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:3764	clotrimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of STAC mRNA	PMID:30047161
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313960	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of STAC mRNA	PMID:32588087
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313960	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STAC mRNA	PMID:25979313
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313960	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of STAC gene	PMID:29154799
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of STAC mRNA	PMID:30047161
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313960	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of STAC mRNA	PMID:20106945
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313960	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of STAC mRNA	PMID:27188386
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313960	E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of STAC mRNA	PMID:27188386
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313960	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of STAC mRNA	PMID:29067470
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313960	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of STAC mRNA	PMID:40512198
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of STAC mRNA	PMID:29391264
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	ISO	RGD:1313960	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of STAC mRNA	PMID:38825487
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313960	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of STAC mRNA	PMID:22714537
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1313960	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of STAC mRNA	PMID:31758290
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of STAC mRNA	PMID:33484710
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313960	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to STAC gene]	PMID:28238834
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of STAC mRNA	PMID:30047161
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of STAC mRNA	PMID:24780913
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of STAC mRNA	PMID:30047161
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1313961	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of STAC mRNA	PMID:36706583
1305745	Stac	SH3 and cysteine rich domain	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313961	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of STAC mRNA	PMID:27131904
1305746	Dpep2	dipeptidase 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313962	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of DPEP2 mRNA	PMID:35967413
1305746	Dpep2	dipeptidase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313963	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DPEP2 mRNA	PMID:33045310
1305746	Dpep2	dipeptidase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313963	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DPEP2 mRNA	PMID:26251327
1305746	Dpep2	dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313962	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DPEP2 mRNA	PMID:19619570
1305746	Dpep2	dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DPEP2 mRNA	PMID:32741896
1305746	Dpep2	dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313962	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DPEP2 mRNA	PMID:19619570
1305746	Dpep2	dipeptidase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313962	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DPEP2 mRNA	PMID:37042841
1305746	Dpep2	dipeptidase 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313963	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in increased expression of DPEP2 mRNA	PMID:31525975
1305746	Dpep2	dipeptidase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313963	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of DPEP2 mRNA	PMID:22401849
1305746	Dpep2	dipeptidase 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DPEP2 mRNA	PMID:32741896
1305746	Dpep2	dipeptidase 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313963	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in increased expression of DPEP2 mRNA	PMID:31525975
1305746	Dpep2	dipeptidase 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of DPEP2 mRNA	PMID:22061828|PMID:33387578
1305746	Dpep2	dipeptidase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313962	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DPEP2 mRNA	PMID:28818685
1305746	Dpep2	dipeptidase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPEP2 mRNA	PMID:37325564
1305746	Dpep2	dipeptidase 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DPEP2 mRNA	PMID:29950665
1305746	Dpep2	dipeptidase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313962	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DPEP2 mRNA	PMID:35430440
1305746	Dpep2	dipeptidase 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of DPEP2 mRNA	PMID:30779732
1305746	Dpep2	dipeptidase 2	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of DPEP2 mRNA	PMID:31129395
1305746	Dpep2	dipeptidase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313963	E	RGD:6480464	20260303	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DPEP2 mRNA	PMID:40389097
1305746	Dpep2	dipeptidase 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DPEP2 mRNA	PMID:31881176
1305746	Dpep2	dipeptidase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313963	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of DPEP2 mRNA	PMID:40618947
1305746	Dpep2	dipeptidase 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313962	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DPEP2 mRNA	PMID:25583101
1305746	Dpep2	dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313963	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DPEP2 mRNA	PMID:26377647
1305746	Dpep2	dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313962	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DPEP2 mRNA	PMID:19619570
1305746	Dpep2	dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313962	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DPEP2 mRNA	PMID:19619570
1305746	Dpep2	dipeptidase 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of DPEP2 mRNA	PMID:28959563
1305746	Dpep2	dipeptidase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313963	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of DPEP2 mRNA	PMID:37682722
1305746	Dpep2	dipeptidase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313962	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DPEP2 mRNA	PMID:38568856
1305746	Dpep2	dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313962	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DPEP2 promoter	PMID:27901495
1305746	Dpep2	dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DPEP2 mRNA	PMID:30085273
1305746	Dpep2	dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313963	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DPEP2 mRNA	PMID:22228805
1305746	Dpep2	dipeptidase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313962	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of DPEP2 gene	PMID:31601247
1305746	Dpep2	dipeptidase 2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of DPEP2 mRNA	PMID:25729387
1305746	Dpep2	dipeptidase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DPEP2 mRNA	PMID:25729387
1305746	Dpep2	dipeptidase 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DPEP2 mRNA	PMID:29950665
1305746	Dpep2	dipeptidase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DPEP2 mRNA	PMID:25181051|PMID:34947998
1305746	Dpep2	dipeptidase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DPEP2 mRNA	PMID:30816183|PMID:32528016
1305746	Dpep2	dipeptidase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of DPEP2 mRNA	PMID:31129395
1305746	Dpep2	dipeptidase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20230207	CTD	MESH:C006780	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of DPEP2 protein	PMID:35999755
1305746	Dpep2	dipeptidase 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DPEP2 mRNA	PMID:23196670
1305746	Dpep2	dipeptidase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313962	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of DPEP2 gene	PMID:31601247
1305746	Dpep2	dipeptidase 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313963	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of DPEP2 mRNA	PMID:26377693
1305746	Dpep2	dipeptidase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313963	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of DPEP2 intron	PMID:28392331
1305746	Dpep2	dipeptidase 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20190702	CTD	MESH:D016264	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of DPEP2 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DPEP2 mRNA	PMID:29950665|PMID:35999755
1305746	Dpep2	dipeptidase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313962	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DPEP2 mRNA	PMID:37042841
1305746	Dpep2	dipeptidase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPEP2 mRNA	PMID:37325564
1305746	Dpep2	dipeptidase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313963	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DPEP2 mRNA	PMID:40194260
1305746	Dpep2	dipeptidase 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313963	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in increased expression of DPEP2 mRNA	PMID:31525975
1305746	Dpep2	dipeptidase 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DPEP2 mRNA	PMID:33387578
1305746	Dpep2	dipeptidase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313963	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DPEP2 mRNA; Nanotubes, Carbon results in increased expression of DPEP2 mRNA	PMID:25554681
1305746	Dpep2	dipeptidase 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313963	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of DPEP2 mRNA	PMID:40234311
1305746	Dpep2	dipeptidase 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313963	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of DPEP2 mRNA	PMID:38701926
1305746	Dpep2	dipeptidase 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of DPEP2 mRNA	PMID:28801915
1305746	Dpep2	dipeptidase 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of DPEP2 mRNA	PMID:25729387
1305746	Dpep2	dipeptidase 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DPEP2 mRNA	PMID:25729387
1305746	Dpep2	dipeptidase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DPEP2 mRNA	PMID:28801915
1305746	Dpep2	dipeptidase 2	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of DPEP2 mRNA	PMID:35283115
1305746	Dpep2	dipeptidase 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DPEP2 mRNA	PMID:32741896
1305746	Dpep2	dipeptidase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313962	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DPEP2 gene]	PMID:28238834
1305746	Dpep2	dipeptidase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313963	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DPEP2 mRNA	PMID:38648751
1305746	Dpep2	dipeptidase 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313962	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DPEP2 mRNA	PMID:38568856
1305746	Dpep2	dipeptidase 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313962	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of DPEP2 mRNA	PMID:29301935
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20180116	CTD	MESH:C007262	[deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA	PMID:28935500
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAT4 mRNA	PMID:20938992
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20250401	CTD	MESH:D011794	[Quercetin co-treated with Lipopolysaccharides] results in decreased expression of STAT4 mRNA; Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT4 protein]	PMID:38823456
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313964	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of STAT4 mRNA	PMID:35811015
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:16412	lipopolysaccharide	increases phosphorylation	ISO	RGD:1313965	E	RGD:6480464	20250401	CTD	MESH:D008070	Lipopolysaccharides results in increased phosphorylation of STAT4 protein	PMID:38823456
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STAT4 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of STAT4 mRNA	PMID:35811015
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20161228	CTD	MESH:D008070	[Quercetin co-treated with Lipopolysaccharides] results in decreased expression of STAT4 mRNA; chlorophyllin inhibits the reaction [Lipopolysaccharides results in increased activity of STAT4 protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT4 protein]	PMID:16275627|PMID:38823456
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of STAT4 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of STAT4 mRNA	PMID:20404318|PMID:30165855
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAT4 mRNA	PMID:20938992
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D001554	Benzene results in increased expression of STAT4 mRNA	PMID:16188087|PMID:19162166|PMID:20036648
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20140408	CTD	MESH:D008550	Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA]	PMID:23963992
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C005556	propionaldehyde results in increased expression of STAT4 mRNA	PMID:26079696
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1313965	E	RGD:6480464	20120613	CTD	MESH:D014050	Toluene results in increased expression of STAT4 mRNA	PMID:21601613
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of STAT4 mRNA	PMID:22061828
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:232141	chlorophyllin	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20241119	CTD	MESH:C007020	chlorophyllin inhibits the reaction [Lipopolysaccharides results in increased activity of STAT4 protein]	PMID:16275627
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of STAT4 protein	PMID:33236894
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of STAT4 mRNA	PMID:19480007
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of STAT4 mRNA	PMID:41430723
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of STAT4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of STAT4 mRNA	PMID:34911549
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:27363	zinc atom	increases activity	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D015032	Zinc deficiency results in increased activity of STAT4 protein	PMID:18356318
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAT4 mRNA	PMID:20938992
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D001151	Arsenic results in increased methylation of STAT4 promoter	PMID:21291286
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of STAT4 mRNA	PMID:40512198
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STAT4 mRNA	PMID:40504410
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D000968	Antimycin A results in decreased expression of STAT4 mRNA	PMID:33512557
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of STAT4 mRNA	PMID:31881176
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of STAT4 mRNA	PMID:41028656
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D002945	Cisplatin results in increased expression of STAT4 mRNA	PMID:27392435
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of STAT4 mRNA	PMID:27392435
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313965	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of STAT4 mRNA	PMID:32186404
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D009532	Nickel results in increased expression of STAT4 mRNA	PMID:25583101
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313965	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STAT4 mRNA	PMID:24058054
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STAT4 mRNA	PMID:18684927|PMID:37172768
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases phosphorylation	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased phosphorylation of STAT4 protein	PMID:18684927
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STAT4 mRNA	PMID:17942748
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D012402	Rotenone results in decreased expression of STAT4 mRNA	PMID:33512557
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C000228	aristolochic acid I results in decreased expression of STAT4 mRNA	PMID:33212167
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of STAT4 mRNA	PMID:28959563
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of STAT4 mRNA	PMID:41028656
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D004317	Doxorubicin results in decreased expression of STAT4 mRNA	PMID:29803840
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313965	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of STAT4 mRNA	PMID:36227756
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C017947	sodium arsenite results in increased expression of STAT4 mRNA	PMID:29301061|PMID:39900124
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of STAT4 mRNA	PMID:40512198
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STAT4 mRNA	PMID:40504410
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STAT4 3' UTR	PMID:27901495
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:29865	benzo[a]pyrene	affects response to substance	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D001564	STAT4 gene SNP affects the susceptibility to Benzo(a)pyrene	PMID:28807506
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of STAT4 promoter	PMID:27901495
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STAT4 mRNA	PMID:32234424
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313965	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STAT4 mRNA	PMID:22228805
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of STAT4 mRNA	PMID:41028656
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:30185	zinc(0)	increases activity	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D015032	Zinc deficiency results in increased activity of STAT4 protein	PMID:18356318
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of STAT4 mRNA	PMID:25895662
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313965	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of STAT4 mRNA	PMID:29341224
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to STAT4 protein]	PMID:26598702
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of STAT4 mRNA	PMID:16483693
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313965	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of STAT4 mRNA	PMID:29264374|PMID:32333507
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of STAT4 mRNA	PMID:34492290
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313965	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of STAT4 promoter	PMID:27334623
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STAT4 mRNA	PMID:25181051|PMID:27178563
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of STAT4 mRNA	PMID:34947998|PMID:41034487
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of STAT4 mRNA	PMID:21241498
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of STAT4 mRNA	PMID:17374397
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20140408	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA]; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA]	PMID:23963992
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313964	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STAT4 mRNA	PMID:37042841
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STAT4 mRNA	PMID:38568856
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:35549	perfluorooctanoic acid	increases activity	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C023036	perfluorooctanoic acid results in increased activity of STAT4 protein	PMID:27589886
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313964	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of STAT4 mRNA	PMID:36326898
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313965	E	RGD:6480464	20230207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of STAT4 protein	PMID:36214631|PMID:37422089
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313965	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of STAT4 mRNA	PMID:40194260
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C473478	Sunitinib results in decreased expression of STAT4 mRNA	PMID:31533062
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313965	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of STAT4 mRNA	PMID:29038090
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D003474	Curcumin promotes the reaction [IFNB1 protein results in increased phosphorylation of STAT4 protein]	PMID:17979888
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D014635	Valproic Acid affects the expression of STAT4 mRNA	PMID:25979313
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D014635	Valproic Acid results in decreased expression of STAT4 mRNA	PMID:26272509
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D014635	Valproic Acid results in increased expression of STAT4 mRNA	PMID:24935251
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STAT4 mRNA	PMID:27188386
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D016572	Cyclosporine results in decreased expression of STAT4 mRNA	PMID:27989131
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D016572	Cyclosporine results in increased expression of STAT4 mRNA	PMID:33631201
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4042	cypermethrin	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C017160	cypermethrin results in decreased expression of STAT4 mRNA	PMID:22528246
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313965	E	RGD:6480464	20211012	CTD	MESH:C017160	cypermethrin results in decreased expression of STAT4 mRNA	PMID:31659573
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20211012	CTD	MESH:C017160	Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of STAT4 mRNA]	PMID:31659573
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C087670	azoxystrobin results in decreased expression of STAT4 mRNA	PMID:33512557
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C107676	deguelin results in decreased expression of STAT4 mRNA	PMID:33512557
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D008727	Methotrexate results in increased expression of STAT4 mRNA	PMID:17400583
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313964	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of STAT4 mRNA	PMID:38832940
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4469	(S)-amphetamine	decreases expression	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D003913	Dextroamphetamine results in decreased expression of STAT4 mRNA	PMID:12205029
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4469	(S)-amphetamine	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D003913	SOD1 inhibits the reaction [Dextroamphetamine results in decreased expression of STAT4 mRNA]	PMID:12205029
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C012589	trichostatin A results in increased expression of STAT4 mRNA	PMID:24935251
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D000082	Acetaminophen results in increased expression of STAT4 mRNA	PMID:26690555
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STAT4 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of STAT4 mRNA	PMID:35811015
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of STAT4 mRNA	PMID:18687144
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of STAT4 mRNA	PMID:24160326
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D001151	Arsenic results in increased methylation of STAT4 promoter	PMID:21291286
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of STAT4 mRNA	PMID:40512198
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STAT4 mRNA	PMID:40504410
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D004008	Diclofenac results in decreased expression of STAT4 mRNA	PMID:19192274
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D018038	Sodium Selenite results in increased expression of STAT4 mRNA	PMID:18175754
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20211012	CTD	MESH:D018038	Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of STAT4 mRNA]	PMID:31659573
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of STAT4 mRNA	PMID:17555576
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STAT4 mRNA	PMID:17942748
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:4917	eugenol	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D005054	Eugenol results in increased expression of STAT4 mRNA	PMID:17374397
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to STAT4 protein]	PMID:26598702
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases response to substance	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D008770	STAT4 gene mutant form results in increased susceptibility to Methylnitrosourea	PMID:11418001
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313965	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of STAT4 mRNA	PMID:25554681
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20140408	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA]; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA]	PMID:23963992
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:52646	leptomycin B	affects localization	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C038753	leptomycin B affects the localization of STAT4 protein	PMID:15004198
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C029938	nickel sulfate results in increased expression of STAT4 mRNA	PMID:16780908|PMID:17374397
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313965	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of STAT4 mRNA	PMID:19042947
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313965	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of STAT4 mRNA	PMID:38701926
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:59132	antigen	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20180116	CTD	MESH:D000941	[deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA; [ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA	PMID:28935500
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:6888	6alpha-methylprednisolone	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D008775	Methylprednisolone results in decreased expression of STAT4 mRNA	PMID:19192274
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313965	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of STAT4 mRNA	PMID:22206623
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20180116	CTD	MESH:C025589	[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA	PMID:28935500
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STAT4 mRNA	PMID:27188386
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:8107	phenytoin	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D010672	Phenytoin results in decreased expression of STAT4 mRNA	PMID:14741686
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D010894	Piroxicam results in decreased expression of STAT4 mRNA	PMID:19192274
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C556557	picoxystrobin results in decreased expression of STAT4 mRNA	PMID:33512557
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:8378	prednisolone	decreases expression	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:D011239	Prednisolone results in decreased expression of STAT4 mRNA	PMID:19192274
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313964	E	RGD:6480464	20220816	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STAT4 mRNA	PMID:27188386
1305747	Stat4	signal transducer and activator of transcription 4	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of STAT4 gene	PMID:31682807
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMEM86A mRNA	PMID:20938992
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1601825	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM86A mRNA	PMID:23724009
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM86A mRNA	PMID:36331819
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1331998	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TMEM86A mRNA	PMID:30319688
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TMEM86A mRNA	PMID:26582142|PMID:39241906
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1601825	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TMEM86A mRNA	PMID:35811015
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1601825	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TMEM86A mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TMEM86A mRNA	PMID:35811015
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM86A mRNA	PMID:33387578
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMEM86A mRNA	PMID:20938992
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1601825	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TMEM86A mRNA	PMID:37042841
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1601825	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TMEM86A mRNA	PMID:26079696
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM86A mRNA	PMID:37992649
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TMEM86A mRNA	PMID:22401849
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of TMEM86A mRNA	PMID:28973375
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1331998	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of TMEM86A mRNA	PMID:33848595
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM86A mRNA	PMID:37992649
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1331998	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of TMEM86A mRNA	PMID:33754040
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TMEM86A mRNA	PMID:34319233
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1601825	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TMEM86A mRNA	PMID:31163220
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TMEM86A mRNA	PMID:33387578
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1601825	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TMEM86A mRNA	PMID:28818685
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D007501	Iron deficiency results in increased expression of TMEM86A mRNA	PMID:16629162
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1601825	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TMEM86A exon	PMID:30157460
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:25710	organophosphorus compound	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in decreased expression of TMEM86A mRNA	PMID:39658253
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1331998	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TMEM86A mRNA	PMID:27339419|PMID:31919559
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMEM86A mRNA	PMID:20938992
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1601825	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM86A gene	PMID:25304211
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM86A mRNA	PMID:40504410
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1601825	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TMEM86A mRNA	PMID:32525701
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TMEM86A mRNA	PMID:31881176
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1331998	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM86A mRNA	PMID:21570461
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM86A mRNA	PMID:32109520|PMID:34747641
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM86A mRNA	PMID:21215274|PMID:33387578
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TMEM86A mRNA]	PMID:21215274
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1601825	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM86A mRNA	PMID:30851411
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM86A mRNA	PMID:39631538
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM86A mRNA	PMID:37992649
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1601825	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMEM86A mRNA	PMID:39719251
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1601825	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TMEM86A mRNA	PMID:38568856
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM86A mRNA	PMID:40504410
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1601825	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM86A 3' UTR	PMID:27901495
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TMEM86A mRNA	PMID:27131904
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1601825	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TMEM86A mRNA	PMID:35984750
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of TMEM86A mRNA	PMID:16507785
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of TMEM86A mRNA	PMID:25729387
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of TMEM86A mRNA	PMID:25729387
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TMEM86A mRNA	PMID:30012374
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1331998	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TMEM86A promoter	PMID:35295148
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TMEM86A mRNA	PMID:34492290
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:33083	fluoranthene	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20170725	CTD	MESH:C007738	fluoranthene results in decreased expression of TMEM86A mRNA	PMID:28329830
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM86A mRNA	PMID:28329830
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM86A mRNA	PMID:25181051|PMID:32145629
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1601825	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TMEM86A mRNA	PMID:28628672
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1331998	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of TMEM86A exon	PMID:33297965
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of TMEM86A mRNA	PMID:26377693
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TMEM86A mRNA	PMID:21266533
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TMEM86A mRNA	PMID:21266533
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1601825	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TMEM86A mRNA	PMID:28628672
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1331998	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of TMEM86A mRNA	PMID:24535843
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1601825	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMEM86A mRNA	PMID:37042841
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TMEM86A mRNA	PMID:35163327
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:3537	cefaloridine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of TMEM86A mRNA	PMID:18500788
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1601825	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMEM86A mRNA	PMID:38382870
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1601825	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMEM86A mRNA	PMID:38174414
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TMEM86A mRNA	PMID:35163327
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1601825	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TMEM86A mRNA	PMID:31533062
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1601825	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TMEM86A mRNA	PMID:40419075
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM86A mRNA	PMID:36331819
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1331998	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM86A mRNA	PMID:19136453|PMID:21427059
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of TMEM86A mRNA	PMID:41580965
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of TMEM86A mRNA	PMID:22733784
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1601825	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TMEM86A mRNA	PMID:28628672
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMEM86A mRNA	PMID:37992649
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1331998	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMEM86A mRNA	PMID:17562736
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM86A mRNA	PMID:33387578
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:46557	zoledronic acid	decreases expression	ISO	RGD:1601825	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TMEM86A mRNA	PMID:24714768
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1601825	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TMEM86A mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TMEM86A mRNA	PMID:35811015
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1601825	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM86A gene	PMID:25304211
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM86A mRNA	PMID:40504410
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1601825	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TMEM86A mRNA	PMID:32525701
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TMEM86A mRNA	PMID:29391264
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TMEM86A mRNA	PMID:35436446
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1601825	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TMEM86A mRNA	PMID:28628672
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TMEM86A mRNA	PMID:25554681
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1331998	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TMEM86A mRNA	PMID:25554681
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TMEM86A mRNA	PMID:24136188
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1331998	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TMEM86A mRNA	PMID:38701926
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1331998	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM86A mRNA	PMID:21641980
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of TMEM86A mRNA	PMID:25729387
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TMEM86A mRNA	PMID:28801915
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1601825	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM86A mRNA	PMID:30851411
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TMEM86A mRNA	PMID:27291303
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of TMEM86A mRNA	PMID:16629162
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1601825	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TMEM86A mRNA	PMID:32525701
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TMEM86A mRNA	PMID:24780913
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1331998	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TMEM86A mRNA	PMID:27131904
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TMEM86A mRNA	PMID:19281266
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1331998	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of TMEM86A mRNA	PMID:28973697
1305749	Tmem86a	transmembrane protein 86A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TMEM86A mRNA	PMID:22570695
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of ZDHHC21 mRNA	PMID:26272509|PMID:27188386
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZDHHC21 mRNA	PMID:27188386
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313970	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ZDHHC21 mRNA	PMID:33045310
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of ZDHHC21 mRNA	PMID:31016361
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313970	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ZDHHC21 mRNA	PMID:20188158
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	ISO	RGD:1313969	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of ZDHHC21 mRNA	PMID:19524605
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313970	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZDHHC21 gene	PMID:20938992
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313969	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ZDHHC21 mRNA	PMID:23724009
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ZDHHC21 mRNA	PMID:21632981
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313970	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZDHHC21 mRNA	PMID:39241906
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ZDHHC21 mRNA	PMID:30165855
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313970	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZDHHC21 gene	PMID:20938992
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313970	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ZDHHC21 mRNA	PMID:23892564
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZDHHC21 mRNA	PMID:33387578
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ZDHHC21 mRNA	PMID:39836092
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZDHHC21 mRNA	PMID:35301059
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313969	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZDHHC21 gene	PMID:27153756
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ZDHHC21 mRNA	PMID:23649840
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZDHHC21 mRNA	PMID:30779732
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313970	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZDHHC21 gene	PMID:20938992
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313970	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZDHHC21 mRNA	PMID:21570461
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZDHHC21 mRNA	PMID:33387578
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZDHHC21 mRNA	PMID:28001369
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZDHHC21 mRNA	PMID:33212167
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ZDHHC21 mRNA	PMID:30851411
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ZDHHC21 mRNA	PMID:32763439
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZDHHC21 mRNA	PMID:29803840
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313969	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ZDHHC21 mRNA	PMID:34032870|PMID:38568856
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313969	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZDHHC21 promoter	PMID:27901495
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:30563	silicon dioxide	increases methylation	ISO	RGD:1313969	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased methylation of ZDHHC21 promoter	PMID:34973136
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313970	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZDHHC21 gene	PMID:35295148
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313970	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZDHHC21 promoter	PMID:35295148
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313970	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ZDHHC21 mRNA	PMID:28472532
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:33146	vanadyl sulfate	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in decreased expression of ZDHHC21 mRNA	PMID:16330358
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZDHHC21 mRNA	PMID:25181051
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of ZDHHC21 mRNA	PMID:31715268
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of ZDHHC21 mRNA	PMID:29097150|PMID:30816183
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:36041667
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZDHHC21 mRNA	PMID:28628672
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:36041667
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:28628672
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313970	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ZDHHC21 mRNA	PMID:38685157
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:36041667
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZDHHC21 mRNA	PMID:18668222
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZDHHC21 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:28628672
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313969	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZDHHC21 mRNA	PMID:37042841
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ZDHHC21 mRNA	PMID:39836092
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZDHHC21 mRNA	PMID:35301059
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ZDHHC21 mRNA	PMID:25539665
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ZDHHC21 mRNA	PMID:19320972
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1313969	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ZDHHC21 mRNA	PMID:24449571
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ZDHHC21 mRNA	PMID:23125180
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313969	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZDHHC21 mRNA	PMID:23179753|PMID:25979313
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:39867	valproic acid	affects splicing	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of ZDHHC21 mRNA	PMID:29427782
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZDHHC21 mRNA	PMID:29427782
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313969	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZDHHC21 gene	PMID:29154799
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313969	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZDHHC21 mRNA	PMID:24383497
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZDHHC21 mRNA	PMID:25562108
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZDHHC21 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:28628672
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313969	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ZDHHC21 mRNA	PMID:27188386
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313970	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZDHHC21 mRNA	PMID:17562736
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZDHHC21 mRNA	PMID:33387578
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ZDHHC21 mRNA	PMID:29097150
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZDHHC21 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:28628672
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313970	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ZDHHC21 mRNA	PMID:25554681
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ZDHHC21 mRNA	PMID:22714537
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ZDHHC21 mRNA	PMID:39836092
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZDHHC21 mRNA	PMID:26378955
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313970	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZDHHC21 mRNA	PMID:22206623
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ZDHHC21 mRNA	PMID:30851411
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZDHHC21 mRNA	PMID:27188386
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313969	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of ZDHHC21 mRNA	PMID:18927307
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313970	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ZDHHC21 mRNA	PMID:21795629
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of ZDHHC21 mRNA	PMID:26923065
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313969	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZDHHC21 mRNA	PMID:27188386
1305750	Zdhhc21	zDHHC palmitoyltransferase 21	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ZDHHC21 mRNA	PMID:23034163
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1346472	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of MFSD1 mRNA	PMID:23724009|PMID:33167477
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1346472	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MFSD1 mRNA	PMID:22378314
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550118	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MFSD1 mRNA	PMID:30319688
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550118	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MFSD1 mRNA	PMID:39241906
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550118	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MFSD1 mRNA	PMID:39298647
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1346472	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MFSD1 mRNA	PMID:23649840
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550118	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MFSD1 mRNA	PMID:34319233
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MFSD1 mRNA	PMID:26577399
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MFSD1 mRNA	PMID:27523638
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of MFSD1 mRNA	PMID:28522335
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1346472	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MFSD1 gene	PMID:28458013
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1346472	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MFSD1 mRNA	PMID:23649840
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:2663	amiodarone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in decreased expression of MFSD1 mRNA	PMID:17991464
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550118	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MFSD1 mRNA	PMID:31919559
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550118	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MFSD1 mRNA	PMID:40504410
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1346472	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MFSD1 mRNA	PMID:23557933
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550118	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MFSD1 mRNA	PMID:20702594|PMID:21570461
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MFSD1 mRNA	PMID:32109520
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1346472	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MFSD1 mRNA	PMID:28001369
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MFSD1 mRNA	PMID:28959563
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1550118	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MFSD1 mRNA	PMID:15467011
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346472	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MFSD1 mRNA	PMID:29803840
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1346472	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of MFSD1 mRNA	PMID:20044591
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346472	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MFSD1 mRNA	PMID:39719251
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550118	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MFSD1 mRNA	PMID:37682722
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1346472	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MFSD1 mRNA	PMID:38568856
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550118	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MFSD1 mRNA	PMID:40504410
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1346472	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MFSD1 promoter	PMID:27901495
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550118	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MFSD1 mRNA	PMID:19770486
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1550118	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MFSD1 mRNA	PMID:15467011
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550118	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MFSD1 gene	PMID:35295148
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MFSD1 mRNA	PMID:23411599
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550118	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of MFSD1 mRNA	PMID:23811191
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MFSD1 mRNA	PMID:25181051|PMID:34947998
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1346472	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MFSD1 mRNA	PMID:25979313
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1550118	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MFSD1 mRNA	PMID:39298647
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550118	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MFSD1 mRNA	PMID:38685157
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550118	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MFSD1 mRNA	PMID:21266533
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550118	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MFSD1 mRNA	PMID:21266533
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of MFSD1 gene	PMID:33148267
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1346472	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MFSD1 mRNA	PMID:37042841
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550118	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of MFSD1 mRNA	PMID:17585979
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1550118	E	RGD:6480464	20150127	CTD	MESH:D002994	Clofibrate results in increased expression of MFSD1 mRNA	PMID:25270620
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1346472	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MFSD1 mRNA	PMID:40419075
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1346472	E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of MFSD1 mRNA	PMID:17685462
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346472	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MFSD1 mRNA	PMID:25979313
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1346472	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MFSD1 gene	PMID:29154799
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346472	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of MFSD1 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1346472	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MFSD1 mRNA	PMID:27188386
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1346472	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MFSD1 mRNA	PMID:25562108
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550118	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MFSD1 mRNA	PMID:17562736
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1550118	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of MFSD1 mRNA	PMID:17585979
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550118	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MFSD1 mRNA	PMID:29279043
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550118	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MFSD1 mRNA	PMID:40504410
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550118	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MFSD1 mRNA	PMID:25554681
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1550118	E	RGD:6480464	20150127	CTD	MESH:D016559	Tacrolimus results in increased expression of MFSD1 mRNA	PMID:25270620
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550118	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MFSD1 mRNA	PMID:23650126
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1550118	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of MFSD1 mRNA	PMID:25270620
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of MFSD1 mRNA	PMID:24136188
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of MFSD1 gene	PMID:33148267
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550118	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MFSD1 mRNA	PMID:22206623
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MFSD1 mRNA	PMID:24136188
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346472	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MFSD1 mRNA	PMID:27188386
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346472	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MFSD1 gene]	PMID:28238834
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1550118	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of MFSD1 mRNA	PMID:20702594
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1550118	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of MFSD1 mRNA	PMID:38995820
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346472	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MFSD1 mRNA	PMID:27188386
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MFSD1 mRNA	PMID:21346803
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550118	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of MFSD1 mRNA	PMID:35537566
1305751	Mfsd1	major facilitator superfamily domain containing 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MFSD1 mRNA	PMID:22570695
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1313973	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of PSMD2 protein	PMID:36252740
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313972	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PSMD2 mRNA	PMID:38218311
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:149906	Tanshinone I	increases expression	ISO	RGD:1313972	E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone results in increased expression of PSMD2 mRNA	PMID:15849732
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of PSMD2 mRNA	PMID:32845096
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313973	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PSMD2 mRNA	PMID:40945087
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313973	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PSMD2 mRNA	PMID:30319688
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313972	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PSMD2 mRNA	PMID:21632981
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313973	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PSMD2 mRNA	PMID:39241906
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313973	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PSMD2 mRNA	PMID:39298647
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PSMD2 mRNA	PMID:30165855
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16602	trichloroethene	affects expression	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene affects the expression of PSMD2 mRNA	PMID:21135412
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of PSMD2 mRNA	PMID:17945193
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:17303	morphine	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine results in decreased expression of PSMD2 protein	PMID:23056601
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:17303	morphine	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine deficiency inhibits the reaction [Morphine results in decreased expression of PSMD2 protein]	PMID:23056601
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313973	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PSMD2 mRNA	PMID:33754040
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PSMD2 mRNA	PMID:21318169
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313972	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PSMD2 protein	PMID:37730182
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD2 mRNA	PMID:35301059
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313972	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PSMD2 mRNA	PMID:19549813
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PSMD2 protein	PMID:23301498
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313972	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PSMD2 mRNA	PMID:22100608
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of PSMD2 mRNA	PMID:32845096
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of PSMD2 protein	PMID:38598786
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD2 mRNA	PMID:35809665
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD2 mRNA	PMID:40504410
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313972	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PSMD2 protein	PMID:35688186
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313973	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of PSMD2 protein	PMID:37208198
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313972	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PSMD2 mRNA	PMID:28903495
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1313972	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of PSMD2 mRNA	PMID:19921347
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313972	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMD2 mRNA	PMID:22574217
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313973	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMD2 mRNA	PMID:21570461
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD2 mRNA	PMID:17942748
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of PSMD2 protein	PMID:35544339
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313972	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of PSMD2 mRNA	PMID:33512557
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313972	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PSMD2 mRNA	PMID:33212167
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313972	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PSMD2 mRNA	PMID:30851411
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of PSMD2 protein	PMID:29459688
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313972	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PSMD2 mRNA	PMID:34032870|PMID:38568856
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD2 mRNA	PMID:40504410
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313972	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PSMD2 exon	PMID:30157460
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313972	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PSMD2 3' UTR; Benzo(a)pyrene results in increased methylation of PSMD2 promoter	PMID:27901495
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1313973	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of PSMD2 mRNA	PMID:34850242
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of PSMD2 mRNA	PMID:30047161
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313973	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PSMD2 mRNA	PMID:23811191
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:32687	piperonyl butoxide	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of PSMD2 mRNA	PMID:22484513
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PSMD2 mRNA	PMID:25181051
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PSMD2 gene	PMID:28505145
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PSMD2 mRNA	PMID:36041667
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313972	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of PSMD2 mRNA	PMID:19244175
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT affects the expression of PSMD2 mRNA	PMID:17984292
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of PSMD2 mRNA	PMID:24096037
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1313973	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of PSMD2 mRNA	PMID:24096037
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313972	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PSMD2 protein	PMID:34186270
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313973	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PSMD2 mRNA	PMID:39298647
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PSMD2 mRNA	PMID:36041667
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PSMD2 mRNA	PMID:28628672
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein	PMID:34896426
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313973	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PSMD2 mRNA	PMID:38685157
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PSMD2 mRNA	PMID:36041667
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD2 protein	PMID:38598786
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PSMD2 mRNA	PMID:28628672
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313972	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PSMD2 mRNA	PMID:37042841
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313973	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PSMD2 mRNA	PMID:18974090
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD2 mRNA	PMID:35301059
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of PSMD2 mRNA	PMID:19429403
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313972	E	RGD:6480464	20121009	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PSMD2 protein	PMID:22609092
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PSMD2 mRNA	PMID:19162173|PMID:21318169|PMID:30047161
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313972	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PSMD2 mRNA	PMID:19320972|PMID:19376846
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1313972	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of PSMD2 protein	PMID:17152098
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone promotes the reaction [NDRG1 protein binds to PSMD2 protein]	PMID:17220478
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of PSMD2 protein	PMID:34896426
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of PSMD2 mRNA	PMID:19429403
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313973	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PSMD2 mRNA	PMID:20936131
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313973	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of PSMD2 mRNA	PMID:31558096
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMD2 mRNA	PMID:21318169
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313972	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMD2 mRNA	PMID:23179753
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PSMD2 mRNA	PMID:30047161
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313972	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PSMD2 mRNA	PMID:20106945|PMID:25562108
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein	PMID:34896426
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein	PMID:34896426
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1313972	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of PSMD2 mRNA	PMID:33512557
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PSMD2 mRNA	PMID:28628672
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PSMD2 mRNA	PMID:24136188
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313972	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PSMD2 mRNA	PMID:38832940
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD2 mRNA	PMID:35809665
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD2 mRNA	PMID:40504410
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1313973	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of PSMD2 mRNA	PMID:26934552
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PSMD2 mRNA	PMID:24096037
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313973	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PSMD2 mRNA	PMID:24096037
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD2 mRNA	PMID:17942748
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1313972	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of PSMD2 mRNA	PMID:17211630
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PSMD2 mRNA	PMID:28628672
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein	PMID:34896426
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PSMD2 mRNA	PMID:24136188
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of PSMD2 mRNA	PMID:30047161
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PSMD2 mRNA	PMID:24136188
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313973	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PSMD2 mRNA	PMID:19042947
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313972	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PSMD2 protein	PMID:32959892
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PSMD2 mRNA	PMID:24136188
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:63952	arsenic trichloride	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD2 mRNA	PMID:35809665
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of PSMD2 mRNA	PMID:24136188
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:64317	isoprenaline	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD2 mRNA	PMID:30303030
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313972	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PSMD2 protein	PMID:34186270
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313973	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PSMD2 mRNA	PMID:22206623
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:74926	patulin	increases expression	ISO	RGD:1313973	E	RGD:6480464	20221101	CTD	MESH:D010365	Patulin results in increased expression of PSMD2 mRNA	PMID:35367319
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:74926	patulin	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20221101	CTD	MESH:D010365	NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMD2 mRNA]	PMID:35367319
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PSMD2 mRNA	PMID:24136188
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313972	E	RGD:6480464	20210406	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMD2 mRNA	PMID:31806706
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313972	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PSMD2 protein	PMID:31285264
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313972	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PSMD2 protein	PMID:39638853
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1313972	E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of PSMD2 protein	PMID:39638853
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313972	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PSMD2 mRNA	PMID:30851411
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:79369	elesclomol	increases expression	ISO	RGD:1313972	E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of PSMD2 mRNA	PMID:18723479
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313973	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PSMD2 mRNA	PMID:30294300
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1313972	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of PSMD2 mRNA	PMID:33512557
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:8493	Propiverine	affects binding	EXP		E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine binds to PSMD2 protein	PMID:29273565
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of PSMD2 mRNA	PMID:30047161
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313972	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PSMD2 mRNA	PMID:38568856
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313972	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of PSMD2 protein	PMID:38598786
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PSMD2 mRNA	PMID:21346803
1305752	Psmd2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PSMD2 mRNA	PMID:23034163
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313974	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZKSCAN3 mRNA	PMID:35811015
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZKSCAN3 mRNA	PMID:39241906
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313974	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ZKSCAN3 mRNA	PMID:35811015
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:16551	alpha,alpha-trehalose	increases expression	ISO	RGD:1614314	E	RGD:6480464	20210608	CTD	MESH:D014199	Trehalose results in increased expression of ZKSCAN3 mRNA	PMID:30335591
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313974	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZKSCAN3 mRNA	PMID:37042841
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of ZKSCAN3 mRNA	PMID:27462272
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614314	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZKSCAN3 mRNA	PMID:37325564
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313974	E	RGD:6480464	20131220	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZKSCAN3 mRNA	PMID:19549813
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313974	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZKSCAN3 gene	PMID:27153756
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:27452	styrene	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20180116	CTD	MESH:D020058	Styrene results in decreased expression of ZKSCAN3 mRNA	PMID:28951217
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of ZKSCAN3 mRNA	PMID:25905778
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:28053	melibiose	increases expression	ISO	RGD:1614314	E	RGD:6480464	20210608	CTD	MESH:D008553	Melibiose results in increased expression of ZKSCAN3 mRNA	PMID:30335591
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313974	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ZKSCAN3 mRNA	PMID:24768652
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614314	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZKSCAN3 mRNA	PMID:21570461|PMID:24058054
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313974	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZKSCAN3 mRNA	PMID:32763439
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614314	E	RGD:6480464	20131220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZKSCAN3 mRNA	PMID:22228805
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313974	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of ZKSCAN3 gene	PMID:31601247
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ZKSCAN3 mRNA	PMID:30047161
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614314	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZKSCAN3 gene; titanium dioxide results in decreased methylation of ZKSCAN3 promoter	PMID:35295148
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1614314	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of ZKSCAN3 mRNA	PMID:29264374
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33146	vanadyl sulfate	increases expression	ISO	RGD:1313974	E	RGD:6480464	20131220	CTD	MESH:C034028	vanadyl sulfate results in increased expression of ZKSCAN3 mRNA	PMID:16330358
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ZKSCAN3 mRNA	PMID:32156529
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313974	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZKSCAN3 gene	PMID:31601247
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZKSCAN3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1614314	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZKSCAN3 mRNA	PMID:33221593|PMID:38074096
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313974	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of ZKSCAN3 gene	PMID:31601247
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ZKSCAN3 mRNA	PMID:38685157
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313974	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZKSCAN3 mRNA	PMID:37042841
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313974	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZKSCAN3 mRNA	PMID:38568856
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614314	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZKSCAN3 mRNA	PMID:37325564
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313974	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ZKSCAN3 mRNA	PMID:40419075
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313974	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZKSCAN3 mRNA	PMID:25979313
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313974	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZKSCAN3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313974	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZKSCAN3 mRNA	PMID:27188386
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZKSCAN3 mRNA	PMID:30047161
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313974	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZKSCAN3 mRNA	PMID:25562108
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1614314	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ZKSCAN3 mRNA	PMID:28973697
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313974	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of ZKSCAN3 mRNA	PMID:24449571
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ZKSCAN3 mRNA	PMID:24136188
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1313974	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ZKSCAN3 mRNA	PMID:24935251
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614314	E	RGD:6480464	20131220	CTD	MESH:D000082	Acetaminophen affects the expression of ZKSCAN3 mRNA	PMID:17562736
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:46345	5-fluorouracil	decreases response to substance	ISO	RGD:1313974	E	RGD:6480464	20131220	CTD	MESH:D005472	ZKSCAN3 protein results in decreased susceptibility to Fluorouracil	PMID:18519692
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313974	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ZKSCAN3 mRNA	PMID:35811015
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ZKSCAN3 mRNA	PMID:29279043
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ZKSCAN3 mRNA	PMID:35436446
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ZKSCAN3 mRNA	PMID:25554681
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614314	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ZKSCAN3 mRNA	PMID:25620056
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZKSCAN3 mRNA	PMID:30047161
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of ZKSCAN3 mRNA	PMID:26377693
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:6359	lactulose	increases expression	ISO	RGD:1614314	E	RGD:6480464	20210608	CTD	MESH:D007792	Lactulose results in increased expression of ZKSCAN3 mRNA	PMID:30335591
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313974	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ZKSCAN3 mRNA	PMID:31758290
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ZKSCAN3 mRNA	PMID:24136188
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313974	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZKSCAN3 mRNA	PMID:27188386
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1614314	E	RGD:6480464	20131220	CTD	MESH:D010634	Phenobarbital affects the expression of ZKSCAN3 mRNA	PMID:23091169
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1614314	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ZKSCAN3 mRNA	PMID:21795629
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of ZKSCAN3 mRNA	PMID:30047161
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZKSCAN3 mRNA	PMID:30047161
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313974	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZKSCAN3 mRNA	PMID:27188386
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20131220	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ZKSCAN3 mRNA	PMID:21346803
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313974	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZKSCAN3 mRNA	PMID:29301935
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20131220	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZKSCAN3 mRNA	PMID:21346803
1305753	Zkscan3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ZKSCAN3 mRNA	PMID:18042343
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TTPAL mRNA]	PMID:31150632
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313977	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TTPAL mRNA	PMID:20188158
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TTPAL mRNA	PMID:36331819
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313976	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of TTPAL mRNA	PMID:24763279
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TTPAL mRNA	PMID:22378314
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313977	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TTPAL mRNA	PMID:30319688
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313977	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TTPAL mRNA	PMID:39241906
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313977	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TTPAL mRNA	PMID:39298647
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of TTPAL mRNA	PMID:26496021
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313976	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of TTPAL mRNA	PMID:30165855
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313976	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TTPAL mRNA	PMID:37042841
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of TTPAL mRNA	PMID:33848595
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of TTPAL mRNA]	PMID:33848595
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1313977	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of TTPAL gene	PMID:34319233
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TTPAL mRNA	PMID:26577399
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TTPAL mRNA	PMID:22061828|PMID:33387578
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TTPAL mRNA	PMID:28818685
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TTPAL mRNA	PMID:36331819
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTPAL mRNA	PMID:28111341|PMID:37325564
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313977	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TTPAL mRNA	PMID:19770486
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TTPAL mRNA	PMID:30779732
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TTPAL mRNA	PMID:31150632
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TTPAL mRNA]	PMID:31150632
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1313976	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TTPAL gene	PMID:25304211
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTPAL mRNA	PMID:40504410
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TTPAL mRNA	PMID:28960355
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313976	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TTPAL mRNA	PMID:23557933
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313977	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTPAL mRNA	PMID:21570461
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TTPAL mRNA	PMID:25975270
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TTPAL mRNA	PMID:30851411
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TTPAL mRNA	PMID:28959563
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTPAL mRNA	PMID:38568856
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTPAL mRNA	PMID:40504410
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313977	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTPAL mRNA	PMID:22228805
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313976	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TTPAL 5' UTR; Benzo(a)pyrene results in increased methylation of TTPAL promoter	PMID:27901495
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TTPAL mRNA	PMID:25351596
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313976	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TTPAL mRNA	PMID:19150397
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of TTPAL mRNA	PMID:34408198
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TTPAL mRNA	PMID:35984750
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TTPAL mRNA	PMID:29264374
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313977	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TTPAL gene	PMID:35295148
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TTPAL mRNA	PMID:23411599|PMID:34492290
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313976	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TTPAL mRNA	PMID:19710929
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TTPAL mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TTPAL mRNA	PMID:26063408
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of TTPAL mRNA	PMID:26496021
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313977	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TTPAL mRNA	PMID:39298647
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313976	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTPAL mRNA	PMID:28628672
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1313976	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TTPAL gene	PMID:22964155
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313976	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTPAL mRNA	PMID:28628672
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313976	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TTPAL mRNA	PMID:37042841
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of TTPAL mRNA	PMID:30589522
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of TTPAL mRNA	PMID:35163327
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTPAL mRNA	PMID:28111341|PMID:37325564
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313977	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TTPAL mRNA	PMID:28903501
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TTPAL mRNA	PMID:24449571
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313976	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TTPAL mRNA	PMID:28302478
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TTPAL mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TTPAL mRNA	PMID:36331819
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313976	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TTPAL mRNA	PMID:23179753
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TTPAL mRNA	PMID:25562108|PMID:27989131
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:41607	crotonaldehyde	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of TTPAL mRNA	PMID:20471460
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313976	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTPAL mRNA	PMID:28628672
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TTPAL mRNA	PMID:28973697
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313977	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TTPAL mRNA	PMID:17562736
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TTPAL mRNA	PMID:33387578
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313976	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TTPAL mRNA	PMID:22230336
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1313976	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TTPAL gene	PMID:25304211
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTPAL mRNA	PMID:40504410
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313976	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTPAL mRNA	PMID:28628672
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313977	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TTPAL mRNA; Nanotubes, Carbon results in increased expression of TTPAL mRNA	PMID:25554681|PMID:25620056
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:50819	ferric oxide	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in decreased expression of TTPAL mRNA	PMID:25086211
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TTPAL mRNA	PMID:35964746
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:52717	bortezomib	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of TTPAL mRNA	PMID:20977926
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TTPAL mRNA	PMID:28988120
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:6809	methamphetamine	decreases methylation	ISO	RGD:1313977	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased methylation of TTPAL promoter	PMID:26307267
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of TTPAL mRNA	PMID:23665939
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TTPAL mRNA	PMID:30851411
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TTPAL mRNA	PMID:38568856
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313976	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TTPAL mRNA	PMID:29301935
1305754	Ttpal	alpha tocopherol transfer protein like	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TTPAL mRNA	PMID:23034163
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1606124	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZDHHC20 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZDHHC20 mRNA	PMID:32699268
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1553018	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ZDHHC20 mRNA	PMID:36331819
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:16130	DDT	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of ZDHHC20 mRNA	PMID:30207508
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1553018	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ZDHHC20 mRNA	PMID:30319688
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1553018	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ZDHHC20 mRNA	PMID:30319688
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1606124	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ZDHHC20 mRNA	PMID:29581250
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1553018	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZDHHC20 mRNA	PMID:39241906
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1553018	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of ZDHHC20 mRNA	PMID:28973375
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553018	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ZDHHC20 mRNA	PMID:33754040
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1606124	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZDHHC20 protein	PMID:37730182
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ZDHHC20 mRNA	PMID:22061828
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553018	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ZDHHC20 mRNA	PMID:36331819
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1553018	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZDHHC20 mRNA	PMID:37236586
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1606124	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZDHHC20 mRNA	PMID:19549813
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606124	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZDHHC20 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZDHHC20 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ZDHHC20 mRNA	PMID:32699268
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1553018	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZDHHC20 mRNA	PMID:27339419|PMID:31919559
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1553018	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZDHHC20 mRNA	PMID:40504410
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of ZDHHC20 gene	PMID:35440735
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1553018	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of ZDHHC20 mRNA	PMID:35897073
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ZDHHC20 mRNA	PMID:31881176
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553018	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZDHHC20 mRNA	PMID:21570461
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZDHHC20 mRNA	PMID:33387578
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553018	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZDHHC20 mRNA	PMID:15034205
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553018	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ZDHHC20 mRNA]	PMID:15034205
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1606124	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ZDHHC20 mRNA	PMID:28001369
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606124	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZDHHC20 mRNA	PMID:33212167
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1606124	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZDHHC20 mRNA	PMID:32763439
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606124	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZDHHC20 mRNA	PMID:29803840
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1606124	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ZDHHC20 protein	PMID:35688186
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1606124	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ZDHHC20 mRNA	PMID:25523186
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1553018	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZDHHC20 mRNA	PMID:40504410
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1606124	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZDHHC20 mRNA	PMID:20106945
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606124	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZDHHC20 promoter	PMID:27901495
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1553018	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZDHHC20 mRNA	PMID:15034205|PMID:19770486
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1553018	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of ZDHHC20 mRNA]	PMID:15034205
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1606124	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ZDHHC20 mRNA	PMID:25523186
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1553018	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ZDHHC20 mRNA	PMID:39716349
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553018	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZDHHC20 promoter	PMID:35295148
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZDHHC20 mRNA	PMID:34492290
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZDHHC20 gene	PMID:28505145
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1606124	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ZDHHC20 gene	PMID:31601247
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1553018	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of ZDHHC20 mRNA	PMID:26682919
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:34631	chlorpyrifos	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZDHHC20 mRNA	PMID:18668222
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606124	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZDHHC20 mRNA	PMID:37042841
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553018	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZDHHC20 mRNA	PMID:37236586
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ZDHHC20 gene	PMID:22079235
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1606124	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZDHHC20 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZDHHC20 mRNA	PMID:32699268
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1606124	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZDHHC20 mRNA	PMID:28302478
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1606124	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ZDHHC20 mRNA	PMID:40419075
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553018	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ZDHHC20 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ZDHHC20 mRNA	PMID:36331819
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ZDHHC20 mRNA	PMID:23125180
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1606124	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of ZDHHC20 mRNA	PMID:25562108
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1553018	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ZDHHC20 mRNA	PMID:28973697
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1606124	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of ZDHHC20 mRNA	PMID:16595896
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553018	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZDHHC20 mRNA	PMID:17562736
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZDHHC20 mRNA	PMID:33387578
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1553018	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZDHHC20 mRNA	PMID:40504410
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1553018	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ZDHHC20 mRNA	PMID:39716349
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of ZDHHC20 mRNA	PMID:25729387
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1553018	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ZDHHC20 mRNA	PMID:23650126
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553018	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZDHHC20 mRNA	PMID:22206623
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606124	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZDHHC20 gene]	PMID:28238834
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:91642	2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester	multiple interactions	ISO	RGD:1606124	E	RGD:6480464	20240702	CTD	MESH:C060446	[homosalate co-treated with Polystyrenes] results in increased expression of ZDHHC20 mRNA	PMID:38381479
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1606124	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ZDHHC20 mRNA	PMID:29301935
1305755	Zdhhc20	zDHHC palmitoyltransferase 20	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ZDHHC20 mRNA	PMID:19015723
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:10101	zalcitabine	increases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D016047	Zalcitabine results in increased expression of TYMP protein	PMID:16457948
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:10110	zidovudine	increases activity	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D015215	Zidovudine results in increased activity of TYMP protein	PMID:16457948
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D015215	Zidovudine results in increased expression of TYMP mRNA; Zidovudine results in increased expression of TYMP protein	PMID:16457948
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D015215	[5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] results in decreased susceptibility to [Zidovudine co-treated with doxifluridine]; [Zidovudine results in increased activity of TYMP protein] which results in increased susceptibility to doxifluridine	PMID:16457948
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:11563	2-deoxy-alpha-D-ribose 1-phosphate	increases abundance	ISO	RGD:1313979	E	RGD:6480464	20140805	CTD	MESH:C031302	TYMP protein results in increased abundance of 2-deoxyribose 1-phosphate	PMID:11103787
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D001241	Aspirin results in decreased expression of TYMP mRNA	PMID:15456535
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D001241	Aspirin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA]	PMID:14573775
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D010100	[Thymidine co-treated with TYMP co-treated with Oxygen deficiency] results in increased expression of HIF1A protein	PMID:15841086
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20130618	CTD	MESH:C029424	hydrazine results in decreased expression of TYMP mRNA	PMID:15282401
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:15640	5-formyltetrahydrofolic acid	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D002955	TYMP mRNA affects the susceptibility to [irinotecan co-treated with Fluorouracil co-treated with Leucovorin]	PMID:17454858
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of TYMP mRNA	PMID:39506029
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313979	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TYMP mRNA	PMID:35811015
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TYMP mRNA]	PMID:35811015
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313979	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of TYMP mRNA	PMID:30510588
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of SCO2 mRNA; Estradiol affects the expression of TYMP mRNA	PMID:32145629
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313980	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TYMP mRNA	PMID:39298647
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of TYMP mRNA	PMID:38568856
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TYMP mRNA	PMID:33387578
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313979	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TYMP mRNA	PMID:18045764|PMID:23649840
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TYMP mRNA	PMID:37992649
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of TYMP mRNA	PMID:33359661
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D013739	Testosterone results in increased expression of TYMP mRNA	PMID:21592394
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of TYMP mRNA	PMID:21592394
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17579	beta-carotene	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20140909	CTD	MESH:D019207	[BCO1 protein affects the susceptibility to beta Carotene] which affects the expression of TYMP mRNA	PMID:24657404
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:175901	gemcitabine	affects response to substance	ISO	RGD:1313979	E	RGD:6480464	20230207	CTD	MESH:C056507	TYMP protein affects the susceptibility to Gemcitabine	PMID:18728667
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:175901	gemcitabine	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20230207	CTD	MESH:C056507	[TYMP protein co-treated with DPYD protein] affects the susceptibility to Gemcitabine; TYMP protein affects the susceptibility to [Gemcitabine co-treated with Mitomycin]	PMID:18728667
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TYMP mRNA	PMID:37992649
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17748	thymidine	increases phosphorylation	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D013936	TYMP protein results in increased phosphorylation of Thymidine	PMID:11103787
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17748	thymidine	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D013936	[Thymidine co-treated with TYMP co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; [Thymidine co-treated with TYMP protein] results in increased expression of HMOX1 protein; [Thymidine co-treated with TYMP protein] results in increased expression of MMP1 protein; [Thymidine co-treated with TYMP protein] results in increased secretion of CXCL8 protein; [TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein; Acetylcysteine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein]; Thymine inhibits the reaction [[Thymidine co-treated with TYMP protein] results in increased expression of MMP1 protein]; Thymine inhibits the reaction [[Thymidine co-treated with TYMP protein] results in increased secretion of CXCL8 protein]; Thymine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein]	PMID:11103787|PMID:15841086
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TYMP mRNA	PMID:26577399
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17821	thymine	increases abundance	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D013941	TYMP protein results in increased abundance of Thymine	PMID:11103787
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17821	thymine	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D013941	Thymine inhibits the reaction [[Thymidine co-treated with TYMP protein] results in increased expression of MMP1 protein]; Thymine inhibits the reaction [[Thymidine co-treated with TYMP protein] results in increased secretion of CXCL8 protein]; Thymine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein]	PMID:11103787
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D002117	Calcitriol results in increased expression of TYMP mRNA	PMID:21592394
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of TYMP mRNA	PMID:21592394
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TYMP mRNA	PMID:36331819
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of TYMP mRNA	PMID:21346803
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:2423	acetylleucyl-leucyl-norleucinal	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:C063261	acetylleucyl-leucyl-norleucinal inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; acetylleucyl-leucyl-norleucinal inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]	PMID:21444628|PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20130618	CTD	MESH:D010126	Ozone results in decreased expression of TYMP mRNA	PMID:12763052
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TYMP mRNA	PMID:35430440
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TYMP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TYMP protein	PMID:38598786
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TYMP mRNA	PMID:22206623
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D016685	Mitomycin results in decreased expression of TYMP mRNA	PMID:16568373
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27504	mitomycin C	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D016685	TYMP protein affects the susceptibility to [Gemcitabine co-treated with Mitomycin]	PMID:18728667
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D012643	Selenium results in increased expression of TYMP mRNA	PMID:19244175
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27641	cycloheximide	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20190702	CTD	MESH:D003513	Cycloheximide results in decreased expression of TYMP protein	PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20190702	CTD	MESH:D003513	salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]; tanespimycin inhibits the reaction [salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]]	PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D003609	Dactinomycin inhibits the reaction [IFNA1 protein results in increased expression of TYMP mRNA]; Dactinomycin inhibits the reaction [IFNB1 protein results in increased expression of TYMP mRNA]; Dactinomycin inhibits the reaction [IFNG protein results in increased expression of TYMP mRNA]; Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]; tanespimycin inhibits the reaction [Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]]	PMID:15937643|PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of TYMP gene	PMID:31011160
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TYMP mRNA	PMID:31881176
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27899	cisplatin	decreases degradation	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D002945	Cisplatin results in decreased degradation of TYMP protein	PMID:21444628
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D002945	Cisplatin results in decreased expression of TYMP mRNA	PMID:16568373|PMID:27392435
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27899	cisplatin	decreases response to substance	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D002945	TYMP protein results in decreased susceptibility to Cisplatin	PMID:21444628
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D002945	[Curcumin results in decreased expression of TYMP protein] which results in increased susceptibility to Cisplatin; [Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein; [TYMP protein co-treated with DPYD protein] affects the susceptibility to Cisplatin; acetylleucyl-leucyl-norleucinal inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; TYMP inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; TYMP inhibits the reaction [Cisplatin results in increased activity of CASP9 protein]; TYMP protein inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; TYMP protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein]; U 0126 inhibits the reaction [Cisplatin results in decreased degradation of TYMP protein]	PMID:12565868|PMID:14727531|PMID:18728667|PMID:21444628|PMID:21493726
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313979	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TYMP mRNA	PMID:25583101
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TYMP mRNA	PMID:32109520
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TYMP mRNA	PMID:28922406
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TYMP mRNA	PMID:28374803
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:28445	vincristine	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20161213	CTD	MESH:D014750	TYMP inhibits the reaction [Vincristine results in increased phosphorylation of BCL2 protein]	PMID:15907805
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:28542	2-deoxy-D-ribofuranose 1-phosphate	increases abundance	ISO	RGD:1313979	E	RGD:6480464	20140805	CTD	MESH:C031302	TYMP protein results in increased abundance of 2-deoxyribose 1-phosphate	PMID:11103787
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:28584	gossypol	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20141111	CTD	MESH:D006072	Gossypol inhibits the reaction [zoledronic acid results in increased expression of TYMP mRNA]	PMID:19825521
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D004317	[Doxorubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein	PMID:15150550
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TYMP mRNA	PMID:37992649
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein]	PMID:11103787
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:2930	aurothioglucose	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20141111	CTD	MESH:D006051	[Dexamethasone co-treated with Aurothioglucose] inhibits the reaction [IL1B protein results in increased expression of TYMP mRNA]	PMID:15990992
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313979	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TYMP mRNA	PMID:38568856|PMID:39719251
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313979	E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TYMP protein	PMID:33278487
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313979	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TYMP 5' UTR; Benzo(a)pyrene results in increased methylation of TYMP exon; Benzo(a)pyrene results in increased methylation of TYMP promoter	PMID:27901495
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of TYMP mRNA	PMID:26014281
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313979	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TYMP mRNA	PMID:25351596
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to TYMP protein]	PMID:26598702
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TYMP mRNA	PMID:35984750
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1313980	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in increased expression of TYMP protein	PMID:30825431
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of TYMP protein]	PMID:30825431
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	affects expression	ISO	RGD:1313979	E	RGD:6480464	20130806	CTD	MESH:C025034	doxifluridine affects the expression of TYMP mRNA	PMID:18630517
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	increases metabolic processing	EXP		E	RGD:6480464	20130806	CTD	MESH:C025034	TYMP protein results in increased metabolism of doxifluridine	PMID:21804305
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	increases metabolic processing	ISO	RGD:1313979	E	RGD:6480464	20130806	CTD	MESH:C025034	TYMP protein results in increased metabolism of doxifluridine	PMID:21804305
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	increases metabolic processing	ISO	RGD:1313980	E	RGD:6480464	20130806	CTD	MESH:C025034	TYMP protein results in increased metabolism of doxifluridine	PMID:21804305
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	increases response to substance	ISO	RGD:1313979	E	RGD:6480464	20130806	CTD	MESH:C025034	TYMP protein results in increased susceptibility to doxifluridine	PMID:15864645
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130806	CTD	MESH:C025034	[5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] results in decreased susceptibility to [Zidovudine co-treated with doxifluridine]; [5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] which results in decreased susceptibility to doxifluridine; [IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to doxifluridine; [Paclitaxel co-treated with doxifluridine] affects the expression of TYMP mRNA; [TYMP protein results in increased expression of IFNA1 mRNA] which results in increased susceptibility to doxifluridine; [Zidovudine results in increased activity of TYMP protein] which results in increased susceptibility to doxifluridine; doxifluridine promotes the reaction [TNF protein results in increased expression of TYMP mRNA]	PMID:15301717|PMID:16457948|PMID:17988526|PMID:18630517
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:31941	oxaliplatin	affects response to substance	ISO	RGD:1313979	E	RGD:6480464	20161213	CTD	MESH:C030110	TYMP protein affects the susceptibility to oxaliplatin	PMID:18728667
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20161213	CTD	MESH:C030110	[TYMP protein co-treated with DPYD protein] affects the susceptibility to oxaliplatin	PMID:18728667
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313980	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TYMP mRNA	PMID:23557971|PMID:29264374
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of TYMP mRNA	PMID:23411599|PMID:34492290
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:32497	thioacetamide	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of TYMP mRNA	PMID:28943392
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313980	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TYMP mRNA	PMID:17426115|PMID:18445702|PMID:23811191
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313980	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TYMP mRNA	PMID:28472532
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1313979	E	RGD:6480464	20180116	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of TYMP protein	PMID:28596144
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313979	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TYMP mRNA	PMID:30903817
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:C006780	bisphenol A results in decreased expression of TYMP mRNA	PMID:20678512
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TYMP mRNA	PMID:33221593
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TYMP mRNA	PMID:25181051
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313979	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of TYMP protein	PMID:34186270
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TYMP gene	PMID:28505145
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1313979	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of TYMP mRNA	PMID:19244175
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313980	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of TYMP mRNA	PMID:39298647
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313979	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of TYMP protein	PMID:34186270
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313980	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TYMP mRNA	PMID:37019170
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313980	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of TYMP mRNA	PMID:34813904
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TYMP protein	PMID:38598786
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TYMP mRNA	PMID:34813904
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of TYMP mRNA	PMID:28943392
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:34892	nocodazole	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D015739	[TYMP co-treated with Nocodazole] results in decreased expression of FASLG mRNA; [TYMP co-treated with Nocodazole] results in decreased expression of FASLG protein; TYMP affects the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK1 protein]; TYMP affects the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK3 protein]; TYMP inhibits the reaction [Nocodazole results in increased cleavage of PARP1 protein]; TYMP inhibits the reaction [Nocodazole results in increased phosphorylation of BCL2 protein]	PMID:15907805
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313979	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TYMP mRNA	PMID:37042841
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of TYMP mRNA	PMID:26377693
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of TYMP mRNA	PMID:30723492
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TYMP mRNA	PMID:38174414|PMID:38568856
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20130618	CTD	MESH:C039281	furan results in increased methylation of TYMP gene	PMID:22079235
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TYMP mRNA	PMID:24449571
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D012643	Selenium results in increased expression of TYMP mRNA	PMID:19244175
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases activity	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased activity of TYMP protein	PMID:14573775
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA	PMID:14573775
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D013755	Aspirin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA]; TNF affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA]	PMID:14573775
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:38221	fumonisin B1	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20130618	CTD	MESH:C056933	fumonisin B1 results in decreased expression of TYMP mRNA	PMID:16221962
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TYMP mRNA	PMID:36331819
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D003474	Curcumin results in decreased expression of TYMP mRNA; Curcumin results in decreased expression of TYMP protein	PMID:21493726
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D003474	[Curcumin results in decreased expression of TYMP protein] which results in increased susceptibility to Cisplatin	PMID:21493726
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313979	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TYMP gene	PMID:29154799
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D003520	[Doxorubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein; [Epirubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein	PMID:15150550
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D016572	Cyclosporine results in increased expression of TYMP mRNA	PMID:20106945
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D003907	[Dexamethasone co-treated with Aurothioglucose] inhibits the reaction [IL1B protein results in increased expression of TYMP mRNA]	PMID:15990992
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TYMP mRNA	PMID:37992649
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:43602	obeticholic acid	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of TYMP mRNA	PMID:27939613
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313979	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TYMP mRNA	PMID:38832940
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1313979	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of TYMP mRNA; Paclitaxel results in increased expression of TYMP protein	PMID:15492279|PMID:18630517
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20161213	CTD	MESH:D017239	[Paclitaxel co-treated with doxifluridine] affects the expression of TYMP mRNA; [TYMP mutant form co-treated with Paclitaxel] results in increased cleavage of CASP8 protein; TYMP inhibits the reaction [Paclitaxel results in increased cleavage of PARP1 protein]; TYMP inhibits the reaction [Paclitaxel results in increased expression of FASLG mRNA]; TYMP inhibits the reaction [Paclitaxel results in increased expression of FASLG protein]; TYMP inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]; TYMP mutant form promotes the reaction [Paclitaxel results in increased cleavage of CASP3 protein]; TYMP mutant form promotes the reaction [Paclitaxel results in increased cleavage of PARP1 protein]	PMID:15492279|PMID:15907805|PMID:18630517
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313980	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of TYMP mRNA	PMID:17562736
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen results in decreased expression of TYMP mRNA	PMID:21420995
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TYMP mRNA	PMID:33387578
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D005472	TYMP protein affects the susceptibility to Fluorouracil	PMID:15041737|PMID:15538739|PMID:15655543|PMID:16160472
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D005472	Fluorouracil results in decreased expression of TYMP mRNA	PMID:16568373
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:46345	5-fluorouracil	decreases response to substance	ISO	RGD:1313980	E	RGD:6480464	20130618	CTD	MESH:D005472	TYMP mRNA results in decreased susceptibility to Fluorouracil	PMID:16525674
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D005472	[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein; [IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to Fluorouracil; acetylleucyl-leucyl-norleucinal inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; TYMP mRNA affects the susceptibility to [irinotecan co-treated with Fluorouracil co-treated with Leucovorin]	PMID:15301717|PMID:17454858|PMID:21444628
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1313979	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TYMP mRNA	PMID:19825521
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:46557	zoledronic acid	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20161213	CTD	MESH:C088658	Gossypol inhibits the reaction [zoledronic acid results in increased expression of TYMP mRNA]	PMID:19825521
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TYMP mRNA]	PMID:35811015
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:47898	4'-epidoxorubicin	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D015251	[Epirubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein	PMID:15150550
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TYMP mRNA	PMID:15953391
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to TYMP protein]	PMID:26598702
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of TYMP mRNA	PMID:23962444
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:C029938	nickel sulfate results in decreased expression of TYMP mRNA	PMID:18832182
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:53001	nickel sulfate	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:C029938	[macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in decreased expression of TYMP mRNA	PMID:18832182
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TYMP mRNA	PMID:38701926
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TYMP protein	PMID:32959892
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:63581	stavudine	increases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D018119	Stavudine results in increased expression of TYMP protein	PMID:16457948
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:63616	pemetrexed	increases response to substance	ISO	RGD:1313979	E	RGD:6480464	20170303	CTD	MESH:C085586	TYMP protein results in increased susceptibility to Pemetrexed	PMID:17575230
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:6382	Lasiocarpine	increases expression	ISO	RGD:1313979	E	RGD:6480464	20190219	CTD	MESH:C005136	lasiocarpine metabolite results in increased expression of TYMP mRNA	PMID:30465738
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313980	E	RGD:6480464	20130618	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TYMP mRNA	PMID:14729362
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:64153	tanespimycin	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20190702	CTD	MESH:C112765	tanespimycin results in decreased expression of TYMP mRNA; tanespimycin results in decreased expression of TYMP protein	PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:64153	tanespimycin	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20190702	CTD	MESH:C112765	[salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA]; [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein]; [tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA; acetylleucyl-leucyl-norleucinal inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]; SB 203580 promotes the reaction [[tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA]; tanespimycin inhibits the reaction [Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]]; tanespimycin inhibits the reaction [salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]]; tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP mRNA]; tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]	PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of TYMP protein]	PMID:30825431
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313979	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TYMP mRNA	PMID:31758290
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TYMP mRNA	PMID:22206623
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]	PMID:21444628|PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20260714	CTD	MESH:D000077143	[FEC protocol co-treated with Docetaxel] results in increased expression of TYMP protein	PMID:15150550
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in increased expression of TYMP mRNA	PMID:26720608
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of TYMP promoter	PMID:27415467
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of TYMP mRNA	PMID:21346803
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:80025	Salinomycin	decreases response to substance	ISO	RGD:1313979	E	RGD:6480464	20190702	CTD	MESH:C010327	TYMP protein results in decreased susceptibility to salinomycin	PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:80025	Salinomycin	increases expression	ISO	RGD:1313979	E	RGD:6480464	20190702	CTD	MESH:C010327	salinomycin results in increased expression of TYMP mRNA; salinomycin results in increased expression of TYMP protein	PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:80025	Salinomycin	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20190702	CTD	MESH:C010327	[salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA]; [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein]; [tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA; acetylleucyl-leucyl-norleucinal inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]; Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]; salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]; SB 203580 inhibits the reaction [salinomycin results in increased expression of TYMP mRNA]; SB 203580 promotes the reaction [[tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA]; tanespimycin inhibits the reaction [Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]]; tanespimycin inhibits the reaction [salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]]; tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP mRNA]; tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]	PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:80630	irinotecan	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20181113	CTD	MESH:D000077146	TYMP mRNA affects the susceptibility to [Irinotecan co-treated with Fluorouracil co-treated with Leucovorin]	PMID:17454858
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital results in decreased expression of TYMP mRNA	PMID:19482888
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20130618	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of TYMP mRNA]	PMID:19482888
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:8093	phenylephrine	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D010656	Phenylephrine results in decreased expression of SCO2 protein	PMID:25107896
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:8093	phenylephrine	multiple interactions	EXP		E	RGD:6480464	20260811	CTD	MESH:D010656	VEGFA protein inhibits the reaction [Phenylephrine results in decreased expression of SCO2 protein]	PMID:25107896
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20130618	CTD	MESH:C045950	propiconazole results in decreased expression of TYMP mRNA	PMID:21278054
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of TYMP mRNA	PMID:31734321
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:90705	SB 203580	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20190702	CTD	MESH:C093642	SB 203580 results in decreased expression of TYMP mRNA	PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20190702	CTD	MESH:C093642	SB 203580 inhibits the reaction [salinomycin results in increased expression of TYMP mRNA]; SB 203580 promotes the reaction [[tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA]	PMID:30796972
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of TYMP mRNA	PMID:26014281
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20130618	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TYMP mRNA	PMID:21346803
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:9334	sulfasalazine	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D012460	Sulfasalazine results in decreased expression of TYMP mRNA	PMID:15269287
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:9334	sulfasalazine	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20130618	CTD	MESH:D012460	Sulfasalazine inhibits the reaction [IFNG protein results in increased activity of TYMP protein]; Sulfasalazine inhibits the reaction [TNF protein results in increased activity of TYMP protein]; Sulfasalazine results in decreased expression of and results in decreased activity of TYMP protein	PMID:15269287
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1313979	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TYMP mRNA	PMID:29301935
1305756	Tymp	thymidine phosphorylase	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313979	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TYMP protein	PMID:38598786
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of ZNF112 mRNA	PMID:31016361
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313981	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ZNF112 mRNA	PMID:23724009
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZNF112 mRNA	PMID:22378314
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ZNF112 mRNA	PMID:21632981
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZNF112 mRNA	PMID:20655997
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP112 mRNA	PMID:33387578
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:17967	urethane	affects expression	ISO	RGD:1313981	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane affects the expression of ZNF112 mRNA	PMID:28818685
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313981	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZNF112 mRNA	PMID:19549813
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZFP112 mRNA	PMID:30779732
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP112 mRNA	PMID:22298810
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP112 mRNA	PMID:33387578
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZNF112 mRNA	PMID:28001369
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313981	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ZNF112 protein	PMID:35688186
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF112 mRNA	PMID:34032870
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313982	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZFP112 mRNA	PMID:37682722
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313981	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZFP112 exon	PMID:27901495
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313981	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZFP112 promoter	PMID:27901495
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ZFP112 mRNA	PMID:25351596
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313982	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ZFP112 mRNA	PMID:18648102
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP112 mRNA	PMID:25181051
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:3423	carmustine	affects response to substance	ISO	RGD:1313981	E	RGD:6480464	20120412	CTD	MESH:D002330	ZNF112 mRNA affects the susceptibility to Carmustine	PMID:16365179
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313982	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP112 mRNA	PMID:37019170
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ZNF112 mRNA	PMID:40419075
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313981	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF112 mRNA	PMID:25979313
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF112 mRNA	PMID:28001369
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313981	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF112 gene	PMID:29154799
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313981	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZFP112 mRNA	PMID:23179753
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ZNF112 mRNA	PMID:38832940
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313981	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ZNF112 mRNA	PMID:27188386
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZFP112 mRNA	PMID:33387578
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313981	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ZNF112 mRNA	PMID:28988120
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1313981	E	RGD:6480464	20130305	CTD	MESH:C047246	ZNF112 mRNA affects the susceptibility to temozolomide	PMID:16365179
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313981	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF112 protein	PMID:31285264
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313981	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF112 gene]	PMID:28238834
1305757	Zfp112	zinc finger protein 112	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ZFP112 mRNA	PMID:19281266
1305759	Pxn	paxillin	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1313984	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PXN mRNA	PMID:38218311
1305759	Pxn	paxillin	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of PXN mRNA	PMID:15928584
1305759	Pxn	paxillin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313984	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of PXN; Tretinoin results in increased expression of PXN mRNA	PMID:24819975|PMID:33167477|PMID:9081214
1305759	Pxn	paxillin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20120412	CTD	MESH:D014212	[LCP2 protein co-treated with CSF1R protein] promotes the reaction [Tretinoin results in increased expression of PXN protein]; SUMO1 mutant form inhibits the reaction [Tretinoin results in increased expression of PXN mRNA]	PMID:16439309|PMID:24819975
1305759	Pxn	paxillin	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PXN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PXN mRNA	PMID:32699268
1305759	Pxn	paxillin	gene	CHEBI:16170	mercury(0)	affects localization	ISO	RGD:1313984	E	RGD:6480464	20231031	CTD	MESH:D008628	Mercury affects the localization of PXN protein	PMID:26600472
1305759	Pxn	paxillin	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313985	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PXN mRNA	PMID:30319688
1305759	Pxn	paxillin	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of PXN protein	PMID:31494107
1305759	Pxn	paxillin	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of PXN protein	PMID:35688186
1305759	Pxn	paxillin	gene	CHEBI:16325	lithocholic acid	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20131210	CTD	MESH:D008095	Lithocholic Acid results in decreased phosphorylation of and results in decreased activity of PXN protein	PMID:21224350
1305759	Pxn	paxillin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PXN mRNA	PMID:39241906
1305759	Pxn	paxillin	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313984	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of PXN mRNA	PMID:22574217
1305759	Pxn	paxillin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of PXN mRNA	PMID:24758408
1305759	Pxn	paxillin	gene	CHEBI:16469	17beta-estradiol	increases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20160607	CTD	MESH:D004958	Estradiol results in increased phosphorylation of PXN protein	PMID:27026707
1305759	Pxn	paxillin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20160412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PXN mRNA; EGF protein inhibits the reaction [Estradiol results in decreased expression of PXN mRNA]	PMID:24758408|PMID:30165855
1305759	Pxn	paxillin	gene	CHEBI:16684	atropine	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20130122	CTD	MESH:D001285	Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]]	PMID:10537051
1305759	Pxn	paxillin	gene	CHEBI:16842	formaldehyde	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased phosphorylation of and results in decreased expression of PXN protein; Formaldehyde results in increased phosphorylation of and results in increased activity of PXN protein	PMID:16352387|PMID:26400731
1305759	Pxn	paxillin	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in decreased expression of PXN protein	PMID:31483951
1305759	Pxn	paxillin	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in increased expression of PXN protein modified form	PMID:31483951
1305759	Pxn	paxillin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; RHOA protein inhibits the reaction [Glucose results in decreased expression of PXN protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]	PMID:31483951
1305759	Pxn	paxillin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in increased expression of PXN protein	PMID:20463053
1305759	Pxn	paxillin	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in decreased expression of PXN protein	PMID:31483951
1305759	Pxn	paxillin	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in increased expression of PXN protein modified form	PMID:31483951
1305759	Pxn	paxillin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; RHOA protein inhibits the reaction [Glucose results in decreased expression of PXN protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]	PMID:31483951
1305759	Pxn	paxillin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313984	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PXN mRNA	PMID:31163220
1305759	Pxn	paxillin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate] results in increased expression of PXN protein	PMID:40914504
1305759	Pxn	paxillin	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PXN protein	PMID:37730182
1305759	Pxn	paxillin	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313984	E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of PXN mRNA	PMID:22562489
1305759	Pxn	paxillin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PXN mRNA	PMID:35301059
1305759	Pxn	paxillin	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PXN protein	PMID:23301498
1305759	Pxn	paxillin	gene	CHEBI:25195	mercury atom	affects localization	ISO	RGD:1313984	E	RGD:6480464	20231031	CTD	MESH:D008628	Mercury affects the localization of PXN protein	PMID:26600472
1305759	Pxn	paxillin	gene	CHEBI:25351	mevalonic acid	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008798	Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [AGT protein results in increased phosphorylation of PXN protein]]	PMID:22306966
1305759	Pxn	paxillin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PXN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PXN mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of PXN mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PXN mRNA	PMID:32699268|PMID:35430440
1305759	Pxn	paxillin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PXN mRNA	PMID:27106289
1305759	Pxn	paxillin	gene	CHEBI:26523	reactive oxygen species	increases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20170303	CTD	MESH:D017382	Reactive Oxygen Species results in increased phosphorylation of PXN protein	PMID:11213483
1305759	Pxn	paxillin	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20170303	CTD	MESH:D017382	Anethole Trithione inhibits the reaction [Reactive Oxygen Species results in increased phosphorylation of PXN protein]	PMID:11213483
1305759	Pxn	paxillin	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of PXN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PXN protein	PMID:38598786
1305759	Pxn	paxillin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40512198
1305759	Pxn	paxillin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40504410
1305759	Pxn	paxillin	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1313984	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PXN mRNA	PMID:26272509
1305759	Pxn	paxillin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PXN mRNA	PMID:27188386
1305759	Pxn	paxillin	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PXN protein	PMID:35688186
1305759	Pxn	paxillin	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased phosphorylation of PXN protein]	PMID:26621445
1305759	Pxn	paxillin	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased phosphorylation of PXN protein]	PMID:26621445
1305759	Pxn	paxillin	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of PXN mRNA	PMID:21151649
1305759	Pxn	paxillin	gene	CHEBI:27961	1,8-cineole	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D000077591	Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of PXN protein modified form]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]	PMID:31483951
1305759	Pxn	paxillin	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PXN mRNA	PMID:30912803
1305759	Pxn	paxillin	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of PXN mRNA	PMID:22228119
1305759	Pxn	paxillin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313985	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PXN mRNA	PMID:21570461
1305759	Pxn	paxillin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PXN mRNA	PMID:34747641
1305759	Pxn	paxillin	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313984	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PXN mRNA	PMID:33212167
1305759	Pxn	paxillin	gene	CHEBI:28304	heparin	decreases phosphorylation	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:D006493	Heparin results in decreased phosphorylation of PXN protein	PMID:18674534
1305759	Pxn	paxillin	gene	CHEBI:28584	gossypol	decreases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20250506	CTD	MESH:D006072	Gossypol results in decreased phosphorylation of PXN protein	PMID:39263880
1305759	Pxn	paxillin	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PXN protein	PMID:35688186
1305759	Pxn	paxillin	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1313984	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of PXN	PMID:9081214
1305759	Pxn	paxillin	gene	CHEBI:29014	cordycepin	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20240604	CTD	MESH:C058120	Ammonium Chloride inhibits the reaction [cordycepin results in decreased expression of PXN protein]; cordycepin results in decreased expression of and results in decreased phosphorylation of PXN protein	PMID:28068557
1305759	Pxn	paxillin	gene	CHEBI:2965	BQ 123	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20141111	CTD	MESH:C072247	[BQ 788 co-treated with cyclo(Trp-Asp-Pro-Val-Leu)] inhibits the reaction [EDN1 protein results in increased phosphorylation of PXN protein]	PMID:12875994
1305759	Pxn	paxillin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PXN protein	PMID:19072884
1305759	Pxn	paxillin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20220809	CTD	MESH:C017947	sodium arsenite results in decreased expression of PXN mRNA	PMID:26674514
1305759	Pxn	paxillin	gene	CHEBI:29678	sodium arsenite	decreases phosphorylation	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased phosphorylation of PXN protein	PMID:15537746
1305759	Pxn	paxillin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40512198
1305759	Pxn	paxillin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40504410
1305759	Pxn	paxillin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313984	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PXN 5' UTR	PMID:27901495
1305759	Pxn	paxillin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20190910	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PXN mRNA; Benzo(a)pyrene results in decreased expression of PXN protein	PMID:31255691|PMID:32717239
1305759	Pxn	paxillin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313984	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PXN mRNA	PMID:32234424
1305759	Pxn	paxillin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313984	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PXN promoter	PMID:27901495
1305759	Pxn	paxillin	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of PXN mRNA	PMID:33053406
1305759	Pxn	paxillin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PXN mRNA	PMID:23806026
1305759	Pxn	paxillin	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313984	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PXN mRNA	PMID:25895662
1305759	Pxn	paxillin	gene	CHEBI:30778	gallic acid	decreases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20240903	CTD	MESH:D005707	Gallic Acid results in decreased phosphorylation of PXN protein	PMID:38100242
1305759	Pxn	paxillin	gene	CHEBI:31206	ammonium chloride	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20240604	CTD	MESH:D000643	Ammonium Chloride inhibits the reaction [cordycepin results in decreased expression of PXN protein]	PMID:28068557
1305759	Pxn	paxillin	gene	CHEBI:31221	Anetholtrithion	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20191114	CTD	MESH:D000781	Anethole Trithione inhibits the reaction [Reactive Oxygen Species results in increased phosphorylation of PXN protein]	PMID:11213483
1305759	Pxn	paxillin	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PXN gene	PMID:31601247
1305759	Pxn	paxillin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PXN mRNA	PMID:18648102
1305759	Pxn	paxillin	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PXN mRNA	PMID:25181051
1305759	Pxn	paxillin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of PXN protein	PMID:34186270
1305759	Pxn	paxillin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313984	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of PXN protein	PMID:37567409
1305759	Pxn	paxillin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313985	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PXN mRNA	PMID:32156529
1305759	Pxn	paxillin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PXN gene	PMID:31601247
1305759	Pxn	paxillin	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1313984	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PXN mRNA	PMID:25979313
1305759	Pxn	paxillin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PXN mRNA	PMID:39298647
1305759	Pxn	paxillin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313985	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PXN exon	PMID:33297965
1305759	Pxn	paxillin	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313984	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PXN protein	PMID:34186270
1305759	Pxn	paxillin	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313985	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PXN intron	PMID:28392331
1305759	Pxn	paxillin	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:C027561	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate] results in increased expression of PXN protein	PMID:40914504
1305759	Pxn	paxillin	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PXN mRNA	PMID:20691718
1305759	Pxn	paxillin	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313985	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PXN mRNA	PMID:32715474|PMID:37019170
1305759	Pxn	paxillin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PXN mRNA	PMID:21266533
1305759	Pxn	paxillin	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:D003993	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate] results in increased expression of PXN protein	PMID:40914504
1305759	Pxn	paxillin	gene	CHEBI:34696	dieldrin	increases response to substance	ISO	RGD:1313984	E	RGD:6480464	20201006	CTD	MESH:D004026	PXN gene mutant form results in increased susceptibility to Dieldrin	PMID:32421776
1305759	Pxn	paxillin	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of PXN protein	PMID:38598786
1305759	Pxn	paxillin	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313984	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PXN mRNA	PMID:37042841
1305759	Pxn	paxillin	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313984	E	RGD:6480464	20171010	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PXN protein	PMID:28527916
1305759	Pxn	paxillin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PXN mRNA	PMID:35301059
1305759	Pxn	paxillin	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PXN mRNA	PMID:19162173
1305759	Pxn	paxillin	gene	CHEBI:35549	perfluorooctanoic acid	increases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20170516	CTD	MESH:C023036	perfluorooctanoic acid results in increased phosphorylation of PXN protein	PMID:27572461
1305759	Pxn	paxillin	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PXN mRNA	PMID:19320972
1305759	Pxn	paxillin	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PXN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PXN mRNA	PMID:32699268
1305759	Pxn	paxillin	gene	CHEBI:38322	oxotremorine M	increases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20130122	CTD	MESH:C042743	oxotremorine M results in increased phosphorylation of PXN protein	PMID:10537051
1305759	Pxn	paxillin	gene	CHEBI:38322	oxotremorine M	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20130122	CTD	MESH:C042743	[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]; Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]]; wortmannin inhibits the reaction [oxotremorine M results in increased phosphorylation of PXN protein]	PMID:10537051
1305759	Pxn	paxillin	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1313984	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PXN mRNA	PMID:28302478
1305759	Pxn	paxillin	gene	CHEBI:38757	isoflavones	affects expression	ISO	RGD:1313984	E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones affects the expression of PXN mRNA	PMID:16365062
1305759	Pxn	paxillin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20170516	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased phosphorylation of PXN protein	PMID:27572461
1305759	Pxn	paxillin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313984	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PXN mRNA	PMID:25979313
1305759	Pxn	paxillin	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in decreased expression of PXN mRNA	PMID:23527032
1305759	Pxn	paxillin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313984	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PXN mRNA	PMID:23179753
1305759	Pxn	paxillin	gene	CHEBI:40070	4-hydroxycoumarin	affects localization	ISO	RGD:1313985	E	RGD:6480464	20120904	CTD	MESH:C068805	4-hydroxycoumarin affects the localization of PXN protein	PMID:18492274
1305759	Pxn	paxillin	gene	CHEBI:40070	4-hydroxycoumarin	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20120904	CTD	MESH:C068805	4-hydroxycoumarin results in decreased expression of PXN mRNA alternative form; 4-hydroxycoumarin results in decreased expression of PXN protein alternative form	PMID:18492274
1305759	Pxn	paxillin	gene	CHEBI:40070	4-hydroxycoumarin	decreases phosphorylation	ISO	RGD:1313985	E	RGD:6480464	20120904	CTD	MESH:C068805	4-hydroxycoumarin results in decreased phosphorylation of PXN protein	PMID:18492274
1305759	Pxn	paxillin	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313984	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PXN mRNA	PMID:25562108
1305759	Pxn	paxillin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313985	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PXN mRNA	PMID:28973697
1305759	Pxn	paxillin	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in decreased expression of PXN protein	PMID:31483951
1305759	Pxn	paxillin	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in increased expression of PXN protein modified form	PMID:31483951
1305759	Pxn	paxillin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; RHOA protein inhibits the reaction [Glucose results in decreased expression of PXN protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]	PMID:31483951
1305759	Pxn	paxillin	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1313984	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of PXN mRNA	PMID:17400583|PMID:21678067
1305759	Pxn	paxillin	gene	CHEBI:4512	Dictamnine	decreases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20230905	CTD	MESH:C026398	dictamnine results in decreased phosphorylation of PXN protein	PMID:34861243
1305759	Pxn	paxillin	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1313984	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PXN mRNA; vorinostat results in increased expression of PXN protein	PMID:19911379
1305759	Pxn	paxillin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PXN mRNA	PMID:17562736
1305759	Pxn	paxillin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313984	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PXN mRNA	PMID:22230336|PMID:26690555
1305759	Pxn	paxillin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40512198
1305759	Pxn	paxillin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40504410
1305759	Pxn	paxillin	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PXN mRNA	PMID:29391264
1305759	Pxn	paxillin	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20171010	CTD	MESH:D004726	Endosulfan results in decreased expression of PXN mRNA	PMID:28108160|PMID:30090376|PMID:40706910
1305759	Pxn	paxillin	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1313984	E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in increased expression of PXN mRNA	PMID:23527032
1305759	Pxn	paxillin	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of PXN mRNA	PMID:18175754
1305759	Pxn	paxillin	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20130122	CTD	MESH:C009687	[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]; Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]]; wortmannin inhibits the reaction [oxotremorine M results in increased phosphorylation of PXN protein]	PMID:10537051
1305759	Pxn	paxillin	gene	CHEBI:5855	ibuprofen	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007052	Ibuprofen results in decreased expression of PXN mRNA; Ibuprofen results in decreased expression of PXN protein	PMID:16463375
1305759	Pxn	paxillin	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1313985	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of PXN mRNA	PMID:20829426
1305759	Pxn	paxillin	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PXN protein	PMID:32959892
1305759	Pxn	paxillin	gene	CHEBI:66331	xanthohumol	decreases expression	ISO	RGD:1313984	E	RGD:6480464	20140408	CTD	MESH:C104536	xanthohumol results in decreased expression of PXN protein	PMID:23503627
1305759	Pxn	paxillin	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313985	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PXN mRNA	PMID:26307267
1305759	Pxn	paxillin	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of PXN mRNA	PMID:20829426
1305759	Pxn	paxillin	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1313984	E	RGD:6480464	20210608	CTD	MESH:C014476	diethyl maleate results in increased expression of PXN mRNA	PMID:33545341
1305759	Pxn	paxillin	gene	CHEBI:6925	microcystin-LR	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of PXN mRNA	PMID:36657700
1305759	Pxn	paxillin	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1313984	E	RGD:6480464	20210608	CTD	MESH:C057862	cyanoginosin LR results in increased expression of PXN mRNA	PMID:27796937
1305759	Pxn	paxillin	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313984	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PXN protein	PMID:34186270
1305759	Pxn	paxillin	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313985	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of PXN mRNA	PMID:22206623
1305759	Pxn	paxillin	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PXN protein	PMID:37664457
1305759	Pxn	paxillin	gene	CHEBI:750004	bq 788	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20260714	CTD	MESH:C086539	[BQ 788 co-treated with cyclo(Trp-Asp-Pro-Val-Leu)] inhibits the reaction [EDN1 protein results in increased phosphorylation of PXN protein]	PMID:12875994
1305759	Pxn	paxillin	gene	CHEBI:75253	phenylarsine oxide	affects localization	ISO	RGD:1313984	E	RGD:6480464	20130903	CTD	MESH:C029341	oxophenylarsine affects the localization of PXN protein	PMID:9546377
1305759	Pxn	paxillin	gene	CHEBI:75253	phenylarsine oxide	increases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20130903	CTD	MESH:C029341	oxophenylarsine results in increased phosphorylation of PXN protein	PMID:10537051
1305759	Pxn	paxillin	gene	CHEBI:75253	phenylarsine oxide	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20130903	CTD	MESH:C029341	[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]; Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]]	PMID:10537051
1305759	Pxn	paxillin	gene	CHEBI:77850	toxaphene	increases degradation	ISO	RGD:1313984	E	RGD:6480464	20140415	CTD	MESH:D014112	Toxaphene results in increased degradation of PXN protein	PMID:12139946
1305759	Pxn	paxillin	gene	CHEBI:77850	toxaphene	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20140415	CTD	MESH:D014112	CAT protein inhibits the reaction [Toxaphene results in increased degradation of PXN protein]	PMID:12139946
1305759	Pxn	paxillin	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PXN mRNA	PMID:27188386
1305759	Pxn	paxillin	gene	CHEBI:78734	tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20140805	CTD	MESH:D001285	Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]]	PMID:10537051
1305759	Pxn	paxillin	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1313984	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PXN mRNA	PMID:26079696
1305759	Pxn	paxillin	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PXN mRNA	PMID:40826991
1305759	Pxn	paxillin	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PXN protein; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PXN mRNA	PMID:27188386|PMID:37664457
1305759	Pxn	paxillin	gene	CHEBI:9150	simvastatin	affects localization	EXP		E	RGD:6480464	20121009	CTD	MESH:D019821	Simvastatin affects the localization of PXN protein	PMID:22306966
1305759	Pxn	paxillin	gene	CHEBI:9150	simvastatin	decreases phosphorylation	EXP		E	RGD:6480464	20121009	CTD	MESH:D019821	Simvastatin results in decreased phosphorylation of PXN protein	PMID:22306966
1305759	Pxn	paxillin	gene	CHEBI:9150	simvastatin	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D019821	Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [AGT protein results in increased phosphorylation of PXN protein]]; Simvastatin inhibits the reaction [AGT protein results in increased phosphorylation of and affects the localization of PXN protein]	PMID:22306966
1305759	Pxn	paxillin	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PXN mRNA	PMID:19281266
1305759	Pxn	paxillin	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PXN mRNA	PMID:21346803
1305759	Pxn	paxillin	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1313984	E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of PXN mRNA	PMID:34581912
1305759	Pxn	paxillin	gene	CHEBI:9448	terbinafine	decreases phosphorylation	ISO	RGD:1313984	E	RGD:6480464	20161213	CTD	MESH:C041359	terbinafine results in decreased phosphorylation of PXN protein	PMID:17172416
1305759	Pxn	paxillin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1313984	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PXN protein	PMID:38598786
1305759	Pxn	paxillin	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PXN mRNA	PMID:21346803
1305759	Pxn	paxillin	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PXN mRNA	PMID:28973697
1305759	Pxn	paxillin	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of PXN mRNA	PMID:23034163
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:10110	zidovudine	decreases response to substance	ISO	RGD:1313986	E	RGD:6480464	20120918	CTD	MESH:D015215	XPC protein results in decreased susceptibility to Zidovudine	PMID:21192964
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1313986	E	RGD:6480464	20140610	CTD	MESH:D015215	Zidovudine results in increased expression of XPC mRNA; Zidovudine results in increased expression of XPC protein	PMID:21192964|PMID:23675285
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPC mRNA	PMID:32699268
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of XPC mRNA	PMID:25596134
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313986	E	RGD:6480464	20180703	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of XPC mRNA	PMID:21751221
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16243	quercetin	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20121009	CTD	MESH:D011794	XPC protein affects the susceptibility to Quercetin	PMID:22280988
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of XPC mRNA	PMID:17103110
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313986	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of XPC mRNA	PMID:21632981
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of XPC mRNA	PMID:32145629
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20140513	CTD	MESH:D004958	Estradiol results in decreased expression of XPC mRNA	PMID:22082530
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20140513	CTD	MESH:D004958	decitabine inhibits the reaction [Estradiol results in decreased expression of XPC mRNA]	PMID:22082530
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313986	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of XPC mRNA	PMID:37042841
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16708	adenine	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of XPC mRNA	PMID:24211769
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of XPC mRNA	PMID:18724895
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313986	E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of XPC mRNA	PMID:19162166
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of XPC mRNA	PMID:15342939
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313986	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of XPC mRNA	PMID:23649840
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:17356	2-acetamidofluorene	decreases response to substance	ISO	RGD:1313987	E	RGD:6480464	20130514	CTD	MESH:D015073	XPC protein results in decreased susceptibility to 2-Acetylaminofluorene	PMID:23153559
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:17488	scopoletin	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20121009	CTD	MESH:D012603	XPC protein affects the susceptibility to Scopoletin	PMID:22280988
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects response to substance	ISO	RGD:1313987	E	RGD:6480464	20170725	CTD	MESH:D004051	XPC protein affects the susceptibility to Diethylhexyl Phthalate	PMID:24084170
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1313986	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of XPC protein	PMID:37730182
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of XPC mRNA	PMID:33387578
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of XPC mRNA	PMID:22061828
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:18227	sterigmatocystin	increases expression	ISO	RGD:1313986	E	RGD:6480464	20130611	CTD	MESH:D013241	Sterigmatocystin results in increased expression of XPC mRNA	PMID:23296099
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of XPC mRNA	PMID:37236586
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20240409	CTD	MESH:C121565	pifithrin inhibits the reaction [benzo(a)pyrene diolepoxide I results in increased expression of XPC mRNA]	PMID:27694624
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313986	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of XPC mRNA	PMID:23649840
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of XPC protein	PMID:20106945
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313986	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of XPC mRNA	PMID:21641981|PMID:27153756|PMID:29445054
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of XPC protein	PMID:39638853
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313986	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of XPC mRNA	PMID:23649840
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313987	E	RGD:6480464	20240206	CTD	MESH:D009151	Mustard Gas results in increased expression of XPC mRNA	PMID:19778212
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313986	E	RGD:6480464	20180220	CTD	MESH:D010126	Ozone results in increased expression of XPC mRNA	PMID:27206323
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Ozone]] which results in decreased expression of XPC mRNA	PMID:36423397
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPC mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of XPC mRNA	PMID:32699268
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of XPC mRNA	PMID:30779732
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of XPC mRNA	PMID:17484886
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of XPC mRNA	PMID:31150632
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of XPC mRNA	PMID:25629700
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPC mRNA]	PMID:30020114
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of XPC mRNA]; Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPC mRNA]	PMID:22206623|PMID:30020114
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of XPC	PMID:21235219
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27563	arsenic atom	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20160705	CTD	MESH:D001151	XPC gene SNP affects the susceptibility to Arsenic	PMID:25759212
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA; NFE2L1 protein alternative form inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA]	PMID:32188015|PMID:39836092
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of XPC mRNA	PMID:40504410
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1313986	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of XPC protein	PMID:35688186
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of XPC mRNA	PMID:25596134
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of XPC mRNA	PMID:33775663
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of XPC mRNA	PMID:23557933
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27882	(S)-colchicine	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of XPC mRNA	PMID:24211769
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20120918	CTD	MESH:D002945	XPC protein affects the susceptibility to Cisplatin	PMID:22331493
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin results in decreased expression of XPC mRNA	PMID:24211769
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	decreases response to substance	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D002945	XPC protein results in decreased susceptibility to Cisplatin	PMID:21327329
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313986	E	RGD:6480464	20150414	CTD	MESH:D002945	Cisplatin results in increased expression of XPC mRNA; Cisplatin results in increased expression of XPC protein	PMID:21532991|PMID:21696631|PMID:21742020|PMID:22331493|PMID:25596134
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	increases response to substance	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D002945	XPC protein results in increased susceptibility to Cisplatin	PMID:21324906
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D002945	[sodium arsenite results in decreased expression of XPC protein] which results in increased susceptibility to Cisplatin; Cisplatin inhibits the reaction [Piroxicam results in decreased expression of XPC mRNA]; RAD23B mutant form inhibits the reaction [Cisplatin results in increased expression of XPC protein]; sodium arsenite inhibits the reaction [Cisplatin results in increased expression of XPC protein]; TP53 protein affects the reaction [Cisplatin results in increased expression of XPC protein]	PMID:21696631|PMID:21742020|PMID:21858171|PMID:22331493
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of XPC mRNA	PMID:30912803
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313987	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of XPC mRNA	PMID:21570461
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of XPC mRNA	PMID:33387578
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XPC mRNA	PMID:19428948
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of XPC mRNA	PMID:17942748
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of XPC mRNA	PMID:28374803
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1313986	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of XPC mRNA	PMID:39709020
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of XPC mRNA	PMID:30851411
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28509	chloroethene	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20121113	CTD	MESH:D014752	XPC gene polymorphism affects the susceptibility to Vinyl Chloride	PMID:21216194
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:2866	ascaridole	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20121009	CTD	MESH:C043372	XPC protein affects the susceptibility to ascaridole	PMID:22280988
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of XPC mRNA	PMID:15467011
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1313986	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of XPC mRNA	PMID:29803840
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20230704	CTD	MESH:D004317	XPC protein affects the susceptibility to Doxorubicin	PMID:36634904
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313986	E	RGD:6480464	20230704	CTD	MESH:D004317	Doxorubicin results in increased expression of XPC mRNA	PMID:36634904|PMID:40854400
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20260203	CTD	MESH:D004317	FOXO3 protein affects the reaction [Doxorubicin results in increased expression of XPC mRNA]	PMID:40854400
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1313986	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of XPC protein	PMID:35688186
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of XPC mRNA	PMID:36057382
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of XPC mRNA; sodium arsenite results in decreased expression of XPC protein	PMID:12377979|PMID:12760830|PMID:19382146|PMID:28237621|PMID:34032870|PMID:37762697
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of XPC mRNA; sodium arsenite results in decreased expression of XPC protein	PMID:17558810|PMID:28237621
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313986	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of XPC mRNA	PMID:38568856
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313987	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of XPC mRNA	PMID:25787150
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in decreased expression of XPC protein] which results in increased susceptibility to Cisplatin; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in decreased expression of XPC protein]; NFE2L1 protein alternative form inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA]; sodium arsenite inhibits the reaction [Cisplatin results in increased expression of XPC protein]; sodium arsenite promotes the reaction [XPC protein binds to CAPRIN1 protein]	PMID:21696631|PMID:22331493|PMID:28237621|PMID:32188015|PMID:33939924|PMID:39836092
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of XPC mRNA	PMID:40504410
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D001564	XPC polyA tail polymorphism affects the susceptibility to Benzo(a)pyrene	PMID:15471894
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	affects response to substance	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D001564	XPC protein affects the susceptibility to Benzo(a)pyrene	PMID:16094661
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20120717	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of XPC mRNA; Benzo(a)pyrene results in decreased expression of XPC protein	PMID:19748547|PMID:30020114
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of XPC mRNA	PMID:20504355|PMID:30020114
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313986	E	RGD:6480464	20140211	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XPC mRNA; Benzo(a)pyrene results in increased expression of XPC protein	PMID:23894430|PMID:27694624|PMID:32234424
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XPC mRNA	PMID:19428948
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D001564	[3,4,5,3',4'-pentachlorobiphenyl co-treated with Benzo(a)pyrene] results in decreased expression of XPC protein; Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPC mRNA]	PMID:19553035|PMID:30020114
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to XPC promoter]; Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPC mRNA]	PMID:19654925|PMID:30020114
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of XPC mRNA	PMID:36057382
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of XPC mRNA	PMID:15467011
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313986	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of XPC mRNA; 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of XPC protein	PMID:18085531|PMID:28593498
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:30621	diarsenic trioxide	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20191114	CTD	MESH:C006632	XPC protein affects the susceptibility to Arsenic Trioxide	PMID:20403967|PMID:22280988
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:31355	carboplatin	decreases response to substance	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D016190	XPC results in decreased susceptibility to Carboplatin	PMID:19372135
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of XPC mRNA	PMID:24136188
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of XPC mRNA	PMID:24136188
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:32509	pirinixic acid	affects response to substance	ISO	RGD:1313987	E	RGD:6480464	20130514	CTD	MESH:C006253	XPC protein affects the susceptibility to pirinixic acid	PMID:23153559
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of XPC mRNA	PMID:19710929
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of XPC mRNA	PMID:12419474
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of XPC mRNA	PMID:25181051
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of XPC mRNA	PMID:32145629
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of XPC protein	PMID:31675489
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313986	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in decreased methylation of XPC promoter	PMID:30352284
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of XPC mRNA	PMID:34947998
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of XPC protein	PMID:31675489
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with Benzo(a)pyrene] results in decreased expression of XPC protein	PMID:19553035
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of XPC mRNA	PMID:39298647
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313987	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of XPC mRNA	PMID:38685157
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1313987	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of XPC mRNA	PMID:36464114
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of XPC mRNA	PMID:21266533
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20200714	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of XPC mRNA	PMID:31318015
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34905	paraquat	affects response to substance	ISO	RGD:1313987	E	RGD:6480464	20170725	CTD	MESH:D010269	XPC protein affects the susceptibility to Paraquat	PMID:24084170
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of XPC mRNA	PMID:25596134|PMID:38568856
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of XPC mRNA	PMID:37236586
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C039281	furan results in decreased expression of XPC mRNA	PMID:22507866
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:3647	chlorpromazine	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in decreased expression of XPC mRNA	PMID:25596134
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:36704	imiquimod	increases expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:C056493	imiquimod results in increased expression of XPC mRNA	PMID:21878529
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPC mRNA	PMID:32699268
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:3696	cidofovir anhydrous	increases expression	ISO	RGD:1313986	E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of XPC mRNA	PMID:25596134
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:39478	buta-1,3-diene	increases response to substance	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:C031763	XPC gene mutant form results in increased susceptibility to 1,3-butadiene	PMID:16730686
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313987	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of XPC mRNA	PMID:31558096
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313986	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of XPC mRNA	PMID:25979313
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of XPC mRNA	PMID:21507255
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid promotes the reaction [CREB1 protein binds to XPC promoter]; Valproic Acid promotes the reaction [SP1 protein binds to XPC promoter]	PMID:21507255
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4027	cyclophosphamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide affects the expression of XPC mRNA	PMID:11056294
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1313986	E	RGD:6480464	20190910	CTD	MESH:D003520	Cyclophosphamide results in increased expression of XPC mRNA	PMID:29445054
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of XPC mRNA	PMID:25596134
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of XPC mRNA	PMID:25596134
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4031	cyclosporin A	decreases response to substance	ISO	RGD:1313987	E	RGD:6480464	20130514	CTD	MESH:D016572	XPC protein results in decreased susceptibility to Cyclosporine	PMID:23153559
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:41922	diethylstilbestrol	decreases response to substance	ISO	RGD:1313987	E	RGD:6480464	20130514	CTD	MESH:D004054	XPC protein results in decreased susceptibility to Diethylstilbestrol	PMID:23153559
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:42068	idarubicin	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20180116	CTD	MESH:D015255	[Dexrazoxane co-treated with Idarubicin] results in increased expression of XPC mRNA	PMID:28973540
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of XPC mRNA	PMID:18647660
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of XPC mRNA	PMID:24136188
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of XPC mRNA	PMID:38832940
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of XPC mRNA	PMID:33387578
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313986	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of XPC mRNA	PMID:22230336
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:46661	asbestos	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20201006	CTD	MESH:D001194	XPC alternative form affects the susceptibility to Asbestos	PMID:28687356
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1313986	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of XPC	PMID:21235219
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:47217	arsane	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20160705	CTD	MESH:D001151	XPC gene SNP affects the susceptibility to Arsenic	PMID:25759212
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA; NFE2L1 protein alternative form inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA]	PMID:32188015|PMID:39836092
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of XPC mRNA	PMID:40504410
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of XPC mRNA	PMID:31675489
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:48513	carbazoles	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20170303	CTD	MESH:D002227	XPC protein affects the susceptibility to Carbazoles	PMID:22280988
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of XPC mRNA	PMID:17942748
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:49900	arsenous acid	affects response to substance	ISO	RGD:1313986	E	RGD:6480464	20191114	CTD	MESH:C032793	XPC protein affects the susceptibility to Arsenic Trioxide	PMID:20403967|PMID:22280988
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of XPC mRNA	PMID:25596134
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of XPC mRNA	PMID:22082530
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Estradiol results in decreased expression of XPC mRNA]	PMID:22082530
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20180116	CTD	MESH:D064730	[Dexrazoxane co-treated with Idarubicin] results in increased expression of XPC mRNA	PMID:28973540
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of XPC mRNA; Nanotubes, Carbon results in decreased expression of XPC mRNA	PMID:25554681
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:5864	ifosfamide	increases expression	ISO	RGD:1313986	E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of XPC mRNA	PMID:25596134
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of XPC mRNA	PMID:24136188
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of XPC mRNA	PMID:25596134
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin results in increased expression of XPC mRNA	PMID:31324951
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1313987	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of XPC mRNA	PMID:36464114
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313987	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of XPC mRNA	PMID:22206623
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of XPC mRNA]	PMID:22206623
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of XPC mRNA	PMID:24136188
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20171114	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in decreased expression of XPC protein]	PMID:28237621
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:75270	nimustine	increases expression	ISO	RGD:1313986	E	RGD:6480464	20130903	CTD	MESH:D015376	Nimustine results in increased expression of XPC mRNA	PMID:18089819
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:75270	nimustine	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20130903	CTD	MESH:D015376	TP53 affects the reaction [Nimustine results in increased expression of XPC mRNA]	PMID:18089819
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:75393	Y-27632	increases expression	ISO	RGD:1313986	E	RGD:6480464	20170303	CTD	MESH:C108830	Y 27632 results in increased expression of XPC mRNA	PMID:20878077
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1313986	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of XPC protein	PMID:31285264
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of XPC protein	PMID:39638853
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of XPC protein	PMID:39638853
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of XPC mRNA	PMID:30851411
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:78708	Nonidet P-40	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in decreased expression of XPC mRNA	PMID:26552463
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to XPC gene]	PMID:28238834
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of XPC protein	PMID:31675489
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of XPC mRNA	PMID:38995820
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of XPC mRNA	PMID:21858171
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1313986	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of XPC mRNA]	PMID:21858171
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:82527	Ptaquiloside	increases expression	ISO	RGD:1313986	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in increased expression of XPC mRNA	PMID:22143989
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1313986	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of XPC mRNA	PMID:33512557
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1313986	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of XPC mRNA	PMID:23726867
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	ISO	RGD:1313986	E	RGD:6480464	20210504	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of XPC mRNA	PMID:33645215
1305760	Xpc	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of XPC mRNA	PMID:25596134
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1313988	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MYLIP mRNA	PMID:26272509
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313989	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYLIP mRNA	PMID:33045310
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MYLIP mRNA	PMID:26251327
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D014212	Tretinoin results in decreased expression of MYLIP mRNA	PMID:20488242
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313988	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of MYLIP mRNA	PMID:21934132
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313988	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MYLIP mRNA	PMID:22378314
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D011794	Quercetin results in increased expression of MYLIP mRNA	PMID:21632981
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MYLIP mRNA	PMID:39241906
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1313988	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of MYLIP mRNA	PMID:30510588
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in decreased expression of MYLIP mRNA	PMID:19167446
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313989	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MYLIP mRNA; Estradiol results in increased expression of MYLIP protein	PMID:39298647
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of MYLIP mRNA	PMID:38568856
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MYLIP mRNA	PMID:33387578
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of MYLIP gene	PMID:27618143
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313988	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MYLIP mRNA	PMID:37042841
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313988	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MYLIP mRNA	PMID:20655997|PMID:23649840
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D011374	Progesterone results in decreased expression of MYLIP mRNA	PMID:21795739
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313988	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of MYLIP mRNA	PMID:18037150
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:C044887	beta-methylcholine affects the expression of MYLIP mRNA	PMID:21179406
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYLIP mRNA	PMID:37992649
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313988	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of MYLIP mRNA	PMID:22017230
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313989	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of MYLIP mRNA	PMID:33848595
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1313988	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of MYLIP mRNA	PMID:33647349
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of MYLIP mRNA	PMID:31256213
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYLIP mRNA	PMID:37992649
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20240109	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MYLIP mRNA	PMID:37536456
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MYLIP mRNA	PMID:26577399
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MYLIP mRNA	PMID:16002434
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MYLIP mRNA	PMID:22061828
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313988	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MYLIP mRNA	PMID:28818685
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:188736	Archazolid B	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20220104	CTD	MESH:C519728	archazolid B results in decreased expression of MYLIP mRNA	PMID:25218289
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313988	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of MYLIP mRNA	PMID:21120746
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYLIP mRNA	PMID:37236586
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D019327	Copper Sulfate results in increased expression of MYLIP mRNA	PMID:19549813
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MYLIP mRNA	PMID:23649840
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313988	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MYLIP gene	PMID:27153756
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313988	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MYLIP mRNA	PMID:23649840
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MYLIP mRNA	PMID:34911549
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of MYLIP mRNA	PMID:18593933
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MYLIP mRNA	PMID:25629700
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYLIP mRNA	PMID:22206623
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:27504	mitomycin C	affects response to substance	ISO	RGD:1313988	E	RGD:6480464	20120412	CTD	MESH:D016685	MYLIP protein affects the susceptibility to Mitomycin	PMID:16217747
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:27563	arsenic atom	decreases response to substance	ISO	RGD:1313988	E	RGD:6480464	20120412	CTD	MESH:D001151	MYLIP mRNA results in decreased susceptibility to Arsenic	PMID:17976673
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MYLIP mRNA	PMID:40512198
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene] which results in decreased expression of MYLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MYLIP mRNA	PMID:40504410
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MYLIP mRNA	PMID:35897073
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MYLIP mRNA	PMID:31881176
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D007854	Lead affects the expression of MYLIP mRNA	PMID:22313790|PMID:28903495
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313988	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of MYLIP mRNA	PMID:18847459
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MYLIP mRNA	PMID:22298810|PMID:34747641
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MYLIP mRNA	PMID:33387578
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MYLIP mRNA	PMID:32109520
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MYLIP mRNA	PMID:21802500
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MYLIP mRNA	PMID:25975270
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313988	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MYLIP mRNA	PMID:28001369
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313988	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MYLIP mRNA	PMID:33212167
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1313988	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MYLIP mRNA	PMID:30851411
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	ISO	RGD:1313988	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of MYLIP mRNA	PMID:26272509
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28428	beta-hexachlorocyclohexane	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in decreased expression of MYLIP mRNA	PMID:25270620
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MYLIP mRNA	PMID:28959563
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313988	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MYLIP mRNA	PMID:32763439
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D003561	Cytarabine results in decreased expression of MYLIP mRNA	PMID:21198554
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MYLIP mRNA; [NSC 689534 binds to Copper] which results in increased expression of MYLIP mRNA	PMID:20971185|PMID:24690739
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313988	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MYLIP mRNA	PMID:29803840
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313989	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of MYLIP mRNA	PMID:25896364|PMID:39631538
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYLIP mRNA	PMID:37992649
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MYLIP mRNA	PMID:39719251
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite results in decreased expression of MYLIP mRNA	PMID:35202923
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313988	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MYLIP mRNA	PMID:38568856
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MYLIP mRNA	PMID:40512198
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20240430	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene] which results in decreased expression of MYLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MYLIP mRNA; salvin inhibits the reaction [sodium arsenite results in decreased expression of MYLIP mRNA]	PMID:35202923|PMID:40504410
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MYLIP mRNA	PMID:22378314
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MYLIP mRNA	PMID:20064835|PMID:21802500|PMID:22316170
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313989	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MYLIP mRNA	PMID:22228805
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313988	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MYLIP promoter	PMID:27901495
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MYLIP mRNA; [NSC 689534 binds to Copper] which results in increased expression of MYLIP mRNA	PMID:20971185|PMID:24690739
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of MYLIP mRNA	PMID:18593933
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MYLIP mRNA	PMID:20018196
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313988	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MYLIP mRNA	PMID:20382639
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MYLIP mRNA	PMID:30047161
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313989	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MYLIP promoter	PMID:35295148
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313989	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MYLIP gene	PMID:35295148
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MYLIP mRNA	PMID:34492290
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1313988	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of MYLIP mRNA	PMID:30690063
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of MYLIP mRNA	PMID:38479592
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MYLIP mRNA	PMID:25181051
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MYLIP mRNA	PMID:30816183|PMID:32528016
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313989	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of MYLIP mRNA	PMID:30951980|PMID:34585602
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MYLIP gene	PMID:28505145
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MYLIP mRNA	PMID:25172293
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313989	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MYLIP gene	PMID:31683443
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313989	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of MYLIP mRNA	PMID:30951980
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:34572	allethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein	PMID:34896426
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313989	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of MYLIP mRNA	PMID:30951980
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313989	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of MYLIP mRNA	PMID:28392331
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:34786	Heptachlor epoxide	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in decreased expression of MYLIP mRNA	PMID:25270620
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of MYLIP mRNA	PMID:36117858
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313988	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MYLIP mRNA	PMID:37042841
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313988	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MYLIP mRNA	PMID:38568856
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYLIP mRNA	PMID:37236586
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of MYLIP mRNA	PMID:27387713
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313989	E	RGD:6480464	20130806	CTD	MESH:D002922	Ciguatoxins affects the expression of MYLIP mRNA	PMID:18353800
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313988	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MYLIP mRNA	PMID:31533062
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D003375	Coumestrol results in decreased expression of MYLIP mRNA	PMID:19167446
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA	PMID:19167446
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of MYLIP protein	PMID:34896426
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1313988	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of MYLIP mRNA	PMID:26352163
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:C016104	sodium bichromate results in increased expression of MYLIP mRNA	PMID:17685462
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313988	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MYLIP mRNA	PMID:25979313
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313989	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MYLIP mRNA	PMID:17292431
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313988	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MYLIP mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313989	E	RGD:6480464	20120515	CTD	MESH:D014635	Valproic Acid results in increased expression of MYLIP mRNA	PMID:19136453|PMID:21427059
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313988	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MYLIP mRNA	PMID:25562108
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:4035	cyhalothrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein	PMID:34896426
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of MYLIP mRNA	PMID:40633821
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:4042	cypermethrin	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein	PMID:34896426
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYLIP mRNA	PMID:37992649
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in decreased expression of MYLIP mRNA	PMID:16849584
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313988	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MYLIP mRNA	PMID:38832940
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1313988	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MYLIP mRNA	PMID:24935251|PMID:26272509
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MYLIP mRNA	PMID:33387578
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D000082	Acetaminophen results in increased expression of MYLIP mRNA	PMID:21420995|PMID:29067470
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1313988	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of MYLIP mRNA	PMID:16584549
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of MYLIP mRNA	PMID:24690739
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:47217	arsane	decreases response to substance	ISO	RGD:1313988	E	RGD:6480464	20140805	CTD	MESH:D001151	MYLIP mRNA results in decreased susceptibility to Arsenic	PMID:17976673
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MYLIP mRNA	PMID:40512198
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene] which results in decreased expression of MYLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MYLIP mRNA	PMID:40504410
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MYLIP mRNA	PMID:29391264
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MYLIP mRNA	PMID:22079256
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:5014	fenvalerate	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein	PMID:34896426
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313989	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of MYLIP mRNA	PMID:25554681
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MYLIP mRNA	PMID:25554681
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313989	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MYLIP mRNA; Nanotubes, Carbon results in increased expression of MYLIP mRNA	PMID:25620056
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MYLIP mRNA	PMID:30047161
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313989	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MYLIP mRNA	PMID:40234311
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D015735	Mifepristone results in decreased expression of MYLIP mRNA	PMID:25972201
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of MYLIP mRNA	PMID:36117858
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313988	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MYLIP mRNA	PMID:22714537
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1313988	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of MYLIP mRNA	PMID:31629900
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1313988	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of MYLIP mRNA	PMID:26272509
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MYLIP mRNA	PMID:25270620
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20130806	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MYLIP mRNA	PMID:22079614
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313989	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of MYLIP mRNA	PMID:20003209
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:65585	carnosic acid	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20240430	CTD	MESH:C018381	salvin inhibits the reaction [sodium arsenite results in decreased expression of MYLIP mRNA]	PMID:35202923
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1313988	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MYLIP mRNA	PMID:31758290
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MYLIP mRNA	PMID:22206623
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYLIP mRNA	PMID:22206623
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1313988	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MYLIP mRNA	PMID:22079256|PMID:22714537
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MYLIP mRNA	PMID:22079256
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1313988	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of MYLIP mRNA	PMID:29522793
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:757488	omega-3 fatty acids	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 results in decreased expression of MYLIP mRNA	PMID:23333450
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1313988	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MYLIP mRNA	PMID:30851411
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MYLIP gene]	PMID:28238834
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:79995	GW 3965	increases expression	ISO	RGD:1313988	E	RGD:6480464	20190219	CTD	MESH:C473027	GW 3965 results in increased expression of MYLIP mRNA	PMID:27598782
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1313988	E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in decreased expression of MYLIP mRNA	PMID:31437187
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313989	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of MYLIP mRNA	PMID:23091169
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of MYLIP mRNA	PMID:19482888
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of MYLIP mRNA]	PMID:19482888
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA	PMID:19167446
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313989	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MYLIP mRNA	PMID:39847705
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MYLIP mRNA	PMID:30047161
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1313988	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of MYLIP mRNA	PMID:26272509
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313988	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MYLIP mRNA	PMID:19281266
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1313988	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MYLIP mRNA	PMID:38568856
1305761	Mylip	myosin regulatory light chain interacting protein	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1313988	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MYLIP mRNA	PMID:29301935
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313990	E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of EBNA1BP2 protein	PMID:39638853
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313991	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of EBNA1BP2 mRNA	PMID:33045310
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313991	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of EBNA1BP2 mRNA	PMID:37995155
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EBNA1BP2 mRNA]	PMID:31150632
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D014212	Tretinoin results in decreased expression of EBNA1BP2 mRNA	PMID:16054129|PMID:23724009
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EBNA1BP2 mRNA	PMID:30529165
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D001280	Atrazine results in decreased expression of EBNA1BP2 mRNA	PMID:22378314
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:16130	DDT	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased expression of EBNA1BP2 mRNA	PMID:30207508
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EBNA1BP2 mRNA	PMID:20044591
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313991	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EBNA1BP2 mRNA	PMID:39241906
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:D004958	Estradiol affects the expression of EBNA1BP2 mRNA	PMID:15598610
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313990	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of EBNA1BP2 mRNA	PMID:38568856
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313990	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EBNA1BP2 mRNA	PMID:37042841
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of EBNA1BP2 protein	PMID:32044396
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313990	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of EBNA1BP2 protein	PMID:34122009
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of EBNA1BP2 mRNA	PMID:22061828
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EBNA1BP2 mRNA	PMID:36331819
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EBNA1BP2 mRNA	PMID:37236586
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of EBNA1BP2 mRNA	PMID:23649840
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313990	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EBNA1BP2 gene	PMID:27153756
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1313990	E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of EBNA1BP2 protein	PMID:39638853
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of EBNA1BP2 mRNA	PMID:23649840
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of EBNA1BP2 mRNA	PMID:41580963
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EBNA1BP2 mRNA	PMID:33387578
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EBNA1BP2 mRNA	PMID:31150632
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EBNA1BP2 mRNA	PMID:27339419|PMID:31919559
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EBNA1BP2 mRNA]	PMID:31150632
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313991	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of EBNA1BP2 mRNA	PMID:25629700
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EBNA1BP2 mRNA	PMID:22206623
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBNA1BP2 mRNA	PMID:40504410
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of EBNA1BP2 mRNA	PMID:33512557
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313990	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of EBNA1BP2 mRNA	PMID:23557933
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of EBNA1BP2 mRNA	PMID:27594783
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D009532	Nickel results in increased expression of EBNA1BP2 mRNA	PMID:25583101
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EBNA1BP2 mRNA	PMID:21570461
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EBNA1BP2 mRNA	PMID:21215274
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EBNA1BP2 mRNA	PMID:30851411
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313991	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of EBNA1BP2 mRNA	PMID:30807115
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EBNA1BP2 mRNA	PMID:29803840
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D024483	Vitamin K 3 affects the expression of EBNA1BP2 mRNA	PMID:20044591
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of EBNA1BP2 mRNA	PMID:38568856
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBNA1BP2 mRNA	PMID:40504410
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EBNA1BP2 mRNA	PMID:22228805
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1313990	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of EBNA1BP2 protein	PMID:34122009
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of EBNA1BP2 mRNA	PMID:25895662
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313991	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EBNA1BP2 mRNA	PMID:35676786
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:D005897	Glafenine results in increased expression of EBNA1BP2 mRNA	PMID:24136188
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of EBNA1BP2 mRNA	PMID:25729387
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313991	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EBNA1BP2 promoter alternative form	PMID:35295148
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:D013853	Thioacetamide results in increased expression of EBNA1BP2 mRNA	PMID:23411599|PMID:34492290
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of EBNA1BP2 mRNA	PMID:18648102
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of EBNA1BP2 mRNA	PMID:33296240
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of EBNA1BP2 mRNA; bisphenol A results in decreased expression of EBNA1BP2 protein	PMID:29275510|PMID:37567409
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:C006780	bisphenol A results in increased expression of EBNA1BP2 mRNA	PMID:25181051|PMID:36779543
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313991	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EBNA1BP2 mRNA	PMID:39298647
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313991	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of EBNA1BP2 intron	PMID:28392331
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20160906	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EBNA1BP2 mRNA	PMID:17602206
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20160906	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EBNA1BP2 mRNA	PMID:17602206
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of EBNA1BP2 mRNA	PMID:32680482
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EBNA1BP2 mRNA	PMID:37236586
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313991	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of EBNA1BP2 mRNA	PMID:28903501
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EBNA1BP2 mRNA	PMID:19320972|PMID:19376846
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of EBNA1BP2 mRNA	PMID:24449571
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of EBNA1BP2 mRNA	PMID:25908611
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:D002994	Clofibrate results in decreased expression of EBNA1BP2 mRNA	PMID:17585979
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of EBNA1BP2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EBNA1BP2 mRNA]	PMID:17585979
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:C100187	chloropicrin results in decreased expression of EBNA1BP2 mRNA	PMID:26352163
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EBNA1BP2 mRNA	PMID:36331819
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:C016104	sodium bichromate results in increased expression of EBNA1BP2 mRNA	PMID:25993096
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D014635	Valproic Acid affects the expression of EBNA1BP2 mRNA	PMID:25979313
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D014635	Valproic Acid results in increased expression of EBNA1BP2 mRNA	PMID:23179753|PMID:25192806|PMID:26272509|PMID:28001369
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1313990	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBNA1BP2 mRNA	PMID:27188386
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D016572	Cyclosporine results in decreased expression of EBNA1BP2 mRNA	PMID:22147139
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D016572	Cyclosporine results in increased expression of EBNA1BP2 mRNA	PMID:20106945
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1313990	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of EBNA1BP2 promoter	PMID:27989131
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of EBNA1BP2 mRNA	PMID:33512557
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:C012655	nimesulide results in increased expression of EBNA1BP2 mRNA	PMID:24136188
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313990	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EBNA1BP2 mRNA	PMID:38832940
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:D000082	Acetaminophen affects the expression of EBNA1BP2 mRNA	PMID:17562736
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of EBNA1BP2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EBNA1BP2 mRNA]	PMID:17585979
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBNA1BP2 mRNA	PMID:40504410
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of EBNA1BP2 mRNA	PMID:29391264
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313991	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EBNA1BP2 mRNA	PMID:35676786
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313991	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EBNA1BP2 mRNA; Nanotubes, Carbon results in increased expression of EBNA1BP2 mRNA	PMID:25554681|PMID:25620056
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of EBNA1BP2 mRNA	PMID:34044035
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:D005485	Flutamide results in increased expression of EBNA1BP2 mRNA	PMID:24136188
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:C015559	trimellitic anhydride results in increased expression of EBNA1BP2 mRNA	PMID:19042947
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EBNA1BP2 protein	PMID:32959892
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160906	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of EBNA1BP2 mRNA	PMID:25729387
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of EBNA1BP2 mRNA	PMID:24136188
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of EBNA1BP2 mRNA	PMID:23650126
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313990	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EBNA1BP2 protein	PMID:34186270
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EBNA1BP2 mRNA	PMID:22206623
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1313990	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EBNA1BP2 protein	PMID:37664457
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160906	CTD	MESH:C051752	nefazodone results in increased expression of EBNA1BP2 mRNA	PMID:24136188
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1313990	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of EBNA1BP2 protein	PMID:31285264
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1313990	E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of EBNA1BP2 protein	PMID:39638853
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20160906	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of EBNA1BP2 mRNA	PMID:21346803
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EBNA1BP2 mRNA	PMID:30851411
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313990	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBNA1BP2 mRNA	PMID:27188386
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1313990	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EBNA1BP2 gene]	PMID:28238834
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313990	E	RGD:6480464	20160906	CTD	MESH:D010894	Piroxicam results in decreased expression of EBNA1BP2 mRNA	PMID:21858171
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313991	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of EBNA1BP2 mRNA	PMID:39847705
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313991	E	RGD:6480464	20160906	CTD	MESH:C045950	propiconazole results in increased expression of EBNA1BP2 mRNA	PMID:21278054
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313990	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EBNA1BP2 protein; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBNA1BP2 mRNA	PMID:27188386|PMID:37664457
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20160906	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EBNA1BP2 mRNA	PMID:21346803
1305762	Ebna1bp2	EBNA1 binding protein 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20160906	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EBNA1BP2 mRNA	PMID:21346803
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313993	E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of NUSAP1 mRNA	PMID:31863870
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in decreased expression of NUSAP1 mRNA	PMID:24172598
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NUSAP1 mRNA	PMID:39752319
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1313993	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of NUSAP1 mRNA	PMID:34925699
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NUSAP1 mRNA	PMID:20938992
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20120613	CTD	MESH:D014212	Tretinoin results in decreased expression of NUSAP1 mRNA	PMID:16249480|PMID:21934132|PMID:33167477
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of NUSAP1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NUSAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of NUSAP1 mRNA	PMID:32699268|PMID:32845096
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NUSAP1 mRNA	PMID:21632981
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16412	lipopolysaccharide	affects expression	ISO	RGD:1313993	E	RGD:6480464	20180313	CTD	MESH:D008070	Lipopolysaccharides affects the expression of NUSAP1 mRNA	PMID:28070326
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20180313	CTD	MESH:D008070	Plant Extracts affects the reaction [Lipopolysaccharides affects the expression of NUSAP1 mRNA]	PMID:28070326
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of NUSAP1 mRNA	PMID:32145629
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of NUSAP1 mRNA	PMID:23019147
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NUSAP1 mRNA	PMID:39298647
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313993	E	RGD:6480464	20130212	CTD	MESH:D004958	Estradiol results in increased expression of NUSAP1 mRNA	PMID:18310284|PMID:19167446
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313994	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of NUSAP1 mRNA	PMID:25210133
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of NUSAP1 mRNA]	PMID:25210133
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA	PMID:25510870
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NUSAP1 mRNA	PMID:33387578
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of NUSAP1 mRNA	PMID:25549359
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NUSAP1 mRNA	PMID:20938992
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:16767	3,4-dichloroaniline	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in decreased expression of NUSAP1 mRNA	PMID:24172598
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of NUSAP1 mRNA	PMID:21795739
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of NUSAP1 mRNA	PMID:18070364
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of NUSAP1 mRNA	PMID:26079696
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NUSAP1 mRNA	PMID:39752319
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of NUSAP1 mRNA	PMID:19031421
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of NUSAP1 mRNA	PMID:21592394
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of NUSAP1 mRNA	PMID:21592394
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17356	2-acetamidofluorene	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of NUSAP1 mRNA	PMID:22584684
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of NUSAP1 mRNA	PMID:27683099
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:177387	brequinar	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in decreased expression of NUSAP1 mRNA	PMID:39900124
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of NUSAP1 mRNA	PMID:26577399
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313993	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NUSAP1 protein	PMID:37730182
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of NUSAP1 mRNA	PMID:21592394
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of NUSAP1 mRNA	PMID:21592394
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1313993	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NUSAP1 mRNA	PMID:28818685
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NUSAP1 mRNA	PMID:36331819
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:2038	5-azacytidine	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D001374	[Azacitidine co-treated with Thalidomide] affects the expression of NUSAP1 mRNA	PMID:18720364
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of NUSAP1 mRNA	PMID:21120746|PMID:24376830
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUSAP1 mRNA	PMID:28111341
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA	PMID:25510870
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA	PMID:25510870
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NUSAP1 mRNA	PMID:19549813
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1313993	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of NUSAP1 mRNA	PMID:23649840
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of NUSAP1 protein	PMID:20106945
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NUSAP1 mRNA	PMID:27153756
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NUSAP1 mRNA	PMID:23630614|PMID:25378103
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1313993	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NUSAP1 mRNA	PMID:23649840
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of NUSAP1 mRNA	PMID:25102026
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NUSAP1 mRNA	PMID:32553695
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of NUSAP1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NUSAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of NUSAP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of NUSAP1 mRNA	PMID:32699268|PMID:32845096
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NUSAP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NUSAP1 mRNA; TTPA protein affects the reaction [Ozone results in increased expression of NUSAP1 mRNA]	PMID:19555225|PMID:27106289|PMID:34911549
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1313993	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of NUSAP1 mRNA	PMID:22171008
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D014747	NUSAP1 protein affects the susceptibility to Vinblastine	PMID:16217747
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of NUSAP1 mRNA	PMID:17484886
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313994	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NUSAP1 mRNA	PMID:27339419|PMID:29987408|PMID:31919559
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NUSAP1 mRNA	PMID:25629700
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of NUSAP1 mRNA	PMID:24657277
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NUSAP1 mRNA	PMID:20938992
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in decreased expression of NUSAP1 mRNA	PMID:25270620
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NUSAP1 mRNA	PMID:39836092
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUSAP1 mRNA	PMID:40504410
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of NUSAP1 mRNA	PMID:26272509
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUSAP1 mRNA	PMID:27188386
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313993	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of NUSAP1 protein	PMID:35688186
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of NUSAP1 mRNA	PMID:28960355
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NUSAP1 mRNA	PMID:31881176
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of NUSAP1 mRNA	PMID:19167446
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in decreased expression of NUSAP1 mRNA	PMID:25270620|PMID:40618947
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in increased expression of NUSAP1 mRNA	PMID:19031421
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUSAP1 mRNA	PMID:22298810
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313993	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUSAP1 mRNA	PMID:22298810
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313994	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUSAP1 mRNA	PMID:21570461
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NUSAP1 mRNA	PMID:32109520|PMID:33387578
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NUSAP1 mRNA	PMID:21802500
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUSAP1 mRNA	PMID:34747641
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NUSAP1 mRNA	PMID:17942748
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of NUSAP1 mRNA	PMID:28374803
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of NUSAP1 mRNA	PMID:33512557
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NUSAP1 mRNA	PMID:33212167
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of NUSAP1 mRNA	PMID:28959563
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of NUSAP1 mRNA	PMID:30556269
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUSAP1 mRNA	PMID:20971185
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D004317	NUSAP1 protein affects the susceptibility to Doxorubicin	PMID:16217747
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NUSAP1 mRNA	PMID:29803840|PMID:30031762
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of NUSAP1 mRNA	PMID:39631538
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313994	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of NUSAP1 mRNA	PMID:36227756
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1313994	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of NUSAP1 mRNA	PMID:32042022
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of NUSAP1 mRNA	PMID:22623647
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NUSAP1 mRNA	PMID:38568856
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of NUSAP1 mRNA	PMID:17998272
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313993	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of NUSAP1 mRNA	PMID:29301061
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313994	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of NUSAP1 mRNA	PMID:39095385
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NUSAP1 mRNA	PMID:39836092
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUSAP1 mRNA	PMID:40504410
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NUSAP1 mRNA	PMID:22378314
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NUSAP1 mRNA	PMID:21632981|PMID:21802500|PMID:26238291
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NUSAP1 mRNA	PMID:21569818
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of NUSAP1 mRNA; Benzo(a)pyrene results in increased expression of NUSAP1 mRNA	PMID:32417428|PMID:32553695
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of NUSAP1 mRNA	PMID:30556269
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUSAP1 mRNA	PMID:20971185
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1313993	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of NUSAP1 mRNA	PMID:22171008
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of NUSAP1 mRNA	PMID:27131904
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313993	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NUSAP1 mRNA	PMID:25351596
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313994	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NUSAP1 mRNA	PMID:29341224
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUSAP1 mRNA	PMID:20018196|PMID:20382639
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313993	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NUSAP1 mRNA	PMID:20458559
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:3090	bicalutamide	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in decreased expression of NUSAP1 mRNA	PMID:15638997
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of NUSAP1 mRNA	PMID:25729387
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUSAP1 mRNA	PMID:25729387
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NUSAP1 mRNA	PMID:30047161
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of NUSAP1 mRNA	PMID:30012374
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313994	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of NUSAP1 mRNA	PMID:23557971
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NUSAP1 mRNA	PMID:23411599|PMID:34492290
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NUSAP1 mRNA	PMID:18648102
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of NUSAP1 mRNA	PMID:17950772
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NUSAP1 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of NUSAP1 mRNA]	PMID:17950772|PMID:19710929
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of NUSAP1 mRNA	PMID:19191707
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313994	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of NUSAP1 mRNA	PMID:28472532
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of NUSAP1 mRNA	PMID:38479592
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of NUSAP1 mRNA	PMID:32145629
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313993	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NUSAP1 mRNA	PMID:30903817
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NUSAP1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NUSAP1 mRNA	PMID:29275510
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NUSAP1 mRNA	PMID:36041667
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of NUSAP1 mRNA	PMID:26682919
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA	PMID:25510870
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA	PMID:25510870
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of NUSAP1 mRNA	PMID:20713471
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of NUSAP1 mRNA	PMID:39298647|PMID:40203079
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NUSAP1 mRNA	PMID:36041667
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of NUSAP1 mRNA	PMID:26377693
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NUSAP1 mRNA	PMID:36041667
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NUSAP1 mRNA	PMID:24535843
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of NUSAP1 mRNA	PMID:26377693
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of NUSAP1 mRNA	PMID:30723492
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NUSAP1 mRNA	PMID:25993096
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUSAP1 mRNA	PMID:28111341
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of NUSAP1 mRNA	PMID:25539665
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NUSAP1 mRNA	PMID:30047161
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313994	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NUSAP1 mRNA	PMID:22698814
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NUSAP1 mRNA	PMID:24386269
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NUSAP1 mRNA	PMID:19376846
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of NUSAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of NUSAP1 mRNA	PMID:32699268
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of NUSAP1 mRNA	PMID:19031421
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of NUSAP1 mRNA	PMID:32588087
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of NUSAP1 mRNA	PMID:40194260
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313994	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NUSAP1 mRNA	PMID:40194260
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NUSAP1 mRNA	PMID:28302478
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NUSAP1 mRNA	PMID:31533062
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313993	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NUSAP1 mRNA	PMID:19167446
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUSAP1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of NUSAP1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of NUSAP1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NUSAP1 mRNA]	PMID:18310284|PMID:19167446
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of NUSAP1 mRNA	PMID:39529242
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NUSAP1 mRNA	PMID:40419075
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NUSAP1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NUSAP1 mRNA	PMID:36331819
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313993	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NUSAP1 mRNA	PMID:25979313
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of NUSAP1 mRNA	PMID:28001369
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of NUSAP1 mRNA	PMID:41580965
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NUSAP1 mRNA	PMID:30047161
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NUSAP1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of NUSAP1 mRNA	PMID:33512557
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:41308	benzophenone	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C047723	benzophenone results in increased expression of NUSAP1 mRNA	PMID:22584684
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of NUSAP1 mRNA	PMID:17555576
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313994	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NUSAP1 mRNA	PMID:28973697
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of NUSAP1 mRNA	PMID:23649840
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of NUSAP1 mRNA	PMID:24657277
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of NUSAP1 mRNA	PMID:24657277
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313993	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NUSAP1 mRNA	PMID:38832940
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:45863	paclitaxel	affects response to substance	ISO	RGD:1313993	E	RGD:6480464	20161213	CTD	MESH:D017239	NUSAP1 protein affects the susceptibility to Paclitaxel	PMID:16217747
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NUSAP1 mRNA	PMID:33387578
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313993	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NUSAP1 mRNA	PMID:22230336
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NUSAP1 mRNA	PMID:39836092
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUSAP1 mRNA	PMID:40504410
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NUSAP1 mRNA	PMID:29391264
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:4846	erythromycin estolate	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D004918	Erythromycin Estolate results in decreased expression of NUSAP1 mRNA	PMID:24412560
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:4846	erythromycin estolate	increases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D004918	Erythromycin Estolate results in increased expression of NUSAP1 mRNA	PMID:24412560
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NUSAP1 mRNA	PMID:17555576
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NUSAP1 mRNA	PMID:17942748
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NUSAP1 mRNA	PMID:17942748
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313993	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NUSAP1 mRNA	PMID:20458559
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1313994	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of NUSAP1 mRNA	PMID:25270620
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313994	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of NUSAP1 mRNA	PMID:25554681
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313994	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NUSAP1 mRNA	PMID:25554681
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NUSAP1 mRNA	PMID:30047161
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of NUSAP1 mRNA	PMID:21148553
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of NUSAP1 mRNA	PMID:24793618
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313994	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NUSAP1 mRNA	PMID:19042947
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313993	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of NUSAP1 protein	PMID:23718831
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313994	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of NUSAP1 mRNA	PMID:38701926
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of NUSAP1 mRNA	PMID:20080153
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NUSAP1 mRNA	PMID:25729387
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUSAP1 mRNA	PMID:25729387
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:63634	valdecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of NUSAP1 mRNA	PMID:24136188
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of NUSAP1 mRNA	PMID:23650126
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of NUSAP1 mRNA	PMID:24136188
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of NUSAP1 mRNA	PMID:28988120
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of NUSAP1 mRNA	PMID:15336504
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NUSAP1 mRNA	PMID:37269647
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NUSAP1 mRNA	PMID:24810058
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of NUSAP1 mRNA	PMID:19031421
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of NUSAP1 mRNA	PMID:35283115
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D008701	Methapyrilene results in increased expression of NUSAP1 mRNA	PMID:22584684
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:70778	GW 7647	increases expression	ISO	RGD:1313994	E	RGD:6480464	20250805	CTD	MESH:C453899	GW 7647 results in increased expression of NUSAP1 mRNA	PMID:40216583
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:70778	GW 7647	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250805	CTD	MESH:C453899	PPARA gene mutant form inhibits the reaction [GW 7647 results in increased expression of NUSAP1 mRNA]	PMID:40216583
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NUSAP1 mRNA	PMID:39752319
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of NUSAP1 mRNA	PMID:27225895
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of NUSAP1 mRNA	PMID:27225895
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of NUSAP1 mRNA	PMID:29522793
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of NUSAP1 mRNA	PMID:27858113
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1313993	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NUSAP1 mRNA	PMID:37199045
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of NUSAP1 mRNA	PMID:29877212
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:76989	phytoestrogen	increases expression	ISO	RGD:1313993	E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of NUSAP1 mRNA	PMID:18310284
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of NUSAP1 mRNA	PMID:34995734
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUSAP1 mRNA	PMID:27188386
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in decreased expression of NUSAP1 mRNA	PMID:20097248
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of NUSAP1 mRNA	PMID:18927307
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of NUSAP1 mRNA	PMID:31324951
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313994	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of NUSAP1 mRNA	PMID:19482888|PMID:23091169
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NUSAP1 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NUSAP1 mRNA]	PMID:19482888|PMID:24535843
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUSAP1 mRNA	PMID:19167446
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313994	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of NUSAP1 mRNA	PMID:38648751
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of NUSAP1 mRNA	PMID:26705709
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of NUSAP1 mRNA	PMID:32234424
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NUSAP1 mRNA	PMID:24780913|PMID:30047161
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of NUSAP1 mRNA	PMID:22869556
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NUSAP1 mRNA	PMID:39752319
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of NUSAP1 mRNA	PMID:32419051
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUSAP1 mRNA	PMID:27188386
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:9111	Senkirkine	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of NUSAP1 mRNA	PMID:32419051
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of NUSAP1 mRNA	PMID:27131904
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:9513	thalidomide	multiple interactions	ISO	RGD:1313993	E	RGD:6480464	20120412	CTD	MESH:D013792	[Azacitidine co-treated with Thalidomide] affects the expression of NUSAP1 mRNA	PMID:18720364
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NUSAP1 mRNA	PMID:22378314
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313993	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of NUSAP1 mRNA	PMID:19140230
1305764	Nusap1	nucleolar and spindle associated protein 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of NUSAP1 mRNA	PMID:35537566
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of NUDT21 mRNA	PMID:15498508|PMID:33167477
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552286	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of NUDT21 mRNA	PMID:30319688
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313996	E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of NUDT21 mRNA	PMID:35877022
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1313996	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NUDT21 mRNA	PMID:38568856
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313996	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NUDT21 mRNA	PMID:37042841
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552286	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NUDT21 mRNA	PMID:33754040
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NUDT21 mRNA	PMID:22061828
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313996	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NUDT21 mRNA	PMID:35301059
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552286	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUDT21 mRNA	PMID:22206623
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:27563	arsenic atom	increases ubiquitination	ISO	RGD:1313996	E	RGD:6480464	20230704	CTD	MESH:D001151	Arsenic results in increased ubiquitination of NUDT21 protein	PMID:35994080
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313996	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NUDT21 mRNA	PMID:23557933
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313996	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of NUDT21 mRNA	PMID:27594783
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1552286	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NUDT21 mRNA	PMID:30912803
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1552286	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of NUDT21 mRNA	PMID:18930951
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313996	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUDT21 mRNA	PMID:22574217
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552286	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUDT21 mRNA	PMID:21570461
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUDT21 mRNA	PMID:33387578
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552286	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUDT21 mRNA	PMID:26290441
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NUDT21 mRNA	PMID:17942748
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313996	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of NUDT21 mRNA	PMID:33512557
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1313996	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NUDT21 mRNA	PMID:28001369
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NUDT21 mRNA	PMID:33212167
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NUDT21 mRNA	PMID:30851411
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313996	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUDT21 mRNA	PMID:20971185
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:29678	sodium arsenite	increases activity	ISO	RGD:1313996	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in increased activity of NUDT21 protein	PMID:30528433
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NUDT21 mRNA	PMID:21632981
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552286	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NUDT21 mRNA	PMID:22228805
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313996	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to NUDT21 protein]; arsenite promotes the reaction [G3BP1 protein binds to NUDT21 mRNA]	PMID:32406909
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313996	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUDT21 mRNA	PMID:20971185
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUDT21 mRNA	PMID:26238291
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUDT21 mRNA	PMID:25729387
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:32181	tamibarotene	affects expression	ISO	RGD:1313996	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of NUDT21 mRNA	PMID:15498508
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552286	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NUDT21 gene	PMID:35295148
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552286	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NUDT21 mRNA	PMID:23811191
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313996	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NUDT21 mRNA	PMID:30903817
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NUDT21 mRNA	PMID:30816183
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of NUDT21 protein	PMID:34186270
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NUDT21 mRNA	PMID:25181051
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of NUDT21 protein	PMID:31675489
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1552286	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of NUDT21 mRNA	PMID:20713471
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313996	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of NUDT21 protein	PMID:34186270
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1313996	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of NUDT21 protein	PMID:34186270
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1552286	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of NUDT21 mRNA	PMID:34813904
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313996	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NUDT21 mRNA	PMID:37042841
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NUDT21 mRNA	PMID:38174414
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313996	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NUDT21 mRNA	PMID:35301059
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313996	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NUDT21 mRNA	PMID:19167446
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552286	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NUDT21 mRNA	PMID:36331819
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313996	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NUDT21 mRNA	PMID:25979313
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of NUDT21 mRNA	PMID:23179753
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1313996	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of NUDT21 gene	PMID:29154799
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313996	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased expression of NUDT21 mRNA; Valproic Acid results in increased expression of NUDT21 protein	PMID:29501571
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1313996	E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of NUDT21 gene	PMID:29501571
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NUDT21 mRNA	PMID:25562108
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1552286	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of NUDT21 mRNA	PMID:19770486
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D013629	Tamoxifen affects the expression of NUDT21 mRNA	PMID:17555576
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1552286	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of NUDT21 mRNA	PMID:17998272
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D008727	Methotrexate affects the expression of NUDT21 mRNA	PMID:18502557
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313996	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUDT21 mRNA	PMID:27188386
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552286	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NUDT21 mRNA	PMID:17562736
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20160210	CTD	MESH:D000082	Acetaminophen results in decreased expression of NUDT21 mRNA	PMID:21420995|PMID:26497421
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:47217	arsane	increases ubiquitination	ISO	RGD:1313996	E	RGD:6480464	20230704	CTD	MESH:D001151	Arsenic results in increased ubiquitination of NUDT21 protein	PMID:35994080
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of NUDT21 mRNA	PMID:31675489
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NUDT21 mRNA	PMID:17555576
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NUDT21 mRNA	PMID:17942748
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NUDT21 mRNA	PMID:17942748
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552286	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of NUDT21 mRNA	PMID:25554681
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552286	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NUDT21 mRNA	PMID:19042947
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20161115	CTD	MESH:D015474	Isotretinoin results in decreased expression of NUDT21 mRNA	PMID:20436886
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NUDT21 protein	PMID:32959892
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUDT21 mRNA	PMID:25729387
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of NUDT21 mRNA	PMID:15336504
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313996	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of NUDT21 mRNA	PMID:15336504
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NUDT21 protein	PMID:24806433
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313996	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NUDT21 protein	PMID:34186270
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552286	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUDT21 mRNA	PMID:22206623
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of NUDT21 mRNA	PMID:22124623
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NUDT21 mRNA	PMID:30851411
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1313996	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUDT21 mRNA	PMID:27188386
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552286	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NUDT21 mRNA	PMID:30294300
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:81892	Brodifacoum	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of NUDT21 protein	PMID:28903499
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1313996	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of NUDT21 protein	PMID:31675489
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:8249	piroxicam	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of NUDT21 mRNA	PMID:21858171
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1313996	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUDT21 mRNA	PMID:27188386
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1552286	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of NUDT21 protein	PMID:24648495
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313996	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of NUDT21 mRNA	PMID:19140230
1305766	Nudt21	nudix hydrolase 21	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552286	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of NUDT21 mRNA	PMID:28973697
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CPSF3 mRNA	PMID:26251327
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313999	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of CPSF3 promoter	PMID:26251327
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CPSF3 mRNA	PMID:33167477
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of CPSF3 protein	PMID:39571964
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CPSF3 mRNA	PMID:22378314
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313999	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CPSF3 mRNA	PMID:30319688
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313999	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CPSF3 mRNA	PMID:39241906
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313999	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CPSF3 mRNA	PMID:39298647
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1313998	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CPSF3 mRNA	PMID:37042841
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of CPSF3 protein	PMID:34122009
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1313998	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CPSF3 protein	PMID:37730182
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CPSF3 mRNA	PMID:22061828
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CPSF3 mRNA	PMID:35301059
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CPSF3 mRNA	PMID:19549813
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CPSF3 protein	PMID:23301498
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1313998	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CPSF3 intron	PMID:30157460
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1313998	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CPSF3 gene	PMID:27153756
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CPSF3 mRNA	PMID:35430440
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1313998	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CPSF3 protein	PMID:35688186
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CPSF3 mRNA	PMID:26302742
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of CPSF3 mRNA	PMID:23195993
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313999	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CPSF3 mRNA	PMID:21570461
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of CPSF3 protein	PMID:39603559
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CPSF3 mRNA	PMID:33212167
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CPSF3 mRNA	PMID:28959563
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CPSF3 mRNA	PMID:20971185
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CPSF3 mRNA	PMID:38568856
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of CPSF3 protein	PMID:39571964
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313998	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CPSF3 intron	PMID:30157460
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of CPSF3 protein	PMID:37955338
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CPSF3 mRNA]	PMID:32406909
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CPSF3 mRNA	PMID:20971185
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of CPSF3 protein	PMID:34122009
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of CPSF3 mRNA	PMID:20542052
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313999	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CPSF3 gene	PMID:35295148
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF3 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF3 protein	PMID:37567409
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313998	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CPSF3 mRNA	PMID:33670352
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CPSF3 gene	PMID:28505145
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CPSF3 protein	PMID:31675489
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313999	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CPSF3 mRNA	PMID:39298647
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CPSF3 mRNA	PMID:37019170
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:34648	clofibric acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CPSF3 mRNA	PMID:17602206
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CPSF3 mRNA	PMID:17361019|PMID:21266533
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CPSF3 mRNA	PMID:17602206
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1313998	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CPSF3 mRNA	PMID:37042841
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CPSF3 mRNA	PMID:38568856
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CPSF3 promoter	PMID:22457795
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CPSF3 mRNA	PMID:35301059
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of CPSF3 mRNA	PMID:17585979
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1313998	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CPSF3 mRNA	PMID:19167446
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CPSF3 mRNA	PMID:21420995
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CPSF3 mRNA	PMID:29279043
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CPSF3 mRNA	PMID:31675489
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CPSF3 mRNA	PMID:22079256
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CPSF3 mRNA	PMID:24136188
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313999	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CPSF3 mRNA	PMID:35964746
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CPSF3 mRNA	PMID:24136188
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CPSF3 protein	PMID:32959892
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313999	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CPSF3 mRNA	PMID:22206623
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CPSF3 mRNA	PMID:24136188
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CPSF3 mRNA	PMID:22079256
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1313998	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CPSF3 mRNA	PMID:22079256
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313999	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CPSF3 mRNA	PMID:30294300
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CPSF3 protein	PMID:31675489
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CPSF3 mRNA	PMID:21346803
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of CPSF3 mRNA	PMID:24136188
1305767	Cpsf3	cleavage and polyadenylation specific factor 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1313998	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CPSF3 mRNA	PMID:38568856
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314000	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CFAP100 mRNA	PMID:39298647
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1602811	E	RGD:6480464	20241001	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CFAP100 mRNA	PMID:31163220
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CFAP100 mRNA	PMID:26577399|PMID:27523638
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CFAP100 mRNA	PMID:33387578
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1314000	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of CFAP100 mRNA	PMID:39984025
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602811	E	RGD:6480464	20241001	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CFAP100 intron	PMID:30157460
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314000	E	RGD:6480464	20241001	CTD	MESH:C024565	ethylene dichloride results in increased expression of CFAP100 mRNA	PMID:28960355
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314000	E	RGD:6480464	20161115	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CFAP100 mRNA	PMID:26377647
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602811	E	RGD:6480464	20241001	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CFAP100 5' UTR; Benzo(a)pyrene affects the methylation of CFAP100 promoter	PMID:27901495
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1602811	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CFAP100 mRNA	PMID:21871943
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602811	E	RGD:6480464	20241001	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CFAP100 exon	PMID:27901495
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314000	E	RGD:6480464	20170110	CTD	MESH:D012834	Silver results in increased expression of CFAP100 mRNA	PMID:27131904
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1602811	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CFAP100 gene	PMID:31601247
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1602811	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CFAP100 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of CFAP100 gene	PMID:31601247
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CFAP100 mRNA	PMID:30047161
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1314000	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of CFAP100 mRNA	PMID:23557971
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CFAP100 mRNA	PMID:25181051
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1602811	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CFAP100 gene	PMID:31601247
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602811	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CFAP100 gene	PMID:31601247
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of CFAP100 mRNA	PMID:23829299
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314000	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CFAP100 mRNA	PMID:39298647
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1602811	E	RGD:6480464	20241001	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CFAP100 intron	PMID:30157460
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:34575	bisphenol F	increases methylation	ISO	RGD:1602811	E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in increased methylation of CFAP100 gene	PMID:31601247
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1602811	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of CFAP100 gene	PMID:31601247
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314000	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CFAP100 intron	PMID:28392331
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CFAP100 mRNA	PMID:35163327
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CFAP100 mRNA	PMID:35163327
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314000	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CFAP100 mRNA	PMID:40194260
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314000	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of CFAP100 mRNA	PMID:39529242
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602811	E	RGD:6480464	20241001	CTD	MESH:D014635	Valproic Acid results in increased methylation of CFAP100 gene	PMID:29154799
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000640	Amitrole results in decreased expression of CFAP100 mRNA	PMID:30047161
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1314000	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of CFAP100 mRNA	PMID:25123088
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CFAP100 mRNA	PMID:33387578
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CFAP100 mRNA	PMID:29391264
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CFAP100 mRNA	PMID:30307764
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314000	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CFAP100 mRNA; Nanotubes, Carbon results in decreased expression of CFAP100 mRNA	PMID:25554681
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D008713	Methimazole results in decreased expression of CFAP100 mRNA	PMID:30047161
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1314000	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CFAP100 mRNA	PMID:38701926
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CFAP100 mRNA	PMID:28801915
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1602811	E	RGD:6480464	20241001	CTD	MESH:D008701	Methapyrilene results in increased methylation of CFAP100 intron	PMID:30157460
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1602811	E	RGD:6480464	20241001	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CFAP100 gene]	PMID:28238834
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CFAP100 mRNA	PMID:30047161
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314000	E	RGD:6480464	20170110	CTD	MESH:D012834	Silver results in increased expression of CFAP100 mRNA	PMID:27131904
1305768	Cfap100	cilia and flagella associated protein 100	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1602811	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CFAP100 mRNA	PMID:29301935
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PINK1 mRNA]	PMID:31150632
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:134606	toyocamycin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240305	CTD	MESH:D014127	Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]	PMID:37692514
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PINK1 mRNA	PMID:30071829
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15343	acetaldehyde	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20221101	CTD	MESH:D000079	Acetaldehyde results in decreased expression of PINK1 mRNA; Acetaldehyde results in decreased expression of PINK1 protein	PMID:35595033
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15343	acetaldehyde	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20221101	CTD	MESH:D000079	PINK1 protein inhibits the reaction [Acetaldehyde results in decreased expression of FTH1 protein]; Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PINK1 mRNA]; Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PINK1 protein]	PMID:35595033
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15355	acetylcholine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211207	CTD	MESH:D000109	Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein]	PMID:34547296
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314001	E	RGD:6480464	20260602	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PINK1 protein	PMID:39829390
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D010100	[Antagomirs results in decreased expression of MIR205 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]; [Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]]; [Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein; dorsomorphin inhibits the reaction [sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein]]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein]; Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]; sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein]	PMID:21159781|PMID:34078833|PMID:34358556
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20260602	CTD	MESH:D010100	3-methyladenine inhibits the reaction [Oxygen deficiency results in increased expression of PINK1 protein]; BNIP3 protein affects the reaction [Oxygen deficiency results in increased expression of PINK1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of PINK1 protein]; YTHDF2 protein affects the reaction [Oxygen deficiency results in increased expression of PINK1 protein]	PMID:39829390
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20171010	CTD	MESH:D010100	[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of PINK1 protein; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of PINK1 protein]	PMID:28477916
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of PINK1 mRNA	PMID:39506029
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1314001	E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of PINK1 protein	PMID:40023272
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20201006	CTD	MESH:D019308	3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PINK1 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PINK1 mRNA; Palmitic Acid inhibits the reaction [Cyclosporine results in decreased expression of PINK1 protein]	PMID:32369900|PMID:40023272
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15891	taurine	multiple interactions	EXP		E	RGD:6480464	20190507	CTD	MESH:D013654	Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PINK1 protein]; Taurine inhibits the reaction [sodium arsenite results in decreased expression of PINK1 protein]	PMID:30551535
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:D001280	Atrazine results in increased expression of PINK1 mRNA; Atrazine results in increased expression of PINK1 protein	PMID:30084861
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PINK1 mRNA; Atrazine results in increased expression of PINK1 protein	PMID:40209350
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D001280	[Curcumin co-treated with Atrazine] results in increased expression of PINK1 mRNA; [Curcumin co-treated with Atrazine] results in increased expression of PINK1 protein; Curcumin inhibits the reaction [Atrazine results in increased expression of PINK1 protein]; Curcumin promotes the reaction [Atrazine results in increased expression of PINK1 mRNA]	PMID:40209350
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:C015329	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PINK1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PINK1 protein]	PMID:33908429|PMID:36583613
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16112	chlorogenic acid	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20260407	CTD	MESH:D002726	Chlorogenic Acid inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of PINK1 mRNA]	PMID:40695427
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16196	oleic acid	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20240604	CTD	MESH:D019301	Oleic Acid results in decreased expression of PINK1 protein	PMID:36592823
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20201006	CTD	MESH:D019301	3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PINK1 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PINK1 mRNA; Metformin inhibits the reaction [Oleic Acid results in decreased expression of PINK1 protein]; qidan inhibits the reaction [Oleic Acid results in decreased expression of PINK1 protein]	PMID:32369900|PMID:36592823
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20221101	CTD	MESH:D000431	Ethanol results in decreased expression of PINK1 mRNA; Ethanol results in decreased expression of PINK1 protein	PMID:35595033
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20221101	CTD	MESH:D000431	PINK1 protein inhibits the reaction [Ethanol results in decreased expression of FTH1 protein]; Silybin inhibits the reaction [Ethanol results in decreased expression of PINK1 mRNA]; Silybin inhibits the reaction [Ethanol results in decreased expression of PINK1 protein]	PMID:35595033
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16240	hydrogen peroxide	affects response to substance	ISO	RGD:1314001	E	RGD:6480464	20130416	CTD	MESH:D006861	PINK1 protein affects the susceptibility to Hydrogen Peroxide	PMID:21366594
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20190219	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of PINK1 mRNA	PMID:30316844
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of PINK1 protein	PMID:21159781
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20130416	CTD	MESH:D006861	BMAL1 protein affects the reaction [Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of PINK1 mRNA]]; HMOX1 protein affects the reaction [PINK1 protein affects the susceptibility to Hydrogen Peroxide]; PINK1 protein affects the reaction [Hydrogen Peroxide results in increased expression of HMOX1 protein]; PINK1 protein affects the reaction [Hydrogen Peroxide results in increased expression of TRAP1 protein]; Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of PINK1 mRNA]	PMID:21366594|PMID:30316844
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D006861	PINK1 protein affects the reaction [Hydrogen Peroxide results in increased chemical synthesis of Reactive Oxygen Species]	PMID:21421046
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PINK1 mRNA	PMID:39241906
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PINK1 mRNA]	PMID:39241906
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PINK1 mRNA	PMID:32145629
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in increased expression of PINK1 mRNA	PMID:35192832
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PINK1 mRNA	PMID:30165855
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16494	lipoic acid	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240109	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Sodium Fluoride results in increased expression of PINK1 mRNA]	PMID:37739047
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16509	1,4-benzoquinone	increases expression	ISO	RGD:1314001	E	RGD:6480464	20180828	CTD	MESH:C004532	quinone results in increased expression of PINK1 mRNA; quinone results in increased expression of PINK1 protein	PMID:29567065
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16509	1,4-benzoquinone	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20180828	CTD	MESH:C004532	Acetylcysteine inhibits the reaction [quinone results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 mRNA]; Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 protein]	PMID:29567065
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PINK1 mRNA	PMID:38568856
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PINK1 mRNA	PMID:33387578
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314001	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PINK1 mRNA	PMID:37042841
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16796	melatonin	increases expression	ISO	RGD:1314001	E	RGD:6480464	20230704	CTD	MESH:D008550	Melatonin results in increased expression of PINK1 protein	PMID:37028639
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16796	melatonin	increases expression	ISO	RGD:1314002	E	RGD:6480464	20230704	CTD	MESH:D008550	Melatonin results in increased expression of PINK1 protein	PMID:37028639
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16796	melatonin	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D008550	Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PINK1 protein]; Melatonin inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]	PMID:26882442|PMID:29966675
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20220111	CTD	MESH:D008550	[PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin promotes the reaction [Paraquat results in increased expression of BNIP3 protein]]; [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]]; [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin results in increased expression of BNIP3 protein]; [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin results in increased expression of PINK1 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]; Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]	PMID:33962019|PMID:37028639
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20230704	CTD	MESH:D008550	[BNIP3 protein co-treated with PINK1 protein] affects the reaction [Melatonin inhibits the reaction [Paraquat results in increased secretion of IL1B protein]]; [BNIP3 protein co-treated with PINK1 protein] affects the reaction [Melatonin inhibits the reaction [Paraquat results in increased secretion of TNF protein]]; Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]	PMID:37028639
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1314002	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of PINK1 mRNA	PMID:34673133
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:168442	Urolithin A	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C026423	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]; 3-methyladenine inhibits the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]; AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]; bardoxolone methyl affects the reaction [AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]]; LONP1 protein affects the reaction [AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]]; PINK1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PRKN protein]]; PINK1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in increased expression of SQSTM1 protein]]	PMID:39725191
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:168442	Urolithin A	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250603	CTD	MESH:C026423	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]	PMID:39725191
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of PINK1 protein	PMID:35243728
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314001	E	RGD:6480464	20220111	CTD	MESH:D005947	Glucose results in increased expression of PINK1 mRNA	PMID:33962019
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of PINK1 protein	PMID:38334676
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Inositol inhibits the reaction [Glucose results in decreased expression of PINK1 protein]	PMID:35243728
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20220111	CTD	MESH:D005947	[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]	PMID:33962019
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	imeglimin inhibits the reaction [Glucose results in increased expression of PINK1 protein]	PMID:38334676
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314002	E	RGD:6480464	20240305	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein	PMID:37692514
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20250311	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased expression of PINK1 protein; Acetylcysteine inhibits the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased expression of PINK1 protein]; mono-(2-ethylhexyl)phthalate affects the cleavage of and affects the expression of PINK1 protein alternative form; PINK1 protein promotes the reaction [[[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] affects the localization of and results in increased activity of and results in increased ubiquitination of PRKN protein] which results in increased degradation of PRKN protein]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of COX4I1 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of MFN1 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of MFN2 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of TIMM23 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of TOMM20 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of VDAC1 protein]]	PMID:33161305|PMID:42054602
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240305	CTD	MESH:C016599	4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]	PMID:37692514
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:173086	ferrostatin-1	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20260407	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [osthol results in increased expression of PINK1 protein]	PMID:40446951
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of PINK1 protein	PMID:35243728
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314001	E	RGD:6480464	20220111	CTD	MESH:D005947	Glucose results in increased expression of PINK1 mRNA	PMID:33962019
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of PINK1 protein	PMID:38334676
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Inositol inhibits the reaction [Glucose results in decreased expression of PINK1 protein]	PMID:35243728
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20220111	CTD	MESH:D005947	[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]	PMID:33962019
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	imeglimin inhibits the reaction [Glucose results in increased expression of PINK1 protein]	PMID:38334676
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:177406	Bardoxolone methyl	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C445068	bardoxolone methyl results in increased expression of PINK1 protein	PMID:39725191
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:177406	Bardoxolone methyl	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C445068	bardoxolone methyl affects the reaction [AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]]	PMID:39725191
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PINK1 protein	PMID:37692514
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314001	E	RGD:6480464	20220705	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PINK1 mRNA; Diethylhexyl Phthalate results in increased expression of PINK1 protein	PMID:34822940
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PINK1 mRNA; Diethylhexyl Phthalate results in increased expression of PINK1 protein	PMID:33908429|PMID:36583613
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:D004051	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PINK1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PINK1 protein]	PMID:33908429|PMID:36583613
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17750	glycine betaine	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:D001622	Betaine inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]	PMID:38651543
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1314001	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of PINK1 mRNA	PMID:16002434
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D005839	Gentamicins results in decreased expression of PINK1 protein	PMID:42173392
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D005839	Formoterol Fumarate inhibits the reaction [Gentamicins results in decreased expression of PINK1 protein]	PMID:42173392
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	affects response to substance	ISO	RGD:1314002	E	RGD:6480464	20190219	CTD	MESH:D015632	PINK1 protein affects the susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	PMID:22511790
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20201215	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of PINK1 mRNA; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of PINK1 protein	PMID:28978077
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20190219	CTD	MESH:D015632	AM 1241 inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of PINK1 mRNA]; AM 1241 inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of PINK1 protein]; PARK7 protein inhibits the reaction [PINK1 protein affects the susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine]; PRKN protein inhibits the reaction [PINK1 protein affects the susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine]	PMID:22511790|PMID:28978077
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314001	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PINK1 mRNA	PMID:28818685
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:18243	dopamine	affects abundance	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D004298	PINK1 protein affects the abundance of Dopamine	PMID:22043175
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:18243	dopamine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D004298	[PINK1 mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Dopamine; Paraquat affects the reaction [PINK1 protein affects the abundance of Dopamine]	PMID:22043175
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:18421	superoxide	affects abundance	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D013481	PINK1 protein affects the abundance of Superoxides	PMID:21421046
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of PINK1 protein	PMID:38373586
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20240903	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of PINK1 protein	PMID:38373586
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:D000517	Cyclosporine inhibits the reaction [ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]]; ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]; TFEB protein promotes the reaction [ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]]	PMID:38373586
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240903	CTD	MESH:D000517	ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]	PMID:38373586
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:18917	1,3-dichloropropan-2-ol	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C033489	1,3-dichloro-2-propanol results in decreased expression of PINK1 protein	PMID:36000575
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:194147	aristolochic acids	increases expression	EXP		E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in increased expression of PINK1 mRNA	PMID:19717638
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:22689	bafilomycin A1	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C040929	bafilomycin A1 inhibits the reaction [Lidocaine results in increased expression of PINK1 protein]	PMID:37914286
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D002104	Cadmium results in decreased expression of PINK1 protein	PMID:40345518
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D002104	Cadmium results in increased expression of PINK1 mRNA	PMID:34816377
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1314002	E	RGD:6480464	20160210	CTD	MESH:D002104	Cadmium results in increased expression of PINK1; Cadmium results in increased expression of PINK1 protein	PMID:25464205|PMID:37270049
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1 mRNA]; Cyclosporine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]	PMID:34816377|PMID:39208572
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20160210	CTD	MESH:D002104	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein; Acetylcarnitine inhibits the reaction [Cadmium results in increased expression of PINK1]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1]; Cyclosporine inhibits the reaction [Cadmium results in increased expression of PINK1]; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKN protein]; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SQSTM1 protein]; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased lipidation of MAP1LC3B protein]	PMID:25464205|PMID:34952138|PMID:37022104
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:232424	MitoTEMPO	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20241203	CTD	MESH:C555916	MitoTEMPO inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]; MitoTEMPO inhibits the reaction [trifloxystrobin results in increased expression of PINK1 protein]	PMID:27853101|PMID:29729358
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:233256	A-967079	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250408	CTD	MESH:C560402	A 967079 inhibits the reaction [Ozone results in decreased expression of PINK1 protein]	PMID:35928613
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:233321	Mitoquinone	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20251007	CTD	MESH:C429014	mitoquinone promotes the reaction [sodium arsenite results in increased expression of PINK1 protein]	PMID:38653026
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	EXP		E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of PINK1 gene	PMID:16495775
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:24848	inositol	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D007294	Inositol inhibits the reaction [Glucose results in decreased expression of PINK1 protein]	PMID:35243728
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PINK1 mRNA	PMID:33354967
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314002	E	RGD:6480464	20221004	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PINK1 mRNA; Aflatoxin B1 results in increased expression of PINK1 protein	PMID:35304092|PMID:35810998
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20221004	CTD	MESH:D016604	PRKN protein affects the reaction [Aflatoxin B1 results in increased expression of PINK1 mRNA]; PRKN protein affects the reaction [Aflatoxin B1 results in increased expression of PINK1 protein]	PMID:35304092
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20231031	CTD	MESH:D010126	Ozone results in decreased expression of PINK1 protein	PMID:35928613
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314002	E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of PINK1 protein	PMID:35866636
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PINK1 mRNA	PMID:35430440
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20220809	CTD	MESH:D010126	3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide inhibits the reaction [Ozone results in decreased expression of PINK1 protein]; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PINK1 mRNA; A 967079 inhibits the reaction [Ozone results in decreased expression of PINK1 protein]	PMID:34911549|PMID:35928613
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:26523	reactive oxygen species	decreases chemical synthesis	ISO	RGD:1314002	E	RGD:6480464	20170303	CTD	MESH:D017382	PINK1 protein results in decreased chemical synthesis of Reactive Oxygen Species	PMID:21421046
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:26523	reactive oxygen species	increases chemical synthesis	ISO	RGD:1314001	E	RGD:6480464	20170303	CTD	MESH:D017382	PINK1 gene mutant form results in increased chemical synthesis of Reactive Oxygen Species	PMID:20547144
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20170303	CTD	MESH:D017382	PINK1 protein affects the reaction [Hydrogen Peroxide results in increased chemical synthesis of Reactive Oxygen Species]	PMID:21421046
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PINK1 mRNA; Carbon Tetrachloride results in decreased expression of PINK1 protein	PMID:26882442|PMID:31150632
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314002	E	RGD:6480464	20221101	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PINK1 protein	PMID:35405287
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D002251	Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PINK1 protein]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PINK1 mRNA]	PMID:26882442|PMID:31150632
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20221101	CTD	MESH:D002251	Sirolimus inhibits the reaction [Carbon Tetrachloride results in increased expression of PINK1 protein]	PMID:35405287
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260113	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PINK1 protein	PMID:40081728
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of PINK1 mRNA	PMID:33512557
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:2762	antimycin A	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20191105	CTD	MESH:D000968	[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of PRKN protein]; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] results in increased expression of SQSTM1 mRNA]; PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]]	PMID:28366621
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PINK1 mRNA	PMID:31881176
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C059514	Resveratrol results in increased expression of PINK1 protein	PMID:32619457
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314002	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of PINK1 mRNA	PMID:22610192
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C059514	[Resveratrol co-treated with Benzo(a)pyrene] results in increased expression of PINK1 protein	PMID:32619457
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PINK1 mRNA	PMID:23557933
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314001	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PINK1 mRNA	PMID:28903495
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D007854	Lead results in decreased expression of PINK1 protein	PMID:40345518
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D007854	Lead results in increased expression of PINK1 mRNA	PMID:34816377
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27889	lead(0)	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D007854	Acetylcysteine inhibits the reaction [Lead results in increased expression of PINK1 mRNA]	PMID:34816377
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20230606	CTD	MESH:D007854	[[amyloid beta-protein (25-35) co-treated with amyloid beta-protein (1-40)] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [amyloid beta-protein (1-40) co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; [amyloid beta-protein (25-35) co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein; amyloid beta-protein (1-40) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; amyloid beta-protein (25-35) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]	PMID:35300571
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1314001	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of PINK1 mRNA	PMID:23300844
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:D002945	Cisplatin results in decreased expression of PINK1	PMID:39102946
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D002945	Cisplatin results in increased expression of PINK1 protein	PMID:28698153
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D002945	Curcumin inhibits the reaction [Cisplatin results in increased expression of PINK1 protein]; Linagliptin inhibits the reaction [Cisplatin results in decreased expression of PINK1]	PMID:28698153|PMID:39102946
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in increased expression of PINK1 mRNA	PMID:21858171
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of PINK1 mRNA	PMID:18930951
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20230801	CTD	MESH:D009532	[nickel chloride results in increased abundance of Nickel] which affects the expression of and affects the localization of PINK1 protein	PMID:36794572
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PINK1 mRNA	PMID:21215274
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PINK1 mRNA	PMID:32109520|PMID:34747641
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314001	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PINK1 mRNA	PMID:20106945|PMID:21632981
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PINK1 mRNA	PMID:17942748
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28135	ponasterone A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C008999	[ponasterone A results in increased expression of PINK1 protein] which results in increased expression of MFN2 protein; ponasterone A results in increased expression of PINK1 protein	PMID:20164189
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28135	ponasterone A	multiple interactions	EXP		E	RGD:6480464	20230606	CTD	MESH:C008999	[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of DNM1L protein; [ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of FIS1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of FIS1 protein]	PMID:20164189
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	affects localization	ISO	RGD:1314001	E	RGD:6480464	20200714	CTD	MESH:D012402	Rotenone affects the localization of PINK1 protein	PMID:32001317
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	affects response to substance	ISO	RGD:1314001	E	RGD:6480464	20130416	CTD	MESH:D012402	PINK1 protein affects the susceptibility to Rotenone	PMID:16226715|PMID:20940149
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	affects response to substance	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D012402	PINK1 protein affects the susceptibility to Rotenone	PMID:21421046|PMID:26916954
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:D012402	Rotenone results in decreased expression of PINK1 mRNA; Rotenone results in decreased expression of PINK1 protein	PMID:32392329|PMID:36538285|PMID:37956489
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of PINK1 mRNA	PMID:33512557
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	decreases response to substance	ISO	RGD:1314001	E	RGD:6480464	20120412	CTD	MESH:D012402	PINK1 protein results in decreased susceptibility to Rotenone	PMID:19492085
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of PINK1 mRNA	PMID:28374803
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314001	E	RGD:6480464	20231205	CTD	MESH:D012402	Rotenone results in increased expression of PINK1 protein	PMID:37156403
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of PINK1 protein	PMID:20464527
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D012402	[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein; Formoterol Fumarate inhibits the reaction [Rotenone results in decreased expression of PINK1 protein]; repaglinide inhibits the reaction [Rotenone results in decreased expression of PINK1 mRNA]; Sirolimus inhibits the reaction [[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein]	PMID:33823232|PMID:36538285|PMID:37956489
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20200714	CTD	MESH:D012402	4,5,6,7-tetrabromobenzotriazole inhibits the reaction [Rotenone results in increased expression of PINK1 protein]; CSNK2A1 protein affects the reaction [Rotenone results in increased expression of PINK1 protein]; DNM1L protein affects the reaction [Rotenone affects the localization of PINK1 protein]; PGAM5 protein affects the reaction [Rotenone results in increased expression of PINK1 protein]; PINK1 protein affects the reaction [Rotenone results in increased cleavage of CASP3 protein]; Rotenone promotes the reaction [PRKN protein binds to PINK1 protein]	PMID:32001317|PMID:37156403
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211012	CTD	MESH:D012402	[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein; Sirolimus inhibits the reaction [[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein]	PMID:33823232
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PINK1 mRNA	PMID:28001369
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314001	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PINK1 mRNA	PMID:33212167
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of PINK1 mRNA	PMID:39709020
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28285	oligomycin A	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20190219	CTD	MESH:C031004	[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of PRKN protein]; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] results in increased expression of SQSTM1 mRNA]; PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]]	PMID:28366621
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PINK1 mRNA	PMID:30851411
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PINK1 mRNA	PMID:28959563
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of PINK1 mRNA	PMID:22465980
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314002	E	RGD:6480464	20240109	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PINK1 mRNA	PMID:37739047
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240109	CTD	MESH:D012969	Thioctic Acid inhibits the reaction [Sodium Fluoride results in increased expression of PINK1 mRNA]	PMID:37739047
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D004317	Doxorubicin results in decreased expression of PINK1 protein	PMID:39725191
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20250603	CTD	MESH:D004317	Doxorubicin results in decreased expression of PINK1 protein	PMID:39725191
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004317	Doxorubicin results in increased expression of PINK1 protein	PMID:26678157|PMID:29966675|PMID:38651543
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314001	E	RGD:6480464	20190219	CTD	MESH:D004317	Doxorubicin results in increased expression of PINK1 protein	PMID:29729358
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]; 3-methyladenine inhibits the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]; AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]; bardoxolone methyl affects the reaction [AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]]; Betaine inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]; LONP1 protein affects the reaction [AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]]; Melatonin inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]; PINK1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PRKN protein]]; PINK1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in increased expression of SQSTM1 protein]]	PMID:29966675|PMID:38651543|PMID:39725191
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20190219	CTD	MESH:D004317	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]; MitoTEMPO inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]	PMID:29729358
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250603	CTD	MESH:D004317	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]	PMID:39725191
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20230704	CTD	MESH:D005632	[Tribulus extract co-treated with Fructose] results in decreased expression of PINK1 protein	PMID:36214339
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20230905	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [Lead results in increased expression of PINK1 mRNA]	PMID:34816377|PMID:39208572
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20180828	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [quinone results in increased expression of PINK1 protein]	PMID:29567065|PMID:33161305
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20160210	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased expression of PINK1 protein]	PMID:25464205|PMID:34547296|PMID:37678662|PMID:37692514
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:28984	aluminium atom	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211207	CTD	MESH:D000535	[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA; [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein; Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA]	PMID:34547296
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite affects the expression of PINK1 protein	PMID:36557995
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1314001	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PINK1 gene	PMID:28589171
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of PINK1 protein	PMID:30551535
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314001	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PINK1 mRNA	PMID:38568856
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314002	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PINK1 mRNA; sodium arsenite results in increased expression of PINK1 protein	PMID:20883709|PMID:36557995|PMID:38653026
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	Rosiglitazone inhibits the reaction [sodium arsenite results in decreased expression of PINK1 protein]; Taurine inhibits the reaction [sodium arsenite results in decreased expression of PINK1 protein]	PMID:30551535
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PINK1 protein; Cyclosporine affects the reaction [sodium arsenite affects the expression of PINK1 protein]; Cyclosporine inhibits the reaction [sodium arsenite results in increased expression of PINK1 protein]; mitoquinone promotes the reaction [sodium arsenite results in increased expression of PINK1 protein]	PMID:36557995|PMID:38653026|PMID:40081728
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of PINK1 mRNA	PMID:17127020
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1314001	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of PINK1 mRNA	PMID:22378314
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PINK1 mRNA	PMID:20127859
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314001	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PINK1 promoter	PMID:27901495
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PINK1 protein	PMID:32619457|PMID:36736873
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001564	[Resveratrol co-treated with Benzo(a)pyrene] results in increased expression of PINK1 protein	PMID:32619457
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of PINK1 mRNA	PMID:22465980
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240109	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Sodium Fluoride results in increased expression of PINK1 mRNA]	PMID:37739047
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PINK1 mRNA; Silicon Dioxide results in decreased expression of PINK1 mRNA; Silicon Dioxide results in decreased expression of PINK1 protein	PMID:25895662|PMID:36309172
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20231205	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PINK1 mRNA; Silicon Dioxide results in decreased expression of PINK1 protein	PMID:36309172
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20231205	CTD	MESH:D012822	PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of COL1A1 mRNA]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of COL1A2 protein]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of FN1 mRNA]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of IL1B mRNA]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of IL1B protein]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of NLRP3 mRNA]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of NLRP3 protein]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of TGFB1 mRNA]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of TGFB1 protein]	PMID:36309172
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PINK1 protein	PMID:30551535
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314001	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PINK1 protein	PMID:27318970
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PINK1 protein]	PMID:30551535
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20191114	CTD	MESH:C006632	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]	PMID:27318970
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:31429	colforsin daropate hydrochloride	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20170725	CTD	MESH:D005576	PINK1 protein affects the reaction [Colforsin results in decreased expression of DNM1L protein]	PMID:24792327
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:31633	formoterol fumarate	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D000068759	Formoterol Fumarate inhibits the reaction [Rotenone results in decreased expression of PINK1 protein]	PMID:37956489
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:31633	formoterol fumarate	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D000068759	Formoterol Fumarate inhibits the reaction [Gentamicins results in decreased expression of PINK1 protein]	PMID:42173392
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PINK1 mRNA	PMID:24136188
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:31705	iodixanol	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:C044834	[Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in increased expression of PINK1 protein	PMID:29860548
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20181113	CTD	MESH:C008261	[[amyloid beta-protein (25-35) co-treated with amyloid beta-protein (1-40)] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [amyloid beta-protein (1-40) co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; [amyloid beta-protein (25-35) co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein; amyloid beta-protein (1-40) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; amyloid beta-protein (25-35) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; lead acetate promotes the reaction [PINK1 protein binds to ATM protein]; lead acetate results in increased expression of and results in increased phosphorylation of PINK1 protein	PMID:29660402|PMID:35300571
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:32130	silver(1+) nitrate	increases expression	ISO	RGD:1314002	E	RGD:6480464	20221206	CTD	MESH:D012835	Silver Nitrate results in increased expression of PINK1 protein	PMID:35697184
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3215	bupivacaine	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20220607	CTD	MESH:D002045	Bupivacaine results in decreased expression of PINK1 protein	PMID:34793778
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3215	bupivacaine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20220607	CTD	MESH:D002045	HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of PINK1 protein]	PMID:34793778
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PINK1 mRNA	PMID:30047161
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of PINK1 mRNA	PMID:24136188
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of PINK1 mRNA	PMID:23557971
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314002	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PINK1 gene	PMID:35295148
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314001	E	RGD:6480464	20190219	CTD	MESH:C009495	titanium dioxide results in increased expression of PINK1 mRNA	PMID:30273564
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PINK1 mRNA	PMID:34492290
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PINK1 mRNA	PMID:19710929
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	affects localization	EXP		E	RGD:6480464	20180313	CTD	MESH:D002258	Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PINK1 protein	PMID:24879156
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	increases expression	ISO	RGD:1314001	E	RGD:6480464	20171114	CTD	MESH:D002258	Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of PINK1 protein	PMID:27318970|PMID:29371327|PMID:37060996
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	increases stability	ISO	RGD:1314001	E	RGD:6480464	20150825	CTD	MESH:D002258	Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased stability of PINK1 protein	PMID:26070385
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D002258	BECN1 protein affects the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PINK1 protein]; PINK1 protein affects the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PRKN protein]	PMID:24879156
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20180313	CTD	MESH:D002258	[Carbonyl Cyanide m-Chlorophenyl Hydrazone co-treated with PRKN protein] results in increased expression of PINK1 protein; [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of and affects the localization of PINK1 protein] promotes the reaction [FKBP5 protein binds to PINK1 protein]; [mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased expression of PINK1 protein; Acetylcysteine inhibits the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased expression of PINK1 protein]; Carbonyl Cyanide m-Chlorophenyl Hydrazone promotes the reaction [PINK1 protein binds to ATM protein]; Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of and affects the localization of PINK1 protein; Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of and results in increased phosphorylation of PINK1 protein; MIR593 inhibits the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of PINK1 protein]; PINK1 protein promotes the reaction [[[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] affects the localization of and results in increased activity of and results in increased ubiquitination of PRKN protein] which results in increased degradation of PRKN protein]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of COX4I1 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of MFN1 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of MFN2 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of TIMM23 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of TOMM20 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of VDAC1 protein]]	PMID:28673964|PMID:29660402|PMID:30734931|PMID:33161305|PMID:37060996
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20141014	CTD	MESH:D002258	PINK1 gene mutant form inhibits the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PRKN protein]	PMID:22872702
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1314001	E	RGD:6480464	20190611	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of PINK1 protein	PMID:30715550|PMID:32866567
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1314002	E	RGD:6480464	20210706	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of PINK1 protein	PMID:32866567
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20210706	CTD	MESH:C074702	HMGA2 protein promotes the reaction [chromium hexavalent ion results in increased expression of PINK1 protein]	PMID:32866567
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of PINK1 mRNA	PMID:32145629
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of PINK1 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314002	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PINK1 mRNA	PMID:26063408
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1314001	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of PINK1 mRNA	PMID:19244175
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:33629	aluminium(0)	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211207	CTD	MESH:D000535	[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA; [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein; Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA]	PMID:34547296
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3374	capsaicin	increases expression	ISO	RGD:1314001	E	RGD:6480464	20230404	CTD	MESH:D002211	Capsaicin results in increased expression of PINK1 mRNA	PMID:36044967
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of PINK1 mRNA	PMID:26682919
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314002	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PINK1 mRNA	PMID:39298647|PMID:40203079
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20190219	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PINK1 mRNA	PMID:29156651
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34631	chlorpyrifos	increases stability	ISO	RGD:1314001	E	RGD:6480464	20150825	CTD	MESH:D004390	Chlorpyrifos results in increased stability of PINK1 protein	PMID:26070385
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34648	clofibric acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of PINK1 mRNA	PMID:17602206
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34679	Di-n-octyl phthalate	increases expression	ISO	RGD:1314001	E	RGD:6480464	20240206	CTD	MESH:C010715	di-n-octyl phthalate results in increased expression of PINK1 mRNA; di-n-octyl phthalate results in increased expression of PINK1 protein	PMID:34822940
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34682	diazinon	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D003976	Diazinon results in decreased expression of PINK1 mRNA	PMID:21968025
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20230801	CTD	MESH:C022838	[nickel chloride results in increased abundance of Nickel] which affects the expression of and affects the localization of PINK1 protein	PMID:36794572
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	affects response to substance	ISO	RGD:1314001	E	RGD:6480464	20210810	CTD	MESH:D010269	PINK1 protein affects the susceptibility to Paraquat	PMID:33383311
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20121113	CTD	MESH:D010269	Paraquat results in decreased expression of PINK1 mRNA	PMID:22563483|PMID:36108500
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314001	E	RGD:6480464	20190219	CTD	MESH:D010269	Paraquat results in increased expression of PINK1 protein	PMID:30144575|PMID:37028639
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314002	E	RGD:6480464	20230704	CTD	MESH:D010269	Paraquat results in increased expression of PINK1 protein	PMID:37028639
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	increases response to substance	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D010269	PINK1 mutant form results in increased susceptibility to Paraquat	PMID:22043175
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20190219	CTD	MESH:D010269	[BNIP3 protein co-treated with PINK1 protein] affects the reaction [Paraquat results in increased expression of COX2 protein]; [BNIP3 protein co-treated with PINK1 protein] affects the reaction [Paraquat results in increased expression of TLR9 protein]; [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin promotes the reaction [Paraquat results in increased expression of BNIP3 protein]]; [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]]; Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]; oren gedoku to inhibits the reaction [Paraquat results in increased expression of and affects the localization of PINK1 protein]; Paraquat results in increased expression of and affects the localization of PINK1 protein; PRKN protein affects the reaction [Paraquat results in increased expression of PINK1 protein]	PMID:30144575|PMID:33383311|PMID:37028639
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D010269	[BNIP3 protein co-treated with PINK1 protein] affects the reaction [Melatonin inhibits the reaction [Paraquat results in increased secretion of IL1B protein]]; [BNIP3 protein co-treated with PINK1 protein] affects the reaction [Melatonin inhibits the reaction [Paraquat results in increased secretion of TNF protein]]; [PINK1 mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Dopamine; Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]; Paraquat affects the reaction [PINK1 protein affects the abundance of Dopamine]	PMID:22043175|PMID:37028639
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PINK1 mRNA]	PMID:39241906
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314001	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PINK1 mRNA	PMID:37042841
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of PINK1 mRNA	PMID:30723492
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PINK1 mRNA	PMID:33453195
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PINK1 protein	PMID:37451666
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314001	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PINK1 mRNA	PMID:38174414
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PINK1 mRNA	PMID:20883709
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20231003	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; SIRT1 protein inhibits the reaction [Cadmium Chloride results in increased expression of PINK1 protein]	PMID:37451666|PMID:39208572
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20220510	CTD	MESH:D019256	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKN protein]; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SQSTM1 protein]; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased lipidation of MAP1LC3B protein]	PMID:34952138|PMID:37022104
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PINK1 mRNA	PMID:30047161
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20210504	CTD	MESH:D002738	Chloroquine inhibits the reaction [Acetaminophen results in increased expression of PINK1 protein]; Chloroquine inhibits the reaction [coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]]	PMID:33271250
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of PINK1 mRNA	PMID:30047161
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:37659	oleanolic acid	increases expression	ISO	RGD:1314001	E	RGD:6480464	20220906	CTD	MESH:D009828	Oleanolic Acid results in increased expression of PINK1 protein	PMID:35690101
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1314002	E	RGD:6480464	20240903	CTD	MESH:C056933	fumonisin B1 results in increased expression of PINK1 protein	PMID:38705344
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:38604	pyrimidifen	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of PINK1 mRNA	PMID:33512557
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:38635	3-methyladenine	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C025946	3-methyladenine inhibits the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]	PMID:39725191
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:38635	3-methyladenine	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20260602	CTD	MESH:C025946	3-methyladenine inhibits the reaction [Oxygen deficiency results in increased expression of PINK1 protein]	PMID:39829390
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PINK1 mRNA	PMID:19167446
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PINK1 protein	PMID:39894534
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of PINK1 mRNA	PMID:25993096
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D003474	Curcumin results in increased expression of PINK1 protein	PMID:40209350
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D003474	Curcumin inhibits the reaction [Cisplatin results in increased expression of PINK1 protein]	PMID:28698153
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D003474	[Curcumin co-treated with Atrazine] results in increased expression of PINK1 mRNA; [Curcumin co-treated with Atrazine] results in increased expression of PINK1 protein; Curcumin inhibits the reaction [Atrazine results in increased expression of PINK1 protein]; Curcumin promotes the reaction [Atrazine results in increased expression of PINK1 mRNA]	PMID:40209350
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PINK1 mRNA	PMID:17292431
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314001	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of PINK1 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PINK1 mRNA	PMID:30047161
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20171114	CTD	MESH:D016572	Cyclosporine results in decreased expression of PINK1 protein	PMID:27318970|PMID:40023272
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:D016572	Cyclosporine results in increased expression of PINK1 protein	PMID:36557995
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:D016572	Cyclosporine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]]	PMID:38373586|PMID:39208572
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20171114	CTD	MESH:D016572	Cyclosporine inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 mRNA]; Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 protein]; Palmitic Acid inhibits the reaction [Cyclosporine results in decreased expression of PINK1 protein]	PMID:27318970|PMID:29567065|PMID:40023272
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20160210	CTD	MESH:D016572	Cyclosporine affects the reaction [sodium arsenite affects the expression of PINK1 protein]; Cyclosporine inhibits the reaction [Cadmium results in increased expression of PINK1]; Cyclosporine inhibits the reaction [sodium arsenite results in increased expression of PINK1 protein]	PMID:25464205|PMID:36557995|PMID:38653026
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of PINK1 mRNA	PMID:33512557
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240305	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]	PMID:37692514
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PINK1 mRNA	PMID:17555576
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:42160	dithionite(2-)	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D004227	[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein]	PMID:34078833
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:42567	fisetin	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20260407	CTD	MESH:C017875	fisetin inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of PINK1 mRNA]	PMID:40695427
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of PINK1 protein	PMID:35243728
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314001	E	RGD:6480464	20220111	CTD	MESH:D005947	Glucose results in increased expression of PINK1 mRNA	PMID:33962019
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of PINK1 protein	PMID:38334676
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D005947	Inositol inhibits the reaction [Glucose results in decreased expression of PINK1 protein]	PMID:35243728
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20220111	CTD	MESH:D005947	[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]	PMID:33962019
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	imeglimin inhibits the reaction [Glucose results in increased expression of PINK1 protein]	PMID:38334676
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:4356	desferrioxamine B	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20220111	CTD	MESH:D003676	[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]	PMID:33962019
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of PINK1 mRNA	PMID:33512557
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:45951	trifluoperazine	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20190219	CTD	MESH:D014268	[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]]	PMID:28366621
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1314001	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PINK1 mRNA	PMID:28542535
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PINK1 mRNA	PMID:17562736
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PINK1 mRNA	PMID:33387578
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20231031	CTD	MESH:D000082	Acetaminophen results in decreased expression of PINK1 mRNA	PMID:37179516
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314001	E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of PINK1 mRNA	PMID:22230336|PMID:25704631
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314002	E	RGD:6480464	20210504	CTD	MESH:D000082	Acetaminophen results in increased expression of PINK1 protein	PMID:33271250
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20210504	CTD	MESH:D000082	Chloroquine inhibits the reaction [Acetaminophen results in increased expression of PINK1 protein]; Chloroquine inhibits the reaction [coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]]; coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]	PMID:33271250
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46245	coenzyme Q10	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20210504	CTD	MESH:C024989	Chloroquine inhibits the reaction [coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]]; coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]	PMID:33271250
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46961	phytosphingosine	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20230404	CTD	MESH:C012491	phytosphingosine results in decreased expression of PINK1 protein	PMID:36334778
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46979	N-acetylsphingosine	decreases response to substance	ISO	RGD:1314001	E	RGD:6480464	20170725	CTD	MESH:C064769	PINK1 protein results in decreased susceptibility to N-acetylsphingosine	PMID:24792327
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:46979	N-acetylsphingosine	decreases response to substance	ISO	RGD:1314002	E	RGD:6480464	20170725	CTD	MESH:C064769	PINK1 protein results in decreased susceptibility to N-acetylsphingosine	PMID:24792327
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260113	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PINK1 protein	PMID:40081728
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:47426	furosemide	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D005665	[Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in increased expression of PINK1 protein	PMID:29860548
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:47495	N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C063509	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased expression of PINK1 protein	PMID:29870751
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:47495	N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:C063509	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [T-2 Toxin results in increased expression of PINK1 protein]	PMID:29870751
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:47697	4,5,6,7-TETRABROMOBENZOTRIAZOLE	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20231205	CTD	MESH:C405354	4,5,6,7-tetrabromobenzotriazole inhibits the reaction [Rotenone results in increased expression of PINK1 protein]	PMID:37156403
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of PINK1 mRNA	PMID:31838189
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1314001	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of PINK1 mRNA	PMID:26833863
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PINK1 mRNA	PMID:17555576
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of PINK1 mRNA	PMID:17942748
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PINK1 mRNA	PMID:17942748
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PINK1 protein	PMID:30551535
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314001	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PINK1 protein	PMID:27318970
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PINK1 protein]	PMID:30551535
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20191114	CTD	MESH:C032793	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]	PMID:27318970
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:5011	fenpyroximate	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of PINK1 mRNA	PMID:33512557
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1314001	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of PINK1 mRNA	PMID:23300844
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PINK1 mRNA	PMID:31734597
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PINK1 mRNA; Nanotubes, Carbon results in decreased expression of PINK1 mRNA	PMID:25554681
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PINK1 mRNA	PMID:30047161
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:50924	sorafenib	affects response to substance	ISO	RGD:1314002	E	RGD:6480464	20180313	CTD	MESH:C471405	PINK1 protein affects the susceptibility to sorafenib	PMID:28673964
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:50924	sorafenib	increases expression	ISO	RGD:1314001	E	RGD:6480464	20180313	CTD	MESH:C471405	sorafenib results in increased expression of PINK1 protein	PMID:28673964
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:50924	sorafenib	increases expression	ISO	RGD:1314002	E	RGD:6480464	20180313	CTD	MESH:C471405	sorafenib results in increased expression of PINK1 protein	PMID:28673964
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:50924	sorafenib	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20180313	CTD	MESH:C471405	[sorafenib co-treated with PRKN protein] results in increased expression of PINK1 protein; PINK1 protein affects the reaction [sorafenib affects the localization of PRKN protein]	PMID:28673964
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:5199	Fusaric acid	increases expression	ISO	RGD:1314001	E	RGD:6480464	20190312	CTD	MESH:D005669	Fusaric Acid results in increased expression of PINK1 protein	PMID:30582969
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:5298	Genipin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20171010	CTD	MESH:C007834	genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of PINK1 protein]	PMID:28477916
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:53248	poly(vinylpyrrolidone)	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20221206	CTD	MESH:D011205	[Silver Compounds co-treated with Povidone] results in increased expression of PINK1 protein	PMID:35697184
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:57589	O-acetyl-L-carnitine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20170103	CTD	MESH:D000108	Acetylcarnitine inhibits the reaction [Cadmium results in increased expression of PINK1]	PMID:25464205
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:5759	Honokiol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C005499	honokiol inhibits the reaction [amyloid beta-protein (1-42) results in decreased expression of PINK1 protein]; SIRT3 protein affects the reaction [honokiol inhibits the reaction [amyloid beta-protein (1-42) results in decreased expression of PINK1 protein]]	PMID:34752757
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:61057	tacrolimus hydrate	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20120412	CTD	MESH:D016559	PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein]	PMID:19492085
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20170516	CTD	MESH:C025340	manganese chloride results in decreased expression of PINK1 mRNA	PMID:27913844
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:63041	manganese(II) chloride	increases methylation	ISO	RGD:1314001	E	RGD:6480464	20170516	CTD	MESH:C025340	manganese chloride results in increased methylation of PINK1 gene	PMID:27913844
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PINK1 mRNA	PMID:26378955
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	affects response to substance	ISO	RGD:1314001	E	RGD:6480464	20120412	CTD	MESH:D015655	PINK1 protein affects the susceptibility to 1-Methyl-4-phenylpyridinium	PMID:16226715
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PINK1 protein	PMID:24475098
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314001	E	RGD:6480464	20230905	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PINK1 protein	PMID:36078115
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases response to substance	ISO	RGD:1314001	E	RGD:6480464	20130514	CTD	MESH:D015655	PINK1 gene mutant form results in increased susceptibility to 1-Methyl-4-phenylpyridinium	PMID:20547144
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20130416	CTD	MESH:D015655	PINK1 protein affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HMOX1 mRNA]; PINK1 protein affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HMOX1 protein]	PMID:21366594
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D008012	Lidocaine results in increased expression of PINK1 protein	PMID:37914286
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:6456	lidocaine	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D008012	bafilomycin A1 inhibits the reaction [Lidocaine results in increased expression of PINK1 protein]; dorsomorphin inhibits the reaction [Lidocaine results in increased expression of PINK1 protein]; MK-8722 promotes the reaction [Lidocaine results in increased expression of PINK1 protein]	PMID:37914286
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:65585	carnosic acid	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20190910	CTD	MESH:C018381	PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of PRKN protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of VDAC1 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of CASP3 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of PARP1 protein]]; salvin inhibits the reaction [Oxidopamine results in decreased expression of PINK1 protein]	PMID:30707903
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:67989	ginsenoside Rb1	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:C442759	Cyclosporine inhibits the reaction [ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]]; ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]; TFEB protein promotes the reaction [ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]]	PMID:38373586
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:67989	ginsenoside Rb1	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240903	CTD	MESH:C442759	ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]	PMID:38373586
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20240604	CTD	MESH:D008687	Metformin inhibits the reaction [Oleic Acid results in decreased expression of PINK1 protein]	PMID:36592823
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240604	CTD	MESH:D008687	Metformin inhibits the reaction [Dietary Fats results in decreased expression of PINK1 protein]	PMID:36592823
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:68610	linagliptin	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D000069476	Linagliptin inhibits the reaction [Cisplatin results in decreased expression of PINK1]	PMID:39102946
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:69478	cannabidiol	affects expression	EXP		E	RGD:6480464	20241203	CTD	MESH:D002185	Cannabidiol affects the expression of PINK1 mRNA	PMID:38182033
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:69832	osthole	increases expression	ISO	RGD:1314001	E	RGD:6480464	20260407	CTD	MESH:C046627	osthol results in increased expression of PINK1 protein	PMID:40446951
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:69832	osthole	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20260407	CTD	MESH:C046627	erastin promotes the reaction [osthol results in increased expression of PINK1 protein]; ferrostatin-1 inhibits the reaction [osthol results in increased expression of PINK1 protein]; TFRC protein promotes the reaction [osthol results in increased expression of PINK1 protein]	PMID:40446951
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PINK1 mRNA	PMID:31758290
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone results in decreased expression of PINK1 protein	PMID:29729358
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	increases expression	ISO	RGD:1314002	E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone results in increased expression of PINK1 protein	PMID:34952138
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [ophiopogonin D results in increased expression of PINK1 protein]	PMID:27318970|PMID:29729358|PMID:35905946
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]	PMID:34952138
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:749016	gossypol acetic acid	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of PINK1 protein	PMID:41134649
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PINK1 mRNA	PMID:24136188
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases cleavage	ISO	RGD:1314001	E	RGD:6480464	20260707	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of PINK1 protein	PMID:37060996
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1314001	E	RGD:6480464	20250311	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PINK1 protein	PMID:39442788
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20230606	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of FIS1 protein]	PMID:20164189
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20250311	CTD	MESH:C072553	BAG2 protein inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PINK1 protein]; MIR593 inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of PINK1 protein]	PMID:37060996|PMID:39442788
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:75458	carbonyl cyanide p-trifluoromethoxyphenylhydrazone	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20180313	CTD	MESH:D002259	PINK1 protein affects the reaction [Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone affects the localization of PRKN protein]	PMID:24879156
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:754906	afuresertib	increases expression	ISO	RGD:1314001	E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of PINK1 mRNA	PMID:28960945
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:755912	aluminum chloride	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260714	CTD	MESH:D000077410	[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA; [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein; Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA]	PMID:34547296
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260714	CTD	MESH:C575881	imeglimin inhibits the reaction [Glucose results in increased expression of PINK1 protein]	PMID:38334676
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of PINK1 mRNA	PMID:19717638
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PINK1 mRNA	PMID:30851411
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C516138	dorsomorphin inhibits the reaction [Lidocaine results in increased expression of PINK1 protein]; dorsomorphin inhibits the reaction [sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein]]	PMID:34358556|PMID:37914286
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:78741	oxidopamine	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20190910	CTD	MESH:D016627	Oxidopamine results in decreased expression of PINK1 protein	PMID:30707903
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:78741	oxidopamine	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20190910	CTD	MESH:D016627	PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of PRKN protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of VDAC1 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of CASP3 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of PARP1 protein]]; salvin inhibits the reaction [Oxidopamine results in decreased expression of PINK1 protein]	PMID:30707903
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:80883	Ophiopogonin D	increases expression	ISO	RGD:1314001	E	RGD:6480464	20230502	CTD	MESH:C046996	ophiopogonin D results in increased expression of PINK1 protein	PMID:35905946
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:80883	Ophiopogonin D	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20230502	CTD	MESH:C046996	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [ophiopogonin D results in increased expression of PINK1 protein]	PMID:35905946
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1314002	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of PINK1 mRNA	PMID:22538082
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:81794	thifluzamide	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of PINK1 mRNA	PMID:33512557
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:81833	trifloxystrobin	increases expression	ISO	RGD:1314001	E	RGD:6480464	20170516	CTD	MESH:C467051	trifloxystrobin results in increased expression of PINK1 protein	PMID:27853101
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:81833	trifloxystrobin	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20170516	CTD	MESH:C467051	MitoTEMPO inhibits the reaction [trifloxystrobin results in increased expression of PINK1 protein]	PMID:27853101
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20200310	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PINK1 mRNA	PMID:29699156
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of PINK1 mRNA	PMID:21858171
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:83197	picoxystrobin	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of PINK1 mRNA	PMID:33512557
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314002	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PINK1 mRNA	PMID:39847705
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PINK1 mRNA	PMID:30047161
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PINK1 mRNA]	PMID:39241906
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:8802	remifentanil	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:C071741	[Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein]; Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]	PMID:34078833
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:8805	Repaglinide	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:C072379	repaglinide inhibits the reaction [Rotenone results in decreased expression of PINK1 mRNA]	PMID:36538285
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:9144	silibinin	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20221101	CTD	MESH:C440975	Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PINK1 mRNA]; Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PINK1 protein]; Silybin inhibits the reaction [Ethanol results in decreased expression of PINK1 mRNA]; Silybin inhibits the reaction [Ethanol results in decreased expression of PINK1 protein]	PMID:35595033
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D020123	Sirolimus inhibits the reaction [[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein]	PMID:33823232
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211012	CTD	MESH:D020123	Sirolimus inhibits the reaction [[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein]; Sirolimus inhibits the reaction [Carbon Tetrachloride results in increased expression of PINK1 protein]	PMID:33823232|PMID:35405287
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PINK1 mRNA	PMID:21346803
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211109	CTD	MESH:D013311	[Dietary Fats co-treated with Streptozocin] results in increased expression of PINK1 mRNA	PMID:33812996
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D013605	T-2 Toxin results in increased expression of PINK1 mRNA; T-2 Toxin results in increased expression of PINK1 protein	PMID:29870751
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:9381	T-2 toxin	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:D013605	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [T-2 Toxin results in increased expression of PINK1 protein]; NFE2L2 protein affects the reaction [T-2 Toxin results in increased expression of PINK1 protein]; PINK1 promotes the reaction [T-2 Toxin results in increased expression of DNM1L mRNA]; PINK1 promotes the reaction [T-2 Toxin results in increased expression of FIS1 mRNA]; PINK1 promotes the reaction [T-2 Toxin results in increased expression of MFN1 mRNA]; PINK1 promotes the reaction [T-2 Toxin results in increased expression of OPA1 mRNA]	PMID:29870751|PMID:36863559
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:9422	tebufenpyrad	decreases expression	ISO	RGD:1314001	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of PINK1 mRNA	PMID:33512557
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1314001	E	RGD:6480464	20260407	CTD	MESH:C477224	erastin promotes the reaction [osthol results in increased expression of PINK1 protein]	PMID:40446951
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1314001	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of PINK1 mRNA	PMID:22378314
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PINK1 mRNA	PMID:21346803
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:9679	tricalcium bis(phosphate)	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240305	CTD	MESH:C018392	Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased expression of PINK1 protein]; tricalcium phosphate results in increased expression of and results in increased localization of PINK1 protein	PMID:37678662
1305769	Pink1	PTEN induced kinase 1	gene	CHEBI:9763	trovafloxacin	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in increased expression of PINK1 mRNA	PMID:24136188
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314003	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RBM22 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RBM22 mRNA	PMID:32699268
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of RBM22 mRNA	PMID:25056781
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314004	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RBM22 mRNA	PMID:30319688
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314003	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RBM22 mRNA	PMID:37042841
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314003	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RBM22 mRNA	PMID:28818685
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314003	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RBM22 mRNA	PMID:19549813
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1314003	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RBM22 mRNA	PMID:23649840
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314004	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of RBM22 mRNA	PMID:27776689
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of RBM22 mRNA	PMID:25056781
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1314003	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RBM22 mRNA	PMID:23649840
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314003	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RBM22 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RBM22 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RBM22 mRNA	PMID:32699268
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1314003	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RBM22 mRNA	PMID:18593933
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RBM22 mRNA	PMID:25629700
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RBM22 protein	PMID:25505154
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314003	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RBM22 mRNA	PMID:27392435
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of RBM22 gene	PMID:28505145
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RBM22 mRNA	PMID:33387578
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314003	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of RBM22 protein	PMID:38228842
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314003	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RBM22 mRNA	PMID:38568856
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314003	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBM22 promoter	PMID:27901495
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1314003	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RBM22 mRNA	PMID:18593933
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1314003	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of RBM22 mRNA	PMID:31745603
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314004	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBM22 gene	PMID:35295148
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RBM22 mRNA	PMID:34492290
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RBM22 mRNA	PMID:33221593
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RBM22 mRNA	PMID:25181051
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314004	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of RBM22 mRNA	PMID:39742910
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of RBM22 gene	PMID:28505145
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RBM22 mRNA	PMID:39298647
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314003	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RBM22 mRNA	PMID:37042841
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314003	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RBM22 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RBM22 mRNA	PMID:32699268
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314003	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RBM22 mRNA	PMID:25979313
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314003	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RBM22 mRNA	PMID:23179753|PMID:27188386
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314003	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RBM22 mRNA	PMID:17183730
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1314003	E	RGD:6480464	20161213	CTD	MESH:C111237	Vorinostat results in decreased expression of RBM22 mRNA	PMID:22083351|PMID:27188386|PMID:33770205
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1314003	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RBM22 mRNA	PMID:28542535
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314004	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RBM22 mRNA	PMID:17562736
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1314003	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of RBM22 mRNA	PMID:21148743
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of RBM22 mRNA	PMID:24793618
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1314003	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RBM22 mRNA	PMID:17183730
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1314003	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RBM22 protein	PMID:32959892
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1314003	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RBM22 protein	PMID:37664457
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	ISO	RGD:1314003	E	RGD:6480464	20220405	CTD	MESH:C045338	RBM22 protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1314003	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of RBM22 protein	PMID:31285264
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314004	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RBM22 mRNA	PMID:30294300
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RBM22 mRNA	PMID:24780913
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1314003	E	RGD:6480464	20210608	CTD	MESH:C496932	Panobinostat results in decreased expression of RBM22 mRNA	PMID:33770205
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314003	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RBM22 protein	PMID:37664457
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RBM22 mRNA	PMID:21346803
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1314003	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of RBM22 mRNA	PMID:29301935
1305770	Rbm22	RNA binding motif protein 22	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1314003	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of RBM22 mRNA	PMID:27188386
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CASP8AP2 mRNA	PMID:33045310
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CASP8AP2 mRNA	PMID:26476374
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D010100	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8AP2 mRNA]	PMID:26476374
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CASP8AP2 mRNA	PMID:22378314
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1314005	E	RGD:155663665|PMID:28367268	20221202	RGD	MESH:D006861	hydrogen peroxide decreases expression of CASP8AP2 protein in umbilical vein endothelial cells	
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8AP2 mRNA]	PMID:26476374
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314006	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CASP8AP2 mRNA	PMID:39241906
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8AP2 mRNA	PMID:24576310
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1314005	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8AP2 mRNA	PMID:38568856
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of CASP8AP2 mRNA	PMID:20655997
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314006	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CASP8AP2 mRNA	PMID:20463053
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CASP8AP2 mRNA	PMID:33754040
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of CASP8AP2 protein	PMID:34122009
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1314005	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CASP8AP2 protein	PMID:37730182
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CASP8AP2 mRNA	PMID:33387578
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CASP8AP2 mRNA	PMID:22061828
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CASP8AP2 mRNA	PMID:19549813
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314006	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CASP8AP2 mRNA	PMID:19770486
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314005	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CASP8AP2 intron	PMID:30157460
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of CASP8AP2 mRNA	PMID:26760959
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1314005	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CASP8AP2 mRNA	PMID:23649840
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CASP8AP2 mRNA	PMID:15674844
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314006	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CASP8AP2 mRNA	PMID:31919559
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CASP8AP2 mRNA	PMID:25629700
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1314005	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CASP8AP2 protein	PMID:35688186
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CASP8AP2 mRNA	PMID:25905778
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA	PMID:19167446
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314005	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CASP8AP2 mRNA	PMID:27594783
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CASP8AP2 mRNA	PMID:30912803
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314005	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of CASP8AP2 mRNA	PMID:15256057
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314006	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CASP8AP2 mRNA	PMID:24680724
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CASP8AP2 mRNA	PMID:32109520|PMID:33387578
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CASP8AP2 mRNA	PMID:18691609
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CASP8AP2 mRNA	PMID:19520675|PMID:34747641
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CASP8AP2 mRNA	PMID:19465110
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CASP8AP2 mRNA	PMID:33212167
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314006	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CASP8AP2 mRNA	PMID:27862939
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CASP8AP2 mRNA	PMID:29803840
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1314005	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of CASP8AP2 protein	PMID:35688186
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CASP8AP2 mRNA	PMID:38568856
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CASP8AP2 mRNA	PMID:16014739
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314005	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CASP8AP2 mRNA	PMID:17879257
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314005	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CASP8AP2 intron	PMID:30157460
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CASP8AP2 mRNA	PMID:40419235
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of CASP8AP2 protein	PMID:34122009
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CASP8AP2 mRNA	PMID:19073995
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1314005	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CASP8AP2 mRNA	PMID:20382639
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CASP8AP2 mRNA	PMID:19730151
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased localization of [CASP8AP2 protein co-treated with PML protein]; Arsenic Trioxide results in increased localization of and results in increased degradation of CASP8AP2 protein	PMID:23673342
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of CASP8AP2 mRNA	PMID:25729387
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CASP8AP2 mRNA	PMID:25729387
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:32063	propylparaben	increases expression	ISO	RGD:1314005	E	RGD:6480464	20180703	CTD	MESH:C006068	propylparaben results in increased expression of CASP8AP2 mRNA	PMID:24481588
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314006	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CASP8AP2 gene; titanium dioxide results in decreased methylation of CASP8AP2 promoter	PMID:35295148
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CASP8AP2 mRNA	PMID:34492290
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CASP8AP2 mRNA	PMID:38479592
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of CASP8AP2 mRNA	PMID:19167457
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CASP8AP2 mRNA	PMID:25181051|PMID:32145629
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of CASP8AP2 mRNA; o,p'-DDT results in decreased expression of CASP8AP2 mRNA	PMID:22937105
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in increased expression of CASP8AP2 mRNA	PMID:22937105
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20140909	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of CASP8AP2 mRNA	PMID:24680724
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314006	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of CASP8AP2 mRNA	PMID:33297965
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CASP8AP2 mRNA	PMID:22546817
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CASP8AP2 mRNA	PMID:22546817
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1314005	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to CASP8AP2 protein	PMID:32991956
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:34778	glycitein	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CASP8AP2 mRNA	PMID:17854601
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CASP8AP2 mRNA]	PMID:17854601
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314005	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CASP8AP2 mRNA	PMID:37042841
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CASP8AP2 mRNA	PMID:24982889
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of CASP8AP2 mRNA	PMID:22079235
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:38319	usnic acid	increases expression	ISO	RGD:1314005	E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of CASP8AP2 mRNA	PMID:32508146
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA	PMID:19167446
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CASP8AP2 mRNA	PMID:27153767|PMID:40419075
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of CASP8AP2 mRNA	PMID:23125180
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of CASP8AP2 mRNA	PMID:22110744
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of CASP8AP2 mRNA	PMID:28001369
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of CASP8AP2 mRNA	PMID:21041162
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:41922	diethylstilbestrol	affects expression	ISO	RGD:1314005	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol affects the expression of CASP8AP2 mRNA	PMID:36621641
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:44185	methotrexate	increases response to substance	ISO	RGD:1314005	E	RGD:6480464	20151013	CTD	MESH:D008727	CASP8AP2 mRNA results in increased susceptibility to Methotrexate	PMID:22753658
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CASP8AP2 mRNA	PMID:17562736
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314005	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CASP8AP2 mRNA	PMID:22230336
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:47519	ketoconazole	affects expression	ISO	RGD:1314005	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole affects the expression of CASP8AP2 mRNA	PMID:36621641
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CASP8AP2 mRNA	PMID:19730151
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased localization of [CASP8AP2 protein co-treated with PML protein]; Arsenic Trioxide results in increased localization of and results in increased degradation of CASP8AP2 protein	PMID:23673342
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314006	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CASP8AP2 mRNA	PMID:19042947
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	increases expression	ISO	RGD:1314005	E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in increased expression of CASP8AP2 mRNA	PMID:17034753
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314006	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CASP8AP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP8AP2 mRNA	PMID:21641980|PMID:26378955
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CASP8AP2 mRNA	PMID:25729387
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of CASP8AP2 mRNA	PMID:33244087
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:6954	Mitotane	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D008939	Mitotane analog results in increased expression of CASP8AP2 mRNA; Mitotane results in increased expression of CASP8AP2 mRNA	PMID:23485034
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CASP8AP2 mRNA	PMID:22206623
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1314005	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of CASP8AP2 protein	PMID:31285264
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of CASP8AP2 mRNA	PMID:30928695
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:80373	glycitin	multiple interactions	ISO	RGD:1314005	E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1314005	E	RGD:6480464	20180515	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CASP8AP2 mRNA	PMID:27589474
1305771	Casp8ap2	caspase 8 associated protein 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CASP8AP2 mRNA	PMID:21346803
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314008	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CLEC16A mRNA	PMID:26251327
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314008	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CLEC16A mRNA	PMID:36331819
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1604037	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CLEC16A mRNA	PMID:22378314
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:16130	DDT	decreases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:D003634	DDT results in decreased methylation of CLEC16A gene	PMID:31682807
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314008	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CLEC16A mRNA	PMID:30319688
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1604037	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CLEC16A mRNA	PMID:21179406
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314008	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CLEC16A mRNA	PMID:39298647
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1604037	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CLEC16A mRNA	PMID:38568856
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1604037	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CLEC16A mRNA	PMID:21179406
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1604037	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CLEC16A protein	PMID:37730182
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1604037	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CLEC16A mRNA	PMID:28818685
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1604037	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CLEC16A intron	PMID:30157460
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1604037	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CLEC16A mRNA	PMID:22100608
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604037	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CLEC16A intron	PMID:30157460
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604037	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CLEC16A gene	PMID:25304211
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1604037	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CLEC16A protein	PMID:35688186
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1604037	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of CLEC16A mRNA	PMID:19561079
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314008	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CLEC16A mRNA	PMID:30912803
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314008	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLEC16A mRNA	PMID:21570461
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:28177	theophylline	decreases expression	ISO	RGD:1604037	E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in decreased expression of CLEC16A mRNA	PMID:18951874
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604037	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CLEC16A mRNA	PMID:38568856
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604037	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CLEC16A intron; Benzo(a)pyrene affects the methylation of CLEC16A promoter	PMID:27901495|PMID:30157460
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604037	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLEC16A mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:26238291
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604037	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CLEC16A 3' UTR	PMID:27901495
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1604037	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CLEC16A mRNA	PMID:26238291
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1604037	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CLEC16A gene	PMID:31601247
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CLEC16A mRNA	PMID:25729387
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314008	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CLEC16A gene	PMID:35295148
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314008	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CLEC16A mRNA	PMID:20813756
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLEC16A mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604037	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CLEC16A gene	PMID:31601247
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1604037	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CLEC16A gene	PMID:31601247
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314008	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CLEC16A mRNA	PMID:39298647
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314008	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CLEC16A intron	PMID:28392331
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314008	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CLEC16A mRNA	PMID:37019170
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314008	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of CLEC16A mRNA	PMID:36117858
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1604037	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CLEC16A mRNA	PMID:37042841
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1604037	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLEC16A mRNA	PMID:38568856
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1604037	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CLEC16A mRNA	PMID:28302478
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314008	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CLEC16A mRNA	PMID:36331819
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314008	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CLEC16A mRNA	PMID:17963808
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604037	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CLEC16A mRNA	PMID:25979313
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604037	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of CLEC16A mRNA	PMID:23179753|PMID:24383497|PMID:28001369
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1604037	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CLEC16A mRNA	PMID:28542535
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1604037	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CLEC16A mRNA	PMID:22230336
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604037	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CLEC16A gene	PMID:25304211
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of CLEC16A mRNA	PMID:30307764
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314008	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of CLEC16A mRNA	PMID:36117858
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1604037	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CLEC16A protein	PMID:32959892
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CLEC16A mRNA	PMID:25729387
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CLEC16A gene	PMID:35440735
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1604037	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CLEC16A mRNA	PMID:31758290
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CLEC16A mRNA	PMID:32109520
1305773	Clec16a	C-type lectin domain containing 16A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of CLEC16A mRNA	PMID:20566332
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1607044	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of DESI1 mRNA	PMID:35967413
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1607044	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of DESI1 mRNA	PMID:23724009
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314012	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of DESI1 mRNA	PMID:30319688
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1607044	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DESI1 mRNA	PMID:20106945|PMID:31614463
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DESI1 mRNA	PMID:33387578
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1607044	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DESI1 mRNA	PMID:37042841
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1607044	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of DESI1 mRNA	PMID:23649840
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314012	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DESI1 mRNA	PMID:36331819
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1607044	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of DESI1 mRNA	PMID:23649840
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314012	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DESI1 mRNA	PMID:19770486
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1607044	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DESI1 mRNA	PMID:23649840
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314012	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DESI1 mRNA	PMID:25629700
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1607044	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of DESI1 mRNA	PMID:23557933
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314012	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DESI1 mRNA	PMID:21570461
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314012	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DESI1 mRNA	PMID:21354282
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DESI1 mRNA	PMID:33387578
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1607044	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DESI1 mRNA	PMID:33212167
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1607044	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DESI1 mRNA	PMID:20106945
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314012	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of DESI1 mRNA	PMID:35295148
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314012	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DESI1 gene; titanium dioxide results in decreased methylation of DESI1 promoter alternative form	PMID:35295148
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DESI1 mRNA	PMID:34492290
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C006780	bisphenol A results in decreased expression of DESI1 mRNA	PMID:25181051
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1607044	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DESI1 mRNA	PMID:33670352
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314012	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of DESI1 mRNA	PMID:40203079
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314012	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of DESI1 mRNA	PMID:34813904
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1314012	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of DESI1 mRNA	PMID:34813904
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314012	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of DESI1 mRNA	PMID:36117858
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1607044	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DESI1 mRNA	PMID:37042841
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1607044	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DESI1 mRNA	PMID:38568856
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314012	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of DESI1 mRNA	PMID:17585979
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1607044	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DESI1 mRNA	PMID:32588087
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314012	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DESI1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of DESI1 mRNA	PMID:36331819
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1607044	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DESI1 mRNA	PMID:25979313
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1607044	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DESI1 gene	PMID:29154799
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1607044	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DESI1 mRNA	PMID:23179753
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1607044	E	RGD:6480464	20160210	CTD	MESH:D016572	Cyclosporine results in increased expression of DESI1 mRNA	PMID:20106945|PMID:25562108
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314012	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DESI1 mRNA	PMID:17555576
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of DESI1 mRNA	PMID:24136188
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1607044	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DESI1 mRNA	PMID:38832940
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DESI1 mRNA	PMID:33387578
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314012	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DESI1 mRNA	PMID:17555576
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314012	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DESI1 mRNA; Nanotubes, Carbon results in increased expression of DESI1 mRNA	PMID:25554681
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DESI1 mRNA	PMID:24136188
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314012	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of DESI1 mRNA	PMID:36117858
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314012	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DESI1 mRNA	PMID:19042947
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1607044	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of DESI1 mRNA	PMID:20436886
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DESI1 mRNA	PMID:28801915
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314012	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DESI1 mRNA	PMID:22206623
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of DESI1 mRNA	PMID:24136188
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1607044	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DESI1 mRNA	PMID:37199045
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DESI1 mRNA	PMID:24780913
1305776	Desi1	desumoylating isopeptidase 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1607044	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of DESI1 mRNA	PMID:29301935
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314013	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of INPP5F mRNA	PMID:33167477
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1314013	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of INPP5F mRNA	PMID:24763279
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of INPP5F gene	PMID:35440735
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1314013	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of INPP5F mRNA	PMID:18951874
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1314014	E	RGD:6480464	20200211	CTD	MESH:D006861	N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of INPP5F protein]	PMID:31494107
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314014	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of INPP5F mRNA	PMID:39241906
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314013	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of INPP5F mRNA	PMID:31614463
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314013	E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of INPP5F mRNA	PMID:38685446
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of INPP5F mRNA	PMID:26496021
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1314013	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of INPP5F protein	PMID:37730182
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314013	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of INPP5F gene	PMID:27153756
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314014	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of INPP5F mRNA	PMID:19770486
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314013	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of INPP5F gene	PMID:28458013
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of INPP5F mRNA	PMID:25629700
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1314013	E	RGD:6480464	20210608	CTD	MESH:D000968	Antimycin A results in decreased expression of INPP5F mRNA	PMID:33770205
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1314013	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of INPP5F protein	PMID:35688186
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA	PMID:33854195
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314013	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of INPP5F mRNA	PMID:28903495
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27889	lead(0)	decreases methylation	ISO	RGD:1314014	E	RGD:6480464	20250311	CTD	MESH:D007854	Lead results in decreased methylation of INPP5F gene	PMID:38833407
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314013	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of INPP5F mRNA	PMID:27392435
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1314014	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of INPP5F mRNA	PMID:16917069
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of INPP5F mRNA	PMID:22298810
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314014	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of INPP5F mRNA	PMID:21570461
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of INPP5F mRNA	PMID:21215274
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of INPP5F mRNA	PMID:19465110
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of INPP5F mRNA]	PMID:21215274
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314013	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of INPP5F mRNA	PMID:33212167
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314013	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of INPP5F mRNA	PMID:29803840
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1314013	E	RGD:6480464	20210608	CTD	MESH:D014415	Tunicamycin results in decreased expression of INPP5F mRNA	PMID:33770205
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of INPP5F mRNA	PMID:22228805
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314014	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of INPP5F mRNA	PMID:19770486|PMID:22228805
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314013	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of INPP5F promoter	PMID:27901495
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of INPP5F protein	PMID:37955338
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314014	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of INPP5F gene; titanium dioxide results in decreased methylation of INPP5F promoter	PMID:35295148
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of INPP5F mRNA	PMID:34492290
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of INPP5F mRNA	PMID:23811191
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314014	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of INPP5F mRNA	PMID:19710929
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314013	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of INPP5F protein	PMID:33376534
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314013	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of INPP5F gene	PMID:31601247
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of INPP5F mRNA	PMID:25181051
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of INPP5F mRNA	PMID:26496021
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314014	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of INPP5F mRNA	PMID:39298647
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of INPP5F mRNA	PMID:26377693
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of INPP5F mRNA	PMID:26377693
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314014	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of INPP5F mRNA	PMID:28392331
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA	PMID:33854195
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1314014	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of INPP5F gene	PMID:38995845
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of INPP5F mRNA	PMID:34813904
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314013	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of INPP5F mRNA	PMID:37042841
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1314013	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of INPP5F mRNA	PMID:24449571
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314013	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of INPP5F mRNA	PMID:40419075
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314013	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of INPP5F mRNA	PMID:25979313
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314013	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of INPP5F mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369|PMID:29154799
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314013	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of INPP5F gene	PMID:29154799
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314013	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5F mRNA	PMID:27188386
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314013	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of INPP5F mRNA	PMID:25562108
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA	PMID:33854195
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314013	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of INPP5F mRNA	PMID:38832940
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1314013	E	RGD:6480464	20210608	CTD	MESH:C111237	Vorinostat results in increased expression of INPP5F mRNA	PMID:33770205
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA	PMID:33854195
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1314013	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of INPP5F mRNA	PMID:28542535
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314014	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of INPP5F mRNA	PMID:17562736
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of INPP5F mRNA	PMID:33387578
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of INPP5F mRNA	PMID:29391264
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314014	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of INPP5F mRNA	PMID:40234311
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314014	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of INPP5F mRNA	PMID:23608068
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA	PMID:33854195
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of INPP5F mRNA	PMID:20080153
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	ISO	RGD:1314013	E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in increased expression of INPP5F mRNA	PMID:16982809
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of INPP5F gene	PMID:35440735
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314013	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5F mRNA	PMID:27188386
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of INPP5F mRNA	PMID:20345932
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314014	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of INPP5F mRNA	PMID:31388691
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of INPP5F mRNA	PMID:24780913
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1314013	E	RGD:6480464	20210608	CTD	MESH:C496932	Panobinostat results in increased expression of INPP5F mRNA	PMID:33770205
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314013	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5F mRNA	PMID:27188386
1305777	Inpp5f	inositol polyphosphate-5-phosphatase F	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1314013	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of INPP5F mRNA	PMID:33770205
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1605563	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SGMS2 mRNA	PMID:27188386
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1331987	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SGMS2 mRNA	PMID:33045310
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SGMS2 mRNA]	PMID:31150632
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1331987	E	RGD:6480464	20241001	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SGMS2 mRNA; Oxygen deficiency results in increased expression of SGMS2 protein	PMID:33111559
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] affects the expression of SGMS2 mRNA	PMID:33729688
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1331987	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SGMS2 mRNA; ML385 affects the reaction [SGMS2 protein affects the reaction [Oxygen deficiency affects the localization of NFE2L2 protein]]; SB 216763 inhibits the reaction [SGMS2 protein inhibits the reaction [Oxygen deficiency results in increased expression of and affects the localization of NFE2L2 protein]]; SGMS2 protein affects the reaction [Oxygen deficiency affects the localization of NFE2L2 protein]; SGMS2 protein inhibits the reaction [Oxygen deficiency results in increased expression of and affects the localization of NFE2L2 protein]; SGMS2 protein promotes the reaction [Oxygen deficiency results in decreased phosphorylation of GSK3B protein]; SGMS2 protein promotes the reaction [Oxygen deficiency results in increased activity of CASP3 protein]	PMID:30529165|PMID:33111559
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1331987	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SGMS2 mRNA	PMID:36331819
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SGMS2 mRNA	PMID:35811015
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1605563	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of SGMS2 mRNA	PMID:30510588
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SGMS2 mRNA	PMID:33387578
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SGMS2 gene	PMID:27618143
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605563	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SGMS2 mRNA	PMID:37042841
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of SGMS2 mRNA	PMID:20655997
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1331987	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SGMS2 mRNA	PMID:33848595
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1605563	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SGMS2 mRNA	PMID:31163220
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SGMS2 mRNA	PMID:33387578
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1605563	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SGMS2 mRNA	PMID:28818685
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1331987	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SGMS2 mRNA	PMID:36331819
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SGMS2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SGMS2 mRNA	PMID:39836092
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SGMS2 mRNA	PMID:35301059
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1605563	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of SGMS2 mRNA	PMID:19549813
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SGMS2 mRNA	PMID:23649840
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1605563	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SGMS2 mRNA	PMID:22100608
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SGMS2 mRNA	PMID:23649840
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SGMS2 mRNA	PMID:18593933
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SGMS2 mRNA	PMID:31150632
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1331987	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SGMS2 mRNA	PMID:31919559
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SGMS2 mRNA]	PMID:31150632
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SGMS2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SGMS2 mRNA	PMID:32525701|PMID:39836092
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SGMS2 mRNA	PMID:31881176
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SGMS2 mRNA	PMID:27392435
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1605563	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SGMS2 mRNA	PMID:27594783
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SGMS2 mRNA	PMID:27392435
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1605563	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SGMS2 mRNA	PMID:24768652|PMID:25583101
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SGMS2 mRNA	PMID:22298810
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1331987	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SGMS2 mRNA	PMID:21570461
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1331987	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SGMS2 mRNA	PMID:27913140|PMID:28238261|PMID:33956508
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1605563	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SGMS2 mRNA	PMID:23152189
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SGMS2 mRNA	PMID:28001369
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SGMS2 mRNA	PMID:33212167
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1605563	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SGMS2 mRNA	PMID:39709020
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1605563	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SGMS2 mRNA	PMID:30851411
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1331987	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of SGMS2 mRNA	PMID:35032568
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605563	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SGMS2 mRNA	PMID:39719251
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SGMS2 mRNA	PMID:39836092
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1331987	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SGMS2 mRNA	PMID:19770486
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1331987	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SGMS2 3' UTR; Benzo(a)pyrene results in decreased methylation of SGMS2 exon; Benzo(a)pyrene results in decreased methylation of SGMS2 intron	PMID:27901495
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1605563	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SGMS2 promoter	PMID:27901495
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1331987	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SGMS2 mRNA	PMID:27195522
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605563	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SGMS2 5' UTR	PMID:27901495
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SGMS2 mRNA	PMID:18593933
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1605563	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SGMS2 mRNA	PMID:26014281
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SGMS2 mRNA	PMID:19150397
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of SGMS2 mRNA	PMID:24395379
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SGMS2 gene	PMID:31601247
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of SGMS2 mRNA	PMID:31745603
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SGMS2 mRNA	PMID:23411599|PMID:34492290
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1331987	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SGMS2 mRNA	PMID:19710929
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SGMS2 mRNA	PMID:19710929
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1331987	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SGMS2 mRNA	PMID:28472532
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1331987	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A affects the expression of SGMS2 mRNA	PMID:26063408
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SGMS2 mRNA	PMID:25181051
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in decreased expression of SGMS2 mRNA	PMID:33476716
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1605563	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SGMS2 gene	PMID:31601247
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SGMS2 gene	PMID:28505145
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SGMS2 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SGMS2 mRNA	PMID:28628672|PMID:31601247
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1331987	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SGMS2 mRNA	PMID:25172293
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1331987	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SGMS2 mRNA	PMID:39298647
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1605563	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of SGMS2 gene	PMID:31601247
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1331987	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S results in increased methylation of SGMS2 gene	PMID:31683443
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1331987	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of SGMS2 mRNA	PMID:26377693
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1331987	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SGMS2 mRNA	PMID:38685157
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:34631	chlorpyrifos	increases methylation	EXP		E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in increased methylation of SGMS2 gene	PMID:32905263
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1331987	E	RGD:6480464	20150512	CTD	MESH:D016264	Dextran Sulfate results in increased expression of SGMS2 mRNA	PMID:25035112
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SGMS2 mRNA	PMID:28628672
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of SGMS2 mRNA	PMID:32680482
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SGMS2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SGMS2 mRNA	PMID:39836092
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SGMS2 mRNA	PMID:35301059
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SGMS2 mRNA	PMID:24386269
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1331987	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SGMS2 mRNA	PMID:40194260
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SGMS2 mRNA	PMID:28302478
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SGMS2 mRNA	PMID:31533062
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1331987	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SGMS2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SGMS2 mRNA	PMID:36331819
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1331987	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SGMS2 mRNA	PMID:17292431
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605563	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SGMS2 mRNA	PMID:25979313
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of SGMS2 mRNA	PMID:24935251
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1605563	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SGMS2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGMS2 mRNA	PMID:27188386
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1331987	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of SGMS2 mRNA	PMID:19770486
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1605563	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SGMS2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SGMS2 mRNA	PMID:28628672
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1331987	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SGMS2 mRNA	PMID:28973697
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605563	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SGMS2 mRNA	PMID:38832940
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SGMS2 mRNA	PMID:24935251
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1605563	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SGMS2 mRNA	PMID:24935251|PMID:26272509
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGMS2 mRNA	PMID:27188386
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1331987	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SGMS2 mRNA	PMID:17562736
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SGMS2 mRNA	PMID:33387578
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1605563	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of SGMS2 mRNA	PMID:21420995
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of SGMS2 mRNA	PMID:35811015
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SGMS2 mRNA	PMID:35811015
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1605563	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SGMS2 mRNA	PMID:18687144
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SGMS2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SGMS2 mRNA	PMID:32525701|PMID:39836092
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1605563	E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of SGMS2 mRNA	PMID:26833863
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SGMS2 mRNA	PMID:28628672
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1331987	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SGMS2 mRNA	PMID:25620056
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1331987	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SGMS2 mRNA; Nanotubes, Carbon results in increased expression of SGMS2 mRNA	PMID:25554681
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:5292	geldanamycin	increases expression	ISO	RGD:1605563	E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SGMS2 mRNA	PMID:26705709
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1605563	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of SGMS2 mRNA	PMID:22714537
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1605563	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of SGMS2 mRNA	PMID:31629900
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1331987	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SGMS2 mRNA	PMID:38701926
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of SGMS2 mRNA	PMID:28801915
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SGMS2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SGMS2 mRNA	PMID:39836092
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SGMS2 mRNA	PMID:28801915
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1331987	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SGMS2 mRNA	PMID:22206623
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1605563	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SGMS2 mRNA	PMID:37199045
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1605563	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SGMS2 mRNA	PMID:30851411
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGMS2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGMS2 mRNA	PMID:27188386
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1331987	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SGMS2 mRNA	PMID:23091169
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1331987	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of SGMS2 mRNA	PMID:31388691
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1331987	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of SGMS2 mRNA	PMID:27029645
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1331987	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SGMS2 mRNA	PMID:39847705
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SGMS2 mRNA	PMID:32525701
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of SGMS2 mRNA	PMID:35688559
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1605563	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of SGMS2 mRNA	PMID:31734321
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1605563	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGMS2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGMS2 mRNA	PMID:27188386
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1605563	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SGMS2 mRNA	PMID:26014281
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605563	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SGMS2 mRNA	PMID:38568856
1305778	Sgms2	sphingomyelin synthase 2	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of SGMS2 gene	PMID:31682807
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1602648	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of LRATD1 mRNA	PMID:26272509
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRATD1 mRNA	PMID:27188386
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20210608	CTD	MESH:D002794	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of LRATD1 mRNA	PMID:33549593
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1602648	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of LRATD1 mRNA	PMID:26079696
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of LRATD1 mRNA	PMID:30319688
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314016	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LRATD1 mRNA	PMID:39241906
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1602648	E	RGD:6480464	20190611	CTD	MESH:D014260	Triclosan results in increased expression of LRATD1 mRNA	PMID:30510588
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1602648	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of LRATD1 mRNA	PMID:31614463
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:D004958	Estradiol results in increased expression of LRATD1 mRNA	PMID:19484750
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20191112	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of LRATD1 mRNA	PMID:30165855
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20210608	CTD	MESH:D008715	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of LRATD1 mRNA	PMID:33549593
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1602648	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LRATD1 mRNA	PMID:26079696
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:17439	cyanocob(III)alamin	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20210608	CTD	MESH:D014805	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of LRATD1 mRNA	PMID:33549593
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRATD1 mRNA	PMID:39150890
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:17750	glycine betaine	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20210608	CTD	MESH:D001622	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of LRATD1 mRNA	PMID:33549593
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1602648	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of LRATD1 mRNA	PMID:26485663
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1602648	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LRATD1 gene	PMID:27153756
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of LRATD1 mRNA	PMID:33549593
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20210608	CTD	MESH:D005492	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of LRATD1 mRNA	PMID:33549593
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRATD1 mRNA	PMID:27188386
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LRATD1 mRNA	PMID:23557933
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314016	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of LRATD1 mRNA	PMID:32186404
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRATD1 mRNA	PMID:32109520
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314016	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of FAM84A mRNA	PMID:32937126
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1602648	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LRATD1 mRNA	PMID:28001369
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D020106	Acrylamide results in increased expression of LRATD1 mRNA	PMID:28959563
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D003300	Copper results in decreased expression of LRATD1 mRNA	PMID:30556269
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of LRATD1 mRNA	PMID:20971185
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1602648	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of LRATD1 mRNA	PMID:30031762
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:29287	gold atom	increases expression	ISO	RGD:1602648	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in increased expression of LRATD1 mRNA	PMID:25523186
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314016	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of LRATD1 mRNA	PMID:37682722
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602648	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM84A 3' UTR; Benzo(a)pyrene affects the methylation of FAM84A 5' UTR	PMID:27901495
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRATD1 mRNA	PMID:19770486
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602648	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FAM84A promoter	PMID:27901495
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:30050	gold(0)	increases expression	ISO	RGD:1602648	E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in increased expression of LRATD1 mRNA	PMID:25523186
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D003300	Copper results in decreased expression of LRATD1 mRNA	PMID:30556269
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of LRATD1 mRNA	PMID:20971185
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of LRATD1 mRNA	PMID:33549593
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of LRATD1 mRNA	PMID:38458666
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1602648	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of LRATD1 mRNA	PMID:23806026|PMID:25895662
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of LRATD1 gene	PMID:31601247
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:C009495	titanium dioxide results in decreased expression of FAM84A mRNA; titanium dioxide results in decreased expression of LRATD1 mRNA	PMID:23557971|PMID:29264374
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314016	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM84A gene	PMID:35295148
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LRATD1 mRNA	PMID:34492290
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:C006253	pirinixic acid results in decreased expression of LRATD1 mRNA	PMID:17426115|PMID:20813756
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LRATD1 mRNA	PMID:19710929
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of LRATD1 mRNA	PMID:38479592
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C069837	fullerene C60 results in decreased expression of LRATD1 mRNA	PMID:19167457
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C006780	bisphenol A results in decreased expression of LRATD1 mRNA	PMID:25181051
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314016	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM84A mRNA	PMID:30951980
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314016	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LRATD1 mRNA	PMID:32156529
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRATD1 mRNA	PMID:28628672
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314016	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of FAM84A gene	PMID:31683443
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314016	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of LRATD1 exon	PMID:33297965
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314016	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of FAM84A mRNA	PMID:30951980
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of LRATD1 gene	PMID:31601247
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRATD1 mRNA	PMID:39150890
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of LRATD1 mRNA	PMID:21266533
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRATD1 mRNA	PMID:39150890
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRATD1 mRNA	PMID:39150890
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRATD1 mRNA	PMID:28628672
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of LRATD1 mRNA	PMID:38458666
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FAM84A mRNA	PMID:35163327
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D002509	Cephaloridine results in increased expression of LRATD1 mRNA	PMID:18500788
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602648	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FAM84A mRNA	PMID:38382870
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1602648	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LRATD1 mRNA	PMID:38174414
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRATD1 mRNA	PMID:39150890
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FAM84A mRNA	PMID:35163327
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C039281	furan results in increased expression of LRATD1 mRNA	PMID:27387713
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1602648	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LRATD1 mRNA	PMID:24449571
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314016	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRATD1 mRNA	PMID:40194260
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602648	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRATD1 mRNA	PMID:28001369
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602648	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of LRATD1 mRNA	PMID:19101580|PMID:23179753|PMID:27188386
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRATD1 mRNA	PMID:28628672
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1602648	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of LRATD1 mRNA	PMID:24935251
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:D000082	Acetaminophen affects the expression of LRATD1 mRNA	PMID:17562736
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FAM84A mRNA	PMID:33387578
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1602648	E	RGD:6480464	20180703	CTD	MESH:D005472	Fluorouracil results in increased expression of LRATD1 mRNA	PMID:24737281
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRATD1 mRNA	PMID:28628672
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	ISO	RGD:1602648	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of LRATD1 mRNA	PMID:38825487
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of LRATD1 mRNA	PMID:26377693
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:6809	methamphetamine	affects expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008694	Methamphetamine affects the expression of LRATD1 mRNA	PMID:19564919
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314016	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FAM84A mRNA	PMID:22206623
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1602648	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of LRATD1 mRNA	PMID:37199045
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1602648	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of LRATD1 mRNA	PMID:22124623
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRATD1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRATD1 mRNA	PMID:27188386
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRATD1 mRNA	PMID:39150890
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:D010634	Phenobarbital results in increased expression of LRATD1 mRNA; Phenobarbital results in increased expression of LRATD1 protein	PMID:19482888|PMID:21424122|PMID:23091169|PMID:33549593
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:D010634	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of LRATD1 mRNA; NR1I3 affects the reaction [Phenobarbital results in increased expression of LRATD1 mRNA]; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LRATD1 mRNA]	PMID:19482888|PMID:21424122|PMID:33549593
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of LRATD1 mRNA	PMID:32109520
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	affects expression	ISO	RGD:1314016	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the expression of LRATD1 mRNA	PMID:31388691
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314016	E	RGD:6480464	20190611	CTD	MESH:C045950	propiconazole results in increased expression of LRATD1 mRNA	PMID:21278054
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602648	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRATD1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRATD1 mRNA	PMID:27188386
1305779	Lratd1	LRAT domain containing 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025643	vinclozolin results in increased expression of LRATD1 mRNA	PMID:20566332
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622774	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TIGD4 mRNA	PMID:33045310
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314017	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TIGD4 mRNA	PMID:35811015
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314017	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of TIGD4 mRNA]	PMID:35811015
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314017	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TIGD4 mRNA	PMID:31163220
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1314017	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of TIGD4 mRNA	PMID:21867686
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314017	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TIGD4 mRNA	PMID:27392435
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314017	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TIGD4 mRNA	PMID:27392435
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314017	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TIGD4 mRNA	PMID:28001369
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TIGD4 mRNA	PMID:25181051
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1622774	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of TIGD4 mRNA	PMID:38701888
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314017	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TIGD4 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314017	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TIGD4 gene	PMID:29154799
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314017	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIGD4 mRNA	PMID:27188386
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1314017	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of TIGD4 mRNA	PMID:24935251
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1314017	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of TIGD4 mRNA]	PMID:35811015
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622774	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TIGD4 mRNA	PMID:22206623
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1314017	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of TIGD4 mRNA	PMID:29522793
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314017	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIGD4 mRNA	PMID:27188386
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:84069	pentanal	decreases expression	ISO	RGD:1314017	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of TIGD4 mRNA	PMID:26079696
1305780	Tigd4	tigger transposable element derived 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314017	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIGD4 mRNA	PMID:27188386
1305781	Atmin	ATM interactor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ATMIN mRNA	PMID:33167477
1305781	Atmin	ATM interactor	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1603699	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ATMIN mRNA	PMID:29581250
1305781	Atmin	ATM interactor	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314018	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ATMIN mRNA	PMID:39241906
1305781	Atmin	ATM interactor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603699	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATMIN mRNA	PMID:37042841
1305781	Atmin	ATM interactor	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of ATMIN mRNA	PMID:23369406
1305781	Atmin	ATM interactor	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ATMIN mRNA	PMID:23649840
1305781	Atmin	ATM interactor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1603699	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ATMIN mRNA	PMID:35430440
1305781	Atmin	ATM interactor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314018	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ATMIN mRNA]	PMID:22206623
1305781	Atmin	ATM interactor	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ATMIN mRNA	PMID:19244175
1305781	Atmin	ATM interactor	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1603699	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA	PMID:19244175
1305781	Atmin	ATM interactor	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of ATMIN mRNA	PMID:33512557
1305781	Atmin	ATM interactor	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314018	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ATMIN mRNA	PMID:28960355
1305781	Atmin	ATM interactor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATMIN mRNA	PMID:22298810
1305781	Atmin	ATM interactor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314018	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATMIN mRNA	PMID:21570461
1305781	Atmin	ATM interactor	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of ATMIN mRNA	PMID:33512557
1305781	Atmin	ATM interactor	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ATMIN mRNA	PMID:30851411
1305781	Atmin	ATM interactor	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATMIN mRNA	PMID:29803840
1305781	Atmin	ATM interactor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603699	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ATMIN mRNA	PMID:22714537
1305781	Atmin	ATM interactor	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1314018	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased methylation of ATMIN gene	PMID:39894169
1305781	Atmin	ATM interactor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1603699	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATMIN mRNA	PMID:26238291
1305781	Atmin	ATM interactor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1603699	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ATMIN mRNA	PMID:26238291
1305781	Atmin	ATM interactor	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314018	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ATMIN mRNA	PMID:29264374
1305781	Atmin	ATM interactor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314018	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATMIN gene	PMID:35295148
1305781	Atmin	ATM interactor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATMIN mRNA	PMID:25181051
1305781	Atmin	ATM interactor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ATMIN mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585
1305781	Atmin	ATM interactor	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATMIN gene	PMID:28505145
1305781	Atmin	ATM interactor	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of ATMIN mRNA	PMID:19244175
1305781	Atmin	ATM interactor	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1603699	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA	PMID:19244175
1305781	Atmin	ATM interactor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314018	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ATMIN mRNA	PMID:39298647
1305781	Atmin	ATM interactor	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314018	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ATMIN intron	PMID:28392331
1305781	Atmin	ATM interactor	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1314018	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of ATMIN mRNA	PMID:31558096
1305781	Atmin	ATM interactor	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603699	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATMIN mRNA	PMID:37042841
1305781	Atmin	ATM interactor	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATMIN mRNA	PMID:38568856
1305781	Atmin	ATM interactor	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATMIN mRNA	PMID:24386269
1305781	Atmin	ATM interactor	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1603699	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATMIN mRNA	PMID:19376846
1305781	Atmin	ATM interactor	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ATMIN mRNA	PMID:19244175
1305781	Atmin	ATM interactor	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1603699	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA	PMID:19244175
1305781	Atmin	ATM interactor	gene	CHEBI:38604	pyrimidifen	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of ATMIN mRNA	PMID:33512557
1305781	Atmin	ATM interactor	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ATMIN mRNA	PMID:28302478
1305781	Atmin	ATM interactor	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1603699	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ATMIN mRNA	PMID:31533062
1305781	Atmin	ATM interactor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603699	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATMIN mRNA	PMID:25979313
1305781	Atmin	ATM interactor	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1603699	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ATMIN gene	PMID:29154799
1305781	Atmin	ATM interactor	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603699	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ATMIN mRNA	PMID:23179753
1305781	Atmin	ATM interactor	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATMIN mRNA	PMID:25562108
1305781	Atmin	ATM interactor	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of ATMIN mRNA	PMID:33512557
1305781	Atmin	ATM interactor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1603699	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ATMIN mRNA	PMID:26690555
1305781	Atmin	ATM interactor	gene	CHEBI:5011	fenpyroximate	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of ATMIN mRNA	PMID:33512557
1305781	Atmin	ATM interactor	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ATMIN mRNA	PMID:28988120
1305781	Atmin	ATM interactor	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ATMIN mRNA	PMID:28801915
1305781	Atmin	ATM interactor	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314018	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ATMIN mRNA	PMID:22206623
1305781	Atmin	ATM interactor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314018	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ATMIN mRNA]	PMID:22206623
1305781	Atmin	ATM interactor	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ATMIN mRNA	PMID:30851411
1305781	Atmin	ATM interactor	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603699	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ASCIZ gene]	PMID:28238834
1305781	Atmin	ATM interactor	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314018	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ATMIN mRNA	PMID:39847705
1305781	Atmin	ATM interactor	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314018	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of ATMIN mRNA	PMID:21278054
1305781	Atmin	ATM interactor	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ATMIN mRNA	PMID:19281266
1305781	Atmin	ATM interactor	gene	CHEBI:9422	tebufenpyrad	decreases expression	ISO	RGD:1603699	E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of ATMIN mRNA	PMID:33512557
1305781	Atmin	ATM interactor	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314018	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ATMIN mRNA	PMID:28973697
1305781	Atmin	ATM interactor	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ATMIN mRNA	PMID:23034163
1305782	Snx10	sorting nexin 10	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1314019	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SNX10 mRNA	PMID:27188386
1305782	Snx10	sorting nexin 10	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314020	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SNX10 mRNA	PMID:33045310
1305782	Snx10	sorting nexin 10	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SNX10 mRNA]	PMID:31150632
1305782	Snx10	sorting nexin 10	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SNX10 mRNA	PMID:23724009
1305782	Snx10	sorting nexin 10	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314019	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SNX10 mRNA	PMID:33167477
1305782	Snx10	sorting nexin 10	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX10 mRNA	PMID:36331819
1305782	Snx10	sorting nexin 10	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314020	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SNX10 mRNA	PMID:30319688
1305782	Snx10	sorting nexin 10	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314020	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SNX10 mRNA	PMID:30319688
1305782	Snx10	sorting nexin 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314019	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SNX10 mRNA	PMID:35811015
1305782	Snx10	sorting nexin 10	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1314019	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of SNX10 mRNA	PMID:30510588
1305782	Snx10	sorting nexin 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314020	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SNX10 mRNA	PMID:39298647
1305782	Snx10	sorting nexin 10	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of SNX10 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SNX10 mRNA	PMID:26496021|PMID:32741896
1305782	Snx10	sorting nexin 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314019	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNX10 mRNA	PMID:37042841
1305782	Snx10	sorting nexin 10	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1314019	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of SNX10 mRNA	PMID:21540246
1305782	Snx10	sorting nexin 10	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SNX10 mRNA	PMID:32741896
1305782	Snx10	sorting nexin 10	gene	CHEBI:17750	glycine betaine	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in decreased expression of SNX10 mRNA	PMID:26391144
1305782	Snx10	sorting nexin 10	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SNX10 mRNA	PMID:26577399
1305782	Snx10	sorting nexin 10	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNX10 mRNA	PMID:36331819
1305782	Snx10	sorting nexin 10	gene	CHEBI:188851	Muraglitazar	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of SNX10 mRNA	PMID:21515302
1305782	Snx10	sorting nexin 10	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of SNX10 mRNA	PMID:23369406
1305782	Snx10	sorting nexin 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of SNX10 mRNA	PMID:37236586
1305782	Snx10	sorting nexin 10	gene	CHEBI:230506	apilimod	affects response to substance	ISO	RGD:1314019	E	RGD:6480464	20240507	CTD	MESH:C504227	SNX10 protein affects the susceptibility to apilimod	PMID:28104689|PMID:28350209
1305782	Snx10	sorting nexin 10	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of SNX10 mRNA	PMID:21396975
1305782	Snx10	sorting nexin 10	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SNX10 mRNA	PMID:22129741
1305782	Snx10	sorting nexin 10	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SNX10 mRNA	PMID:23630614|PMID:25378103
1305782	Snx10	sorting nexin 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314019	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SNX10 intron	PMID:30157460
1305782	Snx10	sorting nexin 10	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	ISO	RGD:1314019	E	RGD:6480464	20120412	CTD	MESH:D014747	SNX10 protein affects the susceptibility to Vinblastine	PMID:16217747
1305782	Snx10	sorting nexin 10	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNX10 mRNA	PMID:31150632
1305782	Snx10	sorting nexin 10	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314020	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNX10 mRNA	PMID:31919559
1305782	Snx10	sorting nexin 10	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SNX10 mRNA]	PMID:31150632
1305782	Snx10	sorting nexin 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314019	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX10 mRNA	PMID:39836092
1305782	Snx10	sorting nexin 10	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SNX10 mRNA	PMID:31881176
1305782	Snx10	sorting nexin 10	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314020	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SNX10 protein	PMID:25505154
1305782	Snx10	sorting nexin 10	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314019	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of SNX10 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of SNX10 mRNA	PMID:19167446|PMID:23557933
1305782	Snx10	sorting nexin 10	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314019	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SNX10 mRNA	PMID:28903495
1305782	Snx10	sorting nexin 10	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314019	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SNX10 mRNA	PMID:27594783
1305782	Snx10	sorting nexin 10	gene	CHEBI:27997	elaidic acid	increases expression	ISO	RGD:1314020	E	RGD:6480464	20260804	CTD	MESH:C011459	elaidic acid results in increased expression of SNX10 mRNA; elaidic acid results in increased expression of SNX10 protein	PMID:42191079
1305782	Snx10	sorting nexin 10	gene	CHEBI:27997	elaidic acid	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20260804	CTD	MESH:C011459	GAS5 protein affects the reaction [elaidic acid results in increased expression of SNX10 protein]; MIR27B inhibits the reaction [elaidic acid results in increased expression of SNX10 mRNA]; MIR27B inhibits the reaction [elaidic acid results in increased expression of SNX10 protein]; SNX10 protein affects the reaction [elaidic acid results in decreased expression of LAMP2 protein]; SNX10 protein affects the reaction [elaidic acid results in increased expression of CTSA protein]	PMID:42191079
1305782	Snx10	sorting nexin 10	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1314019	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SNX10 mRNA	PMID:25583101
1305782	Snx10	sorting nexin 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX10 mRNA	PMID:22298810
1305782	Snx10	sorting nexin 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314020	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX10 mRNA	PMID:21570461
1305782	Snx10	sorting nexin 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNX10 mRNA	PMID:34747641
1305782	Snx10	sorting nexin 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SNX10 mRNA	PMID:25975270
1305782	Snx10	sorting nexin 10	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNX10 mRNA	PMID:33212167
1305782	Snx10	sorting nexin 10	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of SNX10 mRNA	PMID:28959563
1305782	Snx10	sorting nexin 10	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1314019	E	RGD:6480464	20120412	CTD	MESH:D004317	SNX10 protein affects the susceptibility to Doxorubicin	PMID:16217747
1305782	Snx10	sorting nexin 10	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNX10 mRNA	PMID:29803840
1305782	Snx10	sorting nexin 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314020	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX10 mRNA	PMID:37682722
1305782	Snx10	sorting nexin 10	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314019	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SNX10 mRNA	PMID:38568856
1305782	Snx10	sorting nexin 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314019	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX10 mRNA	PMID:39836092
1305782	Snx10	sorting nexin 10	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of SNX10 mRNA	PMID:22378314
1305782	Snx10	sorting nexin 10	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314020	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SNX10 mRNA	PMID:23221170
1305782	Snx10	sorting nexin 10	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314019	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SNX10 gene	PMID:31601247
1305782	Snx10	sorting nexin 10	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of SNX10 mRNA	PMID:22641619
1305782	Snx10	sorting nexin 10	gene	CHEBI:32195	Tesaglitazar	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of SNX10 mRNA	PMID:21515302
1305782	Snx10	sorting nexin 10	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1314020	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of SNX10 enhancer	PMID:35295148
1305782	Snx10	sorting nexin 10	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SNX10 mRNA	PMID:23411599|PMID:34492290
1305782	Snx10	sorting nexin 10	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314020	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SNX10 mRNA	PMID:18648102
1305782	Snx10	sorting nexin 10	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314020	E	RGD:6480464	20120515	CTD	MESH:C006253	pirinixic acid results in increased expression of SNX10 mRNA	PMID:18301758|PMID:18445702
1305782	Snx10	sorting nexin 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX10 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305782	Snx10	sorting nexin 10	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314019	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SNX10 gene	PMID:31601247
1305782	Snx10	sorting nexin 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNX10 mRNA	PMID:25181051
1305782	Snx10	sorting nexin 10	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of SNX10 mRNA	PMID:26496021
1305782	Snx10	sorting nexin 10	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314019	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SNX10 gene	PMID:31601247
1305782	Snx10	sorting nexin 10	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314020	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SNX10 mRNA	PMID:26682919
1305782	Snx10	sorting nexin 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314020	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SNX10 mRNA	PMID:39298647
1305782	Snx10	sorting nexin 10	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314020	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SNX10 mRNA	PMID:32715474|PMID:37019170
1305782	Snx10	sorting nexin 10	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SNX10 mRNA	PMID:19638242
1305782	Snx10	sorting nexin 10	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SNX10 mRNA	PMID:22129741
1305782	Snx10	sorting nexin 10	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of SNX10 gene	PMID:33148267
1305782	Snx10	sorting nexin 10	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314019	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SNX10 mRNA	PMID:37042841
1305782	Snx10	sorting nexin 10	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SNX10 mRNA	PMID:30589522
1305782	Snx10	sorting nexin 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of SNX10 mRNA	PMID:37236586
1305782	Snx10	sorting nexin 10	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of SNX10 mRNA	PMID:25539665
1305782	Snx10	sorting nexin 10	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314020	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SNX10 mRNA	PMID:28903501
1305782	Snx10	sorting nexin 10	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SNX10 mRNA	PMID:24386269
1305782	Snx10	sorting nexin 10	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1314019	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SNX10 mRNA	PMID:19376846
1305782	Snx10	sorting nexin 10	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SNX10 mRNA	PMID:24449571
1305782	Snx10	sorting nexin 10	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314020	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SNX10 mRNA	PMID:18353800
1305782	Snx10	sorting nexin 10	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SNX10 mRNA	PMID:28302478
1305782	Snx10	sorting nexin 10	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1314019	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX10 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of SNX10 mRNA	PMID:19167446
1305782	Snx10	sorting nexin 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SNX10 mRNA	PMID:27153767
1305782	Snx10	sorting nexin 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNX10 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX10 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SNX10 mRNA	PMID:36331819
1305782	Snx10	sorting nexin 10	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314019	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SNX10 mRNA	PMID:25979313
1305782	Snx10	sorting nexin 10	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNX10 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1305782	Snx10	sorting nexin 10	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314020	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNX10 mRNA	PMID:20546886
1305782	Snx10	sorting nexin 10	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314019	E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of SNX10 mRNA	PMID:24935251
1305782	Snx10	sorting nexin 10	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1314020	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SNX10 mRNA	PMID:15331540
1305782	Snx10	sorting nexin 10	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SNX10 mRNA	PMID:25562108|PMID:27989131
1305782	Snx10	sorting nexin 10	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314020	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SNX10 mRNA	PMID:28973697
1305782	Snx10	sorting nexin 10	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314020	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SNX10 mRNA	PMID:28973697
1305782	Snx10	sorting nexin 10	gene	CHEBI:43572	kojic acid	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of SNX10 mRNA	PMID:16595896
1305782	Snx10	sorting nexin 10	gene	CHEBI:45863	paclitaxel	affects response to substance	ISO	RGD:1314019	E	RGD:6480464	20161213	CTD	MESH:D017239	SNX10 protein affects the susceptibility to Paclitaxel	PMID:16217747
1305782	Snx10	sorting nexin 10	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1314019	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SNX10 mRNA	PMID:24935251
1305782	Snx10	sorting nexin 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314020	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNX10 mRNA	PMID:17562736
1305782	Snx10	sorting nexin 10	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SNX10 mRNA	PMID:33387578
1305782	Snx10	sorting nexin 10	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SNX10 mRNA	PMID:21420995
1305782	Snx10	sorting nexin 10	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1314019	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SNX10 mRNA	PMID:35811015
1305782	Snx10	sorting nexin 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314019	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX10 mRNA	PMID:39836092
1305782	Snx10	sorting nexin 10	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1314020	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of SNX10 mRNA	PMID:26934552
1305782	Snx10	sorting nexin 10	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1314019	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of SNX10 mRNA	PMID:19194470
1305782	Snx10	sorting nexin 10	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314020	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SNX10 mRNA; Nanotubes, Carbon results in increased expression of SNX10 mRNA	PMID:25554681|PMID:25620056
1305782	Snx10	sorting nexin 10	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of SNX10 mRNA	PMID:34044035
1305782	Snx10	sorting nexin 10	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SNX10 mRNA	PMID:24793618
1305782	Snx10	sorting nexin 10	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SNX10 mRNA	PMID:24136188
1305782	Snx10	sorting nexin 10	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1314019	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of SNX10 mRNA	PMID:22714537
1305782	Snx10	sorting nexin 10	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314020	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SNX10 mRNA	PMID:38701926
1305782	Snx10	sorting nexin 10	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of SNX10 mRNA	PMID:27188386
1305782	Snx10	sorting nexin 10	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of SNX10 gene	PMID:33148267
1305782	Snx10	sorting nexin 10	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1314019	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SNX10 mRNA	PMID:31758290
1305782	Snx10	sorting nexin 10	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1314019	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of SNX10 mRNA	PMID:22714537
1305782	Snx10	sorting nexin 10	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1314019	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SNX10 mRNA	PMID:37199045
1305782	Snx10	sorting nexin 10	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SNX10 mRNA	PMID:32741896
1305782	Snx10	sorting nexin 10	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of SNX10 mRNA	PMID:23665939
1305782	Snx10	sorting nexin 10	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314020	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SNX10 mRNA	PMID:23091169
1305782	Snx10	sorting nexin 10	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314020	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in increased expression of SNX10 mRNA	PMID:19270015|PMID:19482888
1305782	Snx10	sorting nexin 10	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SNX10 mRNA]	PMID:19482888
1305782	Snx10	sorting nexin 10	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SNX10 mRNA	PMID:32109520
1305782	Snx10	sorting nexin 10	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1314019	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX10 mRNA	PMID:19167446
1305782	Snx10	sorting nexin 10	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314020	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SNX10 mRNA	PMID:21795629
1305782	Snx10	sorting nexin 10	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314020	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SNX10 mRNA	PMID:21278054
1305782	Snx10	sorting nexin 10	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1314019	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of SNX10 mRNA	PMID:22378314
1305782	Snx10	sorting nexin 10	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of SNX10 mRNA	PMID:21515302
1305782	Snx10	sorting nexin 10	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SNX10 mRNA	PMID:19015723
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of HMGXB4 mRNA	PMID:25152437
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of HMGXB4 mRNA	PMID:33167477
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314021	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of HMGXB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of HMGXB4 mRNA	PMID:32699268
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1314021	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of HMGXB4 mRNA	PMID:38568856
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314021	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HMGXB4 mRNA	PMID:37042841
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of HMGXB4 mRNA	PMID:20655997
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of HMGXB4 mRNA	PMID:27683099
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1314021	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of HMGXB4 protein	PMID:37730182
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of HMGXB4 mRNA	PMID:33387578
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314022	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HMGXB4 mRNA	PMID:36331819
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314021	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of HMGXB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of HMGXB4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of HMGXB4 mRNA	PMID:32699268
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1314021	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of HMGXB4 mRNA	PMID:19774075
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of HMGXB4 mRNA	PMID:19244175
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1314021	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA	PMID:19244175
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1314021	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of HMGXB4 protein	PMID:35688186
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314022	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of HMGXB4 mRNA	PMID:28189721|PMID:28960355
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314022	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of HMGXB4 mRNA	PMID:30912803
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314022	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HMGXB4 mRNA	PMID:21570461
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314022	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HMGXB4 mRNA	PMID:17942748
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HMGXB4 mRNA	PMID:33212167
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of HMGXB4 mRNA	PMID:28959563
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of HMGXB4 mRNA	PMID:32763439
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314022	E	RGD:6480464	20250401	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of HMGB2L1 mRNA	PMID:27862939
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HMGXB4 mRNA	PMID:29803840
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1314021	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of HMGXB4 protein	PMID:35688186
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314022	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of HMGXB4 mRNA	PMID:32068019
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314021	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HMGXB4 promoter	PMID:27901495
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314022	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HMGXB4 mRNA	PMID:22228805
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HMGXB4 mRNA	PMID:20382639
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1314021	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of HMGXB4 mRNA	PMID:26238291
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314022	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HMGXB4 gene	PMID:35295148
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314022	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HMGXB4 mRNA	PMID:19710929
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HMGXB4 mRNA	PMID:25181051
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HMGXB4 gene	PMID:28505145
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of HMGXB4 mRNA	PMID:19244175
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1314021	E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA	PMID:19244175
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314022	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HMGXB4 mRNA	PMID:37019170
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HMGXB4 mRNA	PMID:38174414
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314021	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HMGXB4 mRNA	PMID:26472689
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314021	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of HMGXB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of HMGXB4 mRNA	PMID:32699268
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of HMGXB4 mRNA	PMID:19244175
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1314021	E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA	PMID:19244175
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314022	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HMGXB4 mRNA	PMID:36331819
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314021	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HMGXB4 mRNA	PMID:25979313
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314021	E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of HMGXB4 mRNA	PMID:23179753|PMID:25192806
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314022	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of HMGXB4 mRNA	PMID:21427059
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314021	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HMGXB4 gene	PMID:29154799
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314021	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of HMGXB4 mRNA	PMID:17183730
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314021	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of HMGXB4 mRNA	PMID:25562108
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314022	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HMGXB4 mRNA	PMID:17562736
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314022	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HMGXB4 mRNA	PMID:17942748
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of HMGXB4 mRNA	PMID:30307764
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1314021	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of HMGXB4 mRNA	PMID:17183730
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1314021	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of HMGXB4 mRNA	PMID:28988120
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314022	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of HMGXB4 mRNA	PMID:22206623
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1314021	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of HMGXB4 protein	PMID:31285264
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314021	E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HMGXB4 gene]	PMID:28238834
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314022	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of HMGXB4 mRNA	PMID:23091169
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of HMGXB4 mRNA	PMID:23640034
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of HMGXB4 mRNA	PMID:19281266
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1314021	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of HMGXB4 mRNA	PMID:38568856
1305783	Hmgxb4	HMG-box containing 4	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1314021	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of HMGXB4 mRNA	PMID:29301935
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314024	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ELMO2 mRNA	PMID:33045310
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314024	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ELMO2 mRNA	PMID:20188158
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ELMO2 mRNA	PMID:36331819
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ELMO2 mRNA	PMID:30319688
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of ELMO2 mRNA]	PMID:19442820
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314024	E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in decreased expression of ELMO2 mRNA	PMID:22467019
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314024	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ELMO2 mRNA	PMID:39298647
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ELMO2 mRNA	PMID:26496021
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1314023	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ELMO2 mRNA	PMID:38568856
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314023	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ELMO2 mRNA	PMID:37042841
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314023	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ELMO2 mRNA	PMID:21592394
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of ELMO2 mRNA	PMID:21592394
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of ELMO2 mRNA]	PMID:19442820
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ELMO2 mRNA	PMID:26577399
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1314023	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ELMO2 mRNA	PMID:21592394
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of ELMO2 mRNA	PMID:21592394
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314023	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ELMO2 mRNA	PMID:28818685
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ELMO2 mRNA	PMID:39836092
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:194147	aristolochic acids	increases expression	EXP		E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in increased expression of ELMO2 mRNA	PMID:19717638
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ELMO2 mRNA	PMID:29950665
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314023	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ELMO2 exon	PMID:30157460
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314024	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ELMO2 mRNA	PMID:17484886
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ELMO2 mRNA	PMID:31881176
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314023	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of ELMO2 mRNA; Cisplatin results in increased expression of ELMO2 protein	PMID:16803524|PMID:27392435
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ELMO2 mRNA	PMID:27392435
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:27928	parathion	decreases methylation	ISO	RGD:1314023	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of ELMO2 promoter	PMID:22847954
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314024	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ELMO2 mRNA	PMID:21570461
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ELMO2 promoter]	PMID:19654925
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1314023	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ELMO2 protein	PMID:39603559
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [ELMO2 protein binds to CAPRIN1 protein]	PMID:33939924
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELMO2 mRNA	PMID:21839799
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314024	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELMO2 mRNA	PMID:22228805
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314024	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ELMO2 mRNA	PMID:27131904
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:30563	silicon dioxide	decreases methylation	ISO	RGD:1314023	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased methylation of ELMO2 promoter	PMID:34973136
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314023	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ELMO2 mRNA	PMID:34973136
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314023	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ELMO2 mRNA	PMID:19150397
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ELMO2 gene	PMID:31601247
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314024	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ELMO2 promoter	PMID:35295148
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ELMO2 mRNA	PMID:29950665
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ELMO2 mRNA	PMID:34492290
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314024	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ELMO2 mRNA	PMID:28472532
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ELMO2 mRNA	PMID:25181051
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314023	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ELMO2 mRNA; bisphenol A results in decreased expression of ELMO2 protein	PMID:33376534|PMID:36232920
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ELMO2 mRNA	PMID:26496021
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ELMO2 gene	PMID:31601247
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ELMO2 mRNA	PMID:28628672
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314023	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ELMO2 protein	PMID:34186270
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELMO2 mRNA	PMID:28628672
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1314023	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ELMO2 protein	PMID:34186270
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314024	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ELMO2 mRNA	PMID:37019170
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ELMO2 mRNA	PMID:29950665
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELMO2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ELMO2 mRNA	PMID:28628672
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314023	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ELMO2 mRNA	PMID:37042841
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ELMO2 mRNA	PMID:39836092
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1314023	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ELMO2 protein	PMID:26879310
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1314023	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ELMO2 mRNA	PMID:19320972
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:38689	fonofos	decreases methylation	ISO	RGD:1314023	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of ELMO2 promoter	PMID:22847954
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:38960	terbufos	decreases methylation	ISO	RGD:1314023	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of ELMO2 promoter	PMID:22847954
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1314023	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ELMO2 mRNA	PMID:19167446
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ELMO2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ELMO2 mRNA	PMID:36331819
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314023	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ELMO2 mRNA	PMID:25979313
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314023	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ELMO2 gene	PMID:29154799
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELMO2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ELMO2 mRNA	PMID:28628672
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314023	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ELMO2 mRNA	PMID:22230336
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1314023	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of ELMO2 protein	PMID:16803524
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELMO2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ELMO2 mRNA	PMID:28628672
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of ELMO2 mRNA	PMID:30307764
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1314023	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ELMO2 protein	PMID:32959892
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ELMO2 mRNA	PMID:39836092
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314024	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ELMO2 mRNA	PMID:22206623
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of ELMO2 mRNA	PMID:19717638
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ELMO2 gene]	PMID:28238834
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1314023	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ELMO2 protein	PMID:31675489
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ELMO2 mRNA	PMID:24780913
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314024	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ELMO2 mRNA	PMID:27131904
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1314023	E	RGD:6480464	20121113	CTD	MESH:D019284	4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of ELMO2 mRNA]; caffeic acid promotes the reaction [Thapsigargin results in decreased expression of ELMO2 mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in decreased expression of ELMO2 mRNA]	PMID:19442820
1305784	Elmo2	engulfment and cell motility 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ELMO2 mRNA	PMID:21346803
1305785	Manba	mannosidase beta	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MANBA mRNA	PMID:33045310
1305785	Manba	mannosidase beta	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MANBA mRNA]	PMID:31150632
1305785	Manba	mannosidase beta	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314025	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MANBA mRNA	PMID:33167477
1305785	Manba	mannosidase beta	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MANBA gene	PMID:28931070
1305785	Manba	mannosidase beta	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20211012	CTD	MESH:D003634	DDT results in increased methylation of MANBA gene	PMID:31682807
1305785	Manba	mannosidase beta	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of MANBA mRNA	PMID:33711761
1305785	Manba	mannosidase beta	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314025	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MANBA mRNA	PMID:37042841
1305785	Manba	mannosidase beta	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314025	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MANBA mRNA	PMID:28818685
1305785	Manba	mannosidase beta	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314025	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MANBA mRNA	PMID:19549813
1305785	Manba	mannosidase beta	gene	CHEBI:234430	gardiquimod	decreases expression	ISO	RGD:1314025	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in decreased expression of MANBA mRNA	PMID:28003376
1305785	Manba	mannosidase beta	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1314025	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of MANBA mRNA]	PMID:28003376
1305785	Manba	mannosidase beta	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314025	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MANBA intron	PMID:30157460
1305785	Manba	mannosidase beta	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1314025	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MANBA mRNA	PMID:23649840
1305785	Manba	mannosidase beta	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314025	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of MANBA mRNA	PMID:41430723
1305785	Manba	mannosidase beta	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of MANBA mRNA	PMID:18355885
1305785	Manba	mannosidase beta	gene	CHEBI:2666	amitriptyline	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000639	Amitriptyline affects the expression of MANBA mRNA	PMID:18355885
1305785	Manba	mannosidase beta	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314026	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MANBA mRNA	PMID:17484886
1305785	Manba	mannosidase beta	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MANBA mRNA	PMID:31919559
1305785	Manba	mannosidase beta	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MANBA mRNA	PMID:31150632
1305785	Manba	mannosidase beta	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MANBA mRNA]	PMID:31150632
1305785	Manba	mannosidase beta	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of MANBA gene	PMID:31011160
1305785	Manba	mannosidase beta	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314025	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MANBA mRNA	PMID:28903495
1305785	Manba	mannosidase beta	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1314025	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of MANBA mRNA	PMID:23300844
1305785	Manba	mannosidase beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314026	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MANBA mRNA	PMID:25975270
1305785	Manba	mannosidase beta	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of MANBA mRNA	PMID:28374803
1305785	Manba	mannosidase beta	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of MANBA protein	PMID:35544339
1305785	Manba	mannosidase beta	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314025	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of MANBA mRNA	PMID:29955902
1305785	Manba	mannosidase beta	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1314025	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of MANBA mRNA	PMID:39709020
1305785	Manba	mannosidase beta	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1314025	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MANBA mRNA	PMID:30851411
1305785	Manba	mannosidase beta	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314026	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of MANBA protein	PMID:28918527
1305785	Manba	mannosidase beta	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314025	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MANBA intron	PMID:30157460
1305785	Manba	mannosidase beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MANBA mRNA	PMID:19770486
1305785	Manba	mannosidase beta	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314026	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MANBA gene	PMID:35295148
1305785	Manba	mannosidase beta	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MANBA mRNA	PMID:23411599
1305785	Manba	mannosidase beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MANBA mRNA	PMID:30723492
1305785	Manba	mannosidase beta	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of MANBA mRNA	PMID:18445702
1305785	Manba	mannosidase beta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314026	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MANBA mRNA	PMID:18301758|PMID:23811191
1305785	Manba	mannosidase beta	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MANBA mRNA	PMID:25181051
1305785	Manba	mannosidase beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MANBA mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305785	Manba	mannosidase beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20150127	CTD	MESH:C006780	bisphenol A results in decreased expression of MANBA mRNA	PMID:25270620
1305785	Manba	mannosidase beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314025	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of MANBA mRNA	PMID:29275510
1305785	Manba	mannosidase beta	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314025	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MANBA mRNA	PMID:28628672
1305785	Manba	mannosidase beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MANBA mRNA	PMID:39298647
1305785	Manba	mannosidase beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314025	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MANBA mRNA	PMID:28628672
1305785	Manba	mannosidase beta	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1314025	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MANBA intron	PMID:30157460
1305785	Manba	mannosidase beta	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314025	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MANBA mRNA	PMID:28628672
1305785	Manba	mannosidase beta	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314026	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of MANBA intron	PMID:28392331
1305785	Manba	mannosidase beta	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MANBA mRNA	PMID:34813904
1305785	Manba	mannosidase beta	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314025	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MANBA mRNA	PMID:28628672
1305785	Manba	mannosidase beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314025	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MANBA mRNA	PMID:37042841
1305785	Manba	mannosidase beta	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of MANBA mRNA	PMID:30589522
1305785	Manba	mannosidase beta	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MANBA mRNA	PMID:30723492
1305785	Manba	mannosidase beta	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314025	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MANBA mRNA	PMID:24449571
1305785	Manba	mannosidase beta	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1314025	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of MANBA mRNA]	PMID:28003376
1305785	Manba	mannosidase beta	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314025	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MANBA mRNA	PMID:25979313
1305785	Manba	mannosidase beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314025	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of MANBA mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1305785	Manba	mannosidase beta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314025	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MANBA mRNA	PMID:20106945
1305785	Manba	mannosidase beta	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314026	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MANBA mRNA	PMID:20937368
1305785	Manba	mannosidase beta	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314025	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MANBA mRNA	PMID:28628672
1305785	Manba	mannosidase beta	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314026	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MANBA mRNA	PMID:28973697
1305785	Manba	mannosidase beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314025	E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of MANBA mRNA	PMID:25458485
1305785	Manba	mannosidase beta	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314025	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MANBA mRNA	PMID:22230336
1305785	Manba	mannosidase beta	gene	CHEBI:47499	imipramine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007099	Imipramine affects the expression of MANBA mRNA	PMID:18355885
1305785	Manba	mannosidase beta	gene	CHEBI:47519	ketoconazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007654	Ketoconazole affects the expression of MANBA mRNA	PMID:18355885
1305785	Manba	mannosidase beta	gene	CHEBI:47780	clomipramine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002997	Clomipramine affects the expression of MANBA mRNA	PMID:18355885
1305785	Manba	mannosidase beta	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MANBA mRNA	PMID:35436446
1305785	Manba	mannosidase beta	gene	CHEBI:4811	epoxiconazole	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C109476	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MANBA mRNA	PMID:29038839
1305785	Manba	mannosidase beta	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1314025	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MANBA mRNA	PMID:28628672
1305785	Manba	mannosidase beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1314025	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MANBA mRNA	PMID:23300844
1305785	Manba	mannosidase beta	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of MANBA mRNA	PMID:23962444
1305785	Manba	mannosidase beta	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1314025	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of MANBA protein	PMID:32959892
1305785	Manba	mannosidase beta	gene	CHEBI:63598	levofloxacin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of MANBA mRNA	PMID:24136188
1305785	Manba	mannosidase beta	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of MANBA mRNA	PMID:24136188
1305785	Manba	mannosidase beta	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1314025	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MANBA intron	PMID:30157460
1305785	Manba	mannosidase beta	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1314025	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MANBA protein	PMID:34186270
1305785	Manba	mannosidase beta	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MANBA mRNA	PMID:22206623
1305785	Manba	mannosidase beta	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1314025	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MANBA mRNA	PMID:30851411
1305785	Manba	mannosidase beta	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314026	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MANBA mRNA	PMID:31388691
1305785	Manba	mannosidase beta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MANBA mRNA	PMID:31826744
1305785	Manba	mannosidase beta	gene	CHEBI:81758	cyproconazole	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C093628	cyproconazole results in increased expression of MANBA mRNA	PMID:29038839
1305785	Manba	mannosidase beta	gene	CHEBI:81758	cyproconazole	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C093628	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MANBA mRNA	PMID:29038839
1305785	Manba	mannosidase beta	gene	CHEBI:8434	prochloraz	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C045362	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA	PMID:29038839
1305785	Manba	mannosidase beta	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MANBA mRNA	PMID:24780913
1305785	Manba	mannosidase beta	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MANBA mRNA	PMID:21346803
1305785	Manba	mannosidase beta	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1314025	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MANBA mRNA	PMID:29301935
1305785	Manba	mannosidase beta	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MANBA mRNA	PMID:21346803
1305785	Manba	mannosidase beta	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MANBA mRNA	PMID:23034163
1305785	Manba	mannosidase beta	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MANBA mRNA	PMID:20566332
1305786	Plek2	pleckstrin 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PLEK2 mRNA]	PMID:31150632
1305786	Plek2	pleckstrin 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLEK2 mRNA	PMID:20938992
1305786	Plek2	pleckstrin 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1314027	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PLEK2 mRNA	PMID:26079696
1305786	Plek2	pleckstrin 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of PLEK2 mRNA	PMID:19167417
1305786	Plek2	pleckstrin 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1314027	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PLEK2 mRNA	PMID:20044591
1305786	Plek2	pleckstrin 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314027	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PLEK2 mRNA	PMID:35811015
1305786	Plek2	pleckstrin 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLEK2 mRNA	PMID:35811015
1305786	Plek2	pleckstrin 2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1314027	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of PLEK2 mRNA	PMID:30510588
1305786	Plek2	pleckstrin 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PLEK2 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of PLEK2 mRNA	PMID:17404688|PMID:30165855
1305786	Plek2	pleckstrin 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1314027	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PLEK2 mRNA	PMID:38568856
1305786	Plek2	pleckstrin 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PLEK2 mRNA	PMID:33387578
1305786	Plek2	pleckstrin 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLEK2 mRNA	PMID:20938992
1305786	Plek2	pleckstrin 2	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1314027	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of PLEK2 mRNA	PMID:17404688
1305786	Plek2	pleckstrin 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of PLEK2 mRNA	PMID:17404688
1305786	Plek2	pleckstrin 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1314027	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PLEK2 mRNA	PMID:26079696
1305786	Plek2	pleckstrin 2	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLEK2 mRNA	PMID:36139627
1305786	Plek2	pleckstrin 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEK2 mRNA	PMID:39012411
1305786	Plek2	pleckstrin 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314027	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLEK2 mRNA	PMID:22100608
1305786	Plek2	pleckstrin 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314027	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PLEK2 intron	PMID:30157460
1305786	Plek2	pleckstrin 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PLEK2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PLEK2 mRNA	PMID:34911549
1305786	Plek2	pleckstrin 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PLEK2 mRNA	PMID:31150632
1305786	Plek2	pleckstrin 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PLEK2 mRNA]	PMID:31150632
1305786	Plek2	pleckstrin 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLEK2 mRNA	PMID:20938992
1305786	Plek2	pleckstrin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLEK2 mRNA	PMID:39836092
1305786	Plek2	pleckstrin 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314028	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of PLEK2 mRNA	PMID:40618947
1305786	Plek2	pleckstrin 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PLEK2 mRNA	PMID:27392435
1305786	Plek2	pleckstrin 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1314027	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PLEK2 mRNA	PMID:25583101
1305786	Plek2	pleckstrin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314028	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLEK2 mRNA	PMID:21570461|PMID:26377647
1305786	Plek2	pleckstrin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLEK2 mRNA	PMID:15328365
1305786	Plek2	pleckstrin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLEK2 mRNA	PMID:17942748
1305786	Plek2	pleckstrin 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314028	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of PLEK2 mRNA	PMID:32937126
1305786	Plek2	pleckstrin 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PLEK2 mRNA	PMID:28959563
1305786	Plek2	pleckstrin 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314027	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of PLEK2 mRNA	PMID:29301061|PMID:39719251
1305786	Plek2	pleckstrin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLEK2 mRNA	PMID:39836092
1305786	Plek2	pleckstrin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314027	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLEK2 exon	PMID:30157460
1305786	Plek2	pleckstrin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314027	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PLEK2 promoter	PMID:27901495
1305786	Plek2	pleckstrin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLEK2 mRNA	PMID:21839799
1305786	Plek2	pleckstrin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314027	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLEK2 mRNA	PMID:32234424
1305786	Plek2	pleckstrin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLEK2 mRNA	PMID:19770486
1305786	Plek2	pleckstrin 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1314027	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of PLEK2 promoter	PMID:23974009
1305786	Plek2	pleckstrin 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314027	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PLEK2 mRNA	PMID:25895662
1305786	Plek2	pleckstrin 2	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	ISO	RGD:1314027	E	RGD:6480464	20191114	CTD	MESH:C006632	PLEK2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305786	Plek2	pleckstrin 2	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of PLEK2 mRNA	PMID:24915197
1305786	Plek2	pleckstrin 2	gene	CHEBI:31575	ethylparaben	increases expression	ISO	RGD:1314027	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of PLEK2 mRNA	PMID:37690743
1305786	Plek2	pleckstrin 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PLEK2 gene; [bisphenol S co-treated with Fulvestrant] results in increased methylation of PLEK2 gene	PMID:31601247
1305786	Plek2	pleckstrin 2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of PLEK2 mRNA	PMID:25729387
1305786	Plek2	pleckstrin 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLEK2 mRNA	PMID:25729387
1305786	Plek2	pleckstrin 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of PLEK2 mRNA	PMID:30047161
1305786	Plek2	pleckstrin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314028	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLEK2 gene; titanium dioxide results in decreased methylation of PLEK2 promoter	PMID:35295148
1305786	Plek2	pleckstrin 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314028	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PLEK2 promoter	PMID:35295148
1305786	Plek2	pleckstrin 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of PLEK2 mRNA	PMID:17426115|PMID:20813756
1305786	Plek2	pleckstrin 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314028	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PLEK2 mRNA	PMID:28472532
1305786	Plek2	pleckstrin 2	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1314027	E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of PLEK2 mRNA	PMID:30690063
1305786	Plek2	pleckstrin 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PLEK2 mRNA	PMID:25181051
1305786	Plek2	pleckstrin 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PLEK2 mRNA	PMID:32145629|PMID:34947998
1305786	Plek2	pleckstrin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PLEK2 gene	PMID:31601247
1305786	Plek2	pleckstrin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314028	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PLEK2 mRNA	PMID:40203079
1305786	Plek2	pleckstrin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20180116	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of PLEK2 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PLEK2 mRNA	PMID:28628672|PMID:31601247
1305786	Plek2	pleckstrin 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314028	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PLEK2 mRNA	PMID:28392331
1305786	Plek2	pleckstrin 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314028	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PLEK2 mRNA	PMID:37019170
1305786	Plek2	pleckstrin 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314028	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLEK2 mRNA	PMID:32715474
1305786	Plek2	pleckstrin 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PLEK2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PLEK2 mRNA	PMID:28628672
1305786	Plek2	pleckstrin 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314028	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PLEK2 mRNA	PMID:24535843
1305786	Plek2	pleckstrin 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLEK2 mRNA	PMID:35163327
1305786	Plek2	pleckstrin 2	gene	CHEBI:3537	cefaloridine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of PLEK2 mRNA	PMID:18500788
1305786	Plek2	pleckstrin 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314027	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PLEK2 mRNA	PMID:38568856
1305786	Plek2	pleckstrin 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEK2 mRNA	PMID:39012411
1305786	Plek2	pleckstrin 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLEK2 mRNA	PMID:35163327
1305786	Plek2	pleckstrin 2	gene	CHEBI:35559	furan	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of PLEK2 gene	PMID:27387713
1305786	Plek2	pleckstrin 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of PLEK2 mRNA	PMID:25539665|PMID:26194646|PMID:27387713
1305786	Plek2	pleckstrin 2	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PLEK2 gene	PMID:22079235
1305786	Plek2	pleckstrin 2	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1314027	E	RGD:6480464	20171010	CTD	MESH:C100187	chloropicrin results in decreased expression of PLEK2 mRNA	PMID:28476498
1305786	Plek2	pleckstrin 2	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PLEK2 mRNA	PMID:25993096
1305786	Plek2	pleckstrin 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314027	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PLEK2 gene	PMID:29154799
1305786	Plek2	pleckstrin 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314027	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of PLEK2 mRNA	PMID:29154799
1305786	Plek2	pleckstrin 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PLEK2 mRNA	PMID:30047161
1305786	Plek2	pleckstrin 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PLEK2 mRNA	PMID:17555576
1305786	Plek2	pleckstrin 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PLEK2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PLEK2 mRNA	PMID:28628672
1305786	Plek2	pleckstrin 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314027	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PLEK2 mRNA	PMID:38832940
1305786	Plek2	pleckstrin 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314027	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLEK2 mRNA	PMID:22230336
1305786	Plek2	pleckstrin 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLEK2 mRNA	PMID:35811015
1305786	Plek2	pleckstrin 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLEK2 mRNA	PMID:39836092
1305786	Plek2	pleckstrin 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLEK2 mRNA	PMID:29391264
1305786	Plek2	pleckstrin 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLEK2 mRNA	PMID:22079256
1305786	Plek2	pleckstrin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PLEK2 mRNA	PMID:17555576
1305786	Plek2	pleckstrin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PLEK2 mRNA	PMID:17942748
1305786	Plek2	pleckstrin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLEK2 mRNA	PMID:17942748
1305786	Plek2	pleckstrin 2	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1314027	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of PLEK2 mRNA	PMID:38568856
1305786	Plek2	pleckstrin 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PLEK2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PLEK2 mRNA	PMID:28628672
1305786	Plek2	pleckstrin 2	gene	CHEBI:49900	arsenous acid	decreases response to substance	ISO	RGD:1314027	E	RGD:6480464	20191114	CTD	MESH:C032793	PLEK2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1305786	Plek2	pleckstrin 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of PLEK2 mRNA	PMID:28801915
1305786	Plek2	pleckstrin 2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PLEK2 mRNA	PMID:25729387
1305786	Plek2	pleckstrin 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLEK2 mRNA	PMID:25729387
1305786	Plek2	pleckstrin 2	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of PLEK2 mRNA	PMID:19812364
1305786	Plek2	pleckstrin 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314027	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PLEK2 mRNA	PMID:15336504
1305786	Plek2	pleckstrin 2	gene	CHEBI:6456	lidocaine	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in decreased expression of PLEK2 mRNA	PMID:35283115
1305786	Plek2	pleckstrin 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1314027	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PLEK2 mRNA	PMID:31758290
1305786	Plek2	pleckstrin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314028	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PLEK2 mRNA	PMID:22206623
1305786	Plek2	pleckstrin 2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1314027	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PLEK2 mRNA	PMID:22079256|PMID:22714537
1305786	Plek2	pleckstrin 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLEK2 mRNA	PMID:22079256
1305786	Plek2	pleckstrin 2	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of PLEK2 mRNA	PMID:33484710
1305786	Plek2	pleckstrin 2	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1314027	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLEK2 mRNA	PMID:36139627
1305786	Plek2	pleckstrin 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of PLEK2 mRNA	PMID:21346803
1305786	Plek2	pleckstrin 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of PLEK2 mRNA	PMID:32109520
1305786	Plek2	pleckstrin 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1314027	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PLEK2 mRNA	PMID:26079696
1305786	Plek2	pleckstrin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLEK2 mRNA	PMID:24780913
1305786	Plek2	pleckstrin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLEK2 mRNA	PMID:30047161
1305786	Plek2	pleckstrin 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PLEK2 mRNA	PMID:21346803
1305786	Plek2	pleckstrin 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1314027	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PLEK2 mRNA	PMID:38568856
1305786	Plek2	pleckstrin 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PLEK2 mRNA	PMID:21346803
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D015215	Zidovudine results in increased expression of AGPAT3 mRNA	PMID:28619387
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D015215	[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA; Silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA]	PMID:28619387
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of AGPAT3 mRNA	PMID:21551480
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314029	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of AGPAT3 mRNA	PMID:21934132
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGPAT3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGPAT3 mRNA	PMID:32699268
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1314030	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of AGPAT3 mRNA	PMID:15282401
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20140715	CTD	MESH:D002392	Catechin inhibits the reaction [Dietary Fats results in increased expression of AGPAT3 mRNA]	PMID:23365609
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314029	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of AGPAT3 mRNA	PMID:22378314
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314030	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of AGPAT3 mRNA	PMID:30319688
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314030	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of AGPAT3 mRNA	PMID:19693291|PMID:39298647
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of AGPAT3 mRNA	PMID:23649840|PMID:27905399
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314030	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in increased expression of AGPAT3 mRNA	PMID:19693291
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314029	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of AGPAT3 protein	PMID:37730182
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of AGPAT3 mRNA	PMID:22061828
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1314029	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of AGPAT3 intron	PMID:30157460
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of AGPAT3 mRNA	PMID:17103032
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AGPAT3 mRNA	PMID:19549813
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of AGPAT3 mRNA	PMID:23649840
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of AGPAT3 protein	PMID:33236894
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AGPAT3 mRNA	PMID:19770486
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314029	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AGPAT3 gene	PMID:27153756
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314029	E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of AGPAT3 gene	PMID:28458013
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of AGPAT3 mRNA	PMID:23649840
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGPAT3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGPAT3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of AGPAT3 mRNA	PMID:32699268
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000638	Amiodarone results in increased expression of AGPAT3 mRNA	PMID:40216313
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of AGPAT3 mRNA	PMID:30779732
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1314030	E	RGD:6480464	20140715	CTD	MESH:C011559	tributyltin results in increased expression of AGPAT3 mRNA	PMID:23428407
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AGPAT3 mRNA	PMID:31150632
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1314029	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AGPAT3 gene	PMID:25304211
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1314029	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of AGPAT3 mRNA	PMID:26272509
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	PMID:27188386
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of AGPAT3 mRNA	PMID:23557933
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of AGPAT3 mRNA	PMID:25583101
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314030	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AGPAT3 mRNA	PMID:21570461
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AGPAT3 mRNA	PMID:23152189
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AGPAT3 mRNA	PMID:21215274|PMID:26232522
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314029	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AGPAT3 mRNA	PMID:20106945|PMID:21632981
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28201	rotenone	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of AGPAT3 mRNA	PMID:28374803
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of AGPAT3 mRNA	PMID:33212167
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1314029	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of AGPAT3 mRNA	PMID:30851411
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AGPAT3 mRNA	PMID:29803840
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1314029	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of AGPAT3 mRNA	PMID:20044591
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AGPAT3 mRNA	PMID:38568856
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AGPAT3 mRNA	PMID:26238291|PMID:32234424
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AGPAT3 mRNA	PMID:21715664
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314030	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AGPAT3 mRNA	PMID:22228805
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314029	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AGPAT3 5' UTR; Benzo(a)pyrene results in increased methylation of AGPAT3 promoter	PMID:27901495
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314030	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to AGPAT3 promoter]	PMID:19654925
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AGPAT3 mRNA	PMID:20018196
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of AGPAT3 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of AGPAT3 gene	PMID:31601247
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314030	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of AGPAT3 mRNA	PMID:17950772|PMID:18301758|PMID:23811191
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314030	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of AGPAT3 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of AGPAT3 mRNA]	PMID:17950772|PMID:19710929
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314030	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of AGPAT3 mRNA	PMID:28472532
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of AGPAT3 mRNA	PMID:25181051
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AGPAT3 mRNA	PMID:30816183
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314029	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of AGPAT3 gene	PMID:31601247
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314030	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of AGPAT3 mRNA	PMID:34585602|PMID:35479511
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AGPAT3 gene	PMID:28505145
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of AGPAT3 gene	PMID:31601247
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of AGPAT3 mRNA	PMID:26682919
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314030	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of AGPAT3 mRNA	PMID:39298647
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of AGPAT3 gene	PMID:31601247
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of AGPAT3 mRNA	PMID:34813904
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314030	E	RGD:6480464	20140715	CTD	MESH:D015056	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of AGPAT3 mRNA	PMID:23428407
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of AGPAT3 mRNA	PMID:34813904
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314029	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AGPAT3 mRNA	PMID:37042841
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AGPAT3 mRNA	PMID:38568856
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of AGPAT3 promoter	PMID:22457795
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of AGPAT3 mRNA	PMID:21723365
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1314029	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of AGPAT3 mRNA	PMID:17553155
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of AGPAT3 mRNA	PMID:24449571
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGPAT3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGPAT3 mRNA	PMID:32699268
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of AGPAT3 mRNA	PMID:19167446
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314030	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of AGPAT3 mRNA	PMID:17963808
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314029	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of AGPAT3 mRNA	PMID:23179753|PMID:27188386
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314029	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of AGPAT3 gene	PMID:29154799
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of AGPAT3 mRNA	PMID:38685447
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AGPAT3 mRNA	PMID:20106945|PMID:25562108
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1314029	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of AGPAT3 promoter	PMID:27989131
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1314030	E	RGD:6480464	20190910	CTD	MESH:D003907	Dexamethasone results in increased expression of AGPAT3 mRNA	PMID:31053639
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314030	E	RGD:6480464	20140715	CTD	MESH:D003907	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of AGPAT3 mRNA; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of AGPAT3 mRNA]	PMID:23428407|PMID:31053639
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1314029	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of AGPAT3 mRNA	PMID:17400583
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of AGPAT3 mRNA	PMID:38832940
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1314029	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of AGPAT3 mRNA	PMID:24935251|PMID:26272509
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	PMID:27188386
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of AGPAT3 mRNA	PMID:33387578
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of AGPAT3 mRNA	PMID:21420995
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1314029	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AGPAT3 gene	PMID:25304211
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of AGPAT3 mRNA	PMID:29391264
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of AGPAT3 mRNA	PMID:35436446
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:49203	torcetrapib	increases expression	ISO	RGD:1314029	E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of AGPAT3 mRNA	PMID:23228038
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of AGPAT3 mRNA	PMID:36868495
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of AGPAT3 mRNA	PMID:30307764
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314030	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AGPAT3 mRNA; Nanotubes, Carbon results in increased expression of AGPAT3 mRNA	PMID:25554681|PMID:25620056
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of AGPAT3 mRNA	PMID:24136188
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of AGPAT3 mRNA	PMID:41580965
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314030	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of AGPAT3 mRNA	PMID:35964746
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of AGPAT3 mRNA	PMID:24136188
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D007538	Isoniazid results in increased expression of AGPAT3 mRNA	PMID:28619387
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6030	isoniazide	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D007538	[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA]	PMID:28619387
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of AGPAT3 mRNA	PMID:20436886
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of AGPAT3 mRNA	PMID:24136188
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of AGPAT3 mRNA	PMID:30467583
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of AGPAT3 gene	PMID:35440735
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of AGPAT3 mRNA	PMID:22206623
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:77850	toxaphene	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014112	Toxaphene results in increased expression of AGPAT3 mRNA	PMID:23153324
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1314029	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of AGPAT3 mRNA	PMID:30851411
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	PMID:27188386
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of AGPAT3 mRNA	PMID:27291303
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of AGPAT3 mRNA	PMID:23640034
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314029	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	PMID:27188386
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:9144	silibinin	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C440975	Silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA]	PMID:28619387
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of AGPAT3 mRNA	PMID:19281266
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1314029	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AGPAT3 mRNA	PMID:38568856
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of AGPAT3 mRNA	PMID:21346803
1305787	Agpat3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of AGPAT3 mRNA	PMID:28973697
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of SCMH1 mRNA	PMID:21551480
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SCMH1 mRNA	PMID:33045310
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314032	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SCMH1 mRNA	PMID:20188158
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314031	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SCMH1 mRNA	PMID:21934132
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SCMH1 mRNA	PMID:26079696
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SCMH1 mRNA	PMID:21632981
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SCMH1 mRNA	PMID:39241906
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SCMH1 mRNA	PMID:23649840
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314031	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SCMH1 protein	PMID:37730182
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SCMH1 mRNA	PMID:22061828
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SCMH1 mRNA	PMID:28818685
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SCMH1 mRNA	PMID:19549813
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1314032	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SCMH1 mRNA	PMID:32553695
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SCMH1 mRNA	PMID:30779732
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314032	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SCMH1 mRNA]	PMID:22206623
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314031	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SCMH1 mRNA	PMID:40512198
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SCMH1 mRNA	PMID:31881176
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SCMH1 mRNA	PMID:30912803
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of SCMH1 mRNA	PMID:32186404
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314032	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SCMH1 mRNA	PMID:21570461
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SCMH1 mRNA	PMID:20106945|PMID:21632981
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314032	E	RGD:6480464	20201006	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SCMH1 mRNA	PMID:32553695
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SCMH1 mRNA	PMID:33212167
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SCMH1 mRNA	PMID:32763439
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SCMH1 mRNA	PMID:38568856
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314031	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SCMH1 mRNA	PMID:40512198
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314031	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SCMH1 5' UTR	PMID:27901495
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCMH1 mRNA	PMID:20106945|PMID:21632981
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314032	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of SCMH1 mRNA	PMID:32553695
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314032	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SCMH1 mRNA	PMID:27131904
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314032	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SCMH1 gene	PMID:35295148
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SCMH1 mRNA	PMID:19167457
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SCMH1 mRNA	PMID:25181051
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314032	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SCMH1 promoter	PMID:27334623
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314031	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SCMH1 mRNA	PMID:29275510
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SCMH1 gene	PMID:28505145
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SCMH1 mRNA	PMID:19244175
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1314031	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SCMH1 promoter	PMID:30157460
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314031	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCMH1 mRNA	PMID:28628672
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SCMH1 mRNA	PMID:28392331
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314031	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCMH1 mRNA	PMID:28628672
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SCMH1 mRNA	PMID:38568856
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SCMH1 mRNA	PMID:24386269
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314031	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SCMH1 mRNA	PMID:32588087
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314031	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SCMH1 gene	PMID:29154799
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SCMH1 mRNA	PMID:25562108
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314031	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SCMH1 mRNA	PMID:20106945
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314031	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCMH1 mRNA	PMID:28628672
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1314031	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SCMH1 mRNA	PMID:38832940
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SCMH1 mRNA	PMID:33387578
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314031	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SCMH1 mRNA	PMID:40512198
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1314032	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of SCMH1 mRNA	PMID:35436446
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1314031	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCMH1 mRNA	PMID:28628672
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SCMH1 mRNA	PMID:23608068
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1314031	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SCMH1 promoter	PMID:30157460
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314032	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SCMH1 mRNA	PMID:22206623
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314032	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SCMH1 mRNA]	PMID:22206623
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	ISO	RGD:1314031	E	RGD:6480464	20220405	CTD	MESH:C045338	SCMH1 protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314032	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of SCMH1 mRNA	PMID:19482888
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314032	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SCMH1 mRNA]	PMID:19482888
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314032	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SCMH1 mRNA	PMID:21795629
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314032	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SCMH1 mRNA	PMID:27131904
1305788	Scmh1	Scm polycomb group protein homolog 1	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of SCMH1 mRNA	PMID:23034163
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of WDR1 mRNA	PMID:21551480
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314034	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of WDR1 mRNA	PMID:20188158
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314033	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of WDR1 mRNA	PMID:33167477
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of WDR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of WDR1 mRNA	PMID:32699268
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314034	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of WDR1 mRNA	PMID:30319688
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of WDR1 protein	PMID:23178681
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D006861	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of WDR1 protein]	PMID:23178681
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:16325	lithocholic acid	decreases expression	ISO	RGD:1314033	E	RGD:6480464	20131210	CTD	MESH:D008095	Lithocholic Acid results in decreased expression of WDR1 protein	PMID:21224350
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:16336	hyaluronic acid	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D006820	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of WDR1 protein]	PMID:23178681
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314034	E	RGD:6480464	20181113	CTD	MESH:D004958	Estradiol results in increased expression of WDR1 mRNA	PMID:30077407
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20181113	CTD	MESH:D004958	[Polyphenols co-treated with Estradiol] results in increased expression of WDR1 mRNA	PMID:30077407
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:16482	naphthalene	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in decreased expression of WDR1 protein	PMID:19438287
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of WDR1 mRNA	PMID:33387578
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1314033	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of WDR1 mRNA	PMID:20655997|PMID:23649840
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1314033	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of WDR1 mRNA	PMID:21179406
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:17362	quinoline	increases expression	ISO	RGD:1314033	E	RGD:6480464	20120412	CTD	MESH:C037219	quinoline analog results in increased expression of WDR1 protein	PMID:18645022
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1314033	E	RGD:6480464	20170725	CTD	MESH:D014050	Toluene results in decreased expression of WDR1 mRNA	PMID:28245982
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WDR1 mRNA	PMID:33354967
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314033	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WDR1 mRNA	PMID:27153756
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of WDR1 protein	PMID:22248470
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of WDR1 protein	PMID:22248470
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of WDR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of WDR1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of WDR1 mRNA	PMID:32699268
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:2654	aminoglutethimide	increases expression	ISO	RGD:1314033	E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in increased expression of WDR1 protein	PMID:26102013
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of WDR1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of WDR1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of WDR1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of WDR1 protein	PMID:38598786
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314034	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of WDR1 mRNA	PMID:27339419|PMID:31919559
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WDR1 mRNA	PMID:22206623
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDR1 mRNA	PMID:40504410
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1314033	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of WDR1 mRNA	PMID:19244175
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1314033	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of WDR1 mRNA	PMID:26272509
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WDR1 mRNA	PMID:27188386
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1314033	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of WDR1 mRNA	PMID:24768652|PMID:25583101
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314034	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDR1 mRNA	PMID:21570461
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WDR1 mRNA	PMID:34747641
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WDR1 mRNA	PMID:17942748
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1314033	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of WDR1 mRNA	PMID:23179753
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314034	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of WDR1 mRNA	PMID:30807115
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of WDR1 mRNA	PMID:31162603
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of WDR1 mRNA	PMID:29432896
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314033	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of WDR1 mRNA	PMID:38568856
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDR1 mRNA	PMID:40504410
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314033	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of WDR1 intron	PMID:30157460
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of WDR1 mRNA	PMID:19770486
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314034	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WDR1 mRNA	PMID:22228805
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of WDR1 mRNA	PMID:31162603
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314033	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WDR1 mRNA	PMID:19150397|PMID:20018196
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of WDR1 mRNA	PMID:30047161
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314034	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of WDR1 gene	PMID:35295148
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of WDR1 mRNA	PMID:34492290
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of WDR1 mRNA	PMID:18648102
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in decreased expression of WDR1 mRNA	PMID:25270620
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of WDR1 mRNA	PMID:19710929
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of WDR1 mRNA	PMID:25181051
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1314033	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of WDR1 mRNA	PMID:30903817
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314033	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR1 protein	PMID:34186270
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR1 protein	PMID:35999755
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314033	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of WDR1 gene	PMID:31601247
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of WDR1 protein	PMID:32145629
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314033	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of WDR1 protein	PMID:37567409
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1314033	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of WDR1 mRNA	PMID:19244175
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314033	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of WDR1 protein	PMID:34186270
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314034	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of WDR1 mRNA	PMID:30951980|PMID:39298647
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1314033	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of WDR1 protein	PMID:34186270
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314034	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of WDR1 intron	PMID:28392331
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314034	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of WDR1 mRNA	PMID:37019170
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of WDR1 protein	PMID:35999755
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of WDR1 mRNA	PMID:21266533
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314034	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of WDR1 mRNA	PMID:17361019|PMID:21266533
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of WDR1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of WDR1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of WDR1 protein	PMID:38598786
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of WDR1 mRNA	PMID:19638242
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314033	E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of WDR1 protein	PMID:34064677
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1314033	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of WDR1 mRNA	PMID:19320972
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of WDR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of WDR1 mRNA	PMID:32699268
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1314033	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of WDR1 mRNA	PMID:19244175
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:38757	isoflavones	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of WDR1 protein	PMID:22248470
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1314033	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of WDR1 mRNA	PMID:26352163
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314033	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of WDR1 mRNA	PMID:40419075
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314033	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of WDR1 mRNA	PMID:25979313
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314033	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of WDR1 mRNA	PMID:23179753
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of WDR1 mRNA	PMID:38685447
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of WDR1 mRNA	PMID:30047161
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314033	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of WDR1 mRNA	PMID:25562108
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314033	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of WDR1 mRNA	PMID:14699072
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of WDR1 mRNA	PMID:17555576
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of WDR1 mRNA	PMID:18502557
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314033	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of WDR1 mRNA	PMID:38832940
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of WDR1 mRNA	PMID:17562736
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of WDR1 mRNA	PMID:33387578
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314034	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of WDR1 mRNA	PMID:29246445
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of WDR1 mRNA]	PMID:29246445
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1314033	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of WDR1 mRNA	PMID:20977926
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDR1 mRNA	PMID:40504410
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314034	E	RGD:6480464	20120918	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of WDR1 mRNA	PMID:14976129|PMID:17555576|PMID:17942748
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WDR1 mRNA	PMID:17942748
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314034	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of WDR1 mRNA; Nanotubes, Carbon results in increased expression of WDR1 mRNA	PMID:25554681
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of WDR1 mRNA	PMID:31881178
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of WDR1 mRNA	PMID:41580965
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of WDR1 mRNA	PMID:30047161
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of WDR1 mRNA	PMID:35964746
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of WDR1 mRNA	PMID:24793618
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1314033	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of WDR1 protein	PMID:32959892
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314033	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of WDR1 mRNA	PMID:15336504
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1314033	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of WDR1 mRNA	PMID:31758290
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1314033	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of WDR1 protein	PMID:34186270
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WDR1 mRNA	PMID:22206623
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1314033	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of WDR1 mRNA	PMID:37199045
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1314033	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of WDR1 protein	PMID:39638853
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WDR1 mRNA	PMID:27188386
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:79516	Nonylphenol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in increased expression of WDR1 protein	PMID:19260726
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WDR1 gene]	PMID:28238834
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in decreased expression of WDR1 mRNA	PMID:25270620
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of WDR1 mRNA	PMID:19482888
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of WDR1 mRNA]	PMID:19482888
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314034	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of WDR1 mRNA	PMID:31388691
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of WDR1 mRNA	PMID:30047161
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of WDR1 mRNA	PMID:30047161
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1314033	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of WDR1 mRNA	PMID:14699072
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WDR1 mRNA	PMID:27188386
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1314033	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of WDR1 mRNA	PMID:38568856
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of WDR1 protein	PMID:35544339
1305789	Wdr1	WD repeat domain 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1314033	E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of WDR1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of WDR1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of WDR1 protein	PMID:38598786
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314036	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PHYHIP mRNA	PMID:33045310
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314035	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of PHYHIP mRNA	PMID:15498508|PMID:23724009
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1314035	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of PHYHIP mRNA	PMID:24763279
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314036	E	RGD:6480464	20161025	CTD	MESH:D001280	Atrazine results in decreased expression of PHYHIP mRNA	PMID:27655631
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314036	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PHYHIP mRNA	PMID:30319688
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA	PMID:25510870
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PHYHIP mRNA	PMID:33387578
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314035	E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of PHYHIP mRNA	PMID:36695872
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314035	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PHYHIP mRNA	PMID:33359661
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314036	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PHYHIP mRNA	PMID:35716406
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PHYHIP mRNA	PMID:26577399
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1314035	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PHYHIP mRNA	PMID:36139627
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA	PMID:25510870
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA	PMID:25510870
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314035	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PHYHIP mRNA	PMID:19549813
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314035	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PHYHIP gene	PMID:27153756
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHYHIP mRNA	PMID:40504410
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314035	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHYHIP mRNA	PMID:27188386
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314035	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PHYHIP mRNA	PMID:28903495
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1314035	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PHYHIP mRNA	PMID:25583101
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314036	E	RGD:6480464	20150630	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHYHIP mRNA	PMID:21570461|PMID:24680724
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHYHIP mRNA	PMID:33387578
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20150630	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHYHIP mRNA	PMID:17942748
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314036	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of PHYHIP mRNA	PMID:30807115
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314036	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHYHIP mRNA	PMID:39631538
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHYHIP mRNA	PMID:40504410
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314035	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PHYHIP 5' UTR	PMID:27901495
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314035	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHYHIP mRNA	PMID:32234424
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314035	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PHYHIP promoter	PMID:27901495
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314035	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PHYHIP mRNA	PMID:25351596
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1314035	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of PHYHIP mRNA	PMID:37690743
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1314035	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of PHYHIP mRNA	PMID:15498508
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314036	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PHYHIP mRNA	PMID:29264374
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150630	CTD	MESH:C006780	bisphenol A affects the expression of PHYHIP mRNA	PMID:25181051
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PHYHIP mRNA	PMID:30816183|PMID:34947998
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20150630	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA	PMID:25510870
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20150630	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA	PMID:25510870
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314036	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PHYHIP 3' UTR	PMID:28392331
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314036	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PHYHIP mRNA	PMID:32715474
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1314036	E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride affects the expression of PHYHIP mRNA	PMID:29408670
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314036	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PHYHIP mRNA	PMID:40194260
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314036	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PHYHIP mRNA	PMID:39529242
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PHYHIP mRNA	PMID:30047161
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314035	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PHYHIP mRNA	PMID:38832940
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHYHIP mRNA	PMID:40504410
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1314035	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of PHYHIP mRNA	PMID:31838189
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314036	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PHYHIP mRNA	PMID:35436446
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20150630	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHYHIP mRNA	PMID:17942748
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1314035	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in decreased expression of PHYHIP mRNA	PMID:17211630
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PHYHIP mRNA	PMID:30047161
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1314036	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of PHYHIP mRNA	PMID:26377693
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20150630	CTD	MESH:D007649	Ketamine results in increased expression of PHYHIP mRNA	PMID:20080153
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314036	E	RGD:6480464	20150630	CTD	MESH:C017096	n-butoxyethanol results in increased expression of PHYHIP mRNA	PMID:19812364
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314035	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PHYHIP mRNA	PMID:24810058
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314036	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PHYHIP mRNA	PMID:36907384
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1314035	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of PHYHIP mRNA	PMID:36318118
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1314035	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PHYHIP mRNA	PMID:36139627
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314035	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHYHIP mRNA	PMID:27188386
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of PHYHIP mRNA	PMID:30047161
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PHYHIP mRNA	PMID:30047161
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314035	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHYHIP mRNA	PMID:27188386
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20150630	CTD	MESH:D012999	Soman results in decreased expression of PHYHIP mRNA	PMID:19281266
1305790	Phyhip	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1314036	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PHYHIP mRNA	PMID:32835833
1305791	Snx8	sorting nexin 8	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314038	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SNX8 mRNA	PMID:33045310
1305791	Snx8	sorting nexin 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SNX8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX8 gene	PMID:20938992
1305791	Snx8	sorting nexin 8	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314037	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNX8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNX8 mRNA	PMID:32699268
1305791	Snx8	sorting nexin 8	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1314037	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SNX8 mRNA	PMID:26079696
1305791	Snx8	sorting nexin 8	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SNX8 gene	PMID:28931070
1305791	Snx8	sorting nexin 8	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1314037	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SNX8 mRNA	PMID:21632981
1305791	Snx8	sorting nexin 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314038	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SNX8 mRNA	PMID:39241906
1305791	Snx8	sorting nexin 8	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1314037	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SNX8 mRNA	PMID:38568856
1305791	Snx8	sorting nexin 8	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SNX8 mRNA	PMID:33387578
1305791	Snx8	sorting nexin 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SNX8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX8 gene	PMID:20938992
1305791	Snx8	sorting nexin 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314037	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNX8 mRNA	PMID:37042841
1305791	Snx8	sorting nexin 8	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1314037	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SNX8 protein	PMID:37730182
1305791	Snx8	sorting nexin 8	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SNX8 mRNA	PMID:33387578
1305791	Snx8	sorting nexin 8	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1314037	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SNX8 intron	PMID:30157460
1305791	Snx8	sorting nexin 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNX8 mRNA	PMID:37236586
1305791	Snx8	sorting nexin 8	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314037	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SNX8 mRNA	PMID:19549813
1305791	Snx8	sorting nexin 8	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1314037	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SNX8 protein	PMID:23301498
1305791	Snx8	sorting nexin 8	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314037	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SNX8 intron	PMID:30157460
1305791	Snx8	sorting nexin 8	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1314037	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SNX8 mRNA	PMID:23649840
1305791	Snx8	sorting nexin 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314037	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNX8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNX8 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of SNX8 mRNA	PMID:32699268
1305791	Snx8	sorting nexin 8	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SNX8 mRNA	PMID:30779732
1305791	Snx8	sorting nexin 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNX8 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SNX8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX8 gene	PMID:20938992|PMID:22206623
1305791	Snx8	sorting nexin 8	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1314037	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SNX8 gene	PMID:25304211
1305791	Snx8	sorting nexin 8	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1314037	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SNX8 protein	PMID:35688186
1305791	Snx8	sorting nexin 8	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1314037	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SNX8 mRNA	PMID:24768652|PMID:25583101
1305791	Snx8	sorting nexin 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314038	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX8 mRNA	PMID:21570461
1305791	Snx8	sorting nexin 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNX8 mRNA	PMID:33387578
1305791	Snx8	sorting nexin 8	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314037	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SNX8 mRNA	PMID:33212167
1305791	Snx8	sorting nexin 8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314037	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNX8 mRNA	PMID:29803840
1305791	Snx8	sorting nexin 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314038	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX8 mRNA	PMID:37682722
1305791	Snx8	sorting nexin 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314037	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SNX8 mRNA	PMID:38568856
1305791	Snx8	sorting nexin 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314037	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SNX8 mRNA	PMID:20106945
1305791	Snx8	sorting nexin 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314038	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNX8 mRNA	PMID:22228805
1305791	Snx8	sorting nexin 8	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314037	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SNX8 mRNA	PMID:25895662
1305791	Snx8	sorting nexin 8	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1314037	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SNX8 gene	PMID:31601247
1305791	Snx8	sorting nexin 8	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314038	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SNX8 promoter	PMID:35295148
1305791	Snx8	sorting nexin 8	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SNX8 mRNA	PMID:23411599|PMID:34492290
1305791	Snx8	sorting nexin 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SNX8 mRNA	PMID:19710929
1305791	Snx8	sorting nexin 8	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314038	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SNX8 mRNA	PMID:28472532
1305791	Snx8	sorting nexin 8	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SNX8 mRNA	PMID:19167457
1305791	Snx8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX8 mRNA	PMID:34947998
1305791	Snx8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314037	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX8 protein	PMID:31675489
1305791	Snx8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314037	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SNX8 gene	PMID:31601247
1305791	Snx8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNX8 mRNA	PMID:25181051
1305791	Snx8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SNX8 gene	PMID:28505145
1305791	Snx8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SNX8 mRNA	PMID:36041667
1305791	Snx8	sorting nexin 8	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1314037	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SNX8 protein	PMID:31675489
1305791	Snx8	sorting nexin 8	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1314037	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of SNX8 mRNA	PMID:36804509
1305791	Snx8	sorting nexin 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SNX8 mRNA	PMID:36041667
1305791	Snx8	sorting nexin 8	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SNX8 mRNA	PMID:36041667
1305791	Snx8	sorting nexin 8	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314038	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SNX8 mRNA	PMID:34813904
1305791	Snx8	sorting nexin 8	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314038	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SNX8 mRNA	PMID:34813904
1305791	Snx8	sorting nexin 8	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314037	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SNX8 mRNA	PMID:38568856
1305791	Snx8	sorting nexin 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNX8 mRNA	PMID:37236586
1305791	Snx8	sorting nexin 8	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of SNX8 mRNA	PMID:25539665
1305791	Snx8	sorting nexin 8	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SNX8 gene	PMID:22079235
1305791	Snx8	sorting nexin 8	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314037	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNX8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNX8 mRNA	PMID:32699268
1305791	Snx8	sorting nexin 8	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1314037	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SNX8 mRNA	PMID:28302478
1305791	Snx8	sorting nexin 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314037	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SNX8 mRNA	PMID:25979313
1305791	Snx8	sorting nexin 8	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314037	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SNX8 mRNA	PMID:28001369
1305791	Snx8	sorting nexin 8	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314037	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SNX8 gene	PMID:29154799
1305791	Snx8	sorting nexin 8	gene	CHEBI:40036	amitrole	affects expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole affects the expression of SNX8 mRNA	PMID:41580965
1305791	Snx8	sorting nexin 8	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SNX8 mRNA	PMID:38685447
1305791	Snx8	sorting nexin 8	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314037	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SNX8 mRNA	PMID:20106945|PMID:25562108
1305791	Snx8	sorting nexin 8	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314037	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SNX8 mRNA	PMID:38832940
1305791	Snx8	sorting nexin 8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNX8 mRNA	PMID:33387578
1305791	Snx8	sorting nexin 8	gene	CHEBI:46645	isobutanol	multiple interactions	ISO	RGD:1314037	E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SNX8 mRNA	PMID:29432896
1305791	Snx8	sorting nexin 8	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1314037	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SNX8 gene	PMID:25304211
1305791	Snx8	sorting nexin 8	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1314037	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of SNX8 mRNA	PMID:22077320
1305791	Snx8	sorting nexin 8	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1314037	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of SNX8 mRNA	PMID:31675489
1305791	Snx8	sorting nexin 8	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SNX8 mRNA	PMID:29391264
1305791	Snx8	sorting nexin 8	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1314037	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNX8 mRNA	PMID:22079256
1305791	Snx8	sorting nexin 8	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of SNX8 mRNA	PMID:23962444|PMID:34044035
1305791	Snx8	sorting nexin 8	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of SNX8 mRNA	PMID:38685447|PMID:41580965
1305791	Snx8	sorting nexin 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SNX8 mRNA	PMID:35964746
1305791	Snx8	sorting nexin 8	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314038	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SNX8 mRNA	PMID:19042947
1305791	Snx8	sorting nexin 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314038	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SNX8 mRNA	PMID:22206623
1305791	Snx8	sorting nexin 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNX8 mRNA	PMID:22206623
1305791	Snx8	sorting nexin 8	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1314037	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SNX8 mRNA	PMID:22079256
1305791	Snx8	sorting nexin 8	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1314037	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNX8 mRNA	PMID:22079256
1305791	Snx8	sorting nexin 8	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314038	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SNX8 mRNA	PMID:31388691
1305791	Snx8	sorting nexin 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1314037	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SNX8 protein	PMID:31675489
1305791	Snx8	sorting nexin 8	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1314037	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SNX8 protein	PMID:31675489
1305791	Snx8	sorting nexin 8	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SNX8 mRNA	PMID:23034163
1305791	Snx8	sorting nexin 8	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of SNX8 gene	PMID:31079544
1305792	Krt36	keratin 36	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT36 mRNA	PMID:32741896
1305792	Krt36	keratin 36	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KRT36 mRNA	PMID:33387578
1305792	Krt36	keratin 36	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT36 mRNA	PMID:32741896
1305792	Krt36	keratin 36	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314040	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in increased expression of KRT36 mRNA	PMID:31626304
1305792	Krt36	keratin 36	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314039	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KRT36 mRNA	PMID:21867686
1305792	Krt36	keratin 36	gene	CHEBI:27563	arsenic atom	decreases methylation	ISO	RGD:1314039	E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of KRT36 gene	PMID:31135185
1305792	Krt36	keratin 36	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1314039	E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in decreased expression of KRT36 protein	PMID:31195006
1305792	Krt36	keratin 36	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314039	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KRT36 mRNA	PMID:23557933
1305792	Krt36	keratin 36	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314040	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT36 mRNA	PMID:21570461
1305792	Krt36	keratin 36	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314040	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of KRT36 mRNA	PMID:35295148
1305792	Krt36	keratin 36	gene	CHEBI:33146	vanadyl sulfate	increases expression	ISO	RGD:1314039	E	RGD:6480464	20120522	CTD	MESH:C034028	vanadyl sulfate results in increased expression of KRT36 mRNA	PMID:16330358
1305792	Krt36	keratin 36	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT36 mRNA	PMID:25181051
1305792	Krt36	keratin 36	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT36 mRNA	PMID:35163327
1305792	Krt36	keratin 36	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of KRT36 promoter	PMID:22457795
1305792	Krt36	keratin 36	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT36 mRNA	PMID:35163327
1305792	Krt36	keratin 36	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of KRT36 mRNA	PMID:24386269
1305792	Krt36	keratin 36	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314040	E	RGD:6480464	20120522	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of KRT36 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KRT36 mRNA]	PMID:17585979
1305792	Krt36	keratin 36	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314039	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KRT36 gene	PMID:29154799
1305792	Krt36	keratin 36	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314040	E	RGD:6480464	20120522	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of KRT36 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KRT36 mRNA]	PMID:17585979
1305792	Krt36	keratin 36	gene	CHEBI:47217	arsane	decreases methylation	ISO	RGD:1314039	E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of KRT36 gene	PMID:31135185
1305792	Krt36	keratin 36	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314040	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KRT36 mRNA	PMID:22206623
1305792	Krt36	keratin 36	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT36 mRNA	PMID:32741896
1305792	Krt36	keratin 36	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KRT36 mRNA	PMID:23914054
1305792	Krt36	keratin 36	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314040	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of KRT36 mRNA	PMID:28973697
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of WBP1L mRNA	PMID:37995155
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of WBP1L mRNA]	PMID:31150632
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of WBP1L mRNA	PMID:26251327
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314042	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of WBP1L mRNA	PMID:20188158
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1314042	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of WBP1L promoter	PMID:26251327
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314041	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of WBP1L mRNA	PMID:33167477
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1314041	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of WBP1L mRNA	PMID:21632981
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of WBP1L mRNA	PMID:32145629
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of WBP1L mRNA	PMID:39298647
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314041	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of WBP1L mRNA	PMID:37042841
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314041	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of WBP1L mRNA	PMID:21592394
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of WBP1L mRNA	PMID:21592394
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314041	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of WBP1L protein	PMID:37730182
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1314041	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of WBP1L mRNA	PMID:21592394
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of WBP1L mRNA	PMID:21592394
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of WBP1L mRNA	PMID:33387578
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314042	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WBP1L mRNA	PMID:36331819
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA	PMID:39836092
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314042	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WBP1L mRNA	PMID:37236586
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of WBP1L mRNA	PMID:31150632
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of WBP1L mRNA]	PMID:31150632
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA	PMID:39836092
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1314041	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of WBP1L protein	PMID:35688186
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of WBP1L mRNA	PMID:28960355
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of WBP1L mRNA	PMID:31881176
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314041	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of WBP1L mRNA	PMID:28903495
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WBP1L mRNA	PMID:22298810|PMID:34747641
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WBP1L mRNA	PMID:21215274|PMID:33387578
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WBP1L mRNA	PMID:19770486
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314041	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WBP1L mRNA	PMID:20106945|PMID:21632981
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1314041	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WBP1L mRNA	PMID:30851411
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:28509	chloroethene	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in decreased expression of WBP1L mRNA	PMID:18579281
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA; [sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of WBP1L promoter	PMID:18448484|PMID:39836092
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of WBP1L mRNA	PMID:19770486
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314041	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WBP1L mRNA	PMID:20106945
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314041	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WBP1L 5' UTR	PMID:27901495
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314041	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WBP1L mRNA	PMID:19150397
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of WBP1L gene	PMID:31601247
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:3223	buspirone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of WBP1L mRNA	PMID:24136188
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314042	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of WBP1L gene	PMID:35295148
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of WBP1L mRNA	PMID:23411599|PMID:34492290
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314042	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of WBP1L mRNA	PMID:18301758|PMID:23811191
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of WBP1L mRNA	PMID:32145629
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of WBP1L mRNA	PMID:25181051
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of WBP1L gene	PMID:31601247
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to WBP1L promoter]	PMID:20348232
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of WBP1L mRNA	PMID:39298647
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314042	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of WBP1L promoter	PMID:33297965
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314042	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of WBP1L intron	PMID:28392331
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA	PMID:39836092
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314041	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of WBP1L mRNA	PMID:38568856
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314042	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WBP1L mRNA	PMID:37236586
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of WBP1L mRNA	PMID:26194646
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314042	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of WBP1L mRNA	PMID:28903501
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314041	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of WBP1L mRNA	PMID:24449571
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314042	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of WBP1L mRNA	PMID:23811191
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:3766	clozapine	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20120412	CTD	MESH:D003024	Clozapine results in decreased expression of WBP1L mRNA	PMID:14647396
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of WBP1L mRNA	PMID:40194260
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314041	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of WBP1L mRNA	PMID:40419075
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314042	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WBP1L mRNA	PMID:36331819
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314041	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of WBP1L mRNA	PMID:23179753
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of WBP1L mRNA	PMID:41580965
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314041	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of WBP1L mRNA	PMID:20106945
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314042	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of WBP1L mRNA	PMID:17562736
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of WBP1L mRNA	PMID:33387578
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314041	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of WBP1L mRNA	PMID:21420995
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA	PMID:39836092
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of WBP1L mRNA	PMID:24136188
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:5613	haloperidol	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20120412	CTD	MESH:D006220	Haloperidol results in decreased expression of WBP1L mRNA	PMID:14647396
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1314041	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA	PMID:39836092
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of WBP1L gene	PMID:35440735
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314042	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of WBP1L mRNA	PMID:22206623
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1314041	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WBP1L mRNA	PMID:30851411
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:9763	trovafloxacin	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in increased expression of WBP1L mRNA	PMID:24136188
1305793	Wbp1l	WW domain binding protein 1-like	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of WBP1L mRNA	PMID:20566332
1305794	Dsp	desmoplakin	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620673	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DSP mRNA	PMID:33045310
1305794	Dsp	desmoplakin	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein]	PMID:38195004
1305794	Dsp	desmoplakin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314043	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of DSP mRNA	PMID:21934132
1305794	Dsp	desmoplakin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of DSP mRNA	PMID:16604517
1305794	Dsp	desmoplakin	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1620673	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of DSP mRNA	PMID:20880076
1305794	Dsp	desmoplakin	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DSP mRNA	PMID:26079696
1305794	Dsp	desmoplakin	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D000431	Ethanol inhibits the reaction [Dietary Fats results in increased expression of DSP mRNA]	PMID:21051528
1305794	Dsp	desmoplakin	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of DSP mRNA	PMID:29432896
1305794	Dsp	desmoplakin	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314043	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DSP mRNA	PMID:35811015
1305794	Dsp	desmoplakin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of DSP mRNA]	PMID:35811015
1305794	Dsp	desmoplakin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1620673	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DSP mRNA	PMID:39298647
1305794	Dsp	desmoplakin	gene	CHEBI:16583	butane-2,3-dione	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20211109	CTD	MESH:D003931	Diacetyl results in decreased expression of DSP protein	PMID:34031698
1305794	Dsp	desmoplakin	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of DSP mRNA	PMID:38568856
1305794	Dsp	desmoplakin	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DSP mRNA	PMID:33387578
1305794	Dsp	desmoplakin	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of DSP mRNA	PMID:17556502|PMID:22238285
1305794	Dsp	desmoplakin	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:D011374	NCOA2 protein affects the reaction [Progesterone results in decreased expression of DSP mRNA]	PMID:17556502
1305794	Dsp	desmoplakin	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1620673	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DSP mRNA	PMID:23892564
1305794	Dsp	desmoplakin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1620673	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DSP mRNA	PMID:34319233
1305794	Dsp	desmoplakin	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314043	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DSP protein	PMID:37730182
1305794	Dsp	desmoplakin	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1314043	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of DSP mRNA	PMID:26485663
1305794	Dsp	desmoplakin	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314043	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DSP mRNA	PMID:28818685
1305794	Dsp	desmoplakin	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DSP protein	PMID:34915118
1305794	Dsp	desmoplakin	gene	CHEBI:207229	dihydroartemisinin	affects binding	ISO	RGD:1314043	E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to DSP protein	PMID:26340163
1305794	Dsp	desmoplakin	gene	CHEBI:22977	cadmium atom	affects binding	ISO	RGD:1314043	E	RGD:6480464	20150512	CTD	MESH:D002104	DSP protein binds to Cadmium	PMID:23896426
1305794	Dsp	desmoplakin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein	PMID:38195004
1305794	Dsp	desmoplakin	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314043	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DSP mRNA	PMID:19549813
1305794	Dsp	desmoplakin	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DSP protein	PMID:23301498
1305794	Dsp	desmoplakin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1620673	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DSP mRNA	PMID:19770486
1305794	Dsp	desmoplakin	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314043	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DSP gene	PMID:27153756
1305794	Dsp	desmoplakin	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of DSP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DSP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DSP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of DSP protein	PMID:38598786
1305794	Dsp	desmoplakin	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of DSP mRNA	PMID:30779732
1305794	Dsp	desmoplakin	gene	CHEBI:27363	zinc atom	affects binding	ISO	RGD:1314043	E	RGD:6480464	20150512	CTD	MESH:D015032	DSP protein binds to Zinc	PMID:23896426
1305794	Dsp	desmoplakin	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1620673	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of DSP mRNA	PMID:31919559
1305794	Dsp	desmoplakin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620673	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DSP mRNA	PMID:22206623
1305794	Dsp	desmoplakin	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1314043	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of DSP mRNA	PMID:26272509
1305794	Dsp	desmoplakin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1305794	Dsp	desmoplakin	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1314043	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DSP protein	PMID:35688186
1305794	Dsp	desmoplakin	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of DSP mRNA	PMID:41028656
1305794	Dsp	desmoplakin	gene	CHEBI:27889	lead(0)	affects binding	ISO	RGD:1314043	E	RGD:6480464	20150512	CTD	MESH:D007854	DSP protein binds to Lead	PMID:23896426
1305794	Dsp	desmoplakin	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1314043	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of DSP protein	PMID:17075605
1305794	Dsp	desmoplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620673	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DSP mRNA	PMID:21570461
1305794	Dsp	desmoplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DSP mRNA	PMID:33387578
1305794	Dsp	desmoplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314043	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DSP mRNA; Tetrachlorodibenzodioxin results in increased expression of DSP protein	PMID:21632981|PMID:37788135
1305794	Dsp	desmoplakin	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of DSP protein	PMID:39603559
1305794	Dsp	desmoplakin	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of DSP mRNA	PMID:28374803
1305794	Dsp	desmoplakin	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DSP mRNA	PMID:23179753|PMID:27188386
1305794	Dsp	desmoplakin	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of DSP mRNA	PMID:28959563
1305794	Dsp	desmoplakin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of DSP mRNA	PMID:41028656
1305794	Dsp	desmoplakin	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of DSP protein	PMID:28918527
1305794	Dsp	desmoplakin	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1314043	E	RGD:6480464	20120412	CTD	MESH:D004317	DSP protein affects the susceptibility to Doxorubicin	PMID:16217747
1305794	Dsp	desmoplakin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314043	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of DSP mRNA	PMID:29803840
1305794	Dsp	desmoplakin	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1314043	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of DSP protein	PMID:35688186
1305794	Dsp	desmoplakin	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Dietary Fats results in increased expression of DSP mRNA]	PMID:21051528
1305794	Dsp	desmoplakin	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1314043	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of DSP gene	PMID:28589171
1305794	Dsp	desmoplakin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of DSP protein	PMID:29459688
1305794	Dsp	desmoplakin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DSP mRNA	PMID:12634122|PMID:38568856
1305794	Dsp	desmoplakin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite inhibits the reaction [H3-3A protein binds to DSP protein]	PMID:37734572
1305794	Dsp	desmoplakin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314043	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DSP promoter	PMID:27901495
1305794	Dsp	desmoplakin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20190910	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DSP mRNA; Benzo(a)pyrene results in decreased expression of DSP protein	PMID:31255691|PMID:32717239
1305794	Dsp	desmoplakin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314043	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DSP mRNA	PMID:22316170
1305794	Dsp	desmoplakin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620673	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DSP mRNA	PMID:22228805|PMID:27195522
1305794	Dsp	desmoplakin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314043	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DSP 3' UTR	PMID:27901495
1305794	Dsp	desmoplakin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of DSP mRNA	PMID:41028656
1305794	Dsp	desmoplakin	gene	CHEBI:30185	zinc(0)	affects binding	ISO	RGD:1314043	E	RGD:6480464	20150512	CTD	MESH:D015032	DSP protein binds to Zinc	PMID:23896426
1305794	Dsp	desmoplakin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DSP mRNA	PMID:25895662
1305794	Dsp	desmoplakin	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314043	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DSP protein	PMID:25419056
1305794	Dsp	desmoplakin	gene	CHEBI:30772	butyric acid	increases expression	ISO	RGD:1314043	E	RGD:6480464	20220607	CTD	MESH:D020148	Butyric Acid results in increased expression of DSP mRNA	PMID:34581912
1305794	Dsp	desmoplakin	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of DSP mRNA	PMID:24136188
1305794	Dsp	desmoplakin	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of DSP mRNA	PMID:22641619
1305794	Dsp	desmoplakin	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of DSP mRNA	PMID:38568856
1305794	Dsp	desmoplakin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620673	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DSP gene	PMID:35295148
1305794	Dsp	desmoplakin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1620673	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of DSP mRNA	PMID:35295148
1305794	Dsp	desmoplakin	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DSP mRNA	PMID:23411599
1305794	Dsp	desmoplakin	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DSP mRNA	PMID:18445702
1305794	Dsp	desmoplakin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DSP mRNA	PMID:25181051|PMID:32145629
1305794	Dsp	desmoplakin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DSP protein	PMID:31675489
1305794	Dsp	desmoplakin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of DSP mRNA	PMID:26063408|PMID:33221593
1305794	Dsp	desmoplakin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314043	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of DSP mRNA; bisphenol A results in increased expression of DSP protein	PMID:36232920|PMID:37567409
1305794	Dsp	desmoplakin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620673	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of DSP mRNA	PMID:35598803
1305794	Dsp	desmoplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DSP mRNA	PMID:39298647
1305794	Dsp	desmoplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314043	E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in increased expression of DSP mRNA	PMID:25912373
1305794	Dsp	desmoplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1620673	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of DSP exon	PMID:33297965
1305794	Dsp	desmoplakin	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20230704	CTD	MESH:C008745	bisphenol F results in decreased expression of DSP mRNA	PMID:36706583
1305794	Dsp	desmoplakin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1620673	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DSP mRNA	PMID:38685157
1305794	Dsp	desmoplakin	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DSP mRNA	PMID:37019170
1305794	Dsp	desmoplakin	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DSP mRNA	PMID:24893172
1305794	Dsp	desmoplakin	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DSP mRNA	PMID:21266533
1305794	Dsp	desmoplakin	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of DSP protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of DSP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DSP protein	PMID:38598786
1305794	Dsp	desmoplakin	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DSP mRNA	PMID:28628672
1305794	Dsp	desmoplakin	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1620673	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of DSP mRNA	PMID:34813904
1305794	Dsp	desmoplakin	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1314043	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of DSP mRNA	PMID:37047231
1305794	Dsp	desmoplakin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DSP mRNA	PMID:35163327
1305794	Dsp	desmoplakin	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1620673	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of DSP mRNA	PMID:26377693
1305794	Dsp	desmoplakin	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DSP mRNA	PMID:38568856
1305794	Dsp	desmoplakin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein	PMID:38195004
1305794	Dsp	desmoplakin	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of DSP mRNA	PMID:19429403
1305794	Dsp	desmoplakin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DSP mRNA	PMID:35163327
1305794	Dsp	desmoplakin	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of DSP mRNA	PMID:28903501
1305794	Dsp	desmoplakin	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20190910	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of DSP mRNA	PMID:31255691
1305794	Dsp	desmoplakin	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	ISO	RGD:1620673	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of DSP mRNA	PMID:25908611
1305794	Dsp	desmoplakin	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of DSP mRNA	PMID:40194260
1305794	Dsp	desmoplakin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620673	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DSP mRNA	PMID:40194260
1305794	Dsp	desmoplakin	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1314043	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of DSP mRNA	PMID:28302478
1305794	Dsp	desmoplakin	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DSP mRNA	PMID:31533062
1305794	Dsp	desmoplakin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of DSP mRNA	PMID:19429403
1305794	Dsp	desmoplakin	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of DSP mRNA	PMID:29154799
1305794	Dsp	desmoplakin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314043	E	RGD:6480464	20160210	CTD	MESH:D014635	Valproic Acid results in increased expression of DSP mRNA	PMID:23527032|PMID:24383497|PMID:24935251|PMID:26272509|PMID:26705709
1305794	Dsp	desmoplakin	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1305794	Dsp	desmoplakin	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DSP mRNA	PMID:28628672
1305794	Dsp	desmoplakin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1620673	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DSP mRNA	PMID:28973697
1305794	Dsp	desmoplakin	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1620673	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in increased expression of DSP mRNA	PMID:25270620
1305794	Dsp	desmoplakin	gene	CHEBI:45863	paclitaxel	affects response to substance	ISO	RGD:1314043	E	RGD:6480464	20161213	CTD	MESH:D017239	DSP protein affects the susceptibility to Paclitaxel	PMID:16217747
1305794	Dsp	desmoplakin	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1314043	E	RGD:6480464	20160210	CTD	MESH:C012589	trichostatin A results in increased expression of DSP mRNA	PMID:24935251|PMID:26272509|PMID:26705709
1305794	Dsp	desmoplakin	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1305794	Dsp	desmoplakin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DSP mRNA	PMID:17562736
1305794	Dsp	desmoplakin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DSP mRNA	PMID:33387578
1305794	Dsp	desmoplakin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of DSP mRNA]	PMID:35811015
1305794	Dsp	desmoplakin	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1620673	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of DSP mRNA	PMID:30529165
1305794	Dsp	desmoplakin	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DSP mRNA	PMID:29391264
1305794	Dsp	desmoplakin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DSP mRNA	PMID:17557909
1305794	Dsp	desmoplakin	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of DSP mRNA	PMID:38568856
1305794	Dsp	desmoplakin	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1314043	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of DSP mRNA	PMID:26272509
1305794	Dsp	desmoplakin	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1305794	Dsp	desmoplakin	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DSP mRNA	PMID:28628672
1305794	Dsp	desmoplakin	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314043	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DSP protein	PMID:25419056
1305794	Dsp	desmoplakin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of DSP mRNA]	PMID:21095227
1305794	Dsp	desmoplakin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DSP mRNA; Nanotubes, Carbon results in decreased expression of DSP mRNA	PMID:25554681|PMID:25620056
1305794	Dsp	desmoplakin	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of DSP mRNA	PMID:34044035
1305794	Dsp	desmoplakin	gene	CHEBI:63632	topotecan	affects response to substance	ISO	RGD:1314043	E	RGD:6480464	20120412	CTD	MESH:D019772	DSP protein affects the susceptibility to Topotecan	PMID:16217747
1305794	Dsp	desmoplakin	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DSP mRNA	PMID:23650126
1305794	Dsp	desmoplakin	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1314043	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of DSP mRNA	PMID:28988120
1305794	Dsp	desmoplakin	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of DSP mRNA	PMID:36907384
1305794	Dsp	desmoplakin	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	ISO	RGD:1314043	E	RGD:6480464	20240206	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of DSP protein	PMID:37788135
1305794	Dsp	desmoplakin	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1620673	E	RGD:6480464	20200331	CTD	MESH:D012970	Sodium Glutamate results in increased expression of DSP mRNA	PMID:19001666
1305794	Dsp	desmoplakin	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1620673	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of DSP mRNA	PMID:19001666
1305794	Dsp	desmoplakin	gene	CHEBI:6651	malathion	increases expression	ISO	RGD:1314043	E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of DSP mRNA	PMID:37047231
1305794	Dsp	desmoplakin	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1620673	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DSP mRNA	PMID:26307267
1305794	Dsp	desmoplakin	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of DSP mRNA	PMID:39938710
1305794	Dsp	desmoplakin	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1620673	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of DSP mRNA	PMID:22206623
1305794	Dsp	desmoplakin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1620673	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DSP mRNA	PMID:22206623
1305794	Dsp	desmoplakin	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DSP mRNA	PMID:22714537
1305794	Dsp	desmoplakin	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1314043	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DSP mRNA	PMID:37199045
1305794	Dsp	desmoplakin	gene	CHEBI:7590	nitrofen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of DSP mRNA	PMID:33484710
1305794	Dsp	desmoplakin	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1305794	Dsp	desmoplakin	gene	CHEBI:79516	Nonylphenol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in increased expression of DSP protein	PMID:19260726
1305794	Dsp	desmoplakin	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DSP gene]	PMID:28238834
1305794	Dsp	desmoplakin	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620673	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DSP mRNA	PMID:23091169
1305794	Dsp	desmoplakin	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of DSP mRNA	PMID:19363144
1305794	Dsp	desmoplakin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1620673	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DSP mRNA	PMID:38648751
1305794	Dsp	desmoplakin	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of DSP mRNA	PMID:21278054
1305794	Dsp	desmoplakin	gene	CHEBI:91108	SB 431542	increases expression	ISO	RGD:1314043	E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of DSP protein	PMID:25670856
1305794	Dsp	desmoplakin	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1305794	Dsp	desmoplakin	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DSP mRNA	PMID:21346803
1305794	Dsp	desmoplakin	gene	CHEBI:92181	lasalocid	increases expression	ISO	RGD:1314043	E	RGD:6480464	20240206	CTD	MESH:D007832	Lasalocid results in increased expression of DSP protein	PMID:37788135
1305794	Dsp	desmoplakin	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1314043	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DSP mRNA	PMID:29301935
1305794	Dsp	desmoplakin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1314043	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of DSP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DSP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of DSP protein	PMID:38598786
1305794	Dsp	desmoplakin	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DSP mRNA	PMID:21346803
1305794	Dsp	desmoplakin	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1314043	E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon results in decreased expression of DSP mRNA	PMID:26705709
1305794	Dsp	desmoplakin	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DSP mRNA	PMID:19015723
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TRIM21 mRNA]	PMID:31150632
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TRIM21 mRNA	PMID:30071829
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1345175	E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of TRIM21 mRNA	PMID:15928584
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1345175	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TRIM21 mRNA	PMID:33167477
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of TRIM21 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of TRIM21 mRNA	PMID:33729688
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of TRIM21 mRNA	PMID:36841081
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:16118	berberine	multiple interactions	ISO	RGD:1345175	E	RGD:6480464	20230704	CTD	MESH:D001599	Berberine promotes the reaction [IGF2BP3 protein binds to TRIM21 protein]	PMID:36822301
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314046	E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol affects the expression of TRIM21 mRNA	PMID:26730594
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1345175	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TRIM21 mRNA	PMID:21632981
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314046	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRIM21 mRNA	PMID:39241906
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314046	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRIM21 mRNA]	PMID:39241906
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1345175	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of TRIM21 mRNA	PMID:21185374
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314046	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of TRIM21 mRNA	PMID:23892564
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1345175	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TRIM21 mRNA	PMID:31163220
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of TRIM21 protein	PMID:34915118
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1345175	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TRIM21 mRNA	PMID:19549813
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of TRIM21 protein	PMID:33236894
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TRIM21 mRNA	PMID:31150632
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TRIM21 mRNA]	PMID:31150632
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TRIM21 mRNA	PMID:31881176
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:27961	1,8-cineole	decreases expression	ISO	RGD:1345175	E	RGD:6480464	20230704	CTD	MESH:D000077591	Eucalyptol results in decreased expression of TRIM21 mRNA	PMID:36331666
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1345175	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TRIM21 mRNA	PMID:25583101
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314046	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM21 mRNA	PMID:21570461
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRIM21 mRNA	PMID:33387578
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM21 mRNA	PMID:32109520|PMID:34747641
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1345175	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM21 mRNA	PMID:20106945|PMID:21632981
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314046	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRIM21 mRNA	PMID:25896364|PMID:39631538
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1345175	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRIM21 mRNA	PMID:29803840
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1345175	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRIM21 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1345175	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRIM21 promoter	PMID:27901495
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1345175	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of TRIM21 mRNA	PMID:25075043
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314046	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TRIM21 mRNA	PMID:27131904
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1345175	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TRIM21 mRNA	PMID:25351596
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1314046	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TRIM21 mRNA	PMID:39826883
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314046	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TRIM21 mRNA	PMID:29095437
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1314046	E	RGD:6480464	20191114	CTD	MESH:C006632	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of TRIM21 mRNA]	PMID:29095437
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1345175	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TRIM21 gene	PMID:31601247
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314046	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TRIM21 mRNA	PMID:29264374
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314046	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TRIM21 mRNA	PMID:20813756
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1345175	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of TRIM21 mRNA	PMID:38479592
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRIM21 mRNA	PMID:25181051
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TRIM21 gene	PMID:28505145
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1345175	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TRIM21 gene	PMID:31601247
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314046	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TRIM21 mRNA	PMID:28392331
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314046	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TRIM21 mRNA	PMID:17361019
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314046	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRIM21 mRNA]	PMID:39241906
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1345175	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRIM21 mRNA	PMID:37042841
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1345175	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TRIM21 mRNA	PMID:31533062
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1314046	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of TRIM21 mRNA	PMID:39529242
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1345175	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TRIM21 mRNA	PMID:40419075
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1345175	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRIM21 mRNA	PMID:29154799
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314046	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TRIM21 mRNA	PMID:28973697
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1345175	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIM21 mRNA	PMID:21420995
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TRIM21 mRNA	PMID:33387578
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314046	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of TRIM21 mRNA	PMID:19446018
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TRIM21 mRNA	PMID:29391264
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1345175	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIM21 mRNA	PMID:22079256
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314046	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TRIM21 mRNA	PMID:29095437
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1314046	E	RGD:6480464	20191114	CTD	MESH:C032793	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of TRIM21 mRNA]	PMID:29095437
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1345175	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of TRIM21 mRNA	PMID:25075043
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314046	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TRIM21 mRNA	PMID:25620056
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314046	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TRIM21 mRNA; Nanotubes, Carbon results in increased expression of TRIM21 mRNA	PMID:25554681
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of TRIM21 mRNA	PMID:34044035
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of TRIM21 mRNA	PMID:24793618
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:5801	hydroxychloroquine	increases expression	ISO	RGD:1314046	E	RGD:6480464	20200519	CTD	MESH:D006886	Hydroxychloroquine results in increased expression of TRIM21 mRNA	PMID:25321315
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1345175	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TRIM21 protein	PMID:32959892
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314046	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TRIM21 mRNA	PMID:14729362|PMID:15003993
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1314046	E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of TRIM21 mRNA]	PMID:29095437
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1345175	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TRIM21 mRNA	PMID:31758290
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314046	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TRIM21 mRNA	PMID:22206623
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1345175	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TRIM21 mRNA	PMID:22079256
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1345175	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIM21 mRNA	PMID:22079256
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:76989	phytoestrogen	increases expression	ISO	RGD:1345175	E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of TRIM21 mRNA; Phytoestrogens results in increased expression of TRIM21 protein	PMID:9833039
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TRIM21 mRNA	PMID:23914054
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314046	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRIM21 mRNA]	PMID:39241906
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314046	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TRIM21 mRNA	PMID:27131904
1305795	Trim21	tripartite motif-containing 21	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314046	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TRIM21 mRNA	PMID:35537566
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1557923	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ATR mRNA	PMID:33045310
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20170228	CTD	MESH:C015499	[schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased expression of BSCL2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of CHEK1 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased expression of BSCL2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased phosphorylation of CHEK1 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased phosphorylation of TRP53 protein]	PMID:22003191
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D001241	Aspirin results in decreased expression of ATR mRNA	PMID:20514442
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:15368	acrolein	increases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20220510	CTD	MESH:D000171	Acrolein results in increased phosphorylation of ATR protein	PMID:34958888
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1557923	E	RGD:6480464	20160705	CTD	MESH:D001280	Atrazine results in increased expression of ATR protein	PMID:26518232
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of ATR mRNA	PMID:29018328
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D011794	Quercetin results in increased expression of ATR mRNA	PMID:21632981
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557923	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATR mRNA	PMID:39241906
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314047	E	RGD:6480464	20180703	CTD	MESH:D004958	Estradiol results in increased expression of ATR mRNA	PMID:24481588|PMID:31614463|PMID:36581016
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1557923	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ATR mRNA	PMID:39298647
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA	PMID:25510870
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1314047	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ATR mRNA	PMID:38568856
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of ATR mRNA	PMID:34673133
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form]	PMID:23907605
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557923	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATR mRNA	PMID:34319233
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	increases phosphorylation	ISO	RGD:1557923	E	RGD:6480464	20140408	CTD	MESH:D014527	Uric Acid results in increased phosphorylation of ATR protein	PMID:23619996
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20140408	CTD	MESH:D014527	NLRP3 gene mutant form inhibits the reaction [Uric Acid results in increased phosphorylation of ATR protein]	PMID:23619996
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ATR mRNA	PMID:26577399
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ATR protein	PMID:37730182
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:17846	(S)-naringenin	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin co-treated with bisphenol A] results in increased expression of ATR mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of ATR mRNA	PMID:36235125
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ATR mRNA	PMID:28818685
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:18152	myricetin	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20200915	CTD	MESH:C040015	myricetin affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the expression of ATR mRNA]	PMID:32342131
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:18227	sterigmatocystin	increases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20171010	CTD	MESH:D013241	Sterigmatocystin results in increased phosphorylation of ATR protein	PMID:26914363
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:18227	sterigmatocystin	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20171010	CTD	MESH:D013241	ATR protein promotes the reaction [Sterigmatocystin results in increased phosphorylation of CHEK1 protein]	PMID:26914363
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:18358	methoxsalen	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20140311	CTD	MESH:D008730	Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form]	PMID:23907605
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form]	PMID:23907605
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:191092	Decamethylcyclopentasiloxane	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20220614	CTD	MESH:C114768	decamethylcyclopentasiloxane results in decreased expression of ATR mRNA	PMID:27601420
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20200519	CTD	MESH:D008769	ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein]	PMID:26921499
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:229764	selinexor	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20240409	CTD	MESH:C585161	[selinexor co-treated with INCB057643] results in decreased phosphorylation of ATR protein	PMID:37899423
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:22977	cadmium atom	increases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20260303	CTD	MESH:D002104	Cadmium results in increased phosphorylation of ATR protein	PMID:40505819
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20260303	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of ATR protein	PMID:40288561
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA	PMID:25510870
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA	PMID:25510870
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:233415	Pf-06840003	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20250408	CTD	MESH:C000625742	PF-06840003 inhibits the reaction [APP protein mutant form results in decreased expression of ATR mRNA]	PMID:39172838
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ATR mRNA	PMID:19549813
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314047	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ATR mRNA	PMID:27153756
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314047	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ATR gene	PMID:27153756
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:25640	octamethylcyclotetrasiloxane	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20180220	CTD	MESH:C024064	octamethylcyclotetrasiloxane results in decreased expression of ATR mRNA	PMID:27601420
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ATR mRNA	PMID:27106289
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ATR mRNA	PMID:30779732
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ATR mRNA	PMID:25629700
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1314047	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATR gene	PMID:25304211
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27656	camptothecin	decreases response to substance	ISO	RGD:1314047	E	RGD:6480464	20160315	CTD	MESH:D002166	ATR mRNA results in decreased susceptibility to Camptothecin; ATR protein results in decreased susceptibility to Camptothecin	PMID:25269479
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27656	camptothecin	increases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20160315	CTD	MESH:D002166	Camptothecin results in increased phosphorylation of ATR protein	PMID:25269479|PMID:30555576
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27656	camptothecin	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20160315	CTD	MESH:D002166	3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [Camptothecin results in increased phosphorylation of ATR protein]	PMID:25269479
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:2766	aphidicolin	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D016590	[schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased expression of BSCL2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of CHEK1 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein]	PMID:22003191
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27732	caffeine	affects activity	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D002110	Caffeine affects the activity of ATR protein	PMID:11507241
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ATR protein	PMID:35688186
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D002110	[[Caffeine results in decreased activity of ATR protein] co-treated with [Caffeine results in decreased activity of ATM protein]] results in decreased susceptibility to Acrylamide; Caffeine inhibits the reaction [[resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; Caffeine inhibits the reaction [Hydroxyurea promotes the reaction [ATR protein results in increased phosphorylation of and results in increased activity of CHEK1 protein]]; Caffeine inhibits the reaction [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]]	PMID:15975956|PMID:18158334|PMID:20734998
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1557923	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of ATR mRNA	PMID:28960355
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ATR mRNA; [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]; [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] which results in increased phosphorylation of H2AX protein; Caffeine inhibits the reaction [[Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; Caffeine inhibits the reaction [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]]; Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]	PMID:15975956|PMID:23557933
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ATR mRNA	PMID:27594783
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20140812	CTD	MESH:D002945	Cisplatin results in decreased expression of ATR mRNA	PMID:24865317
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	decreases response to substance	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D002945	ATR results in decreased susceptibility to Cisplatin	PMID:21652733
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	increases activity	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D002945	Cisplatin results in increased activity of ATR protein	PMID:21324906
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D002945	Cisplatin results in increased expression of ATR protein modified form	PMID:26739623
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20240109	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of ATR protein	PMID:37802411
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of ATR protein	PMID:22006019
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D002945	Lovastatin inhibits the reaction [Cisplatin results in increased expression of ATR protein modified form]	PMID:26739623
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D002945	3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [Cisplatin results in increased phosphorylation of ATR protein]; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Cisplatin; [ATR co-treated with TP53] results in decreased susceptibility to Cisplatin; Cisplatin promotes the reaction [MSH2 protein binds to and affects the localization of ATR protein]; ERCC6 protein inhibits the reaction [Cisplatin results in increased activity of ATR protein]; PTEN protein affects the reaction [Cisplatin results in increased phosphorylation of ATR protein]	PMID:21258400|PMID:21285353|PMID:21324906|PMID:21730979|PMID:37802411
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D002945	[Cisplatin co-treated with Lutein] results in decreased expression of ATR mRNA; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased expression of BSCL2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased phosphorylation of CHEK1 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased phosphorylation of TRP53 protein]	PMID:22003191|PMID:24865317
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D012402	Rotenone results in increased expression of ATR mRNA	PMID:18191903
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28619	acrylamide	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D020106	[[Caffeine results in decreased activity of ATR protein] co-treated with [Caffeine results in decreased activity of ATM protein]] results in decreased susceptibility to Acrylamide	PMID:20734998
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ATR mRNA	PMID:30911355
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20180828	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATR mRNA	PMID:29653124
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28748	doxorubicin	increases phosphorylation	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D004317	Doxorubicin results in increased phosphorylation of ATR protein	PMID:22242153
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20220607	CTD	MESH:D004317	[3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide affects the susceptibility to Doxorubicin] which results in decreased phosphorylation of ATR protein; [prexasertib affects the susceptibility to Doxorubicin] which results in decreased phosphorylation of ATR protein; [TP53 protein affects the susceptibility to Doxorubicin] which affects the expression of ATR mRNA	PMID:34519926|PMID:36634904
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28838	lutein	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20140812	CTD	MESH:D014975	Lutein results in decreased expression of ATR mRNA	PMID:24865317
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28838	lutein	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20140812	CTD	MESH:D014975	[Cisplatin co-treated with Lutein] results in decreased expression of ATR mRNA	PMID:24865317
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28863	flavanones	decreases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20170303	CTD	MESH:D044950	Flavanones results in decreased phosphorylation of ATR protein	PMID:21616090
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20160210	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ATR protein]	PMID:26451628
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:28984	aluminium atom	increases expression	ISO	RGD:1557923	E	RGD:6480464	20260113	CTD	MESH:D000535	Aluminum results in increased expression of ATR mRNA	PMID:40915522
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:29014	cordycepin	increases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20240604	CTD	MESH:C058120	cordycepin results in increased phosphorylation of ATR protein	PMID:32451092
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:29287	gold atom	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of ATR mRNA	PMID:36057382
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1314047	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ATR gene	PMID:28589171
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATR mRNA; sodium arsenite results in decreased expression of ATR protein	PMID:23618899|PMID:37762697|PMID:38568856|PMID:39719251
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:30050	gold(0)	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of ATR mRNA	PMID:36057382
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ATR mRNA	PMID:30911355
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D012834	Silver affects the expression of ATR mRNA	PMID:19429238
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATR mRNA	PMID:19150397
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:30621	diarsenic trioxide	increases activity	ISO	RGD:1314047	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased activity of ATR protein	PMID:16891316
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:30621	diarsenic trioxide	increases activity	ISO	RGD:1557923	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased activity of ATR protein	PMID:16891316
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314047	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATR mRNA	PMID:29274334
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20191114	CTD	MESH:C006632	Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of ATR mRNA]	PMID:29274334
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D005707	Gallic Acid results in decreased expression of ATR mRNA	PMID:21887735
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1314047	E	RGD:6480464	20180703	CTD	MESH:C015358	methylparaben results in increased expression of ATR mRNA	PMID:24481588
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:32063	propylparaben	increases expression	ISO	RGD:1314047	E	RGD:6480464	20180703	CTD	MESH:C006068	propylparaben results in increased expression of ATR mRNA	PMID:24481588
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:32130	silver(1+) nitrate	increases expression	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in increased expression of ATR mRNA	PMID:22831968
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ATR mRNA	PMID:35295148
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of ATR mRNA	PMID:34492290
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ATR mRNA	PMID:23411599
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557923	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ATR mRNA	PMID:17950772|PMID:18301758|PMID:23811191
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of ATR mRNA]	PMID:17950772
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of ATR mRNA	PMID:12419474
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of ATR mRNA	PMID:19191707
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1557923	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ATR mRNA	PMID:28472532
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33007	chromium(6+)	increases activity	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:C074702	chromium hexavalent ion results in increased activity of ATR protein	PMID:16876463
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20150127	CTD	MESH:C074702	ATR protein affects the reaction [chromium hexavalent ion results in increased phosphorylation of H2AX protein]; ATR protein affects the reaction [chromium hexavalent ion results in increased ubiquitination of H2AX protein]; chromium hexavalent ion promotes the reaction [ATR protein results in increased phosphorylation of SMC1A protein]; RAD17 protein affects the reaction [chromium hexavalent ion promotes the reaction [ATR protein results in increased phosphorylation of SMC1A protein]]	PMID:16876463|PMID:25288669
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20150127	CTD	MESH:C074702	ATR protein affects the reaction [chromium hexavalent ion results in increased phosphorylation of H2AX protein]; ATR protein affects the reaction [chromium hexavalent ion results in increased ubiquitination of H2AX protein]	PMID:25288669
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATR mRNA	PMID:25181051
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ATR mRNA	PMID:30816183
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ATR mRNA	PMID:36235125|PMID:36982678
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314047	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATR gene	PMID:31601247
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ATR mRNA	PMID:32145629
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20230207	CTD	MESH:C006780	[naringenin co-treated with bisphenol A] results in increased expression of ATR mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of ATR mRNA	PMID:36235125
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:33629	aluminium(0)	increases expression	ISO	RGD:1557923	E	RGD:6480464	20260113	CTD	MESH:D000535	Aluminum results in increased expression of ATR mRNA	PMID:40915522
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA	PMID:25510870
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA	PMID:25510870
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:3423	carmustine	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D002330	ATR protein affects the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein]	PMID:19261750
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:1314047	E	RGD:6480464	20230704	CTD	MESH:C005290	oxybenzone results in increased expression of ATR mRNA	PMID:36581016
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557923	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ATR mRNA	PMID:39298647
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1557923	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of ATR mRNA	PMID:36464114
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ATR mRNA	PMID:37019170
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ATR mRNA; Diethylnitrosamine results in increased expression of ATR protein	PMID:19919837
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D004052	ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATR mRNA]; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATR protein]	PMID:19919837
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314047	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATR mRNA	PMID:37042841
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314047	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATR mRNA	PMID:26472689
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:35456	cadmium dichloride	increases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased phosphorylation of ATR protein	PMID:39778856
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20260303	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of ATR protein	PMID:40288561
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ATR mRNA	PMID:24449571
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D015741	Metribolone results in increased expression of ATR mRNA	PMID:19318562
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D015741	Metribolone results in increased phosphorylation of ATR protein	PMID:23272087
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D015741	ATR mutant form inhibits the reaction [Metribolone results in increased expression of H2AX protein]; Metribolone promotes the reaction [AR protein binds to ATR promoter]; Metribolone promotes the reaction [UXT protein binds to ATR promoter]	PMID:19318562|PMID:23272087
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1557923	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ATR mRNA	PMID:40194260
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ATR mRNA	PMID:28302478
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:39171	nitenpyram	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20221004	CTD	MESH:C464843	nitenpyram results in decreased expression of ATR mRNA	PMID:35568224
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314047	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ATR mRNA	PMID:23179753
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:40303	lovastatin	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D008148	Lovastatin inhibits the reaction [Cisplatin results in increased expression of ATR protein modified form]	PMID:26739623
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20230502	CTD	MESH:C017160	cypermethrin results in decreased expression of ATR protein	PMID:36063984
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20141111	CTD	MESH:C107676	deguelin results in decreased expression of ATR mRNA	PMID:22227970
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:44423	hydroxyurea	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D006918	[4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Hydroxyurea; Caffeine inhibits the reaction [Hydroxyurea promotes the reaction [ATR protein results in increased phosphorylation of and results in increased activity of CHEK1 protein]]	PMID:18158334|PMID:21730979
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:44442	6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine	decreases activity	ISO	RGD:1314047	E	RGD:6480464	20170303	CTD	MESH:C475622	4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR	PMID:21730979
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:44442	6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20170303	CTD	MESH:C475622	4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of ATR protein]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased phosphorylation of ATR protein]; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Cisplatin; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Hydroxyurea; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Temozolomide	PMID:21730979|PMID:25748550
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:44616	afimoxifene	decreases response to substance	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:C016601	ATR results in decreased susceptibility to afimoxifene	PMID:21233418
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of ATR mRNA	PMID:29309887
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D000082	Acetaminophen affects the expression of ATR mRNA	PMID:17562736
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATR mRNA	PMID:21420995
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314047	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ATR mRNA	PMID:26690555
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1314047	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATR gene	PMID:25304211
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:472805	ouabain	decreases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20200609	CTD	MESH:D010042	Ouabain results in decreased phosphorylation of ATR protein	PMID:31436044
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of ATR mRNA	PMID:22077320
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATR mRNA	PMID:22079256
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:4911	etoposide	increases phosphorylation	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D005047	Etoposide results in increased phosphorylation of ATR protein	PMID:22242153
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:4918	O-methyleugenol	increases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20180515	CTD	MESH:C005223	methyleugenol results in increased phosphorylation of ATR protein	PMID:28818686
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:49900	arsenous acid	increases activity	ISO	RGD:1314047	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased activity of ATR protein	PMID:16891316
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:49900	arsenous acid	increases activity	ISO	RGD:1557923	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased activity of ATR protein	PMID:16891316
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314047	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATR mRNA	PMID:29274334
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20191114	CTD	MESH:C032793	Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of ATR mRNA]	PMID:29274334
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:50102	N-methyl-N-nitrosourea	affects localization	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D008770	Methylnitrosourea affects the localization of ATR protein	PMID:21285353
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:50102	N-methyl-N-nitrosourea	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D008770	MSH2 protein promotes the reaction [Methylnitrosourea affects the localization of ATR protein]	PMID:21285353
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects localization	ISO	RGD:1314047	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the localization of ATR protein modified form	PMID:17991895
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of ATR mRNA	PMID:27915011
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases activity	ISO	RGD:1314047	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased activity of ATR protein	PMID:17977830
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20191114	CTD	MESH:C014347	ATR protein affects the reaction [Decitabine results in increased expression of TP53 protein]; Decitabine promotes the reaction [ATR protein results in increased phosphorylation of TP53 protein]; RPA1 protein affects the reaction [Decitabine results in increased activity of ATR protein]	PMID:17977830
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:50161	motexafin gadolinium	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in decreased expression of ATR mRNA	PMID:16357179
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ATR mRNA	PMID:16357179
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557923	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ATR mRNA; Nanotubes, Carbon results in increased expression of ATR mRNA	PMID:25620056
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of ATR mRNA	PMID:23962444
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:53212	isocyanates	increases expression	ISO	RGD:1314047	E	RGD:6480464	20170131	CTD	MESH:D017953	Isocyanates results in increased expression of ATR protein	PMID:19283680
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:53509	erlotinib hydrochloride	increases expression	ISO	RGD:1314047	E	RGD:6480464	20190409	CTD	MESH:D000069347	Erlotinib Hydrochloride results in increased expression of ATR mRNA	PMID:29274334
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:53509	erlotinib hydrochloride	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20190409	CTD	MESH:D000069347	Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of ATR mRNA]	PMID:29274334
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:53700	quinoline yellow	increases expression	ISO	RGD:1314047	E	RGD:6480464	20250506	CTD	MESH:C019303	quinoline yellow results in increased expression of ATR mRNA	PMID:28893156
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:60761	floxuridine	decreases response to substance	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D005467	ATR protein results in decreased susceptibility to Floxuridine	PMID:21613406|PMID:22194930
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:62984	zinc acetate	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of ATR mRNA	PMID:16357179
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:62984	zinc acetate	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ATR mRNA	PMID:16357179
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:63020	yttrium chloride	affects expression	EXP		E	RGD:6480464	20220705	CTD	MESH:C064782	yttrium chloride affects the expression of ATR protein	PMID:35088107
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ATR mRNA	PMID:12419474
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of ATR mRNA	PMID:29309887
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of ATR mRNA	PMID:27462272
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20181016	CTD	MESH:C054133	casticin results in decreased expression of ATR protein	PMID:29098808
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:72564	temozolomide	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20130312	CTD	MESH:C047246	[4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to temozolomide	PMID:21730979
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1557923	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of ATR mRNA	PMID:36464114
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1557923	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ATR mRNA	PMID:22206623
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:747627	Prexasertib	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20260714	CTD	MESH:C000608121	[prexasertib affects the susceptibility to Doxorubicin] which results in decreased phosphorylation of ATR protein	PMID:34519926
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20161025	CTD	MESH:C051752	nefazodone results in decreased expression of ATR mRNA	PMID:27288927
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ATR mRNA	PMID:22079256
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATR mRNA	PMID:22079256
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1314047	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ATR mRNA	PMID:37199045
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:756940	abbv-744	increases phosphorylation	ISO	RGD:1314047	E	RGD:6480464	20260714	CTD	MESH:C000706695	ABBV-744 results in increased phosphorylation of ATR protein	PMID:37769529
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:76290	PhIP	affects expression	ISO	RGD:1314047	E	RGD:6480464	20200915	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the expression of ATR mRNA	PMID:32342131
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:76290	PhIP	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20200915	CTD	MESH:C049584	myricetin affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the expression of ATR mRNA]	PMID:32342131
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:78708	Nonidet P-40	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in decreased expression of ATR mRNA	PMID:26552463
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATR gene]	PMID:28238834
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1557923	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ATR mRNA	PMID:23091169
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:80706	Aflatoxin G1	increases activity	ISO	RGD:1314047	E	RGD:6480464	20141111	CTD	MESH:C027955	aflatoxin G1 results in increased activity of ATR protein	PMID:23907605
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:80706	Aflatoxin G1	increases expression	ISO	RGD:1314047	E	RGD:6480464	20141111	CTD	MESH:C027955	aflatoxin G1 results in increased expression of ATR protein modified form	PMID:23907605
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:80706	Aflatoxin G1	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20141111	CTD	MESH:C027955	Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form]; Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form]	PMID:23907605
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:C045950	propiconazole results in increased expression of ATR mRNA	PMID:21278054
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1557923	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of ATR mRNA	PMID:40826991
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:88542	Butylparaben	increases expression	ISO	RGD:1314047	E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of ATR mRNA	PMID:24481588
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1557923	E	RGD:6480464	20130312	CTD	MESH:D012834	Silver affects the expression of ATR mRNA	PMID:19429238
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1314047	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ATR mRNA	PMID:38568856
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ATR mRNA	PMID:35537566
1305796	Atr	ATR checkpoint kinase	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1314047	E	RGD:6480464	20170303	CTD	MESH:C080163	4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of ATR protein]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased phosphorylation of ATR protein]; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of and results in increased activity of ATR protein; trovafloxacin results in increased phosphorylation of and results in increased activity of ATR protein; U 0126 inhibits the reaction [trovafloxacin results in increased activity of ATR protein]	PMID:25748550
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1314048	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TTC39B mRNA	PMID:26272509
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39B mRNA	PMID:27188386
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TTC39B mRNA	PMID:39752319
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of TTC39B mRNA]	PMID:19467301
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TTC39B mRNA	PMID:30529165
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TTC39B mRNA	PMID:36331819
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of TTC39B mRNA	PMID:40945087
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1314049	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of TTC39B mRNA	PMID:18978301
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TTC39B mRNA	PMID:33387578
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1314049	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of TTC39B mRNA	PMID:17251523
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TTC39B mRNA	PMID:37992649
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TTC39B mRNA	PMID:39752319
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:174733	Licochalcone B	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of TTC39B mRNA	PMID:33647349
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TTC39B mRNA	PMID:37992649
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TTC39B mRNA	PMID:33387578
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of TTC39B mRNA	PMID:39836092
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:22718	benzoates	increases expression	ISO	RGD:1314048	E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in increased expression of TTC39B mRNA	PMID:29472718
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTC39B mRNA	PMID:35301059
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTC39B mRNA	PMID:37236586
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314048	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TTC39B mRNA	PMID:19549813
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of TTC39B protein	PMID:33236894
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of TTC39B mRNA	PMID:21396975
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TTC39B mRNA	PMID:27153756
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314048	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TTC39B gene	PMID:27153756
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314049	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TTC39B mRNA	PMID:19770486
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TTC39B mRNA	PMID:32525701
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TTC39B mRNA	PMID:31881176
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:28088	genistein	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of TTC39B gene	PMID:28505145
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314048	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTC39B mRNA	PMID:22574217
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTC39B mRNA	PMID:20106945|PMID:21632981
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TTC39B mRNA	PMID:33387578
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TTC39B mRNA	PMID:33212167
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TTC39B mRNA	PMID:30851411
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:28428	beta-hexachlorocyclohexane	increases expression	ISO	RGD:1314049	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in increased expression of TTC39B mRNA	PMID:25270620
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TTC39B mRNA	PMID:29803840
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TTC39B mRNA	PMID:37992649
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTC39B mRNA	PMID:37682722
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314048	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TTC39B mRNA	PMID:34032870|PMID:38568856
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTC39B mRNA	PMID:20064835
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314049	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TTC39B intron	PMID:27901495
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314049	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTC39B mRNA	PMID:19770486
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314048	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TTC39B promoter	PMID:27901495
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TTC39B mRNA	PMID:25895662
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TTC39B mRNA	PMID:29264374
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314049	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TTC39B gene	PMID:35295148
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of TTC39B mRNA	PMID:23811191
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314049	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TTC39B mRNA	PMID:17426115
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TTC39B mRNA	PMID:25181051
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314049	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of TTC39B mRNA	PMID:26063408
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TTC39B mRNA	PMID:39298647
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314049	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TTC39B intron	PMID:28392331
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TTC39B mRNA	PMID:34813904
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1314049	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of TTC39B mRNA	PMID:25270620
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TTC39B mRNA	PMID:34813904
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314048	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TTC39B mRNA	PMID:37042841
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of TTC39B mRNA	PMID:39836092
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314048	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TTC39B mRNA	PMID:38174414
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTC39B mRNA	PMID:35301059
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTC39B mRNA	PMID:37236586
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of TTC39B mRNA	PMID:24386269
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TTC39B mRNA	PMID:24449571
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314048	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TTC39B mRNA	PMID:32588087
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TTC39B mRNA	PMID:28302478
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1314048	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TTC39B mRNA	PMID:31533062
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of TTC39B mRNA	PMID:19167446
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TTC39B mRNA	PMID:19167446
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TTC39B mRNA	PMID:36331819
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TTC39B mRNA	PMID:23179753|PMID:28001369
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314048	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TTC39B mRNA	PMID:24935251|PMID:27188386
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314048	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TTC39B mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TTC39B mRNA	PMID:37992649
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1314048	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TTC39B mRNA	PMID:24935251
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314049	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TTC39B mRNA	PMID:17562736
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC39B mRNA	PMID:33387578
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314048	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC39B mRNA	PMID:29067470
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TTC39B mRNA	PMID:32525701
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1314049	E	RGD:401827839|PMID:29593532	20230929	RGD	MESH:C045651	(-)-epigallocatechin 3-gallate decreases expression of Ttc39b mRNA and protein in liver	
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of TTC39B mRNA	PMID:18175754
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TTC39B mRNA	PMID:30307764
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314049	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TTC39B mRNA; Nanotubes, Carbon results in increased expression of TTC39B mRNA	PMID:25554681|PMID:25620056
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314049	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of TTC39B mRNA	PMID:40234311
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TTC39B mRNA	PMID:24136188
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314049	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TTC39B mRNA	PMID:19042947
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314049	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TTC39B mRNA	PMID:38701926
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of TTC39B mRNA	PMID:39836092
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1314049	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TTC39B mRNA	PMID:25270620
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of TTC39B mRNA	PMID:19564919
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TTC39B mRNA	PMID:39752319
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1314048	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TTC39B mRNA	PMID:31758290
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TTC39B mRNA	PMID:22206623
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1314048	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TTC39B mRNA	PMID:30851411
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39B mRNA	PMID:27188386
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314049	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TTC39B mRNA	PMID:23091169
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TTC39B mRNA	PMID:19167446
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1314048	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of TTC39B mRNA	PMID:26705709
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TTC39B mRNA	PMID:32525701
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314049	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of TTC39B mRNA	PMID:21278054
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TTC39B mRNA	PMID:39752319
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314048	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39B mRNA	PMID:27188386
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TTC39B mRNA	PMID:19281266
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1314048	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TTC39B mRNA	PMID:38568856
1305797	Ttc39b	tetratricopeptide repeat domain 39B	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TTC39B mRNA	PMID:35537566
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MBOAT2 mRNA	PMID:26251327
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MBOAT2 mRNA	PMID:20938992
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314050	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MBOAT2 mRNA	PMID:33167477
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MBOAT2 mRNA	PMID:20880076
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MBOAT2 mRNA	PMID:30529165
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314051	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MBOAT2 mRNA	PMID:30319688
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1314050	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of MBOAT2 mRNA	PMID:29581250
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of MBOAT2 mRNA; [Testosterone co-treated with Estradiol] results in increased expression of MBOAT2 mRNA	PMID:26496021|PMID:32741896
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314050	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MBOAT2 mRNA	PMID:30165855
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MBOAT2 mRNA	PMID:20938992
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314050	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MBOAT2 mRNA	PMID:37042841
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314050	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MBOAT2 mRNA	PMID:22017230
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] results in increased expression of MBOAT2 mRNA	PMID:32741896
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1314050	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of MBOAT2 mRNA	PMID:31256213
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314051	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MBOAT2 mRNA	PMID:33754040
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314050	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MBOAT2 protein	PMID:37730182
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MBOAT2 mRNA	PMID:18579281
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314050	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MBOAT2 gene	PMID:27153756
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314050	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MBOAT2 intron	PMID:30157460
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MBOAT2 mRNA	PMID:30779732
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MBOAT2 mRNA	PMID:20938992
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1314050	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of MBOAT2 mRNA	PMID:24768652
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314051	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MBOAT2 mRNA	PMID:21570461
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBOAT2 mRNA	PMID:17942748
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314050	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MBOAT2 mRNA	PMID:33212167
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MBOAT2 mRNA	PMID:28959563
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314050	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MBOAT2 mRNA	PMID:29803840
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314050	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MBOAT2 mRNA	PMID:38568856
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314050	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MBOAT2 promoter	PMID:27901495
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MBOAT2 mRNA	PMID:22610609
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA	PMID:27858113
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MBOAT2 mRNA	PMID:27131904
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314050	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of MBOAT2 gene	PMID:31601247
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1314050	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of MBOAT2 mRNA	PMID:31745603
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MBOAT2 mRNA	PMID:30047161
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1314051	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of MBOAT2 promoter	PMID:35295148
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314051	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MBOAT2 gene	PMID:35295148
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MBOAT2 mRNA	PMID:30816183|PMID:34947998
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MBOAT2 gene	PMID:28505145
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of MBOAT2 mRNA	PMID:26496021
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314050	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of MBOAT2 gene	PMID:31601247
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314051	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MBOAT2 mRNA	PMID:26377693
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA	PMID:27858113
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314051	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of MBOAT2 intron	PMID:28392331
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MBOAT2 mRNA	PMID:17361019|PMID:21266533
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D010269	Paraquat results in increased expression of MBOAT2 mRNA	PMID:22563483
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D010269	[Paraquat co-treated with Maneb] affects the expression of MBOAT2 mRNA	PMID:22563483
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314050	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MBOAT2 mRNA	PMID:37042841
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MBOAT2 mRNA	PMID:35163327
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314051	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MBOAT2 mRNA	PMID:26377693
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MBOAT2 mRNA	PMID:35163327
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of MBOAT2 mRNA	PMID:30047161
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314051	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MBOAT2 mRNA	PMID:40194260
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:38626	pyridaben	increases expression	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:C428725	pyridaben results in increased expression of MBOAT2 mRNA	PMID:22563483
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1314050	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MBOAT2 mRNA	PMID:31533062
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314050	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MBOAT2 mRNA	PMID:40419075
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314050	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of MBOAT2 mRNA	PMID:23179753
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314050	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of MBOAT2 mRNA	PMID:29154799
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of MBOAT2 mRNA	PMID:30047161
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314051	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MBOAT2 mRNA	PMID:17555576
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1314050	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MBOAT2 mRNA	PMID:36621641
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314051	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MBOAT2 mRNA	PMID:28973697
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:44616	afimoxifene	multiple interactions	ISO	RGD:1314050	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of MBOAT2 mRNA]	PMID:21233418
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314051	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MBOAT2 mRNA	PMID:17555576
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314051	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MBOAT2 mRNA	PMID:17942748
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBOAT2 mRNA	PMID:17942748
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MBOAT2 mRNA	PMID:30047161
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of MBOAT2 mRNA	PMID:26377693
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA	PMID:27858113
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA	PMID:27858113
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D008344	[Paraquat co-treated with Maneb] affects the expression of MBOAT2 mRNA	PMID:22563483
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314051	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of MBOAT2 mRNA	PMID:23608068
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1314050	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of MBOAT2 mRNA	PMID:20436886
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MBOAT2 gene	PMID:35440735
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314051	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MBOAT2 mRNA	PMID:22206623
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MBOAT2 mRNA	PMID:30047161
1305798	Mboat2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MBOAT2 mRNA	PMID:27131904
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:10101	zalcitabine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016047	[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of DEPDC1B mRNA	PMID:18606552
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DEPDC1B mRNA	PMID:33167477
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of DEPDC1B gene	PMID:28931070
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314052	E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DEPDC1B mRNA	PMID:29432896
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DEPDC1B mRNA	PMID:21632981
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1314052	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of DEPDC1B protein	PMID:35688186
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DEPDC1B mRNA	PMID:39298647
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314052	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DEPDC1B mRNA	PMID:16474171
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEPDC1B mRNA	PMID:32741896
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1314052	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of DEPDC1B mRNA	PMID:38568856
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of DEPDC1B mRNA	PMID:23649840
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1314052	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of DEPDC1B mRNA	PMID:21540246
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of DEPDC1B mRNA	PMID:26079696
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of DEPDC1B mRNA	PMID:28973375
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of DEPDC1B mRNA	PMID:21592394
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEPDC1B mRNA	PMID:32741896
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314052	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of DEPDC1B mRNA	PMID:21592394
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1314052	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of DEPDC1B protein	PMID:37730182
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of DEPDC1B mRNA	PMID:21592394
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1314052	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of DEPDC1B mRNA	PMID:21592394
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of DEPDC1B mRNA	PMID:24376830
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DEPDC1B mRNA	PMID:19549813
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of DEPDC1B mRNA	PMID:23649840
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1550310	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of DEPDC1B intron	PMID:27776689
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1314052	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DEPDC1B protein	PMID:20106945
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DEPDC1B mRNA	PMID:23630614
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DEPDC1B mRNA	PMID:23649840
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of DEPDC1B mRNA	PMID:25102026
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of DEPDC1B mRNA	PMID:24336422
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550310	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DEPDC1B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of DEPDC1B mRNA	PMID:27106289|PMID:34911549
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314052	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of DEPDC1B mRNA	PMID:32525701
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1314052	E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of DEPDC1B mRNA	PMID:33512557
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DEPDC1B mRNA	PMID:31881176
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314052	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DEPDC1B mRNA	PMID:28903495
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1314052	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of DEPDC1B mRNA	PMID:23300844
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314052	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of DEPDC1B mRNA	PMID:16474171
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1314052	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DEPDC1B mRNA	PMID:25583101
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550310	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DEPDC1B mRNA	PMID:21570461|PMID:26377647
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DEPDC1B mRNA	PMID:33387578
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DEPDC1B mRNA	PMID:21632981|PMID:21802500
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314052	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of DEPDC1B mRNA	PMID:33512557
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DEPDC1B mRNA	PMID:33212167
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of DEPDC1B mRNA	PMID:32763439
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of DEPDC1B mRNA	PMID:22623647
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DEPDC1B mRNA	PMID:22714537|PMID:38568856
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DEPDC1B mRNA	PMID:17998272
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314052	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of DEPDC1B mRNA	PMID:29301061
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of DEPDC1B mRNA	PMID:22378314
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1550310	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DEPDC1B exon; Benzo(a)pyrene results in decreased methylation of DEPDC1B intron	PMID:27901495
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550310	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DEPDC1B mRNA	PMID:29341224
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DEPDC1B mRNA	PMID:19150397|PMID:20382639
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:31835	methylparaben	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of DEPDC1B mRNA	PMID:31745603
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DEPDC1B mRNA	PMID:25729387
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550310	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DEPDC1B promoter	PMID:35295148
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550310	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of DEPDC1B mRNA	PMID:23557971
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DEPDC1B mRNA	PMID:34492290
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1314052	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of DEPDC1B mRNA	PMID:38479592
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1314052	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DEPDC1B mRNA	PMID:30903817
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DEPDC1B mRNA	PMID:25181051|PMID:32145629
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DEPDC1B mRNA	PMID:29275510
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314052	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of DEPDC1B mRNA	PMID:16474171
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DEPDC1B gene	PMID:28505145
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1550310	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of DEPDC1B mRNA	PMID:20713471
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1550310	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of DEPDC1B mRNA	PMID:20713471
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550310	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DEPDC1B gene	PMID:31683443
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of DEPDC1B mRNA	PMID:40203079
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550310	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of DEPDC1B mRNA	PMID:26377693
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550310	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DEPDC1B intron	PMID:28392331
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314052	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DEPDC1B mRNA	PMID:37042841
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DEPDC1B mRNA	PMID:30723492
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DEPDC1B mRNA	PMID:38568856
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DEPDC1B mRNA	PMID:36326898
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of DEPDC1B mRNA	PMID:25539665
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of DEPDC1B mRNA	PMID:25908611
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of DEPDC1B mRNA	PMID:32588087
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550310	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DEPDC1B mRNA	PMID:40194260
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1314052	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of DEPDC1B mRNA	PMID:33512557
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DEPDC1B mRNA	PMID:28302478
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DEPDC1B mRNA	PMID:31533062
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1314052	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA]	PMID:18310284
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of DEPDC1B mRNA	PMID:39529242
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DEPDC1B mRNA	PMID:40419075
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of DEPDC1B mRNA	PMID:27188386|PMID:28001369
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DEPDC1B mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:40909	azoxystrobin	increases expression	ISO	RGD:1314052	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of DEPDC1B mRNA	PMID:33512557
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550310	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DEPDC1B mRNA	PMID:28973697
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1314052	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of DEPDC1B mRNA	PMID:33512557
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314052	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DEPDC1B mRNA	PMID:38832940
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550310	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DEPDC1B mRNA	PMID:17562736
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DEPDC1B mRNA	PMID:33387578
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1550310	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DEPDC1B mRNA	PMID:29279043
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314052	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of DEPDC1B mRNA	PMID:32525701
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550310	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of DEPDC1B mRNA	PMID:35436446
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:5011	fenpyroximate	increases expression	ISO	RGD:1314052	E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of DEPDC1B mRNA	PMID:33512557
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1314052	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of DEPDC1B mRNA	PMID:23300844
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1550310	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of DEPDC1B mRNA	PMID:25554681
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550310	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DEPDC1B mRNA	PMID:25554681
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of DEPDC1B mRNA	PMID:21148553
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of DEPDC1B mRNA	PMID:21983209
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550310	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DEPDC1B mRNA	PMID:19042947
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550310	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of DEPDC1B mRNA	PMID:38701926
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:63618	pravastatin	affects expression	ISO	RGD:1550310	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of DEPDC1B mRNA	PMID:27225895
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:63618	pravastatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of DEPDC1B mRNA	PMID:27225895
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of DEPDC1B mRNA	PMID:25729387
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DEPDC1B mRNA	PMID:25729387
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DEPDC1B mRNA	PMID:37269647
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DEPDC1B mRNA	PMID:24810058
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1550310	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of DEPDC1B mRNA	PMID:22078008
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:75170	zaragozic acid A	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of DEPDC1B mRNA	PMID:27225895
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of DEPDC1B mRNA	PMID:27225895
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEPDC1B mRNA	PMID:32741896
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of DEPDC1B mRNA	PMID:32858204
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of DEPDC1B mRNA	PMID:34995734
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of DEPDC1B mRNA	PMID:18927307
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550310	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DEPDC1B mRNA	PMID:23091169
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:81794	thifluzamide	increases expression	ISO	RGD:1314052	E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of DEPDC1B mRNA	PMID:33512557
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of DEPDC1B mRNA	PMID:32234424
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1314052	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of DEPDC1B mRNA	PMID:33512557
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1314052	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of DEPDC1B mRNA	PMID:32525701
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DEPDC1B mRNA	PMID:24780913
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of DEPDC1B mRNA	PMID:26272509
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of DEPDC1B mRNA	PMID:22869556
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1314052	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of DEPDC1B mRNA	PMID:22378314
1305799	Depdc1b	DEP domain containing 1B	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DEPDC1B mRNA	PMID:35537566
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1617487	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MS4A6C mRNA	PMID:37995155
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MS4A6C mRNA	PMID:20188158
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A6C mRNA	PMID:20938992
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1323386	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MS4A6A mRNA	PMID:33167477
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20260811	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MS4A6E mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MS4A6E mRNA	PMID:33729688
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MS4A6C mRNA	PMID:30529165
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:15891	taurine	decreases expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:D013654	Taurine results in decreased expression of MS4A6A mRNA	PMID:16579726
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MS4A6C mRNA	PMID:27339419|PMID:39241906
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1323386	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MS4A6A mRNA	PMID:35811015
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MS4A6C mRNA]	PMID:39241906
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1323386	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of MS4A6A mRNA	PMID:30510588
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MS4A6C mRNA	PMID:39298647
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D004958	Estradiol results in increased expression of MS4A6C mRNA	PMID:19484750
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6A mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6E mRNA	PMID:32741896
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MS4A6E mRNA	PMID:33387578
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A6C mRNA	PMID:20938992
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1323386	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MS4A6A mRNA	PMID:37042841
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A6C mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A6C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MS4A6C mRNA	PMID:37567420|PMID:37992649
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6A mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6E mRNA	PMID:32741896
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A6C mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A6C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MS4A6C mRNA	PMID:37567420|PMID:37992649
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MS4A6C mRNA	PMID:23892564
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:18248	iron atom	decreases expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:D007501	Iron deficiency results in decreased expression of MS4A6A mRNA	PMID:20368581
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1323386	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MS4A6A mRNA	PMID:35301059
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MS4A6C mRNA	PMID:37236586
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:234430	gardiquimod	decreases expression	ISO	RGD:1323386	E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in decreased expression of MS4A6A mRNA	PMID:28003376
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:234430	gardiquimod	multiple interactions	ISO	RGD:1323386	E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of MS4A6A mRNA]	PMID:28003376
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1323386	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MS4A6A mRNA	PMID:35430440
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MS4A6C mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MS4A6C mRNA	PMID:34911549
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D000661	Amphetamine results in decreased expression of MS4A6C mRNA	PMID:30779732
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:27300	vitamin D	affects expression	ISO	RGD:1323386	E	RGD:6480464	20170303	CTD	MESH:D014807	Vitamin D affects the expression of MS4A6A mRNA	PMID:20368581
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MS4A6C mRNA	PMID:27339419|PMID:31919559
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A6C mRNA	PMID:20938992
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MS4A6C mRNA	PMID:40504410
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of MS4A6A mRNA	PMID:38314887
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20240206	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A6C mRNA]; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MS4A6C mRNA	PMID:37567420|PMID:37992649
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of MS4A6A mRNA	PMID:25905778
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D019833	Genistein results in increased expression of MS4A6C mRNA	PMID:32186404
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:D009532	Nickel results in increased expression of MS4A6A mRNA	PMID:24768652|PMID:25583101
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MS4A6A mRNA	PMID:22298810
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MS4A6C mRNA	PMID:26377647
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MS4A6A mRNA	PMID:23238561|PMID:34747641
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MS4A6A mRNA	PMID:31378766
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20231031	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A6C mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A6C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MS4A6C mRNA	PMID:37567420|PMID:37992649
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A6C mRNA]	PMID:37992649
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:2896	astemizole	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D016589	Astemizole results in decreased expression of MS4A6A mRNA	PMID:20221588
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1323386	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of MS4A6A gene	PMID:28589171
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MS4A6C mRNA	PMID:40504410
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1323386	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MS4A6A exon; Benzo(a)pyrene affects the methylation of MS4A6A promoter	PMID:27901495
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MS4A6A mRNA	PMID:21839799
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MS4A6C mRNA	PMID:23735875
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1323386	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MS4A6A 5' UTR	PMID:27901495
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:C015001	arsenite results in increased expression of MS4A6C mRNA	PMID:18929588
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in increased expression of MS4A6C mRNA]	PMID:18929588
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D012834	Silver results in decreased expression of MS4A6C mRNA	PMID:27131904
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MS4A6A mRNA	PMID:22431001
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1323386	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MS4A6A mRNA	PMID:20458559
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:30966	glycidol	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of MS4A6A mRNA	PMID:24915197
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MS4A6A mRNA	PMID:25729387
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:C009495	titanium dioxide results in decreased expression of MS4A6C mRNA	PMID:29264374
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:C009495	titanium dioxide results in increased expression of MS4A6C mRNA	PMID:23557971
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of MS4A6A mRNA	PMID:23411599
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MS4A6A mRNA	PMID:34492290
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of MS4A6C mRNA	PMID:19191707
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MS4A6A mRNA; bisphenol A results in decreased expression of MS4A6C mRNA	PMID:25181051
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:C006780	bisphenol A results in decreased expression of MS4A6C mRNA	PMID:17706920
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of MS4A6A mRNA	PMID:32145629
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1617487	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MS4A6C mRNA	PMID:32156529
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:C006780	LHB protein affects the reaction [bisphenol A results in decreased expression of MS4A6C mRNA]	PMID:17706920
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:C029297	vinylidene chloride results in increased expression of MS4A6C mRNA	PMID:26682919
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of MS4A6A mRNA	PMID:23146750
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of MS4A6A mRNA	PMID:23146750
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1617487	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MS4A6C mRNA	PMID:39298647
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1617487	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of MS4A6C mRNA	PMID:33297965
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MS4A6A mRNA	PMID:21266533
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MS4A6A mRNA	PMID:32680482
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MS4A6C mRNA]	PMID:39241906
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MS4A6A mRNA	PMID:25993096
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1323386	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MS4A6A mRNA	PMID:35301059
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MS4A6C mRNA	PMID:37236586
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1323386	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MS4A6A mRNA	PMID:24449571
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:1323386	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of MS4A6A mRNA]	PMID:28003376
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:38845	profenofos	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C024273	profenofos results in increased expression of MS4A6A mRNA	PMID:17569032
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:C031763	1,3-butadiene results in decreased expression of MS4A6C mRNA	PMID:29038090
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:D014635	Valproic Acid affects the expression of MS4A6A mRNA	PMID:25979313
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D017313	Fenretinide results in decreased expression of MS4A6A mRNA	PMID:28973697
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A6C mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A6C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MS4A6C mRNA	PMID:37567420|PMID:37992649
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D000082	Acetaminophen affects the expression of MS4A6C mRNA	PMID:17562736
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1323386	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of MS4A6A mRNA	PMID:26690555
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1323386	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MS4A6A mRNA	PMID:35811015
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:46661	asbestos	affects expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:D001194	Asbestos affects the expression of MS4A6A mRNA	PMID:17297452
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MS4A6C mRNA	PMID:29279043
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MS4A6C mRNA	PMID:40504410
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:C016766	sulforaphane results in decreased expression of MS4A6A mRNA	PMID:26833863
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260811	CTD	MESH:D004726	Endosulfan results in decreased expression of MS4A6E mRNA	PMID:29391264
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1323386	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MS4A6A mRNA	PMID:20458559
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MS4A6C mRNA; Nanotubes, Carbon results in increased expression of MS4A6C mRNA	PMID:25554681
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:C029938	nickel sulfate results in decreased expression of MS4A6A mRNA	PMID:16780908
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1617487	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MS4A6C mRNA	PMID:38701926
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D016559	Tacrolimus results in increased expression of MS4A6C mRNA	PMID:29362864
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of MS4A6A mRNA	PMID:20080153
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of MS4A6A mRNA	PMID:28801915
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MS4A6A mRNA	PMID:25729387
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of MS4A6A mRNA	PMID:28801915
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of MS4A6A mRNA	PMID:20843944
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MS4A6C mRNA	PMID:22206623
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MS4A6C mRNA	PMID:37567420
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6A mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6E mRNA	PMID:32741896
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of MS4A6A mRNA	PMID:21346803
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1617487	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MS4A6C mRNA	PMID:38648751
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MS4A6A mRNA	PMID:31826744
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:82664	iron(0)	decreases expression	ISO	RGD:1323386	E	RGD:6480464	20160712	CTD	MESH:D007501	Iron deficiency results in decreased expression of MS4A6A mRNA	PMID:20368581
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of MS4A6C mRNA	PMID:39847705
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MS4A6A mRNA	PMID:24780913
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1617487	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MS4A6C mRNA]	PMID:39241906
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:D012834	Silver results in decreased expression of MS4A6C mRNA	PMID:27131904
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MS4A6A mRNA	PMID:21346803
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of MS4A6A mRNA	PMID:25905778
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1617487	E	RGD:6480464	20210608	CTD	MESH:C057693	Troglitazone results in increased expression of MS4A6A mRNA	PMID:28973697
1305800	Ms4a6a	membrane spanning 4-domains A6A	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of MS4A6A mRNA	PMID:23034163
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1331868	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYLK3 mRNA	PMID:33045310
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1604762	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of MYLK3 mRNA	PMID:34925699
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MYLK3 mRNA	PMID:36189433
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYLK3 mRNA	PMID:30529165
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1604762	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of MYLK3 mRNA	PMID:30510588
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MYLK3 mRNA	PMID:32741896
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1604762	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of MYLK3 mRNA	PMID:20404318
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:16899	D-mannitol	increases expression	ISO	RGD:1331868	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in increased expression of MYLK3 mRNA	PMID:25270620
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	ISO	RGD:1604762	E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of MYLK3 mRNA	PMID:39245080
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1331868	E	RGD:6480464	20161025	CTD	MESH:D011374	Progesterone results in decreased expression of MYLK3 mRNA	PMID:27264040|PMID:31566189
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20161025	CTD	MESH:D011374	Mifepristone inhibits the reaction [Progesterone results in decreased expression of MYLK3 mRNA]	PMID:27264040|PMID:31566189
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MYLK3 mRNA	PMID:36189433
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MYLK3 mRNA	PMID:32741896
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1604762	E	RGD:6480464	20250708	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MYLK3 mRNA	PMID:35818422
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1604762	E	RGD:6480464	20250708	CTD	MESH:D004051	Asian ginseng inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MYLK3 mRNA]	PMID:35818422
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MYLK3 mRNA	PMID:33387578
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1604762	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of MYLK3 intron	PMID:30157460
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MYLK3 mRNA	PMID:37325564
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1604762	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MYLK3 mRNA	PMID:32234424
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604762	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MYLK3 intron	PMID:30157460
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MYLK3 mRNA	PMID:34911549
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:D012643	Selenium results in decreased expression of MYLK3 mRNA	PMID:39059692
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1604762	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MYLK3 mRNA	PMID:26272509
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1604762	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLK3 mRNA	PMID:27188386
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1604762	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of MYLK3 mRNA	PMID:41028656
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1331868	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of MYLK3 mRNA	PMID:40618947
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MYLK3 mRNA	PMID:33387578
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1604762	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MYLK3 mRNA	PMID:33212167
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MYLK3 mRNA	PMID:28959563
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1604762	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MYLK3 mRNA	PMID:41028656
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1604762	E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of MYLK3 mRNA	PMID:29319823
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1604762	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MYLK3 intron; Benzo(a)pyrene affects the methylation of MYLK3 promoter	PMID:27901495|PMID:30157460
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1604762	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MYLK3 mRNA	PMID:22316170
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1604762	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MYLK3 5' UTR	PMID:27901495
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1604762	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of MYLK3 gene	PMID:25435355
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1604762	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MYLK3 mRNA	PMID:41028656
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20190219	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MYLK3 mRNA	PMID:30171875
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:3179	bromobenzene	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of MYLK3 mRNA	PMID:32479839
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of MYLK3 mRNA	PMID:32599119
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1331868	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of MYLK3 mRNA	PMID:35295148
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MYLK3 mRNA	PMID:25181051
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1331868	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of MYLK3 mRNA	PMID:31566189
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1604762	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MYLK3 gene	PMID:31601247
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MYLK3 mRNA	PMID:30816183|PMID:32528016
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1331868	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MYLK3 mRNA	PMID:32156529
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1604762	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of MYLK3 mRNA; bisphenol A results in increased expression of MYLK3 protein	PMID:29275510|PMID:37567409
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20220308	CTD	MESH:C006780	Mifepristone inhibits the reaction [bisphenol A results in decreased expression of MYLK3 mRNA]	PMID:31566189
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1331868	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of MYLK3 mRNA	PMID:30951980
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1604762	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MYLK3 intron	PMID:30157460
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1331868	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of MYLK3 mRNA	PMID:30951980
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1331868	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MYLK3 mRNA	PMID:37019170
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1604762	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of MYLK3 gene	PMID:22964155
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MYLK3 mRNA	PMID:37325564
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:D012643	Selenium results in decreased expression of MYLK3 mRNA	PMID:39059692
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:38211	potassium bromate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C019536	potassium bromate results in decreased expression of MYLK3 mRNA	PMID:23588252
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1331868	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MYLK3 mRNA	PMID:40194260
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1331868	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MYLK3 mRNA	PMID:17963808
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604762	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MYLK3 mRNA	PMID:25979313
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1604762	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MYLK3 mRNA	PMID:26272509
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MYLK3 mRNA	PMID:33387578
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	ISO	RGD:1604762	E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of MYLK3 promoter	PMID:29626692
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:46678	amosite asbestos	decreases methylation	ISO	RGD:1604762	E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of MYLK3 promoter	PMID:29626692
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:46680	serpentine asbestos	decreases methylation	ISO	RGD:1604762	E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of MYLK3 promoter	PMID:29626692
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1604762	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of MYLK3 mRNA	PMID:31838189
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1331868	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of MYLK3 mRNA	PMID:30529165
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20190312	CTD	MESH:C016766	[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MYLK3 mRNA	PMID:30529165
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1331868	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MYLK3 mRNA	PMID:25554681
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1604762	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MYLK3 mRNA	PMID:25511174
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:50692	mifepristone	multiple interactions	ISO	RGD:1331868	E	RGD:6480464	20161025	CTD	MESH:D015735	Mifepristone inhibits the reaction [bisphenol A results in decreased expression of MYLK3 mRNA]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of MYLK3 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of MYLK3 mRNA]	PMID:27264040|PMID:31566189
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of MYLK3 mRNA	PMID:28801915
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1331868	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of MYLK3 mRNA	PMID:36851058
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1331868	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of MYLK3 mRNA	PMID:36907384
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of MYLK3 mRNA	PMID:35283115
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1604762	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MYLK3 intron	PMID:30157460
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:6925	microcystin-LR	decreases methylation	ISO	RGD:1604762	E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in decreased methylation of MYLK3 gene	PMID:29518473
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1604762	E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in increased expression of MYLK3 mRNA	PMID:29518473
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1331868	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MYLK3 mRNA	PMID:25566086
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:753435	ginseng, asian	multiple interactions	ISO	RGD:1604762	E	RGD:6480464	20260714	CTD	MESH:C000713447	Asian ginseng inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MYLK3 mRNA]	PMID:35818422
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MYLK3 mRNA	PMID:32741896
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1604762	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLK3 mRNA	PMID:27188386
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:8093	phenylephrine	increases phosphorylation	ISO	RGD:1331868	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased phosphorylation of MYLK3 protein	PMID:18202317
1305801	Mylk3	myosin light chain kinase 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1604762	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLK3 mRNA	PMID:27188386
1305803	Snx15	sorting nexin 15	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX15 mRNA	PMID:36331819
1305803	Snx15	sorting nexin 15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314058	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNX15 mRNA	PMID:37042841
1305803	Snx15	sorting nexin 15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314059	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNX15 mRNA	PMID:33754040
1305803	Snx15	sorting nexin 15	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SNX15 mRNA	PMID:33387578
1305803	Snx15	sorting nexin 15	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314058	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SNX15 mRNA	PMID:28818685
1305803	Snx15	sorting nexin 15	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SNX15 mRNA	PMID:39836092
1305803	Snx15	sorting nexin 15	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNX15 mRNA	PMID:37236586
1305803	Snx15	sorting nexin 15	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SNX15 mRNA	PMID:33354967
1305803	Snx15	sorting nexin 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314058	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SNX15 intron	PMID:30157460
1305803	Snx15	sorting nexin 15	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314059	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SNX15 mRNA	PMID:25629700
1305803	Snx15	sorting nexin 15	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX15 mRNA	PMID:22206623
1305803	Snx15	sorting nexin 15	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1314058	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SNX15 gene	PMID:25304211
1305803	Snx15	sorting nexin 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:39836092
1305803	Snx15	sorting nexin 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:40504410
1305803	Snx15	sorting nexin 15	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1314058	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SNX15 protein	PMID:35688186
1305803	Snx15	sorting nexin 15	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SNX15 mRNA	PMID:23557933
1305803	Snx15	sorting nexin 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314059	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX15 mRNA	PMID:21570461
1305803	Snx15	sorting nexin 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNX15 mRNA	PMID:33387578
1305803	Snx15	sorting nexin 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314059	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNX15 mRNA	PMID:19770486
1305803	Snx15	sorting nexin 15	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1314058	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of SNX15 mRNA	PMID:24834073
1305803	Snx15	sorting nexin 15	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314059	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SNX15 mRNA	PMID:27862939
1305803	Snx15	sorting nexin 15	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1314059	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of SNX15 mRNA	PMID:25270620
1305803	Snx15	sorting nexin 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:39836092
1305803	Snx15	sorting nexin 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:40504410
1305803	Snx15	sorting nexin 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314058	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SNX15 promoter	PMID:27901495
1305803	Snx15	sorting nexin 15	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SNX15 mRNA	PMID:34492290
1305803	Snx15	sorting nexin 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX15 mRNA	PMID:25181051
1305803	Snx15	sorting nexin 15	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SNX15 mRNA	PMID:30816183|PMID:32528016
1305803	Snx15	sorting nexin 15	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of SNX15 mRNA	PMID:23829299
1305803	Snx15	sorting nexin 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314059	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SNX15 gene	PMID:31683443
1305803	Snx15	sorting nexin 15	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNX15 mRNA	PMID:28628672
1305803	Snx15	sorting nexin 15	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases methylation	ISO	RGD:1314059	E	RGD:6480464	20140610	CTD	MESH:D004137	Dinitrochlorobenzene results in increased methylation of SNX15 promoter	PMID:24675093
1305803	Snx15	sorting nexin 15	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNX15 mRNA	PMID:28628672
1305803	Snx15	sorting nexin 15	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SNX15 mRNA	PMID:39836092
1305803	Snx15	sorting nexin 15	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNX15 mRNA	PMID:37236586
1305803	Snx15	sorting nexin 15	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1314058	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SNX15 mRNA	PMID:19320972
1305803	Snx15	sorting nexin 15	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SNX15 mRNA	PMID:24386269
1305803	Snx15	sorting nexin 15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX15 mRNA	PMID:36331819
1305803	Snx15	sorting nexin 15	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314058	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SNX15 mRNA	PMID:25979313
1305803	Snx15	sorting nexin 15	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314058	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SNX15 gene	PMID:29154799
1305803	Snx15	sorting nexin 15	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNX15 mRNA	PMID:28628672
1305803	Snx15	sorting nexin 15	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNX15 mRNA	PMID:33387578
1305803	Snx15	sorting nexin 15	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1314058	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SNX15 gene	PMID:25304211
1305803	Snx15	sorting nexin 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:39836092
1305803	Snx15	sorting nexin 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:40504410
1305803	Snx15	sorting nexin 15	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SNX15 mRNA	PMID:29391264
1305803	Snx15	sorting nexin 15	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNX15 mRNA	PMID:28628672
1305803	Snx15	sorting nexin 15	gene	CHEBI:50091	S-nitrosoglutathione	affects expression	ISO	RGD:1314058	E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione affects the expression of SNX15 mRNA	PMID:38825487
1305803	Snx15	sorting nexin 15	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of SNX15 mRNA	PMID:34044035
1305803	Snx15	sorting nexin 15	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SNX15 mRNA	PMID:24136188
1305803	Snx15	sorting nexin 15	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1314058	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNX15 protein	PMID:32959892
1305803	Snx15	sorting nexin 15	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1314058	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SNX15 mRNA	PMID:39836092
1305803	Snx15	sorting nexin 15	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314059	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNX15 mRNA	PMID:22206623
1305803	Snx15	sorting nexin 15	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX15 mRNA	PMID:22206623
1305803	Snx15	sorting nexin 15	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	ISO	RGD:1314058	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of SNX15 mRNA	PMID:24834073
1305803	Snx15	sorting nexin 15	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SNX15 mRNA	PMID:21346803
1305803	Snx15	sorting nexin 15	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SNX15 mRNA	PMID:21346803
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1314060	E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in increased expression of DUSP2 mRNA	PMID:36828454
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1314060	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DUSP2 mRNA	PMID:38218311
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314061	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DUSP2 mRNA	PMID:33045310
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DUSP2 mRNA	PMID:37995155
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DUSP2 mRNA	PMID:20938992
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of DUSP2 mRNA	PMID:20488242
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314060	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of DUSP2 mRNA	PMID:23724009
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DUSP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DUSP2 mRNA	PMID:32699268
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DUSP2 mRNA	PMID:20044591
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314060	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DUSP2 mRNA	PMID:35811015
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314061	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DUSP2 mRNA	PMID:25890327
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of DUSP2 mRNA]	PMID:35811015
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314060	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of DUSP2 mRNA	PMID:23019147|PMID:36828454
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1314060	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of DUSP2 mRNA	PMID:38568856
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DUSP2 mRNA	PMID:33387578
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DUSP2 mRNA	PMID:20938992
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314060	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DUSP2 mRNA	PMID:37042841
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of DUSP2 mRNA	PMID:15120971|PMID:15122651
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of DUSP2 mRNA	PMID:17938736|PMID:28937961
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314061	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of DUSP2 mRNA	PMID:17178593|PMID:39922521
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP2 mRNA	PMID:37992649
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1314060	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of DUSP2 mRNA	PMID:33647349
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:17627	ferroheme b	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in decreased expression of DUSP2 mRNA	PMID:19191707
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314061	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of DUSP2 mRNA	PMID:17178593|PMID:39922521
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP2 mRNA	PMID:37992649
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DUSP2 mRNA	PMID:28085963|PMID:34319233
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DUSP2 mRNA	PMID:33387578
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:17883	hydrogen chloride	decreases expression	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D006851	Hydrochloric Acid results in decreased expression of DUSP2 mRNA	PMID:15046208
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	decreases expression	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D014284	Triiodothyronine results in decreased expression of DUSP2 mRNA	PMID:14761676
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D014284	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DUSP2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in decreased expression of DUSP2 mRNA]	PMID:14761676
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1314060	E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in increased expression of DUSP2 mRNA	PMID:29993192
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314060	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DUSP2 mRNA	PMID:19549813
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DUSP2 mRNA	PMID:25378103
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314060	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DUSP2 mRNA	PMID:22100608|PMID:32234424
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DUSP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DUSP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of DUSP2 mRNA	PMID:32699268
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DUSP2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DUSP2 mRNA	PMID:34911549
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:26355	heme b	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in decreased expression of DUSP2 mRNA	PMID:19191707
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DUSP2 mRNA	PMID:18593933
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DUSP2 mRNA	PMID:20938992
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20180410	CTD	MESH:D000966	Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP2 mRNA]	PMID:28713220
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1314060	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of DUSP2 mRNA	PMID:31295307
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1314060	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of DUSP2 mRNA	PMID:31295307
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314061	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of DUSP2 mRNA	PMID:28960355
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DUSP2 mRNA	PMID:31881176
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314060	E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of DUSP2 mRNA	PMID:23019147
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DUSP2 mRNA	PMID:34747641
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DUSP2 mRNA	PMID:32109520
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D013749	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DUSP2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in decreased expression of DUSP2 mRNA]	PMID:14761676
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314061	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of DUSP2 mRNA	PMID:32937126
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314060	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DUSP2 mRNA	PMID:33212167
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1314060	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of DUSP2 mRNA	PMID:23649840
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of DUSP2 mRNA	PMID:28959563
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of DUSP2 mRNA	PMID:26033743
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of DUSP2 mRNA	PMID:24690739
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP2 mRNA	PMID:37992649
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of DUSP2 mRNA	PMID:20044591
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:28876	melphalan	increases expression	ISO	RGD:1314060	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in increased expression of DUSP2 mRNA	PMID:22363485
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314060	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of DUSP2 mRNA	PMID:35954277|PMID:39719251
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314060	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of DUSP2 mRNA	PMID:34032870|PMID:38568856
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite inhibits the reaction [BMP6 protein results in increased expression of DUSP2 mRNA]	PMID:23566955|PMID:28713220
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA	PMID:34876320
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA	PMID:34876320
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314060	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DUSP2 promoter	PMID:27901495
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DUSP2 mRNA	PMID:20064835
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DUSP2 mRNA	PMID:21569818
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314060	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DUSP2 3' UTR	PMID:27901495
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314060	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DUSP2 mRNA	PMID:32234424
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314060	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DUSP2 exon	PMID:27901495
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to DUSP2 promoter]	PMID:19654925
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of DUSP2 mRNA	PMID:26033743
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of DUSP2 mRNA	PMID:24690739
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DUSP2 mRNA	PMID:18593933
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of DUSP2 mRNA	PMID:27131904
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314060	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of DUSP2 mRNA	PMID:26014281
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314060	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of DUSP2 mRNA	PMID:25895662
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314061	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DUSP2 mRNA	PMID:19073995|PMID:29341224|PMID:33720480|PMID:38811393
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1314060	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DUSP2 mRNA	PMID:20458559
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of DUSP2 mRNA	PMID:25729387
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of DUSP2 mRNA	PMID:30047161
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314061	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DUSP2 gene	PMID:35295148
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of DUSP2 mRNA	PMID:30012374
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314061	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of DUSP2 mRNA	PMID:23557971
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DUSP2 mRNA	PMID:34492290
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314061	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DUSP2 mRNA	PMID:23811191
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DUSP2 mRNA	PMID:25181051
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314061	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of DUSP2 mRNA	PMID:32156529
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1314061	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of DUSP2 mRNA	PMID:25172293
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314061	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DUSP2 mRNA	PMID:30951980
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314061	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of DUSP2 mRNA	PMID:30951980
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of DUSP2 mRNA	PMID:21241498
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:34696	dieldrin	increases expression	ISO	RGD:1314060	E	RGD:6480464	20201215	CTD	MESH:D004026	Dieldrin results in increased expression of DUSP2 mRNA	PMID:31068361
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314060	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DUSP2 mRNA	PMID:37042841
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:35064	alpha-Zearalanol	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of DUSP2 mRNA	PMID:35163327
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DUSP2 mRNA	PMID:36928142
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314060	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DUSP2 mRNA	PMID:38174414|PMID:38568856
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:36009	omega-6 fatty acid	increases expression	ISO	RGD:1314060	E	RGD:6480464	20170117	CTD	MESH:D043371	Fatty Acids, Omega-6 results in increased expression of DUSP2 mRNA	PMID:16823509
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DUSP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DUSP2 mRNA	PMID:32699268
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1314061	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of DUSP2 mRNA	PMID:38531469
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1314060	E	RGD:6480464	20201215	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of DUSP2 mRNA	PMID:31068361
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:38211	potassium bromate	affects expression	ISO	RGD:1314061	E	RGD:6480464	20160607	CTD	MESH:C019536	potassium bromate affects the expression of DUSP2 mRNA	PMID:27082013
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:38211	potassium bromate	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20160607	CTD	MESH:C019536	[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of DUSP2 mRNA]	PMID:27082013
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of DUSP2 mRNA	PMID:29038090
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314060	E	RGD:6480464	20171114	CTD	MESH:D014635	Valproic Acid results in increased methylation of DUSP2 gene	PMID:28853863|PMID:29154799|PMID:29201983
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of DUSP2 mRNA	PMID:30047161
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of DUSP2 mRNA	PMID:21041162
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in increased expression of DUSP2 mRNA	PMID:19059307
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of DUSP2 mRNA	PMID:21041162
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1314061	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of DUSP2 mRNA	PMID:22733784
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314061	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of DUSP2 mRNA	PMID:17178593|PMID:39922521
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP2 mRNA	PMID:37992649
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1314060	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of DUSP2 mRNA	PMID:23649840
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1314060	E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of DUSP2 mRNA	PMID:17400583
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314060	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DUSP2 mRNA	PMID:38832940
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20120613	CTD	MESH:C012589	[[decitabine co-treated with trichostatin A] affects the methylation of DUSP2 promoter] which affects the expression of DUSP2 mRNA	PMID:18836996
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DUSP2 mRNA	PMID:33387578
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:4659	disulfiram	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of DUSP2 mRNA	PMID:24690739
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of DUSP2 mRNA]	PMID:35811015
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of DUSP2 mRNA	PMID:17331233
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of DUSP2 mRNA	PMID:29391264
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA	PMID:34876320
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:4911	etoposide	affects response to substance	ISO	RGD:1314060	E	RGD:6480464	20120412	CTD	MESH:D005047	DUSP2 protein affects the susceptibility to Etoposide	PMID:16217747
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP2 mRNA	PMID:27188386
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1314060	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DUSP2 mRNA	PMID:20458559
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20191114	CTD	MESH:C014347	[[Decitabine co-treated with trichostatin A] affects the methylation of DUSP2 promoter] which affects the expression of DUSP2 mRNA	PMID:18836996
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314061	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of DUSP2 mRNA	PMID:25554681
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314061	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DUSP2 mRNA	PMID:25554681
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of DUSP2 mRNA	PMID:30047161
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314061	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of DUSP2 mRNA	PMID:26377693
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1314060	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DUSP2 mRNA	PMID:31629900
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314061	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of DUSP2 mRNA	PMID:38701926
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of DUSP2 mRNA	PMID:28801915
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of DUSP2 mRNA	PMID:25729387
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of DUSP2 mRNA	PMID:25729387
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of DUSP2 mRNA	PMID:19812364
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DUSP2 mRNA	PMID:28801915
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314061	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DUSP2 mRNA	PMID:22206623
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1314060	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of DUSP2 mRNA	PMID:22714537
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:757488	omega-3 fatty acids	increases expression	ISO	RGD:1314060	E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 results in increased expression of DUSP2 mRNA	PMID:16823509
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP2 mRNA	PMID:27188386
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1314060	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in increased expression of DUSP2 mRNA; Irinotecan results in increased expression of DUSP2 mRNA	PMID:15956246
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314061	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DUSP2 mRNA	PMID:38648751
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:81781	tebuconazole	decreases expression	ISO	RGD:1314060	E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of DUSP2 mRNA	PMID:30458266
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1314060	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of DUSP2 mRNA	PMID:32234424
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA	PMID:34876320
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of DUSP2 mRNA	PMID:25825206|PMID:30047161
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1314060	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of DUSP2 mRNA	PMID:16497877
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of DUSP2 mRNA	PMID:19059307
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1314060	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of DUSP2 mRNA	PMID:31734321
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314060	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP2 mRNA	PMID:27188386
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of DUSP2 mRNA	PMID:27131904
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314060	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of DUSP2 mRNA	PMID:26014281
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1314060	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DUSP2 mRNA	PMID:38568856
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1314060	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DUSP2 mRNA	PMID:29301935
1305804	Dusp2	dual specificity phosphatase 2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314061	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of DUSP2 mRNA	PMID:35537566
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314062	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of CARD6 mRNA	PMID:23830798|PMID:33167477
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CARD6 mRNA	PMID:39241906
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1314062	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of CARD6 mRNA	PMID:22574217
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of CARD6 mRNA	PMID:32145629
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of CARD6 mRNA	PMID:20106945
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CARD6 mRNA	PMID:39298647
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314062	E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in increased expression of CARD6 mRNA	PMID:23373633
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:16598	DDE	affects expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene affects the expression of CARD6 mRNA	PMID:24576310
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CARD6 mRNA	PMID:38568856
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:17183	sanguinarine	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20160705	CTD	MESH:C005705	[sanguinarine co-treated with arsenic trioxide] results in increased expression of CARD6 mRNA	PMID:24345465
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314062	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of CARD6 mRNA	PMID:21592394
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CARD6 mRNA	PMID:21592394
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314063	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CARD6 mRNA	PMID:34319233
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1314062	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CARD6 mRNA	PMID:21592394
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CARD6 mRNA	PMID:21592394
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CARD6 mRNA	PMID:33387578
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CARD6 mRNA	PMID:28818685
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CARD6 mRNA	PMID:36331819
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CARD6 mRNA	PMID:37236586
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314062	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CARD6 mRNA	PMID:19549813
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1314062	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CARD6 protein	PMID:20106945
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314062	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CARD6 mRNA	PMID:21641981
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314063	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CARD6 mRNA	PMID:19770486
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of CARD6 mRNA	PMID:26760959
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CARD6 mRNA	PMID:34911549
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CARD6 mRNA	PMID:40504410
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD6 mRNA	PMID:27188386
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CARD6 mRNA	PMID:30912803
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of CARD6 mRNA	PMID:23195993
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CARD6 mRNA	PMID:33387578
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CARD6 mRNA	PMID:19520675|PMID:34747641
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1314062	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CARD6 mRNA	PMID:28001369
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CARD6 mRNA	PMID:33212167
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of CARD6 mRNA	PMID:20971185
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CARD6 mRNA	PMID:29803840
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:28757	fructose	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D005632	Fructose results in decreased expression of CARD6 protein	PMID:37186242
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:28757	fructose	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D005632	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Fructose results in decreased expression of CARD6 protein]; nuciferine inhibits the reaction [Fructose results in decreased expression of CARD6 protein]	PMID:37186242
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314062	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CARD6 mRNA	PMID:38568856|PMID:39719251
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CARD6 mRNA	PMID:40504410
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314062	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CARD6 mRNA	PMID:20106945
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314063	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CARD6 mRNA	PMID:22610609
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of CARD6 mRNA	PMID:20971185
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1314062	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CARD6 mRNA	PMID:25075043
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CARD6 mRNA	PMID:25895662
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20191114	CTD	MESH:C006632	[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of CARD6 mRNA	PMID:24345465
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CARD6 mRNA	PMID:38479592
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of CARD6 mRNA	PMID:32145629
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CARD6 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CARD6 mRNA	PMID:28628672
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of CARD6 mRNA	PMID:22937105
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CARD6 mRNA	PMID:39298647
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CARD6 mRNA	PMID:28628672
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CARD6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CARD6 mRNA	PMID:28628672
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in decreased expression of CARD6 mRNA	PMID:18836921
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314062	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CARD6 mRNA	PMID:38174414|PMID:38382870
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CARD6 mRNA	PMID:37236586
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CARD6 mRNA	PMID:32588087
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CARD6 mRNA	PMID:36331819
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of CARD6 mRNA	PMID:29038090
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CARD6 mRNA	PMID:29154799
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314062	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CARD6 gene	PMID:29154799
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CARD6 mRNA	PMID:20106945
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CARD6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CARD6 mRNA	PMID:28628672
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1314062	E	RGD:6480464	20130514	CTD	MESH:C016601	afimoxifene results in increased expression of CARD6 mRNA	PMID:23373633
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CARD6 mRNA	PMID:33387578
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CARD6 mRNA	PMID:21420995|PMID:29067470
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CARD6 mRNA	PMID:40504410
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:47286	CU-O LINKAGE	increases expression	ISO	RGD:1314062	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of CARD6 mRNA	PMID:22077320
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CARD6 mRNA	PMID:35436446
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CARD6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CARD6 mRNA	PMID:28628672
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20191114	CTD	MESH:C032793	[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of CARD6 mRNA	PMID:24345465
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1314062	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CARD6 mRNA	PMID:25075043
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CARD6 mRNA	PMID:25554681
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CARD6 mRNA	PMID:35964746
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Fructose results in decreased expression of CARD6 protein]	PMID:37186242
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD6 mRNA	PMID:27188386
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314062	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CARD6 mRNA	PMID:19159669
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:80770	Brevetoxin B	increases expression	ISO	RGD:1314062	E	RGD:6480464	20170228	CTD	MESH:C043466	brevetoxin 2 results in increased expression of CARD6 mRNA	PMID:20498034
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of CARD6 mRNA	PMID:19095052
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1314062	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of CARD6 mRNA	PMID:24921660
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314062	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD6 mRNA	PMID:27188386
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:93751	PF-3758309	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20240806	CTD	MESH:C550923	PF 3758309 results in decreased expression of CARD6 mRNA	PMID:29048629
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1314062	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CARD6 mRNA	PMID:29301935
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of CARD6 mRNA	PMID:17569031|PMID:28973697
1305805	Card6	caspase recruitment domain family, member 6	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of CARD6 mRNA	PMID:23555832
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of COL14A1 mRNA	PMID:25152437
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of COL14A1 mRNA	PMID:21551480
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1314064	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of COL14A1 mRNA	PMID:26272509
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA	PMID:27188386
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552297	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COL14A1 mRNA	PMID:33045310
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:132448	perfluorohexanesulfonic acid	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230307	CTD	MESH:C471071	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of COL14A1 mRNA	PMID:36270329
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314064	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of COL14A1 mRNA	PMID:21934132
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1552297	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of COL14A1 mRNA	PMID:20880076
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of COL14A1 mRNA	PMID:33729688
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL14A1 mRNA	PMID:36331819
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of COL14A1 gene	PMID:28931070
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in decreased expression of COL14A1 mRNA	PMID:19167417
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314064	E	RGD:6480464	20190611	CTD	MESH:D000431	Ethanol results in increased expression of COL14A1 mRNA	PMID:31059573
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of COL14A1 mRNA	PMID:30510588
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1314064	E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in increased expression of COL14A1 mRNA	PMID:34681664
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of COL14A1 mRNA	PMID:39298647
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in increased expression of COL14A1 mRNA	PMID:32145629|PMID:35192832
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552297	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of COL14A1 mRNA	PMID:19484750
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20130723	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of COL14A1 mRNA	PMID:20226447
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20130723	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of COL14A1 mRNA	PMID:20226447
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL14A1 mRNA	PMID:37992649
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL14A1 mRNA	PMID:37992649
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of COL14A1 mRNA	PMID:27523638
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in increased expression of COL14A1 protein	PMID:34122009
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of COL14A1 mRNA	PMID:33387578
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL14A1 mRNA	PMID:36331819
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1314064	E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in increased expression of COL14A1 mRNA	PMID:19194470
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20200609	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL14A1 mRNA	PMID:31738976
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL14A1 mRNA	PMID:29950665
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in increased expression of COL14A1 protein]	PMID:32272095
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:24814	indole-3-methanol	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of COL14A1 mRNA	PMID:21396975
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COL14A1 mRNA	PMID:23630614
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314064	E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COL14A1 mRNA	PMID:32234424
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of COL14A1 mRNA	PMID:34911549
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of COL14A1 mRNA	PMID:17484886
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552297	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of COL14A1 mRNA	PMID:27339419|PMID:29987408
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of COL14A1 mRNA	PMID:21867686
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL14A1 mRNA	PMID:40504410
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of COL14A1 mRNA	PMID:19244175
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1552297	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of COL14A1 protein	PMID:37208198
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of COL14A1 mRNA	PMID:28189721|PMID:28960355
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of COL14A1 mRNA	PMID:31881176
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of COL14A1 mRNA	PMID:40618947
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1314064	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of COL14A1 promoter	PMID:22847954
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1552297	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of COL14A1 mRNA	PMID:32186404
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of COL14A1 mRNA	PMID:24768652|PMID:25583101
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL14A1 mRNA	PMID:32109520
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552297	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL14A1 mRNA	PMID:16962184|PMID:26377647
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COL14A1 mRNA	PMID:34747641
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COL14A1 mRNA	PMID:19770486|PMID:33956508
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28201	rotenone	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of COL14A1 mRNA	PMID:28374803
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314064	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of COL14A1 protein	PMID:39603559
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of COL14A1 mRNA	PMID:28001369
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of COL14A1 mRNA	PMID:33212167
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of COL14A1 mRNA	PMID:30556269
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of COL14A1 protein	PMID:28918527
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL14A1 mRNA	PMID:39631538
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL14A1 mRNA	PMID:37992649
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL14A1 protein	PMID:29459688
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20191008	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL14A1 mRNA	PMID:31170414
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL14A1 mRNA	PMID:40504410
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314064	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COL14A1 5' UTR; Benzo(a)pyrene affects the methylation of COL14A1 exon	PMID:27901495|PMID:30157460
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314064	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COL14A1 promoter	PMID:27901495
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of COL14A1 mRNA	PMID:30556269
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:3048	benzatropine	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in increased expression of COL14A1 protein	PMID:34122009
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of COL14A1 mRNA	PMID:22431001
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of COL14A1 mRNA	PMID:29203145
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314064	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of COL14A1 mRNA	PMID:20458559
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1552297	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of COL14A1 mRNA	PMID:36087614
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of COL14A1 mRNA	PMID:25729387
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of COL14A1 mRNA	PMID:24136188
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of COL14A1 mRNA	PMID:23557971|PMID:27760801
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552297	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of COL14A1 mRNA	PMID:35295148
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL14A1 mRNA	PMID:29950665
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of COL14A1 mRNA	PMID:25181051|PMID:34947998
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of COL14A1 mRNA	PMID:32145629|PMID:36779543
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314064	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of COL14A1 mRNA	PMID:27685785
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552297	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of COL14A1 mRNA	PMID:30951980|PMID:32156529|PMID:38701888
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of COL14A1 mRNA	PMID:39298647
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552297	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of COL14A1 mRNA	PMID:30951980|PMID:40203079
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of COL14A1 mRNA	PMID:23626723
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of COL14A1 mRNA	PMID:23626723
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552297	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of COL14A1 mRNA	PMID:26377693
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34569	Benzo[k]fluoranthene	affects expression	ISO	RGD:1552297	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene affects the expression of COL14A1 mRNA	PMID:26377693
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552297	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of COL14A1 mRNA	PMID:30951980|PMID:38685157
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1552297	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of COL14A1 intron	PMID:28392331
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1552297	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in increased expression of COL14A1 protein	PMID:32272095
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL14A1 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of COL14A1 protein]	PMID:29950665|PMID:32272095
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20231205	CTD	MESH:D010269	Paraquat results in decreased expression of COL14A1 mRNA	PMID:34681664
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of COL14A1 mRNA	PMID:36117858
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of COL14A1 mRNA	PMID:30589522
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of COL14A1 mRNA	PMID:35163327
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of COL14A1 mRNA	PMID:23626723
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20200609	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL14A1 mRNA	PMID:31738976
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of COL14A1 mRNA	PMID:35163327
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230307	CTD	MESH:C023036	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of COL14A1 mRNA	PMID:36270329
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of COL14A1 mRNA	PMID:27387713
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of COL14A1 mRNA	PMID:19244175
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:38397	perfluorononanoic acid	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230307	CTD	MESH:C101816	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of COL14A1 mRNA	PMID:36270329
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1314064	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of COL14A1 promoter	PMID:22847954
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COL14A1 mRNA	PMID:31533062
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1314064	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of COL14A1 promoter	PMID:22847954
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1552297	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of COL14A1 mRNA	PMID:39529242
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230307	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL14A1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL14A1 mRNA; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of COL14A1 mRNA	PMID:36270329|PMID:36331819
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314064	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COL14A1 mRNA	PMID:25979313
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552297	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of COL14A1 mRNA	PMID:17963808
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314064	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of COL14A1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA	PMID:27188386
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20231205	CTD	MESH:D016572	Cyclosporine results in decreased expression of COL14A1 mRNA	PMID:34681664
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of COL14A1 mRNA	PMID:25047013
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of COL14A1 mRNA	PMID:28973697
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL14A1 mRNA	PMID:37992649
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:44445	nimesulide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of COL14A1 mRNA	PMID:24136188
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of COL14A1 mRNA	PMID:38832940
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1314064	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of COL14A1 mRNA	PMID:24935251
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COL14A1 mRNA	PMID:33387578
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL14A1 mRNA	PMID:40504410
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of COL14A1 mRNA	PMID:29391264
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of COL14A1 mRNA	PMID:37567419
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314064	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of COL14A1 mRNA	PMID:20458559
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1314064	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of COL14A1 mRNA	PMID:19194470
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COL14A1 mRNA; Nanotubes, Carbon results in decreased expression of COL14A1 mRNA	PMID:25554681|PMID:25620056
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of COL14A1 mRNA	PMID:24136188
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of COL14A1 mRNA	PMID:36117858
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:52774	pentane-2,3-dione	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in increased expression of COL14A1 mRNA	PMID:25710175
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314064	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of COL14A1 protein	PMID:23718831
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1314064	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of COL14A1 mRNA	PMID:20436886
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL14A1 mRNA	PMID:21641980
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of COL14A1 mRNA	PMID:25729387
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of COL14A1 mRNA	PMID:25729387
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of COL14A1 mRNA	PMID:19812364
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of COL14A1 mRNA	PMID:36851058
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of COL14A1 gene	PMID:35440735
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of COL14A1 mRNA	PMID:24136188
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1314064	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of COL14A1 mRNA	PMID:29522793
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA	PMID:27188386
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COL14A1 gene]	PMID:28238834
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of COL14A1 mRNA	PMID:32109520
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1552297	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of COL14A1 mRNA	PMID:38648751
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of COL14A1 mRNA	PMID:26705709
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552297	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of COL14A1 mRNA	PMID:39847705
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of COL14A1 mRNA	PMID:24780913
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1314064	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of COL14A1 mRNA	PMID:26272509
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA	PMID:27188386
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:8887	rofecoxib	decreases expression	ISO	RGD:1314064	E	RGD:6480464	20170303	CTD	MESH:C116926	rofecoxib results in decreased expression of COL14A1 mRNA	PMID:17070997
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314064	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA	PMID:27188386
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1314064	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of COL14A1 mRNA	PMID:17440010
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of COL14A1 mRNA	PMID:28973697
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of COL14A1 mRNA	PMID:35537566
1305806	Col14a1	collagen type XIV alpha 1 chain	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of COL14A1 mRNA	PMID:23034163
1305807	Stra6l	STRA6-like	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314065	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of STRA6L mRNA	PMID:37995155
1305807	Stra6l	STRA6-like	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314065	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of STRA6L mRNA	PMID:36331819
1305807	Stra6l	STRA6-like	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314065	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of STRA6L mRNA	PMID:39241906
1305807	Stra6l	STRA6-like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314065	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of STRA6L mRNA	PMID:39298647
1305807	Stra6l	STRA6-like	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D014241	Trichloroethylene results in increased expression of STRA6L mRNA	PMID:33387578
1305807	Stra6l	STRA6-like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314065	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of STRA6L mRNA	PMID:36331819
1305807	Stra6l	STRA6-like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314065	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of STRA6L mRNA	PMID:37236586
1305807	Stra6l	STRA6-like	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314065	E	RGD:6480464	20220719	CTD	MESH:D019833	Genistein results in increased expression of STRA6L mRNA	PMID:32186404
1305807	Stra6l	STRA6-like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314065	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of STRA6L mRNA	PMID:37682722
1305807	Stra6l	STRA6-like	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of STRA6L mRNA	PMID:38458666
1305807	Stra6l	STRA6-like	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D012822	Silicon Dioxide results in increased expression of STRA6L mRNA	PMID:22431001
1305807	Stra6l	STRA6-like	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314065	E	RGD:6480464	20220719	CTD	MESH:D012822	Silicon Dioxide results in increased expression of STRA6L mRNA	PMID:29341224|PMID:38811393
1305807	Stra6l	STRA6-like	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D005897	Glafenine results in increased expression of STRA6L mRNA	PMID:24136188
1305807	Stra6l	STRA6-like	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:C030110	Oxaliplatin results in increased expression of STRA6L mRNA	PMID:25729387
1305807	Stra6l	STRA6-like	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in increased expression of STRA6L mRNA	PMID:25729387
1305807	Stra6l	STRA6-like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314065	E	RGD:6480464	20220719	CTD	MESH:C009495	titanium dioxide results in increased expression of STRA6L mRNA	PMID:27760801
1305807	Stra6l	STRA6-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220719	CTD	MESH:C006780	bisphenol A results in decreased expression of STRA6L mRNA	PMID:25181051
1305807	Stra6l	STRA6-like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314065	E	RGD:6480464	20220719	CTD	MESH:C006780	bisphenol A results in increased expression of STRA6L mRNA	PMID:30245210|PMID:34585602
1305807	Stra6l	STRA6-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314065	E	RGD:6480464	20220719	CTD	MESH:C543008	bisphenol S results in increased expression of STRA6L mRNA	PMID:33297965|PMID:39298647
1305807	Stra6l	STRA6-like	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314065	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of STRA6L intron	PMID:28392331
1305807	Stra6l	STRA6-like	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314065	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of STRA6L mRNA	PMID:37019170
1305807	Stra6l	STRA6-like	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D010269	Paraquat results in increased expression of STRA6L mRNA	PMID:32680482
1305807	Stra6l	STRA6-like	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of STRA6L mRNA	PMID:38458666
1305807	Stra6l	STRA6-like	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20220906	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of STRA6L promoter	PMID:22457795
1305807	Stra6l	STRA6-like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314065	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of STRA6L mRNA	PMID:37236586
1305807	Stra6l	STRA6-like	gene	CHEBI:35559	furan	increases methylation	EXP		E	RGD:6480464	20220906	CTD	MESH:C039281	furan results in increased methylation of STRA6L gene	PMID:22079235
1305807	Stra6l	STRA6-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314065	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of STRA6L mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of STRA6L mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of STRA6L mRNA	PMID:36331819
1305807	Stra6l	STRA6-like	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20220906	CTD	MESH:C016104	sodium bichromate affects the expression of STRA6L mRNA	PMID:22110744
1305807	Stra6l	STRA6-like	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D004726	Endosulfan results in increased expression of STRA6L mRNA	PMID:29391264
1305807	Stra6l	STRA6-like	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1314065	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of STRA6L mRNA	PMID:35436446
1305807	Stra6l	STRA6-like	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D005485	Flutamide results in increased expression of STRA6L mRNA	PMID:24136188
1305807	Stra6l	STRA6-like	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314065	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of STRA6L mRNA	PMID:38701926
1305807	Stra6l	STRA6-like	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D019772	Topotecan results in increased expression of STRA6L mRNA	PMID:25729387
1305807	Stra6l	STRA6-like	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in increased expression of STRA6L mRNA	PMID:25729387
1305807	Stra6l	STRA6-like	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1314065	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of STRA6L mRNA	PMID:36851058
1305807	Stra6l	STRA6-like	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1314065	E	RGD:6480464	20220719	CTD	MESH:C412815	GW 4064 results in increased expression of STRA6L mRNA	PMID:26655953
1305807	Stra6l	STRA6-like	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314065	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of STRA6L mRNA	PMID:39847705
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SLC44A3 mRNA	PMID:38218311
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1602189	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SLC44A3 mRNA	PMID:26272509|PMID:27188386
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1602189	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA	PMID:27188386
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC44A3 gene	PMID:20938992
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SLC44A3 mRNA	PMID:23724009
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1602189	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SLC44A3 mRNA	PMID:21934132
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1620626	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of SLC44A3 mRNA	PMID:36189433
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC44A3 mRNA	PMID:36189433
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC44A3 mRNA	PMID:30529165
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SLC44A3 mRNA	PMID:21632981
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1602189	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC44A3 mRNA	PMID:35811015
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1602189	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of SLC44A3 mRNA	PMID:30510588
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1620626	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SLC44A3 mRNA	PMID:39298647
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1602189	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of SLC44A3 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC44A3 mRNA	PMID:20660070|PMID:30165855
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC44A3 mRNA	PMID:33387578
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC44A3 gene	PMID:20938992
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1620626	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of SLC44A3 mRNA	PMID:17556502
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1602189	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of SLC44A3 mRNA	PMID:20660070
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20120412	CTD	MESH:D011374	NCOA2 protein affects the reaction [Progesterone results in decreased expression of SLC44A3 mRNA]	PMID:17556502
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC44A3 mRNA	PMID:37992649
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC44A3 mRNA	PMID:36189433
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC44A3 mRNA	PMID:37992649
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1602189	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SLC44A3 mRNA	PMID:31163220
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1620626	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SLC44A3 mRNA	PMID:19850644
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of SLC44A3 mRNA]	PMID:19850644
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1602189	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SLC44A3 protein	PMID:37730182
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SLC44A3 mRNA	PMID:33387578
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC44A3 mRNA	PMID:36331819
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC44A3 mRNA	PMID:37236586
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC44A3 mRNA	PMID:29950665
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SLC44A3 mRNA	PMID:19549813
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLC44A3 mRNA	PMID:27153756
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1620626	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC44A3 mRNA	PMID:31919559
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC44A3 gene	PMID:20938992
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1602189	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SLC44A3 mRNA	PMID:26272509
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1602189	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA	PMID:27188386
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of SLC44A3 gene	PMID:35440735
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of SLC44A3 gene	PMID:31011160
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC44A3 mRNA	PMID:31881176
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1620626	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of SLC44A3 mRNA	PMID:18930951
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC44A3 mRNA	PMID:33387578
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1602189	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC44A3 mRNA	PMID:20106945|PMID:21632981
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC44A3 mRNA	PMID:37992649
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of SLC44A3 mRNA	PMID:22623647
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC44A3 mRNA	PMID:39719251
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1602189	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC44A3 promoter	PMID:27901495
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC44A3 mRNA	PMID:21632981
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602189	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC44A3 5' UTR	PMID:27901495
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1602189	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of SLC44A3 mRNA	PMID:25075043
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SLC44A3 mRNA	PMID:25895662
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of SLC44A3 mRNA	PMID:32479839
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SLC44A3 mRNA	PMID:30047161
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC44A3 mRNA	PMID:29950665
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC44A3 mRNA	PMID:34492290
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1620626	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SLC44A3 mRNA	PMID:18301758|PMID:23811191
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC44A3 mRNA	PMID:32145629
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SLC44A3 mRNA	PMID:25181051
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1602189	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of SLC44A3 mRNA	PMID:31715268
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620626	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SLC44A3 mRNA	PMID:34585602
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC44A3 gene	PMID:28505145
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1620626	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SLC44A3 mRNA	PMID:39298647
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620626	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of SLC44A3 mRNA	PMID:40203079
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC44A3 mRNA	PMID:29950665
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:34698	diethyl phthalate	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of SLC44A3 mRNA	PMID:32341500
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1620626	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of SLC44A3 mRNA	PMID:34813904
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1620626	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of SLC44A3 mRNA	PMID:34813904
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SLC44A3 mRNA	PMID:32680482
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SLC44A3 mRNA	PMID:30723492
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC44A3 mRNA	PMID:37236586
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of SLC44A3 mRNA	PMID:25539665
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SLC44A3 mRNA	PMID:30047161
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1620626	E	RGD:6480464	20161025	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SLC44A3 mRNA	PMID:27413110|PMID:28903501
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620626	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC44A3 mRNA	PMID:40194260
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SLC44A3 mRNA	PMID:28302478
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC44A3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SLC44A3 mRNA	PMID:36331819
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1620626	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SLC44A3 mRNA	PMID:17292431
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of SLC44A3 mRNA	PMID:29154799
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602189	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC44A3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602189	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA	PMID:27188386
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SLC44A3 mRNA	PMID:30047161
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC44A3 mRNA	PMID:20106945|PMID:24907557|PMID:25562108|PMID:27989131
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1620626	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC44A3 mRNA	PMID:37992649
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC44A3 mRNA	PMID:33387578
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC44A3 mRNA	PMID:29067470
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1602189	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of SLC44A3 mRNA	PMID:35811015
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1602189	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC44A3 mRNA	PMID:35811015
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SLC44A3 mRNA	PMID:29391264
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1620626	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC44A3 mRNA	PMID:35436446
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1602189	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SLC44A3 mRNA	PMID:26272509
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1602189	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA	PMID:27188386
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1602189	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of SLC44A3 mRNA	PMID:25075043
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620626	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SLC44A3 mRNA; Nanotubes, Carbon results in decreased expression of SLC44A3 mRNA	PMID:25620056
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SLC44A3 mRNA	PMID:30047161
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:61076	belinostat	decreases expression	ISO	RGD:1602189	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of SLC44A3 mRNA	PMID:27188386
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602189	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA	PMID:27188386
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SLC44A3 mRNA	PMID:24780913|PMID:30047161
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of SLC44A3 mRNA	PMID:29162477
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602189	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA	PMID:27188386
1305808	Slc44a3	solute carrier family 44, member 3	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1620626	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of SLC44A3 mRNA	PMID:26217789
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of NKAIN4 mRNA	PMID:21551480|PMID:25152437
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20130806	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NKAIN4 gene	PMID:20938992
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1314067	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NKAIN4 mRNA	PMID:24236059
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NKAIN4 mRNA	PMID:30529165
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1314067	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NKAIN4 mRNA	PMID:26079696
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314068	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of NKAIN4 mRNA	PMID:30319688
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314068	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NKAIN4 mRNA	PMID:39241906
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20130806	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NKAIN4 gene	PMID:20938992
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of NKAIN4 mRNA	PMID:22967744
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of NKAIN4 mRNA	PMID:31606821
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1314067	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of NKAIN4 intron	PMID:30157460
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314067	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NKAIN4 intron	PMID:30157460
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NKAIN4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NKAIN4 mRNA	PMID:34911549
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20130806	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NKAIN4 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of NKAIN4 mRNA]	PMID:20938992|PMID:22206623
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314068	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of NKAIN4 mRNA	PMID:32186404
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NKAIN4 mRNA	PMID:33387578
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314067	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NKAIN4 mRNA	PMID:28001369
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1314067	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NKAIN4 mRNA	PMID:32763439
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314067	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of NKAIN4 mRNA	PMID:29301061
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314067	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NKAIN4 3' UTR	PMID:27901495
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314067	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NKAIN4 exon; Benzo(a)pyrene results in increased methylation of NKAIN4 promoter	PMID:27901495
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to NKAIN4 promoter]	PMID:19654925
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314068	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of NKAIN4 mRNA	PMID:27131904
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1314068	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of NKAIN4 mRNA	PMID:23557971
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of NKAIN4 mRNA	PMID:27760801
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314068	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NKAIN4 gene	PMID:35295148
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NKAIN4 mRNA	PMID:25181051
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of NKAIN4 mRNA	PMID:26063408|PMID:35598803
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314068	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of NKAIN4 mRNA	PMID:32156529
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NKAIN4 gene	PMID:28505145
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314068	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of NKAIN4 mRNA	PMID:30951980
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1314067	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NKAIN4 intron	PMID:30157460
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of NKAIN4 mRNA	PMID:30951980
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314068	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NKAIN4 intron	PMID:28392331
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NKAIN4 mRNA	PMID:21266533
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314067	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NKAIN4 mRNA	PMID:38382870
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314068	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NKAIN4 mRNA	PMID:24982889
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314067	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NKAIN4 mRNA	PMID:25979313
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314068	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NKAIN4 mRNA	PMID:17963808
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314067	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of NKAIN4 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314067	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA	PMID:27188386
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NKAIN4 mRNA	PMID:28973697
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1314067	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of NKAIN4 mRNA	PMID:24449571
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:45716	vorinostat	decreases expression	ISO	RGD:1314067	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of NKAIN4 mRNA	PMID:26272509
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1314067	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA	PMID:27188386
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1314067	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of NKAIN4 mRNA	PMID:24935251|PMID:26272509
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314067	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA	PMID:27188386
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NKAIN4 mRNA	PMID:33387578
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:46742	Nutlin-3	increases expression	ISO	RGD:1314067	E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of NKAIN4 mRNA	PMID:38460933
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of NKAIN4 mRNA; Nanotubes, Carbon results in decreased expression of NKAIN4 mRNA	PMID:25554681
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314068	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of NKAIN4 mRNA	PMID:23608068
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1314067	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of NKAIN4 intron	PMID:30157460
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of NKAIN4 gene	PMID:35440735
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NKAIN4 mRNA	PMID:22206623
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of NKAIN4 mRNA]	PMID:22206623
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314067	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA	PMID:27188386
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314068	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of NKAIN4 mRNA	PMID:38648751
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314067	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA	PMID:27188386
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314068	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of NKAIN4 mRNA	PMID:27131904
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1314068	E	RGD:6480464	20250401	CTD	MESH:D013311	Streptozocin results in increased expression of NKAIN4 mRNA	PMID:31606821
1305809	Nkain4	Sodium/potassium transporting ATPase interacting 4	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of NKAIN4 mRNA	PMID:31606821
1305810	Tspan4	tetraspanin 4	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20150630	CTD	MESH:D004237	Diuron results in decreased expression of TSPAN4 mRNA	PMID:21551480|PMID:25152437
1305810	Tspan4	tetraspanin 4	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of TSPAN4 mRNA	PMID:35967413
1305810	Tspan4	tetraspanin 4	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1314069	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TSPAN4 mRNA	PMID:27188386
1305810	Tspan4	tetraspanin 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552299	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TSPAN4 mRNA	PMID:37995155
1305810	Tspan4	tetraspanin 4	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein]	PMID:38195004
1305810	Tspan4	tetraspanin 4	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of TSPAN4 mRNA]	PMID:19467301
1305810	Tspan4	tetraspanin 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552299	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TSPAN4 mRNA	PMID:20188158|PMID:26251327
1305810	Tspan4	tetraspanin 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of TSPAN4 mRNA	PMID:23830798
1305810	Tspan4	tetraspanin 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314069	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TSPAN4 mRNA	PMID:21934132|PMID:23724009
1305810	Tspan4	tetraspanin 4	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TSPAN4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TSPAN4 mRNA	PMID:32699268
1305810	Tspan4	tetraspanin 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TSPAN4 mRNA	PMID:30529165
1305810	Tspan4	tetraspanin 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TSPAN4 mRNA	PMID:36331819
1305810	Tspan4	tetraspanin 4	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1314069	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TSPAN4 mRNA	PMID:21632981
1305810	Tspan4	tetraspanin 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TSPAN4 mRNA	PMID:39298647
1305810	Tspan4	tetraspanin 4	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TSPAN4 mRNA	PMID:27523638
1305810	Tspan4	tetraspanin 4	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1314069	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TSPAN4 3' UTR	PMID:30157460
1305810	Tspan4	tetraspanin 4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA	PMID:39836092
1305810	Tspan4	tetraspanin 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of TSPAN4 mRNA	PMID:28522335
1305810	Tspan4	tetraspanin 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein	PMID:38195004
1305810	Tspan4	tetraspanin 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TSPAN4 mRNA	PMID:37236586
1305810	Tspan4	tetraspanin 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TSPAN4 mRNA	PMID:33354967
1305810	Tspan4	tetraspanin 4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D010126	Ozone results in increased expression of TSPAN4 mRNA	PMID:17095637
1305810	Tspan4	tetraspanin 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TSPAN4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TSPAN4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TSPAN4 mRNA	PMID:32699268
1305810	Tspan4	tetraspanin 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TSPAN4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TSPAN4 mRNA	PMID:34911549
1305810	Tspan4	tetraspanin 4	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20150630	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TSPAN4 mRNA	PMID:16239168
1305810	Tspan4	tetraspanin 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552299	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TSPAN4 mRNA	PMID:31919559
1305810	Tspan4	tetraspanin 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSPAN4 mRNA	PMID:39836092|PMID:40512198
1305810	Tspan4	tetraspanin 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene] which results in increased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene	PMID:40504410
1305810	Tspan4	tetraspanin 4	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1314069	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TSPAN4 mRNA	PMID:26272509
1305810	Tspan4	tetraspanin 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSPAN4 mRNA	PMID:27188386
1305810	Tspan4	tetraspanin 4	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D014640	Vancomycin results in decreased expression of TSPAN4 mRNA	PMID:18930951
1305810	Tspan4	tetraspanin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TSPAN4 mRNA	PMID:21570461
1305810	Tspan4	tetraspanin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20150630	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TSPAN4 mRNA	PMID:21215274|PMID:32109520
1305810	Tspan4	tetraspanin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TSPAN4 mRNA	PMID:17942748
1305810	Tspan4	tetraspanin 4	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TSPAN4 mRNA	PMID:28374803
1305810	Tspan4	tetraspanin 4	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314069	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TSPAN4 mRNA	PMID:33212167
1305810	Tspan4	tetraspanin 4	gene	CHEBI:28680	cytarabine	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of TSPAN4 mRNA	PMID:21198554
1305810	Tspan4	tetraspanin 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TSPAN4 mRNA	PMID:29803840
1305810	Tspan4	tetraspanin 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TSPAN4 mRNA	PMID:38568856
1305810	Tspan4	tetraspanin 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314069	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TSPAN4 mRNA	PMID:39719251
1305810	Tspan4	tetraspanin 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSPAN4 mRNA	PMID:39836092|PMID:40512198
1305810	Tspan4	tetraspanin 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene] which results in increased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene	PMID:40504410
1305810	Tspan4	tetraspanin 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314069	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TSPAN4 5' UTR	PMID:27901495
1305810	Tspan4	tetraspanin 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TSPAN4 mRNA	PMID:22610609
1305810	Tspan4	tetraspanin 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314069	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TSPAN4 promoter	PMID:27901495
1305810	Tspan4	tetraspanin 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN4 mRNA	PMID:27858113
1305810	Tspan4	tetraspanin 4	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of TSPAN4 mRNA	PMID:38458666
1305810	Tspan4	tetraspanin 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TSPAN4 mRNA	PMID:20458559
1305810	Tspan4	tetraspanin 4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TSPAN4 gene	PMID:31601247
1305810	Tspan4	tetraspanin 4	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TSPAN4 mRNA	PMID:24136188
1305810	Tspan4	tetraspanin 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of TSPAN4 mRNA	PMID:25729387
1305810	Tspan4	tetraspanin 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TSPAN4 mRNA	PMID:30047161
1305810	Tspan4	tetraspanin 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552299	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TSPAN4 gene	PMID:35295148
1305810	Tspan4	tetraspanin 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552299	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of TSPAN4 mRNA	PMID:27760801
1305810	Tspan4	tetraspanin 4	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TSPAN4 mRNA	PMID:34492290
1305810	Tspan4	tetraspanin 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:C006253	pirinixic acid results in decreased expression of TSPAN4 mRNA	PMID:23811191
1305810	Tspan4	tetraspanin 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:C006253	pirinixic acid results in increased expression of TSPAN4 mRNA	PMID:18445702
1305810	Tspan4	tetraspanin 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TSPAN4 mRNA	PMID:19710929
1305810	Tspan4	tetraspanin 4	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20150630	CTD	MESH:C069837	fullerene C60 results in increased expression of TSPAN4 mRNA	PMID:19167457
1305810	Tspan4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TSPAN4 mRNA	PMID:34947998
1305810	Tspan4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of TSPAN4 mRNA	PMID:29161229
1305810	Tspan4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314069	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TSPAN4 gene	PMID:31601247
1305810	Tspan4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1552299	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of TSPAN4 promoter	PMID:27312807
1305810	Tspan4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150630	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN4 mRNA	PMID:25181051
1305810	Tspan4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552299	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN4 mRNA	PMID:32156529|PMID:33221593
1305810	Tspan4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TSPAN4 gene	PMID:31601247
1305810	Tspan4	tetraspanin 4	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of TSPAN4 mRNA	PMID:15980968
1305810	Tspan4	tetraspanin 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TSPAN4 mRNA	PMID:39298647
1305810	Tspan4	tetraspanin 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552299	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TSPAN4 mRNA	PMID:30951980
1305810	Tspan4	tetraspanin 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552299	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TSPAN4 mRNA	PMID:26377693
1305810	Tspan4	tetraspanin 4	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN4 mRNA	PMID:27858113
1305810	Tspan4	tetraspanin 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1314069	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TSPAN4 3' UTR	PMID:30157460
1305810	Tspan4	tetraspanin 4	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1552299	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of TSPAN4 mRNA	PMID:26377693
1305810	Tspan4	tetraspanin 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552299	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TSPAN4 mRNA	PMID:30951980
1305810	Tspan4	tetraspanin 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TSPAN4 mRNA	PMID:21266533
1305810	Tspan4	tetraspanin 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314069	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TSPAN4 mRNA	PMID:37042841
1305810	Tspan4	tetraspanin 4	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of TSPAN4 mRNA	PMID:38458666
1305810	Tspan4	tetraspanin 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TSPAN4 mRNA	PMID:35163327
1305810	Tspan4	tetraspanin 4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA	PMID:39836092
1305810	Tspan4	tetraspanin 4	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1552299	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of TSPAN4 mRNA	PMID:26377693
1305810	Tspan4	tetraspanin 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein	PMID:38195004
1305810	Tspan4	tetraspanin 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TSPAN4 mRNA	PMID:37236586
1305810	Tspan4	tetraspanin 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TSPAN4 mRNA	PMID:35163327
1305810	Tspan4	tetraspanin 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TSPAN4 mRNA	PMID:19376846
1305810	Tspan4	tetraspanin 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TSPAN4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TSPAN4 mRNA	PMID:32699268
1305810	Tspan4	tetraspanin 4	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D002994	Clofibrate results in decreased expression of TSPAN4 mRNA	PMID:17585979
1305810	Tspan4	tetraspanin 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TSPAN4 mRNA	PMID:36331819
1305810	Tspan4	tetraspanin 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314069	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TSPAN4 mRNA	PMID:25979313
1305810	Tspan4	tetraspanin 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314069	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TSPAN4 mRNA	PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369
1305810	Tspan4	tetraspanin 4	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314069	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TSPAN4 gene	PMID:29154799
1305810	Tspan4	tetraspanin 4	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TSPAN4 mRNA	PMID:30047161
1305810	Tspan4	tetraspanin 4	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of TSPAN4 mRNA	PMID:41580965
1305810	Tspan4	tetraspanin 4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TSPAN4 mRNA	PMID:25562108
1305810	Tspan4	tetraspanin 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D008727	Methotrexate affects the expression of TSPAN4 mRNA	PMID:18502557
1305810	Tspan4	tetraspanin 4	gene	CHEBI:44185	methotrexate	affects response to substance	ISO	RGD:1314069	E	RGD:6480464	20120412	CTD	MESH:D008727	TSPAN4 protein affects the susceptibility to Methotrexate	PMID:16217747
1305810	Tspan4	tetraspanin 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D000082	Acetaminophen affects the expression of TSPAN4 mRNA	PMID:17562736
1305810	Tspan4	tetraspanin 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TSPAN4 mRNA	PMID:33387578
1305810	Tspan4	tetraspanin 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TSPAN4 mRNA	PMID:21420995
1305810	Tspan4	tetraspanin 4	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20150630	CTD	MESH:C005219	methyl cellosolve results in increased expression of TSPAN4 mRNA	PMID:21061450
1305810	Tspan4	tetraspanin 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSPAN4 mRNA	PMID:39836092|PMID:40512198
1305810	Tspan4	tetraspanin 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene] which results in increased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene	PMID:40504410
1305810	Tspan4	tetraspanin 4	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1552299	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of TSPAN4 mRNA	PMID:26934552
1305810	Tspan4	tetraspanin 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TSPAN4 mRNA	PMID:35436446
1305810	Tspan4	tetraspanin 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TSPAN4 mRNA	PMID:17942748
1305810	Tspan4	tetraspanin 4	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TSPAN4 mRNA	PMID:20458559
1305810	Tspan4	tetraspanin 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TSPAN4 mRNA	PMID:25554681
1305810	Tspan4	tetraspanin 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552299	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TSPAN4 mRNA; Nanotubes, Carbon results in increased expression of TSPAN4 mRNA	PMID:25554681|PMID:25620056
1305810	Tspan4	tetraspanin 4	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20150630	CTD	MESH:C082360	fipronil results in decreased expression of TSPAN4 mRNA	PMID:23962444
1305810	Tspan4	tetraspanin 4	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TSPAN4 mRNA	PMID:30047161
1305810	Tspan4	tetraspanin 4	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1552299	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of TSPAN4 mRNA	PMID:26377693
1305810	Tspan4	tetraspanin 4	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN4 mRNA	PMID:27858113
1305810	Tspan4	tetraspanin 4	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN4 mRNA	PMID:27858113
1305810	Tspan4	tetraspanin 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552299	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TSPAN4 mRNA	PMID:38701926
1305810	Tspan4	tetraspanin 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA	PMID:39836092
1305810	Tspan4	tetraspanin 4	gene	CHEBI:63632	topotecan	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of TSPAN4 mRNA	PMID:25729387
1305810	Tspan4	tetraspanin 4	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of TSPAN4 mRNA	PMID:25729387
1305810	Tspan4	tetraspanin 4	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552299	E	RGD:6480464	20150630	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TSPAN4 mRNA	PMID:23650126
1305810	Tspan4	tetraspanin 4	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in decreased expression of TSPAN4 mRNA	PMID:36914120
1305810	Tspan4	tetraspanin 4	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1314069	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TSPAN4 3' UTR	PMID:30157460
1305810	Tspan4	tetraspanin 4	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1552299	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of TSPAN4 mRNA	PMID:27858113
1305810	Tspan4	tetraspanin 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSPAN4 mRNA	PMID:27188386
1305810	Tspan4	tetraspanin 4	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of TSPAN4 mRNA	PMID:20097248
1305810	Tspan4	tetraspanin 4	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of TSPAN4 mRNA	PMID:31324951
1305810	Tspan4	tetraspanin 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314069	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of TSPAN4 mRNA	PMID:19159669
1305810	Tspan4	tetraspanin 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552299	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TSPAN4 mRNA	PMID:39847705
1305810	Tspan4	tetraspanin 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TSPAN4 mRNA	PMID:30047161
1305810	Tspan4	tetraspanin 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314069	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSPAN4 mRNA	PMID:27188386
1305810	Tspan4	tetraspanin 4	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1314069	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TSPAN4 mRNA	PMID:38568856
1305810	Tspan4	tetraspanin 4	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TSPAN4 mRNA	PMID:23034163
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of OSR2 mRNA	PMID:38218311
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1345615	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of OSR2 mRNA	PMID:38218311
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:138858	Azaspiracid	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20190219	CTD	MESH:C406592	azaspiracid results in decreased expression of OSR2 mRNA	PMID:28939011
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:144400	dinophysistoxin 1	increases expression	ISO	RGD:1345615	E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of OSR2 mRNA	PMID:21853993
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314073	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OSR2 gene	PMID:20938992
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1345615	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of OSR2 mRNA	PMID:26079696
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1345615	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of OSR2 mRNA	PMID:20044591
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of OSR2 mRNA	PMID:21632981
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of OSR2 mRNA	PMID:35811015
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of OSR2 mRNA	PMID:31614463
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314073	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of OSR2 mRNA	PMID:19484750
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1345615	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of OSR2 mRNA	PMID:21795739
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20130723	CTD	MESH:D004958	Progesterone inhibits the reaction [Estradiol results in increased expression of OSR2 mRNA]	PMID:21795739
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314073	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OSR2 gene	PMID:20938992
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1314073	E	RGD:6480464	20241001	CTD	MESH:D005557	Formaldehyde results in decreased expression of OSR2 mRNA	PMID:33233951
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1345615	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of OSR2 mRNA	PMID:20864642
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone inhibits the reaction [Estradiol results in increased expression of OSR2 mRNA]	PMID:21795739
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of OSR2 mRNA	PMID:22017230
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of OSR2 mRNA	PMID:21592394
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of OSR2 mRNA	PMID:26496021
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of OSR2 mRNA	PMID:21592394
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1345615	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of OSR2 mRNA	PMID:33647349
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1345615	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of OSR2 mRNA	PMID:16002434|PMID:21592394
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of OSR2 mRNA	PMID:21592394
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of OSR2 mRNA	PMID:33387578
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1345615	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of OSR2 mRNA	PMID:28818685
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of OSR2 mRNA	PMID:28522335
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1314073	E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium results in decreased expression of OSR2 mRNA	PMID:34953275
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OSR2 mRNA	PMID:35301059
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of OSR2 mRNA	PMID:19549813
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1345615	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of OSR2 mRNA	PMID:23649840
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1345615	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of OSR2 protein	PMID:20106945
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1345615	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of OSR2 gene	PMID:27153756
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1345615	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of OSR2 mRNA	PMID:22100608
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1345615	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of OSR2 mRNA	PMID:23649840
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1314073	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of OSR2 mRNA	PMID:18579281
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of OSR2 mRNA	PMID:30779732
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314073	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of OSR2 mRNA	PMID:25629700
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314073	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OSR2 gene	PMID:20938992
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of OSR2 mRNA	PMID:38460933
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1345615	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of OSR2 mRNA	PMID:19561079|PMID:27392435
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20151013	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of OSR2 mRNA; [Cisplatin co-treated with Paclitaxel] results in decreased expression of OSR2 mRNA	PMID:20705681|PMID:27392435
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of OSR2 mRNA	PMID:25583101
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OSR2 mRNA	PMID:32109520|PMID:34747641
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1345615	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of OSR2 mRNA	PMID:33212167
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of OSR2 mRNA	PMID:28959563
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of OSR2 mRNA	PMID:30556269
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of OSR2 mRNA	PMID:20971185
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of OSR2 mRNA	PMID:34032870
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314073	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OSR2 mRNA	PMID:34876320
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1314073	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OSR2 mRNA	PMID:34876320
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1345615	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of OSR2 promoter	PMID:27901495
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314073	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of OSR2 mRNA	PMID:20713471
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1345615	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of OSR2 mRNA	PMID:20106945|PMID:21632981|PMID:32234424
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314073	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of OSR2 mRNA]	PMID:22228805
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of OSR2 mRNA	PMID:30556269
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of OSR2 mRNA	PMID:20971185
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of OSR2 mRNA	PMID:25895662
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1345615	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of OSR2 mRNA	PMID:20382639
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314073	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of OSR2 gene; titanium dioxide results in decreased methylation of OSR2 promoter	PMID:35295148
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of OSR2 mRNA	PMID:25181051
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of OSR2 promoter	PMID:27415467
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314073	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of OSR2 promoter	PMID:27334623
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of OSR2 mRNA	PMID:27685785
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of OSR2 mRNA	PMID:26496021
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1345615	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of OSR2 mRNA	PMID:19244175
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1345615	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of OSR2 mRNA	PMID:25979313
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of OSR2 mRNA	PMID:36804509
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of OSR2 mRNA	PMID:23196670
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1314073	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of OSR2 mRNA	PMID:20713471
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of OSR2 mRNA	PMID:28628672
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314073	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of OSR2 mRNA	PMID:30951980
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of OSR2 mRNA	PMID:21266533
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of OSR2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of OSR2 mRNA	PMID:28628672
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OSR2 mRNA	PMID:35301059
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of OSR2 mRNA	PMID:36326898
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in decreased expression of OSR2 mRNA	PMID:16751804
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1345615	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of OSR2 mRNA	PMID:28001369
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of OSR2 mRNA	PMID:25562108
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1345615	E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of OSR2 mRNA	PMID:25047013
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of OSR2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of OSR2 mRNA	PMID:28628672
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1345615	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of OSR2 mRNA	PMID:38832940
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20161213	CTD	MESH:D017239	[Cisplatin co-treated with Paclitaxel] results in decreased expression of OSR2 mRNA	PMID:20705681
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of OSR2 mRNA	PMID:33387578
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of OSR2 mRNA	PMID:35811015
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of OSR2 mRNA	PMID:38460933
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1314073	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OSR2 mRNA	PMID:34876320
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of OSR2 mRNA	PMID:17557909
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1345615	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of OSR2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of OSR2 mRNA	PMID:28628672
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1345615	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of OSR2 mRNA	PMID:31629900
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of OSR2 mRNA	PMID:28801915
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of OSR2 mRNA	PMID:15336504
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of OSR2 mRNA	PMID:28801915|PMID:37269647
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1345615	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of OSR2 mRNA	PMID:22714537
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in decreased methylation of OSR2 promoter	PMID:27415467
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:78492	diallyl trisulfide	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C042577	diallyl trisulfide results in increased expression of OSR2 mRNA	PMID:34014027
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of OSR2 mRNA	PMID:32109520
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314073	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of OSR2 mRNA	PMID:38648751
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1345615	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of OSR2 mRNA	PMID:26705709
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1314073	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OSR2 mRNA	PMID:34876320
1305812	Osr2	odd-skipped related transcription factor 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of OSR2 mRNA	PMID:23034163
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBXL7 mRNA	PMID:30071829
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of FBXL7 mRNA	PMID:20880076
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FBXL7 mRNA	PMID:36331819
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314074	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of FBXL7 mRNA	PMID:31614463
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of FBXL7 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of FBXL7 mRNA	PMID:20660070|PMID:30165855
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of FBXL7 mRNA	PMID:25549359
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FBXL7 mRNA	PMID:33387578
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of FBXL7 mRNA	PMID:20660070
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:37992649
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:37992649
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1314074	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FBXL7 protein	PMID:37730182
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1314074	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of FBXL7 intron	PMID:30157460
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXL7 mRNA	PMID:35301059
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314074	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FBXL7 intron	PMID:30157460
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FBXL7 mRNA	PMID:34911549
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FBXL7 mRNA	PMID:31150632
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1620364	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FBXL7 mRNA	PMID:17484886
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1314074	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FBXL7 gene	PMID:25304211
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL7 mRNA	PMID:39836092
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]	PMID:37992649
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1620364	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of FBXL7 mRNA	PMID:28960355
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FBXL7 mRNA	PMID:23557933
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXL7 mRNA	PMID:19933214
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXL7 mRNA	PMID:33387578
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314074	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FBXL7 mRNA	PMID:33212167
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of FBXL7 mRNA	PMID:26033743
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:26033743
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:37992649
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]	PMID:37992649
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314074	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXL7 mRNA	PMID:38568856
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL7 mRNA	PMID:39836092
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314074	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXL7 intron	PMID:30157460
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FBXL7 mRNA	PMID:21569818
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314074	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FBXL7 3' UTR	PMID:27901495
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314074	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBXL7 5' UTR; Benzo(a)pyrene results in increased methylation of FBXL7 promoter	PMID:27901495
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of FBXL7 mRNA	PMID:26033743
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:26033743
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of FBXL7 mRNA	PMID:27131904
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314074	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FBXL7 mRNA	PMID:20382639
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1314074	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of FBXL7 mRNA	PMID:15725085
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXL7 gene	PMID:31601247
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620364	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXL7 gene	PMID:35295148
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1314074	E	RGD:6480464	20170516	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of FBXL7 mRNA	PMID:27793765
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXL7 mRNA	PMID:34947998
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314074	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FBXL7 gene	PMID:31601247
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXL7 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL7 mRNA	PMID:28628672|PMID:31601247
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1314074	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of FBXL7 mRNA	PMID:19244175
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1314074	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of FBXL7 intron	PMID:30157460
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL7 mRNA	PMID:28628672
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of FBXL7 mRNA	PMID:30723492
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314074	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FBXL7 mRNA	PMID:38382870
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXL7 mRNA	PMID:35301059
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1314074	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FBXL7 mRNA	PMID:24449571
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FBXL7 mRNA	PMID:36331819
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of FBXL7 mRNA	PMID:29038090
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314074	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXL7 mRNA	PMID:23179753
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1620364	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXL7 mRNA	PMID:24896083
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314074	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FBXL7 gene	PMID:29154799
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314074	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of FBXL7 mRNA	PMID:27989131
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1314074	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of FBXL7 promoter	PMID:27989131
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL7 mRNA	PMID:28628672
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1620364	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FBXL7 mRNA	PMID:28973697
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:37992649
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314074	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of FBXL7 mRNA	PMID:38832940
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXL7 mRNA	PMID:33387578
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314074	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXL7 mRNA	PMID:29067470
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:46790	2-methoxyethanol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of FBXL7 mRNA	PMID:21061450
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1314074	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FBXL7 gene	PMID:25304211
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL7 mRNA	PMID:39836092
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FBXL7 mRNA	PMID:22079256
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	EXP		E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of FBXL7 gene	PMID:37958445
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL7 mRNA	PMID:28628672
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1314074	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of FBXL7 mRNA	PMID:15725085
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FBXL7 mRNA	PMID:25554681
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of FBXL7 mRNA	PMID:19042947
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:6067	isotretinoin	increases expression	ISO	RGD:1314074	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of FBXL7 mRNA	PMID:20436886
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1314074	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of FBXL7 intron	PMID:30157460
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FBXL7 gene	PMID:35440735
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1314074	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of FBXL7 mRNA	PMID:31758290
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1620364	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FBXL7 mRNA	PMID:22206623
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1314074	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FBXL7 mRNA	PMID:22079256
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FBXL7 mRNA	PMID:22079256
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314074	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FBXL7 gene]	PMID:28238834
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of FBXL7 mRNA	PMID:23640034
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1620364	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of FBXL7 mRNA	PMID:21795629
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of FBXL7 mRNA	PMID:27131904
1305813	Fbxl7	F-box and leucine-rich repeat protein 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FBXL7 mRNA	PMID:28973697
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of TFDP2 mRNA	PMID:26272509|PMID:27188386
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552301	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of TFDP2 mRNA	PMID:33045310
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:135741	testosterone undecanoate	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20170307	CTD	MESH:C010792	testosterone undecanoate results in decreased expression of TFDP2 mRNA	PMID:19074003
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA	PMID:20938992
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of TFDP2 mRNA	PMID:15498508|PMID:16129123|PMID:33167477
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of TFDP2 mRNA	PMID:32845096
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TFDP2 mRNA	PMID:22629407
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of TFDP2 mRNA]	PMID:22629407
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TFDP2 mRNA	PMID:21632981
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TFDP2 mRNA	PMID:39241906
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552301	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TFDP2 mRNA	PMID:39298647
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TFDP2 gene	PMID:27618143
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA	PMID:20938992
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314075	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TFDP2 mRNA	PMID:37042841
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1314075	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TFDP2 mRNA	PMID:23649840
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:17660	N(6)-dimethylallyladenine	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20120412	CTD	MESH:C001478	N(6)-(delta(2)-isopentenyl)adenine results in decreased expression of TFDP2 mRNA	PMID:16129123
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1314075	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TFDP2 protein	PMID:37730182
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of TFDP2 mRNA	PMID:16129123
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TFDP2 mRNA	PMID:33387578
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314075	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TFDP2 mRNA	PMID:28818685
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1314075	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TFDP2 intron	PMID:30157460
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TFDP2 mRNA	PMID:36331819
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TFDP2 mRNA	PMID:28111341|PMID:37236586
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1314075	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TFDP2 mRNA	PMID:23649840
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TFDP2 mRNA	PMID:33354967
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314075	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TFDP2 intron	PMID:30157460
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of TFDP2 mRNA	PMID:26760959
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20231031	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of TFDP2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of TFDP2 mRNA	PMID:32845096|PMID:35430440
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:2682	amphotericin B	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of TFDP2 mRNA; Amphotericin B results in decreased expression of TFDP2 mRNA	PMID:28534445
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1552301	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TFDP2 mRNA	PMID:17484886
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TFDP2 mRNA	PMID:31150632
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TFDP2 mRNA	PMID:25629700
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA	PMID:20938992
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1314075	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of TFDP2 mRNA	PMID:11134558
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TFDP2 mRNA	PMID:40504410
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of TFDP2 mRNA	PMID:26272509
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TFDP2 mRNA	PMID:28960355
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TFDP2 mRNA	PMID:31881176
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314075	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TFDP2 mRNA	PMID:28903495
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of TFDP2 mRNA	PMID:22023808
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of TFDP2 mRNA	PMID:27594783
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of TFDP2 mRNA	PMID:17898221
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TFDP2 mRNA	PMID:24768652|PMID:25583101
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552301	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TFDP2 mRNA	PMID:21570461|PMID:24058054
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314075	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TFDP2 mRNA	PMID:12377990
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TFDP2 mRNA	PMID:28001369
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of TFDP2 mRNA	PMID:26272509
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552301	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of TFDP2 mRNA	PMID:25896364|PMID:39631538
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1552301	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of TFDP2 mRNA	PMID:32042022
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TFDP2 mRNA	PMID:40504410
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314075	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TFDP2 intron	PMID:30157460
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TFDP2 mRNA	PMID:20106945|PMID:21632981
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TFDP2 mRNA	PMID:21715664
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TFDP2 mRNA	PMID:25729387
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:32130	silver(1+) nitrate	increases expression	ISO	RGD:1314075	E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in increased expression of TFDP2 mRNA	PMID:22831968
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TFDP2 mRNA	PMID:30047161
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of TFDP2 mRNA	PMID:15498508
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552301	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TFDP2 promoter	PMID:35295148
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TFDP2 mRNA	PMID:34492290
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TFDP2 mRNA	PMID:12419474
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TFDP2 mRNA	PMID:25181051
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1552301	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TFDP2 promoter	PMID:27334623
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TFDP2 mRNA	PMID:30816183
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TFDP2 mRNA	PMID:26063408
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of TFDP2 mRNA	PMID:32145629
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552301	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of TFDP2 mRNA	PMID:35598803
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of TFDP2 mRNA	PMID:25172293
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TFDP2 mRNA	PMID:39298647
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1314075	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of TFDP2 intron	PMID:30157460
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552301	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TFDP2 mRNA	PMID:32715474|PMID:37019170
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:34682	diazinon	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of TFDP2 mRNA	PMID:22546817
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TFDP2 mRNA	PMID:17361019|PMID:21266533
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:34696	dieldrin	affects expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of TFDP2 mRNA	PMID:22546817
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314075	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TFDP2 mRNA	PMID:37042841
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TFDP2 mRNA	PMID:31077537
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314075	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TFDP2 mRNA	PMID:12160620|PMID:26472689
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of TFDP2 mRNA	PMID:31077537
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TFDP2 mRNA	PMID:28111341|PMID:37236586
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TFDP2 mRNA	PMID:22941251
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1314075	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of TFDP2 mRNA	PMID:19320972
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:38729	naled	affects expression	ISO	RGD:1314075	E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of TFDP2 mRNA	PMID:40434365
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TFDP2 mRNA	PMID:39529242
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TFDP2 mRNA	PMID:36331819
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314075	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TFDP2 mRNA	PMID:25979313
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TFDP2 mRNA	PMID:23179753|PMID:28001369
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TFDP2 mRNA	PMID:30047161
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1314075	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of TFDP2 mRNA	PMID:15590111
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TFDP2 mRNA	PMID:21658437
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TFDP2 mRNA	PMID:36621641
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TFDP2 mRNA	PMID:38832940
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:C028009	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of TFDP2 mRNA	PMID:31077537
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TFDP2 mRNA	PMID:26272509
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TFDP2 mRNA	PMID:29279043
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of TFDP2 mRNA	PMID:29279043
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1314075	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of TFDP2 mRNA	PMID:11134558
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TFDP2 mRNA	PMID:40504410
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of TFDP2 mRNA	PMID:36621641
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TFDP2 mRNA	PMID:29391264
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TFDP2 mRNA	PMID:22079256
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TFDP2 mRNA	PMID:18936297
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:49553	copper(II) chloride	affects expression	ISO	RGD:1314075	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride affects the expression of TFDP2 mRNA	PMID:17211630
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1552301	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of TFDP2 mRNA; Nanotubes, Carbon analog affects the expression of TFDP2 mRNA	PMID:25554681
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552301	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TFDP2 mRNA	PMID:25620056
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TFDP2 mRNA	PMID:30047161
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1552301	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of TFDP2 mRNA	PMID:23608068
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of TFDP2 mRNA	PMID:20436886
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TFDP2 mRNA	PMID:21641980
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of TFDP2 mRNA	PMID:25729387
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TFDP2 mRNA	PMID:25729387
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1552301	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of TFDP2 mRNA	PMID:19812364
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1552301	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of TFDP2 mRNA	PMID:20003209
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1314075	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of TFDP2 intron	PMID:30157460
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TFDP2 mRNA	PMID:22079256
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TFDP2 mRNA	PMID:22079256
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1314075	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TFDP2 protein	PMID:31285264
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of TFDP2 mRNA	PMID:32858204
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:7719	ochratoxin A	decreases acetylation	ISO	RGD:1314075	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of TFDP2 promoter	PMID:29098329
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1314075	E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of TFDP2 mRNA	PMID:29098329
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of TFDP2 promoter] which results in decreased expression of TFDP2 mRNA	PMID:29098329
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TFDP2 gene]	PMID:28238834
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of TFDP2 mRNA	PMID:19482888
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of TFDP2 mRNA]	PMID:19482888
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552301	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TFDP2 mRNA	PMID:39847705
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TFDP2 mRNA	PMID:30047161
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314075	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TFDP2 mRNA	PMID:19281266
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C001899	triptolide results in increased expression of TFDP2 mRNA	PMID:23639586
1305814	Tfdp2	transcription factor Dp-2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TFDP2 mRNA	PMID:35537566
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552380	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PODXL2 mRNA	PMID:20188158
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552380	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PODXL2 mRNA	PMID:20938992
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1347781	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PODXL2 mRNA	PMID:26079696
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552380	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PODXL2 mRNA	PMID:39241906
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:164200	triclosan	increases expression	ISO	RGD:1347781	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of PODXL2 mRNA	PMID:30510588
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PODXL2 mRNA	PMID:33387578
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552380	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PODXL2 mRNA	PMID:20938992
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1347781	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PODXL2 protein	PMID:37730182
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PODXL2 mRNA	PMID:33387578
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1347781	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PODXL2 mRNA	PMID:19549813
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1347781	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PODXL2 gene	PMID:27153756
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552380	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PODXL2 mRNA	PMID:34911549
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552380	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PODXL2 mRNA	PMID:20938992
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552380	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PODXL2 mRNA	PMID:40504410
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1347781	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PODXL2 mRNA	PMID:26272509
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1347781	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PODXL2 mRNA	PMID:27188386
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1347781	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PODXL2 mRNA	PMID:28903495
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1347781	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PODXL2 mRNA	PMID:27392435
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PODXL2 mRNA	PMID:32109520
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1347781	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PODXL2 mRNA	PMID:33212167
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PODXL2 mRNA	PMID:28959563
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1347781	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of PODXL2 mRNA	PMID:21198554
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PODXL2 mRNA	PMID:30556269
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1347781	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PODXL2 mRNA	PMID:38568856
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552380	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PODXL2 mRNA	PMID:40504410
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1347781	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PODXL2 mRNA	PMID:22378314
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1347781	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PODXL2 mRNA	PMID:22316170
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1347781	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PODXL2 promoter	PMID:27901495
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1552380	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PODXL2 exon; Benzo(a)pyrene results in increased methylation of PODXL2 intron	PMID:27901495
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PODXL2 mRNA	PMID:30556269
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PODXL2 mRNA	PMID:30047161
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552380	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PODXL2 promoter	PMID:35295148
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PODXL2 mRNA	PMID:34492290
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1347781	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PODXL2 mRNA	PMID:30903817
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PODXL2 mRNA	PMID:25181051|PMID:32145629
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PODXL2 mRNA	PMID:30816183|PMID:34947998|PMID:38750585
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PODXL2 gene	PMID:28505145
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552380	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PODXL2 gene	PMID:31683443
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1552380	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of PODXL2 intron	PMID:28392331
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552380	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PODXL2 mRNA	PMID:37019170
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PODXL2 mRNA	PMID:32680482
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1347781	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PODXL2 mRNA	PMID:38568856
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of PODXL2 mRNA	PMID:27387713
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552380	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PODXL2 mRNA	PMID:40194260
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1347781	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PODXL2 mRNA	PMID:31533062
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PODXL2 mRNA	PMID:30047161
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PODXL2 mRNA	PMID:33387578
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552380	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PODXL2 mRNA	PMID:40504410
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PODXL2 mRNA	PMID:30047161
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1552380	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PODXL2 mRNA	PMID:36907384
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1347781	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PODXL2 mRNA	PMID:31758290
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1347781	E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PODXL2 mRNA	PMID:22714537
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1347781	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PODXL2 mRNA	PMID:27188386
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PODXL2 mRNA	PMID:27291303
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1347781	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PODXL2 mRNA	PMID:26079696
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1552380	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of PODXL2 mRNA	PMID:21795629
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:8489	propiconazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of PODXL2 mRNA	PMID:30047161
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PODXL2 mRNA	PMID:30047161
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1552380	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of PODXL2 mRNA	PMID:35278568
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1347781	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PODXL2 mRNA	PMID:27188386
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1347781	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PODXL2 mRNA	PMID:38568856
1305815	Podxl2	podocalyxin-like 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1347781	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PODXL2 mRNA	PMID:29301935
1305816	Kera	keratocan	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of KERA gene	PMID:27618143
1305816	Kera	keratocan	gene	CHEBI:18291	manganese atom	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in increased expression of KERA mRNA	PMID:26745496
1305816	Kera	keratocan	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314078	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KERA gene	PMID:27153756
1305816	Kera	keratocan	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1314079	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of KERA mRNA	PMID:16917069
1305816	Kera	keratocan	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314079	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KERA mRNA	PMID:21570461
1305816	Kera	keratocan	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of KERA mRNA	PMID:28959563
1305816	Kera	keratocan	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314078	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KERA promoter	PMID:27901495
1305816	Kera	keratocan	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314078	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KERA 3' UTR	PMID:27901495
1305816	Kera	keratocan	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KERA mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305816	Kera	keratocan	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of KERA mRNA	PMID:36779543
1305816	Kera	keratocan	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314079	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KERA mRNA	PMID:21266533
1305816	Kera	keratocan	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KERA mRNA	PMID:35163327
1305816	Kera	keratocan	gene	CHEBI:35154	manganese(0)	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in increased expression of KERA mRNA	PMID:26745496
1305816	Kera	keratocan	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KERA mRNA	PMID:35163327
1305816	Kera	keratocan	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1314078	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of KERA mRNA	PMID:24449571
1305816	Kera	keratocan	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314078	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KERA mRNA	PMID:25979313
1305816	Kera	keratocan	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1314078	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of KERA mRNA	PMID:27188386
1305816	Kera	keratocan	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C025340	manganese chloride results in increased expression of KERA mRNA	PMID:26745496
1305816	Kera	keratocan	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of KERA mRNA	PMID:27840820
1305816	Kera	keratocan	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1314078	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of KERA mRNA	PMID:37199045
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1314080	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of EIPR1 mRNA	PMID:38218311
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EIPR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EIPR1 mRNA	PMID:32699268
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550318	E	RGD:6480464	20190702	CTD	MESH:D000431	Ethanol affects the splicing of EIPR1 mRNA	PMID:30319688
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550318	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EIPR1 mRNA	PMID:39241906
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1314080	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of EIPR1 protein	PMID:37730182
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EIPR1 mRNA	PMID:33387578
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1314080	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of EIPR1 intron	PMID:30157460
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1314080	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of EIPR1 protein	PMID:20106945
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1314080	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of EIPR1 intron	PMID:30157460
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314080	E	RGD:6480464	20190702	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EIPR1 intron	PMID:30157460
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EIPR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EIPR1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of EIPR1 mRNA	PMID:32699268
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EIPR1 mRNA	PMID:33387578
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EIPR1 mRNA	PMID:31150632
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1314080	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EIPR1 gene	PMID:25304211
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EIPR1 mRNA	PMID:39836092
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550318	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIPR1 mRNA	PMID:40504410
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1314080	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of EIPR1 protein	PMID:35688186
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314080	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of EIPR1 mRNA	PMID:19561079
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIPR1 mRNA	PMID:21570461
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EIPR1 mRNA	PMID:39836092
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550318	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIPR1 mRNA	PMID:40504410
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314080	E	RGD:6480464	20190702	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EIPR1 intron	PMID:30157460
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314080	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EIPR1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EIPR1 mRNA	PMID:21715664
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EIPR1 mRNA	PMID:22228805
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to EIPR1 mRNA]	PMID:32406909
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314080	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EIPR1 mRNA	PMID:26238291
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:30778	gallic acid	decreases expression	ISO	RGD:1314080	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of EIPR1 mRNA	PMID:34408198
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of EIPR1 mRNA	PMID:24136188
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550318	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TSSC1 gene	PMID:35295148
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of EIPR1 mRNA	PMID:38479592
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EIPR1 mRNA	PMID:25181051|PMID:30816183
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314080	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of EIPR1 protein	PMID:31675489
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314080	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EIPR1 gene	PMID:31601247
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EIPR1 mRNA; bisphenol A results in increased expression of TSSC1 mRNA	PMID:32145629|PMID:34947998
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:C006780	bisphenol A results in increased methylation of EIPR1 gene	PMID:28505145
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1314080	E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EIPR1 protein	PMID:31675489
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550318	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EIPR1 mRNA	PMID:39298647
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1314080	E	RGD:6480464	20190702	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of EIPR1 intron	PMID:30157460
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314080	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EIPR1 mRNA	PMID:38568856
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EIPR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EIPR1 mRNA	PMID:32699268
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D014635	Valproic Acid affects the expression of EIPR1 mRNA	PMID:17292431
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of EIPR1 mRNA	PMID:21346803
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EIPR1 mRNA	PMID:33387578
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of EIPR1 mRNA]	PMID:15016801
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1314080	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EIPR1 gene	PMID:25304211
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EIPR1 mRNA	PMID:39836092
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550318	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIPR1 mRNA	PMID:40504410
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EIPR1 mRNA	PMID:22079256
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EIPR1 mRNA	PMID:25620056
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EIPR1 mRNA; Nanotubes, Carbon results in increased expression of EIPR1 mRNA	PMID:25554681
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550318	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EIPR1 mRNA	PMID:35964746
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1314080	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EIPR1 protein	PMID:32959892
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of EIPR1 mRNA	PMID:23650126
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1314080	E	RGD:6480464	20190702	CTD	MESH:D008701	Methapyrilene results in increased methylation of EIPR1 intron	PMID:30157460
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550318	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TSSC1 mRNA	PMID:22206623
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1314080	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of EIPR1 mRNA	PMID:22079256
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1314080	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EIPR1 mRNA	PMID:22079256
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EIPR1 mRNA	PMID:21346803
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1314080	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EIPR1 mRNA	PMID:38568856
1305817	Eipr1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:9747	Triptolide	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of EIPR1 protein	PMID:32519852
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550006	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC43A2 mRNA	PMID:33045310
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:134926	drometrizole	affects expression	ISO	RGD:1350504	E	RGD:6480464	20250805	CTD	MESH:C033674	benazol P affects the expression of SLC43A2 mRNA	PMID:36586167
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC43A2 mRNA	PMID:20938992
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1350504	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SLC43A2 mRNA	PMID:33167477
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SLC43A2 mRNA	PMID:26516004
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SLC43A2 mRNA	PMID:33729688
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1350504	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SLC43A2 mRNA	PMID:26079696
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SLC43A2 mRNA	PMID:22378314
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1350504	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of SLC43A2 mRNA	PMID:28986285
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550006	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC43A2 mRNA	PMID:39241906
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1350504	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLC43A2 mRNA	PMID:35811015
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC43A2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SLC43A2 mRNA	PMID:35811015
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of SLC43A2 mRNA; Estradiol results in decreased expression of SLC43A2 protein	PMID:21185374|PMID:33181973
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC43A2 mRNA	PMID:33387578
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC43A2 mRNA	PMID:20938992
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1350504	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC43A2 mRNA	PMID:37042841
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1350504	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SLC43A2 mRNA	PMID:26079696
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC43A2 mRNA	PMID:37992649
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SLC43A2 gene	PMID:33872906
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC43A2 mRNA	PMID:37992649
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1350504	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SLC43A2 mRNA	PMID:31163220
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SLC43A2 gene	PMID:33872906
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SLC43A2 mRNA	PMID:22061828
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1350504	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SLC43A2 mRNA	PMID:28818685
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1350504	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SLC43A2 intron	PMID:30157460
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1550006	E	RGD:6480464	20141223	CTD	MESH:D014284	Triiodothyronine results in increased expression of SLC43A2 mRNA	PMID:25172293
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC43A2 mRNA	PMID:39836092
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of SLC43A2 mRNA	PMID:28522335
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC43A2 mRNA	PMID:37325564
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20120501	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SLC43A2 mRNA	PMID:20599845
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1350504	E	RGD:6480464	20120501	CTD	MESH:D019327	Copper Sulfate results in increased expression of SLC43A2 mRNA	PMID:20599845
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1350504	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC43A2 intron	PMID:30157460
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1350504	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC43A2 mRNA	PMID:21641981
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SLC43A2 mRNA	PMID:35430440
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC43A2 mRNA	PMID:31150632
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550006	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SLC43A2 mRNA	PMID:25629700
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC43A2 mRNA	PMID:20938992
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC43A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC43A2 mRNA	PMID:39836092
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SLC43A2 mRNA	PMID:40504410
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1350504	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SLC43A2 protein	PMID:35688186
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550006	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SLC43A2 mRNA	PMID:28960355
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC43A2 mRNA	PMID:31881176
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1350504	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SLC43A2 mRNA	PMID:27594783
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SLC43A2 mRNA	PMID:27392435
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1550006	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of SLC43A2 mRNA	PMID:18930951
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550006	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC43A2 mRNA	PMID:24680724
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC43A2 mRNA	PMID:34747641
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC43A2 mRNA	PMID:29704546
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550006	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC43A2 mRNA	PMID:19933214
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC43A2 mRNA	PMID:21215274|PMID:33387578
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1350504	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC43A2 mRNA	PMID:26238291
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of SLC43A2 mRNA	PMID:29704546
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1350504	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC43A2 mRNA	PMID:33212167
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1350504	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SLC43A2 mRNA	PMID:32763439
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550006	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of SLC43A2 mRNA	PMID:27862939
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC43A2 mRNA	PMID:29803840
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550006	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SLC43A2 mRNA	PMID:39631538
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC43A2 mRNA	PMID:37992649
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550006	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC43A2 mRNA	PMID:37682722
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1550006	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of SLC43A2 gene	PMID:39894169
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC43A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC43A2 mRNA	PMID:39836092
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SLC43A2 mRNA	PMID:40504410
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1350504	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC43A2 3' UTR	PMID:27901495
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550006	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC43A2 mRNA	PMID:19770486|PMID:22228805
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1350504	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC43A2 mRNA	PMID:26238291
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1350504	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC43A2 5' UTR	PMID:27901495
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550006	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SLC43A2 mRNA	PMID:23557971
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550006	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SLC43A2 promoter	PMID:35295148
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:32497	thioacetamide	affects expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of SLC43A2 mRNA	PMID:34492290
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550006	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SLC43A2 mRNA	PMID:28472532
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SLC43A2 mRNA	PMID:25181051
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC43A2 mRNA	PMID:33296240
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1350504	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SLC43A2 gene	PMID:31601247
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SLC43A2 mRNA	PMID:34947998
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1350504	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SLC43A2 mRNA	PMID:29275510
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SLC43A2 mRNA	PMID:28628672
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550006	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SLC43A2 mRNA	PMID:39298647
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1550006	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SLC43A2 exon	PMID:33297965
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1350504	E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of SLC43A2 mRNA	PMID:27685785
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC43A2 mRNA	PMID:28628672
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SLC43A2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC43A2 mRNA	PMID:28628672
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1350504	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC43A2 mRNA	PMID:37042841
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1350504	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SLC43A2 mRNA	PMID:29024780
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC43A2 mRNA	PMID:39836092
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SLC43A2 mRNA	PMID:25380136
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1350504	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC43A2 mRNA	PMID:26472689|PMID:38382870
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC43A2 mRNA	PMID:37325564
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SLC43A2 mRNA	PMID:24449571
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550006	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC43A2 mRNA	PMID:40194260
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SLC43A2 mRNA	PMID:31533062
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SLC43A2 mRNA	PMID:40419075
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1350504	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC43A2 gene	PMID:29154799
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SLC43A2 mRNA	PMID:38685447
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC43A2 mRNA	PMID:25562108
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550006	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC43A2 mRNA	PMID:19770486
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SLC43A2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC43A2 mRNA	PMID:28628672
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC43A2 mRNA	PMID:37992649
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1350504	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SLC43A2 mRNA	PMID:38832940
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC43A2 mRNA	PMID:33387578
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC43A2 mRNA	PMID:29067470
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1350504	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC43A2 mRNA	PMID:22230336
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	ISO	RGD:1350504	E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of SLC43A2 mRNA	PMID:35811015
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC43A2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SLC43A2 mRNA	PMID:35811015
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC43A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC43A2 mRNA	PMID:39836092
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550006	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SLC43A2 mRNA	PMID:40504410
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SLC43A2 mRNA	PMID:29391264
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1550006	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC43A2 mRNA	PMID:35436446
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of SLC43A2 mRNA	PMID:38568856
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SLC43A2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC43A2 mRNA	PMID:28628672
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1350504	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC43A2 mRNA	PMID:39836092
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1350504	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SLC43A2 mRNA	PMID:28988120
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550006	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SLC43A2 mRNA	PMID:22206623
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1350504	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of SLC43A2 mRNA	PMID:32858204
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	ISO	RGD:1350504	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of SLC43A2 mRNA	PMID:32234424
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SLC43A2 mRNA	PMID:24780913
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SLC43A2 mRNA	PMID:19281266
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1350504	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SLC43A2 mRNA	PMID:29301935
1305819	Slc43a2	solute carrier family 43 member 2	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of SLC43A2 mRNA	PMID:23034163
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552022	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DISP3 mRNA	PMID:33045310
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552022	E	RGD:6480464	20170516	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DISP3 gene	PMID:20938992
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552022	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DISP3 mRNA	PMID:30319688
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552022	E	RGD:6480464	20170516	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DISP3 gene	PMID:20938992
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552022	E	RGD:6480464	20170516	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of DISP3 mRNA	PMID:22401849
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1603018	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of DISP3 mRNA	PMID:33647349
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1603018	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DISP3 mRNA	PMID:28818685
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1603018	E	RGD:6480464	20170516	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DISP3 gene	PMID:27153756
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552022	E	RGD:6480464	20170516	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DISP3 gene	PMID:20938992
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1603018	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DISP3 mRNA	PMID:33212167
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:28680	cytarabine	increases expression	ISO	RGD:1603018	E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of DISP3 mRNA	PMID:21198554
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603018	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DISP3 mRNA	PMID:38568856
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1603018	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DISP3 5' UTR; Benzo(a)pyrene affects the methylation of DISP3 polyA tail	PMID:27901495|PMID:30157460
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1603018	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of DISP3 mRNA	PMID:35984750
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1603018	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DISP3 gene	PMID:31601247
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1552022	E	RGD:6480464	20170516	CTD	MESH:C008261	lead acetate results in increased expression of DISP3 mRNA	PMID:20542052
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552022	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DISP3 gene	PMID:35295148
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552022	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DISP3 promoter	PMID:35295148
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of DISP3 mRNA	PMID:30816183
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1552022	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of DISP3 promoter	PMID:27312807
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1603018	E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of DISP3 mRNA	PMID:31715268
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1603018	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DISP3 gene	PMID:31601247
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552022	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of DISP3 exon	PMID:33297965
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1603018	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of DISP3 intron	PMID:30157460
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552022	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DISP3 3' UTR	PMID:28392331
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603018	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DISP3 mRNA	PMID:25979313
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603018	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DISP3 gene	PMID:29154799
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1603018	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DISP3 mRNA	PMID:38832940
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1603018	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of DISP3 mRNA	PMID:40706910
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1603018	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of DISP3 intron	PMID:30157460
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DISP3 gene	PMID:35440735
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552022	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DISP3 mRNA	PMID:22206623
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603018	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DISP3 gene]	PMID:28238834
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of DISP3 mRNA	PMID:32109520
1305820	Disp3	dispatched RND transporter family member 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552022	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DISP3 mRNA	PMID:35537566
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552575	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PLPP7 mRNA	PMID:33045310
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1314085	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein]	PMID:38195004
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1314085	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PLPP7 mRNA	PMID:26079696
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of PLPP7 mRNA	PMID:36841081
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552575	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PLPP7 mRNA	PMID:39241906
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:1314085	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of PLPP7 mRNA	PMID:30510588
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1552575	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PLPP7 mRNA	PMID:33711761
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PLPP7 mRNA	PMID:33387578
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1314085	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PLPP7 mRNA	PMID:21179406
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1314085	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of PLPP7 mRNA	PMID:26079696
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLPP7 mRNA	PMID:37992649
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLPP7 mRNA	PMID:37992649
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314085	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PLPP7 mRNA	PMID:31163220
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314085	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PLPP7 protein	PMID:37730182
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PLPP7 mRNA	PMID:33387578
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1314085	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PLPP7 intron	PMID:30157460
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLPP7 mRNA	PMID:36331819
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1314085	E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of PLPP7 mRNA	PMID:29993192
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314085	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein	PMID:38195004
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1314085	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PLPP7 protein	PMID:35688186
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PLPP7 mRNA	PMID:31881176
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552575	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLPP7 mRNA	PMID:21570461
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314085	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PLPP7 mRNA	PMID:33212167
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552575	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PLPP7 mRNA	PMID:39631538
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLPP7 mRNA	PMID:37992649
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314085	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLPP7 promoter	PMID:27901495
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314085	E	RGD:6480464	20160822	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PLPP7 mRNA	PMID:25895662
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552575	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PLPP7 mRNA	PMID:29264374
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLPP7 mRNA	PMID:25181051
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552575	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PLPP7 gene	PMID:31683443
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552575	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLPP7 mRNA	PMID:37019170
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PLPP7 mRNA	PMID:21266533
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of PLPP7 mRNA	PMID:35163327
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLPP7 mRNA	PMID:35163327
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314085	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein	PMID:38195004
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLPP7 mRNA	PMID:35163327
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1314085	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PLPP7 mRNA	PMID:31533062
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLPP7 mRNA	PMID:36331819
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314085	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLPP7 mRNA	PMID:25979313
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314085	E	RGD:6480464	20160822	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLPP7 mRNA	PMID:26272509|PMID:28001369
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314085	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PLPP7 gene	PMID:29154799
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314085	E	RGD:6480464	20161115	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP7 mRNA	PMID:27188386
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLPP7 mRNA	PMID:37992649
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552575	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PLPP7 mRNA	PMID:17562736
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLPP7 mRNA	PMID:33387578
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1314085	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of PLPP7 mRNA	PMID:40706910
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PLPP7 mRNA	PMID:29391264
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552575	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PLPP7 mRNA	PMID:35436446
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314085	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PLPP7 mRNA	PMID:24810058
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1552575	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PLPP7 mRNA	PMID:36907384
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314085	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP7 mRNA	PMID:27188386
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314085	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP7 mRNA	PMID:27188386
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PLPP7 mRNA	PMID:19281266
1305821	Plpp7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PLPP7 mRNA	PMID:23034163
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DPY19L1 mRNA	PMID:36331819
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DPY19L1 mRNA	PMID:26079696
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of DPY19L1 mRNA	PMID:30319688
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1621284	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DPY19L1 mRNA	PMID:39241906
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1621284	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DPY19L1 mRNA	PMID:39298647
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1603693	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DPY19L1 mRNA	PMID:37042841
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of DPY19L1 mRNA	PMID:23649840
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of DPY19L1 mRNA	PMID:20196124
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DPY19L1 mRNA	PMID:37992649
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1621284	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of DPY19L1 mRNA	PMID:22401849
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DPY19L1 mRNA	PMID:37992649
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of DPY19L1 mRNA	PMID:27523638
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1603693	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of DPY19L1 mRNA	PMID:16002434
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DPY19L1 mRNA	PMID:33387578
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DPY19L1 mRNA	PMID:36331819
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1603693	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPY19L1 mRNA	PMID:35301059
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DPY19L1 mRNA	PMID:37236586
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1603693	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DPY19L1 gene	PMID:27153756
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DPY19L1 mRNA	PMID:31150632
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1621284	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DPY19L1 mRNA	PMID:25629700
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DPY19L1 mRNA	PMID:40504410
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of DPY19L1 mRNA	PMID:27392435
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1603693	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of DPY19L1 mRNA	PMID:27594783
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1621284	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of DPY19L1 mRNA	PMID:40618947
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1603693	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DPY19L1 mRNA	PMID:25583101
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1603693	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DPY19L1 mRNA	PMID:22574217
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DPY19L1 mRNA	PMID:33387578
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1621284	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DPY19L1 mRNA	PMID:19770486
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DPY19L1 mRNA	PMID:33212167
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DPY19L1 mRNA	PMID:37992649
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1621284	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of DPY19L1 gene	PMID:32068019
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DPY19L1 mRNA	PMID:40504410
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1621284	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DPY19L1 intron	PMID:27901495
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1621284	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DPY19L1 mRNA	PMID:39716349
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1603693	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DPY19L1 gene	PMID:31601247
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DPY19L1 mRNA	PMID:25729387
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621284	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DPY19L1 promoter	PMID:35295148
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DPY19L1 mRNA	PMID:30816183|PMID:32145629|PMID:34947998|PMID:38750585
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1621284	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of DPY19L1 mRNA	PMID:40036665
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1603693	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DPY19L1 gene	PMID:31601247
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621284	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DPY19L1 mRNA	PMID:39298647|PMID:40203079
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1603693	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of DPY19L1 protein	PMID:34186270
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1603693	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of DPY19L1 protein	PMID:34186270
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1621284	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DPY19L1 3' UTR	PMID:28392331
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603693	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DPY19L1 mRNA	PMID:37042841
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1603693	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPY19L1 mRNA	PMID:35301059
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DPY19L1 mRNA	PMID:37236586
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DPY19L1 mRNA	PMID:19162173
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1603693	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DPY19L1 mRNA	PMID:31533062
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1603693	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of DPY19L1 mRNA	PMID:19167446
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DPY19L1 mRNA	PMID:19162173
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DPY19L1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DPY19L1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of DPY19L1 mRNA	PMID:36331819
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1603693	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DPY19L1 mRNA	PMID:25979313
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1621284	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DPY19L1 mRNA	PMID:17292431
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of DPY19L1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1603693	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DPY19L1 gene	PMID:29154799
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1603693	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DPY19L1 mRNA	PMID:27188386
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DPY19L1 mRNA	PMID:37992649
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1603693	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of DPY19L1 mRNA	PMID:26272509
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:1603693	E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPY19L1 mRNA	PMID:27188386
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1603693	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of DPY19L1 mRNA	PMID:26272509
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1603693	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPY19L1 mRNA	PMID:27188386
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DPY19L1 mRNA	PMID:33387578
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1603693	E	RGD:6480464	20120412	CTD	MESH:D005472	DPY19L1 protein affects the susceptibility to Fluorouracil	PMID:16217747
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DPY19L1 mRNA	PMID:40504410
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1621284	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DPY19L1 mRNA	PMID:39716349
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of DPY19L1 mRNA	PMID:24136188
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DPY19L1 protein	PMID:32959892
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DPY19L1 mRNA	PMID:25729387
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of DPY19L1 mRNA	PMID:15336504
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DPY19L1 gene	PMID:35440735
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1603693	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DPY19L1 protein	PMID:34186270
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1621284	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DPY19L1 mRNA	PMID:22206623
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of DPY19L1 mRNA	PMID:24136188
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1603693	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of DPY19L1 mRNA	PMID:22124623
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1603693	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPY19L1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DPY19L1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPY19L1 mRNA	PMID:27188386
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of DPY19L1 mRNA	PMID:30928695
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1603693	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DPY19L1 gene]	PMID:28238834
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1621284	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of DPY19L1 mRNA	PMID:19482888
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1621284	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of DPY19L1 mRNA]	PMID:19482888
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of DPY19L1 mRNA	PMID:19095052
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1621284	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of DPY19L1 mRNA	PMID:21278054
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DPY19L1 mRNA	PMID:24780913|PMID:36843608
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1603693	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPY19L1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DPY19L1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPY19L1 mRNA	PMID:27188386
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DPY19L1 mRNA	PMID:21346803
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1603693	E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of DPY19L1 mRNA	PMID:31863870
1305822	Dpy19l1	dpy-19 like C-mannosyltransferase 1	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DPY19L1 mRNA	PMID:19015723
1305823	Cep20	centrosomal protein 20	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1606173	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FOPNL mRNA	PMID:33167477
1305823	Cep20	centrosomal protein 20	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314088	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CEP20 mRNA	PMID:39241906
1305823	Cep20	centrosomal protein 20	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1606173	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FOPNL mRNA	PMID:37042841
1305823	Cep20	centrosomal protein 20	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1606173	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of FOPNL mRNA	PMID:33359661
1305823	Cep20	centrosomal protein 20	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314088	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CEP20 mRNA	PMID:37236586
1305823	Cep20	centrosomal protein 20	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314088	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEP20 mRNA	PMID:34911549
1305823	Cep20	centrosomal protein 20	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1606173	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of FOPNL mRNA	PMID:35430440
1305823	Cep20	centrosomal protein 20	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1606173	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of CEP20 mRNA	PMID:22171008
1305823	Cep20	centrosomal protein 20	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1606173	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CEP20 mRNA	PMID:39836092
1305823	Cep20	centrosomal protein 20	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CEP20 mRNA	PMID:31881176
1305823	Cep20	centrosomal protein 20	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1606173	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CEP20 mRNA	PMID:23557933
1305823	Cep20	centrosomal protein 20	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1606173	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CEP20 mRNA	PMID:30851411
1305823	Cep20	centrosomal protein 20	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1606173	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CEP20 mRNA	PMID:29803840
1305823	Cep20	centrosomal protein 20	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1606173	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FOPNL mRNA	PMID:38568856
1305823	Cep20	centrosomal protein 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1606173	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CEP20 mRNA	PMID:39836092
1305823	Cep20	centrosomal protein 20	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606173	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CEP20 3' UTR; Benzo(a)pyrene affects the methylation of CEP20 promoter	PMID:27901495
1305823	Cep20	centrosomal protein 20	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1606173	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CEP20 mRNA]	PMID:32406909
1305823	Cep20	centrosomal protein 20	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1606173	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of CEP20 mRNA	PMID:22171008
1305823	Cep20	centrosomal protein 20	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1606173	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of CEP20 gene	PMID:31601247
1305823	Cep20	centrosomal protein 20	gene	CHEBI:3223	buspirone	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of CEP20 mRNA	PMID:24136188
1305823	Cep20	centrosomal protein 20	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314088	E	RGD:6480464	20200331	CTD	MESH:C009495	titanium dioxide results in decreased expression of CEP20 mRNA	PMID:29264374
1305823	Cep20	centrosomal protein 20	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CEP20 mRNA	PMID:23411599
1305823	Cep20	centrosomal protein 20	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CEP20 mRNA	PMID:25181051
1305823	Cep20	centrosomal protein 20	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1606173	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of CEP20 gene	PMID:31601247
1305823	Cep20	centrosomal protein 20	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314088	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CEP20 intron	PMID:28392331
1305823	Cep20	centrosomal protein 20	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CEP20 mRNA	PMID:21266533
1305823	Cep20	centrosomal protein 20	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606173	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FOPNL mRNA	PMID:37042841
1305823	Cep20	centrosomal protein 20	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1606173	E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CEP20 mRNA	PMID:38174414
1305823	Cep20	centrosomal protein 20	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314088	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CEP20 mRNA	PMID:37236586
1305823	Cep20	centrosomal protein 20	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1606173	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CEP20 mRNA	PMID:28302478
1305823	Cep20	centrosomal protein 20	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314088	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of FOPNL mRNA	PMID:36331819
1305823	Cep20	centrosomal protein 20	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1606173	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CEP20 mRNA	PMID:25979313
1305823	Cep20	centrosomal protein 20	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606173	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEP20 mRNA	PMID:23179753
1305823	Cep20	centrosomal protein 20	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1606173	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CEP20 mRNA	PMID:29154799
1305823	Cep20	centrosomal protein 20	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1606173	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CEP20 mRNA	PMID:25562108
1305823	Cep20	centrosomal protein 20	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1606173	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CEP20 mRNA	PMID:38832940
1305823	Cep20	centrosomal protein 20	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1606173	E	RGD:6480464	20161213	CTD	MESH:C088658	Zoledronic Acid results in increased expression of CEP20 mRNA	PMID:20977926
1305823	Cep20	centrosomal protein 20	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1606173	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CEP20 mRNA	PMID:39836092
1305823	Cep20	centrosomal protein 20	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1606173	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of CEP20 mRNA	PMID:31838189
1305823	Cep20	centrosomal protein 20	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of CEP20 mRNA	PMID:34044035
1305823	Cep20	centrosomal protein 20	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of CEP20 mRNA	PMID:23962444
1305823	Cep20	centrosomal protein 20	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314088	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CEP20 mRNA	PMID:35964746
1305823	Cep20	centrosomal protein 20	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1606173	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of FOPNL mRNA	PMID:27918106
1305823	Cep20	centrosomal protein 20	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1606173	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CEP20 mRNA	PMID:37199045
1305823	Cep20	centrosomal protein 20	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1606173	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CEP20 mRNA	PMID:30851411
1305823	Cep20	centrosomal protein 20	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314088	E	RGD:6480464	20200331	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CEP20 mRNA	PMID:31388691
1305823	Cep20	centrosomal protein 20	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1314088	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of CEP20 mRNA	PMID:40826991
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314089	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of TMEM134 mRNA	PMID:33045310
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314089	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of TMEM134 mRNA]	PMID:19467301
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314089	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TMEM134 gene	PMID:20938992
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314089	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM134 mRNA	PMID:36331819
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314089	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of TMEM134 mRNA	PMID:40945087
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1604784	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TMEM134 mRNA	PMID:21179406
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1604784	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of TMEM134 mRNA	PMID:23019147
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314089	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TMEM134 gene	PMID:20938992
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1314089	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of TMEM134 mRNA	PMID:17317680
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of TMEM134 mRNA	PMID:22967744
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1604784	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TMEM134 protein	PMID:37730182
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TMEM134 mRNA	PMID:33387578
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314089	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMEM134 mRNA	PMID:36331819
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314089	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM134 mRNA	PMID:37236586
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	ISO	RGD:1604784	E	RGD:6480464	20120412	CTD	MESH:D014747	TMEM134 protein affects the susceptibility to Vinblastine	PMID:16217747
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314089	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TMEM134 gene	PMID:20938992
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1604784	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM134 mRNA	PMID:40512198
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1604784	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TMEM134 mRNA	PMID:28903495
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314089	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM134 mRNA	PMID:21570461
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM134 mRNA	PMID:33387578
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	ISO	RGD:1604784	E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of TMEM134 mRNA	PMID:24834073
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1604784	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM134 mRNA	PMID:32763439
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1604784	E	RGD:6480464	20120412	CTD	MESH:D004317	TMEM134 protein affects the susceptibility to Doxorubicin	PMID:16217747
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1604784	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TMEM134 mRNA	PMID:29432896
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1604784	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TMEM134 mRNA	PMID:39719251
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1604784	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM134 mRNA	PMID:40512198
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1604784	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM134 3' UTR	PMID:27901495
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TMEM134 mRNA	PMID:30047161
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314089	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TMEM134 promoter alternative form	PMID:35295148
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314089	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TMEM134 mRNA	PMID:20813756|PMID:23811191
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1604784	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TMEM134 mRNA	PMID:19710929
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM134 mRNA	PMID:25181051
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314089	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM134 mRNA	PMID:32156529|PMID:33221593
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMEM134 gene	PMID:28505145
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314089	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TMEM134 mRNA	PMID:40203079
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TMEM134 mRNA	PMID:21266533
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314089	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM134 mRNA	PMID:37236586
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1604784	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TMEM134 mRNA	PMID:31533062
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314089	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMEM134 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM134 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TMEM134 mRNA	PMID:36331819
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1604784	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM134 mRNA	PMID:25979313
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1604784	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM134 mRNA	PMID:23179753
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TMEM134 mRNA	PMID:30047161
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1604784	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TMEM134 mRNA	PMID:25562108
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TMEM134 mRNA	PMID:36653537
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1604784	E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TMEM134 mRNA	PMID:36621641
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314089	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TMEM134 mRNA	PMID:28973697
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1604784	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TMEM134 mRNA	PMID:38832940
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:45863	paclitaxel	affects response to substance	ISO	RGD:1604784	E	RGD:6480464	20161213	CTD	MESH:D017239	TMEM134 protein affects the susceptibility to Paclitaxel	PMID:16217747
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314089	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMEM134 mRNA	PMID:17562736
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314089	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of TMEM134 mRNA	PMID:29279043
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1604784	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMEM134 mRNA	PMID:40512198
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314089	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TMEM134 mRNA	PMID:35436446
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TMEM134 mRNA	PMID:30047161
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TMEM134 mRNA	PMID:24136188
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1604784	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TMEM134 mRNA	PMID:31758290
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314089	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMEM134 mRNA	PMID:22206623
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TMEM134 mRNA	PMID:24136188
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of TMEM134 mRNA	PMID:30047161
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TMEM134 mRNA	PMID:30047161
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TMEM134 mRNA	PMID:19281266
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1604784	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TMEM134 mRNA	PMID:38568856
1305824	Tmem134	transmembrane protein 134	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TMEM134 mRNA	PMID:23034163|PMID:23555832
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of TPTE2 gene	PMID:28931070
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TPTE2 mRNA	PMID:33387578
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D011374	Progesterone results in increased expression of TPTE2 mRNA	PMID:21770760
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314090	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TPTE2 mRNA	PMID:22100608
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TPTE2 mRNA	PMID:33354967
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of TPTE2 mRNA	PMID:35737395
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TPTE2 mRNA	PMID:32109520
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TPTE2 mRNA	PMID:28959563
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314090	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TPTE2 mRNA	PMID:25895662
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TPTE2 gene	PMID:28505145
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314090	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of TPTE2 gene	PMID:31601247
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:34911	permethrin	decreases expression	ISO	RGD:1314090	E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased expression of TPTE2 mRNA	PMID:37047231
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314090	E	RGD:6480464	20120522	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TPTE2 mRNA	PMID:17183730
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1314090	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of TPTE2 mRNA	PMID:24449571
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314090	E	RGD:6480464	20171010	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TPTE2 mRNA	PMID:28673683
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1314090	E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of TPTE2 mRNA	PMID:22714537
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1314090	E	RGD:6480464	20120522	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TPTE2 mRNA	PMID:17183730
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:64153	tanespimycin	increases expression	ISO	RGD:1314090	E	RGD:6480464	20200804	CTD	MESH:C112765	tanespimycin analog results in increased expression of TPTE2 protein	PMID:31370342
1305825	Tpte2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of TPTE2 mRNA	PMID:27840820
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DNAJB4 mRNA	PMID:38218311
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314093	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of DNAJB4 mRNA	PMID:33045310
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314093	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of DNAJB4 mRNA	PMID:37995155
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DNAJB4 mRNA]	PMID:31150632
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	ISO	RGD:1314092	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:15368	acrolein	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of DNAJB4 mRNA	PMID:38090360
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB4 mRNA	PMID:32699268
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16016	dihydroxyacetone	increases expression	ISO	RGD:1314092	E	RGD:6480464	20210309	CTD	MESH:D004098	Dihydroxyacetone results in increased expression of DNAJB4 mRNA	PMID:32506039
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DNAJB4 mRNA	PMID:21632981
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314093	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DNAJB4 mRNA	PMID:15919760
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DNAJB4 mRNA	PMID:20106945
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DNAJB4 mRNA	PMID:23829299
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of DNAJB4 mRNA	PMID:38568856
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314092	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DNAJB4 mRNA	PMID:37042841
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1314092	E	RGD:6480464	20121113	CTD	MESH:D001554	Benzene results in increased expression of DNAJB4 mRNA	PMID:21843810
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DNAJB4 mRNA	PMID:20655997|PMID:23649840
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16980	geranial	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:C007076	citral results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:17177	cinnamyl alcohol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:C020722	cinnamyl alcohol results in increased expression of DNAJB4 mRNA	PMID:23999411
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:175304	Dodecyl gallate	increases expression	ISO	RGD:1314092	E	RGD:6480464	20210706	CTD	MESH:C008259	lauryl gallate results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20120412	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DNAJB4 mRNA	PMID:18486366
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DNAJB4 mRNA	PMID:21318169
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314092	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DNAJB4 protein	PMID:37730182
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DNAJB4 mRNA	PMID:33387578
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314092	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DNAJB4 mRNA	PMID:28818685
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:18224	isoeugenol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:C036643	isoeugenol results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA	PMID:39836092
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DNAJB4 protein	PMID:34915118
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:188648	3,3',4',5-tetrachlorosalicylanilide	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:C003390	3,3',4',5-tetrachlorosalicylanilide results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1314092	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of DNAJB4 mRNA	PMID:21120746
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB4 mRNA	PMID:35301059
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:23316	citral	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:C007076	citral results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:23414	copper(II) sulfate	affects expression	ISO	RGD:1314092	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of DNAJB4 mRNA	PMID:19549813
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of DNAJB4 mRNA	PMID:23649840
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of DNAJB4 protein	PMID:33236894
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1314092	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DNAJB4 protein	PMID:20106945
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DNAJB4 mRNA	PMID:23649840
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of DNAJB4 mRNA	PMID:15651846
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25712	organoselenium compound	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20170228	CTD	MESH:D016566	[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB4 mRNA	PMID:25167922
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of DNAJB4 mRNA	PMID:35737395
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120515	CTD	MESH:D010126	Ozone results in increased expression of DNAJB4 mRNA	PMID:21543283
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DNAJB4 mRNA	PMID:32699268
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DNAJB4 mRNA	PMID:18593933
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNAJB4 mRNA	PMID:31150632
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314093	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNAJB4 mRNA	PMID:31919559
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DNAJB4 mRNA]	PMID:31150632
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJB4 mRNA	PMID:39836092
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DNAJB4 mRNA	PMID:19244175
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20210907	CTD	MESH:D000966	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of DNAJB4 mRNA	PMID:32076005
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27638	cobalt atom	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20130514	CTD	MESH:D003035	[tungsten carbide co-treated with Cobalt] results in increased expression of DNAJB4 mRNA	PMID:23052192
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27810	resorcinol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:C031389	resorcinol results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB4 mRNA]	PMID:31298478
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1314092	E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of DNAJB4 mRNA	PMID:37386098
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314092	E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of DNAJB4 mRNA	PMID:19561079
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of DNAJB4 mRNA	PMID:32186404
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNAJB4 mRNA	PMID:32109520|PMID:33387578
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNAJB4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DNAJB4 mRNA	PMID:17942748|PMID:25975270
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of DNAJB4 mRNA	PMID:33512557
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DNAJB4 mRNA	PMID:28001369
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1314092	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of DNAJB4 mRNA	PMID:30851411
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28600	farnesol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:D005204	Farnesol results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314092	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DNAJB4 mRNA	PMID:32763439
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of DNAJB4 mRNA; [Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB4 mRNA	PMID:20971185|PMID:25167922
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28878	dodecan-1-ol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:D007851	Dodecanol analog results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB4 mRNA]	PMID:18723479
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28987	abietic acid	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:C023710	abietic acid results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314092	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAJB4 mRNA	PMID:12634122|PMID:24516582|PMID:38568856
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20210907	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJB4 mRNA; [sodium arsenite results in increased abundance of arsenite] which results in increased expression of DNAJB4 mRNA; sodium arsenite promotes the reaction [DNAJB4 protein binds to CAPRIN1 protein]	PMID:32076005|PMID:33939924|PMID:39836092
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29693	thiostrepton	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140715	CTD	MESH:D013883	Thiostrepton results in increased expression of DNAJB4 mRNA	PMID:22321511
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1314092	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of DNAJB4 mRNA	PMID:21714911
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140909	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of DNAJB4 mRNA; Benzo(a)pyrene results in increased expression of DNAJB4 mRNA; Benzo(a)pyrene results in increased expression of DNAJB4 protein	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:24356939|PMID:26238291|PMID:33278487
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNAJB4 mRNA	PMID:21569818|PMID:22228805
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA	PMID:27858113
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20210907	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in increased expression of DNAJB4 mRNA	PMID:32076005
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of DNAJB4 mRNA; [Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB4 mRNA	PMID:20971185|PMID:25167922
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DNAJB4 mRNA	PMID:18593933
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30297	antimonite	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20210907	CTD	MESH:C061374	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of DNAJB4 mRNA	PMID:32076005
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314092	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of DNAJB4 mRNA	PMID:26014281|PMID:28959546
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314092	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DNAJB4 mRNA	PMID:25351596
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314092	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DNAJB4 mRNA	PMID:15761015|PMID:19417148|PMID:24356939|PMID:25258189
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DNAJB4 gene	PMID:31601247
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1314092	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of DNAJB4 mRNA	PMID:38568856
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of DNAJB4 mRNA	PMID:16507785
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32076	zinc pyrithione	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170303	CTD	MESH:C010423	pyrithione zinc results in increased expression of DNAJB4 mRNA	PMID:21424779
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314093	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DNAJB4 promoter alternative form	PMID:35295148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314093	E	RGD:6480464	20200211	CTD	MESH:C009495	titanium dioxide results in increased expression of DNAJB4 mRNA	PMID:31298478
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20200211	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB4 mRNA]	PMID:31298478
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DNAJB4 mRNA	PMID:18648102
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of DNAJB4 mRNA	PMID:21318169
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of DNAJB4 mRNA]	PMID:21318169
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of DNAJB4 mRNA	PMID:19191707
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140909	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of DNAJB4 mRNA	PMID:24356939
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1314092	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DNAJB4 mRNA	PMID:30903817
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJB4 mRNA	PMID:34947998
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJB4 mRNA	PMID:29275510
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJB4 protein	PMID:35999755
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314092	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DNAJB4 gene	PMID:31601247
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJB4 mRNA	PMID:25181051
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314093	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJB4 mRNA	PMID:39742910
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314093	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DNAJB4 promoter	PMID:27312807
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DNAJB4 gene	PMID:31601247
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33227	(E)-cinnamyl alcohol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140805	CTD	MESH:C020722	cinnamyl alcohol results in increased expression of DNAJB4 mRNA	PMID:23999411
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33234	vitamin E	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DNAJB4 mRNA	PMID:19244175
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1314092	E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of DNAJB4 mRNA	PMID:24752500
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:3390	carbaryl	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:D012721	Carbaryl results in increased expression of DNAJB4 mRNA	PMID:27829164
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34288	2-hydroxyethyl methacrylate	increases expression	ISO	RGD:1314092	E	RGD:6480464	20200310	CTD	MESH:C005044	hydroxyethyl methacrylate results in increased expression of DNAJB4 mRNA	PMID:30497689
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34292	1,3-benzothiazole-2-thiol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:C005563	captax results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314093	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DNAJB4 mRNA	PMID:39298647|PMID:40203079
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34544	Aurin	increases expression	ISO	RGD:1314092	E	RGD:6480464	20150414	CTD	MESH:C017037	aurin results in increased expression of DNAJB4 mRNA	PMID:25477506
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA	PMID:27858113
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34578	Bisphenol A diglycidyl ether	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:C019273	bisphenol A diglycidyl ether results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1314092	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of DNAJB4 protein	PMID:34186270
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314093	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DNAJB4 intron	PMID:28392331
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of DNAJB4 protein	PMID:35362542
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DNAJB4 protein]	PMID:35362542
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34682	diazinon	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140909	CTD	MESH:D003976	Diazinon results in increased expression of DNAJB4 mRNA	PMID:24356939
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DNAJB4 mRNA	PMID:21266533
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:D004137	NFE2L2 protein affects the reaction [Dinitrochlorobenzene results in increased expression of DNAJB4 mRNA]	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34779	glyoxal	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:D006037	Glyoxal results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of DNAJB4 mRNA	PMID:17312168
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314092	E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of DNAJB4 protein	PMID:34064677
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314092	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DNAJB4 mRNA	PMID:37042841
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA	PMID:39836092
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DNAJB4 mRNA	PMID:20551477
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314092	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNAJB4 mRNA	PMID:38174414|PMID:38568856
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB4 mRNA	PMID:35301059
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1314093	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of DNAJB4 mRNA	PMID:24183702
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1314092	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of DNAJB4 mRNA	PMID:19320972|PMID:19376846|PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB4 mRNA	PMID:32699268
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DNAJB4 mRNA	PMID:19244175
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of DNAJB4 mRNA	PMID:17585979
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:3764	clotrimazole	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:D003022	Clotrimazole results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314093	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DNAJB4 mRNA	PMID:40194260
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DNAJB4 mRNA	PMID:28302478
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1314092	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of DNAJB4 mRNA	PMID:26352163
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DNAJB4 mRNA	PMID:40419075
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of DNAJB4 mRNA	PMID:23179753
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314092	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DNAJB4 gene	PMID:29154799
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in increased expression of DNAJB4 mRNA	PMID:19136453|PMID:20546886
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140909	CTD	MESH:D003520	Cyclophosphamide metabolite results in increased expression of DNAJB4 mRNA	PMID:24356939
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of DNAJB4 mRNA	PMID:27989131
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of DNAJB4 mRNA	PMID:19770486
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314092	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of DNAJB4 mRNA	PMID:20106945|PMID:21632981
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:40909	azoxystrobin	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of DNAJB4 mRNA	PMID:33512557
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:41607	crotonaldehyde	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased expression of DNAJB4 mRNA	PMID:20471460
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DNAJB4 mRNA	PMID:17555576
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1314092	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of DNAJB4 mRNA	PMID:27188386
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DNAJB4 mRNA	PMID:17562736
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJB4 mRNA	PMID:21420995|PMID:22230336
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DNAJB4 mRNA]	PMID:18700144
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:46202	undecanal	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:C479548	undecanal analog results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJB4 mRNA	PMID:39836092
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:47381	diclofenac	affects expression	ISO	RGD:1314092	E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of DNAJB4 mRNA	PMID:24752500
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1314092	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of DNAJB4 mRNA	PMID:31838189
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNAJB4 mRNA	PMID:22079256
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DNAJB4 mRNA	PMID:17555576
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DNAJB4 mRNA	PMID:17942748
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNAJB4 mRNA	PMID:17942748
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4917	eugenol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:D005054	Eugenol results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DNAJB4 protein]	PMID:35362542
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314092	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DNAJB4 mRNA	PMID:15761015|PMID:19417148|PMID:24356939|PMID:25258189
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in decreased expression of DNAJB4 mRNA	PMID:21318169
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in decreased expression of DNAJB4 mRNA]	PMID:21318169
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:50161	motexafin gadolinium	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of DNAJB4 mRNA	PMID:16357179
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of DNAJB4 mRNA	PMID:16357179
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:50545	trans-isoeugenol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140805	CTD	MESH:C036643	isoeugenol results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314092	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DNAJB4 mRNA	PMID:17450800
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of DNAJB4 mRNA	PMID:40234311
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA	PMID:27858113
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:51403	1,4-phenylenediamine	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:C029728	4-phenylenediamine results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA	PMID:27858113
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:53049	1-fluoro-2,4-dinitrobenzene	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:D004139	Dinitrofluorobenzene results in increased expression of DNAJB4 mRNA	PMID:23999411
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:D010081	Oxazolone results in increased expression of DNAJB4 mRNA	PMID:23999411
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1314092	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DNAJB4 mRNA	PMID:31629900
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DNAJB4 protein	PMID:32959892
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:62822	4-nitrobenzyl bromide	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:C027563	4-nitrobenzyl bromide results in increased expression of DNAJB4 mRNA	PMID:23999411
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:62823	2-bromo-2-(bromomethyl)pentanedinitrile	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:C039411	1,2-dibromo-2,4-dicyanobutane results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:62984	zinc acetate	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of DNAJB4 mRNA	PMID:16357179
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:62984	zinc acetate	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of DNAJB4 mRNA	PMID:16357179
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA	PMID:39836092
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of DNAJB4 mRNA	PMID:19812364
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DNAJB4 mRNA	PMID:23650126
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:63959	celastrol	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20250311	CTD	MESH:C050414	celastrol results in decreased expression of DNAJB4 mRNA	PMID:39181414
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:63959	celastrol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in increased expression of DNAJB4 mRNA	PMID:17010675
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of DNAJB4 mRNA	PMID:15336504
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:65954	gedunin	increases expression	ISO	RGD:1314092	E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in increased expression of DNAJB4 mRNA	PMID:17010675
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DNAJB4 mRNA	PMID:19564919
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of DNAJB4 mRNA	PMID:19564919
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1314092	E	RGD:6480464	20210608	CTD	MESH:C014476	diethyl maleate results in increased expression of DNAJB4 mRNA	PMID:33545341
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20210209	CTD	MESH:D002185	Cannabidiol results in increased expression of DNAJB4 mRNA	PMID:26504004
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20210209	CTD	MESH:D002185	[Dronabinol co-treated with Cannabidiol] results in increased expression of DNAJB4 mRNA	PMID:26504004
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1314092	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DNAJB4 protein	PMID:34186270
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:73297	SCH 23390	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of DNAJB4 mRNA	PMID:19564919
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DNAJB4 mRNA	PMID:22206623
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DNAJB4 mRNA	PMID:22079256
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNAJB4 mRNA	PMID:22079256
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140909	CTD	MESH:C025589	ochratoxin A metabolite results in increased expression of DNAJB4 mRNA; ochratoxin A results in increased expression of DNAJB4 mRNA	PMID:24356939
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1314092	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of DNAJB4 mRNA	PMID:30851411
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:79369	elesclomol	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of DNAJB4 mRNA	PMID:18723479
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:79369	elesclomol	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20170228	CTD	MESH:C512195	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB4 mRNA]	PMID:18723479
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of DNAJB4 mRNA	PMID:19270015
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of DNAJB4 mRNA	PMID:22538082
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of DNAJB4 mRNA	PMID:38995820
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:82283	Tungsten carbide	multiple interactions	ISO	RGD:1314092	E	RGD:6480464	20170303	CTD	MESH:C002802	[tungsten carbide co-treated with Cobalt] results in increased expression of DNAJB4 mRNA	PMID:23052192
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:82465	2-Ethylhexyl acrylate	increases expression	ISO	RGD:1314092	E	RGD:6480464	20170516	CTD	MESH:C036758	2-ethylhexyl acrylate results in increased expression of DNAJB4 mRNA	PMID:27965148
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of DNAJB4 mRNA	PMID:19363144|PMID:21278054
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:85014	2,5-hexanedione	increases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in increased expression of DNAJB4 mRNA	PMID:22952946
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:87368	diethyl malate	increases expression	ISO	RGD:1314092	E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of DNAJB4 mRNA	PMID:38498338
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1314092	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of DNAJB4 mRNA	PMID:16497877
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of DNAJB4 mRNA	PMID:23999411
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314092	E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of DNAJB4 mRNA	PMID:26014281|PMID:28959546
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DNAJB4 mRNA	PMID:21346803
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1314092	E	RGD:6480464	20140311	CTD	MESH:D013893	Thiram results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148|PMID:38568856
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9513	thalidomide	increases expression	ISO	RGD:1314092	E	RGD:6480464	20120412	CTD	MESH:D013792	Thalidomide analog results in increased expression of DNAJB4 mRNA	PMID:20525221
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1314092	E	RGD:6480464	20120412	CTD	MESH:D013849	Thimerosal results in increased expression of DNAJB4 mRNA	PMID:16870260
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DNAJB4 mRNA	PMID:21346803
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1314093	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in increased expression of DNAJB4 mRNA	PMID:19363144
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314092	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of DNAJB4 mRNA	PMID:19631733
1305826	Dnajb4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314092	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of DNAJB4 mRNA	PMID:19631733
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CNDP2 mRNA	PMID:38218311
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1314094	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CNDP2 mRNA	PMID:38218311
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of CNDP2 mRNA	PMID:21551480
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of CNDP2 gene	PMID:35440735
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CNDP2 mRNA	PMID:22378314
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314095	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CNDP2 mRNA	PMID:30319688
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314095	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CNDP2 mRNA	PMID:39298647
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314095	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CNDP2 mRNA	PMID:15289156|PMID:19484750
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of CNDP2 mRNA	PMID:26496021
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314094	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CNDP2 mRNA	PMID:37042841
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of CNDP2 mRNA	PMID:21540246
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314095	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of CNDP2 mRNA	PMID:20463053
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:17362	quinoline	increases expression	ISO	RGD:1314094	E	RGD:6480464	20120412	CTD	MESH:C037219	quinoline analog results in increased expression of CNDP2 protein	PMID:18645022
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CNDP2 mRNA	PMID:33387578
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:17833	gentamycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein	PMID:30545405
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CNDP2 mRNA	PMID:28818685
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CNDP2 mRNA	PMID:19770486
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:D015127	[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of CNDP2 protein	PMID:39910959
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CNDP2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of CNDP2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CNDP2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CNDP2 protein	PMID:38598786
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CNDP2 mRNA	PMID:30779732
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314095	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CNDP2 mRNA	PMID:31919559
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314095	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CNDP2 mRNA	PMID:25629700
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:27732	caffeine	increases phosphorylation	ISO	RGD:1314094	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CNDP2 protein	PMID:35688186
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA	PMID:33854195
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CNDP2 mRNA	PMID:23557933
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of CNDP2 mRNA	PMID:19921347
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:28001	vancomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein	PMID:30545405
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of CNDP2 mRNA	PMID:15289156
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNDP2 mRNA	PMID:34747641
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314095	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNDP2 mRNA	PMID:21570461|PMID:24680724
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CNDP2 mRNA	PMID:21215274|PMID:32109520
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CNDP2 mRNA	PMID:18691609
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1314094	E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CNDP2 mRNA	PMID:39709020
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:28971	ampicillin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein	PMID:30545405
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CNDP2 mRNA	PMID:38568856
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314094	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CNDP2 5' UTR; Benzo(a)pyrene affects the methylation of CNDP2 exon; Benzo(a)pyrene affects the methylation of CNDP2 promoter	PMID:27901495
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of CNDP2 mRNA	PMID:21829687
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CNDP2 mRNA	PMID:30047161
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314095	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CNDP2 promoter	PMID:35295148
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CNDP2 mRNA	PMID:34492290
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CNDP2 mRNA	PMID:25181051
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1314094	E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A affects the expression of CNDP2 protein	PMID:34186270
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CNDP2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of CNDP2 mRNA	PMID:26496021
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314094	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CNDP2 protein	PMID:34186270
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CNDP2 mRNA	PMID:28628672
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:C041594	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:C105260	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314094	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CNDP2 protein	PMID:34186270
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CNDP2 mRNA	PMID:28628672
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34581	Bisphenol B	increases expression	ISO	RGD:1314094	E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CNDP2 protein	PMID:34186270
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:C027561	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1314095	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of CNDP2 mRNA	PMID:31558096
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA	PMID:33854195
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1314094	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CNDP2 gene	PMID:22964155
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:D003993	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CNDP2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of CNDP2 protein	PMID:38598786
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CNDP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CNDP2 mRNA	PMID:28628672
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314094	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNDP2 mRNA	PMID:37042841
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of CNDP2 mRNA	PMID:30589522
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CNDP2 mRNA	PMID:35163327
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:C019566	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CNDP2 mRNA	PMID:35163327
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CNDP2 mRNA	PMID:17553155|PMID:19376846
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CNDP2 mRNA	PMID:24449571
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314095	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CNDP2 mRNA	PMID:18353800
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	ISO	RGD:1314094	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of CNDP2 protein	PMID:17152098
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone promotes the reaction [NDRG1 protein binds to CNDP2 protein]	PMID:17220478
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1314094	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CNDP2 mRNA	PMID:28302478
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:39285	chloropicrin	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of CNDP2 mRNA	PMID:26352163
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314094	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CNDP2 mRNA	PMID:25979313
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314094	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CNDP2 gene	PMID:29154799
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314094	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of CNDP2 mRNA	PMID:23179753|PMID:24383497
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of CNDP2 mRNA	PMID:19136453
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CNDP2 mRNA	PMID:30047161
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314094	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CNDP2 mRNA	PMID:21163907
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA	PMID:33854195
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CNDP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CNDP2 mRNA	PMID:28628672
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CNDP2 mRNA	PMID:15289156
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314095	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CNDP2 mRNA	PMID:28973697
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CNDP2 mRNA	PMID:24136188
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA	PMID:33854195
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of CNDP2 mRNA	PMID:21346803
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314095	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CNDP2 mRNA	PMID:17562736
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CNDP2 mRNA	PMID:21420995
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	ISO	RGD:1314094	E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of CNDP2 mRNA	PMID:31675489
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CNDP2 mRNA	PMID:17557909
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of CNDP2 mRNA	PMID:36868495
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CNDP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CNDP2 mRNA	PMID:28628672
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314095	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CNDP2 mRNA; Nanotubes, Carbon results in increased expression of CNDP2 mRNA	PMID:25554681
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CNDP2 mRNA	PMID:24136188
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CNDP2 mRNA	PMID:30047161
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA	PMID:33854195
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:6067	isotretinoin	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CNDP2 mRNA	PMID:20436886
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CNDP2 protein	PMID:32959892
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:63634	valdecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CNDP2 mRNA	PMID:24136188
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CNDP2 mRNA	PMID:15003993
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314095	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of CNDP2 mRNA	PMID:36851058
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CNDP2 mRNA	PMID:30467583
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:6909	metronidazole	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein	PMID:30545405
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CNDP2 mRNA	PMID:31758290
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1314094	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CNDP2 protein	PMID:34186270
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314095	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CNDP2 mRNA	PMID:22206623
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:7507	neomycin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein	PMID:30545405
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1314094	E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CNDP2 protein	PMID:39638853
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CNDP2 gene]	PMID:28238834
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of CNDP2 mRNA	PMID:38995820
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of CNDP2 protein	PMID:28903499
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1314095	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of CNDP2 mRNA	PMID:31558096
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CNDP2 mRNA	PMID:32679240
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1314094	E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CNDP2 protein	PMID:31675489
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of CNDP2 protein	PMID:38348393
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1314094	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CNDP2 mRNA	PMID:38568856
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of CNDP2 protein	PMID:35544339
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1314094	E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CNDP2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CNDP2 protein	PMID:38598786
1305827	Cndp2	carnosine dipeptidase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CNDP2 mRNA	PMID:21346803
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1618762	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DPY19L4 mRNA	PMID:33045310
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1618762	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of DPY19L4 mRNA	PMID:26251327
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of DPY19L4 mRNA	PMID:24763279
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1606660	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DPY19L4 mRNA	PMID:26079696
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1618762	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DPY19L4 mRNA	PMID:30319688
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DPY19L4 mRNA	PMID:33387578
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DPY19L4 mRNA	PMID:39836092
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPY19L4 mRNA	PMID:35301059
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618762	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DPY19L4 mRNA	PMID:37236586
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1606660	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DPY19L4 mRNA	PMID:23649840
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1618762	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DPY19L4 mRNA	PMID:31919559
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of DPY19L4 gene	PMID:31011160
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1606660	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of DPY19L4 mRNA	PMID:19921347
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1606660	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DPY19L4 mRNA	PMID:23179753
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1606660	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DPY19L4 mRNA	PMID:33212167
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to DPY19L4 mRNA]	PMID:32406909
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1618762	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DPY19L4 gene	PMID:35295148
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1618762	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of DPY19L4 mRNA	PMID:35295148
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DPY19L4 mRNA	PMID:25181051|PMID:34947998
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1606660	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DPY19L4 mRNA	PMID:33670352
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1606660	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DPY19L4 gene	PMID:31601247
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of DPY19L4 mRNA	PMID:33296240
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1618762	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DPY19L4 mRNA	PMID:39298647
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1618762	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DPY19L4 mRNA	PMID:38685157
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1618762	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DPY19L4 mRNA	PMID:37019170
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1606660	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DPY19L4 mRNA	PMID:37042841
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DPY19L4 mRNA	PMID:39836092
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPY19L4 mRNA	PMID:35301059
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618762	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DPY19L4 mRNA	PMID:37236586
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1606660	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DPY19L4 mRNA	PMID:31533062
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1606660	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of DPY19L4 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DPY19L4 mRNA	PMID:27188386
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1606660	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of DPY19L4 mRNA	PMID:20977926
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DPY19L4 mRNA	PMID:39836092
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DPY19L4 mRNA	PMID:27188386
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DPY19L4 gene]	PMID:28238834
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1618762	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of DPY19L4 mRNA	PMID:21795629
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1618762	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of DPY19L4 mRNA	PMID:40826991
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1606660	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DPY19L4 mRNA	PMID:27188386
1305828	Dpy19l4	dpy-19 like 4	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of DPY19L4 mRNA	PMID:23034163
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314098	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LCMT2 mRNA	PMID:33045310
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314098	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of LCMT2 mRNA	PMID:37995155
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:134751	avobenzone	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of LCMT2 mRNA	PMID:31016361
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314098	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LCMT2 mRNA	PMID:20188158
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of LCMT2 mRNA	PMID:24236059
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of LCMT2 mRNA	PMID:22378314
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1314097	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LCMT2 mRNA	PMID:20044591
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LCMT2 mRNA	PMID:33387578
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314097	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LCMT2 mRNA	PMID:37042841
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of LCMT2 mRNA	PMID:20655997
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LCMT2 mRNA	PMID:33387578
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LCMT2 mRNA	PMID:28818685
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314098	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LCMT2 mRNA	PMID:37236586
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LCMT2 mRNA	PMID:19549813
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314097	E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of LCMT2 mRNA	PMID:35430440
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314098	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LCMT2 mRNA	PMID:28960355
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314097	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LCMT2 mRNA	PMID:23557933
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1314097	E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of LCMT2 mRNA	PMID:23300844
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314097	E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LCMT2 mRNA	PMID:22574217
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LCMT2 mRNA	PMID:33387578
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LCMT2 mRNA	PMID:29803840
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LCMT2 mRNA	PMID:38568856
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314097	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of LCMT2 mRNA	PMID:28595984|PMID:34032870
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of LCMT2 mRNA	PMID:22378314
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of LCMT2 mRNA	PMID:25351596
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of LCMT2 mRNA	PMID:35984750
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:32687	piperonyl butoxide	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in decreased expression of LCMT2 mRNA	PMID:22484513
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of LCMT2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1314097	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of LCMT2 mRNA; Vitamin E results in increased expression of LCMT2 protein	PMID:9359698
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:34682	diazinon	increases methylation	ISO	RGD:1314097	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of LCMT2 gene	PMID:22964155
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314097	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LCMT2 mRNA	PMID:37042841
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314098	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LCMT2 mRNA	PMID:37236586
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20140610	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of LCMT2 mRNA	PMID:23978341
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1314097	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of LCMT2 mRNA	PMID:19167446
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1314097	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LCMT2 mRNA	PMID:19167446
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314097	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LCMT2 mRNA	PMID:25979313
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314098	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LCMT2 mRNA	PMID:17963808
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LCMT2 mRNA	PMID:29154799
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314097	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of LCMT2 mRNA	PMID:23179753
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LCMT2 mRNA	PMID:25562108
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:46345	5-fluorouracil	increases response to substance	ISO	RGD:1314098	E	RGD:6480464	20120412	CTD	MESH:D005472	LCMT2 results in increased susceptibility to Fluorouracil	PMID:9359698
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1314098	E	RGD:6480464	20120412	CTD	MESH:D005472	LCMT2 results in increased susceptibility to [pyrrolidine dithiocarbamic acid co-treated with Fluorouracil]	PMID:9359698
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of LCMT2 mRNA	PMID:18175754
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1314097	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of LCMT2 mRNA	PMID:23300844
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1314097	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of LCMT2 mRNA	PMID:31758290
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:7553	niclosamide	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of LCMT2 mRNA	PMID:36318118
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:78782	pyrrolidine dithiocarbamate	increases expression	ISO	RGD:1314097	E	RGD:6480464	20140708	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid results in increased expression of LCMT2 mRNA; pyrrolidine dithiocarbamic acid results in increased expression of LCMT2 protein	PMID:9359698
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:78782	pyrrolidine dithiocarbamate	increases response to substance	ISO	RGD:1314098	E	RGD:6480464	20140708	CTD	MESH:C020972	LCMT2 results in increased susceptibility to pyrrolidine dithiocarbamic acid	PMID:9359698
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	ISO	RGD:1314097	E	RGD:6480464	20140708	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid promotes the reaction [CEBPB protein binds to LCMT2 promoter]	PMID:9359698
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	ISO	RGD:1314098	E	RGD:6480464	20140708	CTD	MESH:C020972	LCMT2 results in increased susceptibility to [pyrrolidine dithiocarbamic acid co-treated with Fluorouracil]	PMID:9359698
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314097	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LCMT2 gene]	PMID:28238834
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314098	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of LCMT2 mRNA	PMID:19270015
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1314097	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LCMT2 mRNA	PMID:19167446
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LCMT2 mRNA	PMID:21346803
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of LCMT2 mRNA	PMID:38568856
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of LCMT2 mRNA	PMID:29301935
1305829	Lcmt2	leucine carboxyl methyltransferase 2	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1314097	E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of LCMT2 mRNA	PMID:22378314
1305831	Pomp	proteasome maturation protein	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1314101	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of POMP mRNA	PMID:38218311
1305831	Pomp	proteasome maturation protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314102	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POMP mRNA	PMID:39241906
1305831	Pomp	proteasome maturation protein	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1314102	E	RGD:6480464	20150623	CTD	MESH:C031280	pyrazole results in increased expression of POMP mRNA	PMID:17945193
1305831	Pomp	proteasome maturation protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314102	E	RGD:6480464	20150623	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of POMP mRNA	PMID:19850644|PMID:33754040
1305831	Pomp	proteasome maturation protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20150623	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of POMP mRNA]	PMID:19850644
1305831	Pomp	proteasome maturation protein	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1314101	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA	PMID:39836092
1305831	Pomp	proteasome maturation protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314101	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POMP mRNA	PMID:35301059
1305831	Pomp	proteasome maturation protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POMP mRNA	PMID:37236586
1305831	Pomp	proteasome maturation protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314101	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of POMP mRNA	PMID:19549813
1305831	Pomp	proteasome maturation protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314101	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of POMP intron	PMID:30157460
1305831	Pomp	proteasome maturation protein	gene	CHEBI:2679	amphetamine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of POMP mRNA	PMID:30779732
1305831	Pomp	proteasome maturation protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POMP mRNA	PMID:33387578
1305831	Pomp	proteasome maturation protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POMP mRNA	PMID:22206623
1305831	Pomp	proteasome maturation protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314101	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:39836092
1305831	Pomp	proteasome maturation protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:40504410
1305831	Pomp	proteasome maturation protein	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314102	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of POMP protein	PMID:25505154
1305831	Pomp	proteasome maturation protein	gene	CHEBI:28088	genistein	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in decreased methylation of POMP gene	PMID:28505145
1305831	Pomp	proteasome maturation protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314102	E	RGD:6480464	20150623	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POMP mRNA	PMID:21570461
1305831	Pomp	proteasome maturation protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POMP mRNA	PMID:18796159
1305831	Pomp	proteasome maturation protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314102	E	RGD:6480464	20150623	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POMP mRNA	PMID:16214954|PMID:18796159
1305831	Pomp	proteasome maturation protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20150623	CTD	MESH:D013749	AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of POMP mRNA]	PMID:16214954
1305831	Pomp	proteasome maturation protein	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1314101	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POMP mRNA	PMID:30851411
1305831	Pomp	proteasome maturation protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314101	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of POMP mRNA	PMID:32763439
1305831	Pomp	proteasome maturation protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314101	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of POMP mRNA	PMID:29803840
1305831	Pomp	proteasome maturation protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314101	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of POMP mRNA	PMID:39719251
1305831	Pomp	proteasome maturation protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314101	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of POMP mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1305831	Pomp	proteasome maturation protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314101	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA; [sodium arsenite co-treated with lead acetate] results in decreased expression of POMP protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:38072110|PMID:39836092
1305831	Pomp	proteasome maturation protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:40504410
1305831	Pomp	proteasome maturation protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314102	E	RGD:6480464	20150623	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POMP mRNA	PMID:22228805
1305831	Pomp	proteasome maturation protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314101	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POMP promoter	PMID:27901495
1305831	Pomp	proteasome maturation protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1314101	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to POMP mRNA]	PMID:32406909
1305831	Pomp	proteasome maturation protein	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1314101	E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in decreased expression of POMP protein	PMID:38072110
1305831	Pomp	proteasome maturation protein	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of POMP mRNA	PMID:30047161
1305831	Pomp	proteasome maturation protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314102	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POMP gene	PMID:35295148
1305831	Pomp	proteasome maturation protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314102	E	RGD:6480464	20150623	CTD	MESH:C009495	titanium dioxide results in increased expression of POMP mRNA	PMID:23557971
1305831	Pomp	proteasome maturation protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of POMP mRNA	PMID:34492290
1305831	Pomp	proteasome maturation protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314101	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of POMP mRNA	PMID:29275510
1305831	Pomp	proteasome maturation protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314102	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of POMP mRNA	PMID:33221593
1305831	Pomp	proteasome maturation protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in increased expression of POMP mRNA	PMID:25181051
1305831	Pomp	proteasome maturation protein	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of POMP mRNA	PMID:12082028
1305831	Pomp	proteasome maturation protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314102	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of POMP mRNA	PMID:39298647
1305831	Pomp	proteasome maturation protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314102	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of POMP mRNA	PMID:37019170
1305831	Pomp	proteasome maturation protein	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314102	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of POMP mRNA	PMID:34813904
1305831	Pomp	proteasome maturation protein	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314102	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of POMP mRNA	PMID:34813904
1305831	Pomp	proteasome maturation protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314101	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of POMP mRNA	PMID:37042841
1305831	Pomp	proteasome maturation protein	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1314101	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA	PMID:39836092
1305831	Pomp	proteasome maturation protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314101	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of POMP mRNA	PMID:38568856
1305831	Pomp	proteasome maturation protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314101	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POMP mRNA	PMID:35301059
1305831	Pomp	proteasome maturation protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POMP mRNA	PMID:37236586
1305831	Pomp	proteasome maturation protein	gene	CHEBI:35546	perfluorodecanoic acid	increases expression	ISO	RGD:1314101	E	RGD:6480464	20240702	CTD	MESH:C036567	perfluorodecanoic acid results in increased expression of POMP mRNA	PMID:38568856
1305831	Pomp	proteasome maturation protein	gene	CHEBI:3750	clofibrate	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D002994	Clofibrate results in increased expression of POMP mRNA	PMID:12851107
1305831	Pomp	proteasome maturation protein	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1314101	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of POMP mRNA	PMID:28302478
1305831	Pomp	proteasome maturation protein	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1314101	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of POMP mRNA	PMID:26352163
1305831	Pomp	proteasome maturation protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314101	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of POMP mRNA	PMID:25979313
1305831	Pomp	proteasome maturation protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314101	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of POMP mRNA	PMID:23179753
1305831	Pomp	proteasome maturation protein	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of POMP mRNA	PMID:30047161
1305831	Pomp	proteasome maturation protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314101	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of POMP mRNA	PMID:20106945
1305831	Pomp	proteasome maturation protein	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of POMP mRNA	PMID:24136188
1305831	Pomp	proteasome maturation protein	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314101	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of POMP mRNA	PMID:38832940
1305831	Pomp	proteasome maturation protein	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1314101	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of POMP mRNA	PMID:27188386
1305831	Pomp	proteasome maturation protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314101	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:39836092
1305831	Pomp	proteasome maturation protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:40504410
1305831	Pomp	proteasome maturation protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of POMP mRNA	PMID:12082028
1305831	Pomp	proteasome maturation protein	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1314101	E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of POMP mRNA	PMID:17211630
1305831	Pomp	proteasome maturation protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314102	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of POMP mRNA; Nanotubes, Carbon results in increased expression of POMP mRNA	PMID:25554681
1305831	Pomp	proteasome maturation protein	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of POMP mRNA	PMID:24136188
1305831	Pomp	proteasome maturation protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of POMP mRNA	PMID:35964746
1305831	Pomp	proteasome maturation protein	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of POMP mRNA	PMID:24136188
1305831	Pomp	proteasome maturation protein	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1314102	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of POMP mRNA	PMID:26377693
1305831	Pomp	proteasome maturation protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1314101	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA	PMID:39836092
1305831	Pomp	proteasome maturation protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POMP mRNA	PMID:22206623
1305831	Pomp	proteasome maturation protein	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of POMP mRNA	PMID:24136188
1305831	Pomp	proteasome maturation protein	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1314101	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POMP mRNA	PMID:30851411
1305831	Pomp	proteasome maturation protein	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20150623	CTD	MESH:D010634	Phenobarbital results in increased expression of POMP mRNA	PMID:12082028
1305831	Pomp	proteasome maturation protein	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of POMP mRNA	PMID:30047161
1305831	Pomp	proteasome maturation protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of POMP mRNA	PMID:30047161
1305831	Pomp	proteasome maturation protein	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of POMP mRNA	PMID:24136188
1305831	Pomp	proteasome maturation protein	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1314101	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of POMP mRNA	PMID:38568856
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552306	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PRPF31 mRNA	PMID:26251327
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1552306	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of PRPF31 promoter	PMID:26251327
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1552306	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of PRPF31 mRNA	PMID:25056781
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552306	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PRPF31 mRNA	PMID:39241906
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA	PMID:25510870
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:166595	Yessotoxin	decreases expression	ISO	RGD:1314103	E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of PRPF31 mRNA	PMID:30679557
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552306	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of PRPF31 mRNA	PMID:20463053
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314103	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PRPF31 protein	PMID:37730182
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of PRPF31 mRNA	PMID:28111341
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA	PMID:25510870
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA	PMID:25510870
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1314103	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PRPF31 mRNA	PMID:23649840
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of PRPF31 protein	PMID:33236894
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1552306	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of PRPF31 mRNA	PMID:25056781
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1314103	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PRPF31 mRNA	PMID:23649840
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552306	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PRPF31 mRNA	PMID:31919559
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1314103	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRPF31 gene	PMID:25304211
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1314103	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PRPF31 protein	PMID:35688186
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552306	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRPF31 mRNA	PMID:21570461
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRPF31 mRNA	PMID:17942748
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRPF31 mRNA	PMID:17942748
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314103	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PRPF31 mRNA	PMID:33212167
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1314103	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PRPF31 protein	PMID:35688186
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314103	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRPF31 mRNA	PMID:38568856
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314103	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PRPF31 mRNA	PMID:34032870
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314103	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PRPF31 protein	PMID:20097212
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552306	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PRPF31 gene	PMID:35295148
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PRPF31 mRNA	PMID:18301758
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRPF31 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF31 mRNA	PMID:36041667
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA	PMID:25510870
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA	PMID:25510870
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552306	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PRPF31 mRNA	PMID:39298647
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF31 mRNA	PMID:36041667
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF31 mRNA	PMID:36041667
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PRPF31 mRNA	PMID:21266533
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of PRPF31 mRNA	PMID:28111341
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314103	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PRPF31 gene	PMID:29154799
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1314103	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of PRPF31 promoter	PMID:27989131
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PRPF31 mRNA	PMID:17555576
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1314103	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRPF31 gene	PMID:25304211
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PRPF31 mRNA	PMID:17555576
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PRPF31 mRNA	PMID:17942748
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRPF31 mRNA	PMID:17942748
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552306	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PRPF31 mRNA	PMID:19042947
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1314103	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PRPF31 protein	PMID:32959892
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1314103	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PRPF31 protein	PMID:34186270
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552306	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PRPF31 mRNA	PMID:22206623
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1314103	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PRPF31 protein	PMID:37664457
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:756894	tak-243	decreases sumoylation	ISO	RGD:1314103	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PRPF31 protein	PMID:31285264
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314103	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PRPF31 gene]	PMID:28238834
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552306	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PRPF31 mRNA	PMID:30294300
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1314103	E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PRPF31 protein	PMID:31675489
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:81980	triticonazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of PRPF31 mRNA	PMID:36084822
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314103	E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PRPF31 protein	PMID:37664457
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PRPF31 mRNA	PMID:21346803
1305832	Prpf31	pre-mRNA processing factor 31	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PRPF31 mRNA	PMID:23034163
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1604545	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ANKS3 mRNA	PMID:38218311
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1332403	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ANKS3 mRNA	PMID:20188158
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1332403	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ANKS3 gene	PMID:20938992
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1604545	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ANKS3 mRNA	PMID:22378314
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332403	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ANKS3 mRNA	PMID:39241906
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1332403	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ANKS3 gene	PMID:20938992
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1604545	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ANKS3 mRNA	PMID:37042841
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ANKS3 mRNA	PMID:33387578
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1604545	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of ANKS3 intron	PMID:30157460
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332403	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ANKS3 mRNA	PMID:36331819
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1604545	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANKS3 gene	PMID:27153756
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ANKS3 mRNA	PMID:30779732
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1332403	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ANKS3 gene	PMID:20938992
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1604545	E	RGD:6480464	20210406	CTD	MESH:D001151	Arsenic affects the methylation of ANKS3 gene	PMID:32603190
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA	PMID:33854195
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332403	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANKS3 mRNA	PMID:21570461
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1332403	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ANKS3 mRNA	PMID:31961203
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANKS3 mRNA	PMID:33387578
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1604545	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ANKS3 protein	PMID:35688186
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ANKS3 mRNA	PMID:30047161
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332403	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ANKS3 promoter	PMID:35295148
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ANKS3 mRNA	PMID:34492290
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ANKS3 mRNA	PMID:25181051
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1332403	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ANKS3 exon	PMID:33297965
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1332403	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ANKS3 mRNA	PMID:38685157
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ANKS3 mRNA	PMID:21241498
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:34631	chlorpyrifos	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA	PMID:33854195
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332403	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ANKS3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ANKS3 mRNA	PMID:36331819
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1604545	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ANKS3 gene	PMID:29154799
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ANKS3 mRNA	PMID:30047161
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:40909	azoxystrobin	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA	PMID:33854195
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1332403	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ANKS3 mRNA	PMID:17555576
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:45979	thiabendazole	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA	PMID:33854195
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ANKS3 mRNA	PMID:33387578
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1604545	E	RGD:6480464	20210406	CTD	MESH:D001151	Arsenic affects the methylation of ANKS3 gene	PMID:32603190
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1332403	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ANKS3 mRNA	PMID:17555576
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ANKS3 mRNA	PMID:30047161
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA	PMID:33854195
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1604545	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ANKS3 mRNA	PMID:28988120
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332403	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ANKS3 mRNA	PMID:22206623
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1604545	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ANKS3 gene]	PMID:28238834
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ANKS3 mRNA	PMID:30047161
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1604545	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ANKS3 mRNA	PMID:38568856
1305833	Anks3	ankyrin repeat and sterile alpha motif domain containing 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ANKS3 mRNA	PMID:23034163
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ZGRF1 mRNA	PMID:38218311
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314105	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZGRF1 mRNA	PMID:33045310
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ZGRF1 mRNA	PMID:25812627
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ZGRF1 mRNA	PMID:33167477
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZGRF1 mRNA	PMID:26079696
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314105	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZGRF1 mRNA	PMID:39241906
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314105	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ZGRF1 mRNA	PMID:39298647
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1602323	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ZGRF1 mRNA	PMID:38568856
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ZGRF1 mRNA	PMID:26079696
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ZGRF1 mRNA	PMID:21592394
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1602323	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of ZGRF1 mRNA	PMID:21592394
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of ZGRF1 mRNA	PMID:21592394
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1602323	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of ZGRF1 mRNA	PMID:21592394
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ZGRF1 mRNA	PMID:33387578
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:18300	maleic acid	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20180220	CTD	MESH:C030272	maleic acid results in decreased expression of ZGRF1 mRNA	PMID:28392987
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1602323	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ZGRF1 mRNA	PMID:23649840
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZGRF1 mRNA	PMID:33354967
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1602323	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZGRF1 intron	PMID:30157460
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1602323	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZGRF1 mRNA	PMID:23649840
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314105	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ZGRF1 mRNA	PMID:40504410
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ZGRF1 mRNA	PMID:26272509
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1602323	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZGRF1 mRNA	PMID:27188386
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1602323	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ZGRF1 protein	PMID:35688186
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of ZGRF1 gene	PMID:35440735
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1602323	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ZGRF1 mRNA	PMID:23557933
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1602323	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ZGRF1 mRNA	PMID:28903495
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZGRF1 mRNA	PMID:33212167
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ZGRF1 mRNA	PMID:28959563
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZGRF1 mRNA	PMID:29803840
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314105	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZGRF1 mRNA	PMID:36209798
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZGRF1 mRNA	PMID:38568856
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314105	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ZGRF1 mRNA	PMID:40504410
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602323	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZGRF1 5' UTR	PMID:27901495
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1602323	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZGRF1 mRNA	PMID:32234424
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZGRF1 mRNA	PMID:34492290
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZGRF1 mRNA	PMID:25181051
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314105	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ZGRF1 mRNA	PMID:32156529
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ZGRF1 mRNA	PMID:29275510
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314105	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ZGRF1 mRNA	PMID:26063408
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314105	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZGRF1 mRNA	PMID:37019170
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1602323	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZGRF1 mRNA	PMID:37042841
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ZGRF1 mRNA	PMID:25812627|PMID:36326898
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ZGRF1 mRNA	PMID:25812627
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314105	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ZGRF1 mRNA	PMID:40194260
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1602323	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZGRF1 mRNA	PMID:31533062
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314105	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ZGRF1 mRNA	PMID:39529242
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ZGRF1 mRNA	PMID:25812627
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZGRF1 mRNA	PMID:23179753|PMID:27188386
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1602323	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of ZGRF1 mRNA	PMID:28001369
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1602323	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ZGRF1 mRNA	PMID:38832940
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZGRF1 mRNA	PMID:33387578
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1602323	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ZGRF1 mRNA	PMID:22230336
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ZGRF1 mRNA	PMID:29523930
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314105	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ZGRF1 mRNA	PMID:40504410
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1602323	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZGRF1 protein	PMID:31285264
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602323	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZGRF1 mRNA	PMID:27188386
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1602323	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ZGRF1 mRNA	PMID:30928695
1305834	Zgrf1	zinc finger, GRF-type containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602323	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZGRF1 mRNA	PMID:27188386
1305835	Tectb	tectorin beta	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314107	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TECTB mRNA	PMID:33045310
1305835	Tectb	tectorin beta	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TECTB mRNA	PMID:33387578
1305835	Tectb	tectorin beta	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314106	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TECTB gene	PMID:27153756
1305835	Tectb	tectorin beta	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314107	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TECTB mRNA	PMID:28960355
1305835	Tectb	tectorin beta	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314106	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of TECTB mRNA	PMID:41028656
1305835	Tectb	tectorin beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314107	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TECTB mRNA	PMID:21570461
1305835	Tectb	tectorin beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TECTB mRNA	PMID:21724226|PMID:33387578
1305835	Tectb	tectorin beta	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314106	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of TECTB mRNA	PMID:29955902
1305835	Tectb	tectorin beta	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TECTB mRNA	PMID:26033743
1305835	Tectb	tectorin beta	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of TECTB mRNA	PMID:26033743
1305835	Tectb	tectorin beta	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314106	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TECTB mRNA	PMID:41028656
1305835	Tectb	tectorin beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314106	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TECTB mRNA	PMID:32234424
1305835	Tectb	tectorin beta	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314106	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TECTB exon; Benzo(a)pyrene results in increased methylation of TECTB promoter	PMID:27901495
1305835	Tectb	tectorin beta	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TECTB mRNA	PMID:26033743
1305835	Tectb	tectorin beta	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of TECTB mRNA	PMID:26033743
1305835	Tectb	tectorin beta	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314106	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TECTB mRNA	PMID:41028656
1305835	Tectb	tectorin beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314107	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TECTB mRNA	PMID:18648102
1305835	Tectb	tectorin beta	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314107	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TECTB mRNA	PMID:19710929
1305835	Tectb	tectorin beta	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TECTB mRNA	PMID:25181051
1305835	Tectb	tectorin beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TECTB mRNA	PMID:34947998
1305835	Tectb	tectorin beta	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of TECTB mRNA	PMID:32680482
1305835	Tectb	tectorin beta	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TECTB mRNA	PMID:35163327
1305835	Tectb	tectorin beta	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TECTB mRNA	PMID:35163327
1305835	Tectb	tectorin beta	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314107	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of TECTB mRNA	PMID:28962523
1305835	Tectb	tectorin beta	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314107	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TECTB mRNA	PMID:40194260
1305835	Tectb	tectorin beta	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314106	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TECTB gene	PMID:29154799
1305835	Tectb	tectorin beta	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TECTB mRNA	PMID:33387578
1305835	Tectb	tectorin beta	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TECTB mRNA	PMID:29391264
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1314108	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RASGEF1A mRNA	PMID:26272509|PMID:27188386
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1314108	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA	PMID:27188386
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314109	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASGEF1A mRNA	PMID:30529165
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1314108	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RASGEF1A mRNA	PMID:26079696
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314109	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of RASGEF1A mRNA	PMID:30319688
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314108	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RASGEF1A mRNA	PMID:31614463
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RASGEF1A mRNA	PMID:33387578
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314108	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RASGEF1A mRNA	PMID:37042841
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1314108	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of RASGEF1A mRNA	PMID:26079696
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RASGEF1A mRNA	PMID:26577399
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1314108	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RASGEF1A intron	PMID:30157460
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314108	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RASGEF1A intron	PMID:30157460
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314109	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RASGEF1A mRNA	PMID:34911549
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1314108	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RASGEF1A mRNA	PMID:26272509
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314108	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASGEF1A mRNA	PMID:27188386
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314108	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RASGEF1A mRNA	PMID:28903495
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314108	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RASGEF1A mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314109	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RASGEF1A mRNA	PMID:27862939
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1314108	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RASGEF1A gene	PMID:28589171
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314109	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of RASGEF1A mRNA	PMID:36209798
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314108	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RASGEF1A 5' UTR; Benzo(a)pyrene affects the methylation of RASGEF1A intron	PMID:27901495|PMID:30157460
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314108	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RASGEF1A promoter	PMID:27901495
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314108	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RASGEF1A gene	PMID:31601247
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314109	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RASGEF1A mRNA	PMID:23557971|PMID:27760801
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314108	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of RASGEF1A gene	PMID:31601247
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RASGEF1A mRNA	PMID:25181051
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314109	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RASGEF1A mRNA	PMID:32156529
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in increased expression of RASGEF1A mRNA	PMID:27178563
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314108	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RASGEF1A gene	PMID:31601247
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314108	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RASGEF1A gene	PMID:31601247
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1314108	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RASGEF1A intron	PMID:30157460
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314109	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RASGEF1A mRNA	PMID:37019170
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314109	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of RASGEF1A mRNA	PMID:36117858
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314108	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RASGEF1A mRNA	PMID:37042841
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314108	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RASGEF1A mRNA	PMID:24449571
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314108	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RASGEF1A mRNA	PMID:25979313
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314109	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RASGEF1A mRNA	PMID:17963808
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314108	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of RASGEF1A mRNA	PMID:23179753|PMID:26272509|PMID:27188386|PMID:29154799
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314108	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA	PMID:27188386
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1314108	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RASGEF1A mRNA	PMID:27188386
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1314108	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RASGEF1A mRNA	PMID:24935251
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314109	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RASGEF1A mRNA; Nanotubes, Carbon results in decreased expression of RASGEF1A mRNA	PMID:25554681
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314109	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of RASGEF1A mRNA	PMID:36117858
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1314108	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RASGEF1A intron	PMID:30157460
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314109	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RASGEF1A mRNA	PMID:22206623
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314108	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASGEF1A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA	PMID:27188386
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1314108	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of RASGEF1A mRNA	PMID:26079696
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RASGEF1A mRNA	PMID:24780913
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314108	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASGEF1A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA	PMID:27188386
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RASGEF1A mRNA	PMID:19281266
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:9546	thimerosal	decreases expression	ISO	RGD:1314108	E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of RASGEF1A mRNA	PMID:27188386
1305836	Rasgef1a	RasGEF domain family, member 1A	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1314109	E	RGD:6480464	20140715	CTD	MESH:D013849	Thimerosal results in increased expression of RASGEF1A mRNA	PMID:24675092
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SPIRE2 mRNA]	PMID:31150632
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SPIRE2 mRNA	PMID:30071829
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIRE2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPIRE2 gene	PMID:20938992
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of SPIRE2 mRNA	PMID:20488242
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SPIRE2 mRNA	PMID:36331819
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:16243	quercetin	increases phosphorylation	ISO	RGD:1314110	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of SPIRE2 protein	PMID:35688186
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314110	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of SPIRE2 mRNA	PMID:31614463
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314110	E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of SPIRE2 mRNA	PMID:20404318
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPIRE2 mRNA	PMID:33387578
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIRE2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPIRE2 gene	PMID:20938992
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	ISO	RGD:1314110	E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of SPIRE2 gene	PMID:30521419
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:37992649
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:37992649
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	ISO	RGD:1314110	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SPIRE2 protein	PMID:37730182
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1314110	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of SPIRE2 intron	PMID:30157460
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPIRE2 mRNA	PMID:36331819
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314110	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SPIRE2 gene; Aflatoxin B1 results in increased methylation of SPIRE2 intron	PMID:27153756|PMID:30157460
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SPIRE2 mRNA	PMID:31150632
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SPIRE2 mRNA]	PMID:31150632
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314111	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPIRE2 mRNA	PMID:25629700
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIRE2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPIRE2 gene	PMID:20938992
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1314110	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SPIRE2 gene	PMID:25304211
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1314110	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SPIRE2 protein	PMID:35688186
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SPIRE2 mRNA	PMID:31881176
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314110	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SPIRE2 mRNA	PMID:23557933
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPIRE2 mRNA	PMID:22298810
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314111	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPIRE2 mRNA	PMID:21570461|PMID:26377647
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314111	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPIRE2 mRNA	PMID:19933214
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPIRE2 mRNA	PMID:33387578
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314110	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SPIRE2 mRNA	PMID:33212167
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SPIRE2 mRNA	PMID:26033743
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:26033743
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:37992649
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314110	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SPIRE2 mRNA	PMID:39719251
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314110	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPIRE2 intron; Benzo(a)pyrene affects the methylation of SPIRE2 promoter	PMID:27901495|PMID:30157460
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SPIRE2 mRNA	PMID:26033743
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:26033743
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314111	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SPIRE2 mRNA	PMID:29203145
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314111	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPIRE2 gene	PMID:35295148
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314111	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of SPIRE2 mRNA	PMID:29264374
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SPIRE2 mRNA	PMID:23411599|PMID:34492290
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314111	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SPIRE2 mRNA	PMID:18648102
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPIRE2 mRNA	PMID:25181051
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314111	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SPIRE2 mRNA	PMID:32156529
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1314110	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SPIRE2 intron	PMID:30157460
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314111	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SPIRE2 mRNA	PMID:37019170
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPIRE2 mRNA	PMID:36928142
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314111	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SPIRE2 mRNA	PMID:40194260
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1314110	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SPIRE2 mRNA	PMID:31533062
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:3908	coumestrol	decreases expression	ISO	RGD:1314110	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of SPIRE2 mRNA	PMID:19167446
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:39178	clothianidin	decreases expression	ISO	RGD:1314110	E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin results in decreased expression of SPIRE2 mRNA	PMID:29044138
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPIRE2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SPIRE2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SPIRE2 mRNA	PMID:36331819
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314111	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SPIRE2 mRNA	PMID:21427059
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314110	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SPIRE2 gene	PMID:29154799
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314110	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SPIRE2 mRNA	PMID:25562108
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:4031	cyclosporin A	increases methylation	ISO	RGD:1314110	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of SPIRE2 promoter	PMID:27989131
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:37992649
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314111	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SPIRE2 mRNA	PMID:17562736
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SPIRE2 mRNA	PMID:33387578
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314110	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of SPIRE2 mRNA	PMID:29067470
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314111	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SPIRE2 mRNA	PMID:29279043
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1314110	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SPIRE2 gene	PMID:25304211
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SPIRE2 mRNA	PMID:29391264
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1314110	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SPIRE2 intron	PMID:30157460
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314111	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SPIRE2 mRNA	PMID:22206623
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of SPIRE2 mRNA	PMID:26720608
1305837	Spire2	spire-type actin nucleation factor 2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314111	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of SPIRE2 mRNA	PMID:40826991
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1344123	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DPPA5 mRNA	PMID:26272509
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1344123	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA	PMID:27188386
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	ISO	RGD:1344123	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of DPPA5 mRNA	PMID:34925699
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314112	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of DPPA5A mRNA	PMID:30951980
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1344123	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of DPPA5 mRNA	PMID:31614463
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DPPA5 mRNA	PMID:33387578
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1344123	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DPPA5 mRNA	PMID:31163220
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314112	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DPPA5A mRNA	PMID:33754040
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314112	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DPPA5A mRNA	PMID:37325564
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314112	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of DPPA5A mRNA	PMID:39631538
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:29073	L-ascorbic acid	decreases expression	ISO	RGD:1314112	E	RGD:6480464	20131126	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of DPPA5A mRNA	PMID:15305145
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1344123	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DPPA5 promoter	PMID:27901495
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314112	E	RGD:6480464	20131126	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DPPA5 mRNA	PMID:19770486
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314112	E	RGD:6480464	20131126	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DPPA5 mRNA	PMID:18648102
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314112	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DPPA5A mRNA	PMID:28472532
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314112	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of DPPA5A mRNA	PMID:26063408
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1344123	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of DPPA5 mRNA	PMID:37834465
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1344123	E	RGD:6480464	20240206	CTD	MESH:C006780	[bisphenol A co-treated with perfluorooctane sulfonic acid] results in decreased expression of DPPA5 mRNA	PMID:37834465
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314112	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of DPPA5A mRNA	PMID:30951980
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1344123	E	RGD:6480464	20240206	CTD	MESH:C543008	[bisphenol S co-treated with perfluorooctane sulfonic acid] results in decreased expression of DPPA5 mRNA	PMID:37834465
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1314112	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of DPPA5A mRNA	PMID:31558096
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314112	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DPPA5A mRNA	PMID:37325564
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1314112	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of DPPA5A mRNA	PMID:24183702
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1344123	E	RGD:6480464	20240206	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DPPA5 mRNA	PMID:37834465
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1344123	E	RGD:6480464	20240206	CTD	MESH:C076994	[bisphenol A co-treated with perfluorooctane sulfonic acid] results in decreased expression of DPPA5 mRNA; [bisphenol S co-treated with perfluorooctane sulfonic acid] results in decreased expression of DPPA5 mRNA	PMID:37834465
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1314112	E	RGD:6480464	20131126	CTD	MESH:C016104	sodium bichromate results in increased expression of DPPA5A mRNA	PMID:22155349
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344123	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DPPA5 mRNA	PMID:25979313
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344123	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DPPA5 mRNA	PMID:24383497|PMID:28001369
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1344123	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DPPA5 gene	PMID:29154799
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1344123	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of DPPA5 mRNA	PMID:24935251|PMID:26272509
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1344123	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA	PMID:27188386
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314112	E	RGD:6480464	20131126	CTD	MESH:D000082	Acetaminophen affects the expression of DPPA5 mRNA	PMID:17562736
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:61076	belinostat	increases expression	ISO	RGD:1344123	E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of DPPA5 mRNA	PMID:26272509
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:61076	belinostat	multiple interactions	ISO	RGD:1344123	E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA	PMID:27188386
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314112	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DPPA5A mRNA	PMID:22206623
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344123	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA	PMID:27188386
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1314112	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of DPPA5A mRNA	PMID:31558096
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1344123	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of DPPA5 mRNA	PMID:26272509
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1344123	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA	PMID:27188386
1305838	Dppa5	developmental pluripotency associated 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344123	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPPA5 mRNA	PMID:27188386
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ARIH2 mRNA	PMID:37995155
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314114	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of ARIH2 mRNA]	PMID:19467301
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of ARIH2 protein	PMID:39571964
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ARIH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ARIH2 mRNA	PMID:32699268
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314114	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARIH2 mRNA	PMID:30319688
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314114	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ARIH2 mRNA	PMID:39298647
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ARIH2 mRNA	PMID:23829299
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314113	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARIH2 mRNA	PMID:37042841
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARIH2 mRNA	PMID:21318169
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ARIH2 mRNA	PMID:21318169
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARIH2 mRNA	PMID:33387578
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of ARIH2 mRNA	PMID:37748715
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314114	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARIH2 mRNA	PMID:36331819
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARIH2 mRNA	PMID:19770486
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1314113	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ARIH2 mRNA	PMID:23649840
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ARIH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ARIH2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of ARIH2 mRNA	PMID:32699268
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314113	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ARIH2 mRNA	PMID:21867686
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:1314113	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of ARIH2 mRNA	PMID:18414638
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ARIH2 mRNA	PMID:23557933
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314113	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ARIH2 mRNA	PMID:27392435
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314114	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARIH2 mRNA	PMID:21570461
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARIH2 mRNA	PMID:19770486
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1314113	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ARIH2 protein	PMID:39603559
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ARIH2 mRNA	PMID:20061341
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ARIH2 mRNA	PMID:28959563
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314113	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of ARIH2 protein	PMID:38228842
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of ARIH2 protein	PMID:39571964
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1314113	E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of ARIH2 mRNA	PMID:29453283
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314113	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARIH2 5' UTR	PMID:27901495
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314113	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARIH2 mRNA	PMID:26238291
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314113	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ARIH2 mRNA	PMID:25351596
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314113	E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ARIH2 mRNA	PMID:23806026
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of ARIH2 gene	PMID:31601247
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ARIH2 mRNA	PMID:25729387
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ARIH2 mRNA	PMID:30047161
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ARIH2 mRNA	PMID:34492290
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ARIH2 mRNA	PMID:18648102
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ARIH2 mRNA	PMID:15375163
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARIH2 mRNA	PMID:25181051
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1314113	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ARIH2 mRNA	PMID:30903817
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARIH2 mRNA	PMID:33221593|PMID:38074096
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314113	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARIH2 gene	PMID:31601247
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ARIH2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:36041667
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARIH2 mRNA	PMID:28628672
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1314113	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ARIH2 mRNA	PMID:25979313
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314114	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ARIH2 mRNA	PMID:39298647
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:36041667
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:28628672
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34445	4-tert-Octylphenol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C105260	4-tert-octylphenol results in increased expression of ARIH2 mRNA	PMID:17011747
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:36041667
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of ARIH2 gene	PMID:31601247
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314114	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ARIH2 intron	PMID:28392331
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ARIH2 mRNA	PMID:20350560
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARIH2 mRNA	PMID:21266533
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARIH2 mRNA	PMID:21266533
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34696	dieldrin	decreases response to substance	ISO	RGD:1314113	E	RGD:6480464	20201006	CTD	MESH:D004026	ARIH2 gene mutant form results in decreased susceptibility to Dieldrin	PMID:32421776
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARIH2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:28628672
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314113	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARIH2 mRNA	PMID:37042841
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:35096	p-tert-Amylphenol	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C019566	4-tert-octylphenol results in increased expression of ARIH2 mRNA	PMID:17011747
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314113	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARIH2 mRNA	PMID:38568856
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARIH2 mRNA	PMID:33453195
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARIH2 mRNA	PMID:20061341
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ARIH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ARIH2 mRNA	PMID:32699268
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ARIH2 mRNA	PMID:17585979
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314113	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ARIH2 mRNA	PMID:32588087
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314114	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARIH2 mRNA	PMID:36331819
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314113	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARIH2 mRNA	PMID:25979313
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314113	E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of ARIH2 mRNA	PMID:23179753|PMID:25192806|PMID:29154799
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ARIH2 mRNA	PMID:17183730
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ARIH2 mRNA	PMID:30047161
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314113	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ARIH2 mRNA	PMID:20106945
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARIH2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:28628672
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ARIH2 mRNA	PMID:17011747
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314114	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ARIH2 mRNA	PMID:28973697
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1314113	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of ARIH2 mRNA	PMID:33512557
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARIH2 mRNA	PMID:17562736
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314113	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ARIH2 mRNA	PMID:29067470
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314114	E	RGD:6480464	20150414	CTD	MESH:D000082	[CTH gene mutant form results in increased susceptibility to Acetaminophen] which affects the expression of ARIH2 protein	PMID:25499718
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:1314113	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of ARIH2 mRNA	PMID:18414638
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1314113	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ARIH2 mRNA	PMID:18175754
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARIH2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:28628672
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ARIH2 mRNA	PMID:30047161
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ARIH2 mRNA	PMID:24136188
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314114	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of ARIH2 mRNA	PMID:26377693
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1314113	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ARIH2 mRNA	PMID:17183730
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ARIH2 mRNA	PMID:25729387
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of ARIH2 mRNA	PMID:22470460
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	ISO	RGD:1314113	E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of ARIH2 mRNA	PMID:22101062
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314114	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARIH2 mRNA	PMID:22206623
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARIH2 mRNA	PMID:30047161
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ARIH2 mRNA	PMID:19281266
1305839	Arih2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ARIH2 mRNA	PMID:21346803
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314116	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ABCG4 mRNA	PMID:33045310
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314116	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ABCG4 mRNA	PMID:20188158
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1314115	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ABCG4 mRNA	PMID:26079696
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ABCG4 mRNA	PMID:26496021
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314115	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ABCG4 mRNA	PMID:30165855
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:17153	propanal	increases expression	ISO	RGD:1314115	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ABCG4 mRNA	PMID:26079696
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314116	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ABCG4 mRNA	PMID:39922521
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314115	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ABCG4 mRNA	PMID:33359661
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of ABCG4 mRNA	PMID:26496021
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314116	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ABCG4 mRNA	PMID:39922521
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA]	PMID:22129741
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314115	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABCG4 mRNA	PMID:22100608
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ABCG4 mRNA	PMID:25629700
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314116	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ABCG4 mRNA]	PMID:22206623
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314115	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCG4 mRNA	PMID:32525701
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1314115	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ABCG4 mRNA	PMID:38460933
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1314115	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ABCG4 mRNA	PMID:38460933
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314116	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ABCG4 mRNA	PMID:28960355
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ABCG4 mRNA	PMID:31881176
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314115	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ABCG4 mRNA	PMID:28903495
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314115	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ABCG4 mRNA	PMID:27392435
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314115	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ABCG4 mRNA	PMID:27392435
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCG4 mRNA	PMID:22298810
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314116	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCG4 mRNA	PMID:21570461
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:28445	vincristine	multiple interactions	ISO	RGD:1314115	E	RGD:6480464	20161213	CTD	MESH:D014750	[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCG4 mRNA	PMID:19944135
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA]	PMID:22129741
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314115	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ABCG4 promoter	PMID:27901495
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314115	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCG4 mRNA	PMID:32234424
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314116	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCG4 mRNA	PMID:22228805
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314115	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ABCG4 3' UTR	PMID:27901495
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:31575	ethylparaben	decreases expression	ISO	RGD:1314115	E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ABCG4 mRNA	PMID:37690743
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ABCG4 mRNA	PMID:25729387
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ABCG4 mRNA	PMID:25729387
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ABCG4 mRNA	PMID:30047161
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314116	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABCG4 promoter	PMID:35295148
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCG4 mRNA	PMID:30816183
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCG4 mRNA	PMID:32156529
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ABCG4 mRNA; [bisphenol A co-treated with Testosterone] results in decreased expression of ABCG4 mRNA	PMID:26496021
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of ABCG4 mRNA	PMID:26377693
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:34631	chlorpyrifos	affects expression	ISO	RGD:1314116	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos affects the expression of ABCG4 mRNA	PMID:37019170
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ABCG4 mRNA	PMID:21266533
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA]	PMID:22129741
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1314115	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ABCG4 mRNA	PMID:31533062
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1314116	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ABCG4 mRNA	PMID:39529242
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ABCG4 mRNA	PMID:30047161
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ABCG4 mRNA	PMID:28973697
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314116	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ABCG4 mRNA	PMID:39922521
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314116	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ABCG4 mRNA	PMID:18502557
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314115	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ABCG4 mRNA	PMID:38832940
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABCG4 mRNA	PMID:33387578
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1314115	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ABCG4 mRNA	PMID:38460933
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314115	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCG4 mRNA	PMID:32525701
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ABCG4 mRNA	PMID:29391264
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:4953	exemestane	increases expression	ISO	RGD:1314115	E	RGD:6480464	20120412	CTD	MESH:C056516	exemestane results in increased expression of ABCG4 mRNA	PMID:17254854
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ABCG4 mRNA	PMID:30307764
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ABCG4 mRNA	PMID:30047161
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314116	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ABCG4 mRNA	PMID:23608068
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:63632	topotecan	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ABCG4 mRNA	PMID:25729387
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ABCG4 mRNA	PMID:25729387
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ABCG4 mRNA	PMID:22206623
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314116	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ABCG4 mRNA]	PMID:22206623
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1314115	E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ABCG4 mRNA	PMID:36318118
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of ABCG4 mRNA	PMID:33484710
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:7719	ochratoxin A	decreases methylation	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased methylation of ABCG4 gene	PMID:37162024
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased expression of ABCG4 mRNA	PMID:37162024
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314116	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ABCG4 mRNA	PMID:38648751
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:84069	pentanal	increases expression	ISO	RGD:1314115	E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ABCG4 mRNA	PMID:26079696
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1314115	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCG4 mRNA	PMID:32525701
1305840	Abcg4	ATP binding cassette subfamily G member 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ABCG4 mRNA	PMID:30047161
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of GPR158 gene	PMID:28931070
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1314117	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of GPR158 mRNA	PMID:29581250
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314117	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of GPR158 protein	PMID:37730182
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1314117	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of GPR158 intron	PMID:30157460
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314117	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPR158 mRNA	PMID:35301059
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314117	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GPR158 gene; Aflatoxin B1 results in decreased methylation of GPR158 intron	PMID:27153756|PMID:30157460
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of GPR158 mRNA	PMID:31129395
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314117	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GPR158 mRNA	PMID:21867686
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552307	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GPR158 mRNA	PMID:25629700
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of GPR158 gene	PMID:35440735
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPR158 mRNA	PMID:32109520
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552307	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPR158 mRNA	PMID:21570461
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of GPR158 mRNA	PMID:28374803
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552307	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of GPR158 mRNA	PMID:36209798
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552307	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of GPR158 mRNA	PMID:37682722
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314117	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GPR158 3' UTR	PMID:27901495
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1314117	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of GPR158 promoter	PMID:23974009
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314117	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of GPR158 gene	PMID:31601247
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552307	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GPR158 gene	PMID:35295148
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GPR158 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314117	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of GPR158 mRNA	PMID:27685785
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552307	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of GPR158 mRNA	PMID:32156529
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of GPR158 mRNA	PMID:31129395
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552307	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of GPR158 gene	PMID:31683443
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314117	E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of GPR158 gene	PMID:31601247
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552307	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of GPR158 intron	PMID:28392331
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of GPR158 mRNA	PMID:32680482
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314117	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPR158 mRNA	PMID:35301059
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1314117	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GPR158 mRNA	PMID:31533062
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314117	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GPR158 mRNA	PMID:25979313
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314117	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GPR158 gene	PMID:29154799
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314117	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of GPR158 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314117	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR158 mRNA	PMID:27188386
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314117	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of GPR158 mRNA	PMID:20106945
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1314117	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of GPR158 mRNA	PMID:24935251
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552307	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GPR158 mRNA	PMID:17562736
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GPR158 gene	PMID:35440735
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552307	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GPR158 mRNA	PMID:22206623
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314117	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR158 mRNA	PMID:27188386
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1314117	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of GPR158 mRNA	PMID:19095052
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GPR158 mRNA	PMID:24780913|PMID:25825206
1305841	Gpr158	G protein-coupled receptor 158	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314117	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR158 mRNA	PMID:27188386
1305843	Caln1	calneuron 1	gene	CHEBI:132082	entinostat	increases expression	ISO	RGD:1314120	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CALN1 mRNA	PMID:27188386
1305843	Caln1	calneuron 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CALN1 gene	PMID:20938992
1305843	Caln1	calneuron 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314121	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of CALN1 mRNA	PMID:36189433
1305843	Caln1	calneuron 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CALN1 mRNA	PMID:36189433
1305843	Caln1	calneuron 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1314120	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of CALN1 mRNA	PMID:24763279
1305843	Caln1	calneuron 1	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CALN1 gene	PMID:28931070
1305843	Caln1	calneuron 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314121	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CALN1 mRNA	PMID:30319688
1305843	Caln1	calneuron 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314121	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CALN1 mRNA	PMID:39298647
1305843	Caln1	calneuron 1	gene	CHEBI:16548	chlordecone	affects response to substance	ISO	RGD:1314120	E	RGD:6480464	20150609	CTD	MESH:D007631	CALN1 gene SNP affects the susceptibility to Chlordecone	PMID:25622337
1305843	Caln1	calneuron 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CALN1 gene	PMID:27618143
1305843	Caln1	calneuron 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CALN1 gene	PMID:20938992
1305843	Caln1	calneuron 1	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1314121	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in decreased expression of CALN1 mRNA	PMID:37084897
1305843	Caln1	calneuron 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CALN1 mRNA	PMID:23649840
1305843	Caln1	calneuron 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1314121	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of CALN1 mRNA	PMID:22238285
1305843	Caln1	calneuron 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:37992649
1305843	Caln1	calneuron 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CALN1 mRNA	PMID:36189433
1305843	Caln1	calneuron 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314121	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of CALN1 mRNA	PMID:33848595
1305843	Caln1	calneuron 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:37992649
1305843	Caln1	calneuron 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CALN1 mRNA	PMID:31163220
1305843	Caln1	calneuron 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1314120	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of CALN1 intron	PMID:30157460
1305843	Caln1	calneuron 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of CALN1 mRNA	PMID:28522335
1305843	Caln1	calneuron 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CALN1 mRNA	PMID:23649840
1305843	Caln1	calneuron 1	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1314120	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CALN1 protein	PMID:20106945
1305843	Caln1	calneuron 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1314120	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of CALN1 intron	PMID:30157460
1305843	Caln1	calneuron 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CALN1 mRNA	PMID:23649840
1305843	Caln1	calneuron 1	gene	CHEBI:25710	organophosphorus compound	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in increased expression of CALN1 mRNA	PMID:39658253
1305843	Caln1	calneuron 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CALN1 gene	PMID:20938992
1305843	Caln1	calneuron 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CALN1 mRNA	PMID:26272509
1305843	Caln1	calneuron 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314120	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA	PMID:27188386
1305843	Caln1	calneuron 1	gene	CHEBI:27744	glyphosate	increases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of CALN1 gene	PMID:31011160
1305843	Caln1	calneuron 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314120	E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of CALN1 mRNA	PMID:41028656
1305843	Caln1	calneuron 1	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1314120	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CALN1 mRNA	PMID:28903495
1305843	Caln1	calneuron 1	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1314120	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CALN1 promoter	PMID:22847954
1305843	Caln1	calneuron 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CALN1 mRNA	PMID:19684285
1305843	Caln1	calneuron 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314121	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CALN1 mRNA	PMID:19684285
1305843	Caln1	calneuron 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CALN1 mRNA	PMID:17942748
1305843	Caln1	calneuron 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of CALN1 mRNA	PMID:26272509
1305843	Caln1	calneuron 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1314120	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA	PMID:27188386
1305843	Caln1	calneuron 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:26033743
1305843	Caln1	calneuron 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314120	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CALN1 mRNA	PMID:41028656
1305843	Caln1	calneuron 1	gene	CHEBI:28748	doxorubicin	affects methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of CALN1 gene	PMID:28962528
1305843	Caln1	calneuron 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CALN1 mRNA	PMID:30031762
1305843	Caln1	calneuron 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:37992649
1305843	Caln1	calneuron 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1314120	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of CALN1 gene	PMID:28589171
1305843	Caln1	calneuron 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CALN1 mRNA	PMID:21457566
1305843	Caln1	calneuron 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314120	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CALN1 5' UTR	PMID:27901495
1305843	Caln1	calneuron 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CALN1 mRNA	PMID:20106945
1305843	Caln1	calneuron 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314120	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CALN1 mRNA	PMID:22316170
1305843	Caln1	calneuron 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314120	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CALN1 promoter	PMID:27901495
1305843	Caln1	calneuron 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1314120	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CALN1 promoter	PMID:23974009
1305843	Caln1	calneuron 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:26033743
1305843	Caln1	calneuron 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314120	E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CALN1 mRNA	PMID:41028656
1305843	Caln1	calneuron 1	gene	CHEBI:31638	fulvestrant	increases methylation	ISO	RGD:1314120	E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CALN1 gene	PMID:31601247
1305843	Caln1	calneuron 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314120	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CALN1 gene	PMID:31601247
1305843	Caln1	calneuron 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314121	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CALN1 mRNA	PMID:29264374
1305843	Caln1	calneuron 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314121	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CALN1 gene	PMID:35295148
1305843	Caln1	calneuron 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314121	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CALN1 mRNA	PMID:18301758|PMID:23811191
1305843	Caln1	calneuron 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CALN1 mRNA	PMID:25181051|PMID:30816183
1305843	Caln1	calneuron 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314121	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CALN1 mRNA	PMID:32156529
1305843	Caln1	calneuron 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of CALN1 mRNA	PMID:29097150
1305843	Caln1	calneuron 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CALN1 gene	PMID:28505145
1305843	Caln1	calneuron 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314120	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CALN1 gene	PMID:31601247
1305843	Caln1	calneuron 1	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1314120	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CALN1 mRNA	PMID:25979313
1305843	Caln1	calneuron 1	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	ISO	RGD:1314120	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of CALN1 intron	PMID:30157460
1305843	Caln1	calneuron 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314121	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CALN1 mRNA	PMID:38685157
1305843	Caln1	calneuron 1	gene	CHEBI:34575	bisphenol F	increases methylation	ISO	RGD:1314120	E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in increased methylation of CALN1 gene	PMID:31601247
1305843	Caln1	calneuron 1	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314121	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of CALN1 intron	PMID:28392331
1305843	Caln1	calneuron 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of CALN1 mRNA	PMID:36117858
1305843	Caln1	calneuron 1	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of CALN1 gene	PMID:33148267
1305843	Caln1	calneuron 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314120	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CALN1 mRNA	PMID:38568856
1305843	Caln1	calneuron 1	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of CALN1 mRNA	PMID:25539665
1305843	Caln1	calneuron 1	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1314120	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CALN1 promoter	PMID:22847954
1305843	Caln1	calneuron 1	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1314120	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CALN1 promoter	PMID:22847954
1305843	Caln1	calneuron 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314120	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CALN1 mRNA	PMID:25979313
1305843	Caln1	calneuron 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314121	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CALN1 mRNA	PMID:17963808
1305843	Caln1	calneuron 1	gene	CHEBI:4031	cyclosporin A	decreases methylation	ISO	RGD:1314120	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CALN1 promoter	PMID:27989131
1305843	Caln1	calneuron 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:37992649
1305843	Caln1	calneuron 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314121	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CALN1 mRNA	PMID:18502557
1305843	Caln1	calneuron 1	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1314120	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of CALN1 mRNA	PMID:24449571
1305843	Caln1	calneuron 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314120	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of CALN1 mRNA	PMID:29067470
1305843	Caln1	calneuron 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314121	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CALN1 mRNA	PMID:29279043
1305843	Caln1	calneuron 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CALN1 mRNA	PMID:17942748
1305843	Caln1	calneuron 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CALN1 mRNA	PMID:32234424
1305843	Caln1	calneuron 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314121	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CALN1 mRNA	PMID:25620056
1305843	Caln1	calneuron 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of CALN1 mRNA	PMID:36117858
1305843	Caln1	calneuron 1	gene	CHEBI:64211	8-Br-cAMP	decreases expression	ISO	RGD:1314120	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CALN1 mRNA	PMID:22079614
1305843	Caln1	calneuron 1	gene	CHEBI:6820	methapyrilene	affects methylation	ISO	RGD:1314120	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of CALN1 intron	PMID:30157460
1305843	Caln1	calneuron 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of CALN1 gene	PMID:33148267
1305843	Caln1	calneuron 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314120	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA	PMID:27188386
1305843	Caln1	calneuron 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314121	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CALN1 mRNA	PMID:31388691
1305843	Caln1	calneuron 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314121	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CALN1 mRNA	PMID:38648751
1305843	Caln1	calneuron 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1314120	E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of CALN1 mRNA	PMID:26705709
1305843	Caln1	calneuron 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CALN1 mRNA	PMID:24780913
1305843	Caln1	calneuron 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314120	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA	PMID:27188386
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of RALYL gene	PMID:35440735
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314122	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RALYL mRNA	PMID:30319688
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314122	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RALYL mRNA	PMID:25510870
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314122	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RALYL mRNA	PMID:28085963
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RALYL mRNA	PMID:26577399
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1314122	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of RALYL mRNA	PMID:39984025
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314122	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RALYL mRNA	PMID:25510870
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314122	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RALYL mRNA	PMID:25510870
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1606457	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RALYL gene	PMID:27153756
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1606457	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RALYL gene	PMID:25304211
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RALYL mRNA	PMID:32109520
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1606457	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of RALYL mRNA	PMID:29955902
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1606457	E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RALYL mRNA	PMID:23179753
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1606457	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RALYL 5' UTR	PMID:27901495
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1606457	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RALYL exon; Benzo(a)pyrene results in decreased methylation of RALYL promoter	PMID:27901495
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1606457	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RALYL mRNA	PMID:25895662
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314122	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RALYL gene	PMID:35295148
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RALYL mRNA	PMID:25181051
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314122	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RALYL mRNA	PMID:32156529
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314122	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RALYL mRNA	PMID:30951980
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314122	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RALYL mRNA	PMID:25510870
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314122	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RALYL mRNA	PMID:25510870
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314122	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RALYL mRNA	PMID:30951980
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314122	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RALYL intron	PMID:28392331
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1606457	E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of RALYL protein	PMID:34122009
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314122	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RALYL mRNA	PMID:17963808
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314122	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of RALYL mRNA	PMID:24896083
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1606457	E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of RALYL mRNA	PMID:26690555
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1606457	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RALYL gene	PMID:25304211
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	ISO	RGD:1606457	E	RGD:6480464	20220405	CTD	MESH:C045338	RALYL protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RALYL mRNA	PMID:32109520
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1314122	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RALYL mRNA	PMID:27935865
1305844	Ralyl	RALY RNA binding protein-like	gene	CHEBI:9195	Soman	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RALYL mRNA	PMID:19281266
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1353281	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of STYXL1 mRNA	PMID:38218311
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551800	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of STYXL1 mRNA	PMID:33045310
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551800	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STYXL1 gene	PMID:20938992
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1353281	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of STYXL1 mRNA	PMID:33167477
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1353281	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of STYXL1 mRNA	PMID:26079696
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of STYXL1 mRNA	PMID:36841081
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of STYXL1 mRNA	PMID:33387578
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of STYXL1 gene	PMID:27618143
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551800	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STYXL1 gene	PMID:20938992
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353281	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of STYXL1 mRNA	PMID:37042841
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1353281	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of STYXL1 mRNA	PMID:21179406
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1551800	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STYXL1 mRNA	PMID:37992649
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of STYXL1 mRNA	PMID:26496021
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1551800	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STYXL1 mRNA	PMID:37992649
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of STYXL1 mRNA	PMID:26577399
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1353281	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of STYXL1 mRNA	PMID:28818685
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of STYXL1 mRNA	PMID:21346803
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1353281	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STYXL1 mRNA	PMID:35301059
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1353281	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of STYXL1 mRNA	PMID:19549813
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of STYXL1 mRNA	PMID:25378103
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1551800	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of STYXL1 mRNA	PMID:34911549
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551800	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STYXL1 gene	PMID:20938992
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1353281	E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of STYXL1 mRNA	PMID:27424125
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1353281	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of STYXL1 mRNA	PMID:19244175
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:27656	camptothecin	decreases response to substance	ISO	RGD:1353281	E	RGD:6480464	20160315	CTD	MESH:D002166	STYXL1 mRNA results in decreased susceptibility to Camptothecin	PMID:25269479
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of STYXL1 mRNA	PMID:31881176
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1353281	E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of STYXL1 mRNA	PMID:27424125
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STYXL1 mRNA	PMID:32109520|PMID:33387578
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1353281	E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of STYXL1 mRNA	PMID:27424125
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1353281	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of STYXL1 mRNA	PMID:33212167
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	ISO	RGD:1353281	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of STYXL1 mRNA	PMID:30851411
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of STYXL1 mRNA	PMID:28959563
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1551800	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of STYXL1 mRNA	PMID:30807115
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1551800	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of STYXL1 protein	PMID:28918527
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D004317	Doxorubicin results in decreased expression of STYXL1 mRNA	PMID:32289291
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1551800	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STYXL1 mRNA	PMID:37992649
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353281	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of STYXL1 mRNA	PMID:39719251
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1353281	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of STYXL1 mRNA	PMID:22378314|PMID:29453283
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551800	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STYXL1 mRNA	PMID:22228805
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1353281	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to STYXL1 mRNA]	PMID:32406909
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of STYXL1 mRNA	PMID:30047161
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551800	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STYXL1 promoter alternative form	PMID:35295148
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of STYXL1 mRNA	PMID:30816183
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of STYXL1 mRNA	PMID:25181051
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of STYXL1 mRNA	PMID:26496021
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1353281	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of STYXL1 mRNA	PMID:19244175
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:34778	glycitein	multiple interactions	ISO	RGD:1353281	E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of STYXL1 mRNA	PMID:27424125
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1353281	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STYXL1 mRNA	PMID:37042841
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1353281	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STYXL1 mRNA	PMID:35301059
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:35559	furan	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of STYXL1 mRNA	PMID:25539665
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1353281	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of STYXL1 mRNA	PMID:19244175
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:3764	clotrimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of STYXL1 mRNA	PMID:30047161
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1551800	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of STYXL1 mRNA	PMID:39529242
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1551800	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of STYXL1 mRNA	PMID:23125180
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353281	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STYXL1 mRNA	PMID:25979313
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1353281	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of STYXL1 mRNA	PMID:23179753|PMID:27188386
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1353281	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of STYXL1 mRNA	PMID:29154799
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of STYXL1 mRNA	PMID:30047161
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1353281	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of STYXL1 mRNA	PMID:20106945
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	ISO	RGD:1353281	E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of STYXL1 mRNA	PMID:27424125
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551800	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of STYXL1 mRNA	PMID:28973697
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1551800	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STYXL1 mRNA	PMID:37992649
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1353281	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of STYXL1 mRNA	PMID:24449571
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of STYXL1 mRNA	PMID:21346803
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STYXL1 mRNA	PMID:33387578
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:4846	erythromycin estolate	increases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D004918	Erythromycin Estolate results in increased expression of STYXL1 mRNA	PMID:24412560
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551800	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of STYXL1 mRNA; Nanotubes, Carbon results in decreased expression of STYXL1 mRNA	PMID:25554681
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of STYXL1 mRNA	PMID:30047161
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1551800	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of STYXL1 mRNA	PMID:26307267
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of STYXL1 mRNA	PMID:30467583
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1353281	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of STYXL1 mRNA	PMID:37199045
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of STYXL1 mRNA	PMID:21346803
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	ISO	RGD:1353281	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of STYXL1 mRNA	PMID:30851411
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:80373	glycitin	multiple interactions	ISO	RGD:1353281	E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of STYXL1 mRNA	PMID:27424125
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:85014	2,5-hexanedione	increases expression	EXP		E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in increased expression of STYXL1 mRNA	PMID:22952946
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of STYXL1 mRNA	PMID:30047161
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of STYXL1 mRNA	PMID:24780913
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of STYXL1 mRNA	PMID:19281266
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of STYXL1 mRNA	PMID:21346803
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:95077	GSK-J4	decreases expression	ISO	RGD:1353281	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of STYXL1 mRNA	PMID:29301935
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1551800	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of STYXL1 mRNA	PMID:32835833
1305845	Styxl1	serine/threonine/tyrosine interacting-like 1	gene	CHEBI:9986	vinclozolin	increases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of STYXL1 gene	PMID:31079544
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314124	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of HJURP mRNA	PMID:33045310
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314124	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of HJURP mRNA	PMID:26251327
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1314124	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of HJURP promoter	PMID:26251327
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D014212	Tretinoin results in decreased expression of HJURP mRNA	PMID:16249480|PMID:33167477
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314124	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HJURP mRNA	PMID:39241906
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:164200	triclosan	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of HJURP mRNA	PMID:30510588
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of HJURP mRNA	PMID:35192832
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314124	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of HJURP mRNA	PMID:39298647
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D004958	Estradiol results in increased expression of HJURP mRNA	PMID:19167446
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HJURP mRNA	PMID:25510870
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:2292108	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of HJURP mRNA	PMID:38568856
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D005557	Formaldehyde results in decreased expression of HJURP mRNA	PMID:20655997
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D011374	Progesterone results in increased expression of HJURP mRNA	PMID:18070364
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:C044887	beta-methylcholine affects the expression of HJURP mRNA	PMID:21179406
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17153	propanal	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of HJURP mRNA	PMID:26079696
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314124	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of HJURP mRNA	PMID:39922521
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D013739	Testosterone results in decreased expression of HJURP mRNA	PMID:21592394
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of HJURP mRNA	PMID:21592394
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:C031927	hydroquinone results in decreased expression of HJURP mRNA	PMID:23416264
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314124	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of HJURP mRNA	PMID:39922521
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314124	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HJURP mRNA	PMID:27405655
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:2292108	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of HJURP protein	PMID:37730182
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D002117	Calcitriol results in decreased expression of HJURP mRNA	PMID:21592394
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of HJURP mRNA	PMID:21592394
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HJURP mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HJURP mRNA	PMID:37236586|PMID:37325564
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HJURP mRNA	PMID:25510870
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HJURP mRNA	PMID:25510870
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D016604	Aflatoxin B1 affects the expression of HJURP protein	PMID:20106945
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20200114	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of HJURP mRNA	PMID:31555880
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HJURP mRNA	PMID:25378103
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:2292108	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of HJURP gene	PMID:27153756|PMID:31555880
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of HJURP mRNA	PMID:25102026
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of HJURP mRNA	PMID:31129395
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D015032	Zinc deficiency results in increased expression of HJURP mRNA	PMID:22171008
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:2292108	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HJURP gene	PMID:25304211
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HJURP mRNA	PMID:40504410
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:2292108	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of HJURP protein	PMID:35688186
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HJURP mRNA	PMID:31881176
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of HJURP mRNA]	PMID:31298478
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of HJURP mRNA	PMID:19167446
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D002945	Cisplatin results in decreased expression of HJURP mRNA	PMID:19561079
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314124	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HJURP mRNA	PMID:26377647
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HJURP mRNA	PMID:22574217
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HJURP mRNA	PMID:33387578
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314124	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HJURP mRNA	PMID:19770486|PMID:21889950|PMID:26290441
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20140916	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of HJURP mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to HJURP promoter]	PMID:16214954|PMID:19654925
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HJURP mRNA	PMID:33212167
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of HJURP mRNA	PMID:30556269
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of HJURP mRNA	PMID:20971185
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HJURP mRNA	PMID:30031762
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:2292108	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of HJURP protein	PMID:35688186
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:2292108	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of HJURP gene	PMID:28589171
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:2292108	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of HJURP mRNA	PMID:29301061
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HJURP mRNA	PMID:40504410
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HJURP mRNA	PMID:31555880
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:2292108	E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HJURP 3' UTR; Benzo(a)pyrene results in increased methylation of HJURP gene	PMID:27901495|PMID:31555880
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of HJURP mRNA	PMID:30556269
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of HJURP mRNA	PMID:20971185
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D015032	Zinc deficiency results in increased expression of HJURP mRNA	PMID:22171008
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1314124	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of HJURP mRNA	PMID:27131904
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HJURP mRNA	PMID:20382639
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:2292108	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of HJURP mRNA	PMID:35984750
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of HJURP mRNA	PMID:32479839
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314124	E	RGD:6480464	20140916	CTD	MESH:C009495	titanium dioxide results in decreased expression of HJURP mRNA	PMID:23557971|PMID:31298478
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314124	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of HJURP mRNA	PMID:29264374
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20200211	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of HJURP mRNA]	PMID:31298478
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HJURP mRNA	PMID:34492290
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314124	E	RGD:6480464	20140916	CTD	MESH:C006253	pirinixic acid results in increased expression of HJURP mRNA	PMID:17426115
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:2292108	E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of HJURP mRNA	PMID:38479592
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:C069837	fullerene C60 results in decreased expression of HJURP mRNA	PMID:19167457
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HJURP mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314124	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of HJURP mRNA	PMID:32156529
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of HJURP mRNA	PMID:27685785|PMID:29275510
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of HJURP mRNA	PMID:35192832
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of HJURP mRNA	PMID:31129395
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:2292108	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of HJURP mRNA	PMID:25979313
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314124	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of HJURP mRNA	PMID:26682919
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HJURP mRNA	PMID:25510870
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of HJURP mRNA	PMID:23829299
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HJURP mRNA	PMID:25510870
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314124	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HJURP mRNA	PMID:39298647
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314124	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of HJURP mRNA	PMID:38685157
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1314124	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of HJURP mRNA	PMID:31558096
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HJURP mRNA	PMID:33453195
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HJURP mRNA	PMID:38568856
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HJURP mRNA	PMID:21457566
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20140916	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HJURP mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HJURP mRNA; MT3 affects the reaction [Cadmium Chloride affects the expression of HJURP mRNA]	PMID:20371981|PMID:37236586|PMID:37325564
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:35549	perfluorooctanoic acid	affects splicing	ISO	RGD:1314124	E	RGD:6480464	20200804	CTD	MESH:C023036	perfluorooctanoic acid affects the splicing of HJURP mRNA	PMID:32320774
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of HJURP mRNA	PMID:36326898
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:C018021	cobaltous chloride results in decreased expression of HJURP mRNA	PMID:19320972|PMID:19376846
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314124	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HJURP mRNA	PMID:40194260
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HJURP mRNA	PMID:31533062
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D003375	Coumestrol results in increased expression of HJURP mRNA	PMID:19167446
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HJURP mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of HJURP mRNA	PMID:19167446
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:2292108	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HJURP mRNA	PMID:25979313
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of HJURP mRNA	PMID:23179753|PMID:27188386
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D016572	Cyclosporine results in decreased expression of HJURP mRNA	PMID:19159671|PMID:21632981
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314124	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of HJURP mRNA	PMID:39922521
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:2292108	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HJURP mRNA	PMID:38832940
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314124	E	RGD:6480464	20140916	CTD	MESH:D000082	Acetaminophen affects the expression of HJURP mRNA	PMID:17562736
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of HJURP mRNA	PMID:33387578
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of HJURP mRNA	PMID:29067470
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen results in increased expression of HJURP mRNA	PMID:22230336
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:2292108	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HJURP gene	PMID:25304211
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HJURP mRNA	PMID:40504410
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of HJURP mRNA	PMID:29391264
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:2292108	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of HJURP mRNA	PMID:38568856
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314124	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of HJURP mRNA	PMID:25554681
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:51052	lucanthone	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20130618	CTD	MESH:D008154	Lucanthone results in decreased expression of HJURP mRNA	PMID:21148553
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of HJURP mRNA	PMID:37269647
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in decreased expression of HJURP mRNA	PMID:25290377
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:68508	diethyl maleate	increases expression	EXP		E	RGD:6480464	20130618	CTD	MESH:C014476	diethyl maleate results in increased expression of HJURP mRNA	PMID:21161181
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314124	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HJURP mRNA	PMID:22206623
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of HJURP mRNA	PMID:29522793
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:2292108	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of HJURP mRNA	PMID:37199045
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:2292108	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of HJURP protein	PMID:31285264
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of HJURP mRNA	PMID:34995734
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314124	E	RGD:6480464	20140916	CTD	MESH:D010634	Phenobarbital affects the expression of HJURP mRNA	PMID:23091169
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314124	E	RGD:6480464	20140916	CTD	MESH:D010634	Phenobarbital results in increased expression of HJURP mRNA	PMID:19482888
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314124	E	RGD:6480464	20140916	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of HJURP mRNA]	PMID:19482888
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:2292108	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HJURP mRNA	PMID:19167446
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1314124	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of HJURP mRNA	PMID:31558096
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of HJURP mRNA	PMID:32234424
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314124	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of HJURP mRNA	PMID:30953684
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:85993	palbociclib	decreases expression	ISO	RGD:2292108	E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of HJURP mRNA	PMID:22869556
1305846	Hjurp	Holliday junction recognition protein	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1314124	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of HJURP mRNA	PMID:27131904
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1605812	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SPOPL mRNA	PMID:33167477
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1605812	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SPOPL mRNA	PMID:26079696
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314125	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SPOPL mRNA	PMID:39241906
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of SPOPL mRNA	PMID:32145629
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1605812	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SPOPL mRNA	PMID:37042841
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1605812	E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SPOPL gene	PMID:33872906
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314125	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SPOPL mRNA	PMID:21318169
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1605812	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SPOPL gene	PMID:33872906
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314125	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPOPL mRNA	PMID:37236586
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1605812	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SPOPL mRNA	PMID:19549813
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314125	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SPOPL mRNA	PMID:19770486
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1605812	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SPOPL gene	PMID:27153756
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605812	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SPOPL mRNA	PMID:41430723
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1605812	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of SPOPL mRNA	PMID:19774075
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:2679	amphetamine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SPOPL mRNA	PMID:30779732
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314125	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SPOPL mRNA	PMID:28960355
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605812	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SPOPL mRNA	PMID:23557933
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPOPL mRNA	PMID:33387578
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1605812	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of SPOPL mRNA	PMID:33512557
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1605812	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SPOPL mRNA	PMID:28001369
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605812	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SPOPL mRNA	PMID:33212167
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1605812	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SPOPL mRNA	PMID:30851411
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1605812	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SPOPL mRNA	PMID:38568856
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1605812	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPOPL 5' UTR; Benzo(a)pyrene affects the methylation of SPOPL promoter	PMID:27901495
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605812	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SPOPL mRNA	PMID:22316170
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314125	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPOPL 3' UTR; Benzo(a)pyrene results in increased methylation of SPOPL exon; Benzo(a)pyrene results in increased methylation of SPOPL intron	PMID:27901495
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605812	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SPOPL mRNA]	PMID:32406909
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314125	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SPOPL mRNA	PMID:27131904
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605812	E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SPOPL mRNA	PMID:26238291
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1605812	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPOPL gene	PMID:31601247
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SPOPL mRNA	PMID:23411599
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SPOPL mRNA	PMID:25181051
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1605812	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SPOPL gene	PMID:31601247
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SPOPL mRNA	PMID:32145629
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314125	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SPOPL mRNA	PMID:33221593
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1605812	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPOPL gene	PMID:31601247
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1605812	E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of SPOPL mRNA	PMID:36804509
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1605812	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SPOPL mRNA	PMID:37042841
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314125	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPOPL mRNA	PMID:37236586
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1605812	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPOPL mRNA	PMID:25979313
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:40036	amitrole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SPOPL mRNA	PMID:30047161
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314125	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SPOPL mRNA	PMID:28973697
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1605812	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SPOPL mRNA	PMID:33512557
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314125	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SPOPL mRNA	PMID:17562736
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:50673	methimazole	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SPOPL mRNA	PMID:30047161
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1605812	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SPOPL mRNA	PMID:28988120
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314125	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SPOPL mRNA	PMID:22206623
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1605812	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SPOPL mRNA	PMID:30851411
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314125	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SPOPL mRNA	PMID:23091169
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPOPL mRNA	PMID:30047161
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314125	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SPOPL mRNA	PMID:27131904
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1605812	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SPOPL mRNA	PMID:38568856
1305847	Spopl	speckle type BTB/POZ protein like	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1605812	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SPOPL mRNA	PMID:29301935
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1314126	E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ARPC2 mRNA	PMID:35967413
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of ARPC2 mRNA	PMID:21551480
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314126	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ARPC2 mRNA	PMID:33167477
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ARPC2 mRNA	PMID:36331819
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314127	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARPC2 mRNA	PMID:30319688
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ARPC2 protein	PMID:24152438
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006861	NOX1 protein affects the reaction [Hydrogen Peroxide results in increased expression of ARPC2 protein]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of ARPC2 protein]	PMID:24152438
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314127	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ARPC2 mRNA	PMID:39241906
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:165219	PCB138	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ARPC2 protein	PMID:21673325
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ARPC2 protein	PMID:22061828
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARPC2 mRNA	PMID:36331819
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:2430	aconitine	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of ARPC2 protein	PMID:33236894
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314126	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARPC2 gene	PMID:27153756
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1314126	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ARPC2 protein	PMID:38598786
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314127	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARPC2 mRNA	PMID:31919559
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ARPC2 mRNA	PMID:22206623
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:27563	arsenic atom	increases methylation	ISO	RGD:1314126	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of ARPC2 promoter	PMID:21291286
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1314126	E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of ARPC2 mRNA	PMID:37386098
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314126	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ARPC2 mRNA	PMID:27392435
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:27928	parathion	decreases methylation	ISO	RGD:1314126	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of ARPC2 promoter	PMID:22847954
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314126	E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of ARPC2 mRNA	PMID:22228119
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARPC2 mRNA	PMID:34747641
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314127	E	RGD:6480464	20181113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARPC2 protein	PMID:29935226
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARPC2 mRNA	PMID:17942748
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of ARPC2 mRNA	PMID:19013527
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314127	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ARPC2 protein	PMID:28918527
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314126	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARPC2 mRNA	PMID:29803840
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARPC2 protein	PMID:29459688
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314126	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARPC2 mRNA	PMID:32234424
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ARPC2 mRNA	PMID:18685790
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:31835	methylparaben	increases expression	ISO	RGD:1314126	E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of ARPC2 mRNA	PMID:31745603
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ARPC2 mRNA	PMID:30047161
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314127	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARPC2 gene	PMID:35295148
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:33128	C60 fullerene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ARPC2 mRNA	PMID:19167457
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314126	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ARPC2 mRNA; bisphenol A results in decreased expression of ARPC2 protein	PMID:29275510|PMID:31675489|PMID:34186270
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314127	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARPC2 mRNA; bisphenol A results in decreased expression of ARPC2 protein	PMID:33221593|PMID:35999755
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARPC2 gene	PMID:28505145
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ARPC2 mRNA	PMID:25181051
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314126	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ARPC2 protein	PMID:37567409
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1314126	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of ARPC2 mRNA	PMID:15980968
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314126	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ARPC2 protein	PMID:34186270
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314127	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ARPC2 mRNA	PMID:39298647
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314126	E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ARPC2 protein	PMID:34186270
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314127	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ARPC2 intron	PMID:28392331
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314127	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of ARPC2 protein	PMID:35999755
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARPC2 mRNA	PMID:21266533
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314127	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARPC2 mRNA	PMID:17361019|PMID:21266533
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	ISO	RGD:1314126	E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to ARPC2 protein	PMID:32991956
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1314126	E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ARPC2 protein	PMID:38598786
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of ARPC2 gene	PMID:33148267
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314126	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARPC2 mRNA	PMID:37042841
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314126	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARPC2 protein	PMID:24527689
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1314126	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARPC2 mRNA	PMID:19320972
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314126	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ARPC2 mRNA	PMID:24449571
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314127	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of ARPC2 mRNA	PMID:17585979
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D013755	Ro 32-0432 inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [CORO1B protein binds to ARPC2 protein]]; Tetradecanoylphorbol Acetate inhibits the reaction [CORO1B protein binds to ARPC2 protein]	PMID:16027158
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1314126	E	RGD:6480464	20120814	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA]	PMID:15477007
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:38689	fonofos	decreases methylation	ISO	RGD:1314126	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of ARPC2 promoter	PMID:22847954
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:38960	terbufos	decreases methylation	ISO	RGD:1314126	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of ARPC2 promoter	PMID:22847954
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:39285	chloropicrin	increases expression	ISO	RGD:1314126	E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of ARPC2 mRNA	PMID:26352163
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARPC2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ARPC2 mRNA	PMID:36331819
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314126	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ARPC2 mRNA	PMID:23179753
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314126	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ARPC2 gene	PMID:29154799
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ARPC2 mRNA	PMID:30047161
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314126	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ARPC2 mRNA	PMID:20106945|PMID:25562108
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314126	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARPC2 mRNA	PMID:38832940
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314127	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARPC2 mRNA	PMID:17562736
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:47217	arsane	increases methylation	ISO	RGD:1314126	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of ARPC2 promoter	PMID:21291286
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:48843	disodium selenite	increases expression	ISO	RGD:1314126	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ARPC2 mRNA	PMID:18175754
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314127	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARPC2 mRNA	PMID:17942748
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARPC2 mRNA	PMID:17942748
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ARPC2 mRNA	PMID:30047161
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ARPC2 mRNA	PMID:35964746
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1314126	E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of ARPC2 mRNA	PMID:16780908
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1314126	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARPC2 protein	PMID:32959892
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARPC2 mRNA	PMID:21641980
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314127	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ARPC2 mRNA	PMID:23650126
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:63954	ionomycin	multiple interactions	ISO	RGD:1314126	E	RGD:6480464	20120814	CTD	MESH:D015759	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA]	PMID:15477007
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314127	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ARPC2 protein	PMID:26558463
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of ARPC2 gene	PMID:33148267
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1314126	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ARPC2 protein	PMID:34186270
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314127	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARPC2 mRNA	PMID:22206623
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ARPC2 mRNA	PMID:22206623
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	ISO	RGD:1314126	E	RGD:6480464	20140708	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA]	PMID:15477007
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:79516	Nonylphenol	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in decreased expression of ARPC2 protein	PMID:19260726
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of ARPC2 mRNA	PMID:30047161
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314127	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ARPC2 mRNA	PMID:21795629
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARPC2 mRNA	PMID:30047161
1305848	Arpc2	actin related protein 2/3 complex, subunit 2	gene	CHEBI:90705	SB 203580	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:C093642	SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of ARPC2 protein]	PMID:24152438
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RIN3 gene	PMID:20938992
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314128	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RIN3 mRNA	PMID:33167477
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:15930	atrazine	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of RIN3 gene	PMID:35440735
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RIN3 mRNA	PMID:39241906
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314128	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of RIN3 mRNA	PMID:23019147
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RIN3 gene	PMID:20938992
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of RIN3 mRNA	PMID:16809437
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314128	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of RIN3 mRNA	PMID:21592394
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of RIN3 mRNA	PMID:21592394
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314128	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RIN3 mRNA	PMID:31163220
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1314128	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RIN3 mRNA	PMID:21592394
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of RIN3 mRNA	PMID:21592394
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RIN3 mRNA	PMID:22061828
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1314128	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RIN3 mRNA	PMID:28818685
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RIN3 mRNA	PMID:36331819
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of RIN3 protein	PMID:34915118
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RIN3 mRNA	PMID:35301059
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RIN3 mRNA	PMID:37236586|PMID:37325564
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314128	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RIN3 mRNA	PMID:19549813
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314128	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RIN3 mRNA	PMID:21641981
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314128	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RIN3 exon; Aflatoxin B1 results in decreased methylation of RIN3 intron	PMID:30157460
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314128	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RIN3 promoter	PMID:30157460
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1314128	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of RIN3 mRNA	PMID:19774075
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RIN3 gene	PMID:20938992
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RIN3 mRNA	PMID:40512198
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene] which results in decreased expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene	PMID:40504410
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1314128	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RIN3 protein	PMID:35688186
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:27744	glyphosate	decreases methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of RIN3 gene	PMID:31011160
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RIN3 mRNA	PMID:23557933
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RIN3 mRNA	PMID:30912803
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RIN3 mRNA	PMID:22298810|PMID:34747641
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314129	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RIN3 mRNA	PMID:21570461
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314129	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of RIN3 mRNA	PMID:39631538
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314128	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RIN3 mRNA	PMID:38568856
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314128	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of RIN3 mRNA	PMID:39719251
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RIN3 mRNA	PMID:40512198
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene] which results in decreased expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene	PMID:40504410
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314128	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RIN3 intron	PMID:30157460
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314128	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RIN3 mRNA	PMID:26238291
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314129	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RIN3 mRNA	PMID:21569818|PMID:22228805
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314129	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RIN3 intron	PMID:27901495
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1314128	E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of RIN3 gene	PMID:25435355
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RIN3 mRNA	PMID:25729387
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RIN3 mRNA	PMID:23557971
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314129	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RIN3 promoter	PMID:35295148
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RIN3 mRNA	PMID:34492290
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of RIN3 gene	PMID:23968726
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RIN3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314128	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of RIN3 mRNA	PMID:36232920
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314129	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RIN3 mRNA	PMID:30951980|PMID:32156529|PMID:34585602
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RIN3 gene	PMID:28505145
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314129	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RIN3 promoter	PMID:27312807
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20180515	CTD	MESH:D008748	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of RIN3 mRNA	PMID:25926378
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RIN3 mRNA	PMID:39298647
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314129	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RIN3 mRNA	PMID:30951980
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314129	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RIN3 mRNA	PMID:30951980
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314129	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RIN3 intron	PMID:28392331
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RIN3 mRNA	PMID:34813904
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of RIN3 mRNA	PMID:34813904
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of RIN3 gene	PMID:23968726
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314128	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RIN3 mRNA	PMID:37042841
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RIN3 mRNA	PMID:35301059
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RIN3 mRNA	PMID:37236586|PMID:37325564
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1314128	E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RIN3 mRNA	PMID:23146750
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of RIN3 mRNA	PMID:35163327
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314128	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RIN3 mRNA	PMID:24449571
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1314128	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of RIN3 mRNA	PMID:28302478
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RIN3 mRNA	PMID:36331819
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1314129	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of RIN3 mRNA	PMID:23125180
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314128	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RIN3 gene	PMID:29154799
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RIN3 mRNA	PMID:17183730
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314128	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RIN3 mRNA	PMID:25562108
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1314128	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of RIN3 mRNA	PMID:24449571
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314129	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RIN3 mRNA	PMID:17562736
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RIN3 mRNA	PMID:33387578
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RIN3 mRNA	PMID:40512198
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene] which results in decreased expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene	PMID:40504410
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314129	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RIN3 mRNA	PMID:25554681
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20180515	CTD	MESH:D037742	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of RIN3 mRNA	PMID:25926378
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RIN3 mRNA	PMID:35964746
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:5775	hydralazine	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RIN3 mRNA	PMID:17183730
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314129	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RIN3 mRNA	PMID:38701926
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RIN3 mRNA	PMID:25729387
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:64211	8-Br-cAMP	increases expression	ISO	RGD:1314128	E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RIN3 mRNA	PMID:22079614
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314129	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RIN3 mRNA	PMID:22206623
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:7590	nitrofen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of RIN3 mRNA	PMID:33484710
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314128	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RIN3 gene]	PMID:28238834
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1314128	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RIN3 mRNA	PMID:23146750
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of RIN3 mRNA	PMID:39847705
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RIN3 mRNA	PMID:24780913
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RIN3 mRNA	PMID:40826991
1305849	Rin3	Ras and Rab interactor 3	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RIN3 mRNA	PMID:19281266
1305851	Tex261	testis expressed 261	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1346300	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TEX261 mRNA	PMID:38218311
1305851	Tex261	testis expressed 261	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314132	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of TEX261 mRNA]	PMID:19467301
1305851	Tex261	testis expressed 261	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1314132	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of TEX261 mRNA	PMID:24205000
1305851	Tex261	testis expressed 261	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314132	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TEX261 mRNA	PMID:36331819
1305851	Tex261	testis expressed 261	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1346300	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TEX261 mRNA	PMID:22378314
1305851	Tex261	testis expressed 261	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314132	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TEX261 mRNA	PMID:30319688
1305851	Tex261	testis expressed 261	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1346300	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TEX261 mRNA	PMID:37042841
1305851	Tex261	testis expressed 261	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314132	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of TEX261 mRNA	PMID:23892564
1305851	Tex261	testis expressed 261	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1346300	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TEX261 mRNA	PMID:19549813
1305851	Tex261	testis expressed 261	gene	CHEBI:2663	amiodarone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of TEX261 mRNA	PMID:18355885
1305851	Tex261	testis expressed 261	gene	CHEBI:2666	amitriptyline	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000639	Amitriptyline affects the expression of TEX261 mRNA	PMID:18355885
1305851	Tex261	testis expressed 261	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314132	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TEX261 mRNA	PMID:40504410
1305851	Tex261	testis expressed 261	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1346300	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TEX261 mRNA	PMID:28903495
1305851	Tex261	testis expressed 261	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314132	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TEX261 mRNA	PMID:21570461
1305851	Tex261	testis expressed 261	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TEX261 mRNA	PMID:34747641
1305851	Tex261	testis expressed 261	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1346300	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TEX261 mRNA	PMID:33212167
1305851	Tex261	testis expressed 261	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1346300	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TEX261 mRNA	PMID:32763439
1305851	Tex261	testis expressed 261	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1346300	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TEX261 mRNA	PMID:29803840
1305851	Tex261	testis expressed 261	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1314132	E	RGD:6480464	20120918	CTD	MESH:D001379	Azathioprine results in increased expression of TEX261 mRNA	PMID:21621594
1305851	Tex261	testis expressed 261	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1346300	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TEX261 mRNA	PMID:38568856
1305851	Tex261	testis expressed 261	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314132	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TEX261 mRNA	PMID:40504410
1305851	Tex261	testis expressed 261	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314132	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TEX261 mRNA	PMID:22228805
1305851	Tex261	testis expressed 261	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1346300	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TEX261 mRNA	PMID:20458559
1305851	Tex261	testis expressed 261	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TEX261 mRNA	PMID:24136188
1305851	Tex261	testis expressed 261	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1346300	E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TEX261 gene; titanium dioxide results in decreased methylation of TEX261 promoter	PMID:34973136
1305851	Tex261	testis expressed 261	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314132	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TEX261 mRNA	PMID:18648102
1305851	Tex261	testis expressed 261	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314132	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of TEX261 mRNA	PMID:28329830
1305851	Tex261	testis expressed 261	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TEX261 mRNA	PMID:30816183|PMID:34947998
1305851	Tex261	testis expressed 261	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TEX261 mRNA	PMID:25181051
1305851	Tex261	testis expressed 261	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314132	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of TEX261 mRNA	PMID:26063408|PMID:33221593
1305851	Tex261	testis expressed 261	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314132	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TEX261 mRNA	PMID:38685157
1305851	Tex261	testis expressed 261	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314132	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TEX261 mRNA	PMID:37019170
1305851	Tex261	testis expressed 261	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1346300	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TEX261 mRNA	PMID:38174414|PMID:38568856
1305851	Tex261	testis expressed 261	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314132	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TEX261 mRNA	PMID:36331819
1305851	Tex261	testis expressed 261	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1346300	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TEX261 mRNA	PMID:25979313
1305851	Tex261	testis expressed 261	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1346300	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TEX261 mRNA	PMID:23179753|PMID:25192806|PMID:26272509
1305851	Tex261	testis expressed 261	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1346300	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX261 mRNA	PMID:27188386
1305851	Tex261	testis expressed 261	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314132	E	RGD:6480464	20120918	CTD	MESH:D003907	Dexamethasone results in decreased expression of TEX261 mRNA	PMID:21621594
1305851	Tex261	testis expressed 261	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1314132	E	RGD:6480464	20120918	CTD	MESH:D008727	Methotrexate results in increased expression of TEX261 mRNA	PMID:21621594
1305851	Tex261	testis expressed 261	gene	CHEBI:44445	nimesulide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TEX261 mRNA	PMID:24136188
1305851	Tex261	testis expressed 261	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of TEX261 mRNA	PMID:21346803
1305851	Tex261	testis expressed 261	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314132	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TEX261 mRNA	PMID:17562736
1305851	Tex261	testis expressed 261	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1346300	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TEX261 mRNA	PMID:22230336
1305851	Tex261	testis expressed 261	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314132	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TEX261 mRNA	PMID:40504410
1305851	Tex261	testis expressed 261	gene	CHEBI:47499	imipramine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007099	Imipramine affects the expression of TEX261 mRNA	PMID:18355885
1305851	Tex261	testis expressed 261	gene	CHEBI:47519	ketoconazole	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007654	Ketoconazole affects the expression of TEX261 mRNA	PMID:18355885
1305851	Tex261	testis expressed 261	gene	CHEBI:47780	clomipramine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002997	Clomipramine affects the expression of TEX261 mRNA	PMID:18355885
1305851	Tex261	testis expressed 261	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1346300	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TEX261 mRNA	PMID:20458559
1305851	Tex261	testis expressed 261	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TEX261 mRNA	PMID:24136188
1305851	Tex261	testis expressed 261	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in increased expression of TEX261 mRNA	PMID:41580965
1305851	Tex261	testis expressed 261	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314132	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TEX261 mRNA	PMID:35964746
1305851	Tex261	testis expressed 261	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of TEX261 mRNA	PMID:24793618
1305851	Tex261	testis expressed 261	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TEX261 mRNA	PMID:24136188
1305851	Tex261	testis expressed 261	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of TEX261 mRNA	PMID:24136188
1305851	Tex261	testis expressed 261	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314132	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TEX261 mRNA	PMID:22206623
1305851	Tex261	testis expressed 261	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TEX261 mRNA	PMID:24136188
1305851	Tex261	testis expressed 261	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1346300	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX261 mRNA	PMID:27188386
1305851	Tex261	testis expressed 261	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1346300	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TEX261 gene]	PMID:28238834
1305851	Tex261	testis expressed 261	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TEX261 mRNA	PMID:19162173
1305851	Tex261	testis expressed 261	gene	CHEBI:8378	prednisolone	decreases expression	ISO	RGD:1314132	E	RGD:6480464	20120918	CTD	MESH:D011239	Prednisolone results in decreased expression of TEX261 mRNA	PMID:21621594
1305851	Tex261	testis expressed 261	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314132	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of TEX261 mRNA	PMID:30953684
1305851	Tex261	testis expressed 261	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1314132	E	RGD:6480464	20120918	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of TEX261 mRNA	PMID:21621594
1305851	Tex261	testis expressed 261	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1346300	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX261 mRNA	PMID:27188386
1305851	Tex261	testis expressed 261	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TEX261 mRNA	PMID:19281266
1305852	Fkrp	fukutin related protein	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	ISO	RGD:1314133	E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein]	PMID:38195004
1305852	Fkrp	fukutin related protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314133	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of FKRP mRNA	PMID:23724009
1305852	Fkrp	fukutin related protein	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314133	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FKRP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FKRP mRNA	PMID:32699268
1305852	Fkrp	fukutin related protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314133	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of FKRP mRNA	PMID:22378314
1305852	Fkrp	fukutin related protein	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314134	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FKRP mRNA	PMID:30319688
1305852	Fkrp	fukutin related protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1314133	E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FKRP mRNA	PMID:21179406
1305852	Fkrp	fukutin related protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314134	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FKRP mRNA	PMID:39298647
1305852	Fkrp	fukutin related protein	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of FKRP gene	PMID:27618143
1305852	Fkrp	fukutin related protein	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1314133	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of FKRP mRNA	PMID:21179406
1305852	Fkrp	fukutin related protein	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FKRP mRNA	PMID:33387578
1305852	Fkrp	fukutin related protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314133	E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein	PMID:38195004
1305852	Fkrp	fukutin related protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314133	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FKRP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FKRP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of FKRP mRNA	PMID:32699268
1305852	Fkrp	fukutin related protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314134	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FKRP mRNA	PMID:22206623
1305852	Fkrp	fukutin related protein	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1314133	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of FKRP mRNA	PMID:25583101
1305852	Fkrp	fukutin related protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FKRP mRNA	PMID:33387578
1305852	Fkrp	fukutin related protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314134	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKRP mRNA	PMID:31961203
1305852	Fkrp	fukutin related protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314134	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKRP mRNA	PMID:17942748
1305852	Fkrp	fukutin related protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314133	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FKRP mRNA	PMID:29803840
1305852	Fkrp	fukutin related protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314133	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FKRP mRNA	PMID:38568856
1305852	Fkrp	fukutin related protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314133	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FKRP mRNA	PMID:20106945
1305852	Fkrp	fukutin related protein	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314133	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FKRP promoter	PMID:27901495
1305852	Fkrp	fukutin related protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314133	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FKRP 5' UTR	PMID:27901495
1305852	Fkrp	fukutin related protein	gene	CHEBI:30778	gallic acid	increases expression	ISO	RGD:1314133	E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of FKRP mRNA	PMID:34408198
1305852	Fkrp	fukutin related protein	gene	CHEBI:30812	iron dichloride	decreases expression	ISO	RGD:1314133	E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FKRP mRNA	PMID:35984750
1305852	Fkrp	fukutin related protein	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314133	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FKRP gene	PMID:31601247
1305852	Fkrp	fukutin related protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FKRP mRNA	PMID:25181051|PMID:34947998
1305852	Fkrp	fukutin related protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314134	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of FKRP mRNA	PMID:32156529
1305852	Fkrp	fukutin related protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314133	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FKRP gene	PMID:31601247
1305852	Fkrp	fukutin related protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314133	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FKRP gene	PMID:31601247
1305852	Fkrp	fukutin related protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314133	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FKRP mRNA	PMID:37042841
1305852	Fkrp	fukutin related protein	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of FKRP promoter	PMID:22457795
1305852	Fkrp	fukutin related protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314133	E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein	PMID:38195004
1305852	Fkrp	fukutin related protein	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1314133	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FKRP mRNA	PMID:24449571
1305852	Fkrp	fukutin related protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314133	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FKRP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FKRP mRNA	PMID:32699268
1305852	Fkrp	fukutin related protein	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1314133	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FKRP mRNA	PMID:31533062
1305852	Fkrp	fukutin related protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314133	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FKRP mRNA	PMID:25979313
1305852	Fkrp	fukutin related protein	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314133	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FKRP gene	PMID:29154799
1305852	Fkrp	fukutin related protein	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314133	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FKRP mRNA	PMID:25562108
1305852	Fkrp	fukutin related protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314134	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FKRP mRNA	PMID:17562736
1305852	Fkrp	fukutin related protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FKRP mRNA	PMID:33387578
1305852	Fkrp	fukutin related protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314133	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of FKRP mRNA	PMID:22230336|PMID:29067470
1305852	Fkrp	fukutin related protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314134	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKRP mRNA	PMID:17942748
1305852	Fkrp	fukutin related protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314134	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FKRP mRNA	PMID:35964746
1305852	Fkrp	fukutin related protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314134	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FKRP mRNA	PMID:22206623
1305852	Fkrp	fukutin related protein	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1314134	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of FKRP protein	PMID:23618972
1305852	Fkrp	fukutin related protein	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314133	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FKRP gene]	PMID:28238834
1305852	Fkrp	fukutin related protein	gene	CHEBI:86204	chromium trinitrate	increases expression	ISO	RGD:1314134	E	RGD:6480464	20170228	CTD	MESH:C041167	chromium nitrate results in increased expression of FKRP protein	PMID:23618972
1305852	Fkrp	fukutin related protein	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314134	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of FKRP mRNA	PMID:40826991
1305852	Fkrp	fukutin related protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FKRP mRNA	PMID:21346803
1305852	Fkrp	fukutin related protein	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FKRP mRNA	PMID:21346803
1305852	Fkrp	fukutin related protein	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FKRP mRNA	PMID:23034163
1305852	Fkrp	fukutin related protein	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of FKRP mRNA	PMID:23869203
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20170228	CTD	MESH:C014026	hexamethylene bisacetamide results in decreased expression of DBF4 mRNA	PMID:26941288
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DBF4 mRNA	PMID:33045310
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DBF4 mRNA	PMID:39752319
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DBF4 mRNA	PMID:33167477
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DBF4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DBF4 mRNA	PMID:32699268
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of DBF4 mRNA	PMID:26516004
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DBF4 mRNA	PMID:30529165
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DBF4 mRNA	PMID:26079696
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1605697	E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of DBF4 mRNA	PMID:18951874
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of DBF4 mRNA	PMID:21632981|PMID:23727915
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314137	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of DBF4 mRNA	PMID:25210133
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of DBF4 mRNA]	PMID:25210133
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DBF4 mRNA	PMID:25510870
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1605697	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of DBF4 mRNA	PMID:38568856
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DBF4 mRNA	PMID:33387578
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of DBF4 mRNA	PMID:20655997|PMID:23649840
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of DBF4 mRNA	PMID:38160208
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DBF4 mRNA	PMID:39752319
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of DBF4 mRNA	PMID:21592394
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of DBF4 mRNA	PMID:21592394
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of DBF4 mRNA	PMID:27683099
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DBF4 mRNA	PMID:33754040
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1605697	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DBF4 protein	PMID:37730182
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:17823	calcitriol	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of DBF4 mRNA	PMID:21592394
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of DBF4 mRNA	PMID:21592394
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DBF4 mRNA	PMID:35301059
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DBF4 mRNA	PMID:25510870
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DBF4 mRNA	PMID:25510870
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DBF4 mRNA	PMID:19549813
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1605697	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DBF4 protein	PMID:20106945
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1605697	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DBF4 gene	PMID:27153756
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of DBF4 mRNA	PMID:24336422
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DBF4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of DBF4 mRNA	PMID:34911549
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DBF4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DBF4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DBF4 mRNA	PMID:32699268
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314137	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DBF4 mRNA	PMID:31919559
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in decreased expression of DBF4 mRNA	PMID:25270620
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1605697	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DBF4 protein	PMID:35688186
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of DBF4 mRNA	PMID:19167446
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:27889	lead(0)	affects expression	ISO	RGD:1605697	E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DBF4 mRNA	PMID:28903495
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in decreased expression of DBF4 mRNA	PMID:25270620
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of DBF4 mRNA	PMID:27392435
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in increased expression of DBF4 mRNA]	PMID:21858171
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1605697	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DBF4 mRNA	PMID:25583101
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314137	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DBF4 mRNA	PMID:21570461
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DBF4 mRNA	PMID:33387578
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DBF4 mRNA	PMID:20106945|PMID:21632981
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314137	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DBF4 mRNA	PMID:21496263
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1605697	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DBF4 mRNA	PMID:21496263
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1605697	E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of DBF4 mRNA	PMID:33512557
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DBF4 mRNA	PMID:33212167
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1605697	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of DBF4 mRNA	PMID:30851411
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of DBF4 mRNA	PMID:30911355
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:28876	melphalan	increases expression	ISO	RGD:1605697	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in increased expression of DBF4 mRNA	PMID:22363485
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DBF4 mRNA	PMID:21632981|PMID:22316170
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314137	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DBF4 mRNA	PMID:19770486
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1605697	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DBF4 promoter	PMID:27901495
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to DBF4 mRNA]	PMID:32406909
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of DBF4 mRNA	PMID:30911355
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DBF4 mRNA	PMID:20382639
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of DBF4 mRNA	PMID:21829687
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:32130	silver(1+) nitrate	increases expression	ISO	RGD:1605697	E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in increased expression of DBF4 mRNA; Silver Nitrate results in increased expression of DBF4 mRNA	PMID:22831968
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314137	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DBF4 gene	PMID:35295148
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DBF4 mRNA	PMID:23411599
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314137	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of DBF4 mRNA	PMID:18301758
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of DBF4 mRNA	PMID:19191707
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314137	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DBF4 mRNA	PMID:28472532
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DBF4 mRNA	PMID:25181051
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314137	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of DBF4 mRNA	PMID:26682919
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DBF4 mRNA	PMID:25510870
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DBF4 mRNA	PMID:25510870
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:34575	bisphenol F	affects expression	ISO	RGD:1314137	E	RGD:6480464	20230207	CTD	MESH:C008745	bisphenol F affects the expression of DBF4 mRNA	PMID:35387338
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DBF4 mRNA	PMID:37019170
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:34741	equol	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20141111	CTD	MESH:D060754	Equol results in decreased expression of DBF4 mRNA	PMID:16865672
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DBF4 mRNA	PMID:30723492
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DBF4 mRNA	PMID:35301059
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DBF4 mRNA	PMID:19376846
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of DBF4 mRNA	PMID:24449571
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DBF4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DBF4 mRNA	PMID:32699268
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:38604	pyrimidifen	increases expression	ISO	RGD:1605697	E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of DBF4 mRNA	PMID:33512557
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DBF4 mRNA	PMID:28302478
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DBF4 mRNA	PMID:31533062
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1605697	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of DBF4 mRNA	PMID:19167446
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DBF4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DBF4 mRNA	PMID:19167446
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of DBF4 mRNA	PMID:39529242
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of DBF4 mRNA	PMID:23179753
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of DBF4 mRNA	PMID:20106945|PMID:21632981
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314137	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DBF4 mRNA	PMID:28973697
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:4357	deguelin	increases expression	ISO	RGD:1605697	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of DBF4 mRNA	PMID:33512557
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1605697	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DBF4 mRNA	PMID:38832940
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of DBF4 mRNA	PMID:12929121
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1605697	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of DBF4 mRNA	PMID:28542535
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314137	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DBF4 mRNA	PMID:17562736
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DBF4 mRNA	PMID:33387578
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of DBF4 mRNA	PMID:16510598
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of DBF4 mRNA	PMID:22077320
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20150127	CTD	MESH:D005047	Etoposide results in decreased expression of DBF4 mRNA	PMID:25270620
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314137	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DBF4 mRNA	PMID:25554681
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314137	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DBF4 mRNA	PMID:19042947
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1314137	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in increased expression of DBF4 mRNA	PMID:21404309
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:53266	poly(propylene imine) macromolecule	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20170117	CTD	MESH:C443641	poly(propyleneimine) analog results in decreased expression of DBF4 mRNA	PMID:16308212
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1314137	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of DBF4 mRNA	PMID:21404309
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DBF4 mRNA	PMID:23650126
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:6456	lidocaine	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of DBF4 mRNA	PMID:35283115
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of DBF4 mRNA	PMID:36519830
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DBF4 mRNA	PMID:39752319
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314137	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DBF4 mRNA	PMID:22206623
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of DBF4 mRNA	PMID:29522793
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:756894	tak-243	increases sumoylation	ISO	RGD:1605697	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of DBF4 protein	PMID:31285264
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1605697	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of DBF4 mRNA	PMID:30851411
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1605697	E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in increased expression of DBF4 mRNA	PMID:31437187
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:80630	irinotecan	increases response to substance	ISO	RGD:1605697	E	RGD:6480464	20181113	CTD	MESH:D000077146	DBF4 protein results in increased susceptibility to Irinotecan	PMID:16734730
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314137	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DBF4 mRNA	PMID:23091169
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314137	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of DBF4 mRNA	PMID:19482888
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of DBF4 mRNA]	PMID:19482888
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DBF4 mRNA	PMID:19167446
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:8249	piroxicam	increases expression	ISO	RGD:1605697	E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of DBF4 mRNA	PMID:21858171
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1605697	E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in increased expression of DBF4 mRNA]	PMID:21858171
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:83197	picoxystrobin	increases expression	ISO	RGD:1605697	E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of DBF4 mRNA	PMID:33512557
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DBF4 mRNA	PMID:24780913
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1314137	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DBF4 mRNA	PMID:39752319
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:1605697	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in decreased expression of DBF4 mRNA	PMID:17428261
1305854	Dbf4	DBF4-CDC7 kinase regulatory subunit	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314137	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DBF4 mRNA	PMID:35537566
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	affects expression	ISO	RGD:1314138	E	RGD:6480464	20140729	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl affects the expression of DNAH3 mRNA	PMID:20638727
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:16583	butane-2,3-dione	decreases expression	ISO	RGD:1314138	E	RGD:6480464	20190507	CTD	MESH:D003931	Diacetyl results in decreased expression of DNAH3 mRNA	PMID:30710127
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:17303	morphine	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20140729	CTD	MESH:D009020	Morphine results in decreased expression of DNAH3 mRNA	PMID:21178816
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1314138	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of DNAH3 mRNA	PMID:33647349
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of DNAH3 mRNA	PMID:26577399
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314138	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DNAH3 mRNA	PMID:28818685
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1615518	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DNAH3 mRNA	PMID:36331819
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20140729	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA]	PMID:22129741
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:2504	aflatoxin B1	affects methylation	ISO	RGD:1314138	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of DNAH3 intron	PMID:30157460
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:2682	amphotericin B	increases expression	ISO	RGD:1314138	E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in increased expression of DNAH3 mRNA	PMID:28534445
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of DNAH3 mRNA	PMID:38314887
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:27928	parathion	decreases methylation	ISO	RGD:1314138	E	RGD:6480464	20140729	CTD	MESH:D010278	Parathion results in decreased methylation of DNAH3 promoter	PMID:22847954
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20140729	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNAH3 mRNA	PMID:21354282|PMID:39270811|PMID:39401686
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20140729	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA]	PMID:22129741
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314138	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAH3 mRNA	PMID:38568856
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314138	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DNAH3 intron	PMID:30157460
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1314138	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of DNAH3 mRNA	PMID:19150397
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314138	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of DNAH3 gene	PMID:31601247
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20140729	CTD	MESH:C009495	titanium dioxide results in decreased expression of DNAH3 mRNA	PMID:23557971
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAH3 mRNA	PMID:25181051
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAH3 mRNA	PMID:32156529
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314138	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DNAH3 gene	PMID:31601247
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314138	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of DNAH3 gene	PMID:31601247
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	EXP		E	RGD:6480464	20140729	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA]	PMID:22129741
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314138	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNAH3 mRNA	PMID:38568856
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1615518	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DNAH3 mRNA	PMID:40194260
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:38689	fonofos	decreases methylation	ISO	RGD:1314138	E	RGD:6480464	20140729	CTD	MESH:D004397	Fonofos results in decreased methylation of DNAH3 promoter	PMID:22847954
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:38960	terbufos	decreases methylation	ISO	RGD:1314138	E	RGD:6480464	20140729	CTD	MESH:C012568	terbufos results in decreased methylation of DNAH3 promoter	PMID:22847954
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1615518	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DNAH3 mRNA	PMID:36331819
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314138	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DNAH3 mRNA	PMID:38832940
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DNAH3 mRNA	PMID:25554681
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:52774	pentane-2,3-dione	decreases expression	ISO	RGD:1314138	E	RGD:6480464	20190507	CTD	MESH:C013186	2,3-pentanedione results in decreased expression of DNAH3 mRNA	PMID:30710127
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:5613	haloperidol	increases expression	ISO	RGD:1314138	E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in increased expression of DNAH3 protein	PMID:34122009
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of DNAH3 mRNA	PMID:38701926
1305855	Dnah3	dynein, axonemal, heavy chain 3	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314138	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DNAH3 gene]	PMID:28238834
1305856	Prss29	serine protease 29	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1557482	E	RGD:6480464	20150804	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PRSS29 mRNA	PMID:20938992
1305856	Prss29	serine protease 29	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1557482	E	RGD:6480464	20150804	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PRSS29 mRNA	PMID:20938992
1305856	Prss29	serine protease 29	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1557482	E	RGD:6480464	20150804	CTD	MESH:D011374	Progesterone results in increased expression of PRSS29 mRNA; Progesterone results in increased expression of PRSS29 protein	PMID:15349836
1305856	Prss29	serine protease 29	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1557482	E	RGD:6480464	20150804	CTD	MESH:D011374	Estrogens inhibits the reaction [Progesterone results in increased expression of PRSS29 protein]	PMID:15349836
1305856	Prss29	serine protease 29	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557482	E	RGD:6480464	20150804	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PRSS29 mRNA	PMID:20938992
1305856	Prss29	serine protease 29	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1557482	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of PRSS29 mRNA	PMID:28960355
1305856	Prss29	serine protease 29	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1557482	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PRSS29 mRNA	PMID:32186404
1305856	Prss29	serine protease 29	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557482	E	RGD:6480464	20150804	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRSS29 mRNA	PMID:21570461
1305856	Prss29	serine protease 29	gene	CHEBI:28741	sodium fluoride	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PRSS29 protein	PMID:29653260
1305856	Prss29	serine protease 29	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1557482	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PRSS29 mRNA	PMID:27862939
1305856	Prss29	serine protease 29	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1557482	E	RGD:6480464	20150804	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ISP2 mRNA	PMID:18648102
1305856	Prss29	serine protease 29	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1557482	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PRSS29 gene	PMID:31683443
1305856	Prss29	serine protease 29	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1557482	E	RGD:6480464	20150804	CTD	MESH:D013629	Tamoxifen affects the expression of PRSS29 mRNA	PMID:17555576
1305856	Prss29	serine protease 29	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1557482	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PRSS29 mRNA	PMID:28973697
1305856	Prss29	serine protease 29	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1557482	E	RGD:6480464	20150804	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PRSS29 mRNA	PMID:17555576
1305856	Prss29	serine protease 29	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1557482	E	RGD:6480464	20150804	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ISP2 mRNA	PMID:17942748
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1553533	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of SYDE1 protein	PMID:31494107
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1602201	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SYDE1 mRNA	PMID:35811015
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1602201	E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SYDE1 mRNA	PMID:30165855
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1602201	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SYDE1 protein	PMID:37730182
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1602201	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SYDE1 mRNA	PMID:16002434
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SYDE1 mRNA	PMID:28818685
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of SYDE1 mRNA	PMID:17103032
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:187088	Muconic dialdehyde	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20250805	CTD	MESH:C034476	muconaldehyde results in decreased expression of SYDE1 mRNA	PMID:40300100
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1602201	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SYDE1 mRNA	PMID:22100608
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553533	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SYDE1 mRNA	PMID:34911549
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	ISO	RGD:1602201	E	RGD:6480464	20120412	CTD	MESH:D014747	SYDE1 protein affects the susceptibility to Vinblastine	PMID:16217747
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1602201	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SYDE1 mRNA	PMID:32525701
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1553533	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SYDE1 mRNA	PMID:28960355
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SYDE1 mRNA	PMID:31881176
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SYDE1 mRNA	PMID:27392435
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:27928	parathion	increases methylation	ISO	RGD:1602201	E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of SYDE1 promoter	PMID:22847954
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SYDE1 mRNA	PMID:22298810
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553533	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SYDE1 mRNA	PMID:19465110
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:1602201	E	RGD:6480464	20120412	CTD	MESH:D004317	SYDE1 protein affects the susceptibility to Doxorubicin	PMID:16217747
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SYDE1 mRNA	PMID:29803840
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	ISO	RGD:1602201	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SYDE1 protein	PMID:35688186
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1602201	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SYDE1 mRNA	PMID:38568856
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1553533	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYDE1 mRNA	PMID:19770486
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1602201	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SYDE1 3' UTR	PMID:27901495
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SYDE1 mRNA	PMID:21839799
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1602201	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SYDE1 mRNA	PMID:32234424
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1602201	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SYDE1 promoter	PMID:27901495
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:30563	silicon dioxide	decreases methylation	ISO	RGD:1602201	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased methylation of SYDE1 gene	PMID:34973136
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1602201	E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SYDE1 mRNA	PMID:34973136
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SYDE1 mRNA	PMID:34492290
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1553533	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of SYDE1 mRNA	PMID:28329830
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SYDE1 mRNA	PMID:25181051
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:33234	vitamin E	increases expression	ISO	RGD:1602201	E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SYDE1 mRNA	PMID:19244175
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1553533	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SYDE1 mRNA	PMID:38685157
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SYDE1 mRNA	PMID:21266533
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SYDE1 mRNA	PMID:26472689
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:38689	fonofos	increases methylation	ISO	RGD:1602201	E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of SYDE1 promoter	PMID:22847954
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:38960	terbufos	increases methylation	ISO	RGD:1602201	E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of SYDE1 promoter	PMID:22847954
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1602201	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SYDE1 mRNA	PMID:25979313
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYDE1 mRNA	PMID:23179753|PMID:26272509|PMID:29154799
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1602201	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SYDE1 gene	PMID:29154799
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1602201	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYDE1 mRNA	PMID:27188386
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SYDE1 mRNA	PMID:30047161
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SYDE1 mRNA	PMID:38832940
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553533	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SYDE1 mRNA	PMID:17562736
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYDE1 mRNA	PMID:29067470
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1602201	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SYDE1 mRNA	PMID:35811015
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1602201	E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SYDE1 mRNA	PMID:32525701
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1602201	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SYDE1 mRNA	PMID:38568856
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553533	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SYDE1 mRNA	PMID:25554681
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SYDE1 mRNA	PMID:30047161
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of SYDE1 mRNA	PMID:28988120
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:72564	temozolomide	increases expression	ISO	RGD:1602201	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SYDE1 mRNA	PMID:31758290
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1553533	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SYDE1 mRNA	PMID:22206623
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:75408	sulindac sulfide	increases expression	ISO	RGD:1602201	E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in increased expression of SYDE1 mRNA	PMID:12734198
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1602201	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of SYDE1 mRNA	PMID:32858204
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of SYDE1 mRNA	PMID:23665939
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1602201	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYDE1 mRNA	PMID:27188386
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SYDE1 mRNA	PMID:23640034
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1553533	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of SYDE1 mRNA	PMID:27029645
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1602201	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SYDE1 mRNA	PMID:32525701
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SYDE1 mRNA	PMID:30047161
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1602201	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYDE1 mRNA	PMID:27188386
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SYDE1 mRNA	PMID:19281266
1305857	Syde1	synapse defective Rho GTPase activating protein 1	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1602201	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SYDE1 mRNA	PMID:29301935
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in decreased expression of CDC42EP3 mRNA	PMID:15894607|PMID:21934132|PMID:33167477
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314141	E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CDC42EP3 mRNA	PMID:23724009
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in decreased expression of CDC42EP3 mRNA	PMID:15894607
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314142	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDC42EP3 mRNA	PMID:30529165
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CDC42EP3 mRNA	PMID:36841081
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CDC42EP3 mRNA	PMID:22378314
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1314141	E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of CDC42EP3 mRNA	PMID:29581250
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314142	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CDC42EP3 mRNA	PMID:39241906
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CDC42EP3 mRNA	PMID:38568856
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CDC42EP3 mRNA	PMID:33387578
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1314141	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CDC42EP3 mRNA	PMID:23649840
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1314141	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of CDC42EP3 mRNA	PMID:17404688|PMID:21795739
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1314142	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of CDC42EP3 mRNA	PMID:22238285
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1314141	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CDC42EP3 mRNA	PMID:21179406
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314141	E	RGD:6480464	20120522	CTD	MESH:D013739	Testosterone results in increased expression of CDC42EP3 mRNA	PMID:21592394
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of CDC42EP3 mRNA	PMID:26496021
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20120522	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CDC42EP3 mRNA	PMID:21592394
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314142	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDC42EP3 mRNA	PMID:34319233
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314141	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CDC42EP3 protein	PMID:37730182
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1314141	E	RGD:6480464	20120522	CTD	MESH:D002117	Calcitriol results in increased expression of CDC42EP3 mRNA	PMID:21592394
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20120522	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CDC42EP3 mRNA	PMID:21592394
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CDC42EP3 mRNA	PMID:33387578
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314141	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CDC42EP3 mRNA	PMID:28818685
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1314141	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CDC42EP3 mRNA	PMID:23649840
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:2504	aflatoxin B1	affects expression	ISO	RGD:1314141	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CDC42EP3 protein	PMID:20106945
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314141	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDC42EP3 mRNA	PMID:27153756
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CDC42EP3 mRNA	PMID:41430723
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CDC42EP3 mRNA	PMID:18593933
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CDC42EP3 mRNA	PMID:31150632
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314142	E	RGD:6480464	20120522	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CDC42EP3 mRNA	PMID:17484886
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CDC42EP3 mRNA	PMID:25629700
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC42EP3 mRNA	PMID:27188386
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CDC42EP3 mRNA	PMID:35897073
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D002945	Cisplatin results in decreased expression of CDC42EP3 mRNA	PMID:22023808
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314141	E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CDC42EP3 mRNA	PMID:27594783
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314142	E	RGD:6480464	20120522	CTD	MESH:D002945	Cisplatin results in increased expression of CDC42EP3 mRNA	PMID:21151649
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1314141	E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of CDC42EP3 mRNA	PMID:26865667
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314142	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC42EP3 mRNA	PMID:21570461
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC42EP3 mRNA	PMID:34747641
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20120522	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC42EP3 mRNA	PMID:19465110
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of CDC42EP3 mRNA	PMID:29955902
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1314141	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CDC42EP3 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28358	rac-lactic acid	increases expression	ISO	RGD:1314141	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CDC42EP3 mRNA	PMID:30851411
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1314141	E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of CDC42EP3 mRNA	PMID:23649840
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314141	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CDC42EP3 mRNA	PMID:32763439
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDC42EP3 mRNA	PMID:29803840
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28794	coumarin	increases phosphorylation	ISO	RGD:1314141	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CDC42EP3 protein	PMID:35688186
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:28876	melphalan	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of CDC42EP3 mRNA	PMID:22363485
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDC42EP3 mRNA	PMID:34032870
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314141	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CDC42EP3 5' UTR; Benzo(a)pyrene results in decreased methylation of CDC42EP3 promoter	PMID:27901495
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314142	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDC42EP3 mRNA	PMID:22228805
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CDC42EP3 mRNA]	PMID:32406909
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CDC42EP3 mRNA	PMID:18593933
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	ISO	RGD:1314141	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CDC42EP3 mRNA	PMID:20382639
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CDC42EP3 mRNA	PMID:15894607
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDC42EP3 gene	PMID:31601247
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314142	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDC42EP3 promoter	PMID:35295148
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314142	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CDC42EP3 gene; titanium dioxide results in increased methylation of CDC42EP3 promoter	PMID:35295148
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314142	E	RGD:6480464	20120522	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CDC42EP3 mRNA	PMID:19710929
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314142	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of CDC42EP3 mRNA	PMID:28329830
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20131210	CTD	MESH:C006780	bisphenol A results in decreased expression of CDC42EP3 mRNA	PMID:23798566
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314141	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CDC42EP3 gene	PMID:31601247
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CDC42EP3 mRNA	PMID:30816183|PMID:32528016|PMID:33296240
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314142	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of CDC42EP3 mRNA	PMID:30951980|PMID:32156529
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CDC42EP3 gene	PMID:28505145
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of CDC42EP3 mRNA	PMID:26496021
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDC42EP3 gene	PMID:31601247
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1314141	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CDC42EP3 mRNA	PMID:25979313
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314142	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CDC42EP3 mRNA	PMID:30951980|PMID:40203079
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314142	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CDC42EP3 mRNA	PMID:30951980
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314142	E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CDC42EP3 mRNA	PMID:21266533
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314141	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC42EP3 mRNA	PMID:37042841
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CDC42EP3 mRNA	PMID:30589522
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CDC42EP3 mRNA	PMID:36928142
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CDC42EP3 mRNA	PMID:38568856
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CDC42EP3 mRNA	PMID:19320972
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314142	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CDC42EP3 mRNA	PMID:40194260
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CDC42EP3 mRNA	PMID:31533062
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314141	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDC42EP3 mRNA	PMID:25979313
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314142	E	RGD:6480464	20120522	CTD	MESH:D014635	Valproic Acid affects the expression of CDC42EP3 mRNA	PMID:17292431
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314141	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of CDC42EP3 mRNA	PMID:28001369
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of CDC42EP3 mRNA	PMID:27989131
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314142	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CDC42EP3 mRNA	PMID:28973697
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CDC42EP3 mRNA	PMID:38832940
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CDC42EP3 mRNA	PMID:24935251|PMID:26272509
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA	PMID:27188386
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314142	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of CDC42EP3 mRNA	PMID:17562736
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314141	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CDC42EP3 mRNA	PMID:21420995
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of CDC42EP3 mRNA	PMID:33725128
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D007654	Ketoconazole results in increased expression of CDC42EP3 mRNA	PMID:28263823
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDC42EP3 mRNA	PMID:22079256
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CDC42EP3 mRNA	PMID:26865667
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314141	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CDC42EP3 mRNA	PMID:26865667
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CDC42EP3 mRNA	PMID:15894607
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CDC42EP3 mRNA; Nanotubes, Carbon results in decreased expression of CDC42EP3 mRNA	PMID:25554681
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of CDC42EP3 mRNA	PMID:21983209
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:6121	ketamine	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of CDC42EP3 mRNA	PMID:20080153
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of CDC42EP3 mRNA	PMID:28801915
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314141	E	RGD:6480464	20120522	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CDC42EP3 mRNA	PMID:15336504
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CDC42EP3 mRNA	PMID:37269647
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of CDC42EP3 mRNA	PMID:36907384
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20120522	CTD	MESH:D007545	Isoproterenol results in decreased expression of CDC42EP3 mRNA	PMID:20003209
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:67895	corosolic acid	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of CDC42EP3 mRNA	PMID:37939859
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CDC42EP3 mRNA	PMID:19564919
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CDC42EP3 mRNA	PMID:22206623
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CDC42EP3 mRNA	PMID:22079256
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDC42EP3 mRNA	PMID:22079256
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:77012	methylseleninic acid	increases expression	ISO	RGD:1314141	E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of CDC42EP3 mRNA	PMID:18548127
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	ISO	RGD:1314141	E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CDC42EP3 mRNA	PMID:30851411
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC42EP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA	PMID:27188386
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314141	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CDC42EP3 mRNA	PMID:19159669
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:81760	difenoconazole	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C115058	difenoconazole results in increased expression of CDC42EP3 mRNA	PMID:28263823
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:81922	flusilazole	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C061365	flusilazole results in increased expression of CDC42EP3 mRNA	PMID:28263823
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of CDC42EP3 mRNA	PMID:35688559
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:8489	propiconazole	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C045950	propiconazole results in increased expression of CDC42EP3 mRNA	PMID:28970091
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CDC42EP3 mRNA	PMID:24780913
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:85990	panobinostat	decreases expression	ISO	RGD:1314141	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of CDC42EP3 mRNA	PMID:26272509
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA	PMID:27188386
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1314141	E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of CDC42EP3 mRNA	PMID:24921660
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314141	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC42EP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA	PMID:27188386
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C032910	triadimefon results in increased expression of CDC42EP3 mRNA	PMID:28263823
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:9986	vinclozolin	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CDC42EP3 mRNA	PMID:19015723
1305858	Cdc42ep3	CDC42 effector protein 3	gene	CHEBI:9986	vinclozolin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CDC42EP3 mRNA	PMID:23555832
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of ELF5 mRNA	PMID:21551480
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of ELF5 mRNA	PMID:25152437
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ELF5 mRNA	PMID:30529165
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ELF5 mRNA	PMID:30517762
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314143	E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of ELF5 mRNA	PMID:24758408
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314143	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of ELF5 mRNA	PMID:19619570
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314144	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of ELF5 mRNA	PMID:19484750
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ELF5 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELF5 mRNA	PMID:26496021|PMID:32741896
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ELF5 mRNA; EGF protein promotes the reaction [Estradiol results in decreased expression of ELF5 mRNA]	PMID:19619570|PMID:24758408
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314144	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ELF5 mRNA	PMID:33711761
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ELF5 mRNA	PMID:33387578
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ELF5 mRNA	PMID:37992649
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELF5 mRNA	PMID:32741896
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1314143	E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ELF5 mRNA	PMID:31256213
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ELF5 mRNA	PMID:37992649
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ELF5 mRNA	PMID:28085963
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:178199	sotorasib	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ELF5 mRNA	PMID:36139627
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:2208	purine-6-thiol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of ELF5 mRNA	PMID:23358152
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1314144	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of ELF5 mRNA	PMID:39984025
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314143	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ELF5 intron	PMID:30157460
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ELF5 mRNA	PMID:30517762
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314143	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ELF5 mRNA	PMID:21867686
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1314143	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ELF5 mRNA	PMID:26272509
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D019833	Genistein results in increased expression of ELF5 mRNA	PMID:23160963
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D019833	[Genistein co-treated with vinclozolin] results in increased expression of ELF5 mRNA	PMID:23160963
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20141223	CTD	MESH:D019833	[Dexamethasone co-treated with Genistein] results in decreased expression of ELF5 mRNA	PMID:25136773
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1314143	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ELF5 mRNA	PMID:24768652|PMID:25583101
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314143	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELF5 mRNA	PMID:19619570
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314144	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELF5 mRNA	PMID:17035482|PMID:24058054|PMID:37172768
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ELF5 mRNA	PMID:19619570
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ELF5 mRNA	PMID:37992649
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELF5 mRNA	PMID:37682722
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314143	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ELF5 5' UTR	PMID:27901495
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314143	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ELF5 promoter	PMID:27901495
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in decreased expression of ELF5 mRNA	PMID:22609695
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:32161	sulfadimethoxine	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ELF5 mRNA	PMID:30047161
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314144	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ELF5 mRNA	PMID:23557971|PMID:35295148
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314144	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ELF5 promoter	PMID:27334623
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ELF5 mRNA	PMID:25181051
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314144	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ELF5 mRNA	PMID:32156529
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ELF5 gene	PMID:28505145
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314144	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ELF5 promoter	PMID:27312807
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ELF5 mRNA	PMID:26496021
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ELF5 mRNA	PMID:26682919
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314144	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ELF5 promoter	PMID:33297965
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1314143	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ELF5 intron	PMID:30157460
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ELF5 mRNA	PMID:26377693
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ELF5 mRNA	PMID:37019170
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1314143	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of ELF5 mRNA	PMID:29024780
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ELF5 mRNA	PMID:24386269
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:3908	coumestrol	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA	PMID:19167446
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314143	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ELF5 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ELF5 mRNA	PMID:30047161
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314143	E	RGD:6480464	20141223	CTD	MESH:D003907	Dexamethasone results in decreased expression of ELF5 mRNA	PMID:25136773
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20141223	CTD	MESH:D003907	[Dexamethasone co-treated with Genistein] results in decreased expression of ELF5 mRNA	PMID:25136773
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1314144	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ELF5 mRNA	PMID:15171707
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ELF5 mRNA	PMID:37992649
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1314143	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ELF5 mRNA	PMID:24935251|PMID:26272509
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314143	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ELF5 mRNA	PMID:25351596
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:49639	mercury dibromide	increases expression	ISO	RGD:1314143	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of ELF5 mRNA	PMID:26272509
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ELF5 mRNA; Nanotubes, Carbon results in decreased expression of ELF5 mRNA	PMID:25554681
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:50667	mercaptopurine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of ELF5 mRNA	PMID:23358152
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ELF5 mRNA	PMID:30047161
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:50692	mifepristone	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20130723	CTD	MESH:D015735	Mifepristone inhibits the reaction [16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in increased expression of ELF5 protein]	PMID:20519331
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ELF5 mRNA	PMID:38701926
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314144	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of ELF5 mRNA	PMID:15003993
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1314144	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of ELF5 mRNA	PMID:36907384
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:64227	ciglitazone	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ELF5 mRNA; [ciglitazone binds to PPARG protein] which results in increased expression of ELF5 mRNA	PMID:16197558
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1314143	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ELF5 intron	PMID:30157460
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:73390	promegestone	increases expression	ISO	RGD:1314143	E	RGD:6480464	20130723	CTD	MESH:D011397	Promegestone results in increased expression of ELF5 protein	PMID:20519331
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of ELF5 mRNA	PMID:27840820
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ELF5 mRNA	PMID:36139627
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELF5 mRNA	PMID:32741896
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ELF5 gene]	PMID:28238834
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in decreased expression of ELF5 mRNA	PMID:26655953
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ELF5 mRNA	PMID:32109520
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:81555	Enterolactone	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA	PMID:19167446
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ELF5 mRNA	PMID:23640034
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ELF5 mRNA	PMID:30047161
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:85990	panobinostat	increases expression	ISO	RGD:1314143	E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of ELF5 mRNA	PMID:26272509
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:85990	panobinostat	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:91108	SB 431542	affects expression	ISO	RGD:1314143	E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide affects the expression of ELF5 mRNA	PMID:25670856
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:91108	SB 431542	decreases methylation	ISO	RGD:1314143	E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased methylation of ELF5 promoter	PMID:25670856
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314143	E	RGD:6480464	20161220	CTD	MESH:C459179	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with BMP4 protein] results in decreased methylation of ELF5 promoter; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:25670856|PMID:27188386
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of ELF5 mRNA	PMID:23358152
1305859	Elf5	E74 like ETS transcription factor 5	gene	CHEBI:9986	vinclozolin	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C025643	[Genistein co-treated with vinclozolin] results in increased expression of ELF5 mRNA	PMID:23160963
1305860	Cd320	CD320 molecule	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CD320 mRNA	PMID:38218311
1305860	Cd320	CD320 molecule	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CD320 mRNA]	PMID:31150632
1305860	Cd320	CD320 molecule	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CD320 mRNA	PMID:33167477
1305860	Cd320	CD320 molecule	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552632	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CD320 mRNA	PMID:39241906
1305860	Cd320	CD320 molecule	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CD320 mRNA	PMID:25510870
1305860	Cd320	CD320 molecule	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1352822	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CD320 mRNA	PMID:37042841
1305860	Cd320	CD320 molecule	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CD320 mRNA	PMID:37992649
1305860	Cd320	CD320 molecule	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1552632	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of CD320 mRNA	PMID:33848595
1305860	Cd320	CD320 molecule	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of CD320 mRNA	PMID:26496021
1305860	Cd320	CD320 molecule	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CD320 mRNA	PMID:37992649
1305860	Cd320	CD320 molecule	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552632	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CD320 mRNA	PMID:33754040
1305860	Cd320	CD320 molecule	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1352822	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD320 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CD320 mRNA	PMID:39836092
1305860	Cd320	CD320 molecule	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CD320 mRNA	PMID:25510870
1305860	Cd320	CD320 molecule	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CD320 mRNA	PMID:25510870
1305860	Cd320	CD320 molecule	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CD320 mRNA	PMID:23649840
1305860	Cd320	CD320 molecule	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CD320 mRNA	PMID:23649840
1305860	Cd320	CD320 molecule	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CD320 mRNA	PMID:34911549
1305860	Cd320	CD320 molecule	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1352822	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of CD320 mRNA	PMID:19774075
1305860	Cd320	CD320 molecule	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CD320 mRNA	PMID:31150632
1305860	Cd320	CD320 molecule	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CD320 mRNA]	PMID:31150632
1305860	Cd320	CD320 molecule	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CD320 mRNA	PMID:22206623
1305860	Cd320	CD320 molecule	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1352822	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD320 mRNA	PMID:39836092
1305860	Cd320	CD320 molecule	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CD320 mRNA	PMID:40504410
1305860	Cd320	CD320 molecule	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CD320 mRNA	PMID:31881176
1305860	Cd320	CD320 molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CD320 mRNA	PMID:22298810|PMID:34747641
1305860	Cd320	CD320 molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552632	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CD320 mRNA	PMID:21570461
1305860	Cd320	CD320 molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CD320 mRNA	PMID:21215274
1305860	Cd320	CD320 molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CD320 mRNA	PMID:33387578
1305860	Cd320	CD320 molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552632	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CD320 mRNA	PMID:19770486
1305860	Cd320	CD320 molecule	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CD320 mRNA	PMID:32763439
1305860	Cd320	CD320 molecule	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1352822	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CD320 mRNA	PMID:20971185
1305860	Cd320	CD320 molecule	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1352822	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of CD320 mRNA	PMID:29803840
1305860	Cd320	CD320 molecule	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1352822	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CD320 mRNA	PMID:29803840
1305860	Cd320	CD320 molecule	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CD320 mRNA	PMID:37992649
1305860	Cd320	CD320 molecule	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CD320 mRNA	PMID:38568856
1305860	Cd320	CD320 molecule	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1352822	E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of CD320 mRNA	PMID:34032870
1305860	Cd320	CD320 molecule	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1352822	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD320 mRNA	PMID:39836092
1305860	Cd320	CD320 molecule	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CD320 mRNA	PMID:40504410
1305860	Cd320	CD320 molecule	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1352822	E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CD320 mRNA	PMID:32234424
1305860	Cd320	CD320 molecule	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552632	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CD320 mRNA	PMID:22228805
1305860	Cd320	CD320 molecule	gene	CHEBI:29866	arsenite(3-)	increases methylation	ISO	RGD:1352822	E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CD320 promoter	PMID:23974009
1305860	Cd320	CD320 molecule	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1352822	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CD320 mRNA	PMID:20971185
1305860	Cd320	CD320 molecule	gene	CHEBI:31206	ammonium chloride	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CD320 mRNA	PMID:16483693
1305860	Cd320	CD320 molecule	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552632	E	RGD:6480464	20131008	CTD	MESH:C009495	titanium dioxide results in increased expression of CD320 mRNA	PMID:23131501
1305860	Cd320	CD320 molecule	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552632	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CD320 mRNA	PMID:28472532
1305860	Cd320	CD320 molecule	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CD320 mRNA	PMID:25181051
1305860	Cd320	CD320 molecule	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CD320 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1305860	Cd320	CD320 molecule	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CD320 mRNA	PMID:25047013
1305860	Cd320	CD320 molecule	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552632	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CD320 mRNA	PMID:26063408
1305860	Cd320	CD320 molecule	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CD320 gene	PMID:28505145
1305860	Cd320	CD320 molecule	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of CD320 mRNA	PMID:26496021
1305860	Cd320	CD320 molecule	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CD320 mRNA	PMID:25510870
1305860	Cd320	CD320 molecule	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CD320 mRNA	PMID:25510870
1305860	Cd320	CD320 molecule	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1552632	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CD320 exon	PMID:33297965
1305860	Cd320	CD320 molecule	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552632	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CD320 mRNA	PMID:37019170
1305860	Cd320	CD320 molecule	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552632	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CD320 mRNA	PMID:17361019|PMID:21266533
1305860	Cd320	CD320 molecule	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of CD320 mRNA	PMID:35163327
1305860	Cd320	CD320 molecule	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1352822	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD320 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CD320 mRNA	PMID:39836092
1305860	Cd320	CD320 molecule	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CD320 mRNA	PMID:30917596
1305860	Cd320	CD320 molecule	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CD320 promoter	PMID:22457795
1305860	Cd320	CD320 molecule	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of CD320 mRNA	PMID:35163327
1305860	Cd320	CD320 molecule	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CD320 mRNA	PMID:31533062
1305860	Cd320	CD320 molecule	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:1352822	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CD320 mRNA	PMID:19167446
1305860	Cd320	CD320 molecule	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CD320 mRNA	PMID:36331819
1305860	Cd320	CD320 molecule	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1352822	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of CD320 mRNA	PMID:23179753
1305860	Cd320	CD320 molecule	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CD320 mRNA	PMID:25562108
1305860	Cd320	CD320 molecule	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552632	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CD320 mRNA	PMID:17555576
1305860	Cd320	CD320 molecule	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CD320 mRNA	PMID:37992649
1305860	Cd320	CD320 molecule	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1352822	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CD320 mRNA	PMID:38832940
1305860	Cd320	CD320 molecule	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CD320 mRNA	PMID:33387578
1305860	Cd320	CD320 molecule	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1352822	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD320 mRNA	PMID:39836092
1305860	Cd320	CD320 molecule	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CD320 mRNA	PMID:40504410
1305860	Cd320	CD320 molecule	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552632	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CD320 mRNA	PMID:17555576
1305860	Cd320	CD320 molecule	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552632	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CD320 mRNA	PMID:25554681
1305860	Cd320	CD320 molecule	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CD320 mRNA	PMID:24136188
1305860	Cd320	CD320 molecule	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1352822	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD320 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CD320 mRNA	PMID:39836092
1305860	Cd320	CD320 molecule	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552632	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CD320 mRNA	PMID:23650126
1305860	Cd320	CD320 molecule	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CD320 mRNA	PMID:15336504
1305860	Cd320	CD320 molecule	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552632	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CD320 mRNA	PMID:22206623
1305860	Cd320	CD320 molecule	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552632	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of CD320 mRNA	PMID:39847705
1305860	Cd320	CD320 molecule	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CD320 mRNA	PMID:21346803
1305860	Cd320	CD320 molecule	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1352822	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CD320 mRNA	PMID:38568856
1305860	Cd320	CD320 molecule	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CD320 mRNA	PMID:21346803
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1353271	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of HNRNPLL mRNA	PMID:38218311
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1552104	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of HNRNPLL mRNA	PMID:33045310
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1353271	E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of HNRNPLL mRNA	PMID:33167477
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552104	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of HNRNPLL mRNA	PMID:30529165
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:15767	dichloromethane	increases expression	ISO	RGD:1353271	E	RGD:6480464	20120412	CTD	MESH:D008752	Methylene Chloride results in increased expression of HNRNPLL mRNA	PMID:20359517
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:16101	ethylbenzene	increases expression	ISO	RGD:1353271	E	RGD:6480464	20120412	CTD	MESH:C004912	ethylbenzene results in increased expression of HNRNPLL mRNA	PMID:20359517
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552104	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of HNRNPLL mRNA	PMID:30319688
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:16243	quercetin	decreases phosphorylation	ISO	RGD:1353271	E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of HNRNPLL protein	PMID:35688186
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552104	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HNRNPLL mRNA	PMID:39241906
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552104	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of HNRNPLL mRNA	PMID:39298647
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HNRNPLL mRNA	PMID:33387578
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1353271	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of HNRNPLL mRNA	PMID:20359517
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1353271	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HNRNPLL mRNA	PMID:37042841
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1353271	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of HNRNPLL mRNA	PMID:20359517
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1353271	E	RGD:6480464	20120412	CTD	MESH:D014050	Toluene results in increased expression of HNRNPLL mRNA	PMID:20359517
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1552104	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of HNRNPLL mRNA	PMID:17997037
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1353271	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of HNRNPLL protein	PMID:37730182
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HNRNPLL mRNA	PMID:33387578
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1552104	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of HNRNPLL mRNA	PMID:17997037
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1353271	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HNRNPLL mRNA	PMID:35301059
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552104	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HNRNPLL mRNA	PMID:37236586
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	ISO	RGD:1353271	E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HNRNPLL protein	PMID:23301498
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of HNRNPLL protein	PMID:33236894
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552104	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HNRNPLL mRNA	PMID:19770486
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552104	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HNRNPLL mRNA	PMID:22206623
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1353271	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of HNRNPLL protein	PMID:35688186
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C059514	resveratrol results in decreased expression of HNRNPLL mRNA	PMID:25905778
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:28063	o-xylene	increases expression	ISO	RGD:1353271	E	RGD:6480464	20120412	CTD	MESH:C026114	2-xylene results in increased expression of HNRNPLL mRNA	PMID:20359517
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552104	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HNRNPLL mRNA	PMID:21570461
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HNRNPLL mRNA	PMID:21215274|PMID:33387578
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552104	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HNRNPLL mRNA	PMID:17942748
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1353271	E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of HNRNPLL protein	PMID:39603559
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1353271	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of HNRNPLL protein	PMID:35688186
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1353271	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of HNRNPLL mRNA	PMID:28595984
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1353271	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HNRNPLL mRNA	PMID:38568856
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552104	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HNRNPLL mRNA	PMID:19770486|PMID:22228805
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552104	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HNRNPLL gene; titanium dioxide results in decreased methylation of HNRNPLL promoter	PMID:35295148
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552104	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HNRNPLL gene	PMID:35295148
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HNRNPLL mRNA	PMID:34492290
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of HNRNPLL mRNA	PMID:19167457
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C006780	bisphenol A results in decreased expression of HNRNPLL mRNA	PMID:25181051|PMID:41034487
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of HNRNPLL mRNA	PMID:30816183
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552104	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of HNRNPLL mRNA	PMID:33221593
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HNRNPLL mRNA	PMID:36041667
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1353271	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of HNRNPLL gene	PMID:31601247
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HNRNPLL mRNA	PMID:36041667
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HNRNPLL mRNA	PMID:36041667
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1552104	E	RGD:6480464	20180703	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of HNRNPLL mRNA	PMID:21404309
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1353271	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HNRNPLL mRNA	PMID:35301059
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552104	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HNRNPLL mRNA	PMID:37236586
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1353271	E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of HNRNPLL mRNA	PMID:25812627
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1353271	E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HNRNPLL mRNA	PMID:25812627
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1353271	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HNRNPLL mRNA	PMID:25979313
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1353271	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of HNRNPLL mRNA	PMID:23179753|PMID:27188386
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1353271	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HNRNPLL gene	PMID:29154799
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1552104	E	RGD:6480464	20151013	CTD	MESH:D003907	Dexamethasone results in increased expression of HNRNPLL mRNA	PMID:22733784
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1353271	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of HNRNPLL mRNA	PMID:24935251|PMID:26272509
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1353271	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HNRNPLL mRNA	PMID:27188386
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of HNRNPLL mRNA	PMID:33387578
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1552104	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of HNRNPLL mRNA	PMID:30529165
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of HNRNPLL mRNA	PMID:29391264
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1353271	E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of HNRNPLL mRNA	PMID:40706910
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552104	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of HNRNPLL mRNA	PMID:17942748
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552104	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HNRNPLL mRNA	PMID:17942748
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552104	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of HNRNPLL mRNA	PMID:25554681|PMID:25620056
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:5062	finasteride	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of HNRNPLL mRNA	PMID:24136188
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1353271	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of HNRNPLL mRNA	PMID:20977926
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552104	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of HNRNPLL mRNA	PMID:19042947
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1353271	E	RGD:6480464	20151013	CTD	MESH:D010081	Oxazolone results in increased expression of HNRNPLL mRNA	PMID:23999411
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1552104	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in increased expression of HNRNPLL mRNA	PMID:21404309
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1552104	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of HNRNPLL mRNA	PMID:21404309
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:6078	ivermectin	decreases expression	ISO	RGD:1353271	E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HNRNPLL protein	PMID:32959892
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of HNRNPLL mRNA	PMID:28801915
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1552104	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of HNRNPLL protein	PMID:26558463
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552104	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HNRNPLL mRNA	PMID:22206623
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552104	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HNRNPLL mRNA	PMID:22206623
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:747377	LDN-193189	multiple interactions	ISO	RGD:1353271	E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of HNRNPLL protein	PMID:37664457
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1353271	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HNRNPLL mRNA	PMID:27188386
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1353271	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of HNRNPLL mRNA	PMID:31734321
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1353271	E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of HNRNPLL protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HNRNPLL mRNA	PMID:27188386|PMID:37664457
1305861	Hnrnpll	heterogeneous nuclear ribonucleoprotein L-like	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of HNRNPLL mRNA	PMID:21346803
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552901	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TMEM63B mRNA	PMID:33045310
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TMEM63B mRNA]	PMID:31150632
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20130423	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of TMEM63B mRNA]	PMID:19467301
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552901	E	RGD:6480464	20130423	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TMEM63B mRNA	PMID:20188158
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314147	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TMEM63B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TMEM63B mRNA	PMID:32699268
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552901	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TMEM63B mRNA	PMID:30319688
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552901	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TMEM63B mRNA	PMID:39298647
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1314147	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of TMEM63B mRNA	PMID:38568856
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM63B mRNA	PMID:33387578
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314147	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TMEM63B protein	PMID:37730182
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMEM63B mRNA	PMID:36331819
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314147	E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TMEM63B mRNA	PMID:35301059
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM63B mRNA	PMID:37236586
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314147	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TMEM63B gene	PMID:27153756
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314147	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TMEM63B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TMEM63B mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TMEM63B mRNA	PMID:32699268
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM63B mRNA	PMID:31150632
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TMEM63B mRNA]	PMID:31150632
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1552901	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of TMEM63B mRNA	PMID:25629700
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM63B mRNA	PMID:22206623
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1314147	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM63B gene	PMID:25304211
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1314147	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of TMEM63B mRNA	PMID:38460933
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1314147	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of TMEM63B mRNA	PMID:38460933
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314147	E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TMEM63B mRNA	PMID:27392435
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314147	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TMEM63B mRNA	PMID:27392435
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552901	E	RGD:6480464	20130423	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM63B mRNA	PMID:21570461
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM63B mRNA	PMID:33387578
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314147	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TMEM63B mRNA	PMID:33212167
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1314147	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM63B mRNA	PMID:32763439
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314147	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TMEM63B mRNA	PMID:29803840
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20130423	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMEM63B mRNA	PMID:22228805
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314147	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMEM63B 5' UTR	PMID:27901495
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TMEM63B mRNA	PMID:29264374
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552901	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM63B gene	PMID:35295148
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:32497	thioacetamide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TMEM63B mRNA	PMID:34492290
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TMEM63B mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM63B mRNA	PMID:26063408
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314147	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TMEM63B gene	PMID:31601247
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552901	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM63B mRNA	PMID:35479511
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TMEM63B mRNA	PMID:39298647
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1552901	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of TMEM63B exon	PMID:33297965
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552901	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TMEM63B mRNA	PMID:38685157
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1552901	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of TMEM63B mRNA	PMID:34813904
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1552901	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of TMEM63B mRNA	PMID:34813904
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314147	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMEM63B mRNA	PMID:37042841
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314147	E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TMEM63B mRNA	PMID:35301059
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM63B mRNA	PMID:37236586
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TMEM63B mRNA	PMID:28903501
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314147	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TMEM63B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TMEM63B mRNA	PMID:32699268
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMEM63B mRNA	PMID:36331819
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552901	E	RGD:6480464	20130423	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM63B mRNA	PMID:17292431
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314147	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TMEM63B gene	PMID:29154799
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM63B mRNA	PMID:33387578
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314147	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM63B mRNA	PMID:22230336
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:46742	Nutlin-3	increases expression	ISO	RGD:1314147	E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of TMEM63B mRNA	PMID:38460933
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1314147	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of TMEM63B mRNA	PMID:38460933
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1314147	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM63B gene	PMID:25304211
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TMEM63B mRNA	PMID:29391264
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TMEM63B mRNA	PMID:35436446
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TMEM63B mRNA; Nanotubes, Carbon results in decreased expression of TMEM63B mRNA	PMID:25554681|PMID:25620056
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM63B mRNA	PMID:22206623
1305862	Tmem63b	transmembrane protein 63B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TMEM63B mRNA	PMID:21394737
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:10429	beta-lapachone	increases expression	ISO	RGD:1351698	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KLHL21 mRNA	PMID:38218311
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of KLHL21 mRNA	PMID:25152437
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KLHL21 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KLHL21 mRNA	PMID:32699268
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:16240	hydrogen peroxide	affects expression	ISO	RGD:1351698	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of KLHL21 mRNA	PMID:20044591
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1351698	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of KLHL21 mRNA	PMID:21632981
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of KLHL21 mRNA	PMID:35811015
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1351698	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of KLHL21 mRNA	PMID:22574217
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1616516	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of KLHL21 mRNA	PMID:39298647
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1351698	E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of KLHL21 mRNA	PMID:23019147|PMID:31614463
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1351698	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of KLHL21 mRNA	PMID:38568856
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KLHL21 mRNA	PMID:33387578
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:174733	Licochalcone B	increases expression	ISO	RGD:1351698	E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of KLHL21 mRNA	PMID:33647349
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1616516	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KLHL21 mRNA	PMID:34319233
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of KLHL21 mRNA	PMID:33387578
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1351698	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KLHL21 mRNA	PMID:28818685
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL21 mRNA	PMID:39836092
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1351698	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KLHL21 mRNA	PMID:19549813
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of KLHL21 mRNA	PMID:33354967
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1351698	E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KLHL21 mRNA	PMID:22100608
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1351698	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KLHL21 mRNA	PMID:23649840
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KLHL21 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KLHL21 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of KLHL21 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of KLHL21 mRNA	PMID:32699268|PMID:35430440
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of KLHL21 mRNA	PMID:18593933
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1616516	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KLHL21 mRNA	PMID:31919559
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1616516	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KLHL21 mRNA	PMID:25629700
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616516	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KLHL21 mRNA	PMID:22206623
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1351698	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KLHL21 gene	PMID:25304211
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL21 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of KLHL21 mRNA	PMID:32525701|PMID:39836092
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1616516	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL21 mRNA	PMID:40504410
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1351698	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of KLHL21 mRNA	PMID:26272509
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA	PMID:27188386
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in decreased expression of KLHL21 mRNA	PMID:21858171
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1616516	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of KLHL21 mRNA	PMID:34813904
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1616516	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLHL21 mRNA	PMID:21570461
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1616516	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to KLHL21 promoter]	PMID:19654925
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1351698	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KLHL21 mRNA	PMID:28001369
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1351698	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of KLHL21 mRNA	PMID:33212167
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA	PMID:27188386
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1351698	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of KLHL21 mRNA	PMID:32763439
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KLHL21 mRNA	PMID:29432896
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:29021	hexane	decreases methylation	EXP		E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of KLHL21 promoter	PMID:23740543
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1351698	E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of KLHL21 gene	PMID:28589171
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1351698	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KLHL21 mRNA	PMID:38568856
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1616516	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of KLHL21 mRNA	PMID:36209798
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL21 mRNA	PMID:39836092
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1616516	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL21 mRNA	PMID:40504410
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1351698	E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLHL21 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1616516	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLHL21 mRNA	PMID:21569818|PMID:22228805
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of KLHL21 mRNA	PMID:18593933
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1351698	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of KLHL21 mRNA	PMID:26014281
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1616516	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of KLHL21 mRNA	PMID:27131904
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1351698	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of KLHL21 mRNA	PMID:25895662
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1351698	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KLHL21 mRNA	PMID:19150397
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1351698	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of KLHL21 mRNA	PMID:27829220
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1616516	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KLHL21 gene	PMID:35295148
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of KLHL21 mRNA	PMID:34492290
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1616516	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of KLHL21 mRNA	PMID:28329830
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:33128	C60 fullerene	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of KLHL21 mRNA	PMID:19167457
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of KLHL21 mRNA	PMID:25181051
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1351698	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of KLHL21 mRNA	PMID:30903817
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1616516	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of KLHL21 promoter	PMID:27312807
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in increased expression of KLHL21 mRNA	PMID:27178563|PMID:34947998
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1616516	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of KLHL21 mRNA	PMID:33221593
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1616516	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of KLHL21 mRNA	PMID:39298647
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:34575	bisphenol F	decreases methylation	ISO	RGD:1351698	E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in decreased methylation of KLHL21 gene	PMID:31601247
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1616516	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of KLHL21 mRNA	PMID:38685157
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1616516	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of KLHL21 mRNA	PMID:31558096
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1616516	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of KLHL21 mRNA	PMID:34813904
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1616516	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of KLHL21 mRNA	PMID:34813904
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1351698	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KLHL21 mRNA	PMID:37042841
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL21 mRNA	PMID:39836092
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1351698	E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of KLHL21 mRNA	PMID:36326898
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of KLHL21 mRNA	PMID:24386269
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1351698	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of KLHL21 mRNA	PMID:19320972
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1616516	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of KLHL21 mRNA	PMID:18353800
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KLHL21 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KLHL21 mRNA	PMID:32699268
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1616516	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of KLHL21 mRNA	PMID:17585979
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1616516	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of KLHL21 mRNA	PMID:39529242
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1351698	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of KLHL21 mRNA	PMID:40419075
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:39483	sodium dichromate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of KLHL21 mRNA	PMID:22110744
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1351698	E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in increased expression of KLHL21 mRNA	PMID:17685462
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1351698	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in increased expression of KLHL21 mRNA	PMID:17198877
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1351698	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLHL21 mRNA	PMID:25979313
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1351698	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of KLHL21 mRNA	PMID:26272509
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA	PMID:27188386
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1351698	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KLHL21 mRNA	PMID:20106945|PMID:25562108
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1351698	E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of KLHL21 mRNA	PMID:24657277
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1351698	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KLHL21 mRNA	PMID:38832940
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1351698	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of KLHL21 mRNA	PMID:24935251|PMID:26272509
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA	PMID:27188386
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1616516	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KLHL21 mRNA	PMID:17562736
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KLHL21 mRNA	PMID:33387578
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1351698	E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of KLHL21 mRNA	PMID:21420995|PMID:22230336
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of KLHL21 mRNA	PMID:35811015
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1351698	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KLHL21 gene	PMID:25304211
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL21 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of KLHL21 mRNA	PMID:32525701|PMID:39836092
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1616516	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL21 mRNA	PMID:40504410
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1351698	E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of KLHL21 mRNA	PMID:31838189
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KLHL21 mRNA	PMID:29391264
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of KLHL21 mRNA	PMID:22079256
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1616516	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of KLHL21 mRNA	PMID:35436446
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:1351698	E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of KLHL21 mRNA	PMID:38568856
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA	PMID:27188386
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1351698	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of KLHL21 mRNA	PMID:27829220
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1616516	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KLHL21 mRNA; Nanotubes, Carbon results in decreased expression of KLHL21 mRNA	PMID:25554681
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KLHL21 mRNA	PMID:24136188
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLHL21 mRNA	PMID:39836092
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1351698	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of KLHL21 mRNA	PMID:28988120
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1616516	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in increased expression of KLHL21 mRNA	PMID:36914120
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1616516	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KLHL21 mRNA	PMID:22206623
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1351698	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of KLHL21 mRNA	PMID:22079256
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of KLHL21 mRNA	PMID:22079256
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:75408	sulindac sulfide	increases expression	ISO	RGD:1351698	E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in increased expression of KLHL21 mRNA	PMID:16184548
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:7789	orphenadrine	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of KLHL21 mRNA	PMID:23665939
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA	PMID:27188386
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1351698	E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of KLHL21 mRNA	PMID:19159669
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1616516	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of KLHL21 mRNA	PMID:19270015
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KLHL21 mRNA	PMID:23640034
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:8249	piroxicam	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in decreased expression of KLHL21 mRNA	PMID:21858171
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of KLHL21 mRNA	PMID:32525701
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	ISO	RGD:1351698	E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of KLHL21 mRNA	PMID:31734321
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1351698	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA	PMID:27188386
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1351698	E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of KLHL21 mRNA	PMID:26014281
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1616516	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of KLHL21 mRNA	PMID:27131904
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1351698	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KLHL21 mRNA	PMID:38568856
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1351698	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of KLHL21 mRNA	PMID:29301935
1305863	Klhl21	kelch-like family member 21	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1616516	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of KLHL21 mRNA	PMID:28973697
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:10429	beta-lapachone	decreases expression	ISO	RGD:1314150	E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of STK32C mRNA	PMID:38218311
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314151	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of STK32C mRNA	PMID:33045310
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:134751	avobenzone	increases expression	ISO	RGD:1314150	E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of STK32C mRNA	PMID:31016361
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314151	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of STK32C mRNA	PMID:36189433
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314151	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STK32C mRNA	PMID:36189433
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:15743	butanal	increases expression	ISO	RGD:1314150	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of STK32C mRNA	PMID:26079696
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314151	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of STK32C mRNA	PMID:30319688
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of STK32C mRNA	PMID:20068009
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314150	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of STK32C mRNA	PMID:31614463
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314150	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of STK32C mRNA	PMID:37042841
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314151	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of STK32C mRNA	PMID:36189433
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314151	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STK32C mRNA	PMID:36189433
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314150	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of STK32C mRNA	PMID:31163220
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314151	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of STK32C mRNA	PMID:34319233
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:17833	gentamycin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of STK32C mRNA	PMID:33387578
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1314150	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of STK32C mRNA	PMID:28818685
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1314150	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of STK32C intron	PMID:30157460
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1314150	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of STK32C polyA tail	PMID:30157460
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314150	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of STK32C intron; Aflatoxin B1 results in increased methylation of STK32C polyA tail	PMID:30157460
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:27732	caffeine	decreases phosphorylation	ISO	RGD:1314150	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of STK32C protein	PMID:35688186
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of STK32C mRNA	PMID:31881176
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314151	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STK32C mRNA	PMID:24680724
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of STK32C mRNA	PMID:17942748
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of STK32C mRNA	PMID:28959563
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1314151	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of STK32C mRNA	PMID:30807115
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314150	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of STK32C mRNA	PMID:32763439
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314150	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of STK32C mRNA	PMID:38568856
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314151	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of STK32C mRNA	PMID:37682722
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314150	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STK32C intron; Benzo(a)pyrene affects the methylation of STK32C polyA tail	PMID:30157460
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314150	E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STK32C protein	PMID:32717239
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314150	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STK32C promoter	PMID:27901495
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314151	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STK32C 5' UTR; Benzo(a)pyrene results in increased methylation of STK32C exon; Benzo(a)pyrene results in increased methylation of STK32C intron	PMID:27901495
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:30537	triphenylstannane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of STK32C mRNA	PMID:38458666
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314151	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of STK32C mRNA	PMID:29341224
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314150	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of STK32C gene	PMID:31601247
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:31767	lead diacetate	affects expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C008261	lead acetate affects the expression of STK32C protein	PMID:36539177
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STK32C gene; titanium dioxide results in decreased methylation of STK32C promoter	PMID:35295148
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of STK32C gene	PMID:35295148
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of STK32C mRNA	PMID:18648102
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of STK32C mRNA	PMID:19710929
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STK32C mRNA	PMID:25181051
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314150	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of STK32C gene	PMID:31601247
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of STK32C gene	PMID:28505145
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STK32C mRNA	PMID:36041667
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314150	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of STK32C gene	PMID:31601247
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314151	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of STK32C mRNA	PMID:30951980
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314150	E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of STK32C gene	PMID:31601247
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STK32C mRNA	PMID:36041667
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1314150	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of STK32C intron	PMID:30157460
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	ISO	RGD:1314150	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of STK32C polyA tail	PMID:30157460
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STK32C mRNA	PMID:36041667
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:34698	diethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:35036	fentin chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of STK32C mRNA	PMID:38458666
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314150	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of STK32C mRNA	PMID:38382870
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314150	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STK32C mRNA	PMID:25979313
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1314150	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of STK32C gene	PMID:29154799
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of STK32C mRNA	PMID:17555576
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314150	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of STK32C mRNA	PMID:38832940
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:46024	trichostatin A	affects expression	ISO	RGD:1314150	E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of STK32C mRNA	PMID:28542535
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314150	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STK32C mRNA	PMID:27188386
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STK32C mRNA	PMID:33387578
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:46666	crocidolite asbestos	increases methylation	ISO	RGD:1314150	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased methylation of STK32C gene	PMID:29523930
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:46680	serpentine asbestos	increases methylation	ISO	RGD:1314150	E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of STK32C gene	PMID:29523930
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of STK32C mRNA	PMID:29391264
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314151	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of STK32C mRNA	PMID:35436446
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of STK32C mRNA	PMID:17555576
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of STK32C mRNA	PMID:17942748
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of STK32C mRNA	PMID:30307764
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1314150	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of STK32C intron	PMID:30157460
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:6820	methapyrilene	increases methylation	ISO	RGD:1314150	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of STK32C polyA tail	PMID:30157460
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	ISO	RGD:1314150	E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of STK32C mRNA	PMID:37199045
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314150	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STK32C mRNA	PMID:27188386
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314150	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to STK32C gene]	PMID:28238834
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of STK32C mRNA	PMID:36843608
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314150	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STK32C mRNA	PMID:27188386
1305864	Stk32c	serine/threonine kinase 32C	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of STK32C gene	PMID:31079544
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314153	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZFP451 mRNA	PMID:33045310
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314152	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ZNF451 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ZNF451 mRNA	PMID:32699268
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZNF451 mRNA	PMID:26079696
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:15767	dichloromethane	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20171010	CTD	MESH:D008752	Methylene Chloride results in decreased expression of ZFP451 mRNA	PMID:28392392
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ZFP451 gene	PMID:27618143
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1314152	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ZNF451 mRNA	PMID:23649840
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ZFP451 mRNA	PMID:33754040
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:178012	FR900359	increases phosphorylation	ISO	RGD:1314152	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF451 protein	PMID:37730182
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1314152	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of ZNF451 intron	PMID:30157460
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314153	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZFP451 mRNA	PMID:28111341
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1314152	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ZNF451 mRNA	PMID:23649840
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314152	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZNF451 gene	PMID:27153756
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314153	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZFP451 mRNA	PMID:19770486
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1314152	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNF451 mRNA	PMID:23649840
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314152	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ZNF451 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ZNF451 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ZNF451 mRNA	PMID:32699268
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314152	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF451 mRNA	PMID:39836092
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314152	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF451 mRNA	PMID:23557933
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:28077	rifampicin	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in decreased expression of ZNF451 mRNA	PMID:24552687
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314153	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP451 mRNA	PMID:21570461
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZNF451 mRNA	PMID:28001369
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1314153	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ZFP451 gene	PMID:39894169
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314152	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF451 mRNA	PMID:38568856
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314152	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF451 mRNA	PMID:39836092
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314152	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF451 intron	PMID:30157460
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314153	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFP451 mRNA	PMID:22228805
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF451 mRNA	PMID:20018196
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314153	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZFP451 mRNA	PMID:35676786
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314153	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP451 promoter	PMID:35295148
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZFP451 mRNA	PMID:34492290
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF451 mRNA	PMID:25181051
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ZFP451 mRNA	PMID:38685157
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ZFP451 mRNA	PMID:28392331
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP451 mRNA	PMID:37019170
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314153	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ZFP451 mRNA	PMID:21266533
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ZFP451 mRNA	PMID:34813904
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314152	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF451 mRNA	PMID:37042841
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314153	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZFP451 mRNA	PMID:28111341
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314152	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ZNF451 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ZNF451 mRNA	PMID:32699268
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZNF451 mRNA	PMID:28302478
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:39481	chloroprene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ZFP451 mRNA	PMID:23125180
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314152	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF451 mRNA	PMID:25979313
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF451 mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:28001369
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1314152	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF451 gene	PMID:29154799
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314152	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF451 mRNA	PMID:25562108
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314153	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ZNF451 mRNA	PMID:28973697
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:4357	deguelin	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of ZNF451 mRNA	PMID:33512557
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:4393	(-)-demecolcine	increases expression	ISO	RGD:1314152	E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ZNF451 mRNA	PMID:23649840
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1314152	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ZNF451 mRNA	PMID:24935251
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314153	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZFP451 mRNA	PMID:17562736
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ZNF451 mRNA	PMID:29523930
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314152	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF451 mRNA	PMID:39836092
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1314153	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of ZFP451 mRNA	PMID:31099283
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in decreased expression of ZNF451 protein	PMID:26722802
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ZFP451 mRNA	PMID:29097150
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314153	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZFP451 mRNA	PMID:35676786
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ZFP451 mRNA	PMID:24793618
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:5132	flutamide	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in increased expression of ZFP451 mRNA	PMID:20566332
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ZFP451 mRNA	PMID:23608068
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:6076	itraconazole	increases expression	ISO	RGD:1314153	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of ZFP451 mRNA	PMID:31099283
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1314152	E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ZNF451 mRNA	PMID:28988120
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1314153	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ZFP451 mRNA	PMID:20003209
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:72564	temozolomide	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ZNF451 mRNA	PMID:31758290
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP451 mRNA	PMID:22206623
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:756894	tak-243	affects sumoylation	ISO	RGD:1314152	E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of ZNF451 protein	PMID:31285264
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314152	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF451 gene]	PMID:28238834
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1314152	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of ZNF451 mRNA	PMID:19095052
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:94366	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one	increases expression	ISO	RGD:1314153	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of ZFP451 mRNA	PMID:31099283
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1314152	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF451 mRNA	PMID:38568856
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:9986	vinclozolin	decreases methylation	EXP		E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of ZFP451 gene	PMID:31079544
1305865	Zfp451	zinc finger protein 451	gene	CHEBI:9986	vinclozolin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ZFP451 mRNA	PMID:23034163
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SACK1H mRNA	PMID:37995155
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SACK1H mRNA]	PMID:31150632
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SACK1H mRNA	PMID:30529165
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of SACK1H mRNA	PMID:24763279
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:D004958	Estradiol results in increased expression of SACK1H mRNA	PMID:39298647
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SACK1H mRNA	PMID:34319233
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:178012	FR900359	affects phosphorylation	ISO	RGD:1603342	E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SACK1H protein	PMID:37730182
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1603342	E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of SACK1H mRNA	PMID:26485663
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1603342	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SACK1H mRNA	PMID:28818685
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1603342	E	RGD:6480464	20140408	CTD	MESH:D014284	Triiodothyronine results in increased expression of SACK1H mRNA	PMID:23397585
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:C031293	calcium silicate results in increased expression of SACK1H mRNA	PMID:29279043
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SACK1H mRNA	PMID:19770486
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1603342	E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SACK1H mRNA	PMID:21641981
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	ISO	RGD:1603342	E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of SACK1H protein	PMID:19845377
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SACK1H protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SACK1H protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of SACK1H protein	PMID:38598786
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:27385	tetrachloromethane	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SACK1H mRNA	PMID:31150632
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SACK1H mRNA]	PMID:31150632
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:27563	arsenic atom	affects methylation	ISO	RGD:1603342	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SACK1H gene	PMID:25304211
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:27656	camptothecin	increases expression	ISO	RGD:1603342	E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of SACK1H mRNA	PMID:38460933
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of SACK1H mRNA	PMID:38460933
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:27732	caffeine	affects phosphorylation	ISO	RGD:1603342	E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SACK1H protein	PMID:35688186
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C030686	acetamide results in increased expression of SACK1H mRNA	PMID:31881176
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SACK1H mRNA	PMID:27392435
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1603342	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of SACK1H mRNA	PMID:29955902
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1603342	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SACK1H mRNA	PMID:32763439
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:28794	coumarin	affects phosphorylation	ISO	RGD:1603342	E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of SACK1H protein	PMID:35688186
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SACK1H mRNA	PMID:29432896
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1603342	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SACK1H mRNA	PMID:39719251
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1603342	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SACK1H 3' UTR; Benzo(a)pyrene results in decreased methylation of SACK1H 5' UTR	PMID:27901495
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SACK1H mRNA	PMID:19770486
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1603342	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SACK1H mRNA	PMID:21632981
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1603342	E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of SACK1H mRNA	PMID:38568856
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in increased methylation of SACK1H gene	PMID:35295148
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013853	Thioacetamide results in increased expression of SACK1H mRNA	PMID:34492290
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of SACK1H mRNA	PMID:28329830
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A affects the expression of SACK1H mRNA	PMID:25181051
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in increased expression of SACK1H mRNA	PMID:30816183
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in increased expression of SACK1H mRNA	PMID:32156529|PMID:33221593|PMID:34585602
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1603342	E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of SACK1H mRNA	PMID:36232920
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SACK1H mRNA	PMID:28628672
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:C543008	bisphenol S affects the methylation of SACK1H gene	PMID:31683443
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:C543008	bisphenol S results in decreased methylation of SACK1H exon	PMID:33297965
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:C543008	bisphenol S results in increased expression of SACK1H mRNA	PMID:33297965
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SACK1H mRNA	PMID:28628672
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SACK1H mRNA	PMID:21266533
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:34768	furfural	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of SACK1H protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SACK1H protein	PMID:38598786
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SACK1H mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SACK1H mRNA	PMID:28628672
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of SACK1H mRNA	PMID:32680482
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1603342	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SACK1H mRNA	PMID:37042841
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SACK1H mRNA	PMID:35163327
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1603342	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SACK1H mRNA	PMID:38382870
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SACK1H mRNA	PMID:35163327
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:38658	dicrotophos	increases expression	ISO	RGD:1603342	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SACK1H mRNA	PMID:28302478
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1603342	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SACK1H mRNA	PMID:31533062
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:D014635	Valproic Acid affects the expression of SACK1H mRNA	PMID:17292431
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1603342	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of SACK1H mRNA	PMID:29154799
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1603342	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SACK1H mRNA	PMID:23179753
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1603342	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SACK1H gene	PMID:29154799
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SACK1H mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SACK1H mRNA	PMID:28628672
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:D017313	Fenretinide results in increased expression of SACK1H mRNA	PMID:28973697
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1603342	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SACK1H mRNA	PMID:38832940
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1603342	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SACK1H mRNA	PMID:21420995
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of SACK1H mRNA	PMID:38460933
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:47217	arsane	affects methylation	ISO	RGD:1603342	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SACK1H gene	PMID:25304211
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SACK1H mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SACK1H mRNA	PMID:28628672
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SACK1H mRNA	PMID:25554681
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SACK1H mRNA	PMID:28801915
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SACK1H mRNA	PMID:22206623
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SACK1H mRNA	PMID:25825206
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:9495	thiram	increases expression	ISO	RGD:1603342	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SACK1H mRNA	PMID:38568856
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	ISO	RGD:1603342	E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of SACK1H protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SACK1H protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of SACK1H protein	PMID:38598786
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:C001899	triptolide results in increased expression of SACK1H mRNA	PMID:32835833
1305866	Sack1h	scaffolding CK1 anchoring protein H	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314154	E	RGD:6480464	20260707	CTD	MESH:C080163	trovafloxacin results in increased expression of SACK1H mRNA	PMID:35537566
1305867	Snph	syntaphilin	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314156	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SNPH mRNA	PMID:37995155
1305867	Snph	syntaphilin	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314156	E	RGD:6480464	20130618	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SNPH mRNA	PMID:20188158
1305867	Snph	syntaphilin	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314156	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SNPH mRNA	PMID:30319688
1305867	Snph	syntaphilin	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314156	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of SNPH mRNA	PMID:30319688
1305867	Snph	syntaphilin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314156	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SNPH mRNA	PMID:39241906
1305867	Snph	syntaphilin	gene	CHEBI:16598	DDE	decreases expression	ISO	RGD:1314155	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SNPH mRNA	PMID:38568856
1305867	Snph	syntaphilin	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SNPH mRNA	PMID:33387578
1305867	Snph	syntaphilin	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SNPH gene	PMID:27618143
1305867	Snph	syntaphilin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	ISO	RGD:1314155	E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNPH mRNA	PMID:37042841
1305867	Snph	syntaphilin	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	ISO	RGD:1314155	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of SNPH 3' UTR	PMID:30157460
1305867	Snph	syntaphilin	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	ISO	RGD:1314155	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SNPH intron	PMID:30157460
1305867	Snph	syntaphilin	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1314156	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of SNPH mRNA	PMID:39984025
1305867	Snph	syntaphilin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314155	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SNPH gene	PMID:27153756
1305867	Snph	syntaphilin	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314155	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SNPH exon	PMID:30157460
1305867	Snph	syntaphilin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314156	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNPH mRNA	PMID:22206623
1305867	Snph	syntaphilin	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SNPH mRNA	PMID:31881176
1305867	Snph	syntaphilin	gene	CHEBI:27958	cocaine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of SNPH mRNA	PMID:20187946
1305867	Snph	syntaphilin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNPH mRNA	PMID:33387578
1305867	Snph	syntaphilin	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314155	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SNPH mRNA	PMID:33212167
1305867	Snph	syntaphilin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314155	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNPH mRNA	PMID:29803840
1305867	Snph	syntaphilin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314155	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SNPH 3' UTR; Benzo(a)pyrene affects the methylation of SNPH exon	PMID:30157460
1305867	Snph	syntaphilin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314155	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SNPH promoter	PMID:27901495
1305867	Snph	syntaphilin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314155	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SNPH 3' UTR; Benzo(a)pyrene results in increased methylation of SNPH 5' UTR	PMID:27901495
1305867	Snph	syntaphilin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314156	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNPH gene	PMID:35295148
1305867	Snph	syntaphilin	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314156	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SNPH gene	PMID:35295148
1305867	Snph	syntaphilin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314156	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SNPH mRNA	PMID:18648102
1305867	Snph	syntaphilin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SNPH mRNA	PMID:25181051
1305867	Snph	syntaphilin	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1314155	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SNPH intron	PMID:30157460
1305867	Snph	syntaphilin	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314155	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SNPH mRNA	PMID:37042841
1305867	Snph	syntaphilin	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1314155	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SNPH mRNA	PMID:24449571
1305867	Snph	syntaphilin	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314155	E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SNPH mRNA	PMID:38568856
1305867	Snph	syntaphilin	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1314155	E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SNPH mRNA	PMID:31533062
1305867	Snph	syntaphilin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314155	E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SNPH mRNA	PMID:28001369
1305867	Snph	syntaphilin	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1314155	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SNPH mRNA	PMID:38832940
1305867	Snph	syntaphilin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314156	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of SNPH mRNA	PMID:17562736
1305867	Snph	syntaphilin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNPH mRNA	PMID:33387578
1305867	Snph	syntaphilin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314155	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of SNPH mRNA	PMID:29067470
1305867	Snph	syntaphilin	gene	CHEBI:46557	zoledronic acid	increases expression	ISO	RGD:1314155	E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of SNPH mRNA	PMID:24714768
1305867	Snph	syntaphilin	gene	CHEBI:6820	methapyrilene	decreases methylation	ISO	RGD:1314155	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SNPH intron	PMID:30157460
1305867	Snph	syntaphilin	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SNPH gene	PMID:35440735
1305867	Snph	syntaphilin	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1314156	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SNPH mRNA	PMID:27935865
1305867	Snph	syntaphilin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314156	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNPH mRNA	PMID:22206623
1305867	Snph	syntaphilin	gene	CHEBI:81892	Brodifacoum	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of SNPH protein	PMID:28903499
1305867	Snph	syntaphilin	gene	CHEBI:95077	GSK-J4	increases expression	ISO	RGD:1314155	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SNPH mRNA	PMID:29301935
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1550327	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of ADGRF3 mRNA	PMID:36189433
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550327	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADGRF3 mRNA	PMID:36189433
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ADGRF3 mRNA	PMID:33387578
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550327	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADGRF3 mRNA	PMID:36189433
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1314157	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ADGRF3 mRNA	PMID:28818685
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ADGRF3 mRNA	PMID:23630614
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314157	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ADGRF3 gene	PMID:27153756
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:27856	acetamide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ADGRF3 mRNA	PMID:31881176
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314157	E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ADGRF3 mRNA	PMID:23557933
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314157	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ADGRF3 mRNA	PMID:33212167
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	ISO	RGD:1314157	E	RGD:6480464	20161115	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ADGRF3 gene	PMID:25435355
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:3179	bromobenzene	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ADGRF3 mRNA	PMID:32479839
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550327	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ADGRF3 mRNA	PMID:29264374
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRF3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314157	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ADGRF3 gene	PMID:31601247
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550327	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ADGRF3 mRNA	PMID:40203079
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314157	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADGRF3 mRNA	PMID:37042841
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1550327	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of ADGRF3 mRNA	PMID:28962523
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550327	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADGRF3 mRNA	PMID:40194260
1305868	Adgrf3	adhesion G protein-coupled receptor F3	gene	CHEBI:6842	methoxychlor	affects methylation	EXP		E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ADGRF3 gene	PMID:35440735
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1344717	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of ASXL3 mRNA	PMID:26272509
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1344717	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASXL3 mRNA	PMID:27188386
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1344717	E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ASXL3 mRNA	PMID:26516004
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314159	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of ASXL3 mRNA	PMID:19484750
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314159	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASXL3 mRNA	PMID:25510870
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1314159	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of ASXL3 mRNA	PMID:27462272
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314159	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASXL3 mRNA	PMID:25510870
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314159	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASXL3 mRNA	PMID:25510870
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1344717	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ASXL3 gene	PMID:27153756
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	ISO	RGD:1344717	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ASXL3 mRNA	PMID:26272509
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1344717	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL3 mRNA	PMID:27188386
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of ASXL3 gene	PMID:35440735
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ASXL3 mRNA	PMID:32109520
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1344717	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ASXL3 mRNA	PMID:29803840
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314159	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of ASXL3 mRNA	PMID:36209798
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1344717	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ASXL3 5' UTR; Benzo(a)pyrene results in increased methylation of ASXL3 promoter	PMID:27901495
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314159	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ASXL3 promoter	PMID:35295148
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314159	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ASXL3 mRNA	PMID:35295148
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ASXL3 mRNA	PMID:25181051|PMID:34947998
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1344717	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ASXL3 gene	PMID:31601247
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314159	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of ASXL3 mRNA	PMID:30245210|PMID:35598803
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:3387	carbamazepine	affects expression	ISO	RGD:1344717	E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ASXL3 mRNA	PMID:25979313
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314159	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASXL3 mRNA	PMID:25510870
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314159	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASXL3 mRNA	PMID:25510870
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314159	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ASXL3 gene	PMID:31683443
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314159	E	RGD:6480464	20130618	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ASXL3 mRNA	PMID:21266533
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ASXL3 mRNA	PMID:35163327
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ASXL3 mRNA	PMID:30917596
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ASXL3 mRNA	PMID:35163327
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1344717	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ASXL3 mRNA	PMID:24449571
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314159	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of ASXL3 mRNA	PMID:29038090
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1344717	E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ASXL3 mRNA	PMID:25979313
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1344717	E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ASXL3 mRNA	PMID:23179753
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:39867	valproic acid	decreases methylation	ISO	RGD:1344717	E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ASXL3 gene	PMID:29154799
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1344717	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ASXL3 mRNA	PMID:19101580|PMID:24383497|PMID:24935251|PMID:26272509
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1344717	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL3 mRNA	PMID:27188386
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1344717	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ASXL3 mRNA	PMID:24935251|PMID:26272509
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1344717	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL3 mRNA	PMID:27188386
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314159	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of ASXL3 mRNA	PMID:17562736
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ASXL3 mRNA	PMID:29391264
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:61057	tacrolimus hydrate	decreases expression	ISO	RGD:1314159	E	RGD:6480464	20180828	CTD	MESH:D016559	Tacrolimus results in decreased expression of ASXL3 mRNA	PMID:29362864
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1344717	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ASXL3 mRNA	PMID:24810058
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314159	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of ASXL3 mRNA	PMID:36851058
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1344717	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASXL3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL3 mRNA	PMID:27188386
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ASXL3 mRNA	PMID:32109520
1305869	Asxl3	ASXL transcriptional regulator 3	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1344717	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASXL3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL3 mRNA	PMID:27188386
1305870	Pcdh18	protocadherin 18	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PCDH18 mRNA	PMID:27188386
1305870	Pcdh18	protocadherin 18	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PCDH18 mRNA	PMID:33045310
1305870	Pcdh18	protocadherin 18	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PCDH18 mRNA	PMID:20188158
1305870	Pcdh18	protocadherin 18	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of PCDH18 mRNA	PMID:21934132
1305870	Pcdh18	protocadherin 18	gene	CHEBI:15368	acrolein	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PCDH18 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PCDH18 mRNA	PMID:32699268
1305870	Pcdh18	protocadherin 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PCDH18 mRNA	PMID:35811015
1305870	Pcdh18	protocadherin 18	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDH18 mRNA	PMID:35811015
1305870	Pcdh18	protocadherin 18	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDH18 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of PCDH18 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of PCDH18 mRNA	PMID:20660070|PMID:20823114|PMID:30165855
1305870	Pcdh18	protocadherin 18	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDH18 mRNA	PMID:25549359
1305870	Pcdh18	protocadherin 18	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of PCDH18 mRNA	PMID:20660070
1305870	Pcdh18	protocadherin 18	gene	CHEBI:17059	2-methylcholine	affects expression	ISO	RGD:1314160	E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PCDH18 mRNA	PMID:21179406
1305870	Pcdh18	protocadherin 18	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH18 mRNA	PMID:37992649
1305870	Pcdh18	protocadherin 18	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of PCDH18 mRNA	PMID:22967744
1305870	Pcdh18	protocadherin 18	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH18 mRNA	PMID:37992649
1305870	Pcdh18	protocadherin 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314161	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PCDH18 mRNA	PMID:28085963
1305870	Pcdh18	protocadherin 18	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PCDH18 mRNA	PMID:26577399
1305870	Pcdh18	protocadherin 18	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PCDH18 mRNA	PMID:33387578
1305870	Pcdh18	protocadherin 18	gene	CHEBI:2038	5-azacytidine	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in decreased expression of PCDH18 mRNA	PMID:20823114
1305870	Pcdh18	protocadherin 18	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20260113	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PCDH18 mRNA	PMID:40288432
1305870	Pcdh18	protocadherin 18	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314160	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDH18 gene	PMID:27153756
1305870	Pcdh18	protocadherin 18	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCDH18 mRNA	PMID:32553695
1305870	Pcdh18	protocadherin 18	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of PCDH18 mRNA	PMID:19555225
1305870	Pcdh18	protocadherin 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PCDH18 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PCDH18 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of PCDH18 mRNA	PMID:32699268
1305870	Pcdh18	protocadherin 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PCDH18 mRNA	PMID:34911549
1305870	Pcdh18	protocadherin 18	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCDH18 mRNA	PMID:39836092
1305870	Pcdh18	protocadherin 18	gene	CHEBI:27684	phenylmercury acetate	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PCDH18 mRNA	PMID:26272509
1305870	Pcdh18	protocadherin 18	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1305870	Pcdh18	protocadherin 18	gene	CHEBI:27856	acetamide	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PCDH18 mRNA	PMID:31881176
1305870	Pcdh18	protocadherin 18	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1314161	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of PCDH18 mRNA	PMID:16917069
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDH18 mRNA	PMID:21215274|PMID:33387578|PMID:34747641
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDH18 mRNA	PMID:19933214|PMID:32553695
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of PCDH18 mRNA	PMID:29955902
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314161	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of PCDH18 mRNA	PMID:32937126
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PCDH18 mRNA	PMID:28001369
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of PCDH18 mRNA	PMID:26272509
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PCDH18 mRNA	PMID:28959563
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PCDH18 mRNA	PMID:32763439
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PCDH18 mRNA	PMID:20971185
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDH18 mRNA	PMID:29803840
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDH18 mRNA	PMID:39631538
1305870	Pcdh18	protocadherin 18	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH18 mRNA	PMID:37992649
1305870	Pcdh18	protocadherin 18	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PCDH18 mRNA	PMID:29301061|PMID:34032870
1305870	Pcdh18	protocadherin 18	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCDH18 mRNA	PMID:39836092
1305870	Pcdh18	protocadherin 18	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1314160	E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of PCDH18 mRNA	PMID:22378314
1305870	Pcdh18	protocadherin 18	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120717	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of PCDH18 mRNA; Benzo(a)pyrene results in decreased expression of PCDH18 mRNA	PMID:20713471|PMID:21569818|PMID:32553695
1305870	Pcdh18	protocadherin 18	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314160	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PCDH18 3' UTR	PMID:27901495
1305870	Pcdh18	protocadherin 18	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PCDH18 mRNA	PMID:20971185
1305870	Pcdh18	protocadherin 18	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of PCDH18 gene	PMID:31601247
1305870	Pcdh18	protocadherin 18	gene	CHEBI:31653	glafenine	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of PCDH18 mRNA	PMID:24136188
1305870	Pcdh18	protocadherin 18	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of PCDH18 mRNA	PMID:22613225
1305870	Pcdh18	protocadherin 18	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PCDH18 mRNA	PMID:34492290
1305870	Pcdh18	protocadherin 18	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH18 mRNA	PMID:34947998
1305870	Pcdh18	protocadherin 18	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314160	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PCDH18 gene	PMID:31601247
1305870	Pcdh18	protocadherin 18	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PCDH18 mRNA	PMID:25181051|PMID:30816183
1305870	Pcdh18	protocadherin 18	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314160	E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PCDH18 mRNA	PMID:29275510
1305870	Pcdh18	protocadherin 18	gene	CHEBI:34237	2,4-diaminotoluene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in decreased expression of PCDH18 mRNA	PMID:20713471
1305870	Pcdh18	protocadherin 18	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of PCDH18 mRNA	PMID:20713471
1305870	Pcdh18	protocadherin 18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314161	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PCDH18 mRNA	PMID:30951980
1305870	Pcdh18	protocadherin 18	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314161	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PCDH18 mRNA	PMID:30951980
1305870	Pcdh18	protocadherin 18	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of PCDH18 gene	PMID:31601247
1305870	Pcdh18	protocadherin 18	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PCDH18 mRNA	PMID:20350560
1305870	Pcdh18	protocadherin 18	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of PCDH18 mRNA	PMID:36117858
1305870	Pcdh18	protocadherin 18	gene	CHEBI:35033	triphenyl phosphate	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of PCDH18 mRNA	PMID:30589522
1305870	Pcdh18	protocadherin 18	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PCDH18 mRNA	PMID:25993096
1305870	Pcdh18	protocadherin 18	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314160	E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PCDH18 mRNA	PMID:38382870
1305870	Pcdh18	protocadherin 18	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of PCDH18 mRNA	PMID:26194646
1305870	Pcdh18	protocadherin 18	gene	CHEBI:35842	antirheumatic drug	increases expression	ISO	RGD:1314160	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PCDH18 mRNA	PMID:24449571
1305870	Pcdh18	protocadherin 18	gene	CHEBI:36740	alpha-pinene	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PCDH18 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PCDH18 mRNA	PMID:32699268
1305870	Pcdh18	protocadherin 18	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PCDH18 mRNA	PMID:40194260
1305870	Pcdh18	protocadherin 18	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PCDH18 mRNA	PMID:40419075
1305870	Pcdh18	protocadherin 18	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of PCDH18 mRNA	PMID:23125180
1305870	Pcdh18	protocadherin 18	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDH18 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:27188386
1305870	Pcdh18	protocadherin 18	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PCDH18 mRNA	PMID:30047161
1305870	Pcdh18	protocadherin 18	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of PCDH18 mRNA	PMID:40633821
1305870	Pcdh18	protocadherin 18	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PCDH18 mRNA	PMID:28973697
1305870	Pcdh18	protocadherin 18	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH18 mRNA	PMID:37992649
1305870	Pcdh18	protocadherin 18	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PCDH18 mRNA	PMID:38832940
1305870	Pcdh18	protocadherin 18	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PCDH18 mRNA	PMID:24935251|PMID:26272509
1305870	Pcdh18	protocadherin 18	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1305870	Pcdh18	protocadherin 18	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCDH18 mRNA	PMID:33387578
1305870	Pcdh18	protocadherin 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of PCDH18 mRNA	PMID:33725128
1305870	Pcdh18	protocadherin 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDH18 mRNA	PMID:35811015
1305870	Pcdh18	protocadherin 18	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PCDH18 mRNA	PMID:29279043
1305870	Pcdh18	protocadherin 18	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCDH18 mRNA	PMID:39836092
1305870	Pcdh18	protocadherin 18	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	ISO	RGD:1314160	E	RGD:6480464	20121009	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of PCDH18 mRNA	PMID:22079256
1305870	Pcdh18	protocadherin 18	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PCDH18 mRNA	PMID:22079256
1305870	Pcdh18	protocadherin 18	gene	CHEBI:49639	mercury dibromide	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of PCDH18 mRNA	PMID:26272509
1305870	Pcdh18	protocadherin 18	gene	CHEBI:49639	mercury dibromide	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1305870	Pcdh18	protocadherin 18	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDH18 mRNA	PMID:20823114
1305870	Pcdh18	protocadherin 18	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of PCDH18 mRNA	PMID:23962444
1305870	Pcdh18	protocadherin 18	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of PCDH18 mRNA	PMID:30047161
1305870	Pcdh18	protocadherin 18	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of PCDH18 mRNA	PMID:36117858
1305870	Pcdh18	protocadherin 18	gene	CHEBI:53620	methylisothiazolinone	increases expression	ISO	RGD:1314160	E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of PCDH18 mRNA	PMID:31629900
1305870	Pcdh18	protocadherin 18	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of PCDH18 mRNA	PMID:36851058
1305870	Pcdh18	protocadherin 18	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PCDH18 mRNA	PMID:36907384
1305870	Pcdh18	protocadherin 18	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDH18 mRNA	PMID:20823114
1305870	Pcdh18	protocadherin 18	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PCDH18 mRNA	PMID:22079256
1305870	Pcdh18	protocadherin 18	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PCDH18 mRNA	PMID:22079256
1305870	Pcdh18	protocadherin 18	gene	CHEBI:753051	incobotulinumtoxina	increases expression	ISO	RGD:1314160	E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of PCDH18 mRNA	PMID:29522793
1305870	Pcdh18	protocadherin 18	gene	CHEBI:78492	diallyl trisulfide	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of PCDH18 mRNA	PMID:34995734
1305870	Pcdh18	protocadherin 18	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1305870	Pcdh18	protocadherin 18	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDH18 gene]	PMID:28238834
1305870	Pcdh18	protocadherin 18	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1314160	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of PCDH18 mRNA	PMID:19095052
1305870	Pcdh18	protocadherin 18	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of PCDH18 mRNA	PMID:38995820
1305870	Pcdh18	protocadherin 18	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PCDH18 mRNA	PMID:27935865
1305870	Pcdh18	protocadherin 18	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PCDH18 mRNA	PMID:24780913
1305870	Pcdh18	protocadherin 18	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314160	E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of TNFSF13 mRNA	PMID:25152437
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TNFSF13 mRNA	PMID:20938992
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:15743	butanal	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TNFSF13 mRNA	PMID:26079696
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314162	E	RGD:6480464	20191008	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFSF13 mRNA	PMID:31059760
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314163	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFSF13 mRNA	PMID:21131560
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314162	E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of TNFSF13 mRNA	PMID:31059760
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20161228	CTD	MESH:D008070	Tetrachlorodibenzodioxin promotes the reaction [Lipopolysaccharides results in increased expression of TNFSF13 mRNA]	PMID:21131560
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of TNFSF13 mRNA	PMID:35192832
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TNFSF13 mRNA	PMID:20938992
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of TNFSF13 mRNA	PMID:33448797
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of TNFSF13 mRNA]	PMID:33448797|PMID:37992649
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of TNFSF13 mRNA	PMID:21592394
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of TNFSF13 mRNA	PMID:21592394
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of TNFSF13 mRNA	PMID:33448797
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of TNFSF13 mRNA]	PMID:33448797|PMID:37992649
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TNFSF13 mRNA	PMID:27523638
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of TNFSF13 mRNA	PMID:21592394
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of TNFSF13 mRNA	PMID:21592394
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TNFSF13 mRNA	PMID:33387578
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of TNFSF13 mRNA	PMID:28522335
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of TNFSF13 mRNA	PMID:21120746
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:232141	chlorophyllin	multiple interactions	ISO	RGD:1314162	E	RGD:6480464	20241119	CTD	MESH:C007020	chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of TNFSF13 mRNA]	PMID:19152381
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of TNFSF13 mRNA	PMID:26760959
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1314162	E	RGD:6480464	20210608	CTD	MESH:D009151	Mustard Gas results in increased expression of TNFSF13 mRNA	PMID:33491125
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TNFSF13 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TNFSF13 mRNA	PMID:34911549
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314163	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TNFSF13 mRNA	PMID:17484886
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TNFSF13 mRNA	PMID:20938992
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]	PMID:37992649
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of TNFSF13 mRNA	PMID:19921347
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of TNFSF13 mRNA	PMID:18423122
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNFSF13 mRNA	PMID:21215274|PMID:34747641
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNFSF13 mRNA	PMID:21131560
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314163	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFSF13 mRNA	PMID:21131560
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [Lipopolysaccharides results in increased expression of TNFSF13 mRNA]	PMID:21131560
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TNFSF13 mRNA	PMID:28374803
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314162	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TNFSF13 mRNA	PMID:33212167
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:28619	acrylamide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of TNFSF13 mRNA	PMID:28959563
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20260707	CTD	MESH:D005632	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA	PMID:37992649
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20260707	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]	PMID:37992649
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314162	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TNFSF13 5' UTR	PMID:27901495
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TNFSF13 mRNA	PMID:19770486
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314162	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TNFSF13 promoter	PMID:27901495
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TNFSF13 mRNA	PMID:19152381
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:D001564	chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of TNFSF13 mRNA]	PMID:19152381
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TNFSF13 mRNA; Silicon Dioxide results in decreased expression of TNFSF13 mRNA	PMID:25351596|PMID:25895662
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TNFSF13 mRNA	PMID:22431001
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314163	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TNFSF13 mRNA	PMID:29203145
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314162	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TNFSF13 mRNA	PMID:15761015
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:30966	glycidol	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of TNFSF13 mRNA	PMID:24915197
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TNFSF13 mRNA	PMID:25729387
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TNFSF13 mRNA	PMID:34492290
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TNFSF13 mRNA	PMID:25181051|PMID:34947998
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314163	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TNFSF13 mRNA	PMID:26682919
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TNFSF13 mRNA	PMID:23196670
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TNFSF13 mRNA	PMID:38685157
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20180703	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased expression of TNFSF13 mRNA	PMID:21404309
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314162	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TNFSF13 mRNA	PMID:37042841
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:35559	furan	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of TNFSF13 mRNA	PMID:26194646
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TNFSF13 mRNA	PMID:19376846
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:35842	antirheumatic drug	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TNFSF13 mRNA	PMID:24449571
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:38319	usnic acid	increases expression	ISO	RGD:1314162	E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of TNFSF13 mRNA	PMID:32508146
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314163	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TNFSF13 mRNA	PMID:40194260
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of TNFSF13 mRNA	PMID:33448797
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of TNFSF13 mRNA]	PMID:33448797|PMID:37992649
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TNFSF13 mRNA	PMID:38832940
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1314162	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of TNFSF13 mRNA	PMID:18058816
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314163	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TNFSF13 mRNA	PMID:17562736
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TNFSF13 mRNA	PMID:33387578
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of TNFSF13 mRNA	PMID:31059760
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of TNFSF13 mRNA; [Dietary Carbohydrates co-treated with Acetaminophen] results in increased expression of TNFSF13 mRNA	PMID:17093179|PMID:31059760
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of TNFSF13 mRNA	PMID:18423122|PMID:20003335
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:47426	furosemide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005665	Furosemide affects the expression of TNFSF13 mRNA	PMID:17497460
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TNFSF13 mRNA	PMID:29391264
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314162	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TNFSF13 mRNA	PMID:15761015
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	ISO	RGD:1314162	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TNFSF13 mRNA	PMID:17145863
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314163	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of TNFSF13 mRNA	PMID:40234311
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of TNFSF13 mRNA	PMID:19162173
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of TNFSF13 mRNA]	PMID:33448797
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in decreased expression of TNFSF13 mRNA	PMID:21404309
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:53556	toluene 2,4-diisocyanate	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in decreased expression of TNFSF13 mRNA	PMID:21404309
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:59224	cetrorelix	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20120412	CTD	MESH:C062876	cetrorelix results in decreased expression of TNFSF13 mRNA	PMID:21062912
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:6015	isoflurane	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007530	Isoflurane results in decreased expression of TNFSF13 mRNA	PMID:16978161
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TNFSF13 mRNA	PMID:25729387
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of TNFSF13 mRNA	PMID:19751817
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:6820	methapyrilene	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of TNFSF13 mRNA	PMID:30467583
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:7983	pentobarbital	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010424	Pentobarbital results in decreased expression of TNFSF13 mRNA	PMID:16978161
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314162	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TNFSF13 gene]	PMID:28238834
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:8064	phenformin	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of TNFSF13 mRNA	PMID:31324951
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1314163	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of TNFSF13 mRNA	PMID:18958704
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:8207	(+)-pilocarpine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in decreased expression of TNFSF13 mRNA	PMID:17971868
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of TNFSF13 mRNA	PMID:23640034
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of TNFSF13 mRNA	PMID:39847705
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TNFSF13 mRNA	PMID:24780913|PMID:25825206
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:9195	Soman	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TNFSF13 mRNA	PMID:19281266
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:9495	thiram	decreases expression	ISO	RGD:1314162	E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TNFSF13 mRNA	PMID:38568856
1305871	Tnfsf13	TNF superfamily member 13	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314163	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TNFSF13 mRNA	PMID:35537566
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of NAALAD2 mRNA	PMID:26272509
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA	PMID:27188386
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:132612	monobenzyl phthalate	decreases methylation	ISO	RGD:1314164	E	RGD:6480464	20260303	CTD	MESH:C103325	mono-benzyl phthalate results in decreased methylation of NAALAD2 gene	PMID:35032864
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NAALAD2 mRNA	PMID:21632981
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NAALAD2 mRNA	PMID:39241906
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAALAD2 mRNA]	PMID:39241906
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NAALAD2 mRNA	PMID:33387578
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16602	trichloroethene	decreases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of NAALAD2 gene	PMID:27618143
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16899	D-mannitol	increases expression	ISO	RGD:1314165	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in increased expression of NAALAD2 mRNA	PMID:25270620
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAALAD2 mRNA	PMID:37992649
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAALAD2 mRNA	PMID:37992649
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NAALAD2 mRNA	PMID:31163220
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of NAALAD2 mRNA	PMID:28818685
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:18357	(R)-noradrenaline	decreases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D009638	Norepinephrine results in decreased expression of NAALAD2 mRNA	PMID:14618266
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NAALAD2 mRNA	PMID:19549813
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314164	E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NAALAD2 gene	PMID:27153756
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NAALAD2 mRNA	PMID:34911549
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314165	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of NAALAD2 mRNA	PMID:17484886
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NAALAD2 mRNA	PMID:21867686
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314165	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of NAALAD2 mRNA	PMID:28960355
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of NAALAD2 mRNA	PMID:25583101
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NAALAD2 mRNA	PMID:33387578
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314165	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NAALAD2 mRNA	PMID:28213091
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NAALAD2 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1314164	E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NAALAD2 mRNA	PMID:33212167
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314164	E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of NAALAD2 mRNA	PMID:32763439
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314165	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of NAALAD2 mRNA	PMID:39631538
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAALAD2 mRNA	PMID:37992649
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314165	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of NAALAD2 mRNA	PMID:37682722
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314164	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NAALAD2 promoter	PMID:27901495
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NAALAD2 mRNA	PMID:20106945
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314164	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NAALAD2 5' UTR; Benzo(a)pyrene results in increased methylation of NAALAD2 exon	PMID:27901495
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314165	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of NAALAD2 protein	PMID:37955338
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314164	E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NAALAD2 mRNA	PMID:25351596
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NAALAD2 gene	PMID:31601247
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:31823	mercury dichloride	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20161025	CTD	MESH:D008627	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAALAD2 mRNA	PMID:27188386
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of NAALAD2 mRNA	PMID:41034487
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NAALAD2 gene	PMID:28505145
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NAALAD2 gene	PMID:31601247
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NAALAD2 mRNA	PMID:23626723
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NAALAD2 mRNA	PMID:23626723
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:34911	permethrin	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of NAALAD2 gene	PMID:33148267
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAALAD2 mRNA]	PMID:39241906
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1314164	E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NAALAD2 mRNA	PMID:37042841
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NAALAD2 mRNA	PMID:23626723
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of NAALAD2 protein	PMID:26879310
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314165	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of NAALAD2 mRNA	PMID:17585979
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:38658	dicrotophos	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NAALAD2 mRNA	PMID:28302478
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of NAALAD2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314164	E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of NAALAD2 mRNA	PMID:23179753|PMID:24935251|PMID:27188386
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA	PMID:27188386
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NAALAD2 mRNA	PMID:20106945|PMID:25562108
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314165	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of NAALAD2 mRNA	PMID:17555576
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAALAD2 mRNA	PMID:37992649
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NAALAD2 mRNA	PMID:38832940
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of NAALAD2 mRNA	PMID:24935251|PMID:26272509
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1314164	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of NAALAD2 mRNA	PMID:24935251
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA	PMID:27188386
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of NAALAD2 mRNA	PMID:29067470
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of NAALAD2 mRNA	PMID:29391264
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314165	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NAALAD2 mRNA	PMID:17555576
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314165	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NAALAD2 mRNA	PMID:17942748
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C017690	fenvalerate results in increased expression of NAALAD2 protein	PMID:33656234
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of NAALAD2 gene	PMID:33148267
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of NAALAD2 mRNA	PMID:32858204
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAALAD2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA	PMID:27188386
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:78576	aflatoxin M1	decreases expression	ISO	RGD:1314164	E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of NAALAD2 mRNA	PMID:30928695
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NAALAD2 gene]	PMID:28238834
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NAALAD2 mRNA	PMID:27935865
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAALAD2 mRNA]	PMID:39241906
1305872	Naalad2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:1314164	E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAALAD2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA	PMID:27188386
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of RIN2 mRNA	PMID:21551480
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1314166	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of RIN2 mRNA	PMID:26272509
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:132082	entinostat	multiple interactions	ISO	RGD:1314166	E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIN2 mRNA	PMID:27188386
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of RIN2 mRNA	PMID:33045310
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314167	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RIN2 gene	PMID:20938992
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of RIN2 mRNA	PMID:20488242
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314166	E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of RIN2 mRNA	PMID:21934132|PMID:33167477
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314167	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RIN2 mRNA	PMID:30319688
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314167	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RIN2 mRNA	PMID:30319688
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1314166	E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of RIN2 mRNA	PMID:39709020
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1314166	E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of RIN2 mRNA	PMID:21632981
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RIN2 mRNA	PMID:25890327
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314166	E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RIN2 mRNA	PMID:35811015
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314166	E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of RIN2 mRNA	PMID:31614463
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314167	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of RIN2 mRNA	PMID:29980752
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1314166	E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RIN2 mRNA	PMID:38568856
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16602	trichloroethene	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RIN2 gene	PMID:27618143
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314167	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RIN2 gene	PMID:20938992
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1314166	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RIN2 mRNA	PMID:23649840
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314166	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of RIN2 mRNA	PMID:21592394
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314167	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of RIN2 mRNA	PMID:33848595
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314166	E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of RIN2 mRNA	PMID:21592394
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314167	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of RIN2 mRNA]	PMID:33848595
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1314166	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RIN2 mRNA	PMID:21592394
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1314166	E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of RIN2 mRNA	PMID:21592394
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RIN2 mRNA	PMID:33387578
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:17967	urethane	decreases expression	ISO	RGD:1314166	E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RIN2 mRNA	PMID:28818685
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	ISO	RGD:1314166	E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of RIN2 intron	PMID:30157460
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1314166	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RIN2 mRNA	PMID:39836092
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314167	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of RIN2 mRNA	PMID:18579281
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	ISO	RGD:1314166	E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RIN2 mRNA	PMID:23649840
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	ISO	RGD:1314166	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RIN2 exon	PMID:30157460
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	ISO	RGD:1314166	E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RIN2 intron	PMID:30157460
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	ISO	RGD:1314166	E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RIN2 mRNA	PMID:23649840
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of RIN2 mRNA	PMID:41580963
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RIN2 mRNA	PMID:31150632
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RIN2 mRNA	PMID:31919559
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314166	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RIN2 mRNA	PMID:21867686
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314167	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RIN2 gene	PMID:20938992
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314166	E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RIN2 mRNA	PMID:39836092
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314166	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of RIN2 mRNA	PMID:21603599
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314167	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RIN2 mRNA	PMID:21570461
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RIN2 mRNA	PMID:34747641
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314166	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RIN2 mRNA	PMID:20106945|PMID:21632981
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314166	E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RIN2 mRNA	PMID:28001369
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RIN2 mRNA	PMID:19465457
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314166	E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RIN2 mRNA	PMID:29803840
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:2948	azathioprine	increases expression	ISO	RGD:1314166	E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of RIN2 mRNA	PMID:22623647
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314166	E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RIN2 mRNA	PMID:38568856
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1314167	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of RIN2 gene	PMID:39894169
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314166	E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RIN2 mRNA	PMID:39836092
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1314166	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of RIN2 mRNA	PMID:20106945
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314166	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RIN2 3' UTR; Benzo(a)pyrene affects the methylation of RIN2 intron	PMID:27901495|PMID:30157460
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314166	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RIN2 mRNA	PMID:20064835
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314166	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RIN2 mRNA	PMID:21632981|PMID:22316170
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314167	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RIN2 mRNA	PMID:22228805
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314166	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RIN2 exon; Benzo(a)pyrene results in increased methylation of RIN2 promoter	PMID:27901495
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314167	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RIN2 intron	PMID:27901495
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RIN2 mRNA	PMID:19073995|PMID:33720480
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1314166	E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RIN2 mRNA	PMID:19150397
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:31653	glafenine	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of RIN2 mRNA	PMID:24136188
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RIN2 mRNA	PMID:25729387
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RIN2 mRNA	PMID:30047161
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314167	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RIN2 mRNA	PMID:18301758
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314167	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RIN2 mRNA	PMID:19710929
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RIN2 mRNA	PMID:30816183|PMID:32528016
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314166	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RIN2 gene	PMID:31601247
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RIN2 mRNA	PMID:25181051
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RIN2 gene	PMID:28505145
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314167	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of RIN2 gene	PMID:31683443
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RIN2 mRNA	PMID:39298647
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314167	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of RIN2 exon	PMID:33297965
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of RIN2 mRNA	PMID:26377693
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	ISO	RGD:1314166	E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RIN2 intron	PMID:30157460
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RIN2 mRNA	PMID:21266533
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314167	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RIN2 mRNA	PMID:21266533
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	ISO	RGD:1314166	E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RIN2 mRNA	PMID:29024780
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1314166	E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RIN2 mRNA	PMID:39836092
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314166	E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RIN2 mRNA	PMID:38568856
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1314166	E	RGD:6480464	20130514	CTD	MESH:C018021	cobaltous chloride results in increased expression of RIN2 mRNA	PMID:23052192
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314167	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RIN2 mRNA	PMID:40194260
1305873	Rin2	Ras and Rab interactor 2	gene	CHEBI:38561	fluvastatin	multiple interactions	ISO	RGD:1314166	E	RGD:6480464	20120412	CTD	MESH:C065180	[zoledronic acid co-treated with fluvastatin] results in increased expression of RIN2 mRNA	PMID:16996129
1305873	Rin2	Ras and Rab interactor 2	gene	C